PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Chapman, SJ; Schrader, JM; Uhlenbeck, OC				Chapman, Stephen J.; Schrader, Jared M.; Uhlenbeck, Olke C.			Histidine 66 in Escherichia coli Elongation Factor Tu Selectively Stabilizes Aminoacyl-tRNAs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THERMOPHILUS EF-TU; PROTEIN-BIOSYNTHESIS; CRYSTAL-STRUCTURE; TERNARY COMPLEX; GTP HYDROLYSIS; RIBOSOME; AFFINITY; BINDING; ACID; PHE-TRNA(PHE)	The universally conserved His-66 of elongation factor Tu (EF-Tu) stacks on the side chain of the esterified Phe of Phe-tRNA(Phe). The affinities of eight aminoacyl-tRNAs were differentially destabilized by the introduction of the H66A mutation into Escherichia coli EF-Tu, whereas Ala-tRNA(Ala) and Gly-tRNA(Gly) were unaffected. The H66F and H66W proteins each show a different pattern of binding of 10 different aminoacyl-tRNAs, clearly showing that this position is critical in establishing the specificity of EF-Tu for different esterified amino acids. However, the H66A mutation does not greatly affect the ability of the ternary complex to bind ribosomes, hydrolyze GTP, or form dipeptide, suggesting that this residue does not directly participate in ribosomal decoding. Selective mutation of His-66 may improve the ability of certain unnatural amino acids to be incorporated by the ribosome.	[Chapman, Stephen J.; Schrader, Jared M.; Uhlenbeck, Olke C.] Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA	Northwestern University	Uhlenbeck, OC (corresponding author), 2205 Tech Dr,Hogan 2-100, Evanston, IL 60208 USA.	o-uhlenbeck@northwestern.edu	schrader, jared/H-6580-2019	schrader, jared/0000-0002-5728-5882	National Institutes of Health [GM037552]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037552] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM037552 (to O. C. U.).	ANDERSEN C, 1994, EUR J BIOCHEM, V220, P739, DOI 10.1111/j.1432-1033.1994.tb18674.x; Asahara H, 2005, BIOCHEMISTRY-US, V44, P11254, DOI 10.1021/bi050204y; Asahara H, 2002, P NATL ACAD SCI USA, V99, P3499, DOI 10.1073/pnas.052028599; CHLADEK S, 1985, ANGEW CHEM INT EDIT, V24, P371, DOI 10.1002/anie.198503711; Dale T, 2004, BIOCHEMISTRY-US, V43, P6159, DOI 10.1021/bi036290o; Daviter T, 2003, J MOL BIOL, V332, P689, DOI 10.1016/S0022-2836(03)00947-1; Doi Y, 2007, J AM CHEM SOC, V129, P14458, DOI 10.1021/ja075557u; Guo JT, 2009, ANGEW CHEM INT EDIT, V48, P9148, DOI 10.1002/anie.200904035; JANIAK F, 1990, BIOCHEMISTRY-US, V29, P4268, DOI 10.1021/bi00470a002; KNOWLTON RG, 1980, J MOL BIOL, V139, P721, DOI 10.1016/0022-2836(80)90057-1; LaRiviere FJ, 2001, SCIENCE, V294, P165, DOI 10.1126/science.1064242; Ledoux S, 2008, METHODS, V44, P74, DOI 10.1016/j.ymeth.2007.08.001; Ledoux S, 2008, MOL CELL, V31, P114, DOI 10.1016/j.molcel.2008.04.026; LOUIE A, 1985, BIOCHEMISTRY-US, V24, P6433, DOI 10.1021/bi00344a019; LOUIE A, 1984, J BIOL CHEM, V259, P5010; Miller D L, 1974, Methods Enzymol, V30, P219; Nissen P, 1999, STRUCTURE, V7, P143, DOI 10.1016/S0969-2126(99)80021-5; NISSEN P, 1995, SCIENCE, V270, P1464, DOI 10.1126/science.270.5241.1464; OTT G, 1990, BIOCHIM BIOPHYS ACTA, V1050, P222, DOI 10.1016/0167-4781(90)90170-7; Park HS, 2011, SCIENCE, V333, P1151, DOI 10.1126/science.1207203; POWERS T, 1991, EMBO J, V10, P2203, DOI 10.1002/j.1460-2075.1991.tb07756.x; RAVEL JM, 1967, BIOCHEM BIOPH RES CO, V29, P68, DOI 10.1016/0006-291X(67)90542-6; Roy H, 2007, NUCLEIC ACIDS RES, V35, P3420, DOI 10.1093/nar/gkm211; Sanderson LE, 2007, J MOL BIOL, V368, P119, DOI 10.1016/j.jmb.2007.01.075; Schlosser A, 2001, J BIOMOL STRUCT DYN, V19, P285, DOI 10.1080/07391102.2001.10506739; Schmeing TM, 2009, SCIENCE, V326, P688, DOI 10.1126/science.1179700; Schrader JM, 2011, P NATL ACAD SCI USA, V108, P5215, DOI 10.1073/pnas.1102128108; Schrader JM, 2009, J MOL BIOL, V386, P1255, DOI 10.1016/j.jmb.2009.01.021; Schulman R G, 1974, J Mol Biol, V90, P601; Voorhees RM, 2010, SCIENCE, V330, P835, DOI 10.1126/science.1194460; Vorstenbosch ELH, 2000, J BIOCHEM BIOPH METH, V42, P1, DOI 10.1016/S0165-022X(99)00032-9	31	11	11	3	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					1229	1234		10.1074/jbc.M111.294850	http://dx.doi.org/10.1074/jbc.M111.294850			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22105070	Green Published, hybrid			2022-12-27	WOS:000299170300038
J	Fick, A; Lang, I; Schafer, V; Seher, A; Trebing, J; Weisenberger, D; Wajant, H				Fick, Andrea; Lang, Isabell; Schaefer, Viktoria; Seher, Axel; Trebing, Johannes; Weisenberger, Daniela; Wajant, Harald			Studies of Binding of Tumor Necrosis Factor (TNF)-like Weak Inducer of Apoptosis (TWEAK) to Fibroblast Growth Factor Inducible 14 (Fn14)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; INDUCED CELL-DEATH; SKELETAL-MUSCLE; MULTIPLE PATHWAYS; GENE-EXPRESSION; KAPPA-B; TNF; RECEPTOR; PROLIFERATION; REGENERATION	To perform highly sensitive cellular binding studies with TNF-like weak inducer of apoptosis (TWEAK), we developed a bioluminescent variant of soluble TWEAK (GpL-FLAG-TNC-TWEAK) by fusing it genetically to the C terminus of the luciferase of Gaussia princeps (GpL). Equilibrium binding studies on human (HT1080 and HT29) and murine (Renca and B16) cell lines at 37 degrees C revealed high affinities of human TWEAK from 53 to 112 pM. The dissociation rate constant of the TWEAK-Fn14 interaction was between 0.48 x 10(-3) s(-1) (HT29) and 0.58 x 10(-3) s(-1) (HT1080) for the human molecules, and the association rate constant obtained was 3.3 x 10(6) M-1 s(-1) for both cell lines. It has been shown previously that oligomerization of soluble TWEAK trimers results in enhanced Fn14-mediated activation of the classical NF kappa B pathway. Binding studies with GpL-FLAG-TNC-TWEAK trimers oligomerized by help of a FLAG tag-specific antibody gave no evidence for a major increase in Fn14 occupancy by oligomerized ligand despite strongly enhanced induction of the NF kappa B target IL8. Thus, aggregated complexes of soluble TWEAK and Fn14 have a higher intrinsic activity to stimulate the classical NF kappa B pathway and qualitatively differ from isolated trimeric TWEAK-Fn14 complexes. Furthermore, determination of IL8 induction as a function of occupied activated receptors revealed that the intrinsic capability of TNFR1 to stimulate the classical NF kappa B pathway and IL8 production was similar to 100-fold higher than Fn14. Thus, although similar to 25 activated TNFR1 trimers were sufficient to trigger half-maximal IL8 production, more than 2500 cell-bound oligomerized TWEAK trimers were required to elicit a similar response.	[Fick, Andrea; Lang, Isabell; Schaefer, Viktoria; Seher, Axel; Trebing, Johannes; Weisenberger, Daniela; Wajant, Harald] Univ Hosp Wurzburg, Div Mol Internal Med, Dept Internal Med 2, D-97070 Wurzburg, Germany	University of Wurzburg	Wajant, H (corresponding author), Univ Hosp Wurzburg, Div Mol Internal Med, Dept Internal Med 2, Rontgenring 11, D-97070 Wurzburg, Germany.	harald.wajant@mail.uni-wuerzburg.de	Wajant, Harald/A-3020-2017	Wajant, Harald/0000-0002-2005-3949; Lang, Isabell/0000-0002-6369-4973	Deutsche Forschungsgemeinschaft [Sonderforschungsbereich 487];  [Wa 1025/19-2];  [Wa 1025/21-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); ; 	This work was supported by Deutsche Forschungsgemeinschaft (Sonderforschungsbereich 487, Project B7) and Grants Wa 1025/19-2 and Wa 1025/21-1.	Ando T, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2038; Berg D, 2007, CELL DEATH DIFFER, V14, P2021, DOI 10.1038/sj.cdd.4402213; Bover LC, 2007, J IMMUNOL, V178, P8183, DOI 10.4049/jimmunol.178.12.8183; Chicheportiche Y, 1997, J BIOL CHEM, V272, P32401, DOI 10.1074/jbc.272.51.32401; Desplat-Jego S, 2005, CLIN IMMUNOL, V117, P15, DOI 10.1016/j.clim.2005.06.005; Desplat-Jego S, 2002, J NEUROIMMUNOL, V133, P116, DOI 10.1016/S0165-5728(02)00368-5; Dogra C, 2006, J BIOL CHEM, V281, P10327, DOI 10.1074/jbc.M511131200; Dohi T, 2009, GASTROENTEROLOGY, V136, P912, DOI 10.1053/j.gastro.2008.11.017; Feltham R, 2010, J BIOL CHEM, V285, P17525, DOI 10.1074/jbc.M109.087635; Feng SLY, 2000, AM J PATHOL, V156, P1253, DOI 10.1016/S0002-9440(10)64996-6; Gentle IE, 2011, J BIOL CHEM, V286, P13282, DOI 10.1074/jbc.M110.216226; Girgenrath M, 2006, EMBO J, V25, P5826, DOI 10.1038/sj.emboj.7601441; Grell M, 1998, P NATL ACAD SCI USA, V95, P570, DOI 10.1073/pnas.95.2.570; Hotta K, 2011, KIDNEY INT, V79, P179, DOI 10.1038/ki.2010.379; Jakubowski A, 2005, J CLIN INVEST, V115, P2330, DOI 10.1172/JCI23486; Kamata K, 2006, J IMMUNOL, V177, P6433, DOI 10.4049/jimmunol.177.9.6433; Kawakita T, 2004, BIOCHEM BIOPH RES CO, V318, P726, DOI 10.1016/j.bbrc.2004.04.084; Kim JY, 2011, J CELL SCI, V124, P647, DOI 10.1242/jcs.075770; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Lu JX, 2011, NEPHROLOGY, V16, P426, DOI 10.1111/j.1440-1797.2011.01449.x; Maecker H, 2005, CELL, V123, P931, DOI 10.1016/j.cell.2005.09.022; Michaelson JS, 2009, RESULTS PROBL CELL D, V49, P145, DOI 10.1007/400_2008_18; Mittal A, 2010, J CELL BIOL, V188, P833, DOI 10.1083/jcb.200909117; Mittel A, 2010, AM J PATHOL, V177, P1732, DOI 10.2353/ajpath.2010.100335; Moreno JA, 2009, ATHEROSCLEROSIS, V207, P103, DOI 10.1016/j.atherosclerosis.2009.04.033; Mueller AM, 2005, J NEUROIMMUNOL, V159, P55, DOI 10.1016/j.jneuroim.2004.10.001; Nakayama M, 2003, J IMMUNOL, V170, P341, DOI 10.4049/jimmunol.170.1.341; Nakayama M, 2002, J IMMUNOL, V168, P734, DOI 10.4049/jimmunol.168.2.734; Nakayama M, 2000, J EXP MED, V192, P1373, DOI 10.1084/jem.192.9.1373; Perper SJ, 2006, J IMMUNOL, V177, P2610, DOI 10.4049/jimmunol.177.4.2610; Potrovita I, 2004, J NEUROSCI, V24, P8237, DOI 10.1523/JNEUROSCI.1089-04.2004; Roos C, 2010, J IMMUNOL, V185, P1593, DOI 10.4049/jimmunol.0903555; Schneider P, 1999, EUR J IMMUNOL, V29, P1785, DOI 10.1002/(SICI)1521-4141(199906)29:06<1785::AID-IMMU1785>3.0.CO;2-U; Tannous BA, 2005, MOL THER, V11, P435, DOI 10.1016/j.ymthe.2004.10.016; van Kuijk AWR, 2010, ANN RHEUM DIS, V69, P301, DOI 10.1136/ard.2008.090548; Vince JE, 2008, J CELL BIOL, V182, P171, DOI 10.1083/jcb.200801010; Wicovsky A, 2009, CELL DEATH DIFFER, V16, P1445, DOI 10.1038/cdd.2009.80; Willis AL, 2008, MOL CANCER RES, V6, P725, DOI 10.1158/1541-7786.MCR-08-0005; Wilson CA, 2002, CELL DEATH DIFFER, V9, P1321, DOI 10.1038/sj.cdd.4401107; Winkles JA, 2008, NAT REV DRUG DISCOV, V7, P411, DOI 10.1038/nrd2488; Wyzgol A, 2009, J IMMUNOL, V183, P1851, DOI 10.4049/jimmunol.0802597	41	43	44	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					484	495		10.1074/jbc.M111.287656	http://dx.doi.org/10.1074/jbc.M111.287656			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22081603	Green Published, hybrid			2022-12-27	WOS:000298682400047
J	Hou, XH; Tashima, Y; Stanley, P				Hou, Xinghua; Tashima, Yuko; Stanley, Pamela			Galactose Differentially Modulates Lunatic and Manic Fringe Effects on Delta1-induced NOTCH Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-LIKE REPEATS; O-FUCOSE; GLYCOSYLATION MUTANTS; LIGAND-BINDING; MOUSE NOTCH1; PATHWAY; PROTEIN; GENES; SITES; BETA-4GALACTOSYLTRANSFERASE-1	NOTCH signaling induced by Delta1 (DLL1) and Jagged1 (JAG1) NOTCH ligands is modulated by the beta 3N-acetylglucosaminyl transferase Fringe. LFNG (Lunatic Fringe) and MFNG (Manic Fringe) transfer N-acetylglucosamine (GlcNAc) to O-fucose attached to EGF-like repeats of NOTCH receptors. In co-culture NOTCH signaling assays, LFNG generally enhances DLL1-induced, but inhibits JAG1-induced, NOTCH signaling. In mutant Chinese hamster ovary (CHO) cells that do not add galactose (Gal) to the GlcNAc transferred by Fringe, JAG1-induced NOTCH signaling is not inhibited by LFNG or MFNG. In mouse embryos lacking B4galt1, NOTCH signaling is subtly reduced during somitogenesis. Here we show that DLL1-induced NOTCH signaling in CHO cells was enhanced by LFNG, but this did not occur in either Lec8 or Lec20 CHO mutants lacking Gal on O-fucose glycans. Lec20 mutants corrected with a B4galt1 cDNA became responsive to LFNG. By contrast, MFNG promoted DLL1-induced NOTCH signaling better in the absence of Gal than in its presence. This effect was reversed in Lec8 cells corrected by expression of a UDP-Gal transporter cDNA. The MFNG effect was abolished by a DDD to DDA mutation that inactivates MFNG GlcNAc transferase activity. The binding of soluble NOTCH ligands and NOTCH1/EGF1-36 generally reflected changes in NOTCH signaling caused by LFNG and MFNG. Therefore, the presence of Gal on O-fucose glycans differentially affects DLL1-induced NOTCH signaling modulated by LFNG versus MFNG. Gal enhances the effect of LFNG but inhibits the effect of MFNG on DLL1-induced NOTCH signaling, with functional consequences for regulating the strength of NOTCH signaling.	[Hou, Xinghua; Tashima, Yuko; Stanley, Pamela] Albert Einstein Coll Med, Dept Cell Biol, New York, NY 10461 USA	Yeshiva University	Stanley, P (corresponding author), Albert Einstein Coll Med, Dept Cell Biol, New York, NY 10461 USA.	pamela.stanley@einstein.yu.edu		Stanley, Pamela/0000-0001-5704-3747	National Institutes of Health [RO1 95022]; NCI; Albert Einstein Cancer Center [PO1 13330]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Albert Einstein Cancer Center	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 95022 from the NCI (to P. S.) and Albert Einstein Cancer Center Grant PO1 13330.	Aoki K, 2008, J BIOL CHEM, V283, P30385, DOI 10.1074/jbc.M804925200; Artayanis-Tsakonas S, 2010, CURR TOP DEV BIOL, V92, P1, DOI 10.1016/S0070-2153(10)92001-2; Bolos V, 2007, ENDOCR REV, V28, P339, DOI 10.1210/er.2006-0046; Bruckner K, 2000, NATURE, V406, P411, DOI 10.1038/35019075; Chen JH, 2001, P NATL ACAD SCI USA, V98, P13716, DOI 10.1073/pnas.241398098; Chen JH, 2006, GENE EXPR PATTERNS, V6, P376, DOI 10.1016/j.modgep.2005.09.009; Cohen B, 1997, NAT GENET, V16, P283, DOI 10.1038/ng0797-283; Eckhardt M, 1998, J BIOL CHEM, V273, P20189, DOI 10.1074/jbc.273.32.20189; Evrard YA, 1998, NATURE, V394, P377, DOI 10.1038/28632; Haines N, 2003, NAT REV MOL CELL BIO, V4, P786, DOI 10.1038/nrm1228; Hicks C, 2000, NAT CELL BIOL, V2, P515, DOI 10.1038/35019553; Huppert SS, 2000, NATURE, V405, P966, DOI 10.1038/35016111; Irvine KD, 1997, CURR OPIN CELL BIOL, V9, P867, DOI 10.1016/S0955-0674(97)80090-7; Johnston SH, 1997, DEVELOPMENT, V124, P2245; Koch U, 2010, CURR TOP DEV BIOL, V92, P411, DOI 10.1016/S0070-2153(10)92013-9; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Lee JH, 2001, J BIOL CHEM, V276, P13924, DOI 10.1074/jbc.M010046200; Luther KB, 2009, J BIOL CHEM, V284, P3294, DOI 10.1074/jbc.M805502200; Moloney DJ, 2000, J BIOL CHEM, V275, P9604, DOI 10.1074/jbc.275.13.9604; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; North SJ, 2010, J BIOL CHEM, V285, P5759, DOI 10.1074/jbc.M109.068353; Oelmann S, 2001, J BIOL CHEM, V276, P26291, DOI 10.1074/jbc.M011124200; Okajima T, 2003, J BIOL CHEM, V278, P42340, DOI 10.1074/jbc.M308687200; Panin VM, 1997, NATURE, V387, P908, DOI 10.1038/43191; Rampal R, 2005, J BIOL CHEM, V280, P42454, DOI 10.1074/jbc.M509552200; Rampal R, 2005, J BIOL CHEM, V280, P32133, DOI 10.1074/jbc.M506104200; Rampal R, 2007, CURR MOL MED, V7, P427, DOI 10.2174/156652407780831593; Rana NA, 2011, J BIOL CHEM, V286, P31623, DOI 10.1074/jbc.M111.268243; RUSSO RN, 1990, J BIOL CHEM, V265, P3324; Shao L, 2003, J BIOL CHEM, V278, P7775, DOI 10.1074/jbc.M212221200; Shimizu K, 2001, J BIOL CHEM, V276, P25753, DOI 10.1074/jbc.M103473200; Stahl M, 2008, J BIOL CHEM, V283, P13638, DOI 10.1074/jbc.M802027200; Stanley P, 2010, CURR TOP DEV BIOL, V92, P131, DOI 10.1016/S0070-2153(10)92004-8; Stanley P, 2009, IMMUNOL REV, V230, P201, DOI 10.1111/j.1600-065X.2009.00791.x; Strobl LJ, 1997, IMMUNOBIOLOGY, V198, P299, DOI 10.1016/S0171-2985(97)80050-2; Tan JB, 2009, IMMUNITY, V30, P254, DOI 10.1016/j.immuni.2008.12.016; Visan I, 2006, NAT IMMUNOL, V7, P634, DOI 10.1038/ni1345; Yang LT, 2005, MOL BIOL CELL, V16, P927, DOI 10.1091/mbc.e04-07-0614; Zhang NA, 1998, NATURE, V394, P374, DOI 10.1038/28625	39	28	28	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					474	483		10.1074/jbc.M111.317578	http://dx.doi.org/10.1074/jbc.M111.317578			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22081605	Green Published, hybrid			2022-12-27	WOS:000298682400046
J	Drop, B; Webber-Birungi, M; Fusetti, F; Kouril, R; Redding, KE; Boekema, EJ; Croce, R				Drop, Bartlomiej; Webber-Birungi, Mariam; Fusetti, Fabrizia; Kouril, Roman; Redding, Kevin E.; Boekema, Egbert J.; Croce, Roberta			Photosystem I of Chlamydomonas reinhardtii Contains Nine Light-harvesting Complexes (Lhca) Located on One Side of the Core	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUPRAMOLECULAR ORGANIZATION; ARABIDOPSIS-THALIANA; EXCITATION DYNAMICS; ANGSTROM RESOLUTION; ANTENNA STRUCTURE; PSI; PROTEIN; SUPERCOMPLEX; SUBUNIT; FLUORESCENCE	In this work we have purified the Photosystem I (PSI) complex of Chlamydomonas reinhardtii to homogeneity. Biochemical, proteomic, spectroscopic, and structural analyses reveal the main properties of this PSI-LHCI supercomplex. The data show that the largest purified complex is composed of one core complex and nine Lhca antennas and that it contains all Lhca gene products. A projection map at 15 angstrom resolution obtained by electron microscopy reveals that the Lhcas are organized on one side of the core in a double half-ring arrangement, in contrast with previous suggestions. A series of stable disassembled PSI-LHCI intermediates was purified. The analysis of these complexes suggests the sequence of the assembly/disassembly process. It is shown that PSI-LHCI of C. reinhardtii is larger but far less stable than the complex from higher plants. Lhca2 and Lhca9 (the red-most antenna complexes), although present in the largest complex in 1: 1 ratio with the core, are only loosely associated with it. This can explain the large variation in antenna composition of PSI-LHCI from C. reinhardtii found in the literature. The analysis of several subcomplexes with reduced antenna size allows determination of the position of Lhca2 and Lhca9 and leads to a proposal for a model of the organization of the Lhcas within the PSI-LHCI supercomplex.	[Drop, Bartlomiej; Croce, Roberta] Vrije Univ Amsterdam, Dept Phys & Astron, Fac Sci, NL-1081 HV Amsterdam, Netherlands; [Drop, Bartlomiej; Webber-Birungi, Mariam; Kouril, Roman; Boekema, Egbert J.; Croce, Roberta] Univ Groningen, Groningen Biol Sci & Biotechnol Inst, Dept Biophys Chem, NL-9747 AG Groningen, Netherlands; [Fusetti, Fabrizia] Univ Groningen, Groningen Biol Sci & Biotechnol Inst, Dept Biochem, NL-9747 AG Groningen, Netherlands; [Fusetti, Fabrizia] Univ Groningen, Groningen Biol Sci & Biotechnol Inst, Netherlands Prote Ctr, NL-9747 AG Groningen, Netherlands; [Redding, Kevin E.] Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA	Vrije Universiteit Amsterdam; University of Groningen; University of Groningen; University of Groningen; Arizona State University; Arizona State University-Tempe	Croce, R (corresponding author), Vrije Univ Amsterdam, Dept Phys & Astron, Fac Sci, Boelelaan 1081, NL-1081 HV Amsterdam, Netherlands.	r.croce@vu.nl	Croce, Roberta/F-1174-2014; Croce, Roberta/ABG-3595-2021; Croce, Roberta/HGU-9554-2022; KOUŘIL, Roman/A-9587-2018; Croce, Roberta/N-4067-2014; Birungi, Mariam/F-5509-2012	Croce, Roberta/0000-0003-3469-834X; Croce, Roberta/0000-0003-3469-834X; KOUŘIL, Roman/0000-0001-8211-3348; Croce, Roberta/0000-0003-3469-834X; Webber-Birungi, Mariam/0000-0001-9079-9933; Redding, Kevin/0000-0003-2819-4022	De Nederlandse Organisatie voor Wetenschappelijk Onderzoek, Earth and Life Sciences; National Science Foundation [MCB-1052573]	De Nederlandse Organisatie voor Wetenschappelijk Onderzoek, Earth and Life Sciences(Netherlands Organization for Scientific Research (NWO)); National Science Foundation(National Science Foundation (NSF))	This work was supported by De Nederlandse Organisatie voor Wetenschappelijk Onderzoek, Earth and Life Sciences, through a Vidi grant (to R. C.). Work in the Redding laboratory was supported by National Science Foundation Grant MCB-1052573.	Amunts A, 2008, PLANT PHYSIOL BIOCH, V46, P228, DOI 10.1016/j.plaphy.2007.12.013; Amunts A, 2007, NATURE, V447, P58, DOI 10.1038/nature05687; Amunts A, 2010, J BIOL CHEM, V285, P3478, DOI 10.1074/jbc.M109.072645; Amunts A, 2009, STRUCTURE, V17, P637, DOI 10.1016/j.str.2009.03.006; ARNON DI, 1971, P NATL ACAD SCI USA, V68, P2883, DOI 10.1073/pnas.68.11.2883; BASSI R, 1985, CARLSBERG RES COMMUN, V50, P127, DOI 10.1007/BF02907141; BASSI R, 1992, J BIOL CHEM, V267, P25714; Ben-Shem A, 2004, PHOTOSYNTH RES, V81, P239, DOI 10.1023/B:PRES.0000036881.23512.42; Ben-Shem A, 2003, NATURE, V426, P630, DOI 10.1038/nature02200; Boekema EJ, 1999, EUR J BIOCHEM, V266, P444, DOI 10.1046/j.1432-1327.1999.00876.x; BOEKEMA EJ, 1987, FEBS LETT, V217, P283, DOI 10.1016/0014-5793(87)80679-8; Busch A, 2011, BBA-BIOENERGETICS, V1807, P864, DOI 10.1016/j.bbabio.2010.09.009; Croce R, 2002, BIOCHEMISTRY-US, V41, P7334, DOI 10.1021/bi0257437; Dekker JP, 2005, BBA-BIOENERGETICS, V1706, P12, DOI 10.1016/j.bbabio.2004.09.009; Elrad D, 2004, CURR GENET, V45, P61, DOI 10.1007/s00294-003-0460-x; FARAH J, 1995, EMBO J, V14, P4976, DOI 10.1002/j.1460-2075.1995.tb00180.x; Fischer N, 1999, BIOCHEMISTRY-US, V38, P5546, DOI 10.1021/bi982821a; Fischer N, 1997, BIOCHEMISTRY-US, V36, P93, DOI 10.1021/bi962244v; Fischer N, 1998, EMBO J, V17, P849, DOI 10.1093/emboj/17.4.849; Ganeteg U, 2004, PLANT MOL BIOL, V54, P641, DOI 10.1023/B:PLAN.0000040813.05224.94; Germano M, 2002, FEBS LETT, V525, P121, DOI 10.1016/S0014-5793(02)03100-9; Gibasiewicz K, 2005, J PHYS CHEM B, V109, P21180, DOI 10.1021/jp0530909; GORMAN DS, 1965, P NATL ACAD SCI USA, V54, P1665, DOI 10.1073/pnas.54.6.1665; Gulis G, 2008, PHOTOSYNTH RES, V96, P51, DOI 10.1007/s11120-007-9283-9; Haldrup A, 1999, PLANT J, V17, P689, DOI 10.1046/j.1365-313X.1999.00419.x; Ihalainen JA, 2005, BBA-BIOENERGETICS, V1706, P267, DOI 10.1016/j.bbabio.2004.11.007; Ihalainen JA, 2003, J PHYS CHEM B, V107, P9086, DOI 10.1021/jp034778t; Jansson S, 1999, TRENDS PLANT SCI, V4, P236, DOI 10.1016/S1360-1385(99)01419-3; Jensen PE, 2000, J BIOL CHEM, V275, P24701, DOI 10.1074/jbc.M000550200; Jensen PE, 2003, PHYSIOL PLANTARUM, V119, P313, DOI 10.1034/j.1399-3054.2003.00157.x; Jensen PE, 2007, BBA-BIOENERGETICS, V1767, P335, DOI 10.1016/j.bbabio.2007.03.004; Jordan P, 2001, NATURE, V411, P909, DOI 10.1038/35082000; Kargul J, 2005, FEBS J, V272, P4797, DOI 10.1111/j.1742-4658.2005.04894.x; Kargul J, 2003, J BIOL CHEM, V278, P16135, DOI 10.1074/jbc.M300262200; Kouril R, 2005, BIOCHEMISTRY-US, V44, P10935, DOI 10.1021/bi051097a; LAM E, 1984, PLANT PHYSIOL, V74, P650, DOI 10.1104/pp.74.3.650; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Lucinski R, 2006, FEBS LETT, V580, P6485, DOI 10.1016/j.febslet.2006.10.063; Lunde C, 2000, NATURE, V408, P613, DOI 10.1038/35046121; Melkozernov AN, 2005, PHOTOSYNTH RES, V86, P203, DOI 10.1007/s11120-005-4118-z; Melkozernov AN, 2004, J PHYS CHEM B, V108, P10547, DOI 10.1021/jp049375n; Mozzo M, 2010, BBA-BIOENERGETICS, V1797, P212, DOI 10.1016/j.bbabio.2009.10.005; Naumann B, 2005, J BIOL CHEM, V280, P20431, DOI 10.1074/jbc.M414486200; Nelson N, 2005, BIOESSAYS, V27, P914, DOI 10.1002/bies.20278; Oostergetel GT, 1998, ULTRAMICROSCOPY, V74, P47, DOI 10.1016/S0304-3991(98)00022-9; OWENS TG, 1989, BIOPHYS J, V56, P95, DOI 10.1016/S0006-3495(89)82654-2; OWENS TG, 1988, BIOPHYS J, V53, P733, DOI 10.1016/S0006-3495(88)83154-0; Ozawa S, 2010, J BIOL CHEM, V285, P20072, DOI 10.1074/jbc.M109.098954; PETER GF, 1991, J BIOL CHEM, V266, P16745; Pineau B, 2001, PLANT PHYSIOL BIOCH, V39, P73, DOI 10.1016/S0981-9428(00)01215-8; Romero E, 2009, BIOPHYS J, V96, pL35, DOI 10.1016/j.bpj.2008.11.043; Scheller HV, 2001, BBA-BIOENERGETICS, V1507, P41, DOI 10.1016/S0005-2728(01)00196-7; Stauber EJ, 2009, PROTEOMICS, V9, P398, DOI 10.1002/pmic.200700620; Stauber EJ, 2003, EUKARYOT CELL, V2, P978, DOI 10.1128/EC.2.5.978-994.2003; Storf S, 2005, J BIOL CHEM, V280, P5163, DOI 10.1074/jbc.M411248200; Subramanyam R, 2006, FEBS LETT, V580, P233, DOI 10.1016/j.febslet.2005.12.003; Takahashi Y, 2004, BIOCHEMISTRY-US, V43, P7816, DOI 10.1021/bi035988z; Tokutsu R, 2004, PLANT CELL PHYSIOL, V45, P138, DOI 10.1093/pcp/pch013; van Oort B, 2008, BIOPHYS J, V95, P5851, DOI 10.1529/biophysj.108.140467; Wientjes E, 2011, BIOCHEM J, V433, P477, DOI 10.1042/BJ20101538; Wientjes E, 2009, J BIOL CHEM, V284, P7803, DOI 10.1074/jbc.M808395200; WOLLMAN FA, 1982, BIOCHIM BIOPHYS ACTA, V680, P352, DOI 10.1016/0005-2728(82)90149-9; Zhang SP, 2004, J BIOL CHEM, V279, P3180, DOI 10.1074/jbc.M311640200	63	87	87	0	40	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2011	286	52					44878	44887		10.1074/jbc.M111.301101	http://dx.doi.org/10.1074/jbc.M111.301101			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870CA	22049081	Green Published, Green Submitted, hybrid			2022-12-27	WOS:000298645500056
J	Kurakula, K; van der Wal, E; Geerts, D; van Tiel, CM; de Vries, CJM				Kurakula, Kondababu; van der Wal, Erik; Geerts, Dirk; van Tiel, Claudia M.; de Vries, Carlie J. M.			FHL2 Protein Is a Novel Co-repressor of Nuclear Receptor Nur77	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND-BINDING DOMAIN; SMOOTH-MUSCLE-CELLS; TR3 ORPHAN RECEPTOR; NGFI-B; TRANSCRIPTIONAL REGULATORS; COACTIVATOR RECRUITMENT; LENTIVIRAL VECTORS; EXPRESSION; ACTIVATION; NURR1	The three members of the NR4A orphan nuclear receptor subfamily Nur77, Nurr1, and NOR-1, regulate a variety of biological functions including vascular disease and metabolism. In this study, we identified Four and a half LIM domains protein-2 (FHL2) as a novel interacting protein of NR4A nuclear receptors by yeast two-hybrid screen and co-immunoprecipitation studies. Each of the four LIM domains of FHL2 can bind Nur77, and both the amino-terminal domain and the DNA binding domain of Nur77 are involved in the interaction between FHL2 and Nur77. FHL2 represses Nur77 transcriptional activity in a dose-dependent manner, and short hairpin RNA-mediated knockdown of FHL2 results in increased Nur77 transcriptional activity. ChIP experiments on the enolase3 promoter revealed that FHL2 inhibits the association of Nur77 with DNA. FHL2 is highly expressed in human endothelial and smooth muscle cells, but not in monocytes or macrophages. To substantiate functional involvement of FHL2 in smooth muscle cell physiology, we demonstrated that FHL2 overexpression increases the growth of these cells, whereas FHL2 knockdown results in reduced DNA synthesis. Collectively, these studies suggest that association of FHL2 with Nur77 plays a pivotal role in vascular disease.	[Kurakula, Kondababu; van der Wal, Erik; van Tiel, Claudia M.; de Vries, Carlie J. M.] Univ Amsterdam, Acad Med Ctr, Dept Med Biochem, NL-1105 AZ Amsterdam, Netherlands; [Geerts, Dirk] Univ Amsterdam, Acad Med Ctr, Dept Human Genet, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	de Vries, CJM (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Med Biochem K1 113, Meibergdreef 15, NL-1105 AZ Amsterdam, Netherlands.	c.j.devries@amc.uva.nl	Geerts, Dirk/K-8260-2015	Geerts, Dirk/0000-0002-6386-8187; Kurakula, Konda Babu/0000-0002-9830-6344	BioMedical Materials institute [P1.02 NEXTREAM]; Dutch Ministry of Economic Affairs; Nederlandse Hartstichting	BioMedical Materials institute; Dutch Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands); Nederlandse Hartstichting	This work is part of Project P1.02 NEXTREAM of the research program of the BioMedical Materials institute, co-funded by the Dutch Ministry of Economic Affairs. This work was also supported by the Nederlandse Hartstichting.	Arkenbout EK, 2003, ARTERIOSCL THROM VAS, V23, P1535, DOI 10.1161/01.ATV.0000084639.16462.7A; Arkenbout EK, 2002, CIRCULATION, V106, P1530, DOI 10.1161/01.CIR.0000028811.03056.BF; Barry SC, 2001, HUM GENE THER, V12, P1103, DOI 10.1089/104303401750214311; Bonta PI, 2007, TRENDS CARDIOVAS MED, V17, P105, DOI 10.1016/j.tcm.2007.02.001; Bonta PI, 2006, ARTERIOSCL THROM VAS, V26, P2288, DOI 10.1161/01.ATV.0000238346.84458.5d; Chao LC, 2008, MOL ENDOCRINOL, V22, P2596, DOI 10.1210/me.2008-0161; Chu PH, 2010, LIFE SCI, V86, P365, DOI 10.1016/j.lfs.2010.01.007; de Vries CJM, 2000, J BIOL CHEM, V275, P23939, DOI 10.1074/jbc.M910099199; de Waard V, 2006, AM J PATHOL, V168, P2027, DOI 10.2353/ajpath.2006.050932; Flaig R, 2005, J BIOL CHEM, V280, P19250, DOI 10.1074/jbc.M413175200; Johannessen M, 2006, CELL MOL LIFE SCI, V63, P268, DOI 10.1007/s00018-005-5438-z; Kang SA, 2010, BIOCHEM PHARMACOL, V80, P867, DOI 10.1016/j.bcp.2010.04.026; Konig K, 2010, J IMMUNOL, V185, P1466, DOI 10.4049/jimmunol.0903449; Kollara A, 2009, INT J BIOCHEM CELL B, V41, P1182, DOI 10.1016/j.biocel.2008.10.019; Kong YF, 2001, CIRCULATION, V103, P2731; Maira M, 2003, MOL CELL BIOL, V23, P763, DOI 10.1128/MCB.23.3.763-776.2003; Martinez-Gonzalez J, 2005, CARDIOVASC RES, V65, P609, DOI 10.1016/j.cardiores.2004.10.002; Maruyama K, 1998, INT J ONCOL, V12, P1237; Maxwell Megan A, 2006, Nucl Recept Signal, V4, pe002; McMorrow JP, 2011, BIOCHEM SOC T, V39, P688, DOI 10.1042/BST0390688; Muller JM, 2000, EMBO J, V19, P359, DOI 10.1093/emboj/19.3.359; Muller JM, 2002, EMBO J, V21, P736, DOI 10.1093/emboj/21.4.736; Neuman NA, 2009, J BIOL CHEM, V284, P13202, DOI 10.1074/jbc.M900282200; Ng EKO, 2002, J CELL BIOCHEM, V84, P556, DOI 10.1002/jcb.10041.abs; Nomiyama T, 2006, J BIOL CHEM, V281, P33467, DOI 10.1074/jbc.M603436200; Park KC, 2005, MOL ENDOCRINOL, V19, P12, DOI 10.1210/me.2004-0107; Paul C, 2006, ONCOGENE, V25, P5475, DOI 10.1038/sj.onc.1209567; Pearen MA, 2010, MOL ENDOCRINOL, V24, P1891, DOI 10.1210/me.2010-0015; Pei LM, 2006, NAT MED, V12, P1048, DOI 10.1038/nm1471; Pei LM, 2005, J BIOL CHEM, V280, P29256, DOI 10.1074/jbc.M502606200; Philippar U, 2004, MOL CELL, V16, P867, DOI 10.1016/j.molcel.2004.11.039; Pires NMM, 2007, CIRCULATION, V115, P493, DOI 10.1161/CIRCULATIONAHA.106.626838; Pols TWH, 2007, CURR OPIN LIPIDOL, V18, P515, DOI 10.1097/MOL.0b013e3282ef77d1; Qian Z, 2009, LEUKEMIA, V23, P1650, DOI 10.1038/leu.2009.78; Qiao L, 2009, PATHOL ONCOL RES, V15, P31, DOI 10.1007/s12253-008-9085-1; Rambaud J, 2009, J BIOL CHEM, V284, P14147, DOI 10.1074/jbc.M809023200; Root DE, 2006, NAT METHODS, V3, P715, DOI 10.1038/NMETH924; Sastry L, 2002, GENE THER, V9, P1155, DOI 10.1038/sj.gt.3301731; Seppen J, 2002, J HEPATOL, V36, P459, DOI 10.1016/S0168-8278(01)00308-7; Shi XZ, 2010, STEM CELLS, V28, P462, DOI 10.1002/stem.274; Volakakis N, 2006, J MOL ENDOCRINOL, V37, P317, DOI 10.1677/jme.1.02106; Wang ZL, 2003, NATURE, V423, P555, DOI 10.1038/nature01645; Wansa KDSA, 2002, J BIOL CHEM, V277, P33001, DOI 10.1074/jbc.M203572200; WILSON TE, 1991, SCIENCE, V252, P1296, DOI 10.1126/science.1925541; Xiong ZH, 2010, IUBMB LIFE, V62, P669, DOI 10.1002/iub.367; You B, 2009, CIRC RES, V104, P742, DOI 10.1161/CIRCRESAHA.108.192286; Zhao Y, 2010, ARTERIOSCL THROM VAS, V30, P1535, DOI 10.1161/ATVBAHA.109.191163	47	35	36	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2011	286	52					44336	44343		10.1074/jbc.M111.308999	http://dx.doi.org/10.1074/jbc.M111.308999			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870CA	22049082	Green Published, hybrid			2022-12-27	WOS:000298645500005
J	Lammich, S; Kamp, F; Wagner, J; Nuscher, B; Zilow, S; Ludwig, AK; Willem, M; Haass, C				Lammich, Sven; Kamp, Frits; Wagner, Judith; Nuscher, Brigitte; Zilow, Sonja; Ludwig, Ann-Katrin; Willem, Michael; Haass, Christian			Translational Repression of the Disintegrin and Metalloprotease ADAM10 by a Stable G-quadruplex Secondary Structure in Its 5 '-Untranslated Region	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; RNA G-QUADRUPLEX; ALPHA-SECRETASE ADAM10; MESSENGER-RNA; ALZHEIMER-DISEASE; UNTRANSLATED REGION; CIRCULAR-DICHROISM; NRAS PROTOONCOGENE; EUKARYOTIC CELLS; PROMOTER REGION	Anti-amyloidogenic processing of the amyloid precursor protein APP by alpha-secretase prevents formation of the amyloid-beta peptide, which accumulates in senile plaques of Alzheimer disease patients. alpha-Secretase belongs to the family of a disintegrin and metalloproteases (ADAMs), and ADAM10 is the primary candidate for this anti-amyloidogenic activity. We recently demonstrated that ADAM10 translation is repressed by its 5'-UTR and that in particular the first half of ADAM10 5'-UTR is responsible for translational repression. Here, we asked whether specific sequence motifs exist in the ADAM10 5'-UTR that are able to form complex secondary structures and thus potentially inhibit ADAM10 translation. Using circular dichroism spectroscopy, we demonstrate that a G-rich region between nucleotides 66 and 94 of the ADAM10 5'-UTR forms a highly stable, intramolecular, parallel G-quadruplex secondary structure under physiological conditions. Mutation of guanines in this sequence abrogates the formation of the G-quadruplex structure. Although the G-quadruplex structure efficiently inhibits translation of a luciferase reporter in in vitro translation assays and in living cells, inhibition of G-quadruplex formation fails to do so. Moreover, expression of ADAM10 was similarly repressed by the G-quadruplex. Mutation of the G-quadruplex motif results in a significant increase of ADAM10 levels and consequently APPs alpha secretion. Thus, we identified a critical RNA secondary structure within the 5'-UTR, which contributes to the translational repression of ADAM10.	[Lammich, Sven; Kamp, Frits; Wagner, Judith; Nuscher, Brigitte; Zilow, Sonja; Ludwig, Ann-Katrin; Willem, Michael; Haass, Christian] Univ Munich, Adolf Butenandt Inst, D-80336 Munich, Germany; [Haass, Christian] DZNE German Ctr Neurodegenerat Dis, D-80336 Munich, Germany	University of Munich; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Lammich, S (corresponding author), Univ Munich, Adolf Butenandt Inst, Schillerstr 44, D-80336 Munich, Germany.	sven.lammich@uni-muenchen.de			Deutsche Forschungsgemeinschaft (Collaborative Research Center) [SFB596]; Hans and Ilse Breuer Foundation; Helmholtz Alliance (Mental Health in an Aging Society, HelMA); Bundesministerium fur Bildung und Forschung; Center of Integrated Protein Science Munich	Deutsche Forschungsgemeinschaft (Collaborative Research Center)(German Research Foundation (DFG)); Hans and Ilse Breuer Foundation; Helmholtz Alliance (Mental Health in an Aging Society, HelMA); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Center of Integrated Protein Science Munich	This work was supported by the Deutsche Forschungsgemeinschaft (Collaborative Research Center (SFB596) "Molecular Mechanisms of Neurodegeneration" (to S. L., M. W., and C. H.)), a fellowship of the Hans and Ilse Breuer Foundation (to S. Z.), the Helmholtz Alliance (Mental Health in an Aging Society, HelMA), the Bundesministerium fur Bildung und Forschung ("Degenerative Dementias: Target Identification, Validation, and Translation into Treatment Strategies" (to C. H.)), and by the Center of Integrated Protein Science Munich.	Abdelmohsen K, 2011, NUCLEIC ACIDS RES, V39, P8513, DOI 10.1093/nar/gkr488; Anders A, 2001, FASEB J, V15, P1837, DOI 10.1096/fj.01-0007fje; Arora A, 2008, RNA, V14, P1290, DOI 10.1261/rna.1001708; BALAGURUMOORTHY P, 1992, NUCLEIC ACIDS RES, V20, P4061, DOI 10.1093/nar/20.15.4061; Balkwill GD, 2009, BIOCHEMISTRY-US, V48, P11487, DOI 10.1021/bi901420k; Bashkirov VI, 1997, J CELL BIOL, V136, P761, DOI 10.1083/jcb.136.4.761; Beaudoin JD, 2010, NUCLEIC ACIDS RES, V38, P7022, DOI 10.1093/nar/gkq557; Bernstein HG, 2003, J NEUROCYTOL, V32, P153, DOI 10.1023/B:NEUR.0000005600.61844.a6; Blackwell E, 2010, HUM MOL GENET, V19, P1314, DOI 10.1093/hmg/ddq007; Brooks TA, 2010, FEBS J, V277, P3459, DOI 10.1111/j.1742-4658.2010.07759.x; Burge S, 2006, NUCLEIC ACIDS RES, V34, P5402, DOI 10.1093/nar/gkl655; Buxbaum JD, 1998, J BIOL CHEM, V273, P27765, DOI 10.1074/jbc.273.43.27765; Cahill CM, 2009, BBA-GEN SUBJECTS, V1790, P615, DOI 10.1016/j.bbagen.2008.12.001; Castets M, 2005, HUM MOL GENET, V14, P835, DOI 10.1093/hmg/ddi077; Chakraborty P, 2011, DNA REPAIR, V10, P654, DOI 10.1016/j.dnarep.2011.04.013; Cho HH, 2010, J BIOL CHEM, V285, P31217, DOI 10.1074/jbc.M110.149161; Cogoi S, 2006, NUCLEIC ACIDS RES, V34, P2536, DOI 10.1093/nar/gkl286; Colciaghi F, 2002, MOL MED, V8, P67, DOI 10.1007/BF03402076; Creacy SD, 2008, J BIOL CHEM, V283, P34626, DOI 10.1074/jbc.M806277200; Dai JX, 2006, NUCLEIC ACIDS RES, V34, P5133, DOI 10.1093/nar/gkl610; Darnell JC, 2001, CELL, V107, P489, DOI 10.1016/S0092-8674(01)00566-9; Donmez G, 2010, CELL, V142, P320, DOI 10.1016/j.cell.2010.06.020; Fernando H, 2006, BIOCHEMISTRY-US, V45, P7854, DOI 10.1021/bi0601510; Furukawa K, 1996, J NEUROCHEM, V67, P1882, DOI 10.1046/j.1471-4159.1996.67051882.x; Gebauer F, 2004, NAT REV MOL CELL BIO, V5, P827, DOI 10.1038/nrm1488; Gomez D, 2010, NUCLEIC ACIDS RES, V38, P7187, DOI 10.1093/nar/gkq563; Gonzalez V, 2009, J BIOL CHEM, V284, P23622, DOI 10.1074/jbc.M109.018028; GRAY DM, 1981, BIOPOLYMERS, V20, P1337, DOI 10.1002/bip.1981.360200702; HAASS C, 1993, J BIOL CHEM, V268, P3021; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Halder K, 2009, NUCLEIC ACIDS RES, V37, P6811, DOI 10.1093/nar/gkp696; HARDIN CC, 1992, BIOCHEMISTRY-US, V31, P833, DOI 10.1021/bi00118a028; Hartmann D, 2002, HUM MOL GENET, V11, P2615, DOI 10.1093/hmg/11.21.2615; Hentze MW, 2010, CELL, V142, P24, DOI 10.1016/j.cell.2010.06.028; Hinnebusch AG, 1997, J BIOL CHEM, V272, P21661, DOI 10.1074/jbc.272.35.21661; Huppert JL, 2007, NUCLEIC ACIDS RES, V35, P406, DOI 10.1093/nar/gkl1057; Huppert JL, 2010, FEBS J, V277, P3452, DOI 10.1111/j.1742-4658.2010.07758.x; Huppert JL, 2008, NUCLEIC ACIDS RES, V36, P6260, DOI 10.1093/nar/gkn511; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Jorissen E, 2010, J NEUROSCI, V30, P4833, DOI 10.1523/JNEUROSCI.5221-09.2010; Khan MA, 2009, J BIOL CHEM, V284, P30122, DOI 10.1074/jbc.M109.041061; Khateb S, 2004, NUCLEIC ACIDS RES, V32, P4145, DOI 10.1093/nar/gkh745; Khateb S, 2007, NUCLEIC ACIDS RES, V35, P5775, DOI 10.1093/nar/gkm636; Koike H, 1999, BIOCHEM J, V343, P371, DOI 10.1042/0264-6021:3430371; Kostadinov R, 2006, NUCLEIC ACIDS RES, V34, pD119, DOI 10.1093/nar/gkj073; Kuhn PH, 2010, EMBO J, V29, P3020, DOI 10.1038/emboj.2010.167; Kumari S, 2007, NAT CHEM BIOL, V3, P218, DOI 10.1038/nchembio864; Kumari S, 2008, BIOCHEMISTRY-US, V47, P12664, DOI 10.1021/bi8010797; Lammich S, 2004, EMBO REP, V5, P620, DOI 10.1038/sj.embor.7400166; Lammich S, 1999, P NATL ACAD SCI USA, V96, P3922, DOI 10.1073/pnas.96.7.3922; Lammich S, 2010, J BIOL CHEM, V285, P15753, DOI 10.1074/jbc.M110.110742; Lattmann S, 2010, NUCLEIC ACIDS RES, V38, P6219, DOI 10.1093/nar/gkq372; London TBC, 2008, J BIOL CHEM, V283, P36132, DOI 10.1074/jbc.M808152200; Melko M, 2010, BIOCHIMIE, V92, P919, DOI 10.1016/j.biochi.2010.05.018; Menon L, 2008, RNA, V14, P1644, DOI 10.1261/rna.1100708; Mergny JL, 2003, OLIGONUCLEOTIDES, V13, P515, DOI 10.1089/154545703322860825; Meziane H, 1998, P NATL ACAD SCI USA, V95, P12683, DOI 10.1073/pnas.95.21.12683; Morris MJ, 2009, BIOCHEMISTRY-US, V48, P5313, DOI 10.1021/bi900498z; Moss ML, 2007, J BIOL CHEM, V282, P35712, DOI 10.1074/jbc.M703231200; Muckenthaler M, 1998, MOL CELL, V2, P383, DOI 10.1016/S1097-2765(00)80282-8; O'Connor T, 2008, NEURON, V60, P988, DOI 10.1016/j.neuron.2008.10.047; Paramasivan S, 2007, METHODS, V43, P324, DOI 10.1016/j.ymeth.2007.02.009; Patel DJ, 2007, NUCLEIC ACIDS RES, V35, P7429, DOI 10.1093/nar/gkm711; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pickering BM, 2005, SEMIN CELL DEV BIOL, V16, P39, DOI 10.1016/j.semcdb.2004.11.006; Postina R, 2004, J CLIN INVEST, V113, P1456, DOI 10.1172/JCI200420864; Pruessmeyer J, 2009, SEMIN CELL DEV BIOL, V20, P164, DOI 10.1016/j.semcdb.2008.09.005; Qin Y, 2010, BIOCHEMISTRY-US, V49, P4208, DOI 10.1021/bi100330w; Rachwal PA, 2007, FEBS LETT, V581, P1657, DOI 10.1016/j.febslet.2007.03.040; Rachwal PA, 2007, BIOCHEMISTRY-US, V46, P3036, DOI 10.1021/bi062118j; Rogers GW, 2004, P NATL ACAD SCI USA, V101, P2794, DOI 10.1073/pnas.0308576101; Scaria V, 2006, NUCLEIC ACIDS RES, V34, pW683, DOI 10.1093/nar/gkl299; Schaeffer C, 2001, EMBO J, V20, P4803, DOI 10.1093/emboj/20.17.4803; Shahid R, 2010, BIOCHEMISTRY-US, V49, P8300, DOI 10.1021/bi100957h; Shirotani K, 2007, NEUROBIOL DIS, V27, P102, DOI 10.1016/j.nbd.2007.04.011; Siddiqui-Jain A, 2002, P NATL ACAD SCI USA, V99, P11593, DOI 10.1073/pnas.182256799; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Subramanian M, 2011, EMBO REP, V12, P697, DOI 10.1038/embor.2011.76; Tang CF, 2006, J AM CHEM SOC, V128, P5966, DOI 10.1021/ja0603958; Thomson AM, 2005, J BIOL CHEM, V280, P30032, DOI 10.1074/jbc.M502951200; Tippmann F, 2009, FASEB J, V23, P1643, DOI 10.1096/fj.08-121392; Tonelli DD, 2004, NUCLEIC ACIDS RES, V32, P1808, DOI 10.1093/nar/gkh348; van der Velden AW, 1999, INT J BIOCHEM CELL B, V31, P87, DOI 10.1016/S1357-2725(98)00134-4; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Velliquette RA, 2005, J NEUROSCI, V25, P10874, DOI 10.1523/JNEUROSCI.2350-05.2005; Wieland M, 2007, CHEM BIOL, V14, P757, DOI 10.1016/j.chembiol.2007.06.005; Willem M, 2009, SEMIN CELL DEV BIOL, V20, P175, DOI 10.1016/j.semcdb.2009.01.003; Wu YL, 2010, FEBS J, V277, P3470, DOI 10.1111/j.1742-4658.2010.07760.x; Yang P, 2006, PROG NEUROBIOL, V79, P73, DOI 10.1016/j.pneurobio.2006.05.001; Zhang AYQ, 2011, BIOCHEMISTRY-US, V50, P7251, DOI 10.1021/bi200805j; Zhang DH, 2010, BIOCHEMISTRY-US, V49, P4554, DOI 10.1021/bi1002822	91	55	55	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2011	286	52					45063	45072		10.1074/jbc.M111.296921	http://dx.doi.org/10.1074/jbc.M111.296921			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870CA	22065584	hybrid, Green Published			2022-12-27	WOS:000298645500073
J	Ugleholdt, R; Pedersen, J; Bassi, MR; Fuchtbauer, EM; Jorgensen, SM; Kissow, HL; Nytofte, N; Poulsen, SS; Rosenkilde, MM; Seino, Y; Thams, P; Holst, PJ; Holst, JJ				Ugleholdt, Randi; Pedersen, Jens; Bassi, Maria Rosaria; Fuchtbauer, Ernst-Martin; Jorgensen, Signe Marie; Kissow, Hanne-Louise; Nytofte, Nikolaj; Poulsen, Steen Seier; Rosenkilde, Mette Marie; Seino, Yutaka; Thams, Peter; Holst, Peter Johannes; Holst, Jens Juul			Transgenic Rescue of Adipocyte Glucose-dependent Insulinotropic Polypeptide Receptor Expression Restores High Fat Diet-induced Body Weight Gain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GASTRIC-INHIBITORY POLYPEPTIDE; GLUCAGON-LIKE PEPTIDE-1; LIPOPROTEIN-LIPASE ACTIVITY; ADIPOSE-TISSUE; LIPID-METABOLISM; SOLUBILIZED MEMBRANES; ENTEROINSULAR AXIS; GIP; OBESITY; LIPOLYSIS	The glucose-dependent insulinotropic polypeptide receptor (GIPr) has been implicated in high fat diet-induced obesity and is proposed as an anti-obesity target despite an uncertainty regarding the mechanism of action. To independently investigate the contribution of the insulinotropic effects and the direct effects on adipose tissue, we generated transgenic mice with targeted expression of the human GIPr to white adipose tissue or beta-cells, respectively. These mice were then cross-bred with the GIPr knock-out strain. The central findings of the study are that mice with GIPr expression targeted to adipose tissue have a similar high fat diet -induced body weight gain as control mice, significantly greater than the weight gain in mice with a general ablation of the receptor. Surprisingly, this difference was due to an increase in total lean body mass rather than a gain in total fat mass that was similar between the groups. In contrast, glucose-dependent insulinotropic polypeptide-mediated insulin secretion does not seem to be important for regulation of body weight after high fat feeding. The study supports a role of the adipocyte GIPr in nutrient-dependent regulation of body weight and lean mass, but it does not support a direct and independent role for the adipocyte or beta-cell GIPr in promoting adipogenesis.	[Ugleholdt, Randi; Pedersen, Jens; Jorgensen, Signe Marie; Kissow, Hanne-Louise; Nytofte, Nikolaj; Poulsen, Steen Seier; Holst, Jens Juul] Univ Copenhagen, Ctr Basic Metab Res, Novo Nordisk Fdn, DK-2200 Copenhagen N, Denmark; [Ugleholdt, Randi; Pedersen, Jens; Jorgensen, Signe Marie; Kissow, Hanne-Louise; Nytofte, Nikolaj; Poulsen, Steen Seier; Thams, Peter; Holst, Jens Juul] Univ Copenhagen, Fac Hlth Sci, Dept Biomed Sci, DK-2200 Copenhagen N, Denmark; [Bassi, Maria Rosaria; Holst, Peter Johannes] Univ Copenhagen, Fac Hlth Sci, Dept Int Hlth Immunol & Microbiol, DK-1014 Copenhagen, Denmark; [Fuchtbauer, Ernst-Martin] Univ Aarhus, Dept Mol Biol & Genet, DK-8000 Aarhus, Denmark; [Rosenkilde, Mette Marie] Univ Copenhagen, Dept Neurosci & Pharmacol, DK-2200 Copenhagen N, Denmark; [Seino, Yutaka] Kyoto Univ, Dept Diabet & Clin Nutr, Kyoto 6068507, Japan	Novo Nordisk Foundation; University of Copenhagen; University of Copenhagen; University of Copenhagen; Aarhus University; University of Copenhagen; Kyoto University	Holst, JJ (corresponding author), Univ Copenhagen, Ctr Basic Metab Res, Novo Nordisk Fdn, Blegdamsvej 3B, DK-2200 Copenhagen N, Denmark.	jjholst@sund.ku.dk	Holst, Jens/AAA-8022-2022; Kissow, Hannelouise/AAW-2119-2020	Kissow, Hannelouise/0000-0001-9351-8885; Holst, Jens Juul/0000-0001-6853-3805; Bassi, Maria Rosaria/0000-0001-6736-6152; Poulsen, Steen Seier/0000-0003-4419-4911; Rosenkilde, Mette Marie/0000-0001-9600-3254; Holst, Peter Johannes/0000-0002-1279-304X	Danish Medical Research Council; Novo Nordisk Foundation; Fabrikant Vilhelm Pedersen og Hustrus Mindelegat; Aase and Ejnar Danielsens Foundation; Augustinus Foundation; Becket Foundation; Fonden til Laegevidenskabens Fremme	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Fabrikant Vilhelm Pedersen og Hustrus Mindelegat; Aase and Ejnar Danielsens Foundation; Augustinus Foundation; Becket Foundation; Fonden til Laegevidenskabens Fremme	This work was supported by the Danish Medical Research Council, the Novo Nordisk Foundation, Fabrikant Vilhelm Pedersen og Hustrus Mindelegat, the Aase and Ejnar Danielsens Foundation, the Augustinus Foundation, the Becket Foundation, and Fonden til Laegevidenskabens Fremme.	Althage MC, 2008, J BIOL CHEM, V283, P18365, DOI 10.1074/jbc.M710466200; Asmar M, 2010, DIABETES, V59, P2160, DOI 10.2337/db10-0098; Asmar M, 2010, AM J PHYSIOL-ENDOC M, V298, pE614, DOI 10.1152/ajpendo.00639.2009; Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; Barnes KM, 2009, CURR PROTEIN PEPT SC, V10, P96, DOI 10.2174/138920309787315239; BECK B, 1983, REGUL PEPTIDES, V7, P3, DOI 10.1016/0167-0115(83)90276-8; BECK B, 1987, CELL MOL BIOL, V33, P555; Bertin E, 2001, J CLIN ENDOCR METAB, V86, P1229, DOI 10.1210/jc.86.3.1229; Bullock BP, 1996, ENDOCRINOLOGY, V137, P2968, DOI 10.1210/en.137.7.2968; Cammisotto PG, 2002, AM J PHYSIOL-CELL PH, V283, pC244, DOI 10.1152/ajpcell.00033.2002; Carey AL, 2006, DIABETES, V55, P2688, DOI 10.2337/db05-1404; CREUTZFELDT W, 1978, DIABETOLOGIA, V14, P15, DOI 10.1007/BF00429703; de Fonseca FR, 2000, METABOLISM, V49, P709, DOI 10.1053/meta.2000.6251; Deacon CF, 2000, J CLIN ENDOCR METAB, V85, P3575, DOI 10.1210/jc.85.10.3575; Ding KH, 2004, AM J PHYSIOL-ENDOC M, V286, pE773, DOI 10.1152/ajpendo.00507.2003; DUPRE J, 1976, METABOLISM, V25, P1197, DOI 10.1016/S0026-0495(76)80002-9; EBERT R, 1991, HORM METAB RES, V23, P517, DOI 10.1055/s-2007-1003745; ECKEL RH, 1979, DIABETES, V28, P1141, DOI 10.2337/diabetes.28.12.1141; FALKO JM, 1975, J CLIN ENDOCR METAB, V41, P260, DOI 10.1210/jcem-41-2-260; Fulurija A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003163; Getty-Kaushik L, 2006, OBESITY, V14, P1124, DOI 10.1038/oby.2006.129; GRAVES RA, 1992, J CELL BIOCHEM, V49, P219, DOI 10.1002/jcb.240490303; Hansotia T, 2007, J CLIN INVEST, V117, P143, DOI 10.1172/JCI25483; HAUNER H, 1988, ANN NUTR METAB, V32, P282, DOI 10.1159/000177467; HIGUCHI Y, 1992, J EXP MED, V176, P1719, DOI 10.1084/jem.176.6.1719; HOLST JJ, 1980, BIOCHEM J, V187, P337, DOI 10.1042/bj1870337; Isken F, 2008, AM J PHYSIOL-ENDOC M, V295, pE350, DOI 10.1152/ajpendo.00008.2008; Kim SJ, 2007, J BIOL CHEM, V282, P34139, DOI 10.1074/jbc.M704896200; Kim SJ, 2007, J BIOL CHEM, V282, P8557, DOI 10.1074/jbc.M609088200; KNAPPER JME, 1995, J NUTR, V125, P183; Lewis JT, 2000, ENDOCRINOLOGY, V141, P3710, DOI 10.1210/en.141.10.3710; Lynn FC, 2001, DIABETES, V50, P1004, DOI 10.2337/diabetes.50.5.1004; Marroqui L, 2011, DIABETOLOGIA, V54, P843, DOI 10.1007/s00125-010-2024-1; McClean PL, 2007, AM J PHYSIOL-ENDOC M, V293, pE1746, DOI 10.1152/ajpendo.00460.2007; McIntosh CHS, 1999, ENDOCRINOLOGY, V140, P398, DOI 10.1210/en.140.1.398; Meeran K, 1999, ENDOCRINOLOGY, V140, P244, DOI 10.1210/en.140.1.244; MERIDA E, 1993, J CLIN ENDOCR METAB, V77, P1654, DOI 10.1210/jc.77.6.1654; Miyawaki K, 2002, NAT MED, V8, P738, DOI 10.1038/nm727; Miyawaki K, 1999, P NATL ACAD SCI USA, V96, P14843, DOI 10.1073/pnas.96.26.14843; Naitoh R, 2008, BIOCHEM BIOPH RES CO, V376, P21, DOI 10.1016/j.bbrc.2008.08.052; Nogueiras R, 2009, J NEUROSCI, V29, P5916, DOI 10.1523/JNEUROSCI.5977-08.2009; OBEN J, 1991, J ENDOCRINOL, V130, P267, DOI 10.1677/joe.0.1300267; Pamir N, 2003, AM J PHYSIOL-ENDOC M, V284, pE931, DOI 10.1152/ajpendo.00270.2002; Pederson RA, 1996, METABOLISM, V45, P1335, DOI 10.1016/S0026-0495(96)90112-2; Perez C, 2004, DIABETES, V53, P347, DOI 10.2337/diabetes.53.2.347; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rabe K, 2008, MOL MED, V14, P741, DOI 10.2119/2008-00058.Rabe; Rajala MW, 2004, DIABETES, V53, P1671, DOI 10.2337/diabetes.53.7.1671; Ruclovich N, 2007, REGUL PEPTIDES, V142, P138, DOI 10.1016/j.regpep.2007.02.006; RUIZGRANDE C, 1992, PEPTIDES, V13, P13, DOI 10.1016/0196-9781(92)90134-O; Sancho V, 2005, J MOL ENDOCRINOL, V35, P27, DOI 10.1677/jme.1.01747; Sancho V, 2006, INT J MOL MED, V17, P1133; Song DH, 2007, GASTROENTEROLOGY, V133, P1796, DOI 10.1053/j.gastro.2007.09.005; Song Diane H, 2007, Curr Opin Endocrinol Diabetes Obes, V14, P46, DOI 10.1097/MED.0b013e328011aa88; Tang-Christensen M, 2000, NAT MED, V6, P802, DOI 10.1038/77535; TangChristensen M, 1996, AM J PHYSIOL-REG I, V271, pR848, DOI 10.1152/ajpregu.1996.271.4.R848; Thams P, 2001, DIABETOLOGIA, V44, P738, DOI 10.1007/s001250051683; VALVERDE I, 1993, ENDOCRINOLOGY, V132, P75, DOI 10.1210/en.132.1.75; Villanueva-Penacarrillo ML, 2001, HORM METAB RES, V33, P73, DOI 10.1055/s-2001-12428; WASADA T, 1981, J CLIN INVEST, V68, P1106, DOI 10.1172/JCI110335; Yamada C, 2007, BIOCHEM BIOPH RES CO, V364, P175, DOI 10.1016/j.bbrc.2007.09.128; Yip RGC, 1998, ENDOCRINOLOGY, V139, P4004, DOI 10.1210/en.139.9.4004; Zander M, 2002, LANCET, V359, P824, DOI 10.1016/S0140-6736(02)07952-7; Zhou HY, 2005, BIOCHEM BIOPH RES CO, V335, P937, DOI 10.1016/j.bbrc.2005.07.164	64	33	35	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2011	286	52					44632	44645		10.1074/jbc.M111.311779	http://dx.doi.org/10.1074/jbc.M111.311779			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870CA	22027838	hybrid, Green Published			2022-12-27	WOS:000298645500034
J	Carbonell, P; Lecointre, G; Faulon, JL				Carbonell, Pablo; Lecointre, Guillaume; Faulon, Jean-Loup			Origins of Specificity and Promiscuity in Metabolic Networks	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATALYTIC PROMISCUITY; ENZYME PROMISCUITY; AMINO-ACIDS; EVOLUTION; TREE; GENES; LIFE	How enzymes have evolved to their present form is linked to the question of how pathways emerged and evolved into extant metabolic networks. To investigate this mechanism, we have explored the chemical diversity present in a largely unbiased data set of catalytic reactions processed by modern enzymes across the tree of life. In order to get a quantitative estimate of enzyme chemical diversity, we measure enzyme multispecificity or promiscuity using the reaction molecular signatures. Our main finding is that reactions that are catalyzed by a highly specific enzyme are shared by poorly divergent species, suggesting a later emergence of this function during evolution. In contrast, reactions that are catalyzed by highly promiscuous enzymes are more likely to appear uniformly distributed across species in the tree of life. From a functional point of view, promiscuous enzymes are mainly involved in amino acid and lipid metabolisms, which might be associated with the earliest form of biochemical reactions. In this way, results presented in this paper might assist us with the identification of primeval promiscuous catalytic functions contributing to life's minimal metabolism.	Univ Evry, Inst Syst & Synthet Biol, F-91030 Evry, France; [Lecointre, Guillaume] Museum Natl Hist Nat, Dept Systemat & Evolut, UMR Systemat Adaptat Evolut 7138, F-75005 Paris, France	UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite	Faulon, JL (corresponding author), Genopole Campus 1,Genavenir 6,5 Rue Henri Desbrue, F-91030 Evry, France.	jean-loup.faulon@issb.genopole.fr	Carbonell, Pablo/A-3572-2011	Carbonell, Pablo/0000-0002-0993-5625	Genopole through Actions Thematiques Incitatives de Genopole; Agence Nationale de la Recherche Chaire d'Excellence	Genopole through Actions Thematiques Incitatives de Genopole; Agence Nationale de la Recherche Chaire d'Excellence(French National Research Agency (ANR))	Supported by Genopole through an Actions Thematiques Incitatives de Genopole grant.; Supported by Agence Nationale de la Recherche Chaire d'Excellence. To whom correspondence should be addressed: Genopole Campus 1, Genavenir 6, 5 Rue Henri Desbrueres, 91030 EVRY Cedex, France. Fax: 33-1-6947-44-37; E-mail: jean-loup.faulon@issb.genopole.fr.	Alves R, 2002, J MOL BIOL, V320, P751, DOI 10.1016/S0022-2836(02)00546-6; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bernstein MP, 2002, NATURE, V416, P401, DOI 10.1038/416401a; Bloom JD, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-17; Carbonell P, 2010, BIOINFORMATICS, V26, P2012, DOI 10.1093/bioinformatics/btq317; Caro GMM, 2002, NATURE, V416, P403, DOI 10.1038/416403a; Caspi R, 2010, NUCLEIC ACIDS RES, V38, pD473, DOI 10.1093/nar/gkp875; Chang A, 2009, NUCLEIC ACIDS RES, V37, pD588, DOI 10.1093/nar/gkn820; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; Copley SD, 2003, CURR OPIN CHEM BIOL, V7, P265, DOI 10.1016/S1367-5931(03)00032-2; Cunchillos C, 2003, J BIOL CHEM, V278, P47960, DOI 10.1074/jbc.M213028200; Danchin A, 2009, CURR OPIN BIOTECH, V20, P504, DOI 10.1016/j.copbio.2009.07.004; de Groot MJL, 2009, BIOINFORMATICS, V25, P2975, DOI 10.1093/bioinformatics/btp507; Doolittle WF, 2007, P NATL ACAD SCI USA, V104, P2043, DOI 10.1073/pnas.0610699104; Faulon JL, 2004, J CHEM INF COMP SCI, V44, P427, DOI 10.1021/ci0341823; Freilich S, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-247; Gerdes S, 2006, CURR OPIN BIOTECH, V17, P448, DOI 10.1016/j.copbio.2006.08.006; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hedges S. Blair, 2009, P3; HOROWITZ NH, 1945, P NATL ACAD SCI USA, V31, P153, DOI 10.1073/pnas.31.6.153; Hult K, 2007, TRENDS BIOTECHNOL, V25, P231, DOI 10.1016/j.tibtech.2007.03.002; JAKOBY WB, 1990, J BIOL CHEM, V265, P20715; JENSEN RA, 1976, ANNU REV MICROBIOL, V30, P409, DOI 10.1146/annurev.mi.30.100176.002205; Kaltenpoth M, 2009, TRENDS MICROBIOL, V17, P529, DOI 10.1016/j.tim.2009.09.006; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kazlauskas RJ, 2005, CURR OPIN CHEM BIOL, V9, P195, DOI 10.1016/j.cbpa.2005.02.008; Khersonsky O, 2006, CURR OPIN CHEM BIOL, V10, P498, DOI 10.1016/j.cbpa.2006.08.011; Khersonsky O, 2010, COMPREHENSIVE NATURAL PRODUCTS II: CHEMISTRY AND BIOLOGY, VOL 8: ENZYMES AND ENZYME MECHANISMS, P47; Kurtovic S, 2008, J MOL BIOL, V382, P136, DOI 10.1016/j.jmb.2008.07.003; LECOINTRE G, 1993, MOL PHYLOGENET EVOL, V2, P205, DOI 10.1006/mpev.1993.1021; LECOINTRE G, 2007, TREE LIFE PHYLOGENET, P18; Light S, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-15; Lopez P, 2009, CR BIOL, V332, P171, DOI 10.1016/j.crvi.2008.07.003; Marcet-Houben M, 2007, BIOINFORMATION, V2, P135, DOI 10.6026/97320630002135; Markov G, 2008, BIOESSAYS, V30, P349, DOI 10.1002/bies.20730; Meierhenrich UJ, 2004, P NATL ACAD SCI USA, V101, P9182, DOI 10.1073/pnas.0403043101; Nath A, 2008, BIOCHEMISTRY-US, V47, P157, DOI 10.1021/bi701448p; O'Brien PJ, 1999, CHEM BIOL, V6, pR91, DOI 10.1016/S1074-5521(99)80033-7; Pal C, 2001, GENETICS, V158, P927; Peregrin-Alvarez JM, 2003, GENOME RES, V13, P422, DOI 10.1101/gr.246903; Peregrin-Alvarez JM, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r63; Rison SCG, 2002, J MOL BIOL, V318, P911, DOI 10.1016/S0022-2836(02)00140-7; Rison SCG, 2002, CURR OPIN STRUC BIOL, V12, P374, DOI 10.1016/S0959-440X(02)00331-7; Rothman SC, 2003, J MOL BIOL, V327, P593, DOI 10.1016/S0022-2836(03)00095-0; Vitkup D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r39; Warwick RM, 1995, MAR ECOL PROG SER, V129, P301, DOI 10.3354/meps129301; Yamada T, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-130; Yamada T, 2009, NAT REV MOL CELL BIO, V10, P791, DOI 10.1038/nrm2787	48	53	52	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2011	286	51					43994	44004		10.1074/jbc.M111.274050	http://dx.doi.org/10.1074/jbc.M111.274050			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866SH	22052908	Green Published, hybrid			2022-12-27	WOS:000298402300040
J	Lee, S; Kim, JH; Kim, JH; Seo, JW; Han, HS; Lee, WH; Mori, K; Nakao, K; Barasch, J; Suk, K				Lee, Shinrye; Kim, Jong-Heon; Kim, Jae-Hong; Seo, Jung-Wan; Han, Hyung-Soo; Lee, Won-Ha; Mori, Kiyoshi; Nakao, Kazuwa; Barasch, Jonathan; Suk, Kyoungho			Lipocalin-2 Is a Chemokine Inducer in the Central Nervous System ROLE OF CHEMOKINE LIGAND 10 (CXCL10) IN LIPOCALIN-2-INDUCED CELL MIGRATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GELATINASE-ASSOCIATED LIPOCALIN; FIBRILLARY ACIDIC PROTEIN; ACUTE-PHASE PROTEIN; SPINAL-CORD-INJURY; GENE-EXPRESSION; GLIAL-CELLS; MULTIPLE-SCLEROSIS; SIGNALING PATHWAY; BREAST-CANCER; UP-REGULATION	The secreted protein lipocalin-2 (LCN2) has been implicated in diverse cellular processes, including cell morphology and migration. Little is known, however, about the role of LCN2 in the CNS. Here, we show that LCN2 promotes cell migration through up-regulation of chemokines in brain. Studies using cultured glial cells, microvascular endothelial cells, and neuronal cells suggest that LCN2 may act as a chemokine inducer on the multiple cell types in the CNS. In particular, up-regulation of CXCL10 by JAK2/STAT3 and IKK/NF-kappa B pathways in astrocytes played a pivotal role in LCN2-induced cell migration. The cell migration-promoting activity of LCN2 in the CNS was verified in vivo using mouse models. The expression of LCN2 was notably increased in brain following LPS injection or focal injury. Mice lacking LCN2 showed the impaired migration of astrocytes to injury sites with a reduced CXCL10 expression in the neuroinflammation or injury models. Thus, the LCN2 proteins, secreted under inflammatory conditions, may amplify neuroinflammation by inducing CNS cells to secrete chemokines such as CXCL10, which recruit additional inflammatory cells.	[Suk, Kyoungho] Kyungpook Natl Univ, Dept Pharmacol, Sch Med, Taegu 700422, South Korea; [Han, Hyung-Soo] Kyungpook Natl Univ, Dept Physiol, Sch Med, Brain Sci & Engn Inst,Cell & Matrix Res Inst, Taegu 700422, South Korea; [Lee, Won-Ha] Kyungpook Natl Univ, Sch Life Sci & Biotechnol, Sch Med, Taegu 700422, South Korea; [Mori, Kiyoshi; Nakao, Kazuwa] Kyoto Univ, Grad Sch Med, Dept Med & Clin Sci, Kyoto 6068507, Japan; [Barasch, Jonathan] Columbia Univ, Coll Phys & Surg, Dept Med, New York, NY 10027 USA	Kyungpook National University; Kyungpook National University; Kyungpook National University; Kyoto University; Columbia University	Suk, K (corresponding author), Kyungpook Natl Univ, Dept Pharmacol, Sch Med, 101 Dong In, Taegu 700422, South Korea.	ksuk@knu.ac.kr	Mori, Kiyoshi/N-1267-2014	Mori, Kiyoshi/0000-0002-7285-8351	National Research Foundation [2009-0078941]; Ministry of Education, Science and Technology of Korean government; Ministry of Education, Science and Technology [2010-0029460]	National Research Foundation; Ministry of Education, Science and Technology of Korean government(Ministry of Education, Science & Technology (MEST), Republic of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by National Research Foundation Grant 2009-0078941 funded by the Ministry of Education, Science and Technology of Korean government. This work was also supported by the Basic Science Research Program through the National Research Foundation funded by Ministry of Education, Science and Technology Grant 2010-0029460.	Ackerman SL, 1997, NATURE, V386, P838, DOI 10.1038/386838a0; Ambrosini E, 2004, NEUROCHEM RES, V29, P1017, DOI 10.1023/B:NERE.0000021246.96864.89; ANDERSSON PB, 1992, NEUROSCIENCE, V48, P169, DOI 10.1016/0306-4522(92)90347-5; Andjelkovic AV, 2002, J NEUROSCI RES, V70, P219, DOI 10.1002/jnr.10372; Araki W, 2000, ANN NY ACAD SCI, V920, P241; Bassi R, 2008, J NEURO-ONCOL, V87, P23, DOI 10.1007/s11060-007-9488-y; Bauer M, 2008, BREAST CANCER RES TR, V108, P389, DOI 10.1007/s10549-007-9619-3; Behar O, 1996, NATURE, V383, P525, DOI 10.1038/383525a0; Bertollini C, 2006, NEUROPHARMACOLOGY, V51, P816, DOI 10.1016/j.neuropharm.2006.05.027; Biber K, 2002, NEUROSCIENCE, V112, P487, DOI 10.1016/S0306-4522(02)00114-8; Bolignano D, 2008, AM J KIDNEY DIS, V52, P595, DOI 10.1053/j.ajkd.2008.01.020; Boran MS, 2007, J NEUROCHEM, V102, P216, DOI 10.1111/j.1471-4159.2007.04464.x; Brahmachari S, 2006, J NEUROSCI, V26, P4930, DOI 10.1523/JNEUROSCI.5480-05.2006; Cattaneo E, 1999, TRENDS NEUROSCI, V22, P365, DOI 10.1016/S0166-2236(98)01378-2; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Cheeran MCJ, 2003, J VIROL, V77, P4502, DOI 10.1128/JVI.77.8.4502-4515.2003; Chensue SW, 2001, CLIN MICROBIOL REV, V14, P821, DOI 10.1128/CMR.14.4.821-835.2001; Chou SY, 2008, J NEUROSCI, V28, P3277, DOI 10.1523/JNEUROSCI.0116-08.2008; Chung CD, 1997, SCIENCE, V278, P1803, DOI 10.1126/science.278.5344.1803; Chung RS, 2009, NEUROTOX RES, V15, P381, DOI 10.1007/s12640-009-9044-y; COLAMARINO SA, 1995, ANNU REV NEUROSCI, V18, P497, DOI 10.1146/annurev.ne.18.030195.002433; Cunningham C, 2005, J NEUROSCI, V25, P9275, DOI 10.1523/JNEUROSCI.2614-05.2005; Czapski GA, 2007, J NEUROSCI RES, V85, P1694, DOI 10.1002/jnr.21294; Devireddy LR, 2005, CELL, V123, P1293, DOI 10.1016/j.cell.2005.10.027; ENOKIDO Y, 1992, BRAIN RES, V599, P261, DOI 10.1016/0006-8993(92)90400-4; Erskine L, 2000, J NEUROSCI, V20, P4975; Fisher SN, 1995, BRAIN BEHAV IMMUN, V9, P331, DOI 10.1006/brbi.1995.1031; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Flo TH, 2004, NATURE, V432, P917, DOI 10.1038/nature03104; Goldberg SH, 2001, NEUROPATH APPL NEURO, V27, P127, DOI 10.1046/j.1365-2990.2001.00312.x; Guan KL, 2003, NAT REV NEUROSCI, V4, P941, DOI 10.1038/nrn1254; Gwira JA, 2005, J BIOL CHEM, V280, P7875, DOI 10.1074/jbc.M413192200; Hanai J, 2005, J BIOL CHEM, V280, P13641, DOI 10.1074/jbc.M413047200; HEDGECOCK EM, 1990, NEURON, V4, P61, DOI 10.1016/0896-6273(90)90444-K; Herrmann JE, 2008, J NEUROSCI, V28, P7231, DOI 10.1523/JNEUROSCI.1709-08.2008; Hesselgesser J, 1999, J NEUROVIROL, V5, P13, DOI 10.3109/13550289909029741; Hu HY, 1996, NEURON, V16, P933, DOI 10.1016/S0896-6273(00)80116-6; Hvidberg V, 2005, FEBS LETT, V579, P773, DOI 10.1016/j.febslet.2004.12.031; Hwang J, 2008, INT IMMUNOPHARMACOL, V8, P1686, DOI 10.1016/j.intimp.2008.08.004; Ivashkiv L B, 2000, Rev Immunogenet, V2, P220; Kalla R, 2003, GLIA, V41, P50, DOI 10.1002/glia.10176; Kehrer JP, 2010, CELL BIOL TOXICOL, V26, P83, DOI 10.1007/s10565-009-9119-9; Kim B, 2011, J IMMUNOL, V186, P3701, DOI 10.4049/jimmunol.1000212; Kisseleva T, 2002, GENE, V285, P1, DOI 10.1016/S0378-1119(02)00398-0; Kitazawa M, 2005, J NEUROSCI, V25, P8843, DOI 10.1523/JNEUROSCI.2868-05.2005; Klein RS, 2001, DEVELOPMENT, V128, P1971; Kramer SG, 2001, SCIENCE, V292, P737, DOI 10.1126/science.1058766; Lee HJ, 2006, INT J CANCER, V118, P2490, DOI 10.1002/ijc.21657; Lee S, 2007, J IMMUNOL, V179, P3231, DOI 10.4049/jimmunol.179.5.3231; Lee S, 2009, J NEUROSCI, V29, P234, DOI 10.1523/JNEUROSCI.5273-08.2009; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Lim R, 2007, INT J CANCER, V120, P2426, DOI 10.1002/ijc.22352; Lin HH, 2011, INT J BIOL SCI, V7, P74, DOI 10.7150/ijbs.7.74; LIU QS, 1995, J BIOL CHEM, V270, P22565, DOI 10.1074/jbc.270.38.22565; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LUSTER AD, 1985, NATURE, V315, P672, DOI 10.1038/315672a0; Majumder S, 1998, J NEUROSCI RES, V54, P169, DOI 10.1002/(SICI)1097-4547(19981015)54:2<169::AID-JNR5>3.0.CO;2-C; Marques F, 2008, J CEREBR BLOOD F MET, V28, P450, DOI 10.1038/sj.jcbfm.9600557; Matejuk A, 2001, J NEUROSCI RES, V65, P529, DOI 10.1002/jnr.1183; Misse D, 2001, BLOOD, V98, P541, DOI 10.1182/blood.V98.3.541; MONTESANO R, 1990, CELL, V62, P435, DOI 10.1016/0092-8674(90)90009-4; Mori K, 2005, J CLIN INVEST, V115, P610, DOI 10.1172/JCI200523056; Na YJ, 2007, J NEUROCHEM, V103, P637, DOI 10.1111/j.1471-4159.2007.04769.x; Nairz M, 2009, BLOOD, V114, P3642, DOI 10.1182/blood-2009-05-223354; Nelson AM, 2008, J CLIN INVEST, V118, P1468, DOI 10.1172/JCI33869; Neptune ER, 1997, P NATL ACAD SCI USA, V94, P14489, DOI 10.1073/pnas.94.26.14489; Nguyen-Ba-Charvet KT, 2004, J NEUROSCI, V24, P1497, DOI 10.1523/JNEUROSCI.4729-03.2004; Niclou SP, 2000, J NEUROSCI, V20, P4962; Odemis V, 2002, J BIOL CHEM, V277, P39801, DOI 10.1074/jbc.M200472200; Omari KM, 2005, BRAIN, V128, P1003, DOI 10.1093/brain/awh479; Paglinawan R, 2003, GLIA, V44, P219, DOI 10.1002/glia.10286; Park C, 2006, GLIA, V53, P248, DOI 10.1002/glia.20278; Playford RJ, 2006, GASTROENTEROLOGY, V131, P809, DOI 10.1053/j.gastro.2006.05.051; Qin LY, 2007, GLIA, V55, P453, DOI 10.1002/glia.20467; Raper JA, 2000, CURR OPIN NEUROBIOL, V10, P88, DOI 10.1016/S0959-4388(99)00057-4; Rostene W, 2007, NAT REV NEUROSCI, V8, P895, DOI 10.1038/nrn2255; Sallusto F, 2000, ANNU REV IMMUNOL, V18, P593, DOI 10.1146/annurev.immunol.18.1.593; Sauvageot CM, 2002, CURR OPIN NEUROBIOL, V12, P244, DOI 10.1016/S0959-4388(02)00322-7; Schindler CW, 2002, J CLIN INVEST, V109, P1133, DOI 10.1172/JCI200215644; Schmidt-Ott KM, 2006, CURR OPIN NEPHROL HY, V15, P442, DOI 10.1097/01.mnh.0000232886.81142.58; Shi H, 2008, J EXP CLIN CANC RES, V27, DOI 10.1186/1756-9966-27-83; Simpson J, 2000, J NEUROIMMUNOL, V108, P192, DOI 10.1016/S0165-5728(00)00274-5; Sriram K, 2004, J BIOL CHEM, V279, P19936, DOI 10.1074/jbc.M309304200; Sun DM, 1997, J NEUROSCI RES, V48, P192; Sunil VR, 2007, EXP MOL PATHOL, V83, P177, DOI 10.1016/j.yexmp.2007.03.004; Takanaga H, 2004, J BIOL CHEM, V279, P15441, DOI 10.1074/jbc.M311844200; Tanuma N, 2006, ACTA NEUROPATHOL, V112, P195, DOI 10.1007/s00401-006-0083-7; Tong ZM, 2008, CANCER RES, V68, P6100, DOI 10.1158/0008-5472.CAN-08-0540; Tong ZM, 2005, BIOCHEM J, V391, P441, DOI 10.1042/BJ20051020; Ubogu EE, 2006, TRENDS PHARMACOL SCI, V27, P48, DOI 10.1016/j.tips.2005.11.002; VANGURI P, 1995, J NEUROIMMUNOL, V56, P35, DOI 10.1016/0165-5728(94)00131-7; Wilhelmsson U, 2004, J NEUROSCI, V24, P5016, DOI 10.1523/JNEUROSCI.0820-04.2004; Wilkinson DG, 2001, NAT REV NEUROSCI, V2, P155, DOI 10.1038/35058515; Wu W, 1999, NATURE, V400, P331, DOI 10.1038/22477; Yamauchi K, 2006, J NEUROCHEM, V96, P1060, DOI 10.1111/j.1471-4159.2005.03559.x; Yan QW, 2007, DIABETES, V56, P2533, DOI 10.2337/db07-0007; Yang J, 2002, MOL CELL, V10, P1045, DOI 10.1016/S1097-2765(02)00710-4; Yang J, 2009, P NATL ACAD SCI USA, V106, P3913, DOI 10.1073/pnas.0810617106; Zhang HH, 2007, J CLIN PATHOL, V60, P555, DOI 10.1136/jcp.2006.039297; Zhu Y, 1999, NEURON, V23, P473, DOI 10.1016/S0896-6273(00)80801-6	100	107	108	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2011	286	51					43855	43870		10.1074/jbc.M111.299248	http://dx.doi.org/10.1074/jbc.M111.299248			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866SH	22030398	Green Published, hybrid			2022-12-27	WOS:000298402300027
J	Lin, S; Yu, L; Yang, JH; Liu, Z; Karia, B; Bishop, AJR; Jackson, J; Lozano, G; Copland, JA; Mu, XX; Sun, BC; Sun, LZ				Lin, Shu; Yu, Lan; Yang, Junhua; Liu, Zhao; Karia, Bijal; Bishop, Alexander J. R.; Jackson, James; Lozano, Guillermina; Copland, John A.; Mu, Xiaoxin; Sun, Beicheng; Sun, Lu-Zhe			Mutant p53 Disrupts Role of ShcA Protein in Balancing Smad Protein-dependent and -independent Signaling Activity of Transforming Growth Factor-beta (TGF-beta)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER-CELL-LINES; HUMAN PROSTATE CARCINOMA; RECEPTOR-TYPE-II; BREAST-CANCER; MAP KINASE; ADAPTER PROTEIN; MCF-7 CELLS; P66 SHC; INVASION; EXPRESSION	Biomarkers are lacking for identifying the switch of transforming growth factor-beta (TGF-beta) from tumor-suppressing to tumor-promoting. Mutated p53 (mp53) has been suggested to switch TGF-beta to a tumor promoter. However, we found that mp53 does not always promote the oncogenic role of TGF-beta. Here, we show that endogenous mp53 knockdown enhanced cell migration and phosphorylation of ERK in DU145 prostate cancer cells. Furthermore, ectopic expression of mp53 in p53-null PC-3 prostate cancer cells enhanced Smad-dependent signaling but inhibited TGF-beta -induced cell migration by down-regulating activated ERK. Reactivation of ERK by the expression of its activator, MEK-1, restored TGF-beta -induced cell migration. Because TGF-beta is known to activate the MAPK/ERK pathway through direct phosphorylation of the adaptor protein ShcA and MAPK/ERK signaling is pivotal to tumor progression, we investigated whether ShcA contributed to mp53-induced ERK inhibition and the conversion of the role of TGF-beta during carcinogenesis. We found that mp53 expression led to a decrease of phosphorylated p52ShcA/ERK levels and an increase of phosphorylated Smad levels in a panel of mp53-expressing cancer cell lines and in mammary glands and tumors from mp53 knock-in mice. By manipulating ShcA levels to regulate ERK and Smad signaling in human untransformed and cancer cell lines, we showed that the role of TGF-beta in regulating anchorage-dependent and -independent growth and migration can be shifted between growth suppression and migration promotion. Thus, our results for the first time suggest that mp53 disrupts the role of ShcA in balancing the Smad-dependent and -independent signaling activity of TGF-beta and that ShcA/ERK signaling is a major pathway regulating the tumor-promoting activity of TGF-beta	[Lin, Shu; Yu, Lan; Yang, Junhua; Liu, Zhao; Karia, Bijal; Bishop, Alexander J. R.; Mu, Xiaoxin; Sun, Lu-Zhe] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA; [Karia, Bijal; Bishop, Alexander J. R.] Univ Texas Hlth Sci Ctr San Antonio, Greehey Childrens Canc Res Inst, San Antonio, TX 78229 USA; [Bishop, Alexander J. R.; Sun, Lu-Zhe] Univ Texas Hlth Sci Ctr San Antonio, Canc Therapy & Res Ctr, San Antonio, TX 78229 USA; [Jackson, James; Lozano, Guillermina] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA; [Copland, John A.] Mayo Clin, Dept Canc Biol, Jacksonville, FL 32224 USA; [Mu, Xiaoxin; Sun, Beicheng] Nanjing Med Univ, Affiliated Hosp 1, Key Lab Living Donor Liver Transplantat, Nanjing 210009, Peoples R China	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Cancer Therapy & Research Center; University of Texas System; University of Texas Health San Antonio; University of Texas System; UTMD Anderson Cancer Center; Mayo Clinic; Nanjing Medical University	Sun, LZ (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, 7703 Floyd Curl Dr,Mail Code 7762, San Antonio, TX 78229 USA.	sunl@uthscsa.edu	, LuZhe/AAW-4095-2021; Lin, Shu/C-3790-2013	Jackson, James Griffith/0000-0002-2640-6442	National Institutes of Health [R01CA075253, R01CA079683, R01CA104505, P30CA054174-17]; NCI cancer center; NATIONAL CANCER INSTITUTE [R01CA079683, R01CA075253, P30CA054174, R01CA104505] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI cancer center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01CA075253 (to L.-Z. S.), R01CA079683 (to L.-Z. S.), R01CA104505 (to J. A. C.), and P30CA054174-17, an NCI cancer center support grant (to the Cancer Therapy and Research Center at the University of Texas Health Science Center at San Antonio).	Adorno M, 2009, CELL, V137, P87, DOI 10.1016/j.cell.2009.01.039; Aubrecht J, 1999, CARCINOGENESIS, V20, P2229, DOI 10.1093/carcin/20.12.2229; Bandyopadhyay A, 2005, PROSTATE, V63, P81, DOI 10.1002/pros.20166; Bandyopadhyay A, 2006, CANCER RES, V66, P6714, DOI 10.1158/0008-5472.CAN-05-3565; BARTEK J, 1990, ONCOGENE, V5, P893; Berglind H, 2008, CANCER BIOL THER, V7, P699, DOI 10.4161/cbt.7.5.5712; Buganim Y, 2010, CANCER RES, V70, P2274, DOI 10.1158/0008-5472.CAN-09-2661; Chen CG, 1997, J BIOL CHEM, V272, P12862, DOI 10.1074/jbc.272.19.12862; Davies M, 2005, J CELL BIOCHEM, V95, P918, DOI 10.1002/jcb.20458; Davol PA, 2003, CANCER RES, V63, P6772; Dong P, 2007, CLIN EXP METASTAS, V24, P471, DOI 10.1007/s10585-007-9084-8; Frackelton AR, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1631; Huse M, 1999, CELL, V96, P425, DOI 10.1016/S0092-8674(00)80555-3; ISAACS WB, 1991, CANCER RES, V51, P4716; Jackson JG, 2000, CLIN CANCER RES, V6, P1135; Kalo E, 2007, MOL CELL BIOL, V27, P8228, DOI 10.1128/MCB.00374-07; Ko Y, 1998, INT J ONCOL, V12, P87; Lang GA, 2004, CELL, V119, P861, DOI 10.1016/j.cell.2004.11.006; Lee MK, 2007, EMBO J, V26, P3957, DOI 10.1038/sj.emboj.7601818; Lei XF, 2002, ONCOGENE, V21, P7514, DOI 10.1038/sj.onc.1205966; Lei XF, 2007, EXP CELL RES, V313, P1687, DOI 10.1016/j.yexcr.2007.02.016; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Liu G, 2004, NAT GENET, V36, P63, DOI 10.1038/ng1282; Liu XD, 1997, P NATL ACAD SCI USA, V94, P10669, DOI 10.1073/pnas.94.20.10669; Lotti LV, 1996, MOL CELL BIOL, V16, P1946; Luzi L, 2000, CURR OPIN GENET DEV, V10, P668, DOI 10.1016/S0959-437X(00)00146-5; Ma Z, 2010, ONCOGENE, V29, P5559, DOI 10.1038/onc.2010.326; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Migliaccio E, 1997, EMBO J, V16, P706, DOI 10.1093/emboj/16.4.706; Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311; Mulder KM, 2000, CYTOKINE GROWTH F R, V11, P23, DOI 10.1016/S1359-6101(99)00026-X; Muller PAJ, 2009, CELL, V139, P1327, DOI 10.1016/j.cell.2009.11.026; Muraoka RS, 2002, J CLIN INVEST, V109, P1551, DOI 10.1172/JCI200215234; NAVONE NM, 1993, J NATL CANCER I, V85, P1657, DOI 10.1093/jnci/85.20.1657; Northey JJ, 2008, MOL CELL BIOL, V28, P3162, DOI 10.1128/MCB.01734-07; OKADA S, 1995, J BIOL CHEM, V270, P20737, DOI 10.1074/jbc.270.35.20737; Oren M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001107; Post SM, 2010, ONCOGENE, V29, P1260, DOI 10.1038/onc.2009.423; Rajendran M, 2010, CANCER METAST REV, V29, P207, DOI 10.1007/s10555-010-9213-8; Ramachandra M, 2002, CANCER RES, V62, P6045; Ravichandran KS, 2001, ONCOGENE, V20, P6322, DOI 10.1038/sj.onc.1204776; Reddy KB, 2003, CANCER METAST REV, V22, P395, DOI 10.1023/A:1023781114568; Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3; Signoretti S, 2000, AM J PATHOL, V157, P1769, DOI 10.1016/S0002-9440(10)64814-6; Singh J, 2003, BIOORG MED CHEM LETT, V13, P4355, DOI 10.1016/j.bmcl.2003.09.028; Soussi T, 2001, NAT REV CANCER, V1, P233, DOI 10.1038/35106009; Sun LZ, 2004, FRONT BIOSCI, V9, P1925, DOI 10.2741/1382; Ursini-Siegel J, 2008, CELL CYCLE, V7, P1936, DOI 10.4161/cc.7.13.6205; van Bokhoven A, 2003, PROSTATE, V57, P205, DOI 10.1002/pros.10290; vanderGeer P, 1996, CURR BIOL, V6, P1435, DOI 10.1016/S0960-9822(96)00748-8; Ventura A, 2004, J BIOL CHEM, V279, P2299, DOI 10.1074/jbc.M307655200; VOGELSTEIN B, 1993, TRENDS GENET, V9, P138, DOI 10.1016/0168-9525(93)90209-Z; Wang SP, 2009, NAT CELL BIOL, V11, P694, DOI 10.1038/ncb1875; Yang YA, 2002, J CLIN INVEST, V109, P1607, DOI 10.1172/JCI200215333; Zawel L, 1998, MOL CELL, V1, P611, DOI 10.1016/S1097-2765(00)80061-1	56	9	10	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2011	286	51					44023	44034		10.1074/jbc.M111.265397	http://dx.doi.org/10.1074/jbc.M111.265397			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866SH	22039050	Green Published, hybrid			2022-12-27	WOS:000298402300043
J	Chung, KCC; Zamble, DB				Chung, Kim C. Chan; Zamble, Deborah B.			Protein Interactions and Localization of the Escherichia coli Accessory Protein HypA during Nickel Insertion to [NiFe] Hydrogenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LARGE SUBUNIT; MATURATION; COMPLEX; SLYD; ZINC; CHAPERONE; SITE; IDENTIFICATION; BIOSYNTHESIS; RECOGNITION	Nickel delivery during maturation of Escherichia coli [NiFe] hydrogenase 3 includes the accessory proteins HypA, HypB, and SlyD. Although the isolated proteins have been characterized, little is known about how they interact with each other and the hydrogenase 3 large subunit, HycE. In this study the complexes of HypA and HycE were investigated after modification with the Strep-tag II. Multiprotein complexes containing HypA, HypB, SlyD, and HycE were observed, consistent with the assembly of a single nickel insertion cluster. An interaction between HypA and HycE did not require the other nickel insertion proteins, but HypB was not found with the large subunit in the absence of HypA. The HypA-HycE complex was not detected in the absence of the HypC or HypD proteins, involved in the preceding iron insertion step, and this interaction is enhanced by nickel brought into the cell by the NikABCDE membrane transporter. Furthermore, without the hydrogenase 1, 2, and 3 large subunits, complexes between HypA, HypB, and SlyD were observed. These results support the hypothesis that HypA acts as a scaffold for assembly of the nickel insertion proteins with the hydrogenase precursor protein after delivery of the iron center. At different stages of the hydrogenase maturation process, HypA was observed at or near the cell membrane by using fluorescence confocal microscopy, as was HycE, suggesting membrane localization of the nickel insertion event.	[Chung, Kim C. Chan; Zamble, Deborah B.] Univ Toronto, Dept Chem, Toronto, ON M5S 3H6, Canada	University of Toronto	Zamble, DB (corresponding author), 80 St George St, Toronto, ON M5S 3H6, Canada.	dzamble@chem.utoronto.ca		Zamble, Deborah/0000-0002-8976-3375	Canadian Institutes of Health Research; Canada Research Chairs Program	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chairs Program(Canada Research Chairs)	This work was funded in part by grants from Canadian Institutes of Health Research and the Canada Research Chairs Program.	Apweiler R, 2011, NUCLEIC ACIDS RES, V39, pD214, DOI 10.1093/nar/gkq1020; Atanassova A, 2005, J BACTERIOL, V187, P4689, DOI 10.1128/JB.187.14.4689-4697.2005; BALLANTINE SP, 1985, J BACTERIOL, V163, P454, DOI 10.1128/JB.163.2.454-459.1985; Blokesch M, 2004, EUR J BIOCHEM, V271, P3428, DOI 10.1111/j.1432-1033.2004.04280.x; Blokesch M, 2004, J BACTERIOL, V186, P2603, DOI 10.1128/JB.186.9.2603-2611.2004; Blokesch M, 2002, BIOCHEM SOC T, V30, P674, DOI 10.1042/BST0300674; Blokesch M, 2002, J MOL BIOL, V324, P287, DOI 10.1016/S0022-2836(02)01070-7; Bock A, 2006, ADV MICROB PHYSIOL, V51, P1, DOI 10.1016/S0065-2911(06)51001-X; Butland G, 2006, FEBS LETT, V580, P677, DOI 10.1016/j.febslet.2005.12.063; Cai F, 2011, J BIOL INORG CHEM, V16, P857, DOI 10.1007/s00775-011-0782-y; CASADABAN MJ, 1979, P NATL ACAD SCI USA, V76, P4530, DOI 10.1073/pnas.76.9.4530; Chung KCC, 2011, FEBS LETT, V585, P291, DOI 10.1016/j.febslet.2010.12.024; Dias AV, 2008, BIOCHEMISTRY-US, V47, P11981, DOI 10.1021/bi801337x; Dubini A, 2003, FEBS LETT, V549, P141, DOI 10.1016/S0014-5793(03)00802-0; Eppler T, 2002, J BACTERIOL, V184, P3044, DOI 10.1128/JB.184.11.3044-3052.2002; Fontecilla-Camps JC, 2007, CHEM REV, V107, P4273, DOI 10.1021/cr050195z; Forzi L, 2007, BIOMETALS, V20, P565, DOI 10.1007/s10534-006-9048-5; Gamsjaeger R, 2007, TRENDS BIOCHEM SCI, V32, P63, DOI 10.1016/j.tibs.2006.12.007; Graubner W, 2007, J BIOL CHEM, V282, P7116, DOI 10.1074/jbc.M608235200; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Herbst RW, 2010, J AM CHEM SOC, V132, P10338, DOI 10.1021/ja1005724; Hube M, 2002, J BACTERIOL, V184, P3879, DOI 10.1128/JB.184.14.3879-3885.2002; Iwig JS, 2006, MOL MICROBIOL, V62, P252, DOI 10.1111/j.1365-2958.2006.05369.x; JACOBI A, 1992, ARCH MICROBIOL, V158, P444; Jones AK, 2004, BIOCHEMISTRY-US, V43, P13467, DOI 10.1021/bi048837k; Kaluarachchi H, 2010, NAT PROD REP, V27, P681, DOI 10.1039/b906688h; KESSLER D, 1991, FEBS LETT, V281, P59, DOI 10.1016/0014-5793(91)80358-A; Kuchar J, 2004, CHEM REV, V104, P509, DOI 10.1021/cr020613p; Leach MR, 2007, J BIOL CHEM, V282, P16177, DOI 10.1074/jbc.M610834200; Li YJ, 2009, CHEM REV, V109, P4617, DOI 10.1021/cr900010n; Loscher S, 2005, FEBS LETT, V579, P4287, DOI 10.1016/j.febslet.2005.06.063; Maeda T, 2007, APPL MICROBIOL BIOT, V77, P879, DOI 10.1007/s00253-007-1217-0; Magalon A, 2000, FEBS LETT, V473, P254, DOI 10.1016/S0014-5793(00)01542-8; Magalon A, 2000, J BIOL CHEM, V275, P21114, DOI 10.1074/jbc.M000987200; MAIER T, 1993, J BACTERIOL, V175, P630, DOI 10.1128/JB.175.3.630-635.1993; Mansure JJ, 2008, BIOTECHNOL LETT, V30, P1765, DOI 10.1007/s10529-008-9755-9; McGlynn SE, 2007, J BIOL INORG CHEM, V12, P443, DOI 10.1007/s00775-007-0224-z; McGlynn SE, 2009, DALTON T, P4274, DOI 10.1039/b821432h; Mehta N, 2003, J BACTERIOL, V185, P726, DOI 10.1128/JB.185.3.726-734.2003; Nevo-Dinur K, 2011, SCIENCE, V331, P1081, DOI 10.1126/science.1195691; Nobelmann B, 1996, J BACTERIOL, V178, P6790, DOI 10.1128/jb.178.23.6790-6795.1996; Redwood MD, 2008, FEMS MICROBIOL LETT, V278, P48, DOI 10.1111/j.1574-6968.2007.00966.x; ROSSMANN R, 1994, EUR J BIOCHEM, V220, P377, DOI 10.1111/j.1432-1033.1994.tb18634.x; Rowe JL, 2005, J BACTERIOL, V187, P6317, DOI 10.1128/JB.187.18.6317-6323.2005; SAUTER M, 1992, MOL MICROBIOL, V6, P1523, DOI 10.1111/j.1365-2958.1992.tb00873.x; Sawers RG, 2005, BIOCHEM SOC T, V33, P42, DOI 10.1042/BST0330042; Scholz C, 2006, BIOCHEMISTRY-US, V45, P20, DOI 10.1021/bi051922n; Stingl K, 2008, MOL CELL PROTEOMICS, V7, P2429, DOI 10.1074/mcp.M800160-MCP200; Theodoratou E, 2005, BIOCHEM SOC T, V33, P108, DOI 10.1042/BST0330108; VARGA MER, 1995, BIOCHEM CELL BIOL, V73, P147, DOI 10.1139/o95-018; Watanabe S, 2009, J MOL BIOL, V394, P448, DOI 10.1016/j.jmb.2009.09.030; Winter G, 2005, FEBS LETT, V579, P4292, DOI 10.1016/j.febslet.2005.06.064; WU LF, 1989, MOL MICROBIOL, V3, P1709, DOI 10.1111/j.1365-2958.1989.tb00156.x; WU LF, 1986, BIOCHIMIE, V68, P167, DOI 10.1016/S0300-9084(86)81081-1; Wu LF, 2000, ARCH MICROBIOL, V173, P319, DOI 10.1007/s002030000144; Xia W, 2009, J AM CHEM SOC, V131, P10031, DOI 10.1021/ja900543y; Yu CS, 2004, PROTEIN SCI, V13, P1402, DOI 10.1110/ps.03479604; Zhang JW, 2005, J BIOL CHEM, V280, P4360, DOI 10.1074/jbc.M411799200	58	31	31	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					43081	43090		10.1074/jbc.M111.290726	http://dx.doi.org/10.1074/jbc.M111.290726			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22016389	Green Published, hybrid			2022-12-27	WOS:000298351300029
J	Ichikawa, D; Mizuno, M; Yamamura, T; Miyake, S				Ichikawa, Daiju; Mizuno, Miho; Yamamura, Takashi; Miyake, Sachiko			GRAIL (Gene Related to Anergy in Lymphocytes) Regulates Cytoskeletal Reorganization through Ubiquitination and Degradation of Arp2/3 Subunit 5 and Coronin 1A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-CELL ANERGY; CBL-B; NEGATIVE REGULATION; IMMUNOLOGICAL SYNAPSE; ACTIN CYTOSKELETON; TYROSINE KINASE; LIGASE; COMPLEX; BINDING; ACTIVATION	Anergy is an important mechanism for the maintenance of peripheral tolerance and avoidance of autoimmunity. The upregulation of E3 ubiqitin ligases, including GRAIL (gene related to anergy in lymphocytes), is a key event in the induction and preservation of anergy in T cells. However, the mechanisms of GRAIL-mediated anergy induction are still not completely understood. We examined which proteins serve as substrates for GRAIL in anergic T cells. Arp2/3-5 (actin-related protein 2/3 subunit 5) and coronin 1A were polyubiquitinated by GRAIL via Lys-48 and Lys-63 linkages. In anergic T cells and GRAIL-overexpressed T cells, the expression of Arp2/3-5 and coronin 1A was reduced. Furthermore, we demonstrated that GRAIL impaired lamellipodium formation and reduced the accumulation of F-actin at the immunological synapse. GRAIL functions via the ubiquitination and degradation of actin cytoskeleton-associated proteins, in particular Arp2/3-5 and coronin 1A. These data reveal that GRAIL regulates proteins involved in the actin cytoskeletal organization, thereby maintaining the unresponsive state of anergic T cells.	[Ichikawa, Daiju; Mizuno, Miho; Yamamura, Takashi; Miyake, Sachiko] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Immunol, Kodaira, Tokyo 1878502, Japan	National Center for Neurology & Psychiatry - Japan	Miyake, S (corresponding author), 4-1-1 Ogawahigashi, Kodaira, Tokyo 1878502, Japan.	miyake@ncnp.go.jp			Japan Society for the Promotion of Science [7210, 20790093]; Ministry of Health, Labor and Welfare of Japan	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by Grant-in-Aid for Scientific Research B: 7210 (to S. M.) and Grant-in-Aid for Young Scientists B: 20790093 (to D. I.) from the Japan Society for the Promotion of Science, and Health and Labor Sciences Research Grants for Research on Intractable Diseases from the Ministry of Health, Labor and Welfare of Japan.	Anandasabapathy N, 2003, IMMUNITY, V18, P535, DOI 10.1016/S1074-7613(03)00084-0; Andoniou CE, 2000, MOL CELL BIOL, V20, P851, DOI 10.1128/MCB.20.3.851-867.2000; Bachmaier K, 2000, NATURE, V403, P211, DOI 10.1038/35003228; Duan L, 2004, IMMUNITY, V21, P7, DOI 10.1016/j.immuni.2004.06.012; Fang D, 2001, J BIOL CHEM, V276, P4872, DOI 10.1074/jbc.M008901200; Fang DY, 2001, NAT IMMUNOL, V2, P870, DOI 10.1038/ni0901-870; Foger N, 2006, SCIENCE, V313, P839, DOI 10.1126/science.1130563; Goley ED, 2006, NAT REV MOL CELL BIO, V7, P713, DOI 10.1038/nrm2026; Gomez TS, 2007, IMMUNITY, V26, P177, DOI 10.1016/j.immuni.2007.01.008; Haraldsson MK, 2008, IMMUNITY, V28, P40, DOI 10.1016/j.immuni.2007.11.023; Heissmeyer V, 2004, NAT IMMUNOL, V5, P255, DOI 10.1038/ni1047; Holsinger LJ, 1998, CURR BIOL, V8, P563, DOI 10.1016/S0960-9822(98)70225-8; Hsiao HW, 2009, IMMUNITY, V31, P72, DOI 10.1016/j.immuni.2009.04.017; Jeon MS, 2004, IMMUNITY, V21, P167, DOI 10.1016/j.immuni.2004.07.013; Krause M, 2000, J CELL BIOL, V149, P181, DOI 10.1083/jcb.149.1.181; Kriegel MA, 2009, P NATL ACAD SCI USA, V106, P16770, DOI 10.1073/pnas.0908957106; Lineberry N, 2008, J BIOL CHEM, V283, P28497, DOI 10.1074/jbc.M805092200; Lineberry NB, 2008, J IMMUNOL, V181, P1622, DOI 10.4049/jimmunol.181.3.1622; Liu YC, 2004, ANNU REV IMMUNOL, V22, P81, DOI 10.1146/annurev.immunol.22.012703.104813; Lupher ML, 1998, J BIOL CHEM, V273, P35273, DOI 10.1074/jbc.273.52.35273; Lupher ML, 1997, J BIOL CHEM, V272, P33140, DOI 10.1074/jbc.272.52.33140; Machesky LM, 1998, CURR BIOL, V8, P1347, DOI 10.1016/S0960-9822(98)00015-3; Miki H, 1996, EMBO J, V15, P5326, DOI 10.1002/j.1460-2075.1996.tb00917.x; Mueller P, 2008, NAT IMMUNOL, V9, P424, DOI 10.1038/ni1570; Mugnier B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003467; Nolz JC, 2006, CURR BIOL, V16, P24, DOI 10.1016/j.cub.2005.11.036; Nolz JC, 2007, MOL CELL BIOL, V27, P5986, DOI 10.1128/MCB.00136-07; Nurieva RI, 2010, IMMUNITY, V32, P670, DOI 10.1016/j.immuni.2010.05.002; QUILL H, 1987, J IMMUNOL, V138, P3704; Rao NV, 2002, P NATL ACAD SCI USA, V99, P3794, DOI 10.1073/pnas.062055999; Rodal AA, 2005, NAT STRUCT MOL BIOL, V12, P26, DOI 10.1038/nsmb870; Schartner JM, 2009, J BIOL CHEM, V284, P34674, DOI 10.1074/jbc.M109.024497; Schwartz RH, 2003, ANNU REV IMMUNOL, V21, P305, DOI 10.1146/annurev.immunol.21.120601.141110; Su L, 2006, J IMMUNOL, V177, P7559, DOI 10.4049/jimmunol.177.11.7559; Su LL, 2009, J IMMUNOL, V183, P438, DOI 10.4049/jimmunol.0900204; Venuprasad K, 2006, J CLIN INVEST, V116, P1117, DOI 10.1172/JCI26858; Walker LSK, 2002, NAT REV IMMUNOL, V2, P11, DOI 10.1038/nri701	37	18	22	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					43465	43474		10.1074/jbc.M111.222711	http://dx.doi.org/10.1074/jbc.M111.222711			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22016387	Green Published, hybrid			2022-12-27	WOS:000298351300066
J	Kim, J; Eskiocak, U; Stadler, G; Lou, ZJ; Kuro-o, M; Shay, JW; Wright, WE				Kim, Jinyong; Eskiocak, Ugur; Stadler, Guido; Lou, Zhenjun; Kuro-o, Makoto; Shay, Jerry W.; Wright, Woodring E.			Short Hairpin RNA Screen Indicates That Klotho Beta/FGF19 Protein Overcomes Stasis in Human Colonic Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OLFACTORY ENSHEATHING CELLS; CANINE SCHWANN-CELLS; GROWTH-FACTOR; ENDOTHELIAL-CELLS; BETA-KLOTHO; LIFE-SPAN; IN-VITRO; TELOMERASE; IMMORTALIZATION; FGF19	Normal human colonic epithelial cells (HCECs) are not immortalized by telomerase alone but also require CDK4. Some human cell types growth-arrest due to stress-or aberrant signaling-induced senescence (stasis). Stasis represents the consequences of growth conditions culture that are inadequate to maintain long-term proliferation. Overexpressed CDK4 titers out p16 and allows cells to ignore the growth arrest signals produced by stasis. To identify factors contributing to the inadequate culture environment, we used a 62,000-member shRNA library to knock down factors cooperating with human telomerase reverse transcriptase (hTERT) in the immortalization of HCECs. Knockdown of Klotho gamma (KLG; also known as KLPH and LCTL) allowed hTERT to immortalize HCECs. KLG is one isoform of the Klotho family of factors that coordinate interaction between different FGF ligands and the FGF receptor. We also found that knockdown of KLG induced another member of the Klotho family, Klotho beta (KLB). Induction of KLB was maintained and could activate ERK1/2 in immortalized cells. Supplementation of the culture medium with the KLB ligand FGF19 had a similar effect on hTERT-expressing HCECs as knockdown of KLG regarding both immortalization and down-regulation of the tumor suppressor Klotho alpha. Together, these data suggest that KLB is an important regulator in the immortalization of HCECs by facilitating FGF19 growth factor signaling.	[Kim, Jinyong; Eskiocak, Ugur; Stadler, Guido; Lou, Zhenjun; Shay, Jerry W.; Wright, Woodring E.] Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA; [Kuro-o, Makoto] Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Wright, WE (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Cell Biol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	woodring.wright@utsouthwestern.edu	Eskiocak, Ugur/M-9903-2015		National Institutes of Health [AG01228, AG019712, DK091392]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK091392] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG001228, R37AG001228, R01AG019712] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG01228 (to W. E. W.) and AG019712 and DK091392 (to M. K.).	Ashida Reiko, 2005, Inflammopharmacology, V13, P113, DOI 10.1163/156856005774423935; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; de Oliveira RM, 2006, FEBS LETT, V580, P5753, DOI 10.1016/j.febslet.2006.09.036; Desnoyers L, 2008, ONCOGENE, V27, P85, DOI 10.1038/sj.onc.1210623; Drayton S, 2002, CURR OPIN GENET DEV, V12, P98, DOI 10.1016/S0959-437X(01)00271-4; Forsyth NR, 2003, AGING CELL, V2, P235, DOI 10.1046/j.1474-9728.2003.00057.x; Goetz R, 2010, P NATL ACAD SCI USA, V107, P407, DOI 10.1073/pnas.0902006107; HAYFLICK L, 1979, J INVEST DERMATOL, V73, P8, DOI 10.1111/1523-1747.ep12532752; Ikushima M, 2006, BIOCHEM BIOPH RES CO, V339, P827, DOI 10.1016/j.bbrc.2005.11.094; Kharitonenkov A, 2008, J CELL PHYSIOL, V215, P1, DOI 10.1002/jcp.21357; Kurosu H, 2007, J BIOL CHEM, V282, P26687, DOI 10.1074/jbc.M704165200; Kurz DJ, 2003, ARTERIOSCL THROM VAS, V23, P748, DOI 10.1161/01.ATV.0000069624.55424.61; Lee J, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-109; Lin BC, 2007, J BIOL CHEM, V282, P27277, DOI 10.1074/jbc.M704244200; Liu HJ, 2007, SCIENCE, V317, P803, DOI 10.1126/science.1143578; Nisato RE, 2004, AM J PATHOL, V165, P11, DOI 10.1016/S0002-9440(10)63271-3; Ramirez RD, 2004, CANCER RES, V64, P9027, DOI 10.1158/0008-5472.CAN-04-3703; Ramirez RD, 2001, GENE DEV, V15, P398, DOI 10.1101/gad.859201; Roig AI, 2010, GASTROENTEROLOGY, V138, P1012, DOI 10.1053/j.gastro.2009.11.052; Shay JW, 2005, CARCINOGENESIS, V26, P867, DOI 10.1093/carcin/bgh296; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; Tacer KF, 2010, MOL ENDOCRINOL, V24, P2050, DOI 10.1210/me.2010-0142; Techangamsuwan S, 2009, J NEUROSCI METH, V176, P112, DOI 10.1016/j.jneumeth.2008.08.030; Techangamsuwan S, 2008, BRAIN RES, V1240, P31, DOI 10.1016/j.brainres.2008.08.092; WANG H, 2011, J CLIN INVE IN PRESS; Wu XL, 2009, AGING-US, V1, P1023, DOI 10.18632/aging.100108; Zhu HB, 2004, ONCOGENE, V23, P4984, DOI 10.1038/sj.onc.1207645	27	7	8	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					43294	43300		10.1074/jbc.M111.267641	http://dx.doi.org/10.1074/jbc.M111.267641			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22020932	Green Published, hybrid			2022-12-27	WOS:000298351300049
J	Lechardeur, D; Cesselin, B; Liebl, U; Vos, MH; Fernandez, A; Brun, C; Gruss, A; Gaudu, P				Lechardeur, Delphine; Cesselin, Benedicte; Liebl, Ursula; Vos, Marten H.; Fernandez, Annabelle; Brun, Celia; Gruss, Alexandra; Gaudu, Philippe			Discovery of Intracellular Heme-binding Protein HrtR, Which Controls Heme Efflux by the Conserved HrtB-HrtA Transporter in Lactococcus lactis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IRON RESPONSE REGULATOR; STAPHYLOCOCCUS-AUREUS; CORYNEBACTERIUM-DIPHTHERIAE; RESPIRATION CAPACITY; 2-COMPONENT SYSTEM; CYTOCHROME BD; TETR FAMILY; TOXICITY; BACTERIA; GROWTH	Most commensal and food bacteria lack heme biosynthesis genes. For several of these, the capture of environmental heme is a means of activating aerobic respiration metabolism. Our previous studies in the Gram-positive bacterium Lactococcus lactis showed that heme exposure strongly induced expression of a single operon, called here hrtRBA, encoding an ortholog of the conserved membrane hrt (heme-regulated transporter) and a unique transcriptional regulator that we named HrtR. We show that HrtR expressed as a fusion protein is a heme-binding protein. Heme iron interaction with HrtR is non-covalent, hexacoordinated, and involves two histidines, His-72 and His-149. HrtR specifically binds a 15-nt palindromic sequence in the hrtRBA promoter region, which is needed for hrtRBA repression. HrtR-DNA binding is abolished by heme addition, which activates expression of the HrtB-HrtA (HrtBA) transporter in vitro and in vivo. The use of HrtR as an intracellular heme sensor appears to be conserved among numerous commensal bacteria, in contrast with numerous Gram-positive pathogens that use an extracellular heme-sensing system, HssRS, to regulate hrt. Finally, we show for the first time that HrtBA permease controls heme toxicity by its direct and specific efflux. The use of an intracellular heme sensor to control heme efflux constitutes a novel paradigm for bacterial heme homeostasis.	[Lechardeur, Delphine; Cesselin, Benedicte; Fernandez, Annabelle; Brun, Celia; Gruss, Alexandra; Gaudu, Philippe] INRA, UMR1319, Inst Micalis, UMR1319 Micalis, F-78352 Jouy En Josas, France; [Lechardeur, Delphine; Cesselin, Benedicte; Fernandez, Annabelle; Brun, Celia; Gruss, Alexandra; Gaudu, Philippe] AgroParisTech, UMR Micalis, F-78350 Jouy En Josas, France; [Liebl, Ursula; Vos, Marten H.] Ecole Polytech, Lab Opt & Biosci, CNRS, UMR7645, F-91128 Palaiseau, France; [Liebl, Ursula; Vos, Marten H.] INSERM, U696, F-91128 Palaiseau, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Institut Polytechnique de Paris; Institut National de la Sante et de la Recherche Medicale (Inserm)	Lechardeur, D (corresponding author), INRA, UMR1319, Inst Micalis, UMR1319 Micalis, Batiment 222, F-78352 Jouy En Josas, France.	delphine.lechardeur@jouy.inra.fr	GAUDU, Philippe/AAE-9696-2022; GAUDU, Philippe/AFE-8376-2022	Gruss, Alexandra/0000-0001-7426-5229; Vos, Marten/0000-0003-0493-4831; LIEBL, Ursula/0000-0003-0869-4388	French "Agence Nationale de la Recherche"	French "Agence Nationale de la Recherche"(French National Research Agency (ANR))	This work was supported in part by the "StrepRespire" project by the French "Agence Nationale de la Recherche" and Chr. Hansen.	Anzaldi LL, 2010, INFECT IMMUN, V78, P4977, DOI 10.1128/IAI.00613-10; BARRICK D, 1994, BIOCHEMISTRY-US, V33, P6546, DOI 10.1021/bi00187a023; Bibb LA, 2010, J BACTERIOL, V192, P4606, DOI 10.1128/JB.00525-10; Brugna M, 2010, FEBS J, V277, P2663, DOI [10.1111/j.1742-464X.2010.07677.x, 10.1111/j.1742-4658.2010.07677.x]; Christel Garrigues Johansen E., 2006, NAT REV MICROBIOL, V4, pc3; Christel Garrigues Johansen E., 2006, NAT REV MICROBIOL, V4, pc2; Duwat P, 2001, J BACTERIOL, V183, P4509, DOI 10.1128/JB.183.15.4509-4516.2001; Fernandez A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000860; Friedman DB, 2006, PLOS PATHOG, V2, P777, DOI 10.1371/journal.ppat.0020087; Gaudu P, 2003, MOL MICROBIOL, V50, P183, DOI 10.1046/j.1365-2958.2003.03700.x; Gaudu P, 2002, ANTON LEEUW INT J G, V82, P263, DOI 10.1023/A:1020635600343; Hoier E., 2010, TECHNOLOGY CHEESEMAK, P193; KANEKO T, 1990, APPL ENVIRON MICROB, V56, P2644, DOI 10.1128/AEM.56.9.2644-2649.1990; Kaur AP, 2009, J BIOL CHEM, V284, P56, DOI 10.1074/jbc.M806068200; Lechardeur D, 2011, CURR OPIN BIOTECH, V22, P143, DOI 10.1016/j.copbio.2010.12.001; Lechardeur D, 2010, J BIOL CHEM, V285, P16032, DOI 10.1074/jbc.M109.024505; Letoffe S, 2009, P NATL ACAD SCI USA, V106, P11719, DOI 10.1073/pnas.0903842106; Marletta MA, 2006, ACS CHEM BIOL, V1, P73, DOI 10.1021/cb600110g; Miller J.H., 1972, EXPT MOL GENETICS; Moriwaki Y, 2011, BIOCHEMISTRY-US, V50, P7311, DOI 10.1021/bi200493h; Qi ZH, 2002, MOL CELL, V9, P155, DOI 10.1016/S1097-2765(01)00431-2; Ramos JL, 2005, MICROBIOL MOL BIOL R, V69, P326, DOI 10.1128/MMBR.69.2.326-356.2005; Ran YC, 2010, BIOCHEMISTRY-US, V49, P2834, DOI 10.1021/bi901987h; Reniere ML, 2007, BIOMETALS, V20, P333, DOI 10.1007/s10534-006-9032-0; Routh MD, 2009, BBA-PROTEINS PROTEOM, V1794, P844, DOI 10.1016/j.bbapap.2008.12.001; Schultz IJ, 2010, J BIOL CHEM, V285, P26753, DOI 10.1074/jbc.R110.119503; Skaar EP, 2004, J BIOL CHEM, V279, P436, DOI 10.1074/jbc.M307952200; Small S, 2009, BIOMETALS, V22, P89, DOI 10.1007/s10534-008-9192-1; Stauff DL, 2008, J BACTERIOL, V190, P3588, DOI 10.1128/JB.01921-07; Stauff DL, 2007, J BIOL CHEM, V282, P26111, DOI 10.1074/jbc.M703797200; Stauff DL, 2009, CONTRIB MICROBIOL, V16, P120, DOI 10.1159/000219376; Stauff DL, 2009, MOL MICROBIOL, V72, P763, DOI 10.1111/j.1365-2958.2009.06684.x; Stojiljkovic I, 1999, MOL MICROBIOL, V31, P429, DOI 10.1046/j.1365-2958.1999.01175.x; Torres VJ, 2007, CELL HOST MICROBE, V1, P109, DOI 10.1016/j.chom.2007.03.001; VANDERVOSSEN JMBM, 1987, APPL ENVIRON MICROB, V53, P2452, DOI 10.1128/AEM.53.10.2452-2457.1987; Vido K, 2004, J BACTERIOL, V186, P1648, DOI 10.1128/JB.186.6.1648-1657.2004; Wilks A, 1998, J BIOL CHEM, V273, P837, DOI 10.1074/jbc.273.2.837; Winstedt L, 2000, J BACTERIOL, V182, P3863, DOI 10.1128/JB.182.13.3863-3866.2000; Winstedt L, 2000, J BACTERIOL, V182, P6557, DOI 10.1128/JB.182.23.6557-6564.2000; Yang JH, 2006, MOL MICROBIOL, V60, P427, DOI 10.1111/j.1365-2958.2006.05101.x	40	63	68	8	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					4752	4758		10.1074/jbc.M111.297531	http://dx.doi.org/10.1074/jbc.M111.297531			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22084241	Green Published, hybrid			2022-12-27	WOS:000300608500036
J	Rao, JN; Rivera-Santiago, R; Li, XE; Lehman, W; Dominguez, R				Rao, Jampani Nageswara; Rivera-Santiago, Roland; Li, Xiaochuan Edward; Lehman, William; Dominguez, Roberto			Structural Analysis of Smooth Muscle Tropomyosin alpha and beta Isoforms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIN CYTOSKELETAL DYNAMICS; COILED-COIL; CRYSTAL-STRUCTURE; BINDING; TROPONIN; POLYMERIZATION; RECOGNITION; FLEXIBILITY; ACTIVATION; SEQUENCE	A large number of tropomyosin (Tm) isoforms function as gatekeepers of the actin filament, controlling the spatiotemporal access of actin-binding proteins to specialized actin networks. Residues similar to 40-80 vary significantly among Tm isoforms, but the impact of sequence variation on Tm structure and interactions with actin is poorly understood, because structural studies have focused on skeletal muscle Tm beta. We describe structures of N-terminal fragments of smooth muscle Tm alpha and Tm beta (sm-Tm alpha and sm-Tm beta). The 2.0-angstrom structure of sm-Tm alpha 81 (81-aa) resembles that of skeletal Tm alpha, displaying a similar super-helical twist matching the contours of the actin filament. The 1.8-angstrom structure of sm-Tm alpha 98 (98-aa) unexpectedly reveals an antiparallel coiled coil, with the two chains staggered by only 4 amino acids and displaying hydrophobic core interactions similar to those of the parallel dimer. In contrast, the 2.5-angstrom structure of sm-Tm beta 98, containing Gly-Ala-Ser at the N terminus to mimic acetylation, reveals a parallel coiled coil. None of the structures contains coiled-coil stabilizing elements, favoring the formation of head-to-tail overlap complexes in four of five crystallographically independent parallel dimers. These complexes show similarly arranged 4-helix bundles stabilized by hydrophobic interactions, but the extent of the overlap varies between sm-Tm beta 98 and sm-Tm alpha 81 from 2 to 3 helical turns. The formation of overlap complexes thus appears to be an intrinsic property of the Tm coiled coil, with the specific nature of hydrophobic contacts determining the extent of the overlap. Overall, the results suggest that sequence variation among Tm isoforms has a limited effect on actin binding but could determine its gatekeeper function.	[Rao, Jampani Nageswara; Rivera-Santiago, Roland; Dominguez, Roberto] Univ Penn, Perelman Sch Med, Dept Physiol, Philadelphia, PA 19104 USA; [Li, Xiaochuan Edward; Lehman, William] Boston Univ, Sch Med, Dept Physiol & Biophys, Boston, MA 02118 USA	University of Pennsylvania; Pennsylvania Medicine; Boston University	Dominguez, R (corresponding author), A-507 Richards Bldg,3700 Hamilton Walk, Philadelphia, PA 19104 USA.	droberto@mail.med.upenn.edu		Lehman, William/0000-0002-9430-9521	National Institutes of Health [P01 HL086655, RR-01646]; Industrial Macromolecular Crystallography Association through Hauptman-Woodward Medical Research Institute; Department of Energy [W-31-109-Eng-38]; National Science Foundation [DMR-0936384]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001646] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL086655] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Industrial Macromolecular Crystallography Association through Hauptman-Woodward Medical Research Institute; Department of Energy(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant P01 HL086655 (to R. D. and W. L.).; Use of IMCA-CAT beamline 17-ID was supported by the Industrial Macromolecular Crystallography Association through a contract with the Hauptman-Woodward Medical Research Institute. The Advanced Photon Source was supported by the Department of Energy Contract W-31-109-Eng-38. Crystal data collection at CHESS was supported by National Science Foundation Grant DMR-0936384 and National Institutes of Health Grant RR-01646.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ali F, 2005, CAN J PHYSIOL PHARM, V83, P825, DOI 10.1139/Y05-052; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Blanchoin L, 2001, CURR BIOL, V11, P1300, DOI 10.1016/S0960-9822(01)00395-5; Brown JH, 2005, P NATL ACAD SCI USA, V102, P18878, DOI 10.1073/pnas.0509269102; Brown JH, 2005, ADV PROTEIN CHEM, V71, P121, DOI 10.1016/S0065-3233(04)71004-9; Brown JH, 2001, P NATL ACAD SCI USA, V98, P8496, DOI 10.1073/pnas.131219198; Clarkson E, 2004, J PATHOL, V204, P407, DOI 10.1002/path.1648; Conley CA, 2001, AM J PHYSIOL-CELL PH, V280, pC1645, DOI 10.1152/ajpcell.2001.280.6.C1645; Craig R, 2006, CURR OPIN STRUC BIOL, V16, P204, DOI 10.1016/j.sbi.2006.03.006; Dominguez R, 2011, BIOPHYS J, V100, P797, DOI 10.1016/j.bpj.2011.01.018; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071; Frye J, 2010, BIOCHEMISTRY-US, V49, P4908, DOI 10.1021/bi100349a; Gallant C, 2011, AM J PHYSIOL-CELL PH, V300, pC1356, DOI 10.1152/ajpcell.00450.2010; Gerthoffer WT, 2005, CAN J PHYSIOL PHARM, V83, P851, DOI 10.1139/Y05-088; Greenfield NJ, 2003, BIOCHEMISTRY-US, V42, P614, DOI 10.1021/bi026989e; Greenfield NJ, 2006, J MOL BIOL, V364, P80, DOI 10.1016/j.jmb.2006.08.033; Gunning P, 1998, BIOESSAYS, V20, P892, DOI 10.1002/(SICI)1521-1878(199811)20:11<892::AID-BIES4>3.3.CO;2-4; Gunning P, 2008, PHYSIOL REV, V88, P1, DOI 10.1152/physrev.00001.2007; Gunst SJ, 2008, AM J PHYSIOL-CELL PH, V295, pC576, DOI 10.1152/ajpcell.00253.2008; Hitchcock-DeGregori SE, 2008, ADV EXP MED BIOL, V644, P60; HitchcockDeGregori SE, 1996, J BIOL CHEM, V271, P3600; Holmes KC, 2008, J MUSCLE RES CELL M, V29, P213, DOI 10.1007/s10974-008-9157-6; Ishikawa R, 1998, J BIOL CHEM, V273, P26991, DOI 10.1074/jbc.273.41.26991; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kim HR, 2008, J CELL MOL MED, V12, P2165, DOI 10.1111/j.1582-4934.2008.00552.x; LAING NG, 1995, NAT GENET, V9, P75, DOI 10.1038/ng0195-75; Lehrer SS, 2011, J MUSCLE RES CELL M, V32, P63, DOI 10.1007/s10974-011-9254-9; Lehrer SS, 2011, J MUSCLE RES CELL M, V32, P19, DOI 10.1007/s10974-011-9249-6; Lehrer SS, 1997, BIOCHEMISTRY-US, V36, P13449, DOI 10.1021/bi971568w; Li XC, 2011, BIOPHYS J, V100, P1005, DOI 10.1016/j.bpj.2010.12.3697; Li Y, 2002, P NATL ACAD SCI USA, V99, P7378, DOI 10.1073/pnas.102179999; Lord M, 2011, CURR BIOL, V21, pR255, DOI 10.1016/j.cub.2011.02.043; MAK AS, 1981, J MOL BIOL, V149, P541, DOI 10.1016/0022-2836(81)90486-1; Martin C, 2008, ADV EXP MED BIOL, V644, P187; MCLACHLAN AD, 1975, J MOL BIOL, V98, P293, DOI 10.1016/S0022-2836(75)80119-7; Mehta D, 1999, J PHYSIOL-LONDON, V519, P829, DOI 10.1111/j.1469-7793.1999.0829n.x; Minakata S, 2008, BIOPHYS J, V95, P710, DOI 10.1529/biophysj.107.126144; ONEIL KT, 1990, TRENDS BIOCHEM SCI, V15, P59, DOI 10.1016/0968-0004(90)90177-D; Paulucci AA, 2004, EUR J BIOCHEM, V271, P589, DOI 10.1111/j.1432-1033.2003.03961.x; Perrin BJ, 2010, CYTOSKELETON, V67, P630, DOI 10.1002/cm.20475; Saito Shin-Ya, 1996, Journal of Smooth Muscle Research, V32, P51; Seow CY, 2011, J APPL PHYSIOL, V110, P1130, DOI 10.1152/japplphysiol.01192.2010; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Singh A, 2003, BIOCHEMISTRY-US, V42, P14114, DOI 10.1021/bi0348462; Skau CT, 2011, J BIOL CHEM, V286, P26964, DOI 10.1074/jbc.M111.239004; Sousa D, 2010, BIOPHYS J, V99, P862, DOI 10.1016/j.bpj.2010.05.004; Tobacman LS, 2008, ADV EXP MED BIOL, V644, P85; Tojkander S, 2011, CURR BIOL, V21, P539, DOI 10.1016/j.cub.2011.03.007; Tripet B, 2000, J MOL BIOL, V300, P377, DOI 10.1006/jmbi.2000.3866; Wang CLA, 2010, INT REV CEL MOL BIO, V281, P91, DOI 10.1016/S1937-6448(10)81003-2; Whitby FG, 2000, PROTEINS, V38, P49	53	23	24	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					3165	3174		10.1074/jbc.M111.307330	http://dx.doi.org/10.1074/jbc.M111.307330			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22119916	Green Published, hybrid			2022-12-27	WOS:000300295100022
J	Herker, E; Ott, M				Herker, Eva; Ott, Melanie			Emerging Role of Lipid Droplets in Host/Pathogen Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							HEPATITIS-C-VIRUS; NONSTRUCTURAL PROTEIN 5A; CORE PROTEIN; DENGUE VIRUS; MYCOBACTERIUM-TUBERCULOSIS; APOLIPOPROTEIN-E; DIACYLGLYCEROL ACYLTRANSFERASE; VIRAL REPLICATION; SCHWANN-CELLS; TRIACYLGLYCEROL	Lipid droplets (LDs) are highly dynamic cell organelles involved in energy homeostasis and membrane trafficking. Here, we review how select pathogens interact with LDs. Several RNA viruses use host LDs at different steps of their life cycle. Some intracellular bacteria and parasites usurp host LDs or encode their own lipid biosynthesis machinery, thus allowing production of LDs independently of their host. Although many mechanistic details of host/pathogen LD interactions are unknown, a picture emerges in which the unique cellular architecture and energy stored in LDs are important in the replication of diverse pathogens.	[Ott, Melanie] Gladstone Inst Virol & Immunol, San Francisco, CA 94158 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Ctr Liver, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Ott, M (corresponding author), Gladstone Inst Virol & Immunol, San Francisco, CA 94158 USA.	mott@gladstone.ucsf.edu	Herker, Eva/AAQ-1944-2021; Herker, Eva/B-9699-2014	Herker, Eva/0000-0001-9644-2484; Ott, Melanie/0000-0002-5697-1274	National Institutes of Health [R56 AI085056, P30 DK026743]; Gladstone Institutes; Hellman Family Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI085056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026743] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gladstone Institutes(University of California System); Hellman Family Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R56 AI085056 and P30 DK026743 (to the UCSF Liver Center). This work was also supported by the Gladstone Institutes and the Hellman Family Foundation. This is the second article in the Thematic Minireview Series on the Lipid Droplet, a Dynamic Organelle of Biomedical and Commercial Importance.	Appel N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000035; Belland R, 2004, NAT REV MICROBIOL, V2, P530, DOI 10.1038/nrmicro931; Benali-Furet NL, 2005, ONCOGENE, V24, P4921, DOI 10.1038/sj.onc.1208673; Benga WJA, 2010, HEPATOLOGY, V51, P43, DOI 10.1002/hep.23278; Bickel PE, 2009, BBA-MOL CELL BIOL L, V1791, P419, DOI 10.1016/j.bbalip.2009.04.002; Bostrom P, 2007, NAT CELL BIOL, V9, P1286, DOI 10.1038/ncb1648; Boulant S, 2008, TRAFFIC, V9, P1268, DOI 10.1111/j.1600-0854.2008.00767.x; Boulant S, 2006, J BIOL CHEM, V281, P22236, DOI 10.1074/jbc.M601031200; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; Carabeo RA, 2003, P NATL ACAD SCI USA, V100, P6771, DOI 10.1073/pnas.1131289100; Cermelli S, 2006, CURR BIOL, V16, P1783, DOI 10.1016/j.cub.2006.07.062; Chang KS, 2007, J VIROL, V81, P13783, DOI 10.1128/JVI.01091-07; Cheung W, 2010, J VIROL, V84, P6782, DOI 10.1128/JVI.01757-09; Clement S, 2011, HEPATOLOGY, V54, P38, DOI 10.1002/hep.24340; Clyde K, 2006, J VIROL, V80, P11418, DOI 10.1128/JVI.01257-06; Cocchiaro JL, 2008, P NATL ACAD SCI USA, V105, P9379, DOI 10.1073/pnas.0712241105; Coffey CM, 2006, J VIROL, V80, P8422, DOI 10.1128/JVI.02601-05; Cohen AW, 2004, DIABETES, V53, P1261, DOI 10.2337/diabetes.53.5.1261; Cun W, 2010, J VIROL, V84, P11532, DOI 10.1128/JVI.01021-10; D'Avila H, 2006, J IMMUNOL, V176, P3087, DOI 10.4049/jimmunol.176.5.3087; Daniel J, 2004, J BACTERIOL, V186, P5017, DOI 10.1128/jb.186.15.5017-5030.2004; Daniel J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002093; Deb C, 2006, J BIOL CHEM, V281, P3866, DOI 10.1074/jbc.M505556200; Farese RV, 2009, CELL, V139, P855, DOI 10.1016/j.cell.2009.11.005; Fields KA, 2002, ANNU REV CELL DEV BI, V18, P221, DOI 10.1146/annurev.cellbio.18.012502.105845; Gastaminza P, 2008, J VIROL, V82, P2120, DOI 10.1128/JVI.02053-07; Hackstadt T, 1996, EMBO J, V15, P964, DOI 10.1002/j.1460-2075.1996.tb00433.x; Heaton NS, 2010, CELL HOST MICROBE, V8, P422, DOI 10.1016/j.chom.2010.10.006; Heaton NS, 2010, P NATL ACAD SCI USA, V107, P17345, DOI 10.1073/pnas.1010811107; Herker E, 2011, TRENDS ENDOCRIN MET, V22, P241, DOI 10.1016/j.tem.2011.03.004; Herker E, 2010, NAT MED, V16, P1295, DOI 10.1038/nm.2238; HOLZ GG, 1977, B WORLD HEALTH ORGAN, V55, P237; Hope RG, 2000, J GEN VIROL, V81, P1913, DOI 10.1099/0022-1317-81-8-1913; Hope RG, 2002, J BIOL CHEM, V277, P4261, DOI 10.1074/jbc.M108798200; Huang H, 2007, P NATL ACAD SCI USA, V104, P5848, DOI 10.1073/pnas.0700760104; Jackson KE, 2004, MOL MICROBIOL, V54, P109, DOI 10.1111/j.1365-2958.2004.04284.x; Jagerstrom S, 2009, CELL BIOL INT, V33, P934, DOI 10.1016/j.cellbi.2009.06.011; Jhaveri R, 2008, J INFECT DIS, V197, P283, DOI 10.1086/524846; Jirasko V, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001233; Kim KH, 2007, GASTROENTEROLOGY, V132, P1955, DOI 10.1053/j.gastro.2007.03.039; Kim KH, 2007, BIOCHEM BIOPH RES CO, V355, P883, DOI 10.1016/j.bbrc.2007.02.044; Kim MJ, 2010, EMBO MOL MED, V2, P258, DOI 10.1002/emmm.201000079; Korenaga M, 2005, J BIOL CHEM, V280, P37481, DOI 10.1074/jbc.M506412200; Kuerschner L, 2008, TRAFFIC, V9, P338, DOI 10.1111/j.1600-0854.2007.00689.x; Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8; Kumar Y, 2006, CURR BIOL, V16, P1646, DOI 10.1016/j.cub.2006.06.060; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Listenberger LL, 2007, J LIPID RES, V48, P2751, DOI 10.1194/jlr.M700359-JLR200; Ma YH, 2008, J VIROL, V82, P7624, DOI 10.1128/JVI.00724-08; Ma YH, 2011, J VIROL, V85, P86, DOI 10.1128/JVI.01070-10; Majeau N, 2009, J BIOL CHEM, V284, P33915, DOI 10.1074/jbc.M109.018549; Marcinkiewicz A, 2006, J BIOL CHEM, V281, P11901, DOI 10.1074/jbc.M600171200; Masaki T, 2008, J VIROL, V82, P7964, DOI 10.1128/JVI.00826-08; Mattos KA, 2011, J IMMUNOL, V187, P2548, DOI 10.4049/jimmunol.1101344; Mattos KA, 2011, CELL MICROBIOL, V13, P259, DOI 10.1111/j.1462-5822.2010.01533.x; McLauchlan J, 2002, EMBO J, V21, P3980, DOI 10.1093/emboj/cdf414; Miller JL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040017; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Mousseau G, 2011, J GEN VIROL, V92, P101, DOI 10.1099/vir.0.023325-0; Murphy S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015030; Na TY, 2009, HEPATOLOGY, V49, P1122, DOI 10.1002/hep.22740; Niyomrattanakit P, 2004, J VIROL, V78, P13708, DOI 10.1128/JVI.78.24.13708-13716.2004; Palacpac NMQ, 2004, BIOCHEM BIOPH RES CO, V321, P1062, DOI 10.1016/j.bbrc.2004.07.070; Palacpac NMQ, 2004, J CELL SCI, V117, P1469, DOI 10.1242/jcs.00988; Parashar UD, 2006, EMERG INFECT DIS, V12, P304; Parr RD, 2006, J VIROL, V80, P2842, DOI 10.1128/JVI.80.6.2842-2854.2006; Patton JT, 2006, CURR TOP MICROBIOL, V309, P169; Perlemuter G, 2002, FASEB J, V16, P185, DOI 10.1096/fj.01-0396com; Pesavento JB, 2006, CURR TOP MICROBIOL, V309, P189; Robenek H, 2006, J CELL SCI, V119, P4215, DOI 10.1242/jcs.03191; Rodenhuis-Zybert IA, 2010, CELL MOL LIFE SCI, V67, P2773, DOI 10.1007/s00018-010-0357-z; Roingeard P, 2008, J VIRAL HEPATITIS, V15, P157, DOI 10.1111/j.1365-2893.2007.00953.x; Sabahi A, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-117; Samsa MM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000632; Schwer B, 2004, J VIROL, V78, P7958, DOI 10.1128/JVI.78.15.7958-7968.2004; Scollard DM, 2006, CLIN INFECT DIS, V43, pE19, DOI 10.1086/505222; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Sirakova TD, 2006, MICROBIOL-SGM, V152, P2717, DOI 10.1099/mic.0.28993-0; Stapleford KA, 2011, J VIROL, V85, P1706, DOI 10.1128/JVI.02268-10; Syed GH, 2010, TRENDS ENDOCRIN MET, V21, P33, DOI 10.1016/j.tem.2009.07.005; Tanigawa K, 2008, FEMS MICROBIOL LETT, V289, P72, DOI 10.1111/j.1574-6968.2008.01369.x; Tellinghuisen TL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000032; THOMSSEN R, 1992, MED MICROBIOL IMMUN, V181, P293, DOI 10.1007/BF00198849; Tsutsumi T, 2002, HEPATOLOGY, V35, P937, DOI 10.1053/jhep.2002.32470; Unterstab G, 2010, VIROLOGY, V399, P322, DOI 10.1016/j.virol.2010.01.011; van der Schaar HM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000244; van Ooij C, 2000, CELL MICROBIOL, V2, P627, DOI 10.1046/j.1462-5822.2000.00077.x; Vielemeyer O, 2004, MOL BIOCHEM PARASIT, V135, P195, DOI 10.1016/j.molbiopara.2003.08.017; Virchow R., 1863, KRANKHAFTEN GESCHWUL; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Wang ZQ, 2010, INT J OBESITY, V34, P1355, DOI 10.1038/ijo.2010.77; Welte MA, 2005, CURR BIOL, V15, P1266, DOI 10.1016/j.cub.2005.06.062; Welte MA, 2007, TRENDS CELL BIOL, V17, P363, DOI 10.1016/j.tcb.2007.06.004; Yen CLE, 2008, J LIPID RES, V49, P2283, DOI 10.1194/jlr.R800018-JLR200; Zahrt TC, 2003, MICROBES INFECT, V5, P159, DOI 10.1016/S1286-4579(02)00083-7; Zechner R, 2009, J LIPID RES, V50, P3, DOI 10.1194/jlr.R800031-JLR200; Zhang Y, 2004, STRUCTURE, V12, P1607, DOI 10.1016/j.str.2004.06.019; Zhang Y, 2004, FRONT BIOSCI-LANDMRK, V9, P1136, DOI 10.2741/1291; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102; Zybert IA, 2008, J GEN VIROL, V89, P3047, DOI 10.1099/vir.0.2008/002535-0	100	68	69	1	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2280	2287		10.1074/jbc.R111.300202	http://dx.doi.org/10.1074/jbc.R111.300202			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22090026	Green Published, hybrid			2022-12-27	WOS:000300292300003
J	Ivarsson, Y; Wawrzyniak, AM; Wuytens, G; Kosloff, M; Vermeiren, E; Raport, M; Zimmermann, P				Ivarsson, Ylva; Wawrzyniak, Anna Maria; Wuytens, Gunther; Kosloff, Mickey; Vermeiren, Elke; Raport, Marie; Zimmermann, Pascale			Cooperative Phosphoinositide and Peptide Binding by PSD-95/Discs Large/ZO-1 (PDZ) Domain of Polychaetoid, Drosophila Zonulin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLECKSTRIN HOMOLOGY DOMAINS; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; EPITHELIAL-CELLS; MEMBRANE; RECOGNITION; ZO-1; MORPHOGENESIS; LOCALIZATION; DIMERIZATION; SELECTIVITY	PDZ domains are well known protein-protein interaction modules that, as part of multidomain proteins, assemble molecular complexes. Some PDZ domains have been reported to interact with membrane lipids, in particular phosphatidylinositol phosphates, but few studies have been aimed at elucidating the prevalence or the molecular details of such interactions. We screened 46 Drosophila PDZ domains for phosphoinositide-dependent cellular localization and discovered that the second PDZ domain of polychaetoid (Pyd PDZ2) interacts with phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P-2) at the plasma membrane. Surface plasmon resonance binding experiments with recombinant protein established that Pyd PDZ2 interacts with phosphatidylinositol phosphates with apparent affinities in the micromolar range. Electrostatic interactions involving an extended positively charged surface of Pyd PDZ2 are crucial for the PtdIns(4,5)P-2-dependent membrane interactions as shown by a combination of three-dimensional modeling, mutagenesis, binding, and localization studies. In vivo localization studies further suggested that both lipid and peptide binding contribute to membrane localization. We identified the transmembrane protein Crumbs as a Pyd PDZ2 ligand and probed the relation between peptide and PtdIns(4,5)P-2 binding. Contrary to the prevalent view on PDZ/peptide/lipid binding, we did not find competition between peptide and lipid ligands. Instead, pre-loading the protein with the 10-mer Crb3 peptide increased the apparent affinity of Pyd PDZ2 for PtdIns(4,5)P-2 6-fold. Our results suggest that membrane localization of Pyd PDZ2 may be driven by a combination of peptide and PtdIns(4,5)P-2 binding, which raises the intriguing possibility that the domain may coordinate protein-and phospholipid-mediated signals.	[Ivarsson, Ylva; Wawrzyniak, Anna Maria; Wuytens, Gunther; Vermeiren, Elke; Raport, Marie; Zimmermann, Pascale] Katholieke Univ Leuven, Dept Human Genet, B-3000 Louvain, Belgium; [Kosloff, Mickey] Duke Univ, Med Ctr, Durham, NC 27710 USA	KU Leuven; Duke University	Zimmermann, P (corresponding author), Katholieke Univ Leuven, Dept Human Genet, Herestr 49, B-3000 Louvain, Belgium.	pascale.zimmermann@med.kuleuven.be	Ivarsson, Ylva/HGE-0283-2022; Zimmermann, Pascale/P-4190-2017; Kosloff, Mickey/B-5962-2008	Ivarsson, Ylva/0000-0002-7081-3846; Kosloff, Mickey/0000-0003-1807-4000	Fund for Scientific Research-Flanders (FWO); Concerted Actions Program of the Katholieke Universiteit Leuven; Belgian Federation against Cancer (BFK); Interuniversity Attraction Poles of the Prime Ministers Services (IUAP); EMBO	Fund for Scientific Research-Flanders (FWO)(FWO); Concerted Actions Program of the Katholieke Universiteit Leuven; Belgian Federation against Cancer (BFK); Interuniversity Attraction Poles of the Prime Ministers Services (IUAP); EMBO(European Molecular Biology Organization (EMBO))	This work was supported by the Fund for Scientific Research-Flanders (FWO), the Concerted Actions Program of the Katholieke Universiteit Leuven, the Belgian Federation against Cancer (BFK), the Interuniversity Attraction Poles of the Prime Ministers Services (IUAP), and the EMBO young investigator program (to P. Z.).	Balla T, 2005, J CELL SCI, V118, P2093, DOI 10.1242/jcs.02387; Brown FD, 2001, J CELL BIOL, V154, P1007, DOI 10.1083/jcb.200103107; Chen J, 2008, EMBO J, V27, P2113, DOI 10.1038/emboj.2008.138; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Chi CN, 2009, BIOCHEMISTRY-US, V48, P7089, DOI 10.1021/bi900559k; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Djiane A, 2011, J CELL BIOL, V192, P189, DOI 10.1083/jcb.201007023; Fanning AS, 2007, J BIOL CHEM, V282, P37710, DOI 10.1074/jbc.M707255200; Feng W, 2009, NAT REV NEUROSCI, V10, P87, DOI 10.1038/nrn2540; Gallardo R, 2010, CHEMBIOCHEM, V11, P456, DOI 10.1002/cbic.200900616; Gianni S, 2005, J BIOL CHEM, V280, P34805, DOI 10.1074/jbc.M506017200; Gianni S, 2010, NAT STRUCT MOL BIOL, V17, P1431, DOI 10.1038/nsmb.1956; Harris BZ, 2001, J CELL SCI, V114, P3219; He J, 2011, J BIOL CHEM, V286, P18650, DOI 10.1074/jbc.M111.233015; Ivarsson Y, 2008, J BIOL CHEM, V283, P8954, DOI 10.1074/jbc.M707424200; JACKSON SE, 1991, BIOCHEMISTRY-US, V30, P10428, DOI 10.1021/bi00107a010; Kutateladze TG, 2010, NAT CHEM BIOL, V6, P507, DOI [10.1038/NCHEMBIO.390, 10.1038/nchembio.390]; Lee D, 1998, J BIOL CHEM, V273, P13022, DOI 10.1074/jbc.273.21.13022; Lemmon MA, 2003, TRAFFIC, V4, P201, DOI 10.1034/j.1600-0854.2004.00071.x; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Medina E, 2002, BIOL CELL, V94, P305, DOI 10.1016/S0248-4900(02)00004-7; Meerschaert K, 2009, CELL MOL LIFE SCI, V66, P3951, DOI 10.1007/s00018-009-0156-6; Mortier E, 2005, EMBO J, V24, P2556, DOI 10.1038/sj.emboj.7600722; Narayan K, 2006, METHODS, V39, P122, DOI 10.1016/j.ymeth.2006.05.006; Otsuguro KI, 2008, J BIOL CHEM, V283, P10026, DOI 10.1074/jbc.M707306200; Pan L, 2007, EMBO J, V26, P4576, DOI 10.1038/sj.emboj.7601860; PETERS PJ, 1995, J CELL BIOL, V128, P1003, DOI 10.1083/jcb.128.6.1003; Petrey D, 2003, PROTEINS, V53, P430, DOI 10.1002/prot.10550; Pinal N, 2006, CURR BIOL, V16, P140, DOI 10.1016/j.cub.2005.11.068; Rocchia W, 2002, J COMPUT CHEM, V23, P128, DOI 10.1002/jcc.1161; Roh MH, 2003, J CELL SCI, V116, P2895, DOI 10.1242/jcs.00500; Seppa MJ, 2008, DEV BIOL, V318, P1, DOI 10.1016/j.ydbio.2008.02.022; Stolt PC, 2003, STRUCTURE, V11, P569, DOI 10.1016/S0969-2126(03)00068-6; Takahashi K, 1998, MECH DEVELOP, V78, P97, DOI 10.1016/S0925-4773(98)00151-8; Varnai P, 1998, J CELL BIOL, V143, P501, DOI 10.1083/jcb.143.2.501; Varnai P, 2006, J CELL BIOL, V175, P377, DOI 10.1083/jcb.200607116; Watton SJ, 1999, CURR BIOL, V9, P433, DOI 10.1016/S0960-9822(99)80192-4; Wei XR, 2001, MECH DEVELOP, V100, P217, DOI 10.1016/S0925-4773(00)00550-5; Wu H, 2007, MOL CELL, V28, P886, DOI 10.1016/j.molcel.2007.10.028; Xiang ZX, 2001, J MOL BIOL, V311, P421, DOI 10.1006/jmbi.2001.4865; Yu JW, 2004, MOL CELL, V13, P677, DOI 10.1016/S1097-2765(04)00083-8; Yu JW, 2001, J BIOL CHEM, V276, P44179, DOI 10.1074/jbc.M108811200; Zimmermann P, 2005, DEV CELL, V9, P377, DOI 10.1016/j.devcel.2005.07.011; Zimmermann P, 2002, MOL CELL, V9, P1215, DOI 10.1016/S1097-2765(02)00549-X	44	13	13	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2011	286	52					44669	44678		10.1074/jbc.M111.285734	http://dx.doi.org/10.1074/jbc.M111.285734			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870CA	22033935	Green Published, hybrid			2022-12-27	WOS:000298645500037
J	Jeng, WY; Wang, NC; Lin, CT; Shyur, LF; Wang, AHJ				Jeng, Wen-Yih; Wang, Nai-Chen; Lin, Cheng-Tse; Shyur, Lie-Fen; Wang, Andrew H. -J.			Crystal Structures of the Laminarinase Catalytic Domain from Thermotoga maritima MSB8 in Complex with Inhibitors ESSENTIAL RESIDUES FOR beta-1,3- and beta-1,4-GLUCAN SELECTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOHYDRATE-BINDING MODULES; GLYCOSYL HYDROLASES; HUMICOLA-INSOLENS; GLUCAN-BINDING; MODEL; ENDOGLUCANASE; RECOGNITION; SEQUENCE; CRYSTALLOGRAPHY; POLYSACCHARIDES	Laminarinases hydrolyzing the beta-1,3-linkage of glucans play essential roles in microbial saccharide degradation. Here we report the crystal structures at 1.65-1.82 angstrom resolution of the catalytic domain of laminarinase from the thermophile Thermotoga maritima with various space groups in the ligand-free form or in the presence of inhibitors gluconolactone and cetyltrimethylammonium. Ligands were bound at the cleft of the active site near an enclosure formed by Trp-232 and a flexible GASIG loop. A closed configuration at the active site cleft was observed in some molecules. The loop flexibility in the enzyme may contribute to the regulation of endo-or exo-activity of the enzyme and a preference to release laminaritrioses in long chain carbohydrate hydrolysis. Glu-137 and Glu-132 are proposed to serve as the proton donor and nucleophile, respectively, in the retaining catalysis of hydrolyzation. Calcium ions in the crystallization media are found to accelerate crystal growth. Comparison of laminarinase and endoglucanase structures revealed the subtle difference of key residues in the active site for the selection of beta-1,3-glucan and beta-1,4-glucan substrates, respectively. Arg-85 may be pivotal to beta-1,3-glucan substrate selection. The similarity of the structures between the laminarinase catalytic domain and its carbohydrate-binding modules may have evolutionary relevance because of the similarities in their folds.	Acad Sinica, Inst Biol Chem, Taipei 115, Taiwan; [Jeng, Wen-Yih; Wang, Nai-Chen; Wang, Andrew H. -J.] Acad Sinica, Core Facil Prot Prod & Xray Struct Anal, Taipei 115, Taiwan; [Shyur, Lie-Fen] Acad Sinica, Agr Biotechnol Res Ctr, Taipei 115, Taiwan; [Jeng, Wen-Yih] Natl Cheng Kung Univ, Univ Ctr Biosci & Biotechnol, Tainan 701, Taiwan	Academia Sinica - Taiwan; Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Cheng Kung University	Wang, AHJ (corresponding author), 128 Acad Rd,Sec 2, Taipei 115, Taiwan.	ahjwang@gate.sinica.edu.tw			Academia Sinica; National Science Council (Taiwan) [NSC96-3114-P-001-004, NSC97-3114-P-001-001, NSC99-3113-B-001-001]	Academia Sinica(Academia Sinica - Taiwan); National Science Council (Taiwan)(Ministry of Science and Technology, Taiwan)	This work was supported by Academia Sinica and National Science Council (Taiwan) Grants NSC96-3114-P-001-004, NSC97-3114-P-001-001, and NSC99-3113-B-001-001 (to A. H.-J. W.).	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Boisset C, 2000, APPL ENVIRON MICROB, V66, P1444, DOI 10.1128/AEM.66.4.1444-1452.2000; Bolam DN, 1998, BIOCHEM J, V331, P775, DOI 10.1042/bj3310775; Boraston AB, 2002, J MOL BIOL, V319, P1143, DOI 10.1016/S0022-2836(02)00374-1; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; BRUNGER AT, 1993, ACTA CRYSTALLOGR D, V49, P24, DOI 10.1107/S0907444992007352; Burstein T, 2009, FEBS LETT, V583, P879, DOI 10.1016/j.febslet.2009.02.013; Cheng YS, 2011, PROTEINS, V79, P1193, DOI 10.1002/prot.22953; Chhabra SR, 2002, APPL ENVIRON MICROB, V68, P545, DOI 10.1128/AEM.68.2.545-554.2002; Cota J, 2011, BIOCHEM BIOPH RES CO, V406, P590, DOI 10.1016/j.bbrc.2011.02.098; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; Davies GJ, 1995, BIOCHEMISTRY-US, V34, P16210, DOI 10.1021/bi00049a037; DeLano W.L, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fibriansah G, 2007, PROTEINS, V69, P683, DOI 10.1002/prot.21589; Fried B., 1982, THIN LAYER CHROMATOG; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Henrissat B, 1996, BIOCHEM J, V316, P695, DOI 10.1042/bj3160695; Horn SJ, 2006, P NATL ACAD SCI USA, V103, P18089, DOI 10.1073/pnas.0608909103; Ilari A, 2009, FEBS J, V276, P1048, DOI 10.1111/j.1742-4658.2008.06848.x; Jeng WY, 2011, J STRUCT BIOL, V173, P46, DOI 10.1016/j.jsb.2010.07.008; JIRKU V, 1980, FOLIA MICROBIOL, V25, P24, DOI 10.1007/BF02876394; Khosla C, 2001, NATURE, V409, P247, DOI 10.1038/35051723; Kitago Y, 2007, J BIOL CHEM, V282, P35703, DOI 10.1074/jbc.M706835200; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nelson KE, 1999, NATURE, V399, P323, DOI 10.1038/20601; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Sikorski P, 2006, BIOCHEMISTRY-US, V45, P9566, DOI 10.1021/bi060370l; Simpson PJ, 2000, J BIOL CHEM, V275, P41137, DOI 10.1074/jbc.M006948200; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; Vasur J, 2009, FEBS J, V276, P4282, DOI 10.1111/j.1742-4658.2009.07099.x; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; WELFLE K, 1995, EUR J BIOCHEM, V229, P726, DOI 10.1111/j.1432-1033.1995.tb20520.x; Wu HM, 2009, J BIOL CHEM, V284, P26708, DOI 10.1074/jbc.M109.010983; Zverlov VV, 2001, MICROBIOL-SGM, V147, P621, DOI 10.1099/00221287-147-3-621	42	26	29	2	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2011	286	52					45030	45040		10.1074/jbc.M111.271213	http://dx.doi.org/10.1074/jbc.M111.271213			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870CA	22065588	hybrid, Green Published			2022-12-27	WOS:000298645500070
J	Hartung, S; Arvai, AS; Wood, T; Kolappan, S; Shin, DS; Craig, L; Tainer, JA				Hartung, Sophia; Arvai, Andrew S.; Wood, Timothy; Kolappan, Subramaniapillai; Shin, David S.; Craig, Lisa; Tainer, John A.			Ultrahigh Resolution and Full-length Pilin Structures with Insights for Filament Assembly, Pathogenic Functions, and Vaccine Potential	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IV PILUS STRUCTURE; FRANCISELLA-TULARENSIS; BACTEROIDES-NODOSUS; NATURAL TRANSFORMATION; ANTIGENIC VARIATION; PROTEASE SECRETION; TWITCHING MOTILITY; RECEPTOR-BINDING; ATOMIC MOBILITY; II SECRETION	Pilin proteins assemble into Type IV pili (T4P), surface-displayed bacterial filaments with virulence functions including motility, attachment, transformation, immune escape, and colony formation. However, challenges in crystallizing full-length fiber-forming and membrane protein pilins leave unanswered questions regarding pilin structures, assembly, functions, and vaccine potential. Here we report pilin structures of full-length DnFimA from the sheep pathogen Dichelobacter nodosus and FtPilE from the human pathogen Francisella tularensis at 2.3 and 1 angstrom resolution, respectively. The DnFimA structure reveals an extended kinked N-terminal alpha-helix, an unusual centrally located disulfide, conserved subdomains, and assembled epitopes informing serogroup vaccines. An interaction between the conserved Glu-5 carboxyl oxygen and the N-terminal amine of an adjacent subunit in the crystallographic dimer is consistent with the hypothesis of a salt bridge between these groups driving T4P assembly. The FtPilE structure identifies an authentic Type IV pilin and provides a framework for understanding the role of T4P in F. tularensis virulence. Combined results define a unified pilin architecture, specialized subdomain roles in pilus assembly and function, and potential therapeutic targets.	[Kolappan, Subramaniapillai; Craig, Lisa] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada; [Hartung, Sophia; Shin, David S.; Tainer, John A.] Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA; [Arvai, Andrew S.; Wood, Timothy; Tainer, John A.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Arvai, Andrew S.; Wood, Timothy; Tainer, John A.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Simon Fraser University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Scripps Research Institute; Scripps Research Institute	Craig, L (corresponding author), Simon Fraser Univ, Dept Mol Biol & Biochem, 8888 Univ Dr, Burnaby, BC V5A 1S6, Canada.	licraig@sfu.ca; jatainer@lbl.gov	Tainer, John/GWQ-4878-2022	Tainer, John/0000-0003-1659-2429; Craig, Lisa/0000-0001-8515-9915	National Institutes of Health [AI22160]; Office of Science, Office of Biological and Environmental Research, of the United States Department of Energy [DE-AC02-05CH11231]; Canadian Institutes of Health Research; Michael Smith Foundation for Health Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI022160] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Science, Office of Biological and Environmental Research, of the United States Department of Energy(United States Department of Energy (DOE)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI22160.; Supported by the ENIGMA program of the Office of Science, Office of Biological and Environmental Research, of the United States Department of Energy under Contract DE-AC02-05CH11231.; Supported by salary awards from the Canadian Institutes of Health Research and the Michael Smith Foundation for Health Research.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alphonse S, 2010, J STRUCT BIOL, V169, P75, DOI 10.1016/j.jsb.2009.09.003; Ark NM, 2011, MICROB PATHOGENESIS, V51, P110, DOI 10.1016/j.micpath.2011.05.001; Audette GF, 2004, BIOCHEMISTRY-US, V43, P11427, DOI 10.1021/bi048957s; Ayers M, 2010, FUTURE MICROBIOL, V5, P1203, DOI 10.2217/FMB.10.76; BRADLEY DE, 1974, VIROLOGY, V58, P149, DOI 10.1016/0042-6822(74)90150-0; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Cagatay TI, 2008, VET MICROBIOL, V126, P160, DOI 10.1016/j.vetmic.2007.06.007; CLAXTON PD, 1983, AUST VET J, V60, P331, DOI 10.1111/j.1751-0813.1983.tb02834.x; Craig L, 2004, NAT REV MICROBIOL, V2, P363, DOI 10.1038/nrmicro885; Craig L, 2003, MOL CELL, V11, P1139, DOI 10.1016/S1097-2765(03)00170-9; Craig L, 2008, CURR OPIN STRUC BIOL, V18, P267, DOI 10.1016/j.sbi.2007.12.009; Craig L, 2006, MOL CELL, V23, P651, DOI 10.1016/j.molcel.2006.07.004; Criss AK, 2005, MOL MICROBIOL, V58, P510, DOI 10.1111/j.1365-2958.2005.04838.x; Dennis DT, 2001, JAMA-J AM MED ASSOC, V285, P2763, DOI 10.1001/jama.285.21.2763; Dhungyel OP, 2009, VACCINE, V28, P470, DOI 10.1016/j.vaccine.2009.10.012; EGERTON JR, 1969, J COMP PATHOL, V79, P207, DOI 10.1016/0021-9975(69)90007-3; Ellis J, 2002, CLIN MICROBIOL REV, V15, P631, DOI 10.1128/CMR.15.4.631-646.2002; EMERY DL, 1984, AUST VET J, V61, P237, DOI 10.1111/j.1751-0813.1984.tb05999.x; EMERY DL, 1989, VET IMMUNOL IMMUNOP, V21, P339, DOI 10.1016/0165-2427(89)90041-X; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Forest KT, 1996, INFECT IMMUN, V64, P644, DOI 10.1128/IAI.64.2.644-652.1996; Forslund AL, 2006, MOL MICROBIOL, V59, P1818, DOI 10.1111/j.1365-2958.2006.05061.x; Forslund AL, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-227; Franz LP, 2011, ACTA CRYSTALLOGR D, V67, P124, DOI 10.1107/S0907444910051954; Ghosh A, 2011, BIOCHEM J, V437, P43, DOI 10.1042/BJ20110410; Gil H, 2004, INFECT IMMUN, V72, P3042, DOI 10.1128/IAI.72.5.3042-3047.2004; HAGBLOM P, 1985, NATURE, V315, P156, DOI 10.1038/315156a0; Hager AJ, 2006, MOL MICROBIOL, V62, P227, DOI 10.1111/j.1365-2958.2006.05365.x; Han XY, 2008, J BACTERIOL, V190, P3323, DOI 10.1128/JB.01807-07; Han XY, 2007, J BACTERIOL, V189, P5022, DOI 10.1128/JB.00138-07; Hansen JK, 2006, J MOL MICROB BIOTECH, V11, P192, DOI 10.1159/000094054; HOBBS M, 1993, MOL MICROBIOL, V10, P233, DOI 10.1111/j.1365-2958.1993.tb01949.x; Jia-xing Yao, 2005, Acta Crystallogr D Biol Crystallogr, V61, P1465, DOI 10.1107/S090744490502576X; Kallstrom H, 1997, MOL MICROBIOL, V25, P639, DOI 10.1046/j.1365-2958.1997.4841857.x; Keizer DW, 2001, J BIOMOL NMR, V19, P385, DOI 10.1023/A:1011285803129; Kennan RM, 2001, J BACTERIOL, V183, P4451, DOI 10.1128/JB.183.15.4451-4458.2001; Kennan RM, 2011, VET MICROBIOL, V153, P59, DOI 10.1016/j.vetmic.2011.04.005; Kirn TJ, 2003, MOL MICROBIOL, V49, P81, DOI 10.1046/j.1365-2958.2003.03546.x; Kirn TJ, 2000, MOL MICROBIOL, V35, P896, DOI 10.1046/j.1365-2958.2000.01764.x; Kohler R, 2004, MOL MICROBIOL, V54, P647, DOI 10.1111/j.1365-2958.2004.04307.x; Korotkov KV, 2009, J BIOL CHEM, V284, P25466, DOI 10.1074/jbc.C109.037655; Larsson P, 2005, NAT GENET, V37, P153, DOI 10.1038/ng1499; Lemkul JA, 2011, J PHYS CHEM B, V115, P8004, DOI 10.1021/jp202217f; Lim MS, 2010, MOL MICROBIOL, V77, P755, DOI 10.1111/j.1365-2958.2010.07244.x; Maier B, 2002, P NATL ACAD SCI USA, V99, P16012, DOI 10.1073/pnas.242523299; Mattick JS, 2002, ANNU REV MICROBIOL, V56, P289, DOI 10.1146/annurev.micro.56.012302.160938; MATTICK JS, 1987, J BACTERIOL, V169, P33, DOI 10.1128/jb.169.1.33-41.1987; MATTICK JS, 1991, MOL MICROBIOL, V5, P561, DOI 10.1111/j.1365-2958.1991.tb00727.x; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MCKERN NM, 1988, J PROTEIN CHEM, V7, P157, DOI 10.1007/BF01025245; Merz AJ, 2000, NATURE, V407, P98, DOI 10.1038/35024105; Navaza J, 2001, ACTA CRYSTALLOGR D, V57, P1367, DOI 10.1107/S0907444901012422; Oyston PCF, 2004, NAT REV MICROBIOL, V2, P967, DOI 10.1038/nrmicro1045; PARGE HE, 1995, NATURE, V378, P32, DOI 10.1038/378032a0; Pelicic V, 2008, MOL MICROBIOL, V68, P827, DOI 10.1111/j.1365-2958.2008.06197.x; Petersen JM, 2005, VET RES, V36, P455, DOI 10.1051/vetres:2005006; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Salomonsson E, 2009, MICROBIOL-SGM, V155, P2546, DOI 10.1099/mic.0.028183-0; Salomonsson EN, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00029; Sandkvist M, 2001, MOL MICROBIOL, V40, P271, DOI 10.1046/j.1365-2958.2001.02403.x; SCHWARTZKOFF CL, 1993, AUST VET J, V70, P123, DOI 10.1111/j.1751-0813.1993.tb06101.x; Shevchik VE, 1997, EMBO J, V16, P3007, DOI 10.1093/emboj/16.11.3007; Sjostedt A, 2007, ANN NY ACAD SCI, V1105, P1, DOI 10.1196/annals.1409.009; TAINER JA, 1985, ANNU REV IMMUNOL, V3, P501, DOI 10.1146/annurev.iy.03.040185.002441; TAINER JA, 1984, NATURE, V312, P127, DOI 10.1038/312127a0; Terwilliger T, 2004, J SYNCHROTRON RADIAT, V11, P49, DOI 10.1107/S0909049503023938; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; VIRJI M, 1984, J GEN MICROBIOL, V130, P1089; Wolfgang M, 1998, MOL MICROBIOL, V29, P321, DOI 10.1046/j.1365-2958.1998.00935.x; Xicohtencatl-Cortes J, 2009, J BACTERIOL, V191, P411, DOI 10.1128/JB.01306-08; Yamagata A, 2007, EMBO J, V26, P878, DOI 10.1038/sj.emboj.7601544; Zogaj X, 2008, MICROBIOL-SGM, V154, P2139, DOI 10.1099/mic.0.2008/018077-0	73	46	46	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2011	286	51					44254	44265		10.1074/jbc.M111.297242	http://dx.doi.org/10.1074/jbc.M111.297242			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866SH	22027840	Green Published, hybrid			2022-12-27	WOS:000298402300065
J	Kintz, EN; Goldberg, JB				Kintz, Erica N.; Goldberg, Joanna B.			Site-directed Mutagenesis Reveals Key Residue for O Antigen Chain Length Regulation and Protein Stability in Pseudomonas aeruginosa Wzz2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COILED-COIL REGIONS; ESCHERICHIA-COLI; FUNCTIONAL-ANALYSIS; CROSS-LINKING; DETERMINANT; VIRULENCE	The production of preferred lipopolysaccharide O antigen chain lengths is important for the survival of pathogenic Gram-negative bacteria in different environments, yet how Wzz proteins regulate these lengths is not well understood. The Wzz2 proteins from two different serotype O11 Pseudomonas aeruginosa strains are responsible for the expression of different very long chain lengths despite high sequence homology. Site-directed mutagenesis was performed to determine whether a specific amino acid was responsible for this difference in chain length; the residue present in position 321 within the second predicted coiled-coil region was able to determine which chain length was produced. A panel of site-directed mutants introducing different amino acids at this position implicated that the charge of the amino acid affected chain length, with positively charged residues associated with shorter chain lengths. Expression data also suggested this site was important for overall stability of the protein because mutants predicted to disrupt proper folding of the alpha helix led to lower protein levels. Cross-linking studies found that Wzz2 proteins producing shorter chain lengths had more stable higher-order oligomers. Mapping residue 321 onto the solved Escherichia coli Wzz FepE crystal structure predicted it to be located within alpha helix 8, which participates in intermonomeric interactions. These data further support the observation that Wzz oligomerization is necessary for chain length regulating activity but also provide evidence that differences in complex stability or changes in the conformation of the oligomer can lead to shifts in the length of the O antigen side chain.	[Kintz, Erica N.; Goldberg, Joanna B.] Univ Virginia Hlth Syst, Dept Microbiol Immunol & Canc Biol, Charlottesville, VA 22908 USA	University of Virginia	Goldberg, JB (corresponding author), Univ Virginia Hlth Syst, Dept Microbiol Immunol & Canc Biol, Charlottesville, VA 22908 USA.	jbg2b@virginia.edu			National Institutes of Health [1 R01 AI068112, 1 R21 AI53842]; National Institutes of Health through the University of Virginia Infectious Diseases [AI07406]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068112, R21AI053842, T32AI007046] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health through the University of Virginia Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by National Institutes of Health Grants 1 R01 AI068112 and 1 R21 AI53842 (to J. B. G.).; Supported in part by the National Institutes of Health through the University of Virginia Infectious Diseases Training Grant AI07406.	Daniels C, 2002, ENVIRON MICROBIOL, V4, P883, DOI 10.1046/j.1462-2920.2002.00288.x; Daniels C, 1999, MOL MICROBIOL, V34, P181, DOI 10.1046/j.1365-2958.1999.01591.x; Franco AV, 1998, J BACTERIOL, V180, P2670, DOI 10.1128/JB.180.10.2670-2675.1998; Guo H, 2006, PROTEIN EXPRES PURIF, V48, P49, DOI 10.1016/j.pep.2006.01.015; Ivanov IE, 2011, J BACTERIOL, V193, P1259, DOI 10.1128/JB.01308-10; Kalynych S, 2011, J BACTERIOL, V193, P3710, DOI 10.1128/JB.00059-11; Kintz E, 2008, FUTURE MICROBIOL, V3, P191, DOI 10.2217/17460913.3.2.191; Larue K, 2009, J BIOL CHEM, V284, P7395, DOI 10.1074/jbc.M809068200; Marolda CL, 2008, J BACTERIOL, V190, P2128, DOI 10.1128/JB.01746-07; Morona R, 2003, MICROBIOL-SGM, V149, P925, DOI 10.1099/mic.0.26141-0; Morona R, 2009, TRENDS BIOCHEM SCI, V34, P78, DOI 10.1016/j.tibs.2008.11.001; Murray GL, 2003, MOL MICROBIOL, V47, P1395, DOI 10.1046/j.1365-2958.2003.03383.x; Papadopoulos M, 2010, J BACTERIOL, V192, P3385, DOI 10.1128/JB.01134-09; Purins L, 2008, MICROBIOL-SGM, V154, P1104, DOI 10.1099/mic.0.2007/014225-0; Qiu DR, 2008, APPL ENVIRON MICROB, V74, P7422, DOI 10.1128/AEM.01369-08; STEVENSON G, 1995, FEMS MICROBIOL LETT, V125, P23, DOI 10.1016/0378-1097(94)00485-A; Tang KH, 2007, BIOCHEMISTRY-US, V46, P11744, DOI 10.1021/bi701181r; Tocilj A, 2008, NAT STRUCT MOL BIOL, V15, P130, DOI 10.1038/nsmb.1374	18	18	18	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2011	286	51					44277	44284		10.1074/jbc.M111.273979	http://dx.doi.org/10.1074/jbc.M111.273979			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866SH	22069314	Green Published, hybrid			2022-12-27	WOS:000298402300067
J	Kiselar, JG; Datt, M; Chance, MR; Weiss, MA				Kiselar, Janna G.; Datt, Manish; Chance, Mark R.; Weiss, Michael A.			Structural Analysis of Proinsulin Hexamer Assembly by Hydroxyl Radical Footprinting and Computational Modeling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MASS-SPECTROMETRY; INSULIN GENE; SACCHAROMYCES-CEREVISIAE; DIABETES-MELLITUS; DISULFIDE BRIDGE; BINDING SURFACE; PROTEIN; MUTATIONS; RESOLUTION; MONOMER	Mutations in the insulin gene can impair proinsulin folding and cause diabetes mellitus. Although crystal structures of insulin dimers and hexamers are well established, proinsulin is refractory to crystallization. Although an NMR structure of an engineered proinsulin monomer has been reported, structures of the wild-type monomer and hexamer remain undetermined. We have utilized hydroxyl radical footprinting and molecular modeling to characterize these structures. Differences between the footprints of insulin and proinsulin, defining a "shadow" of the connecting (C) domain, were employed to refine the model. Our results demonstrate that in its monomeric form, (i) proinsulin contains a native-like insulin moiety and (ii) the C-domain footprint resides within an adjoining segment (residues B23-B29) that is accessible to modification in insulin but not proinsulin. Corresponding oxidation rates were observed within core insulin moieties of insulin and proinsulin hexamers, suggesting that the proinsulin hexamer retains an A/B structure similar to that of insulin. Further similarities in rates of oxidation between the respective C-domains of proinsulin monomers and hexamers suggest that this loop in each case flexibly projects from an outer surface. Although dimerization or hexamer assembly would not be impaired, an ensemble of predicted C-domain positions would block hexamer-hexamer stacking as visualized in classical crystal lattices. We anticipate that protein footprinting in combination with modeling, as illustrated here, will enable comparative studies of diabetes-associated mutant proinsulins and their aberrant modes of aggregation.	[Kiselar, Janna G.; Datt, Manish; Chance, Mark R.] Case Western Reserve Univ, Ctr Prote & Bioinformat, Cleveland, OH 44106 USA; [Chance, Mark R.] Case Western Reserve Univ, Ctr Synchrotron Biosci, Cleveland, OH 44106 USA; [Weiss, Michael A.] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; [Weiss, Michael A.] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Kiselar, JG (corresponding author), Case Western Reserve Univ, Case Ctr Prote & Bioinformat, 10900 Euclid Ave, Cleveland, OH 44106 USA.	janna.kiselar@case.edu	Datt, Manish/AAD-6989-2019	Datt, Manish/0000-0002-9578-4113	National Institutes of Health, National Institute for Biomedical Imaging and Bioengineering [P30-EB-09998, R01-EB-09688]; National Institute for Biomedical Imaging and Bioengineering; National Institutes of Health through the NIDDK [DK069764, DK40949]; Department of Energy [DE-AC02-98CH10886]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB009688, P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK040949, R01DK069764] Funding Source: NIH RePORTER	National Institutes of Health, National Institute for Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); National Institute for Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); National Institutes of Health through the NIDDK; Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants P30-EB-09998 and R01-EB-09688 from the National Institute for Biomedical Imaging and Bioengineering (to M. R. C.) and by National Institutes of Health Grants DK069764 and DK40949 (to M. A. W.) through the NIDDK.; We thank Dr. N. F. Phillips for assistance with sample preparation and Dr. S. Gupta for assistance with sample irradiation at the Brookhaven National Laboratory (BNL). The National Synchrotron Light Source is supported by the Department of Energy under Contract DE-AC02-98CH10886.	ADAMS MJ, 1969, J MOL BIOL, V41, P159, DOI 10.1016/0022-2836(69)90383-0; Aguilar CF, 1997, J MOL BIOL, V267, P899, DOI 10.1006/jmbi.1996.0880; BAKER EN, 1988, PHILOS T ROY SOC B, V319, P369, DOI 10.1098/rstb.1988.0058; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; CHU YC, 1987, BIOCHEMISTRY-US, V26, P6975, DOI 10.1021/bi00396a018; Colombo C, 2008, J CLIN INVEST, V118, P2148, DOI 10.1172/JCI33777; Davies M.J., 1997, RADICAL MEDIATED PRO; Dong J, 2003, J MOL BIOL, V330, P431, DOI 10.1016/S0022-2836(03)00536-9; Edghill EL, 2008, DIABETES, V57, P1034, DOI 10.2337/db07-1405; Guan JQ, 2002, BIOCHEMISTRY-US, V41, P5765, DOI 10.1021/bi0121104; Gupta S, 2007, BIOCHEMISTRY-US, V46, P9886, DOI 10.1021/bi7003608; Gupta S, 2007, J SYNCHROTRON RADIAT, V14, P233, DOI 10.1107/S0909049507013118; Hayes MG, 2007, DIABETES, V56, P3033, DOI 10.2337/db07-0482; Hua QX, 2006, J BIOL CHEM, V281, P24889, DOI 10.1074/jbc.M602617200; Hua QX, 1998, J MOL BIOL, V277, P103, DOI 10.1006/jmbi.1997.1574; Hua QX, 2001, BIOCHEMISTRY-US, V40, P12299, DOI 10.1021/bi011021o; Izumi T, 2003, DIABETES, V52, P409, DOI 10.2337/diabetes.52.2.409; Kiselar JG, 2007, P NATL ACAD SCI USA, V104, P1552, DOI 10.1073/pnas.0605380104; Kiselar JG, 2003, P NATL ACAD SCI USA, V100, P3942, DOI 10.1073/pnas.0736004100; Kiselar JG, 2002, INT J RADIAT BIOL, V78, P101, DOI 10.1080/09553000110094805; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P842, DOI 10.1107/S0907444995016477; Kristensen C, 1997, J BIOL CHEM, V272, P12978, DOI 10.1074/jbc.272.20.12978; Liu M, 2007, P NATL ACAD SCI USA, V104, P15841, DOI 10.1073/pnas.0702697104; Maleknia SD, 1999, ANAL CHEM, V71, P3965, DOI 10.1021/ac990500e; Molven A, 2008, DIABETES, V57, P1131, DOI 10.2337/db07-1467; Nakagawa SH, 2006, J BIOL CHEM, V281, P22386, DOI 10.1074/jbc.M603547200; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Steiner DF, 2004, EXP DIABESITY RES, V5, P7, DOI 10.1080/15438600490424389; Stoy J, 2007, P NATL ACAD SCI USA, V104, P15040, DOI 10.1073/pnas.0707291104; Takamoto K, 2007, STRUCTURE, V15, P39, DOI 10.1016/j.str.2006.11.005; Takamoto K, 2006, ANNU REV BIOPH BIOM, V35, P251, DOI 10.1146/annurev.biophys.35.040405.102050; Weiss MA, 2000, BIOCHEMISTRY-US, V39, P15429, DOI 10.1021/bi001905s; WEISS MA, 1991, BIOCHEMISTRY-US, V30, P7373, DOI 10.1021/bi00244a004; Weiss MA, 2009, J BIOL CHEM, V284, P19159, DOI 10.1074/jbc.R109.009936; Xu GH, 2007, CHEM REV, V107, P3514, DOI 10.1021/cr0682047; Yang YW, 2010, J BIOL CHEM, V285, P7847, DOI 10.1074/jbc.C109.084921; Ye J, 2001, BBA-PROTEIN STRUCT M, V1547, P18, DOI 10.1016/S0167-4838(01)00160-1; Zoete V, 2004, J MOL BIOL, V342, P913, DOI 10.1016/j.jmb.2004.07.033; Zoete V, 2006, J COMPUT CHEM, V27, P1843, DOI 10.1002/jcc.20512	39	12	12	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2011	286	51					43710	43716		10.1074/jbc.M111.297853	http://dx.doi.org/10.1074/jbc.M111.297853			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866SH	22033917	hybrid, Green Published			2022-12-27	WOS:000298402300014
J	Liu, YC; Lin, MC; Chen, HC; Tam, MF; Lin, LY				Liu, Ya-Chuan; Lin, Meng-Chieh; Chen, Hsiang-Chi; Tam, Ming F.; Lin, Lih-Yuan			The Role of Small Ubiquitin-like Modifier-interacting Motif in the Assembly and Regulation of Metal-responsive Transcription Factor 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METALLOTHIONEIN GENE-EXPRESSION; PROMYELOCYTIC LEUKEMIA PROTEIN; SIGNAL-TRANSDUCTION CASCADES; PLACENTA GROWTH-FACTOR; FACTOR MTF-1; FACTOR-I; FUNCTIONAL-CHARACTERIZATION; INDUCIBLE TRANSCRIPTION; NUCLEAR TRANSLOCATION; SUMO MODIFICATION	Metal-responsive transcription factor 1 (MTF-1) is an essential protein required for mouse embryonic development. We report here the occurrence of sumoylation on MTF-1. Mutational studies demonstrated that sumoylation occurs on the lysine residue at position 627 (Lys(627)) of mouse MTF-1. Small ubiquitin-like modifier (SUMO)-1 was fused to the C terminus of MTF-1 to mimic the sumoylated form of the protein and it suppressed the transcriptional activity of MTF-1. The nuclear translocation activity, DNA-binding activity, and protein stability of SUMO-fused MTF-1 are similar to that of wild type MTF-1. The level of sumoylation was reduced by metal in a dose-and time-dependent manner. The fact that zinc reduces MTF-1 sumoylation makes the suppressive role of sumoylated MTF-1 in transcription physiologically less significant because the SUMO moiety of MTF-1 is removed when MTF-1 translocates into nucleus. We further identified a SUMO-interacting motif (SIM) on MTF-1. Remarkably, MTF-1 binds sumoylated MTF-1 and/or other cellular factors in a SIM-dependent manner. This interaction was disrupted by treating cells with zinc. Gel permeation chromatography demonstrated that MTF-1 forms SIM-dependent complexes. This cross-interaction transpires in the cytoplasm and markedly reduces upon nuclear translocation. It can therefore be concluded that SUMO conjugation and the SIM on MTF-1 do not play a critical role in suppressing transcriptional activity. Instead, MTF-1 forms complexes with cellular factors through SIM and SUMO moiety in the cytoplasm. The result explores a new understanding for the mode of MTF-1 assembly and regulation in cells.	[Liu, Ya-Chuan; Lin, Meng-Chieh; Chen, Hsiang-Chi; Lin, Lih-Yuan] Natl Tsing Hua Univ, Inst Mol & Cellular Biol, Hsinchu, Taiwan; [Liu, Ya-Chuan; Lin, Meng-Chieh; Chen, Hsiang-Chi; Lin, Lih-Yuan] Natl Tsing Hua Univ, Dept Life Sci, Hsinchu, Taiwan; [Tam, Ming F.] Acad Sinica, Inst Mol Biol, Taipei, Taiwan	National Tsing Hua University; National Tsing Hua University; Academia Sinica - Taiwan	Lin, LY (corresponding author), 101,Sec 2,Kuang Fu Rd, Hsinchu, Taiwan.	lylin@life.nthu.edu.tw		Lin, Lih-Yuan/0000-0001-9827-3434	National Science Council, Taiwan, Republic of China [NSC98-2311-B-007-015-MY3]	National Science Council, Taiwan, Republic of China(Ministry of Science and Technology, Taiwan)	This work was supported by Grant NSC98-2311-B-007-015-MY3 from the National Science Council, Taiwan, Republic of China.	Andrews GK, 2001, EMBO J, V20, P1114, DOI 10.1093/emboj/20.5.1114; Bayer P, 1998, J MOL BIOL, V280, P275, DOI 10.1006/jmbi.1998.1839; Bossis G, 2006, MOL CELL, V21, P349, DOI 10.1016/j.molcel.2005.12.019; BRUGNERA E, 1994, NUCLEIC ACIDS RES, V22, P3167, DOI 10.1093/nar/22.15.3167; Chang YJ, 2002, J BIOL CHEM, V277, P7118, DOI 10.1074/jbc.M109924200; Chen WY, 2002, BIOCHEM BIOPH RES CO, V291, P798, DOI 10.1006/bbrc.2002.6517; Cheng Z, 2008, ONCOGENE, V27, P931, DOI 10.1038/sj.onc.1210710; Coyle P, 2002, CELL MOL LIFE SCI, V59, P627, DOI 10.1007/s00018-002-8454-2; Cramer M, 2005, BIOL CHEM, V386, P865, DOI 10.1515/BC.2005.101; Dalton TP, 1996, J BIOL CHEM, V271, P26233, DOI 10.1074/jbc.271.42.26233; Daniels PJ, 2003, NUCLEIC ACIDS RES, V31, P6710, DOI 10.1093/nar/gkg913; der Maur Adrian Auf, 1999, Biological Chemistry, V380, P175; Garcia-Dominguez M, 2009, BBA-GENE REGUL MECH, V1789, P451, DOI 10.1016/j.bbagrm.2009.07.001; Golebiowski F, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000282; Green CJ, 2001, CANCER RES, V61, P2696; Gunes C, 1998, EMBO J, V17, P2846, DOI 10.1093/emboj/17.10.2846; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hecker CM, 2006, J BIOL CHEM, V281, P16117, DOI 10.1074/jbc.M512757200; HEUCHEL R, 1994, EMBO J, V13, P2870, DOI 10.1002/j.1460-2075.1994.tb06581.x; Jakobs A, 2007, NAT METHODS, V4, P245, DOI 10.1038/NMETH1006; Jian OY, 2009, MOL CELL, V34, P145, DOI 10.1016/j.molcel.2009.03.013; Jiang HM, 2004, BIOCHEM J, V382, P33, DOI 10.1042/BJ20040504; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Kerscher O, 2007, EMBO REP, V8, P550, DOI 10.1038/sj.embor.7400980; LaRochelle O, 2001, J BIOL CHEM, V276, P41879, DOI 10.1074/jbc.M108313200; Lee YK, 2007, J BIOL CHEM, V282, P1595, DOI 10.1074/jbc.M606306200; Li YJ, 2010, ONCOGENE, V29, P3509, DOI 10.1038/onc.2010.108; Li Y, 2008, MOL CELL BIOL, V28, P4275, DOI 10.1128/MCB.00369-08; Lichtlen P, 2001, BIOESSAYS, V23, P1010, DOI 10.1002/bies.1146; Lin DY, 2006, MOL CELL, V24, P341, DOI 10.1016/j.molcel.2006.10.019; Lin HK, 2004, NATURE, V431, P205, DOI 10.1038/nature02783; Lin KA, 2005, J CELL PHYSIOL, V205, P428, DOI 10.1002/jcp.20417; Matunis MJ, 2006, DEV CELL, V11, P596, DOI 10.1016/j.devcel.2006.10.011; Matunis MJ, 1996, J CELL BIOL, V135, P1457, DOI 10.1083/jcb.135.6.1457; McNally BA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002277; Merrill JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008794; Meulmeester E, 2008, MOL CELL, V30, P610, DOI 10.1016/j.molcel.2008.03.021; Minty A, 2000, J BIOL CHEM, V275, P36316, DOI 10.1074/jbc.M004293200; Mukhopadhyay D, 2007, TRENDS BIOCHEM SCI, V32, P286, DOI 10.1016/j.tibs.2007.05.002; Murphy BJ, 1999, CANCER RES, V59, P1315; Murphy BJ, 2008, MOL CANCER RES, V6, P483, DOI 10.1158/1541-7786.MCR-07-0341; Nefkens I, 2003, J CELL SCI, V116, P513, DOI 10.1242/jcs.00253; PALMITER RD, 1995, EMBO J, V14, P639, DOI 10.1002/j.1460-2075.1995.tb07042.x; Qu J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001085; Quimby BB, 2006, ONCOGENE, V25, P2999, DOI 10.1038/sj.onc.1209335; RADTKE F, 1993, EMBO J, V12, P1355, DOI 10.1002/j.1460-2075.1993.tb05780.x; RADTKE F, 1995, NUCLEIC ACIDS RES, V23, P2277, DOI 10.1093/nar/23.12.2277; Saydam N, 2002, J BIOL CHEM, V277, P20438, DOI 10.1074/jbc.M110631200; Shen TH, 2006, MOL CELL, V24, P331, DOI 10.1016/j.molcel.2006.09.013; Smirnova IV, 2000, J BIOL CHEM, V275, P9377, DOI 10.1074/jbc.275.13.9377; Stitt MS, 2006, VASC PHARMACOL, V44, P149, DOI 10.1016/j.vph.2005.10.004; Suico MA, 2006, BIOCHEM BIOPH RES CO, V348, P880, DOI 10.1016/j.bbrc.2006.07.151; Takahashi H, 2005, J BIOL CHEM, V280, P5611, DOI 10.1074/jbc.M408130200; Wei F, 2007, J BIOL CHEM, V282, P21551, DOI 10.1074/jbc.M611041200; Wilkinson KA, 2010, BIOCHEM J, V428, P133, DOI 10.1042/BJ20100158; Wyatt D, 2011, J BIOL CHEM, V286, P3884, DOI 10.1074/jbc.M110.152116; Yang PM, 2007, CHEM RES TOXICOL, V20, P406, DOI 10.1021/tx060144c; Yu CW, 1997, FEBS LETT, V420, P69, DOI 10.1016/S0014-5793(97)01489-0; Yurchenko V, 2006, MOL CELL BIOL, V26, P1786, DOI 10.1128/MCB.26.5.1786-1794.2006; Zhang B, 2001, MOL CELL BIOL, V21, P4505, DOI 10.1128/MCB.21.14.4505-4514.2001; Zhao J, 2007, CELL MOL LIFE SCI, V64, P3017, DOI 10.1007/s00018-007-7137-4	61	6	7	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					42818	42829		10.1074/jbc.M111.253203	http://dx.doi.org/10.1074/jbc.M111.253203			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22021037	Green Published, hybrid			2022-12-27	WOS:000298351300003
J	Bock, G; Gebhart, M; Scharinger, A; Jangsangthong, W; Busquet, P; Poggiani, C; Sartori, S; Mangoni, ME; Sinnegger-Brauns, MJ; Herzig, S; Striessnig, J; Koschak, A				Bock, Gabriella; Gebhart, Mathias; Scharinger, Anja; Jangsangthong, Wanchana; Busquet, Perrine; Poggiani, Chiara; Sartori, Simone; Mangoni, Matteo E.; Sinnegger-Brauns, Martina J.; Herzig, Stefan; Striessnig, Joerg; Koschak, Alexandra			Functional Properties of a Newly Identified C-terminal Splice Variant of Ca(v)1.3 L-type Ca2+ Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED CALCIUM-CHANNEL; CA2+-DEPENDENT INACTIVATION; CONGENITAL DEAFNESS; DOPAMINE NEURONS; DOMAIN; SUBUNITS; REVEALS; CELLS; MODULATION; MECHANISMS	An intramolecular interaction between a distal (DCRD) and a proximal regulatory domain (PCRD) within theCterminus of long Ca(v)1.3 L-type Ca2+ channels (Cav1.3(L)) is a major determinant of their voltage-and Ca2+-dependent gating kinetics. Removal of these regulatory domains by alternative splicing generates Ca(v)1.3(42A) channels that activate at a more negative voltage range and exhibit more pronounced Ca2+-dependent inactivation. Here we describe the discovery of a novel short splice variant (Ca(v)1.3(43S)) that is expressed at high levels in the brain but not in the heart. It lacks the DCRD but, in contrast to Ca(v)1.3(42A), still contains PCRD. When expressed together with alpha 2 delta 1 and beta 3 subunits in tsA-201 cells, Ca(v)1.3(43S) also activated at more negative voltages like Ca(v)1.3(42A) but Ca2+-dependent inactivation was less pronounced. Single channel recordings revealed much higher channel open probabilities for both short splice variants as compared with Ca(v)1.3(L). The presence of the proximal C terminus in Ca(v)1.3(43S) channels preserved their modulation by distal C terminus-containing Ca(v)1.3- and Ca(v)1.2-derived C-terminal peptides. Removal of the C-terminal modulation by alternative splicing also induced a faster decay of Ca2+ influx during electrical activities mimicking trains of neuronal action potentials. Our findings extend the spectrum of functionally diverse Ca(v)1.3 L-type channels produced by tissue-specific alternative splicing. This diversity may help to fine tune Ca2+ channel signaling and, in the case of short variants lacking a functional C-terminal modulation, prevent excessive Ca2+ accumulation during burst firing in neurons. This may be especially important in neurons that are affected by Ca2+-induced neurodegenerative processes.	[Bock, Gabriella; Gebhart, Mathias; Scharinger, Anja; Busquet, Perrine; Poggiani, Chiara; Sartori, Simone; Sinnegger-Brauns, Martina J.; Striessnig, Joerg; Koschak, Alexandra] Inst Pharm Pharmacol & Toxicol, A-6020 Innsbruck, Austria; [Bock, Gabriella; Gebhart, Mathias; Scharinger, Anja; Busquet, Perrine; Poggiani, Chiara; Sartori, Simone; Sinnegger-Brauns, Martina J.; Striessnig, Joerg; Koschak, Alexandra] Ctr Mol Biosci Innsbruck, A-6020 Innsbruck, Austria; [Jangsangthong, Wanchana; Herzig, Stefan] Univ Cologne, Dept Pharmacol, D-50931 Cologne, Germany; [Jangsangthong, Wanchana; Herzig, Stefan] Univ Cologne, Ctr Mol Med, D-50931 Cologne, Germany; [Mangoni, Matteo E.] CNRS, Dept Physiol, Inst Genom Fonctionnelle, UMR 5203, F-34000 Montpellier, France; [Sinnegger-Brauns, Martina J.] INSERM, U661, F-34000 Montpellier, France; [Sinnegger-Brauns, Martina J.] Univ Montpellier 1, UMR 5203, F-34000 Montpellier, France; [Sinnegger-Brauns, Martina J.] Univ Montpellier 2, UMR 5203, F-34000 Montpellier, France; [Sinnegger-Brauns, Martina J.] INSERM, U637, F-34000 Montpellier, France	University of Innsbruck; University of Cologne; University of Cologne; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Striessnig, J (corresponding author), Inst Pharm Pharmacol & Toxicol, Peter Mayr Str 1-I, A-6020 Innsbruck, Austria.	joerg.striessnig@uibk.ac.at; alexandra.koschak@meduniwien.ac.at	Striessnig, Joerg/S-9334-2017; Tuluc, Petronel/C-2527-2011; Mangoni, Matteo E/E-6025-2015	Striessnig, Joerg/0000-0002-9406-7120; Mangoni, Matteo E/0000-0002-8892-3373; Sartori, Simone B./0000-0002-2396-1838; Herzig, Stefan/0000-0001-8107-5204; Brauns, Martina/0000-0002-0547-2731	National Institutes of Health [R01HL087120-A2]; Austrian Science Fund (FWF) [P-22528, P-20670, F4402]; European Community Research Training Network [MRTN-CT-2006-35367]; Center for Molecular Medicine Cologne [CMMC A5]; University of Innsbruck; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087120] Funding Source: NIH RePORTER; Austrian Science Fund (FWF) [P 22528, P 20670] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); European Community Research Training Network(European Commission); Center for Molecular Medicine Cologne; University of Innsbruck; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported, in whole or in part, by National Institutes of Health Grant R01HL087120-A2, Austrian Science Fund (FWF) Grants P-22528 (to A.K.) and P-20670 and F4402 (to J.S.), The European Community Research Training Network Cavnet Grant MRTN-CT-2006-35367), Center for Molecular Medicine Cologne Grant CMMC A5 (to S.H.), and the University of Innsbruck.	Andrade A, 2010, NAT NEUROSCI, V13, P1249, DOI 10.1038/nn.2643; Baig SM, 2011, NAT NEUROSCI, V14, P77, DOI 10.1038/nn.2694; Barbado M, 2009, BBA-MOL CELL RES, V1793, P1096, DOI 10.1016/j.bbamcr.2009.02.004; Berkefeld H, 2008, J NEUROSCI, V28, P8238, DOI 10.1523/JNEUROSCI.2274-08.2008; Blythe SN, 2009, J NEUROSCI, V29, P15531, DOI 10.1523/JNEUROSCI.2961-09.2009; Chan CS, 2007, NATURE, V447, P1081, DOI 10.1038/nature05865; Cui GH, 2007, J NEUROSCI, V27, P4776, DOI 10.1523/JNEUROSCI.0139-07.2007; Deisseroth K, 2003, CURR OPIN NEUROBIOL, V13, P354, DOI 10.1016/S0959-4388(03)00076-X; DeJongh KS, 1996, BIOCHEMISTRY-US, V35, P10392, DOI 10.1021/bi953023c; Erickson MG, 2003, NEURON, V39, P97, DOI 10.1016/S0896-6273(03)00395-7; Foehring RC, 2009, J NEUROPHYSIOL, V102, P2326, DOI 10.1152/jn.00038.2009; Gomez-Ospina N, 2006, CELL, V127, P591, DOI 10.1016/j.cell.2006.10.017; Grabner M, 1998, P NATL ACAD SCI USA, V95, P1903, DOI 10.1073/pnas.95.4.1903; Hell JW, 1996, P NATL ACAD SCI USA, V93, P3362, DOI 10.1073/pnas.93.8.3362; Helton TD, 2005, J NEUROSCI, V25, P10247, DOI 10.1523/JNEUROSCI.1089-05.2005; Hulme JT, 2006, J PHYSIOL-LONDON, V576, P87, DOI 10.1113/jphysiol.2006.111799; Hulme JT, 2005, P NATL ACAD SCI USA, V102, P5274, DOI 10.1073/pnas.0409885102; IHARA Y, 1995, MOL ENDOCRINOL, V9, P121, DOI 10.1210/me.9.1.121; Jangsangthong W, 2010, PFLUG ARCH EUR J PHY, V459, P399, DOI 10.1007/s00424-009-0738-z; Jing XJ, 2005, J CLIN INVEST, V115, P146, DOI 10.1172/JCI200522518; Koschak A, 2001, J BIOL CHEM, V276, P22100, DOI 10.1074/jbc.M101469200; Liao P, 2007, J BIOL CHEM, V282, P35133, DOI 10.1074/jbc.M705478200; Lisman JE, 1997, TRENDS NEUROSCI, V20, P38, DOI 10.1016/S0166-2236(96)10070-9; Liss B, 2008, BRAIN RES REV, V58, P314, DOI 10.1016/j.brainresrev.2007.10.004; Marcantoni A, 2010, J NEUROSCI, V30, P491, DOI 10.1523/JNEUROSCI.4961-09.2010; Moosmang S, 2005, J NEUROSCI, V25, P9883, DOI 10.1523/JNEUROSCI.1531-05.2005; Olson PA, 2005, J NEUROSCI, V25, P1050, DOI 10.1523/JNEUROSCI.3327-04.2005; Platzer J, 2000, CELL, V102, P89, DOI 10.1016/S0092-8674(00)00013-1; Schroder F, 1998, CIRCULATION, V98, P969, DOI 10.1161/01.CIR.98.10.969; Shen YR, 2006, J NEUROSCI, V26, P10690, DOI 10.1523/JNEUROSCI.2093-06.2006; Singh A, 2008, J BIOL CHEM, V283, P20733, DOI 10.1074/jbc.M802254200; Singh A, 2006, NAT NEUROSCI, V9, P1108, DOI 10.1038/nn1751; Sinnegger-Brauns MJ, 2009, MOL PHARMACOL, V75, P407, DOI 10.1124/mol.108.049981; Soong TW, 2002, J NEUROSCI, V22, P10142; Striessnig J, 2008, CHANNELS, V2, P233, DOI 10.4161/chan.2.4.5847; Striessnig J, 2010, PFLUG ARCH EUR J PHY, V460, P361, DOI 10.1007/s00424-010-0800-x; Surmeier DJ, 2011, ANTIOXID REDOX SIGN, V14, P1289, DOI 10.1089/ars.2010.3521; Tan BZ, 2011, J BIOL CHEM, V286, P42725, DOI 10.1074/jbc.M111.265207; Tang ZZ, 2004, J BIOL CHEM, V279, P44335, DOI 10.1074/jbc.M407023200; Xu WF, 2001, J NEUROSCI, V21, P5944, DOI 10.1523/JNEUROSCI.21-16-05944.2001	40	89	90	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42736	42748		10.1074/jbc.M111.269951	http://dx.doi.org/10.1074/jbc.M111.269951			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	21998310	hybrid, Green Published			2022-12-27	WOS:000298180900080
J	Nunes-Xavier, CE; Elson, A; Pulido, R				Nunes-Xavier, Caroline E.; Elson, Ari; Pulido, Rafael			Epidermal Growth Factor Receptor (EGFR)-mediated Positive Feedback of Protein-tyrosine Phosphatase epsilon (PTP epsilon) on ERK1/2 and AKT Protein Pathways Is Required for Survival of Human Breast Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMARY-TUMOR CELLS; PHORBOL 12-MYRISTATE 13-ACETATE; THERAPEUTIC TARGET; MAP KINASE; IN-VIVO; ALPHA; SRC; NEU; EXPRESSION; TRANSCRIPTION	Increased tyrosine phosphorylation has been correlated with human cancer, including breast cancer. In general, the activation of tyrosine kinases (TKs) can be antagonized by the action of protein-tyrosine phosphatases (PTPs). However, in some cases PTPs can potentiate the activation of TKs. In this study, we have investigated the functional role of PTP is an element of in human breast cancer cell lines. We found the up-regulation and activation of receptor PTP is an element of (RPTP is an element of) in MCF-7 cells and MDA-MB-231 upon PMA, FGF, and serum stimulation, which depended on EGFR and ERK1/2 activity. Diminishing the expression of PTP is an element of in human breast cancer cells abolished ERK1/2 and AKT activation, and decreased the viability and anchorage-independent growth of the cells. Conversely, stable MCF-7 cell lines expressing inducible high levels of ectopic PTP is an element of displayed higher activation of ERK1/2 and anchorage-independent growth. Our results demonstrate that expression of PTP is an element of is up-regulated and activated in breast cancer cell lines, through EGFR, by sustained activation of the ERK1/2 pathway, generating a positive feedback regulatory loop required for survival of human breast cancer cells.	[Nunes-Xavier, Caroline E.; Pulido, Rafael] Ctr Invest Principe Felipe, Valencia 46013, Spain; [Elson, Ari] Weizmann Inst Sci, IL-76100 Rehovot, Israel	Prince Felipe Research Center; Weizmann Institute of Science	Pulido, R (corresponding author), Ctr Invest Principe Felipe, Avda Autopista Saler 16-3, Valencia 46013, Spain.	rpulido@cipf.es	Ruiz-Lopez, Maria Dolores/U-1925-2017; Nunes-Xavier, Caroline E./R-5893-2018; Fernandez, Mariana F./C-9877-2012; Olea, Nicolas/H-3198-2014	Ruiz-Lopez, Maria Dolores/0000-0001-8523-0689; Nunes-Xavier, Caroline E./0000-0002-1875-6645; Fernandez, Mariana F./0000-0001-6417-8914; Olea, Nicolas/0000-0002-8938-3743; Elson, Ari/0000-0001-9808-9135; Pulido, Rafael/0000-0001-9100-248X	Ministerio de Ciencia e Innovacion (Spain and Fondo Europeo de Desarrollo Regional) [SAF2009-10226]; Generalitat Valenciana (Spain and Fondo Europeo de Desarrollo Regional) [AP-040/10, ACOMP/2010/222, ACOMP/2011/164]; EU Research Training Network [MRTN-CT-2006-035830]; Israel Science Foundation; EU	Ministerio de Ciencia e Innovacion (Spain and Fondo Europeo de Desarrollo Regional)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat Valenciana (Spain and Fondo Europeo de Desarrollo Regional)(Center for Forestry Research & Experimentation (CIEF)); EU Research Training Network; Israel Science Foundation(Israel Science Foundation); EU(European Commission)	This work was supported by Grants SAF2009-10226 from Ministerio de Ciencia e Innovacion (Spain and Fondo Europeo de Desarrollo Regional), AP-040/10, ACOMP/2010/222, and ACOMP/2011/164 from Generalitat Valenciana (Spain and Fondo Europeo de Desarrollo Regional) (to R. P.); by EU Research Training Network MRTN-CT-2006-035830, and by the Israel Science Foundation (to A. E.).; Supported by the EU Marie Curie Research Training Programme and by Ministerio de Ciencia e Innovacion.	Alblas J, 1998, ONCOGENE, V16, P131, DOI 10.1038/sj.onc.1201485; Amos S, 2005, J BIOL CHEM, V280, P7729, DOI 10.1074/jbc.M409056200; Barboule N, 1999, FEBS LETT, V444, P32, DOI 10.1016/S0014-5793(99)00022-8; Bentires-Alj M, 2007, CANCER RES, V67, P2420, DOI 10.1158/0008-5472.CAN-06-4610; Berman-Golan D, 2007, ONCOGENE, V26, P7028, DOI 10.1038/sj.onc.1210505; Berman-Golan D, 2008, CANCER METAST REV, V27, P193, DOI 10.1007/s10555-008-9124-0; Chiusaroli R, 2004, MOL BIOL CELL, V15, P234, DOI 10.1091/mbc.e03-04-0207; De Franceschi L, 2008, PROTEOMICS, V8, P4695, DOI 10.1002/pmic.200700596; Dube N, 2004, CELL CYCLE, V3, P550; Elson A, 1999, ONCOGENE, V18, P7535, DOI 10.1038/sj.onc.1203098; ELSON A, 1995, J BIOL CHEM, V270, P26116, DOI 10.1074/jbc.270.44.26116; Elson A, 1995, P NATL ACAD SCI USA, V92, P12235, DOI 10.1073/pnas.92.26.12235; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; Fortino V, 2008, CANCER INVEST, V26, P13, DOI 10.1080/07357900701637949; Freiss G, 2004, CRIT REV ONCOL HEMAT, V52, P9, DOI 10.1016/j.critrevonc.2004.05.004; Gauthier ML, 2003, BIOCHEM BIOPH RES CO, V307, P839, DOI 10.1016/S0006-291X(03)01273-7; Gil-Henn H, 2000, ONCOGENE, V19, P4375, DOI 10.1038/sj.onc.1203790; Gil-Henn H, 2001, J BIOL CHEM, V276, P31772, DOI 10.1074/jbc.M103395200; Gil-Henn H, 2003, J BIOL CHEM, V278, P15579, DOI 10.1074/jbc.M210273200; Granot-Attas S, 2004, EXP CELL RES, V294, P236, DOI 10.1016/j.yexcr.2003.11.003; Granot-Attas S, 2009, MOL BIOL CELL, V20, P4324, DOI 10.1091/mbc.E08-11-1158; Hynes NE, 2000, BREAST CANCER RES, V2, P154, DOI 10.1186/bcr48; Johnson AC, 1996, J BIOL CHEM, V271, P3033; Julien SG, 2007, NAT GENET, V39, P338, DOI 10.1038/ng1963; Julien SG, 2011, NAT REV CANCER, V11, P35, DOI 10.1038/nrc2980; Kraut J, 2002, EXP CELL RES, V281, P182, DOI 10.1006/excr.2002.5661; Kraut-Cohen J, 2008, J BIOL CHEM, V283, P4612, DOI 10.1074/jbc.M708822200; Moelling K, 2002, J BIOL CHEM, V277, P31099, DOI 10.1074/jbc.M111974200; Morgan Liam, 2008, Endocrine Metabolic & Immune Disorders-Drug Targets, V8, P273, DOI 10.2174/187153008786848295; Mukouyama Y, 1997, MOL BRAIN RES, V50, P230, DOI 10.1016/S0169-328X(97)00193-9; Nakagawa Y, 2005, ZOOL SCI, V22, P169, DOI 10.2108/zsj.22.169; Nord H, 2009, NEURO-ONCOLOGY, V11, P803, DOI 10.1215/15228517-2009-013; Nunes-Xavier CE, 2010, J BIOL CHEM, V285, P26417, DOI 10.1074/jbc.M110.121830; Pallen CJ, 2003, CURR TOP MED CHEM, V3, P821, DOI 10.2174/1568026033452320; Peretz A, 2000, EMBO J, V19, P4036, DOI 10.1093/emboj/19.15.4036; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Sandgren J, 2010, EXP MOL MED, V42, P484, DOI 10.3858/emm.2010.42.7.050; Schumann G, 1998, MOL BRAIN RES, V62, P56, DOI 10.1016/S0169-328X(98)00237-X; Shanmugam M, 1999, MOL CELL ENDOCRINOL, V148, P109, DOI 10.1016/S0303-7207(98)00229-9; Shimizu H, 2010, AM J PHYSIOL-CELL PH, V299, pC1144, DOI 10.1152/ajpcell.00536.2009; Sines T, 2007, MOL CELL BIOL, V27, P7102, DOI 10.1128/MCB.02096-06; Sully V, 2001, BIOCHEM BIOPH RES CO, V286, P184, DOI 10.1006/bbrc.2001.5360; Tanuma N, 1999, EUR J BIOCHEM, V259, P46, DOI 10.1046/j.1432-1327.1999.00004.x; Tanuma N, 2003, ONCOGENE, V22, P1758, DOI 10.1038/sj.onc.1206267; Tanuma N, 2001, BLOOD, V98, P3030, DOI 10.1182/blood.V98.10.3030; Tiran Z, 2006, MOL BIOL CELL, V17, P4330, DOI 10.1091/mbc.E06-02-0151; Toledano-Katchalski H, 2003, MOL CELL BIOL, V23, P5460, DOI 10.1128/MCB.23.15.5460-5471.2003; Toledano-Katchalski H, 2003, MOL CANCER RES, V1, P541; Tonks NK, 2007, CANCER CELL, V11, P214, DOI 10.1016/j.ccr.2007.02.022; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Tozlu S, 2006, ENDOCR-RELAT CANCER, V13, P1109, DOI 10.1677/erc.1.01120; Wabakken T, 2002, SCAND J IMMUNOL, V56, P195, DOI 10.1046/j.1365-3083.2002.01126.x; Wabakken T, 2002, SCAND J IMMUNOL, V56, P276, DOI 10.1046/j.1365-3083.2002.01127.x; Zheng X, 2008, INT J CANCER, V122, P1999, DOI 10.1002/ijc.23321; Zhi HY, 2011, ONCOGENE, V30, P1706, DOI 10.1038/onc.2010.543; Zikherman J, 2009, J IMMUNOL, V182, P4093, DOI 10.4049/jimmunol.0803317; Zimmermann S, 1999, SCIENCE, V286, P1741, DOI 10.1126/science.286.5445.1741	58	16	19	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					3433	3444		10.1074/jbc.M111.293928	http://dx.doi.org/10.1074/jbc.M111.293928			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22117074	hybrid, Green Published			2022-12-27	WOS:000300295100048
J	Purushothaman, A; Sugahara, K; Faissner, A				Purushothaman, Anurag; Sugahara, Kazuyuki; Faissner, Andreas			Chondroitin Sulfate "Wobble Motifs" Modulate Maintenance and Differentiation of Neural Stem Cells and Their Progeny	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							CENTRAL-NERVOUS-SYSTEM; PROTEIN-TYROSINE-PHOSPHATASE; EMBRYONIC PIG BRAIN; PROMOTES NEURITE OUTGROWTH; GROWTH-ASSOCIATED MOLECULE; RADIAL GLIAL-CELLS; TENASCIN-C; HEPARAN-SULFATE; HYBRID CHAINS; DERMATAN SULFATE	Chondroitin sulfate/dermatan sulfate (CS/DS) proteoglycans, major components of the central nervous system, have the potential to interact with a wide range of growth factors and neurotrophic factors that influence neuronal migration, axon guidance pathways, and neurite outgrowth. Recent studies have also revealed the role of CS/DS chains in the orchestration of the neural stem/progenitor cell micromilieu. Individual functional proteins recognize a set of multiple overlapping oligosaccharide sequences decorated to give different sulfation patterns, which are termed here "wobble CS/DS oligosaccharide motifs," and induce signaling pathways essential for the proliferation, self-renewal, and cell lineage commitment of neural stem/progenitor cells.	[Purushothaman, Anurag] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Sugahara, Kazuyuki] Hokkaido Univ, Grad Sch Life Sci, Lab Proteoglycan Signaling & Therapeut, Frontier Res Ctr Postgenom Sci & Technol,Kita Ku, Sapporo, Hokkaido 0010021, Japan; [Faissner, Andreas] Ruhr Univ, Dept Cell Morphol & Mol Neurobiol, D-44801 Bochum, Germany	University of Alabama System; University of Alabama Birmingham; Hokkaido University; Ruhr University Bochum	Purushothaman, A (corresponding author), Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA.	anuragp@uab.edu; andreas.faissner@rub.de	Faissner, Andreas/A-5314-2008	Faissner, Andreas/0000-0002-2211-8259	Deutsche Forschungsgemeinschaft; Bundesministerium fur Bildung und Forschung; Deutscher Akademischer Austausch Dienst; International Graduate School for Neuroscience; Ministerium fur Innovation, Wissenschaft, Forschung und Technologie des Landes Nordrhein-Westfalen; Ministry of Education, Culture, Sports, Science, and Technology of Japan	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Deutscher Akademischer Austausch Dienst(Deutscher Akademischer Austausch Dienst (DAAD)); International Graduate School for Neuroscience; Ministerium fur Innovation, Wissenschaft, Forschung und Technologie des Landes Nordrhein-Westfalen; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants from the Deutsche Forschungsgemeinschaft, the Bundesministerium fur Bildung und Forschung, the Deutscher Akademischer Austausch Dienst, the International Graduate School for Neuroscience, and the Ministerium fur Innovation, Wissenschaft, Forschung und Technologie des Landes Nordrhein-Westfalen (to A. F.) and by a grant from the Matching Program for Innovations in Future Drug Discovery and Medical Care from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to K.S.).	Akatsu C, 2011, GLYCOBIOLOGY, V21, P565, DOI 10.1093/glycob/cwq208; Akita K, 2008, STEM CELLS, V26, P798, DOI 10.1634/stemcells.2007-0448; Alvarez-Buylla A, 2004, NEURON, V41, P683, DOI 10.1016/S0896-6273(04)00111-4; Alvarez-Buylla A, 2001, NAT REV NEUROSCI, V2, P287, DOI 10.1038/35067582; Anthony TE, 2004, NEURON, V41, P881, DOI 10.1016/S0896-6273(04)00140-0; Bandtlow CE, 2000, PHYSIOL REV, V80, P1267, DOI 10.1152/physrev.2000.80.4.1267; Bao XF, 2005, J BIOL CHEM, V280, P35318, DOI 10.1074/jbc.M507304200; Bao XF, 2005, J BIOL CHEM, V280, P23184, DOI 10.1074/jbc.M503036200; Bao XF, 2005, J BIOL CHEM, V280, P9180, DOI 10.1074/jbc.M413423200; Bao XF, 2004, J BIOL CHEM, V279, P9765, DOI 10.1074/jbc.M310877200; Blanchard V, 2007, BIOCHEMISTRY-US, V46, P1167, DOI 10.1021/bi061971f; Bulow HE, 2004, NEURON, V41, P723, DOI 10.1016/S0896-6273(04)00084-4; Clement AM, 1999, NEUROSCI LETT, V269, P125, DOI 10.1016/S0304-3940(99)00432-2; Clement AM, 1998, J BIOL CHEM, V273, P28444, DOI 10.1074/jbc.273.43.28444; Cool SM, 2007, J MOL HISTOL, V38, P377, DOI 10.1007/s10735-007-9146-x; Czopka T, 2010, J NEUROSCI, V30, P12310, DOI 10.1523/JNEUROSCI.4957-09.2010; Czopka T, 2009, GLIA, V57, P1790, DOI 10.1002/glia.20891; Deepa SS, 2002, J BIOL CHEM, V277, P43707, DOI 10.1074/jbc.M207105200; Doetsch F, 2003, NAT NEUROSCI, V6, P1127, DOI 10.1038/nn1144; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Faissner A, 2006, ADV EXP MED BIOL, V557, P25; FAISSNER A, 1994, J CELL BIOL, V126, P783, DOI 10.1083/jcb.126.3.783; Faissner A, 1997, CELL TISSUE RES, V290, P331, DOI 10.1007/s004410050938; Faissner A, 2010, BRAIN RES REV, V63, P26, DOI 10.1016/j.brainresrev.2010.01.001; FINNE J, 1983, BIOCHEM BIOPH RES CO, V112, P482, DOI 10.1016/0006-291X(83)91490-0; FUKUTA M, 1995, J BIOL CHEM, V270, P18575, DOI 10.1074/jbc.270.31.18575; Furuta M, 2004, DEV BRAIN RES, V152, P189, DOI 10.1016/j.devbrainres.2004.06.014; Galtrey CM, 2007, BRAIN, V130, P926, DOI 10.1093/brain/awl372; Galtrey CM, 2007, BRAIN RES REV, V54, P1, DOI 10.1016/j.brainresrev.2006.09.006; Garcion E, 2004, DEVELOPMENT, V131, P3423, DOI 10.1242/dev.01202; Garcion E, 2001, DEVELOPMENT, V128, P2485; Garwood J, 2004, EUR J NEUROSCI, V20, P2524, DOI 10.1111/j.1460-9568.2004.03727.x; Garwood J, 1999, J NEUROSCI, V19, P3888; GATES MA, 1995, J COMP NEUROL, V361, P249, DOI 10.1002/cne.903610205; Gilbert RJ, 2005, MOL CELL NEUROSCI, V29, P545, DOI 10.1016/j.mcn.2005.04.006; Gustafsson E, 2000, EXP CELL RES, V261, P52, DOI 10.1006/excr.2000.5042; Hennen E, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.201095; Hiraoka N, 2000, J BIOL CHEM, V275, P20188, DOI 10.1074/jbc.M002443200; Ida M, 2006, J BIOL CHEM, V281, P5982, DOI 10.1074/jbc.M507130200; Ishii M, 2008, J BIOL CHEM, V283, P32610, DOI 10.1074/jbc.M806331200; Izumikawa T, 2010, J BIOL CHEM, V285, P12190, DOI 10.1074/jbc.M110.100941; Kabos P, 2004, BIOCHEM BIOPH RES CO, V318, P955, DOI 10.1016/j.bbrc.2004.04.114; Kang HG, 2002, J BIOL CHEM, V277, P34766, DOI 10.1074/jbc.M204907200; Kantor DB, 2004, NEURON, V44, P961, DOI 10.1016/j.neuron.2004.12.002; Kiernan BW, 1999, EUR J NEUROSCI, V11, P3082, DOI 10.1046/j.1460-9568.1999.00729.x; Kitagawa H, 2000, J BIOL CHEM, V275, P21075, DOI 10.1074/jbc.M002101200; Kitagawa H, 1997, J BIOL CHEM, V272, P31377, DOI 10.1074/jbc.272.50.31377; Kobayashi M, 1999, J BIOL CHEM, V274, P10474, DOI 10.1074/jbc.274.15.10474; Kreuger J, 2006, J CELL BIOL, V174, P323, DOI 10.1083/jcb.200604035; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Li FC, 2007, J BIOL CHEM, V282, P2956, DOI 10.1074/jbc.M609296200; Li FC, 2010, J BIOL CHEM, V285, P27673, DOI 10.1074/jbc.M110.118703; LOIS C, 1993, P NATL ACAD SCI USA, V90, P2074, DOI 10.1073/pnas.90.5.2074; Maeda N, 2003, J BIOL CHEM, V278, P35805, DOI 10.1074/jbc.M305530200; Maeda N, 1998, J CELL BIOL, V142, P203, DOI 10.1083/jcb.142.1.203; Malatesta P, 2000, DEVELOPMENT, V127, P5253; Mikami T, 2003, J BIOL CHEM, V278, P36115, DOI 10.1074/jbc.M306044200; Mikami T, 2009, J BIOL CHEM, V284, P4494, DOI 10.1074/jbc.M809227200; MILEV P, 1994, J CELL BIOL, V127, P1703, DOI 10.1083/jcb.127.6.1703; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Mitsunaga C, 2006, J BIOL CHEM, V281, P18942, DOI 10.1074/jbc.M510870200; Mizuguchi S, 2003, NATURE, V423, P443, DOI 10.1038/nature01635; Moon LDF, 2001, NAT NEUROSCI, V4, P465, DOI 10.1038/87415; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Nakanishi K, 2010, NEUROCHEM RES, V35, P1131, DOI 10.1007/s11064-010-0164-9; Nakashima K, 1999, J NEUROSCI, V19, P5429; Nishimura K, 2010, NEUROSCIENCE, V169, P1535, DOI 10.1016/j.neuroscience.2010.06.027; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Ohtake S, 2001, J BIOL CHEM, V276, P43894, DOI 10.1074/jbc.M104922200; OOHIRA A, 1986, J NEUROCHEM, V47, P588; Pacheco B, 2009, J BIOL CHEM, V284, P1741, DOI 10.1074/jbc.M805479200; Piecewicz S, 2011, STEM CELLS DEV, V20, P749, DOI 10.1089/scd.2010.0454; Pothacharoen P, 2007, J BIOL CHEM, V282, P35232, DOI 10.1074/jbc.M702255200; Properzi F, 2005, EUR J NEUROSCI, V21, P378, DOI 10.1111/j.1460-9568.2005.03876.x; Purushothaman A, 2007, J BIOL CHEM, V282, P19442, DOI 10.1074/jbc.M700630200; Rhodes KE, 2004, J ANAT, V204, P33, DOI 10.1111/j.1469-7580.2004.00261.x; Rigato F, 2002, J NEUROSCI, V22, P6596; Sasaki N, 2008, J BIOL CHEM, V283, P3594, DOI 10.1074/jbc.M705621200; Sato Y, 2009, CURR STEM CELL RES T, V4, P200, DOI 10.2174/157488809789057419; Scadden DT, 2006, NATURE, V441, P1075, DOI 10.1038/nature04957; Shimazaki Y, 2005, J NEUROSCI RES, V82, P172, DOI 10.1002/jnr.20639; Silbert JE, 2002, IUBMB LIFE, V54, P177, DOI 10.1080/15216540214923; Sirko S, 2007, DEVELOPMENT, V134, P2727, DOI 10.1242/dev.02871; Sirko S, 2010, STEM CELLS, V28, P775, DOI 10.1002/stem.309; Smith RAA, 2011, BIOCHEM SOC T, V39, P383, DOI 10.1042/BST0390383; Sugahara K, 2003, CURR OPIN STRUC BIOL, V13, P612, DOI 10.1016/j.sbi.2003.09.011; Sugahara K, 2007, CURR OPIN STRUC BIOL, V17, P536, DOI 10.1016/j.sbi.2007.08.015; Takahashi M, 1998, MOL CELL NEUROSCI, V12, P340, DOI 10.1006/mcne.1998.0721; Tamura H, 2006, NEUROSCI LETT, V399, P33, DOI 10.1016/j.neulet.2006.01.045; Tham M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015341; VINCENT M, 1984, DEV BIOL, V103, P468, DOI 10.1016/0012-1606(84)90334-8; von Holst A, 2006, J NEUROSCI, V26, P4082, DOI 10.1523/JNEUROSCI.0422-06.2006; von Holst A, 2007, J BIOL CHEM, V282, P9172, DOI 10.1074/jbc.M608067200; Weigmann A, 1997, P NATL ACAD SCI USA, V94, P12425, DOI 10.1073/pnas.94.23.12425; Yamada Shuhei, 2008, Curr Drug Discov Technol, V5, P289; Yamaguchi Y, 2001, SEMIN CELL DEV BIOL, V12, P99, DOI 10.1006/scdb.2000.0238; Yamaguchi Y, 2010, PROG MOL BIOL TRANSL, V93, P133, DOI 10.1016/S1877-1173(10)93007-X; Yamauchi S, 2000, J BIOL CHEM, V275, P8975, DOI 10.1074/jbc.275.12.8975; Yamauchi S, 2011, NEUROSCI LETT, V493, P107, DOI 10.1016/j.neulet.2011.02.019; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	100	77	77	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					2935	2942		10.1074/jbc.R111.298430	http://dx.doi.org/10.1074/jbc.R111.298430			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22094467	Green Published, hybrid			2022-12-27	WOS:000300295100001
J	Mahabeleshwar, GH; Qureshi, MA; Takami, Y; Sharma, N; Lingrel, JB; Jain, MK				Mahabeleshwar, Ganapati H.; Qureshi, Muhammad Awais; Takami, Yoichi; Sharma, Nikunj; Lingrel, Jerry B.; Jain, Mukesh K.			A Myeloid Hypoxia-inducible Factor 1 alpha-Kruppel-like Factor 2 Pathway Regulates Gram-positive Endotoxin-mediated Sepsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; LIPOTEICHOIC ACID; PEPTIDOGLYCAN; SHOCK; ACTIVATION; KLF2; LIPOPOLYSACCHARIDE; IDENTIFICATION; EPIDEMIOLOGY; HIF-1-ALPHA	Although Gram-positive infections account for the majority of cases of sepsis, the molecular mechanisms underlying their effects remains poorly understood. We investigated how cell wall components of Gram-positive bacteria contribute to the development of sepsis. Experimental observations derived from cultured primary macrophages and the cell line indicate that Gram-positive bacterial endotoxins induce hypoxia-inducible factor 1 alpha (HIF-1 alpha) mRNA and protein expression. Inoculation of live or heat-inactivated Gram-positive bacteria with macrophages induced HIF-1 transcriptional activity in macrophages. Concordant with these results, myeloid deficiency of HIF-1 alpha attenuated Gram-positive bacterial endotoxin-induced cellular motility and proinflammatory gene expression in macrophages. Conversely, Gram-positive bacteria and their endotoxins reduced expression of the myeloid anti-inflammatory transcription factor Kruppel-like transcription factor 2 (KLF2). Sustained expression of KLF2 reduced and deficiency of KLF2 enhanced Gram-positive endotoxins induced HIF-1 alpha mRNA and protein expression in macrophages. More importantly, KLF2 attenuated Gram-positive endotoxins induced cellular motility and proinflammatory gene expression in myeloid cells. Consistent with these results, mice deficient in myeloid HIF-1 alpha were protected from Gram-positive endotoxin-induced sepsis mortality and clinical symptomatology. By contrast, myeloid KLF2-deficient mice were susceptible to Gram-positive sepsis induced mortality and clinical symptoms. Collectively, these observations identify HIF-1 alpha and KLF2 as critical regulators of Gram-positive endotoxin-mediated sepsis.	[Mahabeleshwar, Ganapati H.; Qureshi, Muhammad Awais; Takami, Yoichi; Sharma, Nikunj; Jain, Mukesh K.] Case Western Reserve Univ, Sch Med, Dept Med,Univ Hosp Case Med Ctr, Case Cardiovasc Res Inst,Harrington McLaughlin He, Cleveland, OH 44106 USA; [Lingrel, Jerry B.] Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA	Case Western Reserve University; Case Western Reserve University Hospital; University System of Ohio; University of Cincinnati	Mahabeleshwar, GH (corresponding author), Case Western Reserve Univ, Sch Med, Dept Med,Univ Hosp Case Med Ctr, Case Cardiovasc Res Inst,Harrington McLaughlin He, Cleveland, OH 44106 USA.	ghm4@case.edu; mukesh.jain2@case.edu		Takami, Yoichi/0000-0001-9018-6707	National Institutes of Health [HL72952, HL75427, HL76754, HL086548, HL084154, HL097023, HL78806]; American Heart Association [11POST7200004]; Sankyo Foundation of Life Science; Kanae Foundation for the Promotion of Medical Science; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075427, R00HL097023, R01HL076754, R01HL084154, K99HL097023, R01HL110630, R01HL086548, R01HL072952, R01HL078806] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Sankyo Foundation of Life Science; Kanae Foundation for the Promotion of Medical Science; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL72952, HL75427, HL76754, HL086548, and HL084154 (to M.K.J.); HL097023 (to G.H.M); and HL78806 (to J.B.L.). This work was also supported by American Heart Association Grants 11POST7200004 (to N.S.), Sankyo Foundation of Life Science grants, and a Kanae Foundation for the Promotion of Medical Science grant (to Y.T.).	ANDERSON KP, 1995, MOL CELL BIOL, V15, P5957; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; BEHR T, 1992, EUR J BIOCHEM, V207, P1063, DOI 10.1111/j.1432-1033.1992.tb17143.x; Blouin CC, 2004, BLOOD, V103, P1124, DOI 10.1182/blood-2003-07-2427; Campbell J, 2011, ACS CHEM BIOL, V6, P106, DOI 10.1021/cb100269f; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; Danai Pajman, 2005, Curr Infect Dis Rep, V7, P329, DOI 10.1007/s11908-005-0005-1; Das H, 2006, P NATL ACAD SCI USA, V103, P6653, DOI 10.1073/pnas.0508235103; De Bels D, 2011, NEW ENGL J MED, V365, P1845, DOI 10.1056/NEJMc1110602; DEKIMPE SJ, 1995, P NATL ACAD SCI USA, V92, P10359, DOI 10.1073/pnas.92.22.10359; DUNNE DW, 1994, P NATL ACAD SCI USA, V91, P1863, DOI 10.1073/pnas.91.5.1863; Friedman G, 1998, CRIT CARE MED, V26, P2078, DOI 10.1097/00003246-199812000-00045; Humbert M, 2011, LEUKEMIA RES, V35, P909, DOI 10.1016/j.leukres.2011.03.010; Kengatharan KM, 1998, J EXP MED, V188, P305, DOI 10.1084/jem.188.2.305; Kengatharan M, 1996, BRIT J PHARMACOL, V117, P1163, DOI 10.1111/j.1476-5381.1996.tb16711.x; Lappin E, 2009, LANCET INFECT DIS, V9, P281, DOI 10.1016/S1473-3099(09)70066-0; Lever A, 2007, BMJ-BRIT MED J, V335, P879, DOI 10.1136/bmj.39346.495880.AE; Mahabeleshwar GH, 2011, IMMUNITY, V34, P715, DOI 10.1016/j.immuni.2011.04.014; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Nizet V, 2009, NAT REV IMMUNOL, V9, P609, DOI 10.1038/nri2607; Opal SM, 1999, CRIT CARE MED, V27, P1608, DOI 10.1097/00003246-199908000-00039; Peyssonnaux C, 2005, J CLIN INVEST, V115, P1806, DOI 10.1172/JCI23865; Peyssonnaux C, 2007, J IMMUNOL, V178, P7516, DOI 10.4049/jimmunol.178.12.7516; Rius J, 2008, NATURE, V453, P807, DOI 10.1038/nature06905; Schwandner R, 1999, J BIOL CHEM, V274, P17406, DOI 10.1074/jbc.274.25.17406; Semenza CL, 2001, PEDIATR RES, V49, P614, DOI 10.1203/00006450-200105000-00002; Semenza GL, 2001, CELL, V107, P1, DOI 10.1016/S0092-8674(01)00518-9; SenBanerjee S, 2004, J EXP MED, V199, P1305, DOI 10.1084/jem.20031132; Serbina NV, 2008, ANNU REV IMMUNOL, V26, P421, DOI 10.1146/annurev.immunol.26.021607.090326; van Zoelen MAD, 2011, MOL IMMUNOL, V48, P1468, DOI 10.1016/j.molimm.2011.04.001; Walmsley SR, 2005, J EXP MED, V201, P105, DOI 10.1084/jem.20040624; Wang JE, 2000, INFECT IMMUN, V68, P3965, DOI 10.1128/IAI.68.7.3965-3970.2000	32	34	36	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					1448	1457		10.1074/jbc.M111.312702	http://dx.doi.org/10.1074/jbc.M111.312702			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22110137	Green Published, hybrid			2022-12-27	WOS:000299170300058
J	Nili, M; Mukherjee, A; Shinde, U; David, L; Rotwein, P				Nili, Mahta; Mukherjee, Aditi; Shinde, Ujwal; David, Larry; Rotwein, Peter			Defining the Disulfide Bonds of Insulin-like Growth Factor-binding Protein-5 by Tandem Mass Spectrometry with Electron Transfer Dissociation and Collision-induced Dissociation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TISSUE-PLASMINOGEN ACTIVATOR; IGF-BINDING; TERMINAL DOMAINS; STRUCTURAL BASIS; FACTOR-I; LC-MS; IGFBP-5; DIFFERENTIATION; SUBSTITUTIONS; LINKAGES	The six high-affinity insulin-like growth factor-binding proteins (IGFBPs) comprise a conserved family of secreted molecules that modulate IGF actions by regulating their half-life and access to signaling receptors, and also exert biological effects that are independent of IGF binding. IGFBPs are composed of cysteine-rich amino-(N-) and carboxyl-(C-) terminal domains, along with a cysteine-poor central linker segment. IGFBP-5 is the most conserved IGFBP, and contains 18 cysteines, but only 2 of 9 putative disulfide bonds have been mapped to date. Using a mass spectrometry (MS)-based strategy combining sequential electron transfer dissociation (ETD) and collision-induced dissociation (CID) steps, in which ETD fragmentation preferentially induces cleavage of disulfide bonds, and CID provides exact disulfide linkage assignments between liberated peptides, we now have definitively mapped 5 disulfide bonds in IGFBP-5. In addition, in conjunction with ab initio molecular modeling we are able to assign the other 4 disulfide linkages to within a GCGCCXXC motif that is conserved in five IGFBPs. Because of the nature of ETD fragmentation MS experiments were performed without chemical reduction of IGFBP-5. Our results not only establish a disulfide bond map of IGFBP-5 but also define a general approach that takes advantage of the specificity of ETD and the scalability of tandem MS, and the predictive power of ab initio molecular modeling to characterize unknown disulfide linkages in proteins.	[Nili, Mahta; Mukherjee, Aditi; Shinde, Ujwal; David, Larry; Rotwein, Peter] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA	Oregon Health & Science University	Rotwein, P (corresponding author), Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	rotweinp@ohsu.edu	Rotwein, Peter/R-5783-2019	Rotwein, Peter/0000-0002-9505-1817	National Institutes of Health [5R01 DK042748-22, 5R01 EY007755-18, 5P30 EY10572, F31 HL095271-03]; NSF [0746589]; NATIONAL EYE INSTITUTE [R01EY007755, P30EY010572] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F31HL095271] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK042748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM071338] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Research Grants 5R01 DK042748-22 (to P.R.) and 5R01 EY007755-18 and 5P30 EY10572 (to L.D.) and by NSF Grant 0746589 (to U.S.).; Supported by National Institutes of Health Predoctoral Fellowship F31 HL095271-03.	Bach LA, 2005, TRENDS ENDOCRIN MET, V16, P228, DOI 10.1016/j.tem.2005.05.005; Beattie J, 2006, BIOCHEM J, V395, P1, DOI 10.1042/BJ20060086; Bonneau R, 2002, J MOL BIOL, V322, P65, DOI 10.1016/S0022-2836(02)00698-8; Chrisman PA, 2005, J AM SOC MASS SPECTR, V16, P1020, DOI 10.1016/j.jasms.2005.02.010; Clemmons DR, 1998, MOL CELL ENDOCRINOL, V140, P19, DOI 10.1016/S0303-7207(98)00024-0; Cobb LJ, 2004, J CELL SCI, V117, P1737, DOI 10.1242/jcs.01028; Conover CA, 2008, AM J PHYSIOL-ENDOC M, V294, pE10, DOI 10.1152/ajpendo.00648.2007; Daza DO, 2011, ENDOCRINOLOGY, V152, P2278, DOI 10.1210/en.2011-0047; Fernandez-Tornero C, 2005, J BIOL CHEM, V280, P18899, DOI 10.1074/jbc.M500587200; Firth SM, 2002, ENDOCR REV, V23, P824, DOI 10.1210/er.2001-0033; Fleishman S. J., 2011, J MOL BIOL; Forbes BE, 1998, J BIOL CHEM, V273, P4647, DOI 10.1074/jbc.273.8.4647; Gleason CE, 2010, MOL ENDOCRINOL, V24, P178, DOI 10.1210/me.2009-0167; Gorman JJ, 2002, MASS SPECTROM REV, V21, P183, DOI 10.1002/mas.10025; HISE MK, 1994, AM J PHYSIOL, V266, pF147, DOI 10.1152/ajprenal.1994.266.1.F147; Humphries JD, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000396; Hwa V, 1999, ENDOCR REV, V20, P761, DOI 10.1210/er.20.6.761; Imai Y, 2000, J BIOL CHEM, V275, P18188, DOI 10.1074/jbc.M000070200; JAMES PL, 1993, J BIOL CHEM, V268, P22305; Kalus W, 1998, EMBO J, V17, P6558, DOI 10.1093/emboj/17.22.6558; Keshamouni VG, 2009, J PROTEOME RES, V8, P35, DOI 10.1021/pr8006478; Khatib F, 2011, NAT STRUCT MOL BIOL, V18, P1175, DOI 10.1038/nsmb.2119; Kim KS, 2007, MOL BIOL CELL, V18, P4543, DOI 10.1091/mbc.E07-03-0280; Mainathambika BS, 2008, ANNU REV CELL DEV BI, V24, P211, DOI 10.1146/annurev.cellbio.24.110707.175333; Maki RG, 2010, J CLIN ONCOL, V28, P4985, DOI 10.1200/JCO.2009.27.5040; Mikesh LM, 2006, BBA-PROTEINS PROTEOM, V1764, P1811, DOI 10.1016/j.bbapap.2006.10.003; Mohan S, 2002, J ENDOCRINOL, V175, P19, DOI 10.1677/joe.0.1750019; Mukherjee A, 2008, MOL ENDOCRINOL, V22, P1238, DOI 10.1210/me.2008-0001; Mukherjee A, 2008, MOL ENDOCRINOL, V22, P206, DOI 10.1210/me.2007-0336; Mukherjee A, 2007, GROWTH HORM IGF RES, V17, P179, DOI 10.1016/j.ghir.2007.01.005; Nakae J, 2001, ENDOCR REV, V22, P818, DOI 10.1210/edrv.22.6.0452; Neumann GM, 1999, J BIOL CHEM, V274, P14587, DOI 10.1074/jbc.274.21.14587; Ning Y, 2006, MOL ENDOCRINOL, V20, P2173, DOI 10.1210/me.2005-0196; Osaki T, 2011, J PROTEOME RES, V10, P1870, DOI 10.1021/pr101114a; Ren HX, 2008, J CELL BIOL, V182, P979, DOI 10.1083/jcb.200712110; Sala A, 2005, J BIOL CHEM, V280, P29812, DOI 10.1074/jbc.M504304200; Salih DAM, 2005, ENDOCRINOLOGY, V146, P931, DOI 10.1210/en.2004-0816; Salih DAM, 2004, P NATL ACAD SCI USA, V101, P4314, DOI 10.1073/pnas.0400230101; Samani AA, 2007, ENDOCR REV, V28, P20, DOI 10.1210/er.2006-0001; Schneider MR, 2002, J ENDOCRINOL, V172, P423, DOI 10.1677/joe.0.1720423; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Shand JH, 2003, J BIOL CHEM, V278, P17859, DOI 10.1074/jbc.M300526200; Sitar T, 2006, P NATL ACAD SCI USA, V103, P13028, DOI 10.1073/pnas.0605652103; Siwanowicz I, 2005, STRUCTURE, V13, P155, DOI 10.1016/j.str.2004.11.009; Sorrell AM, 2006, J BIOL CHEM, V281, P10883, DOI 10.1074/jbc.M508505200; Tripathi G, 2009, FASEB J, V23, P2616, DOI 10.1096/fj.08-114124; Wiesner J, 2008, PROTEOMICS, V8, P4466, DOI 10.1002/pmic.200800329; Wu SL, 2010, ANAL CHEM, V82, P5296, DOI 10.1021/ac100766r; Wu SL, 2009, ANAL CHEM, V81, P112, DOI 10.1021/ac801560k; Yasuoka H, 2009, AM J RESP CELL MOL, V41, P179, DOI 10.1165/rcmb.2008-0211OC; Zeslawski W, 2001, EMBO J, V20, P3638, DOI 10.1093/emboj/20.14.3638; Zhou R, 2003, J ENDOCRINOL, V178, P177, DOI 10.1677/joe.0.1780177	52	10	14	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					1510	1519		10.1074/jbc.M111.285528	http://dx.doi.org/10.1074/jbc.M111.285528			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22117064	Green Published, hybrid			2022-12-27	WOS:000299170300064
J	Mamenko, M; Zaika, O; Ilatovskaya, DV; Staruschenko, A; Pochynyuk, O				Mamenko, Mykola; Zaika, Oleg; Ilatovskaya, Daria V.; Staruschenko, Alexander; Pochynyuk, Oleh			Angiotensin II Increases Activity of the Epithelial Na+ Channel (ENaC) in Distal Nephron Additively to Aldosterone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORTICAL COLLECTING DUCT; SODIUM-CHANNEL; OPEN PROBABILITY; LIDDLE SYNDROME; AT(1) RECEPTOR; GAMMA-SUBUNIT; TRPV4 CHANNEL; BETA-SUBUNIT; RAT-KIDNEY; HYPERTENSION	Dietary salt intake controls epithelial Na+ channel (ENaC)mediated Na+ reabsorption in the distal nephron by affecting status of the renin-angiotensin-aldosterone system (RAAS). Whereas regulation of ENaC by aldosterone is generally accepted, little is known about whether other components of RAAS, such as angiotensin II (Ang II), have nonredundant to aldosterone-stimulatory actions on ENaC. We combined patch clamp electrophysiology and immunohistochemistry in freshly isolated split-opened distal nephrons of mice to determine the mechanism and molecular signaling pathway of Ang II regulation of ENaC. We found that Ang II acutely increases ENaC P-o, whereas prolonged exposure to Ang II also induces translocation of alpha-ENaC toward the apical membrane in situ. Ang II actions on ENaC P-o persist in the presence of saturated mineralocorticoid status. Moreover, aldosterone fails to stimulate ENaC acutely, suggesting that Ang II and aldosterone have different time frames of ENaC activation. AT(1) but not AT(2) receptors mediate Ang II actions on ENaC. Unlike its effect in vasculature, Ang II did not increase [ Ca2+](i) in split-opened distal nephrons as demonstrated using ratiometric Fura-2-based microscopy. However, application of Ang II to mpkCCD(c14) cells resulted in generation of reactive oxygen species, as probed with fluorescent methods. Consistently, inhibiting NADPH oxidase with apocynin abolished Ang II-mediated increases in ENaC P-o in murine distal nephron. Therefore, we concluded that Ang II directly regulates ENaC activity in the distal nephron, and this effect complements regulation of ENaC by aldosterone. We propose that stimulation of AT(1) receptors with subsequent activation of NADPH oxidase signaling pathway mediates Ang II actions on ENaC.	[Mamenko, Mykola; Zaika, Oleg; Pochynyuk, Oleh] Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA; [Ilatovskaya, Daria V.; Staruschenko, Alexander] Med Coll Wisconsin, Dept Physiol, Milwaukee, WI 53226 USA; [Ilatovskaya, Daria V.] Russian Acad Sci, Inst Cytol, St Petersburg 194064, Russia	University of Texas System; University of Texas Health Science Center Houston; Medical College of Wisconsin; Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; Institute of Cytology RAS	Pochynyuk, O (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, 6431 Fannin, Houston, TX 77030 USA.	oleh.m.pochynyuk@uth.tmc.edu	Mamenko, Mykola/I-6061-2015	Mamenko, Mykola/0000-0001-8683-0715; Ilatovskaya, Daria/0000-0003-4832-4170; Staruschenko, Alexander/0000-0002-5190-8356	American Heart Association [SDG2230391]; American Society of Nephrology; National Institutes of Health, American Diabetes Association [1-10-BS-168, R01HL108880]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL108880] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); American Society of Nephrology; National Institutes of Health, American Diabetes Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by American Heart Association Grant SDG2230391 (to O. P.), a in part Carl W. Gottschalk research scholar grant from the American Society of Nephrology (to O. P.), National Institutes of Health Grant American Diabetes Association Grant 1-10-BS-168 (to A. S.), and R01HL108880 (to A. S.).	Berry C, 2001, AM J PHYSIOL-HEART C, V281, pH2337, DOI 10.1152/ajpheart.2001.281.6.H2337; Beutler KT, 2003, HYPERTENSION, V41, P1143, DOI 10.1161/01.HYP.0000066129.12106.E2; BRAAM B, 1993, AM J PHYSIOL, V264, pF891, DOI 10.1152/ajprenal.1993.264.5.F891; Brooks HL, 2002, HYPERTENSION, V39, P470, DOI 10.1161/hy02t2.102959; Bugaj V, 2009, AM J PHYSIOL-RENAL, V297, pF1411, DOI 10.1152/ajprenal.00371.2009; Butterworth MB, 2005, AM J PHYSIOL-RENAL, V289, pF969, DOI 10.1152/ajprenal.00390.2003; de Gasparo M, 2000, PHARMACOL REV, V52, P415; Eaton DC, 2001, J MEMBRANE BIOL, V184, P313, DOI 10.1007/s00232-001-0098-x; Gao X, 2003, J BIOL CHEM, V278, P27129, DOI 10.1074/jbc.M302517200; Garty H, 1997, PHYSIOL REV, V77, P359, DOI 10.1152/physrev.1997.77.2.359; GUYTON AC, 1991, SCIENCE, V252, P1813, DOI 10.1126/science.2063193; HANSSON JH, 1995, P NATL ACAD SCI USA, V92, P11495, DOI 10.1073/pnas.92.25.11495; HANSSON JH, 1995, NAT GENET, V11, P76, DOI 10.1038/ng0995-76; HarrisonBernard LM, 1997, AM J PHYSIOL-RENAL, V273, pF170, DOI 10.1152/ajprenal.1997.273.1.F170; Hummler E, 2003, CURR HYPERTENS REP, V5, P11, DOI 10.1007/s11906-003-0005-1; Hummler E, 1999, J STEROID BIOCHEM, V69, P385, DOI 10.1016/S0960-0760(99)00073-4; Hunyady L, 2006, MOL ENDOCRINOL, V20, P953, DOI 10.1210/me.2004-0536; Jin M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016713; Kaschina E, 2003, BLOOD PRESSURE, V12, P70, DOI 10.1080/08037050310001057; KEMENDY AE, 1992, AM J PHYSIOL, V263, pC825, DOI 10.1152/ajpcell.1992.263.4.C825; Khawaja Z, 2011, INT J HYPERTENS, V2011, DOI 10.4061/2011/143471; Knepper MA, 2003, ANN NY ACAD SCI, V986, P562, DOI 10.1111/j.1749-6632.2003.tb07254.x; Kobori H, 2007, PHARMACOL REV, V59, P251, DOI 10.1124/pr.59.3.3; Komlosi P, 2003, HYPERTENSION, V42, P195, DOI 10.1161/01.HYP.0000081221.36703.01; Levchenko V, 2010, J CELL PHYSIOL, V223, P252, DOI 10.1002/jcp.22033; Lifton RP, 2001, CELL, V104, P545, DOI 10.1016/S0092-8674(01)00241-0; Ma HP, 2011, J BIOL CHEM, V286, P32444, DOI 10.1074/jbc.M111.254102; Mamenko M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022824; Masilamani S, 1999, J CLIN INVEST, V104, pR19, DOI 10.1172/JCI7840; Miyata N, 1999, AM J PHYSIOL-RENAL, V277, pF437, DOI 10.1152/ajprenal.1999.277.3.F437; Navar LG, 2011, CURR OPIN PHARMACOL, V11, P180, DOI 10.1016/j.coph.2011.01.009; Ozono R, 1997, HYPERTENSION, V30, P1238, DOI 10.1161/01.HYP.30.5.1238; Arroyo JP, 2011, PHYSIOLOGY, V26, P115, DOI 10.1152/physiol.00049.2010; Peti-Peterdi J, 2002, J AM SOC NEPHROL, V13, P1131, DOI 10.1097/01.ASN.0000013292.78621.FD; Pochynyuk O, 2008, AM J PHYSIOL-RENAL, V294, pF38, DOI 10.1152/ajprenal.00403.2007; Pochynyuk O, 2010, FASEB J, V24, P2056, DOI 10.1096/fj.09-151506; Pochynyuk O, 2008, J BIOL CHEM, V283, P36599, DOI 10.1074/jbc.M807129200; Schild L, 2004, REV PHYSIOL BIOCH P, V151, P93, DOI 10.1007/s10254-004-0023-7; Schild L, 2001, ADV EXP MED BIOL, V502, P305; Schild L, 1996, NEPHROLOGIE, V17, P395; SHIMKETS RA, 1994, CELL, V79, P407, DOI 10.1016/0092-8674(94)90250-X; Staruschenko A, 2007, J AM SOC NEPHROL, V18, P1652, DOI 10.1681/ASN.2007010020; Stockand JD, 2002, AM J PHYSIOL-RENAL, V282, pF559, DOI 10.1152/ajprenal.00320.2001; Wang T, 1996, AM J PHYSIOL-RENAL, V271, pF143, DOI 10.1152/ajprenal.1996.271.1.F143; Wang WH, 2009, PFLUG ARCH EUR J PHY, V458, P157, DOI 10.1007/s00424-008-0593-3; Wei YA, 2007, J BIOL CHEM, V282, P6455, DOI 10.1074/jbc.M607477200; Wind S, 2010, BRIT J PHARMACOL, V161, P885, DOI 10.1111/j.1476-5381.2010.00920.x; Wu L, 2007, AM J PHYSIOL-RENAL, V293, pF1699, DOI 10.1152/ajprenal.00462.2006; Yue P, 2011, KIDNEY INT, V79, P423, DOI 10.1038/ki.2010.380; Zaika O, 2011, AM J PHYSIOL-RENAL, V300, pF1105, DOI 10.1152/ajprenal.00606.2010; Zaman MA, 2002, NAT REV DRUG DISCOV, V1, P621, DOI 10.1038/nrd873	51	105	109	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					660	671		10.1074/jbc.M111.298919	http://dx.doi.org/10.1074/jbc.M111.298919			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22086923	Green Published, hybrid			2022-12-27	WOS:000298682400064
J	Rush, JS; Quinalty, LM; Engelman, L; Sherry, DM; Ceresa, BP				Rush, Jamie S.; Quinalty, Leslie M.; Engelman, Luke; Sherry, David M.; Ceresa, Brian P.			Endosomal Accumulation of the Activated Epidermal Growth Factor Receptor (EGFR) Induces Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ERBB SIGNALING NETWORK; ENDOCYTIC TRAFFICKING; CELL-GROWTH; HELA-CELLS; A431 CELLS; CANCER; DEGRADATION; EXPRESSION; SEQUESTRATION; INHIBITORS	Endocytosis positively and negatively regulates cell surface receptor signaling by temporally and spatially controlling interactions with downstream effectors. This process controls receptor-effector communication. However, the relationship between receptor endocytic trafficking and cell physiology is unclear. In MDA-MB-468 cells, cell surface EGF receptors (EGFRs) promote cell growth, whereas intracellular EGFRs induce apoptosis, making these cells an excellent model for studying the endocytic regulation of EGFR signaling. In addition, MDA-MB-468 cells have limited EGFR degradation following stimulation. Here, we report that in MDA-MB-468 cells the phosphorylated EGFR accumulates on the limiting membrane of the endosome with its carboxyl terminus oriented to the cytoplasm. To determine whether perturbation of EGFR trafficking is sufficient to cause apoptosis, we used pharmacological and biochemical strategies to disrupt EGFR endocytic trafficking in HeLa cells, which do not undergo EGF-dependent apoptosis. Manipulation of HeLa cells so that active EGF center dot EGFRs accumulate on the limiting membrane of endosomes reveals that receptor phosphorylation is sustained and leads to apoptosis. When EGF center dot EGFR complexes accumulated in the intraluminal vesicles of the late endosome, phosphorylation of the receptor was not sustained, nor did the cells undergo apoptosis. These data demonstrate that EGFR-mediated apoptosis is initiated by the activated EGFR from the limiting membrane of the endosome.	[Rush, Jamie S.; Quinalty, Leslie M.; Engelman, Luke; Sherry, David M.; Ceresa, Brian P.] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK 73106 USA; [Sherry, David M.] Univ Oklahoma, Hlth Sci Ctr, Oklahoma Ctr Neurosci, Oklahoma City, OK 73106 USA; [Sherry, David M.] Univ Oklahoma, Hlth Sci Ctr, Dept Pharmaceut Sci, Oklahoma City, OK 73106 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Ceresa, BP (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK 73106 USA.	brian-ceresa@ouhsc.edu	Driskill, Leslie/AAI-8748-2021	Driskill, Leslie/0000-0003-3484-2794	National Institutes of Health from National Center for Research Resources [P20 RR 017703]; Oklahoma Center for Advancement of Science and Technology [HR10-012];  [1R01GM092874]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017703] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM092874] Funding Source: NIH RePORTER	National Institutes of Health from National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Oklahoma Center for Advancement of Science and Technology; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants P20 RR 017703 from the COBRE Program of the National Center for Research Resources (to B. P. C.) and 1R01GM092874 (to B. P. C.). This work was also supported by Oklahoma Center for Advancement of Science and Technology Grant HR10-012 (to B. P. C.).	ARMSTRONG DK, 1994, CANCER RES, V54, P5280; Bache KG, 2006, MOL BIOL CELL, V17, P2513, DOI 10.1091/mbc.E05-10-0915; CAILLEAU R, 1978, IN VITRO CELL DEV B, V14, P911; Ceresa BP, 2006, J BIOL CHEM, V281, P1099, DOI 10.1074/jbc.M504175200; DAMKE H, 1995, METHOD ENZYMOL, V257, P209; DIAZ R, 1989, METHOD CELL BIOL, V31, P25; Dinneen JL, 2004, TRAFFIC, V5, P606, DOI 10.1111/j.1398-9219.2004.00204.x; Dinneen JL, 2004, EXP CELL RES, V294, P509, DOI 10.1016/j.yexcr.2003.12.006; FILMUS J, 1985, BIOCHEM BIOPH RES CO, V128, P898, DOI 10.1016/0006-291X(85)90131-7; GILL GN, 1981, NATURE, V293, P305, DOI 10.1038/293305a0; HANSEN MB, 1989, J IMMUNOL METHODS, V119, P203, DOI 10.1016/0022-1759(89)90397-9; Hyatt DC, 2008, EXP CELL RES, V314, P3415, DOI 10.1016/j.yexcr.2008.08.020; KING AC, 1984, BIOCHEM BIOPH RES CO, V124, P585, DOI 10.1016/0006-291X(84)91594-8; Kornilova E, 1996, J BIOL CHEM, V271, P30340, DOI 10.1074/jbc.271.48.30340; Kottke TJ, 1999, J BIOL CHEM, V274, P15927, DOI 10.1074/jbc.274.22.15927; LEY KD, 1992, CARCINOGENESIS, V13, P183, DOI 10.1093/carcin/13.2.183; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Razi M, 2006, MOL BIOL CELL, V17, P3469, DOI 10.1091/mbc.E05-11-1054; Rowinsky EK, 2004, ANNU REV MED, V55, P433, DOI 10.1146/annurev.med.55.091902.104433; SORKIN AD, 1988, EXP CELL RES, V175, P192, DOI 10.1016/0014-4827(88)90266-2; Sorkin A, 2009, EXP CELL RES, V315, P683, DOI [10.1016/j.yexcr.2008.07.029, 10.1016/j.yexcr.2008.08.013]; Taelman VF, 2010, CELL, V143, P1136, DOI 10.1016/j.cell.2010.11.034; Tikhomirov O, 2004, J BIOL CHEM, V279, P12988, DOI 10.1074/jbc.M311655200; Tullo AB, 2005, EYE, V19, P729, DOI 10.1038/sj.eye.6701630; Vanlandingham PA, 2009, J BIOL CHEM, V284, P12110, DOI 10.1074/jbc.M809277200; Vieira AV, 1996, SCIENCE, V274, P2086, DOI 10.1126/science.274.5295.2086; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Zhang G, 2007, CORNEA, V26, P858, DOI 10.1097/ICO.0b013e318064584a	28	63	64	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					712	722		10.1074/jbc.M111.294470	http://dx.doi.org/10.1074/jbc.M111.294470			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22102283	hybrid, Green Published			2022-12-27	WOS:000298682400069
J	Chang, SC; Mulloy, B; Magee, AI; Couchman, JR				Chang, Shu-Chun; Mulloy, Barbara; Magee, Anthony I.; Couchman, John R.			Two Distinct Sites in Sonic Hedgehog Combine for Heparan Sulfate Interactions and Cell Signaling Functions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SELF-RENEWAL; STEM-CELLS; CANCER; PROLIFERATION; CARCINOMAS; PATHWAY; PROTEOGLYCANS; MUTATIONS; INDUCTION; BINDING	Hedgehog (Hh) proteins are morphogens that mediate many developmental processes. Hh signaling is significant for many aspects of embryonic development, whereas dysregulation of this pathway is associated with several types of cancer. Hh proteins require heparan sulfate proteoglycans (HSPGs) for their normal distribution and signaling activity. Here, we have used molecular modeling to examine the heparin-binding domain of sonic hedgehog (Shh). In biochemical and cell biological assays, the importance of specific residues of the putative heparin-binding domain for signaling was assessed. It was determined that key residues in human (h) Shh involved in heparin and HSPG syndecan-4 binding and biological activity included the well known cationic Cardin-Weintraub motif (lysines 32-38) but also a previously unidentified major role for lysine 178. The activity of Shh mutated in these residues was tested by quantitation of alkaline phosphatase activity in C3H10T1/2 cells differentiating into osteoblasts and hShh-inducible gene expression in PANC1 human pancreatic ductal adenocarcinoma cells. Mutated hShhs such as K37S/K38S, K178S, and particularly K37S/K38S/K178S that could not interact with heparin efficiently had reduced signaling activity compared with wild type hShh or a control mutation (K74S). In addition, the mutant hShh proteins supported reduced proliferation and invasion of PANC1 cells compared with control hShh proteins, following endogenous hShh depletion by RNAi knockdown. The data correlated with reduced Shh multimerization where the Lys-37/38 and/or Lys-178 mutations were examined. These studies provide a new insight into the functional roles of hShh interactions with HSPGs, which may allow targeting this aspect of hShh biology in, for example, pancreatic ductal adenocarcinoma.	[Couchman, John R.] Univ Copenhagen, Dept Biomed Sci, Bioctr, DK-2200 Copenhagen N, Denmark; [Chang, Shu-Chun; Magee, Anthony I.] Univ London Imperial Coll Sci Technol & Med, Mol Med Sect, Natl Heart & Lung Inst, London SW7 2AZ, England; [Mulloy, Barbara] Natl Inst Biol Stand & Controls, Potters Bar EN6 3QG, Herts, England	University of Copenhagen; Imperial College London; National Institute for Biological Standards & Control	Couchman, JR (corresponding author), Univ Copenhagen, Dept Biomed Sci, Bioctr, Ole Maaloes Vej 5, DK-2200 Copenhagen N, Denmark.	john.couchman@bric.ku.dk	Magee, Anthony/V-8345-2019	Chang, Shu-Chun/0000-0001-6364-2404	Medical Research Council (United Kingdom) [G007771]; Danish National Research Foundation; Lundbeck Fonden; Danish Medical Research Council; Fabrikant Vilhelm Pedersen og Hustrus Legat through Novo Nordisk Fonden	Medical Research Council (United Kingdom)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish National Research Foundation(Danmarks Grundforskningsfond); Lundbeck Fonden(Lundbeckfonden); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Fabrikant Vilhelm Pedersen og Hustrus Legat through Novo Nordisk Fonden	Supported by Medical Research Council (United Kingdom) Grant G007771.; Supported by the Danish National Research Foundation, Lundbeck Fonden, Danish Medical Research Council, and Fabrikant Vilhelm Pedersen og Hustrus Legat through Novo Nordisk Fonden. To whom correspondence should be addressed. Tel.: 45-353-25670; E-mail: john.couchman@bric.ku.dk.	Alexopoulou AN, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-2; Bhardwaj G, 2001, NAT IMMUNOL, V2, P172, DOI 10.1038/84282; Briscoe J, 2005, DEV CELL, V8, P143, DOI 10.1016/j.devcel.2005.01.008; Capurro MI, 2008, DEV CELL, V14, P700, DOI 10.1016/j.devcel.2008.03.006; Chan JA, 2009, NAT NEUROSCI, V12, P409, DOI 10.1038/nn.2287; Clement V, 2007, CURR BIOL, V17, P165, DOI 10.1016/j.cub.2006.11.033; Couchman JR, 2003, NAT REV MOL CELL BIO, V4, P926, DOI 10.1038/nrm1257; Dierker T, 2009, J BIOL CHEM, V284, P8013, DOI 10.1074/jbc.M806838200; Doles J, 2006, DEV BIOL, V295, P13, DOI 10.1016/j.ydbio.2005.12.002; Ericson J, 1996, CELL, V87, P661, DOI 10.1016/S0092-8674(00)81386-0; Fan HR, 1997, NAT MED, V3, P788, DOI 10.1038/nm0797-788; Feng YZ, 2007, CLIN CANCER RES, V13, P1389, DOI 10.1158/1078-0432.CCR-06-1407; Fowlkes JL, 1997, ENDOCRINOLOGY, V138, P2280, DOI 10.1210/en.138.6.2280; Gallet A, 2008, DEV CELL, V14, P712, DOI 10.1016/j.devcel.2008.03.001; HALL TMT, 1995, NATURE, V378, P212, DOI 10.1038/378212a0; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Kawahira H, 2003, DEVELOPMENT, V130, P4871, DOI 10.1242/dev.00653; Lin XH, 2004, DEVELOPMENT, V131, P6009, DOI 10.1242/dev.01522; Maun HR, 2010, J BIOL CHEM, V285, P26570, DOI 10.1074/jbc.M110.112284; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Morton JP, 2007, CELL CYCLE, V6, P1553, DOI 10.4161/cc.6.13.4467; Morton JP, 2007, P NATL ACAD SCI USA, V104, P5103, DOI 10.1073/pnas.0701158104; MULLOY B, 1993, BIOCHEM J, V293, P849, DOI 10.1042/bj2930849; Mulloy B, 2008, MOL SIMULAT, V34, P481, DOI 10.1080/08927020701784754; Nilsson M, 2000, P NATL ACAD SCI USA, V97, P3438, DOI 10.1073/pnas.050467397; Nybakken K, 2002, CURR OPIN GENET DEV, V12, P503, DOI 10.1016/S0959-437X(02)00333-7; Oro AE, 1997, SCIENCE, V276, P817, DOI 10.1126/science.276.5313.817; Pardal R, 2005, COLD SH Q B, V70, P177, DOI 10.1101/sqb.2005.70.057; Park Y, 2003, DEV BIOL, V253, P247, DOI 10.1016/S0012-1606(02)00019-2; Peacock CD, 2007, P NATL ACAD SCI USA, V104, P4048, DOI 10.1073/pnas.0611682104; Pepinsky RB, 2000, J BIOL CHEM, V275, P10995, DOI 10.1074/jbc.275.15.10995; Rubin JB, 2002, DEVELOPMENT, V129, P2223; Rubin LL, 2006, NAT REV DRUG DISCOV, V5, P1026, DOI 10.1038/nrd2086; Thomas MK, 2000, DIABETES, V49, P2039, DOI 10.2337/diabetes.49.12.2039; Turner TT, 2004, J ANDROL, V25, P514; Vyas N, 2008, CELL, V133, P1214, DOI 10.1016/j.cell.2008.05.026; Whitelock JM, 2008, BIOCHEMISTRY-US, V47, P11174, DOI 10.1021/bi8013938; Wolter M, 1997, CANCER RES, V57, P2581; Woods A., 2001, CURR PROTOC CELL BIO; Xie JW, 1998, NATURE, V391, P90, DOI 10.1038/34201; Yauch RL, 2008, NATURE, V455, P406, DOI 10.1038/nature07275; Zhao C, 2009, NATURE, V458, P776, DOI 10.1038/nature07737	42	49	48	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2011	286	52					44391	44402		10.1074/jbc.M111.285361	http://dx.doi.org/10.1074/jbc.M111.285361			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870CA	22049079	Green Published, hybrid			2022-12-27	WOS:000298645500011
J	Perwitasari, O; Cho, H; Diamond, MS; Gale, M				Perwitasari, Olivia; Cho, Hyelim; Diamond, Michael S.; Gale, Michael, Jr.			Inhibitor of kappa B Kinase epsilon (IKK epsilon), STAT1, and IFIT2 Proteins Define Novel Innate Immune Effector Pathway against West Nile Virus Infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATITIS-C-VIRUS; DOUBLE-STRANDED-RNA; PHOSPHORYLATION-ACETYLATION SWITCH; INTERFERON-INDUCIBLE PROTEIN; ALPHA-INTERFERON; RIG-I; TRANSCRIPTIONAL ACTIVATION; ANTIVIRAL IMMUNITY; SIGNALING PATHWAY; UNITED-STATES	West Nile virus is an emerging virus whose virulence is dependent upon viral evasion of IFN and innate immune defenses. The actions of IFN-stimulated genes (ISGs) impart control of virus infection, but the specific ISGs and regulatory pathways that restrict West Nile virus (WNV) are not defined. Here we show that inhibitor of kappa B kinase epsilon (IKK epsilon) phosphorylation of STAT1 at serine 708 (Ser-708) drives IFIT2 expression to mediate anti-WNV effector function of IFN. WNV infection was enhanced in cells from IKK epsilon(-/-) or IFIT2(-/-) mice. In IKK epsilon(-/-) cells, the loss of IFN-induced IFIT2 expression was linked to lack of STAT1 phosphorylation on Ser-708 but not Tyr-701 nor Ser-727. STAT1 Ser-708 phosphorylation occurs independently of IRF-3 but requires signaling through the IFN-alpha/beta receptor as a late event in the IFN-induced innate immune response that coincides with IKK epsilon-responsive ISGs expression. Biochemical analyses show that STAT1 tyrosine dephosphorylation and CRM1-mediated STAT1 nuclear-cytoplasmic shuttling are required for STAT1 Ser-708 phosphorylation. When compared with WT mice, WNV-infected IKK epsilon(-/-) mice exhibit enhanced kinetics of virus dissemination and increased pathogenesis concomitant with loss of STAT1 Ser-708 phosphorylation and IFIT2 expression. Our results define an IFN-induced IKK epsilon signaling pathway of specific STAT1 phosphorylation and IFIT2 expression that imparts innate antiviral immunity to restrict WNV infection and control viral pathogenesis.	[Perwitasari, Olivia; Gale, Michael, Jr.] Univ Washington, Dept Immunol, Sch Med, Seattle, WA 98195 USA; [Perwitasari, Olivia; Gale, Michael, Jr.] Univ Washington, Mol & Cellular Biol Program, Sch Med, Seattle, WA 98195 USA; [Cho, Hyelim; Diamond, Michael S.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Diamond, Michael S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Gale, M (corresponding author), Univ Washington, Dept Immunol, Sch Med, Box 357650, Seattle, WA 98195 USA.	mgale@u.washington.edu	Cho, Hyelim/C-7408-2014; Diamond, Michael/AAH-1733-2019	Diamond, Michael/0000-0002-8791-3165; Gale, Michael/0000-0002-6332-7436	National Institutes of Health [R01AI074973, U19AI083019]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI083019, R01AI074973] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health grants R01AI074973 and U19AI083019.	BANDYOPADHYAY SK, 1995, J BIOL CHEM, V270, P19624, DOI 10.1074/jbc.270.33.19624; Beasley DWC, 2002, VIROLOGY, V296, P17, DOI 10.1006/viro.2002.1372; Berthet FX, 1997, J GEN VIROL, V78, P2293, DOI 10.1099/0022-1317-78-9-2293; BLUYSSEN HAR, 1994, GENOMICS, V24, P137, DOI 10.1006/geno.1994.1591; Breiman A, 2005, J VIROL, V79, P3969, DOI 10.1128/JVI.79.7.3969-3978.2005; Cheon H, 2009, P NATL ACAD SCI USA, V106, P9373, DOI 10.1073/pnas.0903487106; Daffis S, 2008, J VIROL, V82, P8465, DOI 10.1128/JVI.00918-08; Daffis S, 2007, PLOS PATHOG, V3, P1005, DOI 10.1371/journal.ppat.0030106; Daffis S, 2011, J VIROL, V85, P5664, DOI 10.1128/JVI.00232-11; Daffis S, 2010, NATURE, V468, P452, DOI 10.1038/nature09489; Daffis S, 2009, J INNATE IMMUN, V1, P435, DOI 10.1159/000226248; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Fensterl V, 2011, J INTERF CYTOK RES, V31, P71, DOI 10.1089/jir.2010.0101; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Foy E, 2003, SCIENCE, V300, P1145, DOI 10.1126/science.1082604; Fredericksen BL, 2008, J VIROL, V82, P609, DOI 10.1128/JVI.01305-07; Gale M, 2005, NATURE, V436, P939, DOI 10.1038/nature04078; Gilfoy FD, 2007, J VIROL, V81, P11148, DOI 10.1128/JVI.00446-07; Haspel RL, 1996, EMBO J, V15, P6262, DOI 10.1002/j.1460-2075.1996.tb01016.x; Hemmi H, 2004, J EXP MED, V199, P1641, DOI 10.1084/jem.20040520; Hengel H, 2005, TRENDS IMMUNOL, V26, P396, DOI 10.1016/j.it.2005.05.004; Hui DJ, 2005, J BIOL CHEM, V280, P3433, DOI 10.1074/jbc.M406700200; Jia XY, 1999, LANCET, V354, P1971, DOI 10.1016/S0140-6736(99)05384-2; Jiang D, 2010, J VIROL, V84, P8332, DOI 10.1128/JVI.02199-09; Katsoulidis E, 2005, J INTERF CYTOK RES, V25, P749, DOI 10.1089/jir.2005.25.749; Keller BC, 2007, CYTOKINE GROWTH F R, V18, P535, DOI 10.1016/j.cytogfr.2007.06.006; Keller BC, 2006, J VIROL, V80, P9424, DOI 10.1128/JVI.00768-06; Kramer OH, 2010, MOL CELL ENDOCRINOL, V315, P40, DOI 10.1016/j.mce.2009.10.007; Kramer OH, 2009, GENE DEV, V23, P223, DOI 10.1101/gad.479209; Lanciotti RS, 2002, VIROLOGY, V298, P96, DOI 10.1006/viro.2002.1449; Lanciotti RS, 1999, SCIENCE, V286, P2333, DOI 10.1126/science.286.5448.2333; Levy DE, 2001, CYTOKINE GROWTH F R, V12, P143, DOI 10.1016/S1359-6101(00)00027-7; Loo YM, 2008, J VIROL, V82, P335, DOI 10.1128/JVI.01080-07; Lvov DK, 2004, ARCH VIROL, P85; Maher SG, 2008, CANCER BIOL THER, V7, P1109, DOI 10.4161/cbt.7.7.6192; McBride Kevin M, 2003, Sci STKE, V2003, pRE13; McWhirter SM, 2004, P NATL ACAD SCI USA, V101, P233, DOI 10.1073/pnas.2237236100; Mowen K, 2000, MOL CELL BIOL, V20, P7273, DOI 10.1128/MCB.20.19.7273-7281.2000; PELLEGRINI S, 1989, MOL CELL BIOL, V9, P4605, DOI 10.1128/MCB.9.11.4605; Peters RT, 2000, MOL CELL, V5, P513, DOI 10.1016/S1097-2765(00)80445-1; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Saito T, 2007, CURR OPIN IMMUNOL, V19, P17, DOI 10.1016/j.coi.2006.11.003; Samuel MA, 2006, J VIROL, V80, P7009, DOI 10.1128/JVI.00489-06; Sarkar SN, 2004, PHARMACOL THERAPEUT, V103, P245, DOI 10.1016/j.pharmthera.2004.07.007; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Sen GC, 2001, ANNU REV MICROBIOL, V55, P255, DOI 10.1146/annurev.micro.55.1.255; Smithburn K. C., 1940, J TROP MED HYG, V20, P471; Suthar MS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000757; Tenoever BR, 2007, SCIENCE, V315, P1274, DOI 10.1126/science.1136567; tenOever BR, 2004, J VIROL, V78, P10636, DOI 10.1128/JVI.78.19.10636-10649.2004; Terenzi F, 2006, J BIOL CHEM, V281, P34064, DOI 10.1074/jbc.M605771200; Terenzi F, 2008, EMBO J, V27, P3311, DOI 10.1038/emboj.2008.241; Uddin S, 2000, J BIOL CHEM, V275, P27634; Uddin S, 1999, J BIOL CHEM, V274, P30127, DOI 10.1074/jbc.274.42.30127; Uddin S, 2002, J BIOL CHEM, V277, P14408, DOI 10.1074/jbc.M109671200; Vanhatupa S, 2008, BIOCHEM J, V409, P179, DOI 10.1042/BJ20070620; Varinou L, 2003, IMMUNITY, V19, P793, DOI 10.1016/S1074-7613(03)00322-4; Wacher C, 2007, J VIROL, V81, P860, DOI 10.1128/JVI.01167-06; Wang CF, 2003, J VIROL, V77, P3898, DOI 10.1128/JVI.77.7.3898-3912.2003; Wong AHT, 1997, EMBO J, V16, P1291, DOI 10.1093/emboj/16.6.1291; Xie XD, 2011, P NATL ACAD SCI USA, V108, P6474, DOI 10.1073/pnas.1016132108; Yang JB, 2008, CELL RES, V18, P443, DOI 10.1038/cr.2008.41; Zhang YG, 2007, J VIROL, V81, P11246, DOI 10.1128/JVI.01282-07; Zimnik S, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp020	64	48	52	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2011	286	52					44412	44423		10.1074/jbc.M111.285205	http://dx.doi.org/10.1074/jbc.M111.285205			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870CA	22065572	Green Published, hybrid			2022-12-27	WOS:000298645500013
J	Zhang, HB; Alramini, H; Tran, V; Singh, U				Zhang, Hanbang; Alramini, Hussein; Vy Tran; Singh, Upinder			Nucleus-localized Antisense Small RNAs with 5 '-Polyphosphate Termini Regulate Long Term Transcriptional Gene Silencing in Entamoeba histolytica G3 Strain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMOEBAPORE GENE; HETEROCHROMATIN; IDENTIFICATION; ROLES; INTERFERENCE; MICRORNAS; CHROMATIN; PROTISTS; ADHESION; HISTONE	In the deep-branching eukaryotic parasite Entamoeba histolytica, transcriptional gene silencing (TGS) of the Amoebapore A gene (ap-a) in the G3 strain has been reported with subsequent development of this parasite strain for gene silencing. However, the mechanisms underlying this gene silencing approach are poorly understood. Here we report that antisense small RNAs (sRNAs) specific to the silenced ap-a gene can be identified in G3 parasites. Furthermore, when additional genes are silenced in the G3 strain, antisense sRNAs to the newly silenced genes can also be detected. Characterization of these sRNAs demonstrates that they are similar to 27 nucleotides in size, have 5'-polyphosphate termini, and persist even after removal of the silencing plasmid. Immunofluorescence analysis (IFA) and fluorescence in situ hybridization (FISH) show that both the Argonaute protein EhAGO2-2 and antisense sRNAs to the silenced genes are localized to the parasite nucleus. Furthermore, alpha-EhAGO2-2 immunoprecipitation confirmed the direct association of the antisense sRNAs with EhAGO2-2. Finally, chromatin immunoprecipitation (ChIP) assays demonstrate that the loci of the silenced genes are enriched for histone H3 and EhAGO2-2, indicating that both chromatin modification and the RNA-induced transcriptional silencing complex are involved in permanent gene silencing in G3 parasites. In conclusion, our data demonstrate that G3-based gene silencing in E. histolytica is mediated by an siRNA pathway, which utilizes antisense 5'-polyphosphate sRNAs. To our knowledge, this is the first study to show that 5'-polyphosphate antisense sRNAs can mediate TGS, and it is the first example of RNAi-mediated TGS in protozoan parasites.	[Zhang, Hanbang; Alramini, Hussein; Vy Tran; Singh, Upinder] Stanford Univ, Dept Med, Div Infect Dis, Sch Med, Stanford, CA 94305 USA; [Singh, Upinder] Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA	Stanford University; Stanford University	Singh, U (corresponding author), Stanford Univ, Dept Med, Div Infect Dis, Sch Med, S-143GrantBldg,300Pasteur Dr, Stanford, CA 94305 USA.	usingh@stanford.edu	Tran, Vy/GWC-8836-2022	Singh, Upinder/0000-0003-0630-0306	National Institutes of Health [AI-053724, AI-085178]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI085178, R01AI053724] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI-053724 and AI-085178 (to U. S.).	Anbar M, 2005, EUKARYOT CELL, V4, P1775, DOI 10.1128/EC.4.11.1775-1784.2005; [Anonymous], 1997, B WORLD HEALTH ORGAN, V75, P291; Atayde VD, 2011, TRENDS PARASITOL, V27, P321, DOI 10.1016/j.pt.2011.03.002; Baxt LA, 2010, EUKARYOT CELL, V9, P1283, DOI 10.1128/EC.00015-10; Bracha R, 2003, EUKARYOT CELL, V2, P295, DOI 10.1128/EC.2.2.295-305.2003; Bracha R, 2007, EUKARYOT CELL, V6, P1758, DOI 10.1128/EC.00241-07; Bracha Rivka, 2006, PLoS Pathog, V2, pe48, DOI 10.1371/journal.ppat.0020048; Brower-Toland B, 2007, GENE DEV, V21, P2300, DOI 10.1101/gad.1564307; Buker SM, 2007, NAT STRUCT MOL BIOL, V14, P200, DOI 10.1038/nsmb1211; Cerutti H, 2006, CURR GENET, V50, P81, DOI 10.1007/s00294-006-0078-x; Chapman EJ, 2007, NAT REV GENET, V8, P884, DOI 10.1038/nrg2179; Chen XW, 2009, GENOME BIOL EVOL, V1, P165, DOI 10.1093/gbe/evp017; Chookajorn T, 2007, P NATL ACAD SCI USA, V104, P899, DOI 10.1073/pnas.0609084103; Claycomb JM, 2009, CELL, V139, P123, DOI 10.1016/j.cell.2009.09.014; DIAMOND LS, 1978, T ROY SOC TROP MED H, V72, P431, DOI 10.1016/0035-9203(78)90144-X; Djupedal I, 2009, CELL RES, V19, P282, DOI 10.1038/cr.2009.13; Ehrenkaufer GM, 2007, CELL MICROBIOL, V9, P1426, DOI 10.1111/j.1462-5822.2006.00882.x; Ehrenkaufer GM, 2009, CELL MICROBIOL, V11, P898, DOI 10.1111/j.1462-5822.2009.01300.x; Fisher O, 2004, NUCLEIC ACIDS RES, V32, P287, DOI 10.1093/nar/gkh161; Gent JI, 2010, MOL CELL, V37, P679, DOI 10.1016/j.molcel.2010.01.012; Gilchrist CA, 2003, J BIOL CHEM, V278, P4646, DOI 10.1074/jbc.M211271200; Grishok A, 2005, GENE DEV, V19, P683, DOI 10.1101/gad.1247705; Gu WF, 2009, MOL CELL, V36, P231, DOI 10.1016/j.molcel.2009.09.020; Guang S, 2008, SCIENCE, V321, P537, DOI 10.1126/science.1157647; Hawkins PG, 2009, NUCLEIC ACIDS RES, V37, P2984, DOI 10.1093/nar/gkp127; Huguenin M, 2010, PARASITOLOGY, V137, P619, DOI 10.1017/S0031182009991363; Hutvagner G, 2008, NAT REV MOL CELL BIO, V9, P22, DOI 10.1038/nrm2321; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Lavi T, 2006, MOL MICROBIOL, V62, P1373, DOI 10.1111/j.1365-2958.2006.05464.x; Li CF, 2006, CELL, V126, P93, DOI 10.1016/j.cell.2006.05.032; Lu J, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp482; MacFarlane RC, 2006, INFECT IMMUN, V74, P340, DOI 10.1128/IAI.74.1.340-351.2006; MacFarlane RC, 2007, EUKARYOT CELL, V6, P2139, DOI 10.1128/EC.00174-07; Maniar JM, 2011, CURR BIOL, V21, P449, DOI 10.1016/j.cub.2011.02.019; Moazed D, 2009, NATURE, V457, P413, DOI 10.1038/nature07756; Nowotny M, 2009, CURR OPIN STRUC BIOL, V19, P286, DOI 10.1016/j.sbi.2009.04.006; Pak J, 2007, SCIENCE, V315, P241, DOI 10.1126/science.1132839; Pall GS, 2008, NAT PROTOC, V3, P1077, DOI 10.1038/nprot.2008.67; Pikaard CS, 2008, TRENDS PLANT SCI, V13, P390, DOI 10.1016/j.tplants.2008.04.008; Ramakrishnan G, 2004, MOL BIOCHEM PARASIT, V138, P205, DOI 10.1016/j.molbiopara.2004.09.002; Silahtaroglu AN, 2010, METHODS MOL BIOL, V659, P165, DOI 10.1007/978-1-60761-789-1_11; Suzuki K, 2009, CURR TOP MED CHEM, V9, P1079, DOI 10.2174/156802609789630875; Ullu E, 2004, CELL MICROBIOL, V6, P509, DOI 10.1111/j.1462-5822.2004.00399.x; Verdel A, 2005, FEBS LETT, V579, P5872, DOI 10.1016/j.febslet.2005.08.083; Verdel A, 2009, INT J DEV BIOL, V53, P245, DOI 10.1387/ijdb.082691av; Yin H, 2007, NATURE, V450, P304, DOI 10.1038/nature06263; Zhang HB, 2011, FUTURE MICROBIOL, V6, P103, DOI [10.2217/fmb.10.154, 10.2217/FMB.10.154]; Zhang HB, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000219	48	38	38	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2011	286	52					44467	44479		10.1074/jbc.M111.278184	http://dx.doi.org/10.1074/jbc.M111.278184			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870CA	22049083	hybrid, Green Published			2022-12-27	WOS:000298645500019
J	Chen, ZH; Gopalakrishnan, SM; Bui, MH; Soni, NB; Warrior, U; Johnson, EF; Donnelly, JB; Glaser, KB				Chen, Zehan; Gopalakrishnan, Sujatha M.; Bui, Mai-Ha; Soni, Niru B.; Warrior, Usha; Johnson, Eric F.; Donnelly, Jennifer B.; Glaser, Keith B.			1-Benzyl-3-cetyl-2-methylimidazolium iodide (NH125) Induces Phosphorylation of Eukaryotic Elongation Factor-2 (eEF2) A CAUTIONARY NOTE ON THE ANTICANCER MECHANISM OF AN eEF2 KINASE INHIBITOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; FACTOR-II; IDENTIFICATION; CANCER; INHIBITORS; MECHANISM; CELLS; LEADS; SITE; EF-2	Eukaryotic elongation factor-2 kinase (eEF2K) relays growth and stress signals to protein synthesis through phosphorylation and inactivation of eukaryotic elongation factor 2 (eEF2). 1-Benzyl-3-cetyl-2-methylimidazolium iodide (NH125) is a widely accepted inhibitor of mammalian eEF2K and an efficacious anti-proliferation agent against different cancer cells. It implied that eEF2K could be an efficacious anticancer target. However, eEF2K siRNA was ineffective against cancer cells including those sensitive to NH125. To test if pharmacological intervention differs from siRNA interference, we identified a highly selective small molecule eEF2K inhibitor A-484954. Like siRNA, A-484954 had little effect on cancer cell growth. We carefully examined the effect of NH125 and A-484954 on phosphorylation of eEF2, the known cellular substrate of eEF2K. Surprisingly, NH125 increased eEF2 phosphorylation, whereas A-484954 inhibited the phosphorylation as expected for an eEF2K inhibitor. Both A-484954 and eEF2K siRNA inhibited eEF2K and reduced eEF2 phosphorylation with little effect on cancer cell growth. These data demonstrated clearly that the anticancer activity of NH125 was more correlated with induction of eEF2 phosphorylation than inhibition of eEF2K. Actually, induction of eEF2 phosphorylation was reported to correlate with inhibition of cancer cell growth. We compared several known inducers of eEF2 phosphorylation including AMPK-activators and an mTOR inhibitor. Interestingly, stronger induction of eEF2 phosphorylation correlated with more effective growth inhibition. We also explored signal transduction pathways leading to NH125-induced eEF2 phosphorylation. Preliminary data suggested that NH125-induced eEF2 phosphorylation was likely mediated through multiple pathways. These observations identified an opportunity for a new multipathway approach to anticancer therapies.	[Chen, Zehan] Abbott Labs, Global Pharmaceut Prod Res Div, Canc Res & Adv Technol, Abbott Pk, IL 60064 USA	Abbott Laboratories	Chen, ZH (corresponding author), Abbott Labs, Global Pharmaceut Prod Res Div, Canc Res & Adv Technol, AP9-2,100 Abbott Pk Rd, Abbott Pk, IL 60064 USA.	aj.chen@sbcglobal.net						Anderson SN, 2004, J BIOMOL SCREEN, V9, P112, DOI 10.1177/1087057103260592; Arora S, 2004, MOL PHARMACOL, V66, P460; Arora S, 2003, CANCER RES, V63, P6894; Basso AD, 2005, J BIOL CHEM, V280, P31101, DOI 10.1074/jbc.M503763200; Browne GJ, 2004, MOL CELL BIOL, V24, P2986, DOI 10.1128/MCB.24.7.2986-2997.2004; Browne GJ, 2004, J BIOL CHEM, V279, P12220, DOI 10.1074/jbc.M309773200; Browne GJ, 2002, EUR J BIOCHEM, V269, P5360, DOI 10.1046/j.1432-1033.2002.03290.x; Burns DJ, 2001, DRUG DISCOV TODAY, V6, pS40; Chen W, 2004, CANCER CELL, V5, P127, DOI 10.1016/S1535-6108(04)00026-1; Chen ZH, 2006, INT J CANCER, V119, P2784, DOI 10.1002/ijc.22198; Cho SI, 2000, BBA-GEN SUBJECTS, V1475, P207, DOI 10.1016/S0304-4165(00)00061-1; Cool B, 2006, CELL METAB, V3, P403, DOI 10.1016/j.cmet.2006.05.005; Dorovkov MV, 2002, BIOCHEMISTRY-US, V41, P13444, DOI 10.1021/bi026494p; Hait WN, 2006, AUTOPHAGY, V2, P294, DOI 10.4161/auto.2857; Hong-Brown LQ, 2007, J BIOL CHEM, V282, P3702, DOI 10.1074/jbc.M606593200; Hong-Brown LQ, 2008, J CELL BIOCHEM, V105, P814, DOI 10.1002/jcb.21882; Horman S, 2002, CURR BIOL, V12, P1419, DOI 10.1016/S0960-9822(02)01077-1; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; NAIRN AC, 1987, J BIOL CHEM, V262, P17299; Pavur KS, 2000, BIOCHEMISTRY-US, V39, P12216, DOI 10.1021/bi0007270; REDPATH NT, 1993, EUR J BIOCHEM, V213, P689, DOI 10.1111/j.1432-1033.1993.tb17809.x; Roderick HL, 2008, NAT REV CANCER, V8, P361, DOI 10.1038/nrc2374; Rodriguez-Mora O, 2005, EXPERT OPIN THER TAR, V9, P791, DOI 10.1517/14728222.9.4.791; Ryazanov AG, 2002, FEBS LETT, V514, P26, DOI 10.1016/S0014-5793(02)02299-8; RYAZANOV AG, 1988, NATURE, V334, P170, DOI 10.1038/334170a0; RYAZANOV AG, 1989, FEBS LETT, V251, P187, DOI 10.1016/0014-5793(89)81452-8; Thomson AW, 2009, NAT REV IMMUNOL, V9, P324, DOI 10.1038/nri2546; Wu H, 2006, CANCER RES, V66, P3015, DOI 10.1158/0008-5472.CAN-05-1554; Wu H, 2009, CANCER RES, V69, P2453, DOI 10.1158/0008-5472.CAN-08-2872; Yamamoto K, 2000, BIOSCI BIOTECH BIOCH, V64, P919, DOI 10.1271/bbb.64.919; Yamamoto K, 2001, BIOSCI BIOTECH BIOCH, V65, P2306, DOI 10.1271/bbb.65.2306; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI13505	32	72	75	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2011	286	51					43951	43958		10.1074/jbc.M111.301291	http://dx.doi.org/10.1074/jbc.M111.301291			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866SH	22020937	Green Published, hybrid			2022-12-27	WOS:000298402300036
J	Cheng, H; Yang, ZJ; Estabrook, MM; John, CM; Jarvis, GA; McLaughlin, S; Griffiss, JM				Cheng, Hui; Yang, Zhijie; Estabrook, Michele M.; John, Constance M.; Jarvis, Gary A.; McLaughlin, Stephanie; Griffiss, J. McLeod			Human Lipooligosaccharide IGG That Prevents Endemic Meningococcal Disease Recognizes an Internal Lacto-N-neotetraose Structure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INNER-CORE LIPOPOLYSACCHARIDE; SERUM BACTERICIDAL ACTIVITY; NEISSERIA-MENINGITIDIS; IMMUNE-RESPONSE; GENETIC-BASIS; PYOCIN RESISTANCE; GONORRHOEAE; IDENTIFICATION; OLIGOSACCHARIDES; EXPRESSION	Antibodies that initiate complement-mediated killing of Neisseria meningitidis as they enter the bloodstream from the oropharynx protect against disseminated disease. Human IgGs that bind the neisserial L7 lipooligosaccharide (LOS) are bactericidal for L3,7 and L2,4 meningococci in the presence of human complement. These strains share a lacto-N-neotetraose (nLc(4)) LOS alpha chain. We used a set of mutants that have successive saccharide deletions from the nLc(4) alpha chain to characterize further the binding and bactericidal activity of nLc(4) LOS IgG. We found that the nLc(4) alpha chain conforms at least four different antigens. We separately purified IgG that required the nLc(4) (non-reducing) terminal galactose (Gal) for binding and IgG that bound the truncated nLc(3) alpha chain that lacks this Gal residue. IgG that bound the internal nLc(3) alpha chain killed both L3,7 and L2,4 strains, whereas IgG that required the nLc(4) terminal Gal residue for binding killed L2,4 stains but not L3,7 strains. These results show that the diversity of LOS antibodies in human serum is as much a function of the conformation of multiple antigens by a single glycoform as of the production of multiple glycoforms. Differences in sensitivity to killing by human nLc(4) LOS IgG may account for the fact that fully two-thirds of endemic group B meningococcal disease in infants and children is caused by L3,7 strains, but only 20% is caused by L2,4 stains.	[Cheng, Hui; Yang, Zhijie; Estabrook, Michele M.; John, Constance M.; Jarvis, Gary A.; McLaughlin, Stephanie; Griffiss, J. McLeod] Dept Vet Affairs Med Ctr, San Francisco, CA 94121 USA; [Estabrook, Michele M.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94121 USA; [Jarvis, Gary A.; Griffiss, J. McLeod] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94121 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Griffiss, JM (corresponding author), VAMC 111W1,4150 Clement St, San Francisco, CA 94121 USA.	crapaud@loursage.org	McLaughlin, Stephanie/AFT-3454-2022	McLaughlin, Stephanie/0000-0002-6658-8260; Jarvis, Gary/0000-0002-7576-3702	National Institutes of Health [AI 053728, AI 065605, AI 063927]; Veterans Affairs Merit Review Award; Veterans Affairs Medical Center (San Francisco, CA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065605, R01AI053728, R01AI063927] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Review Award(US Department of Veterans Affairs); Veterans Affairs Medical Center (San Francisco, CA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI 053728 and AI 065605, administered by the Northern California Institute for Research and Education (to J. M. G.) and AI 063927 (to G. A. J.). This work was also supported by a Veterans Affairs Merit Review Award (to G. A. J.) and with resources of the Veterans Affairs Medical Center (San Francisco, CA). This is publication 109 from the Center for Immunochemistry.	APICELLA MA, 1976, J INFECT DIS, V134, P377, DOI 10.1093/infdis/134.4.377; APICELLA MA, 1994, METHOD ENZYMOL, V235, P242; Banerjee A, 1998, P NATL ACAD SCI USA, V95, P10872, DOI 10.1073/pnas.95.18.10872; BERTRAM MA, 1976, J IMMUNOL, V116, P842; Cox AD, 2002, EUR J BIOCHEM, V269, P4169, DOI 10.1046/j.1432-1033.2002.03131.x; DANAHER RJ, 1995, J BACTERIOL, V177, P7275, DOI 10.1128/jb.177.24.7275-7279.1995; DENSEN P, 1987, NEW ENGL J MED, V316, P922, DOI 10.1056/NEJM198704093161506; DIFABIO JL, 1990, CAN J CHEM, V68, P1029, DOI 10.1139/v90-160; DUDAS KC, 1988, INFECT IMMUN, V56, P499, DOI 10.1128/IAI.56.2.499-504.1988; Estabrook MM, 2007, INFECT IMMUN, V75, P1025, DOI 10.1128/IAI.00882-06; Estabrook MM, 1997, INFECT IMMUN, V65, P4436, DOI 10.1128/IAI.65.11.4436-4444.1997; ESTABROOK MM, 1993, J INFECT DIS, V167, P966, DOI 10.1093/infdis/167.4.966; ESTABROOK MM, 1990, INFECT IMMUN, V58, P2204, DOI 10.1128/IAI.58.7.2204-2213.1990; ESTABROOK MM, 1992, 92 ANN M AM SOC MICR, P43; GAMIAN A, 1992, J BIOL CHEM, V267, P922; Gilbert M, 1996, J BIOL CHEM, V271, P28271, DOI 10.1074/jbc.271.45.28271; GOLD R, 1978, J INFECT DIS, V137, P112, DOI 10.1093/infdis/137.2.112; GOLDSCHNEIDER I, 1969, J EXP MED, V129, P1307, DOI 10.1084/jem.129.6.1307; GOLDSCHNEIDER I, 1969, J EXP MED, V129, P1327, DOI 10.1084/jem.129.6.1327; GOTSCHLICH EC, 1994, J EXP MED, V180, P2181, DOI 10.1084/jem.180.6.2181; GRIFFISS JM, 1984, J INFECT DIS, V150, P71, DOI 10.1093/infdis/150.1.71; GRIFFISS JM, 1977, J INFECT DIS, V136, P733, DOI 10.1093/infdis/136.6.733; GRIFFISS JM, 1991, J IMMUNOL, V147, P298; Griffiss JM, 2000, J BIOL CHEM, V275, P9716, DOI 10.1074/jbc.275.13.9716; HITCHCOCK PJ, 1983, J BACTERIOL, V154, P269, DOI 10.1128/JB.154.1.269-277.1983; JOHN CM, 1991, J BIOL CHEM, V266, P19303; John CM, 2009, J BIOL CHEM, V284, P21515, DOI 10.1074/jbc.M109.004887; John CM, 2009, J LIPID RES, V50, P424, DOI 10.1194/jlr.M800184-JLR200; Kahler CM, 1998, CRIT REV MICROBIOL, V24, P281, DOI 10.1080/10408419891294216; KASPER DL, 1973, J INFECT DIS, V127, P378, DOI 10.1093/infdis/127.4.378; KIM JJ, 1994, INFECT IMMUN, V62, P1566, DOI 10.1128/IAI.62.5.1566-1575.1994; KIM JJ, 1989, INFECT IMMUN, V57, P602, DOI 10.1128/IAI.57.2.602-608.1989; Kogan G, 1997, CARBOHYD RES, V298, P191, DOI 10.1016/S0008-6215(96)00305-9; KULSHIN VA, 1992, J BACTERIOL, V174, P1793, DOI 10.1128/jb.174.6.1793-1800.1992; Mackinnon FG, 2002, MOL MICROBIOL, V43, P931, DOI 10.1046/j.1365-2958.2002.02754.x; MANDRELL RE, 1991, J BACTERIOL, V173, P2823, DOI 10.1128/JB.173.9.2823-2832.1991; NICHOLSON A, 1979, SCIENCE, V205, P298, DOI 10.1126/science.451601; PAVLIAK V, 1993, J BIOL CHEM, V268, P14146; Rahman MM, 1998, CARBOHYD RES, V307, P311; Ram S, 2003, J BIOL CHEM, V278, P50853, DOI 10.1074/jbc.M308364200; Rosenstein NE, 2001, NEW ENGL J MED, V344, P1378, DOI 10.1056/NEJM200105033441807; SANDLIN RC, 1994, J BACTERIOL, V176, P6869, DOI 10.1128/JB.176.22.6869-6876.1994; SCHNEIDER H, 1982, J GEN MICROBIOL, V128, P13; SCHNEIDER H, 1988, INFECT IMMUN, V56, P942, DOI 10.1128/IAI.56.4.942-946.1988; SCHNEIDER H, 1984, INFECT IMMUN, V45, P544, DOI 10.1128/IAI.45.3.544-549.1984; SCHNEIDER H, 1991, J EXP MED, V174, P1601, DOI 10.1084/jem.174.6.1601; Swanson KV, 2006, CARBOHYD RES, V341, P388, DOI 10.1016/j.carres.2005.11.017; Weber MVR, 2006, INT J MED MICROBIOL, V296, P475, DOI 10.1016/j.ijmm.2006.05.004; Wright JC, 2004, J BACTERIOL, V186, P6970, DOI 10.1128/JB.186.20.6970-6982.2004; YAMASAKI R, 1988, MOL IMMUNOL, V25, P799, DOI 10.1016/0161-5890(88)90116-2; YAMASAKI R, 1993, J BACTERIOL, V175, P4565, DOI 10.1128/JB.175.14.4565-4568.1993; YAMASAKI R, 1991, BIOCHEMISTRY-US, V30, P10566, DOI 10.1021/bi00107a028; Yang QL, 1996, J EXP MED, V183, P323, DOI 10.1084/jem.183.1.323; ZOLLINGER WD, 1977, INFECT IMMUN, V18, P424, DOI 10.1128/IAI.18.2.424-433.1977	54	11	12	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2011	286	51					43622	43633		10.1074/jbc.M111.291583	http://dx.doi.org/10.1074/jbc.M111.291583			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866SH	22027827	hybrid, Green Published			2022-12-27	WOS:000298402300005
J	Zhou, XR; Green, AG; Singh, SP				Zhou, Xue-Rong; Green, Allan G.; Singh, Surinder P.			Caenorhabditis elegans Delta 12-Desaturase FAT-2 Is a Bifunctional Desaturase Able to Desaturate a Diverse Range of Fatty Acid Substrates at the Delta 12 and Delta 15 Positions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTIONAL-CHARACTERIZATION; SACCHAROMYCES-CEREVISIAE; HETEROLOGOUS EXPRESSION; IDENTIFICATION; REGIOSELECTIVITY; SERIES; GENE	Caenorhabditis elegans FAT-2 has been characterized as fatty acid Delta 12-desaturase able to desaturate C16 and C18 fatty acids. However, in this report we show that when expressed in yeast cells this enzyme can also catalyze Delta 15 desaturation. This results in the production of both linoleic acid (omega 6 C18:2(Delta 9,12)) and linolenic acid (omega 3 C18:3(Delta 9,12,15)) from oleic acid (C18:1(Delta 9)) substrate, and hexadecadienoic acid (omega 4 C16:2(Delta 9,12)) and hexadecatrienoic acid (omega 1 C16:3(Delta 9,12,15)) from palmitoleic acid (C16:1(Delta 9)) substrate. In addition, this enzyme can also produce C14:2 (Delta 9,12), C15:2(Delta 9,12), C17:2(Delta 9,12), and C18:4(Delta 6,9,12,15) when C14:1(Delta 9), C15:1(Delta 9), C17:1(Delta 9), and C18:3(Delta 6,9,12) substrates are available in yeast cells. Mass spectrometry analysis of 2,4-dimethyloxazoline modification of fatty acid methyl esters confirms the positions of all newly formed double bonds. These results indicate that when expressed in yeast the C. elegans Delta 12-desaturase CeFAT-2 shows a characteristic of a bifunctional Delta 12/Delta 15-desaturase and has a great deal of elasticity with respect to fatty acid chain length in being able to accept fatty acids ranging from C14 to C18. Interestingly, despite possessing a bifunctional Delta 12/Delta 15 desaturation activity, phylogenetic analysis suggests that C. elegans Delta 12-desaturase CeFAT-2 might have arisen independently from other reported dual Delta 12/Delta 15-desaturases from fungi and protozoa.	[Zhou, Xue-Rong; Green, Allan G.; Singh, Surinder P.] Commonwealth Sci & Ind Res Org Plant Ind, Canberra, ACT 2601, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Zhou, XR (corresponding author), Commonwealth Sci & Ind Res Org Plant Ind, GPO Box 1600, Canberra, ACT 2601, Australia.	xue-rong.zhou@csiro.au	Green, Allan G/C-6572-2008; Green, Allan/AAM-6856-2021; Zhou, Xue-Rong/D-4706-2009; singh, surinder/C-9528-2009	Zhou, Xue-Rong/0000-0003-3717-2984; singh, surinder/0000-0003-4488-8147				Damude HG, 2006, P NATL ACAD SCI USA, V103, P9446, DOI 10.1073/pnas.0511079103; FAY L, 1991, J CHROMATOGR, V541, P89, DOI 10.1016/S0021-9673(01)95986-2; FELLENBERG AJ, 1987, BIOMED ENVIRON MASS, V14, P127, DOI 10.1002/bms.1200140306; Hoffmann M, 2007, J BIOL CHEM, V282, P26666, DOI 10.1074/jbc.M705068200; Meesapyodsuk D, 2000, BIOCHEMISTRY-US, V39, P11948, DOI 10.1021/bi000756a; Meesapyodsuk D, 2007, J BIOL CHEM, V282, P20191, DOI 10.1074/jbc.M702196200; MORTIMER RK, 1986, GENETICS, V113, P35; Napier JA, 2001, LIPIDS, V36, P761, DOI 10.1007/s11745-001-0782-9; Pan ZQ, 2007, J BIOL CHEM, V282, P4326, DOI 10.1074/jbc.M606343200; Peyou-Ndi MM, 2000, ARCH BIOCHEM BIOPHYS, V376, P399, DOI 10.1006/abbi.2000.1733; Sayanova O, 2006, J BIOL CHEM, V281, P36533, DOI 10.1074/jbc.M605158200; Spychalla JP, 1997, P NATL ACAD SCI USA, V94, P1142, DOI 10.1073/pnas.94.4.1142; Watts JL, 2009, TRENDS ENDOCRIN MET, V20, P58, DOI 10.1016/j.tem.2008.11.002; Watts JL, 2002, P NATL ACAD SCI USA, V99, P5854, DOI 10.1073/pnas.092064799; Zhou XR, 2006, PLANT SCI, V170, P665, DOI 10.1016/j.plantsci.2005.10.021	15	57	62	0	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2011	286	51					43644	43650		10.1074/jbc.M111.266114	http://dx.doi.org/10.1074/jbc.M111.266114			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866SH	22041902	Green Published, hybrid			2022-12-27	WOS:000298402300007
J	Moriwaki, K; Shinzaki, S; Miyoshi, E				Moriwaki, Kenta; Shinzaki, Shinichiro; Miyoshi, Eiji			GDP-mannose-4,6-dehydratase (GMDS) Deficiency Renders Colon Cancer Cells Resistant to Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL) Receptor- and CD95-mediated Apoptosis by Inhibiting Complex II Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORE FUCOSYLATION; MOLECULAR-CLONING; SELECTIVE MUTANTS; DEATH; FUCOSE; ACTIVATION; FAS; SURVEILLANCE; SPECIFICITY; EXPRESSION	Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) induces apoptosis through binding to TRAIL receptors, death receptor 4 (DR4), and DR5. TRAIL has potential therapeutic value against cancer because of its selective cytotoxic effects on several transformed cell types. Fucosylation of proteins and lipids on the cell surface is a very important post-translational modification that is involved in many cellular events. Recently, we found that a deficiency in GDP-mannose-4,6-dehydratase (GMDS) rendered colon cancer cells resistant to TRAIL-induced apoptosis, resulting in tumor development and metastasis by escape from tumor immune surveillance. GMDS is an indispensable regulator of cellular fucosylation. In this study, we investigated the molecular mechanism of inhibition of TRAIL signaling by GMDS deficiency. DR4, but not DR5, was found to be fucosylated; however, GMDS deficiency inhibited both DR4- and DR5-mediated apoptosis despite the absence of fucosylation on DR5. In addition, GMDS deficiency also inhibited CD95-mediated apoptosis but not the intrinsic apoptosis pathway induced by anti-cancer drugs. Binding of TRAIL and CD95 ligand to their cognate receptors primarily leads to formation of a complex comprising the receptor, FADD, and caspase-8, referred to as the death-inducing signaling complex (DISC). GMDS deficiency did not affect formation of the primary DISC or recruitment to and activation of caspase-8 on the DISC. However, formation of secondary FADD-dependent complex II, comprising caspase-8 and cFLIP, was significantly inhibited by GMDS deficiency. These results indicate that GMDS regulates the formation of secondary complex II from the primary DISC independent of direct fucosylation of death receptors.	[Moriwaki, Kenta; Shinzaki, Shinichiro; Miyoshi, Eiji] Osaka Univ, Grad Sch Med, Dept Mol Biochem & Clin Invest, Suita, Osaka 5650871, Japan	Osaka University	Miyoshi, E (corresponding author), Osaka Univ, Grad Sch Med, Dept Mol Biochem & Clin Invest, Eiji Miyoshi,1-7,Yamada Oka, Suita, Osaka 5650871, Japan.	emiyoshi@sahs.med.osaka-u.ac.jp		Moriwaki, Kenta/0000-0002-8724-4715	New Energy and Industrial Technology Development Organization (NEDO) in Japan; Japan Society for the Promotion of Science [21249038]; Global Centers of Excellence (COE) of Osaka University; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Grants-in-Aid for Scientific Research [22790643] Funding Source: KAKEN	New Energy and Industrial Technology Development Organization (NEDO) in Japan(New Energy and Industrial Technology Development Organization (NEDO)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Global Centers of Excellence (COE) of Osaka University; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant from the New Energy and Industrial Technology Development Organization (NEDO) as a part of the developing technology project for implementing sugar chain functions in Japan, Grant-in-Aid for Scientific Research (A) 21249038 from the Japan Society for the Promotion of Science, and the Global Centers of Excellence (COE) program of Osaka University funded by the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Ashkenazi A, 2002, NAT REV CANCER, V2, P420, DOI 10.1038/nrc821; Austin CD, 2006, P NATL ACAD SCI USA, V103, P10283, DOI 10.1073/pnas.0604044103; Becker DJ, 2003, GLYCOBIOLOGY, V13, p41R, DOI 10.1093/glycob/cwg054; DeVries T, 1997, GLYCOBIOLOGY, V7, P921, DOI 10.1093/glycob/7.7.921; Falschlehner C, 2007, INT J BIOCHEM CELL B, V39, P1462, DOI 10.1016/j.biocel.2007.02.007; Gonzalvez F, 2010, ONCOGENE, V29, P4752, DOI 10.1038/onc.2010.221; Haltiwanger RS, 2009, GASTROENTEROLOGY, V137, P36, DOI 10.1053/j.gastro.2009.05.010; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; ITOH N, 1991, CELL, V66, P233, DOI 10.1016/0092-8674(91)90614-5; Jin ZY, 2006, MOL CELL BIOL, V26, P8136, DOI 10.1128/MCB.00257-06; Jin ZY, 2004, J BIOL CHEM, V279, P35829, DOI 10.1074/jbc.M405538200; Johnstone RW, 2008, NAT REV CANCER, V8, P782, DOI 10.1038/nrc2465; Kelley RF, 2005, J BIOL CHEM, V280, P2205, DOI 10.1074/jbc.M410660200; Kohlhaas SL, 2007, J BIOL CHEM, V282, P12831, DOI 10.1074/jbc.M700438200; Lavrik IN, 2008, J BIOL CHEM, V283, P26401, DOI 10.1074/jbc.M800823200; Lee KH, 2006, EMBO J, V25, P1009, DOI 10.1038/sj.emboj.7601016; MacFarlane M, 2005, CANCER RES, V65, P11265, DOI 10.1158/0008-5472.CAN-05-2801; Matsumura K, 2007, J BIOL CHEM, V282, P15700, DOI 10.1074/jbc.M701195200; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Moriwaki K, 2010, WORLD J HEPATOL, V2, P151, DOI 10.4254/wjh.v2.i4.151; Moriwaki K, 2009, GASTROENTEROLOGY, V137, P188, DOI 10.1053/j.gastro.2009.04.002; Ohyama C, 1998, J BIOL CHEM, V273, P14582, DOI 10.1074/jbc.273.23.14582; Osumi D, 2009, CANCER SCI, V100, P888, DOI 10.1111/j.1349-7006.2009.01125.x; Schneider-Brachert W, 2004, IMMUNITY, V21, P415, DOI 10.1016/j.immuni.2004.08.017; Screaton GR, 1997, CURR BIOL, V7, P693, DOI 10.1016/S0960-9822(06)00297-1; Siegel RM, 2004, J CELL BIOL, V167, P735, DOI 10.1083/jcb.200406101; Strasser A, 2009, IMMUNITY, V30, P180, DOI 10.1016/j.immuni.2009.01.001; SUDA T, 1993, CELL, V75, P1169, DOI 10.1016/0092-8674(93)90326-L; Sullivan FX, 1998, J BIOL CHEM, V273, P8193, DOI 10.1074/jbc.273.14.8193; Takeda K, 2001, NAT MED, V7, P94, DOI 10.1038/83416; Tourneur L, 2010, TRENDS IMMUNOL, V31, P260, DOI 10.1016/j.it.2010.05.005; Varfolomeev E, 2005, J BIOL CHEM, V280, P40599, DOI 10.1074/jbc.M509560200; Wagner KW, 2007, NAT MED, V13, P1070, DOI 10.1038/nm1627; Walczak Henning, 2008, V414, P221; Wang XC, 2005, P NATL ACAD SCI USA, V102, P15791, DOI 10.1073/pnas.0507375102; Wang XC, 2006, J BIOL CHEM, V281, P2572, DOI 10.1074/jbc.M510893200; Zhao YY, 2006, J BIOL CHEM, V281, P38343, DOI 10.1074/jbc.M608764200	37	30	32	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					43123	43133		10.1074/jbc.M111.262741	http://dx.doi.org/10.1074/jbc.M111.262741			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22027835	Green Published, hybrid			2022-12-27	WOS:000298351300033
J	Kang, H; Jang, SW; Ko, J				Kang, Hyereen; Jang, Sung-Wuk; Ko, Jesang			Human Leucine Zipper Protein sLZIP Induces Migration and Invasion of Cervical Cancer Cells via Expression of Matrix Metalloproteinase-9	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MATRIX METALLOPROTEINASES; C-JUN; MMP-9; FIBROBLASTS; PROGRESSION; PATHWAY; VP16	Extracellular proteolysis mediates tissue homeostasis. In cancer, altered proteolysis leads to abnormal tumor growth, inflammation, tissue invasion, and metastasis. Matrix metalloproteinase-9 (MMP-9) represents one of the most prominent proteinases associated with inflammation and tumorigenesis. The recently identified human transcription factor sLZIP is a member of the leucine zipper transcription factor family. Although sLZIP is known to function in ligand-induced transactivation of the glucocorticoid receptor, its exact functions and target genes are not known. In this study, we investigated the role of sLZIP in MMP-9 expression and its involvement in cervical cancer development. Our results show that sLZIP increased the expression of MMP-9 at both the mRNA and protein levels and the proteolytic activity of MMP-9 in HeLa and SiHa cells. sLZIP also increased the transcriptional activity of MMP-9 by binding directly to the cAMP-responsive element of the MMP-9 promoter region. Involvement of sLZIP in MMP-9 expression was further supported by the fact that ME-180 cells expressing sLZIP siRNA were refractory to MMP-9 expression. Results from wound healing and invasion assays showed that sLZIP enhanced both the migration and invasion of cervical cancer cells. The increased migration and invasion of HeLa and SiHa cells that were induced by sLZIP were abrogated by inhibition of the proteolytic activity of MMP-9. These results indicate that sLZIP plays a critical role in MMP-9 expression and is probably involved in invasion and metastasis of cervical cancer.	[Kang, Hyereen; Jang, Sung-Wuk; Ko, Jesang] Korea Univ, Sch Life Sci & Biotechnol, Seoul 136701, South Korea	Korea University	Ko, J (corresponding author), Korea Univ, Sch Life Sci & Biotechnol, 5-1 Anam Dong, Seoul 136701, South Korea.	jesangko@korea.ac.kr			National Research Foundation of Korea (NRF) [2011-0017957, 2011-0001573, 2011-0027756]; Ministry of Education, Science, and Technology, Republic of Korea	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science, and Technology, Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by Basic Science Research Program Grant 2011-0017957, Basic Research Laboratory Program Grant 2011-0001573, and Disease Network Research Program Grant 2011-0027756 from the National Research Foundation of Korea (NRF), funded by the Ministry of Education, Science, and Technology, Republic of Korea.	Amalinei C, 2010, ROM J MORPHOL EMBRYO, V51, P215; Belguise K, 2005, ONCOGENE, V24, P1434, DOI 10.1038/sj.onc.1208312; Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; Bourboulia D, 2010, SEMIN CANCER BIOL, V20, P161, DOI 10.1016/j.semcancer.2010.05.002; Bozzuto G, 2010, ANN I SUPER SANITA, V46, P66, DOI 10.4415/ANN_10_01_09; Busti C, 2010, INTERN EMERG MED, V5, P13, DOI 10.1007/s11739-009-0283-y; CASTELLAZZI M, 1990, ONCOGENE, V5, P1541; Chakraborti S, 2003, MOL CELL BIOCHEM, V253, P269, DOI 10.1023/A:1026028303196; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Fic P, 2011, POSTEP HIG MED DOSW, V65, P16, DOI 10.5604/17322693.931536; Freiman RN, 1997, GENE DEV, V11, P3122, DOI 10.1101/gad.11.23.3122; Gialeli C, 2011, FEBS J, V278, P16, DOI 10.1111/j.1742-4658.2010.07919.x; Han HH, 2010, MOL CANCER RES, V8, P1477, DOI 10.1158/1541-7786.MCR-10-0114; Johansson N, 2000, CELL MOL LIFE SCI, V57, P5, DOI 10.1007/s000180050495; Kang H, 2009, MOL ENDOCRINOL, V23, P1746, DOI 10.1210/me.2009-0009; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Kim D, 2001, FASEB J, V15, P1953, DOI 10.1096/fj.01-0198com; Ko J, 2004, FASEB J, V18, P890, DOI 10.1096/fj.03-0867fje; Kupferman ME, 2000, AM J PATHOL, V157, P1777, DOI 10.1016/S0002-9440(10)64815-8; Lee PPH, 2001, J CELL PHYSIOL, V188, P75, DOI 10.1002/jcp.1090; Libra M, 2009, INT J ONCOL, V34, P897, DOI 10.3892/ijo_00000215; Lin LF, 2010, CANCER RES, V70, P192, DOI 10.1158/0008-5472.CAN-09-2641; Liotta L A, 1990, Semin Cancer Biol, V1, P99; Liu LP, 2010, CANCER RES, V70, P3750, DOI 10.1158/0008-5472.CAN-09-3838; Maity G, 2011, J CANCER RES CLIN, V137, P347, DOI 10.1007/s00432-010-0892-x; Matsuura I, 2010, J BIOL CHEM, V285, P1754, DOI 10.1074/jbc.M109.063826; Mook ORF, 2004, BBA-REV CANCER, V1705, P69, DOI 10.1016/j.bbcan.2004.09.006; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Raggo C, 2002, MOL CELL BIOL, V22, P5639, DOI 10.1128/MCB.22.16.5639-5649.2002; Rao JS, 1996, CLIN EXP METASTAS, V14, P12, DOI 10.1007/BF00157681; Sato T, 2002, CANCER RES, V62, P1025; Shin SY, 2010, MOL CANCER RES, V8, P507, DOI 10.1158/1541-7786.MCR-09-0454; STETLERSTEVENSON WG, 1990, CANCER METAST REV, V9, P289, DOI 10.1007/BF00049520; Storz P, 2009, MOL CELL BIOL, V29, P4906, DOI 10.1128/MCB.00077-09; SUZUKI T, 1991, JPN J CANCER RES, V82, P58, DOI 10.1111/j.1349-7006.1991.tb01746.x; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Vu TH, 1998, CELL, V93, P411, DOI 10.1016/S0092-8674(00)81169-1; Wittekindt C, 2011, ACTA OTO-LARYNGOL, V131, P101, DOI 10.3109/00016489.2010.506886; Xie ZL, 2004, J BIOL CHEM, V279, P39513, DOI 10.1074/jbc.M405844200; Yan CH, 2007, J CELL PHYSIOL, V211, P19, DOI 10.1002/jcp.20948; Yang Y, 2008, RHEUMATOLOGY, V47, P1299, DOI 10.1093/rheumatology/ken225	42	21	24	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42072	42081		10.1074/jbc.M111.272302	http://dx.doi.org/10.1074/jbc.M111.272302			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	22009750	hybrid, Green Published			2022-12-27	WOS:000298180900017
J	Sexton, T; Buhr, E; Van Gelder, RN				Sexton, Timothy; Buhr, Ethan; Van Gelder, Russell N.			Melanopsin and Mechanisms of Non-visual Ocular Photoreception	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							RETINAL GANGLION-CELLS; PUPILLARY LIGHT REFLEX; SUPRACHIASMATIC NUCLEUS; CRYSTAL-STRUCTURE; DETECT LIGHT; RESPONSES; ROD; PHOTOTRANSDUCTION; EXPRESSION; MOUSE	In addition to rods and cones, the mammalian eye contains a third class of photoreceptor, the intrinsically photosensitive retinal ganglion cell (ipRGC). ipRGCs are heterogeneous irradiance-encoding neurons that primarily project to non-visual areas of the brain. Characteristics of ipRGC light responses differ significantly from those of rod and cone responses, including depolarization to light, slow on-and off-latencies, and relatively low light sensitivity. All ipRGCs use melanopsin (Opn4) as their photopigment. Melanopsin resembles invertebrate rhabdomeric photopigments more than vertebrate ciliary pigments and uses a G(q) signaling pathway, in contrast to the G(t) pathway used by rods and cones. ipRGCs can recycle chromophore in the absence of the retinal pigment epithelium and are highly resistant to vitamin A depletion. This suggests that melanopsin employs a bistable sequential photon absorption mechanism typical of rhabdomeric opsins.	[Sexton, Timothy; Buhr, Ethan; Van Gelder, Russell N.] Univ Washington, Sch Med, Dept Ophthalmol, Seattle, WA 98104 USA; [Van Gelder, Russell N.] Univ Washington, Sch Med, Dept Biol Struct, Seattle, WA 98104 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Van Gelder, RN (corresponding author), Univ Washington, Sch Med, Dept Ophthalmol, Seattle, WA 98104 USA.	russvg@uw.edu	Van Gelder, Russell/ABB-4225-2021	Van Gelder, Russell/0000-0001-5368-3659; Buhr, Ethan/0000-0002-9250-6644; Sexton, Timothy/0000-0002-8821-880X	National Institutes of Health [T32EY00703, P30EY1730]; Research to Prevent Blindness; Burroughs-Wellcome Translational Scientist Award; NATIONAL EYE INSTITUTE [P30EY001730] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Burroughs-Wellcome Translational Scientist Award(Burroughs Wellcome Fund); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work supported, in whole or in part, by National Institutes of Health Grants T32EY00703 (to T. S.) and P30EY1730 (to R. N. V. G.). This work was also supported by an unrestricted grant from Research to Prevent Blindness and the Burroughs-Wellcome Translational Scientist Award (to R. N. V. G.). This is the sixth article in the Thematic Minireview Series on Focus on Vision.	Altimus CM, 2008, P NATL ACAD SCI USA, V105, P19998, DOI 10.1073/pnas.0808312105; Altimus CM, 2010, NAT NEUROSCI, V13, P1107, DOI 10.1038/nn.2617; Badea TC, 2009, NEURON, V61, P852, DOI 10.1016/j.neuron.2009.01.020; Bakall B, 2003, INVEST OPHTH VIS SCI, V44, P3622, DOI 10.1167/iovs.03-0030; Baver SB, 2008, EUR J NEUROSCI, V27, P1763, DOI 10.1111/j.1460-9568.2008.06149.x; Bellingham J, 2006, PLOS BIOL, V4, P1334, DOI 10.1371/journal.pbio.0040254; Benca RM, 1998, SLEEP, V21, P451, DOI 10.1093/sleep/21.5.451; Berson DM, 2010, J COMP NEUROL, V518, P2405, DOI 10.1002/cne.22381; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Berson DM, 2003, TRENDS NEUROSCI, V26, P314, DOI 10.1016/S0166-2236(03)00130-9; Brown TM, 2011, J PHYSIOL-LONDON, V589, P1173, DOI 10.1113/jphysiol.2010.199877; Brown TM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000558; Chen SK, 2011, NATURE, V476, P92, DOI 10.1038/nature10206; Gomez MD, 2009, P NATL ACAD SCI USA, V106, P9081, DOI 10.1073/pnas.0900708106; Do MTH, 2009, NATURE, V457, P281, DOI 10.1038/nature07682; Dollet A, 2010, CHRONOBIOL INT, V27, P768, DOI 10.3109/07420521003695704; Doyle SE, 2006, P NATL ACAD SCI USA, V103, P10432, DOI 10.1073/pnas.0600934103; EBIHARA S, 1980, PHYSIOL BEHAV, V24, P523, DOI 10.1016/0031-9384(80)90246-2; Ecker JL, 2010, NEURON, V67, P49, DOI 10.1016/j.neuron.2010.05.023; Freedman MS, 1999, SCIENCE, V284, P502, DOI 10.1126/science.284.5413.502; Fu YB, 2005, P NATL ACAD SCI USA, V102, P10339, DOI 10.1073/pnas.0501866102; Goz D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003153; Gooley JJ, 2001, NAT NEUROSCI, V4, P1165, DOI 10.1038/nn768; Graham DM, 2008, J NEUROPHYSIOL, V99, P2522, DOI 10.1152/jn.01066.2007; Guler AD, 2008, NATURE, V453, P102, DOI 10.1038/nature06829; Hannibal J, 2004, NEUROREPORT, V15, P2317, DOI 10.1097/00001756-200410250-00003; Hardie RC, 2001, NATURE, V413, P186, DOI 10.1038/35093002; Hardie RC, 2001, J EXP BIOL, V204, P3403; HARDIE RC, 2008, SENSES COMPREHENSIVE, V1, P77; Hardie RC, 2011, PFLUG ARCH EUR J PHY, V461, P493, DOI 10.1007/s00424-011-0922-9; HARGRAVE PA, 1992, FASEB J, V6, P2323, DOI 10.1096/fasebj.6.6.1544542; Hartwick ATE, 2007, J NEUROSCI, V27, P13468, DOI 10.1523/JNEUROSCI.3626-07.2007; Hatori M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002451; Hattar S, 2003, NATURE, V424, P76, DOI 10.1038/nature01761; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Hattar S, 2006, J COMP NEUROL, V497, P326, DOI 10.1002/cne.20970; HILLMAN P, 1983, PHYSIOL REV, V63, P668, DOI 10.1152/physrev.1983.63.2.668; Johnson J, 2010, P NATL ACAD SCI USA, V107, P17374, DOI 10.1073/pnas.1008533107; Keeler CE, 1927, AM J PHYSIOL, V81, P107, DOI 10.1152/ajplegacy.1927.81.1.107; Kiser P. D., 2011, BIOCH BIOPH IN PRESS; Koyanagi M, 2008, PHOTOCHEM PHOTOBIOL, V84, P1024, DOI 10.1111/j.1751-1097.2008.00369.x; Laemle LK, 1998, PHYSIOL BEHAV, V64, P165, DOI 10.1016/S0031-9384(98)00045-6; Lin B, 2008, P NATL ACAD SCI USA, V105, P16009, DOI 10.1073/pnas.0806114105; Llamosas MM, 2000, DEV BRAIN RES, V120, P1, DOI 10.1016/S0165-3806(99)00175-3; Lucas RJ, 2003, SCIENCE, V299, P245, DOI 10.1126/science.1077293; Lupi D, 2008, NAT NEUROSCI, V11, P1068, DOI 10.1038/nn.2179; Mawad K, 2008, J BIOL RHYTHM, V23, P387, DOI 10.1177/0748730408323063; McNeill DS, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-8; Melyan Z, 2005, NATURE, V433, P741, DOI 10.1038/nature03344; Mrosovsky N, 2003, CHRONOBIOL INT, V20, P989, DOI 10.1081/CBI-120026043; Murakami M, 2008, NATURE, V453, P363, DOI 10.1038/nature06925; Mure LS, 2007, J BIOL RHYTHM, V22, P411, DOI 10.1177/0748730407306043; Newman LA, 2003, BIOCHEMISTRY-US, V42, P12734, DOI 10.1021/bi035418z; Ozturk N, 2007, COLD SPRING HARB SYM, V72, P119, DOI 10.1101/sqb.2007.72.015; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Palczewski K, 2006, ANNU REV BIOCHEM, V75, P743, DOI 10.1146/annurev.biochem.75.103004.142743; Panda S, 2005, SCIENCE, V307, P600, DOI 10.1126/science.1105121; Panda S, 2003, SCIENCE, V301, P525, DOI 10.1126/science.1086179; Panda S, 2002, SCIENCE, V298, P2213, DOI 10.1126/science.1076848; Perez-Leighton CE, 2011, EUR J NEUROSCI, V33, P856, DOI 10.1111/j.1460-9568.2010.07583.x; Provencio I, 2002, NATURE, V415, P493, DOI 10.1038/415493a; Provencio I, 2000, J NEUROSCI, V20, P600, DOI 10.1523/JNEUROSCI.20-02-00600.2000; Provencio I, 1998, P NATL ACAD SCI USA, V95, P340, DOI 10.1073/pnas.95.1.340; Qiu XD, 2005, NATURE, V433, P745, DOI 10.1038/nature03345; RATTO GM, 1991, NATURE, V351, P654, DOI 10.1038/351654a0; Renna JM, 2011, NAT NEUROSCI, V14, P827, DOI 10.1038/nn.2845; ROBLES LJ, 1995, J COMP NEUROL, V358, P605, DOI 10.1002/cne.903580412; Roecklein KA, 2009, J AFFECT DISORDERS, V114, P279, DOI 10.1016/j.jad.2008.08.005; Ruby NF, 2002, SCIENCE, V298, P2211, DOI 10.1126/science.1076701; Schmidt TM, 2011, J COMP NEUROL, V519, P1492, DOI 10.1002/cne.22579; Schmidt TM, 2009, J NEUROSCI, V29, P476, DOI 10.1523/JNEUROSCI.4117-08.2009; Sekaran S, 2005, CURR BIOL, V15, P1099, DOI 10.1016/j.cub.2005.05.053; SEKI T, 1984, J GEN PHYSIOL, V84, P49, DOI 10.1085/jgp.84.1.49; Tarttelin EE, 2003, EXP EYE RES, V76, P393, DOI 10.1016/S0014-4835(02)00300-7; Terakita A, 2008, J NEUROCHEM, V105, P883, DOI 10.1111/j.1471-4159.2007.05184.x; Thompson CL, 2004, MOL BRAIN RES, V122, P158, DOI 10.1016/j.molbrainres.2003.12.006; Thompson CL, 2001, P NATL ACAD SCI USA, V98, P11708, DOI 10.1073/pnas.201301498; Tian N, 2003, NEURON, V39, P85, DOI 10.1016/S0896-6273(03)00389-1; Tsai JW, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000125; Tu DC, 2006, P NATL ACAD SCI USA, V103, P10426, DOI 10.1073/pnas.0600917103; Tu DC, 2005, NEURON, V48, P987, DOI 10.1016/j.neuron.2005.09.031; Van Gelder RN, 2003, SCIENCE, V299, P222, DOI 10.1126/science.1079536; Viney TJ, 2007, CURR BIOL, V17, P981, DOI 10.1016/j.cub.2007.04.058; Walker MT, 2008, P NATL ACAD SCI USA, V105, P8861, DOI 10.1073/pnas.0711397105; Wang JS, 2011, PROG RETIN EYE RES, V30, P115, DOI 10.1016/j.preteyeres.2010.11.001; Wang JS, 2009, CURR BIOL, V19, P1665, DOI 10.1016/j.cub.2009.07.054; Wang JS, 2009, NAT NEUROSCI, V12, P295, DOI 10.1038/nn.2258; Wang XY, 2010, CURR BIOL, V20, P93, DOI 10.1016/j.cub.2009.12.022; Warren EJ, 2006, EUR J NEUROSCI, V23, P2477, DOI 10.1111/j.1460-9568.2006.04777.x; Wee R, 2002, J NEUROSCI, V22, P10427; Ye HF, 2011, SCIENCE, V332, P1565, DOI 10.1126/science.1203535; Zhu YL, 2007, INVEST OPHTH VIS SCI, V48, P1268, DOI 10.1167/iovs.06-0925	93	52	53	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2012	287	3					1649	1656		10.1074/jbc.R111.301226	http://dx.doi.org/10.1074/jbc.R111.301226			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879HT	22074930	Green Published, hybrid			2022-12-27	WOS:000299321000007
J	Hirata, H; Wen, H; Kawakami, Y; Naganawa, Y; Ogino, K; Yamada, K; Saint-Amant, L; Low, SE; Cui, WW; Zhou, WB; Sprague, SM; Asakawa, K; Muto, A; Kawakami, K; Kuwada, JY				Hirata, Hiromi; Wen, Hua; Kawakami, Yu; Naganawa, Yuriko; Ogino, Kazutoyo; Yamada, Kenta; Saint-Amant, Louis; Low, Sean E.; Cui, Wilson W.; Zhou, Weibin; Sprague, Shawn M.; Asakawa, Kazuhide; Muto, Akira; Kawakami, Koichi; Kuwada, John Y.			Connexin 39.9 Protein Is Necessary for Coordinated Activation of Slow-twitch Muscle and Normal Behavior in Zebrafish	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LARVAL ZEBRAFISH; SKELETAL-MUSCLE; LENS DEVELOPMENT; RELAXED MUTANTS; TOUCH RESPONSE; SPINAL-CORD; GENE; EXPRESSION; GAP; EMBRYOS	In many tissues and organs, connexin proteins assemble between neighboring cells to form gap junctions. These gap junctions facilitate direct intercellular communication between adjoining cells, allowing for the transmission of both chemical and electrical signals. In rodents, gap junctions are found in differentiating myoblasts and are important for myogenesis. Although gap junctions were once believed to be absent from differentiated skeletal muscle in mammals, recent studies in teleosts revealed that differentiated muscle does express connexins and is electrically coupled, at least at the larval stage. These findings raised questions regarding the functional significance of gap junctions in differentiated muscle. Our analysis of gap junctions in muscle began with the isolation of a zebrafish motor mutant that displayed weak coiling at day 1 of development, a behavior known to be driven by slow-twitch muscle (slow muscle). We identified a missense mutation in the gene encoding Connexin 39.9. In situ hybridization found connexin 39.9 to be expressed by slow muscle. Paired muscle recordings uncovered that wild-type slow muscles are electrically coupled, whereas mutant slow muscles are not. The further examination of cellular activity revealed aberrant, arrhythmic touch-evoked Ca2+ transients in mutant slow muscle and a reduction in the number of muscle fibers contracting in response to touch in mutants. These results indicate that Connexin 39.9 facilitates the spreading of neuronal inputs, which is irregular during motor development, beyond the muscle cells and that gap junctions play an essential role in the efficient recruitment of slow muscle fibers.	[Hirata, Hiromi; Ogino, Kazutoyo; Yamada, Kenta] Natl Inst Genet, Frontier Res Ctr, Mishima, Shizuoka 4118540, Japan; [Hirata, Hiromi; Asakawa, Kazuhide; Muto, Akira; Kawakami, Koichi] Grad Univ Adv Studies, Dept Genet, Mishima, Shizuoka 4118540, Japan; [Hirata, Hiromi; Kawakami, Yu; Naganawa, Yuriko] Nagoya Univ, Grad Sch Sci, Nagoya, Aichi 4648602, Japan; [Hirata, Hiromi] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol, Ibaraki 5670047, Japan; [Wen, Hua] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA; [Saint-Amant, Louis; Low, Sean E.] Univ Montreal, Dept Pathol & Biol Cellulaire, Grp Rech Syst Nerveux Cent, Montreal, PQ H3T 1J4, Canada; [Low, Sean E.; Cui, Wilson W.; Zhou, Weibin; Sprague, Shawn M.; Kuwada, John Y.] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA; [Cui, Wilson W.; Kuwada, John Y.] Univ Michigan, Program Cell & Mol Biol, Ann Arbor, MI 48109 USA; [Asakawa, Kazuhide; Muto, Akira; Kawakami, Koichi] Natl Inst Genet, Div Mol & Dev Biol, Mishima, Shizuoka 4118540, Japan	Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Graduate University for Advanced Studies - Japan; Nagoya University; Japan Science & Technology Agency (JST); Oregon Health & Science University; Universite de Montreal; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan	Hirata, H (corresponding author), Natl Inst Genet, Frontier Res Ctr, 1111 Yata, Mishima, Shizuoka 4118540, Japan.	hihirata@lab.nig.ac.jp	Kawakami, Koichi/AAF-1380-2019; Asakawa, Kazuhide/ABD-2065-2020; Kuwada, John Y/B-1447-2009; Muto, Akira/E-2580-2015	Asakawa, Kazuhide/0000-0003-0628-1176; Muto, Akira/0000-0003-4276-1775; Hirata, Hiromi/0000-0002-3769-7441	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Precursory Research for Embryonic Science and Technology, Japan Science and Technology Agency (Development and Function of Neural Networks); Takeda Science Foundation; Human Frontier Science Program; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS018205, R01NS018205] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [23700477] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Precursory Research for Embryonic Science and Technology, Japan Science and Technology Agency (Development and Function of Neural Networks); Takeda Science Foundation(Takeda Science Foundation (TSF)); Human Frontier Science Program(Human Frontier Science Program); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, by Precursory Research for Embryonic Science and Technology, Japan Science and Technology Agency (Development and Function of Neural Networks), by the Takeda Science Foundation and by a career development award from the Human Frontier Science Program (to H. H.).	Amores A, 1998, SCIENCE, V282, P1711, DOI 10.1126/science.282.5394.1711; Araya R, 2005, J CELL SCI, V118, P27, DOI 10.1242/jcs.01553; Araya R, 2003, CELL COMMUN ADHES, V10, P451, DOI 10.1080/15419060390263038; Asakawa K, 2008, P NATL ACAD SCI USA, V105, P1255, DOI 10.1073/pnas.0704963105; Ashworth R, 2001, DEV BRAIN RES, V129, P169, DOI 10.1016/S0165-3806(01)00198-5; Bahary N, 2004, METHOD CELL BIOL, V77, P305; Belluardo N, 2005, CELL TISSUE RES, V320, P299, DOI 10.1007/s00441-005-1087-7; Buckingham SD, 2004, J EXP BIOL, V207, P841, DOI 10.1242/jeb.00839; Budick SA, 2000, J EXP BIOL, V203, P2565; Buss RR, 2000, J NEUROPHYSIOL, V84, P1545, DOI 10.1152/jn.2000.84.3.1545; Chatterjee B, 2005, DEV DYNAM, V233, P890, DOI 10.1002/dvdy.20426; Cheng SH, 2004, J BIOL CHEM, V279, P36993, DOI 10.1074/jbc.M401355200; Cheng SH, 2003, DEV DYNAM, V228, P709, DOI 10.1002/dvdy.10436; Codina M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008416; Cruciani V, 2006, CELL MOL LIFE SCI, V63, P1125, DOI 10.1007/s00018-005-5571-8; Devoto SH, 1996, DEVELOPMENT, V122, P3371; Downes GB, 2006, J NEUROBIOL, V66, P437, DOI 10.1002/neu.20226; Eastman SD, 2006, GENOMICS, V87, P265, DOI 10.1016/j.ygeno.2005.10.005; FELSENFELD AL, 1990, DEVELOPMENT, V108, P443; Fero K, 2011, NEUROMETHODS, V52, P249, DOI 10.1007/978.1.60761.922.2_12; Gates MA, 1999, GENOME RES, V9, P334; Gerhart SV, 2009, FEBS LETT, V583, P3419, DOI 10.1016/j.febslet.2009.09.054; Gong XH, 1997, CELL, V91, P833, DOI 10.1016/S0092-8674(00)80471-7; Goodenough DA, 2003, NAT REV MOL CELL BIO, V4, P285, DOI 10.1038/nrm1072; Granato M, 1996, DEVELOPMENT, V123, P399; Guyon JR, 2007, BBA-MOL BASIS DIS, V1772, P205, DOI 10.1016/j.bbadis.2006.07.003; Hirata H, 2005, P NATL ACAD SCI USA, V102, P8345, DOI 10.1073/pnas.0500862102; Hirata H, 2004, DEVELOPMENT, V131, P5457, DOI 10.1242/dev.01410; Hirata H, 2007, DEVELOPMENT, V134, P2771, DOI 10.1242/dev.004531; Ingham PW, 2005, EXP CELL RES, V306, P336, DOI 10.1016/j.yexcr.2005.03.019; Johnston I.A., 1983, P36; KALDERON N, 1977, J CELL BIOL, V75, P788, DOI 10.1083/jcb.75.3.788; Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091; LIU DW, 1988, J PHYSIOL-LONDON, V403, P73, DOI 10.1113/jphysiol.1988.sp017239; Luna VM, 2006, J GEN PHYSIOL, V128, P89, DOI 10.1085/jgp.200609501; McLean DL, 2007, NATURE, V446, P71, DOI 10.1038/nature05588; Moore CA, 2007, DEVELOPMENT, V134, P3145, DOI 10.1242/dev.001214; Muller UK, 2004, J EXP BIOL, V207, P853, DOI 10.1242/jeb.00821; Muto A, 2011, P NATL ACAD SCI USA, V108, P5425, DOI 10.1073/pnas.1000887108; Naganawa Y, 2011, DEV BIOL, V355, P194, DOI 10.1016/j.ydbio.2011.04.027; Nakano Y, 2010, DEVELOPMENT, V137, P1689, DOI 10.1242/dev.047464; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Nguyen PV, 1999, J NEUROPHYSIOL, V81, P2852, DOI 10.1152/jn.1999.81.6.2852; Nusslein-Volhard C., 2002, ZEBRAFISH PRACTICAL; Ochi H, 2007, DEV GROWTH DIFFER, V49, P1, DOI 10.1111/j.1440-169x.2007.00905.x; Ogino K, 2011, J BIOL CHEM, V286, P806, DOI 10.1074/jbc.M110.125500; Ono F, 2001, J NEUROSCI, V21, P5439, DOI 10.1523/JNEUROSCI.21-15-05439.2001; PAUL DL, 1991, J CELL BIOL, V115, P1077, DOI 10.1083/jcb.115.4.1077; Pietri T, 2009, DEV NEUROBIOL, V69, P780, DOI 10.1002/dneu.20741; Proulx A, 1997, DEV GENET, V20, P133, DOI 10.1002/(SICI)1520-6408(1997)20:2<133::AID-DVG6>3.0.CO;2-8; Randall, 1978, FISH PHYSIOL, P361; RASH JE, 1973, DEV BIOL, V30, P166, DOI 10.1016/0012-1606(73)90055-9; Saint-Amant L, 1998, J NEUROBIOL, V37, P622, DOI 10.1002/(SICI)1097-4695(199812)37:4<622::AID-NEU10>3.0.CO;2-S; Saint-Amant L, 2008, DEV NEUROBIOL, V68, P45, DOI 10.1002/dneu.20569; Shimoda N, 1999, GENOMICS, V58, P219, DOI 10.1006/geno.1999.5824; Sohl G, 2004, CARDIOVASC RES, V62, P228, DOI 10.1016/j.cardiores.2003.11.013; Sohl G, 2003, CELL COMMUN ADHES, V10, P27, DOI 10.1080/15419060390220468; von Maltzahn J, 2004, J CELL SCI, V117, P5381, DOI 10.1242/jcs.01413; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE; White TW, 1999, ANNU REV PHYSIOL, V61, P283, DOI 10.1146/annurev.physiol.61.1.283; Yeager M, 2007, CURR OPIN CELL BIOL, V19, P521, DOI 10.1016/j.ceb.2007.09.001; Zhou WB, 2006, CELL CALCIUM, V39, P227, DOI 10.1016/j.ceca.2005.10.015	62	7	7	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					1080	1089		10.1074/jbc.M111.308205	http://dx.doi.org/10.1074/jbc.M111.308205			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22075003	Green Published, hybrid			2022-12-27	WOS:000299170300024
J	Moles, A; Tarrats, N; Fernandez-Checa, JC; Mari, M				Moles, Anna; Tarrats, Nuria; Fernandez-Checa, Jose C.; Mari, Montserrat			Cathepsin B Overexpression Due to Acid Sphingomyelinase Ablation Promotes Liver Fibrosis in Niemann-Pick Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DEATH; DEFICIENT MICE; KNOCKOUT MICE; ROLES; PATHOGENESIS; METABOLISM; ACTIVATION; APOPTOSIS; PATHOLOGY; CIRRHOSIS	Niemann-Pick disease (NPD) is a lysosomal storage disease caused by the loss of acid sphingomyelinase (ASMase) that features neurodegeneration and liver disease. Because ASMase-knock-out mice models NPD and our previous findings revealed that ASMase activates cathepsins B/D (CtsB/D), our aim was to investigate the expression and processing of CtsB/D in hepatic stellate cells (HSCs) from ASMase-null mice and their role in liver fibrosis. Surprisingly, HSCs from ASMase-knock-out mice exhibit increased basal level and activity of CtsB as well as its in vitro processing in culture, paralleling the enhanced expression of fibrogenic markers alpha-smooth muscle actin (alpha-SMA), TGF-beta, and pro-collagen alpha 1(I) (Col1A1). Moreover, pharmacological inhibition of CtsB blunted the expression of alpha-SMA and Col1A1 and proliferation of HSCs from ASMase-knock-out mice. Consistent with the enhanced activation of CtsB in HSCs from ASMase-null mice, the in vivo liver fibrosis induced by chronic treatment with CCl4 increased in ASMase-null compared with wild-type mice, an effect that was reduced upon CtsB inhibition. In addition to liver, the enhanced proteolytic processing of CtsB was also observed in brain and lung of ASMase-knock-out mice, suggesting that the overexpression of CtsB may underlie the phenotype of NPD. Thus, these findings reveal a functional relationship between ASMase and CtsB and that the ablation of ASMase leads to the enhanced processing and activation of CtsB. Therefore, targeting CtsB may be of relevance in the treatment of liver fibrosis in patients with NPD.	[Moles, Anna; Tarrats, Nuria; Fernandez-Checa, Jose C.; Mari, Montserrat] Hosp Clin Barcelona, Liver Unit, Inst Invest Biomed August Pi & Sunyer, Ctr Invest Biomed Red,Area Temat Entermedades Hep, E-08036 Barcelona, Spain; [Moles, Anna; Tarrats, Nuria; Fernandez-Checa, Jose C.; Mari, Montserrat] CSIC, Dept Cell Death & Proliferat, Inst Invest Biomed Barcelona, Barcelona 08036, Spain; [Fernandez-Checa, Jose C.] Univ So Calif, Keck Sch Med, Res Ctr Alcohol Liver & Pancreat Dis, Los Angeles, CA 90089 USA	CIBER - Centro de Investigacion Biomedica en Red; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas de Barcelona (IIBB); University of Barcelona; University of Southern California	Fernandez-Checa, JC (corresponding author), Hosp Clin Barcelona, Liver Unit, Inst Invest Biomed August Pi & Sunyer, Ctr Invest Biomed Red,Area Temat Entermedades Hep, C Villarroel 170, E-08036 Barcelona, Spain.	checa229@yahoo.com; monmari@clinic.ub.es	MARI, MONTSERRAT/M-2871-2019; Moles, Ana/A-5889-2017; Mari, Montserrat/A-7376-2013; Fernández-Checa, José Carlos/L-8342-2014	Moles, Ana/0000-0002-3915-0060; Mari, Montserrat/0000-0002-6116-3247; Fernández-Checa, José Carlos/0000-0003-3422-2990	Research Center for Liver and Pancreatic Diseases, National Institute on Alcohol Abuse and Alcoholism [P50-AA-11999]; Instituto de Salud Carlos III [PI10/02114]; Plan Nacional de I+D, Spain [2009-11417]; Fundacio La Marato de TV3; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P50AA011999] Funding Source: NIH RePORTER	Research Center for Liver and Pancreatic Diseases, National Institute on Alcohol Abuse and Alcoholism; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Plan Nacional de I+D, Spain; Fundacio La Marato de TV3; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	The work was supported, in whole or in part, by Grant P50-AA-11999 from the Research Center for Liver and Pancreatic Diseases, National Institute on Alcohol Abuse and Alcoholism. This work was carried out in part at the Esther Koplowitz Center in Barcelona, and it was also supported by Grants PI10/02114 (Instituto de Salud Carlos III), 2009-11417 (Plan Nacional de I+D), Spain; and the and Fundacio La Marato de TV3.	Amritraj A, 2009, AM J PATHOL, V175, P2540, DOI 10.2353/ajpath.2009.081096; Appelqvist H, 2011, AM J PATHOL, V178, P629, DOI 10.1016/j.ajpath.2010.10.030; Devlin C, 2010, TRAFFIC, V11, P601, DOI 10.1111/j.1600-0854.2010.01046.x; Ledesma MD, 2011, J NEUROCHEM, V116, P779, DOI 10.1111/j.1471-4159.2010.07034.x; Fehrenbacher N, 2008, CANCER RES, V68, P6623, DOI 10.1158/0008-5472.CAN-08-0463; Fotoulaki M, 2007, J INHERIT METAB DIS, V30, P986, DOI 10.1007/s10545-007-0557-3; Futerman AH, 2004, NAT REV MOL CELL BIO, V5, P554, DOI 10.1038/nrm1423; Garcia-Ruiz C, 2003, J CLIN INVEST, V111, P197, DOI 10.1172/JCI200316010; GRABER D, 1994, J NEUROCHEM, V63, P1060; Guicciardi ME, 2000, J CLIN INVEST, V106, P1127, DOI 10.1172/JCI9914; Haque A, 2008, CNS NEUROL DISORD-DR, V7, P270, DOI 10.2174/187152708784936653; Heinrich M, 2004, CELL DEATH DIFFER, V11, P550, DOI 10.1038/sj.cdd.4401382; HORINOUCHI K, 1995, NAT GENET, V10, P288, DOI 10.1038/ng0795-288; JAMALL IS, 1981, ANAL BIOCHEM, V112, P70, DOI 10.1016/0003-2697(81)90261-X; Jenkins RW, 2011, J BIOL CHEM, V286, P3777, DOI 10.1074/jbc.M110.155234; Jenkins RW, 2009, CELL SIGNAL, V21, P836, DOI 10.1016/j.cellsig.2009.01.026; Johansson AC, 2010, APOPTOSIS, V15, P527, DOI 10.1007/s10495-009-0452-5; Jones I, 2008, MOL GENET METAB, V95, P152, DOI 10.1016/j.ymgme.2008.08.004; Kirkegaard T, 2010, NATURE, V463, P549, DOI 10.1038/nature08710; LABRUNE P, 1991, J PEDIATR GASTR NUTR, V13, P104, DOI 10.1097/00005176-199107000-00020; Leto G, 1996, EUR J CLIN CHEM CLIN, V34, P555; Lutgens SPM, 2007, FASEB J, V21, P3029, DOI 10.1096/fj.06-7924com; Mari M, 2004, J CLIN INVEST, V113, P895, DOI 10.1172/JCI200419852; Mari M, 2006, CELL METAB, V4, P185, DOI 10.1016/j.cmet.2006.07.006; Moles A, 2010, AM J PATHOL, V177, P1214, DOI 10.2353/ajpath.2010.091257; Moles A, 2009, HEPATOLOGY, V49, P1297, DOI 10.1002/hep.22753; Morales A, 2007, APOPTOSIS, V12, P923, DOI 10.1007/s10495-007-0721-0; OTTERBACH B, 1995, CELL, V81, P1053, DOI 10.1016/S0092-8674(05)80010-8; Petersen NHT, 2010, CELL CYCLE, V9, P2305, DOI 10.4161/cc.9.12.12052; Prinetti A, 2011, NEUROCHEM RES, V36, P1654, DOI 10.1007/s11064-010-0380-3; SCHNEIDER PB, 1967, J LIPID RES, V8, P202; Schuchman EH, 2009, INT J CLIN PHARM TH, V47, pS48; Schuchman EH, 2010, FEBS LETT, V584, P1895, DOI 10.1016/j.febslet.2009.11.083; Smith EL, 2008, FASEB J, V22, P3419, DOI 10.1096/fj.08-108043; Takahashi T, 1997, HUM PATHOL, V28, P385, DOI 10.1016/S0046-8177(97)90141-6; TASSONI JP, 1991, GASTROENTEROLOGY, V100, P567, DOI 10.1016/0016-5085(91)90233-B; Vasiljeva O, 2007, CURR PHARM DESIGN, V13, P387, DOI 10.2174/138161207780162962; Yu WX, 2005, J BIOL CHEM, V280, P11731, DOI 10.1074/jbc.M412898200	38	42	42	3	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					1178	1188		10.1074/jbc.M111.272393	http://dx.doi.org/10.1074/jbc.M111.272393			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22102288	Green Submitted, Green Published, hybrid			2022-12-27	WOS:000299170300033
J	Chang, TW; Lin, YM; Wang, CF; Liao, YD				Chang, Ting-Wei; Lin, Yu-Ming; Wang, Chiu-Feng; Liao, You-Di			Outer Membrane Lipoprotein Lpp Is Gram-negative Bacterial Cell Surface Receptor for Cationic Antimicrobial Peptides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; HOST-DEFENSE; HUMAN SKIN; MECHANISMS; RESISTANCE; INFECTION; PATHOGENS; PROTEINS; SMAP-29; BINDING	Antimicrobial peptides/proteins (AMPs) are important components of the host innate defense mechanisms. Here we demonstrate that the outer membrane lipoprotein, Lpp, of Enterobacteriaceae interacts with and promotes susceptibility to the bactericidal activities of AMPs. The oligomeric Lpp was specifically recognized by several cationic alpha-helical AMPs, including SMAP-29, CAP-18, and LL-37; AMP-mediated bactericidal activities were blocked by anti-Lpp antibody blocking. Blebbing of the outer membrane and increase in membrane permeability occurred in association with the coordinate internalization of Lpp and AMP. Interestingly, the specific binding of AMP to Lpp was resistant to divalent cations and salts, which were able to inhibit the bactericidal activities of some AMPs. Furthermore, using His-tagged Lpp as a ligand, we retrieved several characterized AMPs, including SMAP-29 and hRNase 7, from a peptide library containing crude mammalian cell lysates. Overall, this study explores a new mechanism and target of antimicrobial activity and provides a novel method for screening of antimicrobials for use against drug-resistant bacteria.	[Chang, Ting-Wei; Lin, Yu-Ming; Wang, Chiu-Feng; Liao, You-Di] Acad Sinica, Inst Biomed Sci, Taipei 115, Taiwan; [Chang, Ting-Wei; Liao, You-Di] Natl Yang Ming Univ, Inst Pharmacol, Taipei 112, Taiwan; [Chang, Ting-Wei; Liao, You-Di] Natl Yang Ming Univ, Program Mol Med, Sch Life Sci, Taipei 112, Taiwan	Academia Sinica - Taiwan; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Liao, YD (corresponding author), Acad Sinica, Inst Biomed Sci, Taipei 115, Taiwan.	ydliao@ibms.sinica.edu.tw	Liao, You-Di/S-7018-2018	Liao, You-Di/0000-0001-5527-4736	Academia Sinica and National Science Council [NSC 98-2311-B-001-017-MY3]	Academia Sinica and National Science Council	This work was supported by Academia Sinica and National Science Council Grant NSC 98-2311-B-001-017-MY3.	Boix E, 2007, MOL BIOSYST, V3, P317, DOI 10.1039/b617527a; Bowdish DME, 2005, CURR PROTEIN PEPT SC, V6, P35, DOI 10.2174/1389203053027494; Brogden KA, 2001, ANTIMICROB AGENTS CH, V45, P331, DOI 10.1128/AAC.45.1.331-334.2001; Brown KL, 2006, CURR OPIN IMMUNOL, V18, P24, DOI 10.1016/j.coi.2005.11.004; CHOI DS, 1986, J BIOL CHEM, V261, P8953; Cowles CE, 2011, MOL MICROBIOL, V79, P1168, DOI 10.1111/j.1365-2958.2011.07539.x; De Pascale G, 2010, CHEMBIOCHEM, V11, P1325, DOI 10.1002/cbic.201000067; Epand RM, 1999, BBA-BIOMEMBRANES, V1462, P11, DOI 10.1016/S0005-2736(99)00198-4; FUNG J, 1978, J BACTERIOL, V133, P1467, DOI 10.1128/JB.133.3.1467-1471.1978; Glaser R, 2005, NAT IMMUNOL, V6, P57, DOI 10.1038/ni1142; Harder J, 2002, J BIOL CHEM, V277, P46779, DOI 10.1074/jbc.M207587200; Harder J, 2001, J BIOL CHEM, V276, P5707, DOI 10.1074/jbc.M008557200; Huang YC, 2007, J BIOL CHEM, V282, P4626, DOI 10.1074/jbc.M607321200; INOUYE M, 1974, P NATL ACAD SCI USA, V71, P2396, DOI 10.1073/pnas.71.6.2396; INOUYE M, 1972, J BIOL CHEM, V247, P8154; INOUYE S, 1976, J BACTERIOL, V127, P555, DOI 10.1128/JB.127.1.555-563.1976; Lin YM, 2010, J BIOL CHEM, V285, P8985, DOI 10.1074/jbc.M109.078725; Mahamoud A, 2007, J ANTIMICROB CHEMOTH, V59, P1223, DOI 10.1093/jac/dkl493; MIZUSHIMA S, 1975, BIOCHIM BIOPHYS ACTA, V375, P44, DOI 10.1016/0005-2736(75)90071-1; Pages JM, 2008, NAT REV MICROBIOL, V6, P893, DOI 10.1038/nrmicro1994; PETERSON AA, 1987, ANTIMICROB AGENTS CH, V31, P230, DOI 10.1128/AAC.31.2.230; Pilhofer M, 2010, METHOD CELL BIOL, V96, P21, DOI 10.1016/S0091-679X(10)96002-0; SANKARAN K, 1994, J BIOL CHEM, V269, P19701; Schroder JM, 2006, CELL MOL LIFE SCI, V63, P469, DOI 10.1007/s00018-005-5364-0; Shepard BD, 2002, MICROBES INFECT, V4, P215, DOI 10.1016/S1286-4579(01)01530-1; Shin SY, 2001, BIOCHEM BIOPH RES CO, V285, P1046, DOI 10.1006/bbrc.2001.5280; Shu W, 2000, J MOL BIOL, V299, P1101, DOI 10.1006/jmbi.2000.3776; Steinberg DA, 1997, ANTIMICROB AGENTS CH, V41, P1738, DOI 10.1128/AAC.41.8.1738; Tack BF, 2002, EUR J BIOCHEM, V269, P1181, DOI 10.1046/j.0014-2956.2002.02751.x; Travis SM, 2000, INFECT IMMUN, V68, P2748, DOI 10.1128/IAI.68.5.2748-2755.2000; Turner J, 1998, ANTIMICROB AGENTS CH, V42, P2206, DOI 10.1128/AAC.42.9.2206; Zaiou M, 2003, J INVEST DERMATOL, V120, P810, DOI 10.1046/j.1523-1747.2003.12132.x; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zavascki AP, 2007, J ANTIMICROB CHEMOTH, V60, P1206, DOI 10.1093/jac/dkm357	34	44	46	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					418	428		10.1074/jbc.M111.290361	http://dx.doi.org/10.1074/jbc.M111.290361			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22084237	Green Published, hybrid			2022-12-27	WOS:000298682400040
J	Gerlt, JA; Babbitt, PC; Jacobson, MP; Almo, SC				Gerlt, John A.; Babbitt, Patricia C.; Jacobson, Matthew P.; Almo, Steven C.			Divergent Evolution in Enolase Superfamily: Strategies for Assigning Functions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							ACYLAMINO ACID RACEMASE; D/L-GLU EPIMERASES; ENZYMATIC-ACTIVITIES; ESCHERICHIA-COLI; BACILLUS-SUBTILIS; IN-SILICO; DEHYDRATASE; (BETA/ALPHA)(8)-BARRELS; ANNOTATION; ASSIGNMENT	Nature's strategies for evolving catalytic functions can be deciphered from the information contained in the rapidly expanding protein sequence databases. However, the functions of many proteins in the protein sequence and structure databases are either uncertain (too divergent to assign function based on homology) or unknown (no homologs), thereby limiting the utility of the databases. The mechanistically diverse enolase superfamily is a paradigm for understanding the structural bases for evolution of enzymatic function. We describe strategies for assigning functions to members of the enolase superfamily that should be applicable to other superfamilies.	[Gerlt, John A.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; [Gerlt, John A.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; [Gerlt, John A.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [Babbitt, Patricia C.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, Sch Pharm, San Francisco, CA 94143 USA; [Jacobson, Matthew P.] Univ Calif San Francisco, Dept Pharmaceut Chem, Sch Pharm, San Francisco, CA 94143 USA; [Almo, Steven C.] Yeshiva Univ Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Yeshiva University; Albert Einstein College of Medicine	Gerlt, JA (corresponding author), Univ Illinois, Dept Biochem, Urbana, IL 61801 USA.	j-gerlt@uiuc.edu	Jacobson, Matthew/Y-5161-2018	Jacobson, Matthew/0000-0001-6262-655X	National Institutes of Health [P01GM071790-07, U54GM093342-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001081] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060595, P01GM071790, U54GM093342] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants P01GM071790-07 and U54GM093342-01. This is the fourth article in the Thematic Minireview Series on Enzyme Evolution in the Post-genomic Era.	Almonacid DE, 2011, CURR OPIN CHEM BIOL, V15, P435, DOI 10.1016/j.cbpa.2011.03.008; Asuncion M, 2002, J BIOL CHEM, V277, P8306, DOI 10.1074/jbc.M111180200; Atkinson HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004345; Babbitt PC, 1996, BIOCHEMISTRY-US, V35, P16489, DOI 10.1021/bi9616413; Brown SD, 2012, J BIOL CHEM, V287, P35, DOI 10.1074/jbc.R111.283408; Frishman D, 2007, CHEM REV, V107, P3448, DOI 10.1021/cr068303k; Gerlt JA, 2001, ANNU REV BIOCHEM, V70, P209, DOI 10.1146/annurev.biochem.70.1.209; Glasner ME, 2006, J MOL BIOL, V360, P228, DOI 10.1016/j.jmb.2006.04.055; Gulick AM, 2001, BIOCHEMISTRY-US, V40, P15716, DOI 10.1021/bi011641p; Gulick AM, 2001, BIOCHEMISTRY-US, V40, P10054, DOI 10.1021/bi010733b; Hermann JC, 2007, NATURE, V448, P775, DOI 10.1038/nature05981; Kalyanaraman C, 2008, STRUCTURE, V16, P1668, DOI 10.1016/j.str.2008.08.015; Levy CW, 2002, STRUCTURE, V10, P105, DOI 10.1016/S0969-2126(01)00696-7; Loewenstein Y, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-2-207; Macchiarulo A, 2004, NAT BIOTECHNOL, V22, P1039, DOI 10.1038/nbt999; Murakami S, 2004, FEMS MICROBIOL LETT, V231, P119, DOI 10.1016/S0378-1097(03)00933-9; NEIDHART DJ, 1990, NATURE, V347, P692, DOI 10.1038/347692a0; Palmer DRJ, 1999, BIOCHEMISTRY-US, V38, P4252, DOI 10.1021/bi990140p; Pegg SCH, 2006, BIOCHEMISTRY-US, V45, P2545, DOI 10.1021/bi052101l; Rakus JF, 2008, BIOCHEMISTRY-US, V47, P9944, DOI 10.1021/bi800914r; Rakus JF, 2007, BIOCHEMISTRY-US, V46, P12896, DOI 10.1021/bi701703w; Rakus JF, 2009, BIOCHEMISTRY-US, V48, P11546, DOI 10.1021/bi901731c; Sakai A, 2006, BIOCHEMISTRY-US, V45, P4455, DOI 10.1021/bi060230b; Sakai A, 2009, BIOCHEMISTRY-US, V48, P1445, DOI 10.1021/bi802277h; Schmidt DMZ, 2003, BIOCHEMISTRY-US, V42, P8387, DOI 10.1021/bi034769a; Schmidt DMZ, 2001, BIOCHEMISTRY-US, V40, P15707, DOI 10.1021/bi011640x; Schnoes AM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000605; Song L, 2007, NAT CHEM BIOL, V3, P486, DOI 10.1038/nchembio.2007.11; Tyagi S, 2006, J BIOTECHNOL, V124, P108, DOI 10.1016/j.jbiotec.2006.01.027; Vick JE, 2007, BIOCHEMISTRY-US, V46, P14589, DOI 10.1021/bi7019063; Vick JE, 2005, BIOCHEMISTRY-US, V44, P11722, DOI 10.1021/bi050963g; Yew WS, 2007, BIOCHEMISTRY-US, V46, P9564, DOI 10.1021/bi7008882; Yew WS, 2006, BIOCHEMISTRY-US, V45, P14582, DOI 10.1021/bi061687o; Yew WS, 2006, BIOCHEMISTRY-US, V45, P14598, DOI 10.1021/bi061688g	34	105	107	0	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					29	34		10.1074/jbc.R111.240945	http://dx.doi.org/10.1074/jbc.R111.240945			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22069326	Green Published, hybrid			2022-12-27	WOS:000298682400005
J	Stewart, EV; Lloyd, SJA; Burg, JS; Nwosu, CC; Lintner, RE; Daza, R; Russ, C; Ponchner, K; Nusbaum, C; Espenshade, PJ				Stewart, Emerson V.; Lloyd, S. Julie-Ann; Burg, John S.; Nwosu, Christine C.; Lintner, Robert E.; Daza, Riza; Russ, Carsten; Ponchner, Karen; Nusbaum, Chad; Espenshade, Peter J.			Yeast Sterol Regulatory Element-binding Protein (SREBP) Cleavage Requires Cdc48 and Dsc5, a Ubiquitin Regulatory X Domain-containing Subunit of the Golgi Dsc E3 Ligase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FISSION YEAST; SCHIZOSACCHAROMYCES-POMBE; DEGRADATION; GENE; COMPLEX; UBX2; EXPRESSION; MUTATIONS; MECHANISM; EFFICIENT	Schizosaccharomyces pombe Sre1 is a membrane-bound transcription factor that controls adaptation to hypoxia. Like its mammalian homolog, sterol regulatory element-binding protein (SREBP), Sre1 activation requires release from the membrane. However, in fission yeast, this release occurs through a strikingly different mechanism that requires the Golgi Dsc E3 ubiquitin ligase complex and the proteasome. The mechanistic details of Sre1 cleavage, including the link between the Dsc E3 ligase complex and proteasome, are not well understood. Here, we present results of a genetic selection designed to identify additional components required for Sre1 cleavage. From the selection, we identified two new components of the fission yeast SREBP pathway: Dsc5 and Cdc48. The AAA(ATPase associated with diverse cellular activities) ATPase Cdc48 and Dsc5, a ubiquitin regulatory X domain-containing protein, interact with known Dsc complex components and are required for SREBP cleavage. These findings provide a mechanistic link between the Dsc E3 ligase complex and the proteasome in SREBP cleavage and add to a growing list of similarities between the Dsc E3 ligase and membrane E3 ligases involved in endoplasmic reticulum-associated degradation.	[Stewart, Emerson V.; Lloyd, S. Julie-Ann; Burg, John S.; Nwosu, Christine C.; Espenshade, Peter J.] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA; [Lintner, Robert E.; Daza, Riza; Russ, Carsten; Ponchner, Karen; Nusbaum, Chad] Broad Inst Massachusetts Inst Technol & Harvard, Genome Sequencing & Anal Program, Cambridge, MA 02141 USA	Johns Hopkins University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Espenshade, PJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Cell Biol, 725 N Wolfe St,Physiol Rm 107B, Baltimore, MD 21205 USA.	peter.espenshade@jhmi.edu	Daza, Riza M./HCH-4047-2022	Lintner, Robert/0000-0002-4379-7799	National Institutes of Health [HL077588]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077588] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079637] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant HL077588 (to P. J. E.).	Alexandru G, 2008, CELL, V134, P804, DOI 10.1016/j.cell.2008.06.048; Alfa C, 1993, EXPT FISSION YEAST L; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Bien CM, 2010, EUKARYOT CELL, V9, P352, DOI 10.1128/EC.00358-09; Bimbo A, 2005, EUKARYOT CELL, V4, P799, DOI 10.1128/EC.4.4.799-813.2005; BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; BURKE JD, 1994, MOL GEN GENET, V242, P169, DOI 10.1007/BF00391010; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; DeLaBarre B, 2006, MOL CELL, V22, P451, DOI 10.1016/j.molcel.2006.03.036; Denic V, 2006, CELL, V126, P349, DOI 10.1016/j.cell.2006.05.045; Espenshade PJ, 2007, ANNU REV GENET, V41, P401, DOI 10.1146/annurev.genet.41.110306.130315; FORSBURG SL, 1993, NUCLEIC ACIDS RES, V21, P2955, DOI 10.1093/nar/21.12.2955; Gauss R, 2006, EMBO J, V25, P1827, DOI 10.1038/sj.emboj.7601088; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; Halawani D, 2009, MOL CELL BIOL, V29, P4484, DOI 10.1128/MCB.00252-09; Hartmann-Petersen R, 2004, CURR BIOL, V14, P824, DOI 10.1016/j.cub.2004.04.029; Hartmann-Petersen R, 2003, INT J BIOCHEM CELL B, V35, P629, DOI 10.1016/S1357-2725(02)00393-X; Hughes AL, 2008, J LIPID RES, V49, P2001, DOI 10.1194/jlr.M800207-JLR200; Hughes AL, 2005, CELL, V120, P831, DOI 10.1016/j.cell.2005.01.012; Kim DU, 2010, NAT BIOTECHNOL, V28, P617, DOI 10.1038/nbt.1628; Lee CYS, 2009, EMBO J, V28, P135, DOI 10.1038/emboj.2008.271; Lee H, 2007, MOL MICROBIOL, V65, P1018, DOI 10.1111/j.1365-2958.2007.05844.x; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Neuber O, 2005, NAT CELL BIOL, V7, P993, DOI 10.1038/ncb1298; Nohturfft A, 2000, CELL, V102, P315, DOI 10.1016/S0092-8674(00)00037-4; Osborne TF, 2009, GENE DEV, V23, P2578, DOI 10.1101/gad.1854309; Petrucelli L, 2004, ANN MED, V36, P315, DOI 10.1080/07853890410031948; Reggiori F, 2002, NAT CELL BIOL, V4, P117, DOI 10.1038/ncb743; Schuberth C, 2008, CELL MOL LIFE SCI, V65, P2360, DOI 10.1007/s00018-008-8072-8; Schuberth C, 2005, NAT CELL BIOL, V7, P999, DOI 10.1038/ncb1299; Stewart EV, 2011, MOL CELL, V42, P160, DOI 10.1016/j.molcel.2011.02.035; Stolz A, 2011, TRENDS BIOCHEM SCI, V36, P515, DOI 10.1016/j.tibs.2011.06.001; Thompson J. F., 2010, CURR PROTOC MOL BIOL, V10, DOI DOI 10.1002/0471142727.MB0710S92; Todd BL, 2006, MOL CELL BIOL, V26, P2817, DOI 10.1128/MCB.26.7.2817-2831.2006; Wang Q, 2005, J BIOL CHEM, V280, P40515, DOI 10.1074/jbc.M509636200; Wang Q, 2004, J STRUCT BIOL, V146, P44, DOI 10.1016/j.jsb.2003.11.014; Wood V, 2002, NATURE, V415, P871, DOI 10.1038/nature724; Yuasa T, 2004, GENES CELLS, V9, P1069, DOI 10.1111/j.1365-2443.2004.00790.x	39	41	41	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					672	681		10.1074/jbc.M111.317370	http://dx.doi.org/10.1074/jbc.M111.317370			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22086920	Green Published, hybrid			2022-12-27	WOS:000298682400065
J	Wangler, NJ; Santos, KL; Schadock, I; Hagen, FK; Escher, E; Bader, M; Speth, RC; Karamyan, VT				Wangler, Naomi J.; Santos, Kira L.; Schadock, Ines; Hagen, Fred K.; Escher, Emanuel; Bader, Michael; Speth, Robert C.; Karamyan, Vardan T.			Identification of Membrane-bound Variant of Metalloendopeptidase Neurolysin (EC 3.4.24.16) as the Non-angiotensin Type 1 (Non-AT1), Non-AT(2) Angiotensin Binding Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-SEQUENCE; THIMET OLIGOPEPTIDASE; RAT-BRAIN; CONVERTING-ENZYME; BIOCHEMICAL-CHARACTERIZATION; SUBCELLULAR-DISTRIBUTION; TISSUE DISTRIBUTION; ENDOPEPTIDASE 24.15; MOLECULAR-CLONING; AT(1) RECEPTOR	Recently, we discovered a novel non-angiotensin type 1 (non-AT(1)), non-AT(2) angiotensin binding site in rodent and human brain membranes, which is distinctly different from angiotensin receptors and key proteases processing angiotensins. It is hypothesized to be a new member of the renin-angiotensin system. This study was designed to isolate and identify this novel angiotensin binding site. An angiotensin analog, photoaffinity probe I-125-SBpa-Ang II, was used to specifically label the non-AT(1), non-AT(2) angiotensin binding site in mouse forebrain membranes, followed by a two-step purification procedure based on the molecular size and isoelectric point of the photo-radiolabeled binding protein. Purified samples were subjected to two-dimensional gel electrophoresis followed by mass spectrometry identification of proteins in the two-dimensional gel sections containing radioactivity. LC-MS/MS analysis revealed eight protein candidates, of which the four most abundant were immunoprecipitated after photoradiolabeling. Immunoprecipitation studies indicated that the angiotensin binding site might be the membrane-bound variant of metalloendopeptidase neurolysin (EC 3.4.24.16). To verify these observations, radioligand binding and photoradiolabeling experiments were conducted in membrane preparations of HEK293 cells overexpressing mouse neurolysin or thimet oligopeptidase (EC 3.4.24.15), a closely related metalloendopeptidase of the same family. These experiments also identified neurolysin as the non-AT(1), non-AT(2) angiotensin binding site. Finally, brain membranes of mice lacking neurolysin were nearly devoid of the non-AT(1), non-AT(2) angiotensin binding site, further establishing membrane-bound neurolysin as the binding site. Future studies will focus on the functional significance of this highly specific, high affinity interaction between neurolysin and angiotensins.	[Wangler, Naomi J.; Karamyan, Vardan T.] Texas Tech Univ, Hlth Sci Ctr, Dept Pharmaceut Sci, Sch Pharm, Amarillo, TX 79106 USA; [Karamyan, Vardan T.] Texas Tech Univ, Hlth Sci Ctr, Vasc Drug Res Ctr, Sch Pharm, Amarillo, TX 79106 USA; [Santos, Kira L.; Speth, Robert C.] Nova SE Univ, Coll Pharm, Dept Pharmaceut Sci, Ft Lauderdale, FL 33328 USA; [Schadock, Ines; Bader, Michael] Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany; [Hagen, Fred K.] Univ Rochester, Med Ctr, Dept Biochem & Biophys, Prote Ctr, Rochester, NY 14642 USA; [Escher, Emanuel] Univ Sherbrooke, Dept Pharmacol, Sherbrooke, PQ J1H 5N4, Canada; [Speth, Robert C.] Univ Florida, Coll Med, Dept Physiol & Funct Genom, Gainesville, FL 32611 USA	Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University Health Sciences Center Amarillo; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University Health Sciences Center Amarillo; Nova Southeastern University; Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Rochester; University of Sherbrooke; State University System of Florida; University of Florida	Karamyan, VT (corresponding author), 1300 Coulter St, Amarillo, TX 79106 USA.	vardan.karamyan@ttuhsc.edu	Bader, Michael/K-2124-2013	Schadock, Ines/0000-0002-6717-6276; Bader, Michael/0000-0003-4780-4164	National Institutes of Health, NHLBI [HL-096357]; Texas Tech University Health Sciences Center School of Pharmacy; American Radiolabeled Chemicals; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL096357] Funding Source: NIH RePORTER	National Institutes of Health, NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Texas Tech University Health Sciences Center School of Pharmacy; American Radiolabeled Chemicals; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health, NHLBI, Grant HL-096357. This work was also supported by Texas Tech University Health Sciences Center School of Pharmacy start-up funds and American Radiolabeled Chemicals.	Abadir PM, 2011, P NATL ACAD SCI USA, V108, P14849, DOI 10.1073/pnas.1101507108; Albiston AL, 2001, J BIOL CHEM, V276, P48623, DOI 10.1074/jbc.C100512200; Alfonso LF, 2009, INT J ONCOL, V34, P597, DOI 10.3892/ijo_00000185; Baker KM, 2006, AM J PHYSIOL-CELL PH, V291, pC995, DOI 10.1152/ajpcell.00238.2006; Berti DA, 2009, J BIOL CHEM, V284, P14105, DOI 10.1074/jbc.M807916200; Bourassa EA, 2010, BRAIN RES, V1359, P98, DOI 10.1016/j.brainres.2010.08.081; Chai SY, 2004, CELL MOL LIFE SCI, V61, P2728, DOI 10.1007/s00018-004-4246-1; CHECLER F, 1986, J BIOL CHEM, V261, P1274; CHECLER F, 1995, METHOD ENZYMOL, V248, P593; Clement M, 2005, J BIOL CHEM, V280, P27121, DOI 10.1074/jbc.M413653200; Cunha FM, 2008, J BIOL CHEM, V283, P24448, DOI 10.1074/jbc.M801252200; DAHMS P, 1992, EUR J BIOCHEM, V208, P145, DOI 10.1111/j.1432-1033.1992.tb17168.x; DAUCH P, 1992, J NEUROCHEM, V59, P1862, DOI 10.1111/j.1471-4159.1992.tb11021.x; DAUCH P, 1995, J BIOL CHEM, V270, P27266, DOI 10.1074/jbc.270.45.27266; de Gasparo M, 2000, PHARMACOL REV, V52, P415; Donoghue M, 2000, CIRC RES, V87, pE1, DOI 10.1161/01.res.87.5.e1; Ferro ES, 2004, PROTEIN PEPTIDE LETT, V11, P415, DOI 10.2174/0929866043406706; Fontenele-Neto JD, 2001, J COMP NEUROL, V438, P399, DOI 10.1002/cne.1323; Gembardt F, 2008, MOL CELL BIOCHEM, V319, P115, DOI 10.1007/s11010-008-9884-4; HAGIWARA H, 1989, EUR J BIOCHEM, V185, P405, DOI 10.1111/j.1432-1033.1989.tb15129.x; Jeske NA, 2006, J NEUROCHEM, V97, P13, DOI 10.1111/j.1471-4159.2006.03706.x; Karamyan VT, 2008, LIFE SCI, V83, P421, DOI 10.1016/j.lfs.2008.07.003; Karamyan VT, 2008, EUR J PHARMACOL, V590, P87, DOI 10.1016/j.ejphar.2008.05.035; Karamyan VT, 2007, REGUL PEPTIDES, V143, P15, DOI 10.1016/j.regpep.2007.03.006; Karamyan VT, 2007, BRAIN RES, V1143, P83, DOI 10.1016/j.brainres.2007.01.051; Karamyan VT, 2010, ENDOCRINE, V37, P442, DOI 10.1007/s12020-010-9328-2; Karamyan VT, 2009, J PHARMACOL EXP THER, V331, P170, DOI 10.1124/jpet.109.157461; Karamyan VT, 2008, NEUROENDOCRINOLOGY, V88, P256, DOI 10.1159/000140635; KATO A, 1994, EUR J BIOCHEM, V221, P159, DOI 10.1111/j.1432-1033.1994.tb18725.x; Kato A, 1997, J BIOL CHEM, V272, P15313, DOI 10.1074/jbc.272.24.15313; Kim SI, 2003, BIOCHEM J, V375, P111, DOI 10.1042/BJ20030490; KIRON MAR, 1989, J BIOL CHEM, V264, P4138; LIND RW, 1985, NEUROENDOCRINOLOGY, V40, P2; Lucero HA, 2010, J BIOL CHEM, V285, P5555, DOI 10.1074/jbc.M109.074740; Marimuthu S, 2011, INT J ONCOL, V39, P1273, DOI 10.3892/ijo.2011.1113; Massarelli EE, 1999, BRAIN RES, V851, P261, DOI 10.1016/S0006-8993(99)02135-6; MCKIE N, 1993, BIOCHEM J, V295, P57, DOI 10.1042/bj2950057; MILLICAN PE, 1991, BIOCHEM J, V276, P583, DOI 10.1042/bj2760583; Nagata S, 2006, BIOCHEM BIOPH RES CO, V350, P1026, DOI 10.1016/j.bbrc.2006.09.146; Nguyen G, 2002, J CLIN INVEST, V109, P1417, DOI 10.1172/JCI200214276; Norman MU, 2003, AM J PHYSIOL-HEART C, V284, pH1942, DOI 10.1152/ajpheart.00948.2002; Portaro FCV, 1999, BIOCHEM BIOPH RES CO, V255, P596, DOI 10.1006/bbrc.1999.0251; Rabey FM, 2010, REGUL PEPTIDES, V162, P5, DOI 10.1016/j.regpep.2010.02.007; Rashid M, 2010, J PHARMACOL EXP THER, V335, P754, DOI 10.1124/jpet.110.171439; Rawlings ND, 2006, NUCLEIC ACIDS RES, V34, pD270, DOI 10.1093/nar/gkj089; Rioli V, 2003, J BIOL CHEM, V278, P8547, DOI 10.1074/jbc.M212030200; Rioli V, 1998, BIOCHEM BIOPH RES CO, V250, P5, DOI 10.1006/bbrc.1998.8941; RODD D, 1995, J BIOL CHEM, V270, P10056, DOI 10.1074/jbc.270.17.10056; Santos RAS, 2003, P NATL ACAD SCI USA, V100, P8258, DOI 10.1073/pnas.1432869100; Saric T, 2001, J BIOL CHEM, V276, P36474, DOI 10.1074/jbc.M105517200; SERIZAWA A, 1995, J BIOL CHEM, V270, P2092, DOI 10.1074/jbc.270.5.2092; Servant G, 1997, J BIOL CHEM, V272, P8653, DOI 10.1074/jbc.272.13.8653; Smith AI, 2000, HYPERTENSION, V35, P626, DOI 10.1161/01.HYP.35.2.626; SUGIURA N, 1992, J BIOL CHEM, V267, P18067; Tadevosyan A, 2010, J BIOL CHEM, V285, P22338, DOI 10.1074/jbc.M110.121749; Thekkumkara TJ, 2003, BIOCHEM J, V370, P631, DOI 10.1042/BJ20020960; Tigerstedt R., 1898, SKAND ARCH PHYSIOL, V8, P223, DOI [10.1111/j.1748-1716.1898.tb00272.x, DOI 10.1111/J.1748-1716.1898.TB00272.X]; Tipnis SR, 2000, J BIOL CHEM, V275, P33238, DOI 10.1074/jbc.M002615200; Unger T, 1999, J HYPERTENS, V17, P1775, DOI 10.1097/00004872-199917121-00001; Vincent B, 1997, J NEUROCHEM, V68, P837; Vincent B, 1996, J NEUROSCI, V16, P5049; Vincent B, 1997, BRIT J PHARMACOL, V121, P705, DOI 10.1038/sj.bjp.0701182; Vincent B, 1997, EUR J PHARMACOL, V334, P49, DOI 10.1016/S0014-2999(97)01209-0; Wallukat G, 1999, J CLIN INVEST, V103, P945, DOI 10.1172/JCI4106; WOULFE J, 1992, EUR J NEUROSCI, V4, P1309, DOI 10.1111/j.1460-9568.1992.tb00156.x	65	30	30	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					114	122		10.1074/jbc.M111.273052	http://dx.doi.org/10.1074/jbc.M111.273052			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22039052	Green Published, hybrid			2022-12-27	WOS:000298682400014
J	Luo, HY; Wu, ZH; Qi, SJ; Jin, W; Han, B; Wu, JP				Luo, Hongyu; Wu, Zenghui; Qi, Shijie; Jin, Wei; Han, Bing; Wu, Jiangping			Ephrinb1 and Ephrinb2 Are Associated with Interleukin-7 Receptor alpha and Retard Its Internalization from the Cell Surface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-CELLS; EPH RECEPTORS; IL-7; EXPRESSION; ANGIOGENESIS; IL-7R-ALPHA; EXPANSION	IL-7 plays vital roles in thymocyte development, T cell homeostasis, and the survival of these cells. IL-7 receptor alpha (IL-7R alpha) on thymocytes and T cells is rapidly internalized upon IL-7 ligation. Ephrins (Efns) are cell surface molecules and ligands of the largest receptor kinase family, Eph kinases. We discovered that T cell-specific double gene knock-out (dKO) of Efnb1 and Efnb2 in mice led to reduced IL-7R alpha expression in thymocytes and T cells, and that IL-7R alpha down-regulation was accelerated in dKO CD4 cells upon IL-7 treatment. On the other hand, Efnb1 and Efnb2 overexpression on T cell lymphoma EL4 cells retarded IL-7R alpha down-regulation. dKO T cells manifested compromised STAT5 activation and homeostatic proliferation, an IL-7-dependent process. Fluorescence resonance energy transfer and immunoprecipitation demonstrated that Efnb1 and Efnb2 interacted physically with IL-7R alpha. Such interaction likely retarded IL-7R alpha internalization, as Efnb1 and Efnb2 were not internalized. Therefore, we revealed a novel function of Efnb1 and Efnb2 in stabilizing IL-7R alpha expression at the post-translational level, and a previously unknown modus operandi of Efnbs in the regulation of expression of other vital cell surface receptors.	[Luo, Hongyu; Wu, Zenghui; Qi, Shijie; Jin, Wei; Han, Bing; Wu, Jiangping] CRCHUM, Notre Dame Hosp, Immunol Lab, Montreal, PQ H2L 4M1, Canada; [Wu, Jiangping] CRCHUM, Notre Dame Hosp, Serv Nephrol, Montreal, PQ H2L 4M1, Canada	Universite de Montreal; Universite de Montreal	Wu, JP (corresponding author), CRCHUM, Notre Dame Hosp, Immunol Lab, Rm Y-5616,1560 Sherbrooke St E, Montreal, PQ H2L 4M1, Canada.	jianping.wu@umontreal.ca	jin, wei/E-6435-2014	Jin, Wei/0000-0001-6123-0588	Canadian Institutes of Health Research [MOP57697, MOP69089, MOP97829]; Heart and Stroke Foundation of Quebec; Quebec Ministry of Economic Development, Innovation and Exportation [PSR-SIIRI-069]; J.-Louis Levesque Foundation; Fonds de la recherche en sante du Quebec for Transfusional and Hemovigilance Medical Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Quebec; Quebec Ministry of Economic Development, Innovation and Exportation; J.-Louis Levesque Foundation; Fonds de la recherche en sante du Quebec for Transfusional and Hemovigilance Medical Research	This work was supported by Canadian Institutes of Health Research Grants MOP57697 and MOP69089 (to J.W.) and MOP97829 (to H. L.), grants from the Heart and Stroke Foundation of Quebec, the Quebec Ministry of Economic Development, Innovation and Exportation Grant PSR-SIIRI-069, and grants from the J.-Louis Levesque Foundation and a group grant from Fonds de la recherche en sante du Quebec for Transfusional and Hemovigilance Medical Research (to J.W.).	Alves NL, 2008, J IMMUNOL, V180, P5201, DOI 10.4049/jimmunol.180.8.5201; Aspinall R, 2006, MECH AGEING DEV, V127, P572, DOI 10.1016/j.mad.2006.01.016; Davis CC, 2010, CANCER RES, V70, P5249, DOI 10.1158/0008-5472.CAN-09-2860; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Flanagan JG, 1997, CELL, V90, P403; Henriques CM, 2010, BLOOD, V115, P3269, DOI 10.1182/blood-2009-10-246876; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Luo HY, 2011, J BIOL CHEM, V286, P41135, DOI 10.1074/jbc.M111.302596; Luo HY, 2004, J CLIN INVEST, V114, P1762, DOI 10.1172/JCI200421846; Munitic I, 2004, BLOOD, V104, P4165, DOI 10.1182/blood-2004-06-2484; Palmer MJ, 2008, CELL MOL IMMUNOL, V5, P79, DOI 10.1038/cmi.2008.10; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Sawamiphak S, 2010, NATURE, V465, P487, DOI 10.1038/nature08995; Sun JC, 2006, J IMMUNOL, V177, P4458, DOI 10.4049/jimmunol.177.7.4458; Takada K, 2009, NAT REV IMMUNOL, V9, P823, DOI 10.1038/nri2657; Thiel S, 2000, FEBS LETT, V470, P15, DOI 10.1016/S0014-5793(00)01276-X; Unsinger J, 2010, J IMMUNOL, V184, P3768, DOI 10.4049/jimmunol.0903151; Vranjkovic A, 2007, INT IMMUNOL, V19, P1329, DOI 10.1093/intimm/dxm102; Walline CC, 2011, GENES IMMUN, V12, P1, DOI 10.1038/gene.2010.49; Wang HU, 1998, CELL, V93, P741, DOI 10.1016/S0092-8674(00)81436-1; Wang Y, 2006, AM J TRANSPLANT, V6, P2851, DOI 10.1111/j.1600-6143.2006.01550.x; Wang YD, 2010, NATURE, V465, P483, DOI 10.1038/nature09002; Wilkinson DG, 2000, INT REV CYTOL, V196, P177; Wouters FS, 2001, TRENDS CELL BIOL, V11, P203, DOI 10.1016/S0962-8924(01)01982-1; Wu Jiangping, 2005, Curr Opin Hematol, V12, P292, DOI 10.1097/01.moh.0000166497.26397.9f	25	29	30	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2011	286	52					44976	44987		10.1074/jbc.M111.316414	http://dx.doi.org/10.1074/jbc.M111.316414			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870CA	22069310	Green Published, hybrid			2022-12-27	WOS:000298645500066
J	Shen, K; Tolbert, CE; Guilluy, C; Swaminathan, VS; Berginski, ME; Burridge, K; Superfine, R; Campbell, SL				Shen, Kai; Tolbert, Caitlin E.; Guilluy, Christophe; Swaminathan, Vinay S.; Berginski, Matthew E.; Burridge, Keith; Superfine, Richard; Campbell, Sharon L.			The Vinculin C-terminal Hairpin Mediates F-actin Bundle Formation, Focal Adhesion, and Cell Mechanical Properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRAMOLECULAR ASSOCIATION; CRYSTAL-STRUCTURE; SELF-ASSOCIATION; BINDING PROTEIN; TAIL DOMAIN; COMPLEX; TALIN; FORCE; DYNAMICS; RECRUITMENT	Vinculin is an essential and highly conserved cell adhesion protein, found at both focal adhesions and adherens junctions, where it couples integrins or cadherins to the actin cytoskeleton. Vinculin is involved in controlling cell shape, motility, and cell survival, and has more recently been shown to play a role in force transduction. The tail domain of vinculin (Vt) contains determinants necessary for binding and bundling of actin filaments. Actin binding to Vt has been proposed to induce formation of a Vt dimer that is necessary for cross-linking actin filaments. Results from this study provide additional support for actin-induced Vt self-association. Moreover, the actin-induced Vt dimer appears distinct from the dimer formed in the absence of actin. To better characterize the role of the Vt strap and carboxyl terminus (CT) in actin binding, Vt self-association, and actin bundling, we employed smaller amino-terminal (NT) and CT deletions that do not perturb the structural integrity of Vt. Although both NT and CT deletions retain actin binding, removal of the CT hairpin (1061-1066) selectively impairs actin bundling in vitro. Moreover, expression of vinculin lacking the CT hairpin in vinculin knock-out murine embryonic fibroblasts affects the number of focal adhesions formed, cell spreading as well as cellular stiffening in response to mechanical force.	[Shen, Kai; Campbell, Sharon L.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Tolbert, Caitlin E.; Guilluy, Christophe; Burridge, Keith] Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA; [Swaminathan, Vinay S.; Superfine, Richard] Univ N Carolina, Dept Phys, Chapel Hill, NC 27599 USA; [Berginski, Matthew E.] Univ N Carolina, Dept Biomed Engn, Chapel Hill, NC 27599 USA; [Burridge, Keith; Campbell, Sharon L.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Campbell, SL (corresponding author), Univ N Carolina, Dept Biochem & Biophys, CB 7260, Chapel Hill, NC 27599 USA.	sharon_campbell@med.unc.edu	Guilluy, Christophe/Z-1015-2019; Superfine, Richard/A-1968-2012; guilluy, christophe/C-6002-2014; , UNC Biomolecular NMR Facility/AAD-7901-2022	Guilluy, Christophe/0000-0003-1141-0809; Superfine, Richard/0000-0002-2569-071X; guilluy, christophe/0000-0003-1141-0809; campbell, sharon/0000-0003-0311-409X	National Institutes of Health [GM081764, GM080568, GM029860]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080568, R01GM029860, R01GM081764] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM081764 (to S. L. C.), GM080568 (to S. L. C.), and GM029860 (to K.B.).	Bakolitsa C, 1999, CELL, V99, P603, DOI 10.1016/S0092-8674(00)81549-4; Bakolitsa C, 2004, NATURE, V430, P583, DOI 10.1038/nature02610; Bausch AR, 1999, BIOPHYS J, V76, P573, DOI 10.1016/S0006-3495(99)77225-5; Berginski ME, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022025; Borgon RA, 2004, STRUCTURE, V12, P1189, DOI 10.1016/j.str.2004.05.009; Brindle NPJ, 1996, BIOCHEM J, V318, P753, DOI 10.1042/bj3180753; BYRNE BJ, 1992, J BIOL CHEM, V267, P12845; Carisey A, 2011, EUR J CELL BIOL, V90, P157, DOI 10.1016/j.ejcb.2010.06.007; Chen H, 2006, J BIOL CHEM, V281, P40389, DOI 10.1074/jbc.M607324200; Cohen DM, 2006, J BIOL CHEM, V281, P16006, DOI 10.1074/jbc.M600738200; Cohen DM, 2005, J BIOL CHEM, V280, P17109, DOI 10.1074/jbc.M414704200; COLL JL, 1995, P NATL ACAD SCI USA, V92, P9161, DOI 10.1073/pnas.92.20.9161; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeMali KA, 2002, J CELL BIOL, V159, P881, DOI 10.1083/jcb.200206043; Diez G, 2009, BIOPHYS J, V97, P3105, DOI 10.1016/j.bpj.2009.09.039; Dixon RDS, 2008, J BIOL CHEM, V283, P6222, DOI 10.1074/jbc.M707694200; Fisher JK, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2166509; Galbraith CG, 2002, J CELL BIOL, V159, P695, DOI 10.1083/jcb.200204153; Geiger B, 2001, CURR OPIN CELL BIOL, V13, P584, DOI 10.1016/S0955-0674(00)00255-6; Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593; Gilmore AP, 1996, NATURE, V381, P531, DOI 10.1038/381531a0; Goldmann WH, 1998, EXP CELL RES, V239, P235, DOI 10.1006/excr.1997.3915; Grashoff C, 2010, NATURE, V466, P263, DOI 10.1038/nature09198; Huttelmaier S, 1997, EUR J BIOCHEM, V247, P1136, DOI 10.1111/j.1432-1033.1997.01136.x; Janmey PA, 2007, ANNU REV BIOMED ENG, V9, P1, DOI 10.1146/annurev.bioeng.9.060906.151927; Janssen MEW, 2006, MOL CELL, V21, P271, DOI 10.1016/j.molcel.2005.11.020; Ji L, 2008, NAT CELL BIOL, V10, P1393, DOI 10.1038/ncb1797; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Johnson RP, 1998, BIOCHEMISTRY-US, V37, P10211, DOI 10.1021/bi9727242; Johnson RP, 2000, J BIOL CHEM, V275, P95, DOI 10.1074/jbc.275.1.95; JOHNSON RP, 1994, J BIOL CHEM, V269, P12611; Kanchanawong P, 2010, NATURE, V468, P580, DOI 10.1038/nature09621; Kioka N, 1999, J CELL BIOL, V144, P59, DOI 10.1083/jcb.144.1.59; KROEMKER M, 1994, FEBS LETT, V355, P259, DOI 10.1016/0014-5793(94)01216-4; Maeda M, 1997, CIRCULATION, V95, P17, DOI 10.1161/01.CIR.95.1.17; Mandai K, 1999, J CELL BIOL, V144, P1001, DOI 10.1083/jcb.144.5.1001; MOLONY L, 1985, J CELL BIOCHEM, V29, P31, DOI 10.1002/jcb.240290104; O'Brien ET, 2008, METHOD CELL BIOL, V89, P433, DOI 10.1016/S0091-679X(08)00616-X; Olson TM, 2002, CIRCULATION, V105, P431, DOI 10.1161/hc0402.102930; Palmer SM, 2008, BIOCHEMISTRY-US, V47, P12467, DOI 10.1021/bi801764a; Palmer SM, 2008, BIOMOL NMR ASSIGM, V2, P69, DOI 10.1007/s12104-008-9087-7; Palmer SM, 2009, J BIOL CHEM, V284, P7223, DOI 10.1074/jbc.M807842200; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Pasapera AM, 2010, J CELL BIOL, V188, P877, DOI 10.1083/jcb.200906012; Saunders RM, 2006, EUR J CELL BIOL, V85, P487, DOI 10.1016/j.ejcb.2006.01.014; Schwartz MA, 2009, SCIENCE, V323, P588, DOI 10.1126/science.1169414; Subauste MC, 2004, J CELL BIOL, V165, P371, DOI 10.1083/jcb.200308011; Thoumine O, 1997, J CELL SCI, V110, P2109; von Wichert G, 2003, EMBO J, V22, P5023, DOI 10.1093/emboj/cdg492; Weekes J, 1996, BIOCHEM J, V314, P827, DOI 10.1042/bj3140827; Weiss EE, 1998, J CELL BIOL, V141, P755, DOI 10.1083/jcb.141.3.755; Wen KK, 2009, J BIOL CHEM, V284, P30463, DOI 10.1074/jbc.M109.021295; Winkler J, 1996, J STRUCT BIOL, V116, P270, DOI 10.1006/jsbi.1996.0042; WOOD CK, 1994, J CELL SCI, V107, P709; Xu WM, 1998, DEVELOPMENT, V125, P327; Zamir E, 1999, J CELL SCI, V112, P1655; Zemljic-Harpf AE, 2004, AM J PATHOL, V165, P1033, DOI 10.1016/S0002-9440(10)63364-0; Ziegler WH, 2006, TRENDS CELL BIOL, V16, P453, DOI 10.1016/j.tcb.2006.07.004	58	44	44	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2011	286	52					45103	45115		10.1074/jbc.M111.244293	http://dx.doi.org/10.1074/jbc.M111.244293			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870CA	22052910	Green Published, hybrid			2022-12-27	WOS:000298645500077
J	Suaud, L; Miller, K; Panichelli, AE; Randell, RL; Marando, CM; Rubenstein, RC				Suaud, Laurence; Miller, Katelyn; Panichelli, Ashley E.; Randell, Rachel L.; Marando, Catherine M.; Rubenstein, Ronald C.			4-Phenylbutyrate Stimulates Hsp70 Expression through the Elp2 Component of Elongator and STAT-3 in Cystic Fibrosis Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; MOLECULAR CHAPERONE HSC70; POLYMERASE-II HOLOENZYME; HEAT-SHOCK PROTEINS; SODIUM 4-PHENYLBUTYRATE; FAMILIAL DYSAUTONOMIA; ENDOPLASMIC-RETICULUM; SIGNAL TRANSDUCER; DELTA-F508 CFTR; GENE-EXPRESSION	Sodium 4-phenylbutyrate (4PBA) corrects trafficking of Delta F508-CFTR in Cystic Fibrosis (CF) epithelia, which is hypothesized to, at least in part, result from increased expression of Hsp70 (stress-induced 70 kDa heat shock protein). To identify other 4PBA-regulated proteins that may promote correction of Delta F508 trafficking, we performed differential display RT-PCRon mRNA from IB3-1 CF bronchiolar epithelial cells treated for 0-24 h with 1mM 4PBA. In this screen, a STAT-3 (signal transducer and activator of transcription-3)-interacting protein, StIP-1 that regulates STAT-3 activation had transiently increased expression. StIP-1 is identical to Elongator protein 2 (Elp2), a component of the Elongator complex that regulates RNA polymerase II. Previous studies have suggested that Elongator regulates Hsp70 mRNA transcription, and that the Hsp70 promoter contains functional STAT-3-binding sites. We therefore tested the hypothesis that 4PB Aincreases Hsp70 expression by an Elongator- and STAT-3-dependent mechanism. 4PBA treatment of IB3-1 CF bronchiolar epithelial cells caused transiently increased expression of Hsp70 protein, as well as Elp2 protein and mRNA. Elp2 depletion by transfection of small interfering RNAs, reduced both Elp2 and Hsp70 protein expression. 4PBA also caused transient activation of STAT-3, and increased abundance of nuclear proteins that bind to the STAT-3-responsive element of the Hsp70 promoter. Luciferase reporter assays demonstrated that both Elp2 overexpression and 4PBA increase Hsp70 promoter activity, while Elp2 depletion blocked the ability of 4PBA to stimulate Hsp70 promoter activity. Together, these data suggest that Elp2 and STAT-3 mediate, at least in part, the stimulation of Hsp70 expression by 4PBA.	[Suaud, Laurence; Miller, Katelyn; Panichelli, Ashley E.; Randell, Rachel L.; Marando, Catherine M.; Rubenstein, Ronald C.] Childrens Hosp Philadelphia, Div Pulm Med, Philadelphia, PA 19104 USA; [Suaud, Laurence; Miller, Katelyn; Panichelli, Ashley E.; Randell, Rachel L.; Marando, Catherine M.; Rubenstein, Ronald C.] Childrens Hosp Philadelphia, Cyst Fibrosis Ctr, Philadelphia, PA 19104 USA; [Rubenstein, Ronald C.] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine	Rubenstein, RC (corresponding author), Childrens Hosp Philadelphia, Div Pulm Med, Abramson 410C,34th St & Civ Ctr Blvd, Philadelphia, PA 19104 USA.	rrubenst@mail.med.upenn.edu		Marando, Catherine/0000-0003-1613-6781; Randell, Rachel/0000-0002-8009-8209; Rubenstein, Ronald/0000-0002-3138-4006	NIDDK, National Institutes of Health [R01 DK058046, R01 DK073185]; Pennsylvania-Delaware Chapter of the American Heart Association; Cystic Fibrosis Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058046, R01DK073185] Funding Source: NIH RePORTER	NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Pennsylvania-Delaware Chapter of the American Heart Association; Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by Grants R01 DK058046 and R01 DK073185 (to R. C. R.) from the NIDDK, National Institutes of Health, from the Pennsylvania-Delaware Chapter of the American Heart Association (to L. S.), and the Cystic Fibrosis Foundation (to R. C. R.).	Anderson SL, 2001, AM J HUM GENET, V68, P753, DOI 10.1086/318808; Bercovich B, 1997, J BIOL CHEM, V272, P9002; Bossu JP, 1996, BIOCHEM J, V318, P547, DOI 10.1042/bj3180547; Brown CR, 1996, CELL STRESS CHAPERON, V1, P117, DOI 10.1379/1466-1268(1996)001<0117:CCCTMP>2.3.CO;2; Burrows JAJ, 2000, P NATL ACAD SCI USA, V97, P1796, DOI 10.1073/pnas.97.4.1796; Chen WY, 1997, P NATL ACAD SCI USA, V94, P5798, DOI 10.1073/pnas.94.11.5798; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Cheong N, 2006, J BIOL CHEM, V281, P9791, DOI 10.1074/jbc.M507515200; Choo-Kang LR, 2001, AM J PHYSIOL-LUNG C, V281, pL58, DOI 10.1152/ajplung.2001.281.1.L58; Close P, 2006, MOL CELL, V22, P521, DOI 10.1016/j.molcel.2006.04.017; Collum RG, 2000, P NATL ACAD SCI USA, V97, P10120, DOI 10.1073/pnas.170192197; CYR DM, 1992, J BIOL CHEM, V267, P20927; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; Esberg A, 2006, MOL CELL, V24, P139, DOI 10.1016/j.molcel.2006.07.031; Farinha CM, 2002, BIOCHEM J, V366, P797, DOI 10.1042/BJ20011717; Fichtner L, 2003, MOL MICROBIOL, V49, P1297, DOI 10.1046/j.1365-2958.2003.03632.x; Goldfarb SB, 2006, P NATL ACAD SCI USA, V103, P5817, DOI 10.1073/pnas.0507903103; Han QJ, 2008, BIOCHEM J, V409, P779, DOI 10.1042/BJ20070578; Han QJ, 2007, ACTA BIOCH BIOPH SIN, V39, P453, DOI 10.1111/j.1745-7270.2007.00293.x; Hawkes NA, 2002, J BIOL CHEM, V277, P3047, DOI 10.1074/jbc.M110445200; Huang B, 2005, RNA, V11, P424, DOI 10.1261/rna.7247705; JENSEN TJ, 1995, CELL, V83, P129, DOI 10.1016/0092-8674(95)90241-4; Jiang CW, 1998, AM J PHYSIOL-CELL PH, V275, pC171, DOI 10.1152/ajpcell.1998.275.1.C171; Johansen LD, 2008, J CELL SCI, V121, P854, DOI 10.1242/jcs.013722; KARTNER N, 1992, NAT GENET, V1, P321, DOI 10.1038/ng0892-321; Kim JH, 2002, P NATL ACAD SCI USA, V99, P1241, DOI 10.1073/pnas.251672198; Krogan NJ, 2001, MOL CELL BIOL, V21, P8203, DOI 10.1128/MCB.21.23.8203-8212.2001; Li D, 2001, CELL MOL LIFE SCI, V58, P2085, DOI 10.1007/PL00000838; Loo MA, 1998, EMBO J, V17, P6879, DOI 10.1093/emboj/17.23.6879; Madamanchi NR, 2001, J BIOL CHEM, V276, P18915, DOI 10.1074/jbc.M008802200; Meacham GC, 2001, NAT CELL BIOL, V3, P100, DOI 10.1038/35050509; Okiyoneda T, 2004, MOL BIOL CELL, V15, P563, DOI 10.1091/mbc.E03-06-0379; Okiyoneda T, 2002, FEBS LETT, V526, P87, DOI 10.1016/S0014-5793(02)03134-4; Otero G, 1999, MOL CELL, V3, P109, DOI 10.1016/S1097-2765(00)80179-3; PASYK EA, 1995, J BIOL CHEM, V270, P12347, DOI 10.1074/jbc.270.21.12347; PIND S, 1994, J BIOL CHEM, V269, P12784; Pruliere-Escabasse V, 2007, J BIOL CHEM, V282, P34048, DOI 10.1074/jbc.M702384200; Rahl PB, 2005, MOL CELL, V17, P841, DOI 10.1016/j.molcel.2005.02.018; Rahmani M, 2002, EXP CELL RES, V277, P31, DOI 10.1006/excr.2002.5548; Ripley BJM, 1999, IMMUNOLOGY, V97, P226; Rosser MFN, 2008, MOL BIOL CELL, V19, P4570, DOI 10.1091/mbc.E08-04-0357; Rubenstein RC, 2000, AM J PHYSIOL-CELL PH, V278, pC259, DOI 10.1152/ajpcell.2000.278.2.C259; Rubenstein RC, 2001, AM J PHYSIOL-LUNG C, V281, pL43, DOI 10.1152/ajplung.2001.281.1.L43; Rubenstein RC, 1998, AM J RESP CRIT CARE, V157, P484, DOI 10.1164/ajrccm.157.2.9706088; Rubenstein RC, 1997, J CLIN INVEST, V100, P2457, DOI 10.1172/JCI119788; Rubenstein RC, 2006, MOL DIAGN THER, V10, P293, DOI 10.1007/BF03256204; Singh OV, 2006, J PROTEOME RES, V5, P562, DOI 10.1021/pr050319o; Slaugenhaupt SA, 2002, CURR OPIN GENET DEV, V12, P307, DOI 10.1016/S0959-437X(02)00303-9; Slaugenhaupt SA, 2001, AM J HUM GENET, V68, P598, DOI 10.1086/318810; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; Stephanou A, 1998, BIOCHEM J, V330, P189, DOI 10.1042/bj3300189; Stephanou A, 1999, J BIOL CHEM, V274, P1723, DOI 10.1074/jbc.274.3.1723; Stephanou A, 1999, GENE EXPRESSION, V7, P311; Strickland E, 1997, J BIOL CHEM, V272, P25421, DOI 10.1074/jbc.272.41.25421; Suaud L, 2011, J BIOL CHEM, V286, P21239, DOI 10.1074/jbc.M111.240267; Vila-Carriles WH, 2006, J BIOL CHEM, V281, P19220, DOI 10.1074/jbc.M603100200; Wang WJ, 2003, J CELL SCI, V116, P683, DOI 10.1242/jcs.00267; WARD CL, 1994, J BIOL CHEM, V269, P25710; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Winkler GS, 2002, P NATL ACAD SCI USA, V99, P3517, DOI 10.1073/pnas.022042899; Winkler GS, 2001, J BIOL CHEM, V276, P32743, DOI 10.1074/jbc.M105303200; Wittschieben BO, 1999, MOL CELL, V4, P123, DOI 10.1016/S1097-2765(00)80194-X; Wright JM, 2004, PHYSIOL GENOMICS, V16, P204, DOI 10.1152/physiolgenomics.00160.2003; Yamagishi N, 2009, FEBS J, V276, P5870, DOI 10.1111/j.1742-4658.2009.07311.x; YANG YP, 1993, P NATL ACAD SCI USA, V90, P9480, DOI 10.1073/pnas.90.20.9480; ZEITLIN PL, 1991, AM J RESP CELL MOL, V4, P313, DOI 10.1165/ajrcmb/4.4.313; Zeitlin PL, 2002, MOL THER, V6, P119, DOI 10.1006/mthe.2002.0639	68	35	36	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2011	286	52					45083	45092		10.1074/jbc.M111.293282	http://dx.doi.org/10.1074/jbc.M111.293282			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870CA	22069317	Green Published, hybrid			2022-12-27	WOS:000298645500075
J	Saini, V; Marchese, A; Tang, WJ; Majetschak, M				Saini, Vikas; Marchese, Adriano; Tang, Wei-Jen; Majetschak, Matthias			Structural Determinants of Ubiquitin-CXC Chemokine Receptor 4 Interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DERIVED FACTOR-1-ALPHA; EXOGENOUS UBIQUITIN; BINDING DOMAINS; SEVERE TRAUMA; INJURY; RECOGNITION; SDF-1-ALPHA; COMPLEX; IDENTIFICATION; RESUSCITATION	Ubiquitin, a post-translational protein modifier inside the functions as a CXC chemokine receptor (CXCR) 4 agonist outside the cell. However, the structural determinants of the interaction between extracellular ubiquitin and CXCR4 remain unknown. Utilizing C-terminal truncated ubiquitin and ubiquitin mutants, in which surface residues that are known to interact with ubiquitin binding domains in interacting proteins are mutated (Phe-4, Leu-8, Ile-44, Asp-58, Val-70), we provide evidence that the ubiquitin-CXCR4 interaction follows a two-site binding mechanism in which the hydrophobic surfaces surrounding Phe-4 and Val-70 are important for receptor binding, whereas the flexible C terminus facilitates receptor activation. Based on these findings and the available crystal structures, we then modeled the ubiquitin-CXCR4 interface with the Rosetta-Dock software followed by small manual adjustments, which were guided by charge complementarity and anticipation of a conformational switch of CXCR4 upon activation. This model suggests three residues of CXCR4 (Phe-29, Phe-189, Lys-271) as potential interaction sites. Binding studies with HEK293 cells overexpressing wild type and CXCR4 after site-directed mutagenesis confirm that these residues are important for ubiquitin binding but that they do not contribute to the binding of stromal cell-derived factor 1 alpha. Our findings suggest that the structural determinants of the CXCR4 agonist activity of ubiquitin mimic the typical structure-function relationship of chemokines. Furthermore, we provide evidence for separate and specific ligand binding sites on CXCR4. As exogenous ubiquitin has been shown to possess therapeutic potential, our findings are expected to facilitate the structure-based design of new compounds with ubiquitin-mimetic actions on CXCR4.	[Saini, Vikas; Majetschak, Matthias] Loyola Univ, Chicago Stritch Sch Med, Dept Surg, Burn & Shock Trauma Inst, Maywood, IL 60153 USA; [Marchese, Adriano; Majetschak, Matthias] Loyola Univ, Chicago Stritch Sch Med, Dept Mol Pharmacol & Therapeut, Maywood, IL 60153 USA; [Tang, Wei-Jen] Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA	Loyola University Chicago; Loyola University Chicago; University of Chicago	Majetschak, M (corresponding author), 2160 S 1st Ave, Maywood, IL 60153 USA.	mmajetschak@lumc.edu		Tang, Wei-Jen/0000-0002-8267-8995	United States Army Medical Research and Materiel Command (USAMRMC); Telemedicine and Advanced Technology Research Center (TATRC) at Fort Detrick, MD [W81XWH1020122]; National Institutes of Health [GM075159, GM081539]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081539, R01GM075159] Funding Source: NIH RePORTER	United States Army Medical Research and Materiel Command (USAMRMC)(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); Telemedicine and Advanced Technology Research Center (TATRC) at Fort Detrick, MD; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was made possible, in part, by a grant that was awarded and administered by the United States Army Medical Research and Materiel Command (USAMRMC) and the Telemedicine and Advanced Technology Research Center (TATRC) at Fort Detrick, MD, under Contract W81XWH1020122 (to M. M.). This work was also supported in part by National Institutes of Health Grants GM075159 (to A. M.) and GM081539 (to W. J. T.). Based on the results of this work, Loyola University Chicago has filed a provisional patent application. The authors are the inventors. None of the authors have received any income related to the patent or patent application.	Ahn HC, 2009, EXP NEUROL, V220, P120, DOI 10.1016/j.expneurol.2009.07.031; Alam SL, 2006, NAT STRUCT MOL BIOL, V13, P186, DOI 10.1038/nsmb0306-186; Block EFJ, 2004, J TRAUMA, V56, P999; Brelot A, 2000, J BIOL CHEM, V275, P23736, DOI 10.1074/jbc.M000776200; Busillo JM, 2007, BBA-BIOMEMBRANES, V1768, P952, DOI 10.1016/j.bbamem.2006.11.002; Choi WT, 2005, J VIROL, V79, P15398, DOI 10.1128/JVI.79.24.15398-15404.2005; Crump MP, 1997, EMBO J, V16, P6996, DOI 10.1093/emboj/16.23.6996; Doranz BJ, 1999, J VIROL, V73, P2752, DOI 10.1128/JVI.73.4.2752-2761.1999; Earle SA, 2005, SURGERY, V138, P431, DOI 10.1016/j.surg.2005.06.026; Earle SA, 2006, TRANSPLANTATION, V82, P1544, DOI 10.1097/01.tp.0000236057.56721.d0; FAN H, 2011, INFLAMMATIO IN PRESS; Garcia-Covarrubias L, 2008, CRIT CARE MED, V36, P979, DOI 10.1097/CCM.0B013E318164E417; Gozansky EK, 2005, J MOL BIOL, V345, P651, DOI 10.1016/j.jmb.2004.11.003; Griebenow M, 2007, J NEUROTRAUM, V24, P1529, DOI 10.1089/neu.2007.0306; Gupta SK, 2001, IMMUNOL LETT, V78, P29, DOI 10.1016/S0165-2478(01)00228-0; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Hu XF, 2007, CIRCULATION, V116, P654, DOI 10.1161/CIRCULATIONAHA.106.672451; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; Karin N, 2010, J LEUKOCYTE BIOL, V88, P463, DOI 10.1189/jlb.0909602; Kofuku Y, 2009, J BIOL CHEM, V284, P35240, DOI 10.1074/jbc.M109.024851; Li MC, 2010, CELL REPROGRAM, V12, P405, DOI 10.1089/cell.2009.0088; Lyskov S, 2008, NUCLEIC ACIDS RES, V36, pW233, DOI 10.1093/nar/gkn216; Majetschak M, 2004, SURGERY, V135, P536, DOI 10.1016/j.surg.2003.09.006; Majetschak M, 2004, J TRAUMA, V56, P991, DOI 10.1097/01.TA.0000127770.29009.5A; Majetschak M, 2003, BLOOD, V101, P1882, DOI 10.1182/blood-2002-03-0918; Majetschak M, 2011, J LEUKOCYTE BIOL, V89, P205, DOI 10.1189/jlb.0510316; Malik R, 2010, MOL BIOL CELL, V21, P2529, DOI 10.1091/mbc.E10-02-0169; Meiron M, 2008, J EXP MED, V205, P2643, DOI 10.1084/jem.20080730; Nagasawa T, 1998, SEMIN IMMUNOL, V10, P179, DOI 10.1006/smim.1998.0128; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Saini V, 2011, J BIOL CHEM, V286, P33466, DOI 10.1074/jbc.M111.233742; Saini V, 2010, J BIOL CHEM, V285, P15566, DOI 10.1074/jbc.M110.103408; Shyu WC, 2008, J PHARMACOL EXP THER, V324, P834, DOI 10.1124/jpet.107.127746; Sloper-Mould KE, 2001, J BIOL CHEM, V276, P30483, DOI 10.1074/jbc.M103248200; Standfuss J, 2011, NATURE, V471, P656, DOI 10.1038/nature09795; Tachibana K, 1998, NATURE, V393, P591, DOI 10.1038/31261; Takada K, 1997, CLIN CHEM, V43, P1188; Teicher BA, 2010, CLIN CANCER RES, V16, P2927, DOI 10.1158/1078-0432.CCR-09-2329; Veldkamp CT, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1160755; Veldkamp CT, 2006, J MOL BIOL, V359, P1400, DOI 10.1016/j.jmb.2006.04.052; Veldkamp CT, 2010, J AM CHEM SOC, V132, P7242, DOI 10.1021/ja1002263; VIJAYKUMAR S, 1987, J MOL BIOL, V194, P531, DOI 10.1016/0022-2836(87)90679-6; Wang C, 2007, J MOL BIOL, V373, P503, DOI 10.1016/j.jmb.2007.07.050; Winget JM, 2010, MOL CELL, V38, P627, DOI 10.1016/j.molcel.2010.05.003; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Zaruba MM, 2010, EXPERT OPIN BIOL TH, V10, P321, DOI 10.1517/14712590903460286	49	30	31	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2011	286	51					44145	44152		10.1074/jbc.M111.298505	http://dx.doi.org/10.1074/jbc.M111.298505			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866SH	22039044	hybrid, Green Published			2022-12-27	WOS:000298402300055
J	Semplici, F; Vaxillaire, M; Fogarty, S; Semache, M; Bonnefond, A; Fontes, G; Philippe, J; Meur, G; Diraison, F; Sessions, RB; Rutter, J; Poitout, V; Froguel, P; Rutter, GA				Semplici, Francesca; Vaxillaire, Martine; Fogarty, Sarah; Semache, Meriem; Bonnefond, Amelie; Fontes, Ghislaine; Philippe, Julien; Meur, Gargi; Diraison, Frederique; Sessions, Richard B.; Rutter, Jared; Poitout, Vincent; Froguel, Philippe; Rutter, Guy A.			Human Mutation within Per-Arnt-Sim (PAS) Domain-containing Protein Kinase (PASK) Causes Basal Insulin Hypersecretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC BETA-CELLS; SERINE/THREONINE KINASE; GLUCAGON-SECRETION; GENE-EXPRESSION; HUMAN ISLETS; GLUCOSE; PHOSPHORYLATION; TRANSCRIPTION; INHIBITION; DEFICIENT	PAS kinase (PASK) is a glucose-regulated protein kinase involved in the control of pancreatic islet hormone release and insulin sensitivity. We aimed here to identify mutations in the PASK gene that may be associated with young-onset diabetes in humans. We screened 18 diabetic probands with unelucidated maturity-onset diabetes of the young (MODY). We identified two rare nonsynonymous mutations in the PASK gene (p.L1051V and p.G1117E), each of which was found in a single MODY family. Wild type or mutant PASKs were expressed in HEK 293 cells. Kinase activity of the affinity-purified proteins was assayed as autophosphorylation at amino acid Thr(307) or against an Ugp1p-derived peptide. Whereas the PASK p.G1117E mutant displayed a similar to 25% increase with respect to wild type PASK in the extent of autophosphorylation, and a similar to 2-fold increase in kinase activity toward exogenous substrates, the activity of the p.L1051V mutant was unchanged. Amino acid Gly(1117) is located in an alpha helical region opposing the active site of PASK and may elicit either: (a) a conformational change that increases catalytic efficiency or (b) a diminished inhibitory interaction with the PAS domain. Mouse islets were therefore infected with adenoviruses expressing wild type or mutant PASK and the regulation of insulin secretion was examined. PASK p.G1117E-infected islets displayed a 4-fold decrease in glucose-stimulated (16.7 versus 3 mM) insulin secretion, chiefly reflecting a 4.5-fold increase in insulin release at low glucose. In summary, we have characterized a rare mutation (p.G1117E) in the PASK gene from a young-onset diabetes family, which modulates glucose-stimulated insulin secretion.	[Rutter, Guy A.] Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Med, Sect Cell Biol,Div Diabet Endocrinol & Metab, London SW7 2AZ, England; [Froguel, Philippe] Univ London Imperial Coll Sci Technol & Med, Dept Genom Common Dis, Sch Publ Hlth, London SW7 2AZ, England; [Vaxillaire, Martine; Bonnefond, Amelie; Philippe, Julien; Froguel, Philippe] Pasteur Inst Lille, CNRS, UMR 8199, F-59019 Lille, France; [Vaxillaire, Martine; Bonnefond, Amelie; Philippe, Julien; Froguel, Philippe] Lille Nord France Univ, F-59019 Lille, France; [Fogarty, Sarah; Rutter, Jared] Univ Utah, Sch Med, Salt Lake City, UT 84132 USA; [Semache, Meriem; Fontes, Ghislaine] Univ Montreal, CRCHUM, Montreal Diabet Res Ctr, Quebec City, PQ, Canada; [Diraison, Frederique] Univ W England, Fac Hlth & Life Sci, Ctr Res Biomed, Bristol BS16 1QY, Avon, England; [Sessions, Richard B.] Univ Bristol, Dept Biochem, Sch Med Sci, Bristol BS8 1TD, Avon, England; [Poitout, Vincent] Univ Montreal, Dept Med, Montreal, PQ H1W 4A4, Canada	Imperial College London; Imperial College London; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Utah System of Higher Education; University of Utah; Universite de Montreal; University of West England; University of Bristol; Universite de Montreal	Rutter, GA (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Med, Sect Cell Biol,Div Diabet Endocrinol & Metab, London SW7 2AZ, England.	g.rutter@imperial.ac.uk	FROGUEL, Philippe/O-6799-2017; Philippe, Julien/R-5183-2019; Bonnefond, Amélie/O-2784-2017	FROGUEL, Philippe/0000-0003-2972-0784; Bonnefond, Amélie/0000-0001-9976-3005; Rutter, Guy/0000-0001-6360-0343; Sessions, Richard/0000-0003-0320-0895; Meur, Gargi/0000-0002-8466-2997; Poitout, Vincent/0000-0002-6555-5053; Philippe, Julien/0000-0003-1906-7259	National Institutes of Health [R01DK58096]; Wellcome Trust [081958/Z/07/Z]; European Community [FP7/2007-2013, 115005]; Servier IdS; French Agence Nationale de la Recherche [ANR-08-GENOPAT]; Contrat de Projets Etat-Region Nord-Pas-De-Calais [CPER 2007-2013]; Fonds de Recherche en Sante du Quebec; Royal Society; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058096, R01DK071962] Funding Source: NIH RePORTER; Medical Research Council [G0401641] Funding Source: researchfish; MRC [G0401641] Funding Source: UKRI	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome Trust); European Community(European Commission); Servier IdS; French Agence Nationale de la Recherche(French National Research Agency (ANR)); Contrat de Projets Etat-Region Nord-Pas-De-Calais(Region Hauts-de-France); Fonds de Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec); Royal Society(Royal Society of London); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported, in whole or in part, by National Institutes of Health Grant R01DK58096 (to V. P.), Wellcome Trust for Programme Grant 081958/Z/07/Z (to G. A. R.), European Community's Seventh Framework Programme Grant FP7/2007-2013 for the Innovative Medicine Initiative in Diabetes (IMIDIA) under agreement numbers 115005 and Servier IdS, French Agence Nationale de la Recherche Grant ANR-08-GENOPAT (to P. F. and M. V.) and the Contrat de Projets Etat-Region Nord-Pas-De-Calais Grant CPER 2007-2013 (to P. F. and M. V.).; Recipient of a doctoral studentship from the Fonds de Recherche en Sante du Quebec.; Recipient of a Royal Society Wolfson Research Merit Award. To whom correspondence should be addressed: Faculty of Medicine, Imperial College London, London SW7 2AZ, United Kingdom. Tel.: 44-20-759-43340; Fax: 44-20-579-433; E-mail: g.rutter@imperial.ac.uk.	Ainscow EK, 2000, DIABETES, V49, P1149, DOI 10.2337/diabetes.49.7.1149; Amezcua CA, 2002, STRUCTURE, V10, P1349, DOI 10.1016/S0969-2126(02)00857-2; Borter E, 2007, DIABETES, V56, P113, DOI 10.2337/db06-0798; Chevre JC, 1998, DIABETOLOGIA, V41, P1017, DOI 10.1007/s001250051025; DALE S, 1995, FEBS LETT, V361, P191, DOI 10.1016/0014-5793(95)00172-6; Diraison F, 2004, DIABETES, V53, pS84, DOI 10.2337/diabetes.53.suppl_3.S84; Diraison F, 2004, BIOCHEM J, V378, P769, DOI 10.1042/BJ20031277; Eckhardt K, 2007, CELL PHYSIOL BIOCHEM, V20, P227, DOI 10.1159/000104169; Evans-Molina C, 2007, DIABETES, V56, P827, DOI 10.2337/db06-1440; Fontes G, 2009, DIABETES, V58, P2048, DOI 10.2337/db08-0579; Frayling TM, 2003, DIABETES, V52, P872, DOI 10.2337/diabetes.52.3.872; Grose JH, 2009, CELL CYCLE, V8, P1824, DOI 10.4161/cc.8.12.8799; Hao HX, 2007, P NATL ACAD SCI USA, V104, P15466, DOI 10.1073/pnas.0705407104; Hofer T, 2001, BIOCHEM BIOPH RES CO, V288, P757, DOI 10.1006/bbrc.2001.5840; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Iype T, 2005, J BIOL CHEM, V280, P16798, DOI 10.1074/jbc.M414381200; Katschinski DM, 2003, MOL CELL BIOL, V23, P6780, DOI 10.1128/MCB.23.19.6780-6789.2003; Kharouta M, 2009, DIABETES RES CLIN PR, V85, P252, DOI 10.1016/j.diabres.2009.06.021; Kikani CK, 2010, J BIOL CHEM, V285, P41034, DOI 10.1074/jbc.M110.157594; Leclerc I, 2004, AM J PHYSIOL-ENDOC M, V286, pE1023, DOI 10.1152/ajpendo.00532.2003; Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135; Moglich A, 2009, STRUCTURE, V17, P1282, DOI 10.1016/j.str.2009.08.011; Mukai E, 2007, J CONTROL RELEASE, V119, P136, DOI 10.1016/j.jconrel.2007.01.012; Ravier MA, 2010, DIABETOLOGIA, V53, P1947, DOI 10.1007/s00125-010-1775-z; Ravier MA, 2005, DIABETES, V54, P1789, DOI 10.2337/diabetes.54.6.1789; Rozen S, 2000, Methods Mol Biol, V132, P365; Rutter J, 2001, P NATL ACAD SCI USA, V98, P8991, DOI 10.1073/pnas.161284798; Schlafli P, 2011, FEBS J, V278, P1757, DOI 10.1111/j.1742-4658.2011.08100.x; Smith TL, 2007, MOL CELL, V26, P491, DOI 10.1016/j.molcel.2007.03.025; Soliz J, 2008, AM J PHYSIOL-REG I, V295, pR649, DOI 10.1152/ajpregu.00876.2007; Sun G, 2010, DIABETOLOGIA, V53, P924, DOI 10.1007/s00125-010-1692-1; Vaxillaire M, 2008, ENDOCR REV, V29, P254, DOI 10.1210/er.2007-0024; Wilson WA, 2005, P NATL ACAD SCI USA, V102, P16596, DOI 10.1073/pnas.0508481102; Xavier GD, 2011, DIABETOLOGIA, V54, P819, DOI 10.1007/s00125-010-2010-7; XAVIER GD, 2004, P NATL ACAD SCI USA, V101, P8319	35	15	16	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2011	286	51					44005	44014		10.1074/jbc.M111.254995	http://dx.doi.org/10.1074/jbc.M111.254995			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866SH	22065581	hybrid, Green Published			2022-12-27	WOS:000298402300041
J	Helwig, M; Lee, SN; Hwang, JR; Ozawa, A; Medrano, JF; Lindberg, I				Helwig, Michael; Lee, Sang-Nam; Hwang, Jae Ryoung; Ozawa, Akihiko; Medrano, Juan F.; Lindberg, Iris			Dynamic Modulation of Prohormone Convertase 2 (PC2)-mediated Precursor Processing by 7B2 Protein PREFERENTIAL EFFECT ON GLUCAGON SYNTHESIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROOPIOMELANOCORTIN-DERIVED PEPTIDES; NULL MICE; NEUROENDOCRINE CELLS; ENZYMATIC-ACTIVITY; CT PEPTIDE; IN-VIVO; PC2; EXPRESSION; OVEREXPRESSION; BIOSYNTHESIS	The small neuroendocrine protein 7B2 is required for the production of active prohormone convertase 2 (PC2), an enzyme involved in the synthesis of peptide hormones, such as glucagon and proopiomelanocortin-derived alpha-melanocyte-stimulating hormone. However, whether 7B2 can dynamically modulate peptide production through regulation of PC2 activity remains unclear. Infection of the pancreatic alpha cell line alpha-TC6 with 7B2-encoding adenovirus efficiently increased production of glucagon, whereas siRNA-mediated knockdown of 7B2 significantly decreased stored glucagon. Furthermore, rescue of 7B2 expression in primary pituitary cultures prepared from 7B2 null mice restored melanocyte-stimulating hormone production, substantiating the role of 7B2 as a regulatory factor in peptide biosynthesis. In anterior pituitary and pancreatic beta cell lines, however, overexpression of 7B2 affected neither production nor secretion of peptides despite increased release of active PC2. In direct contrast, 7B2 overexpression decreased the secretion and increased the activity of PC2 within alpha-TC6 cells; the increased intracellular concentration of active PC2 within these cells may therefore account for the enhanced production of glucagon. In line with these findings, we found elevated circulating glucagon levels in 7B2-overexpressing cast/cast mice in vivo. Surprisingly, when proopiomelanocortin and proglucagon were co-expressed in either pituitary or pancreatic alpha cell lines, proglucagon processing was preferentially decreased when 7B2 was knocked down. Taken together, these results suggest that proglucagon cleavage has a greater dependence on PC2 activity than other precursors and moreover that 7B2-dependent routing of PC2 to secretory granules is cell line-specific. The manipulation of 7B2 could therefore represent an effective way to selectively regulate synthesis of certain PC2-dependent peptides.	[Lindberg, Iris] Univ Maryland, Dept Anat & Neurobiol, Baltimore, MD 21201 USA; [Lee, Sang-Nam] Yonsei Univ, Res Ctr Nat Human Def Syst, Coll Med, Seoul 120752, South Korea; [Hwang, Jae Ryoung] Sungkyunkwan Univ, Mol Therapy Res Ctr, Seoul 135710, South Korea; [Medrano, Juan F.] Univ Calif Davis, Dept Anim Sci, Davis, CA 95616 USA	University System of Maryland; University of Maryland Baltimore; Yonsei University; Yonsei University Health System; Sungkyunkwan University (SKKU); University of California System; University of California Davis	Lindberg, I (corresponding author), Univ Maryland, Dept Anat & Neurobiol, Bldg HSF 2,Rm S251,20 Penn St, Baltimore, MD 21201 USA.	ilind001@umaryland.edu	Lindberg, Iris/Q-3825-2019; Ozawa, Akihiko/U-4426-2019		National Institutes of Health [DK49703]; German Academy of Sciences Leopoldina Foundation [LPDS 2009-33]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK049703] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Academy of Sciences Leopoldina Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK49703 (to I. L.).; Supported by German Academy of Sciences Leopoldina Foundation Grant LPDS 2009-33.	Apletalina EV, 2000, BIOCHEM BIOPH RES CO, V267, P940, DOI 10.1006/bbrc.1999.2060; BENJANNET S, 1995, J NEUROCHEM, V64, P2303; Bouatia-Naji N, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-44; BRAKS JAM, 1994, CELL, V78, P263, DOI 10.1016/0092-8674(94)90296-8; Brunati AM, 2000, FEBS LETT, V471, P151, DOI 10.1016/S0014-5793(00)01378-8; Dion LD, 1996, J VIROL METHODS, V56, P99, DOI 10.1016/0166-0934(95)01973-1; Farber CR, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-34; Fortenberry Y, 1999, J NEUROCHEM, V73, P994, DOI 10.1046/j.1471-4159.1999.0730994.x; GUEST PC, 1992, J BIOL CHEM, V267, P22401; HSI KL, 1982, FEBS LETT, V147, P261, DOI 10.1016/0014-5793(82)81055-7; HUNTER WM, 1962, NATURE, V194, P495, DOI 10.1038/194495a0; Johanning K, 1996, J NEUROCHEM, V66, P898; Lanoue E, 2001, ENDOCRINOLOGY, V142, P4141, DOI 10.1210/en.142.9.4141; Laurent V, 2004, ENDOCRINOLOGY, V145, P519, DOI 10.1210/en.2003-0829; Laurent V, 2002, P NATL ACAD SCI USA, V99, P3087, DOI 10.1073/pnas.261715099; Lee SN, 2008, ENDOCRINOLOGY, V149, P4116, DOI 10.1210/en.2008-0064; Lee SN, 2007, BIOCHEM BIOPH RES CO, V355, P825, DOI 10.1016/j.bbrc.2007.02.034; MAINS RE, 2000, HDB PHYSL 7, V4, P85; Mbikay M, 2001, BIOCHEM J, V357, P329, DOI 10.1042/0264-6021:3570329; Meyre D, 2004, DIABETES, V53, P803, DOI 10.2337/diabetes.53.3.803; Muller L, 1997, J CELL BIOL, V139, P625, DOI 10.1083/jcb.139.3.625; Muller L, 2000, PROG NUCLEIC ACID RE, V63, P69, DOI 10.1016/S0079-6603(08)60720-5; PAQUET L, 1994, J BIOL CHEM, V269, P19279; Paquet L, 1996, MOL CELL ENDOCRINOL, V120, P161, DOI 10.1016/0303-7207(96)03834-8; ROUILLE Y, 1994, P NATL ACAD SCI USA, V91, P3242, DOI 10.1073/pnas.91.8.3242; Sarac MS, 2002, ENDOCRINOLOGY, V143, P2314, DOI 10.1210/en.143.6.2314; Sarac MS, 2002, ENDOCRINOLOGY, V143, P2324, DOI 10.1210/en.143.6.2324; SCHAUER E, 1994, J CLIN INVEST, V93, P2258, DOI 10.1172/JCI117224; Schmidt G, 2006, DIABETES, V55, P452, DOI 10.2337/diabetes.55.02.06.db05-0733; SEIDAH N, 1994, BIOCHIMIE, V76, P197, DOI 10.1016/0300-9084(94)90147-3; SEIDAH NG, 1994, METHOD ENZYMOL, V244, P171; Seidel B, 1998, DNA CELL BIOL, V17, P1017, DOI 10.1089/dna.1998.17.1017; SHEN FS, 1993, J BIOL CHEM, V268, P24910; Wang J, 2001, DIABETES, V50, P534, DOI 10.2337/diabetes.50.3.534; Westphal CH, 1999, CELL, V96, P689, DOI 10.1016/S0092-8674(00)80579-6; ZHOU A, 1994, J BIOL CHEM, V269, P17440; ZHU XR, 1995, J CELL BIOL, V129, P1641, DOI 10.1083/jcb.129.6.1641	37	9	10	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42504	42513		10.1074/jbc.M111.281980	http://dx.doi.org/10.1074/jbc.M111.281980			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	22013069	Green Published, hybrid			2022-12-27	WOS:000298180900058
J	Ma, KL; He, YH; Zhang, HY; Fei, Q; Niu, DD; Wang, DM; Ding, X; Xu, H; Chen, XP; Zhu, JD				Ma, Kelong; He, Yinghua; Zhang, Hongyu; Fei, Qi; Niu, Dandan; Wang, Dongmei; Ding, Xia; Xu, Hua; Chen, Xiaoping; Zhu, Jingde			DNA Methylation-regulated miR-193a-3p Dictates Resistance of Hepatocellular Carcinoma to 5-Fluorouracil via Repression of SRSF2 Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN CANCER-CELLS; THERAPY; CHEMORESISTANCE; APOPTOSIS; MICRORNA; METHYLTRANSFERASES; TRANSCRIPTOME; ESTABLISHMENT; ACTIVATION; BIOMARKERS	Chemoresistance prevents effective cancer therapy and is rarely predictable prior to treatment, particularly for hepatocellular carcinoma (HCC). Following the chemoresistance profiling of eight HCC cell lines to each of nine chemotherapeutics, two cell lines (QGY-7703 as a sensitive and SMMC-7721 as a resistant cell line to 5-fluorouracil (5-FU) treatment) were systematically studied for mechanistic insights underpinning HCC 5-FU chemoresistance. Genomic profiling at both DNA methylation and microRNA (miR) levels and subsequent mechanistic studies illustrate a new mechanism for how DNA methylation-regulated miR-193a-3p dictates the 5-FU resistance of HCC cells via repression of serine/arginine-rich splicing factor 2 (SRSF2) expression. In turn, SRSF2 preferentially up-regulates the proapoptotic splicing form of caspase 2 (CASP2L) and sensitizes HCC cells to 5-FU. Forced changes of miR-193a-3p level reverse all of the phenotypic features examined, including cell proliferation, cell cycle progression, and 5-FU sensitivity, in cell culture and in nude mice. Importantly, the siRNA-mediated repression of SRSF2 phenocopies all of the miR-193a-3p mimic-triggered changes in QGY-7703. This newly identified miR193a-3p-SRSF2 axis highlights a new set of companion diagnostics required for optimal 5-FU therapy of HCC, which involve assaying both the DNA methylation state of the miR-193a gene and the expression of miR-193a-3p and SRSF2 and the relative level of the proapoptotic versus antiapoptotic splicing forms of caspase 2 in clinical samples.	[Ma, Kelong; He, Yinghua; Zhang, Hongyu; Fei, Qi; Niu, Dandan; Zhu, Jingde] Shanghai Jiao Tong Univ, Shanghai Canc Inst, Renji Hosp, Canc Epigenet Program, Shanghai 200032, Peoples R China; [Ma, Kelong] Fudan Univ, Shanghai Med Coll, Shanghai 200032, Peoples R China; [Wang, Dongmei; Ding, Xia] Univ Sci & Technol China, Anhui Key Lab Cellular Dynam & Chem Biol, Hefei 230027, Peoples R China; [Xu, Hua; Chen, Xiaoping] Huazhong Univ Sci & Technol, Tongji Hosp, Dept Liver Surg, Wuhan 430074, Peoples R China; [Zhu, Jingde] Anhui Med Univ, Sch Life Sci, Ctr Basic & Translat Epigenet Res Dis, Hefei 230032, Peoples R China	Shanghai Jiao Tong University; Fudan University; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Huazhong University of Science & Technology; Anhui Medical University	Zhu, JD (corresponding author), Shanghai Jiao Tong Univ, Shanghai Canc Inst, Renji Hosp, Canc Epigenet Program, Shanghai 200032, Peoples R China.	jdzhu@sjtu.edu.cn			National Science Foundation [30921140312]; National Research Program for Basic Research [2009CB825606, 2009CB825607, 2010CB912802]; International Collaboration Grant [2009DFA31010]; China National Key Projects for Infectious Disease Grant [2008ZX10002-021]; Shanghai Science Foundation [09JC141300]	National Science Foundation(National Science Foundation (NSF)); National Research Program for Basic Research; International Collaboration Grant; China National Key Projects for Infectious Disease Grant; Shanghai Science Foundation	This work is supported by National Science Foundation Grant 30921140312 (to J. Z.), National Research Program for Basic Research Grants 2009CB825606, 2009CB825607, and 2010CB912802 (to J. Z.), and International Collaboration Grant 2009DFA31010 (to X. D.). This work was also supported by China National Key Projects for Infectious Disease Grant 2008ZX10002-021 (to D. W.), and Shanghai Science Foundation Grant 09JC141300.	Abou-Alfa GK, 2010, JAMA-J AM MED ASSOC, V304, P2154, DOI 10.1001/jama.2010.1672; Andrisano V, 2001, J CHROMATOGR B, V753, P375, DOI 10.1016/S0378-4347(00)00571-5; Barbour AP, 2003, CANCER RES, V63, P887; Benetti R, 2008, NAT STRUCT MOL BIOL, V15, P268, DOI 10.1038/nsmb.1399; Bonnette MD, 2009, DIAGN MOL PATHOL, V18, P165, DOI 10.1097/PDM.0b013e31818d34d1; Bourgo RJ, 2011, MOL BIOL CELL, V22, P931, DOI 10.1091/mbc.E10-11-0895; Brase JC, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-306; Brinkman AB, 2010, METHODS, V52, P232, DOI 10.1016/j.ymeth.2010.06.012; Chen T, 2006, CURR TOP MICROBIOL, V301, P179; Couzin J, 2009, SCIENCE, V323, P865, DOI 10.1126/science.323.5916.865a; Fabbri M, 2007, P NATL ACAD SCI USA, V104, P15805, DOI 10.1073/pnas.0707628104; Fabbri M, 2010, ADV GENET, V70, P87, DOI [10.1016/S0065-2660(10)70004-3, 10.1016/B978-0-12-380866-0.60004-6]; Field SJ, 1996, CELL, V85, P549, DOI 10.1016/S0092-8674(00)81255-6; Fontana L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002236; Hamburg MA, 2010, NEW ENGL J MED, V363, P301, DOI 10.1056/NEJMp1006304; HE L, 1984, IN VITRO CELL DEV B, V20, P493, DOI 10.1007/BF02619623; Ignath I, 2009, PANCREAS, V38, P921, DOI 10.1097/MPA.0b013e3181b65d34; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Jemal A, 2010, CANCER EPIDEM BIOMAR, V19, P1893, DOI 10.1158/1055-9965.EPI-10-0437; Kantar M, 2009, LEUKEMIA LYMPHOMA, V50, P912, DOI 10.1080/10428190902893819; Lachenmayer A, 2010, DIGEST LIVER DIS, V42, pS264, DOI 10.1016/S1590-8658(10)60515-4; Lencioni R, 2010, HEPATOLOGY, V52, P762, DOI 10.1002/hep.23725; Li YR, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000533; Lin Q, 2009, J CANCER RES CLIN, V135, P1675, DOI 10.1007/s00432-009-0614-4; Lujambio A, 2007, CANCER RES, V67, P1424, DOI 10.1158/0008-5472.CAN-06-4218; Maher CA, 2009, NATURE, V458, P97, DOI 10.1038/nature07638; Meenhuis A, 2011, BLOOD, V118, P916, DOI 10.1182/blood-2011-02-336487; Merdzhanova G, 2008, CELL DEATH DIFFER, V15, P1815, DOI 10.1038/cdd.2008.135; Noda T, 2009, BRIT J CANCER, V100, P1647, DOI 10.1038/sj.bjc.6605064; Orban TI, 2003, J CLIN PATHOL-MOL PA, V56, P191, DOI 10.1136/mp.56.4.191; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Piekielko-Witkowska A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013690; Saito Y, 2006, CANCER CELL, V9, P435, DOI 10.1016/j.ccr.2006.04.020; Salk JJ, 2010, ANNU REV PATHOL-MECH, V5, P51, DOI 10.1146/annurev-pathol-121808-102113; Schmitt CA, 2000, NAT MED, V6, P1029, DOI 10.1038/79542; Schwerk C, 2005, MOL CELL, V19, P1, DOI 10.1016/j.molcel.2005.05.026; Sharma A, 2009, CANCER BIOL THER, V8, P2106, DOI 10.4161/cbt.8.22.9687; Song B, 2009, ONCOGENE, V28, P4065, DOI 10.1038/onc.2009.274; Timmermann B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015661; Valeri N, 2010, P NATL ACAD SCI USA, V107, P21098, DOI 10.1073/pnas.1015541107; Villanueva A, 2010, ANNU REV MED, V61, P317, DOI 10.1146/annurev.med.080608.100623; Ward AJ, 2010, J PATHOL, V220, P152, DOI 10.1002/path.2649; WU JY, 1993, CELL, V75, P1061, DOI 10.1016/0092-8674(93)90316-I; Yang H, 2008, CANCER RES, V68, P425, DOI 10.1158/0008-5472.CAN-07-2488; Yoo BK, 2009, P NATL ACAD SCI USA, V106, P12938, DOI 10.1073/pnas.0901451106; Yoo BK, 2009, J CLIN INVEST, V119, P465, DOI 10.1172/JCI36460; Yu J, 2007, CLIN CANCER RES, V13, P7296, DOI 10.1158/1078-0432.CCR-07-0861	47	95	101	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5639	5649		10.1074/jbc.M111.291229	http://dx.doi.org/10.1074/jbc.M111.291229			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22117060	hybrid, Green Published			2022-12-27	WOS:000300638000041
J	Zaman, G; Sunters, A; Galea, GL; Javaheri, B; Saxon, LK; Moustafa, A; Armstrong, VJ; Price, JS; Lanyon, LE				Zaman, Gul; Sunters, Andrew; Galea, Gabriel L.; Javaheri, Behzad; Saxon, Leanne K.; Moustafa, Alaa; Armstrong, Victoria J.; Price, Joanna S.; Lanyon, Lance E.			Loading-related Regulation of Transcription Factor EGR2/Krox-20 in Bone Cells Is ERK1/2 Protein-mediated and Prostaglandin, Wnt Signaling Pathway-, and Insulin-like Growth Factor-I Axis-dependent	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESTROGEN-RECEPTOR-ALPHA; NITRIC-OXIDE SYNTHASE; EARLY GENE-EXPRESSION; MECHANICAL STRAIN; PARATHYROID-HORMONE; IGF-I; OSTEOBLAST PROLIFERATION; EXOGENOUS PROSTACYCLIN; FUNCTIONAL ADAPTATION; CANCELLOUS BONE	Of the 1,328 genes revealed by microarray to be differentially regulated by disuse, or at 8 h following a single short period of osteogenic loading of the mouse tibia, analysis by predicting associated transcription factors from annotated affinities revealed the transcription factor EGR2/Krox-20 as being more closely associated with more pathways and functions than any other. Real time quantitative PCR confirmed up-regulation of Egr2 mRNA expression by loading of the tibia in vivo. In vitro studies where strain was applied to primary cultures of mouse tibia-derived osteoblastic cells and the osteoblast UMR106 cell line also showed up-regulation of Egr2 mRNA expression. In UMR106 cells, inhibition of beta 1/beta 3 integrin function had no effect on strain-related Egr2 expression, but it was inhibited by a COX2-selective antagonist and imitated by exogenous prostaglandin E2 (PGE2). This response to PGE2 was mediated chiefly through the EP1 receptor and involved stimulation of PKC and attenuation by cAMP/PKA. Neither activators nor inhibitors of nitric oxide, estrogen signaling, or LiCl had any effect on Egr2 mRNA expression, but it was increased by both insulin-like growth factor-1 and high, but not low, dose parathyroid hormone and exogenous Wnt-3a. The increases by strain, PGE2, Wnt-3a, and phorbol 12-myristate 13-acetate were attenuated by inhibition of MEK-1. EGR2 appears to be involved in many of the signaling pathways that constitute early responses of bone cells to strain. These pathways all have multiple functions. Converting their strain-related responses into coherent "instructions" for adaptive (re)modeling is likely to depend upon their contextual activation, suppression, and interaction probably on more than one occasion.	[Zaman, Gul; Sunters, Andrew; Saxon, Leanne K.; Moustafa, Alaa; Armstrong, Victoria J.; Lanyon, Lance E.] Univ London Royal Vet Coll, Dept Vet Basic Sci, London NW1 0TU, England; [Galea, Gabriel L.; Price, Joanna S.] Univ Bristol, Dept Vet Clin Sci, Bristol BS40 5DU, Avon, England; [Javaheri, Behzad] Univ Missouri Kansas City, Sch Dent, Dept Oral Biol, Kansas City, MO 64108 USA	University of London; University of London Royal Veterinary College; University of Bristol; University of Missouri System; University of Missouri Kansas City	Zaman, G (corresponding author), Univ London Royal Vet Coll, Dept Vet Basic Sci, 32 Belgrave Sq, London NW1 0TU, England.	gzaman@rvc.ac.uk	Galea, Gabriel/I-9374-2019; Javaheri, Behzad/AAF-1784-2019; Javaheri, Behzad/L-5997-2018	Galea, Gabriel/0000-0003-2515-1342; Javaheri, Behzad/0000-0001-7941-3104; Javaheri, Behzad/0000-0001-7941-3104	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported in part by a program grant (to L. E. L. and J. S. P.) from the Wellcome Trust.	Aguirre JI, 2007, J BIOL CHEM, V282, P25501, DOI 10.1074/jbc.M702231200; Armstrong VJ, 2007, J BIOL CHEM, V282, P20715, DOI 10.1074/jbc.M703224200; Bakker AD, 2005, OSTEOPOROSIS INT, V16, P983, DOI 10.1007/s00198-004-1785-0; Baron R, 2006, CURR TOP DEV BIOL, V76, P103, DOI 10.1016/S0070-2153(06)76004-5; Bellido T, 2010, J CELL BIOCHEM, V111, P1, DOI 10.1002/jcb.22660; Bellone E, 1999, Hum Mutat, V14, P353, DOI 10.1002/(SICI)1098-1004(199910)14:4<353::AID-HUMU17>3.3.CO;2-W; Chambers TJ, 1999, OSTEOARTHR CARTILAGE, V7, P422, DOI 10.1053/joca.1998.0231; Cheng MZ, 1999, J BONE MINER RES, V14, P1742, DOI 10.1359/jbmr.1999.14.10.1742; CHENG MZ, 1994, J BONE MINER RES, V9, P805; Chow JWM, 1998, J BONE MINER RES, V13, P1039, DOI 10.1359/jbmr.1998.13.6.1039; Damien E, 1998, J BONE MINER RES, V13, P1275, DOI 10.1359/jbmr.1998.13.8.1275; Damien E, 2000, J BONE MINER RES, V15, P2169, DOI 10.1359/jbmr.2000.15.11.2169; Debiais F, 2003, JOINT BONE SPINE, V70, P465, DOI 10.1016/j.jbspin.2003.08.002; Forwood MR, 1996, J BONE MINER RES, V11, P1688; FROST HM, 1987, BONE MINER, V2, P73; Galea GL, 2011, FEBS LETT, V585, P2450, DOI 10.1016/j.febslet.2011.06.019; GASS P, 1995, J CEREBR BLOOD F MET, V15, P989, DOI 10.1038/jcbfm.1995.125; Grose R, 2002, DEV DYNAM, V223, P371, DOI 10.1002/dvdy.10064; Hara E, 1996, BIOCHEM BIOPH RES CO, V224, P153, DOI 10.1006/bbrc.1996.0999; Hirano S, 2000, AM J RESP CELL MOL, V23, P313, DOI 10.1165/ajrcmb.23.3.4112; Hirano S, 2002, IMMUNOLOGY, V107, P86, DOI 10.1046/j.1365-2567.2002.01487.x; Hynes RO, 1999, TRENDS CELL BIOL, V9, pM33, DOI 10.1016/S0962-8924(99)01667-0; Jessop HL, 2002, BONE, V31, P186, DOI 10.1016/S8756-3282(02)00797-4; Jilka RL, 2007, BONE, V40, P1434, DOI 10.1016/j.bone.2007.03.017; Kapur S, 2005, J BIOL CHEM, V280, P20163, DOI 10.1074/jbc.M501460200; Lau KHW, 2006, J BIOL CHEM, V281, P9576, DOI 10.1074/jbc.M509205200; LEAN JM, 1995, AM J PHYSIOL-ENDOC M, V268, pE318, DOI 10.1152/ajpendo.1995.268.2.E318; Leclerc N, 2004, J MOL ENDOCRINOL, V33, P175, DOI 10.1677/jme.0.0330175; Leclerc N, 2008, J CELL BIOCHEM, V103, P1938, DOI 10.1002/jcb.21587; Leclerc N, 2005, ARTHRITIS RHEUM-US, V52, P929, DOI 10.1002/art.20872; Levi G, 1996, DEVELOPMENT, V122, P113; Levi G, 1996, ANN NY ACAD SCI, V785, P288, DOI 10.1111/j.1749-6632.1996.tb56286.x; Li J, 2002, CALCIFIED TISSUE INT, V70, P320, DOI 10.1007/s00223-001-1025-y; Liedert A, 2010, BIOCHEM BIOPH RES CO, V394, P755, DOI 10.1016/j.bbrc.2010.03.065; Moustafa A, 2009, BONE, V44, P930, DOI 10.1016/j.bone.2008.12.026; Nonchev S, 1996, P NATL ACAD SCI USA, V93, P9339, DOI 10.1073/pnas.93.18.9339; Ott CE, 2009, J BONE MINER RES, V24, P1247, DOI [10.1359/JBMR.090206, 10.1359/jbmr.090206]; Pitsillides AA, 1995, FASEB J, V9, P1614, DOI 10.1096/fasebj.9.15.8529841; Plotkin LI, 2005, AM J PHYSIOL-CELL PH, V289, pC633, DOI 10.1152/ajpcell.00278.2004; Plow EF, 2000, J BIOL CHEM, V275, P21785, DOI 10.1074/jbc.R000003200; RAWLINSON SCF, 1993, CALCIFIED TISSUE INT, V53, P324, DOI 10.1007/BF01351837; Robling AG, 2008, J BIOL CHEM, V283, P5866, DOI 10.1074/jbc.M705092200; Roider HG, 2007, BIOINFORMATICS, V23, P134, DOI 10.1093/bioinformatics/btl565; Roider HG, 2009, BIOINFORMATICS, V25, P435, DOI 10.1093/bioinformatics/btn627; Roosa SMM, 2011, J BONE MINER RES, V26, P100, DOI 10.1002/jbmr.193; Sakata T, 2004, J BONE MINER RES, V19, P436, DOI 10.1359/JBMR.0301241; SCHNEIDERMAUNOURY S, 1993, CELL, V75, P1199, DOI 10.1016/0092-8674(93)90329-O; Sugiyama T, 2008, BONE, V43, P238, DOI 10.1016/j.bone.2008.04.012; Sugiyama T, 2010, ENDOCRINOLOGY, V151, P5582, DOI 10.1210/en.2010-0645; Sugiyama T, 2010, BONE, V46, P314, DOI 10.1016/j.bone.2009.08.054; Sunters A, 2010, J BIOL CHEM, V285, P8743, DOI 10.1074/jbc.M109.027086; Swarthout JT, 2002, GENE, V282, P1, DOI 10.1016/S0378-1119(01)00798-3; Visconti LA, 2004, ARCH ORAL BIOL, V49, P485, DOI 10.1016/j.archoralbio.2004.01.006; Walshe J, 2002, CURR BIOL, V12, P1117, DOI 10.1016/S0960-9822(02)00899-0; Warner LE, 1998, NAT GENET, V18, P382, DOI 10.1038/ng0498-382; WATSON P, 1995, BONE, V16, P357, DOI 10.1016/8756-3282(94)00051-4; Winkler DG, 2005, J BIOL CHEM, V280, P2498, DOI 10.1074/jbc.M400524200; Yoon JC, 2010, GENE DEV, V24, P1507, DOI 10.1101/gad.1924910; Zaman G, 1997, J BONE MINER RES, V12, P769, DOI 10.1359/jbmr.1997.12.5.769; Zaman G, 1999, J BONE MINER RES, V14, P1123, DOI 10.1359/jbmr.1999.14.7.1123; Zaman G, 2000, BONE, V27, P233, DOI 10.1016/S8756-3282(00)00324-0; Zaman G, 2006, J BONE MINER RES, V21, P1297, DOI 10.1359/JBMR.060504; Zaman G, 2010, BONE, V46, P628, DOI 10.1016/j.bone.2009.10.021; Zheng B, 1998, P NATL ACAD SCI USA, V95, P11217, DOI 10.1073/pnas.95.19.11217	64	29	30	0	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					3946	3962		10.1074/jbc.M111.252742	http://dx.doi.org/10.1074/jbc.M111.252742			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22049075	hybrid, Green Published			2022-12-27	WOS:000300410900030
J	Majka, J; Alford, B; Ausio, J; Finn, RM; McMurray, CT				Majka, Jerzy; Alford, Brian; Ausio, Juan; Finn, Ron M.; McMurray, Cynthia T.			ATP Hydrolysis by RAD50 Protein Switches MRE11 Enzyme from Endonuclease to Exonuclease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRAND BREAK REPAIR; DNA-DAMAGE RESPONSE; NUCLEASE ACTIVITY; COMPLEX; MRE11/RAD50; CHECKPOINT; DYNAMICS; BINDING; SAE2; CONFORMATIONS	MRE11-RAD50 is a key early response protein for processing DNA ends of broken chromosomes for repair, yet how RAD50 nucleotide dynamics regulate MRE11 nuclease activity is poorly understood. We report here that ATP binding and ATP hydrolysis cause a striking butterfly-like opening and closing of the RAD50 subunits, and each structural state has a dramatic functional effect on MRE11. RAD50-MRE11 has an extended conformation in solution when MRE11 is an active nuclease. However, ATP binding to RAD50 induces a closed conformation, and in this state MRE11 is an endonuclease. ATP hydrolysis opens the RAD50-MRE11 complex, and MRE11 maintains exonuclease activity. Thus, ATP hydrolysis is a molecular switch that converts MRE11 from an endonuclease to an exonuclease. We propose a testable model in which the open-closed transitions are used by RAD50-MRE11 to discriminate among DNA ends and drive the choice of recombination pathways.	[Majka, Jerzy; Alford, Brian; McMurray, Cynthia T.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA; [McMurray, Cynthia T.] Mayo Clin & Mayo Fdn, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN 55905 USA; [McMurray, Cynthia T.] Mayo Clin & Mayo Fdn, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Ausio, Juan; Finn, Ron M.] Univ Victoria, Dept Biochem, Victoria, BC V8W 3P6, Canada	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Mayo Clinic; Mayo Clinic; University of Victoria	McMurray, CT (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, 1 Cyclotron Rd, Berkeley, CA 94720 USA.	ctmcmurray@lbl.gov	Classen, Scott/AAY-8176-2020		National Institutes of Health [NS40738, GM066359, NS062384, NS060115, CA092584]; Mayo Foundation; NATIONAL CANCER INSTITUTE [P01CA092584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066359] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040738, R01NS062384, R01NS060115] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS40738, GM066359, NS062384, and NS060115, and CA092584 (all to C. T. M.). This work was also supported by the Mayo Foundation.	ALANI E, 1989, GENETICS, V122, P47; ALANI E, 1990, CELL, V61, P419, DOI 10.1016/0092-8674(90)90524-I; Buis J, 2008, CELL, V135, P85, DOI 10.1016/j.cell.2008.08.015; Cao WM, 2005, BIOPHYS J, V89, P1589, DOI 10.1529/biophysj.105.061135; Carson CT, 2009, EMBO J, V28, P652, DOI 10.1038/emboj.2009.15; Chen L, 2001, MOL CELL, V8, P1105, DOI 10.1016/S1097-2765(01)00388-4; Clerici M, 2008, EMBO REP, V9, P810, DOI 10.1038/embor.2008.121; Costanzo V, 2001, MOL CELL, V8, P137, DOI 10.1016/S1097-2765(01)00294-5; Demeler B, 2004, ANAL BIOCHEM, V335, P279, DOI 10.1016/j.ab.2004.08.039; Falck J, 2005, NATURE, V434, P605, DOI 10.1038/nature03442; Hirano T, 2005, PHILOS T R SOC B, V360, P507, DOI 10.1098/rstb.2004.1606; Hopfner KP, 2000, J BACTERIOL, V182, P6036, DOI 10.1128/JB.182.21.6036-6041.2000; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; Hopfner KP, 2001, CELL, V105, P473, DOI 10.1016/S0092-8674(01)00335-X; Huertas P, 2009, J BIOL CHEM, V284, P9558, DOI 10.1074/jbc.M808906200; Hura GL, 2009, NAT METHODS, V6, P606, DOI 10.1038/nmeth.1353; Kinoshita E, 2009, CHROMOSOME RES, V17, P277, DOI 10.1007/s10577-008-9018-6; Lammens K, 2011, CELL, V145, P54, DOI 10.1016/j.cell.2011.02.038; Lee SE, 1998, CELL, V94, P399, DOI 10.1016/S0092-8674(00)81482-8; Lengsfeld BM, 2007, MOL CELL, V28, P638, DOI 10.1016/j.molcel.2007.11.001; Lewis LK, 2004, GENETICS, V166, P1701, DOI 10.1534/genetics.166.4.1701; Lim HS, 2011, GENE DEV, V25, P1091, DOI 10.1101/gad.2037811; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Mantiero D, 2007, EMBO REP, V8, P380, DOI 10.1038/sj.embor.7400911; Mimitou EP, 2011, DNA REPAIR, V10, P344, DOI 10.1016/j.dnarep.2010.12.004; Mimitou EP, 2009, DNA REPAIR, V8, P983, DOI 10.1016/j.dnarep.2009.04.017; Mirzoeva OK, 2001, MOL CELL BIOL, V21, P281, DOI 10.1128/MCB.21.1.281-288.2001; Moncalian G, 2004, J MOL BIOL, V335, P937, DOI 10.1016/j.jmb.2003.11.026; Nairz K, 1997, GENE DEV, V11, P2272, DOI 10.1101/gad.11.17.2272; Nakada D, 2003, GENE DEV, V17, P1957, DOI 10.1101/gad.1099003; Nicolette ML, 2010, NAT STRUCT MOL BIOL, V17, P1478, DOI 10.1038/nsmb.1957; Olson E, 2007, J BIOL CHEM, V282, P22939, DOI 10.1074/jbc.M702162200; Owen BAL, 2005, NAT STRUCT MOL BIOL, V12, P663, DOI 10.1038/nsmb965; Owen BAL, 2009, NAT STRUCT MOL BIOL, V16, P550, DOI 10.1038/nsmb.1596; Palmbos PL, 2008, GENETICS, V180, P1809, DOI 10.1534/genetics.108.095539; Paull TT, 2010, DNA REPAIR, V9, P1283, DOI 10.1016/j.dnarep.2010.09.015; Paull TT, 1999, GENE DEV, V13, P1276, DOI 10.1101/gad.13.10.1276; Paull TT, 1998, MOL CELL, V1, P969, DOI 10.1016/S1097-2765(00)80097-0; Polo SE, 2011, GENE DEV, V25, P409, DOI 10.1101/gad.2021311; Putnam CD, 2007, Q REV BIOPHYS, V40, P191, DOI 10.1017/S0033583507004635; Rees DC, 2009, NAT REV MOL CELL BIO, V10, P218, DOI 10.1038/nrm2646; Schuck P, 2010, BIOPHYS J, V98, P2741, DOI 10.1016/j.bpj.2010.03.004; SHARPLES GJ, 1995, MOL MICROBIOL, V17, P1215, DOI 10.1111/j.1365-2958.1995.mmi_17061215_1.x; Shrivastav M, 2008, CELL RES, V18, P134, DOI 10.1038/cr.2007.111; Stracker TH, 2011, NAT REV MOL CELL BIO, V12, P90, DOI 10.1038/nrm3047; Sun YL, 2010, CELL CYCLE, V9, P930, DOI 10.4161/cc.9.5.10931; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Trenz K, 2006, EMBO J, V25, P1764, DOI 10.1038/sj.emboj.7601045; Trujillo KM, 2003, J BIOL CHEM, V278, P48957, DOI 10.1074/jbc.M309877200; Trujillo KM, 2001, J BIOL CHEM, V276, P35458, DOI 10.1074/jbc.M105482200; Wen Q, 2008, MOL BIOL CELL, V19, P1693, DOI 10.1091/mbc.E07-09-0975; Williams GJ, 2011, NAT STRUCT MOL BIOL, V18, P423, DOI 10.1038/nsmb.2038; Williams GJ, 2010, DNA REPAIR, V9, P1299, DOI 10.1016/j.dnarep.2010.10.001; Williams RS, 2008, CELL, V135, P97, DOI 10.1016/j.cell.2008.08.017; Williams RS, 2009, CELL, V139, P87, DOI 10.1016/j.cell.2009.07.033	55	30	31	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2328	2341		10.1074/jbc.M111.307041	http://dx.doi.org/10.1074/jbc.M111.307041			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22102415	Green Published, hybrid			2022-12-27	WOS:000300292300009
J	Punzo, C; Xiong, WJ; Cepko, CL				Punzo, Claudio; Xiong, Wenjun; Cepko, Constance L.			Loss of Daylight Vision in Retinal Degeneration: Are Oxidative Stress and Metabolic Dysregulation to Blame?	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							CONE CELL-DEATH; NEUROPROTECTIVE SURVIVAL SIGNAL; RESTORES VISUAL RESPONSES; PHOTORECEPTOR CELLS; GENE-THERAPY; RETINITIS-PIGMENTOSA; MICE LACKING; PHOSPHOINOSITIDE 3-KINASE; GLUTATHIONE-PEROXIDASE; INCREASED EXPRESSION	Retinitis pigmentosa is characterized by loss of night vision, followed by complete blindness. Over 40 genetic loci for retinitis pigmentosa have been identified in humans, primarily affecting photoreceptor structure and function. The availability of excellent animal models allows for a mechanistic characterization of the disease. Metabolic dysregulation and oxidative stress have been found to correlate with the loss of vision, particularly in cones, the type of photoreceptors that mediate daylight and color vision. The evidence that these problems actually cause loss of vision and potential therapeutic approaches targeting them are discussed.	[Xiong, Wenjun; Cepko, Constance L.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Genet, Boston, MA 02115 USA; [Xiong, Wenjun; Cepko, Constance L.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Ophthalmol, Boston, MA 02115 USA; [Punzo, Claudio] Univ Massachusetts, Sch Med, Dept Ophthalmol, Worcester, MA 01606 USA; [Punzo, Claudio] Univ Massachusetts, Sch Med, Gene Therapy Ctr, Worcester, MA 01606 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Cepko, CL (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Genet, Boston, MA 02115 USA.	cepko@genetics.med.harvard.edu	Punzo, Claudio/AAJ-8291-2021	Punzo, Claudio/0000-0001-5207-0041; XIONG, Wenjun/0000-0001-6836-2807	Foundation for Retinal Research; Thome Foundation; Howard Hughes Medical Institute; Foundation Fighting Blindness; University of Massachusetts	Foundation for Retinal Research; Thome Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Foundation Fighting Blindness(European Commission); University of Massachusetts	This work was supported by the Foundation for Retinal Research, the Thome Foundation, the Howard Hughes Medical Institute, and the Foundation Fighting Blindness (to C. L. C.) and by the University of Massachusetts (to C. P.). This is the fifth article in the Thematic Minireview Series on Focus on Vision.	Akeo K, 1999, PIGM CELL RES, V12, P107, DOI 10.1111/j.1600-0749.1999.tb00750.x; Altomare E, 1997, EUR J CLIN INVEST, V27, P141, DOI 10.1046/j.1365-2362.1997.780629.x; Ames A, 2000, BRAIN RES REV, V34, P42, DOI 10.1016/S0165-0173(00)00038-2; Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; Berson EL, 2008, ADV EXP MED BIOL, V613, P21, DOI 10.1007/978-0-387-74904-4_2; Bi AD, 2006, NEURON, V50, P23, DOI 10.1016/j.neuron.2006.02.026; Biel M, 1999, P NATL ACAD SCI USA, V96, P7553, DOI 10.1073/pnas.96.13.7553; BILL A, 1983, INT OPHTHALMOL, V6, P101, DOI 10.1007/BF00127638; BILL A, 1990, EYE, V4, P319, DOI 10.1038/eye.1990.43; Busskamp V, 2010, SCIENCE, V329, P413, DOI 10.1126/science.1190897; Cai X, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005290; CARTERDAWSON LD, 1978, INVEST OPHTH VIS SCI, V17, P489; Chadderton N, 2009, MOL THER, V17, P593, DOI 10.1038/mt.2008.301; Chen B, 2009, SCIENCE, V323, P256, DOI 10.1126/science.1166226; Chertov AO, 2011, J BIOL CHEM, V286, P34700, DOI 10.1074/jbc.M111.279752; Cronican JJ, 2011, CHEM BIOL, V18, P833, DOI 10.1016/j.chembiol.2011.07.003; DUDLEY PA, 1978, FEBS LETT, V95, P57, DOI 10.1016/0014-5793(78)80051-9; Finkel T, 2003, CURR OPIN CELL BIOL, V15, P247, DOI 10.1016/S0955-0674(03)00002-4; Fleisch VC, 2008, J NEUROSCI, V28, P8208, DOI 10.1523/JNEUROSCI.2367-08.2008; Fletcher EL, 2011, PROG MOL BIOL TRANSL, V100, P211, DOI 10.1016/B978-0-12-384878-9.00006-6; Guzman JN, 2010, NATURE, V468, P696, DOI 10.1038/nature09536; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Haruta M, 2009, P NATL ACAD SCI USA, V106, P9397, DOI 10.1073/pnas.0808940106; Hauswirth WW, 2000, CLIN CHEM LAB MED, V38, P147, DOI 10.1515/CCLM.2000.022; Hoang QV, 2002, VISUAL NEUROSCI, V19, P395, DOI 10.1017/S0952523802194028; Ivanova E, 2010, INVEST OPHTH VIS SCI, V51, P5288, DOI 10.1167/iovs.10-5389; Ivanova E, 2009, MOL VIS, V15, P1680; Ivanovic I, 2011, INVEST OPHTH VIS SCI, V52, P6355, DOI 10.1167/iovs.10-7138; Ivanovic I, 2011, INVEST OPHTH VIS SCI, V52, P3775, DOI 10.1167/iovs.10-7139; KAGAN VE, 1973, BIOCHIM BIOPHYS ACTA, V330, P76, DOI 10.1016/0005-2736(73)90285-X; Kevany BM, 2010, PHYSIOLOGY, V25, P8, DOI 10.1152/physiol.00038.2009; Kjellstrom S, 2007, INVEST OPHTH VIS SCI, V48, P3837, DOI 10.1167/iovs.07-0203; Koilkonda RD, 2010, ARCH OPHTHALMOL-CHIC, V128, P876, DOI 10.1001/archophthalmol.2010.135; Komeima K, 2007, J CELL PHYSIOL, V213, P809, DOI 10.1002/jcp.21152; Komeima K, 2006, P NATL ACAD SCI USA, V103, P11300, DOI 10.1073/pnas.0604056103; Lagali PS, 2008, NAT NEUROSCI, V11, P667, DOI 10.1038/nn.2117; LaVail MM, 2000, P NATL ACAD SCI USA, V97, P11488, DOI 10.1073/pnas.210319397; LaVail MM, 1998, INVEST OPHTH VIS SCI, V39, P592; Lem J, 1999, P NATL ACAD SCI USA, V96, P736, DOI 10.1073/pnas.96.2.736; Leveillard T, 2004, NAT GENET, V36, P755, DOI 10.1038/ng1386; Lewin AS, 1998, NAT MED, V4, P967, DOI 10.1038/nm0898-967; LEWIS A, 1978, P NATL ACAD SCI USA, V75, P549, DOI 10.1073/pnas.75.2.549; Li GY, 2007, J NEUROSCI, V27, P203, DOI 10.1523/JNEUROSCI.0445-06.2007; Li QH, 2008, VISION RES, V48, P332, DOI 10.1016/j.visres.2007.07.026; Lin B, 2008, P NATL ACAD SCI USA, V105, P16009, DOI 10.1073/pnas.0806114105; Lin B, 2009, EXP EYE RES, V88, P589, DOI 10.1016/j.exer.2008.11.022; LISMAN JE, 1977, J GEN PHYSIOL, V70, P621, DOI 10.1085/jgp.70.5.621; Locker M, 2010, ARCH ITAL BIOL, V148, P59; Lu LL, 2009, ANTIOXID REDOX SIGN, V11, P715, DOI [10.1089/ars.2008.2171, 10.1089/ARS.2008.2171]; Ma JX, 1998, BBA-GENE STRUCT EXPR, V1443, P255, DOI 10.1016/S0167-4781(98)00221-8; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Marchetti V, 2010, J CLIN INVEST, V120, P3012, DOI 10.1172/JCI42951; Mata NL, 2002, NEURON, V36, P69, DOI 10.1016/S0896-6273(02)00912-1; Milam AH, 1998, PROG RETIN EYE RES, V17, P175; Miyazono S, 2008, P NATL ACAD SCI USA, V105, P16051, DOI 10.1073/pnas.0806593105; Oguni M, 1996, HISTOL HISTOPATHOL, V11, P695; Okawa H, 2008, CURR BIOL, V18, P1917, DOI 10.1016/j.cub.2008.10.029; Palfi A, 2010, HUM GENE THER, V21, P311, DOI 10.1089/hum.2009.119; Pang JJ, 2008, INVEST OPHTH VIS SCI, V49, P4278, DOI 10.1167/iovs.07-1622; Pang JJ, 2011, MOL THER, V19, P234, DOI 10.1038/mt.2010.273; Park TK, 2009, GENE THER, V16, P916, DOI 10.1038/gt.2009.61; Pawlyk BS, 2005, INVEST OPHTH VIS SCI, V46, P3039, DOI 10.1167/iovs.05-0371; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; Perkins GA, 2003, MOL VIS, V9, P60; POITRYYAMATE CL, 1995, J NEUROSCI, V15, P5179; Punzo C, 2009, NAT NEUROSCI, V12, P44, DOI 10.1038/nn.2234; Qi XP, 2007, INVEST OPHTH VIS SCI, V48, P5360, DOI 10.1167/iovs.07-0254; Rajala A, 2008, J BIOL CHEM, V283, P19781, DOI 10.1074/jbc.M802374200; Rajala RVS, 2010, MOL NEUROBIOL, V42, P39, DOI 10.1007/s12035-010-8130-8; Rajala RVS, 2010, J BIOL CHEM, V285, P8894, DOI 10.1074/jbc.M109.070854; Raz-Prag D, 2009, INVEST OPHTH VIS SCI, V50, P3897, DOI 10.1167/iovs.08-3153; Read SP, 2010, MOL THER, V18, P1917, DOI 10.1038/mt.2010.167; Redmond TM, 1998, NAT GENET, V20, P344, DOI 10.1038/3813; Ripps H, 2002, EXP EYE RES, V74, P327, DOI 10.1006/exer.2002.1155; Rodieck R.W., 1998, 1 STEPS SEEING; Schapira AHV, 2008, NEUROCHEM RES, V33, P2502, DOI 10.1007/s11064-008-9855-x; Schlichtenbrede FC, 2003, GENE THER, V10, P523, DOI 10.1038/sj.gt.3301929; SCOTT BL, 1988, J NEUROSCI RES, V20, P202, DOI 10.1002/jnr.490200209; Shen JK, 2005, J CELL PHYSIOL, V203, P457, DOI 10.1002/jcp.20346; Sparrow JR, 2005, EXP EYE RES, V80, P595, DOI 10.1016/j.exer.2005.01.007; Stearns G, 2007, J NEUROSCI, V27, P13866, DOI 10.1523/JNEUROSCI.3136-07.2007; Suzuki A, 2011, CELL, V144, P810, DOI 10.1016/j.cell.2011.02.018; Usui S, 2011, FREE RADICAL BIO MED, V51, P1347, DOI 10.1016/j.freeradbiomed.2011.06.010; Usui S, 2009, MOL THER, V17, P778, DOI 10.1038/mt.2009.47; Usui S, 2009, J NEUROCHEM, V110, P1028, DOI 10.1111/j.1471-4159.2009.06195.x; Wallace VA, 2011, STEM CELLS, V29, P412, DOI 10.1002/stem.602; Wenzel A, 2005, PROG RETIN EYE RES, V24, P275, DOI 10.1016/j.preteyeres.2004.08.002; Winkler BS, 2008, INVEST OPHTH VIS SCI, V49, P3259, DOI 10.1167/iovs.08-1785; Wolf G, 2004, NUTR REV, V62, P283; Wright AF, 2010, NAT REV GENET, V11, P273, DOI 10.1038/nrg2717; Wyss MT, 2011, J NEUROSCI, V31, P7477, DOI 10.1523/JNEUROSCI.0415-11.2011; Yang RB, 1999, J NEUROSCI, V19, P5889, DOI 10.1523/JNEUROSCI.19-14-05889.1999; Yang Y, 2009, MOL THER, V17, P787, DOI 10.1038/mt.2009.28; Yao JY, 2011, INVEST OPHTH VIS SCI, V52, P1567, DOI 10.1167/iovs.10-5998; YOUNG RW, 1967, J CELL BIOL, V33, P61, DOI 10.1083/jcb.33.1.61; Yu DY, 2000, INVEST OPHTH VIS SCI, V41, P3999; Yu DY, 2004, INVEST OPHTH VIS SCI, V45, P2013, DOI 10.1167/iovs.03-0845; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025; Zou JH, 2011, INVEST OPHTH VIS SCI, V52, P2343, DOI 10.1167/iovs.10-6141	99	125	130	1	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2012	287	3					1642	1648		10.1074/jbc.R111.304428	http://dx.doi.org/10.1074/jbc.R111.304428			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879HT	22074929	hybrid, Green Published			2022-12-27	WOS:000299321000006
J	Cabart, P; Luse, DS				Cabart, Pavel; Luse, Donal S.			Inactivated RNA Polymerase II Open Complexes Can Be Reactivated with TFIIE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR IIE; PREINITIATION COMPLEX; PROMOTER ESCAPE; BASAL TRANSCRIPTION; SACCHAROMYCES-CEREVISIAE; XERODERMA-PIGMENTOSUM; MINIMAL SET; INITIATION; DNA; ELONGATION	Transcript initiation by RNA polymerase II (pol II) requires a helicase within TFIIH to generate the unpaired template strand. However, pol II preinitiation complexes (PICs) lose the ability to synthesize RNA very rapidly upon exposure to ATP alone in the absence of other NTPs. This inactivation is not caused by the TFIIH kinase activity, the loss of transcription factors or pol II from the PIC, or the collapse of the initially formed transcription bubble. TFIIE is necessary for PIC formation, but TFIIE is not retained as a stable component in PICs prepared by our protocol. Nevertheless, activity can be at least partially restored to ATP-treated PICs by the readdition of TFIIE. PICs formed on premelted (bubble) templates require TFIIH for effective transcript elongation to +20. Incubation of bubble template PICs with ATP caused reduced yields of 20-mers, but this effect was partially reversed by the addition of TFIIE. Our results suggest that once the open complex is formed, TFIIH decays into an inactive configuration in the absence of nucleotides for transcription. Although TFIIE does not play a role in transcript initiation itself, inactivation resulting from ATP preincubation can be reversed by a remodeling process mediated by TFIIE. Finally, we have also uncovered a major role for TFIIF in the earliest stages of transcript elongation that is unique to bubble templates.	[Cabart, Pavel; Luse, Donal S.] Cleveland Clin, Dept Mol Genet, Lerner Res Inst, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Luse, DS (corresponding author), Cleveland Clin, Dept Mol Genet, Lerner Res Inst, 9500 Euclid Ave,NE20, Cleveland, OH 44195 USA.	lused@ccf.org		Cabart, Pavel/0000-0003-0065-367X	National Institutes of Health, NIGMS, Public Health Service [GM 29487]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029487] Funding Source: NIH RePORTER	National Institutes of Health, NIGMS, Public Health Service; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health, NIGMS, Public Health Service Grant GM 29487 (to D. S. L.).	Bradsher J, 2000, J BIOL CHEM, V275, P2532, DOI 10.1074/jbc.275.4.2532; Bushnell DA, 1996, J BIOL CHEM, V271, P20170, DOI 10.1074/jbc.271.33.20170; Cabart P, 2011, P NATL ACAD SCI USA, V108, P15786, DOI 10.1073/pnas.1104591108; Chen HT, 2007, NAT STRUCT MOL BIOL, V14, P696, DOI 10.1038/nsmb1272; Coin F, 1999, EMBO J, V18, P1357, DOI 10.1093/emboj/18.5.1357; Di Lello P, 2008, P NATL ACAD SCI USA, V105, P106, DOI 10.1073/pnas.0707892105; Dvir A, 1996, J BIOL CHEM, V271, P7245, DOI 10.1074/jbc.271.13.7245; Forget D, 2004, MOL CELL BIOL, V24, P1122, DOI 10.1128/MCB.24.3.1122-1131.2004; Grohmann D, 2011, MOL CELL, V43, P263, DOI 10.1016/j.molcel.2011.05.030; Hahn S, 2004, NAT STRUCT MOL BIOL, V11, P394, DOI 10.1038/nsmb763; Holstege FCP, 1997, EMBO J, V16, P7468, DOI 10.1093/emboj/16.24.7468; HOLSTEGE FCP, 1995, EMBO J, V14, P810, DOI 10.1002/j.1460-2075.1995.tb07059.x; Juven-Gershon T, 2008, CURR OPIN CELL BIOL, V20, P253, DOI 10.1016/j.ceb.2008.03.003; Khaperskyy DA, 2008, MOL CELL BIOL, V28, P3757, DOI 10.1128/MCB.02272-07; Kim TK, 2000, SCIENCE, V288, P1418, DOI 10.1126/science.288.5470.1418; Klein BJ, 2011, P NATL ACAD SCI USA, V108, P546, DOI 10.1073/pnas.1013828108; LI Y, 1994, SCIENCE, V263, P805, DOI 10.1126/science.8303296; Liu JH, 2001, CELL, V104, P353, DOI 10.1016/S0092-8674(01)00223-9; LUSE DS, 1987, J BIOL CHEM, V262, P289; Maldonado E, 1996, METHOD ENZYMOL, V274, P72; Martinez-Rucobo FW, 2011, EMBO J, V30, P1302, DOI 10.1038/emboj.2011.64; MAXON ME, 1994, GENE DEV, V8, P515, DOI 10.1101/gad.8.5.515; Miller G, 2006, NAT STRUCT MOL BIOL, V13, P603, DOI 10.1038/nsmb1117; Moreland RJ, 1999, J BIOL CHEM, V274, P22127, DOI 10.1074/jbc.274.32.22127; OHKUMA Y, 1995, MOL CELL BIOL, V15, P4856; Pal M, 2005, MOL CELL, V19, P101, DOI 10.1016/j.molcel.2005.05.024; Pal M, 2003, P NATL ACAD SCI USA, V100, P5700, DOI 10.1073/pnas.1037057100; PAN GH, 1994, J BIOL CHEM, V269, P30101; PARVIN JD, 1994, J BIOL CHEM, V269, P18414; PARVIN JD, 1993, CELL, V73, P533, DOI 10.1016/0092-8674(93)90140-L; Sakurai H, 1997, J BIOL CHEM, V272, P15936, DOI 10.1074/jbc.272.25.15936; Sakurai H, 2003, GENES CELLS, V8, P41, DOI 10.1046/j.1365-2443.2003.00613.x; SCHAEFFER L, 1993, SCIENCE, V260, P58, DOI 10.1126/science.8465201; SERIZAWA H, 1993, J BIOL CHEM, V268, P17300; TIMMERS HTM, 1994, EMBO J, V13, P391, DOI 10.1002/j.1460-2075.1994.tb06273.x; Tirode F, 1999, MOL CELL, V3, P87, DOI 10.1016/S1097-2765(00)80177-X; Ujvari A, 2006, NAT STRUCT MOL BIOL, V13, P49, DOI 10.1038/nsmb1026; Ujvari A, 2011, J BIOL CHEM, V286, P23160, DOI 10.1074/jbc.M110.205658; Wang XX, 2003, J BIOL CHEM, V278, P10250, DOI 10.1074/jbc.M210848200; Yan M, 1997, EMBO J, V16, P7457, DOI 10.1093/emboj/16.24.7457; Yan Q, 1999, J BIOL CHEM, V274, P35668, DOI 10.1074/jbc.274.50.35668; Zanton SJ, 2006, GENE DEV, V20, P2250, DOI 10.1101/gad.1437506	42	11	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					961	967		10.1074/jbc.M111.297572	http://dx.doi.org/10.1074/jbc.M111.297572			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22119917	Green Published, hybrid			2022-12-27	WOS:000299170300014
J	Peterson, JM; Aja, S; Wei, ZK; Wong, GW				Peterson, Jonathan M.; Aja, Susan; Wei, Zhikui; Wong, G. William			CTRP1 Protein Enhances Fatty Acid Oxidation via AMP-activated Protein Kinase (AMPK) Activation and Acetyl-CoA Carboxylase (ACC) Inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARNITINE PALMITOYLTRANSFERASE-I; CONSERVED LYSINE RESIDUES; MICE LACKING ADIPONECTIN; C1Q/TNF FAMILY-MEMBERS; INSULIN-RESISTANCE; ADIPOSE-TISSUE; T-CADHERIN; COLLAGENOUS DOMAIN; GLUCOSE-METABOLISM; MALONYL-COA	We previously described the adipokine CTRP1, which has up-regulated expression following exposure to the anti-diabetic drug rosiglitazone and increased circulating levels in adiponectin-null mice (Wong, G. W., Krawczyk, S. A., Kitidis-Mitrokostas, C., Revett, T., Gimeno, R., and Lodish, H. F. (2008) Biochem. J. 416, 161-177). Although recombinant CTRP1 lowers blood glucose in mice, its physiological function, mechanisms of action, and roles in metabolic stress remain unknown. Here, we show that circulating levels of CTRP1 are strikingly reduced in diet-induced obese mice. Overexpressing CTRP1 in transgenic mice improved insulin sensitivity and decreased high-fat diet-induced weight gain. Reduced adiposity resulted from enhanced fatty acid oxidation and energy expenditure, effects mediated by AMP-activated protein kinase (AMPK). In skeletal muscle of transgenic mice, AMPK alpha and its downstream target, acetyl-CoA carboxylase (ACC), were hyperphosphorylated, indicative of AMPK activation and ACC inhibition. Inactivation of ACC promotes mitochondrial fat oxidation. Consistent with the direct effect of CTRP1 on AMPK signaling, recombinant CTRP1 administration acutely stimulated muscle AMPK alpha and ACC phosphorylation in vivo. In isolated soleus muscle, recombinant CTRP1 activated AMPK signaling to increase fatty acid oxidation ex vivo, an effect abrogated by an AMPK inhibitor. These results provide the first in vivo evidence that CTRP1 is a novel regulator of fatty acid metabolism.	[Peterson, Jonathan M.; Wei, Zhikui; Wong, G. William] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; [Aja, Susan] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Peterson, Jonathan M.; Aja, Susan; Wei, Zhikui; Wong, G. William] Johns Hopkins Univ, Sch Med, Ctr Metab & Obes Res, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Wong, GW (corresponding author), Johns Hopkins Univ, Sch Med, Dept Physiol, 855 N Wolfe St, Baltimore, MD 21205 USA.	gwwong@jhmi.edu	Peterson, Jonathan M./H-3122-2019	Peterson, Jonathan M./0000-0002-9873-3880; Wei, Zhikui/0000-0002-2311-9800; Wong, G. William/0000-0002-5286-6506	National Institutes of Health [DK084171]; American Heart Association [SDG2260721, PRE3790034]; Baltimore Diabetes Research and Training Center (DRTC) [P60DK079637]; National Institutes of Health National Research Service [F32DK084607]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK084607, R01DK084171, P30DK079637, P60DK079637] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Baltimore Diabetes Research and Training Center (DRTC); National Institutes of Health National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK084171 (to G.W.W.). This work was also supported in part by American Heart Association Grant SDG2260721 and Baltimore Diabetes Research and Training Center (DRTC) Grant P60DK079637.; Supported by National Institutes of Health National Research Service Award F32DK084607.; Supported by American Heart Association Fellowship PRE3790034.	Arita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.0255; Awazawa M, 2011, CELL METAB, V13, P401, DOI 10.1016/j.cmet.2011.02.010; Davis Kathryn E, 2008, Biochem J, V416, pe7, DOI 10.1042/BJ20082033; Deng YF, 2010, ANN NY ACAD SCI, V1212, pE1, DOI 10.1111/j.1749-6632.2010.05875.x; Denzel MS, 2010, J CLIN INVEST, V120, P4342, DOI 10.1172/JCI43464; Fruebis J, 2001, P NATL ACAD SCI USA, V98, P2005, DOI 10.1073/pnas.041591798; HA J, 1994, J BIOL CHEM, V269, P22162; Hebbard LW, 2008, CANCER RES, V68, P1407, DOI 10.1158/0008-5472.CAN-07-2953; Hug C, 2004, P NATL ACAD SCI USA, V101, P10308, DOI 10.1073/pnas.0403382101; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kaushik VK, 2001, AM J PHYSIOL-ENDOC M, V281, pE335, DOI 10.1152/ajpendo.2001.281.2.E335; Kishore U, 2004, TRENDS IMMUNOL, V25, P551, DOI 10.1016/j.it.2004.08.006; Kubota N, 2006, J BIOL CHEM, V281, P8748, DOI 10.1074/jbc.M505649200; Kubota N, 2002, J BIOL CHEM, V277, P25863, DOI 10.1074/jbc.C200251200; Kubota N, 2007, CELL METAB, V6, P55, DOI 10.1016/j.cmet.2007.06.003; Lusk G, 1928, ELEMENTS SCI NUTR; Ma K, 2002, J BIOL CHEM, V277, P34658, DOI 10.1074/jbc.C200362200; Maeda N, 2002, NAT MED, V8, P731, DOI 10.1038/nm724; MCGARRY JD, 1995, BIOCHEM SOC T, V23, P481, DOI 10.1042/bst0230481; MCGARRY JD, 1978, J BIOL CHEM, V253, P4128; Merrill GF, 1997, AM J PHYSIOL-ENDOC M, V273, pE1107, DOI 10.1152/ajpendo.1997.273.6.E1107; Montague CT, 1997, NATURE, V387, P903, DOI 10.1038/43185; Nawrocki AR, 2006, J BIOL CHEM, V281, P2654, DOI 10.1074/jbc.M505311200; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Oakhill JS, 2011, SCIENCE, V332, P1433, DOI 10.1126/science.1200094; Peterson JM, 2010, J BIOL CHEM, V285, P39691, DOI 10.1074/jbc.M110.180695; Peterson JM, 2009, BIOCHEM BIOPH RES CO, V388, P360, DOI 10.1016/j.bbrc.2009.08.014; Qi Y, 2004, NAT MED, V10, P524, DOI 10.1038/nm1029; Scherer PE, 2006, DIABETES, V55, P1537, DOI 10.2337/db06-0263; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Spranger J, 2006, DIABETES, V55, P141, DOI 10.2337/diabetes.55.1.141; Stein SC, 2000, BIOCHEM J, V345, P437, DOI 10.1042/0264-6021:3450437; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; SULLIVAN JE, 1994, FEBS LETT, V353, P33, DOI 10.1016/0014-5793(94)01006-4; Tang YT, 2005, J MOL EVOL, V61, P372, DOI 10.1007/s00239-004-0375-2; Tang YT, 2005, GENOMICS, V86, P100, DOI 10.1016/j.ygeno.2005.03.001; Tartaglia LA, 1995, CELL, V83, P1263, DOI 10.1016/0092-8674(95)90151-5; Tomas E, 2002, P NATL ACAD SCI USA, V99, P16309, DOI 10.1073/pnas.222657499; Wang Y, 2002, J BIOL CHEM, V277, P19521, DOI 10.1074/jbc.M200601200; Wang Y, 2006, J BIOL CHEM, V281, P16391, DOI 10.1074/jbc.M513907200; Wei ZK, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.201087; WIGLER M, 1977, CELL, V11, P223, DOI 10.1016/0092-8674(77)90333-6; Wong GW, 2009, FASEB J, V23, P241, DOI 10.1096/fj.08-114991; Wong GW, 2008, BIOCHEM J, V416, P161, DOI 10.1042/BJ20081240; Wong GW, 2004, P NATL ACAD SCI USA, V101, P10302, DOI 10.1073/pnas.0403760101; Yamauchi T, 2008, INT J OBESITY, V32, pS13, DOI 10.1038/ijo.2008.233; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yamauchi T, 2007, NAT MED, V13, P332, DOI 10.1038/nm1557; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711; Yano W, 2008, ENDOCR J, V55, P515, DOI 10.1507/endocrj.K08E-093; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI13505; Zierler K, 1999, AM J PHYSIOL-ENDOC M, V276, pE409, DOI 10.1152/ajpendo.1999.276.3.E409	55	121	127	3	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					1576	1587		10.1074/jbc.M111.278333	http://dx.doi.org/10.1074/jbc.M111.278333			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22086915	hybrid, Green Published			2022-12-27	WOS:000299170300071
J	Xu, XJ; Yasuda, M; Nakamura-Tsuruta, S; Mizuno, M; Ashida, H				Xu, Xiaojuan; Yasuda, Michiko; Nakamura-Tsuruta, Sachiko; Mizuno, Masashi; Ashida, Hitoshi			beta-Glucan from Lentinus edodes Inhibits Nitric Oxide and Tumor Necrosis Factor-alpha Production and Phosphorylation of Mitogen-activated Protein Kinases in Lipopolysaccharide-stimulated Murine RAW 264.7 Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; INTERFERON-GAMMA; INOS GENE; PERITONEAL-MACROPHAGES; CYTOKINE INDUCTION; SYNTHASE; EXPRESSION; DECTIN-1; RECOGNITION; DEXAMETHASONE	Lentinan (LNT), a beta-glucan from the fruiting bodies of Lentinus edodes, is well known to have immunomodulatory activity. NO and TNF-alpha are associated with many inflammatory diseases. In this study, we investigated the effects of LNT extracted by sonication (LNT-S) on the NO and TNF-alpha production in LPS-stimulated murine RAW 264.7 macrophages. The results suggested that treatment with LNT-S not only resulted in the striking inhibition of TNF-alpha and NO production in LPS-activated macrophage RAW 264.7 cells, but also the protein expression of inducible NOS (iNOS) and the gene expression of iNOS mRNA and TNF-alpha mRNA. It is surprising that LNT-S enhanced LPS-induced NF-kappa B p65 nuclear translocation and NF-kappa B luciferase activity, but severely inhibited the phosphorylation of JNK1/2 and ERK1/2. The neutralizing antibodies of anti-Dectin-1 and anti-TLR2 hardly affected the inhibition of NO production. All of these results suggested that the suppression of LPS-induced NO and TNF-alpha production was at least partially attributable to the inhibition of JNK1/2 and ERK1/2 activation. This work discovered a promising molecule to control the diseases associated with overproduction of NO and TNF-alpha.	[Xu, Xiaojuan] Wuhan Univ, Dept Chem, Wuhan 430072, Peoples R China; [Yasuda, Michiko; Nakamura-Tsuruta, Sachiko] Kobe Univ, Org Adv Sci & Technol, Nada Ku, Kobe, Hyogo 6578501, Japan; [Xu, Xiaojuan; Mizuno, Masashi; Ashida, Hitoshi] Kobe Univ, Grad Sch Agr Sci, Dept Agrobiosci, Nada Ku, Kobe, Hyogo 6578501, Japan	Wuhan University; Kobe University; Kobe University	Xu, XJ (corresponding author), Wuhan Univ, Dept Chem, Wuhan 430072, Peoples R China.	xuxj626@263.net; ashida@kobe-u.ac.jp		Xu, Xiaojuan/0000-0002-1404-5088; Yasuda, Michiko/0000-0002-8984-6138	Japan Society for the Promotion of Science [20.08431]; National Natural Science Foundation [20874078]; Youth Technology Chenguang Project of Wuhan [200950431193]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Youth Technology Chenguang Project of Wuhan	This work was supported by Japan Society for the Promotion of Science Postdoctoral Fellowship 20.08431 (to X. X.), National Natural Science Foundation Grant 20874078, and Youth Technology Chenguang Project of Wuhan 200950431193.	ABEL G, 1989, INT J IMMUNOPHARMACO, V11, P615, DOI 10.1016/0192-0561(89)90146-X; AKIYAMA T, 1987, MANIPULATION HOST DE, P227; Arbour NC, 2000, NAT GENET, V25, P187, DOI 10.1038/76048; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; Brown GD, 2005, CELL MICROBIOL, V7, P471, DOI 10.1111/j.1462-5822.2005.00505.x; Brown GD, 2003, J EXP MED, V197, P1119, DOI 10.1084/jem.20021890; Brown GD, 2006, NAT REV IMMUNOL, V6, P33, DOI 10.1038/nri1745; Brown GD, 2003, IMMUNITY, V19, P311, DOI 10.1016/S1074-7613(03)00233-4; Casale TB, 1996, AM J RESP CELL MOL, V15, P35, DOI 10.1165/ajrcmb.15.1.8679220; CZOP JK, 1986, PATHOL IMMUNOPATH R, V5, P286, DOI 10.1159/000157022; Davis KL, 2001, ANNU REV PHARMACOL, V41, P203, DOI 10.1146/annurev.pharmtox.41.1.203; De Vera ME, 1997, AM J PHYSIOL-GASTR L, V273, pG1290, DOI 10.1152/ajpgi.1997.273.6.G1290; FEHSEL K, 1995, J IMMUNOL, V155, P2858; FRUEHAUF JP, 1982, IMMUNOPHARMACOLOGY, V5, P65, DOI 10.1016/0162-3109(82)90037-6; Gantner BN, 2005, EMBO J, V24, P1277, DOI 10.1038/sj.emboj.7600594; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Gao JJ, 1997, J BIOL CHEM, V272, P1226, DOI 10.1074/jbc.272.2.1226; Gess B, 1997, AM J PHYSIOL-REG I, V273, pR905, DOI 10.1152/ajpregu.1997.273.3.R905; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Hambleton J, 1996, P NATL ACAD SCI USA, V93, P2774, DOI 10.1073/pnas.93.7.2774; HAN J, 1994, SCIENCE, V265, P808, DOI 10.1126/science.7914033; Hashimoto T, 1997, FEMS IMMUNOL MED MIC, V19, P131, DOI 10.1111/j.1574-695X.1997.tb01082.x; HERLYN D, 1985, JPN J CANCER RES, V76, P37; Hogaboam CM, 1998, INFECT IMMUN, V66, P650, DOI 10.1128/IAI.66.2.650-655.1998; Jeon YJ, 1998, BIOCHEM MOL BIOL INT, V45, P435; Kankkunen P, 2010, J IMMUNOL, V184, P6335, DOI 10.4049/jimmunol.0903019; Kerekgyarto C, 1996, INT J IMMUNOPHARMACO, V18, P347, DOI 10.1016/S0192-0561(96)00038-0; Kim JW, 2005, BIOCHEM PHARMACOL, V70, P1352, DOI 10.1016/j.bcp.2005.08.006; KINDLER V, 1989, CELL, V56, P731, DOI 10.1016/0092-8674(89)90676-4; Kleinert H, 2004, EUR J PHARMACOL, V500, P255, DOI 10.1016/j.ejphar.2004.07.030; Kleinert H, 1996, MOL PHARMACOL, V49, P15; Kroncke KD, 1998, CLIN EXP IMMUNOL, V113, P147; Kupfahl C, 2006, INT IMMUNOPHARMACOL, V6, P686, DOI 10.1016/j.intimp.2005.10.008; LADANYI A, 1993, CANCER IMMUNOL IMMUN, V36, P123, DOI 10.1007/BF01754412; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; LEHMANN V, 1987, J EXP MED, V165, P657, DOI 10.1084/jem.165.3.657; LIEW FY, 1995, CURR OPIN IMMUNOL, V7, P396, DOI 10.1016/0952-7915(95)80116-2; LORSBACH RB, 1993, J BIOL CHEM, V268, P1908; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; Manjeet R, 1999, INT J IMMUNOPHARMACO, V21, P435, DOI 10.1016/S0192-0561(99)00024-7; Miralles C, 2000, FEBS LETT, V476, P253, DOI 10.1016/S0014-5793(00)01748-8; MONCADA S, 1993, NEW ENGL J MED, V329, P2002; MUKAIDA N, 1994, J BIOL CHEM, V269, P13289; Muzio M, 1997, SCIENCE, V278, P1612, DOI 10.1126/science.278.5343.1612; NANBA H, 1987, CHEM PHARM BULL, V35, P2453; NANBA H, 1987, CHEM PHARM BULL, V35, P2459; NATHAN C, 1992, FASEB J, V6, P3051, DOI 10.1096/fasebj.6.12.1381691; Noel M., 1997, INT J IMMUNOPHARMACO, V19, P463; Ohno N, 1996, IMMUNOL LETT, V52, P1, DOI 10.1016/0165-2478(96)02538-2; OKAMURA K, 1986, CANCER, V58, P865, DOI 10.1002/1097-0142(19860815)58:4<865::AID-CNCR2820580411>3.0.CO;2-S; Okugawa S, 2003, AM J PHYSIOL-CELL PH, V285, pC399, DOI 10.1152/ajpcell.00026.2003; Osei SY, 1996, BLOOD, V88, P3583, DOI 10.1182/blood.V88.9.3583.bloodjournal8893583; PETER G, 1988, IMMUNOPHARM IMMUNOT, V10, P157; RIGGI SJ, 1961, AM J PHYSIOL, V200, P297, DOI 10.1152/ajplegacy.1961.200.2.297; Rogers NC, 2005, IMMUNITY, V22, P507, DOI 10.1016/j.immuni.2005.03.004; Ross GD, 1999, IMMUNOPHARMACOLOGY, V42, P61, DOI 10.1016/S0162-3109(99)00013-2; Ruttimann J, 2007, J EXP MED, V204, P3057, DOI 10.1084/jem.20413fta; Saura M, 1998, KIDNEY INT, V53, P38, DOI 10.1046/j.1523-1755.1998.00725.x; SUGA T, 1984, CANCER RES, V44, P5132; Taguchi T., 1986, HOST DEFENSE MECHANI, P221; Takeda K, 2001, GENES CELLS, V6, P733, DOI 10.1046/j.1365-2443.2001.00458.x; Taylor BS, 1998, J BIOL CHEM, V273, P15148, DOI 10.1074/jbc.273.24.15148; Taylor BS, 1998, BIOCHEMISTRY-MOSCOW+, V63, P766; Taylor PR, 2007, NAT IMMUNOL, V8, P31, DOI 10.1038/ni1408; TEBO JM, 1994, J IMMUNOL, V153, P4713; Verstrepen L, 2008, CELL MOL LIFE SCI, V65, P2964, DOI 10.1007/s00018-008-8064-8; Williams DL, 1997, MEDIAT INFLAMM, V6, P247, DOI 10.1080/09629359791550; Williams DL, 1996, CLIN IMMUNOTHER, V5, P392, DOI 10.1007/BF03259335; WINK DA, 1991, SCIENCE, V254, P1001, DOI 10.1126/science.1948068; XIE QW, 1994, J BIOL CHEM, V269, P4705; XIE QW, 1993, J EXP MED, V177, P1779, DOI 10.1084/jem.177.6.1779; Xu XJ, 2011, J BIOL CHEM, V286, P31194, DOI 10.1074/jbc.M111.246470; Yang Eun-Jin, 2009, Interdiscip Toxicol, V2, P245, DOI 10.2478/v10102-009-0022-2; Young SH, 2001, J BIOL CHEM, V276, P20781, DOI 10.1074/jbc.M101111200	74	56	60	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					871	878		10.1074/jbc.M111.297887	http://dx.doi.org/10.1074/jbc.M111.297887			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22102286	Green Published, hybrid			2022-12-27	WOS:000299170300006
J	Clifton, LA; Johnson, CL; Solovyova, AS; Callow, P; Weiss, KL; Ridley, H; Le Brun, AP; Kinane, CJ; Webster, JRP; Holt, SA; Lakey, JH				Clifton, Luke A.; Johnson, Christopher L.; Solovyova, Alexandra S.; Callow, Phil; Weiss, Kevin L.; Ridley, Helen; Le Brun, Anton P.; Kinane, Christian J.; Webster, John R. P.; Holt, Stephen A.; Lakey, Jeremy H.			Low Resolution Structure and Dynamics of a Colicin-Receptor Complex Determined by Neutron Scattering	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PORE-FORMING DOMAINS; TOXIN T DOMAIN; OUTER-MEMBRANE; CRYSTAL-STRUCTURES; RECOGNITION SITE; OMPF PORIN; PROTEIN; TRANSLOCATION; BINDING; INSERTION	Proteins that translocate across cell membranes need to overcome a significant hydrophobic barrier. This is usually accomplished via specialized protein complexes, which provide a polar transmembrane pore. Exceptions to this include bacterial toxins, which insert into and cross the lipid bilayer itself. We are studying the mechanism by which large antibacterial proteins enter Escherichia coli via specific outer membrane proteins. Here we describe the use of neutron scattering to investigate the interaction of colicin N with its outer membrane receptor protein OmpF. The positions of lipids, colicin N, and OmpF were separately resolved within complex structures by the use of selective deuteration. Neutron reflectivity showed, in real time, that OmpF mediates the insertion of colicin N into lipid monolayers. This data were complemented by Brewster Angle Microscopy images, which showed a lateral association of OmpF in the presence of colicin N. Small angle neutron scattering experiments then defined the three-dimensional structure of the colicin N-OmpF complex. This revealed that colicin N unfolds and binds to the OmpF-lipid interface. The implications of this unfolding step for colicin translocation across membranes are discussed.	[Johnson, Christopher L.; Solovyova, Alexandra S.; Ridley, Helen; Le Brun, Anton P.; Lakey, Jeremy H.] Univ Newcastle, Inst Cell & Mol Biosci, Sch Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Clifton, Luke A.; Kinane, Christian J.; Webster, John R. P.; Holt, Stephen A.] Rutherford Appleton Lab, ISIS Spallat Neutron Source, Didcot OX11 0QX, Oxon, England; [Callow, Phil] Inst Laue Langevin, F-38042 Grenoble, France; [Weiss, Kevin L.] Oak Ridge Natl Lab, Ctr Struct Mol Biol, Oak Ridge, TN 37831 USA	Newcastle University - UK; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory; Institut Laue-Langevin (ILL); United States Department of Energy (DOE); Oak Ridge National Laboratory	Lakey, JH (corresponding author), Univ Newcastle, Inst Cell & Mol Biosci, Sch Med, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	Jeremy.Lakey@ncl.ac.uk	Le Brun, Anton P/A-2604-2010; webster, john/GYU-7651-2022; Weiss, Kevin/I-4669-2013; Holt, Stephen A/E-4662-2011	Le Brun, Anton P/0000-0003-2431-6985; Weiss, Kevin/0000-0002-6486-8007; Holt, Stephen A/0000-0003-3189-8047; Kinane, Christy/0000-0002-1185-0719; Lakey, Jeremy/0000-0003-4646-9085; Clifton, Luke/0000-0001-8754-362X; Solovyova, Alexandra/0000-0002-5682-7037	Wellcome Trust [080342]; ISIS [RB910077]; Institut Laue-Langevin; Office of Biological and Environmental Research; LLC [DE-AC05-00OR22725]	Wellcome Trust(Wellcome TrustEuropean Commission); ISIS; Institut Laue-Langevin; Office of Biological and Environmental Research(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); LLC	This work was supported by Wellcome Trust Grant 080342, ISIS Grant RB910077, and the Institut Laue-Langevin. The research at Oak Ridge National Laboratory's Center for Structural Molecular Biology was supported by the Office of Biological and Environmental Research, using facilities supported by the United States Department of Energy, managed by UT-Battelle, LLC under contract DE-AC05-00OR22725.	Anderluh G, 2003, J BIOL CHEM, V278, P21860, DOI 10.1074/jbc.M300411200; Artero JB, 2005, ACTA CRYSTALLOGR D, V61, P1541, DOI 10.1107/S0907444905028532; Baboolal TG, 2008, STRUCTURE, V16, P371, DOI 10.1016/j.str.2007.12.023; Bainbridge G, 1998, FEBS LETT, V432, P117, DOI 10.1016/S0014-5793(98)00846-1; BENEDETTI H, 1992, EMBO J, V11, P441, DOI 10.1002/j.1460-2075.1992.tb05073.x; Berks BC, 2005, CURR OPIN MICROBIOL, V8, P174, DOI 10.1016/j.mib.2005.02.010; BULLOCK JO, 1986, BIOCHIM BIOPHYS ACTA, V856, P101, DOI 10.1016/0005-2736(86)90015-5; Cao Z, 2002, BIOCHIMIE, V84, P399, DOI 10.1016/S0300-9084(02)01455-4; Cascales E, 2007, MICROBIOL MOL BIOL R, V71, P158, DOI 10.1128/MMBR.00036-06; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; Chauleau M, 2011, J BIOL CHEM, V286, P29397, DOI 10.1074/jbc.M111.242354; Chenal A, 2009, J MOL BIOL, V391, P872, DOI 10.1016/j.jmb.2009.06.061; Cisneros DA, 2006, ANGEW CHEM INT EDIT, V45, P3252, DOI 10.1002/anie.200504506; Clifton LA, 2008, J PHYS CHEM B, V112, P15907, DOI 10.1021/jp806016h; COWAN SW, 1992, NATURE, V358, P727, DOI 10.1038/358727a0; DARGENT B, 1988, J MOL BIOL, V201, P497, DOI 10.1016/0022-2836(88)90632-8; Dover LG, 2000, BIOCHEMISTRY-US, V39, P8632, DOI 10.1021/bi000160n; ElKouhen R, 1996, J BACTERIOL, V178, P5316, DOI 10.1128/jb.178.17.5316-5319.1996; Evans LJA, 1996, BIOCHEMISTRY-US, V35, P13180, DOI 10.1021/bi960990u; Evans LJA, 1996, BIOCHEMISTRY-US, V35, P15143, DOI 10.1021/bi9615497; Evans LJA, 1996, J MOL BIOL, V255, P559, DOI 10.1006/jmbi.1996.0047; Fridd SL, 2002, BIOCHIMIE, V84, P477, DOI 10.1016/S0300-9084(02)01418-9; GARAVITO RM, 1986, METHOD ENZYMOL, V125, P309; Gokce I, 2000, J MOL BIOL, V304, P621, DOI 10.1006/jmbi.2000.4232; Hessa T, 2005, NATURE, V433, P377, DOI 10.1038/nature03216; HOENGER A, 1993, J STRUCT BIOL, V111, P212, DOI 10.1006/jsbi.1993.1051; Housden NG, 2005, P NATL ACAD SCI USA, V102, P13849, DOI 10.1073/pnas.0503567102; Housden NG, 2010, P NATL ACAD SCI USA, V107, P21412, DOI 10.1073/pnas.1010780107; Jakes KS, 2010, MOL MICROBIOL, V75, P567, DOI 10.1111/j.1365-2958.2009.06966.x; Jakes KS, 1998, P NATL ACAD SCI USA, V95, P4321, DOI 10.1073/pnas.95.8.4321; Jaroslawski S, 2009, MOL MICROBIOL, V74, P1211, DOI 10.1111/j.1365-2958.2009.06926.x; JEANTEUR D, 1994, P NATL ACAD SCI USA, V91, P10675, DOI 10.1073/pnas.91.22.10675; Krepkiy D, 2009, NATURE, V462, P473, DOI 10.1038/nature08542; Lad MD, 2007, BIOPHYS J, V92, P3575, DOI 10.1529/biophysj.106.097774; LAKEY JH, 1985, BIOCHIM BIOPHYS ACTA, V817, P208, DOI 10.1016/0005-2736(85)90022-7; Lakey JH, 2001, CURR TOP MICROBIOL, V257, P131; LAKEY JH, 1991, EUR J BIOCHEM, V196, P599, DOI 10.1111/j.1432-1033.1991.tb15855.x; Lu JR, 1998, J CHEM SOC FARADAY T, V94, P995, DOI 10.1039/a707853f; McConlogue CW, 1997, LANGMUIR, V13, P7158, DOI 10.1021/la970898e; Mo Y, 2008, J PHYS CHEM B, V112, P13349, DOI 10.1021/jp801266r; Mosbahi K, 2002, NAT STRUCT BIOL, V9, P476, DOI 10.1038/nsb797; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Osickova A, 2010, MOL MICROBIOL, V75, P1550, DOI 10.1111/j.1365-2958.2010.07077.x; Penfold J, 2002, CURR OPIN COLLOID IN, V7, P139, DOI 10.1016/S1359-0294(02)00015-8; PENFOLD J, 1987, J PHYS E SCI INSTRUM, V20, P1411, DOI 10.1088/0022-3735/20/11/024; Raggett EM, 1998, MOL MICROBIOL, V28, P1335, DOI 10.1046/j.1365-2958.1998.00899.x; Rapaport D, 2005, J CELL BIOL, V171, P419, DOI 10.1083/jcb.200507147; Ren JH, 1999, SCIENCE, V284, P955, DOI 10.1126/science.284.5416.955; SCHINDLER H, 1981, P NATL ACAD SCI-BIOL, V78, P2302, DOI 10.1073/pnas.78.4.2302; Schmitz A, 2000, J CELL BIOL, V148, P1203, DOI 10.1083/jcb.148.6.1203; Spector J, 2010, BIOPHYS J, V99, P3880, DOI 10.1016/j.bpj.2010.10.029; Stora T, 1999, ANGEW CHEM INT EDIT, V38, P389, DOI 10.1002/(SICI)1521-3773(19990201)38:3<389::AID-ANIE389>3.0.CO;2-U; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; Svergun DI, 2000, J BIOL CHEM, V275, P14432, DOI 10.1074/jbc.275.19.14432; Thoren KL, 2011, MOL MICROBIOL, V80, P588, DOI 10.1111/j.1365-2958.2011.07614.x; TREWHELLA J, 1983, BIOPHYS J, V42, P233, DOI 10.1016/S0006-3495(83)84391-4; TREWHELLA J, 1986, EMBO J, V5, P3045, DOI 10.1002/j.1460-2075.1986.tb04604.x; VANDERGOOT FG, 1991, NATURE, V354, P408, DOI 10.1038/354408a0; Vetter IR, 1998, STRUCTURE, V6, P863, DOI 10.1016/S0969-2126(98)00088-4; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Vollmer W, 1997, J BACTERIOL, V179, P1580, DOI 10.1128/jb.179.5.1580-1583.1997; Watanabe Y, 2005, PROTEIN J, V24, P167, DOI 10.1007/s10930-005-7840-7; Watanabe Y, 1999, JPN J APPL PHYS 1, V38, P180, DOI 10.7567/JJAPS.38S1.180; Webster J, 2006, PHYSICA B, V385-86, P1164, DOI 10.1016/j.physb.2006.05.400; Xie K, 2008, NAT REV MICROBIOL, V6, P234, DOI 10.1038/nrmicro3595; Yamashita E, 2008, EMBO J, V27, P2171, DOI 10.1038/emboj.2008.137; Zakharov SD, 2004, BIOPHYS J, V87, P3901, DOI 10.1529/biophysj.104.046151	67	48	48	1	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					337	346		10.1074/jbc.M111.302901	http://dx.doi.org/10.1074/jbc.M111.302901			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22081604	Green Published, Green Submitted, hybrid			2022-12-27	WOS:000298682400033
J	Helsen, CW; Glover, JR				Helsen, Christopher W.; Glover, John R.			Insight into Molecular Basis of Curing of [PSI+] Prion by Overexpression of 104-kDa Heat Shock Protein (Hsp104)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; OLIGOPEPTIDE REPEATS; GENETIC-VARIATION; STRUCTURAL BASIS; YEAST; SUP35; MECHANISM; CHAPERONE; HSP70; DISAGGREGATION	Yeast prions are a powerful model for understanding the dynamics of protein aggregation associated with a number of human neurodegenerative disorders. The AAA+ protein disaggregase Hsp104 can sever the amyloid fibrils produced by yeast prions. This action results in the propagation of "seeds" that are transmitted to daughter cells during budding. Overexpression of Hsp104 eliminates the [PSI+] prion but not other prions. Using biochemical methods we identified Hsp104 binding sites in the highly charged middle domain of Sup35, the protein determinant of [PSI+]. Deletion of a short segment of the middle domain (amino acids 129-148) diminishes Hsp104 binding and strongly affects the ability of the middle domain to stimulate the ATPase activity of Hsp104. In yeast, [PSI+] maintained by Sup35 lacking this segment, like other prions, is propagated by Hsp104 but cannot be cured by Hsp104 overexpression. These results provide new insight into the enigmatic specificity of Hsp104-mediated curing of yeast prions and sheds light on the limitations of the ability of Hsp104 to eliminate aggregates produced by other aggregation-prone proteins.	[Helsen, Christopher W.; Glover, John R.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada	University of Toronto	Glover, JR (corresponding author), Rm 5302,Med Sci Bldg,1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada.	john.glover@utoronto.ca			Canadian Institutes of Health Research [MOP-86754]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	The work was supported by Canadian Institutes of Health Research Operating Grant MOP-86754 (to J. R. G.).	ABRAVAYA K, 1992, GENE DEV, V6, P1153, DOI 10.1101/gad.6.7.1153; Alberti S, 2010, METHOD ENZYMOL, V470, P709, DOI 10.1016/S0076-6879(10)70030-6; Allen KD, 2005, GENETICS, V169, P1227, DOI 10.1534/genetics.104.037168; Borchsenius AS, 2006, CURR GENET, V49, P21, DOI 10.1007/s00294-005-0035-0; Borchsenius AS, 2001, EMBO J, V20, P6683, DOI 10.1093/emboj/20.23.6683; Byrne LJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004670; Cashikar AG, 2002, MOL CELL, V9, P751, DOI 10.1016/S1097-2765(02)00499-9; CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; Derdowski A, 2010, SCIENCE, V330, P680, DOI 10.1126/science.1197785; Derkatch IL, 1997, GENETICS, V147, P507; Derkatch IL, 1996, GENETICS, V144, P1375; Du ZQ, 2008, NAT GENET, V40, P460, DOI 10.1038/ng.112; Edskes HK, 1999, P NATL ACAD SCI USA, V96, P1498, DOI 10.1073/pnas.96.4.1498; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; Glover JR, 1997, CELL, V89, P811, DOI 10.1016/S0092-8674(00)80264-0; Grimminger V, 2004, J BIOL CHEM, V279, P7378, DOI 10.1074/jbc.M312403200; Hara H, 2003, GENES CELLS, V8, P925, DOI 10.1111/j.1365-2443.2003.00694.x; Haslberger T, 2010, BIOCHEM CELL BIOL, V88, P63, DOI [10.1139/O09-118, 10.1139/o09-118]; Jensen MA, 2001, GENETICS, V159, P527; Jung GM, 2001, CURR MICROBIOL, V43, P7, DOI 10.1007/s002840010251; Kochneva-Pervukhova NV, 2001, YEAST, V18, P489, DOI 10.1002/yea.700; Krishnan R, 2005, NATURE, V435, P765, DOI 10.1038/nature03679; Kryndushkin DS, 2003, J BIOL CHEM, V278, P49636, DOI 10.1074/jbc.M307996200; Krzewska J, 2006, EMBO J, V25, P822, DOI 10.1038/sj.emboj.7600985; Kushnirov VV, 2000, EMBO J, V19, P324, DOI 10.1093/emboj/19.3.324; Kushnirov VV, 2000, CURR BIOL, V10, P1443, DOI 10.1016/S0960-9822(00)00802-2; Lee DH, 2010, BIOCHEM BIOPH RES CO, V391, P1056, DOI 10.1016/j.bbrc.2009.12.018; Lee S, 2010, P NATL ACAD SCI USA, V107, P8135, DOI 10.1073/pnas.1003572107; Liu JJ, 2002, P NATL ACAD SCI USA, V99, P16446, DOI 10.1073/pnas.252652099; Lum R, 2004, J BIOL CHEM, V279, P29139, DOI 10.1074/jbc.M403777200; Lum R, 2008, J BIOL CHEM, V283, P30139, DOI 10.1074/jbc.M804849200; Mackay RG, 2008, BIOCHEMISTRY-US, V47, P1918, DOI 10.1021/bi701714s; McGlinchey RP, 2011, P NATL ACAD SCI USA, V108, P5337, DOI 10.1073/pnas.1102762108; Miot M, 2011, P NATL ACAD SCI USA, V108, P6915, DOI 10.1073/pnas.1102828108; Mosser DD, 2004, BIOCHEMISTRY-US, V43, P8107, DOI 10.1021/bi0493766; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; Newnam GP, 2011, J MOL BIOL, V408, P432, DOI 10.1016/j.jmb.2011.02.034; Newnam GP, 1999, MOL CELL BIOL, V19, P1325; Osherovich LZ, 2004, PLOS BIOL, V2, P442, DOI 10.1371/journal.pbio.0020086; Parham SN, 2001, EMBO J, V20, P2111, DOI 10.1093/emboj/20.9.2111; PARSELL DA, 1994, NATURE, V372, P475, DOI 10.1038/372475a0; Patel BK, 2009, NAT CELL BIOL, V11, P344, DOI 10.1038/ncb1843; Patino MM, 1996, SCIENCE, V273, P622, DOI 10.1126/science.273.5275.622; Roll-Mecak A, 2008, NATURE, V451, P363, DOI 10.1038/nature06482; Schaupp A, 2007, J MOL BIOL, V370, P674, DOI 10.1016/j.jmb.2007.04.070; Schirmer EC, 1998, J BIOL CHEM, V273, P15546, DOI 10.1074/jbc.273.25.15546; Senechal P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006939; Serio TR, 2000, SCIENCE, V289, P1317, DOI 10.1126/science.289.5483.1317; Serio TR, 2001, BIOCHEM SOC SYMP, V68, P35; Shkundina IS, 2006, GENETICS, V172, P827, DOI 10.1534/genetics.105.048660; Shorter J, 2004, SCIENCE, V304, P1793, DOI 10.1126/science.1098007; Shorter J, 2008, EMBO J, V27, P2712, DOI 10.1038/emboj.2008.194; Shorter J, 2006, MOL CELL, V23, P425, DOI 10.1016/j.molcel.2006.05.042; Sielaff B, 2010, J MOL BIOL, V402, P30, DOI 10.1016/j.jmb.2010.07.030; SMIRNOV MN, 1967, BIOCHEM BIOPH RES CO, V27, P299, DOI 10.1016/S0006-291X(67)80096-2; Song YT, 2005, EUKARYOT CELL, V4, P289, DOI 10.1128/EC.4.2.289-297.2005; STANSFIELD I, 1995, EMBO J, V14, P4365, DOI 10.1002/j.1460-2075.1995.tb00111.x; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392; Tkach JM, 2004, J BIOL CHEM, V279, P35692, DOI 10.1074/jbc.M400782200; Toombs JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021953; Toyama BH, 2007, NATURE, V449, P233, DOI 10.1038/nature06108; True HL, 2000, NATURE, V407, P477, DOI 10.1038/35035005; True HL, 2004, NATURE, V431, P184, DOI 10.1038/nature02885; Uptain SM, 2001, EMBO J, V20, P6236, DOI 10.1093/emboj/20.22.6236; Vashist S, 2010, BIOCHEM CELL BIOL, V88, P1, DOI [10.1139/O09-121, 10.1139/o09-121]; Wegrzyn RD, 2001, MOL CELL BIOL, V21, P4656, DOI 10.1128/MCB.21.14.4656-4669.2001; Weibezahn J, 2004, CELL, V119, P653, DOI 10.1016/j.cell.2004.11.027; Wendler P, 2007, CELL, V131, P1366, DOI 10.1016/j.cell.2007.10.047; Wu YX, 2005, P NATL ACAD SCI USA, V102, P12789, DOI 10.1073/pnas.0506384102; Zenthon JF, 2006, EUKARYOT CELL, V5, P217, DOI 10.1128/EC.5.2.217-225.2006	71	71	73	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					542	556		10.1074/jbc.M111.302869	http://dx.doi.org/10.1074/jbc.M111.302869			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22081611	Green Published, hybrid			2022-12-27	WOS:000298682400053
J	Herod, MR; Jones, DM; McLauchlan, J; McCormick, CJ				Herod, Morgan R.; Jones, Daniel M.; McLauchlan, John; McCormick, Christopher J.			Increasing Rate of Cleavage at Boundary between Non-structural Proteins 4B and 5A Inhibits Replication of Hepatitis C Virus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NS3 SERINE-PROTEASE; RNA REPLICATION; SUBSTRATE-SPECIFICITY; MEMBRANE ASSOCIATION; SYNTHETIC PEPTIDES; VIRAL REPLICATION; NS4B PROTEIN; POLYPROTEIN; NS5A; PRODUCTS	In hepatitis C virus, non-structural proteins are cleaved from the viral polyprotein by viral encoded proteases. Although proteolytic processing goes to completion, the rate of cleavage differs between different boundaries, primarily due to the sequence at these positions. However, it is not known whether slow cleavage is important for viral replication or a consequence of restrictions on sequences that can be tolerated at the cleaved ends of non-structural proteins. To address this question, mutations were introduced into the NS4B side of the NS4B5A boundary, and their effect on replication and polyprotein processing was examined in the context of a subgenomic replicon. Single mutations that modestly increased the rate of boundary processing were phenotypically silent, but a double mutation, which further increased the rate of boundary cleavage, was lethal. Rescue experiments relying on viral RNA polymerase-induced error failed to identify second site compensatory mutations. Use of a replicon library with codon degeneracy did allow identification of second site compensatory mutations, some of which fell exclusively within the NS5A side of the boundary. These mutations slowed boundary cleavage and only enhanced replication in the context of the original lethal NS4B double mutation. Overall, the data indicate that slow cleavage of the NS4B5A boundary is important and identify a previously unrecognized role for NS4B5A-containing precursors requiring them to exist for a minimum finite period of time.	[Herod, Morgan R.; McCormick, Christopher J.] Southampton Gen Hosp, Sir Henry Wellcome Labs, Div Infect Inflammat & Immun, Sch Med, Southampton SO16 6YD, Hants, England; [Jones, Daniel M.; McLauchlan, John] Univ Glasgow, Ctr Virus Res, MRC, Glasgow G11 5JR, Lanark, Scotland	University of Southampton; University of Glasgow	McCormick, CJ (corresponding author), Southampton Gen Hosp, Sir Henry Wellcome Labs, Div Infect Inflammat & Immun, Sch Med, MP814, Southampton SO16 6YD, Hants, England.	cjm@soton.ac.uk		Herod, Morgan/0000-0002-8626-6787; McCormick, Christopher/0000-0002-6155-9161	Medical Research Council [G0701215]; Royal Society; Medical Research Council [MC_U130184143] Funding Source: researchfish; MRC [MC_U130184143, G0701215] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Royal Society(Royal Society of London); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Medical Research Council Grant G0701215 and a Royal Society research grant.	Ambrose RL, 2011, J VIROL, V85, P11274, DOI 10.1128/JVI.05864-11; Appel N, 2005, J VIROL, V79, P896, DOI 10.1128/JVI.79.2.896-909.2005; BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; BARTENSCHLAGER R, 1994, J VIROL, V68, P5045, DOI 10.1128/JVI.68.8.5045-5055.1994; Beyer BM, 2001, PROTEINS, V43, P82, DOI 10.1002/1097-0134(20010501)43:2<82::AID-PROT1020>3.3.CO;2-W; Brass V, 2002, J BIOL CHEM, V277, P8130, DOI 10.1074/jbc.M111289200; Brass V, 2008, P NATL ACAD SCI USA, V105, P14545, DOI 10.1073/pnas.0807298105; Butkiewicz NJ, 1996, VIROLOGY, V225, P328, DOI 10.1006/viro.1996.0607; Egger D, 2002, J VIROL, V76, P5974, DOI 10.1128/JVI.76.12.5974-5984.2002; Elazar M, 2003, J VIROL, V77, P6055, DOI 10.1128/JVI.77.10.6055-6061.2003; Evans MJ, 2004, J VIROL, V78, P12085, DOI 10.1128/JVI.78.21.12085-12089.2004; FAILLA C, 1994, J VIROL, V68, P3753, DOI 10.1128/JVI.68.6.3753-3760.1994; Fernandes F, 2007, HEPATOLOGY, V46, P1026, DOI 10.1002/hep.21809; GONDA DK, 1989, J BIOL CHEM, V264, P16700; Gouttenoire J, 2009, J VIROL, V83, P11378, DOI 10.1128/JVI.01122-09; GRAKOUI A, 1993, J VIROL, V67, P2832, DOI 10.1128/JVI.67.5.2832-2843.1993; GRAKOUI A, 1993, P NATL ACAD SCI USA, V90, P10583, DOI 10.1073/pnas.90.22.10583; GRAKOUI A, 1993, J VIROL, V67, P1385, DOI 10.1128/JVI.67.3.1385-1395.1993; Gretton SN, 2005, J GEN VIROL, V86, P1415, DOI 10.1099/vir.0.80768-0; Hanoulle X, 2009, J BIOL CHEM, V284, P13589, DOI 10.1074/jbc.M809244200; HIJIKATA M, 1993, J VIROL, V67, P4665, DOI 10.1128/JVI.67.8.4665-4675.1993; HIJIKATA M, 1991, P NATL ACAD SCI USA, V88, P5547, DOI 10.1073/pnas.88.13.5547; Hussy P, 1996, VIROLOGY, V224, P93, DOI 10.1006/viro.1996.0510; Ingallinella P, 1998, BIOCHEMISTRY-US, V37, P8906, DOI 10.1021/bi980314n; Jones DM, 2009, J VIROL, V83, P2163, DOI 10.1128/JVI.01885-08; Kaul A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000546; Kim JE, 1999, ARCH VIROL, V144, P329, DOI 10.1007/s007050050507; Kim SY, 2000, ANAL BIOCHEM, V284, P42, DOI 10.1006/abio.2000.4662; KOLYKHALOV AA, 1994, J VIROL, V68, P7525, DOI 10.1128/JVI.68.11.7525-7533.1994; Kusov Y, 1999, J VIROL, V73, P9867, DOI 10.1128/JVI.73.12.9867-9878.1999; Landro JA, 1997, BIOCHEMISTRY-US, V36, P9340, DOI 10.1021/bi963054n; LIN C, 1994, J VIROL, V68, P5063, DOI 10.1128/JVI.68.8.5063-5073.1994; LIN C, 1994, J VIROL, V68, P8147, DOI 10.1128/JVI.68.12.8147-8157.1994; Lundin M, 2003, J VIROL, V77, P5428, DOI 10.1128/JVI.77.9.5428-5438.2003; McCormick CJ, 2006, J GEN VIROL, V87, P635, DOI 10.1099/vir.0.81553-0; McCormick CJ, 2006, J GEN VIROL, V87, P93, DOI 10.1099/vir.0.81180-0; McCormick CJ, 2002, J GEN VIROL, V83, P383, DOI 10.1099/0022-1317-83-2-383; Miller S, 2007, J BIOL CHEM, V282, P8873, DOI 10.1074/jbc.M609919200; MIZUSHIMA H, 1994, J VIROL, V68, P6215, DOI 10.1128/JVI.68.10.6215-6222.1994; Paredes AM, 2008, J VIROL, V82, P10671, DOI 10.1128/JVI.00875-08; Pathak Harsh B, 2008, J Biol Chem, V283, P30677, DOI 10.1074/jbc.M806101200; PETTIT SC, 1994, J VIROL, V68, P8017, DOI 10.1128/JVI.68.12.8017-8027.1994; Quinkert D, 2005, J VIROL, V79, P13594, DOI 10.1128/JVI.79.21.13594-13605.2005; Steinkuhler C, 1996, J VIROL, V70, P6694; TANJI Y, 1994, J VIROL, V68, P8418, DOI 10.1128/JVI.68.12.8418-8422.1994; TOMEI L, 1993, J VIROL, V67, P4017, DOI 10.1128/JVI.67.7.4017-4026.1993; Tong X, 2006, VIRUS RES, V115, P122, DOI 10.1016/j.virusres.2005.07.012; Towner JS, 1998, J VIROL, V72, P7191, DOI 10.1128/JVI.72.9.7191-7200.1998; VanKuppeveld FJM, 1996, J VIROL, V70, P7632, DOI 10.1128/JVI.70.11.7632-7640.1996; Wang WY, 2004, J VIROL, V78, P700, DOI 10.1128/JVI.78.2.700-709.2004; Wiegers K, 1998, J VIROL, V72, P2846, DOI 10.1128/JVI.72.4.2846-2854.1998; Yang F, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001118; Yang Y, 2007, P NATL ACAD SCI USA, V104, P7253, DOI 10.1073/pnas.0611506104; Zhang RM, 1997, J VIROL, V71, P6208, DOI 10.1128/JVI.71.8.6208-6213.1997	54	11	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					568	580		10.1074/jbc.M111.311407	http://dx.doi.org/10.1074/jbc.M111.311407			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22084249	Green Published, hybrid			2022-12-27	WOS:000298682400055
J	Kudelko, M; Brault, JB; Kwok, K; Li, MY; Pardigon, N; Peiris, JSM; Bruzzone, R; Despres, P; Nal, B; Wang, PG				Kudelko, Mateusz; Brault, Jean-Baptiste; Kwok, Kevin; Li, Ming Yuan; Pardigon, Nathalie; Peiris, J. S. Malik; Bruzzone, Roberto; Despres, Philippe; Nal, Beatrice; Wang, Pei Gang			Class II ADP-ribosylation Factors Are Required for Efficient Secretion of Dengue Viruses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TICK-BORNE ENCEPHALITIS; GTP-BINDING PROTEIN; ENDOPLASMIC-RETICULUM; ARF FAMILY; BETA-COP; GOLGI MEMBRANES; PHOSPHOLIPASE-D; FLAVIVIRUS; TRANSPORT; PARTICLES	Identification and characterization of virus-host interactions are very important steps toward a better understanding of the molecular mechanisms responsible for disease progression and pathogenesis. To date, very few cellular factors involved in the life cycle of flaviviruses, which are important human pathogens, have been described. In this study, we demonstrate a crucial role for class II Arf proteins (Arf4 and Arf5) in the dengue flavivirus life cycle. We show that simultaneous depletion of Arf4 and Arf5 blocks recombinant subviral particle secretion for all four dengue serotypes. Immunostaining analysis suggests that class II Arf proteins are required at an early pre-Golgi step for dengue virus secretion. Using a horseradish peroxidase protein fused to a signal peptide, we show that class II Arfs act specifically on dengue virus secretion without altering the secretion of proteins through the constitutive secretory pathway. Co-immunoprecipitation data demonstrate that the dengue prM glycoprotein interacts with class II Arf proteins but not through its C-terminal VXPX motif. Finally, experiments performed with replication-competent dengue and yellow fever viruses demonstrate that the depletion of class II Arfs inhibits virus secretion, thus confirming their implication in the virus life cycle, although data obtained with West Nile virus pointed out the differences in virus-host interactions among flaviviruses. Our findings shed new light on a molecular mechanism used by dengue viruses during the late stages of the life cycle and demonstrate a novel function for class II Arf proteins.	[Kudelko, Mateusz; Kwok, Kevin; Li, Ming Yuan; Peiris, J. S. Malik; Bruzzone, Roberto; Nal, Beatrice; Wang, Pei Gang] Univ Hong Kong, HKU Pasteur Res Ctr, Hong Kong, Hong Kong, Peoples R China; [Peiris, J. S. Malik] Univ Hong Kong, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China; [Nal, Beatrice] Univ Hong Kong, Dept Anat, Hong Kong, Hong Kong, Peoples R China; [Brault, Jean-Baptiste; Pardigon, Nathalie; Despres, Philippe] Inst Pasteur, Unite Interact Mol Flavivirus Hotes, F-75724 Paris, France; [Bruzzone, Roberto] Inst Pasteur, Dept Cell Biol & Infect, F-75724 Paris, France; [Nal, Beatrice] Brunel Univ, Sch Hlth Sci & Social Care, Div Biosci, Uxbridge UB8 3PH, Middx, England	University of Hong Kong; University of Hong Kong; University of Hong Kong; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Brunel University	Nal, B (corresponding author), 1-F Dexter HC Man Bldg,8 Sassoon Rd, Pokfulam, Hong Kong, Peoples R China.	bnal@hku.hk; pgwang@hku.hk	NAL, Beatrice/GYU-8888-2022; Bruzzone, Roberto/C-4719-2009; Bruzzone, Roberto/G-9355-2017; Peiris, Joseph Sriyal Malik/C-4380-2009	Bruzzone, Roberto/0000-0003-4373-1447; Bruzzone, Roberto/0000-0003-4373-1447; Nal, Beatrice/0000-0003-3452-7524; Brault, Jean-Baptiste/0000-0001-5950-2601; Peiris, Joseph Sriyal Malik/0000-0001-8217-5995; Wang, Peigang/0000-0001-6045-2007	Research Fund for Control of Infectious Diseases of Hong Kong [RFCID 08070952, RFCID 10091312]; BNP Paribas Corporate and Investment Banking	Research Fund for Control of Infectious Diseases of Hong Kong; BNP Paribas Corporate and Investment Banking	This work was supported by Research Fund for Control of Infectious Diseases of Hong Kong Grants RFCID 08070952 and RFCID 10091312 and by a donation from BNP Paribas Corporate and Investment Banking.	ALLISON SL, 1995, J VIROL, V69, P5816, DOI 10.1128/JVI.69.9.5816-5820.1995; Bard F, 2006, NATURE, V439, P604, DOI 10.1038/nature04377; Beck R, 2008, P NATL ACAD SCI USA, V105, P11731, DOI 10.1073/pnas.0805182105; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; BROWN HA, 1993, CELL, V75, P1137, DOI 10.1016/0092-8674(93)90323-I; Chu JJH, 2007, P NATL ACAD SCI USA, V104, P3520, DOI 10.1073/pnas.0611681104; Chun J, 2008, MOL BIOL CELL, V19, P3488, DOI 10.1091/mbc.E08-04-0373; COCKCROFT S, 1994, SCIENCE, V263, P523, DOI 10.1126/science.8290961; Courageot MP, 2000, J VIROL, V74, P564, DOI 10.1128/JVI.74.1.564-572.2000; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Deretic D, 2005, P NATL ACAD SCI USA, V102, P3301, DOI 10.1073/pnas.0500095102; DESPRES P, 1993, VIROLOGY, V196, P209, DOI 10.1006/viro.1993.1469; DONALDSON JG, 1992, P NATL ACAD SCI USA, V89, P6408, DOI 10.1073/pnas.89.14.6408; Donaldson JG, 2003, J BIOL CHEM, V278, P41573, DOI 10.1074/jbc.R300026200; Donaldson JG, 2000, CURR OPIN CELL BIOL, V12, P475, DOI 10.1016/S0955-0674(00)00119-8; Duijsings D, 2009, TRAFFIC, V10, P316, DOI 10.1111/j.1600-0854.2008.00868.x; Ferlenghi I, 2001, MOL CELL, V7, P593, DOI 10.1016/S1097-2765(01)00206-4; Gillingham AK, 2007, ANNU REV CELL DEV BI, V23, P579, DOI 10.1146/annurev.cellbio.23.090506.123209; Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0; HALSTEAD SB, 1988, SCIENCE, V239, P476, DOI 10.1126/science.3277268; Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0; HENCHAL EA, 1982, AM J TROP MED HYG, V31, P830, DOI 10.4269/ajtmh.1982.31.830; Hirsch AJ, 2005, J VIROL, V79, P11943, DOI 10.1128/JVI.79.18.11943-11951.2005; Hunt AR, 2001, J VIROL METHODS, V97, P133, DOI 10.1016/S0166-0934(01)00346-9; Junjhon J, 2008, J VIROL, V82, P10776, DOI 10.1128/JVI.01180-08; Kahn RA, 2006, J CELL BIOL, V172, P645, DOI 10.1083/jcb.200512057; Kahn RA, 2005, BIOCHEM SOC T, V33, P1269, DOI 10.1042/BST0331269; Krishnan MN, 2008, NATURE, V455, P242, DOI 10.1038/nature07207; Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998; Li L, 2008, SCIENCE, V319, P1830, DOI 10.1126/science.1153263; LINDENBACH BD, 2001, FIELDS VIROLOGY, P991; Mazelova J, 2009, EMBO J, V28, P183, DOI 10.1038/emboj.2008.267; MISUMI Y, 1986, J BIOL CHEM, V261, P1398; Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067; Nie ZZ, 2003, CURR OPIN CELL BIOL, V15, P396, DOI 10.1016/S0955-0674(03)00071-1; Pastorino B, 2010, ANTIVIR RES, V87, P281, DOI 10.1016/j.antiviral.2010.04.014; PEPPERKOK R, 1993, CELL, V74, P71, DOI 10.1016/0092-8674(93)90295-2; PETER F, 1993, J CELL BIOL, V122, P1155, DOI 10.1083/jcb.122.6.1155; SARASTE J, 1984, CELL, V38, P535, DOI 10.1016/0092-8674(84)90508-7; SARASTE J, 1986, P NATL ACAD SCI USA, V83, P6425, DOI 10.1073/pnas.83.17.6425; Siu YL, 2008, J VIROL, V82, P11318, DOI 10.1128/JVI.01052-08; Stadler K, 1997, J VIROL, V71, P8475, DOI 10.1128/JVI.71.11.8475-8481.1997; STAMNES MA, 1993, CELL, V73, P999, DOI 10.1016/0092-8674(93)90277-W; Volpicelli-Daley LA, 2005, MOL BIOL CELL, V16, P4495, DOI 10.1091/mbc.E04-12-1042; Wang PG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008325; Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007; Yu IM, 2009, J VIROL, V83, P12101, DOI 10.1128/JVI.01637-09; Yu IM, 2008, SCIENCE, V319, P1834, DOI 10.1126/science.1153264; Zhang Y, 2003, EMBO J, V22, P2604, DOI 10.1093/emboj/cdg270	49	47	49	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					767	777		10.1074/jbc.M111.270579	http://dx.doi.org/10.1074/jbc.M111.270579			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22105072	Green Published, hybrid, Green Submitted			2022-12-27	WOS:000298682400074
J	Azarkan, M; Martinez-Rodriguez, S; Buts, L; Baeyens-Volant, D; Garcia-Pino, A				Azarkan, Mohamed; Martinez-Rodriguez, Sergio; Buts, Lieven; Baeyens-Volant, Danielle; Garcia-Pino, Abel			The Plasticity of the beta-Trefoil Fold Constitutes an Evolutionary Platform for Protease Inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANGLE SCATTERING DATA; CHYMOTRYPSIN INHIBITOR; CRYSTAL-STRUCTURE; TRYPSIN-INHIBITOR; PLASMINOGEN-ACTIVATOR; ANGSTROM RESOLUTION; REACTIVE-SITE; PROTEINASES; LANDSCAPE; DEFENSES	Proteases carry out a number of crucial functions inside and outside the cell. To protect the cells against the potentially lethal activities of these enzymes, specific inhibitors are produced to tightly regulate the protease activity. Independent reports suggest that the Kunitz-soybean trypsin inhibitor (STI) family has the potential to inhibit proteases with different specificities. In this study, we use a combination of biophysical methods to define the structural basis of the interaction of papaya protease inhibitor (PPI) with serine proteases. We show that PPI is a multiple-headed inhibitor; a single PPI molecule can bind two trypsin units at the same time. Based on sequence and structural analysis, we hypothesize that the inherent plasticity of the beta-trefoil fold is paramount in the functional evolution of this family toward multiple protease inhibition.	[Martinez-Rodriguez, Sergio; Buts, Lieven; Garcia-Pino, Abel] Vrije Univ Brussel, Mol Recognit Unit, B-1050 Brussels, Belgium; [Azarkan, Mohamed; Baeyens-Volant, Danielle] Univ Libre Bruxelles, Fac Med, Prot Chem Unit, B-1070 Brussels, Belgium; [Martinez-Rodriguez, Sergio; Buts, Lieven; Garcia-Pino, Abel] VIB, Dept Mol & Cellular Interact, B-1050 Brussels, Belgium	Vrije Universiteit Brussel; Universite Libre de Bruxelles; Flanders Institute for Biotechnology (VIB)	Garcia-Pino, A (corresponding author), Vrije Univ Brussel, Mol Recognit Unit, Pleinlaan 2, B-1050 Brussels, Belgium.	agarciap@vub.ac.be	MARTINEZ-RODRIGUEZ, SERGIO/H-3448-2015	MARTINEZ-RODRIGUEZ, SERGIO/0000-0001-6675-1550; Garcia-Pino, Abel/0000-0002-0634-0300	Vlaams Interuniversitair Instituut voor Biotechnologie (VIB); Fonds voor Wetenschappelijk Onderzoek Vlaanderen (FWO); Vrije Universiteit Brussel	Vlaams Interuniversitair Instituut voor Biotechnologie (VIB); Fonds voor Wetenschappelijk Onderzoek Vlaanderen (FWO)(FWO); Vrije Universiteit Brussel	This work was supported by grants from the Vlaams Interuniversitair Instituut voor Biotechnologie (VIB), the Fonds voor Wetenschappelijk Onderzoek Vlaanderen (FWO), and the Onderzoeksraad of the Vrije Universiteit Brussel.	Azarkan M, 2006, ACTA CRYSTALLOGR F, V62, P1239, DOI 10.1107/S1744309106046367; Azarkan M, 2006, BBA-PROTEINS PROTEOM, V1764, P1063, DOI 10.1016/j.bbapap.2006.02.014; Bao R, 2009, J BIOL CHEM, V284, P26676, DOI 10.1074/jbc.M109.022095; Bode W, 2000, BBA-PROTEIN STRUCT M, V1477, P241, DOI 10.1016/S0167-4838(99)00276-9; BODE W, 1992, EUR J BIOCHEM, V204, P433, DOI 10.1111/j.1432-1033.1992.tb16654.x; Capraro DT, 2008, P NATL ACAD SCI USA, V105, P14844, DOI 10.1073/pnas.0807812105; Chavez LL, 2006, P NATL ACAD SCI USA, V103, P10254, DOI 10.1073/pnas.0510110103; Chen CP, 2001, J BIOL CHEM, V276, P45079, DOI 10.1074/jbc.M106182200; *COLL COMP PROJ 4, 1994, TRUNCATE; Dasgupta J, 2006, BIOCHEMISTRY-US, V45, P6783, DOI 10.1021/bi060374q; Dattagupta JK, 1996, ACTA CRYSTALLOGR D, V52, P521, DOI 10.1107/S0907444996000224; Dattagupta JK, 1999, PROTEINS, V35, P321, DOI 10.1002/(SICI)1097-0134(19990515)35:3<321::AID-PROT6>3.3.CO;2-P; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; De Leo F, 2002, NUCLEIC ACIDS RES, V30, P347, DOI 10.1093/nar/30.1.347; de Meester P, 1998, ACTA CRYSTALLOGR D, V54, P589, DOI 10.1107/S0907444997015849; Gahloth D, 2010, ARCH BIOCHEM BIOPHYS, V494, P15, DOI 10.1016/j.abb.2009.11.008; Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699; Kovall RA, 2004, EMBO J, V23, P3441, DOI 10.1038/sj.emboj.7600349; LASKOWSKI M, 1980, ANNU REV BIOCHEM, V49, P593, DOI 10.1146/annurev.bi.49.070180.003113; Loris R, 2002, BBA-GEN SUBJECTS, V1572, P198, DOI 10.1016/S0304-4165(02)00309-4; McCoy AJ, 1997, J MOL BIOL, V269, P881, DOI 10.1006/jmbi.1997.1067; Micheelsen PO, 2008, J MOL BIOL, V380, P681, DOI 10.1016/j.jmb.2008.05.034; MURZIN AG, 1992, J MOL BIOL, V223, P531, DOI 10.1016/0022-2836(92)90668-A; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Ravichandran S, 2001, PROTEIN ENG, V14, P349, DOI 10.1093/protein/14.5.349; Renko M, 2010, J BIOL CHEM, V285, P308, DOI 10.1074/jbc.M109.043331; RYAN CA, 1990, ANNU REV PHYTOPATHOL, V28, P425, DOI 10.1146/annurev.py.28.090190.002233; Song HK, 1998, J MOL BIOL, V275, P347, DOI 10.1006/jmbi.1997.1469; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Vallee F, 1998, STRUCTURE, V6, P649, DOI 10.1016/S0969-2126(98)00066-5; Zavala JA, 2004, PLANT PHYSIOL, V134, P1181, DOI 10.1104/pp.103.035634	32	21	21	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2011	286	51					43726	43734		10.1074/jbc.M111.291310	http://dx.doi.org/10.1074/jbc.M111.291310			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866SH	22027836	Green Published, hybrid			2022-12-27	WOS:000298402300016
J	Nijeholt, JALA; Wu, ZC; Driessen, AJM				Nijeholt, Jelger A. Lycklama A.; Wu, Zht Cheng; Driessen, Arnold J. M.			Conformational Dynamics of the Plug Domain of the SecYEG Protein-conducting Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NASCENT CHAIN COMPLEXES; COLI MEMBRANE-VESICLES; ESCHERICHIA-COLI; TRANSLOCATION CHANNEL; IN-VIVO; SIGNAL SEQUENCE; CROSS-LINKING; LATERAL GATE; SECA PROTEIN; RIBOSOME	The central pore of the SecYEG preprotein-conducting channel is closed at the periplasmic face of the membrane by a plug domain. To study its conformational dynamics, the plug was labeled site-specifically with an environment-sensitive fluorophore. In the presence of a stable preprotein translocation intermediate, the SecY plug showed an enhanced solvent exposure consistent with a displacement from the hydrophobic central pore region. In contrast, binding and insertion of a ribosome-bound nascent membrane protein did not alter the plug conformation. These data indicate different plug dynamics depending on the ligand bound state of the SecYEG channel.	Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, NL-9747 AG Groningen, Netherlands; Univ Groningen, Zernike Inst Adv Mat, NL-9747 AG Groningen, Netherlands	University of Groningen; University of Groningen	Driessen, AJM (corresponding author), Nijenborgh 7, NL-9747 AG Groningen, Netherlands.	a.j.m.driessen@rug.nl	Driessen, Arnold J.M./D-1876-2012; Institute, Zernike/W-7033-2019	Driessen, Arnold J.M./0000-0001-9258-9104				ARKOWITZ RA, 1993, EMBO J, V12, P243, DOI 10.1002/j.1460-2075.1993.tb05650.x; BANEYX F, 1990, J BACTERIOL, V172, P491, DOI 10.1128/JB.172.1.491-494.1990; Becker T, 2009, SCIENCE, V326, P1369, DOI 10.1126/science.1178535; Bol R, 2007, J BIOL CHEM, V282, P29785, DOI 10.1074/jbc.M702140200; Bonardi F, 2010, ANGEW CHEM INT EDIT, V49, P7234, DOI 10.1002/anie.201002243; Bondar AN, 2010, STRUCTURE, V18, P847, DOI 10.1016/j.str.2010.04.010; CABELLI RJ, 1988, CELL, V55, P683, DOI 10.1016/0092-8674(88)90227-9; de Keyzer J, 2002, J BIOL CHEM, V277, P46059, DOI 10.1074/jbc.M208449200; Driessen AJM, 2008, ANNU REV BIOCHEM, V77, P643, DOI 10.1146/annurev.biochem.77.061606.160747; du Plessis DJF, 2009, J BIOL CHEM, V284, P15805, DOI 10.1074/jbc.M901855200; Duong F, 1999, EMBO J, V18, P3263, DOI 10.1093/emboj/18.12.3263; Egea PF, 2010, P NATL ACAD SCI USA, V107, P17182, DOI 10.1073/pnas.1012556107; Evans MS, 2005, NAT METHODS, V2, P757, DOI 10.1038/NMETH790; Fekkes P, 1998, MOL MICROBIOL, V29, P1179, DOI 10.1046/j.1365-2958.1998.00997.x; Frauenfeld J, 2011, NAT STRUCT MOL BIOL, V18, P614, DOI 10.1038/nsmb.2026; Greenough KP, 2006, J PHYS CHEM B, V110, P6351, DOI 10.1021/jp057073v; Gumbart J, 2008, J GEN PHYSIOL, V132, P709, DOI 10.1085/jgp.200810062; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Harris CR, 1999, J BACTERIOL, V181, P3438, DOI 10.1128/JB.181.11.3438-3444.1999; JOLY JC, 1993, EMBO J, V12, P255, DOI 10.1002/j.1460-2075.1993.tb05651.x; Junne T, 2006, MOL BIOL CELL, V17, P4063, DOI 10.1091/mbc.E06-03-0200; KLOSE M, 1993, J BIOL CHEM, V268, P4504; Kusters I, 2011, STRUCTURE, V19, P430, DOI 10.1016/j.str.2010.12.016; LAKOWICZ JR, 1999, PRINCIPLES FLUORESCE, P129; Li WK, 2007, MOL CELL, V26, P511, DOI 10.1016/j.molcel.2007.05.002; LIN S, 1991, PHOTOCHEM PHOTOBIOL, V54, P361, DOI 10.1111/j.1751-1097.1991.tb02028.x; Maillard AP, 2007, J BIOL CHEM, V282, P1281, DOI 10.1074/jbc.M610060200; Manting EH, 1999, J BIOL CHEM, V274, P23868, DOI 10.1074/jbc.274.34.23868; Menetret JF, 2007, MOL CELL, V28, P1083, DOI 10.1016/j.molcel.2007.10.034; Nakatogawa H, 2002, CELL, V108, P629, DOI 10.1016/S0092-8674(02)00649-9; Nijeholt JALA, 2010, J BIOL CHEM, V285, P23747, DOI 10.1074/jbc.M110.124636; OSBORNE RS, 1993, EMBO J, V12, P3391, DOI 10.1002/j.1460-2075.1993.tb06013.x; Plath K, 1998, CELL, V94, P795, DOI 10.1016/S0092-8674(00)81738-9; Prinz A, 2000, EMBO J, V19, P1900, DOI 10.1093/emboj/19.8.1900; Ramachandran R, 2004, NAT STRUCT MOL BIOL, V11, P697, DOI 10.1038/nsmb793; Rutkowska A, 2008, J BIOL CHEM, V283, P4124, DOI 10.1074/jbc.M708294200; Schaffitzel C, 2007, J STRUCT BIOL, V158, P463, DOI 10.1016/j.jsb.2007.01.005; Smith MA, 2005, J BACTERIOL, V187, P6454, DOI 10.1128/JB.187.18.6454-6465.2005; Tam PCK, 2005, EMBO J, V24, P3380, DOI 10.1038/sj.emboj.7600804; Tsukazaki T, 2008, NATURE, V455, P988, DOI 10.1038/nature07421; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; van der Does C, 2003, METHOD ENZYMOL, V372, P86; van der Sluis EO, 2002, FEBS LETT, V527, P159, DOI 10.1016/S0014-5793(02)03202-7; Zhang B, 2010, P NATL ACAD SCI USA, V107, P5399, DOI 10.1073/pnas.0914752107; Zimmer J, 2008, NATURE, V455, P936, DOI 10.1038/nature07335	45	13	13	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2011	286	51					43881	43890		10.1074/jbc.M111.297507	http://dx.doi.org/10.1074/jbc.M111.297507			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866SH	22033919	Green Published, hybrid			2022-12-27	WOS:000298402300029
J	Gardsvoll, H; Kjaergaard, M; Jacobsen, B; Kriegbaum, MC; Huang, MD; Ploug, M				Gardsvoll, Henrik; Kjaergaard, Magnus; Jacobsen, Benedikte; Kriegbaum, Mette C.; Huang, Mingdong; Ploug, Michael			Mimicry of the Regulatory Role of Urokinase in Lamellipodia Formation by Introduction of a Non-native Interdomain Disulfide Bond in Its Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMINOGEN-ACTIVATOR RECEPTOR; BREAST-CANCER; MONOCLONAL-ANTIBODIES; CELLULAR RECEPTOR; ANTHRAX TOXIN; INVASIVE FOCI; STROMAL CELLS; BINDING-SITE; IN-VIVO; VITRONECTIN	The high-affinity interaction between the urokinase-type plasminogen activator (uPA) and its glycolipid-anchored receptor (uPAR) plays a regulatory role for both extravascular fibrinolysis and uPAR-mediated adhesion and migration on vitronectin-coated surfaces. We have recently proposed that the adhesive function of uPAR is allosterically regulated via a "tightening" of its three-domain structure elicited by uPA binding. To challenge this proposition, we redesigned the uPAR structure to limit its inherent conformational flexibility by covalently tethering domains DI and DIII via a non-natural interdomain disulfide bond (uPAR(H47C-N259C)). The corresponding soluble receptor has 1) a smaller hydrodynamic volume, 2) a higher content of secondary structure, and 3) unaltered binding kinetics towards uPA. Most importantly, the purified uPAR(H47C-N259C) also displays a gain in affinity for the somatomedin B domain of vitronectin compared with uPAR(wt), thus recapitulating the improved affinity that accompanies uPA-uPAR(wt) complex formation. This functional mimicry is, intriguingly, operational also in a cellular setting, where it controls lamellipodia formation in uPAR-transfected HEK293 cells adhering to vitronectin. In this respect, the engineered constraint in uPAR(H47C-N259C) thus bypasses the regulatory role of uPA binding, resulting in a constitutively active uPAR. In conclusion, our data argue for a biological relevance of the interdomain dynamics of the glycolipid-anchored uPAR on the cell surface.	[Gardsvoll, Henrik; Jacobsen, Benedikte; Kriegbaum, Mette C.; Ploug, Michael] Rigshosp, Finsen Lab, BRIC, Copenhagen Bioctr, DK-2200 Copenhagen N, Denmark; [Gardsvoll, Henrik; Jacobsen, Benedikte; Huang, Mingdong; Ploug, Michael] Univ Copenhagen, Danish Chinese Ctr Proteases & Canc, DK-2200 Copenhagen N, Denmark; [Kjaergaard, Magnus] Univ Copenhagen, Dept Biol, DK-2200 Copenhagen N, Denmark; [Huang, Mingdong] Chinese Acad Sci, Fujian Inst Res Struct Matter, State Key Lab Struct Chem, Fuzhou 350002, Fujian, Peoples R China	Rigshospitalet; University of Copenhagen; University of Copenhagen; Chinese Academy of Sciences; Fujian Institute of Research on the Structure of Matter, CAS	Ploug, M (corresponding author), Rigshosp, Finsen Lab, BRIC, Copenhagen Bioctr, Rm 3-3-31,Ole Maaloes Vej 5, DK-2200 Copenhagen N, Denmark.	m-ploug@finsenlab.dk	Huang, Mingdong/J-4278-2017; Kjaergaard, Magnus/A-6591-2012; Kjaergaard, Magnus/AAD-7717-2019	Huang, Mingdong/0000-0003-0085-9141; Kjaergaard, Magnus/0000-0002-7020-9366; Ploug, Michael/0000-0003-2215-4265	The Danish National Research Foundation (Centre for Proteases and Cancer); The Lundbeck Foundation	The Danish National Research Foundation (Centre for Proteases and Cancer); The Lundbeck Foundation(Lundbeckfonden)	This work was supported by grants from The Danish National Research Foundation (Centre for Proteases and Cancer) and The Lundbeck Foundation.	BEHRENDT N, 1991, J BIOL CHEM, V266, P7842; Bernstein AM, 2007, MOL BIOL CELL, V18, P2716, DOI 10.1091/mbc.E06-10-0912; Connolly BM, 2010, BLOOD, V116, P1593, DOI 10.1182/blood-2010-03-276642; Deng G, 1996, J CELL BIOL, V134, P1563, DOI 10.1083/jcb.134.6.1563; Foekens JA, 2000, CANCER RES, V60, P636; Gardsvoll H, 2004, PROTEIN EXPRES PURIF, V34, P284, DOI 10.1016/j.pep.2003.12.002; Gardsvoll H, 2007, J BIOL CHEM, V282, P13561, DOI 10.1074/jbc.M610184200; Gardsvoll H, 2006, J BIOL CHEM, V281, P19260, DOI 10.1074/jbc.M513583200; Gardsvoll H, 2011, J BIOL CHEM, V286, P33544, DOI 10.1074/jbc.M111.220087; GRONDAHLHANSEN J, 1988, J LAB CLIN MED, V111, P42; Hildenbrand R, 2009, AM J PATHOL, V174, P2246, DOI 10.2353/ajpath.2009.080785; Hillig T, 2008, J BIOL CHEM, V283, P15217, DOI 10.1074/jbc.C700214200; Huai Q, 2006, SCIENCE, V311, P656, DOI 10.1126/science.1121143; Huai Q, 2008, NAT STRUCT MOL BIOL, V15, P422, DOI 10.1038/nsmb.1404; Jacobsen B, 2007, PROTEIN EXPRES PURIF, V52, P286, DOI 10.1016/j.pep.2006.08.011; Jo M, 2009, J BIOL CHEM, V284, P22825, DOI 10.1074/jbc.M109.023960; Kjaergaard M, 2008, FRONT BIOSCI-LANDMRK, V13, P5441, DOI 10.2741/3092; Kjaergaard M, 2007, PROTEIN SCI, V16, P1934, DOI 10.1110/ps.072949607; Kjoller L, 2001, J CELL BIOL, V152, P1145, DOI 10.1083/jcb.152.6.1145; Kriegbaum MC, 2011, CURR DRUG TARGETS, V12, P1711; Kroon ME, 1999, AM J PATHOL, V154, P1731, DOI 10.1016/S0002-9440(10)65429-6; Lin L, 2010, J BIOL CHEM, V285, P10982, DOI 10.1074/jbc.M109.093492; Liu SH, 2003, P NATL ACAD SCI USA, V100, P657, DOI 10.1073/pnas.0236849100; Liu SH, 2001, J BIOL CHEM, V276, P17976, DOI 10.1074/jbc.M011085200; Llinas P, 2005, EMBO J, V24, P1655, DOI 10.1038/sj.emboj.7600635; Madsen CD, 2007, J CELL BIOL, V177, P927, DOI 10.1083/jcb.200612058; Mazzieri R, 2006, MOL BIOL CELL, V17, P367, DOI 10.1091/mbc.E05-07-0635; Mertens HDT, 2010, J STRUCT BIOL, V172, P128, DOI 10.1016/j.jsb.2010.06.012; Ngo JCK, 2011, CURR DRUG TARGETS, V12, P1729; Nielsen BS, 2007, INT J CANCER, V120, P2086, DOI 10.1002/ijc.22340; Nieves EC, 2010, J BIOL CHEM, V285, P12595, DOI 10.1074/jbc.M109.008581; Pass J, 2007, THROMB HAEMOSTASIS, V97, P1013, DOI 10.1160/TH06-11-0644; Petersen MTN, 1999, PROTEIN ENG, V12, P535, DOI 10.1093/protein/12.7.535; PLOUG M, 1994, BIOCHEMISTRY-US, V33, P8991, DOI 10.1021/bi00196a017; PLOUG M, 1993, J BIOL CHEM, V268, P17539; PLOUG M, 1991, J BIOL CHEM, V266, P1926; PYKE C, 1991, AM J PATHOL, V138, P1059; Resnati M, 2002, P NATL ACAD SCI USA, V99, P1359, DOI 10.1073/pnas.022652999; Riisbro R, 2002, CLIN CANCER RES, V8, P1132; Seeds N, 2011, CELL MOL NEUROBIOL, V31, P961, DOI 10.1007/s10571-011-9701-6; Sidenius N, 2000, FEBS LETT, V470, P40, DOI 10.1016/S0014-5793(00)01282-5; Stephens RW, 1999, JNCI-J NATL CANCER I, V91, P869, DOI 10.1093/jnci/91.10.869; STRATTONTHOMAS JR, 1995, PROTEIN ENG, V8, P463, DOI 10.1093/protein/8.5.463; Teilum K, 2009, CELL MOL LIFE SCI, V66, P2231, DOI 10.1007/s00018-009-0014-6; WALTZ DA, 1994, J BIOL CHEM, V269, P14746; WALTZ DA, 1993, J CLIN INVEST, V91, P1541, DOI 10.1172/JCI116360; Wei C, 2008, NAT MED, V14, P55, DOI 10.1038/nm1696; Wei CL, 2011, NAT MED, V17, P952, DOI 10.1038/nm.2411; Wei Y, 2005, J CELL BIOL, V168, P501, DOI 10.1083/jcb.200404112; Wei Y, 1996, SCIENCE, V273, P1551, DOI 10.1126/science.273.5281.1551	50	27	27	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					43515	43526		10.1074/jbc.M111.300020	http://dx.doi.org/10.1074/jbc.M111.300020			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22025616	Green Published, hybrid			2022-12-27	WOS:000298351300071
J	Kapri-Pardes, E; Katz, A; Haviv, H; Mahmmoud, Y; Ilan, M; Khalfin-Penigel, I; Carmeli, S; Yarden, O; Karlish, SJD				Kapri-Pardes, Einat; Katz, Adriana; Haviv, Haim; Mahmmoud, Yasser; Ilan, Micha; Khalfin-Penigel, Irena; Carmeli, Shmuel; Yarden, Oded; Karlish, Steven J. D.			Stabilization of the alpha 2 Isoform of Na,K-ATPase by Mutations in a Phospholipid Binding Pocket	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA+-K+-ATPASE; SODIUM-POTASSIUM PUMP; CRYSTAL-STRUCTURE; PICHIA-PASTORIS; CARDIAC MYOCYTES; SKELETAL-MUSCLE; FXYD PROTEINS; SUBUNIT; NA+,K+-ATPASE; TRANSPORT	Background: The alpha 2 isoform of Na, K-ATPase is unstable compared with alpha 1 and alpha 3. Results: Mutations in TM8-10 strongly stabilize alpha 2. A novel phospholipid antagonist selectively inactivates alpha 2, and mutations in TM8-10 protect against inactivation. Conclusion: A phosphatidylserine binding pocket within TM8-10 has been identified. Significance: Mechanistic insights into alpha 2 instability and a possible physiological role have been obtained.	[Kapri-Pardes, Einat; Katz, Adriana; Haviv, Haim; Karlish, Steven J. D.] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; [Mahmmoud, Yasser] Univ Aarhus, Dept Biomed, DK-8000 Aarhus, Denmark; [Ilan, Micha; Khalfin-Penigel, Irena] Tel Aviv Univ, Dept Zool, George S Wise Fac Life Sci, IL-69978 Ramat Aviv, Israel; [Carmeli, Shmuel] Tel Aviv Univ, Sch Chem, Raymond & Beverly Sackler Fac Exact Sci, IL-69978 Ramat Aviv, Israel; [Yarden, Oded] Hebrew Univ Jerusalem, Dept Plant Pathol & Microbiol, Robert H Smith Fac Agr Food & Environm, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Aarhus University; Tel Aviv University; Tel Aviv University; Hebrew University of Jerusalem	Karlish, SJD (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	Steven.Karlish@weizmann.ac.il	Yarden, Oded/J-5988-2012; Ilan, Micha/ABG-4106-2020; Carmeli, shmuel/N-1273-2018	Ilan, Micha/0000-0002-4188-4573; Carmeli, shmuel/0000-0002-9641-9943	Minerva Foundation; Israel Science Foundation [ISF 996/06]	Minerva Foundation; Israel Science Foundation(Israel Science Foundation)	This work was supported in part by a grant from the Minerva Foundation (to S.J.D.K.).; Supported by Israel Science Foundation Grant ISF 996/06.	ARYSTARKHOVA E, 1995, J BIOL CHEM, V270, P8785, DOI 10.1074/jbc.270.15.8785; Berry RG, 2007, CARDIOVASC RES, V73, P92, DOI 10.1016/j.cardiores.2006.11.006; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Bers DM, 2009, IUBMB LIFE, V61, P215, DOI 10.1002/iub.163; Blanco G, 1998, AM J PHYSIOL-RENAL, V275, pF633, DOI 10.1152/ajprenal.1998.275.5.F633; Blaustein MP, 2006, AM J PHYSIOL-REG I, V290, pR514, DOI 10.1152/ajpregu.00819.2005; Cohen E, 2005, J BIOL CHEM, V280, P16610, DOI 10.1074/jbc.M414290200; Crambert G, 2000, J BIOL CHEM, V275, P1976, DOI 10.1074/jbc.275.3.1976; Crambert G, 2002, P NATL ACAD SCI USA, V99, P11476, DOI 10.1073/pnas.182267299; De Fusco M, 2003, NAT GENET, V33, P192, DOI 10.1038/ng1081; Despa S, 2007, AM J PHYSIOL-CELL PH, V293, pC321, DOI 10.1152/ajpcell.00597.2006; Despa S, 2010, BIOPHYS J, V98, p201A, DOI 10.1016/j.bpj.2009.12.1075; Donnet C, 2001, J BIOL CHEM, V276, P7357, DOI 10.1074/jbc.M009131200; Dostanic-Larson I, 2006, AM J PHYSIOL-REG I, V290, pR524, DOI 10.1152/ajpregu.00838.2005; Ferrandi M, 2004, J BIOL CHEM, V279, P33306, DOI 10.1074/jbc.M402187200; Garty H, 2006, ANNU REV PHYSIOL, V68, P431, DOI 10.1146/annurev.physiol.68.040104.131852; Geering K, 2006, AM J PHYSIOL-RENAL, V290, pF241, DOI 10.1152/ajprenal.00126.2005; GOLDSHLEGER R, 1995, BIOCHEMISTRY-US, V34, P8668, DOI 10.1021/bi00027a016; Han F, 2009, AM J PHYSIOL-CELL PH, V297, pC699, DOI 10.1152/ajpcell.00063.2009; Hauck C, 2009, EUR J PHARMACOL, V622, P7, DOI 10.1016/j.ejphar.2009.08.039; Haviv H, 2007, BIOCHEMISTRY-US, V46, P12855, DOI 10.1021/bi701248y; Hayashi Y, 1988, Prog Clin Biol Res, V268A, P205; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Jia LG, 2005, AM J PHYSIOL-HEART C, V288, pH1982, DOI 10.1152/ajpheart.00142.2004; JORGENSEN PL, 1974, BIOCHIM BIOPHYS ACTA, V356, P36, DOI 10.1016/0005-2736(74)90292-2; Jorgensen PL, 2003, ANNU REV PHYSIOL, V65, P817, DOI 10.1146/annurev.physiol.65.092101.142558; Juhaszova M, 1997, P NATL ACAD SCI USA, V94, P1800, DOI 10.1073/pnas.94.5.1800; Kaplan JH, 2002, ANNU REV BIOCHEM, V71, P511, DOI 10.1146/annurev.biochem.71.102201.141218; Katz A, 2010, J BIOL CHEM, V285, P19582, DOI 10.1074/jbc.M110.119248; Klodos I, 2002, KIDNEY INT, V62, P2097, DOI 10.1046/j.1523-1755.2002.00654.x; Lee AG, 2003, BBA-BIOMEMBRANES, V1612, P1, DOI 10.1016/S0005-2736(03)00056-7; Leo L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002129; Lifshitz Y, 2007, BIOCHEMISTRY-US, V46, P14937, DOI 10.1021/bi701812c; Lingrel JB, 2010, ANNU REV PHYSIOL, V72, P395, DOI 10.1146/annurev-physiol-021909-135725; Mangialavori I, 2009, J BIOL CHEM, V284, P4823, DOI 10.1074/jbc.M806912200; McDonough AA, 2002, AM J PHYSIOL-RENAL, V282, pF967, DOI 10.1152/ajprenal.00360.2001; Miles AJ, 2011, BBA-BIOMEMBRANES, V1808, P2573, DOI 10.1016/j.bbamem.2011.06.009; Mishra NK, 2011, J BIOL CHEM, V286, P9699, DOI 10.1074/jbc.M110.184234; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Morth JP, 2009, PHILOS T R SOC B, V364, P217, DOI 10.1098/rstb.2008.0201; Muller-Ehmsen J, 2001, AM J PHYSIOL-CELL PH, V281, pC1355, DOI 10.1152/ajpcell.2001.281.4.C1355; NIGGLI V, 1981, J BIOL CHEM, V256, P8588; Obara K, 2005, P NATL ACAD SCI USA, V102, P14489, DOI 10.1073/pnas.0506222102; Ogawa H, 2009, P NATL ACAD SCI USA, V106, P13742, DOI 10.1073/pnas.0907054106; Paz Z, 2010, FUNGAL DIVERS, V42, P17, DOI 10.1007/s13225-010-0020-x; Pedersen PA, 1996, BIOCHEMISTRY-US, V35, P16085, DOI 10.1021/bi961614c; Pietrobon D, 2007, NEUROTHERAPEUTICS, V4, P274, DOI 10.1016/j.nurt.2007.01.008; Rubio MB, 2009, FUNGAL GENET BIOL, V46, P17, DOI 10.1016/j.fgb.2008.10.008; Segall L, 2005, P NATL ACAD SCI USA, V102, P11106, DOI 10.1073/pnas.0504323102; Sharabani-Yosef O, 1999, J CELL PHYSIOL, V180, P236, DOI 10.1002/(SICI)1097-4652(199908)180:2<236::AID-JCP11>3.3.CO;2-N; Shinoda T, 2009, NATURE, V459, P446, DOI 10.1038/nature07939; Strugatsky D, 2003, J BIOL CHEM, V278, P46064, DOI 10.1074/jbc.M308303200; SWEADNER KJ, 1994, CIRC RES, V74, P669, DOI 10.1161/01.RES.74.4.669; Sweadner KJ, 2000, GENOMICS, V68, P41, DOI 10.1006/geno.2000.6274; Swift F, 2008, CARDIOVASC RES, V78, P71, DOI 10.1093/cvr/cvn013; Swift F, 2007, CARDIOVASC RES, V75, P109, DOI 10.1016/j.cardiores.2007.03.017; Swift F, 2010, CELL CALCIUM, V48, P54, DOI 10.1016/j.ceca.2010.06.006; Tanaka K, 2011, J BIOCHEM, V149, P131, DOI 10.1093/jb/mvq140; Tavraz NN, 2008, J BIOL CHEM, V283, P31097, DOI 10.1074/jbc.M802771200; Tavraz NN, 2009, CHANNELS, V3, P82, DOI 10.4161/chan.3.2.8085; Yatime L, 2011, J STRUCT BIOL, V174, P296, DOI 10.1016/j.jsb.2010.12.004; Zhang J, 2005, J PHYSIOL-LONDON, V569, P243, DOI 10.1113/jphysiol.2005.091801	62	36	41	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					42888	42899		10.1074/jbc.M111.293852	http://dx.doi.org/10.1074/jbc.M111.293852			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22027833	Green Published, hybrid			2022-12-27	WOS:000298351300011
J	Liu, XJ; Cheng, YH; Chen, XW; Yang, J; Xu, L; Zhang, CX				Liu, Xiaojun; Cheng, Yunhui; Chen, Xiuwei; Yang, Jian; Xu, Ling; Zhang, Chunxiang			MicroRNA-31 Regulated by the Extracellular Regulated Kinase Is Involved in Vascular Smooth Muscle Cell Growth via Large Tumor Suppressor Homolog 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE; IN-VITRO; EXPRESSION; MIR-31; PROLIFERATION; CANCER; MIR-143; LATS2; METASTASIS; WARTS/LATS	Aberrant growth of vascular smooth muscle cells (VSMCs) is a major cellular event in the pathogenesis of many proliferative vascular diseases. Recently, microRNA-31 (miR-31) has been found to play a critical role in cancer cell proliferation. However, the biological role of miR-31 in VSMC growth and the mechanisms involved are currently unknown. In the present study, the expression of rat mature miR-31 (rno-miR-31) was determined in cultured VSMCs and in rat carotid arteries. We identified that rno-miR-31 is an abundant miRNA in VSMCs, and its expression was significantly increased in proliferative VSMCs and in vascular walls with neointimal growth. The up-regulation of rno-miR-31 in proliferative VSMCs was inhibited by the inhibitor of mitogen-activated protein kinase/extracellular regulated kinase (MAPK/ERK). By both gain-of-function and loss-of-function approaches, we demonstrated that rno-miR-31 had a proproliferative effect on VSMCs. We further identified that LATS2 (large tumor suppressor homolog 2) is a downstream target gene product of rno-miR-31 that is involved in rno-miR-31-mediated effect on VSMC proliferation. The LATS2 as a target gene protein of rno-miR-31 is verified in vivo in balloon-injured rat carotid arteries. The results suggest that MAPK/ERK/miR-31/LATS2 may represent a novel signaling pathway in VSMC growth. miR-31 is able to enhance VSMC proliferation via its downstream target gene product, LATS2.	[Liu, Xiaojun; Cheng, Yunhui; Chen, Xiuwei; Yang, Jian; Xu, Ling; Zhang, Chunxiang] Univ Med & Dent New Jersey, RNA & Cardiovasc Res Lab, Dept Anesthesiol, New Jersey Med Sch, Newark, NJ 07101 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Zhang, CX (corresponding author), Univ Med & Dent New Jersey, RNA & Cardiovasc Res Lab, Dept Anesthesiol, New Jersey Med Sch, 185 S Orange Ave,MSB E548, Newark, NJ 07101 USA.	zhangc3@umdnj.edu	zhang, xiang chun/HCH-7063-2022; Chen, Xiuwei/AAH-6695-2021; Cheng, Yunhui/D-3922-2012	zhang, xiang chun/0000-0001-8303-6495; 	National Institutes of Health [HL080133, HL095707]; American Heart Association [09GRNT2250567]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095707, R01HL080133] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL080133 and HL095707 (to C. Z.). This work was also supported by American Heart Association Grant 09GRNT2250567 (to C. Z.).	Ahn JD, 2002, CIRC RES, V90, P1325, DOI 10.1161/01.RES.0000023200.19316.D5; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Aprelikova O, 2010, CELL CYCLE, V9, P4387, DOI 10.4161/cc.9.21.13674; Bandres E, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-29; Benson DA, 2014, NUCLEIC ACIDS RES, V42, pD32, DOI [10.1093/nar/gkp1024, 10.1093/nar/gkt1030, 10.1093/nar/gks1195, 10.1093/nar/gkw1070, 10.1093/nar/gkq1079, 10.1093/nar/gkn723, 10.1093/nar/gkr1202, 10.1093/nar/gkx1094]; Boettger T, 2009, J CLIN INVEST, V119, P2634, DOI 10.1172/JCI38864; Bornfeldt KE, 1999, CELL SIGNAL, V11, P465, DOI 10.1016/S0898-6568(99)00020-0; Chen G, 2011, J ETHNOPHARMACOL, V135, P7, DOI 10.1016/j.jep.2011.02.011; Chen J, 2011, ARTERIOSCL THROM VAS, V31, P368, DOI 10.1161/ATVBAHA.110.218149; Chen K, 2007, NAT REV GENET, V8, P93, DOI 10.1038/nrg1990; Cheng YH, 2009, CIRC RES, V105, P158, DOI 10.1161/CIRCRESAHA.109.197517; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Cottonham CL, 2010, J BIOL CHEM, V285, P35293, DOI 10.1074/jbc.M110.160069; Creighton CJ, 2010, CANCER RES, V70, P1906, DOI 10.1158/0008-5472.CAN-09-3875; Davis BN, 2009, J BIOL CHEM, V284, P3728, DOI 10.1074/jbc.M808788200; Edlin RS, 2009, J VASC SURG, V49, P1289, DOI 10.1016/j.jvs.2008.11.096; Ella L, 2009, CELL DEATH DIFFER, V16, P1590, DOI 10.1038/cdd.2009.153; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Hori T, 2000, ONCOGENE, V19, P3101, DOI 10.1038/sj.onc.1203659; Ji RR, 2007, CIRC RES, V100, P1579, DOI 10.1161/CIRCRESAHA.106.141986; JUSTICE RW, 1995, GENE DEV, V9, P534, DOI 10.1101/gad.9.5.534; Kamikubo Y, 2003, J BIOL CHEM, V278, P17609, DOI 10.1074/jbc.M211974200; Kavurma MM, 2003, J CELL BIOCHEM, V89, P289, DOI 10.1002/jcb.10497; Lee KH, 2009, EXP CELL RES, V315, P2529, DOI 10.1016/j.yexcr.2009.06.001; Leeper NJ, 2011, J CELL PHYSIOL, V226, P1035, DOI 10.1002/jcp.22422; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li YF, 2003, ONCOGENE, V22, P4398, DOI 10.1038/sj.onc.1206603; Liu CJ, 2010, CANCER RES, V70, P1635, DOI 10.1158/0008-5472.CAN-09-2291; Liu X, 2010, J CLIN INVEST, V120, P1298, DOI 10.1172/JCI39566; Liu XJ, 2009, CIRC RES, V104, P476, DOI 10.1161/CIRCRESAHA.108.185363; Liu XQ, 2009, COMP FUNCT GENOM, DOI 10.1155/2009/837514; Lu R, 2007, J BIOL CHEM, V282, P12249, DOI 10.1074/jbc.M608525200; Mardaryev AN, 2010, FASEB J, V24, P3869, DOI 10.1096/fj.10-160663; Motoyama K, 2009, INT J ONCOL, V34, P1069, DOI 10.3892/ijo_00000233; Paroo Z, 2009, CELL, V139, P112, DOI 10.1016/j.cell.2009.06.044; Pedrioli DML, 2010, MOL CELL BIOL, V30, P3620, DOI 10.1128/MCB.00185-10; Qin SS, 2011, J CARDIOVASC PHARM, V57, P8, DOI 10.1097/FJC.0b013e318203759b; Sakakibara K, 2005, J BIOL CHEM, V280, P25470, DOI 10.1074/jbc.M502320200; Shen JK, 2008, MOL THER, V16, P1208, DOI 10.1038/mt.2008.104; Slaby O, 2007, ONCOLOGY-BASEL, V72, P397, DOI 10.1159/000113489; Suarez Y, 2010, J IMMUNOL, V184, P21, DOI 10.4049/jimmunol.0902369; Sun SG, 2011, EMBO REP, V12, P56, DOI 10.1038/embor.2010.172; Valastyan S, 2010, CELL CYCLE, V9, P2124, DOI 10.4161/cc.9.11.11843; Valastyan S, 2009, CELL, V137, P1032, DOI 10.1016/j.cell.2009.03.047; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037; Xin M, 2009, GENE DEV, V23, P2166, DOI 10.1101/gad.1842409; XU TA, 1995, DEVELOPMENT, V121, P1053; Yabuta N, 2000, GENOMICS, V63, P263, DOI 10.1006/geno.1999.6065; Zhang CX, 2008, PHYSIOL GENOMICS, V33, P139, DOI 10.1152/physiolgenomics.00034.2008	50	80	91	0	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42371	42380		10.1074/jbc.M111.261065	http://dx.doi.org/10.1074/jbc.M111.261065			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	22020941	Green Published, hybrid			2022-12-27	WOS:000298180900046
J	Brasaemle, DL; Wolins, NE				Brasaemle, Dawn L.; Wolins, Nathan E.			Packaging of Fat: An Evolving Model of Lipid Droplet Assembly and Expansion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							ADIPOSE TRIGLYCERIDE LIPASE; CHANARIN-DORFMAN-SYNDROME; HORMONE-SENSITIVE LIPASE; ENDOPLASMIC-RETICULUM; ACYL-COA; DIACYLGLYCEROL ACYLTRANSFERASE-2; TRIACYLGLYCEROL SYNTHESIS; DEFICIENT MICE; PERILIPIN-A; RAT-LIVER	Lipid droplets (LDs) are organelles found in most types of cells in the tissues of vertebrates, invertebrates, and plants, as well as in bacteria and yeast. They differ from other organelles in binding a unique complement of proteins and lacking an aqueous core but share aspects of protein trafficking with secretory membrane compartments. In this minireview, we focus on recent evidence supporting an endoplasmic reticulum origin for LD formation and discuss recent findings regarding LD maturation and fusion.	[Brasaemle, Dawn L.] Rutgers State Univ, Rutgers Ctr Lipid Res, New Brunswick, NJ 08901 USA; [Brasaemle, Dawn L.] Rutgers State Univ, Dept Nutr Sci, New Brunswick, NJ 08901 USA; [Wolins, Nathan E.] Washington Univ, Sch Med, Dept Med, Div Geriatr & Nutr Sci, St Louis, MO 63110 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Washington University (WUSTL)	Brasaemle, DL (corresponding author), Rutgers State Univ, Rutgers Ctr Lipid Res, New Brunswick, NJ 08901 USA.	brasaemle@aesop.rutgers.edu; nwolins@im.wustl.edu		Brasaemle, Dawn/0000-0002-8553-8285	National Institutes of Health [DK054797, DK088206]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054797, R01DK088206] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK054797 (to D. L. B.) and DK088206 (to N. E. W.). This is the first article in the Thematic Minireview Series on the Lipid Droplet, a Dynamic Organelle of Biomedical and Commercial Importance.	Abell BM, 1997, PLANT CELL, V9, P1481, DOI 10.1105/tpc.9.8.1481; Adeyo O, 2011, J CELL BIOL, V192, P1043, DOI 10.1083/jcb.201010111; Bartz R, 2007, J LIPID RES, V48, P837, DOI 10.1194/jlr.M600413-JLR200; Beller M, 2008, PLOS BIOL, V6, P2530, DOI 10.1371/journal.pbio.0060292; Binns D, 2010, BIOCHEMISTRY-US, V49, P10747, DOI 10.1021/bi1013003; BLANCHETTEMACKIE EJ, 1995, J LIPID RES, V36, P1211; Bostrom P, 2007, NAT CELL BIOL, V9, P1286, DOI 10.1038/ncb1648; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; Brasaemle DL, 2009, MOL CELL BIOCHEM, V326, P15, DOI 10.1007/s11010-008-9998-8; Carman GM, 2009, J BIOL CHEM, V284, P2593, DOI 10.1074/jbc.R800059200; Chang TY, 2009, AM J PHYSIOL-ENDOC M, V297, pE1, DOI 10.1152/ajpendo.90926.2008; Cohen AW, 2004, DIABETES, V53, P1261, DOI 10.2337/diabetes.53.5.1261; Cui X, 2011, HUM MOL GENET, V20, P3022, DOI 10.1093/hmg/ddr205; CUSHMAN SW, 1970, J CELL BIOL, V46, P326, DOI 10.1083/jcb.46.2.326; Fei WH, 2008, J CELL BIOL, V180, P473, DOI 10.1083/jcb.200711136; Fei WH, 2011, J LIPID RES, V52, P2136, DOI 10.1194/jlr.M017566; Fei WH, 2011, TRENDS ENDOCRIN MET, V22, P204, DOI 10.1016/j.tem.2011.02.004; Fei WH, 2009, BIOCHEM J, V424, P61, DOI 10.1042/BJ20090785; Friedman EJ, 2011, J BIOL CHEM, V286, P30107, DOI 10.1074/jbc.M111.227256; Goodman JM, 2008, J BIOL CHEM, V283, P28005, DOI 10.1074/jbc.R800042200; Granneman JG, 2007, J BIOL CHEM, V282, P5726, DOI 10.1074/jbc.M610580200; Granneman JG, 2009, J BIOL CHEM, V284, P34538, DOI 10.1074/jbc.M109.068478; Gruber A, 2010, J BIOL CHEM, V285, P12289, DOI 10.1074/jbc.M109.064469; Guo Y, 2008, NATURE, V453, P657, DOI 10.1038/nature06928; Hodges BDM, 2010, J LIPID RES, V51, P262, DOI 10.1194/jlr.R003582; Hoepfner D, 2005, CELL, V122, P85, DOI 10.1016/j.cell.2005.04.025; Horl G, 2011, J BIOL CHEM, V286, P17338, DOI 10.1074/jbc.M111.234534; Huang AHC, 1996, PLANT PHYSIOL, V110, P1055, DOI 10.1104/pp.110.4.1055; Igal RA, 2001, J BIOL CHEM, V276, P42205, DOI 10.1074/jbc.M103386200; Jacquier N, 2011, J CELL SCI, V124, P2424, DOI 10.1242/jcs.076836; Kadereit B, 2008, P NATL ACAD SCI USA, V105, P94, DOI 10.1073/pnas.0708579105; Kohlwein SD, 2010, J BIOL CHEM, V285, P15663, DOI 10.1074/jbc.R110.118356; Krahmer N, 2011, CELL METAB, V14, P504, DOI 10.1016/j.cmet.2011.07.013; KRISANS SK, 1980, J BIOL CHEM, V255, P9599; Kuerschner L, 2008, TRAFFIC, V9, P338, DOI 10.1111/j.1600-0854.2007.00689.x; Lass A, 2006, CELL METAB, V3, P309, DOI 10.1016/j.cmet.2006.03.005; Li LO, 2010, BBA-MOL CELL BIOL L, V1801, P246, DOI 10.1016/j.bbalip.2009.09.024; Liu K, 2009, AM J PHYSIOL-ENDOC M, V297, pE1395, DOI 10.1152/ajpendo.00188.2009; Magre J, 2001, NAT GENET, V28, P365, DOI 10.1038/ng585; Matsusue K, 2008, CELL METAB, V7, P302, DOI 10.1016/j.cmet.2008.03.003; McFie PJ, 2011, J BIOL CHEM, V286, P28235, DOI 10.1074/jbc.M111.256008; Miranda DA, 2011, J BIOL CHEM, V286, P42188, DOI 10.1074/jbc.M111.297127; Moessinger C, 2011, J BIOL CHEM, V286, P21330, DOI 10.1074/jbc.M110.202424; Nagayama M, 2007, J LIPID RES, V48, P9, DOI 10.1194/jlr.M600155-JLR200; Nagayama M, 2010, FEBS LETT, V584, P86, DOI 10.1016/j.febslet.2009.10.088; Nishino N, 2008, J CLIN INVEST, V118, P2808, DOI 10.1172/JCI34090; Pellon-Malson M, 2007, BBA-MOL CELL BIOL L, V1771, P830, DOI 10.1016/j.bbalip.2007.04.001; Puri V, 2007, J BIOL CHEM, V282, P34213, DOI 10.1074/jbc.M707404200; Razani B, 2002, J BIOL CHEM, V277, P8635, DOI 10.1074/jbc.M110970200; RUSINOL AE, 1994, J BIOL CHEM, V269, P27494; Schweiger M, 2006, J BIOL CHEM, V281, P40236, DOI 10.1074/jbc.M608048200; Skinner JR, 2009, J BIOL CHEM, V284, P30941, DOI 10.1074/jbc.M109.013995; Soni KG, 2009, J CELL SCI, V122, P1834, DOI 10.1242/jcs.045849; Stone SJ, 2009, J BIOL CHEM, V284, P5352, DOI 10.1074/jbc.M805768200; Stone SJ, 2006, J BIOL CHEM, V281, P40273, DOI 10.1074/jbc.M607986200; Subramanian V, 2004, J BIOL CHEM, V279, P42062, DOI 10.1074/jbc.M407462200; Sztalryd C, 2003, J CELL BIOL, V161, P1093, DOI 10.1083/jcb.200210169; Szymanski KM, 2007, P NATL ACAD SCI USA, V104, P20890, DOI 10.1073/pnas.0704154104; Takeuchi K, 2009, AM J PHYSIOL-ENDOC M, V296, pE1195, DOI 10.1152/ajpendo.90958.2008; Tauchi-Sato K, 2002, J BIOL CHEM, V277, P44507, DOI 10.1074/jbc.M207712200; Tian Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001364; Toh SY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002890; vandenBosch H, 1997, BBA-LIPID LIPID MET, V1348, P35, DOI 10.1016/S0005-2760(97)00107-0; Wang H, 2011, J LIPID RES, V52, P2159, DOI 10.1194/jlr.M017939; Wang H, 2009, J BIOL CHEM, V284, P32116, DOI 10.1074/jbc.M109.006726; Wendel AA, 2009, BBA-MOL CELL BIOL L, V1791, P501, DOI 10.1016/j.bbalip.2008.10.010; Wolins NE, 2006, FEBS LETT, V580, P5484, DOI 10.1016/j.febslet.2006.08.040; Wolins NE, 2005, J BIOL CHEM, V280, P19146, DOI 10.1074/jbc.M500978200; Wolins NE, 2003, J BIOL CHEM, V278, P37713, DOI 10.1074/jbc.M304025200; Xie MT, 2004, J BIOL CHEM, V279, P28817, DOI 10.1074/jbc.M403311200; Yamaguchi T, 2004, J BIOL CHEM, V279, P30490, DOI 10.1074/jbc.M403920200; Yamaguchi T, 2007, J LIPID RES, V48, P1078, DOI 10.1194/jlr.M600493-JLR200; Yen CLE, 2008, J LIPID RES, V49, P2283, DOI 10.1194/jlr.R800018-JLR200	73	169	177	1	48	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2273	2279		10.1074/jbc.R111.309088	http://dx.doi.org/10.1074/jbc.R111.309088			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22090029	Green Published, hybrid			2022-12-27	WOS:000300292300002
J	Lin-Moshier, Y; Walseth, TF; Churamani, D; Davidson, SM; Slama, JT; Hooper, R; Brailoiu, E; Patel, S; Marchant, JS				Lin-Moshier, Yaping; Walseth, Timothy F.; Churamani, Dev; Davidson, Sean M.; Slama, James T.; Hooper, Robert; Brailoiu, Eugen; Patel, Sandip; Marchant, Jonathan S.			Photoaffinity Labeling of Nicotinic Acid Adenine Dinucleotide Phosphate (NAADP) Targets in Mammalian Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+ RELEASE; 2-PORE CHANNELS; SENSITIVE CA2+; CALCIUM; RECEPTORS; ROLES; LINE	Nicotinic acid adenine dinucleotide phosphate (NAADP) is an agonist-generated second messenger that releases Ca2+ from intracellular acidic Ca2+ stores. Recent evidence has identified the two-pore channels (TPCs) within the endolysosomal system as NAADP-regulated Ca2+ channels that release organellar Ca2+ in response to NAADP. However, little is known about the mechanism coupling NAADP binding to calcium release. To identify the NAADP binding site, we employed a photoaffinity labeling method using a radioactive photoprobe based on 5-azido-NAADP ([P-32-5N(3)]NAADP) that exhibits high affinity binding to NAADP receptors. In several systems that are widely used for studying NAADP-evoked Ca2+ signaling, including sea urchin eggs, human cell lines (HEK293, SKBR3), and mouse pancreas, 5N(3)-NAADP selectively labeled low molecular weight sites that exhibited the diagnostic pharmacology of NAADP-sensitive Ca2+ release. Surprisingly, we were unable to demonstrate labeling of endogenous, or overexpressed, TPCs. Furthermore, labeling of high affinity NAADP binding sites was preserved in pancreatic samples from TPC1 and TPC2 knockout mice. These photolabeling data suggest that an accessory component within a larger TPC complex is responsible for binding NAADP that is unique from the core channel itself. This observation necessitates critical evaluation of current models of NAADP-triggered activation of the TPC family.	[Lin-Moshier, Yaping; Walseth, Timothy F.; Marchant, Jonathan S.] Univ Minnesota, Sch Med, Dept Pharmacol, Minneapolis, MN 55455 USA; [Churamani, Dev; Hooper, Robert; Patel, Sandip] UCL, Dept Cell & Dev Biol, London WC1E 6BT, England; [Davidson, Sean M.] UCL, Hatter Cardiovasc Inst, Dept Med, London WC1E 6HX, England; [Slama, James T.] Univ Toledo, Dept Med & Biol Chem, Toledo, OH 43614 USA; [Brailoiu, Eugen] Temple Univ, Sch Med, Dept Pharmacol, Philadelphia, PA 19140 USA	University of Minnesota System; University of Minnesota Twin Cities; University of London; University College London; University of London; University College London; University System of Ohio; University of Toledo; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Marchant, JS (corresponding author), 6-120 Jackson Hall,321 Church St SE, Minneapolis, MN 55455 USA.	march029@umn.edu	Walseth, Timothy F/F-9518-2010; Marchant, Jonathan/Q-5484-2019; Davidson, Sean M/F-5275-2010; MARCHANT, Jonathan/B-8051-2009; Patel, Sandip/O-9591-2015	Walseth, Timothy F/0000-0003-2558-7859; Marchant, Jonathan/0000-0001-6592-0877; Davidson, Sean M/0000-0001-5182-4980; MARCHANT, Jonathan/0000-0001-6592-0877; Patel, Sandip/0000-0001-7247-2013	National Institutes of Health [GM088790, HL90804]; Biotechnology and Biological Sciences Research Council (BBSRC) [BB/G013721/1]; University of Minnesota Graduate School; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090804] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088790] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/G013721/1] Funding Source: researchfish; British Heart Foundation [PG/10/005/28175] Funding Source: researchfish; BBSRC [BB/G013721/1] Funding Source: UKRI	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); University of Minnesota Graduate School(University of Minnesota System); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported, in whole or in part, by National Institutes of Health Grants GM088790 (to J. S. M.) and HL90804 (to E. B.). This work was also supported by Biotechnology and Biological Sciences Research Council (BBSRC) Grant BB/G013721/1 (to S. P.).; Supported by a doctoral dissertation fellowship from the University of Minnesota Graduate School.	Aarhus R, 1995, J BIOL CHEM, V270, P30327, DOI 10.1074/jbc.270.51.30327; Bak J, 2001, CURR BIOL, V11, P987, DOI 10.1016/S0960-9822(01)00269-X; Billington RA, 2006, FASEB J, V20, P521, DOI 10.1096/fj.05-5058fje; Brailoiu E, 2010, J BIOL CHEM, V285, P38511, DOI 10.1074/jbc.M110.162073; Brailoiu E, 2009, J CELL BIOL, V186, P201, DOI 10.1083/jcb.200904073; Calcraft PJ, 2009, NATURE, V459, P596, DOI 10.1038/nature08030; Cancela JM, 1999, NATURE, V398, P74, DOI 10.1038/18032; Cancela JM, 2000, EMBO J, V19, P2549, DOI 10.1093/emboj/19.11.2549; Dionisio N, 2011, BBA-MOL CELL RES, V1813, P1483, DOI 10.1016/j.bbamcr.2011.05.005; Dorman G, 2000, TRENDS BIOTECHNOL, V18, P64, DOI 10.1016/S0167-7799(99)01402-X; Galione A, 2011, SCI CHINA LIFE SCI, V54, P725, DOI 10.1007/s11427-011-4207-5; Galione A, 2010, BIOCHEM SOC T, V38, P1424, DOI 10.1042/BST0381424; Gambara G, 2008, J CELL PHYSIOL, V216, P396, DOI 10.1002/jcp.21407; Genazzani AA, 1996, J BIOL CHEM, V271, P11599, DOI 10.1074/jbc.271.20.11599; Hooper R., 2012, CALCIUM SIG IN PRESS, V740; Hooper R, 2011, J BIOL CHEM, V286, P9141, DOI 10.1074/jbc.M110.189985; Jain P, 2010, J MED CHEM, V53, P7599, DOI 10.1021/jm1007209; Lamos SM, 2006, ANGEW CHEM INT EDIT, V45, P4329, DOI 10.1002/anie.200600743; LEE HC, 1993, SCIENCE, V261, P352, DOI 10.1126/science.8392749; Lee HC, 2005, J BIOL CHEM, V280, P33693, DOI 10.1074/jbc.R500012200; Ogunbayo OA, 2011, J BIOL CHEM, V286, P9136, DOI 10.1074/jbc.M110.202002; Pitt SJ, 2010, J BIOL CHEM, V285, P35039, DOI 10.1074/jbc.M110.156927; Robinette D, 2006, EXPERT REV PROTEOMIC, V3, P399, DOI 10.1586/14789450.3.4.399; Ruas M, 2010, CURR BIOL, V20, P703, DOI 10.1016/j.cub.2010.02.049; Schieder M, 2010, J BIOL CHEM, V285, P21219, DOI 10.1074/jbc.C110.143123; Tanabe K, 1999, J BIOL CHEM, V274, P3931, DOI 10.1074/jbc.274.7.3931; Tomizawa M, 2007, BIOCHEMISTRY-US, V46, P8798, DOI 10.1021/bi700667v; Tomizawa M, 2009, J MED CHEM, V52, P3735, DOI 10.1021/jm900153c; Walseth TF, 2012, J BIOL CHEM, V287, P2308, DOI 10.1074/jbc.M111.306563; Weber PJA, 1997, J PEPT RES, V49, P375; Yamaguchi S, 2011, J BIOL CHEM, V286, P22934, DOI 10.1074/jbc.M110.210930; Zong XG, 2009, PFLUG ARCH EUR J PHY, V458, P891, DOI 10.1007/s00424-009-0690-y	32	125	126	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2296	2307		10.1074/jbc.M111.305813	http://dx.doi.org/10.1074/jbc.M111.305813			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22117075	Green Published, hybrid			2022-12-27	WOS:000300292300006
J	Lonsdorf, AS; Kramer, BF; Fahrleitner, M; Schonberger, T; Gnerlich, S; Ring, S; Gehring, S; Schneider, SW; Kruhlak, MJ; Meuth, SG; Nieswandt, B; Gawaz, M; Enk, AH; Langer, HF				Lonsdorf, Anke S.; Kraemer, Bjoern F.; Fahrleitner, Manuela; Schoenberger, Tanja; Gnerlich, Stephan; Ring, Sabine; Gehring, Sarah; Schneider, Stefan W.; Kruhlak, Michael J.; Meuth, Sven G.; Nieswandt, Bernhard; Gawaz, Meinrad; Enk, Alexander H.; Langer, Harald F.			Engagement of alpha IIb beta 3 (GPIIb/IIIa) with alpha nu beta 3 Integrin Mediates Interaction of Melanoma Cells with Platelets A CONNECTION TO HEMATOGENOUS METASTASIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONFORMATION-SPECIFIC BLOCKADE; ENDOTHELIAL PROGENITOR CELLS; SINGLE-CHAIN ANTIBODIES; GLYCOPROTEIN IB-ALPHA; IN-VITRO; ADHERENT PLATELETS; COUNTER-RECEPTOR; LUNG METASTASIS; VESSEL WALL; V INTEGRINS	A mutual relationship exists between metastasizing tumor cells and components of the coagulation cascade. The exact mechanisms as to how platelets influence blood-borne metastasis, however, remain poorly understood. Here, we used murine B16 melanoma cells to observe functional aspects of how platelets contribute to the process of hematogenous metastasis. We found that platelets interfere with a distinct step of the metastasis cascade, as they promote adhesion of melanoma cells to the endothelium in vitro under shear conditions. Constitutively active platelet receptor GPIIb/IIIa (integrin alpha IIb beta 3) expressed on Chinese hamster ovary cells promoted melanoma cell adhesion in the presence of fibrinogen, whereas blocking antibodies to a nu beta 3 integrin on melanoma cells or to GPIIb/IIIa significantly reduced melanoma cell adhesion to platelets. Furthermore, using intravital microscopy, we observed functional platelet-melanoma cell interactions, as platelet depletion resulted in significantly reduced melanoma cell adhesion to the injured vascular wall in vivo. Using a mouse model of hematogenous metastasis to the lung, we observed decreased metastasis of B16 melanoma cells to the lung by treatment with a mAb blocking the a nu subunit of a nu beta 3 integrin. This effect was significantly reduced when platelets were depleted in vivo. Thus, the engagement of GPIIb/IIIa with a nu beta 3 integrin interaction mediates tumor cell-platelet interactions and highlights how this interaction is involved in hematogenous tumor metastasis.	[Lonsdorf, Anke S.; Ring, Sabine; Enk, Alexander H.] Univ Heidelberg, Dept Dermatol, Univ Hosp, D-69115 Heidelberg, Germany; [Kraemer, Bjoern F.; Fahrleitner, Manuela; Schoenberger, Tanja; Gnerlich, Stephan; Gehring, Sarah; Gawaz, Meinrad; Langer, Harald F.] Univ Tubingen, Dept Cardiovasc Med, Univ Hosp, D-72076 Tubingen, Germany; [Schneider, Stefan W.] Univ Heidelberg, Dept Dermatol, D-68167 Mannheim, Germany; [Schneider, Stefan W.] Med Fac Mannheim, D-68167 Mannheim, Germany; [Kruhlak, Michael J.] NCI, Expt Immunol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Meuth, Sven G.] Univ Munster, Inst Physiol, Neurol Clinic Inflammatory Disorders Nervous Syst, D-48149 Munster, Germany; [Nieswandt, Bernhard] Univ Wurzburg, Dept Vasc Med, Deutsch Forsch Gemeinschaft Res Ctr Expt Biomed, D-97080 Wurzburg, Germany; [Nieswandt, Bernhard] Univ Wurzburg, Rudolf Virchow Ctr, Deutsch Forsch Gemeinschaft Res Ctr Expt Biomed, D-97080 Wurzburg, Germany	Ruprecht Karls University Heidelberg; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Munster; University of Wurzburg; University of Wurzburg	Lonsdorf, AS (corresponding author), Univ Heidelberg, Dept Dermatol, Univ Hosp, Vossstr 11, D-69115 Heidelberg, Germany.	anke.lonsdorf@med.uni-heidelberg.de; harald.langer@med.uni-tuebingen.de	Meuth, Sven G/HHM-8941-2022; Sauter, Manuela/AAU-5685-2021	Meuth, Sven G/0000-0003-2571-3501; Sauter, Manuela/0000-0002-6411-5697	National Institutes of Health; University of Tubingen (Center for Interdisciplinary Clinical Research); Volkswagen Foundation; Wilhelm Sander Foundation; Deutsche Forschungsgemeinschaft; Ruprecht-Karls-University of Heidelberg; Clinical Research Unit of German Research Council [KFO 274]; Deutsche Forschungsgemeinschaft [SFB/TR23]; NATIONAL CANCER INSTITUTE [ZICBC010915] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Tubingen (Center for Interdisciplinary Clinical Research); Volkswagen Foundation(Volkswagen); Wilhelm Sander Foundation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ruprecht-Karls-University of Heidelberg; Clinical Research Unit of German Research Council; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health research career transition award (to A. S. L.). This work was also supported by the University of Tubingen (Center for Interdisciplinary Clinical Research, junior group program), the Volkswagen Foundation (Lichtenberg program), and Wilhelm Sander Foundation (to H. F. L.).; Supported in part by Deutsche Forschungsgemeinschaft and the Olympia-Morata-Programme of the Ruprecht-Karls-University of Heidelberg.; Members of the Tuebingen Platelet Investigative Consortium funded by the Clinical Research Unit KFO 274 of the German Research Council.; Supported by Deutsche Forschungsgemeinschaft Grant SFB/TR23.	Amirkhosravi A, 2003, THROMB HAEMOSTASIS, V90, P549, DOI 10.1160/TH03-02-0102; Bambace NM, 2011, J THROMB HAEMOST, V9, P237, DOI 10.1111/j.1538-7836.2010.04131.x; Bergmeier W, 2002, CYTOMETRY, V48, P80, DOI 10.1002/cyto.10114; Boilard E, 2010, SCIENCE, V327, P580, DOI 10.1126/science.1181928; Brooks SA, 2010, ACTA HISTOCHEM, V112, P3, DOI 10.1016/j.acthis.2008.11.022; Carvalho-Tavares J, 2000, CIRC RES, V87, P1141, DOI 10.1161/01.RES.87.12.1141; CHAN BMC, 1991, SCIENCE, V251, P1600, DOI 10.1126/science.2011740; Ehlers R, 2003, J EXP MED, V198, P1077, DOI 10.1084/jem.20022181; Eisenhardt SU, 2007, BLOOD, V109, P3521, DOI 10.1182/blood-2006-03-007179; Eliceiri BP, 1999, J CLIN INVEST, V103, P1227, DOI 10.1172/JCI6869; Erpenbeck L, 2010, J INVEST DERMATOL, V130, P576, DOI 10.1038/jid.2009.278; Fang L, 2008, J LEUKOCYTE BIOL, V84, P965, DOI 10.1189/jlb.1107776; Felding-Habermann B, 2002, CLIN EXP METASTAS, V19, P427, DOI 10.1023/A:1016377114119; Felding-Habermann B, 2001, P NATL ACAD SCI USA, V98, P1853, DOI 10.1073/pnas.98.4.1853; GASIC GJ, 1968, P NATL ACAD SCI USA, V61, P46, DOI 10.1073/pnas.61.1.46; Gawaz M, 2005, J CLIN INVEST, V115, P3378, DOI 10.1172/JCI27196; Gawaz M, 2009, NAT REV CARDIOL, V6, P391, DOI 10.1038/nrcardio.2009.76; GAWAZ MP, 1991, J CLIN INVEST, V88, P1128, DOI 10.1172/JCI115412; Gay LJ, 2011, NAT REV CANCER, V11, P123, DOI 10.1038/nrc3004; Gosslar U, 1996, P NATL ACAD SCI USA, V93, P4821, DOI 10.1073/pnas.93.10.4821; Ho-Tin-Noe B, 2008, CANCER RES, V68, P6851, DOI 10.1158/0008-5472.CAN-08-0718; Jain S, 2007, P NATL ACAD SCI USA, V104, P9024, DOI 10.1073/pnas.0700625104; Jin DK, 2006, NAT MED, V12, P557, DOI 10.1038/nm1400; Karpatkin S, 1981, Ann N Y Acad Sci, V370, P101, DOI 10.1111/j.1749-6632.1981.tb29726.x; KATAGIRI Y, 1991, CANCER RES, V51, P1286; Kerk N, 2010, J INVEST DERMATOL, V130, P2259, DOI 10.1038/jid.2010.136; Kopp HG, 2009, CANCER RES, V69, P7775, DOI 10.1158/0008-5472.CAN-09-2123; Laubli H, 2009, BLOOD, V114, P4583, DOI 10.1182/blood-2008-10-186585; Langer H, 2006, CIRC RES, V98, pE2, DOI 10.1161/01.RES.0000201285.87524.9e; Langer HF, 2008, BASIC RES CARDIOL, V103, P299, DOI 10.1007/s00395-008-0721-4; Langer HF, 2008, THROMB HAEMOSTASIS, V99, P480, DOI 10.1160/TH07-11-0685; Langer HF, 2007, ARTERIOSCL THROM VAS, V27, P1463, DOI 10.1161/ATVBAHA.107.141515; Langer HF, 2011, CANCER RES, V71, P4096, DOI 10.1158/0008-5472.CAN-10-2794; Langer HF, 2009, J CELL MOL MED, V13, P1211, DOI 10.1111/j.1582-4934.2009.00811.x; Langer HF, 2009, J MOL CELL CARDIOL, V47, P315, DOI 10.1016/j.yjmcc.2009.03.011; Li XW, 2001, J CELL SCI, V114, P2665; Massberg S, 2006, J EXP MED, V203, P1221, DOI 10.1084/jem.20051772; Murakami T, 2002, CANCER RES, V62, P7328; Nachman RL, 2008, NEW ENGL J MED, V359, P1261, DOI 10.1056/NEJMra0800887; Nemeth JA, 2007, CANCER INVEST, V25, P632, DOI 10.1080/07357900701522638; Nierodzik ML, 2006, CANCER CELL, V10, P355, DOI 10.1016/j.ccr.2006.10.002; Nieswandt B, 1999, CANCER RES, V59, P1295; Peter K, 1996, BLOOD COAGUL FIBRIN, V7, P233, DOI 10.1097/00001721-199603000-00031; Plow EF, 2001, THROMB HAEMOSTASIS, V86, P34; Puerschel WC, 1996, BRIT J DERMATOL, V135, P883, DOI 10.1046/j.1365-2133.1996.d01-1090.x; Ramos OHP, 2008, CLIN EXP METASTAS, V25, P53, DOI 10.1007/s10585-007-9101-y; Ring S, 2009, J ALLERGY CLIN IMMUN, V123, P1287, DOI 10.1016/j.jaci.2009.03.022; Sachs UJH, 2007, J BIOL CHEM, V282, P23603, DOI 10.1074/jbc.M701120200; Sahai E, 2007, NAT REV CANCER, V7, P737, DOI 10.1038/nrc2229; Santoso S, 2002, J EXP MED, V196, P679, DOI 10.1084/jem.20020267; Schwarz M, 2004, FASEB J, V18, P1704, DOI 10.1096/fj.04-1513fje; Schwarz M, 2006, CIRC RES, V99, P25, DOI 10.1161/01.RES.0000232317.84122.0c; Semple JW, 2011, NAT REV IMMUNOL, V11, P264, DOI 10.1038/nri2956; Stellos K, 2008, CIRCULATION, V117, P206, DOI 10.1161/CIRCULATIONAHA.107.714691; Stellos K, 2010, ARTERIOSCL THROM VAS, V30, P1127, DOI 10.1161/ATVBAHA.110.204370; Varga-Szabo D, 2008, ARTERIOSCL THROM VAS, V28, P403, DOI 10.1161/ATVBAHA.107.150474; von Hundelshausen P, 2001, CIRCULATION, V103, P1772, DOI 10.1161/01.CIR.103.13.1772; Wagner DD, 2008, BLOOD, V111, P5271, DOI 10.1182/blood-2008-01-078204; Wang YQ, 2008, THROMB RES, V123, P324, DOI 10.1016/j.thromres.2008.06.021; Weber C, 1997, J CLIN INVEST, V100, P2085, DOI 10.1172/JCI119742; Wiesner T, 2010, CLIN EXP METASTAS, V27, P141, DOI 10.1007/s10585-010-9311-6; Zaslavsky A, 2010, BLOOD, V115, P4605, DOI 10.1182/blood-2009-09-242065; Zernecke A, 2005, CIRC RES, V96, P784, DOI 10.1161/01.RES.0000162100.52009.38	63	79	85	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2012	287	3					2168	2178		10.1074/jbc.M111.269811	http://dx.doi.org/10.1074/jbc.M111.269811			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879HT	22102277	Green Published, hybrid			2022-12-27	WOS:000299321000056
J	Fagete, S; Rousseau, F; Magistrelli, G; Gueneau, F; Ravn, U; Kosco-Vilbois, MH; Fischer, N				Fagete, Severine; Rousseau, Francois; Magistrelli, Giovanni; Gueneau, Franck; Ravn, Ulla; Kosco-Vilbois, Marie H.; Fischer, Nicolas			Dual Specificity of Anti-CXCL10-CXCL9 Antibodies Is Governed by Structural Mimicry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE SEQUENCE ALIGNMENT; HUMAN POLYCLONAL ANTIBODIES; THERAPEUTIC ANTIBODIES; BOTULINUM NEUROTOXIN; CHEMOKINE; BINDING; CXCR3; OLIGOMERIZATION; LIGANDS; GLYCOSAMINOGLYCANS	Dual-specific antibodies are characterized by an antigen-combining site mediating specific interactions with two different antigens. We have generated five dual-specific single chain variable fragments (scFv) that neutralize the activity of the two chemokines, CXCL9 and CXCL10, to bind to their receptor CXCR3. To better understand how these dual-specific scFvs bind these two chemokines that only share a 37% sequence identity, we mapped their epitopes on human CXCL9 and CXCL10 and identified serine 13 (Ser(13)) as a critical residue. It is conserved between the two chemokines but not in the third ligand for CXCR3, CXCL11. Furthermore, Ser(13) is exposed in the tetrameric structure of CXCL10, which is consistent with our finding that the scFvs are able to bind to CXCL9 and CXCL10 immobilized on glycosaminoglycans. Overall, the data indicate that these dual-specific scFvs bind to a conserved surface involved in CXCR3 receptor interaction for CXCL10 and CXCL9. Thus, structural mimicry between the two targets is likely to be responsible for the observed dual specificity of these antibody fragments.	[Fagete, Severine; Rousseau, Francois; Magistrelli, Giovanni; Gueneau, Franck; Ravn, Ulla; Kosco-Vilbois, Marie H.; Fischer, Nicolas] NovImmune SA, CH-1228 Plan Les Ouates, Switzerland	NovImmune SA	Fischer, N (corresponding author), NovImmune SA, 14 Ch Des Aulx, CH-1228 Plan Les Ouates, Switzerland.	nfischer@novimmune.com						Booth V, 2002, BIOCHEMISTRY-US, V41, P10418, DOI 10.1021/bi026020q; Bostrom J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017887; Bostrom J, 2009, SCIENCE, V323, P1610, DOI 10.1126/science.1165480; Bregenholt S, 2006, CURR PHARM DESIGN, V12, P2007, DOI 10.2174/138161206777442173; Chan AC, 2010, NAT REV IMMUNOL, V10, P301, DOI 10.1038/nri2761; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Clark-Lewis I, 2003, J BIOL CHEM, V278, P289, DOI 10.1074/jbc.M209470200; Cox MA, 2001, MOL PHARMACOL, V59, P707, DOI 10.1124/mol.59.4.707; Fagete S, 2009, MABS-AUSTIN, V1, P288, DOI 10.4161/mabs.1.3.8527; Fischer N, 2007, PATHOBIOLOGY, V74, P3, DOI 10.1159/000101046; Garcia-Rodriguez C, 2011, PROTEIN ENG DES SEL, V24, P321, DOI 10.1093/protein/gzq111; Garcia-Rodriguez C, 2007, NAT BIOTECHNOL, V25, P107, DOI 10.1038/nbt1269; Groom JR, 2011, IMMUNOL CELL BIOL, V89, P207, DOI 10.1038/icb.2010.158; Hoogewerf AJ, 1997, BIOCHEMISTRY-US, V36, P13570, DOI 10.1021/bi971125s; Hsieh MF, 2006, J IMMUNOL, V177, P1855, DOI 10.4049/jimmunol.177.3.1855; Ishida Isao, 2002, Cloning and Stem Cells, V4, P91, DOI 10.1089/153623002753632084; James LC, 2003, SCIENCE, V299, P1362, DOI 10.1126/science.1079731; Johnson Z, 2005, CYTOKINE GROWTH F R, V16, P625, DOI 10.1016/j.cytogfr.2005.04.006; Johnson Z, 2004, J IMMUNOL, V173, P5776, DOI 10.4049/jimmunol.173.9.5776; Magistrelli G, 2005, BIOCHEM BIOPH RES CO, V334, P370, DOI 10.1016/j.bbrc.2005.06.091; Nobeli I, 2009, NAT BIOTECHNOL, V27, P157, DOI 10.1038/nbt1519; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Proudfoot AEI, 2006, BIOCHEM SOC T, V34, P422, DOI 10.1042/BST0340422; Proudfoot AEI, 2003, P NATL ACAD SCI USA, V100, P1885, DOI 10.1073/pnas.0334864100; Reichert JM, 2011, MABS-AUSTIN, V3, P76, DOI 10.4161/mabs.3.1.13895; Reid C, 2006, PROTEIN ENG DES SEL, V19, P317, DOI 10.1093/protein/gzl015; Swaminathan GJ, 2003, STRUCTURE, V11, P521, DOI 10.1016/S0969-2126(03)00070-4; Wiberg FC, 2006, BIOTECHNOL BIOENG, V94, P396, DOI 10.1002/bit.20865; Zhang MY, 2004, J VIROL, V78, P9233, DOI 10.1128/JVI.78.17.9233-9242.2004	29	3	4	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					1458	1467		10.1074/jbc.M111.253658	http://dx.doi.org/10.1074/jbc.M111.253658			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22041899	Green Published, hybrid			2022-12-27	WOS:000299170300059
J	Huang, YJ; Wang, WW; Yao, P; Wang, XW; Liu, X; Zhuang, XX; Yan, F; Zhou, JH; Du, J; Ward, T; Zou, HF; Zhang, JC; Fang, GW; Ding, X; Dou, Z; Yao, XB				Huang, Yuejia; Wang, Wenwen; Yao, Phil; Wang, Xiwei; Liu, Xing; Zhuang, Xiaoxuan; Yan, Feng; Zhou, Jinhua; Du, Jian; Ward, Tarsha; Zou, Hanfa; Zhang, Jiancun; Fang, Guowei; Ding, Xia; Dou, Zhen; Yao, Xuebiao			CENP-E Kinesin Interacts with SKAP Protein to Orchestrate Accurate Chromosome Segregation in Mitosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROTUBULE PLUS ENDS; MITOTIC CHECKPOINT; SPINDLE MICROTUBULES; KINETOCHORE PROTEIN; OUTER PLATE; ATTACHMENT; LOCALIZATION; MOTOR; ANEUPLOIDY; COMPLEX	Mitotic chromosome segregation is orchestrated by the dynamic interaction of spindle microtubules with the kinetochore. Although previous studies show that the mitotic kinesin CENP-E forms a link between attachment of the spindle microtubule to the kinetochore and the mitotic checkpoint signaling cascade, the molecular mechanism underlying dynamic kinetochore-microtubule interactions in mammalian cells remains elusive. Here, we identify a novel interaction between CENP-E and SKAP that functions synergistically in governing dynamic kinetochore-microtubule interactions. SKAP binds to the C-terminal tail of CENP-E in vitro and is essential for an accurate kinetochore-microtubule attachment in vivo. Immunoelectron microscopic analysis indicates that SKAP is a constituent of the kinetochore corona fibers of mammalian centromeres. Depletion of SKAP or CENP-E by RNA interference results in a dramatic reduction of inter-kinetochore tension, which causes chromosome mis-segregation with a prolonged delay in achieving metaphase alignment. Importantly, SKAP binds to microtubules in vitro, and this interaction is synergized by CENP-E. Based on these findings, we propose that SKAP cooperates with CENP-E to orchestrate dynamic kinetochore-microtubule interaction for faithful chromosome segregation.	[Huang, Yuejia; Wang, Wenwen; Wang, Xiwei; Liu, Xing; Zhuang, Xiaoxuan; Yan, Feng; Zhou, Jinhua; Du, Jian; Zhang, Jiancun; Fang, Guowei; Dou, Zhen; Yao, Xuebiao] Univ Sci & Technol China, Anhui Key Lab Cellular Dynam & Chem Biol, Sch Life Sci, Hefei 230027, Peoples R China; [Huang, Yuejia; Yao, Phil; Wang, Xiwei; Liu, Xing; Yan, Feng; Ward, Tarsha] Morehouse Sch Med, Dept Physiol, Atlanta, GA 30310 USA; [Zou, Hanfa] Dalian Inst Chem Phys, Dalian 116023, Peoples R China; [Ding, Xia] Beijing Univ Chinese Med, Sch Grad Studies, Beijing 100029, Peoples R China; [Zhang, Jiancun] Guangzhou Inst Hlth Sci, Guangzhou 510515, Guangdong, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Morehouse School of Medicine; Chinese Academy of Sciences; Dalian Institute of Chemical Physics, CAS; Beijing University of Chinese Medicine	Dou, Z (corresponding author), Univ Sci & Technol China, Anhui Key Lab Cellular Dynam & Chem Biol, Sch Life Sci, Hefei 230027, Peoples R China.	douzhen@ustc.edu.cn; yaoxb@ustc.edu.cn	WANG, WENWEN/AAF-1080-2020; Yao, Xuebiao/P-5771-2014; DOU, ZHEN/N-2022-2013; Zhuang, Xiaoxuan/R-7836-2019; Liu, Xing/H-2989-2018	WANG, WENWEN/0000-0002-1545-4369; Zhuang, Xiaoxuan/0000-0003-4004-5329; Liu, Xing/0000-0002-7480-5085; Zhou, Jinhua/0000-0002-3704-4459; DOU, ZHEN/0000-0003-3303-9393	National Institutes of Health [DK-56292, U54CA118948, P20CA132389]; NCRR Clinical and Translational Science [UL1 RR025008]; NCRR [G12RR03034]; Chinese 973 Project [2010CB912103, 2012CB945002, 2007CB914503, 2002CB713700]; Chinese Natural Science Foundation [91129714, 30870990, 31071184, 90508002, 90913016]; Chinese Academy of Science [KSCX1-YW-R-65, KSCX2-YW-H-10, KSCX2-YW-R-195]; International Collaboration Grant [2009DFA31010]; Anhui Province Project [08040102005]; NATIONAL CANCER INSTITUTE [P20CA132389, U54CA118948, R01CA164133] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003034, UL1RR025008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056292, R01DK115812] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [S21MD000101] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCRR Clinical and Translational Science; NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Chinese 973 Project(National Basic Research Program of China); Chinese Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Chinese Academy of Science(Chinese Academy of Sciences); International Collaboration Grant; Anhui Province Project; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported, in whole or in part, by National Institutes of Health Grants DK-56292, U54CA118948, and P20CA132389 (to X.Y.), Grant UL1 RR025008 from the NCRR Clinical and Translational Science Award Program, and Grant G12RR03034 from NCRR. This work was also supported by Chinese 973 Project Grants 2010CB912103, 2012CB945002, 2007CB914503, and 2002CB713700 (to X.Y.), Chinese Natural Science Foundation Grants 91129714 and 30870990 (to X.D.), 31071184 (to Z.D.), 90508002 and 90913016 (to X.Y.), Chinese Academy of Science Grants KSCX1-YW-R-65, KSCX2-YW-H-10, and KSCX2-YW-R-195, International Collaboration Grant 2009DFA31010 (to X.D.), and Anhui Province Project Grant 08040102005 (to X.Y.).	Chan GKT, 1999, J CELL BIOL, V146, P941, DOI 10.1083/jcb.146.5.941; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Cheeseman IM, 2006, CELL, V127, P983, DOI 10.1016/j.cell.2006.09.039; Cheeseman IM, 2004, GENE DEV, V18, P2255, DOI 10.1101/gad.1234104; Chu YJ, 2011, J MOL CELL BIOL, V3, P260, DOI 10.1093/jmcb/mjq037; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; Cooke CA, 1997, CHROMOSOMA, V106, P446, DOI 10.1007/s004120050266; DeLuca JG, 2006, CELL, V127, P969, DOI 10.1016/j.cell.2006.09.047; DeLuca JG, 2005, MOL BIOL CELL, V16, P519, DOI 10.1091/mbc.E04-09-0852; Ding X, 2010, CELL RES, V20, P1386, DOI 10.1038/cr.2010.167; Dou Z, 2003, CELL RES, V13, P443, DOI 10.1038/sj.cr.7290186; Dunsch AK, 2011, J CELL BIOL, V192, P959, DOI 10.1083/jcb.201008023; EVANS L, 1985, J CELL BIOL, V100, P1185, DOI 10.1083/jcb.100.4.1185; Fang L, 2009, CELL CYCLE, V8, P2819, DOI 10.4161/cc.8.17.9514; Fang ZY, 2006, MOL CELL PROTEOMICS, V5, P1437, DOI 10.1074/mcp.M600050-MCP200; Fu CH, 2007, CELL RES, V17, P449, DOI 10.1038/cr.2007.32; Garcia-Saez I, 2004, J MOL BIOL, V340, P1107, DOI 10.1016/j.jmb.2004.05.053; Jiang K, 2009, EMBO REP, V10, P857, DOI 10.1038/embor.2009.94; Kapoor TM, 2006, SCIENCE, V311, P388, DOI 10.1126/science.1122142; Kim Y, 2010, CELL, V142, P444, DOI 10.1016/j.cell.2010.06.039; Kops GJPL, 2009, BIOCHEM SOC T, V37, P971, DOI 10.1042/BST0370971; LIAO H, 1994, SCIENCE, V265, P394, DOI 10.1126/science.8023161; Liu D, 2007, J BIOL CHEM, V282, P21415, DOI 10.1074/jbc.M609026200; Lou Y, 2004, J BIOL CHEM, V279, P20049, DOI 10.1074/jbc.M314205200; Mao YH, 2005, J CELL BIOL, V170, P873, DOI 10.1083/jcb.200505040; Martin-Lluesma S, 2002, SCIENCE, V297, P2267, DOI 10.1126/science.1075596; Pellman D, 2007, NATURE, V446, P38, DOI 10.1038/446038a; Santaguida S, 2009, EMBO J, V28, P2511, DOI 10.1038/emboj.2009.173; Schmidt JC, 2010, J CELL BIOL, V191, P269, DOI 10.1083/jcb.201006129; Wang HM, 2004, J BIOL CHEM, V279, P54590, DOI 10.1074/jbc.M407588200; Waters JC, 1998, J CELL BIOL, V141, P1181, DOI 10.1083/jcb.141.5.1181; Weaver BAA, 2003, J CELL BIOL, V162, P551, DOI 10.1083/jcb.200303167; Weaver BAA, 2007, CANCER CELL, V11, P25, DOI 10.1016/j.ccr.2006.12.003; Westermann S, 2006, NATURE, V440, P565, DOI 10.1038/nature04409; Wood KW, 1997, CELL, V91, P357, DOI 10.1016/S0092-8674(00)80419-5; Yao XB, 2000, NAT CELL BIOL, V2, P484, DOI 10.1038/35019518; Yao XB, 1997, J CELL BIOL, V139, P435, DOI 10.1083/jcb.139.2.435; YEN TJ, 1992, NATURE, V359, P536, DOI 10.1038/359536a0; Zhang LY, 2011, J BIOL CHEM, V286, P3033, DOI 10.1074/jbc.M110.165340; Zhu M, 2008, J BIOL CHEM, V283, P18916, DOI 10.1074/jbc.M710591200	40	35	39	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					1500	1509		10.1074/jbc.M111.277194	http://dx.doi.org/10.1074/jbc.M111.277194			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22110139	Green Published, hybrid			2022-12-27	WOS:000299170300063
J	Campbell, DO; Yaghoubi, SS; Su, Y; Lee, JT; Auerbach, MS; Herschman, H; Satyamurthy, N; Czernin, J; Lavie, A; Radu, CG				Campbell, Dean O.; Yaghoubi, Shahriar S.; Su, Ying; Lee, Jason T.; Auerbach, Martin S.; Herschman, Harvey; Satyamurthy, Nagichettiar; Czernin, Johannes; Lavie, Arnon; Radu, Caius G.			Structure-guided Engineering of Human Thymidine Kinase 2 as a Positron Emission Tomography Reporter Gene for Enhanced Phosphorylation of Non-natural Thymidine Analog Reporter Probe	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMBALANCED DNTP POOLS; PET IMAGING AGENT; IN-VIVO; DEOXYCYTIDINE KINASE; DEOXYRIBONUCLEOSIDE KINASES; SUICIDE GENE; T-CELLS; CELLULAR PROLIFERATION; DEPLETION MYOPATHY; MITOCHONDRIAL-DNA	Positron emission tomography (PET) reporter gene imaging can be used to non-invasively monitor cell-based therapies. Therapeutic cells engineered to express a PET reporter gene (PRG) specifically accumulate a PET reporter probe (PRP) and can be detected by PET imaging. Expanding the utility of this technology requires the development of new non-immunogenic PRGs. Here we describe a new PRG-PRP system that employs, as the PRG, a mutated form of human thymidine kinase 2 (TK2) and 2'-deoxy-2'-F-18-5-methyl-1-beta-L-arabinofuranosyluracil (L-F-18-FMAU) as the PRP. We identified L-F-18-FMAU as a candidate PRP and determined its biodistribution in mice and humans. Using structure-guided enzyme engineering, we generated a TK2 double mutant (TK2-N93D/L109F) that efficiently phosphorylates L-F-18-FMAU. The N93D/L109F TK2 mutant has lower activity for the endogenous nucleosides thymidine and deoxycytidine than wild type TK2, and its ectopic expression in therapeutic cells is not expected to alter nucleotide metabolism. Imaging studies in mice indicate that the sensitivity of the new human TK2-N93D/L109F PRG is comparable with that of a widely used PRG based on the herpes simplex virus 1 thymidine kinase. These findings suggest that the TK2-N93D/L109F/L-F-18-FMAU PRG-PRP system warrants further evaluation in preclinical and clinical applications of cell-based therapies.	[Su, Ying; Lavie, Arnon] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60607 USA; [Campbell, Dean O.; Yaghoubi, Shahriar S.; Lee, Jason T.; Auerbach, Martin S.; Herschman, Harvey; Satyamurthy, Nagichettiar; Czernin, Johannes; Radu, Caius G.] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Campbell, Dean O.; Yaghoubi, Shahriar S.; Lee, Jason T.; Auerbach, Martin S.; Satyamurthy, Nagichettiar; Czernin, Johannes; Radu, Caius G.] Univ Calif Los Angeles, Ahmanson Translat Imaging Div, Los Angeles, CA 90095 USA; [Herschman, Harvey] Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90095 USA; [Yaghoubi, Shahriar S.] CellSight Technol, San Francisco, CA 94107 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Lavie, A (corresponding author), Univ Illinois, Dept Biochem & Mol Genet, 900 S Ashland Ave, Chicago, IL 60607 USA.	Lavie@uic.edu; CRadu@mednet.ucla.edu	Radu, Caius/D-3936-2013; Lavie, Arnon/H-4927-2012	Radu, Caius/0000-0002-9338-5397; Lee, Jason/0000-0003-2590-2011; Lavie, Arnon/0000-0001-5591-8722	National Institutes of Health [P50 CA86306]; National Institute of Biomedical Imaging and Bioengineering [1R01EB13685, 1R01CA16077001]; California Institute for Regenerative Medicine [RT1-01126-1]; United States Department of Energy [DE-FG02-06ER64249]; Chief Scientific Officer of CellSight Technologies, Inc.; NATIONAL CANCER INSTITUTE [P50CA086306, R01CA160770] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB013685] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); United States Department of Energy(United States Department of Energy (DOE)); Chief Scientific Officer of CellSight Technologies, Inc.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported, in whole or in part, by National Institutes of Health Grants P50 CA86306 (In Vivo Cellular and Molecular Imaging Centers Developmental Project) 1R01EB13685 and 1R01CA16077001 (National Institute of Biomedical Imaging and Bioengineering). This work was also funded by California Institute for Regenerative Medicine Grant RT1-01126-1 and United States Department of Energy Contract DE-FG02-06ER64249. Conflict of interest statement: Dean Campbell, Caius Radu, Arnon Lavie, Nagichettiar Satyamurthy, Johannes Czernin, and Shahriar Yaghoubi are among the inventors of the national and Patent Cooperation Treaty (PCT) patent applications for the PRG technology referred to in this article. Shahriar Yaghoubi is also a co-founder and the Chief Scientific Officer of CellSight Technologies, Inc., a molecular imaging company that specializes in imaging tools for cell and gene therapies that has licensed this intellectual property.	Agarwal K C, 1978, Methods Enzymol, V51, P483; Alauddin MM, 2007, EUR J NUCL MED MOL I, V34, P822, DOI 10.1007/s00259-006-0305-1; Alauddin MM, 2004, MOL IMAGING, V3, P76, DOI 10.1162/1535350041464900; Alauddin MM, 1998, NUCL MED BIOL, V25, P175, DOI 10.1016/S0969-8051(97)00160-1; Alauddin MM, 2001, J NUCL MED, V42, P1682; ARNER ESJ, 1995, PHARMACOL THERAPEUT, V67, P155, DOI 10.1016/0163-7258(95)00015-9; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Barroso JF, 2005, BIOCHEMISTRY-US, V44, P4886, DOI 10.1021/bi047766m; Barthel H, 2003, CANCER RES, V63, P3791; Berger C, 2006, BLOOD, V107, P2294, DOI 10.1182/blood-2005-08-3503; Bianchi V, 1997, J BIOL CHEM, V272, P16118, DOI 10.1074/jbc.272.26.16118; Chin FT, 2008, MOL IMAGING BIOL, V10, P82, DOI 10.1007/s11307-007-0122-3; Dotti G, 2009, MOL IMAGING, V8, P230, DOI 10.2310/7290.2009.00022; Eriksson S, 2002, CELL MOL LIFE SCI, V59, P1327, DOI 10.1007/s00018-002-8511-x; Gambhir S. S., 2010, MOL IMAGING REPORTER, P258; Gambhir SS, 2000, P NATL ACAD SCI USA, V97, P2785, DOI 10.1073/pnas.97.6.2785; HAWLEY RG, 1994, GENE THER, V1, P136; Hazra S, 2011, BIOCHEMISTRY-US, V50, P2870, DOI 10.1021/bi2001032; Hazra S, 2010, BIOCHEMISTRY-US, V49, P6784, DOI 10.1021/bi100839e; Hazra S, 2009, BIOCHEMISTRY-US, V48, P1256, DOI 10.1021/bi802062w; Herschman HR, 2004, CRIT REV ONCOL HEMAT, V51, P191, DOI 10.1016/j.critrevonc.2004.04.006; Hung SC, 2005, CLIN CANCER RES, V11, P7749, DOI 10.1158/1078-0432.CCR-05-0876; Jordheim LP, 2004, CLIN CANCER RES, V10, P5614, DOI 10.1158/1078-0432.CCR-04-0506; Kremer RMD, 2004, ADV CARBOHYD CHEM BI, V59, P9, DOI 10.1016/S00065-2318(04)59002-9; Kumar D, 2011, NUCLEIC ACIDS RES, V39, P1360, DOI 10.1093/nar/gkq829; Kumar D, 2010, NUCLEIC ACIDS RES, V38, P3975, DOI 10.1093/nar/gkq128; Likar Y, 2010, J NUCL MED, V51, P1395, DOI 10.2967/jnumed.109.074344; Mangner TJ, 2003, NUCL MED BIOL, V30, P215, DOI 10.1016/S0969-8051(02)00445-6; Miyagawa T, 2008, J NUCL MED, V49, P637, DOI 10.2967/jnumed.107.046227; Mukhopadhyay U, 2007, APPL RADIAT ISOTOPES, V65, P941, DOI 10.1016/j.apradiso.2007.04.003; Nair-Gill E. D., 2010, MOL IMAGING REPORTER, P258; Namavari M, 2011, MOL IMAGING BIOL, V13, P812, DOI 10.1007/s11307-010-0414-x; Nishii R, 2008, EUR J NUCL MED MOL I, V35, P990, DOI 10.1007/s00259-007-0649-1; NOTTEBROCK H, 1977, BIOCHEM PHARMACOL, V26, P2175, DOI 10.1016/0006-2952(77)90271-4; Penuelas I, 2005, GASTROENTEROLOGY, V128, P1787, DOI 10.1053/j.gastro.2005.03.024; Ponomarev V, 2007, J NUCL MED, V48, P819, DOI 10.2967/jnumed.106.036962; Radivoyevitch T, 2011, NUCLEOS NUCLEOT NUCL, V30, P203, DOI 10.1080/15257770.2011.563765; Radu CG, 2008, NAT MED, V14, P783, DOI 10.1038/nm1724; Saada A, 2003, MOL GENET METAB, V79, P1, DOI 10.1016/S1096-7192(03)00063-5; Sabini E, 2003, NAT STRUCT BIOL, V10, P513, DOI 10.1038/nsb942; Sabini E, 2007, J MED CHEM, V50, P3004, DOI 10.1021/jm0700215; SARGENT RG, 1987, J BIOL CHEM, V262, P5546; SCHAPER J, 1985, CIRC RES, V56, P377, DOI 10.1161/01.RES.56.3.377; Schwarzenberg J, 2011, EUR J NUCL MED MOL I, V38, P711, DOI 10.1007/s00259-010-1666-z; Shields AF, 2003, J NUCL MED, V44, P1432; Shields AF, 1998, NAT MED, V4, P1334, DOI 10.1038/3337; Shu CJ, 2010, J NUCL MED, V51, P1092, DOI 10.2967/jnumed.109.073361; Shu CYJ, 2005, P NATL ACAD SCI USA, V102, P17412, DOI 10.1073/pnas.0508698102; Song SW, 2003, J BIOL CHEM, V278, P43893, DOI 10.1074/jbc.C300401200; SPYROU G, 1988, MUTAT RES, V200, P37, DOI 10.1016/0027-5107(88)90069-3; Sun HH, 2005, J NUCL MED, V46, P292; Tjuvajev JG, 1996, CANCER RES, V56, P4087; Traversari C, 2007, BLOOD, V109, P4708, DOI 10.1182/blood-2006-04-015230; Wang JH, 1999, BIOCHEMISTRY-US, V38, P16993, DOI 10.1021/bi9908843; Wang LY, 2000, BIOCHEM J, V351, P469, DOI 10.1042/0264-6021:3510469; Wang LY, 2003, J BIOL CHEM, V278, P6963, DOI 10.1074/jbc.M206143200; Welin M, 2005, FEBS J, V272, P3733, DOI 10.1111/j.1742-4658.2005.04803.x; Wu JC, 2003, CIRCULATION, V108, P1302, DOI 10.1161/01.CIR.0000091252.20010.6E; Yaghoubi S, 2001, J NUCL MED, V42, P1225; Yaghoubi SS, 2009, NAT CLIN PRACT ONCOL, V6, P53, DOI 10.1038/ncponc1278; Yaghoubi SS, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2821415	61	36	37	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					446	454		10.1074/jbc.M111.314666	http://dx.doi.org/10.1074/jbc.M111.314666			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22074768	Green Published, hybrid			2022-12-27	WOS:000298682400043
J	Filosto, S; Ashfaq, M; Chung, S; Fry, W; Goldkorn, T				Filosto, Simone; Ashfaq, Majid; Chung, Samuel; Fry, William; Goldkorn, Tzipora			Neutral Sphingomyelinase 2 Activity and Protein Stability Are Modulated by Phosphorylation of Five Conserved Serines	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LUNG EPITHELIAL-CELLS; NECROSIS-FACTOR-ALPHA; CIGARETTE-SMOKE; INDUCED APOPTOSIS; OXIDATIVE STRESS; CERAMIDE; EXPRESSION; NSMASE2; INFLAMMATION; ACTIVATION	We previously presented that the neutral sphingomyelinase 2 (nSMase2) is the only SMase activated in human airway epithelial (HAE) cells following exposure to oxidative stress (ox-stress), yielding ceramide accumulation and thereby inducing apoptosis. Furthermore, we reported that nSMase2 is a phospho-protein in which the level of phosphorylation controls nSMase2 activation induced by ox-stress. Here we identify five specific serines that are phosphorylated in nSMase2 and demonstrate that their phosphorylation controls the nSMase2 activity upon ox-stress exposure in an interdependent manner. Furthermore, we show that the nSMase2 protein stability and thus its level of expression is also post-translationally regulated by these five serine phosphorylation sites. This study provides initial structure/function insights regarding nSMase2 phosphorylation sites and offers some new links for future studies aiming to fully elucidate nSMase2 regulatory machinery.	[Filosto, Simone; Ashfaq, Majid; Chung, Samuel; Fry, William; Goldkorn, Tzipora] Univ Calif Davis, Sch Med, Genome & Biomed Sci Facil, Dept Internal Med, Davis, CA 95616 USA	University of California System; University of California Davis	Goldkorn, T (corresponding author), Univ Calif Davis, Sch Med, Genome & Biomed Sci Facil, Dept Internal Med, Rm 6321,451 E Hlth Sci Dr, Davis, CA 95616 USA.	ttgoldkorn@ucdavis.edu	Chung, Samuel/H-9472-2019	Chung, Samuel/0000-0002-4988-0606; Filosto, Simone/0000-0002-7854-998X	National Institutes of Health [HL-71871, HL-66189]; Tobacco-related Disease Research Program (TRDRP) [17RT-0131, 20FT-0087]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071871, R01HL066189] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tobacco-related Disease Research Program (TRDRP)(University of California System); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-71871 and HL-66189 (to T. G.). This work was also supported by Tobacco-related Disease Research Program (TRDRP) Grants 17RT-0131 (to T. G.) and 20FT-0087 (to S. F.).	Barak A, 2001, INVEST OPHTH VIS SCI, V42, P247; Bartke N, 2009, J LIPID RES, V50, pS91, DOI 10.1194/jlr.R800080-JLR200; Chan C, 2000, AM J RESP CELL MOL, V22, P460, DOI 10.1165/ajrcmb.22.4.3376; Chen Y, 2001, AM J RESP CELL MOL, V25, P409, DOI 10.1165/ajrcmb.25.4.4413; Clarke CJ, 2008, MOL PHARMACOL, V74, P1022, DOI 10.1124/mol.108.046250; Clarke CJ, 2007, J BIOL CHEM, V282, P1384, DOI 10.1074/jbc.M609216200; Clarke CJ, 2006, BIOCHEMISTRY-US, V45, P11247, DOI 10.1021/bi061307z; Clarke CJ, 2011, ADV ENZYME REGUL, V51, P51, DOI 10.1016/j.advenzreg.2010.09.016; Filosto S, 2011, AM J RESP CELL MOL, V44, P350, DOI 10.1165/rcmb.2009-0422OC; Filosto S, 2010, J BIOL CHEM, V285, P10213, DOI 10.1074/jbc.M109.069963; Goldkorn T, 1998, J CELL SCI, V111, P3209; Goldkorn T., 2001, CLIN APPL IMMUNOLOGY, V1, P173; Goldkorn T, 2010, AM J RESP CELL MOL, V43, P259, DOI 10.1165/rcmb.2010-0220RT; Hofmann K, 2000, P NATL ACAD SCI USA, V97, P5895, DOI 10.1073/pnas.97.11.5895; Hsu PP, 2011, SCIENCE, V332, P1317, DOI 10.1126/science.1199498; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Kolesnick R, 1999, TRENDS BIOCHEM SCI, V24, P224, DOI 10.1016/S0968-0004(99)01408-5; Lavrentiadou SN, 2001, AM J RESP CELL MOL, V25, P676, DOI 10.1165/ajrcmb.25.6.4321; Lawler JF, 1998, J BIOL CHEM, V273, P5053, DOI 10.1074/jbc.273.9.5053; Levy M, 2006, BIOCHEM BIOPH RES CO, V344, P900, DOI 10.1016/j.bbrc.2006.04.013; Levy M, 2009, AM J PHYSIOL-LUNG C, V297, pL125, DOI 10.1152/ajplung.00031.2009; Luberto C, 1999, LIPIDS, V34, pS5, DOI 10.1007/BF02562221; Marchesini N, 2004, J BIOL CHEM, V279, P25101, DOI 10.1074/jbc.M313662200; Marchesini N, 2004, BIOCHEM CELL BIOL, V82, P27, DOI 10.1139/o03-091; Milhas D, 2010, BBA-MOL CELL BIOL L, V1801, P1361, DOI 10.1016/j.bbalip.2010.08.001; Nikolova-Karakashian Mariana, 2008, V49, P469, DOI 10.1007/978-1-4020-8831-5_18; OKAZAKI T, 1994, J BIOL CHEM, V269, P4070; Ravid T, 2003, AM J PHYSIOL-LUNG C, V284, pL1082, DOI 10.1152/ajplung.00172.2002; Robinson CB, 1991, METHODS CELL SCI, V13, P95; Rutkute K, 2007, J LIPID RES, V48, P2443, DOI 10.1194/jlr.M700227-JLR200; Rutkute K, 2007, HEPATOLOGY, V46, P1166, DOI 10.1002/HEP.21777; Satoi H, 2005, NEUROSCIENCE, V130, P657, DOI 10.1016/j.neuroscience.2004.08.056; Uhlig S, 2008, AM J RESP CRIT CARE, V178, P1100, DOI 10.1164/rccm.200804-595SO; Wu BX, 2010, NEUROMOL MED, V12, P320, DOI 10.1007/s12017-010-8120-z	34	22	23	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					514	522		10.1074/jbc.M111.315481	http://dx.doi.org/10.1074/jbc.M111.315481			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22074919	Green Published, hybrid			2022-12-27	WOS:000298682400050
J	Yu, FY; Jiao, Y; Zhu, YH; Wang, Y; Zhu, JD; Cui, XY; Liu, YJ; He, YH; Park, EY; Zhang, HY; Lv, XB; Ma, KL; Su, FX; Park, JH; Song, EW				Yu, Fengyan; Jiao, Yu; Zhu, Yinghua; Wang, Ying; Zhu, Jingde; Cui, Xiuying; Liu, Yujie; He, Yinghua; Park, Eun-Young; Zhang, Hongyu; Lv, Xiaobin; Ma, Kelong; Su, Fengxi; Park, Jong Hoon; Song, Erwei			MicroRNA 34c Gene Down-regulation via DNA Methylation Promotes Self-renewal and Epithelial-Mesenchymal Transition in Breast Tumor-initiating Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER STEM-CELLS; CPG METHYLATION; EPIGENETIC INACTIVATION; EXPRESSION; TRANSCRIPTION; BINDING; MIR-34; SITE; DEMETHYLATION; ACTIVATION	Tumor-initiating cells (T-ICs), a subpopulation of cancer cells with stem cell-like properties, are related to tumor relapse and metastasis. Our previous studies identified a distinct profile of microRNA (miRNA) expression in breast T-ICs (BT-ICs), and the dysregulated miRNAs contribute to the self-renewal and tumorigenesis of these cells. However, the underlying mechanisms for miRNA dysregulation in BT-ICs remain obscure. In the present study, we demonstrated that the expression and function of miR-34c were reduced in the BT-ICs of MCF-7 and SK-3rd cells, a breast cancer cell line enriched for BT-ICs. Ectopic expression of miR-34c reduced the self-renewal of BT-ICs, inhibited epithelial-mesenchymal transition, and suppressed migration of the tumor cells via silencing target gene Notch4. Furthermore, we identified a single hypermethylated CpG site in the promoter region of miR-34c gene that contributed to transcriptional repression of miR-34c in BT-ICs by reducing DNA binding activities of Sp1. Therefore, miR-34c reduction in BT-ICs induced by a single hypermethylated CpG site in the promoter region promotes self-renewal and epithelial-mesenchymal transition of BT-ICs.	[Park, Eun-Young; Park, Jong Hoon] Sookmyung Womens Univ, Dept Biol Sci, Seoul 140742, South Korea; [Yu, Fengyan; Wang, Ying; Liu, Yujie; Su, Fengxi; Song, Erwei] Sun Yat Sen Univ, Dept Breast Surg, Sun Yat Sen Mem Hosp, Guangzhou 510120, Guangdong, Peoples R China; [Jiao, Yu; Zhu, Yinghua; Song, Erwei] Sun Yat Sen Univ, Sch Life Sci, Guangzhou 510006, Guangdong, Peoples R China; [Zhu, Jingde; He, Yinghua; Zhang, Hongyu; Ma, Kelong] Shanghai Jiao Tong Univ, Canc Epigenet & Gene Therapy Grp, Shanghai Canc Inst, Shanghai 200032, Peoples R China; [Cui, Xiuying; Lv, Xiaobin] Sun Yat Sen Univ, Med Res Ctr, Sun Yat Sen Mem Hosp, Guangzhou 510120, Guangdong, Peoples R China	Sookmyung Women's University; Sun Yat Sen University; Sun Yat Sen University; Shanghai Jiao Tong University; Sun Yat Sen University	Park, JH (corresponding author), Sookmyung Womens Univ, Dept Biol Sci, 52 Hyochangwonro, Seoul 140742, South Korea.	parkjh@sookmyung.ac.kr; songerwei02@yahoo.com.cn	Lv, Xiao-Bin/T-7607-2019		Natural Science Foundation of China [30921140312, 30831160515, 30830110, 30973396, 30972785]; Ministry of Science and Technology of China [2010CB912800, 2011CB504203, 2009CB521706, 2009CB825606, 2009CB825607]; Public Health Administration of China; Ministry of Health of China [2011ZX09102-010-02]; Key Laboratory of Malignant Tumor Gene Regulation and Target Therapy of Guang-dong Higher Education Institutes, Sun-Yat-Sen University [KLB09001]; HuoYingdong Educational Foundation [121042]; National Research Foundation of Korea [2011-0001382]; Korea government	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Public Health Administration of China; Ministry of Health of China; Key Laboratory of Malignant Tumor Gene Regulation and Target Therapy of Guang-dong Higher Education Institutes, Sun-Yat-Sen University; HuoYingdong Educational Foundation; National Research Foundation of Korea(National Research Foundation of Korea); Korea government(Korean Government)	This work was supported by Grant 30921140312 from the A3 program of the Natural Science Foundation of China; 973 Projects 2010CB912800, 2011CB504203, 2009CB521706, 2009CB825606, and 2009CB825607 from the Ministry of Science and Technology of China; Grants 30831160515, 30830110, 30973396, and 30972785 from the Natural Science Foundation of China; a Clinical Key Project of the Public Health Administration of China; Grant 2011ZX09102-010-02 for the Development of Important New Drugs from the Ministry of Health of China; Grant KLB09001 from the Key Laboratory of Malignant Tumor Gene Regulation and Target Therapy of Guang-dong Higher Education Institutes, Sun-Yat-Sen University; Young Teacher Grant 121042 from the HuoYingdong Educational Foundation; and National Research Foundation of Korea Grant 2011-0001382 funded by the Korea government.	BENHATTAR J, 1988, GENE, V65, P219, DOI 10.1016/0378-1119(88)90458-1; Cai KM, 2010, INT J MOL MED, V25, P565, DOI 10.3892/ijmm_00000378; Chang CJ, 2011, NAT CELL BIOL, V13, P317, DOI 10.1038/ncb2173; COMB M, 1990, NUCLEIC ACIDS RES, V18, P3975, DOI 10.1093/nar/18.13.3975; Corney DC, 2010, CLIN CANCER RES, V16, P1119, DOI 10.1158/1078-0432.CCR-09-2642; Dalerba P, 2007, ANNU REV MED, V58, P267, DOI 10.1146/annurev.med.58.062105.204854; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Friso S, 2008, ATHEROSCLEROSIS, V199, P323, DOI 10.1016/j.atherosclerosis.2007.11.029; Furuta T, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-39; He CL, 2009, BIOCHEM BIOPH RES CO, V388, P35, DOI 10.1016/j.bbrc.2009.07.101; Honda H, 2006, J BIOL CHEM, V281, P21433, DOI 10.1074/jbc.M603767200; Ji Q, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006816; Ji Q, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-266; Klopp AH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012180; Kong DJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012445; Kong W, 2008, MOL CELL BIOL, V28, P6773, DOI 10.1128/MCB.00941-08; Lehmann U, 2008, J PATHOL, V214, P17, DOI 10.1002/path.2251; Liu C, 2011, NAT MED, V17, P211, DOI 10.1038/nm.2284; Liu Y, 2009, CLIN IMMUNOL, V130, P213, DOI 10.1016/j.clim.2008.08.009; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Meng FY, 2012, J CELL MOL MED, V16, P160, DOI 10.1111/j.1582-4934.2011.01282.x; Michelotti GA, 2007, FASEB J, V21, P1979, DOI 10.1096/fj.06-7118com; Murayama A, 2006, EMBO J, V25, P1081, DOI 10.1038/sj.emboj.7601012; Norton L, 2011, ONCOLOGY-NY, V25, P30; Noseda M, 2004, CIRC RES, V94, P910, DOI 10.1161/01.RES.0000124300.76171.C9; Ozsolak F, 2008, GENE DEV, V22, P3172, DOI 10.1101/gad.1706508; PRENDERGAST GC, 1991, SCIENCE, V251, P186, DOI 10.1126/science.1987636; Ren JQ, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-20; ROBERTSON KD, 1995, MOL CELL BIOL, V15, P6150; Rokhlin OW, 2008, CANCER BIOL THER, V7, P1288, DOI 10.4161/cbt.7.8.6284; Sato H, 2007, CARCINOGENESIS, V28, P2459, DOI 10.1093/carcin/bgm178; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Torng PL, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-120; Toyota M, 2008, CANCER RES, V68, P4123, DOI 10.1158/0008-5472.CAN-08-0325; Vogt M, 2011, VIRCHOWS ARCH, V458, P313, DOI 10.1007/s00428-010-1030-5; Wang ZW, 2009, CANCER RES, V69, P2400, DOI 10.1158/0008-5472.CAN-08-4312; Wenger RH, 1998, EUR J BIOCHEM, V253, P771, DOI 10.1046/j.1432-1327.1998.2530771.x; Wicha MS, 2006, CLIN CANCER RES, V12, P5606, DOI 10.1158/1078-0432.CCR-06-1537; Wilting SM, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-167; Xu J, 2002, CELL RES, V12, P177, DOI 10.1038/sj.cr.7290124; Yu F, 2010, ONCOGENE, V29, P4194, DOI 10.1038/onc.2010.167; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Zhang H, 2004, CELL RES, V14, P283, DOI 10.1038/sj.cr.7290229; Zhu WG, 2003, MOL CELL BIOL, V23, P4056, DOI 10.1128/MCB.23.12.4056-4065.2003; Zou B, 2006, GASTROENTEROLOGY, V131, P1835, DOI 10.1053/j.gastro.2006.09.050	45	113	119	0	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					465	473		10.1074/jbc.M111.280768	http://dx.doi.org/10.1074/jbc.M111.280768			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22074923	Green Published, hybrid			2022-12-27	WOS:000298682400045
J	Zheng, Y; Asara, JM; Tyner, AL				Zheng, Yu; Asara, John M.; Tyner, Angela L.			Protein-tyrosine Kinase 6 Promotes Peripheral Adhesion Complex Formation and Cell Migration by Phosphorylating p130 CRK-associated Substrate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-TUMOR KINASE; EPITHELIAL-MESENCHYMAL TRANSITION; EPIDERMAL-GROWTH-FACTOR; CANCER-CELLS; GASTROINTESTINAL-TRACT; PROSTATE-CANCER; GENE-EXPRESSION; E-CADHERIN; BRK; SRC	Protein-tyrosine kinase 6 (PTK6) is a non-myristoylated intracellular tyrosine kinase evolutionarily related to Src kinases. Aberrant PTK6 expression and intracellular localization have been detected in human prostate tumors. In the PC3 prostate cancer cell line, the pool of endogenous activated PTK6, which is phosphorylated on tyrosine residue 342, is localized at the membrane. Expression of ectopic membrane-targeted PTK6 led to dramatic morphology changes and formation of peripheral adhesion complexes in PC3 cells. Peripheral adhesion complex formation was dependent upon PTK6 kinase activity. We demonstrated that p130 CRK-associated substrate (p130CAS) is a novel direct substrate of PTK6, and it works as a crucial adapter protein in inducing peripheral adhesion complexes. Activation of ERK5 downstream of p130CAS was indispensable for this process. Knockdown of endogenous PTK6 led to reduced cell migration and p130CAS phosphorylation, whereas knockdown of p130CAS attenuated oncogenic signaling induced by membrane-targeted PTK6, including ERK5 and AKT activation. Expression of membrane-targeted PTK6 promoted cell migration, which could be impaired by knockdown of p130CAS or ERK5. Our study reveals a novel function for PTK6 at the plasma membrane and suggests that the PTK6-p130CAS-ERK5 signaling cascade plays an important role in cancer cell migration and invasion.	[Tyner, Angela L.] Univ Illinois, Coll Med, Dept Biochem & Mol Genet, Chicago, IL 60607 USA; [Asara, John M.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Signal Transduct, Boston, MA 02115 USA; [Asara, John M.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School	Tyner, AL (corresponding author), Univ Illinois, Coll Med, Dept Biochem & Mol Genet, 900 S Ashland Ave,M-C 669, Chicago, IL 60607 USA.	atyner@uic.edu		Tyner, Angela/0000-0001-7448-8625	National Institutes of Health [DK044525, DK068503]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068503, R01DK044525, R55DK044525] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK044525 and DK068503 (to A. L. T.).	American Cancer Society, 2010, CANC FACTS FIG 2010; Astier A, 1997, J BIOL CHEM, V272, P19719, DOI 10.1074/jbc.272.32.19719; Avizienyte E, 2004, MOL BIOL CELL, V15, P2794, DOI 10.1091/mbc.E03-12-0879; Avizienyte E, 2002, NAT CELL BIOL, V4, P632, DOI 10.1038/ncb829; Ayala I, 2008, J CELL SCI, V121, P369, DOI 10.1242/jcs.008037; Barker KT, 1997, ONCOGENE, V15, P799, DOI 10.1038/sj.onc.1201241; Brauer PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014789; Brauer PM, 2010, CELL CYCLE, V9, P4190, DOI 10.4161/cc.9.20.13518; Brinkman A, 2000, JNCI-J NATL CANCER I, V92, P112, DOI 10.1093/jnci/92.2.112; Cabodi S, 2006, CANCER RES, V66, P4672, DOI 10.1158/0008-5472.CAN-05-2909; Castro NE, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2622; Chen HY, 2004, MOL CELL BIOL, V24, P10558, DOI 10.1128/MCB.24.24.10558-10572.2004; Derry JJ, 2000, MOL CELL BIOL, V20, P6114, DOI 10.1128/MCB.20.16.6114-6126.2000; Derry JJ, 2003, ONCOGENE, V22, P4212, DOI 10.1038/sj.onc.1206465; Dorssers LCJ, 2004, CLIN CANCER RES, V10, P6194, DOI 10.1158/1078-0432.CCR-04-0444; Easty DJ, 1997, INT J CANCER, V71, P1061, DOI 10.1002/(SICI)1097-0215(19970611)71:6<1061::AID-IJC24>3.0.CO;2-F; Fromont G, 2007, PROSTATE, V67, P268, DOI 10.1002/pros.20516; Grille SJ, 2003, CANCER RES, V63, P2172; HAYWARD SW, 1995, IN VITRO CELL DEV-AN, V31, P14; Honda H, 1998, NAT GENET, V19, P361, DOI 10.1038/1246; Irie HY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011729; Kamalati T, 2000, ONCOGENE, V19, P5471, DOI 10.1038/sj.onc.1203931; KANNER SB, 1991, MOL CELL BIOL, V11, P713, DOI 10.1128/MCB.11.2.713; Kim HI, 2009, J BIOCHEM, V146, P133, DOI 10.1093/jb/mvp050; Ko S, 2009, BIOCHEM BIOPH RES CO, V384, P236, DOI 10.1016/j.bbrc.2009.04.103; Kreegipuu A, 1998, FEBS LETT, V430, P45, DOI 10.1016/S0014-5793(98)00503-1; LEE ST, 1993, ONCOGENE, V8, P3403; Lin HS, 2004, ARCH OTOLARYNGOL, V130, P311, DOI 10.1001/archotol.130.3.311; Liu L, 2006, ONCOGENE, V25, P4904, DOI 10.1038/sj.onc.1209501; Llor X, 1999, CLIN CANCER RES, V5, P1767; Locatelli A, 2011, J BIOL CHEM, V286, P21062, DOI 10.1074/jbc.M110.211409; Mitchell PJ, 1997, ONCOGENE, V15, P1497, DOI 10.1038/sj.onc.1201292; MITCHELL PJ, 1994, ONCOGENE, V9, P2383; Ostrander JH, 2007, CANCER RES, V67, P4199, DOI 10.1158/0008-5472.CAN-06-3409; Palka-Hamblin HL, 2010, J CELL SCI, V123, P236, DOI 10.1242/jcs.053264; PATCH LA, 1995, J CELL SCI, V108, P1371; Pellicena P, 2001, J BIOL CHEM, V276, P28190, DOI 10.1074/jbc.M100055200; Qiu HQ, 2004, ONCOGENE, V23, P2216, DOI 10.1038/sj.onc.1207339; Qiu HQ, 2002, J BIOL CHEM, V277, P34634, DOI 10.1074/jbc.M203877200; Rasband W., 2006, IMAGEJ; REYNOLDS AB, 1989, MOL CELL BIOL, V9, P3951, DOI 10.1128/MCB.9.9.3951; Roberts OL, 2010, J CELL SCI, V123, P3189, DOI 10.1242/jcs.072801; SAKAI R, 1994, EMBO J, V13, P3748, DOI 10.1002/j.1460-2075.1994.tb06684.x; Sanders MA, 2005, J BIOL CHEM, V280, P23516, DOI 10.1074/jbc.M413165200; Schmandt RE, 2006, CANCER BIOL THER, V5, P1136, DOI 10.4161/cbt.5.9.2953; Seals DF, 2005, CANCER CELL, V7, P155, DOI 10.1016/j.ccr.2005.01.006; Serfas MS, 2003, ONCOL RES, V13, P409; Shen CH, 2008, CANCER RES, V68, P7779, DOI 10.1158/0008-5472.CAN-08-0997; Shin DS, 2008, J COMB CHEM, V10, P20, DOI 10.1021/cc7001217; SIYANOVA EY, 1994, ONCOGENE, V9, P2053; Smith HW, 2008, J CELL BIOL, V182, P777, DOI 10.1083/jcb.200712050; Songyang Zhou, 1995, Trends in Biochemical Sciences, V20, P470, DOI 10.1016/S0968-0004(00)89103-3; Tachibana K, 1997, J BIOL CHEM, V272, P29083, DOI 10.1074/jbc.272.46.29083; Vasioukhin V, 1997, P NATL ACAD SCI USA, V94, P14477, DOI 10.1073/pnas.94.26.14477; VASIOUKHIN V, 1995, ONCOGENE, V10, P349; Wang X, 2006, CELL DEATH DIFFER, V13, P2099, DOI 10.1038/sj.cdd.4401969; Weaver AM, 2006, CLIN EXP METASTAS, V23, P97, DOI 10.1007/s10585-006-9014-1; Weaver AM, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1794; Xiang B, 2008, P NATL ACAD SCI USA, V105, P12463, DOI 10.1073/pnas.0805009105; Yu YP, 2004, J CLIN ONCOL, V22, P2790, DOI 10.1200/JCO.2004.05.158; Zheng Y, 2010, MOL CELL BIOL, V30, P4280, DOI 10.1128/MCB.00024-10; Zvara A, 2001, ONCOGENE, V20, P951, DOI 10.1038/sj.onc.1204173	62	29	31	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					148	158		10.1074/jbc.M111.298117	http://dx.doi.org/10.1074/jbc.M111.298117			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22084245	Green Published, hybrid			2022-12-27	WOS:000298682400017
J	Higa, A; Mulot, A; Delom, F; Bouchecareilh, M; Nguyen, DT; Boismenu, D; Wise, MJ; Chevet, E				Higa, Arisa; Mulot, Audrey; Delom, Frederic; Bouchecareilh, Marion; Duc Thang Nguyen; Boismenu, Daniel; Wise, Michael J.; Chevet, Eric			Role of Pro-oncogenic Protein Disulfide Isomerase (PDI) Family Member Anterior Gradient 2 (AGR2) in the Control of Endoplasmic Reticulum Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							QUALITY-CONTROL; HUMAN HOMOLOG; EXPRESSION; CANCER; GENE; TRANSLOCATION; ER; IMMUNOGENICITY; SURVIVAL; ANTIGEN	The protein-disulfide isomerase (PDI) family member anterior gradient 2 (AGR2) is reportedly overexpressed in numerous cancers and plays a role in cancer development. However, to date the molecular functions of AGR2 remain to be characterized. Herein we have identified AGR2 as bound to newly synthesized cargo proteins using a proteomics analysis of endoplasmic reticulum (ER) membrane-bound ribosomes. Nascent protein chains that translocate into the ER associate with specific ER luminal proteins, which in turn ensures proper folding and posttranslational modifications. Using both imaging and biochemical approaches, we confirmed that AGR2 localizes to the lumen of the ER and indirectly associates with ER membrane-bound ribosomes through nascent protein chains. We showed that AGR2 expression is controlled by the unfolded protein response and is in turn is involved in the maintenance of ER homeostasis. Remarkably, we have demonstrated that siRNA-mediated knockdown of AGR2 significantly alters the expression of components of the ER-associated degradation machinery and reduces the ability of cells to cope with acute ER stress, properties that might be relevant to the role of AGR2 in cancer development.	[Higa, Arisa; Mulot, Audrey; Bouchecareilh, Marion; Chevet, Eric] Univ Bordeaux Segalen, INSERM, U1053, F-33076 Bordeaux, France; [Delom, Frederic; Duc Thang Nguyen; Chevet, Eric] McGill Univ, Dept Surg, Montreal, PQ H3A 2T5, Canada; [Boismenu, Daniel] Genome Quebec Innovat Ctr, Montreal, PQ, Canada; [Wise, Michael J.] Univ Western Australia, Dept Biomol Biomed & Chem Sci, Perth, WA 6009, Australia	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; McGill University; University of Western Australia	Chevet, E (corresponding author), Univ Bordeaux Segalen, INSERM, U1053, 146 Rue Leo Saignat, F-33076 Bordeaux, France.	eric.chevet@u-bordeaux2.fr	chevet, eric/E-4992-2016; Wise, Michael/B-5676-2012; Delom, Frederic/J-2782-2014	chevet, eric/0000-0001-5855-4522; Wise, Michael/0000-0001-6559-4303; Delom, Frederic/0000-0002-4600-7633	INSERM; Institut National du Cancer (INCa); Ligue Nationale contre le Cancer; Fondation pour la Recherche Medicale; Association de Recherche contre le Cancer; Conseil Regional d'Aquitaine; French government; Genome Quebec/Canada	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Institut National du Cancer (INCa)(Institut National du Cancer (INCA) France); Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Association de Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); Conseil Regional d'Aquitaine(Region Nouvelle-Aquitaine); French government; Genome Quebec/Canada	This work was supported by grants from INSERM (Avenir) and Institut National du Cancer (INCa), Ligue Nationale contre le Cancer, Fondation pour la Recherche Medicale, Association de Recherche contre le Cancer, and Conseil Regional d'Aquitaine (to E. C.).; Supported by a Ph. D. scholarship from the French government.; Frederic Delom and mass spectrometry sequencing were supported in part by an operating grant from Genome Quebec/Canada to the Montreal Proteomics Network (Cell Map Project).	Bates PA, 2001, PROTEINS, P39; Beckmann R, 2001, CELL, V107, P361, DOI 10.1016/S0092-8674(01)00541-4; Beckmann R, 2001, COLD SPRING HARB SYM, V66, P543, DOI 10.1101/sqb.2001.66.543; BLOBEL G, 1975, J CELL BIOL, V67, P852, DOI 10.1083/jcb.67.3.852; Cameron PH, 2009, J BIOL CHEM, V284, P34570, DOI 10.1074/jbc.M109.053165; Chevet E, 1999, EMBO J, V18, P3655, DOI 10.1093/emboj/18.13.3655; Chevet E, 2001, CURR OPIN STRUC BIOL, V11, P120, DOI 10.1016/S0959-440X(00)00168-8; Dejgaard K, 2010, J PROTEOME RES, V9, P1763, DOI 10.1021/pr900900x; DESHAIES RJ, 1991, NATURE, V349, P806, DOI 10.1038/349806a0; DESHAIES RJ, 1987, J CELL BIOL, V105, P633, DOI 10.1083/jcb.105.2.633; Dong AW, 2011, J BIOL CHEM, V286, P18301, DOI 10.1074/jbc.M110.215707; Dumartin L., 2011, CANC RES IN PRESS; Fritzsche FR, 2006, CLIN CANCER RES, V12, P1728, DOI 10.1158/1078-0432.CCR-05-2057; Hao Y, 2006, GASTROENTEROLOGY, V131, P925, DOI 10.1053/j.gastro.2006.04.026; HARTMANN E, 1993, EUR J BIOCHEM, V214, P375, DOI 10.1111/j.1432-1033.1993.tb17933.x; Hooper SD, 2005, BIOINFORMATICS, V21, P4432, DOI 10.1093/bioinformatics/bti696; Hrstka R, 2010, ONCOGENE, V29, P4838, DOI 10.1038/onc.2010.228; Jenna S, 2005, MOL BIOL CELL, V16, P1629, DOI 10.1091/mbc.E04-08-0760; Johnson AE, 1999, ANNU REV CELL DEV BI, V15, P799, DOI 10.1146/annurev.cellbio.15.1.799; KALIES KU, 1994, J CELL BIOL, V126, P925, DOI 10.1083/jcb.126.4.925; Kleizen B, 2004, CURR OPIN CELL BIOL, V16, P343, DOI 10.1016/j.ceb.2004.06.012; Kovalyova LI, 2006, APPL BIOCHEM MICRO+, V42, P424, DOI 10.1134/S0003683806040156; Kristiansen G, 2005, J PATHOL, V205, P359, DOI 10.1002/path.1676; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lepreux S, 2011, LIVER INT, V31, P322, DOI 10.1111/j.1478-3231.2010.02438.x; Liu D, 2005, CANCER RES, V65, P3796, DOI 10.1158/0008-5472.CAN-04-3823; Maattanen P, 2010, SEMIN CELL DEV BIOL, V21, P500, DOI 10.1016/j.semcdb.2010.03.006; Moenner M, 2007, CANCER RES, V67, P10631, DOI 10.1158/0008-5472.CAN-07-1705; Mori K, 2000, CELL, V101, P451, DOI 10.1016/S0092-8674(00)80855-7; Nguyen DT, 2004, MOL BIOL CELL, V15, P4248, DOI 10.1091/mbc.E03-11-0851; Obeid M, 2007, NAT MED, V13, P54, DOI 10.1038/nm1523; Panaretakis T, 2008, CELL DEATH DIFFER, V15, P1499, DOI 10.1038/cdd.2008.67; Park SW, 2009, P NATL ACAD SCI USA, V106, P6950, DOI 10.1073/pnas.0808722106; Persson S, 2005, MOL PHYLOGENET EVOL, V36, P734, DOI 10.1016/j.ympev.2005.04.002; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pohler E, 2004, MOL CELL PROTEOMICS, V3, P534, DOI 10.1074/mcp.M300089-MCP200; Ramachandran V, 2008, CANCER RES, V68, P7811, DOI 10.1158/0008-5472.CAN-08-1320; Ron E, 2011, MOL BIOL CELL, V22, P3945, DOI 10.1091/mbc.E10-12-0944; Ruddock LW, 2006, J CELL SCI, V119, P4373, DOI 10.1242/jcs.03225; Smirnov DA, 2005, CANCER RES, V65, P4993, DOI 10.1158/0008-5472.CAN-04-4330; Snel B, 2000, NUCLEIC ACIDS RES, V28, P3442, DOI 10.1093/nar/28.18.3442; Thompson DA, 1998, BIOCHEM BIOPH RES CO, V251, P111, DOI 10.1006/bbrc.1998.9440; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; WALTER P, 1984, CELL, V38, P5, DOI 10.1016/0092-8674(84)90520-8; Wang Z, 2008, CANCER RES, V68, P492, DOI 10.1158/0008-5472.CAN-07-2930; Wise Michael J, 2002, Bioinformatics, V18 Suppl 1, pS38; Wise MJ, 2004, TRENDS PLANT SCI, V9, P13, DOI 10.1016/j.tplants.2003.10.012; Zhang JS, 2005, GENE CHROMOSOME CANC, V43, P249, DOI 10.1002/gcc.20188; Zhang Y, 2007, PROSTATE CANCER P D, V10, P293, DOI 10.1038/sj.pcan.4500960; Zhao F, 2010, DEV BIOL, V338, P268, DOI 10.1016/j.ydbio.2009.12.008; Zhu H, 2007, CANCER LETT, V245, P303, DOI 10.1016/j.canlet.2006.01.020	51	80	85	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2011	286	52					44855	44868		10.1074/jbc.M111.275529	http://dx.doi.org/10.1074/jbc.M111.275529			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870CA	22025610	Green Published, hybrid			2022-12-27	WOS:000298645500054
J	Schaefer, JB; Morgan, DO				Schaefer, Jonathan B.; Morgan, David O.			Protein-linked Ubiquitin Chain Structure Restricts Activity of Deubiquitinating Enzymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; CRYSTAL-STRUCTURE; POLYUBIQUITIN; BINDING; MECHANISM; RESIDUES; REVEALS; COMPLEX; YEAST; E2	The attachment of lysine 48 (Lys(48))-linked polyubiquitin chains to proteins is a universal signal for degradation by the proteasome. Here, we report that long Lys(48)-linked chains are resistant to many deubiquitinating enzymes (DUBs). Representative enzymes from this group, Ubp15 from yeast and its human ortholog USP7, rapidly remove mono- and diubiquitin from substrates but are slow to remove longer Lys(48)-linked chains. This resistance is lost if the structure of Lys(48)-linked chains is disrupted by mutation of ubiquitin or if chains are linked through Lys(63). In contrast to Ubp15 and USP7, Ubp12 readily cleaves the ends of long chains, regardless of chain structure. We propose that the resistance to many DUBs of long, substrate-attached Lys(48)-linked chains helps ensure that proteins are maintained free from ubiquitin until a threshold of ubiquitin ligase activity enables degradation.	[Schaefer, Jonathan B.; Morgan, David O.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA	University of California System; University of California San Francisco	Morgan, DO (corresponding author), Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA.	David.Morgan@ucsf.edu		Morgan, David/0000-0001-8753-4416	National Institute of General Medical Sciences [R01-GM053270]; National Cancer Institute [T32-CA09043]; NATIONAL CANCER INSTITUTE [T32CA009043] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM053270, R01GM053270] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by funding from the National Institute of General Medical Sciences (R01-GM053270) and the National Cancer Institute (T32-CA09043).	Amerik AY, 2000, BIOL CHEM, V381, P981, DOI 10.1515/BC.2000.121; Beal R, 1996, P NATL ACAD SCI USA, V93, P861, DOI 10.1073/pnas.93.2.861; Bozza WP, 2011, BIOCHEMISTRY-US, V50, P6423, DOI 10.1021/bi200529z; Bremm A, 2010, NAT STRUCT MOL BIOL, V17, P939, DOI 10.1038/nsmb.1873; Carroll CW, 2005, METHOD ENZYMOL, V398, P219, DOI 10.1016/S0076-6879(05)98018-X; CIECHANOVER A, 1982, J BIOL CHEM, V257, P2537; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Eddins MJ, 2007, J MOL BIOL, V367, P204, DOI 10.1016/j.jmb.2006.12.065; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Hornig NCD, 2002, CURR BIOL, V12, P973, DOI 10.1016/S0960-9822(02)00847-3; Hu M, 2002, CELL, V111, P1041, DOI 10.1016/S0092-8674(02)01199-6; Komander D, 2008, MOL CELL, V29, P451, DOI 10.1016/j.molcel.2007.12.018; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Komander D, 2009, EMBO REP, V10, P466, DOI 10.1038/embor.2009.55; Leggett DS, 2002, MOL CELL, V10, P495, DOI 10.1016/S1097-2765(02)00638-X; Love KR, 2007, NAT CHEM BIOL, V3, P697, DOI 10.1038/nchembio.2007.43; Ma JH, 2010, ARCH BIOCHEM BIOPHYS, V503, P207, DOI 10.1016/j.abb.2010.08.020; Matyskiela ME, 2009, MOL CELL, V34, P68, DOI 10.1016/j.molcel.2009.02.027; Pickart CM, 2004, NAT REV MOL CELL BIO, V5, P177, DOI 10.1038/nrm1336; Rodrigo-Brenni MC, 2007, CELL, V130, P127, DOI 10.1016/j.cell.2007.05.027; Rodrigo-Brenni MC, 2010, MOL CELL, V39, P548, DOI 10.1016/j.molcel.2010.07.027; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Ventii KH, 2008, BIOCHEM J, V414, P161, DOI 10.1042/BJ20080798; Xu P, 2009, CELL, V137, P133, DOI 10.1016/j.cell.2009.01.041; Ye YH, 2009, NAT REV MOL CELL BIO, V10, P755, DOI 10.1038/nrm2780; Ye Y, 2011, EMBO REP, V12, P350, DOI 10.1038/embor.2011.17; Ye Y, 2009, MOL BIOSYST, V5, P1797, DOI 10.1039/b907669g	30	47	48	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2011	286	52					45186	45196		10.1074/jbc.M111.310094	http://dx.doi.org/10.1074/jbc.M111.310094			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870CA	22072716	Green Published, hybrid			2022-12-27	WOS:000298645500084
J	Frobel, J; Rose, P; Muller, M				Froebel, Julia; Rose, Patrick; Mueller, Matthias			Early Contacts between Substrate Proteins and TatA Translocase Component in Twin-arginine Translocation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE-SCANNING MUTAGENESIS; ESCHERICHIA-COLI; TRANSPORT SYSTEM; SIGNAL PEPTIDE; PRECURSOR PROTEINS; IN-VITRO; BACILLUS-SUBTILIS; MEMBRANE-BINDING; PATHWAY; COMPLEX	Twin-arginine translocation (Tat) is a unique protein transport pathway in bacteria, archaea, and plastids. It mediates the transmembrane transport of fully folded proteins, which harbor a consensus twin-arginine motif in their signal sequences. In Gram-negative bacteria and plant chloroplasts, three membrane proteins, named TatA, TatB, and TatC, are required to enable Tat translocation. Available data suggest that TatA assembles into oligomeric pore-like structures that might function as the protein conduit across the lipid bilayer. Using site-specific photo-cross-linking, we have investigated the molecular environment of TatA under resting and translocating conditions. We find that monomeric TatA is an early interacting partner of functionally targeted Tat substrates. This interaction with TatA likely precedes translocation of Tat substrates and is influenced by the proton-motive force. It strictly depends on the presence of TatB and TatC, the latter of which is shown to make contacts with the transmembrane helix of TatA.	[Froebel, Julia; Rose, Patrick; Mueller, Matthias] Univ Freiburg, Inst Biochem & Mol Biol, ZBMZ, D-79104 Freiburg, Germany; [Froebel, Julia; Rose, Patrick] Univ Freiburg, Fac Biol, D-79104 Freiburg, Germany	University of Freiburg; University of Freiburg	Muller, M (corresponding author), Univ Freiburg, Inst Biochem & Mol Biol, ZBMZ, Stefan Meier Str 17, D-79104 Freiburg, Germany.	matthias.mueller@biochemie.uni-freiburg.de			Sonderforschungsbereich 746; Deutsche Forschungsgemeinschaft	Sonderforschungsbereich 746(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Sonderforschungsbereich 746 and Forschergruppe 929 of the Deutsche Forschungsgemeinschaft.	Alami M, 2003, MOL CELL, V12, P937, DOI 10.1016/S1097-2765(03)00398-8; Alami M, 2002, J BIOL CHEM, V277, P20499, DOI 10.1074/jbc.M201711200; Alder NN, 2003, FEBS LETT, V540, P96, DOI 10.1016/S0014-5793(03)00231-X; Bageshwar UK, 2007, J CELL BIOL, V179, P87, DOI 10.1083/jcb.200702082; Bageshwar UK, 2009, MOL MICROBIOL, V74, P209, DOI 10.1111/j.1365-2958.2009.06862.x; Behrendt J, 2007, FEBS LETT, V581, P4085, DOI 10.1016/j.febslet.2007.07.045; Blaudeck N, 2005, J BIOL CHEM, V280, P3426, DOI 10.1074/jbc.M411210200; Blaudeck N, 2003, J BACTERIOL, V185, P2811, DOI 10.1128/JB.185.9.2811-2819.2003; Bolhuis A, 2001, J BIOL CHEM, V276, P20213, DOI 10.1074/jbc.M100682200; Bruser T, 2003, MICROBIOL RES, V158, P7, DOI 10.1078/0944-5013-00176; Chan CS, 2007, BIOCHEMISTRY-US, V46, P7396, DOI 10.1021/bi7005288; Cline K, 2001, J CELL BIOL, V154, P719, DOI 10.1083/jcb.200105149; Cline K, 2007, EMBO J, V26, P3039, DOI 10.1038/sj.emboj.7601759; Dabney-Smith C, 2006, J BIOL CHEM, V281, P5476, DOI 10.1074/jbc.M512453200; Dabney-Smith C, 2009, MOL BIOL CELL, V20, P2060, DOI 10.1091/mbc.E08-12-1189; de Leeuw E, 2002, J MOL BIOL, V322, P1135, DOI 10.1016/S0022-2836(02)00820-3; DeLisa MP, 2003, P NATL ACAD SCI USA, V100, P6115, DOI 10.1073/pnas.0937838100; Fincher V, 1998, FEBS LETT, V423, P66, DOI 10.1016/S0014-5793(98)00066-0; Gerard F, 2006, J BIOL CHEM, V281, P6130, DOI 10.1074/jbc.M512733200; Gohlke U, 2005, P NATL ACAD SCI USA, V102, P10482, DOI 10.1073/pnas.0503558102; Gouffi K, 2004, J BIOL CHEM, V279, P11608, DOI 10.1074/jbc.M313187200; Greene NP, 2007, J BIOL CHEM, V282, P23937, DOI 10.1074/jbc.M702972200; Holzapfel E, 2007, BIOCHEMISTRY-US, V46, P2892, DOI 10.1021/bi062205b; Hu YF, 2010, J AM CHEM SOC, V132, P15942, DOI 10.1021/ja1053785; Hynds PJ, 1998, J BIOL CHEM, V273, P34868, DOI 10.1074/jbc.273.52.34868; Jakob M, 2009, BBA-MOL CELL RES, V1793, P388, DOI 10.1016/j.bbamcr.2008.09.006; Kostecki JS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009225; Kreutzenbeck P, 2007, J BIOL CHEM, V282, P7903, DOI 10.1074/jbc.M610126200; Leake MC, 2008, P NATL ACAD SCI USA, V105, P15376, DOI 10.1073/pnas.0806338105; Lee PA, 2006, J BIOL CHEM, V281, P34072, DOI 10.1074/jbc.M607295200; LESLEY SA, 1991, J BIOL CHEM, V266, P2632; Ma XY, 2010, EMBO J, V29, P1477, DOI 10.1038/emboj.2010.44; Ma XY, 2000, J BIOL CHEM, V275, P10016, DOI 10.1074/jbc.275.14.10016; Maldonado B, 2011, FEBS LETT, V585, P478, DOI 10.1016/j.febslet.2011.01.016; Mangels D, 2005, J MOL BIOL, V345, P415, DOI 10.1016/j.jmb.2004.10.043; Marrichi M, 2008, J BIOL CHEM, V283, P35223, DOI 10.1074/jbc.M802660200; Matos CFRO, 2008, EMBO J, V27, P2055, DOI 10.1038/emboj.2008.132; Maurer C, 2010, MOL BIOL CELL, V21, P4151, DOI 10.1091/mbc.E10-07-0585; Maurer C, 2009, FEBS LETT, V583, P2849, DOI 10.1016/j.febslet.2009.07.038; McDevitt CA, 2005, BIOCHEM BIOPH RES CO, V329, P693, DOI 10.1016/j.bbrc.2005.02.038; McDevitt CA, 2006, FEBS J, V273, P5656, DOI 10.1111/j.1742-4658.2006.05554.x; Mori H, 2002, J CELL BIOL, V157, P205, DOI 10.1083/jcb.200202048; Moser Michael, 2007, V390, P63; Musser SM, 2000, EUR J BIOCHEM, V267, P2588, DOI 10.1046/j.1432-1327.2000.01269.x; Oates J, 2005, J MOL BIOL, V346, P295, DOI 10.1016/j.jmb.2004.11.047; Orriss GL, 2007, FEBS LETT, V581, P4091, DOI 10.1016/j.febslet.2007.07.044; Panahandeh S, 2008, J BIOL CHEM, V283, P33267, DOI 10.1074/jbc.M804225200; Punginelli C, 2007, J BACTERIOL, V189, P5482, DOI 10.1128/JB.00647-07; Richter S, 2005, J BIOL CHEM, V280, P42723, DOI 10.1074/jbc.M509570200; Richter S, 2007, J BIOL CHEM, V282, P33257, DOI 10.1074/jbc.M703303200; Ryu YH, 2006, NAT METHODS, V3, P263, DOI 10.1038/NMETH864; Sanders C, 2001, MOL MICROBIOL, V41, P241, DOI 10.1046/j.1365-2958.2001.02514.x; Santini CL, 1998, EMBO J, V17, P101, DOI 10.1093/emboj/17.1.101; Sargent F, 2007, MICROBIOL-SGM, V153, P633, DOI 10.1099/mic.0.2006/004762-0; Schlesier R, 2010, BIOL CHEM, V391, P1411, DOI 10.1515/BC.2010.138; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Tarry MJ, 2009, P NATL ACAD SCI USA, V106, P13284, DOI 10.1073/pnas.0901566106; Turner RJ, 2004, CAN J MICROBIOL, V50, P225, DOI 10.1139/W03-117; Walther TH, 2010, J AM CHEM SOC, V132, P15945, DOI 10.1021/ja106963s; Warren G, 2009, J MOL BIOL, V388, P122, DOI 10.1016/j.jmb.2009.02.060; White GF, 2010, J BIOL CHEM, V285, P2294, DOI 10.1074/jbc.M109.065458; Yahr TL, 2001, EMBO J, V20, P2472, DOI 10.1093/emboj/20.10.2472	62	40	42	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2011	286	51					43679	43689		10.1074/jbc.M111.292565	http://dx.doi.org/10.1074/jbc.M111.292565			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866SH	22041896	Green Published, hybrid			2022-12-27	WOS:000298402300011
J	McCarty, G; Awad, O; Loeb, DM				McCarty, Gregory; Awad, Ola; Loeb, David M.			WT1 Protein Directly Regulates Expression of Vascular Endothelial Growth Factor and Is a Mediator of Tumor Response to Hypoxia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOFT-TISSUE SARCOMAS; SUPPRESSOR WT1; GENE WT1; WILMS; DIFFERENTIATION; PROMOTER; VEGF; DNA	WT1 is a zinc finger transcription factor expressed at high levels in many types of solid tumors, and high WT1 expression is an adverse prognostic factor. How WT1 contributes to tumor growth and influences prognosis remains unclear. We investigated the hypothesis that WT1 up-regulates VEGF in solid tumors, augmenting the response to hypoxia. We found a correlation between levels of WT1 expression and VEGF expression in Ewing sarcoma cell lines. Transfecting WT1-null SK-ES-1 cells with WT1 up-regulated VEGF mRNA expression and resulted in increased angiogenic activity in vitro. Conversely, diminishing WT1 expression in WT1-positive cell lines using WT1-specific shRNA down-regulated VEGF mRNA expression and decreased angiogenic activity in vitro. Transient transfection assays demonstrated that WT1 can regulate the activity of the VEGF promoter, and chromatin immunoprecipitation assays showed that WT1 can bind directly to the VEGF promoter in intact cells. WT1 expression in Ewing sarcoma cells is up-regulated by hypoxia. Importantly, using shRNA to inhibit this up-regulation blunted the hypoxia-mediated increase in VEGF expression. Taken together, these data demonstrate that VEGF is a direct, bona fide WT1 target gene in sarcoma and that WT1 plays a key role in optimizing the response of tumor cells to hypoxia.	[McCarty, Gregory; Awad, Ola; Loeb, David M.] Johns Hopkins Univ, Dept Oncol, Div Pediat Oncol, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA	Johns Hopkins University; Johns Hopkins Medicine	Loeb, DM (corresponding author), Johns Hopkins Univ, Dept Oncol, Div Pediat Oncol, Sidney Kimmel Comprehens Canc Ctr, Bunting Blaustein Canc Res Bldg,Rm 2M51,1650 Orle, Baltimore, MD 21231 USA.	loebda@jhmi.edu			Flight Attendant Medical Research Institute; The Children's Cancer Foundation; Giant Foods; The Heather Brooke Foundation; Love for Luca Foundation	Flight Attendant Medical Research Institute; The Children's Cancer Foundation; Giant Foods; The Heather Brooke Foundation; Love for Luca Foundation	This work was supported by grants from the Flight Attendant Medical Research Institute and The Children's Cancer Foundation (both to D. M. L.), Giant Foods, The Heather Brooke Foundation, and the Love for Luca Foundation.	CALL KM, 1990, CELL, V60, P509, DOI 10.1016/0092-8674(90)90601-A; Carpentieri DF, 2002, MODERN PATHOL, V15, P1080, DOI 10.1097/01.MP.0000028646.03760.6B; DRUMMOND IA, 1994, MOL CELL BIOL, V14, P3800, DOI 10.1128/MCB.14.6.3800; GESSLER M, 1990, NATURE, V343, P774, DOI 10.1038/343774a0; Graham K, 2006, GENE EXPRESSION, V13, P1, DOI 10.3727/000000006783991953; HABER DA, 1991, P NATL ACAD SCI USA, V88, P9618, DOI 10.1073/pnas.88.21.9618; Hanson J, 2007, FRONT BIOSCI-LANDMRK, V12, P2279, DOI 10.2741/2230; INOUE K, 1994, BLOOD, V84, P3071, DOI 10.1182/blood.V84.9.3071.3071; LARSSON SH, 1995, CELL, V81, P391, DOI 10.1016/0092-8674(95)90392-5; Loeb DM, 2001, CANCER RES, V61, P921; MIWA H, 1992, LEUKEMIA, V6, P405; Simpson LA, 2006, BLOOD, V107, P4695, DOI 10.1182/blood-2005-10-4025; Srivastava A, 2006, CLIN CANCER RES, V12, P4237, DOI 10.1158/1078-0432.CCR-05-2307; Stoll R, 2007, J MOL BIOL, V372, P1227, DOI 10.1016/j.jmb.2007.07.017; Ueda T, 2003, CANCER SCI, V94, P271, DOI 10.1111/j.1349-7006.2003.tb01432.x; Wagner KD, 2003, FASEB J, V17, P1364, DOI 10.1096/fj.02-1065fje; Wagner KD, 2002, FASEB J, V16, P1117, DOI 10.1096/fj.01-0986fje; Wagner N, 2008, ONCOGENE, V27, P3662, DOI 10.1038/sj.onc.1211044; Yoon SS, 2006, J SURG RES, V135, P282, DOI 10.1016/j.jss.2006.01.023	19	49	50	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2011	286	51					43634	43643		10.1074/jbc.M111.310128	http://dx.doi.org/10.1074/jbc.M111.310128			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866SH	22030397	hybrid, Green Published			2022-12-27	WOS:000298402300006
J	Benosman, S; Meng, XJ; Von Grabowiecki, Y; Palamiuc, L; Hritcu, L; Gross, I; Mellitzer, G; Taya, Y; Loeffler, JP; Gaiddon, C				Benosman, Samir; Meng, Xiangjun; Von Grabowiecki, Yannick; Palamiuc, Lavinia; Hritcu, Lucian; Gross, Isabelle; Mellitzer, Georg; Taya, Yoichi; Loeffler, Jean-Philippe; Gaiddon, Christian			Complex Regulation of p73 Isoforms after Alteration of Amyloid Precursor Polypeptide (APP) Function and DNA Damage in Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIN-DEPENDENT KINASES; CENTRAL-NERVOUS-SYSTEM; ALZHEIMERS-DISEASE; CELL-DEATH; SIGNALING PATHWAY; P53 FAMILY; PROTEIN STABILITY; CORTICAL-NEURONS; GENE; APOPTOSIS	Background: Alterations of the APP pathway or DNA damage induce neuronal cell death. Results: Alterations of the APP pathway or DNA damage increase TAp73 expression and reduce Delta Np73 protein levels. Conclusion: A tight control of the expression of p73 isoforms participates in neuronal cell death. Significance: p73 isoforms may play a role in neurodegenerative diseases such as Alzheimer and in the neurotoxicity of anticancer drug therapies.	[Benosman, Samir; Meng, Xiangjun; Von Grabowiecki, Yannick; Loeffler, Jean-Philippe; Gaiddon, Christian] INSERM, U692, F-67000 Strasbourg, France; [Gross, Isabelle; Mellitzer, Georg; Gaiddon, Christian] INSERM, U682, F-67000 Strasbourg, France; [Benosman, Samir; Meng, Xiangjun; Taya, Yoichi] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117456, Singapore; [Benosman, Samir; Meng, Xiangjun; Taya, Yoichi] Natl Univ Singapore, Dept Biochem, Singapore 117456, Singapore; [Palamiuc, Lavinia; Hritcu, Lucian] Alexandru Ioan Cuza Univ, Fac Biol, Physiol Anim Lab, Iasi 700506, Romania; [Von Grabowiecki, Yannick; Gross, Isabelle; Mellitzer, Georg; Loeffler, Jean-Philippe; Gaiddon, Christian] Strasbourg Univ, F-67000 Strasbourg, France; [Meng, Xiangjun] Shanghai Jiao Tong Univ, Dept Gastroenterol, Shanghai Peoples Hosp 1, Sch Med, Shanghai 200087, Peoples R China; [Benosman, Samir; Meng, Xiangjun; Von Grabowiecki, Yannick; Loeffler, Jean-Philippe; Gaiddon, Christian] INSERM, U682, F-67200 Strasbourg, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; National University of Singapore; National University of Singapore; Alexandru Ioan Cuza University; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Shanghai Jiao Tong University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg		gaiddon@unistra.fr	Hritcu, Lucian/G-5378-2010; Gaiddon, Christian/F-7321-2012; Georg, Mellitzer/R-4180-2016; Gross, Isabelle/I-4972-2016; LOEFFLER, Jean-Philippe/AAS-4401-2020; Gross, Isabelle/P-9859-2019	Hritcu, Lucian/0000-0001-6981-4174; Gaiddon, Christian/0000-0003-4315-3851; Georg, Mellitzer/0000-0003-4467-0789; Gross, Isabelle/0000-0002-2783-8773; Gross, Isabelle/0000-0002-2783-8773; von Grabowiecki, Yannick/0000-0003-2189-6953	CNRS; Universite de Strasbourg; Association pour la Recherche Contre le Cancer [3288]; La Ligue Contre le Cancer (Comite du Haut-Rhin, Moselle, and Meurthe-et-Moselle); ANR; Institut National du Cancer; CONECTUS Alsace; Fond National pour la Recherche (Luxembourg, FNR)	CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite de Strasbourg; Association pour la Recherche Contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); La Ligue Contre le Cancer (Comite du Haut-Rhin, Moselle, and Meurthe-et-Moselle); ANR(French National Research Agency (ANR)); Institut National du Cancer(Institut National du Cancer (INCA) France); CONECTUS Alsace(Region Grand-Est); Fond National pour la Recherche (Luxembourg, FNR)(Luxembourg National Research Fund)	This work was supported by CNRS, Universite de Strasbourg, Association pour la Recherche Contre le Cancer Grant 3288, La Ligue Contre le Cancer (Comite du Haut-Rhin, Moselle, and Meurthe-et-Moselle), ANR, Institut National du Cancer, and CONECTUS Alsace, Fond National pour la Recherche (Luxembourg, FNR).	Arrowsmith CH, 1999, CELL DEATH DIFFER, V6, P1169, DOI 10.1038/sj.cdd.4400619; Asher G, 2005, GENE DEV, V19, P316, DOI 10.1101/gad.319905; Benosman S, 2007, CELL DEATH DIFFER, V14, P2047, DOI 10.1038/sj.cdd.4402216; Billon N, 2004, DEVELOPMENT, V131, P1211, DOI 10.1242/dev.01035; Bouron A, 2004, EUR J NEUROSCI, V20, P2071, DOI 10.1111/j.1460-9568.2004.03680.x; Brouwers N, 2008, ANN MED, V40, P562, DOI 10.1080/07853890802186905; Bui T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004373; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Casciano I, 1999, CELL DEATH DIFFER, V6, P391, DOI 10.1038/sj.cdd.4400522; da Costa CA, 2006, J NEUROSCI, V26, P6377, DOI 10.1523/JNEUROSCI.0651-06.2006; de Aguilar JLG, 2000, NEUROBIOL DIS, V7, P406, DOI 10.1006/nbdi.2000.0295; De Laurenzi V, 2000, J BIOL CHEM, V275, P15226, DOI 10.1074/jbc.275.20.15226; De Laurenzi V, 1998, J EXP MED, V188, P1763, DOI 10.1084/jem.188.9.1763; delaMonte SM, 1997, J NEUROL SCI, V152, P73, DOI 10.1016/S0022-510X(97)00131-7; Di Como CJ, 1999, MOL CELL BIOL, V19, P1438; Ding Y, 1999, DNA Res, V6, P347, DOI 10.1093/dnares/6.5.347; Eizenberg O, 1996, MOL CELL BIOL, V16, P5178; Ferreira A, 1996, J CELL SCI, V109, P1509; FREEMAN RS, 1994, NEURON, V12, P343, DOI 10.1016/0896-6273(94)90276-3; Gaiddon C, 2003, J BIOL CHEM, V278, P27421, DOI 10.1074/jbc.M300251200; Gaiddon C, 1999, MOL ENDOCRINOL, V13, P742, DOI 10.1210/me.13.5.742; Gaiddon C, 2001, MOL CELL BIOL, V21, P1874, DOI 10.1128/MCB.21.5.1874-1887.2001; Garden GA, 2004, FASEB J, V18, P1141, DOI 10.1096/fj.04-1676fje; Giovanni A, 1999, J BIOL CHEM, V274, P19011, DOI 10.1074/jbc.274.27.19011; Gong JG, 1999, NATURE, V399, P806; Grob TJ, 2001, CELL DEATH DIFFER, V8, P1213, DOI 10.1038/sj.cdd.4400962; Gross I, 2007, CELL DEATH DIFFER, V14, P1802, DOI 10.1038/sj.cdd.4402188; Huttinger-Kirchhof N, 2006, CELL DEATH DIFFER, V13, P174, DOI 10.1038/sj.cdd.4401809; Irwin MS, 2003, CANCER CELL, V3, P403, DOI 10.1016/S1535-6108(03)00078-3; Jacobs WB, 2005, NEURON, V48, P743, DOI 10.1016/j.neuron.2005.10.027; Jacobs WB, 2004, NEUROSCIENTIST, V10, P443, DOI 10.1177/1073858404263456; Jiang YH, 1998, NEURON, V21, P799, DOI 10.1016/S0896-6273(00)80596-6; Jordan J, 1997, J NEUROSCI, V17, P1397; KEDAR A, 1978, CANCER TREAT REP, V62, P819; Kiryu-Seo S, 2005, J NEUROSCI, V25, P1442, DOI 10.1523/JNEUROSCI.4041-04.2005; Kitamura Y, 1997, BIOCHEM BIOPH RES CO, V232, P418, DOI 10.1006/bbrc.1997.6301; Lebouvier T, 2009, J ALZHEIMERS DIS, V18, P1, DOI 10.3233/JAD-2009-1116; Lee AF, 2004, J NEUROSCI, V24, P9174, DOI 10.1523/JNEUROSCI.1588-04.2004; Li Quanyi, 2004, BMC Med Genet, V5, P14, DOI 10.1186/1471-2350-5-14; Lokshin M, 2007, NUCLEIC ACIDS RES, V35, P340, DOI 10.1093/nar/gkl1047; Lunghi P, 2009, CLIN CANCER RES, V15, P6495, DOI 10.1158/1078-0432.CCR-09-1229; Martin LJ, 2005, J NEUROSCI, V25, P6449, DOI 10.1523/JNEUROSCI.0911-05.2005; Mbebi C, 2005, NEUROBIOL DIS, V19, P129, DOI 10.1016/j.nbd.2004.11.010; Mbebi C, 2002, J BIOL CHEM, V277, P20979, DOI 10.1074/jbc.M107948200; Menendez D, 2009, NAT REV CANCER, V9, P724, DOI 10.1038/nrc2730; Meng XJ, 2009, CANCER RES, V69, P5458, DOI 10.1158/0008-5472.CAN-08-4408; Migliorini D, 2002, MOL CELL BIOL, V22, P5527, DOI 10.1128/MCB.22.15.5527-5538.2002; Mogi M, 2007, NEUROSCI LETT, V414, P94, DOI 10.1016/j.neulet.2006.12.003; Monaco EA, 2005, FRONT BIOSCI-LANDMRK, V10, P143, DOI 10.2741/1516; Morrison RS, 1996, J NEUROSCI, V16, P1337; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Munarriz E, 2005, BIOCHEM BIOPH RES CO, V333, P954, DOI 10.1016/j.bbrc.2005.05.188; Nishimura I, 1998, J NEUROSCI, V18, P2387, DOI 10.1523/jneurosci.18-07-02387.1998; Oberst A, 2005, BIOCHEM BIOPH RES CO, V331, P707, DOI 10.1016/j.bbrc.2005.03.158; Ohyagi Y, 2005, FASEB J, V19, P255, DOI 10.1096/fj.04-2637fje; Pardo LM, 2005, MUTAT RES-FUND MOL M, V592, P89, DOI 10.1016/j.mrfmmm.2005.06.006; Pozniak CD, 2002, J NEUROSCI, V22, P9800; Prives C, 1999, J PATHOL, V187, P112; Rene F, 1996, NEUROENDOCRINOLOGY, V64, P2, DOI 10.1159/000127091; Rossi M, 2005, EMBO J, V24, P836, DOI 10.1038/sj.emboj.7600444; SAKHI S, 1994, P NATL ACAD SCI USA, V91, P7525, DOI 10.1073/pnas.91.16.7525; Seidl R, 1999, NEUROSCI LETT, V260, P9, DOI 10.1016/S0304-3940(98)00945-8; Sohm F, 1999, ONCOGENE, V18, P2762, DOI 10.1038/sj.onc.1202634; Steeghs N, 2003, ANTI-CANCER DRUG, V14, P443, DOI 10.1097/00001813-200307000-00009; Trimmer PA, 1996, NEURODEGENERATION, V5, P233, DOI 10.1006/neur.1996.0031; Urist M, 2004, GENE DEV, V18, P3041, DOI 10.1101/gad.1221004; Vogel Michael W, 2002, Cerebellum, V1, P277, DOI 10.1080/147342202320883588; Wetzel MK, 2008, NEURON, V59, P708, DOI 10.1016/j.neuron.2008.07.021; Wilson C, 2004, NEUROPATH APPL NEURO, V30, P19, DOI 10.1046/j.0305-1846.2003.00496.x; Wu GS, 1997, NAT GENET, V17, P141, DOI 10.1038/ng1097-141; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Yang A, 2000, NATURE, V404, P99, DOI 10.1038/35003607; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Yuan J, 2003, NEURON, V40, P401, DOI 10.1016/S0896-6273(03)00601-9; Zhang Y, 2002, J CELL BIOL, V156, P519, DOI 10.1083/jcb.200110119	75	25	25	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					43013	43025		10.1074/jbc.M111.261271	http://dx.doi.org/10.1074/jbc.M111.261271			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22002055	Green Published, hybrid			2022-12-27	WOS:000298351300022
J	Busnelli, M; Sauliere, A; Manning, M; Bouvier, M; Gales, C; Chini, B				Busnelli, Marta; Sauliere, Aude; Manning, Maurice; Bouvier, Michel; Gales, Celine; Chini, Bice			Functional Selective Oxytocin-derived Agonists Discriminate between Individual G Protein Family Subtypes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE ENERGY-TRANSFER; CAVEOLIN-1 ENRICHED DOMAINS; LIVING CELLS; VASOPRESSIN V1A; RECEPTOR; ACTIVATION; BINDING; BETA; LOCALIZATION; ANTAGONISTS	We used a bioluminescence resonance energy transfer biosensor to screen for functional selective ligands of the human oxytocin (OT) receptor. We demonstrated that OT promoted the direct engagement and activation of G(q) and all the G(i/o) subtypes at the OT receptor. Other peptidic analogues, chosen because of specific substitutions in key OT structural/functional residues, all showed biased activation of G protein subtypes. No ligand, except OT, activated G(oA) or G(oB), and, with only one exception, all of the peptides that activated Gq also activated G(i2) and G(i3) but not G(i1), G(oA), or G(oB), indicating a strong bias toward these subunits. Two peptides (DNalOVT and atosiban) activated only G(i1) or G(i3), failed to recruit beta-arrestins, and did not induce receptor internalization, providing the first clear examples of ligands differentiating individual G(i/o) family members. Both analogs inhibited cell proliferation, showing that a single G(i) subtype-mediated pathway is sufficient to prompt this physiological response. These analogs represent unique tools for examining the contribution of G(i/o) members in complex biological responses and open the way to the development of drugs with peculiar selectivity profiles. This is of particular relevance because OT has been shown to improve symptoms in neurodevelopmental and psychiatric disorders characterized by abnormal social behaviors, such as autism. Functional selective ligands, activating a specific G protein signaling pathway, may possess a higher efficacy and specificity on OT-based therapeutics.	[Busnelli, Marta; Chini, Bice] CNR, Inst Neurosci, I-20143 Milan, Italy; [Busnelli, Marta] Univ Milan, Dept Pharmacol, I-20143 Milan, Italy; [Sauliere, Aude; Gales, Celine] Univ Toulouse 3, Inst Malad Metabol & Cardiovasc, INSERM, Ctr Hosp Univ Toulouse,U1048, F-31432 Toulouse, France; [Manning, Maurice] Univ Toledo, Dept Biochem & Canc Biol, Coll Med, Toledo, OH 43614 USA; [Bouvier, Michel] Univ Montreal, Dept Biochem, Inst Res Immunol & Canc, Montreal, PQ H3T 1J4, Canada	Consiglio Nazionale delle Ricerche (CNR); University of Milan; CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University System of Ohio; University of Toledo; Universite de Montreal	Chini, B (corresponding author), CNR, Inst Neurosci, Via Vanvitelli 32, I-20143 Milan, Italy.	b.chini@in.cnr.it	Bouvier, Michel/H-2758-2014; Busnelli, Marta/AAR-5513-2021	Bouvier, Michel/0000-0003-1128-0100; Busnelli, Marta/0000-0003-3387-2190; GALES, Celine/0000-0002-4938-1583; Chini, Bice/0000-0002-1686-284X	Italian Association for Cancer Research [1328]; Cariplo Foundation [2008.2314]; Italian-French Galileo Program Grant; Canadian Institute for Health Research; National Institutes of Health [GM025280];  [ANR-06-BLAN-0400-02]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM025280] Funding Source: NIH RePORTER	Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro); Cariplo Foundation(Fondazione Cariplo); Italian-French Galileo Program Grant; Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Italian Association for Cancer Research Grant 1328 (to B. C.), Cariplo Foundation Grant 2008.2314 (to B. C.), Italian-French Galileo Program Grant 2008/2009 (to B. C. and C. G.), the Canadian Institute for Health Research (to M. Bouvier), and the ANR-06-BLAN-0400-02 (to G. C.). This work was also supported in part by National Institutes of Health Grant GM025280 (to M. M.).	Albertazzi E, 2000, J AM SOC NEPHROL, V11, P1033, DOI 10.1681/ASN.V1161033; Angers S, 2000, P NATL ACAD SCI USA, V97, P3684, DOI 10.1073/pnas.060590697; Audet N, 2008, J BIOL CHEM, V283, P15078, DOI 10.1074/jbc.M707941200; Ayoub MA, 2007, MOL PHARMACOL, V71, P1329, DOI 10.1124/mol.106.030304; Ayoub MA, 2010, FASEB J, V24, P3522, DOI 10.1096/fj.10-154997; Azzi M, 2003, P NATL ACAD SCI USA, V100, P11406, DOI 10.1073/pnas.1936664100; Cassoni P, 2004, INT J ONCOL, V25, P899; Cassoni P, 1996, INT J CANCER, V66, P817, DOI 10.1002/(SICI)1097-0215(19960611)66:6<817::AID-IJC18>3.0.CO;2-#; CHINI B, 1995, EMBO J, V14, P2176, DOI 10.1002/j.1460-2075.1995.tb07211.x; Chini B, 1995, ADV EXP MED BIOL, V395, P321; Chini B, 2003, BRIT J CANCER, V89, P930, DOI 10.1038/sj.bjc.6601189; Chini B, 1996, FEBS LETT, V397, P201, DOI 10.1016/S0014-5793(96)01135-0; Conti F, 2009, AM J PHYSIOL-ENDOC M, V296, pE532, DOI 10.1152/ajpendo.90590.2008; De A, 2007, CANCER RES, V67, P7175, DOI 10.1158/0008-5472.CAN-06-4623; Dupre DJ, 2007, J BIOL CHEM, V282, P13703, DOI 10.1074/jbc.M608846200; Fanelli F, 1999, MOL PHARMACOL, V56, P214, DOI 10.1124/mol.56.1.214; Favre N, 2005, BIOCHEMISTRY-US, V44, P9990, DOI 10.1021/bi0509853; Gales C, 2005, NAT METHODS, V2, P177, DOI 10.1038/NMETH743; Gales C, 2006, NAT STRUCT MOL BIOL, V13, P778, DOI 10.1038/nsmb1134; GARIBAY JLR, 1991, BIOCHIM BIOPHYS ACTA, V1094, P193, DOI 10.1016/0167-4889(91)90008-L; Gimpl G, 2005, EUR J PHARMACOL, V510, P9, DOI 10.1016/j.ejphar.2005.01.010; Gravati M, 2010, J NEUROCHEM, V114, P1424, DOI 10.1111/j.1471-4159.2010.06861.x; Groer CE, 2007, MOL PHARMACOL, V71, P549, DOI 10.1124/mol.106.028258; Guzzi F, 2002, ONCOGENE, V21, P1658, DOI 10.1038/sj.onc.1205219; Hasbi A, 2004, MOL ENDOCRINOL, V18, P1277, DOI 10.1210/me.2003-0440; Hawtin SR, 2005, FEBS LETT, V579, P349, DOI 10.1016/j.febslet.2004.10.108; Insel TR, 2010, NEURON, V65, P768, DOI 10.1016/j.neuron.2010.03.005; Jean-Alphonse F, 2009, J AM SOC NEPHROL, V20, P2190, DOI 10.1681/ASN.2008121289; Kuehn BM, 2011, JAMA-J AM MED ASSOC, V305, P659, DOI 10.1001/jama.2011.117; Lane JR, 2007, MOL PHARMACOL, V71, P1349, DOI 10.1124/mol.106.032722; Leduc M, 2009, J PHARMACOL EXP THER, V331, P297, DOI 10.1124/jpet.109.156398; Loening AM, 2006, PROTEIN ENG DES SEL, V19, P391, DOI 10.1093/protein/gzl023; Manning M, 2005, J PEPT SCI, V11, P593, DOI 10.1002/psc.667; Manning M, 2008, PROG BRAIN RES, V170, P473, DOI 10.1016/S0079-6123(08)00437-8; Misra S, 2004, J PHARMACOL EXP THER, V311, P1154, DOI 10.1124/jpet.104.071415; MOUILLAC B, 1995, J BIOL CHEM, V270, P25771, DOI 10.1074/jbc.270.43.25771; Oakley RH, 2001, J BIOL CHEM, V276, P19452, DOI 10.1074/jbc.M101450200; Perroy J, 2003, EMBO J, V22, P3816, DOI 10.1093/emboj/cdg383; PHANEUF S, 1993, J ENDOCRINOL, V136, P497, DOI 10.1677/joe.0.1360497; Postina R, 1998, ADV EXP MED BIOL, V449, P371; Rajagopal S, 2010, NAT REV DRUG DISCOV, V9, P373, DOI 10.1038/nrd3024; Reversi A, 2005, J BIOL CHEM, V280, P16311, DOI 10.1074/jbc.M409945200; Rimoldi V, 2003, ONCOGENE, V22, P6054, DOI 10.1038/sj.onc.1206612; Sanborn BM, 2001, EXP PHYSIOL, V86, P223, DOI 10.1113/eph8602179; Shenoy Sudha K, 2005, Sci STKE, V2005, pcm10, DOI 10.1126/stke.2005/308/cm10; Smith MP, 2006, MOL ENDOCRINOL, V20, P379, DOI 10.1210/me.2005-0031; Strakova Z, 1997, AM J PHYSIOL-ENDOC M, V272, pE870, DOI 10.1152/ajpendo.1997.272.5.E870; Terrillon S, 2003, MOL ENDOCRINOL, V17, P677, DOI 10.1210/me.2002-0222; Urban JD, 2007, J PHARMACOL EXP THER, V320, P1, DOI 10.1124/jpet.106.104463; Zhong MA, 2010, MOL CANCER RES, V8, P1164, DOI 10.1158/1541-7786.MCR-09-0329; Zhou XB, 2007, MOL ENDOCRINOL, V21, P740, DOI 10.1210/me.2006-0220	51	110	111	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					3617	3629		10.1074/jbc.M111.277178	http://dx.doi.org/10.1074/jbc.M111.277178			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22069312	Green Published, hybrid			2022-12-27	WOS:000300410900002
J	Bruscoli, S; Velardi, E; Di Sante, M; Bereshchenko, O; Venanzi, A; Coppo, M; Berno, V; Mameli, MG; Colella, R; Cavaliere, A; Riccardi, C				Bruscoli, Stefano; Velardi, Enrico; Di Sante, Moises; Bereshchenko, Oxana; Venanzi, Alessandra; Coppo, Maddalena; Berno, Valeria; Mameli, Maria Grazia; Colella, Renato; Cavaliere, Antonio; Riccardi, Carlo			Long Glucocorticoid-induced Leucine Zipper (L-GILZ) Protein Interacts with Ras Protein Pathway and Contributes to Spermatogenesis Control	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPERMATOGONIAL STEM-CELLS; HORMONE-INDUCED GENE; SELF-RENEWAL; MOLECULAR-MECHANISMS; SIGNAL-TRANSDUCTION; SERTOLI-CELLS; T-LYMPHOCYTES; KINASE; MOUSE; ACTIVATION	Correct function of spermatogonia is critical for the maintenance of spermatogenesis throughout life, but the cellular pathways regulating undifferentiated spermatogonia proliferation, differentiation, and survival are only partially known. We show here that long glucocorticoid-induced leucine zipper (L-GILZ) is highly expressed in spermatogonia and primary spermato-cytes and controls spermatogenesis. Gilz deficiency in knockout (gilz KO) mice leads to a complete loss of germ cell lineage within first cycles of spermatogenesis, resulting in male sterility. Spermatogenesis failure is intrinsic to germ cells and is associated with increased proliferation and aberrant differentiation of undifferentiated spermatogonia and with hyperactivity of Ras signaling pathway as indicated by an increase of ERK and Akt phosphorylation. Spermatogonia differentiation does not proceed beyond the prophase of the first meiotic division due to massive apoptosis associated with accumulation of unrepaired chromosomal damage. These results identify L-GILZ as a novel important factor for undifferentiated spermatogonia function and spermatogenesis.	[Bruscoli, Stefano; Velardi, Enrico; Di Sante, Moises; Bereshchenko, Oxana; Venanzi, Alessandra; Coppo, Maddalena; Riccardi, Carlo] Univ Perugia, Sch Med, Dept Clin & Expt Med, Sect Pharmacol Toxicol & Chemotherapy, I-06122 Perugia, Italy; [Mameli, Maria Grazia; Colella, Renato; Cavaliere, Antonio] Univ Perugia, Sch Med, Inst Pathol Anat & Histol, I-06122 Perugia, Italy; [Berno, Valeria] European Mol Biol Lab, Mouse Biol Unit, I-00015 Rome, Italy	University of Perugia; University of Perugia; European Molecular Biology Laboratory (EMBL)	Riccardi, C (corresponding author), Univ Perugia, Dept Clin & Expt Med, Pharmacol Sect, Via Giochetto, I-06100 Perugia, Italy.	riccardi@unipg.it	di sante, moises/AAZ-4936-2020; Berno, Valeria/AAN-3997-2020; Mameli, Maria Grazia/AAC-2478-2019; Velardi, Enrico/AAB-7443-2019; Riccardi, Carlo/N-4610-2014; velardi, Enrico/AAC-5440-2022	Berno, Valeria/0000-0001-5848-494X; Velardi, Enrico/0000-0001-8383-0453; Riccardi, Carlo/0000-0001-9257-3997; Di Sante, Moises/0000-0002-4174-1257; Bereshchenko, Oxana/0000-0002-2772-6042; bruscoli, stefano/0000-0003-0313-1615	Associazione Italiana per la Ricerca sul Cancro (AIRC), Milan, Italy	Associazione Italiana per la Ricerca sul Cancro (AIRC), Milan, Italy	This work was supported by Associazione Italiana per la Ricerca sul Cancro (AIRC), Milan, Italy (to C. R.).	Almog T, 2008, MOL CELL ENDOCRINOL, V282, P39, DOI 10.1016/j.mce.2007.11.011; Ayroldi E, 2002, MOL CELL BIOL, V22, P7929, DOI 10.1128/MCB.22.22.7929-7941.2002; Ayroldi E, 2001, BLOOD, V98, P743, DOI 10.1182/blood.V98.3.743; Ayroldi E, 2007, J CLIN INVEST, V117, P1605, DOI 10.1172/JCI30724; Ayroldi E, 2009, FASEB J, V23, P3649, DOI 10.1096/fj.09-134684; Beumer TL, 2000, BIOL REPROD, V63, P1893, DOI 10.1095/biolreprod63.6.1893; Blume-Jensen P, 2000, NAT GENET, V24, P157, DOI 10.1038/72814; Bruscoli S, 2010, J BIOL CHEM, V285, P10385, DOI 10.1074/jbc.M109.070136; Buaas FW, 2004, NAT GENET, V36, P647, DOI 10.1038/ng1366; BURGERING BMT, 1995, NATURE, V376, P599, DOI 10.1038/376599a0; CALENDA A, 1994, EMBO J, V13, P100, DOI 10.1002/j.1460-2075.1994.tb06239.x; Cannarile L, 2006, BLOOD, V107, P1039, DOI 10.1182/blood-2005-05-2183; Cannarile L, 2001, CELL DEATH DIFFER, V8, P201, DOI 10.1038/sj.cdd.4400798; Cannarile L, 2009, GASTROENTEROLOGY, V136, P530, DOI 10.1053/j.gastro.2008.09.024; CHAGANTI RSK, 1980, AM J HUM GENET, V32, P833; Clotman F, 2000, MAMM GENOME, V11, P696, DOI 10.1007/s003350010116; Costoya JA, 2004, NAT GENET, V36, P653, DOI 10.1038/ng1367; D'Adamio F, 1997, IMMUNITY, V7, P803, DOI 10.1016/S1074-7613(00)80398-2; De Rooij DG, 2009, MICROSC RES TECHNIQ, V72, P580, DOI 10.1002/jemt.20699; Di Marco B, 2007, NUCLEIC ACIDS RES, V35, P517, DOI 10.1093/nar/gkl1080; Gille H, 1999, J BIOL CHEM, V274, P22033, DOI 10.1074/jbc.274.31.22033; He ZP, 2008, STEM CELLS, V26, P266, DOI 10.1634/stemcells.2007-0436; Hobbs RM, 2010, CELL, V142, P468, DOI 10.1016/j.cell.2010.06.041; Hofmann MC, 2008, MOL CELL ENDOCRINOL, V288, P95, DOI 10.1016/j.mce.2008.04.012; IRIE K, 1994, SCIENCE, V265, P1716, DOI 10.1126/science.8085159; Katz ME, 1997, CURR OPIN GENET DEV, V7, P75, DOI 10.1016/S0959-437X(97)80112-8; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; Lavoie JN, 1996, J BIOL CHEM, V271, P20608, DOI 10.1074/jbc.271.34.20608; Lee J, 2011, CELL RES, V21, P1164, DOI 10.1038/cr.2011.111; Lee J, 2009, CELL STEM CELL, V5, P76, DOI 10.1016/j.stem.2009.04.020; Li WQ, 2000, GENE DEV, V14, P895; Matheny SA, 2004, NATURE, V427, P256, DOI 10.1038/nature02237; Matzuk MM, 2008, NAT MED, V14, P1197, DOI 10.1038/nm.f.1895; Meng XJ, 2000, SCIENCE, V287, P1489, DOI 10.1126/science.287.5457.1489; Mirza AM, 2004, MOL CELL BIOL, V24, P10868, DOI 10.1128/MCB.24.24.10868-10881.2004; Morrison DK, 2003, ANNU REV CELL DEV BI, V19, P91, DOI 10.1146/annurev.cellbio.19.111401.091942; Muise-Helmericks RC, 1998, J BIOL CHEM, V273, P29864, DOI 10.1074/jbc.273.45.29864; Nakagawa T, 2010, SCIENCE, V328, P62, DOI 10.1126/science.1182868; Oatley JA, 2008, ANNU REV CELL DEV BI, V24, P263, DOI 10.1146/annurev.cellbio.24.110707.175355; Oatley JM, 2007, J BIOL CHEM, V282, P25842, DOI 10.1074/jbc.M703474200; Riccardi C, 2001, ADV EXP MED BIOL, V495, P31; Sada A, 2009, SCIENCE, V325, P1394, DOI 10.1126/science.1172645; Sharpe RM, 2003, REPRODUCTION, V125, P769, DOI 10.1530/rep.0.1250769; Shi XM, 2003, EMBO REP, V4, P374, DOI 10.1038/sj.embor.embor805; Su H, 2002, GENESIS, V32, P187, DOI 10.1002/gene.10043; Tartaglia M, 2010, ANN NY ACAD SCI, V1214, P99, DOI 10.1111/j.1749-6632.2010.05790.x; Vojtek AB, 1998, J BIOL CHEM, V273, P19925, DOI 10.1074/jbc.273.32.19925; Wang HG, 1996, P NATL ACAD SCI USA, V93, P7063, DOI 10.1073/pnas.93.14.7063; Wang PJ, 2007, CHROMOSOME RES, V15, P623, DOI 10.1007/s10577-007-1141-2; Wong MD, 2005, ANNU REV GENET, V39, P173, DOI 10.1146/annurev.genet.39.073003.105855; YOMOGIDA K, 1994, DEVELOPMENT, V120, P1759; Zhang WX, 2008, J BIOL CHEM, V283, P4723, DOI 10.1074/jbc.M704147200	52	59	60	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					1242	1251		10.1074/jbc.M111.316372	http://dx.doi.org/10.1074/jbc.M111.316372			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22110132	hybrid, Green Published			2022-12-27	WOS:000299170300040
J	Busygina, V; Saro, D; Williams, G; Leung, WK; Say, AF; Sehorn, MG; Sung, P; Tsubouchi, H				Busygina, Valeria; Saro, Dorina; Williams, Gareth; Leung, Wing-Kit; Say, Amanda F.; Sehorn, Michael G.; Sung, Patrick; Tsubouchi, Hideo			Novel Attributes of Hed1 Affect Dynamics and Activity of the Rad51 Presynaptic Filament during Meiotic Recombination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAK; X-RAY SOLUTION; HOMOLOGOUS RECOMBINATION; RECA HOMOLOGS; DNA; DMC1; PROTEINS; EXCHANGE; PROMOTE; REPAIR	During meiosis, recombination events that occur between homologous chromosomes help prepare the chromosome pairs for proper disjunction in meiosis I. The concurrent action of the Rad51 and Dmc1 recombinases is necessary for an interhomolog bias. Notably, the activity of Rad51 is tightly controlled, so as to minimize the use of the sister chromatid as recombination partner. We demonstrated recently that Hed1, a meiosis-specific protein in Saccharomyces cerevisiae, restricts the access of the recombinase accessory factor Rad54 to presynaptic filaments of Rad51. We now show that Hed1 undergoes self-association in a Rad51-dependent manner and binds ssDNA. We also find a strong stabilizing effect of Hed1 on the Rad51 presynaptic filament. Biochemical and genetic analyses of mutants indicate that these Hed1 attributes are germane for its recombination regulatory and Rad51 presynaptic filament stabilization functions. Our results shed light on the mechanism of action of Hed1 in meiotic recombination control.	[Busygina, Valeria; Saro, Dorina; Sung, Patrick] Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Williams, Gareth] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA; [Leung, Wing-Kit; Tsubouchi, Hideo] Univ Sussex, MRC Genome Damage & Stabil Ctr, Brighton BN1 9RQ, E Sussex, England; [Say, Amanda F.; Sehorn, Michael G.] Clemson Univ, Dept Biochem & Genet, Clemson, SC 29634 USA	Yale University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of Sussex; Clemson University	Sung, P (corresponding author), Yale Univ, Sch Med Mol Biophys & Biochem, 333 Cedar St,SHM C130A, New Haven, CT 06520 USA.	patrick.sung@yale.edu; h.tsubouchi@sussex.ac.uk		Tsubouchi, Hideo/0000-0003-0814-8432; Leung, Wing-Kit/0000-0003-3039-4904	National Institutes of Health Research [R01ES07061, R01ES015632, R01GM57814, R01GM098510]; Ruth L. Kirschstein National Research Service [GM079816]; Marie Curie Cancer Care Transitional Programme; Clemson University; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015632, R01ES007061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM079816, R01GM057814, R01GM098510] Funding Source: NIH RePORTER; Medical Research Council [G0801130B] Funding Source: researchfish	National Institutes of Health Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Marie Curie Cancer Care Transitional Programme; Clemson University; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Research Grants R01ES07061, R01ES015632, and R01GM57814 (to P.S.) and R01GM098510 (to M.G.S.), Ruth L. Kirschstein National Research Service Award GM079816 (to V. B.), Marie Curie Cancer Care Transitional Programme Grant (to H.T.), and by Clemson University (to M.G.S.).	Bianco P. R., 1998, FRONT BIOSCI, V3, pD570; Bishop DK, 1999, GENES CELLS, V4, P425, DOI 10.1046/j.1365-2443.1999.00273.x; BISHOP DK, 1994, CELL, V79, P1081, DOI 10.1016/0092-8674(94)90038-8; Bishop DK, 2004, CELL, V117, P9, DOI 10.1016/S0092-8674(04)00297-1; Busygina V, 2008, GENE DEV, V22, P786, DOI 10.1101/gad.1638708; Chen YK, 2004, P NATL ACAD SCI USA, V101, P10572, DOI 10.1073/pnas.0404195101; Chen ZC, 2008, NATURE, V453, P489, DOI 10.1038/nature06971; Chi P, 2006, DNA REPAIR, V5, P381, DOI 10.1016/j.dnarep.2005.11.005; Chi P, 2007, GENE DEV, V21, P1747, DOI 10.1101/gad.1563007; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Guinier A., 1955, SMALL ANGLE SCATTERI; Hudson JR, 1997, GENOME RES, V7, P1169, DOI 10.1101/gr.7.12.1169; Hunter N, 2001, CELL, V106, P59, DOI 10.1016/S0092-8674(01)00430-5; Hura GL, 2009, NAT METHODS, V6, P606, DOI 10.1038/nmeth.1353; Hyppa RW, 2010, CELL, V142, P243, DOI 10.1016/j.cell.2010.05.041; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; Kim KP, 2010, CELL, V143, P924, DOI 10.1016/j.cell.2010.11.015; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Moore JK, 1996, NATURE, V383, P644, DOI 10.1038/383644a0; Neale MJ, 2006, NATURE, V442, P153, DOI 10.1038/nature04885; Niu HY, 2009, MOL CELL, V36, P393, DOI 10.1016/j.molcel.2009.09.029; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Petukhova G, 1999, J BIOL CHEM, V274, P33839, DOI 10.1074/jbc.274.48.33839; Petukhova GV, 2005, NAT STRUCT MOL BIOL, V12, P449, DOI 10.1038/nsmb923; Poirot O, 2003, NUCLEIC ACIDS RES, V31, P3503, DOI 10.1093/nar/gkg522; Putnam CD, 2007, Q REV BIOPHYS, V40, P191, DOI 10.1017/S0033583507004635; Raschle M, 2004, J BIOL CHEM, V279, P51973, DOI 10.1074/jbc.M410101200; ROCKMILL B, 1995, GENE DEV, V9, P2684, DOI 10.1101/gad.9.21.2684; Schwacha A, 1997, CELL, V90, P1123, DOI 10.1016/S0092-8674(00)80378-5; Sheridan S, 2006, GENE DEV, V20, P1685, DOI 10.1101/gad.1447606; Storici F, 2001, NAT BIOTECHNOL, V19, P773, DOI 10.1038/90837; Sugawara N, 2003, MOL CELL, V12, P209, DOI 10.1016/S1097-2765(03)00269-7; Sung P, 1996, J BIOL CHEM, V271, P27983, DOI 10.1074/jbc.271.45.27983; Sung P, 2006, NAT REV MOL CELL BIO, V7, P739, DOI 10.1038/nrm2008; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Symington LS, 2002, MICROBIOL MOL BIOL R, V66, P630, DOI 10.1128/MMBR.66.4.630-670.2002; Tsubouchi H, 2003, DEV CELL, V5, P915, DOI 10.1016/S1534-5807(03)00357-5; Tsubouchi H, 2002, MOL CELL BIOL, V22, P3078, DOI 10.1128/MCB.22.9.3078-3088.2002; Tsubouchi H, 2006, GENE DEV, V20, P1766, DOI 10.1101/gad.1422506; Van Komen S, 2000, MOL CELL, V6, P563, DOI 10.1016/S1097-2765(00)00055-1; Wolner B, 2003, MOL CELL, V12, P221, DOI 10.1016/S1097-2765(03)00242-9; Wu L, 2006, ANNU REV GENET, V40, P279, DOI 10.1146/annurev.genet.40.110405.090636; Xu LH, 1997, GENE DEV, V11, P106, DOI 10.1101/gad.11.1.106	46	22	23	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					1566	1575		10.1074/jbc.M111.297309	http://dx.doi.org/10.1074/jbc.M111.297309			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22115747	hybrid, Green Published			2022-12-27	WOS:000299170300070
J	Jang, WG; Kim, EJ; Kim, DK; Ryoo, HM; Lee, KB; Kim, SH; Choi, HS; Koh, JT				Jang, Won-Gu; Kim, Eun-Jung; Kim, Don-Kyu; Ryoo, Hyun-Mo; Lee, Keun-Bae; Kim, Sun-Hun; Choi, Hueng-Sik; Koh, Jeong-Tae			BMP2 Protein Regulates Osteocalcin Expression via Runx2-mediated Atf6 Gene Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; BONE MORPHOGENETIC PROTEINS; OSTEOBLAST DIFFERENTIATION; IN-VIVO; RECEPTOR; PATHWAY; BINDING; DOMAIN; CELLS; OASIS	Bone morphogenetic protein 2 (BMP2) activates unfolded protein response (UPR) transducers, such as PERK and OASIS, in osteoblast cells. ATF6, a bZIP transcription factor, is also a UPR transducer. However, the involvement of ATF6 in BMP2-induced osteoblast differentiation has not yet been elucidated. In the present study, BMP2 treatment was shown to markedly induce the expression and activation of ATF6 with an increase in alkaline phosphatase (ALP) and OC expression in MC3T3E1 cells. In contrast, ATF6 activation by BMP2 was not observed in the Runx2(-/-) primary calvarial osteoblasts, and Runx2 overexpression recovered BMP2 action. BMP2 stimulated ATF6 transcription by enhancing the direct binding of Runx2 to the osteoblast-specific cis-acting element 2 (OSE2, ACCACA, -205 to -200 bp) motif of the Atf6 promoter region. In addition, the overexpression of ATF6 increased the Oc promoter activity by enhancing the direct binding to a putative ATF6 binding motif (TGACGT, -1126 to -1121 bp). The inhibition of ATF6 function with the dominant negative form of ATF6 (DN-ATF6) blocked BMP2- or Runx2-induced OC expression. Interestingly, OASIS, which is structurally similar to ATF6, did not induce Oc expression. ALP and Alizarin red staining results confirmed that BMP2-induced matrix mineralization was also dependent on ATF6 in vitro. Overall, these results suggest that BMP2 induces osteoblast differentiation through Runx2-dependent ATF6 expression, which directly regulates Oc transcription.	[Kim, Don-Kyu; Choi, Hueng-Sik] Chonnam Natl Univ, Sch Biol Sci & Technol, Hormone Res Ctr, Natl Creat Res Initiat Ctr Nucl Receptor Signals, Kwangju 500757, South Korea; [Jang, Won-Gu; Kim, Eun-Jung; Kim, Sun-Hun; Koh, Jeong-Tae] Chonnam Natl Univ, Sch Dent, Dent Sci Res Inst, Kwangju 500757, South Korea; [Jang, Won-Gu; Kim, Eun-Jung; Kim, Sun-Hun; Koh, Jeong-Tae] Chonnam Natl Univ, Sch Dent, BK21, Kwangju 500757, South Korea; [Ryoo, Hyun-Mo] Seoul Natl Univ, Sch Dent, Dept Mol Genet, Seoul 110749, South Korea; [Lee, Keun-Bae] Chonnam Natl Univ, Med Sch & Hosp, Dept Orthoped Surg, Kwangju 501746, South Korea; [Choi, Hueng-Sik] Chonnam Natl Univ, Sch Med, Dept Biomed Sci, Res Inst Med Sci, Kwangju 501746, South Korea; [Jang, Won-Gu; Kim, Sun-Hun; Koh, Jeong-Tae] Chonnam Natl Univ, Res Ctr Biomineralizat Disorders, Kwangju 500757, South Korea	Chonnam National University; Chonnam National University; Chonnam National University; Seoul National University (SNU); Chonnam National University; Chonnam National University; Chonnam National University	Choi, HS (corresponding author), Chonnam Natl Univ, Sch Biol Sci & Technol, Hormone Res Ctr, Natl Creat Res Initiat Ctr Nucl Receptor Signals, Kwangju 500757, South Korea.	hsc@chonnam.ac.kr; jtkoh@chonnam.ac.kr	Ryoo, Hyun-Mo/D-5839-2012	Ryoo, Hyun-Mo/0000-0001-6769-8341	National Research Foundation of Korea [2011-0010666, 2011-0030759]; Korea government; Chonnam National University Hospital Research Institute of Clinical Medicine [CRI 11-078-22]; Korean Ministry of Education; National Research Foundation of Korea; Ministry of Education, Science and Technology [20100019512]	National Research Foundation of Korea(National Research Foundation of Korea); Korea government(Korean Government); Chonnam National University Hospital Research Institute of Clinical Medicine; Korean Ministry of Education(Ministry of Education (MOE), Republic of Korea); National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This study was supported by National Research Foundation of Korea Grants 2011-0010666 and 2011-0030759 funded by the Korea government and Chonnam National University Hospital Research Institute of Clinical Medicine Grant CRI 11-078-22 (to J.-T.K.) and partly supported by the National Creative Research Initiatives Grant from the Korean Ministry of Education and the Future-based Technology Development Program (BIO Fields) through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology Grant 20100019512 (to H.-S.C.).	Banerjee C, 1997, J CELL BIOCHEM, V66, P1, DOI 10.1002/(SICI)1097-4644(19970701)66:1<1::AID-JCB1>3.0.CO;2-V; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Canalis E, 2003, ENDOCR REV, V24, P218, DOI 10.1210/er.2002-0023; DUCY P, 1995, MOL CELL BIOL, V15, P1858; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Ducy P, 1999, GENE DEV, V13, P1025, DOI 10.1101/gad.13.8.1025; Gouveia CH, 2001, J ENDOCRINOL, V170, P667, DOI 10.1677/joe.0.1700667; Gunther T, 2005, EMBO J, V24, P3049, DOI 10.1038/sj.emboj.7600773; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Honma Y, 1999, MOL BRAIN RES, V69, P93, DOI 10.1016/S0169-328X(99)00102-3; Jang WG, 2011, BIOCHEM BIOPH RES CO, V404, P1004, DOI 10.1016/j.bbrc.2010.12.099; Javed A, 2001, MOL CELL BIOL, V21, P2891, DOI 10.1128/MCB.21.8.2891-2905.2001; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Komori Toshihisa, 2006, Clin Calcium, V16, P801; Komori T, 2006, J CELL BIOCHEM, V99, P1233, DOI 10.1002/jcb.20958; Lee MH, 2003, J BIOL CHEM, V278, P34387, DOI 10.1074/jbc.M211386200; Lee YS, 2008, BIOCHEM J, V413, P559, DOI 10.1042/BJ20071637; LIAN JB, 1993, J CELL BIOCHEM, V52, P206, DOI 10.1002/jcb.240520212; Murakami T, 2009, NAT CELL BIOL, V11, P1205, DOI 10.1038/ncb1963; NAKASE T, 1994, BONE MINER, V26, P109, DOI 10.1016/S0169-6009(08)80056-6; Omori Y, 2002, BIOCHEM BIOPH RES CO, V293, P470, DOI 10.1016/S0006-291X(02)00253-X; Paredes R, 2004, MOL CELL BIOL, V24, P8847, DOI 10.1128/MCB.24.20.8847-8861.2004; Saito A, 2011, J BIOL CHEM, V286, P4809, DOI 10.1074/jbc.M110.152900; Seo HY, 2008, ENDOCRINOLOGY, V149, P3832, DOI 10.1210/en.2008-0015; Shen JS, 2002, DEV CELL, V3, P99, DOI 10.1016/S1534-5807(02)00203-4; Shin CS, 2006, J MOL ENDOCRINOL, V36, P531, DOI 10.1677/jme.1.01944; Sims NA, 1997, MOL ENDOCRINOL, V11, P1695, DOI 10.1210/me.11.11.1695; Tirasophon W, 1998, GENE DEV, V12, P1812, DOI 10.1101/gad.12.12.1812; Tohmonda T, 2011, EMBO REP, V12, P451, DOI 10.1038/embor.2011.34; Wang Y, 2000, J BIOL CHEM, V275, P27013; Wei JW, 2008, J CELL PHYSIOL, V217, P693, DOI 10.1002/jcp.21543; Welch RD, 1998, J BONE MINER RES, V13, P1483, DOI 10.1359/jbmr.1998.13.9.1483; Xiao GZ, 2005, J BIOL CHEM, V280, P30689, DOI 10.1074/jbc.M500750200; Yamaguchi A, 2000, ENDOCR REV, V21, P393, DOI 10.1210/er.21.4.393; Yang XG, 2004, CELL, V117, P387, DOI 10.1016/S0092-8674(04)00344-7; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Yoshida H, 2000, MOL CELL BIOL, V20, P6755, DOI 10.1128/MCB.20.18.6755-6767.2000; Yoshida H, 1998, J BIOL CHEM, V273, P33741, DOI 10.1074/jbc.273.50.33741	39	125	131	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					905	915		10.1074/jbc.M111.253187	http://dx.doi.org/10.1074/jbc.M111.253187			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22102412	Green Published, hybrid			2022-12-27	WOS:000299170300009
J	Schmucker, AC; Wright, JB; Cole, MD; Brinckerhoff, CE				Schmucker, Adam C.; Wright, Jason B.; Cole, Michael D.; Brinckerhoff, Constance E.			Distal Interleukin-1 beta (IL-1 beta) Response Element of Human Matrix Metalloproteinase-13 (MMP-13) Binds Activator Protein 1 (AP-1) Transcription Factors and Regulates Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN COLLAGENASE-3 GENE; RETINOID-X-RECEPTOR; HUMAN GENOME; CHONDROCYTES; CLONING; CARTILAGE; DISTINCT; P38	The collagenase matrix metalloproteinase-13 (MMP-13) plays an important role in the destruction of cartilage in arthritic joints. MMP-13 expression is strongly up-regulated in arthritis, largely because of stimulation by inflammatory cytokines such as IL-1 beta. Treatment of chondrocytes with IL-1 beta induces transcription of MMP-13 in vitro. IL-1 beta signaling converges upon the activator protein-1 transcription factors, which have been shown to be required for IL-1 beta-induced MMP-13 gene expression. Using chromatin immunoprecipitation (ChIP), we detected activator protein-1 binding within an evolutionarily conserved DNA sequence similar to 20 kb 5' relative to the MMP-13 transcription start site (TSS). Also using ChIP, we detected histone modifications and binding of RNA polymerase II within this conserved region, all of which are consistent with transcriptional activation. Chromosome conformation capture indicates that chromosome looping brings this region in close proximity with the MMP-13 TSS. Finally, a luciferase reporter construct driven by a component of the conserved region demonstrated an expression pattern similar to that of endogenous MMP-13. These data suggest that a conserved region at 20 kb upstream from the MMP-13 TSS includes a distal transcriptional response element of MMP-13, which contributes to MMP-13 gene expression.	[Schmucker, Adam C.; Brinckerhoff, Constance E.] Dartmouth Med Sch, Dept Biochem, Hanover, NH 03755 USA; [Wright, Jason B.; Cole, Michael D.] Dartmouth Med Sch, Dept Genet, Hanover, NH 03755 USA; [Brinckerhoff, Constance E.] Dartmouth Med Sch, Dept Med, Hanover, NH 03755 USA	Dartmouth College; Dartmouth College; Dartmouth College	Schmucker, AC (corresponding author), Dartmouth Med Sch, Dept Med, 1 Med Ctr Dr,Rubin Bldg,HB 7936, Lebanon, NH 03756 USA.	brinckerhoff@dartmouth.edu			National Institutes of Health [AR-26599, CA-77267, T32-AR-007576, CA-080320]; NATIONAL CANCER INSTITUTE [R01CA080320, R01CA077267] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR026599, T32AR007576, R01AR026599] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P50AA011999] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grants AR-26599, CA-77267 (to C. E. B.), T32-AR-007576 (to A. C. S.), and CA-080320 (to M. D. C.).	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Blackburn JS, 2009, ONCOGENE, V28, P4237, DOI 10.1038/onc.2009.272; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; Burrage PS, 2007, ARTHRITIS RHEUM-US, V56, P892, DOI 10.1002/art.22417; Burrage PS, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2564; Burrage PS, 2006, FRONT BIOSCI-LANDMRK, V11, P529, DOI 10.2741/1817; Caron JP, 1996, AM J VET RES, V57, P1631; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Kadauke S, 2009, BBA-GENE REGUL MECH, V1789, P17, DOI 10.1016/j.bbagrm.2008.07.002; Martens JHA, 2003, MOL CELL BIOL, V23, P1808, DOI 10.1128/MCB.23.5.1808-1816.2003; Mengshol JA, 2000, ARTHRITIS RHEUM, V43, P801, DOI 10.1002/1529-0131(200004)43:4<801::AID-ANR10>3.0.CO;2-4; Mengshol JA, 2001, NUCLEIC ACIDS RES, V29, P4361, DOI 10.1093/nar/29.21.4361; Miele A, 2008, MOL BIOSYST, V4, P1046, DOI 10.1039/b803580f; Mitchell PG, 1996, J CLIN INVEST, V97, P761, DOI 10.1172/JCI118475; Pendas AM, 1997, GENOMICS, V40, P222, DOI 10.1006/geno.1996.4554; Robbins JR, 2000, ARTHRITIS RHEUM, V43, P2189, DOI 10.1002/1529-0131(200010)43:10<2189::AID-ANR6>3.0.CO;2-S; Sakabe NJ, 2010, WIRES SYST BIOL MED, V2, P422, DOI 10.1002/wsbm.70; Tardif G, 1997, BIOCHEM J, V323, P13, DOI 10.1042/bj3230013; Tardif Ginette, 2004, Mod Rheumatol, V14, P197; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Vincenti MP, 1998, BIOCHEM J, V331, P341, DOI 10.1042/bj3310341	23	17	20	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					1189	1197		10.1074/jbc.M111.264077	http://dx.doi.org/10.1074/jbc.M111.264077			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22102411	hybrid, Green Published			2022-12-27	WOS:000299170300034
J	Nakaoka, H; Nishiyama, A; Saito, M; Ishikawa, F				Nakaoka, Hidenori; Nishiyama, Atsuya; Saito, Motoki; Ishikawa, Fuyuki			Xenopus laevis Ctc1-Stn1-Ten1 (xCST) Protein Complex Is Involved in Priming DNA Synthesis on Single-stranded DNA Template in Xenopus Egg Extract	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYMERASE-ALPHA-PRIMASE; TELOMERE MAINTENANCE; ACCESSORY PROTEIN; LENGTH REGULATION; CHROMOSOME ENDS; CELL-CYCLE; REPLICATION; RPA; ASSOCIATION; PROTECTION	The Ctc1-Stn1-Ten1 (CST) complex is an RPA (replication protein A)-like protein complex that binds to single-stranded (ss) DNA. It localizes at telomeres and is involved in telomere end protection in mammals and plants. It is also known to stimulate DNA polymerase alpha-primase in vitro. However, it is not known how CST accomplishes these functions in vivo. Here, we report the identification and characterization of Xenopus laevis CST complex (xCST). xCST showed ssDNA binding activity with moderate preference for G (guanine)-rich sequences. xStn1-immunodepleted Xenopus egg extracts supported chromosomal DNA replication in in vitro reconstituted sperm nuclei, suggesting that xCST is not a general replication factor. However, the immunodepletion or neutralization of xStn1 compromised DNA synthesis on ssDNA template. Because primed ssDNA template was replicated in xStn1-immunodepleted extracts as efficiently as in control ones, we conclude that xCST is involved in the priming step on ssDNA template. These results are consistent with the current model that CST is involved in telomeric C-strand synthesis through the regulation of DNA polymerase alpha-primase.	[Nakaoka, Hidenori; Nishiyama, Atsuya; Saito, Motoki; Ishikawa, Fuyuki] Kyoto Univ, Grad Sch Biostudies, Dept Gene Mech, Lab Cell Cycle Regulat,Sakyo Ku, Kyoto 6068501, Japan	Kyoto University	Ishikawa, F (corresponding author), Kyoto Univ, Grad Sch Biostudies, Dept Gene Mech, Lab Cell Cycle Regulat,Sakyo Ku, Yoshida Konoe Cho, Kyoto 6068501, Japan.	fishikaw@lif.kyoto-u.ac.jp	Ishikawa, Fuyuki/AAU-4056-2021; Nishiyama, Atsuya/D-7894-2017	Ishikawa, Fuyuki/0000-0002-5580-2305; Nishiyama, Atsuya/0000-0002-8416-3776; Nakaoka, Hidenori/0000-0001-8465-5853	Ministry of Education, Culture, Sports, Science, and Technology, Japan	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant-in-aid for Cancer Research from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (to F. I.).	Arias EE, 2004, FRONT BIOSCI-LANDMRK, V9, P3029, DOI 10.2741/1457; Baumann P, 2010, FEBS LETT, V584, P3779, DOI 10.1016/j.febslet.2010.05.024; BLOW JJ, 1986, CELL, V47, P577, DOI 10.1016/0092-8674(86)90622-7; Byun TS, 2005, GENE DEV, V19, P1040, DOI 10.1101/gad.1301205; Casteel DE, 2009, J BIOL CHEM, V284, P5807, DOI 10.1074/jbc.M807593200; Dai XY, 2010, EMBO J, V29, P2788, DOI 10.1038/emboj.2010.156; Flynn RL, 2010, CRIT REV BIOCHEM MOL, V45, P266, DOI 10.3109/10409238.2010.488216; Gao H, 2007, NAT STRUCT MOL BIOL, V14, P208, DOI 10.1038/nsmb1205; Giraud-Panis MJ, 2010, MOL CELL, V39, P665, DOI 10.1016/j.molcel.2010.08.024; Gong Y, 2010, MOL CELL, V40, P377, DOI 10.1016/j.molcel.2010.10.016; GOULIAN M, 1990, J BIOL CHEM, V265, P13231; GOULIAN M, 1990, J BIOL CHEM, V265, P13221; Grandin N, 1997, GENE DEV, V11, P512, DOI 10.1101/gad.11.4.512; Grandin N, 2001, EMBO J, V20, P1173, DOI 10.1093/emboj/20.5.1173; Grossi S, 2004, GENE DEV, V18, P992, DOI 10.1101/gad.300004; Li S, 2009, CELL, V136, P50, DOI 10.1016/j.cell.2008.11.027; MacDougall CA, 2007, GENE DEV, V21, P898, DOI 10.1101/gad.1522607; Martin V, 2007, P NATL ACAD SCI USA, V104, P14038, DOI 10.1073/pnas.0705497104; MECHALI M, 1982, CELL, V30, P93, DOI 10.1016/0092-8674(82)90015-0; MEYNE J, 1989, P NATL ACAD SCI USA, V86, P7049, DOI 10.1073/pnas.86.18.7049; Miyake Y, 2009, MOL CELL, V36, P193, DOI 10.1016/j.molcel.2009.08.009; Moser BA, 2009, EMBO J, V28, P810, DOI 10.1038/emboj.2009.31; MURZIN AG, 1993, EMBO J, V12, P861, DOI 10.1002/j.1460-2075.1993.tb05726.x; Nabetani A, 2004, J BIOL CHEM, V279, P25849, DOI 10.1074/jbc.M312652200; Price CM, 2010, CELL CYCLE, V9, P3157, DOI 10.4161/cc.9.16.12547; Richard DJ, 2009, CRIT REV BIOCHEM MOL, V44, P98, DOI 10.1080/10409230902849180; RIEDEL HD, 1982, NUCLEIC ACIDS RES, V10, P5621, DOI 10.1093/nar/10.18.5621; Schramke V, 2004, NAT GENET, V36, P46, DOI 10.1038/ng1284; Sun J, 2009, GENE DEV, V23, P2900, DOI 10.1101/gad.1851909; Surovtseva YV, 2009, MOL CELL, V36, P207, DOI 10.1016/j.molcel.2009.09.017; Ueno M, 2010, BIOSCI BIOTECH BIOCH, V74, P1, DOI 10.1271/bbb.90682; Verdun RE, 2006, CELL, V127, P709, DOI 10.1016/j.cell.2006.09.034; Verdun RE, 2005, MOL CELL, V20, P551, DOI 10.1016/j.molcel.2005.09.024; Walter J, 2000, MOL CELL, V5, P617, DOI 10.1016/S1097-2765(00)80241-5; Walter J, 1998, MOL CELL, V1, P519, DOI 10.1016/S1097-2765(00)80052-0; Wan M, 2009, J BIOL CHEM, V284, P26725, DOI 10.1074/jbc.M109.021105; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61	37	50	50	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					619	627		10.1074/jbc.M111.263723	http://dx.doi.org/10.1074/jbc.M111.263723			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22086929	Green Published, hybrid			2022-12-27	WOS:000298682400060
J	Schicker, K; Uzelac, Z; Gesmonde, J; Bulling, S; Stockner, T; Freissmuth, M; Boehm, S; Rudnick, G; Sitte, HH; Sandtner, W				Schicker, Klaus; Uzelac, Zeljko; Gesmonde, Joan; Bulling, Simon; Stockner, Thomas; Freissmuth, Michael; Boehm, Stefan; Rudnick, Gary; Sitte, Harald H.; Sandtner, Walter			Unifying Concept of Serotonin Transporter-associated Currents	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN DOPAMINE TRANSPORTER; NEUROTRANSMITTER TRANSPORTERS; PLATELET 5-HYDROXYTRYPTAMINE; ALTERNATING ACCESS; CONDUCTING STATES; CHANNEL; ION; AMPHETAMINE; MECHANISM; RELEASE	Serotonin (5-HT) uptake by the human serotonin transporter (hSERT) is driven by ion gradients. The stoichiometry of transported 5-HT and ions is predicted to result in electroneutral charge movement. However, hSERT mediates a current when challenged with 5-HT. This discrepancy can be accounted for by an uncoupled ion flux. Here, we investigated the mechanistic basis of the uncoupled currents and its relation to the conformational cycle of hSERT. Our observations support the conclusion that the conducting state underlying the uncoupled ion flux is in equilibrium with an inward facing state of the transporter with K+ bound. We identified conditions associated with accumulation of the transporter in inward facing conformations. Manipulations that increased the abundance of inward facing states resulted in enhanced steady-state currents. We present a comprehensive kinetic model of the transport cycle, which recapitulates salient features of the recorded currents. This study provides a framework for exploring transporter-associated currents.	[Schicker, Klaus; Uzelac, Zeljko; Bulling, Simon; Stockner, Thomas; Freissmuth, Michael; Boehm, Stefan; Sitte, Harald H.; Sandtner, Walter] Med Univ Vienna, Ctr Physiol & Pharmacol, A-1090 Vienna, Austria; [Gesmonde, Joan; Rudnick, Gary] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA	Medical University of Vienna; Yale University	Sandtner, W (corresponding author), Med Univ Vienna, Ctr Physiol & Pharmacol, A-1090 Vienna, Austria.	walter.sandtner@meduniwien.ac.at	Sitte, Harald/N-2681-2013; Sitte, Harald/O-7025-2019; Stockner, Thomas/A-9509-2014	Sitte, Harald/0000-0002-1339-7444; Sitte, Harald/0000-0002-1339-7444; Stockner, Thomas/0000-0002-7071-8283; Boehm, Stefan/0000-0002-0205-2459; Schicker, Klaus/0000-0002-3068-7830; Freissmuth, Michael/0000-0001-9398-1765	Fonds zur Forderung der Wissenschaftlichen Forschung [P18706, SFB35-06, P17611]; National Institutes of Health [DA007259]; Austrian Science Fund (FWF) [F 3506] Funding Source: researchfish; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA007259, R01DA008213] Funding Source: NIH RePORTER	Fonds zur Forderung der Wissenschaftlichen Forschung(Austrian Science Fund (FWF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by Fonds zur Forderung der Wissenschaftlichen Forschung Grants P18706 and SFB35-06 (to H. H. S.) and P17611 (to S. B.). This work was also supported by National Institutes of Health Grant DA007259 (to G. R.).	Adams SV, 2003, BIOPHYS J, V85, P1548, DOI 10.1016/S0006-3495(03)74587-1; Andrini O, 2008, CHANNELS, V2, P346, DOI 10.4161/chan.2.5.6900; Bartholomaeus I, 2008, J BIOL CHEM, V283, P10978, DOI 10.1074/jbc.M800622200; Boehm S, 1999, J NEUROSCI, V19, P737; Carvelli L, 2004, P NATL ACAD SCI USA, V101, P16046, DOI 10.1073/pnas.0403299101; Carvelli L, 2008, P NATL ACAD SCI USA, V105, P14192, DOI 10.1073/pnas.0802214105; Erreger K, 2008, J NEUROSCI, V28, P976, DOI 10.1523/JNEUROSCI.2796-07.2008; Feige JN, 2005, MICROSC RES TECHNIQ, V68, P51, DOI 10.1002/jemt.20215; Forrest LR, 2008, P NATL ACAD SCI USA, V105, P10338, DOI 10.1073/pnas.0804659105; GALLI A, 1995, J EXP BIOL, V198, P2197; Galli A, 1997, J NEUROSCI, V17, P3401; Hastrup H, 2001, P NATL ACAD SCI USA, V98, P10055, DOI 10.1073/pnas.181344298; Hilber B, 2005, NEUROPHARMACOLOGY, V49, P811, DOI 10.1016/j.neuropharm.2005.08.008; HUMPHREYS CJ, 1994, BIOCHEMISTRY-US, V33, P9118, DOI 10.1021/bi00197a014; Ingram SL, 2002, NAT NEUROSCI, V5, P971, DOI 10.1038/nn920; Jacobs MT, 2007, J BIOL CHEM, V282, P29441, DOI 10.1074/jbc.M704456200; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Just H, 2004, J BIOL CHEM, V279, P6650, DOI 10.1074/jbc.M306092200; Kahlig KM, 2005, P NATL ACAD SCI USA, V102, P3495, DOI 10.1073/pnas.0407737102; Kanner BI, 2008, CHEM REV, V108, P1654, DOI 10.1021/cr078246a; KEYES SR, 1982, J BIOL CHEM, V257, P1172; Kilic F, 2000, P NATL ACAD SCI USA, V97, P3106, DOI 10.1073/pnas.060408997; Krishnamurthy H, 2009, NATURE, V459, P347, DOI 10.1038/nature08143; Laeuger P., 1991, ELECTROGENIC ION PUM; Lin F, 1996, BIOPHYS J, V71, P3126, DOI 10.1016/S0006-3495(96)79506-1; MAGER S, 1994, NEURON, V12, P845, DOI 10.1016/0896-6273(94)90337-9; NELSON PJ, 1979, J BIOL CHEM, V254, P84; Ni YG, 2001, J BIOL CHEM, V276, P30942, DOI 10.1074/jbc.M104653200; PATLAK CLIFFORD S., 1957, BULL MATH BIOPHYS, V19, P209, DOI 10.1007/BF02477764; Petersen CI, 1999, NAT NEUROSCI, V2, P605, DOI 10.1038/10158; Quick MW, 2003, NEURON, V40, P537, DOI 10.1016/S0896-6273(03)00605-6; RUDNICK G, 1978, BIOCHEMISTRY-US, V17, P4739, DOI 10.1021/bi00615a021; Rudnick G., 2002, TRANSMEMBRANE TRANSP, P125; Sandtner W, 2007, BIOPHYS J, V93, pL45, DOI 10.1529/biophysj.107.119073; Schmid JA, 2001, J BIOL CHEM, V276, P3805, DOI 10.1074/jbc.M007357200; Seidel S, 2005, MOL PHARMACOL, V67, P140, DOI 10.1124/mol.67.1.140; Sitte HH, 1998, J NEUROCHEM, V71, P1289; Sonders MS, 1997, J NEUROSCI, V17, P960; Sucic S, 2010, J BIOL CHEM, V285, P10924, DOI 10.1074/jbc.M109.083154; Tao Z, 2009, J BIOL CHEM, V284, P33807, DOI 10.1074/jbc.M109.071977; Tavoulari S, 2009, J NEUROSCI, V29, P9635, DOI 10.1523/JNEUROSCI.0440-09.2009; Zhang YW, 2006, J BIOL CHEM, V281, P36213, DOI 10.1074/jbc.M605468200; Zhang YW, 2005, J BIOL CHEM, V280, P30807, DOI 10.1074/jbc.M504087200; Zhang Z, 2007, P NATL ACAD SCI USA, V104, P18025, DOI 10.1073/pnas.0704570104; Zhao CF, 2011, BIOCHEMISTRY-US, V50, P1848, DOI 10.1021/bi101454f; Zhao YF, 2011, NATURE, V474, P109, DOI 10.1038/nature09971	46	67	67	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					438	445		10.1074/jbc.M111.304261	http://dx.doi.org/10.1074/jbc.M111.304261			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22072712	hybrid, Green Published			2022-12-27	WOS:000298682400042
J	Dai, LS; Tsai-Morris, CH; Sato, H; Villar, J; Kang, JH; Zhang, JB; Dufau, ML				Dai, Lisheng; Tsai-Morris, Chon-Hwa; Sato, Hisashi; Villar, Joaquin; Kang, Jung-Hoon; Zhang, Jiabao; Dufau, Maria L.			Testis-specific miRNA-469 Up-regulated in Gonadotropin-regulated Testicular RNA Helicase (GRTH/DDX25)-null Mice Silences Transition Protein 2 and Protamine 2 Messages at Sites within Coding Region IMPLICATIONS OF ITS ROLE IN GERM CELL DEVELOPMENT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; MICRORNA BIOGENESIS; CHROMATOID BODY; SELF-RENEWAL; EXPRESSION; GRTH/DDX25; GENE; TRANSLATION; LET-7; DIFFERENTIATION	Gonadotropin-regulated testicular RNA helicase (GRTH/DDX25), a testis-specific member of the DEAD-box family, is an essential post-transcriptional regulator of spermatogenesis. Failure of expression of Transition protein 2 (TP2) and Protamine 2 (Prm2) proteins (chromatin remodelers, essential for spermatid elongation and completion of spermatogenesis) with preservation of their mRNA expression was observed in GRTH-null mice (azoospermic due to failure of spermatids to elongate). These were identified as target genes for the testis-specific miR-469, which is increased in the GRTH-null mice. Further analysis demonstrated that miR-469 repressed TP2 and Prm2 protein expression at the translation level with minor effect on mRNA degradation, through binding to the coding regions of TP2 and Prm2 mRNAs. The corresponding primary-microRNAs and the expression levels of Drosha and DGCR8 (both mRNA and protein) were increased significantly in the GRTH-null mice. miR-469 silencing of TP2 and Prm2 mRNA in pachytene spermatocytes and round spermatids is essential for their timely translation at later times of spermiogenesis, which is critical to attain mature sperm. Collectively, these studies indicate that GRTH, a multifunctional RNA helicase, acts as a negative regulator of miRNA-469 biogenesis and consequently their function during spermatogenesis.	[Dai, Lisheng; Tsai-Morris, Chon-Hwa; Sato, Hisashi; Villar, Joaquin; Kang, Jung-Hoon; Dufau, Maria L.] Eunice Kennedy Shriver NICHD, Sect Mol Endocrinol, Program Dev Endocrinol & Genet, NIH, Bethesda, MD 20892 USA; [Dai, Lisheng; Zhang, Jiabao] Jilin Univ, Lab Anim Ctr, Coll Anim Sci & Vet Med, Changchun 130062, Jilin, Peoples R China	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Jilin University	Dufau, ML (corresponding author), Eunice Kennedy Shriver NICHD, Sect Mol Endocrinol, Program Dev Endocrinol & Genet, NIH, Bldg 49,Rm 6A-36, Bethesda, MD 20892 USA.	dufaum@mail.nih.gov		Tsai Morris, Chon Hwa/0000-0002-8113-0979	Eunice Kennedy Shriver National Institute of Child Health and Human Development; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000150] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health Intramural Program through the Eunice Kennedy Shriver National Institute of Child Health and Human Development.	Bjork JK, 2010, DEVELOPMENT, V137, P3177, DOI 10.1242/dev.050955; Bouhallier F, 2010, RNA, V16, P720, DOI 10.1261/rna.1963810; Boyerinas B, 2010, ENDOCR-RELAT CANCER, V17, pF19, DOI 10.1677/ERC-09-0184; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; BUCCI LR, 1986, BIOL REPROD, V34, P195, DOI 10.1095/biolreprod34.1.195; Bueno MJ, 2008, CANCER CELL, V13, P496, DOI 10.1016/j.ccr.2008.04.018; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chieffi P, 2002, ONCOGENE, V21, P3644, DOI 10.1038/sj/onc/1205501; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Damestoy A, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-22; Dufau ML, 2007, TRENDS ENDOCRIN MET, V18, P314, DOI 10.1016/j.tem.2007.09.001; Eddy EM, 2002, RECENT PROG HORM RES, V57, P103, DOI 10.1210/rp.57.1.103; Eiring AM, 2010, CELL, V140, P652, DOI 10.1016/j.cell.2010.01.007; Esau C, 2004, J BIOL CHEM, V279, P52361, DOI 10.1074/jbc.C400438200; Forman JJ, 2008, P NATL ACAD SCI USA, V105, P14879, DOI 10.1073/pnas.0803230105; Fukuda T, 2007, NAT CELL BIOL, V9, P604, DOI 10.1038/ncb1577; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; Han JJ, 2004, GENE DEV, V18, P3016, DOI 10.1101/gad.1262504; Hayashi K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001738; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Itman C, 2008, DEV DYNAM, V237, P97, DOI 10.1002/dvdy.21401; Jennewein C, 2010, J BIOL CHEM, V285, P11846, DOI 10.1074/jbc.M109.066399; Jordan SD, 2011, NAT CELL BIOL, V13, P434, DOI 10.1038/ncb2211; Jung YH, 2010, MOL HUM REPROD, V16, P804, DOI 10.1093/molehr/gaq058; Kent OA, 2010, GENE DEV, V24, P2754, DOI 10.1101/gad.1950610; Kotaja N, 2006, P NATL ACAD SCI USA, V103, P2647, DOI 10.1073/pnas.0509333103; Kotaja N, 2007, NAT REV MOL CELL BIO, V8, P85, DOI 10.1038/nrm2081; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Lee EK, 2011, RNA BIOL, V8, P44, DOI 10.4161/rna.8.1.13863; Long JY, 2011, J BIOL CHEM, V286, P11837, DOI 10.1074/jbc.M110.194969; Medina PP, 2010, NATURE, V467, P86, DOI 10.1038/nature09284; Melton C, 2010, NATURE, V463, P621, DOI 10.1038/nature08725; Mestdagh P, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn725; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Miyaki S, 2010, GENE DEV, V24, P1173, DOI 10.1101/gad.1915510; Miyoshi K, 2010, MOL GENET GENOMICS, V284, P95, DOI 10.1007/s00438-010-0556-1; Park SY, 2009, NAT STRUCT MOL BIOL, V16, P23, DOI 10.1038/nsmb.1533; Qian ZR, 2009, MODERN PATHOL, V22, P431, DOI 10.1038/modpathol.2008.202; Ro S, 2007, DEV BIOL, V311, P592, DOI 10.1016/j.ydbio.2007.09.009; Sato H., 2008, END SOC 90 ANN M SAN, pP1; Sato H, 2010, BBA-MOL CELL RES, V1803, P534, DOI 10.1016/j.bbamcr.2010.02.004; Sgarra R, 2004, FEBS LETT, V574, P1, DOI 10.1016/j.febslet.2004.08.013; Sheng Y, 2003, J BIOL CHEM, V278, P27796, DOI 10.1074/jbc.M302411200; Sheng Y, 2006, J BIOL CHEM, V281, P35048, DOI 10.1074/jbc.M605086200; Shyu AB, 2008, EMBO J, V27, P471, DOI 10.1038/sj.emboj.7601977; Steger K, 2001, ANAT EMBRYOL, V203, P323, DOI 10.1007/s004290100176; Tang PZ, 1999, J BIOL CHEM, V274, P37932, DOI 10.1074/jbc.274.53.37932; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Tsai-Morris CH, 2004, P NATL ACAD SCI USA, V101, P6373, DOI 10.1073/pnas.0401855101; Tsai-Morris CH, 2010, J ANDROL, V31, P45, DOI 10.2164/jandrol.109.008219; Vasileva A, 2009, CURR BIOL, V19, P630, DOI 10.1016/j.cub.2009.02.047; Wang YF, 2009, J BIOL CHEM, V284, P23094, DOI 10.1074/jbc.M109.012617; West JA, 2009, NATURE, V460, P909, DOI 10.1038/nature08210; Yi R, 2008, NATURE, V452, P225, DOI 10.1038/nature06642; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Yu ZR, 2005, BIOL REPROD, V73, P427, DOI 10.1095/biolreprod.105.040998	57	52	61	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2011	286	52					44306	44318		10.1074/jbc.M111.282756	http://dx.doi.org/10.1074/jbc.M111.282756			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870CA	22086916	hybrid, Green Published			2022-12-27	WOS:000298645500002
J	Goodson, ML; Mengeling, BJ; Jonas, BA; Privalsky, ML				Goodson, Michael L.; Mengeling, Brenda J.; Jonas, Brian A.; Privalsky, Martin L.			Alternative mRNA Splicing of Corepressors Generates Variants That Play Opposing Roles in Adipocyte Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR RECEPTOR-COREPRESSOR; THYROID-HORMONE RECEPTOR; N-COR COREPRESSORS; REV-ERB-ALPHA; INTERACTION DOMAINS; TRANSCRIPTIONAL COREGULATORS; DEACETYLASE-3 COMPLEX; SILENCING MEDIATOR; GENE REPRESSION; ADIPOSE-TISSUE	The SMRT and NCoR corepressors partner with, and help mediate repression by, a wide variety of nuclear receptors and non-receptor transcription factors. Both SMRT and NCoR are expressed by alternative mRNA splicing, resulting in the production of a series of interrelated corepressor variants that differ in their tissue distribution and in their biochemical properties. We report here that different corepressor splice variants can exert opposing transcriptional and biological effects during adipocyte differentiation. Most notably, the NCoR omega splice variant inhibits, whereas the NCoR delta splice variant promotes, adipogenesis. Furthermore, the ratio of NCoR omega to NCoR delta decreases during adipogenic differentiation. We propose that this alteration in corepressor splicing helps convert the cellular transcriptional program from one that maintains the pre-adipocyte in an undifferentiated state to a new transcriptional context that promotes differentiation and helps establish the proper physiology of the mature adipocyte.	[Goodson, Michael L.; Mengeling, Brenda J.; Jonas, Brian A.; Privalsky, Martin L.] Univ Calif Davis, Dept Microbiol, Coll Biol Sci, Davis, CA 95616 USA; [Jonas, Brian A.] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA	University of California System; University of California Davis; Stanford University	Privalsky, ML (corresponding author), Univ Calif Davis, Dept Microbiol, Coll Biol Sci, 1 Shields Ave, Davis, CA 95616 USA.	mlprivalsky@ucdavis.edu	Goodson, Michael L/G-4175-2010; Jonas, Brian/AAS-3639-2020	Jonas, Brian/0000-0002-4921-5809; Goodson, Michael/0000-0002-3464-490X	Public Health Service/NIDDK, National Institutes of Health [RO1DK53528]; NATIONAL CANCER INSTITUTE [P30CA093373] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053528] Funding Source: NIH RePORTER	Public Health Service/NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1DK53528 from the Public Health Service/NIDDK.	Alenghat T, 2006, EMBO J, V25, P3966, DOI 10.1038/sj.emboj.7601280; Alenghat T, 2008, NATURE, V456, P997, DOI 10.1038/nature07541; Astapova I, 2011, MOL ENDOCRINOL, V25, P212, DOI 10.1210/me.2010-0462; Astapovaa I, 2008, P NATL ACAD SCI USA, V105, P19544, DOI 10.1073/pnas.0804604105; Buranapramest M, 2009, PROG MOL BIOL TRANSL, V87, P193, DOI 10.1016/S1877-1173(09)87006-3; Burke LJ, 1998, MOL ENDOCRINOL, V12, P248, DOI 10.1210/me.12.2.248; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; CHAWLA A, 1994, ENDOCRINOLOGY, V135, P798, DOI 10.1210/en.135.2.798; CHEN HW, 1995, P NATL ACAD SCI USA, V92, P422, DOI 10.1073/pnas.92.2.422; Cheng SY, 2010, ENDOCR REV, V31, P139, DOI 10.1210/er.2009-0007; Cheng SY, 2005, STEROIDS, V70, P450, DOI 10.1016/j.steroids.2005.02.003; Cohen RN, 1998, MOL ENDOCRINOL, V12, P1567, DOI 10.1210/me.12.10.1567; Cohen RN, 2001, MOL ENDOCRINOL, V15, P1049, DOI 10.1210/me.15.7.1049; Collins TJ, 2007, BIOTECHNIQUES, V43, P25, DOI 10.2144/000112517; Downes M, 1996, NUCLEIC ACIDS RES, V24, P4379, DOI 10.1093/nar/24.22.4379; Downes M, 2000, P NATL ACAD SCI USA, V97, P10330, DOI 10.1073/pnas.97.19.10330; Duong V, 2008, ADV EXP MED BIOL, V617, P121, DOI 10.1007/978-0-387-69080-3_11; Faist F, 2009, BIOSCIENCE REP, V29, P143, DOI 10.1042/BSR20080093; Fang S, 2011, P NATL ACAD SCI USA, V108, P3412, DOI 10.1073/pnas.1017707108; Feige JN, 2007, TRENDS CELL BIOL, V17, P292, DOI 10.1016/j.tcb.2007.04.001; Flamant F, 2006, PHARMACOL REV, V58, P705, DOI 10.1124/pr.58.4.3; Forrest D, 2000, THYROID, V10, P41, DOI 10.1089/thy.2000.10.41; Freiman RN, 2003, CELL, V112, P11, DOI 10.1016/S0092-8674(02)01278-3; Gimble JM, 1998, CRIT REV EUKAR GENE, V8, P141, DOI 10.1615/CritRevEukarGeneExpr.v8.i2.30; Glass CK, 2010, NAT REV IMMUNOL, V10, P365, DOI 10.1038/nri2748; Goodson Michael, 2005, Nucl Recept Signal, V3, pe003; Goodson Michael L, 2007, Nucl Recept Signal, V5, pe002; Goodson ML, 2005, J BIOL CHEM, V280, P7493, DOI 10.1074/jbc.M411514200; Guan HP, 2005, GENE DEV, V19, P453, DOI 10.1101/gad.1263305; Guenther MG, 2001, MOL CELL BIOL, V21, P6091, DOI 10.1128/MCB.21.18.6091-6101.2001; Gurnell M, 2000, J BIOL CHEM, V275, P5754, DOI 10.1074/jbc.275.8.5754; Hager GL, 2001, PROG NUCLEIC ACID RE, V66, P279; Hashimoto K, 2001, P NATL ACAD SCI USA, V98, P3998, DOI 10.1073/pnas.051454698; Hermanson O, 2002, TRENDS ENDOCRIN MET, V13, P55, DOI 10.1016/S1043-2760(01)00527-6; Hodgson MC, 2008, MOL CANCER THER, V7, P3187, DOI 10.1158/1535-7163.MCT-08-0461; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; Hsia EY, 2010, ADV DRUG DELIVER REV, V62, P1227, DOI 10.1016/j.addr.2010.09.016; Hu X, 2001, MOL CELL BIOL, V21, P1747, DOI 10.1128/MCB.21.5.1747-1758.2001; Ishizuka T, 2003, MOL CELL BIOL, V23, P5122, DOI 10.1128/MCB.23.15.5122-5131.2003; Jepsen K, 2000, CELL, V102, P753, DOI 10.1016/S0092-8674(00)00064-7; Jepsen K, 2008, GENE DEV, V22, P740, DOI 10.1101/gad.1637108; Jiang W, 2004, J ENDOCRINOL, V182, P295, DOI 10.1677/joe.0.1820295; Jonas BA, 2007, MOL ENDOCRINOL, V21, P1924, DOI 10.1210/me.2007-0035; Jones PL, 2003, CURR TOP MICROBIOL, V274, P237; Karagianni P, 2007, ONCOGENE, V26, P5439, DOI 10.1038/sj.onc.1210612; Kinkel AD, 2004, CYTOTECHNOLOGY, V46, P49, DOI 10.1007/s10616-004-3903-4; Kraus WL, 2002, EUR J BIOCHEM, V269, P2275, DOI 10.1046/j.1432-1033.2002.02889.x; Kumar N, 2010, ENDOCRINOLOGY, V151, P3015, DOI 10.1210/en.2009-0800; Lahnalampi M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012991; Lazar Mitchell A, 2003, Nucl Recept Signal, V1, pe001; le Maire A, 2010, NAT STRUCT MOL BIOL, V17, P801, DOI 10.1038/nsmb.1855; Lee JW, 2001, CELL MOL LIFE SCI, V58, P289, DOI 10.1007/PL00000856; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Lehrke M, 2005, CELL, V123, P993, DOI 10.1016/j.cell.2005.11.026; Li JW, 2000, EMBO J, V19, P4342, DOI 10.1093/emboj/19.16.4342; Lonard DM, 2007, MOL CELL, V27, P691, DOI 10.1016/j.molcel.2007.08.012; Makowski A, 2003, MOL ENDOCRINOL, V17, P273, DOI 10.1210/me.2002-0310; Malartre M, 2006, DEV BIOL, V292, P333, DOI 10.1016/j.ydbio.2006.01.007; Malartre M, 2004, NUCLEIC ACIDS RES, V32, P4676, DOI 10.1093/nar/gkh786; Mariash CN, 2003, J CLIN ENDOCR METAB, V88, P5603, DOI 10.1210/jc.2003-031800; Marimuthu A, 2002, MOL ENDOCRINOL, V16, P271, DOI 10.1210/me.16.2.271; McEwan Iain J., 2009, V505, P3, DOI 10.1007/978-1-60327-575-0_1; McKenna NJ, 2002, ENDOCRINOLOGY, V143, P2461, DOI 10.1210/endo.143.7.8892; Mengeling BJ, 2011, J BIOL CHEM, V286, P4236, DOI 10.1074/jbc.M110.200964; Moehren U, 2004, ESSAYS BIOCHEM, V40, P89, DOI 10.1042/bse0400089; Muscat GEO, 1998, NUCLEIC ACIDS RES, V26, P2899, DOI 10.1093/nar/26.12.2899; Nagy L, 1997, CELL, V89, P373, DOI 10.1016/S0092-8674(00)80218-4; Nofsinger RR, 2008, P NATL ACAD SCI USA, V105, P20021, DOI 10.1073/pnas.0811012105; O'Shea PJ, 2002, J ENDOCRINOL, V175, P553, DOI 10.1677/joe.0.1750553; Oberste-Berghaus C, 2000, J BIOL CHEM, V275, P1787, DOI 10.1074/jbc.275.3.1787; Obregon MJ, 2008, THYROID, V18, P185, DOI 10.1089/thy.2007.0254; Oetting A, 2007, BEST PRACT RES CL EN, V21, P193, DOI 10.1016/j.beem.2007.04.004; Ordentlich P, 2001, CURR TOP MICROBIOL, V254, P101; Ordentlich P, 1999, P NATL ACAD SCI USA, V96, P2639, DOI 10.1073/pnas.96.6.2639; Pantoja C, 2008, MOL BIOL CELL, V19, P4032, DOI 10.1091/mbc.E08-04-0420; Perissi V, 2004, CELL, V116, P511, DOI 10.1016/S0092-8674(04)00133-3; Perissi V, 1999, GENE DEV, V13, P3198, DOI 10.1101/gad.13.24.3198; Perissi V, 2010, NAT REV GENET, V11, P109, DOI 10.1038/nrg2736; Phelan CA, 2010, NAT STRUCT MOL BIOL, V17, P808, DOI 10.1038/nsmb.1860; Poulos SP, 2010, EXP BIOL MED, V235, P1185, DOI 10.1258/ebm.2010.010063; Privalsky M. L, 2008, NR COREGULATORS HUMA, P243; Privalsky ML, 2004, ANNU REV PHYSIOL, V66, P315, DOI 10.1146/annurev.physiol.66.032802.155556; Rice JC, 2001, CURR OPIN CELL BIOL, V13, P263, DOI 10.1016/S0955-0674(00)00208-8; Rosen MD, 2009, MOL ENDOCRINOL, V23, P1183, DOI 10.1210/me.2009-0126; Sande S, 1996, MOL ENDOCRINOL, V10, P813, DOI 10.1210/me.10.7.813; Savkur RS, 2004, VITAM HORM, V68, P145; Seol W, 1996, MOL ENDOCRINOL, V10, P1646, DOI 10.1210/me.10.12.1646; Short S, 2005, BIOCHEM BIOPH RES CO, V334, P845, DOI 10.1016/j.bbrc.2005.06.175; Smith CL, 2004, ENDOCR REV, V25, P45, DOI 10.1210/er.2003-0023; Sonoda J, 2008, FEBS LETT, V582, P2, DOI 10.1016/j.febslet.2007.11.016; Stanya KJ, 2009, CELL DIV, V4, DOI 10.1186/1747-1028-4-7; STUDENT AK, 1980, J BIOL CHEM, V255, P4745; Sutanto MM, 2007, MOL CELL ENDOCRINOL, V267, P137, DOI 10.1016/j.mce.2006.11.003; Sutanto MM, 2010, J BIOL CHEM, V285, P18485, DOI 10.1074/jbc.M110.107680; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Tsai CC, 2004, VITAM HORM, V68, P93; Varlakhanova N, 2010, MOL CELL BIOL, V30, P1434, DOI 10.1128/MCB.01002-09; Wang CG, 2008, MOL ENDOCRINOL, V22, P539, DOI 10.1210/me.2007-0379; Wang J, 2008, MOL CELL BIOL, V28, P2213, DOI 10.1128/MCB.01608-07; Webb P, 2000, MOL ENDOCRINOL, V14, P1976, DOI 10.1210/me.14.12.1976; Wen YD, 2000, P NATL ACAD SCI USA, V97, P7202, DOI 10.1073/pnas.97.13.7202; Willson TM, 2001, ANNU REV BIOCHEM, V70, P341, DOI 10.1146/annurev.biochem.70.1.341; Wondisford FE, 2003, J INVEST MED, V51, P215, DOI 10.1136/jim-51-04-22; Wong CW, 1998, MOL CELL BIOL, V18, P5724, DOI 10.1128/MCB.18.10.5724; Wong CW, 1998, MOL CELL BIOL, V18, P5500, DOI 10.1128/MCB.18.9.5500; Yoon HG, 2003, EMBO J, V22, P1336, DOI 10.1093/emboj/cdg120; You SH, 2010, MOL ENDOCRINOL, V24, P1359, DOI 10.1210/me.2009-0501; Yu C, 2005, J BIOL CHEM, V280, P13600, DOI 10.1074/jbc.M409468200; Zhang JS, 2000, ANNU REV PHYSIOL, V62, P439, DOI 10.1146/annurev.physiol.62.1.439	109	28	28	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2011	286	52					44988	44999		10.1074/jbc.M111.291625	http://dx.doi.org/10.1074/jbc.M111.291625			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870CA	22065574	Green Published, hybrid			2022-12-27	WOS:000298645500067
J	Kloosterman, TG; Kuipers, OP				Kloosterman, Tomas G.; Kuipers, Oscar P.			Regulation of Arginine Acquisition and Virulence Gene Expression in the Human Pathogen Streptococcus pneumoniae by Transcription Regulators ArgR1 and AhrC	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LAMININ-BINDING PROTEIN; HISTIDINE TRIAD PROTEINS; BACILLUS-SUBTILIS; AMINO-ACIDS; DEIMINASE SYSTEM; GENOME SEQUENCE; CELL-SURFACE; RNA SR1; METABOLISM; PYOGENES	In this study, we investigated for the first time the transcriptional response of the human pathogen Streptococcus pneumoniae to fluctuating concentrations of arginine, an essential amino acid for this bacterium. By means of DNA microarray analyses, several operons and genes were found, the expression of which was affected by the concentration of arginine in the medium. Five of the identified operons were demonstrated to be directly repressed in the presence of high arginine concentrations via the concerted action of the ArgR-type regulators ArgR1 and AhrC. These ArgR1/AhrC targets encompass the putative amino acid transport genes artPQ, abpA, abpB, and aapA; the arginine biosynthetic genes argGH; and the virulence genes aliB and lmB/adcAII-phtD encoding an oligopeptide-binding lipoprotein and cell surface Zn2+-scavenging units, respectively. In addition, the data indicate that three of the amino acid transport genes encode an arginine ATP-binding cassette transporter unit required for efficient growth during arginine limitation. Instead of regulating arginine biosynthetic and catabolic genes as has been reported for other Gram-positive bacteria, our findings suggest that the physiological function of ArgR1/AhrC in S. pneumoniae is to ensure optimal uptake of arginine from the surrounding milieu.	[Kloosterman, Tomas G.; Kuipers, Oscar P.] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Dept Mol Genet, NL-9747 AG Groningen, Netherlands	University of Groningen	Kuipers, OP (corresponding author), Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Dept Mol Genet, Nijenborgh 7, NL-9747 AG Groningen, Netherlands.	o.p.kuipers@rug.nl	Kuipers, Oscar/B-6752-2009	Kuipers, Oscar/0000-0001-5596-7735	European Union [HEALTH-F3-2009-222983]	European Union(European Commission)	Supported by the European Union-funded Pneumopath Project HEALTH-F3-2009-222983.	Adamou JE, 2001, INFECT IMMUN, V69, P949, DOI 10.1128/IAI.69.2.949-958.2001; Albano M, 2005, J BACTERIOL, V187, P2010, DOI 10.1128/JB.187.6.2010-2019.2005; ALBINA JE, 1988, AM J PHYSIOL, V254, pE459, DOI 10.1152/ajpendo.1988.254.4.E459; ALLOING G, 1994, J MOL BIOL, V241, P44, DOI 10.1006/jmbi.1994.1472; Baerends RJS, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-5-r37; Barcelona-Andres B, 2002, J BACTERIOL, V184, P6289, DOI 10.1128/JB.184.22.6289-6300.2002; Belitsky, 2001, BACILLUS SUBTILIS IT, P203; Bolotin A, 2001, GENOME RES, V11, P731, DOI 10.1101/gr.GR-1697R; Bringel F, 1997, J BACTERIOL, V179, P2697, DOI 10.1128/jb.179.8.2697-2706.1997; Bryan JD, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-607; CALOGERO S, 1994, J BACTERIOL, V176, P1234, DOI 10.1128/jb.176.5.1234-1241.1994; Canepa A, 2002, NEPHROL DIAL TRANSPL, V17, P413, DOI 10.1093/ndt/17.3.413; Carvalho SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026707; Chaussee MA, 2004, J BACTERIOL, V186, P7091, DOI 10.1128/JB.186.21.7091-7099.2004; Chaussee MS, 2003, J BACTERIOL, V185, P6016, DOI 10.1128/JB.185.20.6016-6024.2003; CLAVERYS JP, 1986, MICROBIOL REV, V50, P133, DOI 10.1128/MMBR.50.2.133-165.1986; CURRIE GA, 1979, BRIT J CANCER, V39, P613, DOI 10.1038/bjc.1979.112; Degnan BA, 1998, INFECT IMMUN, V66, P3050, DOI 10.1128/IAI.66.7.3050-3058.1998; Degnan BA, 2000, INFECT IMMUN, V68, P2441, DOI 10.1128/IAI.68.5.2441-2448.2000; den Hengst CD, 2005, J BACTERIOL, V187, P512, DOI 10.1128/JB.187.2.512-521.2005; Dennis CA, 2002, ACTA CRYSTALLOGR D, V58, P421, DOI 10.1107/S0907444901021692; Dong YQ, 2004, J BACTERIOL, V186, P2511, DOI 10.1128/JB.186.8.2511-2514.2004; Fulde M, 2011, MICROBIOL-SGM, V157, P572, DOI 10.1099/mic.0.043067-0; Gardan R, 1997, MOL MICROBIOL, V24, P825, DOI 10.1046/j.1365-2958.1997.3881754.x; GARDAN R, 1995, J MOL BIOL, V249, P843, DOI 10.1006/jmbi.1995.0342; Griswold A, 2004, APPL ENVIRON MICROB, V70, P1321, DOI 10.1128/AEM.70.3.1321-1327.2004; Gruening P, 2006, J BACTERIOL, V188, P361, DOI 10.1128/JB.188.2.361-369.2006; Hartel T, 2011, INFECT IMMUN, V79, P44, DOI 10.1128/IAI.00855-10; Hammerschmidt S, 2006, CURR OPIN MICROBIOL, V9, P12, DOI 10.1016/j.mib.2005.11.001; Hava D, 2002, MOL MICROBIOL, V45, P1389, DOI 10.1046/j.1365-2958.2002.03106.x; Heidrich N, 2007, NUCLEIC ACIDS RES, V35, P4331, DOI 10.1093/nar/gkm439; Heidrich N, 2006, MOL MICROBIOL, V62, P520, DOI 10.1111/j.1365-2958.2006.05384.x; Hendriksen WT, 2008, INFECT IMMUN, V76, P1230, DOI 10.1128/IAI.01004-07; Hendriksen WT, 2008, J BACTERIOL, V190, P590, DOI 10.1128/JB.00917-07; Hovel-Miner G, 2010, J BACTERIOL, V192, P4504, DOI 10.1128/JB.00465-10; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; Kazmierczak KM, 2009, MOL MICROBIOL, V72, P590, DOI 10.1111/j.1365-2958.2009.06669.x; Kerr AR, 2004, INFECT IMMUN, V72, P3902, DOI 10.1128/IAI.72.7.3902-3906.2004; KLARSFELD AD, 1994, MOL MICROBIOL, V13, P585, DOI 10.1111/j.1365-2958.1994.tb00453.x; Kloosterman TG, 2006, MICROBIOL-SGM, V152, P351, DOI 10.1099/mic.0.28521-0; Kloosterman TG, 2007, MOL MICROBIOL, V65, P1049, DOI 10.1111/j.1365-2958.2007.05849.x; Kloosterman TG, 2006, J BIOL CHEM, V281, P25097, DOI 10.1074/jbc.M601661200; Kuipers OP, 1998, J BIOTECHNOL, V64, P15, DOI 10.1016/S0168-1656(98)00100-X; Lanie JA, 2007, J BACTERIOL, V189, P38, DOI 10.1128/JB.01148-06; Larsen R, 2005, J BIOL CHEM, V280, P19319, DOI 10.1074/jbc.M413983200; Larsen R, 2004, J BACTERIOL, V186, P1147, DOI 10.1128/JB.186.4.1147-1157.2004; Larsen R, 2005, THESIS U GRONINGEN G; Larsen R, 2008, APPL ENVIRON MICROB, V74, P4768, DOI 10.1128/AEM.00117-08; Li P, 2007, BRIT J NUTR, V98, P237, DOI 10.1017/S000711450769936X; Li W, 2009, FEMS MICROBIOL LETT, V292, P123, DOI 10.1111/j.1574-6968.2008.01476.x; Linke C, 2009, J BACTERIOL, V191, P5814, DOI 10.1128/JB.00485-09; Liu YL, 2008, APPL ENVIRON MICROB, V74, P5023, DOI 10.1128/AEM.00556-08; Loisel E, 2008, J MOL BIOL, V381, P594, DOI 10.1016/j.jmb.2008.05.068; Loisel E, 2011, BIOCHEMISTRY-US, V50, P3551, DOI 10.1021/bi200012f; Lu CD, 2004, J BACTERIOL, V186, P3855, DOI 10.1128/JB.186.12.3855-3861.2004; Lu CD, 1999, J BACTERIOL, V181, P2459, DOI 10.1128/JB.181.8.2459-2464.1999; Lulko AT, 2007, J MOL MICROB BIOTECH, V12, P82, DOI 10.1159/000096463; Maarsingh H, 2008, EUR J PHARMACOL, V585, P375, DOI 10.1016/j.ejphar.2008.02.096; MAAS WK, 1994, MICROBIOL REV, V58, P631, DOI 10.1128/MMBR.58.4.631-640.1994; Melin M, 2010, INFECT IMMUN, V78, P2089, DOI 10.1128/IAI.00811-09; Miller CM, 1997, MOL MICROBIOL, V26, P37, DOI 10.1046/j.1365-2958.1997.5441907.x; Mitchell AM, 2010, CLIN MICROBIOL INFEC, V16, P411, DOI 10.1111/j.1469-0691.2010.03183.x; Nicoloff H, 2004, J BACTERIOL, V186, P6059, DOI 10.1128/JB.186.18.6059-6069.2004; Ogunniyi AD, 2009, FASEB J, V23, P731, DOI 10.1096/fj.08-119537; Park SM, 1997, J BACTERIOL, V179, P5300, DOI 10.1128/jb.179.17.5300-5308.1997; Reyes ED, 2010, J BIOL CHEM, V285, P16521, DOI 10.1074/jbc.M110.119164; Rioux S, 2011, MICROBIOL-SGM, V157, P336, DOI 10.1099/mic.0.042184-0; Ryan S, 2009, ENVIRON MICROBIOL, V11, P432, DOI 10.1111/j.1462-2920.2008.01782.x; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Scott JAG, 2008, J CLIN INVEST, V118, P1291, DOI 10.1172/JCI33947; Senechal H, 2010, FEMS MICROBIOL LETT, V305, P162, DOI 10.1111/j.1574-6968.2010.01921.x; Seth A, 2000, J BACTERIOL, V182, P919, DOI 10.1128/JB.182.4.919-927.2000; Sethuraman R, 2006, NEUROCHEM RES, V31, P1127, DOI 10.1007/s11064-006-9133-8; Shafeeq S, 2011, METALLOMICS, V3, P609, DOI 10.1039/c1mt00030f; Sitkiewicz I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009785; Song JH, 2005, MOL CELLS, V19, P365; Spellerberg B, 1999, INFECT IMMUN, V67, P871, DOI 10.1128/IAI.67.2.871-878.1999; Talaue MT, 2006, J BACTERIOL, V188, P4830, DOI 10.1128/JB.01687-05; Tenenbaum T, 2007, MICROBES INFECT, V9, P714, DOI 10.1016/j.micinf.2007.02.015; Terao Y, 2002, INFECT IMMUN, V70, P993; van Hijum Sacha A F T, 2003, Appl Bioinformatics, V2, P241; van Hijum SAFT, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-77; Wahid RM, 2005, PEDIATR INT, V47, P196, DOI 10.1111/j.1442-200x.2005.02038.x; Weston BF, 2009, INFECT IMMUN, V77, P2840, DOI 10.1128/IAI.01299-08; Winterhoff N, 2002, J BACTERIOL, V184, P6768, DOI 10.1128/JB.184.24.6768-6776.2002; Wu GY, 2009, AMINO ACIDS, V37, P1, DOI 10.1007/s00726-009-0269-0; Zomer AL, 2007, J BACTERIOL, V189, P1366, DOI 10.1128/JB.01013-06	87	40	40	0	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2011	286	52					44594	44605		10.1074/jbc.M111.295832	http://dx.doi.org/10.1074/jbc.M111.295832			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870CA	22084243	hybrid, Green Published, Green Submitted			2022-12-27	WOS:000298645500031
J	Okumoto, K; Kametani, Y; Fujiki, Y				Okumoto, Kanji; Kametani, Yukari; Fujiki, Yukio			Two Proteases, Trypsin Domain-containing 1 (Tysnd1) and Peroxisomal Lon Protease (PsLon), Cooperatively Regulate Fatty Acid beta-Oxidation in Peroxisomal Matrix	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPID TRANSFER PROTEIN; ALKYL-DIHYDROXYACETONEPHOSPHATE SYNTHASE; INSULIN-DEGRADING ENZYME; TARGETING SIGNAL TYPE-2; RAT-LIVER PEROXISOMES; OVARY CELL MUTANT; ACYL-COA OXIDASE; STEROL CARRIER; PTS1 RECEPTOR; FUNCTIONAL COMPLEMENTATION	The molecular mechanisms underlying protein turnover and enzyme regulation in the peroxisomal matrix remain largely unknown. Trypsin domain-containing 1 (Tysnd1) and peroxisomal Lon protease (PsLon) are newly identified peroxisomal matrix proteins that harbor both a serine protease-like domain and a peroxisome-targeting signal 1 (PTS1) sequence. Tysnd1 processes several PTS1-containing proteins and cleaves N-terminal presequences from PTS2-containing protein precursors. Here we report that knockdown of Tysnd1, but not PsLon, resulted in accumulation of endogenous beta-oxidation enzymes in their premature form. The protease activity of Tysnd1 was inactivated by intermolecular self-conversion of the 60-kDa form to 15- and 45-kDa chains, which were preferentially degraded by PsLon. Peroxisomal beta-oxidation of a very long fatty acid was significantly decreased by knockdown of Tysnd1 and partially lowered by PsLon knockdown. Taken together, these data suggest that Tysnd1 is a key regulator of the peroxisomal beta-oxidation pathway via proteolytic processing of beta-oxidation enzymes. The proteolytic activity of oligomeric Tysnd1 is in turn controlled by self-cleavage of Tysnd1 and degradation of Tysnd1 cleavage products by PsLon.	[Okumoto, Kanji; Fujiki, Yukio] Kyushu Univ, Dept Biol, Fac Sci, Grad Sch,Higashi Ku, Fukuoka 8128581, Japan; [Okumoto, Kanji; Kametani, Yukari; Fujiki, Yukio] Kyushu Univ, Grad Sch Syst Life Sci, Grad Sch, Higashi Ku, Fukuoka 8128581, Japan; [Fujiki, Yukio] Core Res Evolut Sci & Technol CREST, Japan Sci & Technol Agcy JST, Tokyo 1020075, Japan	Kyushu University; Kyushu University; Japan Science & Technology Agency (JST)	Fujiki, Y (corresponding author), Kyushu Univ, Dept Biol, Fac Sci, Grad Sch,Higashi Ku, 6-10-1 Hakozaki, Fukuoka 8128581, Japan.	yfujiki@kyudai.jp			Science and Technology Agency of Japan; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Foundation for Applied Enzymology	Science and Technology Agency of Japan(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Foundation for Applied Enzymology	This work was supported in part by a CREST grant (to Y. F.) from the Science and Technology Agency of Japan; by grants-in-aid for scientific research (to Y. F.) and The Global Center of Excellence Program from The Ministry of Education, Culture, Sports, Science, and Technology of Japan; and a grant (to Y. F.) from the Japan Foundation for Applied Enzymology.	ADAMSKI J, 1995, BIOCHEM J, V311, P437, DOI 10.1042/bj3110437; Aksam EB, 2007, AUTOPHAGY, V3, P96, DOI 10.4161/auto.3534; Antonenkov VD, 1997, J BIOL CHEM, V272, P26023, DOI 10.1074/jbc.272.41.26023; AUTHIER F, 1994, J BIOL CHEM, V269, P3010; AUTHIER F, 1995, P NATL ACAD SCI USA, V92, P3859, DOI 10.1073/pnas.92.9.3859; Bota DA, 2002, NAT CELL BIOL, V4, P674, DOI 10.1038/ncb836; Braverman N, 1998, HUM MOL GENET, V7, P1195, DOI 10.1093/hmg/7.8.1195; Brown LA, 2003, J CELL MOL MED, V7, P388, DOI 10.1111/j.1582-4934.2003.tb00241.x; Chang CC, 1999, J CELL SCI, V112, P1579; Clausen T, 2002, MOL CELL, V10, P443, DOI 10.1016/S1097-2765(02)00658-5; deVet ECJM, 1997, J BIOL CHEM, V272, P798, DOI 10.1074/jbc.272.2.798; Dodt G, 1996, J CELL BIOL, V135, P1763, DOI 10.1083/jcb.135.6.1763; Eckert JH, 2003, REV PHYSIOL BIOCH P, V147, P75, DOI 10.1007/s10254-003-0007-z; Friguet Bertrand, 2008, Biotechnology Journal, V3, P757, DOI 10.1002/biot.200800041; Fujiki Y, 2006, BBA-MOL CELL RES, V1763, P1374, DOI 10.1016/j.bbamcr.2006.09.012; Fukuda R, 2007, CELL, V129, P111, DOI 10.1016/j.cell.2007.01.047; GOULD SJ, 1989, J CELL BIOL, V108, P1657, DOI 10.1083/jcb.108.5.1657; Granot Z, 2007, MOL ENDOCRINOL, V21, P2164, DOI 10.1210/me.2005-0458; Gur E, 2008, GENE DEV, V22, P2267, DOI 10.1101/gad.1670908; Helm M, 2007, P NATL ACAD SCI USA, V104, P11501, DOI 10.1073/pnas.0704733104; Honsho M, 2008, BBA-MOL CELL RES, V1783, P1857, DOI 10.1016/j.bbamcr.2008.05.018; Honsho M, 2010, J BIOL CHEM, V285, P8537, DOI 10.1074/jbc.M109.083311; Hori O, 2002, J CELL BIOL, V157, P1151, DOI 10.1083/jcb.200108103; Kikuchi M, 2004, J BIOL CHEM, V279, P421, DOI 10.1074/jbc.M305623200; Kurochkin IV, 2007, EMBO J, V26, P835, DOI 10.1038/sj.emboj.7601525; LAZAROW PB, 1985, ANNU REV CELL BIOL, V1, P489, DOI 10.1146/annurev.cb.01.110185.002421; Lee I, 2008, BBA-PROTEINS PROTEOM, V1784, P727, DOI 10.1016/j.bbapap.2008.02.010; LEENDERS F, 1994, MOL CELL ENDOCRINOL, V104, P127, DOI 10.1016/0303-7207(94)90114-7; Lingard MJ, 2009, PLANT PHYSIOL, V151, P1354, DOI 10.1104/pp.109.142505; LIPINSKA B, 1990, J BACTERIOL, V172, P1791, DOI 10.1128/jb.172.4.1791-1797.1990; Matsumoto M, 2005, PROTEOMICS, V5, P4145, DOI 10.1002/pmic.200401280; Matsumura T, 2000, J BIOL CHEM, V275, P21715, DOI 10.1074/jbc.M000721200; Matsushima Y, 2010, P NATL ACAD SCI USA, V107, P18410, DOI 10.1073/pnas.1008924107; MIURA S, 1992, J BIOL CHEM, V267, P14405; MIYAZAWA S, 1989, MOL CELL BIOL, V9, P83, DOI 10.1128/MCB.9.1.83; MIYAZAWA S, 1987, J BIOL CHEM, V262, P8131; MORI T, 1991, P NATL ACAD SCI USA, V88, P4338, DOI 10.1073/pnas.88.10.4338; Morita M, 2000, CELL STRUCT FUNCT, V25, P309, DOI 10.1247/csf.25.309; Motley AM, 2000, EMBO REP, V1, P40, DOI 10.1093/embo-reports/kvd010; Mukai S, 2006, J BIOL CHEM, V281, P37311, DOI 10.1074/jbc.M607178200; Okumoto K, 2000, J BIOL CHEM, V275, P25700, DOI 10.1074/jbc.M003303200; Okumoto K, 1998, MOL CELL BIOL, V18, P4324, DOI 10.1128/MCB.18.7.4324; Omi S, 2008, J BIOCHEM, V143, P649, DOI 10.1093/jb/mvn020; Ondrovicova G, 2005, J BIOL CHEM, V280, P25103, DOI 10.1074/jbc.M502796200; OSUMI T, 1980, J BIOCHEM, V87, P1735, DOI 10.1093/oxfordjournals.jbchem.a132918; OSUMI T, 1991, BIOCHEM BIOPH RES CO, V181, P947, DOI 10.1016/0006-291X(91)92028-I; Otera H, 2000, J BIOL CHEM, V275, P21703, DOI 10.1074/jbc.M000720200; Otera H, 1998, MOL CELL BIOL, V18, P388, DOI 10.1128/MCB.18.1.388; Otera H, 2001, J BIOL CHEM, V276, P2858, DOI 10.1074/jbc.M007730200; Platta HW, 2007, FEBS LETT, V581, P2811, DOI 10.1016/j.febslet.2007.04.001; Purdue PE, 2001, ANNU REV CELL DEV BI, V17, P701, DOI 10.1146/annurev.cellbio.17.1.701; Rawlings ND, 2004, NUCLEIC ACIDS RES, V32, pD160, DOI 10.1093/nar/gkp971; Rep M, 1996, SCIENCE, V274, P103, DOI 10.1126/science.274.5284.103; Schuhmann H, 2008, PLANT PHYSIOL, V148, P1847, DOI 10.1104/pp.108.125377; SEEDORF U, 1994, J BIOL CHEM, V269, P21277; Shimizu N, 1999, J BIOL CHEM, V274, P12593, DOI 10.1074/jbc.274.18.12593; SUZUKI CK, 1994, SCIENCE, V264, P273, DOI 10.1126/science.8146662; SUZUKI Y, 1991, BIOCHEM PHARMACOL, V41, P453, DOI 10.1016/0006-2952(91)90544-F; SWINKELS BW, 1991, EMBO J, V10, P3255, DOI 10.1002/j.1460-2075.1991.tb04889.x; Tamura S, 2006, J BIOL CHEM, V281, P27693, DOI 10.1074/jbc.M605159200; TSUKAMOTO T, 1990, J CELL BIOL, V110, P651, DOI 10.1083/jcb.110.3.651; van Grunsven EG, 1999, HUM MOL GENET, V8, P1509, DOI 10.1093/hmg/8.8.1509; Van Melderen L, 2009, RES MICROBIOL, V160, P645, DOI 10.1016/j.resmic.2009.08.021; VANDENBOSCH H, 1992, ANNU REV BIOCHEM, V61, P157, DOI 10.1146/annurev.bi.61.070192.001105; Voos W, 2009, RES MICROBIOL, V160, P718, DOI 10.1016/j.resmic.2009.08.003; WAGNER I, 1994, EMBO J, V13, P5135, DOI 10.1002/j.1460-2075.1994.tb06843.x; Wanders RJA, 2006, BBA-MOL CELL RES, V1763, P1707, DOI 10.1016/j.bbamcr.2006.08.010; Wanders RJA, 2006, ANNU REV BIOCHEM, V75, P295, DOI 10.1146/annurev.biochem.74.082803.133329; Weller S, 2003, ANNU REV GENOM HUM G, V4, P165, DOI 10.1146/annurev.genom.4.070802.110424; Wouters FS, 1998, EMBO J, V17, P7179, DOI 10.1093/emboj/17.24.7179; Yokota S, 2008, HISTOCHEM CELL BIOL, V129, P73, DOI 10.1007/s00418-007-0328-0	71	41	45	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2011	286	52					44367	44379		10.1074/jbc.M111.285197	http://dx.doi.org/10.1074/jbc.M111.285197			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870CA	22002062	hybrid, Green Published			2022-12-27	WOS:000298645500009
J	Tongsook, C; Sucharitakul, J; Thotsaporn, K; Chaiyen, P				Tongsook, Chanakan; Sucharitakul, Jeerus; Thotsaporn, Kittisak; Chaiyen, Pimchai			Interactions with the Substrate Phenolic Group Are Essential for Hydroxylation by the Oxygenase Component of p-Hydroxyphenylacetate 3-Hydroxylase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLAVIN-DEPENDENT MONOOXYGENASE; 4-HYDROXYPHENYLACETATE 3-MONOOXYGENASE; HYDROXYBENZOATE HYDROXYLASE; ACINETOBACTER-BAUMANNII; CRYSTAL-STRUCTURE; REDUCTASE; MECHANISM; C4A-HYDROPEROXYFLAVIN; SPECTROSCOPY; RECOGNITION	p-Hydroxyphenylacetate (HPA) 3-hydroxylase is a two-component flavoprotein monooxygenase that catalyzes the hydroxylation of p-hydroxyphenylacetate to form 3,4-dihydroxyphenylacetate. Based on structures of the oxygenase component (C-2), both His-120 and Ser-146 are located similar to 2.8 angstrom from the hydroxyl group of HPA. The variants H120N, H120Q, H120Y, H120D, and H120E can form C4a-hydroperoxy-FMN (a reactive intermediate necessary for hydroxylation) but cannot hydroxylate HPA. The impairment of H120N is not due to substrate binding because the variant can still bind HPA. In contrast, the H120K variant catalyzes hydroxylation with efficiency comparable with that of the wild-type enzyme; the hydroxylation rate constant for H120K is 5.7 +/- 0.6 s(-1), and the product conversion ratio is 75%, compared with values of 16 s(-1) and 90% for the wild-type enzyme. H120R can also catalyze hydroxylation, suggesting that a positive charge on residue 120 can substitute for the hydroxylation function of His-120. Because the hydroxylation reaction of wild-type C2 is pH-independent between pH 6 and 10, the protonation status of key components required for hydroxylation likely remains unchanged in this pH range. His-120 may be positively charged for selective binding to the phenolate form of HPA, i.e. to form the His(delta+).HPA(delta-) complex, which in turn promotes oxygen atom transfer via an electrophilic aromatic substitution mechanism. Analysis of Ser-146 variants revealed that this residue is necessary for but not directly engaged in hydroxylation. Product formation in S146A is pH-independent and constant at similar to 70% over a pH range of 6-10, whereas product formation for S146C decreased from similar to 65% at pH 6.0 to 27% at pH 10.0. These data indicate that the ionization of Cys-146 in the S146C variant has an adverse effect on hydroxylation, possibly by perturbing formation of the His(delta+).HPA(delta-) complex needed for hydroxylation.	[Tongsook, Chanakan; Chaiyen, Pimchai] Mahidol Univ, Dept Biochem, Bangkok 10400, Thailand; [Tongsook, Chanakan; Chaiyen, Pimchai] Mahidol Univ, Ctr Excellence Prot Struct & Funct, Fac Sci, Bangkok 10400, Thailand; [Sucharitakul, Jeerus; Thotsaporn, Kittisak] Chulalongkorn Univ, Dept Biochem, Fac Dent, Bangkok 10330, Thailand	Mahidol University; Mahidol University; Chulalongkorn University	Chaiyen, P (corresponding author), Mahidol Univ, Dept Biochem, Rama 6 Rd, Bangkok 10400, Thailand.	scpcy@mahidol.ac.th	Chaiyen, Pimchai/R-5052-2019	Chaiyen, Pimchai/0000-0002-8533-1604	Thailand Research Fund [BRG5480001, MRG5380240]; Faculty of Science, Mahidol University; Development and Promotion of Science and Technology; Chulalongkorn University; Royal Golden Jubilee Ph.D. Program Grant [PHD/0008/2549]	Thailand Research Fund(Thailand Research Fund (TRF)); Faculty of Science, Mahidol University; Development and Promotion of Science and Technology; Chulalongkorn University(Chulalongkorn University); Royal Golden Jubilee Ph.D. Program Grant	This work was supported in part by Thailand Research Fund Grant BRG5480001 and a grant from the Faculty of Science, Mahidol University (to P. C.).; Supported by the Development and Promotion of Science and Technology Talent Project.; Supported by Thailand Research Fund MRG5380240 and Chulalongkorn University.; Supported by Royal Golden Jubilee Ph.D. Program Grant PHD/0008/2549.	Alfieri A, 2007, P NATL ACAD SCI USA, V104, P1177, DOI 10.1073/pnas.0608381104; Andre I, 2007, J AM CHEM SOC, V129, P15805, DOI 10.1021/ja0721824; ARUNACHALAM U, 1992, J BIOL CHEM, V267, P25848; Ballou DP, 2005, BIOCHEM BIOPH RES CO, V338, P590, DOI 10.1016/j.bbrc.2005.09.081; Chaiyen P, 2004, BIOCHEMISTRY-US, V43, P3933, DOI 10.1021/bi035734d; Chaiyen P, 1997, BIOCHEMISTRY-US, V36, P13856, DOI 10.1021/bi9715122; Chaiyen P, 2001, EUR J BIOCHEM, V268, P5550, DOI 10.1046/j.1432-1033.2001.02490.x; Chaiyen P, 2010, ARCH BIOCHEM BIOPHYS, V493, P62, DOI 10.1016/j.abb.2009.08.021; Chakraborty S, 2010, BIOCHEMISTRY-US, V49, P372, DOI 10.1021/bi901454u; Connors K. A, 1990, CHEM KINETICS STUDY, P62; Dresen C, 2010, J BIOL CHEM, V285, P22264, DOI 10.1074/jbc.M109.099028; DUCH DS, 1971, ANAL BIOCHEM, V44, P42, DOI 10.1016/0003-2697(71)90343-5; Ellis HR, 2010, ARCH BIOCHEM BIOPHYS, V497, P1, DOI 10.1016/j.abb.2010.02.007; ENTSCH B, 1991, J BIOL CHEM, V266, P17341; Entsch B, 2005, ARCH BIOCHEM BIOPHYS, V433, P297, DOI 10.1016/j.abb.2004.09.029; Fagan RL, 2010, COMPREHENSIVE NATURAL PRODUCTS II: CHEMISTRY AND BIOLOGY, VOL 7: COFACTORS, P37; Fersht A., 1999, STRUCTURE MECH PROTE, P169; Galan B, 2000, J BACTERIOL, V182, P627, DOI 10.1128/JB.182.3.627-636.2000; Kantz A, 2011, BIOCHEMISTRY-US, V50, P523, DOI 10.1021/bi101328r; Kim SH, 2008, PROTEINS, V70, P718, DOI 10.1002/prot.21534; Kim SH, 2007, J BIOL CHEM, V282, P33107, DOI 10.1074/jbc.M703440200; Nozaki Y, 1967, METHOD ENZYMOL, V11, P715, DOI DOI 10.1016/S0076-6879(67)11088-4; Okai M, 2006, BIOCHEMISTRY-US, V45, P5103, DOI 10.1021/bi052313i; Ortiz-Maldonado M, 2004, BIOCHEMISTRY-US, V43, P15246, DOI 10.1021/bi048115t; Ortiz-Maldonado M, 1999, BIOCHEMISTRY-US, V38, P8124, DOI 10.1021/bi990560e; Palfey B. A., 1998, COMPREHENSIVE BIOL C, V3, P37; Palfey BA, 1999, BIOCHEMISTRY-US, V38, P1153, DOI 10.1021/bi9826613; Palfey BA, 2010, ARCH BIOCHEM BIOPHYS, V493, P26, DOI 10.1016/j.abb.2009.11.028; Pazmino DET, 2010, J BIOTECHNOL, V146, P9, DOI 10.1016/j.jbiotec.2010.01.021; RIORDAN JF, 1977, SCIENCE, V195, P884, DOI 10.1126/science.190679; Ruangchan N, 2011, J BIOL CHEM, V286, P223, DOI 10.1074/jbc.M110.163881; Sucharitakul J, 2005, BIOCHEMISTRY-US, V44, P10434, DOI 10.1021/bi050615e; Sucharitakul J, 2008, BIOCHEMISTRY-US, V47, P8485, DOI 10.1021/bi801039d; Sucharitakul J, 2007, BIOCHEMISTRY-US, V46, P8611, DOI 10.1021/bi7006614; Sucharitakul J, 2006, J BIOL CHEM, V281, P17044, DOI 10.1074/jbc.M512385200; Thotsaporn K, 2004, BBA-GENE STRUCT EXPR, V1680, P60, DOI 10.1016/j.bbaexp.2004.08.003; Thotsaporn K, 2011, J BIOL CHEM, V286, P28170, DOI 10.1074/jbc.M111.241836; Tishmack PA, 1997, BIOCHEMISTRY-US, V36, P11984, DOI 10.1021/bi9712448; van Berkel WJH, 2006, J BIOTECHNOL, V124, P670, DOI 10.1016/j.jbiotec.2006.03.044; Webb BN, 2010, J BIOL CHEM, V285, P2014, DOI 10.1074/jbc.M109.056135; Wolff N, 2002, PROTEIN SCI, V11, P757, DOI 10.1110/ps.3630102	41	26	27	3	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2011	286	52					44491	44502		10.1074/jbc.M111.284463	http://dx.doi.org/10.1074/jbc.M111.284463			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870CA	22052902	Green Published, hybrid			2022-12-27	WOS:000298645500021
J	Biglione, S; Tsytsykova, AV; Goldfeld, AE				Biglione, Sebastian; Tsytsykova, Alla V.; Goldfeld, Anne E.			Monocyte-specific Accessibility of a Matrix Attachment Region in the Tumor Necrosis Factor Locus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-ALPHA GENE; RNA-POLYMERASE-II; DROSOPHILA TOPOISOMERASE-II; CREB-BINDING-PROTEIN; STRAND DNA CLEAVAGE; HISTONE HYPERACETYLATION; WEB SERVER; TNF GENE; T-CELLS; EXPRESSION	Regulation of TNF gene expression is cell type-and stimulus-specific. We have previously identified highly conserved non-coding regulatory elements within DNase I-hypersensitive sites (HSS) located 9 kb upstream (HSS-9) and 3 kb downstream (HSS+3) of the TNF gene, which play an important role in the transcriptional regulation of TNF in T cells. They act as enhancers and interact with the TNF promoter and with each other, generating a higher order chromatin structure. Here, we report a novel monocyte-specific AT-rich DNase I-hypersensitive element located 7 kb upstream of the TNF gene (HSS-7), which serves as a matrix attachment region in monocytes. We show that HSS-7 associates with topoisomerase II alpha (Top2) in vivo and that induction of endogenous TNF mRNA expression is suppressed by etoposide, a Top2 inhibitor. Moreover, Top2 binds to and cleaves HSS-7 in in vitro analysis. Thus, HSS-7, which is selectively accessible in monocytes, can tether the TNF locus to the nuclear matrix via matrix attachment region formation, potentially promoting TNF gene expression by acting as a Top2 substrate.	[Goldfeld, Anne E.] Harvard Univ, Sch Med, Immune Dis Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Childrens Hosp Boston, Program Cellular & Mol Med, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School	Goldfeld, AE (corresponding author), Harvard Univ, Sch Med, Immune Dis Inst, 200 Longwood Ave, Boston, MA 02115 USA.	goldfeld@idi.harvard.edu	Goldfeld, Anne/AAF-1818-2019		National Institutes of Health [R01 GM076685]; Glaxo-SmithKline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076685] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Glaxo-SmithKline(GlaxoSmithKline); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM076685 (to A. E. G.). This work was also supported by Glaxo-SmithKline (to A. E. G.).	Baena A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000621; Balakrishnan L, 2007, J MOL BIOL, V371, P1022, DOI 10.1016/j.jmb.2007.06.080; Balakrishnan L, 2007, J MOL BIOL, V365, P18, DOI 10.1016/j.jmb.2006.09.044; Barthel R, 2003, J IMMUNOL, V171, P3612, DOI 10.4049/jimmunol.171.7.3612; Barthel R, 2003, MOL CELL BIOL, V23, P526, DOI 10.1128/MCB.23.2.526-533.2003; Bode J, 2003, CHROMOSOME RES, V11, P435, DOI 10.1023/A:1024918525818; Bode J, 1996, CRIT REV EUKAR GENE, V6, P115, DOI 10.1615/CritRevEukarGeneExpr.v6.i2-3.20; Boulikas T, 1995, INT REV CYTOL, V162A, P279; Chattopadhyay Samit, 2007, Subcell Biochem, V41, P213; Cockerill P N, 2000, Methods Mol Biol, V130, P29; Cockerill PN, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.113pe15; Falvo JV, 2010, CURR DIR AUTOIMMUN, V11, P27, DOI 10.1159/000289196; Falvo JV, 2000, P NATL ACAD SCI USA, V97, P3925, DOI 10.1073/pnas.97.8.3925; Falvo JV, 2000, MOL CELL BIOL, V20, P2239, DOI 10.1128/MCB.20.6.2239-2247.2000; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; GOLDFELD AE, 1993, J EXP MED, V178, P1365, DOI 10.1084/jem.178.4.1365; Horiguchi-Yamada J, 2002, ANTICANCER RES, V22, P3827; Hostert A, 1997, J IMMUNOL, V158, P4270; Jiao W, 2005, CANCER RES, V65, P4067, DOI 10.1158/0008-5472.CAN-04-3999; Kumar P, 2007, NAT CELL BIOL, V9, P45, DOI 10.1038/ncb1516; LEE MP, 1989, J BIOL CHEM, V264, P21779; LEE MP, 1989, J BIOL CHEM, V264, P13510; Lehar SM, 1996, ONCOGENE, V12, P1181; Lei JX, 2005, CELL DEATH DIFFER, V12, P1368, DOI 10.1038/sj.cdd.4401671; Leung JY, 2000, P NATL ACAD SCI USA, V97, P6614, DOI 10.1073/pnas.97.12.6614; LIU LF, 1987, P NATL ACAD SCI USA, V84, P7024, DOI 10.1073/pnas.84.20.7024; Mitchell R, 2003, MOL THER, V8, P674, DOI 10.1016/S1525-0016(03)00215-6; Molto Eduardo, 2009, Briefings in Functional Genomics & Proteomics, V8, P283, DOI 10.1093/bfgp/elp031; Mondal N, 2001, NATURE, V413, P435, DOI 10.1038/35096590; Nagashima M, 2001, P NATL ACAD SCI USA, V98, P9671, DOI 10.1073/pnas.161151798; Ramsey SA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000021; SANDER M, 1985, NUCLEIC ACIDS RES, V13, P1057, DOI 10.1093/nar/13.4.1057; Schwartz S, 2000, GENOME RES, V10, P577, DOI 10.1101/gr.10.4.577; Tsai EY, 1996, MOL CELL BIOL, V16, P5232; Tsai EY, 2000, MOL CELL BIOL, V20, P6084, DOI 10.1128/MCB.20.16.6084-6094.2000; Tsytsykova AV, 2007, P NATL ACAD SCI USA, V104, P16850, DOI 10.1073/pnas.0708210104; Tsytsykova AV, 2007, J BIOL CHEM, V282, P11629, DOI 10.1074/jbc.M611418200; Tsytsykova AV, 2000, J EXP MED, V192, P581, DOI 10.1084/jem.192.4.581; Tsytsykova AV, 2002, MOL CELL BIOL, V22, P2620, DOI 10.1128/MCB.22.8.2620-2631.2002; Wang JC, 2009, UNTANGLING DOUBLE HE; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	41	4	4	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2011	286	51					44126	44133		10.1074/jbc.M111.272476	http://dx.doi.org/10.1074/jbc.M111.272476			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866SH	22027829	Green Published, hybrid			2022-12-27	WOS:000298402300053
J	Imagawa, T; Tsurumura, T; Sugimoto, Y; Aki, K; Ishidoh, K; Kuramitsu, S; Tsuge, H				Imagawa, Takahito; Tsurumura, Toshiharu; Sugimoto, Yasushi; Aki, Kenji; Ishidoh, Kazumi; Kuramitsu, Seiki; Tsuge, Hideaki			Structural Basis of Free Reduced Flavin Generation by Flavin Reductase from Thermus thermophilus HB8	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; RIBONUCLEOTIDE REDUCTASE; CRYSTAL-STRUCTURE; 4-HYDROXYPHENYLACETATE 3-MONOOXYGENASE; CHEMICAL-REDUCTION; PRISTINAMYCIN-IIB; OXIDOREDUCTASE; IRON; PURIFICATION; MECHANISMS	Free reduced flavins are involved in a variety of biological functions. They are generated from NAD(P)H by flavin reductase via co-factor flavin bound to the enzyme. Although recent findings on the structure and function of flavin reductase provide new information about co-factor FAD and substrate NAD, there have been no reports on the substrate flavin binding site. Here we report the structure of TTHA0420 from Thermus thermophilus HB8, which belongs to flavin reductase, and describe the dual binding mode of the substrate and co-factor flavins. We also report that TTHA0420 has not only the flavin reductase motif GDH but also a specific motif YGG in C terminus as well as Phe-41 and Arg-11, which are conserved in its subclass. From the structure, these motifs are important for the substrate flavin binding. On the contrary, the C terminus is stacked on the NADH binding site, apparently to block NADH binding to the active site. To identify the function of the C-terminal region, we designed and expressed a mutant TTHA0420 enzyme in which the C-terminal five residues were deleted (TTHA0420-Delta C5). Notably, the activity of TTHA0420-Delta C5 was about 10 times higher than that of the wild-type enzyme at 20-40 degrees C. Our findings suggest that the C-terminal region of TTHA0420 may regulate the alternative binding of NADH and substrate flavin to the enzyme.	[Tsurumura, Toshiharu; Tsuge, Hideaki] Kyoto Sangyo Univ, Fac Life Sci, Dept Prot Struct Biol, Kyoto 6038555, Japan; [Imagawa, Takahito; Sugimoto, Yasushi; Aki, Kenji; Ishidoh, Kazumi; Tsuge, Hideaki] Tokushima Bunri Univ, Inst Hlth Sci, Tokushima 7708514, Japan; [Imagawa, Takahito; Kuramitsu, Seiki; Tsuge, Hideaki] Harima Inst, RIKEN SPring Ctr 8, Sayo, Hyogo 6795148, Japan; [Kuramitsu, Seiki] Osaka Univ, Grad Sch Sci, Dept Biol Sci, Toyonaka, Osaka 5600043, Japan	Kyoto Sangyo University; Tokushima Bunri University; RIKEN; Osaka University	Tsuge, H (corresponding author), Kyoto Sangyo Univ, Fac Life Sci, Dept Prot Struct Biol, Kyoto 6038555, Japan.	tsuge@cc.kyoto-su.ac.jp	Tsuge, Hideaki/ABF-6424-2021	Tsuge, Hideaki/0000-0003-0166-9163	RIKEN Structural Genomics/Proteomics Initiative; MEXT of Japan	RIKEN Structural Genomics/Proteomics Initiative; MEXT of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by the RIKEN Structural Genomics/Proteomics Initiative and the National Project on Protein Structural and Functional Analysis and Strategic Research Foundation Grant-aided Project for Private Universities, MEXT of Japan. This work was also supported in part by grants-in-aid for scientific research from the MEXT of Japan.	[Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; BLANC V, 1995, J BACTERIOL, V177, P5206, DOI 10.1128/jb.177.18.5206-5214.1995; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chiu HJ, 2001, STRUCTURE, V9, P311, DOI 10.1016/S0969-2126(01)00589-5; Christendat D, 2000, NAT STRUCT BIOL, V7, P903; COVES J, 1993, J BIOL CHEM, V268, P18604; COVES J, 1993, EUR J BIOCHEM, V211, P635, DOI 10.1111/j.1432-1033.1993.tb17591.x; COVES J, 1995, EUR J BIOCHEM, V233, P357, DOI 10.1111/j.1432-1033.1995.357_1.x; FONTECAVE M, 1989, J BIOL CHEM, V264, P9164; FONTECAVE M, 1987, J BIOL CHEM, V262, P12325; Galan B, 2000, J BACTERIOL, V182, P627, DOI 10.1128/JB.182.3.627-636.2000; GHISLA S, 1989, EUR J BIOCHEM, V181, P1, DOI 10.1111/j.1432-1033.1989.tb14688.x; Gray KA, 1996, NAT BIOTECHNOL, V14, P1705, DOI 10.1038/nbt1296-1705; HALLE F, 1992, EUR J BIOCHEM, V209, P613, DOI 10.1111/j.1432-1033.1992.tb17327.x; HALLE F, 1992, EUR J BIOCHEM, V209, P621, DOI 10.1111/j.1432-1033.1992.tb17328.x; HENDRICKSON WA, 1990, EMBO J, V9, P1665, DOI 10.1002/j.1460-2075.1990.tb08287.x; Holm L, 1997, NUCLEIC ACIDS RES, V25, P231, DOI 10.1093/nar/25.1.231; Ida K, 2005, BIOCHEM BIOPH RES CO, V333, P359, DOI 10.1016/j.bbrc.2005.05.116; Iyanagi Takashi, 2011, Seikagaku, V83, P273; KENDREW SG, 1995, J BIOL CHEM, V270, P17339, DOI 10.1074/jbc.270.29.17339; Kim SH, 2008, PROTEINS, V70, P718, DOI 10.1002/prot.21534; Kirchner U, 2003, J BIOL CHEM, V278, P47545, DOI 10.1074/jbc.M307397200; LEI BF, 1994, J BACTERIOL, V176, P3552, DOI 10.1128/JB.176.12.3552-3558.1994; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Okai M, 2006, BIOCHEMISTRY-US, V45, P5103, DOI 10.1021/bi052313i; Parry RJ, 1997, J BIOL CHEM, V272, P23303, DOI 10.1074/jbc.272.37.23303; Russell TR, 2004, BIOCHEMISTRY-US, V43, P12887, DOI 10.1021/bi048499n; SIRIVECH S, 1974, BIOCHEM J, V143, P311, DOI 10.1042/bj1430311; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; THIBAUT D, 1995, J BACTERIOL, V177, P5199, DOI 10.1128/jb.177.18.5199-5205.1995; Tsuge H, 2005, J BIOL CHEM, V280, P31045, DOI 10.1074/jbc.C500234200; Tu SC, 2001, ANTIOXID REDOX SIGN, V3, P881, DOI 10.1089/15230860152665046; van den Heuvel RHH, 2004, J BIOL CHEM, V279, P12860, DOI 10.1074/jbc.M313765200; Witschel M, 1997, J BACTERIOL, V179, P6937, DOI 10.1128/jb.179.22.6937-6943.1997; Zhang J, 2001, J BIOL CHEM, V276, P37506, DOI 10.1074/jbc.M105503200	36	8	8	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2011	286	51					44078	44085		10.1074/jbc.M111.257824	http://dx.doi.org/10.1074/jbc.M111.257824			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866SH	22052907	Green Published, hybrid			2022-12-27	WOS:000298402300048
J	Luther, KB; Hulsmeier, AJ; Schegg, B; Deuber, SA; Raoult, D; Hennet, T				Luther, Kelvin B.; Huelsmeier, Andreas J.; Schegg, Belinda; Deuber, Stefan A.; Raoult, Didier; Hennet, Thierry			Mimivirus Collagen Is Modified by Bifunctional Lysyl Hydroxylase and Glycosyltransferase Enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LARGE DNA VIRUSES; GENOME SEQUENCE; TRIPLE-HELIX; STREPTOCOCCUS-PYOGENES; CARBOHYDRATE UNITS; CONNECTIVE-TISSUE; GIANT MIMIVIRUS; SURFACE PROTEIN; GLYCOSYLATION; PEPTIDES	Collagens, the most abundant proteins in animals, are modified by hydroxylation of proline and lysine residues and by glycosylation of hydroxylysine. Dedicated prolyl hydroxylase, lysyl hydroxylase, and collagen glycosyltransferase enzymes localized in the endoplasmic reticulum mediate these modifications prior to the formation of the collagen triple helix. Whereas collagen-like proteins have been described in some fungi, bacteria, and viruses, the post-translational machinery modifying collagens has never been described outside of animals. We demonstrate that the L230 open reading frame of the giant virus Acanthamoeba polyphaga mimivirus encodes an enzyme that has distinct lysyl hydroxylase and collagen glycosyltransferase domains. We show that mimivirus L230 is capable of hydroxylating lysine and glycosylating the resulting hydroxylysine residues in a native mimivirus collagen acceptor substrate. Whereas in animals from sponges to humans the transfer of galactose to hydroxylysine in collagen is conserved, the mimivirus L230 enzyme transfers glucose to hydroxylysine, thereby defining a novel type of collagen glycosylation in nature. The presence of hydroxylysine in mimivirus proteins was confirmed by amino acid analysis of mimivirus recovered from A. polyphaga cultures. This work shows for the first time that collagen post-translational modifications are not confined to the domains of life. The utilization of glucose instead of the galactose found throughout animals as well as a bifunctional enzyme rather than two separate enzymes may represent a parallel evolutionary track in collagen biology. These results suggest that giant viruses may have contributed to the evolution of collagen biology.	[Luther, Kelvin B.; Huelsmeier, Andreas J.; Schegg, Belinda; Deuber, Stefan A.; Hennet, Thierry] Univ Zurich, Inst Physiol, CH-8057 Zurich, Switzerland; [Raoult, Didier] Univ Aix Marseille 2, Fac Med, CNRS, Unite Mixte Rech,Inst Rech Dev 6236,Unite Rech Ma, F-13385 Marseille 5, France	University of Zurich; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite	Hennet, T (corresponding author), Univ Zurich, Inst Physiol, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	thennet@access.uzh.ch	RAOULT, Didier/A-8434-2008	RAOULT, Didier/0000-0002-0633-5974; Luther, Kelvin/0000-0001-9438-9675; Hulsmeier, Andreas J./0000-0001-6987-8979	Swiss National Science Foundation [310030-129633]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by Swiss National Science Foundation Grant 310030-129633 (to T. H.). The University of Zurich has a pending patent application involving the use of the L230 enzyme for biotechnology purposes.	Aldunate R, 2004, BRAIN RES REV, V47, P96, DOI 10.1016/j.brainresrev.2004.07.019; BAMFORD JKH, 1990, VIROLOGY, V177, P445, DOI 10.1016/0042-6822(90)90508-O; Bank RA, 1999, P NATL ACAD SCI USA, V96, P1054, DOI 10.1073/pnas.96.3.1054; Bann JG, 2000, FEBS LETT, V473, P237, DOI 10.1016/S0014-5793(00)01493-9; Benarroch D, 2006, J VIROL, V80, P314, DOI 10.1128/JVI.80.1.314-321.2006; BERG RA, 1973, BIOCHEM BIOPH RES CO, V52, P115, DOI 10.1016/0006-291X(73)90961-3; BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; BOYCE JD, 1995, APPL ENVIRON MICROB, V61, P4105, DOI 10.1128/AEM.61.11.4105-4109.1995; Boyer M, 2011, P NATL ACAD SCI USA, V108, P10296, DOI 10.1073/pnas.1101118108; Duplessis M, 2001, MOL MICROBIOL, V41, P325, DOI 10.1046/j.1365-2958.2001.02521.x; Eriksson M, 1999, J BIOL CHEM, V274, P22131, DOI 10.1074/jbc.274.32.22131; Filee J, 2007, TRENDS GENET, V23, P10, DOI 10.1016/j.tig.2006.11.002; Filee J, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-320; Hakansson K, 2000, PROTEIN SCI, V9, P1607, DOI 10.1110/ps.9.9.1607; Heikkinen J, 2000, J BIOL CHEM, V275, P36158, DOI 10.1074/jbc.M006203200; HYLAND J, 1992, NAT GENET, V2, P228, DOI 10.1038/ng1192-228; Iyer LA, 2006, VIRUS RES, V117, P156, DOI 10.1016/j.virusres.2006.01.009; KATZMAN RL, 1972, BIOCHEMISTRY-US, V11, P1161, DOI 10.1021/bi00757a008; KIVIRIKKO KI, 1982, METHOD ENZYMOL, V82, P245; KIVIRIKKO KI, 1972, BIOCHEMISTRY-US, V11, P122, DOI 10.1021/bi00751a021; La Scola B, 2008, NATURE, V455, P100, DOI 10.1038/nature07218; Legendre M, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-99; Legendre M, 2010, GENOME RES, V20, P664, DOI 10.1101/gr.102582.109; Mann K, 1996, J MOL BIOL, V261, P255, DOI 10.1006/jmbi.1996.0457; Mizuno K, 2003, J BIOL CHEM, V278, P32373, DOI 10.1074/jbc.M304741200; Moreira D, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-12; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; Raoult D, 2004, SCIENCE, V306, P1344, DOI 10.1126/science.1101485; Rasmussen M, 2000, INFECT IMMUN, V68, P6370, DOI 10.1128/IAI.68.11.6370-6377.2000; Richards AA, 2006, MOL ENDOCRINOL, V20, P1673, DOI 10.1210/me.2005-0390; Risteli M, 2004, J BIOL CHEM, V279, P37535, DOI 10.1074/jbc.M405638200; ROSENBLOOM J, 1968, BIOCHEM BIOPH RES CO, V31, P792, DOI 10.1016/0006-291X(68)90632-3; Salo AM, 2008, AM J HUM GENET, V83, P495, DOI 10.1016/j.ajhg.2008.09.004; Schegg B, 2009, MOL CELL BIOL, V29, P943, DOI 10.1128/MCB.02085-07; Shoulders MD, 2009, ANNU REV BIOCHEM, V78, P929, DOI 10.1146/annurev.biochem.77.032207.120833; Simmer F, 2003, PLOS BIOL, V1, P77, DOI 10.1371/journal.pbio.0000012; SPIRO RG, 1967, J BIOL CHEM, V242, P4813; SPIRO RG, 1969, J BIOL CHEM, V244, P2049; SPIRO RG, 1969, J BIOL CHEM, V244, P602; Suzan-Monti M, 2006, VIRUS RES, V117, P145, DOI 10.1016/j.virusres.2005.07.011; van der Slot AJ, 2003, J BIOL CHEM, V278, P40967, DOI 10.1074/jbc.M307380200; van Hulten MCW, 2001, VIROLOGY, V286, P7, DOI 10.1006/viro.2001.1002; Wang C, 2006, P NATL ACAD SCI USA, V103, P6647, DOI 10.1073/pnas.0601951103; WANG IN, 1993, P NATL ACAD SCI USA, V90, P3840, DOI 10.1073/pnas.90.9.3840; Whatmore AM, 2001, MICROBIOL-UK, V147, P419, DOI 10.1099/00221287-147-2-419; Xiao CA, 2005, J MOL BIOL, V353, P493, DOI 10.1016/j.jmb.2005.08.060; Yau S, 2011, P NATL ACAD SCI USA, V108, P6163, DOI 10.1073/pnas.1018221108; Zhang QY, 2004, J VIROL, V78, P6982, DOI 10.1128/JVI.78.13.6982-6994.2004	48	26	29	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2011	286	51					43701	43709		10.1074/jbc.M111.309096	http://dx.doi.org/10.1074/jbc.M111.309096			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866SH	22045808	hybrid, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000298402300013
J	Wang, Y; Keck, ZY; Saha, A; Xia, JM; Conrad, F; Lou, JL; Eckart, M; Marks, JD; Foung, SKH				Wang, Yong; Keck, Zhen-yong; Saha, Anasuya; Xia, Jinming; Conrad, Fraser; Lou, Jianlong; Eckart, Michael; Marks, James D.; Foung, Steven K. H.			Affinity Maturation to Improve Human Monoclonal Antibody Neutralization Potency and Breadth against Hepatitis C Virus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST SURFACE DISPLAY; B TYPE-I; LIVER-TRANSPLANTATION; SCAVENGER RECEPTOR; E2 GLYCOPROTEIN; CELL ENTRY; CONFORMATIONAL EPITOPES; MOLECULAR EVOLUTION; ROBUST PRODUCTION; GRAFT-SURVIVAL	A potent neutralizing antibody to a conserved hepatitis C virus (HCV) epitope might overcome its extreme variability, allowing immunotherapy. The human monoclonal antibody HC-1 recognizes a conformational epitope on the HCV E2 glycoprotein. Previous studies showed that HC-1 neutralizes most HCV genotypes but has modest potency. To improve neutralization, we affinity-matured HC-1 by constructing a library of yeast-displayed HC-1 single chain Fv (scFv) mutants, using for selection an E2 antigen from one of the poorly neutralized HCVpp. We developed an approach by parallel mutagenesis of the heavy chain variable (VH) and k-chain variable (Vk) genes separately, then combining the optimized VH and Vk mutants. This resulted in the generation of HC-1-related scFv variants exhibiting improved affinities. The best scFv variant had a 92-fold improved affinity. After conversion to IgG(1), some of the antibodies exhibited a 30-fold improvement in neutralization activity. Both surface plasmon resonance and solution kinetic exclusion analysis showed that the increase in affinity was largely due to a lowering of the dissociation rate constant, K-off. Neutralization against a panel of HCV pseudoparticles and infectious 2a HCV virus improved with the affinity-matured IgG1 antibodies. Interestingly, some of these antibodies neutralized a viral isolate that was not neutralized by wild-type HC-1. Moreover, propagating 2a HCVcc under the selective pressure of WT HC-1 or affinity-matured HC-1 antibodies yielded no viral escape mutants and, with the affinity-matured IgG1, needed 100-fold less antibody to achieve complete virus elimination. Taken together, these findings suggest that affinity-matured HC-1 antibodies are excellent candidates for therapeutic development.	[Foung, Steven K. H.] Stanford Univ, Sch Med, Dept Pathol, Stanford Blood Ctr, Palo Alto, CA 94304 USA; [Conrad, Fraser; Lou, Jianlong; Marks, James D.] Univ Calif San Francisco, Dept Anesthesia, San Francisco, CA 94110 USA; [Eckart, Michael] Stanford Univ, Sch Med, Prot & Nucle Acid Facil, Stanford, CA 94305 USA	Stanford University; University of California System; University of California San Francisco; Stanford University	Foung, SKH (corresponding author), Stanford Univ, Sch Med, Dept Pathol, Stanford Blood Ctr, 3373 Hillview Ave, Palo Alto, CA 94304 USA.	sfoung@stanford.edu		Foung, Steven/0000-0001-7149-6160	USPHS [HL079381, AI081903]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079381] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI081903] Funding Source: NIH RePORTER	USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by USPHS Grants HL079381 and AI081903 (to S. K. H. F.).	Bartosch B, 2003, J BIOL CHEM, V278, P41624, DOI 10.1074/jbc.M305289200; Biggins Scott W, 2005, Clin Liver Dis, V9, P505, DOI 10.1016/j.cld.2005.05.004; Boder ET, 2000, P NATL ACAD SCI USA, V97, P10701, DOI 10.1073/pnas.170297297; Boder ET, 1997, NAT BIOTECHNOL, V15, P553, DOI 10.1038/nbt0697-553; Bradbury ARM, 2004, J IMMUNOL METHODS, V290, P29, DOI 10.1016/j.jim.2004.04.007; BUKH J, 1995, SEMIN LIVER DIS, V15, P41, DOI 10.1055/s-2007-1007262; Cai ZH, 2005, J VIROL, V79, P13963, DOI 10.1128/JVI.79.22.13963-13973.2005; Chao G, 2006, NAT PROTOC, V1, P755, DOI 10.1038/nprot.2006.94; Charlton M, 2004, LIVER TRANSPLANT, V10, P1120, DOI 10.1002/lt.20211; Charlton M, 1998, HEPATOLOGY, V28, P823, DOI 10.1002/hep.510280333; Delgrange D, 2007, J GEN VIROL, V88, P2495, DOI 10.1099/vir.0.82872-0; FARCI P, 1994, P NATL ACAD SCI USA, V91, P7792, DOI 10.1073/pnas.91.16.7792; Feldhaus Michael, 2004, Methods Mol Biol, V263, P311; Flint M, 2000, J VIROL, V74, P702, DOI 10.1128/JVI.74.2.702-709.2000; FOUNG S, 2011, 18 S HEP C VIR REL V; Gottwein JM, 2009, HEPATOLOGY, V49, P364, DOI 10.1002/hep.22673; Gustchina E, 2009, VIROLOGY, V393, P112, DOI 10.1016/j.virol.2009.07.019; Hadlock KG, 2000, J VIROL, V74, P10407, DOI 10.1128/JVI.74.22.10407-10416.2000; Hsu M, 2003, P NATL ACAD SCI USA, V100, P7271, DOI 10.1073/pnas.0832180100; Johansson DX, 2007, P NATL ACAD SCI USA, V104, P16269, DOI 10.1073/pnas.0705522104; Keck ZY, 2008, J VIROL, V82, P6061, DOI 10.1128/JVI.02475-07; Keck ZY, 2008, J VIROL, V82, P6067, DOI 10.1128/JVI.00252-08; Keck ZY, 2007, J VIROL, V81, P1043, DOI 10.1128/JVI.01710-06; Keck ZY, 2011, J VIROL, V85, P10451, DOI 10.1128/JVI.05259-11; Keck ZY, 2009, J VIROL, V83, P6149, DOI 10.1128/JVI.00248-09; Keck ZY, 2005, J VIROL, V79, P13199, DOI 10.1128/JVI.79.21.13199-13208.2005; Keck ZY, 2004, J VIROL, V78, P9224, DOI 10.1128/JVI.78.17.9224-9232.2004; Law M, 2008, NAT MED, V14, P25, DOI 10.1038/nm1698; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; MARTELL M, 1994, J VIROL, V68, P3425, DOI 10.1128/JVI.68.5.3425-3436.1994; Michalak JP, 1997, J GEN VIROL, V78, P2299, DOI 10.1099/0022-1317-78-9-2299; Miller Keith D, 2008, Curr Protoc Cytom, VChapter 4, DOI 10.1002/0471142956.cy0407s45; Neumann AU, 1998, SCIENCE, V282, P103, DOI 10.1126/science.282.5386.103; Owsianka AM, 2008, J GEN VIROL, V89, P653, DOI 10.1099/vir.0.83386-0; Owsianka AM, 2006, J VIROL, V80, P8695, DOI 10.1128/JVI.00271-06; Pawlotsky Jean-Michel, 2011, Gastroenterology, V140, P746, DOI 10.1053/j.gastro.2011.01.028; Perotti M, 2008, J VIROL, V82, P1047, DOI 10.1128/JVI.01986-07; Razai A, 2005, J MOL BIOL, V351, P158, DOI 10.1016/j.jmb.2005.06.003; Samuel D, 2003, GASTROENTEROLOGY, V124, P642, DOI 10.1053/gast.2003.50095; Scarselli E, 2002, EMBO J, V21, P5017, DOI 10.1093/emboj/cdf529; Schier R, 1996, J MOL BIOL, V263, P551, DOI 10.1006/jmbi.1996.0598; SELBY MJ, 1994, VIROLOGY, V204, P114, DOI 10.1006/viro.1994.1515; SHIMIZU YK, 1994, J VIROL, V68, P1494, DOI 10.1128/JVI.68.3.1494-1500.1994; Simmonds P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/hep.20819; Smith K, 2009, NAT PROTOC, V4, P372, DOI 10.1038/nprot.2009.3; Tan YJ, 2003, VIROLOGY, V308, P250, DOI 10.1016/S0042-6822(02)00136-8; Veldt BJ, 2008, AM J TRANSPLANT, V8, P2426, DOI 10.1111/j.1600-6143.2008.02362.x; Verna Elizabeth C, 2006, Clin Liver Dis, V10, P919; Von Hahn T, 2007, GASTROENTEROLOGY, V132, P667, DOI 10.1053/j.gastro.2006.12.008; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102	50	26	28	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2011	286	51					44218	44233		10.1074/jbc.M111.290783	http://dx.doi.org/10.1074/jbc.M111.290783			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866SH	22002064	hybrid, Green Published			2022-12-27	WOS:000298402300062
J	Hensel, A; Beck, S; El Magraoui, F; Platta, HW; Girzalsky, W; Erdmann, R				Hensel, Astrid; Beck, Sabrina; El Magraoui, Fouzi; Platta, Harald W.; Girzalsky, Wolfgang; Erdmann, Ralf			Cysteine-dependent Ubiquitination of Pex18p Is Linked to Cargo Translocation across the Peroxisomal Membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMPORT RECEPTOR PEX5P; MATRIX PROTEIN IMPORT; YEAST SACCHAROMYCES-CEREVISIAE; SIGNAL TYPE-1 RECEPTOR; PTS1 RECEPTOR; CONSERVED CYSTEINE; TRANSPORT; MACHINERY; MECHANISM; BIOGENESIS	The peroxisomal matrix protein import is facilitated by cycling receptor molecules that shuttle between the cytosol and the peroxisomal membrane. In the yeast Saccharomyces cerevisiae, the import of proteins harboring a peroxisomal targeting signal of type II (PTS2) is mediated by the receptor Pex7p and its co-receptor Pex18p. Here we demonstrate that Pex18p undergoes two kinds of ubiquitin modifications. One of these ubiquitination events depends on lysines 13 and 20 and forces rapid Pex18p turnover by proteasomal degradation. A cysteine residue near the extreme Pex18p amino-terminus is required for the second type of ubiquitination. It turned out that this cysteine residue at position 6 is essential for the function of Pex18p in peroxisomal protein import but does not contribute to receptor-cargo association and binding to the peroxisomal import apparatus. However, in contrast to the wild-type protein, cysteine 6-mutated Pex18p is arrested in a membrane-protected state, whereas Pex7p is accessible in a protease protection assay. This finding indicates that Pex18p export is linked to cargo translocation, which supports the idea of an export-driven import of proteins into peroxisomes.	[Hensel, Astrid; Beck, Sabrina; El Magraoui, Fouzi; Platta, Harald W.; Girzalsky, Wolfgang; Erdmann, Ralf] Ruhr Univ Bochum, Inst Physiol Chem, Abt Syst Biochem, Fak Med, D-44780 Bochum, Germany	Ruhr University Bochum	Erdmann, R (corresponding author), Ruhr Univ Bochum, Inst Physiol Chem, Abt Syst Biochem, Fak Med, Univ Str 150, D-44780 Bochum, Germany.	Ralf.Erdmann@rub.de	Platta, Harald Wolfgang/G-7423-2014	Platta, Harald Wolfgang/0000-0001-8968-7280; Astrid, Hensel/0000-0002-0793-0249	Deutsche Forschungsgemeinschaft [SFB642]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant SFB642.	Agne B, 2003, MOL CELL, V11, P635, DOI 10.1016/S1097-2765(03)00062-5; Albertini M, 1997, CELL, V89, P83, DOI 10.1016/S0092-8674(00)80185-3; Albertini M, 2001, EUR J CELL BIOL, V80, P257, DOI 10.1078/0171-9335-00164; Ausubel FM, 1992, CURRENT PROTOCOLS MO; BIGL M, 1994, BIOL CHEM H-S, V375, P153, DOI 10.1515/bchm3.1994.375.3.153; Borodovsky A, 2001, EMBO J, V20, P5187, DOI 10.1093/emboj/20.18.5187; Brocard C, 1997, EMBO J, V16, P5491, DOI 10.1093/emboj/16.18.5491; Brown LA, 2008, MOL MEMBR BIOL, V25, P363, DOI 10.1080/09687680802130583; Carvalho AF, 2007, BBA-MOL CELL RES, V1773, P1141, DOI 10.1016/j.bbamcr.2007.04.011; Dammai V, 2001, CELL, V105, P187, DOI 10.1016/S0092-8674(01)00310-5; Debelyy MO, 2011, J BIOL CHEM, V286, P28223, DOI 10.1074/jbc.M111.238600; Dodt G, 1996, J CELL BIOL, V135, P1763, DOI 10.1083/jcb.135.6.1763; ELLISON MJ, 1991, J BIOL CHEM, V266, P21150; ENTIAN KD, 1988, FEBS LETT, V236, P195, DOI 10.1016/0014-5793(88)80313-2; ERDMANN R, 1989, P NATL ACAD SCI USA, V86, P5419, DOI 10.1073/pnas.86.14.5419; Erdmann R, 2005, NAT REV MOL CELL BIO, V6, P738, DOI 10.1038/nrm1710; FROHLICH KU, 1995, BBA-PROTEIN STRUCT M, V1253, P25, DOI 10.1016/0167-4838(95)00136-I; Fujiki Y, 2006, BBA-MOL CELL RES, V1763, P1639, DOI 10.1016/j.bbamcr.2006.08.030; GHISLAIN M, 1993, NATURE, V366, P358, DOI 10.1038/366358a0; Girzalsky W, 1999, J CELL BIOL, V144, P1151, DOI 10.1083/jcb.144.6.1151; Girzalsky W, 2006, J BIOL CHEM, V281, P19417, DOI 10.1074/jbc.M603344200; Girzalsky W, 2009, BIOL CHEM, V390, P745, DOI 10.1515/BC.2009.104; Grou CP, 2009, J BIOL CHEM, V284, P10504, DOI 10.1074/jbc.M808978200; Grunau S, 2009, TRAFFIC, V10, P451, DOI [10.1111/j.1600-0854.2009.00876.x, 10.1111/j.1600-0854.2008.00876.x]; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; Halbach A, 2009, J BIOL CHEM, V284, P3906, DOI 10.1074/jbc.M806950200; Harlow E., 1988, ANTIBODIES LAB MANUA; Hazra PP, 2002, TRAFFIC, V3, P560, DOI 10.1034/j.1600-0854.2002.30806.x; Kiel JAKW, 2005, BBA-MOL CELL RES, V1745, P176, DOI 10.1016/j.bbamcr.2005.01.004; Kiel JAKW, 2005, J BIOL CHEM, V280, P1921, DOI 10.1074/jbc.M403632200; Kiel JAKW, 2006, TRAFFIC, V7, P1291, DOI 10.1111/j.1600-0854.2006.00479.x; Klein ATJ, 2002, J BIOL CHEM, V277, P25011, DOI 10.1074/jbc.M203254200; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Kragt A, 2005, J BIOL CHEM, V280, P7867, DOI 10.1074/jbc.M413553200; Lanyon-Hogg T, 2010, BIOL CELL, V102, P245, DOI 10.1042/BC20090159; LAZAROW PB, 1985, ANNU REV CELL BIOL, V1, P489, DOI 10.1146/annurev.cb.01.110185.002421; Leon S, 2006, J CELL BIOL, V172, P67, DOI 10.1083/jcb.200508096; Leon S, 2007, J BIOL CHEM, V282, P7424, DOI 10.1074/jbc.M611627200; Leon S, 2006, BBA-MOL CELL RES, V1763, P1552, DOI 10.1016/j.bbamcr.2006.08.037; MARZIOCH M, 1994, EMBO J, V13, P4908, DOI 10.1002/j.1460-2075.1994.tb06818.x; Meinecke M, 2010, NAT CELL BIOL, V12, P273, DOI 10.1038/ncb2027; Miyata N, 2005, MOL CELL BIOL, V25, P10822, DOI 10.1128/MCB.25.24.10822-10832.2005; Nair DM, 2004, J CELL BIOL, V167, P599, DOI 10.1083/jcb.200407119; OBRIG TG, 1971, J BIOL CHEM, V246, P174; Okumoto K, 2011, TRAFFIC, V12, P1067, DOI 10.1111/j.1600-0854.2011.01217.x; Platta H, 2004, BIOCHEM J, V384, P37, DOI 10.1042/BJ20040572; Platta HW, 2007, J CELL BIOL, V177, P197, DOI 10.1083/jcb.200611012; Platta HW, 2009, MOL CELL BIOL, V29, P5505, DOI 10.1128/MCB.00388-09; Platta HW, 2005, NAT CELL BIOL, V7, P817, DOI 10.1038/ncb1281; Purdue PE, 2001, J BIOL CHEM, V276, P47684, DOI 10.1074/jbc.M106823200; Purdue PE, 1998, J CELL BIOL, V143, P1859; Rehling P, 2000, J BIOL CHEM, V275, P3593, DOI 10.1074/jbc.275.5.3593; Rehling P, 1996, EMBO J, V15, P2901, DOI 10.1002/j.1460-2075.1996.tb00653.x; Schafer A, 2004, MOL CELL BIOL, V24, P8895, DOI 10.1128/MCB.24.20.8895-8906.2004; Schliebs W, 2006, BBA-MOL CELL RES, V1763, P1605, DOI 10.1016/j.bbamcr.2006.08.051; Schliebs W, 2010, NAT REV MOL CELL BIO, V11, P885, DOI 10.1038/nrm3008; SIKORSKI RS, 1989, GENETICS, V122, P19; Smith JJ, 2001, J BIOL CHEM, V276, P1618, DOI 10.1074/jbc.M005072200; Stein K, 2002, MOL CELL BIOL, V22, P6056, DOI 10.1128/MCB.22.17.6056-6069.2002; Wang DY, 2003, J BIOL CHEM, V278, P43340, DOI 10.1074/jbc.M307789200; WIEBEL FF, 1992, NATURE, V359, P73, DOI 10.1038/359073a0; Williams C, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702038200; ZHANG JW, 1995, J CELL BIOL, V129, P65, DOI 10.1083/jcb.129.1.65	63	58	60	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					43495	43505		10.1074/jbc.M111.286104	http://dx.doi.org/10.1074/jbc.M111.286104			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22021076	Green Published, hybrid			2022-12-27	WOS:000298351300069
J	Tsai, AL; Berka, V; Sharina, I; Martin, E				Tsai, Ah-Lim; Berka, Vladimir; Sharina, Iraida; Martin, Emil			Dynamic Ligand Exchange in Soluble Guanylyl Cyclase (sGC) IMPLICATIONS FOR sGC REGULATION AND DESENSITIZATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE RECEPTOR; S-NITROSYLATION; CARBON-MONOXIDE; NITRATE TOLERANCE; NO ACTIVATION; HEME; CELLS; SENSOR; NITROGLYCERIN; DISSOCIATION	Accumulating evidence indicates that the functional properties of soluble guanylyl cyclase (sGC) are affected not only by the binding of NO but also by the NO:sGC ratio and a number of cellular factors, including GTP. In this study, we monitored the time-resolved transformations of sGC and sGC-NO complexes generated with stoichiometric or excess NO in the presence and absence of GTP. We demonstrate that the initial five-coordinate sGC-NO complex is highly activated by stoichiometric NO but is unstable and transforms into a five-coordinate sGC-2 state. This sGC-2 rebinds NO to form a low activity sGC-NO complex. The stability of the initial complex is greatly enhanced by GTP binding, binding of an additional NO molecule, or substitution of beta His-107. We propose that the transient nature of the sGC-NO complex, the formation of a desensitized sGC-2 state, and its transformation into a low activity sGC-NO adduct require beta His-107. We conclude that conformational changes leading to sGC desensitization may be prevented by GTP binding to the catalytic site or by binding of an additional NO molecule to the proximal side of the heme. The implications of these observations for cellular NO/cGMP signaling and the process of rapid desensitization of sGC are discussed in the context of the proposed model of sGC/NO interactions and dynamic transformations.	[Tsai, Ah-Lim; Berka, Vladimir] Univ Texas Hlth Sci Ctr Houston, Sch Med, Dept Internal Med, Div Hematol, Houston, TX 77030 USA; [Sharina, Iraida; Martin, Emil] Univ Texas Hlth Sci Ctr Houston, Sch Med, Dept Internal Med, Div Cardiol, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston	Tsai, AL (corresponding author), Univ Texas Med Sch Houston, Dept Internal Med, Div Hematol, Houston, TX 77030 USA.	ah-lim.tsai@uth.tmc.edu; emil.martin@uth.tmc.edu	Sharina, Iraida/C-9888-2014	Martin, Emil/0000-0002-9094-4165	National Institutes of Health [HL088128, HL088128S, HL095820]; American Heart Association, South Central Affiliate [09GRNT2060182]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095820, F32HL008812, R01HL088128] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association, South Central Affiliate(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL088128 and HL088128S (to E. M.) and HL095820 (to A.-L. T.) from NHLBI. This work was also supported by Grant-in-aid 09GRNT2060182 from the American Heart Association, South Central Affiliate (to E. M.).	Baskaran P, 2011, BIOCHEMISTRY-US, V50, P4291, DOI 10.1021/bi2004087; Batchelor AM, 2010, P NATL ACAD SCI USA, V107, P22060, DOI 10.1073/pnas.1013147107; Bellamy TC, 2000, P NATL ACAD SCI USA, V97, P2928, DOI 10.1073/pnas.97.6.2928; Bellamy TC, 2002, P NATL ACAD SCI USA, V99, P507, DOI 10.1073/pnas.012368499; Bellamy TC, 2001, J BIOL CHEM, V276, P4287, DOI 10.1074/jbc.M006677200; Boon EM, 2005, CURR OPIN CHEM BIOL, V9, P441, DOI 10.1016/j.cbpa.2005.08.015; Brandish PE, 1998, BIOCHEMISTRY-US, V37, P16898, DOI 10.1021/bi9814989; Cary SPL, 2006, TRENDS BIOCHEM SCI, V31, P231, DOI 10.1016/j.tibs.2006.02.003; Cary SPL, 2005, P NATL ACAD SCI USA, V102, P13064, DOI 10.1073/pnas.0506289102; Chen KJ, 2006, FREE RADICAL BIO MED, V41, P668, DOI 10.1016/j.freeradbiomed.2006.05.009; Davis JP, 1997, BIOCHEM BIOPH RES CO, V238, P351, DOI 10.1006/bbrc.1997.7278; Davis KL, 2001, ANNU REV PHARMACOL, V41, P203, DOI 10.1146/annurev.pharmtox.41.1.203; Derbyshire ER, 2008, BIOCHEMISTRY-US, V47, P3892, DOI 10.1021/bi7022943; Derbyshire ER, 2009, BIOCHEMISTRY-US, V48, P7519, DOI 10.1021/bi900696x; Derbyshire Emily R., 2009, V191, P17, DOI 10.1007/978-3-540-68964-5_2; FEELISCH M, 1987, EUR J PHARMACOL, V139, P19, DOI 10.1016/0014-2999(87)90493-6; Fernhoff NB, 2009, P NATL ACAD SCI USA, V106, P21602, DOI 10.1073/pnas.0911083106; Hall CN, 2009, NITRIC OXIDE-BIOL CH, V21, P92, DOI 10.1016/j.niox.2009.07.002; Halvey EJ, 2009, J BIOL CHEM, V284, P25630, DOI 10.1074/jbc.M109.030338; Handy DE, 2006, ARTERIOSCL THROM VAS, V26, P1207, DOI 10.1161/01.ATV.0000217632.98717.a0; HATAKEYAMA K, 1992, J BIOL CHEM, V267, P20734; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Ibrahim M, 2010, BIOCHEMISTRY-US, V49, P4864, DOI 10.1021/bi100506j; KAMISAKI Y, 1986, J BIOL CHEM, V261, P7236; Karow DS, 2004, BIOCHEMISTRY-US, V43, P10203, DOI 10.1021/bi049374l; Kharitonov VG, 1997, BIOCHEMISTRY-US, V36, P6814, DOI 10.1021/bi970201o; Kharitonov VG, 1997, BIOCHEM BIOPH RES CO, V239, P284, DOI 10.1006/bbrc.1997.7470; Kurokawa H, 2004, J BIOL CHEM, V279, P20186, DOI 10.1074/jbc.M314199200; Lanzilotta WN, 2000, NAT STRUCT BIOL, V7, P876; Lawson DM, 2000, EMBO J, V19, P5661, DOI 10.1093/emboj/19.21.5661; Ma XL, 2007, EMBO J, V26, P578, DOI 10.1038/sj.emboj.7601521; Makino R, 1999, J BIOL CHEM, V274, P7714, DOI 10.1074/jbc.274.12.7714; Makino R, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.177576; Marti MA, 2005, J AM CHEM SOC, V127, P7721, DOI 10.1021/ja042870c; Martin E, 2005, METHOD ENZYMOL, V396, P478, DOI 10.1016/S0076-6879(05)96040-0; Martin E, 2003, P NATL ACAD SCI USA, V100, P9208, DOI 10.1073/pnas.1633590100; Martin E, 2001, P NATL ACAD SCI USA, V98, P12938, DOI 10.1073/pnas.231486198; Martin E, 2006, J BIOL CHEM, V281, P27836, DOI 10.1074/jbc.M601078200; Marvin KA, 2008, BIOCHEMISTRY-US, V47, P9016, DOI 10.1021/bi800486x; Mayer B, 2009, MOL PHARMACOL, V75, P886, DOI 10.1124/mol.108.052142; Meurer S, 2009, CIRC RES, V105, P33, DOI 10.1161/CIRCRESAHA.109.198234; Moncada S., 2006, V176, P213; MULSCH A, 1988, EUR J PHARMACOL, V158, P191, DOI 10.1016/0014-2999(88)90066-0; Nioche P, 2004, SCIENCE, V306, P1550, DOI 10.1126/science.1103596; OTERO AD, 1990, BIOCHEM PHARMACOL, V39, P1399; Russwurm M, 2004, EMBO J, V23, P4443, DOI 10.1038/sj.emboj.7600422; Russwurm M, 2002, J BIOL CHEM, V277, P24883, DOI 10.1074/jbc.M110570200; Sato M, 2006, ANAL CHEM, V78, P8175, DOI 10.1021/ac061791b; Sayed N, 2008, CIRC RES, V103, P606, DOI 10.1161/CIRCRESAHA.108.175133; Sayed N, 2007, P NATL ACAD SCI USA, V104, P12312, DOI 10.1073/pnas.0703944104; Schmidt P, 2003, EUR J PHARMACOL, V468, P167, DOI 10.1016/S0014-2999(03)01674-1; Shelver D, 1999, BIOCHEMISTRY-US, V38, P2669, DOI 10.1021/bi982658j; Stasch JP, 2006, J CLIN INVEST, V116, P2552, DOI 10.1172/JCI28371; STONE JR, 1994, BIOCHEMISTRY-US, V33, P5636, DOI 10.1021/bi00184a036; Vogel KM, 1999, J BIOL INORG CHEM, V4, P804, DOI 10.1007/s007750050354; WALDMAN SA, 1986, BIOCHEM PHARMACOL, V35, P3525, DOI 10.1016/0006-2952(86)90622-2; Zhao Y, 1999, P NATL ACAD SCI USA, V96, P14753, DOI 10.1073/pnas.96.26.14753; Zhou ZM, 2008, ARTERIOSCL THROM VAS, V28, P1803, DOI 10.1161/ATVBAHA.108.165043	58	44	45	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					43182	43192		10.1074/jbc.M111.290304	http://dx.doi.org/10.1074/jbc.M111.290304			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22009742	Green Published, hybrid			2022-12-27	WOS:000298351300039
J	Honaker, MT; Acchione, M; Sumida, JP; Atkins, WM				Honaker, Matthew T.; Acchione, Mauro; Sumida, John P.; Atkins, William M.			Ensemble Perspective for Catalytic Promiscuity CALORIMETRIC ANALYSIS OF THE ACTIVE SITE CONFORMATIONAL LANDSCAPE OF A DETOXIFICATION ENZYME	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUTATHIONE-S-TRANSFERASE; DIFFERENTIAL SCANNING CALORIMETRY; C-TERMINAL REGION; LIPID-PEROXIDATION; CRYSTAL-STRUCTURES; SUBSTRATE PROMISCUITY; ENZYME EVOLUTION; A1-1; BINDING; EFFICIENCY	Enzymological paradigms have shifted recently to acknowledge the biological importance of catalytic promiscuity. However, catalytic promiscuity is a poorly understood property, and no thermodynamic treatment has described the conformational landscape of promiscuous versus substrate-specific enzymes. Here, two structurally similar glutathione transferase (GST, glutathione S-transferase) isoforms with high specificity or high promiscuity are compared. Differential scanning calorimetry (DSC) indicates a reversible low temperature transition for the promiscuous GSTA1-1 that is not observed with substrate-specific GSTA4-4. This transition is assigned to rearrangement of the C terminus at the active site of GSTA1-1 based on the effects of ligands and mutations. Near-UV and far-UV circular dichroism indicate that this transition is due to repacking of tertiary contacts with the remainder of the subunit, rather than "unfolding" of the C terminus per se. Analysis of the DSC data using a modified Landau theory indicates that the local conformational landscape of the active site of GSTA1-1 is smooth, with barrier-less transitions between states. The partition function of the C-terminal states is a broad unimodal distribution at all temperatures within this DSC transition. In contrast, the remainder of the GSTA1-1 subunit and the GSTA4-4 protein exhibit folded and unfolded macrostates with a significant energy barrier separating them. Their partition function includes a sharp unimodal distribution of states only at temperatures that yield either folded or unfolded macrostates. At intermediate temperatures the partition function includes a bimodal distribution. The barrierless rearrangement of the GSTA1-1 active site within a local smooth energy landscape suggests a thermodynamic basis for catalytic promiscuity.	[Honaker, Matthew T.; Acchione, Mauro; Sumida, John P.; Atkins, William M.] Univ Washington, Dept Med Chem, Seattle, WA 98177 USA	University of Washington; University of Washington Seattle	Atkins, WM (corresponding author), Univ Washington, Dept Med Chem, Box 357610, Seattle, WA 98177 USA.	winky@uw.edu			National Institutes of Health [GM862284]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grant GM862284 (to W.M.A.).	Adman ET, 2001, PROTEINS, V42, P192, DOI 10.1002/1097-0134(20010201)42:2<192::AID-PROT60>3.0.CO;2-#; Anzenbacher P, 2001, J INORG BIOCHEM, V87, P209, DOI 10.1016/S0162-0134(01)00389-0; Balchin D, 2010, BBA-PROTEINS PROTEOM, V1804, P2228, DOI 10.1016/j.bbapap.2010.09.003; Balogh LM, 2008, J BIOL CHEM, V283, P16702, DOI 10.1074/jbc.M801725200; Benkovic SJ, 2003, SCIENCE, V301, P1196, DOI 10.1126/science.1085515; Blikstad C, 2008, BBA-GEN SUBJECTS, V1780, P1458, DOI 10.1016/j.bbagen.2008.07.007; Bruns CM, 1999, J MOL BIOL, V288, P427, DOI 10.1006/jmbi.1999.2697; CAMERON AD, 1995, STRUCTURE, V3, P717, DOI 10.1016/S0969-2126(01)00206-4; Copley SD, 2003, CURR OPIN CHEM BIOL, V7, P265, DOI 10.1016/S1367-5931(03)00032-2; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Dietze EC, 1998, BIOCHEMISTRY-US, V37, P14948, DOI 10.1021/bi981284r; Dietze EC, 1996, BIOCHEMISTRY-US, V35, P6745, DOI 10.1021/bi9530346; DIRR H, 1994, EUR J BIOCHEM, V220, P645, DOI 10.1111/j.1432-1033.1994.tb18666.x; Dirr HW, 2005, J BIOL CHEM, V280, P19480, DOI 10.1074/jbc.M413608200; Ekins S, 2004, DRUG DISCOV TODAY, V9, P276, DOI 10.1016/S1359-6446(03)03008-3; Ekroos M, 2006, P NATL ACAD SCI USA, V103, P13682, DOI 10.1073/pnas.0603236103; Foti RS, 2011, BIOCHEMISTRY-US, V50, P2387, DOI 10.1021/bi1020716; Freire E, 1995, Methods Mol Biol, V40, P191; Grahn E, 2006, ACTA CRYSTALLOGR D, V62, P197, DOI 10.1107/S0907444905039296; Griswold KE, 2006, J MOL BIOL, V364, P400, DOI 10.1016/j.jmb.2006.09.012; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; Hou L, 2007, J BIOL CHEM, V282, P23264, DOI 10.1074/jbc.M700868200; Hubatsch I, 1998, BIOCHEM J, V330, P175, DOI 10.1042/bj3300175; Ibarra C, 2001, BIOCHEMISTRY-US, V40, P10614, DOI 10.1021/bi010672h; James LC, 2003, SCIENCE, V299, P1362, DOI 10.1126/science.1079731; James LC, 2003, TRENDS BIOCHEM SCI, V28, P361, DOI 10.1016/S0968-0004(03)00135-X; James LC, 2001, PROTEIN SCI, V10, P2600, DOI 10.1110/ps.ps.14601; Keskin O, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-31; Khersonsky O, 2010, ANNU REV BIOCHEM, V79, P471, DOI 10.1146/annurev-biochem-030409-143718; Kuhnert DC, 2005, J MOL BIOL, V349, P825, DOI 10.1016/j.jmb.2005.04.025; Mannervik B, 2009, BIOCHEM SOC T, V37, P740, DOI 10.1042/BST0370740; Meier S, 2007, BIOESSAYS, V29, P1095, DOI 10.1002/bies.20661; MEYER DJ, 1994, FEBS LETT, V351, P427, DOI 10.1016/0014-5793(94)00904-X; Munoz V, 2004, P NATL ACAD SCI USA, V101, P17646, DOI 10.1073/pnas.0405829101; Naganathan AN, 2005, J AM CHEM SOC, V127, P17970, DOI 10.1021/ja055996y; Nath A, 2008, BIOCHEMISTRY-US, V47, P157, DOI 10.1021/bi701448p; Nieslanik BS, 1999, BIOCHEMISTRY-US, V38, P6971, DOI 10.1021/bi9829130; Nieslanik BS, 2001, BIOCHEMISTRY-US, V40, P3536, DOI 10.1021/bi001869x; Nieslanik BS, 2000, J BIOL CHEM, V275, P17447, DOI 10.1074/jbc.M002083200; Nilsson LO, 2000, P NATL ACAD SCI USA, V97, P9408, DOI 10.1073/pnas.150084897; O'Brien PJ, 1999, CHEM BIOL, V6, pR91, DOI 10.1016/S1074-5521(99)80033-7; Patil A, 2010, INT J MOL SCI, V11, P1930, DOI 10.3390/ijms11041930; Schreiber G, 2011, CURR OPIN STRUC BIOL, V21, P50, DOI 10.1016/j.sbi.2010.10.002; Seidegard J, 1997, ENVIRON HEALTH PERSP, V105, P791, DOI 10.2307/3433285; Sethi DK, 2006, IMMUNITY, V24, P429, DOI 10.1016/j.immuni.2006.02.010; Thorolfsson M, 2002, BIOCHEMISTRY-US, V41, P7573, DOI 10.1021/bi0160720; Tokuriki N, 2009, SCIENCE, V324, P203, DOI 10.1126/science.1169375; Wallace LA, 2000, BBA-PROTEIN STRUCT M, V1478, P325, DOI 10.1016/S0167-4838(00)00023-6; Zhan YP, 2004, BIOCHEMISTRY-US, V43, P7244, DOI 10.1021/bi0363329; ZHANG YS, 1995, BIOCHEM BIOPH RES CO, V206, P748, DOI 10.1006/bbrc.1995.1106; Zimmermann J, 2006, P NATL ACAD SCI USA, V103, P13722, DOI 10.1073/pnas.0603282103	52	21	21	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42770	42776		10.1074/jbc.M111.304386	http://dx.doi.org/10.1074/jbc.M111.304386			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	22002059	Green Published, hybrid			2022-12-27	WOS:000298180900083
J	Geula, S; Naveed, H; Liang, J; Shoshan-Barmatz, V				Geula, Shay; Naveed, Hammad; Liang, Jie; Shoshan-Barmatz, Varda			Structure-based Analysis of VDAC1 Protein DEFINING OLIGOMER CONTACT SITES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT ANION CHANNEL; MITOCHONDRIAL OUTER-MEMBRANE; PEPTIDE-SPECIFIC ANTIBODIES; CYTOCHROME-C RELEASE; CELL-DEATH; SELECTIVE CHANNEL; NEUROSPORA-CRASSA; CRYSTAL-STRUCTURE; APOPTOSIS; TOPOLOGY	The outer mitochondrial membrane protein, the voltage-dependent anion channel (VDAC), is increasingly implicated in the control of apoptosis. Oligomeric assembly of VDAC1 was shown to be coupled to apoptosis induction, with oligomerization increasing substantially upon apoptosis induction and inhibited by apoptosis blockers. In this study, structure-and computation-based selection of the predicated VDAC1 dimerization site, in combination with site-directed mutagenesis, cysteine replacement, and chemical cross-linking, were employed to identify contact sites between VDAC1 molecules in dimers and higher oligomers. The predicted weakly stable beta-strands were experimentally found to represent the interfaces between VDAC1 monomers composing the oligomer. Replacing hydrophobic amino acids with charged residues in beta-strands 1, 2, and 19 interfered with VDAC1 oligomerization. The proximity of beta-strands 1, 2, and 19 within the VDAC1 dimer and the existence of other association sites involving beta-strand 16 were confirmed when a cysteine was introduced at defined positions in cysteineless VDAC1 mutants, together with the use of cysteine-specific cross-linker bis(maleimido) ethane. Moreover, the results suggest that VDAC1 also exists as a dimer that upon apoptosis induction undergoes conformational changes and that its oligomerization proceeds through a series of interactions involving two distinct interfaces. Dissection of VDAC1 dimerization/oligomerization as presented here provides structural insight into the oligomeric status of cellular VDAC1 under physiological and apoptotic conditions.	[Geula, Shay; Shoshan-Barmatz, Varda] Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel; [Geula, Shay; Shoshan-Barmatz, Varda] Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, IL-84105 Beer Sheva, Israel; [Naveed, Hammad; Liang, Jie] Univ Illinois, Dept Bioengn, Chicago, IL 60607 USA	Ben Gurion University; Ben Gurion University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Shoshan-Barmatz, V (corresponding author), Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel.	vardasb@bgu.ac.il	Naveed, Hammad/N-8851-2013; Geula, Shay Yosef/Z-3789-2019	Geula, Shay Yosef/0000-0001-8111-4410	Israel Science Foundation [649/09]; Div Of Biological Infrastructure [1062328] Funding Source: National Science Foundation	Israel Science Foundation(Israel Science Foundation); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by Israel Science Foundation Grant 649/09.	Abu-Hamad S, 2006, P NATL ACAD SCI USA, V103, P5787, DOI 10.1073/pnas.0600103103; Abu-Hamad S, 2009, J CELL SCI, V122, P1906, DOI 10.1242/jcs.040188; Adamian L, 2011, BBA-BIOMEMBRANES, V1808, P1092, DOI 10.1016/j.bbamem.2010.12.008; Aram L, 2010, BIOCHEM J, V427, P445, DOI 10.1042/BJ20091690; Bayrhuber M, 2008, P NATL ACAD SCI USA, V105, P15370, DOI 10.1073/pnas.0808115105; Colombini M, 2004, MOL CELL BIOCHEM, V256, P107, DOI 10.1023/B:MCBI.0000009862.17396.8d; Colombini M, 2009, TRENDS BIOCHEM SCI, V34, P382, DOI 10.1016/j.tibs.2009.05.001; DEPINTO V, 1991, BIOCHEMISTRY-US, V30, P10191, DOI 10.1021/bi00106a017; Ferguson AD, 1998, SCIENCE, V282, P2215, DOI 10.1126/science.282.5397.2215; Gogvadze V, 2006, BBA-BIOENERGETICS, V1757, P639, DOI 10.1016/j.bbabio.2006.03.016; Goncalves RP, 2007, J MOL BIOL, V369, P413, DOI 10.1016/j.jmb.2007.03.063; Granville DJ, 2003, CURR MED CHEM, V10, P1527, DOI 10.2174/0929867033457214; GUO XW, 1995, J STRUCT BIOL, V114, P41, DOI 10.1006/jsbi.1995.1004; Hiller S, 2008, SCIENCE, V321, P1206, DOI 10.1126/science.1161302; Hoogenboom BW, 2007, J MOL BIOL, V370, P246, DOI 10.1016/j.jmb.2007.04.073; Jimenez-Morales D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026400; Keinan N, 2010, MOL CELL BIOL, V30, P5698, DOI 10.1128/MCB.00165-10; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lemasters JJ, 2006, BBA-MOL BASIS DIS, V1762, P181, DOI 10.1016/j.bbadis.2005.10.006; Malia TJ, 2007, BIOCHEMISTRY-US, V46, P514, DOI 10.1021/bi061577h; MANNELLA CA, 1983, P NATL ACAD SCI-BIOL, V80, P2243, DOI 10.1073/pnas.80.8.2243; Naveed H, 2009, P NATL ACAD SCI USA, V106, P12735, DOI 10.1073/pnas.0902169106; Pedersen PL, 2008, J BIOENERG BIOMEMBR, V40, P123, DOI 10.1007/s10863-008-9165-7; Saks V, 2010, BBA-BIOENERGETICS, V1797, P678, DOI 10.1016/j.bbabio.2010.01.011; Shimizu S, 2000, J BIOL CHEM, V275, P12321, DOI 10.1074/jbc.275.16.12321; Shoshan-Barmatz V, 2006, CURR PHARM DESIGN, V12, P2249, DOI 10.2174/138161206777585111; Shoshan-Barmatz V, 2010, BBA-BIOENERGETICS, V1797, P1281, DOI 10.1016/j.bbabio.2010.03.003; Shoshan-Barmatz V, 2010, MOL ASPECTS MED, V31, P227, DOI 10.1016/j.mam.2010.03.002; Shoshan-Barmatz V, 2009, BBA-BIOENERGETICS, V1787, P421, DOI 10.1016/j.bbabio.2008.11.009; STANLEY S, 1995, J BIOL CHEM, V270, P16694, DOI 10.1074/jbc.270.28.16694; THOMAS L, 1993, P NATL ACAD SCI USA, V90, P5446, DOI 10.1073/pnas.90.12.5446; Tsujimoto Y, 2002, BIOCHIMIE, V84, P187, DOI 10.1016/S0300-9084(02)01370-6; Ujwal R, 2009, CHANNELS, V3, P167, DOI 10.4161/chan.3.3.9196; Ujwal R, 2008, P NATL ACAD SCI USA, V105, P17742, DOI 10.1073/pnas.0809634105; Walther DM, 2010, MOL BIOL EVOL, V27, P887, DOI 10.1093/molbev/msp294; Walther DM, 2009, P NATL ACAD SCI USA, V106, P2531, DOI 10.1073/pnas.0807830106; Zaid H, 2005, CELL DEATH DIFFER, V12, P751, DOI 10.1038/sj.cdd.4401599; Zalk R, 2005, BIOCHEM J, V386, P73, DOI 10.1042/BJ20041356	38	54	55	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2012	287	3					2179	2190		10.1074/jbc.M111.268920	http://dx.doi.org/10.1074/jbc.M111.268920			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879HT	22117062	Green Published, hybrid			2022-12-27	WOS:000299321000057
J	Paul, G; Marchelletta, RR; McCole, DF; Barrett, KE				Paul, Gisela; Marchelletta, Ronald R.; McCole, Declan F.; Barrett, Kim E.			Interferon-gamma Alters Downstream Signaling Originating from Epidermal Growth Factor Receptor in Intestinal Epithelial Cells FUNCTIONAL CONSEQUENCES FOR ION TRANSPORT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFLAMMATORY-BOWEL-DISEASE; SULFATE-INDUCED COLITIS; PROTEIN-TYROSINE PHOSPHATASES; STIMULATED CHLORIDE SECRETION; CA2+-DEPENDENT K+ CHANNEL; TRANSFORMING-GROWTH; CL-SECRETION; INCREASED SUSCEPTIBILITY; EGF RECEPTOR; FACTOR-ALPHA	The epidermal growth factor receptor (EGFr) regulates many cellular functions, such as proliferation, apoptosis, and ion transport. Our aim was to investigate whether long term treatment with interferon-gamma (IFN-gamma) modulates EGF activation of downstream signaling pathways in intestinal epithelial cells and if this contributes to dysregulation of epithelial ion transport in inflammation. Polarized monolayers of T-84 and HT29/cl. 19A colonocytes were preincubated with IFN-gamma prior to stimulation with EGF. Basolateral potassium transport was studied in Ussing chambers. We also studied inflamed colonic mucosae from C57BL/6 mice treated with dextran sulfate sodium or mdr1a knock-out mice and controls. IFN-gamma increased intestinal epithelial EGFr expression without increasing its phosphorylation. Conversely, IFN-gamma caused a significant decrease in EGF-stimulated phosphorylation of specific EGFr tyrosine residues and activation of ERK but not Akt-1. In IFN gamma -pretreated cells, the inhibitory effect of EGF on carbachol-stimulated K+ channel activity was lost. In inflamed colonic tissues, EGFr expression was significantly increased, whereas ERK phosphorylation was reduced. Thus, although it up-regulates EGFr expression, IFN-gamma causes defective EGFr activation in colonic epithelial cells via reduced phosphorylation of specific EGFr tyrosine residues. This probably accounts for altered downstream signaling consequences. These observations were corroborated in the setting of colitis. IFN-gamma also abrogates the ability of EGF to inhibit carbachol-stimulated basolateral K+ currents. Our data suggest that, in the setting of inflammation, the biological effect of EGF, including the inhibitory effect of EGF on Ca2+-dependent ion transport, is altered, perhaps contributing to diarrheal and other symptoms in vivo.	[Barrett, Kim E.] Univ Calif San Diego, Dept Med, Div Gastroenterol, Sch Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Barrett, KE (corresponding author), Univ Calif San Diego, Dept Med, Div Gastroenterol, Sch Med, 9500 Gilman Dr 0063, La Jolla, CA 92093 USA.	kbarrett@ucsd.edu	Barrett, Kim/AAE-2794-2022; Barrett, Kim Elaine/AAE-7762-2019; McCole, Declan/AAL-2454-2020	Barrett, Kim Elaine/0000-0002-6704-998X; 	National Institutes of Health [T32 DK007202]; Shape-Up settlement fund; UCSD Digestive Diseases Research Development Center (National Institutes of Health) [DK080506]; German Research Foundation (Deutsche Forschungsgemeinschaft); Crohn's and Colitis Foundation of America; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK080506, T32DK007202] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shape-Up settlement fund; UCSD Digestive Diseases Research Development Center (National Institutes of Health); German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); Crohn's and Colitis Foundation of America; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Training Grant T32 DK007202 (to R. R. M.). This work was also supported by an unrestricted grant from the Shape-Up settlement fund (to K. E. B.), the UCSD Digestive Diseases Research Development Center (National Institutes of Health Grant DK080506), a grant from the German Research Foundation (Deutsche Forschungsgemeinschaft) (to G. P.), and a Crohn's and Colitis Foundation of America Senior Research Award (to D. F. M.).	AUGERON C, 1984, CANCER RES, V44, P3961; Barrett KE, 1998, AM J PHYSIOL-CELL PH, V274, pC958, DOI 10.1152/ajpcell.1998.274.4.C958; Bertelsen LS, 2004, J BIOL CHEM, V279, P6271, DOI 10.1074/jbc.M311612200; Bouma G, 2003, NAT REV IMMUNOL, V3, P521, DOI 10.1038/nri1132; Bruewer M, 2006, ANN NY ACAD SCI, V1072, P242, DOI 10.1196/annals.1326.017; Burova E, 2007, FEBS LETT, V581, P1475, DOI 10.1016/j.febslet.2007.03.002; Chow JYC, 2000, J BIOL CHEM, V275, P21169, DOI 10.1074/jbc.M002160200; COLGAN SP, 1994, AM J PHYSIOL, V267, pC402, DOI 10.1152/ajpcell.1994.267.2.C402; Collett A, 2008, INFLAMM BOWEL DIS, V14, P620, DOI 10.1002/ibd.20375; Devor DC, 1997, AM J PHYSIOL-CELL PH, V272, pC976, DOI 10.1152/ajpcell.1997.272.3.C976; DeYulia GJ, 2005, BIOCHEM BIOPH RES CO, V334, P38, DOI 10.1016/j.bbrc.2005.06.056; Duvall MD, 1998, AM J PHYSIOL-CELL PH, V275, pC1313, DOI 10.1152/ajpcell.1998.275.5.C1313; Egan LJ, 2003, AM J PHYSIOL-CELL PH, V285, pC1028, DOI 10.1152/ajpcell.00167.2003; Egger B, 2000, SCAND J GASTROENTERO, V35, P1181; Egger B, 2000, DIGESTION, V62, P240, DOI 10.1159/000007822; Egger B, 1997, GASTROENTEROLOGY, V113, P825, DOI 10.1016/S0016-5085(97)70177-X; Egger B, 1998, GUT, V43, P64, DOI 10.1136/gut.43.1.64; Flores CA, 2007, J PHYSIOL-LONDON, V583, P705, DOI 10.1113/jphysiol.2007.134387; Frey MR, 2009, GASTROENTEROLOGY, V136, P217, DOI 10.1053/j.gastro.2008.09.023; Galietta LJV, 2000, AM J PHYSIOL-LUNG C, V278, pL1186, DOI 10.1152/ajplung.2000.278.6.L1186; Halm ST, 2006, AM J PHYSIOL-CELL PH, V291, pC636, DOI 10.1152/ajpcell.00557.2005; HAMBURGER AW, 1991, BRIT J CANCER, V64, P64, DOI 10.1038/bjc.1991.240; Hassan SW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008868; Heinonen KM, 2009, P NATL ACAD SCI USA, V106, P9368, DOI 10.1073/pnas.0812109106; Heitzmann D, 2008, PHYSIOL REV, V88, P1119, DOI 10.1152/physrev.00020.2007; Hoffmann P, 2000, SCAND J GASTROENTERO, V35, P1174; Hoque KM, 2005, AM J PHYSIOL-GASTR L, V288, pG956, DOI 10.1152/ajpgi.00441.2004; Ito R, 2006, CLIN EXP IMMUNOL, V146, P330, DOI 10.1111/j.1365-2249.2006.03214.x; Johnson HM, 2004, BIOESSAYS, V26, P993, DOI 10.1002/bies.20086; Keely SJ, 1998, J BIOL CHEM, V273, P27111, DOI 10.1074/jbc.273.42.27111; Keely SJ, 2000, J BIOL CHEM, V275, P12619, DOI 10.1074/jbc.275.17.12619; Keely SJ, 1999, J BIOL CHEM, V274, P33449, DOI 10.1074/jbc.274.47.33449; Masunaga Y, 2007, INFLAMM RES, V56, P439, DOI 10.1007/s00011-007-6078-6; McCole DF, 2007, J BIOL CHEM, V282, P13303, DOI 10.1074/jbc.M700424200; McCole DF, 2005, GASTROENTEROLOGY, V129, P591, DOI 10.1053/j.gastro.2005.06.004; McCole DF, 2002, J BIOL CHEM, V277, P42603, DOI 10.1074/jbc.M206487200; Myhre GM, 2004, AM J PHYSIOL-GASTR L, V287, pG1213, DOI 10.1152/ajpgi.00149.2004; Nielsen MS, 1998, PFLUG ARCH EUR J PHY, V435, P267; Obermeier F, 1999, CLIN EXP IMMUNOL, V116, P238; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; PROCACCINO F, 1994, GASTROENTEROLOGY, V107, P12, DOI 10.1016/0016-5085(94)90055-8; SASAKI T, 1992, GASTROENTEROL JPN, V27, P29; Scharl M, 2009, GASTROENTEROLOGY, V137, P2030, DOI 10.1053/j.gastro.2009.07.078; Scharl M, 2009, J BIOL CHEM, V284, P27952, DOI 10.1074/jbc.M109.046292; Schultheiss G, 1997, BRIT J PHARMACOL, V122, P87, DOI 10.1038/sj.bjp.0701353; Silva MA, 2009, INFLAMM BOWEL DIS, V15, P436, DOI 10.1002/ibd.20660; Sinha A, 2003, NEW ENGL J MED, V349, P350, DOI 10.1056/NEJMoa013136; SOTTILI M, 1995, GASTROENTEROLOGY, V109, P24, DOI 10.1016/0016-5085(95)90265-1; Staley EM, 2009, INFLAMM BOWEL DIS, V15, P684, DOI 10.1002/ibd.20824; Sugi K, 2001, GASTROENTEROLOGY, V120, P1393, DOI 10.1053/gast.2001.24045; Thongon N, 2009, AM J PHYSIOL-CELL PH, V296, pC1373, DOI 10.1152/ajpcell.00053.2009; Tonks NK, 2003, FEBS LETT, V546, P140, DOI 10.1016/S0014-5793(03)00603-3; Trzcinski R, 2004, Acta Chir Iugosl, V51, P85; Uribe JM, 1996, AM J PHYSIOL-CELL PH, V271, pC914, DOI 10.1152/ajpcell.1996.271.3.C914; Uribe JM, 2002, AM J PHYSIOL-GASTR L, V283, pG923, DOI 10.1152/ajpgi.00237.2002; Wang DF, 1997, IN VIVO, V11, P141; Wang FJ, 2006, GASTROENTEROLOGY, V131, P1153, DOI 10.1053/j.gastro.2006.08.022; WEYMER A, 1985, J CLIN INVEST, V76, P1828, DOI 10.1172/JCI112175	58	23	23	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2012	287	3					2144	2155		10.1074/jbc.M111.318139	http://dx.doi.org/10.1074/jbc.M111.318139			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879HT	22069319	hybrid, Green Published			2022-12-27	WOS:000299321000054
J	Cash, JN; Angerman, EB; Kattamuri, C; Nolan, K; Zhao, HY; Sidis, Y; Keutmann, HT; Thompson, TB				Cash, Jennifer N.; Angerman, Elizabeth B.; Kattamuri, Chandramohan; Nolan, Kristof; Zhao, Huaying; Sidis, Yisrael; Keutmann, Henry T.; Thompson, Thomas B.			Structure of Myostatin.Follistatin-like 3 N-TERMINAL DOMAINS OF FOLLISTATIN-TYPE MOLECULES EXHIBIT ALTERNATE MODES OF BINDING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MASS-TRANSPORT LIMITATION; SKELETAL-MUSCLE MASS; TGF-BETA; ACTIVIN-BINDING; SURFACE BINDING; MACROMOLECULAR STRUCTURES; BIOLOGICAL-ACTIVITY; THERAPEUTIC TARGET; CRYSTAL-STRUCTURE; GDF-8 PROPEPTIDE	TGF-beta family ligands are involved in a variety of critical physiological processes. For instance, the TGF-beta ligand myostatin is a staunch negative regulator of muscle growth and a therapeutic target for muscle-wasting disorders. Therefore, it is important to understand the molecular mechanisms of TGF-beta family regulation. One form of regulation is through inhibition by extracellular antagonists such as the follistatin (Fst)-type proteins. Myostatin is tightly controlled by Fst-like 3 (Fstl3), which is the only Fst-type molecule that has been identified in the serum bound to myostatin. Here, we present the crystal structure of myostatin in complex with Fstl3. The structure reveals that the N-terminal domain (ND) of Fstl3 interacts uniquely with myostatin as compared with activin A, because it utilizes different surfaces on the ligand. This results in conformational differences in the ND of Fstl3 that alter its position in the type I receptor-binding site of the ligand. We also show that single point mutations in the ND of Fstl3 are detrimental to ligand binding, whereas corresponding mutations in Fst have little effect. Overall, we have shown that the NDs of Fst-type molecules exhibit distinctive modes of ligand binding, which may affect overall affinity of ligand.Fst-type protein complexes.	[Cash, Jennifer N.; Angerman, Elizabeth B.; Kattamuri, Chandramohan; Nolan, Kristof; Thompson, Thomas B.] Univ Cincinnati, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA; [Zhao, Huaying] NIBIB, Lab Cellular Imaging & Mol Biophys, NIH, Bethesda, MD 20892 USA; [Sidis, Yisrael] CHU Vaudois, Dept Endocrinol Diabet & Metab, CH-1011 Lausanne, Switzerland; [Keutmann, Henry T.] Massachusetts Gen Hosp, Reprod Endocrine Unit, Boston, MA 02114 USA	University System of Ohio; University of Cincinnati; National Institutes of Health (NIH) - USA; NIH National Institute of Biomedical Imaging & Bioengineering (NIBIB); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Harvard University; Massachusetts General Hospital	Thompson, TB (corresponding author), Univ Cincinnati, Dept Mol Genet Biochem & Microbiol, Med Sci Bldg,231 Albert Sabin Way, Cincinnati, OH 45267 USA.	thompstb@ucmail.uc.edu	Zhao, Huaying/F-5716-2012	Thompson, Thomas/0000-0002-7041-5047	National Institutes of Health [GM084186]; Muscular Dystrophy Association [93887]; NIBIB, National Institutes of Health; American Heart Association; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084186] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); NIBIB, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM084186 (to T. B. T.). This work was also supported by Muscular Dystrophy Association Grant 93887 (to T. B. T.) and the Intramural Research Program of the NIBIB, National Institutes of Health.; Supported by an American Heart Association predoctoral fellowship.	Benfield CTO, 2011, J BIOL CHEM, V286, P20727, DOI 10.1074/jbc.M111.231381; Bradley L, 2008, CELL MOL LIFE SCI, V65, P2119, DOI 10.1007/s00018-008-8077-3; Cash JN, 2009, EMBO J, V28, P2662, DOI 10.1038/emboj.2009.205; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W, 2002, PYMOL 0 99; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Greenwald J, 2004, MOL CELL, V15, P485, DOI 10.1016/j.molcel.2004.07.011; Harrington AE, 2006, EMBO J, V25, P1035, DOI 10.1038/sj.emboj.7601000; Harrison CA, 2006, ENDOCRINOLOGY, V147, P2744, DOI 10.1210/en.2006-0131; Hart PJ, 2002, NAT STRUCT BIOL, V9, P203, DOI 10.1038/nsb766; Hayette S, 1998, ONCOGENE, V16, P2949, DOI 10.1038/sj.onc.1201807; Hill JJ, 2002, J BIOL CHEM, V277, P40735, DOI 10.1074/jbc.M206379200; Innis CA, 2000, PROTEIN ENG, V13, P839, DOI 10.1093/protein/13.12.839; INOUYE S, 1992, MOL CELL ENDOCRINOL, V90, P1, DOI 10.1016/0303-7207(92)90094-M; Jiang MS, 2004, BIOCHEM BIOPH RES CO, V315, P525, DOI 10.1016/j.bbrc.2004.01.085; Keller S, 2004, NAT STRUCT MOL BIOL, V11, P481, DOI 10.1038/nsmb756; Keutmann HT, 2004, MOL ENDOCRINOL, V18, P228, DOI 10.1210/me.2003-0112; Korupolu RV, 2008, J BIOL CHEM, V283, P3782, DOI 10.1074/jbc.M704530200; Kotzsch A, 2009, EMBO J, V28, P937, DOI 10.1038/emboj.2009.37; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Lee Se-Jin, 2010, Immunology Endocrine & Metabolic Agents in Medicinal Chemistry, V10, P183; Lee SJ, 2004, ANNU REV CELL DEV BI, V20, P61, DOI 10.1146/annurev.cellbio.20.012103.135836; Lee SJ, 2001, P NATL ACAD SCI USA, V98, P9306, DOI 10.1073/pnas.151270098; Lerch TF, 2007, J BIOL CHEM, V282, P15930, DOI 10.1074/jbc.M700737200; MATZUK MM, 1995, NATURE, V374, P354, DOI 10.1038/374354a0; MATZUK MM, 1995, NATURE, V374, P360, DOI 10.1038/374360a0; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; Mukherjee A, 2007, P NATL ACAD SCI USA, V104, P1348, DOI 10.1073/pnas.0607966104; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakatani M, 2008, FASEB J, V22, P477, DOI 10.1096/fj.07-8673com; Nakatani M, 2011, AM J PHYSIOL-ENDOC M, V300, pE543, DOI 10.1152/ajpendo.00430.2010; Nickel J, 2005, J MOL BIOL, V349, P933, DOI 10.1016/j.jmb.2005.04.015; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Salerno WJ, 2004, NUCLEIC ACIDS RES, V32, pW566, DOI 10.1093/nar/gkh434; SCHNEYER AL, 1994, ENDOCRINOLOGY, V135, P667, DOI 10.1210/en.135.2.667; Schneyer AL, 2008, ENDOCRINOLOGY, V149, P4589, DOI 10.1210/en.2008-0259; Schuck P, 2010, METHODS MOL BIOL, V627, P15, DOI 10.1007/978-1-60761-670-2_2; Shimano M, 2011, J BIOL CHEM, V286, P9840, DOI 10.1074/jbc.M110.197079; Sidis Y, 2005, ENDOCRINOLOGY, V146, P130, DOI 10.1210/en.2004-1041; Sidis Y, 2001, J BIOL CHEM, V276, P17718, DOI 10.1074/jbc.M100736200; Sidis Y, 2006, ENDOCRINOLOGY, V147, P3586, DOI 10.1210/en.2006-0089; Stamler R, 2008, J BIOL CHEM, V283, P32831, DOI 10.1074/jbc.M801266200; Svitel J, 2003, BIOPHYS J, V84, P4062, DOI 10.1016/S0006-3495(03)75132-7; Svitel J, 2007, BIOPHYS J, V92, P1742, DOI 10.1529/biophysj.106.094615; Takehara-Kasamatsu Yuka, 2007, J Med Invest, V54, P276, DOI 10.2152/jmi.54.276; Thies RS, 2001, GROWTH FACTORS, V18, P251; Thompson TB, 2005, DEV CELL, V9, P535, DOI 10.1016/j.devcel.2005.09.008; Thompson TB, 2003, EMBO J, V22, P1555, DOI 10.1093/emboj/cdg156; Tsuchida K, 2008, ENDOCR J, V55, P11, DOI 10.1507/endocrj.KR-110; UENO N, 1987, P NATL ACAD SCI USA, V84, P8282, DOI 10.1073/pnas.84.23.8282; Xia Y, 2009, J ENDOCRINOL, V202, P1, DOI 10.1677/JOE-08-0549; Yang M, 2008, BIOCHEMISTRY-US, V47, P771, DOI 10.1021/bi701578m; Zhan HL, 2009, BIOCHEMISTRY-US, V48, P1305, DOI 10.1021/bi801357f; Zimmers TA, 2002, SCIENCE, V296, P1486, DOI 10.1126/science.1069525	56	61	66	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					1043	1053		10.1074/jbc.M111.270801	http://dx.doi.org/10.1074/jbc.M111.270801			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22052913	Green Published, hybrid			2022-12-27	WOS:000299170300021
J	Di Fulvio, M; Frondorf, K; Henkels, KM; Grunwald, WC; Cool, D; Gomez-Cambronero, J				Di Fulvio, Mauricio; Frondorf, Kathleen; Henkels, Karen M.; Grunwald, William C., Jr.; Cool, David; Gomez-Cambronero, Julian			Phospholipase D2 (PLD2) Shortens the Time Required for Myeloid Leukemic Cell Differentiation MECHANISM OF ACTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA EXPRESSION; TRANSCRIPTION FACTOR SP1; EARLY GROWTH RESPONSE-1; C-FES; HL-60 CELLS; HL60 CELLS; GRANULOCYTIC DIFFERENTIATION; TYROSINE KINASE; S6 KINASE; HUMAN NEUTROPHILS	Cell differentiation is compromised in acute leukemias. We report that mammalian target of rapamycin (mTOR) and S6 kinase (S6K) are highly expressed in the undifferentiated promyelomonocytic leukemic HL-60 cell line, whereas PLD2 expression is minimal. The expression ratio of PLD2 to mTOR (or to S6K) is gradually inverted upon in vitro induction of differentiation toward the neutrophilic phenotype. We present three ways that profoundly affect the kinetics of differentiation as follows: (i) simultaneous overexpression of mTOR (or S6K), (ii) silencing of mTOR via dsRNA-mediated interference or inhibition with rapamycin, and (iii) PLD2 overexpression. The last two methods shortened the time required for differentiation. By determining how PLD2 participates in cell differentiation, we found that PLD2 interacts with and activates the oncogene Fes/Fps, a protein-tyrosine kinase known to be involved in myeloid cell development. Fes activity is elevated with PLD2 overexpression, phosphatidic acid or phosphatidylinositol bisphosphate. Co-immunoprecipitation indicates a close PLD2-Fes physical interaction that is negated by a Fes-R483K mutant that incapacitates its Src homology 2 domain. All these suggest for the first time the following mechanism: mTOR/S6K down-regulation -> PLD2 overexpression -> PLD2/Fes association -> phosphatidic acid-led activation of Fes kinase -> granulocytic differentiation. Differentiation shortening could have a clinical impact on reducing the time of return to normalcy of the white cell counts after chemotherapy in patients with acute promyelocytic leukemia.	[Gomez-Cambronero, Julian] Wright State Univ, Dept Biochem & Mol Biol, Sch Med, Dayton, OH 45435 USA; [Grunwald, William C., Jr.; Cool, David] Wright State Univ, Dept Pharmacol & Toxicol, Sch Med, Dayton, OH 45435 USA	Wright State University Dayton; Wright State University Dayton	Gomez-Cambronero, J (corresponding author), Wright State Univ, Dept Biochem & Mol Biol, Sch Med, 3640 Colonel Glenn Highway, Dayton, OH 45435 USA.	julian.cambronero@wright.edu		Gomez-Cambronero, Julian/0000-0002-7581-9227	National Institutes of Health [HL056653]; Research Challenge (Ohio Board of Regents) [668372]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056653, R29HL056653] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Challenge (Ohio Board of Regents); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL056653 (to J. G.-C.). This work was also supported by Research Challenge 668372 (Ohio Board of Regents) (to J. G.-C.).	Abdel-Malak NA, 2009, ARTERIOSCL THROM VAS, V29, P209, DOI 10.1161/ATVBAHA.108.181073; Bajic VB, 2006, PLOS GENET, V2, P614, DOI 10.1371/journal.pgen.0020054; Bechoua S, 2001, J BIOL CHEM, V276, P31752, DOI 10.1074/jbc.M101265200; Bettoun DJ, 2004, J STEROID BIOCHEM, V89-90, P195, DOI 10.1016/j.jsbmb.2004.03.087; BIRNIE GD, 1988, BRIT J CANCER, V58, P41; BORELLINI F, 1990, MOL CELL BIOL, V10, P5541, DOI 10.1128/MCB.10.10.5541; Boyle KB, 2009, CELL DEATH DIFFER, V16, P782, DOI 10.1038/cdd.2009.11; Chen F, 2004, CANCER RES, V64, P5425, DOI 10.1158/0008-5472.CAN-04-0806; COLLINS SJ, 1987, BLOOD, V70, P1233; Di Fulvio M, 2006, ONCOGENE, V25, P3032, DOI 10.1038/sj.onc.1209340; Di Fulvio M, 2005, J LEUKOCYTE BIOL, V77, P999, DOI 10.1189/jlb.1104684; Di Fulvio M, 2008, CELL SIGNAL, V20, P176, DOI 10.1016/j.cellsig.2007.10.009; Dohna CLZ, 2000, FEBS LETT, V484, P77, DOI 10.1016/S0014-5793(00)02133-5; Dufner A, 1999, EXP CELL RES, V253, P100, DOI 10.1006/excr.1999.4683; El Marjou M, 2000, LEUKEMIA, V14, P2118; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; Fang YM, 2001, SCIENCE, V294, P1942, DOI 10.1126/science.1066015; FELDMAN RA, 1985, P NATL ACAD SCI USA, V82, P2379, DOI 10.1073/pnas.82.8.2379; Filippakopoulos P, 2008, CELL, V134, P793, DOI 10.1016/j.cell.2008.07.047; Foster DA, 2003, MOL CANCER RES, V1, P789; Foster DA, 2009, BBA-MOL CELL BIOL L, V1791, P949, DOI 10.1016/j.bbalip.2009.02.009; Greer P, 2002, NAT REV MOL CELL BIO, V3, P278, DOI 10.1038/nrm783; Guillemain I, 1998, BBA-MOL CELL RES, V1405, P161, DOI 10.1016/S0167-4889(98)00107-4; Hackenmiller R, 2002, DEV BIOL, V245, P255, DOI 10.1006/dbio.2002.0643; Haigh J, 1996, CELL GROWTH DIFFER, V7, P931; Ho J, 2003, CELL DEATH DIFFER, V10, P404, DOI 10.1038/sj.cdd.4401191; Horn JM, 2001, BBA-MOL CELL BIOL L, V1530, P97, DOI 10.1016/S1388-1981(00)00172-4; Horton LE, 2002, ONCOGENE, V21, P5325, DOI 10.1038/sj.onc.1205662; Itoh T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000393; Izuhara K, 1996, BLOOD, V88, P3910, DOI 10.1182/blood.V88.10.3910.bloodjournal88103910; JANICKBUCKNER D, 1991, FASEB J, V5, P320, DOI 10.1096/fasebj.5.3.2001792; Jiang H, 2001, J IMMUNOL, V166, P2627, DOI 10.4049/jimmunol.166.4.2627; KHARBANDA S, 1991, J CLIN INVEST, V88, P571, DOI 10.1172/JCI115341; Kim J, 2003, J BIOL CHEM, V278, P14978, DOI 10.1074/jbc.M212118200; Knoepp SM, 2008, MOL PHARMACOL, V74, P574, DOI 10.1124/mol.107.040105; Lee CS, 2009, BBA-MOL CELL BIOL L, V1791, P862, DOI 10.1016/j.bbalip.2009.04.007; Lehman N, 2007, FASEB J, V21, P1075, DOI 10.1096/fj.06-6652com; Lehman N, 2006, BLOOD, V108, P3564, DOI 10.1182/blood-2006-02-005959; Liu J, 2001, INT J ONCOL, V18, P863; MACDONALD I, 1985, MOL CELL BIOL, V5, P2543, DOI 10.1128/MCB.5.10.2543; Maianski NA, 2004, CELL DEATH DIFFER, V11, P143, DOI 10.1038/sj.cdd.4401320; MANFREDINI R, 1993, J EXP MED, V178, P381, DOI 10.1084/jem.178.2.381; Manfredini R, 1997, BLOOD, V89, P135, DOI 10.1182/blood.V89.1.135.135_135_145; Marin M, 1997, CELL, V89, P619, DOI 10.1016/S0092-8674(00)80243-3; MATSUHISA T, 1995, BLOOD CELL MOL DIS, V21, P42, DOI 10.1006/bcmd.1995.0007; McDermott M, 2004, BIOCHEM CELL BIOL, V82, P225, DOI 10.1139/o03-079; Meier KE, 1999, BBA-MOL CELL BIOL L, V1439, P199, DOI 10.1016/S1388-1981(99)00095-5; MEYER PA, 1990, ENVIRON HEALTH PERSP, V88, P179, DOI 10.2307/3431071; Nakamura M, 1998, J LEUKOCYTE BIOL, V63, P781, DOI 10.1002/jlb.63.6.781; Nakashima S, 1998, BBA-LIPID LIPID MET, V1389, P173, DOI 10.1016/S0005-2760(97)00153-7; NGUYEN HQ, 1993, CELL, V72, P197, DOI 10.1016/0092-8674(93)90660-I; Ohguchi K, 1999, BBA-MOL CELL BIOL L, V1439, P215, DOI 10.1016/S1388-1981(99)00096-7; Rao J, 1998, J CELL PHYSIOL, V175, P121, DOI 10.1002/(SICI)1097-4652(199805)175:2<121::AID-JCP1>3.0.CO;2-Q; Ravitz MJ, 2007, CANCER RES, V67, P11209, DOI 10.1158/0008-5472.CAN-06-4351; Redina OE, 1998, BIOCHEM J, V331, P845, DOI 10.1042/bj3310845; RYVES WJ, 1994, CARCINOGENESIS, V15, P2501, DOI 10.1093/carcin/15.11.2501; Sarker KP, 2004, ONCOGENE, V23, P6064, DOI 10.1038/sj.onc.1207819; Shmueli O, 2003, CR BIOL, V326, P1067, DOI 10.1016/j.crvi.2003.09.012; SMITHGALL TE, 1988, J BIOL CHEM, V263, P15050; SODDU S, 1994, BLOOD, V83, P2230, DOI 10.1182/blood.V83.8.2230.bloodjournal8382230; Song J, 1998, J BIOL CHEM, V273, P20603, DOI 10.1074/jbc.273.32.20603; Song J, 2003, INT J MOL MED, V11, P547; SONGYANG Z, 1994, MOL CELL BIOL, V14, P2777, DOI 10.1128/MCB.14.4.2777; Tabatabaian F, 2010, J BIOL CHEM, V285, P18991, DOI 10.1074/jbc.M110.111542; Tsolmon S, 2009, PLANTA MED, V75, P49, DOI 10.1055/s-0028-1088370; TSUCHIYA S, 1982, CANCER RES, V42, P1530; Van Raam BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002013; Voisset E, 2007, BLOOD, V110, P2593, DOI 10.1182/blood-2007-02-076471; Weis L, 1997, MOL CELL BIOL, V17, P2973, DOI 10.1128/MCB.17.6.2973; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yamada O, 2008, J LEUKOCYTE BIOL, V83, P1240, DOI 10.1189/jlb.1207848; Yates KE, 1996, STEM CELLS, V14, P117, DOI 10.1002/stem.140117; Yoshimura S, 1996, BIOCHEM BIOPH RES CO, V225, P494, DOI 10.1006/bbrc.1996.1201; YU G, 1989, J BIOL CHEM, V264, P10276	75	8	8	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					393	407		10.1074/jbc.M111.259465	http://dx.doi.org/10.1074/jbc.M111.259465			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22094461	hybrid, Green Published			2022-12-27	WOS:000298682400038
J	Porotto, M; Palmer, SG; Palermo, LM; Moscona, A				Porotto, Matteo; Palmer, Samantha G.; Palermo, Laura M.; Moscona, Anne			Mechanism of Fusion Triggering by Human Parainfluenza Virus Type III COMMUNICATION BETWEEN VIRAL GLYCOPROTEINS DURING ENTRY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLUORESCENCE COMPLEMENTATION ANALYSIS; HEMAGGLUTININ-NEURAMINIDASE PROTEIN; RECEPTOR-BINDING; PARAMYXOVIRUS FUSION; MEMBRANE-FUSION; MEASLES-VIRUS; CELL-FUSION; HN PROTEIN; F-PROTEIN; N-GLYCANS	Parainfluenza viruses enter host cells by fusing the viral and target cell membranes via concerted action of their two envelope glycoproteins: the hemagglutinin-neuraminidase (HN) and the fusion protein (F). Receptor-bound HN triggers F to undergo conformational changes that render it fusion-competent. To address the role of receptor engagement and to elucidate how HN and F interact during the fusion process, we used bimolecular fluorescence complementation to follow the dynamics of human parainfluenza virus type 3 (HPIV3) HN/F pairs in living cells. We show that HN and F associate before receptor engagement. HN drives the formation of HN-F clusters at the site of fusion, and alterations in HN-F interaction determine the fusogenicity of the glycoprotein pair. An interactive site, at the HN dimer interface modulates HN fusion activation property, which is critical for infection of the natural host. This first evidence for the sequence of initial events that lead to viral entry may indicate a new paradigm for understanding Paramyxovirus infection.	[Moscona, Anne] Cornell Univ, Weill Med Coll, Dept Pediat, New York, NY 10021 USA; Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10021 USA	Cornell University; Cornell University	Moscona, A (corresponding author), Cornell Univ, Weill Med Coll, Dept Pediat, 515 E 71st St,Box 309, New York, NY 10021 USA.	anm2047@med.cornell.edu		POROTTO, Matteo/0000-0003-3866-9220	National Institutes of Health [R01AI31971, 3R01AI031971-19S1, U54AI057158, P41 RR001081]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001081] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI031971, U54AI057158] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants R01AI31971 (to A. M.), 3R01AI031971-19S1 (Research Supplement to Promote Diversity in Health-Related Research Program; to A. M.), and U54AI057158 (Northeast Center of Excellence for Biodefense and Emerging Infectious Disease Research (NIAID; to M. P. and A. M. (Principal Investigator of Center of Excellence grant to W. I. Lipkin)).; We are grateful to Ashton Kutcher and Jonathan Ledecky for support without which the microscopy critical to this work would not have been possible, to Dan and Nancy Paduano for their essential support of innovative research projects, and to the Friedman Family Foundation for our laboratories at Weill Cornell Medical College. We thank Tim McGraw for helpful scientific discussions and advice, Eric M. Jurgens for help with statistical analysis, and Christine C. Yokoyama for critical reading of the manuscript. Molecular graphics images were produced using the UCSF Chimera package from the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco (supported by National Institutes of Health Grant P41 RR001081). We acknowledge the Northeast Center of Excellence for Bio-defense and Emerging Infections Disease Research Proteomics Core for peptide synthesis and purification.	Aguilar HC, 2006, J VIROL, V80, P4878, DOI 10.1128/JVI.80.10.4878-4889.2006; Atanasiu D, 2007, P NATL ACAD SCI USA, V104, P18718, DOI 10.1073/pnas.0707452104; Bishop KA, 2008, J VIROL, V82, P11398, DOI 10.1128/JVI.02654-07; Bishop KA, 2007, J VIROL, V81, P5893, DOI 10.1128/JVI.02022-06; Brindley MA, 2010, J VIROL, V84, P12174, DOI 10.1128/JVI.01222-10; Connolly SA, 2009, J VIROL, V83, P10857, DOI 10.1128/JVI.01191-09; Corey EA, 2007, J VIROL, V81, P9900, DOI 10.1128/JVI.00909-07; Dutch RE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000881; Farnsworth A, 2007, P NATL ACAD SCI USA, V104, P10187, DOI 10.1073/pnas.0703790104; Farzan SF, 2011, J BIOL CHEM, V286, P37945, DOI 10.1074/jbc.M111.256248; Greengard O, 2000, J VIROL, V74, P11108, DOI 10.1128/JVI.74.23.11108-11114.2000; Guo YJ, 2005, J BIOL CHEM, V280, P1438, DOI 10.1074/jbc.M407593200; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; Hernandez LD, 1996, ANNU REV CELL DEV BI, V12, P627, DOI 10.1146/annurev.cellbio.12.1.627; Hu CD, 2003, NAT BIOTECHNOL, V21, P539, DOI 10.1038/nbt816; Iorio RM, 2009, FUTURE VIROL, V4, P335, DOI 10.2217/FVL.09.17; Kerppola TK, 2006, NAT REV MOL CELL BIO, V7, P449, DOI 10.1038/nrm1929; Lamb RA, 2006, VIROLOGY, V344, P30, DOI 10.1016/j.virol.2005.09.007; Lawrence MC, 2004, J MOL BIOL, V335, P1343, DOI 10.1016/j.jmb.2003.11.032; Lee B, 2011, TRENDS MICROBIOL, V19, P389, DOI 10.1016/j.tim.2011.03.005; Li JR, 2004, J VIROL, V78, P5299, DOI 10.1128/JVI.78.10.5299-5310.2004; Lin HP, 2010, BIOL CELL, V102, P525, DOI 10.1042/BC20100033; Lucic V, 2005, STRUCTURE, V13, P423, DOI 10.1016/j.str.2005.02.005; Lucic V, 2005, ANNU REV BIOCHEM, V74, P833, DOI 10.1146/annurev.biochem.73.011303.074112; Mahon PJ, 2008, J VIROL, V82, P10386, DOI 10.1128/JVI.00581-08; Mahon PJ, 2011, J VIROL, V85, P12079, DOI 10.1128/JVI.05679-11; Maurer UE, 2008, P NATL ACAD SCI USA, V105, P10559, DOI 10.1073/pnas.0801674105; MCKIMMBRESCHKIN JL, 1990, J IMMUNOL METHODS, V135, P277, DOI 10.1016/0022-1759(90)90282-Z; Melanson VR, 2006, J VIROL, V80, P623, DOI 10.1128/JVI.80.2.623-633.2006; Melanson VR, 2004, J VIROL, V78, P13053, DOI 10.1128/JVI.78.23.13053-13061.2004; Moscona A, 2005, J CLIN INVEST, V115, P1688, DOI 10.1172/JCI25669; MOSCONA A, 1993, J VIROL, V67, P6463, DOI 10.1128/JVI.67.11.6463-6468.1993; Ottmann C, 2009, BIOL CHEM, V390, P81, DOI 10.1515/BC.2009.008; Palermo LM, 2007, J VIROL, V81, P9152, DOI 10.1128/JVI.00888-07; Palermo LM, 2009, J VIROL, V83, P6900, DOI 10.1128/JVI.00475-09; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Plemper RK, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002058; Plemper RK, 2002, J VIROL, V76, P5051, DOI 10.1128/JVI.76.10.5051-5061.2002; Popa A, 2011, BIOCHEMISTRY-US, V50, P945, DOI 10.1021/bi101597k; Porotto M, 2004, J VIROL, V78, P13911, DOI 10.1128/JVI.78.24.13911-13919.2004; Porotto M, 2007, J VIROL, V81, P3216, DOI 10.1128/JVI.02617-06; Porotto M, 2011, J VIROL, V85, P12867, DOI 10.1128/JVI.05873-11; Porotto M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001168; Rekas A, 2002, J BIOL CHEM, V277, P50573, DOI 10.1074/jbc.M209524200; Robach JG, 2010, VIROLOGY, V406, P189, DOI 10.1016/j.virol.2010.06.049; Rose RH, 2010, BRIT J PHARMACOL, V159, P738, DOI 10.1111/j.1476-5381.2009.00480.x; Saphire EO, 2011, NAT STRUCT MOL BIOL, V18, P115, DOI 10.1038/nsmb0211-115; SCHEID A, 1974, VIROLOGY, V57, P475, DOI 10.1016/0042-6822(74)90187-1; Smith EC, 2009, FEBS J, V276, P7217, DOI 10.1111/j.1742-4658.2009.07401.x; Vigant Frederic, 2011, Infectious Disorders - Drug Targets, V11, P315; Yuan P, 2005, STRUCTURE, V13, P803, DOI 10.1016/j.str.2005.02.019; Yuan P, 2011, P NATL ACAD SCI USA, V108, P14920, DOI 10.1073/pnas.1111691108; Zaitsev V, 2004, J VIROL, V78, P3733, DOI 10.1128/JVI.78.7.3733-3741.2004	53	54	59	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					778	793		10.1074/jbc.M111.298059	http://dx.doi.org/10.1074/jbc.M111.298059			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22110138	Green Published, hybrid			2022-12-27	WOS:000298682400075
J	Kozel, BA; Knutsen, RH; Ye, L; Ciliberto, CH; Broekelmann, TJ; Mecham, RP				Kozel, Beth A.; Knutsen, Russell H.; Ye, Li; Ciliberto, Christopher H.; Broekelmann, Thomas J.; Mecham, Robert P.			Genetic Modifiers of Cardiovascular Phenotype Caused by Elastin Haploinsufficiency Act by Extrinsic Noncomplementation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUPRAVALVULAR AORTIC-STENOSIS; QUANTITATIVE TRAIT LOCI; WILLIAMS-SYNDROME; BLOOD-PRESSURE; ARTERIAL STIFFNESS; NITRIC-OXIDE; MOUSE MODEL; DISEASE; MICE; HYPERTENSION	Elastin haploinsufficiency causes the cardiovascular complications associated with Williams-Beuren syndrome and isolated supravalvular aortic stenosis. Significant variability exists in the vascular pathology in these individuals. Using the Eln(+/-) mouse, we sought to identify the source of this variability. Following outcrossing of C57Bl/6J Eln(+/-), two backgrounds were identified whose cardiovascular parameters deviated significantly from the parental strain. F1 progeny of the C57Bl/6J; Eln(+/-)x129X1/SvJ were more hypertensive and their arteries less compliant. In contrast, Eln+/- animals crossed to DBA/2J were protected from the pathologic changes associated with elastin insufficiency. Among the crosses, aortic elastin and collagen content did not correlate with quantitative vasculopathy traits. Quantitative trait locus analysis performed on F2 C57; Eln(+/-)x129 intercrosses identified highly significant peaks on chromosome 1 (LOD 9.7) for systolic blood pressure and on chromosome 9 (LOD 8.7) for aortic diameter. Additional peaks were identified that affect only Eln(+/-), including a region upstream of Eln on chromosome 5 (LOD 4.5). Bioinformatic analysis of the quantitative trait locus peaks revealed several interesting candidates, including Ren1, Ncf1, and Nos1; genes whose functions are unrelated to elastic fiber assembly, but whose effects may synergize with elastin insufficiency to predispose to hypertension and stiffer blood vessels. Real time RTPCR studies show background-specific increased expression of Ncf1 (a subunit of the NOX2 NAPDH oxidase) that parallel the presence of increased oxidative stress in Eln(+/-) aortas. This finding raises the possibility that polymorphisms in genes affecting the generation of reactive oxygen species alter cardiovascular function in individuals with elastin haploinsufficiency through extrinsic noncomplementation.	[Kozel, Beth A.; Ye, Li] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Knutsen, Russell H.; Ciliberto, Christopher H.; Broekelmann, Thomas J.; Mecham, Robert P.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Kozel, BA (corresponding author), Washington Univ, Sch Med, Dept Pediat, Campus Box 8116,660 S Euclid, St Louis, MO 63110 USA.	Kozel_B@kids.wustl.edu	Kozel, Beth/AAP-9177-2020	Kozel, Beth/0000-0002-9757-7118	National Institutes of Health [T32 HD043010, K12 HL089968, K08 HL109076, HL074138, HL105314, HL53325]; Children's Discovery Institute at Washington University;  [K12-HD01487]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD043010] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K12HD001487] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K12HL089968, K08HL109076, R01HL105314, R01HL074138, R37HL053325, R01HL053325] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Discovery Institute at Washington University; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants T32 HD043010, K12 HL089968, and K08 HL109076 (to B. A. K.) and HL074138, HL105314, and HL53325 (to R. P. M.) and a grant from the Children's Discovery Institute at Washington University (to B. A. K.).; Scholar of the Child Health Research Center of Excellence in Developmental Biology at Washington University School of Medicine supported by Grant K12-HD01487.	Aggoun Y, 2000, HEART, V84, P290, DOI 10.1136/heart.84.3.290; Al Ghouleh I, 2011, FREE RADICAL BIO MED, V51, P1271, DOI 10.1016/j.freeradbiomed.2011.06.011; Bassareo PP, 2010, BLOOD PRESS MONIT, V15, P257, DOI 10.1097/MBP.0b013e32833e4f7d; Broder K, 1999, AM J MED GENET, V83, P356, DOI 10.1002/(SICI)1096-8628(19990423)83:5<356::AID-AJMG2>3.0.CO;2-X; Brooke BS, 2008, NEW ENGL J MED, V358, P2787, DOI 10.1056/NEJMoa0706585; BROWNAUGSBURGER P, 1995, J BIOL CHEM, V270, P17778, DOI 10.1074/jbc.270.30.17778; Cai Hua, 2007, V139, P293; Capettini LSA, 2010, EUR J PHARMACOL, V643, P260, DOI 10.1016/j.ejphar.2010.06.066; CHIARELLA F, 1989, Giornale Italiano di Cardiologia, V19, P497; CLEARY EG, 1967, J CELL BIOL, V33, P469, DOI 10.1083/jcb.33.3.469; CURRAN ME, 1993, CELL, V73, P159, DOI 10.1016/0092-8674(93)90168-P; Del Campo M, 2006, AM J HUM GENET, V78, P533, DOI 10.1086/501073; DeSilva U, 2002, GENOME RES, V12, P3, DOI 10.1101/gr.214802; Ding CM, 2003, P NATL ACAD SCI USA, V100, P3059, DOI 10.1073/pnas.0630494100; Dridi SM, 2005, J VASC RES, V42, P190, DOI 10.1159/000085141; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; EWART AK, 1994, J CLIN INVEST, V93, P1071, DOI 10.1172/JCI117057; Faury G, 2003, J CLIN INVEST, V112, P1419, DOI 10.1172/JCI200319028; Faury G, 1999, AM J PHYSIOL-HEART C, V277, pH1745, DOI 10.1152/ajpheart.1999.277.5.H1745; Feng MJ, 2009, HYPERTENSION, V54, P802, DOI 10.1161/HYPERTENSIONAHA.109.134569; FOSTER JA, 1983, INT REV CONNECT TISS, V10, P65; Gauguier D, 2005, HYPERTENSION, V45, P460, DOI 10.1161/01.HYP.0000155213.83719.7c; Habashi JP, 2006, SCIENCE, V312, P117, DOI 10.1126/science.1124287; Hartman JL, 2001, SCIENCE, V291, P1001, DOI 10.1126/science.291.5506.1001; Hirano E, 2007, CIRC RES, V101, P523, DOI 10.1161/CIRCRESAHA.107.153510; Lacolley P, 2002, CLIN SCI, V103, P21, DOI 10.1042/CS20010287; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Lassegue B, 2010, ARTERIOSCL THROM VAS, V30, P653, DOI 10.1161/ATVBAHA.108.181610; Li DY, 1998, J CLIN INVEST, V102, P1783, DOI 10.1172/JCI4487; Li DY, 1998, NATURE, V393, P276, DOI 10.1038/30522; Ma X, 2008, MOL GENET METAB, V94, P298, DOI 10.1016/j.ymgme.2008.03.018; Massett MP, 2005, AM J PHYSIOL-REG I, V288, pR1006, DOI 10.1152/ajpregu.00476.2004; Melikian N, 2009, TRENDS CARDIOVAS MED, V19, P256, DOI 10.1016/j.tcm.2010.02.007; Metcalfe K, 2000, EUR J HUM GENET, V8, P955, DOI 10.1038/sj.ejhg.5200564; Morris CA, 2000, ANNU REV GENOM HUM G, V1, P461; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Pober BR, 2008, J CLIN INVEST, V118, P1606, DOI 10.1172/JCI35309; Pober BR, 2010, NEW ENGL J MED, V362, P239, DOI 10.1056/NEJMra0903074; Salaymeh KJ, 2001, AM HEART J, V142, P549, DOI 10.1067/mhj.2001.116763; Salzler HR, 2007, KIDNEY INT, V72, P1226, DOI 10.1038/sj.ki.5002519; Shi G, 2009, HYPERTENSION, V53, P35, DOI 10.1161/HYPERTENSIONAHA.108.120071; Sugiyama F, 2002, PHYSIOL GENOMICS, V10, P5, DOI 10.1152/physiolgenomics.00002.2002; Sylos Cristina de, 2002, Arq Bras Cardiol, V79, P173; Tomita H, 2010, CIRC RES, V106, P1052, DOI 10.1161/CIRCRESAHA.109.207175; Wagenseil JE, 2005, AM J PHYSIOL-HEART C, V289, pH1209, DOI 10.1152/ajpheart.00046.2005; Wagenseil JE, 2009, PHYSIOL REV, V89, P957, DOI 10.1152/physrev.00041.2008; Wagenseil JE, 2009, CIRC RES, V104, P1217, DOI 10.1161/CIRCRESAHA.108.192054; Wheeler FC, 2005, MAMM GENOME, V16, P414, DOI 10.1007/s00335-005-2468-7; Yuan ZB, 2009, CIRC-CARDIOVASC GENE, V2, P220, DOI 10.1161/CIRCGENETICS.108.792499; Zhao HT, 2003, FREE RADICAL BIO MED, V34, P1359, DOI 10.1016/S0891-5849(03)00142-4	50	29	29	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2011	286	52					44926	44936		10.1074/jbc.M111.274779	http://dx.doi.org/10.1074/jbc.M111.274779			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870CA	22049077	hybrid, Green Published			2022-12-27	WOS:000298645500061
J	Mancarella, S; Wang, YJ; Deng, XX; Landesberg, G; Scalia, R; Panettieri, RA; Mallilankaraman, K; Tang, XD; Madesh, M; Gill, DL				Mancarella, Salvatore; Wang, Youjun; Deng, Xiaoxiang; Landesberg, Gavin; Scalia, Rosario; Panettieri, Reynold A.; Mallilankaraman, Karthik; Tang, Xiang D.; Madesh, Muniswamy; Gill, Donald L.			Hypoxia-induced Acidosis Uncouples the STIM-Orai Calcium Signaling Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED CA2+ CHANNELS; INFLUX; DOMAINS; BINDING; BORATE	The endoplasmic reticulum Ca2+-sensing STIM proteins mediate Ca2+ entry signals by coupling to activate plasma membrane Orai channels. We reveal that STIM-Orai coupling is rapidly blocked by hypoxia and the ensuing decrease in cytosolic pH. In smooth muscle cells or HEK293 cells coexpressing STIM1 and Orai1, acute hypoxic conditions rapidly blocked store-operated Ca2+ entry and the Orai1-mediated Ca2+ release-activated Ca2+ current (I-CRAC). Hypoxia-induced blockade of Ca2+ entry and I-CRAC was reversed by NH4+-induced cytosolic alkalinization. Hypoxia and acidification both blocked I-CRAC induced by the short STIM1 Orai-activating region. Although hypoxia induced STIM1 translocation into junctions, it did not dissociate the STIM1-Orai1 complex. However, both hypoxia and cytosolic acidosis rapidly decreased Forster resonance energy transfer (FRET) between STIM1-YFP and Orai1-CFP. Thus, although hypoxia promotes STIM1 junctional accumulation, the ensuing acidification functionally uncouples the STIM1-Orai1 complex providing an important mechanism protecting cells from Ca2+ overload under hypoxic stress conditions.	[Mancarella, Salvatore; Wang, Youjun; Deng, Xiaoxiang; Mallilankaraman, Karthik; Madesh, Muniswamy; Gill, Donald L.] Temple Univ, Sch Med, Dept Biochem, Philadelphia, PA 19140 USA; [Landesberg, Gavin; Scalia, Rosario] Temple Univ, Sch Med, Dept Physiol, Cardiovasc Res Ctr, Philadelphia, PA 19140 USA; [Panettieri, Reynold A.] Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA; [Tang, Xiang D.] Nankai Univ, Sch Med, Dept Pharmacol, Tianjin 300071, Peoples R China	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Pennsylvania; Nankai University	Mancarella, S (corresponding author), Temple Univ, Sch Med, Dept Biochem, Philadelphia, PA 19140 USA.	mancas@temple.edu; dgill@temple.edu	panettieri, reynold/AAG-9485-2019; Wang, Youjun/H-4016-2013	Wang, Youjun/0000-0003-0961-1716; Scalia, Rosario/0000-0002-1829-943X; MALLILANKARAMAN, KARTHIK/0000-0002-9492-9050	National Institutes of Health [AI058173, HL086699, DK043442]; NHLBI [F32HL105066]; National Natural Science Foundation of China [30871011]; Project "973" [2010CB945001]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086699, F32HL105066] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI058173] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK043442] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Project "973"(National Basic Research Program of China); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants AI058173 (to D. L. G.), HL086699 (to M. M.), DK043442 (to R. S.), and NHLBI Postdoctoral Fellowship F32HL105066 (to S. M.). This work was also supported by National Natural Science Foundation of China Grant 30871011 (to X. D. T.) and Project "973" Grant 2010CB945001 (to X. D. T.).	Bird GS, 2009, CURR BIOL, V19, P1724, DOI 10.1016/j.cub.2009.08.022; Bogeski I, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000672; Brandman O, 2007, CELL, V131, P1327, DOI 10.1016/j.cell.2007.11.039; Calloway N, 2010, BIOCHEMISTRY-US, V49, P1067, DOI 10.1021/bi901936q; Calloway N, 2009, MOL BIOL CELL, V20, P389, DOI 10.1091/mbc.E07-11-1132; Cassavaugh J, 2011, J CELL BIOCHEM, V112, P735, DOI 10.1002/jcb.22956; Chiche J, 2010, J CELL MOL MED, V14, P771, DOI 10.1111/j.1582-4934.2009.00994.x; Coe H, 2009, GEN PHYSIOL BIOPHYS, V28, pF96; Collins SR, 2011, TRENDS CELL BIOL, V21, P202, DOI 10.1016/j.tcb.2011.01.002; Deng XX, 2009, J BIOL CHEM, V284, P22501, DOI 10.1074/jbc.R109.018655; Di Capite J, 2009, CURR BIOL, V19, P853, DOI 10.1016/j.cub.2009.03.063; Felber LM, 2004, BIOTECHNIQUES, V36, P878, DOI 10.2144/04365PT04; Giachini FRC, 2009, HYPERTENSION, V53, P409, DOI 10.1161/HYPERTENSIONAHA.108.124404; Gusarova GA, 2011, MOL CELL BIOL, V31, P3546, DOI 10.1128/MCB.05114-11; Gwack Y, 2007, J BIOL CHEM, V282, P16232, DOI 10.1074/jbc.M609630200; Hawkins BJ, 2010, J CELL BIOL, V190, P391, DOI 10.1083/jcb.201004152; Hewavitharana T, 2008, J BIOL CHEM, V283, P26252, DOI 10.1074/jbc.M802239200; Hogan PG, 2010, ANNU REV IMMUNOL, V28, P491, DOI 10.1146/annurev.immunol.021908.132550; JAMESKRACKE MR, 1992, J CELL PHYSIOL, V151, P596, DOI 10.1002/jcp.1041510320; Korzeniowski MK, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001122; Lee KP, 2010, FEBS LETT, V584, P2022, DOI 10.1016/j.febslet.2009.11.078; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; Lis A, 2007, CURR BIOL, V17, P794, DOI 10.1016/j.cub.2007.03.065; Ma HT, 2002, J BIOL CHEM, V277, P6915, DOI 10.1074/jbc.M107755200; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; Mancarella S, 2011, NAT CHEM BIOL, V7, P344, DOI 10.1038/nchembio.587; Mancarella S, 2009, CURR BIOL, V19, pR950, DOI 10.1016/j.cub.2009.08.051; Mungai PT, 2011, MOL CELL BIOL, V31, P3531, DOI 10.1128/MCB.05124-11; PANETTIERI RA, 1989, AM J PHYSIOL, V256, pC329, DOI 10.1152/ajpcell.1989.256.2.C329; Parekh AB, 1997, PHYSIOL REV, V77, P901, DOI 10.1152/physrev.1997.77.4.901; Park CY, 2010, SCIENCE, V330, P101, DOI 10.1126/science.1191027; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Peel SE, 2008, AM J RESP CELL MOL, V38, P744, DOI 10.1165/rcmb.2007-0395OC; Prakriya M, 2001, J PHYSIOL-LONDON, V536, P3, DOI 10.1111/j.1469-7793.2001.t01-1-00003.x; Quayle JM, 2006, AM J PHYSIOL-HEART C, V291, pH71, DOI 10.1152/ajpheart.01107.2005; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Shimoda LA, 2011, AM J PHYSIOL-CELL PH, V300, pC951, DOI 10.1152/ajpcell.00512.2010; Smani T, 2002, CARDIOVASC RES, V53, P97, DOI 10.1016/S0008-6363(01)00422-9; Smyth JT, 2010, J CELL MOL MED, V14, P2337, DOI 10.1111/j.1582-4934.2010.01168.x; Soboloff J, 2006, CURR BIOL, V16, P1465, DOI 10.1016/j.cub.2006.05.051; Soboloff J, 2006, J BIOL CHEM, V281, P20661, DOI 10.1074/jbc.C600126200; Soboloff J, 2011, NAT CHEM BIOL, V7, P488, DOI 10.1038/nchembio.619; Tao Z, 2008, J PHYS CHEM A, V112, P1511, DOI 10.1021/jp710176z; Thorne GD, 2004, CELL CALCIUM, V36, P201, DOI 10.1016/j.ceca.2004.02.018; Vaughan-Jones RD, 2009, J MOL CELL CARDIOL, V46, P318, DOI 10.1016/j.yjmcc.2008.10.024; Wang YJ, 2008, CLIN EXP PHARMACOL P, V35, P1127, DOI 10.1111/j.1440-1681.2008.05018.x; Wang YJ, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3148pe42; Wang YJ, 2010, SCIENCE, V330, P105, DOI 10.1126/science.1191086; Wang YJ, 2009, P NATL ACAD SCI USA, V106, P7391, DOI 10.1073/pnas.0900293106; Wray S, 2004, MOL CELL BIOCHEM, V263, P163, DOI 10.1023/B:MCBI.0000041858.78005.d2; Xiao BL, 2011, NAT CHEM BIOL, V7, P351, DOI [10.1038/NCHEMBIO.558, 10.1038/nchembio.558]; Yuan JP, 2009, NAT CELL BIOL, V11, P337, DOI 10.1038/ncb1842; YUAN XJ, 1993, AM J PHYSIOL, V264, pL116, DOI 10.1152/ajplung.1993.264.2.L116; Zhou YD, 2009, J BIOL CHEM, V284, P19164, DOI 10.1074/jbc.C109.010900	54	45	45	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2011	286	52					44788	44798		10.1074/jbc.M111.303081	http://dx.doi.org/10.1074/jbc.M111.303081			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870CA	22084246	hybrid, Green Published			2022-12-27	WOS:000298645500048
J	Gorjestani, S; Yu, M; Tang, B; Zhang, DK; Wang, DM; Lin, X				Gorjestani, Sara; Yu, Mei; Tang, Bing; Zhang, Dekai; Wang, Demin; Lin, Xin			Phospholipase C gamma 2 (PLC gamma 2) Is Key Component in Dectin-2 Signaling Pathway, Mediating Anti-fungal Innate Immune Responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; PATTERN-RECOGNITION RECEPTOR; NUCLEOTIDE EXCHANGE FACTOR; C-TYPE LECTINS; CANDIDA-ALBICANS; HOST-DEFENSE; FUNGAL-INFECTION; ADAPTER PROTEIN; TYROSINE KINASE; SYK	C-type lectin receptors (CLRs) such as Dectin-2 function as pattern recognition receptors to sense fungal infection. However, the signaling pathways induced by these receptors remain largely unknown. Previous studies suggest that the CLR-induced signaling pathway may utilize similar signaling components as the B cell receptor-induced signaling pathway. Phospholipase C gamma 2 (PLC gamma 2) is a key component in B cell receptor signaling, but its role in other signaling pathways has not been fully characterized. Here, we show that PLC gamma 2 functions downstream of Dectin-2 in response to the stimulation by the hyphal form of Candida albicans, an opportunistic pathogenic fungus. Using PLC gamma 2-and PLC gamma 1-deficient macrophages, we found that the lack of PLC gamma 2, but not PLC gamma 1, impairs cytokine production in response to infection with C. albicans. PLC gamma 2 deficiency results in the defective activation of NF-kappa B and MAPK and a significantly reduced production of reactive oxygen species following fungal challenge. In addition, PLC gamma 2-deficient mice are defective in clearing C. albicans infection in vivo. Together, these findings demonstrate that PLC gamma 2 plays a critical role in CLR-induced signaling pathways, governing antifungal innate immune responses.	[Gorjestani, Sara; Tang, Bing; Lin, Xin] Univ Texas MD Anderson Canc Ctr, Dept Cellular Oncol, Houston, TX 77030 USA; [Gorjestani, Sara; Lin, Xin] Univ Texas Houston, Canc Biol Program, Grad Sch Biomed Sci, Houston, TX 77030 USA; [Gorjestani, Sara; Tang, Bing; Lin, Xin] Univ Texas MD Anderson Canc Ctr, Dept Mol Oncol, Houston, TX 77030 USA; [Yu, Mei; Wang, Demin] Blood Ctr Wisconsin, Blood Res Inst, Milwaukee, WI 53226 USA; [Yu, Mei] Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Nanjing 210093, Peoples R China; [Zhang, Dekai] Texas A&M Univ, Inst Biosci & Technol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; UTMD Anderson Cancer Center; Versiti Blood Center of Wisconsin; Nanjing University; Texas A&M University System	Lin, X (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, 1515 Holcombe Blvd,Unit 108, Houston, TX 77030 USA.	xllin@mdanderson.org	Yu, Mei/K-2206-2017; Wang, Demin/AAX-4449-2020	Wang, Demin/0000-0001-5549-3795	National Institutes of Health [RO1AI050848, RO1GM065899, RO1AI079087, PO1HL44612]; Leukemia & Lymphoma Society; National Institutes of Health through MD Anderson's Cancer Center [CA016672]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL044612] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079087, R01AI050848] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065899] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); National Institutes of Health through MD Anderson's Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1AI050848 and RO1GM065899 (to X. L.) and RO1AI079087 and PO1HL44612 (to D. W.). This work was also supported by a Scholar Award from the Leukemia & Lymphoma Society (to D. W.). This study was also supported in part by the National Institutes of Health through MD Anderson's Cancer Center Support Grant CA016672.	Bi LK, 2010, J BIOL CHEM, V285, P25969, DOI 10.1074/jbc.M110.131300; Brown GD, 2002, J EXP MED, V196, P407, DOI 10.1084/jem.20020470; Brown GD, 2003, J EXP MED, V197, P1119, DOI 10.1084/jem.20021890; Brown GD, 2011, ANNU REV IMMUNOL, V29, P1, DOI 10.1146/annurev-immunol-030409-101229; BUDAY L, 1993, CELL, V73, P611, DOI 10.1016/0092-8674(93)90146-H; CHARDIN P, 1993, SCIENCE, V260, P1338, DOI 10.1126/science.8493579; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Drummond RA, 2011, EUR J IMMUNOL, V41, P276, DOI 10.1002/eji.201041252; Fu GP, 2010, J EXP MED, V207, P309, DOI 10.1084/jem.20090880; Gantner BN, 2005, EMBO J, V24, P1277, DOI 10.1038/sj.emboj.7600594; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Graham DB, 2007, J CLIN INVEST, V117, P3445, DOI 10.1172/JCI32729; Gross O, 2006, NATURE, V442, P651, DOI 10.1038/nature04926; Gross O, 2009, NATURE, V459, P433, DOI 10.1038/nature07965; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; HIRASAWA N, 1995, J BIOL CHEM, V270, P10960, DOI 10.1074/jbc.270.18.10960; Hsu YMS, 2007, NAT IMMUNOL, V8, P198, DOI 10.1038/ni1426; Kadosh D, 2005, MOL BIOL CELL, V16, P2903, DOI 10.1091/mbc.E05-01-0073; Kelly EK, 2010, J IMMUNOL, V184, P5545, DOI 10.4049/jimmunol.0901293; Kerrigan AM, 2011, TRENDS IMMUNOL, V32, P151, DOI 10.1016/j.it.2011.01.002; Netea MG, 2008, NAT REV MICROBIOL, V6, P67, DOI 10.1038/nrmicro1815; Robinson MJ, 2009, J EXP MED, V206, P2037, DOI 10.1084/jem.20082818; Rogers NC, 2005, IMMUNITY, V22, P507, DOI 10.1016/j.immuni.2005.03.004; Saijo S, 2007, NAT IMMUNOL, V8, P39, DOI 10.1038/ni1425; Saijo S, 2010, IMMUNITY, V32, P681, DOI 10.1016/j.immuni.2010.05.001; Sato K, 2006, J BIOL CHEM, V281, P38854, DOI 10.1074/jbc.M606542200; Saville SP, 2003, EUKARYOT CELL, V2, P1053, DOI 10.1128/EC.2.5.1053-1060.2003; Slack EC, 2007, EUR J IMMUNOL, V37, P1600, DOI 10.1002/eji.200636830; Tassi I, 2009, EUR J IMMUNOL, V39, P1369, DOI 10.1002/eji.200839313; Taylor PR, 2007, NAT IMMUNOL, V8, P31, DOI 10.1038/ni1408; Turner H, 1997, J EXP MED, V185, P43, DOI 10.1084/jem.185.1.43; Underhill DM, 2005, BLOOD, V106, P2543, DOI 10.1182/blood-2005-03-1239; Wang DM, 2000, IMMUNITY, V13, P25, DOI 10.1016/S1074-7613(00)00005-4; Wheeler RT, 2006, PLOS PATHOG, V2, P328, DOI 10.1371/journal.ppat.0020035; Wheeler RT, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000227; Wilde JI, 2001, CELL SIGNAL, V13, P691, DOI 10.1016/S0898-6568(01)00191-7; Willment JA, 2008, TRENDS MICROBIOL, V16, P27, DOI 10.1016/j.tim.2007.10.012; Wu WH, 2009, NAT IMMUNOL, V10, P1208, DOI 10.1038/ni.1788; Xu S, 2009, J BIOL CHEM, V284, P7038, DOI 10.1074/jbc.M806650200; Zhang J, 1996, J EXP MED, V184, P71, DOI 10.1084/jem.184.1.71	40	43	45	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2011	286	51					43651	43659		10.1074/jbc.M111.307389	http://dx.doi.org/10.1074/jbc.M111.307389			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866SH	22041900	Green Published, hybrid			2022-12-27	WOS:000298402300008
J	Chen, CC; Hardy, DB; Mendelson, CR				Chen, Chien-Cheng; Hardy, Daniel B.; Mendelson, Carole R.			Progesterone Receptor Inhibits Proliferation of Human Breast Cancer Cells via Induction of MAPK Phosphatase 1 (MKP-1/DUSP1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; NF-KAPPA-B; DUAL-SPECIFICITY PHOSPHATASE; ESTROGEN PLUS PROGESTIN; HER-2 NEU ONCOGENE; POSTMENOPAUSAL WOMEN; GROWTH-FACTOR; MEDROXYPROGESTERONE ACETATE; TAMOXIFEN RESISTANCE; SYNTHETIC PROGESTIN	The roles of progesterone (P-4) and of progesterone receptor (PR) in development and pathogenesis of breast cancer remain unclear. In this study, we observed that treatment of T47D breast cancer cells with progestin antagonized effects of fetal bovine serum (FBS) to stimulate cell proliferation, whereas siRNA-mediated knockdown of endogenous PR abrogated progestin-mediated anti-proliferative effects. To begin to define mechanisms for the anti-proliferative action of P-4/PR, we considered the role of MAPK phosphatase 1 (MKP-1/DUSP1), which catalyzes dephosphorylation and inactivation of MAPKs. Progestin treatment of T47D cells rapidly induced MKP-1 expression in a PR-dependent manner. Importantly, P-4 induction of MKP-1 was associated with reduced levels of phosphorylated ERK1/2, whereas siRNA knockdown of MKP-1 blocked progestin-mediated ERK1/2 dephosphorylation and repression of FBS-induced cell proliferation. The importance of PR in MKP-1 expression was supported by findings that MKP-1 and PR mRNA levels were significantly correlated in 30 human breast cancer cell lines. By contrast, no correlation was observed with the glucocorticoid receptor, a known regulator of MKP-1 in other cell types. ChIP and luciferase reporter assay findings suggest that PR acts in a ligand-dependent manner through binding to two progesterone response elements downstream of the MKP-1 transcription start site to up-regulate MKP-1 promoter activity. PR also interacts with two Sp1 sites just downstream of the transcription start site to increase MKP-1 expression. Collectively, these findings suggest that MKP-1 is a critical mediator of antiproliferative and anti-inflammatory actions of PR in the breast.	Univ Texas SW Med Ctr Dallas, N Texas March Dimes Birth Defects Ctr, Dept Biochem, Dallas, TX 75390 USA; Univ Texas SW Med Ctr Dallas, N Texas March Dimes Birth Defects Ctr, Dept Obstet & Gynecol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Mendelson, CR (corresponding author), 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	Carole.Mendelson@UTSouthwestern.edu		Mendelson, Carole Ruth/0000-0003-1696-9791; Hardy, Daniel/0000-0001-5445-273X	National Institutes of Health [5-R01-DK031206, 2-R56-DK031206]; Susan G. Komen Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK031206, R01DK031206] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan G. Komen Foundation(Susan G. Komen Breast Cancer Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants 5-R01-DK031206 and 2-R56-DK031206 (to C. R. M.). This work was also supported by a postdoctoral fellowship from the Susan G. Komen Foundation (to C.-C. C. and D. B. H.).	Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; ARNOLD SF, 1995, J STEROID BIOCHEM, V55, P163, DOI 10.1016/0960-0760(95)00177-2; Arpino G, 2005, JNCI-J NATL CANCER I, V97, P1254, DOI 10.1093/jnci/dji249; Bladh LG, 2009, BBA-MOL CELL RES, V1793, P439, DOI 10.1016/j.bbamcr.2008.11.013; BLUME SW, 1991, J CLIN INVEST, V88, P1613, DOI 10.1172/JCI115474; Buzdar A, 1996, J CLIN ONCOL, V14, P2000, DOI 10.1200/JCO.1996.14.7.2000; Byrne MJ, 1997, J CLIN ONCOL, V15, P3141, DOI 10.1200/JCO.1997.15.9.3141; Cerliani JP, 2011, CANCER RES, V71, P3720, DOI 10.1158/0008-5472.CAN-10-3074; Chen PL, 2002, J IMMUNOL, V169, P6408, DOI 10.4049/jimmunol.169.11.6408; Chen YW, 2005, CARCINOGENESIS, V26, P1296, DOI 10.1093/carcin/bgi062; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Chlebowski RT, 2010, JAMA-J AM MED ASSOC, V304, P1684, DOI 10.1001/jama.2010.1500; Chlebowski RT, 2003, JAMA-J AM MED ASSOC, V289, P3243, DOI 10.1001/jama.289.24.3243; Conneely OM, 2003, J MAMMARY GLAND BIOL, V8, P205, DOI 10.1023/A:1025952924864; Coyle YM, 2007, CANCER LETT, V258, P253, DOI 10.1016/j.canlet.2007.09.011; Daniel AR, 2009, MOL CELL ENDOCRINOL, V308, P47, DOI 10.1016/j.mce.2009.01.004; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; Deroo BJ, 2002, J STEROID BIOCHEM, V81, P309, DOI 10.1016/S0960-0760(02)00072-9; Faivre EJ, 2008, MOL ENDOCRINOL, V22, P823, DOI 10.1210/me.2007-0437; Fox EM, 2009, STEROIDS, V74, P622, DOI 10.1016/j.steroids.2008.10.014; Franklin CC, 1997, J BIOL CHEM, V272, P16917, DOI 10.1074/jbc.272.27.16917; GILL PG, 1991, BREAST CANCER RES TR, V20, P53, DOI 10.1007/BF01833357; Ginestier C, 2006, CLIN CANCER RES, V12, P4533, DOI 10.1158/1078-0432.CCR-05-2339; Gizard F, 2005, FEBS LETT, V579, P5535, DOI 10.1016/j.febslet.2005.08.084; Gizard F, 2006, MOL CELL BIOL, V26, P7632, DOI 10.1128/MCB.00326-06; Goldhar AS, 2011, MOL CELL ENDOCRINOL, V335, P148, DOI 10.1016/j.mce.2011.01.004; Groshong SD, 1997, MOL ENDOCRINOL, V11, P1593, DOI 10.1210/me.11.11.1593; Hardy DB, 2008, MOL ENDOCRINOL, V22, P1812, DOI 10.1210/me.2007-0443; Hardy DB, 2006, MOL ENDOCRINOL, V20, P2724, DOI 10.1210/me.2006-0112; Huang E, 2003, LANCET, V361, P1590, DOI 10.1016/S0140-6736(03)13308-9; Hultborn R, 1996, ACTA ONCOL, V35, P75, DOI 10.3109/02841869609083975; Ismaili N, 2004, ANN NY ACAD SCI, V1024, P86, DOI 10.1196/annals.1321.007; Janowski BA, 2005, NAT CHEM BIOL, V1, P210, DOI 10.1038/nchembio724; Jeffrey KL, 2007, NAT REV DRUG DISCOV, V6, P391, DOI 10.1038/nrd2289; Kalkhoven E, 1996, J BIOL CHEM, V271, P6217, DOI 10.1074/jbc.271.11.6217; Kassel O, 2001, EMBO J, V20, P7108, DOI 10.1093/emboj/20.24.7108; Keith BD, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-84; King EM, 2009, J BIOL CHEM, V284, P26803, DOI 10.1074/jbc.M109.028381; Kobayashi S, 2010, MOL ENDOCRINOL, V24, P2292, DOI 10.1210/me.2010-0289; Lasa M, 2002, MOL CELL BIOL, V22, P7802, DOI 10.1128/MCB.22.22.7802-7811.2002; Lebeau A, 2003, BREAST CANCER RES TR, V79, P187, DOI 10.1023/A:1023958324448; Lin VCL, 2001, CLIN CANCER RES, V7, P2880; Lin VCL, 2000, MOL ENDOCRINOL, V14, P348, DOI 10.1210/me.14.3.348; Lin YW, 2006, J BIOL CHEM, V281, P915, DOI 10.1074/jbc.M508720200; LIU YS, 1995, J BIOL CHEM, V270, P8377, DOI 10.1074/jbc.270.15.8377; Lonard DM, 2006, CELL, V125, P411, DOI 10.1016/j.cell.2006.04.021; Merkhofer EC, 2010, ONCOGENE, V29, P1238, DOI 10.1038/onc.2009.410; Musgrove EA, 1998, MOL CELL BIOL, V18, P1812, DOI 10.1128/MCB.18.4.1812; Osborne CK, 2003, J NATL CANCER I, V95, P353, DOI 10.1093/jnci/95.5.353; OSBORNE CK, 1980, CANCER-AM CANCER SOC, V46, P2884, DOI 10.1002/1097-0142(19801215)46:12+<2884::AID-CNCR2820461429>3.0.CO;2-U; Owen GI, 1998, J BIOL CHEM, V273, P10696, DOI 10.1074/jbc.273.17.10696; Owens DM, 2007, ONCOGENE, V26, P3203, DOI 10.1038/sj.onc.1210412; PANNUTI F, 1988, EUR J CANCER CLIN ON, V24, P423, DOI 10.1016/S0277-5379(98)90012-8; PARAZZINI F, 1993, ONCOLOGY, V50, P483; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Quiles I, 2009, MOL ENDOCRINOL, V23, P809, DOI 10.1210/me.2008-0454; Richardson AL, 2006, CANCER CELL, V9, P121, DOI 10.1016/j.ccr.2006.01.013; Richer JK, 1998, J BIOL CHEM, V273, P31317, DOI 10.1074/jbc.273.47.31317; Robinson MJ, 1997, CURR OPIN CELL BIOL, V9, P180, DOI 10.1016/S0955-0674(97)80061-0; Santen RJ, 2002, J STEROID BIOCHEM, V80, P239, DOI 10.1016/S0960-0760(01)00189-3; Schuetz CS, 2006, CANCER RES, V66, P5278, DOI 10.1158/0008-5472.CAN-05-4610; Shipp LE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013754; Skildum A, 2005, MOL ENDOCRINOL, V19, P327, DOI 10.1210/me.2004-0306; Slack DN, 2001, J BIOL CHEM, V276, P16491, DOI 10.1074/jbc.M010966200; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Song RX, 2004, P NATL ACAD SCI USA, V101, P2076, DOI 10.1073/pnas.0308334100; SUN H, 1993, CELL, V75, P487, DOI 10.1016/0092-8674(93)90383-2; Swarbrick A, 2000, MOL CELL BIOL, V20, P2581, DOI 10.1128/MCB.20.7.2581-2591.2000; TANDON AK, 1989, J CLIN ONCOL, V7, P1120, DOI 10.1200/JCO.1989.7.8.1120; Tchen CR, 2010, J BIOL CHEM, V285, P2642, DOI 10.1074/jbc.M109.037309; Tibbetts TA, 1999, BIOL REPROD, V60, P1158, DOI 10.1095/biolreprod60.5.1158; Tseng L, 2003, DNA CELL BIOL, V22, P633, DOI 10.1089/104454903770238102; VANDERBURG B, 1992, J STEROID BIOCHEM, V42, P457, DOI 10.1016/0960-0760(92)90257-J; Viatour P, 2005, TRENDS BIOCHEM SCI, V30, P43, DOI 10.1016/j.tibs.2004.11.009; VIGNON F, 1983, J CLIN ENDOCR METAB, V56, P1124, DOI 10.1210/jcem-56-6-1124; Wu RC, 2004, MOL CELL, V15, P937, DOI 10.1016/j.molcel.2004.08.019; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; YOUNG PCM, 1980, CANCER-AM CANCER SOC, V46, P2961, DOI 10.1002/1097-0142(19801215)46:12+<2961::AID-CNCR2820461444>3.0.CO;2-E; Yue W, 2007, J STEROID BIOCHEM, V106, P102, DOI 10.1016/j.jsbmb.2007.05.008; Zhang Y, 2009, J BIOL CHEM, V284, P24542, DOI 10.1074/jbc.M109.021469; Zhao Q, 2006, J EXP MED, V203, P131, DOI 10.1084/jem.20051794	81	51	52	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					43091	43102		10.1074/jbc.M111.295865	http://dx.doi.org/10.1074/jbc.M111.295865			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22020934	Green Published, hybrid			2022-12-27	WOS:000298351300030
J	Felder, TK; Soyal, SM; Oberkofler, H; Hahne, P; Auer, S; Weiss, R; Gadermaier, G; Miller, K; Krempler, F; Esterbauer, H; Patsch, W				Felder, Thomas K.; Soyal, Selma M.; Oberkofler, Hannes; Hahne, Penelope; Auer, Simon; Weiss, Richard; Gadermaier, Gabriele; Miller, Karl; Krempler, Franz; Esterbauer, Harald; Patsch, Wolfgang			Characterization of Novel Peroxisome Proliferator-activated Receptor gamma Coactivator-1 alpha (PGC-1 alpha) Isoform in Human Liver	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PPAR-GAMMA; HEPATIC GLUCONEOGENESIS; ENERGY-METABOLISM; SKELETAL-MUSCLE; GENE-EXPRESSION; MESSENGER-RNA; TRANSCRIPTIONAL COACTIVATORS; HUNTINGTONS-DISEASE; INSULIN-RESISTANCE; GENOME-WIDE	Peroxisome proliferator-activated receptor gamma coactivator-1 alpha (PGC-1 alpha) is a transcriptional coactivator that contributes to the regulation of numerous transcriptional programs including the hepatic response to fasting. Mechanisms at transcriptional and post-transcriptional levels allow PGC-1 alpha to support distinct biological pathways. Here we describe a novel human liver-specific PGC-1 alpha transcript that results from alternative promoter usage and is induced by FOXO1 as well as glucocorticoids and cAMP-response element-binding protein signaling but is not present in other mammals. Hepatic tissue levels of novel and wild-type transcripts were similar but were only moderately associated (p< 0.003). Novel mRNA levels were associated with a polymorphism located in its promoter region, whereas wildtype transcript levels were not. Furthermore, hepatic PCK1 mRNA levels exhibited stronger associations with the novel than with the wild-type transcript levels. Except for a deletion of 127 amino acids at the N terminus, the protein, termed L-PGC1 alpha, is identical to PGC-1 alpha. L-PGC-1 alpha was localized in the nucleus and showed coactivation properties that overlap with those of PGC-1 alpha. Collectively, our data support a role of L-PGC-1 alpha in gluconeogenesis, but functional differences predicted from the altered structure suggest that L-PGC-1 alpha may have arisen to adapt PGC-1 alpha to more complex metabolic pathways in humans.	[Felder, Thomas K.; Soyal, Selma M.; Oberkofler, Hannes; Hahne, Penelope; Auer, Simon; Patsch, Wolfgang] Paracelsus Med Univ, Dept Lab Med, A-5020 Salzburg, Austria; [Weiss, Richard; Gadermaier, Gabriele] Salzburg Univ, Dept Mol Biol, A-5020 Salzburg, Austria; [Miller, Karl] Krankenhaus Hallein, Dept Surg, A-5400 Hallein, Austria; [Krempler, Franz] Krankenhaus Hallein, Dept Internal Med, A-5400 Hallein, Austria; [Esterbauer, Harald] Med Univ Vienna, Dept Lab Med, A-1090 Vienna, Austria	Paracelsus Private Medical University; Salzburg University; Medical University of Vienna	Patsch, W (corresponding author), Paracelsus Med Univ, Dept Lab Med, Mullner Hauptstr 48, A-5020 Salzburg, Austria.	wolfgang.patsch@pmu.ac.at	Felder, Thomas K/A-8342-2017; Weiss, Richard/N-7279-2013; Gadermaier, Gabriele/L-5997-2015	Felder, Thomas K/0000-0001-8266-5513; Weiss, Richard/0000-0003-3185-7253; Gadermaier, Gabriele/0000-0002-4886-417X; Esterbauer, Harald/0000-0001-7343-7455	Fonds zur Forderung der wissenschaftlichen Forschung (FWF) [P19893-B05]; Wiener Wissenschafts-, Forschungs-, und Technologiefonds (WWTF) [L507-058]; Land Salzburg; Verein fur Medizinische Forschung Salzburg, Austria	Fonds zur Forderung der wissenschaftlichen Forschung (FWF)(Austrian Science Fund (FWF)); Wiener Wissenschafts-, Forschungs-, und Technologiefonds (WWTF); Land Salzburg; Verein fur Medizinische Forschung Salzburg, Austria	This study was supported by grants from the Fonds zur Forderung der wissenschaftlichen Forschung (FWF Project P19893-B05), the Wiener Wissenschafts-, Forschungs-, und Technologiefonds (WWTF Project L507-058), the Land Salzburg, and the Verein fur Medizinische Forschung Salzburg, Austria.	Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613; Baar K, 2002, FASEB J, V16, P1879, DOI 10.1096/fj.02-0367com; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Chang JS, 2010, J BIOL CHEM, V285, P18039, DOI 10.1074/jbc.M109.083121; Chinsomboon J, 2009, P NATL ACAD SCI USA, V106, P21401, DOI 10.1073/pnas.0909131106; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Cui LB, 2006, CELL, V127, P59, DOI 10.1016/j.cell.2006.09.015; Esterbauer H, 1999, GENOMICS, V62, P98, DOI 10.1006/geno.1999.5977; Esterbauer H, 2001, NAT GENET, V28, P178, DOI 10.1038/88911; Fan M, 2004, GENE DEV, V18, P278, DOI 10.1101/gad.1152204; Felder TK, 2010, INT J OBESITY, V34, P846, DOI 10.1038/ijo.2010.7; Felder TK, 2005, BBA-GENE STRUCT EXPR, V1731, P41, DOI 10.1016/j.bbaexp.2005.08.004; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; Goodrich JA, 2010, NAT REV GENET, V11, P549, DOI 10.1038/nrg2847; Grosso AR, 2008, NUCLEIC ACIDS RES, V36, P4823, DOI 10.1093/nar/gkn463; GULICK T, 1994, P NATL ACAD SCI USA, V91, P11012, DOI 10.1073/pnas.91.23.11012; Hahne P, 2008, J INTERN MED, V264, P452, DOI 10.1111/j.1365-2796.2008.01987.x; Handschin C, 2007, GENE DEV, V21, P770, DOI 10.1101/gad.1525107; Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037; Hartl A, 2004, METHODS, V32, P328, DOI 10.1016/j.ymeth.2003.08.014; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Iyemere VP, 1998, NUCLEIC ACIDS RES, V26, P2098, DOI 10.1093/nar/26.9.2098; Kakuma T, 2000, ENDOCRINOLOGY, V141, P4576, DOI 10.1210/en.141.12.4576; Knutti D, 2000, MOL CELL BIOL, V20, P2411, DOI 10.1128/MCB.20.7.2411-2422.2000; Knutti D, 2001, P NATL ACAD SCI USA, V98, P9713, DOI 10.1073/pnas.171184698; Leitner WW, 1997, J IMMUNOL, V159, P6112; Lerin C, 2006, CELL METAB, V3, P429, DOI 10.1016/j.cmet.2006.04.013; Lewis BP, 2003, P NATL ACAD SCI USA, V100, P189, DOI 10.1073/pnas.0136770100; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Liu C, 2007, NATURE, V447, P477, DOI 10.1038/nature05767; Loots GG, 2004, NUCLEIC ACIDS RES, V32, pW217, DOI 10.1093/nar/gkh383; MARUYAMA K, 1994, GENE, V138, P171; Messeguer X, 2002, BIOINFORMATICS, V18, P333, DOI 10.1093/bioinformatics/18.2.333; Miura S, 2008, ENDOCRINOLOGY, V149, P4527, DOI 10.1210/en.2008-0466; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Oberkofler H, 2004, DIABETES, V53, P1385, DOI 10.2337/diabetes.53.5.1385; Oberkofler H, 2003, BIOCHEM J, V371, P89, DOI 10.1042/BJ20021665; Oberkofler H, 2002, J BIOL CHEM, V277, P16750, DOI 10.1074/jbc.M200475200; Oberkofler H, 2009, J MOL MED, V87, P299, DOI 10.1007/s00109-008-0425-0; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Puigserver P, 1999, SCIENCE, V286, P1368, DOI 10.1126/science.286.5443.1368; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Rha GB, 2009, J BIOL CHEM, V284, P35165, DOI 10.1074/jbc.M109.052506; Rhee J, 2003, P NATL ACAD SCI USA, V100, P4012, DOI 10.1073/pnas.0730870100; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Soyal S, 2006, DIABETOLOGIA, V49, P1477, DOI 10.1007/s00125-006-0268-6; Spiegelman BM, 2004, CELL, V119, P157, DOI 10.1016/j.cell.2004.09.037; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Tcherepanova I, 2000, J BIOL CHEM, V275, P16302, DOI 10.1074/jbc.M001364200; Valle I, 2005, CARDIOVASC RES, V66, P562, DOI 10.1016/j.cardiores.2005.01.026; Vega RB, 2000, MOL CELL BIOL, V20, P1868, DOI 10.1128/MCB.20.5.1868-1876.2000; Weydt P, 2006, CELL METAB, V4, P349, DOI 10.1016/j.cmet.2006.10.004; Weydt P, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-3; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yamagata K, 2004, J BIOL CHEM, V279, P23158, DOI 10.1074/jbc.M314322200; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Zhang YB, 2009, J BIOL CHEM, V284, P32813, DOI 10.1074/jbc.M109.037556; Zhou J, 2008, GASTROENTEROLOGY, V134, P556, DOI 10.1053/j.gastro.2007.11.037	62	25	28	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					42923	42936		10.1074/jbc.M111.227496	http://dx.doi.org/10.1074/jbc.M111.227496			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22009745	Green Published, hybrid			2022-12-27	WOS:000298351300014
J	Gasnereau, I; Herr, P; Chia, PZC; Basler, K; Gleeson, PA				Gasnereau, Isabelle; Herr, Patrick; Chia, Pei Zhi Cheryl; Basler, Konrad; Gleeson, Paul A.			Identification of an Endocytosis Motif in an Intracellular Loop of Wntless Protein, Essential for Its Recycling and the Control of Wnt Protein Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; TRANS-GOLGI NETWORK; RETROMER COMPLEX; TRANSMEMBRANE PROTEIN; RETROGRADE TRANSPORT; GRADIENT FORMATION; ADAPTER COMPLEX; SECRETION; MEMBRANE; WINGLESS	The secretion of Wnt signaling proteins is dependent upon the transmembrane sorting receptor, Wntless (Wls), which recycles between the trans-Golgi network and the cell surface. Loss of Wls results in impairment of Wnt secretion and defects in development and homeostasis in Drosophila, Caenorhabditis elegans, and the mouse. The sorting signals for the internalization and trafficking of Wls have not been defined. Here, we demonstrate that Wls internalization requires clathrin and dynamin I, components of the clathrin-mediated endocytosis pathway. Moreover, we have identified a conserved YXX phi endocytosis motif in the third intracellular loop of the multipass membrane protein Wls. Mutation of the tyrosine-based motif YEGL to AEGL (Y425A) resulted in the accumulation of human mutant Wls on the cell surface of transfected HeLa cells. The cell surface accumulation of Wls(AEGL) was rescued by the insertion of a classical YXX phi motif in the cytoplasmic tail. Significantly, a Drosophila Wls(AEGL) mutant displayed a wing notch phenotype, with reduced Wnt secretion and signaling. These findings demonstrate that YXX phi endocytosis motifs can occur in the intracellular loops of multipass membrane proteins and, moreover, provide direct evidence that the trafficking of Wls is required for efficient secretion of Wnt signaling proteins.	[Gasnereau, Isabelle; Chia, Pei Zhi Cheryl; Gleeson, Paul A.] Univ Melbourne, Dept Biochem & Mol Biol, Melbourne, Vic 3010, Australia; [Gasnereau, Isabelle; Chia, Pei Zhi Cheryl; Gleeson, Paul A.] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Melbourne, Vic 3010, Australia; [Herr, Patrick; Basler, Konrad] Univ Zurich, Inst Mol Life Sci, CH-8057 Zurich, Switzerland	University of Melbourne; University of Melbourne; University of Zurich	Gleeson, PA (corresponding author), Univ Melbourne, Dept Biochem & Mol Biol, Melbourne, Vic 3010, Australia.	pgleeson@unimelb.edu.au	Herr, Patrick/ABA-6092-2021	Herr, Patrick/0000-0003-2945-966X; Basler, Konrad/0000-0003-3534-1529; Gleeson, Paul/0000-0002-5336-6503	National Health and Medical Research Council of Australia; Swiss National Science Foundation; Melbourne International Graduate scholarship	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Melbourne International Graduate scholarship	This work was supported by the National Health and Medical Research Council of Australia and the Swiss National Science Foundation.; Supported by a Melbourne International Graduate scholarship.	Banziger C, 2006, CELL, V125, P509, DOI 10.1016/j.cell.2006.02.049; Bartscherer K, 2008, EMBO REP, V9, P977, DOI 10.1038/embor.2008.167; Bartscherer K, 2006, CELL, V125, P523, DOI 10.1016/j.cell.2006.04.009; Belenkaya TY, 2008, DEV CELL, V14, P120, DOI 10.1016/j.devcel.2007.12.003; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Carpenter AC, 2010, GENESIS, V48, P554, DOI 10.1002/dvg.20651; COLLAWN JF, 1990, CELL, V63, P1061, DOI 10.1016/0092-8674(90)90509-D; Dunn CW, 2008, NATURE, V452, P745, DOI 10.1038/nature06614; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Franch-Marro X, 2008, NAT CELL BIOL, V10, P170, DOI 10.1038/ncb1678; Fu J, 2009, P NATL ACAD SCI USA, V106, P18598, DOI 10.1073/pnas.0904894106; Goodman RM, 2006, DEVELOPMENT, V133, P4901, DOI 10.1242/dev.02674; Harterink M, 2011, NAT CELL BIOL, V13, P914, DOI 10.1038/ncb2281; Hausmann G, 2007, NAT REV MOL CELL BIO, V8, P331, DOI 10.1038/nrm2141; HEUSER J, 1989, J CELL BIOL, V108, P401, DOI 10.1083/jcb.108.2.401; Honing S, 2005, MOL CELL, V18, P519, DOI 10.1016/j.molcel.2005.04.019; Huang FT, 2004, J BIOL CHEM, V279, P16657, DOI 10.1074/jbc.C400046200; Jackson LP, 2010, CELL, V141, P1220, DOI 10.1016/j.cell.2010.05.006; Kim H, 2009, MOL CELL BIOL, V29, P2118, DOI 10.1128/MCB.01503-08; Kirchhausen T, 1999, ANNU REV CELL DEV BI, V15, P705, DOI 10.1146/annurev.cellbio.15.1.705; Kozik P, 2010, TRAFFIC, V11, P843, DOI 10.1111/j.1600-0854.2010.01056.x; Lieu ZZ, 2007, MOL BIOL CELL, V18, P4979, DOI 10.1091/mbc.E07-06-0622; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Nolo R, 2000, CELL, V102, P349, DOI 10.1016/S0092-8674(00)00040-4; Ohno H, 1998, J BIOL CHEM, V273, P25915, DOI 10.1074/jbc.273.40.25915; Owen DJ, 2004, ANNU REV CELL DEV BI, V20, P153, DOI 10.1146/annurev.cellbio.20.010403.104543; Pan CL, 2008, DEV CELL, V14, P132, DOI 10.1016/j.devcel.2007.12.001; Petris MJ, 1996, EMBO J, V15, P6084, DOI 10.1002/j.1460-2075.1996.tb00997.x; Port F, 2008, NAT CELL BIOL, V10, P178, DOI 10.1038/ncb1687; Port F, 2010, TRAFFIC, V11, P1265, DOI 10.1111/j.1600-0854.2010.01076.x; Rohrer J, 1996, J CELL BIOL, V132, P565, DOI 10.1083/jcb.132.4.565; Seebohm G, 2007, CIRC RES, V100, P686, DOI 10.1161/01.RES.0000260250.83824.8f; Sorkin A, 1996, J BIOL CHEM, V271, P13377, DOI 10.1074/jbc.271.23.13377; Strigini M, 2000, CURR BIOL, V10, P293, DOI 10.1016/S0960-9822(00)00378-X; VANDERBLIEK AM, 1993, J CELL BIOL, V122, P553, DOI 10.1083/jcb.122.3.553; Weixel KM, 2001, J BIOL CHEM, V276, P46251, DOI 10.1074/jbc.M104545200; Wolf YI, 2004, GENOME RES, V14, P29, DOI 10.1101/gr.1347404; Yang PT, 2008, DEV CELL, V14, P140, DOI 10.1016/j.devcel.2007.12.004	38	36	38	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					43324	43333		10.1074/jbc.M111.307231	http://dx.doi.org/10.1074/jbc.M111.307231			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22027831	Green Published, Green Accepted, hybrid			2022-12-27	WOS:000298351300052
J	Liu, JM; Fukuda, K; Xu, Z; Ma, YQ; Hirbawi, J; Mao, X; Wu, CY; Plow, EF; Qin, J				Liu, Jianmin; Fukuda, Koichi; Xu, Zhen; Ma, Yan-Qing; Hirbawi, Jamila; Mao, Xian; Wu, Chuanyue; Plow, Edward F.; Qin, Jun			Structural Basis of Phosphoinositide Binding to Kindlin-2 Protein Pleckstrin Homology Domain in Regulating Integrin Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUT SIGNAL-TRANSDUCTION; LEUKOCYTE ADHESION; TALIN; ALPHA(IIB)BETA(3); NMR; MECHANISMS; MIG-2	Kindlins are a subclass of FERM-containing proteins that have recently emerged as key regulators of integrin receptor activation and signaling. As compared with the conventional FERM domain, the kindlin FERM domain contains an inserted pleckstrin homology (PH) domain that recognizes membrane phosphoinositides, including phosphatidylinositol 4,5-bisphosphate (PIP2) and phosphatidylinositol 3,4,5-trisphosphate (PIP3). Using NMR spectroscopy, we show that PIP3 site-specifically binds to kindlin-2 PH with substantial chemical shift changes that are much larger than PIP2. This suggests an enhanced association of kindlin-2 with membrane as mediated by PIP3 upon its conversion from PIP2 by phosphoinositide-3 kinase, a known regulator of integrin activation. We determined the NMR structure of the kindlin-2 PH domain bound to the head group of PIP3, inositol 1,3,4,5-tetraphosphate (IP4). The structure reveals a canonical PH domain fold, yet with a distinct IP4 binding pocket that appears highly conserved for the kindlin family members. Functional experiments demonstrate that although wild type kindlin-2 is capable of cooperating with integrin activator talin to induce synergistic integrin alpha(IIb)beta(3) activation, this ability is significantly impaired for a phosphoinositide binding-defective kindlin-2 mutant. These results define a specific PIP3 recognition mode for the kindlin PH domain. Moreover, they shed light upon a mechanism as to how the PH domain mediates membrane engagement of kindlin-2 to promote its binding to integrin and cooperation with talin for regulation of integrin activation.	[Liu, Jianmin; Fukuda, Koichi; Xu, Zhen; Ma, Yan-Qing; Hirbawi, Jamila; Plow, Edward F.; Qin, Jun] Cleveland Clin, Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH 44195 USA; [Mao, Xian; Qin, Jun] Cleveland Ctr Struct & Membrane Biol, Cleveland, OH 44106 USA; [Wu, Chuanyue] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15261 USA	Cleveland Clinic Foundation; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Plow, EF (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Mol Cardiol, 9500 Euclid Ave, Cleveland, OH 44195 USA.	plowe@ccf.org; qinj@ccf.org		Qin, Jun/0000-0002-2647-9270	National Institutes of Health [GM62823, P01 HL073311, GM65188, DK54639]; American Heart Association [10SDG2610277]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL073311] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054639] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062823, R01GM065188] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM62823 (to J. Q.), P01 HL073311 (to E. F. P.), and GM65188 and DK54639 (to C. W.). This work was also supported by American Heart Association Scientist Development Grant 10SDG2610277 (to Y. M.).; Supported by the Kirschstein-National Research Service Award (NRSA) research training grant through the National Institutes of Health.	Anthis NJ, 2009, EMBO J, V28, P3623, DOI 10.1038/emboj.2009.287; Blin G, 2008, BIOPHYS J, V94, P1021, DOI 10.1529/biophysj.107.110213; Calderwood DA, 2004, J CELL SCI, V117, P657, DOI 10.1242/jcs.01014; Clore GM, 1998, TRENDS BIOTECHNOL, V16, P22, DOI 10.1016/S0167-7799(97)01135-9; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DINITTO JP, 2003, SCI STKE, pRE16, DOI DOI 10.1126/STKE.2132003RE16; Fukuda M, 1996, J BIOL CHEM, V271, P18838, DOI 10.1074/jbc.271.31.18838; Goksoy E, 2008, MOL CELL, V31, P124, DOI 10.1016/j.molcel.2008.06.011; Hamada K, 2000, EMBO J, V19, P4449, DOI 10.1093/emboj/19.17.4449; Harburger DS, 2009, J BIOL CHEM, V284, P11485, DOI 10.1074/jbc.M809233200; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kim C, 2009, BLOOD, V113, P4747, DOI 10.1182/blood-2008-10-186551; Kim M, 2003, SCIENCE, V301, P1720, DOI 10.1126/science.1084174; Kolanus W, 1997, CURR OPIN CELL BIOL, V9, P725, DOI 10.1016/S0955-0674(97)80127-5; Ling K, 2006, TRENDS CELL BIOL, V16, P276, DOI 10.1016/j.tcb.2006.03.007; Ma YQ, 2007, J THROMB HAEMOST, V5, P1345, DOI 10.1111/j.1538-7836.2007.02537.x; Ma YQ, 2008, J CELL BIOL, V181, P439, DOI 10.1083/jcb.200710196; Ma YQ, 2006, BIOCHEMISTRY-US, V45, P6656, DOI 10.1021/bi060279h; Malinin NL, 2009, NAT MED, V15, P313, DOI 10.1038/nm.1917; Martel V, 2001, J BIOL CHEM, V276, P21217, DOI 10.1074/jbc.M102373200; Montanez E, 2008, GENE DEV, V22, P1325, DOI 10.1101/gad.469408; Moser M, 2008, NAT MED, V14, P325, DOI 10.1038/nm1722; Moser M, 2009, SCIENCE, V324, P895, DOI 10.1126/science.1163865; Moser M, 2009, NAT MED, V15, P300, DOI 10.1038/nm.1921; Plow EF, 2009, CURR OPIN HEMATOL, V16, P323, DOI 10.1097/MOH.0b013e32832ea389; Qin J, 2004, PLOS BIOL, V2, P726, DOI 10.1371/journal.pbio.0020169; Qu H, 2011, J CELL SCI, V124, P879, DOI 10.1242/jcs.076976; Rieping W, 2007, BIOINFORMATICS, V23, P381, DOI 10.1093/bioinformatics/btl589; Saltel F, 2009, J CELL BIOL, V187, P715, DOI 10.1083/jcb.200908134; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Shi XH, 2007, J BIOL CHEM, V282, P20455, DOI 10.1074/jbc.M611680200; Svensson L, 2009, NAT MED, V15, P306, DOI 10.1038/nm.1931; Tu YZ, 2003, CELL, V113, P37, DOI 10.1016/S0092-8674(03)00163-6; Vinogradova O, 2002, CELL, V110, P587, DOI 10.1016/S0092-8674(02)00906-6	36	77	79	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					43334	43342		10.1074/jbc.M111.295352	http://dx.doi.org/10.1074/jbc.M111.295352			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22030399	hybrid, Green Published			2022-12-27	WOS:000298351300053
J	Kang, HJ; Kwak, HI; Kaunas, R; Bayless, KJ				Kang, Hojin; Kwak, Hyeong-Il; Kaunas, Roland; Bayless, Kayla J.			Fluid Shear Stress and Sphingosine 1-Phosphate Activate Calpain to Promote Membrane Type 1 Matrix Metalloproteinase (MT1-MMP) Membrane Translocation and Endothelial Invasion into Three-dimensional Collagen Matrices	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOOD-VESSELS; CELL INVASION; GROWTH-FACTOR; CALPAIN/CALPASTATIN NETWORK; MOLECULAR-BASIS; ANGIOGENESIS; FLOW; MORPHOGENESIS; ADHESION; LUMEN	The vascular endothelium continually senses and responds to biochemical and mechanical stimuli to appropriately initiate angiogenesis. We have shown previously that fluid wall shear stress (WSS) and sphingosine 1-phosphate (S1P) cooperatively initiate the invasion of human umbilical vein endothelial cells into collagen matrices (Kang, H., Bayless, K. J., and Kaunas, R. (2008) Am. J. Physiol. Heart Circ. Physiol. 295, H2087-2097). Here, we investigated the role of calpains in the regulation of endothelial cell invasion in response to WSS and S1P. Calpain inhibition significantly decreased S1P- and WSS-induced invasion. Short hairpin RNA-mediated gene silencing demonstrated that calpain 1 and 2 were required for WSS and S1P-induced invasion. Also, S1P synergized with WSS to induce invasion and to activate calpains and promote calpain membrane localization. Calpain inhibition results in a cell morphology consistent with reduced matrix proteolysis. Membrane type 1-matrix metalloproteinase (MT1-MMP) has been shown by others to regulate endothelial cell invasion, prompting us to test whether calpain acted upstream of MT1-MMP. S1P and WSS synergistically activated MT1-MMP and induced cell membrane localization of MT1-MMP in a calpain-dependent manner. Calpain activation, MT1-MMP activation and MT1-MMP membrane localization were all maximal with 5.3 dynes/cm(2) WSS and S1P treatment, which correlated with maximal invasion responses. Our data show for the first time that 5.3 dynes/cm(2) WSS in the presence of S1P combine to activate calpains, which direct MT1-MMP membrane localization to initiate endothelial sprouting into three-dimensional collagen matrices.	[Kwak, Hyeong-Il; Bayless, Kayla J.] Texas A&M Hlth Sci Ctr, Dept Mol & Cellular Med, College Stn, TX 77843 USA; [Kang, Hojin; Kaunas, Roland] Texas A&M Univ, Dept Biomed Engn, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Texas A&M University System; Texas A&M University College Station	Bayless, KJ (corresponding author), Texas A&M Hlth Sci Ctr, Dept Mol & Cellular Med, 440 Reynolds Med Bldg, College Stn, TX 77843 USA.	kbayless@medicine.tamhsc.edu			National Institutes of Health [R01 HL09576]; American Heart Association [0530020N, 0730238N]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association)	This work was supported, in whole or in part, by National Institutes of Health Grant R01 HL09576 (to K. J. B.). This work was also supported by American Heart Association Scientist Development Grants 0530020N (to K. J. B.) and 0730238N (to R. K.).	Ariyoshi H, 2001, J CELL BIOCHEM, V81, P184, DOI 10.1002/1097-4644(20010401)81:1<184::AID-JCB1034>3.3.CO;2-7; Bayless KJ, 2009, NAT PROTOC, V4, P1888, DOI 10.1038/nprot.2009.221; Bayless KJ, 2003, BIOCHEM BIOPH RES CO, V312, P903, DOI 10.1016/j.bbrc.2003.11.017; Boisseau MR, 2005, CLIN HEMORHEOL MICRO, V33, P201; BORNSTEIN MB, 1958, LAB INVEST, V7, P134; Butcher JT, 2004, ARTERIOSCL THROM VAS, V24, P1429, DOI 10.1161/01.ATV.0000130462.50769.5a; Calle Y, 2006, J CELL SCI, V119, P2375, DOI 10.1242/jcs.02939; Carmeliet P, 2000, ANN NY ACAD SCI, V902, P249; Carmeliet P, 2003, NAT REV GENET, V4, P710, DOI 10.1038/nrg1158; Carmeliet P, 2004, J INTERN MED, V255, P538, DOI 10.1111/j.1365-2796.2003.01297.x; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Carragher NO, 2004, NEOPLASIA, V6, P53, DOI 10.1016/S1476-5586(04)80053-8; Chun TH, 2004, J CELL BIOL, V167, P757, DOI 10.1083/jcb.200405001; Clark ER, 1931, ANAT REC, V50, P129, DOI 10.1002/ar.1090500203; Clark ER, 1918, AM J ANAT, V23, P37, DOI 10.1002/aja.1000230103; Cortesio CL, 2008, J CELL BIOL, V180, P957, DOI 10.1083/jcb.200708048; Davis GE, 1996, EXP CELL RES, V224, P39, DOI 10.1006/excr.1996.0109; Davis GE, 2002, ANAT RECORD, V268, P252, DOI 10.1002/ar.10159; English D, 2001, CARDIOVASC RES, V49, P588, DOI 10.1016/S0008-6363(00)00230-3; Flevaris P, 2007, J CELL BIOL, V179, P553, DOI 10.1083/jcb.200703185; Folkman J, 1996, CELL, V87, P1153, DOI 10.1016/S0092-8674(00)81810-3; Franco S, 2004, EXP CELL RES, V299, P179, DOI 10.1016/j.yexcr.2004.05.021; Hiraoka N, 1998, CELL, V95, P365, DOI 10.1016/S0092-8674(00)81768-7; Hla T, 2004, SEMIN CELL DEV BIOL, V15, P513, DOI 10.1016/j.semcdb.2004.05.002; Hoang MV, 2011, BBA-MOL BASIS DIS, V1812, P549, DOI 10.1016/j.bbadis.2010.08.008; Hoang MV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013612; Hogers B, 1997, CIRC RES, V80, P473, DOI 10.1161/01.RES.80.4.473; Holmbeck K, 1999, CELL, V99, P81, DOI 10.1016/S0092-8674(00)80064-1; Hood JL, 2003, BIOCHEM BIOPH RES CO, V310, P1200, DOI 10.1016/j.bbrc.2003.09.142; Hood JL, 2006, BIOESSAYS, V28, P850, DOI 10.1002/bies.20440; Hotary K, 2000, J CELL BIOL, V149, P1309, DOI 10.1083/jcb.149.6.1309; Hotary KB, 2003, CELL, V114, P33, DOI 10.1016/S0092-8674(03)00513-0; Hove JR, 2003, NATURE, V421, P172, DOI 10.1038/nature01282; Ichioka S, 1997, J SURG RES, V72, P29, DOI 10.1006/jsre.1997.5170; Isogai S, 2003, DEVELOPMENT, V130, P5281, DOI 10.1242/dev.00733; Jones EAV, 2004, AM J PHYSIOL-HEART C, V287, pH1561, DOI 10.1152/ajpheart.00081.2004; Kang HJ, 2008, AM J PHYSIOL-HEART C, V295, pH2087, DOI 10.1152/ajpheart.00281.2008; KAUNAS R, 2011, CELL MOL BI IN PRESS; Kim MB, 2003, MICROCIRCULATION, V10, P167, DOI 10.1038/sj.mn.7800182; Koutsiaris AG, 2007, BIORHEOLOGY, V44, P375; Langlois S, 2004, BLOOD, V103, P3020, DOI 10.1182/blood-2003-08-2968; Langlois S, 2007, MOL CANCER RES, V5, P569, DOI 10.1158/1541-7786.MCR-06-0267; Linder S, 2003, TRENDS CELL BIOL, V13, P376, DOI 10.1016/S0962-8924(03)00128-4; Lucitti JL, 2007, DEVELOPMENT, V134, P3317, DOI 10.1242/dev.02883; Martin P, 2005, TRENDS CELL BIOL, V15, P599, DOI 10.1016/j.tcb.2005.09.002; Martyre MC, 1997, BRIT J HAEMATOL, V97, P441, DOI 10.1046/j.1365-2141.1997.292671.x; Marzia M, 2006, J BIOL CHEM, V281, P9745, DOI 10.1074/jbc.M513516200; Miyazaki T, 2007, AM J PHYSIOL-CELL PH, V293, pC1216, DOI 10.1152/ajpcell.00083.2007; Mohle R, 1997, P NATL ACAD SCI USA, V94, P663, DOI 10.1073/pnas.94.2.663; Nasu R, 1999, BRIT J CANCER, V79, P780, DOI 10.1038/sj.bjc.6690125; NEREM RM, 1993, J BIOMECH ENG-T ASME, V115, P510, DOI 10.1115/1.2895532; Nisato RE, 2005, CANCER RES, V65, P9377, DOI 10.1158/0008-5472.CAN-05-1512; Nyalendo C, 2007, J BIOL CHEM, V282, P15690, DOI 10.1074/jbc.M608045200; Olson EN, 1996, SCIENCE, V272, P671, DOI 10.1126/science.272.5262.671; Pepper MS, 2001, ARTERIOSCL THROM VAS, V21, P1104, DOI 10.1161/hq0701.093685; Potter DA, 1998, J CELL BIOL, V141, P647, DOI 10.1083/jcb.141.3.647; Saunders WB, 2006, J CELL BIOL, V175, P179, DOI 10.1083/jcb.200603176; Stratman AN, 2009, BLOOD, V114, P237, DOI 10.1182/blood-2008-12-196451; Su SC, 2008, AM J PHYSIOL-CELL PH, V295, pC1215, DOI 10.1152/ajpcell.00336.2008; Su YC, 2006, FASEB J, V20, P1443, DOI 10.1096/fj.05-5354com; Takahashi M, 1997, J VASC RES, V34, P212, DOI 10.1159/000159225; Tamada Y, 2000, J OCUL PHARMACOL TH, V16, P271, DOI 10.1089/jop.2000.16.271; Wells A, 2005, INT REV CYTOL, V245, P1, DOI 10.1016/S0074-7696(05)45001-9; Yana I, 2007, J CELL SCI, V120, P1607, DOI 10.1242/jcs.000679; Yatomi Y, 1997, J BIOCHEM, V121, P969; Zhou ZJ, 2000, P NATL ACAD SCI USA, V97, P4052, DOI 10.1073/pnas.060037197	66	35	35	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42017	42026		10.1074/jbc.M111.290841	http://dx.doi.org/10.1074/jbc.M111.290841			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	22002053	Green Published, hybrid			2022-12-27	WOS:000298180900012
J	Labasque, M; Devaux, JJ; Leveque, C; Faivre-Sarrailh, C				Labasque, Marilyne; Devaux, Jerome J.; Leveque, Christian; Faivre-Sarrailh, Catherine			Fibronectin Type III-like Domains of Neurofascin-186 Protein Mediate Gliomedin Binding and Its Clustering at the Developing Nodes of Ranvier	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AXONAL SURFACE; ANKYRIN-G; NRCAM; DIFFERENTIATION; CONTACTIN; CHANNELS; COMPLEX; MATRIX; CAM; F11	The cell adhesion molecules (CAMs) of the immunoglobulin superfamily (Ig-CAMs) play a crucial role in the organization of the node of Ranvier in myelinated axons. In the peripheral nervous system, Gliomedin (Gldn) secreted by Schwann cell microvilli binds NgCAM-related CAM (NrCAM) and Neurofascin-186 (NF186) and direct the nodal clustering of voltage-gated sodium channels (Nav). NF186 is the single axonal Gldn partner to ensure Nav clustering at nodes, whereas NrCAM is only required in glial cells (Feinberg, K., Eshed-Eisenbach, Y., Frechter, S., Amor, V., Salomon, D., Sabanay, H., Dupree, J. L., Grumet, M., Brophy, P. J., Shrager, P., and Peles, E. (2010) Neuron 65, 490-502). The olfactomedin domain of Gldn is implicated in the interaction with nodal Ig-CAMs. However, the interacting modules of NrCAM or NF186 involved in Gldn association are unknown. Here, we report that fibronectin type III-like (FnIII) domains of both Ig-CAMs mediate their interaction with Gldn in pulldown and cell binding assays. Using surface plasmon resonance assays, we determined that NrCAM and NF186 display similar affinity constant for their association with Gldn (K-D of 0.9 and 5.7 nM, respectively). We characterized the FnIII domains 1 and 2 of NF186 as interacting modules that ensure association with Gldn. We found that the soluble FnIII domains of NF186 (FnIII-Fc) bind on Schwann cells and inhibit Gldn and Nav clustering at heminodes, the precursors of mature nodes in myelinating cultures. Our study reveals the unexpected importance of FnIII domains of Ig-CAMs in the organization of nodes of Ranvier in peripheral axons. Thus, NF186 utilizes distinct modules to organize the multimeric nodal complex.	[Labasque, Marilyne; Devaux, Jerome J.; Faivre-Sarrailh, Catherine] Aix Marseille Univ, Ctr Rech Neurobiol & Neurophysiol Marseille, F-13344 Marseille, France; [Labasque, Marilyne; Devaux, Jerome J.; Faivre-Sarrailh, Catherine] CNRS, UMR 6231, F-13344 Marseille, France; [Leveque, Christian] Ctr Anal Proteom Marseille, F-13344 Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS)	Faivre-Sarrailh, C (corresponding author), Fac Med Nord, UMR CRN2M 6231, Bd Pierre Dramard, F-13344 Marseille 15, France.	catherine.sarrailh@univmed.fr	Faivre-Sarrailh, Catherine/M-6738-2016; Labasque, Marilyne/AAE-2498-2022; leveque, christian/GVU-3567-2022; Devaux, jerome/X-8581-2019	leveque, christian/0000-0003-2583-2148; Devaux, jerome/0000-0001-6383-4334; Faivre-Sarrailh, Catherine/0000-0002-1718-0533; Labasque, Marilyne/0000-0002-1467-2866	Association pour la Recherche sur la Sclerose en Plaques; National Multiple Sclerosis Society	Association pour la Recherche sur la Sclerose en Plaques; National Multiple Sclerosis Society(National Multiple Sclerosis Society)	This work was supported by the Association pour la Recherche sur la Sclerose en Plaques (to C. F.-S.) and the National Multiple Sclerosis Society (to C. F.-S., fellowship for M. L.).	Bonnon C, 2007, MOL BIOL CELL, V18, P229, DOI 10.1091/mbc.E06-06-0570; Cervello M, 1996, J CELL SCI, V109, P699; Charles P, 2002, CURR BIOL, V12, P217, DOI 10.1016/S0960-9822(01)00680-7; Davis JQ, 1996, J CELL BIOL, V135, P1355, DOI 10.1083/jcb.135.5.1355; Derfuss T, 2010, J MOL MED, V88, P753, DOI 10.1007/s00109-010-0632-3; Devaux JJ, 2004, J NEUROSCI, V24, P1236, DOI 10.1523/JNEUROSCI.4512-03.2004; Dzhashiashvili Y, 2007, J CELL BIOL, V177, P857, DOI 10.1083/jcb.200612012; ELDRIDGE CF, 1987, J CELL BIOL, V105, P1023, DOI 10.1083/jcb.105.2.1023; Eshed Y, 2005, NEURON, V47, P215, DOI 10.1016/j.neuron.2005.06.026; Eshed Y, 2007, J CELL BIOL, V177, P551, DOI 10.1083/jcb.200612139; Falk J, 2004, MOL BIOL CELL, V15, P4695, DOI 10.1091/mbc.E04-03-0171; Feinberg K, 2010, NEURON, V65, P490, DOI 10.1016/j.neuron.2010.02.004; He YN, 2009, STRUCTURE, V17, P460, DOI 10.1016/j.str.2009.01.009; Hedstrom KL, 2007, J CELL BIOL, V178, P875, DOI 10.1083/jcb.200705119; Koticha D, 2006, DEV BIOL, V293, P1, DOI 10.1016/j.ydbio.2005.05.028; Labasque M, 2010, FEBS LETT, V584, P1787, DOI 10.1016/j.febslet.2009.08.025; Liu HL, 2011, J BIOL CHEM, V286, P797, DOI 10.1074/jbc.M110.180281; Lonigro A, 2009, BRAIN, V132, P260, DOI 10.1093/brain/awn281; Lustig M, 2001, CURR BIOL, V11, P1864, DOI 10.1016/S0960-9822(01)00586-3; Maertens B, 2007, J BIOL CHEM, V282, P10647, DOI 10.1074/jbc.M611339200; Marqueze-Pouey B, 2008, TRAFFIC, V9, P1088, DOI 10.1111/j.1600-0854.2008.00743.x; Mathey EK, 2007, J EXP MED, V204, P2363, DOI 10.1084/jem.20071053; Pillai AM, 2009, J NEUROSCI RES, V87, P1773, DOI 10.1002/jnr.22015; Poliak S, 2003, NAT REV NEUROSCI, V4, P968, DOI 10.1038/nrn1253; Rasband Matthew N., 2006, V43, P129, DOI 10.1007/014; Rasband MN, 1999, J NEUROSCI, V19, P7516, DOI 10.1523/JNEUROSCI.19-17-07516.1999; Ratcliffe CF, 2001, J CELL BIOL, V154, P427, DOI 10.1083/jcb.200102086; Sherman DL, 2005, NEURON, V48, P737, DOI 10.1016/j.neuron.2005.10.019; Silletti S, 2000, J CELL BIOL, V149, P1485, DOI 10.1083/jcb.149.7.1485; Thaxton C, 2011, NEURON, V69, P244, DOI 10.1016/j.neuron.2010.12.016; Thaxton C, 2010, J NEUROSCI, V30, P4868, DOI 10.1523/JNEUROSCI.5951-09.2010; VOLKMER H, 1992, J CELL BIOL, V118, P149, DOI 10.1083/jcb.118.1.149; Volkmer H, 1996, J CELL BIOL, V135, P1059, DOI 10.1083/jcb.135.4.1059; Volkmer H, 1998, J CELL BIOL, V142, P1083, DOI 10.1083/jcb.142.4.1083; Zonta B, 2008, J CELL BIOL, V181, P1169, DOI 10.1083/jcb.200712154	35	31	32	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42426	42434		10.1074/jbc.M111.266353	http://dx.doi.org/10.1074/jbc.M111.266353			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	22009740	hybrid, Green Published			2022-12-27	WOS:000298180900051
J	Beenken, A; Eliseenkova, AV; Ibrahimi, OA; Olsen, SK; Mohammadi, M				Beenken, Andrew; Eliseenkova, Anna V.; Ibrahimi, Omar A.; Olsen, Shaun K.; Mohammadi, Moosa			Plasticity in Interactions of Fibroblast Growth Factor 1 (FGF1) N Terminus with FGF Receptors Underlies Promiscuity of FGF1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBROBLAST-GROWTH-FACTOR; LIGAND-BINDING SPECIFICITY; HIGH-AFFINITY RECEPTOR; STRUCTURAL BASIS; SIGNAL-TRANSDUCTION; PHOSPHATIDYLINOSITOL HYDROLYSIS; HOMOLOGOUS FACTORS; CRYSTAL-STRUCTURE; METABOLIC-RATE; FACTOR FAMILY	Tissue-specific alternative splicing in the second half of Ig-like domain 3 (D3) of fibroblast growth factor receptors 1-3 (FGFR1 to -3) generates epithelial FGFR1b-FGFR3b and mesenchymal FGFR1c-FGFR3c splice isoforms. This splicing event establishes a selectivity filter to restrict the ligand binding specificity of FGFRb and FGFRc isoforms to mesenchymally and epithelially derived fibroblast growth factors (FGFs), respectively. FGF1 is termed the "universal FGFR ligand" because it overrides this specificity barrier. To elucidate the molecular basis for FGF1 cross-reactivity with the "b" and "c" splice isoforms of FGFRs, we determined the first crystal structure of FGF1 in complex with an FGFRb isoform, FGFR2b, at 2.1 angstrom resolution. Comparison of the FGF1-FGFR2b structure with the three previously published FGF1-FGFRc structures reveals that plasticity in the interactions of the N-terminal region of FGF1 with FGFR D3 is the main determinant of FGF1 cross-reactivity with both isoforms of FGFRs. In support of our structural data, we demonstrate that substitution of three N-terminal residues (Gly-19, His-25, and Phe-26) of FGF2 (a ligand that does not bind FGFR2b) for the corresponding residues of FGF1 (Phe-16, Asn-22, and Tyr-23) enables the FGF2 triple mutant to bind and activate FGFR2b. These findings taken together with our previous structural data on receptor binding specificity of FGF2, FGF8, and FGF10 conclusively show that sequence divergence at the N termini of FGFs is the primary regulator of the receptor binding specificity and promiscuity of FGFs.	[Beenken, Andrew; Eliseenkova, Anna V.; Ibrahimi, Omar A.; Olsen, Shaun K.; Mohammadi, Moosa] NYU, Dept Pharmacol, Sch Med, New York, NY 10016 USA	New York University	Mohammadi, M (corresponding author), 550 1st Ave,Med Sci Bldg,Rm 425A, New York, NY 10016 USA.	moosa.mohammadi@nyumc.org	Mohammadi, Moosa/ABA-6745-2020; kasaei, fahime/T-7197-2018	Mohammadi, Moosa/0000-0003-2434-9437; Olsen, Shaun/0000-0002-1265-7101	National Institutes of Health (NIH) [DE13686, P30 N5050276]; NIH/NIGMS [T32 GM066704]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE013686] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM066704] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health (NIH) Grant DE13686 (to M. M.).; Supported in part by the Training in Pharmacological Sciences grant (NIH/NIGMS Grant T32 GM066704).; We thank Dr. Regina Goetz for critically reading and editing the manuscript. We are grateful to Drs. R. Abramowitz and J. Schwanof for synchrotron beamline assistance. Beamlines X-4A and X-4C at the National Synchrotron Light Source, Brookhaven National Laboratory, a Department of Energy facility, are supported by the New York Structural Biology Consortium. The Biacore 2000 SPR instrument is supported by National Institutes of Health Instrument Grant P30 N5050276 (to Dr. Thomas A. Neubert).	Beenken A., 2012, VERSATILE BIOL FUNCT; Beenken A, 2009, NAT REV DRUG DISCOV, V8, P235, DOI 10.1038/nrd2792; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Byron SA, 2010, GYNECOL ONCOL, V117, P125, DOI 10.1016/j.ygyno.2009.12.002; Carballada R, 2001, DEVELOPMENT, V128, P35; Chellaiah A, 1999, J BIOL CHEM, V274, P34785, DOI 10.1074/jbc.274.49.34785; CHELLAIAH AT, 1994, J BIOL CHEM, V269, P11620; Chen HB, 2008, P NATL ACAD SCI USA, V105, P19660, DOI 10.1073/pnas.0807752105; Coskun T, 2008, ENDOCRINOLOGY, V149, P6018, DOI 10.1210/en.2008-0816; Dailey L, 2005, CYTOKINE GROWTH F R, V16, P233, DOI 10.1016/j.cytogfr.2005.01.007; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Fu L, 2004, ENDOCRINOLOGY, V145, P2594, DOI 10.1210/en.2003-1671; Gartside MG, 2009, MOL CANCER RES, V7, P41, DOI 10.1158/1541-7786.MCR-08-0021; GIVOL D, 1992, FASEB J, V6, P3362, DOI 10.1096/fasebj.6.15.1464370; Goetz R, 2007, MOL CELL BIOL, V27, P3417, DOI 10.1128/MCB.02249-06; Goetz R, 2009, J BIOL CHEM, V284, P17883, DOI 10.1074/jbc.M109.001842; Goldfarb M, 2005, CYTOKINE GROWTH F R, V16, P215, DOI 10.1016/j.cytogfr.2005.02.002; Hadari YR, 2001, P NATL ACAD SCI USA, V98, P8578, DOI 10.1073/pnas.161259898; Holt JA, 2003, GENE DEV, V17, P1581, DOI 10.1101/gad.1083503; HUANG JT, 1995, J BIOL CHEM, V270, P5065, DOI 10.1074/jbc.270.10.5065; Ibrahimi OA, 2005, MOL CELL BIOL, V25, P671, DOI 10.1128/MCB.25.2.671-684.2005; Ibrahimi OA, 2004, HUM MOL GENET, V13, P2313, DOI 10.1093/hmg/ddh235; Ibrahimi OA, 2001, P NATL ACAD SCI USA, V98, P7182, DOI 10.1073/pnas.121183798; Inoue Y, 2005, BIOCHEM J, V390, P325, DOI 10.1042/BJ20041799; Itoh N, 2004, TRENDS GENET, V20, P563, DOI 10.1016/j.tig.2004.08.007; JOHNSON DE, 1993, ADV CANCER RES, V60, P1; JOHNSON DE, 1991, MOL CELL BIOL, V11, P4627, DOI 10.1128/MCB.11.9.4627; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kharitonenkov A, 2007, ENDOCRINOLOGY, V148, P774, DOI 10.1210/en.2006-1168; Kouhara H, 1997, CELL, V89, P693, DOI 10.1016/S0092-8674(00)80252-4; Kuro-o M, 2008, TRENDS ENDOCRIN MET, V19, P239, DOI 10.1016/j.tem.2008.06.002; Kurosu H, 2006, J BIOL CHEM, V281, P6120, DOI 10.1074/jbc.C500457200; LEE PL, 1989, SCIENCE, V245, P57, DOI 10.1126/science.2544996; Lundasen T, 2006, J INTERN MED, V260, P530, DOI 10.1111/j.1365-2796.2006.01731.x; Luo YD, 1996, J BIOL CHEM, V271, P26876, DOI 10.1074/jbc.271.43.26876; MACARTHUR CA, 1995, DEVELOPMENT, V121, P3603; MIKI T, 1992, P NATL ACAD SCI USA, V89, P246, DOI 10.1073/pnas.89.1.246; Mohammadi M, 2005, CYTOKINE GROWTH F R, V16, P107, DOI 10.1016/j.cytogfr.2005.01.008; MOHAMMADI M, 1992, NATURE, V358, P681, DOI 10.1038/358681a0; Mohammadi M, 1996, MOL CELL BIOL, V16, P977; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Olsen SK, 2006, GENE DEV, V20, P185, DOI 10.1101/gad.1365406; Olsen SK, 2004, P NATL ACAD SCI USA, V101, P935, DOI 10.1073/pnas.0307287101; Olsen SK, 2003, J BIOL CHEM, V278, P34226, DOI 10.1074/jbc.M303183200; Ong SH, 2001, P NATL ACAD SCI USA, V98, P6074, DOI 10.1073/pnas.111114298; Ornitz DM, 1996, J BIOL CHEM, V271, P15292, DOI 10.1074/jbc.271.25.15292; Ornitz DM, 2005, CYTOKINE GROWTH F R, V16, P205, DOI 10.1016/j.cytogfr.2005.02.003; ORNITZ DM, 1992, MOL CELL BIOL, V12, P240, DOI 10.1128/MCB.12.1.240; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Plotnikov AN, 1999, CELL, V98, P641, DOI 10.1016/S0092-8674(00)80051-3; Plotnikov AN, 2000, CELL, V101, P413, DOI 10.1016/S0092-8674(00)80851-X; Popovici C, 2005, BIOESSAYS, V27, P849, DOI 10.1002/bies.20261; RAPRAEGER AC, 1991, SCIENCE, V252, P1705, DOI 10.1126/science.1646484; RON D, 1993, J BIOL CHEM, V268, P5388; Saito H, 2003, J BIOL CHEM, V278, P2206, DOI 10.1074/jbc.M207872200; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; Segawa H, 2003, PFLUG ARCH EUR J PHY, V446, P585, DOI 10.1007/s00424-003-1084-1; Seo JH, 2009, MOL CELL BIOL, V29, P3076, DOI 10.1128/MCB.01686-08; Stauber DJ, 2000, P NATL ACAD SCI USA, V97, P49, DOI 10.1073/pnas.97.1.49; Tomlinson E, 2002, ENDOCRINOLOGY, V143, P1741, DOI 10.1210/en.143.5.1741; Urakawa I, 2006, NATURE, V444, P770, DOI 10.1038/nature05315; VAINIKKA S, 1992, EMBO J, V11, P4273, DOI 10.1002/j.1460-2075.1992.tb05526.x; WANG F, 1995, J BIOL CHEM, V270, P10231, DOI 10.1074/jbc.270.17.10231; Wu XL, 2010, P NATL ACAD SCI USA, V107, P14158, DOI 10.1073/pnas.1009427107; Xu J, 2009, DIABETES, V58, P250, DOI 10.2337/db08-0392; YAYON A, 1992, EMBO J, V11, P1885, DOI 10.1002/j.1460-2075.1992.tb05240.x; YAYON A, 1991, CELL, V64, P841, DOI 10.1016/0092-8674(91)90512-W; Yeh BK, 2003, P NATL ACAD SCI USA, V100, P2266, DOI 10.1073/pnas.0436500100; Zhang XQ, 2006, J BIOL CHEM, V281, P15694, DOI 10.1074/jbc.M601252200	70	30	46	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					3067	3078		10.1074/jbc.M111.275891	http://dx.doi.org/10.1074/jbc.M111.275891			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22057274	hybrid, Green Published			2022-12-27	WOS:000300295100013
J	Lambrecht, JA; Flynn, JM; Downs, DM				Lambrecht, Jennifer A.; Flynn, Jeffrey M.; Downs, Diana M.			Conserved YjgF Protein Family Deaminates Reactive Enamine/Imine Intermediates of Pyridoxal 5 '-Phosphate (PLP)-dependent Enzyme Reactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERINE O-SULFATE; YJGF/YER057C/UK114 FAMILY; CRYSTAL-STRUCTURE; THREONINE DEAMINASE; SALMONELLA-ENTERICA; ESCHERICHIA-COLI; BIOLOGICAL-RESEARCH; MEMBER; DEGRADATION; PATHWAY	The YjgF/YER057c/UK114 family of proteins is conserved in all domains of life, suggesting that the role of these proteins arose early and was maintained throughout evolution. Metabolic consequences of lacking this protein in Salmonella enterica and other organisms have been described, but the biochemical function of YjgF remained unknown. This work provides the first description of a conserved biochemical activity for the YjgF protein family. Our data support the conclusion that YjgF proteins have enamine/imine deaminase activity and accelerate the release of ammonia from reactive enamine/imine intermediates of the pyridoxal 5'-phosphate-dependent threonine dehydratase (IlvA). Results from structure-guided mutagenesis experiments suggest that YjgF lacks a catalytic residue and that it facilitates ammonia release by positioning a critical water molecule in the active site. YjgF is renamed RidA (reactive intermediate/imine deaminase A) to reflect the conserved activity of the protein family described here. This study, combined with previous physiological studies on yjgF mutants, suggests that intermediates of pyridoxal 5'-phosphate-mediated reactions may have metabolic consequences in vivo that were previously unappreciated. The conservation of the RidA/YjgF family suggests that reactive enamine/imine metabolites are of concern to all organisms.	[Lambrecht, Jennifer A.; Flynn, Jeffrey M.; Downs, Diana M.] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Downs, DM (corresponding author), 1550 Linden Dr, Madison, WI 53706 USA.	downs@bact.wisc.edu			National Institutes of Health from the USPHS [R01 GM095837]; National Institutes of Health [T32 GM07215]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095837, T32GM007215] Funding Source: NIH RePORTER	National Institutes of Health from the USPHS; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM095837 from the USPHS (to D. M. D.).; Supported by a Molecular Biosciences Training Grant from the National Institutes of Health (T32 GM07215).	Browne BA, 2006, J BACTERIOL, V188, P6786, DOI 10.1128/JB.00745-06; Burman JD, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-30; Burns RO., 1971, METHOD ENZYMOL, V17B, P555; Chargaff E., 1943, J BIOL CHEM, V151, P273; Christopherson MR, 2008, J BACTERIOL, V190, P3057, DOI 10.1128/JB.01700-07; Colabroy KL, 2005, J BACTERIOL, V187, P7866, DOI 10.1128/JB.187.22.7866-7869.2005; DATTA P, 1978, EUR J BIOCHEM, V91, P527, DOI 10.1111/j.1432-1033.1978.tb12706.x; DAVIS L, 1965, ANAL BIOCHEM, V12, P36, DOI 10.1016/0003-2697(65)90139-9; Davis L., 1972, ENZYMES, V7, P33; Deaconescu AM, 2002, PROTEINS, V48, P431, DOI 10.1002/prot.10151; Deriu D, 2003, ACTA CRYSTALLOGR D, V59, P1676, DOI 10.1107/S0907444903014306; DUNATHAN HC, 1971, ADV ENZYMOL RAMB, V35, P79; Enos-Berlage JL, 1998, J BACTERIOL, V180, P6519, DOI 10.1128/JB.180.24.6519-6528.1998; FELDBERG RS, 1971, EUR J BIOCHEM, V21, P438, DOI 10.1111/j.1432-1033.1971.tb01490.x; FELDBERG RS, 1970, SCIENCE, V170, P1414, DOI 10.1126/science.170.3965.1414; FLAVIN M, 1964, BIOCHEMISTRY-US, V3, P885, DOI 10.1021/bi00895a004; GOOD NE, 1966, BIOCHEMISTRY-US, V5, P467, DOI 10.1021/bi00866a011; GRABOWSKI R, 1993, TRENDS BIOCHEM SCI, V18, P297, DOI 10.1016/0968-0004(93)90040-T; He ZG, 1998, J BACTERIOL, V180, P2502, DOI 10.1128/JB.180.9.2502-2506.1998; HILLEBRAND GG, 1979, BIOCHEMISTRY-US, V18, P1751, DOI 10.1021/bi00576a018; Kim KS, 2010, J BACTERIOL, V192, P4089, DOI 10.1128/JB.00201-10; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; Lambrecht JA, 2010, J BIOL CHEM, V285, P34401, DOI 10.1074/jbc.M110.160515; Leitner-Dagan Y, 2006, PLANTA, V225, P89, DOI 10.1007/s00425-006-0332-y; LI RS, 1995, ANAL BIOCHEM, V230, P37, DOI 10.1006/abio.1995.1434; LIKOS JJ, 1982, BIOCHEMISTRY-US, V21, P4377, DOI 10.1021/bi00261a029; Manjasetty BA, 2004, PROTEINS, V54, P797, DOI 10.1002/prot.10619; Miyakawa T, 2006, PROTEINS, V62, P557, DOI 10.1002/prot.20778; Orii C, 2004, EUR J BIOCHEM, V271, P3248, DOI 10.1111/j.1432-1033.2004.04258.x; Park HS, 2000, J BACTERIOL, V182, P573, DOI 10.1128/JB.182.3.573-580.2000; Parsons L, 2003, BIOCHEMISTRY-US, V42, P80, DOI 10.1021/bi020541w; PHILLIPS AT, 1965, J BIOL CHEM, V240, P4703; Sawers G, 1998, ARCH MICROBIOL, V171, P1, DOI 10.1007/s002030050670; Schmitz G, 2004, J BACTERIOL, V186, P803, DOI 10.1128/JB.186.3.803-810.2004; Sinha S, 1999, P NATL ACAD SCI USA, V96, P13074, DOI 10.1073/pnas.96.23.13074; Takenaka S, 2000, ARCH MICROBIOL, V174, P265, DOI 10.1007/s002030000203; Takenaka S, 2009, FEMS MICROBIOL LETT, V298, P93, DOI 10.1111/j.1574-6968.2009.01699.x; Thakur KG, 2010, PROTEINS, V78, P773, DOI 10.1002/prot.22623; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; UENO H, 1982, BIOCHEMISTRY-US, V21, P4387, DOI 10.1021/bi00261a030; Volz K, 1999, PROTEIN SCI, V8, P2428; WOOD WA, 1949, J BIOL CHEM, V181, P171; ZARLENGO MH, 1968, J BIOL CHEM, V243, P186; Zelyas NJ, 2008, J BACTERIOL, V190, P7957, DOI 10.1128/JB.00698-08; Zhou HX, 2008, ANNU REV BIOPHYS, V37, P375, DOI 10.1146/annurev.biophys.37.032807.125817	45	85	91	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					3454	3461		10.1074/jbc.M111.304477	http://dx.doi.org/10.1074/jbc.M111.304477			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22094463	Green Published, hybrid			2022-12-27	WOS:000300295100050
J	Eylenstein, A; Schmidt, S; Gu, SC; Yang, WT; Schmid, E; Schmidt, EM; Alesutan, I; Szteyn, K; Regel, I; Shumilina, E; Lang, F				Eylenstein, Anja; Schmidt, Sebastian; Gu, Shuchen; Yang, Wenting; Schmid, Evi; Schmidt, Eva-Maria; Alesutan, Ioana; Szteyn, Kalina; Regel, Ivonne; Shumilina, Ekaterina; Lang, Florian			Transcription Factor NF-kappa B Regulates Expression of Pore-forming Ca2+ Channel Unit, Orai1, and Its Activator, STIM1, to Control Ca2+ Entry and Affect Cellular Functions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNALING PATHWAYS; CRAC CHANNEL; EPITHELIAL-CELLS; GENE-EXPRESSION; CALCIUM-ENTRY; MICE LACKING; KINASE; MUSCLE; MIGRATION; APOPTOSIS	The serum and glucocorticoid-inducible kinase SGK1 increases the activity of Orai1, the pore forming unit of store-operated Ca2+ entry, and thus influences Ca2+-dependent cellular functions such as migration. SGK1 further regulates transcription factor nuclear factor kappa B (NF-kappa B). This study explored whether SGK1 influences transcription of Orai1 and/or STIM1, the Orai1-activating Ca2+ sensor. Orai1 and STIM1 transcript levels were decreased in mast cells from SGK1 knock-out mice and increased in HEK293 cells transfected with active (S422D)SGK1 but not with inactive (K127N)SGK1 or in (S422D)SGK1-transfected cells treated with the NF-kappa B inhibitor Wogonin (100 mu M). Treatment with the stem cell factor enhanced transcript levels of STIM1 and Orai1 in sgk1(+/+) but not in sgk1(-/-) mast cells and not in sgk1(+/+) cells treated with Wogonin. Orai1 and STIM1 transcript levels were further increased in sgk1(+/+) and sgk1(-/-) mast cells by transfection with active NF-kappa B subunit p65 as well as in HEK293 cells by transfection with NF-kappa B subunits p65/p50 or p65/p52. They were decreased by silencing of NF-kappa B subunits p65, p50, or p52 or by NF-kappa B inhibitor Wogonin (100 mu M). Luciferase assay and chromatin immuno-precipitation defined NF-kappa B-binding sites in promoter regions accounting for NF-kappa B sensitive genomic regulation of STIM1 and Orai1. Store-operated Ca2+ entry was similarly increased by overexpression of p65/p50 or p65/p52 and decreased by treatment with Wogonin. Transfection of HEK293 cells with p65/p50 or p65/p52 further augmented migration. The present observations reveal powerful genomic regulation of Orai1/STIM1 by SGK1-dependent NF-kappa B signaling.	[Eylenstein, Anja; Schmidt, Sebastian; Gu, Shuchen; Yang, Wenting; Schmid, Evi; Schmidt, Eva-Maria; Alesutan, Ioana; Szteyn, Kalina; Shumilina, Ekaterina; Lang, Florian] Univ Tubingen, Dept Physiol, D-72076 Tubingen, Germany; [Regel, Ivonne] Tech Univ Munich, Dept Surg, Klinikum Rechts Isar, D-81675 Munich, Germany	Eberhard Karls University of Tubingen; Technical University of Munich	Lang, F (corresponding author), Univ Tubingen, Dept Physiol, Gmelinstr 5, D-72076 Tubingen, Germany.	florian.lang@uni-tuebingen.de	Regel, Ivonne/AFS-1831-2022		Deutsche Forschungsgemeinschaft [GK 1302, SFB 773]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (GK 1302 and SFB 773).	Ali K, 2004, NATURE, V431, P1007, DOI 10.1038/nature02991; Baba Y, 2008, NAT IMMUNOL, V9, P81, DOI 10.1038/ni1546; Baryshnikov SG, 2009, AM J PHYSIOL-CELL PH, V297, pC1103, DOI 10.1152/ajpcell.00283.2009; Becchetti A, 2010, ADV EXP MED BIOL, V674, P107; BelAiba RS, 2006, CIRC RES, V98, P828, DOI 10.1161/01.RES.0000210539.54861.27; Bird GS, 2008, METHODS, V46, P204, DOI 10.1016/j.ymeth.2008.09.009; Burgoyne RD, 2007, NAT REV NEUROSCI, V8, P182, DOI 10.1038/nrn2093; Cahalan MD, 2007, CELL CALCIUM, V42, P133, DOI 10.1016/j.ceca.2007.03.002; Chung SC, 2007, J CELL BIOL, V177, P317, DOI 10.1083/jcb.200702050; Criollo A, 2010, AUTOPHAGY, V6, P189, DOI 10.4161/auto.6.1.10818; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Edwards JN, 2010, AM J PHYSIOL-CELL PH, V299, pC42, DOI 10.1152/ajpcell.00524.2009; Eylenstein A, 2011, FASEB J, V25, P2012, DOI 10.1096/fj.10-178210; Fahmer M, 2009, IMMUNOL REV, V231, P99, DOI 10.1111/j.1600-065X.2009.00815.x; Faouzi M, 2011, J CELL PHYSIOL, V226, P542, DOI 10.1002/jcp.22363; Fas SC, 2006, BLOOD, V108, P3700, DOI 10.1182/blood-2006-03-011973; Feske S, 2007, NAT REV IMMUNOL, V7, P690, DOI 10.1038/nri2152; Jandeleit-Dahm K, 2008, CURR PHARM DESIGN, V14, P979, DOI 10.2174/138161208784139684; Johnstone LS, 2010, J CELL MOL MED, V14, P1890, DOI 10.1111/j.1582-4934.2010.01097.x; Jung ID, 2009, CELL SIGNAL, V21, P1698, DOI 10.1016/j.cellsig.2009.07.008; Kasinski AL, 2010, CURR OPIN MOL THER, V12, P147; Keil JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013465; Lang F, 2000, P NATL ACAD SCI USA, V97, P8157, DOI 10.1073/pnas.97.14.8157; Lang F, 2006, PHYSIOL REV, V86, P1151, DOI 10.1152/physrev.00050.2005; Lang F, 2010, INT J BIOCHEM CELL B, V42, P1571, DOI 10.1016/j.biocel.2010.05.016; Lee SO, 2006, BIOCHEM BIOPH RES CO, V351, P118, DOI 10.1016/j.bbrc.2006.10.006; Leong MLL, 2003, J BIOL CHEM, V278, P5871, DOI 10.1074/jbc.M211649200; Liang XB, 2008, J BIOL CHEM, V283, P27418, DOI 10.1074/jbc.M803687200; Lu SC, 2009, MOL ASPECTS MED, V30, P42, DOI 10.1016/j.mam.2008.05.005; Mandrup-Poulsen T, 2010, NAT REV ENDOCRINOL, V6, P158, DOI 10.1038/nrendo.2009.271; Monici MC, 2003, NEUROLOGY, V60, P993, DOI 10.1212/01.WNL.0000049913.27181.51; Motiani RK, 2010, J BIOL CHEM, V285, P19173, DOI 10.1074/jbc.M110.102582; O'Brien CA, 2010, BONE, V46, P911, DOI 10.1016/j.bone.2009.08.050; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Parekh AB, 1997, PHYSIOL REV, V77, P901, DOI 10.1152/physrev.1997.77.4.901; Peinelt C, 2006, NAT CELL BIOL, V8, P771, DOI 10.1038/ncb1435; Penna A, 2008, NATURE, V456, P116, DOI 10.1038/nature07338; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Picard C, 2009, NEW ENGL J MED, V360, P1971, DOI 10.1056/NEJMoa0900082; Porter JD, 2003, HUM MOL GENET, V12, P1813, DOI 10.1093/hmg/ddg197; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Putney JW, 2005, J CELL BIOL, V169, P381, DOI 10.1083/jcb.200503161; Reid IR, 2008, SEMIN CELL DEV BIOL, V19, P473, DOI 10.1016/j.semcdb.2008.08.002; Roderick HL, 2008, NAT REV CANCER, V8, P361, DOI 10.1038/nrc2374; Ruan H, 2009, CURR OPIN INVEST DR, V10, P346; Rudd CE, 2009, IMMUNOL REV, V229, P12, DOI 10.1111/j.1600-065X.2009.00770.x; Salter RD, 2009, IMMUNOL REV, V231, P278, DOI 10.1111/j.1600-065X.2009.00806.x; Sanjabi S, 2005, GENE DEV, V19, P2138, DOI 10.1101/gad.1329805; Schaff UY, 2010, BLOOD, V115, P657, DOI 10.1182/blood-2009-05-224659; Segal RA, 2003, ANNU REV NEUROSCI, V26, P299, DOI 10.1146/annurev.neuro.26.041002.131421; Shen HM, 2009, APOPTOSIS, V14, P348, DOI 10.1007/s10495-009-0315-0; Shih VFS, 2011, CELL RES, V21, P86, DOI 10.1038/cr.2010.161; Shin DM, 2008, NAT CELL BIOL, V10, P639, DOI 10.1038/ncb0608-639; Shumilina E, 2008, J IMMUNOL, V180, P8040, DOI 10.4049/jimmunol.180.12.8040; Snyder PM, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.279pe41; Sobiesiak M, 2009, J IMMUNOL, V183, P4395, DOI 10.4049/jimmunol.0803017; Tai DJC, 2009, J BIOL CHEM, V284, P4073, DOI 10.1074/jbc.M805055200; Tisdale MJ, 2009, PHYSIOL REV, V89, P381, DOI 10.1152/physrev.00016.2008; Vallon V, 2006, J MOL MED, V84, P396, DOI 10.1007/s00109-005-0027-z; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Vig M, 2008, NAT IMMUNOL, V9, P89, DOI 10.1038/ni1550; Wang K, 2010, CELL PHYSIOL BIOCHEM, V25, P271, DOI 10.1159/000276561; Wulff P, 2002, J CLIN INVEST, V110, P1263, DOI 10.1172/JCI200215696; Yang SY, 2009, CANCER CELL, V15, P124, DOI 10.1016/j.ccr.2008.12.019; Yu F, 2010, J CELL BIOL, V191, P523, DOI 10.1083/jcb.201006022; Zhang SYL, 2008, J BIOL CHEM, V283, P17662, DOI 10.1074/jbc.M801536200	66	64	66	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2719	2730		10.1074/jbc.M111.275925	http://dx.doi.org/10.1074/jbc.M111.275925			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22110130	hybrid, Green Published			2022-12-27	WOS:000300292300043
J	Gibbs, PEM; Miralem, T; Lerner-Marmarosh, N; Tudor, C; Maines, MD				Gibbs, Peter E. M.; Miralem, Tihomir; Lerner-Marmarosh, Nicole; Tudor, Cicerone; Maines, Mahin D.			Formation of Ternary Complex of Human Biliverdin Reductase-Protein Kinase C delta-ERK2 Protein Is Essential for ERK2-mediated Activation of Elk1 Protein, Nuclear Factor-kappa B, and Inducible Nitric-oxidase Synthase (iNOS)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IX-ALPHA REDUCTASE; DELTA PKC-DELTA; C-DELTA; HEME OXYGENASE-1; CRYSTAL-STRUCTURE; BILIRUBIN; PHOSPHORYLATION; RECEPTOR; EXPRESSION; INDUCTION	Growth factors, insulin, oxidative stress, and cytokines activate ERK1/2 by PKC delta and MEK1/2. Human biliverdin reductase (hBVR), a Ser/Thr/Tyr kinase and intracellular scaffold/bridge/anchor, is a nuclear transporter of MEK1/2-stimulated ERK1/2 (Lerner-Marmarosh, N., Miralem, T., Gibbs, P. E., and Maines, M. D. (2008) Proc. Natl. Acad. Sci. U. S. A. 105, 6870-6875). hBVR, PKC delta, and MEK1/2 overlap in their tissue expression profile and type of activators. Presently, we report on formation of an hBVR-PKC delta-ERK2 ternary complex that is essential for ERK2 signal transduction and activation of genes linked to cell proliferation and cancer. MEK1/2 and the protein phosphatase PP2A were also present in the complex. When cells were stimulated with insulin-like growth factor-1 (IGF-1), an increased interaction between hBVR and PKC delta was detected by FRET-fluorescence lifetime imaging microscopy. hBVR and ERK2 were phosphorylated by PKC delta; however, the PKC was not a substrate for either ERK2 or hBVR. IGF-1 and phorbol ester increased hBVR/PKC delta binding; hBVR was required for the activation of PKC delta and its interaction with ERK2. The C-terminal phenylalanine residues of PKC delta (Phe(660), Phe(663), and Phe(665)) were necessary for binding to ERK2 but not for hBVR binding. Formation of the hBVR-PKC delta-ERK2 complex required the hBVR docking site for ERK, FXFP (DEF, C-box) and D(delta)-box (ILXXLXL) motifs. The hBVR-based peptide KKRILHCLGLA inhibited PKC activation and PKC delta/ERK2 interaction. Phorbol ester-and TNF-alpha-dependent activation of the ERK-regulated transcription factors Elk1 and NF-kappa B and expression of the iNOS gene were suppressed by hBVR siRNA; those activities were rescued by hBVR. The findings reveal the direct input of hBVR in PKC delta/ERK signaling and identify hBVR-based peptide regulators of ERK-mediated gene activation.	[Gibbs, Peter E. M.; Miralem, Tihomir; Lerner-Marmarosh, Nicole; Maines, Mahin D.] Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, Rochester, NY 14642 USA; [Tudor, Cicerone] Max Planck Inst Immunobiol & Epigenet, D-79108 Freiburg, Germany	University of Rochester; Max Planck Society	Maines, MD (corresponding author), Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, Rochester, NY 14642 USA.	Mahin_Maines@URMC.rochester.edu	Miralem, Tihomir/F-7576-2013	Miralem, Tihomir/0000-0001-7705-0442	National Institutes of Health [ES04066, ES12187]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES012187, R01ES004066] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants ES04066 and ES12187.	Blake RA, 1999, CELL GROWTH DIFFER, V10, P231; Bourbon NA, 2001, AM J PHYSIOL-CELL PH, V280, pC1403, DOI 10.1152/ajpcell.2001.280.6.C1403; Boutros T, 2008, PHARMACOL REV, V60, P261, DOI 10.1124/pr.107.00106; DeVries TA, 2002, EMBO J, V21, P6050, DOI 10.1093/emboj/cdf606; Florczyk UM, 2008, PHARMACOL REP, V60, P38; Gibbs PEM, 2007, INT J CANCER, V121, P2567, DOI 10.1002/ijc.22978; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Hill BG, 2010, J BIOL CHEM, V285, P19699, DOI 10.1074/jbc.R110.101618; Hodgkinson CP, 2002, BIOCHEMISTRY-US, V41, P561, DOI 10.1021/bi010719z; Horovitz-Fried M, 2008, ENDOCRINOLOGY, V149, P1718, DOI 10.1210/en.2007-1572; HUANG TJ, 1989, ARCH BIOCHEM BIOPHYS, V270, P513, DOI 10.1016/0003-9861(89)90533-X; Jackson DN, 2004, FASEB J, V18, P627, DOI 10.1096/fj.03-0979rev; Jacobs D, 1999, GENE DEV, V13, P163, DOI 10.1101/gad.13.2.163; Kabu K, 2006, J IMMUNOL, V177, P1296, DOI 10.4049/jimmunol.177.2.1296; Kapitulnik J, 2009, TRENDS PHARMACOL SCI, V30, P129, DOI 10.1016/j.tips.2008.12.003; Kaur H, 2003, FEBS LETT, V543, P113, DOI 10.1016/S0014-5793(03)00420-4; Keranen LM, 1995, CURR BIOL, V5, P1394, DOI 10.1016/S0960-9822(95)00277-6; Kim EK, 2010, BBA-MOL BASIS DIS, V1802, P396, DOI 10.1016/j.bbadis.2009.12.009; Kim HP, 2004, FASEB J, V18, P1080, DOI 10.1096/fj.03-1391com; Konishi H, 2001, P NATL ACAD SCI USA, V98, P6587, DOI 10.1073/pnas.111158798; Kravets A, 2004, J BIOL CHEM, V279, P19916, DOI 10.1074/jbc.M314251200; Lee PJ, 2003, FREE RADICAL BIO MED, V35, P341, DOI 10.1016/S0891-5849(03)00279-X; Leonard TA, 2011, CELL, V144, P55, DOI 10.1016/j.cell.2010.12.013; Lerner-Marmarosh N, 2005, P NATL ACAD SCI USA, V102, P7109, DOI 10.1073/pnas.0502173102; Lerner-Marmarosh N, 2008, P NATL ACAD SCI USA, V105, P6870, DOI 10.1073/pnas.0800750105; Lerner-Marmarosh N, 2007, FASEB J, V21, P3949, DOI 10.1096/fj.07-8544com; Li Volti G, 2006, NEPHRON EXP NEPHROL, V104, pE135, DOI 10.1159/000094964; LI WQ, 1995, J BIOL CHEM, V270, P8311, DOI 10.1074/jbc.270.14.8311; Liu B, 2007, J VASC SURG, V45, P160, DOI 10.1016/j.jvs.2006.09.053; Maghzal GJ, 2009, J BIOL CHEM, V284, P29251, DOI 10.1074/jbc.M109.037119; Maines MD, 2007, ANTIOXID REDOX SIGN, V9, P2187, DOI 10.1089/ars.2007.1805; Maines MD, 2007, J BIOL CHEM, V282, P8110, DOI 10.1074/jbc.M513427200; Maines MD, 2005, PHYSIOLOGY, V20, P382, DOI 10.1152/physiol.00029.2005; MAINES MD, 1993, ARCH BIOCHEM BIOPHYS, V300, P320, DOI 10.1006/abbi.1993.1044; Maines MD, 1996, EUR J BIOCHEM, V235, P372, DOI 10.1111/j.1432-1033.1996.00372.x; Mancuso C, 2006, REDOX REP, V11, P207, DOI 10.1179/135100006X154978; Mancuso C, 2006, ANTIOXID REDOX SIGN, V8, P487, DOI 10.1089/ars.2006.8.487; Minden A, 1997, BBA-REV CANCER, V1333, pF85, DOI 10.1016/S0304-419X(97)00018-8; Miralem T, 2005, J BIOL CHEM, V280, P17084, DOI 10.1074/jbc.M413121200; Miralem T, 2010, J BIOL CHEM, V285, P12551, DOI 10.1074/jbc.M109.032771; Moncada S, 2002, NAT REV MOL CELL BIO, V3, P214, DOI 10.1038/nrm762; Newton AC, 2010, AM J PHYSIOL-ENDOC M, V298, pE395, DOI 10.1152/ajpendo.00477.2009; Osawa M, 2004, J BIOL CHEM, V279, P29691, DOI 10.1074/jbc.M309371200; Parekh D, 1999, J BIOL CHEM, V274, P34758, DOI 10.1074/jbc.274.49.34758; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; Ranganathan A, 2006, J BIOL CHEM, V281, P15645, DOI 10.1074/jbc.M513866200; Riobo NA, 2006, CANCER RES, V66, P839, DOI 10.1158/0008-5472.CAN-05-2539; ROBBINS DJ, 1993, J BIOL CHEM, V268, P5097; RON D, 1994, P NATL ACAD SCI USA, V91, P839, DOI 10.1073/pnas.91.3.839; Salim M, 2001, J BIOL CHEM, V276, P10929, DOI 10.1074/jbc.M010753200; Schlachter S, 2009, OPT EXPRESS, V17, P1557, DOI 10.1364/OE.17.001557; Sedlak TW, 2009, P NATL ACAD SCI USA, V106, P5171, DOI 10.1073/pnas.0813132106; Shiva S, 2004, BIOCHEM SOC SYMP, V71, P107; Srivastava J, 2002, FEBS LETT, V516, P265, DOI 10.1016/S0014-5793(02)02500-0; Steinberg SF, 2004, BIOCHEM J, V384, P449, DOI 10.1042/BJ20040704; Steinberg SF, 2008, PHYSIOL REV, V88, P1341, DOI 10.1152/physrev.00034.2007; Stempka L, 1997, J BIOL CHEM, V272, P6805, DOI 10.1074/jbc.272.10.6805; STOCKER R, 1987, SCIENCE, V235, P1043, DOI 10.1126/science.3029864; Tanoue T, 2000, NAT CELL BIOL, V2, P110, DOI 10.1038/35000065; TANTI JF, 1994, J BIOL CHEM, V269, P6051; Tudor C, 2008, BIOCHEM J, V413, P405, DOI 10.1042/BJ20080018; Ueda Y, 1996, J BIOL CHEM, V271, P23512, DOI 10.1074/jbc.271.38.23512; Whitby FG, 2002, J MOL BIOL, V319, P1199, DOI 10.1016/S0022-2836(02)00383-2; Wright MM, 2009, BIOCHEM J, V422, P353, DOI 10.1042/BJ20090339; Yazicioglu MN, 2007, J BIOL CHEM, V282, P28759, DOI 10.1074/jbc.M703460200; Zhu YM, 2006, CELL SIGNAL, V18, P807, DOI 10.1016/j.cellsig.2005.07.005	66	29	34	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					1066	1079		10.1074/jbc.M111.279612	http://dx.doi.org/10.1074/jbc.M111.279612			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22065579	Green Published, hybrid			2022-12-27	WOS:000299170300023
J	Jeffries, O; Tian, LJ; McClafferty, H; Shipston, MJ				Jeffries, Owen; Tian, Lijun; McClafferty, Heather; Shipston, Michael J.			An Electrostatic Switch Controls Palmitoylation of the Large Conductance Voltage- and Calcium-activated Potassium (BK) Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE-RICH DOMAIN; PROTEIN PALMITOYLATION; MEMBRANE INTERACTIONS; NEURONAL DEVELOPMENT; DEPENDENT REGULATION; PLASMA-MEMBRANE; CSS-PALM; PHOSPHORYLATION; TRANSFERASES; TRAFFICKING	Protein palmitoylation is a major dynamic posttranslational regulator of protein function. However, mechanisms that control palmitoylation are poorly understood. In many proteins, palmitoylation occurs at cysteine residues juxtaposed to membrane-anchoring domains such as transmembrane helices, sites of irreversible lipid modification, or hydrophobic and/or polybasic domains. In particular, polybasic domains represent an attractive mechanism to dynamically control protein palmitoylation, as the function of these domains can be dramatically influenced by protein phosphorylation. Here we demonstrate that a polybasic domain immediately upstream of palmitoylated cysteine residues within an alternatively spliced insert in the C terminus of the large conductance calcium- and voltage-activated potassium channel is an important determinant of channel palmitoylation and function. Mutation of basic amino acids to acidic residues within the polybasic domain results in inhibition of channel palmitoylation and a significant right-shift in channel half maximal voltage for activation. Importantly, protein kinase A-dependent phosphorylation of a single serine residue within the core of the polybasic domain, which results in channel inhibition, also reduces channel palmitoylation. These data demonstrate the key role of the polybasic domain in controlling stress-regulated exon palmitoylation and suggests that phosphorylation controls the domain by acting as an electrostatic switch.	[Jeffries, Owen; Tian, Lijun; McClafferty, Heather; Shipston, Michael J.] Univ Edinburgh, Ctr Integrat Physiol, Coll Med & Vet Med, Edinburgh EH8 9XD, Midlothian, Scotland	University of Edinburgh	Shipston, MJ (corresponding author), Univ Edinburgh, Ctr Integrat Physiol, Coll Med & Vet Med, Hugh Robson Bldg, Edinburgh EH8 9XD, Midlothian, Scotland.	mike.shipston@ed.ac.uk	Shipston, Mike/C-7309-2013	Shipston, Mike/0000-0001-7544-582X; jeffries, owen/0000-0002-8169-1100	Wellcome Trust; Biotechnology and Biological Sciences Research Council	Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a Wellcome Trust program grant (to M.J.S.).; Recipient of a Biotechnology and Biological Sciences Research Council doctoral training grant PhD studentship.	Belanger C, 2001, FEBS LETT, V499, P59, DOI 10.1016/S0014-5793(01)02513-3; Bijlmakers MJ, 2003, TRENDS CELL BIOL, V13, P32, DOI 10.1016/S0962-8924(02)00008-9; Britto PJ, 2002, J BIOL CHEM, V277, P29018, DOI 10.1074/jbc.M204263200; Brzeska H, 2010, J BIOL CHEM, V285, P5738, DOI 10.1074/jbc.M109.066910; Charych EI, 2010, J NEUROSCI, V30, P9027, DOI 10.1523/JNEUROSCI.1635-10.2010; Chen L, 2005, J BIOL CHEM, V280, P33599, DOI 10.1074/jbc.M505383200; Chen L, 2010, J BIOL CHEM, V285, P23263, DOI 10.1074/jbc.M110.139758; Dietrich LEP, 2004, EMBO REP, V5, P1053, DOI 10.1038/sj.embor.7400277; El-Husseini AED, 2002, NAT REV NEUROSCI, V3, P791, DOI 10.1038/nrn940; Fukata M, 2004, NEURON, V44, P987, DOI 10.1016/j.neuron.2004.12.005; Fukata Y, 2010, NAT REV NEUROSCI, V11, P161, DOI 10.1038/nrn2788; Greaves J, 2010, J BIOL CHEM, V285, P24629, DOI 10.1074/jbc.M110.119289; Greaves J, 2009, MOL BIOL CELL, V20, P1845, DOI 10.1091/mbc.E08-09-0944; Greaves J, 2009, MOL MEMBR BIOL, V26, P67, DOI 10.1080/09687680802620351; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; HONIG B, 1995, SCIENCE, V268, P1144, DOI 10.1126/science.7761829; Jeffries O, 2010, J BIOL CHEM, V285, P33307, DOI 10.1074/jbc.M110.153940; KIM JY, 1994, J BIOL CHEM, V269, P28214; KIM JY, 1994, BIOPHYS J, V67, P227, DOI 10.1016/S0006-3495(94)80473-4; Kummel D, 2006, P NATL ACAD SCI USA, V103, P12701, DOI 10.1073/pnas.0603513103; Lee JH, 2009, BIOPHYS J, V97, P730, DOI 10.1016/j.bpj.2009.04.058; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; McLaughlin S, 2005, NATURE, V438, P605, DOI 10.1038/nature04398; Mulgrew-Nesbitt A, 2006, BBA-MOL CELL BIOL L, V1761, P812, DOI 10.1016/j.bbalip.2006.07.002; Nadolski MJ, 2009, J BIOL CHEM, V284, P17720, DOI 10.1074/jbc.M109.005447; Ren J, 2008, PROTEIN ENG DES SEL, V21, P639, DOI 10.1093/protein/gzn039; RESH MD, 2006, SCI STKE, pRE14, DOI DOI 10.1126/STKE.3592006RE14; Saito M, 1997, J BIOL CHEM, V272, P11710, DOI 10.1074/jbc.272.18.11710; Shipston MJ, 2011, J BIOL CHEM, V286, P8709, DOI 10.1074/jbc.R110.210005; Tian L, 2004, P NATL ACAD SCI USA, V101, P11897, DOI 10.1073/pnas.0402590101; Tian LJ, 2010, J BIOL CHEM, V285, P23954, DOI 10.1074/jbc.M110.137802; Tian LJ, 2008, P NATL ACAD SCI USA, V105, P21006, DOI 10.1073/pnas.0806700106; Tian LJ, 2001, J BIOL CHEM, V276, P7717, DOI 10.1074/jbc.C000741200; Wang LG, 2009, NATURE, V461, P292, DOI 10.1038/nature08291; Wu YK, 2010, NATURE, V466, P393, DOI 10.1038/nature09252; Xie JY, 1998, SCIENCE, V280, P443, DOI 10.1126/science.280.5362.443; Yuan P, 2010, SCIENCE, V329, P182, DOI 10.1126/science.1190414; Zhou FF, 2006, BIOINFORMATICS, V22, P894, DOI 10.1093/bioinformatics/btl013	38	19	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					1468	1477		10.1074/jbc.M111.224840	http://dx.doi.org/10.1074/jbc.M111.224840			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22084244	Green Published, hybrid			2022-12-27	WOS:000299170300060
J	Masola, V; Gambaro, G; Tibaldi, E; Brunati, AM; Gastaldello, A; D'Angelo, A; Onisto, M; Lupo, A				Masola, Valentina; Gambaro, Giovanni; Tibaldi, Elena; Brunati, Anna Maria; Gastaldello, Alessandra; D'Angelo, Angela; Onisto, Maurizio; Lupo, Antonio			Heparanase and Syndecan-1 Interplay Orchestrates Fibroblast Growth Factor-2-induced Epithelial-Mesenchymal Transition in Renal Tubular Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUBULOINTERSTITIAL FIBROSIS; DIABETIC-NEPHROPATHY; EXPRESSION; DISEASE; KIDNEY; BETA; ANGIOGENESIS; MECHANISMS; PATHWAYS; ALVEOLAR	The epithelial-mesenchymal transition (EMT) of proximal tubular epithelial cells (PTECs) into myofibroblasts contributes to the establishment of fibrosis that leads to end stage renal disease. FGF-2 induces EMT in PTECs. Because the interaction between FGF-2 and its receptor is mediated by heparan sulfate (HS) and syndecans, we speculated that a deranged HS/syndecans regulation impairs FGF-2 activity. Heparanase is crucial for the correct turnover of HS/syndecans. The aim of the present study was to assess the role of heparanase on epithelial-mesenchymal transition induced by FGF-2 in renal tubular cells. In human kidney 2 (HK2) PTEC cultures, although FGF-2 induces EMT in the wild-type clone, it is ineffective in heparanase-silenced cells. The FGF-2 induced EMT is through a stable activation of PI3K/AKT which is only transient in heparanase-silenced cells. In PTECs, FGF-2 induces an autocrine loop which sustains its signal through multiple mechanisms (reduction in syndecan-1, increase in heparanase, and matrix metalloproteinase 9). Thus, heparanase is necessary for FGF-2 to produce EMT in PTECs and to sustain FGF-2 intracellular signaling. Heparanase contributes to a synergistic loop for handling syndecan-1, facilitating FGF-2 induced-EMT. In conclusion, heparanase plays a role in the tubular-interstitial compartment favoring the FGF-2-dependent EMT of tubular cells. Hence, heparanase is an interesting pharmacological target for the prevention of renal fibrosis.	[Gambaro, Giovanni] Catholic Univ, Div Nephrol & Dialysis, Columbus Gemelli Univ Hosp, Renal Program,Inst Internal Med & Med Specialties, I-00168 Rome, Italy; [Masola, Valentina; Gastaldello, Alessandra; Onisto, Maurizio] Univ Padua, Dept Expt Biomed Sci, I-35122 Padua, Italy; [Tibaldi, Elena; Brunati, Anna Maria] Univ Padua, Dept Biol Chem, I-35122 Padua, Italy; [D'Angelo, Angela] Univ Padua, Dept Med & Surg Sci, Nephrol Unit, I-35122 Padua, Italy; [Lupo, Antonio] Univ Verona, Dept Med, Nephrol Sect, I-37129 Verona, Italy	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Padua; University of Padua; University of Padua; University of Verona	Gambaro, G (corresponding author), Catholic Univ, Div Nephrol & Dialysis, Columbus Gemelli Univ Hosp, Renal Program,Inst Internal Med & Med Specialties, Via Moscati 31, I-00168 Rome, Italy.	giovanni.gambaro@rm.unicatt.it	Onisto, Maurizio/K-5281-2014; Brunati, Anna Maria/I-8136-2018	Onisto, Maurizio/0000-0002-1191-7418; Brunati, Anna Maria/0000-0002-3481-9503; Masola, Valentina/0000-0003-2341-2481; Gambaro, Giovanni/0000-0001-5733-2370				Almeida S, 2010, NEUROTOX RES, V17, P399, DOI 10.1007/s12640-009-9116-z; BORDER WA, 1992, J CLIN INVEST, V90, P1, DOI 10.1172/JCI115821; Brule S, 2006, GLYCOBIOLOGY, V16, P488, DOI 10.1093/glycob/cwj098; Burns WC, 2006, J AM SOC NEPHROL, V17, P2484, DOI 10.1681/ASN.2006050525; Dailey L, 2005, CYTOKINE GROWTH F R, V16, P233, DOI 10.1016/j.cytogfr.2005.01.007; Fux L, 2009, TRENDS BIOCHEM SCI, V34, P511, DOI 10.1016/j.tibs.2009.06.005; GAMBARO G, 1992, ACTA DIABETOL, V29, P149, DOI 10.1007/BF00573480; Ha H, 2003, J AM SOC NEPHROL, V14, pS246, DOI 10.1097/01.ASN.0000077411.98742.54; Hewitson TD, 2009, AM J PHYSIOL-RENAL, V296, pF1239, DOI 10.1152/ajprenal.90521.2008; Ilan N, 2006, INT J BIOCHEM CELL B, V38, P2018, DOI 10.1016/j.biocel.2006.06.004; Iwano M, 2002, J CLIN INVEST, V110, P341, DOI 10.1172/JCI200215518; KATO M, 1995, MOL BIOL CELL, V6, P559, DOI 10.1091/mbc.6.5.559; Kato M, 1998, NAT MED, V4, P691, DOI 10.1038/nm0698-691; Katoh M, 2006, CANCER BIOL THER, V5, P1059, DOI 10.4161/cbt.5.9.3151; Lan HY, 2003, CURR OPIN NEPHROL HY, V12, P25, DOI 10.1097/00041552-200301000-00005; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Liu YH, 2010, J AM SOC NEPHROL, V21, P212, DOI 10.1681/ASN.2008121226; MALI M, 1993, J BIOL CHEM, V268, P24215; Masola V, 2011, BBA-MOL CELL RES, V1813, P1475, DOI 10.1016/j.bbamcr.2011.05.004; Masola V, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-304; MORITA H, 1994, LAB INVEST, V71, P528; Nath KA, 1998, KIDNEY INT, V54, P992, DOI 10.1046/j.1523-1755.1998.00079.x; Onisto M, 2005, INT J ONCOL, V27, P791; Purushothaman A, 2011, J BIOL CHEM, V286, P30377, DOI 10.1074/jbc.M111.254789; Rane MJ, 2010, AM J PHYSIOL-RENAL, V298, pF49, DOI 10.1152/ajprenal.00032.2009; RAY PE, 1994, KIDNEY INT, V46, P759, DOI 10.1038/ki.1994.331; Reiland J, 2006, NEOPLASIA, V8, P596, DOI 10.1593/neo.06244; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Sharma K, 1996, DIABETES, V45, P522, DOI 10.2337/diabetes.45.4.522; STEFFES MW, 1989, DIABETES, V38, P1077, DOI 10.2337/diabetes.38.9.1077; Strutz F, 2002, KIDNEY INT, V61, P1714, DOI 10.1046/j.1523-1755.2002.00333.x; Strutz FM, 2009, KIDNEY INT, V75, P475, DOI 10.1038/ki.2008.425; Szymczak M, 2010, ARCH IMMUNOL THER EX, V58, P45, DOI 10.1007/s00005-009-0061-6; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; van den Hoven MJ, 2007, KIDNEY INT, V72, P543, DOI 10.1038/sj.ki.5002337; Zong F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007346	36	82	89	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					1478	1488		10.1074/jbc.M111.279836	http://dx.doi.org/10.1074/jbc.M111.279836			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22102278	hybrid, Green Published			2022-12-27	WOS:000299170300061
J	Di Domizio, J; Zhang, R; Stagg, LJ; Gagea, M; Zhuo, M; Ladbury, JE; Cao, W				Di Domizio, Jeremy; Zhang, Ran; Stagg, Loren J.; Gagea, Mihai; Zhuo, Ming; Ladbury, John E.; Cao, Wei			Binding with Nucleic Acids or Glycosaminoglycans Converts Soluble Protein Oligomers to Amyloid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRINSICALLY DISORDERED PROTEINS; RECOMBINANT PRION PROTEIN; BOVINE SERUM-ALBUMIN; FUNCTIONAL AMYLOIDS; ALZHEIMERS-DISEASE; COMMON MECHANISM; BETA-PEPTIDE; DARK SIDE; AGGREGATION; BETA(2)-MICROGLOBULIN	Ample evidence suggests that almost all polypeptides can either adopt a native structure (folded or intrinsically disordered) or form misfolded amyloid fibrils. Soluble protein oligomers exist as an intermediate between these two states, and their cytotoxicity has been implicated in the pathology of multiple human diseases. However, the mechanism by which soluble protein oligomers develop into insoluble amyloid fibrils is not clear, and investigation of this important issue is hindered by the unavailability of stable protein oligomers. Here, we have obtained stabilized protein oligomers generated from common native proteins. These oligomers exert strong cytotoxicity and display a common conformational structure shared with known protein oligomers. They are soluble and remain stable in solution. Intriguingly, the stabilized protein oligomers interact preferentially with both nucleic acids and glycosaminoglycans (GAG), which facilitates their rapid conversion into insoluble amyloid. Concomitantly, binding with nucleic acids or GAG strongly diminished the cytotoxicity of the protein oligomers. EGCG, a small molecule that was previously shown to directly bind to protein oligomers, effectively inhibits the conversion to amyloid. These results indicate that stabilized oligomers of common proteins display characteristics similar to those of disease-associated protein oligomers and represent immediate precursors of less toxic amyloid fibrils. Amyloid conversion is potently expedited by certain physiological factors, such as nucleic acids and GAGs. These findings concur with reports of cofactor involvement with disease-associated amyloid and shed light on potential means to interfere with the pathogenic properties of misfolded proteins.	[Di Domizio, Jeremy; Zhang, Ran; Zhuo, Ming; Cao, Wei] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; [Stagg, Loren J.; Ladbury, John E.] Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Gagea, Mihai] Univ Texas MD Anderson Canc Ctr, Dept Vet Med & Surg, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Cao, W (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Immunol, Unit 901, 7455 Fannin St, Houston, TX 77054 USA.	wcao@mdanderson.org	Di Domizio, Jeremy/L-1777-2019	Cao, Wei/0000-0002-8952-9159; Ladbury, John/0000-0002-6328-7200	National Institutes of Health [AI074809]; University of Texas M. D. Anderson Cancer Center; National Institutes of Health through M. D. Anderson's Cancer Center [CA016672]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074809] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Texas M. D. Anderson Cancer Center; National Institutes of Health through M. D. Anderson's Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is supported, in whole or in part, by National Institutes of Health Grant AI074809 (to W. C.) and grants from The University of Texas M. D. Anderson Cancer Center Institutional Research Grant Program (to W. C.). This work is also supported, in part, by the National Institutes of Health through M. D. Anderson's Cancer Center Support Grant (CA016672).	Ahn BW, 2000, ANAL BIOCHEM, V284, P401, DOI 10.1006/abio.2000.4719; ASTBURY WILLIAM THOMAS, 1935, BIOCHEM JOUR, V29, P2351; Babu MM, 2011, CURR OPIN STRUC BIOL, V21, P432, DOI 10.1016/j.sbi.2011.03.011; Badtke MP, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.280pe43; Barnhart MM, 2006, ANNU REV MICROBIOL, V60, P131, DOI 10.1146/annurev.micro.60.080805.142106; Barrantes A, 2007, J ALZHEIMERS DIS, V12, P345; Bhattacharya M, 2011, J PHYS CHEM B, V115, P4195, DOI 10.1021/jp111528c; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Chapman MR, 2002, SCIENCE, V295, P851, DOI 10.1126/science.1067484; Claessen D, 2003, GENE DEV, V17, P1714, DOI 10.1101/gad.264303; DEGIOIA L, 1994, J BIOL CHEM, V269, P7859; Deleault NR, 2003, NATURE, V425, P717, DOI 10.1038/nature01979; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Ehrnhoefer DE, 2008, NAT STRUCT MOL BIOL, V15, P558, DOI 10.1038/nsmb.1437; Ellis RJ, 2002, NATURE, V416, P483, DOI 10.1038/416483a; Fink AL, 2005, CURR OPIN STRUC BIOL, V15, P35, DOI 10.1016/j.sbi.2005.01.002; Fowler DM, 2007, TRENDS BIOCHEM SCI, V32, P217, DOI 10.1016/j.tibs.2007.03.003; Glabe CG, 2008, J BIOL CHEM, V283, P29639, DOI 10.1074/jbc.R800016200; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Goldschmidt L, 2010, P NATL ACAD SCI USA, V107, P3487, DOI 10.1073/pnas.0915166107; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hegde ML, 2004, J MOL NEUROSCI, V22, P19, DOI 10.1385/JMN:22:1-2:19; Hegde ML, 2007, ARCH BIOCHEM BIOPHYS, V464, P57, DOI 10.1016/j.abb.2007.03.042; Hooper NM, 2011, J NEUROCHEM, V116, P721, DOI 10.1111/j.1471-4159.2010.06936.x; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; Jimenez JS, 2010, J ALZHEIMERS DIS, V22, P375, DOI 10.3233/JAD-2010-100189; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kegel KB, 2002, J BIOL CHEM, V277, P7466, DOI 10.1074/jbc.M103946200; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; Liu K, 2000, NAT STRUCT BIOL, V7, P754; Maji SK, 2009, SCIENCE, V325, P328, DOI 10.1126/science.1173155; McBride PA, 1998, EXP NEUROL, V149, P447, DOI 10.1006/exnr.1997.6740; McParland VJ, 2002, NAT STRUCT BIOL, V9, P326, DOI 10.1038/nsb791; McParland VJ, 2000, BIOCHEMISTRY-US, V39, P8735, DOI 10.1021/bi000276j; Nandi PK, 1998, ARCH VIROL, V143, P1251, DOI 10.1007/s007050050373; Nandi PK, 1999, ARCH VIROL, V144, P1751, DOI 10.1007/s007050050702; Pfefferkorn CM, 2010, P NATL ACAD SCI USA, V107, P21447, DOI 10.1073/pnas.1006424107; RONNBLOM LE, 1990, J INTERN MED, V227, P207; Rysava R, 2007, KIDNEY BLOOD PRESS R, V30, P359, DOI 10.1159/000107980; Sakono M, 2010, FEBS J, V277, P1348, DOI 10.1111/j.1742-4658.2010.07568.x; Schnabel J, 2010, NATURE, V464, P828, DOI 10.1038/464828a; Selkoe DJ, 2003, NATURE, V426, P900, DOI 10.1038/nature02264; Silva JL, 2008, TRENDS BIOCHEM SCI, V33, P132, DOI 10.1016/j.tibs.2007.11.003; Stefani M, 2004, BBA-MOL BASIS DIS, V1739, P5, DOI 10.1016/j.bbadis.2004.08.004; Stefani M, 2010, FEBS J, V277, P4602, DOI 10.1111/j.1742-4658.2010.07889.x; Taylor DR, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000666; Uversky VN, 2008, ANNU REV BIOPHYS, V37, P215, DOI 10.1146/annurev.biophys.37.032807.125924; Vetri V, 2011, ARCH BIOCHEM BIOPHYS, V508, P13, DOI 10.1016/j.abb.2011.01.024; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748; Wright PE, 2009, CURR OPIN STRUC BIOL, V19, P31, DOI 10.1016/j.sbi.2008.12.003; Yu HJ, 2007, BIOPHYS J, V92, P185, DOI 10.1529/biophysj.106.093559; Zhang X., 2010, PROGR MOL BIOL TRANS, P309	54	41	42	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					736	747		10.1074/jbc.M111.238477	http://dx.doi.org/10.1074/jbc.M111.238477			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22102410	Green Published, hybrid			2022-12-27	WOS:000298682400071
J	Durcan, TM; Kontogiannea, M; Bedard, N; Wing, SS; Fon, EA				Durcan, Thomas M.; Kontogiannea, Maria; Bedard, Nathalie; Wing, Simon S.; Fon, Edward A.			Ataxin-3 Deubiquitination Is Coupled to Parkin Ubiquitination via E2 Ubiquitin-conjugating Enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MACHADO-JOSEPH DISEASE; POLYUBIQUITIN CHAINS; PROTEIN LIGASE; DEGRADATION; MECHANISMS; MITOPHAGY; ACTIVATION; PROTEASOME; STABILITY; PROMOTES	We reported previously that parkin, a Parkinson disease-associated E3 ubiquitin-ligase interacts with ataxin-3, a deubiquitinating enzyme associated with Machado-Joseph disease. Ataxin-3 was found to counteract parkin self-ubiquitination both in vitro and in cells. Moreover, ataxin-3-dependent deubiquitination of parkin required the catalytic cysteine 14 in ataxin-3, although the precise mechanism remained unclear. We report here that ataxin-3 interferes with the attachment of ubiquitin (Ub) onto parkin in real-time during conjugation but is unable to hydrolyze previously assembled parkin-Ub conjugates. The mechanism involves an ataxin-3-dependent stabilization of the complex between parkin and the E2 Ub-conjugating enzyme, which impedes the efficient charging of the E2 with Ub. Moreover, within this complex, the transfer of Ub from the E2 is diverted away from parkin and onto ataxin-3, further explaining how ataxin-3 deubiquitination is coupled to parkin ubiquitination. Taken together, our findings reveal an unexpected convergence upon the E2 Ub-conjugating enzyme in the regulation of an E3/deubiquitinating enzyme pair, with important implications for the function of parkin and ataxin-3, two proteins responsible for closely related neurodegenerative diseases.	[Durcan, Thomas M.; Kontogiannea, Maria; Fon, Edward A.] McGill Univ, Montreal Neurol Inst, Ctr Neuronal Survival, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada; [Durcan, Thomas M.; Kontogiannea, Maria; Fon, Edward A.] McGill Univ, Montreal Neurol Inst, McGill Parkinson Program, Montreal, PQ H3A 2B4, Canada; [Bedard, Nathalie; Wing, Simon S.] McGill Univ, Ctr Hlth, Polypeptide Lab, Dept Med,Res Inst, Montreal, PQ H3A 2B4, Canada	McGill University; McGill University; McGill University	Fon, EA (corresponding author), McGill Univ, Montreal Neurol Inst, Ctr Neuronal Survival, Dept Neurol & Neurosurg, Rm MPO36,3801 Univ St, Montreal, PQ H3A 2B4, Canada.	ted.fon@mcgill.ca	Wing, Simon/D-2589-2012	Wing, Simon/0000-0001-8394-7563	Canadian Institutes of Health Research (CIHR) [MOP-84345, MOP-82734]; National Ataxia Foundation; Parkinson's Disease Foundation	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); National Ataxia Foundation; Parkinson's Disease Foundation	This work was supported in part by Canadian Institutes of Health Research (CIHR) Operating Grant MOP-84345 (to E. A. F.).; Supported by fellowships from the National Ataxia Foundation and the Parkinson's Disease Foundation.; Supported by a CIHR Operating Grant MOP-82734.	Ben-Saadon R, 2006, MOL CELL, V24, P701, DOI 10.1016/j.molcel.2006.10.022; Chan NC, 2011, HUM MOL GENET, V20, P1726, DOI 10.1093/hmg/ddr048; Chaugule VK, 2011, EMBO J, V30, P2853, DOI 10.1038/emboj.2011.204; David Y, 2010, J BIOL CHEM, V285, P8595, DOI 10.1074/jbc.M109.089003; de Bie P, 2011, CELL DEATH DIFFER, V18, P1393, DOI 10.1038/cdd.2011.16; de Bie P, 2010, BIOCHEM BIOPH RES CO, V400, P389, DOI 10.1016/j.bbrc.2010.08.082; Durcan TM, 2011, AUTOPHAGY, V7, P233, DOI 10.4161/auto.7.2.14224; Durcan TM, 2011, HUM MOL GENET, V20, P141, DOI 10.1093/hmg/ddq452; Eletr ZM, 2005, NAT STRUCT MOL BIOL, V12, P933, DOI 10.1038/nsmb984; Fallon L, 2002, J BIOL CHEM, V277, P486, DOI 10.1074/jbc.M109806200; Fallon L, 2006, NAT CELL BIOL, V8, P834, DOI 10.1038/ncb1441; Fang SY, 2000, J BIOL CHEM, V275, P8945, DOI 10.1074/jbc.275.12.8945; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Groettrup M, 2008, TRENDS BIOCHEM SCI, V33, P230, DOI 10.1016/j.tibs.2008.01.005; Hanna J, 2006, CELL, V127, P99, DOI 10.1016/j.cell.2006.07.038; Joch M, 2007, MOL BIOL CELL, V18, P3105, DOI 10.1091/mbc.E05-11-1027; KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Klein C, 2009, MOVEMENT DISORD, V24, P2042, DOI 10.1002/mds.22675; Li MY, 2004, MOL CELL, V13, P879, DOI 10.1016/S1097-2765(04)00157-1; Li W, 2008, CELL MOL LIFE SCI, V65, P2397, DOI 10.1007/s00018-008-8090-6; Mallery DL, 2002, EMBO J, V21, P6755, DOI 10.1093/emboj/cdf691; Nakada S, 2010, NATURE, V466, P941, DOI 10.1038/nature09297; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Pelzer C, 2007, J BIOL CHEM, V282, P23010, DOI 10.1074/jbc.C700111200; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Scaglione KM, 2011, MOL CELL, V43, P599, DOI 10.1016/j.molcel.2011.05.036; Scortegagna M, 2011, J BIOL CHEM, V286, P27333, DOI 10.1074/jbc.M111.218214; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Tanaka A, 2010, J CELL BIOL, V191, P1367, DOI 10.1083/jcb.201007013; Wenzel DM, 2011, NATURE, V474, P105, DOI 10.1038/nature09966; Winborn BJ, 2008, J BIOL CHEM, V283, P26436, DOI 10.1074/jbc.M803692200; Wu-Baer F, 2003, J BIOL CHEM, V278, P34743, DOI 10.1074/jbc.C300249200; Ye YH, 2009, NAT REV MOL CELL BIO, V10, P755, DOI 10.1038/nrm2780	36	51	52	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					531	541		10.1074/jbc.M111.288449	http://dx.doi.org/10.1074/jbc.M111.288449			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22081612	Green Published, hybrid			2022-12-27	WOS:000298682400052
J	Li, YY; Li, Q; Long, Y; Cui, ZB				Li, Yuanyuan; Li, Qing; Long, Yong; Cui, Zongbin			Lzts2 Regulates Embryonic Cell Movements and Dorsoventral Patterning through Interaction with and Export of Nuclear beta-Catenin in Zebrafish	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONVERGENT EXTENSION MOVEMENTS; AXIS FORMATION; VERTEBRATE GASTRULATION; TRANSCRIPTION FACTORS; PROTRUSIVE ACTIVITY; XENOPUS EMBRYOS; ACTS DOWNSTREAM; WNT PATHWAY; PROTEIN; GENE	Leucine zipper tumor suppressor 2 (Lzts2) functions in the development and progression of various tumors, but its activities in vertebrate embryogenesis remain unclear. Here, we demonstrate that lzts2 transcripts are of maternal origin in zebrafish embryos. Activation of BMP signaling up-regulates zygotic expression of lzts2, whereas canonical Wnt signaling acts upstream of BMP signaling to inhibit lzts2 expression. Abrogation of lzts2 expression by its specific morpholino-enhanced gastrula convergence and extension (CE) movements, dorsalized early embryos, and inhibited specification of midline progenitors for pancreas, liver, and heart. In contrast, ectopic expression of lzts2 led to the delay of CE movements and midline convergence of organ progenitors and resulted in a certain ratio of ventralized embryos. Mechanistically, Lzts2 regulates the migration of embryonic cells and dorsoventral patterning through its limitation of Wnt/beta-catenin activity, because it physically interacts with beta-catenin-1 and -2 and transports them out of the nucleus. In addition, both beta-catenin-1 and -2 exhibit redundant functions in activation of Stat3 signaling and in induction of Wnt5/11 expression through inhibition of BMP signaling and stimulation of Cyclops and Squint expression. Thus, Lzts2 regulates gastrula CE movements, dorsoventral patterning, and midline convergence and specification of organ precursors through interaction with and the export of nuclear beta-catenins in zebrafish.	[Li, Yuanyuan; Li, Qing; Long, Yong; Cui, Zongbin] Chinese Acad Sci, Inst Hydrobiol, Key Lab Aquat Biodivers & Conservat, Wuhan 430072, Hubei, Peoples R China; [Li, Yuanyuan; Long, Yong] Chinese Acad Sci, Grad Univ, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Cui, ZB (corresponding author), Chinese Acad Sci, Inst Hydrobiol, Key Lab Aquat Biodivers & Conservat, Wuhan 430072, Hubei, Peoples R China.	zbcui@ihb.ac.cn		Li, Yuanyuan/0000-0003-4227-8628	National Natural Science Foundation of China [31171390]; National Basic Research Program of China [2012CB944500]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by National Natural Science Foundation of China Grants 31171390 (to Z.C.) and National Basic Research Program of China Grant 2012CB944500.	Ando R, 2002, P NATL ACAD SCI USA, V99, P12651, DOI 10.1073/pnas.202320599; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Bellipanni G, 2006, DEVELOPMENT, V133, P1299, DOI 10.1242/dev.02295; Brembeck FH, 2004, GENE DEV, V18, P2225, DOI 10.1101/gad.317604; Cabeza-Arvelaiz Y, 2001, ONCOGENE, V20, P6707, DOI 10.1038/sj.onc.1204866; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Carmany-Rampey A, 2001, CURR BIOL, V11, P1261, DOI 10.1016/S0960-9822(01)00353-0; Cheung CY, 2006, INT J DEV BIOL, V50, P561, DOI 10.1387/ijdb.062151cc; Daniels DL, 2002, MOL CELL, V10, P573, DOI 10.1016/S1097-2765(02)00631-7; Darken RS, 2002, EMBO J, V21, P976, DOI 10.1093/emboj/21.5.976; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Dougan ST, 2003, DEVELOPMENT, V130, P1837, DOI 10.1242/dev.00400; Elul T, 2000, DEV BIOL, V224, P3, DOI 10.1006/dbio.2000.9746; Feldman B, 2000, CURR BIOL, V10, P531, DOI 10.1016/S0960-9822(00)00469-3; FUNAYAMA N, 1995, J CELL BIOL, V128, P959, DOI 10.1083/jcb.128.5.959; Gottardi CJ, 2001, CURR BIOL, V11, pR792, DOI 10.1016/S0960-9822(01)00473-0; Habas R, 2001, CELL, V107, P843, DOI 10.1016/S0092-8674(01)00614-6; Heisenberg CP, 2000, NATURE, V405, P76, DOI 10.1038/35011068; Henderson BR, 2002, EMBO REP, V3, P834, DOI 10.1093/embo-reports/kvf181; Huang HG, 2001, MOL CELL ENDOCRINOL, V177, P117, DOI 10.1016/S0303-7207(01)00408-7; Hyun Hwa, 2008, BIOCHIM BIOPHYS ACTA, V1783, P419; Ishii H, 1999, P NATL ACAD SCI USA, V96, P3928, DOI 10.1073/pnas.96.7.3928; Ishii H, 2001, P NATL ACAD SCI USA, V98, P10374, DOI 10.1073/pnas.181222898; Jessen JR, 2002, NAT CELL BIOL, V4, P610, DOI 10.1038/ncb828; Kam Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004580; Karim RZ, 2004, PATHOLOGY, V36, P120, DOI 10.1080/00313020410001671957; Kelly C, 2000, DEVELOPMENT, V127, P3899; Kilian B, 2003, MECH DEVELOP, V120, P467, DOI 10.1016/S0925-4773(03)00004-2; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Kumar A, 2001, J BIOL CHEM, V276, P656, DOI 10.1074/jbc.M004649200; Kutay U, 1997, CELL, V90, P1061, DOI 10.1016/S0092-8674(00)80372-4; Liao GH, 2006, P NATL ACAD SCI USA, V103, P16313, DOI 10.1073/pnas.0602557103; Link V, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-1; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Makita R, 1998, MECH DEVELOP, V71, P165, DOI 10.1016/S0925-4773(98)00013-6; Marlow F, 2002, CURR BIOL, V12, P876, DOI 10.1016/S0960-9822(02)00864-3; Matsui T, 2005, GENE DEV, V19, P164, DOI 10.1101/gad.1253605; Mclin VA, 2007, DEVELOPMENT, V134, P2207, DOI 10.1242/dev.001230; Miyagi C, 2004, J CELL BIOL, V166, P975, DOI 10.1083/jcb.200403110; Mo SJ, 2010, DEV BIOL, V344, P210, DOI 10.1016/j.ydbio.2010.04.033; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Monga SPS, 2006, HEPATOLOGY, V43, P401, DOI 10.1002/hep.21110; Monga SPS, 2003, GASTROENTEROLOGY, V124, P202, DOI 10.1053/gast.2003.50000; MOON RT, 1993, DEVELOPMENT, V119, P97; Myers DC, 2002, TRENDS GENET, V18, P447, DOI 10.1016/S0168-9525(02)02725-7; Myers DC, 2002, DEV BIOL, V243, P81, DOI 10.1006/dbio.2001.0523; Neufeld KL, 2000, EMBO REP, V1, P519; Oates AC, 1999, MECH DEVELOP, V83, P77, DOI 10.1016/S0925-4773(99)00036-2; Ober EA, 2004, EMBO REP, V5, P78, DOI 10.1038/sj.embor.7400047; Ober EA, 2006, NATURE, V442, P688, DOI 10.1038/nature04888; Orsulic S, 1999, J CELL SCI, V112, P1237; OssarehNazari B, 1997, SCIENCE, V278, P141, DOI 10.1126/science.278.5335.141; Peifer M, 2000, SCIENCE, V287, P1606, DOI 10.1126/science.287.5458.1606; Rauch GJ, 1997, COLD SPRING HARB SYM, V62, P227, DOI 10.1101/SQB.1997.062.01.028; SassoneCorsi P, 1995, ANNU REV CELL DEV BI, V11, P355, DOI 10.1146/annurev.cellbio.11.1.355; Schier AF, 2005, ANNU REV GENET, V39, P561, DOI 10.1146/annurev.genet.37.110801.143752; Schneider S, 1996, MECH DEVELOP, V57, P191, DOI 10.1016/0925-4773(96)00546-1; Schoenwolf GC, 2000, METH MOL B, V135, P113; Sepich DS, 2000, GENESIS, V27, P159, DOI 10.1002/1526-968X(200008)27:4<159::AID-GENE50>3.0.CO;2-T; SHIH J, 1992, DEVELOPMENT, V116, P901; Sodhi D, 2005, J HEPATOL, V43, P132, DOI 10.1016/j.jhep.2005.02.019; Solnica-Krezel L, 2001, INT J DEV BIOL, V45, P299; SolnicaKrezel L, 1996, DEVELOPMENT, V123, P67; STACHEL SE, 1993, DEVELOPMENT, V117, P1261; Stainier DYR, 2001, NAT REV GENET, V2, P39, DOI 10.1038/35047564; Sudo H, 2008, HUM MOL GENET, V17, P2524, DOI 10.1093/hmg/ddn153; Sumanas S, 2001, GENESIS, V30, P114, DOI 10.1002/gene.1043; Tan XP, 2008, HEPATOLOGY, V47, P1667, DOI 10.1002/hep.22225; Thyssen G, 2006, MOL CELL BIOL, V26, P8857, DOI 10.1128/MCB.01031-06; Tolwinski NS, 2001, DEVELOPMENT, V128, P2107; Topczewski J, 2001, DEV CELL, V1, P251, DOI 10.1016/S1534-5807(01)00005-3; TRINKAUS JP, 1992, J EXP ZOOL, V261, P40, DOI 10.1002/jez.1402610107; Ueno S, 2007, P NATL ACAD SCI USA, V104, P9685, DOI 10.1073/pnas.0702859104; UNGAR AR, 1995, MECH DEVELOP, V52, P153, DOI 10.1016/0925-4773(95)00386-F; Vincan E, 2004, FRONT BIOSCI-LANDMRK, V9, P1023, DOI 10.2741/1311; von der Hardt S, 2007, CURR BIOL, V17, P475, DOI 10.1016/j.cub.2007.02.013; Wallingford JB, 2001, CURR BIOL, V11, P652, DOI 10.1016/S0960-9822(01)00201-9; Warga RM, 1999, DEVELOPMENT, V126, P827; Wells JM, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-4; Wendl T, 2002, DEVELOPMENT, V129, P3751; Wheelock M J, 1991, In Vivo, V5, P505; Winer J, 1999, ANAL BIOCHEM, V270, P41, DOI 10.1006/abio.1999.4085; WINKLBAUER R, 1992, DEV BIOL, V150, P335, DOI 10.1016/0012-1606(92)90246-D; Xie XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024469; Xiong B, 2006, DEV CELL, V11, P225, DOI 10.1016/j.devcel.2006.06.012; Yamanaka Y, 1998, GENE DEV, V12, P2345, DOI 10.1101/gad.12.15.2345; Yamashita S, 2004, NATURE, V429, P298, DOI 10.1038/nature02545; Yamashita S, 2002, DEV CELL, V2, P363, DOI 10.1016/S1534-5807(02)00126-0; Yeo SY, 2001, DEV BIOL, V230, P1, DOI 10.1006/dbio.2000.0105; Zeng G, 2007, HEPATOLOGY, V45, P195, DOI 10.1002/hep.21473; Zhu SZ, 2006, CELL SIGNAL, V18, P359, DOI 10.1016/j.cellsig.2005.05.019	92	12	12	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2011	286	52					45116	45130		10.1074/jbc.M111.267328	http://dx.doi.org/10.1074/jbc.M111.267328			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870CA	22057270	hybrid, Green Published			2022-12-27	WOS:000298645500078
J	Hu, XY; Laragione, T; Sun, L; Koshy, S; Jones, KR; Ismailov, II; Yotnda, P; Horrigan, FT; Gulko, PS; Beeton, C				Hu, Xueyou; Laragione, Teresina; Sun, Liang; Koshy, Shyny; Jones, Karlie R.; Ismailov, Iskander I.; Yotnda, Patricia; Horrigan, Frank T.; Gulko, Percio S.; Beeton, Christine			KCa1.1 Potassium Channels Regulate Key Proinflammatory and Invasive Properties of Fibroblast-like Synoviocytes in Rheumatoid Arthritis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMORY T-CELLS; CA2+-ACTIVATED K+ CHANNEL; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; MULTIPLE-SCLEROSIS; THERAPEUTIC TARGET; JOINT DESTRUCTION; KV1.3 CHANNELS; EXPRESSION; CLASSIFICATION; PROLIFERATION	Fibroblast-like synoviocytes (FLS) play important roles in the pathogenesis of rheumatoid arthritis (RA). Potassium channels have regulatory roles in many cell functions. We have identified the calcium-and voltage-gated KCa1.1 channel (BK, Maxi-K, Slo1, KCNMA1) as the major potassium channel expressed at the plasma membrane of FLS isolated from patients with RA (RA-FLS). We further show that blocking this channel perturbs the calcium homeostasis of the cells and inhibits the proliferation, production of VEGF, IL-8, and pro-MMP-2, and migration and invasion of RA-FLS. Our findings indicate a regulatory role of KCa1.1 channels in RA-FLS function and suggest this channel as a potential target for the treatment of RA.	[Hu, Xueyou; Sun, Liang; Koshy, Shyny; Jones, Karlie R.; Ismailov, Iskander I.; Horrigan, Frank T.; Beeton, Christine] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA; [Laragione, Teresina; Gulko, Percio S.] Feinstein Inst Med Res, Lab Expt Rheumatol, Ctr Genom & Human Genet, Manhasset, NY 11030 USA; [Yotnda, Patricia] Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA	Baylor College of Medicine; Northwell Health; Baylor College of Medicine	Beeton, C (corresponding author), Baylor Coll Med, Dept Mol Physiol & Biophys, Mail Stop BCM335,Rm S409A, Houston, TX 77030 USA.	beeton@bcm.edu	; Sun, Liang/D-4857-2018	Beeton, Christine/0000-0002-2500-5874; Sun, Liang/0000-0002-7817-5121	Baylor College of Medicine; Feinstein Institute North Shore-Long Island Jewish Health System General Clinical Research National Institutes of Health [M01RR018535]; National Institutes of Health, NIAID [AI084981, AI54348]; NINDS [NS042901]; NIAMS [AR059838, AR0426213]; National Institutes of Health [NCRR S10RR024574, NIAID AI036211, NCI P30CA125123]; NATIONAL CANCER INSTITUTE [P30CA125123] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024574, M01RR018535] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054348, R56AI084981, P30AI036211] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR059838] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042901] Funding Source: NIH RePORTER	Baylor College of Medicine; Feinstein Institute North Shore-Long Island Jewish Health System General Clinical Research National Institutes of Health; National Institutes of Health, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Baylor College of Medicine (to F. T. H. and C. B.), the Feinstein Institute North Shore-Long Island Jewish Health System General Clinical Research National Institutes of Health Grant M01RR018535 (to P. S. G.) and National Institutes of Health, NIAID Grants AI084981 (to C. B.) and AI54348 (to P. S. G.), NINDS Grant NS042901 (to F. T. H.), NIAMS Grants AR059838 (to C. B.), and AR0426213 (to P. S. G.)). The Baylor College of Medicine Cytometry and Cell Sorting Core is supported by National Institutes of Health Grants NCRR S10RR024574, NIAID AI036211, and NCI P30CA125123.	Abeles AM, 2006, BULL HOSP JT DIS, V64, P20; Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Bartok B, 2010, IMMUNOL REV, V233, P233, DOI 10.1111/j.0105-2896.2009.00859.x; Beeton C, 2005, NEUROSCIENTIST, V11, P550, DOI 10.1177/1073858405278016; Beeton C, 2005, MOL PHARMACOL, V67, P1369, DOI 10.1124/mol.104.008193; Beeton C, 2001, J IMMUNOL, V166, P936, DOI 10.4049/jimmunol.166.2.936; Beeton C, 2001, P NATL ACAD SCI USA, V98, P13942, DOI 10.1073/pnas.241497298; Beeton C, 2008, J BIOL CHEM, V283, P988, DOI 10.1074/jbc.M706008200; Beeton C, 2006, P NATL ACAD SCI USA, V103, P17414, DOI 10.1073/pnas.0605136103; Brenner R, 2000, J BIOL CHEM, V275, P6453, DOI 10.1074/jbc.275.9.6453; Brenner R, 1996, J NEUROSCI, V16, P1827; Chan A, 2007, MOL MED, V13, P297, DOI 10.2119/2007-00025.Chan; GALLAGHER RT, 1977, NEW ZEAL J AGR RES, V20, P431, DOI 10.1080/00288233.1977.10427356; GARCIA ML, 1991, J BIOENERG BIOMEMBR, V23, P615, DOI 10.1007/BF00785814; Goldbach-Mansky R, 2000, ARTHRITIS RES, V2, P145, DOI 10.1186/ar79; Gregersen P. K., 2006, RHEUMATOID ARTHRITIS; Gulko P. S., 2001, SAMTERS IMMUNOLOGIC; Gutman GA, 2003, PHARMACOL REV, V55, P583, DOI 10.1124/pr.55.4.9; Hille B., 2001, IONIC CHANNELS EXCIT, P814; Hu Xueyou, 2010, J Vis Exp, DOI 10.3791/2445; Kohler R, 2010, EXPERT OPIN THER TAR, V14, P143, DOI 10.1517/14728220903540257; Lange F, 2005, ANN RHEUM DIS, V64, P599, DOI 10.1136/ard.2004.026120; Laragione T, 2008, ARTHRITIS RHEUM-US, V58, P2296, DOI 10.1002/art.23610; Laragione T, 2010, MOL MED, V16, P352, DOI 10.2119/molmed.2010.00049; Laragione T, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2476; Large RJ, 2010, AM J PHYSIOL-CELL PH, V299, pC1180, DOI 10.1152/ajpcell.00028.2010; Lefevre S, 2009, NAT MED, V15, P1414, DOI 10.1038/nm.2050; Matheu MP, 2008, IMMUNITY, V29, P602, DOI 10.1016/j.immuni.2008.07.015; MCMANUS OB, 1991, J BIOENERG BIOMEMBR, V23, P537, DOI 10.1007/BF00785810; Meredith AL, 2004, J BIOL CHEM, V279, P36746, DOI 10.1074/jbc.M405621200; Meyer LH, 2006, BEST PRACT RES CL RH, V20, P969, DOI 10.1016/j.berh.2006.06.005; Mor A, 2005, CLIN IMMUNOL, V115, P118, DOI 10.1016/j.clim.2004.12.009; Noss EH, 2008, IMMUNOL REV, V223, P252, DOI 10.1111/j.1600-065X.2008.00648.x; Pattacini L, 2007, RHEUMATOLOGY, V46, P1252, DOI 10.1093/rheumatology/kem092; Pennington MW, 2009, MOL PHARMACOL, V75, P762, DOI 10.1124/mol.108.052704; Rangaraju S, 2009, EXPERT OPIN THER TAR, V13, P909, DOI 10.1517/14728220903018957; Striano P, 2009, EXPERT OPIN INV DRUG, V18, P1875, DOI 10.1517/13543780903369341; Tolboom TCA, 2005, ARTHRITIS RHEUM-US, V52, P1999, DOI 10.1002/art.21118; Tolboom TCA, 2002, ANN RHEUM DIS, V61, P975, DOI 10.1136/ard.61.11.975; Wickenden AD, 2009, CURR PHARM DESIGN, V15, P1773, DOI 10.2174/138161209788186326; Wulff H, 2000, P NATL ACAD SCI USA, V97, P8151, DOI 10.1073/pnas.97.14.8151; Wulff H, 2003, J CLIN INVEST, V111, P1703, DOI 10.1172/JCI200316921	43	35	36	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					4014	4022		10.1074/jbc.M111.312264	http://dx.doi.org/10.1074/jbc.M111.312264			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22074915	Green Published, hybrid			2022-12-27	WOS:000300410900035
J	Mavridou, DAI; Stevens, JM; Monkemeyer, L; Daltrop, O; di Gleria, K; Kessler, BM; Ferguson, SJ; Allen, JWA				Mavridou, Despoina A. I.; Stevens, Julie M.; Moenkemeyer, Leonie; Daltrop, Oliver; di Gleria, Katalin; Kessler, Benedikt M.; Ferguson, Stuart J.; Allen, James W. A.			A Pivotal Heme-transfer Reaction Intermediate in Cytochrome c Biogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MATURATION CCM SYSTEM; IN-VITRO FORMATION; ESCHERICHIA-COLI; APOCYTOCHROME-C; BINDING MOTIF; HYDROGENOBACTER-THERMOPHILUS; CHAPERONE CCME; THIOETHER BOND; ACTIVE-SITE; PROTEIN	c-Type cytochromes are widespread proteins, fundamental for respiration or photosynthesis in most cells. They contain heme covalently bound to protein in a highly conserved, highly stereospecific post-translational modification. In many bacteria, mitochondria, and archaea this heme attachment is catalyzed by the cytochrome c maturation (Ccm) proteins. Here we identify and characterize a covalent, ternary complex between the heme chaperone CcmE, heme, and cytochrome c. Formation of the complex from holo-CcmE occurs in vivo and in vitro and involves the specific heme-binding residues of both CcmE and apocytochrome c. The enhancement and attenuation of the amounts of this complex correlates completely with known consequences of mutations in genes for other Ccm proteins. We propose the complex is a trapped catalytic intermediate in the cytochrome c biogenesis process, at the point of heme transfer from CcmE to the cytochrome, the key step in the maturation pathway.	[Mavridou, Despoina A. I.; Stevens, Julie M.; Moenkemeyer, Leonie; Daltrop, Oliver; Ferguson, Stuart J.; Allen, James W. A.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [di Gleria, Katalin] Univ Oxford, Nuffield Dept Med, Weatherall Inst Mol Med, Med Res Council Human Immunol Unit, Oxford OX3 9DS, England; [Kessler, Benedikt M.] Univ Oxford, Dept Med, Oxford OX3 7BN, England	University of Oxford; University of Oxford; University of Oxford	Ferguson, SJ (corresponding author), Univ Oxford, Dept Biochem, S Parks Rd, Oxford OX1 3QU, England.	stuart.ferguson@bioch.ox.ac.uk	Kessler, Benedikt/AAY-8614-2021; Mavridou, Despoina/ABG-5940-2020	Kessler, Benedikt/0000-0002-8160-2446; Mavridou, Despoina/0000-0002-7449-1151	Biotechnology and Biological Sciences Research Council [BB/D019753/1, BB/H017887/1]; Wellcome Trust [092532]; Value-in-People Award; Gustav Born Trust; Edward Penley Abraham Cephalosporin Fund; Biomedical Research Centre (NIHR), Oxford, UK; BBSRC [BB/D019753/1, BB/H017887/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Value-in-People Award; Gustav Born Trust; Edward Penley Abraham Cephalosporin Fund; Biomedical Research Centre (NIHR), Oxford, UK(National Institute for Health Research (NIHR)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by Biotechnology and Biological Sciences Research Council Grants BB/D019753/1 and BB/H017887/1, Wellcome Trust Grant 092532, and a Value-in-People Award.; Supported by the Gustav Born Trust and the Edward Penley Abraham Cephalosporin Fund.; Supported by the Biomedical Research Centre (NIHR), Oxford, UK.	Ahuja U, 2005, J BIOL CHEM, V280, P236, DOI 10.1074/jbc.M410912200; Allen JWA, 2011, FEBS J, V278, P4198, DOI 10.1111/j.1742-4658.2011.08231.x; Allen JWA, 2003, BIOCHEM J, V375, P721, DOI 10.1042/BJ20030752; Allen JWA, 2005, BIOCHEM J, V389, P587, DOI 10.1042/BJ20041894; Allen JWA, 2003, J BIOL CHEM, V278, P52075, DOI 10.1074/jbc.M307196200; Allen JWA, 2003, PHILOS T ROY SOC B, V358, P255, DOI 10.1098/rstb.2002.1192; Allen JWA, 2002, J BIOL CHEM, V277, P33559, DOI 10.1074/jbc.M204963200; Arslan E, 1998, BIOCHEM BIOPH RES CO, V251, P744, DOI 10.1006/bbrc.1998.9549; Barker PD, 1999, STRUCTURE, V7, pR281, DOI 10.1016/S0969-2126(00)88334-3; BARKER PD, 1995, BIOCHEMISTRY-US, V34, P15191, DOI 10.1021/bi00046a027; Bartsch R. G., 1971, METHODS ENZYMOL, V23, P344, DOI [10.1016/S0076-6879(71)23110-4, DOI 10.1016/S0076-6879(71)23110-4]; Batycka M, 2006, RAPID COMMUN MASS SP, V20, P2074, DOI 10.1002/rcm.2563; Christensen O, 2007, FEBS J, V274, P2322, DOI 10.1111/j.1742-4658.2007.05769.x; Daltrop O, 2004, J BIOL CHEM, V279, P45347, DOI 10.1074/jbc.M408637200; Daltrop O, 2003, J BIOL CHEM, V278, P24308, DOI 10.1074/jbc.M301967200; Daltrop O, 2003, J BIOL CHEM, V278, P4404, DOI 10.1074/jbc.M211124200; Daltrop O, 2002, P NATL ACAD SCI USA, V99, P9703, DOI 10.1073/pnas.152120699; Daltrop O, 2002, P NATL ACAD SCI USA, V99, P7872, DOI 10.1073/pnas.132259099; de Vitry C, 2011, FEBS J, V278, P4189, DOI 10.1111/j.1742-4658.2011.08373.x; Feissner RE, 2006, MOL MICROBIOL, V61, P219, DOI 10.1111/j.1365-2958.2006.05221.x; Goddard AD, 2010, J BIOL CHEM, V285, P22880, DOI 10.1074/jbc.M110.133421; Goddard AD, 2010, FEBS J, V277, P726, DOI 10.1111/j.1742-4658.2009.07517.x; GOODHEW CF, 1986, BIOCHIM BIOPHYS ACTA, V852, P288, DOI 10.1016/0005-2728(86)90234-3; Hamel P, 2009, BBA-MOL CELL RES, V1793, P125, DOI 10.1016/j.bbamcr.2008.06.017; Kramer HB, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000893; Kranz RG, 2009, MICROBIOL MOL BIOL R, V73, P510, DOI 10.1128/MMBR.00001-09; Lee DH, 2005, J AM CHEM SOC, V127, P3716, DOI 10.1021/ja044658e; Mavridou DAI, 2011, J BIOL CHEM, V286, P24943, DOI 10.1074/jbc.M111.236141; Meyer EH, 2005, P NATL ACAD SCI USA, V102, P16113, DOI 10.1073/pnas.0503473102; Rayapuram N, 2008, J BIOL CHEM, V283, P25200, DOI 10.1074/jbc.M802621200; Reid E, 1998, FEMS MICROBIOL LETT, V166, P369, DOI 10.1016/S0378-1097(98)00357-7; Richard-Fogal C, 2010, J MOL BIOL, V401, P350, DOI 10.1016/j.jmb.2010.06.041; Robertson IB, 2008, FEBS LETT, V582, P3067, DOI 10.1016/j.febslet.2008.07.052; Schulz H, 1998, SCIENCE, V281, P1197, DOI 10.1126/science.281.5380.1197; Schulz H, 1999, P NATL ACAD SCI USA, V96, P6462, DOI 10.1073/pnas.96.11.6462; Simon J, 2011, FEBS J, V278, P4179, DOI 10.1111/j.1742-4658.2011.08374.x; Stevens JM, 2011, FEBS J, V278, P4170, DOI 10.1111/j.1742-4658.2011.08376.x; Turkarslan S, 2008, MOL MICROBIOL, V70, P652, DOI 10.1111/j.1365-2958.2008.06441.x	38	18	18	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2342	2352		10.1074/jbc.M111.313692	http://dx.doi.org/10.1074/jbc.M111.313692			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22121193	Green Published, hybrid			2022-12-27	WOS:000300292300010
J	Ouyang, H; Ali, YO; Ravichandran, M; Dong, AP; Qiu, W; MacKenzie, F; Dhe-Paganon, S; Arrowsmith, CH; Zhai, RG				Ouyang, Hui; Ali, Yousuf O.; Ravichandran, Mani; Dong, Aiping; Qiu, Wei; MacKenzie, Farrell; Dhe-Paganon, Sirano; Arrowsmith, Cheryl H.; Zhai, R. Grace			Protein Aggregates Are Recruited to Aggresome by Histone Deacetylase 6 via Unanchored Ubiquitin C Termini	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPINOCEREBELLAR ATAXIA TYPE-3; HDAC6; DEGRADATION; AUTOPHAGY; PROTEASOME; STRESS; DOMAIN; NEURODEGENERATION; LOCALIZATION; CYTOSKELETON	The aggresome pathway is activated when proteasomal clearance of misfolded proteins is hindered. Misfolded polyubiquitinated protein aggregates are recruited and transported to the aggresome via the microtubule network by a protein complex consisting of histone deacetylase 6 (HDAC6) and the dynein motor complex. The current model suggests that HDAC6 recognizes protein aggregates by binding directly to polyubiquitinated proteins. Here, we show that there are substantial amounts of unanchored ubiquitin in protein aggregates with solvent-accessible C termini. The ubiquitin-binding domain (ZnF-UBP) of HDAC6 binds exclusively to the unanchored C-terminal diglycine motif of ubiquitin instead of conjugated polyubiquitin. The unanchored ubiquitin C termini in the aggregates are generated in situ by aggregate-associated deubiquitinase ataxin-3. These results provide structural and mechanistic bases for the role of HDAC6 in aggresome formation and further suggest a novel ubiquitin-mediated signaling pathway, where the exposure of ubiquitin C termini within protein aggregates enables HDAC6 recognition and transport to the aggresome.	[Ouyang, Hui; Ravichandran, Mani; Dong, Aiping; MacKenzie, Farrell; Dhe-Paganon, Sirano; Arrowsmith, Cheryl H.] Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L7, Canada; [Ali, Yousuf O.; Zhai, R. Grace] Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA; [Qiu, Wei] Univ Hlth Network, Toronto, ON M5G 2C4, Canada	University of Toronto; Structural Genomics Consortium; University of Miami; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Ouyang, H (corresponding author), Univ Toronto, Struct Genom Consortium, 101 Coll St, Toronto, ON M5G 1L7, Canada.	hui.ouyang@utoronto.ca	Zhai, R. Grace/AGZ-3936-2022	Zhai, Rong/0000-0002-7599-1430; Arrowsmith, Cheryl/0000-0002-4971-3250	National Institutes of Health [1R01NS064269]; Canadian Institutes for Health Research; Canadian Foundation for Innovation; Genome Canada through the Ontario Genomics Institute; GlaxoSmithKline; Karolinska Institutet; Knut and Alice Wallenberg Foundation; Ontario Innovation Trust; Ontario Ministry for Research and Innovation; Merck Co., Inc.; Novartis Research Foundation; Swedish Agency for Innovation Systems; Swedish Foundation for Strategic Research; Wellcome Trust; American Heart Association; Pew Charitable Trust; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064269, R56NS064269] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Genome Canada through the Ontario Genomics Institute(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Karolinska Institutet(Karolinska Institutet); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Ontario Innovation Trust; Ontario Ministry for Research and Innovation(Ministry of Research and Innovation, Ontario); Merck Co., Inc.(Merck & Company); Novartis Research Foundation; Swedish Agency for Innovation Systems(Vinnova); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Wellcome Trust(Wellcome TrustEuropean Commission); American Heart Association(American Heart Association); Pew Charitable Trust; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R01NS064269 (to R. G. Z.). This work was also supported by Canadian Institutes for Health Research, the Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institutet, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck & Co., Inc., the Novartis Research Foundation, the Swedish Agency for Innovation Systems, the Swedish Foundation for Strategic Research, and the Wellcome Trust.; Supported by the American Heart Association.; Supported in part by the Pew Charitable Trust. To whom correspondence may be addressed: 1600 NW 10th Ave., RMSB 6069, Miami, FL 33136. Tel.: 305-243-6316; Fax: 305-243-4555; E-mail: gzhai@med.miami.edu.	Amerik AY, 1997, EMBO J, V16, P4826; Bonnet J, 2008, TRENDS BIOCHEM SCI, V33, P369, DOI 10.1016/j.tibs.2008.05.005; Boyault C, 2007, ONCOGENE, V26, P5468, DOI 10.1038/sj.onc.1210614; Boyault C, 2006, EMBO J, V25, P3357, DOI 10.1038/sj.emboj.7601210; BRICOGNE G, 1993, ACTA CRYSTALLOGR D, V49, P37, DOI 10.1107/S0907444992010400; Burnett B, 2003, HUM MOL GENET, V12, P3195, DOI 10.1093/hmg/ddg344; Burnett BG, 2005, P NATL ACAD SCI USA, V102, P4330, DOI 10.1073/pnas.0407252102; Chin LS, 2010, BIOCHEM SOC T, V38, P144, DOI 10.1042/BST0380144; Dompierre JP, 2007, J NEUROSCI, V27, P3571, DOI 10.1523/JNEUROSCI.0037-07.2007; Donaldson KM, 2003, P NATL ACAD SCI USA, V100, P8892, DOI 10.1073/pnas.1530212100; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FINLEY D, 1991, ANNU REV CELL BIOL, V7, P25, DOI 10.1146/annurev.cb.07.110191.000325; Garcia-Mata R, 2002, TRAFFIC, V3, P388, DOI 10.1034/j.1600-0854.2002.30602.x; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Lee JY, 2010, EMBO J, V29, P969, DOI 10.1038/emboj.2009.405; Mao Y, 2005, P NATL ACAD SCI USA, V102, P12700, DOI 10.1073/pnas.0506344102; Matthias P, 2008, CELL CYCLE, V7, P7, DOI 10.4161/cc.7.1.5186; Menzies FM, 2010, BRAIN, V133, P93, DOI 10.1093/brain/awp292; Mimnaugh EG, 1997, BIOCHEMISTRY-US, V36, P14418, DOI 10.1021/bi970998j; Olzmann JA, 2008, CURR MED CHEM, V15, P47; Pai MT, 2007, J MOL BIOL, V370, P290, DOI 10.1016/j.jmb.2007.04.015; Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853; Paulson HL, 1997, NEURON, V19, P333, DOI 10.1016/S0896-6273(00)80943-5; Pozzi C, 2008, NEUROBIOL DIS, V30, P190, DOI 10.1016/j.nbd.2008.01.011; Raiborg C, 2006, TRENDS BIOCHEM SCI, V31, P541, DOI 10.1016/j.tibs.2006.07.009; Reyes-Turcu FE, 2006, CELL, V124, P1197, DOI 10.1016/j.cell.2006.02.038; Rodriguez-Gonzalez A, 2008, CANCER RES, V68, P2557, DOI 10.1158/0008-5472.CAN-07-5989; Tai HC, 2008, NAT REV NEUROSCI, V9, P826, DOI 10.1038/nrn2499; Trottier Y, 1998, NEUROBIOL DIS, V5, P335, DOI 10.1006/nbdi.1998.0208; Valenzuela-Fernandez A, 2008, TRENDS CELL BIOL, V18, P291, DOI 10.1016/j.tcb.2008.04.003; Zhai RG, 2008, NATURE, V452, P887, DOI 10.1038/nature06721	36	142	144	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2317	2327		10.1074/jbc.M111.273730	http://dx.doi.org/10.1074/jbc.M111.273730			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22069321	Green Published, hybrid			2022-12-27	WOS:000300292300008
J	Speicher, T; Kohler, UA; Chouker, A; Werner, S; Weiland, T; Wendel, A				Speicher, Tobias; Koehler, Ulrike A.; Chouker, Alexander; Werner, Sabine; Weiland, Timo; Wendel, Albrecht			Fructose Protects Murine Hepatocytes from Tumor Necrosis Factor-induced Apoptosis by Modulating JNK Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METABOLIC DEPLETION; CANCER-PATIENTS; PHASE-I; C-JUN; TNF; ACTIVATION; KINASE; LIVER; ATP; TRANSDUCTION	Fructose-induced hepatic ATP depletion prevents TNF-induced apoptosis, whereas it contrarily enhances CD95-induced hepatocyte apoptosis in vitro and in vivo. By contrast, transformed liver cells are not protected against TNF due to metabolic alterations, allowing selective tumor targeting. We analyzed the molecular mechanisms by which fructose modulates cytokine-induced apoptosis. A release of adenosine after fructose-induced ATP depletion, followed by a cAMP response, was demonstrated. Likewise, cAMP and adenosine mimicked per se the modulation by fructose of CD95- and TNF-induced apoptosis. The effects of fructose on cytokine-induced apoptosis were sensitive to inhibition of protein kinase A. Fructose prevented the pro-apoptotic, sustained phase of TNF-induced JNK signaling and thereby blocked bid-mediated activation of the intrinsic mitochondrial apoptosis pathway in a PKA-dependent manner. We explain the dichotomal effects of fructose on CD95- and TNF-induced cell death by the selective requirement of JNK signaling for the latter. These findings provide a mechanistic rationale for the protection of hepatocytes from TNF-induced cell death by pharmacological doses of fructose.	[Speicher, Tobias; Koehler, Ulrike A.; Weiland, Timo; Wendel, Albrecht] Univ Konstanz, Fac Biol, Chair Biochem Pharmacol, D-78457 Constance, Germany; [Chouker, Alexander] Klinikum Grosshadern, Dept Anesthesiol, D-81377 Munich, Germany; [Speicher, Tobias; Werner, Sabine] Swiss Fed Inst Technol, Inst Cell Biol, CH-8093 Zurich, Switzerland	University of Konstanz; University of Munich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Wendel, A (corresponding author), Univ Konstanz, Fac Biol, Chair Biochem Pharmacol, M667, D-78457 Constance, Germany.	albrecht.wendel@uni-konstanz.de	Chouker, Alexander/H-2490-2017	Werner, Sabine/0000-0001-7397-8710	Deutsche Forschungsgemeinschaft; International Research Training Group [1331]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); International Research Training Group	This study was supported in part by a fellowship of the Deutsche Forschungsgemeinschaft-funded International Research Training Group 1331 ( to Marcel Leist and A. W.).	Bohm F, 2010, GASTROENTEROLOGY, V139, P1385, DOI 10.1053/j.gastro.2010.06.069; Cortez-Pinto H, 1999, JAMA-J AM MED ASSOC, V282, P1659, DOI 10.1001/jama.282.17.1659; DERIJARD B, 1995, SCIENCE, V267, P682, DOI 10.1126/science.7839144; Hui HX, 2009, PANCREAS, V38, P706, DOI 10.1097/MPA.0b013e3181a7c6e5; Khan N, 2011, Mymensingh Med J, V20, P332; Latta M, 2000, J EXP MED, V191, P1975, DOI 10.1084/jem.191.11.1975; Lee JD, 2005, J NUCL MED, V46, P1753; LEIST M, 1994, J IMMUNOL, V153, P1778; Lejeune FJ, 2006, B CANC, V93, pE90; Liu HL, 2002, HEPATOLOGY, V35, P772, DOI 10.1053/jhep.2002.32534; Lucas R, 2005, CURR CANCER DRUG TAR, V5, P381, DOI 10.2174/1568009054863627; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; MAENPAA PH, 1968, SCIENCE, V161, P1253, DOI 10.1126/science.161.3847.1253; Minor T, 2000, LIVER TRANSPLANT, V6, P196, DOI 10.1016/S1527-6465(00)80011-8; Moser G. H., 1989, AM J PHYSIOL, V256, P799; Palmer T. M., 2008, BR J PHARM S, V153, P127; Schwabe RF, 2004, FASEB J, V18, P720, DOI 10.1096/fj.03-0771fje; SHERMAN ML, 1988, J CLIN ONCOL, V6, P344, DOI 10.1200/JCO.1988.6.2.344; Speicher T, 2010, J HEPATOL, V53, P896, DOI 10.1016/j.jhep.2010.05.024; SPRIGGS DR, 1988, J NATL CANCER I, V80, P1039, DOI 10.1093/jnci/80.13.1039; Taeger G, 2008, INT J HYPERTHER, V24, P193, DOI 10.1080/02656730701868387; Thiel M, 1997, INFECT IMMUN, V65, P2136, DOI 10.1128/IAI.65.6.2136-2144.1997; Ventura JJ, 2006, MOL CELL, V21, P701, DOI 10.1016/j.molcel.2006.01.018; Wahjudi PN, 2010, CLIN BIOCHEM, V43, P198, DOI 10.1016/j.clinbiochem.2009.08.028; Zechner D, 1997, J CELL BIOL, V139, P115, DOI 10.1083/jcb.139.1.115; Zhang J, 2008, CELL DEATH DIFFER, V15, P1654, DOI 10.1038/cdd.2008.87	26	7	7	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2012	287	3					1837	1846		10.1074/jbc.M111.266742	http://dx.doi.org/10.1074/jbc.M111.266742			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879HT	22086922	hybrid, Green Published			2022-12-27	WOS:000299321000025
J	Badeaux, AI; Yang, YZ; Cardenas, K; Vemulapalli, V; Chen, KF; Kusewitt, D; Richie, E; Li, W; Bedford, MT				Badeaux, Aimee I.; Yang, Yanzhong; Cardenas, Kim; Vemulapalli, Vidyasiri; Chen, Kaifu; Kusewitt, Donna; Richie, Ellen; Li, Wei; Bedford, Mark T.			Loss of the Methyl Lysine Effector Protein PHF20 Impacts the Expression of Genes Regulated by the Lysine Acetyltransferase MOF	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DROSOPHILA MSL COMPLEX; DOSAGE COMPENSATION; HISTONE ACETYLTRANSFERASE; ACETYLATION; DISTINCT; ACTIVATION; 53BP1; H4	In epigenetic signaling pathways, histone tails are heavily modified, resulting in the recruitment of effector molecules that can influence transcription. One such molecule, plant homeodomain finger protein 20 (PHF20), uses a Tudor domain to read dimethyl lysine residues and is a known component of the MOF(male absent on the first) histone acetyltransferase protein complex, suggesting it plays a role in the cross-talk between lysine methylation and histone acetylation. We sought to investigate the biological role of PHF20 by generating a knockout mouse. Without PHF20, mice die shortly after birth and display a wide variety of phenotypes within the skeletal and hematopoietic systems. Mechanistically, PHF20 is not required for maintaining the global H4K16 acetylation levels or locus specific histone acetylation but instead works downstream in transcriptional regulation of MOF target genes.	[Badeaux, Aimee I.; Yang, Yanzhong; Cardenas, Kim; Vemulapalli, Vidyasiri; Kusewitt, Donna; Richie, Ellen; Bedford, Mark T.] Univ Texas MD Anderson Canc Ctr, Dept Mol Carcinogenesis, Smithville, TX 78957 USA; [Chen, Kaifu; Li, Wei] Baylor Coll Med, Div Biostat, Dept Mol & Cellular Biol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine	Bedford, MT (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Mol Carcinogenesis, Smithville, TX 78957 USA.	mtbedford@mdanderson.org	yang, yanzhong/AAH-6132-2019	Richie, Ellen/0000-0003-0786-973X	National Institutes of Health [5T32ES007247-19]; NIEHS National Institutes of Health [ES007784, DA023449]; Cancer Prevention and Research Institute of Texas [RP110471]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES007784, T32ES007247] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA023449] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Cancer Prevention and Research Institute of Texas; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Training Grant 5T32ES007247-19 (to A. B.) and NIEHS National Institutes of Health Institutional Grants ES007784 and DA023449 (to M. T. B.). This work was also supported by Cancer Prevention and Research Institute of Texas Grants RP110471 (to M. T. B.) and RP110471 (to W. L.).	Botuyan MV, 2006, CELL, V127, P1361, DOI 10.1016/j.cell.2006.10.043; Cai Y, 2010, J BIOL CHEM, V285, P4268, DOI 10.1074/jbc.C109.087981; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Heisel SM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002164; Kim J, 2006, EMBO REP, V7, P397, DOI 10.1038/sj.embor.7400625; Kind J, 2008, CELL, V133, P813, DOI 10.1016/j.cell.2008.04.036; Li XZ, 2009, MOL CELL, V36, P290, DOI 10.1016/j.molcel.2009.07.031; Liu HD, 2010, J PROTEOME RES, V9, P5827, DOI 10.1021/pr100597b; Mendjan S, 2006, MOL CELL, V21, P811, DOI 10.1016/j.molcel.2006.02.007; Nagy A., 2003, MANIPULATING MOUSE E; Prestel M, 2010, MOL CELL, V38, P815, DOI 10.1016/j.molcel.2010.05.022; Raja SJ, 2010, MOL CELL, V38, P827, DOI 10.1016/j.molcel.2010.05.021; Shia WJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-217; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Smith ER, 2005, MOL CELL BIOL, V25, P9175, DOI 10.1128/MCB.25.21.9175-9188.2005; Smith ER, 2000, MOL CELL BIOL, V20, P312, DOI 10.1128/MCB.20.1.312-318.2000; Taipale M, 2005, MOL CELL BIOL, V25, P6798, DOI 10.1128/MCB.25.15.6798-6810.2005; Thomas T, 2008, MOL CELL BIOL, V28, P5093, DOI 10.1128/MCB.02202-07; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Ward IM, 2003, MOL CELL BIOL, V23, P2556, DOI 10.1128/MCB.23.7.2556-2563.2003; Yun MY, 2011, CELL RES, V21, P564, DOI 10.1038/cr.2011.42; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	22	25	27	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					429	437		10.1074/jbc.M111.271163	http://dx.doi.org/10.1074/jbc.M111.271163			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22072714	Green Published, hybrid			2022-12-27	WOS:000298682400041
J	Bilyy, RO; Shkandina, T; Tomin, A; Munoz, LE; Franz, S; Antonyuk, V; Kit, YY; Zirngibl, M; Furnrohr, BG; Janko, C; Lauber, K; Schiller, M; Schett, G; Stoika, RS; Herrmann, M				Bilyy, Rostyslav O.; Shkandina, Tanya; Tomin, Andriy; Munoz, Luis E.; Franz, Sandra; Antonyuk, Volodymyr; Kit, Yuriy Ya.; Zirngibl, Matthias; Fuernrohr, Barbara G.; Janko, Christina; Lauber, Kirsten; Schiller, Martin; Schett, Georg; Stoika, Rostyslav S.; Herrmann, Martin			Macrophages Discriminate Glycosylation Patterns of Apoptotic Cell-derived Microparticles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ME SIGNAL; FIND-ME; CLEARANCE; SURFACE; MACROPINOCYTOSIS; RECOGNITION; RECEPTOR; ACID	Inappropriate clearance of apoptotic remnants is considered to be the primary cause of systemic autoimmune diseases, like systemic lupus erythematosus. Here we demonstrate that apoptotic cells release distinct types of subcellular membranous particles (scMP) derived from the endoplasmic reticulum (ER) or the plasma membrane. Both types of scMP exhibit desialylated glycotopes resulting from surface exposure of immature ER-derived glycoproteins or from surface-borne sialidase activity, respectively. Sialidase activity is activated by caspase-dependent mechanisms during apoptosis. Cleavage of sialidase Neu1 by caspase 3 was shown to be directly involved in apoptosis-related increase of surface sialidase activity. ER-derived blebs possess immature mannosidic glycoepitopes and are prioritized by macrophages during clearance. Plasma membrane-derived blebs contain nuclear chromatin (DNA and histones) but not components of the nuclear envelope. Existence of two immunologically distinct types of apoptotic blebs may provide new insights into clearance-related diseases.	[Bilyy, Rostyslav O.; Munoz, Luis E.; Franz, Sandra; Zirngibl, Matthias; Fuernrohr, Barbara G.; Janko, Christina; Schett, Georg; Herrmann, Martin] Univ Erlangen Nurnberg, Dept Internal Med 3, Inst Clin Immunol & Rheumatol, D-91054 Erlangen, Germany; [Bilyy, Rostyslav O.; Shkandina, Tanya; Tomin, Andriy; Antonyuk, Volodymyr; Kit, Yuriy Ya.; Stoika, Rostyslav S.] Natl Acad Sci Ukraine, Inst Cell Biol, UA-79005 Lvov, Ukraine; [Lauber, Kirsten] Univ Munich, Dept Radiat Oncol, D-81377 Munich, Germany; [Schiller, Martin] Univ Heidelberg, Dept Med 5, D-69120 Heidelberg, Germany	University of Erlangen Nuremberg; National Academy of Sciences Ukraine; Institute of Cell Biology of NASU; University of Munich; Ruprecht Karls University Heidelberg	Herrmann, M (corresponding author), Univ Erlangen Nurnberg, Dept Internal Med 3, Inst Clin Immunol & Rheumatol, Krankenhausstr 12, D-91054 Erlangen, Germany.	martin.herrmann@UK-Erlangen.de	Antonyuk, Volodymyr/AAD-4457-2019; Dumych, Tetiana/H-9450-2018; herrmann, martin/AAT-9836-2020; Munoz, Luis E/E-7725-2010; Bilyy, Rostyslav/A-9777-2010; Bilyy, Rostyslav/AAH-9636-2020; Herrmann, Martin/A-9597-2013	Dumych, Tetiana/0000-0002-8489-5600; Munoz, Luis E/0000-0002-5395-804X; Bilyy, Rostyslav/0000-0002-2344-1349; Bilyy, Rostyslav/0000-0002-2344-1349; Herrmann, Martin/0000-0002-0258-2484; Franz, Sandra/0000-0002-3449-2723; Tomin, Andriy/0000-0001-8921-6366; Janko, Christina/0000-0001-5705-6329; Kit, Yuriy/0000-0002-5995-4381; Stoika, Rostyslav/0000-0001-5719-2187	German-Ukrainian Grant [UKR08/035]; NASU; WUBMRC; Ukraine; intramural grant ELAN [M3-09.03.18.1]; DFG [GRK-SFB643]; K&R Wucherpfennigstiftung	German-Ukrainian Grant; NASU; WUBMRC; Ukraine; intramural grant ELAN; DFG(German Research Foundation (DFG)); K&R Wucherpfennigstiftung	This work was supported by German-Ukrainian Grant UKR08/035 (to R. B. and M. H.), Grants from NASU, WUBMRC, and the President of Ukraine (to R. B.), by an intramural grant ELAN M3-09.03.18.1 (to L. E. M.), by the DFG (GRK-SFB643), and the K&R Wucherpfennigstiftung (to M. H.). Confocal microscopy was done at the Nikon Imaging Center at the University of Heidelberg.	Azuma Y, 2007, BIOL PHARM BULL, V30, P1680, DOI 10.1248/bpb.30.1680; Bilyy RO, 2003, CYTOM PART A, V56A, P89, DOI 10.1002/cyto.a.10089; Bilyy R, 2007, AUTOIMMUNITY, V40, P249, DOI 10.1080/08916930701358867; CASCIOLAROSEN LA, 1994, J EXP MED, V179, P1317, DOI 10.1084/jem.179.4.1317; Elliott MR, 2010, J CELL BIOL, V189, P1059, DOI 10.1083/jcb.201004096; Elliott MR, 2009, NATURE, V461, P282, DOI 10.1038/nature08296; Franz S, 2007, CELL DEATH DIFFER, V14, P733, DOI 10.1038/sj.cdd.4402066; Franz S, 2006, CYTOM PART A, V69A, P230, DOI 10.1002/cyto.a.20206; Friggeri A, 2011, J IMMUNOL, V186, P6191, DOI 10.4049/jimmunol.1004134; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Keller P, 2001, NAT CELL BIOL, V3, P140, DOI 10.1038/35055042; Kuno A, 2005, NAT METHODS, V2, P851, DOI 10.1038/NMETH803; Lauber K, 2003, CELL, V113, P717, DOI 10.1016/S0092-8674(03)00422-7; Meesmann HM, 2010, J CELL SCI, V123, P3347, DOI 10.1242/jcs.066696; Mercer J, 2008, SCIENCE, V320, P531, DOI 10.1126/science.1155164; Mercer J, 2009, NAT CELL BIOL, V11, P510, DOI 10.1038/ncb0509-510; Munoz LE, 2010, NAT REV RHEUMATOL, V6, P280, DOI 10.1038/nrrheum.2010.46; Nakano V, 2006, ANAEROBE, V12, P238, DOI 10.1016/j.anaerobe.2006.07.003; Obeid M, 2007, NAT MED, V13, P54, DOI 10.1038/nm1523; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; Ravichandran KS, 2010, J EXP MED, V207, P1807, DOI 10.1084/jem.20101157; Sancho D, 2009, NATURE, V458, P899, DOI 10.1038/nature07750; SAVILL J, 1993, IMMUNOL TODAY, V14, P131, DOI 10.1016/0167-5699(93)90215-7; SAVILL JS, 1989, J CLIN INVEST, V84, P1518, DOI 10.1172/JCI114328; Seyrantepe V, 2010, J BIOL CHEM, V285, P206, DOI 10.1074/jbc.M109.055475; Tomin A., 2011, P SOC PHOTO-OPT INS, V8087; Voll RE, 1997, NATURE, V390, P350, DOI 10.1038/37022; WARNER TG, 1979, BIOCHEMISTRY-US, V18, P2783, DOI 10.1021/bi00580a014	28	61	67	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					496	503		10.1074/jbc.M111.273144	http://dx.doi.org/10.1074/jbc.M111.273144			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22074924	Green Published, hybrid			2022-12-27	WOS:000298682400048
J	Chow, SS; Van Petegem, F; Accili, EA				Chow, Sarah S.; Van Petegem, Filip; Accili, Eric A.			Energetics of Cyclic AMP Binding to HCN Channel C Terminus Reveal Negative Cooperativity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED CATION CHANNEL; PACEMAKER CHANNELS; CAMP MODULATION; LIGHT-SCATTERING; STRUCTURAL BASIS; SINOATRIAL NODE; LIGAND-BINDING; PROTEINS; VOLTAGE; CRYSTALLIZATION	Cyclic AMP binds to the HCN channel C terminus and variably stabilizes its open state. Using isothermal titration calorimetry, we show that cAMP binds to one subunit of tetrameric HCN2 and HCN4 C termini with high affinity (similar to 0.12 mu M) and subsequently with low affinity (similar to 1 mu M) to the remaining three subunits. Changes induced by high affinity binding already exist in both a constrained HCN2 tetramer and the unconstrained HCN1 tetramer. Natural "preactivation" of HCN1 may explain both the smaller effect of cAMP on stabilizing its open state and the opening of unliganded HCN1, which occurs as though already disinhibited.	[Chow, Sarah S.; Accili, Eric A.] Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V6T 1Z3, Canada; [Van Petegem, Filip] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada	University of British Columbia; University of British Columbia	Accili, EA (corresponding author), Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V6T 1Z3, Canada.	eaaccili@mail.ubc.ca	Van Petegem, Filip/M-6061-2016	Van Petegem, Filip/0000-0003-2728-8537	Canadian Institutes for Health Research (CIHR); Tier II Canada Research Chair	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Tier II Canada Research Chair	This work was supported by operating funds from the Canadian Institutes for Health Research (CIHR) (to E. A. A. and F. V. P.).; The recipient of a Tier II Canada Research Chair. To whom correspondence should be addressed. Tel.: 604-822-6900; Fax: 604-822-6048, E-mail: eaaccili@mail.ubc.ca.	Altomare C, 2001, J GEN PHYSIOL, V117, P519, DOI 10.1085/jgp.117.6.519; Berrera M, 2006, BIOPHYS J, V90, P3428, DOI 10.1529/biophysj.105.071621; Chen C, 2001, J GEN PHYSIOL, V117, P491, DOI 10.1085/jgp.117.5.491; Chen S, 2007, J GEN PHYSIOL, V129, P175, DOI 10.1085/jgp.200609585; DiFrancesco D, 1999, J PHYSIOL-LONDON, V515, P367, DOI 10.1111/j.1469-7793.1999.367ac.x; DIFRANCESCO D, 1994, J PHYSIOL-LONDON, V474, P473, DOI 10.1113/jphysiol.1994.sp020038; DIFRANCESCO D, 1993, ANNU REV PHYSIOL, V55, P455, DOI 10.1146/annurev.physiol.55.1.455; DIFRANCESCO D, 1991, NATURE, V351, P145, DOI 10.1038/351145a0; Gauss R, 1998, NATURE, V393, P583, DOI 10.1038/31248; Habel JE, 2001, ACTA CRYSTALLOGR D, V57, P254, DOI 10.1107/S0907444900015225; HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779; Ishii TM, 1999, J BIOL CHEM, V274, P12835, DOI 10.1074/jbc.274.18.12835; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; Kusch J, 2010, NEURON, V67, P75, DOI 10.1016/j.neuron.2010.05.022; Leavitt S, 2001, CURR OPIN STRUC BIOL, V11, P560, DOI 10.1016/S0959-440X(00)00248-7; Ludwig A, 1998, NATURE, V393, P587, DOI 10.1038/31255; Mistrik P, 2005, J BIOL CHEM, V280, P27056, DOI 10.1074/jbc.M502696200; Popovych N, 2006, NAT STRUCT MOL BIOL, V13, P831, DOI 10.1038/nsmb1132; Santoro B, 1998, CELL, V93, P717, DOI 10.1016/S0092-8674(00)81434-8; Stieber J, 2005, J BIOL CHEM, V280, P34635, DOI 10.1074/jbc.M502508200; Taraska JW, 2009, NAT METHODS, V6, P532, DOI 10.1038/nmeth.1341; Tibbs GR, 1998, J BIOL CHEM, V273, P4497, DOI 10.1074/jbc.273.8.4497; Ulens C, 2003, NEURON, V40, P959, DOI 10.1016/S0896-6273(03)00753-0; Velazquez-Campoy A, 2005, BIOPHYS CHEM, V115, P115, DOI 10.1016/j.bpc.2004.12.015; Wainger BJ, 2001, NATURE, V411, P805, DOI 10.1038/35081088; Wang J, 2002, NEURON, V36, P451, DOI 10.1016/S0896-6273(02)00968-6; Wang J, 2001, J GEN PHYSIOL, V118, P237, DOI 10.1085/jgp.118.3.237; WEBER IT, 1987, J MOL BIOL, V198, P311, DOI 10.1016/0022-2836(87)90315-9; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Wu SJ, 2011, BIOPHYS J, V100, P1226, DOI 10.1016/j.bpj.2011.01.034; Xu XP, 2010, J BIOL CHEM, V285, P37082, DOI 10.1074/jbc.M110.152033; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922; Zhou L, 2004, NEURON, V44, P823, DOI 10.1016/j.neuron.2004.11.012; Zhou L, 2007, STRUCTURE, V15, P655, DOI 10.1016/j.str.2007.04.012; ZULAUF M, 1992, J CRYST GROWTH, V122, P102, DOI 10.1016/0022-0248(92)90232-8	35	36	36	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					600	606		10.1074/jbc.M111.269563	http://dx.doi.org/10.1074/jbc.M111.269563			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22084239	hybrid, Green Published			2022-12-27	WOS:000298682400058
J	Yoshida, A; Wei, DD; Nomura, W; Izawa, S; Inoue, Y				Yoshida, Aya; Wei, Dandan; Nomura, Wataru; Izawa, Shingo; Inoue, Yoshiharu			Reduction of Glucose Uptake through Inhibition of Hexose Transporters and Enhancement of Their Endocytosis by Methylglyoxal in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR INTERNALIZATION; INDUCED DEGRADATION; PHOSPHOLIPASE-C; KINASE CASCADE; BETA-ARRESTIN; YEAST; PROTEIN; UBIQUITINATION; EXPRESSION; PATHWAY	Diabetes mellitus is characterized by an impairment of glucose uptake even though blood glucose levels are increased. Methylglyoxal is derived from glycolysis and has been implicated in the development of diabetes mellitus, because methylglyoxal levels in blood and tissues are higher in diabetic patients than in healthy individuals. However, it remains to be elucidated whether such factors are a cause, or consequence, of diabetes. Here, we show that methylglyoxal inhibits the activity of mammalian glucose transporters using recombinant Saccharomyces cerevisiae cells genetically lacking all hexose transporters but carrying cDNA for human GLUT1 or rat GLUT4. We found that methylglyoxal inhibits yeast hexose transporters also. Glucose uptake was reduced in a stepwise manner following treatment with methylglyoxal, i.e. a rapid reduction within 5 min, followed by a slow and gradual reduction. The rapid reduction was due to the inhibitory effect of methylglyoxal on hexose transporters, whereas the slow and gradual reduction seemed due to endocytosis, which leads to a decrease in the amount of hexose transporters on the plasma membrane. We found that Rsp5, a HECT-type ubiquitin ligase, is responsible for the ubiquitination of hexose transporters. Intriguingly, Plc1 (phospholipase C) negatively regulated the endocytosis of hexose transporters in an Rsp5-dependent manner, although the methylglyoxal-induced endocytosis of hexose transporters occurred irrespective of Plc1. Meanwhile, the internalization of hexose transporters following treatment with methylglyoxal was delayed in a mutant defective in protein kinase C.	[Yoshida, Aya; Wei, Dandan; Nomura, Wataru; Izawa, Shingo; Inoue, Yoshiharu] Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Mol Microbiol Lab, Kyoto 6110011, Japan	Kyoto University	Inoue, Y (corresponding author), Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Mol Microbiol Lab, Kyoto 6110011, Japan.	y_inoue@kais.kyoto-u.ac.jp		Izawa, Shingo/0000-0002-4920-2450	Ministry of Education, Science, Sports and Culture of Japan; Institution of Fermentation, Osaka, Japan; Grants-in-Aid for Scientific Research [23380202] Funding Source: KAKEN	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Institution of Fermentation, Osaka, Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a grant-in-aid for scientific research from the Ministry of Education, Science, Sports and Culture of Japan and grants from Institution of Fermentation, Osaka, Japan (to Y. I.).	Bagnat M, 2002, P NATL ACAD SCI USA, V99, P14183, DOI 10.1073/pnas.172517799; Balguerie A, 2002, EUKARYOT CELL, V1, P1021, DOI 10.1128/EC.1.6.1021-1031.2002; Beisswenger PJ, 2001, DIABETES CARE, V24, P726, DOI 10.2337/diacare.24.4.726; Beisswenger PJ, 1999, DIABETES, V48, P198, DOI 10.2337/diabetes.48.1.198; Brondijk THC, 1998, J BIOL CHEM, V273, P15352, DOI 10.1074/jbc.273.25.15352; deHart AKA, 2003, MOL BIOL CELL, V14, P4676, DOI 10.1091/mbc.E03-05-0323; Dunn R, 2004, J CELL BIOL, V165, P135, DOI 10.1083/jcb.200309026; DYER DG, 1991, Z ERNAHRUNGSWISS, V30, P29, DOI 10.1007/BF01910730; Engqvist-Goldstein AEY, 2003, ANNU REV CELL DEV BI, V19, P287, DOI 10.1146/annurev.cellbio.19.111401.093127; Ferguson SSG, 1996, SCIENCE, V271, P363, DOI 10.1126/science.271.5247.363; FLICK JS, 1993, MOL CELL BIOL, V13, P5861, DOI 10.1128/MCB.13.9.5861; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Harrison JC, 2001, NAT CELL BIOL, V3, P417, DOI 10.1038/35070104; HEIN C, 1995, MOL MICROBIOL, V18, P77, DOI 10.1111/j.1365-2958.1995.mmi_18010077.x; Hicke L, 1998, J CELL BIOL, V141, P349, DOI 10.1083/jcb.141.2.349; Huang SH, 2007, CELL METAB, V5, P237, DOI 10.1016/j.cmet.2007.03.006; Inoue Y, 1995, Adv Microb Physiol, V37, P177, DOI 10.1016/S0065-2911(08)60146-0; Inoue Y, 2011, SEMIN CELL DEV BIOL, V22, P278, DOI 10.1016/j.semcdb.2011.02.002; Izawa S, 2004, J BIOL CHEM, V279, P35469, DOI 10.1074/jbc.M403692200; Kalapos MP, 1999, TOXICOL LETT, V110, P145, DOI 10.1016/S0378-4274(99)00160-5; Kaminska J, 2011, EUR J CELL BIOL, V90, P1016, DOI 10.1016/j.ejcb.2011.08.002; Kasahara T, 2003, BIOCHEM J, V372, P247, DOI 10.1042/BJ20030044; Kasahara T, 1996, BIOCHEM J, V315, P177, DOI 10.1042/bj3150177; Kasahara T, 1997, BBA-BIOMEMBRANES, V1324, P111, DOI 10.1016/S0005-2736(96)00217-9; Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973; Krampe S, 2002, FEBS LETT, V513, P193, DOI 10.1016/S0014-5793(02)02297-4; Kranz A, 2001, MOL BIOL CELL, V12, P711, DOI 10.1091/mbc.12.3.711; Kruckeberg AL, 1999, BIOCHEM J, V339, P299, DOI 10.1042/0264-6021:3390299; Lagunas R., 1993, FEMS MICROBIOL REV, V10, P229; Lapolla A, 2003, CLIN CHEM LAB MED, V41, P1166, DOI 10.1515/CCLM.2003.180; Leon S, 2009, EXP CELL RES, V315, P1574, DOI 10.1016/j.yexcr.2008.11.014; LEVIN DE, 1992, J CELL BIOL, V116, P1221, DOI 10.1083/jcb.116.5.1221; Levin DE, 2005, MICROBIOL MOL BIOL R, V69, P262, DOI 10.1128/MMBR.69.2.262-291.2005; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; LOHSE MJ, 1990, SCIENCE, V248, P1547, DOI 10.1126/science.2163110; Maeta K, 2004, MOL CELL BIOL, V24, P8753, DOI 10.1128/MCB.24.19.8753-8764.2004; Maeta K, 2005, J BIOL CHEM, V280, P253, DOI 10.1074/jbc.M408061200; Marchal C, 1998, MOL CELL BIOL, V18, P314, DOI 10.1128/MCB.18.1.314; MCLELLAN AC, 1994, CLIN SCI, V87, P21, DOI 10.1042/cs0870021; Mollapour M, 2007, MOL CELL BIOL, V27, P6446, DOI 10.1128/MCB.02205-06; MUECKLER M, 1994, EUR J BIOCHEM, V219, P713, DOI 10.1111/j.1432-1033.1994.tb18550.x; MUECKLER M, 1994, J BIOL CHEM, V269, P20533; MUECKLER M, 1985, SCIENCE, V229, P941, DOI 10.1126/science.3839598; Nikko E, 2007, TRAFFIC, V8, P566, DOI 10.1111/j.1600-0854.2007.00553.x; Nikko E, 2009, TRAFFIC, V10, P1856, DOI 10.1111/j.1600-0854.2009.00990.x; Ozcan S, 1999, MICROBIOL MOL BIOL R, V63, P554; Pao SS, 1998, MICROBIOL MOL BIOL R, V62, P1; Powers T, 2010, ENZYMES, V27, P177, DOI 10.1016/S1874-6047(10)27010-5; Rea S, 1997, DIABETES, V46, P1667, DOI 10.2337/diabetes.46.11.1667; Rebecchi MJ, 2000, PHYSIOL REV, V80, P1291, DOI 10.1152/physrev.2000.80.4.1291; Roosen J, 2005, MOL MICROBIOL, V55, P862, DOI 10.1111/j.1365-2958.2004.04429.x; Rotin D, 2000, J MEMBRANE BIOL, V176, P1; Schmelzle T, 2004, MOL CELL BIOL, V24, P338, DOI 10.1128/MCB.24.1.338-351.2004; Soulard A, 2010, MOL BIOL CELL, V21, P3475, DOI 10.1091/mbc.E10-03-0182; Thorens B., 1996, AM J PHYSIOL, V270, pG541; Thurmond DC, 2001, MOL MEMBR BIOL, V18, P237; Turk Z, 2010, PHYSIOL RES, V59, P147, DOI 10.33549/physiolres.931585; Uldry M, 2004, PFLUG ARCH EUR J PHY, V447, P480, DOI 10.1007/s00424-003-1085-0; Vina-Vilaseca A, 2011, J BIOL CHEM, V286, P8697, DOI 10.1074/jbc.M110.186858; Walmsley AR, 1998, TRENDS BIOCHEM SCI, V23, P476, DOI 10.1016/S0968-0004(98)01326-7; Wieczorke R, 2003, CELL PHYSIOL BIOCHEM, V13, P123, DOI 10.1159/000071863; YKIJARVINEN H, 1987, DIABETES, V36, P892, DOI 10.2337/diabetes.36.8.892	62	24	25	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					701	711		10.1074/jbc.M111.322222	http://dx.doi.org/10.1074/jbc.M111.322222			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22094464	Green Published, hybrid			2022-12-27	WOS:000298682400068
J	Liu, P; Chen, BJ; Wang, ZW				Liu, Ping; Chen, Bojun; Wang, Zhao-Wen			Gap Junctions Synchronize Action Potentials and Ca2+ Transients in Caenorhabditis elegans Body Wall Muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-ELEGANS; SYNAPTIC-TRANSMISSION; ELECTRICAL SYNAPSES; NERVE CORD; GABA; OSCILLATIONS; LOCOMOTION; NETWORKS; RECEPTOR; ENCODES	The sinusoidal locomotion of Caenorhabditis elegans requires synchronous activities of neighboring body wall muscle cells. However, it is unknown whether the synchrony results from muscle electrical coupling or neural inputs. We analyzed the effects of mutating gap junction proteins and blocking neuromuscular transmission on the synchrony of action potentials (APs) and Ca2+ transients among neighboring body wall muscle cells. In wild-type worms, the percentage of synchronous APs between two neighboring cells varied depending on the anatomical relationship and junctional conductance (G(j)) between them, and Ca2+ transients were synchronous among neighboring muscle cells. Compared with the wild type, knock-out of the gap junction gene unc-9 resulted in greatly reduced coupling coefficient and asynchronous APs and Ca2+ transients. Inhibition of unc-9 expression specifically in muscle by RNAi also reduced the synchrony of APs and Ca2+ transients, whereas expression of wild-type UNC-9 specifically in muscle rescued the synchrony defect. Loss of the stomatin-like protein UNC-1, which is a regulator of UNC-9-based gap junctions, similarly impaired muscle synchrony as unc-9 mutant did. The blockade of muscle ionotropic acetylcholine receptors by (+)-tubocurarine decreased the frequencies of APs and Ca2+ transients, whereas blockade of muscle GABA(A) receptors by gabazine had opposite effects. However, both APs and Ca2+ transients remained synchronous after the application of (+)-tubocurarine and/or gabazine. These observations suggest that gap junctions in C. elegans body wall muscle cells are responsible for synchronizing muscle APs and Ca2+ transients.	[Liu, Ping; Chen, Bojun; Wang, Zhao-Wen] Univ Connecticut, Ctr Hlth, Dept Neurosci, Farmington, CT 06030 USA	University of Connecticut	Wang, ZW (corresponding author), Univ Connecticut, Ctr Hlth, Dept Neurosci, 263 Farmington Ave, Farmington, CT 06030 USA.	zwwang@uchc.edu	Liu, Ping/B-1509-2014		National Institutes of Health [5R01GM083049, 1R01MH085927]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL009294] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083049] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085927] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grants 5R01GM083049 and 1R01MH085927 (to Z.-W. W.).	Altun ZF, 2009, DEV DYNAM, V238, P1936, DOI 10.1002/dvdy.22025; Bamber BA, 1999, J NEUROSCI, V19, P5348; Barnes TM, 1997, J NEUROCHEM, V69, P2251; Beierlein M, 2000, NAT NEUROSCI, V3, P904, DOI 10.1038/78809; Boyle JH, 2008, BIOSYSTEMS, V94, P170, DOI 10.1016/j.biosystems.2008.05.025; BRENNER S, 1974, GENETICS, V77, P71; Bryden J, 2008, BIOL CYBERN, V98, P339, DOI 10.1007/s00422-008-0212-6; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Chalfie M., 1988, NEMATODE CAENORHABDI, P337; Chen BJ, 2007, CURR BIOL, V17, P1334, DOI 10.1016/j.cub.2007.06.060; Chen BJ, 2010, EMBO J, V29, P3184, DOI 10.1038/emboj.2010.194; DAVIDSON JS, 1988, J PHARMACOL EXP THER, V246, P1104; de Bono M, 2005, ANNU REV NEUROSCI, V28, P451, DOI 10.1146/annurev.neuro.27.070203.144259; Deans MR, 2001, NEURON, V31, P477, DOI 10.1016/S0896-6273(01)00373-7; DEBELL JT, 1963, J CELL COMPAR PHYSL, V62, P159, DOI 10.1002/jcp.1030620206; Esposito G, 2007, GENE, V395, P170, DOI 10.1016/j.gene.2007.03.002; EVANS T, 2006, WORMBOOK C ELEGANS R; Francis MM, 2005, NEURON, V46, P581, DOI 10.1016/j.neuron.2005.04.010; Galarreta M, 1999, NATURE, V402, P72, DOI 10.1038/47029; Galarreta M, 2001, NAT REV NEUROSCI, V2, P425, DOI 10.1038/35077566; Gao SB, 2011, P NATL ACAD SCI USA, V108, P2557, DOI 10.1073/pnas.1012346108; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; GOODMAN MB, 2006, WORMBOOK C ELEGANS R; Haspel G, 2010, J NEUROSCI, V30, P11151, DOI 10.1523/JNEUROSCI.2244-10.2010; Hobert O, 2003, J NEUROBIOL, V54, P203, DOI 10.1002/neu.10168; Hormuzdi SG, 2001, NEURON, V31, P487, DOI 10.1016/S0896-6273(01)00387-7; Jospin M, 2002, J CELL BIOL, V159, P337, DOI 10.1083/jcb.200203055; Karbowski J, 2008, J COMPUT NEUROSCI, V24, P253, DOI 10.1007/s10827-007-0054-6; LEWIS JA, 1980, GENETICS, V95, P905; Liu P, 2011, J PHYSIOL-LONDON, V589, P101, DOI 10.1113/jphysiol.2010.200683; Liu Q, 2006, J BIOL CHEM, V281, P7881, DOI 10.1074/jbc.M512382200; Liu Q, 2005, J NEUROSCI, V25, P6745, DOI 10.1523/JNEUROSCI.1730-05.2005; Liu Q, 2007, DEV NEUROBIOL, V67, P123, DOI 10.1002/dneu.20307; Liu Q, 2009, P NATL ACAD SCI USA, V106, P10823, DOI 10.1073/pnas.0903570106; MCINTIRE SL, 1993, NATURE, V364, P334, DOI 10.1038/364334a0; Norman KR, 2007, CURR BIOL, V17, pR812, DOI 10.1016/j.cub.2007.07.043; OKKEMA PG, 1993, GENETICS, V135, P385; PARK EC, 1986, GENETICS, V113, P821; Phelan P, 2005, BBA-BIOMEMBRANES, V1711, P225, DOI 10.1016/j.bbamem.2004.10.004; Rajaram S, 1998, P NATL ACAD SCI USA, V95, P8761, DOI 10.1073/pnas.95.15.8761; Richmond JE, 1999, NAT NEUROSCI, V2, P791, DOI 10.1038/12160; SEDENSKY MM, 1987, SCIENCE, V236, P952, DOI 10.1126/science.3576211; Silverman W, 2008, AM J PHYSIOL-CELL PH, V295, pC761, DOI 10.1152/ajpcell.00227.2008; Touroutine D, 2005, J BIOL CHEM, V280, P27013, DOI 10.1074/jbc.M502818200; Ueno S, 1997, J NEUROSCI, V17, P625; Wang ZW, 2001, NEURON, V32, P867, DOI 10.1016/S0896-6273(01)00522-0; WEISBLAT DA, 1976, J COMP PHYSIOL, V107, P293, DOI 10.1007/BF00656739; WERMUTH CG, 1986, TRENDS PHARMACOL SCI, V7, P421, DOI 10.1016/0165-6147(86)90408-6; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; WHITE JG, 1976, PHILOS T R SOC B, V275, P327, DOI 10.1098/rstb.1976.0086; WHITTINGTON MA, 1995, NATURE, V373, P612, DOI 10.1038/373612a0; Zhang Y, 1998, J NEUROSCI, V18, P9256; Zhou B, 2009, IEEE ENG MED BIO, P4937, DOI 10.1109/IEMBS.2009.5332713	53	18	21	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2011	286	51					44285	44293		10.1074/jbc.M111.292078	http://dx.doi.org/10.1074/jbc.M111.292078			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866SH	22033926	hybrid, Green Published			2022-12-27	WOS:000298402300068
J	MacFarlane, AJ; Anderson, DD; Flodby, P; Perry, CA; Allen, RH; Stabler, SP; Stover, PJ				MacFarlane, Amanda J.; Anderson, Donald D.; Flodby, Per; Perry, Cheryll A.; Allen, Robert H.; Stabler, Sally P.; Stover, Patrick J.			Nuclear Localization of de Novo Thymidylate Biosynthesis Pathway Is Required to Prevent Uracil Accumulation in DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOPLASMIC SERINE HYDROXYMETHYLTRANSFERASE; FOLATE-DEFICIENCY; CANCER-RISK; METHYLENETETRAHYDROFOLATE; MISINCORPORATION; METABOLISM; COBALAMIN; REDUCTASE; CLONING; GENES	Uracil accumulates in DNA as a result of impaired folate-dependent de novo thymidylate biosynthesis, a pathway composed of the enzymes serine hydroxymethyltransferase (SHMT), thymidylate synthase (TYMS), and dihydrofolate reductase. In G1, this pathway is present in the cytoplasm and at S phase undergoes small ubiquitin-like modifier-dependent translocation to the nucleus. It is not known whether this pathway functions in the cytoplasm, nucleus, or both in vivo. SHMT1 generates 5,10-methylenetetrahydrofolate for de novo thymidylate biosynthesis, a limiting step in the pathway, but also tightly binds 5-methyltetrahydrofolate in the cytoplasm, a required cofactor for homocysteine remethylation. Overexpression of SHMT1 in cell cultures inhibits folate-dependent homocysteine remethylation and enhances thymidylate biosynthesis. In this study, the impact of increased Shmt1 expression on folate-mediated one-carbon metabolism was determined in mice that overexpress the Shmt1 cDNA (Shmt1(tg+) mice). Compared with wild type mice, Shmt1(tg+) mice exhibited elevated SHMT1 and TYMS protein levels in tissues and evidence for impaired homocysteine remethylation but surprisingly exhibited depressed levels of nuclear SHMT1 and TYMS, lower rates of nuclear de novo thymidylate biosynthesis, and a nearly 10-fold increase in uracil content in hepatic nuclear DNA when fed a folate-and choline-deficient diet. These results demonstrate that SHMT1 and TYMS localization to the nucleus is essential to prevent uracil accumulation in nuclear DNA and indicate that SHMT1-mediated nuclear de novo thymidylate synthesis is critical for maintaining DNA integrity.	[MacFarlane, Amanda J.; Flodby, Per; Perry, Cheryll A.; Stover, Patrick J.] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA; [Anderson, Donald D.; Stover, Patrick J.] Cornell Univ, Grad Field Biochem Mol & Cell Biol, Ithaca, NY 14853 USA; [Allen, Robert H.; Stabler, Sally P.] Univ Colorado, Sch Med, Dept Med, Aurora, CO 80045 USA; [Allen, Robert H.; Stabler, Sally P.] Univ Colorado, Sch Med, Div Hematol, Aurora, CO 80045 USA	Cornell University; Cornell University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Stover, PJ (corresponding author), Cornell Univ, Div Nutr Sci, 315 Savage Hall, Ithaca, NY 14853 USA.	pjs13@cornell.edu			Public Health Service [DK58144]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK058144, R01DK058144] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Public Health Service Grant DK58144.	ALLEN RH, 1993, METABOLISM, V42, P1448, DOI 10.1016/0026-0495(93)90198-W; Anderson DD, 2007, CLIN CHEM LAB MED, V45, P1760, DOI 10.1515/CCLM.2007.355; Anderson DD, 2011, P NATL ACAD SCI USA, V108, P15163, DOI 10.1073/pnas.1103623108; Anderson DD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005839; Beaudin AE, 2011, AM J CLIN NUTR, V93, P789, DOI 10.3945/ajcn.110.002766; BENSADOUN A, 1976, ANAL BIOCHEM, V70, P241, DOI 10.1016/S0003-2697(76)80064-4; Blount BC, 1997, P NATL ACAD SCI USA, V94, P3290, DOI 10.1073/pnas.94.7.3290; Ching YH, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-106; Field MS, 2006, J BIOL CHEM, V281, P4215, DOI 10.1074/jbc.M510624200; Fox JT, 2009, J BIOL CHEM, V284, P31097, DOI 10.1074/jbc.M109.015800; Friso S, 2002, ANAL CHEM, V74, P4526, DOI 10.1021/ac020050h; GOULIAN M, 1980, P NATL ACAD SCI-BIOL, V77, P1956, DOI 10.1073/pnas.77.4.1956; Herbig K, 2002, J BIOL CHEM, V277, P38381, DOI 10.1074/jbc.M205000200; Lim U, 2005, J NUTR, V135, P1989, DOI 10.1093/jn/135.8.1989; Liu XW, 2001, BIOCHEMISTRY-US, V40, P4932, DOI 10.1021/bi002598t; MacFarlane AJ, 2008, J BIOL CHEM, V283, P25846, DOI 10.1074/jbc.M802671200; MacFarlane AJ, 2011, CANCER RES, V71, P2098, DOI 10.1158/0008-5472.CAN-10-1886; Nakshatri H, 1996, GENE, V174, P79, DOI 10.1016/0378-1119(96)00391-5; Novak A, 2000, GENESIS, V28, P147, DOI 10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.0.CO;2-G; Perry C, 2005, J BIOL CHEM, V280, P396, DOI [10.1074/jbc.M410467200, 10.1074/jbc.M412914200]; Piskac-Collier AL, 2011, GENE CHROMOSOME CANC, V50, P1, DOI 10.1002/gcc.20826; STABLER SP, 1993, BLOOD, V81, P3404; STOVER P, 1991, J BIOL CHEM, V266, P1543; Stover PJ, 1997, J BIOL CHEM, V272, P1842, DOI 10.1074/jbc.272.3.1842; Wernimont SM, 2011, J NUTR, V141, P255, DOI 10.3945/jn.110.132506; Woeller CF, 2007, J BIOL CHEM, V282, P29927, DOI 10.1074/jbc.M706264200; Woeller CF, 2007, J BIOL CHEM, V282, P17623, DOI 10.1074/jbc.M702526200	27	53	55	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2011	286	51					44015	44022		10.1074/jbc.M111.307629	http://dx.doi.org/10.1074/jbc.M111.307629			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866SH	22057276	Green Published, hybrid			2022-12-27	WOS:000298402300042
J	Pickering, BF; Yu, DH; Van Dyke, MW				Pickering, Brian F.; Yu, Dihua; Van Dyke, Michael W.			Nucleolin Protein Interacts with Microprocessor Complex to Affect Biogenesis of MicroRNAs 15a and 16	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRE-RIBOSOMAL-RNA; LEUKEMIA-CELLS; DROSHA COMPLEX; MESSENGER-RNA; LOCALIZATION; APOPTOSIS; BINDING; EXPRESSION; MATURATION; PROMOTES	MicroRNAs (miRNA) are endogenous, short, non-coding RNA that undergo a multistep biogenesis before generating the functional, mature sequence. The core components of the microprocessor complex, consisting of Drosha and DGCR8, are both necessary and sufficient for this process, although accessory proteins have been found that modulate the biogenesis of a subset of miRNA. Curiously, many of the proteins involved in miRNA biogenesis are also needed for ribosomal RNA processing. Here we show that nucleolin, another protein critical for rRNA processing, is involved in the biogenesis of microRNA 15a/16 (miR-15a/16), specifically at the primary to precursor stage of processing. Through overexpression and knockdown studies, we show that miR-15a/16 levels are directly correlated to nucleolin expression. Furthermore, we found that cellular localization is critical for the proper functioning of nucleolin in this pathway and that nucleolin directly interacts with DGCR8 and Drosha in the nucleus. Nucleolin can bind to the primary miRNA both directly and specifically. Finally, we show that in the absence of nucleolin, cell extracts are unable to process miR-15a/16 in vitro and that this can be rescued by the addition of nucleolin. Our findings offer a new protein component in the microRNA biogenesis pathway and lend insight into miRNA dysregulation in certain cancers.	[Pickering, Brian F.; Yu, Dihua] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Pickering, Brian F.; Yu, Dihua] Univ Texas Grad Sch Biomed Sci, Canc Biol Program, Houston, TX 77030 USA; [Van Dyke, Michael W.] Western Carolina Univ, Dept Chem & Phys, Cullowhee, NC 28723 USA	University of Texas System; UTMD Anderson Cancer Center; University of North Carolina; Western Carolina University	Pickering, BF (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, 1515 Holcombe Blvd,Box 108, Houston, TX 77030 USA.	bpickeri@mdanderson.org; dyu@mdanderson.org	Ogunwobi, Olorunseun/F-3172-2010; Van Dyke, Michael W./AAY-6751-2020	Van Dyke, Michael W./0000-0003-0306-4002; Yu, Dihua/0000-0001-6231-9381	Robert A. Welch Foundation [R-1199]; Cancer Prevention Research Institute of Texas [RP100726]; American Legion Auxiliary Fellowship; Rosalie B. Hite Fellowship	Robert A. Welch Foundation(The Welch Foundation); Cancer Prevention Research Institute of Texas; American Legion Auxiliary Fellowship; Rosalie B. Hite Fellowship	This work was supported by the Robert A. Welch Foundation Grant R-1199 (to M. W. V. D.) and Cancer Prevention Research Institute of Texas Grant RP100726 (to D. Y.).; Supported by the American Legion Auxiliary Fellowship and the Rosalie B. Hite Fellowship. To whom correspondence may be addressed: Dept. of Molecular and Cellular Oncology, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Box 108, Houston, TX 77030. Tel.: 713-792-3636; Fax: 713-792-4454; E-mail: bpickeri@mdanderson.org.	Allain FHT, 2000, EMBO J, V19, P6870, DOI 10.1093/emboj/19.24.6870; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; CREANCIER L, 1993, MOL BIOL CELL, V4, P1239, DOI 10.1091/mbc.4.12.1239; Daniely Y, 2002, MOL CELL BIOL, V22, P6014, DOI 10.1128/MCB.22.16.6014-6022.2002; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Fukuda T, 2007, NAT CELL BIOL, V9, P604, DOI 10.1038/ncb1577; Ganesan G, 2008, RNA, V14, P1399, DOI 10.1261/rna.838308; Garzon R, 2007, ONCOGENE, V26, P4148, DOI 10.1038/sj.onc.1210186; Gilbert SL, 2000, J BIOL CHEM, V275, P36491, DOI 10.1074/jbc.C000409200; Ginisty H, 1999, J CELL SCI, V112, P761; Ginisty H, 1998, EMBO J, V17, P1476, DOI 10.1093/emboj/17.5.1476; Gonzalez V, 2010, BIOCHEMISTRY-US, V49, P9706, DOI 10.1021/bi100509s; Gopal YV, 2007, CHEM BIOL, V14, P813, DOI 10.1016/j.chembiol.2007.06.007; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Guil S, 2007, NAT STRUCT MOL BIOL, V14, P591, DOI 10.1038/nsmb1250; Jalal C, 2007, NUCLEIC ACIDS RES, V35, P3590, DOI 10.1093/nar/gkm058; Joo EJ, 2010, J CELL BIOCHEM, V110, P1272, DOI 10.1002/jcb.22643; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Landthaler M, 2004, CURR BIOL, V14, P2162, DOI 10.1016/j.cub.2004.11.001; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2007, METHOD ENZYMOL, V427, P89, DOI 10.1016/S0076-6879(07)27005-3; Liang XH, 2011, NUCLEIC ACIDS RES, V39, P4875, DOI 10.1093/nar/gkr076; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Mi YC, 2003, J BIOL CHEM, V278, P8572, DOI 10.1074/jbc.M207637200; Mourmouras V, 2009, J CUTAN PATHOL, V36, P637, DOI 10.1111/j.1600-0560.2008.01126.x; Otake Y, 2005, MOL PHARMACOL, V67, P319, DOI 10.1124/mol.104.006080; Otake Y, 2007, BLOOD, V109, P3069, DOI 10.1182/blood-2006-08-043257; Politz JCR, 2006, P NATL ACAD SCI USA, V103, P18957, DOI 10.1073/pnas.0609466103; Politz JCR, 2009, RNA, V15, P1705, DOI 10.1261/rna.1470409; Provost P, 2002, EMBO J, V21, P5864, DOI 10.1093/emboj/cdf578; Sakamoto S, 2009, MOL CELL BIOL, V29, P3754, DOI 10.1128/MCB.01836-08; Shiohama A, 2007, EXP CELL RES, V313, P4196, DOI 10.1016/j.yexcr.2007.07.020; Sinkkonen L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012175; Suzuki HI, 2009, NATURE, V460, P529, DOI 10.1038/nature08199; Teng Y, 2007, CANCER RES, V67, P10491, DOI 10.1158/0008-5472.CAN-06-4206; Trabucchi M, 2009, NATURE, V459, P1010, DOI 10.1038/nature08025; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Wu HJ, 2000, J BIOL CHEM, V275, P36957, DOI 10.1074/jbc.M005494200; Yamagata K, 2009, MOL CELL, V36, P340, DOI 10.1016/j.molcel.2009.08.017; Zhang XN, 2011, MOL CELL, V41, P371, DOI 10.1016/j.molcel.2011.01.020	42	51	51	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2011	286	51					44095	44103		10.1074/jbc.M111.265439	http://dx.doi.org/10.1074/jbc.M111.265439			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866SH	22049078	Green Published, hybrid			2022-12-27	WOS:000298402300050
J	Banasavadi-Siddegowda, YK; Mai, JB; Fan, YF; Bhattacharya, S; Giovannucci, DR; Sanchez, ER; Fischer, G; Wang, XD				Banasavadi-Siddegowda, Yeshavanth K.; Mai, Junbo; Fan, Yifei; Bhattacharya, Sumit; Giovannucci, David R.; Sanchez, Edwin R.; Fischer, Gunter; Wang, Xiaodong			FKBP38 Peptidylprolyl Isomerase Promotes the Folding of Cystic Fibrosis Transmembrane Conductance Regulator in the Endoplasmic Reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN 38 FKBP38; MAMMALIAN TARGET; GLUCOCORTICOID-RECEPTOR; DYNEIN INTERACTION; CFTR; DEGRADATION; INHIBITOR; BINDING; DOMAIN; BCL-2	FK506-binding protein 38 (FKBP38), a membrane-anchored, tetratricopeptide repeat (TPR)-containing immunophilin, associates with nascent plasma membrane ion channels in the endoplasmic reticulum (ER). It promotes the maturation of the human ether-a-go-go-related gene (HERG) potassium channel and maintains the steady state level of the cystic fibrosis transmembrane conductance regulator (CFTR), but the underlying mechanisms remain unclear. Using a combination of steady state and pulse-chase analyses, we show that FKBP38 knockdown increases protein synthesis but inhibits the post-translational folding of CFTR, leading to reduced steady state levels of CFTR in the ER, decreased processing, and impaired cell surface functional expression in Calu-3 human airway epithelial cells. The membrane anchorage of FKBP38 is necessary for the inhibition of protein synthesis but not for CFTR post-translational folding. In contrast, the peptidylprolyl cis/trans isomerase active site is utilized to promote CFTR post-translational folding but is not important for regulation of protein synthesis. Uncoupling FKBP38 from Hsp90 by substituting a conserved lysine in the TPR domain modestly enhances CFTR maturation and further reduces its synthesis. Removing the N-terminal glutamate-rich domain (ERD) slightly enhances CFTR synthesis but reduces its maturation, suggesting that the ERD contributes to FKBP38 biological activities. Our data support a dual role for FKBP38 in regulating CFTR synthesis and post-translational folding. In contrast to earlier prediction but consistent with in vitro enzymological studies, FKBP38 peptidylprolyl cis/trans isomerase plays an important role in membrane protein biogenesis on the cytoplasmic side of the ER membrane, whose activity is negatively regulated by Hsp90 through the TPR domain.	[Banasavadi-Siddegowda, Yeshavanth K.; Mai, Junbo; Fan, Yifei; Sanchez, Edwin R.; Wang, Xiaodong] Univ Toledo, Coll Med, Dept Physiol & Pharmacol, Toledo, OH 43614 USA; [Bhattacharya, Sumit; Giovannucci, David R.] Univ Toledo, Coll Med, Dept Neurosci, Toledo, OH 43614 USA; [Sanchez, Edwin R.] Univ Toledo, Coll Med, Ctr Diabet & Endocrine Res, Toledo, OH 43614 USA; [Fischer, Gunter] Max Planck Res Unit Enzymol Prot Folding, D-06120 Halle, Germany	University System of Ohio; University of Toledo; University System of Ohio; University of Toledo; University System of Ohio; University of Toledo; Max Planck Society	Wang, XD (corresponding author), 3000 Arlington Ave,Mail Stop 1008, Toledo, OH 43614 USA.	xiaodong.wang@utoledo.edu	Mai, Junbo/HHC-4505-2022; Giovannucci, David R/A-5657-2018	/0000-0002-4730-6918	American Heart Association; University of Toledo Health Science Campus; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070127] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); University of Toledo Health Science Campus; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a Scientist Development Grant from the American Heart Association (to X. W.) and the University of Toledo Health Science Campus (to X. W.).	Bai XC, 2007, SCIENCE, V318, P977, DOI 10.1126/science.1147379; Barth S, 2007, MOL CELL BIOL, V27, P3758, DOI 10.1128/MCB.01324-06; Barth S, 2009, J BIOL CHEM, V284, P23046, DOI 10.1074/jbc.M109.032631; Bulgakov OV, 2004, DEVELOPMENT, V131, P2149, DOI 10.1242/dev.01122; Choi BH, 2010, J BIOL CHEM, V285, P9770, DOI 10.1074/jbc.M109.032466; CZAR MJ, 1995, MOL ENDOCRINOL, V9, P1549, DOI 10.1210/me.9.11.1549; Dunlop EA, 2009, CELL SIGNAL, V21, P1073, DOI 10.1016/j.cellsig.2009.02.024; Edlich E, 2006, HANDB EXP PHARM, V172, P359; Edlich F, 2005, EMBO J, V24, P2688, DOI 10.1038/sj.emboj.7600739; Edlich F, 2007, J BIOL CHEM, V282, P15341, DOI 10.1074/jbc.M611594200; Edlich F, 2006, J BIOL CHEM, V281, P14961, DOI 10.1074/jbc.M600452200; Edlich F, 2011, CURR OPIN PHARMACOL, V11, P348, DOI 10.1016/j.coph.2011.03.011; Ficker E, 2003, CIRC RES, V92, pE87, DOI 10.1161/01.RES.0000079028.31393.15; Fischer G, 2006, MOL MICROBIOL, V61, P1388, DOI 10.1111/j.1365-2958.2006.05349.x; FRYDMAN J, 1994, NATURE, V370, P111, DOI 10.1038/370111a0; Galigniana MD, 2002, BIOCHEMISTRY-US, V41, P13602, DOI 10.1021/bi020399z; Galigniana MD, 2001, J BIOL CHEM, V276, P14884, DOI 10.1074/jbc.M010809200; GERMAIN M, 2003, SCI STKE, pPE10; Giovannucci DR, 2002, J PHYSIOL-LONDON, V540, P469, DOI 10.1113/jphysiol.2001.013453; Kang CB, 2005, BIOCHEM BIOPH RES CO, V337, P30, DOI 10.1016/j.bbrc.2005.09.023; Loo MA, 1998, EMBO J, V17, P6879, DOI 10.1093/emboj/17.23.6879; Maehama T, 2008, J BIOL CHEM, V283, P35053, DOI 10.1074/jbc.M805822200; Meacham GC, 1999, EMBO J, V18, P1492, DOI 10.1093/emboj/18.6.1492; Meacham GC, 2001, NAT CELL BIOL, V3, P100, DOI 10.1038/35050509; Munkonge Felix, 2004, J Cyst Fibros, V3 Suppl 2, P171, DOI 10.1016/j.jcf.2004.05.036; Nakagawa T, 2007, GENES CELLS, V12, P709, DOI 10.1111/j.1365-2443.2007.01086.x; Nielsen JV, 2004, GENOMICS, V83, P181, DOI 10.1016/j.ygeno.2003.07.001; Norville IH, 2011, BIOCHEM J, V437, P413, DOI 10.1042/BJ20110345; Oberdorf J, 2005, J BIOL CHEM, V280, P38193, DOI 10.1074/jbc.M504200200; Okamoto T, 2006, EMBO J, V25, P5015, DOI 10.1038/sj.emboj.7601367; Peng L, 2010, J BIOL CHEM, V285, P20870, DOI 10.1074/jbc.M110.112045; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Pratt WB, 1997, ANNU REV PHARMACOL, V37, P297, DOI 10.1146/annurev.pharmtox.37.1.297; Riggs DL, 2007, MOL CELL BIOL, V27, P8658, DOI 10.1128/MCB.00985-07; Rosner M, 2003, ONCOGENE, V22, P4786, DOI 10.1038/sj.onc.1206776; Roy G, 2010, MOL BIOL CELL, V21, P597, DOI 10.1091/mbc.E09-05-0427; Rubenstein RC, 2000, AM J PHYSIOL-CELL PH, V278, pC259, DOI 10.1152/ajpcell.2000.278.2.C259; Russell LC, 1999, J BIOL CHEM, V274, P20060, DOI 10.1074/jbc.274.29.20060; Sato T, 2009, J BIOL CHEM, V284, P12783, DOI 10.1074/jbc.M809207200; Shirane M, 2003, NAT CELL BIOL, V5, P28, DOI 10.1038/ncb894; Sivils JC, 2011, CURR OPIN PHARMACOL, V11, P314, DOI 10.1016/j.coph.2011.03.010; Uhlenbrock K, 2009, FEBS LETT, V583, P965, DOI 10.1016/j.febslet.2009.02.015; Walker VE, 2007, J BIOL CHEM, V282, P23509, DOI 10.1074/jbc.M701006200; Walker VE, 2010, J BIOL CHEM, V285, P3319, DOI 10.1074/jbc.M109.024000; Wang HQ, 2005, HUM MOL GENET, V14, P1889, DOI 10.1093/hmg/ddi195; Wang XD, 2008, TRAFFIC, V9, P1878, DOI 10.1111/j.1600-0854.2008.00806.x; Wang XD, 2006, CELL, V127, P803, DOI 10.1016/j.cell.2006.09.043; Wang XM, 2008, J BIOL CHEM, V283, P30482, DOI 10.1074/jbc.M803348200; Yam AYW, 2005, J BIOL CHEM, V280, P41252, DOI 10.1074/jbc.M503615200; YANG YP, 1993, P NATL ACAD SCI USA, V90, P9480, DOI 10.1073/pnas.90.20.9480; Yoon MS, 2011, J BIOL CHEM, V286, P29568, DOI 10.1074/jbc.M111.262816; Youker RT, 2004, MOL BIOL CELL, V15, P4787, DOI 10.1091/mbc.E04-07-0584; Zhang H, 2006, J BIOL CHEM, V281, P11312, DOI 10.1074/jbc.M512013200; Zhang YM, 2001, MOL BIOL CELL, V12, P1303, DOI 10.1091/mbc.12.5.1303	54	28	29	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					43071	43080		10.1074/jbc.M111.269993	http://dx.doi.org/10.1074/jbc.M111.269993			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22030396	Green Published, hybrid			2022-12-27	WOS:000298351300028
J	O'Neill, AK; Gallegos, LL; Justilien, V; Garcia, EL; Leitges, M; Fields, AP; Hall, RA; Newton, AC				O'Neill, Audrey K.; Gallegos, Lisa L.; Justilien, Verline; Garcia, Erin L.; Leitges, Michael; Fields, Alan P.; Hall, Randy A.; Newton, Alexandra C.			Protein Kinase C alpha Promotes Cell Migration through a PDZ-Dependent Interaction with its Novel Substrate Discs Large Homolog 1 (DLG1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LARGE TUMOR-SUPPRESSOR; PKC-ALPHA; ANTISENSE OLIGONUCLEOTIDE; DOMAINS; EXPRESSION; DROSOPHILA; PHOSPHORYLATION; ASSOCIATION; POLARITY; COMPLEX	Protein scaffolds maintain precision in kinase signaling by coordinating kinases with components of specific signaling pathways. Such spatial segregation is particularly important in allowing specificity of signaling mediated by the 10-member family of protein kinase C (PKC) isozymes. Here we identified a novel interaction between PKC alpha and the Discs large homolog (DLG) family of scaffolds that is mediated by a class I C-terminal PDZ (PSD-95, disheveled, and ZO1) ligand unique to this PKC isozyme. Specifically, use of a proteomic array containing 96 purified PDZ domains identified the third PDZ domains of DLG1/SAP97 and DLG4/PSD95 as interaction partners for the PDZ binding motif of PKC alpha. Co-immunoprecipitation experiments verified that PKC alpha and DLG1 interact in cells by a mechanism dependent on an intact PDZ ligand. Functional assays revealed that the interaction of PKC alpha with DLG1 promotes wound healing; scratch assays using cells depleted of PKC alpha and/or DLG1 have impaired cellular migration that is no longer sensitive to PKC inhibition, and the ability of exogenous PKC alpha to rescue cellular migration is dependent on the presence of its PDZ ligand. Furthermore, we identified Thr-656 as a novel phosphorylation site in the SH3-Hook region of DLG1 that acts as a marker for PKC alpha activity at this scaffold. Increased phosphorylation of Thr-656 is correlated with increased invasiveness in non-small cell lung cancer lines from the NCI-60, consistent with this phosphorylation site serving as a marker of PKC alpha mediated invasion. Taken together, these data establish the requirement of scaffolding to DLG1 for PKC alpha to promote cellular migration.	[O'Neill, Audrey K.; Gallegos, Lisa L.; Newton, Alexandra C.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [O'Neill, Audrey K.; Gallegos, Lisa L.] Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA; [Justilien, Verline; Fields, Alan P.] Mayo Clin, Coll Med, Dept Canc Biol, Jacksonville, FL 32224 USA; [Garcia, Erin L.; Hall, Randy A.] Emory Univ, Dept Pharmacol, Atlanta, GA 30322 USA; [Leitges, Michael] Univ Oslo, Biotechnol Ctr Oslo, N-0317 Oslo, Norway	University of California System; University of California San Diego; University of California System; University of California San Diego; Mayo Clinic; Emory University; University of Oslo	Newton, AC (corresponding author), Univ Calif San Diego, Dept Pharmacol, 9500 Gilman Dr, La Jolla, CA 92093 USA.	anewton@ucsd.edu	Leitges, Michael/AAN-1953-2021	Hall, Randy/0000-0002-8318-8728; Leitges, Michael/0000-0003-4203-6995	National Institutes of Health [GM43154, P01 DK54441, CA081436, 1F31GM083628]; University of California at San Diego through NIGMS, National Institutes of Health [T32 GM007752]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California at San Diego through NIGMS, National Institutes of Health	This work was supported, in whole or in part, by National Institutes of Health Grants GM43154 and P01 DK54441 (both to A. C. N.) and CA081436 (to A. P. F.).; Supported in part by the University of California at San Diego Graduate Training Program in Cellular and Molecular Pharmacology through NIGMS, National Institutes of Health Institutional Training Grant T32 GM007752.; Supported by National Research Service Award Grant National Institutes of Health 1F31GM083628. Present address: Dept. of Cell Biology, Harvard Medical School, Cambridge, MA 02115.	Abeyweera TP, 2009, J BIOL CHEM, V284, P17648, DOI 10.1074/jbc.M902005200; Adamski FM, 1998, J BIOL CHEM, V273, P17713, DOI 10.1074/jbc.273.28.17713; Anilkumar N, 2003, EMBO J, V22, P5390, DOI 10.1093/emboj/cdg521; Arora S, 2011, INT J CANCER, V129, P2621, DOI 10.1002/ijc.25939; Bass MD, 2007, J CELL BIOL, V177, P527, DOI 10.1083/jcb.200610076; Bilder D, 2004, GENE DEV, V18, P1909, DOI 10.1101/gad.1211604; Caruana G, 2001, MOL CELL BIOL, V21, P1475, DOI 10.1128/MCB.21.5.1475-1483.2001; CASTAGNA M, 1982, J BIOL CHEM, V257, P7847; Cavatorta AL, 2004, INT J CANCER, V111, P373, DOI 10.1002/ijc.20275; Citro S, 2007, P NATL ACAD SCI USA, V104, P15543, DOI 10.1073/pnas.0702943104; Colledge M, 2000, NEURON, V27, P107, DOI 10.1016/S0896-6273(00)00013-1; Dean N, 1996, CANCER RES, V56, P3499; Dempsey EC, 2000, AM J PHYSIOL-LUNG C, V279, pL429, DOI 10.1152/ajplung.2000.279.3.L429; Diakowski W, 2006, FOLIA HISTOCHEM CYTO, V44, P231; Dujardin DL, 2002, CURR OPIN CELL BIOL, V14, P44, DOI 10.1016/S0955-0674(01)00292-7; Elfenbein A, 2009, J CELL BIOL, V186, P75, DOI 10.1083/jcb.200810179; Etienne-Manneville S, 2005, J CELL BIOL, V170, P895, DOI 10.1083/jcb.200412172; Fan QW, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000014; Fields AP, 2008, ADV ENZYME REGUL, V48, P166, DOI 10.1016/j.advenzreg.2007.11.014; Funke L, 2005, ANNU REV BIOCHEM, V74, P219, DOI 10.1146/annurev.biochem.74.082803.133339; Guo JJ, 2008, CANCER RES, V68, P8473, DOI 10.1158/0008-5472.CAN-08-0131; Holinstat M, 2003, J BIOL CHEM, V278, P28793, DOI 10.1074/jbc.M303900200; Horowitz A, 2002, J CELL BIOL, V157, P715, DOI 10.1083/jcb.200112145; Hough CD, 1997, GENE DEV, V11, P3242, DOI 10.1101/gad.11.23.3242; Hsu YC, 2009, CLIN CANCER RES, V15, P7309, DOI 10.1158/1078-0432.CCR-09-1572; Humbert PO, 2008, ONCOGENE, V27, P6888, DOI 10.1038/onc.2008.341; Kim J, 2011, ONCOGENE, V30, P323, DOI 10.1038/onc.2010.415; Kohutek ZA, 2009, J NEUROSCI, V29, P4605, DOI 10.1523/JNEUROSCI.5126-08.2009; Konopatskaya O, 2010, TRENDS PHARMACOL SCI, V31, P8, DOI 10.1016/j.tips.2009.10.006; Kunkel MT, 2009, J BIOL CHEM, V284, P24653, DOI 10.1074/jbc.M109.024547; Larsson C, 2006, CELL SIGNAL, V18, P276, DOI 10.1016/j.cellsig.2005.07.010; Lau AG, 2001, BIOCHEMISTRY-US, V40, P8572, DOI 10.1021/bi0103516; Lee HJ, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-8; Leitges M, 2004, NEURON, V44, P585, DOI 10.1016/j.neuron.2004.10.024; Lim IA, 2002, J BIOL CHEM, V277, P21697, DOI 10.1074/jbc.M112339200; Lin CW, 2010, J CELL PHYSIOL, V225, P472, DOI 10.1002/jcp.22226; LUE RA, 1994, P NATL ACAD SCI USA, V91, P9818, DOI 10.1073/pnas.91.21.9818; Manneville JB, 2010, J CELL BIOL, V191, P585, DOI 10.1083/jcb.201002151; Manno S, 2005, J BIOL CHEM, V280, P7581, DOI 10.1074/jbc.M410650200; Marcello E, 2007, J NEUROSCI, V27, P1682, DOI 10.1523/JNEUROSCI.3439-06.2007; Mochly-Rosen D, 1998, FASEB J, V12, P35; MOCHLYROSEN D, 1991, P NATL ACAD SCI USA, V88, P3997, DOI 10.1073/pnas.88.9.3997; Newman RA, 2009, J BIOL CHEM, V284, P12924, DOI 10.1074/jbc.M809304200; Newton AC, 2010, AM J PHYSIOL-ENDOC M, V298, pE395, DOI 10.1152/ajpendo.00477.2009; Park ES, 2010, MOL CANCER THER, V9, P257, DOI 10.1158/1535-7163.MCT-09-0743; Parra M, 2000, J BIOL CHEM, V275, P3247, DOI 10.1074/jbc.275.5.3247; Pawson CT, 2010, NAT STRUCT MOL BIOL, V17, P653, DOI 10.1038/nsmb.1843; Paz-Ares L, 2006, J CLIN ONCOL, V24, P1428, DOI 10.1200/JCO.2005.04.3299; Poole AAW, 2004, TRENDS PHARMACOL SCI, V25, P528, DOI 10.1016/j.tips.2004.08.006; Roberts S, 2007, EXP CELL RES, V313, P2521, DOI 10.1016/j.yexcr.2007.05.017; Rosse C, 2010, NAT REV MOL CELL BIO, V11, P103, DOI 10.1038/nrm2847; Staudinger J, 1997, J BIOL CHEM, V272, P32019, DOI 10.1074/jbc.272.51.32019; Tsunoda S, 1997, NATURE, V388, P243, DOI 10.1038/40805; Unno K, 2008, EXP CELL RES, V314, P3118, DOI 10.1016/j.yexcr.2008.07.032; Valster A, 2005, METHODS, V37, P208, DOI 10.1016/j.ymeth.2005.08.001; van Ham M, 2003, MOL BIOL REP, V30, P69, DOI 10.1023/A:1023941703493	56	42	43	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					43559	43568		10.1074/jbc.M111.294603	http://dx.doi.org/10.1074/jbc.M111.294603			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22027822	Green Published, hybrid			2022-12-27	WOS:000298351300075
J	Peeters, A; Fraisl, P; van den Berg, S; van Themaat, EVL; Van Kampen, A; Rider, MH; Takemori, H; van Dijk, KW; Van Veldhoven, PP; Carmeliet, P; Baes, M				Peeters, Annelies; Fraisl, Peter; van den Berg, Sjoerd; van Themaat, Emiel Ver Loren; Van Kampen, Antoine; Rider, Mark H.; Takemori, Hiroshi; van Dijk, Ko Willems; Van Veldhoven, Paul P.; Carmeliet, Peter; Baes, Myriam			Carbohydrate Metabolism Is Perturbed in Peroxisome-deficient Hepatocytes Due to Mitochondrial Dysfunction, AMP-activated Protein Kinase (AMPK) Activation, and Peroxisome Proliferator-activated Receptor gamma Coactivator 1 alpha (PGC-1 alpha) Suppression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCOSE-HOMEOSTASIS; CEREBROHEPATORENAL SYNDROME; INSULIN-RESISTANCE; RAT-LIVER; MULTIFUNCTIONAL PROTEIN-2; HEPATIC GLUCONEOGENESIS; GLYCOGEN-SYNTHASE; OXIDATIVE STRESS; TRIBBLES HOMOLOG; GENE-EXPRESSION	Hepatic peroxisomes are essential for lipid conversions that include the formation of mature conjugated bile acids, the degradation of branched chain fatty acids, and the synthesis of docosahexaenoic acid. Through unresolved mechanisms, deletion of functional peroxisomes from mouse hepatocytes (L-Pex5(-/-) mice) causes severe structural and functional abnormalities at the inner mitochondrial membrane. We now demonstrate that the peroxisomal and mitochondrial anomalies trigger energy deficits, as shown by increased AMP/ATP and decreased NAD(+)/NADH ratios. This causes suppression of gluconeogenesis and glycogen synthesis and up-regulation of glycolysis. As a consequence, L-Pex5(-/-) mice combust more carbohydrates resulting in lower body weights despite increased food intake. The perturbation of carbohydrate metabolism does not require a long term adaptation to the absence of functional peroxisomes as similar metabolic changes were also rapidly induced by acute elimination of Pex5 via adenoviral administration of Cre. Despite its marked activation, peroxisome proliferator-activated receptor alpha (PPAR alpha) was not causally involved in these metabolic perturbations, because all abnormalities still manifested when peroxisomes were eliminated in a peroxisome proliferator-activated receptor alpha null background. Instead, AMP-activated kinase activation was responsible for the down-regulation of glycogen synthesis and induction of glycolysis. Remarkably, PGC-1 alpha was suppressed despite AMP-activated kinase activation, a paradigm not previously reported, and they jointly contributed to impaired gluconeogenesis. In conclusion, lack of functional peroxisomes from hepatocytes results in marked disturbances of carbohydrate homeostasis, which are consistent with adaptations to an energy deficit. Because this is primarily due to impaired mitochondrial ATP production, these L-Pex5-deficient livers can also be considered as a model for secondary mitochondrial hepatopathies.	[Baes, Myriam] Univ Leuven, Fac Pharmaceut Sci, Lab Cell Metab, Dept Pharmaceut Sci, B-3000 Louvain, Belgium; [Carmeliet, Peter] Univ Leuven, Lab Angiogenesis & Neurovasc Link, Vesalius Res Ctr, B-3000 Louvain, Belgium; [Van Veldhoven, Paul P.] Univ Leuven, Lab Lipid Biochem & Prot Interact, Dept Mol Cell Biol, B-3000 Louvain, Belgium; [Fraisl, Peter; Carmeliet, Peter] VIB, Lab Angiogenesis & Neurovasc Link, Vesalius Res Ctr, B-3000 Louvain, Belgium; [Fraisl, Peter; van den Berg, Sjoerd; van Dijk, Ko Willems] Leiden Univ, Med Ctr, Dept Human Genet, NL-2333 ZA Leiden, Netherlands; [van Themaat, Emiel Ver Loren; Van Kampen, Antoine] Acad Med Ctr, Lab Bioinformat, NL-1105 AZ Amsterdam, Netherlands; [Rider, Mark H.] Catholic Univ Louvain, B-1200 Brussels, Belgium; [Rider, Mark H.] Duve Inst, B-1200 Brussels, Belgium; [Takemori, Hiroshi] Natl Inst Biomed Innovat, Lab Cell Signaling & Metab, Osaka 5670085, Japan	KU Leuven; Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven; Flanders Institute for Biotechnology (VIB); Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Amsterdam; Academic Medical Center Amsterdam; Universite Catholique Louvain; National Institute of Health Sciences - Japan	Baes, M (corresponding author), Univ Leuven, Fac Pharmaceut Sci, Lab Cell Metab, Dept Pharmaceut Sci, Campus Gasthuisberg O-N2,Herestr 49,Box 823, B-3000 Louvain, Belgium.	myriam.baes@pharm.kuleuven.be	Carmeliet, Peter/AAQ-5140-2020; van Dijk, Ko Willems/A-1798-2008; van den Berg, Sjoerd AA/B-1994-2009; van den Berg, Sjoerd A/R-9541-2018; Ver Loren van Themaat, Emiel/F-2564-2012; , Van Veldhoven Paul/U-6359-2019; van Dijk, Ko Willems/AAT-4681-2021	Carmeliet, Peter/0000-0001-7961-1821; van Dijk, Ko Willems/0000-0002-2172-7394; , Van Veldhoven Paul/0000-0002-4478-2564; van Dijk, Ko Willems/0000-0002-2172-7394; van den Berg, Sjoerd/0000-0001-8967-376X; van den Berg, Sjoerd/0000-0001-5937-7505; Baes, Myriam/0000-0002-2525-2269	Fonds Wetenschappelijk Onderzoek Vlaanderen [G.0760.09]; Geconcerteerde Onderzoeksacties [2004/08]; OT [08/40]; European Union [LSHG-CT-2004-512018]; Center of Medical Systems Biology; Netherlands Consortium for Systems Biology	Fonds Wetenschappelijk Onderzoek Vlaanderen(FWO); Geconcerteerde Onderzoeksacties; OT; European Union(European Commission); Center of Medical Systems Biology; Netherlands Consortium for Systems Biology	This work was funded by Fonds Wetenschappelijk Onderzoek Vlaanderen Grant G.0760.09, Geconcerteerde Onderzoeksacties Grant 2004/08, OT Grant 08/40, European Union Grant LSHG-CT-2004-512018, FP6, the Center of Medical Systems Biology, and the Netherlands Consortium for Systems Biology (established by The Netherlands Genomics Initiative/Netherlands Organization for Scientific Research).	Aragones J, 2008, NAT GENET, V40, P170, DOI 10.1038/ng.2007.62; Baes M, 2000, J BIOL CHEM, V275, P16329, DOI 10.1074/jbc.M001994200; Baes M, 2002, GENESIS, V32, P177, DOI 10.1002/gene.10047; Canto C, 2010, CELL MOL LIFE SCI, V67, P3407, DOI 10.1007/s00018-010-0454-z; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; CARLING D, 1989, BIOCHIM BIOPHYS ACTA, V1012, P81, DOI 10.1016/0167-4889(89)90014-1; Dirkx R, 2005, HEPATOLOGY, V41, P868, DOI 10.1002/hep.20628; Dirkx R, 2007, BIOCHEM BIOPH RES CO, V357, P718, DOI 10.1016/j.bbrc.2007.03.198; Du KY, 2003, SCIENCE, V300, P1574, DOI 10.1126/science.1079817; Foretz M, 2005, DIABETES, V54, P1331, DOI 10.2337/diabetes.54.5.1331; GOLDFISCHER S, 1973, SCIENCE, V182, P62, DOI 10.1126/science.182.4107.62; Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037; Hardie DG, 2006, J PHYSIOL-LONDON, V574, P7, DOI 10.1113/jphysiol.2006.108944; Hardie DG, 2011, AM J CLIN NUTR, V93, p891S, DOI 10.3945/ajcn.110.001925; Horike N, 2008, J BIOL CHEM, V283, P33902, DOI 10.1074/jbc.M802537200; HUGHES JL, 1990, VIRCHOWS ARCH A, V416, P255, DOI 10.1007/BF01678985; Iynedjian PB, 2005, BIOCHEM J, V386, P113, DOI 10.1042/BJ20041425; Jeninga EH, 2010, ONCOGENE, V29, P4617, DOI 10.1038/onc.2010.206; Jevon GP, 1998, PEDIATR DEVEL PATHOL, V1, P179, DOI 10.1007/s100249900026; JOMAINBAUM M, 1978, J BIOL CHEM, V253, P3648; Katoh Y, 2006, FEBS J, V273, P2730, DOI 10.1111/j.1742-4658.2006.05291.x; Keppler D., 1984, METHOD ENZYMAT AN, V6, P11; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Koo SH, 2004, NAT MED, V10, P530, DOI 10.1038/nm1044; Kumashiro N, 2008, DIABETES, V57, P2083, DOI 10.2337/db08-0144; Le Lay J, 2009, CELL METAB, V10, P55, DOI 10.1016/j.cmet.2009.06.006; LEE SST, 1995, MOL CELL BIOL, V15, P3012; Lee WS, 2007, HEPATOLOGY, V45, P1555, DOI 10.1002/hep.21710; Lerin C, 2006, CELL METAB, V3, P429, DOI 10.1016/j.cmet.2006.04.013; Lochhead PA, 2000, DIABETES, V49, P896, DOI 10.2337/diabetes.49.6.896; Mandard S, 2007, CELL MOL LIFE SCI, V64, P1145, DOI 10.1007/s00018-007-7006-1; Manfredi G, 2002, METHODS, V26, P317, DOI 10.1016/S1046-2023(02)00037-3; Marsin AS, 2000, CURR BIOL, V10, P1247, DOI 10.1016/S0960-9822(00)00742-9; Marsin AS, 2002, J BIOL CHEM, V277, P30778, DOI 10.1074/jbc.M205213200; Martens K, 2008, BBA-MOL CELL BIOL L, V1781, P694, DOI 10.1016/j.bbalip.2008.07.010; MATHIS RK, 1980, GASTROENTEROLOGY, V79, P1311; MOOI WJ, 1983, ULTRASTRUCT PATHOL, V5, P135, DOI 10.3109/01913128309141833; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Okamoto H, 2007, DIABETES, V56, P1350, DOI 10.2337/db06-1448; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Peeters A, 2011, BIOCHIMIE, V93, P1828, DOI 10.1016/j.biochi.2011.06.034; Peeters A, 2010, PPAR RES, V2010, DOI 10.1155/2010/572405; PERONNET F, 1991, CAN J SPORT SCI, V16, P23; PFEIFER U, 1979, VIRCHOWS ARCH A, V384, P269, DOI 10.1007/BF00428229; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Purushotham A, 2009, CELL METAB, V9, P327, DOI 10.1016/j.cmet.2009.02.006; Rajas F, 2000, DIABETES, V49, P1165, DOI 10.2337/diabetes.49.7.1165; Rhee J, 2006, J BIOL CHEM, V281, P14683, DOI 10.1074/jbc.M512636200; Roche TE, 2001, PROG NUCLEIC ACID RE, V70, P33, DOI 10.1016/S0079-6603(01)70013-X; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Schrader M, 2006, BBA-MOL CELL RES, V1763, P1755, DOI 10.1016/j.bbamcr.2006.09.006; She PX, 2003, DIABETES, V52, P1649, DOI 10.2337/diabetes.52.7.1649; Steinberg SJ, 2006, BBA-MOL CELL RES, V1763, P1733, DOI 10.1016/j.bbamcr.2006.09.010; TRIJBELS JMF, 1983, PEDIATR RES, V17, P514, DOI 10.1203/00006450-198306000-00018; Uebi T, 2010, AM J PHYSIOL-ENDOC M, V299, pE413, DOI 10.1152/ajpendo.00525.2009; van den Berg SAA, 2010, METABOLISM, V59, P1612, DOI 10.1016/j.metabol.2010.03.008; VANSCHAFTINGEN E, 1982, EUR J BIOCHEM, V129, P191; VANVELDHOVEN P, 1984, BIOCHEM PHARMACOL, V33, P1153, DOI 10.1016/0006-2952(84)90531-8; VanVeldhoven PP, 1996, ANAL BIOCHEM, V237, P17, DOI 10.1006/abio.1996.0194; Viana AYI, 2006, DIABETES RES CLIN PR, V73, P135, DOI 10.1016/j.diabres.2005.12.011; Viollet B, 2009, ACTA PHYSIOL, V196, P81, DOI 10.1111/j.1748-1716.2009.01970.x; Wanders RJA, 2006, ANNU REV BIOCHEM, V75, P295, DOI 10.1146/annurev.biochem.74.082803.133329; Wang YG, 2009, WORLD J GASTROENTERO, V15, P2329, DOI 10.3748/wjg.15.2329; Wu PF, 2001, BIOCHEM BIOPH RES CO, V287, P391, DOI 10.1006/bbrc.2001.5608; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050	66	29	32	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42162	42179		10.1074/jbc.M111.299727	http://dx.doi.org/10.1074/jbc.M111.299727			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	22002056	Green Published, hybrid			2022-12-27	WOS:000298180900027
J	Shi, Y; Huang, HS; Deng, XY; He, XB; Yang, JW; Yang, HP; Shi, LE; Mei, LJ; Gao, JM; Zhou, NM				Shi, Ying; Huang, Haishan; Deng, Xiaoyan; He, Xiaobai; Yang, Jingwen; Yang, Huipeng; Shi, Liangen; Mei, Lijuan; Gao, Jimin; Zhou, Naiming			Identification and Functional Characterization of Two Orphan G-protein-coupled Receptors for Adipokinetic Hormones from Silkworm Bombyx mori	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COCKROACH PERIPLANETA-AMERICANA; BEETLE TRIBOLIUM-CASTANEUM; CORPORA CARDIACA; CORPUS CARDIACUM; MANDUCA-SEXTA; FAT-BODY; NEUROPEPTIDE; PEPTIDE; FAMILY; LOCUST	Adipokinetic hormones (AKHs) are the best studied insect neuropeptides with the function of mobilizing lipids and carbohydrates during energy-expensive activities and modulating fundamental physiological processes, such as sugar homeostasis, lipid metabolism, and reproduction. Three distinct cDNAs encoding the prepro-Bombyx AKH1-3 have been cloned and confirmed by mass spectrometric methods. Our previous research suggested the Bombyx AKH receptor is activated by AKH1 and AKH2 with high affinity but by AKH3 with quite low affinity. In this study, using stable functional expression of the receptors in HEK293 cells, we have now identified AKH3 as a specific ligand for two orphan G-protein-coupled receptors, and we therefore named them AKHR2a and AKHR2b, respectively. We demonstrated that both AKHR2a and AKHR2b were activated by AKH3 at high affinity and by AKH1 and AKH2 at low affinity, leading to an increase of intracellular cAMP levels and activation of ERK1/2 and receptor internalization, but they were not activated by Bombyx corazonin. Conversely, the Bombyx corazonin receptor was activated by corazonin but not by AKH1-3. Quantitative RT-PCR revealed that AKHR2a and AKHR2b were both highly expressed in the testis but were also detected at low levels in other tissues. These results will lead to a better understanding of the AKH/AKHR system in the regulation of fundamental physiological processes.	[Huang, Haishan; Mei, Lijuan; Gao, Jimin] Wenzhou Med Coll, Sch Life Sci, Zhejiang Prov Key Lab Model Organisms, Wenzhou 325035, Zhejiang, Peoples R China; [Shi, Ying; Deng, Xiaoyan; He, Xiaobai; Yang, Huipeng; Mei, Lijuan; Zhou, Naiming] Zhejiang Univ, Coll Life Sci, Inst Biochem, Hangzhou 310058, Zhejiang, Peoples R China; [Yang, Jingwen; Shi, Liangen] Zhejiang Univ, Coll Anim Sci, Hangzhou 310058, Zhejiang, Peoples R China	Wenzhou Medical University; Zhejiang University; Zhejiang University	Gao, JM (corresponding author), Wenzhou Med Coll, Sch Life Sci, Zhejiang Prov Key Lab Model Organisms, Wenzhou 325035, Zhejiang, Peoples R China.	jimingao@yahoo.com; znm2000@yahoo.com	Zhou, Naiming/AHC-1121-2022		National Natural Science Foundation of China [31072090]; Ministry of Science and Technology [2008AA02Z138]; Zhejiang Natural Science Foundation [Z2080207]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Zhejiang Natural Science Foundation(Natural Science Foundation of Zhejiang Province)	This work was supported by National Natural Science Foundation of China Grant 31072090, Ministry of Science and Technology Grant 2008AA02Z138, and Zhejiang Natural Science Foundation Grant Z2080207.	Arrese EL, 1999, J LIPID RES, V40, P556; Belmont M, 2006, BIOCHEM BIOPH RES CO, V344, P160, DOI 10.1016/j.bbrc.2006.03.117; BRADFIELD JY, 1989, J BIOL CHEM, V264, P12791; Chen Z, 2001, CHEM REV, V101, P2449, DOI 10.1021/cr000241p; Fan Y, 2010, INSECT BIOCHEM MOLEC, V40, P581, DOI 10.1016/j.ibmb.2010.05.005; Gade G, 2006, BIOCHEM J, V393, P705, DOI 10.1042/BJ20050735; GADE G, 1994, PEPTIDES, V15, P1, DOI 10.1016/0196-9781(94)90162-7; Gade G, 2003, GEN COMP ENDOCR, V132, P10, DOI 10.1016/S0016-6480(03)00159-X; Gade G, 2008, PEPTIDES, V29, P1124, DOI 10.1016/j.peptides.2008.03.002; Hansen KK, 2010, J BIOL CHEM, V285, P10736, DOI 10.1074/jbc.M109.045369; Hansen KK, 2006, BIOCHEM BIOPH RES CO, V343, P638, DOI 10.1016/j.bbrc.2006.03.012; Hauser F, 2008, FRONT NEUROENDOCRIN, V29, P142, DOI 10.1016/j.yfrne.2007.10.003; Holmgren S, 2001, BRAIN RES BULL, V55, P723, DOI 10.1016/S0361-9230(01)00556-1; Huang HS, 2011, CELL SIGNAL, V23, P1455, DOI 10.1016/j.cellsig.2011.04.006; Huang HS, 2010, BIOCHEMISTRY-US, V49, P10862, DOI 10.1021/bi1014425; Isabel G, 2005, AM J PHYSIOL-REG I, V288, pR531, DOI 10.1152/ajpregu.00158.2004; ISHIBASHI J, 1992, BIOSCI BIOTECH BIOCH, V56, P66, DOI 10.1271/bbb.56.66; Kaufmann C, 2009, INSECT BIOCHEM MOLEC, V39, P770, DOI 10.1016/j.ibmb.2009.09.002; Li B, 2008, GENOME RES, V18, P113, DOI 10.1101/gr.6714008; Lindemans M, 2009, P NATL ACAD SCI USA, V106, P1642, DOI 10.1073/pnas.0809881106; Marco HG, 2011, PEPTIDES, V32, P454, DOI 10.1016/j.peptides.2010.10.015; Michitsch J, 2008, PEPTIDES, V29, P226, DOI 10.1016/j.peptides.2007.08.031; OUDEJANS RCHM, 1991, EUR J BIOCHEM, V195, P351, DOI 10.1111/j.1432-1033.1991.tb15713.x; Park Y, 2002, P NATL ACAD SCI USA, V99, P11423, DOI 10.1073/pnas.162276199; Pierce KL, 2001, ONCOGENE, V20, P1532, DOI 10.1038/sj.onc.1204184; Roller L, 2008, INSECT BIOCHEM MOLEC, V38, P1147, DOI 10.1016/j.ibmb.2008.04.009; SCHAFFER MH, 1990, BIOCHEM J, V269, P315, DOI 10.1042/bj2690315; Shenoy SK, 2003, BIOCHEM J, V375, P503, DOI 10.1042/BJ20031076; Siegert KJ, 1999, FEBS LETT, V447, P237, DOI 10.1016/S0014-5793(99)00299-9; Staubli F, 2002, P NATL ACAD SCI USA, V99, P3446, DOI 10.1073/pnas.052556499; STONE JV, 1976, NATURE, V263, P207, DOI 10.1038/263207a0; Van der Horst DJ, 2003, COMP BIOCHEM PHYS B, V136, P217, DOI 10.1016/S1096-4959(03)00151-9; VROEMEN SF, 1995, MOL CELL ENDOCRINOL, V107, P165, DOI 10.1016/0303-7207(94)03438-Y; Vroemen SF, 1998, MOL CELL ENDOCRINOL, V141, P7, DOI 10.1016/S0303-7207(98)00079-3; Werry TD, 2005, TRENDS ENDOCRIN MET, V16, P26, DOI 10.1016/j.tem.2004.11.008; Yamanaka N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003048; Zhu CG, 2009, FEBS LETT, V583, P1463, DOI 10.1016/j.febslet.2009.03.060	37	20	20	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42390	42402		10.1074/jbc.M111.275602	http://dx.doi.org/10.1074/jbc.M111.275602			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	22009754	Green Published, hybrid			2022-12-27	WOS:000298180900048
J	Kortholt, A; van Egmond, WN; Plak, K; Bosgraaf, L; Keizer-Gunnink, I; van Haastert, PJM				Kortholt, Arjan; van Egmond, Wouter N.; Plak, Katarzyna; Bosgraaf, Leonard; Keizer-Gunnink, Ineke; van Haastert, Peter J. M.			Multiple Regulatory Mechanisms for the Dictyostelium Roco Protein GbpC	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISEASE-ASSOCIATED MUTATIONS; PARKINSONS-DISEASE; KINASE-ACTIVITY; MYOSIN PHOSPHORYLATION; SIGNALING PATHWAY; GTP-BINDING; GRAM DOMAIN; LRRK2; CHEMOTAXIS; CGMP	GbpC is a multidomain Roco protein in Dictyostelium, involved in transduction of intracellular cGMP that is produced by chemotactic signals. We have shown previously that cGMP binding to GbpC induces an intramolecular signaling cascade by activating subsequently the GEF, Ras, and kinase domains. In this study, we report on the cellular localization of GbpC. In resting cells, the protein is present in the cytoplasm, but GbpC rapidly translocates to the cell boundary upon stimulation with the chemoattractant cAMP. Also, during the formation of cell-cell streams and osmotic shock, the protein localizes toward the plasma membrane and actin cytoskeleton. The translocation upon cAMP stimulation occurs downstream of heterotrimeric G proteins but is independent of guanylyl cyclases and the previously identified cGMP-induced intramolecular signaling cascade in GbpC. Mutations in the GRAM domain of GbpC lead to disturbed membrane association and inactivation of GbpC function during chemotaxis in vivo. Furthermore, we show that the GRAM domain itself associates with cellular membranes and binds various phospholipids in vitro. Together, the results show that GbpC receives multiple input signals that are both required for functional activity in vivo. cAMP-stimulation induces a cGMP-dependent signaling cascade, leading to activation of kinase activity, and, independently, cAMP induces a GRAM-dependent translocation of GbpC toward the plasma membrane and cell cortex, where it may locally phosphorylate effector proteins, which are needed for proper biological activity.	[Kortholt, Arjan; van Egmond, Wouter N.; Plak, Katarzyna; Bosgraaf, Leonard; Keizer-Gunnink, Ineke; van Haastert, Peter J. M.] Univ Groningen, Dept Cell Biochem, NL-9747 AG Groningen, Netherlands	University of Groningen	van Haastert, PJM (corresponding author), Univ Groningen, Dept Cell Biochem, Nijenborgh 7, NL-9747 AG Groningen, Netherlands.	P.J.M.van.haastert@rug.nl	kortholt, arjan/L-9795-2017	kortholt, arjan/0000-0001-8174-6397; Plak, Katarzyna/0000-0001-5268-4289				Araki T, 2003, J CELL SCI, V116, P2907, DOI 10.1242/jcs.00501; Araki T, 2010, J CELL SCI, V123, P837, DOI 10.1242/jcs.064436; Begley MJ, 2003, MOL CELL, V12, P1391, DOI 10.1016/S1097-2765(03)00486-6; Berger P, 2003, P NATL ACAD SCI USA, V100, P12177, DOI 10.1073/pnas.2132732100; Berger Z, 2010, BIOCHEMISTRY-US, V49, P5511, DOI 10.1021/bi100157u; Bosgraaf L, 2003, BBA-MOL CELL RES, V1643, P5, DOI 10.1016/j.bbamcr.2003.08.008; Bosgraaf L, 2002, EMBO J, V21, P4560, DOI 10.1093/emboj/cdf438; Bosgraaf L, 2008, J CELL SCI, V121, P3589, DOI 10.1242/jcs.031781; Bosgraaf L, 2009, CELL MOTIL CYTOSKEL, V66, P156, DOI 10.1002/cm.20338; Chen LF, 2007, DEV CELL, V12, P603, DOI 10.1016/j.devcel.2007.03.005; Cookson MR, 2010, NAT REV NEUROSCI, V11, P791, DOI 10.1038/nrn2935; Cookson MR, 2010, HUM MOL GENET, V19, pR21, DOI 10.1093/hmg/ddq167; de Rooij J, 2000, J BIOL CHEM, V275, P20829, DOI 10.1074/jbc.M001113200; Gasper R, 2009, NAT REV MOL CELL BIO, V10, P423, DOI 10.1038/nrm2689; Goldberg JM, 2002, P NATL ACAD SCI USA, V99, P6749, DOI 10.1073/pnas.102167299; Gotthardt K, 2008, EMBO J, V27, P2239, DOI 10.1038/emboj.2008.150; Greggio E, 2006, NEUROBIOL DIS, V23, P329, DOI 10.1016/j.nbd.2006.04.001; Guo LX, 2007, EXP CELL RES, V313, P3658, DOI 10.1016/j.yexcr.2007.07.007; Iaccarino C, 2007, HUM MOL GENET, V16, P1319, DOI 10.1093/hmg/ddm080; Ito G, 2007, BIOCHEMISTRY-US, V46, P1380, DOI 10.1021/bi061960m; Kamimura Y, 2008, CURR BIOL, V18, P1034, DOI 10.1016/j.cub.2008.06.068; KONIJN TM, 1970, EXPERIENTIA, V26, P367, DOI 10.1007/BF01896891; Kuwayama H, 1996, SCIENCE, V271, P207, DOI 10.1126/science.271.5246.207; Lees AJ, 2009, LANCET, V373, P2055, DOI 10.1016/S0140-6736(09)60492-X; Lewis PA, 2007, BIOCHEM BIOPH RES CO, V357, P668, DOI 10.1016/j.bbrc.2007.04.006; Li XT, 2007, J NEUROCHEM, V103, P238, DOI 10.1111/j.1471-4159.2007.04743.x; Liao XH, 2008, AMINO ACIDS, V35, P761, DOI 10.1007/s00726-008-0100-3; Luzon-Toro B, 2007, HUM MOL GENET, V16, P2031, DOI 10.1093/hmg/ddm151; Marin I, 2008, FASEB J, V22, P3103, DOI 10.1096/fj.08-111310; Nichols RJ, 2010, BIOCHEM J, V430, P393, DOI 10.1042/BJ20100483; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Roelofs J, 2002, J BIOL CHEM, V277, P9167, DOI 10.1074/jbc.M111437200; Sen S, 2009, J BIOL CHEM, V284, P36346, DOI 10.1074/jbc.M109.025437; Tsujita K, 2004, J BIOL CHEM, V279, P13817, DOI 10.1074/jbc.M312294200; van Egmond WN, 2010, EUKARYOT CELL, V9, P751, DOI 10.1128/EC.00366-09; van Egmond Wouter N, 2008, J Biol Chem, V283, P30412, DOI 10.1074/jbc.M804265200; Van Haastert PJM, 2004, NAT REV MOL CELL BIO, V5, P626, DOI 10.1038/nrm1435; Veltman DM, 2008, J CELL BIOL, V180, P747, DOI 10.1083/jcb.200709180; Veltman DM, 2008, J CELL SCI, V121, P120, DOI 10.1242/jcs.015602; Veltman DM, 2006, MOL BIOL CELL, V17, P3921, DOI 10.1091/mbc.E06-05-0381; WEEKS G, 1980, J LIPID RES, V21, P681; West AB, 2005, P NATL ACAD SCI USA, V102, P16842, DOI 10.1073/pnas.0507360102; West AB, 2007, HUM MOL GENET, V16, P223, DOI 10.1093/hmg/ddl471; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	44	10	10	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2749	2758		10.1074/jbc.M111.315739	http://dx.doi.org/10.1074/jbc.M111.315739			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22119747	hybrid, Green Published			2022-12-27	WOS:000300292300046
J	Murphy, L; Cruys-Bagger, N; Damgaard, HD; Baumann, MJ; Olsen, SN; Borch, K; Lassen, SF; Sweeney, M; Tatsumi, H; Westh, P				Murphy, Leigh; Cruys-Bagger, Nicolaj; Damgaard, Heidi Delcomyn; Baumann, Martin J.; Olsen, Soren Nymand; Borch, Kim; Lassen, Soren Flensted; Sweeney, Matt; Tatsumi, Hirosuke; Westh, Peter			Origin of Initial Burst in Activity for Trichoderma reesei endo-Glucanases Hydrolyzing Insoluble Cellulose	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOGLUCANASE-I CEL7B; ENZYMATIC-HYDROLYSIS; CELLOBIOSE DEHYDROGENASE; CELLOBIOHYDROLASE-II; CRYSTAL-STRUCTURE; REACTION-KINETICS; X-RAY; CELLULASES; MODEL; INHIBITION	The kinetics of cellulose hydrolysis have longbeen described by an initial fast hydrolysis rate, tapering rapidly off, leading to a process that takes days rather than hours to complete. This behavior has been mainly attributed to the action of cellobiohydrolases and often linked to the processive mechanism of this exo-acting group of enzymes. The initial kinetics of endo-glucanases (EGs) is far less investigated, partly due to a limited availability of quantitative assay technologies. We have used isothermal calorimetry to monitor the early time course of the hydrolysis of insoluble cellulose by the three main EGs from Trichoderma reesei (Tr): TrCel7B (formerly EG I), TrCel5A (EG II), and TrCel12A (EG III). These endo-glucanases show a distinctive initial burst with a maximal rate that is about 5-fold higher than the rate after 5 min of hydrolysis. The burst is particularly conspicuous for TrCel7B, which reaches a maximal turnover of about 20 s(-1) at 30 degrees C and conducts about 1200 catalytic cycles per enzyme molecule in the initial fast phase. For TrCel5A and TrCel12A the extent of the burst is 2-300 cycles per enzyme molecule. The availability of continuous data on EG activity allows an analysis of the mechanisms underlying the initial kinetics, and it is suggested that the slowdown is linked to transient inactivation of enzyme on the cellulose surface. We propose, therefore, that the frequency of structures on the substrate surface that cause transient inactivation determine the extent of the burst phase.	[Murphy, Leigh; Cruys-Bagger, Nicolaj; Damgaard, Heidi Delcomyn; Westh, Peter] Roskilde Univ, NSM, DK-4000 Roskilde, Denmark; [Murphy, Leigh; Baumann, Martin J.; Olsen, Soren Nymand; Borch, Kim; Lassen, Soren Flensted] Novozymes AS, DK-2880 Bagsvaerd, Denmark; [Sweeney, Matt] Novozymes Inc, Davis, CA 95618 USA; [Tatsumi, Hirosuke] Shinshu Univ, Int Young Researchers Empowerment Ctr, Matsumoto, Nagano 3908621, Japan	Roskilde University; Novozymes; Novozymes; Shinshu University	Westh, P (corresponding author), Roskilde Univ, NSM, 1 Univ Vej, DK-4000 Roskilde, Denmark.	pwesth@ruc.dk	Westh, Peter/AAR-9731-2021	Westh, Peter/0000-0002-6185-0637	Danish Agency for Science, Technology, and Innovation [2104-07-0028]; Carlsberg Foundation	Danish Agency for Science, Technology, and Innovation; Carlsberg Foundation(Carlsberg Foundation)	This work was supported by Danish Agency for Science, Technology, and Innovation Grant 2104-07-0028 (to P. W.) and the Carlsberg Foundation.	Anthon GE, 2002, ANAL BIOCHEM, V305, P287, DOI 10.1006/abio.2002.5644; BAILEY MJ, 1993, BIOTECHNOL APPL BIOC, V17, P65; Barr BK, 1996, BIOCHEMISTRY-US, V35, P586, DOI 10.1021/bi9520388; Bayer EA, 1998, CURR OPIN STRUC BIOL, V8, P548, DOI 10.1016/S0959-440X(98)80143-7; Bertilsson M, 2009, BIOTECHNOL BIOFUELS, V2, DOI 10.1186/1754-6834-2-8; Bohlin C, 2010, BIOTECHNOL BIOENG, V107, P943, DOI 10.1002/bit.22885; Breyer WA, 2001, PROTEIN SCI, V10, P1699, DOI 10.1110/ps.10301; BRIGGNER LE, 1991, J BIOCHEM BIOPH METH, V22, P101, DOI 10.1016/0165-022X(91)90023-P; CALVET E, 1951, J POLYM SCI, V6, P33, DOI 10.1002/pol.1951.120060106; Cao Y, 2002, CARBOHYD RES, V337, P1291, DOI 10.1016/S0008-6215(02)00134-9; CHILD JJ, 1973, CAN J BIOCHEM CELL B, V51, P39, DOI 10.1139/o73-006; Coward-Kelly G, 2003, BIOTECHNOL BIOENG, V82, P745, DOI 10.1002/bit.10620; DALE BE, 1982, J APPL POLYM SCI, V27, P1233, DOI 10.1002/app.1982.070270412; DIVNE C, 1993, J MOL BIOL, V234, P905, DOI 10.1006/jmbi.1993.1640; DONER LW, 1992, ANAL BIOCHEM, V202, P50, DOI 10.1016/0003-2697(92)90204-K; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Eriksson T, 2002, ENZYME MICROB TECH, V31, P353, DOI 10.1016/S0141-0229(02)00134-5; Eriksson T, 2002, APPL BIOCHEM BIOTECH, V101, P41, DOI 10.1385/ABAB:101:1:41; Gruno M, 2004, BIOTECHNOL BIOENG, V86, P503, DOI 10.1002/bit.10838; HARTLEY BS, 1954, BIOCHEM J, V56, P288, DOI 10.1042/bj0560288; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; Hilden L, 2001, ANAL BIOCHEM, V290, P245, DOI 10.1006/abio.2000.4959; HOLTZAPPLE MT, 1984, BIOTECHNOL BIOENG, V26, P753, DOI 10.1002/bit.260260719; Igarashi K, 2006, FEBS J, V273, P2869, DOI 10.1111/j.1742-4658.2006.05299.x; IRWIN DC, 1993, BIOTECHNOL BIOENG, V42, P1002, DOI 10.1002/bit.260420811; Jalak J, 2010, BIOTECHNOL BIOENG, V106, P871, DOI 10.1002/bit.22779; Jeoh T, 2005, ANAL BIOCHEM, V347, P244, DOI 10.1016/j.ab.2005.09.031; JOOS P, 1969, J PHARM PHARMACOL, V21, P848, DOI 10.1111/j.2042-7158.1969.tb08184.x; Karim N, 2005, THERMOCHIM ACTA, V431, P9, DOI 10.1016/j.tca.2005.01.025; Karim N, 2004, THERMOCHIM ACTA, V412, P91, DOI 10.1016/j.tca.2003.09.001; Karlsson J, 2002, J BIOTECHNOL, V99, P63, DOI 10.1016/S0168-1656(02)00156-6; Kipper K, 2005, BIOCHEM J, V385, P527, DOI 10.1042/BJ20041144; KlemanLeyer KM, 1996, APPL ENVIRON MICROB, V62, P2883, DOI 10.1128/AEM.62.8.2883-2887.1996; Kurasin M, 2011, J BIOL CHEM, V286, P169, DOI 10.1074/jbc.M110.161059; Lee JM, 2007, BIORESOURCES, V2, P20; LEE YH, 1983, BIOTECHNOL BIOENG, V25, P939, DOI 10.1002/bit.260250406; LEVER M, 1973, BIOCHEM MED METAB B, V7, P274, DOI 10.1016/0006-2944(73)90083-5; LEVER M, 1972, ANAL BIOCHEM, V47, P273, DOI 10.1016/0003-2697(72)90301-6; Levine SE, 2010, BIOTECHNOL BIOENG, V107, P37, DOI 10.1002/bit.22789; LOBLICH KR, 1994, THERMOCHIM ACTA, V231, P7, DOI 10.1016/0040-6031(94)80002-2; Ludwig R, 2010, CHEMPHYSCHEM, V11, P2674, DOI 10.1002/cphc.201000216; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; Mackenzie LF, 1998, BIOCHEM J, V335, P409, DOI 10.1042/bj3350409; Matulova M, 2008, FEBS J, V275, P3503, DOI 10.1111/j.1742-4658.2008.06497.x; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; MILLER GL, 1960, ANAL BIOCHEM, V1, P127, DOI 10.1016/0003-2697(60)90004-X; MULLINGS R, 1985, ENZYME MICROB TECH, V7, P586, DOI 10.1016/0141-0229(85)90025-0; Murphy L, 2010, ANAL BIOCHEM, V404, P140, DOI 10.1016/j.ab.2010.04.020; Murphy L, 2010, ENZYME MICROB TECH, V46, P141, DOI 10.1016/j.enzmictec.2009.09.009; Nakazawa H, 2009, APPL MICROBIOL BIOT, V83, P649, DOI 10.1007/s00253-009-1901-3; Nelson N, 1944, J BIOL CHEM, V153, P375; NIDETZKY B, 1993, BIOTECHNOL BIOENG, V42, P469, DOI 10.1002/bit.260420410; Okada H, 2000, J MOL CATAL B-ENZYM, V10, P249, DOI 10.1016/S1381-1177(00)00137-5; Olsen SN, 2006, THERMOCHIM ACTA, V448, P12, DOI 10.1016/j.tca.2006.06.019; PENTTILA M, 1986, GENE, V45, P253, DOI 10.1016/0378-1119(86)90023-5; Peri S, 2007, BIOTECHNOL PROGR, V23, P626, DOI 10.1021/bp060322s; Praestgaard E, 2011, FEBS J, V278, P1547, DOI 10.1111/j.1742-4658.2011.08078.x; Rabinovich ML, 2002, APPL BIOCHEM MICRO+, V38, P305, DOI 10.1023/A:1016264219885; ROUVINEN J, 1990, SCIENCE, V249, P380, DOI 10.1126/science.2377893; SALOHEIMO M, 1988, GENE, V63, P11, DOI 10.1016/0378-1119(88)90541-0; Sandgren M, 2001, J MOL BIOL, V308, P295, DOI 10.1006/jmbi.2001.4583; Sengupta S, 2000, APPL MICROBIOL BIOT, V53, P732, DOI 10.1007/s002530000327; SHARROCK KR, 1988, J BIOCHEM BIOPH METH, V17, P81, DOI 10.1016/0165-022X(88)90040-1; SHOEMAKER S, 1983, BIO-TECHNOL, V1, P687, DOI 10.1038/nbt1083-687; SOMOGYI M, 1952, J BIOL CHEM, V195, P19; STAHLBERG J, 1988, EUR J BIOCHEM, V173, P179, DOI 10.1111/j.1432-1033.1988.tb13982.x; Tatsumi H, 2005, J AGR FOOD CHEM, V53, P8123, DOI 10.1021/jf050934c; Tatsumi H, 2006, ANAL BIOCHEM, V357, P257, DOI 10.1016/j.ab.2006.07.019; TAYLOR JB, 1957, T FARADAY SOC, V53, P1198, DOI 10.1039/tf9575301198; Todd MJ, 2001, ANAL BIOCHEM, V296, P179, DOI 10.1006/abio.2001.5218; Valjamae P, 1998, EUR J BIOCHEM, V253, P469, DOI 10.1046/j.1432-1327.1998.2530469.x; Valjamae P, 2001, EUR J BIOCHEM, V268, P4520, DOI 10.1046/j.1432-1327.2001.02377.x; VANDERHART DL, 1984, MACROMOLECULES, V17, P1465, DOI 10.1021/ma00138a009; Vlasenko E., 2005, PCTInternational Patent Appl., Patent No. [WO/2005/067531, 2005067531]; Vlasenko EY, 1998, ENZYME MICROB TECH, V23, P350, DOI 10.1016/S0141-0229(98)00052-0; Watson BJ, 2009, J BACTERIOL, V191, P5697, DOI 10.1128/JB.00481-09; Xiao ZZ, 2004, APPL BIOCHEM BIOTECH, V113, P1115, DOI 10.1385/ABAB:115:1-3:1115; Yang B, 2006, BIOTECHNOL BIOENG, V94, P1122, DOI 10.1002/bit.20942; Zhang S, 2000, EUR J BIOCHEM, V267, P3101, DOI 10.1046/j.1432-1327.2000.01315.x; Zhang S, 1999, BIOTECHNOL BIOENG, V66, P35, DOI 10.1002/(SICI)1097-0290(1999)66:1&lt;35::AID-BIT3&gt;3.0.CO;2-G; Zhang YHP, 2006, BIOTECHNOL ADV, V24, P452, DOI 10.1016/j.biotechadv.2006.03.003; Zhang YHP, 2006, BIOTECHNOL BIOENG, V94, P888, DOI 10.1002/bit.20906; Zhang YHP, 2005, BIOMACROMOLECULES, V6, P1510, DOI 10.1021/bm049235j; Zhang YHP, 2004, BIOTECHNOL BIOENG, V88, P797, DOI 10.1002/bit.20282; Zhang YHP, 2003, ANAL BIOCHEM, V322, P225, DOI 10.1016/j.ab.2003.07.021; Zhou WL, 2004, BIOCHEMISTRY-US, V43, P9655, DOI 10.1021/bi049394n; Zou JY, 1999, STRUCTURE, V7, P1035, DOI 10.1016/S0969-2126(99)80171-3	87	40	45	0	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					1252	1260		10.1074/jbc.M111.276485	http://dx.doi.org/10.1074/jbc.M111.276485			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22110134	Green Published, hybrid			2022-12-27	WOS:000299170300041
J	Hillebrand, M; Gersting, SW; Lotz-Havla, AS; Schafer, A; Rosewich, H; Valerius, O; Muntau, AC; Gartner, J				Hillebrand, Merle; Gersting, Soren W.; Lotz-Havla, Amelie S.; Schaefer, Annika; Rosewich, Hendrik; Valerius, Oliver; Muntau, Ania C.; Gaertner, Jutta			Identification of a New Fatty Acid Synthesis-Transport Machinery at the Peroxisomal Membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-LINKED ADRENOLEUKODYSTROPHY; ACYL-COA SYNTHETASE; ATP-CITRATE LYASE; ABC TRANSPORTERS; HALF-TRANSPORTERS; PMP70 ABCD3; PROTEIN; GENE; SYNTHASE; FATP4	The neurodegenerative disease X-linked adrenoleukodystrophy (X-ALD) is characterized by the abnormal accumulation of very long chain fatty acids. Mutations in the gene encoding the peroxisomal ATP-binding cassette half-transporter, adrenoleukodystrophy protein (ALDP), are the primary cause of X-ALD. To gain a better understanding of ALDP dysfunction, we searched for interaction partners of ALDP and identified binary interactions to proteins with functions in fatty acid synthesis (ACLY, FASN, and ACC) and activation (FATP4), constituting a thus far unknown fatty acid synthesis-transport machinery at the cytoplasmic side of the peroxisomal membrane. This machinery adds to the knowledge of the complex mechanisms of peroxisomal fatty acid metabolism at a molecular level and elucidates potential epigenetic mechanisms as regulatory processes in the pathogenesis and thus the clinical course of X-ALD.	[Hillebrand, Merle; Rosewich, Hendrik; Gaertner, Jutta] Univ Gottingen, Fac Med, Dept Pediat & Pediat Neurol, D-37075 Gottingen, Germany; [Gersting, Soren W.; Lotz-Havla, Amelie S.; Muntau, Ania C.] Univ Munich, Dr von Hauner Childrens Hosp, Dept Mol Pediat, D-80337 Munich, Germany; [Schaefer, Annika] Univ Gottingen, Fac Med, Dept Dermatol Venereol & Allergol, D-37075 Gottingen, Germany; [Valerius, Oliver] Univ Gottingen, Dept Mol Microbiol & Genet, Inst Microbiol & Genet, D-37077 Gottingen, Germany	University of Gottingen; University of Munich; University of Gottingen; University of Gottingen	Gartner, J (corresponding author), Univ Gottingen, Fac Med, Dept Pediat & Pediat Neurol, D-37075 Gottingen, Germany.	gaertnj@med.uni-goettingen.de	Gersting, Soeren/D-4612-2011	Gersting, Soeren/0000-0001-7482-4748	Deutsche Forschungsgemeinschaft [GA354/7-1]; Bavarian Genome Research Network (Bay-Gene); LMUexcellent Grant [42595-6]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bavarian Genome Research Network (Bay-Gene); LMUexcellent Grant	This work was supported by Deutsche Forschungsgemeinschaft Grant GA354/7-1 (to J. G.) and by the Bavarian Genome Research Network (Bay-Gene) and LMUexcellent Grant 42595-6 (to A. C. M.).	Beigneux AP, 2004, J BIOL CHEM, V279, P9557, DOI 10.1074/jbc.M310512200; Braiterman LT, 1998, HUM MOL GENET, V7, P239, DOI 10.1093/hmg/7.2.239; Chirala SS, 2001, P NATL ACAD SCI USA, V98, P3104, DOI 10.1073/pnas.051635998; Di Benedetto R, 2009, NEUROCHEM INT, V54, P37, DOI 10.1016/j.neuint.2008.10.002; EWART GD, 1994, J BIOL CHEM, V269, P10370; Gartner J, 1998, NEUROPEDIATRICS, V29, P3, DOI 10.1055/s-2007-973526; GARTNER J, 1992, NAT GENET, V1, P16, DOI 10.1038/ng0492-16; Germann U A, 1993, Semin Cell Biol, V4, P63; Gloeckner CJ, 2000, BIOCHEM BIOPH RES CO, V271, P144, DOI 10.1006/bbrc.2000.2572; Gottesman MM, 2001, J BIOENERG BIOMEMBR, V33, P453, DOI 10.1023/A:1012866803188; Halbach A, 2005, J BIOL CHEM, V280, P21176, DOI 10.1074/jbc.M501750200; Hall AM, 2005, J BIOL CHEM, V280, P11948, DOI 10.1074/jbc.M412629200; Hannun YA, 2002, J BIOL CHEM, V277, P25847, DOI 10.1074/jbc.R200008200; Herrmann T, 2001, GENE, V270, P31, DOI 10.1016/S0378-1119(01)00489-9; HIGGINS CF, 1992, BRIT MED BULL, V48, P754, DOI 10.1093/oxfordjournals.bmb.a072576; Hillebrand M, 2007, J BIOL CHEM, V282, P26997, DOI 10.1074/jbc.M702122200; Hirsch D, 1998, P NATL ACAD SCI USA, V95, P8625, DOI 10.1073/pnas.95.15.8625; Imanaka T, 1999, J BIOL CHEM, V274, P11968, DOI 10.1074/jbc.274.17.11968; Jia ZZ, 2007, J BIOL CHEM, V282, P20573, DOI 10.1074/jbc.M700568200; KAMIJO K, 1990, J BIOL CHEM, V265, P4534; Kashiwayama Y, 2007, J BIOL CHEM, V282, P33831, DOI 10.1074/jbc.M703369200; Kemp S, 2007, MOL GENET METAB, V90, P268, DOI 10.1016/j.ymgme.2006.10.001; Kemp S, 2011, BRIT J PHARMACOL, V164, P1753, DOI 10.1111/j.1476-5381.2011.01435.x; KORNACKER MS, 1965, P NATL ACAD SCI USA, V54, P899, DOI 10.1073/pnas.54.3.899; Lin MH, 2010, DEV BIOL, V344, P707, DOI 10.1016/j.ydbio.2010.05.503; LINN TC, 1979, J BIOL CHEM, V254, P1691; Liu LX, 1999, J BIOL CHEM, V274, P32738, DOI 10.1074/jbc.274.46.32738; LombardPlatet G, 1996, P NATL ACAD SCI USA, V93, P1265, DOI 10.1073/pnas.93.3.1265; Moser HW, 1997, BRAIN, V120, P1485, DOI 10.1093/brain/120.8.1485; MOSSER J, 1993, NATURE, V361, P726, DOI 10.1038/361726a0; Ohno Y, 2010, P NATL ACAD SCI USA, V107, P18439, DOI 10.1073/pnas.1005572107; Pfleger KDG, 2006, NAT METHODS, V3, P165, DOI 10.1038/nmeth841; RIORDAN JR, 1989, SCIENCE, V245, P1066; Shevchenko A, 1996, P NATL ACAD SCI USA, V93, P14440, DOI 10.1073/pnas.93.25.14440; Smith KD, 1999, NEUROCHEM RES, V24, P521, DOI 10.1023/A:1022535930009; SMITH S, 1994, FASEB J, V8, P1248, DOI 10.1096/fasebj.8.15.8001737; Tanaka AR, 2002, J BIOL CHEM, V277, P40142, DOI 10.1074/jbc.M205079200; van Roermund CWT, 2008, FASEB J, V22, P4201, DOI 10.1096/fj.08-110866; VANGEEL BM, 1994, NEUROLOGY, V44, P2343, DOI 10.1212/WNL.44.12.2343; Pinto MGV, 2009, PROTEOMICS, V9, P5303, DOI 10.1002/pmic.200900298; WAKIL SJ, 1983, ANNU REV BIOCHEM, V52, P537, DOI 10.1146/annurev.bi.52.070183.002541; WAKIL SJ, 1989, BIOCHEMISTRY-US, V28, P4523, DOI 10.1021/bi00437a001; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Zhong Q, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.80	44	26	27	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					210	221		10.1074/jbc.M111.272732	http://dx.doi.org/10.1074/jbc.M111.272732			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22045812	Green Published, hybrid			2022-12-27	WOS:000298682400022
J	Hu, WB; Wang, F; Tang, JS; Liu, XY; Yuan, Z; Nie, CL; Wei, YQ				Hu, Wenbin; Wang, Fang; Tang, Jingsheng; Liu, Xinyu; Yuan, Zhu; Nie, Chunlai; Wei, Yuquan			Proapoptotic Protein Smac Mediates Apoptosis in Cisplatin-resistant Ovarian Cancer Cells When Treated with the Anti-tumor Agent AT101	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C RELEASE; BCL-X-L; CARCINOMA-CELLS; PROSTATE-CANCER; GLUTATHIONE SYNTHESIS; PHASE I/II; DEATH; BAX; GOSSYPOL; P53	Chemoresistance of ovarian cancer has been previously attributed to the expression and activation of Bcl-2 family proteins. BH3-mimetic molecules possessing potential anticancer activity are able to inhibit antiapoptotic Bcl-2 family proteins. AT101 (R-(-)-gossypol), a natural BH3-mimetic molecule, has shown anti-tumor activity as a single agent and in combination with standard anticancer therapies in a variety of tumor models. Here, we report the effect of AT101 on apoptosis in cisplatin-resistant ovarian cancer cells and identify the major molecular events that determine sensitivity. AT101 induced cell apoptosis by activating Bax through a conformational change, translocation, and oligomerization. The inhibition of Bax expression only partially prevented caspase-3 cleavage. However, the gene silencing of Bax had no effect on mitochondrial Smac release. Further experiments demonstrated that Smac reduction inhibited caspase-3 activation and attenuated cell apoptosis. More importantly, the inhibition of Smac or overexpression of XIAP attenuated Bax activation in ovarian cells. Furthermore, our data indicate that the Akt-p53 pathway is involved in the regulation of Smac release. Taken together, our data demonstrate the role of Smac and the molecular mechanisms of AT101-induced apoptosis of chemoresistant ovarian cancer cells. Our findings suggest that AT101 not only triggers Bax activation but also induces mitochondrial Smac release. Activated Smac can enhance Bax-mediated cellular apoptosis. Therefore, Smac mediates Bax activation to determine the threshold for overcoming cisplatin resistance in ovarian cancer cells.	[Hu, Wenbin; Wang, Fang; Liu, Xinyu; Yuan, Zhu; Nie, Chunlai; Wei, Yuquan] Sichuan Univ, W China Hosp, State Key Lab Biotherapy, Chengdu 610041, Peoples R China; [Hu, Wenbin; Wang, Fang; Liu, Xinyu; Yuan, Zhu; Nie, Chunlai; Wei, Yuquan] Sichuan Univ, W China Hosp, Ctr Canc, Chengdu 610041, Peoples R China; [Tang, Jingsheng] ChongQing NewFine Biol Technol Co Ltd, Chongqing 402460, Peoples R China	Sichuan University; Sichuan University	Nie, CL (corresponding author), Sichuan Univ, W China Hosp, State Key Lab Biotherapy, 4 Keyuan Rd, Chengdu 610041, Peoples R China.	niecl1022@hotmail.com			Natural Science Foundation of China (NSFC) [81071817/H1609]; National ST Major Project [2011ZX09102-001-013, 2012ZX09501]	Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National ST Major Project	The work was supported by Natural Science Foundation of China (NSFC) Grant 81071817/H1609 and National S&T Major Project Grants 2011ZX09102-001-013 and 2012ZX09501.	Arnt CR, 2003, CELL DEATH DIFFER, V10, P1118, DOI 10.1038/sj.cdd.4401294; Asselin E, 2001, CANCER RES, V61, P1862; Balakrishnan K, 2009, BLOOD, V113, P149, DOI 10.1182/blood-2008-02-138560; Borner C, 2003, MOL IMMUNOL, V39, P615, DOI 10.1016/S0161-5890(02)00252-3; Chandra D, 2005, J BIOL CHEM, V280, P19051, DOI 10.1074/jbc.M501391200; Chen KF, 2008, CANCER RES, V68, P6698, DOI 10.1158/0008-5472.CAN-08-0257; Deng YB, 2002, GENE DEV, V16, P33, DOI 10.1101/gad.949602; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Fraser M, 2003, CANCER RES, V63, P7081; Genestier AL, 2005, J CLIN INVEST, V115, P3117, DOI 10.1172/JCI22684; GODWIN AK, 1992, P NATL ACAD SCI USA, V89, P3070, DOI 10.1073/pnas.89.7.3070; Hasenjager A, 2004, ONCOGENE, V23, P4523, DOI 10.1038/sj.onc.1207594; JOSEPH AEA, 1986, BRIT J CANCER, V54, P511, DOI 10.1038/bjc.1986.205; Liu G, 2009, CLIN CANCER RES, V15, P3172, DOI 10.1158/1078-0432.CCR-08-2985; Marone M, 1998, CLIN CANCER RES, V4, P517; Meng Y, 2008, MOL CANCER THER, V7, P2192, DOI 10.1158/1535-7163.MCT-08-0333; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; Mohan J, 2006, J BIOL CHEM, V281, P17599, DOI 10.1074/jbc.M602641200; Nie C, 2008, J BIOL CHEM, V283, P15359, DOI 10.1074/jbc.M800847200; Oliver CL, 2005, MOL CANCER THER, V4, P23; Poulain L, 1998, INT J CANCER, V78, P454, DOI 10.1002/(SICI)1097-0215(19981109)78:4<454::AID-IJC11>3.0.CO;2-6; Qiu JP, 2002, EXP BIOL MED, V227, P398, DOI 10.1177/153537020222700605; Rudin CM, 2003, CANCER RES, V63, P312; Salzberg M, 2005, ONCOLOGY-BASEL, V68, P293, DOI 10.1159/000086967; Shawgo ME, 2008, J BIOL CHEM, V283, P35532, DOI 10.1074/jbc.M807656200; Siddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933; Simonin K, 2009, MOL CANCER THER, V8, P3162, DOI 10.1158/1535-7163.MCT-09-0493; Sung BK, 2010, J BIOL CHEM, V285, P35418, DOI 10.1074/jbc.M110.172767; Van Poznak C, 2001, BREAST CANCER RES TR, V66, P239, DOI 10.1023/A:1010686204736; Volate SR, 2010, MOL CANCER THER, V9, P461, DOI 10.1158/1535-7163.MCT-09-0507; Williams J, 2005, GYNECOL ONCOL, V96, P287, DOI 10.1016/j.ygyno.2004.10.026; Wolff S, 2008, CELL RES, V18, P733, DOI 10.1038/cr.2008.62; Yang XK, 2006, CANCER RES, V66, P3126, DOI 10.1158/0008-5472.CAN-05-0425; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Yu J, 2007, ONCOGENE, V26, P4189, DOI 10.1038/sj.onc.1210196; Yuan Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020586; Yuan Z, 2009, CANCER SCI, V100, P1757, DOI 10.1111/j.1349-7006.2009.01242.x; Zhang MC, 2003, BIOCHEM PHARMACOL, V66, P93, DOI 10.1016/S0006-2952(03)00248-X; Zhao YF, 2005, CANCER RES, V65, P3745, DOI 10.1158/0008-5472.CAN-04-3835; Zhao YF, 2006, CARCINOGENESIS, V27, P1692, DOI 10.1093/carcin/bgl037	40	41	42	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					68	80		10.1074/jbc.M111.271205	http://dx.doi.org/10.1074/jbc.M111.271205			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22052903	Green Published, hybrid			2022-12-27	WOS:000298682400010
J	Malapaka, RRV; Khoo, S; Zhang, JF; Choi, JH; Zhou, XE; Xu, Y; Gong, YH; Li, J; Yong, EL; Chalmers, MJ; Chang, L; Resau, JH; Griffin, PR; Chen, YE; Xu, HE				Malapaka, Raghu R. V.; Khoo, SokKean; Zhang, Jifeng; Choi, Jang H.; Zhou, X. Edward; Xu, Yong; Gong, Yinhan; Li, Jun; Yong, Eu-Leong; Chalmers, Michael J.; Chang, Lin; Resau, James H.; Griffin, Patrick R.; Chen, Y. Eugene; Xu, H. Eric			Identification and Mechanism of 10-Carbon Fatty Acid as Modulating Ligand of Peroxisome Proliferator-activated Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-CHAIN TRIGLYCERIDES; WEIGHT-LOSS DIET; PPAR-GAMMA; DIFFERENTIAL EXPRESSION; BINDING SELECTIVITY; NUCLEAR RECEPTORS; GENE-EXPRESSION; RISK-FACTORS; OIL; CONSUMPTION	Peroxisome proliferator-activated receptors (PPAR alpha, -beta/delta, and -gamma) are a subfamily of nuclear receptors that plays key roles in glucose and lipid metabolism. PPAR gamma is the molecular target of the thiazolidinedione class of antidiabetic drugs that has many side effects. PPAR gamma is also activated by long chain unsaturated or oxidized/nitrated fatty acids, but its relationship with the medium chain fatty acids remains unclear even though the medium chain triglyceride oils have been used to control weight gain and glycemic index. Here, we show that decanoic acid (DA), a 10-carbon fatty acid and a major component of medium chain triglyceride oils, is a direct ligand of PPAR gamma. DA binds and partially activates PPAR gamma without leading to adipogenesis. Crystal structure reveals that DA occupies a novel binding site and only partially stabilizes the AF-2 helix. DA also binds weakly to PPAR alpha and PPAR beta/delta. Treatments with DA and its triglyceride form improve glucose sensitivity and lipid profiles without weight gain in diabetic mice. Together, these results suggest that DA is a modulating ligand for PPARs, and the structure can aid in designing better and safer PPAR gamma-based drugs.	[Malapaka, Raghu R. V.; Zhou, X. Edward; Xu, Yong; Xu, H. Eric] Van Andel Res Inst, Lab Struct Sci, Grand Rapids, MI 49503 USA; [Khoo, SokKean] Van Andel Res Inst, Lab Microarray Technol, Grand Rapids, MI 49503 USA; [Khoo, SokKean; Resau, James H.] Van Andel Res Inst, Lab Analyt Cellular & Mol Microscopy, Grand Rapids, MI 49503 USA; [Zhang, Jifeng; Chang, Lin; Chen, Y. Eugene] Univ Michigan, Dept Internal Med, Ctr Cardiovasc, Ann Arbor, MI 48109 USA; [Choi, Jang H.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; [Choi, Jang H.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Gong, Yinhan; Li, Jun; Yong, Eu-Leong] Natl Univ Singapore, Dept Obstet & Gynaecol, Singapore 119228, Singapore; [Chalmers, Michael J.; Griffin, Patrick R.] Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL 33458 USA; [Xu, H. Eric] Chinese Acad Sci, VARI SIMM Ctr Drug Discovery, Ctr Struct & Funct Drug Targets, State Key Lab Drug Res,Shanghai Inst Mat Med, Shanghai 201203, Peoples R China	Van Andel Institute; Van Andel Institute; Van Andel Institute; University of Michigan System; University of Michigan; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; National University of Singapore; Scripps Research Institute; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS	Malapaka, RRV (corresponding author), Brigham & Womens Hosp, Ctr Interdisciplinary Cardiovasc Sci, 3 Blackfan Circle Dr, Boston, MA 02115 USA.	vmalapaka@rics.bwh.harvard.edu	Choi, Jang Hyun/B-3055-2012; Malapaka, Raghu/B-6185-2012; Gong, Yinhan/D-1932-2013; Xu, H. Eric/ABD-7487-2021	Chalmers, Michael/0000-0002-2139-6089; Yong, Eu-Leong/0000-0001-6511-770X; Xu, H. Eric/0000-0002-6829-8144	National Institutes of Health [DK071662, DK066202, HL089301, HL68878, HL089544]; American Heart Association [0835237N, 0840025N]; Jay and Betty Van Andel Foundation, Amway (China) Ltd.; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027270] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068878, R01HL089301, R01HL089544] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071662, R01DK066202] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Jay and Betty Van Andel Foundation, Amway (China) Ltd.; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK071662 and DK066202 and HL089301 (to H. E. X.) and Grants HL68878 and HL089544 (to Y. E. C.). This work was also supported by American Heart Association Grant 0835237N (to J. Z.).; Established Investigator and supported by American Heart Association Grant 0840025N. To whom correspondence may be addressed: Cardiovascular Center, Dept. of Internal Medicine, University of Michigan, Ann Arbor, MI 48109. E-mail:echenum@med.umich.edu.; Supported by the Jay and Betty Van Andel Foundation, Amway (China) Ltd. To whom correspondence may be addressed: Laboratory of Structural Sciences, Van Andel Research Institute, Grand Rapids, MI 49503. Tel.: 616-234-5772; Fax: 616-234-5773; E-mail:eric.xu@vai.org.	Akiyama Taro E, 2005, Curr Diab Rep, V5, P45, DOI 10.1007/s11892-005-0067-3; Amer Diabet Assoc, 2009, DIABETES CARE, V32, pS13, DOI 10.2337/dc09-S013; Bonacci G, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.225029; Braissant O, 1996, ENDOCRINOLOGY, V137, P354, DOI 10.1210/en.137.1.354; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chan JCN, 2009, JAMA-J AM MED ASSOC, V301, P2129, DOI 10.1001/jama.2009.726; Choi JH, 2010, NATURE, V466, P451, DOI 10.1038/nature09291; Davidson MH, 2006, AM J CARDIOL, V98, p27I, DOI 10.1016/j.amjcard.2005.12.024; Feige JN, 2006, PROG LIPID RES, V45, P120, DOI 10.1016/j.plipres.2005.12.002; Feldman PL, 2008, CURR TOP MED CHEM, V8, P728, DOI 10.2174/156802608784535084; FRICK MH, 1987, NEW ENGL J MED, V317, P1237, DOI 10.1056/NEJM198711123172001; Gregoire FM, 2009, MOL ENDOCRINOL, V23, P975, DOI 10.1210/me.2008-0473; Guo W, 2003, J NUTR, V133, P2512, DOI 10.1093/jn/133.8.2512; Hamuro Y, 2006, PROTEIN SCI, V15, P1883, DOI 10.1110/ps.062103006; Han JR, 2003, OBES RES, V11, P734, DOI 10.1038/oby.2003.103; Higgins LS, 2010, AM J CLIN NUTR, V91, p267S, DOI 10.3945/ajcn.2009.28449E; HILL JO, 1990, J LIPID RES, V31, P407; ISSEMANN I, 1990, NATURE, V347, P645, DOI 10.1038/347645a0; Itoh T, 2008, NAT STRUCT MOL BIOL, V15, P924, DOI 10.1038/nsmb.1474; Kliewer SA, 2001, RECENT PROG HORM RES, V56, P239, DOI 10.1210/rp.56.1.239; KLIEWER SA, 1994, P NATL ACAD SCI USA, V91, P7355, DOI 10.1073/pnas.91.15.7355; Kliewer SA, 1997, P NATL ACAD SCI USA, V94, P4318, DOI 10.1073/pnas.94.9.4318; KLIEWER SA, 1995, CELL, V83, P813, DOI 10.1016/0092-8674(95)90194-9; Knopp RH, 2004, AM J CLIN NUTR, V80, P1102, DOI 10.1093/ajcn/80.5.1102; Krotkiewski M, 2001, INT J OBESITY, V25, P1393, DOI 10.1038/sj.ijo.0801682; Labarthe F, 2008, CARDIOVASC DRUG THER, V22, P97, DOI 10.1007/s10557-008-6084-0; LEPAGE G, 1986, J LIPID RES, V27, P114; Li AC, 2004, J LIPID RES, V45, P2161, DOI 10.1194/jlr.R400010-JLR200; Li Y, 2008, NAT STRUCT MOL BIOL, V15, P865, DOI 10.1038/nsmb.1447; Li Y, 2008, J BIOL CHEM, V283, P19132, DOI 10.1074/jbc.M802040200; LOOKENE A, 1994, EUR J BIOCHEM, V222, P395, DOI 10.1111/j.1432-1033.1994.tb18878.x; Maier CS, 2005, METHOD ENZYMOL, V402, P312, DOI 10.1016/S0076-6879(05)02010-0; McKenna NJ, 2002, CELL, V108, P465, DOI 10.1016/S0092-8674(02)00641-4; MIYATA KS, 1994, GENE, V148, P327, DOI 10.1016/0378-1119(94)90707-2; Motani A, 2009, J MOL BIOL, V386, P1301, DOI 10.1016/j.jmb.2009.01.025; NAVAZA J, 1992, MOL REPLACEMENT, P87; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Oberfield JL, 1999, P NATL ACAD SCI USA, V96, P6102, DOI 10.1073/pnas.96.11.6102; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Oliveira MDR, 2008, NEUROSCI LETT, V434, P66, DOI 10.1016/j.neulet.2008.01.032; Schopfer FJ, 2005, P NATL ACAD SCI USA, V102, P2340, DOI 10.1073/pnas.0408384102; St-Onge MP, 2008, J AM COLL NUTR, V27, P547, DOI 10.1080/07315724.2008.10719737; St-Onge MP, 2008, AM J CLIN NUTR, V87, P621, DOI 10.1093/ajcn/87.3.621; St-Onge MP, 2003, INT J OBESITY, V27, P95, DOI 10.1038/sj.ijo.0802169; St-Onge MP, 2002, J NUTR, V132, P329; Su LL, 2010, ANN ACAD MED SINGAP, V39, P675; Sulistio MS, 2008, CURR ATHEROSCLER REP, V10, P134, DOI 10.1007/s11883-008-0020-4; Tsuji H, 2001, J NUTR, V131, P2853, DOI 10.1093/jn/131.11.2853; WAHLI W, 1995, CHEM BIOL, V2, P261, DOI 10.1016/1074-5521(95)90045-4; Waku T, 2009, J MOL BIOL, V385, P188, DOI 10.1016/j.jmb.2008.10.039; Weiss R, 2004, NEW ENGL J MED, V350, P2362, DOI 10.1056/NEJMoa031049; Xu HE, 2001, P NATL ACAD SCI USA, V98, P13919, DOI 10.1073/pnas.241410198	52	92	98	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					183	195		10.1074/jbc.M111.294785	http://dx.doi.org/10.1074/jbc.M111.294785			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22039047	hybrid, Green Published			2022-12-27	WOS:000298682400020
J	Rekdal, O; Haug, BE; Kalaaji, M; Hunter, HN; Lindin, I; Israelsson, I; Solstad, T; Yang, N; Brandl, M; Mantzilas, D; Vogel, HJ				Rekdal, Oystein; Haug, Bengt Erik; Kalaaji, Manar; Hunter, Howard N.; Lindin, Inger; Israelsson, Ingrid; Solstad, Terese; Yang, Nannan; Brandl, Martin; Mantzilas, Dimitrios; Vogel, Hans J.			Relative Spatial Positions of Tryptophan and Cationic Residues in Helical Membrane-active Peptides Determine Their Cytotoxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEGATIVELY CHARGED PHOSPHATIDYLSERINE; ENHANCED ANTITUMOR-ACTIVITY; AROMATIC-AMINO-ACIDS; CYCLOTIDE KALATA B1; ANTIMICROBIAL PEPTIDES; BOVINE LACTOFERRICIN; ANTIBACTERIAL ACTIVITY; CELL-LINES; ANTICANCER ACTIVITY; PROTEIN-STRUCTURE	The cytotoxic activity of 10 analogs of the idealized amphipathic helical 21-mer peptide (KAAKKAA)(3), where three of the Ala residues at different positions have been replaced with Trp residues, has been investigated. The peptide's cytotoxic activity was found to be markedly dependent upon the position of the Trp residues within the hydrophobic sector of an idealized alpha-helix. The peptides with Trp residues located opposite the cationic sector displayed no antitumor activity, whereas those peptides with two or three Trp residues located adjacent to the cationic sector exhibited high cytotoxic activity when tested against three different cancer cell lines. Dye release experiments revealed that in contrast to the peptides with Trp residues located opposite the cationic sector, the peptides with Trp residues located adjacent to the cationic sector induced a strong permeabilizing activity from liposomes composed of a mixture of zwitterionic phosphatidylcholine and negatively charged phosphatidylserine (1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC)/1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-L-serine (POPS)) (2:1) but not from liposomes composed of zwitterionic phosphatidylcholine, POPC. Fluorescence blue shift and quenching experiments revealed that Trp residues inserted deeper into the hydrophobic environment of POPC/POPS liposomes for peptides with high cytotoxic activity. Through circular dichroism studies, a correlation between the cytotoxic activity and the alpha-helical propensity was established. Structural studies of one inactive and two active peptides in the presence of micelles using NMR spectroscopy showed that only the active peptides adopted highly coiled to helical structures when bound to a membrane surface.	[Rekdal, Oystein; Kalaaji, Manar; Lindin, Inger; Israelsson, Ingrid; Solstad, Terese; Yang, Nannan] Univ Tromso, Fac Med, Inst Med Biol, NO-9037 Tromso, Norway; [Brandl, Martin] Univ Tromso, Dept Pharm, Drug Transport & Delivery Grp, NO-9037 Tromso, Norway; [Rekdal, Oystein] Lytix Biopharma AS, NO-9294 Tromso, Norway; [Haug, Bengt Erik] Univ Bergen, Ctr Pharm, NO-5007 Bergen, Norway; [Haug, Bengt Erik] Univ Bergen, Dept Chem, NO-5007 Bergen, Norway; [Hunter, Howard N.; Vogel, Hans J.] Univ Calgary, Dept Biol Sci, Biochem Res Grp, Calgary, AB T2N 1N4, Canada; [Brandl, Martin] Univ So Denmark, Dept Chem & Phys, DK-5230 Odense M, Denmark; [Mantzilas, Dimitrios] Univ Oslo, Dept Mol Biosci, NO-0316 Oslo, Norway	UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University of Bergen; University of Bergen; University of Calgary; University of Southern Denmark; University of Oslo	Rekdal, O (corresponding author), Univ Tromso, Fac Med, Inst Med Biol, NO-9037 Tromso, Norway.	oystein.rekdal@uit.no	Haug, Bengt Erik/O-1754-2015	Haug, Bengt Erik/0000-0003-3014-9538; Brandl, Martin/0000-0003-3561-5016	Research Council of Norway; Norwegian Cancer Society; Alberta Cancer Foundation; Alberta Heritage Foundation for Medical Research	Research Council of Norway(Research Council of Norway); Norwegian Cancer Society(Norwegian Cancer Society); Alberta Cancer Foundation; Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric)	This work was supported by operating grants from the Research Council of Norway and the Norwegian Cancer Society (to O. R.) and from the Alberta Cancer Foundation (to H. J. V.).; Recipient of a Scientist Award from the Alberta Heritage Foundation for Medical Research.	BAKER MA, 1993, CANCER RES, V53, P3052; Berge G, 2010, CANCER IMMUNOL IMMUN, V59, P1285, DOI 10.1007/s00262-010-0857-6; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHAKRABARTTY A, 1991, NATURE, V351, P586, DOI 10.1038/351586a0; Chan DI, 2006, BBA-BIOMEMBRANES, V1758, P1184, DOI 10.1016/j.bbamem.2006.04.006; CRUCIANI RA, 1991, P NATL ACAD SCI USA, V88, P3792, DOI 10.1073/pnas.88.9.3792; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; EIBL H, 1969, ANAL BIOCHEM, V30, P51, DOI 10.1016/0003-2697(69)90372-8; Eliassen LT, 2003, J PEPT SCI, V9, P510, DOI 10.1002/psc.472; Fadnes B, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-183; Fiedler S, 2010, CELL MOL LIFE SCI, V67, P1779, DOI 10.1007/s00018-010-0259-0; GANZ T, 1985, J CLIN INVEST, V76, P1427, DOI 10.1172/JCI112120; HABERMANN E, 1967, H-S Z PHYSIOL CHEM, V348, P37, DOI 10.1515/bchm2.1967.348.1.37; Haney EF, 2009, ANNU REP NMR SPECTRO, V65, P1, DOI 10.1016/S0066-4103(08)00201-9; Hansen T, 2010, J MED CHEM, V53, P595, DOI 10.1021/jm901052r; Haug BE, 2007, CURR MED CHEM, V14, P1, DOI 10.2174/092986707779313435; Haug BE, 2004, J MED CHEM, V47, P4159, DOI 10.1021/jm049582b; Haug BE, 2002, J PEPT SCI, V8, P307, DOI 10.1002/psc.404; Haug BE, 2001, J PEPT SCI, V7, P425, DOI 10.1002/psc.338; Haug BE, 2001, J PEPT SCI, V7, P190, DOI 10.1002/psc.318; Haug BE, 2008, J MED CHEM, V51, P4306, DOI 10.1021/jm701600a; Haug BE, 2007, BIOORG MED CHEM LETT, V17, P2361, DOI 10.1016/j.bmcl.2006.12.049; Henriques ST, 2011, J BIOL CHEM, V286, P24231, DOI 10.1074/jbc.M111.253393; HENRY GD, 1994, METHOD ENZYMOL, V239, P515; HIRAI Y, 1980, BIOMED RES-TOKYO, V1, P185, DOI 10.2220/biomedres.1.185; Hoskin DW, 2008, BBA-BIOMEMBRANES, V1778, P357, DOI 10.1016/j.bbamem.2007.11.008; HU W, 1993, BIOCHEMISTRY-US, V32, P7035, DOI 10.1021/bi00078a032; Huang YH, 2009, J BIOL CHEM, V284, P20699, DOI 10.1074/jbc.M109.003384; HWANG TL, 1995, J MAGN RESON SER A, V112, P275, DOI 10.1006/jmra.1995.1047; Iwasaki T, 2009, PEPTIDES, V30, P660, DOI 10.1016/j.peptides.2008.12.019; Javadpour MM, 1996, J MED CHEM, V39, P3107, DOI 10.1021/jm9509410; Jing W, 2003, J PEPT RES, V61, P219, DOI 10.1034/j.1399-3011.2003.00050.x; Johnstone SA, 2000, ANTI-CANCER DRUG DES, V15, P151; KACHEL K, 1995, BIOCHEMISTRY-US, V34, P15475, DOI 10.1021/bi00047a012; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Matsuzaki K, 1996, BIOCHEMISTRY-US, V35, P11361, DOI 10.1021/bi960016v; Matsuzaki K, 1998, BIOCHEMISTRY-US, V37, P15144, DOI 10.1021/bi9811617; MAYER LD, 1986, BIOCHIM BIOPHYS ACTA, V858, P161, DOI 10.1016/0005-2736(86)90302-0; MORRIS AL, 1992, PROTEINS, V12, P345, DOI 10.1002/prot.340120407; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nilges M, 1998, PROG NUCL MAG RES SP, V32, P107, DOI 10.1016/S0079-6565(97)00025-3; OHSAKI Y, 1992, CANCER RES, V52, P3534; Opella SJ, 1997, NAT STRUCT BIOL, V4, P845; PADMANABHAN S, 1990, NATURE, V344, P268, DOI 10.1038/344268a0; Papo N, 2005, CELL MOL LIFE SCI, V62, P784, DOI 10.1007/s00018-005-4560-2; Papo N, 2004, CANCER RES, V64, P5779, DOI 10.1158/0008-5472.CAN-04-1438; Papo N, 2006, CANCER RES, V66, P5371, DOI 10.1158/0008-5472.CAN-05-4569; Schibli DJ, 2006, BIOPHYS J, V91, P4413, DOI 10.1529/biophysj.106.085837; Schibli DJ, 1999, BIOCHEMISTRY-US, V38, P16749, DOI 10.1021/bi990701c; SCHOLTZ JM, 1991, BIOPOLYMERS, V31, P1463, DOI 10.1002/bip.360311304; Schroder-Borm H, 2005, FEBS LETT, V579, P6128, DOI 10.1016/j.febslet.2005.09.084; SELJELID R, 1986, BIOSCIENCE REP, V6, P845, DOI 10.1007/BF01117108; STEINER H, 1981, NATURE, V292, P246, DOI 10.1038/292246a0; Strom MB, 2000, J PEPT RES, V56, P265, DOI 10.1034/j.1399-3011.2000.00770.x; Strom MB, 2002, J PEPT SCI, V8, P36, DOI 10.1002/psc.365; Strom MB, 2002, J PEPT SCI, V8, P431, DOI 10.1002/psc.398; UTSUGI T, 1991, CANCER RES, V51, P3062; Vogel HJ, 2002, BIOCHEM CELL BIOL, V80, P49, DOI 10.1139/o01-213; WEI J, 1995, BIOCHEMISTRY-US, V34, P6408, DOI 10.1021/bi00019a021; Wieprecht T, 1999, J MOL BIOL, V294, P785, DOI 10.1006/jmbi.1999.3268; Wieprecht T, 1999, BIOCHEMISTRY-US, V38, P10377, DOI 10.1021/bi990913+; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010; Woody RW, 1996, CIRCULAR DICHROISM C, P109; Wuthrich K, 1986, NMR PROTEINS NUCL AC, P117; Yang N, 2002, J PEPT RES, V60, P187, DOI 10.1034/j.1399-3011.2002.21008.x; Yang N., 2003, THESIS U TROMSO TROM; Yang NN, 2003, J PEPT SCI, V9, P300, DOI 10.1002/psc.457; Yau WM, 1998, BIOCHEMISTRY-US, V37, P14713, DOI 10.1021/bi980809c; Zanetti M, 2004, J LEUKOCYTE BIOL, V75, P39, DOI 10.1189/jlb.0403147; ZASLOFF M, 1987, P NATL ACAD SCI USA, V84, P5449, DOI 10.1073/pnas.84.15.5449	71	41	44	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					233	244		10.1074/jbc.M111.279281	http://dx.doi.org/10.1074/jbc.M111.279281			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22057278	Green Published, hybrid			2022-12-27	WOS:000298682400024
J	Zhang, YJ; Shi, JM; Bai, CJ; Wang, H; Li, HY; Wu, Y; Ji, SR				Zhang, Yi-Jiong; Shi, Jing-Ming; Bai, Cai-Juan; Wang, Han; Li, Hai-Yun; Wu, Yi; Ji, Shang-Rong			Intra-membrane Oligomerization and Extra-membrane Oligomerization of Amyloid-beta Peptide Are Competing Processes as a Result of Distinct Patterns of Motif Interplay	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FORMS ION CHANNELS; ALZHEIMERS-DISEASE; SYNAPTIC PLASTICITY; LIPID MONOLAYERS; FIBRIL FORMATION; CELL-MEMBRANES; PATHOGENESIS; MECHANISM; INSERTION; FIBRILLOGENESIS	Soluble oligomers of amyloid-beta peptide (A beta) are emerging as the primary neurotoxic species in Alzheimer disease, however, whether the membrane is among their direct targets that mediate the downstream adverse effects remains elusive. Herein, we show that multiple soluble oligomeric A beta preparations, including A beta-derived diffusible ligand, protofibril, and zinc-induced A beta oligomer, exhibit much weaker capability to insert into the membrane than A beta monomer. A beta monomers prefer incorporating into membrane rather than oligomerizing in solution, and such preference can be reversed by the aggregation-boosting factor, zinc ion. Further analyses indicate that the membrane-embedded oligomers of A beta are derived from rapid assembly of inserted monomers but not due to the insertion of soluble A beta oligomers. By comparing the behavior of a panel of A beta truncation variants, we demonstrate that the intra- and extra-membrane oligomerization are mutually exclusive processes that proceed through distinct motif interplay, both of which require the action of amino acids 37-40/42 to overcome the auto-inhibitory interaction between amino acids 29-36 and the N-terminal portion albeit via different mechanisms. These results indicate that intra- and extra-membrane oligomerization of A beta are competing processes and emphasize a critical regulation of membrane on the behavior of A beta monomer and soluble oligomers, which may determine distinct neurotoxic mechanisms.	[Zhang, Yi-Jiong; Shi, Jing-Ming; Bai, Cai-Juan; Wang, Han; Li, Hai-Yun; Wu, Yi; Ji, Shang-Rong] Lanzhou Univ, Sch Life Sci, Lanzhou 730000, Peoples R China	Lanzhou University	Wu, Y (corresponding author), Lanzhou Univ, Sch Life Sci, Life Sci Bldg,Room 227, Lanzhou 730000, Peoples R China.	wuy@lzu.edu.cn; jsr@lzu.edu.cn	Shi, Jing-Ming/ACS-3321-2022	Shi, Jing-Ming/0000-0002-8185-3130; Ji, Shang-Rong/0000-0001-8595-3756; Wu, Yi/0000-0003-0365-5590	National Nature Science Foundation of China [30970605, 30930024]; Ministry of Education of China [20100211110006, 121108, 109155]; Ministry of Science and Technology of China [2011CB910500]; Lanzhou University [lzujbky-2012-k18, lzujbky-2010-k03]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Lanzhou University(Lanzhou University)	This work was supported by the National Nature Science Foundation of China (Grants 30970605 and 30930024), the Ministry of Education of China (Grants 20100211110006, 121108 and 109155), the Ministry of Science and Technology of China (Grant 2011CB910500), and Lanzhou University (Grants lzujbky-2012-k18 and lzujbky-2010-k03).	Ahmed M, 2010, NAT STRUCT MOL BIOL, V17, P561, DOI 10.1038/nsmb.1799; Ambroggio EE, 2005, BIOPHYS J, V88, P2706, DOI 10.1529/biophysj.104.055582; ARISPE N, 1993, P NATL ACAD SCI USA, V90, P567, DOI 10.1073/pnas.90.2.567; Axelsen PH, 2011, PHYSIOLOGY, V26, P54, DOI 10.1152/physiol.00024.2010; Bitan G, 2001, J BIOL CHEM, V276, P35176, DOI 10.1074/jbc.M102223200; BUSH AI, 1994, SCIENCE, V265, P1464, DOI 10.1126/science.8073293; Cisse M, 2011, NATURE, V469, P47, DOI 10.1038/nature09635; Citron M, 2010, NAT REV DRUG DISCOV, V9, P387, DOI 10.1038/nrd2896; Ege C, 2004, BIOPHYS J, V87, P1732, DOI 10.1529/biophysj.104.043265; Glabe CG, 2006, NEUROBIOL AGING, V27, P570, DOI 10.1016/j.neurobiolaging.2005.04.017; Golde TE, 2011, NEURON, V69, P203, DOI 10.1016/j.neuron.2011.01.002; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hampel H, 2010, NAT REV DRUG DISCOV, V9, P560, DOI 10.1038/nrd3115; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Hoyer W, 2008, P NATL ACAD SCI USA, V105, P5099, DOI 10.1073/pnas.0711731105; Jan A, 2010, NAT PROTOC, V5, P1186, DOI 10.1038/nprot.2010.72; Jang H, 2010, P NATL ACAD SCI USA, V107, P6538, DOI 10.1073/pnas.0914251107; Ji SR, 2009, FASEB J, V23, P1806, DOI 10.1096/fj.08-116962; Ji SR, 2002, J BIOL CHEM, V277, P6273, DOI 10.1074/jbc.M104146200; Jin M, 2011, P NATL ACAD SCI USA, V108, P5819, DOI 10.1073/pnas.1017033108; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Klajnert B, 2006, BIOCHEM BIOPH RES CO, V345, P21, DOI 10.1016/j.bbrc.2006.04.041; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Lin H, 2001, FASEB J, V15, P2433, DOI 10.1096/fj.01-0377com; Liu KN, 2006, ACTA NEUROPATHOL, V112, P163, DOI 10.1007/s00401-006-0077-5; Liu RQ, 2010, J BIOL CHEM, V285, P19986, DOI 10.1074/jbc.M109.036798; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; Marsh D, 1996, BBA-REV BIOMEMBRANES, V1286, P183, DOI 10.1016/S0304-4157(96)00009-3; Martins IC, 2008, EMBO J, V27, P224, DOI 10.1038/sj.emboj.7601953; Mason RP, 1996, BIOCHEM BIOPH RES CO, V222, P78, DOI 10.1006/bbrc.1996.0699; Millucci L, 2009, J BIOSCIENCES, V34, P293, DOI 10.1007/s12038-009-0033-3; Minicozzi V, 2008, J BIOL CHEM, V283, P10784, DOI 10.1074/jbc.M707109200; Nag S, 2011, J BIOL CHEM, V286, P13827, DOI 10.1074/jbc.M110.199885; Nag S, 2010, BIOPHYS J, V99, P1969, DOI 10.1016/j.bpj.2010.07.020; Paravastu AK, 2008, P NATL ACAD SCI USA, V105, P18349, DOI 10.1073/pnas.0806270105; Qi JS, 2001, NEUROSCIENCE, V105, P845, DOI 10.1016/S0306-4522(01)00244-5; Quist A, 2005, P NATL ACAD SCI USA, V102, P10427, DOI 10.1073/pnas.0502066102; SEELIG A, 1987, BIOCHIM BIOPHYS ACTA, V899, P196, DOI 10.1016/0005-2736(87)90400-7; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Sokolov Yuri, 2006, J Gen Physiol, V128, P637, DOI 10.1085/jgp.200609533; Stine WB, 2003, J BIOL CHEM, V278, P11612, DOI 10.1074/jbc.M210207200; Streltsov VA, 2011, J NEUROSCI, V31, P1419, DOI 10.1523/JNEUROSCI.4259-10.2011; Valincius G, 2008, BIOPHYS J, V95, P4845, DOI 10.1529/biophysj.108.130997; Walsh DM, 1999, J BIOL CHEM, V274, P25945, DOI 10.1074/jbc.274.36.25945; Yu LP, 2009, BIOCHEMISTRY-US, V48, P1870, DOI 10.1021/bi802046n; Zhang Lan Y. Y., 2010, ACTA BIOPHYS SIN, V26, P649	49	35	43	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					748	756		10.1074/jbc.M111.281295	http://dx.doi.org/10.1074/jbc.M111.281295			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22105077	hybrid, Green Published			2022-12-27	WOS:000298682400072
J	Henning, C; Smuda, M; Girndt, M; Ulrich, C; Glomb, MA				Henning, Christian; Smuda, Mareen; Girndt, Matthias; Ulrich, Christof; Glomb, Marcus A.			Molecular Basis of Maillard Amide-Advanced Glycation End Product (AGE) Formation in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSINE ACETYLATION; MASS-SPECTROMETRY; METHYLGLYOXAL; PROTEINS; 1-DEOXY-D-ERYTHRO-HEXO-2,3-DIULOSE; COMPLEXES; DIALYSIS; GLYOXAL; SYSTEMS; STRESS	The Maillard reaction in vivo entails alteration of proteins or free amino acids by non-enzymatic glycation or glycoxidation. The resulting modifications are called advanced glycation end products (AGEs) and play a prominent role in various pathologies, including normoglycemic uremia. Recently, we established a new class of lysine amide modifications in vitro. Now, human plasma levels of the novel amide-AGEs N-6-acetyl lysine, N-6-formyl lysine, N-6-lactoyl lysine, and N-6-glycerinyl lysine were determined by means of LC-MS/MS. They were significantly higher in uremic patients undergoing hemodialysis than in healthy subjects. Model reactions with N-1-t-butoxycarbonyllysine under physiological conditions confirmed 1-deoxy-D-erythro-hexo-2,3-diulose as an immediate precursor. Because formation of N-6-formyl lysine from glucose responded considerably to the presence of oxygen, glucosone was identified as another precursor. Comparison of the in vivo results with the model experiments enabled us to elucidate possible formation pathways linked to Maillard chemistry. The results strongly suggest a major participation of non-enzymatic Maillard mechanisms on amide-AGE formation pathways in vivo, which, in the case of N-6-acetyl lysine, parallels enzymatic processes.	[Henning, Christian; Smuda, Mareen; Glomb, Marcus A.] Univ Halle Wittenberg, Inst Chem, D-06120 Halle, Germany; [Girndt, Matthias; Ulrich, Christof] Univ Halle Wittenberg, Dept Internal Med 2, D-06120 Halle, Germany	Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg	Glomb, MA (corresponding author), Kurt Mothes Str 2, D-06120 Halle, Germany.	marcus.glomb@chemie.uni-halle.de	Girndt, Matthias/M-1436-2019	Girndt, Matthias/0000-0003-2823-0847				Agalou S, 2005, ANN NY ACAD SCI, V1043, P734, DOI 10.1196/annals.1333.085; Ahmed MU, 1997, BIOCHEM J, V324, P565, DOI 10.1042/bj3240565; ALLFREY VG, 1964, P NATL ACAD SCI USA, V51, P786, DOI 10.1073/pnas.51.5.786; Bayne S, 1963, METHODS CARBOHYDR CH, P421; Cai HL, 2000, CHEM RES TOXICOL, V13, P327, DOI 10.1021/tx000003p; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Dawnay A, 1998, CELL MOL BIOL, V44, P1081; Friedlander MA, 1996, J CLIN INVEST, V97, P728, DOI 10.1172/JCI118471; Glomb MA, 2001, J AGR FOOD CHEM, V49, P5543, DOI 10.1021/jf010148h; Glomb MA, 2000, CARBOHYD RES, V329, P515, DOI 10.1016/S0008-6215(00)00219-6; GLOMB MA, 1995, J BIOL CHEM, V270, P10017, DOI 10.1074/jbc.270.17.10017; Glomb MA, 2001, J BIOL CHEM, V276, P41638, DOI 10.1074/jbc.M103557200; Gobert J, 2009, J AGR FOOD CHEM, V57, P8591, DOI 10.1021/jf9019085; Hasenkopf K, 2002, J AGR FOOD CHEM, V50, P5697, DOI 10.1021/jf020411u; Jiang T, 2007, P NATL ACAD SCI USA, V104, P60, DOI 10.1073/pnas.0606775103; Kouzarides T, 2000, EMBO J, V19, P1176, DOI 10.1093/emboj/19.6.1176; Lapolla A, 2005, MOL NUTR FOOD RES, V49, P685, DOI 10.1002/mnfr.200400093; Lee KK, 2007, NAT REV MOL CELL BIO, V8, P284, DOI 10.1038/nrm2145; LO TWC, 1994, BIOCHEM PHARMACOL, V48, P1865, DOI 10.1016/0006-2952(94)90584-3; MADSON MA, 1981, CARBOHYD RES, V94, P183, DOI 10.1016/S0008-6215(00)80716-8; Massari J, 2010, CHEM RES TOXICOL, V23, P1762, DOI 10.1021/tx1002244; Materials Testing Standards Committee NA 062 of the Deutsches Institut fur Normung (German Institute for Standardization), 1994, 32645 DIN MAT TEST S; MCLELLAN AC, 1992, ANAL BIOCHEM, V206, P17, DOI 10.1016/S0003-2697(05)80005-3; Mirza MA, 2007, ELECTROPHORESIS, V28, P3940, DOI 10.1002/elps.200700129; Miyata T, 1999, KIDNEY INT, V55, P389, DOI 10.1046/j.1523-1755.1999.00302.x; Odani H, 1999, BIOCHEM BIOPH RES CO, V256, P89, DOI 10.1006/bbrc.1999.0221; Piraud M, 2005, RAPID COMMUN MASS SP, V19, P1587, DOI 10.1002/rcm.1957; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; Smuda M, 2010, J AGR FOOD CHEM, V58, P6458, DOI 10.1021/jf100334r; Thornalley PJ, 2005, PEDIATR NEPHROL, V20, P1515, DOI 10.1007/s00467-005-2011-9; Tsutsui H, 2010, J PROTEOME RES, V9, P3912, DOI 10.1021/pr100121k; Yang XJ, 2004, BIOESSAYS, V26, P1076, DOI 10.1002/bies.20104	32	36	36	0	44	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2011	286	52					44350	44356		10.1074/jbc.M111.282442	http://dx.doi.org/10.1074/jbc.M111.282442			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870CA	22069309	hybrid, Green Published			2022-12-27	WOS:000298645500007
J	Noren Hooten, N; Kompaniez, K; Barnes, J; Lohani, A; Evans, MK				Noren Hooten, Nicole; Kompaniez, Kari; Barnes, Janice; Lohani, Althaf; Evans, Michele K.			Poly(ADP-ribose) Polymerase 1 (PARP-1) Binds to 8-Oxoguanine-DNA Glycosylase (OGG1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASE-EXCISION-REPAIR; DNA-DAMAGE; GENETIC POLYMORPHISMS; OXIDATIVE DAMAGE; HUMAN HOMOLOG; CANCER; CLONING; CELLS; HOGG1; 8-HYDROXYGUANINE	Human 8-oxoguanine-DNA glycosylase (OGG1) plays a major role in the base excision repair pathway by removing 8-oxoguanine base lesions generated by reactive oxygen species. Here we report a novel interaction between OGG1 and Poly( ADP-ribose) polymerase 1 (PARP-1), a DNA-damage sensor protein involved in DNA repair and many other cellular processes. We found that OGG1 binds directly to PARP-1 through the N-terminal region of OGG1, and this interaction is enhanced by oxidative stress. Furthermore, OGG1 binds to PARP-1 through its BRCA1 C-terminal (BRCT) domain. OGG1 stimulated the poly(ADP-ribosyl)ation activity of PARP-1, whereas decreased poly(ADP-ribose) levels were observed in OGG1(-/-) cells compared with wild-type cells in response to DNA damage. Importantly, activated PARP-1 inhibits OGG1. Although the OGG1 polymorphic variant proteins R229Q and S326C bind to PARP-1, these proteins were defective in activating PARP-1. Furthermore, OGG1(-/-) cells were more sensitive to PARP inhibitors alone or in combination with a DNA-damaging agent. These findings indicate that OGG1 binding to PARP-1 plays a functional role in the repair of oxidative DNA damage.	[Noren Hooten, Nicole; Kompaniez, Kari; Barnes, Janice; Lohani, Althaf; Evans, Michele K.] NIA, Lab Mol Biol & Immunol, NIH, 251 Bayview Bld, Baltimore, MD 21224 USA; [Evans, Michele K.] NIA, Clin Res Branch, NIH, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Evans, MK (corresponding author), NIA, Lab Mol Biol & Immunol, NIH, 251 Bayview Bld, Baltimore, MD 21224 USA.	me42v@nih.gov	Noren Hooten, Nicole/J-5498-2019; Evans, Michele Kim/AAE-4776-2019	Noren Hooten, Nicole/0000-0002-1683-3838; Evans, Michele/0000-0002-8546-2831	National Institutes of Health National Institute on Aging (NIA); NATIONAL INSTITUTE ON AGING [ZIAAG000517] Funding Source: NIH RePORTER	National Institutes of Health National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institutes of Health National Institute on Aging, Intramural Research Program (NIA).	Aburatani H, 1997, CANCER RES, V57, P2151; Ame Jean-Christophe, 2008, V464, P267; Arai K, 1997, ONCOGENE, V14, P2857, DOI 10.1038/sj.onc.1201139; Audebert M, 2000, CANCER RES, V60, P4740; Barja G, 2004, TRENDS NEUROSCI, V27, P595, DOI 10.1016/j.tins.2004.07.005; Barnes DE, 2004, ANNU REV GENET, V38, P445, DOI 10.1146/annurev.genet.38.072902.092448; Bhakat KK, 2006, MOL CELL BIOL, V26, P1654, DOI 10.1128/MCB.26.5.1654-1665.2006; BOS JL, 1989, CANCER RES, V49, P4682; Burkle A, 2006, FREE RADICAL RES, V40, P1295, DOI 10.1080/10715760600915288; Cadet J, 1997, Rev Physiol Biochem Pharmacol, V131, P1; Conlon KA, 2003, DNA REPAIR, V2, P1337, DOI 10.1016/j.dnarep.2003.08.002; D'Errico M, 2006, EMBO J, V25, P4305, DOI 10.1038/sj.emboj.7601277; David SS, 2007, NATURE, V447, P941, DOI 10.1038/nature05978; de Souza-Pinto NC, 2009, MOL CELL BIOL, V29, P4441, DOI 10.1128/MCB.00265-09; deMurcia JM, 1997, P NATL ACAD SCI USA, V94, P7303, DOI 10.1073/pnas.94.14.7303; Dherin C, 1999, NUCLEIC ACIDS RES, V27, P4001, DOI 10.1093/nar/27.20.4001; DIZDAROGLU M, 1991, FREE RADICAL BIO MED, V10, P225, DOI 10.1016/0891-5849(91)90080-M; Goode EL, 2002, CANCER EPIDEM BIOMAR, V11, P1513; Hagiwara A, 2005, ONCOL REP, V13, P1009; Hamilton ML, 2001, P NATL ACAD SCI USA, V98, P10469, DOI 10.1073/pnas.171202698; Harris JL, 2009, HUM MOL GENET, V18, P4102, DOI 10.1093/hmg/ddp359; Hegde ML, 2008, CELL RES, V18, P27, DOI 10.1038/cr.2008.8; Hill JW, 2007, CANCER DETECT PREV, V31, P237, DOI 10.1016/j.cdp.2007.05.001; Hill JW, 2006, NUCLEIC ACIDS RES, V34, P1620, DOI 10.1093/nar/gkl060; Hill JW, 2001, NUCLEIC ACIDS RES, V29, P430, DOI 10.1093/nar/29.2.430; Hung RJ, 2005, AM J EPIDEMIOL, V162, P925, DOI 10.1093/aje/kwi318; Kohno T, 1998, ONCOGENE, V16, P3219, DOI 10.1038/sj.onc.1201872; Kumaravel TS, 2006, MUTAT RES-GEN TOX EN, V605, P7, DOI 10.1016/j.mrgentox.2006.03.002; Lu RZ, 1997, CURR BIOL, V7, P397, DOI 10.1016/S0960-9822(06)00187-4; Mao GG, 2007, NUCLEIC ACIDS RES, V35, P2759, DOI 10.1093/nar/gkm189; Marsin S, 2003, J BIOL CHEM, V278, P44068, DOI 10.1074/jbc.M306160200; Masson M, 1998, MOL CELL BIOL, V18, P3563, DOI 10.1128/MCB.18.6.3563; Masutani M, 1999, P NATL ACAD SCI USA, V96, P2301, DOI 10.1073/pnas.96.5.2301; Noren NK, 2006, NAT CELL BIOL, V8, P815, DOI 10.1038/ncb1438; Nyaga SG, 2008, BIOCHEM BIOPH RES CO, V376, P336, DOI 10.1016/j.bbrc.2008.08.134; OLIVE PL, 1990, RADIAT RES, V122, P86, DOI 10.2307/3577587; Park MJ, 2009, DNA REPAIR, V8, P1190, DOI 10.1016/j.dnarep.2009.06.004; Radicella JP, 1997, P NATL ACAD SCI USA, V94, P8010, DOI 10.1073/pnas.94.15.8010; RoldanArjona T, 1997, P NATL ACAD SCI USA, V94, P8016, DOI 10.1073/pnas.94.15.8016; Rosenquist TA, 1997, P NATL ACAD SCI USA, V94, P7429, DOI 10.1073/pnas.94.14.7429; Rouleau M, 2010, NAT REV CANCER, V10, P293, DOI 10.1038/nrc2812; Sakumi K, 2003, CANCER RES, V63, P902; Saxowsky TT, 2008, P NATL ACAD SCI USA, V105, P18877, DOI 10.1073/pnas.0806464105; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; SHIBUTANI S, 1991, NATURE, V349, P431, DOI 10.1038/349431a0; Sidorenko VS, 2008, MOL BIOL+, V42, P794, DOI 10.1134/S0026893308050166; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Sung JS, 2006, FEBS J, V273, P1620, DOI 10.1111/j.1742-4658.2006.05192.x; Trzeciak AR, 2008, FREE RADICAL BIO MED, V45, P1631, DOI 10.1016/j.freeradbiomed.2008.08.031; von Kobbe C, 2003, MOL CELL BIOL, V23, P8601, DOI 10.1128/MCB.23.23.8601-8613.2003; Wang ZL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000951; Wang ZQ, 1997, GENE DEV, V11, P2347, DOI 10.1101/gad.11.18.2347; WARD JF, 1987, BR J CANC S, V8, P105; Weiss JM, 2005, MOL CARCINOGEN, V42, P127, DOI 10.1002/mc.20067; Wikman H, 2000, INT J CANCER, V88, P932, DOI 10.1002/1097-0215(20001215)88:6<932::AID-IJC15>3.0.CO;2-P; Wilson DM, 2011, MUTAT RES-FUND MOL M, V711, P100, DOI 10.1016/j.mrfmmm.2010.12.004; Xie YL, 2008, CARCINOGENESIS, V29, P722, DOI 10.1093/carcin/bgn033; Xie YL, 2004, CANCER RES, V64, P3096, DOI 10.1158/0008-5472.CAN-03-3834; Yamane A, 2004, CARCINOGENESIS, V25, P1689, DOI 10.1093/carcin/bgh166; Zaremba T, 2007, ANTI-CANCER AGENT ME, V7, P515, DOI 10.2174/187152007781668715	60	85	86	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2011	286	52					44679	44690		10.1074/jbc.M111.255869	http://dx.doi.org/10.1074/jbc.M111.255869			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870CA	22057269	Green Published, hybrid			2022-12-27	WOS:000298645500038
J	Yang, X; Yu, RH; Calmettes, C; Moraes, TF; Schryvers, AB				Yang, Xue; Yu, Rong-hua; Calmettes, Charles; Moraes, Trevor F.; Schryvers, Anthony B.			Anchor Peptide of Transferrin-binding Protein B Is Required for Interaction with Transferrin-binding Protein A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEISSERIA-MENINGITIDIS; BACTERIAL TRANSFERRIN; ACTINOBACILLUS-PLEUROPNEUMONIAE; HAEMOPHILUS-INFLUENZAE; RECEPTOR PROTEIN; C-LOBE; IRON; GENES; IDENTIFICATION; PATHOGENS	Gram-negative bacterial pathogens belonging to the Pasteurellaceae, Moraxellaceae, and Neisseriaceae families rely on an iron acquisition system that acquires iron directly from host transferrin (Tf). The process is mediated by a surface receptor composed of transferrin-binding proteins A and B (TbpA and TbpB). TbpA is an integral outer membrane protein that functions as a gated channel for the passage of iron into the periplasm. TbpB is a surface-exposed lipoprotein that facilitates the iron uptake process. In this study, we demonstrate that the region encompassing amino acids 7-40 of Actinobacillus pleuropneumoniae TbpB is required for forming a complex with TbpA and that the formation of the complex requires the presence of porcine Tf. These results are consistent with a model in which TbpB is responsible for the initial capture of iron-loaded Tf and subsequently interacts with TbpA through the anchor peptide. We propose that TonB binding to TbpA initiates the formation of the TbpB-TbpA complex and transfer of Tf to TbpA.	[Yang, Xue; Yu, Rong-hua; Schryvers, Anthony B.] Univ Calgary, Dept Microbiol & Infect Dis, Calgary, AB T2N 4N1, Canada; [Calmettes, Charles; Moraes, Trevor F.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A1, Canada	University of Calgary; University of Toronto	Schryvers, AB (corresponding author), G503A Hlth Sci Ctr,3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.	schryver@ucalgary.ca	Schryvers, Anthony B./AAF-3417-2020	calmettes, charles/0000-0002-2542-4382	Canadian Institutes of Health Research [49603]; Alberta Innovates Health Solutions	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Innovates Health Solutions	This work was supported by Grant 49603 from the Canadian Institutes of Health Research and by a Team Program grant from Alberta Innovates Health Solutions.	ALCANTARA J, 1993, MOL MICROBIOL, V8, P1135, DOI 10.1111/j.1365-2958.1993.tb01658.x; ANDERSON JE, 1994, J BACTERIOL, V176, P3162, DOI 10.1128/jb.176.11.3162-3170.1994; Baltes N, 2002, FEMS MICROBIOL LETT, V209, P283, DOI 10.1111/j.1574-6968.2002.tb11145.x; Calmettes C, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.206102; Cornelissen CN, 1996, J BACTERIOL, V178, P1437, DOI 10.1128/jb.178.5.1437-1444.1996; Cornelissen CN, 1997, MOL MICROBIOL, V26, P25, DOI 10.1046/j.1365-2958.1997.5381914.x; DeRocco AJ, 2009, BIOMETALS, V22, P439, DOI 10.1007/s10534-008-9179-y; DeWinter L. M., 2002, MENINGOCOCCAL VACCIN, P109; GRAYOWEN SD, 1995, INFECT IMMUN, V63, P1201, DOI 10.1128/IAI.63.4.1201-1210.1995; GRAYOWEN SD, 1995, INFECT IMMUN, V63, P3809, DOI 10.1128/IAI.63.10.3809-3815.1995; GRAYOWEN SD, 1993, MICROB PATHOGENESIS, V14, P389, DOI 10.1006/mpat.1993.1038; GrayOwen SD, 1996, TRENDS MICROBIOL, V4, P185, DOI 10.1016/0966-842X(96)10025-1; IRWIN SW, 1993, MOL MICROBIOL, V8, P1125, DOI 10.1111/j.1365-2958.1993.tb01657.x; Krell T, 2003, J BIOL CHEM, V278, P14712, DOI 10.1074/jbc.M204461200; Ling JML, 2010, MOL MICROBIOL, V77, P1301, DOI 10.1111/j.1365-2958.2010.07289.x; Luke NR, 1999, INFECT IMMUN, V67, P5815, DOI 10.1128/IAI.67.11.5815-5819.1999; MacGillivray RTA, 1998, BIOCHEMISTRY-US, V37, P7919, DOI 10.1021/bi980355j; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Moraes TF, 2009, MOL CELL, V35, P523, DOI 10.1016/j.molcel.2009.06.029; Nemish U, 2003, BIOCHEM CELL BIOL, V81, P275, DOI 10.1139/O03-057; Powell NBL, 1998, J MED MICROBIOL, V47, P257, DOI 10.1099/00222615-47-3-257; Retzer MD, 1998, MICROB PATHOGENESIS, V25, P175, DOI 10.1006/mpat.1998.0226; SCHRYVERS AB, 1990, CAN J MICROBIOL, V36, P145, DOI 10.1139/m90-026; Schryvers AB, 1999, MOL MICROBIOL, V32, P1117, DOI 10.1046/j.1365-2958.1999.01411.x; SCHRYVERS AB, 1988, INFECT IMMUN, V56, P1144, DOI 10.1128/IAI.56.5.1144-1149.1988; Silva LP, 2011, J BIOL CHEM, V286, P21353, DOI 10.1074/jbc.M111.226449; Stojiljkovic I, 1997, J BACTERIOL, V179, P805, DOI 10.1128/jb.179.3.805-812.1997; Wong H, 2003, MICROBIOL-SGM, V149, P1729, DOI 10.1099/mic.0.26281-0; YU RH, 1993, MICROB PATHOGENESIS, V15, P433, DOI 10.1006/mpat.1993.1092	29	19	19	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2011	286	52					45165	45173		10.1074/jbc.M110.214171	http://dx.doi.org/10.1074/jbc.M110.214171			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870CA	22069313	hybrid, Green Published			2022-12-27	WOS:000298645500082
J	Khanna, M; Chen, CH; Kimble-Hill, A; Parajuli, B; Perez-Miller, S; Baskaran, S; Kim, J; Dria, K; Vasiliou, V; Mochly-Rosen, D; Hurley, TD				Khanna, May; Chen, Che-Hong; Kimble-Hill, Ann; Parajuli, Bibek; Perez-Miller, Samantha; Baskaran, Sulochanadevi; Kim, Jeewon; Dria, Karl; Vasiliou, Vasilis; Mochly-Rosen, Daria; Hurley, Thomas D.			Discovery of a Novel Class of Covalent Inhibitor for Aldehyde Dehydrogenases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P-HYDROXYACETOPHENONE-SEPHAROSE; ACTIVITY-BASED PROBES; ALCOHOL-DEHYDROGENASE; ESCHERICHIA-COLI; ACTIVATION; GENE; CYCLOPHOSPHAMIDE; IDENTIFICATION; DETOXIFICATION; PURIFICATION	Human aldehyde dehydrogenases (ALDHs) comprise a family of 17 homologous enzymes that metabolize different biogenic and exogenic aldehydes. To date, there are relatively few general ALDH inhibitors that can be used to probe the contribution of this class of enzymes to particular metabolic pathways. Here, we report the discovery of a general class of ALDH inhibitors with a common mechanism of action. The combined data from kinetic studies, mass spectrometric measurements, and crystallographic analyses demonstrate that these inhibitors undergo an enzyme-mediated beta-elimination reaction generating a vinyl ketone intermediate that covalently modifies the active site cysteine residue present in these enzymes. The studies described here can provide the basis for rational approach to design ALDH isoenzyme-specific inhibitors as research tools and perhaps as drugs, to address diseases such as cancer where increased ALDH activity is associated with a cellular phenotype.	[Khanna, May; Kimble-Hill, Ann; Parajuli, Bibek; Perez-Miller, Samantha; Baskaran, Sulochanadevi; Hurley, Thomas D.] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Chen, Che-Hong; Mochly-Rosen, Daria] Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA; [Kim, Jeewon] Stanford Univ, Sch Med, Ctr Comprehens Canc, Stanford, CA 94305 USA; [Kim, Jeewon] Stanford Univ, Sch Med, Transgen Mouse Res Ctr, Stanford, CA 94305 USA; [Dria, Karl] Indiana Univ Purdue Univ, Dept Chem & Chem Biol, Indianapolis, IN 46202 USA; [Vasiliou, Vasilis] Univ Colorado Denver, Dept Pharmaceut Sci, Mol Toxicol & Environm Hlth Sci Program, Aurora, CO 80045 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Stanford University; Stanford University; Stanford University; Indiana University System; Indiana University-Purdue University Indianapolis; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Hurley, TD (corresponding author), Indiana Univ, Sch Med, Dept Biochem & Mol Biol, 635 Barnhill Dr, Indianapolis, IN 46202 USA.	thurley@iupui.edu		Mochly-Rosen, Daria/0000-0002-6691-8733; Kimble-Hill, Ann/0000-0001-9575-5454; Kim, Jeewon/0000-0002-1063-0239; Khanna, May/0000-0002-9989-6374; vasiliou, vasilis/0000-0003-2552-3118; HURLEY, THOMAS/0000-0002-5942-1163; Perez-Miller, Samantha/0000-0002-9034-3693	National Institutes of Health [R01-AA018123, R21-AA019746, R01-AA018123-S1, R01-AA11147, EY11490]; National Science Foundation [0821661]; NCI [Y1-CO-1020]; NIGMS, National Institutes of Health [Y1-GM-1104]; U.S. Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027281] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY011490, R29EY011490] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA018123, R37AA011147, R01AA011147, R21AA019746] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); U.S. Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-AA018123 and R21-AA019746 (to T. D. H.), R01-AA018123-S1 (to A. K.-H.), R01-AA11147 (to D. M.-R.) and EY11490 (V. V.). The mass spectrometry work was supported by National Science Foundation MRI Grant 0821661. General Medical/CAncer Collaborative Access Team was supported in whole or in part by NCI Grant Y1-CO-1020 and NIGMS Grant Y1-GM-1104, National Institutes of Health, at the Advanced Photon Source. Argonne is operated by UChicago Argonne, LLC, for the U.S. Department of Energy, Office of Biological and Environmental Research under Contract DE-AC02-06CH11357. Daria Mochly-Rosen is the founder and a shareholder of KAI Pharmaceuticals. However, none of the work described in this study is based on or supported by the company. Che-Hong Chen and Daria Mochly-Rosen are listed as inventors in pending patents filed by Stanford University that are related to this work.	ALDRIDGE WN, 1972, ENZYME INHIBITORS SU, P1; Allali-Hassani A, 2001, CHEM-BIOL INTERACT, V130, P125, DOI 10.1016/S0009-2797(00)00228-3; Arolfo MP, 2009, ALCOHOL CLIN EXP RES, V33, P1935, DOI 10.1111/j.1530-0277.2009.01031.x; Ascenzi P, 2001, CURR PROTEIN PEPT SC, V2, P137, DOI 10.2174/1389203013381170; Berger AB, 2006, MOL CELL, V23, P509, DOI 10.1016/j.molcel.2006.06.021; Black William, 2009, Human Genomics, V4, P136; BOSRON WF, 1986, BIOCHEMISTRY-US, V25, P1876, DOI 10.1021/bi00356a006; Budas GR, 2010, J MOL CELL CARDIOL, V48, P757, DOI 10.1016/j.yjmcc.2009.10.030; Chen CH, 2008, SCIENCE, V321, P1493, DOI 10.1126/science.1158554; Cheriyan J, 2009, BRIT J CLIN PHARMACO, V68, P518, DOI 10.1111/j.1365-2125.2009.03475.x; Churchill EN, 2009, J MOL CELL CARDIOL, V46, P278, DOI 10.1016/j.yjmcc.2008.09.713; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FARRES J, 1995, BIOCHEMISTRY-US, V34, P2592, DOI 10.1021/bi00008a025; Geoghegan KF, 1999, ANAL BIOCHEM, V267, P169, DOI 10.1006/abio.1998.2990; GHENBOT G, 1992, PROTEIN EXPRES PURIF, V3, P470, DOI 10.1016/1046-5928(92)90064-4; Harada S, 1999, ALCOHOL CLIN EXP RES, V23, P958, DOI 10.1111/j.1530-0277.1999.tb04212.x; HILTON J, 1984, CANCER RES, V44, P5156; JENG JJ, 1991, ARCH BIOCHEM BIOPHYS, V289, P214, DOI 10.1016/0003-9861(91)90464-T; Kumar S, 2004, P NATL ACAD SCI USA, V101, P7943, DOI 10.1073/pnas.0402323101; MANTHEY CL, 1990, CANCER RES, V50, P4991; Marcato P, 2011, STEM CELLS, V29, P32, DOI 10.1002/stem.563; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Moreb JS, 2007, CANCER CHEMOTH PHARM, V59, P127, DOI 10.1007/s00280-006-0233-6; Negoro M, 2005, ALCOHOL CLIN EXP RES, V29, p304S, DOI 10.1097/01.alc.0000191811.06936.04; Ni L, 1997, J BIOL CHEM, V272, P18823, DOI 10.1074/jbc.272.30.18823; Overstreet DH, 2009, PHARMACOL BIOCHEM BE, V94, P255, DOI 10.1016/j.pbb.2009.09.004; Parajuli B, 2011, CHEM-BIOL INTERACT, V191, P153, DOI 10.1016/j.cbi.2011.02.018; Perez-Miller S, 2010, NAT STRUCT MOL BIOL, V17, P159, DOI 10.1038/nsmb.1737; Perez-Miller SJ, 2003, BIOCHEMISTRY-US, V42, P7100, DOI 10.1021/bi034182w; Sladek NE, 2003, J BIOCHEM MOL TOXIC, V17, P7, DOI 10.1002/jbt.10057; Sreerama L, 1997, CLIN CANCER RES, V3, P1901; Vasiliou V, 2000, PHARMACOLOGY, V61, P192, DOI 10.1159/000028400; Vasiliou Vasilis, 2005, Human Genomics, V2, P138; VONEITZEN U, 1994, CANCER LETT, V76, P45, DOI 10.1016/0304-3835(94)90132-5; Yao LN, 2010, NAT MED, V16, P1024, DOI 10.1038/nm.2200	35	53	56	3	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					43486	43494		10.1074/jbc.M111.293597	http://dx.doi.org/10.1074/jbc.M111.293597			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22021038	Green Published, hybrid			2022-12-27	WOS:000298351300068
J	Singarapu, KK; Tonelli, M; Chow, DC; Frederick, RO; Westler, WM; Markley, JL				Singarapu, Kiran K.; Tonelli, Marco; Chow, Darius C.; Frederick, Ronnie O.; Westler, William M.; Markley, John L.			Structural Characterization of Hsp12, the Heat Shock Protein from Saccharomyces cerevisiae, in Aqueous Solution Where It Is Intrinsically Disordered and in Detergent Micelles Where It Is Locally alpha-Helical	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEA-LIKE PROTEIN; TREHALOSE; GENE; SPECTROSCOPY; DESICCATION; TOLERANCE; PROGRAM; STRESS; CELLS	Hsp12 (heat shock protein 12) belongs to the small heat shock protein family, partially characterized as a stress response, stationary phase entry, late embryonic abundant-like protein located at the plasma membrane to protect membrane from desiccation. Here, we report the structural characterization of Hsp12 by NMR and biophysical techniques. The protein was labeled uniformly with nitrogen-15 and carbon-13 so that its conformation could be determined in detail both in aqueous solution and in two membrane-mimetic environments, SDS and dodecylphosphocholine (DPC) micelles. Secondary structural elements determined from assigned chemical shifts indicated that Hsp12 is dynamically disordered in aqueous solution, whereas it gains four helical stretches in the presence of SDS micelles and a single helix in presence of DPC. These conclusions were reinforced by circular dichroism spectra of the protein in all three environments. The lack of long range interactions in NOESY spectra indicated that the helices present in SDS micelles do not pack together. R-1 and R-2, relaxation and heteronuclear NOE measurements showed that the protein is disordered in aqueous solution but becomes more ordered in presence of detergent micelles. NMR spectra collected in presence of paramagnetic spin relaxation agents (5DSA, 16DSA, and Gd(DTPA-BMA)) indicated that the amphipathic alpha-helices of Hsp12 in SDS micelles lie on the membrane surface. These observations are in agreement with studies suggesting that Hsp12 functions to protect the membrane from desiccation.	[Singarapu, Kiran K.; Tonelli, Marco; Westler, William M.; Markley, John L.] Univ Wisconsin, Natl Magnet Resonance Facil Madison, Madison, WI 53705 USA; [Chow, Darius C.; Frederick, Ronnie O.; Markley, John L.] Univ Wisconsin, Ctr Eukaryot Struct Gen, Dept Biochem, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Markley, JL (corresponding author), 433 Babcock Dr, Madison, WI 53706 USA.	markley@nmrfam.wisc.edu	Singarapu, Kiran/AAU-3435-2020		National Institutes of Health [P41 RR02301, P41 GM66326, 1U54 GM074901]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR002301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM074901, P41GM066326] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants P41 RR02301, P41 GM66326, and 1U54 GM074901 (to J. L. M.).	Bahrami A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000307; BARTELS C, 1995, J BIOMOL NMR, V6, P1, DOI 10.1007/BF00417486; Bhattacharya A, 2007, PROTEINS, V66, P778, DOI 10.1002/prot.21165; CRAIG EA, 1993, SCIENCE, V260, P1902, DOI 10.1126/science.8100364; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; FARROW NA, 1995, BIOCHEMISTRY-US, V34, P868, DOI 10.1021/bi00003a021; Guntert Peter, 2004, Methods Mol Biol, V278, P353; HENDRICK JP, 1993, ANNU REV BIOCHEM, V62, P349, DOI 10.1146/annurev.bi.62.070193.002025; Hilty C, 2004, CHEMBIOCHEM, V5, P467, DOI 10.1002/cbic.200300815; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; Martin J, 1997, CURR OPIN STRUC BIOL, V7, P41, DOI 10.1016/S0959-440X(97)80006-1; Motshwene P, 2004, BIOCHEM J, V377, P769, DOI 10.1042/bj20031301; Mtwisha L, 1998, PLANT MOL BIOL, V37, P513, DOI 10.1023/A:1005904219201; Pacheco A, 2009, MICROBIOL-SGM, V155, P2021, DOI 10.1099/mic.0.025981-0; Park JI, 1997, APPL ENVIRON MICROB, V63, P3818, DOI 10.1128/AEM.63.10.3818-3824.1997; PRAEKELT UM, 1990, MOL GEN GENET, V223, P97, DOI 10.1007/BF00315801; Sales K, 2000, BBA-BIOMEMBRANES, V1463, P267, DOI 10.1016/S0005-2736(99)00215-1; Sano F, 1999, CRYOBIOLOGY, V39, P80, DOI 10.1006/cryo.1999.2188; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Schade B, 2004, MOL BIOL CELL, V15, P5492, DOI 10.1091/mbc.E04-03-0167; SCHLESINGER MJ, 1990, J BIOL CHEM, V265, P12111; Shamrock VJ, 2008, CAN J MICROBIOL, V54, P559, DOI [10.1139/W08-044, 10.1139/w08-044]; Sharma SC, 1997, FEMS MICROBIOL LETT, V152, P11, DOI 10.1111/j.1574-6968.1997.tb10402.x; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; STONE RL, 1990, GENE, V96, P171, DOI 10.1016/0378-1119(90)90249-Q; TISSIERES A, 1974, J MOL BIOL, V84, P389, DOI 10.1016/0022-2836(74)90447-1; Tyler RC, 2005, PROTEIN EXPRES PURIF, V40, P268, DOI 10.1016/j.pep.2004.12.024; VARELA JCS, 1995, MOL CELL BIOL, V15, P6232; Welker S, 2010, MOL CELL, V39, P507, DOI 10.1016/j.molcel.2010.08.001; Zara S, 2002, YEAST, V19, P269, DOI 10.1002/yea.831	35	23	23	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					43447	43453		10.1074/jbc.M111.306464	http://dx.doi.org/10.1074/jbc.M111.306464			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	21998307	Green Published, hybrid			2022-12-27	WOS:000298351300064
J	Yang, A; Shi, GL; Zhou, CL; Lu, R; Li, H; Sun, L; Jin, Y				Yang, Acong; Shi, Guilai; Zhou, Chenlin; Lu, Rui; Li, Hui; Sun, Lei; Jin, Ying			Nucleolin Maintains Embryonic Stem Cell Self-renewal by Suppression of p53 Protein-dependent Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERFERING-RNA VECTOR; GENE-EXPRESSION; CLEAVING ACTIVITY; CANCER-CELLS; PLURIPOTENCY; CYCLE; DIFFERENTIATION; PROLIFERATION; NANOG; OCT4	Embryonic stem cells (ESCs) can undergo unlimited self-renewal and retain pluripotent developmental potential. The unique characteristics of ESCs, including a distinct transcriptional network, a poised epigenetic state, and a specific cell cycle profile, distinguish them from somatic cells. However, the molecular mechanisms underlying these special properties of ESCs are not fully understood. Here, we report that nucleolin, a nucleolar protein highly expressed in undifferentiated ESCs, plays an essential role for the maintenance of ESC self-renewal. When nucleolin is knocked down by specific short hairpin RNA (shRNA), ESCs display dramatically reduced cell proliferation rate, increased cell apoptosis, and G(1) phase accumulation. Down-regulation of nucleolin also leads to evident ESC differentiation as well as decreased self-renewal ability. Interestingly, expression of pluripotency markers (Oct4 and Nanog) is unaltered in these differentiated cells. Mechanistically, depletion of nucleolin up-regulates the p53 protein level and activates the p53-dependent pathway, at least in part, via increasing p53 protein stability. Silencing of p53 rescues G(1) phase accumulation and apoptosis caused by nucleolin deficiency entirely, although it partially blocks abnormal differentiation in nucleolin-depleted ESCs. It is noteworthy that knocking down nucleolin in NIH3T3 cells affected cell survival and proliferation in a much milder way, despite the comparable silencing efficiency obtained in ESCs and NIH3T3 cells. Collectively, our data demonstrate that nucleolin is a critical regulator of ESC self-renewal and that suppression of the p53-dependent pathway is the major molecular mechanism underlying functions of nucleolin in ESCs.	[Yang, Acong; Li, Hui; Jin, Ying] Shanghai Jiao Tong Univ, Sch Med, Shanghai Stem Cell Inst, Inst Med Sci, Shanghai 200025, Peoples R China; [Yang, Acong; Shi, Guilai; Zhou, Chenlin; Lu, Rui; Li, Hui; Sun, Lei; Jin, Ying] Shanghai Jiao Tong Univ, Sch Med, Shanghai Inst Biol Sci, Key Lab Stem Cell Biol,Chinese Acad Sci,Inst Hlth, Shanghai 200025, Peoples R China	Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University	Jin, Y (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Stem Cell Inst, Inst Med Sci, 225 S Chongqing Rd, Shanghai 200025, Peoples R China.	yjin@sibs.ac.cn	Sun, Lei/J-9943-2015; Yang, Acong/B-2929-2012	, jin ying/0000-0003-0070-2048; li, hui/0000-0002-7409-7787; Yang, Acong/0000-0002-1279-566X; Lu, Rui/0000-0003-1593-2612	National Natural Science Foundation [91019023, 30730051, 30911130361, 31100990]; National High Technology Research and Development Program of China [2010CB945201, 2011CB965101, 2009CB941103, 2007CB947904, 2007CB948004, 2011DFB30010]; Chinese Academy of Science [XDA01010102]; China Postdoctoral Science Foundation [20090460626]; Shanghai Postdoctoral Research Plan; Shanghai Leading Academic Discipline Project [S30201]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Chinese Academy of Science(Chinese Academy of Sciences); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Shanghai Postdoctoral Research Plan; Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project)	This work was supported by National Natural Science Foundation Grants 91019023, 30730051, 30911130361, and 31100990, National High Technology Research and Development Program of China Grants 2010CB945201, 2011CB965101, 2009CB941103, 2007CB947904, 2007CB948004, and 2011DFB30010, Chinese Academy of Science Grant XDA01010102, China Postdoctoral Science Foundation Grant 20090460626, Shanghai Postdoctoral Research Plan, and Shanghai Leading Academic Discipline Project Grant S30201.	Abujarour R, 2010, STEM CELLS, V28, P1487, DOI 10.1002/stem.472; Bibikova M, 2008, CELL STEM CELL, V2, P123, DOI 10.1016/j.stem.2008.01.005; Boheler KR, 2009, J CELL PHYSIOL, V221, P10, DOI 10.1002/jcp.21866; BUGLER B, 1982, EUR J BIOCHEM, V128, P475; Burdon T, 2002, TRENDS CELL BIOL, V12, P432, DOI 10.1016/S0962-8924(02)02352-8; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; CHEN CM, 1991, J BIOL CHEM, V266, P7754; Chen X, 2008, COLD SH Q B, V73, P203, DOI 10.1101/sqb.2008.73.026; DERENZINI M, 1995, LAB INVEST, V73, P497; Desbaillets I, 2000, EXP PHYSIOL, V85, P645, DOI 10.1017/S0958067000021047; FANG SH, 1993, EXP CELL RES, V208, P48, DOI 10.1006/excr.1993.1221; Ginisty H, 1999, J CELL SCI, V112, P761; Hanna J, 2010, P NATL ACAD SCI USA, V107, P9222, DOI 10.1073/pnas.1004584107; Kafienah W, 2006, STEM CELLS, V24, P1113, DOI 10.1634/stemcells.2005-0416; Lagarkova MA, 2006, CELL CYCLE, V5, P416, DOI 10.4161/cc.5.4.2440; Lange C, 2010, CELL CYCLE, V9, P1893, DOI 10.4161/cc.9.10.11598; LAPEYRE B, 1987, P NATL ACAD SCI USA, V84, P1472, DOI 10.1073/pnas.84.6.1472; Li H, 2009, STEM CELLS, V27, P1244, DOI 10.1002/stem.55; Lin TX, 2005, NAT CELL BIOL, V7, P165, DOI 10.1038/ncb1211; Liu Y, 2008, STEM CELLS, V26, P2475, DOI 10.1634/stemcells.2008-0269; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Mongelard F, 2007, TRENDS CELL BIOL, V17, P80, DOI 10.1016/j.tcb.2006.11.010; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Nomura J, 2009, STEM CELLS, V27, P1066, DOI 10.1002/stem.44; Orford KW, 2008, NAT REV GENET, V9, P115, DOI 10.1038/nrg2269; ORRICK LR, 1973, P NATL ACAD SCI USA, V70, P1316, DOI 10.1073/pnas.70.5.1316; Pardo M, 2010, CELL STEM CELL, V6, P382, DOI 10.1016/j.stem.2010.03.004; Qin H, 2007, J BIOL CHEM, V282, P5842, DOI 10.1074/jbc.M610464200; Saxena A, 2006, ONCOGENE, V25, P7274, DOI 10.1038/sj.onc.1209714; Singh AM, 2009, CELL STEM CELL, V5, P141, DOI 10.1016/j.stem.2009.07.003; Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435; Srivastava M, 1999, FASEB J, V13, P1911, DOI 10.1096/fasebj.13.14.1911; Takagi M, 2005, CELL, V123, P49, DOI 10.1016/j.cell.2005.07.034; Tsai RYL, 2002, GENE DEV, V16, P2991, DOI 10.1101/gad.55671; Tuteja R, 1998, CRIT REV BIOCHEM MOL, V33, P407, DOI 10.1080/10409239891204260; Ugrinova I, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-66; van de Wetering M, 2003, EMBO REP, V4, P609, DOI 10.1038/sj.embor.embor865; van den Berg DLC, 2008, MOL CELL BIOL, V28, P5986, DOI 10.1128/MCB.00301-08; Wang BB, 2006, BIOCHEM BIOPH RES CO, V347, P1129, DOI 10.1016/j.bbrc.2006.07.020	39	40	42	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					43370	43382		10.1074/jbc.M111.225185	http://dx.doi.org/10.1074/jbc.M111.225185			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22013067	Green Published, hybrid			2022-12-27	WOS:000298351300057
J	Haglund, E; Danielsson, J; Kadhirvel, S; Lindberg, MO; Logan, DT; Oliveberg, M				Haglund, Ellinor; Danielsson, Jens; Kadhirvel, Saraboji; Lindberg, Magnus O.; Logan, Derek T.; Oliveberg, Mikael			Trimming Down a Protein Structure to Its Bare Foldons SPATIAL ORGANIZATION OF THE COOPERATIVE UNIT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; FOLDING PATHWAYS; TRANSITION-STATE; S6; AGGREGATION; REFINEMENT; MUTATIONS; DYNAMICS; SYSTEM	Folding of the ribosomal protein S6 is a malleable process controlled by two competing, and partly overlapping, folding nuclei. Together, these nuclei extend over most of the S6 structure, except the edge strand beta 2, which is consistently missing in the folding transition states; despite being part of the S6 four-stranded sheet, beta 2 seems not to be part of the cooperative unit of the protein. The question is then whether beta 2 can be removed from the S6 structure without compromising folding cooperativity or native state integrity. To investigate this, we constructed a truncated variant of S6 lacking beta 2, reducing the size of the protein from 96 to 76 residues (S6(Delta beta 2)). The new S6 variant expresses well in Escherichia coli and has a well dispersed heteronuclear single quantum correlation spectrum and a perfectly wild-type-like crystal structure, but with a smaller three-stranded beta-sheet. Moreover, S6(Delta beta 2) displays an archetypical v-shaped chevron plot with decreased slope of the unfolding limb, as expected from a protein with maintained folding cooperativity and reduced size. The results support the notion that foldons, as defined by the structural distribution of the folding nuclei, represent a property-based level of hierarchy in the build-up of larger protein structures and suggest that the role of beta 2 in S6 is mainly in intermolecular binding, consistent with the position of this strand in the ribosomal assembly.	[Haglund, Ellinor; Danielsson, Jens; Lindberg, Magnus O.; Oliveberg, Mikael] Stockholm Univ, Dept Biochem & Biophys, Arrhenius Labs Nat Sci, S-10691 Stockholm, Sweden; [Kadhirvel, Saraboji; Logan, Derek T.] Lund Univ, Dept Biochem & Struct Biol, S-22100 Lund, Sweden	Stockholm University; Lund University	Oliveberg, M (corresponding author), Stockholm Univ, Dept Biochem & Biophys, Arrhenius Labs Nat Sci, S-10691 Stockholm, Sweden.	mikael@dbb.su.se	Logan, Derek T/A-1114-2011; Logan, Derek/O-2497-2019; Danielsson, Jens/AAG-6915-2021; Kadhirvel, Saraboji/H-4908-2011	Logan, Derek T/0000-0002-0098-8560; Logan, Derek/0000-0002-0098-8560; Kadhirvel, Saraboji/0000-0002-4876-4443; Danielsson, Jens/0000-0002-6048-6896	Swedish Research Council (VR) [VR 2009-5580, VR 2006-4387]; Knut and Alice Wallenberg Foundation; Bertil Hallsten Foundation; Hjarnfonden	Swedish Research Council (VR)(Swedish Research Council); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Bertil Hallsten Foundation; Hjarnfonden	This work was supported by grants from the Swedish Research Council (VR 2009-5580 (to M. O.) and VR 2006-4387) (to D. T. L.), the Knut and Alice Wallenberg Foundation, the Bertil Hallsten Foundation, and Hjarnfonden.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Baber JL, 1999, J MOL BIOL, V289, P949, DOI 10.1006/jmbi.1999.2818; Bieger B, 2003, STRUCTURE, V11, P375, DOI 10.1016/S0969-2126(03)00048-0; Bystrom R, 2010, J BIOL CHEM, V285, P19544, DOI 10.1074/jbc.M109.086074; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chiti F, 1999, NAT STRUCT BIOL, V6, P1005; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Dobson Christopher M., 1999, Current Opinion in Structural Biology, V9, P92, DOI 10.1016/S0959-440X(99)80012-8; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fersht A., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; FUSHMAN D, 1994, J BIOMOL STRUCT DYN, V11, P1377, DOI 10.1080/07391102.1994.10508074; Goddard T. D, 2007, SPARKY 3; Grishin NV, 2001, J STRUCT BIOL, V134, P167, DOI 10.1006/jsbi.2001.4335; Haglund E, 2008, J BIOL CHEM, V283, P27904, DOI 10.1074/jbc.M801776200; Haglund E, 2009, P NATL ACAD SCI USA, V106, P21619, DOI 10.1073/pnas.0907665106; JACKSON SE, 1991, BIOCHEMISTRY-US, V30, P10428, DOI 10.1021/bi00107a010; Jahn TR, 2008, ARCH BIOCHEM BIOPHYS, V469, P100, DOI 10.1016/j.abb.2007.05.015; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; LAMZIN VS, 1993, ACTA CRYSTALLOGR D, V49, P129, DOI 10.1107/S0907444992008886; LINDAHL M, 1994, EMBO J, V13, P1249, DOI 10.1002/j.1460-2075.1994.tb06376.x; Lindberg M, 2002, NAT STRUCT BIOL, V9, P818, DOI 10.1038/nsb847; Lindberg MO, 2007, CURR OPIN STRUC BIOL, V17, P21, DOI 10.1016/j.sbi.2007.01.008; Lindberg MO, 2006, P NATL ACAD SCI USA, V103, P4083, DOI 10.1073/pnas.0508863103; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miyashita O, 2003, P NATL ACAD SCI USA, V100, P12570, DOI 10.1073/pnas.2135471100; Ohman A, 2010, PROTEIN SCI, V19, P183, DOI 10.1002/pro.298; Oliveberg M, 2005, Q REV BIOPHYS, V38, P245, DOI 10.1017/S0033583506004185; Olofsson M, 2007, J MOL BIOL, V365, P237, DOI 10.1016/j.jmb.2006.09.016; Otzen DE, 2002, J MOL BIOL, V317, P613, DOI 10.1006/jmbi.2002.5423; Otzen DE, 1999, BIOCHEMISTRY-US, V38, P6499, DOI 10.1021/bi982819j; Otzen DE, 2000, P NATL ACAD SCI USA, V97, P9907, DOI 10.1073/pnas.160086297; Panchenko AR, 1996, P NATL ACAD SCI USA, V93, P2008, DOI 10.1073/pnas.93.5.2008; Park C, 2004, J MOL BIOL, V343, P1467, DOI 10.1016/j.jmb.2004.08.085; Park CW, 2005, NAT METHODS, V2, P207, DOI 10.1038/NMETH740; PASTORE A, 1992, J MOL BIOL, V224, P427, DOI 10.1016/0022-2836(92)91005-A; Sciara G, 2003, EMBO J, V22, P205, DOI 10.1093/emboj/cdg031; Shaw BF, 2007, TRENDS BIOCHEM SCI, V32, P78, DOI 10.1016/j.tibs.2006.12.005; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Tanford C, 1970, Adv Protein Chem, V24, P1, DOI 10.1016/S0065-3233(08)60241-7; Ternstrom T, 1999, P NATL ACAD SCI USA, V96, P14854, DOI 10.1073/pnas.96.26.14854; Whitford PC, 2008, HFSP J, V2, P61, DOI 10.2976/1.2894846; Williams PM, 2003, NATURE, V422, P446, DOI 10.1038/nature01517	45	15	15	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2731	2738		10.1074/jbc.M111.312447	http://dx.doi.org/10.1074/jbc.M111.312447			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22117065	Green Published, hybrid			2022-12-27	WOS:000300292300044
J	Wang, YC; Pinto, JR; Solis, RS; Dweck, D; Liang, JS; Diaz-Perez, Z; Ge, Y; Walker, JW; Potter, JD				Wang, Yingcai; Pinto, Jose Renato; Solis, Raquel Sancho; Dweck, David; Liang, Jingsheng; Diaz-Perez, Zoraida; Ge, Ying; Walker, Jeffery W.; Potter, James D.			Generation and Functional Characterization of Knock-in Mice Harboring the Cardiac Troponin I-R21C Mutation Associated with Hypertrophic Cardiomyopathy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-A; MOUSE MODEL; LIGHT-CHAIN; PHOSPHORYLATION; GENE; MUSCLE; SITE; SUSCEPTIBILITY; TROPOMYOSIN; AFFINITY	The R21C substitution in cardiac troponin I (cTnI) is the only identified mutation within its unique N-terminal extension that is associated with hypertrophic cardiomyopathy (HCM) in man. Particularly, this mutation is located in the consensus sequence for beta-adrenergic-activated protein kinase A (PKA)-mediated phosphorylation. The mechanisms by which this mutation leads to heart disease are still unclear. Therefore, we generated cTnI knock-in mouse models carrying an R21C mutation to evaluate the resultant functional consequences. Measuring the in vivo levels of incorporated mutant and WT cTnI, and their basal phosphorylation levels by top-down mass spectrometry demonstrated: 1) a dominant-negative effect such that, the R21C+/- hearts incorporated 24.9% of the mutant cTnI within the myofilament; and 2) the R21C mutation abolished the in vivo phosphorylation of Ser(23)/Ser(24) in the mutant cTnI. Adult heterozygous (R21C+/-) and homozygous (R21C+/-) mutant mice activated the fetal gene program and developed a remarkable degree of cardiac hypertrophy and fibrosis. Investigation of cardiac skinned fibers isolated from WT and heterozygous mice revealed that the WT cTnI was completely phosphorylated at Ser(23)/Ser(24) unless the mice were pre-treated with propranolol. After propranolol treatment (-PKA), the pCa-tension relationships of all three mice (i. e. WT, R21C+/-, and R21C+/-) were essentially the same. However, after treatment with propranolol and PKA, the R21C cTnI mutation reduced (R21C+/-) or abolished (R21C+/-) the well known decrease in the Ca2+ sensitivity of tension that accompanies Ser(23)/Ser(24) cTnI phosphorylation. Altogether, the combined effects of the R21C mutation appear to contribute toward the development of HCM and suggest that another physiological role for the phosphorylation of Ser(23)/Ser(24) in cTnI is to prevent cardiac hypertrophy.	[Wang, Yingcai; Pinto, Jose Renato; Dweck, David; Liang, Jingsheng; Diaz-Perez, Zoraida; Potter, James D.] Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA; [Solis, Raquel Sancho; Ge, Ying; Walker, Jeffery W.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Physiol, Madison, WI 53706 USA; [Solis, Raquel Sancho; Ge, Ying; Walker, Jeffery W.] Univ Wisconsin, Sch Med & Publ Hlth, Human Prote Program, Madison, WI 53706 USA; [Walker, Jeffery W.] Univ Arizona, Dept Physiol, Tucson, AZ 85724 USA	University of Miami; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Arizona	Potter, JD (corresponding author), 1600 NW 10th Ave,R-189, Miami, FL 33136 USA.	jdpotter@miami.edu	Pinto, Jose Renato/H-2631-2017	Pinto, Jose Renato/0000-0001-9092-4976	National Institutes of these advances, there is a lack of information in the literature Health [HL042325, RO1 HL081386, 1K99HL103840-01]; JE King Grant [10KN-13]; Wisconsin Partnership Fund for a Healthy Future; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL042325, R00HL103840, R37HL042325, R01HL081386, K99HL103840] Funding Source: NIH RePORTER	National Institutes of these advances, there is a lack of information in the literature Health; JE King Grant; Wisconsin Partnership Fund for a Healthy Future; American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of these advances, there is a lack of information in the literature Health Grants HL042325 (to J. D. P.), RO1 HL081386 (to J. W. W.), 1K99HL103840-01 and J&E King Grant 10KN-13 (to J. R. P.), the Wisconsin Partnership Fund for a Healthy Future, and an American Heart Association Scientist Development Grant (to Y. G.).	Arad M, 2005, CIRCULATION, V112, P2805, DOI 10.1161/CIRCULATIONAHA.105.547448; Ayaz-Guner S, 2009, BIOCHEMISTRY-US, V48, P8161, DOI 10.1021/bi900739f; Barbato JC, 2005, J BIOL CHEM, V280, P6602, DOI 10.1074/jbc.M408525200; Barnabei MS, 2010, PHYSIOL GENOMICS, V42A, P103, DOI 10.1152/physiolgenomics.00071.2010; Baudenbacher F, 2008, J CLIN INVEST, V118, P3893, DOI 10.1172/JCI36642; Biesiadecki BJ, 2010, J BIOL CHEM, V285, P19688, DOI 10.1074/jbc.M109.086892; Bodor GS, 1997, CIRCULATION, V96, P1495, DOI 10.1161/01.CIR.96.5.1495; Burkart EM, 2003, J BIOL CHEM, V278, P11265, DOI 10.1074/jbc.M210712200; Chang AN, 2008, BIOCHEM BIOPH RES CO, V369, P74, DOI 10.1016/j.bbrc.2007.12.081; Day SM, 2007, J MOL MED, V85, P911, DOI 10.1007/s00109-007-0181-6; Deng CX, 1996, CELL, V84, P911, DOI 10.1016/S0092-8674(00)81069-7; Du CK, 2007, CIRC RES, V101, P185, DOI 10.1161/CIRCRESAHA.106.146670; Fewell JG, 1998, J CLIN INVEST, V101, P2630, DOI 10.1172/JCI2825; Gomes AV, 2005, J MOL CELL CARDIOL, V39, P754, DOI 10.1016/j.yjmcc.2005.05.013; Gomes AV, 2004, MOL CELL BIOCHEM, V263, P99, DOI 10.1023/B:MCBI.0000041852.42291.aa; Gordon AM, 2000, PHYSIOL REV, V80, P853, DOI 10.1152/physrev.2000.80.2.853; Huang XP, 1999, CIRC RES, V84, P1; JAQUET K, 1995, EUR J BIOCHEM, V231, P486, DOI 10.1111/j.1432-1033.1995.tb20722.x; KENNELLY PJ, 1991, J BIOL CHEM, V266, P15555; Kentish JC, 2001, CIRC RES, V88, P1059, DOI 10.1161/hh1001.091640; Kimura A, 1997, NAT GENET, V16, P379, DOI 10.1038/ng0897-379; Konno T, 2010, CURR OPIN CARDIOL, V25, P205, DOI 10.1097/HCO.0b013e3283375698; KRANIAS EG, 1982, NATURE, V298, P182, DOI 10.1038/298182a0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Layland J, 2005, CARDIOVASC RES, V66, P12, DOI 10.1016/j.cardiores.2004.12.022; Liew CC, 2004, NAT REV GENET, V5, P811, DOI 10.1038/nrg1470; Marian AJ, 1998, ANN MED, V30, P24; Marston SB, 2003, CIRC RES, V93, P1170, DOI 10.1161/01.RES.0000105088.06696.17; Messer AE, 2007, J MOL CELL CARDIOL, V42, P247, DOI 10.1016/j.yjmcc.2006.08.017; Messer AE, 2009, PROTEOM CLIN APPL, V3, P1371, DOI 10.1002/prca.200900071; MITTMANN K, 1992, FEBS LETT, V302, P133, DOI 10.1016/0014-5793(92)80423-E; Mogensen J, 1999, J CLIN INVEST, V103, pR39, DOI 10.1172/JCI6460; Monasky MM, 2010, J MOL CELL CARDIOL, V48, P1023, DOI 10.1016/j.yjmcc.2010.03.004; NOLAND TA, 1995, J BIOL CHEM, V270, P25445, DOI 10.1074/jbc.270.43.25445; Perry SV, 1999, MOL CELL BIOCHEM, V190, P9, DOI 10.1023/A:1006939307715; Pi YQ, 2003, J PHYSIOL-LONDON, V552, P845, DOI 10.1113/jphysiol.2003.045260; Pi YQ, 2002, CIRC RES, V90, P649, DOI 10.1161/01.RES.0000014080.82861.5F; ROBERTSON SP, 1982, J BIOL CHEM, V257, P260; Robinson P, 2007, CIRC RES, V101, P1266, DOI 10.1161/CIRCRESAHA.107.156380; Solis RS, 2008, J MUSCLE RES CELL M, V29, P203, DOI 10.1007/s10974-009-9168-y; Takeda S, 2003, NATURE, V424, P35, DOI 10.1038/nature01780; Takeishi Y, 1998, J CLIN INVEST, V102, P72, DOI 10.1172/JCI2709; Tardiff JC, 2011, CIRC RES, V108, P765, DOI 10.1161/CIRCRESAHA.110.224170; Wang YC, 1999, P NATL ACAD SCI USA, V96, P4455, DOI 10.1073/pnas.96.8.4455; Wang YC, 2007, FASEB J, V21, P2205, DOI 10.1096/fj.06-7538com; Wen YH, 2008, J BIOL CHEM, V283, P20484, DOI 10.1074/jbc.M801661200; Wen YH, 2009, J MOL BIOL, V392, P1158, DOI 10.1016/j.jmb.2009.07.080; Willott RH, 2010, J MOL CELL CARDIOL, V48, P882, DOI 10.1016/j.yjmcc.2009.10.031; Zhang J, 2011, J PROTEOME RES, V10, P4054, DOI 10.1021/pr200258m; ZHANG R, 1995, CIRC RES, V76, P1028, DOI 10.1161/01.RES.76.6.1028	50	35	35	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2012	287	3					2156	2167		10.1074/jbc.M111.294306	http://dx.doi.org/10.1074/jbc.M111.294306			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879HT	22086914	hybrid, Green Published			2022-12-27	WOS:000299321000055
J	Bargagna-Mohan, P; Paranthan, RR; Hamza, A; Zhan, CG; Lee, DM; Kim, KB; Lau, DL; Srinivasan, C; Nakayama, K; Nakayama, KI; Herrmann, H; Mohan, R				Bargagna-Mohan, Paola; Paranthan, Riya R.; Hamza, Adel; Zhan, Chang-Guo; Lee, Do-Min; Kim, Kyung Bo; Lau, Daniel L.; Srinivasan, Cidambi; Nakayama, Keiko; Nakayama, Keiichi I.; Herrmann, Harald; Mohan, Royce			Corneal Antifibrotic Switch Identified in Genetic and Pharmacological Deficiency of Vimentin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBRILLARY ACIDIC PROTEIN; INTERMEDIATE-FILAMENT NETWORKS; UBIQUITIN-PROTEASOME PATHWAY; MICE LACKING VIMENTIN; MUSCLE ALPHA-ACTIN; CELL-PROLIFERATION; WITHAFERIN-A; MYOFIBROBLAST DIFFERENTIATION; RETINAL-DETACHMENT; LACERATED CORNEAS	The type III intermediate filaments (IFs) are essential cytoskeletal elements of mechanosignal transduction and serve critical roles in tissue repair. Mice genetically deficient for the IF protein vimentin (Vim(-/-)) have impaired wound healing from deficits in myofibroblast development. We report a surprising finding made in Vim(-/-) mice that corneas are protected from fibrosis and instead promote regenerative healing after traumatic alkali injury. This reparative phenotype in Vim(-/-) corneas is strikingly recapitulated by the pharmacological agent withaferin A (WFA), a small molecule that binds to vimentin and down-regulates its injury-induced expression. Attenuation of corneal fibrosis by WFA is mediated by down-regulation of ubiquitin-conjugating E3 ligase Skp2 and up-regulation of cyclin-dependent kinase inhibitors p27(Kip1) and p21(Cip1). In cell culture models, WFA exerts G(2)/M cell cycle arrest in a p27(Kip1)- and Skp2-dependent manner. Finally, by developing a highly sensitive imaging method to measure corneal opacity, we identify a novel role for desmin overexpression in corneal haze. We demonstrate that desmin down-regulation by WFA via targeting the conserved WFA-ligand binding site shared among type III IFs promotes further improvement of corneal transparency without affecting cyclin-dependent kinase inhibitor levels in Vim(-/-) mice. This dissociates a direct role for desmin in corneal cell proliferation. Taken together, our findings illuminate a previously unappreciated pathogenic role for type III IF overexpression in corneal fibrotic conditions and also validate WFA as a powerful drug lead toward anti-fibrosis therapeutic development.	[Mohan, Royce] Univ Connecticut, Ctr Hlth, Dept Neurosci, Lab Chem Biol & Drug Discovery, Farmington, CT 06030 USA; [Paranthan, Riya R.] Univ Kentucky, Dept Ophthalmol & Visual Sci, Lexington, KY 40503 USA; [Hamza, Adel; Zhan, Chang-Guo; Lee, Do-Min; Kim, Kyung Bo] Univ Kentucky, Dept Pharmaceut Sci, Lexington, KY 40503 USA; [Lau, Daniel L.] Univ Kentucky, Dept Comp & Elect Engn, Lexington, KY 40503 USA; [Srinivasan, Cidambi] Univ Kentucky, Dept Stat, Lexington, KY 40503 USA; [Nakayama, Keiko] Tohoku Univ, Grad Sch Med, Div Dev Genet, Sendai, Miyagi 9808575, Japan; [Nakayama, Keiichi I.] Kyushu Univ, Dept Mol & Cellular Biol, Med Inst Bioregulat, Fukuoka 8128582, Japan; [Herrmann, Harald] German Canc Res Ctr, Funct Architecture Cell Grp, D-69120 Heidelberg, Germany	University of Connecticut; University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky; Tohoku University; Kyushu University; Helmholtz Association; German Cancer Research Center (DKFZ)	Mohan, R (corresponding author), Univ Connecticut, Ctr Hlth, Dept Neurosci, Lab Chem Biol & Drug Discovery, 263 Farmington Ave, Farmington, CT 06030 USA.	Mohan@UCHC.edu	Lau, Daniel L/O-5169-2014	Lau, Daniel L/0000-0003-1377-4622	National Institutes of Health [R01 EY016782, R01 CA131059, R01 DA013930, R01 DA025100, R01 DA021416]; John A. and Florence Mattern Solomon Endowed Chair in vision biology and eye diseases; Fight for Sight, Inc.; Kentucky Science and Engineering Foundation [KSEF-578-RDE-005]; NATIONAL CANCER INSTITUTE [R01CA131059] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY016782] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA013930, R01DA025100, R01DA021416] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); John A. and Florence Mattern Solomon Endowed Chair in vision biology and eye diseases; Fight for Sight, Inc.; Kentucky Science and Engineering Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants R01 EY016782 and R01 CA131059 (to R. M.) and R01 DA013930, R01 DA025100, and R01 DA021416 (to C.-G. Z.). This work was also supported in part by the John A. and Florence Mattern Solomon Endowed Chair in vision biology and eye diseases (to R. M.) and funds from Fight for Sight, Inc., and Kentucky Science and Engineering Foundation Grant KSEF-578-RDE-005 (to R. M.).	Amador V, 2007, MOL CELL, V27, P462, DOI 10.1016/j.molcel.2007.06.013; Amano S, 1998, INVEST OPHTH VIS SCI, V39, P18; Ambati BK, 2003, CORNEA, V22, P465, DOI 10.1097/00003226-200307000-00013; Bar H, 2006, J MOL BIOL, V360, P1031, DOI 10.1016/j.jmb.2006.05.068; Bargagna-Mohan P, 2007, CHEM BIOL, V14, P623, DOI 10.1016/j.chembiol.2007.04.010; Bargagna-Mohan P, 2006, INVEST OPHTH VIS SCI, V47, P4138, DOI 10.1167/iovs.05-1452; Bargagna-Mohan P, 2010, J BIOL CHEM, V285, P7657, DOI 10.1074/jbc.M109.093765; Bond M, 2011, FRONT BIOSCI-LANDMRK, V16, P1517, DOI 10.2741/3802; Bornstein G, 2003, J BIOL CHEM, V278, P25752, DOI 10.1074/jbc.M301774200; Chang HC, 2007, MOL CANCER THER, V6, P1572, DOI 10.1158/1535-7163.MCT-06-0812; Chaurasia SS, 2009, EXP EYE RES, V89, P133, DOI 10.1016/j.exer.2009.02.022; Che XJ, 2011, BRAIN PATHOL, V21, P389, DOI 10.1111/j.1750-3639.2010.00463.x; Chou YH, 2007, EXP CELL RES, V313, P2236, DOI 10.1016/j.yexcr.2007.04.008; COLUCCIGUYON E, 1994, CELL, V79, P679, DOI 10.1016/0092-8674(94)90553-3; Conway BR, 2010, J NEUROSCI, V30, P14955, DOI 10.1523/JNEUROSCI.4348-10.2010; Cook JR, 1999, INVEST OPHTH VIS SCI, V40, P3122; Dupps WJ, 2006, EXP EYE RES, V83, P709, DOI 10.1016/j.exer.2006.03.015; Dyer MA, 2000, NAT NEUROSCI, V3, P873, DOI 10.1038/78774; Eckes B, 1998, J CELL SCI, V111, P1897; Eckes B, 2000, J CELL SCI, V113, P2455; Falsey RR, 2006, NAT CHEM BIOL, V2, P33, DOI 10.1038/nchembio755; FRANKE WW, 1982, CELL, V30, P103, DOI 10.1016/0092-8674(82)90016-2; Goldman RD, 2008, CURR OPIN CELL BIOL, V20, P28, DOI 10.1016/j.ceb.2007.11.003; Hara T, 2001, J BIOL CHEM, V276, P48937, DOI 10.1074/jbc.M107274200; Hassell JR, 2010, EXP EYE RES, V91, P326, DOI 10.1016/j.exer.2010.06.021; Helfand BT, 2004, J CELL SCI, V117, P133, DOI 10.1242/jcs.00936; Herrmann H, 2004, ANNU REV BIOCHEM, V73, P749, DOI 10.1146/annurev.biochem.73.011303.073823; Herrmann H, 1999, J MOL BIOL, V286, P1403, DOI 10.1006/jmbi.1999.2528; Herrmann H, 2007, NAT REV MOL CELL BIO, V8, P562, DOI 10.1038/nrm2197; HOPKINSONWOOLLEY J, 1994, J CELL SCI, V107, P1159; Hu D, 2011, CELL CYCLE, V10, P285, DOI 10.4161/cc.10.2.14517; ISHIZAKI M, 1993, INVEST OPHTH VIS SCI, V34, P3320; ISHIZAKI M, 1994, EXP EYE RES, V59, P537, DOI 10.1006/exer.1994.1139; Jester JV, 1999, INVEST OPHTH VIS SCI, V40, P1959; Jester JV, 1999, PROG RETIN EYE RES, V18, P311, DOI 10.1016/S1350-9462(98)00021-4; Jiang XG, 2009, MOL CELL BIOL, V29, P5104, DOI 10.1128/MCB.00465-09; Kase S, 2006, CURR EYE RES, V31, P307, DOI 10.1080/02713680600584687; Lacolley P, 2001, CARDIOVASC RES, V51, P178, DOI 10.1016/S0008-6363(01)00278-4; Lahat G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010105; Lu YB, 2011, FASEB J, V25, P624, DOI 10.1096/fj.10-163790; Lundkvist A, 2004, J CELL SCI, V117, P3481, DOI 10.1242/jcs.01221; Mackey DA, 2011, CLIN EXP OPHTHALMOL, V39, P462, DOI 10.1111/j.1442-9071.2010.02487.x; Macsai MS, 2000, CORNEA, V19, P617, DOI 10.1097/00003226-200009000-00007; Maxwell SA, 2011, LEUKEMIA LYMPHOMA, V52, P849, DOI 10.3109/10428194.2010.551793; Mishra L C, 2000, Altern Med Rev, V5, P334; Mohan Royce, 2004, Angiogenesis, V7, P115, DOI 10.1007/s10456-004-1026-3; MOON RT, 1983, P NATL ACAD SCI-BIOL, V80, P5495, DOI 10.1073/pnas.80.18.5495; Mueller M, 2009, HUM MOL GENET, V18, P1052, DOI 10.1093/hmg/ddn440; Muller LJ, 2001, BRIT J OPHTHALMOL, V85, P437, DOI 10.1136/bjo.85.4.437; Nakayama K, 2000, EMBO J, V19, P2069, DOI 10.1093/emboj/19.9.2069; Nakayama K, 2004, DEV CELL, V6, P661, DOI 10.1016/S1534-5807(04)00131-5; Nakazawa T, 2007, INVEST OPHTH VIS SCI, V48, P2760, DOI 10.1167/iovs.06-1398; Nieminen M, 2006, NAT CELL BIOL, V8, P156, DOI 10.1038/ncb1355; Oshima T, 2006, BRIT J OPHTHALMOL, V90, P218, DOI 10.1136/bjo.2005.077875; Paranthan RR, 2011, MOL VIS, V17, P1901; Pekny M, 1999, J CELL BIOL, V145, P503, DOI 10.1083/jcb.145.3.503; Pekny M, 2004, J PATHOL, V204, P428, DOI 10.1002/path.1645; Pekny M, 2001, Prog Brain Res, V132, P23; Petroll WM, 2004, INVEST OPHTH VIS SCI, V45, P3466, DOI 10.1167/iovs.04-0361; Plodinec M, 2011, J STRUCT BIOL, V174, P476, DOI 10.1016/j.jsb.2011.03.011; Qazi Y, 2010, BRAIN RES BULL, V81, P198, DOI 10.1016/j.brainresbull.2009.05.019; Rogel MR, 2011, FASEB J, V25, P3873, DOI 10.1096/fj.10-170795; Saika S, 2005, AM J PATHOL, V166, P1393, DOI 10.1016/S0002-9440(10)62357-7; Saika S, 2005, LAB INVEST, V85, P474, DOI 10.1038/labinvest.3700247; Salomao MQ, 2009, J REFRACT SURG, V25, P459, DOI 10.3928/1081597X-20090422-09; Satelli A, 2011, CELL MOL LIFE SCI, V68, P3033, DOI 10.1007/s00018-011-0735-1; Schaffeld M, 2001, EUR J CELL BIOL, V80, P692, DOI 10.1078/0171-9335-00206; Schopferer M, 2009, J MOL BIOL, V388, P133, DOI 10.1016/j.jmb.2009.03.005; Scott RS, 2008, AM J PHYSIOL-CELL PH, V295, pC324, DOI 10.1152/ajpcell.90622.2007; SKALLI O, 1992, P NATL ACAD SCI USA, V89, P11959, DOI 10.1073/pnas.89.24.11959; SOELLNER P, 1985, P NATL ACAD SCI USA, V82, P7929, DOI 10.1073/pnas.82.23.7929; Stan SD, 2008, NUTR CANCER, V60, P51, DOI 10.1080/01635580802381477; Stramer BM, 2001, INVEST OPHTH VIS SCI, V42, P1698; Suzuki S, 2007, AM J PATHOL, V171, P473, DOI 10.2353/ajpath.2007.070279; Tandon A, 2010, CURR MOL MED, V10, P565; Taneri S, 2011, J CATARACT REFR SURG, V37, P392, DOI 10.1016/j.jcrs.2010.11.013; Tanter M, 2009, IEEE T MED IMAGING, V28, P1881, DOI 10.1109/TMI.2009.2021471; Thaiparambil JT, 2011, INT J CANCER, V129, P2744, DOI 10.1002/ijc.25938; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Verardo MR, 2008, INVEST OPHTH VIS SCI, V49, P3659, DOI 10.1167/iovs.07-1474; Vij N, 2004, EXP EYE RES, V78, P957, DOI 10.1016/j.exer.2003.12.006; Wang F, 2010, INVEST OPHTH VIS SCI, V51, P1475, DOI 10.1167/iovs.09-4363; West-Mays JA, 1999, INVEST OPHTH VIS SCI, V40, P887; Whitcher JP, 2001, B WORLD HEALTH ORGAN, V79, P214; Yokota Y, 2006, BIOORG MED CHEM LETT, V16, P2603, DOI 10.1016/j.bmcl.2006.02.039; Yoon M, 1998, J CELL BIOL, V143, P147, DOI 10.1083/jcb.143.1.147; Yoshida K, 2002, INVEST OPHTH VIS SCI, V43, P364; Zhao XH, 2007, J CELL SCI, V120, P1801, DOI 10.1242/jcs.001586; Zieske JD, 2000, PROG RETIN EYE RES, V19, P257, DOI 10.1016/S1350-9462(99)00018-X	89	32	34	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					989	1006		10.1074/jbc.M111.297150	http://dx.doi.org/10.1074/jbc.M111.297150			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22117063	Green Published, hybrid			2022-12-27	WOS:000299170300017
J	Mochel, F; Durant, B; Meng, XL; O'Callaghan, J; Yu, H; Brouillet, E; Wheeler, VC; Humbert, S; Schiffmann, R; Durr, A				Mochel, Fanny; Durant, Brandon; Meng, Xingli; O'Callaghan, James; Yu, Hua; Brouillet, Emmanuel; Wheeler, Vanessa C.; Humbert, Sandrine; Schiffmann, Raphael; Durr, Alexandra			Early Alterations of Brain Cellular Energy Homeostasis in Huntington Disease Models	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAG REPEAT INSTABILITY; CREATINE-KINASE; CLINICAL SYMPTOMS; MOUSE MODEL; MITOCHONDRIAL; MICE; THERAPY; DEFICIT; PHOSPHORYLATION; METABOLISM	Brain energy deficit has been a suggested cause of Huntington disease (HD), but ATP depletion has not reliably been shown in preclinical models, possibly because of the immediate post-mortem changes in cellular energy metabolism. To examine a potential role of a low energy state in HD, we measured, for the first time in a neurodegenerative model, brain levels of high energy phosphates using microwave fixation, which instantaneously inactivates brain enzymatic activities and preserves in vivo levels of analytes. We studied HD transgenic R6/2 mice at ages 4, 8, and 12 weeks. We found significantly increased creatine and phosphocreatine, present as early as 4 weeks for phosphocreatine, preceding motor system deficits and decreased ATP levels in striatum, hippocampus, and frontal cortex of R6/2 mice. ATP and phosphocreatine concentrations were inversely correlated with the number of CAG repeats. Conversely, in mice injected with 3-nitroproprionic acid, an acute model of brain energy deficit, both ATP and phosphocreatine were significantly reduced. Increased creatine and phosphocreatine in R6/2 mice was associated with decreased guanidinoacetate N-methyltransferase and creatine kinase, both at the protein and RNA levels, and increased phosphorylated AMP-dependent protein kinase (pAMPK) over AMPK ratio. In addition, in 4-month-old knock-in Hdh(Q111/+) mice, the earliest metabolic alterations consisted of increased phosphocreatine in the frontal cortex and increased the pAMPK/AMPK ratio. Altogether, this study provides the first direct evidence of chronic alteration in homeostasis of high energy phosphates in HD models in the earliest stages of the disease, indicating possible reduced utilization of the brain phosphocreatine pool.	[Mochel, Fanny] Hop La Pitie Salpetriere, Brain & Spine Inst, INSERM UMR S975, F-75013 Paris, France; [Mochel, Fanny; Durr, Alexandra] Hop La Pitie Salpetriere, AP HP, Dept Genet, F-75013 Paris, France; [Mochel, Fanny] Univ Paris 06, F-75005 Paris, France; [Mochel, Fanny; Durant, Brandon; Meng, Xingli] Baylor Res Inst, Inst Metab Dis, Dallas, TX 75226 USA; [O'Callaghan, James] NIOSH, Hlth Effects Lab Div, Ctr Dis Control & Prevent, Morgantown, WV 26505 USA; [Yu, Hua; Humbert, Sandrine; Schiffmann, Raphael] INSERM U1005, Inst Curie, CNRS UMR3306, F-91405 Orsay, France; [Brouillet, Emmanuel] CEA, URA CEA CNRS 2210, Serv MIRCen, F-92265 Fontenay Aux Roses, France; [Wheeler, Vanessa C.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Baylor Scott & White Health; Baylor University Medical Center; Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Harvard University; Massachusetts General Hospital	Mochel, F (corresponding author), Hop La Pitie Salpetriere, Brain & Spine Inst, INSERM UMR S975, F-75013 Paris, France.	fanny.mochel@upmc.fr	Humbert, Sandrine/S-2981-2016; Brouillet, Emmanuel/B-4784-2014; Durant, Brandon/HCH-8003-2022	Brouillet, Emmanuel/0000-0001-6322-7403; Durant, Brandon/0000-0003-3028-6161; Humbert, Sandrine/0000-0002-9501-2658	National Institutes of Health [NS32765, NS049206]; CHDI Foundation, Inc.; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032765, R01NS049206] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CHDI Foundation, Inc.; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS32765 and NS049206 (to V. C. W.). This work was also supported by the CHDI Foundation, Inc.	Andreassen OA, 2001, J NEUROCHEM, V77, P383, DOI 10.1046/j.1471-4159.2001.00188.x; BEAL MF, 1994, CURR OPIN NEUROL, V7, P542, DOI 10.1097/00019052-199412000-00012; Braissant O, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-9; Brouillet E, 2005, J NEUROCHEM, V95, P1521, DOI 10.1111/j.1471-4159.2005.03515.x; CHAN P, 1991, J NEUROCHEM, V57, P348, DOI 10.1111/j.1471-4159.1991.tb02134.x; Ciarmiello A, 2006, J NUCL MED, V47, P215; Cui LB, 2006, CELL, V127, P59, DOI 10.1016/j.cell.2006.09.015; Dedeoglu A, 2003, J NEUROCHEM, V85, P1359, DOI 10.1046/j.1471-4159.2003.01706.x; Delaney SM, 1996, J NEUROSCI METH, V64, P151, DOI 10.1016/0165-0270(95)00119-0; Dragileva E, 2009, NEUROBIOL DIS, V33, P37, DOI 10.1016/j.nbd.2008.09.014; Ferrante Robert J., 2000, Journal of Neuroscience, V20, P4389; Gines S, 2003, HUM MOL GENET, V12, P497, DOI 10.1093/hmg/ddg046; GUSELLA JF, 1983, NATURE, V306, P234, DOI 10.1038/306234a0; in 't Zandt HJA, 2004, J NEUROCHEM, V90, P1321, DOI 10.1111/j.1471-4159.2004.02599.x; Kaltenbach LS, 2007, PLOS GENET, V3, P689, DOI 10.1371/journal.pgen.0030082; Kim J, 2010, BBA-MOL BASIS DIS, V1802, P673, DOI 10.1016/j.bbadis.2010.05.001; Lee JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023647; Lin YS, 2011, J CLIN INVEST, V121, P1519, DOI 10.1172/JCI43220; LOWRY OH, 1964, J BIOL CHEM, V239, P18; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Matthews RT, 1998, J NEUROSCI, V18, P156; Milakovic T, 2005, J BIOL CHEM, V280, P30773, DOI 10.1074/jbc.M504749200; Mochel F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000647; Mochel F, 2011, J CLIN INVEST, V121, P493, DOI 10.1172/JCI45691; Morton AJ, 2009, NEUROBIOL DIS, V33, P331, DOI 10.1016/j.nbd.2008.11.015; O'Callaghan JP, 2004, J NEUROSCI METH, V135, P159, DOI 10.1016/j.jneumeth.2003.12.006; Olah J, 2008, FEBS J, V275, P4740, DOI 10.1111/j.1742-4658.2008.06612.x; Powers WJ, 2007, P NATL ACAD SCI USA, V104, P2945, DOI 10.1073/pnas.0609833104; Rudenko O, 2009, BEHAV BRAIN RES, V203, P188, DOI 10.1016/j.bbr.2009.04.034; Saks V, 1998, MOL CELL BIOCHEM, V184, P291, DOI 10.1023/A:1006828106322; Scharf MT, 2008, J NEUROCHEM, V105, P833, DOI 10.1111/j.1471-4159.2007.05182.x; Seong IS, 2005, HUM MOL GENET, V14, P2871, DOI 10.1093/hmg/ddi319; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; SNELL RG, 1993, NAT GENET, V4, P393, DOI 10.1038/ng0893-393; Steeghs K, 1997, CELL, V89, P93, DOI 10.1016/S0092-8674(00)80186-5; Steele AD, 2007, P NATL ACAD SCI USA, V104, P1983, DOI 10.1073/pnas.0610779104; Tabrizi SJ, 2005, NEUROLOGY, V64, P1655, DOI 10.1212/01.WNL.0000160388.96242.77; Thu DCV, 2010, BRAIN, V133, P1094, DOI 10.1093/brain/awq047; Tkac I, 2007, J NEUROCHEM, V100, P1397, DOI 10.1111/j.1471-4159.2006.04323.x; van der Burg JMM, 2008, NEUROBIOL DIS, V29, P41, DOI 10.1016/j.nbd.2007.07.029; Verbessem P, 2003, NEUROLOGY, V61, P925, DOI 10.1212/01.WNL.0000090629.40891.4B; Weiss RG, 2002, FASEB J, V16, P613, DOI 10.1096/fj.01-0462fje; Weydt P, 2006, CELL METAB, V4, P349, DOI 10.1016/j.cmet.2006.10.004; Wheeler VC, 1999, HUM MOL GENET, V8, P115, DOI 10.1093/hmg/8.1.115; Williams JH, 2008, ANAL BIOCHEM, V372, P135, DOI 10.1016/j.ab.2007.09.020; Yang LC, 2009, J NEUROCHEM, V109, P1427, DOI 10.1111/j.1471-4159.2009.06074.x; Zhang SF, 2011, NEURODEGENER DIS, V8, P194, DOI 10.1159/000321681	47	93	94	1	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					1361	1370		10.1074/jbc.M111.309849	http://dx.doi.org/10.1074/jbc.M111.309849			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22123819	Green Published, hybrid			2022-12-27	WOS:000299170300050
J	Choi, JY; Augagneur, Y; Ben Mamoun, C; Voelker, DR				Choi, Jae-Yeon; Augagneur, Yoann; Ben Mamoun, Choukri; Voelker, Dennis R.			Identification of Gene Encoding Plasmodium knowlesi Phosphatidylserine Decarboxylase by Genetic Complementation in Yeast and Characterization of in Vitro Maturation of Encoded Enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FALCIPARUM PHOSPHOETHANOLAMINE METHYLTRANSFERASE; SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI; TRANSPORT; PHOSPHOLIPIDS; MITOCHONDRIA; PHOSPHATIDYLCHOLINE; ETHANOLAMINE; METABOLISM; EXPRESSION	The 23-megabase genome of Plasmodium falciparum, the causative agent of severe human malaria, contains similar to 5300 genes, most of unknown function or lacking homologs in other organisms. Identification of these gene functions will help in the discovery of novel targets for the development of antimalarial drugs and vaccines. The P. falciparum genome is unusually A + T-rich, which hampers cloning and expressing these genes in heterologous systems for functional analysis. The large repertoire of genetic tools available for Saccharomyces cerevisiae makes this yeast an ideal system for large scale functional complementation analyses of parasite genes. Here, we report the construction of a cDNA library from P. knowlesi, which has a lower A + T content compared with P. falciparum. This library was applied in a yeast complementation assay to identify malaria genes involved in the decarboxylation of phosphatidylserine. Transformation of a psd1 Delta psd2 Delta dpl1 Delta yeast strain, defective in phosphatidylethanolamine synthesis, with the P. knowlesi library led to identification of a new parasite phosphatidylserine decarboxylase (PkPSD). Unlike phosphatidylserine decarboxylase enzymes from other eukaryotes that are tightly associated with membranes, the PkPSD enzyme expressed in yeast was equally distributed between membrane and soluble fractions. In vitro studies reveal that truncated forms of PkPSD are soluble and undergo auto-endoproteolytic maturation in a phosphatidylserine-dependent reaction that is inhibited by other anionic phospholipids. This study defines a new system for probing the function of Plasmodium genes by library-based genetic complementation and its usefulness in revealing new biochemical properties of encoded proteins.	[Choi, Jae-Yeon; Voelker, Dennis R.] Natl Jewish Hlth, Dept Med, Basic Sci Sect, Denver, CO 80206 USA; [Augagneur, Yoann; Ben Mamoun, Choukri] Yale Univ, Sch Med, Dept Internal Med, Infect Dis Sect, New Haven, CT 06520 USA	National Jewish Health; Yale University	Voelker, DR (corresponding author), Natl Jewish Hlth, Dept Med, Basic Sci Sect, 1400 Jackson St, Denver, CO 80206 USA.	voelkerd@njhealth.org	augagneur, yoann/L-2000-2015	augagneur, yoann/0000-0002-6816-5931	National Institutes of Health [5R37 GM32543]; Burroughs Welcome Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM032453, R37GM032543] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Welcome Fund(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 5R37 GM32543 (to D. R. V.). This work was also supported by the Burroughs Welcome Fund (to C. B. M.).	ACHLEITNER G, 1995, J BIOL CHEM, V270, P29836; Achleitner G, 1999, EUR J BIOCHEM, V264, P545, DOI 10.1046/j.1432-1327.1999.00658.x; Ausubel F.M., 1993, CURRENT PROTOCOLS MO; Baunaure F, 2004, MOL MICROBIOL, V51, P33, DOI 10.1046/j.1365-2958.2003.03822.x; Bobenchik AM, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-4; Choi JY, 2004, J BIOL CHEM, V279, P42321, DOI 10.1074/jbc.M405074200; Csordas G, 2006, J CELL BIOL, V174, P915, DOI 10.1083/jcb.200604016; CULLIS PR, 1978, BIOCHIM BIOPHYS ACTA, V513, P31, DOI 10.1016/0005-2736(78)90109-8; DOWHAN W, 1992, METHOD ENZYMOL, V209, P348; DOWHAN W, 1974, J BIOL CHEM, V249, P3079; Elabbadi N, 1997, BIOCHEM J, V324, P435, DOI 10.1042/bj3240435; ELABBADI N, 1992, ANTIMICROB AGENTS CH, V36, P50, DOI 10.1128/AAC.36.1.50; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; GRUNER SM, 1985, ANNU REV BIOPHYS BIO, V14, P211, DOI 10.1146/annurev.biophys.14.1.211; Gulshan K, 2008, MOL CELL BIOL, V28, P5851, DOI 10.1128/MCB.00405-08; LI QX, 1988, J BIOL CHEM, V263, P11516; Miller CA, 1998, NUCLEIC ACIDS RES, V26, P3577, DOI 10.1093/nar/26.15.3577; Pain A, 2008, NATURE, V455, P799, DOI 10.1038/nature07306; Pessi G, 2005, J BIOL CHEM, V280, P12461, DOI 10.1074/jbc.M414626200; Pessi G, 2006, FUTURE LIPIDOL, V1, P173, DOI 10.2217/17460875.1.2.173; Reynolds JM, 2008, J BIOL CHEM, V283, P7894, DOI 10.1074/jbc.M709869200; Rontein D, 2003, PLANT PHYSIOL, V132, P1678, DOI 10.1104/pp.103.023242; Rontein D, 2001, J BIOL CHEM, V276, P35523, DOI 10.1074/jbc.M106038200; Rosenthal PJ, 2003, J EXP BIOL, V206, P3735, DOI 10.1242/jeb.00589; ROUSER G, 1966, LIPIDS, V1, P85, DOI 10.1007/BF02668129; Schumacher MM, 2002, J BIOL CHEM, V277, P51033, DOI 10.1074/jbc.M205301200; Storey MK, 2001, J BIOL CHEM, V276, P48539, DOI 10.1074/jbc.M109043200; TROTTER PJ, 1995, J BIOL CHEM, V270, P6062, DOI 10.1074/jbc.270.11.6062; TROTTER PJ, 1993, J BIOL CHEM, V268, P21416; Trotter PJ, 1998, J BIOL CHEM, V273, P13189, DOI 10.1074/jbc.273.21.13189; VANPOELJE PD, 1990, ANNU REV BIOCHEM, V59, P29, DOI 10.1146/annurev.bi.59.070190.000333; Vial H., 1998, MALARIA PARASITE BIO, P159; VOELKER DR, 1992, METHOD ENZYMOL, V209, P360; Voelker DR, 1997, BBA-LIPID LIPID MET, V1348, P236, DOI 10.1016/S0005-2760(97)00101-X; Wu WI, 2001, J BIOL CHEM, V276, P7114, DOI 10.1074/jbc.M010278200	35	29	31	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					222	232		10.1074/jbc.M111.313676	http://dx.doi.org/10.1074/jbc.M111.313676			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22057268	hybrid, Green Published			2022-12-27	WOS:000298682400023
J	Langelueddecke, C; Roussa, E; Fenton, RA; Wolff, NA; Lee, WK; Thevenod, F				Langelueddecke, Christian; Roussa, Eleni; Fenton, Robert A.; Wolff, Natascha A.; Lee, Wing-Kee; Thevenod, Frank			Lipocalin-2 (24p3/Neutrophil Gelatinase-associated Lipocalin (NGAL)) Receptor Is Expressed in Distal Nephron and Mediates Protein Endocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROXIMAL TUBULE CELLS; ISCHEMIA-REPERFUSION INJURY; RAT-KIDNEY; CONVOLUTED TUBULE; HUMAN TRANSFERRIN; METAL COMPLEXES; IRON; CADMIUM; METALLOTHIONEIN; TRANSPORT	In the kidney, bulk reabsorption of filtered proteins occurs in the proximal tubule via receptor-mediated endocytosis (RME) through the multiligand receptor complex megalin-cubilin. Other mechanisms and nephron sites for RME of proteins are unclear. Recently, the secreted protein 24p3 (lipocalin-2, neutrophil gelatinase-associated lipocalin (NGAL)), which is expressed in the distal nephron, has been identified as a sensitive biomarker of kidney damage. A high-affinity receptor for 24p3 (24p3R) that is involved in endocytotic iron delivery has also been cloned. We investigated the localization of 24p3R in rodent kidney and its role in RME of protein-metal complexes and albumin. Immunostaining of kidney tissue showed expression of 24p3R in apical membranes of distal tubules and collecting ducts, but not of proximal tubule. The differential expression of 24p3R in these nephron segments was confirmed in the respective cell lines. CHO cells transiently transfected with 24p3R or distal tubule cells internalized submicromolar concentrations of fluorescence-coupled proteins transferrin, albumin, or metallothionein (MT) as well as the toxic cadmium-MT (Cd-7(2+)-MT) complex, which caused cell death. Uptake of MT or transferrin and Cd-7(2+)-MT toxicity were prevented by picomolar concentrations of 24p3. An EC50 of 123 +/- 50 nM was determined for binding of MT to 24p3R by microscale thermophoresis. Hence, 24p3R binds proteins filtered by the kidney with high affinity and may contribute to RME of proteins, including 24p3, and to Cd-7(2+)-MT toxicity in distal nephron segments.	[Thevenod, Frank] Univ Witten Herdecke, Inst Physiol & Pathophysiol, ZBAF, Fac Hlth, D-58453 Witten, Germany; [Roussa, Eleni] Univ Freiburg, Inst Anat & Cell Biol 2, D-79104 Freiburg, Germany; [Fenton, Robert A.] Aarhus Univ, Dept Biomed, DK-8000 Aarhus C, Denmark	Witten Herdecke University; University of Freiburg; Aarhus University	Thevenod, F (corresponding author), Univ Witten Herdecke, Inst Physiol & Pathophysiol, ZBAF, Fac Hlth, Stockumer Str 12, D-58453 Witten, Germany.	frank.thevenod@uni-wh.de	Fenton, Robert/AFR-6983-2022; Fenton, Robert A/ABD-9824-2021	Fenton, Robert/0000-0003-1623-199X; Lee, Wing-Kee/0000-0002-7352-4679	Deutsche Forschungsgemeinschaft [TH345/11-1]; ZBAF (Centre for Biomedical Training and Research Witten/Herdecke University); Lundbeck foundation; Danish Medical Research Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); ZBAF (Centre for Biomedical Training and Research Witten/Herdecke University); Lundbeck foundation(Lundbeckfonden); Danish Medical Research Foundation	This work was supported by Deutsche Forschungsgemeinschaft Grant TH345/11-1 and ZBAF (Centre for Biomedical Training and Research Witten/Herdecke University) (to F. T.).; Supported by the Lundbeck foundation and Danish Medical Research Foundation.	Abouhamed M, 2006, AM J PHYSIOL-RENAL, V290, pF1525, DOI 10.1152/ajprenal.00359.2005; Abouhamed M, 2007, AM J PHYSIOL-RENAL, V293, pF705, DOI 10.1152/ajprenal.00198.2007; AISEN P, 1978, J BIOL CHEM, V253, P1930; ANDERSEN O, 1984, ENVIRON HEALTH PERSP, V54, P249, DOI 10.2307/3429813; Baaske P, 2010, ANGEW CHEM INT EDIT, V49, P2238, DOI 10.1002/anie.200903998; Bao GH, 2010, NAT CHEM BIOL, V6, P602, DOI [10.1038/nchembio.402, 10.1038/NCHEMBIO.402]; Berger T, 2006, P NATL ACAD SCI USA, V103, P1834, DOI 10.1073/pnas.0510847103; Birn H, 2006, KIDNEY INT, V69, P440, DOI 10.1038/sj.ki.5000141; BOYLAN JW, 1979, KIDNEY INT, V16, P247, DOI 10.1038/ki.1979.127; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brandes A, 2007, AM J PHYSIOL-REG I, V293, pR2400, DOI 10.1152/ajpregu.00208.2007; BREMNER I, 1987, PROG FOOD NUTR SCI, V11, P1; Campean V, 2001, AM J PHYSIOL-RENAL, V281, pF1028, DOI 10.1152/ajprenal.0148.2001; Christensen EI, 2002, NAT REV MOL CELL BIO, V3, P258, DOI 10.1038/nrm778; Christensen EI, 2009, PFLUG ARCH EUR J PHY, V458, P1039, DOI 10.1007/s00424-009-0685-8; CORTNEY MA, 1970, J CLIN INVEST, V49, P1, DOI 10.1172/JCI106208; Devireddy LR, 2010, CELL, V141, P1006, DOI 10.1016/j.cell.2010.04.040; Devireddy LR, 2005, CELL, V123, P1293, DOI 10.1016/j.cell.2005.10.027; Devireddy LR, 2001, SCIENCE, V293, P829, DOI 10.1126/science.1061075; Duhr S, 2006, P NATL ACAD SCI USA, V103, P19678, DOI 10.1073/pnas.0603873103; Erfurt C, 2003, AM J PHYSIOL-CELL PH, V285, pC1367, DOI 10.1152/ajpcell.00217.2003; Flo TH, 2004, NATURE, V432, P917, DOI 10.1038/nature03104; GALASKE RG, 1979, KIDNEY INT, V16, P394, DOI 10.1038/ki.1979.142; GESEK FA, 1992, J CLIN INVEST, V90, P429, DOI 10.1172/JCI115878; GIROLAMI JP, 1989, TOXICOLOGY, V55, P117, DOI 10.1016/0300-483X(89)90179-0; Goetz DH, 2002, MOL CELL, V10, P1033, DOI 10.1016/S1097-2765(02)00708-6; Hvidberg V, 2005, FEBS LETT, V579, P773, DOI 10.1016/j.febslet.2004.12.031; Johri N, 2010, BIOMETALS, V23, P783, DOI 10.1007/s10534-010-9328-y; Kastner C, 2009, AM J PHYSIOL-RENAL, V296, pF902, DOI 10.1152/ajprenal.90451.2008; Klassen RB, 2004, AM J PHYSIOL-RENAL, V287, pF393, DOI 10.1152/ajprenal.00233.2003; LAUWERYS R, 1989, TOXICOL LETT, V46, P13, DOI 10.1016/0378-4274(89)90113-6; LEBER PD, 1970, AM J PHYSIOL, V219, P358, DOI 10.1152/ajplegacy.1970.219.2.358; Lee WK, 2011, TOXICOL SCI, V121, P343, DOI 10.1093/toxsci/kfr071; Liu ZM, 2011, J BIOL CHEM, V286, P20606, DOI 10.1074/jbc.M110.216549; Loffing J, 2001, AM J PHYSIOL-RENAL, V281, pF1021, DOI 10.1152/ajprenal.0085.2001; Maack T., 1992, KIDNEY PHYSL PATHOPH, P3005; MADSEN KM, 1982, KIDNEY INT, V21, P354, DOI 10.1038/ki.1982.29; MCGRAW TE, 1987, J CELL BIOL, V105, P207, DOI 10.1083/jcb.105.1.207; Mishra J, 2003, J AM SOC NEPHROL, V14, P2534, DOI 10.1097/01.ASN.0000088027.54400.C6; Moeller HB, 2009, KIDNEY INT, V75, P295, DOI 10.1038/ki.2008.505; Mori K, 2005, J CLIN INVEST, V115, P610, DOI 10.1172/JCI200523056; Nielsen R, 2010, PEDIATR NEPHROL, V25, P813, DOI 10.1007/s00467-009-1381-9; Norden AGW, 2001, KIDNEY INT, V60, P1885, DOI 10.1046/j.1523-1755.2001.00016.x; Pabla N, 2008, KIDNEY INT, V73, P994, DOI 10.1038/sj.ki.5002786; Paragas N, 2011, NAT MED, V17, P216, DOI 10.1038/nm.2290; PERRIN DD, 1971, BIOCHIM BIOPHYS ACTA, V230, P96, DOI 10.1016/0304-4165(71)90057-2; ROY AK, 1972, J HISTOCHEM CYTOCHEM, V20, P89, DOI 10.1177/20.2.89; Sabolic I, 2010, BIOMETALS, V23, P897, DOI 10.1007/s10534-010-9351-z; Schmidt-Ott KM, 2007, J AM SOC NEPHROL, V18, P407, DOI 10.1681/ASN.2006080882; STRAUS W, 1964, J HISTOCHEM CYTOCHEM, V12, P470, DOI 10.1177/12.6.470; Tabuchi M, 2000, J BIOL CHEM, V275, P22220, DOI 10.1074/jbc.M001478200; THEVENOD F, 1988, AM J PHYSIOL, V255, pG429, DOI 10.1152/ajpgi.1988.255.4.G429; Thevenod F, 2003, NEPHRON PHYSIOL, V93, P87, DOI DOI 10.1159/000070241; Thevenod F, 2009, TOXICOL APPL PHARM, V238, P221, DOI 10.1016/j.taap.2009.01.013; TOJO A, 1992, AM J PHYSIOL, V263, pF601, DOI 10.1152/ajprenal.1992.263.4.F601; Viau A, 2010, J CLIN INVEST, V120, P4065, DOI 10.1172/JCI42004; WARD JH, 1982, BIOCHEM J, V208, P19, DOI 10.1042/bj2080019; Wienken CJ, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1093; Wolff NA, 2006, J PHARMACOL EXP THER, V318, P782, DOI 10.1124/jpet.106.102574; Wolff NA, 2011, TOXICOL LETT, V203, P210, DOI 10.1016/j.toxlet.2011.03.014; Wolff NA, 2011, J CELL MOL MED, V15, P209, DOI 10.1111/j.1582-4934.2009.00985.x; Yang J, 2002, MOL CELL, V10, P1045, DOI 10.1016/S1097-2765(02)00710-4	62	74	76	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					159	169		10.1074/jbc.M111.308296	http://dx.doi.org/10.1074/jbc.M111.308296			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22084236	Green Published, hybrid			2022-12-27	WOS:000298682400018
J	Wei, X; Guo, YH; Shao, CL; Sun, ZK; Zhurina, D; Liu, DW; Liu, W; Zou, DY; Jiang, Z; Wang, XS; Zhao, JL; Shang, W; Li, XL; Liao, XR; Huang, LY; Riedel, CU; Yuan, J				Wei, Xiao; Guo, Yanhong; Shao, Changlin; Sun, Zhongke; Zhurina, Daria; Liu, Dawei; Liu, Wei; Zou, Dayang; Jiang, Zheng; Wang, Xuesong; Zhao, Jiangli; Shang, Wei; Li, Xuelian; Liao, Xiangru; Huang, Liuyu; Riedel, Christian U.; Yuan, Jing			Fructose Uptake in Bifidobacterium longum NCC2705 Is Mediated by an ATP-binding Cassette Transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MALTOSE ABC TRANSPORTER; FECAL MICROBIOTA; PROTEIN; GLUCOSE; EXPRESSION; SEQUENCE; SYSTEMS; MALF	Recently, a putative ATP-binding cassette (ABC) transport system was identified in Bifidobacterium longum NCC2705 that is highly up-regulated during growth on fructose as the sole carbon source. Cloning and expression of the corresponding ORFs (bl0033-0036) result in efficient fructose uptake by bacteria. Sequence analysis reveals high similarity to typical ABC transport systems and suggests that these genes are organized as an operon. Expression of FruE is induced by fructose, ribose, or xylose and is able to bind these sugars with fructose as the preferred substrate. Our data suggest that BL0033-0036 constitute a high affinity fructose-specific ABC transporter of B. longum NCC2705. We thus suggest to rename the coding genes to fruEKFG and the corresponding proteins to FruE (sugar-binding protein), FruK (ATPase subunit), FruF, and FruG (membrane permeases). Furthermore, protein-protein interactions between the components of the transporter complex were determined by GST pulldown and Western blot analysis. This revealed interactions between the membrane subunits FruF and FruG with FruE, which in vivo is located on the external side of the membrane, and with the cytoplasmatic ATPase FruK. This is in line with the proposed model for bacterial ABC sugar transporters.	[Wei, Xiao; Guo, Yanhong; Shao, Changlin; Sun, Zhongke; Liu, Dawei; Liu, Wei; Zou, Dayang; Jiang, Zheng; Wang, Xuesong; Zhao, Jiangli; Li, Xuelian; Huang, Liuyu; Yuan, Jing] Acad Mil Med Sci, Inst Dis Control & Prevent, Beijing 100071, Peoples R China; [Sun, Zhongke; Zhurina, Daria; Riedel, Christian U.] Univ Ulm, Inst Microbiol & Biotechnol, D-89069 Ulm, Germany; [Guo, Yanhong; Shao, Changlin; Shang, Wei; Liao, Xiangru] Jiangnan Univ, Sch Biotechnol, Wuxi 214122, Peoples R China	Academy of Military Medical Sciences - China; Ulm University; Jiangnan University	Huang, LY (corresponding author), Acad Mil Med Sci, Inst Dis Control & Prevent, 20 Dongda St, Beijing 100071, Peoples R China.	huangliuyuly@163.com; christian.riedel@uni-ulm.de; yuanjing6216@163.com	Sun, Zhongke/R-2274-2019; Sun, Zhongke/AAF-5743-2020	Sun, Zhongke/0000-0002-9784-9769; Riedel, Christian U./0000-0001-7134-7085	National Natural Science Foundation of China [81071321]; Mega-projects of Science and Technology Research of China [2009ZX10004-205]; National High Technology Research and Development Program of China 863 Program [2007AA02Z118]; German Academic Exchange Service/Federal Ministry of Education and Research [D/09/04778]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Mega-projects of Science and Technology Research of China; National High Technology Research and Development Program of China 863 Program(National High Technology Research and Development Program of China); German Academic Exchange Service/Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)Deutscher Akademischer Austausch Dienst (DAAD))	This work was supported by National Natural Science Foundation of China Grant 81071321, Mega-projects of Science and Technology Research of China Grant 2009ZX10004-205, and National High Technology Research and Development Program of China 863 Program Grant 2007AA02Z118.; Supported by German Academic Exchange Service/Federal Ministry of Education and Research Grant D/09/04778. To whom correspondence may be addressed: Inst. of Microbiology and Biotechnology, University of Ulm, D-89069 Ulm, Germany. Tel.: 49-7315024853; Fax: 49-7315022719; E-mail: christian.riedel@uni-ulm.de.	AULKEMEYER P, 1991, MOL MICROBIOL, V5, P2913, DOI 10.1111/j.1365-2958.1991.tb01851.x; Bordignon E, 2010, MOL MICROBIOL, V77, P1354, DOI 10.1111/j.1365-2958.2010.07319.x; Briczinski EP, 2008, APPL ENVIRON MICROB, V74, P6941, DOI 10.1128/AEM.01280-08; Brigidi P, 2001, RES MICROBIOL, V152, P735, DOI 10.1016/S0923-2508(01)01254-2; Caescu CI, 2004, J BACTERIOL, V186, P6515, DOI 10.1128/JB.186.19.6515-6525.2004; DE MAN J. C., 1960, JOUR APPL BACT, V23, P130, DOI 10.1111/j.1365-2672.1960.tb00188.x; Ehrle R, 1996, J BACTERIOL, V178, P2255, DOI 10.1128/jb.178.8.2255-2262.1996; FRANGIONI JV, 1993, ANAL BIOCHEM, V210, P179, DOI 10.1006/abio.1993.1170; Fukuda S, 2011, NATURE, V469, P543, DOI 10.1038/nature09646; Grote M, 2009, J BIOL CHEM, V284, P17521, DOI 10.1074/jbc.M109.006270; He T, 2007, J MICROBIOL METH, V69, P364, DOI 10.1016/j.mimet.2007.02.008; HENDERSON PJF, 1992, INT REV CYTOL, V137A, P149; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Jacso T, 2009, BIOCHEMISTRY-US, V48, P2216, DOI 10.1021/bi801376m; KORNBERG HL, 1989, FEMS MICROBIOL LETT, V63, P193, DOI 10.1016/0168-6445(89)90024-7; Lambert A, 2001, J BACTERIOL, V183, P4709, DOI 10.1128/JB.183.16.4709-4717.2001; Liu DW, 2011, PROTEOMICS, V11, P2628, DOI 10.1002/pmic.201100035; Matsuki T, 1999, APPL ENVIRON MICROB, V65, P4506; Oldham ML, 2007, NATURE, V450, P515, DOI 10.1038/nature06264; Orelle C, 2008, P NATL ACAD SCI USA, V105, P12837, DOI 10.1073/pnas.0803799105; Parche S, 2006, J BACTERIOL, V188, P1260, DOI 10.1128/JB.188.4.1260-1265.2006; Parche S, 2007, J MOL MICROB BIOTECH, V12, P9, DOI 10.1159/000096455; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Rossi M, 1998, LETT APPL MICROBIOL, V26, P101; Saier MH, 2000, MOL MICROBIOL, V35, P699, DOI 10.1046/j.1365-2958.2000.01759.x; SAURIN W, 1994, PROTEIN SCI, V3, P325; Schell MA, 2002, P NATL ACAD SCI USA, V99, P14422, DOI 10.1073/pnas.212527599; Tannock GW, 2004, APPL ENVIRON MICROB, V70, P2129, DOI 10.1128/AEM.70.4.2129-2136.2004; Young SL, 2004, CLIN DIAGN LAB IMMUN, V11, P686, DOI 10.1128/CDLI.11.4.686-690.2004; Yuan J, 2008, J PROTEOME RES, V7, P375, DOI 10.1021/pr0704940; Yuan J, 2006, MOL CELL PROTEOMICS, V5, P1105, DOI 10.1074/mcp.M500410-MCP200; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zimmermann MB, 2010, AM J CLIN NUTR, V92, P1406, DOI 10.3945/ajcn.110.004564	33	14	22	0	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					357	367		10.1074/jbc.M111.266213	http://dx.doi.org/10.1074/jbc.M111.266213			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22102285	hybrid, Green Published			2022-12-27	WOS:000298682400035
J	Yamahashi, Y; Saito, Y; Murata-Kamiya, N; Hatakeyama, M				Yamahashi, Yukie; Saito, Yasuhiro; Murata-Kamiya, Naoko; Hatakeyama, Masanori			Polarity-regulating Kinase Partitioning-defective 1b (PAR1b) Phosphorylates Guanine Nucleotide Exchange Factor H1 (GEF-H1) to Regulate RhoA-dependent Actin Cytoskeletal Reorganization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HELICOBACTER-PYLORI CAGA; C-ELEGANS EMBRYOS; STRESS FIBERS; CELL POLARITY; PROTEIN; LOCALIZATION; BINDING; MICROTUBULES; GTPASES; APKC	Partitioning-defective 1b (PAR1b), also known as microtubule affinity-regulating kinase 2 (MARK2), is a member of evolutionally conserved PAR1/MARK serine/threonine kinase family, which plays a key role in the establishment and maintenance of cell polarity at least partly by phosphorylating microtubule-associated proteins (MAPs) that regulate microtubule stability. PAR1b has also been reported to influence actin cytoskeletal organization, raising the possibility that PAR1b functionally interacts with the Rho family of small GTPases, central regulators of the actin cytoskeletal system. Consistent with this notion, PAR1 was recently found to be physically associated with a RhoA-specific guanine nucleotide exchange factor H1 (GEF-H1). This observation suggests a functional link between PAR1b and GEF-H1. Here we show that PAR1b induces phosphorylation of GEF-H1 on serine 885 and serine 959. We also show that PAR1b-induced serine 885/serine 959 phosphorylation inhibits RhoA-specific GEF activity of GEF-H1. As a consequence, GEF-H1 phosphorylated on both of the serine residues loses the ability to stimulate RhoA and thereby fails to induce RhoA-dependent stress fiber formation. These findings indicate that PAR1b not only regulates microtubule stability through phosphorylation of MAPs but also influences actin stress fiber formation by inducing GEF-H1 phosphorylation. The dual function of PAR1b in the microtubule-based cytoskeletal system and the actin-based cytoskeletal system in the coordinated regulation of cell polarity, cell morphology, and cell movement.	[Hatakeyama, Masanori] Univ Tokyo, Grad Sch Med, Div Microbiol, Bunkyo Ku, Tokyo 1130033, Japan; [Yamahashi, Yukie] Hokkaido Univ, Grad Sch Sci, Div Chem, Sapporo, Hokkaido 0600815, Japan	University of Tokyo; Hokkaido University	Hatakeyama, M (corresponding author), Univ Tokyo, Grad Sch Med, Div Microbiol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	mhata@m.u-tokyo.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; Grants-in-Aid for Scientific Research [22114001, 22240085, 22114002] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for the Scientific Research on Innovative Area from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan.	Aijaz S, 2005, DEV CELL, V8, P777, DOI 10.1016/j.devcel.2005.03.003; Benton R, 2003, CELL, V115, P691, DOI 10.1016/S0092-8674(03)00938-3; Birkenfeld J, 2008, TRENDS CELL BIOL, V18, P210, DOI 10.1016/j.tcb.2008.02.006; Birkenfeld J, 2007, DEV CELL, V12, P699, DOI 10.1016/j.devcel.2007.03.014; Bourzac KM, 2007, INFECT IMMUN, V75, P1203, DOI 10.1128/IAI.01702-06; Brajenovic M, 2004, J BIOL CHEM, V279, P12804, DOI 10.1074/jbc.M312171200; Bridges D., 2005, SCI STKE, V296, pre10, DOI DOI 10.1126/STKE.2962005RE10; Bugyi B, 2010, ANNU REV BIOPHYS, V39, P449, DOI 10.1146/annurev-biophys-051309-103849; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Drewes G, 1997, CELL, V89, P297, DOI 10.1016/S0092-8674(00)80208-1; Ebneth A, 1999, CELL MOTIL CYTOSKEL, V44, P209, DOI 10.1002/(SICI)1097-0169(199911)44:3<209::AID-CM6>3.0.CO;2-4; Etienne-Manneville S, 2003, CURR OPIN CELL BIOL, V15, P67, DOI 10.1016/S0955-0674(02)00005-4; Fujishiro SH, 2008, BIOCHEM BIOPH RES CO, V368, P162, DOI 10.1016/j.bbrc.2008.01.066; Garcia-Mata R, 2006, METHOD ENZYMOL, V406, P425, DOI 10.1016/S0076-6879(06)06031-9; Goldstein B, 2007, DEV CELL, V13, P609, DOI 10.1016/j.devcel.2007.10.007; Higashi H, 2002, SCIENCE, V295, P683, DOI 10.1126/science.1067147; Hornbeck PV, 2004, PROTEOMICS, V4, P1551, DOI 10.1002/pmic.200300772; Hurov JB, 2004, CURR BIOL, V14, P736, DOI 10.1016/j.cub.2004.04.007; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; KEMPHUES KJ, 1988, CELL, V52, P311, DOI 10.1016/S0092-8674(88)80024-2; Krendel M, 2002, NAT CELL BIOL, V4, P294, DOI 10.1038/ncb773; Lu HS, 2009, J BIOL CHEM, V284, P23024, DOI 10.1074/jbc.M109.001008; McCaffrey LM, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001370; Pellegrin S, 2007, J CELL SCI, V120, P3491, DOI 10.1242/jcs.018473; Pertz O, 2006, NATURE, V440, P1069, DOI 10.1038/nature04665; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Saadat I, 2007, NATURE, V447, P330, DOI 10.1038/nature05765; Saito Y, 2010, J EXP MED, V207, P2157, DOI 10.1084/jem.20100602; Sunayama J, 2005, J CELL BIOL, V170, P295, DOI 10.1083/jcb.200409117; Suzuki A, 2004, CURR BIOL, V14, P1425, DOI 10.1016/j.cub.2004.08.021; Suzuki A, 2006, J CELL SCI, V119, P979, DOI 10.1242/jcs.02898; Tapon N, 1997, CURR OPIN CELL BIOL, V9, P86, DOI 10.1016/S0955-0674(97)80156-1; Watts JL, 1996, DEVELOPMENT, V122, P3133; Yoshimura Y, 2011, BIOCHEM BIOPH RES CO, V408, P322, DOI 10.1016/j.bbrc.2011.04.032; Zenke FT, 2004, J BIOL CHEM, V279, P18392, DOI 10.1074/jbc.M400084200	37	41	42	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2011	286	52					44576	44584		10.1074/jbc.M111.267021	http://dx.doi.org/10.1074/jbc.M111.267021			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870CA	22072711	Green Published, hybrid			2022-12-27	WOS:000298645500029
J	Yu, X; Wang, FS; Liu, HS; Adams, G; Aikhionbare, F; Liu, D; Cao, XW; Fan, LB; Hu, GH; Chen, Y; Frost, A; Partridge, E; Ding, X; Yao, XB				Yu, Xue; Wang, Fengsong; Liu, Hongsheng; Adams, Gregory; Aikhionbare, Felix; Liu, Dong; Cao, Xinwang; Fan, Libin; Hu, Guohong; Chen, Yong; Frost, Andra; Partridge, Edward; Ding, Xia; Yao, Xuebiao			ACAP4 Protein Cooperates with Grb2 Protein to Orchestrate Epidermal Growth Factor-stimulated Integrin beta 1 Recycling in Cell Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GUANINE-NUCLEOTIDE EXCHANGE; RECEPTOR TYROSINE KINASES; ENDOCYTIC TRANSPORT; SIGNAL-TRANSDUCTION; BREAST-CANCER; RHOA ACTIVITY; SH3 DOMAINS; RAS PATHWAY; ADHESION; ARF6	ARF6 GTPase is an important regulator of membrane trafficking and actin-based cytoskeleton dynamics active at the leading edge of migrating cells. The integrin family heterodimeric transmembrane proteins serve as major receptors for extracellular matrix proteins, which play essential roles in cell adhesion and migration. Our recent proteomic analyses of ARF6 effectors have identified a novel ARF6 GTPase-activating protein, ACAP4, essential for EGF-induced cell migration. However, molecular mechanisms underlying ACAP4-mediated cell migration have remained elusive. Here, we show that ACAP4 regulates integrin beta 1 dynamics during EGF-stimulated cell migration by interaction with Grb2. Our biochemical study shows that EGF stimulation induces phosphorylation of tyrosine 733, which enables ACAP4 to bind Grb2. This interaction of ACAP4 with Grb2 regulates integrin beta 1 recycling to the plasma membrane. Importantly, knockdown of ACAP4 by siRNA or overexpression of ACAP4 decreased recycling of integrin beta 1 to the plasma membrane and reduced integrin-mediated cell migration. Taken together, these results suggest a novel function for ACAP4 in the regulation cell migration through controlling integrin beta 1 dynamics.	[Yu, Xue; Wang, Fengsong; Liu, Hongsheng; Cao, Xinwang; Yao, Xuebiao] Univ Sci & Technol China, Anhui Key Lab Cellular Dynam, Hefei 230027, Peoples R China; [Wang, Fengsong; Adams, Gregory; Aikhionbare, Felix; Yao, Xuebiao] Morehouse Sch Med, Dept Physiol, Atlanta, GA 30310 USA; [Liu, Dong; Chen, Yong] Xijing Hosp, Dept Hepatobiliary Surg, Xian 710032, Peoples R China; [Cao, Xinwang; Fan, Libin] Anhui Med Univ, Sch Life Sci, Hefei 230027, Peoples R China; [Hu, Guohong] SIBS SJTU Inst Hlth Sci, Key Lab Stem Cell Biol, Shanghai 200025, Peoples R China; [Frost, Andra; Partridge, Edward] Univ Alabama, Sch Med, Ctr Comprehens Canc, Birmingham, AL 35294 USA; [Ding, Xia] Beijing Univ Chinese Med, Sch Grad Studies, Beijing 100029, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Morehouse School of Medicine; Air Force Military Medical University; Anhui Medical University; University of Alabama System; University of Alabama Birmingham; Beijing University of Chinese Medicine	Wang, FS (corresponding author), Univ Sci & Technol China, Anhui Key Lab Cellular Dynam, Hefei 230027, Peoples R China.	fengsong@ustc.edu.cn; xyao@msm.edu	Yao, Xuebiao/P-5771-2014; Cao, Xinwang/W-2883-2019	cao, xinwang/0000-0002-8052-7333; Hu, Guohong/0000-0002-2980-5166	National Institutes of Health [DK-56292, U54CA118948, P20CA132389]; NCRR [UL1 RR025008, G12RR03034]; Chinese 973 Project [2010CB912103, 2012CB945000, 2007CB914503, 2002CB713700]; Chinese Natural Science Foundation [30900497, 30500183, 30870990, 91129714, 90508002, 90913016]; Chinese Academy of Science [KSCX1-YW-R-65, KSCX2-YW-H-10, KSCX2-YW-R-195, 2009DFA31010]; Anhui Province [08040102005]; NATIONAL CANCER INSTITUTE [U54CA118948, P20CA132389] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025008, G12RR003034] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056292] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM058268] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [S21MD000101] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Chinese 973 Project(National Basic Research Program of China); Chinese Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Chinese Academy of Science(Chinese Academy of Sciences); Anhui Province; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported, in whole or in part, by National Institutes of Health Grants DK-56292, U54CA118948, and P20CA132389 (to X. Y.), NCRR Grant UL1 RR025008 from the Clinical and Translational Science Award Program, and NCRR Grant G12RR03034 (for use of facilities). This work was supported in part by Chinese 973 Project Grants 2010CB912103, 2012CB945000, 2007CB914503, and 2002CB713700 (to X. Y.), Chinese Natural Science Foundation Grants 30900497 (to F. W.), 30500183, 30870990, and 91129714 (to X. D.), and 90508002 and 90913016 (to X. Y.), Chinese Academy of Science Grants KSCX1-YW-R-65, KSCX2-YW-H-10, and KSCX2-YW-R-195, International Collaboration Grant 2009DFA31010 (to X. D.), and Anhui Province Project Grant 08040102005 (to X. Y.).	Bretscher MS, 1998, CURR BIOL, V8, P721, DOI 10.1016/S0960-9822(98)70281-7; BRETSCHER MS, 1989, EMBO J, V8, P1341, DOI 10.1002/j.1460-2075.1989.tb03514.x; BRETSCHER MS, 1992, EMBO J, V11, P405, DOI 10.1002/j.1460-2075.1992.tb05068.x; BUDAY L, 1993, CELL, V73, P611, DOI 10.1016/0092-8674(93)90146-H; Carlier MF, 2000, J BIOL CHEM, V275, P21946, DOI 10.1074/jbc.M000687200; Caswell P, 2008, TRENDS CELL BIOL, V18, P257, DOI 10.1016/j.tcb.2008.03.004; Caswell PT, 2009, NAT REV MOL CELL BIO, V10, P843, DOI 10.1038/nrm2799; Caswell PT, 2006, TRAFFIC, V7, P14, DOI 10.1111/j.1600-0854.2005.00362.x; CLARK SG, 1992, NATURE, V356, P340, DOI 10.1038/356340a0; Dai J, 2004, DEV CELL, V7, P771, DOI 10.1016/j.devcel.2004.10.002; Ding X, 2010, J BIOL CHEM, V285, P18769, DOI 10.1074/jbc.M110.129007; Dubash AD, 2007, J CELL SCI, V120, P3989, DOI 10.1242/jcs.003806; Dunphy JL, 2006, CURR BIOL, V16, P315, DOI 10.1016/j.cub.2005.12.032; EGAN SE, 1993, NATURE, V363, P45, DOI 10.1038/363045a0; Fang ZY, 2006, MOL CELL PROTEOMICS, V5, P1437, DOI 10.1074/mcp.M600050-MCP200; GALE NW, 1993, NATURE, V363, P88, DOI 10.1038/363088a0; Giubellino A, 2008, EXPERT OPIN THER TAR, V12, P1021, DOI 10.1517/14728222.12.8.1021 ; Grant BD, 2009, NAT REV MOL CELL BIO, V10, P597, DOI 10.1038/nrm2755; Ha VL, 2008, J BIOL CHEM, V283, P14915, DOI 10.1074/jbc.M709717200; Heibeck TH, 2009, J PROTEOME RES, V8, P3852, DOI 10.1021/pr900044c; HolgadoMadruga M, 1996, NATURE, V379, P560, DOI 10.1038/379560a0; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Inoue H, 2007, TRAFFIC, V8, P1465, DOI 10.1111/j.1600-0854.2007.00624.x; Ismail SA, 2010, CELL, V141, P812, DOI 10.1016/j.cell.2010.03.051; Ivaska J, 2002, EMBO J, V21, P3608, DOI 10.1093/emboj/cdf371; Jones MC, 2006, CURR OPIN CELL BIOL, V18, P549, DOI 10.1016/j.ceb.2006.08.003; Li J, 2005, DEV CELL, V9, P663, DOI 10.1016/j.devcel.2005.09.012; Li J, 2007, J CELL BIOL, V178, P453, DOI 10.1083/jcb.200608033; LI N, 1993, NATURE, V363, P85, DOI 10.1038/363085a0; Lim Y, 2008, J CELL BIOL, V180, P187, DOI 10.1083/jcb.200708194; LOWENSTEIN EJ, 1992, CELL, V70, P431, DOI 10.1016/0092-8674(92)90167-B; Morishige M, 2008, NAT CELL BIOL, V10, P85, DOI 10.1038/ncb1672; Ng T, 1999, EMBO J, V18, P3909, DOI 10.1093/emboj/18.14.3909; Nishimura T, 2007, DEV CELL, V13, P15, DOI 10.1016/j.devcel.2007.05.003; Oh SJ, 2010, J BIOL CHEM, V285, P14610, DOI 10.1074/jbc.M109.043935; Okabe H, 2004, INT J ONCOL, V24, P43; Papusheva E, 2010, EMBO J, V29, P2753, DOI 10.1038/emboj.2010.182; Pellinen T, 2008, DEV CELL, V15, P371, DOI 10.1016/j.devcel.2008.08.001; Powelka AM, 2004, TRAFFIC, V5, P20, DOI 10.1111/j.1600-0854.2004.00150.x; Radhakrishna H, 1997, J CELL BIOL, V139, P49, DOI 10.1083/jcb.139.1.49; Reynolds LE, 2002, NAT MED, V8, P27, DOI 10.1038/nm0102-27; Robertson SE, 2006, MOL BIOL CELL, V17, P645, DOI 10.1091/mbc.E05-07-0662; ROZAKISADCOCK M, 1993, NATURE, V363, P83, DOI 10.1038/363083a0; ROZAKISADCOCK M, 1992, NATURE, V360, P689, DOI 10.1038/360689a0; SCHLAEPFER DD, 1994, NATURE, V372, P786; Sun TT, 2011, CELL, V144, P703, DOI 10.1016/j.cell.2011.02.003; Valderrama F, 2008, NAT CELL BIOL, V10, P16, DOI 10.1038/ncb0108-16; Xue Y, 2008, MOL CELL PROTEOMICS, V7, P1598, DOI 10.1074/mcp.M700574-MCP200; Yamazaki T, 2002, J CELL SCI, V115, P1791	49	16	19	2	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2011	286	51					43735	43747		10.1074/jbc.M111.278770	http://dx.doi.org/10.1074/jbc.M111.278770			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866SH	22027826	Green Published, hybrid			2022-12-27	WOS:000298402300017
J	Feierler, J; Wirth, M; Welte, B; Schussler, S; Jochum, M; Faussner, A				Feierler, Jens; Wirth, Markus; Welte, Benjamin; Schuessler, Steffen; Jochum, Marianne; Faussner, Alexander			Helix 8 Plays a Crucial Role in Bradykinin B-2 Receptor Trafficking and Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED-RECEPTOR; ANGIOTENSIN-II RECEPTOR; LIGHT-DEPENDENT CHANGES; B2 KININ RECEPTORS; BETA-ARRESTIN; BETA(2)-ADRENERGIC RECEPTOR; CYTOPLASMIC END; DOWN-REGULATION; SMALL-MOLECULE; TERMINAL TAIL	Upon activation the human bradykinin B-2 receptor (B2R) acts as guanine nucleotide exchange factor for the G proteins G(q/11) and G(i). Thereafter, it gets phosphorylated by G protein-coupled receptor kinases (GRKs) and recruits beta-arrestins, which block further G protein activation and promote B2R internalization via clathrin-coated pits. As for most G protein-coupled receptors of family A, an intracellular helix 8 after transmembrane domain 7 is also predicted for the B2R. We show here that disruption of helix 8 in the B2R by either C-terminal truncation or just by mutation of a central amino acid (Lys-315) to a helix-breaking proline resulted in strong reduction of surface expression. Interestingly, this malfunction could be overcome by the addition of the membrane-permeable B2R antagonist JSM10292, suggesting that helix 8 has a general role for conformational stabilization that can be accounted for by an appropriate antagonist. Intriguingly, an intact helix 8, but not the C terminus with its phosphorylation sites, was indispensable for receptor sequestration and for interaction of the B2R with GRK2/3 and beta-arrestin2 as shown by co-immunoprecipitation. Recruitment of beta-arrestin1, however, required the presence of the C terminus. Taken together, our results demonstrate that helix 8 of the B2R plays a crucial role not only in efficient trafficking to the plasma membrane or the activation of G proteins but also for the interaction of the B2R with GRK2/3 and beta-arrestins. Additional data obtained with chimera of B2R with other G protein-coupled receptors of family A suggest that helix 8 might have similar functions in other GPCRs as well.	[Feierler, Jens; Wirth, Markus; Welte, Benjamin; Schuessler, Steffen; Jochum, Marianne; Faussner, Alexander] Univ Munich, Abt Klin Chem & Klin Biochem, D-80336 Munich, Germany	University of Munich	Faussner, A (corresponding author), Univ Munich, Abt Klin Chem & Klin Biochem, Nussbaumstr 20, D-80336 Munich, Germany.	alexander.faussner@med.uni-muenchen.de	Wirth, Markus/ABW-6155-2022					Ahn KH, 2010, BIOCHEMISTRY-US, V49, P502, DOI 10.1021/bi901619r; Ahn S, 2003, P NATL ACAD SCI USA, V100, P1740, DOI 10.1073/pnas.262789099; Altenbach C, 2001, BIOCHEMISTRY-US, V40, P15493, DOI 10.1021/bi011545o; Altenbach C, 2001, BIOCHEMISTRY-US, V40, P15483, DOI 10.1021/bi011546g; Andrews G, 2008, MOL PHARMACOL, V73, P855, DOI 10.1124/mol.107.039321; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Blaukat A, 2003, AM J PHYSIOL-HEART C, V284, pH1909, DOI 10.1152/ajpheart.00034.2003; Blaukat A, 2001, J BIOL CHEM, V276, P40431, DOI 10.1074/jbc.M107024200; Claing A, 2002, PROG NEUROBIOL, V66, P61, DOI 10.1016/S0301-0082(01)00023-5; Delos Santos NM, 2006, J BIOL CHEM, V281, P12896, DOI 10.1074/jbc.M508500200; Dowal L, 2011, P NATL ACAD SCI USA, V108, P2951, DOI 10.1073/pnas.1014863108; Ernst OP, 2000, J BIOL CHEM, V275, P1937, DOI 10.1074/jbc.275.3.1937; Faussner A, 2005, FEBS J, V272, P129, DOI 10.1111/j.1432-1033.2004.04390.x; Faussner A, 1998, J BIOL CHEM, V273, P2617, DOI 10.1074/jbc.273.5.2617; Faussner A, 2003, AM J PHYSIOL-HEART C, V284, pH1892, DOI 10.1152/ajpheart.01147.2002; Faussner A, 1999, IMMUNOPHARMACOLOGY, V45, P13, DOI 10.1016/S0162-3109(99)00052-1; Faussner A, 2009, FEBS J, V276, P3491, DOI 10.1111/j.1742-4658.2009.07071.x; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Gehret AU, 2010, MOL PHARMACOL, V77, P288, DOI 10.1124/mol.109.059733; Gibson C, 2009, J MED CHEM, V52, P4370, DOI 10.1021/jm9002445; HESS JF, 1992, BIOCHEM BIOPH RES CO, V184, P260, DOI 10.1016/0006-291X(92)91187-U; Hu JX, 2010, NAT CHEM BIOL, V6, P541, DOI [10.1038/NCHEMBIO.385, 10.1038/nchembio.385]; Huynh J, 2009, MOL CELL ENDOCRINOL, V302, P118, DOI 10.1016/j.mce.2009.01.002; Kai H, 1998, BIOCHEM J, V332, P781, DOI 10.1042/bj3320781; Kakoki M, 2006, J CLIN INVEST, V116, P1302, DOI 10.1172/JCI26958; Kalatskaya I, 2004, J BIOL CHEM, V279, P31268, DOI 10.1074/jbc.M401796200; Kalatskaya I, 2006, BIOL CHEM, V387, P603, DOI 10.1515/BC.2006.077; Kaye RG, 2011, MOL PHARMACOL, V79, P701, DOI 10.1124/mol.110.070177; Krasel C, 2008, J BIOL CHEM, V283, P31840, DOI 10.1074/jbc.M806086200; Leeb-Lundberg LMF, 2005, PHARMACOL REV, V57, P27, DOI 10.1124/pr.57.1.2; Mangmool S, 2006, J BIOL CHEM, V281, P31940, DOI 10.1074/jbc.M602832200; Okuno T, 2005, J BIOL CHEM, V280, P32049, DOI 10.1074/jbc.R500007200; Okuno T, 2003, J BIOL CHEM, V278, P41500, DOI 10.1074/jbc.M307335200; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Qian HW, 2001, MOL ENDOCRINOL, V15, P1706, DOI 10.1210/me.15.10.1706; Ricks TK, 2009, J BIOL CHEM, V284, P34444, DOI 10.1074/jbc.M109.048942; Sano T, 1997, J BIOL CHEM, V272, P23631, DOI 10.1074/jbc.272.38.23631; Shi L, 2001, BIOCHEMISTRY-US, V40, P12339, DOI 10.1021/bi011204a; Shiina T, 2001, J BIOL CHEM, V276, P33019, DOI 10.1074/jbc.M100140200; Simaan M, 2005, CELL SIGNAL, V17, P1074, DOI 10.1016/j.cellsig.2004.12.001; Swift S, 2006, J BIOL CHEM, V281, P4109, DOI 10.1074/jbc.M509525200; Tebben AJ, 2011, METHODS MOL BIOL, V672, P359, DOI 10.1007/978-1-60761-839-3_15; Tetsuka M, 2004, ENDOCRINOLOGY, V145, P3712, DOI 10.1210/en.2003-1638; Thielen A, 2005, FEBS LETT, V579, P5227, DOI 10.1016/j.febslet.2005.08.043; Wess J, 2008, TRENDS PHARMACOL SCI, V29, P616, DOI 10.1016/j.tips.2008.08.006; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Yasuda D, 2009, FASEB J, V23, P1470, DOI 10.1096/fj.08-125385; Zhang X, 2005, J NEUROCHEM, V95, P169, DOI 10.1111/j.1471-4159.2005.03352.x; Zhang XQ, 2008, J NEUROCHEM, V106, P781, DOI 10.1111/j.1471-4159.2008.05431.x	49	25	25	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					43282	43293		10.1074/jbc.M111.256909	http://dx.doi.org/10.1074/jbc.M111.256909			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22016392	Green Published, hybrid			2022-12-27	WOS:000298351300048
J	Fong, YH; Wong, HC; Chuck, CP; Chen, YW; Sun, HZ; Wong, KB				Fong, Yu Hang; Wong, Ho Chun; Chuck, Chi Pang; Chen, Yu Wai; Sun, Hongzhe; Wong, Kam-Bo			Assembly of Preactivation Complex for Urease Maturation in Helicobacter pylori CRYSTAL STRUCTURE OF UreF-UreH PROTEIN COMPLEX	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACCESSORY PROTEIN; NICKEL-BINDING; ACTIVATION; APOPROTEIN; IDENTIFICATION; MUTAGENESIS; FUSION; SITE	Colonization of Helicobacter pylori in the acidic environment of the human stomach depends on the neutralizing activity of urease. Activation of apo-urease involves carboxylation of lysine 219 and insertion of two nickel ions. In H. pylori, this maturation process involves four urease accessory proteins as follows: UreE, UreF, UreG, and UreH. It is postulated that the apo-urease interacts with UreF, UreG, and UreH to form a pre-activation complex that undergoes GTP-dependent activation of urease. The crystal structure of the UreF-UreH complex reveals conformational changes in two distinct regions of UreF upon complex formation. First, the flexible C-terminal residues of UreF become ordered, forming an extra helix alpha 10 and a loop structure stabilized by hydrogen bonds involving Arg-250. Second, the first turn of helix alpha 2 uncoils to expose a conserved residue, Tyr-48. Substitution of R250A or Y48A in UreF abolishes the formation of the heterotrimeric complex of UreG-UreF-UreH and abolishes urease maturation. Our results suggest that the C-terminal residues and helix alpha 2 of UreF are essential for the recruitment of UreG for the formation of the pre-activation complex. The molecular mass of the UreF-UreH complex determined by static light scattering was 116 +/- 2.3 kDa, which is consistent with the quaternary structure of a dimer of heterodimers observed in the crystal structure. Taking advantage of the unique 2-fold symmetry observed in both the crystal structures of H. pylori urease and the UreF-UreH complex, we proposed a topology model of the pre-activation complex for urease maturation.	Chinese Univ Hong Kong, Sch Life Sci, Ctr Prot Sci & Crystallog, Hong Kong, Hong Kong, Peoples R China; [Chen, Yu Wai] Kings Coll London, Randall Div Cell & Mol Biophys, London SE1 1UL, England; [Sun, Hongzhe] Univ Hong Kong, Dept Chem, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; University of London; King's College London; University of Hong Kong	Wong, KB (corresponding author), Chinese Univ Hong Kong, Rm Sci Ctr 289, Shatin, Hong Kong, Peoples R China.	kbwong@cuhk.edu.hk	Wong, Kam-Bo/G-4258-2013; Chen, Yu Wai/AAJ-8037-2020; Wong, Kam-Bo/AAU-9364-2021; /D-3123-2009	Wong, Kam-Bo/0000-0002-6984-5373; Chen, Yu Wai/0000-0001-7833-7533; Wong, Kam-Bo/0000-0002-6984-5373; /0000-0001-6697-6899	Research Grants Council of Hong Kong [HKU 1/07C]; University Grants Council of Hong Kong [SEG CUHK08]	Research Grants Council of Hong Kong(Hong Kong Research Grants Council); University Grants Council of Hong Kong	This work was supported by the Collaborative Research Fund of the Research Grants Council of Hong Kong Grant HKU 1/07C.; We thank Carmen Lau for help with cloning, Ka Ming Lee for help with figure preparation, and Chi Kong Lau, Kwok Ho Chan, and Martin Rees for many helpful discussions. We also thank staff members of the Diamond Light Source beamline I-04, in particular, Michael Mrosek, for assistance with data collection and analysis. The equipment used in this study was supported in part by University Grants Council of Hong Kong One-Off Special Equipment Grant SEG CUHK08.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Balasubramanian A, 2010, J MOL BIOL, V400, P274, DOI 10.1016/j.jmb.2010.05.009; Bellucci M, 2009, BIOCHEM J, V422, P91, DOI 10.1042/BJ20090434; Benini S, 1999, STRUCTURE, V7, P205, DOI 10.1016/S0969-2126(99)80026-4; Boer JL, 2010, BIOCHEMISTRY-US, V49, P5859, DOI 10.1021/bi1004987; Carter EL, 2010, J BACTERIOL, V192, P2294, DOI 10.1128/JB.01426-09; Carter EL, 2009, METALLOMICS, V1, P207, DOI 10.1039/b903311d; Chang ZZ, 2004, J BIOL CHEM, V279, P15305, DOI 10.1074/jbc.M312979200; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gasper R, 2006, J BIOL CHEM, V281, P27492, DOI 10.1074/jbc.M600809200; Gasper R, 2009, NAT REV MOL CELL BIO, V10, P423, DOI 10.1038/nrm2689; Grosse-Kunstleve RW, 2003, ACTA CRYSTALLOGR D, V59, P1966, DOI 10.1107/S0907444903018043; Ha NC, 2001, NAT STRUCT BIOL, V8, P505, DOI 10.1038/88563; Heimer SR, 2001, J BACTERIOL, V183, P1423, DOI 10.1128/JB.183.4.1423-1433.2001; JABRI E, 1995, SCIENCE, V268, P998, DOI 10.1126/science.7754395; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kim JK, 2006, J BACTERIOL, V188, P8413, DOI 10.1128/JB.01265-06; Lam R, 2010, PROTEINS, V78, P2839, DOI 10.1002/prot.22802; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Maier RJ, 2007, BIOMETALS, V20, P655, DOI 10.1007/s10534-006-9061-8; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MOBLEY HLT, 1995, MICROBIOL REV, V59, P451, DOI 10.1128/MMBR.59.3.451-480.1995; Moncrief MBC, 1996, J BACTERIOL, V178, P5417, DOI 10.1128/jb.178.18.5417-5421.1996; Moncrief MBC, 1997, J BACTERIOL, V179, P4081, DOI 10.1128/jb.179.13.4081-4086.1997; PARK IS, 1994, P NATL ACAD SCI USA, V91, P3233, DOI 10.1073/pnas.91.8.3233; PARK IS, 1995, J BACTERIOL, V177, P1947, DOI 10.1128/jb.177.8.1947-1951.1995; PARK IS, 1995, SCIENCE, V267, P1156, DOI 10.1126/science.7855593; Quiroz-Valenzuela S, 2008, ARCH BIOCHEM BIOPHYS, V480, P51, DOI 10.1016/j.abb.2008.09.004; Rain JC, 2001, NATURE, V409, P211, DOI 10.1038/35051615; Salomone-Stagni M, 2007, PROTEINS, V68, P749, DOI 10.1002/prot.21472; Soriano A, 1999, P NATL ACAD SCI USA, V96, P11140, DOI 10.1073/pnas.96.20.11140; Soriano A, 2000, BIOCHEMISTRY-US, V39, P12435, DOI 10.1021/bi001296o; Stingl K, 2008, MOL CELL PROTEOMICS, V7, P2429, DOI 10.1074/mcp.M800160-MCP200; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; Voland P, 2003, AM J PHYSIOL-GASTR L, V284, pG96, DOI 10.1152/ajpgi.00160.2002; WARREN JR, 1983, LANCET, V1, P1273; WEATHERBURN MW, 1967, ANAL CHEM, V39, P971, DOI 10.1021/ac60252a045	42	33	35	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					43241	43249		10.1074/jbc.M111.296830	http://dx.doi.org/10.1074/jbc.M111.296830			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22013070	hybrid, Green Published			2022-12-27	WOS:000298351300044
J	Lahti, M; Bligt, E; Niskanen, H; Parkash, V; Brandt, AM; Jokinen, J; Patrikainen, P; Kapyla, J; Heino, J; Salminen, TA				Lahti, Matti; Bligt, Eva; Niskanen, Henri; Parkash, Vimal; Brandt, Anna-Maria; Jokinen, Johanna; Patrikainen, Pekka; Kapyla, Jarmo; Heino, Jyrki; Salminen, Tiina A.			Structure of Collagen Receptor Integrin alpha I-1 Domain Carrying the Activating Mutation E317A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							I-DOMAIN; CRYSTAL-STRUCTURE; CELL-ADHESION; A-DOMAIN; ALPHA-1-BETA-1; BINDING; RECOGNITION; AFFINITY; INTEGRIN-ALPHA-1-BETA-1; ALPHA(1)BETA(1)	We have analyzed the structure and function of the integrin alpha I-1 domain harboring a gain-of-function mutation E317A. To promote protein crystallization, a double variant with an additional C139S mutation was used. In cell adhesion assays, the E317A mutation promoted binding to collagen. Similarly, the double mutation C139S/E317A increased adhesion compared with C139S alone. Furthermore, soluble alpha I-1 C139S/E317A was a higher avidity collagen binder than alpha I-1 C139S, indicating that the double variant represents an activated form. The crystal structure of the activated variant of alpha I-1 was solved at 1.9 angstrom resolution. The E317A mutation results in the unwinding of the alpha C helix, but the metal ion has moved toward loop 1, instead of loop 2 in the open alpha I-2. Furthermore, unlike in the closed alpha I domains, the metal ion is pentacoordinated and, thus, prepared for ligand binding. Helix 7, which has moved downward in the open alpha I-2 structure, has not changed its position in the activated alpha I-1 variant. During the integrin activation, Glu(335) on helix 7 binds to the metal ion at the metal ion-dependent adhesion site (MIDAS) of the beta(1) subunit. Interestingly, in our cell adhesion assays E317A could activate collagen binding even after mutating Glu(335). This indicates that the stabilization of helix 7 into its downward position is not required if the alpha(1) MIDAS is already open. To conclude, the activated alpha I-1 domain represents a novel conformation of the alpha I domain, mimicking the structural state where the Arg(287)-Glu(317) ion pair has just broken during the integrin activation.	[Bligt, Eva; Parkash, Vimal; Brandt, Anna-Maria; Salminen, Tiina A.] Abo Akad Univ, Dept Biosci, Struct Bioinformat Lab, FI-20520 Turku, Finland; [Lahti, Matti; Niskanen, Henri; Jokinen, Johanna; Patrikainen, Pekka; Kapyla, Jarmo; Heino, Jyrki] Univ Turku, Dept Biochem & Food Chem, FI-20014 Turku, Finland	Abo Akademi University; University of Turku	Salminen, TA (corresponding author), Abo Akad Univ, Dept Biosci, Struct Bioinformat Lab, FI-20520 Turku, Finland.	tiina.salminen@abo.fi	Salminen, Tiina A./AAM-5443-2021; Salminen, Tiina A/G-7492-2019	Salminen, Tiina A./0000-0002-4135-8020; Salminen, Tiina A/0000-0002-4135-8020; Patrikainen, Pekka/0000-0002-4931-1817; Niskanen, Henri/0000-0002-8361-5531; Kapyla, Jarmo/0000-0003-3036-713X	Academy of Finland; Sigrid Juselius Foundation; Cancer Society of Finland; Cancer Society of Southwestern Finland; Tor, Joe, and Pentti Borgs Foundation; Finnish Cultural Foundation; Varsinais-Suomi Regional fund; Turku graduate school of Biomedical Sciences; National Doctoral Programme in Informational and Structural Biology	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Cancer Society of Finland; Cancer Society of Southwestern Finland; Tor, Joe, and Pentti Borgs Foundation; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Varsinais-Suomi Regional fund; Turku graduate school of Biomedical Sciences; National Doctoral Programme in Informational and Structural Biology	This work was supported by the Academy of Finland; the Sigrid Juselius Foundation; the Cancer Society of Finland; the Cancer Society of Southwestern Finland; the Tor, Joe, and Pentti Borgs Foundation; the Finnish Cultural Foundation; the Varsinais-Suomi Regional fund; the Turku graduate school of Biomedical Sciences; and the National Doctoral Programme in Informational and Structural Biology.	Alonso JL, 2002, CURR BIOL, V12, pR340, DOI 10.1016/S0960-9822(02)00852-7; Aquilina A, 2002, EUR J BIOCHEM, V269, P1136, DOI 10.1046/j.0014-2956.2001.02740.x; Arnaout MA, 2005, ANNU REV CELL DEV BI, V21, P381, DOI 10.1146/annurev.cellbio.21.090704.151217; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chen X, 2010, P NATL ACAD SCI USA, V107, P14727, DOI 10.1073/pnas.1008663107; Chen XW, 2004, AM J PATHOL, V165, P617, DOI 10.1016/S0002-9440(10)63326-3; Connors WL, 2007, J BIOL CHEM, V282, P14675, DOI 10.1074/jbc.M700759200; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Ekholm E, 2002, AM J PATHOL, V160, P1779, DOI 10.1016/S0002-9440(10)61124-8; Emsley J, 1997, J BIOL CHEM, V272, P28512, DOI 10.1074/jbc.272.45.28512; Emsley J, 2000, CELL, V101, P47, DOI 10.1016/S0092-8674(00)80622-4; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans R, 2009, J CELL SCI, V122, P215, DOI 10.1242/jcs.019117; Fiorucci S, 2002, IMMUNITY, V17, P769, DOI 10.1016/S1074-7613(02)00476-4; Gardner H, 1999, J CELL SCI, V112, P263; Heino J, 2007, BIOESSAYS, V29, P1001, DOI 10.1002/bies.20636; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jin M, 2004, STRUCTURE, V12, P2137, DOI 10.1016/j.str.2004.10.005; Jokinen J, 2010, EMBO J, V29, P196, DOI 10.1038/emboj.2009.326; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KAMATA T, 1994, J BIOL CHEM, V269, P26006; Kapyla J, 2004, J BIOL CHEM, V279, P51677, DOI 10.1074/jbc.M409412200; Kapyla J, 2000, J BIOL CHEM, V275, P3348, DOI 10.1074/jbc.275.5.3348; KERN A, 1993, EUR J BIOCHEM, V215, P151, DOI 10.1111/j.1432-1033.1993.tb18017.x; LEE JO, 1995, CELL, V80, P631, DOI 10.1016/0092-8674(95)90517-0; Lee JO, 1995, STRUCTURE, V3, P1333, DOI 10.1016/S0969-2126(01)00271-4; Li R, 1998, J CELL BIOL, V143, P1523, DOI 10.1083/jcb.143.6.1523; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; McCleverty CJ, 2003, BIOCHEM J, V372, P121, DOI 10.1042/BJ20021273; McEver RP, 2010, ANNU REV CELL DEV BI, V26, P363, DOI 10.1146/annurev.cellbio.042308.113238; Morgan MR, 2007, NAT REV MOL CELL BIO, V8, P957, DOI 10.1038/nrm2289; Moser M, 2009, SCIENCE, V324, P895, DOI 10.1126/science.1163865; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nolte M, 1999, FEBS LETT, V452, P379, DOI 10.1016/S0014-5793(99)00666-3; Nykvist P, 2000, J BIOL CHEM, V275, P8255, DOI 10.1074/jbc.275.11.8255; Nymalm Y, 2004, J BIOL CHEM, V279, P7962, DOI 10.1074/jbc.M312912200; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Pozzi M, 1998, J CELL BIOL, V142, P587; QU AD, 1995, P NATL ACAD SCI USA, V92, P10277, DOI 10.1073/pnas.92.22.10277; Ray SJ, 2004, IMMUNITY, V20, P167, DOI 10.1016/S1074-7613(04)00021-4; Rich RL, 1999, J BIOL CHEM, V274, P24906, DOI 10.1074/jbc.274.35.24906; Salminen TA, 1999, ACTA CRYSTALLOGR D, V55, P1365, DOI 10.1107/S0907444999006009; Shimaoka M, 2003, CELL, V112, P99, DOI 10.1016/S0092-8674(02)01257-6; Shimaoka M, 2002, ANNU REV BIOPH BIOM, V31, P485, DOI 10.1146/annurev.biophys.31.101101.140922; Shimaoka M, 2000, NAT STRUCT BIOL, V7, P674, DOI 10.1038/77978; Siljander PRM, 2004, J BIOL CHEM, V279, P47763, DOI 10.1074/jbc.M404685200; Smith HW, 2010, NAT REV MOL CELL BIO, V11, P23, DOI 10.1038/nrm2821; Suzuki K, 2007, NATURE, V446, P680, DOI 10.1038/nature05652; Tulla M, 2001, J BIOL CHEM, V276, P48206, DOI 10.1074/jbc.M104058200; Tulla M, 2008, EXP CELL RES, V314, P1734, DOI 10.1016/j.yexcr.2008.01.025; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; VOIGT S, 1995, HISTOCHEM J, V27, P123; Vorup-Jensen T, 2003, P NATL ACAD SCI USA, V100, P1873, DOI 10.1073/pnas.0237387100; Xie C, 2010, EMBO J, V29, P666, DOI 10.1038/emboj.2009.367; Xiong JP, 2000, J BIOL CHEM, V275, P38762, DOI 10.1074/jbc.C000563200; Yang W, 2004, P NATL ACAD SCI USA, V101, P2906, DOI 10.1073/pnas.0307340101; Zhang HM, 2008, MOL CELL, V31, P432, DOI 10.1016/j.molcel.2008.06.022	58	18	18	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					43343	43351		10.1074/jbc.M111.261909	http://dx.doi.org/10.1074/jbc.M111.261909			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22030389	Green Published, hybrid			2022-12-27	WOS:000298351300054
J	Linster, CL; Noel, G; Stroobant, V; Vertommen, D; Vincent, MF; Bommer, GT; Veiga-da-Cunha, M; Van Schaftingen, E				Linster, Carole L.; Noel, Gaetane; Stroobant, Vincent; Vertommen, Didier; Vincent, Marie-Francoise; Bommer, Guido T.; Veiga-da-Cunha, Maria; Van Schaftingen, Emile			Ethylmalonyl-CoA Decarboxylase, a New Enzyme Involved in Metabolite Proofreading	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REDUCED DIPHOSPHOPYRIDINE NUCLEOTIDE; L-2-HYDROXYGLUTARIC ACIDURIA; SHORT-CHAIN; METHYLMALONYL COENZYME; CROTONASE SUPERFAMILY; ESCHERICHIA-COLI; UROPYGIAL GLAND; ANIMAL TISSUES; PROPIONIC ACID; R-PATHWAY	Background: Acetyl-CoA and propionyl-CoA carboxylases slowly form ethylmalonyl-CoA as a side activity. Results: Anew enzyme, ethylmalonyl-CoA decarboxylase, was identified in mammalian tissues and shown to be encoded by the ECHDC1 gene. Knocking down this gene increased the formation of ethylmalonate from butyrate in cultured cells. Conclusion: Ethylmalonyl-CoA decarboxylase may be a new "metabolite proofreading" enzyme. Significance: Its deficiency may cause ethylmalonic aciduria.	[Linster, Carole L.; Noel, Gaetane; Bommer, Guido T.; Veiga-da-Cunha, Maria; Van Schaftingen, Emile] Catholic Univ Louvain, Duve Inst, Welbio & Lab Physiol Chem, B-1200 Brussels, Belgium; [Stroobant, Vincent] Catholic Univ Louvain, Duve Inst, Ludwig Inst Canc Res, B-1200 Brussels, Belgium; [Vertommen, Didier] Catholic Univ Louvain, Duve Inst, Hormone & Metab Res Unit, B-1200 Brussels, Belgium; [Vincent, Marie-Francoise] Clin Univ St Luc, Lab Metab Dis, B-1200 Brussels, Belgium	Universite Catholique Louvain; WELBIO; Ludwig Institute for Cancer Research; Universite Catholique Louvain; Universite Catholique Louvain; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc	Van Schaftingen, E (corresponding author), Catholic Univ Louvain, Duve Inst, Welbio & Lab Physiol Chem, BCHM 7539,Ave Hippocrate 75, B-1200 Brussels, Belgium.	emile.vanschaftingen@uclouvain.be	Van+Schaftingen, Emile/AAF-5532-2020; Bommer, Guido/A-8425-2011	Van Schaftingen, Emile/0000-0002-6199-7647; Bommer, Guido/0000-0001-6898-4884; Vertommen, Didier/0000-0001-7648-8282; Linster, Carole/0000-0001-7143-0719	Fonds de la Recherche Scientifique (FRS-FNRS); European Union [276814]; Welbio (Walloon region)	Fonds de la Recherche Scientifique (FRS-FNRS)(Fonds de la Recherche Scientifique - FNRS); European Union(European Commission); Welbio (Walloon region)(WELBIO)	This work was supported by the Fonds de la Recherche Scientifique (FRS-FNRS), by the European Union Seventh Framework Programme (FP7/2007-2013) under Grant 276814, and by Welbio (Walloon region).	ACHESON SA, 1988, BIOCHEMISTRY-US, V27, P7371, DOI 10.1021/bi00419a030; Adler LN, 2011, J BIOL CHEM, V286, P21511, DOI 10.1074/jbc.M111.238774; BARETZ BH, 1979, J BIOL CHEM, V254, P3468; Benning MM, 2000, BIOCHEMISTRY-US, V39, P4630, DOI 10.1021/bi9928896; BETTEY M, 1992, J PLANT PHYSIOL, V140, P513, DOI 10.1016/S0176-1617(11)80780-7; BUCKNER JS, 1978, ARCH BIOCHEM BIOPHYS, V186, P152, DOI 10.1016/0003-9861(78)90474-5; CHAYKIN S, 1956, J BIOL CHEM, V220, P811; Coleman TM, 2002, CHEM BIOL, V9, P1227, DOI 10.1016/S1074-5521(02)00264-8; Deutsch J, 2002, NEUROCHEM RES, V27, P1577, DOI 10.1023/A:1021614422668; Drozak J, 2010, J BIOL CHEM, V285, P9346, DOI 10.1074/jbc.M109.095505; Duran M, 1980, J Inherit Metab Dis, V3, P109, DOI 10.1007/BF02312543; DUVE CD, 1955, BIOCHEM J, V60, P604, DOI 10.1042/bj0600604; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; FONG JC, 1977, J BIOL CHEM, V252, P542; Galperin MY, 2006, MOL MICROBIOL, V59, P5, DOI 10.1111/j.1365-2958.2005.04950.x; GOODWIN GW, 1989, J BIOL CHEM, V264, P14965; Haller T, 2000, BIOCHEMISTRY-US, V39, P4622, DOI 10.1021/bi992888d; Hamed RB, 2008, CELL MOL LIFE SCI, V65, P2507, DOI 10.1007/s00018-008-8082-6; HILLBRICK GC, 1995, AUST J AGR RES, V46, P1259, DOI 10.1071/AR9951259; JACOB J, 1978, J LIPID RES, V19, P148; KAZIRO Y, 1961, J BIOL CHEM, V236, P1917; KOLATTUKUDY PE, 1987, ARCH BIOCHEM BIOPHYS, V256, P446, DOI 10.1016/0003-9861(87)90601-1; Korman SH, 2005, CLIN CHEM, V51, P610, DOI 10.1373/clinchem.2004.043265; Loupatty FJ, 2006, MOL GENET METAB, V87, P243, DOI 10.1016/j.ymgme.2005.09.019; MAMER OA, 1976, BIOCHEM J, V160, P417, DOI 10.1042/bj1600417a; Mamer OA, 2001, J CHROMATOGR B, V758, P49, DOI 10.1016/S0378-4347(01)00111-6; Marbaix AY, 2011, J BIOL CHEM, V286, P41246, DOI 10.1074/jbc.C111.310847; MAZUMDER R, 1962, J BIOL CHEM, V237, P3065; MEINHART JO, 1956, J BIOL CHEM, V220, P821; Miller A L, 1975, Methods Enzymol, V35, P11, DOI 10.1016/0076-6879(75)35132-X; OPPENHEIMER NJ, 1974, BIOCHEMISTRY-US, V13, P4685, DOI 10.1021/bi00720a002; Pedersen CB, 2008, HUM GENET, V124, P43, DOI 10.1007/s00439-008-0521-9; RAFTER GW, 1954, J BIOL CHEM, V208, P799; Rzem R, 2007, J INHERIT METAB DIS, V30, P681, DOI 10.1007/s10545-007-0487-0; Rzem R, 2006, BIOCHIMIE, V88, P113, DOI 10.1016/j.biochi.2005.06.005; Rzem R, 2004, P NATL ACAD SCI USA, V101, P16849, DOI 10.1073/pnas.0404840101; SPRECHER M, 1966, J BIOL CHEM, V241, P872; Steenweg ME, 2010, HUM MUTAT, V31, P380, DOI 10.1002/humu.21197; Struys EA, 2007, J INHERIT METAB DIS, V30, P690, DOI 10.1007/s10545-007-0697-5; Tiranti V, 2009, NAT MED, V15, P200, DOI 10.1038/nm.1907; Topcu M, 2004, HUM MOL GENET, V13, P2803, DOI 10.1093/hmg/ddh300; Van Schaftingen E, 2009, J INHERIT METAB DIS, V32, P135, DOI 10.1007/s10545-008-1042-3; WAITE M, 1962, J BIOL CHEM, V237, P2750	43	36	41	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					42992	43003		10.1074/jbc.M111.281527	http://dx.doi.org/10.1074/jbc.M111.281527			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22016388	Green Published, hybrid			2022-12-27	WOS:000298351300020
J	Sugai, Y; Ueno, Y; Hayashi, K; Oogami, S; Toyomasu, T; Matsumoto, S; Natsume, M; Nozaki, H; Kawaide, H				Sugai, Yoshinori; Ueno, Yohei; Hayashi, Ken-ichiro; Oogami, Shingo; Toyomasu, Tomonobu; Matsumoto, Sadamu; Natsume, Masahiro; Nozaki, Hiroshi; Kawaide, Hiroshi			Enzymatic C-13 Labeling and Multidimensional NMR Analysis of Miltiradiene Synthesized by Bifunctional Diterpene Cyclase in Selaginella moellendorffii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENT-KAURENE SYNTHASE; FIR ABIES GRANDIS; GIBBERELLIN BIOSYNTHESIS; PHYSCOMITRELLA-PATENS; ABIETADIENE SYNTHASE; COPALYL DIPHOSPHATE; FUNCTIONAL-ANALYSIS; C-13-ENRICHED PROTEINS; BACTERIAL EXPRESSION; TERPENE SYNTHASES	Background: A model lycophyte, Selaginella moellendorffii, has a unique bifunctional terpene cyclase gene. Results: The bifunctional cyclase synthesized miltiradiene from geranylgeranyl diphosphate via (+)-copalyl diphosphate. Conclusion: Fully C-13-labeled miltiradiene was unambiguously elucidated by multidimensional NMR analyses. Significance: Enzymatic synthesis of highly enriched biosynthetic products enables one-dimensional and multidimensional C-13 NMR studies.	[Sugai, Yoshinori; Ueno, Yohei; Natsume, Masahiro; Kawaide, Hiroshi] Tokyo Univ Agr & Technol, Inst Agr, Fuchu, Tokyo 1838509, Japan; [Hayashi, Ken-ichiro; Oogami, Shingo; Nozaki, Hiroshi] Okayama Univ Sci, Fac Sci, Okayama 7000005, Japan; [Toyomasu, Tomonobu] Yamagata Univ, Fac Agr, Tsuruoka, Yamagata 9978555, Japan; [Matsumoto, Sadamu] Natl Museum Nat & Sci, Tsukuba Bot Garden, Tsukuba, Ibaraki 3050005, Japan	Tokyo University of Agriculture & Technology; Okayama University of Science; Yamagata University; National Museum of Nature and Science	Kawaide, H (corresponding author), Tokyo Univ Agr & Technol, Inst Agr, Fuchu, Tokyo 1838509, Japan.	hkawaide@cc.tuat.ac.jp	Kawaide, Hiroshi/F-9243-2013; Natsume, Masahiro/C-2373-2013	Kawaide, Hiroshi/0000-0001-6693-1332; 	NMR facility of RIKEN Yokohama Institute; Research Fellowship for Young Scientists [227977]; Japan Society for Promotion of Science [20510210]; Grants-in-Aid for Scientific Research [10J07977] Funding Source: KAKEN	NMR facility of RIKEN Yokohama Institute; Research Fellowship for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by the NMR facility of RIKEN Yokohama Institute (non-proprietary use) and Research Fellowship for Young Scientists 227977 (to Y. S.) and Grant-in-aid for Scientific Research C 20510210 (to H. N.) from the Japan Society for Promotion of Science.	Banks JA, 2011, SCIENCE, V332, P960, DOI 10.1126/science.1203810; BAX A, 1990, J MAGN RESON, V88, P425, DOI 10.1016/0022-2364(90)90202-K; Breeze AL, 2000, PROG NUCL MAG RES SP, V36, P323, DOI 10.1016/S0079-6565(00)00020-0; Chen F, 2011, PLANT J, V66, P212, DOI 10.1111/j.1365-313X.2011.04520.x; CLARIDGE TDW, 2009, HIGH RESOLUTION NMR, P189; Gao W, 2009, ORG LETT, V11, P5170, DOI 10.1021/ol902051v; Gehring K, 1998, J MAGN RESON, V135, P185, DOI 10.1006/jmre.1998.1543; Hayashi K, 2006, FEBS LETT, V580, P6175, DOI 10.1016/j.febslet.2006.10.018; Hirano K, 2007, PLANT CELL, V19, P3058, DOI 10.1105/tpc.107.051524; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Kawaide H, 2006, BIOSCI BIOTECH BIOCH, V70, P583, DOI 10.1271/bbb.70.583; Kawaide H, 1997, J BIOL CHEM, V272, P21706, DOI 10.1074/jbc.272.35.21706; Kawaide H, 2011, FEBS J, V278, P123, DOI 10.1111/j.1742-4658.2010.07938.x; Keeling CI, 2011, J BIOL CHEM, V286, P21145, DOI 10.1074/jbc.M111.245951; Keeling CI, 2010, PLANT PHYSIOL, V152, P1197, DOI 10.1104/pp.109.151456; Kobayashi N, 2007, J BIOMOL NMR, V39, P31, DOI 10.1007/s10858-007-9175-5; Koksal M, 2011, NAT CHEM BIOL, V7, P431, DOI [10.1038/NCHEMBIO.578, 10.1038/nchembio.578]; Koksal M, 2011, NATURE, V469, P116, DOI 10.1038/nature09628; MACMILLAN J, 1999, COMPREHENSIVE NATURA, V2, P217; Mafu S, 2011, CHEMBIOCHEM, V12, P1984, DOI 10.1002/cbic.201100336; Martin DM, 2004, PLANT PHYSIOL, V135, P1908, DOI 10.1104/pp.104.042028; NAGAYAMA K, 1980, J MAGN RESON, V40, P321, DOI 10.1016/0022-2364(80)90255-3; Otomo K, 2004, PLANT J, V39, P886, DOI 10.1111/j.1365-313X.2004.02175.x; Peters RJ, 2000, BIOCHEMISTRY-US, V39, P15592, DOI 10.1021/bi001997l; Richman AS, 1999, PLANT J, V19, P411, DOI 10.1046/j.1365-313X.1999.00531.x; Sugai Y, 2011, BIOSCI BIOTECH BIOCH, V75, P128, DOI 10.1271/bbb.100733; SUN TP, 1994, PLANT CELL, V6, P1509, DOI 10.1105/tpc.6.10.1509; Toyomasu T, 2000, BIOSCI BIOTECH BIOCH, V64, P660, DOI 10.1271/bbb.64.660; Toyomasu T, 2008, BIOSCI BIOTECH BIOCH, V72, P1038, DOI 10.1271/bbb.70790; Toyomasu T, 2010, COMPREHENSIVE NATURAL PRODUCTS II: CHEMISTRY AND BIOLOGY, VOL 1: NATURAL PRODUCTS STRUCTURAL DIVERSITY-I: SECONDARY METABOLITES: ORGANIZATION AND BIOSYNTHESIS, P643; Trapp S, 2001, ANNU REV PLANT PHYS, V52, P689, DOI 10.1146/annurev.arplant.52.1.689; Vogel BS, 1996, J BIOL CHEM, V271, P23262, DOI 10.1074/jbc.271.38.23262; VUISTER GW, 1992, J MAGN RESON, V98, P428, DOI 10.1016/0022-2364(92)90144-V; Wilderman PR, 2007, J AM CHEM SOC, V129, P15736, DOI 10.1021/ja074977g; WILLKER W, 1993, MAGN RESON CHEM, V31, P287, DOI 10.1002/mrc.1260310315; Yamaguchi S, 1998, PLANT PHYSIOL, V116, P1271, DOI 10.1104/pp.116.4.1271; YAMANE H, 1988, TETRAHEDRON LETT, V29, P3959; Zhou K, 2009, PHYTOCHEMISTRY, V70, P366, DOI 10.1016/j.phytochem.2008.12.022	38	34	37	0	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					42840	42847		10.1074/jbc.M111.302703	http://dx.doi.org/10.1074/jbc.M111.302703			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22027823	hybrid, Green Published			2022-12-27	WOS:000298351300005
J	Wood, KC; Batchelor, AM; Bartus, K; Harris, KL; Garthwaite, G; Vernon, J; Garthwaite, J				Wood, Katherine C.; Batchelor, Andrew M.; Bartus, Katalin; Harris, Kathryn L.; Garthwaite, Giti; Vernon, Jeffrey; Garthwaite, John			Picomolar Nitric Oxide Signals from Central Neurons Recorded Using Ultrasensitive Detector Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOLUBLE GUANYLYL CYCLASE; LONG-TERM POTENTIATION; IN-VIVO; CONCENTRATION DYNAMICS; RAT CEREBELLUM; CHEMICAL BIOLOGY; LIVING CELLS; BRAIN-TISSUE; SYNTHASE; ACTIVATION	Nitric oxide (NO) is a widespread signaling molecule with potentially multifarious actions of relevance to health and disease. A fundamental determinant of how it acts is its concentration, but there remains a lack of coherent information on the patterns of NO release from its sources, such as neurons or endothelial cells, in either normal or pathological conditions. We have used detector cells having the highest recorded NO sensitivity to monitor NO release from brain tissue quantitatively and in real time. Stimulation of NMDA receptors, which are coupled to activation of neuronal NO synthase, routinely generated NO signals from neurons in cerebellar slices. The average computed peak NO concentrations varied across the anatomical layers of the cerebellum, from 12 to 130 pM. The mean value found in the hippocampus was 200 pM. Much variation in the amplitudes recorded by individual detector cells was observed, this being attributable to their location at variable distances from the NO sources. From fits to the data, the NO concentrations at the source surfaces were 120 pM to 1.4 nM, and the underlying rates of NO generation were 36-350 nM/s, depending on area. Our measurements are 4-5 orders of magnitude lower than reported by some electrode recordings in cerebellum or hippocampus. In return, they establish coherence between the NO concentrations able to elicit physiological responses in target cells through guanylyl cyclase-linked NO receptors, the concentrations that neuronal NO synthase is predicted to generate locally, and the concentrations that neurons actually produce.	[Wood, Katherine C.; Batchelor, Andrew M.; Bartus, Katalin; Harris, Kathryn L.; Garthwaite, Giti; Vernon, Jeffrey; Garthwaite, John] UCL, Wolfson Inst Biomed Res, London WC1E 6BT, England	University of London; University College London	Garthwaite, J (corresponding author), UCL, Wolfson Inst Biomed Res, Gower St, London WC1E 6BT, England.	john.garthwaite@ucl.ac.uk	Wood, Katherine/K-6728-2019; Batchelor, Andrew/C-1174-2008	Wood, Katherine/0000-0002-5520-5025; Batchelor, Andrew/0000-0002-5984-7842; Hampden-Smith, Kathryn/0000-0002-8053-5114	Wellcome Trust [081512]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by Programme Grant 081512 from The Wellcome Trust.	Amatore C, 2006, CHEMPHYSCHEM, V7, P181, DOI 10.1002/cphc.200500202; Batchelor AM, 2010, P NATL ACAD SCI USA, V107, P22060, DOI 10.1073/pnas.1013147107; Bellamy TC, 2002, J BIOL CHEM, V277, P31801, DOI 10.1074/jbc.M205936200; BREDT DS, 1994, NEURON, V13, P301, DOI 10.1016/0896-6273(94)90348-4; Brown GC, 2010, NITRIC OXIDE-BIOL CH, V23, P153, DOI 10.1016/j.niox.2010.06.001; Burette A, 2002, J NEUROSCI, V22, P8961; De Visscher G, 2002, J CEREBR BLOOD F MET, V22, P515, DOI 10.1097/00004647-200205000-00002; Ferrer-Sueta G, 2009, ACS CHEM BIOL, V4, P161, DOI 10.1021/cb800279q; Frade JG, 2009, HIPPOCAMPUS, V19, P603, DOI 10.1002/hipo.20536; Gardner PR, 2001, FREE RADICAL BIO MED, V31, P191, DOI 10.1016/S0891-5849(01)00569-X; GARTHWAITE J, 1987, J NEUROCHEM, V48, P29, DOI 10.1111/j.1471-4159.1987.tb13123.x; GARTHWAITE J, 1988, NATURE, V336, P385, DOI 10.1038/336385a0; Garthwaite J, 2008, EUR J NEUROSCI, V27, P2783, DOI 10.1111/j.1460-9568.2008.06285.x; Glitsch M, 1999, J NEUROSCI, V19, P511; Griffiths C, 2003, MOL PHARMACOL, V64, P1349, DOI 10.1124/mol.64.6.1349; Griffiths C, 2002, EUR J NEUROSCI, V15, P962, DOI 10.1046/j.1460-9568.2002.01930.x; Hall CN, 2006, J PHYSIOL-LONDON, V577, P549, DOI 10.1113/jphysiol.2006.118380; Hall CN, 2008, J PHYSIOL-LONDON, V586, P3597, DOI 10.1113/jphysiol.2008.154724; Hall CN, 2009, NITRIC OXIDE-BIOL CH, V21, P92, DOI 10.1016/j.niox.2009.07.002; Halvey EJ, 2009, J BIOL CHEM, V284, P25630, DOI 10.1074/jbc.M109.030338; IGNARRO LJ, 1991, BIOCHEM PHARMACOL, V41, P485, DOI 10.1016/0006-2952(91)90618-F; Keynes RG, 2004, EUR J NEUROSCI, V19, P1163, DOI 10.1111/j.1460-9568.2004.03217.x; Kimura S, 1998, J NEUROSCI, V18, P8551; KNOWLES RG, 1992, TRENDS BIOCHEM SCI, V17, P399, DOI 10.1016/0968-0004(92)90008-W; Ledo A, 2005, P NATL ACAD SCI USA, V102, P17483, DOI 10.1073/pnas.0503624102; Limpert E, 2001, BIOSCIENCE, V51, P341, DOI 10.1641/0006-3568(2001)051[0341:LNDATS]2.0.CO;2; Liu XP, 2010, FREE RADICAL BIO MED, V48, P554, DOI 10.1016/j.freeradbiomed.2009.11.024; Lizasoain I, 1996, PEDIATR RES, V39, P779, DOI 10.1203/00006450-199605000-00006; Lourenco CF, 2011, HIPPOCAMPUS, V21, P622, DOI 10.1002/hipo.20774; Mergia E, 2003, CELL SIGNAL, V15, P189, DOI 10.1016/S0898-6568(02)00078-5; Mullershausen F, 2004, MOL BIOL CELL, V15, P4023, DOI 10.1091/mbc.E03-12-0890; MURAD F, 1994, RECENT PROG HORM RES, V49, P239; Nausch LWM, 2008, P NATL ACAD SCI USA, V105, P365, DOI 10.1073/pnas.0710387105; RAND MJ, 1995, ANNU REV PHYSIOL, V57, P659; Roy B, 2008, J BIOL CHEM, V283, P18841, DOI 10.1074/jbc.M801712200; Salerno JC, 2008, FEBS LETT, V582, P1395, DOI 10.1016/j.febslet.2008.03.051; SALTER M, 1995, NEUROPHARMACOLOGY, V34, P639, DOI 10.1016/0028-3908(95)00036-6; Salter M, 1996, J NEUROCHEM, V66, P1683; Santolini J, 2001, J BIOL CHEM, V276, P1233, DOI 10.1074/jbc.M006858200; Sato M, 2005, P NATL ACAD SCI USA, V102, P14515, DOI 10.1073/pnas.0505136102; Sato M, 2006, ANAL CHEM, V78, P8175, DOI 10.1021/ac061791b; SOUTHAM E, 1991, J NEUROCHEM, V56, P2072, DOI 10.1111/j.1471-4159.1991.tb03468.x; STONE JR, 1994, BIOCHEMISTRY-US, V33, P5636, DOI 10.1021/bi00184a036; Thomas DD, 2001, P NATL ACAD SCI USA, V98, P355, DOI 10.1073/pnas.98.1.355; Thomas DD, 2008, FREE RADICAL BIO MED, V45, P18, DOI 10.1016/j.freeradbiomed.2008.03.020; Valtschanoff JG, 2001, J NEUROSCI, V21, P1211; Wakatsuki H, 1998, J PHYSIOL-LONDON, V513, P71, DOI 10.1111/j.1469-7793.1998.071by.x; Wang W, 1998, DEV BRAIN RES, V111, P65, DOI 10.1016/S0165-3806(98)00123-0; WARREN MA, 1990, J ANAT, V170, P173; Zeng SY, 2010, J NEUROPHYSIOL, V103, P1798, DOI 10.1152/jn.91235.2008; Zhang L, 1996, NEURON, V16, P47, DOI 10.1016/S0896-6273(00)80022-7	51	31	33	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					43172	43181		10.1074/jbc.M111.289777	http://dx.doi.org/10.1074/jbc.M111.289777			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22016390	Green Accepted, Green Published, hybrid			2022-12-27	WOS:000298351300038
J	Sheng, ZT; Xu, JJ; Bai, H; Zhu, F; Palli, SR				Sheng, Zhentao; Xu, Jingjing; Bai, Hua; Zhu, Fang; Palli, Subba R.			Juvenile Hormone Regulates Vitellogenin Gene Expression through Insulin-like Peptide Signaling Pathway in the Red Flour Beetle, Tribolium castaneum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOSQUITO AEDES-AEGYPTI; LOCUST FAT-BODY; DROSOPHILA-MELANOGASTER; BLATTELLA-GERMANICA; MOLECULAR ACTIONS; MESSENGER-RNA; C-ELEGANS; LIFE-SPAN; INDUCTION; TARGET	Our recent studies identified juvenile hormone (JH) and nutrition as the two key signals that regulate vitellogenin (Vg) gene expression in the red flour beetle, Tribolium castaneum. Juvenile hormone regulation of Vg synthesis has been known for a long time in several insects, but the mechanism of JH action is not known. Experiments were conducted to determine the mechanism of action of these two signals in regulation of Vg gene expression. Injection of bovine insulin or FOXO double-stranded RNA into the previtellogenic, starved, or JH-deficient female adults increased Vg mRNA and protein levels, thereby implicating the pivotal role for insulin-like peptide signaling in the regulation of Vg gene expression and possible cross-talk between JH and insulin-like peptide signaling pathways. Reduction in JH synthesis or its action by RNAi-mediated silencing of genes coding for acid methyltransferase or methoprene-tolerant decreased expression of genes coding for insulin-like peptides (ILPs) and influenced FOXO subcellular localization, resulting in the down-regulation of Vg gene expression. Furthermore, JH application to previtellogenic female beetles induced the expression of genes coding for ILP2 and ILP3, and induced Vg gene expression. FOXO protein expressed in baculovirus system binds to FOXO response element present in the Vg gene promoter. These data suggest that JH functions through insulin-like peptide signaling pathway to regulate Vg gene expression.	[Sheng, Zhentao; Xu, Jingjing; Bai, Hua; Zhu, Fang; Palli, Subba R.] Univ Kentucky, Dept Entomol, Coll Agr, Lexington, KY 40546 USA	University of Kentucky	Palli, SR (corresponding author), Univ Kentucky, Dept Entomol, Coll Agr, Lexington, KY 40546 USA.	rpalli@uky.edu	Bai, Hua/A-6665-2012; sheng, Zhentao Sheng/E-8962-2017; PALLI, SUBBA REDDY/AAU-8289-2020; Xu, Jingjing/H-2267-2013	Bai, Hua/0000-0003-2221-7545; PALLI, SUBBA REDDY/0000-0002-0873-3247; Xu, Jingjing/0000-0003-1976-3721	National Institutes of Health [GM070559-07]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070559] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM070559-07). This is contribution number 11-08-057 from the Kentucky Agricultural Experimental Station.	Ashrafi Kaveh, 2007, WormBook, P1; Attardo GM, 2006, J EXP BIOL, V209, P3071, DOI 10.1242/jeb.02349; Carnevali O, 1998, ANN NY ACAD SCI, V839, P556, DOI 10.1111/j.1749-6632.1998.tb10871.x; CHINZEI Y, 1982, CAN J BIOCHEM CELL B, V60, P243, DOI 10.1139/o82-029; Colombani J, 2005, SCIENCE, V310, P667, DOI 10.1126/science.1119432; Comas D, 1999, INSECT BIOCHEM MOLEC, V29, P821, DOI 10.1016/S0965-1748(99)00058-2; Comas D, 2001, MOL CELL ENDOCRINOL, V183, P93, DOI 10.1016/S0303-7207(01)00589-5; Corona M, 2007, P NATL ACAD SCI USA, V104, P7128, DOI 10.1073/pnas.0701909104; DHADIALLA TS, 1983, DEV BIOL, V96, P436, DOI 10.1016/0012-1606(83)90181-1; DHADIALLA TS, 1987, DEV BIOL, V123, P108, DOI 10.1016/0012-1606(87)90432-5; Fronstin RB, 2008, J EXP BIOL, V211, P79, DOI 10.1242/jeb.009530; Geminard C, 2009, CELL METAB, V10, P199, DOI 10.1016/j.cmet.2009.08.002; Grewal SS, 2009, INT J BIOCHEM CELL B, V41, P1006, DOI 10.1016/j.biocel.2008.10.010; Gulia-Nuss M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020401; Hansen IA, 2004, P NATL ACAD SCI USA, V101, P10626, DOI 10.1073/pnas.0403460101; KEELEY LL, 1985, COMP BIOCHEM PHYS A, V80, P115, DOI 10.1016/0300-9629(85)90688-7; Lee RYN, 2001, CURR BIOL, V11, P1950, DOI 10.1016/S0960-9822(01)00595-4; Li B, 2008, GENOME RES, V18, P113, DOI 10.1101/gr.6714008; Maestro JL, 2009, J BIOL CHEM, V284, P5506, DOI 10.1074/jbc.M807042200; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Park JH, 2006, J BIOL CHEM, V281, P11167, DOI 10.1074/jbc.M601517200; Parthasarathy R, 2011, INSECT BIOCHEM MOLEC, V41, P294, DOI 10.1016/j.ibmb.2011.01.006; Parthasarathy R, 2010, INSECT BIOCHEM MOLEC, V40, P429, DOI 10.1016/j.ibmb.2010.04.002; Parthasarathy R, 2010, INSECT BIOCHEM MOLEC, V40, P405, DOI 10.1016/j.ibmb.2010.03.006; Porte D, 2005, DIABETES, V54, P1264, DOI 10.2337/diabetes.54.5.1264; Richard DS, 2005, J INSECT PHYSIOL, V51, P455, DOI 10.1016/j.jinsphys.2004.12.013; Richards S, 2008, NATURE, V452, P949, DOI 10.1038/nature06784; RIDDIFORD LM, 1994, ADV INSECT PHYSIOL, V24, P213, DOI 10.1016/S0065-2806(08)60084-3; Roy SG, 2007, INSECT BIOCHEM MOLEC, V37, P1317, DOI 10.1016/j.ibmb.2007.08.004; Rusten TE, 2004, DEV CELL, V7, P179, DOI 10.1016/j.devcel.2004.07.005; Sheng ZT, 2008, ARCH INSECT BIOCHEM, V69, P143, DOI 10.1002/arch.20268; Shiao SH, 2008, J INSECT PHYSIOL, V54, P231, DOI 10.1016/j.jinsphys.2007.09.007; Sim C, 2008, P NATL ACAD SCI USA, V105, P6777, DOI 10.1073/pnas.0802067105; Soller M, 1999, DEV BIOL, V208, P337, DOI 10.1006/dbio.1999.9210; Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987; Truman JW, 2006, SCIENCE, V312, P1385, DOI 10.1126/science.1123652; Tu MP, 2005, GEN COMP ENDOCR, V142, P347, DOI 10.1016/j.ygcen.2005.02.009; Walkiewicz MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005072; Williams KD, 2006, P NATL ACAD SCI USA, V103, P15911, DOI 10.1073/pnas.0604592103; Wuertz S, 2007, GEN COMP ENDOCR, V150, P140, DOI 10.1016/j.ygcen.2006.07.005; Wyatt GR, 1996, ADV INSECT PHYSIOL, V26, P1, DOI 10.1016/S0065-2806(08)60030-2; Zhang ZL, 2011, J BIOL CHEM, V286, P8437, DOI 10.1074/jbc.M110.191684	42	141	148	8	111	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					41924	41936		10.1074/jbc.M111.269845	http://dx.doi.org/10.1074/jbc.M111.269845			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	22002054	Green Published, hybrid			2022-12-27	WOS:000298180900004
J	Li, WZ; Liu, QP; Pang, Y; Jin, JH; Wang, HG; Cao, HY; Li, Z; Wang, X; Ma, B; Chi, Y; Wang, RJ; Kondo, A; Gu, JG; Taniguchi, N				Li, Wenzhe; Liu, Qingping; Pang, Yue; Jin, Jinhua; Wang, Huiguo; Cao, Hongyu; Li, Zhi; Wang, Xu; Ma, Biao; Chi, Yan; Wang, Renjun; Kondo, Akihiro; Gu, Jianguo; Taniguchi, Naoyuki			Core Fucosylation of mu Heavy Chains Regulates Assembly and Intracellular Signaling of Precursor B Cell Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRE-B; ALPHA-1,6-FUCOSYL-TRANSFERASE-DEFICIENT MICE; BCR; REPERTOIRE; FUCOSE; OLIGOSACCHARIDES; GLYCOSYLATION; ABNORMALITIES; EXPRESSION; PHENOTYPE	alpha 1,6-Fucosyltransferase (Fut8) knock-out (Fut8(-/-)) mice showed an abnormality in pre-B cell generation. Membrane assembly of pre-BCR is a crucial checkpoint for pre-B cell differentiation and proliferation in both humans and mice. The assembly of pre-BCR on the cell surface was substantially blocked in the Fut8-knockdown pre-B cell line, 70Z/3-KD cells, and then completely restored by re-introduction of the Fut8 gene to 70Z/3-KD (70Z/3-KD-re) cells. Moreover, loss of alpha 1,6-fucosylation (also called core fucosylation) of mu HC was associated with the suppression of the interaction between mu HC and lambda 5. In contrast to Fut8(+/+) CD19(+) CD43(-) cells, the subpopulation expressing the mu HC center dot lambda 5 complex in the Fut8(-/-) CD19(+) CD43(-) cell fraction was decreased. The pre-BCR-mediated tyrosine phosphorylation of CD79a and activation of Btk were attenuated in Fut8-KD cells, and restored in 70Z/3-KD-re cells. The frequency of CD19(low)-CD43(-) cells (pre-B cell enriched fraction) was also reduced in Fut8(-/-) bone marrow cells, and then the levels of IgM, IgG, and IgA of 12-week-old Fut8(-/-) mice sera were significantly lower than those of Fut8(-/-) mice. Our results suggest that the core fucosylation of mu HC mediates the assembly of pre-BCR to regulate pre-BCR intracellular signaling and pre-B cell proliferation.	[Li, Wenzhe; Liu, Qingping; Pang, Yue; Jin, Jinhua; Wang, Huiguo; Cao, Hongyu; Wang, Xu; Ma, Biao; Chi, Yan; Wang, Renjun] Dalian Univ Technol, Coll Life Sci & Technol, Inst Immunol, Liaoning 116622, Peoples R China; [Li, Zhi] Dalian Cent Hosp, Clin Lab, Dalian 116003, Liaoning, Peoples R China; [Kondo, Akihiro] Osaka Univ, Grad Sch Med, Dept Mol Diagnost & Informat, Suita, Osaka 5650871, Japan; [Gu, Jianguo] Tohoku Pharmaceut Univ, Div Regulatory Glycobiol, Inst Mol Biomembrane & Glycobiol, Aoba Ku, Sendai, Miyagi 9818558, Japan; [Taniguchi, Naoyuki] RIKEN, Adv Sci Inst, Syst Glycobiol Res Grp, Wako, Saitama 3510198, Japan	Dalian University of Technology; Osaka University; Tohoku Medical & Pharmaceutical University; RIKEN	Li, WZ (corresponding author), Dalian Univ Technol, Coll Life Sci & Technol, Inst Immunol, 10 Xuefu Ave, Liaoning 116622, Peoples R China.	liwenzhe46@hotmail.com	Taniguchi, Naoyuki/I-4182-2014; Gu, Jianguo/ABC-9257-2020; Taniguchi, Naoyuki/A-7086-2016	Taniguchi, Naoyuki/0000-0001-5889-5968; Chi, Yan/0000-0001-9736-4983	National Nature Science Foundation of China [30972675]; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry (SRF for ROCS, SEM); Science and Technology Planning Project of Dalian City, China [2010J21DW011]; Grants-in-Aid for Scientific Research [21591667] Funding Source: KAKEN	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry (SRF for ROCS, SEM)(Scientific Research Foundation for the Returned Overseas Chinese Scholars); Science and Technology Planning Project of Dalian City, China; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by National Nature Science Foundation of China Grant 30972675, the Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry (SRF for ROCS, SEM), and Science and Technology Planning Project of Dalian City, China, Grant 2010J21DW011.	Bankovich AJ, 2007, SCIENCE, V316, P291, DOI 10.1126/science.1139412; Burrows PD, 2002, SEMIN IMMUNOL, V14, P343, DOI 10.1016/S1044-5323(02)00067-2; CAMBIER JC, 1995, J IMMUNOL, V155, P3281; Conley ME, 2000, IMMUNOL REV, V178, P75, DOI 10.1034/j.1600-065X.2000.17809.x; CORCOS D, 1995, CURR BIOL, V5, P1140, DOI 10.1016/S0960-9822(95)00230-2; DWEK RA, 1995, SCIENCE, V269, P1234, DOI 10.1126/science.7652569; Espeli M, 2006, SEMIN IMMUNOL, V18, P56, DOI 10.1016/j.smim.2005.11.002; Fukuda T, 2011, J BIOL CHEM, V286, P18434, DOI 10.1074/jbc.M110.172536; Gauthier L, 2002, P NATL ACAD SCI USA, V99, P13014, DOI 10.1073/pnas.202323999; Granados EL, 2002, J CLIN INVEST, V110, P1029, DOI 10.1172/JCI200215658; Haimovich J, 2010, MOL IMMUNOL, V48, P351, DOI 10.1016/j.molimm.2010.07.005; Hess J, 2001, P NATL ACAD SCI USA, V98, P1745, DOI 10.1073/pnas.041492098; Ishida H, 2002, BIOSCI BIOTECH BIOCH, V66, P1002, DOI 10.1271/bbb.66.1002; Kawano Y, 2006, J IMMUNOL, V177, P2242, DOI 10.4049/jimmunol.177.4.2242; KHAN WN, 1995, IMMUNITY, V3, P283, DOI 10.1016/1074-7613(95)90114-0; LeBien TW, 2000, BLOOD, V96, P9, DOI 10.1182/blood.V96.1.9; Li W, 2008, GLYCOBIOLOGY, V18, P114, DOI 10.1093/glycob/cwm107; Li WZ, 2006, GLYCOBIOLOGY, V16, P1007, DOI 10.1093/glycob/cwl023; Martensson IL, 2010, FEBS LETT, V584, P2572, DOI 10.1016/j.febslet.2010.04.057; Middendorp S, 2002, J IMMUNOL, V168, P2695, DOI 10.4049/jimmunol.168.6.2695; MIYAKE K, 1991, J EXP MED, V173, P599, DOI 10.1084/jem.173.3.599; Muljo SA, 2002, INT IMMUNOL, V14, P577, DOI 10.1093/intimm/dxf023; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; Pinho SS, 2011, CELL MOL LIFE SCI, V68, P1011, DOI 10.1007/s00018-010-0595-0; RABINOVICH E, 1993, J BIOL CHEM, V268, P24145; Shaffer AL, 1997, J IMMUNOL, V159, P1265; Shinkawa T, 2003, J BIOL CHEM, V278, P3466, DOI 10.1074/jbc.M210665200; Stubbs HJ, 1996, BIOCHEMISTRY-US, V35, P937, DOI 10.1021/bi9513719; tenBoekel E, 1997, IMMUNITY, V7, P357; Ubelhart R, 2010, NAT IMMUNOL, V11, P759, DOI 10.1038/ni.1903; Uozumi N, 1996, J BIOCHEM, V120, P385; Wang F, 2003, ANAL BIOCHEM, V314, P266, DOI 10.1016/S0003-2697(02)00693-0; Wang XC, 2005, P NATL ACAD SCI USA, V102, P15791, DOI 10.1073/pnas.0507375102; Wang XC, 2006, J BIOL CHEM, V281, P2572, DOI 10.1074/jbc.M510893200; Wasserman R, 1998, J EXP MED, V187, P259, DOI 10.1084/jem.187.2.259; WINKLER TH, 1995, EUR J IMMUNOL, V25, P446, DOI 10.1002/eji.1830250221; WRIGHT JF, 1990, J BIOL CHEM, V265, P10506; WYSS DF, 1995, SCIENCE, V269, P1273, DOI 10.1126/science.7544493	38	17	19	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2500	2508		10.1074/jbc.M111.303123	http://dx.doi.org/10.1074/jbc.M111.303123			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22084235	Green Published, hybrid			2022-12-27	WOS:000300292300024
J	Mysliwiec, MR; Carlson, CD; Tietjen, J; Hung, H; Ansari, AZ; Lee, Y				Mysliwiec, Matthew R.; Carlson, Clayton D.; Tietjen, Josh; Hung, Holly; Ansari, Aseem Z.; Lee, Youngsook			Jarid2 (Jumonji, AT Rich Interactive Domain 2) Regulates NOTCH1 Expression via Histone Modification in the Developing Heart	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARDIAC DEVELOPMENT; GENE-EXPRESSION; TARGET GENES; PRC2; METHYLTRANSFERASE; DIFFERENTIATION; JARID2/JUMONJI; PROLIFERATION; PROTEIN; H3	Jarid2/Jumonji, the founding member of the Jmj factor family, critically regulates various developmental processes, including cardiovascular development. The Jmj family was identified as histone demethylases, indicating epigenetic regulation by Jmj proteins. Deletion of Jarid2 in mice resulted in cardiac malformation and increased endocardial Notch1 expression during development. Although Jarid2 has been shown to occupy the Notch1 locus in the developing heart, the precise molecular role of Jarid2 remains unknown. Here we show that deletion of Jarid2 results in reduced methylation of lysine 9 on histone H3 (H3K9) at the Notch1 genomic locus in embryonic hearts. Interestingly, SETDB1, a histone H3K9 methyltransferase, was identified as a putative cofactor of Jarid2 by yeast two-hybrid screening, and the physical interaction between Jarid2 and SETDB1 was confirmed by coimmunoprecipitation experiments. Concurrently, accumulation of SETDB1 at the site of Jarid2 occupancy was significantly reduced in Jarid2 knock out (KO) hearts. Employing genome-wide approaches, putative Jarid2 target genes regulated by SETDB1 via H3K9 methylation were identified in the developing heart by ChIP-chip. These targets are involved in biological processes that, when dysregulated, could manifest in the phenotypic defects observed in Jarid2 KO mice. Our data demonstrate that Jarid2 functions as a transcriptional repressor of target genes, including Notch1, through a novel process involving the modification of H3K9 methylation via specific interaction with SETDB1 during heart development. Therefore, our study provides new mechanistic insights into epigenetic regulation by Jarid2, which will enhance our understanding of the molecular basis of other organ development and biological processes.	[Mysliwiec, Matthew R.; Hung, Holly; Lee, Youngsook] Univ Wisconsin Madison, Dept Cellular & Regenerat Biol, Madison, WI 53706 USA; [Carlson, Clayton D.; Tietjen, Josh; Ansari, Aseem Z.] Univ Wisconsin Madison, Dept Biochem, Madison, WI 53706 USA; Univ Wisconsin Madison, Genome Ctr Wisconsin, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Mysliwiec, MR (corresponding author), 1300 Univ Ave,SMI 321, Madison, WI 53706 USA.	youngsooklee@wisc.edu	Ansari, Aseem/AAF-4945-2019		National Institutes of Health [HL067050, NIGMS069420]; American Heart Association [10POST2600279, 0615615Z]; U.S. National Human Genome Research Institute (NHGRI) [5T32HG002760]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067050] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG002760] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); U.S. National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL067050 (to Y. L.) and NIGMS069420 (to A. Z. A.). This work was also supported by American Heart Association Grant 10POST2600279 (to M. R. M.) and predoctoral fellowship 0615615Z (to C. D. C.), and by U.S. National Human Genome Research Institute (NHGRI) training grant to the Genomic Sciences Training Program (GSTP) 5T32HG002760 (to J. T.).	Buck MJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-11-r97; CONLON RA, 1995, DEVELOPMENT, V121, P1533; Grego-Bessa J, 2007, DEV CELL, V12, P415, DOI 10.1016/j.devcel.2006.12.011; Johnson KD, 2006, P NATL ACAD SCI USA, V103, P15939, DOI 10.1073/pnas.0604041103; Jung J, 2005, J BIOL CHEM, V280, P30916, DOI 10.1074/jbc.M414482200; Kim T, 2005, BIOCHEM BIOPH RES CO, V329, P544, DOI 10.1016/j.bbrc.2005.01.154; Kim T, 2004, MOL CELL BIOL, V24, P10151, DOI 10.1128/MCB.24.23.10151-10160.2004; Kim TG, 2003, J BIOL CHEM, V278, P42247, DOI 10.1074/jbc.M307386200; Landeira D, 2010, NAT CELL BIOL, V12, P618, DOI 10.1038/ncb2065; Lee Y, 2000, CIRC RES, V86, P932, DOI 10.1161/01.RES.86.9.932; Li G, 2010, GENE DEV, V24, P368, DOI 10.1101/gad.1886410; Mejetta S, 2011, EMBO J, V30, P3635, DOI 10.1038/emboj.2011.265; Mysliwiec MR, 2011, J BIOL CHEM, V286, P17193, DOI 10.1074/jbc.M110.205146; Mysliwiec MR, 2007, FEBS LETT, V581, P2633, DOI 10.1016/j.febslet.2007.05.006; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Nielsen AL, 2004, MOL CELL BIOL, V24, P5184, DOI 10.1128/MCB.24.12.5184-5196.2004; Nottke A, 2009, DEVELOPMENT, V136, P879, DOI 10.1242/dev.020966; Pasini D, 2010, NATURE, V464, P306, DOI 10.1038/nature08788; Peng JC, 2009, CELL, V139, P1290, DOI 10.1016/j.cell.2009.12.002; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302; Shen XH, 2009, CELL, V139, P1303, DOI 10.1016/j.cell.2009.12.003; Shirato H, 2009, J BIOL CHEM, V284, P733, DOI 10.1074/jbc.M804994200; Takeuchi T, 1999, MECH DEVELOP, V86, P29, DOI 10.1016/S0925-4773(99)00100-8; TAKEUCHI T, 1995, GENE DEV, V9, P1211, DOI 10.1101/gad.9.10.1211; Tietjen JR, 2010, NAT STRUCT MOL BIOL, V17, P1154, DOI 10.1038/nsmb.1900; Toyoda M, 2003, DEV CELL, V5, P85, DOI 10.1016/S1534-5807(03)00189-8; Zhang Z, 2011, STEM CELLS, V29, P229, DOI 10.1002/stem.578	29	52	54	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					1235	1241		10.1074/jbc.M111.315945	http://dx.doi.org/10.1074/jbc.M111.315945			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22110129	hybrid, Green Published			2022-12-27	WOS:000299170300039
J	Rey, O; Chang, WH; Bikle, D; Rozengurt, N; Young, SH; Rozengurt, E				Rey, Osvaldo; Chang, Wenhan; Bikle, Daniel; Rozengurt, Nora; Young, Steven H.; Rozengurt, Enrique			Negative Cross-talk between Calcium-sensing Receptor and beta-Catenin Signaling Systems in Colonic Epithelium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; FAMILIAL HYPOCALCIURIC HYPERCALCEMIA; EXTRACELLULAR CA2+-SENSING RECEPTOR; NEONATAL SEVERE HYPERPARATHYROIDISM; GASTROINTESTINAL-TRACT; COLORECTAL-CANCER; STEM-CELLS; INTESTINAL POLYPOSIS; RISK-FACTORS; AKT KINASE	Here, we examined the role of the extracellular Ca2+-sensing receptor (CaSR) in the control of colonic epithelial cell proliferation in vivo and changes in beta-catenin triggered by CaSR stimulation in human colonic epithelial cells in vitro. The in vivo studies, using a novel Casr intestinal-specific knock-out mouse, indicate that the genetic ablation of the Casr leads to hyperproliferation of colonic epithelial cells, expansion of the proliferative zone, changes in crypt structure, and enhanced beta-catenin nuclear localization. The in vitro results indicate that stimulation of the CaSR, by Ca2+ or by the calcimimetic R-568, produced a striking and time-dependent decrease in the phosphorylation of beta-catenin at Ser-552 and Ser-675, two amino acid residues that promote beta-catenin transcriptional activity. The reduced phosphorylation of beta-catenin coincided with a decline in its nuclear localization and a marked redistribution to the plasma membrane. Furthermore, CaSR stimulation promoted a down-regulation of beta-catenin-mediated transcriptional activation. These studies demonstrate that signaling pathways emanating from the CaSR control colonic epithelial cell proliferation in vivo and suggest that the mechanism involves regulation of beta-catenin phosphorylation.	[Rey, Osvaldo; Rozengurt, Nora; Young, Steven H.; Rozengurt, Enrique] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med,Unit Signal Transduct & Gastrointestinal, Div Digest Dis,CURE Digest Dis Res Ctr,Mol Biol I, Los Angeles, CA 90095 USA; [Rey, Osvaldo; Rozengurt, Nora; Young, Steven H.; Rozengurt, Enrique] Univ Calif Los Angeles, David Geffen Sch Med, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; [Chang, Wenhan; Bikle, Daniel] Univ Calif San Francisco, Endocrine Res Unit, Dept Vet Affairs Med Ctr, Dept Med, San Francisco, CA 94121 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California San Francisco	Rey, O (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Med,Unit Signal Transduct & Gastrointestinal, Div Digest Dis,CURE Digest Dis Res Ctr,Mol Biol I, 900 Veteran Ave,Warren Hall,Rm 11-115, Los Angeles, CA 90095 USA.	orey@mednet.ucla.edu		Rey, Osvaldo/0000-0003-1575-9864	National Institutes of Health [K22CA128883, K22CA128883-03S1, RO1-AG21353, RO1AR050023, RO1 AR055924, RO1DK054793, RO1DK56930, RO1DK55003, P30DK41301]; Veteran Affairs Merit Review; NATIONAL CANCER INSTITUTE [K22CA128883] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050023, R01AR055924] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056930, R01DK055003, R01DK054793, P30DK041301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG021353] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veteran Affairs Merit Review(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants K22CA128883 (to O. R.), K22CA128883-03S1 (to O. R.), RO1-AG21353 (to W. C.), RO1AR050023 (to D. B.), RO1 AR055924 (to D. B.), RO1DK054793 (to D. B.), RO1DK56930 (to E. R.), RO1DK55003 (to E. R.), and P30DK41301 (to E. R.). This work was also supported by Veteran Affairs Merit Review (to D. B.) and Veteran Affairs Merit Review (to E. R.).	Adams GB, 2006, NATURE, V439, P599, DOI 10.1038/nature04247; Baron JA, 1999, NEW ENGL J MED, V340, P101, DOI 10.1056/NEJM199901143400204; Bostick RM, 1997, CANCER EPIDEM BIOMAR, V6, P1011; Brown EM, 2001, PHYSIOL REV, V81, P239, DOI 10.1152/physrev.2001.81.1.239; BROWN EM, 1995, AM J KIDNEY DIS, V25, P506, DOI 10.1016/0272-6386(95)90118-3; CABELL L, 1993, INT J DEV NEUROSCI, V11, P357, DOI 10.1016/0736-5748(93)90007-Z; Chakrabarty S, 2003, CANCER RES, V63, P67; Chang WH, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1159945; Chell S, 2006, BBA-REV CANCER, V1766, P104, DOI 10.1016/j.bbcan.2006.05.002; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Crawford HC, 1999, ONCOGENE, V18, P2883, DOI 10.1038/sj.onc.1202627; Eastwood GL, 1995, J CLIN GASTROENTEROL, V21, pS1; Fang DX, 2007, J BIOL CHEM, V282, P11221, DOI 10.1074/jbc.M611871200; Fox J, 1999, J PHARMACOL EXP THER, V290, P473; GADBOIS DM, 1992, P NATL ACAD SCI USA, V89, P8626, DOI 10.1073/pnas.89.18.8626; Geibel J, 2006, P NATL ACAD SCI USA, V103, P9390, DOI 10.1073/pnas.0602996103; Geibel JP, 2009, ANNU REV PHYSIOL, V71, P205, DOI 10.1146/annurev.physiol.010908.163128; Gradl D, 1999, MOL CELL BIOL, V19, P5576; Grau MV, 2007, JNCI-J NATL CANCER I, V99, P129, DOI 10.1093/jnci/djk016; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; He TC, 1999, CELL, V99, P335, DOI 10.1016/S0092-8674(00)81664-5; He XC, 2007, NAT GENET, V39, P189, DOI 10.1038/ng1928; Heerding DA, 2008, J MED CHEM, V51, P5663, DOI 10.1021/jm8004527; Hendy GN, 2000, HUM MUTAT, V16, P281, DOI 10.1002/1098-1004(200010)16:4<281::AID-HUMU1>3.0.CO;2-A; Hizaki K, 2011, MODERN PATHOL, V24, P876, DOI 10.1038/modpathol.2011.10; HO C, 1995, NAT GENET, V11, P389, DOI 10.1038/ng1295-389; Holt PR, 1997, CANCER EPIDEM BIOMAR, V6, P131; Hope C, 2008, MOL NUTR FOOD RES, V52, pS52, DOI 10.1002/mnfr.200700448; Jin GC, 2009, J CLIN INVEST, V119, P2691, DOI 10.1172/JCI38918; Kallay E, 2000, CANCER DETECT PREV, V24, P127; KASE H, 1987, BIOCHEM BIOPH RES CO, V142, P436, DOI 10.1016/0006-291X(87)90293-2; Koh TJ, 2000, J CLIN INVEST, V106, P533, DOI 10.1172/JCI9476; Lee G, 2010, GASTROENTEROLOGY, V139, P869, DOI 10.1053/j.gastro.2010.05.037; Lickert H, 2000, DEVELOPMENT, V127, P3805; Lin SB, 2009, GASTROENTEROLOGY, V136, P1711, DOI 10.1053/j.gastro.2009.01.002; LIPKIN M, 1984, CANCER RES, V44, P4201; Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200; Mann B, 1999, P NATL ACAD SCI USA, V96, P1603, DOI 10.1073/pnas.96.4.1603; McDonald SAC, 2006, NAT CLIN PRACT GASTR, V3, P267, DOI 10.1038/ncpgasthep0473; Moyer MP, 1996, IN VITRO CELL DEV-AN, V32, P315; Ng SS, 2009, J BIOL CHEM, V284, P35308, DOI 10.1074/jbc.M109.078261; Quarles LD, 2003, CURR OPIN NEPHROL HY, V12, P349, DOI 10.1097/00041552-200307000-00002; Ray JM, 1997, J CLIN INVEST, V99, P2328, DOI 10.1172/JCI119413; Rey O, 2000, J VIROL, V74, P4912, DOI 10.1128/JVI.74.10.4912-4918.2000; Rey O, 2001, J BIOL CHEM, V276, P32616, DOI 10.1074/jbc.M101649200; Rey O, 2010, J CELL PHYSIOL, V225, P73, DOI 10.1002/jcp.22198; Rhodes N, 2008, CANCER RES, V68, P2366, DOI 10.1158/0008-5472.CAN-07-5783; Roose J, 1999, SCIENCE, V285, P1923, DOI 10.1126/science.285.5435.1923; Rozengurt E, 2002, EUR J SURG, V168, P23; Rozengurt E, 2002, TRENDS ENDOCRIN MET, V13, P128, DOI 10.1016/S1043-2760(01)00544-6; Rozengurt E, 2001, ANNU REV PHYSIOL, V63, P49, DOI 10.1146/annurev.physiol.63.1.49; Rozengurt E, 2007, CURR OPIN PHARMACOL, V7, P557, DOI 10.1016/j.coph.2007.10.002; Schulte G, 2010, PHARMACOL REV, V62, P632, DOI 10.1124/pr.110.002931; Sheinin Y, 2000, J HISTOCHEM CYTOCHEM, V48, P595, DOI 10.1177/002215540004800503; Sinnett-Smith J, 2011, J BIOL CHEM, V286, P511, DOI 10.1074/jbc.M110.167528; Taurin S, 2006, J BIOL CHEM, V281, P9971, DOI 10.1074/jbc.M508778200; Taurin S, 2008, AM J PHYSIOL-CELL PH, V294, pC1169, DOI 10.1152/ajpcell.00096.2008; TERPSTRA OT, 1987, GASTROENTEROLOGY, V92, P704, DOI 10.1016/0016-5085(87)90021-7; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Verheyen EM, 2010, DEV DYNAM, V239, P34, DOI 10.1002/dvdy.22019; Vermeulen L, 2010, NAT CELL BIOL, V12, P468, DOI 10.1038/ncb2048; Vezzoli G, 2009, CURR PHARM BIOTECHNO, V10, P302, DOI 10.2174/138920109787847475; Walther A, 2009, NAT REV CANCER, V9, P489, DOI 10.1038/nrc2645; Wei EK, 2010, J CLIN ONCOL, V28, P4052, DOI 10.1200/JCO.2009.26.9324; Wielenga VJM, 1999, AM J PATHOL, V154, P515, DOI 10.1016/S0002-9440(10)65297-2; Wilson CH, 2010, ONCOGENE, V29, P4567, DOI 10.1038/onc.2010.202; Wong NACS, 2002, AM J PATHOL, V160, P389, DOI 10.1016/S0002-9440(10)64856-0; Wu SV, 2002, P NATL ACAD SCI USA, V99, P2392, DOI 10.1073/pnas.042617699	69	56	57	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					1158	1167		10.1074/jbc.M111.274589	http://dx.doi.org/10.1074/jbc.M111.274589			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22094462	Green Published, hybrid			2022-12-27	WOS:000299170300031
J	Zhao, HW; Jin, SH; Gewirtz, AM				Zhao, Huiwu; Jin, Shenghao; Gewirtz, Alan M.			The Histone Acetyltransferase TIP60 Interacts with c-Myb and Inactivates Its Transcriptional Activity in Human Leukemia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING; COACTIVATOR; ACTIVATION; ACETYLATION; SEQUENCE; GENE; TRANSFORMATION; PROLIFERATION; TRANSLOCATION; EXPRESSION	The histone acetyltransferase TIP60 is a coregulator of transcription factors and is implicated in tumorigenesis. In this study, we explored potential regulatory relationships between TIP60 and the c-Myb oncoprotein in hematopoietic cells. We first showed that TIP60 is a c-Myb interacting protein and that the interaction is dependent on the TIP60 acetyltransferase domain and c-Myb transactivation domain. We then found that coexpressing TIP60 decreases the transcriptional activation ability of c-Myb in functional reporter assays. A ChIP assay also revealed that TIP60 binds to the c-Myb target gene c-Myc promoter in a c-Myb-dependent manner. Consistently, knockdown of Tip60 expression by siRNA increased endogenous c-Myc expression. Furthermore, coimmunoprecipitation of Jurkat cell lysates revealed that c-Myb is associated with histone deacetylases HDAC1 and HDAC2, known to interact with TIP60 and repress transcription. Finally, we compared Tip60 expression in six primary AML samples with three normal CD34(+) cell samples using quantitative RT-PCR. Tip60 expression was significantly (similar to 60%) lower in the AML samples. In summary, these studies demonstrate that TIP60 negatively modulates c-Myb transcriptional activity by recruiting histone deacetylases in human hematopoietic cells, leading us to hypothesize that TIP60 is a normal regulator of c-Myb function and that dysregulated or mutated TIP60 may contribute to c-Myb-driven leukemogenesis.	[Zhao, Huiwu; Jin, Shenghao; Gewirtz, Alan M.] Univ Penn, Sch Med, Dept Med, Div Hematol Oncol, Philadelphia, PA 19104 USA	University of Pennsylvania	Zhao, HW (corresponding author), Rm 370 CRB,415 Curie Bld, Philadelphia, PA 19104 USA.	huiwuz@mail.med.upenn.edu			National Institutes of Health [5T32DK007780]; Pennsylvania Department of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007780] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania Department of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant 5T32DK007780. This work was also supported by a tobacco settlement grant from the Pennsylvania Department of Health (the Department specifically disclaims responsibility for any analysis, interpretations, or conclusions).	Baek SH, 2002, CELL, V110, P55, DOI 10.1016/S0092-8674(02)00809-7; Bararia D, 2008, LEUKEMIA, V22, P800, DOI 10.1038/sj.leu.2405101; BARLETTA C, 1987, SCIENCE, V235, P1064, DOI 10.1126/science.3469751; BIEDENKAPP H, 1988, NATURE, V335, P835, DOI 10.1038/335835a0; Clappier E, 2007, BLOOD, V110, P1251, DOI 10.1182/blood-2006-12-064683; Fazzio TG, 2008, CELL, V134, P162, DOI 10.1016/j.cell.2008.05.031; Friedman AD, 2002, J CELL BIOCHEM, V86, P624, DOI 10.1002/jcb.10271; Gaughan L, 2001, J BIOL CHEM, V276, P46841, DOI 10.1074/jbc.M103710200; Gavaravarapu S, 2000, BIOCHEM BIOPH RES CO, V269, P758, DOI 10.1006/bbrc.2000.2358; GEWIRTZ AM, 1989, SCIENCE, V245, P180, DOI 10.1126/science.2665077; Gorrini C, 2007, NATURE, V448, P1063, DOI 10.1038/nature06055; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Hess JL, 2006, BLOOD, V108, P297, DOI 10.1182/blood-2005-12-5014; Ikura T, 2000, CELL, V102, P463, DOI 10.1016/S0092-8674(00)00051-9; Jin SH, 2010, J CLIN INVEST, V120, P593, DOI 10.1172/JCI38030; Kamine J, 1996, VIROLOGY, V216, P357, DOI 10.1006/viro.1996.0071; Kim JH, 2005, NATURE, V434, P921, DOI 10.1038/nature03452; KLEMPNAUER KH, 1982, CELL, V31, P453, DOI 10.1016/0092-8674(82)90138-6; Lidonnici MR, 2008, BLOOD, V111, P4771, DOI 10.1182/blood-2007-08-105072; Muller-Tidow C, 2004, LEUKEMIA, V18, P720, DOI 10.1038/sj.leu.2403296; Murr R, 2006, NAT CELL BIOL, V8, P91, DOI 10.1038/ncb1343; NASONBURCHENAL K, 1993, P NATL ACAD SCI USA, V90, P1619, DOI 10.1073/pnas.90.4.1619; Nomura T, 2004, J BIOL CHEM, V279, P16715, DOI 10.1074/jbc.M313069200; Patel JH, 2004, MOL CELL BIOL, V24, P10826, DOI 10.1128/MCB.24.24.10826-10834.2004; Ramsay RG, 2008, NAT REV CANCER, V8, P523, DOI 10.1038/nrc2439; Reddy VA, 2002, BLOOD, V100, P483, DOI 10.1182/blood.V100.2.483; Saether T, 2007, J BIOL CHEM, V282, P13994, DOI 10.1074/jbc.M700755200; Senese S, 2007, MOL CELL BIOL, V27, P4784, DOI 10.1128/MCB.00494-07; Shetzline SE, 2004, BLOOD, V104, P1833, DOI 10.1182/blood-2003-10-3577; Shiota M, 2010, PROSTATE, V70, P540, DOI 10.1002/pros.21088; Squatrito M, 2006, TRENDS CELL BIOL, V16, P433, DOI 10.1016/j.tcb.2006.07.007; Tomita A, 2000, ONCOGENE, V19, P444, DOI 10.1038/sj.onc.1203329; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Xiao H, 2003, J BIOL CHEM, V278, P11197, DOI 10.1074/jbc.M210816200; Zhao HW, 2009, BLOOD, V113, P505, DOI 10.1182/blood-2008-01-136218	35	27	28	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					925	934		10.1074/jbc.M111.279950	http://dx.doi.org/10.1074/jbc.M111.279950			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22110127	hybrid, Green Published			2022-12-27	WOS:000299170300011
J	Noinaj, N; Song, ES; Bhasin, S; Alper, BJ; Schmidt, WK; Hersh, LB; Rodgers, DW				Noinaj, Nicholas; Song, Eun Suk; Bhasin, Sonia; Alper, Benjamin J.; Schmidt, Walter K.; Hersh, Louis B.; Rodgers, David W.			Anion Activation Site of Insulin-degrading Enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; A-FACTOR; IN-VIVO; INTRACELLULAR DOMAIN; GENETIC SYSTEM; RAT-BRAIN; G1 ARREST; DEGRADATION; PROTEIN; YEAST	Insulin-degrading enzyme (IDE) (insulysin) is a zinc metallopeptidase that metabolizes several bioactive peptides, including insulin and the amyloid beta peptide. IDE is an unusual metallopeptidase in that it is allosterically activated by both small peptides and anions, such as ATP. Here, we report that the ATP-binding site is located on a portion of the substrate binding chamber wall arising largely from domain 4 of the four-domain IDE. Two variants having residues in this site mutated, IDEK898A,K899A,S901A and IDER429S, both show greatly decreased activation by the polyphosphate anions ATP and PPPi. IDEK898A,K899A,S901A is also deficient in activation by small peptides, suggesting a possible mechanistic link between the two types of allosteric activation. Sodium chloride at high concentrations can also activate IDE. There are no observable differences in average conformation between the IDE-ATP complex and unliganded IDE, but regions of the active site and C-terminal domain do show increased crystallographic thermal factors in the complex, suggesting an effect on dynamics. Activation by ATP is shown to be independent of the ATP hydrolysis activity reported for the enzyme. We also report that IDEK898A,K899A,S901A has reduced intracellular function relative to unmodified IDE, consistent with a possible role for anion activation of IDE activity in vivo. Together, the data suggest a model in which the binding of anions activates by reducing the electrostatic attraction between the two halves of the enzyme, shifting the partitioning between open and closed conformations of IDE toward the open form.	[Hersh, Louis B.] Univ Kentucky, Coll Med, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA; [Noinaj, Nicholas; Song, Eun Suk; Bhasin, Sonia; Hersh, Louis B.; Rodgers, David W.] Univ Kentucky, Struct Biol Ctr, Lexington, KY 40536 USA; [Alper, Benjamin J.; Schmidt, Walter K.] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA	University of Kentucky; University of Kentucky; University System of Georgia; University of Georgia	Hersh, LB (corresponding author), Univ Kentucky, Coll Med, Dept Mol & Cellular Biochem, 741 S Limestone, Lexington, KY 40536 USA.	lhersh@uky.edu; david.rodgers@uky.edu			National Institutes of Health [DA02243, NS38041, DA016176, T32 DA016176, GM067092, P20 RR20171]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020171] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067092] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038041, R56NS038041] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA002243, T32DA016176] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants DA02243, NS38041, DA016176, T32 DA016176, GM067092, and P20 RR20171.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Ahmadian MR, 1997, NAT STRUCT BIOL, V4, P686, DOI 10.1038/nsb0997-686; Alper BJ, 2006, BIOCHEM J, V398, P145, DOI 10.1042/BJ20060311; BEESE LS, 1993, SCIENCE, V260, P352, DOI 10.1126/science.8469987; BEIS I, 1975, BIOCHEM J, V152, P23, DOI 10.1042/bj1520023; Bennett RG, 2003, J ENDOCRINOL, V177, P399, DOI 10.1677/joe.0.1770399; Cabrol C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005274; Camberos MD, 2007, EXP BIOL MED, V232, P281; Camberos MC, 2001, EXP BIOL MED, V226, P334, DOI 10.1177/153537020122600411; CHAN RK, 1982, MOL CELL BIOL, V2, P11, DOI 10.1128/MCB.2.1.11; Dixon M., 1979, ENZYMES, P381; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Farris W, 2003, P NATL ACAD SCI USA, V100, P4162, DOI 10.1073/pnas.0230450100; FujimuraKamada K, 1997, J CELL BIOL, V136, P271, DOI 10.1083/jcb.136.2.271; GOLDSTEIN BJ, 1981, METABOLISM, V30, P825, DOI 10.1016/0026-0495(81)90030-5; HARDER KW, 1994, BIOCHEM J, V298, P395, DOI 10.1042/bj2980395; HARI J, 1987, ENDOCRINOLOGY, V120, P829, DOI 10.1210/endo-120-2-829; Heras B, 2005, ACTA CRYSTALLOGR D, V61, P1173, DOI 10.1107/S0907444905019451; Im H, 2007, J BIOL CHEM, V282, P25453, DOI 10.1074/jbc.M701590200; Jones LS, 2004, MOL CELL PROTEOMICS, V3, P746, DOI 10.1074/mcp.R400008-MCP200; Kim S, 2005, J BIOL CHEM, V280, P27481, DOI 10.1074/jbc.M414192200; KUPFER SR, 1994, J BIOL CHEM, V269, P20622; KUROCHKIN IV, 1994, FEBS LETT, V345, P33, DOI 10.1016/0014-5793(94)00387-4; Li QX, 2007, J VIROL, V81, P8525, DOI 10.1128/JVI.00286-07; Li QX, 2006, CELL, V127, P305, DOI 10.1016/j.cell.2006.08.046; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; MARCUS S, 1991, MOL CELL BIOL, V11, P1030, DOI 10.1128/MCB.11.2.1030; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McDermott JR, 1997, NEUROCHEM RES, V22, P49, DOI 10.1023/A:1027325304203; MICHAELIS S, 1988, MOL CELL BIOL, V8, P1309, DOI 10.1128/MCB.8.3.1309; Miller BC, 2003, P NATL ACAD SCI USA, V100, P6221, DOI 10.1073/pnas.1031520100; MISBIN RI, 1983, ENDOCRINOLOGY, V113, P1525, DOI 10.1210/endo-113-4-1525; Morita M, 2000, CELL STRUCT FUNCT, V25, P309, DOI 10.1247/csf.25.309; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Nadanaciva S, 1999, BIOCHEMISTRY-US, V38, P15493, DOI 10.1021/bi9917683; Noinaj N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020864; Oldenburg KR, 1997, NUCLEIC ACIDS RES, V25, P451, DOI 10.1093/nar/25.2.451; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; REISER M, 1987, ACTA HISTOCHEM, V82, P35, DOI 10.1016/S0065-1281(87)80047-8; Rodgers DW, 1997, METHOD ENZYMOL, V276, P183, DOI 10.1016/S0076-6879(97)76059-2; Safavi A, 1996, BIOCHEMISTRY-US, V35, P14318, DOI 10.1021/bi960582q; Shen YQ, 2006, NATURE, V443, P870, DOI 10.1038/nature05143; SIKORSKI RS, 1989, GENETICS, V122, P19; Song ES, 2004, J BIOL CHEM, V279, P54216, DOI 10.1074/jbc.M411177200; Song ES, 2003, J BIOL CHEM, V278, P49789, DOI 10.1074/jbc.M308983200; Song ES, 2001, J BIOL CHEM, V276, P1152, DOI 10.1074/jbc.M008702200; Song ES, 2005, J BIOL CHEM, V280, P17701, DOI 10.1074/jbc.M501896200; Song ES, 2011, J BIOL CHEM, V286, P13852, DOI 10.1074/jbc.M110.191668; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Unni S, 2011, J COMPUT CHEM, V32, P1488, DOI 10.1002/jcc.21720; Vepsalainen S, 2007, J MED GENET, V44, DOI 10.1136/jmg.2006.048470; Yao HB, 2006, ARCH BIOCHEM BIOPHYS, V451, P175, DOI 10.1016/j.abb.2006.04.011; YONEZAWA K, 1986, ENDOCRINOLOGY, V118, P1989, DOI 10.1210/endo-118-5-1989; Zhang YM, 2001, MOL BIOL CELL, V12, P1303, DOI 10.1091/mbc.12.5.1303	55	23	25	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					48	57		10.1074/jbc.M111.264614	http://dx.doi.org/10.1074/jbc.M111.264614			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22049080	Green Published, hybrid			2022-12-27	WOS:000298682400008
J	Gustafsson, C; Edso, JR; Cohn, M				Gustafsson, Cecilia; Edso, Jenny Rhodin; Cohn, Marita			Rap1 Binds Single-stranded DNA at Telomeric Double- and Single-stranded Junctions and Competes with Cdc13 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; LENGTH REGULATION; HUMAN-CHROMOSOMES; CELL-CYCLE; IN-VITRO; YEAST; END; SITES; REPLICATION; RECOGNITION	The ends of eukaryotic chromosomes are protected by specialized telomere chromatin structures. Rap1 and Cdc13 are essential for the formation of functional telomere chromatin in budding yeast by binding to the double-stranded part and the single-stranded 3' overhang, respectively. We analyzed the binding properties of Saccharomyces castellii Rap1 and Cdc13 to partially single-stranded oligonucleotides, mimicking the junction of the double- and single-stranded DNA (ds-ss junction) at telomeres. We determined the optimal and the minimal DNA setup for a simultaneous binding of Rap1 and Cdc13 at the ds-ss junction. Remarkably, Rap1 is able to bind to a partially single-stranded binding site spanning the ds-ss junction. The binding over the ds-ss junction is anchored in a single double-stranded hemi-site and is stabilized by a sequence-independent interaction of Rap1 with the single-stranded 3' overhang. Thus, Rap1 is able to switch between a sequence-specific and a nonspecific binding mode of one hemi-site. At a ds-ss junction configuration where the two binding sites partially overlap, Rap1 and Cdc13 are competing for the binding. These results shed light on the end protection mechanisms and suggest that Rap1 and Cdc13 act together to ensure the protection of both the 3' and the 5' DNA ends at telomeres.	[Gustafsson, Cecilia; Edso, Jenny Rhodin; Cohn, Marita] Lund Univ, Dept Biol, Genet Grp, SE-22362 Lund, Sweden	Lund University	Cohn, M (corresponding author), Lund Univ, Dept Biol, Genet Grp, Biol Bldg A,Solvegatan 35, SE-22362 Lund, Sweden.	marita.cohn@biol.lu.se		Cohn, Marita/0000-0002-3370-2864	Jorgen Lindstrom Foundation; Royal Physiographic Society in Lund; Carl Trygger Foundation; Swedish Research Council	Jorgen Lindstrom Foundation; Royal Physiographic Society in Lund; Carl Trygger Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by grants from the Jorgen Lindstrom Foundation, the Royal Physiographic Society in Lund, the Carl Trygger Foundation, and the Swedish Research Council.	BLACKBURN EH, 1989, GENOME, V31, P553, DOI 10.1139/g89-104; Cohn M, 1998, CURR GENET, V33, P83, DOI 10.1007/s002940050312; COHN M, 1995, SCIENCE, V269, P396, DOI 10.1126/science.7618104; COLLINS K, 1993, GENE DEV, V7, P1364, DOI 10.1101/gad.7.7b.1364; Del Vescovo V, 2004, J MOL BIOL, V338, P877, DOI 10.1016/j.jmb.2004.03.047; Evans SK, 1999, SCIENCE, V286, P117, DOI 10.1126/science.286.5437.117; Fan XQ, 1997, MOL BIOL CELL, V8, P2145, DOI 10.1091/mbc.8.11.2145; Fouche N, 2006, J BIOL CHEM, V281, P37486, DOI 10.1074/jbc.M608778200; Gao H, 2007, NAT STRUCT MOL BIOL, V14, P208, DOI 10.1038/nsmb1205; GARVIK B, 1995, MOL CELL BIOL, V15, P6128; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; GILSON E, 1993, J MOL BIOL, V231, P293, DOI 10.1006/jmbi.1993.1283; Grandin N, 2001, EMBO J, V20, P6127, DOI 10.1093/emboj/20.21.6127; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; Konig P, 1996, CELL, V85, P125, DOI 10.1016/S0092-8674(00)81088-0; Levy DL, 2004, MOL CELL BIOL, V24, P10857, DOI 10.1128/MCB.24.24.10857-10867.2004; Lieb JD, 2001, NAT GENET, V28, P327, DOI 10.1038/ng569; Lin JJ, 1996, P NATL ACAD SCI USA, V93, P13760, DOI 10.1073/pnas.93.24.13760; Makarov VL, 1997, CELL, V88, P657, DOI 10.1016/S0092-8674(00)81908-X; Marcand S, 1997, SCIENCE, V275, P986, DOI 10.1126/science.275.5302.986; Mitton-Fry RM, 2004, J MOL BIOL, V338, P241, DOI 10.1016/j.jmb.2004.01.063; MORETTI P, 1994, GENE DEV, V8, P2257, DOI 10.1101/gad.8.19.2257; Nugent CI, 1996, SCIENCE, V274, P249, DOI 10.1126/science.274.5285.249; Pennock E, 2001, CELL, V104, P387, DOI 10.1016/S0092-8674(01)00226-4; Qi HY, 2000, GENE DEV, V14, P1777; Rhodin Edso Jenny, 2011, Genome Integr, V2, P2, DOI 10.1186/2041-9414-2-2; Rhodin J, 2006, J MOL BIOL, V355, P335, DOI 10.1016/j.jmb.2005.10.078; Sfeir AJ, 2005, MOL CELL, V18, P131, DOI 10.1016/j.molcel.2005.02.035; SHORE D, 1987, CELL, V51, P721, DOI 10.1016/0092-8674(87)90095-X; Shore D, 2009, EMBO J, V28, P2309, DOI 10.1038/emboj.2009.195; Smith CD, 2003, MOL BIOL CELL, V14, P556, DOI 10.1091/mbc.E02-08-0457; Stansel RM, 2001, EMBO J, V20, P5532; Subramanian D, 2005, J BIOL CHEM, V280, P42568, DOI 10.1074/jbc.M506348200; Taggart AKP, 2002, SCIENCE, V297, P1023, DOI 10.1126/science.1074968; Taylor HOB, 2000, J MOL BIOL, V303, P693, DOI 10.1006/jmbi.2000.4161; Teixeira MT, 2004, CELL, V117, P323, DOI 10.1016/S0092-8674(04)00334-4; Wahlin J, 2000, NUCLEIC ACIDS RES, V28, P2292, DOI 10.1093/nar/28.12.2292; Wahlin J, 2002, YEAST, V19, P241, DOI 10.1002/yea.816; Wellinger RJ, 1996, CELL, V85, P423, DOI 10.1016/S0092-8674(00)81120-4; WELLINGER RJ, 1993, CELL, V72, P51, DOI 10.1016/0092-8674(93)90049-V; Williams TL, 2010, J BIOL CHEM, V285, P35814, DOI 10.1074/jbc.M110.170167; Yanez GH, 2005, BIOCHEM BIOPH RES CO, V328, P49, DOI 10.1016/j.bbrc.2004.12.134	42	9	9	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2011	286	52					45174	45185		10.1074/jbc.M111.300517	http://dx.doi.org/10.1074/jbc.M111.300517			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870CA	22075002	Green Published, hybrid			2022-12-27	WOS:000298645500083
J	Reiss, DJ; Mobley, HLT				Reiss, Daniel J.; Mobley, Harry L. T.			Determination of Target Sequence Bound by PapX, Repressor of Bacterial Motility, in flhD Promoter Using Systematic Evolution of Ligands by Exponential Enrichment (SELEX) and High Throughput Sequencing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UROPATHOGENIC ESCHERICHIA-COLI; URINARY-TRACT INFECTIONS; MARR-FAMILY; TRANSCRIPTIONAL REGULATION; PROTEIN-STRUCTURE; CRYSTAL-STRUCTURE; I-TASSER; EXPRESSION; VIRULENCE; STRAINS	Most uncomplicated urinary tract infections (UTIs) are caused by uropathogenic Escherichia coli (UPEC). Both motility and adherence are integral to UTI pathogenesis, yet they represent opposing forces. Therefore, it is logical to reciprocally regulate these functions. In UPEC strain CFT073, PapX, a nonstructural protein encoded by one of the two pap operons encoding P fimbria adherence factor, represses flagella-mediated motility and is a putative member of the winged helix transcription factor family. The mechanism of this repression, however, is not understood. papX is found preferentially in more virulent UPEC isolates, being significantly more prevalent in pyelonephritis strains (53% of isolates) than in asymptomatic bacteriuria (32%) or fecal/commensal (12.5%) strains. To examine PapX structure-function, we generated papX linker insertion and site-directed mutants, which identified two key residues for PapX function (Lys(54) and Arg(127)) within domains predicted by modeling with I-TASSER software to be important for dimerization and DNA binding, respectively. To determine the PapX binding site in the CFT073 genome, systematic evolution of ligands by exponential enrichment (SELEX) in conjunction with high throughput sequencing was utilized for the first time to determine a novel binding site for a bacterial transcription factor. This method identified a 29-bp binding site within the flhDC promoter (TTACGGTGAGTTATTT-TAACTGTGCGCAA), centered 410 bp upstream of the flhD translational start site. Gel shift experiments demonstrated that PapX binds directly to this site to repress transcription of flagellar genes.	[Reiss, Daniel J.; Mobley, Harry L. T.] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48104 USA	University of Michigan System; University of Michigan	Mobley, HLT (corresponding author), Univ Michigan, Sch Med, Dept Microbiol & Immunol, 1150 W Med Ctr Dr,5641 Med Sci Bldg 2, Ann Arbor, MI 48104 USA.	hmobley@umich.edu		Mobley, Harry/0000-0001-9195-7665	National Institutes of Health Public Health Service [AI43363, AI59722, AI007528, T32 GM07863]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007528, R01AI043363, R56AI043363, R01AI059722] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007863] Funding Source: NIH RePORTER	National Institutes of Health Public Health Service(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Public Health Service Grants AI43363, AI59722, AI007528, and T32 GM07863.	Alekshun MN, 2001, NAT STRUCT BIOL, V8, P710, DOI 10.1038/90429; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Clarke MB, 2005, MOL MICROBIOL, V57, P1734, DOI 10.1111/j.1365-2958.2005.04792.x; Connell H, 1996, P NATL ACAD SCI USA, V93, P9827, DOI 10.1073/pnas.93.18.9827; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DEFRANCES CJ, 2008, NATL HLTH STAT REPOR, V5, P1; Djordjevic M, 2007, BIOMOL ENG, V24, P179, DOI 10.1016/j.bioeng.2007.03.001; Hagan EC, 2009, MOL MICROBIOL, V71, P79, DOI 10.1111/j.1365-2958.2008.06509.x; Hong M, 2005, MOL CELL, V20, P131, DOI 10.1016/j.molcel.2005.09.013; IMAI M, 1989, P NATL ACAD SCI USA, V86, P7823, DOI 10.1073/pnas.86.20.7823; JOHNSON JR, 1991, CLIN MICROBIOL REV, V4, P80, DOI 10.1128/CMR.4.1.80-128.1991; Jolma A, 2010, GENOME RES, V20, P861, DOI 10.1101/gr.100552.109; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; KLUG SJ, 1994, MOL BIOL REP, V20, P97, DOI 10.1007/BF00996358; KORHONEN TK, 1982, INFECT IMMUN, V37, P286, DOI 10.1128/IAI.37.1.286-291.1982; Kozarewa I, 2009, NAT METHODS, V6, P291, DOI [10.1038/nmeth.1311, 10.1038/NMETH.1311]; Kumarevel T, 2008, J STRUCT BIOL, V161, P9, DOI 10.1016/j.jsb.2007.08.017; Lane MC, 2007, P NATL ACAD SCI USA, V104, P16669, DOI 10.1073/pnas.0607898104; LEFFLER H, 1981, INFECT IMMUN, V34, P920, DOI 10.1128/IAI.34.3.920-929.1981; Litwin M, 2005, J UROLOGY, V173, P1065, DOI 10.1097/01.ju.0000156555.89385.54; LUND B, 1987, P NATL ACAD SCI USA, V84, P5898, DOI 10.1073/pnas.84.16.5898; MCCLURE WR, 1985, ANNU REV BIOCHEM, V54, P171, DOI 10.1146/annurev.bi.54.070185.001131; MOBLEY HLT, 1990, INFECT IMMUN, V58, P1281, DOI 10.1128/IAI.58.5.1281-1289.1990; MOBLEY HLT, 1993, MOL MICROBIOL, V10, P143, DOI 10.1111/j.1365-2958.1993.tb00911.x; MULHOLLAND SG, 1984, UROLOGY, V24, P232; Nichols CE, 2009, ACTA CRYSTALLOGR F, V65, P204, DOI 10.1107/S174430910900414X; OTT M, 1986, INFECT IMMUN, V54, P646, DOI 10.1128/IAI.54.3.646-653.1986; Pearson MM, 2008, MOL MICROBIOL, V69, P548, DOI 10.1111/j.1365-2958.2008.06307.x; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Saito K, 2003, J BACTERIOL, V185, P6195, DOI 10.1128/JB.185.20.6195-6198.2003; Sampson T., 2003, World Patent Information, V25, P123, Patent No. 25123; Schwan WR, 2008, INT J MED MICROBIOL, V298, P441, DOI 10.1016/j.ijmm.2007.05.009; Simms AN, 2008, INFECT IMMUN, V76, P4833, DOI 10.1128/IAI.00630-08; Simms AN, 2008, J BACTERIOL, V190, P3747, DOI 10.1128/JB.01870-07; Smith TG, 2009, ADV APPL MICROBIOL, V67, P257, DOI 10.1016/S0065-2164(08)01008-3; Soutourina OA, 2003, FEMS MICROBIOL REV, V27, P505, DOI 10.1016/S0168-6445(03)00064-0; Spurbeck RR, 2011, INFECT IMMUN, V79, P4753, DOI 10.1128/IAI.05621-11; Svanborg C, 1997, INFECT DIS CLIN N AM, V11, P513, DOI 10.1016/S0891-5520(05)70371-8; Vigil PD, 2011, MBIO, V2, DOI 10.1128/mBio.00066-11; Welch RA, 2002, P NATL ACAD SCI USA, V99, P17020, DOI 10.1073/pnas.252529799; Wilkinson SP, 2006, CURR ISSUES MOL BIOL, V8, P51; ZHANG XG, 1995, J BIOL CHEM, V270, P11181, DOI 10.1074/jbc.270.19.11181; Zhang Y, 2007, PROTEINS, V69, P108, DOI 10.1002/prot.21702; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zimmermann B, 2010, METHODS, V52, P125, DOI 10.1016/j.ymeth.2010.06.004	46	24	24	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2011	286	52					44726	44738		10.1074/jbc.M111.290684	http://dx.doi.org/10.1074/jbc.M111.290684			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870CA	22039053	Green Published, hybrid			2022-12-27	WOS:000298645500043
J	Sivak, JM; Ostriker, AC; Woolfenden, A; Demirs, J; Cepeda, R; Long, D; Anderson, K; Jaffee, B				Sivak, Jeremy M.; Ostriker, Allison C.; Woolfenden, Amber; Demirs, John; Cepeda, Rosemarie; Long, Debby; Anderson, Karen; Jaffee, Bruce			Pharmacologic Uncoupling of Angiogenesis and Inflammation during Initiation of Pathological Corneal Neovascularization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL GROWTH-FACTOR; MONOCLONAL-ANTIBODY; OCULAR NEOVASCULARIZATION; ANGIOSTATIC STEROIDS; EPITHELIAL REPAIR; GENETIC ABLATION; VEGF; EXPRESSION; INHIBITION; CELL	Pathological neovascularization occurs when a balance of pro-and anti-angiogenic factors is disrupted, accompanied by an amplifying inflammatory cascade. However, the interdependence of these responses and the mechanism triggering the initial angiogenic switch have remained unclear. We present data from an epithelial debridement model of corneal neovascularization describing an initial 3-day period when a substantial component of neovascular growth occurs. Administration of selective inhibitors shows that this initial growth requires signaling through VEGFR-2 (vascular endothelial growth factor receptor-2), independent of the accompanying inflammatory response. Instead, increased VEGF production is found prominently in repair epithelial cells and is increased prior to recruitment of neutrophil/granulocytes and macrophage/monocytes. Consequently, early granulocyte and monocyte depletion has little effect on corneal neovascularization outgrowth. These data indicate that it is possible to pharmacologically uncouple these mechanisms during early injury-driven neovascularization in the cornea and suggest that initial tissue responses are coordinated by repair epithelial cells.	[Sivak, Jeremy M.] Toronto Western Hosp, Dept Vis Sci, Toronto, ON M5T 2S8, Canada; [Sivak, Jeremy M.] Univ Toronto, Dept Ophthalmol & Vis Sci, Toronto, ON M5T 2S8, Canada; [Ostriker, Allison C.] Univ Colorado, Dept Pharmacol, Aurora, CO 80045 USA; [Woolfenden, Amber; Demirs, John; Cepeda, Rosemarie; Long, Debby; Anderson, Karen; Jaffee, Bruce] Novartis Inst Biomed Res, Cambridge, MA 02139 USA	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Colorado System; University of Colorado Anschutz Medical Campus; Novartis	Sivak, JM (corresponding author), Toronto Western Hosp, Dept Vis Sci, 399 Bathurst St, Toronto, ON M5T 2S8, Canada.	jsivak@uhnres.utoronto.ca	Sivak, Jeremy/AAA-3467-2022	Sivak, Jeremy/0000-0002-8776-223X	Novartis Institutes for Biomedical Research (NIBR)	Novartis Institutes for Biomedical Research (NIBR)	This work was supported by the Novartis Institutes for Biomedical Research (NIBR).	Amano S, 1998, INVEST OPHTH VIS SCI, V39, P18; Ambati BK, 2006, NATURE, V443, P993, DOI 10.1038/nature05249; Ambati BK, 2003, CORNEA, V22, P465, DOI 10.1097/00003226-200307000-00013; Ambati BK, 2003, INVEST OPHTH VIS SCI, V44, P590, DOI 10.1167/iovs.02-0685; Bukowski RM, 2010, NAT REV DRUG DISCOV, V9, P17, DOI 10.1038/nrd3073; Chang JH, 2001, CURR OPIN OPHTHALMOL, V12, P242, DOI 10.1097/00055735-200108000-00002; CONLAN JW, 1994, J EXP MED, V179, P259, DOI 10.1084/jem.179.1.259; Crosby LM, 2010, AM J PHYSIOL-LUNG C, V298, pL715, DOI 10.1152/ajplung.00361.2009; Cursiefen C, 2006, CORNEA, V25, P443, DOI 10.1097/01.ico.0000183485.85636.ff; Cursiefen C, 2004, J CLIN INVEST, V113, P1040, DOI 10.1172/JCI200420465; Cursiefen C, 2006, P NATL ACAD SCI USA, V103, P11405, DOI 10.1073/pnas.0506112103; Czuprynski CJ, 1996, INFECT IMMUN, V64, P3946, DOI 10.1128/IAI.64.9.3946-3949.1996; Daley JM, 2008, J LEUKOCYTE BIOL, V83, P64, DOI 10.1189/jlb.0407247; Fini ME, 2005, CORNEA, V24, pS2, DOI 10.1097/01.ico.0000178743.06340.2c; FOLKMAN J, 1987, ANN SURG, V206, P374, DOI 10.1097/00000658-198709000-00016; Fuchs E, 2008, GENE DEV, V22, P976, DOI 10.1101/gad.1645908; Gan LS, 2004, ACTA OPHTHALMOL SCAN, V82, P557, DOI 10.1111/j.1600-0420.2004.00312.x; Gong Y, 2010, CELL TISSUE RES, V339, P437, DOI 10.1007/s00441-009-0908-5; Han YM, 1997, J INFECT DIS, V175, P1169, DOI 10.1086/516455; Hassell JR, 2010, EXP EYE RES, V91, P326, DOI 10.1016/j.exer.2010.06.021; ISHIBASHI T, 1985, ARCH OPHTHALMOL-CHIC, V103, P708; Joussen AM, 2003, INVEST OPHTH VIS SCI, V44, P117, DOI 10.1167/iovs.01-1277; Karrasch T, 2009, Z GASTROENTEROL, V47, P1221, DOI 10.1055/s-0028-1109766; KRUSE FE, 1990, INVEST OPHTH VIS SCI, V31, P1903; Kuchle M, 2002, GRAEF ARCH CLIN EXP, V240, P580, DOI 10.1007/s00417-002-0496-5; Lee P, 1998, SURV OPHTHALMOL, V43, P245, DOI 10.1016/S0039-6257(98)00035-6; LEIBOWITZ HM, 1978, AM J OPHTHALMOL, V86, P418, DOI 10.1016/0002-9394(78)90249-0; Lu PR, 2009, CORNEA, V28, P562, DOI 10.1097/ICO.0b013e3181930bcd; Luttun A, 2002, NAT MED, V8, P831, DOI 10.1038/nm731; Mwaikambo BR, 2006, INVEST OPHTH VIS SCI, V47, P4356, DOI 10.1167/iovs.05-1656; Nakao S, 2007, AM J PATHOL, V171, P1058, DOI 10.2353/ajpath.2007.070172; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Ozaki H, 2000, AM J PATHOL, V156, P697, DOI 10.1016/S0002-9440(10)64773-6; Philipp W, 2000, INVEST OPHTH VIS SCI, V41, P2514; Poulaki V, 2004, AM J PATHOL, V164, P1293, DOI 10.1016/S0002-9440(10)63216-6; PROIA AD, 1993, EXP EYE RES, V57, P693, DOI 10.1006/exer.1993.1177; Raizman M, 1996, ARCH OPHTHALMOL-CHIC, V114, P1000, DOI 10.1001/archopht.1996.01100140208016; Rasband WS, 2011, IMAGEJ; Rose K, 2011, BIOMED PHARMACOTHER, V65, P46, DOI 10.1016/j.biopha.2010.10.002; Sivak B, 2000, Results Probl Cell Differ, V31, P1; Sivak JM, 2004, MOL CELL BIOL, V24, P245, DOI 10.1128/MCB.24.1.245-257.2004; Sivak JM, 2002, PROG RETIN EYE RES, V21, P1, DOI 10.1016/S1350-9462(01)00015-5; Sousa D., 2010, INVEST OPHTHALMOL VI, V42; Tanifuji-Terai N, 2006, INVEST OPHTH VIS SCI, V47, P545, DOI 10.1167/iovs.05-1182; TEPPER RI, 1992, SCIENCE, V257, P548, DOI 10.1126/science.1636093; Tvinnereim AR, 2004, J IMMUNOL, V173, P1994, DOI 10.4049/jimmunol.173.3.1994; West-Mays JA, 2006, INT J BIOCHEM CELL B, V38, P1625, DOI 10.1016/j.biocel.2006.03.010; Wilhelm S, 2006, NAT REV DRUG DISCOV, V5, P835, DOI 10.1038/nrd2130; Zhang SX, 2007, PROG RETIN EYE RES, V26, P1, DOI 10.1016/j.preteyeres.2006.09.002	49	13	13	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2011	286	52					44965	44975		10.1074/jbc.M111.294967	http://dx.doi.org/10.1074/jbc.M111.294967			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870CA	22072717	Green Published, hybrid			2022-12-27	WOS:000298645500065
J	Nishimura, I; Chano, T; Kita, H; Matsusue, Y; Okabe, H				Nishimura, Ichiro; Chano, Tokuhiro; Kita, Hiroko; Matsusue, Yoshitaka; Okabe, Hidetoshi			RB1CC1 Protein Suppresses Type II Collagen Synthesis in Chondrocytes and Causes Dwarfism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUTOSOMAL SEX REVERSAL; MESENCHYMAL STEM-CELLS; FOCAL ADHESION KINASE; HUMAN BREAST-CANCER; SRY-RELATED GENE; CAMPOMELIC DYSPLASIA; FIP200; AUTOPHAGY; COMPLEX; EXPRESSION	RB1-inducible coiled-coil 1 (RB1CC1) functions in various processes, such as cell growth, differentiation, senescence, apoptosis, and autophagy. The conditional transgenic mice with cartilage-specific RB1CC1 excess that were used in the present study were made for the first time by the Cre-loxP system. Cartilage-specific RB1CC1 excess caused dwarfism in mice without causing obvious abnormalities in endochondral ossification and subsequent skeletal development from embryo to adult. In vitro and in vivo analysis revealed that the dwarf phenotype in cartilaginous RB1CC1 excess was induced by reductions in the total amount of cartilage and the number of cartilaginous cells, following suppressions of type II collagen synthesis and Erk1/2 signals. In addition, we have demonstrated that two kinds of SNPs (T-547C and C-468T) in the human RB1CC1 promoter have significant influence on the self-transcriptional level. Accordingly, human genotypic variants of RB1CC1 that either stimulate or inhibit RB1CC1 transcription in vivo may cause body size variations.	[Nishimura, Ichiro; Chano, Tokuhiro; Kita, Hiroko; Okabe, Hidetoshi] Shiga Univ Med Sci, Dept Clin Lab Med, Otsu, Shiga 5202192, Japan; [Nishimura, Ichiro; Matsusue, Yoshitaka] Shiga Univ Med Sci, Dept Orthoped Surg, Otsu, Shiga 5202192, Japan	Shiga University of Medical Science; Shiga University of Medical Science	Chano, T (corresponding author), Tsukinowa Cho, Otsu, Shiga 5202192, Japan.	chano@belle.shiga-med.ac.jp	Chano, Tokuhiro/F-5816-2018	Chano, Tokuhiro/0000-0002-9959-1183	Ministry of Education, Culture, Sports, Science, and Technology, Japan; Japanese Society of Laboratory Medicine	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Society of Laboratory Medicine	This work was supported by KAKENHI (Grant-in-Aid for Scientific Research) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan and the Japanese Society of Laboratory Medicine Fund for the Promotion of Scientific Research.	Abbi S, 2002, MOL BIOL CELL, V13, P3178, DOI 10.1091/mbc.E02-05-0295; Bamba N, 2004, INT J MOL MED, V14, P583; Buhrmann C, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3065; Chan EY, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.284pe51; Chano T, 2002, NAT GENET, V31, P285, DOI 10.1038/ng911; Chano T, 2002, ONCOGENE, V21, P1295, DOI 10.1038/sj.onc.1205178; Chano T, 2002, AM J PATHOL, V161, P359, DOI 10.1016/S0002-9440(10)64190-9; Chano T, 2007, BRAIN RES, V1168, P97, DOI 10.1016/j.brainres.2007.06.075; Chano T, 2006, INT J MOL MED, V18, P425; Chano T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015737; Chano T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011404; FOSTER JW, 1994, NATURE, V372, P525, DOI 10.1038/372525a0; Gan BY, 2006, J CELL BIOL, V175, P121, DOI 10.1083/jcb.200604129; Gan BY, 2005, J CELL BIOL, V170, P379, DOI 10.1083/jcb.200411106; Ganley IG, 2009, J BIOL CHEM, V284, P12297, DOI 10.1074/jbc.M900573200; Ghayor C, 2000, J BIOL CHEM, V275, P27421; Hara T, 2008, J CELL BIOL, V181, P497, DOI 10.1083/jcb.200712064; Hara T, 2009, AUTOPHAGY, V5, P85, DOI 10.4161/auto.5.1.7180; Hoornaert KP, 2007, EUR J HUM GENET, V15, P1269, DOI 10.1038/sj.ejhg.5201913; HORTON WA, 1992, P NATL ACAD SCI USA, V89, P4583, DOI 10.1073/pnas.89.10.4583; Hosokawa N, 2009, MOL BIOL CELL, V20, P1981, DOI 10.1091/mbc.E08-12-1248; Ikebuchi K, 2009, INT J CANCER, V125, P861, DOI 10.1002/ijc.24466; Jung CH, 2009, MOL BIOL CELL, V20, P1992, DOI 10.1091/mbc.E08-12-1249; Kanegae Y, 1996, GENE, V181, P207, DOI 10.1016/S0378-1119(96)00516-1; Korkko J, 2000, AM J MED GENET, V92, P95, DOI 10.1002/(SICI)1096-8628(20000515)92:2<95::AID-AJMG3>3.0.CO;2-9; Ledig S, 2010, SEX DEV, V4, P225, DOI 10.1159/000314958; Liang CC, 2010, J BIOL CHEM, V285, P3499, DOI 10.1074/jbc.M109.072389; Liu F, 2010, BLOOD, V116, P4806, DOI 10.1182/blood-2010-06-288589; Martin N, 2008, MOL CELL BIOL, V28, P2771, DOI 10.1128/MCB.01210-07; Melkoumian ZK, 2005, CANCER RES, V65, P6676, DOI 10.1158/0008-5472.CAN-04-4142; Mizushima N, 2010, CURR OPIN CELL BIOL, V22, P132, DOI 10.1016/j.ceb.2009.12.004; Morselli E, 2011, CELL CYCLE, V10, P2763, DOI 10.4161/cc.10.16.16868; Nishida T, 2007, J CELL COMMUN SIGNAL, V1, P45, DOI 10.1007/s12079-007-0005-z; Ochi Y, 2011, ONCOL REP, V26, P805, DOI 10.3892/or.2011.1329; Oldershaw RA, 2010, NAT BIOTECHNOL, V28, P1221, DOI 10.1038/nbt.1683; Paun BC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007715; Rosner M, 2008, MUTAT RES-REV MUTAT, V658, P234, DOI 10.1016/j.mrrev.2008.01.001; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schmidt-Kittler O, 2003, P NATL ACAD SCI USA, V100, P7737, DOI 10.1073/pnas.1331931100; Shukunami C, 1997, J BONE MINER RES, V12, P1174, DOI 10.1359/jbmr.1997.12.8.1174; Takahashi I, 2003, EUR J CELL BIOL, V82, P182, DOI 10.1078/0171-9335-00307; WAGNER T, 1994, CELL, V79, P1111, DOI 10.1016/0092-8674(94)90041-8; Wehling N, 2009, ARTHRITIS RHEUM-US, V60, P801, DOI 10.1002/art.24352; Wei HJ, 2009, J BIOL CHEM, V284, P6004, DOI 10.1074/jbc.M806375200	44	8	9	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2011	286	51					43925	43932		10.1074/jbc.M111.264192	http://dx.doi.org/10.1074/jbc.M111.264192			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866SH	22049074	Green Published, hybrid			2022-12-27	WOS:000298402300033
J	Sambri, I; Capasso, R; Pucci, P; Perna, AF; Ingrosso, D				Sambri, Irene; Capasso, Rosanna; Pucci, Piero; Perna, Alessandra F.; Ingrosso, Diego			RETRACTED: The MicroRNA 15a/16-1 Cluster Down-regulates Protein Repair Isoaspartyl Methyltransferase in Hepatoma Cells IMPLICATIONS FOR APOPTOSIS REGULATION (Retracted article. See vol. 294, pg. 8350, 2019)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Retracted Publication							X-L DEAMIDATION; CARBOXYL METHYLTRANSFERASE; ASPARTYL RESIDUES; BCL-XL; METHYLATION; PEPTIDES; BCL-X(L); ACCUMULATION; ASSOCIATION; ACTIVATION	Asparaginyl deamidation, a spontaneous protein post-bio-synthetic modification, determines isoaspartyl formation and structure-function impairment. The isoaspartyl protein carbox-yl-O-methyltransferase (PCMT1; EC 2.1.1.77) catalyzes the repair of the isopeptide bonds at isoaspartyl sites, preventing deamidation-related functional impairment. Protein deamidation affects key apoptosis mediators, such as Bcl(xL), thus increasing susceptibility to apoptosis, whereas PCMT1 activity may effectively counteract such alterations. The aim of this work was to establish the role of RNAi as a potential mechanism for regulating PCMT1 expression and its possible implications in apoptosis. We investigated the regulatory properties of the microRNA 15a/16-1 cluster on PCMT1 expression on HepG2 cells. MicroRNA 15a or microRNA 16-1 transfection, as well as their relevant antagonists, showed that PCMT1 is effectively regulated by this microRNA cluster. The direct interaction of these two microRNAs with the seed sequence at the 3' UTR of PCMT1 transcripts was demonstrated by the luciferase assay system. The role of PCMT1 down-regulation in conditioning the susceptibility to apoptosis was investigated using various specific siRNA or shRNA approaches, to prevent non-PCMT1-specific pleiotropic effects to take place. We found that PCMT1 silencing is associated with an increase of the Bcl(xL) isoform reported to be inactivated by deamidation, thus making cells more susceptible to apoptosis induced by cisplatinum. We conclude that PCMT1 is effectively regulated by the microRNA 15a/16-1 cluster and is involved in apoptosis by preserving the structural stability and biological function of Bcl(xL) from deamidation. Control of PCMT1 expression by microRNA 15a/16-1 may thus represent a late checkpoint in apoptosis regulation.	Univ Naples 2, Sch Med & Surg, Dept Biochem & Biophys, Naples, Italy; [Perna, Alessandra F.] Univ Naples 2, Div Nephrol 1, Sch Med & Surg, Naples, Italy; [Pucci, Piero] Univ Naples Federico II, Sch Life Sci, I-80138 Naples, Italy; [Pucci, Piero] Ceinge, Adv Biotechnol, I-80138 Naples, Italy	Universita della Campania Vanvitelli; Universita della Campania Vanvitelli; University of Naples Federico II; CEINGE Biotecnologie Avanzate	Ingrosso, D (corresponding author), Via De Crecchio 7, I-80138 Naples, Italy.	diego.ingrosso@unina2.it	Perna, Alessandra F/AAC-3952-2022; Ingrosso, Diego/AHE-4980-2022	PUCCI, Pietro/0000-0002-5885-1495; PERNA, Alessandra/0000-0003-4048-9392	 [PRIN2005-prot.2005062199_003];  [PRIN2007-prot.2007EBCYYW_004];  [PRIN2007 2007EBCYYW_001]	; ; 	This work was supported in part by Grants PRIN2005-prot.2005062199_003 and PRIN2007-prot.2007EBCYYW_004 (to D. I.) and Grant PRIN2007 2007EBCYYW_001 (to A. F. P.).	Agostini M, 2011, BIOCHEM BIOPH RES CO, V414, P451, DOI 10.1016/j.bbrc.2011.09.081; Aqeilan RI, 2010, CELL DEATH DIFFER, V17, P215, DOI 10.1038/cdd.2009.69; Aritomi M, 1997, J BIOL CHEM, V272, P27886, DOI 10.1074/jbc.272.44.27886; Asakura T, 2008, INT J ONCOL, V33, P389, DOI 10.3892/ijo_00000020; Aswad DW, 2000, J PHARMACEUT BIOMED, V21, P1129, DOI 10.1016/S0731-7085(99)00230-7; ASWAD DW, 1995, DEAMIDATION ISOASPAR, P7; Bohme L, 2008, BIOL CHEM, V389, P1055, DOI 10.1515/BC.2008.125; BOIVIN D, 1995, BIOCHEM J, V309, P993, DOI 10.1042/bj3090993; Bonci D, 2008, NAT MED, V14, P1271, DOI 10.1038/nm.1880; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRENNAN TV, 1994, J BIOL CHEM, V269, P24586; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Calin GA, 2008, P NATL ACAD SCI USA, V105, P5166, DOI 10.1073/pnas.0800121105; Chang BS, 1997, EMBO J, V16, P968, DOI 10.1093/emboj/16.5.968; Chiorazzi N, 2005, NEW ENGL J MED, V352, P804, DOI 10.1056/NEJMra041720; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Cimmino A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003258; Clarke S, 2003, AGEING RES REV, V2, P263, DOI 10.1016/S1568-1637(03)00011-4; Deverman BE, 2002, CELL, V111, P51, DOI 10.1016/S0092-8674(02)00972-8; Deverman BE, 2003, CELL, V115, P503, DOI 10.1016/S0092-8674(03)00892-4; Dzhagalov I, 2007, BLOOD, V109, P1620, DOI 10.1182/blood-2006-03-013771; Fabbri M, 2011, JAMA-J AM MED ASSOC, V305, P59, DOI 10.1001/jama.2010.1919; GALLETTI P, 1995, BIOCHEM J, V306, P313, DOI 10.1042/bj3060313; GALLETTI P, 1988, BIOCHEMISTRY-US, V27, P1752, DOI 10.1021/bi00405a055; Guo CJ, 2009, J HEPATOL, V50, P766, DOI 10.1016/j.jhep.2008.11.025; Huebscher KJ, 1999, GENE, V240, P333, DOI 10.1016/S0378-1119(99)00443-6; Ingrosso D, 2002, EUR J BIOCHEM, V269, P2032, DOI 10.1046/j.1432-1033.2002.02838.x; Ingrosso D, 1996, BRIT J HAEMATOL, V93, P38, DOI 10.1046/j.1365-2141.1996.451990.x; JOHNSON BA, 1987, J BIOL CHEM, V262, P12283; JOHNSON BA, 1987, J BIOL CHEM, V262, P5622; Kaji Y, 2010, CHEM BIODIVERS, V7, P1364, DOI 10.1002/cbdv.200900329; Kim E, 1997, P NATL ACAD SCI USA, V94, P6132, DOI 10.1073/pnas.94.12.6132; Lanthier J, 2004, EXP CELL RES, V293, P96, DOI 10.1016/j.yexcr.2003.10.003; MACFARLANE DE, 1984, J BIOL CHEM, V259, P1357; MCFADDEN PN, 1987, P NATL ACAD SCI USA, V84, P2595, DOI 10.1073/pnas.84.9.2595; OCONNOR CM, 1989, GAMETE RES, V22, P307, DOI 10.1002/mrd.1120220308; Pepperkok R, 2000, J CELL BIOL, V148, P715, DOI 10.1083/jcb.148.4.715; PERNA AF, 1993, J CLIN INVEST, V91, P2497; Reissner KJ, 2003, CELL MOL LIFE SCI, V60, P1281, DOI 10.1007/s00018-003-2287-5; Robinson NE, 2001, P NATL ACAD SCI USA, V98, P944, DOI 10.1073/pnas.98.3.944; Sargaeva NP, 2009, ANAL CHEM, V81, P9778, DOI 10.1021/ac901677t; Takehara T, 2003, CANCER RES, V63, P3054; Zhao R, 2007, PLOS BIOL, V5, P39, DOI 10.1371/journal.pbio.0050001; Zhao R, 2008, NEW ENGL J MED, V359, P2778, DOI 10.1056/NEJMoa0804953	44	18	19	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2011	286	51					43690	43700		10.1074/jbc.M111.290437	http://dx.doi.org/10.1074/jbc.M111.290437			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866SH	22033921	Green Published, hybrid			2022-12-27	WOS:000298402300012
J	Collen, PN; Sassi, JF; Rogniaux, H; Marfaing, H; Helbert, W				Collen, Pi Nyvall; Sassi, Jean-Francois; Rogniaux, Helene; Marfaing, Helene; Helbert, William			Ulvan Lyases Isolated from the Flavobacteria Persicivirga ulvanivorans Are the First Members of a New Polysaccharide Lyase Family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-WALL POLYSACCHARIDES; CHEMICAL-STRUCTURE; RHEOLOGICAL PROPERTIES; ALGINATE LYASES; CHLOROPHYTA; COMPLEX	Ulvans are complex sulfated polysaccharides found in the cell walls of green algae belonging to the genus Ulva. These polysaccharides are composed of disaccharide repetition moieties made up of sulfated rhamnose linked to either glucuronic acid, iduronic acid, or xylose. Two ulvan lyases of 30 and 46 kDa were purified from the culture supernatant of Persicivirga ulvanivorans. Based on peptide sequencing, the gene encoding the 46-kDa ulvan lyase was cloned. Sequence analysis revealed that the protein is modular and possesses a catalytic module similar to that of the 30-kDa ulvan lyase along with a module of unknown function. The ulvan-degrading function of the gene was confirmed by expression of the catalytic module in a heterologous system. The gene encoding the catalytic module has no sequence homolog in sequence databases and is likely to be the first member of a novel polysaccharide lyase family. Analysis of degradation products showed that both the 30- and 46-kDa ulvan lyases are endolytic and cleave the glycosidic bond between the sulfated rhamnose and a glucuronic or iduronic acid.	[Collen, Pi Nyvall; Helbert, William] Univ Paris 06, CNRS, Unite Mixte Rech Marine Plants & Biomol 7139, Biol Stn, F-29682 Roscoff, France; [Sassi, Jean-Francois; Marfaing, Helene] Ctr Etud & Valorisat Algues, F-22610 Pleubian, France; [Rogniaux, Helene] INRA, Biopolymeres Interact Assemblages UR1268, F-44316 Nantes, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; INRAE	Helbert, W (corresponding author), Univ Paris 06, CNRS, Unite Mixte Rech Marine Plants & Biomol 7139, Biol Stn, F-29682 Roscoff, France.	helbert@sb-roscoff.fr	SASSI, Jean Francois/D-4076-2013	MARFAING, Helene/0000-0003-0894-5538	French National Research Agency (ANR) [ANR-07-RIB-019]	French National Research Agency (ANR)(French National Research Agency (ANR))	This work was supported by the French National Research Agency (ANR) by Grant ANR-07-RIB-019.	Barbeyron T, 2011, INT J SYST EVOL MICR, V61, P1899, DOI 10.1099/ijs.0.024489-0; BOUTACHFAITI R, 2010, Patent No. 261894; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Delattre C, 2006, APPL MICROBIOL BIOT, V70, P437, DOI 10.1007/s00253-005-0077-8; GACESA P, 1990, APPL ENVIRON MICROB, V56, P2265, DOI 10.1128/AEM.56.7.2265-2267.1990; Gao S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008571; Garron ML, 2010, GLYCOBIOLOGY, V20, P1547, DOI 10.1093/glycob/cwq122; LAEMMLI UK, 1973, J MOL BIOL, V80, P575, DOI 10.1016/0022-2836(73)90198-8; Lahaye M, 1997, CARBOHYD RES, V304, P325, DOI 10.1016/S0008-6215(97)00270-X; Lahaye M, 1998, CARBOHYD POLYM, V36, P239, DOI 10.1016/S0144-8617(98)00026-5; Lahaye M, 2007, BIOMACROMOLECULES, V8, P1765, DOI 10.1021/bm061185q; LIU YG, 1995, PLANT J, V8, P457, DOI 10.1046/j.1365-313X.1995.08030457.x; LIU YG, 1995, GENOMICS, V25, P674, DOI 10.1016/0888-7543(95)80010-J; PERCIVAL E, 1967, CHEM ENZYMOLOGY MARI, P176; Quemener B, 1997, J APPL PHYCOL, V9, P179, DOI 10.1023/A:1007971023478; Quemener B, 2000, FOOD HYDROCOLLOID, V14, P9, DOI 10.1016/S0268-005X(99)00042-9; RAY B, 1995, CARBOHYD RES, V274, P313, DOI 10.1016/0008-6215(95)00059-3; Robic A, 2008, CARBOHYD POLYM, V74, P344, DOI 10.1016/j.carbpol.2008.02.020; Robic A, 2009, CARBOHYD POLYM, V77, P206, DOI 10.1016/j.carbpol.2008.12.023; Robic A, 2009, J PHYCOL, V45, P962, DOI 10.1111/j.1529-8817.2009.00699.x; Shaya D, 2008, GLYCOBIOLOGY, V18, P270, DOI 10.1093/glycob/cwn002; Shaya D, 2006, J BIOL CHEM, V281, P15525, DOI 10.1074/jbc.M512055200; Tabatabai M. A., 1974, Sulphur Institute Journal, V10, P11; Tondervik A, 2010, J BIOL CHEM, V285, P35284, DOI 10.1074/jbc.M110.162800; Zobell CE, 1941, J MAR RES, V4, P42	25	63	67	5	41	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42063	42071		10.1074/jbc.M111.271825	http://dx.doi.org/10.1074/jbc.M111.271825			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	22009751	Green Published, hybrid			2022-12-27	WOS:000298180900016
J	Maric, HM; Mukherjee, J; Tretter, V; Moss, SJ; Schindelin, H				Maric, Hans-Michael; Mukherjee, Jayanta; Tretter, Verena; Moss, Stephen J.; Schindelin, Hermann			Gephyrin-mediated gamma-Aminobutyric Acid Type A and Glycine Receptor Clustering Relies on a Common Binding Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BRAIN-STEM MOTONEURONS; GABA(A) RECEPTOR; GABAERGIC SYNAPSES; INHIBITORY SYNAPSES; PROTEIN GEPHYRIN; KNOCKOUT MICE; BETA-SUBUNIT; SUBTYPES; PHOSPHORYLATION; COLOCALIZATION	Gephyrin is the major protein determinant for the clustering of inhibitory neurotransmitter receptors. Earlier analyses revealed that gephyrin tightly binds to residues 398-410 of the glycine receptor beta subunit (GlyR beta) and, as demonstrated only recently, also interacts with GABA(A) receptors (GABA(A)Rs) containing the alpha 1, alpha 2, and alpha 3 subunits. Here, we dissect the molecular basis underlying the interactions between gephyrin and GABA(A)Rs containing these alpha-subunits and compare them to the crystal structure of the gephyrin-GlyR beta complex. Biophysical and biochemical assays revealed that, in contrast to its tight interaction with GlyR beta, gephyrin only loosely interacts with GABAAR alpha 2, whereas it has an intermediate affinity for the GABAAR alpha 1 and alpha 3 subunits. Despite the wide variation in affinities and the low overall sequence homology among the identified receptor subunits, competition assays confirmed the receptor-gephyrin interaction to be a mutually exclusive process. Selected gephyrin point mutants that critically weaken complex formation with GlyR beta also abolished the GABA(A)R alpha 1 and alpha 3 interactions. Additionally, we identified a common binding motif with two conserved aromatic residues that are central for gephyrin binding. Consistent with the biochemical data, mutations of the corresponding residues within the cytoplasmic domain of alpha 2 subunit-containing GABA(A)Rs attenuated clustering of these receptors at postsynaptic sites in hippocampal neurons. Taken together, our experiments provide key insights regarding similarities and differences in the complex formation between gephyrin and GABA(A)Rs compared with GlyRs and, hence, the accumulation of these receptors at postsynaptic sites.	[Maric, Hans-Michael; Schindelin, Hermann] Univ Wurzburg, Inst Biol Struct, Rudolf Virchow Ctr Expt Biomed, D-97080 Wurzburg, Germany; [Tretter, Verena] Med Univ Vienna, Ctr Brain Res, Dept Biochem & Mol Biol, A-1090 Vienna, Austria; [Mukherjee, Jayanta; Moss, Stephen J.] Tufts Univ, Dept Neurosci, Boston, MA 02111 USA	University of Wurzburg; Medical University of Vienna; Tufts University	Schindelin, H (corresponding author), Univ Wurzburg, Inst Biol Struct, Rudolf Virchow Ctr Expt Biomed, Josef Schneider Str 2, D-97080 Wurzburg, Germany.	hermann.schindelin@virchow.uni-wuerzburg.de	Maric, Hans Michael/AAQ-8205-2020; Schindelin, Hermann/Q-2697-2019	Maric, Hans Michael/0000-0002-2719-4752; 	Deutsche Forschungsgemeinschaft [RVZ FZ 82, Schi 425/2-1, SFB487 C7]; European Community [HEALTH-F4-2008-202088]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS081986, R01NS051195] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Community(European Commission); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Deutsche Forschungsgemeinschaft (RVZ FZ 82, Schi 425/2-1, and SFB487 C7; to H. S.) and the European Community (EC-FP7 integrated project "Neurocypres"; HEALTH-F4-2008-202088; to V. T.).	Alldred MJ, 2005, J NEUROSCI, V25, P594, DOI 10.1523/JNEUROSCI.4011-04.2005; Ballif BA, 2008, J PROTEOME RES, V7, P311, DOI 10.1021/pr0701254; Fischer F, 2000, J COMP NEUROL, V427, P634, DOI 10.1002/1096-9861(20001127)427:4<634::AID-CNE10>3.0.CO;2-X; Geiman EJ, 2002, J COMP NEUROL, V444, P275, DOI 10.1002/cne.10148; Giesemann T, 2003, J NEUROSCI, V23, P8330; Jacob TC, 2005, J NEUROSCI, V25, P10469, DOI 10.1523/JNEUROSCI.2267-05.2005; Jemth P, 2007, BIOCHEMISTRY-US, V46, P8701, DOI 10.1021/bi7008618; Keller AF, 2001, J NEUROSCI, V21, P7871, DOI 10.1523/JNEUROSCI.21-20-07871.2001; Kim EY, 2006, EMBO J, V25, P1385, DOI 10.1038/sj.emboj.7601029; KIRSCH J, 1991, J BIOL CHEM, V266, P22242; Kittler JT, 2004, P NATL ACAD SCI USA, V101, P12736, DOI 10.1073/pnas.0401860101; Kneussel M, 1999, J NEUROSCI, V19, P9289, DOI 10.1523/jneurosci.19-21-09289.1999; Kneussel M, 2001, MOL CELL NEUROSCI, V17, P973, DOI 10.1006/mcne.2001.0983; Kneussel M, 1999, J NEUROCHEM, V72, P1323, DOI 10.1046/j.1471-4159.1999.0721323.x; Kralic JE, 2006, J COMP NEUROL, V495, P408, DOI 10.1002/cne.20866; Levi S, 2004, J NEUROSCI, V24, P207, DOI 10.1523/JNEUROSCI.1661-03.2004; Li RW, 2005, J NEUROCHEM, V95, P756, DOI 10.1111/j.1471-4159.2005.03426.x; MEYER G, 1995, NEURON, V15, P563, DOI 10.1016/0896-6273(95)90145-0; Mukherjee J, 2011, J NEUROSCI, V31, P14677, DOI 10.1523/JNEUROSCI.2001-11.2011; Munton RP, 2007, MOL CELL PROTEOMICS, V6, P283, DOI 10.1074/mcp.M600046-MCP200; Nabekura J, 2004, NAT NEUROSCI, V7, P17, DOI 10.1038/nn1170; O'Brien JA, 1999, J NEUROPHYSIOL, V82, P1638, DOI 10.1152/jn.1999.82.3.1638; Panzanelli P, 2011, J PHYSIOL-LONDON, V589, P4959, DOI 10.1113/jphysiol.2011.216028; PFEIFFER F, 1982, J BIOL CHEM, V257, P9389; Russier M, 2002, J PHYSIOL-LONDON, V541, P123, DOI 10.1113/jphysiol.2001.016063; Saiepour L, 2010, J BIOL CHEM, V285, P29623, DOI 10.1074/jbc.M110.121368; Sassoe-Pognetto M, 2000, J COMP NEUROL, V420, P481, DOI 10.1002/(SICI)1096-9861(20000515)420:4<481::AID-CNE6>3.0.CO;2-5; SASSOEPOGNETTO M, 1995, J COMP NEUROL, V357, P1, DOI 10.1002/cne.903570102; Schrader N, 2004, J BIOL CHEM, V279, P18733, DOI 10.1074/jbc.M311245200; Schweizer C, 2003, MOL CELL NEUROSCI, V24, P442, DOI 10.1016/S1044-7431(03)00202-1; Studer R, 2006, EUR J NEUROSCI, V24, P1307, DOI 10.1111/j.1460-9568.2006.05006.x; Tretter V, 2008, J NEUROSCI, V28, P1356, DOI 10.1523/JNEUROSCI.5050-07.2008; Tretter V, 2011, J BIOL CHEM, V286, P37702, DOI 10.1074/jbc.M111.291336; Winsky-Sommerer R, 2008, NEUROSCIENCE, V154, P595, DOI 10.1016/j.neuroscience.2008.03.081; Yu W, 2007, MOL CELL NEUROSCI, V36, P484, DOI 10.1016/j.mcn.2007.08.008	35	71	71	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42105	42114		10.1074/jbc.M111.303412	http://dx.doi.org/10.1074/jbc.M111.303412			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	22006921	Green Published, hybrid			2022-12-27	WOS:000298180900021
J	Scott, DA; Richardson, AD; Filipp, FV; Knutzen, CA; Chiang, GG; Ronai, ZA; Osterman, AL; Smith, JW				Scott, David A.; Richardson, Adam D.; Filipp, Fabian V.; Knutzen, Christine A.; Chiang, Gary G.; Ronai, Ze'ev A.; Osterman, Andrei L.; Smith, Jeffrey W.			Comparative Metabolic Flux Profiling of Melanoma Cell Lines BEYOND THE WARBURG EFFECT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUTAMINE-METABOLISM; CANCER; HYPOXIA; ADAPTATION; SENESCENCE; EXPRESSION; KINASE; TARGET; GROWTH	Metabolic rewiring is an established hallmark of cancer, but the details of this rewiring at a systems level are not well characterized. Here we acquire this insight in a melanoma cell line panel by tracking metabolic flux using isotopically labeled nutrients. Metabolic profiling and flux balance analysis were used to compare normal melanocytes to melanoma cell lines in both normoxic and hypoxic conditions. All melanoma cells exhibited the Warburg phenomenon; they used more glucose and produced more lactate than melanocytes. Other changes were observed in melanoma cells that are not described by the Warburg phenomenon. Hypoxic conditions increased fermentation of glucose to lactate in both melanocytes and melanoma cells (the Pasteur effect). However, metabolism was not strictly glycolytic, as the tricarboxylic acid (TCA) cycle was functional in all melanoma lines, even under hypoxia. Furthermore, glutamine was also a key nutrient providing a substantial anaplerotic contribution to the TCA cycle. In the WM35 melanoma line glutamine was metabolized in the "reverse" (reductive) direction in the TCA cycle, particularly under hypoxia. This reverse flux allowed the melanoma cells to synthesize fatty acids from glutamine while glucose was primarily converted to lactate. Altogether, this study, which is the first comprehensive comparative analysis of metabolism in melanoma cells, provides a foundation for targeting metabolism for therapeutic benefit in melanoma.	[Scott, David A.; Richardson, Adam D.; Filipp, Fabian V.; Knutzen, Christine A.; Chiang, Gary G.; Ronai, Ze'ev A.; Osterman, Andrei L.; Smith, Jeffrey W.] Sanford Burnham Med Res Inst, Canc Res Ctr, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute	Osterman, AL (corresponding author), Sanford Burnham Med Res Inst, Canc Res Ctr, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	osterman@sanfordburnham.org	Filipp, Fabian Volker/X-5425-2018; Richardson, Adam D/N-7845-2014	Filipp, Fabian Volker/0000-0001-9889-5727; Richardson, Adam D/0000-0003-3646-2584; Scott, David/0000-0002-8668-2449; Chiang, Gary/0000-0003-3004-7400; RONAI, ZEEV/0000-0002-3859-0400	National Institutes of Health [CA-128814, CA-147978, CA-154887]; NATIONAL CANCER INSTITUTE [P01CA128814, R21CA147978, R00CA154887, K99CA154887] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA-128814 (to Z. A. R.), CA-147978 (to A. D. R.), and CA-154887 (to F. V. F.).	Aziz SA, 2009, CLIN CANCER RES, V15, P3029, DOI 10.1158/1078-0432.CCR-08-2768; Bedogni B, 2009, PIGM CELL MELANOMA R, V22, P166, DOI 10.1111/j.1755-148X.2009.00553.x; Bertout JA, 2008, NAT REV CANCER, V8, P967, DOI 10.1038/nrc2540; Chen Y, 2007, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2007, P181; Cheng TL, 2011, P NATL ACAD SCI USA, V108, P8674, DOI 10.1073/pnas.1016627108; Dang CV, 2010, CANCER RES, V70, P859, DOI 10.1158/0008-5472.CAN-09-3556; DeBerardinis RJ, 2010, ONCOGENE, V29, P313, DOI 10.1038/onc.2009.358; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Ellerhorst JA, 2006, ENDOCR-RELAT CANCER, V13, P1269, DOI 10.1677/erc.1.01239; Eng CH, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000911; Frezza C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024411; Gaglio D, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.56; Gambhir SS, 2002, NAT REV CANCER, V2, P683, DOI 10.1038/nrc882; Gray-Schopfer VC, 2006, BRIT J CANCER, V95, P496, DOI 10.1038/sj.bjc.6603283; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; HINKLE PC, 1991, BIOCHEMISTRY-US, V30, P3576, DOI 10.1021/bi00228a031; Jin ES, 2009, AM J PHYSIOL-ENDOC M, V296, pE748, DOI 10.1152/ajpendo.90935.2008; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; LEE WNP, 1994, AM J PHYSIOL, V266, pE372, DOI 10.1152/ajpendo.1994.266.3.E372; Lemons JMS, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000514; Meadows AL, 2008, BIOTECHNOL PROGR, V24, P334, DOI 10.1021/bp070301d; Metallo CM, 2009, J BIOTECHNOL, V144, P167, DOI 10.1016/j.jbiotec.2009.07.010; Nanchen Annik, 2007, V358, P177, DOI 10.1007/978-1-59745-244-1_11; Palmieri G, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-86; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Porporato PE, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00049; Portnoy VA, 2010, APPL ENVIRON MICROB, V76, P6529, DOI 10.1128/AEM.01178-10; Price NPJ, 2004, ANAL CHEM, V76, P6566, DOI 10.1021/ac049198m; Richardson AD, 2008, BREAST CANCER RES TR, V110, P297, DOI 10.1007/s10549-007-9732-3; Russo AE, 2009, INT J ONCOL, V34, P1481, DOI 10.3892/ijo_00000277; Safran M, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq020; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Shah M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001258; Sharma A, 2005, CANCER RES, V65, P2412, DOI 10.1158/0008-5472.CAN-04-2423; Smalley KSM, 2008, CANCER RES, V68, P5743, DOI 10.1158/0008-5472.CAN-08-0235; Tennant DA, 2010, NAT REV CANCER, V10, P267, DOI 10.1038/nrc2817; van Winden WA, 2002, BIOTECHNOL BIOENG, V80, P477, DOI 10.1002/bit.10393; Vander Heiden MG, 2011, NAT REV DRUG DISCOV, V10, P671, DOI 10.1038/nrd3504; WARBURG O, 1956, SCIENCE, V124, P269; Ward PS, 2010, CANCER CELL, V17, P225, DOI 10.1016/j.ccr.2010.01.020; Weinberg F, 2010, P NATL ACAD SCI USA, V107, P8788, DOI 10.1073/pnas.1003428107; Yoo H, 2008, J BIOL CHEM, V283, P20621, DOI 10.1074/jbc.M706494200; Zhuang D, 2008, ONCOGENE, V27, P6623, DOI 10.1038/onc.2008.258	45	235	239	1	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42626	42634		10.1074/jbc.M111.282046	http://dx.doi.org/10.1074/jbc.M111.282046			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	21998308	Green Published, hybrid			2022-12-27	WOS:000298180900070
J	Damian, M; Marie, J; Leyris, JP; Fehrentz, JA; Verdie, P; Martinez, J; Baneres, JL; Mary, S				Damian, Marjorie; Marie, Jacky; Leyris, Jean-Philippe; Fehrentz, Jean-Alain; Verdie, Pascal; Martinez, Jean; Baneres, Jean-Louis; Mary, Sophie			High Constitutive Activity Is an Intrinsic Feature of Ghrelin Receptor Protein A STUDY WITH A FUNCTIONAL MONOMERIC GHS-R1a RECEPTOR RECONSTITUTED IN LIPID DISCS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE ENERGY-TRANSFER; HORMONE SECRETAGOGUE RECEPTOR; GPCR DRUG DISCOVERY; COUPLED RECEPTORS; INVERSE AGONISM; ALPHA(1B)-ADRENERGIC RECEPTOR; BETA(2)-ADRENERGIC RECEPTOR; CONFORMATIONAL-CHANGES; MONOMERIC RHODOPSIN; STRUCTURAL INSIGHTS	Despite its central role in signaling and the potential therapeutic applications of inverse agonists, the molecular mechanisms underlying G protein-coupled receptor (GPCR) constitutive activity remain largely to be explored. In this context, ghrelin receptor GHS-R1a is a peculiar receptor in the sense that it displays a strikingly high, physiologically relevant, constitutive activity. To identify the molecular mechanisms responsible for this high constitutive activity, we have reconstituted a purified GHS-R1a monomer in a lipid disc. Using this reconstituted system, we show that the isolated ghrelin receptor per se activates G(q) in the absence of agonist, as assessed through guanosine 5'-O-(thiotriphosphate) binding experiments. The measured constitutive activity is similar in its extent to that observed in heterologous systems and in vivo. This is the first direct evidence for the high constitutive activity of the ghrelin receptor being an intrinsic property of the protein rather than the result of influence of its cellular environment. Moreover, we show that the isolated receptor in lipid discs recruits arrestin-2 in an agonist-dependent manner, whereas it interacts with mu-AP2 in the absence of ligand or in the presence of ghrelin. Of importance, these differences are linked to ligand-specific GHS-R1a conformations, as assessed by intrinsic fluorescence measurements. The distinct ligand requirements for the interaction of purified GHS-R1a with arrestin and AP2 provide a new rationale to the differences in basal and agonist-induced internalization observed in cells.	[Damian, Marjorie; Marie, Jacky; Leyris, Jean-Philippe; Fehrentz, Jean-Alain; Verdie, Pascal; Martinez, Jean; Baneres, Jean-Louis; Mary, Sophie] Univ Montpellier 1 & Montpellier 2, Fac Pharm, IBMM, CNRS UMR 5247, F-34093 Montpellier 5, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier	Baneres, JL (corresponding author), Univ Montpellier 1 & Montpellier 2, Fac Pharm, IBMM, CNRS UMR 5247, 15 Ave Charles Flahaut,BP 14491, F-34093 Montpellier 5, France.	jean-louis.baneres@univ-monp1.fr; sophie.mary@univ-montp1.fr	verdie, pascal/AAM-4228-2020; Martinez, Jean/R-9421-2019	Martinez, Jean/0000-0002-9267-4621; Baneres, jean-louis/0000-0001-7078-1285; VERDIe, Pascal/0000-0002-5807-0293	Universities of Montpellier 1 and Montpellier 2; CNRS; Agence Nationale pour la Recherche [PCV08_323163]	Universities of Montpellier 1 and Montpellier 2; CNRS(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale pour la Recherche(French National Research Agency (ANR))	This work was supported by Universities of Montpellier 1 and Montpellier 2, CNRS, and Agence Nationale pour la Recherche Contract PCV08_323163.	Arcemisbehere L, 2010, J BIOL CHEM, V285, P6337, DOI 10.1074/jbc.M109.083477; Arvanitakis L, 1998, TRENDS ENDOCRIN MET, V9, P27, DOI 10.1016/S1043-2760(98)00007-1; Baneres JL, 2011, TRENDS BIOTECHNOL, V29, P314, DOI 10.1016/j.tibtech.2011.03.002; Baneres JL, 2003, J MOL BIOL, V329, P815, DOI 10.1016/S0022-2836(03)00439-X; Baneres JL, 2003, J MOL BIOL, V329, P801, DOI 10.1016/S0022-2836(03)00438-8; Baneres JL, 2005, J BIOL CHEM, V280, P20253, DOI 10.1074/jbc.M412009200; Banerjee S, 2008, J MOL BIOL, V377, P1067, DOI 10.1016/j.jmb.2008.01.066; Bayburt TH, 2007, J BIOL CHEM, V282, P14875, DOI 10.1074/jbc.M701433200; Bayburt TH, 2011, J BIOL CHEM, V286, P1420, DOI 10.1074/jbc.M110.151043; Bayburt TH, 2010, FEBS LETT, V584, P1721, DOI 10.1016/j.febslet.2009.10.024; Bennett KA, 2009, MOL PHARMACOL, V76, P802, DOI 10.1124/mol.109.056101; Bond RA, 2006, TRENDS PHARMACOL SCI, V27, P92, DOI 10.1016/j.tips.2005.12.007; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Camina JP, 2007, J CELL PHYSIOL, V213, P187, DOI 10.1002/jcp.21109; Chabre M, 2005, BIOCHEMISTRY-US, V44, P9395, DOI 10.1021/bi050720o; Chabre M, 2009, TRENDS PHARMACOL SCI, V30, P182, DOI 10.1016/j.tips.2009.01.003; Dahmane T, 2009, BIOCHEMISTRY-US, V48, P6516, DOI 10.1021/bi801729z; Denisov IG, 2004, J AM CHEM SOC, V126, P3477, DOI 10.1021/ja0393574; Deupi X, 2011, CURR OPIN STRUC BIOL, V21, P541, DOI 10.1016/j.sbi.2011.06.002; Deupi X, 2010, PHYSIOLOGY, V25, P293, DOI 10.1152/physiol.00002.2010; Diviani D, 2003, J BIOL CHEM, V278, P19331, DOI 10.1074/jbc.M302110200; Els S, 2010, METHOD ENZYMOL, V485, P103, DOI [10.1016/S0076-6879(10)85006-2, 10.1016/B978-0-12-381296-4.00006-3]; Floquet N, 2010, J MOL BIOL, V395, P769, DOI 10.1016/j.jmb.2009.09.051; Fraile-Ramos A, 2003, TRAFFIC, V4, P243, DOI 10.1034/j.1600-0854.2003.00079.x; Ghanouni P, 2001, J BIOL CHEM, V276, P24433, DOI 10.1074/jbc.C100162200; Granier S, 2007, J BIOL CHEM, V282, P13895, DOI 10.1074/jbc.M611904200; Gurevich VV, 2000, METHOD ENZYMOL, V315, P422; Hartman JL, 1996, J BIOL CHEM, V271, P22591, DOI 10.1074/jbc.271.37.22591; Hickerson R, 2005, J MOL BIOL, V354, P459, DOI 10.1016/j.jmb.2005.09.010; Hoist B, 2006, J CLIN INVEST, V116, P637, DOI 10.1172/JCI27999; Holliday ND, 2007, MOL ENDOCRINOL, V21, P3100, DOI 10.1210/me.2007-0254; Holst B, 2003, MOL ENDOCRINOL, V17, P2201, DOI 10.1210/me.2003-0069; Holst B, 2004, J BIOL CHEM, V279, P53806, DOI 10.1074/jbc.M407676200; Holst B, 2005, MOL ENDOCRINOL, V19, P2400, DOI 10.1210/me.2005-0059; Holst B, 2010, J BIOL CHEM, V285, P3973, DOI 10.1074/jbc.M109.064725; Holst PJ, 2001, J CLIN INVEST, V108, P1789, DOI 10.1172/JCI13622; Kenakin T, 2001, FASEB J, V15, P598, DOI 10.1096/fj.00-0438rev; Kobilka BK, 2007, BBA-BIOMEMBRANES, V1768, P794, DOI 10.1016/j.bbamem.2006.10.021; Kuszak AJ, 2009, J BIOL CHEM, V284, P26732, DOI 10.1074/jbc.M109.026922; Lau PN, 2009, MOL CELL ENDOCRINOL, V299, P232, DOI 10.1016/j.mce.2008.12.006; Leyris JP, 2011, ANAL BIOCHEM, V408, P253, DOI 10.1016/j.ab.2010.09.030; McEwen DP, 2001, ANAL BIOCHEM, V291, P109, DOI 10.1006/abio.2001.5011; Mesnier D, 2004, J BIOL CHEM, V279, P49664, DOI 10.1074/jbc.M404941200; MILANO CA, 1994, P NATL ACAD SCI USA, V91, P10109, DOI 10.1073/pnas.91.21.10109; Milligan G, 2003, MOL PHARMACOL, V64, P1271, DOI 10.1124/mol.64.6.1271; Milligan G, 2009, BRIT J PHARMACOL, V158, P5, DOI 10.1111/j.1476-5381.2009.00169.x; Mokrosinski J, 2010, METHOD ENZYMOL, V484, P53, DOI [10.1016/B978-0-12-381298-8.00003-4, 10.1016/S0076-6879(10)84003-0]; Morisset S, 2000, NATURE, V408, P860, DOI 10.1038/35048583; Moulin A, 2008, J MED CHEM, V51, P689, DOI 10.1021/jm701292s; Owen DJ, 1998, SCIENCE, V282, P1327, DOI 10.1126/science.282.5392.1327; Paing MM, 2006, MOL CELL BIOL, V26, P3231, DOI 10.1128/MCB.26.8.3231-3242.2006; Pantel J, 2006, J CLIN INVEST, V116, P760, DOI 10.1172/JCI25303; Pellissier LP, 2011, J BIOL CHEM, V286, P9985, DOI 10.1074/jbc.M110.201939; Petersen PS, 2009, ENDOCRINOLOGY, V150, P4920, DOI 10.1210/en.2008-1638; Popot JL, 2011, ANNU REV BIOPHYS, V40, P379, DOI 10.1146/annurev-biophys-042910-155219; Ratnala VRP, 2009, METHODS MOL BIOL, V552, P67, DOI 10.1007/978-1-60327-317-6_5; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; SAMAMA P, 1993, J BIOL CHEM, V268, P4625; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; Schneider EH, 2010, METHOD ENZYMOL, V485, P527, DOI [10.1016/S0076-6879(10)85028-1, 10.1016/B978-0-12-381296-4.00028-2]; Sommer ME, 2005, J BIOL CHEM, V280, P6861, DOI 10.1074/jbc.M411341200; Stoddart LA, 2010, METHOD ENZYMOL, V484, P569, DOI [10.1016/S0076-6879(10)84028-5, 10.1016/B978-0-12-381298-8.00028-9]; Tolle V, 2008, DIABETES, V57, P86, DOI 10.2337/db07-0733; Tsukamoto H, 2010, J MOL BIOL, V399, P501, DOI 10.1016/j.jmb.2010.04.029; Vassart G, 2011, NAT REV ENDOCRINOL, V7, P362, DOI 10.1038/nrendo.2011.20; White JF, 2007, P NATL ACAD SCI USA, V104, P12199, DOI 10.1073/pnas.0705312104; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; Yao XJ, 2009, P NATL ACAD SCI USA, V106, P9501, DOI 10.1073/pnas.0811437106; Zoonens M, 2007, BIOCHEMISTRY-US, V46, P10392, DOI 10.1021/bi7007596	69	106	106	2	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					3630	3641		10.1074/jbc.M111.288324	http://dx.doi.org/10.1074/jbc.M111.288324			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22117076	Green Published, hybrid			2022-12-27	WOS:000300410900003
J	Portugal, CC; da Encarnacao, TG; Socodato, R; Moreira, SR; Brudzewsky, D; Ambrosio, AF; Paes-de-Carvalho, R				Portugal, Camila Cabral; da Encarnacao, Thaisa Godinho; Socodato, Renato; Moreira, Sarah Rodrigues; Brudzewsky, Dan; Ambrosio, Antonio Francisco; Paes-de-Carvalho, Roberto			Nitric Oxide Modulates Sodium Vitamin C Transporter 2 (SVCT-2) Protein Expression via Protein Kinase G (PKG) and Nuclear Factor-kappa B (NF-kappa B)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SH-SY5Y NEUROBLASTORNA CELLS; SOLUBLE GUANYLATE-CYCLASE; CHICK-EMBRYO RETINA; ASCORBIC-ACID; S-NITROSYLATION; CREB PHOSPHORYLATION; RECEPTOR REGULATION; SIGNALING PATHWAY; NERVOUS-SYSTEM; NEURONAL CELLS	Ascorbate is an important antioxidant, which also displays important functions in neuronal tissues, including the retina. The retina is responsible for the initial steps of visual processing, which is further refined in cerebral high-order centers. The retina is also a prototypical model for studying physiologic aspects of cells that comprise the nervous system. Of major importance also is the cellular messenger nitric oxide (NO). Previous studies have demonstrated the significance of NO for both survival and proliferation of cultured embryonic retinal cells. Cultured retinal cells express a high-affinity ascorbate transporter, and the release of ascorbate is delicately regulated by ionotropic glutamate receptors. Therefore, we proposed whether there is interplay between the ascorbate transport system and NO signaling pathway in retinal cells. Here we show compelling evidence that ascorbate uptake is tightly controlled by NO and its downstream signaling pathway in culture. NO also modulates the expression of SVCT-2, an effect mediated by cGMP and PKG. Kinetic studies suggest that NO increases the transport capacity for ascorbate, but not the affinity of SVCT-2 for its substrate. Interestingly, NO utilizes the NF-kappa B pathway, in a PKG-dependent manner, to modulate both SVCT-2 expression and ascorbate uptake. These results demonstrate that NO exerts a fine-tuned control of the availability of ascorbate to cultured retinal cells and strongly reinforces ascorbate as an important bioactive molecule in neuronal tissues.	[Portugal, Camila Cabral; da Encarnacao, Thaisa Godinho; Socodato, Renato; Moreira, Sarah Rodrigues; Paes-de-Carvalho, Roberto] Univ Fed Fluminense, Inst Biol, Dept Neurobiol, BR-24001970 Niteroi, RJ, Brazil; [Portugal, Camila Cabral; da Encarnacao, Thaisa Godinho; Socodato, Renato; Moreira, Sarah Rodrigues; Paes-de-Carvalho, Roberto] Univ Fed Fluminense, Inst Biol, Program Neurosci, BR-24001970 Niteroi, RJ, Brazil; [Portugal, Camila Cabral; Socodato, Renato; Brudzewsky, Dan; Ambrosio, Antonio Francisco] Univ Coimbra, Inst Biomed Res Light & Image, Ctr Ophthalmol & Vis Sci, Fac Med, P-3004548 Coimbra, Portugal	Universidade Federal Fluminense; Universidade Federal Fluminense; Universidade de Coimbra	Paes-de-Carvalho, R (corresponding author), Caixa Postal 100180, BR-24001970 Niteroi, RJ, Brazil.	robpaes@vm.uff.br	Ambrósio, António F/I-3722-2012; Socodato, Renato/A-7237-2013; Paes-de-Carvalho, Roberto/F-8788-2018; Portugal, Camila C/A-6267-2013	Ambrósio, António F/0000-0002-0477-1641; Socodato, Renato/0000-0002-6882-5020; Paes-de-Carvalho, Roberto/0000-0002-4081-7547; Portugal, Camila C/0000-0002-1093-6545; Rodrigues Moreira, Sarah/0000-0002-0166-7312	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Fundacao de Amparo a Pesquisa de Estado do Rio de Janeiro; Programa de Apoio de Nucleos de Excelencia/Ministerio da Ciencia e Tecnologia; FCT, Portugal [C/SAU/UI3282/2011]; FEDER-COMPETE-POFC	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa de Estado do Rio de Janeiro; Programa de Apoio de Nucleos de Excelencia/Ministerio da Ciencia e Tecnologia; FCT, Portugal(Portuguese Foundation for Science and TechnologyEuropean Commission); FEDER-COMPETE-POFC	This work was supported in part by grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Fundacao de Amparo a Pesquisa de Estado do Rio de Janeiro, Programa de Apoio de Nucleos de Excelencia/Ministerio da Ciencia e Tecnologia, and Projeto Estrategico C/SAU/UI3282/2011 (FCT, Portugal, and FEDER-COMPETE-POFC).	Aktan F, 2004, LIFE SCI, V75, P639, DOI 10.1016/j.lfs.2003.10.042; Araujo AV, 2011, VASC PHARMACOL, V54, P44, DOI 10.1016/j.vph.2010.12.002; Boehning D, 2003, ANNU REV NEUROSCI, V26, P105, DOI 10.1146/annurev.neuro.26.041002.131047; Bonthius DJ, 2009, NEUROPHARMACOLOGY, V56, P716, DOI 10.1016/j.neuropharm.2008.12.006; Brahma B, 2000, J NEUROCHEM, V74, P1263; BREDT DS, 1990, P NATL ACAD SCI USA, V87, P682, DOI 10.1073/pnas.87.2.682; CAREY DJ, 1987, DEV BRAIN RES, V32, P95, DOI 10.1016/0165-3806(87)90142-8; Cossenza M, 2000, J NEUROCHEM, V74, P1885, DOI 10.1046/j.1471-4159.2000.0741885.x; Socodato RED, 2009, J NEUROCHEM, V108, P417, DOI 10.1111/j.1471-4159.2008.05778.x; Dai SS, 2010, J NEUROSCI, V30, P5802, DOI 10.1523/JNEUROSCI.0268-10.2010; Daruwala R, 1999, FEBS LETT, V460, P480, DOI 10.1016/S0014-5793(99)01393-9; DECARVALHO RP, 1982, J NEUROCHEM, V38, P493; ELDRIDGE CF, 1987, J CELL BIOL, V105, P1023, DOI 10.1083/jcb.105.2.1023; Fredholm BB, 2007, PROG NEUROBIOL, V83, P263, DOI 10.1016/j.pneurobio.2007.07.005; GARTHWAITE J, 1987, J NEUROCHEM, V48, P29, DOI 10.1111/j.1471-4159.1987.tb13123.x; Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954; Gingery A, 2008, EXP CELL RES, V314, P2725, DOI 10.1016/j.yexcr.2008.06.006; Gonzalez-Polo RA, 2004, CELL BIOL INT, V28, P373, DOI 10.1016/j.cellbi.2004.03.005; GOTO K, 1981, BRAIN RES, V207, P239, DOI 10.1016/0006-8993(81)90701-0; Grant MM, 2005, PROTEOMICS, V5, P534, DOI 10.1002/pmic.200300924; Harrison FE, 2009, FREE RADICAL BIO MED, V46, P719, DOI 10.1016/j.freeradbiomed.2008.12.018; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Huang JJ, 2006, BRAIN RES, V1097, P52, DOI 10.1016/j.brainres.2006.04.047; Huerta-Yepez S, 2004, ONCOGENE, V23, P4993, DOI 10.1038/sj.onc.1207655; Jaffrey SR, 1995, ANNU REV CELL DEV BI, V11, P417; Jagnandan D, 2005, AM J PHYSIOL-CELL PH, V289, pC1024, DOI 10.1152/ajpcell.00162.2005; Kanarek N, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000166; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kelleher ZT, 2007, J BIOL CHEM, V282, P30667, DOI 10.1074/jbc.M705929200; KNOWLES RG, 1989, P NATL ACAD SCI USA, V86, P5159, DOI 10.1073/pnas.86.13.5159; Krumenacker J, 2004, BRAIN RES BULL, V62, P505, DOI 10.1016/S0361-9230(03)00102-3; LAM KW, 1993, EXP EYE RES, V56, P601, DOI 10.1006/exer.1993.1074; Lee NPY, 2003, ENDOCRINOLOGY, V144, P3114, DOI 10.1210/en.2002-0167; Li X, 2003, BIOCHEM BIOPH RES CO, V305, P656, DOI 10.1016/S0006-291X(03)00836-2; Lipsky RH, 2001, J NEUROCHEM, V78, P254, DOI 10.1046/j.1471-4159.2001.00386.x; Liu LM, 1999, CELL DEATH DIFFER, V6, P937, DOI 10.1038/sj.cdd.4400578; Magalhaes CR, 2006, INT J DEV NEUROSCI, V24, P53, DOI 10.1016/j.ijdevneu.2005.10.004; MAJEWSKA MD, 1990, BRAIN RES, V537, P328, DOI 10.1016/0006-8993(90)90379-P; Makino Y, 1999, ANTICANCER RES, V19, P3125; Maniatis T, 1997, SCIENCE, V278, P818, DOI 10.1126/science.278.5339.818; Marshall HE, 2004, P NATL ACAD SCI USA, V101, P8841, DOI 10.1073/pnas.0403034101; Mejia-Garcia TA, 2007, J NEUROCHEM, V100, P382, DOI 10.1111/j.1471-4159.2006.04244.x; NG YC, 1985, BIOCHEM PHARMACOL, V34, P2525, DOI 10.1016/0006-2952(85)90537-4; Nott A, 2008, NATURE, V455, P411, DOI 10.1038/nature07238; PEUNOVA N, 1995, NATURE, V375, P68, DOI 10.1038/375068a0; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Portugal CC, 2009, J NEUROCHEM, V108, P507, DOI 10.1111/j.1471-4159.2008.05786.x; Profita M, 2008, EUR J PHARMACOL, V582, P145, DOI 10.1016/j.ejphar.2007.12.029; Qiu S, 2007, J NEUROSCI RES, V85, P1046, DOI 10.1002/jnr.21204; Rameau GA, 2003, NEUROBIOL AGING, V24, P1123, DOI 10.1016/j.neurobiolaging.2003.07.002; Reynaert NL, 2004, P NATL ACAD SCI USA, V101, P8945, DOI 10.1073/pnas.0400588101; Riccio A, 2006, MOL CELL, V21, P283, DOI 10.1016/j.molcel.2005.12.006; Rothwarf DM, 1998, NATURE, V395, P297, DOI 10.1038/26261; Savini I, 2008, AMINO ACIDS, V34, P347, DOI 10.1007/s00726-007-0555-7; Savini I, 2007, BIOCHEM BIOPH RES CO, V361, P385, DOI 10.1016/j.bbrc.2007.07.007; Socodato R, 2011, J NEUROCHEM, V116, P227, DOI 10.1111/j.1471-4159.2010.07096.x; Song SH, 2009, INT IMMUNOPHARMACOL, V9, P298, DOI 10.1016/j.intimp.2008.12.003; STONE JR, 1994, BIOCHEMISTRY-US, V33, P5636, DOI 10.1021/bi00184a036; Tsukaguchi H, 1999, NATURE, V399, P70, DOI 10.1038/19986; Venugopal M, 1996, LIFE SCI, V59, P1389, DOI 10.1016/0024-3205(96)00466-3; Wang YX, 2000, BIOCHEM BIOPH RES CO, V267, P488, DOI 10.1006/bbrc.1999.1929; Wiesinger H, 2001, PROG NEUROBIOL, V64, P365, DOI 10.1016/S0301-0082(00)00056-3	62	35	35	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					3860	3872		10.1074/jbc.M111.260166	http://dx.doi.org/10.1074/jbc.M111.260166			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22041898	hybrid, Green Published			2022-12-27	WOS:000300410900023
J	Colello, D; Mathew, S; Ward, R; Pumiglia, K; LaFlamme, SE				Colello, Diane; Mathew, Shomita; Ward, Rachel; Pumiglia, Kevin; LaFlamme, Susan E.			Integrins Regulate Microtubule Nucleating Activity of Centrosome through Mitogen-activated Protein Kinase/Extracellular Signal-regulated Kinase Kinase/Extracellular Signal-regulated Kinase (MEK/ERK) Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENOMATOUS POLYPOSIS-COLI; ANDROGEN RECEPTOR; GAMMA-TUBULIN; PROSTATE-CANCER; PROGESTERONE-RECEPTOR; CYTOPLASMIC DOMAINS; EPITHELIAL-CELLS; TYROSINE KINASE; TALIN BINDING; SRC	Microtubule nucleation is an essential step in the formation of the microtubule cytoskeleton. We recently showed that androgen and Src promote microtubule nucleation and gamma-tubulin accumulation at the centrosome. Here, we explore the mechanisms by which androgen and Src regulate these processes and ask whether integrins play a role. We perturb integrin function by a tyrosine-to-alanine substitution in membrane-proximal NPIY motif in the integrin beta 1 tail and show that this mutant substantially decreases microtubule nucleation and gamma-tubulin accumulation at the centrosome. Because androgen stimulation promotes the interaction of the androgen receptor with Src, resulting in PI3K/AKT and MEK/ERK signaling, we asked whether these pathways are inhibited by the mutant integrin and whether they regulate microtubule nucleation. Our results indicate that the formation of the androgen receptor-Src complex and the activation of downstream pathways are significantly suppressed when cells are adhered by the mutant integrin. Inhibitor studies indicate that microtubule nucleation requires MEK/ERK but not PI3K/AKT signaling. Importantly, the expression of activated RAF-1 is sufficient to rescue microtubule nucleation inhibited by the mutant integrin by promoting the centrosomal accumulation of gamma-tubulin. Our data define a novel paradigm of integrin signaling, where integrins regulate microtubule nucleation by promoting the formation of androgen receptor-Src signaling complexes to activate the MEK/ERK signaling pathway.	[Colello, Diane; Mathew, Shomita; Ward, Rachel; Pumiglia, Kevin; LaFlamme, Susan E.] Albany Med Coll, Ctr Cell Biol & Canc Res, Albany, NY 12208 USA	Albany Medical College	LaFlamme, SE (corresponding author), Albany Med Coll, Ctr Cell Biol & Canc Res, 47 New Scotland Ave, Albany, NY 12208 USA.	laflams@mail.amc.edu	Mathew, Shomita/B-3775-2012; MATHEW-STEINER, SHOMITA S/AAE-8041-2022	Mathew-Steiner, Shomita/0000-0002-7730-9140; Pumiglia, Kevin/0000-0003-4655-0334	National Institutes of Health [GM51540]; NATIONAL CANCER INSTITUTE [R01CA081419] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051540] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM51540 (to S. E. L.).	Akhmanova A, 2001, CELL, V104, P923, DOI 10.1016/S0092-8674(01)00288-4; Bajaj A, 2010, CANCER RES, V70, P3803, DOI 10.1158/0008-5472.CAN-09-2648; Balasubramanian N, 2007, NAT CELL BIOL, V9, P1381, DOI 10.1038/ncb1657; Baron S, 2004, J BIOL CHEM, V279, P14579, DOI 10.1074/jbc.M306143200; Beeram M, 2005, J CLIN ONCOL, V23, P6771, DOI 10.1200/JCO.2005.08.036; Berrier AL, 2002, J CELL SCI, V115, P4285, DOI 10.1242/jcs.00109; Berrier AL, 2007, J CELL PHYSIOL, V213, P565, DOI 10.1002/jcp.21237; Bodeau AL, 2001, J CELL SCI, V114, P2795; Boonyaratanakornkit V, 2001, MOL CELL, V8, P269, DOI 10.1016/S1097-2765(01)00304-5; Bornens M, 2002, CURR OPIN CELL BIOL, V14, P25, DOI 10.1016/S0955-0674(01)00290-3; Casenghi M, 2003, DEV CELL, V5, P113, DOI 10.1016/S1534-5807(03)00193-X; Cinar B, 2007, J BIOL CHEM, V282, P29584, DOI 10.1074/jbc.M703310200; Colello D, 2010, J CELL SCI, V123, P2093, DOI 10.1242/jcs.057505; Daub H, 2001, J BIOL CHEM, V276, P1677, DOI 10.1074/jbc.C000635200; DiDomenico M, 1996, CANCER RES, V56, P4516; Doxsey S, 2005, ANNU REV CELL DEV BI, V21, P411, DOI 10.1146/annurev.cellbio.21.122303.120418; Echarri A, 2006, CELL CYCLE, V5, P2179, DOI 10.4161/cc.5.19.3264; Efimov A, 2007, DEV CELL, V12, P917, DOI 10.1016/j.devcel.2007.04.002; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; Freeman MR, 2005, TRENDS ENDOCRIN MET, V16, P273, DOI 10.1016/j.tem.2005.06.002; Fumoto K, 2006, EMBO J, V25, P5670, DOI 10.1038/sj.emboj.7601459; Grigoriev I, 2006, CELL MOTIL CYTOSKEL, V63, P29, DOI 10.1002/cm.20107; Haren L, 2006, J CELL BIOL, V172, P505, DOI 10.1083/jcb.200510028; Haren L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005976; Harrison RE, 2001, NEOPLASIA, V3, P385, DOI 10.1038/sj.neo.7900180; HIRAI H, 1990, MOL CELL BIOL, V10, P1307, DOI 10.1128/MCB.10.4.1307; Hirsch E, 2002, J CELL BIOL, V157, P481, DOI 10.1083/jcb.200111065; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kaapa A, 1999, EXP CELL RES, V250, P524, DOI 10.1006/excr.1999.4533; Khodjakov A, 2002, J CELL BIOL, V158, P1171, DOI 10.1083/jcb.200205102; Khodjakov A, 1999, J CELL BIOL, V146, P585, DOI 10.1083/jcb.146.3.585; Kousteni S, 2001, CELL, V104, P719, DOI 10.1016/S0092-8674(01)00268-9; LaFlamme SE, 2008, CURR OPIN CELL BIOL, V20, P576, DOI 10.1016/j.ceb.2008.06.006; Legate KR, 2009, J CELL SCI, V122, P187, DOI 10.1242/jcs.041624; Luders J, 2006, NAT CELL BIOL, V8, P137, DOI 10.1038/ncb1349; Luders J, 2007, NAT REV MOL CELL BIO, V8, P161, DOI 10.1038/nrm2100; Meraldi P, 2002, FEBS LETT, V521, P9, DOI 10.1016/S0014-5793(02)02865-X; Migliaccio A, 2007, ONCOGENE, V26, P6619, DOI 10.1038/sj.onc.1210487; Migliaccio A, 2002, ANN NY ACAD SCI, V963, P185; Migliaccio A, 2000, EMBO J, V19, P5406, DOI 10.1093/emboj/19.20.5406; Migliaccio A, 1998, EMBO J, V17, P2008, DOI 10.1093/emboj/17.7.2008; Nieves B, 2010, J CELL SCI, V123, P1216, DOI 10.1242/jcs.056549; OTOOLE TE, 1995, J BIOL CHEM, V270, P8553, DOI 10.1074/jbc.270.15.8553; Palazzo AF, 2004, SCIENCE, V303, P836, DOI 10.1126/science.1091325; Peterziel H, 1999, ONCOGENE, V18, P6322, DOI 10.1038/sj.onc.1203032; Piehl M, 2004, P NATL ACAD SCI USA, V101, P1584, DOI 10.1073/pnas.0308205100; Reverte CG, 2006, J CELL BIOL, V174, P491, DOI 10.1083/jcb.200603069; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Salaycik KJ, 2005, J CELL SCI, V118, P4113, DOI 10.1242/jcs.02531; Sandilands E, 2008, TRENDS CELL BIOL, V18, P322, DOI 10.1016/j.tcb.2008.05.004; SCHMIDT JW, 1992, J CELL BIOL, V116, P1019, DOI 10.1083/jcb.116.4.1019; Schwartz MA, 2002, NAT CELL BIOL, V4, pE65, DOI 10.1038/ncb0402-e65; Streuli CH, 2009, BIOCHEM J, V418, P491, DOI 10.1042/BJ20081948; Sun M, 2003, J BIOL CHEM, V278, P42992, DOI 10.1074/jbc.M306295200; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Takayama Y, 1997, FEBS LETT, V406, P11, DOI 10.1016/S0014-5793(97)00224-X; Teixido-Travesa N, 2010, MOL BIOL CELL, V21, P3963, DOI 10.1091/mbc.E10-05-0408; Tolg C, 2010, J BIOL CHEM, V285, P26461, DOI 10.1074/jbc.M110.121491; Watanabe T, 2009, J CELL SCI, V122, P2969, DOI 10.1242/jcs.046649; Wen Y, 2004, NAT CELL BIOL, V6, P820, DOI 10.1038/ncb1160; White RA, 2000, MICROSC RES TECHNIQ, V49, P451, DOI 10.1002/(SICI)1097-0029(20000601)49:5<451::AID-JEMT7>3.0.CO;2-9; Wickstrom SA, 2010, DEV CELL, V19, P574, DOI 10.1016/j.devcel.2010.09.007; Wittmann T, 2005, J CELL BIOL, V169, P929, DOI 10.1083/jcb.200412114; YLANNE J, 1993, J CELL BIOL, V122, P223, DOI 10.1083/jcb.122.1.223; Zhang XY, 2009, J CELL SCI, V122, P2240, DOI 10.1242/jcs.042747; Zumbrunn J, 2001, CURR BIOL, V11, P44, DOI 10.1016/S0960-9822(01)00002-1	66	31	31	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2520	2530		10.1074/jbc.M111.254128	http://dx.doi.org/10.1074/jbc.M111.254128			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22117069	hybrid, Green Published			2022-12-27	WOS:000300292300026
J	Lee, KW; Maeng, JS; Choi, JY; Lee, YR; Hwang, CY; Park, SS; Park, HK; Chung, BH; Lee, SG; Kim, YS; Jeon, H; Eom, SH; Kang, C; Kim, DH; Kwon, KS				Lee, Keun Woo; Maeng, Jin-Soo; Choi, Jeong Yi; Lee, Yu Ran; Hwang, Chae Young; Park, Sung Sup; Park, Hyun Kyu; Chung, Bong Hyun; Lee, Seung-Goo; Kim, Yeon-Soo; Jeon, Hyesung; Eom, Soo Hyun; Kang, ChulHee; Kim, Do Han; Kwon, Ki-Sun			Role of Junctin Protein Interactions in Cellular Dynamics of Calsequestrin Polymer upon Calcium Perturbation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE CALSEQUESTRIN; RYANODINE RECEPTOR; BINDING-PROTEIN; RELEASE CHANNEL; VENTRICULAR-TACHYCARDIA; CARDIAC MYOCYTES; CA2+ RELEASE; CASQ2; CONTRACTILITY; TRIADIN	Calsequestrin (CSQ), the major intrasarcoplasmic reticulum calcium storage protein, undergoes dynamic polymerization and depolymerization in a Ca2+-dependent manner. However, no direct evidence of CSQ depolymerization in vivo with physiological relevance has been obtained. In the present study, live cell imaging analysis facilitated characterization of the in vivo dynamics of the macromolecular CSQ structure. CSQ2 appeared as speckles in the presence of normal sarcoplasmic reticulum (SR) Ca2+ that were decondensed upon Ca2+ depletion. Moreover, CSQ2decondensation occurred only in the stoichiometric presence of junctin (JNT). When expressed alone, CSQ2 speckles remained unchanged, even after Ca2+ depletion. FRET analysis revealed constant interactions between CSQ2 and JNT, regardless of the SR Ca2+ concentration, implying that JNT is an essential component of the CSQ scaffold. In vitro solubility assay, electron microscopy, and atomic force microscopy studies using purified recombinant proteins confirmed Ca2+ and JNT-dependent disassembly of the CSQ2 polymer. Accordingly, we conclude that reversible polymerization and depolymerization of CSQ are critical in SR Ca2+ homeostasis.	[Lee, Keun Woo; Choi, Jeong Yi; Lee, Yu Ran; Hwang, Chae Young; Park, Sung Sup; Kwon, Ki-Sun] Korea Res Inst Biosci & Biotechnol, Aging Res Ctr, Lab Cell Signaling, Taejon 305806, South Korea; [Park, Hyun Kyu; Chung, Bong Hyun] Korea Res Inst Biosci & Biotechnol, Bionanotechnol Res Ctr, Taejon 305806, South Korea; [Lee, Seung-Goo] Korea Res Inst Biosci & Biotechnol, Ind Biotechnol & Bioenergy Res Ctr, Taejon 305806, South Korea; [Maeng, Jin-Soo] KFRI, Bionanotechnol Res Ctr, Gyeonggi Do 463746, South Korea; [Kim, Yeon-Soo] Inje Univ, Dept Smart Foods & Drugs, Seoul 100032, South Korea; [Kim, Yeon-Soo] Inje Univ, Indang Inst Mol Biol, Seoul 100032, South Korea; [Jeon, Hyesung] Korea Inst Sci & Technol, Biomed Res Ctr, Seoul 136791, South Korea; [Eom, Soo Hyun; Kim, Do Han] Gwangju Inst Sci & Technol, Sch Life Sci, Kwangju 500712, South Korea; [Kang, ChulHee] Washington State Univ, Dept Chem, Pullman, WA 99163 USA	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Research Institute of Bioscience & Biotechnology (KRIBB); Inje University; Inje University; Korea Institute of Science & Technology (KIST); Gwangju Institute of Science & Technology (GIST); Washington State University	Kwon, KS (corresponding author), Korea Res Inst Biosci & Biotechnol, Aging Res Ctr, Lab Cell Signaling, 125 Gwahangno, Taejon 305806, South Korea.	kwonks@kribb.re.kr	Lee, Seung-Goo/AAS-1613-2021; Lee, Seung-Goo/AAR-9823-2021	Lee, Seung-Goo/0000-0003-4539-9812; Kang, ChulHee/0000-0002-0693-7860	Ministry of Education, Science and Technology [2011-0002141, 2011-0030134, 2011-0027762]; Systems Biology Infrastructure Gwangju Institute of Science and Technology	Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Systems Biology Infrastructure Gwangju Institute of Science and Technology	This work was supported by grants from the Ministry of Education, Science and Technology (Grants 2011-0002141, 2011-0030134, and 2011-0027762) (to K. S. K.) and a grant from the Systems Biology Infrastructure Gwangju Institute of Science and Technology (to S. H. E., H. J., and D. H. K.).	AARON BMB, 1984, J BIOL CHEM, V259, P1876; Beard NA, 2004, PROG BIOPHYS MOL BIO, V85, P33, DOI 10.1016/j.pbiomolbio.2003.07.001; Beard NA, 2009, EUR BIOPHYS J BIOPHY, V39, P27, DOI 10.1007/s00249-009-0449-6; Canato M, 2010, P NATL ACAD SCI USA, V107, P22326, DOI 10.1073/pnas.1009168108; CHEN SRW, 1994, J BIOL CHEM, V269, P22698; COZENS B, 1984, J BIOL CHEM, V259, P6248; di Barletta MR, 2006, CIRCULATION, V114, P1012, DOI 10.1161/CIRCULATIONAHA.106.623793; Duke AM, 2010, J BIOL CHEM, V285, P25645, DOI 10.1074/jbc.M110.104976; Fan GC, 2007, BIOCHEM BIOPH RES CO, V352, P617, DOI 10.1016/j.bbrc.2006.11.093; FRANZINIARMSTRONG C, 1987, J CELL BIOL, V105, P49, DOI 10.1083/jcb.105.1.49; Gatti G, 1997, MOL BIOL CELL, V8, P1789, DOI 10.1091/mbc.8.9.1789; Gergs U, 2007, AM J PHYSIOL-HEART C, V293, pH728, DOI 10.1152/ajpheart.01187.2006; Glover L, 2001, BBA-BIOMEMBRANES, V1515, P120, DOI 10.1016/S0005-2736(01)00406-0; GUO W, 1995, J BIOL CHEM, V270, P9027, DOI 10.1074/jbc.270.16.9027; Gyorke I, 2004, BIOPHYS J, V86, P2121, DOI 10.1016/S0006-3495(04)74271-X; HE ZP, 1993, J BIOL CHEM, V268, P24635; Hong CS, 2002, FASEB J, V16, P1310, DOI 10.1096/fj.01-0908fje; IKEMOTO N, 1974, J BIOL CHEM, V249, P2357; Jones LR, 1998, J CLIN INVEST, V101, P1385, DOI 10.1172/JCI1362; Jones LR, 1995, J BIOL CHEM, V270, P30787, DOI 10.1074/jbc.270.51.30787; Kiarash A, 2004, CARDIOVASC RES, V63, P264, DOI 10.1016/j.cardiores.2004.04.001; Kirchhefer U, 2003, CARDIOVASC RES, V59, P369, DOI 10.1016/S0008-6363(03)00432-2; Kirchhof P, 2007, J MOL CELL CARDIOL, V42, P962, DOI 10.1016/j.yjmcc.2007.02.012; Knollmann BC, 2009, J PHYSIOL-LONDON, V587, P3081, DOI 10.1113/jphysiol.2009.172098; Knollmann BC, 2006, J CLIN INVEST, V116, P2510, DOI 10.1172/JCI29128; KNUDSON CM, 1993, J BIOL CHEM, V268, P12646; Lahat H, 2001, AM J HUM GENET, V69, P1378, DOI 10.1086/324565; Launikonis BS, 2006, P NATL ACAD SCI USA, V103, P2982, DOI 10.1073/pnas.0511252103; Lee EH, 2004, J BIOL CHEM, V279, P26481, DOI 10.1074/jbc.M309574200; MACLENNAN DH, 1971, P NATL ACAD SCI USA, V68, P1231, DOI 10.1073/pnas.68.6.1231; Maguire PB, 1997, BIOCHEM BIOPH RES CO, V240, P721, DOI 10.1006/bbrc.1997.7729; MITCHELL RD, 1988, J BIOL CHEM, V263, P1376; MOORE GA, 1987, FEBS LETT, V224, P331, DOI 10.1016/0014-5793(87)80479-9; OHNISHI M, 1987, BIOCHEMISTRY-US, V26, P7458, DOI 10.1021/bi00397a039; Park HJ, 2003, J BIOL CHEM, V278, P16176, DOI 10.1074/jbc.M300120200; Park HJ, 2004, J BIOL CHEM, V279, P18026, DOI 10.1074/jbc.M311553200; Postma AV, 2002, CIRC RES, V91, pE21, DOI 10.1161/01.RES.0000038886.18992.6B; Pritchard TJ, 2009, J PHYSIOL-LONDON, V587, P3125, DOI 10.1113/jphysiol.2009.172171; SCOTT BT, 1988, J BIOL CHEM, V263, P8958; SEIDLER NW, 1989, J BIOL CHEM, V264, P17816; TANAKA M, 1986, ARCH BIOCHEM BIOPHYS, V251, P369, DOI 10.1016/0003-9861(86)90084-6; Terentyev D, 2008, BIOPHYS J, V95, P2037, DOI 10.1529/biophysj.107.128249; Terentyev D, 2006, CIRC RES, V98, P1151, DOI 10.1161/01.RES.0000220647.93982.08; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; Timerman AP, 1996, J BIOL CHEM, V271, P20385, DOI 10.1074/jbc.271.34.20385; Wang SR, 1998, NAT STRUCT BIOL, V5, P476, DOI 10.1038/nsb0698-476; Wang Y, 2006, J BIOL CHEM, V281, P15572, DOI 10.1074/jbc.M600090200; Wei L, 2006, BIOPHYS J, V91, P1288, DOI 10.1529/biophysj.106.082610; Yuan QQ, 2007, CIRCULATION, V115, P300, DOI 10.1161/CIRCULATIONAHA.106.654699; Zhang L, 1997, J BIOL CHEM, V272, P23389, DOI 10.1074/jbc.272.37.23389; Zhang L, 2001, J MOL CELL CARDIOL, V33, P233, DOI 10.1006/jmcc.2000.1295	51	25	25	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2012	287	3					1679	1687		10.1074/jbc.M111.254045	http://dx.doi.org/10.1074/jbc.M111.254045			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879HT	22123818	Green Published, hybrid			2022-12-27	WOS:000299321000011
J	Khanduja, JS; Muniyappa, K				Khanduja, Jasbeer Singh; Muniyappa, K.			Functional Analysis of DNA Replication Fork Reversal Catalyzed by Mycobacterium tuberculosis RuvAB Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI RUVA; MIGRATION IN-VITRO; HOLLIDAY JUNCTION; BRANCH MIGRATION; CRYSTAL-STRUCTURE; LAGGING-STRAND; RECOMBINATIONAL REPAIR; HUMAN HLTF; REGRESSION; COMPLEX	Initially discovered in Escherichia coli, RuvAB proteins are ubiquitous in bacteria and play a dual role as molecular motor proteins responsible for branch migration of the Holliday junction(s) and reversal of stalled replication forks. Despite mounting genetic evidence for a crucial role of RuvA and RuvB proteins in reversal of stalled replication forks, the mechanistic aspects of this process are still not fully understood. Here, we elucidate the ability of Mycobacterium tuberculosis RuvAB (MtRuvAB) complex to catalyze the reversal of replication forks using a range of DNA replication fork substrates. Our studies show that MtRuvAB, unlike E. coli RuvAB, is able to drive replication fork reversal via the formation of Holliday junction intermediates, suggesting that RuvAB-catalyzed fork reversal involves concerted unwinding and annealing of nascent leading and lagging strands. We also demonstrate the reversal of replication forks carrying hemi-replicated DNA, indicating that MtRuvAB complex-catalyzed fork reversal is independent of symmetry at the fork junction. The fork reversal reaction catalyzed by MtRuvAB is coupled to ATP hydrolysis, is processive, and culminates in the formation of an extended reverse DNA arm. Notably, we found that sequence heterology failed to impede the fork reversal activity of MtRuvAB. We discuss the implications of these results in the context of recognition and processing of varied types of replication fork structures by RuvAB proteins.	[Khanduja, Jasbeer Singh; Muniyappa, K.] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Muniyappa, K (corresponding author), Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India.	kmbc@biochem.iisc.ernet.in			European Community [CSI_LTB LSHP-CT-2007-037235]; Department of Biotechnology, New Delhi under the "Centre of Excellence" in research on mycobacteria; J. C. Bose National Fellowship	European Community(European Commission); Department of Biotechnology, New Delhi under the "Centre of Excellence" in research on mycobacteria; J. C. Bose National Fellowship	This work was supported by European Community Grant CSI_LTB LSHP-CT-2007-037235, the Department of Biotechnology, New Delhi, under the "Centre of Excellence" in research on mycobacteria, and a J. C. Bose National Fellowship (to K. M.).	Achar YJ, 2011, P NATL ACAD SCI USA, V108, P14073, DOI 10.1073/pnas.1101951108; Ariyoshi M, 2000, P NATL ACAD SCI USA, V97, P8257, DOI 10.1073/pnas.140212997; Atkinson J, 2009, NUCLEIC ACIDS RES, V37, P3475, DOI 10.1093/nar/gkp244; Baharoglu Z, 2006, EMBO J, V25, P596, DOI 10.1038/sj.emboj.7600941; Baharoglu Z, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000012; Blastyak A, 2007, MOL CELL, V28, P167, DOI 10.1016/j.molcel.2007.07.030; Blastyak A, 2010, MOL CELL BIOL, V30, P684, DOI 10.1128/MCB.00863-09; Bradley AS, 2011, J BIOL CHEM, V286, P22372, DOI 10.1074/jbc.M111.233908; Bugreev DV, 2011, NUCLEIC ACIDS RES, V39, P2153, DOI 10.1093/nar/gkq1139; Carr AM, 2002, SCIENCE, V297, P557, DOI 10.1126/science.1075456; Chamberlain D, 1998, J MOL BIOL, V284, P385, DOI 10.1006/jmbi.1998.2177; Cox MM, 2000, NATURE, V404, P37, DOI 10.1038/35003501; Cox MM, 2002, MUTAT RES-FUND MOL M, V510, P107, DOI 10.1016/S0027-5107(02)00256-7; Dennis C, 2004, EMBO J, V23, P2413, DOI 10.1038/sj.emboj.7600249; Donaldson JR, 2004, GENETICS, V166, P1631, DOI 10.1534/genetics.166.4.1631; Dresser AR, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000680; Flores MJ, 2001, EMBO J, V20, P619, DOI 10.1093/emboj/20.3.619; Gari K, 2008, P NATL ACAD SCI USA, V105, P16107, DOI 10.1073/pnas.0804777105; Grompone G, 2004, EMBO REP, V5, P607, DOI 10.1038/sj.embor.7400167; Hanawalt P C, 1966, Photochem Photobiol, V5, P1, DOI 10.1111/j.1751-1097.1966.tb05756.x; Hargreaves D, 1998, NAT STRUCT BIOL, V5, P441, DOI 10.1038/nsb0698-441; Heller RC, 2006, NATURE, V439, P557, DOI 10.1038/nature04329; HIGGINS NP, 1976, J MOL BIOL, V101, P417, DOI 10.1016/0022-2836(76)90156-X; Hiom K, 1996, GENES CELLS, V1, P443, DOI 10.1046/j.1365-2443.1996.d01-253.x; HIOM K, 1995, CELL, V80, P787, DOI 10.1016/0092-8674(95)90357-7; Ishioka K, 1998, GENES CELLS, V3, P209, DOI 10.1046/j.1365-2443.1998.00185.x; IWASAKI H, 1991, EMBO J, V10, P4381, DOI 10.1002/j.1460-2075.1991.tb05016.x; IWASAKI H, 1992, GENE DEV, V6, P2214, DOI 10.1101/gad.6.11.2214; Kanagaraj R, 2006, NUCLEIC ACIDS RES, V34, P5217, DOI 10.1093/nar/gkl677; Khanduja JS, 2009, BIOCHEMISTRY-US, V48, P27, DOI 10.1021/bi8016526; Kuzminov A, 1999, MICROBIOL MOL BIOL R, V63, P751, DOI 10.1128/MMBR.63.4.751-813.1999; Le Masson M, 2008, MOL MICROBIOL, V70, P537, DOI 10.1111/j.1365-2958.2008.06431.x; Lin T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000679; Long DT, 2009, EMBO REP, V10, P394, DOI 10.1038/embor.2009.13; Lusetti SL, 2002, ANNU REV BIOCHEM, V71, P71, DOI 10.1146/annurev.biochem.71.083101.133940; Machwe A, 2007, NUCLEIC ACIDS RES, V35, P5729, DOI 10.1093/nar/gkm561; Machwe A, 2006, BIOCHEMISTRY-US, V45, P13939, DOI 10.1021/bi0615487; Machwe A, 2011, J BIOL CHEM, V286, P3497, DOI 10.1074/jbc.M110.105411; Marians KJ, 2000, TRENDS BIOCHEM SCI, V25, P185, DOI 10.1016/S0968-0004(00)01565-6; McGlynn P, 2000, CELL, V101, P35, DOI 10.1016/S0092-8674(00)80621-2; McGlynn P, 2002, NAT REV MOL CELL BIO, V3, P859, DOI 10.1038/nrm951; McGlynn P, 2001, P NATL ACAD SCI USA, V98, P8227, DOI 10.1073/pnas.111008698; McGlynn P, 2001, P NATL ACAD SCI USA, V98, P8235, DOI 10.1073/pnas.121007798; McGlynn P, 2001, J BIOL CHEM, V276, P41938, DOI 10.1074/jbc.M107945200; Michel B, 2004, P NATL ACAD SCI USA, V101, P12783, DOI 10.1073/pnas.0401586101; Michel B, 2000, TRENDS BIOCHEM SCI, V25, P173, DOI 10.1016/S0968-0004(00)01560-7; Michel B, 2001, P NATL ACAD SCI USA, V98, P8181, DOI 10.1073/pnas.111008798; Michel B, 2007, DNA REPAIR, V6, P967, DOI 10.1016/j.dnarep.2007.02.016; MULLER B, 1993, J BIOL CHEM, V268, P17179; Nohmi T, 2006, ANNU REV MICROBIOL, V60, P231, DOI 10.1146/annurev.micro.60.080805.142238; OTSUJI N, 1974, J BACTERIOL, V117, P337, DOI 10.1128/JB.117.2.337-344.1974; Pages V, 2003, SCIENCE, V300, P1300, DOI 10.1126/science.1083964; PARSONS CA, 1995, EMBO J, V14, P5736, DOI 10.1002/j.1460-2075.1995.tb00260.x; PARSONS CA, 1995, NATURE, V374, P375, DOI 10.1038/374375a0; PARSONS CA, 1993, J MOL BIOL, V232, P397, DOI 10.1006/jmbi.1993.1399; Postow L, 2001, J BIOL CHEM, V276, P2790, DOI 10.1074/jbc.M006736200; Prabu JR, 2009, BBA-PROTEINS PROTEOM, V1794, P1001, DOI 10.1016/j.bbapap.2009.04.003; Privezentzev CV, 2005, J BIOL CHEM, V280, P3365, DOI 10.1074/jbc.M409256200; Rachman H, 2006, INFECT IMMUN, V74, P1233, DOI 10.1128/IAI.74.2.1233-1242.2006; Rafferty JB, 1998, J MOL BIOL, V278, P105, DOI 10.1006/jmbi.1998.1697; Ralf C, 2006, J BIOL CHEM, V281, P22839, DOI 10.1074/jbc.M604268200; Rocha EPC, 2005, PLOS GENET, V1, P247, DOI 10.1371/journal.pgen.0010015; Roe SM, 1998, MOL CELL, V2, P361, DOI 10.1016/S1097-2765(00)80280-4; Rudolph CJ, 2010, DNA REPAIR, V9, P210, DOI 10.1016/j.dnarep.2009.12.014; Seigneur M, 2000, MOL MICROBIOL, V38, P565, DOI 10.1046/j.1365-2958.2000.02152.x; Seigneur M, 1998, CELL, V95, P419, DOI 10.1016/S0092-8674(00)81772-9; SHIBA T, 1991, P NATL ACAD SCI USA, V88, P8445, DOI 10.1073/pnas.88.19.8445; SHURVINTON CE, 1984, MOL GEN GENET, V194, P322, DOI 10.1007/BF00383535; Skalka A., 1974, MECHANISMS RECOMBINA, P421; Sogo JM, 2002, SCIENCE, V297, P599, DOI 10.1126/science.1074023; Sun W, 2008, MOL CELL, V32, P118, DOI 10.1016/j.molcel.2008.08.024; Svoboda DL, 1995, P NATL ACAD SCI USA, V92, P11975, DOI 10.1073/pnas.92.26.11975; Thomason Lynn, 2007, Curr Protoc Mol Biol, VChapter 1, DOI 10.1002/0471142727.mb0117s79; TSANEVA IR, 1992, MOL GEN GENET, V235, P1, DOI 10.1007/BF00286175; TSANEVA IR, 1992, CELL, V69, P1171, DOI 10.1016/0092-8674(92)90638-S; West SC, 1997, ANNU REV GENET, V31, P213, DOI 10.1146/annurev.genet.31.1.213; Xu LW, 2003, MOL CELL, V11, P817, DOI 10.1016/S1097-2765(03)00061-3; Yamada K, 2002, MOL CELL, V10, P671, DOI 10.1016/S1097-2765(02)00641-X	78	11	11	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					1345	1360		10.1074/jbc.M111.304741	http://dx.doi.org/10.1074/jbc.M111.304741			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22094465	Green Accepted, Green Published, hybrid			2022-12-27	WOS:000299170300049
J	Almeida, M; Han, L; Ambrogini, E; Weinstein, RS; Manolagas, SC				Almeida, Maria; Han, Li; Ambrogini, Elena; Weinstein, Robert S.; Manolagas, Stavros C.			Glucocorticoids and Tumor Necrosis Factor alpha Increase Oxidative Stress and Suppress Wnt Protein Signaling in Osteoblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE-MINERAL DENSITY; EXTENDS LIFE-SPAN; FORKHEAD-BOX-O; T-CELL-FACTOR; NF-KAPPA-B; REACTIVE OXYGEN; BETA-CATENIN; GENE-EXPRESSION; TRANSCRIPTIONAL ACTIVITY; PROTEASOMAL DEGRADATION	Endogenous glucocorticoids (GCs) and inflammatory cytokines contribute to the age-associated loss of bone mass and strength, but the molecular mechanisms responsible for their deleterious effects on the aging skeleton are unclear. Based on evidence that oxidative stress is a causal mechanism of the insulin resistance produced by either one of these two agents, we tested the hypothesis that their adverse skeletal effects also result from increased oxidative stress. We report that administration of prednisolone to mice increased reactive oxygen species (ROS) and the phosphorylation of p66(shc) (an amplifier of H2O2 generation in mitochondria) in bone. Dexamethasone (Dex) and TNF alpha had a similar effect on osteoblastic cells in vitro. The generation of ROS by Dex and TNF alpha required PKC beta/p66(shc) signaling and was responsible for the activation of JNK and induction of apoptosis by both agents. The activity of Forkhead box O (FoxO) transcription factors was also increased in response to ROS; however, FoxO activation opposed apoptosis induced by Dex and TNF alpha. In addition, both agents suppressed Akt phosphorylation as well as Wnt-induced proliferation and osteoblast differentiation. However, the inhibitory actions on Wnt signaling were independent of PKC beta/p66(shc). Instead, they were mediated by inhibition of Akt and stimulation of FoxOs. These results demonstrate that ROS-induced activation of a PKC beta/p66(shc)/JNK signaling cascade is responsible for the pro-apoptotic effects of Dex and TNF alpha on osteoblastic cells. Moreover, modulation of Akt and FoxOs by GCs and TNF alpha are cell-autonomous mechanisms of Wnt/beta-catenin antagonism contributing to the adverse effects of GC excess and inflammatory cytokines on bone alike.	[Almeida, Maria] Univ Arkansas Med Sci, Div Endocrinol & Metab, Ctr Osteoporosis & Metab Bone Dis, Little Rock, AR 72205 USA; Cent Arkansas Vet Hlth Care Syst, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences; US Department of Veterans Affairs; Veterans Health Administration (VHA); Central Arkansas Veterans Healthcare System	Almeida, M (corresponding author), Univ Arkansas Med Sci, Div Endocrinol & Metab, Ctr Osteoporosis & Metab Bone Dis, 4301 W Markham St 587, Little Rock, AR 72205 USA.	schullermaria@uams.edu		Almeida, Maria/0000-0002-6722-9200; Warren, Aaron D./0000-0002-0042-9021	National Institutes of Health [P01 AG13918, R01 AR56679]; Department of Veterans Affairs; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056679] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG013918] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants P01 AG13918 and R01 AR56679. This work was also supported by Department of Veterans Affairs Merit Review grants (to S. C. M. and R. S. W.).	Almeida M, 2007, J BIOL CHEM, V282, P27285, DOI 10.1074/jbc.M702810200; Almeida M, 2007, J BIOL CHEM, V282, P27298, DOI 10.1074/jbc.M702811200; Almeida M, 2010, MOL ENDOCRINOL, V24, P2030, DOI 10.1210/me.2010-0189; Almeida M, 2009, J BIOL CHEM, V284, P27438, DOI 10.1074/jbc.M109.023572; Ambrogini E, 2010, CELL METAB, V11, P136, DOI 10.1016/j.cmet.2009.12.009; Bellido T, 2003, J BIOL CHEM, V278, P50259, DOI 10.1074/jbc.M307444200; Boyce BF, 2006, CURR OPIN RHEUMATOL, V18, P427, DOI 10.1097/01.bor.0000231913.32364.32; Bruunsgaard H, 2001, CURR OPIN HEMATOL, V8, P131, DOI 10.1097/00062752-200105000-00001; Byun CH, 2005, J BONE MINER RES, V20, P1125, DOI 10.1359/JBMR.050302; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Camm EJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021142; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cooper MS, 2002, J BONE MINER RES, V17, P979, DOI 10.1359/jbmr.2002.17.6.979; Dennison E, 1999, J CLIN ENDOCR METAB, V84, P3058, DOI 10.1210/jc.84.9.3058; Diarra D, 2007, NAT MED, V13, P156, DOI 10.1038/nm1538; Ding C, 2008, J CLIN ENDOCR METAB, V93, P1952, DOI 10.1210/jc.2007-2325; Essers MAG, 2004, EMBO J, V23, P4802, DOI 10.1038/sj.emboj.7600476; Essers MAG, 2005, SCIENCE, V308, P1181, DOI 10.1126/science.1109083; Fang DX, 2007, J BIOL CHEM, V282, P11221, DOI 10.1074/jbc.M611871200; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Giorgio M, 2005, CELL, V122, P221, DOI 10.1016/j.cell.2005.05.011; Guo R, 2008, J BIOL CHEM, V283, P23084, DOI 10.1074/jbc.M709848200; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Helenius M, 1996, BIOCHEM J, V318, P603, DOI 10.1042/bj3180603; Hoogeboom D, 2008, J BIOL CHEM, V283, P9224, DOI 10.1074/jbc.M706638200; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Hurson CJ, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-12; Iuchi T, 2003, CIRC RES, V92, P81, DOI 10.1161/01.RES.0000050588.35034.3C; Jilka RL, 2010, AGING CELL, V9, P851, DOI 10.1111/j.1474-9726.2010.00616.x; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Khaper N, 2010, ANTIOXID REDOX SIGN, V13, P1033, DOI 10.1089/ars.2009.2930; Kim YS, 2007, MOL CELL, V26, P675, DOI 10.1016/j.molcel.2007.04.021; Lecka-Czernik B, 1999, J CELL BIOCHEM, V74, P357, DOI 10.1002/(SICI)1097-4644(19990901)74:3<357::AID-JCB5>3.0.CO;2-7; Lehtinen MK, 2006, CELL, V125, P987, DOI 10.1016/j.cell.2006.03.046; Li Y, 2007, J BONE MINER RES, V22, P646, DOI 10.1359/JBMR.070121; Liu J, 2005, CELL RES, V15, P36, DOI 10.1038/sj.cr.7290262; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Manolagas SC, 2007, MOL ENDOCRINOL, V21, P2605, DOI 10.1210/me.2007-0259; Manolagas SC, 2010, ENDOCR REV, V31, P266, DOI 10.1210/er.2009-0024; Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311; Morgan MJ, 2010, MOL CELLS, V30, P1, DOI 10.1007/s10059-010-0105-0; Mukai T, 2007, BIOCHEM BIOPH RES CO, V356, P1004, DOI 10.1016/j.bbrc.2007.03.099; Nakano H, 2006, CELL DEATH DIFFER, V13, P730, DOI 10.1038/sj.cdd.4401830; Nanes MS, 2003, GENE, V321, P1, DOI 10.1016/S0378-1119(03)00841-2; Neels JG, 2006, AM J PATHOL, V168, P435, DOI 10.2353/ajpath.2006.050699; O'Brien CA, 2004, ENDOCRINOLOGY, V145, P1835, DOI 10.1210/en.2003-0990; Oh SW, 2005, P NATL ACAD SCI USA, V102, P4494, DOI 10.1073/pnas.0500749102; PFEFFER KD, 1994, J IMMUNOL, V153, P1789; Phillips T, 2005, FASEB J, V19, P668, DOI 10.1096/fj.04-2870fje; Pinton P, 2007, SCIENCE, V315, P659, DOI 10.1126/science.1135380; Plotkin LI, 2007, J BIOL CHEM, V282, P24120, DOI 10.1074/jbc.M611435200; Poulsen RC, 2011, ENDOCRINOLOGY, V152, P503, DOI 10.1210/en.2010-1087; Purnell JQ, 2004, J CLIN ENDOCR METAB, V89, P281, DOI 10.1210/jc.2003-030440; Rached MT, 2010, CELL METAB, V11, P147, DOI 10.1016/j.cmet.2010.01.001; Reynolds RM, 2005, CALCIFIED TISSUE INT, V77, P134, DOI 10.1007/s00223-004-0270-2; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Schakman O, 2008, ENDOCRINOLOGY, V149, P3900, DOI 10.1210/en.2008-0439; Shen HM, 2006, FREE RADICAL BIO MED, V40, P928, DOI 10.1016/j.freeradbiomed.2005.10.056; Smith E, 2005, J BIOL CHEM, V280, P2388, DOI 10.1074/jbc.M406294200; SUZUKI H, 1995, HYPERTENSION, V25, P1083, DOI 10.1161/01.HYP.25.5.1083; Trinei M, 2002, ONCOGENE, V21, P3872, DOI 10.1038/sj.onc.1205513; VanCauter E, 1996, J CLIN ENDOCR METAB, V81, P2468, DOI 10.1210/jc.81.7.2468; Walsh NC, 2005, IMMUNOL REV, V208, P228, DOI 10.1111/j.0105-2896.2005.00338.x; Walsh NC, 2009, J BONE MINER RES, V24, P1572, DOI [10.1359/jbmr.090320, 10.1359/JBMR.090320]; Wang FS, 2008, ENDOCRINOLOGY, V149, P1793, DOI 10.1210/en.2007-0910; Wang MC, 2005, CELL, V121, P115, DOI 10.1016/j.cell.2005.02.030; Weinstein RS, 2011, NEW ENGL J MED, V365, P62, DOI 10.1056/NEJMcp1012926; Weinstein RS, 2010, ENDOCRINOLOGY, V151, P2641, DOI 10.1210/en.2009-1488; Weinstein RS, 2010, AGING CELL, V9, P147, DOI 10.1111/j.1474-9726.2009.00545.x; Wilkinson CW, 2001, J CLIN ENDOCR METAB, V86, P545, DOI 10.1210/jc.86.2.545; XI H, 1993, TOXICOL APPL PHARM, V120, P29, DOI 10.1006/taap.1993.1083; Yazdanpanah B, 2009, NATURE, V460, P1159, DOI 10.1038/nature08206	73	187	197	1	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2011	286	52					44326	44335		10.1074/jbc.M111.283481	http://dx.doi.org/10.1074/jbc.M111.283481			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870CA	22030390	Green Published, hybrid			2022-12-27	WOS:000298645500004
J	Jelen, S; Wacker, S; Aponte-Santamaria, C; Skott, M; Rojek, A; Johanson, U; Kjellbom, P; Nielsen, S; de Groot, BL; Rutzler, M				Jelen, Sabina; Wacker, Soeren; Aponte-Santamaria, Camilo; Skott, Martin; Rojek, Aleksandra; Johanson, Urban; Kjellbom, Per; Nielsen, Soren; de Groot, Bert L.; Ruetzler, Michael			Aquaporin-9 Protein Is the Primary Route of Hepatocyte Glycerol Uptake for Glycerol Gluconeogenesis in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUTRAL SOLUTE CHANNEL; RAT HEPATOCYTES; MOLECULAR CHARACTERIZATION; TETRACYCLINE RESISTANCE; WATER PERMEABILITY; LIVER; EXPRESSION; CLONING; PHOSPHORYLATION; SELECTIVITY	It has been hypothesized that aquaporin-9 (AQP9) is part of the unknown route of hepatocyte glycerol uptake. In a previous study, leptin receptor-deficient wild-type mice became diabetic and suffered from fasting hyperglycemia whereas isogenic AQP9(-/-) knock-out mice remained normoglycemic. The reason for this improvement in AQP9(-/-) mice was not established before. Here, we show increased glucose output (by 123% +/- 36% S. E.) in primary hepatocyte culture when 0.5 mM extracellular glycerol was added. This increase depended on AQP9 because it was absent in AQP9(-/-) cells. Likewise, the increase was abolished by 25 mu M HTS13286 (IC50 similar to 2 mu M), a novel AQP9 inhibitor, which we identified in a small molecule library screen. Similarly, AQP9 deletion or chemical inhibition eliminated glycerol-enhanced glucose output in perfused liver preparations. The following control experiments suggested inhibitor specificity to AQP9: (i) HTS13286 affected solute permeability in cell lines expressing AQP9, but not in cell lines expressing AQPs 3, 7, or 8. (ii) HTS13286 did not influence lactate-and pyruvate-dependent hepatocyte glucose output. (iii) HTS13286 did not affect glycerol kinase activity. Our experiments establish AQP9 as the primary route of hepatocyte glycerol uptake for gluconeogenesis and thereby explain the previously observed, alleviated diabetes in leptin receptor-deficient AQP9(-/-) mice.	[Jelen, Sabina; Skott, Martin; Rojek, Aleksandra; Nielsen, Soren; Ruetzler, Michael] Aarhus Univ, Dept Biomed, Water & Salt Res Ctr, DK-8000 Aarhus C, Denmark; [Wacker, Soeren; Aponte-Santamaria, Camilo; de Groot, Bert L.] Max Planck Inst Biophys Chem, Computat Biomol Dynam Grp, D-37077 Gottingen, Germany; [Johanson, Urban; Kjellbom, Per] Lund Univ, Dept Biochem & Struct Biol, Ctr Mol Prot Sci, S-22100 Lund, Sweden	Aarhus University; Max Planck Society; Lund University	Nielsen, S (corresponding author), Aarhus Univ, Dept Biomed, Water & Salt Res Ctr, Wilhelm Meyers Alle, DK-8000 Aarhus C, Denmark.	sn@ana.au.dk; mrr@ana.au.dk	Rutzler, Michael/ABE-7914-2020; Johanson, Urban/D-4344-2015; Johanson, Urban/AHE-8231-2022	Rutzler, Michael/0000-0001-5597-8880; Johanson, Urban/0000-0001-8862-128X; Johanson, Urban/0000-0001-8862-128X; Aponte-Santamaria, Camilo/0000-0002-8427-6965	Lundbeck Foundation [R17A1742]; Marie Curie Research Training Network; Nordic Research Grant for Water Imbalance Related Disorders; European Drug Initiative on Channels and Transporters [HEALTH-F4-2007-201924]; The Danish National Research Foundation	Lundbeck Foundation(Lundbeckfonden); Marie Curie Research Training Network(European Commission); Nordic Research Grant for Water Imbalance Related Disorders; European Drug Initiative on Channels and Transporters; The Danish National Research Foundation(Danmarks Grundforskningsfond)	This work was supported by Lundbeck Foundation Grant R17A1742, a Marie Curie Research Training Network grant, a Nordic Research Grant for Water Imbalance Related Disorders, and European Drug Initiative on Channels and Transporters Grant HEALTH-F4-2007-201924. The Water and Salt Research Center was established and funded by The Danish National Research Foundation.	Andersen B, 1999, BIOCHEM J, V342, P545, DOI 10.1042/0264-6021:3420545; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; BUBLITZ C, 1954, J BIOL CHEM, V211, P951; Carbrey JM, 2003, P NATL ACAD SCI USA, V100, P2945, DOI 10.1073/pnas.0437994100; DANG LX, 1995, J AM CHEM SOC, V117, P6954, DOI 10.1021/ja00131a018; Detmers FJM, 2006, J BIOL CHEM, V281, P14207, DOI 10.1074/jbc.M513072200; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Fenton RA, 2010, AM J PHYSIOL-RENAL, V298, pF224, DOI 10.1152/ajprenal.00463.2009; Halestrap AP, 1999, BIOCHEM J, V343, P281, DOI 10.1042/0264-6021:3430281; HILLEN W, 1994, ANNU REV MICROBIOL, V48, P345, DOI 10.1146/annurev.mi.48.100194.002021; HILLEN W, 1983, J MOL BIOL, V169, P707, DOI 10.1016/S0022-2836(83)80166-1; Hub JS, 2010, BIOPHYS J, V99, pL97, DOI 10.1016/j.bpj.2010.11.003; Ibu J O, 1986, Scand J Gastroenterol Suppl, V124, P75; Ishibashi K, 1997, BIOCHEM BIOPH RES CO, V237, P714, DOI 10.1006/bbrc.1997.7219; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Klingmuller U, 2006, IEE P SYST BIOL, V153, P433, DOI 10.1049/ip-syb:20050067; Klokkers J, 2009, AM J PHYSIOL-RENAL, V297, pF693, DOI 10.1152/ajprenal.00136.2009; Koyama Y, 1997, J BIOL CHEM, V272, P30329, DOI 10.1074/jbc.272.48.30329; Kuriyama H, 2002, DIABETES, V51, P2915, DOI 10.2337/diabetes.51.10.2915; LI CC, 1983, J CELL PHYSIOL, V117, P230, DOI 10.1002/jcp.1041170214; Ma TH, 1997, BIOCHEM BIOPH RES CO, V240, P324, DOI 10.1006/bbrc.1997.7664; Mola MG, 2009, ANAL CHEM, V81, P8219, DOI 10.1021/ac901526k; Morinaga T, 2002, BIOCHEM BIOPH RES CO, V294, P630, DOI 10.1016/S0006-291X(02)00536-3; NEWSHOLME EA, 1967, BIOCHIM BIOPHYS ACTA, V132, P338, DOI 10.1016/0005-2744(67)90153-2; Patsouris D, 2004, J CLIN INVEST, V114, P94, DOI 10.1172/JC1200420468; Phillips JW, 2002, EUR J BIOCHEM, V269, P792, DOI 10.1046/j.0014-2956.2001.02687.x; PUHAKAINEN I, 1992, J CLIN ENDOCR METAB, V75, P789, DOI 10.1210/jc.75.3.789; Rarey M, 1996, J MOL BIOL, V261, P470, DOI 10.1006/jmbi.1996.0477; Rodriguez A, 2011, J CLIN ENDOCR METAB, V96, pE586, DOI 10.1210/jc.2010-1408; Rojek AM, 2007, P NATL ACAD SCI USA, V104, P3609, DOI 10.1073/pnas.0610894104; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; SESTOFT L, 1975, BIOCHIM BIOPHYS ACTA, V375, P462, DOI 10.1016/0005-2736(75)90360-0; Tsukaguchi H, 1998, J BIOL CHEM, V273, P24737, DOI 10.1074/jbc.273.38.24737; Tsukaguchi H, 1999, AM J PHYSIOL-RENAL, V277, pF685, DOI 10.1152/ajprenal.1999.277.5.F685; Westergaard N, 1998, BBA-MOL CELL RES, V1402, P261, DOI 10.1016/S0167-4889(98)00016-0	35	83	91	2	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2011	286	52					44319	44325		10.1074/jbc.M111.297002	http://dx.doi.org/10.1074/jbc.M111.297002			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870CA	22081610	hybrid, Green Published			2022-12-27	WOS:000298645500003
J	Kaizu, A; Fagutao, FF; Kondo, H; Aoki, T; Hirono, I				Kaizu, Akihiro; Fagutao, Fernand F.; Kondo, Hidehiro; Aoki, Takashi; Hirono, Ikuo			Functional Analysis of C-type Lysozyme in Penaeid Shrimp	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PACIFIC WHITE SHRIMP; PRAWN MARSUPENAEUS-JAPONICUS; DOUBLE-STRANDED-RNA; BLACK TIGER SHRIMP; ANTIMICROBIAL PEPTIDES; LITOPENAEUS-VANNAMEI; CALLINECTES-SAPIDUS; BACTERIAL-FLORA; BLUE-CRAB; VIBRIO	Lysozyme is an enzyme that cleaves the beta-1,4-glycosidic linkages between N-acetylmuramic acid and N-acetylglucosamine in peptidoglycan, leading to bacterial lysis. Recently, lysozyme has been found to have anti-HIV and anti-cancer properties in mammals. However, most functional analyses were done in vitro using purified or recombinant lysozyme protein. Here, we used RNA interference to silence c-type lysozyme expression in penaeid shrimp, Marsupenaeus japonicus, to analyze the function of lysozyme in vivo. Silencing of lysozyme expression by dsRNA lysozyme (dsLYZ) led to 100% mortality without any artificial bacterial infection in 5 days. Lysozyme deficiency caused the number of hemocytes in hemolymph to decrease from 1.3 x 10(7) to 2.3 x 10(6) cells/ml and caused the number of bacteria to increase from 78 to 764 colony-forming units/ml. Suppression of bacterial growth using oxytetracycline and kanamycin showed improvement in mortality, suggesting that shrimp mortality post-dsLYZ injection can be attributed to bacterial growth in the shrimp hemolymph. The majority of the bacteria, identified by 16 S rRNA analysis, were Gram-negative species such as Vibrio and Pseudomonas. Furthermore, PKH26 staining showed that the dsLYZ-injected shrimp were unable to eliminate non pathogenic Escherichia coli or Staphylococcus aureus in 24 h. These data suggest that c-type lysozyme in shrimp serves to regulate the growth of bacterial communities, particularly Gram-negative bacteria, in the hemolymph.	[Kaizu, Akihiro; Fagutao, Fernand F.; Kondo, Hidehiro; Aoki, Takashi; Hirono, Ikuo] Tokyo Univ Marine Sci & Technol, Lab Genome Sci, Minato Ku, Tokyo 1088477, Japan	Tokyo University of Marine Science & Technology	Hirono, I (corresponding author), Tokyo Univ Marine Sci & Technol, Lab Genome Sci, Minato Ku, Konan 4-5-7, Tokyo 1088477, Japan.	hirono@kaiyodai.ac.jp	Hirono, Ikuo/O-1940-2014; Kondo, Hidehiro/O-1954-2014; Fagutao, Fernand/GPK-2398-2022	Kondo, Hidehiro/0000-0001-5102-6831; Hirono, Ikuo/0000-0002-2355-3121; Fagutao, Fernand/0000-0001-8618-2586	Japan Society for the Promotion of Science Asian Core University; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Society for the Promotion of Science	Japan Society for the Promotion of Science Asian Core University(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by grants from the Japan Society for the Promotion of Science Asian Core University Program, grants-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, and the Japan Society for the Promotion of Science Fellowship for Foreign Researchers.	Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; BRANDIN ER, 1985, APPL ENVIRON MICROB, V49, P718, DOI 10.1128/AEM.49.3.718-720.1985; Brogden KA, 2003, INT J ANTIMICROB AG, V22, P465, DOI 10.1016/S0924-8579(03)00180-8; Burge EJ, 2007, FISH SHELLFISH IMMUN, V22, P327, DOI 10.1016/j.fsi.2006.06.004; Burgents JE, 2005, DEV COMP IMMUNOL, V29, P681, DOI 10.1016/j.dci.2005.01.004; Cuthbertson BJ, 2002, IMMUNOGENETICS, V54, P442, DOI 10.1007/s00251-002-0487-z; DAVIS JW, 1982, APPL ENVIRON MICROB, V43, P1092, DOI 10.1128/AEM.43.5.1092-1097.1982; de la Vega E, 2008, MOL IMMUNOL, V45, P1916, DOI 10.1016/j.molimm.2007.10.039; Destoumieux D, 1997, J BIOL CHEM, V272, P28398, DOI 10.1074/jbc.272.45.28398; Destoumieux-Garzon D, 2001, J BIOL CHEM, V276, P47070, DOI 10.1074/jbc.M103817200; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fagutao FF, 2009, FEBS J, V276, P5298, DOI 10.1111/j.1742-4658.2009.07225.x; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Gomez-Gil B, 1998, AQUACULTURE, V163, P1, DOI 10.1016/S0044-8486(98)00162-8; Gueguen Y, 2006, DEV COMP IMMUNOL, V30, P283, DOI 10.1016/j.dci.2005.04.003; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Hikima S, 2003, GENE, V316, P187, DOI 10.1016/S0378-1119(03)00761-3; JOLLES P, 1984, MOL CELL BIOCHEM, V63, P165; Lee SY, 2002, FISH SHELLFISH IMMUN, V12, P421, DOI 10.1006/fsim.2002.0420; Lee-Huang S, 1999, P NATL ACAD SCI USA, V96, P2678, DOI 10.1073/pnas.96.6.2678; Mai WJ, 2010, FISH SHELLFISH IMMUN, V28, P727, DOI 10.1016/j.fsi.2010.01.002; Mai WJ, 2009, MOL BIOL REP, V36, P1587, DOI 10.1007/s11033-008-9355-8; Maningas MBB, 2008, MOL IMMUNOL, V45, P1269, DOI 10.1016/j.molimm.2007.09.016; MARTIN E, 1995, J LEUKOCYTE BIOL, V58, P128, DOI 10.1002/jlb.58.2.128; Martin GG, 2000, J CRUSTACEAN BIOL, V20, P209, DOI 10.1651/0278-0372(2000)020[0209:EOSMFT]2.0.CO;2; Minagawa S, 2001, DEV COMP IMMUNOL, V25, P439, DOI 10.1016/S0145-305X(01)00013-1; Nagoshi H, 2006, MOL IMMUNOL, V43, P2061, DOI 10.1016/j.molimm.2005.12.009; Patat SA, 2004, EUR J BIOCHEM, V271, P4825, DOI 10.1111/j.1432-1033.2004.04448.x; Rattanachai A, 2004, FISHERIES SCI, V70, P765, DOI 10.1111/j.1444-2906.2004.00869.x; Regel R, 1998, INSECT BIOCHEM MOLEC, V28, P309, DOI 10.1016/S0965-1748(97)00108-2; SAVA G, 1989, ANTICANCER RES, V9, P583; SIZEMORE RK, 1975, APPL MICROBIOL, V29, P393, DOI 10.1177/0146167202250221; Sotelo-Mundo RR, 2003, FISH SHELLFISH IMMUN, V15, P325, DOI 10.1016/S1050-4648(02)00176-6; Supungul P, 2002, MAR BIOTECHNOL, V4, P487, DOI 10.1007/s10126-002-0043-8; Supungul P, 2010, FISH SHELLFISH IMMUN, V28, P490, DOI 10.1016/j.fsi.2010.01.003; Tassanakajon A, 2010, MAR BIOTECHNOL, V12, P487, DOI [10.1007/s10126-010-9288-9, 10.1007/s10126-011-9381-8]; TUBIASH HS, 1975, APPL MICROBIOL, V29, P388, DOI 10.1128/AEM.29.3.388-392.1975; Tyagi A, 2007, AQUACULTURE, V272, P246, DOI 10.1016/j.aquaculture.2007.08.055; Van De Braak CB, 2002, FISH SHELLFISH IMMUN, V13, P293, DOI 10.1006/fsim.2002.0409; Vargas-Albores F, 2004, COMP BIOCHEM PHYS B, V138, P415, DOI 10.1016/j.cbpc.2004.05.007; Wang Z, 2004, NUCLEIC ACIDS RES, V32, pD590, DOI 10.1093/nar/gkh025; Xing Y., 2009, MOL BIOL REP, V36, P1239, DOI DOI 10.1007/S11033-008-9303-7; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zhang JQ, 2007, J BIOTECHNOL, V127, P605, DOI 10.1016/j.jbiotec.2006.08.013; Zhang XB, 2004, ANTIVIR RES, V61, P93, DOI 10.1016/j.antiviral.2003.08.019	46	53	59	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2011	286	52					44344	44349		10.1074/jbc.M111.292672	http://dx.doi.org/10.1074/jbc.M111.292672			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870CA	22069322	hybrid, Green Published			2022-12-27	WOS:000298645500006
J	Song, EK; Rah, SY; Lee, YR; Yoo, CH; Kim, YR; Yeom, JH; Park, KH; Kim, JS; Kim, UH; Han, MK				Song, Eun-Kyung; Rah, So-Young; Lee, Young-Rae; Yoo, Chae-Hwa; Kim, Yu-Ri; Yeom, Ji-Hyun; Park, Kwang-Hyun; Kim, Jong-Suk; Kim, Uh-Hyun; Han, Myung-Kwan			Connexin-43 Hemichannels Mediate Cyclic ADP-ribose Generation and Its Ca2+-mobilizing Activity by NAD(+)/Cyclic ADP-ribose Transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATES INTRACELLULAR CALCIUM; PHAGOCYTOSIS OCCURS; SPHINGOSINE KINASE; CD38; CA2+; MACROPHAGES; RELEASE; INFLUX; MOBILIZATION; METABOLISM	The ADP-ribosyl cyclase CD38 whose catalytic domain resides in outside of the cell surface produces the second messenger cyclic ADP-ribose (cADPR) from NAD(+). cADPR increases intracellular Ca2+ through the intracellular ryanodine receptor/Ca2+ release channel (RyR). It has been known that intracellularNAD(+) approaches ecto-CD38 via its export by connexin (Cx43) hemichannels, a component of gap junctions. However, it is unclear how cADPR extracellularly generated by ecto-CD38 approaches intracellular RyR although CD38 itself or nucleoside transporter has been proposed to import cADPR. Moreover, it has been unknown what physiological stimulation can trigger Cx43-mediated export of NAD(+). Here we demonstrate that Cx43 hemichannels, but not CD38, import cADPR to increase intracellular calcium through RyR. We also demonstrate that physiological stimulation such as Fc gamma receptor (Fc gamma R) ligation induces calcium mobilization through three sequential steps, Cx43-mediated NAD(+) export, CD38-mediated generation of cADPR and Cx43-mediated cADPR import in J774 cells. Protein kinase A (PKA) activation also induced calcium mobilization in the same way as Fc gamma R stimulation. Fc gamma R stimulation-induced calcium mobilization was blocked by PKA inhibition, indicating that PKA is a linker between Fc gamma R stimulation and NAD(+)/cADPR transport. Cx43 knockdown blocked extracellular cADPR import and extracellular cADPR-induced calcium mobilization in J774 cells. Cx43 overexpression in Cx43-negative cells conferred extracellular cADPR-induced calcium mobilization by the mediation of cADPR import. Our data suggest that Cx43 has a dual function exporting NAD(+) and importing cADPR into the cell to activate intracellular calcium mobilization.	[Rah, So-Young; Lee, Young-Rae; Park, Kwang-Hyun; Kim, Jong-Suk; Kim, Uh-Hyun] Chonbuk Natl Univ Med Sch & Hosp, Dept Biochem, Jeonju 561182, South Korea; [Song, Eun-Kyung; Yoo, Chae-Hwa; Kim, Yu-Ri; Yeom, Ji-Hyun; Han, Myung-Kwan] Chonbuk Natl Univ Med Sch & Hosp, Dept Microbiol, Jeonju 561182, South Korea; [Han, Myung-Kwan] Chonbuk Natl Univ Med Sch & Hosp, Inst Med Sci, Jeonju 561182, South Korea	Jeonbuk National University; Jeonbuk National University Hospital; Jeonbuk National University; Jeonbuk National University Hospital; Jeonbuk National University; Jeonbuk National University Hospital	Kim, UH (corresponding author), Chonbuk Natl Univ Med Sch & Hosp, Dept Biochem, Jeonju 561182, South Korea.	uhkim@chonbuk.ac.kr; iamtom@chonbuk.ac.kr		Han, Myung-Kwan/0000-0003-1931-8898; Kim, Uh-Hyun/0000-0003-3304-7190; Rah, So-Young/0000-0002-0255-1960	Ministry of Health, Welfare & Family Affairs, Republic of Korea [A091087]	Ministry of Health, Welfare & Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This work was supported by Grant [A091087] from the Korea Healthcare Technology R&D Project, Ministry of Health, Welfare & Family Affairs, Republic of Korea.	Bao XY, 2007, P NATL ACAD SCI USA, V104, P4919, DOI 10.1073/pnas.0603154104; Bruzzone S, 2001, J BIOL CHEM, V276, P48300, DOI 10.1074/jbc.M107308200; Bruzzone S, 2001, FASEB J, V15, P10; Choi OH, 1996, NATURE, V380, P634; De Flora A, 2000, CHEM IMMUNOL, V75, P79; De Vuyst E, 2009, CELL CALCIUM, V46, P176, DOI 10.1016/j.ceca.2009.07.002; DIVIRGILIO F, 1988, J CELL BIOL, V106, P657, DOI 10.1083/jcb.106.3.657; Franco L, 1998, FASEB J, V12, P1507; FUNARO A, 1990, J IMMUNOL, V145, P2390; GALIONE A, 1991, SCIENCE, V253, P1143, DOI 10.1126/science.1909457; Guida L, 2002, J BIOL CHEM, V277, P47097, DOI 10.1074/jbc.M207793200; Han MK, 2002, J BIOL CHEM, V277, P5315, DOI 10.1074/jbc.M106439200; Han MK, 2000, J BIOL CHEM, V275, P20799, DOI 10.1074/jbc.M001189200; HISHIKAWA T, 1991, J CELL BIOL, V115, P59, DOI 10.1083/jcb.115.1.59; Kim SY, 2006, EXP MOL MED, V38, P535, DOI 10.1038/emm.2006.63; KIM UH, 1993, BIOCHIM BIOPHYS ACTA, V1178, P121, DOI 10.1016/0167-4889(93)90001-6; KRUSKAL BA, 1987, J CELL BIOL, V105, P2685, DOI 10.1083/jcb.105.6.2685; LEE HC, 1994, VITAM HORM, V48, P199, DOI 10.1016/S0083-6729(08)60499-9; Malavasi F, 2008, PHYSIOL REV, V88, P841, DOI 10.1152/physrev.00035.2007; MCNEIL PL, 1986, J CELL BIOL, V102, P1586, DOI 10.1083/jcb.102.5.1586; Melendez A, 1998, J BIOL CHEM, V273, P9393, DOI 10.1074/jbc.273.16.9393; MESZAROS LG, 1993, NATURE, V364, P76, DOI 10.1038/364076a0; Noguchi N, 1997, J BIOL CHEM, V272, P3133, DOI 10.1074/jbc.272.6.3133; Partida-Sanchez S, 2001, NAT MED, V7, P1209, DOI 10.1038/nm1101-1209; Rakovic S, 1996, CURR BIOL, V6, P989, DOI 10.1016/S0960-9822(02)00643-7; ROSALES C, 1992, J BIOL CHEM, V267, P5265; Schwarzmann N, 2002, J BIOL CHEM, V277, P50636, DOI 10.1074/jbc.M209061200; SHEN SS, 1993, DEV BIOL, V157, P157, DOI 10.1006/dbio.1993.1120; Song EK, 2008, BIOCHEM BIOPH RES CO, V367, P156, DOI 10.1016/j.bbrc.2007.12.131; TAKASAWA S, 1993, SCIENCE, V259, P370, DOI 10.1126/science.8420005; Tang WX, 2002, AM J PHYSIOL-HEART C, V282, pH1304, DOI 10.1152/ajpheart.00843.2001; TSIEN RY, 1982, NATURE, V295, P68, DOI 10.1038/295068a0; YOUNG JDE, 1984, P NATL ACAD SCI-BIOL, V81, P5430, DOI 10.1073/pnas.81.17.5430; ZEMBALA M, 1970, IMMUNOLOGY, V19, P677	34	40	45	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2011	286	52					44480	44490		10.1074/jbc.M111.307645	http://dx.doi.org/10.1074/jbc.M111.307645			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870CA	22033928	Green Published, hybrid			2022-12-27	WOS:000298645500020
J	Ribeiro, LF; Furtado, GP; Lourenzoni, MR; Costa, AJ; Santos, CR; Nogueira, SCP; Betini, JA; Polizeli, MDTM; Murakami, MT; Ward, RJ				Ribeiro, Lucas F.; Furtado, Gilvan P.; Lourenzoni, Marcos R.; Costa-Filho, Antonio J.; Santos, Camila R.; Peixoto Nogueira, Simone C.; Betini, Jorge A.; Polizeli, Maria de Lourdes T. M.; Murakami, Mario T.; Ward, Richard J.			Engineering Bifunctional Laccase-Xylanase Chimeras for Improved Catalytic Performance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACILLUS-SUBTILIS; COTA LACCASE; ENHANCED THERMOSTABILITY; DIOXYGEN REDUCTION; DIRECTED EVOLUTION; FUSION PROTEINS; ENDOSPORE COAT; COPPER SITE; ENZYME; CONSTRUCTION	Background: Rational design methods can be used to create chimeric enzymes with novel catalytic combinations. Results: Bifunctional enzymes combining xylanase and laccase activities showed enhanced catalytic activity and stability. Conclusion: Formation of an inter-domain interface alters enzyme conformation that enhances catalytic performance of the chimera. Significance: Deeper understanding of structural principles of protein fusion can improve the design of novel catalysts.	[Lourenzoni, Marcos R.; Ward, Richard J.] Univ Sao Paulo, Fac Filosofia Ciencias & Letras Ribeirao Preto, Dept Quim, BR-14049901 Ribeirao Preto, SP, Brazil; [Ribeiro, Lucas F.; Furtado, Gilvan P.] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Bioquim & Imunol, BR-14049901 Ribeirao Preto, SP, Brazil; [Lourenzoni, Marcos R.] Verdartis Desenvolvimento Biotecnol Ltda ME, BR-14049901 Ribeirao Preto, SP, Brazil; [Costa-Filho, Antonio J.] Univ Sao Paulo, Fac Filosofia Ciencias & Letras Ribeirao Preto, Dept Fis, BR-14049901 Ribeirao Preto, SP, Brazil; [Costa-Filho, Antonio J.] Univ Sao Paulo, Inst Fis Sao Carlos, Dept Fis & Informat, BR-13560970 Sao Carlos, SP, Brazil; [Santos, Camila R.; Murakami, Mario T.] Ctr Nacl Pesquisas Energia & Mat, BR-13083970 Campinas, SP, Brazil; [Peixoto Nogueira, Simone C.; Betini, Jorge A.; Polizeli, Maria de Lourdes T. M.] Univ Sao Paulo, Fac Filosofia Ciencias & Letras Ribeirao Preto, Dept Biol, BR-14049901 Ribeirao Preto, SP, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Ward, RJ (corresponding author), Univ Sao Paulo, Fac Filosofia Ciencias & Letras Ribeirao Preto, Dept Quim, BR-14049901 Ribeirao Preto, SP, Brazil.	rjward@ffclrp.usp.br	Santos, Camila/F-7095-2013; Ward, Richard John/C-2460-2012; Murakami, Mario T/F-5640-2016; Ribeiro, Lucas/C-1979-2012; Costa-Filho, Antonio José/AAZ-1808-2020; Murakami, Mario T/C-2087-2012; de Lourdes T.M. Polizeli, Maria/C-5350-2013; Fapesp, Biota/F-8655-2017; Costa-Filho, Antonio J/D-3153-2012	Santos, Camila/0000-0003-0652-4211; Ward, Richard John/0000-0003-1136-5737; Murakami, Mario T/0000-0002-0405-8010; Ribeiro, Lucas/0000-0003-4640-8629; de Lourdes T.M. Polizeli, Maria/0000-0002-5026-6363; Fapesp, Biota/0000-0002-9887-8449; Costa-Filho, Antonio J/0000-0001-6730-8737; Pessoa Furtado, Gilvan/0000-0002-8797-7783	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico.	Allen M.P., 1991, COMPUTER SIMULATION; Alper H, 2009, NAT REV MICROBIOL, V7, P715, DOI 10.1038/nrmicro2186; Andersson R, 2003, J SCI FOOD AGR, V83, P617, DOI 10.1002/jsfa.1321; ARNOLD FH, 2003, METHOD MOL BIOL, V230, P193; Ay J, 1998, P NATL ACAD SCI USA, V95, P6613, DOI 10.1073/pnas.95.12.6613; Bajpai P, 2004, CRIT REV BIOTECHNOL, V24, P1, DOI 10.1080/07388550490465817; Bento I, 2005, DALTON T, P3507, DOI 10.1039/b504806k; Bento I, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-28; Bloom JD, 2009, P NATL ACAD SCI USA, V106, P9995, DOI 10.1073/pnas.0901522106; Blum DL, 2000, J BACTERIOL, V182, P1346, DOI 10.1128/JB.182.5.1346-1351.2000; BULOW L, 1987, EUR J BIOCHEM, V163, P443, DOI 10.1111/j.1432-1033.1987.tb10889.x; Chakar FS, 2000, HOLZFORSCHUNG, V54, P647, DOI 10.1515/HF.2000.109; Ciccotti Giovanni., 1987, SIMULATION LIQUIDS S; Claus H, 2004, MICRON, V35, P93, DOI 10.1016/j.micron.2003.10.029; Collins T, 2005, FEMS MICROBIOL REV, V29, P3, DOI 10.1016/j.femsre.2004.06.005; Couto SR, 2006, BIOTECHNOL ADV, V24, P500, DOI 10.1016/j.biotechadv.2006.04.003; Crasto CJ, 2000, PROTEIN ENG, V13, P309, DOI 10.1093/protein/13.5.309; Dan WB, 2008, BIOTECHNOL LETT, V30, P221, DOI 10.1007/s10529-007-9543-y; Danson MJ, 1996, PROTEIN ENG, V9, P629, DOI 10.1093/protein/9.8.629; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DeLano WL, 2005, ABSTR PAP AM CHEM S, V230, pU1371; Doi RH, 2004, NAT REV MICROBIOL, V2, P541, DOI 10.1038/nrmicro925; Durao P, 2006, J BIOL INORG CHEM, V11, P514, DOI 10.1007/s00775-006-0102-0; Durao P, 2008, BIOCHEM J, V412, P339, DOI 10.1042/BJ20080166; Durao P, 2008, J BIOL INORG CHEM, V13, P183, DOI 10.1007/s00775-007-0312-0; Enguita FJ, 2003, J BIOL CHEM, V278, P19416, DOI 10.1074/jbc.M301251200; Fan ZM, 2009, APPL ENVIRON MICROB, V75, P1754, DOI 10.1128/AEM.02181-08; Fan ZM, 2009, BIOTECHNOL BIOENG, V102, P684, DOI 10.1002/bit.22112; Flander L, 2008, J AGR FOOD CHEM, V56, P5732, DOI 10.1021/jf800264a; Gianfreda L., 1999, BIOREMEDIAT J, V3, P1, DOI DOI 10.1080/10889869991219163; Gilbert M, 1998, NAT BIOTECHNOL, V16, P769, DOI 10.1038/nbt0898-769; Grabber JH, 2005, CROP SCI, V45, P820, DOI 10.2135/cropsci2004.0191; Guan ZB, 2007, APPL MICROBIOL BIOT, V73, P1114, DOI 10.1007/s00253-006-0591-3; Heinemann U, 1995, PROG BIOPHYS MOL BIO, V64, P121, DOI 10.1016/0079-6107(95)00013-5; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hong SY, 2007, BIOTECHNOL LETT, V29, P931, DOI 10.1007/s10529-007-9334-5; Hua YW, 2004, J IND MICROBIOL BIOT, V31, P273, DOI 10.1007/s10295-004-0146-5; Hullo MF, 2001, J BACTERIOL, V183, P5426, DOI 10.1128/JB.183.18.5426-5430.2001; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Laskowski RA, 1998, CURR OPIN STRUC BIOL, V8, P631, DOI 10.1016/S0959-440X(98)80156-5; Leone FA, 2005, BIOCHEM MOL BIOL EDU, V33, P399, DOI 10.1002/bmb.2005.49403306399; Mandai T, 2009, BIOCHEM BIOPH RES CO, V384, P61, DOI 10.1016/j.bbrc.2009.04.064; Martins LO, 2002, J BIOL CHEM, V277, P18849, DOI 10.1074/jbc.M200827200; McCann MC, 2008, CURR OPIN PLANT BIOL, V11, P314, DOI 10.1016/j.pbi.2008.04.001; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Murakami MT, 2005, FEBS LETT, V579, P6505, DOI 10.1016/j.febslet.2005.10.039; Nixon AE, 1998, TRENDS BIOTECHNOL, V16, P258, DOI 10.1016/S0167-7799(98)01204-9; Paes G, 2007, PROTEIN ENG DES SEL, V20, P15, DOI 10.1093/protein/gzl049; Pandey A, 2000, J SCI IND RES INDIA, V59, P12; PATEL RN, 1993, APPL MICROBIOL BIOT, V39, P405, DOI 10.1007/BF00192102; Ruller R, 2006, BIOTECHNOL APPL BIOC, V43, P9, DOI 10.1042/BA20050016; Ruller R, 2008, PROTEINS, V70, P1280, DOI 10.1002/prot.21617; Saha BC, 2003, J IND MICROBIOL BIOT, V30, P279, DOI 10.1007/s10295-003-0049-x; Shallom D, 2003, CURR OPIN MICROBIOL, V6, P219, DOI 10.1016/S1369-5274(03)00056-0; Solomon EI, 1996, CHEM REV, V96, P2563, DOI 10.1021/cr950046o; Stoj C.S., 2006, ENCYCL INORG CHEM, DOI [10.1002/0470862106.ia055, DOI 10.1002/0470862106.IA055]; Stoll S, 2006, J MAGN RESON, V178, P42, DOI 10.1016/j.jmr.2005.08.013; Sun JY, 2005, PROTEIN EXPRES PURIF, V42, P122, DOI 10.1016/j.pep.2005.03.009; Svergun DI, 1999, BIOPHYS J, V77, P2896; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; *TAPPI TECHN ASS P, 1996, TAPPI TEST METH; Thulasiram HV, 2007, SCIENCE, V316, P73, DOI 10.1126/science.1137786; TORRONEN A, 1994, EMBO J, V13, P2493, DOI 10.1002/j.1460-2075.1994.tb06536.x; Valls C, 2009, BIORESOURCE TECHNOL, V100, P2032, DOI 10.1016/j.biortech.2008.10.009; van Gunsteren W, 1996, BIOMOLECULAR SIMULAT; Van Gunsteren WF, 1988, MOL SIMULAT, V1, P173, DOI 10.1080/08927028808080941; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wang Q, 2008, APPL BIOCHEM BIOTECH, V144, P273, DOI 10.1007/s12010-007-8016-z; Wong DWS, 2009, APPL BIOCHEM BIOTECH, V157, P174, DOI 10.1007/s12010-008-8279-z; Yuan JS, 2008, TRENDS PLANT SCI, V13, P421, DOI 10.1016/j.tplants.2008.06.001; Zhang PH, 2007, PROTEIN ENG DES SEL, V20, P497, DOI 10.1093/protein/gzm049	72	41	47	4	44	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					43026	43038		10.1074/jbc.M111.253419	http://dx.doi.org/10.1074/jbc.M111.253419			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22006920	Green Published, hybrid			2022-12-27	WOS:000298351300023
J	Leyton, DL; Sevastsyanovich, YR; Browning, DF; Rossiter, AE; Wells, TJ; Fitzpatrick, RE; Overduin, M; Cunningham, AF; Henderson, IR				Leyton, Denisse L.; Sevastsyanovich, Yanina R.; Browning, Douglas F.; Rossiter, Amanda E.; Wells, Timothy J.; Fitzpatrick, Rebecca E.; Overduin, Michael; Cunningham, Adam F.; Henderson, Ian R.			Size and Conformation Limits to Secretion of Disulfide-bonded Loops in Autotransporter Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUTER-MEMBRANE TRANSLOCATION; TOXIN-B-SUBUNIT; ESCHERICHIA-COLI; PASSENGER DOMAIN; CRYSTAL-STRUCTURE; BACTERIAL AUTOTRANSPORTER; SHIGELLA-FLEXNERI; VIRULENCE FACTOR; SERINE-PROTEASE; IGA PROTEASE	Autotransporters are a superfamily of virulence factors typified by a channel-forming C terminus that facilitates translocation of the functional N-terminal passenger domain across the outer membrane of Gram-negative bacteria. This final step in the secretion of autotransporters requires a translocation-competent conformation for the passenger domain that differs markedly from the structure of the fully folded secreted protein. The nature of the translocation-competent conformation remains controversial, in particular whether the passenger domain can adopt secondary structural motifs, such as disulfide-bonded segments, while maintaining a secretion-competent state. Here, we used the endogenous and closely spaced cysteine residues of the plasmid-encoded toxin (Pet) from enteroaggregative Escherichia coli to investigate the effect of disulfide bond-induced folding on translocation of an autotransporter passenger domain. We reveal that rigid structural elements within disulfide-bonded segments are resistant to autotransporter-mediated secretion. We define the size limit of disulfide-bonded segments tolerated by the autotransporter system demonstrating that, when present, cysteine pairs are intrinsically closely spaced to prevent congestion of the translocator pore by large disulfide-bonded regions. These latter data strongly support the hairpin mode of autotransporter biogenesis.	[Leyton, Denisse L.; Sevastsyanovich, Yanina R.; Browning, Douglas F.; Rossiter, Amanda E.; Wells, Timothy J.; Fitzpatrick, Rebecca E.; Cunningham, Adam F.; Henderson, Ian R.] Univ Birmingham, Sch Immun & Infect, Birmingham B15 2TT, W Midlands, England; [Overduin, Michael] Univ Birmingham, Sch Canc Sci, Birmingham B15 2TT, W Midlands, England	University of Birmingham; University of Birmingham	Henderson, IR (corresponding author), Univ Birmingham, Sch Immun & Infect, Birmingham B15 2TT, W Midlands, England.	i.r.henderson@bham.ac.uk	Leyton, Denisse L/A-6915-2015; Henderson, Ian/AAD-5369-2019; Wells, Timothy/AAG-3311-2021; Overduin, Michael/AAG-3632-2020; Wells, Timothy/M-2025-2016	Leyton, Denisse L/0000-0003-4808-9289; Overduin, Michael/0000-0002-3114-6585; Browning, Douglas/0000-0003-4672-3514; Wells, Timothy/0000-0001-7766-5404; Henderson, Ian/0000-0002-9954-4977; Cunningham, Adam/0000-0003-0248-964X	Biotechnology and Biological Sciences Research Council; BBSRC [BB/G022054/1] Funding Source: UKRI; MRC [G0700151] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G022054/1] Funding Source: researchfish; Medical Research Council [G0700151, G9818340B] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Biotechnology and Biological Sciences Research Council (to M. O. and I. R. H.)	Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Barnard TJ, 2007, NAT STRUCT MOL BIOL, V14, P1214, DOI 10.1038/nsmb1322; Brandon LD, 2001, J BACTERIOL, V183, P951, DOI 10.1128/JB.183.3.951-958.2001; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; den Blaauwen T, 2003, MOL MICROBIOL, V47, P539, DOI 10.1046/j.1365-2958.2003.03316.x; Diepold A, 2010, EMBO J, V29, P1928, DOI 10.1038/emboj.2010.84; Emsley P, 1996, NATURE, V381, P90, DOI 10.1038/381090a0; Eslava C, 1998, INFECT IMMUN, V66, P3155, DOI 10.1128/IAI.66.7.3155-3163.1998; Gangwer KA, 2007, P NATL ACAD SCI USA, V104, P16293, DOI 10.1073/pnas.0707447104; Henderson IR, 2001, TRENDS MICROBIOL, V9, P573, DOI 10.1016/S0966-842X(01)02234-X; Ieva R, 2011, P NATL ACAD SCI USA, V108, pE383, DOI 10.1073/pnas.1103827108; Ieva R, 2009, P NATL ACAD SCI USA, V106, P19120, DOI 10.1073/pnas.0907912106; Jain S, 2007, J BACTERIOL, V189, P5393, DOI 10.1128/JB.00228-07; Johnson TA, 2009, J MOL BIOL, V389, P559, DOI 10.1016/j.jmb.2009.04.041; Jong WSP, 2007, MOL MICROBIOL, V63, P1524, DOI 10.1111/j.1365-2958.2007.05605.x; Jose J, 1996, GENE, V178, P107, DOI 10.1016/0378-1119(96)00343-5; Junker M, 2006, P NATL ACAD SCI USA, V103, P4918, DOI 10.1073/pnas.0507923103; Junker M, 2009, MOL MICROBIOL, V71, P1323, DOI 10.1111/j.1365-2958.2009.06607.x; KLAUSER T, 1990, EMBO J, V9, P1991, DOI 10.1002/j.1460-2075.1990.tb08327.x; KLAUSER T, 1992, EMBO J, V11, P2327, DOI 10.1002/j.1460-2075.1992.tb05292.x; Knowles TJ, 2009, NAT REV MICROBIOL, V7, P206, DOI 10.1038/nrmicro2069; Letley DP, 2006, MICROBIOL-SGM, V152, P1319, DOI 10.1099/mic.0.28548-0; Leyton DL, 2010, FEMS MICROBIOL LETT, V311, P133, DOI 10.1111/j.1574-6968.2010.02081.x; Loveless BJ, 1997, MOL MEMBR BIOL, V14, P113, DOI 10.3109/09687689709048171; Mac TT, 2008, J BIOL CHEM, V283, P824, DOI 10.1074/jbc.M707863200; Marin E, 2010, J BACTERIOL, V192, P5588, DOI 10.1128/JB.00432-10; MIYAZAKI H, 1989, J BACTERIOL, V171, P6566, DOI 10.1128/jb.171.12.6566-6572.1989; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Nishimura K, 2010, J MOL MED, V88, P451, DOI 10.1007/s00109-010-0600-y; Oliver DC, 2003, MOL MICROBIOL, V47, P1367, DOI 10.1046/j.1365-2958.2003.03377.x; Oomen CJ, 2004, EMBO J, V23, P1257, DOI 10.1038/sj.emboj.7600148; Otto BR, 2005, J BIOL CHEM, V280, P17339, DOI 10.1074/jbc.M412885200; Peterson JH, 2010, P NATL ACAD SCI USA, V107, P17739, DOI 10.1073/pnas.1009491107; Phan G, 2011, NATURE, V474, P49, DOI 10.1038/nature10109; POHLNER J, 1987, NATURE, V325, P458, DOI 10.1038/325458a0; Purdy GE, 2007, J BACTERIOL, V189, P5566, DOI 10.1128/JB.00483-07; Renn JP, 2008, BIOPOLYMERS, V89, P420, DOI 10.1002/bip.20924; Renn JP, 2011, METHOD ENZYMOL, V492, P233, DOI 10.1016/B978-0-12-381268-1.00030-6; Rossiter AE, 2011, J BACTERIOL, V193, P4250, DOI 10.1128/JB.00192-11; Ruiz-Perez F, 2009, J BACTERIOL, V191, P6571, DOI 10.1128/JB.00754-09; Rutherford N, 2006, J BACTERIOL, V188, P4111, DOI 10.1128/JB.01949-05; SARKAR G, 1990, BIOTECHNIQUES, V8, P404; Sauri A, 2009, MICROBIOL-SGM, V155, P3982, DOI 10.1099/mic.0.034991-0; Skillman KM, 2005, MOL MICROBIOL, V58, P945, DOI 10.1111/j.1365-2958.2005.04885.x; Soprova Z, 2010, J BIOL CHEM, V285, P38224, DOI 10.1074/jbc.M110.180505; St Geme JW, 2000, J BACTERIOL, V182, P6005, DOI 10.1128/JB.182.21.6005-6013.2000; Tajima N, 2010, J MOL BIOL, V402, P645, DOI 10.1016/j.jmb.2010.06.068; THORNTON JM, 1981, J MOL BIOL, V151, P261, DOI 10.1016/0022-2836(81)90515-5; van den Berg B, 2010, J MOL BIOL, V396, P627, DOI 10.1016/j.jmb.2009.12.061; Veiga E, 1999, MOL MICROBIOL, V33, P1232, DOI 10.1046/j.1365-2958.1999.01571.x; Veiga E, 2004, MOL MICROBIOL, V52, P1069, DOI 10.1111/j.1365-2958.2004.04014.x; Voulhoux R, 2003, SCIENCE, V299, P262, DOI 10.1126/science.1078973; Wagner JK, 2009, J BACTERIOL, V191, P815, DOI 10.1128/JB.00989-08; Zhai YJ, 2011, BIOCHEM J, V435, P577, DOI 10.1042/BJ20101548	54	59	61	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42283	42291		10.1074/jbc.M111.306118	http://dx.doi.org/10.1074/jbc.M111.306118			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	22006918	Green Published, hybrid			2022-12-27	WOS:000298180900038
J	Pastore, C; Topalidou, I; Forouhar, F; Yan, AC; Levy, M; Hunt, JF				Pastore, Chiara; Topalidou, Irini; Forouhar, Farhad; Yan, Amy C.; Levy, Matthew; Hunt, John F.			Crystal Structure and RNA Binding Properties of the RNA Recognition Motif (RRM) and AlkB Domains in Human AlkB Homolog 8 (ABH8), an Enzyme Catalyzing tRNA Hypermodification	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE; OXIDATIVE DEMETHYLATION; ALKYLATION DAMAGE; COMPLEX REVEALS; MOLECULAR-BASIS; REPAIR; PROTEIN; TRANSLATION; GENE; ACETYLTRANSFERASE	Humans express nine paralogs of the bacterial DNA repair enzyme AlkB, an iron/2-oxoglutarate-dependent dioxygenase that reverses alkylation damage to nucleobases. The biochemical and physiological roles of these paralogs remain largely uncharacterized, hampering insight into the evolutionary expansion of the AlkB family. However, AlkB homolog 8 (ABH8), which contains RNA recognition motif (RRM) and methyltransferase domains flanking its AlkB domain, recently was demonstrated to hypermodify the anticodon loops in some tRNAs. To deepen understanding of this activity, we performed physiological and biophysical studies of ABH8. Using GFP fusions, we demonstrate that expression of the Caenorhabditis elegans ABH8 ortholog is widespread in larvae but restricted to a small number of neurons in adults, suggesting that its function becomes more specialized during development. In vitro RNA binding studies on several human ABH8 constructs indicate that binding affinity is enhanced by a basic alpha-helix at the N terminus of the RRM domain. The 3.0-angstrom-resolution crystal structure of a construct comprising the RRM and AlkB domains shows disordered loops flanking the active site in the AlkB domain and a unique structural Zn(II)-binding site at its C terminus. Although the catalytic iron center is exposed to solvent, the 2-oxoglutarate co-substrate likely adopts an inactive conformation in the absence of tRNA substrate, which probably inhibits uncoupled free radical generation. A conformational change in the active site coupled to a disorder-to-order transition in the flanking protein segments likely controls ABH8 catalytic activ-ity and tRNA binding specificity. These results provide insight into the functional and structural adaptations underlying evolutionary diversification of AlkB domains.	[Pastore, Chiara; Topalidou, Irini; Forouhar, Farhad; Hunt, John F.] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Pastore, Chiara; Forouhar, Farhad; Hunt, John F.] Albert Einstein Coll Med, NE Struct Genom Consortium, Bronx, NY 10461 USA; [Yan, Amy C.; Levy, Matthew] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA	Columbia University; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Hunt, JF (corresponding author), Columbia Univ, Dept Biol Sci, 702A Fairchild Ctr,MC2434, New York, NY 10027 USA.	jfhunt@biology.columbia.edu	Topalidou, Irini/ABG-2833-2020		National Institutes of Health [R01GM077360, U54GM094597]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077360, U54GM094597] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01GM077360 (to J. F. H.) and U54GM094597 (to the Northeast Structural Genomics Consortium).	Aas PA, 2003, NATURE, V421, P859, DOI 10.1038/nature01363; Agris PF, 2008, EMBO REP, V9, P629, DOI 10.1038/embor.2008.104; Begley U, 2007, MOL CELL, V28, P860, DOI 10.1016/j.molcel.2007.09.021; Bjork GR, 1995, TRNA STRUCTURE BIOSY, P165; Bokut LA, 2009, SCI CHINA SER A, V52, P244, DOI 10.1007/s11425-008-0168-y; Bono F, 2006, CELL, V126, P713, DOI 10.1016/j.cell.2006.08.006; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Byrne Alexandra B, 2007, J Biol, V6, P8, DOI 10.1186/jbiol58; Chan CTY, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001247; Chen CC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000561; Church C, 2010, NAT GENET, V42, P1086, DOI 10.1038/ng.713; Clery A, 2008, CURR OPIN STRUC BIOL, V18, P290, DOI 10.1016/j.sbi.2008.04.002; Costa-Mattioli M, 2007, CELL, V129, P195, DOI 10.1016/j.cell.2007.01.050; Delaney JC, 2005, NAT STRUCT MOL BIOL, V12, P855, DOI 10.1038/nsmb996; Drenth J, 1994, PRINCIPLES PROTEIN X; Duncan T, 2002, P NATL ACAD SCI USA, V99, P16660, DOI 10.1073/pnas.262589799; Falnes PO, 2007, NEUROSCIENCE, V145, P1222, DOI 10.1016/j.neuroscience.2006.11.018; Falnes PO, 2002, NATURE, V419, P178, DOI 10.1038/nature01048; Falnes PO, 2004, NUCLEIC ACIDS RES, V32, P3456, DOI 10.1093/nar/gkh655; Fu D, 2010, MOL CELL BIOL, V30, P2449, DOI 10.1128/MCB.01604-09; Fu Y, 2010, ANGEW CHEM INT EDIT, V49, P8885, DOI 10.1002/anie.201001242; Grosjean H, 2005, TOP CURR GENET, V12, P1, DOI 10.1007/b106848; Gustilo EM, 2008, CURR OPIN MICROBIOL, V11, P134, DOI 10.1016/j.mib.2008.02.003; Han ZF, 2010, NATURE, V464, P1205, DOI 10.1038/nature08921; Holland PJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008680; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Huang B, 2005, RNA, V11, P424, DOI 10.1261/rna.7247705; Hunt-Newbury R, 2007, PLOS BIOL, V5, P1981, DOI 10.1371/journal.pbio.0050237; Kim YO, 2004, P NATL ACAD SCI USA, V101, P159, DOI 10.1073/pnas.0307205101; Kurowski MA, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-48; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Liu BQ, 2007, ASIAN J ANDROL, V9, P821, DOI 10.1111/j.1745-7262.2007.00279.x; Maris C, 2005, FEBS J, V272, P2118, DOI 10.1111/j.1742-4658.2005.04653.x; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Motorin Y, 2010, BIOCHEMISTRY-US, V49, P4934, DOI 10.1021/bi100408z; Nakamura A, 2006, SCIENCE, V312, P1954, DOI 10.1126/science.1127156; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pancevac C, 2010, NUCLEIC ACIDS RES, V38, P3119, DOI 10.1093/nar/gkq002; Petrey D, 2003, METHOD ENZYMOL, V374, P492, DOI 10.1016/S0076-6879(03)74021-X; Pierrel F, 2004, J BIOL CHEM, V279, P47555, DOI 10.1074/jbc.M408562200; Rubin BY, 2008, NEUROMOL MED, V10, P148, DOI 10.1007/s12017-007-8019-5; Shimada K, 2009, CANCER RES, V69, P3157, DOI 10.1158/0008-5472.CAN-08-3530; Simpson CL, 2009, HUM MOL GENET, V18, P472, DOI 10.1093/hmg/ddn375; Songe-Moller L, 2010, MOL CELL BIOL, V30, P1814, DOI 10.1128/MCB.01602-09; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; Stoltenburg R, 2007, BIOMOL ENG, V24, P381, DOI 10.1016/j.bioeng.2007.06.001; Sundheim O, 2006, EMBO J, V25, P3389, DOI 10.1038/sj.emboj.7601219; Suzuki T, 2005, TOP CURR GENET, V12, P23, DOI 10.1007/b106361; Trewick SC, 2002, NATURE, V419, P174, DOI 10.1038/nature00908; Tropea Joseph E., 2009, V498, P297, DOI 10.1007/978-1-59745-196-3_19; Tsujikawa K, 2007, J CELL MOL MED, V11, P1105, DOI 10.1111/j.1582-4934.2007.00094.x; Vagin AA, 2001, ACTA CRYSTALLOGR D, V57, P1451, DOI 10.1107/S0907444901012409; van den Born E, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1173; Ward JJ, 2004, BIOINFORMATICS, V20, P2138, DOI 10.1093/bioinformatics/bth195; Westbye MP, 2008, J BIOL CHEM, V283, P25046, DOI 10.1074/jbc.M803776200; Winkler GS, 2002, P NATL ACAD SCI USA, V99, P3517, DOI 10.1073/pnas.022042899; Wittschieben BO, 1999, MOL CELL, V4, P123, DOI 10.1016/S1097-2765(00)80194-X; Yang CG, 2008, NATURE, V452, P961, DOI 10.1038/nature06889; Yu B, 2006, NATURE, V439, P879, DOI 10.1038/nature04561; Yu B, 2009, P NATL ACAD SCI USA, V106, P14315, DOI 10.1073/pnas.0812938106	61	55	59	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2012	287	3					2130	2143		10.1074/jbc.M111.286187	http://dx.doi.org/10.1074/jbc.M111.286187			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879HT	22065580	Green Published, hybrid			2022-12-27	WOS:000299321000053
J	Martinez-Sanchez, A; Dudek, KA; Murphy, CL				Martinez-Sanchez, Aida; Dudek, Katarzyna A.; Murphy, Chris L.			Regulation of Human Chondrocyte Function through Direct Inhibition of Cartilage Master Regulator SOX9 by MicroRNA-145 (miRNA-145)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OSTEOARTHRITIC ARTICULAR-CARTILAGE; II COLLAGEN; GENE-EXPRESSION; AGGRECAN GENE; STEM-CELLS; DIFFERENTIATION; OVEREXPRESSION; CHONDROGENESIS; ENHANCER; BINDING	Articular cartilage enables weight bearing and near friction-free movement in the joints. Critical to its function is the production of a specialized, mechanocompetent extracellular matrix controlled by master regulator transcription factor SOX9. Mutations in SOX9 cause campomelic dysplasia, a haploinsufficiency disorder resulting in severe skeletal defects and dwarfism. Although much is understood about how SOX9 regulates cartilage matrix synthesis and hence joint function, how this master regulator is itself regulated remains largely unknown. Here we identify a specific microRNA, miR-145, as a direct regulator of SOX9 in normal healthy human articular chondrocytes. We show that miR-145 directly represses SOX9 expression in human cells through a unique binding site in its 3'-UTR not conserved in mice. Modulation of miR-145 induced profound changes in the human chondrocyte phenotype. Specifically, increased miR-145 levels cause greatly reduced expression of critical cartilage extracellular matrix genes (COL2A1 and aggrecan) and tissue-specific microRNAs (miR-675 and miR-140) and increased levels of the hypertrophic markers RUNX2 and MMP13, characteristic of changes occurring in osteoarthritis. We propose miR-145 as an important regulator of human chondrocyte function and a new target for cartilage repair.	[Martinez-Sanchez, Aida; Dudek, Katarzyna A.; Murphy, Chris L.] Univ Oxford, Kennedy Inst Rheumatol, London W6 8LH, England	University of Oxford	Murphy, CL (corresponding author), Univ Oxford, Kennedy Inst Rheumatol, 65 Aspenlea Rd, London W6 8LH, England.	chris.murphy@kennedy.ox.ac.uk	Sanchez, Aida Martinez/ABH-5957-2020	Sanchez, Aida Martinez/0000-0001-5142-2527	Biotechnology and Biological Sciences Research Council [BB/G006555/1]; BBSRC [BB/G006555/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Biotechnology and Biological Sciences Research Council Grant BB/G006555/1.	Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; Alvarez-Garcia I, 2005, DEVELOPMENT, V132, P4653, DOI 10.1242/dev.02073; Bell DM, 1997, NAT GENET, V16, P174, DOI 10.1038/ng0697-174; Bi WM, 1999, NAT GENET, V22, P85, DOI 10.1038/8792; Billinghurst RC, 1997, J CLIN INVEST, V99, P1534, DOI 10.1172/JCI119316; Chekulaeva M, 2009, CURR OPIN CELL BIOL, V21, P452, DOI 10.1016/j.ceb.2009.04.009; Cucchiarini M, 2007, ARTHRITIS RHEUM, V56, P158, DOI 10.1002/art.22299; Diaz-Prado S., 2009, ARTHRITIS RHEUMATISM, V60, P742; Dudek KA, 2010, J BIOL CHEM, V285, P24381, DOI 10.1074/jbc.M110.111328; Ella L, 2009, CELL DEATH DIFFER, V16, P1590, DOI 10.1038/cdd.2009.153; FOSTER JW, 1994, NATURE, V372, P525, DOI 10.1038/372525a0; Haag J, 2008, PATHOBIOLOGY, V75, P195, DOI 10.1159/000124980; Han Y, 2008, MOL CELL BIOL, V28, P4999, DOI 10.1128/MCB.00695-08; Hattori T, 2010, DEVELOPMENT, V137, P901, DOI 10.1242/dev.045203; Jones SW, 2009, OSTEOARTHR CARTILAGE, V17, P464, DOI 10.1016/j.joca.2008.09.012; Kedde M, 2007, CELL, V131, P1273, DOI 10.1016/j.cell.2007.11.034; Kedde M, 2010, NAT CELL BIOL, V12, P1014, DOI 10.1038/ncb2105; Lafont JE, 2007, ARTHRITIS RHEUM, V56, P3297, DOI 10.1002/art.22878; Lefebvre V, 1997, MOL CELL BIOL, V17, P2336, DOI 10.1128/MCB.17.4.2336; Miyaki S, 2010, GENE DEV, V24, P1173, DOI 10.1101/gad.1915510; Miyaki S, 2009, ARTHRITIS RHEUM-US, V60, P2723, DOI 10.1002/art.24745; Murphy CL, 2004, J CELL PHYSIOL, V199, P451, DOI 10.1002/jcp.10481; Nakamura Y, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1242; Peacock JD, 2010, CIRC RES, V106, P712, DOI 10.1161/CIRCRESAHA.109.213702; Sekiya I, 2000, J BIOL CHEM, V275, P10738, DOI 10.1074/jbc.275.15.10738; Tew SR, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2311; Tsuchiya H, 2003, BIOCHEM BIOPH RES CO, V301, P338, DOI 10.1016/S0006-291X(02)03026-7; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; Wang XB, 2004, OSTEOARTHR CARTILAGE, V12, P963, DOI 10.1016/j.joca.2004.08.008; Xin M, 2009, GENE DEV, V23, P2166, DOI 10.1101/gad.1842409; Xu N, 2009, CELL, V137, P647, DOI 10.1016/j.cell.2009.02.038; Yamashita S, 2009, EXP CELL RES, V315, P2231, DOI 10.1016/j.yexcr.2009.03.008; Yang B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021679; Yang KGA, 2006, OSTEOARTHR CARTILAGE, V14, P561, DOI 10.1016/j.joca.2005.12.002; Zhao Q, 1997, DEV DYNAM, V209, P377, DOI 10.1002/(SICI)1097-0177(199708)209:4<377::AID-AJA5>3.0.CO;2-F	35	146	161	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					916	924		10.1074/jbc.M111.302430	http://dx.doi.org/10.1074/jbc.M111.302430			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22102413	Green Published, hybrid			2022-12-27	WOS:000299170300010
J	Kishimoto, S; Ohmiya, A				Kishimoto, Sanae; Ohmiya, Akemi			Carotenoid Isomerase Is Key Determinant of Petal Color of Calendula officinalis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHYTOENE DESATURASE; BIOSYNTHESIS; PATHWAY; IDENTIFICATION; CATALYZE	Orange petals of calendula (Calendula officinalis) accumulate red carotenoids with the cis-configuration at the C-5 or C-5' position (5-cis-carotenoids). We speculated that the orange-flowered calendula is a carotenoid isomerase (crtiso) loss-of-function mutant that impairs the cis-to-trans conversion of 5-cis-carotenoids. We compared the sequences and enzyme activities of CRTISO from orange-and yellow-flowered calendulas. Four types of CRTISO were expressed in calendula petals. The deduced amino acid sequence of one of these genes (CoCRTISO1) was different between orange-and yellow-flowered calendulas, whereas the sequences of the other three CRTISOs were identical between these plants. Analysis of the enzymatic activities of the CoCRTISO homologs showed that CoCRTISO1-Y, which was expressed in yellow petals, converted carotenoids from the cis-to-trans-configuration, whereas both CoCRTISO1-ORa and 1-ORb, which were expressed in orange petals, showed no activity with any of the cis-carotenoids we tested. Moreover, the CoCRTISO1 genotypes of the F-2 progeny obtained by crossing orange and yellow lines linked closely to petal color. These data indicate that CoCRTISO1 is a key regulator of the accumulation of 5-cis-carotenoids in calendula petals. Site-directed mutagenesis showed that the deletion of Cys-His-His at positions 462-464 in CoCRTISO1-ORa and a Gly-to-Glu amino acid substitution at position 450 in CoCRTISO1-ORb abolished enzyme activity completely, indicating that these amino acid residues are important for the enzymatic activity of CRTISO.	[Kishimoto, Sanae; Ohmiya, Akemi] Natl Agr & Food Res Org, Natl Inst Floricultural Sci, Tsukuba, Ibaraki 3058519, Japan	National Agriculture & Food Research Organization - Japan	Ohmiya, A (corresponding author), Natl Agr & Food Res Org, Natl Inst Floricultural Sci, Fujimoto 2-1, Tsukuba, Ibaraki 3058519, Japan.	ohmiya@affrc.go.jp			National Agriculture and Food Research Organization of Japan	National Agriculture and Food Research Organization of Japan	This work was supported in part by a grant-in-aid from the National Agriculture and Food Research Organization of Japan.	BARTLETT L, 1969, J CHEM SOC C, P2527, DOI 10.1039/j39690002527; Bartley GE, 1999, EUR J BIOCHEM, V259, P396, DOI 10.1046/j.1432-1327.1999.00051.x; Breitenbach J, 1999, EUR J BIOCHEM, V265, P376, DOI 10.1046/j.1432-1327.1999.00746.x; Breitenbach J, 2005, PLANTA, V220, P785, DOI 10.1007/s00425-004-1395-2; Breitenbach J, 2001, Z NATURFORSCH C, V56, P915; Breithaupt DE, 2001, J AGR FOOD CHEM, V49, P2064, DOI 10.1021/jf001276t; Chai CL, 2011, PLANT MOL BIOL, V75, P211, DOI 10.1007/s11103-010-9719-z; Chang S. J., 1993, Plant Molecular Biology Reporter, V11, P113, DOI 10.1007/BF02670468; EGGER KURT, 1965, PHYTOCHEMISTRY, V4, P609, DOI 10.1016/S0031-9422(00)86223-8; Emanuelsson O, 1999, PROTEIN SCI, V8, P978, DOI 10.1110/ps.8.5.978; Goodwin T.W., 1988, PLANT PIGMENTS; Hansmann P, 1982, Plant Cell Rep, V1, P111, DOI 10.1007/BF00272366; Hirschberg J, 2001, CURR OPIN PLANT BIOL, V4, P210, DOI 10.1016/S1369-5266(00)00163-1; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Isaacson T, 2004, PLANT PHYSIOL, V136, P4246, DOI 10.1104/pp.104.052092; Isaacson T, 2002, PLANT CELL, V14, P333, DOI 10.1105/tpc.010303; Kishimoto S, 2005, BIOSCI BIOTECH BIOCH, V69, P2122, DOI 10.1271/bbb.69.2122; Kishimoto S, 2004, PHYTOCHEMISTRY, V65, P2781, DOI 10.1016/j.phytochem.2004.08.038; Kishimoto S, 2007, J JPN SOC HORTIC SCI, V76, P250, DOI 10.2503/jjshs.76.250; Li QR, 2010, TRANSGENIC RES, V19, P1053, DOI 10.1007/s11248-010-9381-x; Maoka T, 2009, PHYTOCHEMISTRY, V70, P920, DOI 10.1016/j.phytochem.2009.04.018; MARKIFISCHER E, 1983, HELV CHIM ACTA, V66, P494, DOI 10.1002/hlca.19830660211; Masamoto K, 2001, PLANT CELL PHYSIOL, V42, P1398, DOI 10.1093/pcp/pce167; Matthews PD, 2003, J EXP BOT, V54, P2215, DOI 10.1093/jxb/erg235; Ohmiya A, 2011, JARQ-JPN AGR RES Q, V45, P163, DOI 10.6090/jarq.45.163; Park H, 2002, PLANT CELL, V14, P321, DOI 10.1105/tpc.010302; Sakuta M., 2011, PLANT METABOLISM BIO, P343; SEYBOLD A, 1959, NATURE, V184, P1714, DOI 10.1038/1841714a0; Tanaka Y, 2008, PLANT J, V54, P733, DOI 10.1111/j.1365-313X.2008.03447.x; Yamagishi H, 2009, PLANT BREEDING, V128, P172, DOI 10.1111/j.1439-0523.2008.01558.x; Yamamizo C, 2010, J EXP BOT, V61, P709, DOI 10.1093/jxb/erp335	31	14	17	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					276	285		10.1074/jbc.M111.300301	http://dx.doi.org/10.1074/jbc.M111.300301			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22069331	hybrid, Green Published			2022-12-27	WOS:000298682400028
J	Schneider, K; Peyraud, R; Kiefer, P; Christen, P; Delmotte, N; Massou, S; Portais, JC; Vorholt, JA				Schneider, Kathrin; Peyraud, Remi; Kiefer, Patrick; Christen, Philipp; Delmotte, Nathanael; Massou, Stephane; Portais, Jean-Charles; Vorholt, Julia A.			The Ethylmalonyl-CoA Pathway Is Used in Place of the Glyoxylate Cycle by Methylobacterium extorquens AM1 during Growth on Acetate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRICARBOXYLIC-ACID CYCLE; METHYLENE TETRAHYDROMETHANOPTERIN DEHYDROGENASE; METABOLIC FLUX ANALYSIS; MASS-SPECTROMETRY; NONMETHYLOTROPHIC CONDITIONS; CORYNEBACTERIUM-GLUTAMICUM; RHODOBACTER-SPHAEROIDES; FORMATE DEHYDROGENASE; ESCHERICHIA-COLI; CARBON-SOURCES	Acetyl-CoA assimilation was extensively studied in organisms harboring the glyoxylate cycle. In this study, we analyzed the metabolism of the facultative methylotroph Methylobacterium extorquens AM1, which lacks isocitrate lyase, the key enzyme in the glyoxylate cycle, during growth on acetate. MS/MS-based proteomic analysis revealed that the protein repertoire of M. extorquens AM1 grown on acetate is similar to that of cells grown on methanol and includes enzymes of the ethylmalonyl-CoA (EMC) pathway that were recently shown to operate during growth on methanol. Dynamic C-13 labeling experiments indicate the presence of distinct entry points for acetate: the EMC pathway and the TCA cycle. C-13 steady-state metabolic flux analysis showed that oxidation of acetyl-CoA occurs predominantly via the TCA cycle and that assimilation occurs via the EMC pathway. Furthermore, acetyl-CoA condenses with the EMC pathway product glyoxylate, resulting in malate formation. The latter, also formed by the TCA cycle, is converted to phosphoglycerate by a reaction sequence that is reversed with respect to the serine cycle. Thus, the results obtained in this study reveal the utilization of common pathways during the growth of M. extorquens AM1 on C1 and C2 compounds, but with a major redirection of flux within the central metabolism. Furthermore, our results indicate that the metabolic flux distribution is highly complex in this model methylotroph during growth on acetate and is fundamentally different from organisms using the glyoxylate cycle.	[Schneider, Kathrin; Peyraud, Remi; Kiefer, Patrick; Christen, Philipp; Delmotte, Nathanael; Vorholt, Julia A.] ETH, Inst Microbiol, CH-8093 Zurich, Switzerland; [Massou, Stephane; Portais, Jean-Charles] Univ Toulouse 2, Inst Natl Sci Appl, Inst Natl Polytech Toulouse, Lab Ingn Syst Biol & Proc,Univ Toulouse, F-31077 Toulouse, France; [Massou, Stephane; Portais, Jean-Charles] INRA, UMR792, F-31400 Toulouse, France; [Massou, Stephane; Portais, Jean-Charles] CNRS, UMR5504, F-31400 Toulouse, France	Swiss Federal Institutes of Technology Domain; ETH Zurich; Universite de Toulouse; Universite de Toulouse - Jean Jaures; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); Institut National Polytechnique de Toulouse; INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse	Vorholt, JA (corresponding author), ETH, Inst Microbiol, Wolfgang Pauli Str 10, CH-8093 Zurich, Switzerland.	vorholt@micro.biol.ethz.ch	Kiefer, Patrick/G-5138-2010; Delmotte, Nathanael/G-7531-2016; Peyraud, Rémi/G-5226-2010; Vorholt, Julia/K-3514-2016	Peyraud, Rémi/0000-0002-7580-042X; Vorholt, Julia/0000-0002-6011-4910; Christen, Philipp/0000-0002-3139-2874; Portais, Jean-Charles/0000-0002-3480-0933	ETH Zurich [ETH-0909-2]	ETH Zurich(ETH Zurich)	This work was supported by ETH Zurich Grant ETH-0909-2.	Alber BE, 2006, MOL MICROBIOL, V61, P297, DOI 10.1111/j.1365-2958.2006.05238.x; ALBERS H, 1976, ARCH MICROBIOL, V111, P45, DOI 10.1007/BF00446548; Anthony C., 1982, BIOCH METHYLOTROPHS; Anthony Christopher, 2011, Science Progress, V94, P109, DOI 10.3184/003685011X13044430633960; Bantscheff M, 2007, ANAL BIOANAL CHEM, V389, P1017, DOI 10.1007/s00216-007-1486-6; Bolten CJ, 2007, ANAL CHEM, V79, P3843, DOI 10.1021/ac0623888; Bosch G, 2008, PROTEOMICS, V8, P3494, DOI 10.1002/pmic.200800152; Chistoserdova L, 2004, J BACTERIOL, V186, P22, DOI 10.1128/JB.186.1.22-28.2004; Chistoserdova L, 2003, J BACTERIOL, V185, P2980, DOI 10.1128/JB.185.10.2980-2987.2003; Delmotte N, 2009, P NATL ACAD SCI USA, V106, P16428, DOI 10.1073/pnas.0905240106; Erb TJ, 2007, P NATL ACAD SCI USA, V104, P10631, DOI 10.1073/pnas.0702791104; Erb TJ, 2010, J BACTERIOL, V192, P1249, DOI 10.1128/JB.01267-09; Erb TJ, 2009, MOL MICROBIOL, V73, P992, DOI 10.1111/j.1365-2958.2009.06837.x; Erb TJ, 2009, P NATL ACAD SCI USA, V106, P8871, DOI 10.1073/pnas.0903939106; Gerstmeir R, 2003, J BIOTECHNOL, V104, P99, DOI 10.1016/S0168-1656(03)00167-6; GOTTSCHAL JC, 1980, ARCH MICROBIOL, V126, P33, DOI 10.1007/BF00421888; Hagemeier CH, 2000, EUR J BIOCHEM, V267, P3762, DOI 10.1046/j.1432-1327.2000.01413.x; Han L, 1997, J BACTERIOL, V179, P5157, DOI 10.1128/jb.179.16.5157-5164.1997; HARDER W, 1971, BIOCHEM J, V121, P753, DOI 10.1042/bj1210753; Holms H, 1996, FEMS MICROBIOL REV, V19, P85, DOI 10.1111/j.1574-6976.1996.tb00255.x; Kiefer P, 2008, ANAL BIOCHEM, V382, P94, DOI 10.1016/j.ab.2008.07.010; Kiefer P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007831; Kleijn RJ, 2005, FEBS J, V272, P4970, DOI 10.1111/j.1742-4658.2005.04907.x; KORNBERG HL, 1957, BIOCHIM BIOPHYS ACTA, V24, P651, DOI 10.1016/0006-3002(57)90268-8; KORNBERG HL, 1957, NATURE, V179, P988, DOI 10.1038/179988a0; Korotkova N, 2002, J BACTERIOL, V184, P6174, DOI 10.1128/JB.184.22.6174-6181.2002; Laukel M, 2003, EUR J BIOCHEM, V270, P325, DOI 10.1046/j.1432-1033.2003.03391.x; Laukel M, 2004, PROTEOMICS, V4, P1247, DOI 10.1002/pmic.200300713; Massou S, 2007, PHYTOCHEMISTRY, V68, P2330, DOI 10.1016/j.phytochem.2007.03.011; Massou S, 2007, METAB ENG, V9, P252, DOI 10.1016/j.ymben.2007.03.001; Oh MK, 2002, J BIOL CHEM, V277, P13175, DOI 10.1074/jbc.M110809200; Okubo Y, 2010, J BACTERIOL, V192, P1813, DOI 10.1128/JB.01166-09; Peng L, 2003, APPL MICROBIOL BIOT, V61, P163, DOI 10.1007/s00253-002-1202-6; Peyraud R, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-189; Peyraud R, 2009, P NATL ACAD SCI USA, V106, P4846, DOI 10.1073/pnas.0810932106; Pham TV, 2010, BIOINFORMATICS, V26, P363, DOI 10.1093/bioinformatics/btp677; Schrader J, 2009, TRENDS BIOTECHNOL, V27, P107, DOI 10.1016/j.tibtech.2008.10.009; Smejkalova H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013001; Vorholt JA, 1998, J BACTERIOL, V180, P5351, DOI 10.1128/JB.180.20.5351-5356.1998; Vuilleumier S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005584; WALSH K, 1984, J BIOL CHEM, V259, P9646; Wendisch VF, 2000, J BACTERIOL, V182, P3088, DOI 10.1128/JB.182.11.3088-3096.2000; Wiechert W, 2001, METAB ENG, V3, P265, DOI 10.1006/mben.2001.0188; Zhao J, 2003, J BIOTECHNOL, V101, P101, DOI 10.1016/S0168-1656(02)00316-4	44	59	60	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					757	766		10.1074/jbc.M111.305219	http://dx.doi.org/10.1074/jbc.M111.305219			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22105076	Green Published, hybrid			2022-12-27	WOS:000298682400073
J	Yadav, VR; Prasad, S; Gupta, SC; Sung, B; Phatak, SS; Zhang, SX; Aggarwal, BB				Yadav, Vivek R.; Prasad, Sahdeo; Gupta, Subash C.; Sung, Bokyung; Phatak, Sharangdhar S.; Zhang, Shuxing; Aggarwal, Bharat B.			RETRACTED: 3-Formylchromone Interacts with Cysteine 38 in p65 Protein and with Cysteine 179 in I kappa B alpha Kinase, Leading to Down-regulation of Nuclear Factor-kappa B (NF-kappa B)-regulated Gene Products and Sensitization of Tumor Cells (Retracted article. See vol. 291, pg. 16926, 2016)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Retracted Publication							CHEMOTHERAPEUTIC-AGENTS; ACCURATE DOCKING; TYROSINE KINASE; BETA-DIKETONES; ACTIVATION; INHIBITION; EXPRESSION; PROLIFERATION; DERIVATIVES; PHOSPHORYLATION	3-Formylchromone (3-FC) has been associated with anticancer potential through a mechanism yet to be elucidated. Because of the critical role of NF-kappa B in tumorigenesis, we investigated the effect of this agent on the NF-kappa B activation pathway. Whether activated by inflammatory agents (such as TNF-alpha and endotoxin) or tumor promoters (such as phorbol ester and okadaic acid), 3-FC suppressed NF-kappa B activation. It also inhibited constitutive NF-kappa B expressed by most tumor cells. This activity correlated with sequential inhibition of I kappa B alpha kinase (IKK) activation, I kappa B alpha phosphorylation, I kappa B alpha degradation, p65 phosphorylation, p65 nuclear translocation, and reporter gene expression. We found that 3-FC inhibited the direct binding of p65 to DNA, and this binding was reversed by a reducing agent, thus suggesting a role for the cysteine residue. Furthermore, mutation of Cys(38) to Ser in p65 abolished this effect of the chromone. This result was confirmed by a docking study. 3-FC also inhibited IKK activation directly, and the reducing agent reversed this inhibition. Furthermore, mutation of Cys(179) to Ala in IKK abolished the effect of the chromone. Suppression of NF-kappa B activation led to inhibition of anti-apoptotic (Bcl-2, Bcl-x(L), survivin, and cIAP-1), proliferative (cyclinD(1) and COX-2), invasive (MMP-9 and ICAM-1), and angiogenic (VEGF) gene products and sensitization of tumor cells to cytokines. Thus, this study shows that modification of cysteine residues in IKK and p65 by 3-FC leads to inhibition of the NF-kappa B activation pathway, suppression of anti-apoptotic gene products, and potentiation of apoptosis in tumor cells.	[Yadav, Vivek R.; Prasad, Sahdeo; Gupta, Subash C.; Sung, Bokyung; Aggarwal, Bharat B.] Univ Texas MD Anderson Canc Ctr, Cytokine Res Lab, Dept Expt Therapeut, Houston, TX 77030 USA; [Phatak, Sharangdhar S.; Zhang, Shuxing] Univ Texas MD Anderson Canc Ctr, Integrated Mol Discovery Lab, Dept Expt Therapeut, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Aggarwal, BB (corresponding author), Univ Texas MD Anderson Canc Ctr, Cytokine Res Lab, Dept Expt Therapeut, Houston, TX 77030 USA.	aggarwal@mdanderson.org	Zhang, Shuxing/F-9942-2014; Aggarwal, Bharat B/G-3388-2013		National Institutes of Health [CA-16672, CA-124787-01A2]; Center for Targeted Therapy of The University of Texas MD Anderson Cancer Center; American Cancer Society [IRG-08-061-01]; University of Texas School of Public Health [RP101503]; NATIONAL CANCER INSTITUTE [P30CA016672, P01CA124787] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Targeted Therapy of The University of Texas MD Anderson Cancer Center; American Cancer Society(American Cancer Society); University of Texas School of Public Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Core Grant CA-16672 and Program Project Grant CA-124787-01A2 (to B. B. A.). This work was also supported by grants from the Center for Targeted Therapy of The University of Texas MD Anderson Cancer Center (to B. B. A. and to S. Z.), American Cancer Society Grant IRG-08-061-01 (to S. Z.), and University of Texas Health Innovation for Cancer Prevention Research Predoctoral Fellowship RP101503 from The University of Texas School of Public Health (to S. S. P.).	Aggarwal BB, 2004, CANCER CELL, V6, P203, DOI 10.1016/j.ccr.2004.09.003; Barath Z, 2006, IN VIVO, V20, P645; Blonska M, 2005, J BIOL CHEM, V280, P43056, DOI 10.1074/jbc.M507807200; Chaturvedi MM, 2011, ONCOGENE, V30, P1615, DOI 10.1038/onc.2010.566; CHATURVEDI MM, 1994, LYMPHOKINE CYTOK RES, V13, P309; Darnay BG, 1999, J BIOL CHEM, V274, P7724, DOI 10.1074/jbc.274.12.7724; Davis IW, 2009, J MOL BIOL, V385, P381, DOI 10.1016/j.jmb.2008.11.010; ELLIS GP, 1978, J MED CHEM, V21, P1120, DOI 10.1021/jm00209a006; FALTYNEK CR, 1995, J ENZYM INHIB, V9, P111, DOI 10.3109/14756369509042811; FINCO TS, 1994, P NATL ACAD SCI USA, V91, P11884, DOI 10.1073/pnas.91.25.11884; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Garcia-Pineres AJ, 2001, J BIOL CHEM, V276, P39713, DOI 10.1074/jbc.M101985200; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Gupta SC, 2011, MOL PHARMACOL, V80, P769, DOI 10.1124/mol.111.073122; Gupta SC, 2010, J BIOL CHEM, V285, P35406, DOI 10.1074/jbc.M110.161984; Gupta SC, 2010, BBA-GENE REGUL MECH, V1799, P775, DOI 10.1016/j.bbagrm.2010.05.004; Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s; Hsu HL, 1996, CELL, V84, P299, DOI 10.1016/S0092-8674(00)80984-8; Ishihara M, 2005, IN VIVO, V19, P119; Kapahi P, 2000, J BIOL CHEM, V275, P36062, DOI 10.1074/jbc.M007204200; Kawase M, 2007, IN VIVO, V21, P829; Khan KM, 2010, EUR J MED CHEM, V45, P4058, DOI 10.1016/j.ejmech.2010.05.065; Khan KM, 2009, BIOORGAN MED CHEM, V17, P2983, DOI 10.1016/j.bmc.2009.03.020; Liang MC, 2006, BIOCHEM PHARMACOL, V71, P634, DOI 10.1016/j.bcp.2005.11.013; Meiler J, 2006, PROTEINS, V65, P538, DOI 10.1002/prot.21086; Nakano K, 2004, ANTICANCER RES, V24, P711; Natarajan K, 1996, P NATL ACAD SCI USA, V93, P9090, DOI 10.1073/pnas.93.17.9090; Nawrot-Modranka J, 2006, EUR J MED CHEM, V41, P1301, DOI 10.1016/j.ejmech.2006.06.004; Pandey MK, 2007, J BIOL CHEM, V282, P17340, DOI 10.1074/jbc.M700890200; Prasad S, 2010, J BIOL CHEM, V285, P26987, DOI 10.1074/jbc.M110.121061; Prasad S, 2010, MOL CELL BIOCHEM, V336, P25, DOI 10.1007/s11010-009-0267-2; Reynaert NL, 2004, P NATL ACAD SCI USA, V101, P8945, DOI 10.1073/pnas.0400588101; Rossi A, 2000, NATURE, V403, P103, DOI 10.1038/47520; Sakurai H, 1999, J BIOL CHEM, V274, P30353, DOI 10.1074/jbc.274.43.30353; Sersen F, 2008, MED CHEM, V4, P355, DOI 10.2174/157340608784872262; Shim YS, 2003, BIOORG MED CHEM LETT, V13, P2561, DOI 10.1016/S0960-894X(03)00479-7; Simeonidis S, 1999, P NATL ACAD SCI USA, V96, P49, DOI 10.1073/pnas.96.1.49; Sung B, 2007, MOL PHARMACOL, V71, P1703, DOI 10.1124/mol.107.034512; Takada Y, 2003, J BIOL CHEM, V278, P24233, DOI 10.1074/jbc.M212389200; Vos TA, 1999, HEPATOLOGY, V29, P421, DOI 10.1002/hep.510290231; Yamamoto K, 1995, J BIOL CHEM, V270, P31315, DOI 10.1074/jbc.270.52.31315	42	22	23	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					245	256		10.1074/jbc.M111.274613	http://dx.doi.org/10.1074/jbc.M111.274613			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22065587	Green Published, hybrid			2022-12-27	WOS:000298682400025
J	Wang, WX				Wang, Weixun			Identification of Respective Lysine Donor and Glutamine Acceptor Sites Involved in Factor XIIIa-catalyzed Fibrin alpha Chain Cross-linking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TANDEM MASS-SPECTROMETRY; AMINO-ACID SEQUENCE; LINKED PEPTIDES; C-DOMAINS; LARGE-SCALE; LOCALIZATION; PROTEINS; NOMENCLATURE; ASSIGNMENT; FRAGMENTS	Factor XIIIa-catalyzed epsilon-(gamma-glutamyl)-lysyl bonds between glutamine and lysine residues on fibrin alpha and gamma chains stabilize the fibrin clot and protect it from mechanical and proteolytic damage. The cross-linking of gamma chains is known to involve the reciprocal linkages between Gln(398) and Lys(406.) In alpha chains, however, the respective lysine and glutamine partners remain largely unknown. Traditional biochemical approaches have only identified the possible lysine donor and glutamine acceptor sites but have failed to define the respective relationships between them. Here, a differential mass spectrometry method was implemented to characterize cross-linked alpha chain peptides originating from native fibrin. Tryptic digests of fibrin that underwent differential cross-linking conditions were analyzed by high resolution Fourier transform mass spectrometry. Differential intensities associated with monoisotopic masses of cross-linked peptides were selected for further characterization. A fit-for-purpose algorithm was developed to assign cross-linked peptide pairs of fibrin alpha chains to the monoisotopic masses relying on accurate mass measurement as the primary criterion for identification. Equipped with hypothesized sequences, tandem mass spectrometry was then used to confirm the identities of the cross-linked peptides. In addition to the reciprocal cross-links between Gln(398) and Lys(406) on the gamma chains of fibrin (the positive control of the study), nine specific cross-links (Gln(223)-Lys(508), Gln(223)-Lys(539), Gln(237)-Lys(418), Gln(237)-Lys(508), Gln(237)-Lys(539), Gln(237)-Lys(556), Gln(366)-Lys(539), Gln(563)-Lys(539), and Gln(563)-Lys(601)) on the alpha chains of fibrin were newly identified. These findings provide novel structural details with respect to the alpha chain cross-linking compared with earlier efforts.	Merck Res Labs, Rahway, NJ 07065 USA	Merck & Company	Wang, WX (corresponding author), Merck Res Labs, 126 E Lincoln Ave, Rahway, NJ 07065 USA.	weixun_wang@merck.com						Anderson GA, 2007, J PROTEOME RES, V6, P3412, DOI 10.1021/pr070035z; Beguin S, 1997, THROMB HAEMOSTASIS, V78, P590; BLOMBACK B, 1994, THROMB RES, V75, P327, DOI 10.1016/0049-3848(94)90245-3; BLOMBACK B, 1957, ACTA CHEM SCAND, V11, P194, DOI 10.3891/acta.chem.scand.11-0194; Breuker K, 2008, J AM SOC MASS SPECTR, V19, P1045, DOI 10.1016/j.jasms.2008.05.013; Chen R, 1971, Biochemistry, V10, P4487; Chen R, 2009, J PROTEOME RES, V8, P651, DOI 10.1021/pr8008012; Collet JP, 2005, BLOOD, V106, P3824, DOI 10.1182/blood-2005-05-2150; Coon JJ, 2005, BIOTECHNIQUES, V38, P519, DOI 10.2144/05384TE01; CORCORAN DH, 1980, THROMB RES, V19, P883, DOI 10.1016/0049-3848(80)90016-X; COTTRELL BA, 1979, BIOCHEMISTRY-US, V18, P5405, DOI 10.1021/bi00591a023; DOOLITTLE RF, 1977, BIOCHEMISTRY-US, V16, P1715, DOI 10.1021/bi00627a030; Doolittle RF, 2003, J THROMB HAEMOST, V1, P1559, DOI 10.1046/j.1538-7836.2003.00278.x; GALANAKIS DK, 1983, THROMB RES, V31, P403, DOI 10.1016/0049-3848(83)90405-X; Han XM, 2008, CURR OPIN CHEM BIOL, V12, P483, DOI 10.1016/j.cbpa.2008.07.024; Hanss M, 2001, ANN NY ACAD SCI, V936, P89; Iglesias AH, 2010, ANAL CHEM, V82, P909, DOI 10.1021/ac902051q; KIMURA S, 1986, J BIOL CHEM, V261, P5591; Kollman JM, 2009, BIOCHEMISTRY-US, V48, P3877, DOI 10.1021/bi802205g; Litvinov RI, 2007, BIOCHEMISTRY-US, V46, P9133, DOI 10.1021/bi700944j; Liu T, 2005, J PROTEOME RES, V4, P2070, DOI 10.1021/pr0502065; Makogonenko E, 2002, BIOCHEMISTRY-US, V41, P7907, DOI 10.1021/bi025770x; Matsuda M, 2001, ANN NY ACAD SCI, V936, P65; Matsuka YV, 1996, BIOCHEMISTRY-US, V35, P5810, DOI 10.1021/bi952294k; Medved L, 2009, J THROMB HAEMOST, V7, P355, DOI 10.1111/j.1538-7836.2008.03242.x; Medzihradszky KF, 2005, METHOD ENZYMOL, V402, P209, DOI 10.1016/S0076-6879(05)02007-0; Meng FY, 2005, MASS SPECTROM REV, V24, P126, DOI 10.1002/mas.20009; MOSESSON MW, 1995, J STRUCT BIOL, V115, P88, DOI 10.1006/jsbi.1995.1033; Novak P, 2005, ANAL CHEM, V77, P5101, DOI 10.1021/ac040194r; Paweletz CP, 2010, J PROTEOME RES, V9, P1392, DOI 10.1021/pr900925d; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Ping LF, 2011, BIOCHEMISTRY-US, V50, P9066, DOI 10.1021/bi201094v; PISANO JJ, 1968, SCIENCE, V160, P892, DOI 10.1126/science.160.3830.892; Rinner O, 2008, NAT METHODS, V5, P315, DOI [10.1038/nmeth.1192, 10.1038/NMETH.1192]; Schilling B, 2003, J AM SOC MASS SPECTR, V14, P834, DOI 10.1016/S1044-0305(03)00327-1; Sinz A, 2003, J MASS SPECTROM, V38, P1225, DOI 10.1002/JMS.559; SOBEL JH, 1995, BLOOD, V86, P989, DOI 10.1182/blood.V86.3.989.bloodjournal863989; SOBEL JH, 1994, BLOOD, V84, P535; Sobel JH, 1996, J BIOL CHEM, V271, P19288, DOI 10.1074/jbc.271.32.19288; Tipton JD, 2011, J BIOL CHEM, V286, P25451, DOI 10.1074/jbc.R111.239442; TRAN H, 1995, J BIOL CHEM, V270, P19458, DOI 10.1074/jbc.270.33.19458; Tsurupa G, 2011, BIOCHEMISTRY-US, V50, P8028, DOI 10.1021/bi2008189; Tsurupa G, 2009, BIOCHEMISTRY-US, V48, P12191, DOI 10.1021/bi901640e; Wang WX, 2003, ANAL CHEM, V75, P4818, DOI 10.1021/ac026468x; Weisel JW, 2005, ADV PROTEIN CHEM, V70, P247, DOI 10.1016/S0065-3233(04)70008-X; Weisel JW, 2001, ANN NY ACAD SCI, V936, P312; Wiener MC, 2004, ANAL CHEM, V76, P6085, DOI 10.1021/ac0493875; Wu RH, 2011, NAT METHODS, V8, P677, DOI [10.1038/nmeth.1636, 10.1038/NMETH.1636]; Yang B., 2011, P 59 ANN C MASS SPEC	49	16	16	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2011	286	52					44952	44964		10.1074/jbc.M111.297119	http://dx.doi.org/10.1074/jbc.M111.297119			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870CA	22030394	Green Published, hybrid			2022-12-27	WOS:000298645500064
J	Zoraghi, R; Worrall, L; See, RH; Strangman, W; Popplewell, WL; Gong, HS; Samaai, T; Swayze, RD; Kaur, S; Vuckovic, M; Finlay, BB; Brunham, RC; McMaster, WR; Davies-Coleman, MT; Strynadka, NC; Andersen, RJ; Reiner, NE				Zoraghi, Roya; Worrall, Liam; See, Raymond H.; Strangman, Wendy; Popplewell, Wendy L.; Gong, Huansheng; Samaai, Toufiek; Swayze, Richard D.; Kaur, Sukhbir; Vuckovic, Marija; Finlay, B. Brett; Brunham, Robert C.; McMaster, William R.; Davies-Coleman, Michael T.; Strynadka, Natalie C.; Andersen, Raymond J.; Reiner, Neil E.			Methicillin-resistant Staphylococcus aureus (MRSA) Pyruvate Kinase as a Target for Bis-indole Alkaloids with Antibacterial Activities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MARINE SPONGE; MISCELLANEOUS MECHANISMS; BIS(INDOLE) ALKALOIDS; ANTIVIRAL ACTIVITIES; NERVOUS SYSTEMS; BISINDOLE ALKALOIDS; ALLOSTERIC REGULATION; HAMACANTHIN CLASSES; CRYSTAL-STRUCTURE; ANTIFUNGAL	Novel classes of antimicrobials are needed to address the emergence of multidrug-resistant bacteria such as methicillin-resistant Staphylococcus aureus (MRSA). We have recently identified pyruvate kinase (PK) as a potential novel drug target based upon it being an essential hub in the MRSA interactome (Cherkasov, A., Hsing, M., Zoraghi, R., Foster, L. J., See, R. H., Stoynov, N., Jiang, J., Kaur, S., Lian, T., Jackson, L., Gong, H., Swayze, R., Amandoron, E., Hormozdiari, F., Dao, P., Sahinalp, C., Santos-Filho, O., Axerio-Cilies, P., Byler, K., McMaster, W. R., Brunham, R. C., Finlay, B. B., and Reiner, N. E. (2011) J. Proteome Res. 10, 1139-1150; Zoraghi, R., See, R. H., Axerio-Cilies, P., Kumar, N. S., Gong, H., Moreau, A., Hsing, M., Kaur, S., Swayze, R. D., Worrall, L., Amandoron, E., Lian, T., Jackson, L., Jiang, J., Thorson, L., Labriere, C., Foster, L., Brunham, R. C., McMaster, W. R., Finlay, B. B., Strynadka, N. C., Cherkasov, A., Young, R. N., and Reiner, N. E. (2011) Antimicrob. Agents Chemother. 55, 2042-2053). Screening of an extract library of marine invertebrates against MRSA PK resulted in the identification of bis-indole alkaloids of the spongotine (A), topsentin (B, D), and hamacanthin (C) classes isolated from the Topsentia pachastrelloides as novel bacterial PK inhibitors. These compounds potently and selectively inhibited both MRSA PK enzymatic activity and S. aureus growth in vitro. The most active compounds, cis-3,4-dihyrohyrohamacanthin B (C) and bromodeoxytopsentin (D), were identified as highly potent MRSA PK inhibitors (IC50 values of 16-60 nM) with at least 166-fold selectivity over human PK isoforms. These novel anti-PK natural compounds exhibited significant antibacterial activities against S. aureus, including MRSA (minimal inhibitory concentrations (MIC) of 12.5 and 6.25 mu g/ml, respectively) with selectivity indices (CC50/MIC)>4. We also report the discrete structural features of the MRSA PK tetramer as determined by x-ray crystallography, which is suitable for selective targeting of the bacterial enzyme. The co-crystal structure of compound C with MRSA PK confirms that the latter is a target for bis-indole alkaloids. It elucidates the essential structural requirements for PK inhibitors in "small" interfaces that provide for tetramer rigidity and efficient catalytic activity. Our results identified a series of natural products as novel MRSA PK inhibitors, providing the basis for further development of potential novel antimicrobials.	[Zoraghi, Roya; See, Raymond H.; Gong, Huansheng; Swayze, Richard D.; Kaur, Sukhbir; Brunham, Robert C.; McMaster, William R.; Reiner, Neil E.] Univ British Columbia, Div Infect Dis, Dept Med, Vancouver, BC V5Z 3J5, Canada; [Worrall, Liam; Vuckovic, Marija; Finlay, B. Brett; Strynadka, Natalie C.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V5Z 3J5, Canada; [See, Raymond H.; Brunham, Robert C.] Univ British Columbia, Ctr Dis Control, Vancouver, BC V5Z 3J5, Canada; [Strangman, Wendy; Andersen, Raymond J.] Univ British Columbia, Dept Chem, Vancouver, BC V5Z 3J5, Canada; [Finlay, B. Brett; McMaster, William R.; Reiner, Neil E.] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V5Z 3J5, Canada; [Popplewell, Wendy L.; Davies-Coleman, Michael T.] Rhodes Univ, Dept Chem, ZA-6140 Grahamstown, South Africa; [Samaai, Toufiek] Dept Environm Affairs Ocean & Coast Biodivers & E, Cape Town, South Africa	University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; Rhodes University	Reiner, NE (corresponding author), 2733 Heather St, Vancouver, BC V5Z 3J5, Canada.	ethan@interchange.ubc.ca		Davies-Coleman, Michael/0000-0001-5344-894X; Swayze, Richard/0000-0003-0692-5648; Popplewell, Wendy/0000-0001-9848-5939	Genome Canada; Genome British Columbia; Vancouver General Hospital & University of British Columbia Hospital Foundation; Natural Sciences and Engineering Research Council of Canada; SARS Accelerated Vaccine Initiative; South African National Research Foundation; Department of Environmental Affairs	Genome Canada(Genome Canada); Genome British Columbia; Vancouver General Hospital & University of British Columbia Hospital Foundation; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); SARS Accelerated Vaccine Initiative; South African National Research Foundation(National Research Foundation - South Africa); Department of Environmental Affairs	This work was supported by grants from Genome Canada and Genome British Columbia, Vancouver General Hospital & University of British Columbia Hospital Foundation, The Natural Sciences and Engineering Research Council of Canada, SARS Accelerated Vaccine Initiative to the PRoteomics for Emerging PAthogen REsponse (PREPARE) Project, and the South African National Research Foundation and Department of Environmental Affairs through the SeaChange research program.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Akerley BJ, 2002, P NATL ACAD SCI USA, V99, P966, DOI 10.1073/pnas.012602299; Alanis AJ, 2005, ARCH MED RES, V36, P697, DOI 10.1016/j.arcmed.2005.06.009; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bao BQ, 2007, J NAT PROD, V70, P2, DOI 10.1021/np060206z; Bao BQ, 2005, J NAT PROD, V68, P711, DOI 10.1021/np049577a; Barrett CT, 2003, CURR OPIN BIOTECH, V14, P621, DOI 10.1016/j.copbio.2003.10.003; Casapullo A, 2000, J NAT PROD, V63, P447, DOI 10.1021/np9903292; Chan Maurice, 2007, Travel Med Infect Dis, V5, P125, DOI 10.1016/j.tmaid.2006.01.015; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cherkasov A, 2011, J PROTEOME RES, V10, P1139, DOI 10.1021/pr100918u; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fraser HB, 2002, SCIENCE, V296, P750, DOI 10.1126/science.1068696; Garcia-Lara J, 2005, DRUG DISCOV TODAY, V10, P643, DOI 10.1016/S1359-6446(05)03432-X; Gupta L, 2007, BIOORG MED CHEM LETT, V17, P4075, DOI 10.1016/j.bmcl.2007.04.035; Gupta L, 2007, CURR MED CHEM, V14, P1789; Jurica MS, 1998, STRUCTURE, V6, P195, DOI 10.1016/S0969-2126(98)00021-5; LARSEN TM, 1994, BIOCHEMISTRY-US, V33, P6301, DOI 10.1021/bi00186a033; MARSHALL NJ, 1995, GROWTH REGULAT, V5, P69; Mayer AMS, 2007, COMP BIOCHEM PHYS C, V145, P553, DOI 10.1016/j.cbpc.2007.01.015; Mayer AMS, 2009, BBA-GEN SUBJECTS, V1790, P283, DOI 10.1016/j.bbagen.2009.03.011; Mayer AMS, 2005, COMP BIOCHEM PHYS C, V140, P265, DOI 10.1016/j.cca.2005.04.004; Mayer AMS, 2004, MAR BIOTECHNOL, V6, P37, DOI 10.1007/s10126-003-0007-7; Mayer AMS, 2002, COMP BIOCHEM PHYS C, V132, P315, DOI 10.1016/S1532-0456(02)00094-7; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Monroe S, 2000, CURR OPIN MICROBIOL, V3, P496, DOI 10.1016/S1369-5274(00)00129-6; Morgan HP, 2010, J BIOL CHEM, V285, P12892, DOI 10.1074/jbc.M109.079905; MORRIS SA, 1990, TETRAHEDRON, V46, P715, DOI 10.1016/S0040-4020(01)81355-7; Murai K, 2007, J ORG CHEM, V72, P8947, DOI 10.1021/jo701668s; Nowicki MW, 2008, BIOORGAN MED CHEM, V16, P5050, DOI 10.1016/j.bmc.2008.03.045; Oh KB, 2006, BIOL PHARM BULL, V29, P570, DOI 10.1248/bpb.29.570; Oh KB, 2005, BIOORG MED CHEM LETT, V15, P4927, DOI 10.1016/j.bmcl.2005.08.021; Opperdoes FR, 2001, INT J PARASITOL, V31, P482, DOI 10.1016/S0020-7519(01)00155-2; Pathania R, 2008, BIOCHEM CELL BIOL, V86, P111, DOI 10.1139/O08-011; Phife DW, 1996, BIOORG MED CHEM LETT, V6, P2103, DOI 10.1016/0960-894X(96)00376-9; Rigden DJ, 1999, J MOL BIOL, V291, P615, DOI 10.1006/jmbi.1999.2918; SAKEMI S, 1991, J ORG CHEM, V56, P4304, DOI 10.1021/jo00013a044; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Scheiber J, 2009, J MED CHEM, V52, P3103, DOI 10.1021/jm801546k; Shaffer C, 2005, DRUG DISCOV TODAY, V10, P1489, DOI 10.1016/S1359-6446(05)03653-6; Shin J, 1999, J NAT PROD, V62, P647, DOI 10.1021/np980507b; Song JH, 2005, MOL CELLS, V19, P365; SPERANZA ML, 1989, BIOL CHEM H-S, V370, P211, DOI 10.1515/bchm3.1989.370.1.211; STUART DI, 1979, J MOL BIOL, V134, P109, DOI 10.1016/0022-2836(79)90416-9; Suree N, 2009, BIOORGAN MED CHEM, V17, P7174, DOI 10.1016/j.bmc.2009.08.067; Suzuki K, 2008, J BIOCHEM, V144, P305, DOI 10.1093/jb/mvn069; TSUJII S, 1988, J ORG CHEM, V53, P5446, DOI 10.1021/jo00258a009; Tulloch LB, 2008, J MOL BIOL, V383, P615, DOI 10.1016/j.jmb.2008.08.037; Valentin G, 2000, J BIOL CHEM, V275, P18145, DOI 10.1074/jbc.M001870200; Watts J. L., 2008, M31A3 CLIN LAB STAND, V28, pM31; WRIGHT AE, 1992, J ORG CHEM, V57, P4772, DOI 10.1021/jo00043a045; Xie L, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000387; Yao J, 2006, RNA, V12, P1271, DOI 10.1261/rna.68706; Zhang R, 2004, NUCLEIC ACIDS RES, V32, pD271, DOI 10.1093/nar/gkh024; Zoraghi R, 2011, ANTIMICROB AGENTS CH, V55, P2042, DOI 10.1128/AAC.01250-10; Zoraghi R, 2010, BIOCHEMISTRY-US, V49, P7733, DOI 10.1021/bi100780t	59	86	87	0	41	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2011	286	52					44716	44725		10.1074/jbc.M111.289033	http://dx.doi.org/10.1074/jbc.M111.289033			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870CA	22030393	Green Published, hybrid			2022-12-27	WOS:000298645500042
J	Sclip, A; Antoniou, X; Colombo, A; Camici, GG; Pozzi, L; Cardinetti, D; Feligioni, M; Veglianese, P; Bahlmann, FH; Cervo, L; Balducci, C; Costa, C; Tozzi, A; Calabresi, P; Forloni, G; Borsello, T				Sclip, Alessandra; Antoniou, Xanthi; Colombo, Alessio; Camici, Giovanni G.; Pozzi, Laura; Cardinetti, Daniele; Feligioni, Marco; Veglianese, Pietro; Bahlmann, Ferdinand H.; Cervo, Luigi; Balducci, Claudia; Costa, Cinzia; Tozzi, Alessandro; Calabresi, Paolo; Forloni, Gianluigi; Borsello, Tiziana			c-Jun N-terminal Kinase Regulates Soluble A beta Oligomers and Cognitive Impairment in AD Mouse Model	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; AMYLOID PRECURSOR PROTEIN; ALZHEIMERS-DISEASE; TAU-HYPERPHOSPHORYLATION; SYNAPTIC PLASTICITY; CEREBRAL-ISCHEMIA; CELL-DEATH; PHOSPHORYLATION; JNK; STRESS	Alzheimer disease (AD) is characterized by cognitive impairment that starts with memory loss to end in dementia. Loss of synapses and synaptic dysfunction are closely associated with cognitive impairment in AD patients. Biochemical and pathological evidence suggests that soluble A beta oligomers correlate with cognitive impairment. Here, we used the TgCRND8 AD mouse model to investigate the role of JNK in long term memory deficits. TgCRND8 mice were chronically treated with the cell-penetrating c-Jun N-terminal kinase inhibitor peptide (D-JNKI1). D-JNKI1, preventing JNK action, completely rescued memory impairments (behavioral studies) as well as the long term potentiation deficits of TgCRND8 mice. Moreover, D-JNKI1 inhibited APP phosphorylation in Thr-668 and reduced the amyloidogenic cleavage of APP and A beta oligomers in brain parenchyma of treated mice. In conclusion, by regulating key pathogenic mechanisms of AD, JNK might hold promise as innovative therapeutic target.	[Sclip, Alessandra; Antoniou, Xanthi; Colombo, Alessio; Pozzi, Laura; Cardinetti, Daniele; Feligioni, Marco; Veglianese, Pietro; Cervo, Luigi; Balducci, Claudia; Forloni, Gianluigi; Borsello, Tiziana] Ist Ric Farmacol Mario Negri, Dept Neurosci, Neuronal Death & Neuroprotect Lab, I-20156 Milan, Italy; [Camici, Giovanni G.] Univ Zurich, Inst Physiol, Cardiovasc Res Lab, CH-8057 Zurich, Switzerland; [Bahlmann, Ferdinand H.] Univ Saarland, Med Ctr, Dept Internal Med 4, D-66421 Homburg, Germany; [Costa, Cinzia; Tozzi, Alessandro; Calabresi, Paolo] Univ Perugia, Clin Neurol Div, Osped S Maria della Misericordia, I-06156 Perugia, Italy; [Calabresi, Paolo] Fdn Santa Lucia, Ist Ricovero & Cura Carattere Sci, I-00143 Rome, Italy	Istituto di Ricerche Farmacologiche Mario Negri IRCCS; University of Zurich; Saarland University; Hospital Santa Maria della Misericordia; University of Perugia; IRCCS Santa Lucia	Borsello, T (corresponding author), Ist Ric Farmacol Mario Negri, Dept Neurosci, Neuronal Death & Neuroprotect Lab, Via Masa 19, I-20156 Milan, Italy.	tiziana.borsello@marionegri.it	Costa, Cinzia/K-8485-2016; Pozzi, Laura/F-8687-2011; Veglianese, Pietro/AAA-7394-2020; Balducci, Claudia/AAA-8465-2020; Cervo, Luigi/AAA-8081-2020; Borsello, Tiziana/ABG-7759-2020; Forloni, Gianluigi/AAB-2115-2020; Tozzi, Alessandro/AAB-8707-2022; Camici, Giovanni/H-1631-2018; Tozzi, Alessandro/G-7254-2011; Veglianese, Pietro/R-1871-2019; Calabresi, Paolo/G-8496-2011; Feligioni, Marco/F-8649-2012; Borsello, Tiziana/J-8232-2016	Costa, Cinzia/0000-0002-4862-4221; Pozzi, Laura/0000-0001-7662-2904; Balducci, Claudia/0000-0002-3870-835X; Cervo, Luigi/0000-0003-1314-1876; Forloni, Gianluigi/0000-0001-5374-3914; Camici, Giovanni/0000-0002-0523-0695; Veglianese, Pietro/0000-0002-0183-9428; Calabresi, Paolo/0000-0003-0326-5509; Borsello, Tiziana/0000-0002-9729-7642; Tozzi, Alessandro/0000-0003-3153-2424	Marie Curie Industry-Academia Partnerships and Pathways Cpads; San Paolo [2008-2437]; Cassa di Risparmio delle Provincie Lombarde (CARIPLO) [2009-2425]; Swiss National Foundation (SNF) [310030_130500]	Marie Curie Industry-Academia Partnerships and Pathways Cpads; San Paolo; Cassa di Risparmio delle Provincie Lombarde (CARIPLO)(Fondazione Cariplo); Swiss National Foundation (SNF)(Swiss National Science Foundation (SNSF))	This work was supported by Marie Curie Industry-Academia Partnerships and Pathways Cpads (to T. B.), San Paolo 2008-2437 (to T. B.), Cassa di Risparmio delle Provincie Lombarde (CARIPLO) 2009-2425 (to T.B.), and Swiss National Foundation (SNF) Grant 310030_130500 (to G. G. C.).	Barghorn S, 2005, J NEUROCHEM, V95, P834, DOI 10.1111/j.1471-4159.2005.03407.x; Bellucci A, 2007, NEUROBIOL DIS, V27, P328, DOI 10.1016/j.nbd.2007.06.008; Bonny C, 2001, DIABETES, V50, P77, DOI 10.2337/diabetes.50.1.77; Borsello T, 2003, NAT MED, V9, P1180, DOI 10.1038/nm911; Chen GQ, 2000, NATURE, V408, P975, DOI 10.1038/35050103; Chishti MA, 2001, J BIOL CHEM, V276, P21562, DOI 10.1074/jbc.M100710200; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Colombo A, 2007, CELL DEATH DIFFER, V14, P1845, DOI 10.1038/sj.cdd.4402202; Colombo A, 2009, NEUROBIOL DIS, V33, P518, DOI 10.1016/j.nbd.2008.12.014; FRANCIS BM, 2010, NEUROBIOL AGING; Hyde LA, 2005, BEHAV BRAIN RES, V160, P344, DOI 10.1016/j.bbr.2004.12.017; Janus C, 2000, NATURE, V408, P979, DOI 10.1038/35050110; Jedlicka P, 2008, BEHAV BRAIN RES, V192, P12, DOI 10.1016/j.bbr.2008.02.033; Lee MS, 2003, J CELL BIOL, V163, P83, DOI 10.1083/jcb.200301115; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Li SM, 2010, FRONT CELL NEUROSCI, V4, DOI 10.3389/fncel.2010.00005; Minogue AM, 2003, J BIOL CHEM, V278, P27971, DOI 10.1074/jbc.M302530200; Morishima Y, 2001, J NEUROSCI, V21, P7551, DOI 10.1523/JNEUROSCI.21-19-07551.2001; Muresan Z, 2005, J NEUROSCI, V25, P3741, DOI 10.1523/JNEUROSCI.0152-05.2005; Muresan Z, 2007, MOL BIOL CELL, V18, P3835, DOI 10.1091/mbc.E06-07-0625; O'Donnell E, 2000, EUR J NEUROSCI, V12, P345, DOI 10.1046/j.1460-9568.2000.00900.x; OLTON DS, 1987, BRAIN RES, V404, P180, DOI 10.1016/0006-8993(87)91369-2; Pastorino L, 2006, EUR J PHARMACOL, V545, P29, DOI 10.1016/j.ejphar.2006.06.078; Ploia C, 2011, J ALZHEIMERS DIS, V26, P315, DOI 10.3233/JAD-2011-110320; Puig B, 2004, NEUROPATH APPL NEURO, V30, P491, DOI 10.1111/j.1365-2990.2004.00569.x; Ramelot TA, 2001, J MOL BIOL, V307, P871, DOI 10.1006/jmbi.2001.4535; Ramin M, 2011, BEHAV BRAIN RES, V217, P424, DOI 10.1016/j.bbr.2010.11.017; Repici M, 2007, NEUROSCIENCE, V150, P40, DOI 10.1016/j.neuroscience.2007.08.021; Repici M, 2009, NEUROSCIENCE, V159, P94, DOI 10.1016/j.neuroscience.2008.11.049; Savage MJ, 2002, J NEUROSCI, V22, P3376; Scheinfeld MH, 2003, J BIOL CHEM, V278, P42058, DOI 10.1074/jbc.M304853200; SELKOE DJ, 1991, SCI AM, V265, P40, DOI 10.1038/scientificamerican1191-68; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Sherrin T, 2010, J NEUROSCI, V30, P13348, DOI 10.1523/JNEUROSCI.3492-10.2010; Small BJ, 2007, GERIATRICS-US, V62, P19; Soto C, 2003, NAT REV NEUROSCI, V4, P49, DOI 10.1038/nrn1007; Sperling RA, 2010, NEUROMOL MED, V12, P27, DOI 10.1007/s12017-009-8109-7; SQUIRE LR, 1988, BEHAV NEUROSCI, V102, P210, DOI 10.1037/0735-7044.102.2.210; Standen CL, 2001, J NEUROCHEM, V76, P316, DOI 10.1046/j.1471-4159.2001.00102.x; Tackenberg C, 2009, CURR ALZHEIMER RES, V6, P261, DOI 10.2174/156720509788486554; Thakur A, 2007, J NEUROSCI RES, V85, P1668, DOI 10.1002/jnr.21298; Vogel J, 2009, NEUROPHARMACOLOGY, V57, P539, DOI 10.1016/j.neuropharm.2009.07.021; Yoshida H, 2004, J NEUROCHEM, V90, P352, DOI 10.1111/j.1471-4159.2004.02479.x; Zhu XW, 2001, J NEUROCHEM, V76, P435, DOI 10.1046/j.1471-4159.2001.00046.x	48	67	70	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2011	286	51					43871	43880		10.1074/jbc.M111.297515	http://dx.doi.org/10.1074/jbc.M111.297515			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866SH	22033930	Green Published, hybrid			2022-12-27	WOS:000298402300028
J	Sun, ZZ; Tang, XY; Lin, F; Chen, SH				Sun, Zhizeng; Tang, Xiaoyun; Lin, Fang; Chen, Songhai			The WD40 Repeat Protein WDR26 Binds G beta gamma and Promotes G beta gamma-dependent Signal Transduction and Leukocyte Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCHANGE FACTOR; SMALL-MOLECULE DISRUPTION; NEUTROPHIL CHEMOTAXIS; PHOSPHOINOSITIDE 3-KINASE; SUBUNIT COMPLEX; DISTINCT ROLES; CELL-MIGRATION; HEART-FAILURE; IN-VIVO; ACTIVATION	The G beta gamma subunits of heterotrimeric G proteins transmit signals to control many cellular processes, including leukocyte migration. G beta gamma signaling may regulate and be regulated by numerous signaling partners. Here, we reveal that WDR26, a member of the WD40 repeat protein family, directly bound free G beta gamma in vitro, and formed a complex with endogenous G beta gamma in Jurkat T cells stimulated by the chemokine SDF1 alpha. Suppression of WDR26 by siRNAs selectively inhibited G beta gamma-dependent phospholipase C beta and PI3K activation, and attenuated chemotaxis in Jurkat T cells and differentiated HL60 cells in vitro and Jurkat T cell homing to lymphoid tissues in scid mice. Similarly, disruption of the WDR26/G beta gamma interaction via expression of a WDR26 deletion mutant impaired G beta gamma signaling and Jurkat T cell migration, indicating that the function of WDR26 depends on its binding to G beta gamma. Additional data show that WDR26 also controlled RACK1, a negative regulator, in binding G beta gamma and inhibiting leukocyte migration. Collectively, these experiments identify WDR26 as a novel G beta gamma-binding protein that is required for the efficacy of G beta gamma signaling and leukocyte migration.	[Sun, Zhizeng; Tang, Xiaoyun; Chen, Songhai] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Pharmacol, Iowa City, IA 52242 USA; [Lin, Fang] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Anat & Cell Biol, Iowa City, IA 52242 USA; [Chen, Songhai] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Internal Med, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa	Chen, SH (corresponding author), Bowen Sci Bldg,Rm 2-3452,51 Newton Rd, Iowa City, IA 52242 USA.	songhai-chen@uiowa.edu		Sun, Zhizeng/0000-0002-0033-5885; Lin, Fang/0000-0003-2179-7031; chen, songhai/0000-0001-7316-7125	National Institutes of Health [GM094255]; American Heart Association [10GRNT3620015]; NATIONAL CENTER FOR RESEARCH RESOURCES [R00RR024119] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094255] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM094255 (to S. C.) and American Heart Association Grant 10GRNT3620015 (to S. C.).	Allen WE, 1998, J CELL BIOL, V141, P1147, DOI 10.1083/jcb.141.5.1147; Arai H, 1997, P NATL ACAD SCI USA, V94, P14495, DOI 10.1073/pnas.94.26.14495; Bach TL, 2007, J IMMUNOL, V179, P2223, DOI 10.4049/jimmunol.179.4.2223; Biedermann S, 2011, TRENDS PLANT SCI, V16, P38, DOI 10.1016/j.tplants.2010.09.007; Bookout AL, 2003, J BIOL CHEM, V278, P37569, DOI 10.1074/jbc.M306276200; Cara DC, 2001, J IMMUNOL, V167, P6552, DOI 10.4049/jimmunol.167.11.6552; Casey LM, 2010, CIRC RES, V107, P532, DOI 10.1161/CIRCRESAHA.110.217075; Cathcart MK, 2009, J LIPID RES, V50, pS231, DOI 10.1194/jlr.R800096-JLR200; Chen LF, 2007, DEV CELL, V12, P603, DOI 10.1016/j.devcel.2007.03.005; Chen SH, 2005, J BIOL CHEM, V280, P33445, DOI 10.1074/jbc.M505422200; Chen SH, 2004, J MOL CELL CARDIOL, V37, P399, DOI 10.1016/j.yjmcc.2004.04.019; Chen SH, 2004, J BIOL CHEM, V279, P17861, DOI 10.1074/jbc.M313727200; Chen SH, 2008, MOL BIOL CELL, V19, P3909, DOI 10.1091/mbc.E08-04-0433; Dell EJ, 2002, J BIOL CHEM, V277, P49888, DOI 10.1074/jbc.M202755200; Dong XM, 2005, CURR BIOL, V15, P1874, DOI 10.1016/j.cub.2005.09.014; Ford CE, 1998, SCIENCE, V280, P1271, DOI 10.1126/science.280.5367.1271; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hannigan M, 2002, P NATL ACAD SCI USA, V99, P3603, DOI 10.1073/pnas.052010699; Harding VB, 2001, P NATL ACAD SCI USA, V98, P5809, DOI 10.1073/pnas.091102398; Heit B, 2008, NAT IMMUNOL, V9, P743, DOI 10.1038/ni.1623; Higa LA, 2006, NAT CELL BIOL, V8, P1277, DOI 10.1038/ncb1490; Hirsch E, 2000, SCIENCE, V287, P1049, DOI 10.1126/science.287.5455.1049; Jackson S, 2009, TRENDS BIOCHEM SCI, V34, P562, DOI 10.1016/j.tibs.2009.07.002; Janetopoulos C, 2008, FEBS LETT, V582, P2075, DOI 10.1016/j.febslet.2008.04.035; Kirui JK, 2010, J PHARMACOL EXP THER, V333, P393, DOI 10.1124/jpet.109.164814; Kollet O, 2001, BLOOD, V97, P3283, DOI 10.1182/blood.V97.10.3283; Kunisaki Y, 2006, J CELL BIOL, V174, P647, DOI 10.1083/jcb.200602142; Kunisaki Y, 2006, J IMMUNOL, V176, P4640, DOI 10.4049/jimmunol.176.8.4640; Lehmann DM, 2008, MOL PHARMACOL, V73, P410, DOI 10.1124/mol.107.041780; Li Z, 2005, NAT CELL BIOL, V7, P399, DOI 10.1038/ncb1236; Li Z, 2003, CELL, V114, P215, DOI 10.1016/S0092-8674(03)00559-2; Liu LX, 2007, BLOOD, V110, P1191, DOI 10.1182/blood-2006-11-060103; Mishra RS, 2008, J EXP MED, V205, P347, DOI 10.1084/jem.20071243; Neptune ER, 1997, P NATL ACAD SCI USA, V94, P14489, DOI 10.1073/pnas.94.26.14489; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Peled A, 1999, SCIENCE, V283, P845, DOI 10.1126/science.283.5403.845; Peracino B, 1998, J CELL BIOL, V141, P1529, DOI 10.1083/jcb.141.7.1529; PHILLIPS WJ, 1992, J BIOL CHEM, V267, P17040; PHILLIPS WJ, 1992, J BIOL CHEM, V267, P17032; Preininger AM, 2003, BIOCHEMISTRY-US, V42, P7931, DOI 10.1021/bi0345438; Rickert P, 2000, TRENDS CELL BIOL, V10, P466, DOI 10.1016/S0962-8924(00)01841-9; Sasaki T, 2000, SCIENCE, V287, P1040, DOI 10.1126/science.287.5455.1040; Servant G, 2000, SCIENCE, V287, P1037, DOI 10.1126/science.287.5455.1037; Smith Temple F., 2008, V48, P20, DOI 10.1007/978-0-387-09595-0_3; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; Smrcka AV, 2008, CELL MOL LIFE SCI, V65, P2191, DOI 10.1007/s00018-008-8006-5; Sotsios Y, 1999, J IMMUNOL, V163, P5954; Srinivasan S, 2003, J CELL BIOL, V160, P375, DOI 10.1083/jcb.200208179; Stirnimann CU, 2010, TRENDS BIOCHEM SCI, V35, P565, DOI 10.1016/j.tibs.2010.04.003; Swaney KF, 2010, ANNU REV BIOPHYS, V39, P265, DOI 10.1146/annurev.biophys.093008.131228; Takeda K, 2007, J BIOL CHEM, V282, P11874, DOI 10.1074/jbc.M610984200; Takesono A, 2004, CURR BIOL, V14, P917, DOI 10.1016/j.cub.2004.04.011; Tan WF, 2006, J BIOL CHEM, V281, P39542, DOI 10.1074/jbc.M609062200; Tang XY, 2011, J BIOL CHEM, V286, P13244, DOI 10.1074/jbc.M110.206615; Tesmer JJG, 2010, NAT STRUCT MOL BIOL, V17, P650, DOI 10.1038/nsmb0610-650; Wang F, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002980; Wei X, 2010, BIOCHEM BIOPH RES CO, V393, P860, DOI 10.1016/j.bbrc.2010.02.099; Welch HCE, 2002, CELL, V108, P809, DOI 10.1016/S0092-8674(02)00663-3; Xu JS, 2003, CELL, V114, P201, DOI 10.1016/S0092-8674(03)00555-5; Zhao J, 2009, NEUROSCI LETT, V460, P66, DOI 10.1016/j.neulet.2009.05.024; Zhu Y, 2004, J CELL BIOCHEM, V93, P579, DOI 10.1002/jcb.20175	61	21	23	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2011	286	51					43902	43912		10.1074/jbc.M111.301382	http://dx.doi.org/10.1074/jbc.M111.301382			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866SH	22065575	hybrid, Green Published			2022-12-27	WOS:000298402300031
J	Lamour, NF; Wijesinghe, DS; Mietla, JA; Ward, KE; Stahelin, RV; Chalfant, CE				Lamour, Nadia F.; Wijesinghe, Dayanjan S.; Mietla, Jennifer A.; Ward, Katherine E.; Stahelin, Robert V.; Chalfant, Charles E.			Ceramide Kinase Regulates the Production of Tumor Necrosis Factor alpha (TNF alpha) via Inhibition of TNF alpha-converting Enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRE-MESSENGER-RNA; CYTOSOLIC PHOSPHOLIPASE A(2); HIGHLY POTENT INHIBITIONS; SEPTIC SHOCK; BCL-X; ACID SPHINGOMYELINASE; SHEDDING ACTIVITY; SEVERE SEPSIS; DOUBLE-BLIND; CASPASE 9	Background: Pro-TNF alpha is transformed into the active/soluble form through proteolysis by TNF alpha-converting enzyme (TACE). Results: Genetic ablation of ceramide kinase induces an increase in TACE activity and secreted TNF alpha. Conclusion: Ceramide 1-phosphate (C1P) negatively regulates the activity of TACE. Significance: The TACE/C1P interaction is a viable drug target for the treatment of heart disease and sepsis.	[Lamour, Nadia F.; Wijesinghe, Dayanjan S.; Mietla, Jennifer A.; Chalfant, Charles E.] Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Richmond, VA 23298 USA; [Wijesinghe, Dayanjan S.; Chalfant, Charles E.] Hunter Holmes McGuire Vet Adm Med Ctr, Richmond, VA 23249 USA; [Stahelin, Robert V.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, South Bend, IN 46617 USA; [Ward, Katherine E.; Stahelin, Robert V.] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA; [Stahelin, Robert V.] Univ Notre Dame, Walther Ctr Canc Res, Notre Dame, IN 46556 USA; [Chalfant, Charles E.] Virginia Commonwealth Univ, Med Coll Virginia, Massey Canc Ctr, Richmond, VA 23298 USA	Virginia Commonwealth University; Hunter Holmes McGuire Veterinary Affairs Medical Center; Indiana University System; Indiana University South Bend; University of Notre Dame; University of Notre Dame; Walther Cancer Institute; Virginia Commonwealth University	Chalfant, CE (corresponding author), Virginia Commonwealth Univ, Dept Biochem & Mol Biol, 1101 E Marshall St,POB 980614, Richmond, VA 23298 USA.	cechalfant@vcu.edu	Stahelin, Robert/L-3567-2019	Stahelin, Robert/0000-0001-5443-7863	National Institutes of Health [HL072925, CA117950, T32 GM008695, T31 HL094290, T32GM075762, NH1C06-RR17393]; ONO Pharmaceutical Co., Ltd.; American Heart Association [SDG0735350N]; NATIONAL CANCER INSTITUTE [R01CA154314, R01CA117950] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR017393] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL094290, R01HL072925] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008695, T32GM075762] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD010641] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ONO Pharmaceutical Co., Ltd.(Ono Pharmaceutical Co Ltd); American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grants HL072925 and CA117950 (to C. E. C.). This work was also supported by a research grant supplied by ONO Pharmaceutical Co., Ltd. (to C. E. C.) and by American Heart Association Grant SDG0735350N (to R. V. S.).; Recipient of National Institutes of Health NRSA Post-doctoral Fellowship (in Wound Healing) Grant T32 GM008695.; Recipient of National Institutes of Health NRSA Pre-doctoral Fellowship (in Functional Lipidomics in Cardiovascular and Respiratory Diseases) Grant T31 HL094290.; Recipient of National Institutes of Health Training Fellowship CBBI Grant T32GM075762 and an American Heart Association pre-doctoral fellowship.; We thank Dr. Frederick Bornancin of Novartis Pharma for providing breeding pairs of the CERK<SUP>-/-</SUP> mouse along with wild-type counterparts. Virginia Commonwealth University was recipient of National Institutes of Health Grant NH1C06-RR17393 (for renovation).	Abraham E, 1998, LANCET, V351, P929; Abraham E, 2001, CRIT CARE MED, V29, P503, DOI 10.1097/00003246-200103000-00006; Akira S, 2000, BIOCHEM SOC T, V28, P551, DOI 10.1042/bst0280551; Avni D, 2009, IMMUNOL LETT, V123, P1, DOI 10.1016/j.imlet.2008.12.011; Baumruker T, 2005, IMMUNOL LETT, V96, P175, DOI 10.1016/j.imlet.2004.09.001; BEUTLER B, 1985, SCIENCE, V229, P869, DOI 10.1126/science.3895437; Bhola M, 2000, BIOL NEONATE, V78, P207, DOI 10.1159/000014272; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Boath A, 2008, J BIOL CHEM, V283, P8517, DOI 10.1074/jbc.M707107200; Chalfant CE, 2002, J BIOL CHEM, V277, P12587, DOI 10.1074/jbc.M112010200; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; COLLART MA, 1990, MOL CELL BIOL, V10, P1498, DOI 10.1128/MCB.10.4.1498; DasGupta S, 2009, BIOORGAN MED CHEM, V17, P444, DOI 10.1016/j.bmc.2008.11.067; Doedens JR, 2000, J BIOL CHEM, V275, P14598, DOI 10.1074/jbc.275.19.14598; Eske K, 2009, J IMMUNOL METHODS, V342, P13, DOI 10.1016/j.jim.2008.11.011; Goehe RW, 2010, J CLIN INVEST, V120, P3923, DOI 10.1172/JCI43552; Goldsmith M, 2009, IMMUNOLOGY, V127, P103, DOI 10.1111/j.1365-2567.2008.02928.x; Graf C, 2008, J IMMUNOL, V180, P3457, DOI 10.4049/jimmunol.180.5.3457; Graf C, 2008, BIOCHEM BIOPH RES CO, V373, P159, DOI 10.1016/j.bbrc.2008.06.002; HINSHAW LB, 1990, CIRC SHOCK, V30, P279; Hoareau L, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-1; Horiuchi K, 2007, J IMMUNOL, V179, P2686, DOI 10.4049/jimmunol.179.5.2686; Jenkins RW, 2010, J BIOL CHEM, V285, P35706, DOI 10.1074/jbc.M110.125609; Jozefowski S, 2010, J IMMUNOL, V185, P6960, DOI 10.4049/jimmunol.0902926; Lamour NF, 2007, J LIPID RES, V48, P1293, DOI 10.1194/jlr.M700083-JLR200; Lamour NF, 2009, J BIOL CHEM, V284, P26897, DOI 10.1074/jbc.M109.001677; Le GT, 2005, CURR MED CHEM, V12, P2963, DOI 10.2174/092986705774462851; Lin WJ, 2005, SHOCK, V24, P206, DOI 10.1097/01.shk.0000180074.69143.77; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Massiello A, 2004, J BIOL CHEM, V279, P15799, DOI 10.1074/jbc.M313950200; Massiello A, 2006, FASEB J, V20, P1680, DOI 10.1096/fj.05-5021fje; Massiello A, 2006, J LIPID RES, V47, P892, DOI 10.1194/jlr.C600003-JLR200; Matsui T, 2002, BIOORG MED CHEM LETT, V12, P907, DOI 10.1016/S0960-894X(02)00037-9; Matsui T, 2002, BIOORG MED CHEM LETT, V12, P903, DOI 10.1016/S0960-894X(02)00036-7; Mitsutake S, 2004, J BIOL CHEM, V279, P17570, DOI 10.1074/jbc.M312885200; Newton RC, 2001, ANN RHEUM DIS, V60, pIII25; Ogata T, 2008, SURGERY, V143, P545, DOI 10.1016/j.surg.2007.11.010; Panacek EA, 2004, CRIT CARE MED, V32, P2173, DOI 10.1097/01.CCM.0000145229.59014.6c; Pettus BJ, 2003, J BIOL CHEM, V278, P38206, DOI 10.1074/jbc.M304816200; Pettus BJ, 2004, J BIOL CHEM, V279, P11320, DOI 10.1074/jbc.M309262200; RAETZ CRH, 1990, ANNU REV BIOCHEM, V59, P129, DOI 10.1146/annurev.biochem.59.1.129; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Ramesh G, 2002, J CLIN INVEST, V110, P835, DOI 10.1172/JCI200215606; Rozenova KA, 2010, J BIOL CHEM, V285, P21103, DOI 10.1074/jbc.M109.080671; Shultz JC, 2011, MOL CANCER RES, V9, P889, DOI 10.1158/1541-7786.MCR-11-0061; Shultz JC, 2010, CANCER RES, V70, P9185, DOI 10.1158/0008-5472.CAN-10-1545; Stahelin RV, 2007, J BIOL CHEM, V282, P20467, DOI 10.1074/jbc.M701396200; Stahelin RV, 2002, J BIOL CHEM, V277, P26379, DOI 10.1074/jbc.M201106200; Subramanian P, 2005, J BIOL CHEM, V280, P17601, DOI 10.1074/jbc.M414173200; Subramanian P, 2007, J LIPID RES, V48, P2701, DOI 10.1194/jlr.M700356-JLR200; Sugiura M, 2002, J BIOL CHEM, V277, P23294, DOI 10.1074/jbc.M201535200; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Tellier E, 2008, J CELL PHYSIOL, V214, P687, DOI 10.1002/jcp.21265; Tellier E, 2006, EXP CELL RES, V312, P3969, DOI 10.1016/j.yexcr.2006.08.027; TRACEY KJ, 1987, NATURE, V330, P662, DOI 10.1038/330662a0; Tsuji K, 2008, FEBS J, V275, P3815, DOI 10.1111/j.1742-4658.2008.06527.x; vom Brocke J, 2006, CARCINOGENESIS, V27, P2141, DOI 10.1093/carcin/bg1101; Wakatsuki S, 2004, J NEUROCHEM, V89, P119, DOI 10.1046/j.1471-4159.2003.02303.x; WATSON RWG, 1994, J LEUKOCYTE BIOL, V56, P95, DOI 10.1002/jlb.56.1.95; Wijesinghe DS, 2007, METHOD ENZYMOL, V434, P265, DOI 10.1016/S0076-6879(07)34015-9; Wijesinghe DS, 2010, J LIPID RES, V51, P641, DOI 10.1194/jlr.D000430; Wijesinghe DS, 2009, J LIPID RES, V50, P1986, DOI 10.1194/jlr.M800367-JLR200; Wijesinghe DS, 2005, J LIPID RES, V46, P2706, DOI 10.1194/jlr.M500313-JLR200; Willems SH, 2010, BIOCHEM J, V428, P439, DOI 10.1042/BJ20100179	65	49	49	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					42808	42817		10.1074/jbc.M111.310169	http://dx.doi.org/10.1074/jbc.M111.310169			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22009748	Green Published, hybrid			2022-12-27	WOS:000298351300002
J	McVicker, DP; Chrin, LR; Berger, CL				McVicker, Derrick P.; Chrin, Lynn R.; Berger, Christopher L.			The Nucleotide-binding State of Microtubules Modulates Kinesin Processivity and the Ability of Tau to Inhibit Kinesin-mediated Transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							4-REPEAT TAU; MYOSIN-V; TUBULIN; MOTOR; PROTEINS; MOLECULES; ISOFORMS; 3-REPEAT; SURFACE; LENGTH	Background: Tau inhibits kinesin on GDP-microtubules in vitro, but the physiological significance in neurons is unclear. Results: On GTP-microtubules, Tau loses its inhibitory effect, and kinesin becomes less processive. Conclusion: The nucleotide-binding state of the microtubule influences the behavior of both kinesin and Tau. Significance: Tau has different functions, both inhibitory and non-inhibitory, in regulating axonal transport.	[Chrin, Lynn R.; Berger, Christopher L.] Univ Vermont, Coll Med, Dept Mol Physiol & Biophys, Burlington, VT 05405 USA; [McVicker, Derrick P.] Univ Vermont, Coll Med, Cell & Mol Biol Program, Burlington, VT 05405 USA	University of Vermont; University of Vermont	Berger, CL (corresponding author), Univ Vermont, Coll Med, Dept Mol Physiol & Biophys, Burlington, VT 05405 USA.	cberger@uvm.edu			National Institutes of Health, NINDS [R21 NS066249]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS066249] Funding Source: NIH RePORTER	National Institutes of Health, NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health, NINDS, Grant R21 NS066249 (to C. L. B.).; We thank Dr. Steven King for the 3RS- nd 4RLTau cDNA constructs and the laboratory of Dr. Kathy Trybus for the kinesin cDNA and ongoing support throughout this project.	Ackmann M, 2000, J BIOL CHEM, V275, P30335, DOI 10.1074/jbc.M002590200; Ali MY, 2008, P NATL ACAD SCI USA, V105, P4691, DOI 10.1073/pnas.0711531105; ANDREADIS A, 1992, BIOCHEMISTRY-US, V31, P10626, DOI 10.1021/bi00158a027; Aronov S, 2001, J NEUROSCI, V21, P6577, DOI 10.1523/JNEUROSCI.21-17-06577.2001; Castoldi M, 2003, PROTEIN EXPRES PURIF, V32, P83, DOI 10.1016/S1046-5928(03)00218-3; Dixit R, 2008, SCIENCE, V319, P1086, DOI 10.1126/science.1152993; Dunn S, 2008, J CELL SCI, V121, P1085, DOI 10.1242/jcs.026492; Goode BL, 2000, J BIOL CHEM, V275, P38182, DOI 10.1074/jbc.M007489200; Hammond JW, 2010, MOL BIOL CELL, V21, P572, DOI 10.1091/mbc.E09-01-0044; Higuchi H, 1997, P NATL ACAD SCI USA, V94, P4395, DOI 10.1073/pnas.94.9.4395; Hirokawa N, 2008, PHYSIOL REV, V88, P1089, DOI 10.1152/physrev.00023.2007; Hodges AR, 2007, J BIOL CHEM, V282, P27192, DOI 10.1074/jbc.M703968200; Kar S, 2003, EMBO J, V22, P70, DOI 10.1093/emboj/cdg001; Konishi Y, 2009, NAT NEUROSCI, V12, P559, DOI 10.1038/nn.2314; Lakamper S, 2005, BIOPHYS J, V89, P3223, DOI 10.1529/biophysj.104.057505; Lu HL, 2009, TRAFFIC, V10, P1429, DOI 10.1111/j.1600-0854.2009.00964.x; Makrides V, 2004, P NATL ACAD SCI USA, V101, P6746, DOI 10.1073/pnas.0400992101; Meurer-Grob P, 2001, BIOCHEMISTRY-US, V40, P8000, DOI 10.1021/bi010343p; Morfini Gerardo, 2007, Methods Mol Biol, V392, P51; Morfini G, 2007, J NEUROSCI RES, V85, P2620, DOI 10.1002/jnr.21154; Munson KM, 2007, J PHYS CHEM B, V111, P5053, DOI 10.1021/jp0716637; Nakata T, 2011, J CELL BIOL, V194, P245, DOI 10.1083/jcb.201104034; Peck A, 2011, CYTOSKELETON, V68, P44, DOI 10.1002/cm.20494; Reed NA, 2006, CURR BIOL, V16, P2166, DOI 10.1016/j.cub.2006.09.014; Santarella RA, 2004, J MOL BIOL, V339, P539, DOI 10.1016/j.jmb.2004.04.008; Seitz A, 2002, EMBO J, V21, P4896, DOI 10.1093/emboj/cdf503; Sigala R, 2007, CURR BIOL, V17, pR18, DOI 10.1016/j.cub.2006.11.036; Skiniotis G, 2004, EMBO J, V23, P989, DOI 10.1038/sj.emboj.7600118; Stamer K, 2002, J CELL BIOL, V156, P1051, DOI 10.1083/jcb.200108057; Stoothoff W, 2009, J NEUROCHEM, V111, P417, DOI 10.1111/j.1471-4159.2009.06316.x; SVOBODA K, 1994, CELL, V77, P773, DOI 10.1016/0092-8674(94)90060-4; Takuma H, 2003, DEV BRAIN RES, V142, P121, DOI 10.1016/S0165-3806(03)00056-7; Tran PT, 1997, J STRUCT BIOL, V118, P107, DOI 10.1006/jsbi.1997.3844; TROJANOWSKI JQ, 1989, J HISTOCHEM CYTOCHEM, V37, P209, DOI 10.1177/37.2.2492045; VALE RD, 1994, J BIOL CHEM, V269, P23769; Vershinin M, 2007, P NATL ACAD SCI USA, V104, P87, DOI 10.1073/pnas.0607919104; Wang ZH, 2000, BIOPHYS J, V78, P1955, DOI 10.1016/S0006-3495(00)76743-9; Xiao H, 2006, P NATL ACAD SCI USA, V103, P10166, DOI 10.1073/pnas.0603704103; YU WQ, 1994, J NEUROSCI, V14, P2818	39	56	56	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					42873	42880		10.1074/jbc.M111.292987	http://dx.doi.org/10.1074/jbc.M111.292987			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22039058	hybrid, Green Published			2022-12-27	WOS:000298351300009
J	Cascio, S; Zhang, LX; Finn, OJ				Cascio, Sandra; Zhang, Lixin; Finn, Olivera J.			MUC1 Protein Expression in Tumor Cells Regulates Transcription of Proinflammatory Cytokines by Forming a Complex with Nuclear Factor-kappa B p65 and Binding to Cytokine Promoters IMPORTANCE OF EXTRACELLULAR DOMAIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFLAMMATORY-BOWEL-DISEASE; NECROSIS-FACTOR-ALPHA; GENE-EXPRESSION; COLON-CANCER; PROGRESSION; ANTIGEN; MUCINS; GLYCOSYLATION; THERAPY	MUC1 is a transmembrane glycoprotein abnormally expressed in all stages of development of human adenocarcinomas. Overexpression and hypoglycosylation of MUC1 in cancer cells compared with normal epithelial cells are likely to alter its function and affect the behavior of cancer cells. The extracellular domain, specifically the highly O-glycosylated VNTR (variable number of tandem repeats) region, plays an important role in cell-cell communication; however, we show here that it also participates intracellularly in activation of the NF-kappa B pathway. Transfection of MUC1(-) tumor cells with cDNA encoding MUC1 with 22 tandem repeats (MUC1/22TR) or two tandem repeats (MUC1/2TR) or two isoforms that lack the VNTR region (MUC1/Z and MUC1/Y) showed that the highest expression levels of NF-kappa B family members correlated with the presence of VNTR and the highest number of tandem repeats. Because expression of MUC1 with VNTR on tumors was previously associated with chemotactic activity for cells of the innate immune system, we investigated the influence of MUC1 expression on the NF-kappa B-dependent transcriptional regulation of proinflammatory cytokines. ChIP and real-time PCR experiments revealed that MUC1/22TR up-regulated IL-6 and TNF-alpha expression by binding to their promoter regions in a NF-kappa B p65-dependent manner in both MUC1-transfected and human breast cancer cells that express endogenous MUC1. This newly detected complex of MUC1 and p65 is a novel mechanism that tumors can use to promote inflammation and cancer development.	[Cascio, Sandra; Zhang, Lixin; Finn, Olivera J.] Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA 15261 USA; [Cascio, Sandra] Fdn Ri MED, I-90134 Palermo, Italy	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Cascio, S (corresponding author), Univ Pittsburgh, Sch Med, Dept Immunol, E1046 Biomed Sci Tower, Pittsburgh, PA 15261 USA.	sac131@pitt.edu	Zhang, Li/GWM-7501-2022	Cascio, Sandra/0000-0003-4234-0508	National Institutes of Health from NCI [CA56103]; Fondazione Ri.Med; NATIONAL CANCER INSTITUTE [R01CA056103] Funding Source: NIH RePORTER	National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Fondazione Ri.Med; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA56103 (to O. J. F.) from NCI. This work was also supported by the Fondazione Ri.Med (to S. C.).	Ahmad R, 2007, NAT CELL BIOL, V9, P1419, DOI 10.1038/ncb1661; Ahmad R, 2009, CANCER RES, V69, P7013, DOI 10.1158/0008-5472.CAN-09-0523; Altschuler Y, 2000, MOL BIOL CELL, V11, P819, DOI 10.1091/mbc.11.3.819; Beatty PL, 2007, J IMMUNOL, V179, P735, DOI 10.4049/jimmunol.179.2.735; Beatty PL, 2010, CANCER PREV RES, V3, P438, DOI 10.1158/1940-6207.CAPR-09-0194; Burchell JM, 2001, J MAMMARY GLAND BIOL, V6, P355, DOI 10.1023/A:1011331809881; Carlos CA, 2005, J IMMUNOL, V175, P1628, DOI 10.4049/jimmunol.175.3.1628; COLLART MA, 1990, MOL CELL BIOL, V10, P1498, DOI 10.1128/MCB.10.4.1498; FONTENOT JD, 1995, J BIOMOL STRUCT DYN, V13, P245, DOI 10.1080/07391102.1995.10508837; Hattrup CL, 2008, ANNU REV PHYSIOL, V70, P431, DOI 10.1146/annurev.physiol.70.113006.100659; HOYOS B, 1989, SCIENCE, V244, P457, DOI 10.1126/science.2497518; Huang L, 2005, CANCER RES, V65, P10413, DOI 10.1158/0008-5472.CAN-05-2474; Kufe DW, 2009, NAT REV CANCER, V9, P874, DOI 10.1038/nrc2761; LIBERMANN TA, 1990, MOL CELL BIOL, V10, P2327, DOI 10.1128/MCB.10.5.2327; MERLIN J, 2011, ONCOGENE IN PRESS; Pochampalli MR, 2007, ONCOGENE, V26, P1693, DOI 10.1038/sj.onc.1209976; Price MR, 1998, TUMOR BIOL, V19, P1, DOI 10.1159/000056500; Sica A, 1997, J BIOL CHEM, V272, P30412, DOI 10.1074/jbc.272.48.30412; Singh AP, 2006, PROSTATE, V66, P421, DOI 10.1002/pros.20372; Szlosarek PW, 2003, LANCET ONCOL, V4, P565, DOI 10.1016/S1470-2045(03)01196-3; Taylor-Papadimitriou J, 2002, J MAMMARY GLAND BIOL, V7, P209, DOI 10.1023/A:1020360121451; Tinder TL, 2008, J IMMUNOL, V181, P3116, DOI 10.4049/jimmunol.181.5.3116; Udalova IA, 1998, J BIOL CHEM, V273, P21178, DOI 10.1074/jbc.273.33.21178; Wei XL, 2006, MOL CELL, V21, P295, DOI 10.1016/j.molcel.2005.11.030	24	63	66	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42248	42256		10.1074/jbc.M111.297630	http://dx.doi.org/10.1074/jbc.M111.297630			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	22021035	Green Published, hybrid			2022-12-27	WOS:000298180900034
J	Groulx, N; McGuire, H; Laprade, R; Schwartz, JL; Blunck, R				Groulx, Nicolas; McGuire, Hugo; Laprade, Raynald; Schwartz, Jean-Louis; Blunck, Rikard			Single Molecule Fluorescence Study of the Bacillus thuringiensis Toxin Cry1Aa Reveals Tetramerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLANAR LIPID-BILAYERS; BRUSH-BORDER-MEMBRANE; DELTA-ENDOTOXIN; PORE FORMATION; ION-CHANNEL; INSECTICIDAL TOXINS; SELECTIVE CHANNELS; CRYSTAL PROTEINS; MIDGUT RECEPTORS; CRY4BA TOXIN	Pore-forming toxins constitute a class of potent virulence factors that attack their host membrane in a two- or three-step mechanism. After binding to the membrane, often aided by specific receptors, they form pores in the membrane. Pore formation either unfolds a cytolytic activity in itself or provides a pathway to introduce enzymes into the cells that act upon intracellular proteins. The elucidation of the pore-forming mechanism of many of these toxins represents a major research challenge. As the toxins often refold after entering the membrane, their structure in the membrane is unknown, and key questions such as the stoichiometry of individual pores and their mechanism of oligomerization remain unanswered. In this study, we used single subunit counting based on fluorescence spectroscopy to explore the oligomerization process of the Cry1Aa toxin of Bacillus thuringiensis. Purified Cry1Aa toxin molecules labeled at different positions in the pore-forming domain were inserted into supported lipid bilayers, and the photobleaching steps of single fluorophores in the fluorescence time traces were counted to determine the number of subunits of each oligomer. We found that toxin oligomerization is a highly dynamic process that occurs in the membrane and that tetramers represent the final form of the toxins in a lipid bilayer environment.	[Groulx, Nicolas; McGuire, Hugo; Laprade, Raynald; Blunck, Rikard] Univ Montreal, Dept Phys, Montreal, PQ H3C 3J7, Canada; [Groulx, Nicolas; McGuire, Hugo; Laprade, Raynald; Schwartz, Jean-Louis; Blunck, Rikard] Univ Montreal, Grp Etud Prote Membranaires GEPROM, Montreal, PQ H3C 3J7, Canada; [Schwartz, Jean-Louis] Univ Montreal, Ctr SEVE, Montreal, PQ H3C 3J7, Canada; [Schwartz, Jean-Louis; Blunck, Rikard] Univ Montreal, Dept Physiol, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal	Blunck, R (corresponding author), Univ Montreal, Dept Phys, CP 6128,Succ Ctr Ville, Montreal, PQ H3C 3J7, Canada.	rikard.blunck@umontreal.ca	Blunck, Rikard/L-4226-2013; schwartz, jean-louis/D-9938-2011; Blunck, Rikard/AAM-3078-2020	Blunck, Rikard/0000-0003-4484-2907; Blunck, Rikard/0000-0003-4484-2907	Natural Sciences and Engineering Research Council [327201DG, 171373DG]; Canada Research Chair [202965]; Canadian Foundation for Innovation [202965]; Groupe d'Etude des Proteines Membranaires (GEPROM); Fonds de Recherche de Quebec-Nature et Technologie; FRSQ; FQRNT	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Canadian Foundation for Innovation(Canada Foundation for Innovation); Groupe d'Etude des Proteines Membranaires (GEPROM); Fonds de Recherche de Quebec-Nature et Technologie; FRSQ(Fonds de la Recherche en Sante du Quebec); FQRNT(FQRNT)	The work was supported in part by Natural Sciences and Engineering Research Council Grants 327201DG (to R. B.) and 171373DG (to J.-L. S. and R. L.), Canada Research Chair Grant 202965 and Canadian Foundation for Innovation Grant 202965 (to R. B.), the Groupe d'Etude des Proteines Membranaires (GEPROM), and student fellowships from Fonds de Recherche de Quebec-Nature et Technologie (to N. G. and H. M.). Work performed at GEPROM and Center SEVE was supported by FRSQ and FQRNT, respectively.	Alouf J., 2006, COMPREHENSIVE SOURCE; Alzate O, 2009, BMC BIOCHEM, V10, DOI 10.1186/1471-2091-10-25; Aronson AI, 1999, APPL ENVIRON MICROB, V65, P2503; Aronson AI, 2001, FEMS MICROBIOL LETT, V195, P1, DOI 10.1111/j.1574-6968.2001.tb10489.x; ARONSON AI, 1995, J BACTERIOL, V177, P4059, DOI 10.1128/jb.177.14.4059-4065.1995; Blunck R, 2008, P NATL ACAD SCI USA, V105, P20263, DOI 10.1073/pnas.0807056106; Bravo A, 2011, INSECT BIOCHEM MOLEC, V41, P423, DOI 10.1016/j.ibmb.2011.02.006; Carroll J, 1997, EUR J BIOCHEM, V245, P797, DOI 10.1111/j.1432-1033.1997.00797.x; CARROLL J, 1993, EUR J BIOCHEM, V214, P771, DOI 10.1111/j.1432-1033.1993.tb17979.x; Das SK, 2007, CHEMBIOCHEM, V8, P994, DOI 10.1002/cbic.200600474; Ding H, 2009, BIOPHYS J, V97, P912, DOI 10.1016/j.bpj.2009.05.035; ENGLISH L, 1994, INSECT BIOCHEM MOLEC, V24, P1025, DOI 10.1016/0965-1748(94)90140-6; FENG Q, 1994, BIOCHEMISTRY-US, V33, P8521, DOI 10.1021/bi00194a017; Garcia HG, 2011, BIOPHYS J, V101, P535, DOI 10.1016/j.bpj.2011.06.026; GAZIT E, 1995, J BIOL CHEM, V270, P2571, DOI 10.1074/jbc.270.6.2571; Girard F, 2009, BBA-BIOMEMBRANES, V1788, P575, DOI 10.1016/j.bbamem.2008.11.001; Girard F, 2009, APPL ENVIRON MICROB, V75, P359, DOI 10.1128/AEM.01930-08; Gomez I, 2002, FEBS LETT, V513, P242, DOI 10.1016/S0014-5793(02)02321-9; GROCHULSKI P, 1995, J MOL BIOL, V254, P447, DOI 10.1006/jmbi.1995.0630; Groulx N, 2010, J GEN PHYSIOL, V136, P497, DOI 10.1085/jgp.200910347; Guereca L, 1999, BBA-PROTEIN STRUCT M, V1429, P342, DOI 10.1016/S0167-4838(98)00241-6; HAIDER MZ, 1989, BIOCHIM BIOPHYS ACTA, V978, P216, DOI 10.1016/0005-2736(89)90118-1; HOFTE H, 1989, MICROBIOL REV, V53, P242; KNOWLES BH, 1994, ADV INSECT PHYSIOL, V24, P275, DOI 10.1016/S0065-2806(08)60085-5; KNOWLES BH, 1987, BIOCHIM BIOPHYS ACTA, V924, P509, DOI 10.1016/0304-4165(87)90167-X; Laflamme E, 2008, J MEMBRANE BIOL, V222, P127, DOI 10.1007/s00232-008-9106-8; LATORRE R, 1982, P NATL ACAD SCI-BIOL, V79, P805, DOI 10.1073/pnas.79.3.805; LEE MK, 1995, BIOCHEM BIOPH RES CO, V216, P306, DOI 10.1006/bbrc.1995.2625; Lenn T, 2011, CHEM COMMUN, V47, P400, DOI 10.1039/c0cc01707h; Likitvivatanavong S, 2006, ARCH BIOCHEM BIOPHYS, V445, P46, DOI 10.1016/j.abb.2005.11.007; LORENCE A, 1995, FEBS LETT, V360, P217, DOI 10.1016/0014-5793(95)00092-N; MARTIN FG, 1995, J EXP BIOL, V198, P91; Masson L, 1999, J BIOL CHEM, V274, P31996, DOI 10.1074/jbc.274.45.31996; MASSON L, 1990, BIOCHEM J, V269, P507, DOI 10.1042/bj2690507; Masson L, 2002, BBA-PROTEIN STRUCT M, V1594, P266, DOI 10.1016/S0167-4838(01)00312-0; Nair MS, 2008, J BIOL CHEM, V283, P26324, DOI 10.1074/jbc.M802895200; Ounjai P, 2007, BIOCHEM BIOPH RES CO, V361, P890, DOI 10.1016/j.bbrc.2007.07.086; Peyronnet O, 2002, BBA-BIOMEMBRANES, V1567, P113, DOI 10.1016/S0005-2736(02)00605-3; Peyronnet O, 2001, J MEMBRANE BIOL, V184, P45, DOI 10.1007/s00232-001-0071-8; Pigott CR, 2007, MICROBIOL MOL BIOL R, V71, P255, DOI 10.1128/MMBR.00034-06; Puntheeranurak T, 2005, ULTRAMICROSCOPY, V105, P115, DOI 10.1016/j.ultramic.2005.06.026; Schnepf E, 1998, MICROBIOL MOL BIOL R, V62, P775, DOI 10.1128/MMBR.62.3.775-806.1998; Schwartz JL, 1997, FEBS LETT, V410, P397, DOI 10.1016/S0014-5793(97)00626-1; SCHWARTZ JL, 1993, J MEMBRANE BIOL, V132, P53, DOI 10.1007/BF00233051; Schwartz JL, 1997, FEBS LETT, V412, P270, DOI 10.1016/S0014-5793(97)00801-6; SCHWARTZ JL, 2000, ENTOMOPATHOGENIC BAC, P199; Simonson PD, 2010, BIOPHYS J, V99, pL81, DOI 10.1016/j.bpj.2010.08.076; SLATIN SL, 1990, BIOCHEM BIOPH RES CO, V169, P765, DOI 10.1016/0006-291X(90)90397-6; Smedley DP, 1997, MOL MEMBR BIOL, V14, P13, DOI 10.3109/09687689709048164; Tigue NJ, 2001, APPL ENVIRON MICROB, V67, P5715, DOI 10.1128/AEM.67.12.5715-5720.2001; Tombola F, 2008, NEURON, V58, P546, DOI 10.1016/j.neuron.2008.03.026; Tomimoto K, 2006, COMP BIOCHEM PHYS B, V144, P413, DOI 10.1016/j.cbpb.2006.04.013; Torres J, 2008, BBA-BIOMEMBRANES, V1778, P392, DOI 10.1016/j.bbamem.2007.10.028; Ulbrich MH, 2007, NAT METHODS, V4, P319, DOI 10.1038/NMETH1024; VANFRANKENHUYZEN K, 1991, APPL ENVIRON MICROB, V57, P1650, DOI 10.1128/AEM.57.6.1650-1655.1991; Vie V, 2001, J MEMBRANE BIOL, V180, P195, DOI 10.1007/s002320010070; Villalon M, 1998, BBA-BIOMEMBRANES, V1368, P27, DOI 10.1016/S0005-2736(97)00184-3; WALTERS FS, 1994, INSECT BIOCHEM MOLEC, V24, P963, DOI 10.1016/0965-1748(94)90133-3; WALTERS FS, 1993, BIOCHEM BIOPH RES CO, V196, P921, DOI 10.1006/bbrc.1993.2337	59	33	33	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42274	42282		10.1074/jbc.M111.296103	http://dx.doi.org/10.1074/jbc.M111.296103			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	22006922	Green Published, hybrid			2022-12-27	WOS:000298180900037
J	Hill, J; Chan, SA; Kuri, B; Smith, C				Hill, Jacqueline; Chan, Shyue-An; Kuri, Barbara; Smith, Corey			Pituitary Adenylate Cyclase-activating Peptide (PACAP) Recruits Low Voltage-activated T-type Calcium Influx under Acute Sympathetic Stimulation in Mouse Adrenal Chromaffin Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; VASOACTIVE INTESTINAL POLYPEPTIDE; RAT VENTRICULAR MYOCYTES; LOW-THRESHOLD EXOCYTOSIS; PANCREATIC BETA-CELLS; CATECHOLAMINE SECRETION; CA2+ CHANNELS; DIFFERENTIAL SECRETION; GENE-TRANSCRIPTION; SIGNALING PATHWAY	Low voltage-activated T-type Ca(v)3.2 calcium channels are expressed in neurosecretory chromaffin cells of the adrenal medulla. Previous studies have shown that naive adrenal chromaffin cells express a nominal Ca(v)3.2-dependent conductance. However, Ca(v)3.2 conductance is up-regulated following chronic hypoxia or long term exposure to cAMP analogs. Thus, although a link between chronic stressors and up-regulation of Ca(v)3.2 exists, there are no reports testing the specific role of Ca(v)3.2 channels in the acute sympathoadrenal stress response. In this study, we examined the effects of acute sympathetic stress on T-type Ca(v)3.2 calcium influx in mouse chromaffin cells in situ. Pituitary adenylate cyclase-activating peptide (PACAP) is an excitatory neuroactive peptide transmitter released by the splanchnic nerve under elevated sympathetic activity to stimulate the adrenal medulla. PACAP stimulation did not evoke action potential firing in chromaffin cells but did cause a persistent subthreshold membrane depolarization that resulted in an immediate and robust Ca2+-dependent catecholamine secretion. Moreover, PACAP-evoked secretion was sensitive to block by nickel chloride and was acutely inhibited by protein kinase C blockers. We utilized perforated patch electrophysiological recordings conducted in adrenal tissue slices to investigate the mechanism of PACAP-evoked calcium entry. We provide evidence that stimulation with exogenous PACAP and native neuronal stress stimulation both lead to a protein kinase C-mediated phosphodependent recruitment of a T-type Ca(v)3.2 Ca2+ influx. This in turn evokes catecholamine release during the acute sympathetic stress response.	[Smith, Corey] Case Western Reserve Univ, Dept Physiol & Biophys, Sch Med, Cleveland, OH 44106 USA	Case Western Reserve University	Smith, C (corresponding author), Case Western Reserve Univ, Dept Physiol & Biophys, Sch Med, 2109 Adelbert Rd, Cleveland, OH 44106 USA.	Corey.Smith@Case.Edu		Chan, Shyue-An/0000-0001-9668-2103	National Institutes of Health [T32 HL 07887]; American Heart Association [10PRE4100002]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007887] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant T32 HL 07887. This work was also supported by American Heart Association Grant 10PRE4100002.	Albillos A, 2000, J NEUROSCI, V20, P8323, DOI 10.1523/JNEUROSCI.20-22-08323.2000; Aunis D, 1998, INT REV CYTOL, V181, P213, DOI 10.1016/S0074-7696(08)60419-2; BEVINGTON A, 1985, BIOCHEM PHARMACOL, V34, P1497, DOI 10.1016/0006-2952(85)90690-2; BOKSA P, 1984, J NEUROCHEM, V42, P618, DOI 10.1111/j.1471-4159.1984.tb02727.x; BRAAS KM, 1994, ENDOCRINOLOGY, V134, P186, DOI 10.1210/en.134.1.186; BRANDT BL, 1976, J PHYSIOL-LONDON, V263, P417, DOI 10.1113/jphysiol.1976.sp011638; Braun M, 2008, DIABETES, V57, P1618, DOI 10.2337/db07-0991; BURGOYNE RD, 1995, PFLUG ARCH EUR J PHY, V430, P213, DOI 10.1007/BF00374652; Carabelli V, 2007, EUR BIOPHYS J BIOPHY, V36, P753, DOI 10.1007/s00249-007-0138-2; Carabelli V, 2007, J PHYSIOL-LONDON, V584, P149, DOI 10.1113/jphysiol.2007.132274; Carbone E, 2006, CELL CALCIUM, V40, P147, DOI 10.1016/j.ceca.2006.04.019; CARMICHAEL SW, 1985, SCI AM, V253, P40, DOI 10.1038/scientificamerican0885-40; Chan SA, 2005, ARCH BIOCHEM BIOPHYS, V435, P65, DOI 10.1016/j.abb.2004.12.005; Chan SA, 2003, J PHYSIOL-LONDON, V553, P707, DOI 10.1113/jphysiol.2003.053918; Currie KPM, 1997, J NEUROSCI, V17, P4570; Dreyfus FM, 2010, J NEUROSCI, V30, P99, DOI 10.1523/JNEUROSCI.4305-09.2010; FENWICK EM, 1982, J PHYSIOL-LONDON, V331, P577, DOI 10.1113/jphysiol.1982.sp014393; FLOREY CD, 1993, BRIT MED J, V306, P1181, DOI 10.1136/bmj.306.6886.1181; FURUKAWA T, 1992, CIRC RES, V71, P1242, DOI 10.1161/01.RES.71.5.1242; Garcia AG, 2006, PHYSIOL REV, V86, P1093, DOI 10.1152/physrev.00039.2005; Geng GJ, 1997, AM J PHYSIOL-REG I, V273, pR1339, DOI 10.1152/ajpregu.1997.273.4.R1339; Gerdin Matthew J, 2007, Sci STKE, V2007, ppe15; Giancippoli A, 2006, BIOPHYS J, V90, P1830, DOI 10.1529/biophysj.105.071647; Gillis KD, 1996, NEURON, V16, P1209, DOI 10.1016/S0896-6273(00)80147-6; GUO X, 1994, J PHYSIOL-LONDON, V475, P539, DOI 10.1113/jphysiol.1994.sp020092; Hagen BM, 2006, AM J PHYSIOL-CELL PH, V291, pC375, DOI 10.1152/ajpcell.00495.2005; Hamelink C, 2002, J NEUROSCI, V22, P5310; Hamelink C, 2002, P NATL ACAD SCI USA, V99, P461, DOI 10.1073/pnas.012608999; Hayashi Kentarou, 2002, Bull Tokyo Dent Coll, V43, P31, DOI 10.2209/tdcpublication.43.31; HENRY J P, 1992, Integrative Physiological and Behavioral Science, V27, P66, DOI 10.1007/BF02691093; HOLMAN ME, 1994, J PHYSIOL-LONDON, V478, P115, DOI 10.1113/jphysiol.1994.sp020235; Holz GG, 2006, J PHYSIOL-LONDON, V577, P5, DOI 10.1113/jphysiol.2006.119644; HOSHINO M, 1993, NEUROSCI LETT, V159, P35, DOI 10.1016/0304-3940(93)90792-J; Hucho TB, 2005, J NEUROSCI, V25, P6119, DOI 10.1523/JNEUROSCI.0285-05.2005; Joksovic PM, 2010, MOL PHARMACOL, V77, P87, DOI 10.1124/mol.109.059931; Jorgensen MS, 2002, REGUL PEPTIDES, V103, P59, DOI 10.1016/S0167-0115(01)00327-5; Kang GX, 2003, J BIOL CHEM, V278, P8279, DOI 10.1074/jbc.M211682200; Kang HW, 2006, J BIOL CHEM, V281, P4823, DOI 10.1074/jbc.M510197200; KIDOKORO Y, 1980, J PHYSIOL-LONDON, V307, P199, DOI 10.1113/jphysiol.1980.sp013431; KLEVANS LR, 1970, J PHARMACOL EXP THER, V172, P69; Kuri BA, 2009, J NEUROCHEM, V110, P1214, DOI 10.1111/j.1471-4159.2009.06206.x; Levitsky KL, 2009, J PHYSIOL-LONDON, V587, P1917, DOI 10.1113/jphysiol.2009.168989; Lipscombe D, 2004, J NEUROPHYSIOL, V92, P2633, DOI 10.1152/jn.00486.2004; Marcantoni A, 2008, ACTA PHYSIOL, V192, P233, DOI 10.1111/j.1748-1716.2007.01815.x; MARLEY PD, 1988, TRENDS PHARMACOL SCI, V9, P102, DOI 10.1016/0165-6147(88)90177-0; Maturana A, 2009, ENDOCRINOLOGY, V150, P3726, DOI 10.1210/en.2008-1727; MCFADDEN PN, 1990, P NATL ACAD SCI USA, V87, P2031, DOI 10.1073/pnas.87.5.2031; Montero-Hadjadje M, 2006, ANN NY ACAD SCI, V1070, P431, DOI 10.1196/annals.1317.057; Morita K, 2002, J PHARMACOL EXP THER, V302, P972, DOI 10.1124/jpet.102.033456; Mustafa T, 2007, J BIOL CHEM, V282, P8079, DOI 10.1074/jbc.M609638200; Novara M, 2004, J PHYSIOL-LONDON, V558, P433, DOI 10.1113/jphysiol.2004.061184; Ono K, 2010, J MOL CELL CARDIOL, V48, P65, DOI 10.1016/j.yjmcc.2009.08.021; PARK JY, 2006, MOON, V577, P513; Perez-Reyes E, 2003, PHYSIOL REV, V83, P117, DOI 10.1152/physrev.00018.2002; Perez-Reyes E, 1998, J BIOENERG BIOMEMBR, V30, P313, DOI 10.1023/A:1021981420839; Przywara DA, 1996, J BIOL CHEM, V271, P10545, DOI 10.1074/jbc.271.18.10545; Randall AD, 1997, NEUROPHARMACOLOGY, V36, P879, DOI 10.1016/S0028-3908(97)00086-5; Sala F, 2008, ACTA PHYSIOL, V192, P203, DOI 10.1111/j.1748-1716.2007.01804.x; Smith C, 1999, J NEUROSCI, V19, P589; Smith C, 1997, J CELL BIOL, V139, P885, DOI 10.1083/jcb.139.4.885; Souvannakitti D, 2010, J NEUROSCI, V30, P10763, DOI 10.1523/JNEUROSCI.2307-10.2010; Ster J, 2009, J PHYSIOL-LONDON, V587, P101, DOI 10.1113/jphysiol.2008.157461; Tanaka K, 1996, ENDOCRINOLOGY, V137, P956, DOI 10.1210/en.137.3.956; Tanaka K, 1997, ENDOCRINOLOGY, V138, P4086, DOI 10.1210/en.138.10.4086; Taupenot L, 1999, HYPERTENSION, V34, P1152, DOI 10.1161/01.HYP.34.5.1152; TISCHLER AS, 1995, NEUROSCI LETT, V189, P135, DOI 10.1016/0304-3940(95)11472-9; Turquier V, 2001, MOL PHARMACOL, V60, P42, DOI 10.1124/mol.60.1.42; Wakade A R, 1998, Adv Pharmacol, V42, P595; WALZ W, 2002, PATCH CLAMP ANAL ADV, V35, P163; WATANABE T, 1992, BIOCHEM BIOPH RES CO, V182, P403, DOI 10.1016/S0006-291X(05)80159-7; WATANABE T, 1995, AM J PHYSIOL-ENDOC M, V269, pE903, DOI 10.1152/ajpendo.1995.269.5.E903; Zamponi GW, 2010, PFLUG ARCH EUR J PHY, V460, P395, DOI 10.1007/s00424-009-0772-x; Zhou CJ, 2001, PEPTIDES, V22, P1111, DOI 10.1016/S0196-9781(01)00437-5	73	30	30	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42459	42469		10.1074/jbc.M111.289389	http://dx.doi.org/10.1074/jbc.M111.289389			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	22009744	hybrid, Green Published			2022-12-27	WOS:000298180900054
J	Majumdar, A; Petrescu, AD; Xiong, Y; Noy, N				Majumdar, Avijit; Petrescu, Anca D.; Xiong, Yin; Noy, Noa			Nuclear Translocation of Cellular Retinoic Acid-binding Protein II Is Regulated by Retinoic Acid-controlled SUMOylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED RECEPTOR; BETA/DELTA; LIGAND; LOCALIZATION; RESISTANCE; SUMO; RAR	Cellular retinoic acid-binding protein II (CRABP-II) undergoes nuclear translocation upon binding of retinoic acid (RA). In the nucleus, CRABP-II directly binds to the nuclear receptor RAR to form a complex through which RA is "channeled" from the binding protein to the receptor. CRABP-II thus facilitates the ligation of RAR and markedly enhances its transcriptional activity. The primary sequence of CRABP-II contains three putative SUMOylation sites, centered at K45, K87, and K102. We show here that RA induces interactions of CRABP-II with the E2 SUMO ligase Ubc9 and triggers SUMOylation of the protein both in vitro and in cultured cells. Mutagenesis analyses demonstrate that K102 is the sole CRABP-II residue to be SUMOylated in response to RA. Mutation of this residue abolishes the ability of CRABP-II to undergo nuclear translocation in response RA and thus impairs CRABP-II-mediated activation of RAR. Additional observations demonstrate that apo-CRABP-II is associated with endoplasmic reticulum (ER), and that RA triggers the dissociation of CRABP-II from this location. Furthermore, we show that RA-induced dissociation of CRABP-II from the ER requires SUMOylation of K102. Hence, SUMOylation of K102 in response to RA binding is critical for dissociation of CRABP-II from ER and, consequently, for mobilization of the protein to nucleus and for its cooperation with RAR.	[Majumdar, Avijit; Petrescu, Anca D.; Xiong, Yin; Noy, Noa] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Noy, Noa] Case Western Reserve Univ, Sch Med, Dept Nutr, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University	Noy, N (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pharmacol, 10900 Euclid Ave,W333, Cleveland, OH 44106 USA.	noa.noy@case.edu			National Institutes of Health (NIH) [R01 DK060684, T32 CA059366]; NATIONAL CANCER INSTITUTE [T32CA059366] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060684] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK060684 (to N.N.) and by NIH Training Grant T32 CA059366 (to A.D.P.).	Ayers SD, 2007, BIOCHEMISTRY-US, V46, P6744, DOI 10.1021/bi700047a; Berry DC, 2009, MOL CELL BIOL, V29, P3286, DOI 10.1128/MCB.01742-08; Budhu A, 2001, J MOL BIOL, V305, P939, DOI 10.1006/jmbi.2000.4340; Budhu AS, 2002, MOL CELL BIOL, V22, P2632, DOI 10.1128/MCB.22.8.2632-2641.2002; Donato LJ, 2006, ANAL BIOCHEM, V357, P249, DOI 10.1016/j.ab.2006.07.020; Dong D, 1999, J BIOL CHEM, V274, P23695, DOI 10.1074/jbc.274.34.23695; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Germain P, 2006, PHARMACOL REV, V58, P712, DOI 10.1124/pr.58.4.4; Manor D, 2003, CANCER RES, V63, P4426; Muller S, 2001, NAT REV MOL CELL BIO, V2, P202, DOI 10.1038/35056591; Schug TT, 2008, P NATL ACAD SCI USA, V105, P7546, DOI 10.1073/pnas.0709981105; Schug TT, 2007, CELL, V129, P723, DOI 10.1016/j.cell.2007.02.050; Schwartz DC, 2003, TRENDS BIOCHEM SCI, V28, P321, DOI 10.1016/S0968-0004(03)00113-0; Sessler RJ, 2005, MOL CELL, V18, P343, DOI 10.1016/j.molcel.2005.03.026; Shaw N, 2003, J BIOL CHEM, V278, P41589, DOI 10.1074/jbc.C300368200; Tan NS, 2002, MOL CELL BIOL, V22, P5114, DOI 10.1128/MCB.22.14.5114-5127.2002; Vaezeslami S, 2006, J MOL BIOL, V363, P687, DOI 10.1016/j.jmb.2006.08.059	17	32	34	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42749	42757		10.1074/jbc.M111.293464	http://dx.doi.org/10.1074/jbc.M111.293464			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	21998312	Green Published, hybrid			2022-12-27	WOS:000298180900081
J	Wilczek, C; Chitta, R; Woo, E; Shabanowitz, J; Chait, BT; Hunt, DF; Shechter, D				Wilczek, Carola; Chitta, Raghu; Woo, Eileen; Shabanowitz, Jeffrey; Chait, Brian T.; Hunt, Donald F.; Shechter, David			Protein Arginine Methyltransferase Prmt5-Mep50 Methylates Histones H2A and H4 and the Histone Chaperone Nucleoplasmin in Xenopus laevis Eggs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMATIN DECONDENSATION; MASS-SPECTROMETRY; SM PROTEINS; PRMT5; EXPRESSION; PHOSPHORYLATION; ACTIVATION; CHECKPOINT; BINDS; TRANSCRIPTION	Histone proteins carry information contained in post-translational modifications. Eukaryotic cells utilize this histone code to regulate the usage of the underlying DNA. In the maturing oocytes and eggs of the frog Xenopus laevis, histones are synthesized in bulk in preparation for deposition during the rapid early developmental cell cycles. During this key developmental time frame, embryonic pluripotent chromatin is established. In the egg, non-chromatin-bound histones are complexed with storage chaperone proteins, including nucleoplasmin. Here we describe the identification and characterization of a complex of the protein arginine methyltransferase 5 (Prmt5) and the methylosome protein 50 (Mep50) isolated from Xenopus eggs that specifically methylates predeposition histones H2A/H2A.X-F and H4 and the histone chaperone nucleoplasmin on a conserved motif(GRGXK). We demonstrate that nucleoplasmin (Npm), an exceedingly abundant maternally deposited protein, is a potent substrate for Prmt5-Mep50 and is monomethylated and symmetrically dimethylated at Arg-187. Furthermore, Npm modulates Prmt5-Mep50 activity directed toward histones, consistent with a regulatory role for Npm in vivo. We show that H2A and nucleoplasmin methylation appears late in oogenesis and is most abundant in the laid egg. We hypothesize that these very abundant arginine methylations are constrained to premid blastula transition events in the embryo and therefore may be involved in the global transcriptional repression found in this developmental time frame.	[Wilczek, Carola; Shechter, David] Yeshiva Univ Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA; [Chitta, Raghu; Shabanowitz, Jeffrey; Hunt, Donald F.] Univ Virginia, Dept Chem, Charlottesville, VA 22904 USA; [Woo, Eileen; Chait, Brian T.] Rockefeller Univ, Lab Mass Spectrometry & Gaseous Ion Chem, New York, NY 10065 USA	Yeshiva University; Albert Einstein College of Medicine; University of Virginia; Rockefeller University	Shechter, D (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Biochem, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	david.shechter@einstein.yu.edu	Shechter, David/B-4660-2008; Hunt, Donald F/I-6936-2012	Shechter, David/0000-0001-9388-6004; Hunt, Donald F/0000-0003-2815-6368	National Institutes of Health [GM075486, RR00862, GM037537]; Albert Einstein College of Medicine; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000862] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037537, F32GM075486] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Albert Einstein College of Medicine; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health, Grants GM075486 (to D. S.), RR00862 (to B. T. C.), and GM037537 (to D. F. H.). This work was also supported by startup funds from the Albert Einstein College of Medicine.	Aggarwal P, 2010, CANCER CELL, V18, P329, DOI 10.1016/j.ccr.2010.08.012; Akey CW, 2003, CURR OPIN STRUC BIOL, V13, P6, DOI 10.1016/S0959-440X(03)00002-2; Ancelin K, 2006, NAT CELL BIOL, V8, P623, DOI 10.1038/ncb1413; ANIZET MP, 1981, IN VITRO CELL DEV B, V17, P267; Arnan C, 2003, J BIOL CHEM, V278, P31319, DOI 10.1074/jbc.M305560200; Ausio Juan, 2006, Briefings in Functional Genomics & Proteomics, V5, P228, DOI 10.1093/bfgp/ell020; Banaszynski LA, 2010, METHODS, V51, P3, DOI 10.1016/j.ymeth.2009.12.014; Banuelos S, 2007, J BIOL CHEM, V282, P21213, DOI 10.1074/jbc.M702842200; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bedford MT, 2007, J CELL SCI, V120, P4243, DOI 10.1242/jcs.019885; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; BURGLIN TR, 1987, GENE DEV, V1, P97, DOI 10.1101/gad.1.1.97; Cheng DH, 2004, J BIOL CHEM, V279, P23892, DOI 10.1074/jbc.M401853200; COTTEN M, 1986, BIOCHEMISTRY-US, V25, P5063, DOI 10.1021/bi00366a014; Eitoku M, 2008, CELL MOL LIFE SCI, V65, P414, DOI 10.1007/s00018-007-7305-6; Faber J, 1994, NORMAL TABLE XENOPUS; Friesen WJ, 2001, MOL CELL BIOL, V21, P8289, DOI 10.1128/MCB.21.24.8289-8300.2001; Friesen WJ, 2002, J BIOL CHEM, V277, P8243, DOI 10.1074/jbc.M109984200; Furuno K, 2006, BIOCHEM BIOPH RES CO, V345, P1051, DOI 10.1016/j.bbrc.2006.05.014; Garcia BA, 2007, NAT PROTOC, V2, P933, DOI 10.1038/nprot.2007.106; KALINICH JF, 1994, PROTEIN EXPRES PURIF, V5, P324, DOI 10.1006/prep.1994.1048; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Le Guezennec X, 2006, MOL CELL BIOL, V26, P843, DOI 10.1128/MCB.26.3.843-851.2006; Lee YH, 2009, MOL ENDOCRINOL, V23, P425, DOI 10.1210/me.2008-0380; Leno GH, 1996, J BIOL CHEM, V271, P7253, DOI 10.1074/jbc.271.13.7253; Liu F, 2011, CANCER CELL, V19, P283, DOI 10.1016/j.ccr.2010.12.020; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Luger K, 1999, METH MOL B, V119, P1; Nagamatsu G, 2011, J BIOL CHEM, V286, P10641, DOI 10.1074/jbc.M110.216390; NEWPORT J, 1982, CELL, V30, P687, DOI 10.1016/0092-8674(82)90273-2; Nicklay JJ, 2009, J BIOL CHEM, V284, P1075, DOI 10.1074/jbc.M807274200; Ramos I, 2010, J BIOL CHEM, V285, P33771, DOI 10.1074/jbc.M110.150664; Rho J, 2001, J BIOL CHEM, V276, P11393, DOI 10.1074/jbc.M008660200; SEALY L, 1989, METHOD ENZYMOL, V170, P612; SEALY L, 1986, BIOCHEMISTRY-US, V25, P3064, DOI 10.1021/bi00358a049; Shafa M, 2010, BIOESSAYS, V32, P791, DOI 10.1002/bies.201000033; Shechter D, 2004, P NATL ACAD SCI USA, V101, P10845, DOI 10.1073/pnas.0404143101; SHECHTER D, 2007, NAT REV GENET, V8, pS23; Shechter D, 2009, P NATL ACAD SCI USA, V106, P749, DOI 10.1073/pnas.0812207106; Shechter D, 2009, J BIOL CHEM, V284, P1064, DOI 10.1074/jbc.M807273200; Sible JC, 1998, CURR BIOL, V8, P347, DOI 10.1016/S0960-9822(98)70136-8; SIMEONI I, 2011, STEM CELLS IN PRESS; Stols L, 2002, PROTEIN EXPRES PURIF, V25, P8, DOI 10.1006/prep.2001.1603; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Tamada H, 2006, MOL CELL BIOL, V26, P1259, DOI 10.1128/MCB.26.4.1259-1271.2006; Taneva SG, 2008, BIOCHEMISTRY-US, V47, P13897, DOI 10.1021/bi800975r; Tee WW, 2010, GENE DEV, V24, P2772, DOI 10.1101/gad.606110; Turner BM, 2007, NAT CELL BIOL, V9, P2, DOI 10.1038/ncb0107-2; Wang Y, 2004, SCIENCE, V306, P279, DOI 10.1126/science.1101400; Wolf SS, 2009, CELL MOL LIFE SCI, V66, P2109, DOI 10.1007/s00018-009-0010-x; Woodcock CL, 2006, CHROMOSOME RES, V14, P17, DOI 10.1007/s10577-005-1024-3; Wyrick JJ, 2009, BBA-GENE REGUL MECH, V1789, P37, DOI 10.1016/j.bbagrm.2008.07.001; Wysocka J, 2006, FRONT BIOSCI-LANDMRK, V11, P344, DOI 10.2741/1802; Yamada A, 2004, J CELL BIOL, V167, P841, DOI 10.1083/jcb.200406048; Yanai I, 2011, DEV CELL, V20, P483, DOI 10.1016/j.devcel.2011.03.015	57	45	49	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42221	42231		10.1074/jbc.M111.303677	http://dx.doi.org/10.1074/jbc.M111.303677			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	22009756	Green Published, hybrid			2022-12-27	WOS:000298180900032
J	Shah, S; Henriksen, MA				Shah, Shaili; Henriksen, Melissa A.			A Novel Disrupter of Telomere Silencing 1-like (DOT1L) Interaction Is Required for Signal Transducer and Activator of Transcription 1 (STAT1)-activated Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE H3; INTERFERON-ALPHA; LYSINE METHYLATION; H3K79 METHYLATION; GAMMA-INTERFERON; MAMMALIAN-CELLS; SET DOMAIN; METHYLTRANSFERASE; YEAST; STAT1	JAK-STAT-activated gene expression is both rapid and transient and requires dynamic post-translational modification of the chromatin template. Previously, we showed that following IFN-gamma treatment, trimethylation of histone H3 at lysine 79 (H3K79me3) is rapidly and highly induced in the 5'-end of the STAT1-dependent gene interferon regulatory factor 1 (IRF1), but the role of this histone modification was unexplored. Here we report that DOT1L, the non-SET domain containing methyltransferase that modifies Lys-79, is localized across IRF1 in the uninduced state and is not further recruited by IFN-gamma induction. RNAi-mediated depletion of DOT1L, prevents the induction of H3K79me3 and lowers the transcription of IRF1 2-fold, as expected. Surprisingly, STAT1 binding to its DNA recognition element near the IRF1 promoter is diminished 2-fold in the DOT1L-depleted cell line. In vivo and in vitro protein interaction assays reveal a DOT1L-STAT1 interaction. Domain mapping identifies the middle region of DOT1L. (amino acids 580-1183) as the STAT1 interaction domain. Overexpression of the DOT1L, STAT 1 interaction domain represses IRF1 transcription (2-fold) and interferes with STAT1 DNA binding at IRF1 and endogenous DOT1L, histone methyltransferase activity. Collectively, our findings reveal a novel STAT1-DOT1L, interaction that is required for the regulation JAK-STAT-inducible gene expression.	[Shah, Shaili; Henriksen, Melissa A.] Univ Virginia, Dept Biol, Charlottesville, VA 22903 USA	University of Virginia	Henriksen, MA (corresponding author), Univ Virginia, Dept Biol, POB 400328, Charlottesville, VA 22904 USA.	mah2hx@virginia.edu						Nguyen AT, 2011, GENE DEV, V25, P1345, DOI 10.1101/gad.2057811; Barry ER, 2009, STEM CELLS, V27, P1538, DOI 10.1002/stem.86; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Brierley MM, 2005, J INTERF CYTOK RES, V25, P733, DOI 10.1089/jir.2005.25.733; Buro Lauren J, 2010, J Vis Exp, DOI 10.3791/2053; Buro LJ, 2010, EPIGENET CHROMATIN, V3, DOI 10.1186/1756-8935-3-16; Chandrasekharan MB, 2010, EPIGENETICS-US, V5, DOI 10.4161/epi.5.6.12314; Chatterjee-Kishore M, 2000, TRENDS CELL BIOL, V10, P106, DOI 10.1016/S0962-8924(99)01709-2; Chen XM, 1998, CELL, V93, P827, DOI 10.1016/S0092-8674(00)81443-9; Chipumuro E., 2011, FASEB J IN PRESS; Cumming G, 2007, J CELL BIOL, V177, P7, DOI 10.1083/jcb.200611141; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Elferink CJ, 1996, BIOTECHNIQUES, V20, P470; Feng Q, 2002, CURR BIOL, V12, P1052, DOI 10.1016/S0960-9822(02)00901-6; Feng Y, 2010, BLOOD, V116, P4483, DOI 10.1182/blood-2010-03-276501; FitzGerald J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014714; Gardner KE, 2011, J MOL BIOL, V409, P36, DOI 10.1016/j.jmb.2011.01.040; Haspel RL, 1999, P NATL ACAD SCI USA, V96, P10188, DOI 10.1073/pnas.96.18.10188; Huang M, 2002, NAT CELL BIOL, V4, P774, DOI 10.1038/ncb855; Huyen Y, 2004, NATURE, V432, P406, DOI 10.1038/nature03114; Jones B, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000190; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lee JS, 2007, CELL, V131, P1084, DOI 10.1016/j.cell.2007.09.046; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Mahmoudi T, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000539; McGinty RK, 2008, NATURE, V453, P812, DOI 10.1038/nature06906; MCKENDRY R, 1991, P NATL ACAD SCI USA, V88, P11455, DOI 10.1073/pnas.88.24.11455; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; Min JR, 2003, CELL, V112, P711, DOI 10.1016/S0092-8674(03)00114-4; Mohan M, 2010, GENE DEV, V24, P574, DOI 10.1101/gad.1898410; MULLER M, 1993, EMBO J, V12, P4221, DOI 10.1002/j.1460-2075.1993.tb06106.x; Ng HH, 2003, P NATL ACAD SCI USA, V100, P1820, DOI 10.1073/pnas.0437846100; Ng HH, 2002, J BIOL CHEM, V277, P34655, DOI 10.1074/jbc.C200433200; Ng HH, 2002, GENE DEV, V16, P1518, DOI 10.1101/gad.1001502; Nguyen AT, 2011, GENE DEV, V25, P263, DOI 10.1101/gad.2018511; Nusinzon I, 2003, P NATL ACAD SCI USA, V100, P14742, DOI 10.1073/pnas.2433987100; Oh S, 2010, BIOCHEM BIOPH RES CO, V399, P512, DOI 10.1016/j.bbrc.2010.07.100; Okada Y, 2005, CELL, V121, P167, DOI 10.1016/j.cell.2005.02.020; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Reisenauer MR, 2009, J BIOL CHEM, V284, P35659, DOI 10.1074/jbc.M109.038448; Sawada K, 2004, J BIOL CHEM, V279, P43296, DOI 10.1074/jbc.M405902200; SCHINDLER C, 1992, P NATL ACAD SCI USA, V89, P7836, DOI 10.1073/pnas.89.16.7836; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; Shi S, 2008, NAT CELL BIOL, V10, P491, DOI 10.1038/ncb1713; Shuai K, 1996, MOL CELL BIOL, V16, P4932; Singh P, 2010, MOL CELL BIOL, V30, P2693, DOI 10.1128/MCB.01537-09; Slany RK, 2009, HAEMATOL-HEMATOL J, V94, P984, DOI 10.3324/haematol.2008.002436; Steger DJ, 2008, MOL CELL BIOL, V28, P2825, DOI 10.1128/MCB.02076-07; Vakoc CR, 2006, MOL CELL BIOL, V26, P9185, DOI 10.1128/MCB.01529-06; van Leeuwen F, 2002, CELL, V109, P745, DOI 10.1016/S0092-8674(02)00759-6; Weake VM, 2008, MOL CELL, V29, P653, DOI 10.1016/j.molcel.2008.02.014; Yu ZY, 2010, AM J PHYSIOL-RENAL, V298, pF617, DOI 10.1152/ajprenal.00636.2009; Zhang JJ, 1996, P NATL ACAD SCI USA, V93, P15092, DOI 10.1073/pnas.93.26.15092; Zhang WZ, 2006, J BIOL CHEM, V281, P18059, DOI 10.1074/jbc.M601903200	55	5	6	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41195	41204		10.1074/jbc.M111.284190	http://dx.doi.org/10.1074/jbc.M111.284190			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	22002246	Green Published, hybrid			2022-12-27	WOS:000298057500008
J	Woo, MG; Xue, K; Liu, JY; McBride, H; Tsang, BK				Woo, Michael G.; Xue, Kai; Liu, Jiayin; McBride, Heidi; Tsang, Benjamin K.			Calpain-mediated Processing of p53-associated Parkin-like Cytoplasmic Protein (PARC) Affects Chemosensitivity of Human Ovarian Cancer Cells by Promoting p53 Subcellular Trafficking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CISPLATIN-INDUCED APOPTOSIS; X-LINKED INHIBITOR; TUMOR-SUPPRESSOR; DOWN-REGULATION; ACTIVATION; CLEAVAGE; AKT; BAX; PHOSPHORYLATION; EXPRESSION	Resistance to cisplatin (CDDP)-based therapy is a major hurdle to the successful treatment of human ovarian cancer (OVCA), and the chemoresistant phenotype in OVCA cells is associated with Akt-attenuated p53-mediated apoptosis. Proapoptotic functions of p53 involve both transcription-dependent and -independent signaling pathways, and dysfunctional localization and/or inactivation of p53 contribute to the development of chemoresistance. PARC is a cytoplasmic protein regulating p53 subcellular localization and subsequent function. Little is known about the molecular mechanisms regulating PARC. Although PARC contains putative caspase-3 cleavage sites, and CDDP is known to induce the activation of caspases and calpains and induce proteasomal degradation of anti-apoptotic proteins, if and how PARC is regulated by CDDP in OVCA are unknown. Here, we present evidence that CDDP promotes calpain-mediated PARC down-regulation, mitochondrial and nuclear p53 accumulation, and apoptosis in chemosensitive but not resistant OVCA cells. Inhibition of Akt is required to sensitize chemoresistant cells to CDDP in a p53-dependent manner, an effect enhanced by PARC down-regulation. CDDP-induced PARC down-regulation is reversible by inhibition of calpain but not of caspases or the 26 S proteasome. Furthermore, in vitro experiments confirm the ability of calpain in mediating Ca2+-dependent PARC down-regulation. The role Ca2+ in PARC down-regulation was further confirmed as ionomycin-induced PARC down-regulation in both chemosensitive and chemoresistant ovarian cancer cells. The data presented here implicate the regulation of p53 subcellular localization and apoptosis by PARC as a contributing factor in CDDP resistance in OVCA cells and Ca2+/calpain in PARC post-translational processing and chemosensitivity.	[Woo, Michael G.; Xue, Kai; Tsang, Benjamin K.] Ottawa Hosp Res Inst, Chron Dis Program, Ottawa, ON K1Y 4E9, Canada; [Woo, Michael G.; Xue, Kai; Tsang, Benjamin K.] Univ Ottawa, Reprod Biol Unit, Ottawa, ON K1Y 4E9, Canada; [Woo, Michael G.; Xue, Kai; Tsang, Benjamin K.] Univ Ottawa, Div Gynecol Oncol, Dept Obstet & Gynecol, Ottawa, ON K1Y 4E9, Canada; [Woo, Michael G.; McBride, Heidi; Tsang, Benjamin K.] Univ Ottawa, Div Gynecol Oncol, Dept Cellular & Mol Med, Ottawa, ON K1Y 4E9, Canada; [Xue, Kai; Liu, Jiayin] Nanjing Med Univ, Affiliated Hosp 1, State Key Lab Reprod Med, Nanjing 210029, Jiangsu, Peoples R China; [Xue, Kai; Liu, Jiayin] Nanjing Med Univ, Affiliated Hosp 1, Ctr Clin Reprod Med, Nanjing 210029, Jiangsu, Peoples R China; [Tsang, Benjamin K.] Seoul Natl Univ, World Class Univ Biomodulat Major, Dept Agr Biotechnol, Coll Agr & Life Sci, Seoul 151921, South Korea	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa; University of Ottawa; Nanjing Medical University; Nanjing Medical University; Seoul National University (SNU)	Tsang, BK (corresponding author), Ottawa Hosp Res Inst, Chron Dis Program, 725 Parkdale Ave, Ottawa, ON K1Y 4E9, Canada.	btsang@ohri.ca	McBride, Heidi M./ABD-5774-2021	McBride, Heidi M./0000-0003-4666-2280; Tsang, Benjamin K./0000-0003-1213-3946	Canadian Institute of Health Research [MOP-15691]; World Class University; National Research Foundation of Korea; Ministry of Education, Science and Technology [R31-10056]	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); World Class University; National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported in part by Canadian Institute of Health Research Grant MOP-15691 and World Class University Program, National Research Foundation of Korea, supported by Ministry of Education, Science and Technology Grant R31-10056.	AAGAARDTILLERY KM, 1995, J IMMUNOL, V155, P3297; Al-Bahlani S, 2011, ONCOGENE, V30, P4219, DOI 10.1038/onc.2011.134; ANDREWS PA, 1992, CANCER RES, V52, P1895; Asselin E, 2001, CANCER RES, V61, P1862; Astanehe A, 2008, J CELL SCI, V121, P664, DOI 10.1242/jcs.013029; BAST RC, 1974, NEW ENGL J MED, V290, P1413, DOI 10.1056/NEJM197406202902506; BAST RC, 1974, NEW ENGL J MED, V290, P1458, DOI 10.1056/NEJM197406272902605; Boname JM, 2010, TRAFFIC, V11, P210, DOI 10.1111/j.1600-0854.2009.01011.x; BUICK RN, 1985, CANCER RES, V45, P3668; Dan HC, 2004, J BIOL CHEM, V279, P5405, DOI 10.1074/jbc.M312044200; DISAIA PJ, 1972, AM J OBSTET GYNECOL, V114, P979, DOI 10.1016/0002-9378(72)90109-3; Erster S, 2004, MOL CELL BIOL, V24, P6728, DOI 10.1128/MCB.24.15.6728-6741.2004; Fraser M, 2003, CANCER RES, V63, P7081; Fraser M, 2008, INT J CANCER, V122, P534, DOI 10.1002/ijc.23086; Grusch M, 2002, CELL DEATH DIFFER, V9, P169, DOI 10.1038/sj.cdd.4400937; HAVRILESKY LJ, 1995, OBSTET GYNECOL, V85, P1007, DOI 10.1016/0029-7844(95)00058-Y; Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; Hochstrasser M, 2000, NAT CELL BIOL, V2, pE153, DOI 10.1038/35019643; Hoeller D, 2006, NAT REV CANCER, V6, P776, DOI 10.1038/nrc1994; Hu LM, 2002, CANCER RES, V62, P1087; Jang JS, 1999, ONCOGENE, V18, P1789, DOI 10.1038/sj.onc.1202497; Kmet LM, 2003, CANCER, V97, P389, DOI 10.1002/cncr.11064; Kubbutat MHG, 1997, MOL CELL BIOL, V17, P460, DOI 10.1128/MCB.17.1.460; Liu L, 2008, INT J CANCER, V122, P2210, DOI 10.1002/ijc.23378; Liu L, 2009, INT J CANCER, V125, P2757, DOI 10.1002/ijc.24626; Mandic A, 2002, MOL CELL BIOL, V22, P3003, DOI 10.1128/MCB.22.9.3003-3013.2002; Marchenko ND, 2007, EMBO J, V26, P923, DOI 10.1038/sj.emboj.7601560; Marchenko ND, 2000, J BIOL CHEM, V275, P16202, DOI 10.1074/jbc.275.21.16202; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; MIYASHITA T, 1995, CELL, V80, P293; MOLL UM, 1995, P NATL ACAD SCI USA, V92, P4407, DOI 10.1073/pnas.92.10.4407; MOLTHOFF CFM, 1991, INT J CANCER, V47, P72, DOI 10.1002/ijc.2910470114; Mulhall JP, 2010, BJU INT, V106, P1706, DOI 10.1111/j.1464-410X.2010.09754.x; Mullen P, 2004, METH MOLEC MED, V88, P171; Nikolaev AY, 2003, CELL, V112, P29, DOI 10.1016/S0092-8674(02)01255-2; Pei XH, 2011, CANCER RES, V71, P2969, DOI 10.1158/0008-5472.CAN-10-4300; Sasaki H, 2000, CANCER RES, V60, P5659; Sato K, 2004, J BIOCHEM, V136, P777, DOI 10.1093/jb/mvh187; Schafer DP, 2009, J NEUROSCI, V29, P13242, DOI 10.1523/JNEUROSCI.3376-09.2009; Shaw TJ, 2004, MOL THER, V10, P1032, DOI 10.1016/j.ymthe.2004.08.013; Shayesteh L, 1999, NAT GENET, V21, P99, DOI 10.1038/5042; SIMAN R, 1984, P NATL ACAD SCI-BIOL, V81, P3572, DOI 10.1073/pnas.81.11.3572; Skaar JR, 2007, CANCER RES, V67, P2006, DOI 10.1158/0008-5472.CAN-06-3241; Skaar JR, 2005, MOL CELL BIOL, V25, P5579, DOI 10.1128/mcb.25.13.5579-5589.2005; Smith IJ, 2007, EXP PHYSIOL, V92, P561, DOI 10.1113/expphysiol.2006.035790; Splettstoesser F, 2007, BRIT J PHARMACOL, V151, P1176, DOI 10.1038/sj.bjp.0707335; Takamure M, 2005, MUSCLE NERVE, V32, P303, DOI 10.1002/mus.20362; Tan YF, 2006, J BIOL CHEM, V281, P16016, DOI 10.1074/jbc.M601299200; Unger T, 1999, ONCOGENE, V18, P3205, DOI 10.1038/sj.onc.1202656; Vitali R, 2008, BIOCHEM BIOPH RES CO, V368, P350, DOI 10.1016/j.bbrc.2008.01.093; Wolf JK, 1999, GYNECOL ONCOL, V75, P261, DOI 10.1006/gyno.1999.5565; Wood DE, 1998, ONCOGENE, V17, P1069, DOI 10.1038/sj.onc.1202034; Xirodimas DP, 2004, CELL, V118, P83, DOI 10.1016/j.cell.2004.06.016; Xu GX, 2006, MOL CANCER RES, V4, P235, DOI 10.1158/1541-7786.MCR-05-0174; Yan XJ, 2006, GYNECOL ONCOL, V102, P348, DOI 10.1016/j.ygyno.2005.12.033; Yang L, 2004, CANCER RES, V64, P4394, DOI 10.1158/0008-5472.CAN-04-0343; Yang XK, 2006, CANCER RES, V66, P3126, DOI 10.1158/0008-5472.CAN-05-0425; Yuan ZQ, 2003, J BIOL CHEM, V278, P23432, DOI 10.1074/jbc.M302674200	58	35	39	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					3963	3975		10.1074/jbc.M111.314765	http://dx.doi.org/10.1074/jbc.M111.314765			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22117079	Green Published, hybrid			2022-12-27	WOS:000300410900031
J	Sasser, T; Qiu, QS; Karunakaran, S; Padolina, M; Reyes, A; Flood, B; Smith, S; Gonzales, C; Fratti, RA				Sasser, Terry; Qiu, Quan-Sheng; Karunakaran, Surya; Padolina, Mark; Reyes, Anna; Flood, Blake; Smith, Sheena; Gonzales, Chad; Fratti, Rutilio A.			Yeast Lipin 1 Orthologue Pah1p Regulates Vacuole Homeostasis and Membrane Fusion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VERTEX RING DOMAIN; SACCHAROMYCES-CEREVISIAE; PHOSPHATIDATE PHOSPHATASE; SNARE COMPLEX; GTPASE YPT7P; DOCKING; HOMOLOG; PROTEIN; DIACYLGLYCEROL; HOPS	Vacuole homotypic fusion requires a group of regulatory lipids that includes diacylglycerol, a fusogenic lipid that is produced through multiple metabolic pathways including the dephosphorylation of phosphatidic acid (PA). Here we examined the relationship between membrane fusion and PA phosphatase activity. Pah1p is the single yeast homologue of the Lipin family of PA phosphatases. Deletion of PAH1 was sufficient to cause marked vacuole fragmentation and abolish vacuole fusion. The function of Pah1p solely depended on its phosphatase activity as complementation studies showed that wild type Pah1p restored fusion, whereas the phosphatase dead mutant Pah1p(D398E) had no effect. We discovered that the lack of PA phosphatase activity blocked fusion by inhibiting the binding of SNAREs to Sec18p, an N-ethylmaleimide-sensitive factor homologue responsible for priming inactive cis-SNARE complexes. In addition, pah1 Delta vacuoles were devoid of the late endosome/vacuolar Rab Ypt7p, the phosphatidylinositol 3-kinase Vps34p, and Vps39p, a subunit of the HOPS (homotypic fusion and vacuole protein sorting) tethering complex, all of which are required for vacuole fusion. The lack of Vps34p resulted in the absence of phosphatidylinositol 3-phosphate, a lipid required for SNARE activity and vacuole fusion. These findings demonstrate that Pah1p and PA phosphatase activity are critical for vacuole homeostasis and fusion.	[Sasser, Terry; Qiu, Quan-Sheng; Karunakaran, Surya; Padolina, Mark; Reyes, Anna; Flood, Blake; Smith, Sheena; Gonzales, Chad; Fratti, Rutilio A.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Fratti, RA (corresponding author), Univ Illinois, Dept Biochem, 419 Roger Adams Lab,B-4,600 S Mathews Ave, Urbana, IL 61801 USA.	rfratti@illinois.edu	Smith, Sheena N./AAB-8850-2019	Smith, Sheena N./0000-0002-2162-7107	March of Dimes Birth Defects Foundation [5-FY09-117]; University of Illinois at Urbana-Champaign; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101132] Funding Source: NIH RePORTER	March of Dimes Birth Defects Foundation(March of Dimes); University of Illinois at Urbana-Champaign; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by March of Dimes Birth Defects Foundation Basil O'Connor Starter Scholar Research Award Grant 5-FY09-117 (to R.A.F.) and startup funds provided by the University of Illinois at Urbana-Champaign (to R.A.F.).	Adeyo O, 2011, J CELL BIOL, V192, P1043, DOI 10.1083/jcb.201010111; Asp L, 2009, MOL BIOL CELL, V20, P780, DOI 10.1091/mbc.E08-03-0256; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Boeddinghaus C, 2002, J CELL BIOL, V157, P79, DOI 10.1083/jcb.200112098; Carman GM, 2009, J BIOL CHEM, V284, P2593, DOI 10.1074/jbc.R800059200; Choi HS, 2011, J BIOL CHEM, V286, P1486, DOI 10.1074/jbc.M110.155598; Choi SY, 2006, NAT CELL BIOL, V8, P1255, DOI 10.1038/ncb1487; Collins KM, 2007, P NATL ACAD SCI USA, V104, P8755, DOI 10.1073/pnas.0702290104; Collins KM, 2005, EMBO J, V24, P1775, DOI 10.1038/sj.emboj.7600658; Coluccio A, 2004, GENETICS, V166, P89, DOI 10.1534/genetics.166.1.89; Eitzen G, 2001, EMBO J, V20, P5650, DOI 10.1093/emboj/20.20.5650; Fernandez-Ulibarri I, 2007, MOL BIOL CELL, V18, P3250, DOI 10.1091/mbc.E07-04-0334; Fratti RA, 2004, J CELL BIOL, V167, P1087, DOI 10.1083/jcb.200409068; Fratti RA, 2007, J BIOL CHEM, V282, P14861, DOI 10.1074/jbc.M700971200; Fratti RA, 2007, J BIOL CHEM, V282, P13133, DOI 10.1074/jbc.M700584200; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; HAAS A, 1994, J CELL BIOL, V126, P87, DOI 10.1083/jcb.126.1.87; HAAS A, 1995, EMBO J, V14, P5258, DOI 10.1002/j.1460-2075.1995.tb00210.x; Han GS, 2007, J BIOL CHEM, V282, P37026, DOI 10.1074/jbc.M705777200; Han GS, 2010, J BIOL CHEM, V285, P14628, DOI 10.1074/jbc.M110.117747; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; Han GS, 2001, J BIOL CHEM, V276, P10126, DOI 10.1074/jbc.M011421200; Humeau Y, 2001, P NATL ACAD SCI USA, V98, P15300, DOI 10.1073/pnas.261358698; Jahn R, 1999, ANNU REV BIOCHEM, V68, P863, DOI 10.1146/annurev.biochem.68.1.863; JONES EW, 1982, GENETICS, V102, P665; Jun Y, 2004, J BIOL CHEM, V279, P53186, DOI 10.1074/jbc.M411363200; Jun Y, 2007, P NATL ACAD SCI USA, V104, P13010, DOI 10.1073/pnas.0700970104; Jun Y, 2006, EMBO J, V25, P5260, DOI 10.1038/sj.emboj.7601413; Karanasios E, 2010, P NATL ACAD SCI USA, V107, P17539, DOI 10.1073/pnas.1007974107; Kato M, 2001, EMBO J, V20, P4035, DOI 10.1093/emboj/20.15.4035; Kihara A, 2001, J CELL BIOL, V152, P519, DOI 10.1083/jcb.152.3.519; Kinchen JM, 2010, NATURE, V464, P778, DOI 10.1038/nature08853; Koulov AV, 2003, CELL DEATH DIFFER, V10, P1357, DOI 10.1038/sj.cdd.4401315; Liu S, 2007, TRAFFIC, V8, P1630, DOI 10.1111/j.1600-0854.2007.00628.x; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Loos RJF, 2007, OBESITY, V15, P2723, DOI 10.1038/oby.2007.324; Manifava M, 2001, J BIOL CHEM, V276, P8987, DOI 10.1074/jbc.M010308200; Mayer A, 2000, MOL BIOL CELL, V11, P807, DOI 10.1091/mbc.11.3.807; Mayer A, 1997, J CELL BIOL, V136, P307, DOI 10.1083/jcb.136.2.307; Mayer A, 1996, CELL, V85, P83, DOI 10.1016/S0092-8674(00)81084-3; Merz AJ, 2004, J CELL BIOL, V164, P195, DOI 10.1083/jcb.200310105; Mima J, 2009, J BIOL CHEM, V284, P27114, DOI 10.1074/jbc.M109.010223; Mizogami M, 2010, EUR J ANAESTH, V27, P829, DOI 10.1097/EJA.0b013e32833bf5e4; MORLOCK KR, 1991, J BIOL CHEM, V266, P3586; Nichols BJ, 1997, NATURE, V387, P199, DOI 10.1038/387199a0; Nielsen E, 1999, NAT CELL BIOL, V1, P376, DOI 10.1038/14075; Nordmann M, 2010, CURR BIOL, V20, P1654, DOI 10.1016/j.cub.2010.08.002; O'Hara L, 2006, J BIOL CHEM, V281, P34537, DOI 10.1074/jbc.M606654200; PAPPU AS, 1983, NEUROCHEM RES, V8, P1565, DOI 10.1007/BF00964158; Peplowska K, 2007, DEV CELL, V12, P739, DOI 10.1016/j.devcel.2007.03.006; Peterfy M, 2001, NAT GENET, V27, P121, DOI 10.1038/83685; Phan J, 2005, CELL METAB, V1, P73, DOI 10.1016/j.cmet.2004.12.002; Poteryaev D, 2010, CELL, V141, P497, DOI 10.1016/j.cell.2010.03.011; Qiu QS, 2010, J CELL SCI, V123, P3266, DOI 10.1242/jcs.067637; Reese C, 2005, NATURE, V436, P410, DOI 10.1038/nature03722; Reese C, 2005, J CELL BIOL, V171, P981, DOI 10.1083/jcb.200510018; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Rivera-Molina FE, 2009, P NATL ACAD SCI USA, V106, P14408, DOI 10.1073/pnas.0906536106; Santos-Rosa H, 2005, EMBO J, V24, P1931, DOI 10.1038/sj.emboj.7600672; Seals DF, 2000, P NATL ACAD SCI USA, V97, P9402, DOI 10.1073/pnas.97.17.9402; Slessareva JE, 2006, SCIENCE, V314, P1412, DOI 10.1126/science.1134041; Starai VJ, 2007, P NATL ACAD SCI USA, V104, P13551, DOI 10.1073/pnas.0704741104; Stein A, 2009, NATURE, V460, P525, DOI 10.1038/nature08156; Stroupe C, 2006, EMBO J, V25, P1579, DOI 10.1038/sj.emboj.7601051; Suviolahti E, 2006, HUM MOL GENET, V15, P377, DOI 10.1093/hmg/ddi448; Thorngren N, 2004, EMBO J, V23, P2765, DOI 10.1038/sj.emboj.7600286; Toke DA, 1998, J BIOL CHEM, V273, P14331, DOI 10.1074/jbc.273.23.14331; Torres MP, 2009, J BIOL CHEM, V284, P8931, DOI 10.1074/jbc.M809058200; Trotter PJ, 2000, TRAFFIC, V1, P425, DOI 10.1034/j.1600-0854.2000.010507.x; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; Ungermann C, 1998, NATURE, V396, P543, DOI 10.1038/25069; Wang L, 2003, J CELL BIOL, V160, P365, DOI 10.1083/jcb.200209095; Wang L, 2002, CELL, V108, P357, DOI 10.1016/S0092-8674(02)00632-3; Wurmser AE, 2000, J CELL BIOL, V151, P551, DOI 10.1083/jcb.151.3.551; Xu H, 2010, J BIOL CHEM, V285, P39359, DOI 10.1074/jbc.M110.183111; Xu H, 2010, EMBO J, V29, P1948, DOI 10.1038/emboj.2010.97	77	64	69	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2012	287	3					2221	2236		10.1074/jbc.M111.317420	http://dx.doi.org/10.1074/jbc.M111.317420			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879HT	22121197	Green Published, hybrid			2022-12-27	WOS:000299321000060
J	Dong, GF; Callegari, EA; Gloeckner, CJ; Ueffing, M; Wang, HM				Dong, Gaofeng; Callegari, Eduardo A.; Gloeckner, Christian J.; Ueffing, Marius; Wang, Hongmin			Prothymosin-alpha Interacts with Mutant Huntingtin and Suppresses Its Cytotoxicity in Cell Culture	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CREB-BINDING PROTEIN; NEURONAL DEATH; DISEASE; TOXICITY; NECROSIS; TRANSCRIPTION; CONFORMATION; PATHOGENESIS; AGGREGATION; UBIQUILIN	Huntington disease (HD), a fatal neurodegenerative disorder, is caused by a lengthening of the polyglutamine tract in the huntingtin (Htt) protein. Despite considerable effort, thus far there is no cure or treatment available for the disorder. Using the approach of tandem affinity purification we recently discovered that prothymosin-alpha (ProT alpha), a small highly acidic protein, interacts with mutant Htt (mHtt). This was confirmed by co-immunoprecipitation and a glutathione S-transferase (GST) pull-down assay. Overexpression of ProT alpha remarkably reduced mHtt-induced cytotoxicity in both non-neuronal and neuronal cell models expressing N-terminal mHtt fragments, whereas knockdown of ProT alpha expression in the cells enhanced mHtt-caused cell death. Deletion of the central acidic domain of ProT alpha abolished not only its interaction with mHtt but also its protective effect on mHtt-caused cytotoxicity. Additionally, overexpression of ProT alpha inhibited caspase-3 activation but enhanced aggregation of mHtt. Furthermore, when added to cultured cells expressing mHtt, the purified recombinant ProT alpha protein not only entered the cells but it also significantly suppressed the mHtt-caused cytotoxicity. Taken together, these data suggest that ProT alpha might be a novel therapeutic target for treating HD and other polyglutamine expansion disorders.	[Dong, Gaofeng; Callegari, Eduardo A.; Wang, Hongmin] Univ S Dakota, Div Basic Biomed Sci, Sanford Sch Med, Vermillion, SD 57069 USA; [Gloeckner, Christian J.; Ueffing, Marius] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Res Unit Prot Sci, D-85764 Neuherberg, Germany; [Gloeckner, Christian J.; Ueffing, Marius] Univ Tubingen, Inst Ophthalm Res, Med Proteome Ctr, D-72076 Tubingen, Germany	University of South Dakota; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Wang, HM (corresponding author), Univ S Dakota, Div Basic Biomed Sci, Sanford Sch Med, 414 E Clark St, Vermillion, SD 57069 USA.	Hongmin.Wang@usd.edu	Gloeckner, Christian Johannes/R-5374-2019	Gloeckner, Christian Johannes/0000-0001-6494-6944	Sanford School of Medicine, University of South Dakota; South Dakota Board of Regents; University of South Dakota; NIH [P20 RR 015567]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015567] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103443] Funding Source: NIH RePORTER	Sanford School of Medicine, University of South Dakota; South Dakota Board of Regents; University of South Dakota; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Start-up Funds from the Sanford School of Medicine, University of South Dakota (to H. W.), a Competitive Research Grant Award of the South Dakota Board of Regents (to H. W.), and a New Faculty Development Award of the University of South Dakota (to H. W.).; We thank Dr. Robin Miskimins for critical reading of the manuscript; Drs. Marian DiFiglia, Shihua Li, and Xiao-Jiang Li for providing huntingtin constructs; Dr. Mervyn J. Monteiro for providing the stable cell lines expressing GFP-tagged Htt-exon-1; Justine Ferguson and Dr. Dong Zhang for assistance in cell death analysis; Dr. Khosrow Rezvani for assistance in measuring pixel density of Western blot bands; and Drs. Joyce Keifer and Fran Day at the South Dakota Imaging Core Facility (supported by NIH P20 RR 015567, which is designated as a Center of Biomedical Research Excellence [COBRE] to Dr. Joyce Keifer) for help in fluorescence microscopy.	Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Atwal RS, 2007, HUM MOL GENET, V16, P2600, DOI 10.1093/hmg/ddm217; BATES G, 2002, HUNTINGTONS DIS; Covelo G, 2006, J BIOCHEM, V140, P627, DOI 10.1093/jb/mvj197; Dong G, 2011, CELL MOL NEUROBIOL, V31, P737, DOI 10.1007/s10571-011-9679-0; Fujita R, 2007, CELL DEATH DIFFER, V14, P1839, DOI 10.1038/sj.cdd.4402189; Fujita R, 2009, CELL DEATH DIFFER, V16, P349, DOI 10.1038/cdd.2008.159; Gloeckner Christian Johannes, 2009, Methods Mol Biol, V564, P359, DOI 10.1007/978-1-60761-157-8_21; Hannappel E, 2003, VITAM HORM, V66, P257, DOI 10.1016/S0083-6729(03)01007-0; Harjes P, 2003, TRENDS BIOCHEM SCI, V28, P425, DOI 10.1016/S0968-0004(03)00168-3; Jiang XJ, 2003, SCIENCE, V299, P223, DOI 10.1126/science.1076807; Kaltenbach LS, 2007, PLOS GENET, V3, P689, DOI 10.1371/journal.pgen.0030082; Karetsou Z, 2002, EMBO REP, V3, P361, DOI 10.1093/embo-reports/kvf071; Letsas KP, 2006, NEOPLASMA, V53, P92; Li SH, 2004, TRENDS GENET, V20, P146, DOI 10.1016/j.tig.2004.01.008; Lombardi MS, 2009, EXP NEUROL, V217, P312, DOI 10.1016/j.expneurol.2009.03.004; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Matsunaga H, 2010, CELL DEATH DIFFER, V17, P1760, DOI 10.1038/cdd.2010.52; Mosoian A, 2006, J VIROL, V80, P9200, DOI 10.1128/JVI.00589-06; Orr AL, 2008, J NEUROSCI, V28, P2783, DOI 10.1523/JNEUROSCI.0106-08.2008; Pineiro A, 2000, PEPTIDES, V21, P1433, DOI 10.1016/S0196-9781(00)00288-6; Ratovitski T, 2009, J BIOL CHEM, V284, P10855, DOI 10.1074/jbc.M804813200; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Ross CA, 2011, LANCET NEUROL, V10, P83, DOI 10.1016/S1474-4422(10)70245-3; Sawa A, 2005, NEUROBIOL DIS, V20, P267, DOI 10.1016/j.nbd.2005.02.013; Steffan JS, 2000, P NATL ACAD SCI USA, V97, P6763, DOI 10.1073/pnas.100110097; Sukhacheva EA, 2002, J IMMUNOL METHODS, V266, P185, DOI 10.1016/S0022-1759(02)00098-4; Ueda H, 2007, J CELL BIOL, V176, P853, DOI 10.1083/jcb.200608022; Vonsattel JPG, 1998, J NEUROPATH EXP NEUR, V57, P369; Wang H, 2006, HUM MOL GENET, V15, P1025, DOI 10.1093/hmg/ddl017; Wang HM, 2004, J NEUROSCI, V24, P10963, DOI 10.1523/JNEUROSCI.3461-04.2004; Wang HM, 2007, BIOCHEM BIOPH RES CO, V360, P423, DOI 10.1016/j.bbrc.2007.06.097; Wang Y, 2007, PRION, V1, P128, DOI 10.4161/pri.1.2.4440	33	23	23	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					1279	1289		10.1074/jbc.M111.294280	http://dx.doi.org/10.1074/jbc.M111.294280			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22110140	Green Published, hybrid			2022-12-27	WOS:000299170300044
J	Latypov, RF; Hogan, S; Lau, H; Gadgil, H; Liu, DJ				Latypov, Ramil F.; Hogan, Sabine; Lau, Hollis; Gadgil, Himanshu; Liu, Dingjiang			Elucidation of Acid-induced Unfolding and Aggregation of Human Immunoglobulin IgG1 and IgG2 Fc	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALTERNATIVELY FOLDED STATE; THERAPEUTIC ANTIBODIES; MONOCLONAL-ANTIBODIES; GLOBULAR-PROTEINS; MOLTEN-GLOBULE; STABILITY; DOMAIN; MECHANISM; NMR; CLASSIFICATION	Understanding the underlying mechanisms of Fc aggregation is an important prerequisite for developing stable and efficacious antibody-based therapeutics. In our study, high resolution two-dimensional nuclear magnetic resonance (NMR) was employed to probe structural changes in the IgG1 Fc. A series of H-1-N-15 heteronuclear single-quantum correlation NMR spectra were collected between pH 2.5 and 4.7 to assess whether unfolding of C(H)2 domains precedes that of C(H)3 domains. The same pH range was subsequently screened in Fc aggregation experiments that utilized molecules of IgG1 and IgG2 subclasses with varying levels of C(H)2 glycosylation. In addition, differential scanning calorimetry data were collected over a pH range of 3-7 to assess changes in C(H)2 and C(H)3 thermostability. As a result, compelling evidence was gathered that emphasizes the importance of C(H)2 stability in determining the rate and extent of Fc aggregation. In particular, we found that Fc domains of the IgG1 subclass have a lower propensity to aggregate compared with those of the IgG2 subclass. Our data for glycosylated, partially deglycosylated, and fully deglycosylated molecules further revealed the criticality of CH2 glycans in modulating Fc aggregation. These findings provide important insights into the stability of Fc-based therapeutics and promote better understanding of their acid-induced aggregation process.	[Latypov, Ramil F.; Hogan, Sabine; Lau, Hollis; Gadgil, Himanshu] Amgen Inc, Drug Prod Dev, Seattle, WA 98119 USA; [Liu, Dingjiang] Amgen Inc, Drug Prod Dev, Thousand Oaks, CA 91320 USA	Amgen; Amgen	Latypov, RF (corresponding author), Amgen Inc, Drug Prod Dev, 1201 Amgen Ct W, Seattle, WA 98119 USA.	rlatypov@amgen.com						Beck A, 2010, NAT REV IMMUNOL, V10, P345, DOI 10.1038/nri2747; Beck A, 2008, CURR PHARM BIOTECHNO, V9, P482, DOI 10.2174/138920108786786411; BUCHNER J, 1991, BIOCHEMISTRY-US, V30, P6922, DOI 10.1021/bi00242a016; Carter PJ, 2006, NAT REV IMMUNOL, V6, P343, DOI 10.1038/nri1837; Chames P, 2009, BRIT J PHARMACOL, V157, P220, DOI 10.1111/j.1476-5381.2009.00190.x; Chen S, 2010, PROTEIN SCI, V19, P1191, DOI 10.1002/pro.396; Chen XY, 2009, GLYCOBIOLOGY, V19, P240, DOI 10.1093/glycob/cwn120; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; EDELMAN GM, 1969, P NATL ACAD SCI USA, V63, P78, DOI 10.1073/pnas.63.1.78; Ejima D, 2007, PROTEINS, V66, P954, DOI 10.1002/prot.21243; Fahrner R L, 2001, Biotechnol Genet Eng Rev, V18, P301; Feige MJ, 2004, J MOL BIOL, V344, P107, DOI 10.1016/j.jmb.2004.09.033; FINK AL, 1994, BIOCHEMISTRY-US, V33, P12504, DOI 10.1021/bi00207a018; Garrett DS, 1997, BIOCHEMISTRY-US, V36, P4393, DOI 10.1021/bi970221q; GOTO Y, 1990, BIOCHEMISTRY-US, V29, P3480, DOI 10.1021/bi00466a009; GOTO Y, 1990, P NATL ACAD SCI USA, V87, P573, DOI 10.1073/pnas.87.2.573; GOTO Y, 1990, J MOL BIOL, V214, P803, DOI 10.1016/0022-2836(90)90334-I; Hari SB, 2010, BIOCHEMISTRY-US, V49, P9328, DOI 10.1021/bi100841u; Harris RJ, 2001, J CHROMATOGR B, V752, P233, DOI 10.1016/S0378-4347(00)00548-X; Huang CC, 2009, CURR OPIN BIOTECH, V20, P692, DOI 10.1016/j.copbio.2009.10.010; JENG MF, 1990, BIOCHEMISTRY-US, V29, P10433, DOI 10.1021/bi00498a001; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Joubert MK, 2011, J BIOL CHEM, V286, P25118, DOI 10.1074/jbc.M110.160457; Kayser V, 2011, BIOTECHNOL J, V6, P38, DOI 10.1002/biot.201000091; Kiese S, 2008, J PHARM SCI-US, V97, P4347, DOI 10.1002/jps.21328; Koren E., 2002, Current Pharmaceutical Biotechnology, V3, P349, DOI 10.2174/1389201023378175; Lau H, 2010, J CHROMATOGR B, V878, P868, DOI 10.1016/j.jchromb.2010.02.003; LILIE H, 1995, FEBS LETT, V362, P43, DOI 10.1016/0014-5793(95)00203-L; Liu D, 2007, BIOMOL NMR ASSIGN, V1, P233, DOI 10.1007/s12104-007-9065-5; Liu D, 2008, BIOCHEMISTRY-US, V47, P5088, DOI 10.1021/bi702238b; Low D, 2007, J CHROMATOGR B, V848, P48, DOI 10.1016/j.jchromb.2006.10.033; Manning MC, 2010, PHARM RES-DORDR, V27, P544, DOI 10.1007/s11095-009-0045-6; Nakamura S, 2011, BIOCHEMISTRY-US, V50, P3116, DOI 10.1021/bi101806b; OHGUSHI M, 1983, FEBS LETT, V164, P21, DOI 10.1016/0014-5793(83)80010-6; Ptitsyn OB, 1995, ADV PROTEIN CHEM, V47, P83, DOI 10.1016/S0065-3233(08)60546-X; Rathore AS, 2009, TRENDS BIOTECHNOL, V27, P546, DOI 10.1016/j.tibtech.2009.06.006; Rosenberg AS, 2006, AAPS J, V8, pE501, DOI 10.1208/aapsj080359; Saphire EO, 2001, SCIENCE, V293, P1155, DOI 10.1126/science.1061692; Stackhouse N, 2011, J PHARM SCI-US, V100, P5115, DOI 10.1002/jps.22710; Strohl WR, 2009, CURR OPIN BIOTECH, V20, P685, DOI 10.1016/j.copbio.2009.10.011; TAO MH, 1989, J IMMUNOL, V143, P2595; Thies MJW, 2001, J MOL BIOL, V309, P1077, DOI 10.1006/jmbi.2001.4707; TISCHENKO VM, 1982, EUR J BIOCHEM, V126, P517, DOI 10.1111/j.1432-1033.1982.tb06811.x; Uversky VN, 1998, J MOL BIOL, V278, P879, DOI 10.1006/jmbi.1998.1741; Uversky VN, 1998, P NATL ACAD SCI USA, V95, P5480, DOI 10.1073/pnas.95.10.5480; Vermeer AWP, 2000, BIOPHYS J, V78, P394, DOI 10.1016/S0006-3495(00)76602-1; Wang W, 2005, INT J PHARMACEUT, V289, P1, DOI 10.1016/j.ijpharm.2004.11.014; Wang XL, 2009, MABS-AUSTIN, V1, P254, DOI 10.4161/mabs.1.3.8035; WISHART DS, 1991, J MOL BIOL, V222, P311, DOI 10.1016/0022-2836(91)90214-Q; Wright A, 1997, TRENDS BIOTECHNOL, V15, P26, DOI 10.1016/S0167-7799(96)10062-7; Yamaguchi Y, 2006, BBA-GEN SUBJECTS, V1760, P693, DOI 10.1016/j.bbagen.2005.10.002	52	116	127	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					1381	1396		10.1074/jbc.M111.297697	http://dx.doi.org/10.1074/jbc.M111.297697			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22084250	Green Published, hybrid			2022-12-27	WOS:000299170300052
J	Palazuelos, J; Ortega, Z; Diaz-Alonso, J; Guzman, M; Galve-Roperh, I				Palazuelos, Javier; Ortega, Zaira; Diaz-Alonso, Javier; Guzman, Manuel; Galve-Roperh, Ismael			CB2 Cannabinoid Receptors Promote Neural Progenitor Cell Proliferation via mTORC1 Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TEMPORAL-LOBE EPILEPSY; ENDOCANNABINOID SYSTEM; MAMMALIAN TARGET; SYNAPTIC PLASTICITY; SUBVENTRICULAR ZONE; POSTNATAL BRAIN; ADULT BRAIN; NEUROGENESIS; EXPRESSION; MIGRATION	The endocannabinoid system is known to regulate neural progenitor (NP) cell proliferation and neurogenesis. In particular, CB2 cannabinoid receptors have been shown to promote NP proliferation. As CB2 receptors are not expressed in differentiated neurons, CB2-selective agonists are promising candidates to manipulate NP proliferation and indirectly neurogenesis by overcoming the undesired psychoactive effects of neuronal CB1 cannabinoid receptor activation. Here, by using NP cells, brain organotypic cultures, and in vivo animal models, we investigated the signal transduction mechanism involved in CB2 receptor-induced NP cell proliferation and neurogenesis. Exposure of hippocampal HiB5 NP cells to the CB2 receptor-selective agonist HU-308 led to the activation of the phosphatidylinositol 3-kinase (PI3K)/Akt/mammalian target of rapamycin complex 1 (mTORC1) pathway, which, by inhibiting its downstream target p27Kip1, induced NP proliferation. Experiments conducted with the CB2 receptor-selective antagonist SR144528, inhibitors of the PI3K/Akt/mTORC1 axis, and CB2 receptor transient-transfection vector further supported that CB2 receptors control NP cell proliferation via activation of mTORC1 signaling. Likewise, CB2 receptor engagement induced cell proliferation in an mTORC1-dependent manner both in embryonic cortical slices and in adult hippocampal NPs. Thus, HU-308 increased ribosomal protein S6 phosphorylation and 5-bromo-2'-deoxyuridine incorporation in wild-type but not CB2 receptor-deficient NPs of the mouse subgranular zone. Moreover, adult hippocampal NP proliferation induced by HU-308 and excitotoxicity was blocked by the mTORC1 inhibitor rapamycin. Altogether, these findings provide a mechanism of action and a rationale for the use of nonpsychotomimetic CB2 receptor-selective ligands as a novel strategy for the control of NP cell proliferation and neurogenesis.	[Galve-Roperh, Ismael] Univ Complutense, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Inst Univ Invest Neuroquim, E-28040 Madrid, Spain; Univ Complutense, Inst Ramon y Cajal Invest Sanitaria, E-28040 Madrid, Spain; Univ Complutense, Sch Biol, Dept Biochem & Mol Biol 1, E-28040 Madrid, Spain	CIBERNED; Complutense University of Madrid; Complutense University of Madrid; Complutense University of Madrid	Galve-Roperh, I (corresponding author), Univ Complutense, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Inst Univ Invest Neuroquim, E-28040 Madrid, Spain.	igr@quim.ucm.es	PALAZUELOS, JAVIER/AAD-7313-2020; PALAZUELOS, JAVIER/D-1211-2013; Alonso, Javier Diaz/ABH-6002-2020; Galve-Roperh, Ismael/AAG-2369-2020; Llorente, Zaira Ortega/F-8847-2016	PALAZUELOS, JAVIER/0000-0002-0409-1398; Llorente, Zaira Ortega/0000-0001-9445-0421; Galve-Roperh, Ismael/0000-0003-3501-2434; Guzman, Manuel/0000-0001-7475-118X	Ministerio de Ciencia e Innovacion [PLE2009-0117, SAF2009-08403]; Comunidad de Madrid-Universidad Complutense de Madrid [S-SAL-2006/261, 950344]; Fondo de Investigaciones Sanitarias	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Comunidad de Madrid-Universidad Complutense de Madrid(Comunidad de Madrid); Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III)	This work was supported by Ministerio de Ciencia e Innovacion Grants PLE2009-0117 (to I. G.-R.) and SAF2009-08403 (to M. G.) and Comunidad de Madrid-Universidad Complutense de Madrid Grants S-SAL-2006/261 and 950344 (to M. G. and I. G.-R.).; Supported by Fondo de Investigaciones Sanitarias.	Aguado T, 2005, FASEB J, V19, P1704, DOI 10.1096/fj.05-3995fje; Aguado T, 2007, J BIOL CHEM, V282, P23892, DOI 10.1074/jbc.M700678200; Arevalo-Martin A, 2007, EUR J NEUROSCI, V26, P1548, DOI 10.1111/j.1460-9568.2007.05782.x; Auvin S, 2010, NEUROBIOL DIS, V40, P303, DOI 10.1016/j.nbd.2010.06.004; Buckley  NE, 2000, EUR J PHARMACOL, V396, P141, DOI 10.1016/S0014-2999(00)00211-9; Buckmaster PS, 2009, J NEUROSCI, V29, P8259, DOI 10.1523/JNEUROSCI.4179-08.2009; Ehrhart J, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-29; Fernandez-Ruiz J, 2008, MOL CELL ENDOCRINOL, V286, pS91, DOI 10.1016/j.mce.2008.01.001; Foster KG, 2010, J BIOL CHEM, V285, P14071, DOI 10.1074/jbc.R109.094003; Frank CL, 2009, NEURON, V62, P312, DOI 10.1016/j.neuron.2009.03.029; Galve-Roperh I, 2008, CURR PHARM DESIGN, V14, P2279, DOI 10.2174/138161208785740117; Galve-Roperh I, 2007, NEUROSCIENTIST, V13, P109, DOI 10.1177/1073858406296407; Gomez O, 2011, BRIT J PHARMACOL, V163, P1520, DOI 10.1111/j.1476-5381.2011.01414.x; Goorden SMI, 2011, MOL CELL BIOL, V31, P1672, DOI 10.1128/MCB.00985-10; Han JM, 2011, FEBS LETT, V585, P973, DOI 10.1016/j.febslet.2011.02.001; Hanus L, 1999, P NATL ACAD SCI USA, V96, P14228, DOI 10.1073/pnas.96.25.14228; Harkany T, 2007, TRENDS PHARMACOL SCI, V28, P83, DOI 10.1016/j.tips.2006.12.004; Heifets BD, 2009, ANNU REV PHYSIOL, V71, P283, DOI 10.1146/annurev.physiol.010908.163149; Hoeffer CA, 2010, TRENDS NEUROSCI, V33, P67, DOI 10.1016/j.tins.2009.11.003; Hong F, 2008, MOL CELL, V30, P701, DOI 10.1016/j.molcel.2008.04.027; Jiang SX, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000641; Katona I, 2008, NAT MED, V14, P923, DOI 10.1038/nm.f.1869; Kim S, 2010, NEURON, V66, P69, DOI 10.1016/j.neuron.2010.03.019; Kokaia M, 2011, EUR J NEUROSCI, V33, P1133, DOI 10.1111/j.1460-9568.2011.07612.x; Ludanyi A, 2008, J NEUROSCI, V28, P2976, DOI 10.1523/JNEUROSCI.4465-07.2008; Mackie K, 2006, ANNU REV PHARMACOL, V46, P101, DOI 10.1146/annurev.pharmtox.46.120604.141254; Magloczky Z, 2010, EPILEPSIA, V51, P115, DOI 10.1111/j.1528-1167.2010.02624.x; Malagelada C, 2011, J NEUROSCI, V31, P3186, DOI 10.1523/JNEUROSCI.4011-10.2011; Marsicano G, 2003, SCIENCE, V302, P84, DOI 10.1126/science.1088208; Molina-Holgado E, 2002, J NEUROSCI, V22, P9742, DOI 10.1523/jneurosci.22-22-09742.2002; Molina-Holgado F, 2007, EUR J NEUROSCI, V25, P629, DOI 10.1111/j.1460-9568.2007.05322.x; Monory K, 2006, NEURON, V51, P455, DOI 10.1016/j.neuron.2006.07.006; Mulder J, 2008, P NATL ACAD SCI USA, V105, P8760, DOI 10.1073/pnas.0803545105; Nguyen L, 2006, GENE DEV, V20, P1511, DOI 10.1101/gad.377106; Oudin MJ, 2011, J NEUROSCI, V31, P4000, DOI 10.1523/JNEUROSCI.5483-10.2011; Palazuelos J, 2008, J BIOL CHEM, V283, P13320, DOI 10.1074/jbc.M707960200; Palazuelos J, 2006, FASEB J, V20, P2405, DOI 10.1096/fj.06-6164fje; Palazuelos J, 2009, BRAIN, V132, P3152, DOI 10.1093/brain/awp239; Pertwee RG, 2010, PHARMACOL REV, V62, P588, DOI 10.1124/pr.110.003004; Puighermanal E, 2009, NAT NEUROSCI, V12, P1152, DOI 10.1038/nn.2369; Qiu JH, 2009, STEM CELLS, V27, P920, DOI 10.1002/stem.1; RENFRANZ PJ, 1991, CELL, V66, P713, DOI 10.1016/0092-8674(91)90116-G; Salazar M, 2009, J CLIN INVEST, V119, P1359, DOI 10.1172/JCI37948; Stella N, 2009, NEUROPHARMACOLOGY, V56, P244, DOI 10.1016/j.neuropharm.2008.07.037; Trazzi S, 2010, J BIOL CHEM, V285, P10098, DOI 10.1074/jbc.M109.043711; Van Sickle MD, 2005, SCIENCE, V310, P329, DOI 10.1126/science.1115740; Zeng LH, 2009, J NEUROSCI, V29, P6964, DOI 10.1523/JNEUROSCI.0066-09.2009; Zou J, 2011, DEV CELL, V20, P97, DOI 10.1016/j.devcel.2010.11.020; Zurolo E, 2010, NEUROSCIENCE, V170, P28, DOI 10.1016/j.neuroscience.2010.07.004	49	111	113	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					1198	1209		10.1074/jbc.M111.291294	http://dx.doi.org/10.1074/jbc.M111.291294			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22102284	Green Published, hybrid			2022-12-27	WOS:000299170300035
J	Wang, C; Yu, J; Huo, L; Wang, L; Feng, W; Wang, CC				Wang, Chao; Yu, Jiang; Huo, Lin; Wang, Lei; Feng, Wei; Wang, Chih-chen			Human Protein-disulfide Isomerase Is a Redox-regulated Chaperone Activated by Oxidation of Domain a '	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THIOREDOXIN-LIKE DOMAINS; PROLYL 4-HYDROXYLASE; MOLECULAR CHAPERONES; MISFOLDED PROTEINS; BINDING SITE; PDI FAMILY; DEGRADATION; SUBUNIT; SYSTEM; REGION	Protein-disulfide isomerase (PDI), with domains arranged as abb'xa'c, is a key enzyme and chaperone localized in the endoplasmic reticulum (ER) catalyzing oxidative folding and preventing misfolding/aggregation of proteins. It has been controversial whether the chaperone activity of PDI is redox-regulated, and the molecular basis is unclear. Here, we show that both the chaperone activity and the overall conformation of human PDI are redox-regulated. We further demonstrate that the conformational changes are triggered by the active site of domain a', and the minimum redox-regulated cassette is located in b'xa'. The structure of the reduced bb'xa' reveals for the first time that domain a' packs tightly with both domain b' and linker x to form one compact structural module. Oxidation of domain a' releases the compact conformation and exposes the shielded hydrophobic areas to facilitate its high chaperone activity. Thus, the study unequivocally provides mechanistic insights into the redox-regulated chaperone activity of human PDI.	[Wang, Chao; Huo, Lin; Wang, Lei; Feng, Wei; Wang, Chih-chen] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China; [Wang, Chao] Chinese Acad Sci, Grad Univ, Beijing 100049, Peoples R China; [Yu, Jiang] Hong Kong Univ Sci & Technol, Div Life Sci, Mol Neurosci Ctr, State Key Lab Mol Neurosci, Kowloon, Hong Kong, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Hong Kong University of Science & Technology	Feng, W (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China.	wfeng@ibp.ac.cn; chihwang@sun5.ibp.ac.cn	HUO, LIN/A-6673-2012; Yu, Jiang/C-6980-2012; Wang, Chao/AGP-7000-2022; FENG, WEI/C-8966-2012	Wang, Chao/0000-0002-3048-8559; Wang, Lei/0000-0002-5071-5800	National Major Basic Research Program of China [2011CB910303, 2011CB910503]; National Natural Science Foundation of China [31000351, 31070657]; Chinese Academy of Sciences [KSCX2-YW-R-154, KSCX2-EW-J-3]	National Major Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by National Major Basic Research Program of China Grants 2011CB910303 and 2011CB910503, National Natural Science Foundation of China Grants 31000351 and 31070657, and Knowledge Innovation Program of the Chinese Academy of Sciences Grants KSCX2-YW-R-154 and KSCX2-EW-J-3.	Alanen HI, 2003, ANTIOXID REDOX SIGN, V5, P367, DOI 10.1089/152308603768295096; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CAI H, 1994, J BIOL CHEM, V269, P24550; Cho K, 2011, ANTIOXID REDOX SIGN, V15, P621, DOI 10.1089/ars.2010.3756; DARBY NJ, 1995, BIOCHEMISTRY-US, V34, P11725, DOI 10.1021/bi00037a009; Denisov AY, 2009, FEBS J, V276, P1440, DOI 10.1111/j.1742-4658.2009.06884.x; Dong G, 2009, IMMUNITY, V30, P21, DOI 10.1016/j.immuni.2008.10.018; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Essex DW, 2009, ANTIOXID REDOX SIGN, V11, P1191, DOI [10.1089/ars.2008.2322, 10.1089/ARS.2008.2322]; Fenouillet E, 2007, ANTIOXID REDOX SIGN, V9, P1009, DOI 10.1089/ars.2007.1639; Forster ML, 2009, J BIOL CHEM, V284, P13045, DOI 10.1074/jbc.M808352200; Freedman RB, 2002, EMBO REP, V3, P136, DOI 10.1093/embo-reports/kvf035; Freedman RB, 1998, BIOL CHEM, V379, P321, DOI 10.1515/bchm.1998.379.3.321; GOLDBERGER RF, 1963, J BIOL CHEM, V238, P628; Hatahet F, 2009, ANTIOXID REDOX SIGN, V11, P2807, DOI [10.1089/ars.2009.2466, 10.1089/ARS.2009.2466]; Hoffstrom BG, 2010, NAT CHEM BIOL, V6, P900, DOI [10.1038/nchembio.467, 10.1038/NCHEMBIO.467]; Kadokura H, 2004, SCIENCE, V303, P534, DOI 10.1126/science.1091724; Klappa P, 1998, EMBO J, V17, P927, DOI 10.1093/emboj/17.4.927; Kozlov G, 2010, FEBS J, V277, P3924, DOI 10.1111/j.1742-4658.2010.07793.x; Kumsta C, 2009, BIOCHEMISTRY-US, V48, P4666, DOI 10.1021/bi9003556; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Lee SO, 2010, EMBO J, V29, P363, DOI 10.1038/emboj.2009.359; Li SJ, 2006, J BIOL CHEM, V281, P6581, DOI 10.1074/jbc.M508422200; Lumb RA, 2002, EMBO J, V21, P6763, DOI 10.1093/emboj/cdf685; Maeda K, 2006, STRUCTURE, V14, P1701, DOI 10.1016/j.str.2006.09.012; Malhotra JD, 2007, ANTIOXID REDOX SIGN, V9, P2277, DOI 10.1089/ars.2007.1782; Masui S, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.231357; Mezghrani A, 2001, EMBO J, V20, P6288, DOI 10.1093/emboj/20.22.6288; Molinari M, 2002, J CELL BIOL, V158, P247, DOI 10.1083/jcb.200204122; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakasako M, 2010, BIOCHEMISTRY-US, V49, P6953, DOI 10.1021/bi1006089; Nguyen VD, 2008, J MOL BIOL, V383, P1144, DOI 10.1016/j.jmb.2008.08.085; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; PIHLAJANIEMI T, 1987, EMBO J, V6, P643, DOI 10.1002/j.1460-2075.1987.tb04803.x; Pirneskoski A, 2004, J BIOL CHEM, V279, P10374, DOI 10.1074/jbc.M312193200; Pirneskoski A, 2001, J BIOL CHEM, V276, P11287, DOI 10.1074/jbc.M010656200; Serve O, 2010, J MOL BIOL, V396, P361, DOI 10.1016/j.jmb.2009.11.049; Sitia R, 2003, NATURE, V426, P891, DOI 10.1038/nature02262; SITIA R, 2004, SCI STKE, pPE27; Sun XX, 2000, BBA-PROTEIN STRUCT M, V1481, P45, DOI 10.1016/S0167-4838(00)00122-9; Tian G, 2006, CELL, V124, P61, DOI 10.1016/j.cell.2005.10.044; Tian G, 2008, J BIOL CHEM, V283, P33630, DOI 10.1074/jbc.M806026200; Tsai B, 2001, CELL, V104, P937, DOI 10.1016/S0092-8674(01)00289-6; Tsai M, 2002, J CELL BIOL, V159, P207, DOI 10.1083/jcb.200207120; Turano C, 2002, J CELL PHYSIOL, V193, P154, DOI 10.1002/jcp.10172; Uehara T, 2006, NATURE, V441, P513, DOI 10.1038/nature04782; Walker AK, 2011, NEUROL RES INT, V2011, DOI 10.1155/2011/317340; Walker AK, 2010, BRAIN, V133, P105, DOI 10.1093/brain/awp267; Wang C, 2010, J BIOL CHEM, V285, P26788, DOI 10.1074/jbc.M110.107839; Wang L, 2009, J BIOL CHEM, V284, P199, DOI 10.1074/jbc.M806645200; WETTERAU JR, 1990, J BIOL CHEM, V265, P9800; Wilkinson B, 2004, BBA-PROTEINS PROTEOM, V1699, P35, DOI 10.1016/j.bbapap.2004.02.017; Wilson R, 1998, J BIOL CHEM, V273, P9637, DOI 10.1074/jbc.273.16.9637; Winter J, 2004, CRIT REV BIOCHEM MOL, V39, P297, DOI 10.1080/10409230490900658; Zito E, 2010, MOL CELL, V40, P787, DOI 10.1016/j.molcel.2010.11.010	56	95	97	2	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					1139	1149		10.1074/jbc.M111.303149	http://dx.doi.org/10.1074/jbc.M111.303149			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22090031	hybrid, Green Published			2022-12-27	WOS:000299170300029
J	Zhang, L; Lim, SL; Du, HJ; Zhang, M; Kozak, I; Hannum, G; Wang, XL; Ouyang, H; Hughes, G; Zhao, L; Zhu, XM; Lee, C; Su, ZG; Zhou, XR; Shaw, R; Geum, DH; Wei, XR; Zhu, J; Ideker, T; Oka, C; Wang, NL; Yang, ZL; Shaw, PX; Zhang, K				Zhang, Li; Lim, Siok Lam; Du, Hongjun; Zhang, Ming; Kozak, Igor; Hannum, Gregory; Wang, Xiaolei; Ouyang, Hong; Hughes, Guy; Zhao, Ling; Zhu, Xuemei; Lee, Clara; Su, Zhiguang; Zhou, Xinrong; Shaw, Robert; Geum, Dongho; Wei, Xinran; Zhu, Jin; Ideker, Trey; Oka, Chio; Wang, Ningli; Yang, Zhenglin; Shaw, Peter X.; Zhang, Kang			High Temperature Requirement Factor A1 (HTRA1) Gene Regulates Angiogenesis through Transforming Growth Factor-beta Family Member Growth Differentiation Factor 6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERINE-PROTEASE; MACULAR DEGENERATION; MUTATIONS; GDF6; ASSOCIATION; EXPRESSION; SPECTRUM; BONE; VEGF; EYE	Genome-wide association study (GWAS) has identified genetic variants in the promoter region of the high temperature requirement factor A1 (HTRA1) gene associated with age-related macular degeneration (AMD). As a secreted serine protease, HTRA1 has been reported to interact with members of the transforming growth factor-beta (TGF-beta) family and regulate their signaling pathways. Growth differentiation factor 6 (GDF6), a member of the TGF-beta family, is involved in ectoderm patterning and eye development. Mutations in GDF6 have been associated with abnormal eye development that may result in microphthalmia and anophthalmia. In this report, we identified a single nucleotide polymorphism (SNP) rs6982567 A/G near the GDF6 gene that is significantly associated withAMD(p value = 3.54 x 10(-8)). We demonstrated that the GDF6 AMD risk allele (rs6982567 A) is associated with decreased expression of the GDF6 and increased expression of HTRA1. Similarly, the HTRA1 AMD risk allele (rs10490924 T) is associated with decreased GDF6 and increased HTRA1 expression. We observed decreased vascular development in the retina and significant up-regulation of GDF6 gene in the RPE layer, retinal and brain tissues in HTRA1 knock-out (htra1(-/-)) mice as compared with the wild-type counterparts. Furthermore, we showed enhanced SMAD signaling in htra1(-/-) mice. Our data suggests a critical role of HTRA1 in the regulation of angiogenesis via TGF-beta signaling and identified GDF6 as a novel disease gene for AMD.	[Zhang, Li; Zhang, Ming; Su, Zhiguang; Wei, Xinran; Zhu, Jin; Shaw, Peter X.; Zhang, Kang] Sichuan Univ, Mol Med Res Ctr, W China Hosp, Chengdu 610041, Peoples R China; [Zhang, Li; Zhang, Ming; Su, Zhiguang; Wei, Xinran; Zhu, Jin; Shaw, Peter X.; Zhang, Kang] Sichuan Univ, Dept Ophthalmol, W China Hosp, Chengdu 610041, Peoples R China; [Zhang, Li; Lim, Siok Lam; Du, Hongjun; Kozak, Igor; Ouyang, Hong; Hughes, Guy; Zhao, Ling; Zhu, Xuemei; Lee, Clara; Zhou, Xinrong; Shaw, Robert; Geum, Dongho; Wei, Xinran; Zhu, Jin; Shaw, Peter X.; Zhang, Kang] Univ Calif San Diego, Inst Genom Med, La Jolla, CA 92093 USA; [Zhang, Li; Lim, Siok Lam; Du, Hongjun; Kozak, Igor; Ouyang, Hong; Hughes, Guy; Zhao, Ling; Zhu, Xuemei; Lee, Clara; Zhou, Xinrong; Shaw, Robert; Geum, Dongho; Wei, Xinran; Zhu, Jin; Shaw, Peter X.; Zhang, Kang] Univ Calif San Diego, Shiley Eye Ctr, La Jolla, CA 92093 USA; [Hannum, Gregory; Ideker, Trey] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Wang, Xiaolei; Wang, Ningli] Tong Ren Eye Hosp, Beijing, Peoples R China; [Oka, Chio] Nara Inst Sci & Technol, Div Gene Funct Anim, Nara 6300192, Japan; [Yang, Zhenglin] Sichuan Acad Med Sci, Sichuan Prov Key Lab Human Dis Gene Study, Chengdu 610072, Sichuan, Peoples R China; [Yang, Zhenglin] Sichuan Acad Med Sci, Inst Lab Med, Chengdu 610072, Sichuan, Peoples R China; [Yang, Zhenglin] Sichuan Prov Peoples Hosp, Chengdu 610072, Sichuan, Peoples R China	Sichuan University; Sichuan University; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Nara Institute of Science & Technology; Sichuan Provincial People's Hospital; Sichuan Provincial People's Hospital; Sichuan Provincial People's Hospital	Shaw, PX (corresponding author), Sichuan Univ, Mol Med Res Ctr, W China Hosp, Chengdu 610041, Peoples R China.	pshaw@ucsd.edu; kang.zhang@gmail.com	Su, Zhiguang/AFS-0022-2022; Zhang, Kang/Y-2740-2019; Kozak, Igor/AAC-4645-2019; Zhao, Ling/D-9005-2015	Zhang, Kang/0000-0002-4549-1697; Zhao, Ling/0000-0002-6644-2886; Su, Zhiguang/0000-0001-8635-9310; Ideker, Trey/0000-0002-1708-8454; Ouyang, Hong/0000-0002-7622-7733	NEI; National Basic Research Program of China [2011CB510200]; Chinese National 985 Project; Veterans Affairs Merit Award; Research to Prevent Blindness; BWF; National Natural Science Foundation of China [81025006]; NATIONAL EYE INSTITUTE [R01EY021374, R01EY018660] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001898] Funding Source: NIH RePORTER	NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Basic Research Program of China(National Basic Research Program of China); Chinese National 985 Project; Veterans Affairs Merit Award(US Department of Veterans Affairs); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); BWF; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by a National Institutes of Health grant from the NEI, National Basic Research Program of China Grant 973 Program, No. 2011CB510200, Chinese National 985 Project to Sichuan University and West China Hospital, a Veterans Affairs Merit Award, Research to Prevent Blindness, and a BWF Clinical Scientist Award in Translational Research (to K.Z.).; Supported by National Natural Science Foundation of China Grant 81025006. To whom correspondence may be addressed. E-mail: zliny@yahoo.com.	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Age-Related Eye Disease Study Research Group, 2001, ARCH OPHTHALMOL-CHIC, V119, P1439; Asai-Coakwell M, 2007, AM J HUM GENET, V80, P306, DOI 10.1086/511280; Bakrania P, 2008, AM J HUM GENET, V82, P304, DOI 10.1016/j.ajhg.2007.09.023; Chang CB, 1999, DEVELOPMENT, V126, P3347; Churchill AJ, 2006, HUM MOL GENET, V15, P2955, DOI 10.1093/hmg/ddl238; Dewan A, 2006, SCIENCE, V314, P989, DOI 10.1126/science.1133807; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564; Gallione CJ, 2004, LANCET, V363, P852, DOI 10.1016/S0140-6736(04)15732-2; Gonzalez-Rodriguez J, 2010, BRIT J OPHTHALMOL, V94, P1100, DOI 10.1136/bjo.2009.173500; Grainger DJ, 2004, ARTERIOSCL THROM VAS, V24, P399, DOI 10.1161/01.ATV.0000114567.76772.33; Grau S, 2005, P NATL ACAD SCI USA, V102, P6021, DOI 10.1073/pnas.0501823102; Grau S, 2006, J BIOL CHEM, V281, P6124, DOI 10.1074/jbc.M500361200; Grisanti S, 2008, PROG RETIN EYE RES, V27, P372, DOI 10.1016/j.preteyeres.2008.05.002; Haines JL, 2006, INVEST OPHTH VIS SCI, V47, P329, DOI 10.1167/iovs.05-0116; Hanel ML, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-43; Hara K, 2009, NEW ENGL J MED, V360, P1729, DOI 10.1056/NEJMoa0801560; Johnson DW, 1996, NAT GENET, V13, P189, DOI 10.1038/ng0696-189; Jones A, 2011, P NATL ACAD SCI USA, V108, P14578, DOI 10.1073/pnas.1102853108; Launay S, 2008, CELL DEATH DIFFER, V15, P1408, DOI 10.1038/cdd.2008.82; Mazerbourg S, 2005, J BIOL CHEM, V280, P32122, DOI 10.1074/jbc.M504629200; MCALLISTER KA, 1994, NAT GENET, V8, P345, DOI 10.1038/ng1294-345; Mortlock DP, 2003, GENOME RES, V13, P2069, DOI 10.1101/gr.1306003; Neptune ER, 2003, NAT GENET, V33, P407, DOI 10.1038/ng1116; Oka C, 2004, DEVELOPMENT, V131, P1041, DOI 10.1242/dev.00999; ten Dijke P, 2007, NAT REV MOL CELL BIO, V8, P857, DOI 10.1038/nrm2262; Tsuchiya A, 2005, BONE, V37, P323, DOI 10.1016/j.bone.2005.03.015; Yang ZL, 2006, SCIENCE, V314, P992, DOI 10.1126/science.1133811; Yang ZL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000836; Zumbrunn J, 1996, FEBS LETT, V398, P187, DOI 10.1016/S0014-5793(96)01229-X	30	66	69	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					1520	1526		10.1074/jbc.M111.275990	http://dx.doi.org/10.1074/jbc.M111.275990			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22049084	Green Published, hybrid			2022-12-27	WOS:000299170300065
J	Galperin, MY; Koonin, EV				Galperin, Michael Y.; Koonin, Eugene V.			Divergence and Convergence in Enzyme Evolution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							ALKALINE-PHOSPHATASE SUPERFAMILY; N-TERMINAL NUCLEOPHILE; COMMON STRUCTURAL ELEMENTS; ESCHERICHIA-COLI; ACTIVE-SITES; RIBONUCLEOTIDE SYNTHETASE; MOONLIGHTING PROTEINS; CYSTEINE DIOXYGENASE; ENOLASE SUPERFAMILY; ANALOGOUS ENZYMES	Comparative analysis of the sequences of enzymes encoded in a variety of prokaryotic and eukaryotic genomes reveals convergence and divergence at several levels. Functional convergence can be inferred when structurally distinct and hence non-homologous enzymes show the ability to catalyze the same biochemical reaction. In contrast, as a result of functional diversification, many structurally similar enzyme molecules act on substantially distinct substrates and catalyze diverse biochemical reactions. Here, we present updates on the ATP-grasp, alkaline phosphatase, cupin, HD hydrolase, and N-terminal nucleophile (Ntn) hydrolase enzyme superfamilies and discuss the patterns of sequence and structural conservation and diversity within these superfamilies. Typically, enzymes within a superfamily possess common sequence motifs and key active site residues, as well as (predicted) reaction mechanisms. These observations suggest that the strained conformation (the entatic state) of the active site, which is responsible for the substrate binding and formation of the transition complex, tends to be conserved within enzyme superfamilies. The subsequent fate of the transition complex is not necessarily conserved and depends on the details of the structures of the enzyme and the substrate. This variability of reaction outcomes limits the ability of sequence analysis to predict the exact enzymatic activities of newly sequenced gene products. Nevertheless, sequence-based (super) family assignments and generic functional predictions, even if imprecise, provide valuable leads for experimental studies and remain the best approach to the functional annotation of uncharacterized proteins from new genomes.	[Galperin, Michael Y.; Koonin, Eugene V.] NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20894 USA	National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM)	Koonin, EV (corresponding author), NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20894 USA.	koonin@ncbi.nlm.nih.gov	Zhang, Ning/F-1387-2014; Galperin, Michael Y./B-5859-2013	Galperin, Michael Y./0000-0002-2265-5572	National Institutes of Healtha at the National Library of Medicine; NATIONAL LIBRARY OF MEDICINE [ZIALM000061] Funding Source: NIH RePORTER	National Institutes of Healtha at the National Library of Medicine; NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program at the National Library of Medicine. This is the third article in the Thematic Minireview Series on Enzyme Evolution in the Post-genomic Era.	Allen KN, 2004, TRENDS BIOCHEM SCI, V29, P495, DOI 10.1016/j.tibs.2004.07.008; Andreeva A, 2008, NUCLEIC ACIDS RES, V36, pD419, DOI 10.1093/nar/gkm993; Aravind L, 1998, TRENDS BIOCHEM SCI, V23, P469, DOI 10.1016/S0968-0004(98)01293-6; Balskus EP, 2010, SCIENCE, V329, P1653, DOI 10.1126/science.1193637; BRANNIGAN JA, 1995, NATURE, V378, P416, DOI 10.1038/378416a0; Burroughs AM, 2006, J MOL BIOL, V361, P1003, DOI 10.1016/j.jmb.2006.06.049; Cheng H, 2005, PROTEIN SCI, V14, P1902, DOI 10.1110/ps.051364905; Copley SD, 2012, J BIOL CHEM, V287, P3, DOI 10.1074/jbc.R111.254714; Cuff AL, 2011, NUCLEIC ACIDS RES, V39, pD420, DOI 10.1093/nar/gkq1001; Daugherty M, 2001, J BACTERIOL, V183, P292, DOI 10.1128/JB.183.1.292-300.2001; DAYHOFF MO, 1976, FED PROC, V35, P2132; Denessiouk KA, 1998, PROTEIN SCI, V7, P1768, DOI 10.1002/pro.5560070811; Denessiouk KA, 1999, PROTEINS, V35, P250, DOI 10.1002/(SICI)1097-0134(19990501)35:2<250::AID-PROT10>3.0.CO;2-X; Denessiouk KA, 2000, PROTEINS, V38, P310, DOI 10.1002/(SICI)1097-0134(20000215)38:3<310::AID-PROT7>3.0.CO;2-T; Drummond DA, 2008, CELL, V134, P341, DOI 10.1016/j.cell.2008.05.042; DUGGLEBY HJ, 1995, NATURE, V373, P264, DOI 10.1038/373264a0; Dunwell JM, 2004, PHYTOCHEMISTRY, V65, P7, DOI 10.1016/j.phytochem.2003.08.016; Dunwell JM, 2001, TRENDS BIOCHEM SCI, V26, P740, DOI 10.1016/S0968-0004(01)01981-8; Elias M, 2012, J BIOL CHEM, V287, P11, DOI 10.1074/jbc.R111.257329; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Galperin Michael Y., 1999, Journal of Molecular Microbiology and Biotechnology, V1, P303; Galperin MY, 1997, PROTEIN SCI, V6, P2639; Galperin MY, 1998, GENOME RES, V8, P779, DOI 10.1101/gr.8.8.779; Galperin MY, 1998, PROTEIN SCI, V7, P1829, DOI 10.1002/pro.5560070819; Galperin MY, 2001, PROTEINS, V45, P318, DOI 10.1002/prot.1152; Galperin MY, 1999, GENETICA, V106, P159, DOI 10.1023/A:1003705601428; Gerlt JA, 2005, ARCH BIOCHEM BIOPHYS, V433, P59, DOI 10.1016/j.abb.2004.07.034; Gerlt JA, 2012, J BIOL CHEM, V287, P29, DOI 10.1074/jbc.R111.240945; Gibrat JF, 1996, CURR OPIN STRUC BIOL, V6, P377, DOI 10.1016/S0959-440X(96)80058-3; Glasner ME, 2006, CURR OPIN CHEM BIOL, V10, P492, DOI 10.1016/j.cbpa.2006.08.012; Hanson AD, 2010, BIOCHEM J, V425, P1, DOI 10.1042/BJ20091328; Harris TK, 2002, IUBMB LIFE, V53, P85, DOI 10.1080/15216540211468; HERZBERG O, 1991, PROTEINS, V11, P223, DOI 10.1002/prot.340110307; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Huberts DHEW, 2010, BBA-MOL CELL RES, V1803, P520, DOI 10.1016/j.bbamcr.2010.01.022; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Iyer LM, 2010, NUCLEIC ACIDS RES, V38, P5261, DOI 10.1093/nar/gkq265; Iyer LM, 2009, MOL BIOSYST, V5, P1636, DOI 10.1039/b917682a; Janke C, 2005, SCIENCE, V308, P1758, DOI 10.1126/science.1113010; Jeffery CJ, 2009, MOL BIOSYST, V5, P345, DOI 10.1039/b900658n; Jencks W. P., 1987, CATALYSIS CHEM ENZYM; Jonas S, 2009, PURE APPL CHEM, V81, P731, DOI 10.1351/PAC-CON-08-10-20; Kang YN, 2007, BIOCHEMISTRY-US, V46, P5050, DOI 10.1021/bi061637j; KOONIN EV, 2002, SEQUENCE EVOLUTION F; Lee HS, 2009, J BACTERIOL, V191, P3415, DOI 10.1128/JB.01699-08; Lovering AL, 2011, MBIO, V2, DOI 10.1128/mBio.00163-11; Lu D, 2009, P NATL ACAD SCI USA, V106, P1584, DOI 10.1073/pnas.0809020106; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; McCoy JG, 2006, P NATL ACAD SCI USA, V103, P3084, DOI 10.1073/pnas.0509262103; Meng EC, 2011, CURR OPIN STRUC BIOL, V21, P391, DOI 10.1016/j.sbi.2011.03.007; Miller GJ, 2005, MOL CELL, V18, P201, DOI 10.1016/j.molcel.2005.03.016; Mulkidjanian AY, 1999, FEBS LETT, V463, P199, DOI 10.1016/S0014-5793(99)01536-7; Murphy JE, 1997, NAT STRUCT BIOL, V4, P618, DOI 10.1038/nsb0897-618; Murzin AG, 1996, CURR OPIN STRUC BIOL, V6, P386, DOI 10.1016/S0959-440X(96)80059-5; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Oinonen C, 2000, PROTEIN SCI, V9, P2329, DOI 10.1110/ps.9.12.2329; Omelchenko MV, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-31; Orlean P, 2007, J LIPID RES, V48, P993, DOI 10.1194/jlr.R700002-JLR200; Osterman A, 2003, CURR OPIN CHEM BIOL, V7, P238, DOI 10.1016/S1367-5931(03)00027-9; Osterman AL, 2009, NAT CHEM BIOL, V5, P871, DOI 10.1038/nchembio.267; Panosian TD, 2011, J BIOL CHEM, V286, P8043, DOI 10.1074/jbc.M110.201350; Pazy Y, 2010, P NATL ACAD SCI USA, V107, P1924, DOI 10.1073/pnas.0911185107; Pei JM, 2003, PROTEIN SCI, V12, P1131, DOI 10.1110/ps.0240803; Piatigorsky Joram, 2003, Journal of Structural and Functional Genomics, V3, P131; Ryan RP, 2006, P NATL ACAD SCI USA, V103, P6712, DOI 10.1073/pnas.0600345103; Scheeff ED, 2005, PLOS COMPUT BIOL, V1, P359, DOI 10.1371/journal.pcbi.0010049; Schirner K, 2009, EMBO J, V28, P830, DOI 10.1038/emboj.2009.25; Simmons CR, 2008, BIOCHEMISTRY-US, V47, P11390, DOI 10.1021/bi801546n; Sriram G, 2005, AM J HUM GENET, V76, P911, DOI 10.1086/430799; Thoden JB, 2000, BIOCHEMISTRY-US, V39, P8791, DOI 10.1021/bi000926j; Thoden JB, 1999, BIOCHEMISTRY-US, V38, P15480, DOI 10.1021/bi991618s; Thoden JB, 2002, J BIOL CHEM, V277, P23898, DOI 10.1074/jbc.M202251200; Thorsell AG, 2008, J BIOL CHEM, V283, P15209, DOI 10.1074/jbc.M800348200; Todd AE, 2002, TRENDS BIOCHEM SCI, V27, P419, DOI 10.1016/S0968-0004(02)02158-8; Todd AE, 2001, J MOL BIOL, V307, P1113, DOI 10.1006/jmbi.2001.4513; VALLEE BL, 1968, P NATL ACAD SCI USA, V59, P498, DOI 10.1073/pnas.59.2.498; van Loo B, 2010, P NATL ACAD SCI USA, V107, P2740, DOI 10.1073/pnas.0903951107; Wang YL, 2007, NUCLEIC ACIDS RES, V35, pD298, DOI 10.1093/nar/gkl952; Warshel A, 1998, P NATL ACAD SCI USA, V95, P5950, DOI 10.1073/pnas.95.11.5950; WILLIAMS RJP, 1985, J MOL CATAL, V30, P1, DOI 10.1016/0304-5102(85)80013-4; WILLIAMS RJP, 1995, EUR J BIOCHEM, V234, P363, DOI 10.1111/j.1432-1033.1995.363_b.x; Yang KC, 2004, P NATL ACAD SCI USA, V101, P7919, DOI 10.1073/pnas.0400664101; Zhang Y, 2008, CELL MOL LIFE SCI, V65, P3699, DOI 10.1007/s00018-008-8295-8; Zhang Y, 2008, BIOCHEMISTRY-US, V47, P205, DOI 10.1021/bi701406g; Zimmerman MD, 2008, J MOL BIOL, V378, P215, DOI 10.1016/j.jmb.2008.02.036	85	112	114	1	57	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					21	28		10.1074/jbc.R111.241976	http://dx.doi.org/10.1074/jbc.R111.241976			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22069324	hybrid, Green Published			2022-12-27	WOS:000298682400004
J	Xie, T; Ren, RB; Zhang, YY; Pang, YX; Yan, CY; Gong, XQ; He, Y; Li, WQ; Miao, D; Hao, Q; Deng, HT; Wang, ZX; Wu, JW; Yan, NE				Xie, Tian; Ren, Ruobing; Zhang, Yuan-yuan; Pang, Yuxuan; Yan, Chuangye; Gong, Xinqi; He, Yuan; Li, Wenqi; Miao, Di; Hao, Qi; Deng, Haiteng; Wang, Zhixin; Wu, Jia-Wei; Yan, Nieng			Molecular Mechanism for Inhibition of a Critical Component in the Arabidopsis thaliana Abscisic Acid Signal Transduction Pathways, SnRK2.6, by Protein Phosphatase ABI1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONTINUOUS SPECTROPHOTOMETRIC ASSAY; KINASE; ABA; STRESS; IDENTIFICATION; ACTIVATION; REGULATORS; INTERACTS; REVEALS; DROUGHT	Subclass III SnRK2s (SnRK2.6/2.3/2.2) are the key positive regulators of abscisic acid (ABA) signal transduction in Arabidopsis thaliana. The kinases, activated by ABA or osmotic stress, phosphorylate stress-related transcription factors and ion channels, which ultimately leads to the protection of plants from dehydration or high salinity. In the absence of stressors, SnRK2s are subject to negative regulation by group A protein phosphatase type 2Cs (PP2C), whereas the underlying molecular mechanism remains to be elucidated. Here we report the crystal structure of the kinase domain of SnRK2.6 at 2.6-angstrom resolution. Structure-guided biochemical analyses identified two distinct interfaces between SnRK2.6 and ABI1, a member of group A PP2Cs. Structural modeling suggested that the two interfaces lock SnRK2.6 and ABI1 in an orientation such that the activation loop of SnRK2.6 is posited to the catalytic site of ABI1 for dephosphorylation. These studies revealed the molecular basis for PP2Cs-mediated inhibition of SnRK2s and provided important insights into the downstream signal transduction of ABA.	[Xie, Tian; Ren, Ruobing; Pang, Yuxuan; Yan, Chuangye; Gong, Xinqi; He, Yuan; Li, Wenqi; Hao, Qi; Wu, Jia-Wei; Yan, Nieng] Tsinghua Peking Ctr Life Sci, Struct Biol Ctr, Beijing 100084, Peoples R China; [Xie, Tian; Ren, Ruobing; Pang, Yuxuan; Yan, Chuangye; Gong, Xinqi; He, Yuan; Li, Wenqi; Hao, Qi; Yan, Nieng] State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China; [Xie, Tian; Ren, Ruobing; Pang, Yuxuan; Yan, Chuangye; Gong, Xinqi; He, Yuan; Li, Wenqi; Miao, Di; Hao, Qi; Deng, Haiteng; Wang, Zhixin; Wu, Jia-Wei; Yan, Nieng] Sch Med, Beijing 100084, Peoples R China; [Xie, Tian; Ren, Ruobing; Pang, Yuxuan; Yan, Chuangye; Gong, Xinqi; He, Yuan; Li, Wenqi; Miao, Di; Hao, Qi; Deng, Haiteng; Wang, Zhixin; Wu, Jia-Wei; Yan, Nieng] Sch Life Sci, Beijing 100084, Peoples R China; [Zhang, Yuan-yuan] Chinese Acad Sci, Inst Biophys, Beijing 100101, Peoples R China	Tsinghua University; Chinese Academy of Sciences; Institute of Biophysics, CAS	Wu, JW (corresponding author), Tsinghua Peking Ctr Life Sci, Struct Biol Ctr, Beijing 100084, Peoples R China.	jiaweiwu@tsinghua.edu.cn; nyan@tsinghua.edu.cn	wang, zhixin/GZH-2500-2022; Yan, Chuangye/AAJ-5832-2021	Yan, Chuangye/0000-0001-9338-8048; Xie, Tian/0000-0002-5445-664X; Deng, Haiteng/0000-0001-9496-1280; Ren, Ruobing/0000-0003-4517-7216	National Natural Science Foundation of China [91017011, 31070644]; Tsinghua University; Yuyuan Foundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tsinghua University; Yuyuan Foundation	This work was supported by Projects 91017011 and 31070644 of the National Natural Science Foundation of China, Tsinghua University 985 Phase II funds, and the Yuyuan Foundation.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Belin C, 2006, PLANT PHYSIOL, V141, P1316, DOI 10.1104/pp.106.079327; Chen L, 2009, NATURE, V459, P1146, DOI 10.1038/nature08075; CHENG Q, 1995, ANAL BIOCHEM, V226, P68, DOI 10.1006/abio.1995.1192; DeLano W.L, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eswar N., 2007, CURRENT PROTOCOLS PR, V50, P291; FEDOROFF NV, 2002, SCI STKE, pRE10; Finkelstein R, 2008, ANNU REV PLANT BIOL, V59, P387, DOI 10.1146/annurev.arplant.59.032607.092740; Fujii H, 2007, PLANT CELL, V19, P485, DOI 10.1105/tpc.106.048538; Fujii H, 2011, P NATL ACAD SCI USA, V108, P1717, DOI 10.1073/pnas.1018367108; Fujii H, 2009, P NATL ACAD SCI USA, V106, P8380, DOI 10.1073/pnas.0903144106; Fujita Y, 2009, PLANT CELL PHYSIOL, V50, P2123, DOI 10.1093/pcp/pcp147; Furihata T, 2006, P NATL ACAD SCI USA, V103, P1988, DOI 10.1073/pnas.0505667103; Geiger D, 2009, P NATL ACAD SCI USA, V106, P21425, DOI 10.1073/pnas.0912021106; Gong XQ, 2010, PROTEINS, V78, P3150, DOI 10.1002/prot.22831; Gong XQ, 2010, SCI CHINA LIFE SCI, V53, P1152, DOI 10.1007/s11427-010-4050-0; Hao Q, 2011, MOL CELL, V42, P662, DOI 10.1016/j.molcel.2011.05.011; Hirayama T, 2007, TRENDS PLANT SCI, V12, P343, DOI 10.1016/j.tplants.2007.06.013; Johnson RR, 2002, PLANT PHYSIOL, V130, P837, DOI 10.1104/pp.001354; Klingler JP, 2010, J EXP BOT, V61, P3199, DOI 10.1093/jxb/erq151; Ma Y, 2009, SCIENCE, V324, P1064, DOI 10.1126/science.1172408; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Melcher K, 2009, NATURE, V462, P602, DOI 10.1038/nature08613; Miyazono K, 2009, NATURE, V462, P609, DOI 10.1038/nature08583; Mustilli AC, 2002, PLANT CELL, V14, P3089, DOI 10.1105/tpc.007906; Nakashima K, 2009, PLANT CELL PHYSIOL, V50, P1345, DOI 10.1093/pcp/pcp083; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park SY, 2009, SCIENCE, V324, P1068, DOI 10.1126/science.1173041; ROSKOSKI R, 1983, METHOD ENZYMOL, V99, P3; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Santiago J, 2009, PLANT J, V60, P575, DOI 10.1111/j.1365-313X.2009.03981.x; Sato A, 2009, BIOCHEM J, V424, P439, DOI 10.1042/BJ20091221; Schroeder JI, 2006, CELL, V126, P1023, DOI 10.1016/j.cell.2006.09.001; SERGIENKO EA, 1994, ANAL BIOCHEM, V221, P348, DOI 10.1006/abio.1994.1424; Umezawa T, 2010, PLANT CELL PHYSIOL, V51, P1821, DOI 10.1093/pcp/pcq156; Umezawa T, 2009, P NATL ACAD SCI USA, V106, P17588, DOI 10.1073/pnas.0907095106; Uno Y, 2000, P NATL ACAD SCI USA, V97, P11632, DOI 10.1073/pnas.190309197; Vlad F, 2010, PLANT J, V63, P778, DOI 10.1111/j.1365-313X.2010.04281.x; WEBB MR, 1992, P NATL ACAD SCI USA, V89, P4884, DOI 10.1073/pnas.89.11.4884; Yin P, 2009, NAT STRUCT MOL BIOL, V16, P1230, DOI 10.1038/nsmb.1730; Yoshida R, 2006, J BIOL CHEM, V281, P5310, DOI 10.1074/jbc.M509820200; Yoshida R, 2002, PLANT CELL PHYSIOL, V43, P1473, DOI 10.1093/pcp/pcf188; Zhang YY, 2008, J BIOL CHEM, V283, P26591, DOI 10.1074/jbc.M801703200; Zhou B, 1999, J BIOL CHEM, V274, P35526, DOI 10.1074/jbc.274.50.35526	45	46	57	3	43	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					794	802		10.1074/jbc.M111.313106	http://dx.doi.org/10.1074/jbc.M111.313106			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22090030	Green Published, hybrid			2022-12-27	WOS:000298682400076
J	Airavaara, M; Pletnikova, O; Doyle, ME; Zhang, YE; Troncoso, JC; Liu, QR				Airavaara, Mikko; Pletnikova, Olga; Doyle, Maire E.; Zhang, Yong E.; Troncoso, Juan C.; Liu, Qing-Rong			Identification of Novel GDNF Isoforms and cis-Antisense GDNFOS Gene and Their Regulation in Human Middle Temporal Gyrus of Alzheimer Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURONS IN-VIVO; NEUROTROPHIC FACTOR; PARKINSONS-DISEASE; NUCLEUS-ACCUMBENS; HUMAN BRAIN; BDNF GENES; EXPRESSION; SURVIVAL; MOUSE; IMMUNOREACTIVITY	Primate-specific genes and isoforms could provide insight into human brain diseases. Our bioinformatic analysis revealed that there are possibly five isoforms of human GDNF gene with different pre- and pro-regions by inter- and intra-exon splicing. By using TaqMan primer probe sets, designed between exons, we verified the expression of all isoforms. Furthermore, a novel GDNFOS gene was found to be transcribed from the opposite strand of GDNF gene. GDNFOS gene has four exons that are spliced into different isoforms. GDNFOS1 and GDNFOS2 are long noncoding RNAs, and GDNFOS3 encodes a protein of 105 amino acids. To study human GDNF and GDNFOS regulation in neurodegenerative diseases, the protein and mRNA levels were measured by Western blot and RT-quantitative PCR, respectively, in postmortem middle temporal gyrus (MTG) of Alzheimer disease (AD) and Huntington disease (HD) patients in comparison with those of normal controls. In the MTG of AD patients, the mature GDNF peptide was down-regulated; however, the transcript of GDNF isoform from human exon 2 was up-regulated, whereas that of the conserved isoform from exon 1 remained unchanged in comparison with those of normal controls. In contrast, the mature GDNF peptide and the isoform mRNA levels were not changed in the MTG of HD. The findings of novel GDNF and GDNFOS isoforms and differences in tissue expression patterns dysregulated in AD brains may further reveal the role of endogenous GDNF in human brain diseases.	[Liu, Qing-Rong] NIDA, Behav Neurosci Branch, IRP, NIH,DHSS, Baltimore, MD 21224 USA; [Airavaara, Mikko] NIDA, Neural Protect & Regenerat Sect, IRP, NIH,DHSS, Baltimore, MD 21224 USA; [Pletnikova, Olga; Troncoso, Juan C.] Johns Hopkins Univ, Sch Med, Div Neuropathol, Dept Pathol, Baltimore, MD 21205 USA; [Doyle, Maire E.] Johns Hopkins Med Inst, Div Endocrinol, Baltimore, MD 21224 USA; [Zhang, Yong E.] Chinese Acad Sci, Inst Zool, Key Lab Zool Systemat & Evolut, Beijing 100101, Peoples R China	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA); Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Chinese Academy of Sciences; Institute of Zoology, CAS	Liu, QR (corresponding author), NIDA, Behav Neurosci Branch, IRP, NIH,DHSS, 251 Bayview Blvd,Ste 200, Baltimore, MD 21224 USA.	qliu@intra.nida.nih.gov	Zhang, Yong E./AAC-8610-2019; Liu, Qing-Rong/A-3059-2012; Zhang, Yong/A-7855-2011	Zhang, Yong E./0000-0003-3770-2383; Liu, Qing-Rong/0000-0001-8477-6452; Airavaara, Mikko/0000-0002-2026-1609	National Institutes of Health NIDA; Johns Hopkins University Alzheimer's Disease Research Center (NIA) [P50AG051460]; Huntington's Research Center without Walls (NINDS) [PO1NS16375]; Integrated Islet Distribution Program; NIDDK; JDRF; Alzheimer's Association [IIRG-09-134090]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS016375] Funding Source: NIH RePORTER	National Institutes of Health NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Johns Hopkins University Alzheimer's Disease Research Center (NIA); Huntington's Research Center without Walls (NINDS); Integrated Islet Distribution Program; NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); JDRF(Juvenile Diabetes Research Foundation); Alzheimer's Association(Alzheimer's Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health NIDA intramural research program. This work was also supported by the Johns Hopkins University Alzheimer's Disease Research Center (NIA P50AG051460), the Huntington's Research Center without Walls (NINDS PO1NS16375), the Integrated Islet Distribution Program, funded by the NIDDK and the JDRF.; Supported by a Juvenile Diabetes Research Foundation career award from the Sanford Project (Sioux Falls, SD).; Recipient of a grant from the Alzheimer's Association (IIRG-09-134090).	Airaksinen MS, 2002, NAT REV NEUROSCI, V3, P383, DOI 10.1038/nrn812; Airavaara M, 2011, ADDICT BIOL, V16, P261, DOI 10.1111/j.1369-1600.2010.00281.x; Arenas E, 1995, NEURON, V15, P1465, DOI 10.1016/0896-6273(95)90024-1; Backman CM, 2006, MOL CELL ENDOCRINOL, V252, P160, DOI 10.1016/j.mce.2006.03.013; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; Boucher TJ, 2000, SCIENCE, V290, P124, DOI 10.1126/science.290.5489.124; Bradley LH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009752; Chauhan NB, 2001, J CHEM NEUROANAT, V21, P277, DOI 10.1016/S0891-0618(01)00115-6; Chlocco MJ, 2007, PARKINSONISM RELAT D, V13, pS321, DOI 10.1016/S1353-8020(08)70024-5; Dorus S, 2004, CELL, V119, P1027, DOI 10.1016/j.cell.2004.11.040; Farhi J, 2010, FERTIL STERIL, V93, P2565, DOI 10.1016/j.fertnstert.2009.09.047; Fromont-Hankard G, 2002, ARCH PATHOL LAB MED, V126, P432; Ghitza UE, 2010, NEUROSCI BIOBEHAV R, V35, P157, DOI 10.1016/j.neubiorev.2009.11.009; Grimm L, 1998, HUM MOL GENET, V7, P1873, DOI 10.1093/hmg/7.12.1873; HENDERSON CE, 1994, SCIENCE, V266, P1062, DOI 10.1126/science.7973664; Herndon ES, 2009, J NEUROPATH EXP NEUR, V68, P250, DOI 10.1097/NEN.0b013e318198d320; Hunot S, 1996, J NEURAL TRANSM, V103, P1043, DOI 10.1007/BF01291789; Immonen T, 2008, EXP NEUROL, V210, P793, DOI 10.1016/j.expneurol.2007.12.018; Kent WJ, 2003, P NATL ACAD SCI USA, V100, P11484, DOI 10.1073/pnas.1932072100; Kondo S, 2003, EUR J IMMUNOL, V33, P2233, DOI 10.1002/eji.200323458; Li CY, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000734; Li JT, 2008, NUCLEIC ACIDS RES, V36, P4833, DOI 10.1093/nar/gkn470; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; Lipovich L, 2010, BBA-GENE REGUL MECH, V1799, P597, DOI 10.1016/j.bbagrm.2010.10.001; Little M, 2010, CURR TOP DEV BIOL, V90, P193, DOI 10.1016/S0070-2153(10)90005-7; Liu QR, 2005, AM J MED GENET B, V134B, P93, DOI 10.1002/ajmg.b.30109; Liu QR, 2006, BRAIN RES, V1067, P1, DOI 10.1016/j.brainres.2005.10.004; Lonka-Nevalaita L, 2010, J NEUROSCI, V30, P11403, DOI 10.1523/JNEUROSCI.5888-09.2010; Lucini C, 2008, EUR J HISTOCHEM, V52, P69; Martinelli PM, 2002, HISTOCHEM CELL BIOL, V118, P337, DOI 10.1007/s00418-002-0452-9; Matsushita N, 1997, GENE, V203, P149, DOI 10.1016/S0378-1119(97)00506-4; Mwangi S, 2008, GASTROENTEROLOGY, V134, P727, DOI 10.1053/j.gastro.2007.12.033; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Oh-hashi K, 2009, MOL CELL BIOCHEM, V323, P1, DOI 10.1007/s11010-008-9958-3; Pruunsild P, 2007, GENOMICS, V90, P397, DOI 10.1016/j.ygeno.2007.05.004; Rhead B, 2010, NUCLEIC ACIDS RES, V38, pD613, DOI 10.1093/nar/gkp939; Schroeter ML, 2009, NEUROIMAGE, V47, P1196, DOI 10.1016/j.neuroimage.2009.05.037; Schwartz S, 2003, GENOME RES, V13, P103, DOI 10.1101/gr.809403; Siegel GJ, 2000, BRAIN RES REV, V33, P199, DOI 10.1016/S0165-0173(00)00030-8; Sillerud LO, 2005, CURR PROTEIN PEPT SC, V6, P151, DOI 10.2174/1389203053545462; Stan AD, 2006, BRAIN RES, V1123, P1, DOI 10.1016/j.brainres.2006.09.025; Straten G, 2009, J ALZHEIMERS DIS, V18, P331, DOI 10.3233/JAD-2009-1146; SUTERCRAZZOLARA C, 1994, NEUROREPORT, V5, P2486, DOI 10.1097/00001756-199412000-00020; Trok K, 1996, NEUROSCIENCE, V71, P231, DOI 10.1016/0306-4522(95)00412-2; Troncoso JC, 1998, ANN NEUROL, V43, P673, DOI 10.1002/ana.410430519; TRUPP M, 1995, J CELL BIOL, V130, P137, DOI 10.1083/jcb.130.1.137; von Boyen GBT, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-3; Wang J, 2010, J NEUROSCI, V30, P14502, DOI 10.1523/JNEUROSCI.3909-10.2010; Wang Y, 1997, J NEUROSCI, V17, P4341; Watanabe Y, 2009, GASTROENTEROLOGY, V136, P2149, DOI 10.1053/j.gastro.2009.02.085; Williams LR, 1996, J PHARMACOL EXP THER, V277, P1140; Wu HM, 2009, NEUROPSYCHOPHARMACOL, V34, P2344, DOI 10.1038/npp.2009.64; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhang Y, 2006, NUCLEIC ACIDS RES, V34, P3465, DOI 10.1093/nar/gkl473; Zhang YE, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001179	55	82	90	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2011	286	52					45093	45102		10.1074/jbc.M111.310250	http://dx.doi.org/10.1074/jbc.M111.310250			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870CA	22081608	hybrid, Green Published			2022-12-27	WOS:000298645500076
J	Chandrashekarappa, DG; McCartney, RR; Schmidt, MC				Chandrashekarappa, Dakshayini G.; McCartney, Rhonda R.; Schmidt, Martin C.			Subunit and Domain Requirements for Adenylate-mediated Protection of Snf1 Kinase Activation Loop from Dephosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE; SACCHAROMYCES-CEREVISIAE; BETA-SUBUNITS; STRUCTURAL INSIGHT; CRYSTAL-STRUCTURE; PHOSPHORYLATION; PURIFICATION; MECHANISM; BINDING; AMPK	Members of the AMP-activated protein kinase (AMPK) family are activated by phosphorylation at a conserved threonine residue in the activation loop of the kinase domain. Mammalian AMPK adopts a phosphatase-resistant conformation that is stabilized by binding low energy adenylate molecules. Similarly, binding of ADP to the Snf1 complex, yeast AMPK, protects the kinase from dephosphorylation. Here, we determined the nucleotide specificity of the ligand-mediated protection from dephosphorylation and demonstrate the subunit and domain requirements for this reaction. Protection from dephosphorylation was highly specific for adenine nucleotides, with ADP being the most effective ligand for mediating protection. The full-length alpha subunit (Snf1) was not competent for ADP-mediated protection, confirming the requirement for the regulatory beta and gamma subunits. However, Snf1 heterotrimeric complexes that lacked either the glycogen-binding domain of Gal83 or the linker region of the alpha subunit were competent for ADP-mediated protection. In contrast, adenylate-mediated protection of recombinant human AMPK was abolished when a portion of the linker region containing the alpha-hook domain was deleted. Therefore, the exact means by which the different adenylate nucleotides are distinguished by the Snf1 enzyme may differ compared with its mammalian ortholog.	[Chandrashekarappa, Dakshayini G.; McCartney, Rhonda R.; Schmidt, Martin C.] Univ Pittsburgh, Dept Microbiol & Mol Genet, Sch Med, Pittsburgh, PA 15219 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Schmidt, MC (corresponding author), Univ Pittsburgh, Dept Microbiol & Mol Genet, Sch Med, 450 Technol Dr, Pittsburgh, PA 15219 USA.	mcs2@pitt.edu			National Institutes of Health [GM46443]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM046443, R01GM046443] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM46443.	Amodeo GA, 2007, NATURE, V449, P492, DOI 10.1038/nature06127; CARLING D, 1989, EUR J BIOCHEM, V186, P129, DOI 10.1111/j.1432-1033.1989.tb15186.x; Chen L, 2009, NATURE, V459, P1146, DOI 10.1038/nature08075; Crute BE, 1998, J BIOL CHEM, V273, P35347, DOI 10.1074/jbc.273.52.35347; Elbing K, 2006, BIOCHEM J, V393, P797, DOI 10.1042/BJ20051213; Elbing K, 2006, J BIOL CHEM, V281, P26170, DOI 10.1074/jbc.M603811200; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Hardie DG, 2011, AM J CLIN NUTR, V93, p891S, DOI 10.3945/ajcn.110.001925; Iseli TJ, 2005, J BIOL CHEM, V280, P13395, DOI 10.1074/jbc.M412993200; Jin XS, 2007, STRUCTURE, V15, P1285, DOI 10.1016/j.str.2007.07.017; Kornev AP, 2006, P NATL ACAD SCI USA, V103, P17783, DOI 10.1073/pnas.0607656103; Leech A, 2003, EUKARYOT CELL, V2, P265, DOI 10.1128/EC.2.2.265-273.2003; Mangat S, 2010, EUKARYOT CELL, V9, P173, DOI 10.1128/EC.00267-09; Mayer FV, 2011, CELL METAB, V14, P707, DOI 10.1016/j.cmet.2011.09.009; McCartney RR, 2001, J BIOL CHEM, V276, P36460, DOI 10.1074/jbc.M104418200; McElhinny SAN, 2010, P NATL ACAD SCI USA, V107, P4949, DOI 10.1073/pnas.0914857107; Momcilovic M, 2008, J BIOL CHEM, V283, P19521, DOI 10.1074/jbc.M803624200; Nath N, 2002, J BIOL CHEM, V277, P50403, DOI 10.1074/jbc.M207058200; Neumann D, 2003, PROTEIN EXPRES PURIF, V30, P230, DOI 10.1016/S1046-5928(03)00126-8; Rose MD., 1990, METHODS YEAST GENETI; Rubenstein EM, 2008, J BIOL CHEM, V283, P222, DOI 10.1074/jbc.M707957200; Rudolph MJ, 2005, BIOCHEM BIOPH RES CO, V337, P1224, DOI 10.1016/j.bbrc.2005.09.181; Sanders MJ, 2007, BIOCHEM J, V403, P139, DOI 10.1042/BJ20061520; Sanz P, 2000, MOL CELL BIOL, V20, P1321, DOI 10.1128/MCB.20.4.1321-1328.2000; Schmidt MC, 2000, EMBO J, V19, P4936, DOI 10.1093/emboj/19.18.4936; Suter M, 2006, J BIOL CHEM, V281, P32207, DOI 10.1074/jbc.M606357200; Townley R, 2007, SCIENCE, V315, P1726, DOI 10.1126/science.1137503; Vincent O, 2001, GENE DEV, V15, P1104, DOI 10.1101/gad.879301; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Wilson WA, 1996, CURR BIOL, V6, P1426, DOI 10.1016/S0960-9822(96)00747-6; Xiao B, 2007, NATURE, V449, P496, DOI 10.1038/nature06161; Xiao B, 2011, NATURE, V472, P230, DOI 10.1038/nature09932	32	22	22	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2011	286	52					44532	44541		10.1074/jbc.M111.315895	http://dx.doi.org/10.1074/jbc.M111.315895			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870CA	22065577	Green Published, hybrid			2022-12-27	WOS:000298645500025
J	Georis, I; Tate, JJ; Cooper, TG; Dubois, E				Georis, Isabelle; Tate, Jennifer J.; Cooper, Terrance G.; Dubois, Evelyne			Nitrogen-responsive Regulation of GATA Protein Family Activators Gln3 and Gat1 Occurs by Two Distinct Pathways, One Inhibited by Rapamycin and the Other by Methionine Sulfoximine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETROGRADE GENE-EXPRESSION; CATABOLITE REPRESSION; SACCHAROMYCES-CEREVISIAE; NUCLEAR-LOCALIZATION; TOR PROTEINS; INTRACELLULAR-LOCALIZATION; GLUTAMATE-DEHYDROGENASES; CARBON STARVATION; DAL5 GENE; TRANSCRIPTION	Nitrogen availability regulates the transcription of genes required to degrade non-preferentially utilized nitrogen sources by governing the localization and function of transcription activators, Gln3 and Gat1. TorC1 inhibitor, rapamycin (Rap), and glutamine synthetase inhibitor, methionine sulfoximine (Msx), elicit responses grossly similar to those of limiting nitrogen, implicating both glutamine synthesis and TorC1 in the regulation of Gln3 and Gat1. To better understand this regulation, we compared Msx-versus Rap-elicited Gln3 and Gat1 localization, their DNA binding, nitrogen catabolite repression-sensitive gene expression, and the TorC1 pathway phosphatase requirements for these responses. Using this information we queried whether Rap and Msx inhibit sequential steps in a single, linear cascade connecting glutamine availability to Gln3 and Gat1 control as currently accepted or alternatively inhibit steps in two distinct parallel pathways. We find that Rap most strongly elicits nuclear Gat1 localization and expression of genes whose transcription is most Gat1-dependent. Msx, on the other hand, elicits nuclear Gln3 but not Gat1 localization and expression of genes that are most Gln3-dependent. Importantly, Rap-elicited nuclear Gln3 localization is absolutely Sit4-dependent, but that elicited by Msx is not. PP2A, although not always required for nuclear GATA factor localization, is highly required for GATA factor binding to nitrogen-responsive promoters and subsequent transcription irrespective of the gene GATA factor specificities. Collectively, our data support the existence of two different nitrogen-responsive regulatory pathways, one inhibited by Msx and the other by rapamycin.	[Tate, Jennifer J.; Cooper, Terrance G.] Univ Tennessee, Ctr Hlth Sci, Dept Microbiol Immunol & Biochem, Memphis, TN 38163 USA; [Georis, Isabelle; Dubois, Evelyne] Univ Libre Bruxelles, Microbiol Lab, Inst Rech Microbiol JM Wiame, B-1070 Brussels, Belgium	University of Tennessee System; University of Tennessee Health Science Center; Universite Libre de Bruxelles	Cooper, TG (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Microbiol Immunol & Biochem, Memphis, TN 38163 USA.	tcooper@uthsc.edu		Cooper, Terrance G./0000-0002-7651-9963	National Institutes of Health [GM-35642]; Commission Communautaire Francaise; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035642] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Commission Communautaire Francaise; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-35642 (to J. J. T. and T. G. C.). This work was also supported by Commission Communautaire Francaise (to E. D. and I. G.).	Beck T, 1999, NATURE, V402, P689, DOI 10.1038/45287; Bertram PG, 2000, J BIOL CHEM, V275, P35727, DOI 10.1074/jbc.M004235200; Blinder D, 1996, J BACTERIOL, V178, P4734, DOI 10.1128/jb.178.15.4734-4736.1996; Cardenas ME, 1999, GENE DEV, V13, P3271, DOI 10.1101/gad.13.24.3271; Carvalho J, 2003, J BIOL CHEM, V278, P16878, DOI 10.1074/jbc.M300429200; Carvalho J, 2001, J BIOL CHEM, V276, P25359, DOI 10.1074/jbc.M103050200; CHISHOLM G, 1982, MOL CELL BIOL, V2, P1088, DOI 10.1128/MCB.2.9.1088; Coffman JA, 1996, MOL CELL BIOL, V16, P847; Coffman JA, 1997, J BACTERIOL, V179, P3416, DOI 10.1128/jb.179.11.3416-3429.1997; COFFMAN JA, 1995, J BACTERIOL, V177, P6910, DOI 10.1128/jb.177.23.6910-6918.1995; Cooper T., 1982, MOL BIOL YEAST SACCH, P39, DOI DOI 10.1101/087969180.11B.39; Cooper TG, 2004, TOP CURR GENET, V7, P225; Cooper TG, 2002, FEMS MICROBIOL REV, V26, P223, DOI 10.1111/j.1574-6976.2002.tb00612.x; COORNAERT D, 1992, CURR GENET, V21, P301, DOI 10.1007/BF00351687; COURCHESNE WE, 1988, J BACTERIOL, V170, P708, DOI 10.1128/jb.170.2.708-713.1988; Cox KH, 2004, J BIOL CHEM, V279, P19294, DOI 10.1074/jbc.M309240200; Cox KH, 2004, J BIOL CHEM, V279, P10270, DOI 10.1074/jbc.M312023200; Cox KH, 2002, J BIOL CHEM, V277, P37559, DOI 10.1074/jbc.M204879200; Cox KH, 2000, J BIOL CHEM, V275, P17611, DOI 10.1074/jbc.M001648200; Crespo JL, 2002, P NATL ACAD SCI USA, V99, P6784, DOI 10.1073/pnas.102687599; CUNNINGHAM TS, 1991, MOL CELL BIOL, V11, P6205, DOI 10.1128/MCB.11.12.6205; Cunningham TS, 2000, J BIOL CHEM, V275, P14408, DOI 10.1074/jbc.275.19.14408; DAUGHERTY JR, 1993, J BACTERIOL, V175, P64, DOI 10.1128/JB.175.1.64-73.1993; DiComo CJ, 1996, GENE DEV, V10, P1904, DOI 10.1101/gad.10.15.1904; DRILLIEN R, 1972, J BACTERIOL, V109, P203, DOI 10.1128/JB.109.1.203-208.1972; DRILLIEN R, 1973, BIOCHEM BIOPH RES CO, V53, P367, DOI 10.1016/0006-291X(73)90671-2; DUBOIS E, 1974, EUR J BIOCHEM, V48, P603, DOI 10.1111/j.1432-1033.1974.tb03803.x; DUBOIS EL, 1974, BIOCHEM BIOPH RES CO, V60, P150, DOI 10.1016/0006-291X(74)90185-5; Duvel K, 2003, MOL CELL, V11, P1467, DOI 10.1016/S1097-2765(03)00228-4; Georis I, 2008, J BIOL CHEM, V283, P8919, DOI 10.1074/jbc.M708811200; Georis I, 2011, MOL CELL BIOL, V31, P92, DOI 10.1128/MCB.00482-10; Georis I, 2009, GENETICS, V181, P861, DOI 10.1534/genetics.108.099051; Georis I, 2009, MOL CELL BIOL, V29, P3803, DOI 10.1128/MCB.00399-09; Giannattasio S, 2005, J BIOL CHEM, V280, P42528, DOI 10.1074/jbc.M509187200; GRENSON M, 1972, BIOCHEM BIOPH RES CO, V48, P749, DOI 10.1016/0006-291X(72)90670-5; GRENSON M, 1974, MOL GEN GENET, V128, P73, DOI 10.1007/BF00267295; Hardwick JS, 1999, P NATL ACAD SCI USA, V96, P14866, DOI 10.1073/pnas.96.26.14866; Hofman-Bang J, 1999, MOL BIOTECHNOL, V12, P35, DOI 10.1385/MB:12:1:35; Jiang Y, 1999, EMBO J, V18, P2782, DOI 10.1093/emboj/18.10.2782; Kulkarni A, 2006, FEMS YEAST RES, V6, P218, DOI 10.1111/j.1567-1364.2006.00031.x; Kulkarni AA, 2001, J BIOL CHEM, V276, P32136, DOI 10.1074/jbc.M104580200; Liu ZC, 2003, MOL CELL, V12, P401, DOI 10.1016/S1097-2765(03)00285-5; Magasanik B, 2002, GENE, V290, P1, DOI 10.1016/S0378-1119(02)00558-9; MITCHELL AP, 1984, MOL CELL BIOL, V4, P2758, DOI 10.1128/MCB.4.12.2758; RAI R, 1987, J BACTERIOL, V169, P3521, DOI 10.1128/jb.169.8.3521-3524.1987; Rohde JR, 2003, CURR TOP MICROBIOL, V279, P53; ROON RJ, 1973, J BACTERIOL, V116, P367, DOI 10.1128/JB.116.1.367-372.1973; Scherens B, 2006, FEMS YEAST RES, V6, P777, DOI 10.1111/j.1567-1364.2006.00060.x; Shamji AF, 2000, CURR BIOL, V10, P1574, DOI 10.1016/S0960-9822(00)00866-6; STANBROUGH M, 1995, P NATL ACAD SCI USA, V92, P9450, DOI 10.1073/pnas.92.21.9450; Tate JJ, 2008, FEMS YEAST RES, V8, P1223, DOI 10.1111/j.1567-1364.2008.00441.x; Tate JJ, 2007, J BIOL CHEM, V282, P18467, DOI 10.1074/jbc.M609550200; Tate JJ, 2006, J BIOL CHEM, V281, P37980, DOI 10.1074/jbc.M606973200; Tate JJ, 2010, J BIOL CHEM, V285, P17880, DOI 10.1074/jbc.M109.085712; Tate JJ, 2009, J BIOL CHEM, V284, P2522, DOI 10.1074/jbc.M806162200; Tate JJ, 2002, J BIOL CHEM, V277, P20477, DOI 10.1074/jbc.M200962200; Tate JJ, 2003, J BIOL CHEM, V278, P36924, DOI 10.1074/jbc.M301829200; Tate JJ, 2005, J BIOL CHEM, V280, P27195, DOI 10.1074/jbc.M504052200; TUROSCY V, 1979, J BACTERIOL, V140, P971, DOI 10.1128/JB.140.3.971-979.1979; Wach A, 1996, YEAST, V12, P259, DOI 10.1002/(SICI)1097-0061(19960315)12:3<259::AID-YEA901>3.0.CO;2-C; Wang HM, 2003, MOL BIOL CELL, V14, P4342, DOI 10.1091/mbc.E03-02-0072; WIAME JM, 1985, ADV MICROB PHYSIOL, V26, P1, DOI 10.1016/S0065-2911(08)60394-X; Yan GH, 2006, EMBO J, V25, P3546, DOI 10.1038/sj.emboj.7601239; Zaman S, 2008, ANNU REV GENET, V42, P27, DOI 10.1146/annurev.genet.41.110306.130206	64	37	38	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2011	286	52					44897	44912		10.1074/jbc.M111.290577	http://dx.doi.org/10.1074/jbc.M111.290577			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870CA	22039046	Green Published, hybrid			2022-12-27	WOS:000298645500058
J	Hsieh, YH; Zhang, H; Lin, BR; Cui, NR; Na, B; Yang, HC; Jiang, C; Sui, SF; Tai, PC				Hsieh, Ying-hsin; Zhang, Hao; Lin, Bor-ruei; Cui, Ningren; Na, Bing; Yang, Hsiuchin; Jiang, Chun; Sui, Sen-fang; Tai, Phang C.			SecA Alone Can Promote Protein Translocation and Ion Channel Activity SecYEG INCREASES EFFICIENCY AND SIGNAL PEPTIDE SPECIFICITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLI MEMBRANE-VESICLES; ESCHERICHIA-COLI; CONDUCTING CHANNELS; IN-VITRO; PLUG DOMAIN; COMPLEX; ATP; EXPORT; STATE; PRLA	SecA is an essential component of the Sec-dependent protein translocation pathway across cytoplasmic membranes in bacteria. Escherichia coli SecA binds to cytoplasmic membranes at SecYEG high affinity sites and at phospholipid low affinity sites. It has been widely viewed that SecYEG functions as the essential protein-conducting channel through which precursors cross the membranes in bacterial Sec-dependent pathways, and that SecA functions as a motor to hydrolyze ATP in translocating precursors through SecYEG channels. We have now found that SecA alone can promote precursor translocation into phospholiposomes. Moreover, SecA-liposomes elicit ionic currents in Xenopus oocytes. Patch-clamp recordings further show that SecA alone promotes signal peptide-or precursor-dependent single channel activity. These activities were observed with the functional SecA at about 1-2 mu M. The results show that SecA alone is sufficient to promote protein translocation into liposomes and to elicit ionic channel activity at the phospholipids low affinity binding sites, thus indicating that SecA is able to form the protein-conducting channels. Even so, such SecA-liposomes are less efficient than those with a full complement of Sec proteins, and lose the signal-peptide proofreading function, resembling the effects of PrlA mutations. Addition of purified SecYEG restores the signal peptide specificity and increases protein translocation and ion channel activities. These data show that SecA can promote protein translocation and ion channel activities both when it is bound to lipids at low affinity sites and when it is bound to SecYEG with high affinity. The latter of the two interactions confers high efficiency and specificity.	[Tai, Phang C.] Georgia State Univ, Dept Biol, Ctr Biotechnol & Drug Design, Atlanta, GA 30303 USA; [Sui, Sen-fang] Tsinghua Univ, Sch Life Sci, Struct Biol Ctr, Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China	University System of Georgia; Georgia State University; Tsinghua University	Tai, PC (corresponding author), Georgia State Univ, Dept Biol, Petit Sci Ctr, 161 Jesse Hill Dr,Suite 490, Atlanta, GA 30303 USA.	biopct@gsu.edu	Zhang, Hao/H-4026-2014		National Institutes of Health [GM34676]; Chinese NNSF [30830028]; NBRP [2010CD833706/2010CB912400]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD060959] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034676] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073875] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chinese NNSF(National Natural Science Foundation of China (NSFC)); NBRP; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by National Institutes of Health Grant GM34676 (to P. C. T.) and Chinese NNSF Grant 30830028 and NBRP Grant 2010CD833706/2010CB912400 (to S.-f. S.).	Baars L, 2008, J BACTERIOL, V190, P3505, DOI 10.1128/JB.01631-07; Beckmann R, 1997, SCIENCE, V278, P2123, DOI 10.1126/science.278.5346.2123; BREUKINK E, 1992, BIOCHEMISTRY-US, V31, P1119, DOI 10.1021/bi00119a021; Breyton C, 2002, NATURE, V418, P662, DOI 10.1038/nature00827; CABELLI RJ, 1988, CELL, V55, P683, DOI 10.1016/0092-8674(88)90227-9; CHEN LL, 1987, NATURE, V328, P164, DOI 10.1038/328164a0; CHEN LL, 1985, P NATL ACAD SCI USA, V82, P4384, DOI 10.1073/pnas.82.13.4384; Chen XC, 1996, J BIOL CHEM, V271, P29698, DOI 10.1074/jbc.271.47.29698; Chen XC, 1998, J BACTERIOL, V180, P527, DOI 10.1128/JB.180.3.527-537.1998; Chen Y, 2007, J STRUCT BIOL, V159, P149, DOI 10.1016/j.jsb.2007.01.015; Collinson I, 2001, EMBO J, V20, P2462, DOI 10.1093/emboj/20.10.2462; Das S, 2008, J BACTERIOL, V190, P7302, DOI 10.1128/JB.00593-08; DERMAN AI, 1993, EMBO J, V12, P879, DOI 10.1002/j.1460-2075.1993.tb05728.x; Driessen AJM, 2008, ANNU REV BIOCHEM, V77, P643, DOI 10.1146/annurev.biochem.77.061606.160747; Duong F, 1999, EMBO J, V18, P3263, DOI 10.1093/emboj/18.12.3263; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hamman BD, 1997, CELL, V89, P535, DOI 10.1016/S0092-8674(00)80235-4; Hanein D, 1996, CELL, V87, P721, DOI 10.1016/S0092-8674(00)81391-4; KELLER RCA, 1995, FEBS LETT, V358, P251, DOI 10.1016/0014-5793(94)01439-8; KIM YJ, 1994, CELL, V78, P845; Li WK, 2007, MOL CELL, V26, P511, DOI 10.1016/j.molcel.2007.05.002; Lin BR, 2006, J MEMBRANE BIOL, V214, P103, DOI 10.1007/s00232-006-0079-1; Maillard AP, 2007, J BIOL CHEM, V282, P1281, DOI 10.1074/jbc.M610060200; MITCHELL C, 1993, MOL MICROBIOL, V10, P483, DOI 10.1111/j.1365-2958.1993.tb00921.x; OLIVER DB, 1982, J BACTERIOL, V150, P686, DOI 10.1128/JB.150.2.686-691.1982; OLIVER DB, 1981, CELL, V25, P765, DOI 10.1016/0092-8674(81)90184-7; Or E, 2007, FEBS LETT, V581, P2616, DOI 10.1016/j.febslet.2007.04.083; Pohlschroder M, 2005, ANNU REV MICROBIOL, V59, P91, DOI 10.1146/annurev.micro.59.030804.121353; SILHAVY TJ, 1983, METHOD ENZYMOL, V97, P11; SIMON SM, 1992, CELL, V69, P677, DOI 10.1016/0092-8674(92)90231-Z; TAI PC, 1991, METHOD CELL BIOL, V34, P167; TAKAMATSU H, 1994, J BIOCHEM-TOKYO, V116, P1287, DOI 10.1093/oxfordjournals.jbchem.a124677; Tang Y, 2010, SCI CHINA LIFE SCI, V53, P1049, DOI 10.1007/s11427-010-4061-x; van Voorst F, 1998, BIOCHEMISTRY-US, V37, P12261, DOI 10.1021/bi9809021; Wang HY, 2008, J BACTERIOL, V190, P1413, DOI 10.1128/JB.01633-07; Wang HW, 2003, P NATL ACAD SCI USA, V100, P4221, DOI 10.1073/pnas.0737415100; WATANABE M, 1990, P NATL ACAD SCI USA, V87, P1960, DOI 10.1073/pnas.87.5.1960; Wickner W, 1996, J BIOL CHEM, V271, P29514, DOI 10.1074/jbc.271.47.29514; WOLIN SL, 1994, CELL, V77, P787, DOI 10.1016/0092-8674(94)90124-4; Woodbury RL, 2002, PROTEIN SCI, V11, P875, DOI 10.1110/ps.4090102; Yang YB, 1997, J BIOL CHEM, V272, P13660, DOI 10.1074/jbc.272.21.13660; Yang YB, 1997, J BACTERIOL, V179, P7386, DOI 10.1128/jb.179.23.7386-7393.1997; Yu LY, 2006, PROTEIN EXPRES PURIF, V50, P179, DOI 10.1016/j.pep.2006.06.023; Zimmer J, 2008, NATURE, V455, P936, DOI 10.1038/nature07335	44	32	34	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2011	286	52					44702	44709		10.1074/jbc.M111.300111	http://dx.doi.org/10.1074/jbc.M111.300111			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870CA	22033925	hybrid, Green Published			2022-12-27	WOS:000298645500040
J	Ishihara, T; Inoue, J; Kozaki, K; Imoto, I; Inazawa, J				Ishihara, Takaya; Inoue, Jun; Kozaki, Ken-ichi; Imoto, Issei; Inazawa, Johji			HECT-type Ubiquitin Ligase ITCH Targets Lysosomal-associated Protein Multispanning Transmembrane 5 (LAPTM5) and Prevents LAPTM5-mediated Cell Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE PERMEABILIZATION; DEGRADATION; NEUROBLASTOMA; CANCER	LAPTM5 (lysosomal-associated protein multispanning transmembrane 5) is a membrane protein on the intracellular vesicles. We have previously demonstrated that the accumulation of LAPTM5-positive vesicles was closely associated with the programmed cell death occurring during the spontaneous regression of neuroblastomas. Although the accumulation of LAPTM5 protein might occur at the post-translational level, the molecular mechanism has been unclear. Here, we found that the level of LAPTM5 protein is regulated negatively by the degradation through ubiquitination by ITCH, an E3 ubiquitin ligase. ITCH directly binds to the PPxY motif of LAPTM5 via its WW domains and promotes ubiquitination through a HECT-type ligase domain. Overexpression of ITCH led to the degradation of LAPTM5 protein, and conversely, knockdown of ITCH by siRNA resulted in the stabilization of LAPTM5 protein. In addition, the inhibition of ITCH enhanced the cell death occurred by accumulation of LAPTM5 in neuroblastoma cells. These findings suggest that LAPTM5 is a novel substrate in terms of degradation by the ubiquitin ligase ITCH, and this system might act as a negative regulator in the spontaneous regression of neuroblastomas by preventing LAPTM5-mediated cell death.	[Ishihara, Takaya; Inoue, Jun; Kozaki, Ken-ichi; Imoto, Issei; Inazawa, Johji] Tokyo Med & Dent Univ, Med Res Inst, Dept Mol Cytogenet, Bunkyo Ku, Tokyo 1138510, Japan; [Ishihara, Takaya; Inoue, Jun; Kozaki, Ken-ichi; Imoto, Issei; Inazawa, Johji] Tokyo Med & Dent Univ, Sch Biomed Sci, Bunkyo Ku, Tokyo 1138510, Japan; [Inazawa, Johji] Tokyo Med & Dent Univ, Global Ctr Excellence Program, Int Res Ctr Mol Sci Tooth & Bone Dis, Bunkyo Ku, Tokyo 1138510, Japan; [Kozaki, Ken-ichi; Inazawa, Johji] Tokyo Med & Dent Univ, Dept Genome Med, Hard Tissue Genome Res Ctr, Bunkyo Ku, Tokyo 1138510, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU)	Inazawa, J (corresponding author), Tokyo Med & Dent Univ, Med Res Inst, Dept Mol Cytogenet, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138510, Japan.	johinaz.cgen@mri.tmd.ac.jp	imoto, Issei/D-8065-2012; Imoto, Issei/AAD-5799-2020; Kozaki, Ken-ichi/M-6281-2014	Kozaki, Ken-ichi/0000-0003-3286-819X	Japanese Ministry of Education Core Research for Evolutional Science and Technology of Japan Science and Technology Corporation; New Energy and Industrial Technology Development Organization; Foundation for Promotion of Cancer Research (Japan); Grants-in-Aid for Scientific Research [23390077] Funding Source: KAKEN	Japanese Ministry of Education Core Research for Evolutional Science and Technology of Japan Science and Technology Corporation; New Energy and Industrial Technology Development Organization(New Energy and Industrial Technology Development Organization (NEDO)); Foundation for Promotion of Cancer Research (Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work is supported by a grant-in-aid for Scientific Research on Priority Areas and Innovative Areas, Young Scientists (B), Scientific Research (A) and (C), and a Global Center of Excellence Program from the Japanese Ministry of Education Core Research for Evolutional Science and Technology of Japan Science and Technology Corporation, and New Energy and Industrial Technology Development Organization.; Awardee of Research Resident Fellowship from the Foundation for Promotion of Cancer Research (Japan) for the 3rd Term Comprehensive 10-year Strategy for Cancer Control, 5-1-1 Tsukiji Chuou-ku, Tokyo 104-0045, Japan.	Adra CN, 1996, GENOMICS, V35, P328, DOI 10.1006/geno.1996.0364; Boya P, 2008, ONCOGENE, V27, P6434, DOI 10.1038/onc.2008.310; Boya P, 2003, J EXP MED, V197, P1323, DOI 10.1084/jem.20021952; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; David R, 2011, NAT REV MOL CELL BIO, V12, P135, DOI 10.1038/nrm3063; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Inoue J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007099; Ishihara T, 2008, CANCER SCI, V99, P1940, DOI 10.1111/j.1349-7006.2008.00900.x; Levy F, 2005, MOL BIOL CELL, V16, P1777, DOI 10.1091/mbc.E04-09-0803; Marchese A, 2003, DEV CELL, V5, P709, DOI 10.1016/S1534-5807(03)00321-6; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; Matsui T, 1998, J CELL BIOL, V140, P647, DOI 10.1083/jcb.140.3.647; Melino G, 2008, CELL DEATH DIFFER, V15, P1103, DOI 10.1038/cdd.2008.60; Nishida T, 2007, BIOCHEM J, V405, P481, DOI 10.1042/BJ20070026; Ouchida R, 2008, IMMUNITY, V29, P33, DOI 10.1016/j.immuni.2008.04.024; Ouchida R, 2010, J IMMUNOL, V185, P294, DOI 10.4049/jimmunol.1000371; Pak Y, 2006, J CELL BIOL, V175, P631, DOI 10.1083/jcb.200603001; Perry WL, 1998, NAT GENET, V18, P143, DOI 10.1038/ng0298-143; Qiu L, 2000, J BIOL CHEM, V275, P35734, DOI 10.1074/jbc.M007300200; Salah Z, 2011, CANCER RES, V71, P2010, DOI 10.1158/0008-5472.CAN-10-3516; Schwab M, 2003, LANCET ONCOL, V4, P472, DOI 10.1016/S1470-2045(03)01166-5; SHIMADA Y, 1992, CANCER, V69, P277, DOI 10.1002/1097-0142(19920115)69:2<277::AID-CNCR2820690202>3.0.CO;2-C; Sundvall M, 2008, P NATL ACAD SCI USA, V105, P4162, DOI 10.1073/pnas.0708333105; Zhang PZ, 2010, J BIOL CHEM, V285, P8869, DOI 10.1074/jbc.M109.063321	24	12	12	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2011	286	51					44086	44094		10.1074/jbc.M111.251694	http://dx.doi.org/10.1074/jbc.M111.251694			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866SH	22009753	Green Published, hybrid			2022-12-27	WOS:000298402300049
J	Noda, C; Murata, T; Kanda, T; Yoshiyama, H; Sugimoto, A; Kawashima, D; Saito, S; Isomura, H; Tsurumi, T				Noda, Chieko; Murata, Takayuki; Kanda, Teru; Yoshiyama, Hironori; Sugimoto, Atsuko; Kawashima, Daisuke; Saito, Shinichi; Isomura, Hiroki; Tsurumi, Tatsuya			Identification and Characterization of CCAAT Enhancer-binding Protein (C/EBP) as a Transcriptional Activator for Epstein-Barr Virus Oncogene Latent Membrane Protein 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN EPITHELIAL-CELLS; GENE-EXPRESSION; J-KAPPA; REGULATES EXPRESSION; BZLF1 PROTEIN; B-CELLS; PROMOTER; LMP1; MEMBRANE-PROTEIN-1; LYMPHOMA	Epstein-Barr virus LMP1, a major oncoprotein expressed in latent infection, is critical for primary B cell transformation, functioning as a TNFR family member by aggregation in the plasma membrane resulting in constitutive activation of cellular signals, such as NF-kappa B, MAPK, JAK/STAT, and AKT. Although transcription of LMP1 in latent type III cells is generally under the control of the viral coactivator EBNA2, little is known about EBNA2-independent LMP1 expression in type II latency. We thus screened a cDNA library for factors that can activate the LMP1 promoter in an EBNA2-independent manner, using a reporter assay system. So far, we have screened >20,000 clones, and here identified C/EBP epsilon as a new transcriptional activator. Exogenous expression of C/EBP alpha, -beta, or -epsilon efficiently augmented LMP1 mRNA and protein levels in EBV-positive cell lines, whereas other members of the C/EBP family exhibited modest or little activity. It has been demonstrated that LMP1 gene transcription depends on two promoter regions: proximal (ED-L1) and distal (TR-L1). Interestingly, although we first used the proximal promoter for screening, we found that C/EBP increased transcription from both promoters in latent EBV-positive cells. Mutagenesis in reporter assays and EMSA identified only one functional C/EBP binding site, through which activation of both proximal and distal promoters is mediated. Introduction of point mutations into the identified C/EBP site in EBV-BAC caused reduced LMP1 transcription from both LMP1 promoters in epithelial cells. In conclusion, C/EBP is a newly identified transcriptional activator of the LMP1 gene, independent of the EBNA2 coactivator.	[Noda, Chieko; Murata, Takayuki; Kanda, Teru; Sugimoto, Atsuko; Kawashima, Daisuke; Saito, Shinichi; Isomura, Hiroki; Tsurumi, Tatsuya] Aichi Canc Ctr, Div Virol, Res Inst, Chikusa Ku, Nagoya, Aichi 4648681, Japan; [Noda, Chieko; Tsurumi, Tatsuya] Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Oncol, Nagoya, Aichi 4678603, Japan; [Yoshiyama, Hironori] Hokkaido Univ, Inst Med Genet, Res Ctr Infection Associated Canc, Kita Ku, Sapporo, Hokkaido 0600815, Japan	Aichi Cancer Center; Nagoya City University; Hokkaido University	Tsurumi, T (corresponding author), Aichi Canc Ctr, Div Virol, Res Inst, Chikusa Ku, 1-1 Kanokoden, Nagoya, Aichi 4648681, Japan.	ttsurumi@aichi-cc.jp	Murata, Takayuki/I-2621-2013; Yoshiyama, Hironori/D-7902-2012; Kanda, Teru/J-7313-2019; Yoshiyama, Hironori/H-5674-2019	Murata, Takayuki/0000-0001-7228-0839; Yoshiyama, Hironori/0000-0001-7588-278X; Kanda, Teru/0000-0002-1391-3349	Ministry of Education, Science, Sports, Culture and Technology [20390137, 21022055]; Ministry of Health, Labor and Welfare; Uehara Memorial Research Fund; Yasuda Medical Foundation; Institute for Genetic Medicine, Hokkaido University	Ministry of Education, Science, Sports, Culture and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); Uehara Memorial Research Fund(Uehara Memorial Foundation); Yasuda Medical Foundation; Institute for Genetic Medicine, Hokkaido University	This work was supported by from the Ministry of Education, Science, Sports, Culture and Technology Scientific Research Grants-in-aid 20390137 and 21022055 (to T. T.), the Ministry of Health, Labor and Welfare (to T. T.), the Uehara Memorial Research Fund (to T. T.), the Yasuda Medical Foundation (to T. M.), and the Grant for Joint Research Program of the Institute for Genetic Medicine, Hokkaido University.	Brummelkamp TR, 2002, CANCER CELL, V2, P243, DOI 10.1016/S1535-6108(02)00122-8; Burda P, 2010, LEUKEMIA, V24, P1249, DOI 10.1038/leu.2010.104; Chen HL, 2003, J VIROL, V77, P4139, DOI 10.1128/JVI.77.7.4139-4148.2003; Chen HL, 2001, J VIROL, V75, P2929, DOI 10.1128/JVI.75.6.2929-2937.2001; COOPER C, 1995, NUCLEIC ACIDS RES, V23, P4371, DOI 10.1093/nar/23.21.4371; Delecluse HJ, 1998, P NATL ACAD SCI USA, V95, P8245, DOI 10.1073/pnas.95.14.8245; GROSSMAN SR, 1994, P NATL ACAD SCI USA, V91, P7568, DOI 10.1073/pnas.91.16.7568; Gupta P, 2009, J CELL MOL MED, V13, P4349, DOI 10.1111/j.1582-4934.2009.00757.x; Harada S, 1997, J VIROL, V71, P6611, DOI 10.1128/JVI.71.9.6611-6618.1997; Hsiao JR, 2009, CANCER RES, V69, P4461, DOI 10.1158/0008-5472.CAN-09-0277; JOHANNSEN E, 1995, J VIROL, V69, P253, DOI 10.1128/JVI.69.1.253-262.1995; Kalvakolanu DV, 2005, J INTERF CYTOK RES, V25, P757, DOI 10.1089/jir.2005.25.757; Kanda T, 2004, J VIROL, V78, P7004, DOI 10.1128/JVI.78.13.7004-7015.2004; Kilareski EM, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-118; Kis LL, 2006, IMMUNOL LETT, V104, P83, DOI 10.1016/j.imlet.2005.11.003; Kis LL, 2006, BLOOD, V107, P2928, DOI 10.1182/blood-2005-06-2569; Kis LL, 2011, BLOOD, V117, P165, DOI 10.1182/blood-2010-01-265272; Kis LL, 2010, P NATL ACAD SCI USA, V107, P872, DOI 10.1073/pnas.0912920107; Konforte D, 2008, VIROLOGY, V374, P100, DOI 10.1016/j.virol.2007.12.027; Kordula T, 1996, BIOCHEM J, V313, P1019, DOI 10.1042/bj3131019; Kulwichit W, 1998, P NATL ACAD SCI USA, V95, P11963, DOI 10.1073/pnas.95.20.11963; Lam N, 2003, CELL SIGNAL, V15, P9, DOI 10.1016/S0898-6568(02)00083-9; LAUX G, 1994, EMBO J, V13, P5624, DOI 10.1002/j.1460-2075.1994.tb06900.x; Maruo S, 2001, J GEN VIROL, V82, P2373, DOI 10.1099/0022-1317-82-10-2373; Murata T, 2011, J BIOL CHEM, V286, P22007, DOI 10.1074/jbc.M110.199836; Murata T, 2010, J BIOL CHEM, V285, P23925, DOI 10.1074/jbc.M109.095356; Murata T, 2009, J BIOL CHEM, V284, P8033, DOI 10.1074/jbc.M808466200; Murata T, 2009, VIROLOGY, V389, P75, DOI 10.1016/j.virol.2009.04.007; Ning S, 2003, J VIROL, V77, P9359, DOI 10.1128/JVI.77.17.9359-9368.2003; Osada S, 1996, J BIOL CHEM, V271, P3891; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/bj20020508; Robb BW, 2002, SURGERY, V132, P226, DOI 10.1067/msy.2002.125354; SADLER RH, 1995, J VIROL, V69, P4577, DOI 10.1128/JVI.69.7.4577-4581.1995; Shair KHY, 2007, PLOS PATHOG, V3, P1669, DOI 10.1371/journal.ppat.0030166; Sjoblom A, 1998, J VIROL, V72, P1365; Soni V, 2007, ADV EXP MED BIOL, V597, P173; Sugiyama T, 2001, FEBS LETT, V508, P16, DOI 10.1016/S0014-5793(01)03010-1; Tsai CN, 1999, VIROLOGY, V261, P288, DOI 10.1006/viro.1999.9851; Tsukada J, 2011, CYTOKINE, V54, P6, DOI 10.1016/j.cyto.2010.12.019; Yoshiyama H, 1997, J VIROL, V71, P5688, DOI 10.1128/JVI.71.7.5688-5691.1997	40	17	19	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42524	42533		10.1074/jbc.M111.271734	http://dx.doi.org/10.1074/jbc.M111.271734			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	22013073	hybrid, Green Published			2022-12-27	WOS:000298180900060
J	Dodson, CA; Bayliss, R				Dodson, Charlotte A.; Bayliss, Richard			Activation of Aurora-A Kinase by Protein Partner Binding and Phosphorylation Are Independent and Synergistic	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOTIC SPINDLE; RESISTANT AURORA; STRUCTURAL BASIS; KINETIC BASIS; INHIBITORS; TPX2; MECHANISM; DISCOVERY; SUBSTRATE; MUTANTS	Protein kinases are activated by phosphorylation and by the binding of activator proteins. The interplay of these two factors is incompletely understood. We applied energetic analysis to this question and characterized the activation process of the serine/threonine kinase Aurora-A by phosphorylation and by its protein partner, targeting protein for Xenopus kinesin-like protein 2 (TPX2). We discovered that these two activators act synergistically and without a predefined order: each can individually increase the activity of Aurora-A, and the effect of both bound together is the exact sum of their individual contributions to catalysis. Unexpectedly, the unphosphorylated enzyme has catalytic activity that is increased 15-fold by the binding of TPX2 alone. The energetic contribution of phosphorylation to catalysis is 2-fold greater than that of TPX2 binding, which is independent of the phosphorylation state of the enzyme. Based on this analysis, we propose a revised, fluid model of Aurora-A activation in which the first step is a reduction in the mobility of the activation loop by either TPX2 binding or phosphorylation. Furthermore, our results suggest that unphosphorylated Aurora-A bound to the mitotic spindle by TPX2 is catalytically active and that the phosphorylation state of Aurora-A is an inaccurate surrogate for its activity. Extending this form of analysis will allow us to compare quantitatively the effects of the whole network of kinase-activating partners. Comparison with other kinases showed that kinetic characterization detects those kinases whose activation loops undergo a rearrangement upon phosphorylation and thus whose unphosphorylated state offers a distinct target for the development of Type II inhibitors.	[Dodson, Charlotte A.; Bayliss, Richard] Inst Canc Res, Div Struct Biol, London SW3 6JB, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Bayliss, R (corresponding author), Univ Leicester, Dept Biochem, Lancaster Rd, Leicester LE1 9HN, Leics, England.	richard.bayliss@le.ac.uk		Dodson, Charlotte/0000-0002-8403-726X; Bayliss, Richard/0000-0003-0604-2773	Royal Society; Cancer Research UK [C24461/A8032]; Institute of Cancer Research; National Health Service	Royal Society(Royal Society of London); Cancer Research UK(Cancer Research UK); Institute of Cancer Research; National Health Service	This work was supported by a Royal Society University Research Fellowship (to R. B.) and Cancer Research UK Project Grant C24461/A8032 (to R. B.).; Mass spectrometry data acquisition and analysis were carried out by Angela Paul and Andrew Thompson at The Institute of Cancer Research Proteomics Core Facility. We thank Jessica Schmitt, Kathy Boxall, Wynne Aherne, Rosemary Burke, and Rob van Montfort in the Division of Cancer Therapeutics for practical advice and use of the Caliper EZ Reader system; Tim Sharpe (Department of Biochemistry, University of Cambridge) for helpful discussions; Mark Richards (The Institute of Cancer Research) for mutagenesis; and Clare Stace (The Institute of Cancer Research) for protein production. We acknowledge the Career Development Faculty Programme of The Institute of Cancer Research and National Health Service funding to the National Institute for Health Research Biomedical Research Centre.	ADAMS JA, 1995, BIOCHEMISTRY-US, V34, P2447, DOI 10.1021/bi00008a007; ADAMS JA, 1992, BIOCHEMISTRY-US, V31, P8516, DOI 10.1021/bi00151a019; Anderson K, 2007, BIOCHEMISTRY-US, V46, P10287, DOI 10.1021/bi7011355; Barr AR, 2007, J CELL SCI, V120, P2987, DOI 10.1242/jcs.013136; Bayliss R, 2003, MOL CELL, V12, P851, DOI 10.1016/S1097-2765(03)00392-7; Dodson CA, 2010, BIOCHEM J, V427, P19, DOI 10.1042/BJ20091530; Eyers PA, 2003, CURR BIOL, V13, P691, DOI 10.1016/S0960-9822(03)00166-0; Fersht A. R., 1985, ENZYME STRUCTURE MEC, p[298, 303, 304, 350]; Hagopian JC, 2001, J BIOL CHEM, V276, P275, DOI 10.1074/jbc.M007337200; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; Lew J, 2003, BIOCHEMISTRY-US, V42, P849, DOI 10.1021/bi0269761; Littlepage LE, 2002, P NATL ACAD SCI USA, V99, P15440, DOI 10.1073/pnas.202606599; Liu Y, 2006, NAT CHEM BIOL, V2, P358, DOI 10.1038/nchembio799; Pollard JR, 2009, J MED CHEM, V52, P2629, DOI 10.1021/jm8012129; Saylor P, 1998, BIOCHEMISTRY-US, V37, P17875, DOI 10.1021/bi981775b; Scutt PJ, 2009, J BIOL CHEM, V284, P15880, DOI 10.1074/jbc.M109.005694; Sloane DA, 2010, ACS CHEM BIOL, V5, P563, DOI 10.1021/cb100053q; Stevenson LM, 2002, BIOCHEMISTRY-US, V41, P8528, DOI 10.1021/bi025812h; Toya M, 2011, NAT CELL BIOL, V13, P708, DOI 10.1038/ncb2242; Tyler RK, 2007, CELL CYCLE, V6, P2846, DOI 10.4161/cc.6.22.4940; Tyson JJ, 2003, CURR OPIN CELL BIOL, V15, P221, DOI 10.1016/S0955-0674(03)00017-6; Welburn JPI, 2007, J BIOL CHEM, V282, P3173, DOI 10.1074/jbc.M609151200; WILKINSON AJ, 1983, BIOCHEMISTRY-US, V22, P3581, DOI 10.1021/bi00284a007; Zeng K, 2010, J CELL BIOL, V191, P1315, DOI 10.1083/jcb.201008106; Zhang YY, 2008, J BIOL CHEM, V283, P26591, DOI 10.1074/jbc.M801703200	26	72	76	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					1150	1157		10.1074/jbc.M111.312090	http://dx.doi.org/10.1074/jbc.M111.312090			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22094468	hybrid, Green Published			2022-12-27	WOS:000299170300030
J	Dong, XT; Sumandea, CA; Chen, YC; Garcia-Cazarin, ML; Zhang, J; Balke, CW; Sumandea, MP; Ge, Y				Dong, Xintong; Sumandea, C. Amelia; Chen, Yi-Chen; Garcia-Cazarin, Mary L.; Zhang, Jiang; Balke, C. William; Sumandea, Marius P.; Ge, Ying			Augmented Phosphorylation of Cardiac Troponin I in Hypertensive Heart Failure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; DOWN MASS-SPECTROMETRY; ANGIOTENSIN-CONVERTING ENZYME; ELECTRON-CAPTURE DISSOCIATION; MYOFILAMENT CA2+ SENSITIVITY; FAILING HUMAN HEART; TOP-DOWN; POSTTRANSLATIONAL MODIFICATIONS; CONTRACTILE PROTEINS; MYOCARDIAL FIBROSIS	An altered cardiac myofilament response to activating Ca2+ is a hallmark of human heart failure. Phosphorylation of cardiac troponin I (cTnI) is critical in modulating contractility and Ca2+ sensitivity of cardiac muscle. cTnI can be phosphorylated by protein kinaseA(PKA) at Ser(22/23) and protein kinase C (PKC) at Ser(22/23), Ser(42/44), and Thr(143). Whereas the functional significance of Ser(22/23) phosphorylation is well understood, the role of other cTnI phosphorylation sites in the regulation of cardiac contractility remains a topic of intense debate, in part, due to the lack of evidence of in vivo phosphorylation. In this study, we utilized top-down high resolution mass spectrometry (MS) combined with immunoaffinity chromatography to determine quantitatively the cTnI phosphorylation changes in spontaneously hypertensive rat (SHR) model of hypertensive heart disease and failure. Our data indicate that cTnI is hyperphosphorylated in the failing SHR myocardium compared with age-matched normotensive Wistar-Kyoto rats. The top-down electron capture dissociation MS unambiguously localized augmented phosphorylation sites to Ser(22/23) and Ser(42/44) in SHR. Enhanced Ser(22/23) phosphorylation was verified by immunoblotting with phospho-specific antibodies. Immunoblot analysis also revealed up-regulation of PKC-alpha and -delta, decreased PKC epsilon, but no changes in PKA or PKC-beta levels in the SHR myocardium. This provides direct evidence of in vivo phosphorylation of cTnI-Ser(42/44) (PKC-specific) sites in an animal model of hypertensive heart failure, supporting the hypothesis that PKC phosphorylation of cTnI may be maladaptive and potentially associated with cardiac dysfunction.	[Dong, Xintong; Chen, Yi-Chen; Zhang, Jiang; Ge, Ying] Univ Wisconsin, Human Prote Program, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Ge, Ying] Univ Wisconsin, Dept Cell & Regenerat Biol, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Sumandea, C. Amelia; Garcia-Cazarin, Mary L.; Sumandea, Marius P.] Univ Kentucky, Dept Physiol, Lexington, KY 40536 USA; [Balke, C. William] Univ Calif San Francisco, Clin & Translat Sci Inst, San Francisco, CA 94143 USA; [Balke, C. William] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Kentucky; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Sumandea, MP (corresponding author), Eli Lilly & Co, Lilly Corp Ctr, Indianapolis, IN 46285 USA.	sumandea_marius_p@lilly.com; ge2@wisc.edu	Zhang, Jiang/D-1136-2015		National Institutes of Health [R01HL096971, AG032009]; Wisconsin Partnership Fund for a Healthy Future; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096971] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R03AG032009] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wisconsin Partnership Fund for a Healthy Future; American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01HL096971 (to Y. G.) and AG032009 (to M.P.S.). This work was also supported by the Wisconsin Partnership Fund for a Healthy Future and an American Heart Association Scientist Development grant (to Y. G.).	Ayaz-Guner S, 2009, BIOCHEMISTRY-US, V48, P8161, DOI 10.1021/bi900739f; Belin RJ, 2007, CIRC RES, V101, P195, DOI 10.1161/CIRCRESAHA.107.148288; BING OHL, 1991, CIRC RES, V68, P1390, DOI 10.1161/01.RES.68.5.1390; BING OHL, 1995, J MOL CELL CARDIOL, V27, P383, DOI 10.1016/S0022-2828(08)80035-1; Bing Oscar H L, 2002, Heart Fail Rev, V7, P71; Boknik P, 2001, CARDIOVASC RES, V51, P717, DOI 10.1016/S0008-6363(01)00346-7; Bowling N, 1999, CIRCULATION, V99, P384, DOI 10.1161/01.CIR.99.3.384; Brooks WW, 1997, CIRCULATION, V96, P4002; Burkart EM, 2003, J BIOL CHEM, V278, P11265, DOI 10.1074/jbc.M210712200; Ge Y, 2002, J AM CHEM SOC, V124, P672, DOI 10.1021/ja011335z; Ge Y, 2009, P NATL ACAD SCI USA, V106, P12658, DOI 10.1073/pnas.0813369106; Gray MO, 1997, J BIOL CHEM, V272, P30945, DOI 10.1074/jbc.272.49.30945; Han XM, 2006, SCIENCE, V314, P109, DOI 10.1126/science.1128868; Jiang L, 2007, J BIOL CHEM, V282, P27923, DOI 10.1074/jbc.M704194200; Jideama NM, 1996, J BIOL CHEM, V271, P23277, DOI 10.1074/jbc.271.38.23277; Kang M, 2007, PHYSIOLOGY, V22, P174, DOI 10.1152/physiol.00051.2006; Kelleher NL, 1999, J AM CHEM SOC, V121, P806, DOI 10.1021/ja973655h; Kentish JC, 2001, CIRC RES, V88, P1059, DOI 10.1161/hh1001.091640; Kirk JA, 2009, CIRC RES, V105, P1232, DOI 10.1161/CIRCRESAHA.109.205427; Kobayashi T, 2005, J MOL CELL CARDIOL, V38, P213, DOI 10.1016/j.yjmcc.2004.10.014; KRANIAS EG, 1982, NATURE, V298, P182, DOI 10.1038/298182a0; Layland J, 2005, CARDIOVASC RES, V66, P12, DOI 10.1016/j.cardiores.2004.12.022; Marston SB, 2008, J MOL CELL CARDIOL, V45, P603, DOI 10.1016/j.yjmcc.2008.07.004; Marston SB, 2009, J MUSCLE RES CELL M, V30, P93, DOI 10.1007/s10974-009-9184-y; McCarty MF, 1996, MED HYPOTHESES, V46, P191, DOI 10.1016/S0306-9877(96)90243-1; McMurray JJV, 2005, LANCET, V365, P1877, DOI 10.1016/S0140-6736(05)66621-4; Messer AE, 2007, J MOL CELL CARDIOL, V42, P247, DOI 10.1016/j.yjmcc.2006.08.017; Messer AE, 2009, PROTEOM CLIN APPL, V3, P1371, DOI 10.1002/prca.200900071; Montgomery DE, 2002, AM J PHYSIOL-HEART C, V282, pH2397, DOI 10.1152/ajpheart.00714.2001; Mudd JO, 2008, NATURE, V451, P919, DOI 10.1038/nature06798; NOLAND TA, 1995, J BIOL CHEM, V270, P25445, DOI 10.1074/jbc.270.43.25445; NOLAND TA, 1989, J BIOL CHEM, V264, P20778; OKAMOTO KOZO, 1963, JAPAN CIRCULATION JOUR, V27, P282; Pesavento JJ, 2008, J BIOL CHEM, V283, P14927, DOI 10.1074/jbc.M709796200; Pi YQ, 2003, J PHYSIOL-LONDON, V552, P845, DOI 10.1113/jphysiol.2003.045260; Pi YQ, 2002, CIRC RES, V90, P649, DOI 10.1161/01.RES.0000014080.82861.5F; PRATJE E, 1972, FEBS LETT, V27, P89, DOI 10.1016/0014-5793(72)80416-2; Pyle WG, 2002, AM J PHYSIOL-HEART C, V283, pH1215, DOI 10.1152/ajpheart.00128.2002; ROBERTSON SP, 1982, J BIOL CHEM, V257, P260; Roman BB, 2004, AM J PHYSIOL-HEART C, V286, pH2089, DOI 10.1152/ajpheart.00582.2003; Ryan CM, 2010, MOL CELL PROTEOMICS, V9, P791, DOI 10.1074/mcp.M900516-MCP200; Salas MA, 2001, J MOL CELL CARDIOL, V33, P1957, DOI 10.1006/jmcc.2001.1460; Salazar NC, 2007, BBA-BIOMEMBRANES, V1768, P1006, DOI 10.1016/j.bbamem.2007.02.010; SCHUNKERT H, 1993, CIRCULATION, V87, P1328, DOI 10.1161/01.CIR.87.4.1328; Scruggs SB, 2006, J MOL CELL CARDIOL, V40, P465, DOI 10.1016/j.yjmcc.2005.12.009; Sfichi-Duke L, 2010, J MOL CELL CARDIOL, V48, P934, DOI 10.1016/j.yjmcc.2010.01.005; Simonis G, 2002, BASIC RES CARDIOL, V97, P223, DOI 10.1007/s003950200015; Siuti N, 2007, NAT METHODS, V4, P817, DOI 10.1038/NMETH1097; Solaro RJ, 2008, J BIOL CHEM, V283, P26829, DOI 10.1074/jbc.R800037200; Solaro RJ, 2008, BIOCHEM BIOPH RES CO, V369, P82, DOI 10.1016/j.bbrc.2007.12.114; Solaro RJ, 2010, J MOL CELL CARDIOL, V48, P810, DOI 10.1016/j.yjmcc.2010.02.014; SOLARO RJ, 1976, NATURE, V262, P615, DOI 10.1038/262615a0; Solis RS, 2008, J MUSCLE RES CELL M, V29, P203, DOI 10.1007/s10974-009-9168-y; STRANG KT, 1994, CIRC RES, V74, P542, DOI 10.1161/01.RES.74.3.542; STUDER R, 1994, J CLIN INVEST, V94, P301, DOI 10.1172/JCI117322; STULL JT, 1972, J BIOL CHEM, V247, P5272; Sumandea CA, 2011, J BIOL CHEM, V286, P530, DOI 10.1074/jbc.M110.148684; Sumandea MP, 2008, J BIOL CHEM, V283, P22680, DOI 10.1074/jbc.M802396200; Sumandea MP, 2004, ANN NY ACAD SCI, V1015, P39, DOI 10.1196/annals.1302.004; SUN Y, 1994, CARDIOVASC RES, V28, P1423, DOI 10.1093/cvr/28.9.1423; Sze SK, 2002, P NATL ACAD SCI USA, V99, P1774, DOI 10.1073/pnas.251691898; Takeda S, 2003, NATURE, V424, P35, DOI 10.1038/nature01780; van der Velden J, 2006, CARDIOVASC RES, V69, P876, DOI 10.1016/j.cardiores.2005.11.021; van der Velden J, 2003, CARDIOVASC RES, V57, P37, DOI 10.1016/S0008-6363(02)00606-5; Vlahos CJ, 2003, NAT REV DRUG DISCOV, V2, P99, DOI 10.1038/nrd1009; Walker JW, 2006, J MOL CELL CARDIOL, V40, P446, DOI 10.1016/j.yjmcc.2006.01.013; Wang H, 2006, J MOL CELL CARDIOL, V41, P823, DOI 10.1016/j.yjmcc.2006.08.016; Westfall MV, 2003, J BIOL CHEM, V278, P33694, DOI 10.1074/jbc.M305404200; Xu FM, 2011, INT J MASS SPECTROM, V305, P95, DOI 10.1016/j.ijms.2010.09.007; Zabrouskov V, 2008, MOL CELL PROTEOMICS, V7, P1838, DOI 10.1074/mcp.M700524-MCP200; Zhang J, 2011, J PROTEOME RES, V10, P4054, DOI 10.1021/pr200258m; Zhang JA, 2010, J AM SOC MASS SPECTR, V21, P940, DOI 10.1016/j.jasms.2010.02.005; Zubarev RA, 2000, ANAL CHEM, V72, P563, DOI 10.1021/ac990811p	73	81	83	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					848	857		10.1074/jbc.M111.293258	http://dx.doi.org/10.1074/jbc.M111.293258			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22052912	Green Published, hybrid			2022-12-27	WOS:000299170300004
J	Marathe, N; Rangaswami, H; Zhuang, SH; Boss, GR; Pilz, RB				Marathe, Nisha; Rangaswami, Hema; Zhuang, Shunhui; Boss, Gerry R.; Pilz, Renate B.			Pro-survival Effects of 17 beta-Estradiol on Osteocytes Are Mediated by Nitric Oxide/cGMP via Differential Actions of cGMP-dependent Protein Kinases I and II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC-GMP; INDUCED APOPTOSIS; OXIDATIVE STRESS; POSTMENOPAUSAL WOMEN; BONE-FORMATION; BH3 DOMAIN; ESTROGEN; ALPHA; BAD; PHOSPHORYLATION	Estrogens promote bone health in part by increasing osteocyte survival, an effect that requires activation of the protein kinases Akt and ERK1/2, but the molecular mechanisms involved are only partly understood. Because estrogens increase nitric oxide (NO) synthesis and NO can have anti-apoptotic effects, we examined the role of NO/cGMP signaling in estrogen regulation of osteocyte survival. Etoposide-induced death of MLO-Y4 osteocyte-like cells, assessed by trypan blue staining, caspase-3 cleavage, and TUNEL assays, was completely prevented when cells were pre-treated with 17 beta-estradiol. This protective effect was mimicked when cells were pre-treated with a membrane-permeable cGMP analog and blocked by pharmacological inhibitors of NO synthase, soluble guanylate cyclase, or cGMP-dependent protein kinases (PKGs), supporting a requirement for NO/cGMP/PKG signaling downstream of 17 beta-estradiol. siRNA-mediated knockdown and viral reconstitution of individual PKG isoforms demonstrated that the anti-apoptotic effects of estradiol and cGMP were mediated by PKG I alpha and PKG II. Akt and ERK1/2 activation by 17 beta-estradiol required PKG II, and cGMP mimicked the effects of estradiol on Akt and ERK, including induction of ERK nuclear translocation. cGMP induced BAD phosphorylation on several sites, and experiments with phosphorylation-deficient BAD mutants demonstrated that the anti-apoptotic effects of cGMP and 17 beta-estradiol required BAD phosphorylation on Ser(136) and Ser(155); these sites were targeted by Akt and PKG I, respectively, and regulate BAD interaction with Bcl-2. In conclusion, 17 beta-estradiol protects osteocytes against apoptosis by activating the NO/cGMP/PKG cascade; PKG II is required for estradiol-induced activation of ERK and Akt, and PKG I alpha contributes to pro-survival signaling by directly phosphorylating BAD.	Univ Calif San Diego, Dept Med, San Diego, CA 92093 USA; Univ Calif San Diego, Ctr Canc, San Diego, CA 92093 USA; Univ Calif San Diego, Biomed Sci Grad Progam, San Diego, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Pilz, RB (corresponding author), Univ Calif San Diego, Dept Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	rpilz@ucsd.edu		Boss, Gerry/0000-0002-9758-8714	National Institutes of Health [R01-AR051300];  [T32-HL007261]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007261] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR051300] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-AR051300 (to R. B. P.) and Training Grant T32-HL007261 (to N. M.).	Alexaki VI, 2006, J STEROID BIOCHEM, V98, P97, DOI 10.1016/j.jsbmb.2005.08.017; Almeida M, 2007, J BIOL CHEM, V282, P27285, DOI 10.1074/jbc.M702810200; Almeida M, 2010, J BONE MINER RES, V25, P769, DOI 10.1359/jbmr.091017; Armour KE, 1998, ENDOCRINOLOGY, V139, P799, DOI 10.1210/en.139.2.799; Armour KE, 2001, ENDOCRINOLOGY, V142, P760, DOI 10.1210/en.142.2.760; Blaise GA, 2005, TOXICOLOGY, V208, P177, DOI 10.1016/j.tox.2004.11.032; Casteel DE, 2002, J BIOL CHEM, V277, P32003, DOI 10.1074/jbc.M112332200; Chae HJ, 2006, CLIN CHIM ACTA, V365, P270, DOI 10.1016/j.cca.2005.09.011; Chen JR, 2005, J BIOL CHEM, V280, P4632, DOI 10.1074/jbc.M411530200; Cherney A, 2003, AM J PHYSIOL-REG I, V285, pR842, DOI 10.1152/ajpregu.00035.2003; Cheskis BJ, 2007, J CELL PHYSIOL, V213, P610, DOI 10.1002/jcp.21253; Danial NN, 2008, ONCOGENE, V27, pS53, DOI 10.1038/onc.2009.44; Das A, 2008, J BIOL CHEM, V283, P29572, DOI 10.1074/jbc.M801547200; Datta SR, 2000, MOL CELL, V6, P41, DOI 10.1016/S1097-2765(00)00006-X; Fiscus RR, 2002, NEUROSIGNALS, V11, P175, DOI 10.1159/000065431; Francis SH, 2010, PHARMACOL REV, V62, P525, DOI 10.1124/pr.110.002907; Gohel A, 1999, ENDOCRINOLOGY, V140, P5339, DOI 10.1210/en.140.11.5339; Grassi F, 2006, ENDOCRINOLOGY, V147, P4392, DOI 10.1210/en.2006-0334; Gudi T, 1997, MOL CELL BIOL, V17, P5244, DOI 10.1128/MCB.17.9.5244; Guo XM, 2005, J BIOL CHEM, V280, P19704, DOI 10.1074/jbc.M501244200; Hofmann Franz, 2009, V191, P137, DOI 10.1007/978-3-540-68964-5_8; Hukkanen M, 2003, BONE, V32, P142, DOI 10.1016/S8756-3282(02)00955-9; Jamal SA, 2004, J BONE MINER RES, V19, P1512, DOI 10.1359/JBMR.040716; Jamal SA, 2011, JAMA-J AM MED ASSOC, V305, P800, DOI 10.1001/jama.2011.176; Johlfs MG, 2010, NEUROCHEM INT, V56, P546, DOI 10.1016/j.neuint.2009.12.017; Kato Y, 1997, J BONE MINER RES, V12, P2014, DOI 10.1359/jbmr.1997.12.12.2014; Kim YM, 1999, J NEUROSCI, V19, P6740, DOI 10.1523/JNEUROSCI.19-16-06740.1999; Koga M, 2004, BIOCHEM BIOPH RES CO, V324, P321, DOI 10.1016/j.bbrc.2004.09.060; Kousteni S, 2001, CELL, V104, P719, DOI 10.1016/S0092-8674(01)00268-9; Levin ER, 2011, MOL ENDOCRINOL, V25, P377, DOI 10.1210/me.2010-0284; Li L, 2007, P NATL ACAD SCI USA, V104, P16468, DOI 10.1073/pnas.0704315104; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Manolagas SC, 2010, ENDOCR REV, V31, P266, DOI 10.1210/er.2009-0024; O'Shaughnessy MC, 2000, BIOCHEM BIOPH RES CO, V277, P604, DOI 10.1006/bbrc.2000.3714; Parker JD, 2004, J CLIN INVEST, V113, P352, DOI 10.1172/JCI200421003; Patten RD, 2004, CIRC RES, V95, P692, DOI 10.1161/01.RES.0000144126.57786.89; Pfeifer A, 1996, SCIENCE, V274, P2082, DOI 10.1126/science.274.5295.2082; Plotkin LI, 2005, J BIOL CHEM, V280, P7317, DOI 10.1074/jbc.M412817200; Raisz LG, 2005, J CLIN INVEST, V115, P3318, DOI 10.1172/JCI27071; Rangaswami H, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001423; Rangaswami H, 2009, J BIOL CHEM, V284, P14796, DOI 10.1074/jbc.M806486200; Samuels A, 2001, BONE, V29, P24, DOI 10.1016/S8756-3282(01)00471-9; Schlossmann J, 2000, NATURE, V404, P197, DOI 10.1038/35004606; Soh JW, 2000, CLIN CANCER RES, V6, P4136; Stratton RC, 2010, J BIOL CHEM, V285, P27201, DOI 10.1074/jbc.M110.103630; Surks HK, 1999, SCIENCE, V286, P1583, DOI 10.1126/science.286.5444.1583; Tan SD, 2006, J DENT RES, V85, P905, DOI 10.1177/154405910608501006; Tang M, 2003, NAT MED, V9, P1506, DOI 10.1038/nm958; Tomkinson A, 1997, J CLIN ENDOCR METAB, V82, P3128, DOI 10.1210/jc.82.9.3128; Weber S, 2007, CIRC RES, V101, P1096, DOI 10.1161/CIRCRESAHA.107.154351; Wimalawansa SJ, 1996, BONE, V18, P301, DOI 10.1016/8756-3282(96)00005-1; Wimalawansa SJ, 2007, ANN NY ACAD SCI, V1117, P283, DOI 10.1196/annals.1402.066; Wong JC, 2011, J CELL BIOCHEM, V112, P829, DOI 10.1002/jcb.22981; Zhou XM, 2000, J BIOL CHEM, V275, P25046, DOI 10.1074/jbc.M002526200	54	64	69	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					978	988		10.1074/jbc.M111.294959	http://dx.doi.org/10.1074/jbc.M111.294959			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22117068	Green Published, hybrid			2022-12-27	WOS:000299170300016
J	Mondejar, LG; Lupas, A; Schultz, A; Schultz, JE				Mondejar, Laura Garcia; Lupas, Andrei; Schultz, Anita; Schultz, Joachim E.			HAMP Domain-mediated Signal Transduction Probed with a Mycobacterial Adenylyl Cyclase as a Reporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLI SERINE CHEMORECEPTOR; ESCHERICHIA-COLI; MUTATIONAL ANALYSIS; LINKER REGION; HISTIDINE KINASE; PROTEINS; RECEPTOR; ENVZ; ASPARTATE; HELICES	HAMP domains, similar to 55 amino acid motifs first identified in histidine kinases, adenylyl cyclases, methyl-accepting chemotaxis proteins, and phosphatases, operate as signal mediators in two-component signal transduction proteins. A bioinformatics study identified a coevolving signal-accepting network of 10 amino acids in membrane-delimited HAMP proteins. To probe the functionality of this network we used a HAMP containing mycobacterial adenylyl cyclase, Rv3645, as a reporter enzyme in which the membrane anchor was substituted by the Escherichia coli chemotaxis receptor for serine (Tsr receptor) and the HAMP domain alternately with that from the protein Af1503 of the archaeon Archaeoglobus fulgidus or the Tsr receptor. In a construct with the Tsr-HAMP, cyclase activity was inhibited by serine, whereas in a construct with the HAMP domain from A. fulgidus, enzyme activity was not responsive to serine. Amino acids of the signal-accepting network were mutually swapped between both HAMP domains, and serine signaling was examined. The data biochemically tentatively established the functionality of the signal-accepting network. Based on a two-state gearbox model of rotation in HAMP domain-mediated signal propagation, we characterized the interaction between permanent and transient core residues in a coiled coil HAMP structure. The data are compatible with HAMP rotation in signal propagation but do not exclude alternative models for HAMP signaling. Finally, we present data indicating that the connector, which links the alpha-helices of HAMP domains, plays an important structural role in HAMP function.	[Mondejar, Laura Garcia; Schultz, Anita; Schultz, Joachim E.] Univ Tubingen, Inst Pharmazeut, D-72076 Tubingen, Germany; [Lupas, Andrei] Max Planck Inst Entwicklungsbiol, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Max Planck Society	Schultz, JE (corresponding author), Univ Tubingen, Inst Pharmazeut, Morgenstelle 8, D-72076 Tubingen, Germany.	joachim.schultz@uni-tuebingen.de			Deutsche Forschungsgemeinschaft [SFB 766, TP B8]; Max Planck Society	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Max Planck Society(Max Planck Society)	This work was supported by the Deutsche Forschungsgemeinschaft (SFB 766, TP B8) and by institutional funds of the Max Planck Society.	Airola MV, 2010, STRUCTURE, V18, P436, DOI 10.1016/j.str.2010.01.013; Ames P, 2008, J BACTERIOL, V190, P6676, DOI 10.1128/JB.00750-08; Appleman JA, 2003, J BACTERIOL, V185, P4872, DOI 10.1128/JB.185.16.4872-4882.2003; Appleman JA, 2003, J BACTERIOL, V185, P89, DOI 10.1128/JB.185.1.89-97.2003; Aravind L, 1999, FEMS MICROBIOL LETT, V176, P111, DOI 10.1016/S0378-1097(99)00197-4; BAUMGARTNER JW, 1994, J BACTERIOL, V176, P1157, DOI 10.1128/JB.176.4.1157-1163.1994; Butler SL, 1998, BIOCHEMISTRY-US, V37, P10746, DOI 10.1021/bi980607g; Dunin-Horkawicz S, 2010, J MOL BIOL, V397, P1156, DOI 10.1016/j.jmb.2010.02.031; Ferris HU, 2011, STRUCTURE, V19, P378, DOI 10.1016/j.str.2011.01.006; Galperin MY, 2004, ENVIRON MICROBIOL, V6, P552, DOI 10.1111/j.1462-2920.2004.00633.x; Hammer A., 2004, THESIS EBERHARD KARL; Hazelbauer GL, 2008, TRENDS BIOCHEM SCI, V33, P9, DOI 10.1016/j.tibs.2007.09.014; Hulko M, 2006, CELL, V126, P929, DOI 10.1016/j.cell.2006.06.058; JIN T, 1994, J MOL BIOL, V244, P477, DOI 10.1006/jmbi.1994.1746; Kanchan K, 2010, J BIOL CHEM, V285, P2090, DOI 10.1074/jbc.M109.051698; Kishii R, 2007, J BIOL CHEM, V282, P26401, DOI 10.1074/jbc.M701342200; Kitanovic S, 2011, J BACTERIOL, V193, P5062, DOI 10.1128/JB.05683-11; Linder JU, 2004, EUR J BIOCHEM, V271, P2446, DOI 10.1111/j.1432-1033.2004.04172.x; PARKINSON JS, 1992, ANNU REV GENET, V26, P71, DOI 10.1146/annurev.ge.26.120192.000443; SALOMON Y, 1974, ANAL BIOCHEM, V58, P541, DOI 10.1016/0003-2697(74)90222-X; Swain KE, 2007, BIOCHEMISTRY-US, V46, P13684, DOI 10.1021/bi701832b; UTSUMI R, 1989, SCIENCE, V245, P1246, DOI 10.1126/science.2476847; Watts KJ, 2008, J BACTERIOL, V190, P2118, DOI 10.1128/JB.01858-07; Williams SB, 1999, MOL MICROBIOL, V33, P1093, DOI 10.1046/j.1365-2958.1999.01562.x; Zhou Q, 2009, MOL MICROBIOL, V73, P801, DOI 10.1111/j.1365-2958.2009.06819.x; Zhu Y, 2003, J BIOL CHEM, V278, P22812, DOI 10.1074/jbc.M300916200	26	23	23	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					1022	1031		10.1074/jbc.M111.284067	http://dx.doi.org/10.1074/jbc.M111.284067			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22094466	Green Published, hybrid			2022-12-27	WOS:000299170300019
J	Allewell, NM				Allewell, Norma M.			Thematic Minireview Series on Enzyme Evolution in the Post-genomic Era	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review								The emergence of genomics; ongoing computational advances; and the development of large-scale sequence, structural, and functional databases have created important new interdisciplinary linkages between molecular evolution, molecular biology, and enzymology. The five minireviews in this series survey advances and challenges in this burgeoning field from complementary perspectives. The series has three major themes. The first is the evolution of enzyme superfamilies, in which members exhibit increasing sequence, structural, and functional divergence with increasing time of divergence from a common ancestor. The second is the evolutionary role of promiscuous enzymes, which, in addition to their primary function, have adventitious secondary activities that frequently provide the starting point for the evolution of new enzymes. The third is the importance of in silico approaches to the daunting challenge of assigning and predicting the functions of the many uncharacterized proteins in the large-scale sequence and structural databases that are now available. A recent computational advance, the use of protein similarity networks that map functional data onto proteins clustered by similarity, is presented as an approach that can improve functional insight and inference. The three themes are illustrated with several examples of enzyme superfamilies, including the amidohydrolase, metallo-beta-lactamase, and enolase superfamilies.	Univ Maryland, Dept Mol Genet & Cell Biol, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Allewell, NM (corresponding author), Univ Maryland, Dept Mol Genet & Cell Biol, College Pk, MD 20742 USA.	allewell@umd.edu						Gerlt JA, 2001, ANNU REV BIOCHEM, V70, P209, DOI 10.1146/annurev.biochem.70.1.209; VALLEE BL, 1968, P NATL ACAD SCI USA, V59, P498, DOI 10.1073/pnas.59.2.498	2	6	6	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					1	2		10.1074/jbc.R111.307322	http://dx.doi.org/10.1074/jbc.R111.307322			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22069328	Green Published, hybrid			2022-12-27	WOS:000298682400001
J	de Paula, CAA; Coulson-Thomas, VJ; Ferreira, JG; Maza, PK; Suzuki, E; Nakahata, AM; Nader, HB; Sampaio, MU; Oliva, MLV				Andrade de Paula, Claudia Alessandra; Coulson-Thomas, Vivien Jane; Ferreira, Joana Gasperazzo; Maza, Paloma Korehisa; Suzuki, Erika; Nakahata, Adriana Miti; Nader, Helena Bonciani; Sampaio, Misako Uemura; Oliva, Maria Luiza V.			Enterolobium contortisiliquum Trypsin Inhibitor (EcTI), a Plant Proteinase Inhibitor, Decreases in Vitro Cell Adhesion and Invasion by Inhibition of Src Protein-Focal Adhesion Kinase (FAK) Signaling Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-TUMOR CELLS; BONE-MARROW STROMA; INVADOPODIA FORMATION; CANCER CELLS; N-WASP; PROSTATE-CANCER; MATRIX METALLOPROTEINASES; COLON-CANCER; C-SRC; MIGRATION	Tumor cell invasion is vital for cancer progression and metastasis. Adhesion, migration, and degradation of the extracellular matrix are important events involved in the establishment of cancer cells at a new site, and therefore molecular targets are sought to inhibit such processes. The effect of a plant proteinase inhibitor, Enterolobium contortisiliquum trypsin inhibitor (EcTI), on the adhesion, migration, and invasion of gastric cancer cells was the focus of this study. EcTI showed no effect on the proliferation of gastric cancer cells or fibroblasts but inhibited the adhesion, migration, and cell invasion of gastric cancer cells; however, EcTI had no effect upon the adhesion of fibroblasts. EcTI was shown to decrease the expression and disrupt the cellular organization of molecules involved in the formation and maturation of invadopodia, such as integrin beta 1, cortactin, neuronal Wiskott-Aldrich syndrome protein, membrane type 1 metalloprotease, and metalloproteinase-2. Moreover, gastric cancer cells treated with EcTI presented a significant decrease in intracellular phosphorylated Src and focal adhesion kinase, integrin-dependent cell signaling components. Together, these results indicate that EcTI inhibits the invasion of gastric cancer cells through alterations in integrin-dependent cell signaling pathways.	[Andrade de Paula, Claudia Alessandra; Coulson-Thomas, Vivien Jane; Ferreira, Joana Gasperazzo; Nakahata, Adriana Miti; Nader, Helena Bonciani; Sampaio, Misako Uemura; Oliva, Maria Luiza V.] Univ Fed Sao Paulo, Escola Paulista Med, Dept Biochem & Mol Biol, BR-04044020 Sao Paulo, Brazil; [Maza, Paloma Korehisa; Suzuki, Erika] Univ Fed Sao Paulo, Escola Paulista Med, Dept Microbiol Immunol & Parasitol, BR-04044020 Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP)	Oliva, MLV (corresponding author), Univ Fed Sao Paulo, Escola Paulista Med, Dept Bioquim, Rua Tres Maio 100, BR-04044020 Sao Paulo, Brazil.	olivaml.bioq@epm.br	SAMPAIO, MISAKO/D-8718-2013; Nader, Helena Bonciani/D-9253-2012; de Paula, Claudia/X-2904-2018; Nakahata, Adriana/K-4898-2012; Oliva, Maria Luiza V/B-9537-2012; Vilela Oliva, Maria Luiza/AGI-6283-2022; Suzuki, Erika/B-3456-2008	Suzuki, Erika/0000-0002-4010-8716; NADER, HELENA/0000-0002-7569-2166; Oliva, Maria Luiza Vilela/0000-0001-7346-6328; Gasperazzo Ferreira, Jona/0000-0002-6713-1123; Oliva, Maria Luiza/0000-0002-5822-0060	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2009/53766-5]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo Grant 2009/53766-5, Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico.	Abbenante Giovanni, 2005, Med Chem, V1, P71, DOI 10.2174/1573406053402569; Albiges-Rizo C, 2009, J CELL SCI, V122, P3037, DOI 10.1242/jcs.052704; Albrechtsen R, 2011, EXP CELL RES, V317, P195, DOI 10.1016/j.yexcr.2010.10.003; Ammer Amanda Gatesman, 2009, J Cancer Sci Ther, V1, P52; Anthis NJ, 2011, TRENDS BIOCHEM SCI, V36, P191, DOI 10.1016/j.tibs.2010.11.002; Armstrong AJ, 2010, CLIN CANCER RES, V16, P3057, DOI 10.1158/1078-0432.CCR-10-0124; Artym VV, 2011, EUR J CELL BIOL, V90, P172, DOI 10.1016/j.ejcb.2010.06.006; Artym VV, 2006, CANCER RES, V66, P3034, DOI 10.1158/0008-5472.CAN-05-2177; Ateeq B, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001498; Balzer EM, 2010, ONCOGENE, V29, P6402, DOI 10.1038/onc.2010.360; Batista IFC, 1996, PHYTOCHEMISTRY, V41, P1017, DOI 10.1016/0031-9422(95)00710-5; Bergeron S, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-271; Blouw B, 2008, EUR J CELL BIOL, V87, P555, DOI 10.1016/j.ejcb.2008.02.008; Bolos V, 2010, ONCOTARGETS THER, V3, P83; BORNSTEIN MB, 1958, LAB INVEST, V7, P134; Bouchard V, 2008, APOPTOSIS, V13, P531, DOI 10.1007/s10495-008-0192-y; Boykin C, 2011, BRIT J CANCER, V104, P781, DOI 10.1038/bjc.2011.10; Bozzuto G, 2010, ANN I SUPER SANITA, V46, P66, DOI 10.4415/ANN_10_01_09; Caccia D, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-278; Canel M, 2008, BRIT J CANCER, V98, P1274, DOI 10.1038/sj.bjc.6604286; Cavallaro U, 2004, NAT REV CANCER, V4, P118, DOI 10.1038/nrc1276; Chuu CP, 2011, MED HYPOTHESES, V76, P697, DOI 10.1016/j.mehy.2011.01.037; Coulson-Thomas VJ, 2011, CELL TISSUE RES, V346, P223, DOI 10.1007/s00441-011-1254-y; DesMarais V, 2009, CELL MOTIL CYTOSKEL, V66, P303, DOI 10.1002/cm.20361; Di Florio A, 2007, ENDOCR-RELAT CANCER, V14, P111, DOI 10.1677/erc.1.01318; Donia M, 2011, CELL CYCLE, V10, P492, DOI 10.4161/cc.10.3.14727; Donkor IO, 2011, EXPERT OPIN THER PAT, V21, P601, DOI 10.1517/13543776.2011.568480; Dutta A, 2009, J ONCOL, V2009, DOI 10.1155/2009/627840; Ghiso JAA, 2002, ONCOGENE, V21, P2513, DOI 10.1038/sj/onc/1205342; Gianni D, 2010, ACS CHEM BIOL, V5, P981, DOI 10.1021/cb100219n; Gjorevski N, 2009, CYTOKINE GROWTH F R, V20, P459, DOI 10.1016/j.cytogfr.2009.10.013; Halder J, 2007, CANCER RES, V67, P10976, DOI 10.1158/0008-5472.CAN-07-2667; Hecker TP, 2002, CANCER RES, V62, P2699; Hwang Y. S., 2011, ARCH ORAL B IN PRESS; Johnson FM, 2005, CLIN CANCER RES, V11, P6924, DOI 10.1158/1078-0432.CCR-05-0757; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Kim JY, 2005, BIOCHEM BIOPH RES CO, V330, P921, DOI 10.1016/j.bbrc.2005.03.057; Korting HC, 1999, ANTIMICROB AGENTS CH, V43, P2038, DOI 10.1128/AAC.43.8.2038; Kwiatkowska A, 2011, BBA-MOL CELL RES, V1813, P655, DOI 10.1016/j.bbamcr.2011.01.020; Lang SH, 1997, CLIN EXP METASTAS, V15, P218, DOI 10.1023/A:1018465213641; Lauzier A, 2011, ARTHRITIS RHEUM-US, V63, P1591, DOI 10.1002/art.30305; Lee SH, 2011, J CELL PHYSIOL, V226, P1850, DOI 10.1002/jcp.22510; Legate KR, 2009, J CELL SCI, V122, P187, DOI 10.1242/jcs.041624; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu HY, 2006, MOL PHARMACOL, V69, P1207, DOI 10.1124/mol.105.019075; Lu L, 2011, ANTICANCER RES, V31, P1; Macedo MLR, 2004, J AGR FOOD CHEM, V52, P2533, DOI 10.1021/jf035389z; Malliri A, 2003, CURR OPIN CELL BIOL, V15, P583, DOI 10.1016/S0955-0674(03)00098-X; McCoy AJ, 1997, J MOL BIOL, V269, P881, DOI 10.1006/jmbi.1997.1067; McLean GW, 2005, NAT REV CANCER, V5, P505, DOI 10.1038/nrc1647; Misra A, 2007, BIOCHEM BIOPH RES CO, V364, P908, DOI 10.1016/j.bbrc.2007.10.086; Miyata S, 2007, HUM CELL, V20, P100, DOI 10.1111/j.1749-0774.2007.00035.x; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Nakahata AM, 2011, BIOL CHEM, V392, P327, DOI [10.1515/bc.2011.031, 10.1515/BC.2011.031]; Oser M, 2009, J CELL BIOL, V186, P571, DOI 10.1083/jcb.200812176; Patsenker E, 2007, J HEPATOL, V46, P878, DOI 10.1016/j.jhep.2006.11.011; Pick A, 2011, BIOORGAN MED CHEM, V19, P2090, DOI 10.1016/j.bmc.2010.12.043; Pinkaew D, 2009, BBA-GEN SUBJECTS, V1790, P31, DOI 10.1016/j.bbagen.2008.09.006; Poincloux R, 2009, J CELL SCI, V122, P3015, DOI 10.1242/jcs.034561; Ramsay AK, 2011, BRIT J CANCER, V104, P664, DOI 10.1038/sj.bjc.6606062; Rowe RG, 2009, ANNU REV CELL DEV BI, V25, P567, DOI 10.1146/annurev.cellbio.24.110707.175315; Sanchez AM, 2010, MOL ENDOCRINOL, V24, P2114, DOI 10.1210/me.2010-0252; Schneider JG, 2011, BONE, V48, P54, DOI 10.1016/j.bone.2010.09.016; See AP, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-25; Seiki M, 2003, CANCER METAST REV, V22, P129, DOI 10.1023/A:1023087113214; Shin JS, 2011, INT J MOL MED, V27, P401, DOI 10.3892/ijmm.2011.599; Smith-Pearson PS, 2010, J BIOL CHEM, V285, P40201, DOI 10.1074/jbc.M110.147330; Stahtea XN, 2007, INT J CANCER, V121, P2808, DOI 10.1002/ijc.23029; Steffen A, 2008, CURR BIOL, V18, P926, DOI 10.1016/j.cub.2008.05.044; Sumikawa JT, 2010, PHYTOCHEMISTRY, V71, P214, DOI 10.1016/j.phytochem.2009.10.009; Sun Meng, 2010, Genes Cancer, V1, P283, DOI 10.1177/1947601910368849; Sun XL, 2009, CARCINOGENESIS, V30, P2109, DOI 10.1093/carcin/bgp251; Takino T, 2010, BIOCHEM BIOPH RES CO, V396, P1042, DOI 10.1016/j.bbrc.2010.05.059; Tanjoni I, 2010, CANCER BIOL THER, V9, P764, DOI 10.4161/cbt.9.10.11434; VanderVeldeZimmermann D, 1997, EXP CELL RES, V230, P111, DOI 10.1006/excr.1996.3405; Wilken R, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-12; Xu YJ, 2010, J EXP MED, V207, P2421, DOI 10.1084/jem.20100433; Yamamoto H, 2011, J UROLOGY, V185, P1930, DOI 10.1016/j.juro.2010.12.027; Yoon JR, 2011, BREAST CANCER RES TR, V129, P691, DOI 10.1007/s10549-010-1239-7; Zhang XH, 2007, MOL CELL, V27, P197, DOI 10.1016/j.molcel.2007.05.033	80	32	33	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					170	182		10.1074/jbc.M111.263996	http://dx.doi.org/10.1074/jbc.M111.263996			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22039045	hybrid, Green Published			2022-12-27	WOS:000298682400019
J	Skasko, M; Wang, Y; Tian, Y; Tokarev, A; Munguia, J; Ruiz, A; Stephens, EB; Opella, SJ; Guatelli, J				Skasko, Mark; Wang, Yan; Tian, Ye; Tokarev, Andrey; Munguia, Jason; Ruiz, Autumn; Stephens, Edward B.; Opella, Stanley J.; Guatelli, John			HIV-1 Vpu Protein Antagonizes Innate Restriction Factor BST-2 via Lipid-embedded Helix-Helix Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							3-DIMENSIONAL STRUCTURE; TRANSMEMBRANE DOMAIN; MEMBRANE-PROTEINS; RELEASE; NMR; SENSITIVITY; SPECTRA; MOTIFS; SYSTEM	The Vpu protein of HIV-1 antagonizes BST-2 (tetherin), a broad spectrum effector of the innate immune response to viral infection, by an intermolecular interaction that maps genetically to the alpha-helical transmembrane domains (TMDs) of each protein. Here we utilize NMR spectroscopy to describe key features of the helix-helix pairing that underlies this interaction. The antagonism of BST-2 involves a sequence of three alanines and a tryptophan spaced at four residue intervals within the Vpu TMD helix. Responsiveness to Vpu involves bulky hydrophobic residues in the C-terminal region of the BST-2 TMD helix that likely fit between the alanines on the interactive face of Vpu. These aspects of Vpu and BST-2 form an anti-parallel, lipid-embedded helix-helix interface. Changes in human BST-2 that mimic sequences found in nonhuman primate orthologs unresponsive to Vpu change the tilt angle of the TMD in the lipid bilayer without abrogating its intrinsic ability to interact with Vpu. These data explain the mechanism by which HIV-1 evades a key aspect of innate immunity and the species specificity of Vpu using an anti-parallel helix-helix packing model.	[Wang, Yan; Tian, Ye; Opella, Stanley J.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Skasko, Mark; Tokarev, Andrey; Munguia, Jason; Guatelli, John] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Ruiz, Autumn] Univ Kansas, Med Ctr, Dept Anat & Cell Biol, Kansas City, KS 66160 USA; [Stephens, Edward B.] Univ Kansas, Med Ctr, Dept Microbiol Mol Genet & Immunol, Kansas City, KS 66160 USA; [Guatelli, John] San Diego Vet Affairs Healthcare Syst, San Diego, CA 92161 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center	Opella, SJ (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA.	sopella@ucsd.edu; jguatelli@ucsd.edu		Schulze, Autumn/0000-0003-4589-8435	National Institutes of Health [AI081668, P41EB002031, GM066978, AI051981]; University of California, San Diego Center for AIDS Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081668, R37AI081668, R01AI051981] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB002031] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066978] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California, San Diego Center for AIDS Research(University of California System); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI081668 and related American Reinvestment and Recovery Act supplements (to J. G.), P41EB002031 and GM066978 (to S. J. O.), and AI051981 (to E. B. S.). This work was also supported by the University of California, San Diego Center for AIDS Research.	Battiste JL, 2000, BIOCHEMISTRY-US, V39, P5355, DOI 10.1021/bi000060h; Chou JJ, 2001, J BIOMOL NMR, V21, P377, DOI 10.1023/A:1013336502594; Clore GM, 2007, CURR OPIN STRUC BIOL, V17, P603, DOI 10.1016/j.sbi.2007.08.013; de Planque MRR, 2003, BIOCHEMISTRY-US, V42, P5341, DOI 10.1021/bi027000r; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Ding KY, 2003, J MAGN RESON, V163, P208, DOI 10.1016/S1090-7807(03)00081-8; Fitzpatrick K, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000701; Gray JJ, 2003, J MOL BIOL, V331, P281, DOI 10.1016/S0022-2836(03)00670-3; GRZESIEK S, 1992, BIOCHEMISTRY-US, V31, P8180, DOI 10.1021/bi00150a009; Gupta RK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000443; Kobayashi T, 2011, J VIROL, V85, P932, DOI 10.1128/JVI.01668-10; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kupzig S, 2003, TRAFFIC, V4, P694, DOI 10.1034/j.1600-0854.2003.00129.x; LEMMON MA, 1992, BIOCHEMISTRY-US, V31, P12719, DOI 10.1021/bi00166a002; McNatt MW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000300; Mesleh MF, 2003, J MAGN RESON, V163, P288, DOI 10.1016/S1090-7807(03)00119-8; MORI S, 1995, J MAGN RESON SER B, V108, P94, DOI 10.1006/jmrb.1995.1109; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Nevzorov AA, 2003, J MAGN RESON, V160, P33, DOI 10.1016/S1090-7807(02)00138-6; Park SH, 2006, BIOPHYS J, V91, P3032, DOI 10.1529/biophysj.106.087106; Park SH, 2003, J MOL BIOL, V333, P409, DOI 10.1016/j.jmb.2003.08.048; Perez-Caballero D, 2009, CELL, V139, P499, DOI 10.1016/j.cell.2009.08.039; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ruiz A, 2010, VIROLOGY, V406, P312, DOI 10.1016/j.virol.2010.07.021; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Senes A, 2004, CURR OPIN STRUC BIOL, V14, P465, DOI 10.1016/j.sbi.2004.07.007; Skasko M, 2011, VIROLOGY, V411, P65, DOI 10.1016/j.virol.2010.12.038; Tokarev AA, 2011, J VIROL, V85, P51, DOI 10.1128/JVI.01795-10; Van Damme N, 2008, CELL HOST MICROBE, V3, P245, DOI 10.1016/j.chom.2008.03.001; Vigan R, 2010, J VIROL, V84, P12958, DOI 10.1128/JVI.01699-10; Walters RFS, 2006, P NATL ACAD SCI USA, V103, P13658, DOI 10.1073/pnas.0605878103; Wu CH, 2009, J MAGN RESON, V200, P74, DOI 10.1016/j.jmr.2009.06.004	32	94	95	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					58	67		10.1074/jbc.M111.296772	http://dx.doi.org/10.1074/jbc.M111.296772			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22072710	Green Published, hybrid			2022-12-27	WOS:000298682400009
J	Adak, S; Yang, KS; Macdonald-Obermann, J; Pike, LJ				Adak, Sangeeta; Yang, Katherine S.; Macdonald-Obermann, Jennifer; Pike, Linda J.			The Membrane-proximal Intracellular Domain of the Epidermal Growth Factor Receptor Underlies Negative Cooperativity in Ligand Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINASE-C PHOSPHORYLATION; EGF RECEPTOR; PHORBOL ESTERS; PROTEIN-KINASE; SIGNAL-TRANSDUCTION; CRYSTAL-STRUCTURE; CARCINOMA-CELLS; LIVING CELLS; AFFINITY; ACTIVATION	The binding of EGF induces dimerization of its receptor, leading to the stimulation of its intracellular tyrosine kinase activity. Kinase activation occurs within the context of an asymmetric dimer in which one kinase domain serves as the activator for the other kinase domain but is not itself activated. How ligand binding is related to the formation and dynamics of this asymmetric dimer is not known. The binding of EGF to its receptor is negatively cooperative-that is, EGF binds with lower affinity to the second site on the dimer than to the first site on the dimer. In this study, we analyzed the binding of I-125-EGF to a series of EGF receptor mutants in the intracellular juxtamembrane domain and demonstrate that the most membrane-proximal portion of this region plays a significant role in the genesis of negative cooperativity in the EGF receptor. The data are consistent with a model in which the binding of EGF to the first site on the dimer induces the formation of one asymmetric kinase dimer. The binding of EGF to the second site is required to disrupt the initial asymmetric dimer and allow the formation of the reciprocal asymmetric dimer. Thus, some of the energy of binding to the second site is used to reorient the first asymmetric dimer, leading to a lower binding affinity and the observed negative cooperativity.	[Adak, Sangeeta; Yang, Katherine S.; Macdonald-Obermann, Jennifer; Pike, Linda J.] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA	Washington University (WUSTL)	Pike, LJ (corresponding author), Washington Univ, Sch Med, Dept Biochem & Mol Biophys, 660 So Euclid,Box 8231, St Louis, MO 63110 USA.	pike@biochem.wustl.edu		ADAK, SANGEETA/0000-0003-3855-9099	National Institutes of Health [GM064491]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064491] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM064491 (to L.J.P.).	Adak S, 2011, J BIOL CHEM, V286, P1545, DOI 10.1074/jbc.M110.182899; Arteaga CL, 1997, J BIOL CHEM, V272, P23247, DOI 10.1074/jbc.272.37.23247; Bublil EM, 2010, FASEB J, V24, P4744, DOI 10.1096/fj.10-166199; Burgess AW, 2008, GROWTH FACTORS, V26, P263, DOI 10.1080/08977190802312844; CASTAGNA M, 1982, J BIOL CHEM, V257, P7847; CHANTRY A, 1995, J BIOL CHEM, V270, P3068; Clayton AHA, 2005, J BIOL CHEM, V280, P30392, DOI 10.1074/jbc.M504770200; DORAN DM, 1980, J IMMUNOL METHODS, V39, P155, DOI 10.1016/0022-1759(80)90304-X; DOWNWARD J, 1985, J BIOL CHEM, V260, P4538; Ferguson KM, 2003, MOL CELL, V11, P507, DOI 10.1016/S1097-2765(03)00047-9; FRIEDMAN BA, 1984, P NATL ACAD SCI-BIOL, V81, P3034, DOI 10.1073/pnas.81.10.3034; Gan HK, 2007, J BIOL CHEM, V282, P2840, DOI 10.1074/jbc.M605136200; Garrett TPJ, 2002, CELL, V110, P763, DOI 10.1016/S0092-8674(02)00940-6; HEISERMANN GJ, 1988, J BIOL CHEM, V263, P13152; HUNTER T, 1984, NATURE, V311, P480, DOI 10.1038/311480a0; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Jura N, 2009, CELL, V137, P1293, DOI 10.1016/j.cell.2009.04.025; KING AC, 1982, J BIOL CHEM, V257, P3053; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Li X, 2008, CELL SIGNAL, V20, P2145, DOI 10.1016/j.cellsig.2008.08.006; Lichtner RB, 2001, CANCER RES, V61, P5790; Macdonald JL, 2008, P NATL ACAD SCI USA, V105, P112, DOI 10.1073/pnas.0707080105; Macdonald-Obermann JL, 2009, J BIOL CHEM, V284, P13570, DOI 10.1074/jbc.M109.001487; Macdonald-Obermann JL, 2009, BIOCHEMISTRY-US, V48, P2505, DOI 10.1021/bi802249x; MAGUN BE, 1980, J BIOL CHEM, V255, P6373; Martin-Fernandez M, 2002, BIOPHYS J, V82, P2415, DOI 10.1016/S0006-3495(02)75585-9; NORTHWOOD IC, 1991, J BIOL CHEM, V266, P15266; Ogiso H, 2002, CELL, V110, P775, DOI 10.1016/S0092-8674(02)00963-7; Red Brewer M, 2009, MOL CELL, V34, P641, DOI 10.1016/j.molcel.2009.04.034; REES AR, 1984, EMBO J, V3, P1843, DOI 10.1002/j.1460-2075.1984.tb02057.x; Sako Y, 2000, NAT CELL BIOL, V2, P168, DOI 10.1038/35004044; SHOYAB M, 1979, NATURE, V279, P387, DOI 10.1038/279387a0; TAKISHIMA K, 1991, P NATL ACAD SCI USA, V88, P2520, DOI 10.1073/pnas.88.6.2520; Tao RH, 2008, J CELL SCI, V121, P3207, DOI 10.1242/jcs.033399; Thiel KW, 2007, P NATL ACAD SCI USA, V104, P19238, DOI 10.1073/pnas.0703854104; ULLRICH A, 1984, NATURE, V309, P418, DOI 10.1038/309418a0; Wong I, 1995, METHOD ENZYMOL, V259, P95; Wyman J, 1990, BINDING LINKAGE FUNC; Yu XC, 2002, MOL BIOL CELL, V13, P2547, DOI 10.1091/mbc.01-08-0411; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013	40	18	18	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2011	286	52					45146	45155		10.1074/jbc.M111.274175	http://dx.doi.org/10.1074/jbc.M111.274175			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870CA	22069315	Green Published, hybrid			2022-12-27	WOS:000298645500080
J	Brown, J; Wang, HZ; Suttles, J; Graves, DT; Martin, M				Brown, Jonathan; Wang, Huizhi; Suttles, Jill; Graves, Dana T.; Martin, Michael			Mammalian Target of Rapamycin Complex 2 (mTORC2) Negatively Regulates Toll-like Receptor 4-mediated Inflammatory Response via FoxO1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE B; BINDING PARTNER; PATHWAY; PHOSPHORYLATION; RICTOR; AKT; LIPOPOLYSACCHARIDE; ACTIVATION; RAPTOR; MICE	Activation of the PI3K pathway plays a pivotal role in regulating the inflammatory response. The loss of mTORC2 has been shown to abrogate the activation of Akt, a critical downstream component of PI3K signaling. However, the biological importance of mTORC2 in innate immunity is currently unknown. Here we demonstrate that rictor, a key component of mTORC2, plays a critical role in controlling the innate inflammatory response via its ability to regulate FoxO1. Upon LPS stimulation, both rictor-deficient mouse embryonic fibroblasts (MEFs) and rictor knockdown dendritic cells exhibited a hyperinflammatory phenotype. The hyperinflammatory phenotype was due to a defective Akt signaling axis, because both rictor-deficient MEFs and rictor knockdown dendritic cells exhibited attenuated Akt phosphorylation and kinase activity. Analysis of downstream Akt targets revealed that phosphorylation of FoxO1 was impaired in rictor-deficient cells, resulting in elevated nuclear FoxO1 levels and diminished nuclear export of FoxO1 upon LPS stimulation. Knockdown of FoxO1 attenuated the hyperinflammatory phenotype exhibited by rictor-deficient MEFs. Moreover, FoxO1 deletion in dendritic cells attenuated the capacity of LPS to induce inflammatory cytokine expression. These findings identify a novel signaling pathway by which mTORC2 regulates the TLR-mediated inflammatory response through its ability to regulate FoxO1.	[Brown, Jonathan; Wang, Huizhi; Suttles, Jill; Martin, Michael] Univ Louisville, Dept Microbiol & Immunol, Sch Med, Louisville, KY 40202 USA; [Wang, Huizhi; Martin, Michael] Univ Louisville, Oral Hlth & Syst Dis Res Grp, Sch Dent, Louisville, KY 40202 USA; [Graves, Dana T.] Univ Penn, Sch Dent Med, Philadelphia, PA 19104 USA	University of Louisville; University of Louisville; University of Pennsylvania	Wang, HZ (corresponding author), 501 S Preston St, Louisville, KY 40202 USA.	hhwang01@louisville.edu; jill.suttles@louisville.edu	Wang, Huizhi/M-8229-2015; Wang, Huizhi/AAA-3874-2020		National Institutes of Health [R01DE017680, R01DE017921, R01DE019108, R01DE17732]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060055] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE017732, R01DE017680, R01DE017921, R01DE019108] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DE017680 and R01DE017921 (to M. M.) and R01DE019108 and R01DE17732 (to D. T. G.).	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Androulidaki A, 2009, IMMUNITY, V31, P220, DOI 10.1016/j.immuni.2009.06.024; Arbibe L, 2000, NAT IMMUNOL, V1, P533, DOI 10.1038/82797; Behl Y, 2009, DIABETES, V58, P917, DOI 10.2337/db08-0537; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Fan WQ, 2010, EMBO J, V29, P4223, DOI 10.1038/emboj.2010.268; Feng JH, 2004, J BIOL CHEM, V279, P41189, DOI 10.1074/jbc.M406731200; Fukao T, 2002, NAT IMMUNOL, V3, P295, DOI 10.1038/ni768; Fukao T, 2002, NAT IMMUNOL, V3, P875, DOI 10.1038/ni825; Garcia-Martinez JM, 2008, BIOCHEM J, V416, P375, DOI 10.1042/BJ20081668; Guertin DA, 2005, TRENDS MOL MED, V11, P353, DOI 10.1016/j.molmed.2005.06.007; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Guha M, 2002, J BIOL CHEM, V277, P32124, DOI 10.1074/jbc.M203298200; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Hedrick SM, 2009, NAT IMMUNOL, V10, P1057, DOI 10.1038/ni.1784; Hresko RC, 2005, J BIOL CHEM, V280, P40406, DOI 10.1074/jbc.M508361200; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Kawakami Y, 2004, J BIOL CHEM, V279, P47720, DOI 10.1074/jbc.M408797200; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kortylewski M, 2003, J BIOL CHEM, V278, P5242, DOI 10.1074/jbc.M205403200; Lee K, 2010, IMMUNITY, V32, P743, DOI 10.1016/j.immuni.2010.06.002; Martin M, 2003, J IMMUNOL, V171, P717, DOI 10.4049/jimmunol.171.2.717; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; Ohtani M, 2008, BLOOD, V112, P635, DOI 10.1182/blood-2008-02-137430; Persad S, 2001, J BIOL CHEM, V276, P27462, DOI 10.1074/jbc.M102940200; Peterson TR, 2009, CELL, V137, P873, DOI 10.1016/j.cell.2009.03.046; Rena G, 2001, BIOCHEM J, V354, P605, DOI 10.1042/0264-6021:3540605; SABATINI DM, 1994, CELL, V78, P35, DOI 10.1016/0092-8674(94)90570-3; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Schabbauer G, 2004, ARTERIOSCL THROM VAS, V24, P1963, DOI 10.1161/01.ATV.0000143096.15099.ce; Shiota C, 2006, DEV CELL, V11, P583, DOI 10.1016/j.devcel.2006.08.013; Siqueira MF, 2010, DIABETOLOGIA, V53, P378, DOI 10.1007/s00125-009-1529-y; Stephens L, 1998, SCIENCE, V279, P710, DOI 10.1126/science.279.5351.710; Su DM, 2009, DIABETES, V58, P2624, DOI 10.2337/db09-0232; Tang ED, 1999, J BIOL CHEM, V274, P16741, DOI 10.1074/jbc.274.24.16741; Turnquist HR, 2010, BLOOD, V115, P4758, DOI 10.1182/blood-2009-10-251488; van der Heide LP, 2004, BIOCHEM J, V380, P297, DOI 10.1042/BJ20040167; Weichhart T, 2008, IMMUNITY, V29, P565, DOI 10.1016/j.immuni.2008.08.012	39	122	126	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2011	286	52					44295	44305		10.1074/jbc.M111.258053	http://dx.doi.org/10.1074/jbc.M111.258053			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870CA	22045807	Green Published, hybrid			2022-12-27	WOS:000298645500001
J	Deol, YS; Nasser, MW; Yu, LB; Zou, XH; Ganju, RK				Deol, Yadwinder S.; Nasser, Mohd W.; Yu, Lianbo; Zou, Xianghong; Ganju, Ramesh K.			Tumor-suppressive Effects of Psoriasin (S100A7) Are Mediated through the beta-Catenin/T Cell Factor 4 Protein Pathway in Estrogen Receptor-positive Breast Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL DIFFERENTIATION COMPLEX; MAMMARY EPITHELIAL-CELLS; CARCINOMA IN-SITU; ONCOSTATIN-M; WNT PATHWAY; EXPRESSION; PROGRESSION; BINDING; GENES; APC	Psoriasin (S100A7) is expressed in several epithelial malignancies including breast cancer. Although S100A7 is associated with the worst prognosis in estrogen receptor alpha-negative (ER alpha(-)) invasive breast cancers, its role in ER alpha-positive (ER alpha(+)) breast cancers is relatively unknown. We investigated the significance of S100A7 in ER alpha(+) breast cancer cells and observed that S100A7 overexpression in ER alpha(+) breast cancer cells, MCF7 and T47D, exhibited decreased migration, proliferation, and wound healing. These results were confirmed in vivo in nude mouse model system. Mice injected with S100A7-overexpressing MCF7 cells showed significant reduction in tumor size compared with mice injected with vector control cells. Further mechanistic studies revealed that S100A7 mediates the tumor-suppressive effects via a coordinated regulation of the beta-catenin/TCF4 pathway and an enhanced interaction of beta-catenin and E-cadherin in S100A7-overexpressing ER alpha(+) breast cancer cells. We observed down-regulation of beta-catenin, p-GSK3 beta, TCF4, cyclin D1, and c-myc in S100A7-overexpressing ER alpha(+) breast cancer cells. In addition, we observed increased expression of GSK3 beta. Treatment with GSK3 beta inhibitor CHIR 99021 increased the expression of beta-catenin and its downstream target c-myc in S100A7-overexpressing cells. Tumors derived from mice injected with S100A7-overexpressing MCF7 cells also showed reduced activation of the beta-catenin/TCF4 pathway. Therefore, our studies reveal for the first time that S100A7-overexpressing ER alpha(+) breast cancer cells exhibit tumor suppressor capabilities through down-modulation of the beta-catenin/TCF4 pathway both in vitro and in vivo. Because S100A7 has been shown to enhance tumorigenicity in ER alpha(-) cells, our studies suggest that S100A7 may possess differential activities in ER alpha(+) compared with ER alpha(-) cells.	[Deol, Yadwinder S.; Nasser, Mohd W.; Zou, Xianghong; Ganju, Ramesh K.] Ohio State Univ, Dept Pathol, Med & Comprehens Canc Ctr, Columbus, OH 43210 USA; [Deol, Yadwinder S.; Ganju, Ramesh K.] Ohio State Univ, Mol Cellular & Dev Biol Program, Med & Comprehens Canc Ctr, Columbus, OH 43210 USA; [Yu, Lianbo] Ohio State Univ, Ctr Biostat, Med & Comprehens Canc Ctr, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Ganju, RK (corresponding author), Ohio State Univ, Dept Pathol, Med & Comprehens Canc Ctr, 1645 Neil Ave,185D Hamilton Hall, Columbus, OH 43210 USA.	ramesh.ganju@osumc.edu	zou, Xianghong/E-4374-2011; Nasser, Mohd/Y-3355-2019; yu, lianbo/B-3472-2010		National Institutes of Health [R01CA109527, R01CA153490]; Department of Defense [W81XWH-11-1-0279, W8XWH-11-1-0275]; Ohio State University Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE [R01CA109527, R01CA153490] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Ohio State University Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01CA109527 and R01CA153490 and Department of Defense Grants W81XWH-11-1-0279 and W8XWH-11-1-0275 (to R. K. G.).; Supported by a Pelotonia fellowship from The Ohio State University Comprehensive Cancer Center.	Al-Haddad S, 1999, AM J PATHOL, V155, P2057, DOI 10.1016/S0002-9440(10)65524-1; Amit S, 2002, GENE DEV, V16, P1066, DOI 10.1101/gad.230302; Behrens J, 2000, ANN NY ACAD SCI, V910, P21; Boniface K, 2007, J IMMUNOL, V178, P4615, DOI 10.4049/jimmunol.178.7.4615; Crawford HC, 1999, ONCOGENE, V18, P2883, DOI 10.1038/sj.onc.1202627; de Cid R, 2009, NAT GENET, V41, P211, DOI 10.1038/ng.313; Emberley ED, 2005, CANCER RES, V65, P5696, DOI 10.1158/0008-5472.CAN-04-3927; Emberley ED, 2004, BREAST CANCER RES, V6, pR308, DOI 10.1186/bcr791; Emberley ED, 2003, CLIN CANCER RES, V9, P2627; Emberley ED, 2003, CANCER RES, V63, P1954; Enerback C, 2002, CANCER RES, V62, P43; GILLETT C, 1994, CANCER RES, V54, P1812; Hatsell S, 2003, J MAMMARY GLAND BIOL, V8, P145, DOI 10.1023/A:1025944723047; Iwai S, 2010, INT J ONCOL, V37, P1095, DOI 10.3892/ijo_00000761; Krop I, 2005, CANCER RES, V65, P11326, DOI 10.1158/0008-5472.CAN-05-1523; Leygue E, 1996, CANCER RES, V56, P4606; Lopez-Knowles E, 2010, CANCER EPIDEM BIOMAR, V19, P301, DOI 10.1158/1055-9965.EPI-09-0741; Mischke D, 1996, J INVEST DERMATOL, V106, P989, DOI 10.1111/1523-1747.ep12338501; MOOGLUTZ C, 1995, INT J CANCER, V63, P297, DOI 10.1002/ijc.2910630225; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Morin Patrice J, 2003, Cancer Treat Res, V115, P169; Nagafuchi A, 2001, CURR OPIN CELL BIOL, V13, P600, DOI 10.1016/S0955-0674(00)00257-X; Neth P, 2007, STEM CELL REV, V3, P18, DOI 10.1007/s12015-007-0001-y; Papkoff J, 1996, MOL CELL BIOL, V16, P2128; Paruchuri V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001741; Petersson S, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-205; Prasad A, 2008, J BIOL CHEM, V283, P26624, DOI 10.1074/jbc.M800679200; Preet A, 2011, CANCER PREV RES, V4, P65, DOI 10.1158/1940-6207.CAPR-10-0181; Qamri Z, 2009, MOL CANCER THER, V8, P3117, DOI 10.1158/1535-7163.MCT-09-0448; Ravindranath A, 2008, CURR MOL MED, V8, P38; Ray G, 2005, ONCOL REP, V13, P445; Rubinfeld B, 1996, SCIENCE, V272, P1023, DOI 10.1126/science.272.5264.1023; Saadeddin A, 2009, MOL CANCER RES, V7, P1189, DOI 10.1158/1541-7786.MCR-09-0027; Schmalhofer O, 2009, CANCER METAST REV, V28, P151, DOI 10.1007/s10555-008-9179-y; South AP, 1999, J INVEST DERMATOL, V112, P910, DOI 10.1046/j.1523-1747.1999.00613.x; Tan JQ, 1996, J INVEST DERMATOL, V107, P5, DOI 10.1111/1523-1747.ep12294284; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Vasioukhin V, 2001, CURR OPIN CELL BIOL, V13, P76, DOI 10.1016/S0955-0674(00)00177-0; West NR, 2010, ONCOGENE, V29, P2083, DOI 10.1038/onc.2009.488; Wielenga VJM, 1999, AM J PATHOL, V154, P515, DOI 10.1016/S0002-9440(10)65297-2; Wolf R, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001108; Yue PYK, 2010, J BIOMOL SCREEN, V15, P427, DOI 10.1177/1087057110361772; Zhang XJ, 2009, NAT GENET, V41, P205, DOI 10.1038/ng.310; Zhou G, 2008, ONCOGENE, V27, P3527, DOI 10.1038/sj.onc.1211015	44	28	31	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2011	286	52					44845	44854		10.1074/jbc.M111.225466	http://dx.doi.org/10.1074/jbc.M111.225466			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870CA	22016394	hybrid, Green Published			2022-12-27	WOS:000298645500053
J	Xie, ZW; Liu, DX; Liu, S; Calderon, L; Zhao, GG; Turk, J; Guo, ZH				Xie, Zhongwen; Liu, Dexiang; Liu, Shu; Calderon, Lindsay; Zhao, Guogang; Turk, John; Guo, Zhenheng			Identification of a cAMP-response Element in the Regulator of G-protein Signaling-2 (RGS2) Promoter as a Key Cis-regulatory Element for RGS2 Transcriptional Regulation by Angiotensin II in Cultured Vascular Smooth Muscles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDEPENDENT PHOSPHOLIPASE A(2); MEDIATES CREB PHOSPHORYLATION; BLOOD-PRESSURE REGULATION; UP-REGULATION; HYPERTENSIVE PATIENTS; RHO KINASE; EXPRESSION; GENE; CPI-17; ACTIVATION	Mice deficient in regulator of G-protein signaling-2 (RGS2) have severe hypertension, and RGS2 genetic variations occur in hypertensive humans. A potentially important negative feedback loop in blood pressure homeostasis is that angiotensin II (Ang II) increases vascular smooth muscle cell (VSMC) RGS2 expression. We reported that Group VIA phospholipase A(2) (iPLA(2)beta) is required for this response (Xie, Z., Gong, M. C., Su, W., Turk, J., and Guo, Z. (2007) J. Biol. Chem. 282, 2527825289), but the specific molecular causes and consequences of iPLA(2)beta activation are not known. Here we demonstrate that both protein kinases C (PKC) and A (PKA) participate in Ang II-induced VSMC RGS2 mRNA up-regulation, and that actions of PKC and PKA precede and follow iPLA(2)beta activation, respectively. Moreover, we identified a conserved cAMP-response element (CRE) in the murine RGS2 promoter that is critical for cAMP-response element-binding protein (CREB) binding and RGS2 promoter activation. Forskolin-stimulated RGS2 mRNA up-regulation is inhibited by CREB sequestration or specific disruption of the CREB-RGS2 promoter interaction, and Ang II-induced CREB phosphorylation and nuclear localization are blocked by iPLA(2)beta pharmacologic inhibition or genetic ablation. Ang II-induced intracellular cyclic AMP accumulation precedes CREB phosphorylation and is diminished by inhibiting iPLA2, cyclooxygenase, or lipoxygenase. Moreover, three single nucleotide polymorphisms identified in hypertensive patients are located in the human RGS2 promoter CREB binding site. Point mutations corresponding to these single nucleotide polymorphisms interfere with stimulation of human RGS2 promoter activity by forskolin. Our studies thus delineate a negative feedback loop to attenuate Ang II signaling in VSMC with potential importance in blood pressure homeostasis and the pathogenesis of human essential hypertension.	[Xie, Zhongwen; Liu, Dexiang; Calderon, Lindsay; Guo, Zhenheng] Univ Kentucky, Sch Med, Dept Physiol, Lexington, KY 40536 USA; [Liu, Shu; Zhao, Guogang] Univ Kentucky, Sch Med, Dept Internal Med, Lexington, KY 40536 USA; [Turk, John] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA	University of Kentucky; University of Kentucky; Washington University (WUSTL)	Guo, ZH (corresponding author), 515 Wethington Bldg,900 S Limestone, Lexington, KY 40536 USA.	zguo2@uky.edu		Calderon, Lindsay/0000-0003-0919-0077; zhao, guogang/0000-0002-9783-9704	National Institutes of Health [HL088389, HL088389-02S1]; American Heart Association; United States Public Health Service [R37-DK34388, P41-RR00954, P60-DK20579, P30-DK56341]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000954] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088389] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK034388, P30DK056341, P60DK020579] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants HL088389 and HL088389-02S1 and a Scientist Development Grant from the American Heart Association (to Z. G.).; Supported by United States Public Health Service Grants R37-DK34388, P41-RR00954, P60-DK20579, and P30-DK56341.	Akiba S, 1999, J BIOL CHEM, V274, P19906, DOI 10.1074/jbc.274.28.19906; Antonarakis SE, 1998, HUM MUTAT, V11, P1; Calo LA, 2004, J CLIN ENDOCR METAB, V89, P4153, DOI 10.1210/jc.2004-0498; Chava KR, 2009, ARTERIOSCL THROM VAS, V29, P809, DOI 10.1161/ATVBAHA.109.185777; Cheng YS, 2008, J CELL BIOCHEM, V105, P922, DOI 10.1002/jcb.21893; Cho H, 2003, BIOCHEM J, V371, P973, DOI 10.1042/BJ20021769; Dronadula N, 2006, J LIPID RES, V47, P767, DOI 10.1194/jlr.M500369-JLR200; Dulin NO, 2001, J BIOL CHEM, V276, P20827, DOI 10.1074/jbc.C100195200; Dyer BW, 2000, ANAL BIOCHEM, V282, P158, DOI 10.1006/abio.2000.4605; Funakoshi Y, 2002, J BIOL CHEM, V277, P18710, DOI 10.1074/jbc.M110430200; Grant SL, 2000, MOL PHARMACOL, V57, P460, DOI 10.1124/mol.57.3.460; Gross V, 2005, AM J PHYSIOL-REG I, V288, pR1134, DOI 10.1152/ajpregu.00246.2004; Gu S, 2009, CLIN SCI, V116, P391, DOI 10.1042/CS20080272; Guo ZH, 2005, CARDIOVASC RES, V67, P723, DOI 10.1016/j.cardiores.2005.04.008; HAZEN SL, 1991, J BIOL CHEM, V266, P7227; Hercule HC, 2007, EXP PHYSIOL, V92, P1014, DOI 10.1113/expphysiol.2007.038240; Heximer SP, 2003, J CLIN INVEST, V111, P445, DOI 10.1172/JC1200315598; KUBALAK SW, 1993, AM J PHYSIOL, V264, pH86, DOI 10.1152/ajpheart.1993.264.1.H86; Li YA, 2005, CARDIOVASC RES, V66, P503, DOI 10.1016/j.cardiores.2005.02.005; Ma ZM, 2001, PROG NUCLEIC ACID RE, V67, P1, DOI 10.1016/S0079-6603(01)67023-5; Maggi LB, 2002, J BIOL CHEM, V277, P38449, DOI 10.1074/jbc.M206247200; Martinson BD, 2003, J LIPID RES, V44, P1686, DOI 10.1194/jlr.M300018-JLR200; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Miles RR, 2000, ENDOCRINOLOGY, V141, P28, DOI 10.1210/en.141.1.28; Moran JM, 2005, J BIOL CHEM, V280, P28162, DOI 10.1074/jbc.M500013200; Pang H, 2006, AM J PHYSIOL-CELL PH, V290, pC892, DOI 10.1152/ajpcell.00378.2005; Pang HA, 2005, AM J PHYSIOL-CELL PH, V289, pC352, DOI 10.1152/ajpcell.00111.2005; Park YG, 1999, J BIOL CHEM, V274, P1573, DOI 10.1074/jbc.274.3.1573; Pepperl DJ, 1998, BIOCHEM BIOPH RES CO, V243, P52, DOI 10.1006/bbrc.1997.8056; Riddle EL, 2006, HYPERTENSION, V47, P415, DOI 10.1161/01.HYP.0000200714.81990.61; Semplicini A, 2006, J HYPERTENS, V24, P1115, DOI 10.1097/01.hjh.0000226202.80689.8f; Semplicini A, 2010, J HYPERTENS, V28, P1104, DOI 10.1097/HJH.0b013e328339930f; Steer SA, 2002, AM J PHYSIOL-CELL PH, V283, pC1621, DOI 10.1152/ajpcell.00109.2002; Stevenson AS, 2001, EXP CELL RES, V263, P118, DOI 10.1006/excr.2000.5107; Su W, 2008, AM J PHYSIOL-HEART C, V295, pH1634, DOI 10.1152/ajpheart.00257.2008; Sun XG, 2005, MOL PHARMACOL, V67, P631, DOI 10.1124/mol.104.007724; Tang M, 2003, NAT MED, V9, P1506, DOI 10.1038/nm958; Thirunavukkarasu K, 2002, J CELL BIOCHEM, V85, P837, DOI 10.1002/jcb.10176; Touyz RM, 2000, PHARMACOL REV, V52, P639; Wieland T, 2003, PHARMACOL THERAPEUT, V97, P95, DOI 10.1016/S0163-7258(02)00326-1; Williams SD, 2001, AM J PHYSIOL-HEART C, V281, pH168, DOI 10.1152/ajpheart.2001.281.1.H168; Williams SD, 1997, FEBS LETT, V420, P33, DOI 10.1016/S0014-5793(97)01482-8; Xie Z, 2007, J BIOL CHEM, V282, P25278, DOI 10.1074/jbc.M611206200; Xie ZW, 2010, J BIOL CHEM, V285, P8628, DOI 10.1074/jbc.M109.057711; Xie ZW, 2006, CARDIOVASC RES, V69, P491, DOI 10.1016/j.cardiores.2005.11.002; Yang J, 2005, J HYPERTENS, V23, P1497, DOI 10.1097/01.hjh.0000174606.41651.ae; Zhao Q, 2008, PHARMACOGENET GENOM, V18, P459, DOI 10.1097/FPC.0b013e3282f97fb2	47	40	42	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2011	286	52					44646	44658		10.1074/jbc.M111.265462	http://dx.doi.org/10.1074/jbc.M111.265462			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870CA	22057271	Green Published, hybrid			2022-12-27	WOS:000298645500035
J	Zhang, D; Guo, M; Zhang, W; Lu, XY				Zhang, Di; Guo, Ming; Zhang, Wei; Lu, Xin-Yun			Adiponectin Stimulates Proliferation of Adult Hippocampal Neural Stem/Progenitor Cells through Activation of p38 Mitogen-activated Protein Kinase (p38MAPK)/Glycogen Synthase Kinase 3 beta (GSK-3 beta)/beta-Catenin Signaling Cascade	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN CEREBROSPINAL-FLUID; INSULIN SENSITIVITY; PROGENITOR CELLS; IN-VIVO; HORMONE ADIPONECTIN; CARCINOMA-CELLS; PRECURSOR CELLS; DENTATE GYRUS; STEM-CELLS; C-JUN	Adiponectin is the most abundant adipokine secreted from adipocytes. Accumulating evidence suggests that the physiological roles of adiponectin go beyond its metabolic effects. In the present study, we demonstrate that adiponectin receptors 1 and 2 (AdipoR1 and AdipoR2) are expressed in adult hippocampal neural stem/progenitor cells (hNSCs). Adiponectin treatment increases proliferation of cultured adult hNSCs in a dose-and time-dependent manner, whereas apoptosis and differentiation of adult hNSCs into neuronal or glial lineage were not affected. Adiponectin activates AMP-activated protein kinase and p38 mitogen-activated protein kinase (p38MAPK) signaling pathways in adult hNSCs. Pretreatment with the p38MAPK inhibitor SB203580, but not the AMP-activated protein kinase inhibitor Compound C, attenuates adiponectin-induced cell proliferation. Moreover, adiponectin induces phosphorylation of Ser-389, a key inhibitory site of glycogen synthase kinase 3 beta (GSK-3 beta), and this effect can be blocked by inhibition of p38MAPK with SB203580. Levels of total and nuclear beta-catenin, the primary substrate of GSK-3 beta, were increased by adiponectin treatment. These results indicate that adiponectin stimulates proliferation of adult hNSCs, via acting on GSK-3 beta to promote nuclear accumulation of beta-catenin. Thus, our studies uncover a novel role for adiponectin signaling in regulating proliferation of adult neural stem cells.	[Zhang, Di; Guo, Ming; Zhang, Wei; Lu, Xin-Yun] Univ Texas Hlth Sci Ctr San Antonio, Dept Pharmacol, San Antonio, TX 78229 USA; [Lu, Xin-Yun] Univ Texas Hlth Sci Ctr San Antonio, Dept Psychiat, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Lu, XY (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Pharmacol, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	lux3@uthscsa.edu	Lu, Xin-Yun/M-8657-2016	Guo, Ming/0000-0002-3698-5580	National Institutes of Health [MH073844, MH076929]; National Alliance for Research on Schizophrenia and Depression; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH073844, R01MH076929] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Alliance for Research on Schizophrenia and Depression(NARSAD); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported in part by National Institutes of Health Grants MH073844 and MH076929 (to X.-Y.L.). This work was also supported by a National Alliance for Research on Schizophrenia and Depression Independent Investigator Award (to X.-Y.L.).	Arditi JD, 2007, HORM METAB RES, V39, P9, DOI 10.1055/s-2007-956518; Ben-Hur T, 2003, MOL CELL NEUROSCI, V24, P623, DOI 10.1016/S1044-7431(03)00218-5; Berner HS, 2004, BONE, V35, P842, DOI 10.1016/j.bone.2004.06.008; Bluher M, 2005, BIOCHEM BIOPH RES CO, V329, P1127, DOI 10.1016/j.bbrc.2005.02.081; Bulavin DV, 2002, CURR OPIN GENET DEV, V12, P92, DOI 10.1016/S0959-437X(01)00270-2; Cacci E, 2005, J NEUROSCI RES, V80, P789, DOI 10.1002/jnr.20531; Chen YR, 1996, J BIOL CHEM, V271, P631, DOI 10.1074/jbc.271.2.631; Cnop M, 2003, DIABETOLOGIA, V46, P459, DOI 10.1007/s00125-003-1074-z; Combs TP, 2004, ENDOCRINOLOGY, V145, P367, DOI 10.1210/en.2003-1068; Cong L, 2007, ENDOCR-RELAT CANCER, V14, P713, DOI 10.1677/ERC-07-0065; DiMascio L, 2007, J IMMUNOL, V178, P3511, DOI 10.4049/jimmunol.178.6.3511; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Ebinuma H, 2007, CLIN CHEM, V53, P1541, DOI 10.1373/clinchem.2007.085654; Eom TY, 2009, BIOL PSYCHIAT, V66, P494, DOI 10.1016/j.biopsych.2009.04.015; Fruebis J, 2001, P NATL ACAD SCI USA, V98, P2005, DOI 10.1073/pnas.041591798; Fry M, 2006, J NEUROSCI, V26, P9695, DOI 10.1523/JNEUROSCI.2014-06.2006; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Garza JC, 2008, J BIOL CHEM, V283, P18238, DOI 10.1074/jbc.M800053200; Gomez-Nicola D., MOL BIOL CELL, V22, P1960; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hoeck JD, 2010, NAT NEUROSCI, V13, P1365, DOI 10.1038/nn.2644; Hsieh J, 2004, J CELL BIOL, V164, P111, DOI 10.1083/jcb.200308101; Iosif RE, 2006, J NEUROSCI, V26, P9703, DOI 10.1523/JNEUROSCI.2723-06.2006; Kadowaki T, 2005, ENDOCR REV, V26, P439, DOI 10.1210/er.2005-0005; Kelesidis I, 2006, BRIT J CANCER, V94, P1221, DOI 10.1038/sj.bjc.6603051; Kempermann G, 2008, CURR OPIN PSYCHIATR, V21, P290, DOI 10.1097/YCO.0b013e3282fad375; Keohane A, 2010, MOL CELL NEUROSCI, V43, P127, DOI 10.1016/j.mcn.2009.10.003; Kharroubi I, 2003, BIOCHEM BIOPH RES CO, V312, P1118, DOI 10.1016/j.bbrc.2003.11.042; Kim AY, 2010, MOL ENDOCRINOL, V24, P1441, DOI 10.1210/me.2009-0498; Kim CS, 2007, J RADIAT RES, V48, P407, DOI 10.1269/jrr.07032; Kim SJ, 2007, NEUROCHEM RES, V32, P1399, DOI 10.1007/s11064-007-9323-z; Kim WY, 2009, NAT NEUROSCI, V12, P1390, DOI 10.1038/nn.2408; Kos K, 2007, J CLIN ENDOCR METAB, V92, P1129, DOI 10.1210/jc.2006-1841; Kubota N, 2002, J BIOL CHEM, V277, P25863, DOI 10.1074/jbc.C200251200; Kubota N, 2007, CELL METAB, V6, P55, DOI 10.1016/j.cmet.2007.06.003; Kusminski CM, 2007, DIABETOLOGIA, V50, P634, DOI 10.1007/s00125-006-0577-9; Lara-Castro C, 2006, DIABETES, V55, P249, DOI 10.2337/diabetes.55.1.249; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Lie DC, 2005, NATURE, V437, P1370, DOI 10.1038/nature04108; Liu JF, 1998, EUR J BIOCHEM, V258, P271, DOI 10.1046/j.1432-1327.1998.2580271.x; Ma DK, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-16; Maeda K, 1996, BIOCHEM BIOPH RES CO, V221, P286, DOI 10.1006/bbrc.1996.0587; Maeda N, 2002, NAT MED, V8, P731, DOI 10.1038/nm724; Mikhailov A, 2004, J CELL BIOL, V166, P517, DOI 10.1083/jcb.200405167; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Nawrocki AR, 2006, J BIOL CHEM, V281, P2654, DOI 10.1074/jbc.M505311200; Neumeier M, 2005, BIOCHEM BIOPH RES CO, V334, P924, DOI 10.1016/j.bbrc.2005.06.187; Neumeier M, 2007, AM J PHYSIOL-ENDOC M, V293, pE965, DOI 10.1152/ajpendo.00119.2007; Nusse R, 2008, CELL RES, V18, P523, DOI 10.1038/cr.2008.47; Okamoto SI, 2007, CELL STEM CELL, V1, P230, DOI 10.1016/j.stem.2007.07.010; Palanivel R, 2007, CARDIOVASC RES, V75, P148, DOI 10.1016/j.cardiores.2007.04.011; Pan WH, 2006, PEPTIDES, V27, P911, DOI 10.1016/j.peptides.2005.12.014; Qi Y, 2004, NAT MED, V10, P524, DOI 10.1038/nm1029; Qu QH, 2010, NAT CELL BIOL, V12, P31, DOI 10.1038/ncb2001; Sanalkumar R, 2010, J NEUROCHEM, V113, P807, DOI 10.1111/j.1471-4159.2010.06574.x; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; Sirerol-Piquer M, 2011, HIPPOCAMPUS, V21, P910, DOI 10.1002/hipo.20805; Snyder JS, 2011, NATURE, V476, P458, DOI 10.1038/nature10287; Spranger J, 2006, DIABETES, V55, P141, DOI 10.2337/diabetes.55.1.141; Staiger H, 2004, DIABETES, V53, P2195, DOI 10.2337/diabetes.53.9.2195; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Thornton TM, 2008, SCIENCE, V320, P667, DOI 10.1126/science.1156037; Tian HP, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-139; Tsao TS, 2003, J BIOL CHEM, V278, P50810, DOI 10.1074/jbc.M309469200; Waki H, 2005, ENDOCRINOLOGY, V146, P790, DOI 10.1210/en.2004-1096; Waki H, 2003, J BIOL CHEM, V278, P40352, DOI 10.1074/jbc.M300365200; Wang XF, 2007, MOL CELL NEUROSCI, V36, P343, DOI 10.1016/j.mcn.2007.07.005; Wang Y, 2005, J BIOL CHEM, V280, P18341, DOI 10.1074/jbc.M501149200; Wang Y, 2006, CANCER RES, V66, P11462, DOI 10.1158/0008-5472.CAN-06-1969; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Yamauchi T, 2003, J BIOL CHEM, V278, P2461, DOI 10.1074/jbc.M209033200; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	75	98	104	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2011	286	52					44913	44920		10.1074/jbc.M111.310052	http://dx.doi.org/10.1074/jbc.M111.310052			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870CA	22039048	Green Published, hybrid			2022-12-27	WOS:000298645500059
J	Li, ZH; Alvarez, VE; De Gaudenzi, JG; Sant'Anna, C; Frasch, ACC; Cazzulo, JJ; Docampo, R				Li, Zhu-Hong; Alvarez, Vanina E.; De Gaudenzi, Javier G.; Sant'Anna, Celso; Frasch, Alberto C. C.; Cazzulo, Juan J.; Docampo, Roberto			Hyperosmotic Stress Induces Aquaporin-dependent Cell Shrinkage, Polyphosphate Synthesis, Amino Acid Accumulation, and Global Gene Expression Changes in Trypanosoma cruzi	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONTRACTILE VACUOLE COMPLEX; MESSENGER-RNA; SYSTEM-A; COMPATIBLE OSMOLYTES; HSP70 EXPRESSION; YEAST-CELLS; TRANSPORT; ACIDOCALCISOMES; DIFFERENTIATION; PROTEIN	The protist parasite Trypanosoma cruzi has evolved the ability to transit between completely different hosts and to replicate in adverse environments. In particular, the epimastigote form, the replicative stage inside the vector, is subjected to nutritional and osmotic stresses during its development. In this work, we describe the biochemical and global gene expression changes of epimastigotes under hyperosmotic conditions. Hyperosmotic stress resulted in cell shrinking within a few minutes. Depending on the medium osmolarity, this was followed by lack of volume recovery for at least 2 h or by slow recovery. Experiments with inhibitors, or with cells in which an aquaporin gene (TcAQP1) was knocked down or overexpressed, revealed its importance for the cellular response to hyperosmotic stress. Furthermore, the adaptation to this new environment was shown to involve the regulation of the polyphosphate polymerization state as well as changes in amino acid catabolism to generate compatible osmolytes. A genome-wide transcriptional analysis of stressed parasites revealed down-regulation of genes belonging to diverse functional categories and up-regulation of genes encoding trans-sialidase-like and ribosomal proteins. Several of these changes were confirmed by Northern blot analyses. Sequence analysis of the 3'UTRs of up- and down-regulated genes allowed the identification of conserved structural RNA motifs enriched in each group, suggesting that specific ribonucleoprotein complexes could be of great importance in the adaptation of this parasite to different environments through regulation of transcript abundance.	[Li, Zhu-Hong; Alvarez, Vanina E.; Sant'Anna, Celso; Docampo, Roberto] Univ Georgia, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA; [Li, Zhu-Hong; Alvarez, Vanina E.; Sant'Anna, Celso; Docampo, Roberto] Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA; [Alvarez, Vanina E.; De Gaudenzi, Javier G.; Frasch, Alberto C. C.; Cazzulo, Juan J.] Univ Nacl Gen San Martin, Consejo Nacl Invest Cient & Tecn, Inst Invest Biotecnol, RA-1650 Buenos Aires, DF, Argentina	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Docampo, R (corresponding author), Univ Georgia, Ctr Trop & Emerging Global Dis, 350B Paul D Coverdell Ctr,500 DW Brooks Dr, Athens, GA 30602 USA.	rdocampo@uga.edu		Alvarez, Vanina/0000-0002-9890-6980; Frasch, Alberto Carlos/0000-0001-7532-653X	National Institutes of Health [AI068647, TW07820, TW07888]; Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina; Howard Hughes Medical Institute; NIAID; FOGARTY INTERNATIONAL CENTER [R03TW007820, D43TW007888] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068647] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina(ANPCyT); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI068647, TW07820, and TW07888 (to R. D.).; Supported by the Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina, and by the Howard Hughes Medical Institute.; We thank Todd Minning for initial help with the use of microarrays, Melina Galizzi for help in maintaining T. cruzi cultures, and the NIAID-sponsored Pathogen Functional Genomics Resource Center for providing the microarrays.	Alfieri RR, 2007, PFLUG ARCH EUR J PHY, V454, P173, DOI 10.1007/s00424-006-0195-x; Alfieri RR, 2005, J GEN PHYSIOL, V125, P37, DOI 10.1085/jgp.200409195; Alfieri RR, 2002, J PHYSIOL-LONDON, V540, P499, DOI 10.1113/jphysiol.2001.013395; Alfieri RR, 2001, BIOCHEM BIOPH RES CO, V283, P174, DOI 10.1006/bbrc.2001.4729; Alvarez VE, 2008, J BIOL CHEM, V283, P3454, DOI 10.1074/jbc.M708474200; Benz C, 2005, MOL BIOCHEM PARASIT, V143, P125, DOI 10.1016/j.molbiopara.2005.05.008; BONE GJ, 1956, NATURE, V178, P308, DOI 10.1038/178308a0; Brandao A, 2009, PARASITOL INT, V58, P215, DOI 10.1016/j.parint.2009.06.001; Brigotti M, 2003, BIOCHEM J, V369, P369, DOI 10.1042/BJ20021056; Bussolati O, 2001, MOL MEMBR BIOL, V18, P27, DOI 10.1080/09687680110033756; Campos PC, 2008, INT J PARASITOL, V38, P1383, DOI 10.1016/j.ijpara.2008.07.001; Cassola A, 2007, MOL MICROBIOL, V65, P655, DOI 10.1111/j.1365-2958.2007.05833.x; Causton HC, 2001, MOL BIOL CELL, V12, P323, DOI 10.1091/mbc.12.2.323; COHEN DM, 1991, AM J PHYSIOL, V261, pC594, DOI 10.1152/ajpcell.1991.261.4.C594; CONTRERAS VT, 1985, MOL BIOCHEM PARASIT, V16, P315, DOI 10.1016/0166-6851(85)90073-8; Fang JM, 2007, BIOCHEM J, V407, P161, DOI 10.1042/BJ20070612; Figueiredo RCBQ, 2000, J PARASITOL, V86, P1213, DOI 10.1645/0022-3395(2000)086[1213:DOTCEM]2.0.CO;2; Franchi-Gazzola R, 2004, BBA-BIOMEMBRANES, V1667, P157, DOI 10.1016/j.bbamem.2004.09.012; Frasch ACC, 2000, PARASITOL TODAY, V16, P282, DOI 10.1016/S0169-4758(00)01698-7; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gasch Audrey P, 2002, Funct Integr Genomics, V2, P181, DOI 10.1007/s10142-002-0058-2; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Hohmann S, 2002, INT REV CYTOL, V215, P149; Hohmann S, 2007, METHOD ENZYMOL, V428, P29, DOI 10.1016/S0076-6879(07)28002-4; Huang DW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r183; Kitamura H, 1997, AM J PHYSIOL-RENAL, V272, pF267, DOI 10.1152/ajprenal.1997.272.2.F267; Kollien AH, 2000, PARASITOL TODAY, V16, P381, DOI 10.1016/S0169-4758(00)01724-5; Kramer S, 2008, J CELL SCI, V121, P3002, DOI 10.1242/jcs.031823; Lander N, 2010, INFECT IMMUN, V78, P231, DOI 10.1128/IAI.00780-09; Lang F, 1998, PHYSIOL REV, V78, P247, DOI 10.1152/physrev.1998.78.1.247; MCMANUS ML, 1995, NEW ENGL J MED, V333, P1260, DOI 10.1056/NEJM199511093331906; Minning TA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-370; Montalvetti A, 2004, J BIOL CHEM, V279, P38673, DOI 10.1074/jbc.M406304200; Nawrocki EP, 2009, BIOINFORMATICS, V25, P1335, DOI 10.1093/bioinformatics/btp157; PETRONINI PG, 1993, BRIT J CANCER, V67, P493, DOI 10.1038/bjc.1993.92; Rohloff P, 2003, MOL BIOCHEM PARASIT, V126, P219, DOI 10.1016/S0166-6851(02)00277-3; Rohloff P, 2004, J BIOL CHEM, V279, P52270, DOI 10.1074/jbc.M410372200; Rohloff P, 2008, EXP PARASITOL, V118, P17, DOI 10.1016/j.exppara.2007.04.013; Rohloff P, 2006, MOL BIOCHEM PARASIT, V150, P249, DOI 10.1016/j.molbiopara.2006.08.010; Ruben L, 1996, MOL BIOCHEM PARASIT, V81, P191, DOI 10.1016/0166-6851(96)02707-7; Ruiz FA, 2001, J BIOL CHEM, V276, P26114, DOI 10.1074/jbc.M102402200; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; SKEIKY YAW, 1992, J EXP MED, V176, P201, DOI 10.1084/jem.176.1.201; Soveral G, 2007, APPL ENVIRON MICROB, V73, P2341, DOI 10.1128/AEM.02519-06	44	31	32	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2011	286	51					43959	43971		10.1074/jbc.M111.311530	http://dx.doi.org/10.1074/jbc.M111.311530			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866SH	22039054	hybrid, Green Published			2022-12-27	WOS:000298402300037
J	Anand, PK; Tait, SWG; Lamkanfi, M; Amer, AO; Nunez, G; Pages, G; Pouyssegur, J; McGargill, MA; Green, DR; Kanneganti, TD				Anand, Paras K.; Tait, Stephen W. G.; Lamkanfi, Mohamed; Amer, Amal O.; Nunez, Gabriel; Pages, Gilles; Pouyssegur, Jacques; McGargill, Maureen A.; Green, Douglas R.; Kanneganti, Thirumala-Devi			TLR2 and RIP2 Pathways Mediate Autophagy of Listeria monocytogenes via Extracellular Signal-regulated Kinase (ERK) Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENOME-WIDE ASSOCIATION; INNATE IMMUNITY; INTRACELLULAR PATHOGENS; CRYOPYRIN INFLAMMASOME; ADAPTIVE IMMUNITY; EPITHELIAL-CELLS; CROHN-DISEASE; HOST-DEFENSE; EARLY PHASE; INFECTION	Background: Listeria monocytogenes is an intracellular pathogen that invades the host cytoplasm. Results: Cells deficient in TLR2 and NOD2 show defective autophagy of Listeria monocytogenes. Conclusion: Autophagy of Listeria is dependent on ERK pathway that is perturbed in TLR2- and NOD2-deficient cells. Significance: Our study establishes the role of innate immune receptors in autophagy of intracellular pathogens.	[Anand, Paras K.; Tait, Stephen W. G.; McGargill, Maureen A.; Green, Douglas R.; Kanneganti, Thirumala-Devi] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; [Lamkanfi, Mohamed] Univ Ghent, Dept Biochem, B-9000 Ghent, Belgium; [Lamkanfi, Mohamed] Flanders Inst Biotechnol, Dept Med Prot Res, B-9000 Ghent, Belgium; [Amer, Amal O.] Ohio State Univ, Dept Internal Med, Div Pulm Allergy Crit Care & Sleep Med, Columbus, OH 43210 USA; [Amer, Amal O.] Ohio State Univ, Ctr Microbial Interface Biol, Columbus, OH 43210 USA; [Nunez, Gabriel] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Pages, Gilles; Pouyssegur, Jacques] CNRS UMR 6543 Ctr A, Inst Dev Biol & Canc Res, F-06189 Nice, France	St Jude Children's Research Hospital; Ghent University; Flanders Institute for Biotechnology (VIB); University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of Michigan System; University of Michigan; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur	Kanneganti, TD (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA.	Thirumala-Devi.Kanneganti@stjude.org	Kanneganti, Thirumala-Devi/M-9435-2018; Kanneganti, Thirumala-Devi/Y-2503-2019; McGargill, Maureen/N-8131-2018; Pages, Gilles/N-7135-2017; Anand, Paras/D-3219-2012; Green, Douglas R/N-8083-2018	Kanneganti, Thirumala-Devi/0000-0002-6395-6443; Kanneganti, Thirumala-Devi/0000-0002-6395-6443; McGargill, Maureen/0000-0002-0916-0372; Green, Douglas R/0000-0002-7332-1417; Anand, Paras/0000-0003-2503-3653; Tait, Stephen/0000-0001-7697-132X	National Institute of Health [AR056296, AI088177]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094586] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI088177] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056296] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institute of Health Grants AR056296 and AI088177.	Amano A, 2006, J BIOCHEM, V140, P161, DOI 10.1093/jb/mvj162; Anand PK, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00012; Anand PK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010136; Birmingham CL, 2007, AUTOPHAGY, V3, P442, DOI 10.4161/auto.4450; Birmingham CL, 2006, J BIOL CHEM, V281, P11374, DOI 10.1074/jbc.M509157200; Campoy E, 2009, BBA-MOL CELL RES, V1793, P1465, DOI 10.1016/j.bbamcr.2009.03.003; Colombo MI, 2006, AUTOPHAGY, V2, P162, DOI 10.4161/auto.2827; Cooney R, 2010, NAT MED, V16, P90, DOI 10.1038/nm.2069; Corr SC, 2009, CELL MICROBIOL, V11, P703, DOI 10.1111/j.1462-5822.2009.01294.x; Creagh EM, 2006, TRENDS IMMUNOL, V27, P352, DOI 10.1016/j.it.2006.06.003; Deretic V, 2005, TRENDS IMMUNOL, V26, P523, DOI 10.1016/j.it.2005.08.003; Deretic V., 2009, CURR OPIN CELL BIOL, V22, P1; Deretic V, 2009, CELL HOST MICROBE, V5, P527, DOI 10.1016/j.chom.2009.05.016; Flo TH, 2000, J IMMUNOL, V164, P2064, DOI 10.4049/jimmunol.164.4.2064; GARCIADELPORTILLO F, 1995, TRENDS MICROBIOL, V3, P373, DOI 10.1016/S0966-842X(00)88982-9; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; Glick D, 2010, J PATHOL, V221, P3, DOI 10.1002/path.2697; Grundling A, 2003, J BACTERIOL, V185, P6295, DOI 10.1128/JB.185.21.6295-6307.2003; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Hamon M, 2006, NAT REV MICROBIOL, V4, P423, DOI 10.1038/nrmicro1413; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Henry R, 2006, CELL MICROBIOL, V8, P107, DOI 10.1111/j.1462-5822.2005.00604.x; Huang J, 2009, CURR TOP MICROBIOL, V335, P189, DOI 10.1007/978-3-642-00302-8_9; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Ireton K, 2007, CELL MICROBIOL, V9, P1365, DOI 10.1111/j.1462-5822.2007.00933.x; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kanneganti TD, 2007, IMMUNITY, V27, P549, DOI 10.1016/j.immuni.2007.10.002; Kanneganti TD, 2007, IMMUNITY, V26, P433, DOI 10.1016/j.immuni.2007.03.008; Kawai T, 2009, INT IMMUNOL, V21, P317, DOI 10.1093/intimm/dxp017; Kim YG, 2008, IMMUNITY, V28, P246, DOI 10.1016/j.immuni.2007.12.012; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Lamkanfi M, 2009, J BIOL CHEM, V284, P20574, DOI 10.1074/jbc.M109.023689; Machata S, 2008, J IMMUNOL, V181, P2028, DOI 10.4049/jimmunol.181.3.2028; McCaffrey RL, 2004, P NATL ACAD SCI USA, V101, P11386, DOI 10.1073/pnas.0403215101; Mengaud J, 1996, CELL, V84, P923, DOI 10.1016/S0092-8674(00)81070-3; Meyer-Morse N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008610; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Monack DM, 2001, CELL MICROBIOL, V3, P633, DOI 10.1046/j.1462-5822.2001.00143.x; Mosa A, 2009, INFECT IMMUN, V77, P2908, DOI 10.1128/IAI.01068-08; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; O'Riordan M, 2002, P NATL ACAD SCI USA, V99, P13861, DOI 10.1073/pnas.202476699; Park JH, 2007, J IMMUNOL, V178, P2380, DOI 10.4049/jimmunol.178.4.2380; Pattingre S, 2008, BIOCHIMIE, V90, P313, DOI 10.1016/j.biochi.2007.08.014; PORTNOY DA, 1988, J EXP MED, V167, P1459, DOI 10.1084/jem.167.4.1459; Portnoy DA, 2002, J CELL BIOL, V158, P409, DOI 10.1083/jcb.200205009; Poussin MA, 2005, INFECT IMMUN, V73, P4410, DOI 10.1128/IAI.73.7.4410-4413.2005; Py BF, 2007, AUTOPHAGY, V3, P117, DOI 10.4161/auto.3618; Rich KA, 2003, CELL MICROBIOL, V5, P455, DOI 10.1046/j.1462-5822.2003.00292.x; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Seki E, 2002, J IMMUNOL, V169, P3863, DOI 10.4049/jimmunol.169.7.3863; Torres D, 2004, INFECT IMMUN, V72, P2131, DOI 10.1128/IAI.72.4.2131-2139.2004; Travassos LH, 2010, NAT IMMUNOL, V11, P55, DOI 10.1038/ni.1823; Vazquez-Boland JA, 2001, CLIN MICROBIOL REV, V14, P584, DOI 10.1128/CMR.14.3.584-640.2001; Yang ZF, 2009, CURR TOP MICROBIOL, V335, P1, DOI 10.1007/978-3-642-00302-8_1; Yano T, 2008, NAT IMMUNOL, V9, P908, DOI 10.1038/ni.1634; Yoshikawa Y, 2009, NAT CELL BIOL, V11, P1233, DOI 10.1038/ncb1967; Zhao ZJ, 2008, CELL HOST MICROBE, V4, P458, DOI 10.1016/j.chom.2008.10.003	60	97	101	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					42981	42991		10.1074/jbc.M111.310599	http://dx.doi.org/10.1074/jbc.M111.310599			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22033934	Green Published, hybrid			2022-12-27	WOS:000298351300019
J	Rezabkova, L; Man, P; Novak, P; Herman, P; Vecer, J; Obsilova, V; Obsil, T				Rezabkova, Lenka; Man, Petr; Novak, Petr; Herman, Petr; Vecer, Jaroslav; Obsilova, Veronika; Obsil, Tomas			Structural Basis for the 14-3-3 Protein-dependent Inhibition of the Regulator of G Protein Signaling 3 (RGS3) Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FORKHEAD TRANSCRIPTION FACTOR; GTPASE-ACTIVATING PROTEINS; LIGAND-BINDING; CRYSTAL-STRUCTURE; FACTOR FOXO4; SUBCELLULAR-LOCALIZATION; NUCLEAR IMPORT; ALPHA-SUBUNITS; DNA-BINDING; COMPLEXES	Regulator of G protein signaling (RGS) proteins function as GTPase-activating proteins for the alpha-subunit of heterotrimeric G proteins. The function of certain RGS proteins is negatively regulated by 14-3-3 proteins, a family of highly conserved regulatory molecules expressed in all eukaryotes. In this study, we provide a structural mechanism for 14-3-3-dependent inhibition of RGS3-G alpha interaction. We have used small angle x-ray scattering, hydrogen/deuterium exchange kinetics, and Forster resonance energy transfer measurements to determine the low-resolution solution structure of the 14-3-3 zeta.RGS3 complex. The structure shows the RGS domain of RGS3 bound to the 14-3-3 zeta dimer in an as-yet-unrecognized manner interacting with less conserved regions on the outer surface of the 14-3-3 dimer outside its central channel. Our results suggest that the 14-3-3 protein binding affects the structure of the G alpha interaction portion of RGS3 as well as sterically blocks the interaction between the RGS domain and the G alpha subunit of heterotrimeric G proteins.	[Rezabkova, Lenka; Obsil, Tomas] Charles Univ Prague, Fac Sci, Dept Phys & Macromol Chem, Prague 12843, Czech Republic; [Man, Petr; Novak, Petr] Charles Univ Prague, Fac Sci, Dept Biochem, Prague 12843, Czech Republic; [Rezabkova, Lenka; Obsilova, Veronika; Obsil, Tomas] Acad Sci Czech Republ, Inst Physiol, CR-14220 Prague, Czech Republic; [Man, Petr; Novak, Petr] Acad Sci Czech Republ, Inst Microbiol, CR-14220 Prague, Czech Republic; [Herman, Petr; Vecer, Jaroslav] Charles Univ Prague, Fac Math & Phys, Inst Phys, CR-12116 Prague, Czech Republic	Charles University Prague; Charles University Prague; Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; Charles University Prague	Obsil, T (corresponding author), Charles Univ Prague, Fac Sci, Dept Phys & Macromol Chem, Hlavova 8, Prague 12843, Czech Republic.	obsil@natur.cuni.cz	Man, Petr/H-2451-2014; Herman, Petr/A-2626-2008; Rezabkova, Lenka/O-8229-2017; Obsilova, Veronika/B-7116-2012; Novak, Petr/F-9655-2014; Obsil, Tomas/B-7142-2012	Man, Petr/0000-0002-1485-2197; Herman, Petr/0000-0001-6918-2576; Rezabkova, Lenka/0000-0002-7274-8080; Obsilova, Veronika/0000-0003-4887-0323; Novak, Petr/0000-0001-8688-529X; Obsil, Tomas/0000-0003-4602-1272	Grant Agency of the Academy of Sciences of the Czech Republic [IAA501110801]; Grant Agency of Charles University [28510]; Czech Science Foundation [P305/11/0708, P207/10/1040]; Ministry of Education, Youth, and Sports of the Czech Republic [MSM0021620857, MSM0021620835]; Ministry of Education, Youth, and Sports of the Czech Republic Center of Neurosciences [LC554]; Academy of Sciences of the Czech Republic [AV0Z50110509, AV0Z50200510]	Grant Agency of the Academy of Sciences of the Czech Republic(Czech Academy of SciencesGrant Agency of the Czech Republic); Grant Agency of Charles University; Czech Science Foundation(Grant Agency of the Czech Republic); Ministry of Education, Youth, and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Ministry of Education, Youth, and Sports of the Czech Republic Center of Neurosciences; Academy of Sciences of the Czech Republic(Czech Academy of Sciences)	This work was supported by the Grant Agency of the Academy of Sciences of the Czech Republic (Grant IAA501110801); Grant Agency of Charles University (Grant 28510); Czech Science Foundation (Projects P305/11/0708 and P207/10/1040); Ministry of Education, Youth, and Sports of the Czech Republic Research (Projects MSM0021620857 and MSM0021620835 and Center of Neurosciences LC554); and Academy of Sciences of the Czech Republic (Research Projects AV0Z50110509 and AV0Z50200510).	Abramow-Newerly M, 2006, CELL SIGNAL, V18, P579, DOI 10.1016/j.cellsig.2005.08.010; Abramow-Newerly M, 2006, CELL SIGNAL, V18, P2209, DOI 10.1016/j.cellsig.2006.05.011; Aitken A, 2006, SEMIN CANCER BIOL, V16, P162, DOI 10.1016/j.semcancer.2006.03.005; Benzing T, 2000, J BIOL CHEM, V275, P28167; Benzing T, 2002, J BIOL CHEM, V277, P32954, DOI 10.1074/jbc.M200859200; Benzinger A, 2005, CELL RES, V15, P219, DOI 10.1038/sj.cr.7290290; Berman DM, 1996, CELL, V86, P445, DOI 10.1016/S0092-8674(00)80117-8; Boura E, 2007, J BIOL CHEM, V282, P8265, DOI 10.1074/jbc.M605682200; Bridges D, 2004, SCI STKE, pre10; Brownawell AM, 2001, MOL CELL BIOL, V21, P3534, DOI 10.1128/MCB.21.10.3534-3546.2001; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Bustos DM, 2006, PROTEINS, V63, P35, DOI 10.1002/prot.20888; Davezac N, 2000, ONCOGENE, V19, P2179, DOI 10.1038/sj.onc.1203545; De Vries L, 1999, TRENDS CELL BIOL, V9, P138, DOI 10.1016/S0962-8924(99)01515-9; Engen JR, 2003, ANALYST, V128, P623, DOI 10.1039/b212800b; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; Gardino AK, 2006, SEMIN CANCER BIOL, V16, P173, DOI 10.1016/j.semcancer.2006.03.007; Guinier A., 1939, ANN PHYS-NEW YORK, V11, P161, DOI DOI 10.1051/ANPHYS/193911120161; Hepler JR, 1997, P NATL ACAD SCI USA, V94, P428, DOI 10.1073/pnas.94.2.428; Houtman JCD, 2007, PROTEIN SCI, V16, P30, DOI 10.1110/ps.062558507; Lakowicz J.R., 1999, PRINCIPLES FLUORESCE, P321; LEE RH, 1988, EXP EYE RES, V46, P829, DOI 10.1016/S0014-4835(88)80035-6; LIU D, 1995, NATURE, V376, P191, DOI 10.1038/376191a0; Mackintosh C, 2004, BIOCHEM J, V381, P329, DOI 10.1042/BJ20031332; Marcoux J, 2010, J BIOL CHEM, V285, P28980, DOI 10.1074/jbc.M110.139824; Margolis SS, 2004, CELL CYCLE, V3, P425; McKinsey TA, 2001, MOL CELL BIOL, V21, P6312, DOI 10.1128/MCB.21.18.6312-6321.2001; MELHUISH WH, 1961, J PHYS CHEM-US, V65, P229, DOI 10.1021/j100820a009; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; Niu JX, 2002, BIOCHEM J, V365, P677, DOI 10.1042/BJ20020390; Obsil T, 2001, CELL, V105, P257, DOI 10.1016/S0092-8674(01)00316-6; Obsilova V, 2005, BIOCHEMISTRY-US, V44, P11608, DOI 10.1021/bi050618r; Obsilova V, 2004, J BIOL CHEM, V279, P4531, DOI 10.1074/jbc.M306939200; Ottmann C, 2007, MOL CELL, V25, P427, DOI 10.1016/j.molcel.2006.12.017; Petosa C, 1998, J BIOL CHEM, V273, P16305, DOI 10.1074/jbc.273.26.16305; Porod G., 1982, SMALL ANGLE XRAY SCA, P17, DOI DOI 10.1002/ACTP.1985.010360520; Rezabkova L, 2010, J STRUCT BIOL, V170, P451, DOI 10.1016/j.jsb.2010.03.009; Rittinger K, 1999, MOL CELL, V4, P153, DOI 10.1016/S1097-2765(00)80363-9; Roessle MW, 2007, J APPL CRYSTALLOGR, V40, pS190, DOI 10.1107/S0021889806055506; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Silhan J, 2004, J BIOL CHEM, V279, P49113, DOI 10.1074/jbc.M408671200; Silhan J, 2009, J BIOL CHEM, V284, P19349, DOI 10.1074/jbc.M109.002725; Strohalm M, 2010, ANAL CHEM, V82, P4648, DOI 10.1021/ac100818g; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tesmer JJG, 1997, CELL, V89, P251, DOI 10.1016/S0092-8674(00)80204-4; Vecer J, 2011, J FLUORESC, V21, P873, DOI 10.1007/s10895-009-0589-1; Veisova D, 2010, BIOCHEMISTRY-US, V49, P3853, DOI 10.1021/bi100273k; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Ward RJ, 2005, MOL PHARMACOL, V68, P1821, DOI 10.1124/moi.105.015073; Watson N, 1996, NATURE, V383, P172, DOI 10.1038/383172a0; Wilker EW, 2005, J BIOL CHEM, V280, P18891, DOI 10.1074/jbc.M500982200; Willardson BM, 1996, P NATL ACAD SCI USA, V93, P1475, DOI 10.1073/pnas.93.4.1475; Woodcock JM, 2003, J BIOL CHEM, V278, P36323, DOI 10.1074/jbc.M304689200; Xiao Bing, 1995, Nature (London), V376, P188, DOI 10.1038/376188a0; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yang J, 1999, EMBO J, V18, P2174, DOI 10.1093/emboj/18.8.2174; Yang XW, 2006, P NATL ACAD SCI USA, V103, P17237, DOI 10.1073/pnas.0605779103	58	31	31	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					43527	43536		10.1074/jbc.M111.273573	http://dx.doi.org/10.1074/jbc.M111.273573			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22027839	Green Published, hybrid			2022-12-27	WOS:000298351300072
J	Bernert, B; Porsch, H; Heldin, P				Bernert, Berit; Porsch, Helena; Heldin, Paraskevi			Hyaluronan Synthase 2 (HAS2) Promotes Breast Cancer Cell Invasion by Suppression of Tissue Metalloproteinase Inhibitor 1 (TIMP-1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH FACTOR-BB; MATRIX METALLOPROTEINASES; DERMAL FIBROBLASTS; EPITHELIAL-CELLS; EXPRESSION; CD44; RECEPTOR; ACTIVATION; MIGRATION; TUMORIGENESIS	Invasion and metastasis are the primary causes of breast cancer mortality, and increased knowledge about the molecular mechanisms involved in these processes is highly desirable. High levels of hyaluronan in breast tumors have been correlated with poor patient survival. The involvement of hyaluronan in the early invasive phase of a clone of breast cancer cell line MDA-MB-231 that forms bone metastases was studied using an in vivo-like basement membrane model. The metastatic to bone tumor cells exhibited a 7-fold higher hyaluronan-synthesizing capacity compared with MDA-MB-231 cells predominately due to an increased expression of hyaluronan synthase 2 (HAS2). We found that knockdown of HAS2 completely suppressed the invasive capability of these cells by the induction of tissue metalloproteinase inhibitor 1 (TIMP-1) and dephosphorylation of focal adhesion kinase. HAS2 knockdown-mediated inhibition of basement membrane remodeling was rescued by HAS2 overexpression, transfection with TIMP-1 siRNA, or addition of TIMP-1-blocking antibodies. Moreover, knockdown of HAS2 suppressed the EGF-mediated induction of the focal adhesion kinase/PI3K/Akt signaling pathway. Thus, this study provides new insights into a possible mechanism whereby HAS2 enhances breast cancer invasion.	[Bernert, Berit; Porsch, Helena; Heldin, Paraskevi] Uppsala Univ, Ludwig Inst Canc Res, Biomed Ctr, SE-75124 Uppsala, Sweden	Ludwig Institute for Cancer Research; Uppsala University	Heldin, P (corresponding author), Uppsala Univ, Ludwig Inst Canc Res, Biomed Ctr, Box 595, SE-75124 Uppsala, Sweden.	evi.heldin@licr.uu.se			Swedish Cancer Society; Mizutani Foundation for Glycoscience; Agnes and Mac Rudbergs Foundation (Uppsala University)	Swedish Cancer Society(Swedish Cancer Society); Mizutani Foundation for Glycoscience; Agnes and Mac Rudbergs Foundation (Uppsala University)	The work was supported by grants from the Swedish Cancer Society, the Mizutani Foundation for Glycoscience, and the Agnes and Mac Rudbergs Foundation (Uppsala University).	Akahane T, 2004, EXP CELL RES, V301, P158, DOI 10.1016/j.yexcr.2004.08.002; Auvinen P, 2000, AM J PATHOL, V156, P529, DOI 10.1016/S0002-9440(10)64757-8; Bigelow RLH, 2009, BREAST CANCER RES TR, V117, P31, DOI 10.1007/s10549-008-0170-7; BIRKEDALHANSEN H, 1982, BIOCHEM BIOPH RES CO, V107, P1173, DOI 10.1016/S0006-291X(82)80120-4; Boregowda Rajeev K, 2006, J Carcinog, V5, P2, DOI 10.1186/1477-3163-5-2; Bourguignon LYW, 2008, SEMIN CANCER BIOL, V18, P251, DOI 10.1016/j.semcancer.2008.03.007; Camenisch TD, 2000, J CLIN INVEST, V106, P349, DOI 10.1172/JCI10272; Corte MD, 2010, J CANCER RES CLIN, V136, P745, DOI 10.1007/s00432-009-0713-2; Deckers M, 2006, CANCER RES, V66, P2202, DOI 10.1158/0008-5472.CAN-05-3560; DelaTorre M, 1995, ANTICANCER RES, V15, P2791; DELATORRE M, 1993, HUM PATHOL, V24, P1294, DOI 10.1016/0046-8177(93)90262-F; Draffin JE, 2004, CANCER RES, V64, P5702, DOI 10.1158/0008-5472.CAN-04-0389; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Ghatak S, 2005, J BIOL CHEM, V280, P8875, DOI 10.1074/jbc.M410882200; HELDIN P, 1989, BIOCHEM J, V258, P919, DOI 10.1042/bj2580919; Heldin P, 1996, ONCOL REP, V3, P1011; HELDIN P, 1993, EXP CELL RES, V208, P422, DOI 10.1006/excr.1993.1264; Hibbard MK, 2000, CANCER RES, V60, P4869; Hotary K, 2006, GENE DEV, V20, P2673, DOI 10.1101/gad.1451806; Itano N, 2008, CANCER SCI, V99, P1720, DOI 10.1111/j.1349-7006.2008.00885.x; Itoh Y, 2006, J CELL PHYSIOL, V206, P1, DOI 10.1002/jcp.20431; Jacobson A, 2000, BIOCHEM J, V348, P29, DOI 10.1042/0264-6021:3480029; Jacobson A, 2002, INT J CANCER, V102, P212, DOI 10.1002/ijc.10683; Jokela TA, 2011, J BIOL CHEM, V286, P33632, DOI 10.1074/jbc.M111.265637; Jones S, 2001, KIDNEY INT, V59, P1739, DOI 10.1046/j.1523-1755.2001.0590051739.x; Jung KK, 2006, EMBO J, V25, P3934, DOI 10.1038/sj.emboj.7601281; Kalluri R, 2003, NAT REV CANCER, V3, P422, DOI 10.1038/nrc1094; Karousou E, 2010, J BIOL CHEM, V285, P23647, DOI 10.1074/jbc.M110.127050; Koyama H, 2008, AM J PATHOL, V172, P179, DOI 10.2353/ajpath.2008.070360; Koyama H, 2007, AM J PATHOL, V170, P1086, DOI 10.2353/ajpath.2007.060793; Lambert E, 2003, BIOCHEM J, V372, P767, DOI 10.1042/BJ20030187; Li LL, 2007, BIOCHEM J, V404, P327, DOI 10.1042/BJ20061757; Li LL, 2006, J BIOL CHEM, V281, P26512, DOI 10.1074/jbc.M605607200; Li Y, 2001, BRIT J CANCER, V85, P600, DOI 10.1054/bjoc.2001.1922; Li YJ, 2007, INT J CANCER, V120, P2557, DOI 10.1002/ijc.22550; Liu KC, 2011, ONCOL REP, V26, P177, DOI 10.3892/or.2011.1264; Liu XW, 2005, CANCER RES, V65, P898; Liu XW, 2003, J BIOL CHEM, V278, P40364, DOI 10.1074/jbc.M302999200; Naor D, 2008, SEMIN CANCER BIOL, V18, P260, DOI 10.1016/j.semcancer.2008.03.015; Olsson M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001332; Orian-Rousseau V, 2010, EUR J CANCER, V46, P1271, DOI 10.1016/j.ejca.2010.02.024; Orian-Rousseau V, 2008, ADV CANCER RES, V101, P63, DOI 10.1016/S0065-230X(08)00404-1; Paget S, 1989, LANCET, V8, P98, DOI [DOI 10.1016/S0140-6736(00)49915-0, 10.1016/S0140-6736(00)49915-0]; Persson U, 1997, J BIOL CHEM, V272, P21187, DOI 10.1074/jbc.272.34.21187; Pienimaki JP, 2001, J BIOL CHEM, V276, P20428, DOI 10.1074/jbc.M007601200; Pivetta E, 2011, J CELL PHYSIOL, V226, P769, DOI 10.1002/jcp.22398; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Sato N, 2004, CANCER RES, V64, P6950, DOI 10.1158/0008-5472.CAN-04-0677; Schlaepfer DD, 2004, CURR OPIN GENET DEV, V14, P92, DOI 10.1016/j.gde.2003.12.002; Schmalfeldt B, 2001, CLIN CANCER RES, V7, P2396; Schraufstatter Ingrid, 2009, J Stem Cells, V4, P191, DOI jsc.2010.4.4.191; Schrohl AS, 2004, CLIN CANCER RES, V10, P2289, DOI 10.1158/1078-0432.CCR-03-0360; Simpson RML, 2010, AM J PATHOL, V176, P1215, DOI 10.2353/ajpath.2010.090802; Srivastava A, 2007, P NATL ACAD SCI USA, V104, P2721, DOI 10.1073/pnas.0611666104; Stamenkovic I, 2000, SEMIN CANCER BIOL, V10, P415, DOI 10.1006/scbi.2000.0379; Stern R, 2008, SEMIN CANCER BIOL, V18, P275, DOI 10.1016/j.semcancer.2008.03.017; SUZUKI M, 1995, BIOCHEM J, V307, P817, DOI 10.1042/bj3070817; Tammi RH, 2011, FEBS J, V278, P1419, DOI 10.1111/j.1742-4658.2011.08070.x; Tool BP, 2001, SEMIN CELL DEV BIOL, V12, P79, DOI 10.1006/scdb.2000.0244; Toole BP, 2009, CLIN CANCER RES, V15, P7462, DOI 10.1158/1078-0432.CCR-09-0479; Udabage L, 2005, CANCER RES, V65, P6139, DOI 10.1158/0008-5472.CAN-04-1622; Unger K, 2010, ENDOCR-RELAT CANCER, V17, P87, DOI 10.1677/ERC-09-0065; Vigetti D, 2009, GLYCOBIOLOGY, V19, P537, DOI 10.1093/glycob/cwp022; Wang AM, 2004, J BIOL CHEM, V279, P10279, DOI 10.1074/jbc.M312045200; Yu Q, 1999, GENE DEV, V13, P35, DOI 10.1101/gad.13.1.35; Yu WH, 2002, GENE DEV, V16, P307, DOI 10.1101/gad.925702; Zhang W, 2000, BIOCHEM J, V349, P91, DOI 10.1042/0264-6021:3490091; Zoltan-Jones A, 2003, J BIOL CHEM, V278, P45801, DOI 10.1074/jbc.M308168200	68	81	85	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42349	42359		10.1074/jbc.M111.278598	http://dx.doi.org/10.1074/jbc.M111.278598			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	22016393	Green Published, hybrid			2022-12-27	WOS:000298180900044
J	Wang, HL; Cheng, XL; Sine, SM				Wang, Hai-Long; Cheng, Xiaolin; Sine, Steven M.			Intramembrane Proton Binding Site Linked to Activation of Bacterial Pentameric Ion Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTORS; ALLOSTERIC TRANSMEMBRANE SITE; X-RAY-STRUCTURE; SINGLE-CHANNEL; LOOP; CYANOBACTERIA; POTENTIATION; SIMULATION; DOMAIN; CELLS	Prokaryotic orthologs of eukaryotic Cys-loop receptor channels recently emerged as structural and mechanistic surrogates to investigate this superfamily of intercellular signaling proteins. Here, we examine proton activation of the prokaryotic ortholog GLIC using patch clamp electrophysiology, mutagenesis, and molecular dynamics (MD) simulations. Whole-cell current recordings from human embryonic kidney (HEK) 293 cells expressing GLIC show half-maximal activation at pH 6, close to the pK(a) of histidine, implicating the three native His residues in proton sensing linked to activation. The mutation H235F abolishes proton activation, H277Y is without effect, and all nine mutations of His-127 prevent expression on the cell surface. In the GLIC crystal structure, His-235 on transmembrane (TM) alpha-helix 2, hydrogen bonds to the main chain carbonyl oxygen of Ile-259 on TM alpha-helix 3. MD simulations show that when His-235 is protonated, the hydrogen bond persists, and the channel remains in the open conformation, whereas when His-235 is deprotonated, the hydrogen bond dissociates, and the channel closes. Mutations of the proximal Tyr-263, which also links TM alpha-helices 2 and 3 via a hydrogen bond, alter proton sensitivity over a 1.5 pH unit range. MD simulations show that mutations of Tyr-263 alter the hydrogen bonding capacity of His-235. The overall findings show that His-235 in the TM region of GLIC is a novel proton binding site linked to channel activation.	[Wang, Hai-Long; Sine, Steven M.] Mayo Clin, Coll Med, Dept Physiol & Biomed Engn, Rochester, MN 55905 USA; [Sine, Steven M.] Mayo Clin, Coll Med, Dept Neurol, Rochester, MN 55905 USA; [Cheng, Xiaolin] Oak Ridge Natl Lab, Ctr Biophys Mol, Oak Ridge, TN 37830 USA; [Cheng, Xiaolin] Univ Tennessee, Dept Biochem Cellular & Mol Biol, Knoxville, TN 37996 USA	Mayo Clinic; Mayo Clinic; United States Department of Energy (DOE); Oak Ridge National Laboratory; University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Knoxville	Sine, SM (corresponding author), Mayo Clin, Coll Med, Dept Physiol & Biomed Engn, Rochester, MN 55905 USA.	sine@mayo.edu		Cheng, Xiaolin/0000-0002-7396-3225	National Institutes of Health [NS31744]; U.S. Department of Energy [FWP ERKJE84]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS031744, R37NS031744] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS31744 (to S.M.S.) and the Advanced Computing Program, U.S. Department of Energy Grant FWP ERKJE84 (to X.C.). This work also used resources of the National Center for Computational Sciences at Oak Ridge National Laboratory, which is supported by the U.S. Department of Energy.	BELKIN S, 1987, PLANT PHYSIOL, V84, P25, DOI 10.1104/pp.84.1.25; Bhaya D, 2004, MOL MICROBIOL, V53, P745, DOI 10.1111/j.1365-2958.2004.04160.x; Bocquet N, 2007, NATURE, V445, P116, DOI 10.1038/nature05371; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; Cheng XL, 2006, J MOL BIOL, V355, P310, DOI 10.1016/j.jmb.2005.10.039; daCosta CJB, 2011, J NEUROSCI, V31, P13870, DOI 10.1523/JNEUROSCI.2652-11.2011; Gao F, 2005, J BIOL CHEM, V280, P8443, DOI 10.1074/jbc.M412389200; Gill JK, 2011, P NATL ACAD SCI USA, V108, P5867, DOI 10.1073/pnas.1017975108; Hansen SB, 2005, EMBO J, V24, P3635, DOI 10.1038/sj.emboj.7600828; Heginbotham L, 1999, J GEN PHYSIOL, V114, P551, DOI 10.1085/jgp.114.4.551; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; Howard RJ, 2011, P NATL ACAD SCI USA, V108, P12149, DOI 10.1073/pnas.1104480108; Iyer R, 2002, NATURE, V419, P715, DOI 10.1038/nature01000; LEE NG, 1991, ONCOGENE, V6, P1161; Ma ZY, 2008, BIOCHEM BIOPH RES CO, V371, P437, DOI 10.1016/j.bbrc.2008.04.090; Nury H, 2011, NATURE, V469, P428, DOI 10.1038/nature09647; Parikh RB, 2011, J BIOL CHEM, V286, P14098, DOI 10.1074/jbc.M111.221895; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Sine SM, 2002, J NEUROBIOL, V53, P431, DOI 10.1002/neu.10139; Sine SM, 2002, J BIOL CHEM, V277, P29210, DOI 10.1074/jbc.M203396200; Sine SM, 2006, NATURE, V440, P448, DOI 10.1038/nature04708; Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X; Tasneem A, 2005, GENOME BIOL, V6; Thompson AJ, 2010, Q REV BIOPHYS, V43, P449, DOI 10.1017/S0033583510000168; van der Straaten TA, 2005, MOL SIMULAT, V31, P151, DOI 10.1080/08927020412331308700; Wang HL, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040041; Wang HL, 2009, BIOPHYS J, V96, P3582, DOI 10.1016/j.bpj.2009.02.020; WILSON PT, 1985, P NATL ACAD SCI USA, V82, P8790, DOI 10.1073/pnas.82.24.8790; Young GT, 2008, P NATL ACAD SCI USA, V105, P14686, DOI 10.1073/pnas.0804372105	31	39	39	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6482	6489		10.1074/jbc.M111.305839	http://dx.doi.org/10.1074/jbc.M111.305839			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22084238	Green Published, Green Submitted, hybrid			2022-12-27	WOS:000300791800037
J	Ballester, LY; Capo-Velez, CM; Garcia-Beltran, WF; Ramos, FM; Vazquez-Rosa, E; Rios, R; Mercado, JR; Melendez, RI; Lasalde-Dominicci, JA				Ballester, Leomar Y.; Capo-Velez, Coral M.; Garcia-Beltran, Wilfredo F.; Ramos, Felix M.; Vazquez-Rosa, Edwin; Rios, Raymond; Mercado, Jose R.; Melendez, Roberto I.; Lasalde-Dominicci, Jose A.			Up-regulation of the Neuronal Nicotinic Receptor alpha 7 by HIV Glycoprotein 120 POTENTIAL IMPLICATIONS FOR HIV-ASSOCIATED NEUROCOGNITIVE DISORDER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; ACTIVE ANTIRETROVIRAL THERAPY; HUMAN NEUROBLASTOMA-CELLS; SUB-SAHARAN AFRICA; COAT PROTEIN GP120; ACETYLCHOLINE-RECEPTOR; RISK-FACTORS; HIPPOCAMPAL-NEURONS; CHEMOKINE RECEPTORS; PRIMARY MACROPHAGES	Approximately 30-50% of the >30 million HIV-infected subjects develop neurological complications ranging from mild symptoms to dementia. HIV does not infect neurons, and the molecular mechanisms behind HIV-associated neurocognitive decline are not understood. There are several hypotheses to explain the development of dementia in HIV+ individuals, including neuroinflammation mediated by infected microglia and neuronal toxicity by HIV proteins. A key protein associated with the neurological complications of HIV, gp120, forms part of the viral envelope and can be found in the CSF of infected individuals. HIV-1-gp120 interacts with several receptors including CD4, CCR5, CXCR4, and nicotinic acetylcholine receptors (nAChRs). However, the role of nAChRs in HIV-associated neurocognitive disorder has not been investigated. We studied the effects of gp120(IIIB) on the expression and function of the nicotinic receptor alpha 7 (alpha 7-nAChR). Our results show that gp120, through activation of the CXCR4 chemokine receptor, induces a functional up-regulation of alpha 7-nAChRs. Because alpha 7-nAChRs have a high permeability to Ca2+, we performed TUNEL staining to investigate the effects of receptor up-regulation on cell viability. Our data revealed an increase in cell death, which was blocked by the selective antagonist alpha-bungarotoxin. The in vitro data are supported by RT-PCR and Western blot analysis, confirming a remarkable up-regulation of the alpha 7-nAChR in gp120-transgenic mice brains. Specifically, alpha 7-nAChR up-regulation is observed in mouse striatum, a region severely affected in HIV+ patients. In summary, CXCR4 activation induces up-regulation of alpha 7-nAChR, causing cell death, suggesting that alpha 7-nAChR is a previously unrecognized contributor to the neurotoxicity associated with HIV infection.	[Rios, Raymond; Mercado, Jose R.; Lasalde-Dominicci, Jose A.] Univ Puerto Rico, Dept Biol, Rio Piedras, PR 00931 USA; [Melendez, Roberto I.] Univ Puerto Rico, Dept Anat & Neurobiol, San Juan, PR 00936 USA	University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico Rio Piedras; University of Puerto Rico	Lasalde-Dominicci, JA (corresponding author), Univ Puerto Rico, Dept Biol, Rio Piedras Campus, Rio Piedras, PR 00931 USA.	jlasalde@gmail.com		Melendez, Roberto/0000-0001-5262-9757	National Institutes of Health [SNRP-U54N54301]; Research Initiative for Scientific Enhancement-Minority Bio-medical Research Support (RISE-MBRS) National Institutes of Health [2R25GM061151]; Minority Access to Research Careers (MARC)-MBRS-National Institutes of Health; NATIONAL CANCER INSTITUTE [T32CA078586] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM061151, T34GM007821] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Initiative for Scientific Enhancement-Minority Bio-medical Research Support (RISE-MBRS) National Institutes of Health; Minority Access to Research Careers (MARC)-MBRS-National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant SNRP-U54N54301.; Supported by Research Initiative for Scientific Enhancement-Minority Bio-medical Research Support (RISE-MBRS) National Institutes of Health Program Grant 2R25GM061151.; Supported by the Minority Access to Research Careers (MARC)-MBRS-National Institutes of Health program.	Aracava Y, 2005, J PHARMACOL EXP THER, V312, P1195, DOI 10.1124/jpet.104.077172; Bardi G, 2006, J NEUROVIROL, V12, P211, DOI 10.1080/13550280600848373; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; BRACCI L, 1992, FEBS LETT, V311, P115, DOI 10.1016/0014-5793(92)81380-5; BUZY J, 1992, BRAIN RES, V598, P10, DOI 10.1016/0006-8993(92)90161-2; Catani MV, 2000, J NEUROCHEM, V74, P2373, DOI 10.1046/j.1471-4159.2000.0742373.x; Conejero-Goldberg C, 2008, NEUROSCI BIOBEHAV R, V32, P693, DOI 10.1016/j.neubiorev.2007.10.007; Counts SE, 2007, ARCH NEUROL-CHICAGO, V64, P1771, DOI 10.1001/archneur.64.12.1771; Criado M, 1997, J NEUROSCI, V17, P6554; D'Hooge R, 1999, EUR J NEUROSCI, V11, P4398, DOI 10.1046/j.1460-9568.1999.00857.x; De Rosa MJ, 2005, J NEUROIMMUNOL, V160, P154, DOI 10.1016/j.jneuroim.2004.11.010; Del Corno M, 2001, BLOOD, V98, P2909, DOI 10.1182/blood.V98.10.2909; DREYER EB, 1990, SCIENCE, V248, P364, DOI 10.1126/science.2326646; Geminder H, 2001, J IMMUNOL, V167, P4747, DOI 10.4049/jimmunol.167.8.4747; Ghafouri M, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-28; Giunta B, 2004, BRAIN RES BULL, V64, P165, DOI 10.1016/j.brainresbull.2004.06.008; Hesselgesser J, 1998, CURR BIOL, V8, P595, DOI 10.1016/S0960-9822(98)70230-1; JOHNSON EM, 1992, EXP NEUROL, V115, P163, DOI 10.1016/0014-4886(92)90242-I; Jonnala RR, 2001, J NEUROSCI RES, V66, P565, DOI 10.1002/jnr.10022; Kaul M, 2007, CELL DEATH DIFFER, V14, P296, DOI 10.1038/sj.cdd.4402006; Kaul M, 2009, CURR OPIN NEUROL, V22, P315, DOI 10.1097/WCO.0b013e328329cf3c; Kenzel S, 2009, INFECT IMMUN, V77, P2474, DOI 10.1128/IAI.01343-08; Lee C, 2003, J LEUKOCYTE BIOL, V74, P676, DOI 10.1189/jlb.0503206; LIPTON SA, 1992, NEUROLOGY, V42, P1403, DOI 10.1212/WNL.42.7.1403; Liu QH, 2000, P NATL ACAD SCI USA, V97, P4832, DOI 10.1073/pnas.090521697; Luo YQ, 2008, J BIOL CHEM, V283, P24789, DOI 10.1074/jbc.M800649200; Marambaud P, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-20; Mattson MP, 2005, CELL DEATH DIFFER, V12, P893, DOI 10.1038/sj.cdd.4401577; Mattson MP, 2003, NAT CELL BIOL, V5, P1041, DOI 10.1038/ncb1203-1041; MCGEHEE DS, 1995, ANNU REV PHYSIOL, V57, P521, DOI 10.1146/annurev.ph.57.030195.002513; Misse D, 1999, BLOOD, V93, P2454, DOI 10.1182/blood.V93.8.2454.408k35_2454_2462; Nagavarapu U, 2001, J BIOL CHEM, V276, P16749, DOI 10.1074/jbc.M009712200; Navedo MF, 2006, J GEN PHYSIOL, V127, P611, DOI 10.1085/jgp.200609519; Nieves DMT, 2007, J NEUROVIROL, V13, P315, DOI 10.1080/13550280701361508; Njamnshi AK, 2009, J NEUROL SCI, V285, P149, DOI 10.1016/j.jns.2009.06.043; Okamoto SI, 2007, CELL STEM CELL, V1, P230, DOI 10.1016/j.stem.2007.07.010; Peng H, 2006, GLIA, V54, P619, DOI 10.1002/glia.20409; Rock RB, 2008, J NEUROIMMUNE PHARM, V3, P143, DOI 10.1007/s11481-007-9098-7; Sacktor N, 2001, NEUROLOGY, V56, P257, DOI 10.1212/WNL.56.2.257; Sacktor N, 2002, J NEUROVIROL, V8, P115, DOI 10.1080/13550280290101094; SEGUELA P, 1993, J NEUROSCI, V13, P596; Stalmeijer EHB, 2004, J VIROL, V78, P2722, DOI 10.1128/JVI.78.6.2722-2728.2004; Stantchev TS, 2001, CYTOKINE GROWTH F R, V12, P219, DOI 10.1016/S1359-6101(00)00033-2; TOGGAS SM, 1994, NATURE, V367, P188, DOI 10.1038/367188a0; Tozzi V, 2007, JAIDS-J ACQ IMM DEF, V45, P174, DOI 10.1097/QAI.0b013e318042e1ee; Tyagi E, 2010, INNATE IMMUN-LONDON, V16, P3, DOI 10.1177/1753425909104680; *UNAIDS WHO, 2008, REP GLOB AIDS EP; Uteshev VV, 2002, BRAIN RES, V948, P33, DOI 10.1016/S0006-8993(02)02946-3; van der Meer P, 2000, EXP MOL PATHOL, V69, P192, DOI 10.1006/exmp.2000.2336; Wong MH, 2007, NEUROLOGY, V68, P350, DOI 10.1212/01.wnl.0000252811.48891.6d; Woods SP, 2009, NEUROPSYCHOL REV, V19, P152, DOI 10.1007/s11065-009-9102-5; Zheng JL, 1999, J NEUROIMMUNOL, V98, P185, DOI 10.1016/S0165-5728(99)00049-1	52	35	37	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					3079	3086		10.1074/jbc.M111.262543	http://dx.doi.org/10.1074/jbc.M111.262543			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22084248	hybrid, Green Published			2022-12-27	WOS:000300295100014
J	Abudu, A; Wang, XJ; Dang, Y; Zhou, T; Xiang, SH; Zheng, YH				Abudu, Aierken; Wang, Xiaojun; Dang, Ying; Zhou, Tao; Xiang, Shi-Hua; Zheng, Yong-Hui			Identification of Molecular Determinants from Moloney Leukemia Virus 10 Homolog (MOV10) Protein for Virion Packaging and Anti-HIV-1 Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EDITING ENZYME APOBEC3G; HIV-1 VIRIONS; STRESS GRANULES; RNA HELICASES; VIF; REPLICATION; GAG; DOMAIN; DEGRADATION; EXPRESSION	Discovery of novel antiretroviral mechanism is essential for the design of innovative antiretroviral therapy. Recently, we and others reported that ectopic expression of Moloney leukemia virus 10 (MOV10) protein strongly inhibits retrovirus replication. MOV10, a putative RNA helicase, can be packaged into HIV-1 virions by binding to the nucleocapsid (NC) region of Gag and inhibit viral replication at a postentry step. Here, we report critical determinants for MOV10 virion packaging and antiviral activity. MOV10 has 1,003 amino acids and seven helicase motifs. We found that MOV10 packaging requires the NC basic linker, and Gag binds to the N-terminal amino acids 261-305 region of MOV10. Our predicted MOV10 three-dimensional structure model indicates that the Gag binding region is located in a structurally exposed domain, which spans amino acids 93-305 and is Cys-His-rich. Simultaneous mutation of residues Cys-188, Cys-195, His-199, His-201, and His-202 in this domain significantly compromised MOV10 anti-HIV-1 activity. Notably, although MOV10-Gag interaction is required, it is not sufficient for MOV10 packaging, which also requires its C-terminal all but one of seven helicase motifs. Moreover, we have mapped the minimal MOV10 antiviral region to amino acids 99-949, indicating that nearly all MOV10 residues are required for its antiviral activity. Mutations of residues Cys-947, Pro-948, and Phe-949 at the C terminus of this region completely disrupted MOV10 anti-HIV-1 activity. Taken together, we have identified two critical MOV10 packaging determinants and eight other critical residues for anti-HIV-1 activity. These results provide a molecular basis for further understanding the MOV10 antiretroviral mechanism.	[Abudu, Aierken; Wang, Xiaojun; Dang, Ying; Zhou, Tao; Zheng, Yong-Hui] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA; [Wang, Xiaojun] Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, Harbin 150001, Peoples R China; [Xiang, Shi-Hua] Univ Nebraska, Sch Biol Sci, Nebraska Ctr Virol, Lincoln, NE 68583 USA	Michigan State University; Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS; University of Nebraska System; University of Nebraska Lincoln	Zheng, YH (corresponding author), Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA.	zhengyo@msu.edu	Zhou, Tao/B-5757-2017; Zheng, Yong-Hui/AAP-4492-2021	Zhou, Tao/0000-0002-3648-9923; Zheng, Yong-Hui/0000-0002-1098-7385; Wang, Xiaojun/0000-0003-4521-4099	National Institutes of Health [AI063944, AI080225]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K02AI080225, R01AI063944, R56AI063944] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI063944 and AI080225 (to Y.-H. Z).	Burdick R, 2010, J VIROL, V84, P10241, DOI 10.1128/JVI.00585-10; Burnett A, 2007, J VIROL, V81, P5000, DOI 10.1128/JVI.02237-06; Caruthers JM, 2002, CURR OPIN STRUC BIOL, V12, P123, DOI 10.1016/S0959-440X(02)00298-1; Cen S, 2004, J BIOL CHEM, V279, P33177, DOI 10.1074/jbc.M402062200; Chendrimada TP, 2007, NATURE, V447, P823, DOI 10.1038/nature05841; Chertova E, 2006, J VIROL, V80, P9039, DOI 10.1128/JVI.01013-06; Chiu YL, 2006, P NATL ACAD SCI USA, V103, P15588, DOI 10.1073/pnas.0604524103; Clerici M, 2009, EMBO J, V28, P2293, DOI 10.1038/emboj.2009.175; Derdowski A, 2004, J VIROL, V78, P1230, DOI 10.1128/JVI.78.3.1230-1242.2004; Furtak V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009081; Gallois-Montbrun S, 2007, J VIROL, V81, P2165, DOI 10.1128/JVI.02287-06; Garrus JE, 2001, CELL, V107, P55, DOI 10.1016/S0092-8674(01)00506-2; Heise CT, 2007, BIOCHEMISTRY-US, V46, P1612, DOI 10.1021/bi062174k; Huang Y, 2001, J VIROL, V75, P4947, DOI 10.1128/JVI.75.10.4947-4951.2001; Huthoff H, 2007, J VIROL, V81, P3807, DOI 10.1128/JVI.02795-06; Jeang KT, 2006, NUCLEIC ACIDS RES, V34, P4198, DOI 10.1093/nar/gkl398; Kadlec J, 2006, RNA, V12, P1817, DOI 10.1261/rna.177606; KOONIN EV, 1992, TRENDS BIOCHEM SCI, V17, P495, DOI 10.1016/0968-0004(92)90338-A; Kozak SL, 2006, J BIOL CHEM, V281, P29105, DOI 10.1074/jbc.M601901200; Luo K, 2004, J VIROL, V78, P11841, DOI 10.1128/JVI.78.21.11841-11852.2004; Mariani R, 2003, CELL, V114, P21, DOI 10.1016/S0092-8674(03)00515-4; Marin M, 2003, NAT MED, V9, P1398, DOI 10.1038/nm946; Meister G, 2005, CURR BIOL, V15, P2149, DOI 10.1016/j.cub.2005.10.048; MOOSLEHNER K, 1991, MOL CELL BIOL, V11, P886, DOI 10.1128/MCB.11.2.886; Schafer A, 2004, VIROLOGY, V328, P163, DOI 10.1016/j.virol.2004.08.006; Sheehy AM, 2003, NAT MED, V9, P1404, DOI 10.1038/nm945; Stopak K, 2003, MOL CELL, V12, P591, DOI 10.1016/S1097-2765(03)00353-8; Svarovskaia ES, 2004, J BIOL CHEM, V279, P35822, DOI 10.1074/jbc.M405761200; Wang XJ, 2010, J BIOL CHEM, V285, P14346, DOI 10.1074/jbc.M110.109314; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Zennou W, 2004, J VIROL, V78, P12058, DOI 10.1128/JVI.78.21.12058-12061.2004; Zheng YH, 2004, J VIROL, V78, P6073, DOI 10.1128/JVI.78.11.6073-6076.2004	32	36	36	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					1220	1228		10.1074/jbc.M111.309831	http://dx.doi.org/10.1074/jbc.M111.309831			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22105071	Green Published, hybrid			2022-12-27	WOS:000299170300037
J	Martinez, V; Ingwers, M; Smith, J; Glushka, J; Yang, T; Bar-Peled, M				Martinez, Viviana; Ingwers, Miles; Smith, James; Glushka, John; Yang, Ting; Bar-Peled, Maor			Biosynthesis of UDP-4-keto-6-deoxyglucose and UDP-rhamnose in Pathogenic Fungi Magnaporthe grisea and Botryotinia fuckeliana	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							D-GLUCOSE; HERICIUM-ERINACEUS; FRUITING BODIES; CELL-WALLS; COMPONENTS; SUGAR; EXOPOLYSACCHARIDE; 4,6-DEHYDRATASE; COLLETOTRICHUM; IDENTIFICATION	There is increasing evidence that in several fungi, rhamnose-containing glycans are involved in processes that affect hostpathogen interactions, including adhesion, recognition, virulence, and biofilm formation. Nevertheless, little is known about the pathways for the synthesis of these glycans. We show that rhamnose is present in glycans isolated from the rice pathogen Magnaporthe grisea and from the plant pathogen Botryotinia fuckeliana. We also provide evidence that these fungi produce UDP-rhamnose. This is in contrast to bacteria where dTDP-rhamnose is the activated form of this sugar. In bacteria, formation of dTDP-rhamnose requires three enzymes. Here, we demonstrate that in fungi only two genes are required for UDP-Rha synthesis. The first gene encodes a UDP-glucose-4,6-dehydratase that converts UDP-glucose to UDP-4-keto-6-deoxyglucose. The product was shown by time-resolved H-1 NMR spectroscopy to exist in solution predominantly as a hydrated form along with minor amounts of a keto form. The second gene encodes a bifunctional UDP-4-keto-6-deoxyglucose-3,5-epimerase/-4-reductase that converts UDP-4-keto-6-deoxyglucose to UDP-rhamnose. Sugar composition analysis and gene expression studies at different stages of growth indicate that the synthesis of rhamnose-containing glycans is under tissue-specific regulation. Together, our results provide new insight into the formation of rhamnose-containing glycans during the fungal life cycle. The role of these glycans in the interactions between fungal pathogens and their hosts is discussed. Knowledge of the metabolic pathways involved in the formation of rhamnose-containing glycans may facilitate the development of drugs to combat fungal diseases in humans, as to the best of our knowledge mammals do not make these types of glycans.	[Martinez, Viviana; Smith, James; Glushka, John; Bar-Peled, Maor] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; [Ingwers, Miles; Bar-Peled, Maor] Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA; [Yang, Ting] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Bar-Peled, M (corresponding author), Univ Georgia, Complex Carbohydrate Res Ctr, 315 Riverbend Rd, Athens, GA 30602 USA.	peled@ccrc.uga.edu			National Science Foundation [IOB-0453664]; BioEnergy Science Center (Office of Biological and Environmental Research in the Department of Energy Office of Science) [DE-PS02-06ER64304]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM066340] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); BioEnergy Science Center (Office of Biological and Environmental Research in the Department of Energy Office of Science); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Science Foundation Grant IOB-0453664 (to M. B.-P.) and by BioEnergy Science Center Grant DE-PS02-06ER64304 (supported by the Office of Biological and Environmental Research in the Department of Energy Office of Science).	Ahrazem O, 2002, MYCOL RES, V106, P1187, DOI 10.1017/S0953756202006482; Allard STM, 2002, STRUCTURE, V10, P81, DOI 10.1016/S0969-2126(01)00694-3; Allard STM, 2001, J MOL BIOL, V307, P283, DOI 10.1006/jmbi.2000.4470; Beis K, 2003, J AM CHEM SOC, V125, P11872, DOI 10.1021/ja035796r; Chothi MP, 2010, J VIROL, V84, P8829, DOI 10.1128/JVI.00770-10; DeVicente JI, 1996, FUNGAL GENET BIOL, V20, P115, DOI 10.1006/fgbi.1996.0026; Dong C, 2007, J MOL BIOL, V365, P146, DOI 10.1016/j.jmb.2006.09.063; Dong SL, 2010, J BACTERIOL, V192, P5053, DOI 10.1128/JB.00568-10; Epstein L, 2006, BIOLOGICAL ADHESIVES, P41, DOI 10.1007/978-3-540-31049-5_3; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; GORIN PAJ, 1970, CARBOHYD RES, V13, P339, DOI 10.1016/S0008-6215(00)80591-1; Gu XG, 2010, J BIOL CHEM, V285, P24825, DOI 10.1074/jbc.M110.125872; HAMER JE, 1988, SCIENCE, V239, P288, DOI 10.1126/science.239.4837.288; Harki E, 2006, FOOD CHEM, V99, P394, DOI 10.1016/j.foodchem.2005.08.030; Hegeman AD, 2002, BIOCHEMISTRY-US, V41, P2797, DOI 10.1021/bi011748c; Jia LM, 2004, CARBOHYD RES, V339, P2667, DOI [10.1016/j.carres.2004.07.027, 10.1016/j.carrres.2004.07.027]; Lal P, 2010, J APPL MICROBIOL, V109, P128, DOI 10.1111/j.1365-2672.2009.04634.x; Ma YF, 2002, J BACTERIOL, V184, P3392, DOI 10.1128/JB.184.12.3392-3395.2002; MacFarlane H. H., 1968, REV APPL MYCOLOGY PL, V1-40, P1922; Molinaro A, 2002, CARBOHYD RES, V337, P1707, DOI 10.1016/S0008-6215(02)00283-5; Oka T, 2007, J BIOL CHEM, V282, P5389, DOI 10.1074/jbc.M610196200; Perfect SE, 1999, FUNGAL GENET BIOL, V27, P186, DOI 10.1006/fgbi.1999.1143; Pettolino F, 2009, FEBS J, V276, P4122, DOI 10.1111/j.1742-4658.2009.07086.x; RAMADOSS CS, 1985, J AGR FOOD CHEM, V33, P728, DOI 10.1021/jf00064a041; RIZZA V, 1969, J GEN MICROBIOL, V58, P307, DOI 10.1099/00221287-58-3-307; Ruiz-Baca E, 2009, MED MYCOL, V47, P185, DOI 10.1080/13693780802165789; Soares RMD, 1995, MYCOPATHOLOGIA, V132, P71, DOI 10.1007/BF01103778; Taylor LH, 2001, PHILOS T R SOC B, V356, P983, DOI 10.1098/rstb.2001.0888; Thibodeaux CJ, 2007, NATURE, V446, P1008, DOI 10.1038/nature05814; Turnock DC, 2007, EUKARYOT CELL, V6, P1450, DOI 10.1128/EC.00175-07; Valent B, 2010, CURR OPIN PLANT BIOL, V13, P434, DOI 10.1016/j.pbi.2010.04.012; Watt G, 2004, PLANT PHYSIOL, V134, P1337, DOI 10.1104/pp.103.037192; Williams GJ, 2005, J BIOL CHEM, V280, P23000, DOI 10.1074/jbc.M501534200; Wu SC, 1997, MOL PLANT MICROBE IN, V10, P700, DOI 10.1094/MPMI.1997.10.6.700; Yang T, 2009, J BIOL CHEM, V284, P21526, DOI 10.1074/jbc.M109.014761; YORK WS, 1986, METHOD ENZYMOL, V118, P3; Zeigler R. S., 1994, CAB INT PUBLICATION; Zhang AQ, 2006, CARBOHYD RES, V341, P645, DOI 10.1016/j.carres.2005.11.038	38	40	43	3	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					879	892		10.1074/jbc.M111.287367	http://dx.doi.org/10.1074/jbc.M111.287367			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22102281	hybrid, Green Published			2022-12-27	WOS:000299170300007
J	Michaki, V; Guix, FX; Vennekens, K; Munck, S; Dingwall, C; Davis, JB; Townsend, DM; Tew, KD; Feiguin, F; De Strooper, B; Dotti, CG; Wahle, T				Michaki, Vasiliki; Guix, Francesc X.; Vennekens, Krist'l; Munck, Sebastian; Dingwall, Colin; Davis, John B.; Townsend, Danyelle M.; Tew, Kenneth D.; Feiguin, Fabian; De Strooper, Bart; Dotti, Carlos G.; Wahle, Tina			Down-regulation of the ATP-binding Cassette Transporter 2 (Abca2) Reduces Amyloid-beta Production by Altering Nicastrin Maturation and Intracellular Localization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-SECRETASE ACTIVITY; LDL-DERIVED CHOLESTEROL; NIEMANN-PICK DISEASE; PRECURSOR PROTEIN; ALZHEIMERS-DISEASE; LIPID RAFTS; HIPPOCAMPAL-NEURONS; GLYCOSYLATED NICASTRIN; DEPENDENT CLEAVAGE; NERVOUS-SYSTEM	Clinical, pharmacological, biochemical, and genetic evidence support the notion that alteration of cholesterol homeostasis strongly predisposes to Alzheimer disease (AD). The ATP-binding cassette transporter-2 (Abca2), which plays a role in intracellular sterol trafficking, has been genetically linked to AD. It is unclear how these two processes are related. Here we demonstrate that down-regulation of Abca2 in mammalian cells leads to decreased amyloid-beta (A beta) generation. In vitro studies revealed altered gamma-secretase complex formation in Abca2 knock-out cells due to the altered levels, post-translational modification, and subcellular localization of Nicastrin. Reduced Abca2 levels in mammalian cells in vitro, in Drosophila melanogaster and in mice resulted in altered gamma-secretase processing of APP, and thus A beta generation, without affecting Notch cleavage.	[Michaki, Vasiliki; Guix, Francesc X.; Vennekens, Krist'l; Munck, Sebastian; De Strooper, Bart; Dotti, Carlos G.; Wahle, Tina] Katholieke Univ Leuven, Ctr Human Genet, B-3000 Louvain, Belgium; [Michaki, Vasiliki; Guix, Francesc X.; Vennekens, Krist'l; Munck, Sebastian; De Strooper, Bart; Dotti, Carlos G.; Wahle, Tina] Katholieke Univ Leuven, LIND, B-3000 Louvain, Belgium; [Michaki, Vasiliki; Guix, Francesc X.; Vennekens, Krist'l; Munck, Sebastian; De Strooper, Bart; Dotti, Carlos G.] Vlaams Inst Biotechnol, VIB11, B-3000 Louvain, Belgium; [Dotti, Carlos G.] CSIC UAM, Ctr Biol Mol Severo Ochoa, Madrid 28049, Spain; [Dingwall, Colin] Kings Coll London, Div Pharmaceut Sci, London SE1 9NH, England; [Davis, John B.] GlaxoSmithKline Res & Dev Ltd, Neurosci Ctr Excellence Drug Discovery, Harlow CM19 5AW, Essex, England; [Townsend, Danyelle M.; Tew, Kenneth D.] Med Univ S Carolina, Dept Pharmaceut & Biomed Sci, Charleston, SC 29425 USA; [Feiguin, Fabian] Int Ctr Genet Engn & Biotechnol, I-34149 Trieste, Italy	KU Leuven; KU Leuven; Flanders Institute for Biotechnology (VIB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); University of London; King's College London; GlaxoSmithKline; Medical University of South Carolina; International Center for Genetic Engineering & Biotechnology (ICGEB)	Dotti, CG (corresponding author), Katholieke Univ Leuven, Ctr Human Genet, B-3000 Louvain, Belgium.	carlos.dotti@med.kuleuven.be	de+Strooper, Bart/Z-1638-2019; Feiguin, Fabian/ABC-2514-2020; Guix, Francesc/AAA-7462-2020; De Strooper, Bart/F-6507-2012; Dotti, Carlos G/I-5533-2015	De Strooper, Bart/0000-0001-5455-5819; Dotti, Carlos G/0000-0003-4052-1719; Guix Rafols, Francesc Xavier/0000-0001-5781-3799; Munck, Sebastian/0000-0002-5182-5358	Fund for Scientific Research Flanders (FWO); Federal Office for Scientific Affairs [IUAP P6/43/]; Stichting voor Alzheimer Onderzooek/Fondation pour la Recherche sur Maladie d' Alzheimer (SAO/FRMA); Flemish Government; Spanish Government [CSD2010-00064, SAF2010-14906]; Spanish Grant Beatriu de Pinos (AGAUR); European Molecular Biology Organization; Deutsche Forschungsgemeinschaft	Fund for Scientific Research Flanders (FWO)(FWO); Federal Office for Scientific Affairs; Stichting voor Alzheimer Onderzooek/Fondation pour la Recherche sur Maladie d' Alzheimer (SAO/FRMA); Flemish Government(European Commission); Spanish Government(Spanish GovernmentEuropean Commission); Spanish Grant Beatriu de Pinos (AGAUR); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported in part by the Fund for Scientific Research Flanders (FWO), Federal Office for Scientific Affairs (IUAP P6/43/), Stichting voor Alzheimer Onderzooek/Fondation pour la Recherche sur Maladie d' Alzheimer (SAO/FRMA), the Flemish Government (Methusalem grant), and Spanish Government Grants Ministerio de Ciencia e Innovacion Ingenio-Consolider CSD2010-00064 and Ministerio de Ciencia e Innovacion SAF2010-14906 (to C. G. D.).; Supported by the Spanish Grant Beatriu de Pinos (AGAUR).; Supported by European Molecular Biology Organization and Deutsche Forschungsgemeinschaft long-term fellowships. To whom correspondence may be addressed: Laboratory of Neuronal Differentiation, Center for Human Genetics and Leuven Institute for Neurodegenerative diseases (LIND), KU Leuven and Vlaams institute voor Biotechnologie, VIB11, Herestraat 49-bus 602, 3000 Leuven, Belgium. Tel.: 32-0-16-3-30525; Fax: 32-0-16-3-30939; E-mail: tina.wahle@med.kuleuven.be.	Abad-Rodriguez J, 2004, J CELL BIOL, V167, P953, DOI 10.1083/jcb.200404149; Annaert W, 2002, ANNU REV CELL DEV BI, V18, P25, DOI 10.1146/annurev.cellbio.18.020402.142302; Arawaka S, 2002, J NEUROCHEM, V83, P1065, DOI 10.1046/j.1471-4159.2002.01207.x; Bammens L, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.216978; Broccardo C, 2006, J NEUROCHEM, V97, P345, DOI 10.1111/j.1471-4159.2006.03714.x; Burns M, 2003, J NEUROSCI, V23, P5645; Chen FW, 2005, BIOCHEM J, V390, P549, DOI 10.1042/BJ20050236; Chen ZJJ, 2004, FASEB J, V18, P1129, DOI 10.1096/fj.03-1490fje; Cheng HP, 2009, J BIOL CHEM, V284, P1373, DOI 10.1074/jbc.M806380200; Cordy JM, 2003, P NATL ACAD SCI USA, V100, P11735, DOI 10.1073/pnas.1635130100; Culvenor JG, 2004, EUR J BIOCHEM, V271, P375, DOI 10.1046/j.1432-1033.2003.03936.x; Davis W, 2004, BBA-MOL CELL BIOL L, V1683, P89, DOI 10.1016/j.bbalip.2004.04.009; Davis W, 2010, CURR ALZHEIMER RES, V7, P566, DOI 10.2174/156720510793499002; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; Dean M, 2001, J LIPID RES, V42, P1007; Dejaegere T, 2008, P NATL ACAD SCI USA, V105, P9775, DOI 10.1073/pnas.0800507105; Edbauer D, 2002, P NATL ACAD SCI USA, V99, P8666, DOI 10.1073/pnas.132277899; Ehehalt R, 2003, J CELL BIOL, V160, P113, DOI 10.1083/jcb.200207113; Esselens C, 2004, J CELL BIOL, V166, P1041, DOI 10.1083/jcb.200406060; Falls DL, 2003, J NEUROCYTOL, V32, P619, DOI 10.1023/B:NEUR.0000020614.83883.be; Fluhrer R, 2002, J NEUROCHEM, V81, P1011, DOI 10.1046/j.1471-4159.2002.00908.x; Grbovic OM, 2003, J BIOL CHEM, V278, P31261, DOI 10.1074/jbc.M304122200; Grimm MOW, 2008, J BIOL CHEM, V283, P11302, DOI 10.1074/jbc.M801520200; Gu YJ, 2003, J BIOL CHEM, V278, P7374, DOI 10.1074/jbc.M209499200; Guo M, 2003, HUM MOL GENET, V12, P2669, DOI 10.1093/hmg/ddg292; Hartmann T, 2006, NEURODEGENER DIS, V3, P305, DOI 10.1159/000095271; Herreman A, 2003, J CELL SCI, V116, P1127, DOI 10.1242/jcs.00292; HIGGINS JJ, 1992, NEUROLOGY, V42, P2286, DOI 10.1212/WNL.42.12.2286; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kalvodova L, 2005, J BIOL CHEM, V280, P36815, DOI 10.1074/jbc.M504484200; Kimberly WT, 2002, J BIOL CHEM, V277, P35113, DOI 10.1074/jbc.M204446200; Klein I, 1999, BBA-BIOMEMBRANES, V1461, P237, DOI 10.1016/S0005-2736(99)00161-3; Kojro E, 2001, P NATL ACAD SCI USA, V98, P5815, DOI 10.1073/pnas.081612998; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Liu KN, 2002, BIOCHEMISTRY-US, V41, P3128, DOI 10.1021/bi015800g; Louvi A, 2006, NAT REV NEUROSCI, V7, P93, DOI 10.1038/nrn1847; Mace S, 2005, NEUROBIOL DIS, V18, P119, DOI 10.1016/j.nbd.2004.09.011; Mack JT, 2008, EXPERT OPIN THER TAR, V12, P491, DOI 10.1517/14728222.12.4.491 ; Mack JT, 2007, CURR DRUG METAB, V8, P47, DOI 10.2174/138920007779315044; Mack JT, 2007, MOL CELL BIOL, V27, P44, DOI 10.1128/MCB.01824-06; Michailov GV, 2004, SCIENCE, V304, P700, DOI 10.1126/science.1095862; Neufeld EB, 1999, J BIOL CHEM, V274, P9627, DOI 10.1074/jbc.274.14.9627; Newsome TP, 2000, DEVELOPMENT, V127, P851; Nyabi O, 2003, J BIOL CHEM, V278, P43430, DOI 10.1074/jbc.M306957200; PENTCHEV PG, 1994, BBA-MOL BASIS DIS, V1225, P235, DOI 10.1016/0925-4439(94)90001-9; Refolo LM, 2000, NEUROBIOL DIS, V7, P321, DOI 10.1006/nbdi.2000.0304; Riddell DR, 2001, CURR BIOL, V11, P1288, DOI 10.1016/S0960-9822(01)00394-3; Rouyer O, 2009, CLIN TRANSPLANT, V23, P897, DOI 10.1111/j.1399-0012.2009.01013.x; Runz H, 2002, J NEUROSCI, V22, P1679, DOI 10.1523/JNEUROSCI.22-05-01679.2002; Schmitz G, 2001, FRONT BIOSCI, V6, pD505, DOI 10.2741/Schmitz; Selkoe Dennis J, 2008, Handb Clin Neurol, V89, P245, DOI 10.1016/S0072-9752(07)01223-7; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Serneels L, 2005, P NATL ACAD SCI USA, V102, P1719, DOI 10.1073/pnas.0408901102; Simons M, 2001, NEUROLOGY, V57, P1089, DOI 10.1212/WNL.57.6.1089; Simons M, 1998, P NATL ACAD SCI USA, V95, P6460, DOI 10.1073/pnas.95.11.6460; Sobo K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000851; Sorensen EB, 2010, TRAFFIC, V11, P1234, DOI 10.1111/j.1600-0854.2010.01090.x; Struhl G, 2000, MOL CELL, V6, P625, DOI 10.1016/S1097-2765(00)00061-7; Struhl G, 1999, NATURE, V398, P522, DOI 10.1038/19091; Stuven E, 2003, J BIOL CHEM, V278, P53112, DOI 10.1074/jbc.M300402200; Thaveau F, 2009, J SURG RES, V155, P65, DOI 10.1016/j.jss.2008.08.001; Tomita T, 2002, FEBS LETT, V520, P117, DOI 10.1016/S0014-5793(02)02802-8; VANIER MT, 1991, BIOCHIM BIOPHYS ACTA, V1096, P328, DOI 10.1016/0925-4439(91)90069-L; Vetrivel KS, 2006, NEUROLOGY, V66, pS69, DOI 10.1212/01.wnl.0000192107.17175.39; Vetrivel KS, 2004, J BIOL CHEM, V279, P44945, DOI 10.1074/jbc.M407986200; Vetrivel KS, 2005, J BIOL CHEM, V280, P25892, DOI 10.1074/jbc.M503570200; Vetrivel KS, 2010, BBA-MOL CELL BIOL L, V1801, P860, DOI 10.1016/j.bbalip.2010.03.007; Wahrle S, 2002, NEUROBIOL DIS, V9, P11, DOI 10.1006/nbdi.2001.0470; Walter J, 2001, J BIOL CHEM, V276, P14634, DOI 10.1074/jbc.M011116200; Wollmer MA, 2006, AM J MED GENET B, V141B, P534, DOI 10.1002/ajmg.b.30345; Wolozin B, 2004, NEURON, V41, P7, DOI 10.1016/S0896-6273(03)00840-7; Xiong HQ, 2008, NEUROBIOL DIS, V29, P422, DOI 10.1016/j.nbd.2007.10.005; Yang DS, 2002, J BIOL CHEM, V277, P28135, DOI 10.1074/jbc.M110871200; Zhao LX, 2000, BIOCHEM J, V350, P865, DOI 10.1042/0264-6021:3500865	74	29	31	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					1100	1111		10.1074/jbc.M111.288258	http://dx.doi.org/10.1074/jbc.M111.288258			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22086926	Green Published, hybrid			2022-12-27	WOS:000299170300026
J	Anavi-Goffer, S; Baillie, G; Irving, AJ; Gertsch, J; Greig, IR; Pertwee, RG; Ross, RA				Anavi-Goffer, Sharon; Baillie, Gemma; Irving, Andrew J.; Gertsch, Juerg; Greig, Iain R.; Pertwee, Roger G.; Ross, Ruth A.			Modulation of L-alpha-Lysophosphatidylinositol/GPR55 Mitogen-activated Protein Kinase (MAPK) Signaling by Cannabinoids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							L-ALPHA-LYSOPHOSPHATIDYLINOSITOL; CANCER-CELL PROLIFERATION; CB1 RECEPTOR ANTAGONIST; B-RAF INHIBITORS; ALLOSTERIC MODULATION; PLANT CANNABINOIDS; ENDOTHELIAL-CELLS; NEUROPATHIC PAIN; GPR55; IDENTIFICATION	GPR55 is activated by L-alpha-lysophosphatidylinositol (LPI) but also by certain cannabinoids. In this study, we investigated the GPR55 pharmacology of various cannabinoids, including analogues of the CB1 receptor antagonist Rimonabant (R), CB2 receptor agonists, and Cannabis sativa constituents. To test ERK1/2 phosphorylation, a primary downstream signaling pathway that conveys LPI-induced activation of GPR55, a high throughput system, was established using the AlphaScreen (R) SureFire (R) assay. Here, we show that CB1 receptor antagonists can act both as agonists alone and as inhibitors of LPI signaling under the same assay conditions. This study clarifies the controversy surrounding the GPR55-mediated actions of SR141716A; some reports indicate the compound to be an agonist and some report antagonism. In contrast, we report that the CB2 ligand GW405833 behaves as a partial agonist of GPR55 alone and enhances LPI signaling. GPR55 has been implicated in pain transmission, and thus our results suggest that this receptor may be responsible for some of the antinociceptive actions of certain CB2 receptor ligands. The phytocannabinoids Delta(9)-tetrahydrocannabivarin, cannabidivarin, and cannabigerovarin are also potent inhibitors of LPI. These Cannabis sativa constituents may represent novel therapeutics targeting GPR55.	[Anavi-Goffer, Sharon; Baillie, Gemma; Greig, Iain R.; Pertwee, Roger G.; Ross, Ruth A.] Univ Aberdeen, Kosterlitz Ctr Therapeut, Inst Med Sci, Sch Med Sci, Aberdeen AB25 2ZD, Scotland; [Irving, Andrew J.] Univ Dundee, Ninewells Hosp & Med Sch, Div Med Sci, Dundee DD1 9SY, Scotland; [Gertsch, Juerg] Univ Bern, Inst Biochem & Mol Med, CH-3012 Bern, Switzerland; [Anavi-Goffer, Sharon] Ariel Univ, Ctr Samaria, Dept Behav Sci, IL-40700 Ariel, Israel; [Anavi-Goffer, Sharon] Ariel Univ, Ctr Samaria, Dept Mol Biol, IL-40700 Ariel, Israel	University of Aberdeen; University of Dundee; University of Bern; Ariel University; Ariel University	Anavi-Goffer, S (corresponding author), Univ Aberdeen, Kosterlitz Ctr Therapeut, Inst Med Sci, Sch Med Sci, Aberdeen AB25 2ZD, Scotland.	s.goffer@ariel.ac.il	Ross, R./AAG-7468-2019; Anavi-Goffer, Sharon/H-6111-2019	Anavi-Goffer, Sharon/0000-0002-3364-5134; Gertsch, Jurg/0000-0003-0978-1555; Pertwee, Roger/0000-0003-3227-2783; Greig, Iain/0000-0003-0603-3383	National Institutes of Health [DA-03672, DA-09789]; University of Aberdeen; GW Pharmaceuticals; NATIONAL INSTITUTE ON DRUG ABUSE [R37DA003672, P01DA009789, R01DA003672] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Aberdeen; GW Pharmaceuticals; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants DA-03672 and DA-09789 (to R. A. R. and R. G. P.). This work was also supported by a Knowledge Transfer Grant Award from the University of Aberdeen. R. G. P. and R. A. R. received funding from GW Pharmaceuticals.	Adwanikar H, 2004, PAIN, V111, P125, DOI 10.1016/j.pain.2004.06.009; Andradas C, 2011, ONCOGENE, V30, P245, DOI 10.1038/onc.2010.402; Aragona M, 2009, CLIN NEUROPHARMACOL, V32, P41, DOI 10.1097/WNF.0b013e3181633497; Atwood BK, 2010, BRIT J PHARMACOL, V160, P467, DOI 10.1111/j.1476-5381.2010.00729.x; Beltramo M, 2009, MINI-REV MED CHEM, V9, P11, DOI 10.2174/138955709787001785; Bondarenko A, 2010, BRIT J PHARMACOL, V161, P308, DOI 10.1111/j.1476-5381.2010.00744.x; Boutros T, 2008, PHARMACOL REV, V60, P261, DOI 10.1124/pr.107.00106; Chu CT, 2004, EUR J BIOCHEM, V271, P2060, DOI 10.1111/j.1432-1033.2004.04132.x; Comelli F, 2010, EUR J PHARMACOL, V637, P62, DOI 10.1016/j.ejphar.2010.03.061; Costa B, 2005, PAIN, V116, P52, DOI 10.1016/j.pain.2005.03.043; De Petrocellis L, 2008, J PHARMACOL EXP THER, V325, P1007, DOI 10.1124/jpet.107.134809; Elmes SJR, 2004, EUR J NEUROSCI, V20, P2311, DOI 10.1111/j.1460-9568.2004.03690.x; Ford LA, 2010, BRIT J PHARMACOL, V160, P762, DOI 10.1111/j.1476-5381.2010.00743.x; Gertsch J, 2008, P NATL ACAD SCI USA, V105, P9099, DOI 10.1073/pnas.0803601105; Hatzivassiliou G, 2010, NATURE, V464, P431, DOI 10.1038/nature08833; Henstridge CM, 2010, BRIT J PHARMACOL, V160, P604, DOI 10.1111/j.1476-5381.2009.00625.x; Henstridge CM, 2009, FASEB J, V23, P183, DOI 10.1096/fj.08-108670; Ishiguro H, 2011, SYNAPSE, V65, P103, DOI 10.1002/syn.20821; Izzo AA, 2009, TRENDS PHARMACOL SCI, V30, P515, DOI 10.1016/j.tips.2009.07.006; Jafari MR, 2007, BEHAV PHARMACOL, V18, P691, DOI 10.1097/FBP.0b013e3282f00c10; Ji RR, 2002, J NEUROSCI, V22, P478, DOI 10.1523/JNEUROSCI.22-02-00478.2002; Johnson JR, 2010, J PAIN SYMPTOM MANAG, V39, P167, DOI 10.1016/j.jpainsymman.2009.06.008; Kapur A, 2009, J BIOL CHEM, V284, P29817, DOI 10.1074/jbc.M109.050187; Kim EK, 2010, BBA-MOL BASIS DIS, V1802, P396, DOI 10.1016/j.bbadis.2009.12.009; Klein RM, 2008, MOL BIOL CELL, V19, P498, DOI 10.1091/mbc.E07-09-0895; Kotsikorou E, 2011, BIOCHEMISTRY-US, V50, P5633, DOI 10.1021/bi200010k; Lauckner JE, 2008, P NATL ACAD SCI USA, V105, P2699, DOI 10.1073/pnas.0711278105; Li HF, 2010, CURR MED CHEM, V17, P1618, DOI 10.2174/092986710791111242; Ligresti A, 2006, J PHARMACOL EXP THER, V318, P1375, DOI 10.1124/jpet.106.105247; Lin YW, 2003, J BIOL CHEM, V278, P21534, DOI 10.1074/jbc.M301854200; Marcu JP, 2010, MOL CANCER THER, V9, P180, DOI 10.1158/1535-7163.MCT-09-0407; May LT, 2007, ANNU REV PHARMACOL, V47, P1, DOI 10.1146/annurev.pharmtox.47.120505.105159; Mazella J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000355; McAllister SD, 2007, MOL CANCER THER, V6, P2921, DOI 10.1158/1535-7163.MCT-07-0371; Milligan G, 2009, BRIT J PHARMACOL, V158, P146, DOI 10.1111/j.1476-5381.2009.00421.x; Oka S, 2007, BIOCHEM BIOPH RES CO, V362, P928, DOI 10.1016/j.bbrc.2007.08.078; Oka S, 2010, J BIOCHEM, V147, P671, DOI 10.1093/jb/mvp208; Osmond RIW, 2010, ANAL BIOCHEM, V403, P94, DOI 10.1016/j.ab.2010.04.007; Padwal RS, 2007, LANCET, V369, P71, DOI 10.1016/S0140-6736(07)60033-6; Pertwee RG, 2008, BRIT J PHARMACOL, V153, P199, DOI 10.1038/sj.bjp.0707442; Pietr M, 2009, FEBS LETT, V583, P2071, DOI 10.1016/j.febslet.2009.05.028; Pineiro R, 2011, ONCOGENE, V30, P142, DOI 10.1038/onc.2010.417; Price MR, 2005, MOL PHARMACOL, V68, P1484, DOI 10.1124/mol.105.016162; Pritchard CA, 2004, MOL CELL BIOL, V24, P5937, DOI 10.1128/MCB.24.13.5937-5952.2004; Ramer R, 2010, BIOCHEM PHARMACOL, V79, P955, DOI 10.1016/j.bcp.2009.11.007; Riedel G, 2009, BRIT J PHARMACOL, V156, P1154, DOI 10.1111/j.1476-5381.2008.00107.x; Ryberg E, 2007, BRIT J PHARMACOL, V152, P1092, DOI 10.1038/sj.bjp.0707460; Scheen AJ, 2006, LANCET, V368, P1660, DOI 10.1016/S0140-6736(06)69571-8; Schuelert N, 2010, OSTEOARTHR CARTILAGE, V18, P1536, DOI 10.1016/j.joca.2010.09.005; Shepherd C, 2010, CURR ONCOL REP, V12, P146, DOI 10.1007/s11912-010-0095-2; Shih HH, 2009, AM J PHYSIOL-HEART C, V296, pH1643, DOI 10.1152/ajpheart.00938.2008; Staton PC, 2008, PAIN, V139, P225, DOI 10.1016/j.pain.2008.04.006; Sutphen R, 2004, CANCER EPIDEM BIOMAR, V13, P1185; Szydlowska K, 2010, J NEUROCHEM, V113, P904, DOI 10.1111/j.1471-4159.2010.06656.x; Tsai J, 2008, P NATL ACAD SCI USA, V105, P3041, DOI 10.1073/pnas.0711741105; Uehara Y, 2009, BIOCHEM BIOPH RES CO, V380, P627, DOI 10.1016/j.bbrc.2009.01.137; Valant C, 2009, MOL INTERV, V9, P125, DOI 10.1124/mi.9.3.6; Waldeck-Weiermair M, 2008, J CELL SCI, V121, P1704, DOI 10.1242/jcs.020958; Whyte LS, 2009, P NATL ACAD SCI USA, V106, P16511, DOI 10.1073/pnas.0902743106; Wigle TJ, 2010, J BIOMOL SCREEN, V15, P62, DOI 10.1177/1087057109352902; Xu ZW, 2009, J BIOMOL SCREEN, V14, P1257, DOI 10.1177/1087057109349356; Yin H, 2009, J BIOL CHEM, V284, P12328, DOI 10.1074/jbc.M806516200	62	108	111	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					91	104		10.1074/jbc.M111.296020	http://dx.doi.org/10.1074/jbc.M111.296020			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22027819	Green Published, hybrid			2022-12-27	WOS:000298682400012
J	Elias, M; Tawfik, DS				Elias, Mikael; Tawfik, Dan S.			Divergence and Convergence in Enzyme Evolution: Parallel Evolution of Paraoxonases from Quorum-quenching Lactonases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							ARCHAEON SULFOLOBUS-SOLFATARICUS; UNIVERSAL COMMON ANCESTOR; AMIDOHYDROLASE SUPERFAMILY; DIRECTED EVOLUTION; BACILLUS-THURINGIENSIS; DEINOCOCCUS-RADIODURANS; 3-DIMENSIONAL STRUCTURE; CATALYTIC DIVERSITY; ENOLASE SUPERFAMILY; PHOSPHOTRIESTERASE	We discuss the basic features of divergent versus convergent evolution and of the common scenario of parallel evolution. The example of quorum-quenching lactonases is subsequently described. Three different quorum-quenching lactonase families are known, and they belong to three different superfamilies. Their key active-site architectures have converged and are strikingly similar. Curiously, a promiscuous organophosphate hydrolase activity is observed in all three families. We describe the structural and mechanistic features that underline this converged promiscuity and how this promiscuity drove the parallel divergence of organophosphate hydrolases within these lactonase families by either natural or laboratory evolution.	[Elias, Mikael; Tawfik, Dan S.] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Tawfik, DS (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	tawfik@weizmann.ac.il	Elias, Mikael/AAH-9385-2021; Elias, Mikael/C-8484-2011	Elias, Mikael/0000-0003-0406-7539; Elias, Mikael/0000-0003-0406-7539	Israel Science Foundation; Marie Curie Intra-European Fellowship [252836]	Israel Science Foundation(Israel Science Foundation); Marie Curie Intra-European Fellowship(European Commission)	This work was supported in part by the Israel Science Foundation. This is the second article in the Thematic Minireview Series on Enzyme Evolution in the Post-genomic Era.; Supported by Marie Curie Intra-European Fellowship 252836.	Afriat L, 2006, BIOCHEMISTRY-US, V45, P13677, DOI 10.1021/bi061268r; Aharoni A, 2004, P NATL ACAD SCI USA, V101, P482, DOI 10.1073/pnas.2536901100; Aravind L, 2002, PROTEINS, V48, P1, DOI 10.1002/prot.10064; BABBITT PC, 1995, SCIENCE, V267, P1159, DOI 10.1126/science.7855594; Bebrone C, 2007, BIOCHEM PHARMACOL, V74, P1686, DOI 10.1016/j.bcp.2007.05.021; BLOBEL G, 1980, P NATL ACAD SCI-BIOL, V77, P1496, DOI 10.1073/pnas.77.3.1496; Bokhove M, 2010, P NATL ACAD SCI USA, V107, P686, DOI 10.1073/pnas.0911839107; BOLTON DPG, 1984, J PHYSIOL-LONDON, V351, P451, DOI 10.1113/jphysiol.1984.sp015255; Burroughs AM, 2006, J MOL BIOL, V361, P1003, DOI 10.1016/j.jmb.2006.06.049; Chow JY, 2010, J BIOL CHEM, V285, P40911, DOI 10.1074/jbc.M110.177139; Chow JY, 2009, BIOCHEMISTRY-US, V48, P4344, DOI 10.1021/bi9004045; Connelly PW, 2011, BBA-MOL CELL BIOL L, V1811, P39, DOI 10.1016/j.bbalip.2010.10.002; Copley SD, 2012, J BIOL CHEM, V287, P3, DOI 10.1074/jbc.R111.254714; Daiyasu H, 2001, FEBS LETT, V503, P1, DOI 10.1016/S0014-5793(01)02686-2; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; Del Vecchio P, 2009, EXTREMOPHILES, V13, P461, DOI 10.1007/s00792-009-0231-9; Dong YJ, 2005, J MOL BIOL, V353, P655, DOI 10.1016/j.jmb.2005.08.057; Draganov DI, 2005, J LIPID RES, V46, P1239, DOI 10.1194/jlr.M400511-JLR200; Draganov DI, 2004, N-S ARCH PHARMACOL, V369, P78, DOI 10.1007/s00210-003-0833-1; Draganov DI, 2010, CHEM-BIOL INTERACT, V187, P370, DOI 10.1016/j.cbi.2010.01.039; Dyhrman ST, 2006, NATURE, V439, P68, DOI 10.1038/nature04203; Elias M, 2008, J MOL BIOL, V379, P1017, DOI 10.1016/j.jmb.2008.04.022; ENGELMAN DM, 1980, P NATL ACAD SCI-BIOL, V77, P5894, DOI 10.1073/pnas.77.10.5894; Erez E, 2009, NATURE, V459, P371, DOI 10.1038/nature08146; Estin ML, 2010, ADV EXP MED BIOL, V660, P183, DOI 10.1007/978-1-60761-350-3_17; FUQUA WC, 1994, J BACTERIOL, V176, P269, DOI 10.1128/JB.176.2.269-275.1994; Galperin MY, 2012, J BIOL CHEM, V287, P21, DOI 10.1074/jbc.R111.241976; Gerlt JA, 2003, CURR OPIN CHEM BIOL, V7, P252, DOI 10.1016/S1367-5931(03)00019-X; Gerlt JA, 2012, J BIOL CHEM, V287, P29, DOI 10.1074/jbc.R111.240945; Glasner ME, 2006, CURR OPIN CHEM BIOL, V10, P492, DOI 10.1016/j.cbpa.2006.08.012; Gupta RD, 2011, NAT CHEM BIOL, V7, P120, DOI [10.1038/nchembio.510, 10.1038/NCHEMBIO.510]; Harel M, 2004, NAT STRUCT MOL BIOL, V11, P412, DOI 10.1038/nsmb767; Hawwa R, 2009, J MOL BIOL, V393, P36, DOI 10.1016/j.jmb.2009.06.083; Horne I, 2003, FEMS MICROBIOL LETT, V222, P1, DOI 10.1016/S0378-1097(03)00211-8; Huey R, 2007, J COMPUT CHEM, V28, P1145, DOI 10.1002/jcc.20634; Iyer LM, 2010, NUCLEIC ACIDS RES, V38, P5261, DOI 10.1093/nar/gkq265; Iyer LM, 2004, J STRUCT BIOL, V146, P11, DOI 10.1016/j.jsb.2003.10.010; Jayaraman A, 2008, ANNU REV BIOMED ENG, V10, P145, DOI 10.1146/annurev.bioeng.10.061807.160536; Khersonsky O, 2006, J BIOL CHEM, V281, P7649, DOI 10.1074/jbc.M512594200; Khersonsky O, 2005, BIOCHEMISTRY-US, V44, P6371, DOI 10.1021/bi047440d; Khersonsky O, 2010, ANNU REV BIOCHEM, V79, P471, DOI 10.1146/annurev-biochem-030409-143718; Kim KM, 2010, MOL BIOL EVOL, V27, P1710, DOI 10.1093/molbev/msq106; Kim MH, 2005, P NATL ACAD SCI USA, V102, P17606, DOI 10.1073/pnas.0504996102; Koonin EV, 2003, NAT REV MICROBIOL, V1, P127, DOI 10.1038/nrmicro751; KOONIN EV, 2002, SEQUENCE EVOLUTION F; Kun Adam, 2008, V1, P39; Leipe DD, 2002, J MOL BIOL, V317, P41, DOI 10.1006/jmbi.2001.5378; Liu D, 2008, BIOCHEMISTRY-US, V47, P7706, DOI 10.1021/bi800368y; Liu DL, 2007, BIOCHEMISTRY-US, V46, P11789, DOI 10.1021/bi7012849; Liu DL, 2005, P NATL ACAD SCI USA, V102, P11882, DOI 10.1073/pnas.0505255102; Lupas AN, 2001, J STRUCT BIOL, V134, P191, DOI 10.1006/jsbi.2001.4393; Merone L, 2005, EXTREMOPHILES, V9, P297, DOI 10.1007/s00792-005-0445-4; Momb J, 2008, BIOCHEMISTRY-US, V47, P7715, DOI 10.1021/bi8003704; Mulbry W, 1998, PESTIC SCI, V52, P268, DOI 10.1002/(SICI)1096-9063(199803)52:3&lt;268::AID-PS719&gt;3.0.CO;2-2; MUNNECKE DM, 1974, APPL MICROBIOL, V28, P212, DOI 10.1128/AEM.28.2.212-217.1974; O'Brien PJ, 1999, CHEM BIOL, V6, pR91, DOI 10.1016/S1074-5521(99)80033-7; OMBURO GA, 1992, J BIOL CHEM, V267, P13278; Ouzounis CA, 2006, RES MICROBIOL, V157, P57, DOI 10.1016/j.resmic.2005.06.015; Poelarends GJ, 2004, J AM CHEM SOC, V126, P15658, DOI 10.1021/ja044304n; Ringia EAT, 2004, BIOCHEMISTRY-US, V43, P224, DOI 10.1021/bi035815+; Roodveldt C, 2005, BIOCHEMISTRY-US, V44, P12728, DOI 10.1021/bi051021e; ROTH RH, 1967, BIOCHEM PHARMACOL, V16, P596, DOI 10.1016/0006-2952(67)90110-4; Schaefer AL, 2008, NATURE, V454, P595, DOI 10.1038/nature07088; Schmidt DMZ, 2003, BIOCHEMISTRY-US, V42, P8387, DOI 10.1021/bi034769a; Seibert CM, 2005, BIOCHEMISTRY-US, V44, P6383, DOI 10.1021/bi047326v; SERDAR CM, 1982, APPL ENVIRON MICROB, V44, P246, DOI 10.1128/AEM.44.1.246-249.1982; Siddavattam D, 2003, APPL ENVIRON MICROB, V69, P2533, DOI 10.1128/AEM.69.5.2533-2539.2003; Teiber JF, 2008, INFECT IMMUN, V76, P2512, DOI 10.1128/IAI.01606-07; Teiber JF, 2011, METHODS MOL BIOL, V692, P291, DOI 10.1007/978-1-60761-971-0_21; Theobald DL, 2010, NATURE, V465, P219, DOI 10.1038/nature09014; Trifonov EN, 2009, CURR OPIN STRUC BIOL, V19, P335, DOI 10.1016/j.sbi.2009.03.007; Tuller T, 2010, GENOME RES, V20, P122, DOI 10.1101/gr.096115.109; Wang SC, 2003, J AM CHEM SOC, V125, P14282, DOI 10.1021/ja0370948; Wang WZ, 2010, APPL ENVIRON MICROB, V76, P2524, DOI 10.1128/AEM.02738-09; Wang YL, 2007, NUCLEIC ACIDS RES, V35, pD298, DOI 10.1093/nar/gkl952; Wierenga RK, 2001, FEBS LETT, V492, P193, DOI 10.1016/S0014-5793(01)02236-0; Xiang DF, 2009, BIOCHEMISTRY-US, V48, P2237, DOI 10.1021/bi802274f; Yang F, 2005, FEBS LETT, V579, P3713, DOI 10.1016/j.febslet.2005.05.060; Yang H, 2003, PROTEIN ENG, V16, P135, DOI 10.1093/proeng/gzg013; Yang KC, 2004, P NATL ACAD SCI USA, V101, P7919, DOI 10.1073/pnas.0400664101	80	82	86	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					11	20		10.1074/jbc.R111.257329	http://dx.doi.org/10.1074/jbc.R111.257329			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22069329	hybrid, Green Published			2022-12-27	WOS:000298682400003
J	Hamidi, A; von Bulow, V; Hamidi, R; Winssinger, N; Barluenga, S; Heldin, CH; Landstrom, M				Hamidi, Anahita; von Bulow, Verena; Hamidi, Rosita; Winssinger, Nicolas; Barluenga, Sofia; Heldin, Carl-Henrik; Landstrom, Marene			Polyubiquitination of Transforming Growth Factor beta (TGF beta)-associated Kinase 1 Mediates Nuclear Factor-kappa B Activation in Response to Different Inflammatory Stimuli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTATE-CANCER; TAK1; TRAF6; APOPTOSIS; PATHWAY; BINDING; SIGNAL; IKK; UBIQUITINATION; TRANSCRIPTION	The transcription factor nuclear factor kappa B (NF-kappa B) plays a central role in regulating inflammation in response to several external signals. The TGF beta-associated kinase 1 (TAK1) is an upstream regulator of NF-kappa B signaling. In TGF beta-stimulated cells, TAK1 undergoes Lys-63-linked polyubiquitination at Lys-34 by TNF receptor-associated factor 6 and is thereby activated. The aim of this study was to investigate whether TAK1 polyubiquitination at Lys-34 is also essential for NF-kappa B activation via TNF receptor, IL-1 receptor and toll-like receptor 4. We observed that TAK1 polyubiquitination occurred at Lys-34 and required the E3 ubiquitin ligase TNF receptor-associated factor 6 after stimulation of cells with IL-1 beta. Polyubiquitination of TAK1 also occurred at Lys-34 in cells stimulated by TNF-alpha and LPS, which activates TLR4, as well as in HepG2 and prostate cancer cells stimulated with TGF beta, which in all cases resulted in NF-kappa B activation. Expression of a K34R-mutant TAK1 led to a reduced NF-kappa B activation, IL-6 promoter activity, and proinflammatory cytokine secretion by TNF-alpha-stimulated PC-3U cells. Similar results were obtained in the mouse macrophage cell line RAW264.7 after LPS treatment. In conclusion, polyubiquitination of TAK1 is correlated with activation of TAK1 and is essential for activation of NF-kappa B signaling downstream of several receptors.	[Landstrom, Marene] Umea Univ, Dept Med Biosci, Pathol Sect, S-90185 Umea, Sweden; [Hamidi, Anahita; von Bulow, Verena; Hamidi, Rosita; Heldin, Carl-Henrik; Landstrom, Marene] Uppsala Univ, Ludwig Inst Canc Res, Uppsala, Sweden; [Winssinger, Nicolas; Barluenga, Sofia] Univ Strasbourg, CNRS, UMR7006, Organ & Bioorgan Lab, Strasbourg, France	Umea University; Ludwig Institute for Cancer Research; Uppsala University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Landstrom, M (corresponding author), Umea Univ, Dept Med Biosci, Pathol Sect, S-90185 Umea, Sweden.	marene.landstrom@licr.uu.se	Winssinger, Nicolas/B-6710-2017	Winssinger, Nicolas/0000-0003-1636-7766; Landstrom, Marene/0000-0001-6737-7230; Hamidi, Anahita/0000-0002-5445-2446	Swedish Medical Research Council; Swedish Cancer Society; Torsten and Ragnar Soderbergs Foundation; ALF	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Swedish Cancer Society(Swedish Cancer Society); Torsten and Ragnar Soderbergs Foundation; ALF	This work was supported in part by grants from the Swedish Medical Research Council, the Swedish Cancer Society, the Torsten and Ragnar Soderbergs Foundation, and ALF (to M. L.).	Adhikari A, 2007, ONCOGENE, V26, P3214, DOI 10.1038/sj.onc.1210413; Aggarwal BB, 2006, BIOCHEM PHARMACOL, V72, P1605, DOI 10.1016/j.bcp.2006.06.029; Allen DL, 2010, AM J PHYSIOL-REG I, V298, pR198, DOI 10.1152/ajpregu.00325.2009; Arsura M, 2003, ONCOGENE, V22, P412, DOI 10.1038/sj.onc.1206132; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Conner SH, 2006, BIOCHEM J, V399, P427, DOI 10.1042/BJ20061077; Dakas PY, 2007, ANGEW CHEM INT EDIT, V46, P6899, DOI 10.1002/anie.200702406; De Marzo AM, 2007, NAT REV CANCER, V7, P256, DOI 10.1038/nrc2090; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Dong W, 2006, J BIOL CHEM, V281, P26029, DOI 10.1074/jbc.M513057200; Edlund S, 2005, MOL CELL BIOL, V25, P1475, DOI 10.1128/MCB.25.4.1475-1488.2005; Edlund S, 2003, MOL BIOL CELL, V14, P529, DOI 10.1091/mbc.02-03-0037; Fan YH, 2010, J BIOL CHEM, V285, P5347, DOI 10.1074/jbc.M109.076976; FRANZEN P, 1993, EXP CELL RES, V207, P1, DOI 10.1006/excr.1993.1156; Grivennikov S, 2008, CANCER CELL, V13, P7, DOI 10.1016/j.ccr.2007.12.020; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; HACKER H, 2006, SCI STKE, DOI DOI 10.1126/STKE.3572006RE13; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Hirschfeld M, 1999, J IMMUNOL, V163, P2382; Irie T, 2000, FEBS LETT, V467, P160, DOI 10.1016/S0014-5793(00)01146-7; Iwai K, 2009, EMBO REP, V10, P706, DOI 10.1038/embor.2009.144; Jogireddy R, 2009, CHEM-EUR J, V15, P11498, DOI 10.1002/chem.200901375; Kajino T, 2006, J BIOL CHEM, V281, P39891, DOI 10.1074/jbc.M608155200; Kanayama A, 2004, MOL CELL, V15, P535, DOI 10.1016/j.molcel.2004.08.008; Karin M, 2009, IMMUNOL REV, V228, P225, DOI 10.1111/j.1600-065X.2008.00755.x; Kirschning CJ, 1998, J EXP MED, V188, P2091, DOI 10.1084/jem.188.11.2091; Kishida S, 2005, GENES CELLS, V10, P447, DOI 10.1111/j.1365-2443.2005.00852.x; Lamothe B, 2007, J BIOL CHEM, V282, P4102, DOI 10.1074/jbc.M609503200; Li S, 2009, MOL CELL, V33, P30, DOI 10.1016/j.molcel.2008.11.023; Naugler WE, 2008, CURR OPIN GENET DEV, V18, P19, DOI 10.1016/j.gde.2008.01.020; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Paule B, 2007, WORLD J UROL, V25, P477, DOI 10.1007/s00345-007-0175-6; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Scholz R, 2010, J BIOL CHEM, V285, P25753, DOI 10.1074/jbc.M109.093468; Shibuya H, 1996, SCIENCE, V272, P1179, DOI 10.1126/science.272.5265.1179; Sorrentino A, 2008, NAT CELL BIOL, V10, P1199, DOI 10.1038/ncb1780; Tang ED, 2003, J BIOL CHEM, V278, P37297, DOI 10.1074/jbc.M303389200; Tseng PH, 2010, NAT IMMUNOL, V11, P70, DOI 10.1038/ni.1819; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Xia ZP, 2009, NATURE, V461, P114, DOI 10.1038/nature08247; Xiao WH, 2004, PROSTATE, V61, P354, DOI 10.1002/pros.20113; Xu M, 2009, MOL CELL, V36, P302, DOI 10.1016/j.molcel.2009.10.002; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008; Yamashita M, 2008, MOL CELL, V31, P918, DOI 10.1016/j.molcel.2008.09.002; Yamazaki K, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000387; Zhang XP, 2009, INT J CANCER, V124, P1980, DOI 10.1002/ijc.24139; Zhu P, 2006, CELL, V124, P615, DOI 10.1016/j.cell.2005.12.032	48	43	44	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					123	133		10.1074/jbc.M111.285122	http://dx.doi.org/10.1074/jbc.M111.285122			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22069318	Green Published, hybrid			2022-12-27	WOS:000298682400015
J	Neasta, J; Kiely, PA; He, DY; Adams, DR; O'Connor, R; Ron, D				Neasta, Jeremie; Kiely, Patrick A.; He, Dao-Yao; Adams, David R.; O'Connor, Rosemary; Ron, Dorit			Direct Interaction between Scaffolding Proteins RACK1 and 14-3-3 zeta Regulates Brain-derived Neurotrophic Factor ( BDNF) Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINASE-C; ADENYLYL CYCLASES; ACTIN DYNAMICS; SPOT SYNTHESIS; HISTONE CODE; BETA-IIPKC; CELLS; PHOSPHORYLATION; ACTIVATION; EXPRESSION	RACK1 is a scaffolding protein that spatially and temporally regulates numerous signaling cascades. We previously found that activation of the cAMP signaling pathway induces the translocation of RACK1 to the nucleus. We further showed that nuclear RACK1 is required to promote the transcription of the brain-derived neurotrophic factor (BDNF). Here, we set out to elucidate the mechanism underlying cAMP-dependent RACK1 nuclear translocation and BDNF transcription. We identified the scaffolding protein 14-3-3 zeta as a direct binding partner of RACK1. Moreover, we found that 14-3-3 zeta was necessary for the cAMP-dependent translocation of RACK1 to the nucleus. We further observed that the disruption of RACK1/14-3-3 zeta interaction with a peptide derived from the RACK1/14-3-3 zeta binding site or shRNA-mediated 14-3-3 zeta knockdown inhibited cAMP induction of BDNF transcription. Together, these data reveal that the function of nuclear RACK1 is mediated through its interaction with 14-3-3 zeta. As RACK1 and 14-3-3 zeta are two multifunctional scaffolding proteins that coordinate a wide variety of signaling events, their interaction is likely to regulate other essential cellular functions.	[Neasta, Jeremie; He, Dao-Yao; Ron, Dorit] Univ Calif San Francisco, Ernest Gallo Res Ctr, Dept Neurol, Emeryville, CA 94608 USA; [Kiely, Patrick A.; O'Connor, Rosemary] Univ Coll Cork, Cell Biol Lab, Dept Biochem, BioSci Inst, Cork, Ireland; [Adams, David R.] Heriot Watt Univ, Dept Chem, Edinburgh EH14AS, Midlothian, Scotland	University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center; University College Cork; Heriot Watt University	Ron, D (corresponding author), Univ Calif San Francisco, Ernest Gallo Res Ctr, Dept Neurol, 5858 Horton St,Suite 200, Emeryville, CA 94608 USA.	dron@gallo.ucsf.edu	O'Connor, Rosemary/B-7902-2014; Adams, David R/E-3916-2010	O'Connor, Rosemary/0000-0002-0687-3422; Adams, David R/0000-0002-7154-7332; Neasta, Jeremie/0000-0002-7801-4176	National Institutes of Health [R01 AA016848]; NIAAA; Cancer Research Ireland; Health Research Board of Ireland; Science Foundation Ireland; State of California for medical research on alcohol and substance Abuse through the University of California, San Francisco; La Jolla Institute for Allergy and Immunology [GST-14-3-3zeta, GST-14-3-3theta]; Sandler Family Foundation; Gordon and Betty Moore Foundation,; National Institutes of Health/NCI Cancer Center [P30 CA082103]; NATIONAL CANCER INSTITUTE [P30CA082103] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA016848] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAAA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Cancer Research Ireland; Health Research Board of Ireland; Science Foundation Ireland(Science Foundation IrelandEuropean Commission); State of California for medical research on alcohol and substance Abuse through the University of California, San Francisco(University of California System); La Jolla Institute for Allergy and Immunology; Sandler Family Foundation; Gordon and Betty Moore Foundation,(Gordon and Betty Moore Foundation); National Institutes of Health/NCI Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AA016848 from the NIAAA (to D. R.). This work was also supported by Cancer Research Ireland and the Health Research Board of Ireland (to P. A. K. and R. O.), Science Foundation Ireland (to R. O.), and the State of California for medical research on alcohol and substance Abuse through the University of California, San Francisco (to D. R.).; We thank Dr. Yun-Cai Liu (La Jolla Institute for Allergy and Immunology) for providing the GST-14-3-3 zeta and GST-14-3-3 theta constructs. The University of California, San Francisco Sandler-Moore Mass Spectrometry Core Facility acknowledges support from the Sandler Family Foundation, the Gordon and Betty Moore Foundation, and National Institutes of Health/NCI Cancer Center Support Grant P30 CA082103. PyMOL from W. L. DeLano, DeLano Scientific, was used to create the protein structure images in this work.	Adams DR, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-22; Agassandian M, 2010, FASEB J, V24, P1271, DOI 10.1096/fj.09-136044; Aguilera C, 2006, J CELL SCI, V119, P3695, DOI 10.1242/jcs.03086; Arimoto K, 2008, NAT CELL BIOL, V10, P1324, DOI 10.1038/ncb1791; Beaulieu JM, 2009, ANNU REV PHARMACOL, V49, P327, DOI 10.1146/annurev.pharmtox.011008.145634; BRIDGES D, 2005, SCI STKE, pRE10, DOI DOI 10.1126/STKE.2962005RE10; Brunet A, 2002, J CELL BIOL, V156, P817, DOI 10.1083/jcb.200112059; CHEN FS, 1994, FEBS LETT, V347, P128, DOI 10.1016/0014-5793(94)00520-6; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Dougherty MK, 2004, J CELL SCI, V117, P1875, DOI 10.1242/jcs.01171; Drobic B, 2010, NUCLEIC ACIDS RES, V38, P3196, DOI 10.1093/nar/gkq030; Fogal V, 2000, EMBO J, V19, P6185, DOI 10.1093/emboj/19.22.6185; Fomenkov A, 2004, CELL CYCLE, V3, P1285, DOI 10.4161/cc.3.10.1155; Frank R, 1996, Methods Mol Biol, V66, P149; Frank R, 2002, J IMMUNOL METHODS, V267, P13, DOI 10.1016/S0022-1759(02)00137-0; Gangisetty O, 2009, J NEUROSCI METH, V181, P58, DOI 10.1016/j.jneumeth.2009.04.016; Ganguly S, 2005, P NATL ACAD SCI USA, V102, P1222, DOI 10.1073/pnas.0406871102; Gohla A, 2002, CURR BIOL, V12, P1704, DOI 10.1016/S0960-9822(02)01184-3; Grosso S, 2008, BIOCHEM J, V415, P77, DOI 10.1042/BJ20080463; Gump JM, 2007, TRENDS MOL MED, V13, P443, DOI 10.1016/j.molmed.2007.08.002; He DY, 2010, J BIOL CHEM, V285, P19043, DOI 10.1074/jbc.M110.100693; He DY, 2002, MOL PHARMACOL, V62, P272, DOI 10.1124/mol.62.2.272; Hong EJ, 2008, NEURON, V60, P610, DOI 10.1016/j.neuron.2008.09.024; Huang TY, 2006, CURR OPIN CELL BIOL, V18, P26, DOI 10.1016/j.ceb.2005.11.005; Jeanblanc J, 2009, J NEUROSCI, V29, P13494, DOI 10.1523/JNEUROSCI.2243-09.2009; JONES DHA, 1995, J MOL BIOL, V245, P375, DOI 10.1006/jmbi.1994.0031; Kholodenko BN, 2010, NAT REV MOL CELL BIO, V11, P414, DOI 10.1038/nrm2901; Kiely PA, 2008, J BIOL CHEM, V283, P22952, DOI 10.1074/jbc.M800802200; Kiely PA, 2009, J BIOL CHEM, V284, P20263, DOI 10.1074/jbc.M109.017640; Li ZG, 2008, P NATL ACAD SCI USA, V105, P162, DOI 10.1073/pnas.0710905105; Liu YV, 2007, J BIOL CHEM, V282, P37064, DOI 10.1074/jbc.M705015200; MacDonald N, 2005, MOL CELL, V20, P199, DOI 10.1016/j.molcel.2005.08.032; Mackintosh JA, 2003, PROTEOMICS, V3, P2273, DOI 10.1002/pmic.200300578; McCahill A, 2002, MOL PHARMACOL, V62, P1261, DOI 10.1124/mol.62.6.1261; McGough NNH, 2004, J NEUROSCI, V24, P10542, DOI 10.1523/JNEUROSCI.3714-04.2004; McKinsey TA, 2000, P NATL ACAD SCI USA, V97, P14400, DOI 10.1073/pnas.260501497; Meller N, 1996, MOL CELL BIOL, V16, P5782; Morrison DK, 2009, TRENDS CELL BIOL, V19, P16, DOI 10.1016/j.tcb.2008.10.003; Mouledous L, 2005, MOL PHARMACOL, V68, P467, DOI 10.1124/mol.105.013391; Muslin AJ, 2000, CELL SIGNAL, V12, P703, DOI 10.1016/S0898-6568(00)00131-5; Nadella KS, 2009, EMBO REP, V10, P599, DOI 10.1038/embor.2009.58; Nilsson J, 2004, EMBO REP, V5, P1137, DOI 10.1038/sj.embor.7400291; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Ptasznik A, 2004, NAT MED, V10, P1187, DOI 10.1038/nm1127; Qiu YF, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000514; ROBINSON K, 1994, BIOCHEM J, V299, P853, DOI 10.1042/bj2990853; Robles MS, 2010, SCIENCE, V327, P463, DOI 10.1126/science.1180067; Ron D, 1999, J BIOL CHEM, V274, P27039, DOI 10.1074/jbc.274.38.27039; RON D, 1995, J BIOL CHEM, V270, P24180, DOI 10.1074/jbc.270.41.24180; RON D, 1994, P NATL ACAD SCI USA, V91, P839, DOI 10.1073/pnas.91.3.839; Ron D, 2000, FASEB J, V14, P2303, DOI 10.1096/fj.00-0143com; Ruvinsky I, 2006, TRENDS BIOCHEM SCI, V31, P342, DOI 10.1016/j.tibs.2006.04.003; Scott JD, 2009, SCIENCE, V326, P1220, DOI 10.1126/science.1175668; Seimiya H, 2000, EMBO J, V19, P2652, DOI 10.1093/emboj/19.11.2652; Shaw AS, 2009, NAT REV IMMUNOL, V9, P47, DOI 10.1038/nri2473; Stirnimann CU, 2010, TRENDS BIOCHEM SCI, V35, P565, DOI 10.1016/j.tibs.2010.04.003; Sumioka A, 2005, J BIOL CHEM, V280, P42364, DOI 10.1074/jbc.M504278200; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Thornton C, 2004, J BIOL CHEM, V279, P31357, DOI 10.1074/jbc.M402316200; TOKER A, 1992, EUR J BIOCHEM, V206, P453, DOI 10.1111/j.1432-1033.1992.tb16946.x; Ullah H, 2008, PROTEIN SCI, V17, P1771, DOI 10.1110/ps.035121.108; van Hemert MJ, 2004, J CELL SCI, V117, P1411, DOI 10.1242/jcs.00990; Wang HB, 2003, MOL PHARMACOL, V63, P463, DOI 10.1124/mol.63.3.463; WATANABE M, 1994, MOL BRAIN RES, V25, P113, DOI 10.1016/0169-328X(94)90285-2; Willoughby D, 2007, PHYSIOL REV, V87, P965, DOI 10.1152/physrev.00049.2006; Winter S, 2008, EMBO J, V27, P88, DOI 10.1038/sj.emboj.7601954; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527; Xia ZG, 2005, NAT REV NEUROSCI, V6, P267, DOI 10.1038/nrn1647; Yaka R, 2003, J BIOL CHEM, V278, P9630, DOI 10.1074/jbc.M209141200; Yuan HB, 2003, CURR BIOL, V13, P638, DOI 10.1016/S0960-9822(03)00208-2; Zippo A, 2009, CELL, V138, P1122, DOI 10.1016/j.cell.2009.07.031	72	23	25	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					322	336		10.1074/jbc.M111.272195	http://dx.doi.org/10.1074/jbc.M111.272195			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22069327	Green Published, hybrid			2022-12-27	WOS:000298682400032
J	Huang, JH; Vogel, G; Yu, ZB; Almazan, G; Richard, S				Huang, Jinghan; Vogel, Gillian; Yu, Zhenbao; Almazan, Guillermina; Richard, Stephane			Type II Arginine Methyltransferase PRMT5 Regulates Gene Expression of Inhibitors of Differentiation/DNA Binding Id2 and Id4 during Glial Cell Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYELIN PROTEOLIPID PROTEIN; C6 GLIOMA-CELLS; OLIGODENDROCYTE DIFFERENTIATION; TRANSCRIPTIONAL REPRESSION; TUMOR-SUPPRESSOR; PROMOTER METHYLATION; STEM-CELLS; RAT-BRAIN; HISTONE; CANCER	PRMT5 is a type II protein arginine methyltranferase that catalyzes monomethylation and symmetric dimethylation of arginine residues. PRMT5 is functionally involved in a variety of biological processes including embryo development and circadian clock regulation. However, the role of PRMT5 in oligodendrocyte differentiation and central nervous system myelination is unknown. Here we show that PRMT5 expression gradually increases throughout postnatal brain development, coinciding with the period of active myelination. PRMT5 expression was observed in neurons, astrocytes, and oligodendrocytes. siRNA-mediated depletion of PRMT5 in mouse primary oligodendrocyte progenitor cells abrogated oligodendrocyte differentiation. In addition, the PRMT5-depleted oligodendrocyte progenitor and C6 glioma cells expressed high levels of the inhibitors of differentiation/DNA binding, Id2 and Id4, known repressors of glial cell differentiation. We observed that CpG-rich islands within the Id2 and Id4 genes were bound by PRMT5 and were hypomethylated in PRMT5-deficient cells, suggesting that PRMT5 plays a role in gene silencing during glial cell differentiation. Our findings define a role of PRMT5 in glial cell differentiation and link PRMT5 to epigenetic changes during oligodendrocyte differentiation.	[Huang, Jinghan; Vogel, Gillian; Yu, Zhenbao; Richard, Stephane] Sir Mortimer B Davis Jewish Hosp, Terry Fox Mol Oncol Grp, Montreal, PQ H3T 1E2, Canada; [Huang, Jinghan; Vogel, Gillian; Yu, Zhenbao; Richard, Stephane] Sir Mortimer B Davis Jewish Hosp, Bloomfield Ctr Res Aging, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada; [Huang, Jinghan; Vogel, Gillian; Yu, Zhenbao; Richard, Stephane] McGill Univ, Dept Oncol, Montreal, PQ H3T 1E2, Canada; [Huang, Jinghan; Vogel, Gillian; Yu, Zhenbao; Richard, Stephane] McGill Univ, Dept Med, Montreal, PQ H3T 1E2, Canada; [Almazan, Guillermina] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ H3G 1Y6, Canada	McGill University; Lady Davis Institute; McGill University; McGill University; McGill University; McGill University	Richard, S (corresponding author), Segal Canc Ctr, 3755 Cote Ste Catherine Rd, Montreal, PQ H3T 1E2, Canada.	stephane.richard@mcgill.ca			Canadian Institutes of Health Research [MOP-67070]; Multiple Sclerosis Society of Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Multiple Sclerosis Society of Canada	This work was supported by Grant MOP-67070 from the Canadian Institutes of Health Research (to S. R.).; Supported by the Multiple Sclerosis Society of Canada.	ALMAZAN G, 1993, J NEUROSCI RES, V36, P163, DOI 10.1002/jnr.490360206; Ancelin K, 2006, NAT CELL BIOL, V8, P623, DOI 10.1038/ncb1413; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; Carey JPW, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-173; Chan ASW, 2003, ONCOGENE, V22, P6946, DOI 10.1038/sj.onc.1206799; Chittka A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013807; COYLE DE, 1995, J NEUROSCI RES, V41, P374, DOI 10.1002/jnr.490410310; Dacwag CS, 2007, MOL CELL BIOL, V27, P384, DOI 10.1128/MCB.01528-06; Fabbrizio E, 2002, EMBO REP, V3, P641, DOI 10.1093/embo-reports/kvf136; Hollnagel A, 1999, J BIOL CHEM, V274, P19838, DOI 10.1074/jbc.274.28.19838; Hong S, 2010, P NATL ACAD SCI USA, V107, P21211, DOI 10.1073/pnas.1011987107; Hou ZY, 2008, MOL CELL BIOL, V28, P3198, DOI 10.1128/MCB.01435-07; Hou ZY, 2010, P NATL ACAD SCI USA, V107, P2938, DOI 10.1073/pnas.0908656107; Huddleston JE, 2011, NAT REV MOL CELL BIO, V12, DOI 10.1038/nrm3056; Jansson M, 2008, NAT CELL BIOL, V10, P1431, DOI 10.1038/ncb1802; Kondo T, 2000, EMBO J, V19, P1998, DOI 10.1093/emboj/19.9.1998; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Kwak YT, 2003, MOL CELL, V11, P1055, DOI 10.1016/S1097-2765(03)00101-1; Larocque D, 2005, NAT NEUROSCI, V8, P27, DOI 10.1038/nn1359; Le Guezennec X, 2006, MOL CELL BIOL, V26, P843, DOI 10.1128/MCB.26.3.843-851.2006; Leisewitz AV, 2008, J CELL PHYSIOL, V217, P367, DOI 10.1002/jcp.21509; MCMORRIS FA, 1977, P NATL ACAD SCI USA, V74, P4501, DOI 10.1073/pnas.74.10.4501; MILNER RJ, 1985, CELL, V42, P931, DOI 10.1016/0092-8674(85)90289-2; Nakahiro T, 2010, BIOCHEM BIOPH RES CO, V399, P416, DOI 10.1016/j.bbrc.2010.07.090; Nakashima K, 2001, P NATL ACAD SCI USA, V98, P5868, DOI 10.1073/pnas.101109698; NAVE KA, 1991, J NEUROSCI, V11, P3060; Noetzel E, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-154; Pal S, 2004, MOL CELL BIOL, V24, P9630, DOI 10.1128/MCB.24.21.9630-9645.2004; Pal S, 2003, MOL CELL BIOL, V23, P7475, DOI 10.1128/MCB.23.21.7475-7487.2003; Samanta J, 2004, DEVELOPMENT, V131, P4131, DOI 10.1242/dev.01273; Sanchez SE, 2010, NATURE, V468, P112, DOI 10.1038/nature09470; Shen SM, 2005, J CELL BIOL, V169, P577, DOI 10.1083/jcb.200412101; Swiss VA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018088; Tae S, 2011, NUCLEIC ACIDS RES, V39, P5424, DOI 10.1093/nar/gkr170; Tee WW, 2010, GENE DEV, V24, P2772, DOI 10.1101/gad.606110; Wang L, 2008, MOL CELL BIOL, V28, P6262, DOI 10.1128/MCB.00923-08; Wang SL, 2001, NEURON, V29, P603, DOI 10.1016/S0896-6273(01)00237-9; Wegner M, 2005, TRENDS NEUROSCI, V28, P583, DOI 10.1016/j.tins.2005.08.008; Wegner M, 2008, J MOL NEUROSCI, V35, P3, DOI 10.1007/s12031-007-9008-8; Xu XJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-396; Ye F, 2009, NAT NEUROSCI, V12, P829, DOI 10.1038/nn.2333; Yu L, 2005, NAT GENET, V37, P265, DOI 10.1038/ng1521; Yu Y, 2010, EPIGENETICS-US, V5, P124, DOI 10.4161/epi.5.2.11160; Yu ZB, 2009, MOL CELL BIOL, V29, P2982, DOI 10.1128/MCB.00042-09; Zhao Q, 2009, NAT STRUCT MOL BIOL, V16, P304, DOI 10.1038/nsmb.1568	46	49	50	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2011	286	52					44424	44432		10.1074/jbc.M111.277046	http://dx.doi.org/10.1074/jbc.M111.277046			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870CA	22041901	Green Published, hybrid			2022-12-27	WOS:000298645500014
J	Palacios-Rodriguez, Y; Garcia-Lainez, G; Sancho, M; Gortat, A; Orzaez, M; Perez-Paya, E				Palacios-Rodriguez, Yadira; Garcia-Lainez, Guillermo; Sancho, Monica; Gortat, Anna; Orzaez, Mar; Perez-Paya, Enrique			Polypeptide Modulators of Caspase Recruitment Domain (CARD)-CARD-mediated Protein-Protein Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; ACTIVATING FACTOR-1 APAF-1; CYTOCHROME-C; CELL-DEATH; DEPENDENT APOPTOSIS; RNA INTERFERENCE; STRUCTURAL BASIS; IN-VIVO; PEPTIDE; PROCASPASE-9	The caspase recruitment domain (CARD) is present in a large number of proteins. Initially, the CARD was recognized as part of the caspase activation machinery. CARD-CARD interactions play a role in apoptosis and are responsible for the Apaf-1-mediated activation of procaspase-9 in the apoptosome. CARD-containing proteins mediate the inflammasome-dependent activation of proinflammatory caspase-1. More recently, new roles for CARD-containing proteins have been reported in signaling pathways associated with immune responses. The functional role of CARD-containing proteins and CARDs in coordinating apoptosis and inflammatory and immune responses is not completely understood. We have explored the putative cross-talk between apoptosis and inflammation by analyzing the modulatory activity on both the Apaf-1/procaspase-9 interaction and the inflammasome-mediated procaspase-1 activation of CARD-derived polypeptides. To this end, we analyzed the activity of individual recombinant CARDs, rationally designed CARD-derived peptides, and peptides derived from phage display.	[Palacios-Rodriguez, Yadira; Garcia-Lainez, Guillermo; Sancho, Monica; Gortat, Anna; Orzaez, Mar; Perez-Paya, Enrique] Ctr Invest Principe Felipe, Lab Peptide & Prot Chem, E-46012 Valencia, Spain; [Palacios-Rodriguez, Yadira; Garcia-Lainez, Guillermo; Perez-Paya, Enrique] Consejo Super Invest Cient, Inst Biomed Valencia, E-46010 Valencia, Spain	Prince Felipe Research Center; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biomedicina de Valencia (IBV)	Orzaez, M (corresponding author), Ctr Invest Principe Felipe, Lab Peptide & Prot Chem, Avda Autopista Saler 16, E-46012 Valencia, Spain.	morzaez@cipf.es; eperez@cipf.es	Orzaez, Mar/B-4992-2014; Medina, Mónica Sancho/L-4660-2014; Lainez, Guillermo Garcia/AAX-3516-2020; Garcia-Lainez, Guillermo/AAO-1837-2021; Palacios, Yadira/G-8808-2019	Orzaez, Mar/0000-0003-3231-5835; Medina, Mónica Sancho/0000-0003-3707-062X; Garcia-Lainez, Guillermo/0000-0003-1459-0702; Palacios, Yadira/0000-0003-0712-4439	Spanish Ministry of Science and Innovation (MICINN) [BIO2007-60066, SAF2010 15512]; European Regional Development Fund; MICINN [CSD2008-00005C]; National Autonomous University of Mexico; Consejo Superior de Investigaciones Cientificas, Spain (UNAM-CSIC); CSIC	Spanish Ministry of Science and Innovation (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Regional Development Fund(European Commission); MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); National Autonomous University of Mexico(Universidad Nacional Autonoma de Mexico); Consejo Superior de Investigaciones Cientificas, Spain (UNAM-CSIC); CSIC	This work has been supported by Spanish Ministry of Science and Innovation (MICINN) Grants BIO2007-60066 and SAF2010 15512, Laboratorios Salvat, SA, Generalitat Valenciana Prometeo 2010/005 (partially funded with the European Regional Development Fund), and Consolider-Ingenio 2010 (MICINN Grant CSD2008-00005C) (to E. P.-P).; Supported by a postdoctoral fellowship from the National Autonomous University of Mexico and Consejo Superior de Investigaciones Cientificas, Spain (UNAM-CSIC).; Supported through JAE-Pre from the CSIC.	Acehan D, 2002, MOL CELL, V9, P423, DOI 10.1016/S1097-2765(02)00442-2; Agopian A, 2009, J BIOL CHEM, V284, P254, DOI 10.1074/jbc.M802199200; Boatright KM, 2003, MOL CELL, V11, P529, DOI 10.1016/S1097-2765(03)00051-0; Bouchier-Hayes L, 2002, EMBO REP, V3, P616, DOI 10.1093/embo-reports/kvf139; Bruey JM, 2007, CELL, V129, P45, DOI 10.1016/j.cell.2007.01.045; Caratu G, 2007, MOL CELL PROTEOMICS, V6, P333, DOI 10.1074/mcp.M600289-MCP200; Chu ZL, 2001, J BIOL CHEM, V276, P9239, DOI 10.1074/jbc.M006309200; Churchill EN, 2009, TRENDS ENDOCRIN MET, V20, P25, DOI 10.1016/j.tem.2008.10.002; Coussens NP, 2007, BIOCHEM BIOPH RES CO, V353, P1, DOI 10.1016/j.bbrc.2006.11.122; Day TW, 2009, MINI-REV MED CHEM, V9, P741, DOI 10.2174/138955709788452748; de Alba E, 2009, J BIOL CHEM, V284, P32932, DOI 10.1074/jbc.M109.024273; Fearnhead HO, 2001, METHOD CELL BIOL, V66, P167; Fenske SA, 2008, J BIOL CHEM, V283, P22097, DOI 10.1074/jbc.M800029200; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Gong YN, 2010, CELL RES, V20, P1289, DOI 10.1038/cr.2010.135; Hiscott J, 2006, TRENDS MOL MED, V12, P53, DOI 10.1016/j.molmed.2005.12.003; Hu YM, 1999, EMBO J, V18, P3586, DOI 10.1093/emboj/18.13.3586; Inohara N, 1999, J BIOL CHEM, V274, P14560, DOI 10.1074/jbc.274.21.14560; Inohara N, 2003, NAT REV IMMUNOL, V3, P371, DOI 10.1038/nri1086; Ippagunta SK, 2011, NAT IMMUNOL, V12, P1010, DOI 10.1038/ni.2095; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Mahoney DJ, 2008, P NATL ACAD SCI USA, V105, P11778, DOI 10.1073/pnas.0711122105; Malet G, 2006, CELL DEATH DIFFER, V13, P1523, DOI 10.1038/sj.cdd.4401828; Malladi S, 2009, EMBO J, V28, P1916, DOI 10.1038/emboj.2009.152; Mandava S, 2004, PROTEOMICS, V4, P1439, DOI 10.1002/pmic.200300680; Manon F, 2007, J MOL BIOL, V365, P160, DOI 10.1016/j.jmb.2006.09.067; Marasco D, 2009, BIOCHEM J, V422, P553, DOI 10.1042/BJ20090055; Mondragon L, 2008, J MED CHEM, V51, P521, DOI 10.1021/jm701195j; Mondragon L, 2009, APOPTOSIS, V14, P182, DOI 10.1007/s10495-008-0310-x; Mora P, 2006, J PEPT SCI, V12, P491, DOI 10.1002/psc.755; Orzaez M, 2007, PEPTIDES, V28, P958, DOI 10.1016/j.peptides.2007.02.014; Paddison PJ, 2002, CANCER CELL, V2, P17, DOI 10.1016/S1535-6108(02)00092-2; Palacios-Rodriguez Y, 2007, J MICROBIOL METH, V68, P225, DOI 10.1016/j.mimet.2006.08.001; Park HH, 2007, ANNU REV IMMUNOL, V25, P561, DOI 10.1146/annurev.immunol.25.022106.141656; Perez-Paya E, 2011, MED RES REV, V31, P649, DOI 10.1002/med.20198; PEREZPAYA E, 1994, BIOCHEM J, V299, P587, DOI 10.1042/bj2990587; Pop C, 2006, MOL CELL, V22, P269, DOI 10.1016/j.molcel.2006.03.009; Proell M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002119; Qin HX, 1999, NATURE, V399, P549, DOI 10.1038/21124; Riedl SJ, 2005, NATURE, V434, P926, DOI 10.1038/nature03465; Rubinstein M, 2009, BIOPOLYMERS, V91, P505, DOI 10.1002/bip.21164; Saleh A, 1999, J BIOL CHEM, V274, P17941, DOI 10.1074/jbc.274.25.17941; Schlegel BP, 2003, ONCOGENE, V22, P983, DOI 10.1038/sj.onc.1206195; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; SCOTT JK, 1990, SCIENCE, V249, P386, DOI 10.1126/science.1696028; Serasinghe MN, 2010, J BIOL CHEM, V285, P620, DOI 10.1074/jbc.M109.027508; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Shiozaki EN, 2002, P NATL ACAD SCI USA, V99, P4197, DOI 10.1073/pnas.072544399; Smith FD, 2002, CURR BIOL, V12, pR32, DOI 10.1016/S0960-9822(01)00646-7; Stennicke HR, 1999, METHODS, V17, P313, DOI 10.1006/meth.1999.0745; Stephanou A, 2002, J BIOL CHEM, V277, P13693, DOI 10.1074/jbc.M108530200; Ting JPY, 2008, NAT REV IMMUNOL, V8, P372, DOI 10.1038/nri2296; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Varnai P, 2005, J CELL SCI, V118, P4879, DOI 10.1242/jcs.02606; Vicent MJ, 2006, J MED CHEM, V49, P3763, DOI 10.1021/jm060458x; Walensky LD, 2004, SCIENCE, V305, P1466, DOI 10.1126/science.1099191; Yeon SW, 2007, PEPTIDES, V28, P838, DOI 10.1016/j.peptides.2007.01.006; Yu XC, 2005, STRUCTURE, V13, P1725, DOI 10.1016/j.str.2005.09.006; Zender L, 2004, APOPTOSIS, V9, P51, DOI 10.1023/B:APPT.0000012121.52210.23; Zhou P, 1999, P NATL ACAD SCI USA, V96, P11265, DOI 10.1073/pnas.96.20.11265; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2	61	11	12	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2011	286	52					44457	44466		10.1074/jbc.M111.255364	http://dx.doi.org/10.1074/jbc.M111.255364			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870CA	22065589	Green Published, Green Submitted, hybrid			2022-12-27	WOS:000298645500018
J	Peruchetti, DB; Pinheiro, AAS; Landgraf, SS; Wengert, M; Takiya, CM; Guggino, WB; Caruso-Neves, C				Peruchetti, Diogo B.; Pinheiro, Ana Acacia S.; Landgraf, Sharon S.; Wengert, Mira; Takiya, Christina M.; Guggino, William B.; Caruso-Neves, Celso			(Na+ + K+)-ATPase Is a Target for Phosphoinositide 3-Kinase/Protein Kinase B and Protein Kinase C Pathways Triggered by Albumin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; PROXIMAL TUBULE CELLS; ACTIVATION; ALBUMIN; INHIBITION; KIDNEY; PHOSPHORYLATION; ENDOCYTOSIS; EXPRESSION; PATHWAYS	In recent decades, evidence has confirmed the crucial role of albumin in the progression of renal disease. However, the possible role of signaling pathways triggered by physiologic concentrations of albumin in the modulation of proximal tubule (PT) sodium reabsorption has not been considered. In the present work, we have shown that a physiologic concentration of albumin increases the expression of the alpha 1 subunit of (Na+ + K+)-ATPase in LLC-PK1 cells leading to an increase in enzyme activity. This process involves the sequential activation of PI3K/protein kinase B and protein kinase C pathways promoting inhibition of protein kinase A. This integrative network is inhibited when albumin concentration is increased, similar to renal disease, leading to a decrease in the alpha 1 subunit of (Na+ + K+)-ATPase expression. Together, the results indicate that variation in albumin concentration in PT cells has an important effect on PT sodium reabsorption and, consequently, on renal sodium excretion.	[Peruchetti, Diogo B.; Pinheiro, Ana Acacia S.; Landgraf, Sharon S.; Wengert, Mira; Takiya, Christina M.; Caruso-Neves, Celso] Univ Fed Rio de Janeiro, Ctr Ciencias Saude, Inst Biofis Carlos Chagas Filho, BR-21949900 Rio De Janeiro, Brazil; [Guggino, William B.] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA	Universidade Federal do Rio de Janeiro; Johns Hopkins University	Caruso-Neves, C (corresponding author), Ave Carlos Chagas Filho 373, BR-21949900 Rio De Janeiro, Brazil.	caruso@biof.ufrj.br	Takiya, Christina/AAU-5959-2021; Caruso-Neves, Celso/C-4014-2013; Fisiologia, Ciencias Biologicas/C-2407-2012; Peruchetti, Diogo B/L-3706-2017	Takiya, Christina/0000-0002-8019-628X; Caruso-Neves, Celso/0000-0002-2415-7753; Peruchetti, Diogo B/0000-0002-7572-9731; Pinheiro, Ana Acacia/0000-0002-3894-1645	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Instituto Nacional de Ciencia e Tecnologia para Pesquisa Translacional em Saude e Ambiente na Regiao Amazonica (INPeTAm/CNPq); Instituto Nacional de Ciencia e Tecnologia em Biologia Estrutural e Bioimagem (INBEB/CNPq)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Instituto Nacional de Ciencia e Tecnologia para Pesquisa Translacional em Saude e Ambiente na Regiao Amazonica (INPeTAm/CNPq); Instituto Nacional de Ciencia e Tecnologia em Biologia Estrutural e Bioimagem (INBEB/CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), Instituto Nacional de Ciencia e Tecnologia para Pesquisa Translacional em Saude e Ambiente na Regiao Amazonica (INPeTAm/CNPq), and Instituto Nacional de Ciencia e Tecnologia em Biologia Estrutural e Bioimagem (INBEB/CNPq).	Abbate M, 2006, J AM SOC NEPHROL, V17, P2974, DOI 10.1681/ASN.2006040377; Baines RJ, 2008, NEPHRON EXP NEPHROL, V110, pE67, DOI 10.1159/000161982; Barragan M, 2006, J LEUKOCYTE BIOL, V80, P1473, DOI 10.1189/jlb.0106041; Bauer B, 2001, J BIOL CHEM, V276, P31627, DOI 10.1074/jbc.M103098200; Beazely MA, 2006, EUR J PHARMACOL, V535, P1, DOI 10.1016/j.ejphar.2006.01.054; Brunskill NJ, 1998, J CLIN INVEST, V101, P2140, DOI 10.1172/JCI1923; Carranza A, 2008, AM J PHYSIOL-CELL PH, V295, pC1602, DOI 10.1152/ajpcell.00090.2008; Caruso-Neves C, 2005, P NATL ACAD SCI USA, V102, P17513, DOI 10.1073/pnas.0507255102; Caruso-Neves C, 2006, P NATL ACAD SCI USA, V103, P18810, DOI 10.1073/pnas.0605029103; Christensen EI, 2009, PFLUG ARCH EUR J PHY, V458, P1039, DOI 10.1007/s00424-009-0685-8; Cianciaruso B, 1996, J AM SOC NEPHROL, V7, P306; Doornbos RP, 1999, J BIOL CHEM, V274, P8589, DOI 10.1074/jbc.274.13.8589; EDDY AA, 1989, AM J PATHOL, V135, P719; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Feraille E, 2001, PHYSIOL REV, V81, P345, DOI 10.1152/physrev.2001.81.1.345; Gekle M, 2007, KIDNEY INT, V71, P479, DOI 10.1038/sj.ki.5002123; GRUBMEYER C, 1981, J BIOL CHEM, V256, P3718; Landgraf SS, 2011, AM J PHYSIOL-RENAL, V300, pF499, DOI 10.1152/ajprenal.00384.2010; Lee YJ, 2008, AM J PHYSIOL-RENAL, V294, pF534, DOI 10.1152/ajprenal.00408.2007; Li XN, 2010, J AM SOC NEPHROL, V21, P1115, DOI 10.1681/ASN.2009070760; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maia J. C, 1993, GENES ANTIGENS PARAS, P144; Mao ML, 2000, BIOCHEM J, V352, P475, DOI 10.1042/0264-6021:3520475; Matsumoto M, 2001, J BIOL CHEM, V276, P14400, DOI 10.1074/jbc.M011093200; Morigi M, 2002, J AM SOC NEPHROL, V13, P1179; Nakajima H, 2004, J AM SOC NEPHROL, V15, P276, DOI 10.1097/01.ASN.0000109672.83594.02; O'Shaughnessy KM, 2006, ANNU REV NUTR, V26, P343, DOI 10.1146/annurev.nutr.26.061505.111316; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Pierre SV, 2011, AM J PHYSIOL-CELL PH, V300, pC42, DOI 10.1152/ajpcell.00386.2010; Poulsen H, 2010, FEBS LETT, V584, P2589, DOI 10.1016/j.febslet.2010.04.035; Russo LM, 2007, KIDNEY INT, V71, P504, DOI 10.1038/sj.ki.5002041; Tang S, 2003, J CLIN INVEST, V111, P515, DOI [10.1172/JCI16079, 10.1172/JCI200316079]; Theilig F, 2010, ANN ANAT, V192, P125, DOI 10.1016/j.aanat.2010.03.003; Tremblay F, 2001, DIABETES, V50, P1901, DOI 10.2337/diabetes.50.8.1901; Vlachojannis J, 1997, NEPHROL DIAL TRANSPL, V12, P470, DOI 10.1093/ndt/12.3.470; Yuseff MI, 2007, TRAFFIC, V8, P1215, DOI 10.1111/j.1600-0854.2007.00601.x; Zhang YR, 2010, CLIN EXP PHARMACOL P, V37, P613, DOI 10.1111/j.1440-1681.2010.05364.x; Zhong Z, 2005, DIABETOLOGIA, V48, P187, DOI 10.1007/s00125-004-1602-5	38	19	21	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2011	286	52					45041	45047		10.1074/jbc.M111.260737	http://dx.doi.org/10.1074/jbc.M111.260737			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870CA	22057272	hybrid, Green Published			2022-12-27	WOS:000298645500071
J	Su, T; Chapin, SJ; Bryant, DM; Shewan, AM; Young, K; Mostov, KE				Su, Tao; Chapin, Steven J.; Bryant, David M.; Shewan, Annette M.; Young, Kitty; Mostov, Keith E.			Reduced Immunoglobulin A Transcytosis Associated with Immunoglobulin A Nephropathy and Nasopharyngeal Carcinoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPSTEIN-BARR-VIRUS; FREE SECRETORY COMPONENT; EPITHELIAL-CELLS; IGA NEPHROPATHY; RECEPTOR; POLYMORPHISMS; TRANSPORT; ENTRY	Polymeric IgA (pIgA) is transcytosed by the pIgA receptor (pIgR) across mucosal epithelial cells. After transcytosis to the apical surface, the extracellular, ligand-binding portion of the pIgR is proteolytically cleaved. A missense mutation in human pIgR, A580V, is associated with IgA nephropathy and nasopharyngeal carcinoma. We report that this mutation reduces the rate of transcytosis of pIgR and pIgA, and seemingly the rate of pIgR cleavage. We propose that the defects in pIgR trafficking caused by the A580V mutation may underlie the pathogenesis of both diseases.	[Su, Tao; Chapin, Steven J.; Bryant, David M.; Shewan, Annette M.; Young, Kitty; Mostov, Keith E.] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94158 USA; [Mostov, Keith E.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Mostov, KE (corresponding author), UCSF GH N212B,600 16th St, San Francisco, CA 94158 USA.	keith.mostov@ucsf.edu	Shewan, Annette/B-3251-2011; Su, Tao/T-4411-2019; Bryant, David/AAH-5620-2019	Shewan, Annette/0000-0003-4936-9207; Su, Tao/0000-0002-9148-6127; Bryant, David/0000-0003-2721-5012; mostov, keith/0000-0002-8123-6247	National Institutes of Health [R01AI25144]; Susan G. Komen Foundation; National Health and Medical Research Council; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI025144] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan G. Komen Foundation(Susan G. Komen Breast Cancer Foundation); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01AI25144 (to K. E. M.).; Supported by a Susan G. Komen Foundation postdoctoral fellowship.; Supported by a National Health and Medical Research Council C.J. Martin fellowship. Present address: School of Chemistry and Molecular Biosciences, the University of Queensland, St. Lucia, Queensland 4072, Australia.	Chang ET, 2006, CANCER EPIDEM BIOMAR, V15, P1765, DOI 10.1158/1055-9965.EPI-06-0353; EIFFERT H, 1984, H-S Z PHYSIOL CHEM, V365, P1489, DOI 10.1515/bchm2.1984.365.2.1489; EMANCIPATOR SN, 1989, LAB INVEST, V60, P168; Fan Qin, 2005, Ai Zheng, V24, P915; Gan YJ, 1997, J VIROL, V71, P519, DOI 10.1128/JVI.71.1.519-526.1997; Gharavi AG, 2011, NAT GENET, V43, P321, DOI 10.1038/ng.787; Hirunsatit R, 2003, BMC GENET, V4, DOI 10.1186/1471-2156-4-3; Hughes GJ, 1997, FEBS LETT, V410, P443, DOI 10.1016/S0014-5793(97)00629-7; Hutt-Fletcher LM, 2007, J VIROL, V81, P7825, DOI 10.1128/JVI.00445-07; Johansen FE, 2011, MUCOSAL IMMUNOL, V4, P598, DOI 10.1038/mi.2011.37; Kaetzel CS, 2005, IMMUNOL REV, V206, P83, DOI 10.1111/j.0105-2896.2005.00278.x; Kiryluk Krzysztof, 2010, Pediatr Nephrol, V25, P2257, DOI 10.1007/s00467-010-1500-7; Luton F, 2009, TRAFFIC, V10, P1128, DOI 10.1111/j.1600-0854.2009.00941.x; Mostov K, 2003, NAT CELL BIOL, V5, P287, DOI 10.1038/ncb0403-287; Obara W, 2003, J HUM GENET, V48, P293, DOI 10.1007/s10038-003-0027-1; Rojas R, 2002, NAT REV MOL CELL BIO, V3, P944, DOI 10.1038/nrm972; SIXBEY JW, 1992, SCIENCE, V255, P1578, DOI 10.1126/science.1312750; SONG WX, 1994, P NATL ACAD SCI USA, V91, P163, DOI 10.1073/pnas.91.1.163; Su T, 2010, NAT CELL BIOL, V12, P1143, DOI 10.1038/ncb2118; Weisz OA, 2009, J CELL SCI, V122, P4253, DOI 10.1242/jcs.032615	20	5	6	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2011	286	52					44921	44925		10.1074/jbc.M111.296731	http://dx.doi.org/10.1074/jbc.M111.296731			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870CA	22086919	Green Published, hybrid			2022-12-27	WOS:000298645500060
J	Thomas, ST; VanderVen, BC; Sherman, DR; Russell, DG; Sampson, NS				Thomas, Suzanne T.; VanderVen, Brian C.; Sherman, David R.; Russell, David G.; Sampson, Nicole S.			Pathway Profiling in Mycobacterium tuberculosis ELUCIDATION OF CHOLESTEROL-DERIVED CATABOLITE AND ENZYMES THAT CATALYZE ITS METABOLISM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIDE-CHAIN DEGRADATION; 3-KETOSTEROID 9-ALPHA-HYDROXYLASE; HEXAHYDROINDANONE DERIVATIVES; MICROBIOLOGICAL DEGRADATION; SQUALENE BIOSYNTHESIS; ACID; DEHYDROGENASE; MACROPHAGES; IDENTIFICATION; MONOOXYGENASE	Mycobacterium tuberculosis, the bacterium that causes tuberculosis, imports and metabolizes host cholesterol during infection. This ability is important in the chronic phase of infection. Here we investigate the role of the intracellular growth operon (igr), which has previously been identified as having a cholesterol-sensitive phenotype in vitro and which is important for intracellular growth of the mycobacteria. We have employed isotopically labeled low density lipoproteins containing either [1,7,15,22,26-C-14] cholesterol or [1,7,15,22,26-C-13] cholesterol and high resolution LC/MS as tools to profile the cholesterol-derived metabolome of an igr operon-disrupted mutant (Delta igr) of M. tuberculosis. A partially metabolized cholesterol species accumulated in the Delta igr knock-out strain that was absent in the complemented and parental wild-type strains. Structural elucidation by multidimensional H-1 and C-13 NMR spectroscopy revealed the accumulated metabolite to be methyl 1 beta-(2'-propanoate)-3a alpha-H-4 alpha-(3'-propanoic acid)-7a beta-methylhexahydro5-indanone. Heterologously expressed and purified FadE28-FadE29, an acyl-CoA dehydrogenase encoded by the igr operon, catalyzes the dehydrogenation of 2'-propanoyl-CoA ester side chains in substrates with structures analogous to the characterized metabolite. Based on the structure of the isolated metabolite, enzyme activity, and bioinformatic annotations, we assign the primary function of the igr operon to be degradation of the 2'-propanoate side chain. Therefore, the igr operon is necessary to completely metabolize the side chain of cholesterol metabolites.	[VanderVen, Brian C.; Russell, David G.] Cornell Univ, Dept Microbiol & Immunol, Ithaca, NY 14853 USA; [Thomas, Suzanne T.; Sampson, Nicole S.] SUNY Stony Brook, Dept Chem, Stony Brook, NY 11794 USA; [Sherman, David R.] Seattle Biomed Res Inst, Seattle, WA 98109 USA	Cornell University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Center for Infectious Disease Research	VanderVen, BC (corresponding author), Cornell Univ, Dept Microbiol & Immunol, Ithaca, NY 14853 USA.	bcv8@cornell.edu; nicole.sampson@stonybrook.edu	Russell, David G/D-4533-2009; Russell, David G/N-5280-2019; Sampson, Nicole/C-4598-2014	Russell, David G/0000-0002-9748-750X; Russell, David G/0000-0002-9748-750X; Sampson, Nicole/0000-0002-2835-7760	National Institutes of Health [R21AI092455, R01HL53306, S10RR021008, R01AI067027, S10RR025072]; DOE-GAANN; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR021008, S10RR025072] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL053306] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067027, R21AI092455] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOE-GAANN(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R21AI092455, R01HL53306, S10RR021008 (to N. S. S.), R01AI067027 (to D. G. R.), and S10RR025072 (to Orbitrap). This work was also supported by a DOE-GAANN fellowship (to S. T. T.).	BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BLOCH K, 1965, SCIENCE, V150, P19, DOI 10.1126/science.150.3692.19; Capyk JK, 2011, J BIOL CHEM, V286, P40717, DOI 10.1074/jbc.M111.289975; Capyk JK, 2009, J BIOL CHEM, V284, P35534, DOI 10.1074/jbc.M109.072132; Capyk JK, 2009, J BIOL CHEM, V284, P9937, DOI 10.1074/jbc.M900719200; Chang JC, 2007, J INFECT DIS, V196, P788, DOI 10.1086/520089; Chang JC, 2009, J BACTERIOL, V191, P5232, DOI 10.1128/JB.00452-09; Dobson G., 1985, CHEM METHODS BACTERI, P237; Dresen C, 2010, J BIOL CHEM, V285, P22264, DOI 10.1074/jbc.M109.099028; Griffin JE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002251; HASHIMOTO S, 1977, BIOCHEM J, V164, P715, DOI 10.1042/bj1640715; HAYAKAWA S, 1967, NATURE, V214, P520, DOI 10.1038/214520b0; Horinouchi M, 2005, APPL ENVIRON MICROB, V71, P5275, DOI 10.1128/AEM.71.9.5275-5281.2005; INHOFFEN HH, 1954, CHEM BER-RECL, V87, P1, DOI 10.1002/cber.19540870102; INHOFFEN HH, 1958, CHEM BER-RECL, V91, P781, DOI 10.1002/cber.19580910412; ISLER O, 1957, HELV CHIM ACTA, V40, P2369, DOI 10.1002/hlca.19570400733; Johnston JB, 2010, J BIOL CHEM, V285, P36352, DOI 10.1074/jbc.M110.161117; KIESLICH K, 1985, J BASIC MICROB, V25, P461, DOI 10.1002/jobm.3620250713; Knol J, 2008, BIOCHEM J, V410, P339, DOI 10.1042/BJ20071130; Lack NA, 2010, J BIOL CHEM, V285, P434, DOI 10.1074/jbc.M109.058081; LEHMAN TC, 1990, BIOCHEMISTRY-US, V29, P10594, DOI 10.1021/bi00499a004; LEHMAN TC, 1990, ANAL BIOCHEM, V186, P280, DOI 10.1016/0003-2697(90)90080-S; LEPPIK RA, 1982, BIOCHEM J, V202, P747, DOI 10.1042/bj2020747; Marrero J, 2010, P NATL ACAD SCI USA, V107, P9819, DOI 10.1073/pnas.1000715107; McKinney JD, 2000, NATURE, V406, P735, DOI 10.1038/35021074; MICLO A, 1992, APPL MICROBIOL BIOT, V36, P456; MINCIONE E, 1989, SYNTHETIC COMMUN, V19, P723, DOI 10.1080/00397918908050987; Munoz-Elias EJ, 2006, MOL MICROBIOL, V60, P1109, DOI 10.1111/j.1365-2958.2006.05155.x; NAKAMATSU T, 1980, AGR BIOL CHEM TOKYO, V44, P1469, DOI 10.1080/00021369.1980.10864160; Nesbitt NM, 2010, INFECT IMMUN, V78, P275, DOI 10.1128/IAI.00893-09; Ouellet H, 2010, MOL MICROBIOL, V77, P730, DOI 10.1111/j.1365-2958.2010.07243.x; Pandey AK, 2008, P NATL ACAD SCI USA, V105, P4376, DOI 10.1073/pnas.0711159105; POPJAK G, 1977, J AM CHEM SOC, V99, P931, DOI 10.1021/ja00445a041; POPJAK G, 1966, BIOCHEM J, V101, P553, DOI 10.1042/bj1010553; POPJAK G, 1961, J BIOL CHEM, V236, P1934; Russell DG, 2009, NAT IMMUNOL, V10, P943, DOI 10.1038/ni.1781; SEGAL W, 1956, J BACTERIOL, V72, P132, DOI 10.1128/JB.72.2.132-141.1956; SIH CJ, 1968, BIOCHEMISTRY-US, V7, P808, DOI 10.1021/bi00842a039; Sim E, 2008, CURR DRUG METAB, V9, P510, DOI 10.2174/138920008784892100; SLOMP G, 1958, J AM CHEM SOC, V80, P915, DOI 10.1021/ja01537a041; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; van der Geize R, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002181; Van der Geize R, 2007, P NATL ACAD SCI USA, V104, P1947, DOI 10.1073/pnas.0605728104; World Health Organisation, 2011, WHOHTMTB201116; Yam KC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000344; Yang XX, 2007, BIOCHEMISTRY-US, V46, P9058, DOI 10.1021/bi700688x	46	74	82	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2011	286	51					43668	43678		10.1074/jbc.M111.313643	http://dx.doi.org/10.1074/jbc.M111.313643			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866SH	22045806	Green Published, hybrid			2022-12-27	WOS:000298402300010
J	Williams, KC; Coppolino, MG				Williams, Karla C.; Coppolino, Marc G.			Phosphorylation of Membrane Type 1-Matrix Metalloproteinase (MT1-MMP) and Its Vesicle-associated Membrane Protein 7 (VAMP7)-dependent Trafficking Facilitate Cell Invasion and Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							I-MATRIX-METALLOPROTEINASE; HUMAN ENDOTHELIAL-CELLS; EXTRACELLULAR-MATRIX; PERICELLULAR PROTEOLYSIS; CANCER INVASION; TUMOR-CELLS; KINASE-C; ACTIVATION; DEGRADATION; PROGRESSION	In multicellular organisms, uncontrolled movement of cells can contribute to pathological conditions, such as multiple sclerosis and cancer. In highly aggressive tumors, the expression of matrix metalloproteinases (MMPs) is linked to the capacity of tumor cells to invade surrounding tissue and current research indicates that the membrane-anchored membrane type 1-matrix metalloproteinase (MT1-MMP) has a central role in this process. Endocytosis and trafficking of MT1-MMP are essential for its proper function, and here we examine the phosphorylation, internalization, and recycling of this enzyme, and the associated biochemical signaling in HeLa and HT-1080 fibrosarcoma cells. Activation of protein kinase C with phorbol 12-myristate 13-acetate resulted in phosphorylation of endogenous MT1-MMP at Thr(567) in vivo. Mutation of Thr(567) to alanine (to mimic non-phosphorylated MT1-MMP) reduced internalization of MT1-MMP, whereas mutation of Thr(567) to glutamic acid (to mimic phosphorylation) resulted in decreased levels of MT1-MMP on the cell surface. The endosomal trafficking and recycling of MT1-MMP was found to be dependent upon Rab7 and VAMP7, and blocking the function of these proteins reduced cell migration and invasion. Intracellular trafficking of MT1-MMP was observed to be coupled to the trafficking of integrin alpha 5 and phosphorylation of ERK that coincided with this was dependent on phosphorylation of MT1-MMP. Together, these results reveal important roles for MT1-MMP phosphorylation and trafficking in both cell signaling and cell invasion.	[Williams, Karla C.; Coppolino, Marc G.] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada	University of Guelph	Coppolino, MG (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada.	mcoppoli@uoguelph.ca		Williams, Karla/0000-0003-2954-2869	Natural Sciences and Engineering Research Council of Canada (NSERC); Ontario Ministry of Research and Innovation	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario)	This work was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC) and the Ontario Ministry of Research and Innovation.; Recipent of an NSERC scholarship.	Baciu PC, 2003, EXP CELL RES, V291, P167, DOI 10.1016/S0014-4827(03)00387-2; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Bravo-Cordero JJ, 2007, EMBO J, V26, P1499, DOI 10.1038/sj.emboj.7601606; Cho JA, 2008, J BIOL CHEM, V283, P17391, DOI 10.1074/jbc.M708943200; D'Alessio S, 2008, J BIOL CHEM, V283, P87, DOI 10.1074/jbc.M705492200; de Araujo Mariana Eca Guimaraes, 2008, V424, P317, DOI 10.1007/978-1-60327-064-9_25; Galvez BG, 2004, MOL BIOL CELL, V15, P678, DOI 10.1091/mbc.E03-07-0516; Galvez BG, 2002, J CELL BIOL, V159, P509, DOI 10.1083/jcb.200205026; Gialeli C, 2011, FEBS J, V278, P16, DOI 10.1111/j.1742-4658.2010.07919.x; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; Hadler-Olsen E, 2011, FEBS J, V278, P28, DOI 10.1111/j.1742-4658.2010.07920.x; Itoh Y, 2006, IUBMB LIFE, V58, P589, DOI 10.1080/15216540600962818; Kean MJ, 2009, J CELL SCI, V122, P4089, DOI 10.1242/jcs.052761; Langlois S, 2007, MOL CANCER RES, V5, P569, DOI 10.1158/1541-7786.MCR-06-0267; Linder S, 2007, TRENDS CELL BIOL, V17, P107, DOI 10.1016/j.tcb.2007.01.002; McKenzie JA, 2010, CANCER RES, V70, P7927, DOI 10.1158/0008-5472.CAN-10-0194; Mierke CT, 2011, J CELL SCI, V124, P369, DOI 10.1242/jcs.071985; Miyata T, 2004, BIOCHEM BIOPH RES CO, V323, P118, DOI 10.1016/j.bbrc.2004.08.064; Moss NM, 2009, CANCER RES, V69, P7121, DOI 10.1158/0008-5472.CAN-08-4151; Moss NM, 2009, J BIOL CHEM, V284, P19791, DOI 10.1074/jbc.M109.020362; Newton PM, 2010, BIOCHEM J, V427, P189, DOI 10.1042/BJ20091302; Nyalendo C, 2007, J BIOL CHEM, V282, P15690, DOI 10.1074/jbc.M608045200; Nyalendo C, 2010, ANTICANCER RES, V30, P1887; Proux-Gillardeaux V, 2005, P NATL ACAD SCI USA, V102, P6362, DOI 10.1073/pnas.0409613102; Remacle A, 2003, J CELL SCI, V116, P3905, DOI 10.1242/jcs.00710; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Sabeh F, 2004, J CELL BIOL, V167, P769, DOI 10.1083/jcb.200408028; Sabeh F, 2009, J CELL BIOL, V185, P11, DOI 10.1083/jcb.200807195; Sato H, 2005, CANCER SCI, V96, P212, DOI 10.1111/j.1349-7006.2005.00039.x; SATO H, 1994, NATURE, V370, P61, DOI 10.1038/370061a0; Seftor REB, 2001, CANCER RES, V61, P6322; Seiki M, 2003, CANCER SCI, V94, P569, DOI 10.1111/j.1349-7006.2003.tb01484.x; Shin S, 2010, MOL CELL, V38, P114, DOI 10.1016/j.molcel.2010.02.020; Skalski M, 2005, BIOCHEM BIOPH RES CO, V335, P1199, DOI 10.1016/j.bbrc.2005.07.195; Sodek KL, 2007, BRIT J CANCER, V97, P358, DOI 10.1038/sj.bjc.6603863; Sounni NE, 2003, MATRIX BIOL, V22, P55, DOI 10.1016/S0945-053X(03)00003-9; Steffen A, 2008, CURR BIOL, V18, P926, DOI 10.1016/j.cub.2008.05.044; Strongin AY, 2010, BBA-MOL CELL RES, V1803, P133, DOI 10.1016/j.bbamcr.2009.04.009; Takino T, 2006, EXP CELL RES, V312, P1381, DOI 10.1016/j.yexcr.2006.01.008; Takino T, 2004, CANCER RES, V64, P1044, DOI 10.1158/0008-5472.CAN-03-1843; Tanimura S, 2003, BIOCHEM BIOPH RES CO, V304, P801, DOI 10.1016/S0006-291X(03)00670-3; Tayeb MA, 2005, EXP CELL RES, V305, P63, DOI 10.1016/j.yexcr.2004.12.004; Uekita T, 2001, J CELL BIOL, V155, P1345, DOI 10.1083/jcb.200108112; Wang X, 2004, J BIOL CHEM, V279, P9331, DOI 10.1074/jbc.M312369200; Weaver AM, 2006, CLIN EXP METASTAS, V23, P97, DOI 10.1007/s10585-006-9014-1; Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006; Zhai YL, 2005, CANCER RES, V65, P6543, DOI 10.1158/0008-5472.CAN-05-0231; Zucker S, 1999, ANN NY ACAD SCI, V878, P212, DOI 10.1111/j.1749-6632.1999.tb07687.x; Zucker S, 2002, LAB INVEST, V82, P1673, DOI 10.1097/01.LAB.0000041713.74852.2A	49	88	88	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					43405	43416		10.1074/jbc.M111.297069	http://dx.doi.org/10.1074/jbc.M111.297069			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22002060	hybrid, Green Published			2022-12-27	WOS:000298351300060
J	Palacios, L; Dickinson, RJ; Sacristan-Reviriego, A; Didmon, MP; Marin, MJ; Martin, H; Keyse, SM; Molina, M				Palacios, Lorena; Dickinson, Robin J.; Sacristan-Reviriego, Almudena; Didmon, Mark P.; Jose Marin, Maria; Martin, Humberto; Keyse, Stephen M.; Molina, Maria			Distinct Docking Mechanisms Mediate Interactions between the Msg5 Phosphatase and Mating or Cell Integrity Mitogen-activated Protein Kinases (MAPKs) in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DUAL-SPECIFICITY PHOSPHATASE; TYROSINE PHOSPHATASES; INTERACTION MOTIF; PTP-SL; DIFFERENTIAL REGULATION; CATALYTIC ACTIVATION; STE5 SCAFFOLD; YEAST; PATHWAY; SITES	MAPK phosphatases (MKPs) are negative regulators of signaling pathways with distinct MAPK substrate specificities. For example, the yeast dual specificity phosphatase Msg5 dephosphorylates the Fus3 and Slt2 MAPKs operating in the mating and cell wall integrity pathways, respectively. Like other MAPK-interacting proteins, most MKPs bind MAPKs through specific docking domains. These include D-motifs, which contain basic residues that interact with acidic residues in the common docking (CD) domain of MAPKs. Here we show that Msg5 interacts not only with Fus3, Kss1, and Slt2 but also with the pseudokinase Slt2 paralog Mlp1. Using yeast two-hybrid and in vitro interaction assays, we have identified distinct regions within the N-terminal domain of Msg5 that differentially bind either the MAPKs Fus3 and Kss1 or Slt2 and Mlp1. Whereas a canonical D-site within Msg5 mediates interaction with the CD domains of Fus3 and Kss1, a novel motif ((IYT104)-I-102) within Msg5 is involved in binding to Slt2 and Mlp1. Furthermore, mutation of this site prevents the phosphorylation of Msg5 by Slt2. This motif is conserved in Sdp1, another MKP that dephosphorylates Slt2, as well as in Msg5 orthologs from other yeast species. A region spanning amino acids 274-373 within Slt2 and Mlp1 mediates binding to this Msg5 motif in a CD domain-independent manner. In contrast, Slt2 uses its CD domain to bind to its upstream activator Mkk1. This binding flexibility may allow MAPK pathways to exploit additional regulatory controls in order to provide fine modulation of both pathway activity and specificity.	[Dickinson, Robin J.; Didmon, Mark P.; Keyse, Stephen M.] Univ Dundee, Ninewells Hosp & Med Sch, CR UK Stress Response Lab, Med Res Inst, Dundee DD1 9SY, Scotland; [Palacios, Lorena; Sacristan-Reviriego, Almudena; Jose Marin, Maria; Martin, Humberto; Molina, Maria] Univ Complutense Madrid, Fac Farm, Dept Microbiol 2, E-28040 Madrid, Spain; [Palacios, Lorena; Sacristan-Reviriego, Almudena; Jose Marin, Maria; Martin, Humberto; Molina, Maria] Inst Ramon & Cajal Invest Sanitarias, Madrid 28040, Spain	University of Dundee; Complutense University of Madrid	Keyse, SM (corresponding author), Univ Dundee, Ninewells Hosp & Med Sch, CR UK Stress Response Lab, Med Res Inst, Dundee DD1 9SY, Scotland.	s.m.keyse@dundee.ac.uk; molmifa@farm.ucm.es	Brieva, Humberto Martin/E-9254-2016; Martín, Humberto/Z-3423-2019; Molina, Maria/ABE-7186-2021; Keyse, Stephen M./B-9575-2009	Brieva, Humberto Martin/0000-0002-6736-3602; Martín, Humberto/0000-0002-6736-3602; Molina, Maria/0000-0003-0074-3309; Keyse, Stephen M./0000-0002-5150-8221	Ministerio de Ciencia e Innovacion (Spain) [BIO2007-67299, BIO2010-22369-C02-01]; BSCH-UCM [920628]; Cancer Research UK [C8227/A12053]; Cancer Research UK [12053] Funding Source: researchfish	Ministerio de Ciencia e Innovacion (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); BSCH-UCM; Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK)	This work was supported by Ministerio de Ciencia e Innovacion (Spain) Grants BIO2007-67299 and BIO2010-22369-C02-01 and Program for UCM Research Groups Grant 920628 from BSCH-UCM (to M. M.). Research in the CR-UK Stress Response Laboratory (to R. J. D., M. P. D., and S. M. K.) is supported by Cancer Research UK Program Grant C8227/A12053 (to S. M. K.).	Aberg E, 2009, J BIOL CHEM, V284, P19392, DOI 10.1074/jbc.M109.023283; Akella R, 2008, BBA-PROTEINS PROTEOM, V1784, P48, DOI 10.1016/j.bbapap.2007.09.016; Andersson J, 2004, EMBO J, V23, P2564, DOI 10.1038/sj.emboj.7600250; Aoyama K, 2001, J BIOL CHEM, V276, P27575, DOI 10.1074/jbc.M100408200; Bardwell L, 2006, BIOCHEM SOC T, V34, P837, DOI 10.1042/BST0340837; Bardwell L, 2006, METHODS, V40, P213, DOI 10.1016/j.ymeth.2006.06.008; Bhattacharyya RP, 2006, SCIENCE, V311, P822, DOI 10.1126/science.1120941; Caffrey DR, 1999, J MOL EVOL, V49, P567, DOI 10.1007/PL00006578; Camps M, 1998, SCIENCE, V280, P1262, DOI 10.1126/science.280.5367.1262; Chang CI, 2002, MOL CELL, V9, P1241, DOI 10.1016/S1097-2765(02)00525-7; Chen RE, 2007, BBA-MOL CELL RES, V1773, P1311, DOI 10.1016/j.bbamcr.2007.05.003; Collister M, 2002, FEBS LETT, V527, P186, DOI 10.1016/S0014-5793(02)03220-9; Coulombe P, 2007, BBA-MOL CELL RES, V1773, P1376, DOI 10.1016/j.bbamcr.2006.11.001; Diskin R, 2007, J MOL BIOL, V365, P66, DOI 10.1016/j.jmb.2006.08.043; DOI K, 1994, EMBO J, V13, P61, DOI 10.1002/j.1460-2075.1994.tb06235.x; Flandez M, 2004, J BIOL CHEM, V279, P11027, DOI 10.1074/jbc.M306412200; Fox GC, 2007, NATURE, V447, P487, DOI 10.1038/nature05804; Garcia R, 2004, J BIOL CHEM, V279, P15183, DOI 10.1074/jbc.M312954200; Grewal S, 2006, CELL SIGNAL, V18, P123, DOI 10.1016/j.cellsig.2005.04.001; Hahn JS, 2002, J BIOL CHEM, V277, P21278, DOI 10.1074/jbc.M202557200; Jacobs D, 1999, GENE DEV, V13, P163, DOI 10.1101/gad.13.2.163; Jimenez-Sanchez M, 2007, J BIOL CHEM, V282, P31174, DOI 10.1074/jbc.M706270200; Jung US, 2002, MOL MICROBIOL, V46, P781, DOI 10.1046/j.1365-2958.2002.03198.x; Khokhlatchev AV, 1998, CELL, V93, P605, DOI 10.1016/S0092-8674(00)81189-7; Kim KY, 2008, MOL CELL BIOL, V28, P2579, DOI 10.1128/MCB.01795-07; Kim KY, 2007, YEAST, V24, P335, DOI 10.1002/yea.1475; Kusari AB, 2004, J CELL BIOL, V164, P267, DOI 10.1083/jcb.200310021; Lee T, 2004, MOL CELL, V14, P43, DOI 10.1016/S1097-2765(04)00161-3; Levin-Salomon V, 2009, BIOCHEM J, V417, P331, DOI 10.1042/BJ20081335; Lin YW, 2006, J BIOL CHEM, V281, P915, DOI 10.1074/jbc.M508720200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marin MJ, 2009, MOL GENET GENOMICS, V281, P345, DOI 10.1007/s00438-008-0415-5; Martin H, 2005, MOL MICROBIOL, V58, P6, DOI 10.1111/j.1365-2958.2005.04822.x; Martin H, 2000, J BIOL CHEM, V275, P1511, DOI 10.1074/jbc.275.2.1511; Mayor F, 2007, CELL CYCLE, V6, P528, DOI 10.4161/cc.6.5.3920; Munoz JJ, 2003, BIOCHEM J, V372, P193, DOI 10.1042/BJ20021941; Owens DM, 2007, ONCOGENE, V26, P3203, DOI 10.1038/sj.onc.1210412; Patterson KI, 2009, BIOCHEM J, V418, P475, DOI 10.1042/BJ20082234; Pulido R, 1998, EMBO J, V17, P7337, DOI 10.1093/emboj/17.24.7337; Remenyi A, 2005, MOL CELL, V20, P951, DOI 10.1016/j.molcel.2005.10.030; Limardo RGR, 2011, BIOCHEMISTRY-US, V50, P1384, DOI 10.1021/bi1007518; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Slack DN, 2001, J BIOL CHEM, V276, P16491, DOI 10.1074/jbc.M010966200; Tanoue T, 2002, PHARMACOL THERAPEUT, V93, P193, DOI 10.1016/S0163-7258(02)00188-2; Tanoue T, 2002, J BIOL CHEM, V277, P22942, DOI 10.1074/jbc.M202096200; Tanoue T, 2000, NAT CELL BIOL, V2, P110, DOI 10.1038/35000065; Tanoue TJ, 2003, CELL SIGNAL, V15, P455, DOI 10.1016/S0898-6568(02)00112-2; Truman AW, 2006, EUKARYOT CELL, V5, P1914, DOI 10.1128/EC.00263-06; Truman AW, 2009, MOL CELL BIOL, V29, P6449, DOI 10.1128/MCB.00794-09; Turjanski AG, 2007, ONCOGENE, V26, P3240, DOI 10.1038/sj.onc.1210415; Zhan XL, 1997, GENE DEV, V11, P1690, DOI 10.1101/gad.11.13.1690; Zhou TJ, 2006, STRUCTURE, V14, P1011, DOI 10.1016/j.str.2006.04.006; Zuniga A, 1999, J BIOL CHEM, V274, P21900, DOI 10.1074/jbc.274.31.21900	53	13	15	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42037	42050		10.1074/jbc.M111.286948	http://dx.doi.org/10.1074/jbc.M111.286948			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	22006927	hybrid, Green Published			2022-12-27	WOS:000298180900014
J	Burian, J; Ramon-Garcia, S; Sweet, G; Gomez-Velasco, A; Av-Gay, Y; Thompson, CJ				Burian, Jan; Ramon-Garcia, Santiago; Sweet, Gaye; Gomez-Velasco, Anaximandro; Av-Gay, Yossef; Thompson, Charles J.			The Mycobacterial Transcriptional Regulator whiB7 Gene Links Redox Homeostasis and Intrinsic Antibiotic Resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; MACROLIDE RESISTANCE; SIGMA FACTORS; TUBERCULOSIS; MECHANISMS; SMEGMATIS; EXPRESSION; MYCOTHIOL; PROTEINS; BIOSYNTHESIS	Intrinsic drug resistance in Mycobacterium tuberculosis limits therapeutic options for treating tuberculosis. The mycobacterial transcriptional regulator whiB7 contributes to intrinsic resistance by activating its own expression and many drug resistance genes in response to antibiotics. To investigate whiB7 activation, we constructed a GFP reporter to monitor its expression, and we used it to investigate the whiB7 promoter and to screen our custom library of almost 600 bioactive compounds, including the majority of clinical antibiotics. Results showed whiB7 was transcribed from a promoter that was conserved across mycobacteria and other actinomycetes, including an AT-rich sequence that was likely targeted by WhiB7. Expression was induced by compounds having diverse structures and targets, independent of the ability of whiB7 to mediate resistance, and was dependent on media composition. Pretreatment with whiB7 activators resulted in clinically relevant increases in intrinsic drug resistance. Antibiotic-induced transcription was synergistically increased by the reductant dithiothreitol, an effect mirrored by a whiB7-dependent shift to a highly reduced cytoplasm reflected by the ratio of reduced/oxidized mycothiol. These data provided evidence that intrinsic resistance resulting from whiB7 activation is linked to fundamental changes in cell metabolism.	[Burian, Jan; Ramon-Garcia, Santiago; Sweet, Gaye; Av-Gay, Yossef; Thompson, Charles J.] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z3, Canada; [Burian, Jan; Ramon-Garcia, Santiago; Sweet, Gaye; Gomez-Velasco, Anaximandro; Av-Gay, Yossef; Thompson, Charles J.] Univ British Columbia, Ctr TB Res, Vancouver, BC V6T 1Z3, Canada; [Gomez-Velasco, Anaximandro; Av-Gay, Yossef] Univ British Columbia, Dept Med, Div Infect Dis, Vancouver, BC V6T 1Z3, Canada	University of British Columbia; University of British Columbia; University of British Columbia	Thompson, CJ (corresponding author), Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z3, Canada.	charles.thompson@ubc.ca	ramon, santi/C-6077-2013; Gómez-Velasco, Anaximandro/AAZ-7915-2021; Ramon Garcia, Santiago/V-8242-2017; Av-Gay, Yossef/H-5128-2019; Av-Gay, Yossef/H-2311-2014; Gómez-Velasco, Anaximandro/E-7951-2019	ramon, santi/0000-0002-8480-0325; Ramon Garcia, Santiago/0000-0002-8480-0325; Av-Gay, Yossef/0000-0002-9547-0237; 	Canadian Institute of Health Research [MOP-82855]	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institute of Health Research Grant MOP-82855 (to C.J.T.).	Alam MS, 2009, FEBS J, V276, P76, DOI 10.1111/j.1742-4658.2008.06755.x; Bajorath J, 2001, J CHEM INF COMP SCI, V41, P233, DOI 10.1021/ci0001482; Boshoff HIM, 2008, J BIOL CHEM, V283, P19329, DOI 10.1074/jbc.M800694200; Boshoff HIM, 2004, J BIOL CHEM, V279, P40174, DOI 10.1074/jbc.M406796200; Brazas MD, 2005, DRUG DISCOV TODAY, V10, P1245, DOI 10.1016/S1359-6446(05)03566-X; Buriankova K, 2004, ANTIMICROB AGENTS CH, V48, P143, DOI 10.1128/AAC.48.1.143-150.2004; Fischbach MA, 2009, SCIENCE, V325, P1089, DOI 10.1126/science.1176667; Geiman DE, 2006, ANTIMICROB AGENTS CH, V50, P2836, DOI 10.1128/AAC.00295-06; Goh EB, 2002, P NATL ACAD SCI USA, V99, P17025, DOI 10.1073/pnas.252607699; Gomez JE, 2000, P NATL ACAD SCI USA, V97, P8554, DOI 10.1073/pnas.140225297; Green J, 2004, NAT REV MICROBIOL, V2, P954, DOI 10.1038/nrmicro1022; Homolka S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000988; Kaps I, 2001, GENE, V278, P115, DOI 10.1016/S0378-1119(01)00712-0; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Louw GE, 2011, AM J RESP CRIT CARE, V184, P269, DOI 10.1164/rccm.201011-1924OC; MEIGHEN EA, 1991, MICROBIOL REV, V55, P123, DOI 10.1128/MMBR.55.1.123-142.1991; Mendoza-Vargas A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007526; Mesak LR, 2009, PLASMID, V61, P182, DOI 10.1016/j.plasmid.2009.01.003; Morris RP, 2005, P NATL ACAD SCI USA, V102, P12200, DOI 10.1073/pnas.0505446102; Murakami T, 2011, P NATL ACAD SCI USA, V108, P16020, DOI 10.1073/pnas.1108124108; Nash KA, 2003, ANTIMICROB AGENTS CH, V47, P3053, DOI 10.1128/AAC.47.10.3053-3060.2003; Newton GL, 2008, MICROBIOL MOL BIOL R, V72, P471, DOI 10.1128/MMBR.00008-08; Nguyen L, 2006, TRENDS MICROBIOL, V14, P304, DOI 10.1016/j.tim.2006.05.005; Nishino K, 2009, BBA-PROTEINS PROTEOM, V1794, P834, DOI 10.1016/j.bbapap.2009.02.002; Poole K, 2001, J PHARM PHARMACOL, V53, P283, DOI 10.1211/0022357011775514; Ramon-Garcia S, 2011, ANTIMICROB AGENTS CH, V55, P3861, DOI 10.1128/AAC.00474-11; Rawat M, 2002, ANTIMICROB AGENTS CH, V46, P3348, DOI 10.1128/AAC.46.11.3348-3355.2002; REEVES R, 1990, J BIOL CHEM, V265, P8573; Rodrigue S, 2006, FEMS MICROBIOL REV, V30, P926, DOI 10.1111/j.1574-6976.2006.00040.x; Rybniker J, 2010, MOL MICROBIOL, V77, P642, DOI 10.1111/j.1365-2958.2010.07235.x; Sachdeva P, 2010, FEBS J, V277, P605, DOI 10.1111/j.1742-4658.2009.07479.x; San KY, 2002, METAB ENG, V4, P182, DOI 10.1006/mben.2001.0220; Singh A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000545; Smith LJ, 2010, BIOCHEM J, V432, P417, DOI 10.1042/BJ20101440; Smulski DR, 2001, J BACTERIOL, V183, P3353, DOI 10.1128/JB.183.11.3353-3364.2001; SNAPPER SB, 1990, MOL MICROBIOL, V4, P1911, DOI 10.1111/j.1365-2958.1990.tb02040.x; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Ung KSE, 2006, FEBS LETT, V580, P2712, DOI 10.1016/j.febslet.2006.04.026; VANBOGELEN RA, 1990, P NATL ACAD SCI USA, V87, P5589, DOI 10.1073/pnas.87.15.5589; Venketaraman V, 2005, INFECT IMMUN, V73, P1886, DOI 10.1128/IAI.73.3.1886-1889.2005; Walsh C, 2000, NATURE, V406, P775, DOI 10.1038/35021219; Wecke T, 2011, J ANTIMICROB CHEMOTH, V66, P2689, DOI 10.1093/jac/dkr373; Zaunbrecher MA, 2009, P NATL ACAD SCI USA, V106, P20004, DOI 10.1073/pnas.0907925106	43	71	78	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					299	310		10.1074/jbc.M111.302588	http://dx.doi.org/10.1074/jbc.M111.302588			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22069311	Green Published, hybrid			2022-12-27	WOS:000298682400030
J	Goyal, R; Das, AK; Singh, R; Singh, PK; Korpole, S; Sarkar, D				Goyal, Rajni; Das, Arijit Kumar; Singh, Ranjeet; Singh, Pradip K.; Korpole, Suresh; Sarkar, Dibyendu			Phosphorylation of PhoP Protein Plays Direct Regulatory Role in Lipid Biosynthesis of Mycobacterium tuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-TRANSDUCTION; GENE; VIRULENCE; EXPRESSION; SYSTEM; RECOGNITION; PERSISTENCE; ACYLTREHALOSES; AUTOREGULATION; IDENTIFICATION	Mycobacterium tuberculosis PhoP is essential for virulence and intracellular growth of the tubercle bacilli. Genetic evidence suggests that PhoP regulates complex lipid biosynthesis, and absence of some of these lipid molecules in a phoP mutant partly accounts for its attenuated growth in macrophages and/or mice. To investigate the mechanism of regulation, here we demonstrate the essentiality of phosphorylation of PhoP in the regulation of complex lipid biosynthesis. We show that phosphorylated PhoP activates transcription of pks2 and msl3, gene(s) encoding polyketide beta-ketoacyl synthases through direct DNA binding at the upstream regulatory region(s) of the target genes. Our results identify the genetic determinants recognized by PhoP and show that activation of target genes requires interaction( s) of the phosphorylated regulator at the cognate binding sites. The fact that these sites within the regulatory region of respective genes do not bind in vitro with either unphosphorylated or phosphorylation-deficient PhoP protein is consistent with phosphorylation-dependent assembly of the transcription initiation complex leading to in vivo transcriptional activation. Together, these results reveal so far unknown molecular mechanisms of how PhoP contributes to M. tuberculosis cell wall composition by regulating complex lipid biosynthesis.	[Goyal, Rajni; Das, Arijit Kumar; Singh, Ranjeet; Singh, Pradip K.; Korpole, Suresh; Sarkar, Dibyendu] CSIR, Inst Microbial Technol, Chandigarh 160036, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Sarkar, D (corresponding author), CSIR, Inst Microbial Technol, Sect 39 A, Chandigarh 160036, India.	dibyendu@imtech.res.in	singh, pradip/ACF-9094-2022; Singh, Pradip_not in use../GLR-1752-2022; Singh, Ranjeet/Y-8408-2019	Singh, Pradip_not in use../0000-0003-0551-6877; 	Council of Scientific and Industrial Research [SIP-10]; Department of Biotechnology; Department of Science and Technology, Government of India	Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology; Department of Science and Technology, Government of India(Department of Science & Technology (India))	This work was supported in part by Council of Scientific and Industrial Research Supra Institutional Project SIP-10 and by research grants from the Department of Biotechnology and Department of Science and Technology, Government of India (to D.S.).	Abramovitch RB, 2011, MOL MICROBIOL, V80, P678, DOI 10.1111/j.1365-2958.2011.07601.x; Asensio JG, 2006, J BIOL CHEM, V281, P1313, DOI 10.1074/jbc.C500388200; Av-Gay Y, 2005, TUBERCULOSIS AND THE TUBERCLE BACILLUS, P359; Besra GS, 1998, METH MOL B, V101, P91, DOI 10.1385/0-89603-471-2:91; Betts JC, 2002, MOL MICROBIOL, V43, P717, DOI 10.1046/j.1365-2958.2002.02779.x; Bijisma JJE, 2003, TRENDS MICROBIOL, V11, P359, DOI 10.1016/S0966-842X(03)00176-8; Blanco AG, 2002, STRUCTURE, V10, P701, DOI 10.1016/S0969-2126(02)00761-X; BOWTELL D, 2003, DNA MICROARRAYS MOL; Brodin P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001100; Chesne-Seck ML, 2008, J BACTERIOL, V190, P1329, DOI 10.1128/JB.01465-07; Converse SE, 2003, P NATL ACAD SCI USA, V100, P6121, DOI 10.1073/pnas.1030024100; Domenech P, 2004, J BIOL CHEM, V279, P21257, DOI 10.1074/jbc.M400324200; Dubey VS, 2002, MOL MICROBIOL, V45, P1451, DOI 10.1046/j.1365-2958.2002.03119.x; Dussurget O, 1999, J BACTERIOL, V181, P3402, DOI 10.1128/JB.181.11.3402-3408.1999; Ehrt S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni013; Ewann F, 2004, MICROBIOL-SGM, V150, P241, DOI 10.1099/mic.0.26516-0; Ferrer NL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012978; Frigui W, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040033; Gao R, 2007, TRENDS BIOCHEM SCI, V32, P225, DOI 10.1016/j.tibs.2007.03.002; Gao R, 2010, CURR OPIN MICROBIOL, V13, P160, DOI 10.1016/j.mib.2009.12.009; Glickman MS, 2000, MOL CELL, V5, P717, DOI 10.1016/S1097-2765(00)80250-6; Gonzalo-Asensio J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003496; Goude Renan, 2008, V465, P203, DOI [10.1007/978-1-59745-207-6_13, 10.3791/761]; Graham JE, 1999, P NATL ACAD SCI USA, V96, P11554, DOI 10.1073/pnas.96.20.11554; Gupta S, 2006, FEBS LETT, V580, P5328, DOI 10.1016/j.febslet.2006.09.004; Gupta S, 2009, J BACTERIOL, V191, P7466, DOI 10.1128/JB.00669-09; He HJ, 2005, J BACTERIOL, V187, P202, DOI 10.1128/JB.187.1.202-212.2005; Hu JM, 1999, J BACTERIOL, V181, P469, DOI 10.1128/JB.181.2.469-476.1999; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Lee JS, 2008, CELL HOST MICROBE, V3, P97, DOI 10.1016/j.chom.2008.01.002; Lejona S, 2004, J BACTERIOL, V186, P2476, DOI 10.1128/JB.186.8.2476-2480.2004; Li AH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011066; Ludwiczak P, 2002, MICROBIOL-SGM, V148, P3029, DOI 10.1099/00221287-148-10-3029; Manganelli R, 1999, MOL MICROBIOL, V31, P715, DOI 10.1046/j.1365-2958.1999.01212.x; Mannan MAU, 2009, ANAL BIOCHEM, V389, P77, DOI 10.1016/j.ab.2009.03.014; Martin C, 2006, VACCINE, V24, P3408, DOI 10.1016/j.vaccine.2006.03.017; Martin JF, 2004, J BACTERIOL, V186, P5197, DOI 10.1128/JB.186.16.5197-5201.2004; Menon S, 2011, BIOCHEMISTRY-US, V50, P5948, DOI 10.1021/bi2005575; Nowak E, 2006, J BIOL CHEM, V281, P9659, DOI 10.1074/jbc.M512004200; Pathak A, 2010, J BIOL CHEM, V285, P34309, DOI 10.1074/jbc.M110.135822; Perez E, 2001, MOL MICROBIOL, V41, P179, DOI 10.1046/j.1365-2958.2001.02500.x; Rousseau C, 2003, INFECT IMMUN, V71, P4684, DOI 10.1128/IAI.71.8.4684-4690.2003; Rousseau C, 2003, CELL MICROBIOL, V5, P405, DOI 10.1046/j.1462-5822.2003.00289.x; Ryndak M, 2008, TRENDS MICROBIOL, V16, P528, DOI 10.1016/j.tim.2008.08.006; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Sherman DR, 2001, P NATL ACAD SCI USA, V98, P7534, DOI 10.1073/pnas.121172498; Sinha A, 2008, J BACTERIOL, V190, P1317, DOI 10.1128/JB.01074-07; Sirakova TD, 2001, J BIOL CHEM, V276, P16833, DOI 10.1074/jbc.M011468200; SNAPPER SB, 1990, MOL MICROBIOL, V4, P1911, DOI 10.1111/j.1365-2958.1990.tb02040.x; Sola-Landa A, 2003, P NATL ACAD SCI USA, V100, P6133, DOI 10.1073/pnas.0931429100; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; TIMM JL, 1994, J BACTERIOL, V176, P6749, DOI 10.1128/JB.176.21.6749-6753.1994; Voskuil MI, 2003, J EXP MED, V198, P705, DOI 10.1084/jem.20030205; Walters SB, 2006, MOL MICROBIOL, V60, P312, DOI 10.1111/j.1365-2958.2006.05102.x; Wang S, 2007, BIOCHEMISTRY-US, V46, P14751, DOI 10.1021/bi700970a; Zahrt TC, 2001, P NATL ACAD SCI USA, V98, P12706, DOI 10.1073/pnas.221272198; Zhao H, 2002, STRUCTURE, V10, P1041, DOI 10.1016/S0969-2126(02)00803-1	57	30	34	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2011	286	52					45197	45208		10.1074/jbc.M111.307447	http://dx.doi.org/10.1074/jbc.M111.307447			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870CA	22072719	Green Published, hybrid			2022-12-27	WOS:000298645500085
J	Hartney, JM; Gustafson, CE; Bowler, RP; Pelanda, R; Torres, RM				Hartney, John M.; Gustafson, Claire E.; Bowler, Russell P.; Pelanda, Roberta; Torres, Raul M.			Thromboxane Receptor Signaling Is Required for Fibronectin-induced Matrix Metalloproteinase 9 Production by Human and Murine Macrophages and Is Attenuated by the Arhgef1 Molecule	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARACHIDONIC-ACID METABOLISM; NECROSIS-FACTOR-ALPHA; EXTRACELLULAR-MATRIX; PROSTAGLANDIN E-2; HUMAN MONOCYTES; LYSOPHOSPHATIDIC ACID; PROSTANOID RECEPTORS; IMMUNE-RESPONSES; GENE-EXPRESSION; CELL-MIGRATION	During an inflammatory response, resident and newly recruited tissue macrophages adhere to extracellular matrix and cell-bound integrin ligands. This interaction induces the expression of pro-inflammatory mediators that include matrix metalloproteinases (MMPs). Arhgef1 is an intracellular signaling molecule expressed by myeloid cells that normally attenuates murine macrophage MMP production in vivo and in vitro after cell culture on the extracellular matrix protein, fibronectin. In this study, we have extended the characterization of this fibronectin-induced Arhgef1-regulated signaling pathway in both human and murine myeloid cells. Our results show that MMP9 production by fibronectin-stimulated monocytes and macrophages depends on autocrine thromboxane receptor signaling and that under normal conditions, this signaling pathway is attenuated by Arhgef1. Finally, we show that the expression of ARHGEF1 by human peripheral blood monocytes varies between individuals and inversely correlates with fibronectin-mediated MMP9 production.	[Hartney, John M.; Gustafson, Claire E.; Pelanda, Roberta; Torres, Raul M.] Natl Jewish Hlth, Integrated Dept Immunol, Denver, CO 80206 USA; [Bowler, Russell P.] Natl Jewish Hlth, Dept Med, Denver, CO 80206 USA; [Bowler, Russell P.] Univ Colorado, Sch Med, Denver, CO 80206 USA	National Jewish Health; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Torres, RM (corresponding author), 1400 Jackson St,K810, Denver, CO 80206 USA.	torresr@njhealth.org			National Institutes of Health NIAID [T32-AI07045]; FAMRI; National Jewish Health Translational Research Initiative; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052157] Funding Source: NIH RePORTER	National Institutes of Health NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); FAMRI; National Jewish Health Translational Research Initiative; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health NIAID Training Grant T32-AI07045 (to J. M. H.). This work was also supported by a FAMRI Young Clinical Scientist Award (to J. M. H.), the Herman Dana Trust (to R. M. T.), and a National Jewish Health Translational Research Initiative award (to R. M. T.).	Abram CL, 2009, ANNU REV IMMUNOL, V27, P339, DOI 10.1146/annurev.immunol.021908.132554; ALLAN CJ, 1994, J PHARMACOL EXP THER, V270, P446; ALTAVILLA D, 1995, EUR J PHARMACOL, V286, P31, DOI 10.1016/0014-2999(95)00431-J; Breyer RM, 2001, ANNU REV PHARMACOL, V41, P661, DOI 10.1146/annurev.pharmtox.41.1.661; BROWN GP, 1988, AM J PHYSIOL, V254, pC809, DOI 10.1152/ajpcell.1988.254.6.C809; Caughey GE, 1997, J IMMUNOL, V158, P351; Choi JW, 2010, ANNU REV PHARMACOL, V50, P157, DOI 10.1146/annurev.pharmtox.010909.105753; COLEMAN RA, 1981, BRIT J PHARMACOL, V73, P773, DOI 10.1111/j.1476-5381.1981.tb16814.x; CORCORAN ML, 1995, J BIOL CHEM, V270, P10365, DOI 10.1074/jbc.270.18.10365; de Fougerolles AR, 2002, IMMUNOL REV, V186, P208, DOI 10.1034/j.1600-065X.2002.18617.x; Dubash AD, 2007, J CELL SCI, V120, P3989, DOI 10.1242/jcs.003806; Duong CQ, 2004, BBA-MOL CELL BIOL L, V1682, P112; Esparza J, 1999, BLOOD, V94, P2754, DOI 10.1182/blood.V94.8.2754.420k09_2754_2766; Fan H, 2008, MOL MED, V14, P422, DOI 10.2119/2007-00106.Fan; Francis SA, 2006, BLOOD, V107, P1627, DOI 10.1182/blood-2005-03-1164; FU JY, 1990, J BIOL CHEM, V265, P16737; Gelosa P, 2010, J PHARMACOL EXP THER, V334, P199, DOI 10.1124/jpet.110.165787; Girkontaite I, 2001, NAT IMMUNOL, V2, P855, DOI 10.1038/ni0901-855; GUDEWICZ PW, 1994, J LEUKOCYTE BIOL, V55, P423, DOI 10.1002/jlb.55.4.423; GUDEWICZ PW, 1991, J CELL PHYSIOL, V149, P195, DOI 10.1002/jcp.1041490204; HALL RA, 1987, EUR J PHARMACOL, V135, P193, DOI 10.1016/0014-2999(87)90611-X; Harenberg A, 2005, EUR J IMMUNOL, V35, P1977, DOI 10.1002/eji.200425769; Hart MJ, 1998, SCIENCE, V280, P2112, DOI 10.1126/science.280.5372.2112; Hartney JM, 2006, AM J PHYSIOL-LUNG C, V290, pL105, DOI 10.1152/ajplung.00221.2005; Hartney JM, 2010, AM J PATHOL, V176, P1157, DOI 10.2353/ajpath.2010.090200; HARTUNG HP, 1983, J IMMUNOL, V130, P2861; Hoshino M, 1999, J ALLERGY CLIN IMMUN, V103, P1054, DOI 10.1016/S0091-6749(99)70179-X; Hu JC, 2008, MOL IMMUNOL, V45, P1825, DOI 10.1016/j.molimm.2007.11.002; Hughes JE, 2008, CIRC RES, V102, P950, DOI 10.1161/CIRCRESAHA.107.170779; Johnson JL, 1995, ARCH BIOCHEM BIOPHYS, V324, P26, DOI 10.1006/abbi.1995.9934; JOHNSON WD, 1977, J EXP MED, V146, P1613, DOI 10.1084/jem.146.6.1613; Kandasamy P, 2011, J BIOL CHEM, V286, P7841, DOI 10.1074/jbc.M110.170241; Kehrl JH, 2004, CRIT REV IMMUNOL, V24, P409; Khan KMF, 2004, J BIOL CHEM, V279, P22039, DOI 10.1074/jbc.M312735200; Kozasa T, 1998, SCIENCE, V280, P2109, DOI 10.1126/science.280.5372.2109; KUHN DC, 1993, PROSTAG OTH LIPID M, V46, P195, DOI 10.1016/0090-6980(93)90003-P; Kuroda E, 2003, J IMMUNOL, V170, P757, DOI 10.4049/jimmunol.170.2.757; Laskin DL, 2011, ANNU REV PHARMACOL, V51, P267, DOI 10.1146/annurev.pharmtox.010909.105812; Lee M, 2009, AM J PHYSIOL-GASTR L, V297, pG641, DOI 10.1152/ajpgi.00191.2009; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; MORLEY J, 1979, PROSTAGLANDINS, V17, P729, DOI 10.1016/S0090-6980(79)80044-1; MORRIS DD, 1989, CIRC SHOCK, V28, P149; MUFSON RA, 1989, CELL IMMUNOL, V119, P182, DOI 10.1016/0008-8749(89)90234-7; MUROTA SI, 1978, BIOCHIM BIOPHYS ACTA, V528, P507; Nakahata N, 2008, PHARMACOL THERAPEUT, V118, P18, DOI 10.1016/j.pharmthera.2008.01.001; Narumiya S, 1999, PHYSIOL REV, V79, P1193, DOI 10.1152/physrev.1999.79.4.1193; Nathan C, 2010, CELL, V140, P871, DOI 10.1016/j.cell.2010.02.029; NICOLAOU KC, 1979, P NATL ACAD SCI USA, V76, P2566, DOI 10.1073/pnas.76.6.2566; OFFERMANNS S, 1994, P NATL ACAD SCI USA, V91, P504, DOI 10.1073/pnas.91.2.504; Pavlovic S, 2006, J BIOL CHEM, V281, P3321, DOI 10.1074/jbc.M506846200; Penglis PS, 2000, J IMMUNOL, V165, P1605, DOI 10.4049/jimmunol.165.3.1605; Retamales I, 2001, AM J RESP CRIT CARE, V164, P469, DOI 10.1164/ajrccm.164.3.2007149; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Rosen H, 2009, ANNU REV BIOCHEM, V78, P743, DOI 10.1146/annurev.biochem.78.072407.103733; Rubtsov A, 2005, IMMUNITY, V23, P527, DOI 10.1016/j.immuni.2005.09.018; SHAPIRO SD, 1993, J BIOL CHEM, V268, P8170; Shi H, 1998, EUR RESPIR J, V11, P624; Soehnlein O, 2010, NAT REV IMMUNOL, V10, P427, DOI 10.1038/nri2779; Sorokin L, 2010, NAT REV IMMUNOL, V10, P712, DOI 10.1038/nri2852; Sun LK, 2001, INFLAMM RES, V50, P496, DOI 10.1007/PL00000224; Takayama K, 2002, J BIOL CHEM, V277, P44147, DOI 10.1074/jbc.M204810200; Thomas DW, 2003, J IMMUNOL, V171, P6389, DOI 10.4049/jimmunol.171.12.6389; WEIDEMANN MJ, 1978, FEBS LETT, V89, P136, DOI 10.1016/0014-5793(78)80539-0; Xie B, 1998, J BIOL CHEM, V273, P11576, DOI 10.1074/jbc.273.19.11576; Zhang L, 2006, MOL PHARMACOL, V69, P1433, DOI 10.1124/mol.105.019703	65	13	14	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2011	286	52					44521	44531		10.1074/jbc.M111.282772	http://dx.doi.org/10.1074/jbc.M111.282772			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870CA	22086927	hybrid, Green Published			2022-12-27	WOS:000298645500024
J	Mihelich, BL; Khramtsova, EA; Arva, N; Vaishnav, A; Johnson, DN; Giangreco, AA; Martens-Uzunova, E; Bagasra, O; Kajdacsy-Balla, A; Nonn, L				Mihelich, Brittany L.; Khramtsova, Ekaterina A.; Arva, Nicole; Vaishnav, Avani; Johnson, Daniel N.; Giangreco, Angeline A.; Martens-Uzunova, Elena; Bagasra, Omar; Kajdacsy-Balla, Andre; Nonn, Larisa			miR-183-96-182 Cluster Is Overexpressed in Prostate Tissue and Regulates Zinc Homeostasis in Prostate Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICRORNA EXPRESSION; DOWN-REGULATION; CANCER; MIR-182; IDENTIFICATION	Decreased zinc levels are a hallmark of prostate cancer tumors as zinc uniquely concentrates in healthy prostate tissue. Increased dietary zinc correlates with decreased risk of advanced prostate cancer and decreased mortality from prostate cancer. The mechanisms of prostatic zinc homeostasis are not known. Lower zinc levels in the tumor are correlated directly with decreased expression of the zinc transporter hZIP1. We report identification of a microRNA cluster that regulates multiple zinc transporters, including hZIP1. Screening in laser capture microdissected prostate cancer tumors identified miR-182 as a potential regulator of hZIP1. Regulation of hZIP1 by miR-182 via two binding sites was confirmed in primary prostate cell cultures. miR-96 and miR-183 are expressed as a cluster with miR-182 and share similar sequences. Array profiling of tissue showed that miR-183, -96, and -182 are higher in prostate cancer tissue compared with normal prostate. Overexpression of the entire miR-183-96-182 cluster suppressed five additional zinc transporters. Overexpression of miR-183, -96, and -182 individually or as a cluster diminished labile zinc pools and reduced zinc uptake, demonstrating this miR cluster as a regulator of zinc homeostasis. We observed regulation of zinc homeostasis by this cluster in prostate cells and HEK-293 cells, suggesting a universal mechanism that is not prostate-specific. To our knowledge, this is the first report of a miR cluster targeting a family of metal transport proteins. Individually or as a cluster, miR-183, -96, and -182 are overexpressed in other cancers too, implicating this miR cluster in carcinogenesis.	[Mihelich, Brittany L.; Khramtsova, Ekaterina A.; Arva, Nicole; Vaishnav, Avani; Johnson, Daniel N.; Giangreco, Angeline A.; Kajdacsy-Balla, Andre; Nonn, Larisa] Univ Illinois, Dept Pathol, Chicago, IL 60612 USA; [Martens-Uzunova, Elena] Erasmus MC, Dept Urol, Josephine Nefkens Inst, NL-3015 GE Rotterdam, Netherlands; [Bagasra, Omar] Claflin Univ, Dept Biol, Orangeburg, SC 29115 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Erasmus University Rotterdam; Erasmus MC; Claflin University	Nonn, L (corresponding author), 840 S Wood St,Rm 130 CSN, Chicago, IL 60612 USA.	lnonn@uic.edu	Martens-Uzunova, Elena/D-9768-2012	Martens-Uzunova, Elena/0000-0002-5363-2525	University of Illinois at Chicago Institute for Research on Race and Public Policy; Department of Defense [PC074307]; University of Illinois at Chicago Honors College; Sigma Xi grant-in-aid Research award; Phi Kappa Phi Scholarly Projects grant; C. M. Craig Fellowship Summer Research program; European Union [201438]	University of Illinois at Chicago Institute for Research on Race and Public Policy; Department of Defense(United States Department of Defense); University of Illinois at Chicago Honors College; Sigma Xi grant-in-aid Research award; Phi Kappa Phi Scholarly Projects grant; C. M. Craig Fellowship Summer Research program; European Union(European Commission)	This work was supported by the Faculty Seed Award from the University of Illinois at Chicago Institute for Research on Race and Public Policy (to L. N.), Department of Defense Grant PC074307 (to A. K.-B.), University of Illinois at Chicago Honors College Undergraduate award (to E. A. K.), Sigma Xi grant-in-aid Research award (to E. A. K.), Phi Kappa Phi Scholarly Projects grant (to E. A. K.), the C. M. Craig Fellowship Summer Research program (to D. N. J.), and Grant 201438 from the European Union Seventh Framework Programme (FP7/20072013) (to E. M.-U.).	Albrecht AL, 2008, BIOMETALS, V21, P405, DOI 10.1007/s10534-007-9129-0; Altuvia Y, 2005, NUCLEIC ACIDS RES, V33, P2697, DOI 10.1093/nar/gki567; Ambs S, 2008, CANCER RES, V68, P6162, DOI 10.1158/0008-5472.CAN-08-0144; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Coppola V, 2010, ENDOCR-RELAT CANCER, V17, pF1, DOI 10.1677/ERC-09-0172; Cortesi M, 2008, PROSTATE, V68, P994, DOI 10.1002/pros.20766; Costello LC, 2005, CANCER CAUSE CONTROL, V16, P901, DOI 10.1007/s10552-005-2367-y; Costello LC, 1997, J BIOL CHEM, V272, P28875, DOI 10.1074/jbc.272.46.28875; Dai RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014302; Epstein MM, 2011, AM J CLIN NUTR, V93, P586, DOI 10.3945/ajcn.110.004804; Franklin RB, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-32; Ghosh SK, 2010, CANCER RES, V70, P6119, DOI 10.1158/0008-5472.CAN-10-1008; Gonzalez A, 2009, NUTR CANCER, V61, P206, DOI 10.1080/01635580802419749; Guttilla IK, 2009, J BIOL CHEM, V284, P23204, DOI 10.1074/jbc.M109.031427; HABIB FK, 1979, BRIT J CANCER, V39, P700, DOI 10.1038/bjc.1979.123; Hwang HW, 2009, P NATL ACAD SCI USA, V106, P7016, DOI 10.1073/pnas.0811523106; Jin ZB, 2009, MOL VIS, V15, P523; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Kruger J, 2006, NUCLEIC ACIDS RES, V34, pW451, DOI 10.1093/nar/gkl243; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li GR, 2009, MECH AGEING DEV, V130, P731, DOI 10.1016/j.mad.2009.09.002; Lichten LA, 2009, ANNU REV NUTR, V29, P153, DOI 10.1146/annurev-nutr-033009-083312; Lin HX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015797; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martens-Uzunova E. S., 2011, ONCOGENE; MAWSON CA, 1952, CAN J MED SCI, V30, P336, DOI 10.1139/cjms52-043; Moskwa P, 2011, MOL CELL, V41, P210, DOI 10.1016/j.molcel.2010.12.005; Nonn L, 2010, EXP MOL PATHOL, V88, P45, DOI 10.1016/j.yexmp.2009.10.005; Ohana E, 2009, J BIOL CHEM, V284, P17677, DOI 10.1074/jbc.M109.007203; Ozen M, 2008, ONCOGENE, V27, P1788, DOI 10.1038/sj.onc.1210809; Peehl D. M, 2003, PROSTATE CANC METHOD, P41; Peehl DM, 2005, ENDOCR-RELAT CANCER, V12, P19, DOI 10.1677/erc.1.00795; Prasad AS, 2010, J MED FOOD, V13, P70, DOI 10.1089/jmf.2009.0042; Rasband WS, 2011, IMAGEJ; Rishi I, 2003, APPL IMMUNOHISTO M M, V11, P253; Sarver AL, 2010, CANCER RES, V70, P9570, DOI 10.1158/0008-5472.CAN-10-2074; Schaefer A, 2010, INT J CANCER, V126, P1166, DOI 10.1002/ijc.24827; Segura MF, 2009, P NATL ACAD SCI USA, V106, P1814, DOI 10.1073/pnas.0808263106; Truong-Tran AQ, 2000, J NUTR, V130, p1459S, DOI 10.1093/jn/130.5.1459S; Xu JZ, 2008, RNA, V14, P1276, DOI 10.1261/rna.997708; Xu SB, 2007, J BIOL CHEM, V282, P25053, DOI 10.1074/jbc.M700501200; Yamada Y, 2011, CANCER SCI, V102, P522, DOI 10.1111/j.1349-7006.2010.01816.x; Zou J., 2011, PROSTATE	44	108	113	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2011	286	52					44503	44511		10.1074/jbc.M111.262915	http://dx.doi.org/10.1074/jbc.M111.262915			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870CA	22045813	Green Published, hybrid			2022-12-27	WOS:000298645500022
J	Riddle, RC; Leslie, JM; Gross, TS; Clemens, TL				Riddle, Ryan C.; Leslie, Julie M.; Gross, Ted S.; Clemens, Thomas L.			Hypoxia-inducible Factor-1 alpha Protein Negatively Regulates Load-induced Bone Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WNT SIGNALING PATHWAY; CANCER CELL-LINE; BETA-CATENIN; FLUID-FLOW; GROWTH-FACTOR; RAT ULNA; IN-VIVO; MC3T3-E1 OSTEOBLASTS; PROSTAGLANDIN E-2; MAMMALIAN TARGET	Mechanical loads induce profound anabolic effects in the skeleton, but the molecular mechanisms that transduce such signals are still poorly understood. In this study, we demonstrate that the hypoxia-inducible factor-1 alpha (Hif-1 alpha) is acutely up-regulated in response to exogenous mechanical stimuli secondary to prostanoid signaling and Akt/mTOR (mammalian target of rapamycin) activation. In this context, Hif-1 alpha associates with beta-catenin to inhibit Wnt target genes associated with bone anabolic activity. Mice lacking Hif-1 alpha in osteoblasts and osteocytes form more bone when subjected to tibia loading as a result of increased osteoblast activity. Taken together, these studies indicate that Hif-1 alpha serves as a negative regulator of skeletal mechanotransduction to suppress load-induced bone formation by altering the sensitivity of osteoblasts and osteocytes to mechanical signals.	[Riddle, Ryan C.; Leslie, Julie M.; Clemens, Thomas L.] Johns Hopkins Univ, Dept Orthopaed Surg, Sch Med, Baltimore, MD 21205 USA; [Riddle, Ryan C.; Clemens, Thomas L.] Vet Adm Med Ctr, Baltimore, MD 21201 USA; [Gross, Ted S.] Univ Washington, Dept Orthopaed & Sports Med, Seattle, WA 98195 USA	Johns Hopkins University; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Washington; University of Washington Seattle	Riddle, RC (corresponding author), Johns Hopkins Univ, Dept Orthopaed Surg, Sch Med, 1721 E Madison St,Ross 232, Baltimore, MD 21205 USA.	rriddle1@jhmi.edu			National Institutes of Health [AR049410]; Veterans Administration; Johns Hopkins University Center for Musculoskeletal Research; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049410] Funding Source: NIH RePORTER; Veterans Affairs [IK2BX001284] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Administration(US Department of Veterans Affairs); Johns Hopkins University Center for Musculoskeletal Research; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grant AR049410 (to T. L. C.). This work was also supported by a Career Development Award from the Veterans Administration (to R. C. R).; Supported by a Pilot and Feasibility Grant from the Johns Hopkins University Center for Musculoskeletal Research. To whom correspondence should be addressed: Dept. of Orthopaedic Surgery, Johns Hopkins University School of Medicine, 1721 E. Madison St., Ross 232, Baltimore, MD 21205. Fax: 443287- 4428; E-mail: rriddle1@ jhmi. edu.	Akeno N, 2002, ENDOCRINOLOGY, V143, P420, DOI 10.1210/en.143.2.420; Almeida M, 2007, J BIOL CHEM, V282, P27298, DOI 10.1074/jbc.M702811200; Armstrong VJ, 2007, J BIOL CHEM, V282, P20715, DOI 10.1074/jbc.M703224200; Bakker AD, 2001, J BIOMECH, V34, P671, DOI 10.1016/S0021-9290(00)00231-1; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Brunelle JK, 2005, CELL METAB, V1, P409, DOI 10.1016/j.cmet.2005.05.002; Case N, 2008, J BIOL CHEM, V283, P29196, DOI 10.1074/jbc.M801907200; Donahue SW, 2003, J BIOMECH, V36, P35, DOI 10.1016/S0021-9290(02)00318-4; FRANGOS JA, 1988, BIOTECHNOL BIOENG, V32, P1053, DOI 10.1002/bit.260320812; Genetos DC, 2005, J BONE MINER RES, V20, P41, DOI 10.1359/jbmr.041009; Gross TS, 2002, J BONE MINER RES, V17, P493, DOI 10.1359/jbmr.2002.17.3.493; Gruber M, 2007, P NATL ACAD SCI USA, V104, P2301, DOI 10.1073/pnas.0608382104; Hens JR, 2005, J BONE MINER RES, V20, P1103, DOI 10.1359/JBMR.050210; Hill TP, 2005, DEV CELL, V8, P727, DOI 10.1016/j.devcel.2005.02.013; HILLAM RA, 1995, J BONE MINER RES, V10, P683; Holmen SL, 2005, J BIOL CHEM, V280, P21162, DOI 10.1074/jbc.M501900200; Hudson CC, 2002, MOL CELL BIOL, V22, P7004, DOI 10.1128/MCB.22.20.7004-7014.2002; HUNG CT, 1995, CLIN ORTHOP RELAT R, P256; Kaidi A, 2007, NAT CELL BIOL, V9, P210, DOI 10.1038/ncb1534; Kato Y, 1997, J BONE MINER RES, V12, P2014, DOI 10.1359/jbmr.1997.12.12.2014; Kim CH, 2002, CIRC RES, V90, pE25, DOI 10.1161/hh0202.104923; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Land SC, 2007, J BIOL CHEM, V282, P20534, DOI 10.1074/jbc.M611782200; Lang CH, 2010, AM J PHYSIOL-ENDOC M, V298, pE1283, DOI 10.1152/ajpendo.00676.2009; Lim JH, 2008, CANCER RES, V68, P5177, DOI 10.1158/0008-5472.CAN-07-6234; Liu XH, 2002, J BIOL CHEM, V277, P50081, DOI 10.1074/jbc.M201095200; Maretto S, 2003, P NATL ACAD SCI USA, V100, P3299, DOI 10.1073/pnas.0434590100; Matsuzaki H, 2007, CALCIFIED TISSUE INT, V80, P391, DOI 10.1007/s00223-007-9031-3; Mazumdar J, 2010, NAT CELL BIOL, V12, P1007, DOI 10.1038/ncb2102; McKenzie JA, 2011, BONE, V48, P250, DOI 10.1016/j.bone.2010.09.005; Milkiewicz M, 2007, J PHYSIOL-LONDON, V583, P753, DOI 10.1113/jphysiol.2007.136325; MOREY ER, 1978, SCIENCE, V201, P1138, DOI 10.1126/science.150643; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; PEAD MJ, 1989, CALCIFIED TISSUE INT, V45, P34, DOI 10.1007/BF02556658; PEAD MJ, 1988, J BONE MINER RES, V3, P647; Phillips RJ, 2005, J BIOL CHEM, V280, P22473, DOI 10.1074/jbc.M500963200; PIEKARSKI K, 1977, NATURE, V269, P80, DOI 10.1038/269080a0; Powers SK, 2008, PHYSIOL REV, V88, P1243, DOI 10.1152/physrev.00031.2007; Riddle RC, 2006, AM J PHYSIOL-CELL PH, V290, pC776, DOI 10.1152/ajpcell.00082.2005; Robling AG, 2001, J EXP BIOL, V204, P3389; Robling AG, 2008, J BIOL CHEM, V283, P5866, DOI 10.1074/jbc.M705092200; Santos A, 2010, BIOCHEM BIOPH RES CO, V391, P364, DOI 10.1016/j.bbrc.2009.11.064; Sawakami K, 2006, J BIOL CHEM, V281, P23698, DOI 10.1074/jbc.M601000200; Schipani E, 2001, GENE DEV, V15, P2865; Semenza GL, 2000, GENE DEV, V14, P1983; Semenza GL, 2001, CELL, V107, P1, DOI 10.1016/S0092-8674(01)00518-9; Shi YH, 2005, J PATHOL, V205, P530, DOI 10.1002/path.1734; Shomento SH, 2010, J CELL BIOCHEM, V109, P196, DOI 10.1002/jcb.22396; Simon MC, 2006, ADV EXP MED BIOL, V588, P165; Srinivasan S, 2003, BONE, V33, P946, DOI 10.1016/j.bone.2003.07.009; Srinivasan S, 2007, J APPL PHYSIOL, V102, P1945, DOI 10.1152/japplphysiol.00507.2006; Treins C, 2002, J BIOL CHEM, V277, P27975, DOI 10.1074/jbc.M204152200; Wang Y, 2007, J CLIN INVEST, V117, P1616, DOI 10.1172/JCI31581; Xia XC, 2010, MOL CELL BIOL, V30, P206, DOI 10.1128/MCB.01844-08; Yang ZQ, 2010, J CELL PHYSIOL, V223, P435, DOI 10.1002/jcp.22057; You J, 2001, J BIOL CHEM, V276, P13365, DOI 10.1074/jbc.M009846200; Zhang M, 2002, J BIOL CHEM, V277, P44005, DOI 10.1074/jbc.M208265200	58	28	31	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2011	286	52					44449	44456		10.1074/jbc.M111.276683	http://dx.doi.org/10.1074/jbc.M111.276683			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870CA	22081627	Green Published, hybrid			2022-12-27	WOS:000298645500017
J	Havard, M; Dautry, F; Tchenio, T				Havard, Maryline; Dautry, Francois; Tchenio, Thierry			A Dormant State Modulated by Osmotic Pressure Controls Clonogenicity of Prostate Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TGF-BETA; METASTATIC INEFFICIENCY; EPITHELIAL-CELLS; STEM-CELLS; P53; PROGRESSION; SENESCENCE; BONE	Cell dormancy constitutes a limiting step of the metastatic process by preventing the proliferation of isolated cancer cells disseminated at distant sites from the primary tumor. The study of cancer cell dormancy is severely hampered by the lack of biological samples so that the mechanisms that regulate cell dormancy have not been extensively explored. In this work, we describe the rapid induction in vitro of a dormant state in prostate cancer cells by exposure to a slightly hypertonic growth medium. This quiescence is observed only when cells are seeded at low density and, once established, requires additional stimuli besides osmotic pressure to be reversed. Media conditioned by cells grown at high density can partially prevent or reverse dormancy, a phenomenon which can be reproduced with citric acid. In addition to this role of small metabolites, inactivation of the p53 and smad pathways also counters the entry into dormancy, whereas exposure to activin A induces it to some extent. Thus, this easily inducible dormancy reproduces several features associated with the dormancy of stem cells and cancer cells in vivo.	[Havard, Maryline; Dautry, Francois; Tchenio, Thierry] Ecole Normale Super, CNRS, LBPA, UMR8113, F-94235 Cachan, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay	Tchenio, T (corresponding author), Ecole Normale Super, CNRS, LBPA, UMR8113, 61 Ave President Wilson, F-94235 Cachan, France.	ttchenio@ens-cachan.fr	Tchenio, Thierry/O-8336-2017	Tchenio, Thierry/0000-0002-6969-3138				Buijs JT, 2007, CLIN EXP METASTAS, V24, P609, DOI 10.1007/s10585-007-9118-2; Cameron MD, 2000, CANCER RES, V60, P2541; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Chambers A F, 2001, Surg Oncol Clin N Am, V10, P243; Chambers AF, 2000, BREAST CANCER RES, V2, P400, DOI 10.1186/bcr86; Chambers AF, 2001, SURG ONCOL CLIN N AM, V10, pvii; Costello LC, 1997, UROLOGY, V50, P3, DOI 10.1016/S0090-4295(97)00124-6; Di K, 2006, BIOL CELL, V98, P523, DOI 10.1042/BC20060026; Ding ZH, 2011, NATURE, V470, P269, DOI 10.1038/nature09677; Dmitrieva NI, 2005, MUTAT RES-FUND MOL M, V569, P65, DOI 10.1016/j.mrfmmm.2004.06.053; Guba M, 2001, CANCER RES, V61, P5575; Inman GJ, 2011, CURR OPIN GENET DEV, V21, P93, DOI 10.1016/j.gde.2010.12.004; Junger WG, 1997, J TRAUMA, V42, P437, DOI 10.1097/00005373-199703000-00011; Lin AW, 1998, GENE DEV, V12, P3008, DOI 10.1101/gad.12.19.3008; Liu Y, 2009, CELL STEM CELL, V4, P37, DOI 10.1016/j.stem.2008.11.006; Naumov GN, 2001, SEMIN CANCER BIOL, V11, P271, DOI 10.1006/scbi.2001.0382; Salm SN, 2005, J CELL BIOL, V170, P81, DOI 10.1083/jcb.200412015; Singer G.G., 2008, HARRISONS PRINCIPLES, P274; Taylor WR, 2001, ONCOGENE, V20, P1803, DOI 10.1038/sj.onc.1204252; Tchenio T, 2006, MOL CELL BIOL, V26, P580, DOI 10.1128/MCB.26.2.580-591.2006; Townson JL, 2006, CELL CYCLE, V5, P1744, DOI 10.4161/cc.5.16.2864; Tumminello FM, 2010, CLIN EXP METASTAS, V27, P549, DOI 10.1007/s10585-010-9344-x; Wiig H, 2010, FIBROGENESIS TISSUE, V3, DOI 10.1186/1755-1536-3-12; Wu Kai-Jie, 2009, Zhonghua Nan Ke Xue, V15, P41; Yamazaki S, 2009, CURR OPIN HEMATOL, V16, P255, DOI 10.1097/MOH.0b013e32832c6705; Yan XH, 2011, BIOCHEM J, V434, P1, DOI 10.1042/BJ20101827	26	14	14	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2011	286	51					44177	44186		10.1074/jbc.M111.262709	http://dx.doi.org/10.1074/jbc.M111.262709			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866SH	22039055	Green Published, hybrid			2022-12-27	WOS:000298402300058
J	Lands, B				Lands, Bill			Everything Is Connected Everything Else	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACIDS; ALCOHOL; BIOSYNTHESIS; GROWTH; PLASMA					wemlands@att.net						GRAFF G, 1983, ARCH BIOCHEM BIOPHYS, V224, P342, DOI 10.1016/0003-9861(83)90218-7; HOLUB BJ, 1975, CAN J BIOCHEM CELL B, V53, P1262, DOI 10.1139/o75-172; KEEN RR, 1991, CRIT CARE MED, V19, P1114, DOI 10.1097/00003246-199109000-00004; Kresge N, 2009, J BIOL CHEM, V284; Kulmacz Richard J., 1997, P134; KULMACZ RJ, 1994, J BIOL CHEM, V269, P5527; Lands B, 2008, PROG LIPID RES, V47, P77, DOI 10.1016/j.plipres.2007.12.001; Lands B, 2011, PROSTAG OTH LIPID M, V96, P90, DOI 10.1016/j.prostaglandins.2011.07.003; Lands B, 2009, CURR ATHEROSCLER REP, V11, P272, DOI 10.1007/s11883-009-0042-6; Lands W., 2005, FISH OMEGA 3 HUMAN H; LANDS WEM, 1990, AM J CLIN NUTR, V51, P991, DOI 10.1093/ajcn/51.6.991; LANDS WEM, 1979, ANNU REV PHYSIOL, V41, P633, DOI 10.1146/annurev.ph.41.030179.003221; Lands WEM, 1999, ALCOHOL, V18, P109, DOI 10.1016/S0741-8329(98)00073-1; Lands WEM, 2005, J MEMBRANE BIOL, V206, P75, DOI 10.1007/s00232-005-0785-0; Lands WEM, 1998, ALCOHOL, V15, P147, DOI 10.1016/S0741-8329(97)00110-9; LANDS WEM, 1991, ANNU REV NUTR, V11, P41, DOI 10.1146/annurev.nu.11.070191.000353; Lands WEM, 2001, NUTR HLTH, P375; LANDS WEM, 1978, LIPIDS, V13, P878, DOI 10.1007/BF02533843; LANDS WEM, 1965, ANNU REV BIOCHEM, V34, P313, DOI 10.1146/annurev.bi.34.070165.001525; Lands WEM, 2000, BBA-MOL CELL BIOL L, V1483, P1, DOI 10.1016/S1388-1981(99)00177-8; LANDS WEM, 1995, ALCOHOL CLIN EXP RES, V19, P928, DOI 10.1111/j.1530-0277.1995.tb00969.x; LANDS WEM, 1992, BIOCHIM BIOPHYS ACTA, V1180, P147, DOI 10.1016/0925-4439(92)90063-S; Lands WEM., 1986, FISH HUMAN HLTH; OKUYAMA H, 1972, J BIOL CHEM, V247, P1414	24	0	0	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2011	286	51					43589	43595		10.1074/jbc.X111.318873	http://dx.doi.org/10.1074/jbc.X111.318873			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866SH	22045809	Green Published, hybrid			2022-12-27	WOS:000298402300001
J	Lynagh, T; Webb, TI; Dixon, CL; Cromer, BA; Lynch, JW				Lynagh, Timothy; Webb, Timothy I.; Dixon, Christine L.; Cromer, Brett A.; Lynch, Joseph W.			Molecular Determinants of Ivermectin Sensitivity at the Glycine Receptor Chloride Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; TRYPTOPHAN-SCANNING MUTAGENESIS; GABA(A) RECEPTOR; TRANSMEMBRANE DOMAIN; ONCHOCERCA-VOLVULUS; ION-CHANNEL; AGONIST; ACID; LOOP; ACTIVATION	Ivermectin is an anthelmintic drug that works by activating glutamate-gated chloride channel receptors (GluClRs) in nematode parasites. GluClRs belong to the Cys-loop receptor family that also includes glycine receptor (GlyR) chloride channels. GluClRs and A288G mutant GlyRs are both activated by low nanomolar ivermectin concentrations. The crystal structure of the Caenorhabditis elegans alpha GluClR complexed with ivermectin has recently been published. Here, we probed ivermectin sensitivity determinants on the alpha 1 GlyR using site-directed mutagenesis and electrophysiology. Based on a mutagenesis screen of transmembrane residues, we identified Ala(288) and Pro(230) as crucial sensitivity determinants. A comparison of the actions of selamectin and ivermectin suggested the benzofuran C05-OH was required for high efficacy. When taken together with docking simulations, these results supported a GlyR ivermectin binding orientation similar to that seen in the GluClR crystal structure. However, whereas the crystal structure shows that ivermectin interacts with the alpha GluClR via H-bonds with Leu(218), Ser(260), and Thr(285) (alpha GluClR numbering), our data indicate that H-bonds with residues homologous to Ser(260) and Thr(285) are not important for high ivermectin sensitivity or direct agonist efficacy in A288G alpha 1 GlyRs or three other GluClRs. Our data also suggest that van der Waals interactions between the ivermectin disaccharide and GlyR M2-M3 loop residues are unimportant for high ivermectin sensitivity. Thus, although our results corroborate the ivermectin binding orientation as revealed by the crystal structure, they demonstrate that some of the binding interactions revealed by this structure do not pertain to other highly ivermectin-sensitive Cys-loop receptors.	[Lynagh, Timothy; Webb, Timothy I.; Dixon, Christine L.; Lynch, Joseph W.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia; [Lynch, Joseph W.] Univ Queensland, Sch Biomed Sci, Brisbane, Qld 4072, Australia; [Cromer, Brett A.] RMIT Univ, Hlth Innovat Res Inst, Melbourne, Vic 2476, Australia	University of Queensland; University of Queensland; Royal Melbourne Institute of Technology (RMIT)	Lynch, JW (corresponding author), Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia.	j.lynch@uq.edu.au	Webb, Timothy I/H-6941-2015; Lynch, Joseph/C-8636-2009; Cromer, Brett/AAQ-6533-2020	Webb, Timothy I/0000-0002-6263-6296; Cromer, Brett/0000-0003-0743-1535; Lynagh, Timothy/0000-0003-4888-4098	Australian Research Council; National Health and Medical Research Council of Australia; Australian postgraduate awards	Australian Research Council(Australian Research Council); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian postgraduate awards(Australian Government)	This work was supported in part by the Australian Research Council and the National Health and Medical Research Council of Australia.; Supported by Australian postgraduate awards.	Adelsberger H, 2000, EUR J PHARMACOL, V394, P163, DOI 10.1016/S0014-2999(00)00164-3; Awadzi K, 2004, ANN TROP MED PARASIT, V98, P231, DOI 10.1179/000349804225003253; Bertaccini EJ, 2010, J CHEM INF MODEL, V50, P2248, DOI 10.1021/ci100266c; Bourguinat C, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000072; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Cederholm JME, 2009, EUR BIOPHYS J BIOPHY, V39, P37, DOI 10.1007/s00249-009-0452-y; Choe S, 1995, P NATL ACAD SCI USA, V92, P12046, DOI 10.1073/pnas.92.26.12046; CULLY DF, 1994, NATURE, V371, P707, DOI 10.1038/371707a0; Otero-Cruz JD, 2007, J BIOL CHEM, V282, P9162, DOI 10.1074/jbc.M607492200; Forrester SG, 2003, MOL BIOCHEM PARASIT, V129, P115, DOI 10.1016/S0166-6851(03)00102-6; Gilbert DF, 2009, FRONT MOL NEUROSCI, V2, DOI 10.3389/neuro.02.017.2009; Greenfield LJ, 2002, NEUROPHARMACOLOGY, V42, P502, DOI 10.1016/S0028-3908(01)00196-4; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hosie AM, 2006, NATURE, V444, P486, DOI 10.1038/nature05324; Kane NS, 2000, P NATL ACAD SCI USA, V97, P13949, DOI 10.1073/pnas.240464697; Krasowski MD, 1998, MOL PHARMACOL, V53, P530, DOI 10.1124/mol.53.3.530; Krause RM, 1998, MOL PHARMACOL, V53, P283, DOI 10.1124/mol.53.2.283; Kwon DH, 2010, INSECT MOL BIOL, V19, P583, DOI 10.1111/j.1365-2583.2010.01017.x; Lobo IA, 2005, INT REV NEUROBIOL, V65, P53, DOI 10.1016/S0074-7742(04)65003-3; Lynagh T, 2010, INT J PARASITOL, V40, P1477, DOI 10.1016/j.ijpara.2010.07.010; Lynagh T, 2010, J BIOL CHEM, V285, P14890, DOI 10.1074/jbc.M110.107789; Lynch JW, 2001, J NEUROSCI, V21, P2589, DOI 10.1523/JNEUROSCI.21-08-02589.2001; McCavera S, 2009, MOL PHARMACOL, V75, P1347, DOI 10.1124/mol.108.053363; Michael B, 2001, J PARASITOL, V87, P692, DOI 10.1645/0022-3395(2001)087[0692:COIDSA]2.0.CO;2; Miller PS, 2010, TRENDS PHARMACOL SCI, V31, P161, DOI 10.1016/j.tips.2009.12.005; MROZIK H, 1982, J MED CHEM, V25, P658, DOI 10.1021/jm00348a010; Navedo M, 2004, BIOCHEMISTRY-US, V43, P78, DOI 10.1021/bi0356496; Nevin ST, 2003, J BIOL CHEM, V278, P28985, DOI 10.1074/jbc.M300097200; Njue AI, 2004, J NEUROCHEM, V89, P1137, DOI 10.1111/j.1471-4159.2004.02379.x; Omura S, 2008, INT J ANTIMICROB AG, V31, P91, DOI 10.1016/j.ijantimicag.2007.08.023; Osei-Atweneboano MY, 2007, LANCET, V369, P2021, DOI 10.1016/S0140-6736(07)60942-8; Pan ZH, 1997, P NATL ACAD SCI USA, V94, P6490, DOI 10.1073/pnas.94.12.6490; Perkins DI, 2008, J NEUROCHEM, V106, P1337, DOI 10.1111/j.1471-4159.2008.05476.x; Perkins DI, 2009, J BIOL CHEM, V284, P27304, DOI 10.1074/jbc.M109.023598; Raymond V, 2000, NEUROSCIENCE, V101, P785, DOI 10.1016/S0306-4522(00)00279-7; Shan Q, 2001, J BIOL CHEM, V276, P12556, DOI 10.1074/jbc.M011264200; Silberberg SD, 2007, NEURON, V54, P263, DOI 10.1016/j.neuron.2007.03.020; Truhlar DG, 2007, J COMPUT CHEM, V28, P73, DOI 10.1002/jcc.20529; Ueno S, 2000, BRIT J PHARMACOL, V131, P296, DOI 10.1038/sj.bjp.0703504; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Webb TI, 2007, CURR PHARM DESIGN, V13, P2350; Wolstenholme AJ, 2005, PARASITOLOGY, V131, pS85, DOI 10.1017/S0031182005008218	43	46	51	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2011	286	51					43913	43924		10.1074/jbc.M111.262634	http://dx.doi.org/10.1074/jbc.M111.262634			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866SH	22033924	Green Published, hybrid, Green Accepted			2022-12-27	WOS:000298402300032
J	Francois, KO; Balzarini, J				Francois, Katrien O.; Balzarini, Jan			The Highly Conserved Glycan at Asparagine 260 of HIV-1 gp120 Is Indispensable for Viral Entry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ENVELOPE GLYCOPROTEIN GP120; CARBOHYDRATE-BINDING AGENTS; LINKED GLYCOSYLATION SITES; CYANOVIRIN-N; ANTIBODY 2G12; TYPE-1; RESISTANCE; DELETIONS; PROTEIN	Carbohydrate-binding agents bind to the N-glycans of HIV-1 envelope gp120 and prevent viral entry. Carbohydrate-binding agents can select for mutant viruses with deleted envelope glycans. Not all glycosylation motifs are mutated to the same extent. Site-directed mutagenesis revealed that deletions destroying the highly conserved (260)NGS(262) glycosylation motif resulted in non-infectious virus particles. We observed a significant lower CD4 binding in the case of the N260Q mutant gp120 virus strains, caused by a strikingly lower expression of gp120 and gp41 in the virus particle. In addition, the mutant N260Q HIV-1 envelope expressed in 293T cells was unable to form syncytia in co-cultures with U87.CD4.CXCR4.CCR5 cells, due to the lower expression of envelope protein on the surface of the transfected 293T cells. The detrimental consequence of this N-glycan deletion on virus infectivity could not be compensated for by the creation of novel glycosylation sites near this amino acid, leaving this uncovered envelope epitope susceptible to neutralizing antibody binding. Thus, the Asn-260 glycan in the gp120 envelope of HIV-1 represents a hot spot for targeting suicidal drugs or antibodies in a therapeutic effort to efficiently neutralize a broad array of virus strains.	[Francois, Katrien O.; Balzarini, Jan] Katholieke Univ Leuven, Rega Inst Med Res, B-3000 Louvain, Belgium	KU Leuven	Balzarini, J (corresponding author), Katholieke Univ Leuven, Rega Inst Med Res, Minderbroedersstr 10, B-3000 Louvain, Belgium.	jan.balzarini@rega.kuleuven.be			Katholieke Universiteit Leuven Centers of Excellence [EF-05/15]; Geconcerteerde Onderzoeksactie [10/014]; Fonds voor Wetenschappelijk Onderzoek [G.485.08]; European Commission;  [PF/10/018]	Katholieke Universiteit Leuven Centers of Excellence; Geconcerteerde Onderzoeksactie; Fonds voor Wetenschappelijk Onderzoek(FWO); European Commission(European CommissionEuropean Commission Joint Research Centre); 	This work was supported by Katholieke Universiteit Leuven Centers of Excellence Grant EF-05/15 and Program Financing Grant PF/10/018, Geconcerteerde Onderzoeksactie Grant 10/014, Fonds voor Wetenschappelijk Onderzoek Grant G.485.08, and the CHAARM Network Project of the European Commission.	ABACIOGLU YH, 1994, AIDS RES HUM RETROV, V10, P371, DOI 10.1089/aid.1994.10.371; Auwerx J, 2008, VIROLOGY, V382, P10, DOI 10.1016/j.virol.2008.09.010; Balzarini J, 2006, ANTIVIR RES, V71, P237, DOI 10.1016/j.antiviral.2006.02.004; Balzarini J, 2005, MOL PHARMACOL, V67, P1556, DOI 10.1124/mol.104.005082; Balzarini J, 2004, J VIROL, V78, P10617, DOI 10.1128/JVI.78.19.10617-10627.2004; Balzarini J, 2005, J BIOL CHEM, V280, P41005, DOI 10.1074/jbc.M508801200; Balzarini J, 2007, NAT REV MICROBIOL, V5, P583, DOI 10.1038/nrmicro1707; Balzarini J, 2007, J VIROL, V81, P362, DOI 10.1128/JVI.01404-06; Balzarini J, 2006, J VIROL, V80, P8411, DOI 10.1128/JVI.00369-06; Balzarini J, 2010, ANTIMICROB AGENTS CH, V54, P1425, DOI 10.1128/AAC.01347-09; Botos I, 2005, PROG BIOPHYS MOL BIO, V88, P233, DOI 10.1016/j.pbiomolbio.2004.05.001; Boyd MR, 1997, ANTIMICROB AGENTS CH, V41, P1521, DOI 10.1128/AAC.41.7.1521; Calarese DA, 2005, P NATL ACAD SCI USA, V102, P13372, DOI 10.1073/pnas.0505763102; Checkley MA, 2011, J MOL BIOL, V410, P582, DOI 10.1016/j.jmb.2011.04.042; Chen B, 2005, NATURE, V433, P834, DOI 10.1038/nature03327; Chiba H, 2001, BIOCHEM BIOPH RES CO, V282, P595, DOI 10.1006/bbrc.2001.4495; Fikkert V, 2002, ANTIMICROB AGENTS CH, V46, P3954, DOI 10.1128/AAC.46.12.3954-3962.2002; Hebert DN, 1997, J CELL BIOL, V139, P613, DOI 10.1083/jcb.139.3.613; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Hoorelbeke B, 2010, ANTIMICROB AGENTS CH, V54, P3287, DOI 10.1128/AAC.00254-10; Hu QX, 2007, VIROLOGY, V368, P145, DOI 10.1016/j.virol.2007.06.029; Huskens D, 2010, J BIOL CHEM, V285, P24845, DOI 10.1074/jbc.M110.128546; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Land A, 2001, BIOCHIMIE, V83, P783, DOI 10.1016/S0300-9084(01)01314-1; LEE WR, 1992, P NATL ACAD SCI USA, V89, P2213, DOI 10.1073/pnas.89.6.2213; LEONARD CK, 1990, J BIOL CHEM, V265, P10373; O'Keefe BR, 2009, P NATL ACAD SCI USA, V106, P6099, DOI 10.1073/pnas.0901506106; Pikora C, 2005, J VIROL, V79, P12575, DOI 10.1128/JVI.79.19.12575-12583.2005; Princen Katrien, 2004, Retrovirology, V1, P2, DOI 10.1186/1742-4690-1-2; Sanders RW, 2002, J VIROL, V76, P7293, DOI 10.1128/JVI.76.14.7293-7305.2002; Scanlan CN, 2007, NATURE, V446, P1038, DOI 10.1038/nature05818; Scanlan CN, 2002, J VIROL, V76, P7306, DOI 10.1128/JVI.76.14.7306-7321.2002; Staropoli I, 2000, J BIOL CHEM, V275, P35137, DOI 10.1074/jbc.M003868200; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; Tsai CC, 2003, AIDS RES HUM RETROV, V19, P535, DOI 10.1089/088922203322230897; Van Damme EJM, 1998, HDB PLANT LECTINS PR; Van Laethem K, 2005, J VIROL METHODS, V123, P25, DOI 10.1016/j.jviromet.2004.09.003; VANDAMME EJM, 1988, PLANT PHYSIOL, V86, P598, DOI 10.1104/pp.86.2.598; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Watanabe I, 2004, J BIOL CHEM, V279, P8879, DOI 10.1074/jbc.M309802200; Weber J, 2006, J VIROL METHODS, V136, P102, DOI 10.1016/j.jviromet.2006.04.004; Weis WI, 1998, IMMUNOL REV, V163, P19, DOI 10.1111/j.1600-065X.1998.tb01185.x; WILLEY RL, 1988, J VIROL, V62, P139, DOI 10.1128/JVI.62.1.139-147.1988; Witvrouw M, 2005, J VIROL, V79, P7777, DOI 10.1128/JVI.79.12.7777-7784.2005; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884	46	23	23	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					42900	42910		10.1074/jbc.M111.274456	http://dx.doi.org/10.1074/jbc.M111.274456			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22006924	Green Published, hybrid			2022-12-27	WOS:000298351300012
J	Haque, I; Banerjee, S; Mehta, S; De, A; Majumder, M; Mayo, MS; Kambhampati, S; Campbell, DR; Banerjee, SK				Haque, Inamul; Banerjee, Snigdha; Mehta, Smita; De, Archana; Majumder, Monami; Mayo, Matthew S.; Kambhampati, Suman; Campbell, Donald R.; Banerjee, Sushanta K.			Cysteine-rich 61-Connective Tissue Growth Factor-nephroblastoma-overexpressed 5 (CCN5)/Wnt-1-induced Signaling Protein-2 (WISP-2) Regulates MicroRNA-10b via Hypoxia-inducible Factor-1 alpha-TWIST Signaling Networks in Human Breast Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL-TRANSITION; MOLECULAR CROSS-TALKS; TUMOR-SUPPRESSOR; GENE-EXPRESSION; INVASIVE PHENOTYPES; UP-REGULATION; REAL-TIME; METASTASIS; P53; PROLIFERATION	MicroRNAs (miRNAs) are naturally occurring single-stranded RNA molecules that post-transcriptionally regulate the expression of target mRNA transcripts. Many of these target mRNA transcripts are involved in regulating processes commonly altered during tumorigenesis and metastatic growth. These include cell proliferation, differentiation, apoptosis, migration, and invasion. Among the several miRNAs, miRNA-10b (miR-10b) expression is increased in metastatic breast cancer cells and positively regulates cell migration and invasion through the suppression of the homeobox D10 (HOXD10) tumor suppressor signaling pathway. In breast metastatic cells, miR-10b expression is enhanced by a transcription factor TWIST1. We find that miR-10b expression in breast cancer cells can be suppressed by CCN5, and this CCN5 effect is mediated through the inhibition of TWIST1 expression. Moreover, CCN5-induced inhibition of TWIST1 expression is mediated through the translational inhibition/modification of hypoxia-inducible factor-1 alpha via impeding JNK signaling pathway. Collectively, these studies suggest a novel regulatory pathway exists through which CCN5 exerts its anti-invasive function. On the basis of these findings, it is plausible that reactivation of CCN5 in miR-10b-positive invasive/metastatic breast cancers alone or in combination with current therapeutic regimens could provide a unique, alternative strategy to existing breast cancer therapy.	[Banerjee, Sushanta K.] Vet Affairs Med Ctr, Canc Res Unit, Res Div 151, Kansas City, MO 64128 USA; [Haque, Inamul; Banerjee, Snigdha; Mehta, Smita; De, Archana; Majumder, Monami; Kambhampati, Suman] Univ Kansas, Med Ctr, Div Hematol & Oncol, Kansas City, KS 66205 USA; [Banerjee, Sushanta K.] Univ Kansas, Med Ctr, Dept Anat & Cell Biol, Kansas City, KS 66205 USA; [Mayo, Matthew S.] Univ Kansas, Med Ctr, Dept Biostat, Kansas City, KS 66205 USA; [Banerjee, Sushanta K.] St Lukes Hosp, Sch Pharm, Div Pharmacol & Toxicol, Kansas City, MO 64112 USA; [Campbell, Donald R.] St Lukes Hosp, Dept Med, Kansas City, MO 64112 USA; Univ Missouri, Kansas City, MO 64112 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; Saint Luke's Hospital - Missouri; Saint Luke's Hospital - Missouri; University of Missouri System; University of Missouri Kansas City	Banerjee, SK (corresponding author), Vet Affairs Med Ctr, Canc Res Unit, Res Div 151, 4801 Linwood Blvd, Kansas City, MO 64128 USA.	sbanerjee2@kumc.edu	Haque, Inamul/I-2482-2019; Mayo, Matthew S/E-3774-2015	Banerjee, Sushanta/0000-0002-7698-0717; Haque, Inamul/0000-0002-1307-9446				Adam L, 2009, CLIN CANCER RES, V15, P5060, DOI 10.1158/1078-0432.CCR-08-2245; Adorno M, 2009, CELL, V137, P87, DOI 10.1016/j.cell.2009.01.039; Anastasiadis PZ, 2001, CURR OPIN CELL BIOL, V13, P604, DOI 10.1016/S0955-0674(00)00258-1; Banerjee S, 2005, MOL CANCER RES, V3, P151, DOI 10.1158/1541-7786.MCR-04-0130; Banerjee S, 2003, NEOPLASIA, V5, P63, DOI 10.1016/S1476-5586(03)80018-0; Banerjee S, 2008, CANCER RES, V68, P7606, DOI 10.1158/0008-5472.CAN-08-1461; Banerjee S, 2006, MOL CARCINOGEN, V45, P871, DOI 10.1002/mc.20248; Blenkiron C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r214; Blenkiron C, 2007, HUM MOL GENET, V16, pR106, DOI 10.1093/hmg/ddm056; Bourguignon LYW, 2010, J BIOL CHEM, V285, P36721, DOI 10.1074/jbc.M110.162305; Brigstock DR, 2003, J ENDOCRINOL, V178, P169, DOI 10.1677/joe.0.1780169; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Christofori G, 2006, NATURE, V441, P444, DOI 10.1038/nature04872; Chung CH, 2002, NAT GENET, V32, P533, DOI 10.1038/ng1038; Dhar G, 2008, CANCER RES, V68, P4580, DOI 10.1158/0008-5472.CAN-08-0316; Dhar G, 2007, CANCER LETT, V254, P63, DOI 10.1016/j.canlet.2007.02.012; Dhar K, 2007, CANCER RES, V67, P1520, DOI 10.1158/0008-5472.CAN-06-3753; Espinosa C. E. Stahlhut, 2006, YALE J BIOL MED, V79, P131; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Farazi TA, 2011, J PATHOL, V223, P102, DOI 10.1002/path.2806; Fritah A, 2008, MOL CELL BIOL, V28, P1114, DOI 10.1128/MCB.01335-07; Gasco M, 2002, BREAST CANCER RES, V4, P70, DOI 10.1186/bcr426; Gurtner A, 2010, J BIOL CHEM, V285, P14160, DOI 10.1074/jbc.M109.094813; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Lim LY, 2009, BRIT J CANCER, V101, P1606, DOI 10.1038/sj.bjc.6605335; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Ma L, 2008, CELL CYCLE, V7, P570, DOI 10.4161/cc.7.5.5547; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Ma L, 2010, NAT BIOTECHNOL, V28, P341, DOI 10.1038/nbt.1618; Mehta SA, 2007, ONCOGENE, V26, P3329, DOI 10.1038/sj.onc.1210120; Negrini M, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1867; Oren M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001107; Parkin DM, 1998, SEMIN CANCER BIOL, V8, P219, DOI 10.1006/scbi.1998.0080; Petroff BK, 2006, ANAL QUANT CYTOL, V28, P297; Ramaswamy S, 2001, P NATL ACAD SCI USA, V98, P15149, DOI 10.1073/pnas.211566398; Rothe F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020980; Russo JW, 2010, J CELL COMMUN SIGNAL, V4, P119, DOI 10.1007/s12079-010-0098-7; Saxena N, 2001, MOL CELL BIOCHEM, V228, P99, DOI 10.1023/A:1013338912642; Sengupta K, 2006, BIOCHEMISTRY-US, V45, P10698, DOI 10.1021/bi060888p; Slack Frank J, 2006, Future Oncol, V2, P73, DOI 10.2217/14796694.2.1.73; Slack Frank J, 2006, Genome Biol, V7, P328, DOI 10.1186/gb-2006-7-9-328; Song YX, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-1; Steeg PS, 2007, NATURE, V449, P671, DOI 10.1038/449671a; Thompson EW, 2005, CANCER RES, V65, P5991, DOI 10.1158/0008-5472.CAN-05-0616; Ventura A, 2009, CELL, V136, P586, DOI 10.1016/j.cell.2009.02.005; Xiang J, 2010, CURR GENOMICS, V11, P129, DOI 10.2174/138920210790886853; Yang AD, 2006, CANCER RES, V66, P46, DOI 10.1158/0008-5472.CAN-05-3086; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang MH, 2008, NAT CELL BIOL, V10, P295, DOI 10.1038/ncb1691; Yu ZR, 2010, AM J PATHOL, V176, P1058, DOI 10.2353/ajpath.2010.090664; Zhang R, 1998, MOL CELL BIOL, V18, P6131, DOI 10.1128/MCB.18.10.6131; Zhu SM, 2008, CELL RES, V18, P350, DOI 10.1038/cr.2008.24; Zou ZQ, 2000, J BIOL CHEM, V275, P6051, DOI 10.1074/jbc.275.9.6051	54	58	60	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					43475	43485		10.1074/jbc.M111.284158	http://dx.doi.org/10.1074/jbc.M111.284158			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22020939	hybrid, Green Published			2022-12-27	WOS:000298351300067
J	Scott-Craig, JS; Borrusch, MS; Banerjee, G; Harvey, CM; Walton, JD				Scott-Craig, John S.; Borrusch, Melissa S.; Banerjee, Goutami; Harvey, Christopher M.; Walton, Jonathan D.			Biochemical and Molecular Characterization of Secreted alpha-Xylosidase from Aspergillus niger	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							XYLOGLUCAN OLIGOSACCHARIDES; DEGRADING ENZYMES; CLASSIFICATION; DECONSTRUCTION; PURIFICATION; MIXTURES; PROTEINS; REVEALS; CLONING	Background: Microbial secreted alpha-xylosidases are rare. Results: An alpha-xylosidase of Aspergillus niger (AxlA) was purified and expressed in Pichia pastoris. Conclusion: Native and recombinant AxlA act on pNP alpha X and isoprimeverose. Together with beta-glucosidase, AxlA degrades xyloglucan (XG) heptasaccharide. Together with xyloglucanase, beta-galactosidase, and beta-glucosidase, it degrades tamarind XG. Significance: The biochemical function of AxlA is established.	[Walton, Jonathan D.] Michigan State Univ, Dept Energy, Plant Res Lab, E Lansing, MI 48824 USA; Michigan State Univ, Dept Energy, Great Lakes Bioenergy Res Ctr, E Lansing, MI 48824 USA	Michigan State University; Michigan State University; United States Department of Energy (DOE)	Walton, JD (corresponding author), Michigan State Univ, Dept Energy, Plant Res Lab, E Lansing, MI 48824 USA.	walton@msu.edu			U.S. Department of Energy Great Lakes Bioenergy Research Center (Department of Energy Office of Science BER ) [DE-FC02-07ER64494]; U.S. Department of Energy, Office of Basic Energy Sciences, Division of Chemical Sciences, Geosciences, and Biosciences [DE-FG02-91ER200021]	U.S. Department of Energy Great Lakes Bioenergy Research Center (Department of Energy Office of Science BER )(United States Department of Energy (DOE)); U.S. Department of Energy, Office of Basic Energy Sciences, Division of Chemical Sciences, Geosciences, and Biosciences(United States Department of Energy (DOE))	This work was supported by the U.S. Department of Energy Great Lakes Bioenergy Research Center (Department of Energy Office of Science BER DE-FC02-07ER64494) and by Grant DE-FG02-91ER200021 to the Michigan State University-Plant Research Laboratory from the U.S. Department of Energy, Office of Basic Energy Sciences, Division of Chemical Sciences, Geosciences, and Biosciences.	Andersen MR, 2008, P NATL ACAD SCI USA, V105, P4387, DOI 10.1073/pnas.0709964105; Andersen MR, 2011, GENOME RES, V21, P885, DOI 10.1101/gr.112169.110; Banerjee G, 2010, BIORESOURCE TECHNOL, V101, P9097, DOI 10.1016/j.biortech.2010.07.028; Banerjee G, 2010, BIOTECHNOL BIOENG, V106, P707, DOI 10.1002/bit.22741; Banerjee G, 2010, BIOENERG RES, V3, P82, DOI 10.1007/s12155-009-9067-5; Bauer S, 2006, P NATL ACAD SCI USA, V103, P11417, DOI 10.1073/pnas.0604632103; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carpita N., 2000, BIOCH MOL BIOL PLANT, P52; Chaillou S, 1998, J BACTERIOL, V180, P2312, DOI 10.1128/JB.180.9.2312-2320.1998; de Oliveira JMPF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020865; Foster CE, 2010, J VIS EXP, DOI [10.3791/1837, DOI 10.3791/1837]; FRY SC, 1993, PHYSIOL PLANTARUM, V89, P1; Gonzalez-Vogel A, 2011, APPL MICROBIOL BIOT, V89, P145, DOI 10.1007/s00253-010-2953-0; Grishutin SG, 2004, BBA-GEN SUBJECTS, V1674, P268, DOI 10.1016/j.bbagen.2004.07.001; HAYASHI T, 1989, ANNU REV PLANT PHYS, V40, P139, DOI 10.1146/annurev.pp.40.060189.001035; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; Hsieh YSY, 2009, MOL PLANT, V2, P943, DOI 10.1093/mp/ssp061; Jorgensen TR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-44; Larsbrink J, 2011, BIOCHEM J, V436, P567, DOI 10.1042/BJ20110299; LORENCES EP, 1994, CARBOHYD RES, V263, P285, DOI 10.1016/0008-6215(94)00170-7; Matsuo M, 1996, BIOSCI BIOTECH BIOCH, V60, P341, DOI 10.1271/bbb.60.341; MATSUSHITA J, 1987, AGR BIOL CHEM TOKYO, V51, P2015, DOI 10.1080/00021369.1987.10868301; McIlvaine TC, 1921, J BIOL CHEM, V49, P183; Moracci M, 2000, J BIOL CHEM, V275, P22082, DOI 10.1074/jbc.M910392199; Nagendran S, 2009, FUNGAL GENET BIOL, V46, P427, DOI 10.1016/j.fgb.2009.02.001; Nakai H, 2007, J BIOCHEM, V142, P491, DOI 10.1093/jb/mvm174; Okuyama M, 2004, PROTEIN EXPRES PURIF, V37, P170, DOI 10.1016/j.pep.2004.05.008; ONEILL RA, 1989, J BIOL CHEM, V264, P20430; Pauly M, 2008, PLANT J, V54, P559, DOI 10.1111/j.1365-313X.2008.03463.x; Pel HJ, 2007, NAT BIOTECHNOL, V25, P221, DOI 10.1038/nbt1282; Sampedro J, 2001, PLANT PHYSIOL, V126, P910, DOI 10.1104/pp.126.2.910; van den Brink J, 2011, APPL MICROBIOL BIOT, V91, P1477, DOI 10.1007/s00253-011-3473-2; Yang B, 2011, BIOFUELS-UK, V2, P421, DOI 10.4155/BFS.11.116; YOSHIKAWA K, 1994, BIOSCI BIOTECH BIOCH, V58, P1392, DOI 10.1271/bbb.58.1392; Yuan XL, 2008, MOL GENET GENOMICS, V279, P545, DOI 10.1007/s00438-008-0332-7	35	21	26	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					42848	42854		10.1074/jbc.M111.307397	http://dx.doi.org/10.1074/jbc.M111.307397			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22033931	Green Published, hybrid			2022-12-27	WOS:000298351300006
J	Abu Jawdeh, BG; Khan, S; Deschenes, I; Hoshi, M; Goel, M; Lock, JT; Shinlapawittayatorn, K; Babcock, G; Lakhe-Reddy, S; DeCaro, G; Yadav, SP; Mohan, ML; Prasad, SVN; Schilling, WP; Ficker, E; Schelling, JR				Abu Jawdeh, Bassam G.; Khan, Shenaz; Deschenes, Isabelle; Hoshi, Malcolm; Goel, Monu; Lock, Jeffrey T.; Shinlapawittayatorn, Krekwit; Babcock, Gerald; Lakhe-Reddy, Sujata; DeCaro, Garren; Yadav, Satya P.; Mohan, Maradumane L.; Prasad, Sathyamangla V. Naga; Schilling, William P.; Ficker, Eckhard; Schelling, Jeffrey R.			Phosphoinositide Binding Differentially Regulates NHE1 Na+/H+ Exchanger-dependent Proximal Tubule Cell Survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOLIPASE-C ACTIVATION; PLASMA-MEMBRANE; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; RENAL-FUNCTION; APOPTOSIS; PROTEIN; PH; ISOFORMS; DOMAIN; PIP2	Tubular atrophy predicts chronic kidney disease progression, and is caused by proximal tubular epithelial cell (PTC) apoptosis. The normally quiescent Na+/H+ exchanger-1 (NHE1) defends against PTC apoptosis, and is regulated by PI(4,5)P-2 binding. Because of the vast array of plasma membrane lipids, we hypothesized that NHE1-mediated cell survival is dynamically regulated by multiple anionic inner leaflet phospholipids. In membrane overlay and surface plasmon resonance assays, the NHE1 C terminus bound phospholipids with low affinity and according to valence (PIP3 > PIP2> PIP = PA > PS). NHE1-phosphoinositide binding was enhanced by acidic pH, and abolished by NHE1 Arg/Lys to Ala mutations within two juxtamembrane domains, consistent with electrostatic interactions. PI(4,5)P-2-incorporated vesicles were distributed to apical and lateral PTC domains, increased NHE1-regulated Na+/H+ exchange, and blunted apoptosis, whereas NHE1 activity was decreased in cells enriched with PI(3,4,5)P-3, which localized to basolateral membranes. Divergent PI(4,5)P-2 and PI(3,4,5)P-3 effects on NHE1-dependent Na+/H+ exchange and apoptosis were confirmed by selective phosphoinositide sequestration with pleckstrin homology domain-containing phospholipase C delta and Akt peptides, PI 3-kinase, and Akt inhibition in wild-type and NHE1-null PTCs. The results reveal an on-off switch model, whereby NHE1 toggles between weak interactions with PI(4,5)P-2 and PI(3,4,5)P-3. In response to apoptotic stress, NHE1 is stimulated by PI(4,5)P-2, which leads to PI 3-kinase activation, and PI(4,5)P-2 phosphorylation. The resulting PI(3,4,5)P-3 dually stimulates sustained, downstream Akt survival signaling, and dampens NHE1 activity through competitive inhibition and depletion of PI(4,5)P-2.	[Schelling, Jeffrey R.] Case Western Reserve Univ, Rammelkamp Ctr Res, Dept Med, Cleveland, OH 44109 USA; [Deschenes, Isabelle; Hoshi, Malcolm; Goel, Monu; Lock, Jeffrey T.; Shinlapawittayatorn, Krekwit; Babcock, Gerald; Schilling, William P.] Case Western Reserve Univ, Dept Physiol & Biophys, Lerner Res Inst, Cleveland, OH 44109 USA; [Yadav, Satya P.; Mohan, Maradumane L.; Prasad, Sathyamangla V. Naga] Case Western Reserve Univ, Cleveland Clin Fdn, Cleveland, OH 44109 USA	Case Western Reserve University; MetroHealth System; Case Western Reserve University; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation	Schelling, JR (corresponding author), Case Western Reserve Univ, Rammelkamp Ctr Res, Dept Med, 2500 MetroHlth Dr,R415, Cleveland, OH 44109 USA.	jeffrey.schelling@case.edu	Shinlapawittayatorn, Krekwit/AAW-2698-2021	Shinlapawittayatorn, Krekwit/0000-0003-1114-0087; Lock, Jeffrey T./0000-0003-1522-3189	National Institutes of Health [R01 DK067528, R01 DK072348, R01 HL097355]; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097355] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067528, R01DK072348] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007250] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK067528 and R01 DK072348 (to J. R. S.) and R01 HL097355 (to W. P. S.) and an American Heart Association fellowship grant (to B. G. A. J.).	Aharonovitz O, 2000, J CELL BIOL, V150, P213, DOI 10.1083/jcb.150.1.213; Alexander RT, 2011, EMBO J, V30, P679, DOI 10.1038/emboj.2010.356; Antonsson B, 1997, SCIENCE, V277, P370, DOI 10.1126/science.277.5324.370; Bachmann O, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-70; Bal M, 2008, J PHYSIOL-LONDON, V586, P2307, DOI 10.1113/jphysiol.2008.152777; BARBER DL, 1991, CELL SIGNAL, V3, P387, DOI 10.1016/0898-6568(91)90069-7; Baumgartner M, 2004, AM J PHYSIOL-CELL PH, V287, pC844, DOI 10.1152/ajpcell.00094.2004; BIEMESDERFER D, 1992, AM J PHYSIOL, V263, pF833, DOI 10.1152/ajprenal.1992.263.5.F833; Blin G, 2008, BIOPHYS J, V94, P1021, DOI 10.1529/biophysj.107.110213; Bohle A, 1996, KIDNEY INT, V49, pS2; Bourguignon LYW, 2004, J BIOL CHEM, V279, P26991, DOI 10.1074/jbc.M311838200; Bullis BL, 2002, EUR J BIOCHEM, V269, P4887, DOI 10.1046/j.1432-1033.2002.03202.x; Bunnag S, 2009, J AM SOC NEPHROL, V20, P1149, DOI 10.1681/ASN.2008080863; Cheng WWL, 2011, BIOPHYS J, V100, P620, DOI 10.1016/j.bpj.2010.12.3724; Cooke FT, 2010, METHODS MOL BIOL, V645, P179, DOI 10.1007/978-1-60327-175-2_12; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Cox GA, 1997, CELL, V91, P139, DOI 10.1016/S0092-8674(01)80016-7; Denker SP, 2000, MOL CELL, V6, P1425, DOI 10.1016/S1097-2765(00)00139-8; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Dibrov P, 2000, BIOSCIENCE REP, V20, P185, DOI 10.1023/A:1005567519792; Frantz C, 2008, J CELL BIOL, V183, P865, DOI 10.1083/jcb.200804161; Fujita A, 2009, P NATL ACAD SCI USA, V106, P9256, DOI 10.1073/pnas.0900216106; Fuster D, 2004, P NATL ACAD SCI USA, V101, P10482, DOI 10.1073/pnas.0403930101; Gamper N, 2007, NAT REV NEUROSCI, V8, P921, DOI 10.1038/nrn2257; Gassama-Diagne A, 2006, NAT CELL BIOL, V8, P963, DOI 10.1038/ncb1461; Hansen SB, 2011, NATURE, V477, P495, DOI 10.1038/nature10370; Hilgemann DW, 1996, SCIENCE, V273, P956, DOI 10.1126/science.273.5277.956; Huang BX, 2011, J CELL BIOL, V192, P979, DOI 10.1083/jcb.201005100; KAPUS A, 1994, J BIOL CHEM, V269, P23544; Khan S, 2006, CELL MOL BIOL, V52, P115, DOI 10.1170/T769; Khan S, 1999, LAB INVEST, V79, P1089; Kumar D, 2004, MOL CELL BIOCHEM, V259, P67, DOI 10.1023/B:MCBI.0000021346.03260.7e; Kunkel MT, 2005, J BIOL CHEM, V280, P5581, DOI 10.1074/jbc.M411534200; LACOWICZ JR, 2006, PRINCIPLES FLUORESCE, P443; Lagadic-Gossmann D, 2004, CELL DEATH DIFFER, V11, P953, DOI 10.1038/sj.cdd.4401466; Lagana A, 2000, J CELL SCI, V113, P3649; Lindsay Y, 2006, J CELL SCI, V119, P5160, DOI 10.1242/jcs.000133; Lishko VK, 2004, J BIOL CHEM, V279, P44897, DOI 10.1074/jbc.M408012200; Liu AP, 2006, BIOPHYS J, V91, P4064, DOI 10.1529/biophysj.106.090852; Martin-Belmonte F, 2007, CELL, V128, P383, DOI 10.1016/j.cell.2006.11.051; Matsuyama S, 2000, NAT CELL BIOL, V2, P318, DOI 10.1038/35014006; McCullough PA, 2010, AM J KIDNEY DIS, V55, pS1, DOI 10.1053/j.ajkd.2009.12.017; McLaughlin S, 2002, ANNU REV BIOPH BIOM, V31, P151, DOI 10.1146/annurev.biophys.31.082901.134259; Meima ME, 2009, J BIOL CHEM, V284, P26666, DOI 10.1074/jbc.M109.019448; Mejillano M, 2001, J BIOL CHEM, V276, P1865, DOI 10.1074/jbc.M007271200; MIAO B, 2010, P NATL ACAD SCI US; Mohan S, 2010, J BIOL CHEM, V285, P34566, DOI 10.1074/jbc.M110.165712; Nath SK, 1996, AM J PHYSIOL-GASTR L, V270, pG431, DOI 10.1152/ajpgi.1996.270.3.G431; ORLOWSKI J, 1992, J BIOL CHEM, V267, P9331; ORLOWSKI J, 1993, J BIOL CHEM, V268, P16369; Ortiz A, 2000, KIDNEY INT, V58, P467, DOI 10.1046/j.1523-1755.2000.00188.x; Papayannopoulos V, 2005, MOL CELL, V17, P181, DOI 10.1016/j.molcel.2004.11.054; Pochynyuk O, 2006, AM J PHYSIOL-RENAL, V290, pF949, DOI 10.1152/ajprenal.00386.2005; Prasad SVN, 2005, NAT CELL BIOL, V7, P785, DOI 10.1038/ncb1278; RISDON RA, 1968, LANCET, V2, P363; Rohacs T, 2003, P NATL ACAD SCI USA, V100, P745, DOI 10.1073/pnas.0236364100; Rohacs T, 2009, CELL CALCIUM, V45, P554, DOI 10.1016/j.ceca.2009.03.011; Schainuck L I, 1970, Hum Pathol, V1, P631, DOI 10.1016/S0046-8177(70)80061-2; Schelling JR, 2008, AM J PHYSIOL-RENAL, V295, pF625, DOI 10.1152/ajprenal.90212.2008; Schelling JR, 1999, KIDNEY INT, V56, P1313, DOI 10.1046/j.1523-1755.1999.00684.x; SCHELLING JR, 1992, J CLIN INVEST, V90, P2472, DOI 10.1172/JCI116139; SCHELLING JR, 1994, KIDNEY INT, V46, P675, DOI 10.1038/ki.1994.320; Schelling JR, 1998, LAB INVEST, V78, P813; Segal MS, 2001, AM J PHYSIOL-CELL PH, V281, pC1196, DOI 10.1152/ajpcell.2001.281.4.C1196; SHINLAPAWITTAYA.K, 2011, CIRC CARDIO IN PRESS; Snabaitis AK, 2008, CIRC RES, V103, P881, DOI 10.1161/CIRCRESAHA.108.175877; Soleimani M, 1998, KIDNEY INT, V53, P423, DOI 10.1046/j.1523-1755.1998.00771.x; Susztak K, 2005, PLOS MED, V2, P152, DOI 10.1371/journal.pmed.0020045; Varnai P, 2005, J CELL SCI, V118, P4879, DOI 10.1242/jcs.02606; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Wakabayashi S, 1997, PHYSIOL REV, V77, P51, DOI 10.1152/physrev.1997.77.1.51; Wakabayashi S, 2010, J BIOL CHEM, V285, P26652, DOI 10.1074/jbc.M110.130120; Wang JY, 2001, J BIOL CHEM, V276, P5012, DOI 10.1074/jbc.M008355200; Wu KL, 2003, AM J PHYSIOL-RENAL, V284, pF829, DOI 10.1152/ajprenal.00314.2002; Wu Y, 2006, TRENDS CELL BIOL, V16, P189, DOI 10.1016/j.tcb.2006.02.003	76	26	27	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42435	42445		10.1074/jbc.M110.212845	http://dx.doi.org/10.1074/jbc.M110.212845			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	22020933	Green Published, hybrid			2022-12-27	WOS:000298180900052
J	Li, WG; Yu, Y; Huang, C; Cao, H; Xu, TL				Li, Wei-Guang; Yu, Ye; Huang, Chen; Cao, Hui; Xu, Tian-Le			Nonproton Ligand Sensing Domain Is Required for Paradoxical Stimulation of Acid-sensing Ion Channel 3 (ASIC3) Channels by Amiloride	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED CATION CHANNEL; NA+ CHANNEL; INFLAMMATORY PAIN; MOLECULAR-CLONING; SENSORY NEURONS; CONTRIBUTES; CALCIUM; MODULATION; ISCHEMIA; LINKER	Acid-sensing ion channels (ASICs), which belong to the epithelial sodium channel/degenerin family, are activated by extracellular protons and are inhibited by amiloride (AMI), an important pharmacological tool for studying all known members of epithelial sodium channel/degenerin. In this study, we reported that AMI paradoxically opened homomeric ASIC3 and heteromeric ASIC3 plus ASIC1b channels at neutral pH and synergistically enhanced channel activation induced by mild acidosis (pH 7.2 to 6.8). The characteristic profile of AMI stimulation of ASIC3 channels was reminiscent of the channel activation by the newly identified nonproton ligand, 2-guanidine-4-methylquinazoline. Using site-directed mutagenesis, we showed that ASIC3 activation by AMI, but not its inhibitory effect, was dependent on the integrity of the nonproton ligand sensing domain in ASIC3 channels. Moreover, the structure-activity relationship study demonstrated the differential requirement of the 5-amino group in AMI for the stimulation or inhibition effect, strengthening the different interactions within ASIC3 channels that confer the paradoxical actions of AMI. Furthermore, using covalent modification analyses, we provided strong evidence supporting the nonproton ligand sensing domain is required for the stimulation of ASIC3 channels by AMI. Finally, we showed that AMI causes pain-related behaviors in an ASIC3-dependent manner. These data reinforce the idea that ASICs can sense nonproton ligands in addition to protons. The results also indicate caution in the use of AMI for studying ASIC physiology and in the development of AMI-derived ASIC inhibitors for treating pain syndromes.	[Li, Wei-Guang; Yu, Ye; Cao, Hui; Xu, Tian-Le] Chinese Acad Sci, Inst Neurosci, Shanghai 200031, Peoples R China; [Li, Wei-Guang; Yu, Ye; Cao, Hui; Xu, Tian-Le] Chinese Acad Sci, State Key Lab Neurosci, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China; [Yu, Ye] Shanghai Jiao Tong Univ, Sch Med, Dept Physiol, Inst Med Sci, Shanghai 200025, Peoples R China; [Li, Wei-Guang; Huang, Chen; Cao, Hui; Xu, Tian-Le] Shanghai Jiao Tong Univ, Sch Med, Dept Biochem & Mol Cell Biol, Inst Med Sci, Shanghai 200025, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Xu, TL (corresponding author), 280 S Chongqing Rd, Shanghai 200025, Peoples R China.	xu-happiness@shsmu.edu.cn			National Natural Science Foundation of China [30830035]; National Basic Research Program of China [2011CBA00408]; Shanghai Municipal Government [09XD1404900]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Shanghai Municipal Government	This work was supported by National Natural Science Foundation of China Grant 30830035, National Basic Research Program of China Grant 2011CBA00408, and Shanghai Municipal Government Grant 09XD1404900.	Adams CM, 1998, J BIOL CHEM, V273, P30204, DOI 10.1074/jbc.273.46.30204; Adams CM, 1999, J BIOL CHEM, V274, P15500, DOI 10.1074/jbc.274.22.15500; Askwith CC, 2000, NEURON, V26, P133, DOI 10.1016/S0896-6273(00)81144-7; Babinski K, 1999, J NEUROCHEM, V72, P51, DOI 10.1046/j.1471-4159.1999.0720051.x; Bagriantsev SN, 2010, NEURON, V68, P1, DOI 10.1016/j.neuron.2010.09.038; Catarsi S, 2001, NEUROPHARMACOLOGY, V41, P592, DOI 10.1016/S0028-3908(01)00107-1; Chen CC, 2002, P NATL ACAD SCI USA, V99, P8992, DOI 10.1073/pnas.122245999; Chen XM, 2006, NEUROPHARMACOLOGY, V50, P964, DOI 10.1016/j.neuropharm.2006.01.007; Cushman KA, 2007, J GEN PHYSIOL, V129, P345, DOI 10.1085/jgp.200709757; de Weille JR, 1998, FEBS LETT, V433, P257, DOI 10.1016/S0014-5793(98)00916-8; Deval E, 2008, EMBO J, V27, P3047, DOI 10.1038/emboj.2008.213; Deval E, 2010, PHARMACOL THERAPEUT, V128, P549, DOI 10.1016/j.pharmthera.2010.08.006; Duan B, 2007, J NEUROSCI, V27, P11139, DOI 10.1523/JNEUROSCI.3364-07.2007; Dube GR, 2005, PAIN, V117, P88, DOI 10.1016/j.pain.2005.05.021; FRELIN C, 1988, BIOCHIMIE, V70, P1285, DOI 10.1016/0300-9084(88)90196-4; Gao J, 2005, NEURON, V48, P635, DOI 10.1016/j.neuron.2005.10.011; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Krishtal O, 2003, TRENDS NEUROSCI, V26, P477, DOI 10.1016/S0166-2236(03)00210-8; Kuduk SD, 2009, BIOORG MED CHEM LETT, V19, P2514, DOI 10.1016/j.bmcl.2009.03.029; Li TB, 2010, J BIOL CHEM, V285, P31285, DOI 10.1074/jbc.M110.160382; Li TB, 2010, J BIOL CHEM, V285, P22706, DOI 10.1074/jbc.M110.134114; Li WG, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-88; Li WG, 2011, ACS CHEM NEUROSCI, V2, P26, DOI 10.1021/cn100094b; Li YF, 2003, NEUROSCI LETT, V345, P173, DOI 10.1016/S0304-3940(03)00541-X; Lu YJ, 2009, NEURON, V64, P885, DOI 10.1016/j.neuron.2009.11.007; Mazzuca M, 2007, NAT NEUROSCI, V10, P943, DOI 10.1038/nn1940; Page AJ, 2005, GUT, V54, P1408, DOI 10.1136/gut.2005.071084; Price MP, 2000, NATURE, V407, P1007, DOI 10.1038/35039512; Price MP, 2001, NEURON, V32, P1071, DOI 10.1016/S0896-6273(01)00547-5; Qadri YJ, 2010, J BIOL CHEM, V285, P9627, DOI 10.1074/jbc.M109.082735; Salinas M, 2009, J BIOL CHEM, V284, P31851, DOI 10.1074/jbc.M109.043984; Sluka KA, 2003, PAIN, V106, P229, DOI 10.1016/S0304-3959(03)00269-0; Springauf A, 2011, J BIOL CHEM, V286, P24374, DOI 10.1074/jbc.M111.230797; Sutherland SP, 2001, P NATL ACAD SCI USA, V98, P711, DOI 10.1073/pnas.011404498; TANG CM, 1988, SCIENCE, V240, P213, DOI 10.1126/science.2451291; Waldmann R, 1997, J BIOL CHEM, V272, P20975, DOI 10.1074/jbc.272.34.20975; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Wemmie JA, 2002, NEURON, V34, P463, DOI 10.1016/S0896-6273(02)00661-X; Wemmie JA, 2006, TRENDS NEUROSCI, V29, P578, DOI 10.1016/j.tins.2006.06.014; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; Xu TL, 2009, PROG NEUROBIOL, V87, P171, DOI 10.1016/j.pneurobio.2009.01.004; Yagi J, 2006, CIRC RES, V99, P501, DOI 10.1161/01.RES.0000238388.79295.4c; Yu Y, 2011, J BIOL CHEM, V286, P24996, DOI 10.1074/jbc.M111.239558; Yu Y, 2010, NEURON, V68, P61, DOI 10.1016/j.neuron.2010.09.001; Ziemann AE, 2008, NAT NEUROSCI, V11, P816, DOI 10.1038/nn.2132; Ziemann AE, 2009, CELL, V139, P1012, DOI 10.1016/j.cell.2009.10.029	47	36	36	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42635	42646		10.1074/jbc.M111.289058	http://dx.doi.org/10.1074/jbc.M111.289058			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	21998313	Green Published, hybrid			2022-12-27	WOS:000298180900071
J	Rawat, R; Sandoval, FJ; Wei, ZY; Winkler, R; Roje, S				Rawat, Renu; Sandoval, Francisco J.; Wei, Zhaoyang; Winkler, Robert; Roje, Sanja			An FMN Hydrolase of the Haloacid Dehalogenase Superfamily Is Active in Plant Chloroplasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLAVIN-ADENINE-DINUCLEOTIDE; WEIGHT ACID-PHOSPHATASE; PARTIAL-PURIFICATION; FAD PYROPHOSPHATASE; PHASEOLUS RADIATUS; RIBOFLAVIN KINASE; MASS-SPECTROMETRY; STATISTICAL-MODEL; RAT-LIVER; BIOSYNTHESIS	FMN hydrolases catalyze dephosphorylation of FMN to riboflavin. Although these enzymes have been described in many organisms, few had their corresponding genes cloned and their recombinant proteins biochemically characterized, and none had their physiological roles determined. We found previously that FMN hydrolase activity in pea chloroplasts is Mg2+-dependent, suggesting an enzyme of the haloacid dehalogenase (HAD) superfamily. In this study, a new FMN hydrolase was purified by multistep chromatography after ammonium sulfate precipitation. The molecular weight of the native protein was estimated at similar to 59,400, a dimer of about twice the predicted molecular weight of most HAD superfamily phosphatases. After SDS-PAGE of the partially purified material, two separate protein bands within 25-30 kDa were extracted from the gel and analyzed by nanoLC-MS/MS. Peptide sequence matching to the protein samples suggested the presence of three HAD-like hydrolases. cDNAs for sequence homologs from Arabidopsis thaliana of these proteins were expressed in Escherichia coli. Activity screening of the encoded proteins showed that the At1g79790 gene encodes an FMN hydrolase (AtcpFHy1). Plastid localization of AtcpFHy1 was confirmed using fluorescence microscopy of A. thaliana protoplasts transiently expressing the N-terminal fusion of AtcpFHy1 to enhanced green fluorescent protein. Phosphatase activity of AtcpFHy1 is FMN-specific, as assayed with 19 potential substrates. Kinetic parameters and pH and temperature optima for AtcpFHy1 were determined. A phylogenetic analysis of putative phosphatases of the HAD superfamily suggested distinct evolutionary origins for the plastid AtcpFHy1 and the cytosolic FMN hydrolase characterized previously.	[Rawat, Renu; Sandoval, Francisco J.; Wei, Zhaoyang; Roje, Sanja] Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA; [Winkler, Robert] Inst Tecnol & Estudios Super Monterrey, Dept Biotecnol & Tecnol Alimentos, Monterrey 64849, Nuevo Leon, Mexico	Washington State University; Tecnologico de Monterrey	Roje, S (corresponding author), Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA.	sanja@wsu.edu	Winkler, Robert/A-1500-2009	Winkler, Robert/0000-0001-6732-1958; Roje, Sanja/0000-0002-6302-5382	United States National Institute of Food and Agriculture [2007-35318-18438]; National Science Foundation [MCB-1052492]; Murdoch Foundation; Instituto Tecnologico y de Estudios Superiores de Monterrey (Mexico) [CAT 161]	United States National Institute of Food and Agriculture; National Science Foundation(National Science Foundation (NSF)); Murdoch Foundation; Instituto Tecnologico y de Estudios Superiores de Monterrey (Mexico)	This work was supported by the United States National Institute of Food and Agriculture under National Research Initiative Competitive Grant 2007-35318-18438 (to S. R.), the National Science Foundation Grant MCB-1052492 (to S. R.), the Murdoch Foundation, and the Instituto Tecnologico y de Estudios Superiores de Monterrey (Mexico) under Bioengineering and Nano-particles Research Chair Grant CAT 161 (to R. W.).	Bacher A, 2001, VITAM HORM, V61, P1; Bacher A, 2000, ANNU REV NUTR, V20, P153, DOI 10.1146/annurev.nutr.20.1.153; Barile M, 1997, EUR J BIOCHEM, V249, P777, DOI 10.1111/j.1432-1033.1997.00777.x; Barsnes H, 2009, NAT BIOTECHNOL, V27, P598, DOI 10.1038/nbt0709-598; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BYRD JC, 1985, J BIOL CHEM, V260, P7474; Caparros-Martin JA, 2007, PLANT MOL BIOL, V63, P505, DOI 10.1007/s11103-006-9104-0; CLINE K, 1986, J BIOL CHEM, V261, P4804; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Doerner P, 2008, CURR OPIN PLANT BIOL, V11, P536, DOI 10.1016/j.pbi.2008.05.006; DOUCE R, 1987, METHOD ENZYMOL, V148, P403; FUCHS KR, 1992, BIOCHEM BIOPH RES CO, V189, P1598, DOI 10.1016/0006-291X(92)90259-N; Garcia NAT, 2004, PLANT PHYSIOL BIOCH, V42, P585, DOI 10.1016/j.plaphy.2004.04.004; Geer LY, 2004, J PROTEOME RES, V3, P958, DOI 10.1021/pr0499491; Giancaspero TA, 2009, FEBS J, V276, P219, DOI 10.1111/j.1742-4658.2008.06775.x; Granjeiro JM, 1997, BIOCHEM MOL BIOL INT, V41, P1201; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; KUMAR SA, 1963, BIOCHIM BIOPHYS ACTA, V73, P98; KUMAR SA, 1965, ARCH BIOCHEM BIOPHYS, V111, P646, DOI 10.1016/0003-9861(65)90246-8; Kuznetsova E, 2006, J BIOL CHEM, V281, P36149, DOI 10.1074/jbc.M605449200; LEE RSF, 1988, J BIOL CHEM, V263, P14878; Lin WY, 2009, J EXP BOT, V60, P1427, DOI 10.1093/jxb/ern303; MCCORMICK DB, 1962, COMP BIOCHEM PHYSIOL, V5, P113, DOI 10.1016/0010-406X(62)90123-8; Meyer S. L., 1975, DATA ANAL SCI ENG, P39; MITSUDA H, 1970, J VITAMINOL, V16, P52, DOI 10.5925/jnsv1954.16.52; MITSUDA H, 1965, J VITAMINOL, V11, P20, DOI 10.5925/jnsv1954.11.20; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Ogawa T, 2008, PLANT PHYSIOL, V148, P1412, DOI 10.1104/pp.108.128413; Pratt J, 2009, PLANT PHYSIOL, V151, P1646, DOI 10.1104/pp.109.144626; Roje S, 2007, PHYTOCHEMISTRY, V68, P1904, DOI 10.1016/j.phytochem.2007.03.038; Rouached H, 2010, MOL PLANT, V3, P288, DOI 10.1093/mp/ssp120; Sandoval FJ, 2005, J BIOL CHEM, V280, P38337, DOI 10.1074/jbc.M500350200; Sandoval FJ, 2008, J BIOL CHEM, V283, P30890, DOI 10.1074/jbc.M803416200; SENSABAUGH GF, 1978, AM J HUM GENET, V30, P553; Sheen J, 2001, PLANT PHYSIOL, V127, P1466, DOI 10.1104/pp.010820; SHIN H, 1988, ARCH BIOCHEM BIOPHYS, V267, P95, DOI 10.1016/0003-9861(88)90012-4; Strohalm M, 2010, ANAL CHEM, V82, P4648, DOI 10.1021/ac100818g; TAGA EM, 1982, ARCH BIOCHEM BIOPHYS, V214, P505, DOI 10.1016/0003-9861(82)90054-6; ZHANG ZY, 1990, ARCH BIOCHEM BIOPHYS, V282, P39, DOI 10.1016/0003-9861(90)90084-C	40	16	19	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42091	42098		10.1074/jbc.M111.260885	http://dx.doi.org/10.1074/jbc.M111.260885			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	22002057	hybrid, Green Published			2022-12-27	WOS:000298180900019
J	Palczewski, K				Palczewski, Krzysztof			Chemistry and Biology of Vision	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							PROTEIN-COUPLED RECEPTOR; LEBER-CONGENITAL-AMAUROSIS; RETINAL-PIGMENT EPITHELIUM; ROD OUTER SEGMENTS; ALL-TRANS-RETINOL; CRYSTAL-STRUCTURE; MOUSE MODEL; 3-DIMENSIONAL STRUCTURE; VISUAL CYCLE; STRUCTURAL DETERMINANTS	Visual perception in humans occurs through absorption of electromagnetic radiation from 400 to 780 nm by photoreceptors in the retina. A photon of visible light carries a sufficient amount of energy to cause, when absorbed, a cis,trans-geometric isomerization of the 11-cis-retinal chromophore, a vitamin A derivative bound to rhodopsin and cone opsins of retinal photoreceptors. The unique biochemistry of these complexes allows us to reliably and reproducibly collect continuous visual information about our environment. Moreover, other nonconventional retinal opsins such as the circadian rhythm regulator melanopsin also initiate light-activated signaling based on similar photochemistry.	Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA	Case Western Reserve University	Palczewski, K (corresponding author), Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA.	kxp65@case.edu			National Institutes of Health [EY009339]; NATIONAL EYE INSTITUTE [R01EY008061, R01EY009339] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grant EY009339. This is the first article in the Thematic Minireview Series on Focus on Vision.	Ames JB, 1999, J BIOL CHEM, V274, P19329, DOI 10.1074/jbc.274.27.19329; Ames JB, 1997, NATURE, V389, P198, DOI 10.1038/38310; Angel TE, 2009, P NATL ACAD SCI USA, V106, P8555, DOI 10.1073/pnas.0903545106; Arora A, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-1; Arshavsky VY, 2002, ANNU REV PHYSIOL, V64, P153, DOI 10.1146/annurev.physiol.64.082701.102229; Batten ML, 2005, PLOS MED, V2, P1177, DOI 10.1371/journal.pmed.0020333; Batten ML, 2004, J BIOL CHEM, V279, P10422, DOI 10.1074/jbc.M312410200; BLAUROCK AE, 1969, NATURE, V223, P906, DOI 10.1038/223906a0; BOK D, 1993, J CELL SCI, P189; Chen SK, 2011, NATURE, V476, P92, DOI 10.1038/nature10206; Choe HW, 2011, NATURE, V471, P651, DOI 10.1038/nature09789; Corbo JC, 2005, PLOS GENET, V1, P140, DOI 10.1371/journal.pgen.0010011; CORLESS JM, 1995, EXP EYE RES, V61, P335, DOI 10.1016/S0014-4835(05)80128-9; DAEMEN FJM, 1973, BIOCHIM BIOPHYS ACTA, V300, P255, DOI 10.1016/0304-4157(73)90006-3; Damiani D, 2008, J NEUROSCI, V28, P4878, DOI 10.1523/JNEUROSCI.0828-08.2008; Dell'Orco D, 2011, BIOCHEM J, V440, P263, DOI 10.1042/BJ20110871; FEIN A, 1982, PHOTORECEPTORS THEIR; Filipek S, 2003, ANNU REV PHYSIOL, V65, P851, DOI 10.1146/annurev.physiol.65.092101.142611; Fotiadis D, 2006, CURR OPIN STRUC BIOL, V16, P252, DOI 10.1016/j.sbi.2006.03.013; Fotiadis D, 2003, NATURE, V421, P127, DOI 10.1038/421127a; Goc A, 2010, J MOL BIOL, V401, P363, DOI 10.1016/j.jmb.2010.06.044; Granzin J, 1998, NATURE, V391, P918, DOI 10.1038/36147; Gurzadyan GG, 2007, PHYS CHEM CHEM PHYS, V9, P288, DOI 10.1039/b609165m; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; He XQ, 2009, P NATL ACAD SCI USA, V106, P18545, DOI 10.1073/pnas.0907454106; Hofmann KP, 2009, TRENDS BIOCHEM SCI, V34, P540, DOI 10.1016/j.tibs.2009.07.005; Humphries MM, 1997, NAT GENET, V15, P216, DOI 10.1038/ng0297-216; Imanishi Y, 2004, J CELL BIOL, V164, P373, DOI 10.1083/jcb.200311079; Jastrzebska B, 2011, J STRUCT BIOL, V176, P387, DOI 10.1016/j.jsb.2011.08.016; Jastrzebska B, 2011, PROG LIPID RES, V50, P267, DOI 10.1016/j.plipres.2011.03.002; Jeon CJ, 1998, J NEUROSCI, V18, P8936; Kajimura N, 2002, J STRUCT BIOL, V139, P27, DOI 10.1016/S1047-8477(02)00502-6; Karali M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-715; Kevany BM, 2010, PHYSIOLOGY, V25, P8, DOI 10.1152/physiol.00038.2009; Kiser PD, 2010, PROG RETIN EYE RES, V29, P428, DOI 10.1016/j.preteyeres.2010.03.002; Kiser PD, 2009, P NATL ACAD SCI USA, V106, P17325, DOI 10.1073/pnas.0906600106; KUHNE W, 1977, VISION RES, V17, P1269, DOI 10.1016/0042-6989(77)90114-6; LAMBRIGHT DG, 1994, NATURE, V369, P621, DOI 10.1038/369621a0; Liang XQ, 2001, J BIOL CHEM, V276, P30987, DOI 10.1074/jbc.M104018200; Liang Y, 2003, J BIOL CHEM, V278, P21655, DOI 10.1074/jbc.M302536200; Liang Y, 2004, J BIOL CHEM, V279, P48189, DOI 10.1074/jbc.M408362200; LINDEN H, 1994, PLANT MOL BIOL, V24, P369, DOI 10.1007/BF00020174; Lobanova ES, 2007, J NEUROSCI, V27, P1151, DOI 10.1523/JNEUROSCI.5010-06.2007; Maeda A, 2009, J BIOL CHEM, V284, P15173, DOI 10.1074/jbc.M900322200; Mata NL, 2002, NEURON, V36, P69, DOI 10.1016/S0896-6273(02)00912-1; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; MATTHEWS RG, 1963, J GEN PHYSIOL, V47, P215, DOI 10.1085/jgp.47.2.215; Mayhew TM, 1997, J NEUROCYTOL, V26, P53, DOI 10.1023/A:1018563409196; McBee JK, 2000, BIOCHEMISTRY-US, V39, P11370, DOI 10.1021/bi001061c; McBee JK, 2001, PROG RETIN EYE RES, V20, P469, DOI 10.1016/S1350-9462(01)00002-7; Moise AR, 2005, TRENDS PLANT SCI, V10, P178, DOI 10.1016/j.tplants.2005.02.006; Molday RS, 1998, INVEST OPHTH VIS SCI, V39, P2493; Murakami M, 2008, NATURE, V453, P363, DOI 10.1038/nature06925; Mustafi D, 2011, FASEB J, V25, P3157, DOI 10.1096/fj.11-186767; Mustafi D, 2009, PROG RETIN EYE RES, V28, P289, DOI 10.1016/j.preteyeres.2009.05.003; Nakamichi H, 2006, P NATL ACAD SCI USA, V103, P12729, DOI 10.1073/pnas.0601765103; Nickell S, 2007, J CELL BIOL, V177, P917, DOI 10.1083/jcb.200612010; NOEL JP, 1993, NATURE, V366, P654, DOI 10.1038/366654a0; Oberhauser V, 2008, P NATL ACAD SCI USA, V105, P19000, DOI 10.1073/pnas.0807805105; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; Okada T, 2002, P NATL ACAD SCI USA, V99, P5982, DOI 10.1073/pnas.082666399; OLSSON JE, 1992, NEURON, V9, P815, DOI 10.1016/0896-6273(92)90236-7; Orban T, 2011, J BIOL CHEM, V286, P17248, DOI 10.1074/jbc.M110.195198; Orban T, 2010, BIOCHEMISTRY-US, V49, P827, DOI 10.1021/bi901889t; Palczewska G, 2010, NAT MED, V16, P1444, DOI 10.1038/nm.2260; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; PALCZEWSKI K, 1994, NEURON, V13, P395, DOI 10.1016/0896-6273(94)90355-7; Palczewski K, 2006, ANNU REV BIOCHEM, V75, P743, DOI 10.1146/annurev.biochem.75.103004.142743; Palczewski K, 2010, ARCH OPHTHALMOL-CHIC, V128, P1483, DOI 10.1001/archophthalmol.2010.245; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Pauling L., 1939, NATURE CHEM BOND STR; Provencio I, 2000, J NEUROSCI, V20, P600, DOI 10.1523/JNEUROSCI.20-02-00600.2000; Provencio I, 1998, P NATL ACAD SCI USA, V95, P340, DOI 10.1073/pnas.95.1.340; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Redmond TM, 1998, NAT GENET, V20, P344, DOI 10.1038/3813; Rickman CB, 2006, INVEST OPHTH VIS SCI, V47, P2305, DOI 10.1167/iovs.05-1437; Ridge KD, 2003, TRENDS BIOCHEM SCI, V28, P479, DOI 10.1016/S0968-0004(03)00172-5; Ritter LM, 2011, J NEUROSCI, V31, P11231, DOI 10.1523/JNEUROSCI.2875-11.2011; Sakami S, 2011, J BIOL CHEM, V286, P10551, DOI 10.1074/jbc.M110.209759; Salom D, 2006, P NATL ACAD SCI USA, V103, P16123, DOI 10.1073/pnas.0608022103; Singh P, 2008, J BIOL CHEM, V283, P14053, DOI 10.1074/jbc.M708974200; Slep KC, 2001, NATURE, V409, P1071, DOI 10.1038/35059138; Smith SO, 2010, ANNU REV BIOPHYS, V39, P309, DOI 10.1146/annurev-biophys-101209-104901; SONDEK J, 1994, NATURE, V372, P276, DOI 10.1038/372276a0; Sparrow JR, 2010, J LIPID RES, V51, P247, DOI 10.1194/jlr.R000687; Stephen R, 2007, STRUCTURE, V15, P1392, DOI 10.1016/j.str.2007.09.013; Stephen R, 2006, J MOL BIOL, V359, P266, DOI 10.1016/j.jmb.2006.03.042; Struts AV, 2011, P NATL ACAD SCI USA, V108, P8263, DOI 10.1073/pnas.1014692108; Struts AV, 2011, NAT STRUCT MOL BIOL, V18, P392, DOI 10.1038/nsmb.1982; TANAKA T, 1995, NATURE, V376, P444, DOI 10.1038/376444a0; Terakita A, 2008, J NEUROCHEM, V105, P883, DOI 10.1111/j.1471-4159.2007.05184.x; Travis GH, 2007, ANNU REV PHARMACOL, V47, P469, DOI 10.1146/annurev.pharmtox.47.120505.105225; Van Eps N, 2011, P NATL ACAD SCI USA, V108, P9420, DOI 10.1073/pnas.1105810108; Van Hooser JP, 2002, J BIOL CHEM, V277, P19173, DOI 10.1074/jbc.M112384200; von Lintig J, 2010, TRENDS BIOCHEM SCI, V35, P400, DOI 10.1016/j.tibs.2010.01.005; WALD G, 1968, SCIENCE, V162, P230, DOI 10.1126/science.162.3850.230; Wang JS, 2011, PROG RETIN EYE RES, V30, P115, DOI 10.1016/j.preteyeres.2010.11.001; Wee R, 2004, OPHTHALMOLOGY, V111, P297, DOI 10.1016/j.ophtha.2003.05.014; Xu SB, 2007, J BIOL CHEM, V282, P25053, DOI 10.1074/jbc.M700501200; YOUNG RW, 1969, J CELL BIOL, V42, P392, DOI 10.1083/jcb.42.2.392; Zhang HB, 2011, NAT NEUROSCI, V14, P874, DOI 10.1038/nn.2835; Zhu QB, 2011, J BIOL CHEM, V286, P31749, DOI 10.1074/jbc.M111.259028	102	198	199	1	93	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2012	287	3					1612	1619		10.1074/jbc.R111.301150	http://dx.doi.org/10.1074/jbc.R111.301150			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879HT	22074921	hybrid, Green Published			2022-12-27	WOS:000299321000002
J	Wang, H; Huang, ZB; Huang, LS; Niu, SN; Rao, XR; Xu, J; Kong, H; Yang, JZ; Yang, C; Wu, DH; Li, SH; Li, XJ; Liu, TH; Sheng, GQ				Wang, Hao; Huang, Zhenbo; Huang, Liansha; Niu, Shaona; Rao, Xiurong; Xu, Jing; Kong, Hui; Yang, Jianzhong; Yang, Chuan; Wu, Donghai; Li, Shihua; Li, Xiao-Jiang; Liu, Tonghua; Sheng, Guoqing			Hypothalamic Ahi1 Mediates Feeding Behavior through Interaction with 5-HT2C Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MELANOCYTE-STIMULATING HORMONE; NEUROPEPTIDE-Y CONCENTRATIONS; JOUBERT-SYNDROME; BODY-WEIGHT; FOOD-INTAKE; PARAVENTRICULAR NUCLEUS; MELANOCORTIN RECEPTORS; OLANZAPINE TREATMENT; ENERGY-BALANCE; GENE-MUTATIONS	It is indicated that there are important molecules interacting with brain nervous systems to regulate feeding and energy balance by influencing the signaling pathways of these systems, but relatively few of the critical players have been identified. In the present study, we provide the evidence for the role of Abelson helper integration site 1 (Ahi1) protein as a mediator of feeding behavior through interaction with serotonin receptor 2C (5-HT2CR), known for its critical role in feeding and appetite control. First, we demonstrated the co-localization and interaction between hypothalamic Ahi1 and 5-HT2CR. Ahi1 promoted the degradation of 5-HT2CR through the lysosomal pathway. Then, we investigated the effects of fasting on the expression of hypothalamic Ahi1 and 5-HT2CR. Fasting resulted in an increased Ahi1 expression and a concomitant decreased expression of 5-HT2CR. Knockdown of hypothalamic Ahi1 led to a concomitant increased expression of 5-HT2CR and a decrease of food intake and body weight. Last, we found that Ahi1 could regulate the expression of neuropeptide Y and proopiomelanocortin. Taken together, our results indicate that Ahi1 mediates feeding behavior by interacting with 5-HT2CR to modulate the serotonin signaling pathway.	[Huang, Liansha; Liu, Tonghua] Beijing Univ Chinese Med, Dept Sci & Technol, Beijing 100029, Peoples R China; [Wang, Hao; Huang, Zhenbo; Rao, Xiurong; Xu, Jing; Kong, Hui; Wu, Donghai; Sheng, Guoqing] Chinese Acad Sci, CAS Key Lab Regenerat Biol, S China Inst Stem Cell Biol & Regenerat Med, Guangzhou Inst Biomed & Hlth, Guangzhou 510530, Guangdong, Peoples R China; [Niu, Shaona] Linyi Peoples Hosp, Dept Endocrinol, Linyi 276003, Peoples R China; [Yang, Jianzhong] Red Cross Hosp Yunnan Prov, Kunming 650030, Peoples R China; [Yang, Chuan] Sun Yat Sen Univ, Affiliated Hosp 2, Dept Endocrinol & Metab, Guangzhou 510020, Guangdong, Peoples R China; [Li, Shihua; Li, Xiao-Jiang] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA	Beijing University of Chinese Medicine; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Sun Yat Sen University; Emory University	Liu, TH (corresponding author), Beijing Univ Chinese Med, Dept Sci & Technol, Beijing 100029, Peoples R China.	thliu@vip.163.com; shenggibh@gmail.com			National Institutes of Health [NS036232]; National Natural Science Foundation of China (NSFC) [30700213, 30811120429]; Guangdong Natural Science Foundation (GDSF) [07007215]; "973" Projects [2007CB947804, 2010CB945503]; International Traditional Chinese Medicine Program for Cooperation in Science and Technology (ISCP) [2011DFA30920]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036232] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG031153, R01AG019206] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Guangdong Natural Science Foundation (GDSF); "973" Projects(National Basic Research Program of China); International Traditional Chinese Medicine Program for Cooperation in Science and Technology (ISCP); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant NS036232 (to X.-J. L). This work was also supported by National Natural Science Foundation of China (NSFC) Grants 30700213 and 30811120429, Guangdong Natural Science Foundation (GDSF) Grant 07007215, and "973" Projects 2007CB947804 and 2010CB945503 (to G. S.) and by International Traditional Chinese Medicine Program for Cooperation in Science and Technology (ISCP) Grant 2011DFA30920 (to T. L.).	ADAN RAH, 1994, MOL PHARMACOL, V46, P1182; Ascher-Svanum H, 2005, BMC PSYCHIATRY, V5, DOI 10.1186/1471-244X-5-3; Biebermann H, 2006, CELL METAB, V3, P141, DOI 10.1016/j.cmet.2006.01.007; Boston BA, 1997, SCIENCE, V278, P1641, DOI 10.1126/science.278.5343.1641; BROWN CM, 1995, PHARMACOL BIOCHEM BE, V51, P641, DOI 10.1016/0091-3057(94)00431-H; Cone RD, 2005, NAT NEUROSCI, V8, P571, DOI 10.1038/nn1455; Currie PJ, 1999, NEUROREPORT, V10, P3033, DOI 10.1097/00001756-199909290-00029; De Vry J, 2000, NEUROSCI BIOBEHAV R, V24, P341, DOI 10.1016/S0149-7634(99)00083-4; Dixon-Salazar T, 2004, AM J HUM GENET, V75, P979, DOI 10.1086/425985; Doering JE, 2008, J COMP NEUROL, V511, P238, DOI 10.1002/cne.21824; DRYDEN S, 1993, PEPTIDES, V14, P791, DOI 10.1016/0196-9781(93)90115-W; Fan W, 1997, NATURE, V385, P165, DOI 10.1038/385165a0; Ferland RJ, 2004, NAT GENET, V36, P1008, DOI 10.1038/ng1419; Garfield AS, 2009, J PHYSIOL-LONDON, V587, P49, DOI 10.1113/jphysiol.2008.164152; GOODALL E, 1988, BRIT J PSYCHIAT, V153, P208, DOI 10.1192/bjp.153.2.208; Han SB, 2009, BIOCHEM BIOPH RES CO, V390, P535, DOI 10.1016/j.bbrc.2009.09.133; Heisler LK, 2003, ANN NY ACAD SCI, V994, P169, DOI 10.1111/j.1749-6632.2003.tb03177.x; Heisler LK, 2002, SCIENCE, V297, P609, DOI 10.1126/science.1072327; Henderson DC, 2005, ARCH GEN PSYCHIAT, V62, P19, DOI 10.1001/archpsyc.62.1.19; Hsiao SH, 2006, NEUROSCI LETT, V394, P256, DOI 10.1016/j.neulet.2005.10.054; Hsiao YC, 2009, HUM MOL GENET, V18, P3926, DOI 10.1093/hmg/ddp335; JESPERSEN S, 1973, J PHARM PHARMACOL, V25, P49, DOI 10.1111/j.2042-7158.1973.tb09114.x; Jiang XY, 2002, J VIROL, V76, P9046, DOI 10.1128/JVI.76.18.9046-9059.2002; Keller LC, 2009, MOL BIOL CELL, V20, P1150, DOI 10.1091/mbc.E08-06-0619; KENNETT GA, 1989, EUR J PHARMACOL, V164, P445, DOI 10.1016/0014-2999(89)90252-5; Kinon BJ, 2001, J CLIN PSYCHIAT, V62, P92, DOI 10.4088/JCP.v62n0204; KOCH CA, 1991, SCIENCE, V252, P668, DOI 10.1126/science.1708916; Kring SII, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006696; L'ltalien GJ, 2007, J CLIN PSYCHIAT, V68, P1510, DOI 10.4088/JCP.v68n1006; Lam DD, 2008, ENDOCRINOLOGY, V149, P1323, DOI 10.1210/en.2007-1321; Lee YS, 2006, CELL METAB, V3, P135, DOI 10.1016/j.cmet.2006.01.006; Lordanidou M, 2008, PHARMACOGENET GENOM, V18, P153, DOI 10.1097/FPC.0b013e3282f4ae93; Louie CM, 2010, NAT GENET, V42, P175, DOI 10.1038/ng.519; Matsui-Sakata Akiko, 2005, Drug Metab Pharmacokinet, V20, P368, DOI 10.2133/dmpk.20.368; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; Nasrallah H, 2003, PSYCHONEUROENDOCRINO, V28, P83, DOI 10.1016/S0306-4530(02)00114-2; Nasrallah HA, 2008, MOL PSYCHIATR, V13, P27, DOI 10.1038/sj.mp.4002066; NASRALLAH HA, 2004, J CLIN PSYCHOPHARM, V24, P7, DOI DOI 10.1097/01.JCP.0000142282.62336.E9; NEER EJ, 1994, NATURE, V371, P297, DOI 10.1038/371297a0; Niu SN, 2011, FEBS LETT, V585, P85, DOI 10.1016/j.febslet.2010.11.059; Nonogaki K, 1998, NAT MED, V4, P1152, DOI 10.1038/2647; Ollmann MM, 1997, SCIENCE, V278, P135, DOI 10.1126/science.278.5335.135; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; PINDER RM, 1975, DRUGS, V10, P241, DOI 10.2165/00003495-197510040-00001; POIRIER Y, 1988, J VIROL, V62, P3985, DOI 10.1128/JVI.62.11.3985-3992.1988; Prior MJ, 2010, METABOLISM, V59, P1057, DOI 10.1016/j.metabol.2009.11.002; ROGERS P, 1991, PEPTIDES, V12, P251, DOI 10.1016/0196-9781(91)90007-C; Salonen JT, 2007, AM J HUM GENET, V81, P338, DOI 10.1086/520599; Sandoval D, 2008, ANNU REV PHYSIOL, V70, P513, DOI 10.1146/annurev.physiol.70.120806.095256; Scheepers FE, 2001, J CLIN PSYCHOPHARM, V21, P575, DOI 10.1097/00004714-200112000-00006; Sheng G, 2008, J CLIN INVEST, V118, P2785, DOI 10.1172/JCI35339; SHORPOSNER G, 1986, BRAIN RES BULL, V17, P663, DOI 10.1016/0361-9230(86)90198-X; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; STANLEY BG, 1984, LIFE SCI, V35, P2635, DOI 10.1016/0024-3205(84)90032-8; Sutton GM, 2006, ENDOCRINOLOGY, V147, P2183, DOI 10.1210/en.2005-1209; SWANDULLA D, 1990, J NEUROPHYSIOL, V64, P715, DOI 10.1152/jn.1990.64.3.715; TECOTT LH, 1995, NATURE, V374, P542, DOI 10.1038/374542a0; Utsch B, 2006, PEDIATR NEPHROL, V21, P32, DOI 10.1007/s00467-005-2054-y; Valente EM, 2006, ANN NEUROL, V59, P527, DOI 10.1002/ana.20749; Vezzosi D, 2007, EUR J ENDOCRINOL, V156, P21, DOI 10.1530/eje.1.02324; Vickers SP, 2003, PSYCHOPHARMACOLOGY, V167, P274, DOI 10.1007/s00213-002-1378-6; Vickers SP, 2000, BRIT J PHARMACOL, V130, P1305, DOI 10.1038/sj.bjp.0703443; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85; Zhou L, 2007, CELL METAB, V6, P398, DOI 10.1016/j.cmet.2007.10.008	64	11	12	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2012	287	3					2237	2246		10.1074/jbc.M111.277871	http://dx.doi.org/10.1074/jbc.M111.277871			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879HT	22123816	Green Published, hybrid			2022-12-27	WOS:000299321000061
J	Kiyohara, M; Nakatomi, T; Kurihara, S; Fushinobu, S; Suzuki, H; Tanaka, T; Shoda, S; Kitaoka, M; Katayama, T; Yamamoto, K; Ashida, H				Kiyohara, Masashi; Nakatomi, Takashi; Kurihara, Shin; Fushinobu, Shinya; Suzuki, Hideyuki; Tanaka, Tomonari; Shoda, Shin-ichiro; Kitaoka, Motomitsu; Katayama, Takane; Yamamoto, Kenji; Ashida, Hisashi			alpha-N-Acetylgalactosaminidase from Infant-associated Bifidobacteria Belonging to Novel Glycoside Hydrolase Family 129 Is Implicated in Alternative Mucin Degradation Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-MILK OLIGOSACCHARIDES; MOLECULAR-CLONING; BIOSE-I; TRANSGLYCOSYLATION ACTIVITY; CLOSTRIDIUM-PERFRINGENS; DIPLOCOCCUS-PNEUMONIAE; METABOLIC PATHWAYS; GENOME SEQUENCE; BINDING PROTEIN; MUCUS LAYERS	Bifidobacteria inhabit the lower intestine of mammals including humans where the mucin gel layer forms a space for commensal bacteria. We previously identified that infant-associated bifidobacteria possess an extracellular membrane-bound endo-alpha-N-acetylgalactosaminidase (EngBF) that may be involved in degradation and assimilation of mucin-type oligosaccharides. However, EngBF is highly specific for core-1-type O-glycan (Gal beta 1-3GalNAc alpha 1-Ser/Thr), also called T antigen, which is mainly attached onto gastroduodenal mucins. By contrast, core-3-type O-glycans (GlcNAc beta 1-3GalNAc alpha 1-Ser/Thr) are predominantly found on the mucins in the intestines. Here, we identified a novel alpha-N-acetylgalactosaminidase (NagBb) from Bifidobacterium bifidum JCM 1254 that hydrolyzes the Tn antigen (GalNAc alpha 1-Ser/Thr). Sialyl and galactosyl core-3 (Gal beta 1-3/4GlcNAc beta 1-3(Neu5Ac alpha 2-6)GalNAc alpha 1-Ser/Thr), a major tetrasaccharide structure on MUC2 mucin primarily secreted from goblet cells in human sigmoid colon, can be serially hydrolyzed into Tn antigen by previously identified bifidobacterial extracellular glycosidases such as alpha-sialidase (SiaBb2), lacto-N-biosidase (LnbB), beta-galactosidase (BbgIII), and beta-N-acetylhexosaminidases (BbhI and BbhII). Because NagBb is an intracellular enzyme without an N-terminal secretion signal sequence, it is likely involved in intracellular degradation and assimilation of Tn antigen-containing polypeptides, which might be incorporated through unknown transporters. Thus, bifidobacteria possess two distinct pathways for assimilation of O-glycans on gastroduodenal and intestinal mucins. NagBb homologs are conserved in infant-associated bifidobacteria, suggesting a significant role for their adaptation within the infant gut, and they were found to form a new glycoside hydrolase family 129.	[Kiyohara, Masashi; Nakatomi, Takashi; Kurihara, Shin; Yamamoto, Kenji; Ashida, Hisashi] Kyoto Univ, Grad Sch Biostudies, Sakyo Ku, Kyoto 6068502, Japan; [Kiyohara, Masashi; Katayama, Takane; Yamamoto, Kenji] Ishikawa Prefectural Univ, Res Inst Bioresources & Biotechnol, Nonoichi, Ishikawa 9218836, Japan; [Fushinobu, Shinya] Univ Tokyo, Dept Biotechnol, Bunkyo Ku, Tokyo 1138657, Japan; [Suzuki, Hideyuki; Tanaka, Tomonari] Kyoto Inst Technol, Grad Sch Sci & Technol, Sakyo Ku, Kyoto 6068585, Japan; [Shoda, Shin-ichiro] Tohoku Univ, Grad Sch Engn, Aoba Ku, Sendai, Miyagi 9808579, Japan; [Kitaoka, Motomitsu] Natl Agr & Food Res Org, Natl Food Res Inst, Tsukuba, Ibaraki 3058642, Japan	Kyoto University; Ishikawa Prefecture University; University of Tokyo; Kyoto Institute of Technology; Tohoku University; National Agriculture & Food Research Organization - Japan; National Food Research Institute - Japan	Ashida, H (corresponding author), Kyoto Univ, Grad Sch Biostudies, Sakyo Ku, Kyoto 6068502, Japan.	ashida@lif.kyoto-u.ac.jp	Tanaka, Tomonari/GPP-2232-2022; Fushinobu, Shinya/E-4987-2011; Kitaoka, Motomitsu/R-1536-2019; Ashida, Hisashi/HCI-0293-2022	Fushinobu, Shinya/0000-0003-1346-6435; Kitaoka, Motomitsu/0000-0002-0083-1838; Katayama, Takane/0000-0003-4009-7874; Ashida, Hisashi/0000-0001-5844-4075; Tanaka, Tomonari/0000-0002-7050-9043	Program for Promotion of Basic Research Activities for Innovative Biosciences	Program for Promotion of Basic Research Activities for Innovative Biosciences	This work was supported in part by the Program for Promotion of Basic Research Activities for Innovative Biosciences.	Anderson K, 2000, ANAL BIOCHEM, V287, P337, DOI 10.1006/abio.2000.4829; Ashida H, 2000, ARCH BIOCHEM BIOPHYS, V373, P394, DOI 10.1006/abbi.1999.1565; Ashida H, 2000, ARCH BIOCHEM BIOPHYS, V384, P305, DOI 10.1006/abbi.2000.2114; Ashida H, 2001, CARBOHYD RES, V330, P487, DOI 10.1016/S0008-6215(01)00008-8; Ashida H, 2008, GLYCOBIOLOGY, V18, P727, DOI 10.1093/glycob/cwn053; Ashida H, 2010, GLYCOCONJUGATE J, V27, P125, DOI 10.1007/s10719-009-9247-8; Ashida H, 2009, GLYCOBIOLOGY, V19, P1010, DOI 10.1093/glycob/cwp082; Calcutt MJ, 2002, FEMS MICROBIOL LETT, V214, P77, DOI 10.1111/j.1574-6968.2002.tb11327.x; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Comfort DA, 2007, BIOCHEMISTRY-US, V46, P3319, DOI 10.1021/bi061521n; ENDO Y, 1976, J BIOCHEM-TOKYO, V80, P1; FAN JQ, 1990, AGR BIOL CHEM TOKYO, V54, P233, DOI 10.1080/00021369.1990.10869928; Fujita K, 2005, J BIOL CHEM, V280, P37415, DOI 10.1074/jbc.M506874200; Fushinobu S, 2010, BIOSCI BIOTECH BIOCH, V74, P2374, DOI 10.1271/bbb.100494; Goda HM, 2008, BIOCHEM BIOPH RES CO, V375, P541, DOI 10.1016/j.bbrc.2008.08.065; Goulas T, 2009, APPL MICROBIOL BIOT, V82, P471, DOI 10.1007/s00253-008-1750-5; GUM JR, 1994, J BIOL CHEM, V269, P2440; Honda Y, 2004, J BIOL CHEM, V279, P55097, DOI 10.1074/jbc.M409832200; Imamura A, 2005, ORG LETT, V7, P4415, DOI 10.1021/ol051592z; Johansson MEV, 2011, P NATL ACAD SCI USA, V108, P4659, DOI 10.1073/pnas.1006451107; Johansson MEV, 2008, P NATL ACAD SCI USA, V105, P15064, DOI 10.1073/pnas.0803124105; Kamitori S, 2002, J MOL BIOL, V318, P443, DOI 10.1016/S0022-2836(02)00111-0; Katayama T, 2004, J BACTERIOL, V186, P4885, DOI 10.1128/JB.186.15.4885-4893.2004; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kitaoka M, 2005, APPL ENVIRON MICROB, V71, P3158, DOI 10.1128/AEM.71.6.3158-3162.2005; Kiyohara M, 2011, GLYCOBIOLOGY, V21, P437, DOI 10.1093/glycob/cwq175; Kiyohara M, 2009, BIOSCI BIOTECH BIOCH, V73, P1175, DOI 10.1271/bbb.80697; Koga D, 1998, BIOSCI BIOTECH BIOCH, V62, P1643, DOI 10.1271/bbb.62.1643; Koutsioulis D, 2008, GLYCOBIOLOGY, V18, P799, DOI 10.1093/glycob/cwn069; Kurihara S, 2005, J BIOL CHEM, V280, P4602, DOI 10.1074/jbc.M411114200; Larsson JMH, 2009, GLYCOBIOLOGY, V19, P756, DOI 10.1093/glycob/cwp048; Liu QYP, 2007, NAT BIOTECHNOL, V25, P454, DOI 10.1038/nbt1298; Miwa M, 2010, GLYCOBIOLOGY, V20, P1402, DOI 10.1093/glycob/cwq101; Nagae M, 2007, J BIOL CHEM, V282, P18497, DOI 10.1074/jbc.M702246200; Nishimoto M, 2007, BIOSCI BIOTECH BIOCH, V71, P2101, DOI 10.1271/bbb.70320; Nishimoto M, 2009, CARBOHYD RES, V344, P2573, DOI 10.1016/j.carres.2009.09.031; Noguchi M, 2009, J ORG CHEM, V74, P2210, DOI 10.1021/jo8024708; Picard C, 2005, ALIMENT PHARM THER, V22, P495, DOI 10.1111/j.1365-2036.2005.02615.x; Schell MA, 2002, P NATL ACAD SCI USA, V99, P14422, DOI 10.1073/pnas.212527599; Sela DA, 2008, P NATL ACAD SCI USA, V105, P18964, DOI 10.1073/pnas.0809584105; Suzuki R, 2008, J BIOL CHEM, V283, P13165, DOI 10.1074/jbc.M709777200; Suzuki R, 2009, J BIOCHEM, V146, P389, DOI 10.1093/jb/mvp086; Tanaka T, 2008, CHEM COMMUN, P2016, DOI 10.1039/b801090k; Turroni F, 2010, P NATL ACAD SCI USA, V107, P19514, DOI 10.1073/pnas.1011100107; UMEMOTO J, 1977, J BIOL CHEM, V252, P8609; Wada J, 2008, APPL ENVIRON MICROB, V74, P3996, DOI 10.1128/AEM.00149-08; Wada J, 2007, ACTA CRYSTALLOGR F, V63, P751, DOI 10.1107/S1744309107036263; Zhao H, 2008, FEMS MICROBIOL LETT, V285, P278, DOI 10.1111/j.1574-6968.2008.01246.x	48	68	69	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					693	700		10.1074/jbc.M111.277384	http://dx.doi.org/10.1074/jbc.M111.277384			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22090027	Green Published, hybrid			2022-12-27	WOS:000298682400067
J	Lok, HC; Rahmanto, YS; Hawkins, CL; Kalinowski, DS; Morrow, CS; Townsend, AJ; Ponka, P; Richardson, DR				Lok, Hiu Chuen; Rahmanto, Yohan Suryo; Hawkins, Clare L.; Kalinowski, Danuta S.; Morrow, Charles S.; Townsend, Alan J.; Ponka, Prem; Richardson, Des R.			Nitric Oxide Storage and Transport in Cells Are Mediated by Glutathione S-Transferase P1-1 and Multidrug Resistance Protein 1 via Dinitrosyl Iron Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOTOXIC ACTIVATED MACROPHAGES; NITROGEN MONOXIDE; DRUG-RESISTANCE; INHIBITION; NO; PREECLAMPSIA; MOBILIZATION; METABOLISM; EXPRESSION; PROTECTION	Nitrogen monoxide (NO) plays a role in the cytotoxic mechanisms of activated macrophages against tumor cells by inducing iron release. We showed that NO-mediated iron efflux from cells required glutathione (GSH) (Watts, R. N., and Richardson, D. R. (2001) J. Biol. Chem. 276, 4724-4732) and that the GSH-conjugate transporter, multidrug resistance-associated protein 1 (MRP1), mediates this release potentially as a dinitrosyl-dithiol iron complex (DNIC; Watts, R. N., Hawkins, C., Ponka, P., and Richardson, D. R. (2006) Proc. Natl. Acad. Sci. U. S. A. 103, 7670-7675). Recently, glutathione S-transferase P1-1 (GST P1-1) was shown to bind DNICs as dinitrosyl-diglutathionyl iron complexes. Considering this and that GSTs and MRP1 form an integrated detoxification unit with chemotherapeutics, we assessed whether these proteins coordinately regulate storage and transport of DNICs as long lived NO intermediates. Cells transfected with GSTP1 (but not GSTA1 or GSTM1) significantly decreased NO-mediated Fe-59 release from cells. This NO-mediated Fe-59 efflux and the effect of GST P1-1 on preventing this were observed with NO-generating agents and also in cells transfected with inducible nitric oxide synthase. Notably, Fe-59 accumulated in cells within GST P1-1-containing fractions, indicating an alteration in intracellular Fe-59 distribution. Furthermore, electron paramagnetic resonance studies showed that MCF7-VP cells transfected with GSTP1 contain significantly greater levels of a unique DNIC signal. These investigations indicate that GST P1-1 acts to sequester NO as DNICs, reducing their transport out of the cell by MRP1. Cell proliferation studies demonstrated the importance of the combined effect of GST P1-1 and MRP1 in protecting cells from the cytotoxic effects of NO. Thus, the DNIC storage function of GST P1-1 and ability of MRP1 to efflux DNICs are vital in protection against NO cytotoxicity.	[Lok, Hiu Chuen; Rahmanto, Yohan Suryo; Kalinowski, Danuta S.; Richardson, Des R.] Univ Sydney, Dept Pathol, Sydney, NSW 2006, Australia; [Hawkins, Clare L.] Heart Res Inst, Sydney, NSW 2042, Australia; [Morrow, Charles S.; Townsend, Alan J.] Wake Forest Univ, Dept Biochem, Winston Salem, NC 27157 USA; [Ponka, Prem] Lady Davis Inst, Montreal, PQ H3T 1E2, Canada	University of Sydney; University of Sydney; Heart Research Institute; Wake Forest University; Lady Davis Institute; McGill University	Richardson, DR (corresponding author), Univ Sydney, Dept Pathol, Blackburn Bldg,D06, Sydney, NSW 2006, Australia.	d.richardson@med.usyd.edu.au	Ponka, Prem/A-4123-2011; Hawkins, Clare/AAV-7424-2021; Townsend, Alan/AAE-9602-2019; Suryo Rahmanto, Yohan/K-8043-2018; Hawkins, Clare L/F-6696-2014	Hawkins, Clare/0000-0003-2738-5089; Suryo Rahmanto, Yohan/0000-0003-1453-7872; Hawkins, Clare L/0000-0003-2738-5089; Ponka, Prem/0000-0001-5835-1477; Richardson, Des/0000-0002-5506-3274; Richardson, Des/0000-0003-0960-6415; Kalinowski, Danuta/0000-0002-9303-7405	Australian Research Council [DP1092734]; Canadian Institute of Health research; Cancer Institute NSW [08/ECF/1-36, 08/ECF/1-30]; National Heart Foundation [CR08S 3959]; National Health and Medical Research Council of Australia [570829, 571123]	Australian Research Council(Australian Research Council); Canadian Institute of Health research(Canadian Institutes of Health Research (CIHR)); Cancer Institute NSW; National Heart Foundation(National Heart Foundation of Australia); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by Discovery Grant DP1092734 from the Australian Research Council (to D. R. R.) and a Canadian Institute of Health research grant (to P. P.).; Supported by Cancer Institute NSW Early Career Fellowship 08/ECF/1-36.; Supported by National Heart Foundation Fellowship CR08S 3959 and National Health and Medical Research Council of Australia Project Grant 570829.; Supported by Cancer Institute NSW Early Career Fellowship 08/ECF/1-30.; Supported by the National Health and Medical Research Council of Australia for Senior Principal Research Fellowship 571123 and project grants. To whom correspondence should be addressed: Blackburn Bldg. - D06, Dept. of Pathology, University of Sydney, NSW 2006, Australia. Tel.: 61-2-9036-6548; Fax: 61-2-9351-3429; E-mail: d.richardson@med.usyd.edu.au.	BASTIAN NR, 1994, J BIOL CHEM, V269, P5127; BOESE M, 1995, J BIOL CHEM, V270, P29244, DOI 10.1074/jbc.270.49.29244; Bosworth CA, 2009, P NATL ACAD SCI USA, V106, P4671, DOI 10.1073/pnas.0710416106; Canto P, 2008, HYPERTENS RES, V31, P1015, DOI 10.1291/hypres.31.1015; Cesareo E, 2005, J BIOL CHEM, V280, P42172, DOI 10.1074/jbc.M507916200; Choi JW, 2002, ANN CLIN LAB SCI, V32, P257; De Luca A, 2011, BIOCHEM J, V440, P175, DOI 10.1042/BJ20111333; Depeille P, 2005, BRIT J CANCER, V93, P216, DOI 10.1038/sj.bjc.6602681; Depeille P, 2004, MOL PHARMACOL, V65, P897, DOI 10.1124/mol.65.4.897; DRAPIER JC, 1986, J CLIN INVEST, V78, P790, DOI 10.1172/JCI112642; GRIFFITH OW, 1979, J BIOL CHEM, V254, P7558; Harbottle A, 2001, INT J CANCER, V92, P777, DOI 10.1002/ijc.1283; Harrop TC, 2008, J AM CHEM SOC, V130, P15602, DOI 10.1021/ja8054996; HIBBS JB, 1984, BIOCHEM BIOPH RES CO, V123, P716, DOI 10.1016/0006-291X(84)90288-2; Hickok JR, 2011, FREE RADICAL BIO MED, V51, P1558, DOI 10.1016/j.freeradbiomed.2011.06.030; Kalinowski DS, 2005, PHARMACOL REV, V57, P547, DOI 10.1124/pr.57.4.2; Kielar D, 2003, J INVEST DERMATOL, V121, P465, DOI 10.1046/j.1523-1747.2003.12404.x; LANCASTER JR, 1990, P NATL ACAD SCI USA, V87, P1223, DOI 10.1073/pnas.87.3.1223; MacLeod AK, 2009, CARCINOGENESIS, V30, P1571, DOI 10.1093/carcin/bgp176; Morrow CS, 1998, CARCINOGENESIS, V19, P109, DOI 10.1093/carcin/19.1.109; Morrow CS, 1998, J BIOL CHEM, V273, P20114, DOI 10.1074/jbc.273.32.20114; Morrow CS, 1998, BIOCHEM PHARMACOL, V56, P1013, DOI 10.1016/S0006-2952(98)00240-8; Nath N, 2010, J NEUROIMMUNE PHARM, V5, P240, DOI 10.1007/s11481-009-9187-x; Pedersen JZ, 2007, J BIOL CHEM, V282, P6364, DOI 10.1074/jbc.M609905200; REDDY D, 1983, SCIENCE, V221, P769, DOI 10.1126/science.6308761; Richardson DR, 2008, BBA-GEN SUBJECTS, V1780, P638, DOI 10.1016/j.bbagen.2007.12.009; STAMLER JS, 1992, SCIENCE, V258, P1898, DOI 10.1126/science.1281928; Thomas DD, 2001, P NATL ACAD SCI USA, V98, P355, DOI 10.1073/pnas.98.1.355; Turella P, 2003, J BIOL CHEM, V278, P42294, DOI 10.1074/jbc.M305569200; VANIN AF, 1991, FEBS LETT, V289, P1, DOI 10.1016/0014-5793(91)80894-9; Wardrop SL, 2000, BIOCHEMISTRY-US, V39, P2748, DOI 10.1021/bi991099t; Watts RN, 2006, P NATL ACAD SCI USA, V103, P7670, DOI 10.1073/pnas.0602515103; Watts RN, 2003, BIOCHEM J, V369, P429, DOI 10.1042/BJ20021302; Watts RN, 2001, J BIOL CHEM, V276, P4724, DOI 10.1074/jbc.M006318200; Xu X, 2008, MOL PHARMACOL, V73, P833, DOI 10.1124/mol.107.041335; Zai A, 1999, J CLIN INVEST, V103, P393, DOI 10.1172/JCI4890; Zaman K, 2004, BIOCHEM J, V380, P67, DOI 10.1042/BJ20031687	37	46	49	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					607	618		10.1074/jbc.M111.310987	http://dx.doi.org/10.1074/jbc.M111.310987			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22084240	Green Published, hybrid			2022-12-27	WOS:000298682400059
J	Wang, K; Lin, ZQ; Long, B; Li, JH; Zhou, J; Li, PF				Wang, Kun; Lin, Zhi-Qiang; Long, Bo; Li, Jian-Hui; Zhou, Jing; Li, Pei-Feng			Cardiac Hypertrophy Is Positively Regulated by MicroRNA miR-23a	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEART-FAILURE; CARDIOMYOCYTE HYPERTROPHY; IN-VIVO; TRANSCRIPTION FACTOR; DOWN-REGULATION; DISEASE; APOPTOSIS; PHOSPHORYLATION; MYOCARDIN; TARGETS	MicroRNAs (miRNAs) are a class of small noncoding RNAs that mediate post-transcriptional gene silencing. Myocardial hypertrophy is frequently associated with the development of heart failure. A variety of miRNAs are involved in the regulation of cardiac hypertrophy, however, the molecular targets of miRNAs in the cardiac hypertrophic cascades remain to be fully identified. We produced miR-23a transgenic mice, and these mice exhibit exaggerated cardiac hypertrophy in response to the stimulation with phenylephrine or pressure overload by transverse aortic banding. The endogenous miR-23a is up-regulated upon treatment with phenylephrine, endothelin-1, or transverse aortic banding. Knockdown of miR-23a attenuates hypertrophic responses. To identify the downstream targets of miR-23a, we found that transcription factor Foxo3a is suppressed by miR-23a. Luciferase assay indicates that miR-23a directly inhibits the translation activity of Foxo3a 3' UTR. Introduction or knockdown of miR-23a leads to the alterations of Foxo3a protein levels. Enforced expression of the constitutively active form of Foxo3a counteracts the provocative effect of miR-23a on hypertrophy. Furthermore, we observed that miR-23a is able to alter the expression levels of manganese superoxide dismutase and the consequent reactive oxygen species, and this effect is mediated by Foxo3a. In addition, our results show that miR-23a and Foxo3a bi-transgenic mice exhibit a reduced hypertrophic response compared with the miR-23a transgenic mice alone. Our present study reveals that miR-23a can mediate the hypertrophic signal through regulating Foxo3a. They form an axis in hypertrophic machinery and can be targets for the development of hypertrophic treatment.	[Wang, Kun; Lin, Zhi-Qiang; Long, Bo; Li, Jian-Hui; Zhou, Jing; Li, Pei-Feng] Chinese Acad Sci, Inst Zool, State Key Lab Biomembrane & Membrane Biotechnol, Div Cardiovasc Res, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS	Li, PF (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Biomembrane & Membrane Biotechnol, Div Cardiovasc Res, Beijing 100101, Peoples R China.	peifli@ioz.ac.cn	Long, Bo/GQH-5131-2022; Li, Peifeng/ABD-5663-2021; Li, Peifeng/AHE-6906-2022; Long, Bo/AGX-8013-2022	Li, Peifeng/0000-0002-0969-9407; Lin, zhiqiang/0000-0002-2034-2492	National Natural Science Foundation of China [30730045, 30900761, 31010103911]; National Basic Research Program of China 973 Program [2007CB512000, 2011CB965300]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China 973 Program(National Basic Research Program of China)	This work was supported by National Natural Science Foundation of China Grants 30730045, 30900761, and 31010103911 and National Basic Research Program of China 973 Program Grants 2007CB512000 and 2011CB965300.	Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Ago T, 2007, ANTIOXID REDOX SIGN, V9, P679, DOI 10.1089/ars.2007.1529; Amin JK, 2001, J MOL CELL CARDIOL, V33, P131, DOI 10.1006/jmcc.2000.1285; Anderson MJ, 1998, GENOMICS, V47, P187, DOI 10.1006/geno.1997.5122; Arya R, 2004, J CELL BIOL, V167, P1147, DOI 10.1083/jcb.200402033; Badorff C, 2005, CIRC RES, V97, P645, DOI 10.1161/01.RES.0000184684.88750.FE; Brown JH, 2006, CIRC RES, V98, P730, DOI 10.1161/01.RES.0000216039.75913.9e; Callis TE, 2009, J CLIN INVEST, V119, P2772, DOI 10.1172/JCI36154; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Cassidy-Stone A, 2008, DEV CELL, V14, P193, DOI 10.1016/j.devcel.2007.11.019; Chen D, 2005, BIOCHEM PHARMACOL, V69, P1421, DOI 10.1016/j.bcp.2005.02.022; Divakaran V, 2008, CIRC RES, V103, P1072, DOI 10.1161/CIRCRESAHA.108.183087; Dorn GW, 2011, TRANSL RES, V157, P226, DOI 10.1016/j.trsl.2010.12.013; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Guo JF, 2009, CIRC RES, V104, P660, DOI 10.1161/CIRCRESAHA.108.186288; Han MY, 2009, CIRCULATION, V120, pS732; Huang ZP, 2010, J CARDIOVASC TRANSL, V3, P212, DOI 10.1007/s12265-010-9165-y; Ikeda S, 2010, CURR DRUG TARGETS, V11, P913, DOI 10.2174/138945010791591304; Kedar V, 2004, P NATL ACAD SCI USA, V101, P18135, DOI 10.1073/pnas.0404341102; Latronico MVG, 2011, EXP BIOL MED, V236, P125, DOI 10.1258/ebm.2010.010269; Li HH, 2007, J CLIN INVEST, V117, P3211, DOI 10.1172/JCI31757; Li MY, 2006, J BIOL CHEM, V281, P40429, DOI 10.1074/jbc.M606596200; Li YZ, 2008, MOL CELL BIOL, V28, P564, DOI 10.1128/MCB.00738-07; Lin HJ, 2011, INVEST OPHTH VIS SCI, V52, P6308, DOI 10.1167/iovs.10-6632; Lin ZQ, 2009, P NATL ACAD SCI USA, V106, P12103, DOI 10.1073/pnas.0811371106; Markham DW, 2010, CIRC RES, V106, P1011, DOI 10.1161/CIRCRESAHA.110.219030; Martins PAD, 2010, NAT CELL BIOL, V12, P1220, DOI 10.1038/ncb2126; Matkovich SJ, 2011, CIRC RES, V108, P18, DOI 10.1161/CIRCRESAHA.110.233528; Murtaza I, 2008, J BIOL CHEM, V283, P5996, DOI 10.1074/jbc.M706466200; Nakamura K, 1998, CIRCULATION, V98, P794, DOI 10.1161/01.CIR.98.8.794; Ni YG, 2006, CIRCULATION, V114, P1159, DOI 10.1161/CIRCULATIONAHA.106.637124; Ohtani K, 2011, BASIC RES CARDIOL, V106, P5, DOI 10.1007/s00395-010-0139-7; Patrick DM, 2010, J CLIN INVEST, V120, P3912, DOI 10.1172/JCI43604; Port JD, 2010, J CARDIOVASC PHARM, V56, P444, DOI 10.1097/FJC.0b013e3181f605b6; ROCKMAN HA, 1991, P NATL ACAD SCI USA, V88, P8277, DOI 10.1073/pnas.88.18.8277; Sayed D, 2007, CIRC RES, V100, P416, DOI 10.1161/01.RES.0000257913.42552.23; Siegel C, 2011, P NATL ACAD SCI USA, V108, P11662, DOI 10.1073/pnas.1102635108; Skurk C, 2005, J BIOL CHEM, V280, P20814, DOI 10.1074/jbc.M500528200; Sundaresan NR, 2009, J CLIN INVEST, V119, P2758, DOI 10.1172/JCI39162; Tan WQ, 2008, J BIOL CHEM, V283, P29730, DOI 10.1074/jbc.M805514200; Thum T, 2011, J CLIN INVEST, V121, P461, DOI 10.1172/JCI45938; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; Topkara VK, 2010, PERS MED, V7, P531, DOI 10.2217/PME.10.44; Van Rooij E, 2007, PHYSIOL GENOMICS, V31, P365, DOI 10.1152/physiolgenomics.00206.2007; Van Rooij E, 2007, J CLIN INVEST, V117, P2369, DOI 10.1172/JCI33099; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; van Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103; Vo NK, 2010, P NATL ACAD SCI USA, V107, P19231, DOI 10.1073/pnas.1013162107; Wang JX, 2011, NAT MED, V17, P71, DOI 10.1038/nm.2282; Wang K, 2010, J BIOL CHEM, V285, P11903, DOI 10.1074/jbc.M109.098004; Willis MS, 2007, CIRC RES, V100, P456, DOI 10.1161/01.RES.0000259559.48597.32; Xing WB, 2006, CIRC RES, V98, P1089, DOI 10.1161/01.RES.0000218781.23144.3e; Yang YF, 2011, CIRC RES, V108, P305, DOI 10.1161/CIRCRESAHA.110.228437	53	92	96	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					589	599		10.1074/jbc.M111.266940	http://dx.doi.org/10.1074/jbc.M111.266940			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22084234	Green Published, hybrid			2022-12-27	WOS:000298682400057
J	Wildling, L; Rankl, C; Haselgrubler, T; Gruber, HJ; Holy, M; Newman, AH; Zou, MF; Zhu, R; Freissmuth, M; Sitte, HH; Hinterdorfer, P				Wildling, Linda; Rankl, Christian; Haselgruebler, Thomas; Gruber, Hermann J.; Holy, Marion; Newman, Amy Hauck; Zou, Mu-Fa; Zhu, Rong; Freissmuth, Michael; Sitte, Harald H.; Hinterdorfer, Peter			Probing Binding Pocket of Serotonin Transporter by Single Molecular Force Spectroscopy on Living Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUROTRANSMITTER TRANSPORTERS; DOPAMINE TRANSPORTER; MONOAMINE TRANSPORTERS; BACTERIAL HOMOLOG; MICROSCOPE TIPS; AMPHETAMINES; LEUT; RECOGNITION; RECEPTORS; ATTACHMENT	The serotonin transporter (SERT) terminates neurotransmission by removing serotonin from the synaptic cleft. In addition, it is the site of action of antidepressants (which block the transporter) and of amphetamines (which induce substrate efflux). The interaction energies involved in binding of such compounds to the transporter are unknown. Here, we used atomic force microscopy (AFM) to probe single molecular interactions between the serotonin transporter and MFZ2-12 (a potent cocaine analog) in living CHOK1 cells. For the AFM measurements, MFZ2-12 was immobilized on AFM tips by using a heterobifunctional cross-linker. By varying the pulling velocity in force distance cycles drug-transporter complexes were ruptured at different force loadings allowing for mapping of the interaction energy landscape. We derived chemical rate constants from these recordings and compared them with those inferred from inhibition of transport and ligand binding: k(off) values were in good agreement with those derived from uptake experiments; in contrast, the k(on) values were scaled down when determined by AFM. Our observations generated new insights into the energy landscape of the interaction between SERT and inhibitors. They thus provide a useful framework for molecular dynamics simulations by exploring the range of forces and energies that operate during the binding reaction.	[Wildling, Linda; Gruber, Hermann J.; Zhu, Rong; Hinterdorfer, Peter] Johannes Kepler Univ Linz, Inst Biophys, A-4040 Linz, Austria; [Rankl, Christian] Austria GmbH, Agilent Technol, A-4040 Linz, Austria; [Haselgruebler, Thomas; Hinterdorfer, Peter] Ctr Adv Bioanal, A-4020 Linz, Austria; [Holy, Marion; Freissmuth, Michael; Sitte, Harald H.] Med Univ Vienna, Ctr Physiol & Pharmacol, A-1090 Vienna, Austria; [Newman, Amy Hauck; Zou, Mu-Fa] Natl Inst Drug Abuse, Med Chem Sect, Mol Targets & Medicat Discovery Branch, Intramural Res Program, Baltimore, MD 21224 USA	Johannes Kepler University Linz; Agilent Technologies; Medical University of Vienna; National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA)	Hinterdorfer, P (corresponding author), Johannes Kepler Univ Linz, Inst Biophys, Altenbergerstr 69, A-4040 Linz, Austria.	peter.hinterdorfer@jku.at	Sitte, Harald/O-7025-2019; Hinterdorfer, Peter/C-4235-2013; Sitte, Harald/N-2681-2013; Gruber, Hermann J./C-4234-2013	Sitte, Harald/0000-0002-1339-7444; Sitte, Harald/0000-0002-1339-7444; Freissmuth, Michael/0000-0001-9398-1765; Hinterdorfer, Peter/0000-0003-2583-1305; Rankl, Christian/0000-0002-7354-7651	Austrian Science Fund [F35]; National Institute on Drug Abuse-NIH; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000389] Funding Source: NIH RePORTER; Austrian Science Fund (FWF) [F 3503] Funding Source: researchfish	Austrian Science Fund(Austrian Science Fund (FWF)); National Institute on Drug Abuse-NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by Austrian Science Fund Grant F35 and the National Institute on Drug Abuse-Intramural Research Program, NIH (to A. H. N. and M.-F. Z.).	Baumgartner W, 2000, P NATL ACAD SCI USA, V97, P4005, DOI 10.1073/pnas.070052697; Beuming T, 2006, MOL PHARMACOL, V70, P1630, DOI 10.1124/mol.106.026120; Binning T, 1986, Clin Podiatr Med Surg, V3, P769; Cha JH, 2005, J MED CHEM, V48, P7513, DOI 10.1021/jm050431y; Dror RO, 2011, P NATL ACAD SCI USA, V108, P13118, DOI 10.1073/pnas.1104614108; Ebner A., 2008, FUNCTIONALIZATION PR, P29; Ebner A, 2007, ULTRAMICROSCOPY, V107, P922, DOI 10.1016/j.ultramic.2007.02.035; El-Kasaby A, 2010, J BIOL CHEM, V285, P39201, DOI 10.1074/jbc.M110.118000; Evans E, 1997, BIOPHYS J, V72, P1541, DOI 10.1016/S0006-3495(97)78802-7; Evans E, 1999, BIOPHYS J, V76, P2439, DOI 10.1016/S0006-3495(99)77399-6; FLORIN EL, 1994, SCIENCE, V264, P415, DOI 10.1126/science.8153628; Forrest LR, 2008, P NATL ACAD SCI USA, V105, P10338, DOI 10.1073/pnas.0804659105; Hilber B, 2005, NEUROPHARMACOLOGY, V49, P811, DOI 10.1016/j.neuropharm.2005.08.008; Jacobs MT, 2007, J BIOL CHEM, V282, P29441, DOI 10.1074/jbc.M704456200; Just H, 2004, J BIOL CHEM, V279, P6650, DOI 10.1074/jbc.M306092200; Kamruzzahan ASM, 2006, BIOCONJUGATE CHEM, V17, P1473, DOI 10.1021/bc060252a; Kaufmann KW, 2009, PROTEINS, V74, P630, DOI 10.1002/prot.22178; Korkhov VM, 2006, J BIOL CHEM, V281, P13439, DOI 10.1074/jbc.M511382200; Kristensen AS, 2011, PHARMACOL REV, V63, P585, DOI 10.1124/pr.108.000869; Kuhar MJ, 1999, DRUG ALCOHOL DEPEN, V56, P9, DOI 10.1016/S0376-8716(99)00005-8; LEE GU, 1994, SCIENCE, V266, P771, DOI 10.1126/science.7973628; Marshall BT, 2003, NATURE, V423, P190, DOI 10.1038/nature01605; MOY VT, 1994, SCIENCE, V266, P257, DOI 10.1126/science.7939660; Muller DJ, 2007, NAT PROTOC, V2, P2191, DOI 10.1038/nprot.2007.309; Newman AH, 2001, BIOORG MED CHEM LETT, V11, P1659, DOI 10.1016/S0960-894X(01)00271-2; Quick MW, 2003, NEURON, V40, P537, DOI 10.1016/S0896-6273(03)00605-6; Rankl C, 2007, JPN J APPL PHYS 1, V46, P5536, DOI 10.1143/JJAP.46.5536; Rankl C, 2011, METHODS MOL BIOL, V736, P197, DOI 10.1007/978-1-61779-105-5_13; Rankl C, 2008, P NATL ACAD SCI USA, V105, P17778, DOI 10.1073/pnas.0806451105; Riener CK, 2003, ANAL CHIM ACTA, V497, P101, DOI 10.1016/j.aca.2003.08.041; Riener CK, 2003, ANAL CHIM ACTA, V479, P59, DOI 10.1016/S0003-2670(02)01373-9; Rudnick G, 2006, J MEMBRANE BIOL, V213, P101, DOI 10.1007/s00232-006-0878-4; Sarker S, 2010, MOL PHARMACOL, V78, P1026, DOI 10.1124/mol.110.067538; Scanlon SM, 2001, BIOCHEMISTRY-US, V40, P10507, DOI 10.1021/bi010730z; Schmid JA, 2001, J BIOL CHEM, V276, P3805, DOI 10.1074/jbc.M007357200; Schmitt KC, 2010, J NEUROCHEM, V112, P1605, DOI 10.1111/j.1471-4159.2010.06583.x; Scholze P, 2000, J PHARMACOL EXP THER, V293, P870; Seidel S, 2005, MOL PHARMACOL, V67, P140, DOI 10.1124/mol.67.1.140; Singh SK, 2007, NATURE, V448, P952, DOI 10.1038/nature06038; Singh SK, 2008, SCIENCE, V322, P1655, DOI 10.1126/science.1166777; Sinning S, 2010, J BIOL CHEM, V285, P8363, DOI 10.1074/jbc.M109.045401; Sitte HH, 2010, J NEUROCHEM, V112, P340, DOI 10.1111/j.1471-4159.2009.06474.x; Sucic S, 2010, J BIOL CHEM, V285, P10924, DOI 10.1074/jbc.M109.083154; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zhou Z, 2007, SCIENCE, V317, P1390, DOI 10.1126/science.1147614; Zhou Z, 2009, NAT STRUCT MOL BIOL, V16, P652, DOI 10.1038/nsmb.1602	49	55	57	3	54	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					105	113		10.1074/jbc.M111.304873	http://dx.doi.org/10.1074/jbc.M111.304873			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22033932	Green Published, hybrid			2022-12-27	WOS:000298682400013
J	Cantore, M; Reinehr, R; Sommerfeld, A; Becker, M; Haussinger, D				Cantore, Miriam; Reinehr, Roland; Sommerfeld, Annika; Becker, Martin; Haeussinger, Dieter			The Src Family Kinase Fyn Mediates Hyperosmolarity-induced Mrp2 and Bsep Retrieval from Canalicular Membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIDRUG-RESISTANCE PROTEIN-2; SALT EXPORT PUMP; GROWTH-FACTOR RECEPTOR; PERFUSED-RAT-LIVER; ORGANIC ANION TRANSPORTER; TYROSINE PHOSPHORYLATION; DOWN-REGULATION; CELL-VOLUME; DYNAMIC LOCALIZATION; HEPATOCYTE COUPLETS	In perfused rat liver, hyperosmolarity induces Mrp2-(Kubitz, R., D'urso, D., Keppler, D., and Haussinger, D. (1997) Gastroenterology 113, 1438-1442) and Bsep retrieval (Schmitt, M., Kubitz, R., Lizun, S., Wettstein, M., and Haussinger, D. (2001) Hepatology 33, 509-518) from the canalicular membrane leading to cholestasis. The aim of this study was to elucidate the underlying signaling events. Hyperosmolarity-induced retrieval of Mrp2 and Bsep from the canalicular membrane in perfused rat liver was accompanied by an activating phosphorylation of the Src kinases Fyn and Yes but not of c-Src. Both hyperosmotic transporter retrieval and Src kinase activation were sensitive to apocynin (300 mu mol/liter), N-acetylcysteine (NAC; 10 mmol/liter), and SU6656 (1 mu mol/liter). Also PP-2 (250 nmol/liter), which inhibited hyperosmotic Fyn but not Yes activation, prevented hyperosmotic transporter retrieval from the canalicular membrane, suggesting that Fyn but not Yes mediates hyperosmotic Bsep and Mrp2 retrieval. Neither hyperosmotic Fyn activation nor Bsep/Mrp2 retrieval was observed in livers from p47phox knock-out mice. Hyperosmotic activation of JNKs was sensitive to apocynin and NAC but insensitive to SU6656 and PP-2, indicating that JNKs are not involved in transporter retrieval, as also evidenced by experiments using the JNK inhibitors L-JNKI-1 and SP6001255, respectively. Hyperosmotic transporter retrieval was accompanied by a NAC and Fyn knockdown-sensitive inhibition of biliary excretion of the glutathione conjugate of 1-chloro-2,4-dinitrobenzene in perfused rat liver and of cholyl-L-lysyl-fluorescein secretion into the pseudocanaliculi formed by hepatocyte couplets. Hyperosmolarity triggered an association between Fyn and cortactin and increased the amount of phosphorylated cortactin underneath the canalicular membrane. It is concluded that the hyperosmotic cholestasis is triggered by a NADPH oxidase-driven reactive oxygen species formation that mediates Fyn-dependent retrieval of the Mrp2 and Bsep from the canalicular membrane, which may involve an increased cortactin phosphorylation.	[Cantore, Miriam; Reinehr, Roland; Sommerfeld, Annika; Becker, Martin; Haeussinger, Dieter] Univ Dusseldorf, Clin Gastroenterol Hepatol & Infectiol, D-40225 Dusseldorf, Germany	Heinrich Heine University Dusseldorf	Haussinger, D (corresponding author), Univ Klinikum Dusseldorf, Klin Gastroenterol Hepatol & Infektol, Moorenstr 5, D-40225 Dusseldorf, Germany.	haeussin@uni-duesseldorf.de	Reinehr, Roland/G-6118-2016		Deutsche Forschungsgemeinschaft [Sonderforschungsbereich 575, Klinische Forschergruppe 217]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft through Sonderforschungsbereich 575 "Experimentelle Hepatologie" and Klinische Forschergruppe 217 "Hepatobili rer Transport und Lebererkrankungen" (Dusseldorf).	AKERBOOM TPM, 1989, METHOD ENZYMOL, V173, P523; Bastie CC, 2007, CELL METAB, V5, P371, DOI 10.1016/j.cmet.2007.04.005; Becker S, 2007, CELL PHYSIOL BIOCHEM, V19, P89, DOI 10.1159/000099197; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Bjorge JD, 2000, ONCOGENE, V19, P5620, DOI 10.1038/sj.onc.1203923; Blake RA, 2000, MOL CELL BIOL, V20, P9018, DOI 10.1128/MCB.20.23.9018-9027.2000; Bonny C, 2001, DIABETES, V50, P77, DOI 10.2337/diabetes.50.1.77; Bruck R., 1996, AM J PHYSIOL, V2, P806; Buchler M, 1996, J BIOL CHEM, V271, P15091; Crocenzi FA, 2003, AM J PHYSIOL-GASTR L, V285, pG449, DOI 10.1152/ajpgi.00508.2002; de Waart DR, 2010, J PHARMACOL EXP THER, V334, P78, DOI 10.1124/jpet.110.166991; Demeule M, 1999, FEBS LETT, V442, P208, DOI 10.1016/S0014-5793(98)01663-9; Dombrowski F, 2000, BIOCHEM J, V348, P183, DOI 10.1042/0264-6021:3480183; Donner MG, 2007, AM J PHYSIOL-GASTR L, V293, pG1134, DOI 10.1152/ajpgi.00079.2007; Fukunishi S, 2011, J CLIN BIOCHEM NUTR, V49, P20, DOI 10.3164/jcbn.10-115; GATMAITAN ZC, 1995, PHYSIOL REV, V75, P261, DOI 10.1152/physrev.1995.75.2.261; Gerloff T, 1998, J BIOL CHEM, V273, P10046, DOI 10.1074/jbc.273.16.10046; GRAF J, 1984, P NATL ACAD SCI-BIOL, V81, P6516, DOI 10.1073/pnas.81.20.6516; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; Haussinger D, 2003, GASTROENTEROLOGY, V124, P1476, DOI 10.1016/S0016-5085(03)00274-9; Haussinger D, 1996, BIOCHEM J, V313, P697; HAUSSINGER D, 1992, BIOCHEM J, V288, P681; HAUSSINGER D, 1993, BIOCHEM J, V291, P355; Huang C, 1997, J BIOL CHEM, V272, P13911, DOI 10.1074/jbc.272.21.13911; Kapus A, 1999, J BIOL CHEM, V274, P8093, DOI 10.1074/jbc.274.12.8093; Kara B, 2009, TRANSPL P, V41, P4401, DOI 10.1016/j.transproceed.2009.09.082; Keppler D, 1997, FASEB J, V11, P509, DOI 10.1096/fasebj.11.7.9212074; Klein NP, 1997, MOL CELL BIOL, V17, P6427, DOI 10.1128/MCB.17.11.6427; Koopen NR, 1998, HEPATOLOGY, V27, P537, DOI 10.1002/hep.510270231; Kubitz R, 1997, GASTROENTEROLOGY, V113, P1438, DOI 10.1053/gast.1997.v113.pm9352844; Kubitz R, 1999, BIOCHEM J, V340, P585, DOI 10.1042/0264-6021:3400585; Kubitz R, 1999, GASTROENTEROLOGY, V116, P401, DOI 10.1016/S0016-5085(99)70138-1; Lang F, 1998, PHYSIOL REV, V78, P247, DOI 10.1152/physrev.1998.78.1.247; Meier PJ, 1995, AM J PHYSIOL-GASTR L, V269, pG801, DOI 10.1152/ajpgi.1995.269.6.G801; Muhfeld A, 2003, ARCH BIOCHEM BIOPHYS, V413, P32, DOI 10.1016/S0003-9861(03)00098-5; Muller M, 1997, AM J PHYSIOL-GASTR L, V272, pG1285, DOI 10.1152/ajpgi.1997.272.6.G1285; Noe B, 1996, GASTROENTEROLOGY, V110, P858, DOI 10.1053/gast.1996.v110.pm8608896; ONeill AJ, 1997, J PATHOL, V183, P325, DOI 10.1002/(SICI)1096-9896(199711)183:3<325::AID-PATH941>3.0.CO;2-A; Perez LM, 2006, TOXICOL SCI, V91, P150, DOI 10.1093/toxsci/kfj113; Piiper A, 2003, J BIOL CHEM, V278, P7065, DOI 10.1074/jbc.M211234200; Pols TWH, 2011, J HEPATOL, V54, P1263, DOI 10.1016/j.jhep.2010.12.004; Reinehr R, 2003, FASEB J, V17, P731, DOI 10.1096/fj.02-0915fje; Reinehr R, 2004, J BIOL CHEM, V279, P23977, DOI 10.1074/jbc.M401519200; Reinehr R, 2002, HEPATOLOGY, V36, P602, DOI 10.1053/jhep.2002.35447; Reinehr R, 2006, J BIOL CHEM, V281, P23150, DOI 10.1074/jbc.M601451200; Reinehr R, 2010, J BIOL CHEM, V285, P25904, DOI 10.1074/jbc.M110.125781; Schliess F, 1997, GASTROENTEROLOGY, V113, P1306, DOI 10.1053/gast.1997.v113.pm9322526; Schmitt M, 2001, HEPATOLOGY, V33, P509, DOI 10.1053/jhep.2001.22648; Schmitt M, 2000, BIOL CHEM, V381, P487, DOI 10.1515/BC.2000.063; Sies H, 1978, Methods Enzymol, V52, P48; STEVENSON BR, 1986, J CELL BIOL, V103, P755, DOI 10.1083/jcb.103.3.755; Stross C, 2010, AM J PHYSIOL-GASTR L, V299, pG320, DOI 10.1152/ajpgi.00180.2010; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Trauner M, 1998, J CLIN INVEST, V101, P2092, DOI 10.1172/JCI1680; Tsygankova OM, 1998, J CELL BIOCHEM, V69, P63, DOI 10.1002/(SICI)1097-4644(19980401)69:1<63::AID-JCB7>3.0.CO;2-T; vom Dahl S, 2003, J BIOL CHEM, V278, P27088, DOI 10.1074/jbc.M210699200; VOMDAHL S, 1991, BIOCHEM J, V280, P105, DOI 10.1042/bj2800105; Vos TA, 1998, HEPATOLOGY, V28, P1637, DOI 10.1002/hep.510280625; WAHLLANDER A, 1979, EUR J BIOCHEM, V96, P441, DOI 10.1111/j.1432-1033.1979.tb13056.x; Warskulat U, 1999, BIOL CHEM, V380, P1273, DOI 10.1515/BC.1999.162; Webster CRL, 2000, J BIOL CHEM, V275, P29754, DOI 10.1074/jbc.M002831200	61	22	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2011	286	52					45014	45029		10.1074/jbc.M111.292896	http://dx.doi.org/10.1074/jbc.M111.292896			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870CA	22057277	Green Published, hybrid			2022-12-27	WOS:000298645500069
J	Kim, HJ; Ham, SA; Kim, MY; Hwang, JS; Lee, H; Kang, ES; Yoo, T; Woo, IS; Yabe-Nishimura, C; Paek, KS; Kim, JH; Seo, HG				Kim, Hyo Jung; Ham, Sun Ah; Kim, Min Young; Hwang, Jung Seok; Lee, Hanna; Kang, Eun Sil; Yoo, Taesik; Woo, Im Sun; Yabe-Nishimura, Chihiro; Paek, Kyung Shin; Kim, Jin-Hoi; Seo, Han Geuk			PPAR delta Coordinates Angiotensin II-induced Senescence in Vascular Smooth Muscle Cells through PTEN-mediated Inhibition of Superoxide Generation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED-RECEPTOR-DELTA; TUMOR-SUPPRESSOR; ENDOTHELIAL DYSFUNCTION; HUMAN ATHEROSCLEROSIS; CELLULAR SENESCENCE; HUMAN FIBROBLASTS; OXIDASE ACTIVITY; UP-REGULATION; LIFE-SPAN; PATHWAY	Cellular senescence-associated changes in blood vessels have been implicated in aging and age-related cardiovascular disorders. Here, we demonstrate that peroxisome proliferator-activated receptor (PPAR) delta coordinates angiotensin (Ang) II-induced senescence of human vascular smooth muscle cells (VSMCs). Activation of PPAR delta by GW501516, a specific ligand for PPAR delta, significantly attenuated Ang II-induced generation of superoxides and suppressed senescence of VSMCs. A marked increase in the levels of p53 and p21 induced by Ang II was blunted by the treatment with GW501516. Ligand-activated PPAR delta up-regulated expression of phosphatase and tensin homolog deleted on chromosome 10 (PTEN) and suppressed the phosphatidylinositol 3-kinase (PI3K)/Akt pathway. Knockdown of PTEN with siRNA abrogated the effects of PPAR delta on cellular senescence, on PI3K/Akt signaling, and on generation of ROS in VSMCs treated with Ang II. Finally, administration of GW501516 to apoE-deficient mice treated with Ang II significantly reduced the number of senescent cells in the aorta, where up-regulation of PTEN with reduced levels of phosphorylated Akt and ROS was demonstrated. Thus, ligand-activated PPAR delta confers resistance to Ang II-induced senescence by up-regulation of PTEN and ensuing modulation of the PI3K/Akt signaling to reduce ROS generation in vascular cells.	[Kim, Hyo Jung; Kim, Min Young; Hwang, Jung Seok; Lee, Hanna; Yoo, Taesik; Kim, Jin-Hoi; Seo, Han Geuk] Konkuk Univ, Dept Anim Biotechnol, Seoul 143701, South Korea; [Ham, Sun Ah; Kang, Eun Sil; Woo, Im Sun] Gyeongsang Natl Univ, Sch Med, Dept Pharmacol, Jinju 660751, South Korea; [Yabe-Nishimura, Chihiro] Kyoto Prefectural Univ Med, Dept Pharmacol, Kyoto 6028566, Japan; [Paek, Kyung Shin] Semyung Univ, Dept Nursing, Jechon 390711, South Korea	Konkuk University; Gyeongsang National University; Kyoto Prefectural University of Medicine; Semyung University	Kim, JH (corresponding author), Hwayang Dong, Seoul, South Korea.	jhkim541@konkuk.ac.kr; hgseo@konkuk.ac.kr		kim, jin-hoi/0000-0003-1232-5307	MEST [2011-0012427, 2011-0006200]; Rural Development Administration, Republic of Korea [PJ007980]; Mid-career Research Program; MRC through an NRF	MEST(Ministry of Education, Science & Technology (MEST), Republic of Korea); Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea); Mid-career Research Program; MRC through an NRF	This work was supported in part by the Mid-career Research Program and MRC Program through an NRF grant funded by MEST (2011-0012427 and 2011-0006200) and Next-Generation BioGreen 21 Program (PJ007980), Rural Development Administration, Republic of Korea.	Bennett MR, 1998, CIRC RES, V82, P704, DOI 10.1161/01.RES.82.6.704; Brandes RP, 2005, CARDIOVASC RES, V65, P16, DOI 10.1016/j.cardiores.2004.08.007; Cai H, 2000, CIRC RES, V87, P840, DOI 10.1161/01.RES.87.10.840; Campisi J, 2001, TRENDS CELL BIOL, V11, pS27, DOI 10.1016/S0962-8924(01)02151-1; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Chen QM, 2001, EXP CELL RES, V265, P294, DOI 10.1006/excr.2001.5182; Chow LML, 2006, CANCER LETT, V241, P184, DOI 10.1016/j.canlet.2005.11.042; Collins CJ, 2003, AGING CELL, V2, P145, DOI 10.1046/j.1474-9728.2003.00048.x; COOPER LT, 1994, J GERONTOL, V49, pB191, DOI 10.1093/geronj/49.5.B191; Di-Poi N, 2002, MOL CELL, V10, P721, DOI 10.1016/S1097-2765(02)00646-9; Ehrenborg E, 2009, PHARMACOL REV, V61, P373, DOI 10.1124/pr.109.001560; Graham TL, 2005, ATHEROSCLEROSIS, V181, P29, DOI 10.1016/j.atherosclerosis.2004.12.028; GRIENDLING KK, 1994, CIRC RES, V74, P1141, DOI 10.1161/01.RES.74.6.1141; Han JK, 2008, CIRCULATION, V118, P1021, DOI 10.1161/CIRCULATIONAHA.108.777169; Han SW, 2005, J BIOL CHEM, V280, P33240, DOI 10.1074/jbc.M507617200; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Hathaway CA, 2002, CIRC RES, V90, P277, DOI 10.1161/hh0302.104724; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; Herbert KE, 2008, CIRC RES, V102, P201, DOI 10.1161/CIRCRESAHA.107.158626; HOLLIDAY R, 1986, EXP CELL RES, V166, P543, DOI 10.1016/0014-4827(86)90499-4; Imanishi T, 2008, HYPERTENS RES, V31, P757, DOI 10.1291/hypres.31.757; Jandeleit-Dahm KAM, 2009, CURR OPIN LIPIDOL, V20, P24, DOI 10.1097/MOL.0b013e32831f1b18; Kim HJ, 2008, CIRC RES, V102, P193, DOI 10.1161/CIRCRESAHA.107.158477; Kim HJ, 2009, CIRC RES, V105, P16, DOI 10.1161/CIRCRESAHA.108.189159; Kunieda T, 2006, CIRCULATION, V114, P953, DOI 10.1161/CIRCULATIONAHA.106.626606; Lawless C, 2010, EXP GERONTOL, V45, P772, DOI 10.1016/j.exger.2010.01.018; Lee CH, 2003, SCIENCE, V302, P453, DOI 10.1126/science.1087344; Li AC, 2004, J CLIN INVEST, V114, P1564, DOI 10.1172/JCI200418730; Minamino T, 2002, CIRCULATION, V105, P1541, DOI 10.1161/01.CIR.0000013836.85741.17; Miyauchi H, 2004, EMBO J, V23, P212, DOI 10.1038/sj.emboj.7600045; Nielsen R, 2006, MOL CELL BIOL, V26, P5698, DOI 10.1128/MCB.02266-05; Ogryzko VV, 1996, MOL CELL BIOL, V16, P5210; Oliver WR, 2001, P NATL ACAD SCI USA, V98, P5306, DOI 10.1073/pnas.091021198; Patel L, 2001, CURR BIOL, V11, P764, DOI 10.1016/S0960-9822(01)00225-1; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; ROSS R, 1984, AM J PATHOL, V114, P79; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Seshiah PN, 2002, CIRC RES, V91, P406, DOI 10.1161/01.RES.0000033523.08033.16; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Stambolic V, 2001, MOL CELL, V8, P317, DOI 10.1016/S1097-2765(01)00323-9; Takata Y, 2008, P NATL ACAD SCI USA, V105, P4277, DOI 10.1073/pnas.0708647105; Virolle T, 2001, NAT CELL BIOL, V3, P1124, DOI 10.1038/ncb1201-1124; VONZGLINICKI T, 1995, EXP CELL RES, V220, P186, DOI 10.1006/excr.1995.1305; Wang YX, 2003, CELL, V113, P159, DOI 10.1016/S0092-8674(03)00269-1; Zhang W, 2006, CANCER BIOL THER, V5, P1008, DOI 10.4161/cbt.5.8.2887; Zhu JY, 1998, GENE DEV, V12, P2997, DOI 10.1101/gad.12.19.2997	46	32	33	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2011	286	52					44585	44593		10.1074/jbc.M111.222562	http://dx.doi.org/10.1074/jbc.M111.222562			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870CA	22072715	Green Published, hybrid			2022-12-27	WOS:000298645500030
J	Siednienko, J; Maratha, A; Yang, S; Mitkiewicz, M; Miggin, SM; Moynagh, PN				Siednienko, Jakub; Maratha, Ashwini; Yang, Shuo; Mitkiewicz, Malgorzata; Miggin, Sinead M.; Moynagh, Paul N.			Nuclear Factor kappa B Subunits RelB and cRel Negatively Regulate Toll-like Receptor 3-mediated beta-Interferon Production via Induction of Transcriptional Repressor Protein YY1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYD88 ADAPTER-LIKE; I INTERFERONS; SIGNALING PATHWAY; IMMUNE-RESPONSES; GENE INDUCTION; PROMOTER; EXPRESSION; IDENTIFICATION; AUTOIMMUNITY; ENHANCEOSOME	The induction of beta-interferon (IFN-beta) is a key anti-viral response to infection by RNA viruses. Virus-induced expression of IFN-beta requires the co-operative action of the transcription factors IRF-3/7, NF-kappa B, and ATF-2/c-Jun on the IFN-beta promoter leading to the orderly recruitment of chromatin remodeling complexes. Although viruses strongly activate NF-kappa B and promote its binding to the IFN-beta promoter, recent studies have indicated that NF-kappa B is not essential for virus-induced expression of IFN-beta. Herein, we examined the role of NF-kappa B in regulating IFN-beta expression in response to the viral-sensing Toll-like receptor 3 (TLR3). Intriguingly pharmacological inhibition of the NF-kappa B pathway augments late phase expression of IFN-beta expression in response to TLR3 stimulation. We show that the negative effect of NF-kappa B on IFN-beta expression is dependent on the induction of the transcriptional repressor protein YinYang1. We demonstrate that the TLR3 ligand polyriboinosinic: polyribocytidylic acid (poly(I: C)) induces expression and nuclear translocation of YinYang1 where it interacts with the IFN-beta promoter and inhibits the binding of IRF7 to the latter. Evidence is also presented showing that the NF-kappa B subunits c-Rel and RelB are the likely key drivers of these negative effects on IFN-beta expression. These findings thus highlight for the first time a novel self-regulatory mechanism that is employed by TLR3 to limit the level and duration of IFN-beta expression.	[Siednienko, Jakub; Maratha, Ashwini; Yang, Shuo; Miggin, Sinead M.; Moynagh, Paul N.] Natl Univ Ireland Maynooth, Inst Immunol, Maynooth, Kildare, Ireland; [Siednienko, Jakub; Mitkiewicz, Malgorzata] Polish Acad Sci, Inst Immunol & Expt Therapy, PL-53114 Wroclaw, Poland	Maynooth University; Polish Academy of Sciences; Hirszfeld Institute of Immunology & Experimental Therapy of the Polish Academy of Sciences	Moynagh, PN (corresponding author), Natl Univ Ireland Maynooth, Inst Immunol, Maynooth, Kildare, Ireland.	Paul.Moynagh@nuim.ie		Moynagh, Paul/0000-0002-4139-3061; Siednienko, Jakub/0000-0003-2358-5876; Mitkiewicz, Malgorzata/0000-0003-4026-3860; Miggin, Sinead/0000-0002-3421-3552	Science Foundation Ireland; Health Research Board of Ireland	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Health Research Board of Ireland	This work was supported by a Science Foundation Ireland award (to P. N. M.) and Health Research Board of Ireland awards (to P. N. M. and S. M. M.).	Agalioti T, 2000, CELL, V103, P667, DOI 10.1016/S0092-8674(00)00169-0; Basagoudanavar SH, 2011, J VIROL, V85, P2599, DOI 10.1128/JVI.02213-10; Curran NM, 2005, J BIOL CHEM, V280, P35797, DOI 10.1074/jbc.M507959200; Donohoe ME, 2007, MOL CELL, V25, P43, DOI 10.1016/j.molcel.2006.11.017; Downer EJ, 2011, J BIOL CHEM, V286, P10316, DOI 10.1074/jbc.M110.188599; Doyle SE, 2002, IMMUNITY, V17, P251, DOI 10.1016/S1074-7613(02)00390-4; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Galvin KM, 1997, MOL CELL BIOL, V17, P3723, DOI 10.1128/MCB.17.7.3723; GAROUFALIS E, 1994, J VIROL, V68, P4707, DOI 10.1128/JVI.68.8.4707-4715.1994; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Gordon S, 2006, ONCOGENE, V25, P1125, DOI 10.1038/sj.onc.1209080; Hall JC, 2010, NAT REV RHEUMATOL, V6, P40, DOI 10.1038/nrrheum.2009.237; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kenny EF, 2009, J IMMUNOL, V183, P3642, DOI 10.4049/jimmunol.0901140; Le May N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040013; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Mokrani H, 2006, MOL CELL BIOL, V26, P8551, DOI 10.1128/MCB.00420-06; Moynagh Paul N, 2005, J Cell Sci, V118, P4589, DOI 10.1242/jcs.02579; Moynagh PN, 2005, TRENDS IMMUNOL, V26, P469, DOI 10.1016/j.it.2005.06.009; Panne D, 2008, CURR OPIN STRUC BIOL, V18, P236, DOI 10.1016/j.sbi.2007.12.002; Panne D, 2007, CELL, V129, P1111, DOI 10.1016/j.cell.2007.05.019; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Shin HM, 2004, FEBS LETT, V571, P50, DOI 10.1016/j.febslet.2004.06.056; Siednienko J, 2011, J IMMUNOL, V186, P2514, DOI 10.4049/jimmunol.1003093; Siednienko J, 2010, EUR J IMMUNOL, V40, P3150, DOI 10.1002/eji.201040547; Stetson DB, 2006, IMMUNITY, V25, P373, DOI 10.1016/j.immuni.2006.08.007; THANOS D, 1995, MOL CELL BIOL, V15, P152, DOI 10.1128/MCB.15.1.152; Theofilopoulos AN, 2005, ANNU REV IMMUNOL, V23, P307, DOI 10.1146/annurev.immunol.23.021704.115843; Thomas MJ, 1999, GENE, V236, P197, DOI 10.1016/S0378-1119(99)00261-9; Wang HT, 2007, MOL CELL BIOL, V27, P4374, DOI 10.1128/MCB.02020-06; Wang JM, 2010, J IMMUNOL, V185, P1720, DOI 10.4049/jimmunol.1000114; Wang XY, 2007, J IMMUNOL, V178, P6770, DOI 10.4049/jimmunol.178.11.6770; Weill L, 2003, J VIROL, V77, P2903, DOI 10.1128/JVI.77.5.2903-2914.2003; Wietek C, 2003, J BIOL CHEM, V278, P50923, DOI 10.1074/jbc.M308135200; Yamamoto Y, 2004, TRENDS BIOCHEM SCI, V29, P72, DOI 10.1016/j.tibs.2003.12.003; Yun JJ, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-15; Zhao XJ, 2008, J IMMUNOL, V181, P3049, DOI 10.4049/jimmunol.181.5.3049	40	29	30	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2011	286	52					44750	44763		10.1074/jbc.M111.250894	http://dx.doi.org/10.1074/jbc.M111.250894			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870CA	22065573	Green Accepted, hybrid, Green Published			2022-12-27	WOS:000298645500045
J	Tate, J; Gollnick, P				Tate, Jessica; Gollnick, Paul			Role of Forward Translocation in Nucleoside Triphosphate Phosphohydrolase I (NPH I)-mediated Transcription Termination of Vaccinia Virus Early Genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; REPAIR COUPLING FACTOR; NASCENT RNA; ELONGATION COMPLEX; TERNARY COMPLEXES; ESCHERICHIA-COLI; ECORI ENDONUCLEASE; CLEAVAGE CENTER; CAPPING ENZYME; RELEASE	Termination of transcription of vaccinia virus early genes requires the virion form of the viral RNA polymerase (RNAP), a termination signal (UUUUUNU) in the nascent RNA, vaccinia termination factor, nucleoside triphosphate phosphohydrolase I (NPH I), and ATP. NPH I uses ATP hydrolysis to mediate transcript release, and in vitro, ATPase activity requires single-stranded DNA. NPH I shows sequence similarity with the DEXH-box family of proteins, which includes an Escherichia coli ATP-dependent motor protein, Mfd. Mfd releases transcripts and rescues arrested transcription complexes by moving the transcription elongation complex downstream on the DNA template in the absence of transcription elongation. This mechanism is known as forward translocation. In this study, we demonstrate that NPH I also uses forward translocation to catalyze transcript release from viral RNAP. Moreover, we show that NPH I-mediated release can occur at a stalled RNAP in the absence of vaccinia termination factor and U5NU when transcription elongation is prevented.	[Tate, Jessica; Gollnick, Paul] SUNY Buffalo, Dept Biol Sci, Buffalo, NY 14226 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Gollnick, P (corresponding author), SUNY Buffalo, Dept Biol Sci, Buffalo, NY 14226 USA.	gollnick@buffalo.edu			University at Buffalo	University at Buffalo	This work was supported by funds from the Principal Investigator Incentive Program at the University at Buffalo.	AHN BY, 1992, P NATL ACAD SCI USA, V89, P3536, DOI 10.1073/pnas.89.8.3536; AHN BY, 1994, J BIOL CHEM, V269, P7552; Birse CE, 1998, SCIENCE, V280, P298, DOI 10.1126/science.280.5361.298; BORUKHOV S, 1993, CELL, V72, P459, DOI 10.1016/0092-8674(93)90121-6; Broyles SS, 2003, J GEN VIROL, V84, P2293, DOI 10.1099/vir.0.18942-0; Buratowski S, 2003, NAT STRUCT BIOL, V10, P679, DOI 10.1038/nsb0903-679; Cheung ACM, 2011, NATURE, V471, P249, DOI 10.1038/nature09785; Christen LA, 2008, VIROLOGY, V376, P225, DOI 10.1016/j.virol.2008.03.031; Christen LM, 1998, VIROLOGY, V245, P360, DOI 10.1006/viro.1998.9177; Deng L, 1996, J BIOL CHEM, V271, P29386, DOI 10.1074/jbc.271.46.29386; Deng L, 1998, GENE DEV, V12, P538, DOI 10.1101/gad.12.4.538; Deng L, 1996, J BIOL CHEM, V271, P19556, DOI 10.1074/jbc.271.32.19556; Galburt EA, 2007, NATURE, V446, P820, DOI 10.1038/nature05701; Gilmour DS, 2008, J BIOL CHEM, V283, P661, DOI 10.1074/jbc.R700032200; GRIEVE SJ, 2005, NAT REV MOL STRUCT B, V6, P221; HAGLER J, 1992, P NATL ACAD SCI USA, V89, P10099, DOI 10.1073/pnas.89.21.10099; HAGLER J, 1994, J BIOL CHEM, V269, P10050; HAGLER J, 1993, J BIOL CHEM, V268, P2166; Henkin T., 2002, TRANSCRIPTION TERMIN, P149; HIRSCHMANN P, 1990, J VIROL, V64, P6063, DOI 10.1128/JVI.64.12.6063-6069.1990; Kim M, 2004, EMBO J, V23, P354, DOI 10.1038/sj.emboj.7600053; Kim M, 2004, NATURE, V432, P517, DOI 10.1038/nature03041; KING K, 1989, J BIOL CHEM, V264, P11807; LUO Y, 1993, J BIOL CHEM, V268, P21253; Mahdi AA, 2003, EMBO J, V22, P724, DOI 10.1093/emboj/cdg043; MARAIA RJ, 1994, MOL CELL BIOL, V14, P2147, DOI 10.1128/MCB.14.3.2147; Maraia RJ, 2001, MOL CELL BIOL, V21, P367, DOI 10.1128/MCB.21.2.367-379.2001; Mohamed MR, 2000, J BIOL CHEM, V275, P25798, DOI 10.1074/jbc.M002250200; Moss B, 2007, FIELDS VIROLOGY; Nudler E, 1997, CELL, V89, P33, DOI 10.1016/S0092-8674(00)80180-4; PAOLETTI E, 1972, J VIROL, V10, P866, DOI 10.1128/JVI.10.4.866-868.1972; Park JS, 2006, P NATL ACAD SCI USA, V103, P4870, DOI 10.1073/pnas.0600145103; Park JS, 2002, CELL, V109, P757, DOI 10.1016/S0092-8674(02)00769-9; PAVCO PA, 1990, J BIOL CHEM, V265, P9960; Piacente S, 2008, VIROLOGY, V376, P211, DOI 10.1016/j.virol.2008.03.011; Reeder RH, 1997, TRENDS BIOCHEM SCI, V22, P473, DOI 10.1016/S0968-0004(97)01133-X; REINES D, 1993, CELL MOL BIOL RES, V39, P331; Roberts J, 2004, CURR OPIN MICROBIOL, V7, P120, DOI 10.1016/j.mib.2004.02.014; ROHRMANN G, 1986, CELL, V46, P1029, DOI 10.1016/0092-8674(86)90702-6; Santangelo TJ, 2004, MOL CELL, V14, P117, DOI 10.1016/S1097-2765(04)00154-6; Shatzer AN, 2008, VIROLOGY, V375, P236, DOI 10.1016/j.virol.2008.01.028; SHUMAN S, 1987, J BIOL CHEM, V262, P12372; SHUMAN S, 1989, J BIOL CHEM, V264, P21356; SHUMAN S, 1988, J BIOL CHEM, V263, P6220; UCHIDA K, 1989, NUCLEIC ACIDS RES, V17, P10259, DOI 10.1093/nar/17.24.10259; Venkataraman K, 2005, GENE DEV, V19, P1315, DOI 10.1101/gad.1298605; West S, 2004, NATURE, V432, P522, DOI 10.1038/nature03035; WRIGHT DJ, 1989, J BIOL CHEM, V264, P11816; Yarnell WS, 1999, SCIENCE, V284, P611, DOI 10.1126/science.284.5414.611; YUEN L, 1986, J VIROL, V60, P320, DOI 10.1128/JVI.60.1.320-323.1986; YUEN L, 1987, P NATL ACAD SCI USA, V84, P6069, DOI 10.1073/pnas.84.17.6069; Zhang ZQ, 2006, MOL CELL, V21, P65, DOI 10.1016/j.molcel.2005.11.002; Zhang ZQ, 2005, GENE DEV, V19, P1572, DOI 10.1101/gad.1296305	53	4	4	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2011	286	52					44764	44775		10.1074/jbc.M111.263822	http://dx.doi.org/10.1074/jbc.M111.263822			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870CA	22069335	Green Published, hybrid			2022-12-27	WOS:000298645500046
J	van der Ploeg, R; Barnett, JP; Vasisht, N; Goosens, VJ; Pother, DC; Robinson, C; van Dijl, JM				van der Ploeg, Rene; Barnett, James P.; Vasisht, Nishi; Goosens, Vivianne J.; Pother, Dierk C.; Robinson, Colin; van Dijl, Jan Maarten			Salt Sensitivity of Minimal Twin Arginine Translocases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN TRANSLOCATION; SIGNAL PEPTIDE; TRANSPORT-SYSTEM; TATA COMPONENT; EXPORT SYSTEM; PATHWAY; SECRETION; COMPLEX; MEMBRANE; SUBUNITS	Bacterial twin arginine translocation (Tat) pathways have evolved to facilitate transport of folded proteins across membranes. Gram-negative bacteria contain a TatABC translocase composed of three subunits named TatA, TatB, and TatC. In contrast, the Tat translocases of most Gram-positive bacteria consist of only TatA and TatC subunits. In these minimal TatAC translocases, a bifunctional TatA subunit fulfils the roles of both TatA and TatB. Here we have probed the importance of conserved residues in the bifunctional TatAy subunit of Bacillus subtilis by site-specific mutagenesis. A set of engineered TatAy proteins with mutations in the cytoplasmic hinge and amphipathic helix regions were found to be inactive in protein translocation under standard growth conditions for B. subtilis or when heterologously expressed in Escherichia coli. Nevertheless, these mutated TatAy proteins did assemble into TatAy and TatAyCy complexes, and they facilitated membrane association of twin arginine precursor proteins in E. coli. Interestingly, most of the mutated TatAyCy translocases were salt-sensitive in B. subtilis. Similarly, the TatAC translocases of Bacillus cereus and Staphylococcus aureus were salt-sensitive when expressed in B. subtilis. Taken together, our present observations imply that salt-sensitive electrostatic interactions have critical roles in the preprotein translocation activity of certain TatAC type translocases from Gram-positive bacteria.	[van Dijl, Jan Maarten] Univ Med Ctr Groningen, Dept Med Microbiol, NL-9700 RB Groningen, Netherlands; [van Dijl, Jan Maarten] Univ Groningen, NL-9700 RB Groningen, Netherlands; [Barnett, James P.; Vasisht, Nishi; Robinson, Colin] Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England	University of Groningen; University of Groningen; University of Warwick	van Dijl, JM (corresponding author), Univ Med Ctr Groningen, Dept Med Microbiol, Hanzepl 1,POB 30001, NL-9700 RB Groningen, Netherlands.	J.M.van.Dijl@med.umcg.nl	Pöther, Dierk-Christoph/A-4568-2017; van Dijl, Jan Maarten/G-1205-2013	Pöther, Dierk-Christoph/0000-0001-7000-3520; Barnett, James/0000-0003-1827-036X; van der Ploeg, Rene/0000-0003-2490-9262; Goosens, Vivianne/0000-0002-7808-5185	Commission of the European Union [LSHM-CT-2006-019064, LSHG-CT-2006-037469, 244093]; Research Council for Earth and Life Sciences of the Netherlands Organization for Scientific Research [04-EScope 01-011]; Biotechnology and Biological Sciences Research council;  [LSHG-CT-2004-005257];  [PITN-GA-2008-215524]	Commission of the European Union(European Commission); Research Council for Earth and Life Sciences of the Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Biotechnology and Biological Sciences Research council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); ; 	Supported in part by Projects LSHG-CT-2004-005257 and PITN-GA-2008-215524.; Supported in part by Commission of the European Union Projects LSHM-CT-2006-019064, LSHG-CT-2006-037469, and 244093, a transnational SysMO initiative through projects BACELL SysMO 1 and 2, and Research Council for Earth and Life Sciences of the Netherlands Organization for Scientific Research Grant 04-EScope 01-011.; Supported by a Biotechnology and Biological Sciences Research council grant.	Alami M, 2003, MOL CELL, V12, P937, DOI 10.1016/S1097-2765(03)00398-8; Aldridge C, 2009, FEBS J, V276, P1177, DOI 10.1111/j.1742-4658.2009.06875.x; Barnett JP, 2008, J BIOL CHEM, V283, P2534, DOI 10.1074/jbc.M708134200; Barnett JP, 2011, ARCH MICROBIOL, V193, P583, DOI 10.1007/s00203-011-0699-4; Barnett JP, 2009, FEBS J, V276, P232, DOI 10.1111/j.1742-4658.2008.06776.x; Barrett CML, 2007, J BIOL CHEM, V282, P36206, DOI 10.1074/jbc.M704127200; Barrett CML, 2005, FEBS J, V272, P2261, DOI 10.1111/j.1742-4658.2005.04654.x; Barrett CML, 2005, J MOL BIOL, V347, P453, DOI 10.1016/j.jmb.2005.01.026; Barrett CML, 2003, FEBS LETT, V537, P42, DOI 10.1016/S0014-5793(03)00068-1; Berks BC, 2000, MOL MICROBIOL, V35, P260, DOI 10.1046/j.1365-2958.2000.01719.x; Berks BC, 1996, MOL MICROBIOL, V22, P393, DOI 10.1046/j.1365-2958.1996.00114.x; Blaudeck N, 2005, J BIOL CHEM, V280, P3426, DOI 10.1074/jbc.M411210200; Bogsch EG, 1998, J BIOL CHEM, V273, P18003, DOI 10.1074/jbc.273.29.18003; Bolhuis A, 2001, J BIOL CHEM, V276, P20213, DOI 10.1074/jbc.M100682200; CASADABAN MJ, 1976, J MOL BIOL, V104, P541, DOI 10.1016/0022-2836(76)90119-4; CHADDOCK AM, 1995, EMBO J, V14, P2715, DOI 10.1002/j.1460-2075.1995.tb07272.x; Chan CS, 2007, BIOCHEMISTRY-US, V46, P7396, DOI 10.1021/bi7005288; CLINE K, 1992, J BIOL CHEM, V267, P2688; Cline K, 2001, J CELL BIOL, V154, P719, DOI 10.1083/jcb.200105149; CLINE K, 2007, SEC TAT PROTEIN TRAN; Cristobal S, 1999, EMBO J, V18, P2982, DOI 10.1093/emboj/18.11.2982; Dabney-Smith C, 2006, J BIOL CHEM, V281, P5476, DOI 10.1074/jbc.M512453200; Dabney-Smith C, 2009, MOL BIOL CELL, V20, P2060, DOI 10.1091/mbc.E08-12-1189; De Keersmaeker S, 2006, ARCH MICROBIOL, V186, P507, DOI 10.1007/s00203-006-0161-1; DeLisa MP, 2002, J BIOL CHEM, V277, P29825, DOI 10.1074/jbc.M201956200; DeLisa MP, 2003, P NATL ACAD SCI USA, V100, P6115, DOI 10.1073/pnas.0937838100; Eijlander RT, 2009, MICROBIOL-SGM, V155, P1776, DOI 10.1099/mic.0.027987-0; Gandhi M, 2007, INT J FOOD MICROBIOL, V113, P1, DOI 10.1016/j.ijfoodmicro.2006.07.008; Gerard F, 2006, J BIOL CHEM, V281, P6130, DOI 10.1074/jbc.M512733200; Gerard F, 2007, J BIOL CHEM, V282, P5263, DOI 10.1074/jbc.M610337200; Gohlke U, 2005, P NATL ACAD SCI USA, V102, P10482, DOI 10.1073/pnas.0503558102; Gouffi K, 2004, J BIOL CHEM, V279, P11608, DOI 10.1074/jbc.M313187200; Greene NP, 2007, J BIOL CHEM, V282, P23937, DOI 10.1074/jbc.M702972200; Hicks MG, 2003, FEBS LETT, V539, P61, DOI 10.1016/S0014-5793(03)00198-4; Hu YF, 2010, J AM CHEM SOC, V132, P15942, DOI 10.1021/ja1053785; Jongbloed JDH, 2006, TRENDS MICROBIOL, V14, P2, DOI 10.1016/j.tim.2005.11.001; Jongbloed JDH, 2002, J BIOL CHEM, V277, P44068, DOI 10.1074/jbc.M203191200; Jongbloed JDH, 2000, J BIOL CHEM, V275, P41350, DOI 10.1074/jbc.M004887200; Jongbloed JDH, 2004, MOL MICROBIOL, V54, P1319, DOI 10.1111/j.1365-2958.2004.04341.x; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; KUNST F, 1995, J BACTERIOL, V177, P2403, DOI 10.1128/jb.177.9.2403-2407.1995; Lange C, 2007, BBA-BIOMEMBRANES, V1768, P2627, DOI 10.1016/j.bbamem.2007.06.021; Lee PA, 2002, J BACTERIOL, V184, P5871, DOI 10.1128/JB.184.21.5871-5879.2002; Mori H, 2002, J CELL BIOL, V157, P205, DOI 10.1083/jcb.200202048; Muller SD, 2007, BBA-BIOMEMBRANES, V1768, P3071, DOI 10.1016/j.bbamem.2007.09.008; Natale P, 2008, BBA-BIOMEMBRANES, V1778, P1735, DOI 10.1016/j.bbamem.2007.07.015; Palmer T, 2005, TRENDS MICROBIOL, V13, P175, DOI 10.1016/j.tim.2005.02.002; Panahandeh S, 2008, J BIOL CHEM, V283, P33267, DOI 10.1074/jbc.M804225200; Pop O, 2002, J BIOL CHEM, V277, P3268, DOI 10.1074/jbc.M110829200; Robinson C, 2004, BBA-MOL CELL RES, V1694, P135, DOI 10.1016/j.bbamcr.2004.03.010; ROBINSON C, 1993, FEBS LETT, V325, P67, DOI 10.1016/0014-5793(93)81415-V; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Santini CL, 1998, EMBO J, V17, P101, DOI 10.1093/emboj/17.1.101; Sargent F, 2007, BIOCHEM SOC T, V35, P835, DOI 10.1042/BST0350835; Sargent F, 1998, EMBO J, V17, P3640, DOI 10.1093/emboj/17.13.3640; Stanley NR, 2000, J BIOL CHEM, V275, P11591, DOI 10.1074/jbc.275.16.11591; van der Ploeg R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018140; Walther TH, 2010, J AM CHEM SOC, V132, P15945, DOI 10.1021/ja106963s; Weiner JH, 1998, CELL, V93, P93, DOI 10.1016/S0092-8674(00)81149-6; Wexler M, 2000, J BIOL CHEM, V275, P16717, DOI 10.1074/jbc.M000800200; Wexler M, 1998, FEBS LETT, V431, P339, DOI 10.1016/S0014-5793(98)00790-X; Widdick DA, 2006, P NATL ACAD SCI USA, V103, P17927, DOI 10.1073/pnas.0607025103; Yen MR, 2002, ARCH MICROBIOL, V177, P441, DOI 10.1007/s00203-002-0408-4	63	23	23	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2011	286	51					43759	43770		10.1074/jbc.M111.243824	http://dx.doi.org/10.1074/jbc.M111.243824			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866SH	22041895	Green Published, hybrid			2022-12-27	WOS:000298402300019
J	Balamatsias, D; Kong, AM; Waters, JE; Sriratana, A; Gurung, R; Bailey, CG; Rasko, JEJ; Tiganis, T; Macaulay, SL; Mitchell, CA				Balamatsias, Demis; Kong, Anne M.; Waters, Joanne E.; Sriratana, Absorn; Gurung, Rajendra; Bailey, Charles G.; Rasko, John E. J.; Tiganis, Tony; Macaulay, S. Lance; Mitchell, Christina A.			Identification of P-Rex1 as a Novel Rac1-Guanine Nucleotide Exchange Factor (GEF) That Promotes Actin Remodeling and GLUT4 Protein Trafficking in Adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STIMULATED GLUCOSE-TRANSPORT; GREEN-FLUORESCENT PROTEIN; PLASMA-MEMBRANE; PHOSPHATIDYLINOSITOL 3-KINASE; 3T3-L1 ADIPOCYTES; SIGNALING PATHWAY; SKELETAL-MUSCLE; RAT ADIPOCYTES; CELL-MIGRATION; MYOSIN MYO1C	Phosphoinositide 3-kinase (PI3K) signaling promotes the translocation of the glucose transporter, GLUT4, to the plasma membrane in insulin-sensitive tissues to facilitate glucose uptake. In adipocytes, insulin-stimulated reorganization of the actin cytoskeleton has been proposed to play a role in promoting GLUT4 translocation and glucose uptake, in a PI3K-dependent manner. However, the PI3K effectors that promote GLUT4 translocation via regulation of the actin cytoskeleton in adipocytes remain to be fully elucidated. Here we demonstrate that the PI3K-dependent Rac exchange factor, P-Rex1, enhances membrane ruffling in 3T3-L1 adipocytes and promotes GLUT4 trafficking to the plasma membrane at submaximal insulin concentrations. P-Rex1-facilitated GLUT4 trafficking requires a functional actin network and membrane ruffle formation and occurs in a PI3K- and Rac1-dependent manner. In contrast, expression of other Rho GTPases, such as Cdc42 or Rho, did not affect insulin-stimulated P-Rex1-mediated GLUT4 trafficking. P-Rex1 siRNA knockdown or expression of a P-Rex1 dominant negative mutant reduced but did not completely inhibit glucose uptake in response to insulin. Collectively, these studies identify a novel RacGEF in adipocytes as P-Rex1 that, at physiological insulin concentrations, functions as an insulin-dependent regulator of the actin cytoskeleton that contributes to GLUT4 trafficking to the plasma membrane.	[Balamatsias, Demis; Kong, Anne M.; Waters, Joanne E.; Sriratana, Absorn; Gurung, Rajendra; Tiganis, Tony; Mitchell, Christina A.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Bailey, Charles G.; Rasko, John E. J.] Univ Sydney, Centenary Inst, Gene & Stem Cell Therapy Program, Camperdown, NSW 2050, Australia; [Rasko, John E. J.] Royal Prince Alfred Hosp, Camperdown, NSW 2050, Australia; [Macaulay, S. Lance] CSIRO Mat Sci & Engn CMSE, Commonwealth Sci & Ind Res Org Preventat Hlth Fla, Parkville, Vic 3052, Australia	Monash University; University of Sydney; Centenary Institute; University of Sydney; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Mitchell, CA (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Wellington Rd, Clayton, Vic 3800, Australia.	christina.mitchell@monash.edu	Tiganis, Tony/AAV-3495-2020; Macaulay, Stuart Lance/A-6086-2008; Rasko, John EJ/F-5754-2013	Tiganis, Tony/0000-0002-8065-9942; Macaulay, Stuart Lance/0000-0001-5069-9516; rasko, John/0000-0003-2975-807X; Mitchell, Christina A/0000-0001-9372-3192; Bailey, Charles/0000-0002-4725-7829	National Health and Medical Research Council, Australia [491029]	National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by National Health and Medical Research Council, Australia, Grant 491029.	AILHAUD G, 1992, ANNU REV NUTR, V12, P207, DOI 10.1146/annurev.nu.12.070192.001231; Arabkhari M, 2010, GLYCOBIOLOGY, V20, P603, DOI 10.1093/glycob/cwq010; Asimakopoulos FA, 1996, BRIT J HAEMATOL, V95, P219; Baumann CA, 2000, NATURE, V407, P202, DOI 10.1038/35025089; Bento JL, 2008, GENOMICS, V92, P226, DOI 10.1016/j.ygeno.2008.06.004; Berry R, 2000, AM J HUM GENET, V67, P82, DOI 10.1086/302994; Blondeau F, 2000, HUM MOL GENET, V9, P2223, DOI 10.1093/oxfordjournals.hmg.a018913; Bose A, 2002, NATURE, V420, P821, DOI 10.1038/nature01246; Bose A, 2004, MOL CELL BIOL, V24, P5447, DOI 10.1128/MCB.24.12.5447-5458.2004; Carretero-Ortega J, 2010, MOL PHARMACOL, V77, P435, DOI 10.1124/mol.109.060400; Charriere G, 2003, J BIOL CHEM, V278, P9850, DOI 10.1074/jbc.M210811200; Chiang SH, 2002, J BIOL CHEM, V277, P13067, DOI 10.1074/jbc.M109471200; Chiu TT, 2011, CELL SIGNAL, V23, P1546, DOI 10.1016/j.cellsig.2011.05.022; Cousin B, 1999, FASEB J, V13, P305, DOI 10.1096/fasebj.13.2.305; Dobson SP, 1996, FEBS LETT, V393, P179, DOI 10.1016/0014-5793(96)00879-4; Donald S, 2004, FEBS LETT, V572, P172, DOI 10.1016/j.febslet.2004.06.096; Dong XM, 2005, CURR BIOL, V15, P1874, DOI 10.1016/j.cub.2005.09.014; Dorrestijn J, 1997, EXP CLIN ENDOCR DIAB, V105, P254, DOI 10.1055/s-0029-1211762; Eyster CA, 2005, J BIOL CHEM, V280, P17978, DOI 10.1074/jbc.M409806200; Fayard E, 2010, CURR TOP MICROBIOL, V346, P31, DOI 10.1007/82_2010_58; Fletcher LM, 2000, BIOCHEM J, V352, P267, DOI 10.1042/0264-6021:3520267; Fossey SC, 2001, GENOMICS, V76, P45, DOI 10.1006/geno.2001.6584; Funaki M, 2004, MOL CELL BIOL, V24, P7567, DOI 10.1128/MCB.24.17.7567-7577.2004; Hernandez-Negrete I, 2007, J BIOL CHEM, V282, P23708, DOI 10.1074/jbc.M703771200; Hou JC, 2006, J BIOL CHEM, V281, P23307, DOI 10.1074/jbc.M603127200; Ishiki M, 2005, J BIOL CHEM, V280, P28792, DOI 10.1074/jbc.M500501200; Jebailey L, 2004, MOL ENDOCRINOL, V18, P359, DOI 10.1210/me.2003-0294; Jiang ZY, 2002, J BIOL CHEM, V277, P509, DOI 10.1074/jbc.M108280200; Kanzaki M, 2002, MOL BIOL CELL, V13, P2334, DOI 10.1091/mbc.01-10-0490; Kanzaki M, 2001, J BIOL CHEM, V276, P42436, DOI 10.1074/jbc.M108297200; Kanzaki M, 2004, J BIOL CHEM, V279, P30622, DOI 10.1074/jbc.M401443200; Khayat ZA, 2000, J CELL SCI, V113, P279; Kong AM, 2006, MOL CELL BIOL, V26, P6065, DOI 10.1128/MCB.00203-06; KRIEGERBRAUER HI, 1992, J CLIN INVEST, V89, P1006, DOI 10.1172/JCI115641; Larramendy ML, 2000, CANCER GENET CYTOGEN, V119, P132, DOI 10.1016/S0165-4608(99)00226-5; Lewis JP, 2010, GENOMICS, V96, P211, DOI 10.1016/j.ygeno.2010.07.006; Li GL, 2005, ENDOCRINOLOGY, V146, P4690, DOI 10.1210/en.2005-0505; Lin Y, 2000, J BIOL CHEM, V275, P24255, DOI 10.1074/jbc.M002137200; Liu LB, 2006, MOL BIOL CELL, V17, P4249, DOI 10.1091/mbc.E06-04-0278; Lopez JA, 2009, MOL BIOL CELL, V20, P3918, DOI 10.1091/mbc.E09-03-0187; MARCUSOHN J, 1995, CURR BIOL, V5, P1296, DOI 10.1016/S0960-9822(95)00256-9; Martemyanov KA, 2003, J NEUROSCI, V23, P10175; Martin SS, 1996, J BIOL CHEM, V271, P17605, DOI 10.1074/jbc.271.30.17605; Montero JC, 2011, ONCOGENE, V30, P1059, DOI 10.1038/onc.2010.489; Oatey PB, 1997, BIOCHEM J, V327, P637; Oikawa T, 2004, NAT CELL BIOL, V6, P420, DOI 10.1038/ncb1125; OLEFSKY JM, 1978, BIOCHEM J, V172, P137, DOI 10.1042/bj1720137; Olson AL, 2001, J BIOL CHEM, V276, P10706, DOI 10.1074/jbc.M007610200; Omata W, 2000, BIOCHEM J, V346, P321, DOI 10.1042/0264-6021:3460321; Patki V, 2001, MOL BIOL CELL, V12, P129, DOI 10.1091/mbc.12.1.129; Pelton PD, 1999, BIOCHEM BIOPH RES CO, V261, P456, DOI 10.1006/bbrc.1999.1071; Qin J, 2009, ONCOGENE, V28, P1853, DOI 10.1038/onc.2009.30; Rowland AF, 2011, TRAFFIC, V12, P672, DOI 10.1111/j.1600-0854.2011.01178.x; Semiz S, 2003, EMBO J, V22, P2387, DOI 10.1093/emboj/cdg237; SLOT JW, 1991, P NATL ACAD SCI USA, V88, P7815, DOI 10.1073/pnas.88.17.7815; Stumpf E, 2000, GENE CHROMOSOME CANC, V29, P83, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1011>3.0.CO;2-Z; Sweeney G, 2004, J BIOL CHEM, V279, P32233, DOI 10.1074/jbc.M402897200; SYLOW L, 2010, 70 SCI SESS ORL FL J; Tong P, 2001, J CLIN INVEST, V108, P371, DOI 10.1172/JCI12348; TSAKIRIDIS T, 1994, J BIOL CHEM, V269, P29934; Ueda S, 2010, FASEB J, V24, P2254, DOI 10.1096/fj.09-137380; Usui I, 2003, J BIOL CHEM, V278, P13765, DOI 10.1074/jbc.M208904200; van Ham M, 2003, MOL BIOL REP, V30, P69, DOI 10.1023/A:1023941703493; Walker DM, 2001, CURR BIOL, V11, P1600, DOI 10.1016/S0960-9822(01)00501-2; Wang QH, 1998, BIOCHEM J, V331, P917, DOI 10.1042/bj3310917; Waters JE, 2008, J CELL SCI, V121, P2892, DOI 10.1242/jcs.030353; Welch HCE, 2005, CURR BIOL, V15, P1867, DOI 10.1016/j.cub.2005.09.050; Welch HCE, 2002, CELL, V108, P809, DOI 10.1016/S0092-8674(02)00663-3; Yoshizawa M, 2005, J NEUROSCI, V25, P4406, DOI 10.1523/JNEUROSCI.4955-04.2005	69	47	48	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					43229	43240		10.1074/jbc.M111.306621	http://dx.doi.org/10.1074/jbc.M111.306621			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22002247	hybrid, Green Published			2022-12-27	WOS:000298351300043
J	Klein, G; Lindner, B; Brade, H; Raina, S				Klein, Gracjana; Lindner, Buko; Brade, Helmut; Raina, Satish			Molecular Basis of Lipopolysaccharide Heterogeneity in Escherichia coli ENVELOPE STRESS-RESPONSIVE REGULATORS CONTROL THE INCORPORATION OF GLYCOFORMS WITH A THIRD 3-DEOXY-alpha-D-MANNO-OCT-2-ULOSONIC ACID AND RHAMNOSE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUTER-MEMBRANE PROTEINS; EXTRACYTOPLASMIC STRESS; CHROMOSOMAL GENES; ASSEMBLY SYSTEM; SIGMA-FACTOR; CORE REGION; CELL-LYSIS; RPOE GENE; K-12; SALMONELLA	Background: LPS is essential for viability, although it is highly heterogeneous. Results: Synthesis of different glycoforms is regulated by differential expression of WaaZ (KdoIII transferase) and WaaR (glycosyltransferase). RpoE-transcribed rybB sRNA represses WaaR synthesis, and ppGpp is required for KdoIII incorporation in RpoE-inducing conditions. Conclusion: RpoE induction causes truncation of outer core and rhamnose addition to KdoIII. Significance: LPS alterations are crucial for outer membrane function.	[Klein, Gracjana; Raina, Satish] Gdansk Univ Technol, Dept Microbiol, PL-80233 Gdansk, Poland; [Klein, Gracjana; Lindner, Buko; Brade, Helmut; Raina, Satish] Leibniz Ctr Med & Biosci, Res Ctr Borstel, D-23845 Borstel, Germany	Fahrenheit Universities; Gdansk University of Technology; Forschungszentrum Borstel	Raina, S (corresponding author), Gdansk Univ Technol, Dept Microbiol, Narutowicza 11-12, PL-80233 Gdansk, Poland.	satish.raina@pg.gda.pl	Raina, Satish/AAU-9550-2021	Raina, Satish/0000-0003-3175-4932; Klein, Gracjana/0000-0001-8695-8065				Costanzo A, 2006, J BACTERIOL, V188, P4627, DOI 10.1128/JB.01981-05; Dartigalongue C, 1998, EMBO J, V17, P3968, DOI 10.1093/emboj/17.14.3968; Dartigalongue C, 2001, J BIOL CHEM, V276, P20866, DOI 10.1074/jbc.M100464200; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DeLasPenas A, 1997, MOL MICROBIOL, V24, P373, DOI 10.1046/j.1365-2958.1997.3611718.x; Frirdich E, 2003, J BACTERIOL, V185, P1659, DOI 10.1128/JB.185.5.1659-1671.2003; GALANOS C, 1969, EUR J BIOCHEM, V9, P245, DOI 10.1111/j.1432-1033.1969.tb00601.x; Gronow S, 2010, EUR J CELL BIOL, V89, P3, DOI 10.1016/j.ejcb.2009.10.002; Heinrichs DE, 1998, J BIOL CHEM, V273, P8849, DOI 10.1074/jbc.273.15.8849; Heinrichs DE, 1998, J BIOL CHEM, V273, P29497, DOI 10.1074/jbc.273.45.29497; Hsieh YJ, 2010, CURR OPIN MICROBIOL, V13, P198, DOI 10.1016/j.mib.2010.01.014; JANSSON PE, 1981, EUR J BIOCHEM, V115, P571; Kabir MS, 2005, MICROBIOL-SGM, V151, P2721, DOI 10.1099/mic.0.28004-0; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; Klein G, 2009, J BIOL CHEM, V284, P15369, DOI 10.1074/jbc.M900490200; Kondakov A, 2005, EUR J MASS SPECTROM, V11, P535, DOI 10.1255/ejms.721; Leipold MD, 2007, J BIOL CHEM, V282, P26786, DOI 10.1074/jbc.M704131200; Magnusson LU, 2007, J BACTERIOL, V189, P5193, DOI 10.1128/JB.00330-07; Magnusson LU, 2005, TRENDS MICROBIOL, V13, P236, DOI 10.1016/j.tim.2005.03.008; Malinverni JC, 2009, P NATL ACAD SCI USA, V106, P8009, DOI 10.1073/pnas.0903229106; MECSAS J, 1993, GENE DEV, V7, P2618, DOI 10.1101/gad.7.12b.2618; Missiakas D, 1997, MOL MICROBIOL, V24, P355, DOI 10.1046/j.1365-2958.1997.3601713.x; MISSIAKAS D, 1993, P NATL ACAD SCI USA, V90, P7084, DOI 10.1073/pnas.90.15.7084; Missiakas D, 1996, MOL MICROBIOL, V21, P871, DOI 10.1046/j.1365-2958.1996.561412.x; Moon K, 2009, MOL MICROBIOL, V74, P1314, DOI 10.1111/j.1365-2958.2009.06944.x; Muller-Loennies S, 2003, J BIOL CHEM, V278, P34090, DOI 10.1074/jbc.M303985200; Murata M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020063; Noor R, 2009, GENES CELLS, V14, P885, DOI 10.1111/j.1365-2443.2009.01318.x; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; RAINA S, 1995, EMBO J, V14, P1043, DOI 10.1002/j.1460-2075.1995.tb07085.x; Reynolds CM, 2009, BIOCHEMISTRY-US, V48, P9627, DOI 10.1021/bi901391g; Reynolds CM, 2005, J BIOL CHEM, V280, P21202, DOI 10.1074/jbc.M500964200; SIMONS RW, 1987, GENE, V53, P85, DOI 10.1016/0378-1119(87)90095-3; Sperandeo P, 2007, J BACTERIOL, V189, P244, DOI 10.1128/JB.01126-06; TORRIANI A, 1960, BIOCHIM BIOPHYS ACTA, V38, P460, DOI 10.1016/0006-3002(60)91281-6; Uzzau S, 2001, P NATL ACAD SCI USA, V98, P15264, DOI 10.1073/pnas.261348198; Valentin-Hansen P, 2007, CURR OPIN MICROBIOL, V10, P152, DOI 10.1016/j.mib.2007.03.001; Vorachek-Warren MK, 2002, J BIOL CHEM, V277, P14194, DOI 10.1074/jbc.M200409200; WOLLIN R, 1983, J BIOL CHEM, V258, P3769	40	36	38	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					42787	42807		10.1074/jbc.M111.291799	http://dx.doi.org/10.1074/jbc.M111.291799			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22021036	hybrid, Green Published			2022-12-27	WOS:000298351300001
J	Kokabu, Y; Murayama, Y; Kuwabara, N; Oroguchi, T; Hashimoto, H; Tsutsui, Y; Nozaki, N; Akashi, S; Unzai, S; Shimizu, T; Iwasaki, H; Sato, M; Ikeguchi, M				Kokabu, Yuichi; Murayama, Yasuto; Kuwabara, Naoyuki; Oroguchi, Tomotaka; Hashimoto, Hiroshi; Tsutsui, Yasuhiro; Nozaki, Naohito; Akashi, Satoko; Unzai, Satoru; Shimizu, Toshiyuki; Iwasaki, Hiroshi; Sato, Mamoru; Ikeguchi, Mitsunori			Fission Yeast Swi5-Sfr1 Protein Complex, an Activator of Rad51 Recombinase, Forms an Extremely Elongated Dogleg-shaped Structure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-ANGLE SCATTERING; DNA STRAND EXCHANGE; HOMOLOGOUS RECOMBINATION; REPAIR; RECA; MECHANISM; FILAMENT; MEDIATOR; SWI5; RPA	In eukaryotes, DNA strand exchange is the central reaction of homologous recombination, which is promoted by Rad51 recombinases forming a right-handed nucleoprotein filament on single-stranded DNA, also known as a presynaptic filament. Accessory proteins known as recombination mediators are required for the formation of the active presynaptic filament. One such mediator in the fission yeast Schizosaccharomyces pombe is the Swi5-Sfr1 complex, which has been identified as an activator of Rad51 that assists in presynaptic filament formation and stimulates its strand exchange reaction. Here, we determined the 1: 1 binding stoichiometry between the two subunits of the Swi5-Sfr1 complex using analytical ultracentrifugation and electrospray ionization mass spectrometry. Small-angle x-ray scattering experiments revealed that the Swi5-Sfr1 complex displays an extremely elongated dogleg-shaped structure in solution, which is consistent with its exceptionally high frictional ratio (f/f(0)) of 2.0 +/- 0.2 obtained by analytical ultracentrifugation. Furthermore, we determined a rough topology of the complex by comparing the small-angle x-ray scattering-based structures of the Swi5-Sfr1 complex and four Swi5-Sfr1-Fab complexes, in which the Fab fragments of monoclonal antibodies were specifically bound to experimentally determined sites of Sfr1. We propose a model for how the Swi5-Sfr1 complex binds to the Rad51 filament, in which the Swi5-Sfr1 complex fits into the groove of the Rad51 filament, leading to an active and stable presynaptic filament.	[Kokabu, Yuichi; Oroguchi, Tomotaka; Hashimoto, Hiroshi; Akashi, Satoko; Unzai, Satoru; Sato, Mamoru; Ikeguchi, Mitsunori] Yokohama City Univ, Grad Sch Nanobiosci, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Murayama, Yasuto; Tsutsui, Yasuhiro; Iwasaki, Hiroshi] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Midori Ku, Yokohama, Kanagawa 2268501, Japan; [Nozaki, Naohito] Tokyo Inst Technol, Biofrontier Res Ctr, Midori Ku, Yokohama, Kanagawa 2268501, Japan; [Kuwabara, Naoyuki; Shimizu, Toshiyuki] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan	Yokohama City University; Tokyo Institute of Technology; Tokyo Institute of Technology; University of Tokyo	Ikeguchi, M (corresponding author), Yokohama City Univ, Grad Sch Nanobiosci, Tsurumi Ku, 1-7-29 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan.	ike@tsurumi.yokohama-cu.ac.jp	Iwasaki, Hiroshi/Y-7946-2018	Iwasaki, Hiroshi/0000-0002-0153-6873; Kuwabara, Naoyuki/0000-0002-1659-323X; Akashi, Satoko/0000-0002-8978-6358; Hashimoto, Hiroshi/0000-0003-1503-6789	Ministry of Education, Culture, Sports, Science, and Technology of Japan MEXT; Japan Society for the Promotion of Science (JSPS); Takeda Science Foundation; Grants-in-Aid for Scientific Research [21113003] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants-in-aids for scientific research on innovative areas from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT; to S.A., T.S., H.I., M.S., and M.I.) and for scientific research A to H.I.) and B (to M.I.)); by the Grand Challenges in Next-Generation Integrated Simulation of Living Matter, part of the Development and Use of the Next-Generation Supercomputer Project of MEXT (to M.I.); by the Japan Society for the Promotion of Science (JSPS); and by research grants for bioscience from the Takeda Science Foundation (to H.I.).	Akamatsu Y, 2003, P NATL ACAD SCI USA, V100, P15770, DOI 10.1073/pnas.2632890100; Akamatsu Y, 2007, EMBO J, V26, P1352, DOI 10.1038/sj.emboj.7601582; Akamatsu Y, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001160; Bianco P. R., 1998, FRONT BIOSCI, V3, pD570; Chen J, 2010, NUCLEIC ACIDS RES, V38, P4889, DOI 10.1093/nar/gkq209; Chen ZC, 2008, NATURE, V453, P489, DOI 10.1038/nature06971; Cox MM, 2007, NAT REV MOL CELL BIO, V8, P127, DOI 10.1038/nrm2099; DeLano W.L, PYMOL MOL GRAPHICS S; Ellermeier C, 2004, GENETICS, V168, P1891, DOI 10.1534/genetics.104.034280; Fujisawa T, 2000, J APPL CRYSTALLOGR, V33, P797, DOI 10.1107/S002188980000131X; Galkin VE, 2006, STRUCTURE, V14, P983, DOI 10.1016/j.str.2006.04.001; Glatter O., 1982, SMALL ANGLE XRAY SCA; Haruta N, 2006, NAT STRUCT MOL BIOL, V13, P823, DOI 10.1038/nsmb1136; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Krejci L, 2002, J BIOL CHEM, V277, P40132, DOI 10.1074/jbc.M206511200; Krogh BO, 2004, ANNU REV GENET, V38, P233, DOI 10.1146/annurev.genet.38.072902.091500; Kurokawa Y, 2008, PLOS BIOL, V6, P836, DOI 10.1371/journal.pbio.0060088; Kuwabara N, 2010, ACTA CRYSTALLOGR F, V66, P1124, DOI 10.1107/S1744309110032239; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Masson JY, 2001, TRENDS BIOCHEM SCI, V26, P131, DOI 10.1016/S0968-0004(00)01742-4; New JH, 1998, NATURE, V391, P407, DOI 10.1038/34950; Plate I, 2008, J BIOL CHEM, V283, P29077, DOI 10.1074/jbc.M804881200; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schuck P, 2002, BIOPHYS J, V82, P1096, DOI 10.1016/S0006-3495(02)75469-6; Sharan SK, 1997, NATURE, V386, P804, DOI 10.1038/386804a0; Shinohara A, 1998, NATURE, V391, P404, DOI 10.1038/34943; Sugiyama T, 2002, J BIOL CHEM, V277, P31663, DOI 10.1074/jbc.M203494200; Sung P, 2003, J BIOL CHEM, V278, P42729, DOI 10.1074/jbc.R300027200; Sung P, 1997, J BIOL CHEM, V272, P28194, DOI 10.1074/jbc.272.45.28194; Sung P, 2006, NAT REV MOL CELL BIO, V7, P739, DOI 10.1038/nrm2008; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Symington LS, 2002, MICROBIOL MOL BIOL R, V66, P630, DOI 10.1128/MMBR.66.4.630-670.2002; VanLoock MS, 2003, STRUCTURE, V11, P187, DOI 10.1016/S0969-2126(03)00003-0; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Xing X, 2004, BIOCHEMISTRY-US, V43, P16142, DOI 10.1021/bi048165y; Yuan JS, 2011, J BIOL CHEM, V286, P9888, DOI 10.1074/jbc.M110.207290	39	19	19	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					43569	43576		10.1074/jbc.M111.303339	http://dx.doi.org/10.1074/jbc.M111.303339			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22033972	Green Published, hybrid			2022-12-27	WOS:000298351300076
J	Rauen, T; Hedrich, CM; Juang, YT; Tenbrock, K; Tsokos, GC				Rauen, Thomas; Hedrich, Christian M.; Juang, Yuang-Taung; Tenbrock, Klaus; Tsokos, George C.			cAMP-responsive Element Modulator (CREM)alpha Protein Induces Interleukin 17A Expression and Mediates Epigenetic Alterations at the Interleukin-17A Gene Locus in Patients with Systemic Lupus Erythematosus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATORY T-CELLS; TCR ZETA-CHAIN; TRANSCRIPTIONAL REGULATION; DNA DEMETHYLATION; IL-2 PRODUCTION; HOST-DEFENSE; DIFFERENTIATION; ALPHA; CREM; AUTOIMMUNITY	IL-17A is a proinflammatory cytokine that is produced by specialized T helper cells and contributes to the development of several autoimmune diseases such as systemic lupus erythematosus (SLE). Transcription factor cAMP-responsive element modulator (CREM)alpha displays increased expression levels in T cells from SLE patients and has been described to account for aberrant T cell function in SLE pathogenesis. In this report, we provide evidence that CREM alpha physically binds to a cAMP-responsive element, CRE (-111/-104), within the proximal human IL17A promoter and increases its activity. Chromatin immunoprecipitation assays reveal that activated naive CD4(+) T cells as well as T cells from SLE patients display increased CREM alpha binding to this site compared with T cells from healthy controls. The histone H3 modification pattern at the CRE site (-111/-104) and neighboring conserved noncoding sequences within the human IL17A gene locus suggests an accessible chromatin structure (H3K27 hypomethylation/H3K18 hyperacetylation) in activated naive CD4(+) T cells and SLE T cells. H3K27 hypomethylation is accompanied by decreased cytosine phosphate guanosine (CpG)-DNA methylation in these regions in SLE T cells. Decreased recruitment of histone deacetylase (HDAC) 1 and DNA methyltransferase (DNMT)3a to the CRE site (-111/-104) probably accounts for the observed epigenetic alterations. Reporter studies confirmed that DNA methylation of the IL17A promoter indeed abrogates its inducibility. Our findings demonstrate an extended role for CREM alpha in the immunopathogenesis of SLE because it contributes to increased expression of IL-17A.	[Rauen, Thomas; Hedrich, Christian M.; Juang, Yuang-Taung; Tsokos, George C.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Rheumatol,Dept Med, Boston, MA 02115 USA; [Rauen, Thomas] Rhein Westfal TH Aachen, Dept Nephrol & Clin Immunol, D-52074 Aachen, Germany; [Tenbrock, Klaus] Rhein Westfal TH Aachen, Dept Pediat, Div Allergol & Immunol, D-52074 Aachen, Germany	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; RWTH Aachen University; RWTH Aachen University	Rauen, T (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Rheumatol,Dept Med, CLS 937,330 Brookline Ave, Boston, MA 02115 USA.	trauen@bidmc.harvard.edu; gtsokos@bidmc.harvard.edu	tsokos, george C/O-3360-2013; Hedrich, Christian/AAD-6855-2019; Hedrich, Christian/AAW-3958-2020	tsokos, george C/0000-0001-9589-2360; Hedrich, Christian/0000-0002-1295-6179	National Institutes of Health [R01 AI42269, R01 AI49954, R01 AI85567]; Deutsche Forschungsgemeinschaft [RA1927-1/1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042269, R01AI049954, R01AI085567] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AI42269, R01 AI49954, and R01 AI85567 (to G. C. T.). This work was also supported by Deutsche Forschungsgemeinschaft Grant RA1927-1/1 (to T. R.).	Ahlmann M, 2009, J IMMUNOL, V182, P4167, DOI 10.4049/jimmunol.0802976; Akimzhanov AM, 2007, J BIOL CHEM, V282, P5969, DOI 10.1074/jbc.C600322200; Asahara H, 2001, MOL CELL BIOL, V21, P7892, DOI 10.1128/MCB.21.23.7892-7900.2001; Bailey J, 2005, J MOL ENDOCRINOL, V34, P1, DOI 10.1677/jme.1.01594; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bird A, 2003, NAT IMMUNOL, V4, P208, DOI 10.1038/ni0303-208; Brenner C, 2007, DEV CELL, V12, P843, DOI 10.1016/j.devcel.2007.05.011; Chedin F, 2011, PROG MOL BIOL TRANSL, V101, P255, DOI 10.1016/B978-0-12-387685-0.00007-X; Chen Z, 2007, SEMIN IMMUNOL, V19, P400, DOI 10.1016/j.smim.2007.10.015; Crispin JC, 2008, J IMMUNOL, V181, P8761, DOI 10.4049/jimmunol.181.12.8761; De Cesare D, 2000, PROG NUCLEIC ACID RE, V64, P343, DOI 10.1016/S0079-6603(00)64009-6; DELMAS V, 1992, P NATL ACAD SCI USA, V89, P4226, DOI 10.1073/pnas.89.10.4226; Foulkes NS, 1996, NATURE, V381, P83, DOI 10.1038/381083a0; Hedrich CM, 2011, J BIOL CHEM, V286, P43429, DOI 10.1074/jbc.M111.299339; HEDRICH CM, 2011, TRENDS MOL IN PRESS; Hirahara K, 2010, CYTOKINE GROWTH F R, V21, P425, DOI 10.1016/j.cytogfr.2010.10.006; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; HUNDORFEAN G, 2011, INFLAMM BOWEL D 0304, DOI DOI 10.1002/IBD.21677; Iwakura Y, 2008, IMMUNOL REV, V226, P57, DOI 10.1111/j.1600-065X.2008.00699.x; Juang YT, 2005, J CLIN INVEST, V115, P996, DOI 10.1172/JCI22854; Juang YT, 2011, J BIOL CHEM, V286, P1795, DOI 10.1074/jbc.M110.166785; Kyttaris VC, 2006, LUPUS, V15, P840, DOI 10.1177/0961203306069985; Kyttaris VC, 2004, J IMMUNOL, V173, P3557, DOI 10.4049/jimmunol.173.5.3557; Li YP, 2010, ARTHRITIS RHEUM-US, V62, P1438, DOI 10.1002/art.27363; Mishra N, 2003, J CLIN INVEST, V111, P539, DOI 10.1172/JC1200316153; Morinobu A, 2004, J BIOL CHEM, V279, P40640, DOI 10.1074/jbc.M407576200; Nalbandian A, 2009, CLIN EXP IMMUNOL, V157, P209, DOI 10.1111/j.1365-2249.2009.03944.x; Nambiar MP, 2002, J CELL BIOCHEM, V85, P459, DOI 10.1002/jcb.10160; Nistala K, 2009, RHEUMATOLOGY, V48, P602, DOI 10.1093/rheumatology/kep028; Pappu R, 2011, IMMUNOLOGY, V134, P8, DOI 10.1111/j.1365-2567.2011.03465.x; Patel DR, 2010, CURR OPIN RHEUMATOL, V22, P478, DOI 10.1097/BOR.0b013e32833ae915; Rauen T, 2011, J BIOL CHEM, V286, P32366, DOI 10.1074/jbc.M111.245811; Renaudineau Yves, 2011, Keio Journal of Medicine, V60, P10; SassoneCorsi P, 1995, ANNU REV CELL DEV BI, V11, P355, DOI 10.1146/annurev.cellbio.11.1.355; Solomou EE, 2001, J IMMUNOL, V166, P4216, DOI 10.4049/jimmunol.166.6.4216; Strickland FM, 2008, AUTOIMMUNITY, V41, P278, DOI 10.1080/08916930802024616; Sunahori K, 2011, J IMMUNOL, V186, P4508, DOI 10.4049/jimmunol.1000340; Tenbrock K, 2005, J IMMUNOL, V175, P5975, DOI 10.4049/jimmunol.175.9.5975; Tenbrock K, 2006, J IMMUNOL, V177, P6159, DOI 10.4049/jimmunol.177.9.6159; TSOKOS GC, 2011, N ENGL J ME IN PRESS; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Yang L, 2008, NATURE, V454, P350, DOI 10.1038/nature07021; YOO ZB, 1995, J IMMUNOL, V155, P5483; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488	44	93	95	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					43437	43446		10.1074/jbc.M111.299313	http://dx.doi.org/10.1074/jbc.M111.299313			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22025620	hybrid, Green Published			2022-12-27	WOS:000298351300063
J	Palczewski, K				Palczewski, Krzysztof			Thematic Minireview Series on Focus on Vision	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material									Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA	Case Western Reserve University	Palczewski, K (corresponding author), Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA.	kxp65@case.edu			NATIONAL EYE INSTITUTE [R01EY008061, R01EY009339] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY009339, R01 EY008061] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))			0	3	3	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2012	287	3					1610	1611		10.1074/jbc.R111.322347	http://dx.doi.org/10.1074/jbc.R111.322347			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879HT	22074916	Green Published, hybrid			2022-12-27	WOS:000299321000001
J	Beisang, D; Rattenbacher, B; Vlasova-St Louis, IA; Bohjanen, PR				Beisang, Daniel; Rattenbacher, Bernd; Vlasova-St Louis, Irina A.; Bohjanen, Paul R.			Regulation of CUG-binding Protein 1 (CUGBP1) Binding to Target Transcripts upon T Cell Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA DECAY; GU-RICH ELEMENTS; GENE-EXPRESSION; INCREASES TRANSLATION; COORDINATE REGULATION; MYOTONIC-DYSTROPHY; BETA; IL-2; ABNORMALITIES; STABILITY	The RNA-binding protein, CUG-binding protein 1 (CUGBP1), regulates gene expression at the levels of alternative splicing, mRNA degradation, and translation. We used RNA immunoprecipitation followed by microarray analysis to identify the cytoplasmic mRNA targets of CUGBP1 in resting and activated primary human T cells and found that CUGBP1 targets were highly enriched for the presence of GU-rich elements (GREs) in their 3'-untranslated regions. The number of CUGBP1 target transcripts decreased dramatically following T cell activation as a result of activation-dependent phosphorylation of CUGBP1 and decreased ability of CUGBP1 to bind to GRE-containing RNA. A large percentage of CUGBP1 target transcripts exhibited rapid and transient up-regulation, and a smaller percentage exhibited transient down-regulation following T cell activation. Many of the transiently up-regulated CUGBP1 target transcripts encode important regulatory proteins necessary for transition from a quiescent state to a state of cellular activation and proliferation. Overall, our results show that CUGBP1 binding to certain GRE-containing target transcripts decreased following T cell activation through activation-dependent phosphorylation of CUGBP1.	[Beisang, Daniel; Rattenbacher, Bernd; Vlasova-St Louis, Irina A.; Bohjanen, Paul R.] Univ Minnesota, Ctr Infect Dis & Microbiol Translat Res, Minneapolis, MN 55455 USA; [Beisang, Daniel; Rattenbacher, Bernd; Vlasova-St Louis, Irina A.; Bohjanen, Paul R.] Univ Minnesota, Dept Microbiol, Minneapolis, MN 55455 USA; [Bohjanen, Paul R.] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Bohjanen, PR (corresponding author), Univ Minnesota, Ctr Infect Dis & Microbiol Translat Res, 3-214 MTRF,2001 6th St SE, Minneapolis, MN 55455 USA.	Bohja001@umn.edu	Bohjanen, Paul/B-2329-2015; Louis, Vlasova-St./ABC-1933-2020; Louis, Irina Vlasova-St/B-1254-2009	Bohjanen, Paul/0000-0002-2772-3597; Louis, Irina Vlasova-St/0000-0003-0795-4723; Rattenbacher, Bernd/0000-0003-1435-0100	National Institutes of Health [AIO57484, AIO72068, 3T32GM8244-24S1]; Swiss National Science Foundation; Lymphoma Research Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K24AI096925, R01AI072068] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008244] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Lymphoma Research Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AIO57484 and AIO72068 (to P. R. B.).; Supported by National Institutes of Health Medical Scientist Training Program Grant 3T32GM8244-24S1.; Supported by a postdoctoral fellowship from the Swiss National Science Foundation. Present address: Dept. of Clinical Research, Institute of internal medicine, University of Bern, 3010 Bern, Switzerland.; Supported by a fellowship from the Lymphoma Research Foundation.	Al-Ahmadi W, 2009, NUCLEIC ACIDS RES, V37, P3612, DOI 10.1093/nar/gkp223; Cheadle C, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-75; Choi WT, 2007, CANCER GENET CYTOGEN, V177, P108, DOI 10.1016/j.cancergencyto.2007.07.002; Crispin JC, 2009, AUTOIMMUN REV, V8, P190, DOI 10.1016/j.autrev.2008.07.042; Dustin ML, 2009, IMMUNITY, V30, P482, DOI 10.1016/j.immuni.2009.03.010; Han J, 2005, NUCLEIC ACIDS RES, V33, P2769, DOI 10.1093/nar/gki561; Iakova P, 2004, EMBO J, V23, P406, DOI 10.1038/sj.emboj.7600052; Kalsotra A, 2008, P NATL ACAD SCI USA, V105, P20333, DOI 10.1073/pnas.0809045105; Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; Koshelev M, 2010, HUM MOL GENET, V19, P1066, DOI 10.1093/hmg/ddp570; Kress C, 2007, MOL CELL BIOL, V27, P1146, DOI 10.1128/MCB.01009-06; Kuyumcu-Martinez NM, 2007, MOL CELL, V28, P68, DOI 10.1016/j.molcel.2007.07.027; Lee JE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011201; Liu X, 2001, Pac Symp Biocomput, P127; Merup M, 1998, MED ONCOL, V15, P79, DOI 10.1007/BF02989584; Mukherjee N, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.44; Ogilvie RL, 2009, J BIOL CHEM, V284, P11216, DOI 10.1074/jbc.M901229200; Ogilvie RL, 2005, J IMMUNOL, V174, P953, DOI 10.4049/jimmunol.174.2.953; Pearson PL, 1998, J INTERN MED, V243, P413; Raghavan A, 2004, GENOMICS, V84, P1002, DOI 10.1016/j.ygeno.2004.08.007; Raghavan A, 2002, NUCLEIC ACIDS RES, V30, P5529, DOI 10.1093/nar/gkf682; Ramskold D, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000598; Rattenbacher B, 2010, MOL CELL BIOL, V30, P3970, DOI 10.1128/MCB.00624-10; Salisbury E, 2008, EXP CELL RES, V314, P2266, DOI 10.1016/j.yexcr.2008.04.018; Sanchez-Lockhart M, 2004, J IMMUNOL, V173, P7120, DOI 10.4049/jimmunol.173.12.7120; Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390; Starr TK, 2009, SCIENCE, V323, P1747, DOI 10.1126/science.1163040; Stellato C, 2011, J IMMUNOL, V187, P441, DOI 10.4049/jimmunol.1001881; Tenenbaum SA, 2000, P NATL ACAD SCI USA, V97, P14085, DOI 10.1073/pnas.97.26.14085; Timchenko LT, 2006, J BIOL CHEM, V281, P32806, DOI 10.1074/jbc.M605701200; Timchenko NA, 2005, J BIOL CHEM, V280, P20549, DOI 10.1074/jbc.M409563200; Vlasova IA, 2005, GENOMICS, V86, P159, DOI 10.1016/j.ygeno.2005.04.013; Vlasova IA, 2008, MOL CELL, V29, P263, DOI 10.1016/j.molcel.2007.11.024; Vlasova-St Louis I, 2011, CURR OPIN GENET DEV, V21, P444, DOI 10.1016/j.gde.2011.03.002; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang GS, 2009, J CLIN INVEST, V119, P3797, DOI 10.1172/JCI37976; Whistler T, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-496; Zhang LB, 2008, J BIOL CHEM, V283, P22457, DOI 10.1074/jbc.M802803200	38	42	43	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					950	960		10.1074/jbc.M111.291658	http://dx.doi.org/10.1074/jbc.M111.291658			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22117072	Green Published, hybrid			2022-12-27	WOS:000299170300013
J	Moore, PB				Moore, Peter B.			Neutrons, Magnets, and Photons: A Career in Structural Biology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LARGE RIBOSOMAL-SUBUNIT; PHENYLALANINE TRANSFER-RNA; ELONGATION-FACTOR-G; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; ANGSTROM RESOLUTION; 3-DIMENSIONAL RECONSTRUCTION; ELECTRON MICROGRAPHS; PROTEINS; COMPLEX	The purpose of Reflections articles, it seems, is to give elderly scientists a chance to write about the "good old days," when everyone walked to school in the snow. They enjoy this activity so much that your editor, Martha Fedor, must have known that I would accept her invitation to write such an article, no matter how much I demurred at first. As everyone knows, flattery will get you everywhere. It may comfort the apprehensive reader to learn that there is not going to be much walking to school in the snow in this story. On the contrary, rather than thinking how hard I had it during my scientific career, I find it inconceivable that anyone could have had a smoother ride. At the time I began my career, science was an expanding enterprise in the United States that welcomed the young. Only in such an opportunity-rich environment would someone like me have stood a chance. The contrast between that world and the dog-eat-dog world young scientists confront today is stark.	Yale Univ, Dept Chem, New Haven, CT 06520 USA	Yale University	Moore, PB (corresponding author), Yale Univ, Dept Chem, 225 Prospect St, New Haven, CT 06520 USA.	peter.moore@yale.edu						ABDELMEGUID SS, 1983, J MOL BIOL, V171, P207, DOI 10.1016/S0022-2836(83)80353-2; AEVARSSON A, 1994, EMBO J, V13, P3669, DOI 10.1002/j.1460-2075.1994.tb06676.x; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Ban N, 1998, CELL, V93, P1105, DOI 10.1016/S0092-8674(00)81455-5; Ben-Shem A, 2010, SCIENCE, V330, P1203, DOI 10.1126/science.1194294; Berk V, 2007, CURR OPIN STRUC BIOL, V17, P302, DOI 10.1016/j.sbi.2007.05.009; Blaha G, 2008, J MOL BIOL, V379, P505, DOI 10.1016/j.jmb.2008.03.075; CAPEL MS, 1988, J MOL BIOL, V200, P65, DOI 10.1016/0022-2836(88)90334-8; CAPEL MS, 1987, SCIENCE, V238, P1403, DOI 10.1126/science.3317832; Correll CC, 1997, CELL, V91, P705, DOI 10.1016/S0092-8674(00)80457-2; Correll CC, 1998, P NATL ACAD SCI USA, V95, P13436, DOI 10.1073/pnas.95.23.13436; CZWORKOWSKI J, 1994, EMBO J, V13, P3661, DOI 10.1002/j.1460-2075.1994.tb06675.x; DEROSIER DJ, 1968, NATURE, V217, P130, DOI 10.1038/217130a0; DEROSIER DJ, 1970, J MOL BIOL, V52, P355, DOI 10.1016/0022-2836(70)90036-7; ENGELMAN DM, 1972, P NATL ACAD SCI USA, V69, P1997, DOI 10.1073/pnas.69.8.1997; ENGELMAN DM, 1975, P NATL ACAD SCI USA, V72, P3888, DOI 10.1073/pnas.72.10.3888; Frank J, 1995, BIOCHEM CELL BIOL, V73, P757, DOI 10.1139/o95-084; Gurel G, 2009, J MOL BIOL, V389, P146, DOI 10.1016/j.jmb.2009.04.005; Hansen JL, 2003, J MOL BIOL, V330, P1061, DOI 10.1016/S0022-2836(03)00668-5; HARDY SJS, 1975, MOL GEN GENET, V140, P253, DOI 10.1007/BF00334270; HARDY SJS, 1969, BIOCHEMISTRY-US, V8, P2897, DOI 10.1021/bi00835a031; Jin H, 2007, MOL CELL, V26, P205, DOI 10.1016/j.molcel.2007.03.014; Jovine L, 2000, J MOL BIOL, V301, P401, DOI 10.1006/jmbi.2000.3950; KIME MJ, 1983, FEBS LETT, V153, P199, DOI 10.1016/0014-5793(83)80147-1; LEBOY PS, 1964, P NATL ACAD SCI USA, V52, P1367, DOI 10.1073/pnas.52.6.1367; Lu M, 2000, P NATL ACAD SCI USA, V97, P2023, DOI 10.1073/pnas.97.5.2023; Merianos HJ, 2004, RNA, V10, P954, DOI 10.1261/rna.7030704; Moore P. B., 2012, ANN REV BIO IN PRESS, V41; MOORE PB, 1968, J MOL BIOL, V31, P441, DOI 10.1016/0022-2836(68)90420-8; MOORE PB, 1970, J MOL BIOL, V50, P279, DOI 10.1016/0022-2836(70)90192-0; Moore PB, 2001, COLD SPRING HARB SYM, V66, P607, DOI 10.1101/sqb.2001.66.607; MOORE PB, 1966, J MOL BIOL, V18, P21, DOI 10.1016/S0022-2836(66)80073-6; MOORE PB, 1966, J MOL BIOL, V22, P145, DOI 10.1016/0022-2836(66)90186-0; NISSEN P, 1995, SCIENCE, V270, P1464, DOI 10.1126/science.270.5241.1464; Rabl J, 2011, SCIENCE, V331, P730, DOI 10.1126/science.1198308; Schluenzen F, 2000, CELL, V102, P615, DOI 10.1016/S0092-8674(00)00084-2; Schmeing TM, 2002, NAT STRUCT BIOL, V9, P225, DOI 10.1038/nsb758; Shi HJ, 2000, RNA, V6, P1091, DOI 10.1017/S1355838200000364; Szep S., 2002, RNA IN PRESS; SZEWCZAK AA, 1993, P NATL ACAD SCI USA, V90, P9581, DOI 10.1073/pnas.90.20.9581; TRAUB P, 1968, P NATL ACAD SCI USA, V59, P777, DOI 10.1073/pnas.59.3.777; TRAUT RR, 1967, P NATL ACAD SCI USA, V57, P1294, DOI 10.1073/pnas.57.5.1294; VONBOHLEN K, 1991, J MOL BIOL, V222, P11, DOI 10.1016/0022-2836(91)90730-T; Voss NR, 2006, J MOL BIOL, V360, P893, DOI 10.1016/j.jmb.2006.05.023; WALLER JP, 1964, J MOL BIOL, V10, P319, DOI 10.1016/S0022-2836(64)80050-4; WALLER JP, 1961, P NATL ACAD SCI USA, V47, P18, DOI 10.1073/pnas.47.1.18; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006	48	2	2	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					805	818		10.1074/jbc.X111.324509	http://dx.doi.org/10.1074/jbc.X111.324509			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22086921	hybrid, Green Published			2022-12-27	WOS:000299170300001
J	Wu, YL; Sommers, JA; Khan, I; de Winter, JP; Brosh, RM				Wu, Yuliang; Sommers, Joshua A.; Khan, Irfan; de Winter, Johan P.; Brosh, Robert M., Jr.			Biochemical Characterization of Warsaw Breakage Syndrome Helicase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SISTER-CHROMATID COHESION; DNA SUBSTRATE-SPECIFICITY; GENOMIC STABILITY; FANCONI-ANEMIA; G-QUADRUPLEX; HOLLIDAY JUNCTIONS; PAPILLOMAVIRUS E2; REPLICATION FORKS; ESCHERICHIA-COLI; BREAST-CANCER	Mutations in the human ChlR1 gene are associated with a unique genetic disorder known as Warsaw breakage syndrome characterized by cellular defects in sister chromatid cohesion and hypersensitivity to agents that induce replication stress. A role of ChlR1 helicase in sister chromatid cohesion was first evidenced by studies of the yeast homolog Chl1p; however, its cellular functions in DNA metabolism are not well understood. We carefully examined the DNA substrate specificity of purified recombinant human ChlR1 protein and the biochemical effect of a patient-derived mutation, a deletion of a single lysine (K897del) in the extreme C terminus of ChlR1. The K897del clinical mutation abrogated ChlR1 helicase activity on forked duplex or D-loop DNA substrates by perturbing its DNA binding and DNA-dependent ATPase activity. Wild-type ChlR1 required a minimal 5' single-stranded DNA tail of 15 nucleotides to efficiently unwind a simple duplex DNA substrate. The additional presence of a 3' single-stranded DNA tail as short as five nucleotides dramatically increased ChlR1 helicase activity, demonstrating the preference of the enzyme for forked duplex structures. ChlR1 unwound G-quadruplex (G4) DNA with a strong preference for a two-stranded antiparallel G4 (G2') substrate and was only marginally active on a four-stranded parallel G4 structure. The marked difference in ChlR1 helicase activity on the G4 substrates, reflected by increased binding to the G2' substrate, distinguishes ChlR1 from the sequence-related FANCJ helicase mutated in Fanconi anemia. The biochemical results are discussed in light of the known cellular defects associated with ChlR1 deficiency.	[Wu, Yuliang; Sommers, Joshua A.; Khan, Irfan; Brosh, Robert M., Jr.] NIA, Lab Mol Gerontol, NIH, Biomed Res Ctr, Baltimore, MD 21224 USA; [de Winter, Johan P.] Vrije Univ Amsterdam Med Ctr, Dept Clin Genet, NL-1081 BT Amsterdam, Netherlands	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Brosh, RM (corresponding author), NIA, Lab Mol Gerontol, NIH, Biomed Res Ctr, 251 Bayview Blvd, Baltimore, MD 21224 USA.	broshr@mail.nih.gov	Brosh, Robert/AAR-6124-2020		National Institutes of Health of the NIA; Fanconi Anemia Research Fund; NATIONAL INSTITUTE ON AGING [ZIAAG000753, ZIAAG000752, ZIAAG000741] Funding Source: NIH RePORTER	National Institutes of Health of the NIA; Fanconi Anemia Research Fund; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program of the NIA (to R. M. B.). This work was also supported by the Fanconi Anemia Research Fund (to R. M. B.).	Ansbach AB, 2008, MOL BIOL CELL, V19, P595, DOI 10.1091/mbc.E07-06-0618; Boule JB, 2006, NUCLEIC ACIDS RES, V34, P4147, DOI 10.1093/nar/gkl561; Brosh RM, 2002, J BIOL CHEM, V277, P23236, DOI 10.1074/jbc.M111446200; Cheung I, 2002, NAT GENET, V31, P405, DOI [10.1038/ng928, 10.1038/417405a]; Dewar JM, 2010, EMBO J, V29, P4020, DOI 10.1038/emboj.2010.267; Ding H, 2004, CELL, V117, P873, DOI 10.1016/j.cell.2004.05.026; Farina A, 2008, J BIOL CHEM, V283, P20925, DOI 10.1074/jbc.M802696200; Feeney KM, 2011, VIROLOGY, V414, P1, DOI 10.1016/j.virol.2011.03.015; Gupta R, 2005, J BIOL CHEM, V280, P25450, DOI 10.1074/jbc.M501995200; Haider S, 2002, J MOL BIOL, V320, P189, DOI 10.1016/S0022-2836(02)00428-X; Hirota Y, 2000, NUCLEIC ACIDS RES, V28, P917, DOI 10.1093/nar/28.4.917; Horvath MP, 2001, J MOL BIOL, V310, P367, DOI 10.1006/jmbi.2001.4766; Hud NV, 1996, BIOCHEMISTRY-US, V35, P15383, DOI 10.1021/bi9620565; Inoue A, 2007, CELL CYCLE, V6, P1646, DOI 10.4161/cc.6.13.4411; Lehmann AR, 2001, GENE DEV, V15, P15, DOI 10.1101/gad.859501; Leman AR, 2010, J CELL SCI, V123, P660, DOI 10.1242/jcs.057984; Levitus M, 2005, NAT GENET, V37, P934, DOI 10.1038/ng1625; Levran O, 2005, NAT GENET, V37, P931, DOI 10.1038/ng1624; Litman R, 2005, CANCER CELL, V8, P255, DOI 10.1016/j.ccr.2005.08.004; London TBC, 2008, J BIOL CHEM, V283, P36132, DOI 10.1074/jbc.M808152200; Maizels N, 2006, NAT STRUCT MOL BIOL, V13, P1055, DOI 10.1038/nsmb1171; Mayer ML, 2004, MOL BIOL CELL, V15, P1736, DOI 10.1091/mbc.E03-08-0619; Mohaghegh P, 2001, NUCLEIC ACIDS RES, V29, P2843, DOI 10.1093/nar/29.13.2843; Nakagawa T, 2002, J BIOL CHEM, V277, P28019, DOI 10.1074/jbc.M204165200; Ozsoy AZ, 2003, NUCLEIC ACIDS RES, V31, P1554, DOI 10.1093/nar/gkg243; Paeschke K, 2011, CELL, V145, P678, DOI 10.1016/j.cell.2011.04.015; Parish JL, 2006, MOL CELL, V24, P867, DOI 10.1016/j.molcel.2006.11.005; Parish JL, 2006, J CELL SCI, V119, P4857, DOI 10.1242/jcs.03262; Petronczki M, 2004, J CELL SCI, V117, P3547, DOI 10.1242/jcs.01231; Pugh RA, 2008, J BIOL CHEM, V283, P1732, DOI 10.1074/jbc.M707064200; Ribeyre C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000475; Saharia A, 2008, CURR BIOL, V18, P496, DOI 10.1016/j.cub.2008.02.071; Schultze P, 1999, NUCLEIC ACIDS RES, V27, P3018, DOI 10.1093/nar/27.15.3018; Sharma S, 2006, BIOCHEM J, V398, P319, DOI 10.1042/BJ20060450; Skibbens RV, 2004, GENETICS, V166, P33, DOI 10.1534/genetics.166.1.33; SMITH FW, 1992, NATURE, V356, P164, DOI 10.1038/356164a0; Sommers JA, 2009, J BIOL CHEM, V284, P7505, DOI 10.1074/jbc.M809019200; Sun H, 1998, J BIOL CHEM, V273, P27587, DOI 10.1074/jbc.273.42.27587; van Brabant AJ, 2000, BIOCHEMISTRY-US, V39, P14617, DOI 10.1021/bi0018640; van der Lelij P, 2010, AM J HUM GENET, V86, P262, DOI 10.1016/j.ajhg.2010.01.008; Voloshin ON, 2007, J BIOL CHEM, V282, P18437, DOI 10.1074/jbc.M700376200; Whitby MC, 1998, J BIOL CHEM, V273, P19729, DOI 10.1074/jbc.273.31.19729; Wu Y, 2009, CELL MOL LIFE SCI, V66, P1209, DOI 10.1007/s00018-008-8580-6; Wu YL, 2008, MOL CELL BIOL, V28, P4116, DOI 10.1128/MCB.02210-07	44	73	74	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					1007	1021		10.1074/jbc.M111.276022	http://dx.doi.org/10.1074/jbc.M111.276022			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22102414	Green Published, hybrid			2022-12-27	WOS:000299170300018
J	Canals, M; Lane, JR; Wen, A; Scammells, PJ; Sexton, PM; Christopoulos, A				Canals, Meritxell; Lane, J. Robert; Wen, Adriel; Scammells, Peter J.; Sexton, Patrick M.; Christopoulos, Arthur			A Monod-Wyman-Changeux Mechanism Can Explain G Protein-coupled Receptor (GPCR) Allosteric Modulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCARINIC ACETYLCHOLINE-RECEPTORS; FUNCTIONAL SELECTIVITY; PLAUSIBLE MODEL; DRUG DISCOVERY; 2-STATE MODEL; BINDING; ACTIVATION; LIGAND; AGONISTS; PHARMACOLOGY	The Monod-Wyman-Changeux (MWC) model was initially proposed to describe the allosteric properties of regulatory enzymes and subsequently extended to receptors. Yet despite GPCRs representing the largest family of receptors and drug targets, no study has systematically evaluated the MWC mechanism as it applies to GPCR allosteric ligands. We reveal how the recently described allosteric modulator, benzyl quinolone carboxylic acid (BQCA), behaves according to a strict, two-state MWC mechanism at the M-1 muscarinic acetylcholine receptor (mAChR). Despite having a low affinity for the M1 mAChR, BQCA demonstrated state dependence, exhibiting high positive cooperativity with orthosteric agonists in a manner that correlated with efficacy but negative cooperativity with inverse agonists. The activity of BQCA was significantly increased at a constitutively active M-1 mAChR but abolished at an inactive mutant. Interestingly, BQCA possessed intrinsic signaling efficacy, ranging from near-quiescence to full agonism depending on the coupling efficiency of the chosen intracellular pathway. This latter cellular property also determined the difference in magnitude of positive cooperativity between BQCA and the orthosteric agonist, carbachol, across pathways. The lack of additional, pathway-biased, allosteric modulation by BQCA was confirmed in genetically engineered yeast strains expressing different chimeras between the endogenous yeast G(pa1) protein and human G alpha subunits. These findings define a chemical biological framework that can be applied to the study and classification of allosteric modulators across different GPCR families.	[Christopoulos, Arthur] Monash Univ, Monash Inst Pharmaceut Sci, Dept Pharmacol, Parkville, Vic 3052, Australia	Monash University	Christopoulos, A (corresponding author), Monash Univ, Monash Inst Pharmaceut Sci, Dept Pharmacol, 399 Royal Pde, Parkville, Vic 3052, Australia.	arthur.christopoulos@monash.edu	Christopoulos, Arthur/B-6207-2013; Sexton, Patrick M/B-1319-2008	Christopoulos, Arthur/0000-0003-4442-3294; Sexton, Patrick M/0000-0001-8902-2473; Scammells, Peter/0000-0003-2930-895X; Canals, Meritxell/0000-0002-7942-5006; Lane, J. Robert/0000-0002-7361-7875	National Health and Medical Research Council [519461, APP1011796, APP1011920]; Australian Research Council [DP110100687]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	This work was funded in part by National Health and Medical Research Council Program Grants 519461 (to A. C. and P. M. S.), APP1011796 (to M. C.), and APP1011920 (to J. R. L.) by and Australian Research Council Discovery Grant DP110100687 (A. C.).	Armbruster BN, 2007, P NATL ACAD SCI USA, V104, P5163, DOI 10.1073/pnas.0700293104; Avlani V, 2004, J PHARMACOL EXP THER, V308, P1062, DOI 10.1124/jpet.103.059840; Avlani VA, 2007, J BIOL CHEM, V282, P25677, DOI 10.1074/jbc.M702311200; Avlani VA, 2010, MOL PHARMACOL, V78, P94, DOI 10.1124/mol.110.064345; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Canals M, 2011, TRENDS BIOCHEM SCI, V36, P663, DOI 10.1016/j.tibs.2011.08.005; Changeux JP, 2005, SCIENCE, V308, P1424, DOI 10.1126/science.1108595; Christopoulos A, 1998, TRENDS PHARMACOL SCI, V19, P351, DOI 10.1016/S0165-6147(98)01240-1; Christopoulos A, 2002, NAT REV DRUG DISCOV, V1, P198, DOI 10.1038/nrd746; Conn PJ, 2009, NAT REV DRUG DISCOV, V8, P41, DOI 10.1038/nrd2760; EHLERT FJ, 1988, MOL PHARMACOL, V33, P187; Giraldo J, 2004, FEBS LETT, V556, P13, DOI 10.1016/S0014-5793(03)01404-2; Gregory KJ, 2010, J BIOL CHEM, V285, P7459, DOI 10.1074/jbc.M109.094011; Hall DA, 2000, MOL PHARMACOL, V58, P1412, DOI 10.1124/mol.58.6.1412; KARLIN A, 1967, J THEOR BIOL, V16, P306, DOI 10.1016/0022-5193(67)90011-2; Keov P, 2011, NEUROPHARMACOLOGY, V60, P24, DOI 10.1016/j.neuropharm.2010.07.010; Klinkenberg I, 2010, NEUROSCI BIOBEHAV R, V34, P1307, DOI 10.1016/j.neubiorev.2010.04.001; Lanzafame A, 1996, EUR J PHARMACOL, V316, P27, DOI 10.1016/S0014-2999(96)00639-5; Leach K, 2007, TRENDS PHARMACOL SCI, V28, P382, DOI 10.1016/j.tips.2007.06.004; Leach K, 2010, NEUROPSYCHOPHARMACOL, V35, P855, DOI 10.1038/npp.2009.194; LEFF P, 1995, TRENDS PHARMACOL SCI, V16, P89, DOI 10.1016/S0165-6147(00)88989-0; Lu ZL, 1999, J BIOL CHEM, V274, P7309, DOI 10.1074/jbc.274.11.7309; Ma L, 2009, P NATL ACAD SCI USA, V106, P15950, DOI 10.1073/pnas.0900903106; May LT, 2007, ANNU REV PHARMACOL, V47, P1, DOI 10.1146/annurev.pharmtox.47.120505.105159; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Murray CW, 2009, NAT CHEM, V1, P187, DOI [10.1038/NCHEM.217, 10.1038/nchem.217]; Nawaratne V, 2008, MOL PHARMACOL, V74, P1119, DOI 10.1124/mol.108.049353; Pertz O, 2006, NATURE, V440, P1069, DOI 10.1038/nature04665; PROSKA J, 1994, MOL PHARMACOL, V45, P709; Scholten D., 2011, BR J PHARM IN PRESS; Shekhar A, 2008, AM J PSYCHIAT, V165, P1033, DOI 10.1176/appi.ajp.2008.06091591; Shirey JK, 2009, J NEUROSCI, V29, P14271, DOI 10.1523/JNEUROSCI.3930-09.2009; Stallaert W, 2011, EXPERT OPIN DRUG DIS, V6, P811, DOI 10.1517/17460441.2011.586691; Stewart GD, 2010, ACS CHEM BIOL, V5, P365, DOI 10.1021/cb900276p; STOCKTON JM, 1983, MOL PHARMACOL, V23, P551; Thomas RL, 2008, J PHARMACOL EXP THER, V327, P365, DOI 10.1124/jpet.108.141788; TUCEK S, 1990, MOL PHARMACOL, V38, P674; Valant C, 2010, MOL PHARMACOL, V78, P444, DOI 10.1124/mol.110.064568; Whalen EJ, 2011, TRENDS MOL MED, V17, P126, DOI 10.1016/j.molmed.2010.11.004; Wisler JW, 2007, P NATL ACAD SCI USA, V104, P16657, DOI 10.1073/pnas.0707936104; Yu RC, 2008, NATURE, V456, P755, DOI 10.1038/nature07513	41	93	94	0	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					650	659		10.1074/jbc.M111.314278	http://dx.doi.org/10.1074/jbc.M111.314278			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22086918	Green Published, hybrid			2022-12-27	WOS:000298682400063
J	Goel, S; Krishnamurthy, S; Hampsey, M				Goel, Shivani; Krishnamurthy, Shankarling; Hampsey, Michael			Mechanism of Start Site Selection by RNA Polymerase II INTERPLAY BETWEEN TFIIB AND Ssl2/XPB HELICASE SUBUNIT OF TFIIH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION PREINITIATION COMPLEX; II INITIATION COMPLEX; PHOTO-CROSS-LINKING; N-TERMINAL REGION; SACCHAROMYCES-CEREVISIAE; GENE LOOPS; EXCISION-REPAIR; YEAST TFIIB; CHROMOSOME CONFORMATION; FUNCTIONAL INTERACTION	TFIIB is essential for transcription initiation by RNA polymerase II. TFIIB also cross-links to terminator regions and is required for gene loops that juxtapose promoter-terminator elements in a transcription-dependent manner. The Saccharomyces cerevisiae sua7-1 mutation encodes an altered form of TFIIB (E62K) that is defective for both start site selection and gene looping. Here we report the isolation of an ssl2 mutant, encoding an altered form of TFIIH, as a suppressor of the cold-sensitive growth defect of the sua7-1 mutation. Ssl2 (Rad25) is orthologous to human XPB and is a member of the SF2 family of ATP-dependent DNA helicases. The ssl2 suppressor allele encodes an arginine replacement of the conserved histidine residue (H508R) located within the DEVH-containing helicase domain. In addition to suppressing the TFIIB E62K growth defect, Ssl2 H508R partially restores both normal start site selection and gene looping. Moreover, Ssl2, like TFIIB, associates with promoter and terminator regions, and the diminished association of TFIIB E62K with the PMA1 terminator is restored by the Ssl2 H508R suppressor. These results define a novel, functional interaction between TFIIB and Ssl2 that affects start site selection and gene looping.	[Goel, Shivani; Krishnamurthy, Shankarling; Hampsey, Michael] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Hampsey, M (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA.	michael.hampsey@umdnj.edu			National Institutes of Health [GM39484, GM068887]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068887, R29GM039484, R01GM039484] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM39484 (to M. H.) and GM068887 (to Claire Moore (Tufts Medical School) and M. H.).	Ahn SH, 2004, MOL CELL, V13, P67, DOI 10.1016/S1097-2765(03)00492-1; Ansari A, 2005, GENE DEV, V19, P2969, DOI 10.1101/gad.1362305; Armache KJ, 2003, P NATL ACAD SCI USA, V100, P6964, DOI 10.1073/pnas.1030608100; Bangur CS, 1997, MOL CELL BIOL, V17, P6784, DOI 10.1128/MCB.17.12.6784; Bushnell DA, 2004, SCIENCE, V303, P983, DOI 10.1126/science.1090838; Bushnell DA, 2003, P NATL ACAD SCI USA, V100, P6969, DOI 10.1073/pnas.1130601100; Chang CR, 2005, GENE DEV, V19, P3031, DOI 10.1101/gad.1356305; Chen BS, 2004, BIOCHEMISTRY-US, V43, P12741, DOI 10.1021/bi048993r; Chen BS, 2004, MOL CELL BIOL, V24, P3983, DOI 10.1128/MCB.24.9.3983-3991.2004; Chen HT, 2004, CELL, V119, P169, DOI 10.1016/j.cell.2004.09.028; Chen HT, 2007, NAT STRUCT MOL BIOL, V14, P696, DOI 10.1038/nsmb1272; Cho EJ, 1999, J BIOL CHEM, V274, P25807, DOI 10.1074/jbc.274.36.25807; Dekker J, 2006, NAT METHODS, V3, P17, DOI 10.1038/NMETH823; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Douziech M, 2000, MOL CELL BIOL, V20, P8168, DOI 10.1128/MCB.20.21.8168-8177.2000; Egly JM, 2011, DNA REPAIR, V10, P714, DOI 10.1016/j.dnarep.2011.04.021; EXINGER F, 1992, CURR GENET, V22, P9, DOI 10.1007/BF00351735; Fairman-Williams ME, 2010, CURR OPIN STRUC BIOL, V20, P313, DOI 10.1016/j.sbi.2010.03.011; Faitar SL, 2001, MOL CELL BIOL, V21, P4427, DOI 10.1128/MCB.21.14.4427-4440.2001; Fan L, 2006, MOL CELL, V22, P27, DOI 10.1016/j.molcel.2006.02.017; Forget D, 2004, MOL CELL BIOL, V24, P1122, DOI 10.1128/MCB.24.3.1122-1131.2004; Freire-Picos MA, 2005, NUCLEIC ACIDS RES, V33, P5045, DOI 10.1093/nar/gki825; Ghazy MA, 2004, MOL CELL BIOL, V24, P10975, DOI 10.1128/MCB.24.24.10975-10985.2004; Greger IH, 1998, EMBO J, V17, P4771, DOI 10.1093/emboj/17.16.4771; GUARENTE L, 1983, METHOD ENZYMOL, V101, P181; GULYAS KD, 1992, CELL, V69, P1031, DOI 10.1016/0092-8674(92)90621-I; GUZDER SN, 1994, NATURE, V369, P578, DOI 10.1038/369578a0; Hahn S, 2004, NAT STRUCT MOL BIOL, V11, P394, DOI 10.1038/nsmb763; Kapanidis AN, 2006, SCIENCE, V314, P1144, DOI 10.1126/science.1131399; Kawauchi J, 2008, GENE DEV, V22, P1082, DOI 10.1101/gad.463408; Kim TK, 2000, SCIENCE, V288, P1418, DOI 10.1126/science.288.5470.1418; Kim TK, 1997, P NATL ACAD SCI USA, V94, P12268, DOI 10.1073/pnas.94.23.12268; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; Kostrewa D, 2009, NATURE, V462, P323, DOI 10.1038/nature08548; Kuehner JN, 2006, J BIOL CHEM, V281, P14119, DOI 10.1074/jbc.M601937200; Laine JP, 2009, GENE DEV, V23, P2604, DOI 10.1101/gad.1823609; Lee BS, 1998, GENETICS, V148, P1743; Liu X, 2011, SCIENCE, V333, P633, DOI 10.1126/science.1206629; Liu X, 2010, SCIENCE, V327, P206, DOI 10.1126/science.1182015; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lykke-Andersen S, 2011, CELL CYCLE, V10, P863, DOI 10.4161/cc.10.6.14931; Mapendano CK, 2010, MOL CELL, V40, P410, DOI 10.1016/j.molcel.2010.10.012; Mavrich TN, 2008, GENOME RES, V18, P1073, DOI 10.1101/gr.078261.108; Miller G, 2006, NAT STRUCT MOL BIOL, V13, P603, DOI 10.1038/nsmb1117; Mischo HE, 2011, MOL CELL, V41, P21, DOI 10.1016/j.molcel.2010.12.007; O'Sullivan JM, 2004, NAT GENET, V36, P1014, DOI 10.1038/ng1411; Orphanides G, 1996, GENE DEV, V10, P2657, DOI 10.1101/gad.10.21.2657; Pardee TS, 1998, J BIOL CHEM, V273, P17859, DOI 10.1074/jbc.273.28.17859; PARVIN JD, 1993, CELL, V73, P533, DOI 10.1016/0092-8674(93)90140-L; PINTO I, 1992, CELL, V68, P977, DOI 10.1016/0092-8674(92)90040-J; PINTO I, 1994, J BIOL CHEM, V269, P30569; PINTO I, 1992, GENETICS, V132, P97; Powell W, 1996, J BIOL CHEM, V271, P6866, DOI 10.1074/jbc.271.12.6866; Robert F, 1998, MOL CELL, V2, P341, DOI 10.1016/S1097-2765(00)80278-6; ROSE MD, 1987, GENE, V60, P237, DOI 10.1016/0378-1119(87)90232-0; ROTHSTEIN R, 1991, METHOD ENZYMOL, V194, P281; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Singh BN, 2007, MOL CELL, V27, P806, DOI 10.1016/j.molcel.2007.07.013; Singh BN, 2009, METHODS, V48, P361, DOI 10.1016/j.ymeth.2009.02.018; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Skourti-Stathaki K, 2011, MOL CELL, V42, P794, DOI 10.1016/j.molcel.2011.04.026; Steinmetz EJ, 1996, MOL CELL BIOL, V16, P6993, DOI 10.1128/mcb.16.12.6993; Steinmetz EJ, 2006, MOL CELL, V24, P735, DOI 10.1016/j.molcel.2006.10.023; SUN ZW, 1995, P NATL ACAD SCI USA, V92, P3127, DOI 10.1073/pnas.92.8.3127; Sun ZW, 1996, NUCLEIC ACIDS RES, V24, P2560, DOI 10.1093/nar/24.13.2560; SWEDER KS, 1994, J BIOL CHEM, V269, P1852; Tan-Wong SM, 2009, GENE DEV, V23, P2610, DOI 10.1101/gad.1823209; Tirode F, 1999, MOL CELL, V3, P87, DOI 10.1016/S1097-2765(00)80177-X; Toyn JH, 2000, YEAST, V16, P553, DOI 10.1002/(SICI)1097-0061(200004)16:6<553::AID-YEA554>3.0.CO;2-7; Vasiljeva L, 2008, NAT STRUCT MOL BIOL, V15, P795, DOI 10.1038/nsmb.1468; Venters BJ, 2011, MOL CELL, V41, P480, DOI 10.1016/j.molcel.2011.01.015; Woychik NA, 2002, CELL, V108, P453, DOI 10.1016/S0092-8674(02)00646-3; Wu WH, 1999, GENETICS, V153, P643; Zhang DY, 2002, NUCLEIC ACIDS RES, V30, P3078, DOI 10.1093/nar/gkf422; [No title captured]	75	19	19	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					557	567		10.1074/jbc.M111.281576	http://dx.doi.org/10.1074/jbc.M111.281576			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22081613	Green Published, hybrid			2022-12-27	WOS:000298682400054
J	Li, Y; Martin, BR; Cravatt, BF; Hofmann, SL				Li, Yi; Martin, Brent R.; Cravatt, Benjamin F.; Hofmann, Sandra L.			DHHC5 Protein Palmitoylates Flotillin-2 and Is Rapidly Degraded on Induction of Neuronal Differentiation in Cultured Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN-CELLS; REGGIE/FLOTILLIN PROTEINS; SACCHAROMYCES-CEREVISIAE; MEMBRANE MICRODOMAINS; AXON REGENERATION; S-ACYLATION; ENDOCYTOSIS; PSD-95; DOMAIN; REGGIE-1/FLOTILLIN-2	Post-translational palmitoylation of intracellular proteins is mediated by protein palmitoyltransferases belonging to the DHHC family, which share a common catalytic Asp-His-His-Cys (DHHC) motif. Several members have been implicated in neuronal development, neurotransmission, and synaptic plasticity. We previously observed that mice homozygous for a hypomorphic allele of the ZDHHC5 gene are impaired in context-dependent learning and memory. To identify potentially relevant protein substrates of DHHC5, we performed a quantitative proteomic analysis of stable isotope-labeled neuronal stem cell cultures from forebrains of normal and DHHC5-GT(gene-trapped) mice using the bioorthogonal palmitate analog 17-octadecynoic acid. We identified similar to 300 17-octadecynoic acid-modified and hydroxylamine-sensitive proteins, of which a subset was decreased in abundance in DHHC5-GT cells. Palmitoylation and oligomerization of one of these proteins (flotillin-2) was abolished in DHHC5-GT neuronal stem cells. In COS-1 cells, overexpression of DHHC5 markedly stimulated the palmitoylation of flotillin-2, strongly suggesting a direct enzyme-substrate relationship. Serendipitously, we found that down-regulation of DHHC5 was triggered within minutes following growth factor withdrawal from normal neural stem cells, a maneuver that is used to induce neural differentiation in culture. The effect was reversible for up to 4 h, and degradation was partially prevented by inhibitors of ubiquitin-mediated proteolysis. These findings suggest that protein palmitoylation can be regulated through changes in DHHC PAT levels in response to differentiation signals.	[Li, Yi; Hofmann, Sandra L.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Li, Yi; Hofmann, Sandra L.] Univ Texas SW Med Ctr Dallas, Hamon Ctr Therapeut Oncol Res, Dallas, TX 75390 USA; [Martin, Brent R.; Cravatt, Benjamin F.] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Martin, Brent R.; Cravatt, Benjamin F.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Scripps Research Institute; Scripps Research Institute	Hofmann, SL (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Internal Med, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	sandra.hofmann@utsouthwestern.edu	Martin, Brent/B-4370-2012	Martin, Brent/0000-0002-7136-2397	National Institutes of Health [R37 NS36867, K99CA151460]; Robert A. Welch Foundation [I-1187]; NATIONAL CANCER INSTITUTE [K99CA151460, R37CA087660] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS036867] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R37 NS36867 (to S. L. H.) and K99CA151460 (B. R. M.). This work was also supported by Robert A. Welch Foundation Grant I-1187 (to S. L. H.).	ADAMSON P, 1992, J BIOL CHEM, V267, P20033; Babuke T, 2007, EUR J CELL BIOL, V86, P525, DOI 10.1016/j.ejcb.2007.03.003; Babuke T, 2009, CELL SIGNAL, V21, P1287, DOI 10.1016/j.cellsig.2009.03.012; Bartels DJ, 1999, MOL CELL BIOL, V19, P6775, DOI 10.1128/mcb.19.10.6775; Bickel PE, 1997, J BIOL CHEM, V272, P13793, DOI 10.1074/jbc.272.21.13793; Caldwell MA, 2004, EXP NEUROL, V188, P408, DOI 10.1016/j.expneurol.2004.05.007; Cheng HP, 2009, J BIOL CHEM, V284, P1373, DOI 10.1074/jbc.M806380200; Cremona ML, 2011, NAT NEUROSCI, V14, P469, DOI 10.1038/nn.2781; Damm EM, 2005, J CELL BIOL, V168, P477, DOI 10.1083/jcb.200407113; El-Husseini AE, 2002, CELL, V108, P849, DOI 10.1016/S0092-8674(02)00683-9; Forrester MT, 2011, J LIPID RES, V52, P393, DOI 10.1194/jlr.D011106; Frick M, 2007, CURR BIOL, V17, P1151, DOI 10.1016/j.cub.2007.05.078; Fukata M, 2004, NEURON, V44, P987, DOI 10.1016/j.neuron.2004.12.005; Fukata Y, 2010, NAT REV NEUROSCI, V11, P161, DOI 10.1038/nrn2788; Glebov OO, 2006, NAT CELL BIOL, V8, P46, DOI 10.1038/ncb1342; Montoro AG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016969; Greaves J, 2011, MOL BIOL CELL, V22, P1887, DOI 10.1091/mbc.E10-11-0924; Greaves J, 2011, TRENDS BIOCHEM SCI, V36, P245, DOI 10.1016/j.tibs.2011.01.003; HANCOCK JF, 1989, CELL, V57, P1167, DOI 10.1016/0092-8674(89)90054-8; Hartman IZ, 2010, J BIOL CHEM, V285, P19288, DOI 10.1074/jbc.M110.134213; Hayashi T, 2005, NEURON, V47, P709, DOI 10.1016/j.neuron.2005.06.035; HESS DT, 1992, J NEUROSCI, V12, P4634; Huang K, 2005, CURR OPIN NEUROBIOL, V15, P527, DOI 10.1016/j.conb.2005.08.001; Kang RJ, 2008, NATURE, V456, P904, DOI 10.1038/nature07605; Kim Ki-Bum, 2008, V424, P413, DOI 10.1007/978-1-60327-064-9_32; Kokkola T, 2011, FEBS LETT, V585, P2665, DOI 10.1016/j.febslet.2011.07.028; LAING JG, 1995, J BIOL CHEM, V270, P26399, DOI 10.1074/jbc.270.44.26399; Langhorst MF, 2008, EUR J CELL BIOL, V87, P211, DOI 10.1016/j.ejcb.2007.12.001; Li Y, 2010, J BIOL CHEM, V285, P13022, DOI 10.1074/jbc.M109.079426; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Lobo S, 2002, J BIOL CHEM, V277, P41268, DOI 10.1074/JBC.M206573200; Martin B. R., 2011, NAT METHODS IN PRESS; Martin BR, 2009, NAT METHODS, V6, P135, DOI [10.1038/NMETH.1293, 10.1038/nmeth.1293]; Mitchell DA, 2006, J LIPID RES, V47, P1118, DOI 10.1194/jlr.R600007-JLR200; Morrow IC, 2005, TRAFFIC, V6, P725, DOI 10.1111/j.1600-0854.2005.00318.x; Munderloh C, 2009, J NEUROSCI, V29, P6607, DOI 10.1523/JNEUROSCI.0870-09.2009; Neumann-Giesen C, 2004, BIOCHEM J, V378, P509, DOI 10.1042/BJ20031100; Noritake J, 2009, J CELL BIOL, V186, P147, DOI 10.1083/jcb.200903101; Ponimaskin E, 2008, J NEUROSCI, V28, P8897, DOI 10.1523/JNEUROSCI.2171-08.2008; RESH MD, 2006, SCI STKE, pRE14, DOI DOI 10.1126/STKE.3592006RE14; Riento K, 2009, J CELL SCI, V122, P912, DOI 10.1242/jcs.039024; Roth AF, 2002, J CELL BIOL, V159, P23, DOI 10.1083/jcb.200206120; Roth AF, 2006, CELL, V125, P1003, DOI 10.1016/j.cell.2006.03.042; Saslowsky DE, 2010, J CLIN INVEST, V120, P4399, DOI 10.1172/JCI42958; Schulte T, 1997, DEVELOPMENT, V124, P577; SKENE JHP, 1989, J CELL BIOL, V108, P613, DOI 10.1083/jcb.108.2.613; Solis GP, 2007, BIOCHEM J, V403, P313, DOI 10.1042/BJ20061686; Stuermer CAO, 2011, J NEUROCHEM, V116, P708, DOI 10.1111/j.1471-4159.2010.07007.x; Tian LJ, 2010, J BIOL CHEM, V285, P23954, DOI 10.1074/jbc.M110.137802; Uechi Y, 2009, BIOCHEM BIOPH RES CO, V378, P732, DOI 10.1016/j.bbrc.2008.11.107; Wan J, 2007, NAT PROTOC, V2, P1573, DOI 10.1038/nprot.2007.225; WEDEGAERTNER PB, 1994, CELL, V77, P1063, DOI 10.1016/0092-8674(94)90445-6; Yang W, 2010, MOL CELL PROTEOMICS, V9, P54, DOI 10.1074/mcp.M800448-MCP200; Zhang CL, 2008, NATURE, V451, P1004, DOI 10.1038/nature06562; Zhang MM, 2010, P NATL ACAD SCI USA, V107, P8627, DOI 10.1073/pnas.0912306107	55	93	97	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					523	530		10.1074/jbc.M111.306183	http://dx.doi.org/10.1074/jbc.M111.306183			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22081607	Green Published, hybrid			2022-12-27	WOS:000298682400051
J	Niture, SK; Jaiswal, AK				Niture, Suryakant K.; Jaiswal, Anil K.			Inhibitor of Nrf2 (INrf2 or Keap1) Protein Degrades Bcl-xL via Phosphoglycerate Mutase 5 and Controls Cellular Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTHYMOSIN-ALPHA; OXIDATIVE STRESS; DEFICIENT MICE; LUNG-CANCER; DEATH; COMPLEX; CARCINOGENESIS; EXPRESSION; ABUNDANCE; BCL-X(L)	INrf2 (Keap1) is an adaptor protein that facilitates INrf2-Cul3-Rbx1-mediated ubiquitination/degradation of Nrf2, a master regulator of cytoprotective gene expression. Here, we present evidence that members of the phosphoglycerate mutase family 5 (PGAM5) proteins are involved in the INrf2-mediated ubiquitination/degradation of anti-apoptotic factor Bcl-xL. Mass spectrometry and co-immunoprecipitation assays revealed that INrf2, through its DGR domain, interacts with PGAM5, which in turn interacts with anti-apoptotic Bcl-xL protein. INrf2-Cul3-Rbx1 complex facilitates ubiquitination and degradation of both PGAM5 and Bcl-xL. Overexpression of PGAM5 protein increased INrf2-mediated degradation of BclxL, whereas knocking down PGAM5 by siRNA decreased INrf2 degradation of Bcl-xL, resulting in increased stability of Bcl-xL. Mutation of PGMA5-E79A/S80A abolished INrf2/PGAM5/Bcl-xL interaction. Therefore, PGAM5 protein acts as a bridge between INrf2 and Bcl-xL interaction. Further studies showed that overexpression of INrf2 enhanced degradation of PGAM5-Bcl-xL complex, led to etoposide-mediated accumulation of Bax, increased release of cytochrome c from mitochondria, activated caspase-3/7, and enhanced DNA fragmentation and apoptosis. In addition, antioxidant (tert-butylhydroquinone) treatment destabilized the Nrf2-INrf2-PGAM5-Bcl-xL complex, which resulted in release of Nrf2 in cytosol and mitochondria, release of Bcl-xL in mitochondria, increase in Bcl-xL heterodimerization with Bax in mitochondria, and reduced cellular apoptosis. These data provide the first evidence that INrf2 controls Bcl-xL via PGAM5 and controls cellular apoptosis.	[Niture, Suryakant K.; Jaiswal, Anil K.] Univ Maryland, Dept Pharmacol & Expt Therapeut, Sch Med, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Jaiswal, AK (corresponding author), Univ Maryland, Dept Pharmacol & Expt Therapeut, Sch Med, 655 W Baltimore St, Baltimore, MD 21201 USA.	ajaiswal@som.umaryland.edu		Niture, Suryakant/0000-0003-0613-9399	National Institutes of Health [RO1 ES012265, RO1 GM047466]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES012265] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047466] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 ES012265 and RO1 GM047466.	Aoki Y, 2001, TOXICOL APPL PHARM, V173, P154, DOI 10.1006/taap.2001.9176; Aravind L, 2001, SCIENCE, V291, P1279, DOI 10.1126/science.291.5507.1279; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; Chan KM, 2001, P NATL ACAD SCI USA, V98, P4611, DOI 10.1073/pnas.081082098; CHAO DT, 1995, J EXP MED, V182, P821, DOI 10.1084/jem.182.3.821; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Hammond PW, 2001, J BIOL CHEM, V276, P20898, DOI 10.1074/jbc.M011641200; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hu XM, 2006, MOL CELL BIOL, V26, P940, DOI 10.1128/MCB.26.3.940-954.2006; Iida K, 2004, CANCER RES, V64, P6424, DOI 10.1158/0008-5472.CAN-04-1906; Iizuka T, 2005, GENES CELLS, V10, P1113, DOI 10.1111/j.1365-2443.2005.00905.x; Karapetian RN, 2005, MOL CELL BIOL, V25, P1089, DOI 10.1128/MCB.25.3.1089-1099.2005; Kaspar JW, 2010, J BIOL CHEM, V285, P21349, DOI 10.1074/jbc.M110.121863; Kaspar JW, 2009, FREE RADICAL BIO MED, V47, P1304, DOI 10.1016/j.freeradbiomed.2009.07.035; Kwak MK, 2003, J BIOL CHEM, V278, P8135, DOI 10.1074/jbc.M211898200; Kweon MH, 2006, J BIOL CHEM, V281, P33761, DOI 10.1074/jbc.M604748200; Lee DF, 2009, MOL CELL, V36, P131, DOI 10.1016/j.molcel.2009.07.025; Lee OH, 2007, J BIOL CHEM, V282, P36412, DOI 10.1074/jbc.M706517200; Lo SC, 2008, EXP CELL RES, V314, P1789, DOI 10.1016/j.yexcr.2008.02.014; Lo SC, 2006, J BIOL CHEM, V281, P37893, DOI 10.1074/jbc.M606539200; Muchmore SW, 1996, NATURE, V381, P335, DOI 10.1038/381335a0; Niture SK, 2011, CELL DEATH DIFFER, V18, P439, DOI 10.1038/cdd.2010.114; Niture SK, 2010, TOXICOL APPL PHARM, V244, P37, DOI 10.1016/j.taap.2009.06.009; Niture SK, 2009, J BIOL CHEM, V284, P13856, DOI 10.1074/jbc.M808084200; Padmanabhan B, 2006, MOL CELL, V21, P689, DOI 10.1016/j.molcel.2006.01.013; Ramos-Gomez M, 2001, P NATL ACAD SCI USA, V98, P3410, DOI 10.1073/pnas.051618798; Rangasamy T, 2005, J EXP MED, V202, P47, DOI 10.1084/jem.20050538; Ranger AM, 2003, P NATL ACAD SCI USA, V100, P9324, DOI 10.1073/pnas.1533446100; Singh A, 2006, PLOS MED, V3, P1865, DOI 10.1371/journal.pmed.0030420; Strachan GD, 2004, BIOCHEMISTRY-US, V43, P12113, DOI 10.1021/bi0494166; Wakabayashi N, 2003, NAT GENET, V35, P238, DOI 10.1038/ng1248; Wang WP, 2006, J BIOL CHEM, V281, P19676, DOI 10.1074/jbc.M602802200	33	42	46	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2011	286	52					44542	44556		10.1074/jbc.M111.275073	http://dx.doi.org/10.1074/jbc.M111.275073			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870CA	22072718	hybrid, Green Published			2022-12-27	WOS:000298645500026
J	Golini, L; Chouabe, C; Berthier, C; Cusimano, V; Fornaro, M; Bonvallet, R; Formoso, L; Giacomello, E; Jacquemond, V; Sorrentino, V				Golini, Lucia; Chouabe, Christophe; Berthier, Christine; Cusimano, Vincenza; Fornaro, Mara; Bonvallet, Robert; Formoso, Luca; Giacomello, Emiliana; Jacquemond, Vincent; Sorrentino, Vincenzo			Junctophilin 1 and 2 Proteins Interact with the L-type Ca2+ Channel Dihydropyridine Receptors (DHPRs) in Skeletal Muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RYANODINE RECEPTOR; SARCOPLASMIC-RETICULUM; CHARGE MOVEMENT; CALCIUM-CHANNELS; TRIADIC PROTEINS; CONTRACTION; RELEASE; COMPLEX; FIBERS; ENTRY	Junctophilins (JPs) anchor the endo/sarcoplasmic reticulum to the plasma membrane, thus contributing to the assembly of junctional membrane complexes in striated muscles and neurons. Recent studies have shown that JPs may be also involved in regulating Ca2+ homeostasis. Here, we report that in skeletal muscle, JP1 and JP2 are part of a complex that, in addition to ryanodine receptor 1 (RyR1), includes caveolin 3 and the dihydropyridine receptor (DHPR). The interaction between JPs and DHPR was mediated by a region encompassing amino acids 230-369 and amino acids 216-399 in JP1 and JP2, respectively. Immunofluorescence studies revealed that the pattern of DHPR and RyR signals in C2C12 cells knocked down for JP1 and JP2 was rather diffused and characterized by smaller puncta in contrast to that observed in control cells. Functional experiments revealed that down-regulation of JPs in differentiated C2C12 cells resulted in a reduction of intramembrane charge movement and the L-type Ca2+ current accompanied by a reduced number of DHPRs at the plasma membrane, whereas there was no substantial alteration in Ca2+ release from the sterol regulatory element-binding protein. Altogether, these results suggest that JP1 and JP2 can facilitate the assembly of DHPR with other proteins of the excitation-contraction coupling machinery.	[Golini, Lucia; Cusimano, Vincenza; Fornaro, Mara; Formoso, Luca; Giacomello, Emiliana; Sorrentino, Vincenzo] Univ Siena, Mol Med Sect, Dept Neurosci, I-53100 Siena, Italy; [Chouabe, Christophe; Berthier, Christine; Bonvallet, Robert; Jacquemond, Vincent] Univ Lyon 1, CNRS, UMR 5534, Ctr Genet & Physiol Mol & Cellulaire, F-69622 Villeurbanne, France; [Golini, Lucia; Cusimano, Vincenza; Fornaro, Mara; Formoso, Luca; Giacomello, Emiliana; Sorrentino, Vincenzo] Univ Siena, Interuniv Inst Myol, I-53100 Siena, Italy	University of Siena; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; University of Siena	Sorrentino, V (corresponding author), Univ Siena, Mol Med Sect, Dept Neurosci, Via A Moro, I-53100 Siena, Italy.	vincenzo.sorrentino@unisi.it	berthier, christine/AAO-1247-2021; Sorrentino, Vincenzo/A-4793-2014; Giacomello, Emiliana/E-3080-2018	Sorrentino, Vincenzo/0000-0002-8573-8631; Giacomello, Emiliana/0000-0003-3329-6269; BERTHIER, Christine/0000-0002-9608-643X; Jacquemond, Vincent/0000-0003-4944-270X	Telethon [GGP08153]	Telethon(Fondazione Telethon)	This work was supported in part by a grant from Telethon (GGP08153).	Berbey C, 2009, J BIOL CHEM, V284, P36387, DOI 10.1074/jbc.M109.073221; CHENG H, 1993, SCIENCE, V262, P740, DOI 10.1126/science.8235594; Collet C, 2003, BIOPHYS J, V84, P251, DOI 10.1016/S0006-3495(03)74846-2; Conti A, 1996, BIOCHEM J, V316, P19, DOI 10.1042/bj3160019; FRANZINIARMSTRO.C, 2004, MYOLOGY, P232; Hirata Y, 2006, BIOPHYS J, V90, P4418, DOI 10.1529/biophysj.105.076570; Ito K, 2001, J CELL BIOL, V154, P1059, DOI 10.1083/jcb.200105040; Jacquemond V, 1997, BIOPHYS J, V73, P920, DOI 10.1016/S0006-3495(97)78124-4; Kakizawa S, 2008, CEREBELLUM, V7, P385, DOI 10.1007/s12311-008-0040-1; Komazaki S, 2002, FEBS LETT, V524, P225, DOI 10.1016/S0014-5793(02)03042-9; Landstrom AP, 2011, CIRC-HEART FAIL, V4, P214, DOI 10.1161/CIRCHEARTFAILURE.110.958694; Lee EH, 2006, J BIOL CHEM, V281, P10042, DOI 10.1074/jbc.M600981200; Legrand C, 2008, J PHYSIOL-LONDON, V586, P441, DOI 10.1113/jphysiol.2007.145862; LEUNG AT, 1987, J BIOL CHEM, V262, P7943; Li HL, 2010, J BIOL CHEM, V285, P39171, DOI 10.1074/jbc.M110.149690; Lyfenko AD, 2008, J PHYSIOL-LONDON, V586, P4815, DOI 10.1113/jphysiol.2008.160481; Ma H, 2006, CELL RES, V16, P466, DOI 10.1038/sj.cr.7310058; MARTY I, 1994, P NATL ACAD SCI USA, V91, P2270, DOI 10.1073/pnas.91.6.2270; Matsushita Y, 2007, J HUM GENET, V52, P543, DOI 10.1007/s10038-007-0149-y; Minamisawa S, 2004, BIOCHEM BIOPH RES CO, V325, P852, DOI 10.1016/j.bbrc.2004.10.107; Mouton J, 2001, BIOCHEM J, V354, P597, DOI 10.1042/0264-6021:3540597; Murray BE, 1997, BIOCHEM J, V324, P689, DOI 10.1042/bj3240689; Nishi M, 2000, BIOCHEM BIOPH RES CO, V273, P920, DOI 10.1006/bbrc.2000.3011; Nishi M, 2003, MOL BRAIN RES, V118, P102, DOI 10.1016/S0169-328X(03)00341-3; Park CY, 2010, SCIENCE, V330, P101, DOI 10.1126/science.1191027; Phimister AJ, 2007, J BIOL CHEM, V282, P8667, DOI 10.1074/jbc.M609936200; Pouvreau S, 2006, BIOPHYS J, V91, P2206, DOI 10.1529/biophysj.105.078089; RIOS E, 1992, ANNU REV PHYSIOL, V54, P109, DOI 10.1146/annurev.ph.54.030192.000545; Rossi AE, 2006, MUSCLE NERVE, V33, P715, DOI 10.1002/mus.20512; Serysheva II, 2004, BIOCHEMISTRY-MOSCOW+, V69, P1226, DOI 10.1007/s10541-005-0068-5; Sorrentino V, 2011, INT J BIOCHEM CELL B, V43, P1075, DOI 10.1016/j.biocel.2011.04.004; Stiber J, 2008, NAT CELL BIOL, V10, P688, DOI 10.1038/ncb1731; TAKAHASHI M, 1987, P NATL ACAD SCI USA, V84, P5478, DOI 10.1073/pnas.84.15.5478; Takeshima H, 2000, MOL CELL, V6, P11, DOI 10.1016/S1097-2765(00)00003-4; van Oort RJ, 2011, CIRCULATION, V123, P979, DOI 10.1161/CIRCULATIONAHA.110.006437; Vassilopoulos S, 2010, BIOCHEMISTRY-US, V49, P6130, DOI 10.1021/bi100796v; Wang YJ, 2010, SCIENCE, V330, P105, DOI 10.1126/science.1191086; Wang ZM, 2000, BIOPHYS J, V78, P1947, DOI 10.1016/S0006-3495(00)76742-7; Woo JS, 2008, BIOCHEM J, V411, P399, DOI [10.1042/BJ20071504, 10.1042/bj20071504]; Woo JS, 2009, MOL CELL BIOCHEM, V328, P25, DOI 10.1007/s11010-009-0070-0; Xu M, 2007, PLOS BIOL, V5, P203, DOI 10.1371/journal.pbio.0050021; Zanou N, 2010, AM J PHYSIOL-CELL PH, V298, pC149, DOI 10.1152/ajpcell.00241.2009	42	60	62	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2011	286	51					43717	43725		10.1074/jbc.M111.292755	http://dx.doi.org/10.1074/jbc.M111.292755			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866SH	22020936	Green Published, hybrid			2022-12-27	WOS:000298402300015
J	Nacev, BA; Grassi, P; Dell, A; Haslam, SM; Liu, JO				Nacev, Benjamin A.; Grassi, Paola; Dell, Anne; Haslam, Stuart M.; Liu, Jun O.			The Antifungal Drug Itraconazole Inhibits Vascular Endothelial Growth Factor Receptor 2 (VEGFR2) Glycosylation, Trafficking, and Signaling in Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LUNG-CANCER; LANOSTEROL 14-ALPHA-DEMETHYLASE; TUMOR ANGIOGENESIS; MASS-SPECTROMETRY; CANDIDA-ALBICANS; PLC-GAMMA; GOLGI; BEVACIZUMAB; CHOLESTEROL; ACTIVATION	Itraconazole is a safe and widely used antifungal drug that was recently found to possess potent antiangiogenic activity. Currently, there are four active clinical trials evaluating itraconazole as a cancer therapeutic. Tumor growth is dependent on angiogenesis, which is driven by the secretion of growth factors from the tumor itself. We report here that itraconazole significantly inhibited the binding of vascular endothelial growth factor (VEGF) to VEGF receptor 2 (VEGFR2) and that both VEGFR2 and an immediate downstream substrate, phospholipase C gamma 1, failed to become activated after VEGF stimulation. These effects were due to a defect in VEGFR2 trafficking, leading to a decrease in cell surface expression, and were associated with the accumulation of immature N-glycans on VEGFR2. Small molecule inducers of lysosomal cholesterol accumulation and mammalian target of rapamycin (mTOR) inhibition, two previously reported itraconazole activities, failed to recapitulate itraconazole's effects on VEGFR2 glycosylation and signaling. Likewise, glycosylation inhibitors did not alter cholesterol trafficking or inhibit mTOR. Repletion of cellular cholesterol levels, which was known to rescue the effects of itraconazole onmTOR and cholesterol trafficking, was also able to restore VEGFR2 glycosylation and signaling. This suggests that the new effects of itraconazole occur in parallel to those previously reported but are downstream of a common target. We also demonstrated that itraconazole globally reduced poly-N-acetyllactosamine and tetra-antennary complex N-glycans in endothelial cells and induced hypoglycosylation of the epidermal growth factor receptor in a renal cell carcinoma line, suggesting that itraconazole's effects extend beyond VEGFR2.	[Nacev, Benjamin A.; Liu, Jun O.] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Nacev, Benjamin A.] Johns Hopkins Univ, Sch Med, Med Scientist Training Program, Baltimore, MD 21205 USA; [Liu, Jun O.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Grassi, Paola; Dell, Anne; Haslam, Stuart M.] Univ London Imperial Coll Sci Technol & Med, Fac Nat Sci, Div Mol Biosci, London SW7 2AZ, England	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Imperial College London	Liu, JO (corresponding author), 725 N Wolfe St,Hunterian 516, Baltimore, MD 21205 USA.	joliu@jhu.edu		Dell, Anne/0000-0003-1380-2347	National Institutes of Health (NIH) [T32GM07309]; NIH, NCI [CA122814]; National Center for Research Resources (NCRR), NIH [UL1 RR 025005]; Flight Attendant Medical Research Institute; Commonwealth Foundation; Biotechnology and Biological Sciences Research Council [BBF0083091]; Marie Curie Initial Training Network; NATIONAL CANCER INSTITUTE [R01CA122814] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007309] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Research Resources (NCRR), NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Flight Attendant Medical Research Institute; Commonwealth Foundation; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Marie Curie Initial Training Network(European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health (NIH) Medical Scientist Training Program Grant T32GM07309 (to B. A. N.); by NIH, NCI Grant CA122814 (to J. O. L.); National Center for Research Resources (NCRR), NIH, Grant UL1 RR 025005; and the NIH Roadmap for Medical Research. This work was also supported by the Flight Attendant Medical Research Institute and the Commonwealth Foundation (to J. O. L.). Additional support was provided by Biotechnology and Biological Sciences Research Council Grant BBF0083091 and the Marie Curie Initial Training Network, Euro-glycoArrays Project, part of the FP7 People Programme.	Aftab BT, 2011, CANCER RES, V71, P6764, DOI 10.1158/0008-5472.CAN-11-0691; Ball SG, 2007, J CELL BIOL, V177, P489, DOI 10.1083/jcb.200608093; Ceroni A, 2008, J PROTEOME RES, V7, P1650, DOI 10.1021/pr7008252; Chong CR, 2007, ACS CHEM BIOL, V2, P263, DOI 10.1021/cb600362d; Choudhury A, 2002, J CLIN INVEST, V109, P1541, DOI 10.1172/JCI200215420; Christian AE, 1997, J LIPID RES, V38, P2264; Cross MJ, 2001, TRENDS PHARMACOL SCI, V22, P201, DOI 10.1016/S0165-6147(00)01676-X; Cunningham SA, 1997, BIOCHEM BIOPH RES CO, V240, P635, DOI 10.1006/bbrc.1997.7719; DELL A, 1994, METHOD ENZYMOL, V230, P108; Ellis LM, 2006, MOL CANCER THER, V5, P1099, DOI 10.1158/1535-7163.MCT-05-0538; Faivre S, 2007, NAT REV DRUG DISCOV, V6, P734, DOI 10.1038/nrd2380; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Frey T, 2009, J BIOL CHEM, V284, P16882, DOI 10.1074/jbc.M109.007609; Giaccone G, 2005, J CLIN ONCOL, V23, P3235, DOI 10.1200/JCO.2005.08.409; Grunewald FS, 2010, BBA-PROTEINS PROTEOM, V1804, P567, DOI 10.1016/j.bbapap.2009.09.002; Hayes DF, 2011, JAMA-J AM MED ASSOC, V305, P506, DOI 10.1001/jama.2011.57; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Jang-Lee J, 2006, METHOD ENZYMOL, V415, P59, DOI 10.1016/S0076-6879(06)15005-3; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Kim J, 2010, CANCER CELL, V17, P388, DOI 10.1016/j.ccr.2010.02.027; Lamb DC, 1999, YEAST, V15, P755, DOI 10.1002/(SICI)1097-0061(19990630)15:9&lt;755::AID-YEA417&gt;3.0.CO;2-8; Lee PL, 2009, GLYCOBIOLOGY, V19, P655, DOI 10.1093/glycob/cwp035; Lippincott-Schwartz J, 2010, ANNU REV BIOPHYS, V39, P559, DOI 10.1146/annurev.biophys.093008.131357; Nacev BA, 2011, J PHARMACOL EXP THER, V338, P466, DOI 10.1124/jpet.111.180851; Nagy JA, 2007, ANNU REV PATHOL-MECH, V2, P251, DOI 10.1146/annurev.pathol.2.010506.134925; NEUFELD G, 1985, J BIOL CHEM, V260, P3860; Rahimi N, 2006, FRONT BIOSCI-LANDMRK, V11, P818; Ranpura V, 2011, JAMA-J AM MED ASSOC, V305, P487, DOI 10.1001/jama.2011.51; Raymond E, 2011, NEW ENGL J MED, V364, P501, DOI 10.1056/NEJMoa1003825; ROTH J, 1982, J CELL BIOL, V93, P223, DOI 10.1083/jcb.93.1.223; Ruch C, 2007, NAT STRUCT MOL BIOL, V14, P249, DOI 10.1038/nsmb1202; Sandler A, 2006, NEW ENGL J MED, V355, P2542, DOI 10.1056/NEJMoa061884; Schmitz KR, 2008, DEV CELL, V14, P523, DOI 10.1016/j.devcel.2008.02.016; Schweitzer JK, 2009, CURR DRUG TARGETS, V10, P653, DOI 10.2174/138945009788680437; Scott KL, 2009, NATURE, V459, P1085, DOI 10.1038/nature08109; Shi W, 2010, ACS MED CHEM LETT, V1, P155, DOI 10.1021/ml1000068; Sutton-Smith M, 2006, CELL BIOL LAB HDB, P415; SWINNEY DC, 1994, BIOCHEMISTRY-US, V33, P4702, DOI 10.1021/bi00181a030; Takahashi T, 1997, ONCOGENE, V14, P2079, DOI 10.1038/sj.onc.1201047; Takahashi T, 2001, EMBO J, V20, P2768, DOI 10.1093/emboj/20.11.2768; Trosken ER, 2006, TOXICOLOGY, V228, P24, DOI 10.1016/j.tox.2006.08.007; Tu L, 2008, SCIENCE, V321, P404, DOI 10.1126/science.1159411; VAISMAN N, 1990, J BIOL CHEM, V265, P19461; Xu J, 2010, P NATL ACAD SCI USA, V107, P4764, DOI 10.1073/pnas.0910872107; Yu Y, 1999, J CELL PHYSIOL, V178, P235, DOI 10.1002/(SICI)1097-4652(199902)178:2<235::AID-JCP13>3.3.CO;2-J	46	82	92	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2011	286	51					44045	44056		10.1074/jbc.M111.278754	http://dx.doi.org/10.1074/jbc.M111.278754			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866SH	22025615	hybrid, Green Published			2022-12-27	WOS:000298402300045
J	Messaed, C; Akoury, E; Djuric, U; Zeng, JB; Saleh, M; Gilbert, L; Seoud, M; Qureshi, S; Slim, R				Messaed, Christiane; Akoury, Elie; Djuric, Ugljesa; Zeng, Jibin; Saleh, Maya; Gilbert, Lucy; Seoud, Muhieddine; Qureshi, Salman; Slim, Rima			NLRP7, a Nucleotide Oligomerization Domain-like Receptor Protein, Is Required for Normal Cytokine Secretion and Co-localizes with Golgi and the Microtubule-organizing Center	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECURRENT HYDATIDIFORM MOLE; MATERNAL EFFECT GENE; TROPHOBLASTIC NEOPLASIA; REPRODUCTIVE WASTAGE; AUTOINFLAMMATORY DISORDER; MUTATIONS; NALP7; INFLAMMATION; SPECTRUM; PYPAF3	A hydatidiform mole (HM) is a human pregnancy with hyperproliferative placenta and abnormal embryonic development. Mutations in NLRP7, a member of the nucleotide oligomerization domain-like receptor family of proteins with roles in inflammation and apoptosis, are responsible for recurrent HMs. However, little is known about the functional role of NLRP7. Here, we demonstrate that peripheral blood mononuclear cells from patients with NLRP7 mutations and rare variants secrete low levels of IL-1 beta and TNF in response to LPS. We show that the cells from patients, carrying mutations or rare variants, have variable levels of increased intracellular pro-IL-1 beta indicating that normal NLRP7 down-regulates pro-IL-1 beta synthesis in response to LPS. Using transient transfections, we confirm the role of normal NLRP7 in inhibiting pro-IL-1 beta and demonstrate that this inhibitory function is abolished by protein-truncating mutations after the Pyrin domain. Within peripheral blood mononuclear cells, NLRP7 co-localizes with the Golgi and the microtubule-organizing center and is associated with microtubules. This suggests that NLRP7 mutations may affect cytokine secretion by interfering, directly or indirectly, with their trafficking. We propose that the impaired cytokine trafficking and secretion caused by NLRP7 defects makes the patients tolerant to the growth of these earlier arrested conceptions with no fetal vessels and that the retention of these conceptions until the end of the first trimester contribute to the molar phenotype. Our data will impact our understanding of postmolar choriocarcinomas, the only allograft non-self tumors that are able to invade maternal tissues.	[Messaed, Christiane; Akoury, Elie; Djuric, Ugljesa; Zeng, Jibin; Slim, Rima] McGill Univ, Ctr Hlth, Dept Human Genet, Montreal, PQ H3G 1A4, Canada; [Messaed, Christiane; Akoury, Elie; Djuric, Ugljesa; Zeng, Jibin; Gilbert, Lucy; Slim, Rima] McGill Univ, Ctr Hlth, Dept Obstet & Gynecol, Montreal, PQ H3G 1A4, Canada; [Saleh, Maya; Qureshi, Salman] McGill Univ, Ctr Hlth, Dept Med, Montreal, PQ H3G 1A4, Canada; [Saleh, Maya; Qureshi, Salman] McGill Univ, Ctr Hlth, Ctr Study Host Resistance, Montreal, PQ H3G 1A4, Canada; [Seoud, Muhieddine] Amer Univ Beirut, Dept Obstet & Gynecol, Beirut, Lebanon	McGill University; McGill University; McGill University; McGill University; American University of Beirut	Slim, R (corresponding author), Montreal Gen Hosp, Res Inst, L3-121,1650 Cedar Ave, Montreal, PQ H3G 1A4, Canada.	rima.slim@muhc.mcgill.ca	Slim, Rima/J-4104-2019; Gilbert, Lucy/M-6879-2019	Slim, Rima/0000-0002-4060-2159; Gilbert, Lucy/0000-0001-8605-5472; Djuric, Ugljesa/0000-0003-0027-3079; Saleh, Maya/0000-0003-1538-9146	Canadian Institutes of Health Research [MOP 86546, MOP 102469]; Centre for the Study of Reproduction; Hugh & Helen McPherson Memorial Award	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Centre for the Study of Reproduction; Hugh & Helen McPherson Memorial Award	This work was supported by Canadian Institutes of Health Research Grants MOP 86546 and MOP 102469.; Supported in part by a trainee award from the Centre for the Study of Reproduction.; Supported by a Hugh & Helen McPherson Memorial Award. To whom correspondence should be addressed: Montreal General Hospital Research Institute, L3-121, 1650 Cedar Ave., Montreal, Quebec H3G 1A4, Canada. Tel.: 514-934-1934(ext. 44550); Fax: 514-934-8261; E-mail: rima. slim@muhc.mcgill.ca.	Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Altieri A, 2003, LANCET ONCOL, V4, P670, DOI 10.1016/S1470-2045(03)01245-2; Carta S, 2006, BLOOD, V108, P1618, DOI 10.1182/blood-2006-03-014126; Deveault C, 2009, HUM MOL GENET, V18, P888, DOI 10.1093/hmg/ddn418; EDWARDS R, 1990, LANCET, V335, P1030, DOI 10.1016/0140-6736(90)91089-S; Hayward BE, 2009, HUM MUTAT, V30, pE629, DOI 10.1002/humu.20993; Helwani MN, 1999, HUM GENET, V105, P112, DOI 10.1007/s004390051071; HO PC, 1980, J REPROD IMMUNOL, V1, P307, DOI 10.1016/0165-0378(80)90004-2; Hoffman HM, 2001, NAT GENET, V29, P301, DOI 10.1038/ng756; Jeru I, 2010, ARTHRITIS RHEUM-US, V62, P1176, DOI 10.1002/art.27326; Kastner DL, 2010, CELL, V140, P784, DOI 10.1016/j.cell.2010.03.002; KHANNA A, 1985, J SURG ONCOL, V28, P4, DOI 10.1002/jso.2930280103; Kinoshita T, 2005, J BIOL CHEM, V280, P21720, DOI 10.1074/jbc.M410057200; Kou YC, 2008, MOL HUM REPROD, V14, P33, DOI 10.1093/molehr/gam079; Loock J, 2010, J ALLERGY CLIN IMMUN, V125, P500, DOI 10.1016/j.jaci.2009.10.066; Messaed C, 2011, J MED GENET, V48, P540, DOI 10.1136/jmg.2011.089144; Milhavet F, 2008, HUM MUTAT, V29, P803, DOI 10.1002/humu.20720; Muhlstein J, 2011, EUR J OBSTET GYN R B, V157, P197, DOI 10.1016/j.ejogrb.2011.02.019; Murdoch S, 2006, NAT GENET, V38, P300, DOI 10.1038/ng1740; Ohno S, 2008, ANTICANCER RES, V28, P2493; Okada K, 2004, CANCER SCI, V95, P949, DOI 10.1111/j.1349-7006.2004.tb03182.x; Puechberty J, 2009, CLIN GENET, V75, P298, DOI 10.1111/j.1399-0004.2008.01098.x; Qian JH, 2007, HUM MUTAT, V28, DOI 10.1002/humu.9498; Seckl MJ, 2010, LANCET, V376, P717, DOI 10.1016/S0140-6736(10)60280-2; Slim R, 2011, PLACENTA, V32, P409, DOI 10.1016/j.placenta.2011.02.001; TOMODA Y, 1976, AM J OBSTET GYNECOL, V126, P661, DOI 10.1016/0002-9378(76)90515-9; Tong ZB, 2000, NAT GENET, V26, P267, DOI 10.1038/81547; Tschopp J, 2003, NAT REV MOL CELL BIO, V4, P95, DOI 10.1038/nrm1019; Wang CM, 2009, J MED GENET, V46, P569, DOI 10.1136/jmg.2008.064196; Zheng P, 2009, P NATL ACAD SCI USA, V106, P7473, DOI 10.1073/pnas.0900519106	30	49	51	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					43313	43323		10.1074/jbc.M111.306191	http://dx.doi.org/10.1074/jbc.M111.306191			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22025618	hybrid, Green Published			2022-12-27	WOS:000298351300051
J	Anderson, K; Nordquist, KA; Gao, XL; Hicks, KC; Zhai, B; Gygi, SP; Patel, TB				Anderson, Kimberly; Nordquist, Kyle A.; Gao, Xianlong; Hicks, Kristin C.; Zhai, Bo; Gygi, Steven P.; Patel, Tarun B.			Regulation of Cellular Levels of Sprouty2 Protein by Prolyl Hydroxylase Domain and von Hippel-Lindau Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR PROTEIN; HYPOXIA-INDUCIBLE FACTOR; TYROSINE PHOSPHORYLATION; PROSTATE-CANCER; DOWN-REGULATION; GENE-PRODUCT; C-TERMINUS; GROWTH; ACTIVATION; PATHWAY	Sprouty (Spry) proteins modulate the actions of receptor tyrosine kinases during development and tumorigenesis. Decreases in cellular levels of Spry, especially Sprouty2 (Spry2), have been implicated in the growth and progression of tumors of the breast, prostate, lung, and liver. During development and tumor growth, cells experience hypoxia. Therefore, we investigated how hypoxia modulates the levels of Spry proteins. Hypoxia elevated the levels of all four expressed Spry isoforms in HeLa cells. Amounts of endogenous Spry2 in LS147T and HEP3B cells were also elevated by hypoxia. Using Spry2 as a prototype, we demonstrate that silencing and expression of prolyl hydroxylase domain proteins (PHD1-3) increase and decrease, respectively, the cellular content of Spry2. Spry2 also preferentially interacted with PHD1-3 and von Hippel-Lindau protein (pVHL) during normoxia but not in hypoxia. Additionally, Spry2 is hydroxylated on Pro residues 18, 144, and 160, and substitution of these residues with Ala enhanced stability of Spry2 and abrogated its interactions with pVHL. Silencing of pVHL increased levels of Spry2 by decreasing its ubiquitylation and degradation and thereby augmented the ability of Spry2 to inhibit FGF-elicited activation of ERK1/2. Thus, prolyl hydroxylase mediated hydroxylation and subsequent pVHL-elicited ubiquitylation of Spry2 target it for degradation and, consequently, provide a novel mechanism of regulating growth factor signaling.	[Anderson, Kimberly; Nordquist, Kyle A.; Gao, Xianlong; Hicks, Kristin C.; Patel, Tarun B.] Loyola Univ Chicago, Stritch Sch Med, Dept Mol Pharmacol & Therapeut, Maywood, IL 60153 USA; [Nordquist, Kyle A.; Gao, Xianlong; Patel, Tarun B.] Loyola Univ Chicago, Stritch Sch Med, Inst Signal Transduct, Maywood, IL 60153 USA; [Zhai, Bo; Gygi, Steven P.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Loyola University Chicago; Loyola University Chicago; Harvard University; Harvard Medical School	Patel, TB (corresponding author), Loyola Univ Chicago, Stritch Sch Med, Dept Mol Pharmacol & Therapeut, 2160 S 1st Ave, Maywood, IL 60153 USA.	tpatel7@lumc.edu		Hicks, Kristin/0000-0001-9192-875X	National Institutes of Health [073181, HG3456]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003456] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported, in whole or in part, by National Institutes of Health Grants 073181 (to T. B. P.) and HG3456 (to S. P. G.).	Akbulut S, 2010, MOL BIOL CELL, V21, P3487, DOI 10.1091/mbc.E10-02-0123; Appelhoff RJ, 2004, J BIOL CHEM, V279, P38458, DOI 10.1074/jbc.M406026200; Ayada T, 2009, ONCOGENE, V28, P1076, DOI 10.1038/onc.2008.464; Brady SC, 2009, CANCER RES, V69, P6773, DOI 10.1158/0008-5472.CAN-08-4447; Cabrita MA, 2008, ANGIOGENESIS, V11, P53, DOI 10.1007/s10456-008-9089-1; de Maximy AA, 1999, MECH DEVELOP, V81, P213, DOI 10.1016/S0925-4773(98)00241-X; Edwin F, 2006, J BIOL CHEM, V281, P4816, DOI 10.1074/jbc.M508300200; Edwin F, 2008, J BIOL CHEM, V283, P3181, DOI 10.1074/jbc.M706567200; Edwin F, 2010, J BIOL CHEM, V285, P255, DOI 10.1074/jbc.M109.030882; Egan JE, 2002, P NATL ACAD SCI USA, V99, P6041, DOI 10.1073/pnas.052090899; Feng YH, 2011, CANCER BIOL THER, V11, P111, DOI 10.4161/cbt.11.1.13965; Fong CW, 2006, CANCER RES, V66, P2048, DOI 10.1158/0008-5472.CAN-05-1072; Fong CW, 2003, J BIOL CHEM, V278, P33456, DOI 10.1074/jbc.M301317200; Frank MJ, 2009, BLOOD, V113, P2478, DOI 10.1182/blood-2008-05-156943; GLENN GM, 1991, HUM GENET, V87, P207, DOI 10.1007/BF00204184; Gross I, 2001, J BIOL CHEM, V276, P46460, DOI 10.1074/jbc.M108234200; Hacohen N, 1998, CELL, V92, P253, DOI 10.1016/S0092-8674(00)80919-8; Haglund K, 2005, EMBO REP, V6, P635, DOI 10.1038/sj.embor.7400453; Haigl B, 2010, BIOL CHEM, V391, P813, DOI 10.1515/BC.2010.082; Hall AB, 2003, CURR BIOL, V13, P308, DOI 10.1016/S0960-9822(03)00086-1; Hanafusa H, 2002, NAT CELL BIOL, V4, P850, DOI 10.1038/ncb867; Hon WC, 2002, NATURE, V417, P975, DOI 10.1038/nature00767; Horowitz A, 2008, CIRC RES, V103, P784, DOI 10.1161/CIRCRESAHA.108.181818; ILIOPOULOS O, 1995, NAT MED, V1, P822, DOI 10.1038/nm0895-822; Impagnatiello MA, 2001, J CELL BIOL, V152, P1087, DOI 10.1083/jcb.152.5.1087; Iwai K, 1999, P NATL ACAD SCI USA, V96, P12436, DOI 10.1073/pnas.96.22.12436; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kwabi-Addo B, 2004, CANCER RES, V64, P4728, DOI 10.1158/0008-5472.CAN-03-3759; Lao DH, 2006, J BIOL CHEM, V281, P29993, DOI 10.1074/jbc.M604044200; Lee SH, 2001, J BIOL CHEM, V276, P4128, DOI 10.1074/jbc.M006922200; Lee SA, 2008, HEPATOLOGY, V47, P1200, DOI 10.1002/hep.22169; Lee SA, 2010, HEPATOLOGY, V52, P506, DOI 10.1002/hep.23681; Li DX, 2004, J BIOL CHEM, V279, P55051, DOI 10.1074/jbc.M410287200; Lin F, 2008, AM J CLIN PATHOL, V129, P592, DOI 10.1309/Q0FLUXFJ4FTTW1XR; Lo TL, 2004, CANCER RES, V64, P6127, DOI 10.1158/0008-5472.CAN-04-1207; Mason JM, 2004, MOL BIOL CELL, V15, P2176, DOI 10.1091/mbc.E03-07-0503; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; McKie AB, 2005, ONCOGENE, V24, P2166, DOI 10.1038/sj.onc.1208371; Minowada G, 1999, DEVELOPMENT, V126, P4465; Minowada G, 2009, AM J RESP CELL MOL, V40, P31, DOI 10.1165/rcmb.2008-0147OC; Nadeau RJ, 2007, J CELL BIOCHEM, V100, P151, DOI 10.1002/jcb.21040; Paltoglou S, 2007, ONCOGENE, V26, P604, DOI 10.1038/sj.onc.1209818; Poppleton HM, 2004, BIOCHEM BIOPH RES CO, V323, P98, DOI 10.1016/j.bbrc.2004.08.070; Qi JF, 2008, P NATL ACAD SCI USA, V105, P16713, DOI 10.1073/pnas.0804063105; Reich A, 1999, DEVELOPMENT, V126, P4139; Rubin C, 2003, CURR BIOL, V13, P297, DOI 10.1016/S0960-9822(03)00053-8; Sasaki A, 2003, NAT CELL BIOL, V5, P427, DOI 10.1038/ncb978; Sayed D, 2008, MOL BIOL CELL, V19, P3272, DOI 10.1091/mbc.E08-02-0159; Siddiq A, 2007, NEUROCHEM RES, V32, P931, DOI 10.1007/s11064-006-9268-7; Stiehl DP, 2006, J BIOL CHEM, V281, P23482, DOI 10.1074/jbc.M601719200; Sutterluty H, 2007, MOL CANCER RES, V5, P509, DOI 10.1158/1541-7786.MCR-06-0273; Tanimoto K, 2000, EMBO J, V19, P4298, DOI 10.1093/emboj/19.16.4298; Warburton David, 2008, Proc Am Thorac Soc, V5, P703, DOI 10.1513/pats.200801-012AW; Webb JD, 2009, CELL MOL LIFE SCI, V66, P3539, DOI 10.1007/s00018-009-0147-7; Wong ESM, 2002, EMBO J, V21, P4796, DOI 10.1093/emboj/cdf493; Wong ESM, 2001, J BIOL CHEM, V276, P5866, DOI 10.1074/jbc.M006945200; Xie L, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000444; Yigzaw Y, 2001, J BIOL CHEM, V276, P22742, DOI 10.1074/jbc.M100123200; Zhang CX, 2005, ARTERIOSCL THROM VAS, V25, P533, DOI 10.1161/01.ATV.0000155461.50450.5a	59	44	44	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42027	42036		10.1074/jbc.M111.303222	http://dx.doi.org/10.1074/jbc.M111.303222			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	22006925	Green Published, hybrid			2022-12-27	WOS:000298180900013
J	Chung, SM; Miller, JT; Johnson, BC; Hughes, SH; Le Grice, SFJ				Chung, Suhman; Miller, Jennifer T.; Johnson, Barry C.; Hughes, Stephen H.; Le Grice, Stuart F. J.			Mutagenesis of Human Immunodeficiency Virus Reverse Transcriptase p51 Subunit Defines Residues Contributing to Vinylogous Urea Inhibition of Ribonuclease H Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIV RNASE-H; WILD-TYPE; POSITIONAL ADAPTABILITY; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; DRUG-RESISTANCE; DNA-POLYMERASE; NUCLEIC-ACID; TYPE-1; DESIGN	The vinylogous urea, NSC727447, was proposed to allosterically inhibit ribonucleaseH(RNase H) activity of human immunodeficiency virus type 1 reverse transcriptase (HIV-1 RT) by interacting with the thumb subdomain of its non-catalytic p51 subunit. Proximity of the p51 thumb to the p66 RNase H domain implied that inhibitor binding altered active site geometry, whereas protein footprinting suggested a contribution from alpha-helix I residues Cys-280 and Lys-281. To more thoroughly characterize the vinylogous urea binding site, horizontal alanine scanning mutagenesis between p51 residues Lys-275 and Thr-286 (comprising alpha-helix I and portions of the neighboring alpha H/alpha I and alpha I/alpha J connecting loops) was combined with a limited vertical scan of Cys-280. A contribution from Cys-280 was strengthened by our observation that all substitutions at this position rendered selectively mutated, reconstituted p66/p51 heterodimers similar to 45-fold less sensitive to inhibition. An similar to 19-fold reduced IC50 for p51 mutant T286A coupled with a 2-8-fold increased IC50 when intervening residues were substituted supports our original proposal of p51 alpha-helix I as the vinylogous urea binding site. In contrast to these allosteric inhibitors, mutant enzymes retained equivalent sensitivity to the natural product alpha-hydroxytropolone inhibitor manicol, which x-ray crystallography has demonstrated functions by chelating divalent metal at the p66 RNase H active site. Finally, reduced DNA strand-transfer activity together with increased vinylogous urea sensitivity of p66/p51 heterodimers containing short p51 C-terminal deletions suggests an additional role for the p51 C terminus in nucleic acid binding that is compromised by inhibitor binding.	[Chung, Suhman; Miller, Jennifer T.; Johnson, Barry C.; Hughes, Stephen H.; Le Grice, Stuart F. J.] NCI, HIV Drug Resistance Program, NIH, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Le Grice, SFJ (corresponding author), Bldg 535,Rm 312,1050 Boyles St, Frederick, MD 21702 USA.	legrices@mail.nih.gov		Johnson, Barry/0000-0001-9482-2248	National Institutes of Health, NCI, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC010481, ZIABC010494] Funding Source: NIH RePORTER	National Institutes of Health, NCI, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program, NCI, Center for Cancer Research.	Abbondanzieri EA, 2008, NATURE, V453, P184, DOI 10.1038/nature06941; Beilhartz GL, 2009, J MOL BIOL, V388, P462, DOI 10.1016/j.jmb.2009.03.025; Budihas SR, 2005, NUCLEIC ACIDS RES, V33, P1249, DOI 10.1093/nar/gki268; Cameron CE, 1997, P NATL ACAD SCI USA, V94, P6700, DOI 10.1073/pnas.94.13.6700; Chung SM, 2011, J MED CHEM, V54, P4462, DOI 10.1021/jm2000757; Chung SM, 2010, ANTIMICROB AGENTS CH, V54, P3913, DOI 10.1128/AAC.00434-10; Cullen MD, 2009, J MED CHEM, V52, P6467, DOI 10.1021/jm901167t; Das K, 2005, PROG BIOPHYS MOL BIO, V88, P209, DOI 10.1016/j.pbiomolbio.2004.07.001; Das K, 1996, J MOL BIOL, V264, P1085, DOI 10.1006/jmbi.1996.0698; Das K, 2004, J MED CHEM, V47, P2550, DOI 10.1021/jm030558s; Das K, 2008, P NATL ACAD SCI USA, V105, P1466, DOI 10.1073/pnas.0711209105; Ghosh M, 1997, BIOCHEMISTRY-US, V36, P5758, DOI 10.1021/bi963045e; GOPALAKRISHNAN V, 1992, P NATL ACAD SCI USA, V89, P10763, DOI 10.1073/pnas.89.22.10763; HERMANN T, 1994, NUCLEIC ACIDS RES, V22, P4625, DOI 10.1093/nar/22.22.4625; Hermann T, 1996, EUR J BIOCHEM, V242, P98, DOI 10.1111/j.1432-1033.1996.0098r.x; Himmel DM, 2006, ACS CHEM BIOL, V1, P702, DOI 10.1021/cb600303y; Himmel DM, 2009, STRUCTURE, V17, P1625, DOI 10.1016/j.str.2009.09.016; Hsiou Y, 1998, J MOL BIOL, V284, P313, DOI 10.1006/jmbi.1998.2171; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; JACOBOMOLINA A, 1993, P NATL ACAD SCI USA, V90, P6320, DOI 10.1073/pnas.90.13.6320; JACQUES PS, 1994, J BIOL CHEM, V269, P1388; Janssen PAJ, 2005, J MED CHEM, V48, P1901, DOI 10.1021/jm040840e; Jochmans D, 2006, J VIROL, V80, P12283, DOI 10.1128/JVI.00889-06; Kirschberg TA, 2009, J MED CHEM, V52, P5781, DOI 10.1021/jm900597q; Klumpp K, 2003, NUCLEIC ACIDS RES, V31, P6852, DOI 10.1093/nar/gkg881; Klumpp K, 2006, CURR PHARM DESIGN, V12, P1909, DOI 10.2174/138161206776873653; Lansdon EB, 2011, ANTIMICROB AGENTS CH, V55, P2905, DOI 10.1128/AAC.01594-10; LEGRICE SFJ, 1991, EMBO J, V10, P3905, DOI 10.1002/j.1460-2075.1991.tb04960.x; LEGRICE SFJ, 1990, EUR J BIOCHEM, V187, P307, DOI 10.1111/j.1432-1033.1990.tb15306.x; Ohishi M, 2007, VIROLOGY, V362, P131, DOI 10.1016/j.virol.2006.12.030; PELISKA JA, 1992, SCIENCE, V258, P1112, DOI 10.1126/science.1279806; Rausch JW, 2000, J BIOL CHEM, V275, P16015, DOI 10.1074/jbc.M909808199; Rausch JW, 2002, BIOCHEMISTRY-US, V41, P4856, DOI 10.1021/bi015970t; Sahlberg Christer, 2008, Anti-Infective Agents in Medicinal Chemistry, V7, P101, DOI 10.2174/187152108783954597; Sarafianos SG, 2001, EMBO J, V20, P1449, DOI 10.1093/emboj/20.6.1449; Sevilya Z, 2003, J MOL BIOL, V327, P19, DOI 10.1016/S0022-2836(03)00052-4; Shaw-Reid CA, 2005, BIOCHEMISTRY-US, V44, P1595, DOI 10.1021/bi0486740; Shaw-Reid CA, 2003, J BIOL CHEM, V278, P2777, DOI 10.1074/jbc.C200621200; Sluis-Cremer N, 2000, BIOCHEMISTRY-US, V39, P1427, DOI 10.1021/bi991682+; Sluis-Cremer N, 2006, J MED CHEM, V49, P4834, DOI 10.1021/jm0604575; Srivastava S, 2006, CURR PHARM DESIGN, V12, P1879, DOI 10.2174/138161206776873590; Su HP, 2010, J VIROL, V84, P7625, DOI 10.1128/JVI.00353-10; WANG J, 1994, P NATL ACAD SCI USA, V91, P7242, DOI 10.1073/pnas.91.15.7242; Wendeler M, 2008, ACS CHEM BIOL, V3, P635, DOI 10.1021/cb8001039	44	18	18	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					4066	4075		10.1074/jbc.M111.314781	http://dx.doi.org/10.1074/jbc.M111.314781			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22105069	hybrid, Green Published			2022-12-27	WOS:000300410900040
J	Gu, YZ; Barry, J; McDougel, R; Terman, D; Gu, C				Gu, Yuanzheng; Barry, Joshua; McDougel, Robert; Terman, David; Gu, Chen			Alternative Splicing Regulates Kv3.1 Polarized Targeting to Adjust Maximal Spiking Frequency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AXON INITIAL SEGMENT; GATED POTASSIUM CHANNELS; K+ CHANNELS; A-TYPE; AUDITORY NEURONS; RAT-BRAIN; GABAERGIC INTERNEURONS; DEVELOPMENTAL-CHANGES; HIPPOCAMPAL-NEURONS; DISTINCT ROLES	Synaptic inputs received at dendrites are converted into digital outputs encoded by action potentials generated at the axon initial segment in most neurons. Here, we report that alternative splicing regulates polarized targeting of Kv3.1 voltage-gated potassium (Kv) channels to adjust the input-output relationship. The spiking frequency of cultured hippocampal neurons correlated with the level of endogenous Kv3 channels. Expression of axonal Kv3.1b, the longer form of Kv3.1 splice variants, effectively converted slow-spiking young neurons to fast-spiking ones; this was not the case for Kv1.2 or Kv4.2 channel constructs. Despite having identical biophysical properties as Kv3.1b, dendritic Kv3.1a was significantly less effective at increasing the maximal firing frequency. This suggests a possible role of channel targeting in regulating spiking frequency. Mutagenesis studies suggest the electrostatic repulsion between the Kv3.1b N/C termini, created by its C-terminal splice domain, unmasks the Kv3.1b axonal targeting motif. Kv3.1b axonal targeting increased the maximal spiking frequency in response to prolonged depolarization. This finding was further supported by the results of local application of channel blockers and computer simulations. Taken together, our studies have demonstrated that alternative splicing controls neuronal firing rates by regulating the polarized targeting of Kv3.1 channels.	[Gu, Yuanzheng; Gu, Chen] Ohio State Univ, Dept Neurosci, Columbus, OH 43210 USA; [Gu, Yuanzheng; Gu, Chen] Ohio State Univ, Ctr Mol Neurobiol, Columbus, OH 43210 USA; [Barry, Joshua; Gu, Chen] Ohio State Univ, Mol Cellular & Dev Biol Grad Program, Columbus, OH 43210 USA; [McDougel, Robert; Terman, David] Ohio State Univ, Dept Math, Columbus, OH 43210 USA	Ohio State University; Ohio State University; Ohio State University; Ohio State University	Gu, C (corresponding author), 182 Rightmire Hall,1060 Carmack Rd, Columbus, OH 43210 USA.	gu.49@osu.edu	Gu, Chen/E-3163-2011		National Institutes of Health [R01NS062720]; NINDS; National Science Foundation [DMS-1022627]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062720] Funding Source: NIH RePORTER; Direct For Mathematical & Physical Scien [1022627] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01NS062720 from the NINDS (to C. G.) and National Science Foundation Grant DMS-1022627 (to D. T.). All animal experiments have been conducted in accordance with the National Institutes of Health Animal Use Guidelines.	Atzori M, 2000, NAT NEUROSCI, V3, P791, DOI 10.1038/77693; BACCAGLINI PI, 1977, J PHYSIOL-LONDON, V271, P93, DOI 10.1113/jphysiol.1977.sp011992; Bartos M, 2007, NAT REV NEUROSCI, V8, P45, DOI 10.1038/nrn2044; Bean BP, 2007, NAT REV NEUROSCI, V8, P451, DOI 10.1038/nrn2148; Bender KJ, 2009, NEURON, V61, P259, DOI 10.1016/j.neuron.2008.12.004; Brooke RE, 2004, NEUROSCIENCE, V126, P1001, DOI 10.1016/j.neuroscience.2004.03.051; Chang SY, 2007, J COMP NEUROL, V502, P953, DOI 10.1002/cne.21353; Chow A, 1999, J NEUROSCI, V19, P9332; Coetzee WA, 1999, ANN NY ACAD SCI, V868, P233, DOI 10.1111/j.1749-6632.1999.tb11293.x; Cooper EC, 1998, J NEUROSCI, V18, P965; CRAIG AM, 1994, ANNU REV NEUROSCI, V17, P267, DOI 10.1146/annurev.ne.17.030194.001411; Du J, 1998, NEUROSCIENCE, V84, P37, DOI 10.1016/S0306-4522(97)00519-8; Gittis AH, 2010, J NEUROSCI, V30, P2223, DOI 10.1523/JNEUROSCI.4870-09.2010; Goldberg EM, 2005, J NEUROSCI, V25, P5230, DOI 10.1523/JNEUROSCI.0722-05.2005; Goldberg EM, 2008, NEURON, V58, P387, DOI 10.1016/j.neuron.2008.03.003; Golomb D, 2007, PLOS COMPUT BIOL, V3, P1498, DOI 10.1371/journal.pcbi.0030156; Grubb MS, 2010, NATURE, V465, P1070, DOI 10.1038/nature09160; Gu C, 2003, SCIENCE, V301, P646, DOI 10.1126/science.1086998; Gu C, 2006, NEURON, V52, P803, DOI 10.1016/j.neuron.2006.10.022; Gu C, 2011, PROG NEUROBIOL, V94, P115, DOI 10.1016/j.pneurobio.2011.04.009; Guan DX, 2011, J NEUROPHYSIOL, V105, P2976, DOI 10.1152/jn.00758.2010; Gurantz D, 1996, J NEUROSCI, V16, P3287; HARRIS GL, 1988, NEURON, V1, P739, DOI 10.1016/0896-6273(88)90172-9; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; Horton AC, 2003, NEURON, V40, P277, DOI 10.1016/S0896-6273(03)00629-9; Hu WQ, 2009, NAT NEUROSCI, V12, P996, DOI 10.1038/nn.2359; HWANG PM, 1993, NEUROSCIENCE, V55, P613, DOI 10.1016/0306-4522(93)90427-H; Ishikawa T, 2003, J NEUROSCI, V23, P10445; Itri JN, 2005, NAT NEUROSCI, V8, P650, DOI 10.1038/nn1448; Johnston J, 2010, J PHYSIOL-LONDON, V588, P3187, DOI 10.1113/jphysiol.2010.191973; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kole MHP, 2007, NEURON, V55, P633, DOI 10.1016/j.neuron.2007.07.031; Kuba H, 2010, NATURE, V465, P1075, DOI 10.1038/nature09087; Lewis DA, 2005, NAT REV NEUROSCI, V6, P312, DOI 10.1038/nrn1648; Lim ST, 2000, NEURON, V25, P385, DOI 10.1016/S0896-6273(00)80902-2; Lorincz A, 2008, J NEUROSCI, V28, P14329, DOI 10.1523/JNEUROSCI.4833-08.2008; Ma DH, 2011, CELL, V145, P1102, DOI 10.1016/j.cell.2011.06.007; Martina M, 2003, J NEUROSCI, V23, P5698; Monaghan MM, 2001, J NEUROSCI, V21, P5973, DOI 10.1523/JNEUROSCI.21-16-05973.2001; Nakamura Y, 2007, J PHYSIOL-LONDON, V581, P1101, DOI 10.1113/jphysiol.2007.128702; Ozaita A, 2002, J NEUROPHYSIOL, V88, P394, DOI 10.1152/jn.2002.88.1.394; Parameshwaran S, 2001, J NEUROSCI, V21, P485, DOI 10.1523/JNEUROSCI.21-02-00485.2001; PERNEY TM, 1992, J NEUROPHYSIOL, V68, P756, DOI 10.1152/jn.1992.68.3.756; Pongs O, 2010, PHYSIOL REV, V90, P755, DOI 10.1152/physrev.00020.2009; Rasband M, 1998, J NEUROSCI, V18, P36; Rivera JF, 2003, NAT NEUROSCI, V6, P243, DOI 10.1038/nn1020; Rudy B, 2001, TRENDS NEUROSCI, V24, P517, DOI 10.1016/S0166-2236(00)01892-0; Scannevin RH, 2004, NEURON, V41, P587, DOI 10.1016/S0896-6273(04)00049-2; SHENG M, 1992, NEURON, V9, P271, DOI 10.1016/0896-6273(92)90166-B; Song AH, 2009, CELL, V136, P1148, DOI 10.1016/j.cell.2009.01.016; Song P, 2005, NAT NEUROSCI, V8, P1335, DOI 10.1038/nn1533; Tombola F, 2006, ANNU REV CELL DEV BI, V22, P23, DOI 10.1146/annurev.cellbio.21.020404.145837; Trimmer JS, 2004, ANNU REV PHYSIOL, V66, P477, DOI 10.1146/annurev.physiol.66.032102.113328; TRIMMER JS, 1991, P NATL ACAD SCI USA, V88, P10764, DOI 10.1073/pnas.88.23.10764; Varga AW, 2004, J NEUROSCI, V24, P3643, DOI 10.1523/JNEUROSCI.0154-04.2004; VEH RW, 1995, EUR J NEUROSCI, V7, P2189, DOI 10.1111/j.1460-9568.1995.tb00641.x; von Hehn CAA, 2004, J NEUROSCI, V24, P1936, DOI 10.1523/JNEUROSCI.4554-03.2004; WANG H, 1993, NATURE, V365, P75, DOI 10.1038/365075a0; Winckler B, 1999, NATURE, V397, P698, DOI 10.1038/17789; Xu MX, 2007, J NEUROSCI, V27, P14158, DOI 10.1523/JNEUROSCI.3675-07.2007; Xu MX, 2010, J NEUROSCI, V30, P15987, DOI 10.1523/JNEUROSCI.3565-10.2010; Yang B, 2007, J NEUROSCI, V27, P2617, DOI 10.1523/JNEUROSCI.5308-06.2007	62	32	32	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2012	287	3					1755	1769		10.1074/jbc.M111.299305	http://dx.doi.org/10.1074/jbc.M111.299305			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879HT	22105078	Green Published, hybrid			2022-12-27	WOS:000299321000018
J	Knorzer, P; Silakov, A; Foster, CE; Armstrong, FA; Lubitz, W; Happe, T				Knoerzer, Philipp; Silakov, Alexey; Foster, Carina E.; Armstrong, Fraser A.; Lubitz, Wolfgang; Happe, Thomas			Importance of the Protein Framework for Catalytic Activity of [FeFe]-Hydrogenases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FE-ONLY HYDROGENASE; DENSITY-FUNCTIONAL CALCULATIONS; ALGA CHLAMYDOMONAS-REINHARDTII; AMINO-ACID-SEQUENCE; H-CLUSTER; DESULFOVIBRIO-DESULFURICANS; CLOSTRIDIUM-ACETOBUTYLICUM; ELECTRONIC-STRUCTURE; LIGHT SENSITIVITY; EVOLUTIONARY CONSERVATION	The active center (H-cluster) of [FeFe]-hydrogenases is embedded into a hydrophobic pocket within the protein. We analyzed several amino acids, located in the vicinity of this niche, by site-directed mutagenesis of the [FeFe]-hydrogenases from Clostridium pasteurianum (CpI) and Chlamydomonas reinhardtii (CrHydA1). These amino acids are highly conserved and predicted to be involved in H-cluster coordination. Characterization of two hydrogenase variants confirmed this hypothesis. The exchange of residues CrHydA1Met(415) and CrHydA1Lys(228) resulted in inactive proteins, which, according to EPR and FTIR analyses, contain no intact H-cluster. However, [FeFe]-hydrogenases in which CpIMet(353) (CrHydA1Met(223)) and CpICys(299) (CrHydA1Cys(169)) were exchanged to leucine and serine, respectively, showed a structurally intact H-cluster with catalytic activity either absent (CpIC299S) or strongly diminished (CpIM353L). In the case of CrHydA1C169S, the H-cluster was trapped in an inactive state exhibiting g values and vibrational frequencies that resembled the H-trans state of DdH from Desulfovibrio desulfuricans. This cysteine residue, interacting with the bridge head nitrogen of the di(methyl) amine ligand, seems therefore to represent an essential contribution of the immediate protein environment to the reaction mechanism. Exchanging methionine CpIM353 (CrHydA1M(223)) to leucine led to a strong decrease in turnover without affecting the K-m value of the electron donor. We suggest that this methionine constitutes a "fine-tuning" element of hydrogenase activity.	[Knoerzer, Philipp; Happe, Thomas] Ruhr Univ Bochum, Lehrstuhl Biochem Pflanzen, AG Photobiotechnol, D-44780 Bochum, Germany; [Silakov, Alexey; Lubitz, Wolfgang] Max Planck Inst Bioanorgan Chem, D-45470 Mulheim, Germany; [Foster, Carina E.; Armstrong, Fraser A.] Univ Oxford, Inorgan Chem Lab, Oxford OX1 3QR, England	Ruhr University Bochum; Max Planck Society; University of Oxford	Happe, T (corresponding author), Ruhr Univ Bochum, Lehrstuhl Biochem Pflanzen, AG Photobiotechnol, Univ Str 150, D-44780 Bochum, Germany.	thomas.happe@rub.de	Silakov, Alexey/D-6318-2018	Silakov, Alexey/0000-0002-9285-1253; Happe, Thomas/0000-0003-1206-5234	EU; Bundesministerium fur Bildung und Forschung (BMBF) [Bio-H2]; Volkswagen (VW) foundation [LigH2t]	EU(European Commission); Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); Volkswagen (VW) foundation(Volkswagen)	Supported by the EU-SOLAR-H2 program, the Bundesministerium fur Bildung und Forschung (BMBF) (Bio-H2), and the Volkswagen (VW) foundation (LigH2t). To whom correspondence should be addressed: Ruhr Universitat Bochum, Lehrstuhl fur Biochemie der Pflanzen, AG Photobiotechnologie, Univesitatsstrasse 150, 44780 Bochum, Germany. Tel.: 49-234-32-27026; Fax: 49-234-32-14322; E-mail: thomas.happe@rub.de.	ADAMS MWW, 1984, J BIOL CHEM, V259, P7045; Albracht SPJ, 2006, J BIOL INORG CHEM, V11, P88, DOI 10.1007/s00775-005-0039-8; Apfel UP, 2009, J INORG BIOCHEM, V103, P1236, DOI 10.1016/j.jinorgbio.2009.07.005; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Barton BE, 2010, CURR OPIN BIOTECH, V21, P292, DOI 10.1016/j.copbio.2010.03.003; Barton BE, 2008, J AM CHEM SOC, V130, P16834, DOI 10.1021/ja8057666; Bennett B, 2000, BIOCHEMISTRY-US, V39, P7455, DOI 10.1021/bi992583z; BERNSTEIN HD, 1989, NATURE, V340, P482, DOI 10.1038/340482a0; Bingham S. A., 2011, INT J HYDRO IN PRESS; BOONE DR, 1989, APPL ENVIRON MICROB, V55, P1735, DOI 10.1128/AEM.55.7.1735-1741.1989; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bruschi M, 2002, INORG CHEM, V41, P1421, DOI 10.1021/ic010770r; Bruschi M, 2003, INORG CHEM, V42, P4773, DOI 10.1021/ic0262132; Bruschi M, 2009, ANGEW CHEM INT EDIT, V48, P3503, DOI 10.1002/anie.200900494; BURLEY SK, 1988, ADV PROTEIN CHEM, V39, P125; Cammack R., 2001, HYDROGEN FUEL LEARNI; Cao ZX, 2001, J AM CHEM SOC, V123, P3734, DOI 10.1021/ja000116v; Chen ZJ, 2002, BIOCHEMISTRY-US, V41, P2036, DOI 10.1021/bi011510o; Cohen RO, 2004, BIOCHEMISTRY-US, V43, P4741, DOI 10.1021/bi035633f; Czech I, 2010, FEBS LETT, V584, P638, DOI 10.1016/j.febslet.2009.12.016; Dementin S, 2009, J AM CHEM SOC, V131, P10156, DOI 10.1021/ja9018258; Erdem OF, 2011, ANGEW CHEM INT EDIT, V50, P1439, DOI 10.1002/anie.201006244; Fan HJ, 2001, J AM CHEM SOC, V123, P3828, DOI 10.1021/ja004120i; Fontecilla-Camps JC, 2007, CHEM REV, V107, P4273, DOI 10.1021/cr050195z; Fontecilla-Camps JC, 2009, NATURE, V460, P814, DOI 10.1038/nature08299; Gao WM, 2010, CHEM-EUR J, V16, P2537, DOI 10.1002/chem.200902278; GELLMAN SH, 1991, BIOCHEMISTRY-US, V30, P6633, DOI 10.1021/bi00241a001; Girbal L, 2005, APPL ENVIRON MICROB, V71, P2777, DOI 10.1128/AEM.71.5.2777-2781.2005; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; Goldet G, 2009, J AM CHEM SOC, V131, P14979, DOI [10.1021/ja905388j, 10.1021/ja905388i]; Greco C, 2007, INORG CHEM, V46, P5911, DOI 10.1021/ic062320a; Greco C, 2007, INORG CHEM, V46, P7256, DOI 10.1021/ic701051h; Green KN, 2009, DALTON T, P4344, DOI 10.1039/b823152d; HAPPE T, 1993, EUR J BIOCHEM, V214, P475, DOI 10.1111/j.1432-1033.1993.tb17944.x; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Hiromoto T, 2009, ANGEW CHEM INT EDIT, V48, P6457, DOI 10.1002/anie.200902695; Ibrahim S, 2010, CHEM COMMUN, V46, P8189, DOI 10.1039/c0cc02962a; Jablonskyte A, 2010, DALTON T, V39, P3026, DOI 10.1039/b923191a; JANIN J, 1978, J MOL BIOL, V125, P357, DOI 10.1016/0022-2836(78)90408-4; Kamp C, 2008, BBA-BIOENERGETICS, V1777, P410, DOI 10.1016/j.bbabio.2008.02.002; Karle IL, 1999, J MOL STRUCT, V474, P103, DOI 10.1016/S0022-2860(98)00564-X; King P., 2004, U.S. Patent, Patent No. [7,501,270 B2, 7501270]; Krassen H, 2011, PHYS CHEM CHEM PHYS, V13, P47, DOI 10.1039/c0cp0M63k; Kubas GJ, 2007, CHEM REV, V107, P4152, DOI 10.1021/cr050197j; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Lautier T, 2011, FARADAY DISCUSS, V148, P385, DOI 10.1039/c004099c; Liu ZP, 2002, J AM CHEM SOC, V124, P5175, DOI 10.1021/ja0118690; Liu ZP, 2002, J CHEM PHYS, V117, P8177, DOI 10.1063/1.1519252; Lubitz W, 2007, CHEM REV, V107, P4331, DOI 10.1021/cr050186q; Mulder DW, 2010, NATURE, V465, P248, DOI 10.1038/nature08993; Mulder DW, 2009, BIOCHEMISTRY-US, V48, P6240, DOI 10.1021/bi9000563; Nicolet Y, 1999, STRUCTURE, V7, P13, DOI 10.1016/S0969-2126(99)80005-7; Pandey AS, 2008, J AM CHEM SOC, V130, P4533, DOI 10.1021/ja711187e; Papadopoulos JS, 2007, BIOINFORMATICS, V23, P1073, DOI 10.1093/bioinformatics/btm076; PATIL DS, 1988, J BIOL CHEM, V263, P18732; Pereira AS, 2001, J AM CHEM SOC, V123, P2771, DOI 10.1021/ja003176+; Peters JW, 1998, SCIENCE, V282, P1853, DOI 10.1126/science.282.5395.1853; Popescu CV, 1999, J AM CHEM SOC, V121, P7877, DOI 10.1021/ja991243y; Roseboom W, 2006, J BIOL INORG CHEM, V11, P102, DOI 10.1007/s00775-005-0040-2; Schink B, 1997, MICROBIOL MOL BIOL R, V61, P262, DOI 10.1128/.61.2.262-280.1997; SCHWARTZ RM, 1978, ATLAS PROTEIN SEQ S3, V5, P345; Schweiger A., 2001, PRINCIPLES PULSE ELE; Shima S, 2007, CHEM REC, V7, P37, DOI 10.1002/tcr.20111; Silakov A, 2007, J AM CHEM SOC, V129, P11447, DOI 10.1021/ja072592s; Silakov A, 2011, EUR J INORG CHEM, P1056, DOI 10.1002/ejic.201001080; Silakov A, 2009, BIOCHEMISTRY-US, V48, P7780, DOI 10.1021/bi9009105; Silakov A, 2009, PHYS CHEM CHEM PHYS, V11, P6592, DOI 10.1039/b905841a; Singleton ML, 2011, INORG CHEM, V50, P5015, DOI 10.1021/ic200272x; Singleton ML, 2010, J AM CHEM SOC, V132, P8870, DOI 10.1021/ja103774j; SOUCAILLE P, 2006, Patent No. 2006066997; Stripp S, 2009, BIOCHEMISTRY-US, V48, P5042, DOI 10.1021/bi900010b; Stripp ST, 2009, P NATL ACAD SCI USA, V106, P17331, DOI 10.1073/pnas.0905343106; Tye JW, 2006, INORG CHEM, V45, P1552, DOI 10.1021/ic051231f; Vignais PM, 2007, CHEM REV, V107, P4206, DOI 10.1021/cr050196r; von Abendroth G, 2008, INT J HYDROGEN ENERG, V33, P6076, DOI 10.1016/j.ijhydene.2008.07.122; Wait AF, 2011, J AM CHEM SOC, V133, P1282, DOI 10.1021/ja110103p; WIESENBORN DP, 1988, APPL ENVIRON MICROB, V54, P2717, DOI 10.1128/AEM.54.11.2717-2722.1988; Winkler M, 2009, J BIOL CHEM, V284, P36620, DOI 10.1074/jbc.M109.053496; ZHANG MJ, 1994, J BIOL CHEM, V269, P15546; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110; Zhou TJ, 2005, INORG CHEM, V44, P4941, DOI 10.1021/ic0484699; Zhou TJ, 2004, INORG CHEM, V43, P923, DOI 10.1021/ic0342301	82	111	112	1	79	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					1489	1499		10.1074/jbc.M111.305797	http://dx.doi.org/10.1074/jbc.M111.305797			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22110126	Green Published, hybrid			2022-12-27	WOS:000299170300062
J	Maruyama, S; Shibata, R; Kikuchi, R; Izumiya, Y; Rokutanda, T; Araki, S; Kataoka, Y; Ohashi, K; Daida, H; Kihara, S; Ogawa, H; Murohara, T; Ouchi, N				Maruyama, Sonomi; Shibata, Rei; Kikuchi, Ryosuke; Izumiya, Yasuhiro; Rokutanda, Taku; Araki, Satoshi; Kataoka, Yoshiyuki; Ohashi, Koji; Daida, Hiroyuki; Kihara, Shinji; Ogawa, Hisao; Murohara, Toyoaki; Ouchi, Noriyuki			Fat-derived Factor Omentin Stimulates Endothelial Cell Function and Ischemia-induced Revascularization via Endothelial Nitric Oxide Synthase-dependent Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; METABOLIC SYNDROME; GENE-EXPRESSION; TISSUE ISCHEMIA; ADIPOSE-TISSUE; OBESITY; AKT; ANGIOGENESIS; ADIPONECTIN; DISEASE	Obesity-related diseases are associated with vascular dysfunction and impaired revascularization. Omentin is a fat-derived secreted protein, which is down-regulated in association with obese complications. Here, we investigated whether omentin modulates endothelial cell function and revascularization processes in vitro and in vivo. Systemic delivery of an adenoviral vector expressing omentin (Ad-omentin) enhanced blood flow recovery and capillary density in ischemic limbs of wild-type mice in vivo, which were accompanied by increased phosphorylation of Akt and endothelial nitric oxide synthase (eNOS). In cultured human umbilical vein endothelial cells (HUVECs), a physiological concentration of recombinant omentin protein increased differentiation into vascular-like structures and decreased apoptotic activity under conditions of serum starvation. Treatment with omentin protein stimulated the phosphorylation of Akt and eNOS in HUVECs. Inhibition of Akt signaling by treatment with dominant-negative Akt or LY294002 blocked the stimulatory effects of omentin on differentiation and survival of HUVECs and reversed omentin-stimulated eNOS phosphorylation. Pretreatment with the NOS inhibitor also reduced the omentin-induced increase in HUVEC differentiation and survival. Omentin protein also stimulated the phosphorylation of AMP-activated protein kinase in HUVECs. Transduction with dominant-negative AMP-activated protein kinase diminished omentin-induced phosphorylation of Akt and omentin-stimulated increase in HUVEC differentiation and survival. Of importance, in contrast to wild-type mice, systemic administration of Ad-omentin did not affect blood flow in ischemic muscle in eNOS-deficient mice in vivo. These data indicate that omentin promotes endothelial cell function and revascularization in response to ischemia through its ability to stimulate an Akt-eNOS signaling pathway.	[Shibata, Rei] Nagoya Univ, Grad Sch Med, Dept Cardiol, Showa Ku, Nagoya, Aichi 4668550, Japan; [Izumiya, Yasuhiro; Rokutanda, Taku; Araki, Satoshi; Ogawa, Hisao] Kumamoto Univ, Sch Med, Dept Cardiol, Kumamoto 8608556, Japan; [Ohashi, Koji; Ouchi, Noriyuki] Nagoya Univ, Grad Sch Med, Dept Mol Cardiol, Nagoya, Aichi 4668550, Japan; [Maruyama, Sonomi; Daida, Hiroyuki] Juntendo Univ, Dept Cardiol, Sch Med, Tokyo 1138421, Japan; [Kihara, Shinji] Osaka Univ, Grad Sch Med, Dept Biomed Informat, Suita, Osaka 5650871, Japan	Nagoya University; Kumamoto University; Nagoya University; Juntendo University; Osaka University	Shibata, R (corresponding author), Nagoya Univ, Grad Sch Med, Dept Cardiol, Showa Ku, 65 Tsurumai, Nagoya, Aichi 4668550, Japan.	rshibata@med.nagoya-u.ac.jp; nouchi@med.nagoya-u.ac.jp	OHASHI, Koji/I-7307-2014; OUCHI, Noriyuki/I-7306-2014; Murohara, Toyoaki/M-4958-2014; Kikuchi, Ryosuke/AAX-4971-2021		Takeda Science Foundation, Suzuken Memorial Foundation, Japan Research Foundation for Clinical Pharmacology; Uehara Memorial Foundation; Japan Heart Foundation/Novartis; Japan Heart Foundation and Astellas/Pfizer	Takeda Science Foundation, Suzuken Memorial Foundation, Japan Research Foundation for Clinical Pharmacology; Uehara Memorial Foundation(Uehara Memorial Foundation); Japan Heart Foundation/Novartis; Japan Heart Foundation and Astellas/Pfizer	This work was supported by a grant-in-aid for Scientific Research and grants from the Takeda Science Foundation, Suzuken Memorial Foundation, Japan Research Foundation for Clinical Pharmacology, and the Uehara Memorial Foundation (to N. O.).; Supported by a grant-in-aid for Young Scientists B, the Uehara Memorial Foundation, Japan Heart Foundation/Novartis Grant for Research Award on Molecular and Cellular Cardiology (2011), and the Japan Heart Foundation and Astellas/Pfizer grant for Research on Atherosclerosis Update. To whom correspondence may be addressed: Dept. of Cardiology, Nagoya University Graduate School of Medicine, 65 Tsurumai, Showa, Nagoya 4668550, Japan. Tel.: 81-52-744-2427; Fax: 81-52-744-2427; E-mail: rshibata@med.nagoya-u.ac.jp.	Batista CMDS, 2007, DIABETES, V56, P1655, DOI 10.2337/db06-1506; Chen GX, 1996, P NATL ACAD SCI USA, V93, P14795, DOI 10.1073/pnas.93.25.14795; Enomoto T, 2011, J BIOL CHEM, V286, P34552, DOI 10.1074/jbc.M111.277319; Friedman JM, 2003, SCIENCE, V299, P856, DOI 10.1126/science.1079856; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Goukassian DA, 2007, CIRCULATION, V115, P752, DOI 10.1161/CIRCULATIONAHA.106.647255; Horike N, 2008, J BIOL CHEM, V283, P33902, DOI 10.1074/jbc.M802537200; Kimura T, 2010, J BIOL CHEM, V285, P4387, DOI 10.1074/jbc.M109.043869; Levine YC, 2007, J BIOL CHEM, V282, P20351, DOI 10.1074/jbc.M702182200; Li HG, 2002, NITRIC OXIDE-BIOL CH, V7, P149, DOI 10.1016/S1089-8603(02)00111-8; LIND L, 1993, AM HEART J, V125, P1494, DOI 10.1016/0002-8703(93)90446-G; Liu R, 2011, DIABETES RES CLIN PR, V93, P21, DOI 10.1016/j.diabres.2011.03.001; Luo ZY, 2000, J CLIN INVEST, V106, P493, DOI 10.1172/JCI9419; Moreno-Navarrete JM, 2011, OBESITY, V19, P1552, DOI 10.1038/oby.2010.351; Murohara T, 1998, J CLIN INVEST, V101, P2567, DOI 10.1172/JCI1560; Oshima Y, 2009, CIRCULATION, V120, P1606, DOI 10.1161/CIRCULATIONAHA.109.872200; Ouchi N, 2004, J BIOL CHEM, V279, P1304, DOI 10.1074/jbc.M310389200; Ouchi N, 2003, CURR OPIN LIPIDOL, V14, P561, DOI 10.1097/00041433-200312000-00003; Ouchi N, 2008, J BIOL CHEM, V283, P32802, DOI 10.1074/jbc.M803440200; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Pan HY, 2010, DIABETES RES CLIN PR, V88, P29, DOI 10.1016/j.diabres.2010.01.013; Reilly MP, 2003, CIRCULATION, V108, P1546, DOI 10.1161/01.CIR.0000088846.10655.E0; Schaffler A, 2005, BBA-GENE STRUCT EXPR, V1732, P96, DOI 10.1016/j.bbaexp.2005.11.005; Shibata R, 2004, J BIOL CHEM, V279, P28670, DOI 10.1074/jbc.M402558200; Shibata R., 2011, HYPERTENS RES; Shiojima I, 2002, CIRC RES, V90, P1243, DOI 10.1161/01.RES.0000022200.71892.9F; Shiojima I, 2002, J BIOL CHEM, V277, P37670, DOI 10.1074/jbc.M204572200; Tsuji S, 2001, J BIOL CHEM, V276, P23456, DOI 10.1074/jbc.M103162200; WARLEY A, 1995, DIABETOLOGIA, V38, P413, DOI 10.1007/s001250050300; Yamawaki H, 2011, BIOCHEM BIOPH RES CO, V408, P339, DOI 10.1016/j.bbrc.2011.04.039; Yamawaki H, 2010, BIOCHEM BIOPH RES CO, V393, P668, DOI 10.1016/j.bbrc.2010.02.053; Yang RZ, 2006, AM J PHYSIOL-ENDOC M, V290, pE1253, DOI 10.1152/ajpendo.00572.2004; Yilmaz MB, 2003, INT J OBESITY, V27, P1541, DOI 10.1038/sj.ijo.0802474; Zhang W, 2010, J NEUROENDOCRINOL, V22, P175, DOI 10.1111/j.1365-2826.2010.01953.x; Zhong X, 2011, ACTA PHARMACOL SIN, V32, P873, DOI 10.1038/aps.2011.26	35	122	132	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					408	417		10.1074/jbc.M111.261818	http://dx.doi.org/10.1074/jbc.M111.261818			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22081609	Green Published, hybrid			2022-12-27	WOS:000298682400039
J	Burstel, I; Hummel, P; Siebert, E; Wisitruangsakul, N; Zebger, I; Friedrich, B; Lenz, O				Buerstel, Ingmar; Hummel, Philipp; Siebert, Elisabeth; Wisitruangsakul, Nattawadee; Zebger, Ingo; Friedrich, Baerbel; Lenz, Oliver			Probing the Origin of the Metabolic Precursor of the CO Ligand in the Catalytic Center of [NiFe] Hydrogenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MATURATION PROTEINS HYPC; RALSTONIA-EUTROPHA H16; ACTIVE-SITE; ESCHERICHIA-COLI; H-2 SENSOR; CYANIDE; NICKEL; OXYGEN; FE; BIOSYNTHESIS	The O-2-tolerant [NiFe] hydrogenases of Ralstonia eutropha are capable of H-2 conversion in the presence of ambient O-2. Oxygen represents not only a challenge for catalysis but also for the complex assembling process of the [NiFe] active site. Apart from nickel and iron, the catalytic center contains unusual diatomic ligands, namely two cyanides (CN-) and one carbon monoxide (CO), which are coordinated to the iron. One of the open questions of the maturation process concerns the origin and biosynthesis of the CO group. Isotope labeling in combination with infrared spectroscopy revealed that externally supplied gaseous (CO)-C-13 serves as precursor of the carbonyl group of the regulatory [NiFe] hydrogenase in R. eutropha. Corresponding (CO)-C-13 titration experiments showed that a concentration 130-fold higher than ambient CO(0.1 ppmv) caused a 50% labeling of the carbonyl ligand in the [NiFe] hydrogenase, leading to the conclusion that the carbonyl ligand originates from an intracellular metabolite. A novel setup allowed us to the study effects of CO depletion on maturation in vivo. Upon induction of CO depletion by addition of the CO scavenger PdCl2, cells cultivated on H-2, CO2, and O-2 showed severe growth retardation at low cell concentrations, which was on the basis of partially arrested hydrogenase maturation, leading to reduced hydrogenase activity. This suggests gaseous CO as a metabolic precursor under these conditions. The addition of PdCl2 to cells cultivated heterotrophically on organic substrates had no effect on hydrogenase maturation. These results indicate at least two different pathways for biosynthesis of the CO ligand of [NiFe] hydrogenase.	[Zebger, Ingo] Tech Univ Berlin, Inst Chem PC 14, Max Volmer Lab, D-10623 Berlin, Germany; [Buerstel, Ingmar; Friedrich, Baerbel; Lenz, Oliver] Univ Berlin, Inst Biol Mikrobiol, D-10115 Berlin, Germany	Technical University of Berlin	Zebger, I (corresponding author), Tech Univ Berlin, Inst Chem PC 14, Max Volmer Lab, Str 17,Juni 135, D-10623 Berlin, Germany.	ingo.zebger@tu-berlin.de; oliver.lenz@cms.hu-berlin.de	Lenz, Oliver/C-1582-2019; Lenz, Oliver/N-5130-2019; vedha, angeline/F-7272-2012	Lenz, Oliver/0000-0003-4550-5128; Lenz, Oliver/0000-0003-4550-5128; 	Deutsche Forschungsgemeinschaft (DFG) via the Cluster of Excellence "Unifying Concept in Catalysis" [Sfb 498]	Deutsche Forschungsgemeinschaft (DFG) via the Cluster of Excellence "Unifying Concept in Catalysis"(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (DFG) via the Cluster of Excellence "Unifying Concept in Catalysis" and the Sfb 498.	Atanassova A, 2005, J BACTERIOL, V187, P4689, DOI 10.1128/JB.187.14.4689-4697.2005; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; Bernhard M, 1997, EUR J BIOCHEM, V248, P179, DOI 10.1111/j.1432-1033.1997.00179.x; Bernhard M, 2001, J BIOL CHEM, V276, P15592, DOI 10.1074/jbc.M009802200; Blokesch M, 2004, EUR J BIOCHEM, V271, P3428, DOI 10.1111/j.1432-1033.2004.04280.x; Blokesch M, 2004, J BACTERIOL, V186, P2603, DOI 10.1128/JB.186.9.2603-2611.2004; Blokesch M, 2002, J MOL BIOL, V324, P287, DOI 10.1016/S0022-2836(02)01070-7; Blokesch M, 2004, J MOL BIOL, V344, P155, DOI 10.1016/j.jmb.2004.09.040; Blokesch M, 2006, FEBS LETT, V580, P4065, DOI 10.1016/j.febslet.2006.06.045; Bock A, 2006, ADV MICROB PHYSIOL, V51, P1, DOI 10.1016/S0065-2911(06)51001-X; Buhrke T, 2002, J BIOL INORG CHEM, V7, P897, DOI 10.1007/s00775-002-0379-6; Buhrke T, 2005, J BIOL CHEM, V280, P23791, DOI 10.1074/jbc.M503260200; Buhrke T, 2005, J BIOL CHEM, V280, P19488, DOI 10.1074/jbc.M500601200; Burgdorf T, 2005, J MOL MICROB BIOTECH, V10, P181, DOI 10.1159/000091564; Conrad R, 1996, MICROBIOL REV, V60, P609, DOI 10.1128/MMBR.60.4.609-640.1996; Driesener RC, 2010, ANGEW CHEM INT EDIT, V49, P1687, DOI 10.1002/anie.200907047; Fontecilla-Camps JC, 2007, CHEM REV, V107, P4273, DOI 10.1021/cr050195z; Forzi L, 2007, FEBS LETT, V581, P3317, DOI 10.1016/j.febslet.2007.06.028; Forzi L, 2007, BIOMETALS, V20, P565, DOI 10.1007/s10534-006-9048-5; FRIEDRICH B, 1981, J BACTERIOL, V145, P1144, DOI 10.1128/JB.145.3.1144-1149.1981; FRIEDRICH CG, 1981, J GEN MICROBIOL, V122, P69; Hube M, 2002, J BACTERIOL, V184, P3879, DOI 10.1128/JB.184.14.3879-3885.2002; JACOBI A, 1992, ARCH MICROBIOL, V158, P444; Jones AK, 2004, BIOCHEMISTRY-US, V43, P13467, DOI 10.1021/bi048837k; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leach MR, 2005, BIOCHEMISTRY-US, V44, P12229, DOI 10.1021/bi050993j; Lenz O, 2007, FEBS LETT, V581, P3322, DOI 10.1016/j.febslet.2007.06.027; Lenz O, 2010, CHEMPHYSCHEM, V11, P1107, DOI 10.1002/cphc.200901002; Lubitz W, 2008, ENERG ENVIRON SCI, V1, P15, DOI 10.1039/b808792j; McGlynn SE, 2010, J BACTERIOL, V192, P595, DOI 10.1128/JB.01125-09; Mulder DW, 2011, STRUCTURE, V19, P1038, DOI 10.1016/j.str.2011.06.008; Pierik AJ, 1998, FEBS LETT, V438, P231, DOI 10.1016/S0014-5793(98)01306-4; Reimann W., 1980, GERICHTSMEDIZIN; Reissmann S, 2003, SCIENCE, V299, P1067, DOI 10.1126/science.1080972; Roseboom W, 2005, FEBS LETT, V579, P469, DOI 10.1016/j.febslet.2004.12.013; Schwartz E, 1998, J BACTERIOL, V180, P3197, DOI 10.1128/JB.180.12.3197-3204.1998; Schwartz E, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 2, THIRD EDITION, P496, DOI 10.1007/0-387-30742-7_17; Shepard EM, 2010, J AM CHEM SOC, V132, P9247, DOI 10.1021/ja1012273; Shima S, 2008, SCIENCE, V321, P572, DOI 10.1126/science.1158978; Soboh B, 2010, FEBS LETT, V584, P4109, DOI 10.1016/j.febslet.2010.08.037; Thauer RK, 2010, ANNU REV BIOCHEM, V79, P507, DOI 10.1146/annurev.biochem.030508.152103; Thiemermann S, 1996, J BACTERIOL, V178, P2368, DOI 10.1128/jb.178.8.2368-2374.1996; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Watanabe S, 2007, MOL CELL, V27, P29, DOI 10.1016/j.molcel.2007.05.039; WAUGH R, 1986, BIOCHIMIE, V68, P157, DOI 10.1016/S0300-9084(86)81080-X; Zhang JW, 2005, J BIOL CHEM, V280, P4360, DOI 10.1074/jbc.M411799200	46	26	26	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2011	286	52					44937	44944		10.1074/jbc.M111.309351	http://dx.doi.org/10.1074/jbc.M111.309351			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870CA	22049085	Green Published, hybrid			2022-12-27	WOS:000298645500062
J	Lim, JH; Liu, Y; Reineke, E; Kao, HY				Lim, Jun Hee; Liu, Yu; Reineke, Erin; Kao, Hung-Ying			Mitogen-activated Protein Kinase Extracellular Signal-regulated Kinase 2 Phosphorylates and Promotes Pin1 Protein-dependent Promyelocytic Leukemia Protein Turnover	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-BODY FORMATION; TUMOR-SUPPRESSOR PML; RAR-ALPHA; BODIES; DEGRADATION; PATHWAY; GROWTH; CELLS; ERK; TRANSLOCATION	The promyelocytic leukemia (PML) protein is a tumor suppressor that has an important role in several cellular processes, including apoptosis, viral infection, DNA damage repair, cell cycle regulation, and senescence. PML is an essential component of sub-nuclear structures called PML nuclear bodies (NBs). Our laboratory has previously demonstrated that the peptidyl-prolyl cis-trans isomerase, Pin1, binds and targets PML for degradation in a phosphorylation-dependent manner. To further elucidate the mechanisms underlying Pin1-mediated PML degradation, we aimed to identify one or more factors that promote PML phosphorylation. Here we show that treatment with U0126, an inhibitor of the ERK2 upstream kinases MEK1/2, leads to an increase in PML protein accumulation and an inhibition of the interaction between Pin1 and PML in MDA-MB-231 breast cancer cells. Consistent with this observation, phosphorylated ERK2 partially co-localized with PML NBs. Although U0126 up-regulated exogenous wild-type PML levels, it did not have an effect on the steady-state level of a mutant form of PML that is defective in binding Pin1. In addition, exogenous wildtype, but not Pin1 binding-defective PML protein expression levels were decreased by overexpression of ERK2. In contrast, knockdown of ERK2 by siRNA resulted in an increase in PML protein levels and an increase in the formation of PML NBs. Using phospho-specific antibodies, we identified Ser-403 and Ser-505 as the ERK2 targets that promote Pin1-mediated PML degradation. Finally, we demonstrated that EGF induced activation of ERK and interaction between PML and phosphorylated ERK resulting in a decrease in PML protein levels. Taken together, our results support a model in which Pin1 promotes PML degradation in an ERK2-dependent manner.	[Lim, Jun Hee; Liu, Yu; Reineke, Erin; Kao, Hung-Ying] Case Western Reserve Univ CWRU, Sch Med, Dept Biochem, Cleveland, OH 44106 USA; [Kao, Hung-Ying] CWRU, Ctr Comprehens Canc, Cleveland, OH 44106 USA; [Kao, Hung-Ying] Univ Hosp, Res Inst, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; University Hospitals of Cleveland	Kao, HY (corresponding author), 10900 Euclid Ave, Cleveland, OH 44106 USA.	hxk43@cwru.edu			National Institutes of Health [R01 DK078965, HL093269]; Pardee Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093269] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078965] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pardee Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK078965 and HL093269 (to H.-Y. K.). This work was also supported by the Pardee Foundation (to H.-Y. K.).	Bernardi R, 2007, NAT REV MOL CELL BIO, V8, P1006, DOI 10.1038/nrm2277; Bernardi R, 2006, NATURE, V442, P779, DOI 10.1038/nature05029; Borden KLB, 2002, MOL CELL BIOL, V22, P5259, DOI 10.1128/MCB.22.15.5259-5269.2002; Brunet A, 1999, EMBO J, V18, P664, DOI 10.1093/emboj/18.3.664; Calvo F, 2010, BIOESSAYS, V32, P412, DOI 10.1002/bies.200900155; ChelbiAlix MK, 1995, LEUKEMIA, V9, P2027; Chen Z, 2001, CHEM REV, V101, P2449, DOI 10.1021/cr000241p; de Stanchina E, 2004, MOL CELL, V13, P523, DOI 10.1016/S1097-2765(04)00062-0; DETHE H, 1991, CELL, V66, P675, DOI 10.1016/0092-8674(91)90113-D; Dror N, 2007, J BIOL CHEM, V282, P5633, DOI 10.1074/jbc.M607825200; El Mchichi B, 2010, J VIROL, V84, P11634, DOI 10.1128/JVI.01321-10; Gao CZ, 2008, MOL BIOL CELL, V19, P3020, DOI 10.1091/mbc.E07-11-1203; Gao CZ, 2008, MOL CELL BIOL, V28, P5658, DOI 10.1128/MCB.00874-08; Giorgi C, 2010, SCIENCE, V330, P1247, DOI 10.1126/science.1189157; Gurrieri C, 2004, JNCI-J NATL CANCER I, V96, P269, DOI 10.1093/jnci/djh043; Hayakawa F, 2004, CANCER CELL, V5, P389, DOI 10.1016/S1535-6108(04)00082-0; Jeanne M, 2010, CANCER CELL, V18, P88, DOI 10.1016/j.ccr.2010.06.003; Ji HT, 2009, MOL CELL, V36, P547, DOI 10.1016/j.molcel.2009.09.034; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; KAKIZUKA A, 1991, CELL, V66, P663, DOI 10.1016/0092-8674(91)90112-C; Lallemand-Breitenbach V, 2001, J EXP MED, V193, P1361, DOI 10.1084/jem.193.12.1361; Lallemand-Breitenbach V, 2008, NAT CELL BIOL, V10, P547, DOI 10.1038/ncb1717; LAVAU C, 1995, ONCOGENE, V11, P871; Ling PD, 2008, J VIROL, V82, P8000, DOI 10.1128/JVI.02752-07; Maul GG, 2000, J STRUCT BIOL, V129, P278, DOI 10.1006/jsbi.2000.4239; Ramos JW, 2008, INT J BIOCHEM CELL B, V40, P2707, DOI 10.1016/j.biocel.2008.04.009; Reineke EL, 2008, MOL CELL BIOL, V28, P997, DOI 10.1128/MCB.01848-07; Reineke Erin L, 2009, Cancer Ther, V7, P219; Reineke EL, 2010, J BIOL CHEM, V285, P9485, DOI 10.1074/jbc.M109.063362; Reineke EL, 2009, INT J BIOL SCI, V5, P366; Salomoni P, 2002, CELL, V108, P165, DOI 10.1016/S0092-8674(02)00626-8; Salomoni P, 2008, CELL RES, V18, P620, DOI 10.1038/cr.2008.58; Sebolt-Leopold JS, 2004, NAT REV CANCER, V4, P937, DOI 10.1038/nrc1503; Shen TH, 2006, MOL CELL, V24, P331, DOI 10.1016/j.molcel.2006.09.013; Stadler M, 1995, ONCOGENE, V11, P2565; Tatham MH, 2008, NAT CELL BIOL, V10, P538, DOI 10.1038/ncb1716; Wang ZG, 1998, NAT GENET, V20, P266, DOI 10.1038/3073; Wang ZG, 1998, SCIENCE, V279, P1547; Yang QK, 2010, CANCER CELL, V18, P258, DOI 10.1016/j.ccr.2010.08.008; Yuan WC, 2011, CANCER CELL, V20, P214, DOI 10.1016/j.ccr.2011.07.008; Zhang H, 2009, J BIOL CHEM, V284, P2867, DOI 10.1074/jbc.M807526200; Zhang XW, 2010, SCIENCE, V328, P240, DOI 10.1126/science.1183424	42	28	31	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2011	286	52					44403	44411		10.1074/jbc.M111.289512	http://dx.doi.org/10.1074/jbc.M111.289512			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870CA	22033920	Green Published, hybrid			2022-12-27	WOS:000298645500012
J	Zhou, C; Lu, L; Tan, SY; Jiang, SB; Chen, YH				Zhou, Chang; Lu, Lu; Tan, Suiyi; Jiang, Shibo; Chen, Ying-Hua			HIV-1 Glycoprotein 41 Ectodomain Induces Activation of the CD74 Protein-mediated Extracellular Signal-regulated Kinase/Mitogen-activated Protein Kinase Pathway to Enhance Viral Infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; MIGRATION INHIBITORY FACTOR; CC-CHEMOKINE RANTES; HTLV-III; ENVELOPE GLYCOPROTEIN; CELL-PROLIFERATION; IMMUNE-RESPONSE; TARGET-CELLS; FACTOR MIF; GP41 CORE	Besides mediating the viral entry process, the human immunodeficiency virus (HIV-1) envelope protein gp41 can bind to many host cell components and regulate cell functions. Using a yeast two-hybrid system, we screened a human bone marrow cDNA library and identified a novel gp41-binding protein, CD74 (the MHC class II-associated invariant chain). Here, we report possible biological effects mediated by interaction between gp41 and CD74. We found that HIV-1 gp41 could bind directly to host CD74 in HIV-1-infected cells, and the peptide 6358 derived from gp41 loop region (aa 597-611) could effectively block the gp41-CD74 interaction. As a result of this binding, recombinant soluble gp41 and gp41 peptide 6358 activated the CD74-mediated ERK/MAPK pathway and significantly enhanced HIV-1 infection in vitro. Conversely, the enhancing effect could be suppressed by the recombinant CD74 extracellular domain. These results reveal a novel mechanism underlying gp41 mediation of HIV-1 infection and replication.	[Lu, Lu; Jiang, Shibo] Fudan Univ, Shanghai Med Coll, Inst Med Microbiol, Minist Hlth Key Lab Med Mol Virol,Minist Educ, Shanghai 200032, Peoples R China; [Zhou, Chang; Chen, Ying-Hua] Tsinghua Univ, Beijing Key Lab Prot Therapeut, Sch Life Sci, Prot Sci Lab,Lab Immunol,Minist Educ, Beijing 100084, Peoples R China; [Lu, Lu; Tan, Suiyi; Jiang, Shibo] New York Blood Ctr, Lindsley F Kimball Res Inst, Lab Viral Immunol, New York, NY 10065 USA	Fudan University; Tsinghua University; New York Blood Center	Jiang, SB (corresponding author), Fudan Univ, Shanghai Med Coll, Inst Med Microbiol, Minist Hlth Key Lab Med Mol Virol,Minist Educ, Shanghai 200032, Peoples R China.	shibojiang@fudan.edu.cn; chenyh@mail.tsinghua.edu.cn	lu, lu/HGA-0894-2022; Jiang, Shibo/L-4500-2014; Zhou, Chang/C-8999-2013; chen, ying/HHS-8254-2022; Lu, Lu/K-7070-2014; lu, lu/HII-7530-2022	Jiang, Shibo/0000-0001-8283-7135; Zhou, Chang/0000-0002-6990-0395; Lu, Lu/0000-0002-2255-0391; 	National Natural Science Foundation of China [81171548, 81173098, 81102476]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China Grants 81171548 (to Y.-H.C.), 81173098 (to S.J.), and 81102476 (to L. L.).	BENKIRANE M, 1994, EMBO J, V13, P5559, DOI 10.1002/j.1460-2075.1994.tb06893.x; Bernhagen J, 1998, J MOL MED-JMM, V76, P151, DOI 10.1007/s001090050204; Beswick EJ, 2005, INFECT IMMUN, V73, P2736, DOI 10.1128/IAI.73.5.2736-2743.2005; Briant L, 1998, J VIROL, V72, P6207, DOI 10.1128/JVI.72.7.6207-6214.1998; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Chan DC, 1998, CELL, V93, P681, DOI 10.1016/S0092-8674(00)81430-0; Chang TLY, 2002, J VIROL, V76, P2245, DOI 10.1128/JVI.76.5.2245-2254.2002; CHEN BYH, 1994, INT ARCH ALLERGY IMM, V104, P227, DOI 10.1159/000236670; CHEN YH, 1993, IMMUNOL LETT, V37, P41, DOI 10.1016/0165-2478(93)90130-T; Chen YH, 1995, IMMUNOL LETT, V48, P39, DOI 10.1016/0165-2478(95)02439-5; CHEN YH, 1993, IMMUNOBIOLOGY, V188, P323, DOI 10.1016/S0171-2985(11)80216-0; CHEN YH, 1992, AIDS, V6, P533, DOI 10.1097/00002030-199206000-00002; CHEN YH, 1993, MOL IMMUNOL, V30, P1583, DOI 10.1016/0161-5890(93)90449-L; Cicala C, 2002, P NATL ACAD SCI USA, V99, P9380, DOI 10.1073/pnas.142287999; Cohen T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001085; CRESSWELL P, 1994, ANNU REV IMMUNOL, V12, P259, DOI 10.1146/annurev.immunol.12.1.259; DENNER J, 1994, AIDS, V8, P1063, DOI 10.1097/00002030-199408000-00005; Dunn SJ, 2004, VIROLOGY, V321, P260, DOI 10.1016/j.virol.2004.01.010; Grainger DJ, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-23; HENDERSON LA, 1993, J BIOL CHEM, V268, P15291; HENNE C, 1995, IMMUNOLOGY, V84, P177; Hovanessian AG, 2004, IMMUNITY, V21, P617, DOI 10.1016/j.immuni.2004.08.015; Huang JH, 2008, J BIOL CHEM, V283, P14994, DOI 10.1074/jbc.M800525200; Huang JH, 2007, J BIOL CHEM, V282, P6143, DOI 10.1074/jbc.M607701200; Jacque JM, 1998, EMBO J, V17, P2607, DOI 10.1093/emboj/17.9.2607; Jiang SB, 2004, ANTIMICROB AGENTS CH, V48, P4349, DOI 10.1128/AAC.48.11.4349-4359.2004; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Leng L, 2006, CELL RES, V16, P162, DOI 10.1038/sj.cr.7310022; Leng L, 2003, J EXP MED, V197, P1467, DOI 10.1084/jem.20030286; Marozsan AJ, 2001, J VIROL, V75, P8624, DOI 10.1128/JVI.75.18.8624-8638.2001; McCubrey JA, 2007, BBA-MOL CELL RES, V1773, P1263, DOI 10.1016/j.bbamcr.2006.10.001; McMichael AJ, 2003, NAT MED, V9, P874, DOI 10.1038/nm0703-874; Mitchell RA, 1999, J BIOL CHEM, V274, P18100, DOI 10.1074/jbc.274.25.18100; POPOVIC M, 1984, LANCET, V2, P1472; POPOVIC M, 1984, SCIENCE, V224, P497, DOI 10.1126/science.6200935; QURESHI NM, 1990, AIDS, V4, P553, DOI 10.1097/00002030-199006000-00009; Ramos JW, 2008, INT J BIOCHEM CELL B, V40, P2707, DOI 10.1016/j.biocel.2008.04.009; RATNER L, 1985, NATURE, V313, P277, DOI 10.1038/313277a0; Robinson MJ, 1997, CURR OPIN CELL BIOL, V9, P180, DOI 10.1016/S0955-0674(97)80061-0; Roscic-Mrkic B, 2003, BLOOD, V102, P1169, DOI 10.1182/blood-2003-02-0488; RUEGG CL, 1989, J VIROL, V63, P3257, DOI 10.1128/JVI.63.8.3257-3260.1989; STRUBIN M, 1986, CELL, V47, P619, DOI 10.1016/0092-8674(86)90626-4; Swanson CM, 2008, CELL, V133, DOI 10.1016/j.cell.2008.05.005; Trkola A, 1999, J VIROL, V73, P6370, DOI 10.1128/JVI.73.8.6370-6379.1999; Ueda H, 1998, J CLIN INVEST, V102, P804, DOI 10.1172/JCI3273; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; Weissman D, 1997, NATURE, V389, P981, DOI 10.1038/40173; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Yang XY, 1999, J VIROL, V73, P3460, DOI 10.1128/JVI.73.4.3460-3466.1999; Yang XY, 1998, J BIOL CHEM, V273, P29879, DOI 10.1074/jbc.273.45.29879; Yoder A, 2008, CELL, V134, P782, DOI 10.1016/j.cell.2008.06.036	51	9	10	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2011	286	52					44869	44877		10.1074/jbc.M111.267393	http://dx.doi.org/10.1074/jbc.M111.267393			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870CA	22039051	Green Published, hybrid			2022-12-27	WOS:000298645500055
J	Powell, RD; Holland, PJ; Hollis, T; Perrino, FW				Powell, Rebecca D.; Holland, Paul J.; Hollis, Thomas; Perrino, Fred W.			Aicardi-Goutieres Syndrome Gene and HIV-1 Restriction Factor SAMHD1 Is a dGTP-regulated Deoxynucleotide Triphosphohydrolas	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DEGRADATION ACTIVITY; INNATE IMMUNE-RESPONSE; GAMMA-INDUCED PROTEIN; ESCHERICHIA-COLI; ACCESSORY PROTEINS; TRIPHOSPHATE TRIPHOSPHOHYDROLASE; DEOXYGUANOSINE TRIPHOSPHATE; AUTOIMMUNE-DISEASE; DOMINANT MUTATIONS; TREX1	The SAMHD1 protein is an HIV-1 restriction factor that is targeted by the HIV-2 accessory protein Vpx in myeloid lineage cells. Mutations in the SAMHD1 gene cause Aicardi-Goutieres syndrome, a genetic disease that mimics congenital viral infection. To determine the physiological function of the SAMHD1 protein, the SAMHD1 gene was cloned, recombinant protein was produced, and the catalytic activity of the purified enzyme was identified. We show that SAMHD1 contains a dGTP-regulated deoxynucleotide triphosphohydrolase. We propose that Vpx targets SAMHD1 for degradation in a viral strategy to control cellular deoxynucleotide levels for efficient replication.	[Powell, Rebecca D.; Holland, Paul J.; Hollis, Thomas; Perrino, Fred W.] Wake Forest Sch Med, Dept Biochem, Winston Salem, NC 27157 USA	Wake Forest University	Perrino, FW (corresponding author), Wake Forest Sch Med, Dept Biochem, Winston Salem, NC 27157 USA.	fperrino@wakehealth.edu			National Institutes of Health [GM069962]; Alliance for Lupus Research [179222]; American Heart Association [10GRNT3650033]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069962] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alliance for Lupus Research; American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in part, by National Institutes of Health Grant GM069962 (to F. W. P.). This work was also supported by Alliance for Lupus Research Grant 179222 (to F. W. P.) and American Heart Association Grant 10GRNT3650033 (to T. H.).	AICARDI J, 1984, ANN NEUROL, V15, P49, DOI 10.1002/ana.410150109; Aravind L, 1998, TRENDS BIOCHEM SCI, V23, P469, DOI 10.1016/S0968-0004(98)01293-6; Ayinde D, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-35; BEAUCHAMP BB, 1988, P NATL ACAD SCI USA, V85, P2563, DOI 10.1073/pnas.85.8.2563; Bennett-Lovsey RM, 2008, PROTEINS, V70, P611, DOI 10.1002/prot.21688; Coffin SR, 2011, J BIOL CHEM, V286, P16984, DOI 10.1074/jbc.M111.228833; Crow MK, 2003, AUTOIMMUNITY, V36, P481, DOI 10.1080/08916930310001625952; Crow YJ, 2006, NAT GENET, V38, P910, DOI 10.1038/ng1842; Crow YJ, 2006, NAT GENET, V38, P917, DOI 10.1038/ng1845; Crow YJ, 2009, HUM MOL GENET, V18, pR130, DOI 10.1093/hmg/ddp293; Fye JM, 2011, J BIOL CHEM, V286, P32373, DOI 10.1074/jbc.M111.276287; Genovesio A, 2011, J BIOMOL SCREEN, V16, P945, DOI 10.1177/1087057111415521; Goujon C, 2008, J VIROL, V82, P12335, DOI 10.1128/JVI.01181-08; Goutieres F, 1998, ANN NEUROL, V44, P900, DOI 10.1002/ana.410440608; Goutieres F, 2005, BRAIN DEV-JPN, V27, P201, DOI 10.1016/j.braindev.2003.12.011; Gramberg Thomas, 2009, Curr HIV/AIDS Rep, V6, P36, DOI 10.1007/s11904-009-0006-z; Hoss M, 1999, EMBO J, V18, P3868, DOI 10.1093/emboj/18.13.3868; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; Kaushik R, 2009, CELL HOST MICROBE, V6, P68, DOI 10.1016/j.chom.2009.05.022; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kondo N, 2004, J BIOCHEM, V136, P221, DOI 10.1093/jb/mvh115; KORNBERG SR, 1958, J BIOL CHEM, V233, P159; Kuznetsova E, 2005, FEMS MICROBIOL REV, V29, P263, DOI 10.1016/j.femsre.2004.12.006; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Lehtinen DA, 2008, J BIOL CHEM, V283, P31649, DOI 10.1074/jbc.M806155200; Li N, 2000, IMMUNOL LETT, V74, P221, DOI 10.1016/S0165-2478(00)00276-5; Liao WP, 2008, PROTEOMICS, V8, P2640, DOI 10.1002/pmic.200700954; Malim MH, 2008, CELL HOST MICROBE, V3, P388, DOI 10.1016/j.chom.2008.04.008; Mazur DJ, 1999, J BIOL CHEM, V274, P19655, DOI 10.1074/jbc.274.28.19655; Orebaugh CD, 2011, J BIOL CHEM, V286, P40246, DOI 10.1074/jbc.M111.297903; Perrino FW, 2009, J MOL MED-JMM, V87, P25, DOI 10.1007/s00109-008-0422-3; Rice GI, 2009, NAT GENET, V41, P829, DOI 10.1038/ng.373; SAITO H, 1981, J VIROL, V37, P343, DOI 10.1128/JVI.37.1.343-351.1981; SETO D, 1988, J BIOL CHEM, V263, P1494; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; STOCCHI V, 1987, ANAL BIOCHEM, V167, P181, DOI 10.1016/0003-2697(87)90150-3; Vorontsov II, 2011, J BIOL CHEM, V286, P33158, DOI 10.1074/jbc.M111.250456; Wolfrum N, 2007, VIROLOGY, V364, P330, DOI 10.1016/j.virol.2007.03.008; WURGLER SM, 1990, P NATL ACAD SCI USA, V87, P2740, DOI 10.1073/pnas.87.7.2740; Yan N, 2011, CURR OPIN IMMUNOL, V23, P21, DOI 10.1016/j.coi.2010.11.004; Yan N, 2010, NAT IMMUNOL, V11, P1005, DOI 10.1038/ni.1941; Yang YG, 2007, CELL, V131, P873, DOI 10.1016/j.cell.2007.10.017; Zhao DC, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-114	43	257	263	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2011	286	51					43596	43600		10.1074/jbc.C111.317628	http://dx.doi.org/10.1074/jbc.C111.317628			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866SH	22069334	Green Published, hybrid			2022-12-27	WOS:000298402300002
J	Soon, CPW; Donnelly, PS; Turner, BJ; Hung, LW; Crouch, PJ; Sherratt, NA; Tan, JL; Lim, NKH; Lam, L; Bica, L; Lim, S; Hickey, JL; Morizzi, J; Powell, A; Finkelstein, DI; Culvenor, JG; Masters, CL; Duce, J; White, AR; Barnham, KJ; Li, QX				Soon, Cynthia P. W.; Donnelly, Paul S.; Turner, Bradley J.; Hung, Lin W.; Crouch, Peter J.; Sherratt, Nicki A.; Tan, Jiang-Li; Lim, Nastasia K. -H.; Lam, Linh; Bica, Laura; Lim, SinChun; Hickey, James L.; Morizzi, Julia; Powell, Andrew; Finkelstein, David I.; Culvenor, Janetta G.; Masters, Colin L.; Duce, James; White, Anthony R.; Barnham, Kevin J.; Li, Qiao-Xin			Diacetylbis(N(4)-methylthiosemicarbazonato) Copper(II) (Cu-II(atsm)) Protects against Peroxynitrite-induced Nitrosative Damage and Prolongs Survival in Amyotrophic Lateral Sclerosis Mouse Model	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FRONTOTEMPORAL LOBAR DEGENERATION; MOTOR-NEURON DEGENERATION; SOD1 TRANSGENIC MICE; SUPEROXIDE-DISMUTASE; SPINAL-CORD; OXIDATIVE STRESS; TDP-43; ALS; DISEASE; AGGREGATION	Amyotrophic lateral sclerosis (ALS) is a progressive paralyzing disease characterized by tissue oxidative damage and motor neuron degeneration. This study investigated the in vivo effect of diacetylbis(N(4)-methylthiosemicarbazonato) copper(II) (Cu-II(atsm)), which is an orally bioavailable, blood-brain barrier-permeable complex. In vitro the compound inhibits the action of peroxynitrite on Cu,Zn-superoxide dismutase (SOD1) and subsequent nitration of cellular proteins. Oral treatment of transgenic SOD1(G93A) mice with Cu-II(atsm) at presymptomatic and symptomatic ages was performed. The mice were examined for improvement in lifespan and motor function, as well as histological and biochemical changes to key disease markers. Systemic treatment of SOD1(G93A) mice significantly delayed onset of paralysis and prolonged lifespan, even when administered to symptomatic animals. Consistent with the properties of this compound, treated mice had reduced protein nitration and carbonylation, as well as increased antioxidant activity in spinal cord. Treatment also significantly preserved motor neurons and attenuated astrocyte and microglial activation in mice. Furthermore, Cu-II(atsm) prevented the accumulation of abnormally phosphorylated and fragmented TAR DNA-binding protein-43 (TDP-43) in spinal cord, a protein pivotal to the development of ALS. Cu-II(atsm) therefore represents a potential new class of neuroprotective agents targeting multiple major disease pathways of motor neurons with therapeutic potential for ALS.	[Soon, Cynthia P. W.; Hung, Lin W.; Crouch, Peter J.; Sherratt, Nicki A.; Tan, Jiang-Li; Lim, Nastasia K. -H.; Bica, Laura; Culvenor, Janetta G.; White, Anthony R.; Barnham, Kevin J.; Li, Qiao-Xin] Univ Melbourne, Dept Pathol, Parkville, Vic 3010, Australia; [Soon, Cynthia P. W.; Hung, Lin W.; Crouch, Peter J.; Sherratt, Nicki A.; Lim, Nastasia K. -H.; Lam, Linh; Finkelstein, David I.; Masters, Colin L.; Duce, James; White, Anthony R.; Barnham, Kevin J.; Li, Qiao-Xin] Univ Melbourne, Mental Hlth Res Inst, Parkville, Vic 3010, Australia; [Donnelly, Paul S.; Lim, SinChun; Hickey, James L.] Univ Melbourne, Sch Chem, Parkville, Vic 3010, Australia; [Donnelly, Paul S.; Hung, Lin W.; Sherratt, Nicki A.; Lim, SinChun; Hickey, James L.; Barnham, Kevin J.] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3010, Australia; [Turner, Bradley J.; Crouch, Peter J.; Lim, Nastasia K. -H.; Culvenor, Janetta G.; White, Anthony R.; Li, Qiao-Xin] Univ Melbourne, Ctr Neurosci, Parkville, Vic 3010, Australia; [Turner, Bradley J.] Univ Melbourne, Florey Neurosci Inst, Parkville, Vic 3010, Australia; [Morizzi, Julia; Powell, Andrew] Monash Univ, Monash Inst Pharmaceut Sci, Ctr Drug Candidate Optimisat, Parkville, Vic 3052, Australia	University of Melbourne; Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Melbourne; University of Melbourne; University of Melbourne; Florey Institute of Neuroscience & Mental Health; University of Melbourne; Monash University	Barnham, KJ (corresponding author), Univ Melbourne, Dept Pathol, Parkville, Vic 3010, Australia.	kbarnham@unimelb.edu.au; q.li@unimelb.edu.au	Finkelstein, David/B-9617-2009; Powell, Andrew K/G-7886-2011; White, Anthony/P-5596-2016	Finkelstein, David/0000-0002-8167-4917; Duce, James/0000-0002-8762-2245; Lim, Nastasia/0000-0003-4245-3692; Powell, Andrew/0000-0002-9779-1122; Crouch, Peter/0000-0002-7777-4747; White, Anthony/0000-0003-1802-9891; Turner, Bradley/0000-0001-6580-7655	Australian National Health and Medical Research Council (NHMRC); C. J. Martin Fellowship [359269]; Bethlehem Griffiths Research Foundation; Motor Neurone Disease Research Institute of Australia; Australian Research Council	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); C. J. Martin Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Bethlehem Griffiths Research Foundation; Motor Neurone Disease Research Institute of Australia; Australian Research Council(Australian Research Council)	This work was supported by the Australian National Health and Medical Research Council (NHMRC), C. J. Martin Fellowship 359269 (to B. J. T.), the Bethlehem Griffiths Research Foundation, the Motor Neurone Disease Research Institute of Australia, and the Australian Research Council.	Almer G, 2001, ANN NEUROL, V49, P176, DOI 10.1002/1531-8249(20010201)49:2<176::AID-ANA37>3.0.CO;2-X; Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Basso M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008130; Beal MF, 2002, FREE RADICAL BIO MED, V32, P797, DOI 10.1016/S0891-5849(02)00780-3; Beal MF, 1997, ANN NEUROL, V42, P644, DOI 10.1002/ana.410420416; BEAUCHAM.C, 1971, ANAL BIOCHEM, V44, P276, DOI 10.1016/0003-2697(71)90370-8; BECKMAN JS, 1993, NATURE, V364, P584, DOI 10.1038/364584a0; Beckman JS, 2001, TRENDS NEUROSCI, V24, pS15, DOI 10.1016/S0166-2236(00)01981-0; Blower PJ, 2003, DALTON T, P4416, DOI 10.1039/b307499d; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; Caccamo A, 2009, J BIOL CHEM, V284, P27416, DOI 10.1074/jbc.M109.031278; Casoni F, 2005, J BIOL CHEM, V280, P16295, DOI 10.1074/jbc.M413111200; Cassina P, 2002, J NEUROSCI RES, V67, P21, DOI 10.1002/jnr.10107; Colombrita C, 2009, J NEUROCHEM, V111, P1051, DOI 10.1111/j.1471-4159.2009.06383.x; Cozzolino M, 2008, ANTIOXID REDOX SIGN, V10, P405, DOI 10.1089/ars.2007.1760; Crow JP, 2006, EXPERT OPIN INV DRUG, V15, P1383, DOI 10.1517/13543784.15.11.1383; Dewey CM, 2011, MOL CELL BIOL, V31, P1098, DOI 10.1128/MCB.01279-10; Feeney SJ, 2001, MUSCLE NERVE, V24, P1510, DOI 10.1002/mus.1176; Fodero-Tavoletti MT, 2010, J ALZHEIMERS DIS, V20, P49, DOI 10.3233/JAD-2010-1359; Fujibayashi Y, 1997, J NUCL MED, V38, P1155; GINGRAS BA, 1962, CAN J CHEM, V40, P1053, DOI 10.1139/v62-161; GRAHAM JM, 1997, SUBCELLULAR FRACTION, P71; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Hensley K, 2003, NEUROBIOL DIS, V14, P74, DOI 10.1016/S0969-9961(03)00087-1; Igaz LM, 2008, AM J PATHOL, V173, P182, DOI 10.2353/ajpath.2008.080003; Kiaei M, 2006, J NEUROSCI, V26, P2467, DOI 10.1523/JNEUROSCI.5253-05.2006; Lagier-Tourenne C, 2010, HUM MOL GENET, V19, pR46, DOI 10.1093/hmg/ddq137; Lewis JS, 2008, J NUCL MED, V49, P1177, DOI 10.2967/jnumed.108.051326; Li QX, 2006, AGING CELL, V5, P153, DOI 10.1111/j.1474-9726.2006.00200.x; Mariani E, 2005, J CHROMATOGR B, V827, P65, DOI 10.1016/j.jchromb.2005.04.023; MARKLUND S, 1974, European Journal of Biochemistry, V47, P469, DOI 10.1111/j.1432-1033.1974.tb03714.x; Martin LJ, 2007, J COMP NEUROL, V500, P20, DOI 10.1002/cne.21160; Meyerowitz J, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-57; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Peluffo H, 2004, J NEUROCHEM, V89, P602, DOI 10.1046/j.1471-4159.2004.02363.x; Robertson J, 2007, NEUROSCI LETT, V420, P128, DOI 10.1016/j.neulet.2007.03.066; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Scott S, 2008, AMYOTROPH LATERAL SC, V9, P4, DOI 10.1080/17482960701856300; Shan XY, 2009, NEUROSCI LETT, V458, P70, DOI 10.1016/j.neulet.2009.04.031; Soon CPW, 2010, NEUROMUSCULAR DISORD, V20, P260, DOI 10.1016/j.nmd.2009.11.015; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Sumi H, 2009, J NEUROPATH EXP NEUR, V68, P37, DOI 10.1097/NEN.0b013e3181919cb5; Turner BJ, 2008, PROG NEUROBIOL, V85, P94, DOI 10.1016/j.pneurobio.2008.01.001; Turner BJ, 2009, NEUROBIOL DIS, V34, P511, DOI 10.1016/j.nbd.2009.03.005; Turner BJ, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-104; WADA K, 1994, ARCH BIOCHEM BIOPHYS, V310, P1, DOI 10.1006/abbi.1994.1132; WADA K, 1994, BIOL PHARM BULL, V17, P701; Zhang YJ, 2009, P NATL ACAD SCI USA, V106, P7607, DOI 10.1073/pnas.0900688106	49	98	98	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2011	286	51					44035	44044		10.1074/jbc.M111.274407	http://dx.doi.org/10.1074/jbc.M111.274407			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866SH	22033929	Green Published, hybrid			2022-12-27	WOS:000298402300044
J	Dange, T; Smith, D; Noy, T; Rommel, PC; Jurzitza, L; Cordero, RJB; Legendre, A; Finley, D; Goldberg, AL; Schmidt, M				Dange, Thomas; Smith, David; Noy, Tahel; Rommel, Philipp C.; Jurzitza, Lukas; Cordero, Radames J. B.; Legendre, Anne; Finley, Daniel; Goldberg, Alfred L.; Schmidt, Marion			Blm10 Protein Promotes Proteasomal Substrate Turnover by an Active Gating Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							20 S-PROTEASOMES; SACCHAROMYCES-CEREVISIAE; PROTEOLYTIC MACHINE; REGULATORY PARTICLE; GENE DISRUPTION; 26S PROTEASOME; CORE PARTICLE; C-TERMINI; ATPASES; COMPLEX	Background: Association of the proteasome core with activators regulates proteasome activity. Results: Blm10 association increases proteasome activity toward peptides and the unstructured proteasome substrate tau-441. This process is mediated by the C terminus of Blm10. Conclusion: C-terminal docking-mediated proteasome activation by Blm10 facilitates the turnover of peptide and protein substrates. Significance: Blm10 contributes to the regulation of proteasome activity.	[Dange, Thomas; Noy, Tahel; Rommel, Philipp C.; Jurzitza, Lukas; Cordero, Radames J. B.; Schmidt, Marion] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA; [Smith, David; Legendre, Anne; Finley, Daniel; Goldberg, Alfred L.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Yeshiva University; Albert Einstein College of Medicine; Harvard University; Harvard Medical School	Schmidt, M (corresponding author), Albert Einstein Coll Med, Dept Biochem, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	marion.schmidt@einstein.yu.edu	Rommel, Philipp C/AAP-1813-2020; Cordero, Radamés JB/F-6912-2011; Smith, David/AAL-7662-2020	Rommel, Philipp C/0000-0002-9790-4086; Cordero, Radamés JB/0000-0002-3026-7094; Smith, David/0000-0002-1502-676X; Noy, Tahel/0000-0002-8492-8505	National Institutes of Health [NIH-NIGMS-084228, NIH-NIGMS-043601, NIH-NIGMS 5R01GM51923]; Multiple Myeloma Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051923, R37GM043601, R01GM084228] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Multiple Myeloma Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants NIH-NIGMS-084228 (to M. S.), NIH-NIGMS-043601 (to D. F.), and NIH-NIGMS 5R01GM51923 (to A. L. G.). This work was also supported by the Multiple Myeloma Research Foundation.	Blickwedehl J, 2008, P NATL ACAD SCI USA, V105, P16165, DOI 10.1073/pnas.0803145105; Brachmann CB, 1998, YEAST, V14, P115; Braun BC, 1999, NAT CELL BIOL, V1, P221, DOI 10.1038/12043; Cascio P, 2002, EMBO J, V21, P2636, DOI 10.1093/emboj/21.11.2636; David DC, 2002, J NEUROCHEM, V83, P176, DOI 10.1046/j.1471-4159.2002.01137.x; Dohmen RJ, 2007, BBA-MOL CELL RES, V1773, P1599, DOI 10.1016/j.bbamcr.2007.05.015; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Fehlker M, 2003, EMBO REP, V4, P959, DOI 10.1038/sj.embor.embor938; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Forster A, 2005, MOL CELL, V18, P589, DOI 10.1016/j.molcel.2005.04.016; Gillette TG, 2008, J BIOL CHEM, V283, P31813, DOI 10.1074/jbc.M805935200; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Groll M, 2000, NAT STRUCT BIOL, V7, P1062, DOI 10.1038/80992; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Hartmann-Petersen R, 2001, ARCH BIOCHEM BIOPHYS, V386, P89, DOI 10.1006/abbi.2000.2178; Hendil KB, 1998, BIOCHEM J, V332, P749, DOI 10.1042/bj3320749; Iwanczyk J, 2006, J MOL BIOL, V363, P648, DOI 10.1016/j.jmb.2006.08.010; Kajava AV, 2004, J STRUCT BIOL, V146, P425, DOI 10.1016/j.jsb.2004.01.013; Kisselev AF, 2002, J BIOL CHEM, V277, P22260, DOI 10.1074/jbc.M112360200; Kisselev AF, 2006, J BIOL CHEM, V281, P8582, DOI 10.1074/jbc.M509043200; Knowlton JR, 1997, NATURE, V390, P639, DOI 10.1038/37670; Kopp F, 2001, J MOL BIOL, V313, P465, DOI 10.1006/jmbi.2001.5063; Kruegel U, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002253; Kumar B, 2010, J BIOL CHEM, V285, P39523, DOI 10.1074/jbc.M110.153627; Lehmann A, 2008, EMBO REP, V9, P1237, DOI 10.1038/embor.2008.190; Li XT, 2007, MOL CELL, V26, P831, DOI 10.1016/j.molcel.2007.05.028; Liu CW, 2002, J BIOL CHEM, V277, P26815, DOI 10.1074/jbc.M201782200; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lopez AD, 2011, MOL BIOL CELL, V22, P528, DOI 10.1091/mbc.E10-04-0352; Marques AJ, 2007, J BIOL CHEM, V282, P34869, DOI 10.1074/jbc.M705836200; Ortega J, 2005, J MOL BIOL, V346, P1221, DOI 10.1016/j.jmb.2004.12.049; Park S, 2009, NATURE, V459, P866, DOI 10.1038/nature08065; Peth A, 2009, MOL CELL, V36, P794, DOI 10.1016/j.molcel.2009.11.015; Pickart CM, 2004, NAT REV MOL CELL BIO, V5, P177, DOI 10.1038/nrm1336; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; Rabl J, 2008, MOL CELL, V30, P360, DOI 10.1016/j.molcel.2008.03.004; Rechsteiner M, 2005, TRENDS CELL BIOL, V15, P27, DOI 10.1016/j.tcb.2004.11.003; Sadre-Bazzaz K, 2010, MOL CELL, V37, P728, DOI 10.1016/j.molcel.2010.02.002; Schmidt M, 2005, BIOL CHEM, V386, P725, DOI 10.1515/BC.2005.085; Schmidt M, 2005, NAT STRUCT MOL BIOL, V12, P294, DOI 10.1038/nsmb914; Schwartz AL, 2009, ANNU REV PHARMACOL, V49, P73, DOI 10.1146/annurev.pharmtox.051208.165340; Smith DM, 2007, MOL CELL, V27, P731, DOI 10.1016/j.molcel.2007.06.033; Smith DM, 2011, CELL, V144, P526, DOI 10.1016/j.cell.2011.02.005; Smith DM, 2005, MOL CELL, V20, P687, DOI 10.1016/j.molcel.2005.10.019; Stadtmueller BM, 2011, MOL CELL, V41, P8, DOI 10.1016/j.molcel.2010.12.020; Tomko RJ, 2010, MOL CELL, V38, P393, DOI 10.1016/j.molcel.2010.02.035; Ustrell V, 2002, EMBO J, V21, P3516, DOI 10.1093/emboj/cdf333; Whitby FG, 2000, NATURE, V408, P115, DOI 10.1038/35040607; Wolf DH, 2004, BBA-MOL CELL RES, V1695, P19, DOI 10.1016/j.bbamcr.2004.10.007; Yao Y, 1999, J BIOL CHEM, V274, P33921, DOI 10.1074/jbc.274.48.33921; Yu YD, 2010, EMBO J, V29, P692, DOI 10.1038/emboj.2009.382; Zhang F, 2009, MOL CELL, V34, P473, DOI 10.1016/j.molcel.2009.04.021	52	57	61	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					42830	42839		10.1074/jbc.M111.300178	http://dx.doi.org/10.1074/jbc.M111.300178			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22025621	Green Published, hybrid			2022-12-27	WOS:000298351300004
J	Kojima, Y; Nakayama, M; Nishina, T; Nakano, H; Koyanagi, M; Takeda, K; Okumura, K; Yagita, H				Kojima, Yuko; Nakayama, Masafumi; Nishina, Takashi; Nakano, Hiroyasu; Koyanagi, Makoto; Takeda, Kazuyoshi; Okumura, Ko; Yagita, Hideo			Importin beta 1 Protein-mediated Nuclear Localization of Death Receptor 5 (DR5) Limits DR5/Tumor Necrosis Factor (TNF)-related Apoptosis-inducing Ligand (TRAIL)-induced Cell Death of Human Tumor Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRAIL-INDUCED APOPTOSIS; DECOY RECEPTORS; CANCER-THERAPY; PERMEABILIZATION; APO2L/TRAIL; GLYCOSYLATION; ENDOCYTOSIS; MECHANISMS; RESISTANCE; EXPRESSION	Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)/death receptor 5 (DR5)-mediated cell death plays an important role in the elimination of tumor cells and transformed cells. Recently, recombinant TRAIL and agonistic anti-DR5 monoclonal antibodies have been developed and applied to cancer therapy. However, depending on the type of cancer, the sensitivity to TRAIL has been reportedly different, and some tumor cells are resistant to TRAIL-mediated apoptosis. Using confocal microscopy, we found that large amounts of DR5 were localized in the nucleus in HeLa and HepG2 cells. Moreover, these tumor cells were resistant to TRAIL, whereas DU145 cells, which do not have nuclear DR5, were highly sensitive to TRAIL. By means of immunoprecipitation and Western blot analysis, we found that DR5 and importin beta 1 were physically associated, suggesting that the nuclear DR5 was transported through the nuclear import pathway mediated by importin beta 1. Two functional nuclear localization signals were identified in DR5, the mutation of which abrogated the nuclear localization of DR5 in HeLa cells. Moreover, the nuclear transport of DR5 was also prevented by the knockdown of importin beta 1 using siRNA, resulting in the up-regulation of DR5 expression on the cell surface and an increased sensitivity of HeLa and HepG2 cells to TRAIL. Taken together, our findings suggest that the importin beta 1-mediated nuclear localization of DR5 limits the DR5/TRAIL-induced cell death of human tumor cells and thus can be a novel target to improve cancer therapy with recombinant TRAIL and anti-DR5 antibodies.	[Kojima, Yuko] Juntendo Univ, Sch Med, Biomed Res Ctr, Lab Biomed Imaging Res,Bunkyo Ku, Tokyo 1138421, Japan; [Nakayama, Masafumi; Nishina, Takashi; Nakano, Hiroyasu; Koyanagi, Makoto; Takeda, Kazuyoshi; Okumura, Ko; Yagita, Hideo] Juntendo Univ, Sch Med, Dept Immunol, Bunkyo Ku, Tokyo 1138421, Japan; [Nishina, Takashi; Okumura, Ko] Juntendo Univ, Sch Med, Atopy Res Ctr, Bunkyo Ku, Tokyo 1138421, Japan; [Nakano, Hiroyasu] Juntendo Univ, Sch Med, Biomed Res Ctr, Lab Mol & Biochem Res,Bunkyo Ku, Tokyo 1138421, Japan; [Nakayama, Masafumi] Tohoku Univ, Inst Dev Aging & Canc, Dept Immunobiol, Aoba Ku, Sendai, Miyagi 9805875, Japan	Juntendo University; Juntendo University; Juntendo University; Juntendo University; Tohoku University	Kojima, Y (corresponding author), Juntendo Univ, Sch Med, Biomed Res Ctr, Lab Biomed Imaging Res,Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.	kojima-y@juntendo.ac.jp	Nishina, Takashi/AAQ-3942-2021	Nishina, Takashi/0000-0003-2301-9874; Nakayama, Masafumi/0000-0002-9839-7143; Nakano, Hiroyasu/0000-0003-4843-1427	Ministry of Education, Culture, Sports, Science and Technology, Japan [19590257, 22240089]; Grants-in-Aid for Scientific Research [23659404, 23300355] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-aid for Scientific Research 19590257 and 22240089 from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Akazawa Y, 2009, GASTROENTEROLOGY, V136, P2365, DOI 10.1053/j.gastro.2009.02.071; Akiba H, 1998, J BIOL CHEM, V273, P13353, DOI 10.1074/jbc.273.21.13353; Ashkenazi A, 2008, NAT REV DRUG DISCOV, V7, P1001, DOI 10.1038/nrd2637; Austin CD, 2006, P NATL ACAD SCI USA, V103, P10283, DOI 10.1073/pnas.0604044103; Baake M, 2001, EUR J CELL BIOL, V80, P669, DOI 10.1078/0171-9335-00208; Bridgham JT, 2003, CELL DEATH DIFFER, V10, P19, DOI 10.1038/sj.cdd.4401174; Carpenter G, 2003, CURR OPIN CELL BIOL, V15, P143, DOI 10.1016/S0955-0674(03)00015-2; Chen HC, 2010, J IMMUNOL, V185, P64, DOI 10.4049/jimmunol.0903323; Elrod HA, 2008, CANCER BIOL THER, V7, P163, DOI 10.4161/cbt.7.2.5335; Falschlehner C, 2009, IMMUNOLOGY, V127, P145, DOI 10.1111/j.1365-2567.2009.03058.x; Gonzalvez F, 2010, ONCOGENE, V29, P4752, DOI 10.1038/onc.2010.221; Hintersteiner M, 2010, ACS CHEM BIOL, V5, P967, DOI 10.1021/cb100094k; Jazirehi AR, 2001, CLIN CANCER RES, V7, P3874; Johnstone RW, 2008, NAT REV CANCER, V8, P782, DOI 10.1038/nrc2465; Kanazawa T, 2008, J CELL PHYSIOL, V215, P517, DOI 10.1002/jcp.21328; Kau TR, 2004, NAT REV CANCER, V4, P106, DOI 10.1038/nrc1274; Kayagaki N, 1999, J EXP MED, V189, P1451, DOI 10.1084/jem.189.9.1451; Kayagaki N, 1999, J IMMUNOL, V163, P1906; Kohlhaas SL, 2007, J BIOL CHEM, V282, P12831, DOI 10.1074/jbc.M700438200; Lanza F, 1997, CYTOMETRY, V30, P134; Leithner K, 2009, LUNG CANCER, V65, P98, DOI 10.1016/j.lungcan.2008.10.015; Lin-Lee YC, 2006, J BIOL CHEM, V281, P18878, DOI 10.1074/jbc.M513315200; MacFarlane M, 2003, TOXICOL LETT, V139, P89, DOI 10.1016/S0378-4274(02)00422-8; Marsters SA, 1997, CURR BIOL, V7, P1003, DOI 10.1016/S0960-9822(06)00422-2; McDonald ER, 2001, J BIOL CHEM, V276, P14939, DOI 10.1074/jbc.M100399200; Miyakawa K, 1999, J BIOL CHEM, V274, P29352, DOI 10.1074/jbc.274.41.29352; Miyakawa K, 2003, J BIOL CHEM, V278, P35718, DOI 10.1074/jbc.M300690200; Petrocca F, 2011, J CLIN ONCOL, V29, P747, DOI 10.1200/JCO.2009.27.6287; SANDERS SL, 1992, J BIOL CHEM, V267, P13791; Sheridan JP, 1997, SCIENCE, V277, P818, DOI 10.1126/science.277.5327.818; Sorokin AV, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1439, DOI 10.1134/S0006297907130032; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; Takeda K, 2007, ONCOGENE, V26, P3745, DOI 10.1038/sj.onc.1210374; Takeda K, 2004, J EXP MED, V199, P437, DOI 10.1084/jem.20031457; Ullman KS, 1997, CELL, V90, P967, DOI 10.1016/S0092-8674(00)80361-X; Uno T, 2006, NAT MED, V12, P693, DOI 10.1038/nm1405; VONHEIJNE G, 1981, EUR J BIOCHEM, V116, P419; Wagner KW, 2007, NAT MED, V13, P1070, DOI 10.1038/nm1627; Walczak H, 1997, EMBO J, V16, P5386, DOI 10.1093/emboj/16.17.5386; West CM, 2002, GLYCOBIOLOGY, V12, p17R, DOI 10.1093/glycob/12.2.17R; Yagita H, 2004, CANCER SCI, V95, P777, DOI 10.1111/j.1349-7006.2004.tb02181.x; Zhang LD, 2005, CANCER GENE THER, V12, P228, DOI 10.1038/sj.cgt.7700792; Zhang XD, 2000, FEBS LETT, V482, P193, DOI 10.1016/S0014-5793(00)02042-1; Zhang XD, 2000, J IMMUNOL, V164, P3961, DOI 10.4049/jimmunol.164.8.3961	44	49	53	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					43383	43393		10.1074/jbc.M111.309377	http://dx.doi.org/10.1074/jbc.M111.309377			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22020938	hybrid, Green Published			2022-12-27	WOS:000298351300058
J	Miyaji, T; Sawada, K; Omote, H; Moriyama, Y				Miyaji, Takaaki; Sawada, Keisuke; Omote, Hiroshi; Moriyama, Yoshinori			Divalent Cation Transport by Vesicular Nucleotide Transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMAFFIN GRANULES; GLUTAMATE TRANSPORT; SECRETORY VESICLES; ATP; IDENTIFICATION; BIOENERGETICS; MAGNESIUM; PROTEIN; CALCIUM; MG2+	Background: The vesicular nucleotide transporter (VNUT) transports nucleotides in the presence of Mg2+. Results: VNUT transports divalent cations in a membrane potential-and nucleotide-dependent manner. Conclusion: VNUT transports divalent cations as a nucleotide complex. Significance: VNUT functions as a divalent cation importer in secretory vesicles.	[Sawada, Keisuke; Omote, Hiroshi; Moriyama, Yoshinori] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Membrane Biochem, Okayama 7008530, Japan; [Miyaji, Takaaki; Moriyama, Yoshinori] Okayama Univ, Adv Sci Res Ctr, Okayama 7008530, Japan	Okayama University; Okayama University	Moriyama, Y (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Membrane Biochem, Okayama 7008530, Japan.	moriyama@pharm.okayama-u.ac.jp	OMOTE, Hiroshi/B-1635-2011	Miyaji, Takaaki/0000-0002-7257-7621	Ministry of Education, Science, Sports and Culture of Japan; Japan Society for the Promotion of Science	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by grants-in-aid for scientific research from the Ministry of Education, Science, Sports and Culture of Japan (to Y. M., T. M., and H. O.) and for salt science (to Y.M.).; Supported by a research fellowship for young scientists from the Japan Society for the Promotion of Science.	AUSTIN J, 1984, J BIOL CHEM, V259, P154; BURGER A, 1984, J NEUROCHEM, V43, P806, DOI 10.1111/j.1471-4159.1984.tb12803.x; FABIATO A, 1979, J PHYSIOL-PARIS, V75, P463; FIEDLER J, 1984, J NEUROCHEM, V42, P1291, DOI 10.1111/j.1471-4159.1984.tb02786.x; Gropp T, 1999, BIOPHYS J, V77, P714, DOI 10.1016/S0006-3495(99)76926-2; Gunther T, 2006, MAGNESIUM RES, V19, P225; Henrich M, 2008, AM J PHYSIOL-CELL PH, V294, pC280, DOI 10.1152/ajpcell.00345.2007; Iharada M, 2010, J BIOL CHEM, V285, P26107, DOI 10.1074/jbc.M110.122721; JOHNSON RG, 1988, PHYSIOL REV, V68, P232, DOI 10.1152/physrev.1988.68.1.232; Juge N, 2010, NEURON, V68, P99, DOI 10.1016/j.neuron.2010.09.002; Juge N, 2006, J BIOL CHEM, V281, P39499, DOI 10.1074/jbc.M607670200; Khakh BS, 2009, SCI AM, V301, P84, DOI 10.1038/scientificamerican1209-84; KING SC, 1988, BIOCHEM BIOPH RES CO, V155, P656, DOI 10.1016/S0006-291X(88)80545-X; KRIEGERBRAUER H, 1982, BIOCHIM BIOPHYS ACTA, V691, P61, DOI 10.1016/0005-2736(82)90214-0; Miyaji T, 2008, P NATL ACAD SCI USA, V105, P11720, DOI 10.1073/pnas.0804015105; Montezinho Liliana P., 2002, Metal-Based Drugs, V9, P69, DOI 10.1155/MBD.2002.69; NELSON N, 1988, METHOD ENZYMOL, V157, P619; NJUS D, 1986, BIOCHIM BIOPHYS ACTA, V853, P237, DOI 10.1016/0304-4173(87)90003-6; Omote H, 2011, BIOCHEMISTRY-US, V50, P5558, DOI 10.1021/bi200567k; OSULLIVAN WJ, 1964, BIOCHEMISTRY-US, V3, P18, DOI 10.1021/bi00889a005; Reimer RJ, 2004, PFLUG ARCH EUR J PHY, V447, P629, DOI 10.1007/s00424-003-1087-y; SAGARA Y, 1991, J BIOL CHEM, V266, P13503; Sawada K, 2008, P NATL ACAD SCI USA, V105, P5683, DOI 10.1073/pnas.0800141105; SCHAFFNE.W, 1973, ANAL BIOCHEM, V56, P502, DOI 10.1016/0003-2697(73)90217-0; WEBER J, 1994, J BIOL CHEM, V269, P20462	25	20	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					42881	42887		10.1074/jbc.M111.277269	http://dx.doi.org/10.1074/jbc.M111.277269			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22052906	Green Published, hybrid			2022-12-27	WOS:000298351300010
J	Wang, F; Song, WS; Brancati, G; Segatori, L				Wang, Fan; Song, Wensi; Brancati, Giovanna; Segatori, Laura			Inhibition of Endoplasmic Reticulum-associated Degradation Rescues Native Folding in Loss of Function Protein Misfolding Diseases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSOSOMAL STORAGE DISORDERS; ENZYME REPLACEMENT THERAPY; ER MANNOSIDASE-I; GAUCHER-DISEASE; GLUCOCEREBROSIDASE; RETROTRANSLOCATION; ENHANCEMENT; FIBROBLASTS; CHAPERONES; MUTATION	Lysosomal storage disorders are often caused by mutations that destabilize native folding and impair trafficking of secretory proteins. We demonstrate that endoplasmic reticulum (ER)-associated degradation (ERAD) prevents native folding of mutated lysosomal enzymes in patient-derived fibroblasts from two clinically distinct lysosomal storage disorders, namely Gaucher and Tay-Sachs disease. Prolonging ER retention via ERAD inhibition enhanced folding, trafficking, and activity of these unstable enzyme variants. Furthermore, combining ERAD inhibition with enhancement of the cellular folding capacity via proteostasis modulation resulted in synergistic rescue of mutated enzymes. ERAD inhibition was achieved by cell treatment with small molecules that interfere with recognition (kifunensine) or retrotranslocation (eeyarestatin I) of misfolded substrates. These different mechanisms of ERAD inhibition were shown to enhance ER retention of mutated proteins but were associated with dramatically different levels of ER stress, unfolded protein response activation, and unfolded protein response-induced apoptosis.	[Wang, Fan; Song, Wensi; Brancati, Giovanna; Segatori, Laura] Rice Univ, Dept Chem & Biomol Engn, Houston, TX 77005 USA	Rice University	Segatori, L (corresponding author), CHBE-MS 362,6100 Main St, Houston, TX 77005 USA.	segatori@rice.edu		Brancati, Giovanna/0000-0002-8589-3463				Avezov E, 2008, MOL BIOL CELL, V19, P216, DOI 10.1091/mbc.E07-05-0505; Fagioli C, 2001, J BIOL CHEM, V276, P12885, DOI 10.1074/jbc.M009603200; Fiebiger E, 2004, MOL BIOL CELL, V15, P1635, DOI 10.1091/mbc.E03-07-0506; Futerman AH, 2004, NAT REV MOL CELL BIO, V5, P554, DOI 10.1038/nrm1423; Gilis D, 2000, PROTEIN ENG, V13, P849, DOI 10.1093/protein/13.12.849; Grabowski GA, 1997, GENET TEST, V1, P5, DOI 10.1089/gte.1997.1.5; GRACE ME, 1994, J BIOL CHEM, V269, P2283; Hosokawa N, 2003, J BIOL CHEM, V278, P26287, DOI 10.1074/jbc.M303395200; Hruska KS, 2008, HUM MUTAT, V29, P567, DOI 10.1002/humu.20676; Ishii S, 2007, BIOCHEM J, V406, P285, DOI 10.1042/BJ20070479; Jeyakumar M, 2002, NEUROPATH APPL NEURO, V28, P343, DOI 10.1046/j.1365-2990.2002.00422.x; Kwasigroch JM, 2002, BIOINFORMATICS, V18, P1701, DOI 10.1093/bioinformatics/18.12.1701; Lederkremer GZ, 2005, TRENDS BIOCHEM SCI, V30, P297, DOI 10.1016/j.tibs.2005.04.010; Lim-Melia ER, 2009, PEDIATR ANN, V38, P448, DOI 10.3928/00904481-20090723-09; Lu J, 2010, P NATL ACAD SCI USA, V107, P21665, DOI 10.1073/pnas.1014376107; Maegawa GHB, 2007, J BIOL CHEM, V282, P9150, DOI 10.1074/jbc.M609304200; MALEY F, 1989, ANAL BIOCHEM, V180, P195, DOI 10.1016/0003-2697(89)90115-2; McCracken AA, 1996, J CELL BIOL, V132, P291, DOI 10.1083/jcb.132.3.291; MICHELAKAKIS H, 1995, J INHERIT METAB DIS, V18, P609, DOI 10.1007/BF02436006; Mu TW, 2008, CELL, V134, P769, DOI 10.1016/j.cell.2008.06.037; Muresan Z, 1998, MOL ENDOCRINOL, V12, P458, DOI 10.1210/me.12.3.458; Nakatsukasa K, 2008, TRAFFIC, V9, P861, DOI 10.1111/j.1600-0854.2008.00729.x; Nishikawa S, 2001, J CELL BIOL, V153, P1061, DOI 10.1083/jcb.153.5.1061; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Rohrbach M, 2007, DRUGS, V67, P2697, DOI 10.2165/00003495-200767180-00005; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Ron I, 2005, HUM MOL GENET, V14, P2387, DOI 10.1093/hmg/ddi240; Sawkar AR, 2006, ACS CHEM BIOL, V1, P235, DOI 10.1021/cb600187q; Schmitz M, 2005, INT J BIOCHEM CELL B, V37, P2310, DOI 10.1016/j.biocel.2005.05.008; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Schueler UH, 2004, J INHERIT METAB DIS, V27, P649, DOI 10.1023/B:BOLI.0000042959.44318.7c; Sidransky E, 2007, MOL GENET METAB, V90, P122, DOI 10.1016/j.ymgme.2006.09.007; Tropak MB, 2004, J BIOL CHEM, V279, P13478, DOI 10.1074/jbc.M308523200; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Wang F, 2011, CHEM BIOL, V18, P766, DOI 10.1016/j.chembiol.2011.04.008; Wang F, 2011, ACS CHEM BIOL, V6, P158, DOI 10.1021/cb100321m; Wang QY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015479	37	70	70	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					43454	43464		10.1074/jbc.M111.274332	http://dx.doi.org/10.1074/jbc.M111.274332			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22006919	Green Published, hybrid			2022-12-27	WOS:000298351300065
J	Bai, YP; Luo, Y; Liu, SJ; Zhang, LJ; Shen, K; Dong, YS; Walls, CD; Quilliam, LA; Wells, CD; Cao, YJ; Zhang, ZY				Bai, Yunpeng; Luo, Yong; Liu, Sijiu; Zhang, Lujuan; Shen, Kui; Dong, Yuanshu; Walls, Chad D.; Quilliam, Lawrence A.; Wells, Clark D.; Cao, Youjia; Zhang, Zhong-Yin			PRL-1 Protein Promotes ERK1/2 and RhoA Protein Activation through a Non-canonical Interaction with the Src Homology 3 Domain of p115 Rho GTPase-activating Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE PHOSPHATASES; CELL-GROWTH; INVASION; MIGRATION; CANCER; FAMILY; PRENYLATION; PROGRESSION; METASTASIS; MOTILITY	Phosphatases of the regenerating liver (PRL) play oncogenic roles in cancer development and metastasis. Although previous studies indicate that PRL-1 promotes cell growth and migration by activating both the ERK1/2 and RhoA pathways, the mechanism by which it activates these signaling events remains unclear. We have identified a PRL-1-binding peptide (Peptide 1) that shares high sequence identity with a conserved motif in the Src homology 3 (SH3) domain of p115 Rho GTPase-activating protein (GAP). p115 RhoGAP directly binds PRL-1 in vitro and in cells via its SH3 domain. Structural analyses of the PRL-1 . Peptide 1 complex revealed a novel protein-protein interaction whereby a sequence motif within the PxxP ligand-binding site of the p115 RhoGAP SH3 domain occupies a folded groove within PRL-1. This prevents the canonical interaction between the SH3 domain of p115 RhoGAP and MEKK1 and results in activation of ERK1/2. Furthermore, PRL-1 binding activates RhoA signaling by inhibiting the catalytic activity of p115 RhoGAP. The results demonstrate that PRL-1 binding to p115 RhoGAP provides a coordinated mechanism underlying ERK1/2 and RhoA activation.	[Bai, Yunpeng; Luo, Yong; Liu, Sijiu; Zhang, Lujuan; Dong, Yuanshu; Walls, Chad D.; Quilliam, Lawrence A.; Wells, Clark D.; Zhang, Zhong-Yin] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Shen, Kui] No Illinois Univ, Dept Chem & Biochem, De Kalb, IL 60115 USA; [Cao, Youjia] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China	Indiana University System; Indiana University Bloomington; Northern Illinois University; Nankai University	Zhang, ZY (corresponding author), Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA.	zyzhang@iupui.edu	Quilliam, Lawrence/B-6447-2015; Quilliam, Lawrence/Q-4987-2019; Bai, Yunpeng/M-8396-2014		National Institutes of Health [CA69202, CA126937]; NATIONAL CANCER INSTITUTE [R01CA151765, R01CA126937, R01CA069202] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA69202 and CA126937.	Achiwa H, 2007, CANCER RES, V67, P643, DOI 10.1158/0008-5472.CAN-06-2436; Bessette DC, 2008, CANCER METAST REV, V27, P231, DOI 10.1007/s10555-008-9121-3; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; BOLLAG G, 1995, METHOD ENZYMOL, V255, P161; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cates CA, 1996, CANCER LETT, V110, P49, DOI 10.1016/S0304-3835(96)04459-X; Christerson LB, 2002, J CELL PHYSIOL, V192, P200, DOI 10.1002/jcp.10125; DIAMOND RH, 1994, MOL CELL BIOL, V14, P3752, DOI 10.1128/MCB.14.6.3752; Fiordalisi JJ, 2006, CANCER RES, V66, P3153, DOI 10.1158/0008-5472.CAN-05-3116; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Li XF, 2006, J BIOL CHEM, V281, P28430, DOI 10.1074/jbc.M604135200; Luo Y, 2009, BIOCHEMISTRY-US, V48, P1838, DOI 10.1021/bi8020789; Nakashima Masanao, 2010, J Pharmacol Exp Ther, V334, P627, DOI 10.1124/jpet.110.167809; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Quilliam LA, 2001, METHOD ENZYMOL, V333, P187; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Saha S, 2001, SCIENCE, V294, P1343, DOI 10.1126/science.1065817; Soderling SH, 2002, NAT CELL BIOL, V4, P970, DOI 10.1038/ncb886; Stephens BJ, 2005, MOL CANCER THER, V4, P1653, DOI 10.1158/1535-7163.MCT-05-0248; Sun JP, 2007, J BIOL CHEM, V282, P29043, DOI 10.1074/jbc.M703537200; Sun JP, 2005, BIOCHEMISTRY-US, V44, P12009, DOI 10.1021/bi0509191; Tcherkezian J, 2007, BIOL CELL, V99, P67, DOI 10.1042/BC20060086; Tribioli C, 1996, P NATL ACAD SCI USA, V93, P695, DOI 10.1073/pnas.93.2.695; Vogt DL, 2007, MOL CELL NEUROSCI, V36, P332, DOI 10.1016/j.mcn.2007.07.004; Wang J, 2002, J BIOL CHEM, V277, P46659, DOI 10.1074/jbc.M206407200; Wells CD, 2001, J BIOL CHEM, V276, P28897, DOI 10.1074/jbc.M102913200; Werner SR, 2003, CANCER LETT, V202, P201, DOI 10.1016/S0304-3835(03)00517-2; Wong K, 2001, CELL, V107, P209, DOI 10.1016/S0092-8674(01)00530-X; Zeng Q, 2000, J BIOL CHEM, V275, P21444, DOI 10.1074/jbc.M000453200; Zeng Q, 2003, CANCER RES, V63, P2716	33	29	29	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42316	42324		10.1074/jbc.M111.286302	http://dx.doi.org/10.1074/jbc.M111.286302			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	22009749	Green Published, hybrid			2022-12-27	WOS:000298180900041
J	Lu, YZ; Roy, S; Nuovo, G; Ramaswamy, B; Miller, T; Shapiro, C; Jacob, ST; Majumder, S				Lu, Yuanzhi; Roy, Satavisha; Nuovo, Gerard; Ramaswamy, Bhuvaneswari; Miller, Tyler; Shapiro, Charles; Jacob, Samson T.; Majumder, Sarmila			RETRACTED: Anti-microRNA-222 (Anti-miR-222) and-181B Suppress Growth of Tamoxifen-resistant Xenografts in Mouse by Targeting TIMP3 Protein and Modulating Mitogenic Signal (Retracted article. See vol. 293, pg. 3588, 2018)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Retracted Publication							ESTROGEN-RECEPTOR-ALPHA; CONVERTING-ENZYME TACE; BREAST-CANCER CELLS; ENDOCRINE THERAPY; GENE-EXPRESSION; MECHANISMS; MICRORNAS; APOPTOSIS; PROFILES; CLUSTER	We have shown earlier that miR-221 and -222 are up-regulated in tamoxifen-resistant MCF-7 (OHTR) cells and Her2-positive human breast tumors when compared with Her2 negative tumors. In this study, we report markedly enhanced expression of miR-181b in OHTR cells and endocrine-resistant tumors. Further, anti-miR-222 or -181b in combination with tamoxifen suppressed growth of tamoxifen-resistant xenografts in mice. Luciferase reporter assay and expression analysis showed that TIMP3, a tissue metalloproteinase inhibitor, is a common target of miR-221/222 and -181b. In situ hybridization and immunohistochemical analysis demonstrated reciprocal relationships between TIMP3 and miR-221/222/181b expression in primary human breast carcinomas. Ectopic expression of TIMP3 inhibited growth of the OHTR cells, and its depletion in MCF-7 cells reduced sensitivity to tamoxifen in vitro and in vivo. EGF-induced MAPK and AKT phosphorylation were significantly higher in OHTR cells and miR-221/222-overexpressing MCF-7 cells than in control cells, which suggests modulation of mitogenic signaling by TIMP3 and the miRs. On the contrary, phosphoMAPK and phosphoAKT levels were diminished in TIMP3-overexpressing OHTR cells and increased in TIMP3-depleted MCF-7 cells. Low levels of estrogen or tamoxifen elicited similar differences in phosphoMAPK levels in these cells. Reduced levels of TIMP3 facilitated growth of tamoxifen-resistant cells by alleviating its inhibitory effect on ADAM10 and ADAM17, which are critical for OHTR cell growth. In conclusion, miR-221/222 and -181b facilitate growth factor signaling in tamoxifen-resistant breast cancer by down-regulating TIMP3, and corresponding anti-miRs can be used to render these tumors responsive to tamoxifen.	[Jacob, Samson T.] Ohio State Univ, Dept Mol & Cellular Biochem, Tzagournis Med Res Facil 646, Columbus, OH 43210 USA; [Nuovo, Gerard] Ohio State Univ, Dept Pathol, Columbus, OH 43210 USA; [Ramaswamy, Bhuvaneswari; Shapiro, Charles; Jacob, Samson T.] Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA; [Lu, Yuanzhi; Ramaswamy, Bhuvaneswari; Shapiro, Charles; Jacob, Samson T.; Majumder, Sarmila] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Majumder, Sarmila] Ohio State Univ, Dept Mol & Cellular Biochem, Tzagournis Med Res Facil 690D, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Jacob, ST (corresponding author), Ohio State Univ, Dept Mol & Cellular Biochem, Tzagournis Med Res Facil 646, 420 W 12th Ave, Columbus, OH 43210 USA.	Samson.Jacob@osumc.edu; Sarmila.majumder@osumc.edu	Jacob, Samson/H-3135-2011; Ramaswamy, Bhuvaneswari/E-3919-2011	Miller, Tyler E/0000-0002-1269-1895	NCI, National Institutes of Health from the USPHS [CA137567]; NATIONAL CANCER INSTITUTE [R21CA137567] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025755] Funding Source: NIH RePORTER	NCI, National Institutes of Health from the USPHS; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by NCI, National Institutes of Health Grant CA137567 from the USPHS.	Amour A, 1998, FEBS LETT, V435, P39, DOI 10.1016/S0014-5793(98)01031-X; Clarke M, 1998, LANCET, V351, P1451; Datta J, 2008, CANCER RES, V68, P5049, DOI 10.1158/0008-5472.CAN-07-6655; Di Leva G, 2010, JNCI-J NATL CANCER I, V102, P706, DOI 10.1093/jnci/djq102; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Edwards DR, 2004, J PATHOL, V202, P391, DOI 10.1002/path.1548; Fan MY, 2006, CANCER RES, V66, P11954, DOI 10.1158/0008-5472.CAN-06-1666; Fan P, 2007, CANCER RES, V67, P1352, DOI 10.1158/0008-5472.CAN-06-1020; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Garofalo M, 2008, ONCOGENE, V27, P3845, DOI 10.1038/onc.2008.6; Gupta GP, 2007, NATURE, V446, P765, DOI 10.1038/nature05760; Helleman J, 2008, CLIN CANCER RES, V14, P5555, DOI 10.1158/1078-0432.CCR-08-0555; HENDERSON BE, 1988, CANCER RES, V48, P246; Iliopoulos D, 2010, MOL CELL, V39, P493, DOI 10.1016/j.molcel.2010.07.023; Jordan NJ, 2004, BREAST CANCER RES TR, V87, P167, DOI 10.1023/B:BREA.0000041623.21338.47; KEY TJA, 1988, EUR J CANCER CLIN ON, V24, P29, DOI 10.1016/0277-5379(88)90173-3; Lee EJ, 2007, INT J CANCER, V120, P1046, DOI 10.1002/ijc.22394; Lim LP, 2003, SCIENCE, V299, P1540, DOI 10.1126/science.1080372; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maillot G, 2009, CANCER RES, V69, P8332, DOI 10.1158/0008-5472.CAN-09-2206; Merlos-Suarez A, 2001, J BIOL CHEM, V276, P48510, DOI 10.1074/jbc.M103488200; Miller TE, 2008, J BIOL CHEM, V283, P29897, DOI 10.1074/jbc.M804612200; Nasser MW, 2008, J BIOL CHEM, V283, P33394, DOI 10.1074/jbc.M804788200; Obad S, 2011, NAT GENET, V43, P371, DOI 10.1038/ng.786; Osborne CK, 2011, ANNU REV MED, V62, P233, DOI 10.1146/annurev-med-070909-182917; PIKE MC, 1993, EPIDEMIOL REV, V15, P17, DOI 10.1093/oxfordjournals.epirev.a036102; Pogribny IP, 2010, INT J CANCER, V127, P1785, DOI 10.1002/ijc.25191; Samaddar JS, 2008, MOL CANCER THER, V7, P2977, DOI 10.1158/1535-7163.MCT-08-0447; Span PN, 2004, J PATHOL, V202, P395, DOI 10.1002/path.1528; Sun T, 2009, CANCER RES, V69, P3356, DOI 10.1158/0008-5472.CAN-08-4112; Sunnarborg SW, 2002, J BIOL CHEM, V277, P12838, DOI 10.1074/jbc.M112050200; Wang B, 2010, ONCOGENE, V29, P1787, DOI 10.1038/onc.2009.468; Wang B, 2009, HEPATOLOGY, V50, P1152, DOI 10.1002/hep.23100; Xin FX, 2009, BIOINFORMATICS, V25, P430, DOI 10.1093/bioinformatics/btn646; Yan LX, 2008, RNA, V14, P2348, DOI 10.1261/rna.1034808; Yan YB, 2002, J CELL BIOL, V158, P221, DOI 10.1083/jcb.200112026; Zhang CZ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-367; Zhao JJ, 2008, J BIOL CHEM, V283, P31079, DOI 10.1074/jbc.M806041200; Zhu SM, 2007, J BIOL CHEM, V282, P14328, DOI 10.1074/jbc.M611393200	39	86	89	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42292	42302		10.1074/jbc.M111.270926	http://dx.doi.org/10.1074/jbc.M111.270926			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	22009755	Green Published, hybrid			2022-12-27	WOS:000298180900039
J	Chapman, KD; Ohlrogge, JB				Chapman, Kent D.; Ohlrogge, John B.			Compartmentation of Triacylglycerol Accumulation in Plants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							COA-DIACYLGLYCEROL ACYLTRANSFERASE; COENZYME-A SYNTHETASE; FATTY-ACID SYNTHESIS; ENDOPLASMIC-RETICULUM; SEED OIL; LIPID-SYNTHESIS; MICROSOMAL PREPARATIONS; TRANSGENIC ARABIDOPSIS; DEVELOPING EMBRYOS; KEY ENZYME	Triacylglycerols from plants, familiar to most people as vegetable oils, supply 25% of dietary calories to the developed world and are increasingly a source for renewable biomaterials and fuels. Demand for vegetable oils will double by 2030, which can be met only by increased oil production. Triacylglycerol synthesis is accomplished through the coordinate action of multiple pathways in multiple subcellular compartments. Recent information has revealed an underappreciated complexity in pathways for synthesis and accumulation of this important energy-rich class of molecules.	[Chapman, Kent D.] Univ N Texas, Dept Biol Sci, Ctr Plant Lipid Res, Denton, TX 76203 USA; [Ohlrogge, John B.] Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA	University of North Texas System; University of North Texas Denton; Michigan State University	Chapman, KD (corresponding author), Univ N Texas, Dept Biol Sci, Ctr Plant Lipid Res, Denton, TX 76203 USA.	chapman@unt.edu		Chapman, Kent/0000-0003-0489-3072	United States Department of Energy, Office of Science (Biological Environmental Research and Basic Energy Sciences) [DBI-0701919]; Great Lakes Bioenergy Research Center Department of Energy [DE-FC02-07ER64494]	United States Department of Energy, Office of Science (Biological Environmental Research and Basic Energy Sciences)(United States Department of Energy (DOE)); Great Lakes Bioenergy Research Center Department of Energy(United States Department of Energy (DOE))	This work was supported by the United States Department of Energy, Office of Science (Biological Environmental Research and Basic Energy Sciences); National Science Foundation Grant DBI-0701919; and Great Lakes Bioenergy Research Center Department of Energy Grant DE-FC02-07ER64494. This is the third article in the Thematic Minireview Series on the Lipid Droplet, a Dynamic Organelle of Biomedical and Commercial Importance.	Adeyo O, 2011, J CELL BIOL, V192, P1043, DOI 10.1083/jcb.201010111; Allen DK, 2009, PLANT J, V58, P220, DOI 10.1111/j.1365-313X.2008.03771.x; Andersson MX, 2007, J BIOL CHEM, V282, P1170, DOI 10.1074/jbc.M608124200; Andersson MX, 2004, BBA-MOL CELL BIOL L, V1684, P46, DOI 10.1016/j.bbalip.2004.06.003; Andrianov V, 2010, PLANT BIOTECHNOL J, V8, P277, DOI 10.1111/j.1467-7652.2009.00458.x; BAFOR M, 1990, BIOCHEM J, V272, P31, DOI 10.1042/bj2720031; Bao XM, 1999, PLANT PHYSIOL, V120, P1057, DOI 10.1104/pp.120.4.1057; Bates PD, 2007, J BIOL CHEM, V282, P31206, DOI 10.1074/jbc.M705447200; Bates PD, 2011, PLANT J, V68, P387, DOI 10.1111/j.1365-313X.2011.04693.x; Bates PD, 2009, PLANT PHYSIOL, V150, P55, DOI 10.1104/pp.109.137737; Baud S, 2010, PROG LIPID RES, V49, P235, DOI 10.1016/j.plipres.2010.01.001; Benning C, 2009, ANNU REV CELL DEV BI, V25, P71, DOI 10.1146/annurev.cellbio.042308.113414; Bourgis F, 2011, P NATL ACAD SCI USA, V108, P12527, DOI 10.1073/pnas.1106502108; Bouvier-Nave P, 2000, EUR J BIOCHEM, V267, P85, DOI 10.1046/j.1432-1327.2000.00961.x; BROWSE J, 1991, ANNU REV PLANT PHYS, V42, P467, DOI 10.1146/annurev.pp.42.060191.002343; BROWSE J, 1981, BIOCHEM J, V196, P347, DOI 10.1042/bj1960347; Burgal J, 2008, PLANT BIOTECHNOL J, V6, P819, DOI 10.1111/j.1467-7652.2008.00361.x; Cahoon EB, 2007, CURR OPIN PLANT BIOL, V10, P236, DOI 10.1016/j.pbi.2007.04.005; Cao JS, 2006, P NATL ACAD SCI USA, V103, P19695, DOI 10.1073/pnas.0609140103; Carlsson AS, 2011, EUR J LIPID SCI TECH, V113, P812, DOI 10.1002/ejlt.201100032; Carman GM, 2009, J BIOL CHEM, V284, P2593, DOI 10.1074/jbc.R800059200; Cernac A, 2004, PLANT J, V40, P575, DOI 10.1111/j.1365-313X.2004.02235.x; Dahlqvist A, 2000, P NATL ACAD SCI USA, V97, P6487, DOI 10.1073/pnas.120067297; Eastmond PJ, 2010, PLANT CELL, V22, P2796, DOI 10.1105/tpc.109.071423; Gidda SK, 2009, PLANT PHYSIOL BIOCH, V47, P867, DOI 10.1016/j.plaphy.2009.05.008; Goffman FD, 2005, PLANT PHYSIOL, V138, P2269, DOI 10.1104/pp.105.063628; Hanson MR, 2011, PLANT PHYSIOL, V155, P1486, DOI 10.1104/pp.110.170852; Harwood JL, 1996, BBA-LIPID LIPID MET, V1301, P7, DOI 10.1016/0005-2760(95)00242-1; He XH, 2004, LIPIDS, V39, P311, DOI 10.1007/s11745-004-1234-2; JONES A, 1995, PLANT CELL, V7, P359, DOI 10.1105/tpc.7.3.359; Jouhet J, 2007, PROG LIPID RES, V46, P37, DOI 10.1016/j.plipres.2006.06.002; Kim HU, 2005, PLANT CELL, V17, P1073, DOI 10.1105/tpc.104.030403; Kim HU, 2011, PLANT CELL PHYSIOL, V52, P983, DOI 10.1093/pcp/pcr051; Koo AJK, 2004, J BIOL CHEM, V279, P16101, DOI 10.1074/jbc.M311305200; Kroon JTM, 2006, PHYTOCHEMISTRY, V67, P2541, DOI 10.1016/j.phytochem.2006.09.020; LANDS WEM, 1965, ANNU REV BIOCHEM, V34, P313, DOI 10.1146/annurev.bi.34.070165.001525; Li RZ, 2010, LIPIDS, V45, P145, DOI 10.1007/s11745-010-3385-4; Lu CF, 2009, P NATL ACAD SCI USA, V106, P18837, DOI 10.1073/pnas.0908848106; Lung SC, 2006, LIPIDS, V41, P1073, DOI 10.1007/s11745-006-5057-y; Maisonneuve S, 2010, PLANT PHYSIOL, V152, P670, DOI 10.1104/pp.109.148247; Mhaske V, 2005, PLANT PHYSIOL BIOCH, V43, P413, DOI 10.1016/j.plaphy.2005.01.013; Mietkiewska E, 2011, FEBS J, V278, P764, DOI 10.1111/j.1742-4658.2010.07995.x; Mongrand S, 2000, PLANT PHYSIOL, V122, P845, DOI 10.1104/pp.122.3.845; Nakamura Y, 2009, P NATL ACAD SCI USA, V106, P20978, DOI 10.1073/pnas.0907173106; Napier JA, 2010, CURR OPIN PLANT BIOL, V13, P330, DOI 10.1016/j.pbi.2010.01.008; Nikolau BJ, 2003, ARCH BIOCHEM BIOPHYS, V414, P211, DOI 10.1016/S0003-9861(03)00156-5; Oelkers P, 2002, J BIOL CHEM, V277, P8877, DOI 10.1074/jbc.M111646200; Ohlrogge J., 2011, BIOCHEMISTRY-US, V33, P34, DOI [10.1042/BIO03302034, DOI 10.1042/BIO03302034]; Ohlrogge JB, 1997, ANNU REV PLANT PHYS, V48, P109, DOI 10.1146/annurev.arplant.48.1.109; Ohto M, 2005, P NATL ACAD SCI USA, V102, P3123, DOI 10.1073/pnas.0409858102; Pollard M, 1999, PLANT PHYSIOL, V121, P1217, DOI 10.1104/pp.121.4.1217; Reue K, 2009, J LIPID RES, V50, pS109, DOI 10.1194/jlr.R800052-JLR200; Roesler K, 1997, PLANT PHYSIOL, V113, P75, DOI 10.1104/pp.113.1.75; Routaboul JM, 1999, PLANT PHYSIOL BIOCH, V37, P831, DOI 10.1016/S0981-9428(99)00115-1; Ruuska SA, 2002, PLANT CELL, V14, P1191, DOI 10.1105/tpc.000877; Schnurr JA, 2002, PLANT PHYSIOL, V129, P1700, DOI 10.1104/pp.003251; Schwender J, 2004, NATURE, V432, P779, DOI 10.1038/nature03145; Shen B, 2010, PLANT PHYSIOL, V153, P980, DOI 10.1104/pp.110.157537; Shockey JM, 2006, PLANT CELL, V18, P2294, DOI 10.1105/tpc.106.043695; Shockey JM, 2002, PLANT PHYSIOL, V129, P1710, DOI 10.1104/pp.003269; SPERLING P, 1993, EUR J BIOCHEM, V213, P965, DOI 10.1111/j.1432-1033.1993.tb17841.x; Stahl U, 2004, PLANT PHYSIOL, V135, P1324, DOI 10.1104/pp.104.044354; STYMNE S, 1983, BIOCHIM BIOPHYS ACTA, V752, P198, DOI 10.1016/0005-2760(83)90113-3; STYMNE S, 1984, BIOCHEM J, V223, P305, DOI 10.1042/bj2230305; Tranbarger TJ, 2011, PLANT PHYSIOL, V156, P564, DOI 10.1104/pp.111.175141; van Erp H, 2011, PLANT PHYSIOL, V155, P683, DOI 10.1104/pp.110.167239; Vigeolas H, 2011, PLANT PHYSIOL, V155, P1435, DOI 10.1104/pp.110.166462; Voelker T, 2001, ANNU REV PLANT PHYS, V52, P335, DOI 10.1146/annurev.arplant.52.1.335; Yang WL, 2010, P NATL ACAD SCI USA, V107, P12040, DOI 10.1073/pnas.0914149107; Zhang M, 2009, PLANT CELL, V21, P3885, DOI 10.1105/tpc.109.071795; Zhao LF, 2010, PLANT J, V64, P1048, DOI 10.1111/j.1365-313X.2010.04396.x	71	296	330	7	100	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2288	2294		10.1074/jbc.R111.290072	http://dx.doi.org/10.1074/jbc.R111.290072			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22090025	hybrid, Green Published			2022-12-27	WOS:000300292300004
J	Sethi, MK; Buettner, FFR; Ashikov, A; Krylov, VB; Takeuchi, H; Nifantiev, NE; Haltiwanger, RS; Gerardy-Schahn, R; Bakker, H				Sethi, Maya K.; Buettner, Falk F. R.; Ashikov, Angel; Krylov, Vadim B.; Takeuchi, Hideyuki; Nifantiev, Nikolay E.; Haltiwanger, Robert S.; Gerardy-Schahn, Rita; Bakker, Hans			Molecular Cloning of a Xylosyltransferase That Transfers the Second Xylose to O-Glucosylated Epidermal Growth Factor Repeats of Notch	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-LIKE DOMAIN; CELL LINE HEPG2; FACTOR-IX; EXTRACELLULAR DOMAIN; MAMMALIAN NOTCH; SERINE RESIDUE; MODIFIES NOTCH; MOUSE NOTCH1; FACTOR-VII; FRINGE	The extracellular domain of Notch contains epidermal growth factor (EGF) repeats that are extensively modified with different O-linked glycans. O-Fucosylation is essential for receptor function, and elongation with N-acetylglucosamine, catalyzed by members of the Fringe family, modulates Notch activity. Only recently, genes encoding enzymes involved in the O-glucosylation pathway have been cloned. In the Drosophila mutant rumi, characterized by a mutation in the protein O-glucosyltransferase, Notch signaling is impaired in a temperature-dependent manner, and a mouse knock-out leads to embryonic lethality. We have previously identified two human genes, GXYLT1 and GXYLT2, encoding glucoside xylosyltransferases responsible for the transfer of xylose to O-linked glucose. The identity of the enzyme further elongating the glycan to generate the final trisaccharide xylose-xylose-glucose, however, remained unknown. Here, we describe that the human gene C3ORF21 encodes a UDP-xylose: alpha-xyloside alpha 1,3-xylosyl-transferase, acting on xylose-alpha 1,3-glucose beta 1-containing acceptor structures. We have, therefore, renamed it XXYLT1 (xyloside xylosyltransferase 1). XXYLT1 cannot act on a synthetic acceptor containing an alpha-linked xylose alone, but requires the presence of the underlying glucose. Activity on Notch EGF repeats was proven by in vitro xylosylation of a mouse Notch1 fragment recombinantly produced in Sf9 insect cells, a bacterially expressed EGF repeat from mouse Notch2 modified in vitro by Rumi and Gxylt2 and in vivo by co-expression of the enzyme with the Notch1 fragment. The enzyme was shown to be a typical type II membrane-bound glycosyltransferase localized in the endoplasmic reticulum.	[Sethi, Maya K.; Buettner, Falk F. R.; Ashikov, Angel; Gerardy-Schahn, Rita; Bakker, Hans] Hannover Med Sch, Dept Cellular Chem, D-30625 Hannover, Germany; [Krylov, Vadim B.; Nifantiev, Nikolay E.] Russian Acad Sci, Lab Glycoconjugate Chem, ND Zelinsky Inst Organ Chem, Moscow 119991, Russia; [Takeuchi, Hideyuki; Haltiwanger, Robert S.] SUNY Stony Brook, Dept Biochem & Cell Biol, Inst Cell & Dev Biol, Stony Brook, NY 11794 USA	Hannover Medical School; Russian Academy of Sciences; Zelinsky Institute of Organic Chemistry; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Bakker, H (corresponding author), Hannover Med Sch, Dept Cellular Chem, Carl Neuberg Str 1, D-30625 Hannover, Germany.	bakker.hans@mh-hannover.de	Bakker, Hans/A-1787-2017; Takeuchi, Hideyuki/AAZ-9210-2020; Ashikov, Angel/N-7714-2015; Nifantiev, Nikolay E/O-6579-2015; Krylov, Vadim B./AAE-9936-2022; Bakker, Hans/AAA-1623-2020; Krylov, Vadim B./AES-8666-2022	Bakker, Hans/0000-0002-1364-9154; Ashikov, Angel/0000-0001-9679-7955; Nifantiev, Nikolay E/0000-0002-0727-4050; Krylov, Vadim B./0000-0001-9477-4610; Bakker, Hans/0000-0002-1364-9154; Krylov, Vadim B./0000-0001-9477-4610	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation); National Institutes of Health [GM61126]; National Science Foundation Research Coordination Networks [0090281]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061126] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)(German Research Foundation (DFG)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Research Coordination Networks(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by funding from the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) for the Cluster of Excellence REBIRTH (From Regenerative Biology to Reconstructive Therapy) and by National Institutes of Health Grant GM61126 (to R. S. H.).; UDP-Xyl isolation by the CarboSource Services at the Complex Carbohydrate Research Center, University of Georgia, Athens GA, was supported in part by National Science Foundation Research Coordination Networks Grant 0090281.	Acar M, 2008, CELL, V132, P247, DOI 10.1016/j.cell.2007.12.016; Aoki K, 2008, J BIOL CHEM, V283, P30385, DOI 10.1074/jbc.M804925200; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bruckner K, 2000, NATURE, V406, P411, DOI 10.1038/35019075; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Donoviel DB, 1999, GENE DEV, V13, P2801, DOI 10.1101/gad.13.21.2801; Erkens GB, 2011, NAT STRUCT MOL BIOL, V18, P755, DOI 10.1038/nsmb.2073; Fernandez-Valdivia R, 2011, DEVELOPMENT, V138, P1925, DOI 10.1242/dev.060020; Fleming RJ, 1997, DEVELOPMENT, V124, P2973; Grewal PK, 2005, GLYCOBIOLOGY, V15, P912, DOI 10.1093/glycob/cwi094; Grewal PK, 2001, NAT GENET, V28, P151, DOI 10.1038/88865; HASE S, 1990, J BIOL CHEM, V265, P1858; HASE S, 1988, J BIOCHEM-TOKYO, V104, P867, DOI 10.1093/oxfordjournals.jbchem.a122571; Hicks C, 2000, NAT CELL BIOL, V2, P515, DOI 10.1038/35019553; Ishimizu T, 2007, J BIOCHEM, V141, P593, DOI 10.1093/jb/mvm064; Jafar-Nejad H, 2010, GLYCOBIOLOGY, V20, P931, DOI 10.1093/glycob/cwq053; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Krylov V, 2007, SYNTHESIS-STUTTGART, P3147, DOI 10.1055/s-2007-990784; Leonardi J, 2011, DEVELOPMENT, V138, P3569, DOI 10.1242/dev.068361; Luo Y, 2005, J BIOL CHEM, V280, P11289, DOI 10.1074/jbc.M414574200; Matsuura A, 2008, J BIOL CHEM, V283, P35486, DOI 10.1074/jbc.M806202200; Minamida S, 1996, J BIOCHEM-TOKYO, V120, P1002; Moloney DJ, 2000, J BIOL CHEM, V275, P9604, DOI 10.1074/jbc.275.13.9604; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; Munro S, 2000, CURR BIOL, V10, P813, DOI 10.1016/S0960-9822(00)00578-9; NISHIMURA H, 1989, J BIOL CHEM, V264, P20320; NISHIMURA H, 1992, J BIOL CHEM, V267, P17520; OKA C, 1995, DEVELOPMENT, V121, P3291; Okajima T, 2002, CELL, V111, P893, DOI 10.1016/S0092-8674(02)01114-5; Omichi K, 1997, EUR J BIOCHEM, V245, P143, DOI 10.1111/j.1432-1033.1997.00143.x; Panin VM, 1997, NATURE, V387, P908, DOI 10.1038/43191; PARKER CG, 1995, EMBO J, V14, P1294, DOI 10.1002/j.1460-2075.1995.tb07115.x; PITCHER J, 1988, EUR J BIOCHEM, V176, P391, DOI 10.1111/j.1432-1033.1988.tb14294.x; Rana NA, 2011, J BIOL CHEM, V286, P31623, DOI 10.1074/jbc.M111.268243; Rana NA, 2010, GLYCOBIOLOGY, V20, P1486; RUSSO RN, 1992, J BIOL CHEM, V267, P9241; Schneider D, 2004, J MOL BIOL, V343, P799, DOI 10.1016/j.jmb.2004.08.083; Sethi MK, 2010, J BIOL CHEM, V285, P1582, DOI 10.1074/jbc.C109.065409; Shao L, 2003, J BIOL CHEM, V278, P7775, DOI 10.1074/jbc.M212221200; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shi SL, 2003, P NATL ACAD SCI USA, V100, P5234, DOI 10.1073/pnas.0831126100; Stanley P, 2007, CURR OPIN STRUC BIOL, V17, P530, DOI 10.1016/j.sbi.2007.09.007; Sun QA, 2011, J BIOL CHEM, V286, P11529, DOI 10.1074/jbc.M110.173591; Takeuchi H, 2011, P NATL ACAD SCI USA, V108, P16600, DOI 10.1073/pnas.1109696108; Takeuchi H, 2010, SEMIN CELL DEV BIOL, V21, P638, DOI 10.1016/j.semcdb.2010.03.003; Whitworth GE, 2010, GLYCOBIOLOGY, V20, P287, DOI 10.1093/glycob/cwp173	46	55	57	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2739	2748		10.1074/jbc.M111.302406	http://dx.doi.org/10.1074/jbc.M111.302406			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22117070	Green Published, hybrid			2022-12-27	WOS:000300292300045
J	Malmstrom, J; Karlsson, C; Nordenfelt, P; Ossola, R; Weisser, H; Quandt, A; Hansson, K; Aebersold, R; Malmstrom, L; Bjorck, L				Malmstrom, Johan; Karlsson, Christofer; Nordenfelt, Pontus; Ossola, Reto; Weisser, Hendrik; Quandt, Andreas; Hansson, Karin; Aebersold, Ruedi; Malmstroem, Lars; Bjorck, Lars			Streptococcus pyogenes in Human Plasma ADAPTIVE MECHANISMS ANALYZED BY MASS SPECTROMETRY-BASED PROTEOMICS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROUP-A STREPTOCOCCI; HUMAN-SERUM-ALBUMIN; STATISTICAL-MODEL; ABSOLUTE PROTEIN; BINDING; SURFACE; IDENTIFICATIONS; QUANTIFICATION; M1-PROTEIN; FIBRINOGEN	Streptococcus pyogenes is a major bacterial pathogen and a potent inducer of inflammation causing plasma leakage at the site of infection. A combination of label-free quantitative mass spectrometry-based proteomics strategies were used to measure how the intracellular proteome homeostasis of S. pyogenes is influenced by the presence of human plasma, identifying and quantifying 842 proteins. In plasma the bacterium modifies its production of 213 proteins, and the most pronounced change was the complete down-regulation of proteins required for fatty acid biosynthesis. Fatty acids are transported by albumin (HSA) in plasma. S. pyogenes expresses HSA-binding surface proteins, and HSA carrying fatty acids reduced the amount of fatty acid biosynthesis proteins to the same extent as plasma. The results clarify the function of HSA-binding proteins in S. pyogenes and underline the power of the quantitative mass spectrometry strategy used here to investigate bacterial adaptation to a given environment.	[Malmstrom, Johan; Karlsson, Christofer; Nordenfelt, Pontus; Hansson, Karin] Lund Univ, Dept Immunotechnol, SE-22100 Lund, Sweden; [Karlsson, Christofer; Nordenfelt, Pontus; Bjorck, Lars] Lund Univ, Dept Clin Sci, SE-22100 Lund, Sweden; [Ossola, Reto; Weisser, Hendrik; Quandt, Andreas; Aebersold, Ruedi; Malmstroem, Lars] ETH, Dept Biol, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland; [Weisser, Hendrik] Univ Zurich, Life Sci Zurich Ph D Program Syst Biol Complex Di, CH-8057 Zurich, Switzerland; [Aebersold, Ruedi] Univ Zurich, Fac Sci, CH-8057 Zurich, Switzerland	Lund University; Lund University; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; University of Zurich	Malmstrom, J (corresponding author), BMC, D13, SE-22184 Lund, Sweden.	Johan.Malmstrom@immun.lth.se	Nordenfelt, Pontus/H-5310-2019; Malmström, Lars/R-4991-2019; Malmström, Johan A/B-7660-2009	Nordenfelt, Pontus/0000-0002-9481-9951; Malmström, Lars/0000-0001-9885-9312; Malmström, Johan A/0000-0002-2889-7169	Swedish Research Council [2008-3356, 7480]; Crafoord Foundation; Swedish Foundation for Swedish Research [FFL4]; Swedish Government; Hansa Medical AB; Foundation of Johan; Foundation of Greta Kock; Foundation of Alfred Osterlund; Foundation of Torsten and Ragnar Soderberg; SystemsX.ch, the Swiss initiative for systems biology	Swedish Research Council(Swedish Research CouncilEuropean Commission); Crafoord Foundation; Swedish Foundation for Swedish Research; Swedish Government; Hansa Medical AB; Foundation of Johan; Foundation of Greta Kock; Foundation of Alfred Osterlund; Foundation of Torsten and Ragnar Soderberg; SystemsX.ch, the Swiss initiative for systems biology	Supported by Swedish Research Council Project 2008-3356, the Crafoord Foundation, and the Swedish Foundation for Swedish Research (FFL4). To whom correspondence should be addressed: BMC, D13, SE-221 84 Lund, Sweden. Tel.: 4646-2220830; Fax: 4646-2224200; E-mail: Johan.Malmstrom@immun.lth.se.; Supported by Swedish Research Council Project 7480, the Swedish Government Funds for Clinical Research (ALF), Hansa Medical AB, and the Foundations of Johan and Greta Kock, Alfred Osterlund, and Torsten and Ragnar Soderberg.; Supported by SystemsX.ch, the Swiss initiative for systems biology.	AKESSON P, 1994, BIOCHEM J, V300, P877, DOI 10.1042/bj3000877; Ashbaugh CD, 1998, J CLIN INVEST, V102, P550, DOI 10.1172/JCI3065; Aziz RK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009798; BJORCK L, 1987, MOL IMMUNOL, V24, P1113, DOI 10.1016/0161-5890(87)90080-0; BLACK PN, 1994, BBA-LIPID LIPID MET, V1210, P123, DOI 10.1016/0005-2760(94)90113-9; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Christner M, 2010, MOL MICROBIOL, V75, P187, DOI 10.1111/j.1365-2958.2009.06981.x; Craig R, 2003, RAPID COMMUN MASS SP, V17, P2310, DOI 10.1002/rcm.1198; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; deChateau M, 1996, P NATL ACAD SCI USA, V93, P8490, DOI 10.1073/pnas.93.16.8490; DECHATEAU M, 1994, J BIOL CHEM, V269, P12147; deChateau M, 1996, J BIOL CHEM, V271, P26609, DOI 10.1074/jbc.271.43.26609; Egesten A, 2011, J BIOL CHEM, V286, P2469, DOI 10.1074/jbc.M110.148171; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Ferretti JJ, 2001, P NATL ACAD SCI USA, V98, P4658, DOI 10.1073/pnas.071559398; FISCHETTI VA, 1989, CLIN MICROBIOL REV, V2, P285, DOI 10.1128/CMR.2.3.285-314.1989; Frick IM, 2006, EMBO J, V25, P5569, DOI 10.1038/sj.emboj.7601422; Geer LY, 2004, J PROTEOME RES, V3, P958, DOI 10.1021/pr0499491; Graham MR, 2005, AM J PATHOL, V166, P455, DOI 10.1016/S0002-9440(10)62268-7; Gubbe K, 1997, BIOCHEMISTRY-US, V36, P8107, DOI 10.1021/bi962991s; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; Hong K, 2007, CURR MICROBIOL, V55, P427, DOI 10.1007/s00284-007-9012-9; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Keller A, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100024; Kihlberg BM, 1995, MICROB PATHOGENESIS, V19, P299, DOI 10.1016/S0882-4010(96)80003-9; Kohlbacher O, 2007, BIOINFORMATICS, V23, pE191, DOI 10.1093/bioinformatics/btl299; KRONVALL G, 1979, INFECT IMMUN, V25, P1; Lange V, 2008, MOL CELL PROTEOMICS, V7, P1489, DOI 10.1074/mcp.M800032-MCP200; Liao JF, 2005, J LIPID RES, V46, P597, DOI 10.1194/jlr.D400023-JLR200; Lu P, 2007, NAT BIOTECHNOL, V25, P117, DOI 10.1038/nbt1270; Lu YJ, 2006, MOL MICROBIOL, V59, P551, DOI 10.1111/j.1365-2958.2005.04951.x; Malmstrom J, 2009, NATURE, V460, P762, DOI 10.1038/nature08184; Malmstrom L, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-158; McNeil LK, 2007, NUCLEIC ACIDS RES, V35, pD347, DOI 10.1093/nar/gkl947; Musser JM, 2005, AM J PATHOL, V167, P1461, DOI 10.1016/S0002-9440(10)61232-1; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Oehmcke S, 2010, CLIN CHIM ACTA, V411, P1172, DOI 10.1016/j.cca.2010.04.032; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Picotti P, 2010, NAT METHODS, V7, P43, DOI [10.1038/NMETH.1408, 10.1038/nmeth.1408]; Rasmussen M, 2002, MOL MICROBIOL, V43, P537, DOI 10.1046/j.1365-2958.2002.02766.x; RETNONINGRUM DS, 1994, INFECT IMMUN, V62, P2387, DOI 10.1128/IAI.62.6.2387-2394.1994; SCHMIDT KH, 1990, ZBL BAKT-INT J MED M, V273, P216; Schujman GE, 2005, CURR OPIN MICROBIOL, V8, P149, DOI 10.1016/j.mib.2005.02.003; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Silva JC, 2006, MOL CELL PROTEOMICS, V5, P144, DOI 10.1074/mcp.M500230-MCP200; Sturm M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-163; Tillett WS, 1934, B JOHNS HOPKINS HOSP, V54, P145; Venables WN., 2002, MODERN APPL STAT S; Vogel C, 2008, NAT PROTOC, V3, P1444, DOI [10.1038/nprot.2008.132, 10.1038/nport.2008.132]; White SW, 2005, ANNU REV BIOCHEM, V74, P791, DOI 10.1146/annurev.biochem.74.082803.133524; Zhang YM, 2008, NAT REV MICROBIOL, V6, P222, DOI 10.1038/nrmicro1839	52	31	31	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					1415	1425		10.1074/jbc.M111.267674	http://dx.doi.org/10.1074/jbc.M111.267674			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22117078	hybrid, Green Published			2022-12-27	WOS:000299170300055
J	Dagalv, A; Holmborn, K; Kjellen, L; Abrink, M				Dagalv, Anders; Holmborn, Katarina; Kjellen, Lena; Abrink, Magnus			Lowered Expression of Heparan Sulfate/Heparin Biosynthesis Enzyme N-Deacetylase/N-Sulfotransferase 1 Results in Increased Sulfation of Mast Cell Heparin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC STEM-CELLS; NDST1 GENE-FUNCTION; MICE DEFICIENT; CARBOXYPEPTIDASE-A; TUMOR SUPPRESSORS; IN-VIVO; PROTEOGLYCANS; MOUSE; IDENTIFICATION; ANGIOGENESIS	Deficiency of the heparan sulfate biosynthesis enzyme N-deacetylase/N-sulfotransferase 1 (NDST1) in mice causes severely disturbed heparan sulfate biosynthesis in all organs, whereas lack of NDST2 only affects heparin biosynthesis in mast cells (MCs). To investigate the individual and combined roles of NDST1 and NDST2 during MC development, in vitro differentiated MCs derived from mouse embryos and embryonic stem cells, respectively, have been studied. Whereas MC development will not occur in the absence of both NDST1 and NDST2, lack of NDST2 alone results in the generation of defective MCs. Surprisingly, the relative amount of heparin produced in NDST1(+/-) and NDST1(-/-) MCs is higher (approximate to 30%) than in control MCs where approximate to 95% of the S-35-labeled glycosaminoglycans produced is chondroitin sulfate. Lowered expression of NDST1 also results in a higher sulfate content of the heparin synthesized and is accompanied by increased levels of stored MC proteases. A model of the GAGosome, a hypothetical Golgi enzyme complex, is used to explain the results.	[Kjellen, Lena] Biomed Ctr, Dept Med Biochem & Microbiol, SE-75123 Uppsala, Sweden; [Abrink, Magnus] SLU, Dept Biomed Sci & Vet Publ Hlth, SE-75123 Uppsala, Sweden	Swedish University of Agricultural Sciences	Kjellen, L (corresponding author), Biomed Ctr, Dept Med Biochem & Microbiol, Box 582, SE-75123 Uppsala, Sweden.	lena.kjellen@imbim.uu.se; magnus.abrink@slu.se	Åbrink, Magnus/AAK-8346-2020	Abrink, Magnus/0000-0002-1335-3927	Swedish Research Council; Swedish Research Council Formas; Swedish Cancer Society; Goran Gustafsson Foundation; Gustaf V:s 80-arsfond; Magnus Bergvall Foundation; Polysackaridforskning AB	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas); Swedish Cancer Society(Swedish Cancer Society); Goran Gustafsson Foundation; Gustaf V:s 80-arsfond; Magnus Bergvall Foundation; Polysackaridforskning AB	This work was supported by the Swedish Research Council (to L. K. and M. A.), the Swedish Research Council Formas (to M. A.), the Swedish Cancer Society (to L. K.), the Goran Gustafsson Foundation (to M. A.), Gustaf V:s 80-arsfond (to L. K.), the Magnus Bergvall Foundation (to M. A.), and Polysackaridforskning AB (to L. K.).	Abramsson A, 2007, GENE DEV, V21, P316, DOI 10.1101/gad.398207; Aikawa J, 2001, J BIOL CHEM, V276, P5876, DOI 10.1074/jbc.M009606200; Bengtsson J, 2003, BIOCHEMISTRY-US, V42, P2110, DOI 10.1021/bi026928g; Cheung WF, 1996, BIOCHEMISTRY-US, V35, P5250, DOI 10.1021/bi952325b; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Fan GP, 2000, FEBS LETT, V467, P7, DOI 10.1016/S0014-5793(00)01111-X; Forsberg E, 1999, NATURE, V400, P773, DOI 10.1038/23488; Fuster MM, 2007, J CELL BIOL, V177, P539, DOI 10.1083/jcb.200610086; Grobe K, 2005, DEVELOPMENT, V132, P3777, DOI 10.1242/dev.01935; Grobe K, 2002, BBA-GEN SUBJECTS, V1573, P209, DOI 10.1016/S0304-4165(02)00386-0; Gurish MF, 2001, J EXP MED, V194, pF1, DOI 10.1084/jem.194.1.F1; Henningsson F, 2005, J CELL SCI, V118, P2035, DOI 10.1242/jcs.02333; Henningsson F, 2002, BIOL CHEM, V383, P793, DOI 10.1515/BC.2002.083; Henningsson F, 2006, FEBS J, V273, P4901, DOI 10.1111/j.1742-4658.2006.05489.x; Holmborn K, 2004, J BIOL CHEM, V279, P42355, DOI 10.1074/jbc.C400373200; Hu ZH, 2007, BONE, V40, P1462, DOI 10.1016/j.bone.2007.01.021; Hu ZH, 2009, J CELL SCI, V122, P1145, DOI 10.1242/jcs.034736; Humphries DE, 1999, NATURE, V400, P769, DOI 10.1038/23481; Jakobsson L, 2006, DEV CELL, V10, P625, DOI 10.1016/j.devcel.2006.03.009; Kolset SO, 2004, BIOCHEM J, V379, P217, DOI 10.1042/BJ20031230; Kusche-Gullberg M, 1998, J BIOL CHEM, V273, P11902, DOI 10.1074/jbc.273.19.11902; Lander AD, 2002, DEV CELL, V2, P785, DOI 10.1016/S1534-5807(02)00179-X; Ledin J, 2004, J BIOL CHEM, V279, P42732, DOI 10.1074/jbc.M405382200; Ledin J, 2006, J BIOL CHEM, V281, P35727, DOI 10.1074/jbc.M604113200; Lin X, 2000, DEV BIOL, V224, P299, DOI 10.1006/dbio.2000.9798; Lin XH, 2004, DEVELOPMENT, V131, P6009, DOI 10.1242/dev.01522; Lindahl U, 1998, J BIOL CHEM, V273, P24979, DOI 10.1074/jbc.273.39.24979; MacArthur JM, 2007, J CLIN INVEST, V117, P153, DOI 10.1172/JCI29154; McCormick C, 2000, P NATL ACAD SCI USA, V97, P668, DOI 10.1073/pnas.97.2.668; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Pallerla SR, 2008, J BIOL CHEM, V283, P16885, DOI 10.1074/jbc.M709774200; Pallerla SR, 2007, DEV DYNAM, V236, P556, DOI 10.1002/dvdy.21038; Pan Y, 2008, DEVELOPMENT, V135, P301, DOI 10.1242/dev.014829; Pan Y, 2006, DEVELOPMENT, V133, P4933, DOI 10.1242/dev.02679; Pellegrini L, 2001, CURR OPIN STRUC BIOL, V11, P629, DOI 10.1016/S0959-440X(00)00258-X; Pikas DS, 2000, BIOCHEMISTRY-US, V39, P4552, DOI 10.1021/bi992524l; Pinhal MAS, 2001, P NATL ACAD SCI USA, V98, P12984, DOI 10.1073/pnas.241175798; Presto J, 2008, P NATL ACAD SCI USA, V105, P4751, DOI 10.1073/pnas.0705807105; Ringvall M, 2000, J BIOL CHEM, V275, P25926, DOI 10.1074/jbc.C000359200; Ringvall M, 2010, PROG MOL BIOL TRANSL, V93, P35, DOI 10.1016/S1877-1173(10)93003-2; SCHWARTZ NB, 1974, BIOCHEM BIOPH RES CO, V56, P717, DOI 10.1016/0006-291X(74)90664-0; Senay C, 2000, EMBO REP, V1, P282, DOI 10.1093/embo-reports/kvd045; SHIVELY JE, 1976, BIOCHEMISTRY-US, V15, P3943, DOI 10.1021/bi00663a006; Stickens D, 2005, DEVELOPMENT, V132, P5055, DOI 10.1242/dev.02088; Tsai M, 2000, P NATL ACAD SCI USA, V97, P9186, DOI 10.1073/pnas.160254997; Vial D, 2003, J IMMUNOL, V171, P6178, DOI 10.4049/jimmunol.171.11.6178; Wang LC, 2005, NAT IMMUNOL, V6, P902, DOI 10.1038/ni1233	47	29	30	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2011	286	52					44433	44440		10.1074/jbc.M111.303891	http://dx.doi.org/10.1074/jbc.M111.303891			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870CA	22049073	hybrid, Green Published			2022-12-27	WOS:000298645500015
J	Hankins, JL; Fox, TE; Barth, BM; Unrath, KA; Kester, M				Hankins, Jody L.; Fox, Todd E.; Barth, Brian M.; Unrath, Kellee A.; Kester, Mark			Exogenous Ceramide-1-phosphate Reduces Lipopolysaccharide (LPS)-mediated Cytokine Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TANDEM MASS-SPECTROMETRY; TOLL-LIKE-RECEPTORS; NF-KAPPA-B; CERAMIDE 1-PHOSPHATE; BLOCKS APOPTOSIS; TNF-ALPHA; LPS; MACROPHAGES; ACTIVATION; KINASE	Toll-like receptor 4 (TLR4) is a component of the innate immune system that recognizes a diverse group of molecular structures, such as lipopolysaccharide (LPS) from Gram-negative bacteria. TLR4 signaling ultimately leads to activation of the transcription factor, nuclear factor kappa B(NF-kappa B), and the production of cytokines. Ceramide is a bioactive sphingolipid that has been suggested to regulate TLR4-induced NF-kappa B signaling, although reports on the role of ceramide in TLR4 activation conflict. We investigated the possibility that ceramide metabolites, such as ceramide-1-phosphate (C-1-P), may explain these discrepancies. We now report that exogenous C-1-P, but not ceramide, reduces NF-kappa B-mediated gene transcription in HEK 293 cells stably transfected with human TLR4, CD14, and MD-2. We demonstrate that inhibition of NF-kappa B by exogenous C-1-P is dose-dependent and specific to TLR4 in a reporter assay. We further demonstrate a requirement for both the phosphate moiety and the sphingoid backbone to inhibit LPS-activated NF-kappa B transcription. Specifically, C-1-P prevents the degradation of I kappa B, the phosphorylation of the p65 subunit of NF-kappa B, and LPS-stimulated MAPK activation. The functional consequence of C-1-P inhibition of NF-kappa B is a reduction in LPS-mediated cytokine release from HEK 293 TLR4-expressing cells and human peripheral blood mononuclear cells. Taken together, these data demonstrate that C-1-P may function as an anti-inflammatory lipid mediator of immune response.	[Hankins, Jody L.; Fox, Todd E.; Barth, Brian M.; Unrath, Kellee A.; Kester, Mark] Penn State Univ, Coll Med, Dept Pharmacol, Hershey, PA 17033 USA; [Fox, Todd E.; Kester, Mark] Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Kester, M (corresponding author), Penn State Coll Med, Dept Pharmacol, R130, Hershey, PA 17033 USA.	mkester@psu.edu	Kester, Mark/ABG-4615-2020	Barth, Brian/0000-0002-3542-1804	National Institutes of Health [R01HL076789]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076789] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01HL076789 (to M. K.). The Penn State Research Foundation has previously licensed ceramide nanotechnologies to Keystone Nano Inc. (State College, PA); Dr. Kester is Chief Medical Officer of Keystone Nano Inc.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Alvarez SE, 2010, NATURE, V465, P1084, DOI 10.1038/nature09128; Andreakos E, 2004, BLOOD, V103, P2229, DOI 10.1182/blood-2003-04-1356; Chiba N, 2007, J CELL PHYSIOL, V213, P126, DOI 10.1002/jcp.21101; Cuschieri Joseph, 2007, Surg Infect (Larchmt), V8, P91, DOI 10.1089/sur.2006.050; DBAIBO GS, 1993, J BIOL CHEM, V268, P17762; Fischer H, 2007, CELL MICROBIOL, V9, P1239, DOI 10.1111/j.1462-5822.2006.00867.x; Gomez-Munoz A, 2004, J LIPID RES, V45, P99, DOI 10.1194/jlr.M300158-JLR200; Graf C, 2008, J IMMUNOL, V180, P3457, DOI 10.4049/jimmunol.180.5.3457; Granado MH, 2009, BBA-MOL CELL BIOL L, V1791, P263, DOI 10.1016/j.bbalip.2009.01.023; Hoshino K, 1999, J IMMUNOL, V162, P3749; JOSEPH CK, 1994, J BIOL CHEM, V269, P17606; Jozefowski S, 2010, J IMMUNOL, V185, P6960, DOI 10.4049/jimmunol.0902926; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Lamour NF, 2011, J BIOL CHEM, V286, P42808, DOI 10.1074/jbc.M111.310169; Lamour NF, 2009, J BIOL CHEM, V284, P26897, DOI 10.1074/jbc.M109.001677; MacKichan ML, 1999, J BIOL CHEM, V274, P1767, DOI 10.1074/jbc.274.3.1767; Matzinger P, 1998, SEMIN IMMUNOL, V10, P399, DOI 10.1006/smim.1998.0143; Merrill AH, 2005, METHODS, V36, P207, DOI 10.1016/j.ymeth.2005.01.009; Mitsutake S, 2007, BIOCHEM BIOPH RES CO, V363, P519, DOI 10.1016/j.bbrc.2007.09.010; Pfeiffer A, 2001, EUR J IMMUNOL, V31, P3153, DOI 10.1002/1521-4141(200111)31:11<3153::AID-IMMU3153>3.0.CO;2-0; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Qi HY, 2005, J BIOL CHEM, V280, P38969, DOI 10.1074/jbc.M509352200; Rifkin IR, 2005, IMMUNOL REV, V204, P27, DOI 10.1111/j.0105-2896.2005.00239.x; Rovina P, 2010, BIOCHEM BIOPH RES CO, V401, P164, DOI 10.1016/j.bbrc.2010.09.041; Rovina P, 2010, BIOCHEM BIOPH RES CO, V399, P150, DOI 10.1016/j.bbrc.2010.07.034; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; Stahelin RV, 2007, J BIOL CHEM, V282, P20467, DOI 10.1074/jbc.M701396200; Subramanian P, 2005, J BIOL CHEM, V280, P17601, DOI 10.1074/jbc.M414173200; Sun Y, 2008, J LEUKOCYTE BIOL, V83, P1512, DOI 10.1189/jlb.0108076; Triantafilou K, 2001, NAT IMMUNOL, V2, P338, DOI 10.1038/86342; Triantafilou M, 2002, TRENDS IMMUNOL, V23, P301, DOI 10.1016/S1471-4906(02)02233-0; Wijesinghe DS, 2010, J LIPID RES, V51, P641, DOI 10.1194/jlr.D000430; Wittebole X, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/568396; Wolska A, 2009, CELL MOL BIOL LETT, V14, P248, DOI 10.2478/s11658-008-0048-z; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262	37	40	40	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2011	286	52					44357	44366		10.1074/jbc.M111.264010	http://dx.doi.org/10.1074/jbc.M111.264010			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870CA	22065582	Green Published, hybrid			2022-12-27	WOS:000298645500008
J	Jeong, BR; Lin, Y; Joe, A; Guo, M; Korneli, C; Yang, HR; Wang, P; Yu, M; Cerny, RL; Staiger, D; Alfano, JR; Xu, YH				Jeong, Byeong-ryool; Lin, Yan; Joe, Anna; Guo, Ming; Korneli, Christin; Yang, Huirong; Wang, Ping; Yu, Min; Cerny, Ronald L.; Staiger, Dorothee; Alfano, James R.; Xu, Yanhui			Structure Function Analysis of an ADP-ribosyltransferase Type III Effector and Its RNA-binding Target in Plant Immunity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARABIDOPSIS-THALIANA; SECRETION SYSTEM; INNATE IMMUNITY; RIBOSYLATING TOXINS; BACTERIAL EFFECTORS; RECOGNITION MOTIF; CRYSTAL-STRUCTURE; PROTEIN ATGRP7; VIRULENCE; DISCOVERY	The Pseudomonas syringae type III effector HopU1 is a mono-ADP-ribosyltransferase that is injected into plant cells by the type III protein secretion system. Inside the plant cell it suppresses immunity by modifying RNA-binding proteins including the glycine-rich RNA-binding protein GRP7. The crystal structure of HopU1 at 2.7-angstrom resolution reveals two unique protruding loops, L1 and L4, not found in other mono-ADP-ribosyltransferases. Site-directed mutagenesis demonstrates that these loops are essential for substrate recognition and enzymatic activity. HopU1 ADP-ribosylates the conserved arginine 49 of GRP7, and this reduces the ability of GRP7 to bind RNA in vitro. In vivo, expression of GRP7 with Arg-49 replaced with lysine does not complement the reduced immune responses of the Arabidopsis thaliana grp7-1 mutant demonstrating the importance of this residue for GRP7 function. These data provide mechanistic details how HopU1 recognizes this novel type of substrate and highlights the role of GRP7 in plant immunity.	[Jeong, Byeong-ryool; Joe, Anna; Guo, Ming; Alfano, James R.] Univ Nebraska, Ctr Plant Sci Innovat, Lincoln, NE 68588 USA; [Jeong, Byeong-ryool; Guo, Ming; Alfano, James R.] Univ Nebraska, Dept Plant Pathol, Lincoln, NE 68588 USA; [Lin, Yan; Yang, Huirong; Wang, Ping; Xu, Yanhui] Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Lin, Yan; Yang, Huirong; Wang, Ping; Xu, Yanhui] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Lin, Yan; Yu, Min; Xu, Yanhui] Fudan Univ, Inst Biomed Sci, Shanghai 200032, Peoples R China; [Joe, Anna] Univ Nebraska, Sch Biol Sci, Lincoln, NE 68588 USA; [Korneli, Christin; Staiger, Dorothee] Univ Bielefeld, Dept Mol Cell Physiol, D-33501 Bielefeld, Germany; [Cerny, Ronald L.] Univ Nebraska, Dept Chem, Lincoln, NE 68588 USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; Fudan University; Fudan University; Fudan University; University of Nebraska System; University of Nebraska Lincoln; University of Bielefeld; University of Nebraska System; University of Nebraska Lincoln	Alfano, JR (corresponding author), Univ Nebraska, Ctr Plant Sci Innovat, Lincoln, NE 68588 USA.	jalfano2@unl.edu; xuyh@fudan.edu.cn	Jeong, Byeong-ryool/N-1661-2019; Xu, Yanhui/D-5119-2019; Wang, Ping/GZB-2001-2022	Jeong, Byeong-ryool/0000-0003-0642-1650; Staiger, Dorothee/0000-0002-1341-1381; Wang, Ping/0000-0002-2710-7188	National Institutes of Health [1R01AI069146-01A2]; Center for Plant Science Innovation at the University of Nebraska; German Research Foundation [STA 653/2, STA 653/3]; National Basic Research Program of China [2009CB918600]; Science and Technology Commission of Shanghai Municipality [10430709300]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069146] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Plant Science Innovation at the University of Nebraska; German Research Foundation(German Research Foundation (DFG)); National Basic Research Program of China(National Basic Research Program of China); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R01AI069146-01A2 (to J. R. A.). This work was also supported by Center for Plant Science Innovation at the University of Nebraska (to J. R. A.), German Research Foundation Grants STA 653/2 and STA 653/3 (to D. S.), and National Basic Research Program of China Grant 2009CB918600 and the International Collaboration Program from Science and Technology Commission of Shanghai Municipality Grant 10430709300 (to Y. X.).	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Aktories K, 2005, REV PHYSIOL BIOCH P, V152, P1, DOI 10.1007/s10254-004-0034-4; Alfano JR, 2004, ANNU REV PHYTOPATHOL, V42, P385, DOI 10.1146/annurev.phyto.42.040103.110731; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Arnold Konstantin, 2009, Journal of Structural and Functional Genomics, V10, P1, DOI 10.1007/s10969-008-9048-5; BARBIERI JT, 2003, BACTERIAL PROTEIN TO, P215; BECHTOLD N, 1993, CR ACAD SCI III-VIE, V316, P1194; Block A, 2011, CURR OPIN MICROBIOL, V14, P39, DOI 10.1016/j.mib.2010.12.011; Block A, 2010, CELL MICROBIOL, V12, P318, DOI 10.1111/j.1462-5822.2009.01396.x; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; Buttner D, 2009, PLANT PHYSIOL, V150, P1656, DOI 10.1104/pp.109.139089; Chen R, 2003, PROTEINS, V52, P80, DOI 10.1002/prot.10389; Clery A, 2008, CURR OPIN STRUC BIOL, V18, P290, DOI 10.1016/j.sbi.2008.04.002; Crabill E, 2010, PLANT PHYSIOL, V154, P233, DOI 10.1104/pp.110.159723; Deng Q, 2008, ANNU REV MICROBIOL, V62, P271, DOI 10.1146/annurev.micro.62.081307.162848; Ding JZ, 1999, GENE DEV, V13, P1102, DOI 10.1101/gad.13.9.1102; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Espinosa A, 2003, MOL MICROBIOL, V49, P377, DOI 10.1046/j.1365-2958.2003.03588.x; Fieldhouse RJ, 2008, TRENDS BIOCHEM SCI, V33, P546, DOI 10.1016/j.tibs.2008.08.003; Fu ZQ, 2007, NATURE, V447, P284, DOI 10.1038/nature05737; Galan JE, 2009, CELL HOST MICROBE, V5, P571, DOI 10.1016/j.chom.2009.04.008; Gimenez-Ibanez S, 2009, CURR BIOL, V19, P423, DOI 10.1016/j.cub.2009.01.054; Goehre V, 2008, CURR BIOL, V18, P1824, DOI 10.1016/j.cub.2008.10.063; Guo M, 2009, MOL PLANT MICROBE IN, V22, P1069, DOI 10.1094/MPMI-22-9-1069; Han S, 2002, INT J MED MICROBIOL, V291, P523; Hann DR, 2010, CURR OPIN PLANT BIOL, V13, P388, DOI 10.1016/j.pbi.2010.04.003; Heintzen C, 1997, P NATL ACAD SCI USA, V94, P8515, DOI 10.1073/pnas.94.16.8515; Holbourn KP, 2006, FEBS J, V273, P4579, DOI 10.1111/j.1742-4658.2006.05442.x; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Hottiger MO, 2010, TRENDS BIOCHEM SCI, V35, P208, DOI 10.1016/j.tibs.2009.12.003; Jelenska J, 2010, P NATL ACAD SCI USA, V107, P13177, DOI 10.1073/pnas.0910943107; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kayser J P, 2004, J Biomol Tech, V15, P285; Kim JS, 2008, PLANT J, V55, P455, DOI 10.1111/j.1365-313X.2008.03518.x; KING EO, 1954, J LAB CLIN MED, V44, P301; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Lee AL, 1997, BIOCHEMISTRY-US, V36, P14306, DOI 10.1021/bi970830y; Lin Y, 2010, ACTA CRYSTALLOGR F, V66, P932, DOI 10.1107/S1744309110022463; Lindeberg M, 2006, MOL PLANT MICROBE IN, V19, P1151, DOI 10.1094/MPMI-19-1151; LUDDEN PW, 1989, CURR TOP CELL REGUL, V30, P23; Maris C, 2005, FEBS J, V272, P2118, DOI 10.1111/j.1742-4658.2005.04653.x; Menetry J, 2008, PROTEIN SCI, V17, P878, DOI 10.1110/ps.073398508; Mueller-Dieckmann C, 2002, J MOL BIOL, V322, P687, DOI 10.1016/S0022-2836(02)00818-5; NAGAI K, 1990, NATURE, V348, P515, DOI 10.1038/348515a0; Nomura K, 2006, SCIENCE, V313, P220, DOI 10.1126/science.1129523; Okazaki IJ, 1996, REV PHYSIOL BIOCH P, V129, P51; RAO ST, 1973, J MOL BIOL, V76, P241, DOI 10.1016/0022-2836(73)90388-4; Rosebrock TR, 2007, NATURE, V448, P370, DOI 10.1038/nature05966; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Sambrook J., 2001, MOL CLONING LAB MANU; Schmidt F, 2010, MOL BIOL REP, V37, P839, DOI 10.1007/s11033-009-9636-x; Schoning JC, 2007, PLANT J, V52, P1119, DOI 10.1111/j.1365-313X.2007.03302.x; Shan LB, 2008, CELL HOST MICROBE, V4, P17, DOI 10.1016/j.chom.2008.05.017; Singer AU, 2004, STRUCTURE, V12, P1669, DOI 10.1016/j.str.2004.06.023; Streitner C, 2008, PLANT J, V56, P239, DOI 10.1111/j.1365-313X.2008.03591.x; Streitner C, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-221; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; Tsuda K, 2010, CURR OPIN PLANT BIOL, V13, P459, DOI 10.1016/j.pbi.2010.04.006; Tsuge H, 2008, P NATL ACAD SCI USA, V105, P7399, DOI 10.1073/pnas.0801215105; Wang YJ, 2010, PLANT CELL, V22, P2033, DOI 10.1105/tpc.110.075697; Wilton M, 2010, P NATL ACAD SCI USA, V107, P2349, DOI 10.1073/pnas.0904739107; Xiang TT, 2008, CURR BIOL, V18, P74, DOI 10.1016/j.cub.2007.12.020; Yuan J, 1996, J BACTERIOL, V178, P6399, DOI 10.1128/jb.178.21.6399-6402.1996; Zhang J, 2007, CELL HOST MICROBE, V1, P175, DOI 10.1016/j.chom.2007.03.006	64	75	79	2	49	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					43272	43281		10.1074/jbc.M111.290122	http://dx.doi.org/10.1074/jbc.M111.290122			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22013065	hybrid, Green Published			2022-12-27	WOS:000298351300047
J	Chun, Y; Park, B; Koh, W; Lee, S; Cheon, Y; Kim, R; Che, L; Lee, S				Chun, Younghwa; Park, Byoungwoo; Koh, Wansoo; Lee, Sunhee; Cheon, Yeongmi; Kim, Raehyung; Che, Lihua; Lee, Soojin			New Centromeric Component CENP-W Is an RNA-associated Nuclear Matrix Protein That Interacts with Nucleophosmin/B23 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBOSOME BIOGENESIS; NUCLEOLUS; CANCER; KINETOCHORE; COMPLEX; CELLS; IDENTIFICATION; CHROMATIN; DYNAMICS; CUG2	CENP-W was originally identified as a putative oncogene, cancer-upregulated gene 2 (CUG2) that was commonly up-regulated in many cancer tissues. Recently, CENP-W has also been identified as a new centromeric component that interacts with CENP-T. As a complex with CENP-T, CENP-W plays crucial roles in assembly of the functional kinetochore complex. In this study, the subnuclear localization of CENP-W was extensively analyzed using various approaches. We found that ectopically expressed CENP-W primarily accumulated in the nucleolus and remained substantially associated with the nucleolus in stable cells. The following fractionation study also showed that CENP-W is associated with RNA as well as DNA. Moreover, a considerable amount of CENP-W was found in the nuclear mesh-like structure, nuclear matrix, possibly indicating that CENP-W participates in diverse subnuclear activities. Finally, biochemical affinity binding analysis revealed that CENP-W specifically interacts with the nucleolar phosphoprotein, nucleophosmin (B23). Depletion of cellular B23 by siRNA treatment induced a dramatic decrease of CENP-W stability and severe mislocalization during prophase. Our data proposed that B23 may function in the assembly of the kinetochore complex by interacting with CENP-W during interphase.	[Chun, Younghwa; Park, Byoungwoo; Koh, Wansoo; Lee, Sunhee; Cheon, Yeongmi; Kim, Raehyung; Che, Lihua; Lee, Soojin] Chungnam Natl Univ, Dept Mol Biol & Microbiol, Taejon 305764, South Korea	Chungnam National University	Lee, S (corresponding author), Chungnam Natl Univ, Dept Mol Biol & Microbiol, Taejon 305764, South Korea.	leesoojin@cnu.ac.kr		Lee, Soojin/0000-0002-0383-5025	Korean Government; National Research Foundation [20100005431]; Ministry for Health, Welfare and Family Affairs [A080588-21]	Korean Government(Korean Government); National Research Foundation; Ministry for Health, Welfare and Family Affairs	This work was supported by grants funded by Korean Government, the Basic Science Research Program through National Research Foundation (Grant 20100005431), and the Korea Healthcare Technology R and D Project through the Ministry for Health, Welfare and Family Affairs (Grant A080588-21).	Ahmad Y, 2009, NUCLEIC ACIDS RES, V37, pD181, DOI 10.1093/nar/gkn804; Albrethsen J, 2009, J PROTEOMICS, V72, P71, DOI 10.1016/j.jprot.2008.09.005; Anachkova B, 2005, J CELL BIOCHEM, V96, P951, DOI 10.1002/jcb.20610; Andersen JS, 2005, NATURE, V433, P77, DOI 10.1038/nature03207; BEREZNEY R, 1974, BIOCHEM BIOPH RES CO, V60, P1410, DOI 10.1016/0006-291X(74)90355-6; Biggiogera M, 2008, DIFFERENTIATION, V76, P57, DOI 10.1111/j.1432-0436.2007.00211.x; Boisvert FM, 2007, NAT REV MOL CELL BIO, V8, P574, DOI 10.1038/nrm2184; Carmo-Fonseca M, 2000, NAT CELL BIOL, V2, pE107, DOI 10.1038/35014078; CIEJEK EM, 1983, NATURE, V306, P607, DOI 10.1038/306607a0; FEUERSTEIN N, 1987, J IMMUNOL, V139, P1818; Foltz DR, 2006, NAT CELL BIOL, V8, P458, DOI 10.1038/ncb1397; Grisendi S, 2006, NAT REV CANCER, V6, P493, DOI 10.1038/nrc1885; Hager GL, 2002, CURR OPIN GENET DEV, V12, P137, DOI 10.1016/S0959-437X(02)00278-2; He D, 1995, INT REV CYTOL, V162B, P1; He D, 1996, J CELL SCI, V109, P2693; Hori T, 2008, CELL, V135, P1039, DOI 10.1016/j.cell.2008.10.019; Huang M, 2008, LEUKEMIA RES, V32, P131, DOI 10.1016/j.leukres.2007.03.025; Kim H, 2009, MOL CELLS, V27, P697, DOI 10.1007/s10059-009-0083-2; Korgaonkar C, 2005, MOL CELL BIOL, V25, P1258, DOI 10.1128/MCB.25.4.1258-1271.2005; Kurg R, 2005, J VIROL, V79, P10528, DOI 10.1128/JVI.79.16.10528-10539.2005; Lee S, 2007, BIOCHEM BIOPH RES CO, V360, P633, DOI 10.1016/j.bbrc.2007.06.102; Leonhardt H, 1995, INT REV CYTOL, V162B, P303; LIAO H, 1995, J CELL BIOL, V130, P507, DOI 10.1083/jcb.130.3.507; Ma Z, 2006, MOL CELL BIOL, V26, P9016, DOI 10.1128/MCB.01383-06; Meder VS, 2005, J CELL SCI, V118, P211, DOI 10.1242/jcs.01606; Mellone B, 2006, NAT CELL BIOL, V8, P427, DOI 10.1038/ncb0506-427; Nickerson JA, 1997, P NATL ACAD SCI USA, V94, P4446, DOI 10.1073/pnas.94.9.4446; OCHS RL, 1992, EXP CELL RES, V200, P339, DOI 10.1016/0014-4827(92)90181-7; Okuwaki M, 2002, MOL BIOL CELL, V13, P2016, DOI 10.1091/mbc.02-03-0036; Olson MOJ, 2000, TRENDS CELL BIOL, V10, P189, DOI 10.1016/S0962-8924(00)01738-4; Oudes AJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-92; Pederson T, 2009, J CELL BIOL, V184, P771, DOI 10.1083/jcb.200812014; Peterson JT, 2000, CARDIOVASC RES, V46, P307, DOI 10.1016/S0008-6363(00)00029-8; Pluta AF, 1996, J BIOL CHEM, V271, P18767, DOI 10.1074/jbc.271.31.18767; Reyes JC, 1997, J CELL BIOL, V137, P263, DOI 10.1083/jcb.137.2.263; Scherl A, 2002, MOL BIOL CELL, V13, P4100, DOI 10.1091/mbc.E02-05-0271; Sjakste N, 2004, EXP ONCOL, V26, P170; Strezoska Z, 2000, MOL CELL BIOL, V20, P5516, DOI 10.1128/MCB.20.15.5516-5528.2000; Szebeni A, 1999, PROTEIN SCI, V8, P905; Weber JD, 1999, NAT CELL BIOL, V1, P20, DOI 10.1038/8991; Weng JJ, 2005, BIOCHEM BIOPH RES CO, V335, P826, DOI 10.1016/j.bbrc.2005.07.150; Zaidi SK, 2007, NAT REV CANCER, V7, P454, DOI 10.1038/nrc2149	42	23	29	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42758	42769		10.1074/jbc.M111.228411	http://dx.doi.org/10.1074/jbc.M111.228411			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	22002061	Green Published, hybrid			2022-12-27	WOS:000298180900082
J	Pan, XO; Kane, LA; Van Eyk, JE; Coulombe, PA				Pan, Xiaoou; Kane, Lesley A.; Van Eyk, Jennifer E.; Coulombe, Pierre A.			Type I Keratin 17 Protein Is Phosphorylated on Serine 44 by p90 Ribosomal Protein S6 Kinase 1 (RSK1) in a Growth- and Stress-dependent Fashion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERMEDIATE-FILAMENT PHOSPHORYLATION; BASAL-CELL CARCINOMAS; EPITHELIAL-CELLS; OKADAIC ACID; PACHYONYCHIA-CONGENITA; MUTATIONS CAUSE; CULTURED-CELLS; SKIN; REORGANIZATION; EXPRESSION	Keratin 17 (K17) is a type I intermediate filament protein that is constitutively expressed in ectoderm-derived epithelial appendages and robustly induced in epidermis following injury, during inflammation, and in chronic diseases such as psoriasis and cancer. Mutations within K17 are responsible for two rare diseases related to ectodermal dysplasias. Studies in K17-null mice uncovered several roles for K17, including structural support, resistance to TNF alpha-induced apoptosis, regulation of protein synthesis, and modulation of cytokine expression. Yet, little is known about the regulation of K17 protein via post-translational modification. Here, we report that serine 44 in the N-terminal head domain of K17 (K17-Ser(44)) is phosphorylated in response to extracellular stimuli (serum, EGF, and the phorbol ester 12-O-tetradecanoylphorbol-13-acetate) that alter skin keratinocyte growth, and to cellular stresses (sorbitol-induced hyperosmotic shock, UV irradiation, and hydrogen peroxide-induced oxidative stress). It also occurs in basaloid skin tumors in situ. Upon its stimulation in skin keratinocytes, K17-Ser(44) phosphorylation is induced rapidly but stays on transiently. The majority of the phosphorylated K17-Ser(44) pool is polymer-bound and is not obviously related to a change in filament organization. The amino acid sequence surrounding K17-Ser(44) matches the consensus for the AGC family of basophilic kinases. We show that p90 RSK1, an AGC kinase involved in the regulation of cell survival and proliferation, phosphorylates K17-Ser(44) in skin keratinocytes. These findings confirm and expand the tight link that has emerged between K17 up-regulation and growth and stress responses in the skin epithelium.	[Pan, Xiaoou; Coulombe, Pierre A.] Johns Hopkins Univ, Dept Biochem & Mol Biol, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Kane, Lesley A.; Van Eyk, Jennifer E.; Coulombe, Pierre A.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; [Kane, Lesley A.; Van Eyk, Jennifer E.] Johns Hopkins Univ, Johns Hopkins Bayview Prote Ctr, Div Cardiol, Dept Med, Baltimore, MD 21205 USA; [Coulombe, Pierre A.] Johns Hopkins Univ, Dept Dermatol, Sch Med, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Coulombe, PA (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, 615 N Wolfe St,Rm W8041, Baltimore, MD 21205 USA.	coulombe@jhsph.edu			National Institutes of Health through NIAMS [AR44232, CA160255]; NATIONAL CANCER INSTITUTE [R01CA160255] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044232] Funding Source: NIH RePORTER	National Institutes of Health through NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant AR44232 and CA160255 (to P. A. C.) through NIAMS.	Anjum R, 2008, NAT REV MOL CELL BIO, V9, P747, DOI 10.1038/nrm2509; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Bass-Zubek AE, 2008, J CELL BIOL, V181, P605, DOI 10.1083/jcb.200712133; Bernot KM, 2005, J CELL BIOL, V168, P965, DOI 10.1083/jcb.200408116; Bickers DR, 2006, J INVEST DERMATOL, V126, P2565, DOI 10.1038/sj.jid.5700340; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; BODE AM, 2003, SCI STKE, pRE2; BOGUSKI MS, 1993, NAT GENET, V4, P332, DOI 10.1038/ng0893-332; Breitkreutz D, 2007, J CANCER RES CLIN, V133, P793, DOI 10.1007/s00432-007-0280-3; Brose N, 2002, J CELL SCI, V115, P4399, DOI 10.1242/jcs.00122; Burg MB, 2007, PHYSIOL REV, V87, P1441, DOI 10.1152/physrev.00056.2006; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; COULOMBE PA, 1991, J CELL BIOL, V115, P1661, DOI 10.1083/jcb.115.6.1661; Covello SP, 1998, BRIT J DERMATOL, V139, P475; DEJONG EMGJ, 1991, ARCH DERMATOL RES, V283, P480, DOI 10.1007/BF00371788; DePianto D, 2010, NAT GENET, V42, P910, DOI 10.1038/ng.665; Fuchs E, 1995, ANNU REV CELL DEV BI, V11, P123, DOI 10.1146/annurev.cb.11.110195.001011; Goto H, 2002, GENES CELLS, V7, P91, DOI 10.1046/j.1356-9597.2001.00504.x; Grachtchouk M, 2000, NAT GENET, V24, P216, DOI 10.1038/73417; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; Hyder CL, 2008, FEBS LETT, V582, P2140, DOI 10.1016/j.febslet.2008.04.064; Izawa I, 2006, CANCER SCI, V97, P167, DOI 10.1111/j.1349-7006.2006.00161.x; KASAHARA K, 1993, J BIOL CHEM, V268, P23531; Kim S, 2006, NATURE, V441, P362, DOI 10.1038/nature04659; Kim S, 2007, GENE DEV, V21, P1581, DOI 10.1101/gad.1552107; Kim S, 2010, NAT REV MOL CELL BIO, V11, P75, DOI 10.1038/nrm2818; Komine M, 1996, J INVEST DERMATOL, V107, P569, DOI 10.1111/1523-1747.ep12582820; Ku NO, 2006, J CELL BIOL, V174, P115, DOI 10.1083/jcb.200602146; KU NO, 1994, J CELL BIOL, V127, P161, DOI 10.1083/jcb.127.1.161; Ku NO, 1998, J CELL BIOL, V143, P2023, DOI 10.1083/jcb.143.7.2023; Ku NO, 2002, J BIOL CHEM, V277, P10775, DOI 10.1074/jbc.M107623200; Laan M, 2001, BRIT J PHARMACOL, V133, P200, DOI 10.1038/sj.bjp.0704063; LEIGH IM, 1995, BRIT J DERMATOL, V133, P501, DOI 10.1111/j.1365-2133.1995.tb02696.x; Liao J, 1996, ELECTROPHORESIS, V17, P1671, DOI 10.1002/elps.1150171104; Liao J, 1997, J BIOL CHEM, V272, P17565, DOI 10.1074/jbc.272.28.17565; Liovic M, 2008, EXP CELL RES, V314, P2066, DOI 10.1016/j.yexcr.2008.02.020; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Mahoney SJ, 2009, PROG MOL BIOL TRANSL, V90, P53, DOI 10.1016/S1877-1173(09)90002-3; Malago JJ, 2002, CELL STRESS CHAPERON, V7, P191, DOI 10.1379/1466-1268(2002)007<0191:THSRAC>2.0.CO;2; MARKEY AC, 1992, BRIT J DERMATOL, V126, P154, DOI 10.1111/j.1365-2133.1992.tb07813.x; McGowan KM, 1998, J CELL BIOL, V143, P469, DOI 10.1083/jcb.143.2.469; McGowan KM, 2002, GENE DEV, V16, P1412, DOI 10.1101/gad.979502; MCLEAN WHI, 1995, NAT GENET, V9, P273, DOI 10.1038/ng0395-273; Milbradt J, 2010, J BIOL CHEM, V285, P13979, DOI 10.1074/jbc.M109.063628; Murray AJ, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.122re4; Muthusamy V, 2010, ARCH DERMATOL RES, V302, P5, DOI 10.1007/s00403-009-0994-y; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Omary MB, 2006, TRENDS BIOCHEM SCI, V31, P383, DOI 10.1016/j.tibs.2006.05.008; Omary MB, 2004, NEW ENGL J MED, V351, P2087, DOI 10.1056/NEJMra040319; Paladini RD, 1996, J CELL BIOL, V132, P381, DOI 10.1083/jcb.132.3.381; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; PROBY CM, 1993, AM J PATHOL, V143, P1667; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Ravid A, 2002, J ENDOCRINOL, V173, DOI 10.1677/joe.0.1730525; Richards SA, 2001, MOL CELL BIOL, V21, P7470, DOI 10.1128/MCB.21.21.7470-7480.2001; Ridge KM, 2005, J BIOL CHEM, V280, P30400, DOI 10.1074/jbc.M504239200; Sahlgren CM, 2001, J BIOL CHEM, V276, P16456, DOI 10.1074/jbc.M009669200; Schweizer J, 2006, J CELL BIOL, V174, P169, DOI 10.1083/jcb.200603161; SMEDTS F, 1992, AM J PATHOL, V140, P601; Soh JW, 2003, J BIOL CHEM, V278, P34709, DOI 10.1074/jbc.M302016200; STRICKLAND JE, 1988, CANCER RES, V48, P165; Strnad P, 2001, CELL TISSUE RES, V306, P277, DOI 10.1007/s004410100455; Szeverenyi I, 2008, HUM MUTAT, V29, P351, DOI 10.1002/humu.20652; Toivola DM, 2010, TRENDS CELL BIOL, V20, P79, DOI 10.1016/j.tcb.2009.11.004; Toivola DM, 2002, MOL BIOL CELL, V13, P1857, DOI 10.1091/mbc.01-12-0591; Tong XM, 2003, TRENDS MOL MED, V9, P79, DOI 10.1016/S1471-4914(02)00025-4; Tong XM, 2006, GENE DEV, V20, P1353, DOI 10.1101/gad.1387406; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; van de Rijn M, 2002, AM J PATHOL, V161, P1991, DOI 10.1016/S0002-9440(10)64476-8; Wallis S, 2000, MOL BIOL CELL, V11, P1077, DOI 10.1091/mbc.11.3.1077; Xue Y, 2008, MOL CELL PROTEOMICS, V7, P1598, DOI 10.1074/mcp.M700574-MCP200; YATSUNAMI J, 1993, CANCER RES, V53, P992; Zhou Q, 2006, J BIOL CHEM, V281, P16453, DOI 10.1074/jbc.M512284200	73	25	26	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42403	42413		10.1074/jbc.M111.302042	http://dx.doi.org/10.1074/jbc.M111.302042			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	22006917	hybrid, Green Published			2022-12-27	WOS:000298180900049
J	Ingaramo, M; Beckett, D				Ingaramo, Maria; Beckett, Dorothy			Selectivity in Post-translational Biotin Addition to Five Human Carboxylases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETYL-COA CARBOXYLASE; HUMAN HOLOCARBOXYLASE SYNTHETASE; ESCHERICHIA-COLI; BIOTINYLATION; PROTEINS; SUBUNIT; DOMAIN; CDNA	Human holocarboxylase synthetase (HCS) catalyzes linkage of the vitamin biotin to the biotin carboxyl carrier protein (BCCP) domain of five biotin-dependent carboxylases. In the two-step reaction, the activated intermediate, bio-5'-AMP, is first synthesized from biotin and ATP, followed by covalent linkage of the biotin moiety to a specific lysine residue of each carboxylase BCCP domain. Selectivity in HCS-catalyzed biotinylation to the carboxylases was investigated in single turnover stopped flow and quench flow measurements of biotin transfer to the minimal biotin acceptor BCCP fragments of the carboxylases. The results demonstrate that biotinylation of the BCCP fragments of the mitochondrial carboxylases propionyl-CoA carboxylase, pyruvate carboxylase, and methylcrotonoyl-CoA carboxylase is fast and limited by the bimolecular association rate of the enzyme with substrate. By contrast, biotinylation of the acetyl-CoA carboxylase 1 and 2 (ACC1 and ACC2) fragments, both of which are accessible to HCS in the cytoplasm, is slow and displays a hyperbolic dependence on substrate concentration. The correlation between HCS accessibility to biotin acceptor substrates and the kinetics of biotinylation suggests that mitochondrial carboxylase sequences evolved to produce fast association rates with HCS in order to ensure biotinylation prior to mitochondrial import. In addition, the results are consistent with a role for HCS specificity in dictating biotin distribution among carboxylases.	[Ingaramo, Maria; Beckett, Dorothy] Univ Maryland, Dept Chem & Biochem, Ctr Biol Struct & Org, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Beckett, D (corresponding author), Univ Maryland, Dept Chem & Biochem, Ctr Biol Struct & Org, College Pk, MD 20742 USA.	dbeckett@umd.edu			National Institutes of Health [R01GM46511, S10RR15899]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR015899] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046511] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM46511 and S10RR15899 (to D. B.).	Abu-Elheiga L, 2000, P NATL ACAD SCI USA, V97, P1444, DOI 10.1073/pnas.97.4.1444; Bailey LM, 2010, ARCH BIOCHEM BIOPHYS, V496, P45, DOI 10.1016/j.abb.2010.01.015; Brownsey RW, 2006, BIOCHEM SOC T, V34, P223, DOI 10.1042/BST0340223; Chapman-Smith A, 1999, J BIOL CHEM, V274, P1449, DOI 10.1074/jbc.274.3.1449; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Healy S, 2010, BIOCHEMISTRY-US, V49, P4687, DOI 10.1021/bi901612y; Healy S, 2009, PROTEIN SCI, V18, P314, DOI 10.1002/pro.37; Hiratsuka M, 1998, BBA-PROTEIN STRUCT M, V1385, P165, DOI 10.1016/S0167-4838(98)00032-6; Ingaramo M, 2009, J BIOL CHEM, V284, P30862, DOI 10.1074/jbc.M109.046201; Ingaranno M, 2011, J BIOL CHEM, V286, P13071, DOI 10.1074/jbc.M110.183624; Jitrapakdee S, 2003, CURR PROTEIN PEPT SC, V4, P217, DOI 10.2174/1389203033487199; JOHNSON ML, 1981, BIOPHYS J, V36, P575, DOI 10.1016/S0006-3495(81)84753-4; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; LANE MD, 1964, J BIOL CHEM, V239, P2865; Lee CK, 2010, FEBS LETT, V584, P675, DOI 10.1016/j.febslet.2009.12.059; LEONDELRIO A, 1995, P NATL ACAD SCI USA, V92, P4626, DOI 10.1073/pnas.92.10.4626; LEONDELRIO A, 1994, J BIOL CHEM, V269, P22964; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; Nenortas E, 1996, J BIOL CHEM, V271, P7559, DOI 10.1074/jbc.271.13.7559; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SUZUKI Y, 1994, NAT GENET, V8, P122, DOI 10.1038/ng1094-122; TARONI F, 1991, J BIOL CHEM, V266, P13267; Xiang S, 2008, NAT STRUCT MOL BIOL, V15, P295, DOI 10.1038/nsmb.1393	24	8	8	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2012	287	3					1813	1822		10.1074/jbc.M111.275982	http://dx.doi.org/10.1074/jbc.M111.275982			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879HT	22123817	Green Published, hybrid			2022-12-27	WOS:000299321000023
J	Schack, VR; Holm, R; Vilsen, B				Schack, Vivien Rodacker; Holm, Rikke; Vilsen, Bente			Inhibition of Phosphorylation of Na+,K+-ATPase by Mutations Causing Familial Hemiplegic Migraine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ONSET DYSTONIA-PARKINSONISM; TRANSMEMBRANE SEGMENT M1; ATPASE GENE ATP1A2; CRYSTAL-STRUCTURE; K+-ATPASE; FUNCTIONAL CONSEQUENCES; ALTERNATING HEMIPLEGIA; NA+ INTERACTION; NA,K-ATPASE; PUMP	The neurological disorder familial hemiplegic migraine type II (FHM2) is caused by mutations in the alpha 2-isoform of the Na+, K+-ATPase. We have studied the partial reaction steps of the Na+, K+-pump cycle in nine FHM2 mutants retaining overall activity at a level still compatible with cell growth. Although it is believed that the pathophysiology of FHM2 results from reduced extracellular K+ clearance and/or changes in Na+ gradient-dependent transport processes in neuroglia, a reduced affinity for K+ or Na+ is not a general finding with the FHM2 mutants. Six of the FHM2 mutations markedly affect the maximal rate of phosphorylation from ATP leading to inhibition by intracellular K+, thereby likely compromising pump function under physiological conditions. In mutants R593W, V628M, and M731T, the defective phosphorylation is caused by local perturbations within the Rossmann fold, possibly interfering with the bending of the P-domain during phosphoryl transfer. In mutants V138A, T345A, and R834Q, long range effects reaching from as far away as the M2 transmembrane helix perturb the function of the catalytic site. Mutant E700K exhibits a reduced rate of E2P dephosphorylation without effect on phosphorylation from ATP. An extremely reduced vanadate affinity of this mutant indicates that the slow dephosphorylation reflects a destabilization of the phosphoryl transition state. This seems to be caused by insertion of the lysine between two other positively charged residues of the Rossmann fold. In mutants R202Q and T263M, effects on the A-domain structure are responsible for a reduced rate of the E1P to E2P transition.	[Schack, Vivien Rodacker; Holm, Rikke; Vilsen, Bente] Aarhus Univ, Dept Biomed, DK-8000 Aarhus C, Denmark	Aarhus University	Vilsen, B (corresponding author), Aarhus Univ, Dept Biomed, Ole Worms Alle 6,Bldg 1180, DK-8000 Aarhus C, Denmark.	bv@fi.au.dk		Vilsen, Bente/0000-0002-4727-9382	Danish Medical Research Council; Novo Nordisk Foundation (Fabrikant Vilhelm Pedersen og Hustrus Legat); Lundbeck Foundation; Lundbeck Foundation [R48-2009-4638] Funding Source: researchfish	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Novo Nordisk Foundation (Fabrikant Vilhelm Pedersen og Hustrus Legat)(Novo Nordisk Foundation); Lundbeck Foundation(Lundbeckfonden); Lundbeck Foundation(Lundbeckfonden)	This work was supported in part by grants from the Danish Medical Research Council, the Novo Nordisk Foundation (Fabrikant Vilhelm Pedersen og Hustrus Legat), and the Lundbeck Foundation.	Bassi MT, 2004, J MED GENET, V41, P621, DOI 10.1136/jmg.2003.017863; Blanco-Arias P, 2009, HUM MOL GENET, V18, P2370, DOI 10.1093/hmg/ddp170; CANTLEY LC, 1978, J BIOL CHEM, V253, P7361; Castro MJ, 2008, CLIN GENET, V73, P37, DOI 10.1111/j.1399-0004.2007.00918.x; Castro MJ, 2007, J HUM GENET, V52, P990, DOI 10.1007/s10038-007-0205-7; Cornelius F, 2011, J BIOL CHEM, V286, P29882, DOI 10.1074/jbc.M111.259663; Danko S, 2004, J BIOL CHEM, V279, P14991, DOI 10.1074/jbc.M313363200; De Fusco M, 2003, NAT GENET, V33, P192, DOI 10.1038/ng1081; Einholm AP, 2007, J BIOL CHEM, V282, P23854, DOI 10.1074/jbc.M702259200; Einholm AP, 2010, J BIOL CHEM, V285, P26245, DOI 10.1074/jbc.M110.123976; Einholm AP, 2005, P NATL ACAD SCI USA, V102, P11254, DOI 10.1073/pnas.0501201102; ESMANN M, 1985, BIOCHEM BIOPH RES CO, V127, P857, DOI 10.1016/S0006-291X(85)80022-X; Fedosova NU, 2003, BIOCHEMISTRY-US, V42, P3536, DOI 10.1021/bi0268302; Jen JC, 2007, J NEUROL NEUROSUR PS, V78, P523, DOI 10.1136/jnnp.2006.103267; JORGENSEN PL, 1991, SOC GEN PHY, V46, P189; Kaunisto MA, 2004, NEUROGENETICS, V5, P141, DOI 10.1007/s10048-004-0178-z; Lencesova L, 2004, J BIOL CHEM, V279, P2885, DOI 10.1074/jbc.M310365200; MCGRAIL KM, 1991, J NEUROSCI, V11, P381, DOI 10.1523/jneurosci.11-02-00381.1991; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Patchornik G, 2000, P NATL ACAD SCI USA, V97, P11954, DOI 10.1073/pnas.220332897; Pierelli F, 2006, CEPHALALGIA, V26, P324, DOI 10.1111/j.1468-2982.2006.01002.x; Riant F, 2005, HUM MUTAT, V26, DOI 10.1002/humu.9361; Rodacker V, 2006, J BIOL CHEM, V281, P18539, DOI 10.1074/jbc.M601780200; Rose EM, 2009, J NEUROSCI, V29, P8143, DOI 10.1523/JNEUROSCI.1081-09.2009; Segall L, 2005, P NATL ACAD SCI USA, V102, P11106, DOI 10.1073/pnas.0504323102; Segall L, 2004, J BIOL CHEM, V279, P43692, DOI 10.1074/jbc.M407471200; Shinoda T, 2009, NATURE, V459, P446, DOI 10.1038/nature07939; Skou J. C, 1991, SODIUM PUMP RECENT D, P317; SKOU JC, 1957, BIOCHIM BIOPHYS ACTA, V23, P394, DOI 10.1016/0006-3002(57)90343-8; Somjen GG, 2001, PHYSIOL REV, V81, P1065, DOI 10.1152/physrev.2001.81.3.1065; Swoboda KJ, 2004, ANN NEUROL, V55, P884, DOI 10.1002/ana.20134; Tavraz NN, 2008, J BIOL CHEM, V283, P31097, DOI 10.1074/jbc.M802771200; Thomsen LL, 2007, BRAIN, V130, P346, DOI 10.1093/brain/awl334; Todt U, 2005, HUM MUTAT, V26, P315, DOI 10.1002/humu.20229; Toustrup-Jensen M, 2002, J BIOL CHEM, V277, P38607, DOI 10.1074/jbc.M203665200; Toustrup-Jensen M, 2001, BIOCHEMISTRY-US, V40, P5521, DOI 10.1021/bi002367m; Toyoshima C, 2004, NATURE, V430, P529, DOI 10.1038/nature02680; Toyoshima C, 2009, BBA-MOL CELL RES, V1793, P941, DOI 10.1016/j.bbamcr.2008.10.008; Vanmolkot KRJ, 2007, EUR J HUM GENET, V15, P884, DOI 10.1038/sj.ejhg.5201841; Vanmolkot KR, 2006, EUR J HUM GENET, V14, P555, DOI 10.1038/sj.ejhg.5201607; Vanmolkot KRJ, 2003, ANN NEUROL, V54, P360, DOI 10.1002/ana.10674; Vilsen B, 1999, BIOCHEMISTRY-US, V38, P11389, DOI 10.1021/bi990951t; VILSEN B, 1992, FEBS LETT, V314, P301, DOI 10.1016/0014-5793(92)81494-7; YODA A, 1987, J BIOL CHEM, V262, P110; YODA S, 1987, J BIOL CHEM, V262, P103	45	16	16	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2012	287	3					2191	2202		10.1074/jbc.M111.323022	http://dx.doi.org/10.1074/jbc.M111.323022			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879HT	22117059	hybrid, Green Published			2022-12-27	WOS:000299321000058
J	Thompson, JA; Marzahn, MR; O'Donnell, M; Bloom, LB				Thompson, Jennifer A.; Marzahn, Melissa R.; O'Donnell, Mike; Bloom, Linda B.			Replication Factor C Is a More Effective Proliferating Cell Nuclear Antigen (PCNA) Opener than the Checkpoint Clamp Loader, Rad24-RFC	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-POLYMERASE-III; BETA-SLIDING CLAMP; ESCHERICHIA-COLI; ENERGY-TRANSFER; COMPLEX; MECHANISM; DELTA; ATP; DYNAMICS; MACHINE	Clamp loaders from all domains of life load clamps onto DNA. The clamp tethers DNA polymerases to DNA to increase the processivity of synthesis as well as the efficiency of replication. Here, we investigated proliferating cell nuclear antigen (PCNA) binding and opening by the Saccharomyces cerevisiae clamp loader, replication factor C (RFC), and the DNA damage checkpoint clamp loader, Rad24-RFC, using two separate fluorescence intensity-based assays. Analysis of PCNA opening by RFC revealed a two-step reaction in which RFC binds PCNA before opening PCNA rather than capturing clamps that have transiently and spontaneously opened in solution. The affinity of RFC for PCNA is about an order of magnitude lower in the absence of ATP than in its presence. The affinity of Rad24-RFC for PCNA in the presence of ATP is about an order magnitude weaker than that of RFC for PCNA, similar to the RFC-PCNA interaction in the absence of ATP. Importantly, fewer open clamp loader-clamp complexes are formed when PCNA is bound by Rad24-RFC than when bound by RFC.	[Thompson, Jennifer A.; Marzahn, Melissa R.; Bloom, Linda B.] Univ Florida, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA; [O'Donnell, Mike] Rockefeller Univ, New York, NY 10021 USA; [O'Donnell, Mike] Howard Hughes Med Inst, New York, NY 10021 USA	State University System of Florida; University of Florida; Rockefeller University; Howard Hughes Medical Institute	Bloom, LB (corresponding author), 1600 SW Archer Rd,JHMHC Rm R3-234, Gainesville, FL 32601 USA.	lbloom@ufl.edu	Bloom, Linda B/F-3684-2014	O'Donnell, Michael/0000-0001-9002-4214	National Institutes of Health [GM082849, GM038839]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038839, R01GM082849, R37GM038839] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM082849 (to L. B. B.) and GM038839 (to M. O. D.).	Alley SC, 2000, BIOCHEMISTRY-US, V39, P3076, DOI 10.1021/bi992377r; AYYAGARI R, 1995, MOL CELL BIOL, V15, P4420; BAUER GA, 1988, P NATL ACAD SCI USA, V85, P7506, DOI 10.1073/pnas.85.20.7506; Bermudez VP, 2003, P NATL ACAD SCI USA, V100, P1633, DOI 10.1073/pnas.0437927100; Bloom LB, 2009, DNA REPAIR, V8, P570, DOI 10.1016/j.dnarep.2008.12.014; Bowman GD, 2004, NATURE, V429, P724, DOI 10.1038/nature02585; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Erzberger JP, 2006, ANNU REV BIOPH BIOM, V35, P93, DOI 10.1146/annurev.biophys.35.040405.101933; Finkelstein J, 2003, ANAL BIOCHEM, V319, P78, DOI 10.1016/S0003-2697(03)00273-2; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Gomes XV, 2001, J BIOL CHEM, V276, P34768, DOI 10.1074/jbc.M011631200; Indiani C, 2003, J BIOL CHEM, V278, P40272, DOI 10.1074/jbc.M305828200; Indiani C, 2006, NAT REV MOL CELL BIO, V7, P751, DOI 10.1038/nrm2022; Jeruzalmi D, 2001, CELL, V106, P417, DOI 10.1016/S0092-8674(01)00462-7; Johnson A, 2005, ANNU REV BIOCHEM, V74, P283, DOI 10.1146/annurev.biochem.73.011303.073859; Kazmirski SL, 2005, P NATL ACAD SCI USA, V102, P13801, DOI 10.1073/pnas.0506430102; KRISHNA TSR, 1994, CELL, V79, P1233, DOI 10.1016/0092-8674(94)90014-0; Majka J, 2004, J BIOL CHEM, V279, P20921, DOI 10.1074/jbc.M400898200; McHenry CS, 2011, ANNU REV BIOCHEM, V80, P403, DOI 10.1146/annurev-biochem-061208-091655; Miyata T, 2005, P NATL ACAD SCI USA, V102, P13795, DOI 10.1073/pnas.0506447102; NAKTINIS V, 1995, J BIOL CHEM, V270, P13358, DOI 10.1074/jbc.270.22.13358; Navadgi-Patil VM, 2011, BIOCHEM SOC T, V39, P600, DOI 10.1042/BST0390600; Paschall CO, 2011, J BIOL CHEM, V286, P42704, DOI 10.1074/jbc.M111.268169; Simonetta KR, 2009, CELL, V137, P659, DOI 10.1016/j.cell.2009.03.044; Snyder AK, 2004, J BIOL CHEM, V279, P4386, DOI 10.1074/jbc.M310430200; Tainer JA, 2010, J AM CHEM SOC, V132, P7372, DOI 10.1021/ja100365x; Thompson JA, 2009, J BIOL CHEM, V284, P32147, DOI 10.1074/jbc.M109.045997; Trakselis MA, 2001, P NATL ACAD SCI USA, V98, P8368, DOI 10.1073/pnas.111006698; Yao N, 2003, J BIOL CHEM, V278, P50744, DOI 10.1074/jbc.M309206200; Yao N, 1996, GENES CELLS, V1, P101, DOI 10.1046/j.1365-2443.1996.07007.x; Yao NY, 2006, J BIOL CHEM, V281, P17528, DOI 10.1074/jbc.M601273200; Zhuang ZH, 2006, P NATL ACAD SCI USA, V103, P2546, DOI 10.1073/pnas.0511263103	32	26	28	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2012	287	3					2203	2209		10.1074/jbc.C111.318899	http://dx.doi.org/10.1074/jbc.C111.318899			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879HT	22115746	hybrid, Green Published			2022-12-27	WOS:000299321000059
J	Wooldridge, L; Ekeruche-Makinde, J; van den Berg, HA; Skowera, A; Miles, JJ; Tan, MP; Dolton, G; Clement, M; Llewellyn-Lacey, S; Price, DA; Peakman, M; Sewell, AK				Wooldridge, Linda; Ekeruche-Makinde, Julia; van den Berg, Hugo A.; Skowera, Anna; Miles, John J.; Tan, Mai Ping; Dolton, Garry; Clement, Mathew; Llewellyn-Lacey, Sian; Price, David A.; Peakman, Mark; Sewell, Andrew K.			A Single Autoimmune T Cell Receptor Recognizes More Than a Million Different Peptides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYELIN BASIC-PROTEIN; CROSS-REACTIVITY; MOLECULAR MIMICRY; ALLORECOGNITION; ALLOREACTIVITY; SPECIFICITY; REPERTOIRE; ACTIVATION; LIGANDS	The T cell receptor (TCR) orchestrates immune responses by binding to foreign peptides presented at the cell surface in the context of major histocompatibility complex (MHC) molecules. Effective immunity requires that all possible foreign peptide MHC molecules are recognized or risks leaving holes in immune coverage that pathogens could quickly evolve to exploit. It is unclear how a limited pool of <10(8) human TCRs can successfully provide immunity to the vast array of possible different peptides that could be produced from 20 proteogenic amino acids and presented by self-MHC molecules (>10(15) distinct peptide-MHCs). One possibility is that T cell immunity incorporates an extremely high level of receptor degeneracy, enabling each TCR to recognize multiple peptides. However, the extent of such TCR degeneracy has never been fully quantified. Here, we perform a comprehensive experimental and mathematical analysis to reveal that a single patient-derived autoimmune CD8(+) T cell clone of pathogenic relevance in human type I diabetes recognizes >one million distinct decamer peptides in the context of a single MHC class I molecule. A large number of peptides that acted as substantially better agonists than the wild-type "index" preproinsulin-derived peptide (ALWGPDPAAA) were identified. The RQFGPDFPTI peptide (sampled from >10(8) peptides) was >100-fold more potent than the index peptide despite differing from this sequence at 7 of 10 positions. Quantification of this previously unappreciated high level of CD8(+) T cell cross-reactivity represents an important step toward understanding the system requirements for adaptive immunity and highlights the enormous potential of TCR degeneracy to be the causative factor in autoimmune disease.	[Wooldridge, Linda; Ekeruche-Makinde, Julia; Miles, John J.; Tan, Mai Ping; Dolton, Garry; Clement, Mathew; Llewellyn-Lacey, Sian; Price, David A.; Sewell, Andrew K.] Cardiff Univ, Sch Med, Inst Infect & Immun, Cardiff CF14 4XN, S Glam, Wales; [van den Berg, Hugo A.] Univ Warwick, Math Inst, Coventry CV4 7AL, W Midlands, England; [Skowera, Anna; Peakman, Mark] Kings Coll London, Dept Immunobiol, London SE1 9RT, England; [Skowera, Anna; Peakman, Mark] Guys & St Thomas Natl Hlth Serv Fdn Trust, Natl Inst Hlth Res, Biomed Res Ctr, London SE1 9RT, England	Cardiff University; University of Warwick; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust	Sewell, AK (corresponding author), Cardiff Univ, Sch Med, Inst Infect & Immun, Henry Wellcome Bldg,Heath Pk, Cardiff CF14 4XN, S Glam, Wales.	sewellak@cardiff.ac.uk	Miles, John J/ABC-1105-2020; Sewell, Andrew/GPT-4220-2022; Price, David A/C-7876-2013	Miles, John J/0000-0001-5506-6304; Sewell, Andrew/0000-0003-3194-3135; Price, David A/0000-0001-9416-2737; Peakman, Mark/0000-0003-3328-3513; Wooldridge, Linda/0000-0002-6213-347X; Makinde, Julia/0000-0002-9906-7437; van den Berg, Hugo/0000-0002-8230-6227	Biotechnology and Biological Sciences Research Council [BB/H001085/1]; United Kingdom Department of Health via the National Institute for Health Research comprehensive Biomedical Research Centre; Wellcome Trust [WT079848MA]; Juvenile Diabetes Research Foundation [7-2005-877, 1-2007-1803, 17-2009-806]; Welsh Office of Research and Development; BBSRC [BB/H001085/1] Funding Source: UKRI; MRC [G0501963] Funding Source: UKRI; Medical Research Council [G0501963, MR/J006742/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); United Kingdom Department of Health via the National Institute for Health Research comprehensive Biomedical Research Centre; Wellcome Trust(Wellcome TrustEuropean Commission); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Welsh Office of Research and Development; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Biotechnology and Biological Sciences Research Council Grant BB/H001085/1 and the United Kingdom Department of Health via the National Institute for Health Research comprehensive Biomedical Research Centre award to Guy's and St. Thomas' NHS Foundation Trust in partnership with King's College London (to A. S. and M. P.).; Supported by Wellcome Trust Clinical Intermediate Fellow Grant WT079848MA.; Supported by Juvenile Diabetes Research Foundation Grants 7-2005-877, 1-2007-1803, or 17-2009-806.; Supported by a Welsh Office of Research and Development translational fellowship.	Archbold JK, 2008, MOL IMMUNOL, V45, P583, DOI 10.1016/j.molimm.2006.05.018; Archbold JK, 2006, J BIOL CHEM, V281, P34324, DOI 10.1074/jbc.M606755200; Arstila TP, 1999, SCIENCE, V286, P958, DOI 10.1126/science.286.5441.958; BHARDWAJ V, 1993, J IMMUNOL, V151, P5000; Crawford F, 2004, PLOS BIOL, V2, P523, DOI 10.1371/journal.pbio.0020090; Dai S, 2008, IMMUNITY, V28, P324, DOI 10.1016/j.immuni.2008.01.008; EVAVOLD BD, 1995, IMMUNITY, V2, P655, DOI 10.1016/1074-7613(95)90010-1; Felix NJ, 2007, NAT REV IMMUNOL, V7, P942, DOI 10.1038/nri2200; Hemmer B, 1997, J EXP MED, V185, P1651, DOI 10.1084/jem.185.9.1651; Hiemstra HS, 2000, CURR OPIN IMMUNOL, V12, P80, DOI 10.1016/S0952-7915(99)00054-0; Ishizuka J, 2009, J IMMUNOL, V183, P4337, DOI 10.4049/jimmunol.0901607; Kan-Mitchell J, 2006, J IMMUNOL, V176, P6690, DOI 10.4049/jimmunol.176.11.6690; Karlin S., 1974, 1 COURSE STOCHASTIC, P495; Kersh EN, 1998, SCIENCE, V281, P572, DOI 10.1126/science.281.5376.572; Kissler S, 2002, J AUTOIMMUN, V19, P183, DOI 10.1006/jaut.2002.0614; Lee JK, 2004, J EXP MED, V200, P1455, DOI 10.1084/jem.20041251; Macdonald WA, 2009, IMMUNITY, V31, P897, DOI 10.1016/j.immuni.2009.09.025; Mason D, 1998, IMMUNOL TODAY, V19, P395, DOI 10.1016/S0167-5699(98)01299-7; Nejentsev S, 2007, NATURE, V450, P887, DOI 10.1038/nature06406; Nino-Vasquez JJ, 2004, MOL IMMUNOL, V40, P1063, DOI 10.1016/j.molimm.2003.11.005; REAY PA, 1994, J IMMUNOL, V152, P3946; Reiser JB, 2000, NAT IMMUNOL, V1, P291, DOI 10.1038/79728; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Rudolph MG, 2002, CURR OPIN IMMUNOL, V14, P52, DOI 10.1016/S0952-7915(01)00298-9; Skowera A, 2008, J CLIN INVEST, V118, P3390, DOI 10.1172/JCI35449; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; UDAKA K, 1992, CELL, V69, P989, DOI 10.1016/0092-8674(92)90617-L; Van Den Berg HA, 2001, J THEOR BIOL, V209, P465, DOI 10.1006/jtbi.2001.2281; van den Berg HA, 2007, IMMUNOL REV, V216, P81; Wilson DB, 2004, MOL IMMUNOL, V40, P1047, DOI 10.1016/j.molimm.2003.11.022; Wooldridge L, 2010, J IMMUNOL, V185, P4625, DOI 10.4049/jimmunol.1001480; WRAITH DC, 1992, J IMMUNOL, V149, P3765; WUCHERPFENNIG KW, 1995, CELL, V80, P695, DOI 10.1016/0092-8674(95)90348-8	33	269	278	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					1168	1177		10.1074/jbc.M111.289488	http://dx.doi.org/10.1074/jbc.M111.289488			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22102287	hybrid, Green Accepted, Green Published			2022-12-27	WOS:000299170300032
J	Chou, YC; Keszei, AFA; Rohde, JR; Tyers, M; Sicheri, F				Chou, Yang-Chieh; Keszei, Alexander F. A.; Rohde, John R.; Tyers, Mike; Sicheri, Frank			Conserved Structural Mechanisms for Autoinhibition in IpaH Ubiquitin Ligases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNITY; ACTIVATION; FAMILY; SOPA	The IpaH family of novel E3 ligase (NEL) enzymes occur in a variety of pathogenic and commensal bacteria that interact with eukaryotic hosts. We demonstrate that the leucine-rich repeat (LRR) substrate recognition domains of different IpaH enzymes autoinhibit the enzymatic activity of the adjacent catalytic novel E3 ligase domain by two distinct but conserved structural mechanisms. Autoinhibition is required for the in vivo biological activity of two IpaH enzymes in a eukaryotic model system. Autoinhibition was retro-engineered into a constitutively active IpaH enzyme from Yersinia pestis by introduction of single site substitutions, thereby demonstrating the conservation of autoregulatory infrastructure across the IpaH enzyme family.	[Chou, Yang-Chieh; Keszei, Alexander F. A.; Tyers, Mike; Sicheri, Frank] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Chou, Yang-Chieh; Keszei, Alexander F. A.; Tyers, Mike; Sicheri, Frank] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Rohde, John R.] Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS B3H 1V7, Canada; [Tyers, Mike] Univ Montreal, Inst Res Immunol & Canc, Montreal, PQ H3T 1J4, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; Dalhousie University; Universite de Montreal	Tyers, M (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	md.tyers@umontreal.ca; sicheri@lunenfeld.ca	Rohde, John/F-1479-2013; Sicheri, Frank/F-8856-2013; Tyers, Michael/ABE-3194-2021	Keszei, Alexander/0000-0002-8524-7998	Canadian Institutes of Health Research [MOP-57795]; Canada Research Chair in Systems and Synthetic Biology; Canada Research Chair in Structural Biology of Signal Transduction	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chair in Systems and Synthetic Biology; Canada Research Chair in Structural Biology of Signal Transduction(Canada Research Chairs)	This work was supported by a grant from the Canadian Institutes of Health Research (Grant MOP-57795) (to F. S. and M. T.); Supported by a Canadian Institutes of Health Research Doctoral Research Scholarship.; Supported by a Canada Research Chair in Systems and Synthetic Biology. To whom correspondence may be addressed. Tel.:514-343-6668; E-mail: md.tyers@umontreal.ca.; Supported by a Canada Research Chair in Structural Biology of Signal Transduction. To whom correspondence may be addressed. Tel.:416-586-8471; E-mail: sicheri@lunenfeld.ca.	Abramovitch RB, 2006, P NATL ACAD SCI USA, V103, P2851, DOI 10.1073/pnas.0507892103; Ashida H, 2010, NAT CELL BIOL, V12, P66, DOI 10.1038/ncb2006; Diao J, 2008, NAT STRUCT MOL BIOL, V15, P65, DOI 10.1038/nsmb1346; Haraga A, 2006, CELL MICROBIOL, V8, P837, DOI 10.1111/j.1462-5822.2005.00670.x; Hicks SW, 2010, CURR OPIN MICROBIOL, V13, P41, DOI 10.1016/j.mib.2009.11.008; Merlet J, 2009, CELL MOL LIFE SCI, V66, P1924, DOI 10.1007/s00018-009-8712-7; Ntoukakis V, 2009, SCIENCE, V324, P784, DOI 10.1126/science.1169430; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Quezada CM, 2009, P NATL ACAD SCI USA, V106, P4864, DOI 10.1073/pnas.0811058106; Rohde JR, 2007, CELL HOST MICROBE, V1, P77, DOI 10.1016/j.chom.2007.02.002; Singer AU, 2008, NAT STRUCT MOL BIOL, V15, P1293, DOI 10.1038/nsmb.1511; Wiesner S, 2007, CELL, V130, P651, DOI 10.1016/j.cell.2007.06.050; Wu B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000960; Xia ZP, 2009, NATURE, V461, P114, DOI 10.1038/nature08247; Xing W, 2007, NATURE, V449, P243, DOI 10.1038/nature06109; Zhang Y, 2006, MOL MICROBIOL, V62, P786, DOI 10.1111/j.1365-2958.2006.05407.x; Zhu YQ, 2008, NAT STRUCT MOL BIOL, V15, P1302, DOI 10.1038/nsmb.1517	18	33	33	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					268	275		10.1074/jbc.M111.316265	http://dx.doi.org/10.1074/jbc.M111.316265			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22065585	hybrid, Green Published			2022-12-27	WOS:000298682400027
J	Garcia, BL; Summers, BJ; Lin, Z; Ramyar, KX; Ricklin, D; Kamath, DV; Fu, ZQ; Lambris, JD; Geisbrecht, BV				Garcia, Brandon L.; Summers, Brady J.; Lin, Zhuoer; Ramyar, Kasra X.; Ricklin, Daniel; Kamath, Divya V.; Fu, Zheng-Qing; Lambris, John D.; Geisbrecht, Brian V.			Diversity in the C3b Contact Residues and Tertiary Structures of the Staphylococcal Complement Inhibitor (SCIN) Protein Family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALTERNATIVE PATHWAY; IMMUNE EVASION; REVEALS; SYSTEM; RECOGNITION; ACTIVATION; INSIGHTS; SITE	To survive in immune-competent hosts, the pathogen Staphylococcus aureus expresses and secretes a sophisticated array of proteins that inhibit the complement system. Among these are the staphylococcal complement inhibitors (SCIN), which are composed of three active proteins (SCIN-A, -B, and -C) and one purportedly inactive member (SCIN-D or ORF-D). Because previous work has focused almost exclusively on SCIN-A, we sought to provide initial structure/function information on additional SCIN proteins. To this end we determined crystal structures of an active, N-terminal truncation mutant of SCIN-B (denoted SCIN-B18-85) both free and bound to the C3c fragment of complement component C3 at 1.5 and 3.4 angstrom resolution, respectively. Comparison of the C3c/SCIN-B18-85 structure with that of C3c/SCIN-A revealed that both proteins target the same functional hotspot on the C3b/C3c surface yet harbor diversity in both the type of residues and interactions formed at their C3b/C3c interfaces. Most importantly, these structures allowed identification of Arg(44) and Tyr(51) as residues key for SCIN-B binding to C3b and subsequent inhibition of the AP C3 convertase. In addition, we also solved several crystal structures of SCIN-D to 1.3 angstrom limiting resolution. This revealed an unexpected structural deviation in the N-terminal alpha helix relative to SCIN-A and SCIN-B. Comparative analysis of both electrostatic potentials and surface complementarity suggest a physical explanation for the inability of SCIN-D to bind C3b/C3c. Together, these studies provide a more thorough understanding of immune evasion by S. aureus and enhance potential use of SCIN proteins as templates for design of complement targeted therapeutics.	[Garcia, Brandon L.; Summers, Brady J.; Ramyar, Kasra X.; Kamath, Divya V.; Geisbrecht, Brian V.] Univ Missouri, Sch Biol Sci, Div Cell Biol & Biophys, Kansas City, MO 64110 USA; [Lin, Zhuoer; Ricklin, Daniel; Lambris, John D.] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Fu, Zheng-Qing] Argonne Natl Lab, Adv Photon Source, Argonne, IL 60439 USA	University of Missouri System; University of Missouri Kansas City; University of Pennsylvania; United States Department of Energy (DOE); Argonne National Laboratory	Geisbrecht, BV (corresponding author), Univ Missouri, Sch Biol Sci, Div Cell Biol & Biophys, Kansas City, MO 64110 USA.	GeisbrechtB@umkc.edu	Lambris, John/Q-5633-2018; Ricklin, Daniel/F-5104-2011	Lambris, John/0000-0002-9370-5776; Ricklin, Daniel/0000-0001-6140-0233	National Institutes of Health [AI071028, AI030040, AI068730, AI072106]; American Heart Association; United States Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]; SER-CAT Institutional Members website; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI068730, R01AI072106, R01AI030040, N01AI030040, R01AI071028] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); SER-CAT Institutional Members website; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grants AI071028, AI030040, AI068730, and AI072106 (to B. V. G. and J. D. L.). This work was also supported by an American Heart Association Predoctoral Fellowship (to B. L. G.).; We acknowledge the generous technical assistance of Drs. Rod Salazar and Andy Howard during x-ray diffraction data collection and Dr. Samuel Bouyain for use of the EnSpire plate reader. Use of the Advanced Photon Source was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences under Contract W-31-109-Eng-38. Data were collected at Southeast Regional Collaborative Access Team (SER-CAT) beamlines at the Advanced Photon Source, Argonne National Laboratory. A list of supporting member institutions may be found at the SER-CAT Institutional Members website.	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Beneken J, 2000, NEURON, V26, P143, DOI 10.1016/S0896-6273(00)81145-9; Bielefeld-Sevigny M, 2009, ASSAY DRUG DEV TECHN, V7, P90, DOI 10.1089/adt.2009.9996; Chavakis T, 2007, TRENDS IMMUNOL, V28, P408, DOI 10.1016/j.it.2007.07.002; Chen H, 2010, P NATL ACAD SCI USA, V107, P17621, DOI 10.1073/pnas.1003750107; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Foster TJ, 2005, NAT REV MICROBIOL, V3, P948, DOI 10.1038/nrmicro1289; Garcia BL, 2010, J MOL BIOL, V402, P17, DOI 10.1016/j.jmb.2010.07.029; Garcia BL, 2009, ACTA CRYSTALLOGR F, V65, P482, DOI 10.1107/S174430910901207X; Garcia KC, 1999, ANNU REV IMMUNOL, V17, P369, DOI 10.1146/annurev.immunol.17.1.369; Geisbrecht BV, 2008, ADV EXP MED BIOL, V632, P221, DOI 10.1007/978-0-387-78952-1_16; Geisbrecht BV, 2006, PROTEIN EXPRES PURIF, V46, P23, DOI 10.1016/j.pep.2005.09.003; Hammel M, 2007, J BIOL CHEM, V282, P30051, DOI 10.1074/jbc.M704247200; Hammel M, 2007, NAT IMMUNOL, V8, P430, DOI 10.1038/ni1450; Harboe M, 2004, CLIN EXP IMMUNOL, V138, P439, DOI 10.1111/j.1365-2249.2004.02627.x; HEMKER HC, 1975, BIOCHIM BIOPHYS ACTA, V379, P180, DOI 10.1016/0005-2795(75)90020-3; Janssen BJC, 2007, J BIOL CHEM, V282, P29241, DOI 10.1074/jbc.M704587200; Janssen BJC, 2006, NATURE, V444, P213, DOI 10.1038/nature05172; Janssen BJC, 2005, NATURE, V437, P505, DOI 10.1038/nature04005; Jongerius I, 2007, J EXP MED, V204, P2461, DOI 10.1084/jem.20070818; Jongerius I, 2010, J IMMUNOL, V184, P420, DOI 10.4049/jimmunol.0902865; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Laarman A, 2010, J MOL MED, V88, P115, DOI 10.1007/s00109-009-0572-y; Lambris JD, 2008, NAT REV MICROBIOL, V6, P132, DOI 10.1038/nrmicro1824; MERI S, 1994, BIOCHEM BIOPH RES CO, V198, P52, DOI 10.1006/bbrc.1994.1008; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PANGBURN MK, 1986, BIOCHEM J, V235, P723, DOI 10.1042/bj2350723; Pangburn MK, 2000, IMMUNOPHARMACOLOGY, V49, P149, DOI 10.1016/S0162-3109(00)80300-8; Ricklin D, 2007, NAT BIOTECHNOL, V25, P1265, DOI 10.1038/nbt1342; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Ricklin D, 2009, J IMMUNOL, V183, P2565, DOI 10.4049/jimmunol.0901443; Rooijakkers SHM, 2005, TRENDS MICROBIOL, V13, P596, DOI 10.1016/j.tim.2005.10.002; Rooijakkers SHM, 2005, NAT IMMUNOL, V6, P920, DOI 10.1038/ni1235; Rooijakkers SHM, 2007, J IMMUNOL, V179, P2989, DOI 10.4049/jimmunol.179.5.2989; Rooijakkers SHM, 2009, NAT IMMUNOL, V10, P721, DOI 10.1038/ni.1756; RUSSELL RB, 1992, PROTEINS, V14, P309, DOI 10.1002/prot.340140216; SARKAR G, 1990, BIOTECHNIQUES, V8, P404; Tedesco F, 2004, COMPLEMENT SYSTEM: NOVEL ROLES IN HEALTH AND DISEASE, P97, DOI 10.1007/1-4020-8056-5_6; Wiesmann C, 2006, NATURE, V444, P217, DOI 10.1038/nature05263; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wu J, 2009, NAT IMMUNOL, V10, P728, DOI 10.1038/ni.1755; Zhou P, 2009, PROTEINS, V76, P151, DOI 10.1002/prot.22327; Zipfel PF, 2009, NAT REV IMMUNOL, V9, P729, DOI 10.1038/nri2620	45	21	21	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					628	640		10.1074/jbc.M111.298984	http://dx.doi.org/10.1074/jbc.M111.298984			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22086928	hybrid, Green Published			2022-12-27	WOS:000298682400061
J	Yao, DCI; Brune, DC; Vavilin, D; Vermaas, WFJ				Yao, Danny C. I.; Brune, Daniel C.; Vavilin, Dmitri; Vermaas, Wim F. J.			Photosystem II Component Lifetimes in the Cyanobacterium Synechocystis sp Strain PCC 6803 SMALL Cab-LIKE PROTEINS STABILIZE BIOSYNTHESIS INTERMEDIATES AND AFFECT EARLY STEPS IN CHLOROPHYLL SYNTHESIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLET OXYGEN PRODUCTION; SP PCC-6803; CHLOROPHYLL; MEMBRANE; PHOTOINHIBITION; DEGRADATION; BINDING; REPAIR; POLYPEPTIDES; METABOLISM	To gain insight in the lifetimes of photosystem II (PSII) chlorophyll and proteins, a combined stable isotope labeling (N-15)/mass spectrometry method was used to follow both old and new pigments and proteins. Photosystem I-less Synechocystis cells were grown to exponential or post-exponential phase and then diluted in BG-11 medium with [N-15] ammonium and [N-15] nitrate. PSII was isolated, and the masses of PSII protein fragments and chlorophyll were determined. Lifetimes of PSII components ranged from 1.5 to 40 h, implying that at least some of the proteins and chlorophyll turned over independently from each other. Also, a significant amount of nascent PSII components accumulated in thylakoids when cells were in post-exponential growth phase. In a mutant lacking small Cab-like proteins (SCPs), most PSII protein lifetimes were unaffected, but the lifetime of chlorophyll and the amount of nascent PSII components that accumulated were decreased. In the absence of SCPs, one of the PSII biosynthesis intermediates, the monomeric PSII complex without CP43, was missing. Therefore, SCPs may stabilize nascent PSII protein complexes. Moreover, upon SCP deletion, the rate of chlorophyll synthesis and the accumulation of early tetrapyrrole precursors were drastically reduced. When [N-14] aminolevulinic acid (ALA) was supplemented to N-15-BG-11 cultures, the mutant lacking SCPs incorporated much more exogenous ALA into chlorophyll than the control demonstrating that ALA biosynthesis was impaired in the absence of SCPs. This illustrates the major effects that nonstoichiometric PSII components such as SCPs have on intermediates and assembly but not on the lifetime of PSII proteins.	[Vermaas, Wim F. J.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; Arizona State Univ, Ctr Bioenergy & Photosynth, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Vermaas, WFJ (corresponding author), Arizona State Univ, Sch Life Sci, Box 874501, Tempe, AZ 85287 USA.	wim@asu.edu			Division of Chemical Sciences, Geosciences and Biosciences, Office of Basic Energy Sciences of the United States Department of Energy [DE-FG02-08ER15543]	Division of Chemical Sciences, Geosciences and Biosciences, Office of Basic Energy Sciences of the United States Department of Energy(United States Department of Energy (DOE))	This work was supported by Division of Chemical Sciences, Geosciences and Biosciences, Office of Basic Energy Sciences of the United States Department of Energy Grant DE-FG02-08ER15543.	Bricker TM, 1998, BBA-BIOENERGETICS, V1409, P50, DOI 10.1016/S0005-2728(98)00148-0; Cormann KU, 2009, BIOCHEMISTRY-US, V48, P8768, DOI 10.1021/bi9012726; Funk C, 1999, BIOCHEMISTRY-US, V38, P9397, DOI 10.1021/bi990545+; He QF, 1998, P NATL ACAD SCI USA, V95, P5830, DOI 10.1073/pnas.95.10.5830; Herranen M, 2004, PLANT PHYSIOL, V134, P470, DOI 10.1104/pp.103.032326; Jansson S, 2000, PLANT MOL BIOL, V42, P345, DOI 10.1023/A:1006365213954; JANSSON S, 1994, BBA-BIOENERGETICS, V1184, P1, DOI 10.1016/0005-2728(94)90148-1; Joyard J, 2009, MOL PLANT, V2, P1154, DOI 10.1093/mp/ssp088; Kashino Y, 2002, BIOCHEMISTRY-US, V41, P8004, DOI 10.1021/bi026012+; Komenda J, 2006, J BIOL CHEM, V281, P1145, DOI 10.1074/jbc.M503852200; Komenda J, 2002, EUR J BIOCHEM, V269, P610, DOI 10.1046/j.0014-2956.2001.02693.x; Krieger-Liszkay A, 2005, J EXP BOT, V56, P337, DOI 10.1093/jxb/erh237; Krieger-Liszkay A, 2008, PHOTOSYNTH RES, V98, P551, DOI 10.1007/s11120-008-9349-3; Kufryk G, 2008, PHOTOSYNTH RES, V95, P135, DOI 10.1007/s11120-007-9244-3; Loll B, 2007, BBA-BIOENERGETICS, V1767, P509, DOI 10.1016/j.bbabio.2006.12.009; MACPHERSON AN, 1993, BIOCHIM BIOPHYS ACTA, V1143, P301, DOI 10.1016/0005-2728(93)90201-P; MATTOO AK, 1984, P NATL ACAD SCI-BIOL, V81, P1380, DOI 10.1073/pnas.81.5.1380; Mattoo AK, 1999, PHYSIOL PLANTARUM, V107, P454, DOI 10.1034/j.1399-3054.1999.100412.x; Muh F, 2008, PLANT PHYSIOL BIOCH, V46, P238, DOI 10.1016/j.plaphy.2008.01.003; MULLET JE, 1990, P NATL ACAD SCI USA, V87, P4038, DOI 10.1073/pnas.87.11.4038; Nixon PJ, 2010, ANN BOT-LONDON, V106, P1, DOI 10.1093/aob/mcq059; Nixon PJ, 2005, J EXP BOT, V56, P357, DOI 10.1093/jxb/eri021; OHAD I, 1984, J CELL BIOL, V99, P481, DOI 10.1083/jcb.99.2.481; POWLES SB, 1984, ANNU REV PLANT PHYS, V35, P15, DOI 10.1146/annurev.pp.35.060184.000311; PRASIL O, 1992, TOPICS PHOTOSYNTHESI, V2, P293; Promnares K, 2006, J BIOL CHEM, V281, P32705, DOI 10.1074/jbc.M606360200; Richter A, 2010, PLANT CELL PHYSIOL, V51, P670, DOI 10.1093/pcp/pcq047; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; SCHUSTER G, 1988, EUR J BIOCHEM, V177, P403, DOI 10.1111/j.1432-1033.1988.tb14389.x; Shalygo N, 2009, PLANT MOL BIOL, V71, P425, DOI 10.1007/s11103-009-9532-8; SHEN GZ, 1993, PLANT CELL, V5, P1853, DOI 10.1105/tpc.5.12.1853; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; SMITH D, 1993, FEMS MICROBIOL LETT, V110, P341, DOI 10.1016/0378-1097(93)90126-M; Sobotka R, 2008, J BACTERIOL, V190, P2086, DOI 10.1128/JB.01678-07; Sonoike Kintake, 2006, V24, P657; Stewart DH, 1998, BBA-BIOENERGETICS, V1367, P63, DOI 10.1016/S0005-2728(98)00139-X; Storm P, 2008, PHOTOSYNTH RES, V98, P479, DOI 10.1007/s11120-008-9368-0; Triantaphylides C, 2009, TRENDS PLANT SCI, V14, P219, DOI 10.1016/j.tplants.2009.01.008; VASS I, 1992, P NATL ACAD SCI USA, V89, P1408, DOI 10.1073/pnas.89.4.1408; Vavilin D, 2005, BBA-BIOENERGETICS, V1708, P91, DOI 10.1016/j.bbabio.2004.12.011; Vavilin D, 2007, J BIOL CHEM, V282, P37660, DOI 10.1074/jbc.M707133200; Wu QG, 1995, PLANT MOL BIOL, V29, P933, DOI 10.1007/BF00014967; Xu H, 2004, J BIOL CHEM, V279, P27971, DOI 10.1074/jbc.M403307200; Xu H, 2002, PLANT MOL BIOL, V49, P149, DOI 10.1023/A:1014900806905; Yao D, 2007, J BIOL CHEM, V282, P267, DOI 10.1074/jbc.M605463200; Zak E, 2001, P NATL ACAD SCI USA, V98, P13443, DOI 10.1073/pnas.241503898; Zhang LX, 2002, FEBS LETT, V512, P13, DOI 10.1016/S0014-5793(02)02218-4	48	44	47	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					682	692		10.1074/jbc.M111.320994	http://dx.doi.org/10.1074/jbc.M111.320994			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22090028	Green Published, hybrid			2022-12-27	WOS:000298682400066
J	Arnold, LH; Butt, LE; Prior, SH; Read, CM; Fields, GB; Pickford, AR				Arnold, Laurence H.; Butt, Louise E.; Prior, Stephen H.; Read, Christopher M.; Fields, Gregg B.; Pickford, Andrew R.			The Interface between Catalytic and Hemopexin Domains in Matrix Metalloproteinase-1 Conceals a Collagen Binding Exosite	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TERMINAL DOMAIN; SCATTERING DATA-ANALYSIS; EHLERS-DANLOS-SYNDROME; FIBROBLAST COLLAGENASE; I COLLAGEN; SUBSTRATE-SPECIFICITY; MAMMALIAN COLLAGENASES; EXTRACELLULAR-MATRIX; OSTEO-SARCOMA; CELL-SURFACE	Matrix metalloproteinase-1 (MMP-1) is an instigator of collagenolysis, the catabolism of triple helical collagen. Previous studies have implicated its hemopexin (HPX) domain in binding and possibly destabilizing the collagen substrate in preparation for hydrolysis of the polypeptide backbone by the catalytic (CAT) domain. Here, we use biophysical methods to study the complex formed between the MMP-1 HPX domain and a synthetic triple helical peptide (THP) that encompasses theMMP-1 cleavage site of the collagen alpha 1(I) chain. The two components interact with 1: 1 stoichiometry and micromolar affinity via a binding site within blades 1 and 2 of the four-bladed HPX domain propeller. Subsequent site-directed mutagenesis and assay implicates blade 1 residues Phe(301), Val(319), and Asp(338) in collagen binding. Intriguingly, Phe(301) is partially masked by the CAT domain in the crystal structure of full-length MMP-1 implying that transient separation of the domains is important in collagen recognition. However, mutation of this residue in the intact enzyme disrupts the CAT-HPX interface resulting in a drastic decrease in binding activity. Thus, a balanced equilibrium between these compact and dislocated states may be an essential feature of MMP-1 collagenase activity.	[Butt, Louise E.; Prior, Stephen H.; Read, Christopher M.; Pickford, Andrew R.] Univ Portsmouth, Inst Biomed & Biomol Sci, Biophys Labs, Portsmouth PO1 2DY, Hants, England; [Arnold, Laurence H.] MRC Natl Inst Med Res, Div Mol Struct, London NW7 1AA, England; [Fields, Gregg B.] Torrey Pines Inst Mol Studies, Port St Lucie, FL 34987 USA	University of Portsmouth; MRC National Institute for Medical Research; Torrey Pines Institute for Molecular Studies, Florida	Pickford, AR (corresponding author), Univ Portsmouth, Inst Biomed & Biomol Sci, Biophys Labs, Portsmouth PO1 2DY, Hants, England.	andy.pickford@port.ac.uk	Pickford, Andy/AGB-6901-2022	Prior, Steve/0000-0002-6133-0607; Butt, Louise/0000-0003-2422-1046; Arnold, Laurence/0000-0001-6785-1035; Pickford, Andy/0000-0002-7237-0030	National Institutes of Health [CA098799]; Royal Society; Biotechnology and Biological Sciences Research Council [BB/F004532/1]; Wellcome Trust; NATIONAL CANCER INSTITUTE [R01CA098799] Funding Source: NIH RePORTER; BBSRC [BB/F004532/1] Funding Source: UKRI	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Royal Society(Royal Society of London); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome Trust); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported, in whole or in part, by National Institutes of Health Grant CA098799 (to G. B. F.).; Supported by the Royal Society and Biotechnology and Biological Sciences Research Council Grant BB/F004532/1.; We are extremely grateful to Hideaki Nagase and Robert Visse for providing the original pET-3a plasmid constructs for expressing pro-MMP-1* and HPX-1. We thank Tom Frenkiel, Geoff Kelly, and Alain Oregioni for help at the MRC Biomedical NMR Centre, Mill Hill, UK. We are also indebted to Helen Vincent, Anastasia Callaghan, and Marc Malfois for help in the acquisition and processing of SAXS data at the Diamond Light Source. Funding for the University of Portsmouth NMR facility was provided by the Wellcome Trust.	ALLAN JA, 1991, J CELL SCI, V99, P789; ASOKAN R, 1993, MOL CELL BIOCHEM, V121, P99, DOI 10.1007/BF00925968; Bertini I, 2008, J AM CHEM SOC, V130, P7011, DOI 10.1021/ja710491y; Bertini I, 2009, J BIOL CHEM, V284, P12821, DOI 10.1074/jbc.M809627200; CHERVENKA CH, 1970, ANAL BIOCHEM, V34, P24, DOI 10.1016/0003-2697(70)90082-5; Chung L, 2000, J BIOL CHEM, V275, P29610, DOI 10.1074/jbc.M004039200; Chung LD, 2004, EMBO J, V23, P3020, DOI 10.1038/sj.emboj.7600318; CLARK IM, 1989, BIOCHEM J, V263, P201, DOI 10.1042/bj2630201; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W.L, PYMOL MOL GRAPHICS S; EHRLICH HP, 1982, BIOCHEM MED METAB B, V28, P273, DOI 10.1016/0006-2944(82)90080-1; FIELDS GB, 1991, J THEOR BIOL, V153, P585, DOI 10.1016/S0022-5193(05)80157-2; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; GLATTER O, 1979, J APPL CRYSTALLOGR, V12, P166, DOI 10.1107/S0021889879012139; Hadler-Olsen E, 2011, FEBS J, V278, P28, DOI 10.1111/j.1742-4658.2010.07920.x; Han SJ, 2010, J BIOL CHEM, V285, P22276, DOI 10.1074/jbc.M110.102079; Hurst DR, 2004, BIOCHEM J, V377, P775, DOI 10.1042/bj20031067; Itoh Y, 2001, EMBO J, V20, P4782, DOI 10.1093/emboj/20.17.4782; Itoh Y, 2006, MOL BIOL CELL, V17, P5390, DOI 10.1091/mbc.e06-08-0740; Iyer S, 2006, J MOL BIOL, V362, P78, DOI 10.1016/j.jmb.2006.06.079; JIMENEZ SA, 1977, BIOCHEM BIOPH RES CO, V78, P1354, DOI 10.1016/0006-291X(77)91441-3; Jozic D, 2005, J BIOL CHEM, V280, P9578, DOI 10.1074/jbc.M411084200; KNAUPER V, 1993, BIOCHEM J, V291, P847; Knauper V, 1997, J BIOL CHEM, V272, P7608, DOI 10.1074/jbc.272.12.7608; Knauper V, 2001, EUR J BIOCHEM, V268, P1888, DOI 10.1046/j.1432-1033.2001.02062.x; Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Lauer-Fields JL, 2009, J BIOL CHEM, V284, P24017, DOI 10.1074/jbc.M109.016873; Lauer-Fields JL, 2000, J CHROMATOGR A, V890, P117, DOI 10.1016/S0021-9673(00)00396-4; Leikina E, 2002, P NATL ACAD SCI USA, V99, P1314, DOI 10.1073/pnas.032307099; LI J, 1995, STRUCTURE, V3, P541, DOI 10.1016/S0969-2126(01)00188-5; Makareeva E, 2010, CANCER RES, V70, P4366, DOI 10.1158/0008-5472.CAN-09-4057; Malfait F, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.038224; MORO L, 1977, ARCH BIOCHEM BIOPHYS, V182, P33, DOI 10.1016/0003-9861(77)90280-6; MURPHY G, 1992, J BIOL CHEM, V267, P9612; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; NAGASE H, 1990, BIOCHEMISTRY-US, V29, P5783, DOI 10.1021/bi00476a020; NARAYANAN AS, 1980, BIOCHEMISTRY-US, V19, P5037, DOI 10.1021/bi00563a016; O'Farrell TJ, 2006, BIOCHEMISTRY-US, V45, P15411, DOI 10.1021/bi060849d; Ohuchi E, 1997, J BIOL CHEM, V272, P2446, DOI 10.1074/jbc.272.4.2446; Ottl J, 2000, CHEM BIOL, V7, P119, DOI 10.1016/S1074-5521(00)00077-6; Overall CM, 2002, MOL BIOTECHNOL, V22, P51, DOI 10.1385/MB:22:1:051; Pace JM, 2008, J BIOL CHEM, V283, P16061, DOI 10.1074/jbc.M801982200; Pardo A, 2005, INT J BIOCHEM CELL B, V37, P283, DOI 10.1016/j.biocel.2004.06.017; ROJKIND M, 1979, GASTROENTEROLOGY, V76, P710; Rosenblum G, 2007, STRUCTURE, V15, P1227, DOI 10.1016/j.str.2007.07.019; Schwarze U, 2004, AM J HUM GENET, V74, P917, DOI 10.1086/420794; SHAPIRO FD, 1982, J NATL CANCER I, V69, P1009; Sober H. A, 1968, HDB BIOCH SELECTED D; STRICKLIN GP, 1983, BIOCHEMISTRY-US, V22, P61, DOI 10.1021/bi00270a009; SUZUKI K, 1990, BIOCHEMISTRY-US, V29, P10261, DOI 10.1021/bi00496a016; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 1998, P NATL ACAD SCI USA, V95, P2267, DOI 10.1073/pnas.95.5.2267; Tochowicz A, 2011, J BIOL CHEM, V286, P7587, DOI 10.1074/jbc.M110.178434; Tsukada H, 2002, J BIOL CHEM, V277, P27378, DOI 10.1074/jbc.M201367200; VANWART HE, 1990, P NATL ACAD SCI USA, V87, P5578, DOI 10.1073/pnas.87.14.5578; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; WELGUS HG, 1985, COLLAGEN REL RES, V5, P167; Xiao JX, 2010, J BIOL CHEM, V285, P34181, DOI 10.1074/jbc.M110.128355; YAMAGATA S, 1984, J BIOCHEM-TOKYO, V96, P17, DOI 10.1093/oxfordjournals.jbchem.a134809	63	39	39	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2011	286	52					45073	45082		10.1074/jbc.M111.285213	http://dx.doi.org/10.1074/jbc.M111.285213			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870CA	22030392	Green Published, hybrid			2022-12-27	WOS:000298645500074
J	Isfort, K; Ebert, F; Bornhorst, J; Sargin, S; Kardakaris, R; Pasparakis, M; Bahler, M; Schwerdtle, T; Schwab, A; Hanley, PJ				Isfort, Katrin; Ebert, Franziska; Bornhorst, Julia; Sargin, Sarah; Kardakaris, Rozina; Pasparakis, Manolis; Baehler, Martin; Schwerdtle, Tanja; Schwab, Albrecht; Hanley, Peter J.			Real-time Imaging Reveals That P2Y(2) and P2Y(12) Receptor Agonists Are Not Chemoattractants and Macrophage Chemotaxis to Complement C5a Is Phosphatidylinositol 3-Kinase (PI3K)- and p38 Mitogen-activated Protein Kinase (MAPK)-independent	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRACELLULAR ATP; NEUTROPHIL CHEMOTAXIS; INDUCE CHEMOTAXIS; IN-VIVO; CELLS; SIGNAL; ADP; NUCLEOTIDES; BRAIN; MICE	Adenosine 5'-triphosphate (ATP) has been implicated in the recruitment of professional phagocytes (neutrophils and macrophages) to sites of infection and tissue injury in two distinct ways. First, ATP itself is thought to be a chemotactic "find me" signal released by dying cells, and second, autocrine ATP signaling is implicated as an amplifier mechanism for chemotactic navigation to end-target chemoattractants, such as complement C5a. Here we show using real-time chemotaxis assays that mouse peritoneal macrophages do not directionally migrate to stable analogs of ATP (adenosine-5'-(gamma-thio)-triphosphate (ATP gamma S)) or its hydrolysis product ADP (adenosine-5'-(gamma-thio)-diphosphate (ADP beta S)). HPLC revealed that these synthetic P2Y(2) (ATP gamma S) and P2Y(12) (ADP gamma S) receptor ligands were in fact slowly degraded. We also found that ATP gamma S, but not ADP beta S, promoted chemokinesis (increased random migration). Furthermore, we found that photorelease of ATP or ADP induced lamellipodial membrane extensions. At the cell signaling level, C5a, but not ATP gamma S, activated Akt, whereas both ligands induced p38 MAPK activation. p38 MAPK and Akt activation are strongly implicated in neutrophil chemotaxis. However, we found that inhibitors of phosphatidylinositol 3-kinase (PI3K; upstream of Akt) and p38 MAPK(or conditional deletion of p38 alpha MAPK) did not impair macrophage chemotactic efficiency or migration velocity. Our results suggest that PI3K and p38 MAPK are redundant for macrophage chemotaxis and that purinergic P2Y(2) and P2Y(12) receptor ligands are not chemotactic. We propose that ATP signaling is strictly autocrine or paracrine and that ATP and ADP may act as short-range "touch me" (rather than long-range find me) signals to promote phagocytic clearance via cell spreading.	[Baehler, Martin; Hanley, Peter J.] Univ Munster, Inst Mol Zellbiol, D-48149 Munster, Germany; [Isfort, Katrin; Sargin, Sarah; Schwab, Albrecht] Univ Munster, Inst Physiol 2, D-48149 Munster, Germany; [Ebert, Franziska; Bornhorst, Julia; Schwerdtle, Tanja] Univ Munster, Inst Lebensmittelchem, D-48149 Munster, Germany; [Bornhorst, Julia] Univ Munster, Grad Sch Chem, D-48149 Munster, Germany; [Kardakaris, Rozina; Pasparakis, Manolis] Univ Cologne, Inst Genet, D-50674 Cologne, Germany	University of Munster; University of Munster; University of Munster; University of Munster; University of Cologne	Hanley, PJ (corresponding author), Univ Munster, Inst Mol Zellbiol, D-48149 Munster, Germany.	hanley@uni-muenster.de	Hanley, Peter J/H-4915-2017; Pasparakis, Manolis/H-9292-2017; Pasparakis, Manolis/N-4350-2019	Pasparakis, Manolis/0000-0002-9870-0966; Pasparakis, Manolis/0000-0002-9870-0966	Deutsche Forschungsgemeinschaft (DFG) [SCHW 407/9-3, SCHW 903/3-2, SCHW 903/4-1]; Graduate School of Chemistry; Westfalische Wilhelms-Universitat Munster [IS611005]; Innovative Medizinische Forschung (IMF) [HA110710]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Graduate School of Chemistry; Westfalische Wilhelms-Universitat Munster; Innovative Medizinische Forschung (IMF)	This work was supported in part by Deutsche Forschungsgemeinschaft (DFG) Grants SCHW 407/9-3 and SCHW 903/3-2 (to A. S.) and SCHW 903/4-1 (to T. S.). In addition, this work was supported by a grant from the Graduate School of Chemistry (to J. B.) and Innovative Medizinische Forschung (IMF) Grants HA110710 (to P. J. H.) and IS611005 (to K. I.) from the Westfalische Wilhelms-Universitat Munster.	Bodor ET, 2003, MOL PHARMACOL, V64, P1210, DOI 10.1124/mol.64.5.1210; Chen Y, 2006, SCIENCE, V314, P1792, DOI 10.1126/science.1132559; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Communi D, 2001, J BIOL CHEM, V276, P41479, DOI 10.1074/jbc.M105912200; Couzin-Frankel J, 2010, SCIENCE, V330, P1621, DOI 10.1126/science.330.6011.1621; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; del Rey A, 2006, J BIOL CHEM, V281, P35147, DOI 10.1074/jbc.M607713200; ELFERINK JGR, 1992, ARCH INT PHARMACOD T, V317, P93; Elliott MR, 2009, NATURE, V461, P282, DOI 10.1038/nature08296; Fitz J Gregory, 2007, Trans Am Clin Climatol Assoc, V118, P199; Foster CJ, 2001, J CLIN INVEST, V107, P1591, DOI 10.1172/JCI12242; Foxman EF, 1997, J CELL BIOL, V139, P1349, DOI 10.1083/jcb.139.5.1349; Hanley PJ, 2010, P NATL ACAD SCI USA, V107, P12145, DOI 10.1073/pnas.0911986107; Hanley PJ, 2004, P NATL ACAD SCI USA, V101, P9479, DOI 10.1073/pnas.0400733101; Haynes SE, 2006, NAT NEUROSCI, V9, P1512, DOI 10.1038/nn1805; Heinrichsdorff J, 2008, EMBO REP, V9, P1048, DOI 10.1038/embor.2008.149; Heit B, 2002, J CELL BIOL, V159, P91, DOI 10.1083/jcb.200202114; Heit B, 2008, NAT IMMUNOL, V9, P743, DOI 10.1038/ni.1623; Honda S, 2001, J NEUROSCI, V21, P1975, DOI 10.1523/JNEUROSCI.21-06-01975.2001; Huang JX, 2009, BIOCHEM SOC T, V37, P217, DOI 10.1042/BST0370217; Junger WG, 2011, NAT REV IMMUNOL, V11, P201, DOI 10.1038/nri2938; Kaufmann A, 2005, J BIOL CHEM, V280, P32459, DOI 10.1074/jbc.M505301200; Koizumi S, 2007, NATURE, V446, P1091, DOI 10.1038/nature05704; Kronlage M, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000588; Lazarowski ER, 2011, ADV PHARMACOL, V61, P221, DOI 10.1016/B978-0-12-385526-8.00008-4; McCloskey MA, 1999, J IMMUNOL, V163, P970; Mortensen SP, 2011, J PHYSIOL-LONDON, V589, P1847, DOI 10.1113/jphysiol.2010.203034; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Praetorius HA, 2009, PURINERG SIGNAL, V5, P433, DOI 10.1007/s11302-009-9146-2; Riedl J, 2010, NAT METHODS, V7, P168, DOI 10.1038/nmeth0310-168; Sasaki Y, 2003, GLIA, V44, P242, DOI 10.1002/glia.10293; Stefan Cristiana, 2006, Purinergic Signal, V2, P361, DOI 10.1007/s11302-005-5303-4; Trautmann A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.256pe6; Verghese MW, 1996, J BIOL CHEM, V271, P15597, DOI 10.1074/jbc.271.26.15597; Yegutkin GG, 2008, BBA-MOL CELL RES, V1783, P673, DOI 10.1016/j.bbamcr.2008.01.024; Yen HH, 1997, J LEUKOCYTE BIOL, V61, P529, DOI 10.1002/jlb.61.4.529; Zantl R, 2011, METHODS MOL BIOL, V769, P191, DOI 10.1007/978-1-61779-207-6_13; Zhang FL, 2001, J BIOL CHEM, V276, P8608, DOI 10.1074/jbc.M009718200	38	39	41	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2011	286	52					44776	44787		10.1074/jbc.M111.289793	http://dx.doi.org/10.1074/jbc.M111.289793			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870CA	22057273	Green Published, hybrid			2022-12-27	WOS:000298645500047
J	Subramanian, H; Gupta, K; Guo, Q; Price, R; Ali, H				Subramanian, Hariharan; Gupta, Kshitij; Guo, Qiang; Price, Ryan; Ali, Hydar			Mas-related Gene X2 (MrgX2) Is a Novel G Protein-coupled Receptor for the Antimicrobial Peptide LL-37 in Human Mast Cells RESISTANCE TO RECEPTOR PHOSPHORYLATION, DESENSITIZATION, AND INTERNALIZATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN CATHELICIDIN LL-37; SIGNAL-REGULATED KINASE; CHEMOKINE PRODUCTION; INNATE IMMUNITY; DIFFERENTIAL REGULATION; P2Y6 RECEPTORS; ACTIVATION; FAMILY; CHEMOATTRACTANT; NEUTROPHILS	Human LL-37 is a multifunctional antimicrobial peptide that promotes inflammation, angiogenesis, wound healing, and tumor metastasis. Most effects of LL-37 are mediated via the activation of the cell surface G protein-coupled receptor FPR2 on leukocytes and endothelial cells. Although LL-37 induces chemotaxis, degranulation, and chemokine production in mast cells, the receptor involved and the mechanism of its regulation remain unknown. MrgX2 is a member of Mas-related genes that is primarily expressed in human dorsal root ganglia and mast cells. We found that a human mast cell line LAD2 and CD34(+) cell-derived primary mast cells, which natively express MrgX2, responded to LL-37 for sustained Ca2+ mobilization and substantial degranulation. However, an immature human mast cell line, HMC-1, that lacks functional MrgX2 did not respond to LL-37. shRNA-mediated knockdown of MrgX2 in LAD2 mast cell line and primary CD34(+) cell-derived mast cells caused a substantial reduction in LL-37-induced degranulation. Furthermore, mast cell lines stably expressing MrgX2 responded to LL-37 for chemotaxis, degranulation, and CCL4 production. Surprisingly, MrgX2 was resistant to LL-37-induced phosphorylation, desensitization, and internalization. In addition, shRNA-mediated knockdown of the G protein-coupled receptor kinases (GRK2 and GRK3) had no effect on LL-37-induced mast cell degranulation. This study identified MrgX2 as a novel G protein-coupled receptor for the antibacterial peptide LL-37 and demonstrated that unlike most G protein-coupled receptors it is resistant to agonist-induced receptor phosphorylation, desensitization, and internalization.	[Subramanian, Hariharan; Gupta, Kshitij; Guo, Qiang; Price, Ryan; Ali, Hydar] Univ Penn, Sch Dent Med, Dept Pathol, Philadelphia, PA 19104 USA	University of Pennsylvania	Ali, H (corresponding author), Univ Penn, Sch Dent Med, Dept Pathol, 240 S 40th St, Philadelphia, PA 19104 USA.	alih@upenn.edu	Subramanian, Hariharan/AHC-5755-2022		National Institutes of Health [HL085774]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085774] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL085774.	Ahamed J, 2002, J BIOL CHEM, V277, P22685, DOI 10.1074/jbc.M110210200; Ahamed J, 2001, J IMMUNOL, V167, P3559, DOI 10.4049/jimmunol.167.7.3559; Ali H, 2000, J IMMUNOL, V165, P7215, DOI 10.4049/jimmunol.165.12.7215; ALI H, 1994, J BIOL CHEM, V269, P24557; ALI H, 1993, J BIOL CHEM, V268, P24247; Bowdish DME, 2006, CURR TOP MICROBIOL, V306, P27; Brinson AE, 2001, J BIOL CHEM, V276, P11939, DOI 10.1074/jbc.M009909200; Burstein ES, 2006, BRIT J PHARMACOL, V147, P73, DOI 10.1038/sj.bjp.0706448; BUTTERFIELD JH, 1989, INT ARCH ALLER A IMM, V89, P297, DOI 10.1159/000234963; Chang WC, 2008, J BIOL CHEM, V283, P4622, DOI 10.1074/jbc.M705002200; Chen XJ, 2006, J DERMATOL SCI, V43, P63, DOI 10.1016/j.jdermsci.2006.03.001; Coffelt SB, 2009, MOL CANCER RES, V7, P907, DOI 10.1158/1541-7786.MCR-08-0326; Coffelt SB, 2009, P NATL ACAD SCI USA, V106, P3806, DOI 10.1073/pnas.0900244106; Dong XZ, 2001, CELL, V106, P619, DOI 10.1016/S0092-8674(01)00483-4; Girnita A, 2012, ONCOGENE, V31, P352, DOI 10.1038/onc.2011.239; Guo Q, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022559; HIDE M, 1991, J BIOL CHEM, V266, P15221; Jiang YF, 2009, J IMMUNOL, V182, P1129, DOI 10.4049/jimmunol.182.2.1129; Kajiwara N, 2010, J ALLERGY CLIN IMMUN, V125, P1137, DOI 10.1016/j.jaci.2010.01.056; Kashem SW, 2011, EUR J PHARMACOL, V668, P299, DOI 10.1016/j.ejphar.2011.06.027; Kirshenbaum AS, 2003, LEUKEMIA RES, V27, P677, DOI 10.1016/S0145-2126(02)00343-0; Koczulla R, 2003, J CLIN INVEST, V111, P1665, DOI 10.1172/JCI200317545; Krupnick JG, 1998, ANNU REV PHARMACOL, V38, P289, DOI 10.1146/annurev.pharmtox.38.1.289; Langkabel P, 1999, EUR J IMMUNOL, V29, P3035, DOI 10.1002/(SICI)1521-4141(199909)29:09<3035::AID-IMMU3035>3.0.CO;2-Z; Lee SY, 2008, FEBS LETT, V582, P273, DOI 10.1016/j.febslet.2007.12.015; Lembo PMC, 2002, NAT NEUROSCI, V5, P201, DOI 10.1038/nn815; Li Y, 2011, ONCOGENE, V30, P3887, DOI 10.1038/onc.2011.112; McDermott AM, 2009, OPHTHALMIC RES, V41, P60, DOI 10.1159/000187622; Montreekachon P, 2011, J PERIODONTAL RES, V46, P327, DOI 10.1111/j.1600-0765.2011.01346.x; Murakami M, 2002, J INVEST DERMATOL, V119, P1090, DOI 10.1046/j.1523-1747.2002.19507.x; Niyonsaba F, 2001, EUR J IMMUNOL, V31, P1066, DOI 10.1002/1521-4141(200104)31:4<1066::AID-IMMU1066>3.0.CO;2-#; Niyonsaba F, 2002, IMMUNOLOGY, V106, P20, DOI 10.1046/j.1365-2567.2002.01398.x; Niyonsaba Francois, 2003, Current Drug Targets - Inflammation and Allergy, V2, P224, DOI 10.2174/1568010033484115; Niyonsaba F, 2010, J IMMUNOL, V184, P3526, DOI 10.4049/jimmunol.0900712; Ong PY, 2002, NEW ENGL J MED, V347, P1151, DOI 10.1056/NEJMoa021481; Pitcher JA, 1998, ANNU REV BIOCHEM, V67, P653, DOI 10.1146/annurev.biochem.67.1.653; Radinger M., 2011, CURR PROTOC IMMUNOL; Robas N, 2003, J BIOL CHEM, V278, P44400, DOI 10.1074/jbc.M302456200; Schiemann F, 2009, J IMMUNOL, V183, P2223, DOI 10.4049/jimmunol.0803587; Stevens RL, 2007, IMMUNOL REV, V217, P155, DOI 10.1111/j.1600-065X.2007.00525.x; Subramanian H, 2011, MOL PHARMACOL, V79, P1005, DOI 10.1124/mol.111.071472; Tatemoto K, 2006, BIOCHEM BIOPH RES CO, V349, P1322, DOI 10.1016/j.bbrc.2006.08.177; Thakurdas SM, 2007, J BIOL CHEM, V282, P20809, DOI 10.1074/jbc.M611842200; Tjabringa GS, 2006, INT ARCH ALLERGY IMM, V140, P103, DOI 10.1159/000092305; Tomasinsig L, 2008, J BIOL CHEM, V283, P30471, DOI 10.1074/jbc.M802185200; Venkatesha RT, 2005, MOL IMMUNOL, V42, P581, DOI 10.1016/j.molimm.2004.09.009; Venkatesha RT, 2004, J BIOL CHEM, V279, P44606, DOI 10.1074/jbc.M408035200; Vibhuti A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019585; Yang D, 2000, J EXP MED, V192, P1069, DOI 10.1084/jem.192.7.1069; Yang D, 2001, J LEUKOCYTE BIOL, V69, P691; Yoshioka M, 2008, BIOL PHARM BULL, V31, P212, DOI 10.1248/bpb.31.212; Zanetti M, 2004, J LEUKOCYTE BIOL, V75, P39, DOI 10.1189/jlb.0403147; Zhang ZF, 2009, EUR J IMMUNOL, V39, P3181, DOI 10.1002/eji.200939496; Zylka MJ, 2003, P NATL ACAD SCI USA, V100, P10043, DOI 10.1073/pnas.1732949100	54	148	156	2	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2011	286	52					44739	44749		10.1074/jbc.M111.277152	http://dx.doi.org/10.1074/jbc.M111.277152			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870CA	22069323	hybrid, Green Published			2022-12-27	WOS:000298645500044
J	Cendron, L; Berto, P; D'Adamo, S; Vallese, F; Govoni, C; Posewitz, MC; Giacometti, GM; Costantini, P; Zanotti, G				Cendron, Laura; Berto, Paola; D'Adamo, Sarah; Vallese, Francesca; Govoni, Chiara; Posewitz, Matthew C.; Giacometti, Giorgio M.; Costantini, Paola; Zanotti, Giuseppe			Crystal Structure of HydF Scaffold Protein Provides Insights into [FeFe]-Hydrogenase Maturation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FE-ONLY HYDROGENASE; H-CLUSTER; DESULFOVIBRIO-DESULFURICANS; THERMOTOGA-MARITIMA; ACTIVE-SITE; HYDA(DELTA-EFG); BIOSYNTHESIS; COORDINATION; ACTIVATION; GTPASE	[FeFe]-hydrogenases catalyze the reversible production of H-2 in some bacteria and unicellular eukaryotes. These enzymes require ancillary proteins to assemble the unique active site H-cluster, a complex structure composed of a 2Fe center bridged to a [4Fe-4S] cubane. The first crystal structure of a key factor in the maturation process, HydF, has been determined at 3 angstrom resolution. The protein monomer present in the asymmetric unit of the crystal comprises three domains: a GTP-binding domain, a dimerization domain, and a metal cluster-binding domain, all characterized by similar folding motifs. Two monomers dimerize, giving rise to a stable dimer, held together mainly by the formation of a continuous beta-sheet comprising eight beta-strands from two monomers. Moreover, in the structure presented, two dimers aggregate to form a supramolecular organization that represents an inactivated form of the HydF maturase. The crystal structure of the latter furnishes several clues about the events necessary for cluster generation/transfer and provides an excellent model to begin elucidating the structure/function of HydF in [FeFe]-hydrogenase maturation.	[Cendron, Laura; Zanotti, Giuseppe] Univ Padua, Dept Biol Chem, I-35131 Padua, Italy; [Berto, Paola; D'Adamo, Sarah; Vallese, Francesca; Giacometti, Giorgio M.; Costantini, Paola] Univ Padua, Dept Biol, I-35131 Padua, Italy; [D'Adamo, Sarah; Posewitz, Matthew C.] Colorado Sch Mines, Dept Chem & Geochem, Golden, CO 80401 USA; [Govoni, Chiara] Univ Verona, Dept Biotechnol, I-37134 Verona, Italy	University of Padua; University of Padua; Colorado School of Mines; University of Verona	Costantini, P (corresponding author), Viale G Colombo 3, I-35131 Padua, Italy.	paola.costantini@unipd.it; giuseppe.zanotti@unipd.it	cendron, Laura/A-5202-2014	D'Adamo, Sarah/0000-0001-7654-941X; Cendron, Laura/0000-0002-0125-0461; Zanotti, Giuseppe/0000-0002-0945-6501	Ministero Istruzione, Universita, Ricerca; Ministero delle Politiche Agricole e Forestali; United States Air Force Office of Scientific Research [FA9550-11-1-0211]	Ministero Istruzione, Universita, Ricerca(Ministry of Education, Universities and Research (MIUR)); Ministero delle Politiche Agricole e Forestali; United States Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR))	This work was supported by Grants PRIN (2003) and FISR (2005) from Ministero Istruzione, Universita, Ricerca and Ministero delle Politiche Agricole e Forestali (2007) (to G. M. G.) and United States Air Force Office of Scientific Research Grant FA9550-11-1-0211 (to M. C. P.).	ADAMS MWW, 1990, BIOCHIM BIOPHYS ACTA, V1020, P115, DOI 10.1016/0005-2728(90)90044-5; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Brazzolotto X, 2006, J BIOL CHEM, V281, P769, DOI 10.1074/jbc.M510310200; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Czech I, 2011, FEBS LETT, V585, P225, DOI 10.1016/j.febslet.2010.11.052; Czech I, 2010, FEBS LETT, V584, P638, DOI 10.1016/j.febslet.2009.12.016; DELANO WL, 2007, MACPYMOL PYMOL BASED; Driesener RC, 2010, ANGEW CHEM INT EDIT, V49, P1687, DOI 10.1002/anie.200907047; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Ghirardi ML, 2007, ANNU REV PLANT BIOL, V58, P71, DOI 10.1146/annurev.arplant.58.032806.103848; Hattori M, 2009, STRUCTURE, V17, P1345, DOI 10.1016/j.str.2009.08.007; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; McGlynn SE, 2008, FEBS LETT, V582, P2183, DOI 10.1016/j.febslet.2008.04.063; McGlynn SE, 2007, J BIOL INORG CHEM, V12, P443, DOI 10.1007/s00775-007-0224-z; Mulder DW, 2010, NATURE, V465, P248, DOI 10.1038/nature08993; Mulder DW, 2009, BIOCHEMISTRY-US, V48, P6240, DOI 10.1021/bi9000563; Nicolet Y, 2000, TRENDS BIOCHEM SCI, V25, P138, DOI 10.1016/S0968-0004(99)01536-4; Nicolet Y, 1999, STRUCTURE, V7, P13, DOI 10.1016/S0969-2126(99)80005-7; Nicolet Y, 2001, J AM CHEM SOC, V123, P1596, DOI 10.1021/ja0020963; Nicolet Y, 2008, J BIOL CHEM, V283, P18861, DOI 10.1074/jbc.M801161200; Peters JW, 1998, SCIENCE, V282, P1853, DOI 10.1126/science.282.5395.1853; Peters JW, 2006, FEBS LETT, V580, P363, DOI 10.1016/j.febslet.2005.12.040; Posewitz MC, 2004, J BIOL CHEM, V279, P25711, DOI 10.1074/jbc.M403206200; Rubach JK, 2005, FEBS LETT, V579, P5055, DOI 10.1016/j.febslet.2005.07.092; Scrima A, 2006, EMBO J, V25, P2940, DOI 10.1038/sj.emboj.7601171; Shepard EM, 2010, J AM CHEM SOC, V132, P9247, DOI 10.1021/ja1012273; Shepard EM, 2010, P NATL ACAD SCI USA, V107, P10448, DOI 10.1073/pnas.1001937107; Silakov A, 2009, PHYS CHEM CHEM PHYS, V11, P6592, DOI 10.1039/b905841a; Tu C, 2009, P NATL ACAD SCI USA, V106, P14843, DOI 10.1073/pnas.0904032106; Vignais PM, 2007, CHEM REV, V107, P4206, DOI 10.1021/cr050196r	34	27	27	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2011	286	51					43944	43950		10.1074/jbc.M111.281956	http://dx.doi.org/10.1074/jbc.M111.281956			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866SH	22057316	Green Published, hybrid			2022-12-27	WOS:000298402300035
J	Chua, GL; Tang, XY; Amalraj, M; Tan, SM; Bhattacharjya, S				Chua, Geok-Lin; Tang, Xiao-Yan; Amalraj, Monalisa; Tan, Suet-Mien; Bhattacharjya, Surajit			Structures and Interaction Analyses of Integrin alpha M beta 2 Cytoplasmic Tails	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR FOXP1; BINDING PROTEIN; MONOCYTE DIFFERENTIATION; INDUCED PHOSPHORYLATION; TRANSMEMBRANE DOMAIN; CELL-ADHESION; NMR ANALYSIS; ACTIVATION; ALPHA; ALPHA-IIB-BETA-3	Integrins are heterodimeric (alpha and beta subunits) signal transducer proteins involved in cell adhesions and migrations. The cytosolic tails of integrins are essential for transmitting bidirectional signaling and also implicated in maintaining the resting states of the receptors. In addition, cytosolic tails of integrins often undergo post-translation modifications like phosphorylation. However, the consequences of phosphorylation on the structures and interactions are not clear. The leukocyte-specific integrin alpha M beta 2 is essential for myeloid cell adhesion, phagocytosis, and degranulation. In this work, we determined solution structures of the myristoylated cytosolic tail of alpha M and a Ser phosphorylated variant in dodecylphosphocholine micelles by NMR spectroscopy. Furthermore, the interactions between non-phosphorylated and phosphorylated alpha M tails with beta 2 tail were investigated by NMR and fluorescence resonance energy transfer (FRET). The three-dimensional structures of the 24-residue cytosolic tail of alpha M or phosphorylated alpha M are characterized by an N-terminal amphipathic helix and a loop at the C terminus. The residues at the loop are involved in packing interactions with the hydrophobic face of the helix. N-15-H-1 heteronuclear single quantum coherence experiments identified residues of alpha M and beta 2 tails that may be involved in the formation of a tail-tail heterocomplex. We further examined interactions between myristoylated beta 2 tail in dodecylphosphocholine micelles with dansylated alpha M tail peptides by FRET. These studies revealed enhanced interactions between alpha M or phosphorylated alpha M tails with beta(2) tail with K-d values similar to 5.2 +/- 0.6 and similar to 4.4 +/- 0.7 mu M, respectively. Docked structures of tail-tail complexes delineated that the alpha M/beta 2 interface at the cytosolic region could be sustained by a network of polar interactions, ionic interactions, and/or hydrogen bonds.	[Chua, Geok-Lin; Tang, Xiao-Yan; Amalraj, Monalisa; Tan, Suet-Mien; Bhattacharjya, Surajit] Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Tan, SM (corresponding author), Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore.	smtan@ntu.edu.sg; surajit@ntu.edu.sg	Tan, Suet/A-2224-2011	Tan, Suet-Mien/0000-0003-2371-8739	A*Star Biomedical Research Council, Singapore [08/1/22/19/556]; Singapore Ministry of Education [2010-T2-2-014, ARC3/11]	A*Star Biomedical Research Council, Singapore(Agency for Science Technology & Research (A*STAR)); Singapore Ministry of Education(Ministry of Education, Singapore)	This work was supported by Grant 08/1/22/19/556 from A*Star Biomedical Research Council, Singapore and Singapore Ministry of Education Grant 2010-T2-2-014, ARC3/11.	Abram CL, 2009, IMMUNOL CELL BIOL, V87, P440, DOI 10.1038/icb.2009.32; Abram CL, 2009, ANNU REV IMMUNOL, V27, P339, DOI 10.1146/annurev.immunol.021908.132554; Adler A J, 1973, Methods Enzymol, V27, P675; Alahari SK, 2004, EMBO J, V23, P2777, DOI 10.1038/sj.emboj.7600291; Arnaout MA, 2007, CURR OPIN CELL BIOL, V19, P495, DOI 10.1016/j.ceb.2007.08.002; Berjanskii MV, 2006, NUCLEIC ACIDS RES, V34, pW63, DOI 10.1093/nar/gkl341; Bhunia A, 2009, J BIOL CHEM, V284, P3873, DOI 10.1074/jbc.M807236200; Burke JR, 2010, J BIOL CHEM, V285, P16286, DOI 10.1074/jbc.M110.108167; BUYON JP, 1990, J IMMUNOL, V144, P191; Calderwood DA, 1999, J BIOL CHEM, V274, P28071, DOI 10.1074/jbc.274.40.28071; CHAN BM, 1992, CELL, V68, P1051, DOI 10.1016/0092-8674(92)90077-P; CHATILA TA, 1989, J CELL BIOL, V109, P3435, DOI 10.1083/jcb.109.6.3435; Clore GM, 2007, CURR OPIN STRUC BIOL, V17, P603, DOI 10.1016/j.sbi.2007.08.013; Cohen P, 2001, EUR J BIOCHEM, V268, P5001, DOI 10.1046/j.0014-2956.2001.02473.x; Cywes C, 1996, INFECT IMMUN, V64, P5373, DOI 10.1128/IAI.64.12.5373-5383.1996; Danen EHJ, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.289pe58; DAVIS GE, 1992, EXP CELL RES, V200, P242, DOI 10.1016/0014-4827(92)90170-D; DeNucci CC, 2009, CRIT REV IMMUNOL, V29, P87, DOI 10.1615/CritRevImmunol.v29.i2.10; Diaz-Moreno I, 2009, NAT STRUCT MOL BIOL, V16, P238, DOI 10.1038/nsmb.1558; Edwards RJ, 2007, NAT CHEM BIOL, V3, P108, DOI 10.1038/nchembio854; Ehlers MRW, 2000, MICROBES INFECT, V2, P289, DOI 10.1016/S1286-4579(00)00299-9; Fagerholm SC, 2004, TRENDS BIOCHEM SCI, V29, P504, DOI 10.1016/j.tibs.2004.07.005; Fagerholm SC, 2006, BLOOD, V108, P3379, DOI 10.1182/blood-2006-03-013557; Fisher LE, 1999, J MOL BIOL, V293, P639, DOI 10.1006/jmbi.1999.3126; Forsyth CB, 1998, J IMMUNOL, V161, P6198; Geng X, 2005, IMMUNOLOGY, V115, P347, DOI 10.1111/j.1365-2567.2005.02175.x; Graff JC, 2007, J LEUKOCYTE BIOL, V82, P603, DOI 10.1189/jlb.0207125; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Haas TA, 1996, J BIOL CHEM, V271, P6017, DOI 10.1074/jbc.271.11.6017; Harley JB, 2007, NAT GENET, V39, P1053, DOI 10.1038/ng0907-1053; Hogg N, 2000, MATRIX BIOL, V19, P211, DOI 10.1016/S0945-053X(00)00066-4; HUNTER T, 1992, CELL, V70, P375, DOI 10.1016/0092-8674(92)90162-6; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jaroniec CP, 2005, BIOCHEMISTRY-US, V44, P16167, DOI 10.1021/bi051672a; Johnson LN, 2001, CHEM REV, V101, P2209, DOI 10.1021/cr000225s; KASSNER PD, 1993, J EXP MED, V178, P649, DOI 10.1084/jem.178.2.649; Kim M, 2003, SCIENCE, V301, P1720, DOI 10.1126/science.1084174; Kinashi T, 2007, ADV IMMUNOL, V93, P185, DOI 10.1016/S0065-2776(06)93005-3; LARSON RS, 1990, IMMUNOL REV, V114, P181, DOI 10.1111/j.1600-065X.1990.tb00565.x; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lau TL, 2009, EMBO J, V28, P1351, DOI 10.1038/emboj.2009.63; Li RH, 2001, P NATL ACAD SCI USA, V98, P12462, DOI 10.1073/pnas.221463098; Liu JL, 2005, BLOOD, V105, P4345, DOI 10.1182/blood-2004-07-2718; Liu S, 1999, NATURE, V402, P676, DOI 10.1038/45264; Losonczi JA, 1998, BIOCHEMISTRY-US, V37, P706, DOI 10.1021/bi9717791; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Lyskov S, 2008, NUCLEIC ACIDS RES, V36, pW233, DOI 10.1093/nar/gkn216; Ma YQ, 2008, J CELL BIOL, V181, P439, DOI 10.1083/jcb.200710196; Metcalf DG, 2010, P NATL ACAD SCI USA, V107, P22481, DOI 10.1073/pnas.1015545107; Montanez E, 2008, GENE DEV, V22, P1325, DOI 10.1101/gad.469408; Moser M, 2008, NAT MED, V14, P325, DOI 10.1038/nm1722; Naik UP, 1997, J BIOL CHEM, V272, P4651, DOI 10.1074/jbc.272.8.4651; Plow EF, 2000, J BIOL CHEM, V275, P21785, DOI 10.1074/jbc.R000003200; Pluskota E, 2008, J IMMUNOL, V181, P3609, DOI 10.4049/jimmunol.181.5.3609; Santoso S, 2002, J EXP MED, V196, P679, DOI 10.1084/jem.20020267; Schneider D, 2004, J BIOL CHEM, V279, P9840, DOI 10.1074/jbc.M312749200; Schwarzinger S, 2001, J AM CHEM SOC, V123, P2970, DOI 10.1021/ja003760i; Shi C, 2004, J CLIN INVEST, V114, P408, DOI 10.1172/jci200421100; Shi C, 2008, BLOOD, V112, P4699, DOI 10.1182/blood-2008-01-137018; Skoberne M, 2006, BLOOD, V108, P947, DOI 10.1182/blood-2005-12-4812; Svensson L, 2009, NAT MED, V15, P306, DOI 10.1038/nm.1931; Szilak L, 1997, NAT STRUCT BIOL, V4, P112, DOI 10.1038/nsb0297-112; Tang ML, 2008, J BIOL CHEM, V283, P25392, DOI 10.1074/jbc.M802311200; Tang RH, 2006, FEBS LETT, V580, P4435, DOI 10.1016/j.febslet.2006.06.099; Ulmer TS, 2001, BIOCHEMISTRY-US, V40, P7498, DOI 10.1021/bi010338l; Vallar L, 1999, J BIOL CHEM, V274, P17257, DOI 10.1074/jbc.274.24.17257; Varga G, 2007, BLOOD, V109, P661, DOI 10.1182/blood-2005-12-023044; Vinogradova O, 2004, P NATL ACAD SCI USA, V101, P4094, DOI 10.1073/pnas.0400742101; Vinogradova O, 2002, CELL, V110, P587, DOI 10.1016/S0092-8674(02)00906-6; WISHART DS, 1994, J BIOMOL NMR, V4, P171; Xue ZH, 2010, J IMMUNOL, V184, P3697, DOI 10.4049/jimmunol.0903316; Yang J, 2009, P NATL ACAD SCI USA, V106, P17729, DOI 10.1073/pnas.0909589106; Zaidel-Bar R, 2007, NAT CELL BIOL, V9, P858, DOI 10.1038/ncb0807-858	73	12	12	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2011	286	51					43842	43854		10.1074/jbc.M111.280164	http://dx.doi.org/10.1074/jbc.M111.280164			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866SH	22052909	Green Published, hybrid			2022-12-27	WOS:000298402300026
J	Liu, C; van Dyk, D; Choe, V; Yan, J; Majumder, S; Costanzo, M; Bao, X; Boone, C; Huo, K; Winey, M; Fisk, H; Andrews, B; Rao, H				Liu, Chang; van Dyk, Dewald; Choe, Vitnary; Yan, Jing; Majumder, Shubhra; Costanzo, Michael; Bao, Xin; Boone, Charles; Huo, Keke; Winey, Mark; Fisk, Harold; Andrews, Brenda; Rao, Hai			Ubiquitin Ligase Ufd2 Is Required for Efficient Degradation of Mps1 Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPINDLE-ASSEMBLY CHECKPOINT; ANAPHASE-PROMOTING COMPLEX; CELL-CYCLE; TURNOVER; YEAST; E4; MULTIUBIQUITYLATION; PROTEOLYSIS; PROTEASOME; APC/C	Ufd2 is a U-box-containing ubiquitylation enzyme that promotes ubiquitin chain assembly on substrates. The physiological function of Ufd2 remains poorly understood. Here, we show that ubiquitylation and degradation of the cell cycle kinase Mps1, a known target of the anaphase-promoting complex E3, require Ufd2 enzyme. Yeast cells lacking UFD2 exhibit altered chromosome stability and several spindle-related phenotypes, expanding the biological function of Ufd2. We demonstrate that Ufd2-mediated Mps1 degradation is conserved in humans. Our results underscore the significance of Ufd2 in proteolysis and further suggest that Ufd2-like enzymes regulate far more substrates than previously envisioned.	[Liu, Chang; Choe, Vitnary; Yan, Jing; Bao, Xin; Rao, Hai] Univ Texas Hlth Sci Ctr San Antonio, Inst Biotechnol, Dept Mol Med, San Antonio, TX 78245 USA; [van Dyk, Dewald; Costanzo, Michael; Boone, Charles; Andrews, Brenda] Univ Toronto, Dept Mol & Med Genet, Banting & Best Dept Med Res, Toronto, ON M5G 1L6, Canada; [Yan, Jing; Huo, Keke] Fudan Univ, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Majumder, Shubhra; Fisk, Harold] Ohio State Univ, Dept Mol Genet, Columbus, OH 43210 USA; [Winey, Mark] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA	University of Texas System; University of Texas Health San Antonio; University of Toronto; Fudan University; University System of Ohio; Ohio State University; University of Colorado System; University of Colorado Boulder	Rao, H (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Inst Biotechnol, Dept Mol Med, 15355 Lambda Dr, San Antonio, TX 78245 USA.	raoh@uthscsa.edu		RAO, HAI/0000-0002-4235-2210; Majumder, Shubhra/0000-0002-5753-7568	National Institutes of Health [GM 078085]; Welch Foundation [1747]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077311, R01GM078085] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by National Institutes of Health Grant GM 078085 and Welch Foundation Grant AQ 1747.	Alexandru G, 2008, CELL, V134, P804, DOI 10.1016/j.cell.2008.06.048; Biggins S, 1996, J CELL BIOL, V133, P1331, DOI 10.1083/jcb.133.6.1331; Caren H, 2006, EUR J CANCER, V42, P381, DOI 10.1016/j.ejca.2005.09.030; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Cui YP, 2010, J BIOL CHEM, V285, P32988, DOI 10.1074/jbc.M110.140905; Dikic I, 2009, NAT REV MOL CELL BIO, V10, P659, DOI 10.1038/nrm2767; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Fisk HA, 2004, CELL CYCLE, V3, P439; Hochstrasser M, 2009, CHEM REV, V109, P1479, DOI 10.1021/cr900054t; Hoppe T, 2005, TRENDS BIOCHEM SCI, V30, P183, DOI 10.1016/j.tibs.2005.02.004; Hoppe T, 2004, CELL, V118, P337, DOI 10.1016/j.cell.2004.07.014; Hosoda M, 2005, ONCOGENE, V24, P7156, DOI 10.1038/sj.onc.1208872; Kemmler S, 2009, EMBO J, V28, P1099, DOI 10.1038/emboj.2009.62; Kim I, 2004, MOL BIOL CELL, V15, P3357, DOI 10.1091/mbc.E03-11-0835; Kim I, 2006, J CELL BIOL, V172, P211, DOI 10.1083/jcb.200507149; Koegl M, 1999, CELL, V96, P635, DOI 10.1016/S0092-8674(00)80574-7; Lan WJ, 2010, J CELL BIOL, V190, P21, DOI 10.1083/jcb.201006080; Liu C, 2010, J BIOL CHEM, V285, P10265, DOI 10.1074/jbc.M110.110551; Matsumoto M, 2004, EMBO J, V23, P659, DOI 10.1038/sj.emboj.7600081; Matyskiela Mary E., 2009, Journal of Biology (London), V8, P92, DOI 10.1186/jbiol184; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Ohira M, 2000, ONCOGENE, V19, P4302, DOI 10.1038/sj.onc.1203786; Palframan WJ, 2006, SCIENCE, V313, P680, DOI 10.1126/science.1127205; Pines J, 2011, NAT REV MOL CELL BIO, V12, P427, DOI 10.1038/nrm3132; Pines J, 2009, MOL CELL, V34, P135, DOI 10.1016/j.molcel.2009.04.006; Rape M, 2006, CELL, V124, P89, DOI 10.1016/j.cell.2005.10.032; Richly H, 2005, CELL, V120, P73, DOI 10.1016/j.cell.2004.11.013; Rodrigo-Brenni MC, 2007, CELL, V130, P127, DOI 10.1016/j.cell.2007.05.027; Sheltzer JM, 2011, SCIENCE, V333, P1026, DOI 10.1126/science.1206412; Skaar JR, 2009, CURR OPIN CELL BIOL, V21, P816, DOI 10.1016/j.ceb.2009.08.004; Song L, 2010, MOL CELL, V38, P369, DOI 10.1016/j.molcel.2010.02.038; SPENCER F, 1990, GENETICS, V124, P237; Verma R, 2004, CELL, V118, P99, DOI 10.1016/j.cell.2004.06.014; Zich J, 2010, TRENDS BIOCHEM SCI, V35, P18, DOI 10.1016/j.tibs.2009.09.002	34	17	18	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2011	286	51					43660	43667		10.1074/jbc.M111.286229	http://dx.doi.org/10.1074/jbc.M111.286229			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866SH	22045814	Green Published, hybrid			2022-12-27	WOS:000298402300009
J	Jiang, YL; Yu, WL; Zhang, JW; Frolet, C; Di Guilmi, AM; Zhou, CZ; Vernet, T; Chen, YX				Jiang, Yong-Liang; Yu, Wei-Li; Zhang, Jun-Wei; Frolet, Cecile; Di Guilmi, Anne-Marie; Zhou, Cong-Zhao; Vernet, Thierry; Chen, Yuxing			Structural Basis for the Substrate Specificity of a Novel beta-N-Acetylhexosaminidase StrH Protein from Streptococcus pneumoniae R6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASSISTED CATALYSIS; CRYSTAL-STRUCTURE; SEQUENCE; CLASSIFICATION; CHITOBIASE; RECOGNITION; MECHANISM; INSIGHTS; PROVIDES; CLONING	The beta-N-acetylhexosaminidase (EC 3.2.1.52) from glycoside hydrolase family 20 (GH20) catalyzes the hydrolysis of the beta-N-acetylglucosamine (NAG) group from the nonreducing end of various glycoconjugates. The putative surface-exposed N-acetylhexosaminidase StrH/Spr0057 from Streptococcus pneumoniae R6 was proved to contribute to the virulence by removal of beta(1,2)-linked NAG on host defense molecules following the cleavage of sialic acid and galactose by neuraminidase and beta-galactosidase, respectively. StrH is the only reported GH20 enzyme that contains a tandem repeat of two 53% sequence-identical catalytic domains (designated as GH20-1 and GH20-2, respectively). Here, we present the 2.1 angstrom crystal structure of the N-terminal domain of StrH (residues Glu-175 to Lys-642) complexed with NAG. It adopts an overall structure similar to other GH20 enzymes: a (beta/alpha)(8) TIM barrel with the active site residing at the center of the beta-barrel convex side. The kinetic investigation using 4-nitrophenyl N-acetyl-beta-D-glucosaminide as the substrate demonstrated that GH20-1 had an enzymatic activity (k(cat)/K-m) of one-fourth compared with GH20-2. The lower activity of GH20-1 could be attributed to the substitution of active site Cys-469 of GH20-1 to the counterpart Tyr-903 of GH20-2. A complex model of NAG beta(1,2) Man at the active site of GH20-1 combined with activity assays of the corresponding site-directed mutants characterized two key residues Trp-443 and Tyr-482 at subsite +1 of GH20-1 (Trp-876 and Tyr-914 of GH20-2) that might determine the beta(1,2) substrate specificity. Taken together, these findings shed light on the mechanism of catalytic specificity toward the beta(1,2)-inked beta-N-acetylglucosides.	[Vernet, Thierry] Inst Biol Struct Jean Pierre Ebel, UMR 5075, Lab Ingn Macromol, F-38027 Grenoble, France; [Jiang, Yong-Liang; Yu, Wei-Li; Zhang, Jun-Wei; Zhou, Cong-Zhao; Chen, Yuxing] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China; [Jiang, Yong-Liang; Yu, Wei-Li; Zhang, Jun-Wei; Zhou, Cong-Zhao; Chen, Yuxing] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Anhui, Peoples R China	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Vernet, T (corresponding author), Inst Biol Struct Jean Pierre Ebel, UMR 5075, Lab Ingn Macromol, 41 Rue Jules Horowitz, F-38027 Grenoble, France.	thierry.vernet@ibs.fr; cyxing@ustc.edu.cn	Zhou, Cong-Zhao/E-9174-2011; Vernet, Thierry/G-1118-2012; Chen, Yuxing/P-4156-2014	Zhou, Cong-Zhao/0000-0002-6881-7151; Chen, Yuxing/0000-0002-7560-1922; Jiang, YongLiang/0000-0001-5441-4936; Di Guilmi, Anne Marie/0000-0001-7335-3470	Ministry of Science and Technology of China [2009CB918804]; National Natural Science Foundation of China [30870488]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Ministry of Science and Technology of China Grant 2009CB918804 and National Natural Science Foundation of China 30870488.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bateman A, 2005, BIOINFORMATICS, V21, P1301, DOI 10.1093/bioinformatics/bti206; Bergmann S, 2006, MICROBIOL-SGM, V152, P295, DOI 10.1099/mic.0.28610-0; Brodersen DE, 2000, ACTA CRYSTALLOGR D, V56, P431, DOI 10.1107/S0907444900000834; Burnaugh AM, 2008, J BACTERIOL, V190, P221, DOI 10.1128/JB.01251-07; CLARKE VA, 1995, J BIOL CHEM, V270, P8805, DOI 10.1074/jbc.270.15.8805; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W.L, PYMOL MOL GRAPHICS S; Drouillard S, 1997, BIOCHEM J, V328, P945, DOI 10.1042/bj3280945; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Garcia-Suarez MDM, 2006, ENFERM INFEC MICR CL, V24, P512, DOI 10.1157/13092469; Hava D, 2002, MOL MICROBIOL, V45, P1389, DOI 10.1046/j.1365-2958.2002.03106.x; Henrissat B, 1996, BIOCHEM J, V316, P695, DOI 10.1042/bj3160695; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; HENRISSAT B, 1993, BIOCHEM J, V293, P781, DOI 10.1042/bj2930781; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; HONDA S, 1989, ANAL BIOCHEM, V180, P351, DOI 10.1016/0003-2697(89)90444-2; Intra J, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-214; King SJ, 2006, MOL MICROBIOL, V59, P961, DOI 10.1111/j.1365-2958.2005.04984.x; Langley DB, 2008, J MOL BIOL, V377, P104, DOI 10.1016/j.jmb.2007.09.028; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lemieux MJ, 2006, J MOL BIOL, V359, P913, DOI 10.1016/j.jmb.2006.04.004; Liu TA, 2011, J BIOL CHEM, V286, P4049, DOI 10.1074/jbc.M110.184796; Maier T, 2003, J MOL BIOL, V328, P669, DOI 10.1016/S0022-2836(03)00311-5; Mark BL, 2001, J BIOL CHEM, V276, P10330, DOI 10.1074/jbc.M011067200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pluvinage B, 2011, STRUCTURE, V19, P1603, DOI 10.1016/j.str.2011.08.011; Prag G, 2000, J MOL BIOL, V300, P611, DOI 10.1006/jmbi.2000.3906; Ramasubbu N, 2005, J MOL BIOL, V349, P475, DOI 10.1016/j.jmb.2005.03.082; Ren J, 2009, CELL RES, V19, P271, DOI 10.1038/cr.2009.6; Ruggiero A, 2009, J MOL BIOL, V385, P153, DOI 10.1016/j.jmb.2008.10.042; Sumida T, 2009, J MOL BIOL, V392, P87, DOI 10.1016/j.jmb.2009.06.025; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; Tews I, 1996, NAT STRUCT BIOL, V3, P638, DOI 10.1038/nsb0796-638; Williams SJ, 2002, J BIOL CHEM, V277, P40055, DOI 10.1074/jbc.M206481200; Yang XB, 2005, ANAL SCI, V21, P1177, DOI 10.2116/analsci.21.1177	41	28	32	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					43004	43012		10.1074/jbc.M111.256578	http://dx.doi.org/10.1074/jbc.M111.256578			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22013074	Green Published, hybrid			2022-12-27	WOS:000298351300021
J	Kwakman, PHS; Krijgsveld, J; de Boer, L; Nguyen, LT; Boszhard, L; Vreede, J; Dekker, HL; Speijer, D; Drijfhout, JW; Velde, AAT; Crielaard, W; Vogel, HJ; Vandenbroucke-Grauls, CMJE; Zaat, SAJ				Kwakman, Paulus H. S.; Krijgsveld, Jeroen; de Boer, Leonie; Nguyen, Leonard T.; Boszhard, Laura; Vreede, Jocelyne; Dekker, Henk L.; Speijer, Dave; Drijfhout, Jan W.; Velde, Anje A. Te; Crielaard, Wim; Vogel, Hans J.; Vandenbroucke-Grauls, Christina M. J. E.; Zaat, Sebastian A. J.			Native Thrombocidin-1 and Unfolded Thrombocidin-1 Exert Antimicrobial Activity via Distinct Structural Elements	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATING PEPTIDE-III; BETA-DEFENSIN 3; PROTEOLYTIC ACTIVATION; HUMAN BETA-DEFENSIN-3; BACTERICIDAL ACTIVITY; CXC CHEMOKINES; ANTIBACTERIAL; PROTEIN; CCL20/MIP-3-ALPHA; PURIFICATION	Chemokines (chemotactic cytokines) can have direct antimicrobial activity, which is apparently related to the presence of a distinct positively charged patch on the surface. However, chemokines can retain antimicrobial activity upon linearization despite the loss of their positive patch, thus questioning the importance of this patch for activity. Thrombocidin-1 (TC-1) is a microbicidal protein isolated from human blood platelets. TC-1 only differs from the chemokine NAP-2/CXCL7 by a two-amino acid C-terminal deletion, but this truncation is crucial for antimicrobial activity. We assessed the structure-activity relationship for antimicrobial activity of TC-1. Reduction of the charge of the TC-1-positive patch by replacing lysine 17 with alanine reduced the activity against bacteria and almost abolished activity against the yeast Candida albicans. Conversely, augmentation of the positive patch by increasing charge density or size resulted in a 2-3-fold increased activity against Staphylococcus aureus, Escherichia coli, and Bacillus subtilis but did not substantially affect activity against C. albicans. Reduction of TC-1 resulted in loss of the folded conformation, but this disruption of the positive patch did not affect antimicrobial activity. Using overlapping 15-mer synthetic peptides, we demonstrate peptides corresponding to the N-terminal part of TC-1 to have similar antimicrobial activity as intact TC-1. Although we demonstrate that the positive patch is essential for activity of folded TC-1, unfolded TC-1 retained antimicrobial activity despite the absence of a positive patch. This activity is probably exerted by a linear peptide stretch in the N-terminal part of the molecule. We conclude that intact TC-1 and unfolded TC-1 exert antimicrobial activity via distinct structural elements.	[Kwakman, Paulus H. S.; de Boer, Leonie; Boszhard, Laura; Vandenbroucke-Grauls, Christina M. J. E.; Zaat, Sebastian A. J.] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam, Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands; [Velde, Anje A. Te] Univ Amsterdam, Acad Med Ctr, Tytgat Inst Liver & Intestinal Res, NL-1105 AZ Amsterdam, Netherlands; [Vreede, Jocelyne] Univ Amsterdam, Acad Ctr Dent Amsterdam, Van tHoff Inst Mol Sci, NL-1098 XH Amsterdam, Netherlands; [Dekker, Henk L.] Univ Amsterdam, Acad Ctr Dent Amsterdam, Swammerdam Inst Life Sci, NL-1098 XH Amsterdam, Netherlands; [Crielaard, Wim] Univ Amsterdam, Acad Ctr Dent Amsterdam, Dept Cariol Endodontol & Pedodontol, NL-1098 XH Amsterdam, Netherlands; [Vandenbroucke-Grauls, Christina M. J. E.] Vrije Univ Amsterdam Med Ctr, Dept Med Microbiol & Infect Dis, NL-1081 BT Amsterdam, Netherlands; [Drijfhout, Jan W.] Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, NL-2333 AA Leiden, Netherlands; [Krijgsveld, Jeroen] EMBL, Genome Biol Unit, D-69117 Heidelberg, Germany; [Nguyen, Leonard T.; Vogel, Hans J.] Univ Calgary, Dept Biol Sci, Biochem Res Grp, Calgary, AB T2N 1N4, Canada	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Academic Center for Dentistry Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; Academic Center for Dentistry Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; Academic Center for Dentistry Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; European Molecular Biology Laboratory (EMBL); University of Calgary	Zaat, SAJ (corresponding author), Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam, Dept Med Microbiol, Meibergdreef 15, NL-1105 AZ Amsterdam, Netherlands.	s.a.zaat@amc.uva.nl	Speijer, Dave/AAE-4613-2019; Drijfhout, Jan Wouter/ABA-6318-2021; Krijgsveld, Jeroen/F-5974-2011; Vandenbroucke-Grauls, Christina/AAO-7953-2020	Speijer, Dave/0000-0002-2340-2753; Drijfhout, Jan Wouter/0000-0003-4808-5296; Vandenbroucke-Grauls, Christina/0000-0003-2074-1597; Krijgsveld, Jeroen/0000-0001-7549-9326				Antcheva N, 2004, ANTIMICROB AGENTS CH, V48, P685, DOI 10.1128/AAC.48.2.685-688.2004; Bauer F, 2001, PROTEIN SCI, V10, P2470, DOI 10.1110/ps.ps.24401; Berahovich RD, 2005, J IMMUNOL, V174, P7341, DOI 10.4049/jimmunol.174.11.7341; Bjorstad A, 2005, ANTIMICROB AGENTS CH, V49, P3889, DOI 10.1128/AAC.49.9.3889-3895.2005; BRANDT E, 1991, CYTOKINE, V3, P311, DOI 10.1016/1043-4666(91)90499-4; Callihan D, 1996, J MAGN RESON SER B, V112, P82, DOI 10.1006/jmrb.1996.0114; Chan DI, 2008, ANTIMICROB AGENTS CH, V52, P883, DOI 10.1128/AAC.00805-07; Chandrababu KB, 2009, BIOCHEMISTRY-US, V48, P6052, DOI 10.1021/bi900154f; Cole AM, 2001, J IMMUNOL, V167, P623, DOI 10.4049/jimmunol.167.2.623; Dankert J, 2001, J INFECT DIS, V184, P597, DOI 10.1086/322802; DEKOSTER HS, 1995, J IMMUNOL METHODS, V187, P179, DOI 10.1016/0022-1759(95)00182-A; Dhople V, 2006, BBA-BIOMEMBRANES, V1758, P1499, DOI 10.1016/j.bbamem.2006.07.007; Epand RM, 1999, BBA-BIOMEMBRANES, V1462, P11, DOI 10.1016/S0005-2736(99)00198-4; Fernandez EJ, 2002, ANNU REV PHARMACOL, V42, P469, DOI 10.1146/annurev.pharmtox.42.091901.115838; GOODSELL DS, 2005, CURR PROTOC BIOINFOR, P23, DOI DOI 10.1002/0471250953.BI0504S11; HARWIG SSL, 1993, ANAL BIOCHEM, V208, P382, DOI 10.1006/abio.1993.1065; HARWIG SSL, 1994, METHOD ENZYMOL, V236, P160; Hasan L, 2006, J IMMUNOL, V176, P6512, DOI 10.4049/jimmunol.176.11.6512; Hoover DM, 2003, ANTIMICROB AGENTS CH, V47, P2804, DOI 10.1128/AAC.47.9.2804-2809.2003; Hoover DM, 2002, J BIOL CHEM, V277, P37647, DOI 10.1074/jbc.M203907200; Huang HW, 2000, BIOCHEMISTRY-US, V39, P8347, DOI 10.1021/bi000946l; Kluver E, 2006, J PEPT SCI, V12, P243, DOI 10.1002/psc.749; Kobayashi S, 2000, BIOCHEMISTRY-US, V39, P8648, DOI 10.1021/bi0004549; Krijgsveld J, 2000, J BIOL CHEM, V275, P20374, DOI 10.1074/jbc.275.27.20374; KRIJGSVELD J, 1999, THESIS U AMSTERDAM A; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEHRER RI, 1989, J CLIN INVEST, V84, P553, DOI 10.1172/JCI114198; Linge HM, 2008, ANTIMICROB AGENTS CH, V52, P2599, DOI 10.1128/AAC.00028-08; Liu B, 2010, EUR J IMMUNOL, V40, P186, DOI 10.1002/eji.200939819; Liu SP, 2008, CHEMBIOCHEM, V9, P964, DOI 10.1002/cbic.200700560; MALKOWSKI MG, 1995, J BIOL CHEM, V270, P7077, DOI 10.1074/jbc.270.13.7077; Mandal M, 2002, PEPTIDES, V23, P413, DOI 10.1016/S0196-9781(01)00628-3; Matsuzaki K, 1999, BBA-BIOMEMBRANES, V1462, P1, DOI 10.1016/S0005-2736(99)00197-2; Nguyen LT, 2011, TRENDS BIOTECHNOL, V29, P464, DOI 10.1016/j.tibtech.2011.05.001; Nguyen LT, 2011, ANTIMICROB AGENTS CH, V55, P2074, DOI 10.1128/AAC.01351-10; Nguyen LT, 2010, BBA-BIOMEMBRANES, V1798, P1062, DOI 10.1016/j.bbamem.2009.11.021; Pazgier M, 2007, CURR PHARM DESIGN, V13, P3096, DOI 10.2174/138161207782110381; Perez-Canadillas JM, 2001, J BIOL CHEM, V276, P28372, DOI 10.1074/jbc.M103121200; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Reynolds NL, 2010, ANTIMICROB AGENTS CH, V54, P1922, DOI 10.1128/AAC.01568-09; Richter R, 2005, J IMMUNOL, V175, P1599, DOI 10.4049/jimmunol.175.3.1599; Schroeder BO, 2011, NATURE, V469, P419, DOI 10.1038/nature09674; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Semple CAM, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-5-r31; Shai Y, 2002, BIOPOLYMERS, V66, P236, DOI 10.1002/bip.10260; WALZ A, 1990, J EXP MED, V171, P449, DOI 10.1084/jem.171.2.449; WENGER RH, 1989, BLOOD, V73, P1498; Wolf M, 2008, INT J BIOCHEM CELL B, V40, P1185, DOI 10.1016/j.biocel.2007.12.009; Wu ZB, 2003, P NATL ACAD SCI USA, V100, P8880, DOI 10.1073/pnas.1533186100; Yang D, 2003, J LEUKOCYTE BIOL, V74, P448, DOI 10.1189/jlb.0103024; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	52	29	29	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					43506	43514		10.1074/jbc.M111.248641	http://dx.doi.org/10.1074/jbc.M111.248641			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22025617	Green Published, hybrid			2022-12-27	WOS:000298351300070
J	Singh, RK; Larson, JD; Zhu, WD; Rambo, RP; Hura, GL; Becker, DF; Tanner, JJ				Singh, Ranjan K.; Larson, John D.; Zhu, Weidong; Rambo, Robert P.; Hura, Greg L.; Becker, Donald F.; Tanner, John J.			Small-angle X-ray Scattering Studies of the Oligomeric State and Quaternary Structure of the Trifunctional Proline Utilization A (PutA) Flavoprotein from Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALDEHYDE DEHYDROGENASE; SALMONELLA-TYPHIMURIUM; MULTIFUNCTIONAL PUTA; CONFORMATIONAL-CHANGES; MEMBRANE ASSOCIATION; CRYSTAL-STRUCTURE; GENE-EXPRESSION; DNA-BINDING; PROTEIN; DOMAIN	The trifunctional flavoprotein proline utilization A (PutA) links metabolism and gene regulation in Gram-negative bacteria by catalyzing the two-step oxidation of proline to glutamate and repressing transcription of the proline utilization regulon. Small-angle x-ray scattering (SAXS) and domain deletion analysis were used to obtain solution structural information for the 1320-residue PutA from Escherichia coli. Shape reconstructions show that PutA is a symmetric V-shaped dimer having dimensions of 205 x 85 x 55 angstrom. The particle consists of two large lobes connected by a 30-angstrom diameter cylinder. Domain deletion analysis shows that the N-terminal DNA-binding domain mediates dimerization. Rigid body modeling was performed using the crystal structure of the DNA-binding domain and a hybrid x-ray/homology model of residues 87-1113. The calculations suggest that the DNA-binding domain is located in the connecting cylinder, whereas residues 87-1113, which contain the two catalytic active sites, reside in the large lobes. The SAXS data and amino acid sequence analysis suggest that the Delta(1)-pyrroline-5-carboxylate dehydrogenase domains lack the conventional oligomerization flap, which is unprecedented for the aldehyde dehydrogenase superfamily. The data also provide insight into the function of the 200-residue C-terminal domain. It is proposed that this domain serves as a lid that covers the internal substrate channeling cavity, thus preventing escape of the catalytic intermediate into the bulk medium. Finally, the SAXS model is consistent with a cloaking mechanism of gene regulation whereby interaction of PutA with the membrane hides the DNA-binding surface from the put regulon thereby activating transcription.	[Singh, Ranjan K.; Larson, John D.; Tanner, John J.] Univ Missouri, Dept Chem, Columbia, MO 65211 USA; [Tanner, John J.] Univ Missouri, Dept Biochem, Columbia, MO 65211 USA; [Zhu, Weidong; Becker, Donald F.] Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA; [Rambo, Robert P.; Hura, Greg L.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Nebraska System; University of Nebraska Lincoln; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Tanner, JJ (corresponding author), Univ Missouri, Dept Chem, Columbia, MO 65211 USA.	tannerjj@missouri.edu	SINGH, RANJAN/Q-2752-2017	SINGH, RANJAN/0000-0002-6929-0670; Hura, Greg/0000-0003-0501-8464; Tanner, John/0000-0001-8314-113X	National Institutes of Health [GM065546, GM061068]; Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy [DE-AC02-05CH11231]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061068, R01GM065546] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM065546 and GM061068.; We thank Kevin Dyer of the SIBYLS Mail In SAXS Program for collecting some of the SAXS data. We also thank Prof. Krishna K. Sharma for use of his SEC-MALS instrument, and Dr. Santhoshkumar Puttur for helping with SEC-MALS data collection and analysis. Part of this research was performed at the Advanced Light Source. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy under Contract DE-AC02-05CH11231.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; BROWN ED, 1992, J BIOL CHEM, V267, P13086; BROWN ED, 1993, J BIOL CHEM, V268, P8972; Chacon P, 2002, J MOL BIOL, V317, P375, DOI 10.1006/jmbi.2002.5438; de Bakker PIW, 2003, PROTEINS, V51, P21, DOI 10.1002/prot.10235; DESPICER PO, 1993, P NATL ACAD SCI USA, V90, P4295, DOI 10.1073/pnas.90.9.4295; Easley KE, 2007, BIOCHEMISTRY-US, V46, P369, DOI 10.1021/bi061537d; Hura GL, 2009, NAT METHODS, V6, P606, DOI 10.1038/nmeth.1353; Inagaki E, 2006, J MOL BIOL, V362, P490, DOI 10.1016/j.jmb.2006.07.048; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Larson JD, 2006, PROTEIN SCI, V15, P2630, DOI 10.1110/ps.062425706; Lee YH, 2003, NAT STRUCT BIOL, V10, P109, DOI 10.1038/nsb885; Liu ZJ, 1997, NAT STRUCT BIOL, V4, P317, DOI 10.1038/nsb0497-317; MALOY SR, 1983, J BACTERIOL, V154, P561, DOI 10.1128/JB.154.2.561-568.1983; MENZEL R, 1981, J MOL BIOL, V148, P21, DOI 10.1016/0022-2836(81)90233-3; Moore SA, 1998, STRUCTURE, V6, P1541, DOI 10.1016/S0969-2126(98)00152-X; MUROPASTOR AM, 1995, J BIOL CHEM, V270, P9819, DOI 10.1074/jbc.270.17.9819; MuroPastor AM, 1997, J BACTERIOL, V179, P2788, DOI 10.1128/jb.179.8.2788-2791.1997; Mylonas E, 2007, J APPL CRYSTALLOGR, V40, pS245, DOI 10.1107/S002188980700252X; Ostrander EL, 2009, BIOCHEMISTRY-US, V48, P951, DOI 10.1021/bi802094k; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Rambo RP, 2011, BIOPOLYMERS, V95, P559, DOI 10.1002/bip.21638; RATZKIN B, 1978, J BACTERIOL, V133, P744, DOI 10.1128/JB.133.2.744-754.1978; Schneidman-Duhovny D, 2010, NUCLEIC ACIDS RES, V38, pW540, DOI 10.1093/nar/gkq461; Schreiter ER, 2007, NAT REV MICROBIOL, V5, P710, DOI 10.1038/nrmicro1717; Sophos NA, 2003, CHEM-BIOL INTERACT, V143, P5, DOI 10.1016/S0009-2797(02)00163-1; Srivastava D, 2010, P NATL ACAD SCI USA, V107, P2878, DOI 10.1073/pnas.0906101107; Srivastava D, 2010, BIOCHEMISTRY-US, V49, P560, DOI 10.1021/bi901717s; Steinmetz CG, 1997, STRUCTURE, V5, P701, DOI 10.1016/S0969-2126(97)00224-4; Surber MW, 1998, ARCH BIOCHEM BIOPHYS, V354, P281, DOI 10.1006/abbi.1998.0697; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Tanner JJ, 2008, AMINO ACIDS, V35, P719, DOI 10.1007/s00726-008-0062-5; Vilchez S, 2000, APPL ENVIRON MICROB, V66, P5221, DOI 10.1128/AEM.66.12.5221-5225.2000; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; WILLIAMS I, 1975, ANAL BIOCHEM, V64, P85, DOI 10.1016/0003-2697(75)90408-X; WOOD JM, 1987, P NATL ACAD SCI USA, V84, P373, DOI 10.1073/pnas.84.2.373; Wriggers Willy, 2010, Biophys Rev, V2, P21, DOI 10.1007/s12551-009-0026-3; Yoshida A, 1998, EUR J BIOCHEM, V251, P549, DOI 10.1046/j.1432-1327.1998.2510549.x; Zhang M, 2004, BIOCHEMISTRY-US, V43, P12539, DOI 10.1021/bi048737e; Zhang WM, 2007, BIOCHEMISTRY-US, V46, P483, DOI 10.1021/bi061935g; Zhang WM, 2004, BIOCHEMISTRY-US, V43, P13165, DOI 10.1021/bi048596g; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhou YZ, 2008, AMINO ACIDS, V35, P711, DOI 10.1007/s00726-008-0053-6; Zhou YZ, 2008, J MOL BIOL, V381, P174, DOI 10.1016/j.jmb.2008.05.084; Zhu WD, 2005, BIOCHEMISTRY-US, V44, P12297, DOI 10.1021/bi051026b; Zhu WD, 2003, BIOCHEMISTRY-US, V42, P5469, DOI 10.1021/bi0272196	48	17	17	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					43144	43153		10.1074/jbc.M111.292474	http://dx.doi.org/10.1074/jbc.M111.292474			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22013066	Green Published, Green Submitted, hybrid			2022-12-27	WOS:000298351300035
J	Nemecz, A; Taylor, P				Nemecz, Akos; Taylor, Palmer			Creating an alpha 7 Nicotinic Acetylcholine Recognition Domain from the Acetylcholine-binding Protein CRYSTALLOGRAPHIC AND LIGAND SELECTIVITY ANALYSES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							4 BETA 2; CONFORMATIONAL-CHANGES; IN-VITRO; PHARMACOLOGICAL-PROPERTIES; EXTRACELLULAR DOMAINS; CRYSTAL-STRUCTURE; RECEPTOR; SITE; AGONISTS; SUBUNIT	Determining the structure of the ligand-binding domain of the nicotinic acetylcholine receptor (nAChR) has been a long standing goal in the design of selective drugs useful in implicated diseases for this prevalent receptor family. Acetylcholine-binding proteins have proven to be valuable surrogates with structural similarity and sequence identity to the extracellular domain of the nicotinic receptor, yet these soluble proteins have their unique features and do not serve as exact replicates of the nAChRs of interest. Here we systematically modify the sequence of these proteins toward the homomeric human alpha 7 nAChR. These chimeric proteins exhibit a shift in affinities to reflect alpha 7 binding characteristics yet maintain expression levels and stability conducive for crystallization. We also present a pentameric humanoid nAChR extracellular domain with the structural determination of the alpha 7 nAChR glycosylation site.	[Taylor, Palmer] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, Dept Pharmacol, La Jolla, CA 92093 USA; Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, Dept Chem & Biochem, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Taylor, P (corresponding author), Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, Dept Pharmacol, Pharmaceut Sci Bldg 0657,9500 Gilman Dr, La Jolla, CA 92093 USA.	pwtaylor@ucsd.edu			National Institutes of Health [T32 GM-007752, R01 GM 18360, U01 DA 019372]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM018360, T32GM007752] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [U01DA019372] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants T32 GM-007752 (to A.N.) and R01 GM 18360 and U01 DA 019372 (to P.T.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ALKONDON M, 1993, J PHARMACOL EXP THER, V265, P1455; Astles PC, 2002, CNS NEUROL DISORD-DR, V1, P337, DOI 10.2174/1568007023339256; Avramopoulou V, 2004, J BIOL CHEM, V279, P38287, DOI 10.1074/jbc.M402533200; Bodnar AL, 2005, J MED CHEM, V48, P905, DOI 10.1021/jm049363q; Bond CS, 2009, ACTA CRYSTALLOGR D, V65, P510, DOI 10.1107/S0907444909007835; Bourne Y, 2005, EMBO J, V24, P1512, DOI 10.1038/sj.emboj.7600620; Briggs CA, 1999, EUR J PHARMACOL, V366, P301, DOI 10.1016/S0014-2999(98)00909-1; Briggs CA, 1997, PHARMACOL BIOCHEM BE, V57, P231, DOI 10.1016/S0091-3057(96)00354-1; BRIGGS CA, 1995, NEUROPHARMACOLOGY, V34, P583, DOI 10.1016/0028-3908(95)00028-5; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; Celie PHN, 2005, NAT STRUCT MOL BIOL, V12, P582, DOI 10.1038/nsmb951; Changeux J-P, 2005, NICOTINIC ACETYLCHOL; ChavezNoriega LE, 1997, J PHARMACOL EXP THER, V280, P346; Cheng XL, 2007, BIOPHYS J, V93, P2622, DOI 10.1529/biophysj.107.109843; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; de Kloe GE, 2010, J MED CHEM, V53, P7192, DOI 10.1021/jm100834y; Ellison M, 2003, J BIOL CHEM, V278, P757, DOI 10.1074/jbc.M204565200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fischer M, 2001, P NATL ACAD SCI USA, V98, P3567, DOI 10.1073/pnas.041594798; GALZI JL, 1991, FEBS LETT, V294, P198, DOI 10.1016/0014-5793(91)80668-S; GALZI JL, 1990, J BIOL CHEM, V265, P10430; Gao F, 2005, J BIOL CHEM, V280, P8443, DOI 10.1074/jbc.M412389200; Hajos M, 2005, J PHARMACOL EXP THER, V312, P1213, DOI 10.1124/jpet.104.076968; Hansen SB, 2005, EMBO J, V24, P3635, DOI 10.1038/sj.emboj.7600828; Hansen SB, 2002, J BIOL CHEM, V277, P41299, DOI 10.1074/jbc.C200462200; Hansen SB, 2007, J MOL BIOL, V369, P895, DOI 10.1016/j.jmb.2007.03.067; Hibbs RE, 2009, EMBO J, V28, P3040, DOI 10.1038/emboj.2009.227; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hurst RS, 2005, J NEUROSCI, V25, P4396, DOI 10.1523/JNEUROSCI.5269-04.2005; Innocent N, 2008, J PHARMACOL EXP THER, V327, P529, DOI 10.1124/jpet.108.142943; Jensen AA, 2005, J MED CHEM, V48, P4705, DOI 10.1021/jm040219e; Karlin A, 2002, NAT REV NEUROSCI, V3, P102, DOI 10.1038/nrn731; KATZ B, 1957, J PHYSIOL-LONDON, V138, P63, DOI 10.1113/jphysiol.1957.sp005838; Kem WR, 2004, MOL PHARMACOL, V65, P56, DOI 10.1124/mol.65.1.56; Macor JE, 2001, BIOORG MED CHEM LETT, V11, P319, DOI 10.1016/S0960-894X(00)00670-3; Mank M, 2008, NAT METHODS, V5, P805, DOI 10.1038/NMETH.1243; Marinou M, 2003, BIOCHEM J, V372, P543, DOI 10.1042/BJ20021537; Mazurov A, 2006, CURR MED CHEM, V13, P1567, DOI 10.2174/092986706777442011; MIDDLETON RE, 1991, BIOCHEMISTRY-US, V30, P6987, DOI 10.1021/bi00242a026; MISHINA M, 1985, NATURE, V313, P364, DOI 10.1038/313364a0; Nguyen QT, 2010, NAT NEUROSCI, V13, P127, DOI 10.1038/nn.2469; Papke RL, 2005, NEUROSCI LETT, V378, P140, DOI 10.1016/j.neulet.2004.12.025; Papke RL, 2002, BRIT J PHARMACOL, V137, P49, DOI 10.1038/sj.bjp.0704833; PENG X, 1994, MOL PHARMACOL, V45, P546; Pereira EFR, 1996, J PHARMACOL EXP THER, V278, P1472; Person AM, 2005, J BIOL CHEM, V280, P39990, DOI 10.1074/jbc.M505087200; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; Schrodinger L., 2020, PYMOL MOL GRAPHICS S; Shi JX, 2006, J BIOL CHEM, V281, P12170, DOI 10.1074/jbc.M600154200; SINE S, 1979, J BIOL CHEM, V254, P3315; SINE SM, 1994, J BIOL CHEM, V269, P8808; Stokes C, 2004, MOL PHARMACOL, V66, P14, DOI 10.1124/mol.66.1.14; Sullivan JP, 1996, NEUROPHARMACOLOGY, V35, P725, DOI 10.1016/0028-3908(96)84644-2; Talley TT, 2006, BIOCHEMISTRY-US, V45, P8894, DOI 10.1021/bi060534y; TAYLOR P, 1990, P1; Taylor P, 2007, BIOCHEM PHARMACOL, V74, P1164, DOI 10.1016/j.bcp.2007.07.038; Tierney ML, 2000, J MOL BIOL, V303, P185, DOI 10.1006/jmbi.2000.4137; Toshima K, 2009, NEUROPHARMACOLOGY, V56, P264, DOI 10.1016/j.neuropharm.2008.08.022; Walker DP, 2006, BIOORGAN MED CHEM, V14, P8219, DOI 10.1016/j.bmc.2006.09.019; Wang HL, 2009, BIOPHYS J, V96, P3582, DOI 10.1016/j.bpj.2009.02.020; Wells GB, 1998, J BIOL CHEM, V273, P964, DOI 10.1074/jbc.273.2.964; Whiteaker P, 2007, BIOCHEMISTRY-US, V46, P6628, DOI 10.1021/bi7004202; Wishka DG, 2006, J MED CHEM, V49, P4425, DOI 10.1021/jm0602413; Wyllie DJA, 2007, BRIT J PHARMACOL, V150, P541, DOI 10.1038/sj.bjp.0706997; Yamauchi JG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016519; Zouridakis M, 2007, INT J BIOL MACROMOL, V41, P423, DOI 10.1016/j.ijbiomac.2007.05.012; Zouridakis M, 2009, BBA-PROTEINS PROTEOM, V1794, P355, DOI 10.1016/j.bbapap.2008.11.002	70	56	56	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42555	42565		10.1074/jbc.M111.286583	http://dx.doi.org/10.1074/jbc.M111.286583			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	22009746	Green Published, hybrid			2022-12-27	WOS:000298180900063
J	Shibata, T; Kimura, Y; Mukai, A; Mori, H; Ito, S; Asaka, Y; Oe, S; Tanaka, H; Takahashi, T; Uchida, K				Shibata, Takahiro; Kimura, Yuuki; Mukai, Akihiro; Mori, Hitoshi; Ito, Sohei; Asaka, Yukio; Oe, Sho; Tanaka, Hiroshi; Takahashi, Takashi; Uchida, Koji			Transthiocarbamoylation of Proteins by Thiolated Isothiocyanates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK; TRANSCRIPTION FACTOR; PANCREATIC-CANCER; GLUTATHIONE; SULFORAPHANE; APOPTOSIS; CELLS; IDENTIFICATION; METABOLITES; ACTIVATION	Isothiocyanates, membrane-permeable electrophiles that form adducts with thiols, have been suggested to have important medical benefits. Here we shed light on isothiocyanate-thiol conjugates and studied their electrophilic potential transferring an isothiocyanate moiety to cellular proteins. When we examined the effect of sulfhydryl molecules on cellular response induced by 6-methylsulfinylhexyl isothiocyanate (6-HITC), an analog of sulforaphane isolated from broccoli, we observed significant induction of heme oxygenase-1 by 6-HITC even in the presence of N-acetyl-L-cysteine or glutathione (GSH). In addition, the authentic 6-HITC-beta-mercaptoethanol (6-HITC-ME) conjugate markedly up-regulated the enzyme expression, suggesting the electrophilic potential of thiolated isothiocyanates. To gain a chemical insight into the cellular response induced by thiolated isothiocyanates, we studied the occurrence of transthiocarbamoylation of sulfhydryl molecules by 6-HITC-ME and observed that, upon incubation of 6-HITC-ME with GSH, a single product corresponding to the GSH conjugate of 6-HITC was generated. To test the functional ability of thiolated isothiocyanates to thiocarbamoylate proteins in living cells, we designed a novel probe, combining an isothiocyanate-reactive group and an alkyne functionality, and revealed that the transthiocarbamoylation of proteins occurred in the cells upon exposure to 6-HITC-ME. The target of thiocarbamoylation included heat shock protein 90 beta (Hsp90 beta), a chaperone ATPase of the Hsp90 family implicated in protein maturation and targeting. To identify the sites of the Hsp90 beta modification, we utilized nano-LC/MALDI-TOF MS/MS and suggested that a thiol group on the peptide containing Cys-521 reacted with 6-HITC, resulting in a covalent adduct in a 6-HITC-treated recombinant Hsp90 beta in vitro. The site-selective binding to Cys-521 was supported by in silico modeling. Further study on the thiocarbamoylation of Hsp90 beta suggested that the formation of 6-HITC-Hsp90 beta conjugate might cause activation of heat shock factor-1, rapidly signaling a potential heat shock response. These data suggest that thiolated isothiocyanates are an active metabolite that could contribute to cellular responses through transthiocarbamoylation of cellular proteins.	[Shibata, Takahiro; Kimura, Yuuki; Mukai, Akihiro; Mori, Hitoshi; Uchida, Koji] Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan; [Ito, Sohei] Univ Shizuoka, Sch Food & Nutr Sci, Shizuoka 4228526, Japan; [Asaka, Yukio; Oe, Sho; Tanaka, Hiroshi; Takahashi, Takashi] Tokyo Inst Technol, Grad Sch Sci & Engn, Tokyo 1528552, Japan	Nagoya University; University of Shizuoka; Tokyo Institute of Technology	Uchida, K (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan.	uchidak@agr.nagoya-u.ac.jp	Ito, Sohei/M-5930-2019; Tanaka, Hiroshi/I-2402-2012; Shibata, Takahiro/I-6872-2014	Ito, Sohei/0000-0002-9937-3100; Shibata, Takahiro/0000-0003-3194-607X; Uchida, Koji/0000-0003-3894-5299	Grant-in-Aid for Scientific Research on Innovative Areas (Research in a Proposed Research Area), Japan [20117007]	Grant-in-Aid for Scientific Research on Innovative Areas (Research in a Proposed Research Area), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas (Research in a Proposed Research Area), Japan (Grant 20117007, to K. U.).	ABRAVAYA K, 1992, GENE DEV, V6, P1153, DOI 10.1101/gad.6.7.1153; Adams J, 2000, ONCOGENE, V19, P6687, DOI 10.1038/sj.onc.1204088; Ahn YH, 2010, P NATL ACAD SCI USA, V107, P9590, DOI 10.1073/pnas.1004104107; Ali MMU, 2006, NATURE, V440, P1013, DOI 10.1038/nature04716; Baillie T A, 1994, Adv Pharmacol, V27, P163, DOI 10.1016/S1054-3589(08)61032-7; BAILLIE TA, 1991, ACCOUNTS CHEM RES, V24, P264, DOI 10.1021/ar00009a003; BRUGGEMAN IM, 1986, TOXICOL APPL PHARM, V83, P349, DOI 10.1016/0041-008X(86)90312-1; Carbone DL, 2005, J PHARMACOL EXP THER, V315, P8, DOI 10.1124/jpet.105.088088; Chiao JW, 2004, CARCINOGENESIS, V25, P1403, DOI 10.1093/carcin/bgh136; Depree JA, 1998, FOOD RES INT, V31, P329, DOI 10.1016/S0963-9969(98)00105-7; DIDOMENICO BJ, 1982, P NATL ACAD SCI-BIOL, V79, P6181, DOI 10.1073/pnas.79.20.6181; Dollins DE, 2007, MOL CELL, V28, P41, DOI 10.1016/j.molcel.2007.08.024; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gillet LCJ, 2008, MOL CELL PROTEOMICS, V7, P1241, DOI 10.1074/mcp.M700505-MCP200; Heiss E, 2001, J BIOL CHEM, V276, P32008, DOI 10.1074/jbc.M104794200; HICKEY E, 1989, MOL CELL BIOL, V9, P2615, DOI 10.1128/MCB.9.6.2615; Itoh K, 2003, GENES CELLS, V8, P379, DOI 10.1046/j.1365-2443.2003.00640.x; Jacobs AT, 2007, J BIOL CHEM, V282, P33412, DOI 10.1074/jbc.M706799200; Jacobs AT, 2010, ACCOUNTS CHEM RES, V43, P673, DOI 10.1021/ar900286y; Johnson BD, 1998, J BIOL CHEM, V273, P3679, DOI 10.1074/jbc.273.6.3679; JOSHIBARVE S, 1992, J BIOL CHEM, V267, P21038; Kassahun K, 1997, CHEM RES TOXICOL, V10, P1228, DOI 10.1021/tx970080t; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; LEE HP, 1989, INT J CANCER, V43, P1007, DOI 10.1002/ijc.2910430609; LIS J, 1993, CELL, V74, P1, DOI 10.1016/0092-8674(93)90286-Y; Macpherson LJ, 2007, NATURE, V445, P541, DOI 10.1038/nature05544; MEHTA RG, 1995, CARCINOGENESIS, V16, P399, DOI 10.1093/carcin/16.2.399; MORIMOTO RI, 1993, SCIENCE, V259, P1409, DOI 10.1126/science.8451637; Nakajima M, 2001, DRUG METAB DISPOS, V29, P1110; OLSEN GW, 1991, CANCER CAUSE CONTROL, V2, P291, DOI 10.1007/BF00051668; Pham NA, 2004, MOL CANCER THER, V3, P1239; Rostovtsev VV, 2002, ANGEW CHEM INT EDIT, V41, P2596, DOI 10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4; SARGE KD, 1993, MOL CELL BIOL, V13, P1392, DOI 10.1128/MCB.13.3.1392; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Shiau AK, 2006, CELL, V127, P329, DOI 10.1016/j.cell.2006.09.027; Speers AE, 2003, J AM CHEM SOC, V125, P4686, DOI 10.1021/ja034490h; Speers AE, 2004, CHEM BIOL, V11, P535, DOI 10.1016/j.chembiol.2004.03.012; Talalay P, 1995, TOXICOL LETT, V82-3, P173, DOI 10.1016/0378-4274(95)03553-2; Voellmy R, 2004, CELL STRESS CHAPERON, V9, P122, DOI 10.1379/CSC-14R.1; Wu X, 2009, ACTA PHARMACOL SIN, V30, P501, DOI 10.1038/aps.2009.50; Yonehara M, 1996, J BIOL CHEM, V271, P2641, DOI 10.1074/jbc.271.5.2641; Zhang YH, 2005, FREE RADICAL BIO MED, V38, P874, DOI 10.1016/j.freeradbiomed.2004.12.012; ZHANG YS, 1992, P NATL ACAD SCI USA, V89, P2399, DOI 10.1073/pnas.89.6.2399; ZHANG YS, 1995, BIOCHEM BIOPH RES CO, V206, P748, DOI 10.1006/bbrc.1995.1106; ZHENG GQ, 1992, J MED CHEM, V35, P185, DOI 10.1021/jm00079a025	45	38	39	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42150	42161		10.1074/jbc.M111.308049	http://dx.doi.org/10.1074/jbc.M111.308049			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	21998322	Green Published, hybrid			2022-12-27	WOS:000298180900026
J	Moon, MJ; Kim, HY; Park, S; Kim, DK; Cho, EB; Park, CR; You, DJ; Hwang, JI; Kim, K; Choe, H; Seong, JY				Moon, Mi Jin; Kim, Hee Young; Park, Sumi; Kim, Dong-Kyu; Cho, Eun Bee; Park, Cho Rong; You, Dong-Joo; Hwang, Jong-Ik; Kim, Kyungjin; Choe, Han; Seong, Jae Young			Evolutionarily Conserved Residues at Glucagon-like Peptide-1 (GLP-1) Receptor Core Confer Ligand-induced Receptor Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULINOTROPIC POLYPEPTIDE GIP; GASTRIC-INHIBITORY POLYPEPTIDE; TERMINAL EXTRACELLULAR DOMAIN; PROTEIN-COUPLED-RECEPTOR; CRYSTAL-STRUCTURE; CRITICAL DETERMINANTS; PARATHYROID-HORMONE; CHIMERIC RECEPTORS; SECRETIN RECEPTOR; AGONIST BINDING	Glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) play important roles in insulin secretion through their receptors, GLP1R and GIPR. Although GLP-1 and GIP are attractive candidates for treatment of type 2 diabetes and obesity, little is known regarding the molecular interaction of these peptides with the heptahelical core domain of their receptors. These core domains are important not only for specific ligand binding but also for ligand-induced receptor activation. Here, using chimeric and point-mutated GLP1R/GIPR, we determined that evolutionarily conserved amino acid residues such as Ile(196) at transmembrane helix 2, Leu(232) and Met(233) at extracellular loop 1, and Asn(302) at extracellular loop 2 of GLP1R are responsible for interaction with ligand and receptor activation. Application of chimeric GLP-1/GIP peptides together with molecular modeling suggests that His(1) of GLP-1 interacts with Asn(302) of GLP1R and that Thr(7) of GLP-1 has close contact with a binding pocket formed by Ile(196), Leu(232), and Met(233) of GLP1R. This study may provide critical clues for the development of peptide and/or nonpeptide agonists acting at GLP1R.	[Choe, Han] Univ Ulsan, Dept Physiol, Coll Med, Seoul 138736, South Korea; [Choe, Han] Univ Ulsan, Biomed Inst Technol, Coll Med, Seoul 138736, South Korea; [Moon, Mi Jin; Park, Sumi; Kim, Dong-Kyu; Cho, Eun Bee; Park, Cho Rong; You, Dong-Joo; Hwang, Jong-Ik; Seong, Jae Young] Korea Univ, Grad Sch Med, Seoul 136705, South Korea; [Kim, Hee Young] Korea Univ, Coll Med, Dept Internal Med, Div Endocrinol & Metab, Seoul 136705, South Korea; [Kim, Kyungjin] Seoul Natl Univ, Sch Biol Sci, Seoul 151742, South Korea	University of Ulsan; University of Ulsan; Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine); Seoul National University (SNU)	Choe, H (corresponding author), Univ Ulsan, Dept Physiol, Coll Med, Seoul 138736, South Korea.	hchoe@amc.seoul.kr; jyseong@korea.ac.kr	choe, han/A-5679-2010; Seong, Jae Young/A-5794-2012	choe, han/0000-0003-4604-647X; Seong, Jae Young/0000-0002-3312-6924; Hwang, Jong-Ik/0000-0002-0729-1782	Brain Research Center of the 21st Century Frontier Research Program [2011K00277, 2011K000279]; National Research Foundation of Korea [2011-0019205]; Ministry of Education, Science and Technology	Brain Research Center of the 21st Century Frontier Research Program(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by Grants 2011K00277 and 2011K000279 from the Brain Research Center of the 21st Century Frontier Research Program and Grant 2011-0019205 from the Brain Research Program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology.	Al-Sabah S, 2003, BRIT J PHARMACOL, V140, P339, DOI 10.1038/sj.bjp.0705453; Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; Bergwitz C, 1996, J BIOL CHEM, V271, P26469, DOI 10.1074/jbc.271.43.26469; Bregenbolt S, 2005, BIOCHEM BIOPH RES CO, V330, P577, DOI 10.1016/j.bbrc.2005.03.013; BROWN JC, 1981, PEPTIDES, V2, P241, DOI 10.1016/0196-9781(81)90038-3; BROWN JC, 1971, CAN J BIOCHEM CELL B, V49, P867, DOI 10.1139/o71-122; BUGGY JJ, 1995, J BIOL CHEM, V270, P7474, DOI 10.1074/jbc.270.13.7474; Castro M, 2005, P NATL ACAD SCI USA, V102, P16084, DOI 10.1073/pnas.0503942102; Chen QA, 2010, J BIOL CHEM, V285, P24508, DOI 10.1074/jbc.M110.135749; Chen Q, 2009, J BIOL CHEM, V284, P34135, DOI 10.1074/jbc.M109.038109; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; de Maturana RL, 2003, J BIOL CHEM, V278, P10195, DOI 10.1074/jbc.M212147200; de Maturana RL, 2004, PROTEIN PEPTIDE LETT, V11, P15, DOI 10.2174/0929866043478491; de Maturana RL, 2002, FEBS LETT, V530, P244, DOI 10.1016/S0014-5793(02)03492-0; Di Paolo E, 1998, FEBS LETT, V424, P207, DOI 10.1016/S0014-5793(98)00175-6; Dong MQ, 2003, J BIOL CHEM, V278, P48300, DOI 10.1074/jbc.M309166200; During MJ, 2003, NAT MED, V9, P1173, DOI 10.1038/nm919; Gallwitz B, 1996, REGUL PEPTIDES, V63, P17, DOI 10.1016/0167-0115(96)00019-5; Gault VA, 2007, DIABETOLOGIA, V50, P1752, DOI 10.1007/s00125-007-0710-4; Gourlet P, 1996, PEPTIDES, V17, P825, DOI 10.1016/0196-9781(96)00107-6; Graziano MP, 1996, RECEPTOR CHANNEL, V4, P9; Hansotia T, 2005, REGUL PEPTIDES, V128, P125, DOI 10.1016/j.regpep.2004.07.019; Hinke SA, 2003, BIOL CHEM, V384, P403, DOI 10.1515/BC.2003.046; Hinke SA, 2002, BIOCHEM BIOPH RES CO, V291, P1302, DOI 10.1006/bbrc.2002.6607; Hinke SA, 2001, BBA-PROTEIN STRUCT M, V1547, P143, DOI 10.1016/S0167-4838(01)00181-9; Hjorth SA, 1996, ACTA PHYSIOL SCAND, V157, P343, DOI 10.1046/j.1365-201X.1996.37259000.x; Holtmann MH, 1996, J BIOL CHEM, V271, P14944, DOI 10.1074/jbc.271.25.14944; HOLTMANN MH, 1995, J BIOL CHEM, V270, P14394, DOI 10.1074/jbc.270.24.14394; Knudsen LB, 2007, P NATL ACAD SCI USA, V104, P937, DOI 10.1073/pnas.0605701104; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lin F, 2009, J MOL MODEL, V15, P53, DOI 10.1007/s00894-008-0372-2; Moon MJ, 2010, MOL CELLS, V30, P149, DOI 10.1007/s10059-010-0100-5; NAUCK MA, 1993, J CLIN INVEST, V91, P301, DOI 10.1172/JCI116186; Parthier C, 2007, P NATL ACAD SCI USA, V104, P13942, DOI 10.1073/pnas.0706404104; Runge S, 2003, BRIT J PHARMACOL, V138, P787, DOI 10.1038/sj.bjp.0705120; Runge S, 2008, J BIOL CHEM, V283, P11340, DOI 10.1074/jbc.M708740200; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sloop KW, 2010, DIABETES, V59, P3099, DOI 10.2337/db10-0689; THORENS B, 1993, DIABETES, V42, P1678, DOI 10.2337/diabetes.42.11.1678; Underwood CR, 2010, J BIOL CHEM, V285, P723, DOI 10.1074/jbc.M109.033829; VanEyll B, 1996, PEPTIDES, V17, P565, DOI 10.1016/0196-9781(96)00019-8; Wilmen A, 1996, FEBS LETT, V398, P43, DOI 10.1016/S0014-5793(96)01214-8; Wilmen A, 1997, PEPTIDES, V18, P301, DOI 10.1016/S0196-9781(96)00321-X; Wittelsberger A, 2006, BIOCHEMISTRY-US, V45, P2027, DOI 10.1021/bi051833a; Xiao Q, 2000, J MOL ENDOCRINOL, V25, P321, DOI 10.1677/jme.0.0250321; Yaqub T, 2010, MOL PHARMACOL, V77, P547, DOI 10.1124/mol.109.060111	46	16	16	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					3873	3884		10.1074/jbc.M111.276808	http://dx.doi.org/10.1074/jbc.M111.276808			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22105074	hybrid, Green Published			2022-12-27	WOS:000300410900024
J	Barsotti, AM; Beckerman, R; Laptenko, O; Huppi, K; Caplen, NJ; Prives, C				Barsotti, Anthony M.; Beckerman, Rachel; Laptenko, Oleg; Huppi, Konrad; Caplen, Natasha J.; Prives, Carol			p53-dependent Induction of PVT1 and miR-1204	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE ARREST; WILD-TYPE P53; P53-MEDIATED APOPTOSIS; C-MYC; GENE-EXPRESSION; NONCODING RNA; BREAST-CANCER; G(2) ARREST; DNA-DAMAGE; STEM-CELLS	p53 is a tumor suppressor protein that acts as a transcription factor to regulate (either positively or negatively) a plethora of downstream target genes. Although its ability to induce protein coding genes is well documented, recent studies have implicated p53 in the regulation of non-coding RNAs, including both microRNAs (e.g. miR-34a) and long non-coding RNAs (e.g. lincRNA-p21). We have identified the non-protein coding locus PVT1 as a p53-inducible target gene. PVT1, a very large (>300 kb) locus located downstream of c-myc on chromosome 8q24, produces a wide variety of spliced non-coding RNAs as well as a cluster of six annotated microRNAs: miR-1204, miR-1205, miR-1206, miR-1207-5p, miR-1207-3p, and miR-1208. Chromatin immunoprecipitation (ChIP), electrophoretic mobility shift assay (EMSA), and luciferase assays reveal that p53 binds and activates a canonical response element within the vicinity of miR-1204. Consistently, we demonstrate the p53-dependent induction of endogenous PVT1 transcripts and consequent upregulation of mature miR-1204. Finally, we have shown that ectopic expression of miR-1204 leads to increased p53 levels and causes cell death in a partially p53-dependent manner.	[Barsotti, Anthony M.; Beckerman, Rachel; Laptenko, Oleg; Prives, Carol] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Huppi, Konrad; Caplen, Natasha J.] NCI, Gene Silencing Sect, Genet Branch, Ctr Canc Res,NIH, Bethesda, MD 20892 USA	Columbia University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Prives, C (corresponding author), Columbia Univ, Dept Biol Sci, 1212 Amsterdam Ave, New York, NY 10027 USA.	clp3@columbia.edu	Caplen, Natasha J/H-2768-2016	Caplen, Natasha J/0000-0002-0001-9460	National Institutes of Health [CA77742]; (Center for Cancer Research, NCI) of the National Institutes of Health; NATIONAL CANCER INSTITUTE [ZIABC010612, R01CA077742] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); (Center for Cancer Research, NCI) of the National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA77742 and the Intramural Research Program (Center for Cancer Research, NCI) of the National Institutes of Health.	ALONIGRINSTEIN R, 1995, EMBO J, V14, P1392, DOI 10.1002/j.1460-2075.1995.tb07125.x; Barsotti AM, 2010, CELL, V142, P358, DOI 10.1016/j.cell.2010.07.029; Beck-Engeser GB, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-4; Beckerman R, 2009, GENE DEV, V23, P1364, DOI 10.1101/gad.1795709; BORG A, 1992, INT J CANCER, V51, P687, DOI 10.1002/ijc.2910510504; BRUGAROLAS J, 1995, NATURE, V377, P552, DOI 10.1038/377552a0; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Carramusa L, 2007, J CELL PHYSIOL, V213, P511, DOI 10.1002/jcp.21133; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; ELDEIRY WS, 1994, CANCER RES, V54, P1169; Enciso-Mora V, 2010, NAT GENET, V42, P1126, DOI 10.1038/ng.696; Georges SA, 2008, CANCER RES, V68, P10105, DOI 10.1158/0008-5472.CAN-08-1846; Gieni RS, 2009, BIOCHEM CELL BIOL, V87, P711, DOI 10.1139/O09-057; Guan YH, 2007, CLIN CANCER RES, V13, P5745, DOI 10.1158/1078-0432.CCR-06-2882; HARPER JW, 1993, CELL, V75, P805; Haverty PM, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-21; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Hermeking H, 2010, CELL DEATH DIFFER, V17, P193, DOI 10.1038/cdd.2009.56; Hermeking H, 2007, CANCER CELL, V12, P414, DOI 10.1016/j.ccr.2007.10.028; Ho JSL, 2005, MOL CELL BIOL, V25, P7423, DOI 10.1128/MCB.25.17.7423-7431.2005; Hoh J, 2002, P NATL ACAD SCI USA, V99, P8467, DOI 10.1073/pnas.132268899; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; Huppi K, 2008, MOL CANCER RES, V6, P212, DOI 10.1158/1541-7786.MCR-07-0105; Janicke RU, 2007, CELL CYCLE, V6, P407; Kamath A, 2008, CANCER GENET CYTOGEN, V183, P117, DOI 10.1016/j.cancergencyto.2008.02.011; Laptenko O, 2011, P NATL ACAD SCI USA, V108, P10385, DOI 10.1073/pnas.1105680108; LAZO PA, 1990, P NATL ACAD SCI USA, V87, P170, DOI 10.1073/pnas.87.1.170; Lozano G, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001115; MacPherson D, 2004, EMBO J, V23, P3689, DOI 10.1038/sj.emboj.7600363; Marasa BS, 2010, AGING-US, V2, P333, DOI 10.18632/aging.100159; MARCU KB, 1992, ANNU REV BIOCHEM, V61, P809, DOI 10.1146/annurev.bi.61.070192.004113; PALUMBO AP, 1990, CANCER RES, V50, P6478; Petitjean A, 2007, HUM MUTAT, V28, P622, DOI 10.1002/humu.20495; Raver-Shapira N, 2007, MOL CELL, V26, P731, DOI 10.1016/j.molcel.2007.05.017; Sachdeva M, 2009, P NATL ACAD SCI USA, V106, P3207, DOI 10.1073/pnas.0808042106; Schiffman JD, 2010, CANCER RES, V70, P512, DOI 10.1158/0008-5472.CAN-09-1851; SHAULSKY G, 1991, P NATL ACAD SCI USA, V88, P8982, DOI 10.1073/pnas.88.20.8982; Sheikh MS, 2000, LEUKEMIA, V14, P1509, DOI 10.1038/sj.leu.2401865; Sircoulomb F, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-539; Song B, 2008, CLIN CANCER RES, V14, P8080, DOI 10.1158/1078-0432.CCR-08-1422; Soussi T, 2007, ONCOGENE, V26, P2145, DOI 10.1038/sj.onc.1210280; Suzuki HI, 2009, NATURE, V460, P529, DOI 10.1038/nature08199; Tazawa H, 2007, P NATL ACAD SCI USA, V104, P15472, DOI 10.1073/pnas.0707351104; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; Wu GS, 1997, NAT GENET, V17, P141, DOI 10.1038/ng1097-141; Wu WS, 2005, CELL, V123, P641, DOI 10.1016/j.cell.2005.09.029; Xu N, 2009, CELL, V137, P647, DOI 10.1016/j.cell.2009.02.038; Yamakuchi M, 2008, P NATL ACAD SCI USA, V105, P13421, DOI 10.1073/pnas.0801613105; Yamakuchi M, 2010, P NATL ACAD SCI USA, V107, P6334, DOI 10.1073/pnas.0911082107; You L, 2011, BIOCHEM BIOPH RES CO, V407, P1, DOI 10.1016/j.bbrc.2011.02.027; Yu J, 2005, BIOCHEM BIOPH RES CO, V331, P851, DOI 10.1016/j.bbrc.2005.03.189; Zhao J, 2010, MOL CELL, V40, P939, DOI 10.1016/j.molcel.2010.12.011; Zilfou JT, 2005, CELL, V123, P545, DOI 10.1016/j.cell.2005.11.003	55	143	153	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2509	2519		10.1074/jbc.M111.322875	http://dx.doi.org/10.1074/jbc.M111.322875			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22110125	Green Published, hybrid			2022-12-27	WOS:000300292300025
J	Carman, GM				Carman, George M.			Thematic Minireview Series on the Lipid Droplet, a Dynamic Organelle of Biomedical and Commercial Importance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material									[Carman, George M.] Rutgers State Univ, Dept Food Sci, New Brunswick, NJ 08901 USA; [Carman, George M.] Rutgers State Univ, Rutgers Ctr Lipid Res, New Brunswick, NJ 08901 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick	Carman, GM (corresponding author), Rutgers State Univ, Dept Food Sci, New Brunswick, NJ 08901 USA.	gcarman@asbmb.org			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM028140] Funding Source: NIH RePORTER; NIGMS NIH HHS [R37 GM028140] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))			0	12	13	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2272	2272		10.1074/jbc.R111.323931	http://dx.doi.org/10.1074/jbc.R111.323931			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22090032	Green Published, hybrid			2022-12-27	WOS:000300292300001
J	Buler, M; Aatsinki, SM; Skoumal, R; Komka, Z; Toth, M; Kerkela, R; Georgiadi, A; Kersten, S; Hakkola, J				Buler, Marcin; Aatsinki, Sanna-Mari; Skoumal, Reka; Komka, Zsolt; Toth, Miklos; Kerkela, Risto; Georgiadi, Anastasia; Kersten, Sander; Hakkola, Jukka			Energy-sensing Factors Coactivator Peroxisome Proliferator-activated Receptor gamma Coactivator 1-alpha (PGC-1 alpha) and AMP-activated Protein Kinase Control Expression of Inflammatory Mediators in Liver INDUCTION OF INTERLEUKIN 1 RECEPTOR ANTAGONIST	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; NECROSIS-FACTOR-ALPHA; INSULIN-RESISTANCE; SKELETAL-MUSCLE; HEPATIC GLUCONEOGENESIS; CALORIC RESTRICTION; METABOLIC SYNDROME; DIABETES-MELLITUS; NUCLEAR RECEPTORS; HUMAN OBESITY	Obesity and insulin resistance are associated with chronic, low grade inflammation. Moreover, regulation of energy metabolism and immunity are highly integrated. We hypothesized that energy-sensitive coactivator peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1 alpha) and AMP-activated protein kinase (AMPK) may modulate inflammatory gene expression in liver. Microarray analysis revealed that PGC-1 alpha up-regulated expression of several cytokines and cytokine receptors, including interleukin 15 receptor alpha (IL15R alpha) and, even more importantly, anti-inflammatory interleukin 1 receptor antagonist (IL1Rn). Overexpression of PGC-1 alpha and induction of PGC-1 alpha by fasting, physical exercise, glucagon, or cAMP was associated with increased IL1Rn mRNA and protein expression in hepatocytes. Knockdown of PGC-1 alpha by siRNA down-regulated cAMP-induced expression of IL1Rn in mouse hepatocytes. Furthermore, knockdown of peroxisome proliferator-activated receptor alpha (PPAR alpha) attenuated IL1Rn induction by PGC-1 alpha. Overexpression of PGC-1 alpha, at least partially through IL1Rn, suppressed interleukin 1 beta-induced expression of acute phase proteins, C-reactive protein, and haptoglobin. Fasting and exercise also induced IL15R alpha expression, whereas glucagon and cAMP resulted in reduction in IL15R alpha mRNA levels. Finally, AMPK activator metformin and adenoviral overexpression of AMPK up-regulated IL1Rn and down-regulated IL15R alpha in primary hepatocytes. We conclude that PGC-1 alpha and AMPK alter inflammatory gene expression in liver and thus integrate energy homeostasis and inflammation. Induction of IL1Rn by PGC-1 alpha and AMPK may be involved in the beneficial effects of exercise and caloric restriction and putative anti-inflammatory effects of metformin.	[Buler, Marcin; Aatsinki, Sanna-Mari; Skoumal, Reka; Kerkela, Risto; Hakkola, Jukka] Univ Oulu, Dept Pharmacol & Toxicol, Inst Biomed, Oulu 90014, Finland; [Skoumal, Reka; Komka, Zsolt; Toth, Miklos] Semmelweis Univ, Dept Hlth Sci & Sports Med, Fac Phys Educ & Sport Sci, H-1085 Budapest, Hungary; [Georgiadi, Anastasia; Kersten, Sander] Wageningen Univ, Nutr Metab & Genom Grp, Div Human Nutr, NL-6703 HD Wageningen, Netherlands	University of Oulu; Semmelweis University; University of Physical Education; Wageningen University & Research	Hakkola, J (corresponding author), Univ Oulu, Dept Pharmacol & Toxicol, Inst Biomed, POB 5000,Aapistie 5B, Oulu 90014, Finland.	jukka.hakkola@oulu.fi	Buler, Marcin/J-8871-2012; Kersten, Sander/A-1116-2011	Kersten, Sander/0000-0003-4488-7734; Hakkola, Jukka/0000-0001-5048-4363	European Union; Academy of Finland [110591]; Sigrid Juselius Foundation; National Development Agency of Hungary [TAMOP 4.2.2-08/01/KMR-2008-004]	European Union(European Commission); Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); National Development Agency of Hungary	This work was supported by grants from the European Union (Marie Curie RTN NucSys), the Academy of Finland (Contract 110591), the Sigrid Juselius Foundation, and the National Development Agency of Hungary (Grant TAMOP 4.2.2-08/01/KMR-2008-004).	Arpiainen S, 2008, TOXICOL APPL PHARM, V232, P135, DOI 10.1016/j.taap.2008.06.001; Baker RG, 2011, CELL METAB, V13, P11, DOI 10.1016/j.cmet.2010.12.008; Bensinger SJ, 2008, NATURE, V454, P470, DOI 10.1038/nature07202; Berglund ED, 2010, AM J PHYSIOL-ENDOC M, V299, pE607, DOI 10.1152/ajpendo.00263.2010; Budagian V, 2006, CYTOKINE GROWTH F R, V17, P259, DOI 10.1016/j.cytogfr.2006.05.001; Bulcao C, 2007, AM J CARDIOVASC DRUG, V7, P219, DOI 10.2165/00129784-200707030-00007; Canto C, 2009, CURR OPIN LIPIDOL, V20, P98, DOI 10.1097/MOL.0b013e328328d0a4; Carstensen M, 2010, DIABETES, V59, P1222, DOI 10.2337/db09-1199; Corton JC, 2005, J GERONTOL A-BIOL, V60, P1494, DOI 10.1093/gerona/60.12.1494; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; De Souza AT, 2006, NUCLEIC ACIDS RES, V34, P4486, DOI 10.1093/nar/gkl609; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Ehses JA, 2009, P NATL ACAD SCI USA, V106, P13998, DOI 10.1073/pnas.0810087106; Estall JL, 2009, P NATL ACAD SCI USA, V106, P22510, DOI 10.1073/pnas.0912533106; Feng F, 2008, ENDOCRINOLOGY, V149, P1505, DOI 10.1210/en.2007-1119; Gaillard S, 2006, MOL CELL, V24, P797, DOI 10.1016/j.molcel.2006.10.012; Handschin C, 2008, NATURE, V454, P463, DOI 10.1038/nature07206; Hardie DG, 2011, GENE DEV, V25, P1895, DOI 10.1101/gad.17420111; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Hoene M, 2009, J PHYSIOL-LONDON, V587, P241, DOI 10.1113/jphysiol.2008.160275; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936; Huang W, 2010, ARTERIOSCL THROM VAS, V30, P1542, DOI 10.1161/ATVBAHA.109.191189; Hummasti S, 2010, CIRC RES, V107, P579, DOI 10.1161/CIRCRESAHA.110.225698; Im SS, 2011, J BIOL CHEM, V286, P1157, DOI 10.1074/jbc.M110.157875; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Kerkela R, 2009, CTS-CLIN TRANSL SCI, V2, P15, DOI 10.1111/j.1752-8062.2008.00090.x; Kuczynski S, 2005, DIABETES RES CLIN PR, V69, P231, DOI 10.1016/j.diabres.2005.02.007; Lamacchia C, 2010, J IMMUNOL, V185, P2516, DOI 10.4049/jimmunol.1000872; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Liu XJ, 2005, BIOINFORMATICS, V21, P3637, DOI 10.1093/bioinformatics/bti583; Liu XJ, 2006, BIOINFORMATICS, V22, P2107, DOI 10.1093/bioinformatics/btl361; Longuet C, 2008, CELL METAB, V8, P359, DOI 10.1016/j.cmet.2008.09.008; Lukic ML, 2003, J AUTOIMMUN, V21, P239, DOI 10.1016/S0896-8411(03)00115-X; Meier CA, 2002, J CLIN ENDOCR METAB, V87, P1184, DOI 10.1210/jc.87.3.1184; Mortier E, 2006, J BIOL CHEM, V281, P1612, DOI 10.1074/jbc.M508624200; Mortier E, 2004, J IMMUNOL, V173, P1681, DOI 10.4049/jimmunol.173.3.1681; Nielsen AR, 2007, J PHYSIOL-LONDON, V584, P305, DOI 10.1113/jphysiol.2007.139618; Perrier S, 2006, FEBS LETT, V580, P6289, DOI 10.1016/j.febslet.2006.10.061; Pickup JC, 1997, DIABETOLOGIA, V40, P1286, DOI 10.1007/s001250050822; Ranhotra HS, 2010, INDIAN J BIOCHEM BIO, V47, P272; Riechman SE, 2004, J APPL PHYSIOL, V97, P2214, DOI 10.1152/japplphysiol.00491.2004; Ruchatz H, 1998, J IMMUNOL, V160, P5654; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Smith XG, 2000, J IMMUNOL, V165, P3444, DOI 10.4049/jimmunol.165.6.3444; Soyal S, 2006, DIABETOLOGIA, V49, P1477, DOI 10.1007/s00125-006-0268-6; Spranger J, 2003, DIABETES, V52, P812, DOI 10.2337/diabetes.52.3.812; STEINKASSERER A, 1992, FEBS LETT, V310, P60, DOI 10.1016/0014-5793(92)81146-D; Stienstra R, 2007, J HEPATOL, V46, P869, DOI 10.1016/j.jhep.2006.11.019; Suwa M, 2008, METABOLISM, V57, P986, DOI 10.1016/j.metabol.2008.02.017; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Zhang PX, 2005, FEBS LETT, V579, P1446, DOI 10.1016/j.febslet.2005.01.046	54	39	43	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2012	287	3					1847	1860		10.1074/jbc.M111.302356	http://dx.doi.org/10.1074/jbc.M111.302356			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879HT	22117073	Green Published, hybrid			2022-12-27	WOS:000299321000026
J	Lee, SG; Kim, Y; Alpert, TD; Nagata, A; Jez, JM				Lee, Soon Goo; Kim, Youngchang; Alpert, Tara D.; Nagata, Akina; Jez, Joseph M.			Structure and Reaction Mechanism of Phosphoethanolamine Methyltransferase from the Malaria Parasite Plasmodium falciparum AN ANTIPARASITIC DRUG TARGET	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCINE N-METHYLTRANSFERASE; GUANIDINOACETATE METHYLTRANSFERASE; PHOSPHATIDYLCHOLINE BIOSYNTHESIS; PHOSPHOCHOLINE BIOSYNTHESIS; CATALYTIC MECHANISM; CRYSTAL-STRUCTURES; METHYL TRANSFER; PATHWAY; MODEL; INHIBITORS	In the malarial parasite Plasmodium falciparum, a multifunctional phosphoethanolamine methyltransferase (PfPMT) catalyzes the methylation of phosphoethanolamine (pEA) to phosphocholine for membrane biogenesis. This pathway is also found in plant and nematodes, but PMT from these organisms use multiple methyltransferase domains for the S-adenosylmethionine (AdoMet) reactions. Because PfPMT is essential for normal growth and survival of Plasmodium and is not found in humans, it is an antiparasitic target. Here we describe the 1.55 angstrom resolution crystal structure of PfPMT in complex with AdoMet by single-wavelength anomalous dispersion phasing. In addition, 1.19-1.52 angstrom resolution structures of PfPMT with pEA (substrate), phosphocholine (product), sinefungin (inhibitor), and both pEA and S-adenosylhomocysteine bound were determined. These structures suggest that domain rearrangements occur upon ligand binding and provide insight on active site architecture defining the AdoMet and phosphobase binding sites. Functional characterization of 27 site-directed mutants identifies critical active site residues and suggests that Tyr-19 and His-132 form a catalytic dyad. Kinetic analysis, isothermal titration calorimetry, and protein crystallography of the Y19F and H132A mutants suggest a reaction mechanism for the PMT. Not only are Tyr-19 and His-132 required for phosphobase methylation, but they also form a "catalytic" latch that locks ligands in the active site and orders the site for catalysis. This study provides the first insight on this antiparasitic target enzyme essential for survival of the malaria parasite; however, further studies of the multidomain PMT from plants and nematodes are needed to understand the evolutionary division of metabolic function in the phosphobase pathway of these organisms.	[Lee, Soon Goo; Alpert, Tara D.; Nagata, Akina; Jez, Joseph M.] Washington Univ, Dept Biol, St Louis, MO 63130 USA; [Kim, Youngchang] Argonne Natl Lab, Adv Photon Source, Argonne, IL 60439 USA; [Nagata, Akina] Knox Coll, Dept Biol, Galesburg, IL 61401 USA	Washington University (WUSTL); United States Department of Energy (DOE); Argonne National Laboratory	Jez, JM (corresponding author), Washington Univ, Dept Biol, 1 Brookings Dr,Campus Box 1137, St Louis, MO 63130 USA.	jjez@biology2.wustl.edu		Lee, Soon Goo/0000-0002-1541-8587; Kim, Youngchang/0000-0002-1610-4889	Washington University; Knox College Howard Hughes Medical Institute (HHMI)-SURF; University of Chicago for the United States Department of Energy Office of Biological and Environmental Research [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI097119] Funding Source: NIH RePORTER	Washington University; Knox College Howard Hughes Medical Institute (HHMI)-SURF; University of Chicago for the United States Department of Energy Office of Biological and Environmental Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by funds from Washington University and the Washington University Summer Undergraduate Research Fellowship Program (to T.D.A.) and from the Knox College Howard Hughes Medical Institute (HHMI)-SURF Program (to A.N.).; Portions of this research were carried out at the Argonne National Laboratory Structural Biology Center of the Advanced Photon Source, a national user facility operated by the University of Chicago for the United States Department of Energy Office of Biological and Environmental Research (Grant DE-AC02-06CH11357).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bobenchik AM, 2011, FEMS MICROBIOL REV, V35, P609, DOI 10.1111/j.1574-6976.2011.00267.x; Bobenchik AM, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-4; Boissier F, 2006, J BIOL CHEM, V281, P4434, DOI 10.1074/jbc.M510250200; Bolognese CP, 2000, PLANT PHYSIOL, V124, P1800, DOI 10.1104/pp.124.4.1800; Brendza KM, 2007, BIOCHEM J, V404, P439, DOI 10.1042/BJ20061815; Calas M, 2000, J MED CHEM, V43, P505, DOI 10.1021/jm9911027; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fu ZJ, 1996, BIOCHEMISTRY-US, V35, P11985, DOI 10.1021/bi961068n; Horton JR, 2001, STRUCTURE, V9, P837, DOI 10.1016/S0969-2126(01)00643-8; Huang CYF, 2002, J BIOL CHEM, V277, P34367, DOI 10.1074/jbc.M202468200; Hunter WN, 2009, J BIOL CHEM, V284, P11749, DOI 10.1074/jbc.R800072200; Jez J.M., 2007, CURR ENZYM INHIB, V3, P133, DOI [10.2174/157340807780598378, DOI 10.2174/157340807780598378]; Jost R, 2009, J BIOL CHEM, V284, P31962, DOI 10.1074/jbc.M109.022657; KENT C, 1995, ANNU REV BIOCHEM, V64, P315, DOI 10.1146/annurev.bi.64.070195.001531; Komoto J, 2004, BIOCHEMISTRY-US, V43, P14385, DOI 10.1021/bi0486785; Komoto J, 2002, J MOL BIOL, V320, P223, DOI 10.1016/S0022-2836(02)00448-5; Lee Soon Goo, 2011, Curr Chem Biol, V5, P183, DOI 10.2174/2212796811105030183; Lee SG, 2011, J BIOL CHEM, V286, P38060, DOI 10.1074/jbc.M111.290619; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7; Nuccio ML, 2000, J BIOL CHEM, V275, P14095, DOI 10.1074/jbc.275.19.14095; Palavalli LH, 2006, BIOCHEMISTRY-US, V45, P6056, DOI 10.1021/bi060199d; Pessi G, 2005, J BIOL CHEM, V280, P12461, DOI 10.1074/jbc.M414626200; Pessi G, 2004, P NATL ACAD SCI USA, V101, P6206, DOI 10.1073/pnas.0307742101; Reynolds JM, 2008, J BIOL CHEM, V283, P7894, DOI 10.1074/jbc.M709869200; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Soriano A, 2006, BIOCHEMISTRY-US, V45, P14917, DOI 10.1021/bi061319k; Takata Y, 2003, BIOCHEMISTRY-US, V42, P8394, DOI 10.1021/bi034245a; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Velichkova P, 2006, J PHYS CHEM B, V110, P16, DOI 10.1021/jp055120d; Velichkova P, 2005, J PHYS CHEM B, V109, P8216, DOI 10.1021/jp0443254; Wengelnik K, 2002, SCIENCE, V295, P1311, DOI 10.1126/science.1067236; *WHO EXP COMM MAL, 2000, WHO TECHN REP SER, V892; Witola WH, 2008, J BIOL CHEM, V283, P27636, DOI 10.1074/jbc.M804360200; Wu Q, 2005, J MED CHEM, V48, P7243, DOI 10.1021/jm050568o	39	38	40	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					1426	1434		10.1074/jbc.M111.315267	http://dx.doi.org/10.1074/jbc.M111.315267			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22117061	hybrid, Green Published			2022-12-27	WOS:000299170300056
J	Ma, LJ; Liu, Y; El-Achkar, TM; Wu, XR				Ma, Lijie; Liu, Yan; El-Achkar, Tarek M.; Wu, Xue-Ru			Molecular and Cellular Effects of Tamm-Horsfall Protein Mutations and Their Rescue by Chemical Chaperones	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							JUVENILE HYPERURICEMIC NEPHROPATHY; 1-FIMBRIATED ESCHERICHIA-COLI; CHRONIC KIDNEY-DISEASE; ENDOPLASMIC-RETICULUM; PHARMACOLOGICAL CHAPERONES; UROMODULIN DISORDERS; ANCHORED COUNTERPART; STONE FORMATION; DEFENSE FACTOR; UMOD GENE	Correct folding of a nascent polypeptide in the lumen of the endoplasmic reticulum (ER) into a three-dimensional conformation is a crucial step in the stability, intracellular trafficking, and targeting to the final destination of a protein. By transiently and stably expressing human-relevant mutants of Tamm-Horsfall protein in polarized Madin-Darby canine kidney cells, we show here that a cysteine-altering mutation in the evolutionally conserved cysteine-rich domain had more severe defects in ER exit and surface translocation and triggered more apoptosis than a cysteine-altering mutation outside the domain. Both mutants were able to specifically bind and trap the wild-type Tamm-Horsfall protein (THP) and prevent it from exiting the ER and translocating to the cell surface. This explains at least partly why in patients with THP-associated diseases there is a marked urinary reduction of both the mutant and the wild-type THP. Exposure of mutant-expressing cells to low temperature (30 degrees C), osmolytes (glycerol, trimethylamine N-oxide, and dimethyl sulfoxide), and the Ca2+-ATP inhibitor thapsigargin only slightly relieved ER retention and increased surface targeting of the mutants. In contrast, sodium 4-phenylbutyrate and probenecid, the latter a uricosuric drug used clinically to treat gout, markedly reduced ER retention of the mutants and increased their surface translocation and secretion into the culture media. The rescue of the THP mutants was associated with the restoration of the level and subcellular localization of cytosolic chaperone HSP70. Our results reveal intricate mechanistic details that may underlie THP-associated diseases and suggest that novel therapeutics enhancing the refolding of THP mutants may be of important value in therapy.	[Wu, Xue-Ru] Vet Affairs New York Harbor Healthcare Syst, New York, NY 10010 USA; [Ma, Lijie; Liu, Yan; Wu, Xue-Ru] NYU, Sch Med, Dept Urol, New York, NY 10016 USA; [Wu, Xue-Ru] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; [El-Achkar, Tarek M.] St Louis Univ, Div Nephrol, St Louis, MO 63108 USA; [El-Achkar, Tarek M.] St Louis Vet Affairs Med Ctr, St Louis, MO 63108 USA	New York University; New York University; Saint Louis University	Wu, XR (corresponding author), NYU, Sch Med, Dept Urol, Vet Affairs Med Ctr Manhattan, 423 E23 St,Rm 18064 S, New York, NY 10010 USA.	xue-ru.wu@med.nyu.edu		Wu, Xue-Ru/0000-0001-6058-6291	National Institutes of Health [DK56903]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056903] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK56903.	Allen S, 2001, BIOCHEM BIOPH RES CO, V280, P448, DOI 10.1006/bbrc.2000.4139; Arakawa T, 2006, BBA-PROTEINS PROTEOM, V1764, P1677, DOI 10.1016/j.bbapap.2006.08.012; Bates JM, 2004, KIDNEY INT, V65, P791, DOI 10.1111/j.1523-1755.2004.00452.x; Bernascone I, 2006, TRAFFIC, V7, P1567, DOI 10.1111/j.1600-0854.2006.00481.x; Bleyer AJ, 2006, ADV CHRONIC KIDNEY D, V13, P124, DOI 10.1053/j.ackd.2006.01.008; Bleyer AJ, 2004, KIDNEY INT, V66, P974, DOI 10.1111/j.1523-1755.2004.00845.x; Bleyer AJ, 2010, SEMIN NEPHROL, V30, P366, DOI 10.1016/j.semnephrol.2010.06.003; Brodsky JL, 2007, BIOCHEM J, V404, P353, DOI 10.1042/BJ20061890; Buckland PR, 2004, HUM MOL GENET, V13, pR255, DOI 10.1093/hmg/ddh227; Cameron JS, 2005, SEMIN NEPHROL, V25, P9, DOI 10.1016/j.semnephrol.2004.09.003; Cavallone D, 2004, J BIOL CHEM, V279, P216, DOI 10.1074/jbc.M308821200; Cavallone D, 2001, BIOCHEM BIOPH RES CO, V280, P110, DOI 10.1006/bbrc.2000.4090; Choi SW, 2005, J AM SOC NEPHROL, V16, P3006, DOI 10.1681/ASN.2005050461; Choo-Kang LR, 2001, AM J PHYSIOL-LUNG C, V281, pL58, DOI 10.1152/ajplung.2001.281.1.L58; Chung Y, 2008, AM J MED SCI, V335, P219, DOI 10.1097/MAJ.0b013e31815acb10; Dahan K, 2003, J AM SOC NEPHROL, V14, P2883, DOI 10.1097/01.ASN.0000092147.83480.B5; Delisle BP, 2003, J BIOL CHEM, V278, P35749, DOI 10.1074/jbc.M305787200; Devuyst O, 2005, NEPHROL DIAL TRANSPL, V20, P1290, DOI 10.1093/ndt/gfh851; Fischer H, 2001, AM J PHYSIOL-LUNG C, V281, pL52, DOI 10.1152/ajplung.2001.281.1.L52; Fukuoka SI, 2001, BIOCHEM BIOPH RES CO, V289, P1044, DOI 10.1006/bbrc.2001.6112; Gong B, 2009, MOL VIS, V15, P2829; Gudbjartsson DF, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001039; Hart TC, 2002, J MED GENET, V39, P882, DOI 10.1136/jmg.39.12.882; Hosoyamada M, 2004, J AM SOC NEPHROL, V15, P261, DOI 10.1097/01.ASN.0000107560.80107.19; Jennings P, 2007, J AM SOC NEPHROL, V18, P264, DOI 10.1681/ASN.2006020158; Jovine L, 2002, NAT CELL BIOL, V4, P457, DOI 10.1038/ncb802; Kottgen A, 2010, J AM SOC NEPHROL, V21, P337, DOI 10.1681/ASN.2009070725; Kottgen A, 2009, NAT GENET, V41, P712, DOI 10.1038/ng.377; KUMAR S, 1990, KIDNEY INT, V37, P1395, DOI 10.1038/ki.1990.128; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Lens XM, 2005, AM J KIDNEY DIS, V46, P52, DOI 10.1053/j.ajkd.2005.04.003; Liu Y, 2010, AM J PHYSIOL-RENAL, V299, pF469, DOI 10.1152/ajprenal.00243.2010; Maattanen P, 2010, SEMIN CELL DEV BIOL, V21, P500, DOI 10.1016/j.semcdb.2010.03.006; Malagolini N, 1997, KIDNEY INT, V52, P1340, DOI 10.1038/ki.1997.459; Mo L, 2004, KIDNEY INT, V66, P1159, DOI 10.1111/j.1523-1755.2004.00867.x; Mo L, 2004, AM J PHYSIOL-RENAL, V286, pF795, DOI 10.1152/ajprenal.00357.2003; Mo L, 2007, AM J PHYSIOL-RENAL, V293, pF1935, DOI 10.1152/ajprenal.00383.2007; Morano KA, 2007, ANN NY ACAD SCI, V1113, P1, DOI 10.1196/annals.1391.018; Morello JP, 2000, TRENDS PHARMACOL SCI, V21, P466, DOI 10.1016/S0165-6147(00)01575-3; Nasr SH, 2008, KIDNEY INT, V73, P971, DOI 10.1038/sj.ki.5002679; Ohashi T, 2003, HISTOCHEM CELL BIOL, V119, P257, DOI 10.1007/s00418-003-0511-x; OJAKIAN GK, 1988, J CELL BIOL, V107, P2377, DOI 10.1083/jcb.107.6.2377; Pak J, 2001, J BIOL CHEM, V276, P9924, DOI 10.1074/jbc.M008610200; Puig JG, 2006, NUCLEOS NUCLEOT NUCL, V25, P1295, DOI 10.1080/15257770600894766; Raffi HS, 2009, J UROLOGY, V181, P2332, DOI 10.1016/j.juro.2009.01.014; Raffi HS, 2005, AM J NEPHROL, V25, P570, DOI 10.1159/000088990; Rampoldi L, 2003, HUM MOL GENET, V12, P3369, DOI 10.1093/hmg/ddg353; Rampoldi L, 2011, KIDNEY INT, V80, P338, DOI 10.1038/ki.2011.134; Rezende-Lima W, 2004, KIDNEY INT, V66, P558, DOI 10.1111/j.1523-1755.2004.00774.x; RINDLER MJ, 1990, J BIOL CHEM, V265, P20784; Robben JH, 2006, MOL BIOL CELL, V17, P379, DOI 10.1091/mbc.E05-06-0579; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Schaeffer C, 2009, MOL BIOL CELL, V20, P589, DOI 10.1091/mbc.E08-08-0876; Scolari F, 2004, AM J KIDNEY DIS, V44, P987, DOI 10.1053/j.ajkd.2004.08.021; Sedor JR, 2010, J AM SOC NEPHROL, V21, P204, DOI 10.1681/ASN.2009121283; Serafini-Cessi F, 2003, AM J KIDNEY DIS, V42, P658, DOI 10.1016/S0272-6386(03)00829-1; Tamarappoo BK, 1998, J CLIN INVEST, V101, P2257, DOI 10.1172/JCI2303; Turner JJO, 2003, J CLIN ENDOCR METAB, V88, P1398, DOI 10.1210/jc.2002-021973; Vylet'al P, 2006, KIDNEY INT, V70, P1155, DOI 10.1038/sj.ki.5001728; Williams SE, 2009, HUM MOL GENET, V18, P2963, DOI 10.1093/hmg/ddp235; Yang HR, 2004, FEBS LETT, V578, P236, DOI 10.1016/j.febslet.2004.10.092; Zaucke F, 2010, HUM MOL GENET, V19, P1985, DOI 10.1093/hmg/ddq077	62	22	23	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					1290	1305		10.1074/jbc.M111.283036	http://dx.doi.org/10.1074/jbc.M111.283036			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22117067	Green Published, hybrid			2022-12-27	WOS:000299170300045
J	Schroder, S; Cho, SY; Zeng, L; Zhang, Q; Kaehlcke, K; Mak, L; Lau, J; Bisgrove, D; Schnolzer, M; Verdin, E; Zhou, MM; Ott, M				Schroeder, Sebastian; Cho, Sungyoo; Zeng, Lei; Zhang, Qiang; Kaehlcke, Katrin; Mak, Lily; Lau, Joann; Bisgrove, Dwayne; Schnoelzer, Martina; Verdin, Eric; Zhou, Ming-Ming; Ott, Melanie			Two-pronged Binding with Bromodomain-containing Protein 4 Liberates Positive Transcription Elongation Factor b from Inactive Ribonucleoprotein Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P-TEFB; HIV-1 TAT; 7SK SNRNA; INTERACTING DOMAIN; BRD4; CHROMATIN; ACETYLATION; RECOGNITION; HEXIM1; EQUILIBRIUM	The positive transcription elongation factor b (P-TEFb) exists in two forms in cells as follows: an inactive form where the core components cyclin T1 and CDK9 are incorporated in the 7SK small nuclear ribonucleoprotein complex containing the inhibitory molecule HEXIM1, and an active form, part of which associates with the bromodomain-containing protein BRD4. Here, we define a novel interaction between P-TEFb and BRD4 involving tri-acetylated cyclin T1 (acK380, acK386, and acK309) and the second bromodomain in BRD4. This interaction is observed with the short splice variant of BRD4 (amino acids 1-722) lacking a previously defined C-terminal P-TEFb-interacting domain (PID). Notably, P-TEFb complexes associated with short BRD4 contain HEXIM1 and 7SK snRNA, implicating the PID in the liberation of P-TEFb from the 7SK small nuclear ribonucleoprotein complex (7SK snPNP). Overexpression of the PID alone in cells dissociates HEXIM1 and 7SK snRNA from P-TEFb, but it is not sufficient to activate P-TEFb-dependent transcription of the HIV LTR. Our data support a model where two BRD4 domains, the second bromodomain and the PID, bind P-TEFb and are required for full transcriptional activation of P-TEFb response genes.	[Schroeder, Sebastian; Cho, Sungyoo; Kaehlcke, Katrin; Mak, Lily; Lau, Joann; Bisgrove, Dwayne; Verdin, Eric; Ott, Melanie] Univ Calif San Francisco, Gladstone Inst Virol & Immunol, San Francisco, CA 94158 USA; [Cho, Sungyoo; Verdin, Eric; Ott, Melanie] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Zeng, Lei; Zhang, Qiang; Zhou, Ming-Ming] Mt Sinai Sch Med, Dept Struct & Chem Biol, New York, NY 10029 USA; [Schnoelzer, Martina] German Canc Res Ctr, D-69120 Heidelberg, Germany	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; Icahn School of Medicine at Mount Sinai; Helmholtz Association; German Cancer Research Center (DKFZ)	Ott, M (corresponding author), Univ Calif San Francisco, Gladstone Inst Virol & Immunol, 1650 Owens St, San Francisco, CA 94158 USA.	mott@gladstone.ucsf.edu	Verdin, Eric/AAB-7999-2019	Verdin, Eric/0000-0003-3703-3183; Ott, Melanie/0000-0002-5697-1274	National Institutes of Health [R01 AI081651]; GIVI-UCSF Center for AIDS Research; Boehringer Ingelheim Fonds; NATIONAL CANCER INSTITUTE [P01CA080058] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081651, P30AI027763] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); GIVI-UCSF Center for AIDS Research; Boehringer Ingelheim Fonds(Boehringer Ingelheim); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AI081651 (to M. O.). This work was also supported by the GIVI-UCSF Center for AIDS Research (to S. C.) and Boehringer Ingelheim Fonds (to S. S.).	Abbate EA, 2006, MOL CELL, V24, P877, DOI 10.1016/j.molcel.2006.11.002; Bisgrovet DA, 2007, P NATL ACAD SCI USA, V104, P13690, DOI 10.1073/pnas.0705053104; Chen RC, 2008, GENE DEV, V22, P1356, DOI 10.1101/gad.1636008; Cho S, 2010, CELL CYCLE, V9, P1697, DOI 10.4161/cc.9.9.11346; Cho SY, 2009, EMBO J, V28, P1407, DOI 10.1038/emboj.2009.99; Contreras X, 2007, PLOS PATHOG, V3, P1459, DOI 10.1371/journal.ppat.0030146; Dames SA, 2007, P NATL ACAD SCI USA, V104, P14312, DOI 10.1073/pnas.0701848104; Dey A, 2003, P NATL ACAD SCI USA, V100, P8758, DOI 10.1073/pnas.1433065100; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; Florence B, 2001, FRONT BIOSCI-LANDMRK, V6, pD1008, DOI 10.2741/Florence; French CA, 2003, CANCER RES, V63, P304; He NH, 2006, MOL CELL BIOL, V26, P7068, DOI 10.1128/MCB.00778-06; He NH, 2010, MOL CELL, V38, P428, DOI 10.1016/j.molcel.2010.04.013; Houzelstein D, 2002, MOL CELL BIOL, V22, P3794, DOI 10.1128/MCB.22.11.3794-3802.2002; Jacobson RH, 2000, SCIENCE, V288, P1422, DOI 10.1126/science.288.5470.1422; Jang MK, 2005, MOL CELL, V19, P523, DOI 10.1016/j.molcel.2005.06.027; Jiang YW, 1998, P NATL ACAD SCI USA, V95, P8538, DOI 10.1073/pnas.95.15.8538; Krueger BJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012335; Michels AA, 2004, EMBO J, V23, P2608, DOI 10.1038/sj.emboj.7600275; Moriniere J, 2009, NATURE, V461, P664, DOI 10.1038/nature08397; Myers LC, 2000, ANNU REV BIOCHEM, V69, P729, DOI 10.1146/annurev.biochem.69.1.729; Nakamura Y, 2007, J BIOL CHEM, V282, P4193, DOI 10.1074/jbc.M605971200; Ott M, 1999, CURR BIOL, V9, P1489, DOI 10.1016/S0960-9822(00)80120-7; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Qiang Z, 2006, MICROBIOL MOL BIOL R, V70, P646, DOI 10.1128/MMBR.00011-06; Reynoird N, 2010, EMBO J, V29, P2943, DOI 10.1038/emboj.2010.176; Saunders A, 2006, NAT REV MOL CELL BIO, V7, P557, DOI 10.1038/nrm1981; Smith JA, 2010, P NATL ACAD SCI USA, V107, P3752, DOI 10.1073/pnas.0914818107; Sobhian B, 2010, MOL CELL, V38, P439, DOI 10.1016/j.molcel.2010.04.012; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Urano E, 2008, FEBS LETT, V582, P4053, DOI 10.1016/j.febslet.2008.10.047; VanLint C, 1997, J VIROL, V71, P6113, DOI 10.1128/JVI.71.8.6113-6127.1997; Vollmuth F, 2009, J BIOL CHEM, V284, P36547, DOI 10.1074/jbc.M109.033712; Wade JT, 2008, CURR OPIN GENET DEV, V18, P130, DOI 10.1016/j.gde.2007.12.008; Wang Y, 2008, J BIOL CHEM, V283, P33578, DOI 10.1074/jbc.M807495200; Wu SY, 2006, GENE DEV, V20, P2383, DOI 10.1101/gad.1448206; Wu SY, 2007, J BIOL CHEM, V282, P13141, DOI 10.1074/jbc.R700001200; Yang ZY, 2005, MOL CELL, V19, P535, DOI 10.1016/j.molcel.2005.06.029; Yik JHN, 2003, MOL CELL, V12, P971, DOI 10.1016/S1097-2765(03)00388-5; Zeng L, 2008, STRUCTURE, V16, P643, DOI 10.1016/j.str.2008.01.010; Zippo A, 2009, CELL, V138, P1122, DOI 10.1016/j.cell.2009.07.031	41	123	140	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					1090	1099		10.1074/jbc.M111.282855	http://dx.doi.org/10.1074/jbc.M111.282855			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22084242	hybrid, Green Published			2022-12-27	WOS:000299170300025
J	Yu, X; Liu, Y; Xie, XL; Zheng, XD; Li, SM				Yu, Xia; Liu, Yan; Xie, Xiulan; Zheng, Xiao-Dong; Li, Shu-Ming			Biochemical Characterization of Indole Prenyltransferases FILLING THE LAST GAP OF PRENYLATION POSITIONS BY A 5-DIMETHYLALLYLTRYPTOPHAN SYNTHASE FROM ASPERGILLUS CLAVATUS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIOSYNTHETIC GENE-CLUSTER; ASPERGILLUS-FUMIGATUS; 4-DIMETHYLALLYLTRYPTOPHAN SYNTHASE; 7-DIMETHYLALLYLTRYPTOPHAN SYNTHASE; DIMETHYLALLYLTRYPTOPHAN SYNTHASE; DERIVATIVES; ALKALOIDS; PURIFICATION; OVERPRODUCTION; PRENYLATION	The putative prenyltransferase gene ACLA_031240 belonging to the dimethylallyltryptophan synthase superfamily was identified in the genome sequence of Aspergillus clavatus and overexpressed in Escherichia coli. The soluble His-tagged protein EAW08391 was purified to near homogeneity and used for biochemical investigation with diverse aromatic substrates in the presence of different prenyl diphosphates. It has shown that in the presence of dimethylallyl diphosphate (DMAPP), the recombinant enzyme accepted very well simple indole derivatives with L-tryptophan as the best substrate. Product formation was also observed for tryptophan-containing cyclic dipeptides but with much lower conversion yields. In contrast, no product formation was detected in the reaction mixtures of L-tryptophan with geranyl or farnesyl diphosphate. Structure elucidation of the enzyme products by NMR and MS analyses proved unequivocally the highly regiospecific regular prenylation at C-5 of the indole nucleus of the simple indole derivatives. EAW08391 was therefore termed 5-dimethylallyltryptophan synthase, and it filled the last gap in the toolbox of indole prenyltransferases regarding their prenylation positions. K-m values of 5-dimethylallyltryptophan synthase were determined for L-tryptophan and DMAPP at 34 and 76 mu M, respectively. Average turnover number (k(cat)) at 1.1 s(-1) was calculated from kinetic data of L-tryptophan and DMAPP. Catalytic efficiencies of 5-dimethylallyltryptophan synthase for L-tryptophan at 25,588 s(-1).M-1 and for other 11 simple indole derivatives up to 1538 s(-1).M-1 provided evidence for its potential usage as a catalyst for chemoenzymatic synthesis.	[Yu, Xia; Liu, Yan; Li, Shu-Ming] Univ Marburg, Inst Pharmazeut Biol & Biotechnol, D-35037 Marburg, Germany; [Zheng, Xiao-Dong] Zhejiang Univ, Dept Food Sci & Nutr, Hangzhou 310058, Zhejiang, Peoples R China; [Xie, Xiulan] Univ Marburg, Fachbereich Chem, D-35032 Marburg, Germany	Philipps University Marburg; Zhejiang University; Philipps University Marburg	Li, SM (corresponding author), Univ Marburg, Inst Pharmazeut Biol & Biotechnol, Deutschhausstr 17A, D-35037 Marburg, Germany.	shuming.li@staff.uni-marburg.de			Deutsche Forschungsgemeinschaft [Li844/4-1]; Deutscher Akademischer Austauschdienst, Programme des Projektbezogenen Personenaustauschs; China Scholarship Council for fellowships	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutscher Akademischer Austauschdienst, Programme des Projektbezogenen Personenaustauschs(Deutscher Akademischer Austausch Dienst (DAAD)); China Scholarship Council for fellowships	This work was supported in part by Deutsche Forschungsgemeinschaft Grant Li844/4-1 (to S.-M.L.) and by the Deutscher Akademischer Austauschdienst within the Programme des Projektbezogenen Personenaustauschs.; Recipient of a Ph.D. scholarship from the China Scholarship Council for fellowships.	ACHENBACH H, 1995, LIEBIGS ANN, P1327; Balibar CJ, 2007, NAT CHEM BIOL, V3, P584, DOI 10.1038/nchembio.2007.20; BELOFSKY GN, 1995, TETRAHEDRON, V51, P3959, DOI 10.1016/0040-4020(95)00138-X; Berger S, 2004, 200 MORE NMR EXPT PR, P1; Cleveland TE, 2009, TRENDS BIOTECHNOL, V27, P151, DOI 10.1016/j.tibtech.2008.11.008; Ding YS, 2008, J BIOL CHEM, V283, P16068, DOI 10.1074/jbc.M801991200; Ding YS, 2010, J AM CHEM SOC, V132, P12733, DOI 10.1021/ja1049302; Edwards DJ, 2004, J AM CHEM SOC, V126, P11432, DOI 10.1021/ja047876g; Fredenhagen A, 1997, J ANTIBIOT, V50, P395, DOI 10.7164/antibiotics.50.395; Fujimoto K, 1999, CHEM PHARM BULL, V47, P1426; Grundmann A, 2005, MICROBIOL-SGM, V151, P2199, DOI 10.1099/mic.0.27962-0; Grundmann A, 2008, CHEMBIOCHEM, V9, P2059, DOI 10.1002/cbic.200800240; Heide L, 2009, CURR OPIN CHEM BIOL, V13, P171, DOI 10.1016/j.cbpa.2009.02.020; Kremer A, 2008, APPL MICROBIOL BIOT, V79, P951, DOI 10.1007/s00253-008-1505-3; Kremer A, 2007, MICROBIOL-SGM, V153, P3409, DOI 10.1099/mic.0.2007/009019-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li SM, 2010, NAT PROD REP, V27, P57, DOI 10.1039/b909987p; Li SM, 2009, PHYTOCHEMISTRY, V70, P1746, DOI 10.1016/j.phytochem.2009.03.019; Li SM, 2009, APPL MICROBIOL BIOT, V84, P631, DOI 10.1007/s00253-009-2128-z; Liang PH, 2009, BIOCHEMISTRY-US, V48, P6562, DOI 10.1021/bi900371p; Lindel T, 2012, TOP CURR CHEM, V309, P67, DOI 10.1007/128_2011_204; Liu XY, 2009, BIOCHEMISTRY-US, V48, P11032, DOI 10.1021/bi901597j; Machida M, 2005, NATURE, V438, P1157, DOI 10.1038/nature04300; Markert A, 2008, PLANT PHYSIOL, V147, P296, DOI 10.1104/pp.108.116699; Nielsen KF, 2003, J CHROMATOGR A, V1002, P111, DOI 10.1016/S0021-9673(03)00490-4; Ooike M, 1997, CAN J CHEM, V75, P625, DOI 10.1139/v97-075; Peters L, 2002, J NAT PROD, V65, P1633, DOI 10.1021/np0105984; Ruiz-Sanchis P, 2011, CHEM-EUR J, V17, P1388, DOI 10.1002/chem.201001451; Sacchettini JC, 1997, SCIENCE, V277, P1788, DOI 10.1126/science.277.5333.1788; Schardl CL, 2006, ALKALOIDS-CHEM BIOL, V63, P45, DOI 10.1016/S1099-4831(06)63002-2; Schultz AW, 2010, J NAT PROD, V73, P373, DOI 10.1021/np9006876; Sings Heather, 2003, Alkaloids Chem Biol, V60, P51, DOI 10.1016/S0099-9598(03)60002-7; Steffan N, 2009, CURR MED CHEM, V16, P218, DOI 10.2174/092986709787002772; Steffan N, 2007, CHEMBIOCHEM, V8, P1298, DOI 10.1002/cbic.200700107; Steffan N, 2009, ARCH MICROBIOL, V191, P461, DOI 10.1007/s00203-009-0467-x; Steiner U, 2011, MYCOLOGIA, V103, P1133, DOI 10.3852/11-031; Takahashi S, 2010, J BACTERIOL, V192, P2839, DOI 10.1128/JB.01557-09; Turunen M, 2004, BBA-BIOMEMBRANES, V1660, P171, DOI 10.1016/j.bbamem.2003.11.012; Uhlig S, 2009, J AGR FOOD CHEM, V57, P11112, DOI 10.1021/jf902208w; Unsold IA, 2006, CHEMBIOCHEM, V7, P158, DOI 10.1002/cbic.200500318; Unsold IA, 2005, MICROBIOL-SGM, V151, P1499, DOI 10.1099/mic.0.27759-0; Wallwey C, 2011, NAT PROD REP, V28, P496, DOI 10.1039/c0np00060d; Wang WL, 2007, J NAT PROD, V70, P1558, DOI 10.1021/np070208z; Williams RM, 2000, TOP CURR CHEM, V209, P97; WOODSIDE AB, 1988, ORG SYNTH, V66, P211; Xu MJ, 2007, TETRAHEDRON, V63, P435, DOI 10.1016/j.tet.2006.10.050; Yazaki K, 2009, PHYTOCHEMISTRY, V70, P1739, DOI 10.1016/j.phytochem.2009.08.023; Yin WB, 2010, ORG BIOMOL CHEM, V8, P2430, DOI 10.1039/c000587h; Yin WB, 2009, J BIOL CHEM, V284, P100, DOI 10.1074/jbc.M807606200; Yu X, 2011, CHEMBIOCHEM, V12, P2280, DOI 10.1002/cbic.201100413; Yu X, 2011, APPL MICROBIOL BIOT, V92, P737, DOI 10.1007/s00253-011-3351-y; Zou HX, 2010, ORG BIOMOL CHEM, V8, P3037, DOI 10.1039/c002850a	52	64	65	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					1371	1380		10.1074/jbc.M111.317982	http://dx.doi.org/10.1074/jbc.M111.317982			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22123822	Green Submitted, hybrid, Green Published			2022-12-27	WOS:000299170300051
J	Baek, JY; Han, SH; Sung, SH; Lee, HE; Kim, YM; Noh, H; Bae, SH; Rhee, SG; Chang, TS				Baek, Jin Young; Han, Sun Hee; Sung, Su Haeng; Lee, Hye Eun; Kim, Yu-Mi; Noh, Hyun; Bae, Soo Han; Rhee, Sue Goo; Chang, Tong-Shin			Sulfiredoxin Protein Is Critical for Redox Balance and Survival of Cells Exposed to Low Steady-state Levels of H2O2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE-SULFINIC ACID; HYDROGEN-PEROXIDE; ACTIVE-SITE; INTRACELLULAR MESSENGER; OXIDATIVE STRESS; TARGET GENE; PEROXIREDOXIN; REDUCTION; INACTIVATION; MITOCHONDRIA	Sulfiredoxin (Srx) is an enzyme that catalyzes the reduction of cysteine sulfinic acid of hyperoxidized peroxiredoxins (Prxs). Having high affinity toward H2O2, 2-Cys Prxs can efficiently reduce H2O2 at low concentration. We previously showed that Prx I is hyperoxidized at a rate of 0.072% per turnover even in the presence of low steady-state levels of H2O2. Here we examine the novel role of Srx in cells exposed to low steady-state levels of H2O2, which can be achieved by using glucose oxidase. Exposure of low steady-state levels of H2O2 (10-20 mu M) to A549 or wild-type mouse embryonic fibroblast (MEF) cells does not lead to any significant change in oxidative injury because of the maintenance of balance between H2O2 production and elimination. In contrast, loss-of-function studies using Srx-depleted A549 and Srx(-/-) MEF cells demonstrate a dramatic increase in extra-and intracellular H2O2, sulfinic 2-Cys Prxs, and apoptosis. Concomitant with hyperoxidation of mitochondrial Prx III, Srx-depleted cells show an activation of mitochondria-mediated apoptotic pathways including mitochondria membrane potential collapse, cytochrome c release, and caspaseactivation. Furthermore, adenoviralre-expressionofSrxin Srx-depleted A549 or Srx(-/-) MEF cells promotes the reactivation of sulfinic 2-Cys Prxs and results in cellular resistance to apoptosis, with enhanced removal of H2O2. These results indicate that Srx functions as a novel component to maintain the balance between H2O2 production and elimination and then protects cells from apoptosis even in the presence of low steady-state levels of H2O2.	[Baek, Jin Young; Han, Sun Hee; Sung, Su Haeng; Lee, Hye Eun; Kim, Yu-Mi; Noh, Hyun; Bae, Soo Han; Rhee, Sue Goo; Chang, Tong-Shin] Ewha Womans Univ, Div Life & Pharmaceut Sci, Seoul 120750, South Korea; [Baek, Jin Young; Han, Sun Hee; Sung, Su Haeng; Lee, Hye Eun; Kim, Yu-Mi; Noh, Hyun; Bae, Soo Han; Rhee, Sue Goo; Chang, Tong-Shin] Ewha Womans Univ, Ctr Cell Signaling & Drug Discovery Res, Seoul 120750, South Korea; [Chang, Tong-Shin] Ewha Womans Univ, Coll Pharm, Seoul 120750, South Korea	Ewha Womans University; Ewha Womans University; Ewha Womans University	Chang, TS (corresponding author), Ewha Womans Univ, Div Life & Pharmaceut Sci, Sci Bldg C,Rm 208,52 Ewhayeodae Gil, Seoul 120750, South Korea.	changts@ewha.ac.kr			Bio RD Program [M10642040002-07N4204-00210]; National Core Research Center through the National Research Foundation of Korea [2011-0006244]; Korea government (Ministry of Education, Science and Technology (MEST)); Brain Korea 21 Scholars Program	Bio RD Program; National Core Research Center through the National Research Foundation of Korea(National Research Foundation of Korea); Korea government (Ministry of Education, Science and Technology (MEST))(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Brain Korea 21 Scholars Program(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea)	This work was supported by Bio R&D Program Grant M10642040002-07N4204-00210, National Core Research Center Program Grant 2011-0006244 through the National Research Foundation of Korea funded by the Korea government (Ministry of Education, Science and Technology (MEST)), and the Brain Korea 21 Scholars Program (to J. Y. B., S. H. H., and Y. H. N.).	Bae SH, 2009, ANTIOXID REDOX SIGN, V11, P937, DOI [10.1089/ars.2008.2325, 10.1089/ARS.2008.2325]; Bae SH, 2011, HEPATOLOGY, V53, P945, DOI 10.1002/hep.24104; Biteau B, 2003, NATURE, V425, P980, DOI 10.1038/nature02075; Chang TS, 2004, J BIOL CHEM, V279, P50994, DOI 10.1074/jbc.M409482200; Chang TS, 2004, J BIOL CHEM, V279, P41975, DOI 10.1074/jbc.M407707200; Finkel T, 1998, CURR OPIN CELL BIOL, V10, P248, DOI 10.1016/S0955-0674(98)80147-6; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Flohe Leopold, 2007, V44, P1; Gay CA, 2002, ANAL BIOCHEM, V304, P42, DOI 10.1006/abio.2001.5566; Giorgio M, 2007, NAT REV MOL CELL BIO, V8, p722A; Hall A, 2011, ANTIOXID REDOX SIGN, V15, P795, DOI 10.1089/ars.2010.3624; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Kang SW, 1998, J BIOL CHEM, V273, P6297, DOI 10.1074/jbc.273.11.6297; Kim H, 2010, J BIOL CHEM, V285, P34419, DOI 10.1074/jbc.M110.126839; Lei K, 2008, ONCOGENE, V27, P4877, DOI 10.1038/onc.2008.132; Ott M, 2002, P NATL ACAD SCI USA, V99, P1259, DOI 10.1073/pnas.241655498; Poole LB, 2008, CURR OPIN CHEM BIOL, V12, P18, DOI 10.1016/j.cbpa.2008.01.021; Rabilloud T, 2002, J BIOL CHEM, V277, P19396, DOI 10.1074/jbc.M106585200; Rhee S G, 2000, Sci STKE, V2000, ppe1; Rhee SG, 2005, CURR OPIN CELL BIOL, V17, P183, DOI 10.1016/j.ceb.2005.02.004; Rhee SG, 1999, EXP MOL MED, V31, P53, DOI 10.1038/emm.1999.9; Rhee SG, 2001, IUBMB LIFE, V52, P35, DOI 10.1080/15216540252774748; Scaduto RC, 1999, BIOPHYS J, V76, P469, DOI 10.1016/S0006-3495(99)77214-0; Schroder E, 2000, STRUCTURE, V8, P605, DOI 10.1016/S0969-2126(00)00147-7; Singh A, 2009, FREE RADICAL BIO MED, V46, P376, DOI 10.1016/j.freeradbiomed.2008.10.026; Suzuki YJ, 1999, J MOL CELL CARDIOL, V31, P345, DOI 10.1006/jmcc.1998.0872; Wei QO, 2011, P NATL ACAD SCI USA, V108, P7004, DOI 10.1073/pnas.1013012108; Wei Q, 2008, P NATL ACAD SCI USA, V105, P19738, DOI 10.1073/pnas.0810676105; Woo HA, 2005, J BIOL CHEM, V280, P3125, DOI 10.1074/jbc.C400496200; Woo HA, 2003, J BIOL CHEM, V278, P47361, DOI 10.1074/jbc.C300428200; Woo HA, 2003, SCIENCE, V300, P653, DOI 10.1126/science.1080273; Yang KS, 2002, J BIOL CHEM, V277, P38029, DOI 10.1074/jbc.M206626200	32	53	57	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					81	89		10.1074/jbc.M111.316711	http://dx.doi.org/10.1074/jbc.M111.316711			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22086924	Green Published, hybrid			2022-12-27	WOS:000298682400011
J	Ding, J; Polier, G; Kohler, R; Giaisi, M; Krammer, PH; Li-Weber, M				Ding, Jie; Polier, Gernot; Koehler, Rebecca; Giaisi, Marco; Krammer, Peter H.; Li-Weber, Min			Wogonin and Related Natural Flavones Overcome Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL) Protein Resistance of Tumors by Down-regulation of c-FLIP Protein and Up-regulation of TRAIL Receptor 2 Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; T-CELL LEUKEMIA; ENDOPLASMIC-RETICULUM STRESS; IN-VITRO; MEDIATED APOPTOSIS; GENE-EXPRESSION; TARGET; DEATH; P53; PATHWAY	Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is a promising anticancer agent that kills various tumor cells without damaging normal tissues. However, many cancers remain resistant to TRAIL. To overcome TRAIL resistance, combination therapies using sensitizers of the TRAIL pathway would be an efficacious approach. To investigate potential sensitizers of TRAIL-induced apoptosis, we used TRAIL-resistant human T cell leukemia virus type 1 (HTLV-1)-associated adult T cell leukemia/lymphoma (ATL) cells as a model system. So far, HTLV-1-associated ATL is incurable by presently known therapies. Here, we show that wogonin and the structurally related natural flavones apigenin and chrysin break TRAIL resistance in HTLV-1-associated ATL by transcriptional down-regulation of c-FLIP, a key inhibitor of death receptor signaling, and by up-regulation of TRAIL receptor 2 (TRAIL-R2). This effect is mediated through transcriptional inhibition of the p53 antagonist murine double minute 2(Mdm2), leading to an increase in p53 levels and, consequently, to up-regulation of the p53 target gene TRAIL-R2. We also show that these flavones can sensitize to TNF alpha- and CD95-mediated cell death. Furthermore, we show that wogonin, apigenin, and chrysin also enhance TRAIL-mediated apoptosis in other human cancer cell lines including breast cancer cell line MDA-MB-231, colon cancer cell line HT-29, hepatocellular carcinoma cell line HepG2, melanoma cell line SK-MEL-37, and pancreatic carcinoma cell line Capan-1 by the same mechanism. Thus, our study suggests the potential use of these flavones as an adjuvant for TRAIL-mediated anticancer therapy.	[Ding, Jie; Polier, Gernot; Koehler, Rebecca; Giaisi, Marco; Krammer, Peter H.; Li-Weber, Min] German Canc Res Ctr, Tumor Immunol Program D030, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ)	Li-Weber, M (corresponding author), German Canc Res Ctr, Tumor Immunol Program D030, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.	m.li-weber@dkfz-heidelberg.de			Helmholtz Alliance on Immunotherapy of Cancer in the Helmholtz Association	Helmholtz Alliance on Immunotherapy of Cancer in the Helmholtz Association	This work was supported by the Helmholtz Alliance on Immunotherapy of Cancer in the Helmholtz Association.	Baumann S, 2008, BLOOD, V111, P2354, DOI 10.1182/blood-2007-06-096198; Baumbusch LO, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-47; Chang LF, 2006, CELL, V124, P601, DOI 10.1016/j.cell.2006.01.021; Chung HY, 2008, INT J CANCER, V122, P816, DOI 10.1002/ijc.23182; Eckelman BP, 2006, EMBO REP, V7, P988, DOI 10.1038/sj.embor.7400795; Enoksson M, 2004, J BIOL CHEM, V279, P49575, DOI 10.1074/jbc.C400374200; Fas SC, 2006, BLOOD, V108, P3700, DOI 10.1182/blood-2006-03-011973; Fricker M, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.38; Gomes NP, 2010, GENE DEV, V24, P111, DOI 10.1101/gad.1893610; Itahana K, 2007, CANCER CELL, V12, P355, DOI 10.1016/j.ccr.2007.09.007; Johnstone RW, 2008, NAT REV CANCER, V8, P782, DOI 10.1038/nrc2465; Krammer PH, 2007, NAT REV IMMUNOL, V7, P532, DOI 10.1038/nri2115; Kreuz S, 2001, MOL CELL BIOL, V21, P3964, DOI 10.1128/MCB.21.12.3964-3973.2001; Krueger A, 2006, BLOOD, V107, P3933, DOI 10.1182/blood-2005-06-2567; Lawrence D, 2001, NAT MED, V7, P383, DOI 10.1038/86397; Lu N, 2008, LIFE SCI, V82, P956, DOI 10.1016/j.lfs.2008.02.013; Manfredi JJ, 2010, GENE DEV, V24, P1580, DOI 10.1101/gad.1941710; Marine JC, 2010, CELL DEATH DIFFER, V17, P93, DOI 10.1038/cdd.2009.68; Matsuoka M, 2007, NAT REV CANCER, V7, P270, DOI 10.1038/nrc2111; McCullough KD, 2001, MOL CELL BIOL, V21, P1249, DOI 10.1128/MCB.21.4.1249-1259.2001; Micheau O, 2001, MOL CELL BIOL, V21, P5299, DOI 10.1128/MCB.21.16.5299-5305.2001; MIYOSHI I, 1981, GANN, V72, P978; Okamoto K, 2006, GENES CELLS, V11, P177, DOI 10.1111/j.1365-2443.2006.00927.x; Osman F, 2008, J VIROL METHODS, V154, P69, DOI 10.1016/j.jviromet.2008.09.005; Peng J, 2009, J ETHNOPHARMACOL, V124, P257, DOI 10.1016/j.jep.2009.04.031; Polier G, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.66; Poukkula M, 2005, J BIOL CHEM, V280, P27345, DOI 10.1074/jbc.M504019200; Proksch P, 2005, J IMMUNOL, V174, P7075, DOI 10.4049/jimmunol.174.11.7075; Qi Q, 2009, PHYTOTHER RES, V23, P417, DOI 10.1002/ptr.2645; Robertson JD, 2004, EMBO REP, V5, P643, DOI 10.1038/sj.embor.7400153; Romano G, 2008, CELL CYCLE, V7, P3664, DOI 10.4161/cc.7.23.7122; ROWE T, 1995, LEUKEMIA RES, V19, P621, DOI 10.1016/0145-2126(95)00030-R; Salvesen GS, 2002, NAT REV MOL CELL BIO, V3, P401, DOI 10.1038/nrm830; Scaffidi C, 1997, J BIOL CHEM, V272, P26953, DOI 10.1074/jbc.272.43.26953; Sun MM, 2008, ONCOL REP, V19, P177; Takimoto R, 2000, ONCOGENE, V19, P1735, DOI 10.1038/sj.onc.1203489; Walczak H, 1999, NAT MED, V5, P157, DOI 10.1038/5517; Wang S, 2008, TRENDS PHARMACOL SCI, V29, P302, DOI 10.1016/j.tips.2008.03.003; Wang W, 2006, BIOL PHARM BULL, V29, P1132, DOI 10.1248/bpb.29.1132; Wilda M, 2004, LEUKEMIA, V18, P584, DOI 10.1038/sj.leu.2403254; Wuchter C, 2001, LEUKEMIA, V15, P921, DOI 10.1038/sj.leu.2402131; Yamaguchi H, 2004, J BIOL CHEM, V279, P45495, DOI 10.1074/jbc.M406933200; Yang JK, 2008, YONSEI MED J, V49, P19, DOI 10.3349/ymj.2008.49.1.19; Yoshida T, 2001, FEBS LETT, V507, P381, DOI 10.1016/S0014-5793(01)02947-7	44	67	73	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					641	649		10.1074/jbc.M111.286526	http://dx.doi.org/10.1074/jbc.M111.286526			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22086925	Green Published, hybrid			2022-12-27	WOS:000298682400062
J	Ghosh, AK; Rossi, ML; Singh, DK; Dunn, C; Ramamoorthy, M; Croteau, DL; Liu, Y; Bohr, VA				Ghosh, Avik K.; Rossi, Marie L.; Singh, Dharmendra Kumar; Dunn, Christopher; Ramamoorthy, Mahesh; Croteau, Deborah L.; Liu, Yie; Bohr, Vilhelm A.			RECQL4, the Protein Mutated in Rothmund-Thomson Syndrome, Functions in Telomere Maintenance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; MAMMALIAN TELOMERES; HOMOLOGOUS RECOMBINATION; CANCER PREDISPOSITION; SYNDROME HELICASE; GENOTOXIC AGENTS; BLM HELICASE; REPLICATION; TRF1; INITIATION	Telomeres are structures at the ends of chromosomes and are composed of long tracks of short tandem repeat DNA sequences bound by a unique set of proteins (shelterin). Telomeric DNA is believed to form G-quadruplex and D-loop structures, which presents a challenge to the DNA replication and repair machinery. Although the RecQ helicases WRN and BLM are implicated in the resolution of telomeric secondary structures, very little is known about RECQL4, the RecQ helicase mutated in Rothmund-Thomson syndrome (RTS). Here, we report that RTS patient cells have elevated levels of fragile telomeric ends and that RECQL4-depleted human cells accumulate fragile sites, sister chromosome exchanges, and double strand breaks at telomeric sites. Further, RECQL4 localizes to telomeres and associates with shelterin proteins TRF1 and TRF2. Using recombinant proteins we showed that RECQL4 resolves telomeric D-loop structures with the help of shelterin proteins TRF1, TRF2, and POT1. We also found a novel functional synergistic interaction of this protein with WRN during D-loop unwinding. These data implicate RECQL4 in telomere maintenance.	[Ghosh, Avik K.; Rossi, Marie L.; Singh, Dharmendra Kumar; Dunn, Christopher; Ramamoorthy, Mahesh; Croteau, Deborah L.; Liu, Yie; Bohr, Vilhelm A.] NIA, Lab Mol Gerontol, Biomed Res Ctr, NIH, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Bohr, VA (corresponding author), NIA, Lab Mol Gerontol, Biomed Res Ctr, NIH, 251 Bayview Blvd, Baltimore, MD 21224 USA.	vbohr@nih.gov	Croteau, Deb/AAP-5933-2020; Liu, Yie/AAO-2092-2020; Bohr, Vilhelm/AAP-5931-2020	Ramamoorthy, Mahesh/0000-0002-2359-5647; Dunn, Christopher/0000-0001-7899-0110; Croteau, Deborah/0000-0002-6094-4084	National Institutes of Health NIA; NATIONAL INSTITUTE ON AGING [ZIAAG000749, ZIAAG000754, ZIAAG000744, ZIAAG000726] Funding Source: NIH RePORTER	National Institutes of Health NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by the National Institutes of Health NIA Intramural Program.	Bailey SM, 2004, NUCLEIC ACIDS RES, V32, P3743, DOI 10.1093/nar/gkh691; Bohr VA, 2008, TRENDS BIOCHEM SCI, V33, P609, DOI 10.1016/j.tibs.2008.09.003; Brosh RM, 2000, NUCLEIC ACIDS RES, V28, P2420, DOI 10.1093/nar/28.12.2420; Cabral REC, 2008, MUTAT RES-FUND MOL M, V643, P41, DOI 10.1016/j.mrfmmm.2008.06.002; Chen Y, 2008, SCIENCE, V319, P1092, DOI 10.1126/science.1151804; Chu WK, 2009, NAT REV CANCER, V9, P644, DOI 10.1038/nrc2682; de Lange T, 2004, NAT REV MOL CELL BIO, V5, P323, DOI 10.1038/nrm1359; de Lange T, 2002, ONCOGENE, V21, P532, DOI 10.1038/sj.onc.1205080; Ghosh A, 2009, J BIOL CHEM, V284, P31074, DOI 10.1074/jbc.M109.027532; Gilson E, 2007, NAT REV MOL CELL BIO, V8, P825, DOI 10.1038/nrm2259; Glover TW, 2005, HUM MOL GENET, V14, pR197, DOI 10.1093/hmg/ddi265; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; Hagelstrom RT, 2010, P NATL ACAD SCI USA, V107, P15768, DOI 10.1073/pnas.1006338107; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Hickson ID, 2003, NAT REV CANCER, V3, P169, DOI 10.1038/nrc1012; Hoki Y, 2003, HUM MOL GENET, V12, P2293, DOI 10.1093/hmg/ddg254; Jin WD, 2008, HUM GENET, V123, P643, DOI 10.1007/s00439-008-0518-4; Karow JK, 1999, CURR BIOL, V9, P597, DOI 10.1016/S0960-9822(99)80264-4; Kitao S, 1999, NAT GENET, V22, P82, DOI 10.1038/8788; Larizza L, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-2; Lei M, 2004, NAT STRUCT MOL BIOL, V11, P1223, DOI 10.1038/nsmb867; Lillard-Wetherell K, 2004, HUM MOL GENET, V13, P1919, DOI 10.1093/hmg/ddh193; Lingner J, 1997, SCIENCE, V276, P561, DOI 10.1126/science.276.5312.561; Liu FJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011152; Liu YL, 2010, DNA REPAIR, V9, P325, DOI 10.1016/j.dnarep.2010.01.006; Mann MB, 2005, HUM MOL GENET, V14, P813, DOI 10.1093/hmg/ddi075; Martinez P, 2009, GENE DEV, V23, P2060, DOI 10.1101/gad.543509; Matsuno K, 2006, MOL CELL BIOL, V26, P4843, DOI 10.1128/MCB.02267-05; Mohaghegh P, 2001, HUM MOL GENET, V10, P741, DOI 10.1093/hmg/10.7.741; Opresko PL, 2004, MOL CELL, V14, P763, DOI 10.1016/j.molcel.2004.05.023; Opresko PL, 2005, J BIOL CHEM, V280, P32069, DOI 10.1074/jbc.M505211200; Opresko PL, 2002, J BIOL CHEM, V277, P41110, DOI 10.1074/jbc.M205396200; Orren DK, 1999, NUCLEIC ACIDS RES, V27, P3557, DOI 10.1093/nar/27.17.3557; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Popuri V, 2008, J BIOL CHEM, V283, P17766, DOI 10.1074/jbc.M709749200; Rossi ML, 2010, DNA REPAIR, V9, P796, DOI 10.1016/j.dnarep.2010.04.003; Saharia A, 2010, J BIOL CHEM, V285, P27057, DOI 10.1074/jbc.M110.112276; Sangrithi MN, 2005, CELL, V121, P887, DOI 10.1016/j.cell.2005.05.015; Schurman SH, 2009, HUM MOL GENET, V18, P3470, DOI 10.1093/hmg/ddp291; Sfeir A, 2009, CELL, V138, P90, DOI 10.1016/j.cell.2009.06.021; Siitonen HA, 2009, EUR J HUM GENET, V17, P151, DOI 10.1038/ejhg.2008.154; SINGER MS, 1994, SCIENCE, V266, P404, DOI 10.1126/science.7545955; Singh DK, 2010, AGING CELL, V9, P358, DOI 10.1111/j.1474-9726.2010.00562.x; Smogorzewska A, 2004, ANNU REV BIOCHEM, V73, P177, DOI 10.1146/annurev.biochem.73.071403.160049; Stinco G, 2008, J DERMATOL, V35, P154, DOI 10.1111/j.1346-8138.2008.00436.x; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; Thangavel S, 2010, MOL CELL BIOL, V30, P1382, DOI 10.1128/MCB.01290-09; Tripathi V, 2007, J CELL BIOL, V178, P9, DOI 10.1083/jcb.200610051; VENNOS EM, 1992, J AM ACAD DERMATOL, V27, P750, DOI 10.1016/0190-9622(92)70249-F; Verdun RE, 2007, NATURE, V447, P924, DOI 10.1038/nature05976; Verdun RE, 2006, CELL, V127, P709, DOI 10.1016/j.cell.2006.09.034; von Kobbe C, 2002, J BIOL CHEM, V277, P22035, DOI 10.1074/jbc.M200914200; Walne AJ, 2010, HUM MOL GENET, V19, P4453, DOI 10.1093/hmg/ddq371; Walpita D, 1999, P NATL ACAD SCI USA, V96, P5622, DOI 10.1073/pnas.96.10.5622; Wang LL, 2001, AM J MED GENET, V102, P11, DOI 10.1002/1096-8628(20010722)102:1<11::AID-AJMG1413>3.0.CO;2-A; Wang ZL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000951; Xu XH, 2009, EMBO J, V28, P3005, DOI 10.1038/emboj.2009.235; Xu XH, 2009, EMBO J, V28, P568, DOI 10.1038/emboj.2009.13; Yu CE, 1996, SCIENCE, V272, P258, DOI 10.1126/science.272.5259.258; Zijlmans JMJM, 1997, P NATL ACAD SCI USA, V94, P7423, DOI 10.1073/pnas.94.14.7423; Zinchuk Vadim, 2008, Curr Protoc Cell Biol, VChapter 4, DOI 10.1002/0471143030.cb0419s39	62	76	78	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					196	209		10.1074/jbc.M111.295063	http://dx.doi.org/10.1074/jbc.M111.295063			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22039056	Green Published, hybrid			2022-12-27	WOS:000298682400021
J	Nanou, E; Martinez, GQ; Scheuer, T; Catterall, WA				Nanou, Evanthia; Martinez, Gilbert Q.; Scheuer, Todd; Catterall, William A.			Molecular Determinants of Modulation of Ca(V)2.1 Channels by Visinin-like Protein 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRESYNAPTIC CALCIUM CURRENT; TERM SYNAPTIC PLASTICITY; CA2+ CHANNELS; RAT-BRAIN; NEUROTRANSMITTER RELEASE; SUBCELLULAR-DISTRIBUTION; ALPHA(1A) SUBUNITS; BINDING PROTEIN-1; CALMODULIN; P/Q	CaV2.1 channels, which conduct P/Q-type Ca2+ currents, initiate synaptic transmission at most synapses in the central nervous system. Ca2+/calmodulin-dependent facilitation and inactivation of these channels contributes to short-term facilitation and depression of synaptic transmission, respectively. Other calcium sensor proteins displace calmodulin (CaM) from its binding site, differentially regulate Ca(V)2.1 channels, and contribute to the diversity of short-term synaptic plasticity. The neuronal calcium sensor protein visinin-like protein 2 (VILIP-2) inhibits inactivation and enhances facilitation of Ca(V)2.1 channels. Here we examine the molecular determinants for differential regulation of Ca(V)2.1 channels by VILIP-2 and CaM by construction and functional analysis of chimeras in which the functional domains of VILIP-2 are substituted in CaM. Our results show that the N-terminal domain, including its myristoylation site, the central alpha-helix, and the C-terminal lobe containing EF-hands 3 and 4 of VILIP-2 are sufficient to transfer its regulatory properties to CaM. This regulation by VILIP-2 requires binding to the IQ-like domain of Ca(V)2.1 channels. Our results identify the essential molecular determinants of differential regulation of Ca(V)2.1 channels by VILIP-2 and define the molecular code that these proteins use to control short-term synaptic plasticity.	[Nanou, Evanthia; Martinez, Gilbert Q.; Scheuer, Todd; Catterall, William A.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Catterall, WA (corresponding author), Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA.	wcatt@uw.edu			National Institutes of Health [R01 NS22625]; Swedish Research Council [524-2010-913]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS022625] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Research Council(Swedish Research CouncilEuropean Commission); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Research Grant R01 NS22625 (to W. A. C.). This work was also supported by Postdoctoral Fellowship 524-2010-913 from the Swedish Research Council (to E. N.).	Burgoyne RD, 2004, TRENDS NEUROSCI, V27, P203, DOI 10.1016/j.tins.2004.01.010; Burgoyne RD, 2001, BIOCHEM J, V353, P1; Catterall WA, 2008, NEURON, V59, P882, DOI 10.1016/j.neuron.2008.09.005; Cuttle MF, 1998, J PHYSIOL-LONDON, V512, P723, DOI 10.1111/j.1469-7793.1998.723bd.x; DeMaria CD, 2001, NATURE, V411, P484, DOI 10.1038/35078091; DUNLAP K, 1995, TRENDS NEUROSCI, V18, P89, DOI 10.1016/0166-2236(95)93882-X; Few AP, 2011, J BIOL CHEM, V286, P41917, DOI 10.1074/jbc.M111.292417; Few AP, 2005, J NEUROSCI, V25, P7071, DOI 10.1523/JNEUROSCI.0452-05.2005; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Forsythe ID, 1998, NEURON, V20, P797, DOI 10.1016/S0896-6273(00)81017-X; Haeseleer F, 2000, J BIOL CHEM, V275, P1247, DOI 10.1074/jbc.275.2.1247; Haeseleer F, 2002, BIOCHEM BIOPH RES CO, V290, P615, DOI 10.1006/bbrc.2001.6228; Igarashi M, 2007, NEUROSCI RES, V58, P226, DOI 10.1016/j.neures.2007.03.005; Inchauspe CG, 2004, J NEUROSCI, V24, P10379, DOI 10.1523/JNEUROSCI.2104-04.2004; Jurado LA, 1999, PHYSIOL REV, V79, P661, DOI 10.1152/physrev.1999.79.3.661; Lautermilch NJ, 2005, J NEUROSCI, V25, P7062, DOI 10.1523/JNEUROSCI.0447-05.2005; Leal K., 2010, 40 ANN M SAN DIEG CA; Lee A, 2003, P NATL ACAD SCI USA, V100, P16059, DOI 10.1073/pnas.2237000100; Lee A, 2000, J NEUROSCI, V20, P6830, DOI 10.1523/JNEUROSCI.20-18-06830.2000; Lee A, 1999, NATURE, V399, P155, DOI 10.1038/20194; Lee A, 2002, NAT NEUROSCI, V5, P210, DOI 10.1038/nn805; Liang HY, 2003, NEURON, V39, P951, DOI 10.1016/S0896-6273(03)00560-9; Mochida S, 2008, NEURON, V57, P210, DOI 10.1016/j.neuron.2007.11.036; Neher E, 2008, NEURON, V59, P861, DOI 10.1016/j.neuron.2008.08.019; OLIVERA BM, 1994, ANNU REV BIOCHEM, V63, P823, DOI 10.1146/annurev.bi.63.070194.004135; Paterlini M, 2000, NEUROSCIENCE, V99, P205, DOI 10.1016/S0306-4522(00)00201-3; Sakurai T, 1996, J CELL BIOL, V134, P511, DOI 10.1083/jcb.134.2.511; Schaad NC, 1996, P NATL ACAD SCI USA, V93, P9253, DOI 10.1073/pnas.93.17.9253; Sippy T, 2003, NAT NEUROSCI, V6, P1031, DOI 10.1038/nn1117; STEA A, 1994, P NATL ACAD SCI USA, V91, P10576, DOI 10.1073/pnas.91.22.10576; TANAKA O, 1995, MOL BRAIN RES, V30, P1, DOI 10.1016/0169-328X(94)00265-G; Tsujimoto T, 2002, SCIENCE, V295, P2276, DOI 10.1126/science.1068278; WESTENBROEK RE, 1995, J NEUROSCI, V15, P6403; Xu JH, 2005, NEURON, V46, P633, DOI 10.1016/j.neuron.2005.03.024; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	35	7	7	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					504	513		10.1074/jbc.M111.292581	http://dx.doi.org/10.1074/jbc.M111.292581			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22074920	Green Published, hybrid			2022-12-27	WOS:000298682400049
J	Tokgoz, Z; Siepmann, TJ; Streich, F; Kumar, B; Klein, JM; Haas, AL				Tokgoez, Zeynep; Siepmann, Thomas J.; Streich, Frederick, Jr.; Kumar, Brajesh; Klein, Jennifer M.; Haas, Arthur L.			E1-E2 Interactions in Ubiquitin and Nedd8 Ligation Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATING ENZYME; CONJUGATING ENZYME; MECHANISTIC INSIGHTS; PROTEIN-ACTIVATION; CARRIER PROTEIN; E1; E2; IDENTIFICATION; AFFINITY; BINDING	Initial rates of E1-catalyzed E2 transthiolation have been used as a reporter function to probe the mechanism of I-125-ubiquitin transfer between activation and ligation half-reactions of ubiquitin conjugation. A functional survey of 11 representative human E2 paralogs reveals similar K-m for binding to human Uba1 ternary complex (K-m(ave) = 121 +/- 72 nM) and k(cat) for ubiquitin transfer (k(cat(ave)) = 4.0 +/- 1.2 s(-1)), suggesting that they possess a conserved binding site and transition state geometry and that they compete for charging through differences in intracellular concentration. Sequence analysis and mutagenesis localize this binding motif to three basic residues within Helix 1 of the E2 core domain, confirmed by transthiolation kinetics. Partial conservation of the motif among E2 paralogs not recognized by Uba1 suggests that another factor(s) account for the absolute specificity of cognate E2 binding. Truncation of the Uba1 carboxyl-terminal beta-grasp domain reduces cognate Ubc2b binding by 31-fold and k(cat) by 3.5 x 10(4)-fold, indicating contributions to E2 binding and transition state stabilization. Truncation of the paralogous domain from the Nedd8 activating enzyme has negligible effect on cognate Ubc12 transthiolation but abrogates E2 specificity toward non-cognate carrier proteins. Exchange of the beta-grasp domains between ubiquitin and Nedd8 activating enzymes fails to reverse the effect of truncation. Thus, the conserved Helix 1 binding motif and the beta-grasp domain direct general E2 binding, whereas the latter additionally serves as a specificity filter to exclude charging of non-cog-nate E2 paralogs in order to maintain the fidelity of downstream signaling.	[Streich, Frederick, Jr.; Kumar, Brajesh; Klein, Jennifer M.; Haas, Arthur L.] Louisiana State Univ, Sch Med, Dept Biochem & Mol Biol, New Orleans, LA 70112 USA; [Haas, Arthur L.] Louisiana State Univ, Sch Med, Stanley S Scott Canc Ctr, New Orleans, LA 70112 USA; [Tokgoez, Zeynep; Siepmann, Thomas J.] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA	Louisiana State University System; Louisiana State University System; Medical College of Wisconsin	Haas, AL (corresponding author), LSU Hlth Sci Ctr, Dept Biochem & Mol Biol, 1901 Perdido St, New Orleans, LA 70112 USA.	ahaas@lsuhsc.edu	Gromley, Zeynep/AAG-3958-2022; Gromley, Zeynep/AEG-5353-2022	Streich Jr, Frederick/0000-0002-7549-424X	National Institutes of Health [GM034009]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034009] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM034009 (to A. L. H.).	Aguilar RC, 2003, CURR OPIN CELL BIOL, V15, P184, DOI 10.1016/S0955-0674(03)00010-3; ARNOLD JE, 1990, BIOCHEM J, V267, P751, DOI 10.1042/bj2670751; Baboshina OV, 1996, J BIOL CHEM, V271, P2823, DOI 10.1074/jbc.271.5.2823; Baboshina OV, 2001, J BIOL CHEM, V276, P39428, DOI 10.1074/jbc.M106967200; Badciong JC, 2002, J BIOL CHEM, V277, P49668, DOI 10.1074/jbc.M208593200; Bencsath KP, 2002, J BIOL CHEM, V277, P47938, DOI 10.1074/jbc.M207442200; Bohnsack RN, 2003, J BIOL CHEM, V278, P26823, DOI 10.1074/jbc.M303177200; Demon D, 2009, MOL CELL PROTEOMICS, V8, P2700, DOI 10.1074/mcp.M900310-MCP200; GILBERT HF, 1977, J AM CHEM SOC, V99, P7931, DOI 10.1021/ja00466a029; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; HAAS AL, 1982, J BIOL CHEM, V257, P2543; HAAS AL, 1983, BIOCHEMISTRY-US, V22, P4388, DOI 10.1021/bi00288a007; HAAS AL, 1982, J BIOL CHEM, V257, P329; HAAS AL, 1981, P NATL ACAD SCI-BIOL, V78, P6845, DOI 10.1073/pnas.78.11.6845; Haas AL, 1997, FASEB J, V11, P1257; HAAS AL, 2006, PROTEIN DEGRADATION, P103; Haas Arthur L., 2005, V301, P23; HANDLEYGEARHART PM, 1994, J BIOL CHEM, V269, P33171; Higy M, 2004, BIOCHEMISTRY-US, V43, P12716, DOI 10.1021/bi048368m; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Huang DT, 2008, NAT STRUCT MOL BIOL, V15, P280, DOI 10.1038/nsmb.1387; Huang DT, 2007, NATURE, V445, P394, DOI 10.1038/nature05490; Huang DT, 2005, MOL CELL, V17, P341, DOI 10.1016/j.molcel.2004.12.020; Huang DT, 2004, ONCOGENE, V23, P1958, DOI 10.1038/sj.onc.1207393; Huang DT, 2004, NAT STRUCT MOL BIOL, V11, P927, DOI 10.1038/nsmb826; Huang L, 1999, SCIENCE, V286, P1321, DOI 10.1126/science.286.5443.1321; Hussain T, 2010, P NATL ACAD SCI USA, V107, P22117, DOI 10.1073/pnas.1014299107; Johnson ES, 1997, J BIOL CHEM, V272, P26799, DOI 10.1074/jbc.272.43.26799; Kumar B, 2010, J BIOL CHEM, V285, P41300, DOI 10.1074/jbc.M110.169136; LALELISAHIN EA, 2001, THESIS MED COLL WISC; Liu Z, 1996, J BIOL CHEM, V271, P2817, DOI 10.1074/jbc.271.5.2817; Lois LM, 2005, EMBO J, V24, P439, DOI 10.1038/sj.emboj.7600552; Nijman SMB, 2005, MOL CELL, V17, P331, DOI 10.1016/j.molcel.2005.01.008; Osaka F, 1998, GENE DEV, V12, P2263, DOI 10.1101/gad.12.15.2263; Schulman BA, 2009, NAT REV MOL CELL BIO, V10, P319, DOI 10.1038/nrm2673; Schwartz DC, 2003, TRENDS BIOCHEM SCI, V28, P321, DOI 10.1016/S0968-0004(03)00113-0; Siepmann TJ, 2003, J BIOL CHEM, V278, P9448, DOI 10.1074/jbc.M211240200; Streich FC, 2010, SUBCELL BIOCHEM, V54, P1, DOI 10.1007/978-1-4419-6676-6_1; SULLIVAN ML, 1993, J BIOL CHEM, V268, P8777; SULLIVAN ML, 1991, J BIOL CHEM, V266, P23878; SUNG P, 1991, EMBO J, V10, P2187, DOI 10.1002/j.1460-2075.1991.tb07754.x; Tokgoz Z, 2006, J BIOL CHEM, V281, P14729, DOI 10.1074/jbc.M513562200; Walden H, 2003, NATURE, V422, P330, DOI 10.1038/nature01456; Wang JH, 2007, MOL CELL, V27, P228, DOI 10.1016/j.molcel.2007.05.023; Wang JH, 2010, J BIOL CHEM, V285, P33457, DOI 10.1074/jbc.M110.135582; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; Wenzel DM, 2011, BIOCHEM J, V433, P31, DOI 10.1042/BJ20100985; Winn PJ, 2004, STRUCTURE, V12, P1563, DOI 10.1016/j.str.2004.06.017; Zhao C, 2004, P NATL ACAD SCI USA, V101, P7578, DOI 10.1073/pnas.0402528101; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	50	41	42	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					311	321		10.1074/jbc.M111.294975	http://dx.doi.org/10.1074/jbc.M111.294975			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22069333	Green Published, hybrid			2022-12-27	WOS:000298682400031
J	Lepine, S; Allegood, JC; Edmonds, Y; Milstien, S; Spiegel, S				Lepine, Sandrine; Allegood, Jeremy C.; Edmonds, Yvette; Milstien, Sheldon; Spiegel, Sarah			Autophagy Induced by Deficiency of Sphingosine-1-phosphate Phosphohydrolase 1 Is Switched to Apoptosis by Calpain-mediated Autophagy-related Gene 5 (Atg5) Cleavage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOXORUBICIN-INDUCED APOPTOSIS; CELL-DEATH; SPHINGOSINE 1-PHOSPHATE; CERAMIDE; STRESS; INHIBITION; ACTIVATION; GENERATION; KINASE; PHOSPHATASE-1	Sphingosine 1-phosphate (S1P) and ceramide have been implicated in both autophagy and apoptosis. However, the roles of these sphingolipid metabolites in the links between these two processes are not completely understood. Depletion of S1P phosphohydrolase-1 (SPP1), which degrades intracellular S1P, induces the unfolded protein response and endoplasmic reticulum stress-induced autophagy (Lepine, S., Allegood, J. C., Park, M., Dent, P., Milstien, S., and Spiegel, S. (2011) Cell Death Differ. 18, 350-361). Surprisingly, however, treatment with doxorubicin, which by itself also induced autophagy, markedly reduced the extent of autophagy mediated by depletion of SPP1. Concomitantly, doxorubicin-induced apoptosis was greatly enhanced by down-regulation of SPP1. Autophagy and apoptosis seemed to be sequentially linked because inhibiting autophagy with 3-methyladenine also markedly attenuated apoptosis. Moreover, silencing Atg5 or the three sensors of the unfolded protein response, IRE1 alpha, ATF6, and PKR-like eIF2 alpha kinase (PERK), significantly decreased both autophagy and apoptosis. Doxorubicin stimulated calpain activity and Atg5 cleavage, which were significantly enhanced in SPP1-depleted cells. Inhibition or depletion of calpain not only suppressed Atg5 cleavage, it also markedly decreased the robust apoptosis induced by doxorubicin in SPP1-deficient cells. Importantly, doxorubicin also increased de novo synthesis of the pro-apoptotic sphingolipid metabolite ceramide. Elevation of ceramide in turn stimulated calpain; conversely, inhibiting ceramide formation suppressed Atg5 cleavage and apoptosis. Hence, doxorubicin switches protective autophagy in SPP1-depleted cells to apoptosis by calpain-mediated Atg5 cleavage.	[Spiegel, Sarah] Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Sch Med, Richmond, VA 23298 USA; Virginia Commonwealth Univ, Massey Canc Ctr, Sch Med, Richmond, VA 23298 USA	Virginia Commonwealth University; Virginia Commonwealth University	Spiegel, S (corresponding author), Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Sch Med, Med Coll Virginia Campus, Richmond, VA 23298 USA.	sspiegel@vcu.edu			NIGMS [5R37GM043880]; National Institutes of Health [P30 CA16059]; NINDS Center [5P30NS047463]; NATIONAL CANCER INSTITUTE [P30CA016059] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM043880] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047463] Funding Source: NIH RePORTER	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NINDS Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant 5R37GM043880 from NIGMS (to S. S.).; We are grateful to Drs. T. Yoshimori (National Institute of Genetics, Mishima, Japan), K. Kirkegaard (Stanford University School of Medicine, Stanford, CA), J. A. Diehl (University of Pennsylvania), David Ron (Skirball Institute, New York University), and Andrew Thorburn (University of Colorado) for generous gifts of reagents. Confocal microscopy and electron microscopy were supported in part by National Institutes of Health Grant P30 CA16059 to the Massey Cancer Center and NINDS Center core Grant 5P30NS047463, respectively.	Akar U, 2008, AUTOPHAGY, V4, P669, DOI 10.4161/auto.6083; Alvarez SE, 2007, TRENDS ENDOCRIN MET, V18, P300, DOI 10.1016/j.tem.2007.07.005; Bar-Joseph H, 2010, REPROD TOXICOL, V30, P566, DOI 10.1016/j.reprotox.2010.07.003; Bernales S, 2006, PLOS BIOL, V4, P2311, DOI 10.1371/journal.pbio.0040423; Bhutia SK, 2010, CANCER RES, V70, P3667, DOI 10.1158/0008-5472.CAN-09-3647; Buchberger A, 2010, MOL CELL, V40, P238, DOI 10.1016/j.molcel.2010.10.001; Coward J, 2009, AUTOPHAGY, V5, P184, DOI 10.4161/auto.5.2.7361; Cuvillier O, 1996, NATURE, V381, P800, DOI 10.1038/381800a0; Cuvillier O, 2001, CELL DEATH DIFFER, V8, P162, DOI 10.1038/sj.cdd.4400793; Daido S, 2004, CANCER RES, V64, P4286, DOI 10.1158/0008-5472.CAN-03-3084; Ding WX, 2007, J BIOL CHEM, V282, P4702, DOI 10.1074/jbc.M609267200; Eisenberg-Lerner A, 2009, CELL DEATH DIFFER, V16, P966, DOI 10.1038/cdd.2009.33; GHOSH TK, 1990, SCIENCE, V248, P1653, DOI 10.1126/science.2163543; Gomez BP, 2007, FASEB J, V21, P4013, DOI 10.1096/fj.06-7990com; Gozuacik D, 2008, CELL DEATH DIFFER, V15, P1875, DOI 10.1038/cdd.2008.121; Green DR, 2009, NATURE, V458, P1127, DOI 10.1038/nature07986; Guenther GG, 2008, P NATL ACAD SCI USA, V105, P17402, DOI 10.1073/pnas.0802781105; Hagen N, 2011, CELL DEATH DIFFER, V18, P1356, DOI 10.1038/cdd.2011.7; Hait NC, 2009, SCIENCE, V325, P1254, DOI 10.1126/science.1176709; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; Ji C, 2010, ONCOGENE, V29, P6557, DOI 10.1038/onc.2010.379; Johnson KR, 2003, J BIOL CHEM, V278, P34541, DOI 10.1074/jbc.M301741200; Kim SJ, 2006, BIOCHEM BIOPH RES CO, V339, P463, DOI 10.1016/j.bbrc.2005.11.040; Kolesnick R, 2002, J CLIN INVEST, V110, P3, DOI 10.1172/JCI200216127; Kolesnick R, 2007, CANCER CELL, V11, P473, DOI 10.1016/j.ccr.2007.05.003; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Kumar A, 2011, CELL SIGNAL, V23, P1144, DOI 10.1016/j.cellsig.2011.02.009; Lai HC, 2010, EUR J PHARMACOL, V644, P176, DOI 10.1016/j.ejphar.2010.07.010; Lavieu G, 2006, J BIOL CHEM, V281, P8518, DOI 10.1074/jbc.M506182200; Lepine S, 2011, CELL DEATH DIFFER, V18, P350, DOI 10.1038/cdd.2010.104; Li DD, 2009, ONCOGENE, V28, P886, DOI 10.1038/onc.2008.441; Liu YY, 2008, FASEB J, V22, P2541, DOI 10.1096/fj.07-092981; Menuz V, 2009, SCIENCE, V324, P381, DOI 10.1126/science.1168532; Munoz-Gomez JA, 2009, AUTOPHAGY, V5, P61, DOI 10.4161/auto.5.1.7272; Ogata M, 2006, MOL CELL BIOL, V26, P9220, DOI 10.1128/MCB.01453-06; Ogretmen B, 2004, NAT REV CANCER, V4, P604, DOI 10.1038/nrc1411; Ogretmen B, 2002, J BIOL CHEM, V277, P12960, DOI 10.1074/jbc.M110699200; Pyne NJ, 2010, NAT REV CANCER, V10, P489, DOI 10.1038/nrc2875; Sankala HM, 2007, CANCER RES, V67, P10466, DOI 10.1158/0008-5472.CAN-07-2090; Scarlatti F, 2004, J BIOL CHEM, V279, P18384, DOI 10.1074/jbc.M313561200; Senkal CE, 2010, FASEB J, V24, P296, DOI 10.1096/fj.09-135087; Spassieva SD, 2009, BIOCHEM J, V424, P273, DOI 10.1042/BJ20090699; Spiegel S, 2011, NAT REV IMMUNOL, V11, P403, DOI 10.1038/nri2974; Swanton C, 2007, CANCER CELL, V11, P498, DOI 10.1016/j.ccr.2007.04.011; Tasdemir E, 2008, NAT CELL BIOL, V10, P676, DOI 10.1038/ncb1730; Xia HG, 2010, AUTOPHAGY, V6, P61, DOI 10.4161/auto.6.1.10326; Yousefi S, 2006, NAT CELL BIOL, V8, P1124, DOI 10.1038/ncb1482; Zhao YT, 2007, J BIOL CHEM, V282, P14165, DOI 10.1074/jbc.M701279200; Zhou HL, 1998, J BIOL CHEM, V273, P16568, DOI 10.1074/jbc.273.26.16568	49	65	73	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2011	286	52					44380	44390		10.1074/jbc.M111.257519	http://dx.doi.org/10.1074/jbc.M111.257519			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870CA	22052905	hybrid, Green Published			2022-12-27	WOS:000298645500010
J	Yonemura, Y; Futai, E; Yagishita, S; Suo, S; Tomita, T; Iwatsubo, T; Ishiura, S				Yonemura, Yoji; Futai, Eugene; Yagishita, Sosuke; Suo, Satoshi; Tomita, Taisuke; Iwatsubo, Takeshi; Ishiura, Shoichi			Comparison of Presenilin 1 and Presenilin 2 gamma-Secretase Activities Using a Yeast Reconstitution System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; PATHOGENIC MECHANISM; MUTANT PRESENILIN; COMPLEX; EXPRESSION; NICASTRIN; ENDOPROTEOLYSIS; OVERPRODUCTION; STABILIZATION; MUTATIONS	gamma-Secretase is composed of at least four proteins, presenilin (PS), nicastrin (NCT), Aph1, and Pen2. PS is the catalytic subunit of the gamma-secretase complex, having aspartic protease activity. PS has two homologs, namely, PS1 and PS2. To compare the activity of these complexes containing different PSs, we reconstituted them in yeast, which lacks gamma-secretase homologs. Yeast cells were transformed with PS1 or PS2, NCT, Pen2, Aph1, and artificial substrate C55-Gal4p. After substrate cleavage, Gal4p translocates to the nucleus and activates transcription of the reporter genes ADE2, HIS3, and lacZ. gamma-Secretase activity was measured based on yeast growth on selective media and beta-galactosidase activity. PS1 gamma-secretase was similar to 24-fold more active than PS2 gamma-secretase in the beta-galactosidase assay. Using yeast microsomes containing gamma-secretase and C55, we compared the concentration of A beta generated by PS1 or PS2 gamma-secretase. PS1 gamma-secretase produced similar to 24-fold more A beta than PS2 gamma-secretase. We found the optimal pH of A beta production by PS2 to be 7.0, as for PS1, and that the PS2 complex included immature NCT, unlike the PS1 complex, which included mature NCT. In this study, we compared the activity of PS1 or PS2 per one gamma-secretase complex. Co-immunoprecipitation experiments using yeast microsomes showed that PS1 concentrations in the gamma-secretase complex were similar to 28 times higher than that of PS2. Our data suggest that the PS1 complex is only marginally less active than the PS2 complex in A beta production.	[Yonemura, Yoji; Futai, Eugene; Yagishita, Sosuke; Suo, Satoshi; Ishiura, Shoichi] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Tokyo 1538902, Japan; [Tomita, Taisuke; Iwatsubo, Takeshi] Univ Tokyo, Grad Sch Pharmaceut Sci, Dept Neuropathol & Neurosci, Tokyo 1130033, Japan	University of Tokyo; University of Tokyo	Ishiura, S (corresponding author), 3-8-1 Komaba,Meguro Ku, Tokyo 1538902, Japan.	cishiura@mail.ecc.u-tokyo.ac.jp	Tomita, Taisuke/L-5427-2015	Tomita, Taisuke/0000-0002-0075-5943; Futai, Eugene/0000-0002-0879-6117	Human Frontier Science Program; Ministry of Health, Labor and Welfare, Japan	Human Frontier Science Program(Human Frontier Science Program); Ministry of Health, Labor and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported in part by grants from Human Frontier Science Program and The Ministry of Health, Labor and Welfare, Japan.	Edbauer D, 2003, NAT CELL BIOL, V5, P486, DOI 10.1038/ncb960; Fraering PC, 2004, BIOCHEMISTRY-US, V43, P9774, DOI 10.1021/bi0494976; Fraering PC, 2004, BIOCHEMISTRY-US, V43, P323, DOI 10.1021/bi035748j; Franberg J, 2011, BIOCHEM BIOPH RES CO, V404, P564, DOI 10.1016/j.bbrc.2010.12.029; Futai E, 2009, J BIOL CHEM, V284, P13013, DOI 10.1074/jbc.M807653200; Herreman A, 1999, P NATL ACAD SCI USA, V96, P11872, DOI 10.1073/pnas.96.21.11872; James P, 1996, GENETICS, V144, P1425; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; Jayadev S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015743; Lai MT, 2003, J BIOL CHEM, V278, P22475, DOI 10.1074/jbc.M300974200; LaVoie MJ, 2003, J BIOL CHEM, V278, P37213, DOI 10.1074/jbc.M303941200; Lee MK, 1996, J NEUROSCI, V16, P7513, DOI 10.1523/jneurosci.16-23-07513.1996; Levitan D, 1996, P NATL ACAD SCI USA, V93, P14940, DOI 10.1073/pnas.93.25.14940; Li YM, 2000, P NATL ACAD SCI USA, V97, P6138, DOI 10.1073/pnas.110126897; Miller CA, 1998, NUCLEIC ACIDS RES, V26, P3577, DOI 10.1093/nar/26.15.3577; Moehlmann T, 2002, P NATL ACAD SCI USA, V99, P8025, DOI 10.1073/pnas.112686799; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Niimura M, 2005, J BIOL CHEM, V280, P12967, DOI 10.1074/jbc.M409829200; Sato T, 2007, J BIOL CHEM, V282, P33985, DOI 10.1074/jbc.M705248200; Shah S, 2005, CELL, V122, P435, DOI 10.1016/j.cell.2005.05.022; Shen J, 1997, CELL, V89, P629, DOI 10.1016/S0092-8674(00)80244-5; Shen J, 2007, P NATL ACAD SCI USA, V104, P403, DOI 10.1073/pnas.0608332104; Shirotani K, 2007, NEUROBIOL DIS, V27, P102, DOI 10.1016/j.nbd.2007.04.011; Steiner H, 2000, NAT CELL BIOL, V2, P848, DOI 10.1038/35041097; Steiner H, 1999, J BIOL CHEM, V274, P28669, DOI 10.1074/jbc.274.40.28669; Tomita T, 1999, J NEUROSCI, V19, P10627, DOI 10.1523/JNEUROSCI.19-24-10627.1999; Tomita T, 1998, J BIOL CHEM, V273, P21153, DOI 10.1074/jbc.273.33.21153; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Wong PC, 1997, NATURE, V387, P288, DOI 10.1038/387288a0; Yagishita S, 2008, BIOCHEM BIOPH RES CO, V377, P141, DOI 10.1016/j.bbrc.2008.09.090; Zhang JM, 1998, J BIOL CHEM, V273, P12436, DOI 10.1074/jbc.273.20.12436	31	25	25	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2011	286	52					44569	44575		10.1074/jbc.M111.270108	http://dx.doi.org/10.1074/jbc.M111.270108			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870CA	22074918	Green Published, hybrid			2022-12-27	WOS:000298645500028
J	Kumar, R; Chadha, S; Saraswat, D; Bajwa, JS; Li, RA; Conti, HR; Edgerton, M				Kumar, Rohitashw; Chadha, Sonia; Saraswat, Darpan; Bajwa, Jashanjot Singh; Li, Rui A.; Conti, Heather R.; Edgerton, Mira			Histatin 5 Uptake by Candida albicans Utilizes Polyamine Transporters Dur3 and Dur31 Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAJOR FACILITATOR SUPERFAMILY; YEAST ABC PROTEINS; SACCHAROMYCES-CEREVISIAE; PLASMA-MEMBRANE; ANTIMICROBIAL PEPTIDES; NONAQUEOUS SOLUTIONS; CATIONIC PEPTIDES; H+-ATPASE; TRANSLOCATION; SPERMIDINE	Histatin 5 (Hst 5) is a salivary gland-secreted cationic peptide with potent fungicidal activity against Candida albicans. Hst 5 kills fungal cells following intracellular translocation, although its selective transport mechanism is unknown. C. albicans cells grown in the presence of polyamines were resistant to Hst 5 due to reduced intracellular uptake, suggesting that this cationic peptide may enter candidal cells through native yeast polyamine transporters. Based upon homology to known Saccharomyces cerevisiae polyamine permeases, we identified six C. albicans Dur polyamine transporter family members and propose a new nomenclature. Gene deletion mutants were constructed for C. albicans polyamine transporters Dur3, Dur31, Dur33, Dur34, and were tested for Hst 5 sensitivity and uptake of spermidine. We found spermidine uptake and Hst 5 mediated killing were decreased significantly in Delta dur3, Delta dur31, and Delta dur3/Delta dur31 strains; whereas a DUR3 overexpression strain increased Hst 5 sensitivity and higher spermidine uptake. Treatment of cells with a spermidine synthase inhibitor increased spermidine uptake and Hst 5 killing, whereas protonophores and cold treatment reduced spermidine uptake. Inhibition assays showed that Hst 5 is a competitive analog of spermidine for uptake into C. albicans cells, and that Hst 5 K-i values were increased by 80-fold in Delta dur3/Delta dur31 cells. Thus, Dur3p and Dur31p are preferential spermidine transporters used by Hst 5 for its entry into candidal cells. Understanding of polyamine transporter-mediated internalization of Hst 5 provides new insights into the uptake mechanism for C. albicans toxicity, and further suggests design for targeted fungal therapeutic agents.	[Kumar, Rohitashw; Chadha, Sonia; Saraswat, Darpan; Bajwa, Jashanjot Singh; Li, Rui A.; Conti, Heather R.; Edgerton, Mira] SUNY Buffalo, Sch Dent Med, Dept Oral Biol, Buffalo, NY 14214 USA; [Chadha, Sonia] Bhabha Atom Res Ctr, Nucl Agr & Biotechnol Div, Bombay 400085, Maharashtra, India	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Bhabha Atomic Research Center (BARC)	Edgerton, M (corresponding author), SUNY Buffalo, Sch Dent Med, Dept Oral Biol, 310 Foster Hall,3435 Main St, Buffalo, NY 14214 USA.	edgerto@buffalo.edu	Kumar, Rohitashw/D-1968-2014; Chadha, Sonia/AAJ-2483-2020	Kumar, Rohitashw/0000-0001-8695-3555; CHADHA, SONIA/0000-0003-2831-6907; Saraswat, Darpan/0000-0002-3226-8656	National Institutes of Health from the NIDCR [DE10641]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE010641] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R29DE010641] Funding Source: NIH RePORTER	National Institutes of Health from the NIDCR; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grant DE10641 from the NIDCR (to M. E.).	Aouida M, 2005, J BIOL CHEM, V280, P24267, DOI 10.1074/jbc.M503071200; Aouida M, 2004, BIOCHEM J, V384, P47, DOI 10.1042/BJ20040392; Aouida M, 2010, J BIOL CHEM, V285, P6275, DOI 10.1074/jbc.M109.046151; Baev D, 2004, J BIOL CHEM, V279, P55060, DOI 10.1074/jbc.M411031200; Baev D, 2001, MICROBIOL-SGM, V147, P3323, DOI 10.1099/00221287-147-12-3323; Bauer BE, 1999, BBA-BIOMEMBRANES, V1461, P217, DOI 10.1016/S0005-2736(99)00160-1; Bensen ES, 2004, MOL MICROBIOL, V54, P1335, DOI 10.1111/j.1365-2958.2004.04350.x; Braun BR, 2005, PLOS GENET, V1, P36, DOI 10.1371/journal.pgen.0010001; Brewer D, 1998, BIOCHEM CELL BIOL, V76, P247, DOI 10.1139/bcb-76-2-3-247; Chattopadhyay MK, 2009, YEAST, V26, P531, DOI 10.1002/yea.1703; Cheng WWL, 2009, J GEN PHYSIOL, V133, P295, DOI 10.1085/jgp.200810125; Choi JH, 2000, BIOINFORMATICS, V16, P1056, DOI 10.1093/bioinformatics/16.11.1056; Decottignies A, 1997, NAT GENET, V15, P137, DOI 10.1038/ng0297-137; den Hertog AL, 2004, BIOCHEM J, V379, P665, DOI 10.1042/BJ20031785; FERREIRAPEREIRA A, 1994, J BIOL CHEM, V269, P12074; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; FONZI WA, 1993, GENETICS, V134, P717; Goossens A, 2000, MOL CELL BIOL, V20, P7654, DOI 10.1128/MCB.20.20.7654-7661.2000; Hancock REW, 1998, TRENDS BIOTECHNOL, V16, P82, DOI 10.1016/S0167-7799(97)01156-6; Igarashi K, 1999, BIOCHEM J, V344, P633, DOI 10.1042/0264-6021:3440633; Jang WS, 2008, ANTIMICROB AGENTS CH, V52, P497, DOI 10.1128/AAC.01199-07; Jang WS, 2010, MOL MICROBIOL, V77, P354, DOI 10.1111/j.1365-2958.2010.07210.x; Jungwirth H, 2006, FEBS LETT, V580, P1131, DOI 10.1016/j.febslet.2005.12.050; Kaouass M, 1998, J BIOL CHEM, V273, P2109, DOI 10.1074/jbc.273.4.2109; Koshlukova SE, 1999, J BIOL CHEM, V274, P18872, DOI 10.1074/jbc.274.27.18872; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LEAR JD, 1988, SCIENCE, V240, P1177, DOI 10.1126/science.2453923; Li XWS, 2006, J BIOL CHEM, V281, P22453, DOI 10.1074/jbc.M604064200; Millson SH, 2005, EUKARYOT CELL, V4, P849, DOI 10.1128/EC.4.5.849-860.2005; Mochon AB, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000190; Morschhauser J, 1999, MOL MICROBIOL, V32, P547, DOI 10.1046/j.1365-2958.1999.01393.x; Navarathna DHMLP, 2011, MICROBIOL-SGM, V157, P270, DOI 10.1099/mic.0.045005-0; Nozaki T, 1996, BIOCHEM BIOPH RES CO, V228, P452, DOI 10.1006/bbrc.1996.1681; Oliver D, 2000, EUR J BIOCHEM, V267, P5824, DOI 10.1046/j.1432-1327.2000.01669.x; OPPENHEIM FG, 1988, J BIOL CHEM, V263, P7472; Pao SS, 1998, MICROBIOL MOL BIOL R, V62, P1; Pasrija R, 2007, EUKARYOT CELL, V6, P443, DOI 10.1128/EC.00315-06; Raj PA, 1998, BIOPOLYMERS, V45, P51, DOI 10.1002/(SICI)1097-0282(199801)45:1<51::AID-BIP5>3.0.CO;2-Y; Rothstein DM, 2001, ANTIMICROB AGENTS CH, V45, P1367, DOI 10.1128/AAC.45.5.1367-1373.2001; Ruissen ALA, 2001, BIOCHEM J, V356, P361, DOI 10.1042/0264-6021:3560361; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sanglard D, 1999, ANTIMICROB AGENTS CH, V43, P2753, DOI 10.1128/AAC.43.11.2753; Shah P, 2009, EXP BIOL MED, V234, P403, DOI 10.3181/0809-RM-269; Shai Y, 2002, BIOPOLYMERS, V66, P236, DOI 10.1002/bip.10260; Situ H, 2000, BBA-GEN SUBJECTS, V1475, P377, DOI 10.1016/S0304-4165(00)00096-9; Spyropoulos IC, 2004, BIOINFORMATICS, V20, P3258, DOI 10.1093/bioinformatics/bth358; Tomitori H, 2001, BIOCHEM J, V353, P681, DOI 10.1042/0264-6021:3530681; Uemura T, 2005, BIOCHEM BIOPH RES CO, V328, P1028, DOI 10.1016/j.bbrc.2005.01.064; Uemura T, 2007, J BIOL CHEM, V282, P7733, DOI 10.1074/jbc.M611105200; Veerman ECI, 2007, J BIOL CHEM, V282, P18831, DOI 10.1074/jbc.M610555200; Vylkova S, 2007, PURINERG SIGNAL, V3, P91, DOI 10.1007/s11302-006-9040-0; Woolridge DP, 1997, J BIOL CHEM, V272, P8864; XU T, 1991, INFECT IMMUN, V59, P2549, DOI 10.1128/IAI.59.8.2549-2554.1991; Xu YY, 1999, ANTIMICROB AGENTS CH, V43, P2256, DOI 10.1128/AAC.43.9.2256	55	48	57	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2011	286	51					43748	43758		10.1074/jbc.M111.311175	http://dx.doi.org/10.1074/jbc.M111.311175			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866SH	22033918	Green Published, hybrid			2022-12-27	WOS:000298402300018
J	Gadd, MS; Bhati, M; Jeffries, CM; Langley, DB; Trewhella, J; Guss, JM; Matthews, JM				Gadd, Morgan S.; Bhati, Mugdha; Jeffries, Cy M.; Langley, David B.; Trewhella, Jill; Guss, J. Mitchell; Matthews, Jacqueline M.			Structural Basis for Partial Redundancy in a Class of Transcription Factors, the LIM Homeodomain Proteins, in Neural Cell Type Specification	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANGLE SCATTERING DATA; MOTOR-NEURON; MACROMOLECULAR STRUCTURES; INTERNEURON IDENTITY; LMO4-LDB1 COMPLEX; LHX3; CRYSTALLIZATION; PROGRAM; DOMAINS; BINDING	Background: Lhx and Isl proteins contribute to genetic control in developing neurons. Results: The Lhx3/4-binding motif in Isl2 was identified, and the structures of Lhx-Isl complexes were characterized and compared. Conclusion: There are minor differences in the structures of Lhx3/4 binding Isl1/2 reflected by mutational and biophysical analyses. Significance: Redundant sets of interactions conserve function in developing neurons while allowing divergence in other contexts.	[Gadd, Morgan S.; Bhati, Mugdha; Jeffries, Cy M.; Langley, David B.; Trewhella, Jill; Guss, J. Mitchell; Matthews, Jacqueline M.] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia	University of Sydney	Matthews, JM (corresponding author), Univ Sydney, Sch Mol Biosci, Bldg G08, Sydney, NSW 2006, Australia.	jacqui.matthews@sydney.edu.au	Guss, Jules Mitchell/N-1387-2019; Matthews, Jacqueline/A-7322-2013; Langley, David B/B-1861-2009	Guss, Jules Mitchell/0000-0003-4259-6079; Langley, David B/0000-0003-2752-0041; Trewhella, Jill/0000-0002-8555-6766; Gadd, Morgan/0000-0001-6124-0858; /0000-0002-8718-7343; Matthews, Jacqueline/0000-0001-8518-3472	Australian Research Council; Australian Government; Viertel Foundation; National Health and Medical Research Council	Australian Research Council(Australian Research Council); Australian Government(Australian GovernmentCGIAR); Viertel Foundation; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by grants from the Australian Research Council.; Supported by Australian Postgraduate Awards from the Australian Government.; Supported by senior research fellowships from the Viertel Foundation and National Health and Medical Research Council. To whom correspondence should be addressed: Bldg. G08, School of Molecular Bioscience, The University of Sydney, New South Wales 2006, Australia. E-mail: jacqui.matthews@sydney.edu.au.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Agulnick AD, 1996, NATURE, V384, P270, DOI 10.1038/384270a0; Bachy I, 2002, NEUROREPORT, V13, pA23, DOI 10.1097/00001756-200202110-00002; Bhati M, 2008, EMBO J, V27, P2018, DOI 10.1038/emboj.2008.123; Bhati M, 2008, ACTA CRYSTALLOGR F, V64, P297, DOI 10.1107/S174430910800691X; Cross AJ, 2010, J MOL BIOL, V399, P133, DOI 10.1016/j.jmb.2010.04.006; Deane JE, 2004, EMBO J, V23, P3589, DOI 10.1038/sj.emboj.7600376; Deane JE, 2003, ACTA CRYSTALLOGR D, V59, P1484, DOI 10.1107/S0907444903011843; Deane JE, 2003, EMBO J, V22, P2224, DOI 10.1093/emboj/cdg196; Deane JE, 2001, PROTEIN ENG, V14, P493, DOI 10.1093/protein/14.7.493; El Omari K, 2011, BLOOD, V117, P2146, DOI 10.1182/blood-2010-07-293357; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Failli V, 2000, GENOMICS, V64, P307, DOI 10.1006/geno.2000.6123; Gadd MS, 2009, ACTA CRYSTALLOGR F, V65, P151, DOI 10.1107/S1744309108043431; Hutchinson SA, 2006, DEVELOPMENT, V133, P2137, DOI 10.1242/dev.02355; Jeffries CM, 2008, J MOL BIOL, V377, P1186, DOI 10.1016/j.jmb.2008.01.080; Jeffries CM, 2006, PROTEIN SCI, V15, P2612, DOI 10.1110/ps.062377006; Jurata LW, 1996, P NATL ACAD SCI USA, V93, P11693, DOI 10.1073/pnas.93.21.11693; Jurata LW, 1997, MOL CELL BIOL, V17, P5688, DOI 10.1128/MCB.17.10.5688; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lee C, 2005, J BIOMOL NMR, V33, P198, DOI 10.1007/s10858-005-3209-7; LI H, 1994, EMBO J, V13, P2876, DOI 10.1002/j.1460-2075.1994.tb06582.x; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Matthews JM, 2009, CURR PHARM DESIGN, V15, P3681, DOI 10.2174/138161209789271861; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Netchine I, 2000, NAT GENET, V25, P182, DOI 10.1038/76041; Orthaber D, 2000, J APPL CRYSTALLOGR, V33, P218, DOI 10.1107/S0021889899015216; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Pfaff SL, 1996, CELL, V84, P309, DOI 10.1016/S0092-8674(00)80985-X; Ryan DP, 2006, J MOL BIOL, V359, P66, DOI 10.1016/j.jmb.2006.02.074; Sharma K, 1998, CELL, V95, P817, DOI 10.1016/S0092-8674(00)81704-3; Sheng HZ, 1996, SCIENCE, V272, P1004, DOI 10.1126/science.272.5264.1004; Song MR, 2009, DEVELOPMENT, V136, P2923, DOI 10.1242/dev.037986; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tanabe Y, 1998, CELL, V95, P67, DOI 10.1016/S0092-8674(00)81783-3; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Thaler JP, 2002, CELL, V110, P237, DOI 10.1016/S0092-8674(02)00823-1; Thaler JP, 2004, NEURON, V41, P337, DOI 10.1016/S0896-6273(04)00011-X; TSUCHIDA T, 1994, CELL, V79, P957, DOI 10.1016/0092-8674(94)90027-2; van Meyel DJ, 1999, MOL CELL, V4, P259, DOI 10.1016/S1097-2765(00)80373-1; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Whitten AE, 2008, J APPL CRYSTALLOGR, V41, P222, DOI 10.1107/S0021889807055136; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736	47	31	33	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					42971	42980		10.1074/jbc.M111.248559	http://dx.doi.org/10.1074/jbc.M111.248559			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22025611	Green Published, hybrid			2022-12-27	WOS:000298351300018
J	Hanfrey, CC; Pearson, BM; Hazeldine, S; Lee, J; Gaskin, DJ; Woster, PM; Phillips, MA; Michael, AJ				Hanfrey, Colin C.; Pearson, Bruce M.; Hazeldine, Stuart; Lee, Jeongmi; Gaskin, Duncan J.; Woster, Patrick M.; Phillips, Margaret A.; Michael, Anthony J.			Alternative Spermidine Biosynthetic Route Is Critical for Growth of Campylobacter jejuni and Is the Dominant Polyamine Pathway in Human Gut Microbiota	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							S-ADENOSYLMETHIONINE DECARBOXYLASE; AMINO-ACID DECARBOXYLASES; ALKYLPOLYAMINE ANALOGS; SUBSTRATE-SPECIFICITY; VIBRIO-ALGINOLYTICUS; SYM-HOMOSPERMIDINE; BACILLUS-SUBTILIS; BIOFILM FORMATION; GENOME SEQUENCE; PUTRESCINE	The availability of fully sequenced bacterial genomes has revealed that many species known to synthesize the polyamine spermidine lack the spermidine biosynthetic enzymes S-adenosylmethionine decarboxylase and spermidine synthase. We found that such species possess orthologues of the sym-norspermidine biosynthetic enzymes carboxynorspermidine dehydrogenase and carboxynorspermidine decarboxylase. By deleting these genes in the food-borne pathogen Campylobacter jejuni, we found that the carboxynorspermidine decarboxylase orthologue is responsible for synthesizing spermidine and not symnorspermidine in vivo. In polyamine auxotrophic gene deletion strains of C. jejuni, growth is highly compromised but can be restored by exogenous sym-homospermidine and to a lesser extent by sym-norspermidine. The alternative spermidine biosynthetic pathway is present in many bacterial phyla and is the dominant spermidine route in the human gut, stomach, and oral microbiomes, and it appears to have supplanted the S-adenosylmethionine decarboxylase/spermidine synthase pathway in the gut microbiota. Approximately half of the gut Firmicutes species appear to be polyamine auxotrophs, but all encode the pot-ABCD spermidine/putrescine transporter. Orthologues encoding carboxyspermidine dehydrogenase and carboxyspermidine decarboxylase are found clustered with an array of diverse putrescine biosynthetic genes in different bacterial genomes, consistent with a role in spermidine, rather than sym-norspermidine biosynthesis. Due to the pervasiveness of epsilon-proteobacteria in deep sea hydrothermal vents and to the ubiquity of the alternative spermidine biosynthetic pathway in that phylum, the carboxyspermidine route is also dominant in deep sea hydrothermal vents. The carboxyspermidine pathway for polyamine biosynthesis is found in diverse human pathogens, and this alternative spermidine biosynthetic route presents an attractive target for developing novel antimicrobial compounds.	[Phillips, Margaret A.; Michael, Anthony J.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Hanfrey, Colin C.; Pearson, Bruce M.; Gaskin, Duncan J.] Inst Food Res, Norwich NR4 7UA, Norfolk, England; [Hazeldine, Stuart] Wayne State Univ, Dept Pharmaceut Sci, Detroit, MI 48202 USA; [Lee, Jeongmi] Sungkyunkwan Univ, Sch Pharm, Suwon 440747, South Korea; [Woster, Patrick M.] Med Univ S Carolina, Dept Pharmaceut & Biomed Sci, Charleston, SC 29425 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute; University of East Anglia; Wayne State University; Sungkyunkwan University (SKKU); Medical University of South Carolina	Michael, AJ (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pharmacol, 6001 Forest Pk, Dallas, TX 75390 USA.	anthony.michael@utsouthwestern.edu	Woster, Patrick M/A-5604-2010; Lee, Jeongmi/AAJ-7720-2020	Woster, Patrick M/0000-0002-9471-1916; Lee, Jeongmi/0000-0002-9948-7554; Pearson, Bruce/0000-0002-9223-7712	National Institutes of Health [7RO1 CA149095, R01 AI034432]; Biotechnology and Biological Sciences Research Council (United Kingdom) CSG [BB/E024467/1]; University of Texas Southwestern Medical Center; Welch Foundation [I-1257]; BBSRC [BB/E024467/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E024467/1, BBS/E/F/00042254] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R01CA149095] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI034432, R37AI034432] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Biological Sciences Research Council (United Kingdom) CSG; University of Texas Southwestern Medical Center; Welch Foundation(The Welch Foundation); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants 7RO1 CA149095 (to P. M. W.) and R01 AI034432 (to M. A. P.). This work was also supported by a Biotechnology and Biological Sciences Research Council (United Kingdom) CSG Grant, Institute Development Fellowship BB/E024467/1, University of Texas Southwestern Medical Center grant (to A. J. M.), and the Welch Foundation Grant I-1257 (to M. A. P.).	Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Bellevue FH, 1996, BIOORG MED CHEM LETT, V6, P2765, DOI 10.1016/S0960-894X(96)00510-0; Burrell M, 2010, J BIOL CHEM, V285, P39224, DOI 10.1074/jbc.M110.163154; Chalker AF, 2001, J BACTERIOL, V183, P1259, DOI 10.1128/JB.183.4.1259-1268.2001; Chou HT, 2008, J BACTERIOL, V190, P1966, DOI 10.1128/JB.01804-07; Covassin L, 2003, BIOORG MED CHEM LETT, V13, P3267, DOI 10.1016/S0960-894X(03)00668-1; Deng XY, 2010, J BIOL CHEM, V285, P25708, DOI 10.1074/jbc.M110.121137; Frostesjo L, 1997, J BIOL CHEM, V272, P4359, DOI 10.1074/jbc.272.7.4359; Gilbreath JJ, 2011, MICROBIOL MOL BIOL R, V75, P84, DOI 10.1128/MMBR.00035-10; HAMANA K, 1994, J GEN APPL MICROBIOL, V40, P181, DOI 10.2323/jgam.40.181; HAMANA K, 2004, MICROBIOL CULTURE CO, V20, P3; Hamana K., 1998, MICROBIOL CULT COLL, V14, P1; HAMANA K, 1999, MICROBIOL CULT COLL, V15, P9; Hosoya R, 2004, J GEN APPL MICROBIOL, V50, P255, DOI 10.2323/jgam.50.255; Hosoya R., 2006, MICROBIOL CULT; Huber JA, 2007, SCIENCE, V318, P97, DOI 10.1126/science.1146689; Hutchison CA, 1999, SCIENCE, V286, P2165, DOI 10.1126/science.286.5447.2165; Igarashi K, 2010, PLANT PHYSIOL BIOCH, V48, P506, DOI 10.1016/j.plaphy.2010.01.017; Kim JH, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.88; Lee J, 2007, J BIOL CHEM, V282, P27115, DOI 10.1074/jbc.M704066200; Lee J, 2009, J BIOL CHEM, V284, P9899, DOI 10.1074/jbc.M900110200; Li Y, 2006, SYNTHETIC COMMUN, V36, P925, DOI 10.1080/00397910500466199; LINDEROTH N, 1983, BIOCHEM BIOPH RES CO, V117, P616, DOI 10.1016/0006-291X(83)91245-7; NAKAO H, 1991, J GEN MICROBIOL, V137, P1737, DOI 10.1099/00221287-137-7-1737; Pearson BM, 2007, J BACTERIOL, V189, P8402, DOI 10.1128/JB.01404-07; Pegg AE, 2009, ESSAYS BIOCHEM, V46, P25, DOI [10.1042/BSE0460003, 10.1042/bse0460003]; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Sekowska A, 2000, MOL MICROBIOL, V36, P1135, DOI 10.1046/j.1365-2958.2000.01930.x; Shaw FL, 2010, J BIOL CHEM, V285, P14711, DOI 10.1074/jbc.M110.107219; TABOR CW, 1976, ANNU REV BIOCHEM, V45, P285, DOI 10.1146/annurev.bi.45.070176.001441; TAIT GH, 1976, BIOCHEM SOC T, V4, P610, DOI 10.1042/bst0040610; Takaki Y, 2010, DNA RES, V17, P123, DOI 10.1093/dnares/dsq005; Toms AV, 2004, J BIOL CHEM, V279, P33837, DOI 10.1074/jbc.M403369200; WANG WLL, 1980, J CLIN MICROBIOL, V12, P479, DOI 10.1128/JCM.12.3.479-480.1980; Wu H, 2007, BIOCHEMISTRY-US, V46, P8331, DOI 10.1021/bi602498k; YAMAMOTO S, 1994, MICROBIOL-UK, V140, P3117, DOI 10.1099/13500872-140-11-3117; Zou Y, 2001, BIOORG MED CHEM LETT, V11, P1613, DOI 10.1016/S0960-894X(01)00315-8	37	65	67	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					43301	43312		10.1074/jbc.M111.307835	http://dx.doi.org/10.1074/jbc.M111.307835			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22025614	Green Published, hybrid			2022-12-27	WOS:000298351300050
J	Tokuoka, H; Muramatsu, S; Sumi-Ichinose, C; Sakane, H; Kojima, M; Aso, Y; Nomura, T; Metzger, D; Ichinose, H				Tokuoka, Hirofumi; Muramatsu, Shin-ichi; Sumi-Ichinose, Chiho; Sakane, Hiroaki; Kojima, Masayo; Aso, Yoshinori; Nomura, Takahide; Metzger, Daniel; Ichinose, Hiroshi			Compensatory Regulation of Dopamine after Ablation of the Tyrosine Hydroxylase Gene in the Nigrostriatal Projection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TARGETED DISRUPTION; PARKINSONS-DISEASE; DEFICIENT MICE; NEURONS; RAT; TRANSPORT; RELEASE; PHOSPHORYLATION; NORADRENALINE; MECHANISMS	The tyrosine hydroxylase (TH; EC 1.14.16.2) is a rate-limiting enzyme in the dopamine synthesis and important for the central dopaminergic system, which controls voluntary movements and reward-dependent behaviors. Here, to further explore the regulatory mechanism of dopamine levels by TH in adult mouse brains, we employed a genetic method to inactivate the Th gene in the nigrostriatal projection using the Cre-loxP system. Stereotaxic injection of adeno-associated virus expressing Cre recombinase (AAV-Cre) into the substantia nigra pars compacta (SNc), where dopaminergic cell bodies locate, specifically inactivated the Th gene. Whereas the number of TH-expressing cells decreased to less than 40% in the SNc 2 weeks after the AAV-Cre injection, the striatal TH protein level decreased to 75%, 50%, and 39% at 2, 4, and 8 weeks, respectively, after the injection. Thus, unexpectedly, the reduction of TH protein in the striatum, where SNc dopaminergic axons innervate densely, was slower than in the SNc. Moreover, despite the essential requirement of TH for dopamine synthesis, the striatal dopamine contents were only moderately decreased, to 70% even 8 weeks after AAV-Cre injection. Concurrently, in vivo synthesis activity of L-dihydroxyphenylalanine, the dopamine precursor, per TH protein level was augmented, suggesting up-regulation of dopamine synthesis activity in the intact nigrostriatal axons. Collectively, our conditional Th gene targeting method demonstrates two regulatory mechanisms of TH in axon terminals for dopamine homeostasis in vivo: local regulation of TH protein amount independent of soma and trans-axonal regulation of apparent L-dihydroxyphenylalanine synthesis activity per TH protein.	[Tokuoka, Hirofumi; Sakane, Hiroaki; Kojima, Masayo; Aso, Yoshinori; Ichinose, Hiroshi] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Dept Life Sci, Midori Ku, Yokohama, Kanagawa 2268501, Japan; [Muramatsu, Shin-ichi] Jichi Med Univ, Dept Med, Div Neurol, Shimotsuke, Tochigi 3290498, Japan; [Sumi-Ichinose, Chiho; Nomura, Takahide] Fujita Hlth Univ, Sch Med, Dept Pharmacol, Toyoake, Aichi 4701192, Japan; [Metzger, Daniel] Inst Genet & Biol Mol & Cellulaire, F-67400 Illkirch Graffenstaden, France; [Metzger, Daniel] CNRS, Illkirch Graffenstaden, France; [Metzger, Daniel] Univ Strasbourg, F-67000 Strasbourg, France	Tokyo Institute of Technology; Jichi Medical University; Fujita Health University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Tokuoka, H (corresponding author), Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Dept Life Sci, Midori Ku, 4259 B-7 Nagatsuta, Yokohama, Kanagawa 2268501, Japan.	htokuoka@bio.titech.ac.jp; hichinos@bio.titech.ac.jp	Aso, Yoshinori/ACJ-9439-2022; Ichinose, Hiroshi/D-8986-2015; Muramatsu, Shinichi/ABC-6093-2021; Muramatsu, Shin-ichi/K-9420-2013	Ichinose, Hiroshi/0000-0001-6008-6860; Muramatsu, Shinichi/0000-0002-3185-7790; Muramatsu, Shin-ichi/0000-0002-3185-7790; Metzger, Daniel/0000-0002-5555-046X; Sumi-Ichinose, Chiho/0000-0001-5261-0853	Ministry of Health, Labor and Welfare of Japan [18A-2]; MEXT; Nakajima Foundation; Core Research for Evolutional Science and Technology, Japan Science and Technology Agency (CREST, JST); Grants-in-Aid for Scientific Research [21500305] Funding Source: KAKEN	Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Nakajima Foundation; Core Research for Evolutional Science and Technology, Japan Science and Technology Agency (CREST, JST)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-aid for Human Frontier Science Program; by Research Grant 18A-2 for Nervous and Mental Disorders from the Ministry of Health, Labor and Welfare of Japan; by KAKENHI from MEXT; by the Nakajima Foundation; and by Core Research for Evolutional Science and Technology, Japan Science and Technology Agency (CREST, JST).	BERNHEIMER H, 1973, J NEUROL SCI, V20, P415, DOI 10.1016/0022-510X(73)90175-5; Bezard E, 2003, TRENDS NEUROSCI, V26, P215, DOI 10.1016/S0166-2236(03)00038-9; CUBEDDU LX, 1982, J PHARMACOL EXP THER, V223, P497; Dittgen T, 2004, P NATL ACAD SCI USA, V101, P18206, DOI 10.1073/pnas.0407976101; Dunkley PR, 2004, J NEUROCHEM, V91, P1025, DOI 10.1111/j.1471-4159.2004.02797.x; Fahn S, 2003, ANN NY ACAD SCI, V991, P1, DOI 10.1111/j.1749-6632.2003.tb07458.x; Fernandez E, 1999, J NEUROCHEM, V73, P169, DOI 10.1046/j.1471-4159.1999.0730169.x; FUKUSHIMA T, 1980, ANAL BIOCHEM, V102, P176, DOI 10.1016/0003-2697(80)90336-X; Gordon SL, 2008, J NEUROCHEM, V106, P1614, DOI 10.1111/j.1471-4159.2008.05509.x; Grace AA, 2007, TRENDS NEUROSCI, V30, P220, DOI 10.1016/j.tins.2007.03.003; Graybiel AM, 2000, TRENDS NEUROSCI, V23, pS71, DOI 10.1016/S1471-1931(00)00027-6; Hakansson K, 2004, EUR J NEUROSCI, V20, P1108, DOI 10.1111/j.1460-9568.2004.03547.x; HEFTI F, 1985, NEUROPHARMACOLOGY, V24, P19, DOI 10.1016/0028-3908(85)90090-5; Hirokawa N, 2010, NEURON, V68, P610, DOI 10.1016/j.neuron.2010.09.039; Hnasko TS, 2006, P NATL ACAD SCI USA, V103, P8858, DOI 10.1073/pnas.0603081103; JARROTT B, 1972, P NATL ACAD SCI USA, V69, P3440, DOI 10.1073/pnas.69.11.3440; Kadkhodaei B, 2009, J NEUROSCI, V29, P15923, DOI 10.1523/JNEUROSCI.3910-09.2009; KOBAYASHI K, 1995, J BIOL CHEM, V270, P27235, DOI 10.1074/jbc.270.45.27235; Lane EL, 2005, J PHARMACOL EXP THER, V312, P1124, DOI 10.1124/jpet.104.076554; Li XG, 2006, MOL THER, V13, P160, DOI 10.1016/j.ymthe.2005.08.009; Lin AC, 2008, CURR OPIN NEUROBIOL, V18, P60, DOI 10.1016/j.conb.2008.05.004; Matsuda W, 2009, J NEUROSCI, V29, P444, DOI 10.1523/JNEUROSCI.4029-08.2009; McCallum SE, 2006, J NEUROCHEM, V96, P960, DOI 10.1111/j.1471-4159.2005.03610.x; Mosharov EV, 2009, NEURON, V62, P218, DOI 10.1016/j.neuron.2009.01.033; NAGATSU T, 1964, J BIOL CHEM, V239, P2910; Paxinos G, 2004, MOUSE BRAIN STEREOTA; Perez XA, 2008, J NEUROCHEM, V105, P1861, DOI 10.1111/j.1471-4159.2008.05268.x; Pifl C, 2006, NEUROCHEM INT, V49, P519, DOI 10.1016/j.neuint.2006.03.013; Pothos EN, 1998, J NEUROSCI, V18, P4106; Prensa L, 2001, J NEUROSCI, V21, P7247, DOI 10.1523/JNEUROSCI.21-18-07247.2001; Rice ME, 2008, BRAIN RES REV, V58, P303, DOI 10.1016/j.brainresrev.2008.02.004; Schultz W, 2007, TRENDS NEUROSCI, V30, P203, DOI 10.1016/j.tins.2007.03.007; Simpson EH, 2010, NEURON, V65, P585, DOI 10.1016/j.neuron.2010.02.014; Szczypka MS, 2001, NEURON, V30, P819, DOI 10.1016/S0896-6273(01)00319-1; TANK AW, 1986, MOL PHARMACOL, V30, P497; Terada S, 2003, NEUROSCI RES, V47, P367, DOI 10.1016/j.neures.2003.08.005; THOMAS SA, 1995, NATURE, V374, P643, DOI 10.1038/374643a0; Tye KM, 2010, NAT NEUROSCI, V13, P475, DOI 10.1038/nn.2506; UNGERSTEDT U, 1970, Brain Research, V24, P485, DOI 10.1016/0006-8993(70)90187-3; Willis DE, 2006, CURR OPIN NEUROBIOL, V16, P111, DOI 10.1016/j.conb.2006.01.002; ZHOU QY, 1995, NATURE, V374, P640, DOI 10.1038/374640a0; Zhou QY, 1995, CELL, V83, P1197, DOI 10.1016/0092-8674(95)90145-0; ZIGMOND MJ, 1984, ARCH NEUROL-CHICAGO, V41, P856, DOI 10.1001/archneur.1984.04050190062015	43	16	18	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					43549	43558		10.1074/jbc.M111.284729	http://dx.doi.org/10.1074/jbc.M111.284729			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22027820	Green Published, hybrid			2022-12-27	WOS:000298351300074
J	Tan, BZ; Jiang, FL; Tan, MY; Yu, DJ; Huang, H; Shen, YR; Soong, TW				Tan, Bao Zhen; Jiang, Fengli; Tan, Ming Yeong; Yu, Dejie; Huang, Hua; Shen, Yiru; Soong, Tuck Wah			Functional Characterization of Alternative Splicing in the C Terminus of L-type Ca(V)1.3 Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+-DEPENDENT INACTIVATION; CALCIUM-CHANNELS; CA2+ CHANNELS; IDENTIFICATION; CALMODULIN; MODULATION; PROTEINS; SUBUNITS	Ca(V)1.3 channels are unique among the high voltage-activated Ca2+ channel family because they activate at the most negative potentials and display very rapid calcium-dependent inactivation. Both properties are of crucial importance in neurons of the suprachiasmatic nucleus and substantia nigra, where the influx of Ca2+ ions at subthreshold membrane voltages supports pace-making function. Previously, alternative splicing in the Ca(V)1.3C terminus gives rise to a long (Ca(V)1.3(42)) and a short form (Ca(V)1.3(42A)), resulting in a pronounced activation at more negative voltages and faster inactivation in the latter. It was further shown that the C-terminal modulator in the Ca(V)1.3(42) isoforms modulates calmodulin binding to the IQ domain. Using splice variant-specific antibodies, we determined that protein localization of both splice variants in different brain regions were similar. Using the transcript-scanning method, we further identified alternative splicing at four loci in the C terminus of Ca(V)1.3 channels. Alternative splicing of exon 41 removes the IQ motif, resulting in a truncated Ca(V)1.3 protein with diminished inactivation. Splicing of exon 43 causes a frameshift and exhibits a robust inactivation of similar intensity to Ca(V)1.3(42A). Alternative splicing of exons 44 and 48 are in-frame, altering interaction of the distal modulator with the IQ domain and tapering inactivation slightly. Thus, alternative splicing in the C terminus of Ca(V)1.3 channels modulates its electrophysiological properties, which could in turn alter neuronal firing properties and functions.	[Tan, Bao Zhen; Jiang, Fengli; Tan, Ming Yeong; Yu, Dejie; Huang, Hua; Soong, Tuck Wah] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Singapore 117597, Singapore; [Tan, Bao Zhen; Huang, Hua; Soong, Tuck Wah] Natl Univ Singapore, NUS Grad Sch Integrat Engn & Sci, Singapore 117597, Singapore; [Shen, Yiru; Soong, Tuck Wah] Natl Neurosci Inst, Singapore 308433, Singapore	National University of Singapore; National University of Singapore; National Neuroscience Institute (NNI)	Soong, TW (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, MD9,2 Med Dr, Singapore 117597, Singapore.	phsstw@nus.edu.sg	Tuluc, Petronel/C-2527-2011	Huang, Hua/0000-0002-7421-3696	National Institutes of Health [RO1DC00276]; Singapore Biomedical Research Council; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000276] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Singapore Biomedical Research Council(Agency for Science Technology & Research (A*STAR)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1DC00276 and the Singapore Biomedical Research Council.	Altier C, 2011, NAT NEUROSCI, V14, P173, DOI 10.1038/nn.2712; Bean BP, 2007, NAT REV NEUROSCI, V8, P451, DOI 10.1038/nrn2148; Bock G, 2011, J BIOL CHEM, V286, P42736, DOI 10.1074/jbc.M111.269951; Cui GY, 2007, J PHYSIOL-LONDON, V585, P791, DOI 10.1113/jphysiol.2007.142307; DUNLAP K, 1995, TRENDS NEUROSCI, V18, P89, DOI 10.1016/0166-2236(95)93882-X; Erickson MG, 2003, NEURON, V39, P97, DOI 10.1016/S0896-6273(03)00395-7; Gamelli AE, 2011, HIPPOCAMPUS, V21, P133, DOI 10.1002/hipo.20728; Gomez-Ospina N, 2006, CELL, V127, P591, DOI 10.1016/j.cell.2006.10.017; Haeseleer F, 2000, J BIOL CHEM, V275, P1247, DOI 10.1074/jbc.275.2.1247; HELL JW, 1993, J CELL BIOL, V123, P949, DOI 10.1083/jcb.123.4.949; Helton TD, 2005, J NEUROSCI, V25, P10247, DOI 10.1523/JNEUROSCI.1089-05.2005; Hetzenauer A, 2006, NEUROSCIENCE, V139, P1005, DOI 10.1016/j.neuroscience.2006.01.059; HUI A, 1991, NEURON, V7, P35, DOI 10.1016/0896-6273(91)90072-8; Koschak A, 2001, J BIOL CHEM, V276, P22100, DOI 10.1074/jbc.M101469200; Liang HY, 2003, NEURON, V39, P951, DOI 10.1016/S0896-6273(03)00560-9; Lipscombe D, 2004, J NEUROPHYSIOL, V92, P2633, DOI 10.1152/jn.00486.2004; Liu XD, 2010, NATURE, V463, P968, DOI 10.1038/nature08766; Mangoni ME, 2003, P NATL ACAD SCI USA, V100, P5543, DOI 10.1073/pnas.0935295100; Manji HK, 2001, NAT MED, V7, P541, DOI 10.1038/87865; Mittman S, 1999, NEUROSCI LETT, V274, P143, DOI 10.1016/S0304-3940(99)00716-8; Olson PA, 2005, J NEUROSCI, V25, P1050, DOI 10.1523/JNEUROSCI.3327-04.2005; Patil PG, 1998, NEURON, V20, P1027, DOI 10.1016/S0896-6273(00)80483-3; Peterson BZ, 2000, BIOPHYS J, V78, P1906, DOI 10.1016/S0006-3495(00)76739-7; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; Pitt GS, 2001, J BIOL CHEM, V276, P30794, DOI 10.1074/jbc.M104959200; Shen YR, 2006, J NEUROSCI, V26, P10690, DOI 10.1523/JNEUROSCI.2093-06.2006; Singh A, 2008, J BIOL CHEM, V283, P20733, DOI 10.1074/jbc.M802254200; Singh A, 2006, NAT NEUROSCI, V9, P1108, DOI 10.1038/nn1751; Soldatov NM, 1997, J BIOL CHEM, V272, P3560, DOI 10.1074/jbc.272.6.3560; Soong TW, 2002, J NEUROSCI, V22, P10142; Xu WF, 2001, J NEUROSCI, V21, P5944, DOI 10.1523/JNEUROSCI.21-16-05944.2001; Yang PS, 2006, J NEUROSCI, V26, P10677, DOI 10.1523/JNEUROSCI.3236-06.2006; Zhang H, 2006, EUR J NEUROSCI, V23, P2297, DOI 10.1111/j.1460-9568.2006.04734.x	33	60	60	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42725	42735		10.1074/jbc.M111.265207	http://dx.doi.org/10.1074/jbc.M111.265207			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	21998309	Green Published, hybrid			2022-12-27	WOS:000298180900079
J	Saman, S; Kim, W; Raya, M; Visnick, Y; Miro, S; Saman, S; Jackson, B; McKee, AC; Alvarez, VE; Lee, NCY; Hall, GF				Saman, Sudad; Kim, WonHee; Raya, Mario; Visnick, Yvonne; Miro, Suhad; Saman, Sarmad; Jackson, Bruce; McKee, Ann C.; Alvarez, Victor E.; Lee, Norman C. Y.; Hall, Garth F.			Exosome-associated Tau Is Secreted in Tauopathy Models and Is Selectively Phosphorylated in Cerebrospinal Fluid in Early Alzheimer Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-SYNUCLEIN; NEUROFIBRILLARY DEGENERATION; CORTICOBASAL DEGENERATION; CELLULAR-MODEL; PROTEIN; BETA; CSF; OLIGOMERIZATION; ACCUMULATION; BIOCHEMISTRY	Recent demonstrations that the secretion, uptake, and interneuronal transfer of tau can be modulated by disease-associated tau modifications suggest that secretion may be an important element in tau-induced neurodegeneration. Here, we show that much of the tau secreted by M1C cells occurs via exosomal release, a widely characterized mechanism that mediates unconventional secretion of other aggregation-prone proteins (alpha-synuclein, prion protein, and beta-amyloid) in neurodegenerative disease. Exosome-associated tau is also present in human CSF samples and is phosphorylated at Thr-181 (AT270), an established phosphotau biomarker for Alzheimer disease (AD), in both M1C cells and in CSF samples from patients with mild (Braak stage 3) AD. A preliminary analysis of proteins co-purified with tau in secreted exosomes identified several that are known to be involved in disease-associated tau misprocessing. Our results suggest that exosome-mediated secretion of phosphorylated tau may play a significant role in the abnormal processing of tau and in the genesis of elevated CSF tau in early AD.	[Saman, Sudad; Kim, WonHee; Hall, Garth F.] Univ Massachusetts, Dept Biol Sci, Lowell, MA 01854 USA; [Raya, Mario; Visnick, Yvonne; Miro, Suhad; Saman, Sarmad; Jackson, Bruce] MassBay Community Coll Sci Dept STEM Div, Wellesley Hills, MA 02481 USA; [McKee, Ann C.; Alvarez, Victor E.] Vet Affairs Med Ctr, GRECC Unit, Bedford, MA 01730 USA; [McKee, Ann C.; Alvarez, Victor E.] Boston Univ, Dept Neurol, Sch Med, Boston, MA 02215 USA; [McKee, Ann C.; Alvarez, Victor E.] Boston Univ, Dept Pathol, Sch Med, Boston, MA 02215 USA; [Lee, Norman C. Y.] Boston Univ, Dept Chem, Chem Instrumentat Ctr, Boston, MA 02215 USA	University of Massachusetts System; University of Massachusetts Lowell; US Department of Veterans Affairs; Veterans Health Administration (VHA); Boston University; Boston University; Boston University	Hall, GF (corresponding author), Univ Massachusetts, Dept Biol Sci, 198 Riverside St, Lowell, MA 01854 USA.	garth_hall@uml.edu		Kim, WonHee/0000-0001-5530-7606	Boston University Alzheimer's Disease Center (BUADC); NIA [P30 AG13846]; Department of Veterans Affairs; NATIONAL INSTITUTE ON AGING [P30AG013846] Funding Source: NIH RePORTER	Boston University Alzheimer's Disease Center (BUADC); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the Boston University Alzheimer's Disease Center (BUADC), NIA grant P30 AG13846, a BUADC pilot grant (to G. F. H.), and the Department of Veterans Affairs.	Arai H, 1998, NEUROSCI LETT, V256, P174, DOI 10.1016/S0304-3940(98)00781-2; Berger Z, 2007, J NEUROSCI, V27, P3650, DOI 10.1523/JNEUROSCI.0587-07.2007; Boland B, 2008, J NEUROSCI, V28, P6926, DOI 10.1523/JNEUROSCI.0800-08.2008; Borroni B, 2009, NEUROBIOL AGING, V30, P34, DOI 10.1016/j.neurobiolaging.2007.05.009; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Braak H, 2006, ACTA NEUROPATHOL, V112, P389, DOI 10.1007/s00401-006-0127-z; Buee L, 1999, BRAIN PATHOL, V9, P681; BUSCIGLIO J, 1995, NEURON, V14, P879, DOI 10.1016/0896-6273(95)90232-5; Chirita CN, 2003, J BIOL CHEM, V278, P25644, DOI 10.1074/jbc.M301663200; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; Clinton LK, 2010, J NEUROSCI, V30, P7281, DOI 10.1523/JNEUROSCI.0490-10.2010; Cushman M, 2010, J CELL SCI, V123, P1191, DOI 10.1242/jcs.051672; Dickey CA, 2006, J NEUROSCI, V26, P6985, DOI 10.1523/JNEUROSCI.0746-06.2006; Emmanouilidou E, 2010, J NEUROSCI, V30, P6838, DOI 10.1523/JNEUROSCI.5699-09.2010; Fevrier B, 2004, P NATL ACAD SCI USA, V101, P9683, DOI 10.1073/pnas.0308413101; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; Gomez-Ramos A, 2006, FEBS LETT, V580, P4842, DOI 10.1016/j.febslet.2006.07.078; Guillozet-Bongaarts AL, 2005, NEUROBIOL AGING, V26, P1015, DOI 10.1016/j.neurobiolaging.2004.09.019; Hall GF, 2011, NEURODEGENERATIVE DISEASES - PROCESSES, PREVENTION, PROTECTION AND MONITORING, P3; Hall GF, 2002, J MOL NEUROSCI, V19, P253; Hall GF, 2001, AM J PATHOL, V158, P235, DOI 10.1016/S0002-9440(10)63962-4; Harrington MG, 2009, FLUIDS BARRIERS CNS, V6, DOI 10.1186/1743-8454-6-10; Johnson GVW, 1997, J NEUROCHEM, V68, P430; Kim W, 2010, FEBS LETT, V584, P3085, DOI 10.1016/j.febslet.2010.05.042; Kim W, 2010, J ALZHEIMERS DIS, V19, P647, DOI 10.3233/JAD-2010-1273; Ko LW, 2004, J ALZHEIMERS DIS, V6, P605; Lee G, 1998, J CELL SCI, V111, P3167; Lee S., 2012, INT J ALZ D IN PRESS; LEE VMY, 1991, SCIENCE, V251, P675, DOI 10.1126/science.1899488; Makrides V, 2003, J BIOL CHEM, V278, P33298, DOI 10.1074/jbc.M305207200; Mathivanan S, 2009, PROTEOMICS, V9, P4997, DOI 10.1002/pmic.200900351; Nickel W, 2005, TRAFFIC, V6, P607, DOI 10.1111/j.1600-0854.2005.00302.x; Pan S, 2009, J PROTEOME RES, V8, P787, DOI 10.1021/pr800538n; Parnetti L, 2001, NEUROL SCI, V22, P77, DOI 10.1007/s100720170055; Patterson KR, 2011, J BIOL CHEM, V286, P23063, DOI 10.1074/jbc.M111.237974; Rajendran L, 2006, P NATL ACAD SCI USA, V103, P11172, DOI 10.1073/pnas.0603838103; Sahara N, 2008, CURR ALZHEIMER RES, V5, P591, DOI 10.2174/156720508786898442; Sharples RA, 2008, FASEB J, V22, P1469, DOI 10.1096/fj.07-9357com; Gadad BS, 2011, J ALZHEIMERS DIS, V24, P223, DOI 10.3233/JAD-2011-110182; Simpson RJ, 2009, EXPERT REV PROTEOMIC, V6, P267, DOI [10.1586/epr.09.17, 10.1586/EPR.09.17]; Stoothoff WH, 2005, BBA-MOL BASIS DIS, V1739, P280, DOI 10.1016/j.bbadis.2004.06.017; Sverdlov M, 2007, J CELL MOL MED, V11, P1239, DOI 10.1111/j.1582-4934.2007.00127.x; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Urakami K, 2001, J NEUROL SCI, V183, P95, DOI 10.1016/S0022-510X(00)00480-9; Vanderstichele H, 2006, CLIN CHEM LAB MED, V44, P1472, DOI 10.1515/CCLM.2006.258; Vega IE, 2005, MOL BRAIN RES, V138, P135, DOI 10.1016/j.molbrainres.2005.04.015; Wang JZ, 2007, EUR J NEUROSCI, V25, P59, DOI 10.1111/j.1460-9568.2006.05226.x; WEINGARTEN MD, 1975, P NATL ACAD SCI USA, V72, P1858, DOI 10.1073/pnas.72.5.1858; Zilka N, 2010, ACTA NEUROPATHOL, V119, P679, DOI 10.1007/s00401-010-0680-3	50	655	676	5	114	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					3842	3849		10.1074/jbc.M111.277061	http://dx.doi.org/10.1074/jbc.M111.277061			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22057275	Green Published, hybrid			2022-12-27	WOS:000300410900021
J	Arshavsky, VY; Burns, ME				Arshavsky, Vadim Y.; Burns, Marie E.			Photoreceptor Signaling: Supporting Vision across a Wide Range of Light Intensities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							MULTIPLE PHOSPHORYLATION SITES; INTACT CONE PHOTORECEPTORS; GTPASE-ACTIVATING COMPLEX; ROD-PHOTORECEPTORS; GUANYLYL CYCLASE; RETINAL RODS; MOUSE RODS; VERTEBRATE PHOTORECEPTORS; TRANSDUCIN TRANSLOCATION; DRIVEN TRANSLOCATION	For decades, photoreceptors have been an outstanding model system for elucidating basic principles in sensory transduction and biochemistry and for understanding many facets of neuronal cell biology. In recent years, new knowledge of the kinetics of signaling and the large-scale movements of proteins underlying signaling has led to a deeper appreciation of the photoreceptor's unique challenge in mediating the first steps in vision over a wide range of light intensities.	[Arshavsky, Vadim Y.] Duke Univ, Dept Ophthalmol, Durham, NC 27710 USA; [Arshavsky, Vadim Y.] Duke Univ, Dept Pharmacol, Durham, NC 27710 USA; [Burns, Marie E.] Univ Calif Davis, Dept Ophthalmol & Visual Sci, Davis, CA 95618 USA; [Burns, Marie E.] Univ Calif Davis, Dept Cell Biol & Human Anat, Davis, CA 95618 USA	Duke University; Duke University; University of California System; University of California Davis; University of California System; University of California Davis	Arshavsky, VY (corresponding author), Duke Univ, Dept Ophthalmol, Durham, NC 27710 USA.	vadim.arshavsky@duke.edu; meburns@ucdavis.edu			National Institutes of Health [EY12859, EY10336, EY14147]; NATIONAL EYE INSTITUTE [P30EY005722, R01EY014047, R01EY010336, R01EY012859] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Supported by National Institutes of Health Grants EY12859 and EY10336. To whom correspondence may be addressed. E-mail:vadim.arshavsky@duke.edu.; Supported by National Institutes of Health Grant EY14147. To whom correspondence may be addressed. E-mail:meburns@ucdavis.	Anderson GR, 2009, CELL BIOCHEM BIOPHYS, V54, P33, DOI 10.1007/s12013-009-9052-9; Arshavsky VY, 2002, ANNU REV PHYSIOL, V64, P153, DOI 10.1146/annurev.physiol.64.082701.102229; Artemyev NO, 2008, MOL NEUROBIOL, V37, P44, DOI 10.1007/s12035-008-8015-2; Baehr W, 2007, J BIOL CHEM, V282, P8837, DOI 10.1074/jbc.M610369200; BIGAY J, 1994, BIOCHEMISTRY-US, V33, P14081, DOI 10.1021/bi00251a017; BURKHARDT DA, 1994, J NEUROSCI, V14, P1091, DOI 10.1523/JNEUROSCI.14-03-01091.1994; Burns ME, 2009, BIOPHYS J, V97, P1538, DOI 10.1016/j.bpj.2009.06.037; Burns ME, 2001, ANNU REV NEUROSCI, V24, P779, DOI 10.1146/annurev.neuro.24.1.779; Burns ME, 2005, NEURON, V48, P387, DOI 10.1016/j.neuron.2005.10.014; Burns ME, 2002, NEURON, V36, P81, DOI 10.1016/S0896-6273(02)00911-X; Calvert PD, 1998, J GEN PHYSIOL, V111, P39, DOI 10.1085/jgp.111.1.39; Calvert PD, 2002, J GEN PHYSIOL, V119, P129, DOI 10.1085/jgp.119.2.129; Calvert PD, 2006, TRENDS CELL BIOL, V16, P560, DOI 10.1016/j.tcb.2006.09.001; Chan S, 2007, INVEST OPHTH VIS SCI, V48, P1968, DOI 10.1167/iovs.06-1287; Chen CK, 2010, J NEUROSCI, V30, P1213, DOI 10.1523/JNEUROSCI.4353-09.2010; CHEN CK, 1995, J BIOL CHEM, V270, P18060, DOI 10.1074/jbc.270.30.18060; Chen J, 2010, J NEUROSCI, V30, P16232, DOI 10.1523/JNEUROSCI.2868-10.2010; Chertov AO, 2011, J BIOL CHEM, V286, P34700, DOI 10.1074/jbc.M111.279752; Coleman JE, 2005, INVEST OPHTH VIS SCI, V46, P12, DOI 10.1167/iovs.04-0691; Cowan CW, 1998, P NATL ACAD SCI USA, V95, P5351, DOI 10.1073/pnas.95.9.5351; Dizhoor AM, 2010, MOL CELL BIOCHEM, V334, P117, DOI 10.1007/s11010-009-0328-6; Doan T, 2006, SCIENCE, V313, P530, DOI 10.1126/science.1126612; Eckmiller MS, 2000, VISUAL NEUROSCI, V17, P711, DOI 10.1017/S0952523800175054; Elias R, 2004, MOL VIS, V10, P672; Fain GL, 2006, BIOESSAYS, V28, P344, DOI 10.1002/bies.20382; Fain GL, 2001, PHYSIOL REV, V81, P117, DOI 10.1152/physrev.2001.81.1.117; Fu YB, 2007, PFLUG ARCH EUR J PHY, V454, P805, DOI 10.1007/s00424-006-0194-y; Gopalakrishna KN, 2011, J BIOL CHEM, V286, P28954, DOI 10.1074/jbc.M111.268821; Govardovskii VI, 2000, J GEN PHYSIOL, V116, P791, DOI 10.1085/jgp.116.6.791; Gross OP, 2010, J NEUROSCI, V30, P3450, DOI 10.1523/JNEUROSCI.5391-09.2010; Gurevich VV, 2011, PROG RETIN EYE RES, V30, P405, DOI 10.1016/j.preteyeres.2011.07.002; Hanson SM, 2007, J MOL BIOL, V368, P375, DOI 10.1016/j.jmb.2007.02.053; Hanson SM, 2007, EMBO J, V26, P1726, DOI 10.1038/sj.emboj.7601614; Heck M, 2001, J BIOL CHEM, V276, P10000, DOI 10.1074/jbc.M009475200; HODGKIN AL, 1988, J PHYSIOL-LONDON, V403, P439, DOI 10.1113/jphysiol.1988.sp017258; Howes KA, 2002, EMBO J, V21, P1545, DOI 10.1093/emboj/21.7.1545; HSU YT, 1993, NATURE, V361, P76, DOI 10.1038/361076a0; Imai H, 1997, P NATL ACAD SCI USA, V94, P2322, DOI 10.1073/pnas.94.6.2322; Kassai H, 2005, NEURON, V47, P529, DOI 10.1016/j.neuron.2005.07.025; Kawamura S, 2008, COMP BIOCHEM PHYS A, V150, P369, DOI 10.1016/j.cbpa.2008.04.600; Kennedy MJ, 2004, NEURON, V41, P915, DOI 10.1016/S0896-6273(04)00086-8; Keresztes G, 2004, J BIOL CHEM, V279, P1581, DOI 10.1074/jbc.C300456200; Kerov V, 2011, MOL CELL NEUROSCI, V46, P340, DOI 10.1016/j.mcn.2010.10.006; Kim M, 2011, BIOCHEMISTRY-US, V50, P2235, DOI 10.1021/bi1018607; KLENCHIN VA, 1995, J BIOL CHEM, V270, P16147, DOI 10.1074/jbc.270.27.16147; Kosloff M, 2008, J BIOL CHEM, V283, P31197, DOI 10.1074/jbc.M803799200; KOUTALOS Y, 1995, J GEN PHYSIOL, V106, P863, DOI 10.1085/jgp.106.5.863; Krispel CM, 2006, NEURON, V51, P409, DOI 10.1016/j.neuron.2006.07.010; Krispel CM, 2003, J GEN PHYSIOL, V122, P703, DOI 10.1085/jgp.200308938; Leskov IB, 2000, NEURON, V27, P525, DOI 10.1016/S0896-6273(00)00063-5; Lobanova ES, 2007, J NEUROSCI, V27, P1151, DOI 10.1523/JNEUROSCI.5010-06.2007; Lobanova ES, 2010, J NEUROSCI, V30, P6815, DOI 10.1523/JNEUROSCI.0613-10.2010; Lyubarsky AL, 2000, J NEUROSCI, V20, P2209; Maeda T, 2003, PROG RETIN EYE RES, V22, P417, DOI 10.1016/S1350-9462(03)00017-X; Makino CL, 2004, J GEN PHYSIOL, V123, P729, DOI 10.1085/jgp.200308994; Makino CL, 2008, J BIOL CHEM, V283, P29135, DOI 10.1074/jbc.M804445200; Matthews HR, 2010, J GEN PHYSIOL, V135, P355, DOI 10.1085/jgp.200910394; Mendez A, 2000, NEURON, V28, P153, DOI 10.1016/S0896-6273(00)00093-3; Mendez A, 2001, P NATL ACAD SCI USA, V98, P9948, DOI 10.1073/pnas.171308998; Nair KS, 2005, NEURON, V46, P555, DOI 10.1016/j.neuron.2005.03.023; Nikonov S, 2000, J GEN PHYSIOL, V116, P795, DOI 10.1085/jgp.116.6.795; Nikonov SS, 2008, NEURON, V59, P462, DOI 10.1016/j.neuron.2008.06.011; Nikonov SS, 2006, J GEN PHYSIOL, V127, P359, DOI 10.1085/jgp.200609490; Norton AW, 2005, J BIOL CHEM, V280, P1248, DOI 10.1074/jbc.M410475200; Okawa H, 2008, CURR BIOL, V18, P1917, DOI 10.1016/j.cub.2008.10.029; Organisciak DT, 2010, PROG RETIN EYE RES, V29, P113, DOI 10.1016/j.preteyeres.2009.11.004; Orisme W, 2010, CELL SIGNAL, V22, P447, DOI 10.1016/j.cellsig.2009.10.016; OttoBruc A, 1997, BIOCHEMISTRY-US, V36, P4295, DOI 10.1021/bi963000d; Peshenko IV, 2011, BIOCHEMISTRY-US, V50, P5590, DOI 10.1021/bi200491b; Peterson JJ, 2005, INVEST OPHTH VIS SCI, V46, P3988, DOI 10.1167/iovs.05-0567; Pugh EN, 1999, CURR OPIN NEUROBIOL, V9, P410, DOI 10.1016/S0959-4388(99)80062-2; Punzo C, 2009, NAT NEUROSCI, V12, P44, DOI 10.1038/nn.2234; Rajala A, 2009, BIOCHEMISTRY-US, V48, P5563, DOI 10.1021/bi9000062; Rajala RVS, 2010, MOL NEUROBIOL, V42, P39, DOI 10.1007/s12035-010-8130-8; RAMDAS L, 1991, BIOCHEMISTRY-US, V30, P11637, DOI 10.1021/bi00114a005; Rebrik TI, 2000, J GEN PHYSIOL, V116, P521, DOI 10.1085/jgp.116.4.521; Rebrik TI, 1998, J GEN PHYSIOL, V112, P537, DOI 10.1085/jgp.112.5.537; Reidel B, 2006, VISION RES, V46, P4464, DOI 10.1016/j.visres.2006.07.019; Rosenzweig DH, 2007, J NEUROSCI, V27, P5484, DOI 10.1523/JNEUROSCI.1421-07.2007; Sakurai K, 2011, J NEUROSCI, V31, P7991, DOI 10.1523/JNEUROSCI.6650-10.2011; Sampath AP, 1999, J GEN PHYSIOL, V113, P267, DOI 10.1085/jgp.113.2.267; Sampath AP, 1998, J GEN PHYSIOL, V111, P53, DOI 10.1085/jgp.111.1.53; Shi G, 2007, J NEUROSCI, V27, P10084, DOI 10.1523/JNEUROSCI.2211-07.2007; SITARAMAYYA A, 1983, J BIOL CHEM, V258, P2106; Skiba NP, 2000, J BIOL CHEM, V275, P32716, DOI 10.1074/jbc.C000413200; Slepak VZ, 2008, IUBMB LIFE, V60, P2, DOI 10.1002/iub.7; Sokolov M, 2004, J BIOL CHEM, V279, P19149, DOI 10.1074/jbc.M311058200; Sokolov M, 2002, NEURON, V34, P95, DOI 10.1016/S0896-6273(02)00636-0; Song X, 2011, NEUROSCIENCE, V174, P37, DOI 10.1016/j.neuroscience.2010.11.009; Stephen R, 2008, PHOTOCHEM PHOTOBIOL, V84, P903, DOI 10.1111/j.1751-1097.2008.00323.x; Strissel KJ, 2006, J NEUROSCI, V26, P1146, DOI 10.1523/JNEUROSCI.4289-05.2006; Tachibanaki S, 2005, P NATL ACAD SCI USA, V102, P9329, DOI 10.1073/pnas.0501875102; Vishnivetskiy SA, 2007, J BIOL CHEM, V282, P32075, DOI 10.1074/jbc.M706057200; Xu J, 1997, NATURE, V389, P505, DOI 10.1038/39068; Xu XZ, 2011, PROTEINS, V79, P1910, DOI 10.1002/prot.23014; Yang RB, 1999, J NEUROSCI, V19, P5889, DOI 10.1523/JNEUROSCI.19-14-05889.1999; YOSHIDA T, 1994, J BIOL CHEM, V269, P24050; Zhang H, 2007, P NATL ACAD SCI USA, V104, P8857, DOI 10.1073/pnas.0701681104; Zhang HB, 2011, NAT NEUROSCI, V14, P874, DOI 10.1038/nn.2835; Zhang X, 2003, J NEUROSCI, V23, P1287, DOI 10.1523/JNEUROSCI.23-04-01287.2003	100	130	134	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2012	287	3					1620	1626		10.1074/jbc.R111.305243	http://dx.doi.org/10.1074/jbc.R111.305243			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879HT	22074925	Green Published, hybrid			2022-12-27	WOS:000299321000003
J	Asanoma, K; Kubota, K; Chakraborty, D; Renaud, SJ; Wake, N; Fukushima, K; Soares, MJ; Rumi, MAK				Asanoma, Kazuo; Kubota, Kaiyu; Chakraborty, Damayanti; Renaud, Stephen J.; Wake, Norio; Fukushima, Kotaro; Soares, Michael J.; Rumi, M. A. Karim			SATB Homeobox Proteins Regulate Trophoblast Stem Cell Renewal and Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MATRIX ATTACHMENT REGION; MAR-BINDING PROTEIN; GENE-EXPRESSION; MOUSE EMBRYOS; DNA-BINDING; FATE SPECIFICATION; MULTIPLE GENES; SELF-RENEWAL; TROPHECTODERM; CHROMATIN	The morphogenesis of the hemochorial placenta is dependent upon the precise expansion and differentiation of trophoblast stem (TS) cells. SATB homeobox 1 (SATB1) and SATB2 are related proteins that have been implicated as regulators of some stem cell populations. SATB1 is highly expressed in TS cells, which prompted an investigation of SATB1 and the related SATB2 as regulators of TS cells. SATB1 and SATB2 were highly expressed in rat TS cells maintained in the stem state and rapidly declined following induction of differentiation. SATB proteins were also present within the rat placenta during early stages of its morphogenesis and disappeared as gestation advanced. Silencing Satb1 or Satb2 expression decreased TS cell self-renewal and increased differentiation, whereas ectopic expression of SATB proteins promoted TS cell expansion and blunted differentiation. Eomes, a key transcriptional regulator of TS cells, was identified as a target for SATB proteins. SATB knockdown decreased Eomes transcript levels and promoter activity, whereas SATB ectopic expression increased Eomes transcript levels and promoter activity. Electrophoretic mobility shift assay as well as chromatin immunoprecipitation analyses demonstrated that SATB proteins physically associate with a regulatory site within the Eomes promoter. We conclude that SATB proteins promote TS cell renewal and inhibit differentiation. These actions are mediated in part by regulating the expression of the TS cell stem-associated transcription factor, EOMES.	[Asanoma, Kazuo; Kubota, Kaiyu; Chakraborty, Damayanti; Renaud, Stephen J.; Soares, Michael J.; Rumi, M. A. Karim] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Inst Reprod Hlth & Regenerat Med, Kansas City, KS 66160 USA; [Wake, Norio; Fukushima, Kotaro] Kyushu Univ, Dept Obstet & Gynecol, Grad Sch Med Sci, Fukuoka 8128582, Japan	University of Kansas; University of Kansas Medical Center; Kyushu University	Rumi, MAK (corresponding author), Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Inst Reprod Hlth & Regenerat Med, HLSIC 3056,3901 Rainbow Blvd, Kansas City, KS 66160 USA.	mrumi@kumc.edu			National Institutes of Health [HD20676]; American Heart Association; Lalor Foundation; Canadian Institutes of Health Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD020676] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Lalor Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health Grant HD20676.; Recipient of a predoctoral fellowship from the American Heart Association.; Recipient of postdoctoral fellowships from the Lalor Foundation and the Canadian Institutes of Health Research.	Agrelo R, 2009, DEV CELL, V16, P507, DOI 10.1016/j.devcel.2009.03.006; Ahlfors H, 2010, BLOOD, V116, P1443, DOI 10.1182/blood-2009-11-252205; Ain R, 2006, METH MOLEC MED, V121, P295; Alcamo EA, 2008, NEURON, V57, P364, DOI 10.1016/j.neuron.2007.12.012; Alvarez JD, 2000, GENE DEV, V14, P521; Asanoma K, 2011, DEV BIOL, V351, P110, DOI 10.1016/j.ydbio.2010.12.038; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Britanova O, 2005, EUR J NEUROSCI, V21, P658, DOI 10.1111/j.1460-9568.2005.03897.x; Britanova O, 2008, NEURON, V57, P378, DOI 10.1016/j.neuron.2007.12.028; Cai ST, 2006, NAT GENET, V38, P1278, DOI 10.1038/ng1913; Cai ST, 2003, NAT GENET, V34, P42, DOI 10.1038/ng1146; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Dickinson LA, 1997, J BIOL CHEM, V272, P11463; DICKINSON LA, 1992, CELL, V70, P631, DOI 10.1016/0092-8674(92)90432-C; Dobreva G, 2003, GENE DEV, V17, P3048, DOI 10.1101/gad.1153003; Dobreva G, 2006, CELL, V125, P971, DOI 10.1016/j.cell.2006.05.012; Erlebacher A, 2004, DEV BIOL, V275, P158, DOI 10.1016/j.ydbio.2004.07.032; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; FARIA TN, 1991, ENDOCRINOLOGY, V129, P2895, DOI 10.1210/endo-129-6-2895; Farthing CR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000116; Georgiades P, 2006, DEVELOPMENT, V133, P1059, DOI 10.1242/dev.02277; Gyorgy AB, 2008, EUR J NEUROSCI, V27, P865, DOI 10.1111/j.1460-9568.2008.06061.x; Hamatani T, 2004, P NATL ACAD SCI USA, V101, P10326, DOI 10.1073/pnas.0402597101; Han HJ, 2008, NATURE, V452, P187, DOI 10.1038/nature06781; Hemberger M, 2010, EPIGENETICS-US, V5, P24, DOI 10.4161/epi.5.1.10589; Ho L, 2010, NATURE, V463, P474, DOI 10.1038/nature08911; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Kent LN, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-97; Keramari M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013952; Kidder BL, 2010, GENOME RES, V20, P458, DOI 10.1101/gr.101469.109; Kuckenberg P, 2010, MOL CELL BIOL, V30, P3310, DOI 10.1128/MCB.01215-09; Kunath T, 2005, DEVELOPMENT, V132, P1649, DOI 10.1242/dev.01715; Lessard JA, 2010, ANNU REV CELL DEV BI, V26, P503, DOI 10.1146/annurev-cellbio-051809-102012; Loots GG, 2004, NUCLEIC ACIDS RES, V32, pW217, DOI 10.1093/nar/gkh383; Maltepe E, 2010, J CLIN INVEST, V120, P1016, DOI 10.1172/JCI41211; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Nakayama Y, 2005, CELL CYCLE, V4, P1099; Ng RK, 2008, NAT CELL BIOL, V10, P1280, DOI 10.1038/ncb1786; Nishioka N, 2008, MECH DEVELOP, V125, P270, DOI 10.1016/j.mod.2007.11.002; Nishioka N, 2009, DEV CELL, V16, P398, DOI 10.1016/j.devcel.2009.02.003; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Notani D, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000296; Odiatis C, 2010, PLACENTA, V31, P630, DOI 10.1016/j.placenta.2010.05.001; Purbey PK, 2008, NUCLEIC ACIDS RES, V36, P2107, DOI 10.1093/nar/gkm1151; Ralston A, 2005, CLIN GENET, V68, P106, DOI 10.1111/j.1399-0004.2005.00478.x; Ralston A, 2010, DEVELOPMENT, V137, P395, DOI 10.1242/dev.038828; Rielland M, 2008, DEV BIOL, V322, P1, DOI 10.1016/j.ydbio.2008.07.017; Roberts RM, 2011, BIOL REPROD, V84, P412, DOI 10.1095/biolreprod.110.088724; Rugg-Gunn PJ, 2010, P NATL ACAD SCI USA, V107, P10783, DOI 10.1073/pnas.0914507107; Russ AP, 2000, NATURE, V404, P95, DOI 10.1038/35003601; Sahgal N, 2006, METH MOLEC MED, V121, P159; Santos J, 2010, EPIGENET CHROMATIN, V3, DOI 10.1186/1756-8935-3-1; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sasaki H, 2010, DEV GROWTH DIFFER, V52, P263, DOI 10.1111/j.1440-169X.2009.01158.x; Savarese F, 2009, GENE DEV, V23, P2625, DOI 10.1101/gad.1815709; Senner CE, 2010, PLACENTA, V31, P944, DOI 10.1016/j.placenta.2010.07.013; Simmons DG, 2005, DEV BIOL, V284, P12, DOI 10.1016/j.ydbio.2005.05.010; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Strumpf D, 2005, DEVELOPMENT, V132, P2093, DOI 10.1242/dev.01801; Szemes M, 2006, NEUROCHEM RES, V31, P237, DOI 10.1007/s11064-005-9012-8; Tanaka S, 1998, SCIENCE, V282, P2072, DOI 10.1126/science.282.5396.2072; THOMSON JA, 1995, P NATL ACAD SCI USA, V92, P7844, DOI 10.1073/pnas.92.17.7844; Tremblay GB, 2001, GENE DEV, V15, P833, DOI 10.1101/gad.873401; Wen F, 2007, DEV BIOL, V312, P284, DOI 10.1016/j.ydbio.2007.09.024; Wen J, 2005, BLOOD, V105, P3330, DOI 10.1182/blood-2004-08-2988; Yamasaki K, 2007, NUCLEIC ACIDS RES, V35, P5073, DOI 10.1093/nar/gkm504; Yasui D, 2002, NATURE, V419, P641, DOI 10.1038/nature01084; Zhang XF, 2008, J BIOL CHEM, V283, P35825, DOI 10.1074/jbc.M803481200; Zhou Q, 2007, P NATL ACAD SCI USA, V104, P16438, DOI 10.1073/pnas.0701014104	69	42	46	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2012	287	3					2257	2268		10.1074/jbc.M111.287128	http://dx.doi.org/10.1074/jbc.M111.287128			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879HT	22123820	hybrid, Green Published			2022-12-27	WOS:000299321000063
J	Jo, SH; Ren, RB				Jo, Seung-Hee; Ren, Ruibao			IRF-4 Suppresses BCR/ABL Transformation of Myeloid Cells in a DNA Binding-independent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERFERON REGULATORY FACTOR-4; CHRONIC MYELOGENOUS LEUKEMIA; TOLL-LIKE RECEPTORS; TRANSCRIPTION FACTOR; BCR-ABL; PRE-B; INTESTINAL TUMORIGENESIS; MULTIPLE-MYELOMA; EXPRESSION; GENE	Interferon regulatory factor 4 (IRF-4) is essential for B and T cell development and immune response regulation, and has both nuclear and cytoplasmic functions. IRF-4 was originally identified as a proto-oncogene resulting from a t(6; 14) chromosomal translocation in multiple myeloma and its expression was shown to be essential for multiple myeloma cell survival. However, we have previously shown that IRF-4 functions as a tumor suppressor in the myeloid lineage and in early stages of B cell development. In this study, we found that IRF-4 suppresses BCR/ABL transformation of myeloid cells. To gain insight into the molecular pathways that mediate IRF-4 tumor suppressor function, we performed a structure-function analysis of IRF-4 as a suppressor of BCR/ABL transformation. We found that the DNA binding domain deletion mutant of IRF-4, which is localized only in the cytoplasm, is still able to inhibit BCR/ABL transformation of myeloid cells. IRF-4 also functions as a tumor suppressor in bone marrow cells deficient in MyD88, an IRF-4-interacting protein found in the cytoplasm. However, IRF-4 tumor suppressor activity is lost in IRF association domain (IAD) deletion mutants. These results demonstrate that IRF-4 suppresses BCR/ABL transformation by a novel cytoplasmic function involving its IAD domain.	[Ren, Ruibao] Brandeis Univ, Rosenstiel Basic Med Sci Res Ctr, Waltham, MA 02454 USA; [Ren, Ruibao] Brandeis Univ, Dept Biol, Waltham, MA 02454 USA	Brandeis University; Brandeis University	Ren, RB (corresponding author), Brandeis Univ, Rosenstiel Basic Med Sci Res Ctr, Waltham, MA 02454 USA.	ren@brandeis.edu			National Institutes of Health [R01HL083515]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083515] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work is supported, in whole or in part, by National Institutes of Health Grant R01HL083515 (to R. R.).	Acquaviva J, 2008, BLOOD, V112, P3798, DOI 10.1182/blood-2007-10-117838; Brass AL, 1999, EMBO J, V18, P977, DOI 10.1093/emboj/18.4.977; Brass AL, 1996, GENE DEV, V10, P2335, DOI 10.1101/gad.10.18.2335; Chen QZ, 2008, IMMUNITY, V29, P899, DOI 10.1016/j.immuni.2008.10.011; Chiron D, 2008, BLOOD, V112, P2205, DOI 10.1182/blood-2008-02-140673; Coligan J.E., 1996, CURRENT PROTOCOLS IM; Gross AW, 1999, MOL CELL BIOL, V19, P6918; Gupta S, 2003, J BIOL CHEM, V278, P43541, DOI 10.1074/jbc.M308960200; Gupta S, 2003, HUM IMMUNOL, V64, P389, DOI 10.1016/S0198-8859(03)00024-7; Hao SX, 2000, MOL CELL BIOL, V20, P1149, DOI 10.1128/MCB.20.4.1149-1161.2000; Himmelmann A, 1997, BLOOD, V90, P3984, DOI 10.1182/blood.V90.10.3984; Holtschke T, 1996, CELL, V87, P307, DOI 10.1016/S0092-8674(00)81348-3; Honma K, 2005, P NATL ACAD SCI USA, V102, P16001, DOI 10.1073/pnas.0504226102; Huang B, 2008, ONCOGENE, V27, P218, DOI 10.1038/sj.onc.1210904; Iida S, 1997, NAT GENET, V17, P226, DOI 10.1038/ng1097-226; Ito M, 2002, JPN J CANCER RES, V93, P685, DOI 10.1111/j.1349-7006.2002.tb01307.x; Jo SH, 2010, BLOOD, V116, P2759, DOI 10.1182/blood-2009-07-234559; Johnson K, 2008, IMMUNITY, V28, P335, DOI 10.1016/j.immuni.2007.12.019; Kanno Y, 2005, J INTERF CYTOK RES, V25, P770, DOI 10.1089/jir.2005.25.770; Klein F, 2005, J IMMUNOL, V174, P367, DOI 10.4049/jimmunol.174.1.367; Lee SH, 2010, NAT MED, V16, P665, DOI 10.1038/nm.2143; Lu RQ, 2003, GENE DEV, V17, P1703, DOI 10.1101/gad.1104803; Lu RQ, 2008, TRENDS IMMUNOL, V29, P487, DOI 10.1016/j.it.2008.07.006; Ma SB, 2008, BLOOD, V111, P1396, DOI 10.1182/blood-2007-08-110106; Mamane Y, 2000, IMMUNITY, V12, P129, DOI 10.1016/S1074-7613(00)80166-1; Marecki S, 2001, J IMMUNOL, V166, P6829, DOI 10.4049/jimmunol.166.11.6829; Marecki S, 2002, J INTERF CYTOK RES, V22, P121, DOI 10.1089/107999002753452737; Negishi H, 2005, P NATL ACAD SCI USA, V102, P15989, DOI 10.1073/pnas.0508327102; Ortmann CA, 2005, NUCLEIC ACIDS RES, V33, P6895, DOI 10.1093/nar/gki1001; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Rakoff-Nahoum S, 2009, NAT REV CANCER, V9, P57, DOI 10.1038/nrc2541; Rakoff-Nahoum S, 2007, SCIENCE, V317, P124, DOI 10.1126/science.1140488; Ren R, 2005, NAT REV CANCER, V5, P172, DOI 10.1038/nrc1567; Schmidt M, 2000, J CLIN ONCOL, V18, P3331, DOI 10.1200/JCO.2000.18.19.3331; Schmidt M, 2001, BLOOD, V97, P3648, DOI 10.1182/blood.V97.11.3648; Sciammas R, 2006, IMMUNITY, V25, P225, DOI 10.1016/j.immuni.2006.07.009; Shaffer AL, 2008, NATURE, V454, P226, DOI 10.1038/nature07064; Shaffer AL, 2009, CLIN CANCER RES, V15, P2954, DOI 10.1158/1078-0432.CCR-08-1845; Takaoka A, 2005, NATURE, V434, P243, DOI 10.1038/nature03308; Tamura T, 2002, J INTERF CYTOK RES, V22, P145, DOI 10.1089/107999002753452755; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; Thomas EK, 2008, LEUKEMIA, V22, P898, DOI 10.1038/leu.2008.71	42	9	9	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2012	287	3					1770	1778		10.1074/jbc.M111.289728	http://dx.doi.org/10.1074/jbc.M111.289728			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879HT	22110133	Green Published, hybrid			2022-12-27	WOS:000299321000019
J	von Lintig, J				von Lintig, Johannes			Metabolism of Carotenoids and Retinoids Related to Vision	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							PHOTORECEPTOR OUTER SEGMENTS; PARALLEL VISUAL CYCLES; VITAMIN-A; BINDING-PROTEIN; BETA-CAROTENE; CELLULAR UPTAKE; COMPLEMENT ACTIVATION; RETINAL DEGENERATION; CONE PHOTORECEPTORS; OXIDATIVE CLEAVAGE	All animals endowed with the ability to detect light through visual pigments must have evolved pathways in which dietary precursors for the involved chromophore are absorbed, transported, and metabolized. Knowledge about this metabolism has exponentially increased over the past decade. Genetic manipulation of animal models provided insights into the metabolic flow of these compounds through the body and in the eyes, unraveling their regulatory aspects and aberrant side reactions. The scheme that emerges reveals a common origin of key components for chromophore metabolism that have been adapted to the specific requirements of retinoid biology in different animal classes.	Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA	Case Western Reserve University	von Lintig, J (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA.	johannes.vonlintig@case.edu		von Lintig, Johannes/0000-0002-2079-2143	National Institutes of Health [EY019641, EY020551]; NATIONAL EYE INSTITUTE [R01EY019641, R01EY020551] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants EY019641 and EY020551. This is the third article in the Thematic Minireview Series on Focus on Vision.	Allikmets R, 1997, SCIENCE, V277, P1805, DOI 10.1126/science.277.5333.1805; Amengual J, 2011, FASEB J, V25, P948, DOI 10.1096/fj.10-173906; Arshavsky VY, 2002, ANNU REV PHYSIOL, V64, P153, DOI 10.1146/annurev.physiol.64.082701.102229; Batten ML, 2004, J BIOL CHEM, V279, P10422, DOI 10.1074/jbc.M312410200; Bhosale P, 2004, J BIOL CHEM, V279, P49447, DOI 10.1074/jbc.M405334200; Choi MY, 2006, DEVELOPMENT, V133, P4119, DOI 10.1242/dev.02537; Clagett-Dame M, 2002, ANNU REV NUTR, V22, P347, DOI 10.1146/annurev.nutr.22.010402.102745E; During A, 2008, J LIPID RES, V49, P1715, DOI 10.1194/jlr.M700580-JLR200; EDWARDS RB, 1994, EXP EYE RES, V59, P161, DOI 10.1006/exer.1994.1094; EPISKOPOU V, 1993, P NATL ACAD SCI USA, V90, P2375, DOI 10.1073/pnas.90.6.2375; Fan J, 2003, P NATL ACAD SCI USA, V100, P13662, DOI 10.1073/pnas.2234461100; Fleisch VC, 2008, J NEUROSCI, V28, P8208, DOI 10.1523/JNEUROSCI.2367-08.2008; Fleisch VC, 2010, PROG RETIN EYE RES, V29, P476, DOI 10.1016/j.preteyeres.2010.05.001; Ford NA, 2010, J NUTR, V140, P2134, DOI 10.3945/jn.110.128033; Golzio C, 2007, AM J HUM GENET, V80, P1179, DOI 10.1086/518177; GOODMAN DS, 1965, J LIPID RES, V6, P390; Haeseleer F, 2002, J BIOL CHEM, V277, P45537, DOI 10.1074/jbc.M208882200; Haeseleer F, 1998, J BIOL CHEM, V273, P21790, DOI 10.1074/jbc.273.34.21790; HAMEL CP, 1993, J BIOL CHEM, V268, P15751; HARRIS WA, 1977, NATURE, V266, P648, DOI 10.1038/266648a0; Hessel S, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M706763200; Hu KQ, 2006, J BIOL CHEM, V281, P19327, DOI 10.1074/jbc.M512095200; Imanishi Y, 2004, J CELL BIOL, V166, P447, DOI 10.1083/jcb.200405110; Isken A, 2008, CELL METAB, V7, P258, DOI 10.1016/j.cmet.2008.01.009; Janecke AR, 2004, NAT GENET, V36, P850, DOI 10.1038/ng1394; Jastrzebska B, 2011, J BIOL CHEM, V286, P18930, DOI 10.1074/jbc.M111.234583; Jin MH, 2005, CELL, V122, P449, DOI 10.1016/j.cell.2005.06.042; Kawaguchi R, 2007, SCIENCE, V315, P820, DOI 10.1126/science.1136244; Kawaguchi R, 2011, ACS CHEM BIOL, V6, P1041, DOI 10.1021/cb200178w; Kiefer C, 2002, P NATL ACAD SCI USA, V99, P10581, DOI 10.1073/pnas.162182899; Kiefer C, 2001, J BIOL CHEM, V276, P14110, DOI 10.1074/jbc.M011510200; Kiser PD, 2009, P NATL ACAD SCI USA, V106, P17325, DOI 10.1073/pnas.0906600106; Kloer DP, 2005, SCIENCE, V308, P267, DOI 10.1126/science.1108965; Kushiro T, 2004, EMBO J, V23, P1647, DOI 10.1038/sj.emboj.7600121; Li BX, 2011, BIOCHEMISTRY-US, V50, P2541, DOI 10.1021/bi101906y; Lindqvist A, 2002, J BIOL CHEM, V277, P23942, DOI 10.1074/jbc.M202756200; Lobo GP, 2010, FASEB J, V24, P1656, DOI 10.1096/fj.09-150995; Maeda A, 2005, J BIOL CHEM, V280, P18822, DOI 10.1074/jbc.M501757200; Maeda A, 2008, J BIOL CHEM, V283, P26684, DOI 10.1074/jbc.M804505200; Maeda A, 2007, P NATL ACAD SCI USA, V104, P19565, DOI 10.1073/pnas.0707477104; Maeda A, 2009, J BIOL CHEM, V284, P15173, DOI 10.1074/jbc.M900322200; Mardones P, 2002, J NUTR, V132, P443, DOI 10.1093/jn/132.3.443; Mark M, 2006, ANNU REV PHARMACOL, V46, P451, DOI 10.1146/annurev.pharmtox.46.120604.141156; Marlhens F, 1997, NAT GENET, V17, P139, DOI 10.1038/ng1097-139; Mata NL, 2004, J BIOL CHEM, V279, P635, DOI 10.1074/jbc.M310042200; Mata NL, 2002, NEURON, V36, P69, DOI 10.1016/S0896-6273(02)00912-1; Mein JR, 2011, ARCH BIOCHEM BIOPHYS, V506, P109, DOI 10.1016/j.abb.2010.11.005; Messing SAJ, 2010, PLANT CELL, V22, P2970, DOI 10.1105/tpc.110.074815; Moise AR, 2005, TRENDS PLANT SCI, V10, P178, DOI 10.1016/j.tplants.2005.02.006; Moiseyev G, 2006, J BIOL CHEM, V281, P2835, DOI 10.1074/jbc.M508903200; Moiseyev G, 2005, P NATL ACAD SCI USA, V102, P12413, DOI 10.1073/pnas.0503460102; Mustafi D, 2009, PROG RETIN EYE RES, V28, P289, DOI 10.1016/j.preteyeres.2009.05.003; O'Byrne SM, 2005, J BIOL CHEM, V280, P35647, DOI 10.1074/jbc.M507924200; Oberhauser V, 2008, P NATL ACAD SCI USA, V105, P19000, DOI 10.1073/pnas.0807805105; OZAKI K, 1993, NEURON, V10, P1113, DOI 10.1016/0896-6273(93)90059-Z; Paik J, 2004, J NUTR, V134, p276S, DOI 10.1093/jn/134.1.276S; Palczewski K, 2010, TRENDS PHARMACOL SCI, V31, P284, DOI 10.1016/j.tips.2010.03.001; Pasutto F, 2007, AM J HUM GENET, V80, P550, DOI 10.1086/512203; Poliakov E, 2005, J BIOL CHEM, V280, P29217, DOI 10.1074/jbc.M500409200; Quadro L, 1999, EMBO J, V18, P4633, DOI 10.1093/emboj/18.17.4633; Rattner A, 2000, J BIOL CHEM, V275, P11034, DOI 10.1074/jbc.275.15.11034; Reboul E, 2011, PROG LIPID RES, V50, P388, DOI 10.1016/j.plipres.2011.07.001; Redmond TM, 1998, NAT GENET, V20, P344, DOI 10.1038/3813; REDMOND TM, 1985, BIOCHEMISTRY-US, V24, P787, DOI 10.1021/bi00324a038; Redmond TM, 2005, P NATL ACAD SCI USA, V102, P13658, DOI 10.1073/pnas.0504167102; Rigotti A, 2003, ENDOCR REV, V24, P357, DOI 10.1210/er.2001-0037; SAARI JC, 1988, J BIOL CHEM, V263, P8084; SAARI JC, 1987, J BIOL CHEM, V262, P7618; Sakudoh T, 2010, J BIOL CHEM, V285, P7739, DOI 10.1074/jbc.M109.074435; Samardzija M, 2009, HUM MOL GENET, V18, P1266, DOI 10.1093/hmg/ddp026; Schonthaler HB, 2007, EUR J NEUROSCI, V26, P1940, DOI 10.1111/j.1460-9568.2007.05801.x; Schwartz SH, 1997, SCIENCE, V276, P1872, DOI 10.1126/science.276.5320.1872; Seeliger MW, 1999, INVEST OPHTH VIS SCI, V40, P3; Seeliger MW, 2001, NAT GENET, V29, P70, DOI 10.1038/ng712; Seino Y, 2008, J BIOL CHEM, V283, P4905, DOI 10.1074/jbc.M707928200; Sparrow JR, 2010, ADV EXP MED BIOL, V703, P63, DOI 10.1007/978-1-4419-5635-4_5; Tang PH, 2011, J NEUROSCI, V31, P10403, DOI 10.1523/JNEUROSCI.0182-11.2011; Travis GH, 2007, ANNU REV PHARMACOL, V47, P469, DOI 10.1146/annurev.pharmtox.47.120505.105225; Tsybovsky Y, 2010, ADV EXP MED BIOL, V703, P105, DOI 10.1007/978-1-4419-5635-4_8; Underwood BA, 2004, J NUTR, V134, p231S, DOI 10.1093/jn/134.1.231S; van Bennekum A, 2005, BIOCHEMISTRY-US, V44, P4517, DOI 10.1021/bi0484320; van Bennekum AM, 1999, J LIPID RES, V40, P565; von Lintig J, 2001, P NATL ACAD SCI USA, V98, P1130, DOI 10.1073/pnas.031576398; von Lintig J, 2010, TRENDS BIOCHEM SCI, V35, P400, DOI 10.1016/j.tibs.2010.01.005; Voolstra O, 2006, BIOCHEMISTRY-US, V45, P13429, DOI 10.1021/bi060701u; Voolstra O, 2010, J BIOL CHEM, V285, P2130, DOI 10.1074/jbc.M109.056101; Wang JS, 2009, CURR BIOL, V19, P1665, DOI 10.1016/j.cub.2009.07.054; Wang T, 2005, J NEUROSCI, V25, P5187, DOI 10.1523/JNEUROSCI.0995-05.2005; Wang T, 2007, J CELL BIOL, V177, P305, DOI 10.1083/jcb.200610081; Wang XY, 2010, CURR BIOL, V20, P93, DOI 10.1016/j.cub.2009.12.022; Wenzel A, 2007, INVEST OPHTH VIS SCI, V48, P534, DOI 10.1167/iovs.06-0652; Wolf G, 2001, J NUTR, V131, P1647, DOI 10.1093/jn/131.6.1647; Wongsiriroj N, 2008, J BIOL CHEM, V283, P13510, DOI 10.1074/jbc.M800777200; Woodruff ML, 2003, NAT GENET, V35, P158, DOI 10.1038/ng1246; Xu H, 2004, EMBO J, V23, P811, DOI 10.1038/sj.emboj.7600112; Xue LL, 2004, CELL, V117, P761, DOI 10.1016/j.cell.2004.05.016; Zhang HB, 2008, J NEUROSCI, V28, P4008, DOI 10.1523/JNEUROSCI.0317-08.2008; Zhou JL, 2006, P NATL ACAD SCI USA, V103, P16182, DOI 10.1073/pnas.0604255103	98	60	63	1	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2012	287	3					1627	1634		10.1074/jbc.R111.303990	http://dx.doi.org/10.1074/jbc.R111.303990			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879HT	22074927	Green Published, hybrid			2022-12-27	WOS:000299321000004
J	Jager, R; Russwurm, C; Schwede, F; Genieser, HG; Koesling, D; Russwurm, M				Jaeger, Ronald; Russwurm, Corina; Schwede, Frank; Genieser, Hans-Gottfried; Koesling, Doris; Russwurm, Michael			Activation of PDE10 and PDE11 Phosphodiesterases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC-NUCLEOTIDE PHOSPHODIESTERASES; GAF DOMAINS; SPLICE VARIANTS; HUMAN TISSUES; GENE FAMILY; CGMP; CAMP; 11A; LOCALIZATION; CLONING	The most recently identified cyclic nucleotide phosphodiesterases, PDE10 and PDE11, contain a tandem of so-called GAF domains in their N-terminal regulatory regions. In PDE2 and PDE5, the GAF domains mediate cGMP stimulation; however, their function in PDE10 and PDE11 remains controversial. Although the GAF domains of PDE10 mediate cAMP-induced stimulation of chimeric adenylyl cyclases, cAMP binding did not stimulate the PDE10 holoenzyme. Comparable data about cGMP and the PDE11 GAF domains exist. Here, we identified synthetic ligands for the GAF domains of PDE10 and PDE11 to reduce interference of the GAF ligand with the catalytic reaction of PDE. With these ligands, GAF-mediated stimulation of the PDE10 and PDE11 holoenzymes is demonstrated for the first time. Furthermore, PDE10 is shown to be activated by cAMP, which paradoxically results in potent competitive inhibition of cGMP turnover by cAMP. PDE11, albeit susceptible to GAF-dependent stimulation, is not activated by the native cyclic nucleotides cAMP and cGMP. In summary, PDE11 can be stimulated by GAF domain ligands, but its native ligand remains to be identified, and PDE10 is the only PDE activated by cAMP.	[Jaeger, Ronald; Russwurm, Corina; Koesling, Doris; Russwurm, Michael] Ruhr Univ Bochum, Inst Pharmakol & Toxikol, Fak Med, D-44780 Bochum, Germany; [Schwede, Frank; Genieser, Hans-Gottfried] BIOLOG Life Sci Inst, D-28071 Bremen, Germany	Ruhr University Bochum	Russwurm, M (corresponding author), Ruhr Univ Bochum, Inst Pharmakol & Toxikol, Fak Med, MA N1, D-44780 Bochum, Germany.	michael.russwurm@ruhr-uni-bochum.de		Genieser, Hans-Gottfried/0000-0002-4904-5790	Deutsche Forschungsgemeinschaft [Ko1157]; Kommission fur Finanzautonomie und Erganzungsmittel of the Medical Faculty (KOFFER)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Kommission fur Finanzautonomie und Erganzungsmittel of the Medical Faculty (KOFFER)	This work was supported by Deutsche Forschungsgemeinschaft Grant Ko1157 and the Kommission fur Finanzautonomie und Erganzungsmittel of the Medical Faculty (KOFFER). H. G. G. is the chief executive officer and F. S. is the head of research and development of BIOLOG Life Science Institute, which sells cyclic nucleotide analogues for research purposes.	Aravind L, 1997, TRENDS BIOCHEM SCI, V22, P458, DOI 10.1016/S0968-0004(97)01148-1; BEAVO JA, 1971, J BIOL CHEM, V246, P3841; Bender AT, 2006, PHARMACOL REV, V58, P488, DOI 10.1124/pr.58.3.5; Conti M, 2007, ANNU REV BIOCHEM, V76, P481, DOI 10.1146/annurev.biochem.76.060305.150444; Corbin JD, 2003, MOL PHARMACOL, V63, P1364, DOI 10.1124/mol.63.6.1364; D'Andrea MR, 2005, J HISTOCHEM CYTOCHEM, V53, P895, DOI 10.1369/jhc.5A6625.2005; Fawcett L, 2000, P NATL ACAD SCI USA, V97, P3702, DOI 10.1073/pnas.050585197; Francis Sharron H., 2009, V191, P367, DOI 10.1007/978-3-540-68964-5_16; Fujishige K, 1999, J BIOL CHEM, V274, P18438, DOI 10.1074/jbc.274.26.18438; GILLESPIE PG, 1989, MOL PHARMACOL, V36, P773; Gross-Langenhoff M, 2006, J BIOL CHEM, V281, P2841, DOI 10.1074/jbc.M511468200; Gross-Langenhoff M, 2008, FEBS J, V275, P1643, DOI 10.1111/j.1742-4658.2008.06319.x; Habert R, 2001, MOL CELL ENDOCRINOL, V179, P47, DOI 10.1016/S0303-7207(01)00461-0; Handa N, 2008, J BIOL CHEM, V283, P19657, DOI 10.1074/jbc.M800595200; Hetman JM, 2000, P NATL ACAD SCI USA, V97, P12891, DOI 10.1073/pnas.200355397; HURLEY JH, 2003, SCI STKE, pPE1; Jager R, 2010, BRIT J PHARMACOL, V161, P1645, DOI 10.1111/j.1476-5381.2010.00977.x; Kelly MP, 2010, P NATL ACAD SCI USA, V107, P8457, DOI 10.1073/pnas.1000730107; Kotera J, 2004, J BIOL CHEM, V279, P4366, DOI 10.1074/jbc.M308471200; Loughney K, 1999, GENE, V234, P109, DOI 10.1016/S0378-1119(99)00171-7; Loughney K, 2005, INT J IMPOT RES, V17, P320, DOI 10.1038/sj.ijir.3901317; Martinez Sergio E, 2002, Mol Interv, V2, P317, DOI 10.1124/mi.2.5.317; Matthiesen K, 2009, BIOCHEM J, V423, P401, DOI 10.1042/BJ20090982; Mullershausen F, 2003, J CELL BIOL, V160, P719, DOI 10.1083/jcb.200211041; O'Connor V, 2004, J BIOL CHEM, V279, P15841, DOI 10.1074/jbc.M312500200; Pandit J, 2009, P NATL ACAD SCI USA, V106, P18225, DOI 10.1073/pnas.0907635106; Russwurm C, 2009, J BIOL CHEM, V284, P25782, DOI 10.1074/jbc.M109.017194; Russwurm M, 2007, BIOCHEM J, V407, P69, DOI 10.1042/BJ20070348; Rybalkin SD, 2003, EMBO J, V22, P469, DOI 10.1093/emboj/cdg051; Schmidt CJ, 2008, J PHARMACOL EXP THER, V325, P681, DOI 10.1124/jpet.107.132910; Schultz Joachim E., 2009, V191, P93, DOI 10.1007/978-3-540-68964-5_6; Seeger TF, 2003, BRAIN RES, V985, P113, DOI 10.1016/S0006-8993(03)02754-9; Soderling SH, 1999, P NATL ACAD SCI USA, V96, P7071, DOI 10.1073/pnas.96.12.7071; Vasta V, 2006, P NATL ACAD SCI USA, V103, P19925, DOI 10.1073/pnas.0609483103; Wang HC, 2007, P NATL ACAD SCI USA, V104, P5782, DOI 10.1073/pnas.0700279104; Yuasa K, 2000, J BIOL CHEM, V275, P31469, DOI 10.1074/jbc.M003041200; Yuasa K, 2001, EUR J BIOCHEM, V268, P4440, DOI 10.1046/j.1432-1327.2001.02366.x; Yuasa K, 2001, EUR J BIOCHEM, V268, P168, DOI 10.1046/j.1432-1327.2001.01866.x; Zoraghi R, 2004, MOL PHARMACOL, V65, P267, DOI 10.1124/mol.65.2.267	39	51	53	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					1210	1219		10.1074/jbc.M111.263806	http://dx.doi.org/10.1074/jbc.M111.263806			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22105073	hybrid, Green Published			2022-12-27	WOS:000299170300036
J	Mainz, A; Bardiaux, B; Kuppler, F; Multhaup, G; Felli, IC; Pierattelli, R; Reif, B				Mainz, Andi; Bardiaux, Benjamin; Kuppler, Frank; Multhaup, Gerd; Felli, Isabella C.; Pierattelli, Roberta; Reif, Bernd			Structural and Mechanistic Implications of Metal Binding in the Small Heat-shock Protein alpha B-crystallin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHAPERONE-LIKE ACTIVITY; ZINC SUPEROXIDE-DISMUTASE; DESMIN-RELATED MYOPATHY; N-TERMINAL DOMAIN; SOLID-STATE NMR; MOLECULAR CHAPERONE; COMPLETE ASSIGNMENT; OXIDATIVE STRESS; PROTONLESS NMR; SPECTROSCOPY	The human small heat-shock protein alpha B-crystallin (alpha B) rescues misfolded proteins from irreversible aggregation during cellular stress. Binding of Cu(II) was shown to modulate the oligomeric architecture and the chaperone activity of alpha B. However, the mechanistic basis of this stimulation is so far not understood. We provide here first structural insights into this Cu(II)-mediated modulation of chaperone function using NMR spectroscopy and other biophysical approaches. We show that the alpha-crystallin domain is the elementary Cu(II)-binding unit specifically coordinating one Cu(II) ion with picomolar binding affinity. Putative Cu(II) ligands are His(83), His(104), His(111), and Asp(109) at the dimer interface. These loop residues are conserved among different metazoans, but also for human alpha A-crystallin, HSP20, and HSP27. The involvement of Asp109 has direct implications for dimer stability, because this residue forms a salt bridge with the disease-related Arg(120) of the neighboring monomer. Furthermore, we observe structural reorganization of strands beta 2-beta 3 triggered by Cu(II) binding. This N-terminal region is known to mediate both the intermolecular arrangement in alpha B oligomers and the binding of client proteins. In the presence of Cu(II), the size and the heterogeneity of alpha B multimers are increased. Atthesametime, Cu(II) increases the chaperone activity of alpha B toward the lens-specific protein beta(L)-crystallin. We therefore suggest that Cu(II) binding unblocks potential client binding sites and alters quaternary dynamics of both the dimeric building block as well as the higher order assemblies of alpha B.	[Reif, Bernd] Tech Univ Munich, Dept Chem, Ctr Integrated Prot Sci Munich, D-85747 Garching, Germany; [Mainz, Andi; Bardiaux, Benjamin; Reif, Bernd] Leibniz Inst Mol Pharmakol FMP, D-13125 Berlin, Germany; [Mainz, Andi; Reif, Bernd] Deutsch Forschungszentrum Gesundheit & Umwelt, Helmholtz Zentrum Munchen, D-85764 Neuherberg, Germany; [Kuppler, Frank; Multhaup, Gerd] Free Univ Berlin, Inst Chem & Biochem, D-14195 Berlin, Germany; [Felli, Isabella C.; Pierattelli, Roberta] Univ Florence, Magnet Resonance Ctr, I-50019 Sesto Fiorentino, Italy; [Felli, Isabella C.; Pierattelli, Roberta] Univ Florence, Dept Chem, I-50019 Sesto Fiorentino, Italy	Technical University of Munich; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Free University of Berlin; University of Florence; University of Florence	Reif, B (corresponding author), Tech Univ Munich, Dept Chem, Ctr Integrated Prot Sci Munich, Lichtenbergstr 4, D-85747 Garching, Germany.	reif@tum.de	Felli, Isabella C./O-1751-2015; Bardiaux, Benjamin/AAN-2741-2021; Pierattelli, Roberta/F-9439-2012; Bardiaux, Benjamin/A-4799-2011	Felli, Isabella C./0000-0002-6018-9090; Bardiaux, Benjamin/0000-0003-4014-9195; Pierattelli, Roberta/0000-0001-7755-0885; Reif, Bernd/0000-0001-7368-7198	Leibniz-Gemeinschaft; Helmholtz-Gemeinschaft; Deutsche Forschungsgemeinschaft [Re1435, SFB449, SFB740, SFB610]; EC [261863]; Center for Integrated Protein Science Munich	Leibniz-Gemeinschaft; Helmholtz-Gemeinschaft(Helmholtz Association); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); EC(European CommissionEuropean Commission Joint Research Centre); Center for Integrated Protein Science Munich	This work was supported by the Leibniz-Gemeinschaft, by the Helmholtz-Gemeinschaft, by the Deutsche Forschungsgemeinschaft (Grants Re1435, SFB449, SFB740, and SFB610), by access to research infrastructures activity in the 7th Framework Programme of the EC (project number 261863, Bio-NMR), and by the Center for Integrated Protein Science Munich.	Ahmad MF, 2008, J MOL BIOL, V382, P812, DOI 10.1016/j.jmb.2008.07.068; Aquilina JA, 2004, J BIOL CHEM, V279, P28675, DOI 10.1074/jbc.M403348200; Aquilina JA, 2003, P NATL ACAD SCI USA, V100, P10611, DOI 10.1073/pnas.1932958100; Bagneris C, 2009, J MOL BIOL, V392, P1242, DOI 10.1016/j.jmb.2009.07.069; BAX A, 1991, Journal of Biomolecular NMR, V1, P99, DOI 10.1007/BF01874573; Benesch JLP, 2008, J BIOL CHEM, V283, P28513, DOI 10.1074/jbc.M804729200; Bermel W, 2006, J MAGN RESON, V178, P56, DOI 10.1016/j.jmr.2005.08.011; Bermel W, 2005, ANGEW CHEM INT EDIT, V44, P3089, DOI 10.1002/anie.200461794; Bermel W, 2003, J AM CHEM SOC, V125, P16423, DOI 10.1021/ja037676p; Bermel W, 2007, J MAGN RESON, V188, P301, DOI 10.1016/j.jmr.2007.07.004; Bertini I, 2005, CHEMBIOCHEM, V6, P1536, DOI 10.1002/cbic.200500124; Bertini I, 2011, P NATL ACAD SCI USA, V108, P10396, DOI 10.1073/pnas.1103854108; Bertini I, 2010, COORDIN CHEM REV, V254, P506, DOI 10.1016/j.ccr.2009.07.024; Bhattacharyya J, 2006, BIOCHEMISTRY-US, V45, P3069, DOI 10.1021/bi0518141; Biswas A, 2008, BIOCHEMISTRY-US, V47, P804, DOI 10.1021/bi7011965; Bloemendal H, 2004, PROG BIOPHYS MOL BIO, V86, P407, DOI 10.1016/j.pbiomolbio.2003.11.012; Bova MP, 1999, P NATL ACAD SCI USA, V96, P6137, DOI 10.1073/pnas.96.11.6137; Brewer GJ, 2010, CHEM RES TOXICOL, V23, P319, DOI 10.1021/tx900338d; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Clark AR, 2011, J MOL BIOL, V408, P118, DOI 10.1016/j.jmb.2011.02.020; CLUBB RT, 1992, J MAGN RESON, V97, P213, DOI 10.1016/0022-2364(92)90252-3; de la Torre JG, 2000, J MAGN RESON, V147, P138, DOI 10.1006/jmre.2000.2170; Ecroyd H, 2007, BIOCHEM J, V401, P129, DOI 10.1042/BJ20060981; FUSHMAN D, 1994, J BIOMOL STRUCT DYN, V11, P1377, DOI 10.1080/07391102.1994.10508074; Ganadu ML, 2004, J INORG BIOCHEM, V98, P1103, DOI 10.1016/j.jinorgbio.2004.03.013; Garrett DS, 1997, BIOCHEMISTRY-US, V36, P4393, DOI 10.1021/bi970221q; Ghosh JG, 2005, PROTEIN SCI, V14, P684, DOI 10.1110/ps.041152805; Ghosh JG, 2005, BIOCHEMISTRY-US, V44, P14854, DOI 10.1021/bi0503910; Ghosh JG, 2006, CELL STRESS CHAPERON, V11, P187, DOI 10.1379/CSC-186.1; Ghosh KS, 2011, BIOCHEMISTRY-US, V50, P3279, DOI 10.1021/bi200091q; Haley DA, 1998, J MOL BIOL, V277, P27, DOI 10.1006/jmbi.1997.1611; Harding MM, 2006, ACTA CRYSTALLOGR D, V62, P678, DOI 10.1107/S0907444906014594; Haslbeck M, 2005, NAT STRUCT MOL BIOL, V12, P842, DOI 10.1038/nsmb993; Hawse JR, 2003, INVEST OPHTH VIS SCI, V44, P672, DOI 10.1167/iovs.02-0018; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; Hough MA, 1999, J MOL BIOL, V287, P579, DOI 10.1006/jmbi.1999.2610; IWAKI T, 1990, J HISTOCHEM CYTOCHEM, V38, P31, DOI 10.1177/38.1.2294148; Jehle S, 2011, P NATL ACAD SCI USA, V108, P6409, DOI 10.1073/pnas.1014656108; Jehle S, 2010, NAT STRUCT MOL BIOL, V17, P1037, DOI 10.1038/nsmb.1891; Jehle S, 2009, J MOL BIOL, V385, P1481, DOI 10.1016/j.jmb.2008.10.097; Jomova K, 2010, MOL CELL BIOCHEM, V345, P91, DOI 10.1007/s11010-010-0563-x; KAY LE, 1990, J MAGN RESON, V89, P496, DOI 10.1016/0022-2364(90)90333-5; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; Koretz JF, 1998, INT J BIOL MACROMOL, V22, P283, DOI 10.1016/S0141-8130(98)00026-9; Kuszewski J, 1996, PROTEIN SCI, V5, P1067; Laganowsky A, 2010, PROTEIN SCI, V19, P1031, DOI 10.1002/pro.380; Lawless MW, 2010, EXPERT OPIN THER TAR, V14, P1225, DOI 10.1517/14728222.2010.526933; Linge JP, 1999, J BIOMOL NMR, V13, P51, DOI 10.1023/A:1008365802830; Liu LY, 2006, ANAL BIOCHEM, V350, P186, DOI 10.1016/j.ab.2005.12.019; Mainz A, 2009, J AM CHEM SOC, V131, P15968, DOI 10.1021/ja904733v; Moroz OV, 2003, ACTA CRYSTALLOGR D, V59, P859, DOI 10.1107/S0907444903004700; Nakamoto H, 2007, CELL MOL LIFE SCI, V64, P294, DOI 10.1007/s00018-006-6321-2; Narayanan S, 2006, FEBS LETT, V580, P5941, DOI 10.1016/j.febslet.2006.09.063; Peschek J, 2009, P NATL ACAD SCI USA, V106, P13272, DOI 10.1073/pnas.0902651106; Prabhu S, 2011, FREE RADICAL BIO MED, V51, P755, DOI 10.1016/j.freeradbiomed.2011.05.021; Reif B, 2007, TOP CURR CHEM, V272, P117, DOI 10.1007/128_066; Rekas A, 2004, J MOL BIOL, V340, P1167, DOI 10.1016/j.jmb.2004.05.054; Santhoshkumar P, 2006, PROTEIN SCI, V15, P2488, DOI 10.1110/ps.062338206; Sarell CJ, 2009, BIOCHEMISTRY-US, V48, P4388, DOI 10.1021/bi900254n; SHAKA AJ, 1983, J MAGN RESON, V53, P313, DOI 10.1016/0022-2364(83)90035-5; SHAKA AJ, 1985, J MAGN RESON, V64, P547, DOI 10.1016/0022-2364(85)90122-2; Srinivas V, 2005, MOL VIS, V11, P249; Steinman L, 2009, NAT REV IMMUNOL, V9, P440, DOI 10.1038/nri2548; Stengel F, 2010, P NATL ACAD SCI USA, V107, P2007, DOI 10.1073/pnas.0910126107; Sun Y, 2005, FEBS J, V272, P2613, DOI 10.1111/j.1742-4658.2005.04708.x; Thompsett AR, 2005, J BIOL CHEM, V280, P42750, DOI 10.1074/jbc.M506521200; Truscott RJW, 2005, EXP EYE RES, V80, P709, DOI 10.1016/j.exer.2004.12.007; Veinger L, 1998, J BIOL CHEM, V273, P11032, DOI 10.1074/jbc.273.18.11032; Vicart P, 1998, NAT GENET, V20, P92, DOI 10.1038/1765; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; WISHART DS, 1994, J BIOMOL NMR, V4, P171	71	55	56	0	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					1128	1138		10.1074/jbc.M111.309047	http://dx.doi.org/10.1074/jbc.M111.309047			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22090033	Green Published, hybrid			2022-12-27	WOS:000299170300028
J	Sharma, M; Jamieson, C; Johnson, M; Molloy, MP; Henderson, BR				Sharma, Manisha; Jamieson, Cara; Johnson, Michael; Molloy, Mark P.; Henderson, Beric R.			Specific Armadillo Repeat Sequences Facilitate beta-Catenin Nuclear Transport in Live Cells via Direct Binding to Nucleoporins Nup62, Nup153, and RanBP2/Nup358	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMPORTIN-BETA; PORE COMPLEX; TUMOR-SUPPRESSOR; PROTEIN IMPORT; LIVING CELLS; P62 COMPLEX; E-CADHERIN; EXPORT; CANCER; TRANSLOCATION	beta-Catenin transduces the Wnt signal from the membrane to nucleus, and certain gene mutations trigger its nuclear accumulation leading to cell transformation and cancer. beta-Catenin shuttles between the nucleus and cytoplasm independent of classical Ran/transport receptor pathways, and this movement was previously hypothesized to involve the central Armadillo (Arm) domain. Fluorescence recovery after photobleaching (FRAP) assays were used to delineate functional transport regions of the Arm domain in living cells. The strongest nuclear import/export activity was mapped to Arm repeats R10-12 using both in vivo FRAP and in vitro export assays. By comparison, Arm repeats R3-8 of beta-catenin were highly active for nuclear import but displayed a comparatively weak export activity. We show for the first time using purified components that specific Arm sequences of beta-catenin interact directly in vitro with the FG repeats of the nuclear pore complex (NPC) components Nup62, Nup98, and Nup153, indicating an independent ability of beta-catenin to traverse the NPC. Moreover, a proteomics screen identified RanBP2/Nup358 as a binding partner of Arm R10-12, and beta-catenin was confirmed to interact with endogenous and ectopic forms of Nup358. Wefurther demonstrate that knock-down of endogenous Nup358 and Nup62 impeded the rate of nuclear import/export of beta-catenin to a greater extent than that of importin-beta. The Arm R10-12 sequence facilitated transport even when beta-catenin was bound to the Arm-binding partner LEF-1, and its activity was stimulated by phosphorylation at Tyr-654. These findings provide functional evidence that the Arm domain contributes to regulated beta-catenin transport through direct interaction with the NPC.	[Sharma, Manisha; Jamieson, Cara; Johnson, Michael; Henderson, Beric R.] Univ Sydney, Westmead Hosp, Westmead Millennium Inst, Westmead Inst Canc Res, Westmead, NSW 2145, Australia; [Molloy, Mark P.] Macquarie Univ, Australian Proteome Anal Facil, Dept Chem & Biomol Sci, Sydney, NSW 2109, Australia	University of Sydney; Westmead Institute for Medical Research; Macquarie University	Sharma, M (corresponding author), Univ Sydney, Westmead Hosp, Westmead Millennium Inst, Westmead Inst Canc Res, Westmead, NSW 2145, Australia.	manisha.sharma@sydney.edu.au; beric.henderson@sydney.edu.au			National Health and Medical Research Council of Australia (NHMRC); NHMRC	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by grants from the National Health and Medical Research Council of Australia (NHMRC).; Recipient of an NHMRC Career Development Award.	Arce L, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-159; Asally M, 2005, EXP CELL RES, V308, P357, DOI 10.1016/j.yexcr.2005.05.011; Ben-Efraim I, 2001, J CELL BIOL, V152, P411, DOI 10.1083/jcb.152.2.411; Brabletz S, 2009, J PATHOL, V217, P307, DOI 10.1002/path.2475; Brabletz T, 2001, P NATL ACAD SCI USA, V98, P10356, DOI 10.1073/pnas.171610498; Cadigan KM, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002881; Dolai S, 2011, PROTEOMICS, V11, P2683, DOI 10.1002/pmic.201000801; Eleftheriou A, 2001, J BIOL CHEM, V276, P25883, DOI 10.1074/jbc.M102656200; Fagotto F, 1998, CURR BIOL, V8, P181, DOI 10.1016/S0960-9822(98)70082-X; Hamada M, 2011, J CELL BIOL, V194, P597, DOI 10.1083/jcb.201102018; Henderson BR, 2000, NAT CELL BIOL, V2, P653, DOI 10.1038/35023605; Henderson BR, 2000, EXP CELL RES, V256, P213, DOI 10.1006/excr.2000.4825; Henderson BR, 2002, EMBO REP, V3, P834, DOI 10.1093/embo-reports/kvf181; Hendriksen J, 2005, J CELL BIOL, V171, P785, DOI 10.1083/jcb.200502141; Hsu HT, 2006, BIOCHEM BIOPH RES CO, V343, P893, DOI 10.1016/j.bbrc.2006.02.193; Hu TH, 1996, J CELL BIOL, V134, P589, DOI 10.1083/jcb.134.3.589; Huber AH, 1997, CELL, V90, P871, DOI 10.1016/S0092-8674(00)80352-9; Hutten S, 2008, MOL BIOL CELL, V19, P2300, DOI 10.1091/mbc.E07-12-1279; Hutten S, 2009, J CELL SCI, V122, P1100, DOI 10.1242/jcs.040154; Jamieson C, 2011, TRAFFIC, V12, P983, DOI 10.1111/j.1600-0854.2011.01207.x; Johnson M, 2009, CELL SIGNAL, V21, P339, DOI 10.1016/j.cellsig.2008.11.004; Kapon R, 2010, NUCLEUS-PHILA, V1, P475, DOI 10.4161/nucl.1.6.13112; Koike M, 2004, J BIOL CHEM, V279, P34038, DOI 10.1074/jbc.M405821200; Krieghoff E, 2006, J CELL SCI, V119, P1453, DOI 10.1242/jcs.02864; Kuroda S, 1998, SCIENCE, V281, P832, DOI 10.1126/science.281.5378.832; Lee SJ, 2000, J MOL BIOL, V302, P251, DOI 10.1006/jmbi.2000.4055; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Maher MT, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-5; Monette A, 2011, J CELL BIOL, V193, P619, DOI 10.1083/jcb.201008064; Najdi Rani, 2011, J Carcinog, V10, P5, DOI 10.4103/1477-3163.78111; Otsuka S, 2008, P NATL ACAD SCI USA, V105, P16101, DOI 10.1073/pnas.0802647105; Polakis P, 2007, CURR OPIN GENET DEV, V17, P45, DOI 10.1016/j.gde.2006.12.007; Rabut G, 2004, NAT CELL BIOL, V6, P1114, DOI 10.1038/ncb1184; Rodriguez JA, 2000, J BIOL CHEM, V275, P38589, DOI 10.1074/jbc.M003851200; Rosin-Arbesfeld R, 2003, EMBO J, V22, P1101, DOI 10.1093/emboj/cdg105; Roura S, 1999, J BIOL CHEM, V274, P36734, DOI 10.1074/jbc.274.51.36734; Sabri N, 2007, J CELL BIOL, V178, P557, DOI 10.1083/jcb.200612135; Schmalhofer O, 2009, CANCER METAST REV, V28, P151, DOI 10.1007/s10555-008-9179-y; Schwarz-Herion K, 2007, J MOL BIOL, V370, P796, DOI 10.1016/j.jmb.2007.05.030; Stewart M, 2001, FEBS LETT, V498, P145, DOI 10.1016/S0014-5793(01)02489-9; Stochaj U, 2006, EXP CELL RES, V312, P2490, DOI 10.1016/j.yexcr.2006.04.007; Suh EK, 2003, EXP CELL RES, V290, P447, DOI 10.1016/S0014-4827(03)00370-7; Tauriello DVF, 2010, CELL CYCLE, V9, P3700, DOI 10.4161/cc.9.18.13204; Thyssen G, 2006, MOL CELL BIOL, V26, P8857, DOI 10.1128/MCB.01031-06; van Veelen W, 2011, GUT, V60, P1204, DOI 10.1136/gut.2010.233460; Walde S., 2011, TRAFFIC, DOI [10.1111/j.1600-854.2011.01302x, DOI 10.1111/J.1600-854.2011.01302X]; Wang Y, 2006, J CELL SCI, V119, P4002, DOI 10.1242/jcs.03169; Wiechens N, 2004, J BIOL CHEM, V279, P5263, DOI 10.1074/jbc.M307253200; Wiechens N, 2001, CURR BIOL, V11, P18, DOI 10.1016/S0960-9822(00)00045-2; Wong SCC, 2004, CLIN CANCER RES, V10, P1401, DOI 10.1158/1078-0432.CCR-0157-03; Xing Y, 2008, STRUCTURE, V16, P478, DOI 10.1016/j.str.2007.12.021; Xu WQ, 2007, J CELL SCI, V120, P3337, DOI 10.1242/jcs.013771; Yokoya F, 1999, MOL BIOL CELL, V10, P1119, DOI 10.1091/mbc.10.4.1119	53	60	63	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					819	831		10.1074/jbc.M111.299099	http://dx.doi.org/10.1074/jbc.M111.299099			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22110128	hybrid, Green Published			2022-12-27	WOS:000299170300002
J	Zhao, LX; He, F; Liu, HY; Zhu, YS; Tian, WL; Gao, P; He, HP; Yue, W; Lei, XB; Ni, BY; Wang, XH; Jin, HJ; Hao, XJ; Lin, JL; Chen, Q				Zhao, Lixia; He, Feng; Liu, Haiyang; Zhu, Yushan; Tian, Weili; Gao, Ping; He, Hongping; Yue, Wen; Lei, Xiaobo; Ni, Biyun; Wang, Xiaohui; Jin, Haijing; Hao, Xiaojiang; Lin, Jialing; Chen, Quan			Natural Diterpenoid Compound Elevates Expression of Bim Protein, Which Interacts with Antiapoptotic Protein Bcl-2, Converting It to Proapoptotic Bax-like Molecule	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE PERMEABILIZATION; MITOCHONDRIAL DYSFUNCTION; BH3-ONLY PROTEINS; BH3 DOMAIN; APOPTOSIS; FAMILY; ACTIVATION; BINDING; CONVERSION; PROTECTOR	Overwhelming evidence indicates that Bax and Bak are indispensable for mediating cytochrome c release from mitochondria during apoptosis. Here we report a Bax/Bak-independent mechanism of cytochrome c release and apoptosis. We identified a natural diterpenoid compound that induced apoptosis in bax/bak double knock-out murine embryonic fibroblasts and substantially reduced the tumor growth from these cells implanted in mice. Treatment with the compound significantly increased expression of Bim, which migrated to mitochondria, altering the conformation of and forming oligomers with resident Bcl-2 to induce cytochrome c release and caspase activation. Importantly, purified Bim and Bcl-2 proteins cooperated to permeabilize a model mitochondrial outer membrane; this was accompanied by oligomerization of these proteins and deep embedding of Bcl-2 in the membrane. Therefore, the diterpenoid compound induces a structural and functional conversion of Bcl-2 through Bim to permeabilize the mitochondrial outer membrane, thereby inducing apoptosis independently of Bax and Bak. Because Bcl-2 family proteins play important roles in cancer development and relapse, this novel cell death mechanism can be explored for developing more effective anticancer therapeutics.	[Liu, Haiyang; He, Hongping; Hao, Xiaojiang] Chinese Acad Sci, Kunming Inst Bot, State Key Lab Phytochem & Plant Resources W China, Kunming 650204, Peoples R China; [Zhao, Lixia; Zhu, Yushan; Tian, Weili; Gao, Ping; Yue, Wen; Lei, Xiaobo; Ni, Biyun; Wang, Xiaohui; Jin, Haijing; Chen, Quan] Chinese Acad Sci, State Key Lab Biomembrane & Membrane Biotechnol, Inst Zool, Joint Lab Apoptosis & Mitochondrial Biol, Beijing 100101, Peoples R China; [Zhao, Lixia; Zhu, Yushan; Tian, Weili; Gao, Ping; Yue, Wen; Lei, Xiaobo; Ni, Biyun; Wang, Xiaohui; Jin, Haijing; Chen, Quan] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China; [He, Feng; Lin, Jialing] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73126 USA	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; Institute of Zoology, CAS; Nankai University; University of Oklahoma System; University of Oklahoma Health Sciences Center	Hao, XJ (corresponding author), Chinese Acad Sci, Kunming Inst Bot, State Key Lab Phytochem & Plant Resources W China, Kunming 650204, Peoples R China.	haoxj@mail.kib.ac.cn; jialing-lin@ouhsc.edu; chenq@ioz.ac.cn	He, Feng/J-6984-2019	He, Feng/0000-0003-0276-3303; Chen, Quan/0000-0001-7539-8728	Ministry of Science and Technology of China [2011CB910903, 2010CB912200, 2009CB512800]; National Science Foundation [90713006, 30971062, 30910103910]; National Institutes of Health [GM062964]; Oklahoma Center for the Advancement of Science and Technology [HR10-121]; 973 Project [2009CB522303]; National Natural Science Funding of China [U1032603]; State Key Laboratory of Phytochemistry and Plant Resources of China [520807D81211]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062964] Funding Source: NIH RePORTER	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oklahoma Center for the Advancement of Science and Technology; 973 Project(National Basic Research Program of China); National Natural Science Funding of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Phytochemistry and Plant Resources of China; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by 973 Project Grants (2011CB910903, 2010CB912200, and 2009CB512800) from the Ministry of Science and Technology of China and grants from the National Science Foundation (90713006, 30971062, and 30910103910, to Q. C.). This work was also supported by National Institutes of Health Grant GM062964 (to J. L.), Grant HR10-121 from the Oklahoma Center for the Advancement of Science and Technology (to J. L.), 973 Project Grant (2009CB522303), National Natural Science Funding of China (U1032603), and Grant 520807D81211 from the State Key Laboratory of Phytochemistry and Plant Resources of China (to X. H.).	Annis MG, 2005, EMBO J, V24, P2096, DOI 10.1038/sj.emboj.7600675; Billen LP, 2008, PLOS BIOL, V6, P1268, DOI 10.1371/journal.pbio.0060147; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Chen Q, 2000, CELL DEATH DIFFER, V7, P227, DOI 10.1038/sj.cdd.4400629; Cheng EHY, 1997, SCIENCE, V278, P1966, DOI 10.1126/science.278.5345.1966; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Cory S, 2003, ONCOGENE, V22, P8590, DOI 10.1038/sj.onc.1207102; Dewson G, 2008, MOL CELL, V30, P369, DOI 10.1016/j.molcel.2008.04.005; Dlugosz PJ, 2006, EMBO J, V25, P2287, DOI 10.1038/sj.emboj.7601126; Gavathiotis E, 2008, NATURE, V455, P1076, DOI 10.1038/nature07396; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hardwick JM, 2009, CELL, V138, P404, DOI 10.1016/j.cell.2009.07.003; Harvey NL, 1997, J BIOL CHEM, V272, P13134, DOI 10.1074/jbc.272.20.13134; Hinds MG, 2007, CELL DEATH DIFFER, V14, P128, DOI 10.1038/sj.cdd.4401934; Hsu YT, 1998, J BIOL CHEM, V273, P10777, DOI 10.1074/jbc.273.17.10777; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; Kim H, 2009, MOL CELL, V36, P487, DOI 10.1016/j.molcel.2009.09.030; Kim PK, 2004, MOL CELL, V14, P523, DOI 10.1016/S1097-2765(04)00263-1; Kolluri SK, 2008, CANCER CELL, V14, P285, DOI 10.1016/j.ccr.2008.09.002; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Lanave C, 2004, GENE, V333, P71, DOI 10.1016/j.gene.2004.02.017; Leber B, 2007, APOPTOSIS, V12, P897, DOI 10.1007/s10495-007-0746-4; Lei XB, 2006, FASEB J, V20, P2147, DOI 10.1096/fj.05-5665fje; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Letai AG, 2008, NAT REV CANCER, V8, P121, DOI 10.1038/nrc2297; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Lin BZ, 2004, CELL, V116, P527, DOI 10.1016/S0092-8674(04)00162-X; Lovell JF, 2008, CELL, V135, P1074, DOI 10.1016/j.cell.2008.11.010; Marani M, 2002, MOL CELL BIOL, V22, P3577, DOI 10.1128/MCB.22.11.3577-3589.2002; Merino D, 2009, J CELL BIOL, V186, P355, DOI 10.1083/jcb.200905153; Muchmore SW, 1996, NATURE, V381, P335, DOI 10.1038/381335a0; O'Connor L, 1998, EMBO J, V17, P384, DOI 10.1093/emboj/17.2.384; O'Reilly LA, 2000, AM J PATHOL, V157, P449, DOI 10.1016/S0002-9440(10)64557-9; Peng J, 2006, J BIOL CHEM, V281, P35802, DOI 10.1074/jbc.M608303200; Peng J, 2009, APOPTOSIS, V14, P1145, DOI 10.1007/s10495-009-0389-8; Polzien L, 2011, BBA-GEN SUBJECTS, V1810, P162, DOI 10.1016/j.bbagen.2010.11.002; Puthalakath H, 1999, MOL CELL, V3, P287, DOI 10.1016/S1097-2765(00)80456-6; Rathmell JC, 2002, NAT IMMUNOL, V3, P932, DOI 10.1038/ni834; Ren DC, 2010, SCIENCE, V330, P1390, DOI 10.1126/science.1190217; Schlesinger PH, 1997, P NATL ACAD SCI USA, V94, P11357, DOI 10.1073/pnas.94.21.11357; Suzuki M, 2000, CELL, V103, P645, DOI 10.1016/S0092-8674(00)00167-7; Vander Heiden MG, 1999, MOL CELL, V3, P159; Venturoli D, 2005, AM J PHYSIOL-RENAL, V288, pF605, DOI 10.1152/ajprenal.00171.2004; Weber A, 2007, J CELL BIOL, V177, P625, DOI 10.1083/jcb.200610148; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; YIN XM, 1994, NATURE, V369, P321, DOI 10.1038/369321a0; Yip KW, 2008, ONCOGENE, V27, P6398, DOI 10.1038/onc.2008.307; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhang Z, 2004, J BIOL CHEM, V279, P43920, DOI 10.1074/jbc.M406412200; Zhang Z, 2010, J BIOL CHEM, V285, P17614, DOI 10.1074/jbc.M110.113456; Zong WX, 2001, GENE DEV, V15, P1481, DOI 10.1101/gad.897601	54	22	24	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					1054	1065		10.1074/jbc.M111.264481	http://dx.doi.org/10.1074/jbc.M111.264481			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22065578	Green Published, hybrid			2022-12-27	WOS:000299170300022
J	Morita, K; Tokuda, H; Nishiyama, K				Morita, Kazuhiro; Tokuda, Hajime; Nishiyama, Ken-ichi			Multiple SecA Molecules Drive Protein Translocation across a Single Translocon with SecG Inversion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTON MOTIVE FORCE; EVERTED MEMBRANE-VESICLES; COLI PLASMA-MEMBRANE; DISTINCT ATP-BINDING; ESCHERICHIA-COLI; PREPROTEIN TRANSLOCASE; CYTOPLASMIC MEMBRANE; DEPENDENT STIMULATION; TOPOLOGY INVERSION; SECRETORY PROTEIN	SecA is a translocation ATPase that drives protein translocation. D209N SecA, a dominant-negative mutant, binds ATP but is unable to hydrolyze it. This mutant was inactive to proOmpA translocation. However, it generated a translocation intermediate of 18 kDa. Further addition of wild-type SecA caused its translocation into either mature OmpA or another intermediate of 28 kDa that can be translocated into mature by a proton motive force. The addition of excess D209N SecA during translocation caused a topology inversion of SecG. Moreover, an intermediate of SecG inversion was identified when wild-type and D209N SecA were used in the same amounts. These results indicate that multiple SecA molecules drive translocation across a single translocon with SecG inversion. Here, we propose a revised model of proOmpA translocation in which a single catalytic cycle of SecA causes translocation of 10-13 kDa with ATP binding and hydrolysis, and SecG inversion is required when the next SecA cycle begins with additional ATP hydrolysis.	[Morita, Kazuhiro; Tokuda, Hajime; Nishiyama, Ken-ichi] Univ Tokyo, Inst Mol & Cellular Biosci, Tokyo 1130032, Japan	University of Tokyo	Nishiyama, K (corresponding author), Iwate Univ, Cryobiofrontier Res Ctr, Fac Agr, Morioka, Iwate 0208550, Japan.	nishiyam@iwate-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan; Grants-in-Aid for Scientific Research [21570110] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	AKITA M, 1990, J BIOL CHEM, V265, P8164; AKITA M, 1991, BIOCHEM BIOPH RES CO, V174, P211, DOI 10.1016/0006-291X(91)90507-4; Bonardi F, 2011, P NATL ACAD SCI USA, V108, P7775, DOI 10.1073/pnas.1101705108; CABELLI RJ, 1991, J BIOL CHEM, V266, P24420; DEVRIJE T, 1988, NATURE, V334, P173, DOI 10.1038/334173a0; DOUVILLE K, 1995, J BIOL CHEM, V270, P20106, DOI 10.1074/jbc.270.34.20106; Du Plessis DJF, 2011, BBA-BIOMEMBRANES, V1808, P851, DOI 10.1016/j.bbamem.2010.08.016; Duong F, 1997, EMBO J, V16, P2756, DOI 10.1093/emboj/16.10.2756; Economou A, 1995, CELL, V83, P1171, DOI 10.1016/0092-8674(95)90143-4; ECONOMOU A, 1994, CELL, V78, P835, DOI 10.1016/S0092-8674(94)90582-7; Eichler J, 1997, P NATL ACAD SCI USA, V94, P5574, DOI 10.1073/pnas.94.11.5574; HANADA M, 1994, J BIOL CHEM, V269, P23625; HUSSAIN M, 1980, J BIOL CHEM, V255, P3707; JOLY JC, 1993, EMBO J, V12, P255, DOI 10.1002/j.1460-2075.1993.tb05651.x; KATO M, 1993, J BIOL CHEM, V268, P3586; KIM YJ, 1994, CELL, V78, P845; KUHN A, 1995, FEMS MICROBIOL REV, V17, P185; Kusters I, 2011, CELL MOL LIFE SCI, V68, P2053, DOI 10.1007/s00018-011-0681-y; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LILL R, 1990, CELL, V60, P271, DOI 10.1016/0092-8674(90)90742-W; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Matsumoto G, 1997, EMBO J, V16, P6384, DOI 10.1093/emboj/16.21.6384; MATSUYAMA S, 1990, J BIOL CHEM, V265, P8760; MITCHELL C, 1993, MOL MICROBIOL, V10, P483, DOI 10.1111/j.1365-2958.1993.tb00921.x; Nagamori S, 2000, J BIOCHEM-TOKYO, V128, P129, DOI 10.1093/oxfordjournals.jbchem.a022723; Nagamori S, 2002, J BIOCHEM, V132, P629, DOI 10.1093/oxfordjournals.jbchem.a003266; NISHIYAMA K, 1992, J BIOL CHEM, V267, P7170; Nishiyama K, 1999, EMBO J, V18, P1049, DOI 10.1093/emboj/18.4.1049; NISHIYAMA K, 1994, EMBO J, V13, P3272, DOI 10.1002/j.1460-2075.1994.tb06628.x; NISHIYAMA K, 1993, EMBO J, V12, P3409, DOI 10.1002/j.1460-2075.1993.tb06015.x; Nishiyama KI, 1996, CELL, V85, P71, DOI 10.1016/S0092-8674(00)81083-1; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; Sardis MF, 2010, MOL MICROBIOL, V76, P1070, DOI 10.1111/j.1365-2958.2010.07176.x; SCHIEBEL E, 1991, CELL, V64, P927, DOI 10.1016/0092-8674(91)90317-R; SHINKAI A, 1990, BIOCHEM BIOPH RES CO, V172, P1217, DOI 10.1016/0006-291X(90)91578-G; SHIOZUKA K, 1990, J BIOL CHEM, V265, P18843; Sugai R, 2007, J BIOL CHEM, V282, P29540, DOI 10.1074/jbc.M704716200; Suzuki H, 1998, MOL MICROBIOL, V29, P331, DOI 10.1046/j.1365-2958.1998.00937.x; TANI K, 1991, FEBS LETT, V285, P127, DOI 10.1016/0014-5793(91)80741-K; TANI K, 1989, J BIOL CHEM, V264, P18582; TANI K, 1990, J BIOL CHEM, V265, P17341; TOKUDA H, 1993, BIOCHEM BIOPH RES CO, V195, P1415, DOI 10.1006/bbrc.1993.2201; Tsukazaki T, 2008, NATURE, V455, P988, DOI 10.1038/nature07421; Tsukazaki T, 2011, NATURE, V474, P235, DOI 10.1038/nature09980; Uchida K, 1995, J BIOL CHEM, V270, P30862, DOI 10.1074/jbc.270.52.30862; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; van der Does C, 1998, BIOCHEMISTRY-US, V37, P201, DOI 10.1021/bi972105t; van der Slius EO, 2006, J BACTERIOL, V188, P1188, DOI 10.1128/JB.188.3.1188-1190.2006; van der Wolk JPW, 1997, EMBO J, V16, P7297, DOI 10.1093/emboj/16.24.7297; vanderDoes C, 1996, MOL MICROBIOL, V22, P619, DOI 10.1046/j.1365-2958.1996.d01-1712.x; WATANABE M, 1993, P NATL ACAD SCI USA, V90, P9011, DOI 10.1073/pnas.90.19.9011; YAMADA H, 1989, J BIOL CHEM, V264, P1723; YAMADA H, 1989, J BIOL CHEM, V264, P18577; YAMANE K, 1987, J BIOL CHEM, V262, P2358; Zimmer J, 2008, NATURE, V455, P936, DOI 10.1038/nature07335	55	15	15	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					455	464		10.1074/jbc.M111.301754	http://dx.doi.org/10.1074/jbc.M111.301754			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22074917	Green Published, hybrid			2022-12-27	WOS:000298682400044
J	Rajpal, G; Schuiki, I; Liu, M; Volchuk, A; Arvan, P				Rajpal, Gautam; Schuiki, Irmgard; Liu, Ming; Volchuk, Allen; Arvan, Peter			Action of Protein Disulfide Isomerase on Proinsulin Exit from Endoplasmic Reticulum of Pancreatic beta-Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHAPERONE ACTIVITIES; INSULIN; REDUCTASE; STRESS	For insulin synthesis, the proinsulin precursor is translated at the endoplasmic reticulum (ER), folds to include its three native disulfide bonds, and is exported to secretory granules for processing and secretion. Protein disulfide isomerase (PDI) has long been assumed to assist proinsulin in this process. Herein we have examined the effect of PDI knockdown (PDI-KD) in beta-cells. The data establish that upon PDI-KD, oxidation of proinsulin to form native disulfide bonds is unimpaired and in fact enhanced. This is accompanied by improved proinsulin exit from the ER and increased total insulin secretion, with no evidence of ER stress. We provide evidence for direct physical interaction between PDI and proinsulin in the ER of pancreatic beta-cells, in a manner requiring the catalytic activity of PDI. In beta-cells after PDI-KD, enhanced export is selective for proinsulin over other secretory proteins, but the same effect is observed for recombinant proinsulin trafficking upon PDI-KD in heterologous cells. We hypothesize that PDI exhibits unfoldase activity for proinsulin, increasing retention of proinsulin within the ER of pancreatic beta-cells.	[Rajpal, Gautam; Liu, Ming; Arvan, Peter] Univ Michigan, Div Metab Endocrinol & Diabet, Med Ctr, Ann Arbor, MI 48105 USA; [Rajpal, Gautam; Liu, Ming; Arvan, Peter] Univ Michigan, Cellular & Mol Biol Program, Med Ctr, Ann Arbor, MI 48105 USA; [Schuiki, Irmgard; Volchuk, Allen] Univ Hlth Network, Toronto Gen Res Inst, Div Cellular & Mol Biol, Toronto, ON M5G 2M9, Canada	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital	Arvan, P (corresponding author), Univ Michigan, Div Metab Endocrinol & Diabet, Med Ctr, 5112 Brehm Ctr,1000 Wall St, Ann Arbor, MI 48105 USA.	parvan@umich.edu			National Institutes of Health [R01-DK48280]; Canadian Institutes of Health Research [MOP-86641]; Rackham Graduate School; Cell and Molecular Biology Training Program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK048280, P30DK020572, P60DK020572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007315] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Rackham Graduate School; Cell and Molecular Biology Training Program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-DK48280 (to P. A.). This work was also supported by Canadian Institutes of Health Research Grant MOP-86641 (to A. V.).; Supported by grants from the Rackham Graduate School and the Cell and Molecular Biology Training Program.	Ahmed M, 2005, J PROTEOME RES, V4, P931, DOI 10.1021/pr050024a; Cras-Meneur C, 2004, DIABETOLOGIA, V47, P284, DOI 10.1007/s00125-003-1300-8; Forster ML, 2006, J CELL BIOL, V173, P853, DOI 10.1083/jcb.200602046; Frand AR, 2000, TRENDS CELL BIOL, V10, P203, DOI 10.1016/S0962-8924(00)01745-1; Guo ZY, 2008, ANTIOXID REDOX SIGN, V10, P127, DOI 10.1089/ars.2007.1860; Honjo Y, 2010, BRAIN RES, V1349, P90, DOI 10.1016/j.brainres.2010.06.016; Karala AR, 2010, J MOL BIOL, V396, P883, DOI 10.1016/j.jmb.2009.12.014; Khoo C, 2011, ENDOCRINOLOGY, V152, P2599, DOI 10.1210/en.2010-1420; Kitiphongspattana K, 2007, AM J PHYSIOL-ENDOC M, V292, pE1543, DOI 10.1152/ajpendo.00620.2006; Kozlov G, 2010, FEBS J, V277, P3924, DOI 10.1111/j.1742-4658.2010.07793.x; Liu M, 2010, TRENDS ENDOCRIN MET, V21, P652, DOI 10.1016/j.tem.2010.07.001; Liu M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013333; LUNDSTROM J, 1990, J BIOL CHEM, V265, P9114; PUIG A, 1994, J BIOL CHEM, V269, P19128; Rutkevich LA, 2010, MOL BIOL CELL, V21, P3093, DOI 10.1091/mbc.E10-04-0356; Schulman S, 2010, P NATL ACAD SCI USA, V107, P15027, DOI 10.1073/pnas.1009972107; TANG JG, 1988, BIOCHEM J, V255, P451, DOI 10.1042/bj2550451; Tsai B, 2001, CELL, V104, P937, DOI 10.1016/S0092-8674(01)00289-6; Tu BP, 2000, SCIENCE, V290, P1571, DOI 10.1126/science.290.5496.1571; Wang CC, 1998, BIOCHEMISTRY-MOSCOW+, V63, P407; Weiss MA, 2009, J BIOL CHEM, V284, P19159, DOI 10.1074/jbc.R109.009936; Winter J, 2002, J BIOL CHEM, V277, P310, DOI 10.1074/jbc.M107832200; Zhang LL, 2009, J BIOL CHEM, V284, P5289, DOI 10.1074/jbc.M805477200; Zito E, 2010, J CELL BIOL, V188, P821, DOI 10.1083/jcb.200911086	24	45	46	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					43	47		10.1074/jbc.C111.279927	http://dx.doi.org/10.1074/jbc.C111.279927			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22105075	hybrid, Green Published			2022-12-27	WOS:000298682400007
J	Durgan, DJ; Pat, BM; Laczy, B; Bradley, JA; Tsai, JY; Grenett, MH; Ratcliffe, WF; Brewer, RA; Nagendran, J; Villegas-Montoya, C; Zou, CH; Zou, LY; Johnson, RL; Dyck, JRB; Bray, MS; Gamble, KL; Chatham, JC; Young, ME				Durgan, David J.; Pat, Betty M.; Laczy, Boglarka; Bradley, Jerry A.; Tsai, Ju-Yun; Grenett, Maximiliano H.; Ratcliffe, William F.; Brewer, Rachel A.; Nagendran, Jeevan; Villegas-Montoya, Carolina; Zou, Chenhang; Zou, Luyun; Johnson, Russell L., Jr.; Dyck, Jason R. B.; Bray, Molly S.; Gamble, Karen L.; Chatham, John C.; Young, Martin E.			O-GlcNAcylation, Novel Post-Translational Modification Linking Myocardial Metabolism and Cardiomyocyte Circadian Clock	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONTRACTILE FUNCTION; NUCLEOCYTOPLASMIC PROTEINS; DIURNAL-VARIATIONS; GENE-EXPRESSION; RHYTHMS; HEART; PHOSPHORYLATION; MOUSE; RESPONSIVENESS; TRANSCRIPTION	The cardiomyocyte circadian clock directly regulates multiple myocardial functions in a time-of-day-dependent manner, including gene expression, metabolism, contractility, and ischemic tolerance. These same biological processes are also directly influenced by modification of proteins by monosaccharides of O-linked beta-N-acetylglucosamine (O-GlcNAc). Because the circadian clock and protein O-GlcNAcylation have common regulatory roles in the heart, we hypothesized that a relationship exists between the two. We report that total cardiac protein O-GlcNAc levels exhibit a diurnal variation in mouse hearts, peaking during the active/awake phase. Genetic ablation of the circadian clock specifically in cardiomyocytes in vivo abolishes diurnal variations in cardiac O-GlcNAc levels. These time-of-day- dependent variations appear to be mediated by clock-dependent regulation of O-GlcNAc transferase and O-GlcNAcase protein levels, glucose metabolism/uptake, and glutamine synthesis in an NAD-independent manner. We also identify the clock component Bmal1 as an O-GlcNAc-modified protein. Increasing protein O-GlcNAcylation (through pharmacological inhibition of O-GlcNAcase) results in diminished Per2 protein levels, time-of-day-dependent induction of bmal1 gene expression, and phase advances in the suprachiasmatic nucleus clock. Collectively, these data suggest that the cardiomyocyte circadian clock increases protein O-GlcNAcylation in the heart during the active/awake phase through coordinated regulation of the hexosamine biosynthetic pathway and that protein O-GlcNAcylation in turn influences the timing of the circadian clock.	[Durgan, David J.; Pat, Betty M.; Bradley, Jerry A.; Grenett, Maximiliano H.; Ratcliffe, William F.; Brewer, Rachel A.; Young, Martin E.] Univ Alabama Birmingham, Dept Med, Div Cardiovasc Dis, Birmingham, AL 35294 USA; [Laczy, Boglarka; Zou, Chenhang; Zou, Luyun; Chatham, John C.] Univ Alabama Birmingham, Div Mol & Cellular Pathol, Dept Pathol, Birmingham, AL 35294 USA; [Johnson, Russell L., Jr.; Gamble, Karen L.] Univ Alabama Birmingham, Div Behav Neurobiol, Dept Psychiat, Birmingham, AL 35294 USA; [Bray, Molly S.] Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL 35294 USA; [Tsai, Ju-Yun; Villegas-Montoya, Carolina] ARS, USDA, Childrens Nutr Res Ctr, Dept Pediat,Baylor Coll Med, Houston, TX 77030 USA; [Nagendran, Jeevan; Dyck, Jason R. B.] Univ Alberta, Fac Med & Dent, Dept Pediat, Cardiovasc Res Ctr, Edmonton, AB T6G 2S2, Canada	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Baylor College of Medicine; United States Department of Agriculture (USDA); University of Alberta	Young, ME (corresponding author), Univ Alabama Birmingham, Dept Med, Div Cardiovasc Dis, 703 19th St S,ZRB 308, Birmingham, AL 35294 USA.	meyoung@uab.edu		Gamble, Karen/0000-0003-3813-8577; Dyck, Jason/0000-0002-7045-2884	National Institutes of Health [HL074259, HL106199, HL101192, HL079364]; National Science Foundation; Baylor College of Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T35HL007473, R01HL101192, R01HL074259, R21HL106199, R01HL079364] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Baylor College of Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL074259 and HL106199 (NHLBI, to M. E. Y.) and HL101192 and HL079364 (NHLBI, to J. C. C.).; Supported by a National Science Foundation GK-12 Fellowship.; Supported by the DeBakey Heart Fund at Baylor College of Medicine.	Asher G, 2011, CELL METAB, V13, P125, DOI 10.1016/j.cmet.2011.01.006; Asher G, 2010, CELL, V142, P943, DOI 10.1016/j.cell.2010.08.016; Bray MS, 2007, OBES REV, V8, P169, DOI 10.1111/j.1467-789X.2006.00277.x; Bray MS, 2009, OBES REV, V10, P6, DOI 10.1111/j.1467-789X.2009.00684.x; Bray MS, 2008, CARDIOVASC RES, V79, P228, DOI 10.1093/cvr/cvn054; Bray MS, 2008, AM J PHYSIOL-HEART C, V294, pH1036, DOI 10.1152/ajpheart.01291.2007; Cardone L, 2005, SCIENCE, V309, P1390, DOI 10.1126/science.1110689; Chatham JC, 2010, BBA-GEN SUBJECTS, V1800, P57, DOI 10.1016/j.bbagen.2009.07.004; Dardente H, 2007, CHRONOBIOL INT, V24, P195, DOI 10.1080/07420520701283693; Doi M, 2006, CELL, V125, P497, DOI 10.1016/j.cell.2006.03.033; Doi R, 2010, J BIOL CHEM, V285, P22114, DOI 10.1074/jbc.M110.110361; Durgan DJ, 2007, AM J PHYSIOL-HEART C, V293, pH2385, DOI 10.1152/ajpheart.01361.2006; Durgan DJ, 2006, J BIOL CHEM, V281, P24254, DOI 10.1074/jbc.M601704200; Durgan DJ, 2011, CHRONOBIOL INT, V28, P187, DOI 10.3109/07420528.2010.550406; Durgan DJ, 2010, CIRC RES, V106, P647, DOI 10.1161/CIRCRESAHA.109.209957; Durgan DJ, 2010, CIRC RES, V106, P546, DOI 10.1161/CIRCRESAHA.109.209346; Edery I, 2000, PHYSIOL GENOMICS, V3, P59, DOI 10.1152/physiolgenomics.2000.3.2.59; Fulop N, 2007, AM J PHYSIOL-CELL PH, V292, pC1370, DOI 10.1152/ajpcell.00422.2006; Fulop N, 2007, CARDIOVASC RES, V73, P288, DOI 10.1016/j.cardiores.2006.07.018; Gamble KL, 2007, J NEUROSCI, V27, P12078, DOI 10.1523/JNEUROSCI.1109-07.2007; Goodwin GW, 1998, J BIOL CHEM, V273, P29530, DOI 10.1074/jbc.273.45.29530; Hanover JA, 2010, BBA-GEN SUBJECTS, V1800, P80, DOI 10.1016/j.bbagen.2009.07.017; Hardin PE, 2006, CELL, V125, P424, DOI 10.1016/j.cell.2006.04.010; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; Hu Y, 2005, CIRC RES, V96, P1006, DOI 10.1161/01.RES.0000165478.06813.58; Hu Y, 2004, J BIOL CHEM, V279, P29988, DOI 10.1074/jbc.M401547200; Iitaka C, 2005, J BIOL CHEM, V280, P29397, DOI 10.1074/jbc.M503526200; Kamemura K, 2003, PROG NUCLEIC ACID RE, V73, P107, DOI 10.1016/S0079-6603(03)01004-3; Katada S, 2010, NAT STRUCT MOL BIOL, V17, P1414, DOI 10.1038/nsmb.1961; Kloss B, 1998, CELL, V94, P97, DOI 10.1016/S0092-8674(00)81225-8; Laczy B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018417; Laczy B, 2009, CIRC RES, V105, pE50; Lamia KA, 2009, SCIENCE, V326, P437, DOI 10.1126/science.1172156; LEIGHTON B, 1988, AM J PHYSIOL, V255, pE41, DOI 10.1152/ajpendo.1988.255.1.E41; Love, 2005, SCI STKE, V2005, DOI DOI 10.1126/STKE.3122005RE13; Marcheva B, 2010, NATURE, V466, P627, DOI 10.1038/nature09253; Marsh SA, 2011, AMINO ACIDS, V40, P819, DOI 10.1007/s00726-010-0699-8; Millar AJ, 2000, CURR BIOL, V10, pR529, DOI 10.1016/S0960-9822(00)00586-8; Oishi K, 2004, BIOCHEM BIOPH RES CO, V317, P330, DOI 10.1016/j.bbrc.2004.03.055; POWANDA MC, 1970, J NUTR, V100, P1471, DOI 10.1093/jn/100.12.1471; Rutter J, 2001, SCIENCE, V293, P510, DOI 10.1126/science.1060698; Sadacca LA, 2011, DIABETOLOGIA, V54, P120, DOI 10.1007/s00125-010-1920-8; Shimba S, 2005, P NATL ACAD SCI USA, V102, P12071, DOI 10.1073/pnas.0502383102; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Tamaru T, 2009, NAT STRUCT MOL BIOL, V16, P446, DOI 10.1038/nsmb.1578; Tsai JY, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.077800; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Um JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018450; Yao ZL, 2006, PHARM RES, V23, P670, DOI 10.1007/s11095-005-9608-3; Yin L, 2006, SCIENCE, V311, P1002, DOI 10.1126/science.1121613; Yoo SH, 2005, P NATL ACAD SCI USA, V102, P2608, DOI 10.1073/pnas.0409763102; Young ME, 2001, CIRC RES, V89, P1199, DOI 10.1161/hh2401.100741; Young ME, 2002, J MOL CELL CARDIOL, V34, P223, DOI 10.1006/jmcc.2001.1504; Young ME, 2001, CIRC RES, V88, P1142, DOI 10.1161/hh1101.091190; Zachara NE, 2004, J BIOL CHEM, V279, P30133, DOI 10.1074/jbc.M403773200; Zou LY, 2009, AM J PHYSIOL-HEART C, V296, pH515, DOI 10.1152/ajpheart.01025.2008	57	92	95	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2011	286	52					44606	44619		10.1074/jbc.M111.278903	http://dx.doi.org/10.1074/jbc.M111.278903			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870CA	22069332	hybrid, Green Published			2022-12-27	WOS:000298645500032
J	Liu, LW; Zhang, GQ; Zhang, Z; Wang, SY; Chen, HG				Liu, Liangwei; Zhang, Guoqiang; Zhang, Zhang; Wang, Suya; Chen, Hongge			Terminal Amino Acids Disturb Xylanase Thermostability and Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MECHANICAL STABILITY; CLOSTRIDIUM-THERMOCELLUM; NONOMURAEA-FLEXUOSA; DIRECTED EVOLUTION; TRICHODERMA-REESEI; ENZYMATIC-ACTIVITY; THERMAL-STABILITY; SUBSTRATE-BINDING; PROTEIN-STRUCTURE; SWISS-MODEL	Protein structure is composed of regular secondary structural elements (alpha-helix and beta-strand) and non-regular region. Unlike the helix and strand, the non-regular region consists of an amino acid defined as a disordered residue (DR). When compared with the effect of the helix and strand, the effect of the DR on enzyme structure and function is elusive. An Aspergillus niger GH10 xylanase (Xyn) was selected as a model molecule of (beta/alpha)(8) because the general structure consists of similar to 10% enzymes. The Xyn has five N-terminal DRs and one C-terminal DR, respectively, which were deleted to construct three mutants, Xyn Delta N, Xyn Delta C, and Xyn Delta NC. Each mutant was similar to 2-, 3-, or 4-fold more thermostable and 7-, 4-, or 4-fold more active than the Xyn. The N-terminal deletion decreased the xylanase temperature optimum for activity (T-opt) 6 degrees C, but the C-terminal deletion increased its T-opt 6 degrees C. The N-and C-terminal deletions had opposing effects on the enzyme T-opt but had additive effects on its thermostability. The five N-terminal DR deletions had more effect on the enzyme kinetics but less effect on its thermo property than the one C-terminal DR deletion. CD data showed that the terminal DR deletions increased regular secondary structural contents, and hence, led to slow decreased Gibbs free energy changes (Delta G(0)) in the thermal denaturation process, which ultimately enhanced enzyme thermostabilities.	[Liu, Liangwei; Zhang, Guoqiang; Zhang, Zhang; Chen, Hongge] Henan Agr Univ, Life Sci Coll, Zhengzhou 450002, Peoples R China; [Wang, Suya] Nanjing Univ Econ, Dept Food Sci & Engn, Nanjing 210003, Jiangsu, Peoples R China; [Chen, Hongge] Henan Agr Univ, Key Lab Enzyme Engn Agr Microbiol, Minist Agr, Zhengzhou 450002, Peoples R China	Henan Agricultural University; Nanjing University of Finance & Economics; Henan Agricultural University; Ministry of Agriculture & Rural Affairs	Liu, LW (corresponding author), Henan Agr Univ, Life Sci Coll, 95 Wenhua Rd, Zhengzhou 450002, Peoples R China.	LLW321@yahoo.com.cn		liu, liangwei/0000-0002-1896-8437	Natural Science Foundation of China [30972123]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Natural Science Foundation of China (Grant 30972123).	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Chen NG, 2011, BBA-PROTEINS PROTEOM, V1814, P1318, DOI 10.1016/j.bbapap.2011.06.010; Chiti F, 1998, BIOCHEMISTRY-US, V37, P1447, DOI 10.1021/bi971692f; Dumon C, 2008, J BIOL CHEM, V283, P22557, DOI 10.1074/jbc.M800936200; Goda S, 2000, PROTEIN ENG, V13, P299, DOI 10.1093/protein/13.4.299; Guzman DL, 2010, P NATL ACAD SCI USA, V107, P1989, DOI 10.1073/pnas.0905796107; Hakulinen N, 2003, EUR J BIOCHEM, V270, P1399, DOI 10.1046/j.1432-1033.2003.03496.x; Hamana H, 1999, J BIOCHEM-TOKYO, V125, P109, DOI 10.1093/oxfordjournals.jbchem.a022246; Huang BH, 1996, BIOCHEMISTRY-US, V35, P12164, DOI 10.1021/bi960234o; Ihsanawati, 2005, PROTEINS, V61, P999, DOI 10.1002/prot.20700; KAUFMANN E, 1984, FEBS LETT, V170, P81, DOI 10.1016/0014-5793(84)81373-3; Kumar PR, 2000, J MOL BIOL, V295, P581, DOI 10.1006/jmbi.1999.3348; Kumar S, 2000, PROTEIN ENG, V13, P179, DOI 10.1093/protein/13.3.179; Lee CF, 2005, J MOL BIOL, V348, P419, DOI 10.1016/j.jmb.2005.02.052; Li HB, 2008, J MOL BIOL, V379, P871, DOI 10.1016/j.jmb.2008.04.018; Liu LW, 2011, PROCESS BIOCHEM, V46, P395, DOI 10.1016/j.procbio.2010.07.026; Liu LW, 2008, J BIOTECHNOL, V136, pS201, DOI 10.1016/j.jbiotec.2008.07.423; Lo Leggio L, 1999, PROTEINS, V36, P295; Ma YF, 2000, BIOCHEMISTRY-US, V39, P13350, DOI 10.1021/bi000688s; MILLWARDSADLER SJ, 1995, BIOCHEM J, V312, P39, DOI 10.1042/bj3120039; NICHOLSON H, 1991, BIOCHEMISTRY-US, V30, P9816, DOI 10.1021/bi00105a002; Niu D, 2010, BIOTECHNOL LETT, V32, P963, DOI 10.1007/s10529-010-0241-9; Paloheimo M, 2007, APPL ENVIRON MICROB, V73, P3215, DOI 10.1128/AEM.02967-06; Pel HJ, 2007, NAT BIOTECHNOL, V25, P221, DOI 10.1038/nbt1282; Phannachet K, 2010, CURR MICROBIOL, V61, P549, DOI 10.1007/s00284-010-9651-0; Querol E, 1996, PROTEIN ENG, V9, P265, DOI 10.1093/protein/9.3.265; Ruiz-Arribas A, 1998, EUR J BIOCHEM, V253, P462, DOI 10.1046/j.1432-1327.1998.2530462.x; Ruller R, 2008, PROTEINS, V70, P1280, DOI 10.1002/prot.21617; Schmidt A, 1998, PROTEIN SCI, V7, P2081, DOI 10.1002/pro.5560071004; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Sharma D, 2008, BIOPHYS J, V95, P3935, DOI 10.1529/biophysj.108.134072; Shin ES, 2002, APPL ENVIRON MICROB, V68, P3496, DOI 10.1128/AEM.68.7.3496-3501.2002; Turunen O, 2001, J BIOTECHNOL, V88, P37, DOI 10.1016/S0168-1656(01)00253-X; Wang SJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008335; Wassenberg D, 1997, PROTEIN SCI, V6, P1718, DOI 10.1002/pro.5560060812; Wen TN, 2005, BIOCHEMISTRY-US, V44, P9197, DOI 10.1021/bi0500630; Yano JK, 2003, CURR OPIN BIOTECH, V14, P360, DOI 10.1016/S0958-1669(03)00075-2; Zhang S, 2010, BIOCHEM BIOPH RES CO, V395, P200, DOI 10.1016/j.bbrc.2010.03.159; Zhao GS, 2005, BIOSCI BIOTECH BIOCH, V69, P1562, DOI 10.1271/bbb.69.1562; ZHUKOVSKY EA, 1994, BIOCHEMISTRY-US, V33, P9856, DOI 10.1021/bi00199a006	40	49	55	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2011	286	52					44710	44715		10.1074/jbc.M111.269753	http://dx.doi.org/10.1074/jbc.M111.269753			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870CA	22072708	hybrid, Green Published			2022-12-27	WOS:000298645500041
J	Das, A; Ghosh, J; Bhattacharya, A; Samanta, D; Das, D; Das Gupta, C				Das, Anindita; Ghosh, Jaydip; Bhattacharya, Arpita; Samanta, Dibyendu; Das, Debasis; Das Gupta, Chanchal			Involvement of Mitochondrial Ribosomal Proteins in Ribosomal RNA-mediated Protein Folding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI RIBOSOME; DOMAIN-V; IN-VITRO; DENATURED PROTEINS; LARGE SUBUNIT; REACTIVATION; WORLD; EXTRACTION; EVOLUTION; PEPTIDE	The peptidyl transferase center of the domain V of large ribosomal RNA in the prokaryotic and eukaryotic cytosolic ribosomes acts as general protein folding modulator. We showed earlier that one part of the domain V (RNA1 containing the peptidyl transferase loop) binds unfolded protein and directs it to a folding competent state (FCS) that is released by the other part (RNA2) to attain the folded native state by itself. Here we show that the peptidyl transferase loop of the mitochondrial ribosome releases unfolded proteins in FCS extremely slowly despite its lack of the rRNA segment analogous to RNA2. The release of FCS can be hastened by the equivalent activity of RNA2 or the large subunit proteins of the mitochondrial ribosome. The RNA2 or large subunit proteins probably introduce some allosteric change in the peptidyl transferase loop to enable it to release proteins in FCS.	[Das, Anindita; Ghosh, Jaydip; Bhattacharya, Arpita; Samanta, Dibyendu; Das, Debasis; Das Gupta, Chanchal] Univ Calcutta, Univ Coll Sci, Dept Biophys Mol Biol & Bioinformat, Kolkata 700009, India; [Das, Anindita; Das Gupta, Chanchal] Indian Inst Sci Educ & Res, Dept Biol Sci, Mohanpur 741252, Nadia, India; [Ghosh, Jaydip] St Xaviers Coll, Dept Microbiol, Kolkata 700016, India	University of Calcutta; Indian Institute of Science Education & Research (IISER) - Kolkata; St. Xavier's College Kolkata	Das Gupta, C (corresponding author), Univ Calcutta, Univ Coll Sci, Dept Biophys Mol Biol & Bioinformat, Kolkata 700009, India.	chanchaldg2000@yahoo.com		Bhattacharya, Arpita/0000-0002-0252-1550	Department of Science and Technology; Department of Biotechnology; Council for Scientific and Industrial Research, Government of India	Department of Science and Technology(Department of Science & Technology (India)); Department of Biotechnology; Council for Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by grants from the Department of Science and Technology, Department of Biotechnology, and Council for Scientific and Industrial Research, Government of India.	Altman S, 2007, BIOL CHEM, V388, P663, DOI 10.1515/BC.2007.085; Argent RH, 2000, J BIOL CHEM, V275, P9263, DOI 10.1074/jbc.275.13.9263; Basu A, 2008, BIOCHEM BIOPH RES CO, V366, P592, DOI 10.1016/j.bbrc.2007.11.142; BERA AK, 1994, BIOCHEM MOL BIOL INT, V32, P315; Cech TR, 2009, COLD SH Q B, V74, P11, DOI 10.1101/sqb.2009.74.024; Cech TR, 2009, CELL, V136, P599, DOI 10.1016/j.cell.2009.02.002; Chattopadhyay S, 1996, P NATL ACAD SCI USA, V93, P8284, DOI 10.1073/pnas.93.16.8284; Chattopadhyay S, 1999, BBA-PROTEIN STRUCT M, V1429, P293, DOI 10.1016/S0167-4838(98)00179-4; CHATTOPADHYAY S, 1994, BIOCHEM J, V300, P717, DOI 10.1042/bj3000717; Chowdhury S, 2002, NUCLEIC ACIDS RES, V30, P1278, DOI 10.1093/nar/30.5.1278; CRICK FHC, 1968, J MOL BIOL, V38, P367, DOI 10.1016/0022-2836(68)90392-6; DAS B, 1992, BIOCHEM BIOPH RES CO, V183, P774, DOI 10.1016/0006-291X(92)90550-5; Das B, 1996, EUR J BIOCHEM, V235, P613, DOI 10.1111/j.1432-1033.1996.00613.x; Das Debasis, 2008, Biotechnology Journal, V3, P999, DOI 10.1002/biot.200800098; Evans MS, 2008, J MOL BIOL, V383, P683, DOI 10.1016/j.jmb.2008.07.035; Ghosh J, 2003, MOL MICROBIOL, V48, P1679, DOI 10.1046/j.1365-2958.2003.03538.x; Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476; GUTELL RR, 1992, NUCLEIC ACIDS RES, V20, P2095, DOI 10.1093/nar/20.suppl.2095; Hardesty B, 2001, PROG NUCLEIC ACID RE, V66, P41; Jeffares DC, 1998, J MOL EVOL, V46, P18, DOI 10.1007/PL00006280; Kim HK, 2010, BIOCHEM BIOPH RES CO, V391, P1177, DOI 10.1016/j.bbrc.2009.11.176; Kramer G, 2001, INT J BIOCHEM CELL B, V33, P541, DOI 10.1016/S1357-2725(01)00044-9; Kudlicki W, 1997, FOLD DES, V2, P101, DOI 10.1016/S1359-0278(97)00014-X; Margulis L, 1970, ORIGIN EUKARYOTIC CE; MATTHEWS DE, 1982, J BIOL CHEM, V257, P8788; NOLLER HF, 1992, SCIENCE, V256, P1416, DOI 10.1126/science.1604315; ORGEL LE, 1968, J MOL BIOL, V38, P381, DOI 10.1016/0022-2836(68)90393-8; Pal D, 1997, NUCLEIC ACIDS RES, V25, P5047, DOI 10.1093/nar/25.24.5047; Pal S, 1999, J BIOL CHEM, V274, P32771, DOI 10.1074/jbc.274.46.32771; Samanta D, 2008, J BACTERIOL, V190, P3344, DOI 10.1128/JB.01800-07; SCHIEBER GL, 1982, J BIOL CHEM, V257, P8781; Sharma MR, 2003, CELL, V115, P97, DOI 10.1016/S0092-8674(03)00762-1; Sulijoadikusumo I, 2001, BIOCHEMISTRY-US, V40, P11559, DOI 10.1021/bi015526q; Suzuki T, 2001, J BIOL CHEM, V276, P21724, DOI 10.1074/jbc.M100432200; Tribouillard-Tanvier D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002174; VONAHSEN U, 1995, SCIENCE, V267, P234, DOI 10.1126/science.7528943; Woese CR, 2001, RNA, V7, P1055, DOI 10.1017/S1355838201010615	38	12	12	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2011	286	51					43771	43781		10.1074/jbc.M111.263574	http://dx.doi.org/10.1074/jbc.M111.263574			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866SH	22020935	Green Published, hybrid			2022-12-27	WOS:000298402300020
J	Jain, S; Kahnt, J; van der Does, C				Jain, Samta; Kahnt, Joerg; van der Does, Chris			Processing and Maturation of the Pilin of the Type IV Secretion System Encoded within the Gonococcal Genetic Island	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GRAM-NEGATIVE BACTERIA; T-PILUS BIOGENESIS; AGROBACTERIUM-TUMEFACIENS; NEISSERIA-GONORRHOEAE; ESCHERICHIA-COLI; F-PILIN; DNA TRANSFER; MUTATIONAL ANALYSIS; MEMBRANE INSERTION; SIGNAL PEPTIDASES	The type IV secretion system (T4SS) encoded within the gonococcal genetic island (GGI) of Neisseria gonorrhoeae has homology to the T4SS encoded on the F plasmid. The GGI encodes the putative pilin protein TraA and a serine protease TrbI, which is homologous to the TraF protein of the RP4 plasmid involved in circularization of pilin subunits of P-type pili. TraA was processed to a 68-amino acid long circular peptide by leader peptidase and TrbI. Processing occurred after co-translational membrane insertion and was independent of other proteins. Circularization occurred after removal of three C-terminal amino acids. Mutational analysis of TraA revealed limited flexibility at the cleavage and joining sites. Mutagenesis of TrbI showed that the conserved Lys-93 and Asp-155 are essential, whereas mutagenesis of Ser-52, the putative catalytic serine did not influence circularization. Further mutagenesis of other serine residues did not identify a catalytic serine, indicating that TrbI either contains redundant catalytic serine residues or does not function via a serine-lysine dyad mechanism. In vitro studies revealed that circularization occurs via a covalent intermediate between the C terminus of TraA and TrbI. The intermediate is processed to the circular form after cleavage of the N-terminal signal sequence. This is the first demonstration of a covalent intermediate in the circularization mechanism of conjugative pili.	[Jain, Samta; Kahnt, Joerg; van der Does, Chris] Max Planck Inst Terr Microbiol, Dept Ecophysiol, D-35043 Marburg, Germany; [Jain, Samta; van der Does, Chris] Univ Groningen, Dept Microbiol, Groningen Biomol Sci & Biotechnol Inst, NL-9747 AG Groningen, Netherlands; [Jain, Samta; van der Does, Chris] Univ Groningen, Zernike Inst Adv Mat, NL-9747 AG Groningen, Netherlands	Max Planck Society; University of Groningen; University of Groningen	van der Does, C (corresponding author), Max Planck Inst Terr Microbiol, Dept Ecophysiol, Karl von Frisch Str, D-35043 Marburg, Germany.	does@mpi-marburg.mpg.de	Institute, Zernike/W-7033-2019					Aas FE, 2007, MOL MICROBIOL, V65, P607, DOI 10.1111/j.1365-2958.2007.05806.x; ACHTMAN M, 1978, J BACTERIOL, V135, P1053, DOI 10.1128/JB.135.3.1053-1061.1978; Alvarez-Martinez CE, 2009, MICROBIOL MOL BIOL R, V73, P775, DOI 10.1128/MMBR.00023-09; Arts J, 2007, J BACTERIOL, V189, P2069, DOI 10.1128/JB.01236-06; BARKOCYGALLAGHER GA, 1992, J BIOL CHEM, V267, P1231; BERGER BR, 1994, J BACTERIOL, V176, P3646, DOI 10.1128/JB.176.12.3646-3660.1994; BOLLAND S, 1990, J BACTERIOL, V172, P5795, DOI 10.1128/jb.172.10.5795-5802.1990; BRADLEY DE, 1980, PLASMID, V4, P155, DOI 10.1016/0147-619X(80)90005-0; Cascales E, 2003, NAT REV MICROBIOL, V1, P137, DOI 10.1038/nrmicro753; Chandran V, 2009, NATURE, V462, P1011, DOI 10.1038/nature08588; Christie PJ, 2005, ANNU REV MICROBIOL, V59, P451, DOI 10.1146/annurev.micro.58.030603.123630; Craik DJ, 1999, J MOL BIOL, V294, P1327, DOI 10.1006/jmbi.1999.3383; Craik DJ, 2003, J BACTERIOL, V185, P4011, DOI 10.1128/JB.185.14.4011-4021.2003; CUNNINGHAM K, 1989, P NATL ACAD SCI USA, V86, P8630, DOI 10.1073/pnas.86.22.8630; Dalbey RE, 1997, PROTEIN SCI, V6, P1129, DOI 10.1002/pro.5560060601; de Keyzer Jeanine, 2007, V390, P17; de la Cruz F, 2010, FEMS MICROBIOL REV, V34, P18, DOI 10.1111/j.1574-6976.2009.00195.x; DEVRIJE T, 1987, BIOCHIM BIOPHYS ACTA, V900, P63, DOI 10.1016/0005-2736(87)90278-1; Dillard JP, 2001, MOL MICROBIOL, V41, P263, DOI 10.1046/j.1365-2958.2001.02520.x; Dominguez NM, 2011, J BACTERIOL, V193, P377, DOI 10.1128/JB.00948-10; Eisenbrandt R, 1999, J BIOL CHEM, V274, P22548, DOI 10.1074/jbc.274.32.22548; Eisenbrandt R, 2000, J BACTERIOL, V182, P6751, DOI 10.1128/JB.182.23.6751-6761.2000; Ekici OD, 2008, PROTEIN SCI, V17, P2023, DOI 10.1110/ps.035436.108; Felnagle EA, 2008, MOL PHARMACEUT, V5, P191, DOI 10.1021/mp700137g; Francetic O, 2007, J BACTERIOL, V189, P1783, DOI 10.1128/JB.01230-06; Fronzes R, 2008, EMBO J, V27, P2271, DOI 10.1038/emboj.2008.155; Fronzes R, 2009, NAT REV MICROBIOL, V7, P703, DOI 10.1038/nrmicro2218; Fronzes R, 2009, SCIENCE, V323, P266, DOI 10.1126/science.1166101; Fullner KJ, 1996, SCIENCE, V273, P1107, DOI 10.1126/science.273.5278.1107; Geertsma ER, 2007, NAT METHODS, V4, P705, DOI 10.1038/NMETH1073; Gonzalez C, 2000, P NATL ACAD SCI USA, V97, P11221, DOI 10.1073/pnas.210301097; Haase J, 1997, J BACTERIOL, V179, P5728, DOI 10.1128/jb.179.18.5728-5735.1997; HAASE J, 1995, J BACTERIOL, V177, P4779, DOI 10.1128/jb.177.16.4779-4791.1995; Hamilton HL, 2005, MOL MICROBIOL, V55, P1704, DOI 10.1111/j.1365-2958.2005.04521.x; Harris RL, 1999, MOL MICROBIOL, V34, P780, DOI 10.1046/j.1365-2958.1999.01640.x; Hernandez JF, 2000, BIOCHEMISTRY-US, V39, P5722, DOI 10.1021/bi9929756; Jakubowski SJ, 2009, MOL MICROBIOL, V71, P779, DOI 10.1111/j.1365-2958.2008.06565.x; Jones AL, 1996, J BACTERIOL, V178, P5706, DOI 10.1128/jb.178.19.5706-5711.1996; Kalkum M, 2004, CURR PROTEIN PEPT SC, V5, P417, DOI 10.2174/1389203043379639; Kalkum M, 2002, TRENDS MICROBIOL, V10, P382, DOI 10.1016/S0966-842X(02)02399-5; Kaufmann A, 1999, BIOCHEMISTRY-US, V38, P9115, DOI 10.1021/bi990539d; KELLOGG DS, 1963, J BACTERIOL, V85, P1274, DOI 10.1128/JB.85.6.1274-1279.1963; Kerr JE, 2010, J BACTERIOL, V192, P4923, DOI 10.1128/JB.00557-10; Lai EM, 2000, J BACTERIOL, V182, P3705, DOI 10.1128/JB.182.13.3705-3716.2000; Lai EM, 1998, J BACTERIOL, V180, P2711, DOI 10.1128/JB.180.10.2711-2717.1998; Lai EM, 2002, FEMS MICROBIOL LETT, V210, P111, DOI 10.1111/j.1574-6968.2002.tb11168.x; Lai EM, 2002, J BACTERIOL, V184, P327, DOI 10.1128/JB.184.1.327-330.2002; Lawley TD, 2003, FEMS MICROBIOL LETT, V224, P1, DOI 10.1016/S0378-1097(03)00430-0; Lawley TD, 2003, J BACTERIOL, V185, P581, DOI 10.1128/JB.185.2.581-591.2003; LEI SP, 1987, J BACTERIOL, V169, P4379, DOI 10.1128/jb.169.9.4379-4383.1987; Luckett S, 1999, J MOL BIOL, V290, P525, DOI 10.1006/jmbi.1999.2891; Majdalani N, 1996, J BACTERIOL, V178, P3742, DOI 10.1128/jb.178.13.3742-3747.1996; Manchak J, 2002, MOL MICROBIOL, V43, P195, DOI 10.1046/j.1365-2958.2002.02731.x; MANEEWANNAKUL K, 1995, J BACTERIOL, V177, P2957, DOI 10.1128/jb.177.11.2957-2964.1995; MOORE D, 1993, J BACTERIOL, V175, P1375, DOI 10.1128/JB.175.5.1375-1383.1993; Pachulec E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009962; Paetzel M, 1998, NATURE, V396, P186, DOI 10.1038/24196; Paetzel M, 1997, TRENDS BIOCHEM SCI, V22, P28, DOI 10.1016/S0968-0004(96)10065-7; Paetzel M, 2000, PHARMACOL THERAPEUT, V87, P27, DOI 10.1016/S0163-7258(00)00064-4; Salgado-Pabon W, 2007, MOL MICROBIOL, V66, P930, DOI 10.1111/j.1365-2958.2007.05966.x; STROM MS, 1993, P NATL ACAD SCI USA, V90, P2404, DOI 10.1073/pnas.90.6.2404; SWANSON J, 1971, J EXP MED, V134, P886, DOI 10.1084/jem.134.4.886; Tang YQ, 1999, SCIENCE, V286, P498, DOI 10.1126/science.286.5439.498; TAYLOR RG, 1993, NUCLEIC ACIDS RES, V21, P1677, DOI 10.1093/nar/21.7.1677; Trabi M, 2004, PLANT CELL, V16, P2204, DOI 10.1105/tpc.104.021790; van der Laan M, 2004, J BIOL CHEM, V279, P1659, DOI 10.1074/jbc.M306527200; Waksman G, 2010, TRENDS BIOCHEM SCI, V35, P691, DOI 10.1016/j.tibs.2010.06.002; Williams NK, 2005, J MOL BIOL, V346, P1095, DOI 10.1016/j.jmb.2004.12.037	68	5	5	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2011	286	51					43601	43610		10.1074/jbc.M111.264028	http://dx.doi.org/10.1074/jbc.M111.264028			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866SH	22006923	Green Published, hybrid			2022-12-27	WOS:000298402300003
J	Naka, T; Maeda, S; Niki, M; Ohara, N; Yamamoto, S; Yano, I; Maeyama, J; Ogura, H; Kobayashi, K; Fujiwara, N				Naka, Takashi; Maeda, Shinji; Niki, Mamiko; Ohara, Naoya; Yamamoto, Saburo; Yano, Ikuya; Maeyama, Jun-ichi; Ogura, Hisashi; Kobayashi, Kazuo; Fujiwara, Nagatoshi			Lipid Phenotype of Two Distinct Subpopulations of Mycobacterium bovis Bacillus Calmette-Guerin Tokyo 172 Substrain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BCG VACCINE STRAINS; IMMUNE-RESPONSE; GENOME SEQUENCE; MULTIPLEX PCR; TUBERCULOSIS; IDENTIFICATION; INTRACELLULARE; GENE; DIACYLGLYCEROL; DERIVATIZATION	Bacillus Calmette-Guerin (BCG) Tokyo 172 is a predominant World Health Organization Reference Reagent for the BCG vaccine. Recently, the BCG Tokyo 172 substrain was reported to consist of two subpopulations with different colony morphologies, smooth and rough. Smooth colonies had a characteristic 22-bp deletion in Rv3405c of the region of difference (RD) 16 (type I), and rough colonies were complete in this region (type II). We hypothesized that the morphological difference is related to lipid phenotype and affects their antigenicity. We determined the lipid compositions and biosynthesis of types I and II. Scanning electron microscopy showed that type I was 1.5 times longer than type II. Phenolic glycolipid (PGL) and phthiocerol dimycocerosate (PDIM) were found only in type I. Although it has been reported that the RD16 is involved in the expression of PGL, type II did not possess PGL/PDIM. We examined the ppsA-E gene responsible for PGL/PDIM biosynthesis and found that the existence of PGL/PDIM in types I and II is caused by a ppsA gene mutation not regulated by the RD16. PGL suppressed the host recognition of total lipids via Toll-like receptor 2, and this suggests that PGL is antigenic and involved in host responses, acting as a cell wall component. This is the first report to show the difference between lipid phenotypes of types I and II. It is important to clarify the heterogeneity of BCG vaccine substrains to discuss and evaluate the quality, safety, and efficacy of the BCG vaccine.	[Fujiwara, Nagatoshi] Osaka City Univ, Grad Sch Med, Dept Bacteriol, Abeno Ku, Osaka 5458585, Japan; [Ogura, Hisashi] Osaka City Univ, Grad Sch Med, Dept Virol, Osaka 5458585, Japan; [Naka, Takashi] MBR Co Ltd, Osaka 5608552, Japan; [Maeda, Shinji] Japan AntiTB Assoc, Res Inst TB, Mol Epidemiol Div, Mycobacterium Reference Ctr, Tokyo 2048533, Japan; [Ohara, Naoya] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Oral Microbiol, Okayama 7008558, Japan; [Yamamoto, Saburo; Yano, Ikuya] Japan BCG Lab, Tokyo 2040022, Japan; [Maeyama, Jun-ichi] Natl Inst Infect Dis, Dept Safety Res Blood & Biol Prod, Tokyo 2080011, Japan; [Kobayashi, Kazuo] Natl Inst Infect Dis, Dept Immunol, Tokyo 2080011, Japan	Osaka Metropolitan University; Osaka Metropolitan University; Okayama University; National Institute of Infectious Diseases (NIID); National Institute of Infectious Diseases (NIID)	Fujiwara, N (corresponding author), Osaka City Univ, Grad Sch Med, Dept Bacteriol, Abeno Ku, 1-4-3 Asahi Machi, Osaka 5458585, Japan.	fujiwara@med.osaka-cu.ac.jp	OHARA, Naoya/B-2481-2011		Ministry of Education, Culture, Sports, Science and Technology in Japan; Japan Health Sciences Foundation, Ministry of Health, Labour and Welfare in Japan	Ministry of Education, Culture, Sports, Science and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Health Sciences Foundation, Ministry of Health, Labour and Welfare in Japan	This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology in Japan; and the Japan Health Sciences Foundation (Research on Publicly Essential Drugs and Medical Devices), the Ministry of Health, Labour and Welfare in Japan.	[Anonymous], 2011, GLOB TUB CONTR 2010; BARROW WW, 1982, J BACTERIOL, V150, P381, DOI 10.1128/JB.150.1.381-384.1982; Bedwell J, 2001, VACCINE, V19, P2146, DOI 10.1016/S0264-410X(00)00369-8; Behr MA, 1999, SCIENCE, V284, P1520, DOI 10.1126/science.284.5419.1520; Behr MA, 2000, J BACTERIOL, V182, P3394, DOI 10.1128/JB.182.12.3394-3399.2000; Behr MA, 2002, LANCET INFECT DIS, V2, P86, DOI 10.1016/S1473-3099(02)00182-2; Bhatt A, 2007, P NATL ACAD SCI USA, V104, P5157, DOI 10.1073/pnas.0608654104; BRENNAN PJ, 1995, ANNU REV BIOCHEM, V64, P29, DOI 10.1146/annurev.bi.64.070195.000333; Brosch R, 2005, TUBERCULOSIS AND THE TUBERCLE BACILLUS, P155; Brosch R, 2007, P NATL ACAD SCI USA, V104, P5596, DOI 10.1073/pnas.0700869104; Camacho LR, 2001, J BIOL CHEM, V276, P19845, DOI 10.1074/jbc.M100662200; Chen JM, 2007, VACCINE, V25, P8114, DOI 10.1016/j.vaccine.2007.09.041; Etienne G, 2005, MICROBIOL-SGM, V151, P2075, DOI 10.1099/mic.0.27869-0; FUJIWARA N, 2008, GLYCOLIPIDS NEW RES, P99; Fujiwara N, 2008, J BACTERIOL, V190, P3613, DOI 10.1128/JB.01850-07; Geisel RE, 2005, J IMMUNOL, V174, P5007, DOI 10.4049/jimmunol.174.8.5007; GILBART J, 1987, EUR J CLIN MICROBIOL, V6, P715, DOI 10.1007/BF02013084; Gilleron M, 2003, J BIOL CHEM, V278, P29880, DOI 10.1074/jbc.M303446200; Gomes LHF, 2011, J BACTERIOL, V193, P5600, DOI 10.1128/JB.05827-11; Guenin-Mace L, 2009, TRANSBOUND EMERG DIS, V56, P255, DOI 10.1111/j.1865-1682.2009.01072.x; Guilhot C, 2008, MYCOBACTERIAL CELL ENVELOPE, P273; Hayashi D, 2009, FEMS IMMUNOL MED MIC, V56, P116, DOI 10.1111/j.1574-695X.2009.00559.x; Ho MM, 2008, VACCINE, V26, P4754, DOI 10.1016/j.vaccine.2008.06.026; Ho MM, 2011, VACCINE, V29, P512, DOI 10.1016/j.vaccine.2010.10.066; Honda I, 2006, VACCINE, V24, P4969, DOI 10.1016/j.vaccine.2006.03.055; Knezevic I, 2006, VACCINE, V24, P3874, DOI 10.1016/j.vaccine.2006.03.014; Kremer L, 2005, MOL MICROBIOL, V57, P1113, DOI 10.1111/j.1365-2958.2005.04717.x; Leung AS, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-413; Markey K, 2010, VACCINE, V28, P6964, DOI [10.1016/j.vaccine.2010.08.045, 10.1016/j.vaccine.2010.07.086]; Martinez A, 1999, J BACTERIOL, V181, P7331; MILLER LT, 1982, J CLIN MICROBIOL, V16, P584, DOI 10.1128/JCM.16.3.584-586.1982; Naka T, 2011, J BACTERIOL, V193, P5766, DOI 10.1128/JB.05412-11; Reed MB, 2004, NATURE, V431, P84, DOI 10.1038/nature02837; Rousseau C, 2004, CELL MICROBIOL, V6, P277, DOI 10.1046/j.1462-5822.2004.00368.x; Scherman H, 2009, J BACTERIOL, V191, P6769, DOI 10.1128/JB.00431-09; Seki M, 2009, VACCINE, V27, P1710, DOI 10.1016/j.vaccine.2009.01.034; Simeone R, 2010, FEBS J, V277, P2715, DOI [10.1111/j.1742-4658.2010.07688.x, 10.1111/j.1742-464X.2010.07688.x]; Sirakova TD, 2006, MICROBIOL-SGM, V152, P2717, DOI 10.1099/mic.0.28993-0; Yuan Y, 1998, MOL MICROBIOL, V29, P1449, DOI 10.1046/j.1365-2958.1998.01026.x; Zwerling A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001012	40	21	21	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2011	286	51					44153	44161		10.1074/jbc.M111.310037	http://dx.doi.org/10.1074/jbc.M111.310037			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866SH	22030395	Green Published, hybrid			2022-12-27	WOS:000298402300056
J	Needham, PG; Mikoluk, K; Dhakarwal, P; Khadem, S; Snyder, AC; Subramanya, AR; Brodsky, JL				Needham, Patrick G.; Mikoluk, Kasia; Dhakarwal, Pradeep; Khadem, Shaheen; Snyder, Avin C.; Subramanya, Arohan R.; Brodsky, Jeffrey L.			The Thiazide-sensitive NaCl Cotransporter Is Targeted for Chaperone-dependent Endoplasmic Reticulum-associated Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; ER-ASSOCIATED DEGRADATION; CL-COTRANSPORTER; UBIQUITIN-LIGASE; FUNCTIONAL EXPRESSION; PROTEIN TRANSLOCATION; INTRACELLULAR TRAFFICKING; MOLECULAR CHAPERONES; MEMBRANE-PROTEINS; DISTINCT ROLES	The thiazide-sensitive NaCl cotransporter (NCC, SLC12A3) mediates salt reabsorption in the distal nephron of the kidney and is the target of thiazide diuretics, which are commonly prescribed to treat hypertension. Mutations in NCC also give rise to Gitelman syndrome, a hereditary salt-wasting disorder thought in most cases to arise from impaired NCC biogenesis through enhanced endoplasmic reticulum-associated degradation (ERAD). Because the machinery that mediates NCC quality control is completely undefined, we employed yeast as a model heterologous expression system to identify factors involved in NCC degradation. We confirmed that NCC was a bona fide ERAD substrate in yeast, as the majority of NCC polypeptide was integrated into ER membranes, and its turnover rate was sensitive to proteasome inhibition. NCC degradation was primarily dependent on the ER membrane-associated E3 ubiquitin ligase Hrd1. Whereas several ER luminal chaperones were dispensable for NCC ERAD, NCC ubiquitination and degradation required the activity of Ssa1, a cytoplasmic Hsp70 chaperone. Compatible findings were observed when NCC was expressed in mammalian kidney cells, as the cotransporter was polyubiquitinated and degraded by the proteasome, and mammalian cytoplasmic Hsp70 (Hsp72) coexpression stimulated the degradation of newly synthesized NCC. Hsp70 also preferentially associated with the ER-localized NCC glycosylated species, indicating that cytoplasmic Hsp70 plays a critical role in selecting immature forms of NCC for ERAD. Together, these results provide the first survey of components involved in the ERAD of a mammalian SLC12 cation chloride cotransporter and provide a framework for future studies on NCC ER quality control.	[Needham, Patrick G.; Mikoluk, Kasia; Brodsky, Jeffrey L.] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15261 USA; [Dhakarwal, Pradeep; Khadem, Shaheen; Snyder, Avin C.; Subramanya, Arohan R.] Univ Pittsburgh, Sch Med, Renal Electrolyte Div, Dept Med, Pittsburgh, PA 15261 USA; [Khadem, Shaheen; Subramanya, Arohan R.] Vet Affairs Pittsburgh Healthcare Syst, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System	Needham, PG (corresponding author), 3550 Terrace St,S832 Scaife Hall, Pittsburgh, PA 15261 USA.	ars129@pitt.edu	Subramanya, Arohan R./AAN-5217-2020	Subramanya, Arohan R./0000-0002-2609-7643	National Institutes of Health [DK79307, GM75061, DK84566]; United States Department of Veterans Affairs; American Heart Association [10BGIA3890010]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079307, R21DK084566] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075061] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Veterans Affairs(US Department of Veterans Affairs); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK79307 (to the Pittsburgh Center for Kidney Research-Model Organisms Core), GM75061 (to J. L. B.), and DK84566 (to A. R. S.). This work was also supported by a Mid-Level Career Development Award from the United States Department of Veterans Affairs (to A. R. S.) and James A. Shaver Fund of the American Heart Association Grant 10BGIA3890010 (to A. R. S.).	Ahner A, 2005, ARCH BIOCHEM BIOPHYS, V435, P32, DOI 10.1016/j.abb.2004.11.005; Ahner A, 2007, MOL BIOL CELL, V18; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Becker J, 1996, MOL CELL BIOL, V16, P4378; Bordallo J, 1998, MOL BIOL CELL, V9, P209, DOI 10.1091/mbc.9.1.209; Bostonjoglo M, 1998, J AM SOC NEPHROL, V9, P1347; BRODSKY JL, 1993, J CELL BIOL, V120, P95, DOI 10.1083/jcb.120.1.95; Buck TM, 2010, MOL BIOL CELL, V21, P1047, DOI 10.1091/mbc.E09-11-0944; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; Carvalho P, 2010, CELL, V143, P579, DOI 10.1016/j.cell.2010.10.028; Choo-Kang LR, 2001, AM J PHYSIOL-LUNG C, V281, pL58, DOI 10.1152/ajplung.2001.281.1.L58; Cyr DM, 2002, TRENDS BIOCHEM SCI, V27, P368, DOI 10.1016/S0968-0004(02)02125-4; DAVIDSON HW, 1993, J BIOL CHEM, V268, P4216; De Jong JC, 2003, J AM SOC NEPHROL, V14, P2428, DOI 10.1097/01.ASN.0000089832.52063.F5; De Jong JC, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000017904.77985.03; Devuyst O, 2008, NAT GENET, V40, P495, DOI 10.1038/ng0508-495; ELLISON DH, 1987, AM J PHYSIOL, V253, pF546, DOI 10.1152/ajprenal.1987.253.3.F546; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; Gaczynska M, 2005, METHOD ENZYMOL, V398, P425, DOI 10.1016/S0076-6879(05)98035-X; Gamba G, 2005, PHYSIOL REV, V85, P423, DOI 10.1152/physrev.00011.2004; Goldfarb SB, 2006, P NATL ACAD SCI USA, V103, P5817, DOI 10.1073/pnas.0507903103; Han S, 2007, J BIOL CHEM, V282, P26140, DOI 10.1074/jbc.M701969200; Hassink G, 2005, BIOCHEM J, V388, P647, DOI 10.1042/BJ20041241; Hoover RS, 2003, J AM SOC NEPHROL, V14, P271, DOI 10.1097/01.ASN.0000043903.93452.D0; Huang P, 2005, NAT STRUCT MOL BIOL, V12, P497, DOI 10.1038/nsmb942; Hutt DM, 2009, FEBS LETT, V583, P2639, DOI 10.1016/j.febslet.2009.07.014; Huyer G, 2004, J BIOL CHEM, V279, P38369, DOI 10.1074/jbc.M402468200; JENSEN TJ, 1995, CELL, V83, P129, DOI 10.1016/0092-8674(95)90241-4; Ji WZ, 2008, NAT GENET, V40, P592, DOI 10.1038/ng.118; JONES EW, 1982, GENETICS, V102, P665; Kashlan OB, 2007, J BIOL CHEM, V282, P28149, DOI 10.1074/jbc.M703409200; Knoers NVAM, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-22; Kolb AR, 2011, AM J PHYSIOL-RENAL, V301, pF1, DOI 10.1152/ajprenal.00141.2011; Kunchaparty S, 1999, AM J PHYSIOL-RENAL, V277, pF643, DOI 10.1152/ajprenal.1999.277.4.F643; Lee DH, 1996, J BIOL CHEM, V271, P27280, DOI 10.1074/jbc.271.44.27280; Lim KL, 2005, J NEUROSCI, V25, P2002, DOI 10.1523/JNEUROSCI.4474-04.2005; Mueller B, 2008, P NATL ACAD SCI USA, V105, P12325, DOI 10.1073/pnas.0805371105; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Nakatsukasa K, 2008, CELL, V132, P101, DOI 10.1016/j.cell.2007.11.023; Nishikawa S, 2001, J CELL BIOL, V153, P1061, DOI 10.1083/jcb.153.5.1061; Ong DST, 2011, CURR OPIN CELL BIOL, V23, P231, DOI 10.1016/j.ceb.2010.11.002; Arroyo JP, 2011, J AM SOC NEPHROL, V22, P1707, DOI 10.1681/ASN.2011020132; Ravid T, 2006, EMBO J, V25, P533, DOI 10.1038/sj.emboj.7600946; Rubenstein RC, 2000, AM J PHYSIOL-CELL PH, V278, pC259, DOI 10.1152/ajpcell.2000.278.2.C259; Sabath E, 2004, AM J PHYSIOL-RENAL, V287, pF195, DOI 10.1152/ajprenal.00044.2004; Sato BK, 2009, MOL CELL, V34, P212, DOI 10.1016/j.molcel.2009.03.010; Shmueli A, 2009, BIOCHEM BIOPH RES CO, V390, P758, DOI 10.1016/j.bbrc.2009.10.045; Simon DB, 1996, NAT GENET, V12, P24, DOI 10.1038/ng0196-24; Singh OV, 2006, J PROTEOME RES, V5, P562, DOI 10.1021/pr050319o; Staub O, 1997, EMBO J, V16, P6325, DOI 10.1093/emboj/16.21.6325; STIRLING CJ, 1992, MOL BIOL CELL, V3, P129, DOI 10.1091/mbc.3.2.129; Subramanya AR, 2011, AM J PHYSIOL-RENAL, V300, pF838, DOI 10.1152/ajprenal.00078.2011; Subramanya AR, 2009, J BIOL CHEM, V284, P18471, DOI 10.1074/jbc.M109.008185; Sullivan ML, 2003, J HISTOCHEM CYTOCHEM, V51, P545, DOI 10.1177/002215540305100417; Valentijn JA, 1998, J BIOL CHEM, V273, P30344, DOI 10.1074/jbc.273.46.30344; Vargas-Poussou R, 2011, J AM SOC NEPHROL, V22, P693, DOI 10.1681/ASN.2010090907; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Wang XD, 2006, CELL, V127, P803, DOI 10.1016/j.cell.2006.09.043; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; Youker RT, 2004, MOL BIOL CELL, V15, P4787, DOI 10.1091/mbc.E04-07-0584; Zaarour N, 2009, J BIOL CHEM, V284, P21752, DOI 10.1074/jbc.M109.000679; Zhang Yimao, 2002, Methods Mol Med, V70, P257; Zhang YM, 2001, MOL BIOL CELL, V12, P1303, DOI 10.1091/mbc.12.5.1303	64	37	37	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2011	286	51					43611	43621		10.1074/jbc.M111.288928	http://dx.doi.org/10.1074/jbc.M111.288928			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866SH	22027832	Green Published, hybrid			2022-12-27	WOS:000298402300004
J	Westergard, L; Turnbaugh, JA; Harris, DA				Westergard, Laura; Turnbaugh, Jessie A.; Harris, David A.			A Naturally Occurring C-terminal Fragment of the Prion Protein (PrP) Delays Disease and Acts as a Dominant-negative Inhibitor of PrPSc Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE AMINO-ACID; CELLULAR PRION; TRANSGENIC MICE; NEUROBLASTOMA-CELLS; CULTURED-CELLS; SCRAPIE ISOFORM; INCUBATION-TIME; KNOCKOUT MICE; N-TERMINUS; IN-VIVO	The cellular prion protein (PrPC) undergoes constitutive proteolytic cleavage between residues 111/112 to yield a soluble N-terminal fragment (N1) and a membrane-anchored C-terminal fragment (C1). The C1 fragment represents the major proteolytic fragment of PrPC in brain and several cell types. To explore the role of C1 in prion disease, we generated Tg(C1) transgenic mice expressing this fragment (PrP(Delta 23-111)) in the presence and absence of endogenous PrP. In contrast to several other N-terminally deleted forms of PrP, the C1 fragment does not cause a spontaneous neurological disease in the absence of endogenous PrP. Tg(C1) mice inoculated with scrapie prions remain healthy and do not accumulate protease-resistant PrP, demonstrating that C1 is not a substrate for conversion to PrPSc (the disease-associated isoform). Interestingly, Tg(C1) mice co-expressing C1 along with wild-type PrP (either endogenous or encoded by a second transgene) become ill after scrapie inoculation, but with a dramatically delayed time course compared with mice lacking C1. In addition, accumulation of PrPSc was markedly slowed in these animals. Similar effects were produced by a shorter C-terminal fragment of PrP(Delta 23-134). These results demonstrate that C1 acts as dominant-negative inhibitor of PrPSc formation and accumulation of neurotoxic forms of PrP. Thus, C1, a naturally occurring fragment of PrPC, might play a modulatory role during the course of prion diseases. In addition, enhancing production of C1, or exogenously administering this fragment, represents a potential therapeutic strategy for the treatment of prion diseases.	[Turnbaugh, Jessie A.; Harris, David A.] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; [Westergard, Laura] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Boston University; Washington University (WUSTL)	Harris, DA (corresponding author), Boston Univ, Sch Med, Dept Biochem, 72 E Concord St,K225, Boston, MA 02118 USA.	daharris@bu.edu		Harris, David/0000-0002-6985-5790	National Institutes of Health [NS40975, NS052526, NS056376, NS065244]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065244, R01NS052526, R01NS040975, R01NS056376] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS40975, NS052526, NS056376, and NS065244 (to D. A. H.).	Aguzzi A, 2008, ANNU REV NEUROSCI, V31, P439, DOI 10.1146/annurev.neuro.31.060407.125620; Barron RM, 2001, EMBO J, V20, P5070, DOI 10.1093/emboj/20.18.5070; Baumann F, 2007, EMBO J, V26, P538, DOI 10.1038/sj.emboj.7601510; Borchelt DR, 1996, GENET ANAL-BIOMOL E, V13, P159, DOI 10.1016/S1050-3862(96)00167-2; BORCHELT DR, 1993, GLYCOBIOLOGY, V3, P319, DOI 10.1093/glycob/3.4.319; Bremer J, 2010, NAT NEUROSCI, V13, P310, DOI 10.1038/nn.2483; Chabry J, 1999, J VIROL, V73, P6245, DOI 10.1128/JVI.73.8.6245-6250.1999; CHEN SG, 1995, J BIOL CHEM, V270, P19173, DOI 10.1074/jbc.270.32.19173; Chiesa R, 2001, NEUROBIOL DIS, V8, P743, DOI 10.1006/nbdi.2001.0433; Chiesa R, 1998, NEURON, V21, P1339, DOI 10.1016/S0896-6273(00)80653-4; Cisse MA, 2005, J BIOL CHEM, V280, P40624, DOI 10.1074/jbc.M506069200; COLLINGE J, 1995, LANCET, V346, P569, DOI 10.1016/S0140-6736(95)91405-6; COLLINGE J, 1990, LANCET, V336, P7, DOI 10.1016/0140-6736(90)91518-F; Enari M, 2001, P NATL ACAD SCI USA, V98, P9295, DOI 10.1073/pnas.151242598; Fischer M, 1996, EMBO J, V15, P1255, DOI 10.1002/j.1460-2075.1996.tb00467.x; Flechsig E, 2000, NEURON, V27, P399, DOI 10.1016/S0896-6273(00)00046-5; Geoghegan JC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000535; HARRIS DA, 1993, BIOCHEMISTRY-US, V32, P1009, DOI 10.1021/bi00055a003; Holscher C, 1998, J VIROL, V72, P1153; Horiuchi M, 1999, EMBO J, V18, P3193, DOI 10.1093/emboj/18.12.3193; Horiuchi M, 2001, J BIOL CHEM, V276, P15489, DOI 10.1074/jbc.M100288200; HSIAO KK, 1994, P NATL ACAD SCI USA, V91, P9126, DOI 10.1073/pnas.91.19.9126; HSIAO KK, 1990, SCIENCE, V250, P1587, DOI 10.1126/science.1980379; Jimenez-Huete A, 1998, AM J PATHOL, V153, P1561, DOI 10.1016/S0002-9440(10)65744-6; Kaneko K, 1997, P NATL ACAD SCI USA, V94, P10069, DOI 10.1073/pnas.94.19.10069; Laffont-Proust I, 2005, FEBS LETT, V579, P6333, DOI 10.1016/j.febslet.2005.10.013; Lasmezas CI, 1997, SCIENCE, V275, P402, DOI 10.1126/science.275.5298.402; Lee CI, 2007, PROTEIN SCI, V16, P2166, DOI 10.1110/ps.072954607; Li AM, 2007, EMBO J, V26, P548, DOI 10.1038/sj.emboj.7601507; Magalhaes AC, 2002, J BIOL CHEM, V277, P33311, DOI 10.1074/jbc.M203661200; Mallucci G, 2003, SCIENCE, V302, P871, DOI 10.1126/science.1090187; Mallucci GR, 2007, NEURON, V53, P325, DOI 10.1016/j.neuron.2007.01.005; Mange A, 2004, BIOL CELL, V96, P125, DOI 10.1016/j.biolcel.2003.11.007; Manson JC, 1999, EMBO J, V18, P6855, DOI 10.1093/emboj/18.23.6855; McMahon HEM, 2001, J BIOL CHEM, V276, P2286, DOI 10.1074/jbc.M007243200; Moore RC, 2001, P NATL ACAD SCI USA, V98, P15288, DOI 10.1073/pnas.251550798; Moroncini G, 2004, P NATL ACAD SCI USA, V101, P10404, DOI 10.1073/pnas.0403522101; Muramoto T, 1997, NAT MED, V3, P750, DOI 10.1038/nm0797-750; Norstrom EM, 2005, J BIOL CHEM, V280, P27236, DOI 10.1074/jbc.M413441200; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; Parkin ET, 2004, J BIOL CHEM, V279, P11170, DOI 10.1074/jbc.M312105200; Peretz D, 2001, NATURE, V412, P739, DOI 10.1038/35089090; Peretz D, 1997, J MOL BIOL, V273, P614, DOI 10.1006/jmbi.1997.1328; Perrier V, 2002, P NATL ACAD SCI USA, V99, P13079, DOI 10.1073/pnas.182425299; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Rigter Alan, 2007, BMC Biochemistry, V8, DOI 10.1186/1471-2091-8-6; Rossi D, 2001, EMBO J, V20, P694, DOI 10.1093/emboj/20.4.694; SAFAR J, 1993, J BIOL CHEM, V268, P20276; Sakaguchi S, 1996, NATURE, V380, P528, DOI 10.1038/380528a0; Sandberg MK, 2011, NATURE, V470, P540, DOI 10.1038/nature09768; Selkoe DJ, 2008, BEHAV BRAIN RES, V192, P106, DOI 10.1016/j.bbr.2008.02.016; Shmerling D, 1998, CELL, V93, P203, DOI 10.1016/S0092-8674(00)81572-X; SHYNG SL, 1993, J BIOL CHEM, V268, P15922; SHYNG SL, 1994, J CELL BIOL, V125, P1239, DOI 10.1083/jcb.125.6.1239; Solforosi L, 2007, J BIOL CHEM, V282, P7465, DOI 10.1074/jbc.M610051200; Solomon IH, 2011, J BIOL CHEM, V286, P14724, DOI 10.1074/jbc.M110.214973; Solomon IH, 2010, J BIOL CHEM, V285, P26719, DOI 10.1074/jbc.M110.134619; STAHL N, 1987, CELL, V51, P229, DOI 10.1016/0092-8674(87)90150-4; Sunyach C, 2003, EMBO J, V22, P3591, DOI 10.1093/emboj/cdg344; Sunyach C, 2007, J BIOL CHEM, V282, P1956, DOI 10.1074/jbc.M609663200; Taguchi Y, 2009, MOL BIOL CELL, V20, P233, DOI 10.1091/mbc.E08-06-0635; TARABOULOS A, 1995, J CELL BIOL, V129, P121, DOI 10.1083/jcb.129.1.121; TARABOULOS A, 1992, MOL BIOL CELL, V3, P851, DOI 10.1091/mbc.3.8.851; Toupet K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002773; Vincent B, 2000, J BIOL CHEM, V275, P35612, DOI 10.1074/jbc.M004628200; Vincent B, 2001, J BIOL CHEM, V276, P37743; Walmsley AR, 2009, MOL CELL NEUROSCI, V40, P242, DOI 10.1016/j.mcn.2008.10.012; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Watt NT, 2005, J BIOL CHEM, V280, P35914, DOI 10.1074/jbc.M507327200; Westergard L, 2011, J NEUROSCI, V31, P14005, DOI 10.1523/JNEUROSCI.1243-11.2011; White MD, 2008, P NATL ACAD SCI USA, V105, P10238, DOI 10.1073/pnas.0802759105; Yadavalli R, 2004, J BIOL CHEM, V279, P21948, DOI 10.1074/jbc.M400793200; Yamaguchi N, 2004, BIOCHEM BIOPH RES CO, V319, P1247, DOI 10.1016/j.bbrc.2004.05.115	73	71	72	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2011	286	51					44234	44242		10.1074/jbc.M111.286195	http://dx.doi.org/10.1074/jbc.M111.286195			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866SH	22025612	hybrid, Green Published			2022-12-27	WOS:000298402300063
J	Nomme, J; Fanning, AS; Caffrey, M; Lye, MF; Anderson, JM; Lavie, A				Nomme, Julian; Fanning, Alan S.; Caffrey, Michael; Lye, Ming F.; Anderson, James M.; Lavie, Arnon			The Src Homology 3 Domain Is Required for Junctional Adhesion Molecule Binding to the Third PDZ Domain of the Scaffolding Protein ZO-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GUANYLATE KINASE DOMAINS; TIGHT-JUNCTION; INTRAMOLECULAR INTERACTION; LIGAND-BINDING; CELL POLARITY; LOCALIZATION; MEMBRANE; PSD-95; SITES; DIMERIZATION	Tight junctions are cell-cell contacts that regulate the paracellular flux of solutes and prevent pathogen entry across cell layers. The assembly and permeability of this barrier are dependent on the zonula occludens (ZO) membrane-associated guanylate kinase (MAGUK) proteins ZO-1, -2, and -3. MAGUK proteins are characterized by a core motif of protein-binding domains that include a PDZ domain, a Src homology 3 (SH3) domain, and a region of homology to guanylate kinase (GUK); the structure of this core motif has never been determined for any MAGUK. To better understand how ZO proteins organize the assembly of protein complexes we have crystallized the entire PDZ3-SH3-GUK core motif of ZO-1. We have also crystallized this core motif in complex with the cytoplasmic tail of the ZO-1 PDZ3 ligand, junctional adhesion molecule A (JAM-A) to determine how the activity of different domains is coordinated. Our study shows a new feature for PDZ class II ligand binding that implicates the two highly conserved Phe(-2) and Ser(-3) residues of JAM. Our x-ray structures and NMR experiments also show for the first time a role for adjacent domains in the binding of ligands to PDZ domains in the MAGUK proteins family.	[Nomme, Julian; Caffrey, Michael; Lye, Ming F.; Lavie, Arnon] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60607 USA; [Fanning, Alan S.] Univ N Carolina, Dept Cell & Mol Physiol, Chapel Hill, NC 27599 USA; [Anderson, James M.] NHLBI, NIH, Bethesda, MD 20892 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of North Carolina; University of North Carolina Chapel Hill; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Lavie, A (corresponding author), Univ Illinois, Dept Biochem & Mol Genet, 900 S Ashland Ave,Mol Biol Res Bldg,Rm 1108, Chicago, IL 60607 USA.	lavie@uic.edu	Lavie, Arnon/H-4927-2012	Lavie, Arnon/0000-0001-5591-8722; Anderson, James/0000-0003-2765-7996	National Institutes of Health [DK61397]; University of North Carolina; University of Illinois; National Institutes of Health Division of Intramural Research; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK061397, R01DK061397] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of North Carolina; University of Illinois; National Institutes of Health Division of Intramural Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported, in whole or in part, by National Institutes of Health Grant DK61397 (to A. S. F. and A. L.). This work was also supported by the National Institutes of Health Division of Intramural Research and the Universities of North Carolina and Illinois.	Brenman JE, 1998, J NEUROSCI, V18, P8805; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen J, 2008, EMBO J, V27, P2113, DOI 10.1038/emboj.2008.138; Dalvit C, 2001, J BIOMOL NMR, V21, P349, DOI 10.1023/A:1013302231549; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Elias GM, 2007, TRENDS CELL BIOL, V17, P343, DOI 10.1016/j.tcb.2007.07.005; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fanning AS, 2007, J BIOL CHEM, V282, P37710, DOI 10.1074/jbc.M707255200; Fanning AS, 2007, MOL BIOL CELL, V18, P721, DOI 10.1091/mbc.E06-08-0764; Fanning AS, 2009, ANN NY ACAD SCI, V1165, P113, DOI 10.1111/j.1749-6632.2009.04440.x; Funke L, 2005, ANNU REV BIOCHEM, V74, P219, DOI 10.1146/annurev.biochem.74.082803.133339; Good MC, 2011, SCIENCE, V332, P680, DOI 10.1126/science.1198701; Harris BZ, 2001, J CELL SCI, V114, P3219; Hoskins R, 1996, DEVELOPMENT, V122, P97; Javier RT, 2008, ONCOGENE, V27, P7031, DOI 10.1038/onc.2008.352; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kausalya PJ, 2004, MOL BIOL CELL, V15, P5503, DOI 10.1091/mbc.E04-04-0350; Lye MF, 2010, J BIOL CHEM, V285, P13907, DOI 10.1074/jbc.M109.093674; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McGee AW, 1999, J BIOL CHEM, V274, P17431, DOI 10.1074/jbc.274.25.17431; Mehta S, 2001, J BIOL CHEM, V276, P16092, DOI 10.1074/jbc.M100643200; Montgomery JM, 2004, CELL MOL LIFE SCI, V61, P911, DOI 10.1007/s00018-003-3364-5; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Raleigh DR, 2011, J CELL BIOL, V193, P565, DOI 10.1083/jcb.201010065; Saro D, 2007, BIOCHEMISTRY-US, V46, P6340, DOI 10.1021/bi062088k; Sasaki H, 2003, P NATL ACAD SCI USA, V100, P3971, DOI 10.1073/pnas.0630649100; Severson EA, 2009, ANN NY ACAD SCI, V1165, P10, DOI 10.1111/j.1749-6632.2009.04034.x; Shen L, 2008, J CELL BIOL, V181, P683, DOI 10.1083/jcb.200711165; Shin HW, 2000, J NEUROSCI, V20, P3580, DOI 10.1523/JNEUROSCI.20-10-03580.2000; Tavares GA, 2001, MOL CELL, V8, P1313, DOI 10.1016/S1097-2765(01)00416-6; Umeda K, 2006, CELL, V126, P741, DOI 10.1016/j.cell.2006.06.043; Woods DF, 1996, J CELL BIOL, V134, P1469, DOI 10.1083/jcb.134.6.1469; Wu HJ, 2000, EMBO J, V19, P5740, DOI 10.1093/emboj/19.21.5740; Yamamoto T, 1997, J CELL BIOL, V139, P785, DOI 10.1083/jcb.139.3.785; Yokoyama S, 2001, MOL BIOL CELL, V12, P1595, DOI 10.1091/mbc.12.6.1595	36	55	60	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					43352	43360		10.1074/jbc.M111.304089	http://dx.doi.org/10.1074/jbc.M111.304089			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22030391	Green Published, Green Submitted, hybrid			2022-12-27	WOS:000298351300055
J	Ramirez-Aguilar, SJ; Keuthe, M; Rocha, M; Fedyaev, VV; Kramp, K; Gupta, KJ; Rasmusson, AG; Schulze, WX; van Dongen, JT				Ramirez-Aguilar, Santiago J.; Keuthe, Mandy; Rocha, Marcio; Fedyaev, Vadim V.; Kramp, Katharina; Gupta, Kapuganti J.; Rasmusson, Allan G.; Schulze, Waltraud X.; van Dongen, Joost T.			The Composition of Plant Mitochondrial Supercomplexes Changes with Oxygen Availability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPIRATORY-CHAIN SUPERCOMPLEXES; OXIDATIVE-PHOSPHORYLATION SYSTEM; CYTOCHROME-C-OXIDASE; COMPLEX-I; NICOTIANA-SYLVESTRIS; MAMMALIAN MITOCHONDRIA; PH; MEMBRANE; ASSEMBLY/STABILITY; DEHYDROGENASES	Background: Respiratory supercomplexes are known to exist, but their function remains to be revealed. Results: Plant supercomplexes are affected by hypoxia and a concomitant drop in pH. Conclusion: Respiratory supercomplexes are dynamic structures that are affected by the intracellular environment. Significance: Supercomplexes could have a regulatory function in guiding electrons through alternative respiratory pathways.	[Ramirez-Aguilar, Santiago J.; Keuthe, Mandy; Rocha, Marcio; Fedyaev, Vadim V.; Kramp, Katharina; Gupta, Kapuganti J.; Schulze, Waltraud X.; van Dongen, Joost T.] Max Planck Inst Mol Plant Physiol, Energy Metab Res Grp, D-14476 Potsdam, Germany; [Fedyaev, Vadim V.] Bashkir State Univ, Dept Biol, Chair Plant Physiol, Ufa 450074, Russia; [Rasmusson, Allan G.] Lund Univ, Dept Cell & Organism Biol, SE-22362 Lund, Sweden	Max Planck Society; Bashkir State University; Lund University	van Dongen, JT (corresponding author), Max Planck Inst Mol Plant Physiol, Energy Metab Res Grp, Muhlenberg 1, D-14476 Potsdam, Germany.	dongen@mpimp-golm.mpg.de	van Dongen, Joost T/F-5372-2016; Schulze, Waltraud X/E-9800-2011; Fedyaev, Vadim/G-3019-2017; Kapuganti, Jagadis Gupta/D-3429-2014	van Dongen, Joost T/0000-0001-7944-9289; Schulze, Waltraud X/0000-0001-9957-7245; Fedyaev, Vadim/0000-0003-3373-9445; Kapuganti, Jagadis Gupta/0000-0002-7090-5097	Max Planck Society; German Research Foundation [SFB429]; Swedish Research Council	Max Planck Society(Max Planck SocietyFoundation CELLEX); German Research Foundation(German Research Foundation (DFG)); Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by the Max Planck Society, the German Research Foundation (SFB429), and the Swedish Research Council.	Abad MFC, 2004, J BIOL CHEM, V279, P11521, DOI 10.1074/jbc.M306766200; Acin-Perez R, 2008, MOL CELL, V32, P529, DOI 10.1016/j.molcel.2008.10.021; Boekema EJ, 2007, J BIOL CHEM, V282, P1, DOI 10.1074/jbc.R600031200; Bultema JB, 2009, BBA-BIOENERGETICS, V1787, P60, DOI 10.1016/j.bbabio.2008.10.010; Chien LF, 2011, PLANT PHYSIOL BIOCH, V49, P449, DOI 10.1016/j.plaphy.2011.01.024; Collins TJ, 2007, BIOTECHNIQUES, V43, P25, DOI 10.2144/000112517; Couldwell DL, 2009, ANN BOT-LONDON, V103, P249, DOI 10.1093/aob/mcn174; DEPAEPE R, 1990, MOL GEN GENET, V222, P206, DOI 10.1007/BF00633819; Diaz F, 2006, MOL CELL BIOL, V26, P4872, DOI 10.1128/MCB.01767-05; Douce R., 1985, MITOCHONDRIA HIGHER; Dudkina NV, 2006, TRENDS PLANT SCI, V11, P232, DOI 10.1016/j.tplants.2006.03.007; Dudkina NV, 2005, P NATL ACAD SCI USA, V102, P3225, DOI 10.1073/pnas.0408870102; Eubel H, 2004, PLANT PHYSIOL, V134, P1450, DOI 10.1104/pp.103.038018; Eubel H, 2004, PLANT PHYSIOL BIOCH, V42, P937, DOI 10.1016/j.plaphy.2004.09.010; Eubel H, 2003, PLANT PHYSIOL, V133, P274, DOI 10.1104/pp.103.024620; Felle HH, 2005, ANN BOT-LONDON, V96, P519, DOI 10.1093/aob/mci207; Felle HH, 2001, PLANT BIOLOGY, V3, P577, DOI 10.1055/s-2001-19372; Galkin A, 2009, J BIOL CHEM, V284, P36055, DOI 10.1074/jbc.M109.054346; Geigenberger P, 2003, CURR OPIN PLANT BIOL, V6, P247, DOI 10.1016/S1369-5266(03)00038-4; Geisler DA, 2007, J BIOL CHEM, V282, P28455, DOI 10.1074/jbc.M704674200; Gupta KJ, 2009, PHYSIOL PLANTARUM, V137, P383, DOI 10.1111/j.1399-3054.2009.01253.x; Gutierres S, 1997, P NATL ACAD SCI USA, V94, P3436, DOI 10.1073/pnas.94.7.3436; Heinemeyer J, 2007, J BIOL CHEM, V282, P12240, DOI 10.1074/jbc.M610545200; JENSEN BD, 1986, ARCH BIOCHEM BIOPHYS, V248, P305, DOI 10.1016/0003-9861(86)90427-3; KAMO N, 1979, J MEMBRANE BIOL, V49, P105, DOI 10.1007/BF01868720; Kierszniowska S, 2009, PROTEOMICS, V9, P1916, DOI 10.1002/pmic.200800443; Krause F, 2004, J BIOL CHEM, V279, P26453, DOI 10.1074/jbc.M402756200; Li YF, 2007, J BIOL CHEM, V282, P17557, DOI 10.1074/jbc.M701056200; Llopis J, 1998, P NATL ACAD SCI USA, V95, P6803, DOI 10.1073/pnas.95.12.6803; Maas MFPM, 2009, J MOL BIOL, V387, P259, DOI 10.1016/j.jmb.2008.12.025; MANDOLINO G, 1983, BIOCHIM BIOPHYS ACTA, V723, P428, DOI 10.1016/0005-2728(83)90050-6; Michalecka AM, 2004, PLANT J, V37, P415, DOI 10.1046/j.1365-313X.2003.01970.x; Millar AH, 2001, PLANT PHYSIOL, V127, P1711, DOI 10.1104/pp.010387; Narsai R, 2011, NEW PHYTOL, V190, P472, DOI 10.1111/j.1469-8137.2010.03589.x; Olsen JV, 2004, MOL CELL PROTEOMICS, V3, P608, DOI 10.1074/mcp.T400003-MCP200; Orij R, 2009, MICROBIOL-SGM, V155, P268, DOI 10.1099/mic.0.022038-0; Pineau B, 2005, J BIOL CHEM, V280, P25994, DOI 10.1074/jbc.M500508200; RASMUSSON AG, 1991, PHYSIOL PLANTARUM, V83, P357, DOI 10.1111/j.1399-3054.1991.tb00106.x; Rasmusson AG, 2008, MITOCHONDRION, V8, P47, DOI 10.1016/j.mito.2007.10.004; Rosca MG, 2008, CARDIOVASC RES, V80, P30, DOI 10.1093/cvr/cvn184; Sabar M, 2000, PLANT PHYSIOL, V124, P1239, DOI 10.1104/pp.124.3.1239; Sabar M, 2005, PLANT J, V44, P893, DOI 10.1111/j.1365-313X.2005.02577.x; Schafer E, 2007, BIOCHEMISTRY-US, V46, P12579, DOI 10.1021/bi700983h; Schagger H, 2004, J BIOL CHEM, V279, P36349, DOI 10.1074/jbc.M404033200; Schagger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777; Schagger H, 2001, IUBMB LIFE, V52, P119, DOI 10.1080/15216540152845911; van Dongen JT, 2011, J PLANT PHYSIOL, V168, P1434, DOI 10.1016/j.jplph.2010.11.004; van Dongen JT, 2009, ANN BOT-LONDON, V103, P269, DOI 10.1093/aob/mcn126; Vidal G, 2007, PLANT CELL, V19, P640, DOI 10.1105/tpc.106.044461; Wessa P, 2008, PEARSON CORRELATION; Zerbetto E, 1997, ELECTROPHORESIS, V18, P2059, DOI 10.1002/elps.1150181131	51	76	76	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					43045	43053		10.1074/jbc.M111.252544	http://dx.doi.org/10.1074/jbc.M111.252544			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22009743	hybrid, Green Published			2022-12-27	WOS:000298351300025
J	Shchedrina, VA; Everley, RA; Zhang, Y; Gygi, SP; Hatfield, DL; Gladyshev, VN				Shchedrina, Valentina A.; Everley, Robert A.; Zhang, Yan; Gygi, Steven P.; Hatfield, Dolph L.; Gladyshev, Vadim N.			Selenoprotein K Binds Multiprotein Complexes and Is Involved in the Regulation of Endoplasmic Reticulum Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; MEMBRANE-PROTEIN; QUALITY-CONTROL; RETRO-TRANSLOCATION; MISFOLDED PROTEINS; ER PROTEIN; HUMAN HRD1; STRESS; RETROTRANSLOCATION; DEGRADATION	Background: Selenoprotein K (SelK) is an endoplasmic reticulum (ER) protein of unknown function. Results: SelK associates with proteins involved in elimination of misfolded proteins from the ER. Conclusion: SelK is a functional component of ER homeostasis. Significance: This study defines a new family of selenoproteins and links it to an ER-associated degradation.	[Shchedrina, Valentina A.; Zhang, Yan; Gladyshev, Vadim N.] Brigham & Womens Hosp, Div Genet, Dept Med, Boston, MA 02115 USA; [Everley, Robert A.; Gygi, Steven P.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Hatfield, Dolph L.] NCI, Mol Biol Selenium Sect, Lab Canc Prevent, Ctr Canc Res,NIH, Bethesda, MD 20892 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Gladyshev, VN (corresponding author), Brigham & Womens Hosp, Div Genet, Dept Med, New Res Bldg,77 Ave Louis Pasteur,Rm 435, Boston, MA 02115 USA.	vgladyshev@rics.bwh.harvard.edu	shchedrina, valentina a/B-8398-2015; Gladyshev, Vadim N/J-6187-2013; Gladyshev, Vadim N/A-9894-2013	shchedrina, valentina a/0000-0003-1627-982X; Gladyshev, Vadim/0000-0002-0372-7016	National Institutes of Health [GM061603]; Center for Cancer Research, NCI, National Institutes of Health; NATIONAL CANCER INSTITUTE [ZIABC010889] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061603] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Cancer Research, NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM061603 (to V. N. G.). This work was also supported by the Intramural Research Program of the Center for Cancer Research, NCI, National Institutes of Health (to D. L. H.).	Adachi Y, 2008, CELL STRUCT FUNCT, V33, P75, DOI 10.1247/csf.07044; Bagola K, 2011, BBA-BIOMEMBRANES, V1808, P925, DOI 10.1016/j.bbamem.2010.06.025; Ballar P, 2006, J BIOL CHEM, V281, P35359, DOI 10.1074/jbc.M603355200; Bernardi KM, 2008, MOL BIOL CELL, V19, P877, DOI 10.1091/mbc.E07-08-0755; Chen CL, 2006, BIOCHEM BIOPH RES CO, V348, P1296, DOI 10.1016/j.bbrc.2006.07.203; Chung YM, 2006, BIOCHEM BIOPH RES CO, V347, P649, DOI 10.1016/j.bbrc.2006.06.140; Crawshaw SG, 2007, MOL MEMBR BIOL, V24, P113, DOI 10.1080/09687860600988727; Du SQ, 2010, ARCH BIOCHEM BIOPHYS, V502, P137, DOI 10.1016/j.abb.2010.08.001; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Gao Y, 2004, FEBS LETT, V563, P185, DOI 10.1016/S0014-5793(04)00296-0; Gewurz BE, 2002, J BIOL CHEM, V277, P11306, DOI 10.1074/jbc.M107904200; Gobler CJ, 2011, P NATL ACAD SCI USA, V108, P4352, DOI 10.1073/pnas.1016106108; Gromer S, 2005, CELL MOL LIFE SCI, V62, P2414, DOI 10.1007/s00018-005-5143-y; Hatfield DL, 2006, PROG NUCLEIC ACID RE, V81, P97, DOI 10.1016/S0079-6603(06)81003-2; Hebert DN, 2010, SEMIN CELL DEV BIOL, V21, P526, DOI 10.1016/j.semcdb.2009.12.007; Hegde RS, 2010, CURR OPIN CELL BIOL, V22, P437, DOI 10.1016/j.ceb.2010.05.005; Hirsch C, 2009, NATURE, V458, P453, DOI 10.1038/nature07962; Hoffmann PR, 2007, NUCLEIC ACIDS RES, V35, P3963, DOI 10.1093/nar/gkm355; Huang Z, 2011, J BIOL CHEM, V286, P34830, DOI 10.1074/jbc.M111.265520; Kaneko M, 2007, FEBS LETT, V581, P5355, DOI 10.1016/j.febslet.2007.10.033; Katiyar S, 2005, MOL BIOL CELL, V16, P4584, DOI 10.1091/mbc.E05-04-0345; Kelleher DJ, 2006, GLYCOBIOLOGY, V16, p47R, DOI 10.1093/glycob/cwj066; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Liang J, 2006, J CELL SCI, V119, P4011, DOI 10.1242/jcs.03163; Lilley BN, 2005, P NATL ACAD SCI USA, V102, P14296, DOI 10.1073/pnas.0505014102; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; Lilley BN, 2006, J VIROL, V80, P8739, DOI 10.1128/JVI.00791-06; Lobanov AV, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r198; Lobanov AV, 2006, NUCLEIC ACIDS RES, V34, P496, DOI 10.1093/nar/gkj450; Lu CL, 2006, FEBS LETT, V580, P5189, DOI 10.1016/j.febslet.2006.08.065; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Mueller B, 2008, P NATL ACAD SCI USA, V105, P12325, DOI 10.1073/pnas.0805371105; Na AR, 2008, BIOCHEM BIOPH RES CO, V369, P672, DOI 10.1016/j.bbrc.2008.02.098; Novoselov SV, 2007, P NATL ACAD SCI USA, V104, P7857, DOI 10.1073/pnas.0610683104; Oda Y, 2006, J CELL BIOL, V172, P383, DOI 10.1083/jcb.200507057; Reeves MA, 2009, CELL MOL LIFE SCI, V66, P2457, DOI 10.1007/s00018-009-0032-4; Roy B, 1999, NUCLEIC ACIDS RES, V27, P1437, DOI 10.1093/nar/27.6.1437; Ruiz-Canada C, 2009, CELL, V136, P272, DOI 10.1016/j.cell.2008.11.047; Schelhaas M, 2007, CELL, V131, P516, DOI 10.1016/j.cell.2007.09.038; Shchedrina VA, 2007, P NATL ACAD SCI USA, V104, P13919, DOI 10.1073/pnas.0703448104; Shchedrina VA, 2010, ANTIOXID REDOX SIGN, V12, P839, DOI 10.1089/ars.2009.2865; Shibatani T, 2005, BIOCHEMISTRY-US, V44, P5982, DOI 10.1021/bi047328f; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Turanov AA, 2009, SCIENCE, V323, P259, DOI 10.1126/science.1164748; Papp LV, 2007, ANTIOXID REDOX SIGN, V9, P775, DOI 10.1089/ars.2007.1528; Verma S, 2011, J IMMUNOL, V186, P2127, DOI 10.4049/jimmunol.1002878; Wahlman J, 2007, CELL, V129, P943, DOI 10.1016/j.cell.2007.03.046; Yamamoto K, 2004, J BIOCHEM, V136, P343, DOI 10.1093/jb/mvh122; Yamamoto K, 2008, J BIOCHEM, V144, P477, DOI 10.1093/jb/mvn091; Ye YH, 2005, P NATL ACAD SCI USA, V102, P14132, DOI 10.1073/pnas.0505006102; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656; Ye YH, 2006, J STRUCT BIOL, V156, P29, DOI 10.1016/j.jsb.2006.01.005	54	91	107	2	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					42937	42948		10.1074/jbc.M111.310920	http://dx.doi.org/10.1074/jbc.M111.310920			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22016385	Green Published, hybrid			2022-12-27	WOS:000298351300015
J	Wedeken, L; Singh, P; Klempnauer, KH				Wedeken, Lena; Singh, Priyanka; Klempnauer, Karl-Heinz			Tumor Suppressor Protein Pdcd4 Inhibits Translation of p53 mRNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRAMMED CELL-DEATH; INITIATION-FACTOR 4A; DNA-DAMAGE; EUKARYOTIC TRANSLATION; COLORECTAL-CANCER; STRUCTURAL BASIS; GENE-EXPRESSION; BINDING-PROTEIN; TRANSFORMATION; MA-3	Background: Pdcd4 is a tumor suppressor involved in translational regulation. Results: Pdcd4 interacts with p53 mRNA and inhibits its translation via the 5'-UTR. Under stress conditions, the expression of Pdcd4 decreases. Conclusion: Translation of p53 mRNA is suppressed by Pdcd4 under normal growth conditions. Significance: Pdcd4 is a new translational regulator of p53.	[Wedeken, Lena; Singh, Priyanka; Klempnauer, Karl-Heinz] Univ Munster, Inst Biochem, D-48149 Munster, Germany	University of Munster	Klempnauer, KH (corresponding author), Univ Munster, Inst Biochem, Wilhelm Klemm Str 2, D-48149 Munster, Germany.	klempna@uni-muenster.de	Xie, Huangming/B-2260-2012	Singh, Priyanka/0000-0002-5928-6280; Wedeken, Lena/0000-0003-1061-9459	Deutsche Krebshilfe; Wilhelm-Sander-Stiftung; Deutsche Forschungsgemeinschaft; Graduate School of Chemistry, University of Munster	Deutsche Krebshilfe(Deutsche Krebshilfe); Wilhelm-Sander-Stiftung; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Graduate School of Chemistry, University of Munster	This work was supported in part by grants from the Deutsche Krebshilfe, the Wilhelm-Sander-Stiftung, and the Deutsche Forschungsgemeinschaft.; Supported by fellowships from the Graduate School of Chemistry, University of Munster.	Afonja O, 2004, ONCOGENE, V23, P8135, DOI 10.1038/sj.onc.1207983; Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Bensaad K, 2007, TRENDS CELL BIOL, V17, P286, DOI 10.1016/j.tcb.2007.04.004; Bitomsky N, 2008, ONCOGENE, V27, P4820, DOI 10.1038/onc.2008.115; Bitomsky N, 2004, ONCOGENE, V23, P7484, DOI 10.1038/sj.onc.1208064; Chang JH, 2009, P NATL ACAD SCI USA, V106, P3148, DOI 10.1073/pnas.0808275106; Chen J, 2010, GENE DEV, V24, P2146, DOI 10.1101/gad.1968910; Chen Y, 2003, J PATHOL, V200, P640, DOI 10.1002/path.1378; Cmarik JL, 1999, P NATL ACAD SCI USA, V96, P14037, DOI 10.1073/pnas.96.24.14037; Dorrello NV, 2006, SCIENCE, V314, P467, DOI 10.1126/science.1130276; Green DR, 2009, NATURE, V458, P1127, DOI 10.1038/nature07986; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; LaRonde-LeBlanc N, 2007, MOL CELL BIOL, V27, P147, DOI 10.1128/MCB.00867-06; Le MTN, 2009, GENE DEV, V23, P862, DOI 10.1101/gad.1767609; Leupold JH, 2007, ONCOGENE, V26, P4550, DOI 10.1038/sj.onc.1210234; Loh PG, 2009, EMBO J, V28, P274, DOI 10.1038/emboj.2008.278; Lu Z, 2008, ONCOGENE, V27, P4373, DOI 10.1038/onc.2008.72; Mathew R, 2007, NAT REV CANCER, V7, P961, DOI 10.1038/nrc2254; Mazan-Mamczarz K, 2003, P NATL ACAD SCI USA, V100, P8354, DOI 10.1073/pnas.1432104100; MOSNER J, 1995, EMBO J, V14, P4442, DOI 10.1002/j.1460-2075.1995.tb00123.x; Mudduluru G, 2007, CANCER-AM CANCER SOC, V110, P1697, DOI 10.1002/cncr.22983; Ofir-Rosenfeld Y, 2008, MOL CELL, V32, P180, DOI 10.1016/j.molcel.2008.08.031; Ray PS, 2006, EMBO REP, V7, P404, DOI 10.1038/sj.embor.7400623; Shibahara K, 1995, GENE, V166, P297, DOI 10.1016/0378-1119(95)00607-9; Singh P, 2011, ONCOGENE, V30, P4864, DOI 10.1038/onc.2011.202; Singh P, 2009, ONCOGENE, V28, P3758, DOI 10.1038/onc.2009.239; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Suzuki C, 2008, P NATL ACAD SCI USA, V105, P3274, DOI 10.1073/pnas.0712235105; Takagi M, 2005, CELL, V123, P49, DOI 10.1016/j.cell.2005.07.034; Vilborg A, 2010, J MOL MED, V88, P645, DOI 10.1007/s00109-010-0609-2; Vilborg A, 2009, P NATL ACAD SCI USA, V106, P15756, DOI 10.1073/pnas.0900862106; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Vousden KH, 2009, NAT REV CANCER, V9, P691, DOI 10.1038/nrc2715; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Waters LC, 2007, ONCOGENE, V26, P4941, DOI 10.1038/sj.onc.1210305; Waters LC, 2011, J BIOL CHEM, V286, P17270, DOI 10.1074/jbc.M110.166157; Wedeken Lena, 2010, Genes Cancer, V1, P293, DOI 10.1177/1947601910364227; Wethkamp N, 2009, J BIOL CHEM, V284, P28783, DOI 10.1074/jbc.M109.041186; Xiong L, 2007, J CELL BIOL, V178, P995, DOI 10.1083/jcb.200703044; Yang DQ, 2006, ONCOGENE, V25, P4613, DOI 10.1038/sj.onc.1209483; Yang HS, 2003, MOL CELL BIOL, V23, P26, DOI 10.1128/MCB.23.1.26-37.2003; Yang HS, 2004, MOL CELL BIOL, V24, P3894, DOI 10.1128/MCB.24.9.3894-3906.2004; Yang HS, 2003, ONCOGENE, V22, P3712, DOI 10.1038/sj.onc.1206433; Zhang H, 2006, ONCOGENE, V25, P6101, DOI 10.1038/sj.onc.1209634; Zhang YJ, 2009, FEBS LETT, V583, P3725, DOI 10.1016/j.febslet.2009.10.002	46	58	64	3	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					42855	42862		10.1074/jbc.M111.269456	http://dx.doi.org/10.1074/jbc.M111.269456			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22033922	Green Published, hybrid			2022-12-27	WOS:000298351300007
J	Bohnekamp, J; Schoneberg, T				Bohnekamp, Jens; Schoeneberg, Torsten			Cell Adhesion Receptor GPR133 Couples to G(s) Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENOME-WIDE ASSOCIATION; V2 VASOPRESSIN RECEPTOR; CONSTITUTIVE ACTIVITY; TRANSMEMBRANE DOMAIN; ANGIOGENESIS; FAMILY; GPCRS; ACTIVATION; MUTATIONS; MIGRATION	Adhesion G protein-coupled receptors (GPCR), with their very large and complex N termini, are thought to participate in cell-cell and cell-matrix interactions and appear to be highly relevant in several developmental processes. Their intracellular signaling is still poorly understood. Here we demonstrate that GPR133, a member of the adhesion GPCR subfamily, activates the Gs protein/adenylyl cyclase pathway. The presence of the N terminus and the cleavage at the GPCR proteolysis site are not required for G protein signaling. Gs protein coupling was verified by G alpha(s) knockdown with siRNA, overexpression of G alpha(s), co-expression of the chimeric Gq(s4) protein that routes GPR133 activity to the phospholipase C/inositol phosphate pathway, and missense mutation within the transmembrane domain that abolished receptor activity without changing cell surface expression. It is likely that not only GPR133 but also other adhesion GPCR signal via classical receptor/G protein-interaction.	[Bohnekamp, Jens; Schoeneberg, Torsten] Univ Leipzig, Fac Med, Inst Biochem, Sect Mol Biochem, D-04103 Leipzig, Germany	Leipzig University	Schoneberg, T (corresponding author), Univ Leipzig, Fac Med, Inst Biochem, Sect Mol Biochem, Johannisallee 30, D-04103 Leipzig, Germany.	schoberg@medizin.uni-leipzig.de			Deutsche Forschungsgemeinschaft [Sfb 610]; Bundesministerium fur Bildung, Wissenschaft, Forschung und Technologie (Integriertes Forschungs- und Behandlungszentrum AdipositasDiseases Leipzig)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung, Wissenschaft, Forschung und Technologie (Integriertes Forschungs- und Behandlungszentrum AdipositasDiseases Leipzig)	This work was supported by grants from the Deutsche Forschungsgemeinschaft (Grant Sfb 610) and the Bundesministerium fur Bildung, Wissenschaft, Forschung und Technologie (Integriertes Forschungs- und Behandlungszentrum AdipositasDiseases Leipzig).	BERRIDGE MJ, 1983, BIOCHEM J, V212, P849, DOI 10.1042/bj2120849; Biebermann H, 1998, FASEB J, V12, P1461, DOI 10.1096/fasebj.12.14.1461; Bjarnadottir TK, 2007, CELL MOL LIFE SCI, V64, P2104, DOI 10.1007/s00018-007-7067-1; Boselt I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005573; Buch TRH, 2009, J BIOL CHEM, V284, P26411, DOI 10.1074/jbc.M109.039339; Chiang NY, 2011, J BIOL CHEM, V286, P14215, DOI 10.1074/jbc.M110.183830; CONKLIN BR, 1993, NATURE, V363, P274, DOI 10.1038/363274a0; Dessauer CW, 2009, MOL PHARMACOL, V76, P935, DOI 10.1124/mol.109.059345; EGGERICKX D, 1995, BIOCHEM J, V309, P837, DOI 10.1042/bj3090837; Feldman RD, 2007, LIFE SCI, V81, P267, DOI 10.1016/j.lfs.2007.05.015; Hsiao CC, 2011, FEBS LETT, V585, P313, DOI 10.1016/j.febslet.2010.12.005; Iguchi T, 2008, J BIOL CHEM, V283, P14469, DOI 10.1074/jbc.M708919200; Jaschke H, 2006, J BIOL CHEM, V281, P9841, DOI 10.1074/jbc.C600014200; Jeong BC, 2006, FEBS LETT, V580, P669, DOI 10.1016/j.febslet.2005.12.086; Johannessen M, 2004, CELL SIGNAL, V16, P1211, DOI 10.1016/j.cellsig.2004.05.001; Krasnoperov V, 2009, BIOCHEMISTRY-US, V48, P3230, DOI 10.1021/bi802163p; Kuhnert F, 2010, SCIENCE, V330, P985, DOI 10.1126/science.1196554; Kwakkenbos MJ, 2004, IMMUNOGENETICS, V55, P655, DOI 10.1007/s00251-003-0625-2; Langenhan T, 2009, DEV CELL, V17, P494, DOI 10.1016/j.devcel.2009.08.008; Lawrence PA, 2007, NAT REV GENET, V8, P555, DOI 10.1038/nrg2125; LEFKOWITZ RJ, 1993, TRENDS PHARMACOL SCI, V14, P303, DOI 10.1016/0165-6147(93)90048-O; LEFKOWITZ RJ, 1993, NATURE, V365, P603, DOI 10.1038/365603a0; Liberles SD, 2006, NATURE, V442, P645, DOI 10.1038/nature05066; Lin HH, 2004, J BIOL CHEM, V279, P31823, DOI 10.1074/jbc.M402974200; Marroni F, 2009, CIRC-CARDIOVASC GENE, V2, P322, DOI 10.1161/CIRCGENETICS.108.833806; Monk KR, 2009, SCIENCE, V325, P1402, DOI 10.1126/science.1173474; Nordstrom KJV, 2009, MOL BIOL EVOL, V26, P71, DOI 10.1093/molbev/msn228; Okajima D, 2010, J RECEPT SIG TRANSD, V30, P143, DOI 10.3109/10799891003671139; Park D, 2007, NATURE, V450, P430, DOI 10.1038/nature06329; Piao XH, 2004, SCIENCE, V303, P2033, DOI 10.1126/science.1092780; Preuss H, 2007, J PHARMACOL EXP THER, V321, P983, DOI 10.1124/jpet.107.120014; Rompler H, 2006, GENOMICS, V87, P724, DOI 10.1016/j.ygeno.2006.02.009; Rompler M, 2005, J BIOL CHEM, V280, P31068, DOI 10.1074/jbc.M503586200; Sanchez-Mas J, 2004, PIGM CELL RES, V17, P386, DOI 10.1111/j.1600-0749.2004.00160.x; Sangkuhl K, 2002, J BIOL CHEM, V277, P47748, DOI 10.1074/jbc.M203491200; Schmidt C, 2003, J BIOL CHEM, V278, P30248, DOI 10.1074/jbc.M304991200; Schoneberg T, 1998, HUM MUTAT, V12, P196, DOI 10.1002/(SICI)1098-1004(1998)12:3<196::AID-HUMU7>3.0.CO;2-F; Schulz A, 2003, J BIOL CHEM, V278, P35531, DOI 10.1074/jbc.M303346200; Silva JP, 2009, J BIOL CHEM, V284, P6495, DOI 10.1074/jbc.M806979200; Tissir F, 2005, NAT NEUROSCI, V8, P451, DOI 10.1038/nn1428; Tonjes A, 2009, HUM MOL GENET, V18, P4662, DOI 10.1093/hmg/ddp423; Vanti WB, 2003, BIOCHEM BIOPH RES CO, V305, P67, DOI 10.1016/S0006-291X(03)00709-5; Veninga H, 2008, J IMMUNOL, V181, P6574, DOI 10.4049/jimmunol.181.9.6574; Volynski KE, 2004, EMBO J, V23, P4423, DOI 10.1038/sj.emboj.7600443; Waller-Evans H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014047; Weston MD, 2004, AM J HUM GENET, V74, P357, DOI 10.1086/381685; Yona S, 2008, TRENDS BIOCHEM SCI, V33, P491, DOI 10.1016/j.tibs.2008.07.005; Yona S, 2008, FASEB J, V22, P741, DOI 10.1096/fj.07-9435com; Zhang ML, 2005, J BIOL CHEM, V280, P26169, DOI 10.1074/jbc.M502102200	49	69	70	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					41912	41916		10.1074/jbc.C111.265934	http://dx.doi.org/10.1074/jbc.C111.265934			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	22025619	hybrid, Green Published			2022-12-27	WOS:000298180900002
J	Cai, J; Chen, ZJ; Ruan, Q; Han, S; Liu, L; Qi, XP; Boye, SL; Hauswirth, WW; Grant, MB; Boulton, ME				Cai, Jun; Chen, Zhijuan; Ruan, Qing; Han, Song; Liu, Li; Qi, Xiaoping; Boye, Sanford L.; Hauswirth, William W.; Grant, Maria B.; Boulton, Michael E.			gamma-Secretase and Presenilin Mediate Cleavage and Phosphorylation of Vascular Endothelial Growth Factor Receptor-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATED INTRAMEMBRANE PROTEOLYSIS; PROTEIN-TYROSINE PHOSPHATASES; VE-PTP; ANGIOGENESIS; COMPLEX; CANCER; CELL; IDENTIFICATION; ASSOCIATION; EXPRESSION	We have reported previously that pigment epithelium-derived factor (PEDF) can, via gamma-secretase-mediated events, inhibit VEGF-induced angiogenesis in microvascular endothelial cells by both (a) cleavage and intracellular translocation of a C-terminal fragment of VEGF receptor-1 (VEGFR1) and (b) inhibition of VEGF-induced phosphorylation of VEGFR1. Using site-direct mutagenesis and transfection of wild type and mutated receptors into endothelial cells, we showed that transmembrane cleavage of VEGFR1 occurs at valine 767 and that a switch from valine to alanine at this position prevented cleavage and formation of a VEGFR1 intracellular fragment. Using siRNA to selectively knock down protein-tyrosine phosphatases (PTPs) in endothelial cells, we demonstrated that vascular endothelial PTP is responsible for dephosphorylation of activated VEGFR1. PEDF up-regulation of full-length presenilin 1 (Fl.PS1) facilitated the association of vascular endothelial PTP and VEGFR1. Knockdown of Fl.PS1 prevented dephosphorylation of VEGFR1, whereas up-regulation of Fl.PS1 stimulated VEGFR1 dephosphorylation. Fl.PS1 associated with VEGFR1 within 15 min after PEDF treatment. In conclusion, we determined the PEDF-mediated events responsible for VEGFR1 signaling and identified full-length presenilin as a critical adaptor molecule in the dephosphorylation of VEGFR1. This greater understanding of the regulation of VEGFR1 signaling will help identify novel anti-VEGF therapeutic strategies.	[Cai, Jun; Chen, Zhijuan; Ruan, Qing; Qi, Xiaoping; Boulton, Michael E.] Univ Florida, Dept Anat & Cell Biol, Gainesville, FL 32610 USA; [Han, Song] Univ Florida, Dept Surg, Gainesville, FL 32610 USA; [Liu, Li; Grant, Maria B.] Univ Florida, Dept Pharmacol & Therapeut, Gainesville, FL 32610 USA; [Boye, Sanford L.; Hauswirth, William W.] Univ Florida, Dept Ophthalmol, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Boulton, ME (corresponding author), Univ Florida, Dept Anat & Cell Biol, 1600 SW Archer Rd,POB 100235, Gainesville, FL 32610 USA.	meboulton@ufl.edu		hauswirth, william/0000-0002-3244-4947; Han, Song/0000-0002-6542-335X	National Institutes of Health [R01EY018358, R01EY018358-04S1, EY012601, DK090730, R01EY11123, P30EY021721]; Macular Vision Research Foundation; Foundation Fighting Blindness; Eldon Family Foundation; Vision for Children; Research to Prevent Blindness, Inc.; NATIONAL EYE INSTITUTE [R01EY018358, P30EY021721, R01EY011123, R01EY012601] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090730] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Macular Vision Research Foundation; Foundation Fighting Blindness(European Commission); Eldon Family Foundation; Vision for Children; Research to Prevent Blindness, Inc.(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01EY018358 and R01EY018358-04S1 (to M. B.), EY012601 and DK090730 (to M. B. G.), and R01EY11123 and P30EY021721 (to W. W. H.). W. W. H. and the University of Florida have a financial interest in the use of AAV therapies and own equity in a company (AGTC Inc.) that might, in the future, commercialize some aspects of this work.; Supported by grants from the Macular Vision Research Foundation, Foundation Fighting Blindness, Eldon Family Foundation, Vision for Children, and Research to Prevent Blindness, Inc.	Adachi M, 1996, CELL, V85, P15; Baek SH, 2011, MOL CELL, V42, P274, DOI 10.1016/j.molcel.2011.03.022; Boulton ME, 2008, J CELL MOL MED, V12, P781, DOI 10.1111/j.1582-4934.2008.00274.x; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Cai J, 2006, J BIOL CHEM, V281, P3604, DOI 10.1074/jbc.M507401200; Cai J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021164; Cai J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018076; Chen AC, 2010, J BIOL CHEM, V285, P11378, DOI 10.1074/jbc.M109.088815; Dumanchin C, 1999, HUM MOL GENET, V8, P1263, DOI 10.1093/hmg/8.7.1263; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; Foveau B, 2009, MOL BIOL CELL, V20, P2495, DOI 10.1091/mbc.E08-09-0969; Haapasalo A, 2007, J BIOL CHEM, V282, P9063, DOI 10.1074/jbc.M611324200; Hunter T, 2007, MOL CELL, V28, P730, DOI 10.1016/j.molcel.2007.11.019; Kametani F, 2004, NEUROCHEM INT, V44, P313, DOI 10.1016/S0197-0186(03)00176-1; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Kusari J, 2010, INVEST OPHTH VIS SCI, V51, P1044, DOI 10.1167/iovs.08-3293; Lee JH, 2010, CELL, V141, P1146, DOI 10.1016/j.cell.2010.05.008; Lieber T, 2002, GENE DEV, V16, P209, DOI 10.1101/gad.942302; Markusic DM, 2010, MOL THER, V18, P2048, DOI 10.1038/mt.2010.172; Marron MB, 2007, J BIOL CHEM, V282, P30509, DOI 10.1074/jbc.M702535200; Mellberg S, 2009, FASEB J, V23, P1490, DOI 10.1096/fj.08-123810; Nottebaum AF, 2008, J EXP MED, V205, P2929, DOI 10.1084/jem.20080406; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Pinto CA, 2003, CLIN CANCER RES, V9, P3098; Rahimi N, 2006, FRONT BIOSCI-LANDMRK, V11, P818; Rahimi N, 2009, CANCER RES, V69, P2607, DOI 10.1158/0008-5472.CAN-08-2905; Repetto E, 2007, J BIOL CHEM, V282, P31504, DOI 10.1074/jbc.M704273200; Scheper W, 2004, MOL BRAIN RES, V122, P17, DOI 10.1016/j.molbrainres.2003.11.013; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Schulz B, 2008, CIRC RES, V102, P1192, DOI 10.1161/CIRCRESAHA.107.169805; Shiraishi H, 2006, GENES CELLS, V11, P83, DOI 10.1111/j.1365-2443.2005.00914.x; Smith SKF, 2000, MOL BRAIN RES, V78, P100, DOI 10.1016/S0169-328X(00)00079-6; Steiner H, 2002, J BIOL CHEM, V277, P39062, DOI 10.1074/jbc.C200469200; Takasugi N, 2003, NATURE, V422, P438, DOI 10.1038/nature01506; Taniguchi Y, 2003, J BIOL CHEM, V278, P30425, DOI 10.1074/jbc.C300239200; Wolfe MS, 2009, SEMIN CELL DEV BIOL, V20, P219, DOI 10.1016/j.semcdb.2008.12.011; Zhao B, 2004, MICROVASC RES, V68, P239, DOI 10.1016/j.mvr.2004.07.004; Zhao S, 2010, PLACENTA, V31, P512, DOI 10.1016/j.placenta.2010.03.014	39	33	34	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42514	42523		10.1074/jbc.M111.296590	http://dx.doi.org/10.1074/jbc.M111.296590			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	22016384	Green Published, hybrid			2022-12-27	WOS:000298180900059
J	Mbantenkhu, M; Wang, XW; Nardozzi, JD; Wilkens, S; Hoffman, E; Patel, A; Cosgrove, MS; Chen, XJ				Mbantenkhu, MacMillan; Wang, Xiaowen; Nardozzi, Jonathan D.; Wilkens, Stephan; Hoffman, Elizabeth; Patel, Anamika; Cosgrove, Michael S.; Chen, Xin Jie			Mgm101 Is a Rad52-related Protein Required for Mitochondrial DNA Recombination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; HOMOLOGOUS RECOMBINATION; BINDING-PROTEIN; STRAND EXCHANGE; INVERTED-REPEAT; RAD52 PROTEIN; ORGANIZATION; REPLICATION; MAINTENANCE; GENOME	Homologous recombination is a conserved molecular process that has primarily evolved for the repair of double-stranded DNA breaks and stalled replication forks. However, the recombination machinery in mitochondria is poorly understood. Here, we show that the yeast mitochondrial nucleoid protein, Mgm101, is related to the Rad52-type recombination proteins that are widespread in organisms from bacteriophage to humans. Mgm101 is required for repeat-mediated recombination and suppression of mtDNA fragmentation in vivo. It preferentially binds to single-stranded DNA and catalyzes the annealing of ssDNA precomplexed with the mitochondrial ssDNA-binding protein, Rim1. Transmission electron microscopy showed that Mgm101 forms large oligomeric rings of similar to 14-fold symmetry and highly compressed helical filaments. Specific mutations affecting ring formation reduce protein stability in vitro. The data suggest that the ring structure may provide a scaffold for stabilization of Mgm101 by preventing the aggregation of the otherwise unstable monomeric conformation. Upon binding to ssDNA, Mgm101 is remobilized from the rings to form distinct nucleoprotein filaments. These studies reveal a recombination protein of likely bacteriophage origin in mitochondria and support the notion that recombination is indispensable for mtDNA integrity.	[Mbantenkhu, MacMillan; Wang, Xiaowen; Nardozzi, Jonathan D.; Wilkens, Stephan; Hoffman, Elizabeth; Chen, Xin Jie] SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA; [Patel, Anamika; Cosgrove, Michael S.] Syracuse Univ, Dept Biol, Syracuse, NY 13244 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Syracuse University	Chen, XJ (corresponding author), SUNY Upstate Med Univ, Dept Biochem & Mol Biol, 750 E Adams St, Syracuse, NY 13210 USA.	chenx@upstate.edu		Nardozzi, Jonathan/0000-0002-6655-4765	National Institutes of Health [R01AG023731, R01GM058600, R01CA140522]; NATIONAL CANCER INSTITUTE [R01CA140522] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058600] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG023731] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01AG023731, R01GM058600, and R01CA140522 (to X. J. C., S. W., and M. S. C.).	Bacman SR, 2009, NUCLEIC ACIDS RES, V37, P4218, DOI 10.1093/nar/gkp348; Bai Y, 1996, GENE DEV, V10, P2025, DOI 10.1101/gad.10.16.2025; Bogenhagen DF, 2010, EXP GERONTOL, V45, P473, DOI 10.1016/j.exger.2009.12.002; Bogenhagen DF, 2001, PROG NUCLEIC ACID RE, V68, P257; Bonawitz ND, 2006, MOL CELL, V24, P813, DOI 10.1016/j.molcel.2006.11.024; BROWN WM, 1979, P NATL ACAD SCI USA, V76, P1967, DOI 10.1073/pnas.76.4.1967; Chen XJ, 2005, NAT REV GENET, V6, P815, DOI 10.1038/nrg1708; CHEN XJ, 1993, NUCLEIC ACIDS RES, V21, P3473, DOI 10.1093/nar/21.15.3473; Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646; Davis AP, 2001, GENETICS, V159, P515; Dujon B., 1981, MOL BIOL YEAST SACCH, P505; Feng Q, 2007, DNA REPAIR, V6, P27, DOI 10.1016/j.dnarep.2006.08.007; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Gerhold JM, 2010, MOL CELL, V39, P851, DOI 10.1016/j.molcel.2010.09.002; Gilkerson RW, 2008, J CELL BIOL, V181, P1117, DOI 10.1083/jcb.200712101; Holt IJ, 2007, MITOCHONDRION, V7, P311, DOI 10.1016/j.mito.2007.06.004; Howell N, 1996, AM J HUM GENET, V59, P749; Iyer LM, 2002, BMC GENOMICS, V3, DOI 10.1186/1471-2164-3-8; Kagawa W, 2002, MOL CELL, V10, P359, DOI 10.1016/S1097-2765(02)00587-7; Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455; Kantake N, 2002, P NATL ACAD SCI USA, V99, P15327, DOI 10.1073/pnas.252633399; KOWALCZYKOWSKI SC, 1994, MICROBIOL REV, V58, P401, DOI 10.1128/MMBR.58.3.401-465.1994; Kraytsberg Y, 2004, SCIENCE, V304, P981, DOI 10.1126/science.1096342; Larsson NG, 2010, ANNU REV BIOCHEM, V79, P683, DOI 10.1146/annurev-biochem-060408-093701; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; LING F, 1995, EMBO J, V14, P4090, DOI 10.1002/j.1460-2075.1995.tb00081.x; Ling F, 2002, EMBO J, V21, P4730, DOI 10.1093/emboj/cdf466; Ling F, 2000, NUCLEIC ACIDS RES, V28, P4956, DOI 10.1093/nar/28.24.4956; Ling F, 2009, J BIOL CHEM, V284, P9341, DOI 10.1074/jbc.M900023200; Lopes A, 2010, NUCLEIC ACIDS RES, V38, P3952, DOI 10.1093/nar/gkq096; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Luria SE, 1943, GENETICS, V28, P491; Masuda T, 2010, FEBS J, V277, P1440, DOI 10.1111/j.1742-4658.2010.07574.x; Mazin AV, 2010, DNA REPAIR, V9, P286, DOI 10.1016/j.dnarep.2009.12.006; Meeusen S, 1999, J CELL BIOL, V145, P291, DOI 10.1083/jcb.145.2.291; Meeusen S, 2003, J CELL BIOL, V163, P503, DOI 10.1083/jcb.200304040; Mortensen UH, 2002, GENETICS, V161, P549; Mortensen UH, 1996, P NATL ACAD SCI USA, V93, P10729, DOI 10.1073/pnas.93.20.10729; Mott C, 2011, DNA REPAIR, V10, P408, DOI 10.1016/j.dnarep.2011.01.007; Neiman M, 2009, P ROY SOC B-BIOL SCI, V276, P1201, DOI 10.1098/rspb.2008.1758; New JH, 1998, NATURE, V391, P407, DOI 10.1038/34950; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Passy SI, 1999, P NATL ACAD SCI USA, V96, P4279, DOI 10.1073/pnas.96.8.4279; Phadnis N, 2005, GENETICS, V171, P1549, DOI 10.1534/genetics.105.047092; Ploquin M, 2008, CURR BIOL, V18, P1142, DOI 10.1016/j.cub.2008.06.071; Pohjoismaki JLO, 2011, BIOESSAYS, V33, P290, DOI 10.1002/bies.201000137; Pohjoismaki JLO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010426; Pohjoismaki JLO, 2009, J BIOL CHEM, V284, P21446, DOI 10.1074/jbc.M109.016600; POTEETE AR, 1983, J MOL BIOL, V171, P401, DOI 10.1016/0022-2836(83)90037-2; Sage JM, 2010, J BIOL CHEM, V285, P18984, DOI 10.1074/jbc.M109.099846; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shedge V, 2007, PLANT CELL, V19, P1251, DOI 10.1105/tpc.106.048355; Shi I, 2009, J BIOL CHEM, V284, P33275, DOI 10.1074/jbc.M109.057752; Shibata T, 2007, MITOCHONDRION, V7, P17, DOI 10.1016/j.mito.2006.11.024; Singleton MR, 2002, P NATL ACAD SCI USA, V99, P13492, DOI 10.1073/pnas.212449899; Spelbrink JN, 2010, IUBMB LIFE, V62, P19, DOI 10.1002/iub.282; Steele DF, 1996, P NATL ACAD SCI USA, V93, P5253, DOI 10.1073/pnas.93.11.5253; Sugiyama T, 1997, J BIOL CHEM, V272, P7940, DOI 10.1074/jbc.272.12.7940; Sugiyama T, 2006, EMBO J, V25, P5539, DOI 10.1038/sj.emboj.7601412; Sung P, 1997, J BIOL CHEM, V272, P28194, DOI 10.1074/jbc.272.45.28194; Symington LS, 2002, MICROBIOL MOL BIOL R, V66, P630, DOI 10.1128/MMBR.66.4.630-670.2002; VANDYCK E, 1992, EMBO J, V11, P3421, DOI 10.1002/j.1460-2075.1992.tb05421.x; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Weissman L, 2007, NEUROSCIENCE, V145, P1318, DOI 10.1016/j.neuroscience.2006.08.061; Wu Y, 2006, J BIOL CHEM, V281, P15441, DOI 10.1074/jbc.M601827200; Zuo XM, 2007, FEMS YEAST RES, V7, P131, DOI 10.1111/j.1567-1364.2006.00141.x; Zuo XM, 2002, GENETICS, V160, P1389	68	33	34	3	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42360	42370		10.1074/jbc.M111.307512	http://dx.doi.org/10.1074/jbc.M111.307512			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	22027892	hybrid, Green Published			2022-12-27	WOS:000298180900045
J	Walseth, TF; Lin-Moshier, Y; Jain, P; Ruas, M; Parrington, J; Galione, A; Marchant, JS; Slama, JT				Walseth, Timothy F.; Lin-Moshier, Yaping; Jain, Pooja; Ruas, Margarida; Parrington, John; Galione, Antony; Marchant, Jonathan S.; Slama, James T.			Photoaffinity Labeling of High Affinity Nicotinic Acid Adenine Dinucleotide Phosphate (NAADP)-Binding Proteins in Sea Urchin Egg	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NAADP-SENSITIVE CA2+; 2-PORE CHANNELS; CALCIUM-RELEASE; MOBILIZES CALCIUM; INACTIVATION; RECEPTORS	Nicotinic acid adenine dinucleotide phosphate (NAADP) is a messenger that regulates calcium release from intracellular acidic stores. Recent studies have identified two-pore channels (TPCs) as endolysosomal channels that are regulated by NAADP; however, the nature of the NAADP receptor binding site is unknown. To further study NAADP binding sites, we have synthesized and characterized [P-32-5-azido] nicotinic acid adenine dinucleotide phosphate ([P-32-5N(3)] NAADP) as a photoaffinity probe. Photolysis of sea urchin egg homogenates preincubated with [P-32-5N(3)] NAADP resulted in specific labeling of 45-, 40-, and 30-kDa proteins, which was prevented by inclusion of nanomolar concentrations of unlabeled NAADP or 5N(3)-NAADP, but not by micromolar concentrations of structurally related nucleotides such as NAD, nicotinic acid adenine dinucleotide, nicotinamide mononucleotide, nicotinic acid, or nicotinamide. [P-32-5N(3)]NAADP binding was saturable and displayed high affinity (K-d similar to 10 nM) in both binding and photolabeling experiments. [P-32-5N(3)]NAADP photolabeling was irreversible in a high K+ buffer, a hallmark feature of NAADP binding in the egg system. The proteins photolabeled by [P-32-5N(3)]NAADP have molecular masses smaller than the sea urchin TPCs, and antibodies to TPCs do not detect any immunoreactivity that comigrates with either the 45-kDa or the 40-kDa photolabeled proteins. Interestingly, antibodies to TPC1 and TPC3 were able to immunoprecipitate a small fraction of the 45- and 40-kDa photolabeled proteins, suggesting that these proteins associate with TPCs. These data suggest that high affinity NAADP binding sites are distinct from TPCs.	[Walseth, Timothy F.; Lin-Moshier, Yaping; Marchant, Jonathan S.] Univ Minnesota, Sch Med, Dept Pharmacol, Minneapolis, MN 55455 USA; [Jain, Pooja; Slama, James T.] Univ Toledo, Dept Med & Biol Chem, Toledo, OH 43614 USA; [Ruas, Margarida; Parrington, John; Galione, Antony] Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England	University of Minnesota System; University of Minnesota Twin Cities; University System of Ohio; University of Toledo; University of Oxford	Walseth, TF (corresponding author), Univ Minnesota, Sch Med, Dept Pharmacol, Minneapolis, MN 55455 USA.	walse001@umn.edu	Walseth, Timothy F/F-9518-2010; MARCHANT, Jonathan/B-8051-2009; Marchant, Jonathan/Q-5484-2019	Walseth, Timothy F/0000-0003-2558-7859; MARCHANT, Jonathan/0000-0001-6592-0877; Marchant, Jonathan/0000-0001-6592-0877; Galione, Antony/0000-0002-4132-7646; Ruas, Margarida/0000-0002-4872-7618	National Institutes of Health [GM088790]; University of Minnesota Academic Health Center [2101.95]; Wellcome Trust; University of Minnesota Graduate School; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088790] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Minnesota Academic Health Center; Wellcome Trust(Wellcome TrustEuropean Commission); University of Minnesota Graduate School(University of Minnesota System); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM088790 (to J. S. M.). This work was also supported by University of Minnesota Academic Health Center Seed Grant 2101.95 (to T. F. W.) and a Wellcome Trust Programme Grant (to A. G. and J. P.).; Supported by a doctoral dissertation fellowship from the University of Minnesota Graduate School.	Aarhus R, 1996, J BIOL CHEM, V271, P8513, DOI 10.1074/jbc.271.15.8513; Aarhus R, 1995, J BIOL CHEM, V270, P30327, DOI 10.1074/jbc.270.51.30327; Billington RA, 2000, BIOCHEM BIOPH RES CO, V276, P112, DOI 10.1006/bbrc.2000.3444; Brailoiu E, 2010, J BIOL CHEM, V285, P38511, DOI 10.1074/jbc.M110.162073; Brailoiu E, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.C109.081943; Brailoiu E, 2009, J CELL BIOL, V186, P201, DOI 10.1083/jcb.200904073; Calcraft PJ, 2009, NATURE, V459, P596, DOI 10.1038/nature08030; CLAPPER DL, 1987, J BIOL CHEM, V262, P9561; Dickinson GD, 2003, BIOCHEM J, V375, P805, DOI 10.1042/BJ20030672; Dorman G, 2000, TRENDS BIOTECHNOL, V18, P64, DOI 10.1016/S0167-7799(99)01402-X; Evans AM, 2010, ADV EXP MED BIOL, V661, P57, DOI 10.1007/978-1-60761-500-2_4; Galione A, 2010, BIOCHEM SOC T, V38, P1424, DOI 10.1042/BST0381424; Galione A, 2009, PFLUG ARCH EUR J PHY, V458, P869, DOI 10.1007/s00424-009-0682-y; Genazzani AA, 1996, J BIOL CHEM, V271, P11599, DOI 10.1074/jbc.271.20.11599; Guse AH, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.144re10; Jain P, 2010, J MED CHEM, V53, P7599, DOI 10.1021/jm1007209; LEE HC, 1995, J BIOL CHEM, V270, P2152, DOI 10.1074/jbc.270.5.2152; Lee HC, 1997, J BIOL CHEM, V272, P4172, DOI 10.1074/jbc.272.7.4172; Lee HC, 2005, J BIOL CHEM, V280, P33693, DOI 10.1074/jbc.R500012200; Lin-Moshier Y, 2012, J BIOL CHEM, V287, P2296, DOI 10.1074/jbc.M111.305813; Patel S, 2010, CELL CALCIUM, V47, P480, DOI 10.1016/j.ceca.2010.05.001; Pitt SJ, 2010, J BIOL CHEM, V285, P35039, DOI 10.1074/jbc.M110.156927; Rietdorf K, 2011, J BIOL CHEM, V286, P37058, DOI 10.1074/jbc.C111.289835; Robinette D, 2006, EXPERT REV PROTEOMIC, V3, P399, DOI 10.1586/14789450.3.4.399; Ruas M, 2010, CURR BIOL, V20, P703, DOI 10.1016/j.cub.2010.02.049; Schieder M, 2010, J BIOL CHEM, V285, P21219, DOI 10.1074/jbc.C110.143123; Yamaguchi S, 2011, J BIOL CHEM, V286, P22934, DOI 10.1074/jbc.M110.210930; Zhu Michael X., 2010, Communicative & Integrative Biology, V3, P12; Zhu MX, 2010, FEBS LETT, V584, P1966, DOI 10.1016/j.febslet.2010.02.028; Zhu MX, 2010, AM J PHYSIOL-CELL PH, V298, pC430, DOI 10.1152/ajpcell.00475.2009; Zong XG, 2009, PFLUG ARCH EUR J PHY, V458, P891, DOI 10.1007/s00424-009-0690-y	31	87	87	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2308	2315		10.1074/jbc.M111.306563	http://dx.doi.org/10.1074/jbc.M111.306563			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22117077	hybrid, Green Published			2022-12-27	WOS:000300292300007
J	Hu, LN; Gocke, AR; Knapp, E; Rosenzweig, JM; Grishkan, IV; Baxi, EG; Zhang, H; Margolick, JB; Whartenby, KA; Calabresi, PA				Hu, Lina; Gocke, Anne R.; Knapp, Edward; Rosenzweig, Jason M.; Grishkan, Inna V.; Baxi, Emily G.; Zhang, Hao; Margolick, Joseph B.; Whartenby, Katharine A.; Calabresi, Peter A.			Functional Blockade of the Voltage-gated Potassium Channel Kv1.3 Mediates Reversion of T Effector to Central Memory Lymphocytes through SMAD3/p21(cip1) Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELLS; INDUCTION; P27(KIP1); SMAD; SUPPRESSION; CURRENTS	The maintenance of T cell memory is critical for the development of rapid recall responses to pathogens, but may also have the undesired side effect of clonal expansion of T effector memory (T-EM) cells in chronic autoimmune diseases. The mechanisms by which lineage differentiation of T cells is controlled have been investigated, but are not completely understood. Our previous work demonstrated a role of the voltage-gated potassium channel Kv1.3 in effector T cell function in autoimmune disease. In the present study, we have identified a mechanism by which Kv1.3 regulates the conversion of T central memory cells (T-CM) into T-EM. Using a lentiviral-dominant negative approach, we show that loss of function of Kv1.3 mediates reversion of T-EM into T-CM, via a delay in cell cycle progression at the G2/M stage. The inhibition of Kv1.3 signaling caused an up-regulation of SMAD3 phosphorylation and induction of nuclear p21(cip1) with resulting suppression of Cdk1 and cyclin B1. These data highlight a novel role for Kv1.3 in T cell differentiation and memory responses, and provide further support for the therapeutic potential of Kv1.3 specific channel blockers in T-EM-mediated autoimmune diseases.	[Hu, Lina; Gocke, Anne R.; Knapp, Edward; Rosenzweig, Jason M.; Grishkan, Inna V.; Baxi, Emily G.; Whartenby, Katharine A.; Calabresi, Peter A.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21287 USA; [Zhang, Hao; Margolick, Joseph B.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Calabresi, PA (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurol, 600 N Wolfe St, Baltimore, MD 21287 USA.	Calabresi@jhmi.edu	Calabresi, Peter A./AAF-2288-2019		National Institutes of Health [R01NS041435]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041435] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01NS041435 (to P. A. C.).	Abdollah S, 1997, J BIOL CHEM, V272, P27678, DOI 10.1074/jbc.272.44.27678; Ahmed R, 2009, NAT REV IMMUNOL, V9, P662, DOI 10.1038/nri2619; Blackiston DJ, 2009, CELL CYCLE, V8, P3527, DOI 10.4161/cc.8.21.9888; Calabresi PA, 2003, J NEUROIMMUNOL, V139, P58, DOI 10.1016/S0165-5728(03)00127-9; CONE CD, 1976, SCIENCE, V192, P155, DOI 10.1126/science.56781; DECOURSEY TE, 1987, J GEN PHYSIOL, V89, P405, DOI 10.1085/jgp.89.3.405; Dutton RW, 1998, ANNU REV IMMUNOL, V16, P201, DOI 10.1146/annurev.immunol.16.1.201; Gerlach C, 2011, ANN NY ACAD SCI, V1217, P139, DOI 10.1111/j.1749-6632.2010.05830.x; Gocke AR, 2007, J IMMUNOL, V178, P1341, DOI 10.4049/jimmunol.178.3.1341; GRISSMER S, 1993, J GEN PHYSIOL, V102, P601, DOI 10.1085/jgp.102.4.601; Harrington LE, 2008, NATURE, V452, P356, DOI 10.1038/nature06672; Hu L, 2007, J IMMUNOL, V179, P4563, DOI 10.4049/jimmunol.179.7.4563; Jacob J, 1999, NATURE, V399, P593, DOI 10.1038/21208; Johns DC, 1997, J BIOL CHEM, V272, P31598, DOI 10.1074/jbc.272.50.31598; Koni PA, 2003, J BIOL CHEM, V278, P39443, DOI 10.1074/jbc.M304879200; Li LQ, 2006, NAT IMMUNOL, V7, P1157, DOI 10.1038/ni1398; Matheu MP, 2008, IMMUNITY, V29, P602, DOI 10.1016/j.immuni.2008.07.015; Newton MA, 2001, J COMPUT BIOL, V8, P37, DOI 10.1089/106652701300099074; Reiner SL, 2007, SCIENCE, V317, P622, DOI 10.1126/science.1143775; Rudd CE, 2006, NAT IMMUNOL, V7, P1130, DOI 10.1038/ni1106-1130; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3; Wicks SJ, 2000, MOL CELL BIOL, V20, P8103, DOI 10.1128/MCB.20.21.8103-8111.2000; Wolfraim LA, 2005, J IMMUNOL, V174, P2481, DOI 10.4049/jimmunol.174.5.2481; Wolfraim LA, 2004, J IMMUNOL, V173, P3093, DOI 10.4049/jimmunol.173.5.3093; Wulff H, 2003, J CLIN INVEST, V111, P1703, DOI 10.1172/JCI200316921; Zimmerman CM, 1998, J BIOL CHEM, V273, P677, DOI 10.1074/jbc.273.2.677	27	27	27	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					1261	1268		10.1074/jbc.M111.296798	http://dx.doi.org/10.1074/jbc.M111.296798			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22110135	Green Published, hybrid			2022-12-27	WOS:000299170300042
J	Jin, F; Claessens, F; Fondell, JD				Jin, Feng; Claessens, Frank; Fondell, Joseph D.			Regulation of Androgen Receptor-dependent Transcription by Coactivator MED1 Is Mediated through a Newly Discovered Noncanonical Binding Motif	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; PROSTATE-CANCER CELLS; NUCLEAR RECEPTOR; LIGAND-BINDING; CONSTITUTIVE ACTIVATION; HORMONE-RECEPTORS; COREGULATORY ROLE; GENE-EXPRESSION; TERMINAL DOMAIN; LXXLL MOTIFS	Nuclear receptor (NR) activation by cognate ligand generally involves allosteric realignment of C-terminal alpha-helices thus generating a binding surface for coactivators containing canonical LXXLL alpha-helical motifs. The androgen receptor (AR) is uncommon among NRs in that ligand triggers an intramolecular interaction between its N- and C-terminal domains (termed the N/C interaction) and that coactivators can alternatively bind to surfaces in the AR N-terminal or hinge regions. The evolutionary conserved Mediator complex plays a key coregulatory role in steroid hormone-dependent transcription and is chiefly targeted to NRs via the LXXLL-containing MED1 subunit. Whereas MED1 has been demonstrated to serve as a key transcriptional coactivator for AR, the mechanisms by which AR recruits MED1 have remained unclear. Here we show that MED1 binds to a distinct AR N-terminal region termed transactivation unit-1 (Tau-1) via two newly discovered noncanonical alpha-helical motifs located between MED1 residues 505 and 537. Neither of the two MED1 LXXLL motifs is required for AR binding, whereas loss of the intramolecular AR N/C interaction decreases MED1 binding. We further demonstrate that mitogen-activated protein kinase phosphorylation of MED1 enhances the AR-MED1 interaction in prostate cancer cells. In sum, our findings reveal a novel AR-coactivator binding mechanism that may have clinical implications for AR activity in prostate cancer.	[Jin, Feng; Fondell, Joseph D.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Physiol & Biophys, Piscataway, NJ 08854 USA; [Claessens, Frank] Catholic Univ Louvain, Dept Mol Cell Biol, Mol Endocrinol Lab, B-3000 Louvain, Belgium	Rutgers State University New Brunswick; Rutgers State University Medical Center; Universite Catholique Louvain	Fondell, JD (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Physiol & Biophys, 683 Hoes Lane,Room 164, Piscataway, NJ 08854 USA.	fondeljd@umdnj.edu	Claessens, Frank/M-8565-2016	Claessens, Frank/0000-0002-8676-7709	United States Department of Defense [W81XWH-10-1-0227]	United States Department of Defense(United States Department of Defense)	This work was supported by a United States Department of Defense Prostate Cancer Research Program Award W81XWH-10-1-0227 (to J. D. F.).	Alen P, 1999, MOL CELL BIOL, V19, P6085; Baek SH, 2006, P NATL ACAD SCI USA, V103, P3100, DOI 10.1073/pnas.0510842103; Bakin RE, 2003, CANCER RES, V63, P1981; Belakavadi M, 2006, REV PHYSIOL BIOCH P, V156, P23, DOI 10.1007/s10254-005-0002-7; Belakavadi M, 2008, MOL CELL BIOL, V28, P3932, DOI 10.1128/MCB.02191-07; Bevan CL, 1999, MOL CELL BIOL, V19, P8383; Bright RK, 1997, CANCER RES, V57, P995; Callewaert L, 2006, CANCER RES, V66, P543, DOI 10.1158/0008-5472.CAN-05-2389; Callewaert L, 2003, J BIOL CHEM, V278, P8212, DOI 10.1074/jbc.M210744200; CELIS L, 1993, MOL CELL ENDOCRINOL, V94, P165, DOI 10.1016/0303-7207(93)90165-G; Chen Z, 2011, EMBO J, V30, P2405, DOI 10.1038/emboj.2011.154; Christiaens V, 2002, J BIOL CHEM, V277, P49230, DOI 10.1074/jbc.M209322200; Claessens Frank, 2008, Nucl Recept Signal, V6, pe008, DOI 10.1621/nrs.06008; Cleutjens KBJM, 1997, MOL ENDOCRINOL, V11, P148, DOI 10.1210/me.11.2.148; DANIELIAN PS, 1992, EMBO J, V11, P1025, DOI 10.1002/j.1460-2075.1992.tb05141.x; Darimont BD, 1998, GENE DEV, V12, P3343, DOI 10.1101/gad.12.21.3343; Dehm SM, 2007, MOL ENDOCRINOL, V21, P2855, DOI 10.1210/me.2007-0223; Dubbink HJ, 2004, MOL ENDOCRINOL, V18, P2132, DOI 10.1210/me.2003-0375; Emrick MA, 2001, J BIOL CHEM, V276, P46469, DOI 10.1074/jbc.M107708200; Gao H, 2006, P NATL ACAD SCI USA, V103, P14477, DOI 10.1073/pnas.0606836103; Garcia-Pedrero JM, 2006, J BIOL CHEM, V281, P22656, DOI 10.1074/jbc.M602561200; Gioeli D, 1999, CANCER RES, V59, P279; Glass CK, 2000, GENE DEV, V14, P121; Gregory CW, 2004, J BIOL CHEM, V279, P7119, DOI 10.1074/jbc.M307649200; He B, 2000, J BIOL CHEM, V275, P22986, DOI 10.1074/jbc.M002807200; He B, 2004, MOL CELL, V16, P425, DOI 10.1016/j.molcel.2004.09.036; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; Hittelman AB, 1999, EMBO J, V18, P5380, DOI 10.1093/emboj/18.19.5380; Huang ZQ, 2003, EMBO J, V22, P2146, DOI 10.1093/emboj/cdg219; Hur E, 2004, PLOS BIOL, V2, P1303, DOI 10.1371/journal.pbio.0020274; JENSTER G, 1995, J BIOL CHEM, V270, P7341, DOI 10.1074/jbc.270.13.7341; Jin F, 2009, NUCLEIC ACIDS RES, V37, P4826, DOI 10.1093/nar/gkp510; Knuesel MT, 2011, TRANSCR-AUSTIN, V2, P28, DOI 10.4161/trns.2.1.13950; Kornberg RD, 2005, TRENDS BIOCHEM SCI, V30, P235, DOI 10.1016/j.tibs.2005.03.011; Lee JE, 2005, J BIOL CHEM, V280, P8819, DOI 10.1074/jbc.M413184200; Li JW, 2006, MOL ENDOCRINOL, V20, P776, DOI 10.1210/me.2005-0298; Link KA, 2008, CANCER RES, V68, P4551, DOI 10.1158/0008-5472.CAN-07-6392; Malik S, 2010, NAT REV GENET, V11, P761, DOI 10.1038/nrg2901; MANSOUR SJ, 1994, SCIENCE, V265, P966, DOI 10.1126/science.8052857; Migliaccio A, 2000, EMBO J, V19, P5406, DOI 10.1093/emboj/19.20.5406; Moras D, 1998, CURR OPIN CELL BIOL, V10, P384, DOI 10.1016/S0955-0674(98)80015-X; Nolte RT, 1998, NATURE, V395, P137, DOI 10.1038/25931; Pandey PK, 2005, MOL CELL BIOL, V25, P10695, DOI 10.1128/MCB.25.24.10695-10710.2005; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Ren YS, 2000, MOL CELL BIOL, V20, P5433, DOI 10.1128/MCB.20.15.5433-5446.2000; Taatjes DJ, 2004, MOL CELL, V14, P675, DOI 10.1016/j.molcel.2004.05.014; Unni E, 2004, CANCER RES, V64, P7156, DOI 10.1158/0008-5472.CAN-04-1121; Vijayvargia R, 2007, CANCER RES, V67, P4034, DOI 10.1158/0008-5472.CAN-06-3039; Wang QB, 2005, MOL CELL, V19, P631, DOI 10.1016/j.molcel.2005.07.018; Wang QB, 2002, J BIOL CHEM, V277, P42852, DOI 10.1074/jbc.M206061200; Wang QB, 2009, CELL, V138, P245, DOI 10.1016/j.cell.2009.04.056; Weber MJ, 2004, J CELL BIOCHEM, V91, P13, DOI 10.1002/jcb.10683; Zhang XT, 2005, MOL CELL, V19, P89, DOI 10.1016/j.molcel.2005.05.015; Zhou XE, 2010, J BIOL CHEM, V285, P9161, DOI 10.1074/jbc.M109.085779; Zhu P, 2006, CELL, V124, P615, DOI 10.1016/j.cell.2005.12.032; Zhu X, 1999, MOL CELL ENDOCRINOL, V152, P199, DOI 10.1016/S0303-7207(99)00031-3	56	23	24	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					858	870		10.1074/jbc.M111.304519	http://dx.doi.org/10.1074/jbc.M111.304519			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22102282	hybrid, Green Published			2022-12-27	WOS:000299170300005
J	Liokatis, S; Edlich, C; Soupsana, K; Giannios, I; Panagiotidou, P; Tripsianes, K; Sattler, M; Georgatos, SD; Politou, AS				Liokatis, Stamatis; Edlich, Christian; Soupsana, Katerina; Giannios, Ioannis; Panagiotidou, Parthena; Tripsianes, Konstantinos; Sattler, Michael; Georgatos, Spyros D.; Politou, Anastasia S.			Solution Structure and Molecular Interactions of Lamin B Receptor Tudor Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INNER NUCLEAR-MEMBRANE; HISTONE H3; PROTEIN LBR; ARGININE RESIDUES; NMR EXPERIMENTS; DNA-REPAIR; BINDING; RECOGNITION; ENVELOPE; SMN	Lamin B receptor (LBR) is a polytopic protein of the nuclear envelope thought to connect the inner nuclear membrane with the underlying nuclear lamina and peripheral heterochromatin. To better understand the function of this protein, we have examined in detail its nucleoplasmic region, which is predicted to harbor a Tudor domain (LBR-TD). Structural analysis by multidimensional NMR spectroscopy establishes that LBR-TD indeed adopts a classical beta-barrel Tudor fold in solution, which, however, features an incomplete aromatic cage. Removal of LBR-TD renders LBR more mobile at the plane of the nuclear envelope, but the isolated module does not bind to nuclear lamins, heterochromatin proteins (MeCP2), and nucleosomes, nor does it associate with methylated Arg/Lys residues through its aromatic cage. Instead, LBR-TD exhibits tight and stoichiometric binding to the "histone-fold" region of unassembled, free histone H3, suggesting an interesting role in histone assembly. Consistent with such a role, robust binding to native nucleosomes is observed whenLBR-TDis extended toward its carboxyl terminus, to include an area rich in Ser-Arg residues. The Ser-Arg region, alone or in combination with LBR-TD, binds both unassembled and assembled H3/H4 histones, suggesting that the TD/RS interface may operate as a "histone chaperone-like platform."	[Liokatis, Stamatis; Panagiotidou, Parthena; Politou, Anastasia S.] Univ Ioannina, Sch Med, Biol Chem Lab, GR-45110 Ioannina, Greece; [Soupsana, Katerina; Giannios, Ioannis; Georgatos, Spyros D.] Univ Ioannina, Sch Med, Biol Lab, GR-45110 Ioannina, Greece; [Edlich, Christian; Sattler, Michael] European Mol Biol Lab, Struct & Computat Biol Unit, D-69012 Heidelberg, Germany; [Soupsana, Katerina; Giannios, Ioannis; Georgatos, Spyros D.; Politou, Anastasia S.] Fdn Res & Technol BRI FORTH, Biomed Res Inst, GR-45110 Ioannina, Greece; [Tripsianes, Konstantinos; Sattler, Michael] Helmholtz Zentrum Munchen, Inst Biol Struct, D-85764 Neuherberg, Germany; [Tripsianes, Konstantinos; Sattler, Michael] Tech Univ Munich, Dept Chem, Munich Ctr Integrated Prot Sci CiPSM, D-85747 Garching, Germany	University of Ioannina; University of Ioannina; European Molecular Biology Laboratory (EMBL); Foundation for Research & Technology - Hellas (FORTH); Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich	Politou, AS (corresponding author), Univ Ioannina, Sch Med, Biol Chem Lab, GR-45110 Ioannina, Greece.	apolitou@cc.uoi.gr	Sattler, Michael/A-2407-2012; Tripsianes, Konstantinos/I-8382-2014	Sattler, Michael/0000-0002-1594-0527; Tripsianes, Konstantinos/0000-0003-0948-813X; Georgatos, Spyros/0000-0002-2078-7467	Greek Ministry of Education; European Commission; Programme of Scientific Exchange and Cooperation between Greece and Germany [IKYDAD 2004]	Greek Ministry of Education(Greek Ministry of Development-GSRT); European Commission(European CommissionEuropean Commission Joint Research Centre); Programme of Scientific Exchange and Cooperation between Greece and Germany	This work was supported by the Greek Ministry of Education and the European Commission Program "Pythagoras II," Greek General Secretariat for Research and Development Program "PENED2003," and Grant IKYDAD 2004 Programme of Scientific Exchange and Cooperation between Greece and Germany.	BLOBEL G, 1966, SCIENCE, V154, P1662, DOI 10.1126/science.154.3757.1662; Botuyan MV, 2006, CELL, V127, P1361, DOI 10.1016/j.cell.2006.10.043; Brahms H, 2001, RNA, V7, P1531, DOI 10.1017/S135583820101442X; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buhler D, 1999, HUM MOL GENET, V8, P2351, DOI 10.1093/hmg/8.13.2351; Charier G, 2004, STRUCTURE, V12, P1551, DOI 10.1016/j.str.2004.06.014; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Corsini L, 2007, NAT STRUCT MOL BIOL, V14, P98, DOI 10.1038/nsmb0207-98; Cote J, 2005, J BIOL CHEM, V280, P28476, DOI 10.1074/jbc.M414328200; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W.L, PYMOL MOL GRAPHICS S; Friberg A, 2009, J MOL BIOL, V387, P921, DOI 10.1016/j.jmb.2009.02.018; Georgatos SD, 2001, EMBO J, V20, P2989, DOI 10.1093/emboj/20.12.2989; GEORGATOS SD, 1987, J CELL BIOL, V105, P105, DOI 10.1083/jcb.105.1.105; Grenon M, 2007, YEAST, V24, P105, DOI 10.1002/yea.1441; Guarda A, 2009, EXP CELL RES, V315, P1895, DOI 10.1016/j.yexcr.2009.01.019; Herrmann T, 2002, J BIOMOL NMR, V24, P171, DOI 10.1023/A:1021614115432; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Horton JR, 2010, NAT STRUCT MOL BIOL, V17, P38, DOI 10.1038/nsmb.1753; Huang Y, 2006, SCIENCE, V312, P748, DOI 10.1126/science.1125162; Jacobs SA, 2002, SCIENCE, V295, P2080, DOI 10.1126/science.1069473; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Kim J, 2006, EMBO REP, V7, P397, DOI 10.1038/sj.embor.7400625; Kirino Y, 2010, RNA, V16, P70, DOI 10.1261/rna.1869710; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lee J, 2008, NAT STRUCT MOL BIOL, V15, P109, DOI 10.1038/nsmb1326; Lin F, 1996, HEPATOLOGY, V23, P57, DOI 10.1002/hep.510230109; Ling XF, 1996, GENE DEV, V10, P686, DOI 10.1101/gad.10.6.686; Liu HP, 2010, GENE DEV, V24, P1876, DOI 10.1101/gad.1956010; Liu K, 2010, P NATL ACAD SCI USA, V107, P18398, DOI 10.1073/pnas.1013106107; Luger K, 1997, J MOL BIOL, V272, P301, DOI 10.1006/jmbi.1997.1235; MAISON C, 1993, J CELL BIOL, V123, P1491, DOI 10.1083/jcb.123.6.1491; Makatsori D, 2004, J BIOL CHEM, V279, P25567, DOI 10.1074/jbc.M313606200; Matsuo H, 1999, J AM CHEM SOC, V121, P9903, DOI 10.1021/ja991881g; Maurer-Stroh S, 2003, TRENDS BIOCHEM SCI, V28, P69, DOI 10.1016/S0968-0004(03)00004-5; Mousson F, 2005, P NATL ACAD SCI USA, V102, P5975, DOI 10.1073/pnas.0500149102; Natsume R, 2007, NATURE, V446, P338, DOI 10.1038/nature05613; Nielsen PR, 2002, NATURE, V416, P103, DOI 10.1038/nature722; Nikolakaki E, 1996, J BIOL CHEM, V271, P8365, DOI 10.1074/jbc.271.14.8365; Nikolakaki E, 2008, BBA-GEN SUBJECTS, V1780, P214, DOI 10.1016/j.bbagen.2007.10.014; Oganesyan Natalia, 2005, Journal of Structural and Functional Genomics, V6, P177, DOI 10.1007/s10969-005-2827-3; Olins AL, 2010, NUCLEUS-PHILA, V1, P53, DOI 10.4161/nucl.1.1.10515; Park YJ, 2006, P NATL ACAD SCI USA, V103, P1248, DOI 10.1073/pnas.0508002103; Polioudaki H, 2001, EMBO REP, V2, P920, DOI 10.1093/embo-reports/kve199; Ponting CP, 1997, TRENDS BIOCHEM SCI, V22, P51, DOI 10.1016/S0968-0004(96)30049-2; Ramos A, 2006, STRUCTURE, V14, P21, DOI 10.1016/j.str.2005.09.018; Roy S, 2010, J MOL BIOL, V398, P489, DOI 10.1016/j.jmb.2010.03.024; Sambrook J., 2002, MOL CLONING LAB MANU; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Schirmer EC, 2007, EXP CELL RES, V313, P2167, DOI 10.1016/j.yexcr.2007.03.012; Selenko P, 2001, NAT STRUCT BIOL, V8, P27; Shaw N, 2007, NAT STRUCT MOL BIOL, V14, P779, DOI 10.1038/nsmb1269; SIMON RH, 1979, NUCLEIC ACIDS RES, V6, P689, DOI 10.1093/nar/6.2.689; Sprangers R, 2003, J MOL BIOL, V327, P507, DOI 10.1016/S0022-2836(03)00148-7; Talbot K, 1998, HUM MOL GENET, V7, P2149, DOI 10.1093/hmg/7.13.2149; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Wilson KL, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000554; WORMAN HJ, 1988, P NATL ACAD SCI USA, V85, P8531, DOI 10.1073/pnas.85.22.8531; YAMAZAKI T, 1993, J AM CHEM SOC, V115, P11054, DOI 10.1021/ja00076a099; Yang YZ, 2010, MOL CELL, V40, P1016, DOI 10.1016/j.molcel.2010.11.024; YE Q, 1994, J BIOL CHEM, V269, P11306; Ye QA, 1997, J BIOL CHEM, V272, P14983, DOI 10.1074/jbc.272.23.14983	62	16	17	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					1032	1042		10.1074/jbc.M111.281303	http://dx.doi.org/10.1074/jbc.M111.281303			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22052904	Green Published, hybrid			2022-12-27	WOS:000299170300020
J	Dominguez, JM; Fuertes, A; Orozco, L; del Monte-Millan, M; Delgado, E; Medina, M				Manuel Dominguez, Juan; Fuertes, Ana; Orozco, Leyre; del Monte-Millan, Maria; Delgado, Elena; Medina, Miguel			Evidence for Irreversible Inhibition of Glycogen Synthase Kinase-3 beta by Tideglusib	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; GSK-3 INHIBITORS; KINASE INHIBITORS; PROTEIN; TAU; PHOSPHORYLATION; BINDING; GLYCOGEN-SYNTHASE-KINASE-3-BETA; ASSOCIATION; MECHANISM	Tideglusib is a GSK-3 inhibitor currently in phase II clinical trials for the treatment of Alzheimer disease and progressive supranuclear palsy. Sustained oral administration of the compound to a variety of animal models decreases Tau hyperphosphorylation, lowers brain amyloid plaque load, improves learning and memory, and prevents neuronal loss. We report here that tideglusib inhibits GSK-3 beta irreversibly, as demonstrated by the lack of recovery in enzyme function after the unbound drug has been removed from the reaction medium and the fact that its dissociation rate constant is non-significantly different from zero. Such irreversibility may explain the non-competitive inhibition pattern with respect to ATP shown by tideglusib and perhaps other structurally related compounds. The replacement of Cys-199 by an Ala residue in the enzyme seems to increase the dissociation rate, although the drug retains its inhibitory activity with decreased potency and long residence time. In addition, tideglusib failed to inhibit a series of kinases that contain a Cys homologous to Cys-199 in their active site, suggesting that its inhibition of GSK-3 beta obeys to a specific mechanism and is not a consequence of nonspecific reactivity. Results obtained with [S-35]tideglusib do not support unequivocally the existence of a covalent bond between the drug and GSK-3 beta. The irreversibility of the inhibition and the very low protein turnover rate observed for the enzyme are particularly relevant from a pharmacological perspective and could have significant implications on its therapeutic potential.	[Manuel Dominguez, Juan; Fuertes, Ana; Orozco, Leyre; del Monte-Millan, Maria; Delgado, Elena; Medina, Miguel] Noscira SA, Tres Cantos 28760, Spain		Dominguez, JM (corresponding author), Noscira SA, Ave Ind 52, Tres Cantos 28760, Spain.	jmdominguez@noscira.com; mmedina@noscira.com	Medina, Miguel/J-1642-2019; Dominguez, Juan Manuel/I-9993-2019; Medina, Miguel/I-7135-2019; Medina, Miguel/H-5676-2012	Dominguez, Juan Manuel/0000-0001-9472-6969; Medina, Miguel/0000-0002-7016-5340	European Commission [223276]; CDTI [IDI-20110884]	European Commission(European CommissionEuropean Commission Joint Research Centre); CDTI	This work was supported by European Commission Grant EU-FP7 (Neuro. GSK3, Project 223276) and CDTI Grant IDI-20110884. All of the authors are employees of Noscira, the owner of tideglusib.	Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Blalock EM, 2004, P NATL ACAD SCI USA, V101, P2173, DOI 10.1073/pnas.0308512100; Coghlan MP, 2000, CHEM BIOL, V7, P793, DOI 10.1016/S1074-5521(00)00025-9; Cohen MS, 2005, SCIENCE, V308, P1318, DOI 10.1126/science1108367; Cole A, 2004, BIOCHEM J, V377, P249, DOI 10.1042/BJ20031259; Cook P. F., 2007, ENZYME KINETICS MECH; COPELAND RA, 1994, P NATL ACAD SCI USA, V91, P11202, DOI 10.1073/pnas.91.23.11202; Copeland RA, 2000, ENZYMES PRACTICAL IN, P318, DOI 10.1002/0471220639.ch10; Cornish-Bowden A., 2004, FUNDAMENTALS ENZYME, V3rd, P113; del Ser T., 2010, ALZHEIMERS DEMENT, V6, pS147, DOI DOI 10.1016/J.JALZ.2010.05.455; Fersht A., 1999, STRUCTURE MECH PROTE; Gentles RG, 2009, ANNU REP MED CHEM, V44, P3, DOI 10.1016/S0065-7743(09)04401-7; Gimenez-Cassina A, 2009, J BIOL CHEM, V284, P3001, DOI 10.1074/jbc.M808698200; Grimes CA, 2001, J NEUROCHEM, V78, P1219, DOI 10.1046/j.1471-4159.2001.00495.x; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; HANGER DP, 1992, NEUROSCI LETT, V147, P58, DOI 10.1016/0304-3940(92)90774-2; Hardy J, 2006, NEURON, V52, P3, DOI 10.1016/j.neuron.2006.09.016; Hernandez F, 2010, EXP NEUROL, V223, P322, DOI 10.1016/j.expneurol.2009.09.011; Hongisto V, 2008, MOL CELL BIOL, V28, P1515, DOI 10.1128/MCB.02227-06; Hooper C, 2008, J NEUROCHEM, V104, P1433, DOI 10.1111/j.1471-4159.2007.05194.x; ISHIGURO K, 1993, FEBS LETT, V325, P167, DOI 10.1016/0014-5793(93)81066-9; Ittner LM, 2011, NAT REV NEUROSCI, V12, P67, DOI 10.1038/nrn2967; Ittner LM, 2010, CELL, V142, P387, DOI 10.1016/j.cell.2010.06.036; Jo J, 2011, NAT NEUROSCI, V14, P545, DOI 10.1038/nn.2785; Kluter S, 2010, CHEMBIOCHEM, V11, P2557, DOI 10.1002/cbic.201000352; Kwok JBJ, 2008, ANN NEUROL, V64, P446, DOI 10.1002/ana.21476; Leost M, 2000, EUR J BIOCHEM, V267, P5983, DOI 10.1046/j.1432-1327.2000.01673.x; Leroy K, 2002, ACTA NEUROPATHOL, V103, P91; Marcinkeviciene J, 2001, J BIOL CHEM, V276, P23790, DOI 10.1074/jbc.M101896200; Martinez A, 2005, J MED CHEM, V48, P7103, DOI 10.1021/jm040895g; Martinez A, 2002, J MED CHEM, V45, P1292, DOI 10.1021/jm011020u; Mateo I, 2006, DEMENT GERIATR COGN, V21, P228, DOI 10.1159/000091044; Mateo I, 2009, ACTA NEUROL SCAND, V120, P130, DOI 10.1111/j.1600-0404.2008.01128.x; Medina M, 2008, CURR OPIN DRUG DISC, V11, P533; Medina Miguel, 2011, Int J Alzheimers Dis, V2011, P479249, DOI 10.4061/2011/479249; Medina M, 2011, ALZHEIMER'S DISEASE PATHOGENESIS - CORE CONCEPTS, SHIFTING PARADIGMS AND THERAPEUTIC TARGETS, P197; Medina M, 2010, CURR PHARM DESIGN, V16, P2790, DOI 10.2174/138161210793176581; Moreno H, 2009, P NATL ACAD SCI USA, V106, P5901, DOI 10.1073/pnas.0900944106; MORRISON JF, 1988, ADV ENZYMOL RAMB, V61, P201; MunozMontano JR, 1997, FEBS LETT, V411, P183, DOI 10.1016/S0014-5793(97)00688-1; Muyllaert D, 2008, GENES BRAIN BEHAV, V7, P57, DOI 10.1111/j.1601-183X.2007.00376.x; Patrick GN, 1998, J BIOL CHEM, V273, P24057, DOI 10.1074/jbc.273.37.24057; Pei JJ, 1997, J NEUROPATH EXP NEUR, V56, P70, DOI 10.1097/00005072-199701000-00007; Ring DB, 2003, DIABETES, V52, P588, DOI 10.2337/diabetes.52.3.588; Robertson JG, 2005, BIOCHEMISTRY-US, V44, P5561, DOI 10.1021/bi050247e; Schaffer BAJ, 2008, ARCH NEUROL-CHICAGO, V65, P1368, DOI 10.1001/archneur.65.10.1368; Schirmer A, 2006, P NATL ACAD SCI USA, V103, P4234, DOI 10.1073/pnas.0600445103; Segel I.H., 1975, ENZYME KINETICS BEHA, Vsecond, P100; Sereno L, 2009, NEUROBIOL DIS, V35, P359, DOI 10.1016/j.nbd.2009.05.025; Singh J, 2011, NAT REV DRUG DISCOV, V10, P307, DOI 10.1038/nrd3410; Thies W, 2011, ALZHEIMERS DEMENT, V7, P175, DOI [10.1016/j.jalz.2011.02.004, 10.1016/j.jalz.2011.02.002]; Turenne GA, 2001, BMC CELL BIOL, V2, DOI 10.1186/1471-2121-2-12; Wang XM, 2009, J BIOL CHEM, V284, P32619, DOI 10.1074/jbc.M109.067785; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012; Zhao A, 1999, J ANTIBIOT, V52, P1086, DOI 10.7164/antibiotics.52.1086; Zhou Pengbo, 2004, Methods Mol Biol, V284, P67; Zumbrunn J, 2001, CURR BIOL, V11, P44, DOI 10.1016/S0960-9822(01)00002-1	57	161	166	3	45	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					893	904		10.1074/jbc.M111.306472	http://dx.doi.org/10.1074/jbc.M111.306472			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22102280	Green Published, hybrid			2022-12-27	WOS:000299170300008
J	Copley, SD				Copley, Shelley D.			Toward a Systems Biology Perspective on Enzyme Evolution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							UNIVERSAL COMMON ANCESTOR; ESCHERICHIA-COLI; RHODOCOCCUS-CHLOROPHENOLICUS; GENOME EVOLUTION; MUTATIONS; REVEALS; PROTEINS; 4-NITROTOLUENE; EVOLVABILITY; DUPLICATION	Large superfamilies of enzymes derived from a common progenitor have emerged by duplication and divergence of genes encoding metabolic enzymes. Division of the functions of early generalist enzymes enhanced catalytic power and control over metabolic fluxes. Later, novel enzymes evolved from inefficient secondary activities in specialized enzymes. Enzymes operate in the context of complex metabolic and regulatory networks. The potential for evolution of a new enzyme depends upon the collection of enzymes in a microbe, the topology of the metabolic network, the environmental conditions, and the net effect of trade-offs between the original and novel activities of the enzyme.	[Copley, Shelley D.] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; [Copley, Shelley D.] Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Copley, SD (corresponding author), Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA.	shelley@cires.colorado.edu			National Institutes of Health [GM083285, GM078554]; National Science Foundation [MCB 0919617]; Div Of Molecular and Cellular Bioscience [0919617] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083285, R01GM078554] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM083285 and GM078554. This work was also supported by National Science Foundation Grant MCB 0919617. This is the first article in the Thematic Minireview Series on Enzyme Evolution in the Post-genomic Era.	Amitai G, 2007, HFSP J, V1, P67, DOI [10.2976/1.2739115/10.2976/1, 10.2976/1.2739115]; ANDERSON RP, 1977, ANNU REV MICROBIOL, V31, P473, DOI 10.1146/annurev.mi.31.100177.002353; APAJALAHTI JHA, 1987, J BACTERIOL, V169, P5125, DOI 10.1128/jb.169.11.5125-5130.1987; Barrick JE, 2009, NATURE, V461, P1243, DOI 10.1038/nature08480; Bergthorsson U, 2007, P NATL ACAD SCI USA, V104, P17004, DOI 10.1073/pnas.0707158104; Bershtein S, 2008, J MOL BIOL, V379, P1029, DOI 10.1016/j.jmb.2008.04.024; Blank LM, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-6-r49; Bloom JD, 2006, P NATL ACAD SCI USA, V103, P5869, DOI 10.1073/pnas.0510098103; BROWN JE, 1970, J GEN MICROBIOL, V64, P329, DOI 10.1099/00221287-64-3-329; CLARKE PH, 1988, BIOSCIENCE REP, V8, P103, DOI 10.1007/BF01116455; Copley SD, 2010, COMPREHENSIVE NATURAL PRODUCTS II: CHEMISTRY AND BIOLOGY, VOL 8: ENZYMES AND ENZYME MECHANISMS, P9; de Souza ML, 1998, J BACTERIOL, V180, P1951, DOI 10.1128/JB.180.7.1951-1954.1998; Desai KK, 2008, BIOCHEMISTRY-US, V47, P7983, DOI 10.1021/bi801054v; Elias M, 2012, J BIOL CHEM, V287, P11, DOI 10.1074/jbc.R111.257329; Freilich S, 2005, J MOL BIOL, V349, P745, DOI 10.1016/j.jmb.2005.04.027; Gerlt JA, 2001, ANNU REV BIOCHEM, V70, P209, DOI 10.1146/annurev.biochem.70.1.209; HAIGLER BE, 1993, APPL ENVIRON MICROB, V59, P2239, DOI 10.1128/AEM.59.7.2239-2243.1993; HALL BG, 1976, J MOL BIOL, V107, P71, DOI 10.1016/S0022-2836(76)80018-6; He ZQ, 2000, APPL ENVIRON MICROB, V66, P3010, DOI 10.1128/AEM.66.7.3010-3015.2000; Herring CD, 2006, NAT GENET, V38, P1406, DOI 10.1038/ng1906; HUGHES AL, 1994, P ROY SOC B-BIOL SCI, V256, P119, DOI 10.1098/rspb.1994.0058; Ishii N, 2007, SCIENCE, V316, P593, DOI 10.1126/science.1132067; JENSEN RA, 1976, ANNU REV MICROBIOL, V30, P409, DOI 10.1146/annurev.mi.30.100176.002205; Jurgens C, 2000, P NATL ACAD SCI USA, V97, P9925, DOI 10.1073/pnas.160255397; Khersonsky O, 2010, ANNU REV BIOCHEM, V79, P471, DOI 10.1146/annurev-biochem-030409-143718; Kim JH, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.88; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; Lunzer M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001162; McLoughlin SY, 2008, P NATL ACAD SCI USA, V105, P13497, DOI 10.1073/pnas.0804804105; Miller BG, 2004, BIOCHEMISTRY-US, V43, P6387, DOI 10.1021/bi049424m; Miller C, 2010, BIOPHYS J, V99, P887, DOI 10.1016/j.bpj.2010.04.076; Mirkin BG, 2003, BMC EVOL BIOL, V3, DOI 10.1186/1471-2148-3-2; Nakahigashi K, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.65; Ouzounis CA, 2006, RES MICROBIOL, V157, P57, DOI 10.1016/j.resmic.2005.06.015; Palmer DRJ, 1999, BIOCHEMISTRY-US, V38, P4252, DOI 10.1021/bi990140p; Parera M, 2009, J MOL BIOL, V392, P243, DOI 10.1016/j.jmb.2009.07.015; Park HS, 2006, SCIENCE, V311, P535, DOI 10.1126/science.1118953; Patrick WM, 2008, J MOL BIOL, V377, P323, DOI 10.1016/j.jmb.2008.01.043; Patrick WM, 2007, MOL BIOL EVOL, V24, P2716, DOI 10.1093/molbev/msm204; Raushel FM, 2000, ADV ENZYMOL RAMB, V74, P51; Reams AB, 2010, GENETICS, V184, P1077, DOI 10.1534/genetics.109.111963; Salverda MLM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001321; Seebeck FP, 2003, J AM CHEM SOC, V125, P10158, DOI 10.1021/ja036707d; Segel IH, 1975, ENZYME KINETICS BEHA; Soo VWC, 2011, P NATL ACAD SCI USA, V108, P1484, DOI 10.1073/pnas.1012108108; Uotila J. S., 1995, Biodegradation, V6, P119, DOI 10.1007/BF00695342; Veeravalli K, 2011, NAT CHEM BIOL, V7, P101, DOI 10.1038/NCHEMBIO.499; Weinreich DM, 2006, SCIENCE, V312, P111, DOI 10.1126/science.1123539; WU TT, 1968, J BACTERIOL, V96, P447, DOI 10.1128/JB.96.2.447-456.1968; Yin Y, 2007, P NATL ACAD SCI USA, V104, P17353, DOI 10.1073/pnas.0708265104	50	54	54	1	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					3	10		10.1074/jbc.R111.254714	http://dx.doi.org/10.1074/jbc.R111.254714			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22069330	hybrid, Green Published			2022-12-27	WOS:000298682400002
J	Pinto, MFS; Fensterseifer, ICM; Migliolo, L; Sousa, DA; de Capdville, G; Arboleda-Valencia, JW; Colgrave, ML; Craik, DJ; Magalhaes, BS; Dias, SC; Franco, OL				Pinto, Michelle F. S.; Fensterseifer, Isabel C. M.; Migliolo, Ludovico; Sousa, Daniel A.; de Capdville, Guy; Arboleda-Valencia, Jorge W.; Colgrave, Michelle L.; Craik, David J.; Magalhaes, Beatriz S.; Dias, Simoni C.; Franco, Octavio L.			Identification and Structural Characterization of Novel Cyclotide with Activity against an Insect Pest of Sugar Cane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KALATA B1; PLANT CYCLOTIDES; CIRCULAR PROTEINS; TRYPSIN-INHIBITOR; CYCLOVIOLACIN O2; KNOTTED PROTEINS; PEPTIDES; DISCOVERY; POLYPEPTIDE; RECOGNITION	Cyclotides are a family of plant-derived cyclic peptides comprising six conserved cysteine residues connected by three intermolecular disulfide bonds that form a knotted structure known as a cyclic cystine knot (CCK). This structural motif is responsible for the pronounced stability of cyclotides against chemical, thermal, or proteolytic degradation and has sparked growing interest in this family of peptides. Here, we isolated and characterized a novel cyclotide from Palicourea rigida (Rubiaceae), which was named parigidin-br1. The sequence indicated that this peptide is a member of the bracelet subfamily of cyclotides. Parigidin-br1 showed potent insecticidal activity against neonate larvae of Lepidoptera (Diatraea saccharalis), causing 60% mortality at a concentration of 1 mu M but had no detectable antibacterial effects. A decrease in the in vitro viability of the insect cell line from Spodoptera frugiperda (SF-9) was observed in the presence of parigidin-br1, consistent with in vivo insecticidal activity. Transmission electron microscopy and fluorescence microscopy of SF-9 cells after incubation with parigidin-br1 or parigidin-br1-fluorescein isothiocyanate, respectively, revealed extensive cell lysis and swelling of cells, consistent with an insecticidal mechanism involving membrane disruption. This hypothesis was supported by in silico analyses, which suggested that parigidin-br1 is able to complex with cell lipids. Overall, the results suggest promise for the development of parigidin-br1 as a novel biopesticide.	[Pinto, Michelle F. S.; Fensterseifer, Isabel C. M.; Migliolo, Ludovico; Magalhaes, Beatriz S.; Dias, Simoni C.; Franco, Octavio L.] Univ Catolica Brasilia, Ctr Anal Prote & Bioquim, Programa Posgrad Ciencias Genom & Biotecnol, Brasilia, DF, Brazil; [Arboleda-Valencia, Jorge W.] Univ Brasilia, Dept Biol Celular, Brasilia, DF, Brazil; [de Capdville, Guy; Arboleda-Valencia, Jorge W.] Embrapa Recursos Genet & Biotecnol, CENARGEN, Ctr Nacl Pesquisa Recursos Genet & Biotecnol, Brasilia, DF, Brazil; [Colgrave, Michelle L.] Commonwealth Sci & Ind Res Org Livestock Ind, St Lucia, Qld 4067, Australia; [Craik, David J.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Sousa, Daniel A.] Univ Brasilia, Programa Posgrad Patol Mol, Brasilia, DF, Brazil	Universidade Catolica de Brasilia; Universidade de Brasilia; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Queensland; Universidade de Brasilia	Franco, OL (corresponding author), Univ Catolica Brasilia SGAN, Ctr Anal Prote & Bioquim, Programa Posgrad Ciencias Genom & Biotecnol, Quadra 916,Av W5 Norte, BR-70790160 Brasilia, DF, Brazil.	ocfranco@pos.ucb.br	MIGLIOLO, LUDOVICO/AAV-6913-2021; Franco, Octavio L/T-3020-2017; Craik, David/B-1695-2010; Sousa, Daniel/HHS-6778-2022; Colgrave, Michelle/A-5710-2012	MIGLIOLO, LUDOVICO/0000-0002-6606-2189; Craik, David/0000-0003-0007-6796; Colgrave, Michelle/0000-0001-8463-805X; Franco, Octavio/0000-0001-9546-0525	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Conselho Nacional de Pesquisa e Desenvolvimento; Fundacao de Amparo a Pesquisa do Distrito Federal; Fundacao de Amparo a Pesquisa de Minas Gerais; Universidade Catolica de Brasilia; Australian Research Council	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Pesquisa e Desenvolvimento(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Distrito Federal(Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); Fundacao de Amparo a Pesquisa de Minas Gerais(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Universidade Catolica de Brasilia; Australian Research Council(Australian Research Council)	This work was supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Conselho Nacional de Pesquisa e Desenvolvimento, Fundacao de Amparo a Pesquisa do Distrito Federal, Fundacao de Amparo a Pesquisa de Minas Gerais, and Universidade Catolica de Brasilia. Work at the University of Queensland was supported in part by a grant from the Australian Research Council.	Bagla P, 2010, SCIENCE, V327, P1439, DOI 10.1126/science.327.5972.1439; Barbeta BL, 2008, P NATL ACAD SCI USA, V105, P1221, DOI 10.1073/pnas.0710338104; Benko-Iseppon AM, 2010, CURR PROTEIN PEPT SC, V11, P181, DOI 10.2174/138920310791112075; Biello David, 2008, SCI AM          0207; BIGNAMI GS, 1993, TOXICON, V31, P817, DOI 10.1016/0041-0101(93)90389-Z; Bliss CI, 1934, SCIENCE, V79, P409, DOI 10.1126/science.79.2053.409; Bokesch HR, 2001, J NAT PROD, V64, P249, DOI 10.1021/np000372l; Burman R, 2010, BIOPOLYMERS, V94, P626, DOI 10.1002/bip.21408; CHAGOLLALOPEZ A, 1994, J BIOL CHEM, V269, P23675; Chen B, 2005, J BIOL CHEM, V280, P22395, DOI 10.1074/jbc.M501737200; Colgrave ML, 2008, BIOCHEMISTRY-US, V47, P5581, DOI 10.1021/bi800223y; Colgrave ML, 2010, ANTIMICROB AGENTS CH, V54, P2160, DOI 10.1128/AAC.01306-09; Craik DJ, 2010, TOXICON, V56, P1092, DOI 10.1016/j.toxicon.2010.02.021; Craik DJ, 2009, TRENDS PLANT SCI, V14, P328, DOI 10.1016/j.tplants.2009.03.003; Craik DJ, 2006, CURR OPIN DRUG DISC, V9, P251; Craik DJ, 1999, J MOL BIOL, V294, P1327, DOI 10.1006/jmbi.1999.3383; Craik DJ, 2001, LETT PEPT SCI, V8, P119, DOI 10.1007/BF02446507; Daly NL, 2006, BIOCHEM J, V393, P619, DOI 10.1042/BJ20051371; Daly NL, 1999, BIOCHEMISTRY-US, V38, P10606, DOI 10.1021/bi990605b; Daly NL, 2009, ADV DRUG DELIVER REV, V61, P918, DOI 10.1016/j.addr.2009.05.003; Desai PN, 2010, BIOTECHNOL ADV, V28, P427, DOI 10.1016/j.biotechadv.2010.01.005; Felizmenio-Quimio ME, 2001, J BIOL CHEM, V276, P22875, DOI 10.1074/jbc.M101666200; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Goransson U, 2003, J BIOL CHEM, V278, P48188, DOI 10.1074/jbc.M308771200; Gran L, 2000, J ETHNOPHARMACOL, V70, P197, DOI 10.1016/S0378-8741(99)00175-0; Gruber CW, 2007, TOXICON, V49, P561, DOI 10.1016/j.toxicon.2006.11.018; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Gustafson KR, 2004, CURR PROTEIN PEPT SC, V5, P331, DOI 10.2174/1389203043379468; Heitz A, 2001, BIOCHEMISTRY-US, V40, P7973, DOI 10.1021/bi0106639; Henriques ST, 2011, J BIOL CHEM, V286, P24231, DOI 10.1074/jbc.M111.253393; Hoover DM, 2001, J BIOL CHEM, V276, P39021, DOI 10.1074/jbc.M103830200; Huang YH, 2009, J BIOL CHEM, V284, P20699, DOI 10.1074/jbc.M109.003384; Ireland DC, 2008, BIOPOLYMERS, V90, P51, DOI 10.1002/bip.20886; Jennings C, 2001, P NATL ACAD SCI USA, V98, P10614, DOI 10.1073/pnas.191366898; Jennings CV, 2005, BIOCHEMISTRY-US, V44, P851, DOI 10.1021/bi047837h; JOHNSON JA, 1995, J ECON ENTOMOL, V88, P734, DOI 10.1093/jee/88.3.734; Kamimori H, 2005, ANAL BIOCHEM, V337, P149, DOI 10.1016/j.ab.2004.10.028; Koltay A, 2005, INT J PEPT RES THER, V11, P99, DOI 10.1007/s10989-004-1722-2; Lindholm P, 2002, MOL CANCER THER, V1, P365; Marheineke K, 1998, FEBS LETT, V441, P49, DOI 10.1016/S0014-5793(98)01523-3; Massatochi N., 2000, MOL EVOLUTION PHYLOG, P73; Nourse A, 2004, J BIOL CHEM, V279, P562, DOI 10.1074/jbc.M306826200; Oerke EC, 2004, CROP PROT, V23, P275, DOI 10.1016/j.cropro.2003.10.001; Oldroyd BP, 2007, PLOS BIOL, V5, P1195, DOI 10.1371/journal.pbio.0050168; Peters B, 2006, BMC STRUCT BIOL, V6, DOI 10.1186/1472-6807-6-4; Plan MR, 2010, BIOPOLYMERS, V94, P647, DOI 10.1002/bip.21409; Plan MRR, 2008, J AGR FOOD CHEM, V56, P5237, DOI 10.1021/jf800302f; Poth AG, 2011, P NATL ACAD SCI USA, V108, P10127, DOI 10.1073/pnas.1103660108; Pranting M, 2010, J ANTIMICROB CHEMOTH, V65, P1964, DOI 10.1093/jac/dkq220; Ritchie DW, 2008, CURR PROTEIN PEPT SC, V9, P1, DOI 10.2174/138920308783565741; Rosengren KJ, 2003, J BIOL CHEM, V278, P8606, DOI 10.1074/jbc.M211147200; Rossmann M, 2008, STRUCTURE, V16, P809, DOI 10.1016/j.str.2008.02.016; SAETHER O, 1995, BIOCHEMISTRY-US, V34, P4147, DOI 10.1021/bi00013a002; Saska I, 2007, J BIOL CHEM, V282, P29721, DOI 10.1074/jbc.M705185200; Seydel P, 2007, APPL MICROBIOL BIOT, V77, P275, DOI 10.1007/s00253-007-1159-6; Shenkarev ZO, 2006, FEBS J, V273, P2658, DOI 10.1111/j.1742-4658.2006.05282.x; Simonsen SM, 2005, PLANT CELL, V17, P3176, DOI 10.1105/tpc.105.034678; Sumathi K, 2006, NUCLEIC ACIDS RES, V34, pW128, DOI 10.1093/nar/gkl036; Tam JP, 1999, P NATL ACAD SCI USA, V96, P8913, DOI 10.1073/pnas.96.16.8913; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Trabi M, 2004, PLANT CELL, V16, P2204, DOI 10.1105/tpc.104.021790; VAUGHN JL, 1977, IN VITRO CELL DEV B, V13, P213; Wang CK, 2009, J BIOL CHEM, V284, P10672, DOI 10.1074/jbc.M900021200; Wang CKL, 2008, NUCLEIC ACIDS RES, V36, pD206, DOI 10.1093/nar/gkm953; Wang Z, 2004, NUCLEIC ACIDS RES, V32, pD590, DOI 10.1093/nar/gkh025; Watts J. L., 2006, PERFORMANCE STANDARD, V28, P5; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; WITHERUP KM, 1994, J NAT PRODUCTS, V57, P1619, DOI 10.1021/np50114a002	69	67	70	0	19	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					134	147		10.1074/jbc.M111.294009	http://dx.doi.org/10.1074/jbc.M111.294009			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22074926	hybrid, Green Published			2022-12-27	WOS:000298682400016
J	Viola, IL; Reinheimer, R; Ripoll, R; Manassero, NGU; Gonzalez, DH				Viola, Ivana L.; Reinheimer, Renata; Ripoll, Rodrigo; Uberti Manassero, Nora G.; Gonzalez, Daniel H.			Determinants of the DNA Binding Specificity of Class I and Class II TCP Transcription Factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE SEQUENCE ALIGNMENT; CRYSTAL-STRUCTURE; DOMAIN; GENES; COMPLEX; PROTEINS; GROWTH; SITES; TRANSFORMATION; INTERFERENCE	TCP proteins constitute a family of plant transcription factors with more than 20 members in angiosperms. They can be divided in two classes based on sequence homology and the presence of an insertion within the basic region of the TCP DNA binding and dimerization domain. Here, we describe binding site selection studies with the class I protein TCP16, showing that its DNA binding preferences are similar to those of class II proteins. Through sequence comparison and the analysis of mutants and chimeras of TCP16, TCP20 (class I), and TCP4 (class II), we established that the identity of residue 11 of the class I TCP domain or the equivalent residue 15 of the class II domain, whether it is Gly or Asp, determines a preference for a class I or a class II sequence, respectively. Footprinting analysis indicated that specific DNA contacts related to these preferences are established with one of the strands of DNA. The dimerization motif also influences the selectivity of the proteins toward class I and class II sequences and determines a requirement of an extended basic region in proteins with Asp-15. We postulate that differences in orientation of base-contacting residues brought about by the presence of either Gly or Asp are responsible for the binding site preferences of TCP proteins. Expression of repressor forms of TCP16 with Asp-11 or Gly-11 differently affects leaf development. TCP16-like proteins with Asp-11 in the TCP domain arose in rosids and may be related to developmental characteristics of this lineage of eudicots.	[Viola, Ivana L.; Ripoll, Rodrigo; Uberti Manassero, Nora G.; Gonzalez, Daniel H.] Univ Nacl Litoral, Inst Agrobiotecnol Litoral CONICET UNL, Catedra Biol Celular & Mol, Fac Bioquim & Ciencias Biol, RA-3000 Santa Fe, Argentina; [Reinheimer, Renata] Inst Bota Darwin, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of the Littoral	Gonzalez, DH (corresponding author), Univ Nacl Litoral, Inst Agrobiotecnol Litoral CONICET UNL, Catedra Biol Celular & Mol, Fac Bioquim & Ciencias Biol, CC 242 Paraje El Pozo, RA-3000 Santa Fe, Argentina.	dhgonza@fbcb.unl.edu.ar			Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT); Universidad Nacional del Litoral	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT)(ANPCyT); Universidad Nacional del Litoral	This work was supported by grants from Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) and Universidad Nacional del Litoral.	Aggarwal P, 2010, PLANT CELL, V22, P1174, DOI 10.1105/tpc.109.066647; Aguilar-Martinez JA, 2007, PLANT CELL, V19, P458, DOI 10.1105/tpc.106.048934; BLACKWELL TK, 1990, SCIENCE, V250, P1104, DOI 10.1126/science.2174572; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Doebley J, 1997, NATURE, V386, P485, DOI 10.1038/386485a0; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; ELLENBERGER T, 1994, GENE DEV, V8, P970, DOI 10.1101/gad.8.8.970; FERREDAMARE AR, 1994, EMBO J, V13, P180, DOI 10.1002/j.1460-2075.1994.tb06247.x; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Giraud E, 2010, PLANT CELL, V22, P3921, DOI 10.1105/tpc.110.074518; Gonzalez DH, 2007, PLANT J, V51, P105, DOI 10.1111/j.1365-313X.2007.03121.x; Herve C, 2009, PLANT PHYSIOL, V149, P1462, DOI 10.1104/pp.108.126136; Hiratsu K, 2003, PLANT J, V34, P733, DOI 10.1046/j.1365-313X.2003.01759.x; Jain SS, 2008, NAT PROTOC, V3, P1092, DOI 10.1038/nprot.2008.72; Kieffer M, 2011, PLANT J, V68, P147, DOI 10.1111/j.1365-313X.2011.04674.x; Kosugi S, 2002, PLANT J, V30, P337, DOI 10.1046/j.1365-313X.2002.01294.x; Koyama T, 2007, PLANT CELL, V19, P473, DOI 10.1105/tpc.106.044792; Koyama T, 2010, PLANT CELL, V22, P3574, DOI 10.1105/tpc.110.075598; Li CX, 2005, P NATL ACAD SCI USA, V102, P12978, DOI 10.1073/pnas.0504039102; Longo A, 2008, BIOCHEMISTRY-US, V47, P218, DOI 10.1021/bi701527r; Luo D, 1996, NATURE, V383, P794, DOI 10.1038/383794a0; MA PCM, 1994, CELL, V77, P451, DOI 10.1016/0092-8674(94)90159-7; Martin-Trillo M, 2010, TRENDS PLANT SCI, V15, P31, DOI 10.1016/j.tplants.2009.11.003; Nath U, 2003, SCIENCE, V299, P1404, DOI 10.1126/science.1079354; Navaud O, 2007, J MOL EVOL, V65, P23, DOI 10.1007/s00239-006-0174-z; OLIPHANT AR, 1989, MOL CELL BIOL, V9, P2944, DOI 10.1128/MCB.9.7.2944; Ori N, 2007, NAT GENET, V39, P787, DOI 10.1038/ng2036; Palatnik JF, 2003, NATURE, V425, P257, DOI 10.1038/nature01958; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320; Pruneda-Paz JL, 2009, SCIENCE, V323, P1481, DOI 10.1126/science.1167206; Ree RH, 2004, MOL BIOL EVOL, V21, P321, DOI 10.1093/molbev/msh022; Reynolds A., 1997, CURRENT PROTOCOLS MO; Schommer C, 2008, PLOS BIOL, V6, P1991, DOI 10.1371/journal.pbio.0060230; Shimizu T, 1997, EMBO J, V16, P4689, DOI 10.1093/emboj/16.15.4689; Silver J, 1995, PCR STRATEGIES, P179; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Takeda T, 2006, PLANT MOL BIOL, V61, P165, DOI 10.1007/s11103-006-6265-9; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tatematsu K, 2008, PLANT J, V53, P42, DOI 10.1111/j.1365-313X.2007.03308.x; Uberti Manassero N. G., 2011, J EXP BOT       1020, DOI [10.1093/jxb/err305, DOI 10.1093/JXB/ERR305]; Viola IL, 2007, BIOCHEMISTRY-US, V46, P7416, DOI 10.1021/bi602657e; Viola IL, 2011, BIOCHEM J, V435, P143, DOI 10.1042/BJ20101019; Viola IL, 2009, BIOCHIMIE, V91, P974, DOI 10.1016/j.biochi.2009.04.021; Welchen E, 2006, PLANT PHYSIOL, V141, P540, DOI 10.1104/pp.105.075366	46	38	42	0	20	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					347	356		10.1074/jbc.M111.256271	http://dx.doi.org/10.1074/jbc.M111.256271			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22074922	Green Published, hybrid			2022-12-27	WOS:000298682400034
J	Zhang, WN; Wang, L; Wang, Q; Luo, X; Fang, DF; Chen, Y; Pan, X; Man, JH; Xia, Q; Jin, BF; Li, WH; Li, T; Liang, B; Chen, L; Gong, WL; Yu, M; Li, AL; Zhou, T; Li, HY				Zhang, Wei-Na; Wang, Li; Wang, Qiong; Luo, Xue; Fang, Di-Feng; Chen, Yuan; Pan, Xin; Man, Jiang-Hong; Xia, Qing; Jin, Bao-Feng; Li, Wei-Hua; Li, Tao; Liang, Bing; Chen, Liang; Gong, Wei-Li; Yu, Ming; Li, Ai-Ling; Zhou, Tao; Li, Hui-Yan			CUEDC2 (CUE Domain-containing 2) and SOCS3 (Suppressors of Cytokine Signaling 3) Cooperate to Negatively Regulate Janus Kinase 1/Signal Transducers and Activators of Transcription 3 Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; TYROSINE PHOSPHORYLATION; STAT3 ACTIVATION; JAK/STAT PATHWAY; SH2 DOMAIN; RECEPTOR; PROTEIN; BINDING; DEGRADATION; INHIBITION	Janus kinase 1/signal transducers and activators of transcription 3 (JAK1/STAT3) pathway is one of the recognized oncogenic signaling pathways that frequently overactivated in a variety of human tumors. Despite rapid progress in elucidating the molecular mechanisms of activation of JAK/STAT pathway, the processes that regulate JAK/STAT deactivation need to be further clarified. Here we demonstrate that CUE domain-containing 2 (CUEDC2) inhibits cytokine-induced phosphorylation of JAK1 and STAT3 and the subsequent STAT3 transcriptional activity. Further analysis by a yeast two-hybrid assay showed that CUEDC2 could engage in a specific interaction with a key JAK/STAT inhibitor, SOCS3 (suppressors of cytokine signaling 3). The interaction between CUEDC2 and SOCS3 is required for the inhibitory effect of CUEDC2 on JAK1 and STAT3 activity. Additionally, we found CUEDC2 functions collaboratively with SOCS3 to inhibit JAK1/STAT3 signaling by increasing SOCS3 stability via enhancing its association with Elongin C. Therefore, our findings revealed a new biological activity for CUEDC2 as the regulator of JAK1/STAT3 signaling and paved the way to a better understanding of the mechanisms by which SOCS3 has been linked to suppression of the JAK/STAT pathway.	[Zhang, Wei-Na; Luo, Xue; Fang, Di-Feng; Chen, Yuan; Pan, Xin; Man, Jiang-Hong; Xia, Qing; Jin, Bao-Feng; Li, Wei-Hua; Li, Tao; Liang, Bing; Chen, Liang; Gong, Wei-Li; Yu, Ming; Li, Ai-Ling; Zhou, Tao; Li, Hui-Yan] Natl Ctr Biomed Anal, Inst Basic Med Sci, Beijing 100850, Peoples R China; [Wang, Li] Beijing Inst Biotechnol, Beijing 100071, Peoples R China; [Wang, Qiong] Beijing Inst Radiat Med, Beijing 100850, Peoples R China	Academy of Military Medical Sciences - China	Li, HY (corresponding author), Natl Ctr Biomed Anal, Inst Basic Med Sci, 27 Tai Ping Rd, Beijing 100850, Peoples R China.	lihy@nic.bmi.ac.cn	FANG, DIFENG/G-7796-2018	FANG, DIFENG/0000-0003-2105-6743; Pan, Xin/0000-0002-1982-2261; Li, Tao/0000-0002-0746-8322; Man, Jianghong/0000-0001-6020-3537	National Basic Research Program of China [2012CB9100700]; National Natural Science Foundation of China [81130037, 30900754, 31100978]; National High Technology Research and Development Program of China [2009AA02Z103]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	This work was supported by National Basic Research Program of China Grant 2012CB9100700, National Natural Science Foundation of China Grants 81130037, 30900754, and 31100978, and National High Technology Research and Development Program of China Grant 2009AA02Z103.	ASO T, 1995, SCIENCE, V269, P1439, DOI 10.1126/science.7660129; Bjorbaek C, 2000, J BIOL CHEM, V275, P40649, DOI 10.1074/jbc.M007577200; Bowman T, 2000, ONCOGENE, V19, P2474, DOI 10.1038/sj.onc.1203527; BRADSHER JN, 1993, J BIOL CHEM, V268, P25587; Bromberg J, 2002, J CLIN INVEST, V109, P1139, DOI 10.1172/JCI200215617; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Chung CD, 1997, SCIENCE, V278, P1803, DOI 10.1126/science.278.5344.1803; DUAN DR, 1995, SCIENCE, V269, P1402, DOI 10.1126/science.7660122; Endo TA, 1997, NATURE, V387, P921, DOI 10.1038/43213; Greenhalgh CJ, 2001, J LEUKOCYTE BIOL, V70, P348; Haan S, 2003, J BIOL CHEM, V278, P31972, DOI 10.1074/jbc.M303170200; Hanada T, 2001, J BIOL CHEM, V276, P40746, DOI 10.1074/jbc.M106139200; Hilton DJ, 1998, P NATL ACAD SCI USA, V95, P114, DOI 10.1073/pnas.95.1.114; Hortner M, 2002, J IMMUNOL, V169, P1219, DOI 10.4049/jimmunol.169.3.1219; Hortner M, 2002, EUR J BIOCHEM, V269, P2516, DOI 10.1046/j.1432-1033.2002.02916.x; Igaz P, 2001, INFLAMM RES, V50, P435, DOI 10.1007/PL00000267; Irie-Sasaki J, 2001, NATURE, V409, P349, DOI 10.1038/35053086; Kamura T, 1998, GENE DEV, V12, P3872, DOI 10.1101/gad.12.24.3872; KIBEL A, 1995, SCIENCE, V269, P1444, DOI 10.1126/science.7660130; Kile BT, 2002, TRENDS BIOCHEM SCI, V27, P235, DOI 10.1016/S0968-0004(02)02085-6; KISHIMOTO T, 1994, CELL, V76, P253, DOI 10.1016/0092-8674(94)90333-6; Komyod W, 2007, MOL CANCER RES, V5, P271, DOI 10.1158/1541-7786.MCR-06-0274; Krebs DL, 2000, J CELL SCI, V113, P2813; Kwon MC, 2008, EMBO J, V27, P642, DOI 10.1038/sj.emboj.7601986; Lee H, 2010, NAT MED, V16, P1421, DOI 10.1038/nm.2250; Lee H, 2009, CANCER CELL, V15, P283, DOI 10.1016/j.ccr.2009.02.015; Leong H, 2009, BREAST CANCER RES TR, V117, P505, DOI 10.1007/s10549-008-0196-x; Lesina M, 2011, CANCER CELL, V19, P456, DOI 10.1016/j.ccr.2011.03.009; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Levy DE, 2002, J CLIN INVEST, V109, P1143, DOI 10.1172/JCI200215650; Li HY, 2008, NAT IMMUNOL, V9, P533, DOI 10.1038/ni.1600; Lufei CC, 2003, EMBO J, V22, P1325, DOI 10.1093/emboj/cdg135; Matsumoto A, 1997, BLOOD, V89, P3148, DOI 10.1182/blood.V89.9.3148; Muromoto R, 2006, ONCOGENE, V25, P2131, DOI 10.1038/sj.onc.1209235; Myers MP, 2001, J BIOL CHEM, V276, P47771, DOI 10.1074/jbc.C100583200; Naka T, 1997, NATURE, V387, P924, DOI 10.1038/43219; Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485; Nicholson SE, 2000, P NATL ACAD SCI USA, V97, P6493, DOI 10.1073/pnas.100135197; O'Shea JJ, 2002, CELL, V109, pS121, DOI 10.1016/S0092-8674(02)00701-8; Pan X, 2011, NAT MED, V17, P708, DOI 10.1038/nm.2369; Pezet A, 1999, J BIOL CHEM, V274, P24497, DOI 10.1074/jbc.274.35.24497; Rodel B, 2000, EMBO J, V19, P5845, DOI 10.1093/emboj/19.21.5845; Sasaki A, 2000, J BIOL CHEM, V275, P29338, DOI 10.1074/jbc.M003456200; Sasaki A, 1999, GENES CELLS, V4, P339, DOI 10.1046/j.1365-2443.1999.00263.x; Schmitz J, 2000, J BIOL CHEM, V275, P12848, DOI 10.1074/jbc.275.17.12848; Sekine Y, 2006, ONCOGENE, V25, P5801, DOI 10.1038/sj.onc.1209578; Sinibaldi D, 2000, ONCOGENE, V19, P5419, DOI 10.1038/sj.onc.1203947; Suzuki R, 1998, ONCOGENE, V17, P2271, DOI 10.1038/sj.onc.1202143; Wang TH, 2004, NAT MED, V10, P48, DOI 10.1038/nm976; Yang XP, 2011, NAT IMMUNOL, V12, P247, DOI 10.1038/ni.1995; Yasukawa H, 1999, EMBO J, V18, P1309, DOI 10.1093/emboj/18.5.1309; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275; Zhang PJ, 2007, EMBO J, V26, P1831, DOI 10.1038/sj.emboj.7601602; ZHONG Z, 1994, SCIENCE, V264, P95, DOI 10.1126/science.8140422	54	23	27	6	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					382	392		10.1074/jbc.M111.276832	http://dx.doi.org/10.1074/jbc.M111.276832			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22084247	Green Published, hybrid			2022-12-27	WOS:000298682400037
J	Allsopp, RC; Evans, RJ				Allsopp, Rebecca C.; Evans, Richard J.			The Intracellular Amino Terminus Plays a Dominant Role in Desensitization of ATP-gated P2X Receptor Ion Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIRST TRANSMEMBRANE DOMAIN; SMOOTH-MUSCLE; CATION CHANNELS; ACTIVATION; CELLS; PORE; IDENTIFICATION; MUTAGENESIS; EXPRESSION; RESPONSES	P2X receptors show marked variations in the time-course of response to ATP application from rapidly desensitizing P2X1 receptors to relatively sustained P2X2 receptors. In this study we have used chimeras between human P2X1 and P2X2 receptors in combination with mutagenesis to address the contribution of the extracellular ligand binding loop, the transmembrane channel, and the intracellular regions to receptor time-course. Swapping either the extracellular loop or both transmembrane domains (TM1 and -2) between the P2X1 and P2X2 receptors had no effect on the time-course of ATP currents in the recipient receptor. These results suggest that the agonist binding and channel-forming portions of the receptor do not play a major role in the control of the time-course. In contrast replacing the amino terminus of the P2X1 receptor with that from the non-desensitizing P2X2 receptor (P2X1-2N) slowed desensitization, and the mirror chimera induced rapid desensitization in the P2X2-1N chimera. These reciprocal effects on time-course can be replicated by changing four variant amino acids just before the first transmembrane (TM1) segment. These pre-TM1 residues also had a dominant effect on chimeras where both TMs had been transferred; mutating the variant amino acids 21-23 to those found in the P2X2 receptor removed desensitization from the P2X1-2TM1/-2 chimera, and the reciprocal mutants induced rapid desensitization in the non-desensitizing P2X2-1TM1/-2 chimera. These results suggest that the intracellular amino terminus, in particular the region just before TM1, plays a dominant role in the regulation of the time-course of ATP evoked P2X receptor currents.	[Allsopp, Rebecca C.; Evans, Richard J.] Univ Leicester, Dept Cell Physiol & Pharmacol, Leicester LE1 9HN, Leics, England	University of Leicester	Evans, RJ (corresponding author), Univ Leicester, Dept Cell Physiol & Pharmacol, Leicester LE1 9HN, Leics, England.	rje6@le.ac.uk			Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust.	Allsopp RC, 2011, J BIOL CHEM, V286, P29207, DOI 10.1074/jbc.M111.260364; Armstrong N, 2006, CELL, V127, P85, DOI 10.1016/j.cell.2006.08.037; Bavan S, 2011, MOL PHARMACOL, V79, P776, DOI 10.1124/mol.110.070037; BENHAM CD, 1989, J PHYSIOL-LONDON, V419, P689, DOI 10.1113/jphysiol.1989.sp017893; Boue-Grabot E, 2000, J BIOL CHEM, V275, P10190, DOI 10.1074/jbc.275.14.10190; Brandle U, 1997, FEBS LETT, V404, P294, DOI 10.1016/S0014-5793(97)00128-2; Burnstock G, 2006, TRENDS PHARMACOL SCI, V27, P166, DOI 10.1016/j.tips.2006.01.005; Coddou C, 2011, PHARMACOL REV, V63, P641, DOI 10.1124/pr.110.003129; Collo G, 1996, J NEUROSCI, V16, P2495; Egan TM, 1998, J NEUROSCI, V18, P2350; Egan TM, 2004, J NEUROSCI, V24, P3413, DOI 10.1523/JNEUROSCI.5429-03.2004; Ennion S, 2000, J BIOL CHEM, V275, P29361, DOI 10.1074/jbc.M003637200; Ennion SJ, 2002, BIOCHEM BIOPH RES CO, V291, P611, DOI 10.1006/bbrc.2002.6488; Evans RJ, 2010, BRIT J PHARMACOL, V161, P961, DOI 10.1111/j.1476-5381.2010.00728.x; Evans RJ, 1996, J PHYSIOL-LONDON, V497, P413, DOI 10.1113/jphysiol.1996.sp021777; Finger TE, 2005, SCIENCE, V310, P1495, DOI 10.1126/science.1118435; Fountain SJ, 2006, J BIOL CHEM, V281, P15044, DOI 10.1074/jbc.M600442200; Fujiwara Y, 2006, J PHYSIOL-LONDON, V576, P135, DOI 10.1113/jphysiol.2006.115246; Giniatullin R, 2005, TRENDS NEUROSCI, V28, P371, DOI 10.1016/j.tins.2005.04.009; Haines WR, 2001, J NEUROSCI, V21, P5885, DOI 10.1523/JNEUROSCI.21-16-05885.2001; Haines WR, 2001, J BIOL CHEM, V276, P32793, DOI 10.1074/jbc.M104216200; Hechler B, 2003, J EXP MED, V198, P661, DOI 10.1084/jem.20030144; Jiang LH, 2001, J BIOL CHEM, V276, P14902, DOI 10.1074/jbc.M011327200; Kawate T, 2009, NATURE, V460, P592, DOI 10.1038/nature08198; Khakh BS, 2006, NATURE, V442, P527, DOI 10.1038/nature04886; Khakh BS, 2000, NATURE, V406, P405, DOI 10.1038/35019066; Kracun S, 2010, J BIOL CHEM, V285, P10110, DOI 10.1074/jbc.M109.089185; Lalo U, 2008, J NEUROSCI, V28, P5473, DOI 10.1523/JNEUROSCI.1149-08.2008; Lalo U, 2010, J NEUROCHEM, V113, P1177, DOI 10.1111/j.1471-4159.2010.06730.x; Lecut C, 2009, J IMMUNOL, V183, P2801, DOI 10.4049/jimmunol.0804007; Lewis CJ, 2000, BRIT J PHARMACOL, V131, P1659, DOI 10.1038/sj.bjp.0703744; Li MF, 2008, NAT NEUROSCI, V11, P883, DOI 10.1038/nn.2151; Li MF, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1048; Liu GJ, 2003, AUTON NEUROSCI-BASIC, V108, P12, DOI 10.1016/S1566-0702(03)00154-1; Mahaut-Smith MP, 2011, PURINERG SIGNAL, V7, P341, DOI 10.1007/s11302-011-9224-0; Mulryan K, 2000, NATURE, V403, P86, DOI 10.1038/47495; NAKAZAWA K, 1994, J NEUROSCI, V14, P740; North RA, 2000, ANNU REV PHARMACOL, V40, P563, DOI 10.1146/annurev.pharmtox.40.1.563; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Oury C, 2003, BLOOD, V101, P3969, DOI 10.1182/blood-2002-10-3215; Pankratov Y, 2009, NEUROSCIENCE, V158, P137, DOI 10.1016/j.neuroscience.2008.03.076; Rassendren F, 1997, EMBO J, V16, P3446, DOI 10.1093/emboj/16.12.3446; Ren JH, 2003, J PHYSIOL-LONDON, V552, P809, DOI 10.1113/jphysiol.2003.047944; Rettinger J, 2004, J BIOL CHEM, V279, P6426, DOI 10.1074/jbc.M306987200; Robertson SJ, 2001, CURR OPIN NEUROBIOL, V11, P378, DOI 10.1016/S0959-4388(00)00222-1; Simon J, 1997, MOL PHARMACOL, V52, P237, DOI 10.1124/mol.52.2.237; Surprenant A, 1996, SCIENCE, V272, P735, DOI 10.1126/science.272.5262.735; SURPRENANT A, 1995, TRENDS NEUROSCI, V18, P224, DOI 10.1016/0166-2236(95)93907-F; Surprenant A, 2009, ANNU REV PHYSIOL, V71, P333, DOI 10.1146/annurev.physiol.70.113006.100630; Vial C, 2000, BRIT J PHARMACOL, V131, P1489, DOI 10.1038/sj.bjp.0703720; Vial C, 2002, MOL PHARMACOL, V62, P1438, DOI 10.1124/mol.62.6.1438; Vulchanova L, 1996, P NATL ACAD SCI USA, V93, P8063, DOI 10.1073/pnas.93.15.8063; Wen HR, 2009, J NEUROCHEM, V108, P331, DOI 10.1111/j.1471-4159.2008.05761.x; Werner P, 1996, P NATL ACAD SCI USA, V93, P15485, DOI 10.1073/pnas.93.26.15485; Zemkova H, 2004, J NEUROSCI, V24, P6968, DOI 10.1523/JNEUROSCI.1471-04.2004	55	31	31	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2011	286	52					44691	44701		10.1074/jbc.M111.303917	http://dx.doi.org/10.1074/jbc.M111.303917			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870CA	22027824	hybrid, Green Published			2022-12-27	WOS:000298645500039
J	Murakami, K; Murata, N; Noda, Y; Tahara, S; Kaneko, T; Kinoshita, N; Hatsuta, H; Murayama, S; Barnham, KJ; Irie, K; Shirasawa, T; Shimizu, T				Murakami, Kazuma; Murata, Nakaba; Noda, Yoshihiro; Tahara, Shoichi; Kaneko, Takao; Kinoshita, Noriaki; Hatsuta, Hiroyuki; Murayama, Shigeo; Barnham, Kevin J.; Irie, Kazuhiro; Shirasawa, Takuji; Shimizu, Takahiko			SOD1 (Copper/Zinc Superoxide Dismutase) Deficiency Drives Amyloid beta Protein Oligomerization and Memory Loss in Mouse Model of Alzheimer Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ABNORMAL TAU-PHOSPHORYLATION; OXIDATIVE STRESS; A-BETA; MACULAR DEGENERATION; TRANSGENIC MICE; PRECURSOR PROTEIN; IN-VIVO; PLAQUE-FORMATION; PATHOGENESIS; MECHANISM	Oxidative stress is closely linked to the pathogenesis of neurodegeneration. Soluble amyloid beta (A beta) oligomers cause cognitive impairment and synaptic dysfunction in Alzheimer disease (AD). However, the relationship between oligomers, oxidative stress, and their localization during disease progression is uncertain. Our previous study demonstrated that mice deficient in cytoplasmic copper/zinc superoxide dismutase (CuZn-SOD, SOD1) have features of drusen formation, a hallmark of agerelated macular degeneration (Imamura, Y., Noda, S., Hashizume, K., Shinoda, K., Yamaguchi, M., Uchiyama, S., Shimizu, T., Mizushima, Y., Shirasawa, T., and Tsubota, K. (2006) Proc. Natl. Acad. Sci. U. S. A. 103, 11282-11287). Amyloid assembly has been implicated as a common mechanism of plaque and drusen formation. Here, we show that Sod1 deficiency in an amyloid precursor protein-overexpressing mouse model (AD mouse, Tg2576) accelerated A beta oligomerization and memory impairment as compared with control AD mouse and that these phenomena were basically mediated by oxidative damage. The increased plaque and neuronal inflammation were accompanied by the generation of N-is an element of-carboxymethyl lysine in advanced glycation end products, a rapid marker of oxidative damage, induced by Sod1 gene-dependent reduction. The Sod1 deletion also caused Tau phosphorylation and the lower levels of synaptophysin. Furthermore, the levels of SOD1 were significantly decreased in human AD patients rather than non-AD agematched individuals, but mitochondrial SOD (Mn-SOD, SOD2) and extracellular SOD (CuZn-SOD, SOD3) were not. These findings suggest that cytoplasmic superoxide radical plays a critical role in the pathogenesis of AD. Activation of Sod1 may be a therapeutic strategy for the inhibition of AD progression.	[Hatsuta, Hiroyuki; Murayama, Shigeo] Tokyo Metropolitan Inst Gerontol, Dept Neuropathol, Itabashi Ku, Tokyo 1730015, Japan; [Murakami, Kazuma; Irie, Kazuhiro] Kyoto Univ, Grad Sch Agr, Div Food Sci & Biotechnol, Kyoto 6068502, Japan; [Murata, Nakaba; Shimizu, Takahiko] Tokyo Univ Agr & Technol, United Grad Sch Agr Sci, Fuchu, Tokyo 1838509, Japan; [Kinoshita, Noriaki] Immunobiol Labs Co Ltd, Gunma 3700831, Japan; [Barnham, Kevin J.] Univ Melbourne, Mol & Biotechnol Inst Bio21, Dept Pathol, Melbourne, Vic 3010, Australia; [Shirasawa, Takuji] Juntendo Univ, Grad Sch Med, Dept Aging Control Med, Bunkyo Ku, Tokyo 1130033, Japan	Tokyo Metropolitan Institute of Gerontology; Kyoto University; Tokyo University of Agriculture & Technology; Immuno-Biological Laboratories Co. Ltd.; University of Melbourne; Juntendo University	Shimizu, T (corresponding author), Chiba Univ, Grad Sch Med, Dept Adv Aging Med, Chuo Ku, 1-8-1 Inohana, Chiba 2608760, Japan.	shimizut@chiba-u.jp	Kaneko, Takao/Q-8779-2019; Murakami, Kazuma/GQA-7062-2022; Irie, Kazuhiro/A-6121-2014	Murakami, Kazuma/0000-0003-3152-1784; Irie, Kazuhiro/0000-0001-7109-8568; Noda, Yoshihiro/0000-0002-2657-2555	Ministry of Education, Culture, Sports, Science, and Technology of the Japanese Government [20390085, 20500641, 18208011, 21248015, 22603006, 19.0403]; Grants-in-Aid for Scientific Research [21248015] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of the Japanese Government(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by the Program for the Promotion of Basic Research Activities for Innovative Biosciences (to T. Shimizu), Grants-in-aid for Scientific Research (B) 20390085 (to T. Shirasawa), (C) 20500641 (to T. Shimizu), (A) 18208011 and 21248015 (to K. I.), and (C) 22603006 (to K. M.), and funds for the Promotion of Science for Young Scientists Grant 19.0403 (to K. M.) from the Ministry of Education, Culture, Sports, Science, and Technology of the Japanese Government.	Adlard PA, 2008, NEURON, V59, P43, DOI 10.1016/j.neuron.2008.06.018; Angeletti B, 2005, J BIOL CHEM, V280, P17930, DOI 10.1074/jbc.M412034200; Ansari MA, 2010, J NEUROPATH EXP NEUR, V69, P155, DOI 10.1097/NEN.0b013e3181cb5af4; Barnham KJ, 2004, NAT REV DRUG DISCOV, V3, P205, DOI 10.1038/nrd1330; Barnham KJ, 2004, FASEB J, V18, P1427, DOI 10.1096/fj.04-1890fje; Bayer TA, 2003, P NATL ACAD SCI USA, V100, P14187, DOI 10.1073/pnas.2332818100; BRAMBLETT GT, 1993, NEURON, V10, P1089, DOI 10.1016/0896-6273(93)90057-X; De Felice FG, 2007, J BIOL CHEM, V282, P11590, DOI 10.1074/jbc.M607483200; Demuro A, 2005, J BIOL CHEM, V280, P17294, DOI 10.1074/jbc.M500997200; Ding JD, 2008, VISION RES, V48, P339, DOI 10.1016/j.visres.2007.07.025; Esposito L, 2006, J NEUROSCI, V26, P5167, DOI 10.1523/JNEUROSCI.0482-06.2006; Frederikse PH, 1996, J BIOL CHEM, V271, P10169, DOI 10.1074/jbc.271.17.10169; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; Gray EH, 2010, J ALZHEIMERS DIS, V21, P1101, DOI 10.3233/JAD-2010-100717; Gray F., 2003, ESCOUROLLE POIRIERS, P197; Gsell W, 1995, J NEUROCHEM, V64, P1216, DOI 10.1046/j.1471-4159.1995.64031216; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Harman D, 2002, ANN NY ACAD SCI, V959, P384, DOI 10.1111/j.1749-6632.2002.tb02109.x; Harman D, 2002, ANN NY ACAD SCI, V959, P463; Himeno E, 2011, ANN NEUROL, V69, P248, DOI 10.1002/ana.22319; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Iadecola C, 1999, NAT NEUROSCI, V2, P157, DOI 10.1038/5715; Imamura Y, 2006, P NATL ACAD SCI USA, V103, P11282, DOI 10.1073/pnas.0602131103; Iuchi Y, 2007, BIOCHEM J, V402, P219, DOI 10.1042/BJ20061386; Jacobsen JS, 2006, P NATL ACAD SCI USA, V103, P5161, DOI 10.1073/pnas.0600948103; Johnson LV, 2002, P NATL ACAD SCI USA, V99, P11830, DOI 10.1073/pnas.192203399; Kaneko T, 2004, FREE RADICAL RES, V38, P839, DOI 10.1080/10715760410001715167; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Klaver AC, 2011, J NEUROSCI METH, V195, P249, DOI 10.1016/j.jneumeth.2010.12.001; Li F, 2004, J NEUROCHEM, V89, P1308, DOI 10.1111/j.1471-4159.2004.02455.x; Luibl V, 2006, J CLIN INVEST, V116, P378, DOI 10.1172/JCI25843; MARKLUND SL, 1985, J NEUROL SCI, V67, P319, DOI 10.1016/0022-510X(85)90156-X; Marlatt M, 2004, ACTA NEUROBIOL EXP, V64, P81; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; Melov S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000536; Moreira PI, 2005, ANN NY ACAD SCI, V1043, P545, DOI 10.1196/annals.1333.062; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Murakami K, 2005, J AM CHEM SOC, V127, P15168, DOI 10.1021/ja054041c; Murakami K, 2011, J ALZHEIMERS DIS, V26, P7, DOI [10.3233/JAD-2011-101971, 10.1177/1533317510395375]; Murakami K, 2011, BIOCHEM BIOPH RES CO, V409, P34, DOI 10.1016/j.bbrc.2011.04.101; Murakami K, 2010, ACS CHEM NEUROSCI, V1, P747, DOI 10.1021/cn100072e; Murakami K, 2009, BIOCHEM BIOPH RES CO, V382, P457, DOI 10.1016/j.bbrc.2009.03.053; Murata N, 2010, BIOSCI BIOTECH BIOCH, V74, P2299, DOI 10.1271/bbb.100524; Murayama S, 2004, NEUROPATHOLOGY, V24, P254, DOI 10.1111/j.1440-1789.2004.00571.x; Niwa K, 2000, J CEREBR BLOOD F MET, V20, P1659, DOI 10.1097/00004647-200012000-00005; Noda Y., 2011, BIOL REPROD IN PRESS; Nojiri H, 2011, J BONE MINER RES, V26, P2682, DOI 10.1002/jbmr.489; Okado-Matsumoto A, 2001, J BIOL CHEM, V276, P38388, DOI 10.1074/jbc.M105395200; Ono K, 2009, P NATL ACAD SCI USA, V106, P14745, DOI 10.1073/pnas.0905127106; Resende R, 2008, FREE RADICAL BIO MED, V44, P2051, DOI 10.1016/j.freeradbiomed.2008.03.012; Rhein V, 2009, P NATL ACAD SCI USA, V106, P20057, DOI 10.1073/pnas.0905529106; RICHARDSON JS, 1993, ANN NY ACAD SCI, V695, P73, DOI 10.1111/j.1749-6632.1993.tb23031.x; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Roychaudhuri R, 2009, J BIOL CHEM, V284, P4749, DOI 10.1074/jbc.R800036200; Sasaki T, 2011, J NEUROSCI RES, V89, P601, DOI 10.1002/jnr.22581; Sayre LM, 2008, CHEM RES TOXICOL, V21, P172, DOI 10.1021/tx700210j; Schwab C, 2008, J ALZHEIMERS DIS, V13, P359; Shang LS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010092; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Smith DG, 2007, BBA-BIOMEMBRANES, V1768, P1976, DOI 10.1016/j.bbamem.2007.02.002; Tejada-Simon MV, 2005, MOL CELL NEUROSCI, V29, P97, DOI 10.1016/j.mcn.2005.01.007; Toda T, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/617974; Tomiyama T, 2010, J NEUROSCI, V30, P4845, DOI 10.1523/JNEUROSCI.5825-09.2010; Uchiyama S, 2006, J BIOL CHEM, V281, P31713, DOI 10.1074/jbc.M603422200; Umeda T, 2011, J NEUROSCI RES, V89, P1031, DOI 10.1002/jnr.22640; Varadarajan S, 2000, J STRUCT BIOL, V130, P184, DOI 10.1006/jsbi.2000.4274; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wang J, 2005, J NEUROCHEM, V93, P953, DOI 10.1111/j.1471-4159.2005.03053.x; Xia WM, 2009, ARCH NEUROL-CHICAGO, V66, P190, DOI 10.1001/archneurol.2008.565; Yoon EJ, 2009, EXP MOL MED, V41, P611, DOI 10.3858/emm.2009.41.9.067; Yoshida T, 2005, J CLIN INVEST, V115, P2793, DOI 10.1172/JCI24635	71	174	177	0	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2011	286	52					44557	44568		10.1074/jbc.M111.279208	http://dx.doi.org/10.1074/jbc.M111.279208			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870CA	22072713	Green Published, hybrid			2022-12-27	WOS:000298645500027
J	Sangwan, V; Abella, J; Lai, A; Bertos, N; Stuible, M; Tremblay, ML; Park, M				Sangwan, Veena; Abella, Jasmine; Lai, Andrea; Bertos, Nicholas; Stuible, Matthew; Tremblay, Michel L.; Park, Morag			Protein-tyrosine Phosphatase 1B Modulates Early Endosome Fusion and Trafficking of Met and Epidermal Growth Factor Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ETHYLMALEIMIDE-SENSITIVE FACTOR; SIGNAL-TRANSDUCTION; DOWN-REGULATION; INSULIN SENSITIVITY; VESICLE FUSION; PTP1B; ENDOCYTOSIS; KINASE; PHOSPHORYLATION; INHIBITION	The endoplasmic reticulum-localized non-receptor protein-tyrosine phosphatase 1B (PTP1B) is associated with oncogenic, metabolic, and cytokine-related signaling and functionally targets multiple receptor tyrosine kinases (RTKs) for dephosphorylation. Loss of PTP1B activity leads to enhanced ligand-dependent biological activity of the Met RTK among others. Here, we demonstrate that knockdown of PTP1B or expression of a PTP1B trapping aspartic acid-to-alanine substitution (D/A) mutant delayed ligand-induced degradation of the Met and EGF RTKs. Loss of PTP1B function abrogated trafficking of Met and EGF receptor to Rab5- and phosphatidylinositol 3-phosphate (P13P)-positive early endosomes and subsequent trafficking through the degradative pathway. Under these conditions, internalization of the Met and EGF receptors was unaltered, suggesting a block at the level of early endosome formation. We show that the N-ethylmaleimide-sensitive factor (NSF), an essential component of the vesicle fusion machinery, was hyperphosphorylated in PTP1B knockdown or PTP1B D/A-expressing cells and was a target for PTP1B. NSF knockdown phenocopied PTP1B knockdown, demonstrating a mechanism through which PTP1B regulates endocytic trafficking. Finally, we show that PTP1B dephosphorylated NSF and that this interaction was required for physiological RTK trafficking and appropriate attenuation of downstream signaling.	[Sangwan, Veena; Abella, Jasmine; Lai, Andrea; Bertos, Nicholas; Stuible, Matthew; Tremblay, Michel L.; Park, Morag] McGill Univ, Dept Biochem, Montreal, PQ H3A 1A1, Canada; [Sangwan, Veena; Abella, Jasmine; Lai, Andrea; Bertos, Nicholas; Stuible, Matthew; Park, Morag] McGill Univ, Dept Med, Montreal, PQ H3A 1A1, Canada; [Park, Morag] McGill Univ, Dept Oncol, Montreal, PQ H3A 1A1, Canada; [Sangwan, Veena; Abella, Jasmine; Lai, Andrea; Bertos, Nicholas; Stuible, Matthew; Tremblay, Michel L.; Park, Morag] McGill Univ, Goodman Canc Res Ctr, Montreal, PQ H3G 1Y6, Canada	McGill University; McGill University; McGill University; McGill University	Park, M (corresponding author), Rosalind & Morris Goodman Canc Res Ctr, Rm 511,1160 Pine Ave W, Montreal, PQ H3A 1A3, Canada.	morag.park@mcgill.ca			Cancer Research Society; Terry Fox Foundation; United States Department of Defense Breast Cancer Research Initiative [DAMD17-99-1-9284]; Canadian Institutes of Health Research [MOP-62887, MOP-1154]	Cancer Research Society; Terry Fox Foundation; United States Department of Defense Breast Cancer Research Initiative(United States Department of Defense); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported in part by fellowships from the Cancer Research Society and the Terry Fox Foundation (to V. S.), United States Department of Defense Breast Cancer Research Initiative Grant DAMD17-99-1-9284 (to J. A.), and Canadian Institutes of Health Research Operating Grants MOP-62887 (to M. L. T.) and MOP-1154 (to M. P.).	Abella JV, 2009, AM J PHYSIOL-ENDOC M, V296, pE973, DOI 10.1152/ajpendo.90857.2008; Abella JV, 2005, MOL CELL BIOL, V25, P9632, DOI 10.1128/MCB.25.21.9632-9645.2005; Andreeva AV, 2006, EXPERT OPIN THER TAR, V10, P723, DOI 10.1517/14728222.10.5.723; BLOCK MR, 1988, P NATL ACAD SCI USA, V85, P7852, DOI 10.1073/pnas.85.21.7852; Cheng A, 2002, EUR J BIOCHEM, V269, P1050, DOI 10.1046/j.0014-2956.2002.02756.x; Dube N, 2005, CANCER RES, V65, P10088, DOI 10.1158/0008-5472.CAN-05-1353; Eden ER, 2010, NAT CELL BIOL, V12, P267, DOI 10.1038/ncb2026; Eden ER, 2009, BIOCHEM SOC T, V37, P173, DOI 10.1042/BST0370173; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; Galic S, 2005, MOL CELL BIOL, V25, P819, DOI 10.1128/MCB.25.2.819-829.2005; Galic S, 2003, MOL CELL BIOL, V23, P2096, DOI 10.1128/MCB.23.6.2096-2108.2003; Haj FG, 2002, SCIENCE, V295, P1708, DOI 10.1126/science.1067566; Hammond DE, 2004, CURR TOP MICROBIOL, V286, P21; Hammond DE, 2003, MOL BIOL CELL, V14, P1346, DOI 10.1091/mbc.E02-09-0578; Hammond DE, 2001, ONCOGENE, V20, P2761, DOI 10.1038/sj.onc.1204475; Heinrich R, 2002, MOL CELL, V9, P957, DOI 10.1016/S1097-2765(02)00528-2; Hornberg JJ, 2005, FEBS J, V272, P244, DOI 10.1111/j.1432-1033.2004.04404.x; Huynh H, 2004, NAT CELL BIOL, V6, P831, DOI 10.1038/ncb1164; Julien SG, 2007, NAT GENET, V39, P338, DOI 10.1038/ng1963; Klaman LD, 2000, MOL CELL BIOL, V20, P5479, DOI 10.1128/MCB.20.15.5479-5489.2000; Kong-Beltran M, 2006, CANCER RES, V66, P283, DOI 10.1158/0008-5472.CAN-05-2749; Kulas DT, 1996, J BIOL CHEM, V271, P748, DOI 10.1074/jbc.271.2.748; Levkowitz G, 1998, GENE DEV, V12, P3663, DOI 10.1101/gad.12.23.3663; Littleton JT, 2001, P NATL ACAD SCI USA, V98, P12233, DOI 10.1073/pnas.221450198; Machide M, 2006, J BIOL CHEM, V281, P8765, DOI 10.1074/jbc.M512298200; Matveeva EA, 2001, J BIOL CHEM, V276, P12174, DOI 10.1074/jbc.M007394200; Meng TC, 2002, MOL CELL, V9, P387, DOI 10.1016/S1097-2765(02)00445-8; Mills IG, 1999, MOL MEMBR BIOL, V16, P73, DOI 10.1080/096876899294788; Nakagawa Y, 2005, ZOOL SCI, V22, P169, DOI 10.2108/zsj.22.169; Nievergall E, 2010, J CELL BIOL, V191, P1189, DOI 10.1083/jcb.201005035; Palka HL, 2003, J BIOL CHEM, V278, P5728, DOI 10.1074/jbc.M210656200; Peschard P, 2001, MOL CELL, V8, P995, DOI 10.1016/S1097-2765(01)00378-1; Peschard P, 2003, CANCER CELL, V3, P519, DOI 10.1016/S1535-6108(03)00136-3; Pestana ES, 1999, ONCOGENE, V18, P4069, DOI 10.1038/sj.onc.1202794; Reynolds AR, 2003, NAT CELL BIOL, V5, P447, DOI 10.1038/ncb981; RODRIGUES GA, 1991, MOL CELL BIOL, V11, P2962, DOI 10.1128/MCB.11.6.2962; RODRIGUEZ L, 1994, MOL BIOL CELL, V5, P773, DOI 10.1091/mbc.5.7.773; Salmeen A, 2003, NATURE, V423, P769, DOI 10.1038/nature01680; Sangwan V, 2006, J BIOL CHEM, V281, P221, DOI 10.1074/jbc.M507858200; Sangwan V, 2008, J BIOL CHEM, V283, P34374, DOI 10.1074/jbc.M805916200; Schmidt-Arras DE, 2005, MOL CELL BIOL, V25, P3690, DOI 10.1128/MCB.25.9.3690-3703.2005; Seely BL, 1996, DIABETES, V45, P1379, DOI 10.2337/diabetes.45.10.1379; Sollner TH, 1996, EXPERIENTIA, V52, P1021; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; Sorkin A, 2009, EXP CELL RES, V315, P683, DOI [10.1016/j.yexcr.2008.07.029, 10.1016/j.yexcr.2008.08.013]; Steele-Mortimer O, 1999, CELL MICROBIOL, V1, P33, DOI 10.1046/j.1462-5822.1999.00003.x; Stuible M, 2008, CANCER METAST REV, V27, P215, DOI 10.1007/s10555-008-9115-1; Stuible M, 2010, J BIOL CHEM, V285, P23899, DOI 10.1074/jbc.M110.115295; Tenev T, 1997, J BIOL CHEM, V272, P5966, DOI 10.1074/jbc.272.9.5966; Tonks NK, 2003, FEBS LETT, V546, P140, DOI 10.1016/S0014-5793(03)00603-3; Vieira AV, 1996, SCIENCE, V274, P2086, DOI 10.1126/science.274.5295.2086; Waterman H, 2002, EMBO J, V21, P303, DOI 10.1093/emboj/21.3.303; YANG XM, 1993, DEV BIOL, V157, P308, DOI 10.1006/dbio.1993.1137; Zarelli VEP, 2009, J BIOL CHEM, V284, P10491, DOI 10.1074/jbc.M807614200	55	25	25	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2011	286	52					45000	45013		10.1074/jbc.M111.270934	http://dx.doi.org/10.1074/jbc.M111.270934			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870CA	22045810	Green Published, hybrid			2022-12-27	WOS:000298645500068
J	Alam, S; Li, HL; Margariti, A; Martin, D; Zampetaki, A; Habi, O; Cockerill, G; Hu, YH; Xu, QB; Zeng, LF				Alam, Saydul; Li, Hongling; Margariti, Andriana; Martin, Daniel; Zampetaki, Anna; Habi, Ouassila; Cockerill, Gillian; Hu, Yanhua; Xu, Qingbo; Zeng, Lingfang			Galectin-9 Protein Expression in Endothelial Cells Is Positively Regulated by Histone Deacetylase 3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; KAPPA-B; T-CELL; TIM-3; MICE; ACETYLATION; INHIBITORS; MONOCYTES; PROLONGS; IMMUNITY	Galectin-9 expression in endothelial cells can be induced in response to inflammation. However, the mechanism of its expression remains unclear. In this study, we found that interferon-gamma (IFN-gamma) induced galectin-9 expression in human endothelial cells in a time-dependent manner, which coincided with the activation of histone deacetylase (HDAC). When endothelial cells were treated with the HDAC3 inhibitor, apicidin, or shRNA-HDAC3 knockdown, IFN-gamma-induced galectin-9 expression was abolished. Overexpression of HDAC3 induced the interaction between phosphoinositol 3-kinase (PI3K) and IFN response factor 3 (IRF3), leading to IRF3 phosphorylation, nuclear translocation, and galectin-9 expression. HDAC3 functioned as a scaffold protein for PI3K/IRF3 interaction. In addition to galectin-9 expression, IFN-gamma also induced galectin-9 location onto plasma membrane, which was HDAC3-independent. Importantly, HDAC3 was essential for the constitutive transcription of PI3K and IRF3, which might be responsible for the basal level of galectin-9 expression. The phosphorylation of IRF3 was essential for galectin-9 expression. This study provides new evidence that HDAC3 regulates galectin-9 expression in endothelial cells via interaction with PI3K-IRF3 signal pathway.	[Alam, Saydul; Li, Hongling; Margariti, Andriana; Martin, Daniel; Zampetaki, Anna; Habi, Ouassila; Hu, Yanhua; Xu, Qingbo; Zeng, Lingfang] Kings Coll London, Div Cardiovasc, British Heart Founcat Ctr, London SE5 9NU, England; [Cockerill, Gillian] St Georges Univ London, Dept Cardiovasc Sci, London SW17 0RE, England	University of London; King's College London; St Georges University London	Zeng, LF (corresponding author), Kings Coll London, Div Cardiovasc, British Heart Founcat Ctr, 125 Cold Harbour La, London SE5 9NU, England.	lingfang.zeng@kcl.ac.uk	Margariti, Andriana/AAH-5318-2019	Zampetaki, Anna/0000-0002-7257-8624; Zeng, Lingfang/0000-0002-0390-4561	British Heart Foundation; Oak Foundation	British Heart Foundation(British Heart Foundation); Oak Foundation	This work was supported by grants from British Heart Foundation and Oak Foundation.	Arikawa T, 2010, EUR J IMMUNOL, V40, P548, DOI 10.1002/eji.200939886; Chagan-Yasutan Haorile, 2010, Clin Mol Allergy, V8, P12, DOI 10.1186/1476-7961-8-12; Fischle W, 2001, J BIOL CHEM, V276, P35826, DOI 10.1074/jbc.M104935200; Gray SG, 2001, EXP CELL RES, V262, P75, DOI 10.1006/excr.2000.5080; Gregoire S, 2007, MOL CELL BIOL, V27, P1280, DOI 10.1128/MCB.00882-06; He WT, 2009, TRANSPLANTATION, V88, P782, DOI 10.1097/TP.0b013e3181b47f25; Hirofumi A, 2002, J IMMUNOL, V169, P5912, DOI 10.4049/jimmunol.169.10.5912; Imaizumi T, 2003, INT ARCH ALLERGY IMM, V131, P57, DOI 10.1159/000070436; Imaizumi T, 2002, J LEUKOCYTE BIOL, V72, P486; Imaizumi T, 2007, GLYCOBIOLOGY, V17, p12C, DOI 10.1093/glycob/cwm045; Inoue K, 2006, ARTERIOSCL THROM VAS, V26, P2652, DOI 10.1161/01.ATV.0000247247.89787.e7; Irie A, 2005, CLIN CANCER RES, V11, P2962, DOI 10.1158/1078-0432.CCR-04-0861; Jayaraman P, 2010, J EXP MED, V207, P2343, DOI 10.1084/jem.20100687; Jung SB, 2010, CIRC RES, V107, P877, DOI 10.1161/CIRCRESAHA.110.222968; Kirshner JR, 2005, J VIROL, V79, P9320, DOI 10.1128/JVI.79.14.9320-9324.2005; Leffler H, 2002, GLYCOCONJUGATE J, V19, P433, DOI 10.1023/B:GLYC.0000014072.34840.04; Longworth MS, 2006, ONCOGENE, V25, P4495, DOI 10.1038/sj.onc.1209473; Matsumoto R, 1998, J BIOL CHEM, V273, P16976, DOI 10.1074/jbc.273.27.16976; Matsuura A, 2009, GENES CELLS, V14, P511, DOI 10.1111/j.1365-2443.2009.01287.x; Matteucci E, 2007, MOL CANCER RES, V5, P833, DOI 10.1158/1541-7786.MCR-07-0054; Montgomery RL, 2008, J CLIN INVEST, V118, P3588, DOI 10.1172/JCI35847; Norling LV, 2009, J ENDOCRINOL, V201, P169, DOI 10.1677/JOE-08-0512; Ozaki T, 2009, BIOCHEM BIOPH RES CO, V386, P207, DOI 10.1016/j.bbrc.2009.06.035; Savitsky D, 2010, CANCER IMMUNOL IMMUN, V59, P489, DOI 10.1007/s00262-009-0804-6; Seki M, 2008, CLIN IMMUNOL, V127, P78, DOI 10.1016/j.clim.2008.01.006; Strobl JS, 2007, J PARASITOL, V93, P694, DOI 10.1645/GE-1043R.1; Su EW, 2011, GLYCOBIOLOGY, V21, P1258, DOI 10.1093/glycob/cwq214; Tsuboi Y, 2007, CLIN IMMUNOL, V124, P221, DOI 10.1016/j.clim.2007.04.015; Wada J, 1997, J CLIN INVEST, V99, P2452, DOI 10.1172/JCI119429; Wang F, 2007, CELL IMMUNOL, V250, P68, DOI 10.1016/j.cellimm.2008.01.006; Wang F, 2009, IMMUNOBIOLOGY, V214, P342, DOI 10.1016/j.imbio.2008.10.007; Wang JG, 2007, J BIOL CHEM, V282, P28408, DOI 10.1074/jbc.M703586200; Xiao QZ, 2006, ARTERIOSCL THROM VAS, V26, P2244, DOI 10.1161/01.ATV.0000240251.50215.50; Xu HG, 2010, MOL BIOL REP, V37, P3073, DOI 10.1007/s11033-009-9880-0; Yang Ri-Yao, 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000719; Yang WM, 2002, J BIOL CHEM, V277, P9447, DOI 10.1074/jbc.M105993200; Zampetaki A, 2010, CIRCULATION, V121, P132, DOI 10.1161/CIRCULATIONAHA.109.890491; Zeng LF, 2006, J CELL BIOL, V174, P1059, DOI 10.1083/jcb.200605113; Zhang MX, 2008, MOL BIOL CELL, V19, P3997, DOI 10.1091/mbc.E07-11-1186; Zhao Y, 2006, GLIA, V54, P775, DOI 10.1002/glia.20418; Zhu C, 2005, NAT IMMUNOL, V6, P1245, DOI 10.1038/ni1271	41	36	39	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2011	286	51					44211	44217		10.1074/jbc.M111.242289	http://dx.doi.org/10.1074/jbc.M111.242289			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866SH	22027828	hybrid, Green Published			2022-12-27	WOS:000298402300061
J	Lohman, GJS; Chen, LX; Evans, TC				Lohman, Gregory J. S.; Chen, Lixin; Evans, Thomas C., Jr.			Kinetic Characterization of Single Strand Break Ligation in Duplex DNA by T4 DNA Ligase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASE-PAIRED ENDS; DEOXYRIBONUCLEIC ACID; ENZYMATIC BREAKAGE; POLYNUCLEOTIDE LIGASE; MUTATIONAL ANALYSIS; NICK RECOGNITION; ADENYLATE INTERMEDIATE; RNA LIGASES; MECHANISM; BACTERIOPHAGE	T4 DNA ligase catalyzes phosphodiester bond formation between juxtaposed 5'-phosphate and 3'-hydroxyl termini in duplex DNA in three steps: 1) enzyme-adenylylate formation by reaction with ATP; 2) adenylyl transfer to a 5'-phosphorylated polynucleotide to generate adenylylated DNA; and 3) phosphodiester bond formation with release of AMP. This investigation used synthetic, nicked DNA substrates possessing either a 5'-phosphate or a 5'-adenylyl phosphate. Steady state experiments with a nicked substrate containing juxtaposed dC and 5'-phosphorylated dT deoxynucleotides (substrate 1) yielded k(cat) and k(cat)/K-m values of 0.4 +/- 0.1 s(-1) and 150 +/- 50 mu M-1 s(-1), respectively. Under identical reaction conditions, turnover of an adenylylated version of this substrate (substrate 1A) yielded k(cat) and k(cat)/K-m values of 0.64 +/- 0.08 s(-1) and 240 +/- 40 mu M-1 s(-1). Single turnover experiments utilizing substrate 1 gave fits for the forward rates of Step 2 (k(2)) and Step 3 (k(3)) of 5.3 and 38 s(-1), respectively, with the slowest step similar to 10-fold faster than the rate of turnover seen under steady state conditions. Single turnover experiments with substrate 1A produced a Step 3 forward rate constant of 4.3 s(-1), also faster than the turnover rate of 1A. Enzyme self-adenylylation was confirmed to also occur on a fast time scale (similar to 6 s(-1)), indicating that the rate-limiting step for T4 DNA ligase nick sealing is not a chemical step but rather is most likely product release. Pre-steady state reactions displayed a clear burst phase, consistent with this conclusion.	[Lohman, Gregory J. S.; Chen, Lixin; Evans, Thomas C., Jr.] New England Biolabs Inc, Ipswich, MA 01938 USA	New England Biolabs	Evans, TC (corresponding author), New England Biolabs Inc, 240 Cty Rd, Ipswich, MA 01938 USA.	evanst@neb.com		Lohman, Gregory/0000-0002-0638-7555				Cherepanov A, 2001, J BIOCHEM-TOKYO, V129, P61, DOI 10.1093/oxfordjournals.jbchem.a002837; Cherepanov AV, 2008, P NATL ACAD SCI USA, V105, P8563, DOI 10.1073/pnas.0709140105; Cherepanov AV, 2003, EUR J BIOCHEM, V270, P4315, DOI 10.1046/j.1432-1033.2003.03824.x; Cherepanov AV, 2002, J BIOL CHEM, V277, P1695, DOI 10.1074/jbc.M109616200; Cherepanov AV, 2001, BIOPHYS J, V81, P3545, DOI 10.1016/S0006-3495(01)75985-1; Chiuman W, 2002, BIOORG CHEM, V30, P332, DOI 10.1016/S0045-2068(02)00018-4; Cotner-Gohara E, 2008, J BIOL CHEM, V283, P10764, DOI 10.1074/jbc.M708175200; Cotner-Gohara E, 2010, BIOCHEMISTRY-US, V49, P6165, DOI 10.1021/bi100503w; Crut A, 2008, P NATL ACAD SCI USA, V105, P6894, DOI 10.1073/pnas.0800113105; DEUGAU KV, 1978, BIOCHEMISTRY-US, V17, P723, DOI 10.1021/bi00597a026; HARVEY CL, 1971, J BIOL CHEM, V246, P4523; HAYASHI KI, 1985, NUCLEIC ACIDS RES, V13, P7979, DOI 10.1093/nar/13.22.7979; Johnson KA, 2009, METHOD ENZYMOL, V467, P601, DOI 10.1016/S0076-6879(09)67023-3; Johnson KA, 2009, ANAL BIOCHEM, V387, P20, DOI 10.1016/j.ab.2008.12.024; Lohman G. J. S., 2011, CURR PROTOC MOL BIOL; MONTECUCCO A, 1988, NUCLEIC ACIDS RES, V16, P7369, DOI 10.1093/nar/16.15.7369; Nair PA, 2007, NAT STRUCT MOL BIOL, V14, P770, DOI 10.1038/nsmb1266; Nandakumar J, 2007, MOL CELL, V26, P257, DOI 10.1016/j.molcel.2007.02.026; Odell M, 2003, NUCLEIC ACIDS RES, V31, P5090, DOI 10.1093/nar/gkg665; Pascal JM, 2004, NATURE, V432, P473, DOI 10.1038/nature03082; Pascal JM, 2008, CURR OPIN STRUC BIOL, V18, P96, DOI 10.1016/j.sbi.2007.12.008; Patel MP, 2008, BIOORG CHEM, V36, P46, DOI 10.1016/j.bioorg.2007.10.001; Rossi R, 1997, NUCLEIC ACIDS RES, V25, P2106, DOI 10.1093/nar/25.11.2106; Samai P, 2011, J BIOL CHEM, V286, P22642, DOI 10.1074/jbc.M111.245399; Sannai P, 2011, J BIOL CHEM, V286, P13314, DOI 10.1074/jbc.M111.226191; SGARAMELLA V, 1972, FARMACO-ED SCI, V27, P809; Shuman S, 1995, BIOCHEMISTRY-US, V34, P16138, DOI 10.1021/bi00049a029; Shuman S, 2009, J BIOL CHEM, V284, P17365, DOI 10.1074/jbc.R900017200; Sogaramella V, 1972, J Mol Biol, V72, P493; Sriskanda V, 1998, NUCLEIC ACIDS RES, V26, P525, DOI 10.1093/nar/26.2.525; Sriskanda V, 1999, NUCLEIC ACIDS RES, V27, P3953, DOI 10.1093/nar/27.20.3953; Sriskanda V, 1998, NUCLEIC ACIDS RES, V26, P4618, DOI 10.1093/nar/26.20.4618; Sriskanda V, 2002, NUCLEIC ACIDS RES, V30, P903, DOI 10.1093/nar/30.4.903; Taylor MR, 2011, J BIOL CHEM, V286, P23054, DOI 10.1074/jbc.M111.248831; Tomkinson AE, 2006, CHEM REV, V106, P687, DOI 10.1021/cr040498d; Vollmer M, 2009, METHODS MOL BIOL, V544, P3, DOI 10.1007/978-1-59745-483-4_1; Wang Y, 2007, BIOCHEMISTRY-US, V46, P4962, DOI 10.1021/bi0621516; WEISS B, 1968, J BIOL CHEM, V243, P4543; WEISS B, 1967, J BIOL CHEM, V242, P4270; WEISS B, 1967, P NATL ACAD SCI USA, V57, P1021, DOI 10.1073/pnas.57.4.1021; WU DY, 1989, GENE, V76, P245, DOI 10.1016/0378-1119(89)90165-0; Yuan CL, 2007, NUCLEIC ACIDS RES, V35, P5294, DOI 10.1093/nar/gkm582; Zhelkovsky AM, 2011, NUCLEIC ACIDS RES, V39, pE117, DOI 10.1093/nar/gkr544	43	28	31	2	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2011	286	51					44187	44196		10.1074/jbc.M111.284992	http://dx.doi.org/10.1074/jbc.M111.284992			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866SH	22027837	Green Published, hybrid			2022-12-27	WOS:000298402300059
J	Luchsinger, LL; Patenaude, CA; Smith, BD; Layne, MD				Luchsinger, Larry L.; Patenaude, Cassandra A.; Smith, Barbara D.; Layne, Matthew D.			Myocardin-related Transcription Factor-A Complexes Activate Type I Collagen Expression in Lung Fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERUM-RESPONSE FACTOR; GROWTH-FACTOR-BETA; EXTRACELLULAR-MATRIX SYNTHESIS; IDIOPATHIC PULMONARY FIBROSIS; MUSCLE ALPHA-ACTIN; GENE-EXPRESSION; POSTTRANSCRIPTIONAL REGULATION; DEPENDENT TRANSCRIPTION; COL1A2 TRANSCRIPTION; MECHANICAL-STRESS	Pulmonary fibrosis is characterized by the excessive deposition of a collagen-rich extracellular matrix. The accumulation of collagen within the lung interstitium leads to impaired respiratory function. Furthermore, smooth muscle actin-positive myofibroblasts within the fibrotic lung contribute to disease progression. Because collagen and smooth muscle cell alpha-actin are coordinately expressed in the setting of fibrosis, the hypothesis was tested that specific transcriptional regulators of the myocardin family might also regulate collagen gene expression in myofibroblasts. Myocardin-related transcription factors (MRTFs), through their interaction with the serum-response factor (SRF) on CArG box regulatory elements (CC(A/T)(6)GG), are important regulators of myofibroblast differentiation. MRTF-A transactivated type I collagen gene reporters as much as 100-fold in lung myofibroblasts. Loss of functional MRTF-A using either a dominant negative MRTF-A isoform, shRNA targeting MRTF-A, or genetic deletion of MRTF-A in lung fibroblasts significantly disrupted type I collagen synthesis relative to controls. Analysis of the COL1A2 proximal promoter revealed a noncanonical CArG box (CCAAACTTGG), flanked by several Sp1 sites important for MRTF-A activation. Chromatin immunoprecipitation experiments confirmed the co-localization of MRTF-A, SRF, and Sp1 bound to the same region of the COL1A2 promoter. Mutagenesis of either the noncanonical CArG box or the Sp1 sites significantly disrupted MRTF-A activation of COL1A2. Together, our findings show that MRTF-A is an important regulator of collagen synthesis in lung fibroblasts and exhibits a dependence on both SRF and Sp1 function to enhance collagen expression.	[Luchsinger, Larry L.; Patenaude, Cassandra A.; Smith, Barbara D.; Layne, Matthew D.] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA	Boston University	Smith, BD (corresponding author), 72 E Concord St,K420, Boston, MA 02118 USA.	bdsmith@bu.edu; mlayne@bu.edu		Layne, Matthew/0000-0003-0007-4870; Smith, Barbara/0000-0002-5375-7627	National Institutes of Health [HL68094, HL078869, T32 HL007969]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068094, R01HL078869, T32HL007969] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL68094 (to B. D. S.) and HL078869 (to M. D. L.).; Supported by National Institutes of Health Grant T32 HL007969.	ADLER KB, 1989, LAB INVEST, V60, P473; BLUME SW, 1991, J CLIN INVEST, V88, P1613, DOI 10.1172/JCI115474; Cen B, 2003, MOL CELL BIOL, V23, P6597, DOI 10.1128/MCB.23.18.6597-6608.2003; Chan MWC, 2010, J BIOL CHEM, V285, P9273, DOI 10.1074/jbc.M109.075218; Chen CH, 2010, ARTERIOSCL THROM VAS, V30, P835, DOI 10.1161/ATVBAHA.109.197251; Chen SJ, 1999, J INVEST DERMATOL, V112, P49, DOI 10.1046/j.1523-1747.1999.00477.x; Chin MT, 1998, J BIOL CHEM, V273, P9755, DOI 10.1074/jbc.273.16.9755; Chiquet M, 1996, BIOCHEM CELL BIOL, V74, P737, DOI 10.1139/o96-080; Chung KY, 1996, J BIOL CHEM, V271, P3272, DOI 10.1074/jbc.271.6.3272; COUREY AJ, 1988, CELL, V55, P887, DOI 10.1016/0092-8674(88)90144-4; Cushing L, 2011, AM J RESP CELL MOL, V45, P287, DOI 10.1165/rcmb.2010-0323OC; Czuwara-Ladykowska J, 2002, J BIOL CHEM, V277, P20399, DOI 10.1074/jbc.M200206200; Czuwara-Ladykowska J, 2001, J BIOL CHEM, V276, P20839, DOI 10.1074/jbc.M010133200; Davis-Dusenbery BN, 2011, J BIOL CHEM, V286, P28097, DOI 10.1074/jbc.M111.236950; Du H, 2010, HYPERTENS RES, V33, P37, DOI 10.1038/hr.2009.173; Elferink CJ, 1996, BIOTECHNIQUES, V20, P470; EVANS JN, 1982, AM REV RESPIR DIS, V125, P89; Fan LZ, 2007, MOL BIOL CELL, V18, P1083, DOI 10.1091/mbc.E06-07-0602; Galera P, 1996, J BIOL CHEM, V271, P21331, DOI 10.1074/jbc.271.35.21331; Greenwel P, 2000, MOL CELL BIOL, V20, P912, DOI 10.1128/MCB.20.3.912-918.2000; Hendrix JA, 2005, J CLIN INVEST, V115, P418, DOI 10.1172/JCI200522648; Hinson JS, 2007, AM J PHYSIOL-HEART C, V292, pH1170, DOI 10.1152/ajpheart.00864.2006; Iwasaki K, 2008, J BIOL CHEM, V283, P21230, DOI 10.1074/jbc.M710525200; Jordan JD, 2000, CELL, V103, P193, DOI 10.1016/S0092-8674(00)00112-4; KARSENTY G, 1990, J BIOL CHEM, V265, P9934; KUHN C, 1991, AM J PATHOL, V138, P1257; Kuwahara K, 2005, MOL CELL BIOL, V25, P3173, DOI 10.1128/MCB.25.8.3173-3181.2005; Kuwahara K, 2010, MOL CELL BIOL, V30, P4134, DOI 10.1128/MCB.00154-10; Layne MD, 2002, CIRC RES, V90, P728, DOI 10.1161/01.RES.0000013289.97650.C8; Lee SM, 2010, J BIOL CHEM, V285, P22036, DOI 10.1074/jbc.M110.108878; LEUNG S, 1989, NUCLEIC ACIDS RES, V17, P1177, DOI 10.1093/nar/17.3.1177; Li SJ, 2006, MOL CELL BIOL, V26, P5797, DOI 10.1128/MCB.00211-06; Liao XH, 2011, IUBMB LIFE, V63, P54, DOI 10.1002/iub.415; Lindquist JN, 2000, AM J PHYSIOL-GASTR L, V279, pG471, DOI 10.1152/ajpgi.2000.279.3.G471; Mack CP, 2005, J THROMB HAEMOST, V3, P1976, DOI 10.1111/j.1538-7836.2005.01316.x; MAITY SN, 1988, SCIENCE, V241, P582, DOI 10.1126/science.3399893; Medjkane S, 2009, NAT CELL BIOL, V11, P257, DOI 10.1038/ncb1833; Miano JM, 2003, J MOL CELL CARDIOL, V35, P577, DOI 10.1016/S0022-2828(03)00110-X; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Morita T, 2007, J CELL BIOL, V179, P1027, DOI 10.1083/jcb.200708174; Morita T, 2007, EXP CELL RES, V313, P3432, DOI 10.1016/j.yexcr.2007.07.008; NEHLS MC, 1993, J CLIN INVEST, V92, P2916, DOI 10.1172/JCI116914; Olson EN, 2010, NAT REV MOL CELL BIO, V11, P353, DOI 10.1038/nrm2890; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Pawlowski R, 2010, EMBO J, V29, P3448, DOI 10.1038/emboj.2010.216; Pipes GCT, 2006, GENE DEV, V20, P1545, DOI 10.1101/gad.1428006; Poser S, 2000, EMBO J, V19, P4955, DOI 10.1093/emboj/19.18.4955; Ramirez F, 2006, MATRIX BIOL, V25, P365, DOI 10.1016/j.matbio.2006.05.002; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; RITZENTHALER JD, 1991, BIOCHEM J, V280, P157, DOI 10.1042/bj2800157; Sastry L, 2002, GENE THER, V9, P1155, DOI 10.1038/sj.gt.3301731; Sebe A, 2008, FEBS LETT, V582, P291, DOI 10.1016/j.febslet.2007.12.021; SELMAN M, 1986, THORAX, V41, P355, DOI 10.1136/thx.41.5.355; Sengupta P, 2005, J BIOL CHEM, V280, P21004, DOI 10.1074/jbc.M413191200; Sengupta PK, 2002, J BIOL CHEM, V277, P24926, DOI 10.1074/jbc.M111712200; SHORE P, 1995, EUR J BIOCHEM, V229, P1, DOI 10.1111/j.1432-1033.1995.tb20430.x; Sleiman SF, 2011, J NEUROSCI, V31, P6858, DOI 10.1523/JNEUROSCI.0710-11.2011; Small EM, 2010, CIRC RES, V107, P294, DOI 10.1161/CIRCRESAHA.110.223172; Stefanovic B, 1997, MOL CELL BIOL, V17, P5201, DOI 10.1128/MCB.17.9.5201; Stefanovic B, 2003, J BIOL CHEM, V278, P927, DOI 10.1074/jbc.M209175200; Stefanovic B, 2002, J BIOL CHEM, V277, P18229, DOI 10.1074/jbc.M108065200; Sun Y, 2006, MOL CELL BIOL, V26, P5809, DOI 10.1128/MCB.00024-06; TAMAKI T, 1995, J BIOL CHEM, V270, P4299, DOI 10.1074/jbc.270.9.4299; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Wilson MS, 2009, MUCOSAL IMMUNOL, V2, P103, DOI 10.1038/mi.2008.85; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Xu Y, 2004, J BIOL CHEM, V279, P41319, DOI 10.1074/jbc.M404174200; Xu Y, 2007, MOL IMMUNOL, V44, P1709, DOI 10.1016/j.molimm.2006.07.294; ZHANG K, 1994, AM J PATHOL, V145, P114; ZHANG K, 1995, AM J PATHOL, V147, P352; Zhang W, 2000, J BIOL CHEM, V275, P39237, DOI 10.1074/jbc.M003339200; Zhao XH, 2007, J CELL SCI, V120, P1801, DOI 10.1242/jcs.001586	73	91	94	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2011	286	51					44116	44125		10.1074/jbc.M111.276931	http://dx.doi.org/10.1074/jbc.M111.276931			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866SH	22049076	Green Published, hybrid			2022-12-27	WOS:000298402300052
J	Chang, CL; Wang, HS; Soong, YK; Huang, SY; Pai, SY; Hsu, SYT				Chang, Chia Lin; Wang, Hsin-Shih; Soong, Yung-Kuei; Huang, Shang Yu; Pai, Shun Yuan; Hsu, Sheau Yu Teddy			Regulation of Oocyte and Cumulus Cell Interactions by Intermedin/Adrenomedullin 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-DIFFERENTIATION FACTOR-9; OVARIAN FOLLICULAR DEVELOPMENT; EXPANSION-ENABLING FACTOR; PREANTRAL GRANULOSA-CELL; RECEPTOR-LIKE-RECEPTOR; GENE-EXPRESSION; MOUSE OOCYTES; IN-VITRO; MICE LACKING; INTERCELLULAR COMMUNICATION	Ovarian folliculogenesis has been studied as a model of hormonal regulation of development and differentiation, cell death, and cell-cell communication. In addition to gonadotropins from the pituitary and follicular paracrine factors, oocyte secreted factors have been shown to play critical roles in the regulation of follicular cell functions. Except for the well characterized BMP family proteins, including GDF9 and BMP15, oocytes are known to secrete oocyte secreted factors that are important for the regulation of cumulus cell survival and the maintenance of tertiary structure of cumulus cell-enclosed oocyte complexes (COCs). Based on genomic screening and studies of COCs cultured in vitro, we showed that intermedin (IMD)/adrenomedullin 2 (ADM2) is a novel oocyte-derived ligand important for the regulation of cell interactions in COCs that functions, in part, by suppressing cumulus cell apoptosis. Consistently, we showed that suppression of IMD/ADM2 signaling in growing rat ovaries in vivo leads to oocyte atresia and aberrant cell cycle progression in follicular cells. Together, our studies indicated that mammalian oocytes deploy a G protein-coupled receptor ligand to coordinate normal interactions of oocytes and cumulus cells and provided a better understanding of how the tertiary structure of a COC is maintained as follicles undergo exponential growth during the late stages of folliculogenesis.	[Chang, Chia Lin; Wang, Hsin-Shih; Soong, Yung-Kuei; Huang, Shang Yu; Pai, Shun Yuan] Chang Gung Univ, Chang Gung Mem Hosp, Linkou Med Ctr, Sch Med,Dept Obstet & Gynecol, Tao Yuan 333, Taiwan; [Hsu, Sheau Yu Teddy] Stanford Univ, Sch Med, Dept Obstet & Gynecol, Reprod Biol & Stem Cell Res Program, Stanford, CA 94305 USA	Chang Gung Memorial Hospital; Chang Gung University; Stanford University	Chang, CL (corresponding author), Chang Gung Univ, Chang Gung Mem Hosp, Linkou Med Ctr, Sch Med,Dept Obstet & Gynecol, 5 Fu Shin St, Tao Yuan 333, Taiwan.	amego@cgmh.org.tw; relaxinangel@gmail.com			National Institutes of Health [DK70652]; Avon Foundation [02-2009-054]; New Century Health Care Promotion Foundation, Taiwan [NCHCPF-94001]; Chang Gung Memorial Hospital [CMRPG34002]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070652] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Avon Foundation; New Century Health Care Promotion Foundation, Taiwan; Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK70652 (to S. Y. T. H.). This work was also supported by Avon Foundation Research Award 02-2009-054 (to S. Y. T. H.), New Century Health Care Promotion Foundation, Taiwan, Grant NCHCPF-94001 (to C. L. C.), and Chang Gung Memorial Hospital Grant CMRPG34002 (to C. L. C.).	ADASHI EY, 1985, ENDOCR REV, V6, P400, DOI 10.1210/edrv-6-3-400; Akiyama-Oda Y, 2003, DEVELOPMENT, V130, P1735, DOI 10.1242/dev.00390; BACHVAROVA R, 1980, J EXP ZOOL, V211, P159, DOI 10.1002/jez.1402110206; Bell D, 2008, BRIT J PHARMACOL, V153, pS247, DOI 10.1038/sj.bjp.0707494; Ben-Shlomo Izhar, 2003, Sci STKE, V2003, pRE9, DOI 10.1126/stke.2003.187.re9; Bruzzone R, 1996, EUR J BIOCHEM, V238, P1, DOI 10.1111/j.1432-1033.1996.0001q.x; BUCCIONE R, 1990, DEV BIOL, V138, P16, DOI 10.1016/0012-1606(90)90172-F; BUCCIONE R, 1990, BIOL REPROD, V43, P543, DOI 10.1095/biolreprod43.4.543; Byskov AG, 1997, MOL REPROD DEV, V46, P296, DOI 10.1002/(SICI)1098-2795(199703)46:3&lt;296::AID-MRD8&gt;3.0.CO;2-K; Canipari R, 2000, HUM REPROD UPDATE, V6, P279, DOI 10.1093/humupd/6.3.279; Chang CL, 2005, MOL ENDOCRINOL, V19, P2824, DOI 10.1210/me.2004-0191; Chang H, 2002, ENDOCR REV, V23, P787, DOI 10.1210/er.2002-0003; Clark HF, 2003, GENOME RES, V13, P2265, DOI 10.1101/gr.1293003; Dackor RT, 2006, MOL CELL BIOL, V26, P2511, DOI 10.1128/MCB.26.7.2511-2518.2006; De A, 2006, MOL ENDOCRINOL, V20, P2528, DOI 10.1210/me.2006-0028; Diaz FJ, 2007, DEV BIOL, V305, P300, DOI 10.1016/j.ydbio.2007.02.019; Diaz FJ, 2006, DEV BIOL, V299, P91, DOI 10.1016/j.ydbio.2006.07.012; Dong JW, 1996, NATURE, V383, P531, DOI 10.1038/383531a0; Elvin JA, 1999, MOL ENDOCRINOL, V13, P1035, DOI 10.1210/me.13.6.1035; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Eppig JJ, 2002, P NATL ACAD SCI USA, V99, P2890, DOI 10.1073/pnas.052658699; Eppig JJ, 2001, REPRODUCTION, V122, P829, DOI 10.1530/rep.0.1220829; FISCHER B, 1992, EUR J OBSTET GYN R B, V43, P39, DOI 10.1016/0028-2243(92)90241-P; Gilchrist RB, 2008, HUM REPROD UPDATE, V14, P159, DOI 10.1093/humupd/dmm040; Gilchrist RB, 2006, J CELL SCI, V119, P3811, DOI 10.1242/jcs.03105; GILULA NB, 1978, J CELL BIOL, V78, P58, DOI 10.1083/jcb.78.1.58; Grimmond SM, 2003, GENOME RES, V13, P1350, DOI 10.1101/gr.983703; GWATKIN RBL, 1976, LIFE SCI, V19, P527, DOI 10.1016/0024-3205(76)90232-0; HERLANDS RL, 1984, J EXP ZOOL, V229, P317, DOI 10.1002/jez.1402290217; HERNANDEZ ER, 1990, ENDOCRINOLOGY, V127, P2804, DOI 10.1210/endo-127-6-2804; Hernandez-Gonzalez I, 2006, MOL ENDOCRINOL, V20, P1300, DOI 10.1210/me.2005-0420; HILLENSJO T, 1976, ACTA PHYSIOL SCAND, V96, P558, DOI 10.1111/j.1748-1716.1976.tb10226.x; Hsueh AJW, 1996, RECENT PROG HORM RES, V51, P433; Juneja SC, 1999, BIOL REPROD, V60, P1263, DOI 10.1095/biolreprod60.5.1263; Kocabas AM, 2006, P NATL ACAD SCI USA, V103, P14027, DOI 10.1073/pnas.0603227103; Ma J, 2006, DEVELOPMENT, V133, P2053, DOI 10.1242/dev.02371; Matzuk MM, 2002, SCIENCE, V296, P2178, DOI 10.1126/science.1071965; McGee E, 1997, ENDOCRINOLOGY, V138, P2417, DOI 10.1210/en.138.6.2417; McKenzie LJ, 2004, HUM REPROD, V19, P2869, DOI 10.1093/humrep/deh535; McLatchie LM, 1998, NATURE, V393, P333, DOI 10.1038/30666; MILLER WA, 1973, FERTIL STERIL, V24, P609; MOOR RM, 1977, J REPROD FERTIL, V49, P101, DOI 10.1530/jrf.0.0490101; Neulen J, 1998, MOL HUM REPROD, V4, P203, DOI 10.1093/molehr/4.3.203; Pan H, 2005, DEV BIOL, V286, P493, DOI 10.1016/j.ydbio.2005.08.023; Pan H, 2008, DEV BIOL, V316, P397, DOI 10.1016/j.ydbio.2008.01.048; Pangas SA, 2005, BIOL REPROD, V73, P582, DOI 10.1095/biolreprod.105.042127; Pangas SA, 2007, MOL ENDOCRINOL, V21, P2458, DOI 10.1210/me.2007-0146; Park JY, 2004, SCIENCE, V303, P682, DOI 10.1126/science.1092463; Pfeil U, 2009, AM J PHYSIOL-LUNG C, V297, pL837, DOI 10.1152/ajplung.90608.2008; Potireddy S, 2006, DEV BIOL, V298, P155, DOI 10.1016/j.ydbio.2006.06.024; Richards JS, 2005, MOL CELL ENDOCRINOL, V234, P75, DOI 10.1016/j.mce.2005.01.004; Richards JS, 2002, ANNU REV PHYSIOL, V64, P69, DOI 10.1146/annurev.physiol.64.081501.131029; RICHARDS JS, 1994, ENDOCR REV, V15, P725, DOI 10.1210/er.15.6.725; Roberts AE, 2007, BIOL REPROD, V76, P218, DOI 10.1095/biolreprod.106.050880; Roh J, 2004, J BIOL CHEM, V279, P7264, DOI 10.1074/jbc.M305332200; SALUSTRI A, 1989, J BIOL CHEM, V264, P13840; SALUSTRI A, 1990, DEV BIOL, V138, P26, DOI 10.1016/0012-1606(90)90173-G; Sela-Abramovich S, 2006, ENDOCRINOLOGY, V147, P2280, DOI 10.1210/en.2005-1011; Shimasaki S, 1999, P NATL ACAD SCI USA, V96, P7282, DOI 10.1073/pnas.96.13.7282; Shravage BV, 2007, DEVELOPMENT, V134, P2261, DOI 10.1242/dev.02856; Sicinski P, 1996, NATURE, V384, P470, DOI 10.1038/384470a0; Simon AM, 1997, NATURE, V385, P525, DOI 10.1038/385525a0; Smith RS, 2009, AM J PHYSIOL-HEART C, V297, pH1040, DOI 10.1152/ajpheart.00404.2009; Su YQ, 2007, DEV BIOL, V302, P104, DOI 10.1016/j.ydbio.2006.09.008; Su YQ, 2004, DEV BIOL, V276, P64, DOI 10.1016/j.ydbio.2004.08.020; Sugiura K, 2005, DEV BIOL, V279, P20, DOI 10.1016/j.ydbio.2004.11.027; Sugiura K, 2007, DEVELOPMENT, V134, P2593, DOI 10.1242/dev.006882; Takei Y, 2004, FEBS LETT, V556, P53, DOI 10.1016/S0014-5793(03)01368-1; Thibault C., 1973, The regulation of mammalian reproduction., P231; THIBAULT C, 1975, J REPROD FERTIL, V45, P605, DOI 10.1530/jrf.0.0450605; THIBAULT C, 1977, J REPROD FERTIL, V51, P1; Tsafriri A, 1996, DEV BIOL, V178, P393, DOI 10.1006/dbio.1996.0226; TSAFRIRI A, 1972, J REPROD FERTIL, V31, P39, DOI 10.1530/jrf.0.0310039; VANDERHYDEN BC, 1990, DEV BIOL, V140, P307, DOI 10.1016/0012-1606(90)90081-S; Varani S, 2002, MOL ENDOCRINOL, V16, P1154, DOI 10.1210/me.16.6.1154; Wan LB, 2008, DEVELOPMENT, V135, P2729, DOI 10.1242/dev.024539; WIESEN JF, 1993, ENDOCRINOLOGY, V133, P741, DOI 10.1210/en.133.2.741; Yan CN, 2001, MOL ENDOCRINOL, V15, P854, DOI 10.1210/me.15.6.854; Yoshino O, 2006, P NATL ACAD SCI USA, V103, P10678, DOI 10.1073/pnas.0600507103; ZACHOW RJ, 1993, ENDOCRINOLOGY, V133, P2269, DOI 10.1210/en.133.5.2269; Zeng FY, 2004, DEV BIOL, V272, P483, DOI 10.1016/j.ydbio.2004.05.018	81	19	19	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					43193	43203		10.1074/jbc.M111.297358	http://dx.doi.org/10.1074/jbc.M111.297358			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22009752	Green Published, hybrid			2022-12-27	WOS:000298351300040
J	Dong, CM; Li, CM; Wu, GY				Dong, Chunmin; Li, Chunman; Wu, Guangyu			Regulation of alpha(2B)-Adrenergic Receptor-mediated Extracellular Signal-regulated Kinase 1/2 (ERK1/2) Activation by ADP-ribosylation Factor 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; PHOSPHOLIPASE-D; ENDOPLASMIC-RETICULUM; ALPHA(2)-ADRENERGIC RECEPTORS; ANGIOTENSIN-II; 7-TRANSMEMBRANE RECEPTORS; ANTEROGRADE TRANSPORT; ADRENERGIC-RECEPTORS; GOLGI-COMPLEX; CELL-SURFACE	A number of signaling molecules are involved in the activation of the mitogen-activated protein kinase (MAPK) pathway by G protein-coupled receptors. In this study, we have demonstrated that alpha(2B)-adrenergic receptor (alpha(2B)-AR) interacts with ADP-ribosylation factor 1 (ARF1), a small GTPase involved in vesicle-mediated trafficking, in an agonist activation-dependent manner and that the interaction is mediated through a unique double Trp motif in the third intracellular loop of the receptor. Interestingly, mutation of the double Trp motif and siRNA-mediated depletion of ARF1 attenuate alpha(2B)-AR-mediated activation of extracellular signal-regulated kinases 1/2 (ERK1/2) without altering receptor intracellular trafficking, whereas expression of the constitutively active mutant ARF1Q71L and ARNO, a GDP-GTP exchange factor of ARF1, markedly enhances the activation of Raf1, MEK1, and ERK1/2. These data strongly demonstrate that the small GTPase ARF1 modulates ERK1/2 activation by alpha(2B)-AR and provide the first evidence indicating a novel function for ARF1 in regulating the MAPK signaling pathway.	[Li, Chunman; Wu, Guangyu] Georgia Hlth Sci Univ, Dept Pharmacol & Toxicol, Augusta, GA 30912 USA; [Dong, Chunmin; Wu, Guangyu] Louisiana State Univ, Hlth Sci Ctr, Dept Pharmacol & Expt Therapeut, New Orleans, LA 70112 USA	University System of Georgia; Augusta University; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Wu, GY (corresponding author), Georgia Hlth Sci Univ, Dept Pharmacol & Toxicol, 1459 Laney Walker Blvd, Augusta, GA 30912 USA.	guwu@georgiahealth.edu			National Institutes of Health [R01GM076167]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076167] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM076167 (to G. W.).	BALCH WE, 1992, J BIOL CHEM, V267, P13053; Bonifacino JS, 2004, NAT REV MOL CELL BIO, V5, P23, DOI 10.1038/nrm1279; BROWN HA, 1993, CELL, V75, P1137, DOI 10.1016/0092-8674(93)90323-I; Chiu VK, 2002, NAT CELL BIOL, V4, P343, DOI 10.1038/ncb783; Claing A, 2001, J BIOL CHEM, V276, P42509, DOI 10.1074/jbc.M108399200; COCKCROFT S, 1994, SCIENCE, V263, P523, DOI 10.1126/science.8290961; CUKIERMAN E, 1995, SCIENCE, V270, P1999, DOI 10.1126/science.270.5244.1999; Cussac D, 2002, J BIOL CHEM, V277, P19882, DOI 10.1074/jbc.M110142200; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; DeGraff JL, 1999, J BIOL CHEM, V274, P11253, DOI 10.1074/jbc.274.16.11253; DeGraff JL, 2002, J BIOL CHEM, V277, P43247, DOI 10.1074/jbc.M207495200; Deretic D, 2005, P NATL ACAD SCI USA, V102, P3301, DOI 10.1073/pnas.0500095102; Dong CM, 2007, CELL SIGNAL, V19, P2388, DOI 10.1016/j.cellsig.2007.07.017; Dong CM, 2006, J BIOL CHEM, V281, P38543, DOI 10.1074/jbc.M605734200; Dong CM, 2010, J BIOL CHEM, V285, P20369, DOI 10.1074/jbc.M109.081521; Dong CM, 2010, J PHARMACOL EXP THER, V333, P174, DOI 10.1124/jpet.109.161489; Duvernay MT, 2011, J BIOL CHEM, V286, P14080, DOI 10.1074/jbc.M111.222323; Filipeanu CM, 2004, J BIOL CHEM, V279, P41077, DOI 10.1074/jbc.M405988200; Goldsmith ZG, 2007, ONCOGENE, V26, P3122, DOI 10.1038/sj.onc.1210407; Gsandtner I, 2005, J BIOL CHEM, V280, P31898, DOI 10.1074/jbc.M506515200; Hiroi T, 2006, P NATL ACAD SCI USA, V103, P10672, DOI 10.1073/pnas.0604091103; Houndolo T, 2005, J BIOL CHEM, V280, P5598, DOI 10.1074/jbc.M411456200; Kumari S, 2008, NAT CELL BIOL, V10, P30, DOI 10.1038/ncb1666; Lee MH, 2008, J BIOL CHEM, V283, P2088, DOI 10.1074/jbc.M706892200; Lefkowitz RJ, 2006, MOL CELL, V24, P643, DOI 10.1016/j.molcel.2006.11.007; Luo JS, 2008, MOL PHARMACOL, V74, P338, DOI 10.1124/mol.107.044750; Madziva MT, 2006, J BIOL CHEM, V281, P12178, DOI 10.1074/jbc.M601357200; MASSENBURG D, 1994, P NATL ACAD SCI USA, V91, P11718, DOI 10.1073/pnas.91.24.11718; Misra S, 2002, NATURE, V415, P933, DOI 10.1038/415933a; Mitchell R, 2003, J BIOL CHEM, V278, P33818, DOI 10.1074/jbc.M305825200; Mitchell R, 1998, NATURE, V392, P411, DOI 10.1038/32937; Palacios F, 2001, EMBO J, V20, P4973, DOI 10.1093/emboj/20.17.4973; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Puertollano R, 2001, CELL, V105, P93, DOI 10.1016/S0092-8674(01)00299-9; Robertson DN, 2003, MOL PHARMACOL, V64, P1239, DOI 10.1124/mol.64.5.1239; Roth MG, 1999, CELL, V97, P149, DOI 10.1016/S0092-8674(00)80723-0; Roth MG, 2008, TRAFFIC, V9, P1233, DOI 10.1111/j.1600-0854.2008.00742.x; Schmitt JM, 2000, J BIOL CHEM, V275, P25342, DOI 10.1074/jbc.M003213200; Spang A, 2002, CURR OPIN CELL BIOL, V14, P423, DOI 10.1016/S0955-0674(02)00346-0; STEARNS T, 1990, P NATL ACAD SCI USA, V87, P1238, DOI 10.1073/pnas.87.3.1238; Tague SE, 2004, P NATL ACAD SCI USA, V101, P9671, DOI 10.1073/pnas.0403531101; Tushir JS, 2007, EMBO J, V26, P1806, DOI 10.1038/sj.emboj.7601644; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; Volpicelli-Daley LA, 2005, MOL BIOL CELL, V16, P4495, DOI 10.1091/mbc.E04-12-1042; Wade SM, 1996, MOL PHARMACOL, V50, P351; Wess J, 1998, PHARMACOL THERAPEUT, V80, P231, DOI 10.1016/S0163-7258(98)00030-8; Williams NG, 1998, J BIOL CHEM, V273, P24624, DOI 10.1074/jbc.273.38.24624; Wu GY, 1997, J BIOL CHEM, V272, P17836, DOI 10.1074/jbc.272.28.17836; Wu GY, 2003, J BIOL CHEM, V278, P47062, DOI 10.1074/jbc.M305707200; Wu GY, 1998, J BIOL CHEM, V273, P7197, DOI 10.1074/jbc.273.13.7197; Yang JS, 2002, J CELL BIOL, V159, P69, DOI 10.1083/jcb.200206015; ZHANG GF, 1995, J BIOL CHEM, V270, P21, DOI 10.1074/jbc.270.1.21	52	23	24	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					43361	43369		10.1074/jbc.M111.267286	http://dx.doi.org/10.1074/jbc.M111.267286			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22025613	Green Published, hybrid			2022-12-27	WOS:000298351300056
J	Fukumoto, Y; Kurita, S; Takai, Y; Ogita, H				Fukumoto, Yuri; Kurita, Souichi; Takai, Yoshimi; Ogita, Hisakazu			Role of Scaffold Protein Afadin Dilute Domain-interacting Protein (ADIP) in Platelet-derived Growth Factor-induced Cell Movement by Activating Rac Protein through Vav2 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOVING NIH3T3 CELLS; ADHERENS JUNCTIONS; LEADING EDGES; PDGF RECEPTOR; NECL-5/POLIOVIRUS RECEPTOR; EPITHELIAL-CELLS; BINDING PROTEIN; SRC FAMILY; E-CADHERIN; MIGRATION	Cell movement is an important cellular function not only in physiological but also in pathological conditions. Although numerous studies have been conducted to reveal the mechanism of cell movement, the full picture has yet to be depicted, likely due to the complex features of cell movement. We show here that the scaffold protein afadin dilute domain-interacting protein (ADIP), an afadin-binding protein, is involved in the regulation of cell movement. ADIP localized at the leading edge of moving cells in response to platelet-derived growth factor (PDGF) and was required for the formation of the leading edge and the promotion of cell movement. Impaired cell movement observed in ADIP knockdown cells was not rescued by expression of an ADIP mutant that is incapable of binding to afadin, leading to the notion that the function of ADIP in moving cells depends on its interaction with afadin. Knockdown of ADIP as well as knockdown of afadin inhibited the activation of the small G protein Rac, which is important for the formation of the leading edge and the promotion of cell movement. Furthermore, ADIP interacted with Vav2, a GDP/GTP exchange factor for Rac, in a Src phosphorylation-dependent manner, suggesting that ADIP mediates the activation of Rac through Vav2. These results indicate that ADIP plays an essential role in PDGF-induced cell movement by interacting with afadin and Vav2 and regulating the activation of Rac.	[Ogita, Hisakazu] Shiga Univ Med Sci, Dept Biochem & Mol Biol, Div Mol Med Biochem, Otsu, Shiga 5202192, Japan; [Fukumoto, Yuri; Kurita, Souichi; Takai, Yoshimi] Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Mol & Cellular Biol, Kobe, Hyogo 6500017, Japan	Shiga University of Medical Science; Kobe University	Ogita, H (corresponding author), Shiga Univ Med Sci, Dept Biochem & Mol Biol, Div Mol Med Biochem, Seta Tsukinowa Cho, Otsu, Shiga 5202192, Japan.	hogita@belle.shiga-med.ac.jp	Ogita, Hisakazu/AAE-4416-2020	Ogita, Hisakazu/0000-0001-6750-1668	Ministry of Education, Culture, Sports, Science, and Technology, Japan; The Uehara Memorial Foundation; Japan Foundation for Applied Enzymology; Grants-in-Aid for Scientific Research [23590335] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); The Uehara Memorial Foundation(Uehara Memorial Foundation); Japan Foundation for Applied Enzymology; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants-in-aid for scientific research and by the Targeted Proteins Research Program from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (2010 and 2011); The Uehara Memorial Foundation; and the Japan Foundation for Applied Enzymology.	ABERCROMBIE M, 1970, EXP CELL RES, V60, P437, DOI 10.1016/0014-4827(70)90537-9; Affolter M, 2005, DEV CELL, V9, P19, DOI 10.1016/j.devcel.2005.06.003; Aghazadeh B, 2000, CELL, V102, P625, DOI 10.1016/S0092-8674(00)00085-4; Aman A, 2010, DEV BIOL, V341, P20, DOI 10.1016/j.ydbio.2009.11.014; Amano H, 2008, GENES CELLS, V13, P269, DOI 10.1111/j.1365-2443.2008.01167.x; Arias-Salgado EG, 2003, P NATL ACAD SCI USA, V100, P13298, DOI 10.1073/pnas.2336149100; Arthur WT, 2004, J CELL BIOL, V167, P111, DOI 10.1083/jcb.200404068; Asada M, 2003, J BIOL CHEM, V278, P4103, DOI 10.1074/jbc.M209832200; Bustelo XR, 2001, ONCOGENE, V20, P6372, DOI 10.1038/sj.onc.1204780; CONDEELIS J, 1993, ANNU REV CELL BIOL, V9, P411, DOI 10.1146/annurev.cb.09.110193.002211; de Bruijn DRH, 2002, GENE CHROMOSOME CANC, V34, P285, DOI 10.1002/gcc.10073; Du D, 2010, DEV CELL, V18, P52, DOI 10.1016/j.devcel.2009.12.008; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Fujito T, 2005, J CELL BIOL, V171, P165, DOI 10.1083/jcb.200501090; Fukuyama T, 2005, J BIOL CHEM, V280, P815, DOI 10.1074/jbc.M411099200; Goldfinger LE, 1999, J CELL SCI, V112, P2615; Guinn B, 2005, BIOCHEM BIOPH RES CO, V335, P1293, DOI 10.1016/j.bbrc.2005.08.024; Hornstein I, 2004, CELL SIGNAL, V16, P1, DOI 10.1016/S0898-6568(03)00110-4; Ikeda W, 2004, J BIOL CHEM, V279, P18015, DOI 10.1074/jbc.M312969200; Ikeda W, 2003, J BIOL CHEM, V278, P28167, DOI 10.1074/jbc.M303586200; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Kanzaki N, 2008, J CELL SCI, V121, P2008, DOI 10.1242/jcs.024620; Kawakatsu T, 2005, J BIOL CHEM, V280, P4940, DOI 10.1074/jbc.M408710200; Kiosses WB, 2001, NAT CELL BIOL, V3, P316, DOI 10.1038/35060120; Klinghoffer RA, 1999, EMBO J, V18, P2459, DOI 10.1093/emboj/18.9.2459; KYPTA RM, 1990, CELL, V62, P481, DOI 10.1016/0092-8674(90)90013-5; le Duc Q, 2010, J CELL BIOL, V189, P1107, DOI 10.1083/jcb.201001149; Mandai K, 1997, J CELL BIOL, V139, P517, DOI 10.1083/jcb.139.2.517; Minami Y, 2007, J BIOL CHEM, V282, P18481, DOI 10.1074/jbc.M611330200; Miyata M, 2009, J CELL SCI, V122, P4319, DOI 10.1242/jcs.048439; Miyata M, 2009, J BIOL CHEM, V284, P24595, DOI 10.1074/jbc.M109.016436; Nagamatsu Y, 2008, J BIOL CHEM, V283, P14532, DOI 10.1074/jbc.M801647200; Nakata S, 2007, J BIOL CHEM, V282, P37815, DOI 10.1074/jbc.M707461200; Nugent MA, 2000, INT J BIOCHEM CELL B, V32, P115, DOI 10.1016/S1357-2725(99)00123-5; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Ronnstrand L, 2001, INT J CANCER, V91, P757, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1136>3.0.CO;2-J; Sakamoto Y, 2006, J BIOL CHEM, V281, P19631, DOI 10.1074/jbc.M600301200; Sakisaka T, 1999, ONCOGENE, V18, P1609, DOI 10.1038/sj.onc.1202451; Sato T, 2006, J BIOL CHEM, V281, P5288, DOI 10.1074/jbc.M510070200; Takahashi M, 2008, GENES CELLS, V13, P549, DOI 10.1111/j.1365-2443.2008.01187.x; Takai Y, 2008, NAT REV MOL CELL BIO, V9, P603, DOI 10.1038/nrm2457; Tsukita S, 1999, TRENDS CELL BIOL, V9, P268, DOI 10.1016/S0962-8924(99)01578-0; Tureci O, 1996, CANCER RES, V56, P4766; White CD, 2009, FEBS LETT, V583, P1817, DOI 10.1016/j.febslet.2009.05.007; Woodard AS, 1998, J CELL SCI, V111, P469; YATOHGO T, 1988, CELL STRUCT FUNCT, V13, P281, DOI 10.1247/csf1975.13.281; Zaidel-Bar R, 2004, BIOCHEM SOC T, V32, P416, DOI 10.1042/BST0320416; Ziegler WH, 2006, TRENDS CELL BIOL, V16, P453, DOI 10.1016/j.tcb.2006.07.004	48	17	19	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					43537	43548		10.1074/jbc.M111.308858	http://dx.doi.org/10.1074/jbc.M111.308858			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22027834	hybrid, Green Published			2022-12-27	WOS:000298351300073
J	Kweider, N; Fragoulis, A; Rosen, C; Pecks, U; Rath, W; Pufe, T; Wruck, CJ				Kweider, Nisreen; Fragoulis, Athanassios; Rosen, Christian; Pecks, Ulrich; Rath, Werner; Pufe, Thomas; Wruck, Christoph Jan			Interplay between Vascular Endothelial Growth Factor (VEGF) and Nuclear Factor Erythroid 2-related Factor-2 (Nrf2) IMPLICATIONS FOR PREECLAMPSIA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE STRESS; SIGNAL-TRANSDUCTION; GENE-EXPRESSION; MEDIATED DAMAGE; ACTIVATION; CELLS; ANTIOXIDANTS; PREGNANCY; PLACENTA; RECEPTOR	Background: Several studies have suggested that decreasing VEGF levels might result in placental oxidative stress in preeclampsia. Results: VEGF activates Nrf2 in an ERK1/2-dependent manner, protecting against oxidative stress, and, in turn, up-regulates VEGF expression. Conclusion: Reduced VEGF bioavailability may lead to aggregation of oxidative stress and result in preeclampsia. Significance: Nrf2 activation might be considered as an adjunct therapeutic strategy to combat preeclampsia.	[Kweider, Nisreen; Fragoulis, Athanassios; Rosen, Christian; Pufe, Thomas; Wruck, Christoph Jan] Rhein Westfal TH Aachen, Dept Anat & Cell Biol, Fac Med, D-52074 Aachen, Germany; [Pecks, Ulrich; Rath, Werner] Univ Hosp RWTH, Dept Obstet & Gynecol, D-52074 Aachen, Germany	RWTH Aachen University; RWTH Aachen University; RWTH Aachen University Hospital	Wruck, CJ (corresponding author), Rhein Westfal TH Aachen, Dept Anat & Cell Biol, Fac Med, Wendlingweg 2, D-52074 Aachen, Germany.	cwruck@ukaachen.de	Fragoulis, Athanassios/O-1191-2019; Pecks, Ulrich/D-1190-2012; Fragoulis, Athanassios/K-9623-2015	Fragoulis, Athanassios/0000-0002-6973-3080; Pecks, Ulrich/0000-0002-0784-1262; 	Deutsche Forschungsgemeinschaft [Pu 214/3-2, Pu 214/4-2, Pu 214/5-2, SFB617]; START Program of the Faculty of Medicine; RWTH Aachen University; Department of Histology, Faculty of Medicine, Damascus University	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); START Program of the Faculty of Medicine; RWTH Aachen University; Department of Histology, Faculty of Medicine, Damascus University	This work was supported by Deutsche Forschungsgemeinschaft Grants Pu 214/3-2, Pu 214/4-2, Pu 214/5-2, and SFB617; the START Program of the Faculty of Medicine, RWTH Aachen University; and the Department of Histology, Faculty of Medicine, Damascus University.	AHMED A, 1995, GROWTH FACTORS, V12, P235, DOI 10.3109/08977199509036883; Ahmed A, 2009, BIOCHEM SOC T, V37, P1237, DOI 10.1042/BST0371237; Angeloni C, 2011, AM J PHYSIOL-HEART C, V300, pH2196, DOI 10.1152/ajpheart.00934.2010; Bainbridge SA, 2005, FREE RADICAL BIO MED, V38, P979, DOI 10.1016/j.freeradbiomed.2004.11.002; Baranano DE, 2002, P NATL ACAD SCI USA, V99, P16093, DOI 10.1073/pnas.252626999; BLENIS J, 1993, P NATL ACAD SCI USA, V90, P5889, DOI 10.1073/pnas.90.13.5889; Borzychowski AM, 2006, SEMIN FETAL NEONAT M, V11, P309, DOI 10.1016/j.siny.2006.04.001; Bridges JP, 2009, AM J HYPERTENS, V22, P564, DOI 10.1038/ajh.2009.24; Choi YK, 2010, J BIOL CHEM, V285, P32116, DOI 10.1074/jbc.M110.131284; Cudmore M, 2007, CIRCULATION, V115, P1789, DOI 10.1161/CIRCULATIONAHA.106.660134; de Vries HE, 2008, FREE RADICAL BIO MED, V45, P1375, DOI 10.1016/j.freeradbiomed.2008.09.001; Denhardt DT, 1996, BIOCHEM J, V318, P729, DOI 10.1042/bj3180729; Dinkova-Kostova AT, 2002, P NATL ACAD SCI USA, V99, P11908, DOI 10.1073/pnas.172398899; Faleo G, 2008, TRANSPLANTATION, V85, P1833, DOI 10.1097/TP.0b013e31817c6f63; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Hung TH, 2002, CIRC RES, V90, P1274, DOI 10.1161/01.RES.0000024411.22110.AA; Jaiswal AK, 2004, FREE RADICAL BIO MED, V36, P1199, DOI 10.1016/j.freeradbiomed.2004.02.074; Kaspar JW, 2009, FREE RADICAL BIO MED, V47, P1304, DOI 10.1016/j.freeradbiomed.2009.07.035; Kulkarni AV, 2010, HYPERTENS RES, V33, P561, DOI 10.1038/hr.2010.31; Kwak MK, 2004, MUTAT RES-FUND MOL M, V555, P133, DOI 10.1016/j.mrfmmm.2004.06.041; Lee JM, 2005, FASEB J, V19, P1061, DOI 10.1096/fj.04-2591hyp; Lee JM, 2004, J BIOCHEM MOL BIOL, V37, P139; Lin HH, 2011, J BIOL CHEM, V286, P3829, DOI 10.1074/jbc.M110.168831; Loset M, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.08.043; Mann Giovanni E., 2007, Shengli Xuebao, V59, P117; Maraldi T, 2010, INT J ONCOL, V36, P1581, DOI 10.3892/ijo_00000645; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; Mistry HD, 2010, PLACENTA, V31, P401, DOI 10.1016/j.placenta.2010.02.011; Moll SJ, 2007, APOPTOSIS, V12, P1611, DOI 10.1007/s10495-007-0092-6; Orendi K, 2011, PLACENTA, V32, pS49, DOI 10.1016/j.placenta.2010.11.023; Owuor ED, 2002, BIOCHEM PHARMACOL, V64, P765, DOI 10.1016/S0006-2952(02)01137-1; Perkins AV, 2006, AUST NZ J OBSTET GYN, V46, P77, DOI 10.1111/j.1479-828X.2006.00532.x; Redman CW, 2005, SCIENCE, V308, P1592, DOI 10.1126/science.1111726; ROBERTS JM, 1993, LANCET, V341, P1447, DOI 10.1016/0140-6736(93)90889-O; Sahlin L, 2000, PLACENTA, V21, P603, DOI 10.1053/plac.2000.0554; SHARKEY AM, 1993, J REPROD FERTIL, V99, P609; Sitras V, 2009, PLACENTA, V30, P424, DOI 10.1016/j.placenta.2009.01.012; SUZUKI Y, 1980, J CLIN INVEST, V66, P1409, DOI 10.1172/JCI109994; Vuorela P, 1997, BIOL REPROD, V56, P489, DOI 10.1095/biolreprod56.2.489; Watson AL, 1998, J CLIN ENDOCR METAB, V83, P1697, DOI 10.1210/jc.83.5.1697; *WHO, 2003, WHO SURV; *WHO, 2005, MAK MOTH CHILD COUNT; Wruck CJ, 2007, J NEURAL TRANSM-SUPP, P57; Wruck CJ, 2008, MOL PHARMACOL, V73, P1785, DOI 10.1124/mol.107.042499; Wruck CJ, 2011, ANN RHEUM DIS, V70, P844, DOI 10.1136/ard.2010.132720; Wruck CJ, 2011, J BIOL CHEM, V286, P4493, DOI 10.1074/jbc.M110.162008; Wruck CJ, 2009, HISTOPATHOLOGY, V55, P102, DOI 10.1111/j.1365-2559.2009.03339.x; Yoshida Y, 2003, FREE RADICAL RES, V37, P861, DOI 10.1080/1071576031000148736; Zhao H, 2009, PLACENTA, V30, P861, DOI 10.1016/j.placenta.2009.07.012	50	72	78	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					42863	42872		10.1074/jbc.M111.286880	http://dx.doi.org/10.1074/jbc.M111.286880			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22033923	Green Published, hybrid			2022-12-27	WOS:000298351300008
J	Shirakabe, K; Hattori, S; Seiki, M; Koyasu, S; Okada, Y				Shirakabe, Kyoko; Hattori, Seisuke; Seiki, Motoharu; Koyasu, Shigeo; Okada, Yasunori			VIP36 Protein Is a Target of Ectodomain Shedding and Regulates Phagocytosis in Macrophage Raw 264.7 Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EARLY SECRETORY PATHWAY; SUGAR-BINDING-ACTIVITY; MEMBRANE-PROTEIN; MDCK CELLS; ERGIC-53; RECEPTOR; LECTINS; GLYCOPROTEINS; TRANSPORT; GLYCANS	Ectodomain shedding is a posttranslational modification mechanism, which liberates extracellular domains of membrane proteins through juxtamembrane processing executed mainly by the ADAM (a disintegrin and metalloprotease) family of metalloproteases. Shedding is a unique and effective mechanism for inducing multifaceted effects through the soluble extracellular domains released and/or the remaining membrane-bound portions; however, the physiological functions of shedding are not yet fully understood. In this study, we performed unbiased proteomic screening for shedding targets in a lipopolysaccharide (LPS)-stimulated macrophage cell line to elucidate a new immunological function of shedding. We identified VIP36 (36-kDa vesicular integral membrane protein), a lectin domain-containing transmembrane protein postulated as a cargo receptor for Golgi-to-endoplasmic reticulum transport, as a new target for shedding and found that the shedding of VIP36 occurs mainly on the cell surface. In addition, we demonstrate that the amount of VIP36 precisely regulates phagocytosis in macrophages and that the shedding of VIP36 is required for this regulation. These results substantially expand our knowledge of the immunological and cell biological functions of both the shedding process and VIP36 itself.	[Shirakabe, Kyoko] Keio Univ Sch Med, Ctr Integrated Med Res, Shinjuku Ku, Tokyo 1608582, Japan; [Koyasu, Shigeo] Keio Univ Sch Med, Dept Microbiol & Immunol, Shinjuku Ku, Tokyo 1608582, Japan; [Okada, Yasunori] Keio Univ Sch Med, Dept Pathol, Shinjuku Ku, Tokyo 1608582, Japan; [Shirakabe, Kyoko] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Hattori, Seisuke] Kitasato Univ, Sch Pharmaceut Sci, Div Biochem, Minato Ku, Tokyo 1088641, Japan; [Seiki, Motoharu] Univ Tokyo, Inst Med Sci, Div Canc Cell Res, Minato Ku, Tokyo 1088639, Japan	Keio University; Keio University; Keio University; Japan Science & Technology Agency (JST); Kitasato University; University of Tokyo	Shirakabe, K (corresponding author), Keio Univ Sch Med, Ctr Integrated Med Res, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	kshira@z8.keio.jp	Okada, Yasunori/B-5550-2014; Koyasu, Shigeo/J-5583-2015; Seiki, Motoharu/K-9443-2015	Okada, Yasunori/0000-0001-9208-4755; Koyasu, Shigeo/0000-0001-9585-3038; 	Japan Society for the Promotion of Science [21790328, 19109004]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by Grant-in-aid for Young Scientists (B) 21790328 (to K. S.) and Grant-in-aid for Scientific Research (S) 19109004 (to Y. O.) from the Japan Society for the Promotion of Science. S. K. is a consultant for Medical and Biological Laboratories, Co. Ltd.	Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; FIEDLER K, 1994, EMBO J, V13, P1729, DOI 10.1002/j.1460-2075.1994.tb06437.x; FIEDLER K, 1994, CELL, V77, P625, DOI 10.1016/0092-8674(94)90047-7; Fullekrug J, 1999, J CELL SCI, V112, P2813; Hara-Kuge S, 1999, GLYCOBIOLOGY, V9, P833, DOI 10.1093/glycob/9.8.833; Hara-Kuge S, 2002, J BIOL CHEM, V277, P16332, DOI 10.1074/jbc.M112188200; Hauri HP, 2000, FEBS LETT, V476, P32, DOI 10.1016/S0014-5793(00)01665-3; Hieda M, 2008, J CELL BIOL, V180, P763, DOI 10.1083/jcb.200710022; Hood BL, 2005, J PROTEOME RES, V4, P1561, DOI 10.1021/pr050107r; Horiuchi K, 2007, J IMMUNOL, V179, P2686, DOI 10.4049/jimmunol.179.5.2686; Huovila APJ, 2005, TRENDS BIOCHEM SCI, V30, P413, DOI 10.1016/j.tibs.2005.05.006; ITIN C, 1995, J CELL BIOL, V131, P57, DOI 10.1083/jcb.131.1.57; ITIN C, 1995, EMBO J, V14, P2250, DOI 10.1002/j.1460-2075.1995.tb07219.x; JUE DM, 1990, BIOCHEMISTRY-US, V29, P8371, DOI 10.1021/bi00488a025; Kamiya Y, 2005, J BIOL CHEM, V280, P37178, DOI 10.1074/jbc.M505757200; Kappeler F, 1997, J BIOL CHEM, V272, P31801, DOI 10.1074/jbc.272.50.31801; Kawasaki N, 2007, J BIOCHEM, V141, P221, DOI 10.1093/jh/mvm024; LEEUWENBERG JFM, 1994, J IMMUNOL, V152, P5070; Morrison CJ, 2009, CURR OPIN CELL BIOL, V21, P645, DOI 10.1016/j.ceb.2009.06.006; Nufer O, 2003, J BIOL CHEM, V278, P15886, DOI 10.1074/jbc.M211199200; Rovida E, 2001, J IMMUNOL, V166, P1583, DOI 10.4049/jimmunol.166.3.1583; Satoh T, 2007, J BIOL CHEM, V282, P28246, DOI 10.1074/jbc.M703064200; Schilling O, 2007, CURR OPIN CHEM BIOL, V11, P36, DOI 10.1016/j.cbpa.2006.11.037; SCHINDLER R, 1993, EUR J CELL BIOL, V61, P1; Schrag JD, 2003, TRENDS BIOCHEM SCI, V28, P49, DOI 10.1016/S0968-0004(02)00004-X; Seals DF, 2003, GENE DEV, V17, P7, DOI 10.1101/gad.1039703; Yamaguchi D, 2007, GLYCOBIOLOGY, V17, P1061, DOI 10.1093/glycob/cwm074	27	27	27	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					43154	43163		10.1074/jbc.M111.275586	http://dx.doi.org/10.1074/jbc.M111.275586			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22016386	Green Published, hybrid			2022-12-27	WOS:000298351300036
J	Yamada, K; Kanai, M; Osakabe, Y; Ohiraki, H; Shinozaki, K; Yamaguchi-Shinozaki, K				Yamada, Kohji; Kanai, Motoki; Osakabe, Yuriko; Ohiraki, Haruka; Shinozaki, Kazuo; Yamaguchi-Shinozaki, Kazuko			Monosaccharide Absorption Activity of Arabidopsis Roots Depends on Expression Profiles of Transporter Genes under High Salinity Conditions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHYSIOLOGICAL CHARACTERIZATION; SUGAR TRANSPORTERS; HEXOSE TRANSPORTER; GLUCOSE-UPTAKE; ORGANIC-ACIDS; THALIANA; IDENTIFICATION; RHIZOSPHERE; BACTERIA; ROLES	Plant roots are able to absorb sugars from the rhizosphere but also release sugars and other metabolites that are critical for growth and environmental signaling. Reabsorption of released sugar molecules could help reduce the loss of photosynthetically fixed carbon through the roots. Although biochemical analyses have revealed monosaccharide uptake mechanisms in roots, the transporters that are involved in this process have not yet been fully characterized. In the present study we demonstrate that Arabidopsis STP1 and STP13 play important roles in roots during the absorption of monosaccharides from the rhizosphere. Among 14 STP transporter genes, we found that STP1 had the highest transcript level and that STP1 was a major contributor for monosaccharide uptake under normal conditions. In contrast, STP13 was found to be induced by abiotic stress, with low expression under normal conditions. We analyzed the role of STP13 in roots under high salinity conditions where membranes of the epidermal cells were damaged, and we detected an increase in the amount of STP13-dependent glucose uptake. Furthermore, the amount of glucose efflux from stp13 mutants was higher than that from wild type plants under high salinity conditions. These results indicate that STP13 can reabsorb the monosaccharides that are released by damaged cells under high salinity conditions. Overall, our data indicate that sugar uptake capacity in Arabidopsis roots changes in response to environmental stresses and that this activity is dependent on the expression pattern of sugar transporters.	[Yamada, Kohji; Kanai, Motoki; Osakabe, Yuriko; Ohiraki, Haruka; Yamaguchi-Shinozaki, Kazuko] Univ Tokyo, Grad Sch Agr & Life Sci, Lab Plant Mol Physiol, Tokyo 1138657, Japan; [Yamada, Kohji; Kanai, Motoki; Yamaguchi-Shinozaki, Kazuko] Japan Int Res Ctr Agr Sci, Biol Resources & Post Harvest Div, Ibaraki 3058686, Japan; [Shinozaki, Kazuo] RIKEN Plant Sci Ctr, Kanagawa 2030045, Japan	University of Tokyo; Japan International Research Center for Agricultural Sciences; RIKEN	Yamaguchi-Shinozaki, K (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Lab Plant Mol Physiol, Tokyo 1138657, Japan.	akys@mail.ecc.u-tokyo.ac.jp	Shinozaki, Kazuo/AAB-4945-2019; Yamada, Kohji/O-6731-2015; Osakabe, Yuriko/GRI-9818-2022; Osakabe, Yuriko/Y-2507-2019; Shinozaki, Kazuo/G-4202-2013; Yamaguchi-Shinozaki, Kazuko/K-9004-2015	Shinozaki, Kazuo/0000-0002-6317-9867; Yamada, Kohji/0000-0001-7779-9656; Osakabe, Yuriko/0000-0001-5503-1427; Osakabe, Yuriko/0000-0001-5503-1427; Shinozaki, Kazuo/0000-0002-6317-9867; Yamaguchi-Shinozaki, Kazuko/0000-0002-0249-8258	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Science and Technology Agency/Japan International Cooperation Agency; Program for the Promotion of Basic Research Activities for Innovative Biosciences of Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency/Japan International Cooperation Agency(Japan Science & Technology Agency (JST)); Program for the Promotion of Basic Research Activities for Innovative Biosciences of Japan	This work was supported by grants-in-aid for Scientific Research in Priority Areas (to K.Y.-S.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, the Science and Technology Research Partnership for Sustainable Development of the Japan Science and Technology Agency/Japan International Cooperation Agency, and the Program for the Promotion of Basic Research Activities for Innovative Biosciences of Japan (to K.Y.-S.).	Aluri S, 2007, P NATL ACAD SCI USA, V104, P2537, DOI 10.1073/pnas.0610278104; Bacilio-Jimenez M, 2003, PLANT SOIL, V249, P271, DOI 10.1023/A:1022888900465; Buttner M, 2007, FEBS LETT, V581, P2318, DOI 10.1016/j.febslet.2007.03.016; Chen LQ, 2010, NATURE, V468, P527, DOI 10.1038/nature09606; Etxeberria E, 2005, J EXP BOT, V56, P1905, DOI 10.1093/jxb/eri185; Farrar JF, 2000, NEW PHYTOL, V147, P43, DOI 10.1046/j.1469-8137.2000.00688.x; Kamilova F, 2006, MOL PLANT MICROBE IN, V19, P250, DOI 10.1094/MPMI-19-0250; Kamilova F, 2006, MOL PLANT MICROBE IN, V19, P1121, DOI 10.1094/MPMI-19-1121; Kuzyakov Y, 2006, SOIL BIOL BIOCHEM, V38, P851, DOI 10.1016/j.soilbio.2005.07.012; Lalonde S, 2004, ANNU REV PLANT BIOL, V55, P341, DOI 10.1146/annurev.arplant.55.031903.141758; LIN W, 1984, PLANT PHYSIOL, V76, P894, DOI 10.1104/pp.76.4.894; Mizuno S, 2007, PLANT J, V50, P751, DOI 10.1111/j.1365-313X.2007.03083.x; Norholm MHH, 2006, FEBS LETT, V580, P2381, DOI 10.1016/j.febslet.2006.03.064; Osakabe Y, 2005, PLANT CELL, V17, P1105, DOI 10.1105/tpc.104.027474; Pego JV, 1999, PLANT PHYSIOL, V119, P1017, DOI 10.1104/pp.119.3.1017; Poschet G, 2010, PLANT CELL PHYSIOL, V51, P1571, DOI 10.1093/pcp/pcq100; Reinders A, 2005, J BIOL CHEM, V280, P1594, DOI 10.1074/jbc.M410831200; Rudrappa T, 2008, PLANT PHYSIOL, V148, P1547, DOI 10.1104/pp.108.127613; Sacchi GA, 2000, PLANT SOIL, V220, P1, DOI 10.1023/A:1004701912815; SAUER N, 1990, EMBO J, V9, P3045, DOI 10.1002/j.1460-2075.1990.tb07500.x; Schneider S, 2008, PLANT CELL, V20, P1073, DOI 10.1105/tpc.107.055632; Schneidereit A, 2003, PLANT PHYSIOL, V133, P182, DOI 10.1104/pp.103.026674; Shaw LJ, 2006, ENVIRON MICROBIOL, V8, P1867, DOI 10.1111/j.1462-2920.2006.01141.x; Sherson SM, 2003, J EXP BOT, V54, P525, DOI 10.1093/jxb/erg055; Sherson SM, 2000, PLANT J, V24, P849, DOI 10.1046/j.1365-313x.2000.00935.x; Smith AM, 2005, ANNU REV PLANT BIOL, V56, P73, DOI 10.1146/annurev.arplant.56.032604.144257; Stadler R, 2003, PLANT PHYSIOL, V133, P528, DOI 10.1104/pp.103.024240; Takahashi H, 2000, PLANT J, V23, P171, DOI 10.1046/j.1365-313x.2000.00768.x; Takano J, 2006, PLANT CELL, V18, P1498, DOI 10.1105/tpc.106.041640; Truernit E, 1996, PLANT CELL, V8, P2169, DOI 10.1105/tpc.8.12.2169; Wang HX, 2006, MOL BIOL CELL, V17, P4257, DOI 10.1091/mbc.E06-01-0046; Wieczorke R, 2003, CELL PHYSIOL BIOCHEM, V13, P123, DOI 10.1159/000071863; Williams LE, 2000, TRENDS PLANT SCI, V5, P283, DOI 10.1016/S1360-1385(00)01681-2; Wormit A, 2006, PLANT CELL, V18, P3476, DOI 10.1105/tpc.106.047290; Yamada K, 2010, J BIOL CHEM, V285, P1138, DOI 10.1074/jbc.M109.054288	35	59	61	6	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					43577	43586		10.1074/jbc.M111.269712	http://dx.doi.org/10.1074/jbc.M111.269712			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22041897	Green Published, hybrid			2022-12-27	WOS:000298351300077
J	Beckmann, S; Hahnel, S; Cailliau, K; Vanderstraete, M; Browaeys, E; Dissous, C; Grevelding, CG				Beckmann, Svenja; Hahnel, Steffen; Cailliau, Katia; Vanderstraete, Mathieu; Browaeys, Edith; Dissous, Colette; Grevelding, Christoph G.			Characterization of the Src/Abl Hybrid Kinase SmTK6 of Schistosoma mansoni	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR TYROSINE KINASES; MALE-FEMALE INTERACTION; GROWTH-FACTOR RECEPTOR; REPRODUCTIVE-ORGANS; SIGNAL-TRANSDUCTION; C-ABL; FAMILY; IMATINIB; DOMAINS; IDENTIFICATION	Cellular protein-tyrosine kinases play key roles in signal transduction processes in eukaryotes. SmTK4 was the first Syk kinase identified in a parasite and found to be tissue-specifically transcribed in the gonads of adult Schistosoma mansoni. Functional analyses confirmed its role in oogenesis and spermatogenesis. As an SmTK4 upstream binding partner, the cellular protein-tyrosine kinase SmTK6 was isolated from a yeast two-hybrid library. Phylogenetic analyses performed in this study confirmed the first suggestions of a hybrid character of SmTK6. Biochemical studies made in Xenopus oocytes using inhibitors against Src (herbimycin A) and Abl (imatinib) kinases exhibited a biochemical inhibition profile of SmTK6, which was intermediate of Src and Abl kinases. As SmTK6 upstream interaction partners, we identified among others the known Src kinase SmTK3 and the Venus kinase receptor SmVKR1 of S. mansoni by yeast two-hybrid analyses, all of which co-localized in the gonads. Co-immunoprecipitation experiments confirmed interactions between SmTK6 and SmTK3 or SmVKR1. In Xenopus oocytes, it was finally shown that SmVKR1 but also SmTK3 were able to activate SmTK6 enzymatic activity indicating its functions in a receptor tyrosine kinase signal transduction cascade. These results not only demonstrate an intermediate but Src-biased profile of the unusual kinase SmTK6. They also strongly substantiate previous indications for a kinase complex, consisting of a receptor tyrosine kinase, Syk and Src kinases, which has been hypothesized to be involved in proliferation and differentiation processes in the gonads of schistosomes.	[Beckmann, Svenja; Hahnel, Steffen; Grevelding, Christoph G.] Univ Giessen, Inst Parasitol, D-35392 Giessen, Germany; [Vanderstraete, Mathieu; Dissous, Colette] Inst Pasteur, CNRS UMR 8204, Inserm U1019, Ctr Infect & Immun Lille, F-59019 Lille, France; [Cailliau, Katia; Browaeys, Edith] Univ Lille 1 Sci & Technol, EA 4479, IFR 147, F-59655 Villeneuve Dascq, France	Justus Liebig University Giessen; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Universite de Lille - ISITE; Universite de Lille	Grevelding, CG (corresponding author), Univ Giessen, Inst Parasitol, Rudolf Buchheimstr 2, D-35392 Giessen, Germany.	Christoph.Grevelding@vetmed.uni-giessen.de		Dissous, Colette/0000-0002-5003-8205; Cailliau, Katia/0000-0001-7993-8437; cailliau, katia/0000-0003-1772-1034	Deutsche Forschungsgemeinschaft [GR1549/8-2]; Bill and Melinda Gates Foundation through the Grand Challenges Exploration Initiative [OPP1024324]; INSERM; CNRS; Universite de Lille 1-Lille 2; H.-J. and G. Engemann Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bill and Melinda Gates Foundation through the Grand Challenges Exploration Initiative; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite de Lille 1-Lille 2; H.-J. and G. Engemann Foundation	This work was supported by Deutsche Forschungsgemeinschaft Grant GR1549/8-2, Bill and Melinda Gates Foundation Grant OPP1024324 through the Grand Challenges Exploration Initiative, by INSERM, CNRS, Universite de Lille 1-Lille 2, and by the H.-J. and G. Engemann Foundation (to S. H.).	Ahier A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005651; Bafna S, 2010, ONCOGENE, V29, P2893, DOI 10.1038/onc.2010.87; Baumgartner M, 2009, EXP CELL RES, V315, P2888, DOI 10.1016/j.yexcr.2009.07.028; Beckmann S, 2010, INT J PARASITOL, V40, P521, DOI 10.1016/j.ijpara.2010.01.007; Beckmann S, 2010, PARASITOLOGY, V137, P497, DOI 10.1017/S0031182010000053; Beckmann S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000769; Berriman M, 2009, NATURE, V460, P352, DOI 10.1038/nature08160; Bromann PA, 2004, ONCOGENE, V23, P7957, DOI 10.1038/sj.onc.1208079; Brunton VG, 2004, BBA-MOL CELL RES, V1692, P121, DOI 10.1016/j.bbamcr.2004.04.010; Chitsulo L, 2004, NAT REV MICROBIOL, V2, P12, DOI 10.1038/nrmicro801; Colicelli J, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3139re6; Dissous C, 2011, TRENDS PARASITOL, V27, P59, DOI 10.1016/j.pt.2010.09.001; Doenhoff MJ, 2008, CURR OPIN INFECT DIS, V21, P659, DOI 10.1097/QCO.0b013e328318978f; Fichelson Pierre, 2007, Prog Mol Subcell Biol, V45, P97; GOUIGNARD N, 2011, EXP PARASIT IN PRESS; Grevelding CG, 2004, CURR BIOL, V14, pR545, DOI 10.1016/j.cub.2004.07.006; GREVELDING CG, 1995, MOL BIOCHEM PARASIT, V71, P269, DOI 10.1016/0166-6851(94)00058-U; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; Hubbard SR, 2000, ANNU REV BIOCHEM, V69, P373, DOI 10.1146/annurev.biochem.69.1.373; Hunter T, 2009, CURR OPIN CELL BIOL, V21, P140, DOI 10.1016/j.ceb.2009.01.028; Kapp K, 2004, MOL BIOCHEM PARASIT, V138, P171, DOI 10.1016/j.molbiopara.2004.07.010; Kapp K, 2001, PARASITOLOGY, V122, P317, DOI 10.1017/S0031182001007430; Knobloch J, 2002, GENE, V294, P87, DOI 10.1016/S0378-1119(02)00760-6; Knobloch J, 2007, EXP PARASITOL, V117, P318, DOI 10.1016/j.exppara.2007.04.006; Knobloch J, 2006, INT J PARASITOL, V36, P1261, DOI 10.1016/j.ijpara.2006.06.004; Krautz-Peterson G, 2010, PARASITOLOGY, V137, P485, DOI 10.1017/S0031182009991168; Kunz W, 2001, TRENDS PARASITOL, V17, P227, DOI 10.1016/S1471-4922(01)01893-1; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Larson RA, 2008, BLOOD, V111, P4022, DOI 10.1182/blood-2007-10-116475; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Li Q, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-60; Long T, 2010, INT J PARASITOL, V40, P1075, DOI 10.1016/j.ijpara.2010.03.002; LoVerde PT, 2004, CAN J ZOOL, V82, P357, DOI 10.1139/Z03-217; Manley PW, 2002, EUR J CANCER, V38, pS19, DOI 10.1016/S0959-8049(02)80599-8; Matsunami H, 1997, CELL, V90, P775, DOI 10.1016/S0092-8674(00)80537-1; Nagar B, 2002, CANCER RES, V62, P4236; Newman RA, 2009, J BIOL CHEM, V284, P12924, DOI 10.1074/jbc.M809304200; OVERDUIN M, 1992, P NATL ACAD SCI USA, V89, P11673, DOI 10.1073/pnas.89.24.11673; Quack T, 2006, BERL MUNCH TIERARZTL, V119, P365; Quack T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006998; RESH MD, 1994, CELL, V76, P411, DOI 10.1016/0092-8674(94)90104-X; RESH MD, 2006, SCI STKE, pRE14, DOI DOI 10.1126/STKE.3592006RE14; Ross AGP, 2002, NEW ENGL J MED, V346, P1212, DOI 10.1056/NEJMra012396; Schroeder JA, 2001, J BIOL CHEM, V276, P13057, DOI 10.1074/jbc.M011248200; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Shan YB, 2009, P NATL ACAD SCI USA, V106, P139, DOI 10.1073/pnas.0811223106; Singh PK, 2006, TRENDS CELL BIOL, V16, P467, DOI 10.1016/j.tcb.2006.07.006; Stothard JR, 2009, PARASITOLOGY, V136, P1665, DOI 10.1017/S0031182009991272; Takahashi A, 2009, EXP CELL RES, V315, P1117, DOI 10.1016/j.yexcr.2009.02.010; Vicogne J, 2004, J BIOL CHEM, V279, P37407, DOI 10.1074/jbc.M313738200; Vicogne J, 2003, MOL BIOCHEM PARASIT, V126, P51, DOI 10.1016/S0166-6851(02)00249-9; Yamanaka T, 2008, FRONT BIOSCI-LANDMRK, V13, P6693, DOI 10.2741/3182; Yan Y, 2007, INT J PARASITOL, V37, P1539, DOI 10.1016/j.ijpara.2007.06.001	53	33	34	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42325	42336		10.1074/jbc.M110.210336	http://dx.doi.org/10.1074/jbc.M110.210336			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	22013071	hybrid, Green Published			2022-12-27	WOS:000298180900042
J	Blahna, MT; Jones, MR; Quinton, LJ; Matsuura, KY; Mizgerd, JP				Blahna, Matthew T.; Jones, Matthew R.; Quinton, Lee J.; Matsuura, Kori Y.; Mizgerd, Joseph P.			Terminal Uridyltransferase Enzyme Zcchc11 Promotes Cell Proliferation Independent of Its Uridyltransferase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							S-PHASE; PROTEIN; RNA; TUMORIGENESIS; CARCINOMA; FAMILY; GROWTH; CID1	Zcchc11 is a uridyltransferase protein with enzymatic activity directed against diverse RNA species. On the basis of its known uridylation targets, we hypothesized that Zcchc11 might regulate cell proliferation. Confirming this, loss-of-function and complementary gain-of-function experiments consistently revealed that Zcchc11 promotes the transition from G(1) to S phase of the cell cycle. This activity takes place through both Rb-dependent and Rb-independent mechanisms by promoting the expression of multiple G(1)-associated proteins, including cyclins D-1 and A and CDK4. Surprisingly, a Zcchc11 construct with point mutations inactivating the uridyltransferase domain enhanced cell proliferation as effectively as wild-type Zcchc11. Furthermore, truncated mutant constructs revealed that the cell cycle effects of Zcchc11 were driven by the N-terminal region of the protein that lacks the RNA-binding domains and uridyltransferase activity of the full protein. Therefore, the N-terminal portion of Zcchc11, which lacks nucleotidyltransferase capabilities, is biologically active and mediates a previously unrecognized role for Zcchc11 in facilitating cell proliferation.	[Blahna, Matthew T.; Jones, Matthew R.; Quinton, Lee J.; Matsuura, Kori Y.; Mizgerd, Joseph P.] Boston Univ, Sch Med, Ctr Pulm, Boston, MA 02118 USA; [Blahna, Matthew T.] Harvard Univ, Sch Publ Hlth, Mol & Integrat Physiol Sci Program, Boston, MA 02115 USA	Boston University; Harvard University; Harvard T.H. Chan School of Public Health	Mizgerd, JP (corresponding author), Boston Univ, Sch Med, Ctr Pulm, 72 E Concord St, Boston, MA 02118 USA.	jmizgerd@bu.edu	Blahna, Matthew T/F-3172-2013; Mizgerd, Joseph/GRY-6369-2022	Jones, Matthew/0000-0003-4647-2962; Mizgerd, Joseph/0000-0002-4042-3169; Quinton, Lee/0000-0003-1938-2507	National Institutes of Health [R01 HL079392, R01 HL068153, R01 HL104053, R00 HL092956, T32 HL007035, T90 DK070078]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL092956, T32HL007035, R01HL079392, R01HL068153, R01HL104053] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T90DK070078] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL079392 and R01 HL068153 (to J. P. M.), R01 HL104053 (to M. R. J.), R00 HL092956 (to L. J. Q.), and T32 HL007035 and T90 DK070078 (to M. T. B.).	Aravind L, 1999, NUCLEIC ACIDS RES, V27, P1609, DOI 10.1093/nar/27.7.1609; Arnold Konstantin, 2009, Journal of Structural and Functional Genomics, V10, P1, DOI 10.1007/s10969-008-9048-5; Bandi N, 2009, CANCER RES, V69, P5553, DOI 10.1158/0008-5472.CAN-08-4277; Blajeski AL, 2002, J CLIN INVEST, V110, P91, DOI 10.1172/JCI200213275; CARNEY DN, 1981, P NATL ACAD SCI-BIOL, V78, P3185, DOI 10.1073/pnas.78.5.3185; Hagan JP, 2009, NAT STRUCT MOL BIOL, V16, P1021, DOI 10.1038/nsmb.1676; Heo I, 2009, CELL, V138, P696, DOI 10.1016/j.cell.2009.08.002; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Jones MR, 2009, NAT CELL BIOL, V11, P1157, DOI 10.1038/ncb1931; Kota J, 2009, CELL, V137, P1005, DOI 10.1016/j.cell.2009.04.021; Kumar MS, 2008, P NATL ACAD SCI USA, V105, P3903, DOI 10.1073/pnas.0712321105; Kwak JE, 2007, RNA, V13, P860, DOI 10.1261/rna.514007; Lu JA, 2011, CANCER RES, V71, P225, DOI 10.1158/0008-5472.CAN-10-1850; Lukas J, 1997, GENE DEV, V11, P1479, DOI 10.1101/gad.11.11.1479; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Minoda Y, 2006, BIOCHEM BIOPH RES CO, V344, P1023, DOI 10.1016/j.bbrc.2006.04.006; Mullen TE, 2008, GENE DEV, V22, P50, DOI 10.1101/gad.1622708; Olsen A, 2006, SCIENCE, V312, P1381, DOI 10.1126/science.1124981; Qi YT, 2007, J CELL PHYSIOL, V210, P63, DOI 10.1002/jcp.20816; Read RL, 2002, P NATL ACAD SCI USA, V99, P12079, DOI 10.1073/pnas.192467799; Rissland OS, 2007, MOL CELL BIOL, V27, P3612, DOI 10.1128/MCB.02209-06; Schmidt MJ, 2011, RNA, V17, P39, DOI 10.1261/rna.2252511; Schultz J, 2008, CELL RES, V18, P549, DOI 10.1038/cr.2008.45; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Stevenson AL, 2006, YEAST, V23, P991, DOI 10.1002/yea.1408; Wang SW, 2000, MOL CELL BIOL, V20, P3234, DOI 10.1128/MCB.20.9.3234-3244.2000; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zheng L, 2001, EXP CELL RES, V264, P2, DOI 10.1006/excr.2000.5129	29	16	17	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42381	42389		10.1074/jbc.M111.259689	http://dx.doi.org/10.1074/jbc.M111.259689			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	22006926	Green Published, hybrid			2022-12-27	WOS:000298180900047
J	Ghosh, S; Sulistyoningrum, DC; Glier, MB; Verchere, CB; Devlin, AM				Ghosh, Sanjoy; Sulistyoningrum, Dian C.; Glier, Melissa B.; Verchere, C. Bruce; Devlin, Angela M.			Altered Glutathione Homeostasis in Heart Augments Cardiac Lipotoxicity Associated with Diet-induced Obesity in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-GLUTAMYLCYSTEINE SYNTHETASE; KAPPA-B ACTIVITY; OXIDATIVE STRESS; ENDOTHELIAL DYSFUNCTION; HOMOCYSTEINE METABOLISM; MITOCHONDRIAL DAMAGE; LIPID-METABOLISM; FATTY-ACIDS; CYSTEINE; DISEASE	Obesity-related cardiac lipid accumulation is associated with increased myocardial oxidative stress. The role of the antioxidant glutathione in cardiac lipotoxicity is unclear. Cystathionine beta-synthase (Cbs) catalyzes the first step in the trans-sulfuration of homocysteine to cysteine, which is estimated to provide similar to 50% of cysteine for hepatic glutathione biosynthesis. As cardiac glutathione is a reflection of the liver glutathione pool, we hypothesize that mice heterozygous for targeted disruption of Cbs (Cbs(+/-)) are more susceptible to obesity-related cardiolipotoxicity because of impaired liver glutathione synthesis. Cbs(+/+) and Cbs(+/-) mice were fed a high fat diet (60% energy) from weaning for 13 weeks to induce obesity and had similar increases in body weight and body fat. This was accompanied by increased hepatic triglyceride but no differences in hepatic glutathione levels compared with mice fed chow. However, Cbs(+/-) mice with diet-induced obesity had greater glucose intolerance and lower total and reduced glutathione levels in the heart, accompanied by lower plasma cysteine levels compared with Cbs(+/+) mice. Higher triglyceride concentrations, increased oxidative stress, and increased markers of apoptosis were also observed in heart from Cbs(+/-) mice with diet-induced obesity compared with Cbs(+/+) mice. This study suggests a novel role for Cbs in maintaining the cardiac glutathione pool and protecting against cardiac lipid accumulation and oxidative stress during diet-induced obesity in mice.	[Devlin, Angela M.] Univ British Columbia, Dept Paediat, Child & Family Res Inst, Vancouver, BC V5Z 4H4, Canada; [Ghosh, Sanjoy; Sulistyoningrum, Dian C.; Glier, Melissa B.; Verchere, C. Bruce; Devlin, Angela M.] Univ British Columbia, Dept Pathol & Lab Med, Child & Family Res Inst, Vancouver, BC V5Z 4H4, Canada	Child & Family Research Institute; University of British Columbia; Child & Family Research Institute; University of British Columbia	Devlin, AM (corresponding author), Univ British Columbia, Dept Paediat, Child & Family Res Inst, 272-950 W 28th Ave, Vancouver, BC V5Z 4H4, Canada.	adevlin@cfri.ubc.ca		Verchere, Cameron Bruce/0000-0002-9262-0586; Glier, Melissa/0000-0003-3723-3177; Devlin, Angela/0000-0002-1390-6587	Heart and Stroke Foundation of British Columbia and Yukon; Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research; Michael Smith Foundation for Health Research; Heart and Stroke Foundation of Canada	Heart and Stroke Foundation of British Columbia and Yukon; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada)	This work was supported in part by a grant-in-aid from the Heart and Stroke Foundation of British Columbia and Yukon (to A. M. D.) and a Natural Sciences and Engineering Research Council of Canada Discovery Grant (to A. M. D.).; Supported by postdoctoral fellowships from the Canadian Institutes of Health Research and the Michael Smith Foundation for Health Research.; Supported by a New Investigator award from the Heart and Stroke Foundation of Canada.	Andrikopoulos S, 2008, AM J PHYSIOL-ENDOC M, V295, pE1323, DOI 10.1152/ajpendo.90617.2008; Antunes F, 2002, FREE RADICAL BIO MED, V33, P1260, DOI 10.1016/S0891-5849(02)01016-X; Arany Z, 2005, CELL METAB, V1, P259, DOI 10.1016/j.cmet.2005.03.002; Aronis A, 2005, FREE RADICAL BIO MED, V38, P1221, DOI 10.1016/j.freeradbiomed.2005.01.015; Baron V, 1999, BBA-GEN SUBJECTS, V1472, P173, DOI 10.1016/S0304-4165(99)00118-X; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brosnan JT, 2006, J NUTR, V136, p1636S, DOI 10.1093/jn/136.6.1636S; Cabrero A, 2003, J LIPID RES, V44, P388, DOI 10.1194/jlr.M200294-JLR200; CECONI C, 1988, J MOL CELL CARDIOL, V20, P5, DOI 10.1016/S0022-2828(88)80174-3; Chen P, 1999, ADV ENZYME REGUL, V39, P93, DOI 10.1016/S0065-2571(98)00029-6; Chinen I, 2007, ENDOCRINOLOGY, V148, P160, DOI 10.1210/en.2006-1132; De Mattia G, 1998, DIABETOLOGIA, V41, P1392, DOI 10.1007/s001250051082; Devlin AM, 2007, J BIOL CHEM, V282, P37082, DOI 10.1074/jbc.M704256200; Elshorbagy AK, 2008, AM J CLIN NUTR, V88, P738, DOI 10.1093/ajcn/88.3.738; FOLCH J, 1957, J BIOL CHEM, V226, P497; Friesen RW, 2007, J NUTR, V137, P2641; Ghosh S, 2005, AM J PHYSIOL-HEART C, V289, pH768, DOI 10.1152/ajpheart.00038.2005; Ghosh S, 2009, AM J PHYSIOL-RENAL, V296, pF700, DOI 10.1152/ajprenal.90548.2008; Ghosh S, 2006, FREE RADICAL BIO MED, V41, P1413, DOI 10.1016/j.freeradbiomed.2006.07.021; Griffith OW, 1999, FREE RADICAL BIO MED, V27, P922, DOI 10.1016/S0891-5849(99)00176-8; HUANG CS, 1993, J BIOL CHEM, V268, P19675; Innis SM, 2002, J LIPID RES, V43, P1529, DOI 10.1194/jlr.M200120-JLR200; Keaney JF, 2003, ARTERIOSCL THROM VAS, V23, P434, DOI 10.1161/01.ATV.0000058402.34138.11; LAUTERBURG BH, 1984, HEPATOLOGY, V4, P586, DOI 10.1002/hep.1840040402; Lin CC, 2004, LIPIDS, V39, P843, DOI 10.1007/s11745-004-1305-4; Lou H, 2007, J BIOL CHEM, V282, P29470, DOI 10.1074/jbc.M706145200; Lu SC, 1999, HEPATOLOGY, V30, P209, DOI 10.1002/hep.510300134; Malmezat T, 2000, J NUTR, V130, P1239, DOI 10.1093/jn/130.5.1239; Molnar J, 2005, CIRC RES, V96, P1178, DOI 10.1161/01.RES.0000168634.74330.ed; Mosharov E, 2000, BIOCHEMISTRY-US, V39, P13005, DOI 10.1021/bi001088w; Namekata K, 2004, J BIOL CHEM, V279, P52961, DOI 10.1074/jbc.M406820200; Pechanova O, 2010, J HYPERTENS, V28, pS39, DOI 10.1097/01.hjh.0000388493.81578.b1; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Shen X, 2004, AM J PHYSIOL-ENDOC M, V287, pE896, DOI 10.1152/ajpendo.00047.2004; Sies H, 1999, FREE RADICAL BIO MED, V27, P916, DOI 10.1016/S0891-5849(99)00177-X; Srivastava S, 2007, FREE RADICAL RES, V41, P38, DOI 10.1080/10715760600943900; *SUBC LAB AN NUTR, 1995, NUTR REQ LAB AN, P80; Suliman HB, 2004, CARDIOVASC RES, V64, P279, DOI 10.1016/j.cardiores.2004.07.005; Szczepaniak LS, 2007, CIRC RES, V101, P759, DOI 10.1161/CIRCRESAHA.107.160457; Unger RH, 2002, ANNU REV MED, V53, P319, DOI 10.1146/annurev.med.53.082901.104057; Vincent BRD, 1999, EUR J BIOCHEM, V262, P873, DOI 10.1046/j.1432-1327.1999.00449.x; Vitvitsky V, 2004, AM J PHYSIOL-REG I, V287, pR39, DOI 10.1152/ajpregu.00036.2004; Vitvitsky V, 2003, REDOX REP, V8, P57, DOI 10.1179/135100003125001260; WANG J, 1992, ATHEROSCLEROSIS, V97, P97, DOI 10.1016/0021-9150(92)90055-L; Weiss N, 2001, P NATL ACAD SCI USA, V98, P12503, DOI 10.1073/pnas.231428998; Werstuck GH, 2001, J CLIN INVEST, V107, P1263, DOI 10.1172/JCI11596; Zhou YT, 2000, P NATL ACAD SCI USA, V97, P1784, DOI 10.1073/pnas.97.4.1784	47	28	29	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42483	42493		10.1074/jbc.M111.304592	http://dx.doi.org/10.1074/jbc.M111.304592			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	22021075	hybrid, Green Published			2022-12-27	WOS:000298180900056
J	Sharma, A; Jenkins, KR; Heroux, A; Bowman, GD				Sharma, Amit; Jenkins, Katherine R.; Heroux, Annie; Bowman, Gregory D.			Crystal Structure of the Chromodomain Helicase DNA-binding Protein 1 (Chd1) DNA-binding Domain in Complex with DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMATIN; MECHANISM; CONTAINS; CLEAVAGE; ENZYME; SANT	Chromatin remodelers are ATP-dependent machines that dynamically alter the chromatin packaging of eukaryotic genomes by assembling, sliding, and displacing nucleosomes. The Chd1 chromatin remodeler possesses a C-terminal DNA-binding domain that is required for efficient nucleosome sliding and believed to be essential for sensing the length of DNA flanking the nucleosome core. The structure of the Chd1 DNA-binding domain was recently shown to consist of a SANT and SLIDE domain, analogous to the DNA-binding domain of the ISWI family, yet the details of how Chd1 recognized DNA were not known. Here we present the crystal structure of the Saccharomyces cerevisiae Chd1 DNA-binding domain in complex with a DNA duplex. The bound DNA duplex is straight, consistent with the preference exhibited by the Chd1 DNA-binding domain for extranucleosomal DNA. Comparison of this structure with the recently solved ISW1a DNA-binding domain bound to DNA reveals that DNA lays across each protein at a distinct angle, yet contacts similar surfaces on the SANT and SLIDE domains. In contrast to the minor groove binding seen for Isw1 and predicted for Chd1, the SLIDE domain of the Chd1 DNA-binding domain contacts the DNA major groove. The majority of direct contacts with the phosphate backbone occur only on one DNA strand, suggesting that Chd1 may not strongly discriminate between major and minor grooves.	[Sharma, Amit; Jenkins, Katherine R.; Bowman, Gregory D.] Johns Hopkins Univ, Thomas C Jenkins Dept Biophys, Baltimore, MD 21218 USA; [Heroux, Annie] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA	Johns Hopkins University; United States Department of Energy (DOE); Brookhaven National Laboratory	Bowman, GD (corresponding author), Johns Hopkins Univ, Thomas C Jenkins Dept Biophys, 3400 N Charles St, Baltimore, MD 21218 USA.	gdbowman@jhu.edu			National Institutes of Health [R01 GM084192]; National Center for Research Resources (NCRR), National Institutes of Health [P41RR012408]; Office of Biological and Environmental Research; Office of Basic Energy Sciences of the United States Department of Energy; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR012408] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084192] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources (NCRR), National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Office of Biological and Environmental Research(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Office of Basic Energy Sciences of the United States Department of Energy(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM084192) (to G. D. B.).; We thank T. Owen-Hughes and D. Ryan for providing us with the coordinates for the uncomplexed Chd1 DNA-binding domain prior to publication (2XB0) and Chd1-DNA models. We greatly appreciate G. Hauk for help with data collection and I. Nodelman for critical comments on the manuscript. Support for beamlines X25 and X29 of the National Synchrotron Light Source comes principally from the Offices of Biological and Environmental Research and Basic Energy Sciences of the United States Department of Energy and from the National Center for Research Resources (NCRR), National Institutes of Health (Grant P41RR012408).	Aasland R, 1996, TRENDS BIOCHEM SCI, V21, P87, DOI 10.1016/S0968-0004(96)30009-1; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Chen CY, 2011, BIOPHYS J, V101, P1139, DOI 10.1016/j.bpj.2011.07.016; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; DELMAS V, 1993, P NATL ACAD SCI USA, V90, P2414, DOI 10.1073/pnas.90.6.2414; Doudeva LG, 2006, PROTEIN SCI, V15, P269, DOI 10.1110/ps.051903406; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gangaraju VK, 2007, MUTAT RES-FUND MOL M, V618, P3, DOI 10.1016/j.mrfmmm.2006.08.015; Gaspar-Maia A, 2009, NATURE, V460, P863, DOI 10.1038/nature08212; Grune T, 2003, MOL CELL, V12, P449, DOI 10.1016/S1097-2765(03)00273-9; Kleywegt G.J., 1994, PROTEIN CRYSTALLOGR, V31, P9; Konev AY, 2007, SCIENCE, V317, P1087, DOI 10.1126/science.1145339; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li CL, 2003, EMBO J, V22, P4014, DOI 10.1093/emboj/cdg377; Lu XJ, 2003, NUCLEIC ACIDS RES, V31, P5108, DOI 10.1093/nar/gkg680; Lusser A, 2005, NAT STRUCT MOL BIOL, V12, P160, DOI 10.1038/nsmb884; Marfella CGA, 2007, MUTAT RES-FUND MOL M, V618, P30, DOI 10.1016/j.mrfmmm.2006.07.012; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ryan DP, 2011, CURR OPIN CHEM BIOL, V15, P649, DOI 10.1016/j.cbpa.2011.07.022; Ryan DP, 2011, EMBO J, V30, P2596, DOI 10.1038/emboj.2011.166; Stockdale C, 2006, J BIOL CHEM, V281, P16279, DOI 10.1074/jbc.M600682200; STOKES DG, 1995, MOL CELL BIOL, V15, P2745; Tahirov TH, 2002, CELL, V108, P57, DOI 10.1016/S0092-8674(01)00636-5; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Walfridsson J, 2005, NUCLEIC ACIDS RES, V33, P2868, DOI 10.1093/nar/gki579; Walfridsson J, 2007, EMBO J, V26, P2868, DOI 10.1038/sj.emboj.7601728; Wang YT, 2007, NUCLEIC ACIDS RES, V35, P584, DOI 10.1093/nar/gkl621; Yamada K, 2011, NATURE, V472, P448, DOI 10.1038/nature09947; YUAN H, 1992, BIOCHEMISTRY-US, V31, P8009, DOI 10.1021/bi00149a035	31	31	32	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42099	42104		10.1074/jbc.C111.294462	http://dx.doi.org/10.1074/jbc.C111.294462			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	22033927	hybrid, Green Published			2022-12-27	WOS:000298180900020
J	Tang, WJ; Yang, F; Li, Y; de Crombrugghe, B; Jiao, HL; Xiao, GZ; Zhang, C				Tang, Wanjin; Yang, Fan; Li, Yang; de Crombrugghe, Benoit; Jiao, Hongli; Xiao, Guozhi; Zhang, Chi			Transcriptional Regulation of Vascular Endothelial Growth Factor (VEGF) by Osteoblast-specific Transcription Factor Osterix (Osx) in Osteoblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; RECEPTOR-MEDIATED TRANSCRIPTION; BONE-FORMATION; SKELETAL DEVELOPMENT; MULTIPLE ROLES; DIFFERENTIATION; ANGIOGENESIS; EXPRESSION; OSTEOGENESIS; PROTEIN	Osterix (Osx) is an osteoblast-specific transcription factor required for bone formation and osteoblast differentiation. The critical step in bone formation is to replace the avascular cartilage template with vascularized bone. Osteogenesis and angiogenesis are associated with each other, sharing some essential regulators. Vascular endothelial growth factor (VEGF) is involved in both angiogenesis and osteogenesis. Transcriptional regulation of VEGF expression is not well known in osteoblasts. In this study, quantitative real-time RT-PCR results revealed that VEGF expression was downregulated in Osx-null calvarial cells and that osteoblast marker osteocalcin expression was absent. Overexpression of Osx in stable C2C12 mesenchymal cells using a Tet-off system resulted in up-regulation of both osteocalcin and VEGF expression. The inhibition of Osx by siRNA led to repression of VEGF expression in osteoblasts. These results suggest that Osx controls VEGF expression. Transfection assays demonstrated that Osx activated VEGF promoter activity. A series of VEGF promoter deletion mutants were examined and the minimal Osx-responsive region was defined to the proximal 140-bp region of the VEGF promoter. Additional point mutants were used to identify two GC-rich regions that were responsible for VEGF promoter activation by Osx. Gel shift assay showed that Osx bound to the VEGF promoter sequence directly. Chromatin immunoprecipitation assays indicated that endogenous Osx associated with the native VEGF promoter in primary osteoblasts. Moreover, immunohistochemistry staining showed decreased VEGF protein levels in the tibiae of Osx conditional knock-out mice. We provide the first evidence that Osx controlled VEGF expression, suggesting a potential role of Osx in coordinating osteogenesis and angiogenesis.	[Tang, Wanjin; Yang, Fan; Li, Yang; Zhang, Chi] Univ Texas SW Med Ctr Dallas, Texas Scottish Rite Hosp Children, Bone Res Lab, Dallas, TX 75219 USA; [de Crombrugghe, Benoit] Univ Texas MD Anderson Canc Ctr, Dept Genet, Dallas, TX 77030 USA; [Jiao, Hongli; Xiao, Guozhi] Univ Pittsburgh, Dept Med, Pittsburgh, PA 15240 USA; [Zhang, Chi] Univ Texas SW Med Ctr Dallas, Dept Orthoped Surg, Dallas, TX 75390 USA; [Zhang, Chi] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA	Texas Scottish Rite Hospital for Children; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; UTMD Anderson Cancer Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Zhang, C (corresponding author), Univ Texas SW Med Ctr Dallas, Texas Scottish Rite Hosp Children, Bone Res Lab, 2222 Welborn St, Dallas, TX 75219 USA.	Chi5.Zhang@utsouthwestern.edu	Zhang, Chi/K-4467-2012	Jiao, Hongli/0000-0001-8005-8496	National Institutes of Health [AR059647, DK072230]; Arthritis Foundation; Texas Scottish Rite Hospital for Children [RAP01]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049072, R01AR059647] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072230] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arthritis Foundation; Texas Scottish Rite Hospital for Children; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants AR059647 and DK072230 (to G. X.), a research grant from the Arthritis Foundation to the Bone Research Laboratory (to C. Z.), and Texas Scottish Rite Hospital for Children Grant RAP01 (to C. Z.).	COOLBAUGH CC, 1952, AM J PHYSIOL, V169, P26, DOI 10.1152/ajplegacy.1952.169.1.26; Deckers MML, 2000, ENDOCRINOLOGY, V141, P1667, DOI 10.1210/en.141.5.1667; Furumatsu T, 2003, J BIOCHEM, V133, P633, DOI 10.1093/jb/mvg081; Gerber HP, 1999, NAT MED, V5, P623, DOI 10.1038/9467; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Kotch LE, 1999, DEV BIOL, V209, P254, DOI 10.1006/dbio.1999.9253; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/s0092-8674(01)00622-5; Riddle RC, 2009, J MOL MED, V87, P583, DOI 10.1007/s00109-009-0477-9; Schipani E, 2009, J BONE MINER RES, V24, P1347, DOI [10.1359/JBMR.090602, 10.1359/jbmr.090602]; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; Vladimirova V, 2008, J NEUROSCI RES, V86, P2450, DOI 10.1002/jnr.21686; Wan C, 2008, P NATL ACAD SCI USA, V105, P686, DOI 10.1073/pnas.0708474105; Wan C, 2010, ANN NY ACAD SCI, V1192, P322, DOI 10.1111/j.1749-6632.2009.05238.x; Wang Y, 2007, J CLIN INVEST, V117, P1616, DOI 10.1172/JCI31581; Yang F, 2010, BIOCHEM BIOPH RES CO, V400, P684, DOI 10.1016/j.bbrc.2010.08.128; Zelzer E, 2005, CURR TOP DEV BIOL, V65, P169; Zelzer E, 2002, DEVELOPMENT, V129, P1893; Zelzer E, 2001, MECH DEVELOP, V106, P97, DOI 10.1016/S0925-4773(01)00428-2; Zhang C, 2001, J BIOL CHEM, V276, P40614, DOI 10.1074/jbc.M106263200; Zhang C, 2003, J BIOL CHEM, V278, P35325, DOI 10.1074/jbc.M305191200; Zhang C, 2008, P NATL ACAD SCI USA, V105, P6936, DOI 10.1073/pnas.0710831105; Zhang C, 2010, J ORTHOP SURG RES, V5, DOI 10.1186/1749-799X-5-37; Zhou X, 2010, P NATL ACAD SCI USA, V107, P12919, DOI 10.1073/pnas.0912855107	23	57	63	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2012	287	3					1671	1678		10.1074/jbc.M111.288472	http://dx.doi.org/10.1074/jbc.M111.288472			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879HT	22110141	hybrid, Green Published			2022-12-27	WOS:000299321000010
J	Tan, GMY; Yu, DJ; Wang, JJ; Soong, TW				Tan, Gregory Ming Yeong; Yu, Dejie; Wang, Juejin; Soong, Tuck Wah			Alternative Splicing at C Terminus of Ca(V)1.4 Calcium Channel Modulates Calcium-dependent Inactivation, Activation Potential, and Current Density	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STATIONARY NIGHT BLINDNESS; AUDITORY HAIR-CELLS; CA2+ CHANNEL; ALPHA(1) SUBUNIT; CA2+-DEPENDENT INACTIVATION; DIHYDROPYRIDINE RECEPTORS; SYNAPTIC TRANSFER; RODS; GENE; DOMAIN	The Ca(V)1.4 voltage-gated calcium channel is predominantly expressed in the retina, and mutations to this channel have been associated with human congenital stationary night blindness type-2. The L-type Ca(V)1.4 channel displays distinct properties such as absence of calcium-dependent inactivation (CDI) and slow voltage-dependent inactivation (VDI) due to the presence of an autoinhibitory domain (inhibitor of CDI) in the distal C terminus. We hypothesized that native Ca(V)1.4 is subjected to extensive alternative splicing, much like the other voltage-gated calciumchannels, andemployedthetranscriptscanningmethodto identify alternatively spliced exons within the Ca(V)1.4 transcripts isolated from the human retina. In total, we identified 19 alternative splice variations, of which 16 variations have not been previously reported. Characterization of the C terminus alternatively spliced exons using whole-cell patch clamp electrophysiology revealed a splice variant that exhibits robust CDI. This splice variant arose from the splicing of a novel alternate exon (43*) that can be found in 13.6% of the full-length transcripts screened. Inclusion of exon 43* inserts a stop codon that truncates half the C terminus. The Ca(V)1.443* channel exhibited robust CDI, alarger current density, a hyperpolarized shift in activation potential by similar to 10 mV, and a slower VDI. Through deletional experiments, we showed that the inhibitor of CDI was responsible for modulating channel activation and VDI, in addition to CDI. Calcium currents in the photoreceptors were observed to exhibit CDI and are more negatively activated as compared with currents elicited from heterologously expressed full-length Ca(V)1.4. Naturally occurring alternative splice variants may in part contribute to the properties of the native Ca(V)1.4 channels.	[Soong, Tuck Wah] Natl Univ Singapore, Yong Loo Lin Sch Med, Ion Channel & Transporter Lab, Dept Physiol,Ctr Life Sci,Neurobiol Programme, Singapore 117456, Singapore; [Soong, Tuck Wah] Natl Neurosci Inst, Singapore 308433, Singapore	National University of Singapore; National Neuroscience Institute (NNI)	Soong, TW (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Ion Channel & Transporter Lab, Dept Physiol,Ctr Life Sci,Neurobiol Programme, Level 4,04-07,28 Med Dr, Singapore 117456, Singapore.	tuck_wah_soong@nuhs.edu.sg	Juejin, Wang/ABA-7017-2020; Wang, Jue/GVU-0480-2022					Barrett CF, 2008, P NATL ACAD SCI USA, V105, P2157, DOI 10.1073/pnas.0710501105; Baumann L, 2004, INVEST OPHTH VIS SCI, V45, P708, DOI 10.1167/iovs.03-0937; Bech-Hansen NT, 1998, NAT GENET, V19, P264, DOI 10.1038/947; Boycott KM, 2001, HUM GENET, V108, P91, DOI 10.1007/s004390100461; Chenchik A, 1996, BIOTECHNIQUES, V21, P526; Cia D, 2005, J NEUROPHYSIOL, V93, P1468, DOI 10.1152/jn.00874.2004; COREY DP, 1984, J PHYSIOL-LONDON, V354, P557, DOI 10.1113/jphysiol.1984.sp015393; Cui GY, 2007, J PHYSIOL-LONDON, V585, P791, DOI 10.1113/jphysiol.2007.142307; Findeisen F, 2009, J GEN PHYSIOL, V133, P327, DOI 10.1085/jgp.200810143; Gao TY, 2001, J BIOL CHEM, V276, P21089, DOI 10.1074/jbc.M008000200; Griessmeier K, 2009, J BIOL CHEM, V284, P29809, DOI 10.1074/jbc.M109.048082; Haeseleer F, 2004, NAT NEUROSCI, V7, P1079, DOI 10.1038/nn1320; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hulme JT, 2006, J PHYSIOL-LONDON, V576, P87, DOI 10.1113/jphysiol.2006.111799; Jurkat-Rott K, 2004, J PHYSIOL-LONDON, V554, P609, DOI 10.1113/jphysiol.2003.052712; Koschak A, 2003, J NEUROSCI, V23, P6041, DOI 10.1523/JNEUROSCI.23-14-06041.2003; Liao P, 2005, CARDIOVASC RES, V68, P197, DOI 10.1016/j.cardiores.2005.06.024; Liao P, 2007, J BIOL CHEM, V282, P35133, DOI 10.1074/jbc.M705478200; Liu XD, 2010, NATURE, V463, P968, DOI 10.1038/nature08766; McRory JE, 2004, J NEUROSCI, V24, P1707, DOI 10.1523/JNEUROSCI.4846-03.2004; Mittman S, 1999, NEUROSCI LETT, V269, P121, DOI 10.1016/S0304-3940(99)00319-5; Mittman S, 1999, NEUROSCI LETT, V274, P143, DOI 10.1016/S0304-3940(99)00716-8; MIYAKE Y, 1986, ARCH OPHTHALMOL-CHIC, V104, P1013, DOI 10.1001/archopht.1986.01050190071042; Morgans CW, 2005, VISUAL NEUROSCI, V22, P561, DOI 10.1017/S0952523805225038; Mori MX, 2004, SCIENCE, V304, P432, DOI 10.1126/science.1093490; Moriondo A, 2001, EUR J NEUROSCI, V14, P19, DOI 10.1046/j.0953-816x.2001.01605.x; Morrill JA, 2000, J GEN PHYSIOL, V116, P341, DOI 10.1085/jgp.116.3.341; Rabl K, 2002, EUR J NEUROSCI, V16, P2070, DOI 10.1046/j.1460-9568.2002.02277.x; Ren DJ, 1997, J BIOL CHEM, V272, P22393, DOI 10.1074/jbc.272.36.22393; Schneeweis DM, 2000, VISUAL NEUROSCI, V17, P659, DOI 10.1017/S0952523800175017; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Sharp PA, 1997, CELL, V91, P875, DOI 10.1016/S0092-8674(00)80479-1; Shen YR, 2006, J NEUROSCI, V26, P10690, DOI 10.1523/JNEUROSCI.2093-06.2006; Singh A, 2008, J BIOL CHEM, V283, P20733, DOI 10.1074/jbc.M802254200; Singh A, 2006, NAT NEUROSCI, V9, P1108, DOI 10.1038/nn1751; Soong TW, 2002, J NEUROSCI, V22, P10142; Stroffekova K, 2008, PFLUG ARCH EUR J PHY, V455, P873, DOI 10.1007/s00424-007-0344-x; Strom TM, 1998, NAT GENET, V19, P260, DOI 10.1038/940; Tadross MR, 2008, CELL, V133, P1228, DOI 10.1016/j.cell.2008.05.025; Tang ZZ, 2004, J BIOL CHEM, V279, P44335, DOI 10.1074/jbc.M407023200; Thoreson WB, 2007, MOL NEUROBIOL, V36, P205, DOI 10.1007/s12035-007-0019-9; Thoreson WB, 2003, NEUROSCIENCE, V122, P785, DOI 10.1016/j.neuroscience.2003.08.012; vonGersdorff H, 1996, J NEUROSCI, V16, P115; Wahl-Schott C, 2006, P NATL ACAD SCI USA, V103, P15657, DOI 10.1073/pnas.0604621103; WEI XY, 1994, J BIOL CHEM, V269, P1635; Witkovsky P, 1997, J NEUROSCI, V17, P7297; Xu WF, 2001, J NEUROSCI, V21, P5944, DOI 10.1523/JNEUROSCI.21-16-05944.2001	47	41	42	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					832	847		10.1074/jbc.M111.268722	http://dx.doi.org/10.1074/jbc.M111.268722			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22069316	Green Published, hybrid			2022-12-27	WOS:000299170300003
J	Brown, SD; Babbitt, PC				Brown, Shoshana D.; Babbitt, Patricia C.			Inference of Functional Properties from Large-scale Analysis of Enzyme Superfamilies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							DIVERGENT EVOLUTION; CATALYTIC DIVERSITY; ENOLASE SUPERFAMILY; PROTEIN FUNCTION; ANNOTATION; CLASSIFICATION; AMIDOHYDROLASE; ALGORITHM; MECHANISM; NETWORKS	As increasingly large amounts of data from genome and other sequencing projects become available, new approaches are needed to determine the functions of the proteins these genes encode. We show how large-scale computational analysis can help to address this challenge by linking functional information to sequence and structural similarities using protein similarity networks. Network analyses using three functionally diverse enzyme superfamilies illustrate the use of these approaches for facile updating and comparison of available structures for a large superfamily, for creation of functional hypotheses for metagenomic sequences, and to summarize the limits of our functional knowledge about even well studied superfamilies.	[Brown, Shoshana D.; Babbitt, Patricia C.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, Sch Pharm, San Francisco, CA 94158 USA; [Babbitt, Patricia C.] Univ Calif San Francisco, Dept Pharmaceut Chem, Sch Pharm, San Francisco, CA 94158 USA; [Babbitt, Patricia C.] Univ Calif San Francisco, Calif Inst Quantitat Biosci, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Babbitt, PC (corresponding author), Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, Sch Pharm, San Francisco, CA 94158 USA.	babbitt@cgl.ucsf.edu			National Institutes of Health [R01 GM60595, U54 GM093342]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001081] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060595, U54GM093342] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM60595 and U54 GM093342. This is the fifth article in the Thematic Minireview Series on Enzyme Evolution in the Post-genomic Era.	Adai AT, 2004, J MOL BIOL, V340, P179, DOI 10.1016/j.jmb.2004.04.047; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Apweiler R, 2011, NUCLEIC ACIDS RES, V39, pD214, DOI 10.1093/nar/gkq1020; Atkinson HJ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000541; Atkinson HJ, 2009, BIOCHEMISTRY-US, V48, P11108, DOI 10.1021/bi901180v; Atkinson HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004345; Babbitt PC, 1996, BIOCHEMISTRY-US, V35, P16489, DOI 10.1021/bi9616413; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bateman A, 2010, BIOINFORMATICS, V26, P991, DOI 10.1093/bioinformatics/btq101; Benson DA, 2014, NUCLEIC ACIDS RES, V42, pD32, DOI [10.1093/nar/gkp1024, 10.1093/nar/gkt1030, 10.1093/nar/gks1195, 10.1093/nar/gkw1070, 10.1093/nar/gkq1079, 10.1093/nar/gkn723, 10.1093/nar/gkr1202, 10.1093/nar/gkx1094]; Brown DP, 2007, PLOS COMPUT BIOL, V3, P1526, DOI 10.1371/journal.pcbi.0030160; Burroughs AM, 2006, J MOL BIOL, V361, P1003, DOI 10.1016/j.jmb.2006.06.049; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Dethlefsen L, 2011, P NATL ACAD SCI USA, V108, P4554, DOI 10.1073/pnas.1000087107; Dutta S, 2009, MOL BIOTECHNOL, V42, P1, DOI 10.1007/s12033-008-9127-7; Eisen JA, 1998, GENOME RES, V8, P163, DOI 10.1101/gr.8.3.163; Enright AJ, 2001, BIOINFORMATICS, V17, P853, DOI 10.1093/bioinformatics/17.9.853; Frickey T, 2004, BIOINFORMATICS, V20, P3702, DOI 10.1093/bioinformatics/bth444; Frishman D, 2007, CHEM REV, V107, P3448, DOI 10.1021/cr068303k; Gariev IA, 2006, BIOINFORMATICS, V22, P2574, DOI 10.1093/bioinformatics/btl413; Gerlt JA, 2001, ANNU REV BIOCHEM, V70, P209, DOI 10.1146/annurev.biochem.70.1.209; Gerlt JA, 2012, J BIOL CHEM, V287, P29, DOI 10.1074/jbc.R111.240945; Hicks MA, 2011, PROTEINS, V79, P3082, DOI 10.1002/prot.23135; Holden HM, 2001, ACCOUNTS CHEM RES, V34, P145, DOI 10.1021/ar000053l; Holliday GL, 2007, NUCLEIC ACIDS RES, V35, pD515, DOI 10.1093/nar/gkl774; Holm L, 1997, PROTEINS, V28, P72, DOI 10.1002/(SICI)1097-0134(199705)28:1<72::AID-PROT7>3.0.CO;2-L; Hsiao TL, 2010, NAT CHEM BIOL, V6, P34, DOI [10.1038/NCHEMBIO.266, 10.1038/nchembio.266]; Huttenhower C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-417; Kannan N, 2007, PLOS BIOL, V5, P467, DOI 10.1371/journal.pbio.0050017; Mannervik B, 2005, METHOD ENZYMOL, V401, P1, DOI 10.1016/S0076-6879(05)01001-3; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Mildvan AS, 2005, ARCH BIOCHEM BIOPHYS, V433, P129, DOI 10.1016/j.abb.2004.08.017; Nagano N, 2005, NUCLEIC ACIDS RES, V33, pD407, DOI 10.1093/nar/gki080; Ojha S, 2007, PLOS COMPUT BIOL, V3, P1268, DOI 10.1371/journal.pcbi.0030121; Pearson WR, 2005, METHOD ENZYMOL, V401, P186, DOI 10.1016/S0076-6879(05)01012-8; Pegg SCH, 2006, BIOCHEMISTRY-US, V45, P2545, DOI 10.1021/bi052101l; Pieper Ursula, 2009, Journal of Structural and Functional Genomics, V10, P107, DOI 10.1007/s10969-008-9056-5; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Raes J, 2007, CURR OPIN STRUC BIOL, V17, P362, DOI 10.1016/j.sbi.2007.05.010; Rentzsch R, 2009, TRENDS BIOTECHNOL, V27, P210, DOI 10.1016/j.tibtech.2009.01.002; Roberts RJ, 2011, NUCLEIC ACIDS RES, V39, pD11, DOI 10.1093/nar/gkq1168; Scheeff ED, 2005, PLOS COMPUT BIOL, V1, P359, DOI 10.1371/journal.pcbi.0010049; Scheer M, 2011, NUCLEIC ACIDS RES, V39, pD670, DOI 10.1093/nar/gkq1089; Schnoes AM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000605; Seibert CM, 2005, BIOCHEMISTRY-US, V44, P6383, DOI 10.1021/bi047326v; TAYLOR SS, 1994, STRUCTURE, V2, P345, DOI 10.1016/S0969-2126(00)00036-8; Yooseph S, 2007, PLOS BIOL, V5, P432, DOI 10.1371/journal.pbio.0050016; Zhu JH, 2005, PROTEINS, V58, P618, DOI 10.1002/prot.20331	48	35	35	1	16	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					35	42		10.1074/jbc.R111.283408	http://dx.doi.org/10.1074/jbc.R111.283408			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22069325	Green Published, hybrid			2022-12-27	WOS:000298682400006
J	Oh, YT; Yue, P; Zhou, W; Balko, JM; Black, EP; Owonikoko, TK; Khuri, FR; Sun, SY				Oh, You-Take; Yue, Ping; Zhou, Wei; Balko, Justin M.; Black, Esther P.; Owonikoko, Taofeek K.; Khuri, Fadlo R.; Sun, Shi-Yong			Oncogenic Ras and B-Raf Proteins Positively Regulate Death Receptor 5 Expression through Co-activation of ERK and JNK Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LUNG-CANCER CELLS; NF-KAPPA-B; CCAAT/ENHANCER-BINDING PROTEIN; ENDOPLASMIC-RETICULUM STRESS; TRAIL-INDUCED APOPTOSIS; HOMOLOGOUS PROTEIN; UP-REGULATION; K-RAS; CARCINOMA-CELLS; PATHWAY	Oncogenic mutations of ras and B-raf frequently occur in many cancer types and are critical for cell transformation and tumorigenesis. Death receptor 5 (DR5) is a cell surface pro-apoptotic death receptor for tumor necrosis factor-related apoptosis-inducing ligand and has been targeted in cancer therapy. The current study has demonstrated induction of DR5 expression by the oncogenic proteins Ras and B-Raf and revealed the underlying mechanisms. We demonstrated that both Ras and B-Raf induce DR5 expression by enforced expression of oncogenic Ras (e.g. H-Ras12V or K-Ras12V) or B-Raf (i.e. V600E) in cells and by analyzing gene expression array data generated from cancer cell lines and from human cancer tissues. This finding is further supported by our results that knockdown of endogenous K-Ras or B-Raf (V600E) reduced the expression of DR5. Importantly, we have elucidated that Ras induces DR5 expression through co-activation of ERK/RSK and JNK signaling pathways and subsequent cooperative effects among the transcriptional factors CHOP, Elk1, and c-Jun to enhance DR5 gene transcription. Moreover, we found that the majority of cancer cell lines highly sensitive to the DR5 agonistic antibody AMG655 have either Ras or B-Raf mutations. Our findings warrant further study on the biology of DR5 regulation by Ras and B-Raf, which may provide new insight into the biology of Ras and B-Raf, and on the potential impact of Ras or B-Raf mutations on the outcome of DR5targeted cancer therapy.	[Oh, You-Take; Yue, Ping; Zhou, Wei; Owonikoko, Taofeek K.; Khuri, Fadlo R.; Sun, Shi-Yong] Emory Univ, Dept Hematol & Med Oncol, Sch Med, Atlanta, GA 30322 USA; [Oh, You-Take; Yue, Ping; Zhou, Wei; Owonikoko, Taofeek K.; Khuri, Fadlo R.; Sun, Shi-Yong] Winship Canc Inst, Atlanta, GA 30322 USA; [Balko, Justin M.] Vanderbilt Univ, Dept Med, Nashville, TN 37232 USA; [Black, Esther P.] Univ Kentucky, Dept Pharmaceut Sci, Lexington, KY 40536 USA	Emory University; Vanderbilt University; University of Kentucky	Sun, SY (corresponding author), Emory Univ, Dept Hematol & Med Oncol, Sch Med, 1365-C Clifton Rd,Clinical Bldg C3088, Atlanta, GA 30322 USA.	ssun@emory.edu	Khuri, Fadlo R./AAU-4942-2020; Owonikoko, Taofeek/C-3012-2011	Khuri, Fadlo R./0000-0002-8638-7618; Owonikoko, Taofeek/0000-0002-7724-7728	National Institutes of Health [P50, CA128613]; NCI; Georgia Cancer Coalition Distinguished Cancer Scholar award; Dept. of Defense VITAL [W81XWH-04-1-0142]; NATIONAL CANCER INSTITUTE [K23CA164015, P50CA128613] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Georgia Cancer Coalition Distinguished Cancer Scholar award; Dept. of Defense VITAL(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health SPORE P50 Grant CA128613 from NCI (to S.-Y. S.) for Project 2. This work was also supported by a Georgia Cancer Coalition Distinguished Cancer Scholar award (to S.-Y. S.) and by a Dept. of Defense VITAL Grant W81XWH-04-1-0142 (to S.-Y. S.) for Project	Anjum R, 2008, NAT REV MOL CELL BIO, V9, P747, DOI 10.1038/nrm2509; Ashkenazi A, 2008, CYTOKINE GROWTH F R, V19, P325, DOI 10.1016/j.cytogfr.2008.04.001; Balmanno K, 2009, CELL DEATH DIFFER, V16, P368, DOI 10.1038/cdd.2008.148; Barbero S, 2009, CANCER RES, V69, P3755, DOI 10.1158/0008-5472.CAN-08-3937; Baritaki S, 2007, J IMMUNOL, V179, P5441, DOI 10.4049/jimmunol.179.8.5441; Benanti JA, 2004, CELL CYCLE, V3, P715; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Bivona TG, 2006, MOL CELL, V21, P481, DOI 10.1016/j.molcel.2006.01.012; Cazanave SC, 2010, AM J PHYSIOL-GASTR L, V299, pG236, DOI 10.1152/ajpgi.00091.2010; Chen GA, 2005, P NATL ACAD SCI USA, V102, P12507, DOI 10.1073/pnas.0500397102; Chen L, 2010, NATURE, V465, P492, DOI 10.1038/nature09075; DeNicola Gina M, 2009, Eur J Cancer, V45 Suppl 1, P211, DOI 10.1016/S0959-8049(09)70036-X; DiMauro T, 2010, CURR CANCER DRUG TAR, V10, P869, DOI 10.2174/156800910793357998; Drosopoulos KG, 2005, J BIOL CHEM, V280, P22856, DOI 10.1074/jbc.M412483200; Elrod HA, 2008, CANCER BIOL THER, V7, P163, DOI 10.4161/cbt.7.2.5335; Feig LA, 2006, MOL CELL, V21, P447, DOI 10.1016/j.molcel.2006.02.002; Feig LA, 2002, CURR BIOL, V12, pR259, DOI 10.1016/S0960-9822(02)00787-X; Grosse-Wilde A, 2008, J CLIN INVEST, V118, P100, DOI 10.1172/JCI33061; Guan BX, 2002, ONCOGENE, V21, P3121, DOI 10.1038/sj.onc.1205430; Guo P, 2009, J BIOL CHEM, V284, P28243, DOI 10.1074/jbc.M109.036160; Helfer B, 2006, CANCER RES, V66, P4273, DOI 10.1158/0008-5472.CAN-05-4183; Hoogwater FJH, 2010, GASTROENTEROLOGY, V138, P2357, DOI 10.1053/j.gastro.2010.02.046; Khambata-Ford S, 2007, J CLIN ONCOL, V25, P3230, DOI 10.1200/JCO.2006.10.5437; Khokhlatchev A, 2002, CURR BIOL, V12, P253, DOI 10.1016/S0960-9822(02)00683-8; Kyriakis JM, 2009, J BIOL CHEM, V284, P10993, DOI 10.1074/jbc.R800085200; Li HC, 2009, GASTROENTEROLOGY, V137, P934, DOI 10.1053/j.gastro.2009.06.004; Lin YD, 2008, CANCER RES, V68, P5335, DOI 10.1158/0008-5472.CAN-07-6209; Liu XG, 2004, JNCI-J NATL CANCER I, V96, P1769, DOI 10.1093/jnci/djh322; Lu ZM, 2006, IUBMB LIFE, V58, P621, DOI 10.1080/15216540600957438; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; Nesterov A, 2004, CANCER RES, V64, P3922, DOI 10.1158/0008-5472.CAN-03-2219; Nijkamp MW, 2010, J HEPATOL, V53, P1069, DOI 10.1016/j.jhep.2010.04.040; Oh YT, 2010, J BIOL CHEM, V285, P41310, DOI 10.1074/jbc.M110.153775; Pratilas CA, 2009, P NATL ACAD SCI USA, V106, P4519, DOI 10.1073/pnas.0900780106; Ravi R, 2001, NAT CELL BIOL, V3, P409, DOI 10.1038/35070096; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Schubbert S, 2007, NAT REV CANCER, V7, P295, DOI 10.1038/nrc2109; Senft J, 2007, CANCER RES, V67, P11505, DOI 10.1158/0008-5472.CAN-07-5755; Shetty S, 2005, MOL CELL BIOL, V25, P5404, DOI 10.1128/MCB.25.13.5404-5416.2005; Spandidos DA, 2002, INT J ONCOL, V21, P237; Sun SY, 2007, J BIOL CHEM, V282, P18800, DOI 10.1074/jbc.M611438200; Sun SY, 1997, CANCER RES, V57, P4931; Takimoto R, 2000, ONCOGENE, V19, P1735, DOI 10.1038/sj.onc.1203489; Ubeda M, 1999, MOL CELL BIOL, V19, P7589; Wiezorek J, 2010, CLIN CANCER RES, V16, P1701, DOI 10.1158/1078-0432.CCR-09-1692; Wu GS, 1997, NAT GENET, V17, P141, DOI 10.1038/ng1097-141; Yamaguchi H, 2004, J BIOL CHEM, V279, P45495, DOI 10.1074/jbc.M406933200; Yang A, 2010, CURR OPIN CELL BIOL, V22, P837, DOI 10.1016/j.ceb.2010.08.001; Yoshida T, 2005, CANCER RES, V65, P5662, DOI 10.1158/0008-5472.CAN-05-0693; Young A, 2009, ADV CANCER RES, V102, P1, DOI 10.1016/S0065-230X(09)02001-6; Zou W, 2004, CANCER RES, V64, P7570, DOI 10.1158/0008-5472.CAN-04-1238; Zou W, 2008, CANCER RES, V68, P7484, DOI 10.1158/0008-5472.CAN-08-1318	52	35	37	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					257	267		10.1074/jbc.M111.304006	http://dx.doi.org/10.1074/jbc.M111.304006			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22065586	Green Published, hybrid			2022-12-27	WOS:000298682400026
J	Villadangos, AF; Fu, HL; Gil, JA; Messens, J; Rosen, BP; Mateos, LM				Villadangos, Almudena F.; Fu, Hsueh-Liang; Gil, Jose A.; Messens, Joris; Rosen, Barry P.; Mateos, Luis M.			Efflux Permease CgAcr3-1 of Corynebacterium glutamicum Is an Arsenite-specific Antiporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANION-TRANSLOCATING ATPASE; ESCHERICHIA-COLI; ARSA ATPASE; ALKALIPHILUS-METALLIREDIGENS; SACCHAROMYCES-CEREVISIAE; MEMBRANE SUBUNIT; RESISTANCE; GENES; TRANSPORTER; PROTEIN	Resistance to arsenite (As(III)) by cells is generally accomplished by arsenite efflux permeases from Acr3 or ArsB unrelated families. We analyzed the function of three Acr3 proteins from Corynebacterium glutamicum, CgAcr3-1, CgAcr3-2, and CgAcr3-3. CgAcr3-1 conferred the highest level of As(III) resistance and accumulation in vivo. CgAcr3-1 was also the most active when everted membranes vesicles from Escherichia coli or C. glutamicum mutants were assayed for efflux with different energy sources. As(III) and antimonite (Sb(III)) resistance and accumulation studies using E. coli or C. glutamicum arsenite permease mutants clearly show that CgAcr3-1 is specific for As(III). In everted membrane vesicles expressing CgAcr3-1, dissipation of either the membrane potential or the pH gradient of the proton motive force did not prevent As(III) uptake, whereas dissipation of both components eliminated uptake. Further, a mutagenesis study of CgAcr3-1 suggested that a conserved cysteine and glutamate are involved in active transport. Therefore, we propose that CgAcr3-1 is an antiporter that catalyzes arsenite-proton exchange with residues Cys(129) and Glu(305) involved in efflux.	[Rosen, Barry P.] Florida Int Univ, Herbert Wertheim Coll Med, Dept Cellular Biol & Pharmacol, Miami, FL 33099 USA; [Villadangos, Almudena F.; Gil, Jose A.; Mateos, Luis M.] Univ Leon, Fac Biol Ambientales, Area Microbiol, Dept Biol Mol, E-24071 Leon, Spain; [Fu, Hsueh-Liang] Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI 48201 USA; [Messens, Joris] Vrije Univ Brussel VIB, Dept Biol Struct, B-1050 Brussels, Belgium; [Messens, Joris] Brussels Ctr Redox Biol, B-1050 Brussels, Belgium	State University System of Florida; Florida International University; Universidad de Leon; Wayne State University; Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel	Rosen, BP (corresponding author), Florida Int Univ, Herbert Wertheim Coll Med, Dept Cellular Biol & Pharmacol, Miami, FL 33099 USA.	brosen@fiu.edu; luis.mateos@unileon.es	Gil, José A./L-1800-2019; Gil, Jose A./C-3902-2009; MATEOS DELGADO, LUIS MARIANO/ABB-8848-2021; Messens, Joris/AAH-3008-2020	Gil, José A./0000-0002-5069-2637; Gil, Jose A./0000-0002-5069-2637; MATEOS DELGADO, LUIS MARIANO/0000-0001-7763-582X; Messens, Joris/0000-0002-2128-8264; Rosen, Barry P./0000-0002-5230-4271	National Institutes of Health [GM55425]; Spanish Ministerio de Ciencia e Innovacion [BIO2008-00519]; Junta de Castilla y Leon [LE028A10-2]; Vrije Universiteit Brussel, Belgium; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055425, R37GM055425] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Junta de Castilla y Leon(Junta de Castilla y Leon); Vrije Universiteit Brussel, Belgium; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM55425 (to B. P. R.). This work was also supported by Spanish Ministerio de Ciencia e Innovacion Grant BIO2008-00519 (to J. A. G.), Junta de Castilla y Leon Grant LE028A10-2 (to L. M. M.), and by a Horizontale Onderzoeksactie grant of the Vrije Universiteit Brussel, Belgium (to J. M.).	Achour AR, 2007, RES MICROBIOL, V158, P128, DOI 10.1016/j.resmic.2006.11.006; Bhattacharjee H, 2007, MOL MICROBIOLOGY HEA, P371, DOI [10.1007/7171_2006_086, DOI 10.1007/7171_2006_086]; CHEN CM, 1986, J BIOL CHEM, V261, P5030; Deeley RG, 2006, PHYSIOL REV, V86, P849, DOI 10.1152/physrev.00035.2005; DEY S, 1994, J BIOL CHEM, V269, P25442; FernandezGonzalez C, 1996, APPL MICROBIOL BIOT, V46, P554, DOI 10.1007/s002530050860; Fu HL, 2009, J BIOL CHEM, V284, P19887, DOI 10.1074/jbc.M109.011882; Fu HL, 2010, FEBS LETT, V584, P3089, DOI 10.1016/j.febslet.2010.05.044; Ghosh M, 1999, P NATL ACAD SCI USA, V96, P5001, DOI 10.1073/pnas.96.9.5001; Indriolo E, 2010, PLANT CELL, V22, P2045, DOI 10.1105/tpc.109.069773; Kuroda M, 1997, J BIOL CHEM, V272, P326; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Legare D, 2001, J BIOL CHEM, V276, P26301, DOI 10.1074/jbc.M102351200; Letek M, 2006, J BACTERIOL, V188, P409, DOI 10.1128/JB.188.2.409-423.2006; Lievremont D, 2009, BIOCHIMIE, V91, P1229, DOI 10.1016/j.biochi.2009.06.016; Lopez-Maury L, 2003, J BACTERIOL, V185, P5363, DOI 10.1128/JB.185.18.5363-5371.2003; Maciaszczyk E, 2004, FEMS YEAST RES, V4, P821, DOI 10.1016/j.femsyr.2004.03.002; Maciaszczyk-Dziubinska E, 2011, BBA-BIOMEMBRANES, V1808, P1855, DOI 10.1016/j.bbamem.2011.03.014; Maciaszczyk-Dziubinska E, 2010, BBA-BIOMEMBRANES, V1798, P2170, DOI 10.1016/j.bbamem.2010.07.017; Mansour NM, 2007, FEBS J, V274, P612, DOI 10.1111/j.1742-4658.2006.05627.x; MARGER MD, 1993, TRENDS BIOCHEM SCI, V18, P13, DOI 10.1016/0968-0004(93)90081-W; Mateos LM, 1996, J BACTERIOL, V178, P5768, DOI 10.1128/jb.178.19.5768-5775.1996; Mateos LM, 2006, INT MICROBIOL, V9, P207; Meng YL, 2004, J BIOL CHEM, V279, P18334, DOI 10.1074/jbc.M400037200; NAKAMURA T, 1986, J BIOL CHEM, V261, P678; Ordonez E, 2005, APPL ENVIRON MICROB, V71, P6206, DOI 10.1128/AEM.71.10.6206-6215.2005; Ordonez E, 2008, J BIOL CHEM, V283, P25706, DOI 10.1074/jbc.M803209200; Paez-Espino D, 2009, BIOMETALS, V22, P117, DOI 10.1007/s10534-008-9195-y; Rosen BP, 2010, ADV EXP MED BIOL, V679, P47; Ruan X, 2006, J BIOL CHEM, V281, P9925, DOI 10.1074/jbc.M600125200; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Sato T, 1998, J BACTERIOL, V180, P1655, DOI 10.1128/JB.180.7.1655-1661.1998; TISA LS, 1990, J BIOL CHEM, V265, P190; Verkhovskaya ML, 1997, P NATL ACAD SCI USA, V94, P10128, DOI 10.1073/pnas.94.19.10128; WU JH, 1992, J BIOL CHEM, V267, P12570; Xia XB, 2008, MOL MEMBR BIOL, V25, P691, DOI 10.1080/09687680802535930; Yang JB, 2011, MOL MICROBIOL, V79, P872, DOI 10.1111/j.1365-2958.2010.07494.x	37	27	28	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					723	735		10.1074/jbc.M111.263335	http://dx.doi.org/10.1074/jbc.M111.263335			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22102279	Green Published, hybrid			2022-12-27	WOS:000298682400070
J	Sacho, EJ; Maizels, N				Sacho, Elizabeth J.; Maizels, Nancy			DNA Repair Factor MRE11/RAD50 Cleaves 3 '-Phosphotyrosyl Bonds and Resects DNA to Repair Damage Caused by Topoisomerase 1 Poisons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENYLATE KINASE-ACTIVITY; STRAND BREAK REPAIR; COVALENT COMPLEXES; MRE11; RAD50; NUCLEASE; TDP1; GENE; PATHWAYS; FURIOSUS	MRE11-RAD50 is a highly conserved multifunctional DNA repair factor. Here, we show that MRE11-RAD50 cleaves the covalent 3'-phosphotyrosyl-DNA bonds that join topoisomerase 1 (Top1) to the DNA backbone and that are the hallmark of damage caused by Top1 poisons such as camptothecin. Cleavage generates a 3'-phosphate DNA end that MRE11-RAD50 can resect in an ATP-regulated reaction, to produce a 3'-hydroxyl that can prime repair synthesis. The 3'-phosphotyrosyl cleavage activity maps to the MRE11 active site. These results define a new activity of MRE11 and distinguish MRE11-RAD50 functions in repair of Top1-DNA complexes and double-strand breaks.	[Sacho, Elizabeth J.; Maizels, Nancy] Univ Washington, Sch Med, Dept Immunol, Seattle, WA 98195 USA; [Maizels, Nancy] Univ Washington, Dept Biochem, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Maizels, N (corresponding author), Univ Washington, Sch Med, Dept Immunol, Box 357650,1959 NE Pacific St, Seattle, WA 98195 USA.	maizels@u.washington.edu		Sacho, Elizabeth/0000-0002-4499-5869	National Institutes of Health [P01 CA77852, T32 AI007411]; NCI [R01 GM41712]; NIAID; American Cancer Society [PF-10-083-01]; Hillcrest Committee of Southern Oregon; NATIONAL CANCER INSTITUTE [P01CA077852] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007411] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041712] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); American Cancer Society(American Cancer Society); Hillcrest Committee of Southern Oregon; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Program Project Grant P01 CA77852 from NCI and Grant R01 GM41712 (to N. M.). This work was also supported by National Institutes of Health Grant T32 AI007411 from NIAID and by American Cancer Society Postdoctoral Fellowship Award PF-10-083-01 from the Hillcrest Committee of Southern Oregon (to E. J. S.).	Attwooll CL, 2009, MOL CELL BIOL, V29, P5540, DOI 10.1128/MCB.00479-09; Bastin-Shanower SA, 2003, MOL CELL BIOL, V23, P3487, DOI 10.1128/MCB.23.10.3487-3496.2003; Bhaskara V, 2007, MOL CELL, V25, P647, DOI 10.1016/j.molcel.2007.01.028; Bressan DA, 1998, GENETICS, V150, P591; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; de Jager M, 2002, NUCLEIC ACIDS RES, V30, P4425, DOI 10.1093/nar/gkf574; Deng CC, 2005, GENETICS, V170, P591, DOI 10.1534/genetics.104.028795; Giannini G, 2002, EMBO REP, V3, P248, DOI 10.1093/embo-reports/kvf044; Hamilton NK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015387; Hopfner KP, 2000, J BACTERIOL, V182, P6036, DOI 10.1128/JB.182.21.6036-6041.2000; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; Hopfner KP, 2001, CELL, V105, P473, DOI 10.1016/S0092-8674(01)00335-X; Hopkins BB, 2008, CELL, V135, P250, DOI 10.1016/j.cell.2008.09.054; Interthal H, 2005, J BIOL CHEM, V280, P36518, DOI 10.1074/jbc.M508898200; Interthal H, 2001, P NATL ACAD SCI USA, V98, P12009, DOI 10.1073/pnas.211429198; Kilian A, 1997, HUM MOL GENET, V6, P2011, DOI 10.1093/hmg/6.12.2011; Kinoshita E, 2009, CHROMOSOME RES, V17, P277, DOI 10.1007/s10577-008-9018-6; Krogh BO, 2005, GENETICS, V171, P1561, DOI 10.1534/genetics.105.049478; Lammens A, 2010, J MOL BIOL, V401, P265, DOI 10.1016/j.jmb.2010.06.029; Lammens K, 2011, CELL, V145, P54, DOI 10.1016/j.cell.2011.02.038; Larson ED, 2005, MOL CELL, V20, P367, DOI 10.1016/j.molcel.2005.09.018; Lewis LK, 2004, GENETICS, V166, P1701, DOI 10.1534/genetics.166.4.1701; Liu CY, 2004, DNA REPAIR, V3, P593, DOI 10.1016/j.dnarep.2004.03.030; Liu CY, 2002, P NATL ACAD SCI USA, V99, P14970, DOI 10.1073/pnas.182557199; Malik M, 2004, EUKARYOT CELL, V3, P82, DOI 10.1128/EC.3.1.82-90.2004; Marra G, 2005, ADV EXP MED BIOL, V570, P83; Miquel C, 2007, ONCOGENE, V26, P5919, DOI 10.1038/sj.onc.1210419; Moncalian G, 2004, J MOL BIOL, V335, P937, DOI 10.1016/j.jmb.2003.11.026; Neale MJ, 2005, NATURE, V436, P1053, DOI 10.1038/nature03872; Paull TT, 1998, MOL CELL, V1, P969, DOI 10.1016/S1097-2765(00)80097-0; Paull TT, 2005, CELL CYCLE, V4, P737, DOI 10.4161/cc.4.6.1715; Pommier Y, 2006, PROG NUCLEIC ACID RE, V81, P179, DOI 10.1016/S0079-6603(06)81005-6; Stracker TH, 2008, CELL CYCLE, V7, P3618, DOI 10.4161/cc.7.23.7064; Trujillo KM, 1998, J BIOL CHEM, V273, P21447, DOI 10.1074/jbc.273.34.21447; Vance JR, 2002, P NATL ACAD SCI USA, V99, P13669, DOI 10.1073/pnas.202242599; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Wen Q, 2008, MOL BIOL CELL, V19, P1693, DOI 10.1091/mbc.E07-09-0975; Williams GJ, 2011, NAT STRUCT MOL BIOL, V18, P423, DOI 10.1038/nsmb.2038; Williams RS, 2008, CELL, V135, P97, DOI 10.1016/j.cell.2008.08.017; Yabuki M, 2005, NAT IMMUNOL, V6, P730, DOI 10.1038/ni1215; Yang SW, 1996, P NATL ACAD SCI USA, V93, P11534, DOI 10.1073/pnas.93.21.11534	41	35	35	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2011	286	52					44945	44951		10.1074/jbc.M111.299347	http://dx.doi.org/10.1074/jbc.M111.299347			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870CA	22039049	hybrid, Green Published			2022-12-27	WOS:000298645500063
J	Du, F; Hui, Y; Zhang, M; Linton, MF; Fazio, S; Fan, DP				Du, Fen; Hui, Yvonne; Zhang, Michelle; Linton, MacRae F.; Fazio, Sergio; Fan, Daping			Novel Domain Interaction Regulates Secretion of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENSITY-LIPOPROTEIN RECEPTOR; AUTOSOMAL-DOMINANT HYPERCHOLESTEROLEMIA; PLASMA LDL-CHOLESTEROL; C-TERMINAL DOMAIN; NONHUMAN-PRIMATES; CRYSTAL-STRUCTURE; SERUM LDL; MUTATIONS; DEGRADATION; GENE	PCSK9 (proprotein convertase subtilisin/kexin type 9) has emerged as a novel therapeutic target for hypercholesterolemia due to its LDL receptor (LDLR)-reducing activity. Although its structure has been solved, the lack of a detailed understanding of the structure-function relation hinders efforts to develop small molecule inhibitors. In this study, we used mutagenesis and transfection approaches to investigate the roles of the prodomain (PD) and the C-terminal domain (CD) and its modules (CM1-3) in the secretion and function of PCSK9. Deletion of PD residues 31-40, 41-50, or 51-60 did not affect the self-cleavage, secretion, or LDLR-degrading activity of PCSK9, whereas deletion of residues 61-70 abolished all of these functions. Deletion of the entire CD protein did not impair PCSK9 self-cleavage or secretion but completely abolished LDLR-degrading activity. Deletion of any one or two of the CD modules did not affect self-cleavage but influenced secretion and LDLR-reducing activity. Furthermore, in cotransfection experiments, a secretion-defective PD deletion mutant (Delta PD) was efficiently secreted in the presence of CD deletion mutants. This was due to the transfer of PD from the cotransfected CD mutants to the Delta PD mutant. Finally, we found that a discrete CD protein fragment competed with full-length PCSK9 for binding to LDLR in vitro and attenuated PCSK9-mediated hypercholesterolemia in mice. These results show a previously unrecognized domain interaction as a critical determinant in PCSK9 secretion and function. This knowledge should fuel efforts to develop novel approaches to PCSK9 inhibition.	[Linton, MacRae F.; Fazio, Sergio] Vanderbilt Univ, Med Ctr, Atherosclerosis Res Unit, Div Cardiol,Dept Med, Nashville, TN 37232 USA; [Du, Fen; Hui, Yvonne; Zhang, Michelle; Fan, Daping] Univ S Carolina, Sch Med, Dept Cell Biol & Anat, Columbia, SC 29209 USA; [Linton, MacRae F.] Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37232 USA; [Fazio, Sergio] Vanderbilt Univ, Med Ctr, Dept Pathol, Nashville, TN 37232 USA	Vanderbilt University; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Vanderbilt University; Vanderbilt University	Fazio, S (corresponding author), Vanderbilt Univ, Med Ctr, Atherosclerosis Res Unit, Div Cardiol,Dept Med, PRB318,2220 Pierce Ave, Nashville, TN 37232 USA.	sergio.fazio@vanderbilt.edu; daping.fan@uscmed.sc.edu			National Institutes of Health [HL106845, HL106325]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000062] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL106325, R01HL106845] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL106845 (to S. F.) and HL106325 (to D. F.).	Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Abifadel M, 2009, HUM MUTAT, V30, P520, DOI 10.1002/humu.20882; Alborn WE, 2007, CLIN CHEM, V53, P1814, DOI 10.1373/clinchem.2007.091280; Benjannet S, 2004, J BIOL CHEM, V279, P48865, DOI 10.1074/jbc.M409699200; Benjannet S, 2006, J BIOL CHEM, V281, P30561, DOI 10.1074/jbc.M606495200; Berge KE, 2006, ARTERIOSCL THROM VAS, V26, P1094, DOI 10.1161/01.ATV.0000204337.81286.1c; Betzel C, 2001, BIOCHEMISTRY-US, V40, P3080, DOI 10.1021/bi002538n; Brown MS, 2006, SCIENCE, V311, P1721, DOI 10.1126/science.1125884; Cameron J, 2006, HUM MOL GENET, V15, P1551, DOI 10.1093/hmg/ddl077; Chan JCY, 2009, P NATL ACAD SCI USA, V106, P9820, DOI 10.1073/pnas.0903849106; Cohen J, 2005, NAT GENET, V37, P328, DOI 10.1038/ng0305-328c; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Cunningham D, 2007, NAT STRUCT MOL BIOL, V14, P413, DOI 10.1038/nsmb1235; Duff CJ, 2009, BIOCHEM J, V419, P577, DOI 10.1042/BJ20082407; Fan D, 2008, BIOCHEMISTRY-US, V47, P1631, DOI 10.1021/bi7016359; Fazio S, 2007, CURR OPIN LIPIDOL, V18, P387, DOI 10.1097/MOL.0b013e3282a0794d; Frank-Kamenetsky M, 2008, P NATL ACAD SCI USA, V105, P11915, DOI 10.1073/pnas.0805434105; Graham MJ, 2007, J LIPID RES, V48, P763, DOI 10.1194/jlr.C600025-JLR200; Hampton EN, 2007, P NATL ACAD SCI USA, V104, P14604, DOI 10.1073/pnas.0703402104; Henrich S, 2003, NAT STRUCT BIOL, V10, P520, DOI 10.1038/nsb941; Holla OL, 2011, BIOCHEM BIOPH RES CO, V406, P234, DOI 10.1016/j.bbrc.2011.02.023; Hooper AJ, 2007, ATHEROSCLEROSIS, V193, P445, DOI 10.1016/j.atherosclerosis.2006.08.039; Horton JD, 2007, TRENDS BIOCHEM SCI, V32, P71, DOI 10.1016/j.tibs.2006.12.008; Kotowski IK, 2006, AM J HUM GENET, V78, P410, DOI 10.1086/500615; Kwon HJ, 2008, P NATL ACAD SCI USA, V105, P1820, DOI 10.1073/pnas.0712064105; Li J, 2007, BIOCHEM J, V406, P203, DOI 10.1042/BJ20070664; Lilly SM, 2007, CURR OPIN LIPIDOL, V18, P650, DOI 10.1097/MOL.0b013e3282f169c6; Maxwell KN, 2005, CURR OPIN LIPIDOL, V16, P167, DOI 10.1097/01.mol.0000162321.31925.a3; McNutt MC, 2007, J BIOL CHEM, V282, P20799, DOI 10.1074/jbc.C700095200; MCPHALEN CA, 1988, BIOCHEMISTRY-US, V27, P6582, DOI 10.1021/bi00417a058; Miyake Y, 2008, ATHEROSCLEROSIS, V196, P29, DOI 10.1016/j.atherosclerosis.2006.12.035; Mousavi SA, 2009, J INTERN MED, V266, P507, DOI 10.1111/j.1365-2796.2009.02167.x; Nassoury N, 2007, TRAFFIC, V8, P718, DOI 10.1111/j.1600-0854.2007.00562.x; Ni YG, 2010, J BIOL CHEM, V285, P12882, DOI 10.1074/jbc.M110.113035; Piper DE, 2007, STRUCTURE, V15, P545, DOI 10.1016/j.str.2007.04.004; Rashid S, 2005, P NATL ACAD SCI USA, V102, P5374, DOI 10.1073/pnas.0501652102; Seidah NG, 2009, EXPERT OPIN THER TAR, V13, P19, DOI 10.1517/14728220802600715 ; Seidah NG, 2003, P NATL ACAD SCI USA, V100, P928, DOI 10.1073/pnas.0335507100; WRIGHT CS, 1969, NATURE, V221, P235, DOI 10.1038/221235a0; Yamamoto T, 2011, J BIOL CHEM, V286, P5464, DOI 10.1074/jbc.M110.199042; Zhang DW, 2008, P NATL ACAD SCI USA, V105, P13045, DOI 10.1073/pnas.0806312105; Zhang DW, 2007, J BIOL CHEM, V282, P18602, DOI 10.1074/jbc.M702027200; Zhao ZZ, 2006, AM J HUM GENET, V79, P514, DOI 10.1086/507488	43	65	67	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					43054	43061		10.1074/jbc.M111.273474	http://dx.doi.org/10.1074/jbc.M111.273474			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22027821	Green Published, hybrid			2022-12-27	WOS:000298351300026
J	Tanaka, N; Chakravarty, AK; Maughan, B; Shuman, S				Tanaka, Naoko; Chakravarty, Anupam K.; Maughan, Bill; Shuman, Stewart			Novel Mechanism of RNA Repair by RtcB via Sequential 2 ',3 '-Cyclic Phosphodiesterase and 3 '-Phosphate/5 '-Hydroxyl Ligation Reactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; POLYNUCLEOTIDE KINASE; ADENYLATE INTERMEDIATE; 3'-TERMINAL PHOSPHATE; NUCLEOTIDYL TRANSFER; MUTATIONAL ANALYSIS; JUNCTION PHOSPHATE; CELL EXTRACT; DNA-LIGASE; CYCLASE	RtcB enzymes are a newly discovered family of RNA ligases, implicated in tRNA splicing and other RNA repair reactions, that seal broken RNAs with 2',3'-cyclic phosphate and 5'-OH ends. Parsimony and energetics would suggest a one-step mechanism for RtcB sealing via attack by the O5' nucleophile on the cyclic phosphate, with expulsion of the ribose O2' and generation of a 3',5'-phosphodiester at the splice junction. Yet we find that RtcB violates Occam's razor, insofar as (i) it is adept at ligating 3'-monophosphate and 5'-OH ends; (ii) it has an intrinsic 2',3'-cyclic phosphodiesterase activity. The 2',3'-cyclic phosphodiesterase and ligase reactions both require manganese and are abolished by mutation of the RtcB active site. Thus, RtcB executes a unique two-step pathway of strand joining whereby the 2',3'-cyclic phosphodiester end is hydrolyzed to a 3'-monophosphate, which is then linked to the 5'-OH end to form the splice junction. The energy for the 3'-phosphate ligase activity is provided by GTP, which reacts with RtcB in the presence of manganese to form a covalent RtcB-guanylate adduct. This adduct is sensitive to acid and hydroxylamine but resistant to alkali, consistent with a phosphoramidate bond.	[Tanaka, Naoko; Chakravarty, Anupam K.; Maughan, Bill; Shuman, Stewart] Sloan Kettering Inst, Program Mol Biol, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center	Shuman, S (corresponding author), Amer Canc Soc, Atlanta, GA 30329 USA.	s-shuman@ski.mskcc.org			National Institutes of Health [GM46330]; Medical Research Council [G9817803B] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM046330, R01GM046330] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM46330.	AMITSUR M, 1987, EMBO J, V6, P2499, DOI 10.1002/j.1460-2075.1987.tb02532.x; Chan CM, 2009, SCIENCE, V326, P247, DOI 10.1126/science.1179480; Englert M, 2011, P NATL ACAD SCI USA, V108, P1290, DOI 10.1073/pnas.1018307108; FILIPOWICZ W, 1985, P NATL ACAD SCI USA, V82, P1316, DOI 10.1073/pnas.82.5.1316; FILIPOWICZ W, 1983, CELL, V32, P547, DOI 10.1016/0092-8674(83)90474-9; Genschik P, 1998, J BIOL CHEM, V273, P25516, DOI 10.1074/jbc.273.39.25516; Gonzalez TN, 1999, EMBO J, V18, P3119, DOI 10.1093/emboj/18.11.3119; GREER CL, 1983, CELL, V32, P537, DOI 10.1016/0092-8674(83)90473-7; GUMPORT RI, 1971, P NATL ACAD SCI USA, V68, P2559, DOI 10.1073/pnas.68.10.2559; KONARSKA M, 1982, P NATL ACAD SCI-BIOL, V79, P1474, DOI 10.1073/pnas.79.5.1474; LASKI FA, 1983, J BIOL CHEM, V258, P1974; Martins A, 2005, RNA, V11, P1271, DOI 10.1261/rna.2690505; Nair PA, 2007, NAT STRUCT MOL BIOL, V14, P770, DOI 10.1038/nsmb1266; Nandakumar J, 2008, MOL CELL, V31, P278, DOI 10.1016/j.molcel.2008.05.019; Nandakumar J, 2006, CELL, V127, P71, DOI 10.1016/j.cell.2006.08.038; Okada C, 2006, PROTEINS, V63, P1119, DOI 10.1002/prot.20912; Popow J, 2011, SCIENCE, V331, P760, DOI 10.1126/science.1197847; Sawaya R, 2003, J BIOL CHEM, V278, P43928, DOI 10.1074/jbc.M307839200; Schwer B, 2004, P NATL ACAD SCI USA, V101, P2788, DOI 10.1073/pnas.0305859101; Shuman S, 1998, MOL CELL, V1, P741, DOI 10.1016/S1097-2765(00)80073-8; Sidrauski C, 1996, CELL, V87, P405, DOI 10.1016/S0092-8674(00)81361-6; Tanaka N, 2011, J BIOL CHEM, V286, P30253, DOI 10.1074/jbc.C111.274597; Tanaka N, 2011, J BIOL CHEM, V286, P7727, DOI 10.1074/jbc.C111.219022; Tanaka N, 2010, STRUCTURE, V18, P449, DOI 10.1016/j.str.2010.01.016; Wang LK, 2006, NUCLEIC ACIDS RES, V34, P517, DOI 10.1093/nar/gkj441; Wang LK, 2003, J BIOL CHEM, V278, P29454, DOI 10.1074/jbc.M304320200; Wang LK, 2002, NUCLEIC ACIDS RES, V30, P1073, DOI 10.1093/nar/30.4.1073; Zofallova L, 2000, RNA, V6, P1019, DOI 10.1017/S1355838200000613	28	70	74	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					43134	43143		10.1074/jbc.M111.302133	http://dx.doi.org/10.1074/jbc.M111.302133			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22045815	Green Published, hybrid			2022-12-27	WOS:000298351300034
J	Gunn, A; Bennardo, N; Cheng, A; Stark, JM				Gunn, Amanda; Bennardo, Nicole; Cheng, Anita; Stark, Jeremy M.			Correct End Use during End Joining of Multiple Chromosomal Double Strand Breaks Is Influenced by Repair Protein RAD50, DNA-dependent Protein Kinase DNA-PKcs, and Transcription Context	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENOMIC INSTABILITY; V(D)J RECOMBINATION; HISTONE H2AX; HOMOLOGOUS RECOMBINATION; MRE11/RAD50 COMPLEXES; MAMMALIAN-CELLS; MURINE CELLS; ATM; TRANSLOCATIONS; PATHWAYS	During repair of multiple chromosomal double strand breaks (DSBs), matching the correct DSB ends is essential to limit rearrangements. To investigate the maintenance of correct end use, we examined repair of two tandem noncohesive DSBs generated by endonuclease I-SceI and the 3' nonprocessive exonuclease Trex2, which can be expressed as an I-SceI-Trex2 fusion. We examined end joining (EJ) repair that maintains correct ends (proximal-EJ) versus using incorrect ends (distal-EJ), which provides a relative measure of incorrect end use (distal end use). Previous studies showed that ATM is important to limit distal end use. Here we show that DNA-PKcs kinase activity and RAD50 are also important to limit distal end use, but that H2AX is dispensable. In contrast, we find that ATM, DNA-PKcs, and RAD50 have distinct effects on repair events requiring end processing. Furthermore, we developed reporters to examine the effects of the transcription context on DSB repair, using an inducible promoter. We find that a DSB downstream from an active promoter shows a higher frequency of distal end use, and a greater reliance on ATM for limiting incorrect end use. Conversely, DSB transcription context does not affect end processing during EJ, the frequency of homology-directed repair, or the role of RAD50 and DNA-PKcs in limiting distal end use. We suggest that RAD50, DNA-PKcs kinase activity, and transcription context are each important to limit incorrect end use during EJ repair of multiple DSBs, but that these factors and conditions have distinct roles during repair events requiring end processing.	[Gunn, Amanda; Bennardo, Nicole; Cheng, Anita; Stark, Jeremy M.] Beckman Res Inst,City Hope, Dept Canc Biol, Duarte, CA 91010 USA; [Gunn, Amanda; Bennardo, Nicole; Stark, Jeremy M.] Beckman Res Inst City Hope, Irell & Manella Grad Sch Biol Sci, Duarte, CA 91010 USA	City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope	Bennardo, N (corresponding author), 1500 E Duarte Rd, Duarte, CA 91010 USA.	jstark@coh.org		Gunn, Amanda Lyn/0000-0002-9450-4976	National Cancer Institute of the NIH [RO1CA120954]; NATIONAL CANCER INSTITUTE [R01CA120954] Funding Source: NIH RePORTER	National Cancer Institute of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Grant RO1CA120954 from the National Cancer Institute of the NIH (to J. M. S.).	Abuzeid WM, 2009, J CLIN INVEST, V119, P1974, DOI 10.1172/JCI33816; Allen C, 2003, MOL CANCER RES, V1, P913; Allen C, 2003, DNA REPAIR, V2, P1147, DOI 10.1016/S1568-7864(03)00139-3; Bassing CH, 2003, CELL, V114, P359, DOI 10.1016/S0092-8674(03)00566-X; Bassing CH, 2002, P NATL ACAD SCI USA, V99, P8173, DOI 10.1073/pnas.122228699; Bennardo N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001194; Bennardo N, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000683; Bennardo N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000110; Bhaskara V, 2007, MOL CELL, V25, P647, DOI 10.1016/j.molcel.2007.01.028; Bothmer A, 2011, MOL CELL, V42, P319, DOI 10.1016/j.molcel.2011.03.019; Bredemeyer AL, 2008, J IMMUNOL, V181, P2620, DOI 10.4049/jimmunol.181.4.2620; Chen MJ, 2007, NUCLEIC ACIDS RES, V35, P2682, DOI 10.1093/nar/gkm151; Davis AJ, 2010, CELL CYCLE, V9, P2529, DOI 10.4161/cc.9.13.12148; DeFazio LG, 2002, EMBO J, V21, P3192, DOI 10.1093/emboj/cdf299; Della-Maria J, 2011, J BIOL CHEM, V286, P33845, DOI 10.1074/jbc.M111.274159; Deriano L, 2009, MOL CELL, V34, P13, DOI 10.1016/j.molcel.2009.03.009; Dobbs TA, 2010, DNA REPAIR, V9, P1307, DOI 10.1016/j.dnarep.2010.09.019; Fattah F, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000855; Franco S, 2006, MOL CELL, V21, P201, DOI 10.1016/j.molcel.2006.01.005; Gan WJ, 2011, GENE DEV, V25, P2041, DOI 10.1101/gad.17010011; Gapud EJ, 2011, CELL CYCLE, V10, P1928, DOI 10.4161/cc.10.12.16011; Golding SE, 2004, J BIOL CHEM, V279, P15402, DOI 10.1074/jbc.M314191200; Goodarzi AA, 2008, MOL CELL, V31, P167, DOI 10.1016/j.molcel.2008.05.017; Gottipati P, 2008, MOL CELL BIOL, V28, P154, DOI 10.1128/MCB.00816-07; Hammel M, 2010, J BIOL CHEM, V285, P1414, DOI 10.1074/jbc.M109.065615; Helmink BA, 2011, NATURE, V469, P245, DOI 10.1038/nature09585; Helmink BA, 2009, J EXP MED, V206, P669, DOI 10.1084/jem.20081326; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Kass EM, 2010, FEBS LETT, V584, P3703, DOI 10.1016/j.febslet.2010.07.057; Lee K, 2008, NATURE, V454, P543, DOI 10.1038/nature07054; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Lin CR, 2009, CELL, V139, P1069, DOI 10.1016/j.cell.2009.11.030; Mahaney BL, 2009, BIOCHEM J, V417, P639, DOI 10.1042/BJ20080413; Mani RS, 2009, SCIENCE, V326, P1230, DOI 10.1126/science.1178124; Mathas S, 2009, CELL, V139, P1047, DOI 10.1016/j.cell.2009.11.037; Mathas S, 2009, P NATL ACAD SCI USA, V106, P5831, DOI 10.1073/pnas.0900912106; Meek K, 2008, ADV IMMUNOL, V99, P33, DOI 10.1016/S0065-2776(08)00602-0; Moreno-Herrero F, 2005, NATURE, V437, P440, DOI 10.1038/nature03927; Nakai W, 2011, DNA REPAIR, V10, P102, DOI 10.1016/j.dnarep.2010.10.004; Neal JA, 2011, MOL CELL BIOL, V31, P1719, DOI 10.1128/MCB.01298-10; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Palli SR, 2003, EUR J BIOCHEM, V270, P1308, DOI 10.1046/j.1432-1033.2003.03501.x; Paull TT, 2010, DNA REPAIR, V9, P1283, DOI 10.1016/j.dnarep.2010.09.015; Paulsen RD, 2009, MOL CELL, V35, P228, DOI 10.1016/j.molcel.2009.06.021; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Rahal EA, 2010, CELL CYCLE, V9, P2866, DOI 10.4161/cc.9.14.12408; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Rooney S, 2003, J EXP MED, V197, P553, DOI 10.1084/jem.20021891; Shanbhag NM, 2010, CELL, V141, P970, DOI 10.1016/j.cell.2010.04.038; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Shrivastav M, 2009, DNA REPAIR, V8, P920, DOI 10.1016/j.dnarep.2009.05.006; Stark JM, 2004, MOL CELL BIOL, V24, P9305, DOI 10.1128/MCB.24.21.9305-9316.2004; Stark JM, 2003, MOL CELL BIOL, V23, P733, DOI 10.1128/MCB.23.2.733-743.2003; Stark JM, 2002, J BIOL CHEM, V277, P20185, DOI 10.1074/jbc.M112132200; Stephens PJ, 2009, NATURE, V462, P1005, DOI 10.1038/nature08645; Stracker TH, 2011, NAT REV MOL CELL BIO, V12, P90, DOI 10.1038/nrm3047; Stratton MR, 2011, SCIENCE, V331, P1553, DOI 10.1126/science.1204040; Sung P, 2003, J BIOL CHEM, V278, P42729, DOI 10.1074/jbc.R300027200; Tsai CJ, 2007, P NATL ACAD SCI USA, V104, P7851, DOI 10.1073/pnas.0702620104; Uematsu N, 2007, J CELL BIOL, V177, P219, DOI 10.1083/jcb.200608077; van der Burg M, 2009, J CLIN INVEST, V119, P91, DOI 10.1172/JCI37141; vanderBurgt I, 1996, J MED GENET, V33, P153, DOI 10.1136/jmg.33.2.153; Veuger SJ, 2003, CANCER RES, V63, P6008; Waltes R, 2009, AM J HUM GENET, V84, P605, DOI 10.1016/j.ajhg.2009.04.010; Weinstock DM, 2006, BLOOD, V107, P777, DOI 10.1182/blood-2005-06-2437; Weterings E, 2003, NUCLEIC ACIDS RES, V31, P7238, DOI 10.1093/nar/gkg889; Williams GJ, 2010, DNA REPAIR, V9, P1299, DOI 10.1016/j.dnarep.2010.10.001; Xie AY, 2004, MOL CELL, V16, P1017, DOI 10.1016/j.molcel.2004.12.007; Xu Y, 2011, CELL CYCLE, V10, P261, DOI 10.4161/cc.10.2.14543; Yang YG, 2006, EMBO J, V25, P5527, DOI 10.1038/sj.emboj.7601411; Yin B, 2009, J EXP MED, V206, P2625, DOI 10.1084/jem.20091320; Yuan JS, 2010, FEBS LETT, V584, P3717, DOI 10.1016/j.febslet.2010.05.021; Zha S, 2008, P NATL ACAD SCI USA, V105, P9302, DOI 10.1073/pnas.0803520105	73	81	89	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42470	42482		10.1074/jbc.M111.309252	http://dx.doi.org/10.1074/jbc.M111.309252			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	22027841	Green Published, hybrid			2022-12-27	WOS:000298180900055
J	Jones, EM; Wu, B; Surewicz, K; Nadaud, PS; Helmus, JJ; Chen, SG; Jaroniec, CP; Surewicz, WK				Jones, Eric M.; Wu, Bo; Surewicz, Krystyna; Nadaud, Philippe S.; Helmus, Jonathan J.; Chen, Shugui; Jaroniec, Christopher P.; Surewicz, Witold K.			Structural Polymorphism in Amyloids NEW INSIGHTS FROM STUDIES WITH Y145Stop PRION PROTEIN FIBRILS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN PRION PROTEIN; NUCLEAR-MAGNETIC-RESONANCE; STATE NMR-SPECTROSCOPY; BETA-SHEET STRUCTURE; SECONDARY STRUCTURE; Y145STOP VARIANT; STRAIN VARIANTS; IN-VITRO; FIBRILS; PROPAGATION	The C-terminally-truncated human prion protein variant Y145Stop (or PrP23-144), associated with a familial prion disease, provides a valuable model for studying the fundamental properties of protein amyloids. In previous solid-state NMR experiments, we established that the beta-sheet core of the PrP23-144 amyloid is composed of two beta-strand regions encompassing residues similar to 113-125 and similar to 130-140. The former segment contains a highly conserved hydrophobic palindrome sequence, (113)AGAAAAGA(120), which has been considered essential to PrP conformational conversion. Here, we examine the role of this segment in fibrillization of PrP23-144 using a deletion variant, Delta 113-120 PrP23-144, in which the palindrome sequence is missing. Surprisingly, we find that deletion of the palindrome sequence affects neither the amyloidogenicity nor the polymerization kinetics of PrP23-144, although it does alter amyloid conformation and morphology. Using two-dimensional and three-dimensional solid-state NMR methods, we find that Delta 113-120 PrP23-144 fibrils contain an altered beta-core extended N-terminally to residue similar to 106, encompassing residues not present in the core of wild-type PrP23-144 fibrils. The C-terminal beta-strand of the core, however, is similar in both fibril types. Collectively, these data indicate that amyloid cores of PrP23-144 variants contain "essential" (i.e. nucleation-determining) and "nonessential" regions, with the latter being "movable" in amino acid sequence space. These findings reveal an intriguing new mechanism for structural polymorphism in amyloids and suggest a potential means for modulating the physicochemical properties of amyloid fibrils without compromising their polymerization characteristics.	[Wu, Bo; Nadaud, Philippe S.; Helmus, Jonathan J.; Jaroniec, Christopher P.] Ohio State Univ, Dept Chem, Columbus, OH 43210 USA; [Jones, Eric M.; Surewicz, Krystyna; Chen, Shugui; Surewicz, Witold K.] Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA	Ohio State University; Case Western Reserve University	Jaroniec, CP (corresponding author), Ohio State Univ, Dept Chem, Columbus, OH 43210 USA.	jaroniec@chemistry.ohio-state.edu; witold.surewicz@case.edu	Jaroniec, Christopher/A-4948-2008	Jaroniec, Christopher/0000-0003-0364-2888	National Institutes of Health [R01NS038604, R01NS044158, R01GM094357]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094357] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038604, R01NS044158] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grants R01NS038604 and R01NS044158 (to W.K.S.) and R01GM094357 (to C.P.J.).	Apostol MI, 2011, BIOCHEMISTRY-US, V50, P2456, DOI 10.1021/bi101803k; Auer S, 2007, HFSP J, V1, P137, DOI 10.2976/1.2760023; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; BYLER DM, 1986, BIOPOLYMERS, V25, P469, DOI 10.1002/bip.360250307; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; Channon K, 2008, SOFT MATTER, V4, P647, DOI 10.1039/b713013a; Cherny I, 2008, ANGEW CHEM INT EDIT, V47, P4062, DOI 10.1002/anie.200703133; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Cobb NJ, 2007, P NATL ACAD SCI USA, V104, P18946, DOI 10.1073/pnas.0706522104; Cobb NJ, 2009, BIOCHEMISTRY-US, V48, P2574, DOI 10.1021/bi900108v; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; GASSET M, 1992, P NATL ACAD SCI USA, V89, P10940, DOI 10.1073/pnas.89.22.10940; Gebbink MFBG, 2005, NAT REV MICROBIOL, V3, P333, DOI 10.1038/nrmicro1127; Goddard T. D., 2006, SPARKY 3; Greenwald J, 2010, STRUCTURE, V18, P1244, DOI 10.1016/j.str.2010.08.009; Helmus JJ, 2008, P NATL ACAD SCI USA, V105, P6284, DOI 10.1073/pnas.0711716105; Helmus JJ, 2011, J AM CHEM SOC, V133, P13934, DOI 10.1021/ja206469q; Helmus JJ, 2010, J AM CHEM SOC, V132, P2393, DOI 10.1021/ja909827v; Hiramatsu H, 2010, B CHEM SOC JPN, V83, P495, DOI 10.1246/bcsj.20090317; Jones EM, 2006, J BIOL CHEM, V281, P8190, DOI 10.1074/jbc.M513417200; Jones EM, 2005, CELL, V121, P63, DOI 10.1016/j.cell.2005.01.034; KITAMOTO T, 1993, BIOCHEM BIOPH RES CO, V192, P525, DOI 10.1006/bbrc.1993.1447; Kundu B, 2003, P NATL ACAD SCI USA, V100, P12069, DOI 10.1073/pnas.2033281100; Kuwata K, 2003, P NATL ACAD SCI USA, V100, P14790, DOI 10.1073/pnas.2433563100; Lee SW, 2008, J MOL BIOL, V378, P1142, DOI 10.1016/j.jmb.2008.03.035; Lu XJ, 2007, P NATL ACAD SCI USA, V104, P1510, DOI 10.1073/pnas.0608447104; Miller Y, 2010, CHEM REV, V110, P4820, DOI 10.1021/cr900377t; Moore RA, 2006, PROTEIN SCI, V15, P609, DOI 10.1110/ps.051822606; Morillas M, 1999, J BIOL CHEM, V274, P36859, DOI 10.1074/jbc.274.52.36859; Mossuto MF, 2010, J MOL BIOL, V402, P783, DOI 10.1016/j.jmb.2010.07.005; Nadaud PS, 2007, BIOMOL NMR ASSIGN, V1, P117, DOI 10.1007/s12104-007-9041-0; Norstrom EM, 2005, J BIOL CHEM, V280, P27236, DOI 10.1074/jbc.M413441200; Paravastu AK, 2008, P NATL ACAD SCI USA, V105, P18349, DOI 10.1073/pnas.0806270105; Pepys MB, 2001, PHILOS T R SOC B, V356, P203, DOI 10.1098/rstb.2000.0766; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Shewmaker F, 2011, J BIOL CHEM, V286, P16533, DOI 10.1074/jbc.R111.227108; Surewicz WK, 2006, ACCOUNTS CHEM RES, V39, P654, DOI 10.1021/ar050226c; Tanaka M, 2005, CELL, V121, P49, DOI 10.1016/j.cell.2005.03.008; TATEISHI J, 1995, BRAIN PATHOL, V5, P53, DOI 10.1111/j.1750-3639.1995.tb00577.x; Tessier PM, 2009, NAT STRUCT MOL BIOL, V16, P598, DOI 10.1038/nsmb.1617; Toyama BH, 2007, NATURE, V449, P233, DOI 10.1038/nature06108; Tycko R, 2010, BIOCHEMISTRY-US, V49, P9488, DOI 10.1021/bi1013134; Vanik DL, 2004, MOL CELL, V14, P139, DOI 10.1016/S1097-2765(04)00155-8; Verges KJ, 2011, NAT STRUCT MOL BIOL, V18, P493, DOI 10.1038/nsmb.2030; Voisine C, 2010, NEUROBIOL DIS, V40, P12, DOI 10.1016/j.nbd.2010.05.007; Walsh P, 2009, STRUCTURE, V17, P417, DOI 10.1016/j.str.2008.12.018; Wang L, 2010, ANGEW CHEM INT EDIT, V49, P3904, DOI 10.1002/anie.201000068; Westermark P, 2011, PHYSIOL REV, V91, P795, DOI 10.1152/physrev.00042.2009; Wiltzius JJW, 2008, PROTEIN SCI, V17, P1467, DOI 10.1110/ps.036509.108; Wiltzius JJW, 2009, NAT STRUCT MOL BIOL, V16, P973, DOI 10.1038/nsmb.1643; Yoshiike Y, 2007, BIOCHEMISTRY-US, V46, P9805, DOI 10.1021/bi700455c	52	29	29	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42777	42784		10.1074/jbc.M111.302539	http://dx.doi.org/10.1074/jbc.M111.302539			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	22002245	hybrid, Green Published			2022-12-27	WOS:000298180900084
J	Bartoszewski, R; Brewer, JW; Rab, A; Crossman, DK; Bartoszewska, S; Kapoor, N; Fuller, C; Collawn, JF; Bebok, Z				Bartoszewski, Rafal; Brewer, Joseph W.; Rab, Andras; Crossman, David K.; Bartoszewska, Sylwia; Kapoor, Niren; Fuller, Cathy; Collawn, James F.; Bebok, Zsuzsa			The Unfolded Protein Response (UPR)-activated Transcription Factor X-box-binding Protein 1 (XBP1) Induces MicroRNA-346 Expression That Targets the Human Antigen Peptide Transporter 1 (TAP1) mRNA and Governs Immune Regulatory Genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; ER STRESS; MAMMALIAN-CELLS; CHAIN; DECAY	To identify endoplasmic reticulum (ER) stress-induced microRNAs (miRNA) that govern ER protein influx during the adaptive phase of unfolded protein response, we performed miRNA microarray profiling and analysis in human airway epithelial cells following ER stress induction using proteasome inhibition or tunicamycin treatment. We identified miR-346 as the most significantly induced miRNA by both classic stressors. miR-346 is encoded within an intron of the glutamate receptor ionotropic delta-1 gene (GRID1), but its ER stress-associated expression is independent of GRID1. We demonstrated that the spliced X-box-binding protein-1 (sXBP1) is necessary and sufficient for ER stress-associated miR-346 induction, revealing a novel role for this unfolded protein response-activated transcription factor. In mRNA profiling arrays, we identified 21 mRNAs that were reduced by both ER stress and miR-346. The target genes of miR-346 regulate immune responses and include the major histocompatibility complex (MHC) class I gene products, interferon-induced genes, and the ER antigen peptide transporter 1 (TAP1). Although most of the repressed mRNAs appear to be indirect targets because they lack specific seeding sites for miR-346, we demonstrate that the human TAP1 mRNA is a direct target of miR-346. The human TAP1 mRNA 3'-UTR contains a 6-mer canonical seeding site for miR-346. Importantly, the ER stress-associated reduction in human TAP1 mRNA and protein levels could be reversed with an miR-346 antagomir. Because TAP function is necessary for proper MHC class I-associated antigen presentation, our results provide a novel mechanistic explanation for reduced MHC class I-associated antigen presentation that was observed during ER stress.	[Bartoszewski, Rafal; Rab, Andras; Bartoszewska, Sylwia; Collawn, James F.; Bebok, Zsuzsa] Univ Alabama Birmingham, Dept Cell Biol, Birmingham, AL 35294 USA; [Crossman, David K.] Univ Alabama Birmingham, Dept Genet, Birmingham, AL 35294 USA; [Kapoor, Niren; Fuller, Cathy] Univ Alabama Birmingham, Dept Physiol, Birmingham, AL 35294 USA; [Brewer, Joseph W.] Univ S Alabama, Dept Microbiol & Immunol, Mobile, AL 36688 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of South Alabama	Bartoszewski, R (corresponding author), Univ Alabama Birmingham, Dept Cell Biol, 1918 Univ Blvd,MCLM 350, Birmingham, AL 35294 USA.	rafalbar@uab.edu; bebok@uab.edu	Bartoszewski, Rafal A/D-6311-2011; Bartoszewska, Sylwia/L-3922-2019; Rab, András/AAR-7804-2021; Rab, Andras/AAI-9402-2021	Bartoszewski, Rafal A/0000-0002-2864-6757; Bartoszewska, Sylwia/0000-0001-8063-1272; Rab, András/0000-0003-2154-0017; Collawn, James/0000-0002-2528-2759; Crossman, David/0000-0002-0981-169X	National Institutes of Health [HL076587, GM61970, DK060065]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076587] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK037206, R01DK060065] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061970] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL076587 (to Z. B.), GM61970 (to J. W. B.), and DK060065 (to J. F. C.).	Adachi Y, 2008, CELL STRUCT FUNCT, V33, P75, DOI 10.1247/csf.07044; Alexiou P, 2010, NUCLEIC ACIDS RES, V38, pD137, DOI 10.1093/nar/gkp888; Alsaleh G, 2009, J IMMUNOL, V182, P5088, DOI 10.4049/jimmunol.0801613; Applied Biosystems, 2004, REL QUANT APPL BIOS; Asirvatham AJ, 2008, MOL IMMUNOL, V45, P1995, DOI 10.1016/j.molimm.2007.10.035; BAHRAM S, 1991, P NATL ACAD SCI USA, V88, P10094, DOI 10.1073/pnas.88.22.10094; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartoszewski R, 2008, J BIOL CHEM, V283, P12154, DOI 10.1074/jbc.M707610200; Bartoszewski R, 2011, METHOD ENZYMOL, V491, P3, DOI 10.1016/B978-0-12-385928-0.00001-8; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Behrman S, 2011, J CELL BIOL, V192, P919, DOI 10.1083/jcb.201010055; Bommiasamy H, 2009, J CELL SCI, V122, P1626, DOI 10.1242/jcs.045625; de Almeida SF, 2007, J IMMUNOL, V178, P3612, DOI 10.4049/jimmunol.178.6.3612; DuRose JB, 2009, MOL CELL BIOL, V29, P4295, DOI 10.1128/MCB.00260-09; ELLIOTT T, 1991, NATURE, V351, P402, DOI 10.1038/351402a0; Fonseca SG, 2011, TRENDS ENDOCRIN MET, V22, P266, DOI 10.1016/j.tem.2011.02.008; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Granados DP, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-10; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; HEEMELS MT, 1995, ANNU REV BIOCHEM, V64, P463, DOI 10.1146/annurev.bi.64.070195.002335; Herget M, 2007, PFLUG ARCH EUR J PHY, V453, P591, DOI 10.1007/s00424-006-0083-4; Hollien J, 2006, SCIENCE, V313, P104, DOI 10.1126/science.1129631; Hollien J, 2009, J CELL BIOL, V186, P323, DOI 10.1083/jcb.200903014; KLEIJMEER MJ, 1992, NATURE, V357, P342, DOI 10.1038/357342a0; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lankat-Buttgereit B, 2002, PHYSIOL REV, V82, P187, DOI 10.1152/physrev.00025.2001; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-166; Lin Hui-Ju, 2004, Mol Diagn, V8, P245, DOI 10.2165/00066982-200408040-00006; Malhotra JD, 2007, SEMIN CELL DEV BIOL, V18, P716, DOI 10.1016/j.semcdb.2007.09.003; Malhotra JD, 2007, ANTIOXID REDOX SIGN, V9, P2277, DOI 10.1089/ars.2007.1782; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; NEEFJES JJ, 1993, CURR OPIN IMMUNOL, V5, P27, DOI 10.1016/0952-7915(93)90077-6; Oda Y, 2006, J CELL BIOL, V172, P383, DOI 10.1083/jcb.200507057; POWIS SJ, 1991, NATURE, V354, P528, DOI 10.1038/354528a0; Rab A, 2007, AM J PHYSIOL-CELL PH, V292, pC756, DOI 10.1152/ajpcell.00391.2006; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; Saetrom O, 2005, RNA, V11, P995, DOI 10.1261/rna.7290705; Saetrom P, 2007, NUCLEIC ACIDS RES, V35, P2333, DOI 10.1093/nar/gkm133; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Semaan N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019827; Shaffer AL, 2004, IMMUNITY, V21, P81, DOI 10.1016/j.immuni.2004.06.010; Sriburi R, 2004, J CELL BIOL, V167, P35, DOI 10.1083/jcb.200406136; Tardif KD, 2003, J VIROL, V77, P11644, DOI 10.1128/JVI.77.21.11644-11650.2003; Thompson LH, 2010, CELL CYCLE, V9, P4213, DOI 10.4161/cc.9.20.13543; Tsai NP, 2009, BIOCHEM J, V424, P411, DOI 10.1042/BJ20090915; Ulianich L., 2011, BIOCHIM BIOPHYS ACTA, V1812, P431; Weber F, 2006, J CLIN ENDOCR METAB, V91, P3584, DOI 10.1210/jc.2006-0693; Welihinda AA, 1999, GENE EXPRESSION, V7, P293; Yadav D, 2009, J IMMUNOL, V182, P39, DOI 10.4049/jimmunol.182.1.39; Yoshida H, 2006, J CELL BIOL, V172, P565, DOI 10.1083/jcb.200508145; Zhu YL, 2009, SCHIZOPHR RES, V109, P86, DOI 10.1016/j.schres.2009.01.022	57	104	108	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41862	41870		10.1074/jbc.M111.304956	http://dx.doi.org/10.1074/jbc.M111.304956			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	22002058	Green Published, hybrid			2022-12-27	WOS:000298057500068
J	Xu, G; Ahn, J; Chang, S; Eguchi, M; Ogier, A; Han, S; Park, Y; Shim, C; Jang, YS; Yang, B; Xu, AM; Wang, Y; Sweeney, G				Xu, Guoxiong; Ahn, JinHee; Chang, SoYoung; Eguchi, Megumi; Ogier, Arnaud; Han, SungJun; Park, YoungSam; Shim, ChiYoung; Jang, YangSoo; Yang, Bo; Xu, Aimin; Wang, Yu; Sweeney, Gary			Lipocalin-2 Induces Cardiomyocyte Apoptosis by Increasing Intracellular Iron Accumulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GELATINASE-ASSOCIATED LIPOCALIN; CHRONIC HEART-FAILURE; NEUTROPHIL-GELATINASE; INSULIN-RESISTANCE; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; DOWN-REGULATION; CELLS; OBESITY; NGAL	Our objective was to determine whether lipocalin-2 (Lcn2) regulates cardiomyocyte apoptosis, the mechanisms involved, and the functional significance. Emerging evidence suggests that Lcn2 is a proinflammatory adipokine associated with insulin resistance and obesity-related complications, such as heart failure. Here, we used both primary neonatal rat cardiomyocytes and H9c2 cells and demonstrated for the first time that Lcn2 directly induced cardiomyocyte apoptosis, an important component of cardiac remodeling leading to heart failure. This was shown by detection of DNA fragmentation using TUNEL assay, phosphatidylserine exposure using flow cytometry to detect annexin V-positive cells, caspase-3 activity using enzymatic assay and immunofluorescence, and Western blotting for the detection of cleaved caspase-3. We also observed that Lcn2 caused translocation of the proapoptotic protein Bax to mitochondria and disruption of mitochondrial membrane potential. Using transient transfection of GFP-Bax, we confirmed that Lcn2 induced co-localization of Bax with MitoTracker (R) dye. Importantly, we used the fluorescent probe Phen Green SK to demonstrate an increase in intracellular iron in response to Lcn2, and depleting intracellular iron using an iron chelator prevented Lcn2-induced cardiomyocyte apoptosis. Administration of recombinant Lcn2 to mice for 14 days increased cardiomyocyte apoptosis as well as an acute inflammatory response with compensatory changes in cardiac functional parameters. In conclusion, Lcn2-induced cardiomyocyte apoptosis is of physiological significance and occurs via a mechanism involving elevated intracellular iron levels and Bax translocation.	[Shim, ChiYoung; Jang, YangSoo] Yonsei Univ, Coll Med, Dept Cardiol, Seoul 120752, South Korea; [Yang, Bo; Xu, Aimin; Wang, Yu] Univ Hong Kong, Dept Pharmacol, Pokfulam, Hong Kong, Peoples R China; [Eguchi, Megumi; Sweeney, Gary] York Univ, Dept Biol, Toronto, ON M3J 1P3, Canada; [Xu, Guoxiong; Ahn, JinHee; Eguchi, Megumi; Sweeney, Gary] Inst Pasteur Korea, Diabet Grp, Songnam 463400, Gyeonggi, South Korea; [Ogier, Arnaud] Inst Pasteur Korea, Toxic Grp, Songnam 463400, Gyeonggi, South Korea; [Park, YoungSam; Shim, ChiYoung] Inst Pasteur Korea, Drug Biol Grp, Songnam 463400, Gyeonggi, South Korea	Yonsei University; Yonsei University Health System; University of Hong Kong; York University - Canada; Institut Pasteur Korea; Institut Pasteur Korea; Institut Pasteur Korea	Sweeney, G (corresponding author), Inst Pasteur Korea, 696 Sampyung dong, Songnam 463400, Gyeonggi, South Korea.	gary@ip-korea.org	Shim, Chi Young/AAK-1057-2021; Xu, Aimin/D-3291-2013; Han, Sung-Jun/B-9547-2012	Shim, Chi Young/0000-0002-6136-0136; Xu, Aimin/0000-0002-0668-033X; Chang, So Young/0000-0002-6390-6462; Jang, Yangsoo/0000-0002-2169-3112; wang, yu/0000-0001-8697-2940	National Research Foundation of Korea [2010-0012009]; Research Grants Council of Hong Kong [HKU 2/07C, 4/HKU/10C]	National Research Foundation of Korea(National Research Foundation of Korea); Research Grants Council of Hong Kong(Hong Kong Research Grants Council)	This work was supported by National Research Foundation of Korea Grant 2010-0012009 (to G. S.) and by Collaborative Research Fund HKU 2/07C and 4/HKU/10C from the Research Grants Council of Hong Kong (to A.X. and Y.W.).	Abel ED, 2008, PHYSIOL REV, V88, P389, DOI 10.1152/physrev.00017.2007; Aigner F, 2007, AM J TRANSPLANT, V7, P779, DOI 10.1111/j.1600-6143.2006.01723.x; Artham Surya M, 2008, J Cardiometab Syndr, V3, P155, DOI 10.1111/j.1559-4572.2008.00001.x; Arvapalli RK, 2010, CARDIOVASC TOXICOL, V10, P108, DOI 10.1007/s12012-010-9068-9; Bachman MA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000622; Bolignano D, 2009, REJUV RES, V12, P7, DOI 10.1089/rej.2008.0803; Bong JJ, 2004, MOL CELLS, V17, P29; Borgna-Pignatti C, 2006, BLOOD, V107, P3733, DOI 10.1182/blood-2005-07-2933; Bu DX, 2006, AM J PATHOL, V169, P2245, DOI 10.2353/ajpath.2006.050706; Chan YR, 2009, J IMMUNOL, V182, P4947, DOI 10.4049/jimmunol.0803282; Choi KM, 2008, EUR J ENDOCRINOL, V158, P203, DOI 10.1530/EJE-07-0633; Cowland JB, 1997, GENOMICS, V45, P17, DOI 10.1006/geno.1997.4896; Damman K, 2008, EUR J HEART FAIL, V10, P997, DOI 10.1016/j.ejheart.2008.07.001; Devireddy LR, 2005, CELL, V123, P1293, DOI 10.1016/j.cell.2005.10.027; Devireddy LR, 2001, SCIENCE, V293, P829, DOI 10.1126/science.1061075; Flo TH, 2004, NATURE, V432, P917, DOI 10.1038/nature03104; Flower DR, 1996, BIOCHEM J, V318, P1; Goetz DH, 2002, MOL CELL, V10, P1033, DOI 10.1016/S1097-2765(02)00708-6; Goswami T, 2002, BIOCHEM CELL BIOL, V80, P679, DOI 10.1139/O02-159; Guo H, 2010, DIABETES, V59, P1376, DOI 10.2337/db09-1735; Hemdahl AL, 2006, ARTERIOSCL THROM VAS, V26, P136, DOI 10.1161/01.ATV.0000193567.88685.f4; Hou Q, 2005, AM J PHYSIOL-HEART C, V289, pH477, DOI 10.1152/ajpheart.00879.2004; Hvidberg V, 2005, FEBS LETT, V579, P773, DOI 10.1016/j.febslet.2004.12.031; Jang Y., 2011, CLIN EXP PH IN PRESS; Kahn E, 2010, INT J NANOMED, V5, P185; KJELDSEN L, 1993, J BIOL CHEM, V268, P10425; Kohgo Y, 2008, INT J HEMATOL, V88, P7, DOI 10.1007/s12185-008-0120-5; Kooncumchoo P, 2006, J MOL NEUROSCI, V28, P125, DOI 10.1385/JMN:28:2:125; Law IKM, 2010, DIABETES, V59, P872, DOI 10.2337/db09-1541; Lee S, 2009, J NEUROSCI, V29, P234, DOI 10.1523/JNEUROSCI.5273-08.2009; Mazzone T, 2008, LANCET, V371, P1800, DOI 10.1016/S0140-6736(08)60768-0; Mishra Jaya, 2005, Lancet, V365, P1231, DOI 10.1016/S0140-6736(05)74811-X; Munoz JP, 2010, FREE RADICAL BIO MED, V48, P526, DOI 10.1016/j.freeradbiomed.2009.11.017; Narula J, 1996, NEW ENGL J MED, V335, P1182, DOI 10.1056/NEJM199610173351603; Narula J, 2000, CURR OPIN CARDIOL, V15, P183, DOI 10.1097/00001573-200005000-00011; Olivetti G, 1997, NEW ENGL J MED, V336, P1131, DOI 10.1056/NEJM199704173361603; Oudit GY, 2004, CIRCULATION, V109, P1877, DOI 10.1161/01.CIR.0000124229.40424.80; Palanivel R, 2007, CARDIOVASC RES, V75, P148, DOI 10.1016/j.cardiores.2007.04.011; Petrat F, 1999, HEPATOLOGY, V29, P1171, DOI 10.1002/hep.510290435; Poniatowski B, 2009, KIDNEY BLOOD PRESS R, V32, P77, DOI 10.1159/000208989; Schmidt-Ott KM, 2006, CURR OPIN NEPHROL HY, V15, P442, DOI 10.1097/01.mnh.0000232886.81142.58; Schwartz N, 2007, ANN NY ACAD SCI, V1109, P265, DOI 10.1196/annals.1398.032; Shin E, 2009, J CELL PHYSIOL, V221, P490, DOI 10.1002/jcp.21883; Spagnuolo RD, 2011, BRIT J PHARMACOL, V163, P299, DOI 10.1111/j.1476-5381.2011.01208.x; Takemura G, 2004, PHARMACOL THERAPEUT, V104, P1, DOI 10.1016/j.pharmthera.2004.07.005; Trivedi PS, 2008, CURR HYPERTENS REP, V10, P454, DOI 10.1007/s11906-008-0085-z; van Dam RM, 2007, CLIN CHEM, V53, P5, DOI 10.1373/clinchem.2006.080432; VelezPardo C, 1997, PHARMACOL TOXICOL, V80, P76, DOI 10.1111/j.1600-0773.1997.tb00287.x; Walsh K, 2009, CIRC J, V73, P13, DOI 10.1253/circj.CJ-08-0961; Wang YL, 2011, J PHARMACOL EXP THER, V336, P56, DOI 10.1124/jpet.110.172668; Wang Y, 2007, CLIN CHEM, V53, P34, DOI 10.1373/clinchem.2006.075614; Whittaker P, 1996, TOXICOL PATHOL, V24, P558, DOI 10.1177/019262339602400504; Xu GX, 2006, MOL CANCER RES, V4, P235, DOI 10.1158/1541-7786.MCR-05-0174; Yan QW, 2007, DIABETES, V56, P2533, DOI 10.2337/db07-0007; Yang J, 2002, MOL CELL, V10, P1045, DOI 10.1016/S1097-2765(02)00710-4; Yndestad A, 2009, EUR HEART J, V30, P1229, DOI 10.1093/eurheartj/ehp088; Zheng LT, 2009, J NEUROCHEM, V111, P1238, DOI 10.1111/j.1471-4159.2009.06410.x	57	91	94	0	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					4808	4817		10.1074/jbc.M111.275719	http://dx.doi.org/10.1074/jbc.M111.275719			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22117066	Green Published, hybrid			2022-12-27	WOS:000300608500042
J	Egger, S; Chaikuad, A; Klimacek, M; Kavanagh, KL; Oppermann, U; Nidetzky, B				Egger, Sigrid; Chaikuad, Apirat; Klimacek, Mario; Kavanagh, Kathryn L.; Oppermann, Udo; Nidetzky, Bernd			Structural and Kinetic Evidence That Catalytic Reaction of Human UDP-glucose 6-Dehydrogenase Involves Covalent Thiohemiacetal and Thioester Enzyme Intermediates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							URIDINE DIPHOSPHOGLUCOSE DEHYDROGENASE; MECHANISM; INHIBITION; RESIDUES; REVEALS; BINDING; 2ND	Biosynthesis of UDP-glucuronic acid by UDP-glucose 6-dehydrogenase (UGDH) occurs through the four-electron oxidation of the UDP-glucose C6 primary alcohol in two NAD(+)-dependent steps. The catalytic reaction of UGDH is thought to involve a Cys nucleophile that promotes formation of a thiohemiacetal enzyme intermediate in the course of the first oxidation step. The thiohemiacetal undergoes further oxidation into a thioester, and hydrolysis of the thioester completes the catalytic cycle. Herein we present crystallographic and kinetic evidence for the human form of UGDH that clarifies participation of covalent catalysis in the enzymatic mechanism. Substitution of the putative catalytic base for water attack on the thioester (Glu(161)) by an incompetent analog (Gln(161)) gave a UGDH variant (E161Q) in which the hydrolysis step had become completely rate-limiting so that a thioester enzyme intermediate accumulated at steady state. By crystallizing E161Q in the presence of 5 mM UDP-glucose and 2 mM NAD(+), we succeeded in trapping a thiohemiacetal enzyme intermediate and determined its structure at 2.3 angstrom resolution. Cys(276) was covalently modified in the structure, establishing its role as catalytic nucleophile of the reaction. The thiohemiacetal reactive C6 was in a position suitable to become further oxidized by hydride transfer to NAD(+). The proposed catalytic mechanism of human UGDH involves Lys(220) as general base for UDP-glucose alcohol oxidation and for oxyanion stabilization during formation and breakdown of the thiohemiacetal and thioester enzyme intermediates. Water coordinated to Asp(280) deprotonates Cys(276) to function as an aldehyde trap and also provides oxyanion stabilization. Glu(161) is the Bronsted base catalytically promoting the thioester hydrolysis.	[Egger, Sigrid; Klimacek, Mario; Nidetzky, Bernd] Graz Univ Technol, Inst Biotechnol & Biochem Engn, A-8010 Graz, Austria; [Chaikuad, Apirat; Kavanagh, Kathryn L.; Oppermann, Udo] Univ Oxford, Struct Genom Consortium, Oxford OX3 7DQ, England; [Oppermann, Udo] Univ Oxford, Botnar Res Ctr, Natl Inst Hlth Res Oxford Biomed Res Unit, Oxford OX3 7LD, England; [Egger, Sigrid; Nidetzky, Bernd] Austrian Ctr Ind Biotechnol, A-8010 Graz, Austria	Graz University of Technology; University of Oxford; University of Oxford; Austrian Centre of Industrial Biotechnology	Nidetzky, B (corresponding author), Graz Univ Technol, Inst Biotechnol & Biochem Engn, Petersgasse 12-1, A-8010 Graz, Austria.	bernd.nidetzky@tugraz.at		Chaikuad, Apirat/0000-0003-1120-2209; Nidetzky, Bernd/0000-0002-5030-2643	Austrian Science Fund (DK Molecular Enzymology) [W901-B05]; Structural Genomics Consortium [1097737]; Wellcome Trust; GlaxoSmithKline; Genome Canada; Canadian Institutes of Health Research; Ontario Innovation Trust; Ontario Research and Development Challenge Fund; Canadian Foundation for Innovation; Vinnova; Swedish Strategic Research Foundation; Knut and Alice Wallenberg Foundation; Karolinska Institute; National Institute for Health Research Oxford Biomedical Research Unit; Austrian Science Fund (FWF) [W 901] Funding Source: researchfish	Austrian Science Fund (DK Molecular Enzymology)(Austrian Science Fund (FWF)); Structural Genomics Consortium(University of Toronto); Wellcome Trust(Wellcome TrustEuropean Commission); GlaxoSmithKline(GlaxoSmithKline); Genome Canada(Genome Canada); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Innovation Trust; Ontario Research and Development Challenge Fund(General Electric); Canadian Foundation for Innovation(Canada Foundation for Innovation); Vinnova(Vinnova); Swedish Strategic Research Foundation(Swedish Foundation for Strategic Research); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Karolinska Institute(Karolinska Institutet); National Institute for Health Research Oxford Biomedical Research Unit; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Fund (DK Molecular Enzymology W901-B05) and the Structural Genomics Consortium registered charity (no. 1097737) funded by the Wellcome Trust, GlaxoSmithKline, Genome Canada, the Canadian Institutes of Health Research, the Ontario Innovation Trust, the Ontario Research and Development Challenge Fund, the Canadian Foundation for Innovation, Vinnova, the Swedish Strategic Research Foundation, the Knut and Alice Wallenberg Foundation, and the Karolinska Institute. This work was also further supported by the National Institute for Health Research Oxford Biomedical Research Unit.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Campbell RE, 1997, J BIOL CHEM, V272, P3416, DOI 10.1074/jbc.272.6.3416; Campbell RE, 1999, J ORG CHEM, V64, P9487, DOI 10.1021/jo991092h; Campbell RE, 2000, BIOCHEMISTRY-US, V39, P7012, DOI 10.1021/bi000181h; Chen YY, 2011, J STRUCT BIOL, V175, P300, DOI 10.1016/j.jsb.2011.04.010; Clarkin CE, 2011, MATRIX BIOL, V30, P163, DOI 10.1016/j.matbio.2011.01.002; Clarkin CE, 2011, J CELL PHYSIOL, V226, P749, DOI 10.1002/jcp.22393; D'Ambrosio K, 2006, BIOCHEMISTRY-US, V45, P2978, DOI 10.1021/bi0515117; Easley KE, 2007, BIOCHEMISTRY-US, V46, P369, DOI 10.1021/bi061537d; ECCLESTON ED, 1979, J BIOL CHEM, V254, P1399; Egger S, 2011, J BIOL CHEM, V286, P23877, DOI 10.1074/jbc.M111.234682; Egger S, 2010, BIOCHEM SOC T, V38, P1378, DOI 10.1042/BST0381378; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FRANZEN JS, 1973, BIOCHEM BIOPH RES CO, V50, P517, DOI 10.1016/0006-291X(73)90870-X; FRANZEN JS, 1976, BIOCHEMISTRY-US, V15, P5665, DOI 10.1021/bi00670a036; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Ge X, 2004, EUR J BIOCHEM, V271, P14, DOI 10.1046/j.1432-1033.2003.03876.x; Ge X, 1998, J AM CHEM SOC, V120, P6613, DOI 10.1021/ja9805977; Kadirvelraj R, 2011, BIOCHEMISTRY-US, V50, P5780, DOI 10.1021/bi2005637; Leslie AGW, 1999, ACTA CRYSTALLOGR D, V55, P1696, DOI 10.1107/S090744499900846X; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Munoz-Clares RA, 2011, CHEM-BIOL INTERACT, V191, P137, DOI 10.1016/j.cbi.2010.12.024; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NELSESTUEN GL, 1971, J BIOL CHEM, V246, P3828; ORDMAN AB, 1977, BIOCHIM BIOPHYS ACTA, V481, P25, DOI 10.1016/0005-2744(77)90133-4; ORDMAN AB, 1977, J BIOL CHEM, V252, P1320; Rajakannan V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025226; RIDLEY WP, 1973, BIOCHEM BIOPH RES CO, V54, P955, DOI 10.1016/0006-291X(73)90787-0; RIDLEY WP, 1975, J BIOL CHEM, V250, P8761; Rocha J, 2011, J BACTERIOL, V193, P3978, DOI 10.1128/JB.01076-10; SCHILLER JG, 1972, CARBOHYD RES, V21, P249, DOI 10.1016/S0008-6215(00)82151-5; Sommer BJ, 2004, J BIOL CHEM, V279, P23590, DOI 10.1074/jbc.M401928200; Tsai J, 1999, J MOL BIOL, V290, P253, DOI 10.1006/jmbi.1999.2829; Tukey RH, 2000, ANNU REV PHARMACOL, V40, P581, DOI 10.1146/annurev.pharmtox.40.1.581	34	23	24	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2012	287	3					2119	2129		10.1074/jbc.M111.313015	http://dx.doi.org/10.1074/jbc.M111.313015			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879HT	22123821	Green Published, hybrid			2022-12-27	WOS:000299321000052
J	Kefalov, VJ				Kefalov, Vladimir J.			Rod and Cone Visual Pigments and Phototransduction through Pharmacological, Genetic, and Physiological Approaches	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							RETINOID-BINDING PROTEIN; DARK-ADAPTATION; VERTEBRATE PHOTORECEPTORS; FRIEDENWALD-LECTURE; OPSIN ACTIVATION; OUTER SEGMENTS; ZEBRAFISH RETINA; NIGHT BLINDNESS; 9-METHYL GROUP; KNOCKOUT MICE	Activation of the visual pigment by light in rod and cone photoreceptors initiates our visual perception. As a result, the signaling properties of visual pigments, consisting of a protein, opsin, and a chromophore, 11-cis-retinal, play a key role in shaping the light responses of photoreceptors. The combination of pharmacological, physiological, and genetic tools has been a powerful approach advancing our understanding of the interactions between opsin and chromophore and how they affect the function of visual pigments. The signaling properties of the visual pigments modulate many aspects of the function of rods and cones, producing their unique physiological properties.	Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA	Washington University (WUSTL)	Kefalov, VJ (corresponding author), Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA.	kefalov@wustl.edu		Kefalov, Vladimir/0000-0002-1659-008X	National Institutes of Health [EY019312, EY021126, EY002687]; Research to Prevent Blindness career development award; NATIONAL EYE INSTITUTE [R01EY019312, P30EY002687, R24EY021126] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness career development award(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants EY019312 and EY021126 (to V. J. K.) and by Grant EY002687 (to the Department of Ophthalmology and Visual Sciences, Washington University). This work was also supported by a Research to Prevent Blindness career development award (to V. J. K.). This is the fourth article in the Thematic Minireview Series on Focus on Vision.	Ala-Laurila P, 2004, BIOPHYS J, V86, P3653, DOI 10.1529/biophysj.103.035626; Arshavsky VY, 2002, ANNU REV PHYSIOL, V64, P153, DOI 10.1146/annurev.physiol.64.082701.102229; BARLOW HB, 1957, NATURE, V179, P255, DOI 10.1038/179255b0; BAYLOR DA, 1979, J PHYSIOL-LONDON, V288, P613; BAYLOR DA, 1987, INVEST OPHTH VIS SCI, V28, P34; BAYLOR DA, 1980, J PHYSIOL-LONDON, V309, P591, DOI 10.1113/jphysiol.1980.sp013529; BOWNDS D, 1967, NATURE, V216, P1178, DOI 10.1038/2161178a0; BOYNTON RM, 1970, SCIENCE, V170, P1423, DOI 10.1126/science.170.3965.1423; Buczylko J, 1996, J BIOL CHEM, V271, P20621, DOI 10.1074/jbc.271.34.20621; Burns ME, 2010, PHYSIOLOGY, V25, P72, DOI 10.1152/physiol.00001.2010; Burns ME, 2001, ANNU REV NEUROSCI, V24, P779, DOI 10.1146/annurev.neuro.24.1.779; Burns ME, 2002, NEURON, V36, P81, DOI 10.1016/S0896-6273(02)00911-X; BUSTAMANTE JJ, 1995, AM J PHYSIOL-REG I, V269, pR1346; Chen CK, 1999, P NATL ACAD SCI USA, V96, P3718, DOI 10.1073/pnas.96.7.3718; CORNWALL MC, 1994, J PHYSIOL-LONDON, V480, P261, DOI 10.1113/jphysiol.1994.sp020358; CORNWALL MC, 1995, J GEN PHYSIOL, V106, P543, DOI 10.1085/jgp.106.3.543; Cornwall MC, 2000, METHOD ENZYMOL, V316, P224; Corson DW, 1996, PHOTOCHEM PHOTOBIOL, V63, P595, DOI 10.1111/j.1751-1097.1996.tb05661.x; Corson DW, 2000, J GEN PHYSIOL, V116, P283, DOI 10.1085/jgp.116.2.283; CRESCITELLI F, 1984, VISION RES, V24, P1551, DOI 10.1016/S0042-6989(84)80004-8; CROUCH RK, 1982, VISION RES, V22, P1451, DOI 10.1016/0042-6989(82)90209-7; Das J, 2004, BIOCHEMISTRY-US, V43, P5532, DOI 10.1021/bi036097u; DAS SR, 1992, BIOCHEM J, V285, P907, DOI 10.1042/bj2850907; DEFOE DM, 1983, INVEST OPHTH VIS SCI, V24, P1211; Dizhoor AM, 2008, J NEUROSCI, V28, P11662, DOI 10.1523/JNEUROSCI.4006-08.2008; Ebrey T, 2001, PROG RETIN EYE RES, V20, P49, DOI 10.1016/S1350-9462(00)00014-8; Estevez ME, 2009, J GEN PHYSIOL, V134, P137, DOI 10.1085/jgp.200910232; Fain GL, 1996, TRENDS NEUROSCI, V19, P502, DOI 10.1016/S0166-2236(96)10056-4; Fain GL, 2001, PHYSIOL REV, V81, P117, DOI 10.1152/physrev.2001.81.1.117; Fan J, 2005, J PHYSIOL-LONDON, V568, P83, DOI 10.1113/jphysiol.2005.091942; Fleisch VC, 2008, J NEUROSCI, V28, P8208, DOI 10.1523/JNEUROSCI.2367-08.2008; Fleisch VC, 2010, PROG RETIN EYE RES, V29, P476, DOI 10.1016/j.preteyeres.2010.05.001; Fu YB, 2008, NAT NEUROSCI, V11, P565, DOI 10.1038/nn.2110; Fu YB, 2007, PFLUG ARCH EUR J PHY, V454, P805, DOI 10.1007/s00424-006-0194-y; Gonzalez-Fernandez F, 2003, VISION RES, V43, P3021, DOI 10.1016/j.visres.2003.09.019; GREEN DG, 1971, SCIENCE, V174, P598, DOI 10.1126/science.174.4009.598; Hargrave PA, 2001, INVEST OPHTH VIS SCI, V42, P3; Imai H, 1997, P NATL ACAD SCI USA, V94, P2322, DOI 10.1073/pnas.94.6.2322; Imai H, 2007, J BIOL CHEM, V282, P6677, DOI 10.1074/jbc.M610086200; Isayama T, 2006, VISUAL NEUROSCI, V23, P899, DOI 10.1017/S0952523806230256; JIN J, 1993, NEURON, V11, P513, DOI 10.1016/0896-6273(93)90155-K; JIN J, 1994, VISUAL NEUROSCI, V11, P389, DOI 10.1017/S0952523800001735; Jin MH, 2009, J NEUROSCI, V29, P1486, DOI 10.1523/JNEUROSCI.3882-08.2009; Jin SN, 2003, NAT NEUROSCI, V6, P731, DOI 10.1038/nn1070; JONES GJ, 1989, P NATL ACAD SCI USA, V86, P9606, DOI 10.1073/pnas.86.23.9606; Jones GJ, 1996, J GEN PHYSIOL, V108, P333, DOI 10.1085/jgp.108.4.333; Kawamura S, 2008, COMP BIOCHEM PHYS A, V150, P369, DOI 10.1016/j.cbpa.2008.04.600; Kefalov V, 2003, NATURE, V425, P526, DOI 10.1038/nature01992; Kefalov V, 2010, ENCY EYE, V3, P389; Kefalov VJ, 1999, J GEN PHYSIOL, V113, P491, DOI 10.1085/jgp.113.3.491; Kefalov VJ, 2005, NEURON, V46, P879, DOI 10.1016/j.neuron.2005.05.009; Kefalov VJ, 2001, NEURON, V29, P749, DOI 10.1016/S0896-6273(01)00249-5; Kefalov VJ, 2010, METHODS MOL BIOL, V652, P95, DOI 10.1007/978-1-60327-325-1_5; Kiser P. D., 2012, BIOCH BIOPH IN PRESS; Kolesnikov AV, 2011, J NEUROSCI, V31, P7900, DOI 10.1523/JNEUROSCI.0438-11.2011; Kono M, 2010, METHODS MOL BIOL, V652, P85, DOI 10.1007/978-1-60327-325-1_4; Koutalos Y, 2010, METHODS MOL BIOL, V652, P129, DOI 10.1007/978-1-60327-325-1_7; Kusakabe TG, 2009, PHILOS T R SOC B, V364, P2897, DOI 10.1098/rstb.2009.0043; Lamb TD, 2004, PROG RETIN EYE RES, V23, P307, DOI 10.1016/j.preteyeres.2004.03.001; Leibrock CS, 1997, J PHYSIOL-LONDON, V501, P97, DOI 10.1111/j.1469-7793.1997.00097.x; Liang Y, 2003, J BIOL CHEM, V278, P21655, DOI 10.1074/jbc.M302536200; Luo D. G., 2008, SENSES COMPREHENSIVE, P269; Luo DG, 2008, P NATL ACAD SCI USA, V105, P9855, DOI 10.1073/pnas.0708405105; Luo DG, 2011, SCIENCE, V332, P1307, DOI 10.1126/science.1200172; Lyubarsky AL, 2004, VISION RES, V44, P3235, DOI 10.1016/j.visres.2004.09.019; Ma JX, 2001, NEURON, V32, P451, DOI 10.1016/S0896-6273(01)00482-2; Maeda A, 2007, P NATL ACAD SCI USA, V104, P19565, DOI 10.1073/pnas.0707477104; Mahroo OAR, 2004, J PHYSIOL-LONDON, V554, P417, DOI 10.1113/jphysiol.2003.051250; Makino CL, 2003, CURR OPIN NEUROBIOL, V13, P404, DOI 10.1016/S0959-4388(03)00091-6; Mata NL, 2002, NEURON, V36, P69, DOI 10.1016/S0896-6273(02)00912-1; MATSUMOTO H, 1975, BIOCHIM BIOPHYS ACTA, V404, P300, DOI 10.1016/0304-4165(75)90337-2; MATSUMOTO H, 1975, NATURE, V258, P523, DOI 10.1038/258523a0; McBee JK, 2001, PROG RETIN EYE RES, V20, P469, DOI 10.1016/S1350-9462(01)00002-7; Nickell S, 2007, J CELL BIOL, V177, P917, DOI 10.1083/jcb.200612010; Nikonov SS, 2008, NEURON, V59, P462, DOI 10.1016/j.neuron.2008.06.011; Palczewski K, 1999, BIOCHEMISTRY-US, V38, P12012, DOI 10.1021/bi990504d; Parker R, 2011, J NEUROSCI, V31, P4714, DOI 10.1523/JNEUROSCI.3722-10.2011; Parker RO, 2010, EXP EYE RES, V91, P788, DOI 10.1016/j.exer.2010.08.013; Parker RO, 2009, J NEUROSCI, V29, P4616, DOI 10.1523/JNEUROSCI.0063-09.2009; PEPPERBERG DR, 1978, J GEN PHYSIOL, V71, P369, DOI 10.1085/jgp.71.4.369; Rieke F, 2000, NEURON, V26, P181, DOI 10.1016/S0896-6273(00)81148-4; Ripps H, 2000, VISUAL NEUROSCI, V17, P97, DOI 10.1017/S095252380017110X; RUSHTON WAH, 1965, PROC R SOC SER B-BIO, V162, P20, DOI 10.1098/rspb.1965.0024; RUSHTON WAH, 1965, J PHYSIOL-LONDON, V181, P641, DOI 10.1113/jphysiol.1965.sp007788; Saari JC, 2000, INVEST OPHTH VIS SCI, V41, P337; Sakurai K, 2007, J GEN PHYSIOL, V130, P21, DOI 10.1085/jgp.200609729; Sampath AP, 2002, BIOPHYS J, V83, P184, DOI 10.1016/S0006-3495(02)75160-6; Shi G, 2007, J NEUROSCI, V27, P10084, DOI 10.1523/JNEUROSCI.2211-07.2007; Shichida Y, 1998, CELL MOL LIFE SCI, V54, P1299, DOI 10.1007/s000180050256; Tachibanaki S, 2005, P NATL ACAD SCI USA, V102, P9329, DOI 10.1073/pnas.0501875102; Tachibanaki S, 2001, P NATL ACAD SCI USA, V98, P14044, DOI 10.1073/pnas.241396898; Wang JS, 2011, PROG RETIN EYE RES, V30, P115, DOI 10.1016/j.preteyeres.2010.11.001; Wang JS, 2009, CURR BIOL, V19, P1665, DOI 10.1016/j.cub.2009.07.054; Wang JS, 2009, NAT NEUROSCI, V12, P295, DOI 10.1038/nn.2258; Wisard J, 2011, INVEST OPHTH VIS SCI, V52, P5804, DOI 10.1167/iovs.10-7129; Xu J, 1997, NATURE, V389, P505, DOI 10.1038/39068; YAU KW, 1994, INVEST OPHTH VIS SCI, V35, P9	97	63	64	1	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2012	287	3					1635	1641		10.1074/jbc.R111.303008	http://dx.doi.org/10.1074/jbc.R111.303008			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879HT	22074928	hybrid, Green Published			2022-12-27	WOS:000299321000005
J	Brown, DB; Forsberg, LS; Kannenberg, EL; Carlson, RW				Brown, Dusty B.; Forsberg, L. Scott; Kannenberg, Elmar L.; Carlson, Russell W.			Characterization of Galacturonosyl Transferase Genes rgtA, rgtB, rgtC, rgtD, and rgtE Responsible for Lipopolysaccharide Synthesis in Nitrogen-fixing Endosymbiont Rhizobium leguminosarum LIPOPOLYSACCHARIDE CORE AND LIPID GALACTURONOSYL RESIDUES CONFER MEMBRANE STABILITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXPRESSION CLONING; ACID; MUTANT; BIOSYNTHESIS; SALMONELLA; GENERATION; STRAINS	Rhizobium lipopolysaccharide (LPS) contains four terminally linked galacturonic acid (GalA) residues; one attached to the lipid A and three attached to the core oligosaccharide moiety. Attachment of the GalA residues requires the lipid donor dodecaprenyl-phosphate GalA (Dod-P-GalA), which is synthesized by the GalA transferase RgtE reported here. The galacturonosyl transferases RgtA, -B, and -C utilize Dod-P-GalA to attach GalAs on the LPS core region, and RgtD attaches GalA to the lipid A 4' position. As reported here, the functions of the rgtD and rgtE genes were determined via insertion mutagenesis and structural characterization of the mutant lipid A. The rgtE(-) mutant lacked Dod-P-GalA as determined by mass spectrometry of total lipid extracts and the inability of rgtE(-) mutant membranes to provide the substrate for heterologously expressed RgtA activity. In addition, we created single mutations in each of the rgtA, -B, -C, -D, and -E genes to study the biological function of the GalA residues. The structures of the core oligosaccharide region from each of the rgt mutants were elucidated by glycosyl linkage analysis. Each mutant was assayed for its sensitivity to sodium deoxycholate and to the antimicrobial cationic peptide, polymyxin B (PmxB). The rgt mutants were more sensitive than the parent strain to deoxycholate by varying degrees. However, the rgtA, -B, and -C mutants were more resistant to PmxB, whereas the rgtD and E mutants were less resistant in comparison to the parent strain.	[Brown, Dusty B.; Forsberg, L. Scott; Kannenberg, Elmar L.; Carlson, Russell W.] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Carlson, RW (corresponding author), Univ Georgia, Complex Carbohydrate Res Ctr, 315 Riverbend Rd, Athens, GA 30602 USA.	rcarlson@ccrc.uga.edu			National Institutes of Health [GM39583]; Department of Energy [DE-FG-02-93ER20097]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM039583] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM39583 (to R. W. C.). This work was also supported by Department of Energy Grant DE-FG-02-93ER20097 (to the Complex Carbohydrate Research Center). This work is in partial fulfillment for the Ph.D. degree of D. B. B.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ANUMULA KR, 1992, ANAL BIOCHEM, V203, P101, DOI 10.1016/0003-2697(92)90048-C; BECKER A, 1995, GENE, V162, P37, DOI 10.1016/0378-1119(95)00313-U; BERINGER JE, 1974, J GEN MICROBIOL, V84, P188; BHAT UR, 1994, J BIOL CHEM, V269, P14402; Brown DB, 2011, J BACTERIOL, V193, P4766, DOI 10.1128/JB.00392-11; Carlson RW, 2010, SUBCELL BIOCHEM, V53, P339, DOI 10.1007/978-90-481-9078-2_16; CIUCANU I, 1984, CARBOHYD RES, V131, P209, DOI 10.1016/0008-6215(84)85242-8; Cointe D, 1998, CARBOHYD RES, V311, P51, DOI 10.1016/S0008-6215(98)00196-7; Forsberg LS, 1998, J BIOL CHEM, V273, P2747, DOI 10.1074/jbc.273.5.2747; Forsberg LS, 2003, J BIOL CHEM, V278, P51347, DOI 10.1074/jbc.M309016200; Fraysse N, 2002, GLYCOBIOLOGY, V12, P741, DOI 10.1093/glycob/cwf078; Haag AF, 2009, J BACTERIOL, V191, P4681, DOI 10.1128/JB.00318-09; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; Kanjilal-Kolar S, 2006, J BIOL CHEM, V281, P12865, DOI 10.1074/jbc.M513864200; Kanjilal-Kolar S, 2006, J BIOL CHEM, V281, P12879, DOI 10.1074/jbc.M513865200; Karbarz MJ, 2009, J BIOL CHEM, V284, P414, DOI 10.1074/jbc.M808390200; KITTELBERGER R, 1993, J BIOCHEM BIOPH METH, V26, P81, DOI 10.1016/0165-022X(93)90024-I; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; PHADNIS SH, 1987, J BIOSCIENCE, V12, P131, DOI 10.1007/BF02702964; Plotz BM, 2000, J BIOL CHEM, V275, P11222, DOI 10.1074/jbc.275.15.11222; PRICE NPJ, 1995, P NATL ACAD SCI USA, V92, P7352, DOI 10.1073/pnas.92.16.7352; Que-Gewirth NLS, 2003, J BIOL CHEM, V278, P12120, DOI 10.1074/jbc.M300379200; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; REUHS BL, 1993, J BACTERIOL, V175, P3570, DOI 10.1128/jb.175.11.3570-3580.1993; RYAN JM, 1974, ARCH BIOCHEM BIOPHYS, V162, P530, DOI 10.1016/0003-9861(74)90213-6; Smit J, 2008, INNATE IMMUN-LONDON, V14, P25, DOI 10.1177/1753425907087588; Snyder S, 1999, BIOCHEMISTRY-US, V38, P10758, DOI 10.1021/bi990867d; Song F, 2009, BIOCHEMISTRY-US, V48, P1173, DOI 10.1021/bi802212t; Trent MS, 2006, J ENDOTOXIN RES, V12, P205, DOI 10.1179/096805106X118825; Trent MS, 2001, J BIOL CHEM, V276, P43122, DOI 10.1074/jbc.M106961200; Van de Velde W, 2010, SCIENCE, V327, P1122, DOI 10.1126/science.1184057; Vedam V, 2004, MOL PLANT MICROBE IN, V17, P283, DOI 10.1094/MPMI.2004.17.3.283; WANG TL, 1982, PLANTA, V155, P345, DOI 10.1007/BF00429463; Wang XY, 2009, BIOCHEMISTRY-US, V48, P1162, DOI 10.1021/bi802211k; Westphal O., 1965, METHODS CARBOHYDRATE, V5, P83, DOI DOI 10.1016/J.WATRES.2010.04.030; YORK WS, 1986, METHOD ENZYMOL, V118, P3	38	7	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					935	949		10.1074/jbc.M111.311571	http://dx.doi.org/10.1074/jbc.M111.311571			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22110131	Green Published, hybrid			2022-12-27	WOS:000299170300012
J	Yu, ED; Girardi, E; Wang, J; Mac, TT; Yu, KOA; Van Calenbergh, S; Porcelli, SA; Zajonc, DM				Yu, Esther Dawen; Girardi, Enrico; Wang, Jing; Thien-Thi Mac; Yu, Karl O. A.; Van Calenbergh, Serge; Porcelli, Steven A.; Zajonc, Dirk M.			Structural Basis for the Recognition of C20:2-alpha GalCer by the Invariant Natural Killer T Cell Receptor-like Antibody L363	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-GALACTOSYLCERAMIDE; RECOMBINANT ANTIBODIES; NKT CELLS; CD1D; GLYCOLIPIDS; ANTIGENS; COMPLEX; MODEL; SPECIFICITY; RESPONSES	Natural killer T (NKT) cells express a semi-invariant V alpha 14T cell receptor (TCR) and recognize structurally diverse antigens presented by the antigen-presenting molecule CD1d that range from phosphoglycerolipids to alpha- and beta-anomeric glycosphingolipids, as well as microbial alpha-glycosyl diacylglycerolipids. Recently developed antibodies that are specific for the complex of the prototypical invariant NKT (iNKT) cell antigen alpha GalCer (KRN7000) bound to mouse CD1d have become valuable tools in elucidating the mechanism of antigen loading and presentation. Here, we report the 3.1 angstrom resolution crystal structure of the Fab of one of these antibodies, L363, bound to mCD1d complexed with the alpha GalCer analog C20:2, revealing that L363 is an iNKT TCR-like antibody that binds CD1d-presented alpha GalCer in a manner similar to the TCR. The structure reveals that L363 depends on both the L and H chains for binding to the glycolipid-mCD1d complex, although only the L chain is involved in contacts with the glycolipid antigen. The H chain of L363 features residue Trp-104, which mimics the TCR CDR3 alpha residue Leu-99, which is crucial for CD1d binding. We characterized the antigen-specificity of L363 toward several different glycolipids, demonstrating that whereas the TCR can induce structural changes in both antigen and CD1d to recognize disparate lipid antigens, the antibody L363 can only induce the F' roof formation in CD1d but fails to reorient the glycolipid headgroup necessary for binding. In summary, L363 is a powerful tool to study mechanism of iNKT cell activation for structural analogs of KRN7000, and our study can aid in the design of antibodies with altered antigen specificity.	[Yu, Esther Dawen; Girardi, Enrico; Wang, Jing; Thien-Thi Mac; Zajonc, Dirk M.] La Jolla Inst Allergy & Immunol, Div Cell Biol, La Jolla, CA 92037 USA; [Yu, Karl O. A.; Porcelli, Steven A.] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA; [Van Calenbergh, Serge] Univ Ghent, Med Chem Lab, B-9000 Ghent, Belgium	La Jolla Institute for Immunology; Yeshiva University; Albert Einstein College of Medicine; Ghent University	Zajonc, DM (corresponding author), La Jolla Inst Allergy & Immunol, Div Cell Biol, 9420 Athena Circle, La Jolla, CA 92037 USA.	dzajonc@liai.org	Van Calenbergh, Serge/A-3167-2008; Girardi, Enrico/L-4033-2014; Yu, Karl/ABC-4547-2020; Girardi, Enrico/AAD-2260-2020; Wang, Jing/L-5095-2013; Yu, Dawen/AAE-6444-2019	Van Calenbergh, Serge/0000-0002-4201-1264; Girardi, Enrico/0000-0003-3508-2723; Girardi, Enrico/0000-0003-3508-2723; Yu, Dawen/0000-0002-3970-3753	National Institutes of Health [AI074952, AI45889]; Cancer Research Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074952, R01AI045889, R56AI074952] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI074952 (to D. M. Z.) and AI45889 (to S. A. P.). This work was also supported by an investigator award from the Cancer Research Institute (to D. M. Z.).	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Aspeslagh S, 2011, EMBO J, V30, P2294, DOI 10.1038/emboj.2011.145; Bai L, 2009, P NATL ACAD SCI USA, V106, P10254, DOI 10.1073/pnas.0901228106; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Borg NA, 2007, NATURE, V448, P44, DOI 10.1038/nature05907; Brossay L, 1998, J EXP MED, V188, P1521, DOI 10.1084/jem.188.8.1521; Cohen CJ, 2003, J MOL RECOGNIT, V16, P324, DOI 10.1002/jmr.640; Dahan R, 2011, EUR J IMMUNOL, V41, P1465, DOI 10.1002/eji.201041241; Denkberg G, 2008, EUR J IMMUNOL, V38, P829, DOI 10.1002/eji.200737518; Denkberg G, 2006, AUTOIMMUN REV, V5, P252, DOI 10.1016/j.autrev.2005.07.004; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fujii SI, 2006, P NATL ACAD SCI USA, V103, P11252, DOI 10.1073/pnas.0604812103; Girardi E, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001189; Godfrey DI, 2008, IMMUNITY, V28, P304, DOI 10.1016/j.immuni.2008.02.004; Godfrey DI, 2004, NAT REV IMMUNOL, V4, P231, DOI 10.1038/nri1309; Goff RD, 2004, J AM CHEM SOC, V126, P13602, DOI 10.1021/ja045385q; Im JS, 2009, IMMUNITY, V30, P888, DOI 10.1016/j.immuni.2009.03.022; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; Kinjo Y, 2005, NATURE, V434, P520, DOI 10.1038/nature03407; Kinjo Y, 2006, NAT IMMUNOL, V7, P978, DOI 10.1038/ni1380; Kinjo Y, 2011, NAT IMMUNOL, V12, P966, DOI 10.1038/ni.2096; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Lefranc MP, 1999, NUCLEIC ACIDS RES, V27, P209, DOI 10.1093/nar/27.1.209; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Li YL, 2010, J EXP MED, V207, P2383, DOI 10.1084/jem.20101335; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Mareeva T, 2008, J BIOL CHEM, V283, P29053, DOI 10.1074/jbc.M804996200; Matulis G, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000402; Miyamoto K, 2001, NATURE, V413, P531, DOI 10.1038/35097097; Pellicci DG, 2009, IMMUNITY, V31, P47, DOI 10.1016/j.immuni.2009.04.018; Reid C, 2006, PROTEIN ENG DES SEL, V19, P317, DOI 10.1093/protein/gzl015; Scott-Browne JP, 2007, NAT IMMUNOL, V8, P1105, DOI 10.1038/ni1510; Stewart-Jones G, 2009, P NATL ACAD SCI USA, V106, P5784, DOI 10.1073/pnas.0901425106; Sullivan BA, 2010, J IMMUNOL, V184, P141, DOI 10.4049/jimmunol.0902880; Trappeniers M, 2008, J AM CHEM SOC, V130, P16468, DOI 10.1021/ja8064182; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Wang J, 2010, P NATL ACAD SCI USA, V107, P1535, DOI 10.1073/pnas.0909479107; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Wu D, 2006, P NATL ACAD SCI USA, V103, P3972, DOI 10.1073/pnas.0600285103; Wu D, 2005, P NATL ACAD SCI USA, V102, P1351, DOI 10.1073/pnas.0408696102; Wun KS, 2008, J EXP MED, V205, P939, DOI 10.1084/jem.20072141; Wun KS, 2011, IMMUNITY, V34, P327, DOI 10.1016/j.immuni.2011.02.001; Yu ED, 2011, J IMMUNOL, V187, P2079, DOI 10.4049/jimmunol.1101636; Yu KOA, 2007, J IMMUNOL METHODS, V323, P11, DOI 10.1016/j.jim.2007.03.006; Yu KOA, 2005, P NATL ACAD SCI USA, V102, P3383, DOI 10.1073/pnas.0407488102; Zajonc DM, 2008, J MOL BIOL, V377, P1104, DOI 10.1016/j.jmb.2008.01.061; Zajonc DM, 2005, NAT IMMUNOL, V6, P810, DOI 10.1038/ni1224; Zajonc DM, 2005, J EXP MED, V202, P1517, DOI 10.1084/jem.20051625	50	19	19	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					1269	1278		10.1074/jbc.M111.308783	http://dx.doi.org/10.1074/jbc.M111.308783			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22110136	Green Published, hybrid			2022-12-27	WOS:000299170300043
J	Diegelmann, J; Olszak, T; Goke, B; Blumberg, RS; Brand, S				Diegelmann, Julia; Olszak, Torsten; Goeke, Burkhard; Blumberg, Richard S.; Brand, Stephan			A Novel Role for Interleukin-27 (IL-27) as Mediator of Intestinal Epithelial Barrier Protection Mediated via Differential Signal Transducer and Activator of Transcription (STAT) Protein Signaling and Induction of Antibacterial and Anti-inflammatory Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFLAMMATORY-BOWEL-DISEASE; INDOLEAMINE 2,3-DIOXYGENASE GENE; SCAVENGER RECEPTOR GP340; CD4(+) T-CELLS; CROHNS-DISEASE; TH17 CELLS; EXPRESSION; COLITIS; GROWTH; DMBT1	The role of the Th17 cell inhibiting cytokine IL-27 in the pathogenesis of inflammatory bowel disease is contradictory. Its effects on the intestinal barrier have so far not been investigated, which was the aim of this study. We show that intestinal epithelial cells (IEC) express both IL-27 receptor subunits IL-27RA and gp130. The IL-27 receptor expression is up-regulated in intestinal inflammation and during bacterial infection. IL-27 activates ERK and p38 MAPKs as well as Akt, STAT1, STAT3, and STAT6 in IEC. IL-27 significantly enhances cell proliferation and IEC restitution. These functions of IL-27 are dependent on the activation of STAT3 and STAT6 signaling pathways. As analyzed by microarray, IL-27 modulates the expression of 428 target genes in IEC (316 up and 112 down; p < 0.05). IL-27 as well as its main target genes are up-regulated in colonic tissue and IEC isolated from mice with dextran sulfate sodium (DSS)-induced colitis. The IL-27-induced expression of the anti-bacterial gene deleted in malignant brain tumor 1 (DMBT1) is mediated by p38 and STAT3 signaling, whereas the activation of the anti-inflammatory and anti-bacterial gene indoleamine 2,3-dioxygenase (IDO1) is dependent on STAT1 signal transduction. IL-27-induced indoleamine 2,3-dioxygenase enzymatic activity leads to growth inhibition of intestinal bacteria by causing local tryptophan depletion. For the first time, we characterize IL-27 as a mediator of intestinal epithelial barrier protection mediated via transcriptional activation of anti-inflammatory and antibacterial target genes.	[Diegelmann, Julia; Olszak, Torsten; Goeke, Burkhard; Brand, Stephan] Univ Munich, Dept Med Grosshadern 2, D-81377 Munich, Germany; [Diegelmann, Julia] Univ Munich, Dept Prevent Dent & Periodontol, D-81377 Munich, Germany; [Olszak, Torsten; Blumberg, Richard S.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Gastroenterol Hepatol & Endoscopy, Boston, MA 02115 USA	University of Munich; University of Munich; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Brand, S (corresponding author), Univ Hosp Munich Grosshadern, Dept Med 2, Marchioninistr 15, D-81377 Munich, Germany.	stephan.brand@med.uni-muenchen.de			National Institutes of Health [DK44319, DK51362]; Ludwig-Maximilians-University Munich (Promotionsstipendium); Deutsche Forschungsgemeinschaft [1912/6-1]; Else-Kroner-Fresenius-Stiftung (Else Kroner-Exzellenzstipendium [2010_EKES.32]; Ludwig-Maximilians-University of Munich; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK044319, R01DK051362, R01DK088199, R01DK044319] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ludwig-Maximilians-University Munich (Promotionsstipendium); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Else-Kroner-Fresenius-Stiftung (Else Kroner-Exzellenzstipendium; Ludwig-Maximilians-University of Munich; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK44319 and DK51362 (to R. S. B.).; Supported by a grant from the Ludwig-Maximilians-University Munich (Promotionsstipendium).; Supported by Deutsche Forschungsgemeinschaft Grant Ol 324/1-1.; Supported by Deutsche Forschungsgemeinschaft Grant 1912/6-1, the Else-Kroner-Fresenius-Stiftung (Else Kroner-Exzellenzstipendium) Grant 2010_EKES.32, and by Ludwig-Maximilians-University of Munich (Excellence Initiative, Investment Funds 2008 and FoFoLe). To whom correspondence should be addressed: Dept. of Medicine II, University Hospital Munich-Grosshadern, Marchioninistr. 15, 81377 Munich, Germany. Tel.: 49-89-7095-2295; Fax: 49-89-7095-5291; E-mail: stephan.brand@med.unimuenchen.de.	Baban B, 2009, J IMMUNOL, V183, P2475, DOI 10.4049/jimmunol.0900986; Becker K, 1999, Z GASTROENTEROL, V37, P597; Brand S, 2006, AM J PHYSIOL-GASTR L, V290, pG827, DOI 10.1152/ajpgi.00513.2005; Brand S, 2009, GUT, V58, P1152, DOI 10.1136/gut.2008.163667; Brand S, 2007, AM J PHYSIOL-GASTR L, V292, pG1019, DOI 10.1152/ajpgi.00239.2006; Chon SY, 1996, J BIOL CHEM, V271, P17247, DOI 10.1074/jbc.271.29.17247; CHON SY, 1995, J INTERF CYTOK RES, V15, P517, DOI 10.1089/jir.1995.15.517; Ciorba MA, 2010, J IMMUNOL, V184, P3907, DOI 10.4049/jimmunol.0900291; De Luca A, 2007, J IMMUNOL, V179, P5999, DOI 10.4049/jimmunol.179.9.5999; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Diveu C, 2009, J IMMUNOL, V182, P5748, DOI 10.4049/jimmunol.0801162; Eckmann L, 2000, J BIOL CHEM, V275, P14084, DOI 10.1074/jbc.275.19.14084; Edwards AM, 2008, MOL MICROBIOL, V68, P1378, DOI 10.1111/j.1365-2958.2008.06220.x; El-behi M, 2009, J IMMUNOL, V183, P4957, DOI 10.4049/jimmunol.0900735; Elrod JW, 2005, INFLAMM BOWEL DIS, V11, P883, DOI 10.1097/01.MIB.0000182871.76434.57; Fallarino F, 2006, J IMMUNOL, V176, P6752, DOI 10.4049/jimmunol.176.11.6752; Ferdinande L, 2008, INT J IMMUNOPATH PH, V21, P289, DOI 10.1177/039463200802100205; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Fukui H, 2011, INFLAMM BOWEL DIS, V17, P1177, DOI 10.1002/ibd.21473; Ghia JE, 2009, GASTROENTEROLOGY, V137, P1649, DOI 10.1053/j.gastro.2009.08.041; Guzzo C, 2010, J BIOL CHEM, V285, P24404, DOI 10.1074/jbc.M110.112599; Honda K, 2005, INFLAMM BOWEL DIS, V11, P1044, DOI 10.1097/01.MIB.0000191611.05466.1f; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Imielinski M, 2009, NAT GENET, V41, P1335, DOI 10.1038/ng.489; Kanda N, 2008, EUR J IMMUNOL, V38, P1287, DOI 10.1002/eji.200738051; Kida H, 2008, AM J PATHOL, V172, P1542, DOI 10.2353/ajpath.2008.071052; Loimaranta V, 2009, J BIOL CHEM, V284, P18614, DOI 10.1074/jbc.M900581200; Mackenzie CR, 1998, J NEUROIMMUNOL, V89, P191; MacKenzie CR, 1998, J INFECT DIS, V178, P875, DOI 10.1086/515347; Mao RC, 2011, J VIROL, V85, P1048, DOI 10.1128/JVI.01998-10; Murugaiyan G, 2009, J IMMUNOL, V183, P2435, DOI 10.4049/jimmunol.0900568; Nieuwenhuis EES, 2002, P NATL ACAD SCI USA, V99, P16951, DOI 10.1073/pnas.252648899; Owaki T, 2005, J IMMUNOL, V175, P2191, DOI 10.4049/jimmunol.175.4.2191; Pflanz S, 2002, IMMUNITY, V16, P779, DOI 10.1016/S1074-7613(02)00324-2; Pflanz S, 2004, J IMMUNOL, V172, P2225, DOI 10.4049/jimmunol.172.4.2225; Renner M, 2007, GASTROENTEROLOGY, V133, P1499, DOI 10.1053/j.gastro.2007.08.007; Rosenstiel P, 2007, J IMMUNOL, V178, P8203, DOI 10.4049/jimmunol.178.12.8203; THOMAS SM, 1993, J IMMUNOL, V150, P5529; Troy AE, 2009, J IMMUNOL, V183, P2037, DOI 10.4049/jimmunol.0802918; Villarino AV, 2008, INT IMMUNOL, V20, P739, DOI 10.1093/intimm/dxn032; Wirtz S, 2011, GASTROENTEROLOGY, V141, P1875, DOI 10.1053/j.gastro.2011.07.040; Wolf AM, 2004, CLIN IMMUNOL, V113, P47, DOI 10.1016/j.clim.2004.05.004; Yoshimoto T, 2007, J IMMUNOL, V179, P4415, DOI 10.4049/jimmunol.179.7.4415; Zhang MS, 2006, CANCER LETT, V243, P38, DOI 10.1016/j.canlet.2005.11.020	44	95	96	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					286	298		10.1074/jbc.M111.294355	http://dx.doi.org/10.1074/jbc.M111.294355			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22069308	Green Published, hybrid			2022-12-27	WOS:000298682400029
J	Ishibashi, Y; Ikeda, K; Sakaguchi, K; Okino, N; Taguchi, R; Ito, M				Ishibashi, Yohei; Ikeda, Kazutaka; Sakaguchi, Keishi; Okino, Nozomu; Taguchi, Ryo; Ito, Makoto			Quality Control of Fungus-specific Glucosylceramide in Cryptococcus neoformans by Endoglycoceramidase-related Protein 1 (EGCrP1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAENIBACILLUS SP TS12; CERAMIDE N-DEACYLASE; SACCHAROMYCES-CEREVISIAE; MOLECULAR-CLONING; CANDIDA-ALBICANS; CELL-WALL; RHODOCOCCUS SP; GENE; PURIFICATION; SEQUENCE	A fungus-specific glucosylceramide (GlcCer), which contains a unique sphingoid base possessing two double bonds and a methyl substitution, is essential for pathogenicity in fungi. Although the biosynthetic pathway of the GlcCer has been well elucidated, little is known about GlcCer catabolism because a GlcCer-degrading enzyme (glucocerebrosidase) has yet to be identified in fungi. We found a homologue of endoglycoceramidase tentatively designated endoglycoceramidase-related protein 1 (EGCrP1) in several fungal genomic databases. The recombinant EGCrP1 hydrolyzed GlcCer but not other glycosphingolipids, whereas endoglycoceramidase hydrolyzed oligosaccharide-linked glycosphingolipids but not GlcCer. Disruption of egcrp1 in Cryptococcus neoformans, a typical pathogenic fungus causing cryptococcosis, resulted in the accumulation of fungus-specific GlcCer and immature GlcCer that possess sphingoid bases without a methyl substitution concomitant with a dysfunction of polysaccharide capsule formation. These results indicated that EGCrP1 participates in the catabolism of GlcCer and especially functions to eliminate immature GlcCer in vivo that are generated as by-products due to the broad specificity of GlcCer synthase. We conclude that EGCrP1, a glucocerebrosidase identified for the first time in fungi, controls the quality of GlcCer by eliminating immature GlcCer incorrectly generated in C. neoformans, leading to accurate processing of fungus-specific GlcCer.	[Ishibashi, Yohei; Sakaguchi, Keishi; Okino, Nozomu; Ito, Makoto] Kyushu Univ, Dept Biosci & Biotechnol, Grad Sch Bioresource & Bioenvironm Sci, Higashi Ku, Fukuoka 8128581, Japan; [Ikeda, Kazutaka; Taguchi, Ryo] Univ Tokyo, Dept Metabolome, Grad Sch Med, Bunkyo Ku, Tokyo 1130033, Japan; [Ikeda, Kazutaka] Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata 9970052, Japan; [Taguchi, Ryo] Chubu Univ, Dept Biomed Sci, Coll Life & Hlth Sci, Kasugai, Aichi 4878501, Japan; [Ito, Makoto] New Energy & Ind Technol Dev Org NEDO, MUZA, Saiwai Ku, Kawasaki, Kanagawa 2128554, Japan	Kyushu University; University of Tokyo; Keio University; Chubu University	Ito, M (corresponding author), Kyushu Univ, Dept Biosci & Biotechnol, Grad Sch Bioresource & Bioenvironm Sci, Higashi Ku, 6-10-1 Hakozaki, Fukuoka 8128581, Japan.	makotoi@agr.kyushu-u.ac.jp	Okino, Nozomu/AAY-2635-2021; Ito, Makoto/Q-6164-2019	ito, Makoto/0000-0003-3159-7818	New Energy and Industrial Technology Development Organization; Japanese Ministry of Education, Culture, Sports, Science and Technology; Naito Foundation; Japan Society for the Promotion of Science	New Energy and Industrial Technology Development Organization(New Energy and Industrial Technology Development Organization (NEDO)); Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Naito Foundation(Naito Memorial Foundation); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by the New Energy and Industrial Technology Development Organization (to M. I.), Basic Research B from the Japanese Ministry of Education, Culture, Sports, Science and Technology (to M. I.), the Naito Foundation (to Y. I.), and the Japan Society for the Promotion of Science for Young Scientists (to Y. I.).	BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boisrame A, 2009, APPL MICROBIOL BIOT, V82, P663, DOI 10.1007/s00253-008-1780-z; Brunner F, 2002, PHYTOCHEMISTRY, V59, P689, DOI 10.1016/S0031-9422(02)00045-6; Byrnes EJ, 2009, J INFECT DIS, V199, P1081, DOI 10.1086/597306; Caines MEC, 2007, J BIOL CHEM, V282, P14300, DOI 10.1074/jbc.M611455200; COX GM, 1995, J MED VET MYCOL, V33, P261; Davidson RC, 2000, FUNGAL GENET BIOL, V29, P38, DOI 10.1006/fgbi.1999.1180; Doering TL, 2009, ANNU REV MICROBIOL, V63, P223, DOI 10.1146/annurev.micro.62.081307.162753; Erb-Downward JR, 2008, MOL MICROBIOL, V68, P1428, DOI 10.1111/j.1365-2958.2008.06245.x; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Haak D, 1997, J BIOL CHEM, V272, P29704, DOI 10.1074/jbc.272.47.29704; Hayashi Y, 2007, J BIOL CHEM, V282, P30889, DOI 10.1074/jbc.M700832200; Horibata Y, 2004, J BIOL CHEM, V279, P33379, DOI 10.1074/jbc.M401460200; Horibata Y, 2000, J BIOL CHEM, V275, P31297, DOI 10.1074/jbc.M003575200; Ikeda K, 2011, ANAL BIOANAL CHEM, V400, P1853, DOI 10.1007/s00216-011-4703-2; Ishibashi Y, 2007, J BIOCHEM, V142, P239, DOI 10.1093/jb/mvm125; Ishibashi Y, 2007, J BIOL CHEM, V282, P11386, DOI 10.1074/jbc.M608445200; ITO M, 1986, J BIOL CHEM, V261, P14278; ITO M, 1989, J BIOL CHEM, V264, P9510; Izu H, 1997, J BIOL CHEM, V272, P19846, DOI 10.1074/jbc.272.32.19846; Kauffman Carol A, 2006, Proc Am Thorac Soc, V3, P35, DOI 10.1513/pats.200510-110JH; Kim MS, 2009, BIOCHEM BIOPH RES CO, V390, P983, DOI 10.1016/j.bbrc.2009.10.089; KOBAYASHI T, 1981, J BIOL CHEM, V256, P7768; Kolter T, 2005, ANNU REV CELL DEV BI, V21, P81, DOI 10.1146/annurev.cellbio.21.122303.120013; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leipelt M, 2001, J BIOL CHEM, V276, P33621, DOI 10.1074/jbc.M104952200; Levery SB, 2002, FEBS LETT, V525, P59, DOI 10.1016/S0014-5793(02)03067-3; Liu OW, 2008, CELL, V135, P174, DOI 10.1016/j.cell.2008.07.046; Matern H, 2001, J BIOL CHEM, V276, P37929; McDade HC, 2001, MED MYCOL, V39, P151, DOI 10.1080/714030997; Michaelson LV, 2009, PLANT PHYSIOL, V149, P487, DOI 10.1104/pp.108.129411; Michel C, 1997, J BIOL CHEM, V272, P22432, DOI 10.1074/jbc.272.36.22432; Nakagawa T, 1999, J BIOCHEM, V126, P604, DOI 10.1093/oxfordjournals.jbchem.a022492; Nelson RT, 2003, FUNGAL GENET BIOL, V38, P1, DOI 10.1016/S1087-1845(02)00510-8; Noble SM, 2010, NAT GENET, V42, P590, DOI 10.1038/ng.605; Oura T, 2008, MICROBIOL-SGM, V154, P3795, DOI 10.1099/mic.0.2008/018788-0; Oura T, 2010, MICROBIOL-SGM, V156, P1234, DOI 10.1099/mic.0.033985-0; Paal K, 2004, BIOCHEM J, V378, P141, DOI 10.1042/BJ20031028; PERFECT JR, 1992, GENE, V122, P213, DOI 10.1016/0378-1119(92)90053-R; Pinto MR, 2002, GLYCOBIOLOGY, V12, P251, DOI 10.1093/glycob/12.4.251; Ramamoorthy V, 2007, MOL MICROBIOL, V66, P771, DOI 10.1111/j.1365-2958.2007.05955.x; Ramamoorthy V, 2009, EUKARYOT CELL, V8, P217, DOI 10.1128/EC.00255-08; Rhome R, 2007, EUKARYOT CELL, V6, P1715, DOI 10.1128/EC.00208-07; Rittershaus PC, 2006, J CLIN INVEST, V116, P1651, DOI 10.1172/JCI27890; Rodrigues ML, 2007, EUKARYOT CELL, V6, P48, DOI 10.1128/EC.00318-06; Rodrigues ML, 2000, INFECT IMMUN, V68, P7049, DOI 10.1128/IAI.68.12.7049-7060.2000; Saito K, 2006, APPL MICROBIOL BIOT, V71, P515, DOI 10.1007/s00253-005-0187-3; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sakaguchi K, 2000, J BIOCHEM-TOKYO, V128, P145, DOI 10.1093/oxfordjournals.jbchem.a022725; Sakon J, 1996, BIOCHEMISTRY-US, V35, P10648, DOI 10.1021/bi9604439; SCHREUDER MP, 1993, YEAST, V9, P399, DOI 10.1002/yea.320090410; Sumida T, 2002, J BIOCHEM, V132, P237, DOI 10.1093/oxfordjournals.jbchem.a003216; Ternes P, 2006, J BIOL CHEM, V281, P5582, DOI 10.1074/jbc.M512864200; Ternes P, 2011, J BIOL CHEM, V286, P11401, DOI 10.1074/jbc.M110.193094; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tsuge J, 2008, BIOSCI BIOTECH BIOCH, V72, P2667, DOI 10.1271/bbb.80331; Zama K, 2009, GLYCOBIOLOGY, V19, P767, DOI 10.1093/glycob/cwp047	57	23	26	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					368	381		10.1074/jbc.M111.311340	http://dx.doi.org/10.1074/jbc.M111.311340			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22072709	Green Published, hybrid			2022-12-27	WOS:000298682400036
J	Kunze, M; Neuberger, G; Maurer-Stroh, S; Ma, JM; Eck, T; Braverman, N; Schmid, JA; Eisenhaber, F; Berger, J				Kunze, Markus; Neuberger, Georg; Maurer-Stroh, Sebastian; Ma, Jianmin; Eck, Thomas; Braverman, Nancy; Schmid, Johannes A.; Eisenhaber, Frank; Berger, Johannes			Structural Requirements for Interaction of Peroxisomal Targeting Signal 2 and Its Receptor PEX7	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHIZOMELIC CHONDRODYSPLASIA PUNCTATA; ACID ALPHA-OXIDATION; SACCHAROMYCES-CEREVISIAE; 3-KETOACYL-COA THIOLASE; PROTEIN IMPORT; SUBCELLULAR-LOCALIZATION; SECONDARY-STRUCTURE; OLIGOMERIC PROTEIN; AMINO-TERMINUS; PREDICTION	The import of a subset of peroxisomal matrix proteins is mediated by the peroxisomal targeting signal 2 (PTS2). The results of our sequence and physical property analysis of known PTS2 signals and of a mutational study of the least characterized amino acids of a canonical PTS2 motif indicate that PTS2 forms an amphipathic helix accumulating all conserved residues on one side. Three-dimensional structural modeling of the PTS2 receptor PEX7 reveals a groove with an evolutionarily conserved charge distribution complementary to PTS2 signals. Mammalian two-hybrid assays and cross-complementation of a mutation in PTS2 by a compensatory mutation in PEX7 confirm the interaction site. An unstructured linker region separates the PTS2 signal from the core protein. This additional information on PTS2 signals was used to generate a PTS2 prediction algorithm that enabled us to identify novel PTS2 signals within human proteins and to describe KChIP4 as a novel peroxisomal protein.	[Kunze, Markus; Eck, Thomas; Berger, Johannes] Med Univ Vienna, Ctr Brain Res, A-1090 Vienna, Austria; [Neuberger, Georg; Maurer-Stroh, Sebastian; Ma, Jianmin; Eisenhaber, Frank] Agcy Sci Technol & Res, Bioinformat Inst, Singapore 138671, Singapore; [Eisenhaber, Frank] Natl Univ Singapore, Dept Biol Sci, Singapore 117597, Singapore; [Eisenhaber, Frank] Nanyang Technol Univ, Sch Comp Engn, Singapore 637553, Singapore; [Braverman, Nancy] McGill Univ, Montreal Childrens Hosp, Res Inst, Dept Human Genet, Montreal, PQ H3Z 2Z3, Canada; [Braverman, Nancy] McGill Univ, Montreal Childrens Hosp, Res Inst, Dept Pediat, Montreal, PQ H3Z 2Z3, Canada; [Schmid, Johannes A.] Med Univ Vienna, Dept Vasc Biol & Thrombosis Res, A-1090 Vienna, Austria; [Maurer-Stroh, Sebastian] Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore	Medical University of Vienna; Agency for Science Technology & Research (A*STAR); A*STAR - Bioinformatics Institute (BII); National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; McGill University; McGill University; Medical University of Vienna; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Kunze, M (corresponding author), Med Univ Vienna, Ctr Brain Res, Spitalgasse 4, A-1090 Vienna, Austria.	markus.kunze@meduniwien.ac.at	Maurer-Stroh, Sebastian/Q-9476-2019; Schmid, Johannes A./C-7659-2009; Berger, Johannes/A-9122-2014	Maurer-Stroh, Sebastian/0000-0003-0813-9640; Schmid, Johannes A./0000-0002-6586-3507; Berger, Johannes/0000-0003-0182-2658; Braverman, Nancy/0000-0003-1621-5164	European Union [LSHG-C/2004-512018]; Austrian Science Fund (FWF) [P15510, P21950-B20]; Austrian Genomforschung in Osterreich: Bioinformatik Integrationsnetzwerk; Austrian Science Fund (FWF) [P 21950] Funding Source: researchfish	European Union(European Commission); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Genomforschung in Osterreich: Bioinformatik Integrationsnetzwerk; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported in part by European Union Project "Peroxisomes" LSHG-C/2004-512018, by Austrian Science Fund (FWF) Projects P15510 and P21950-B20, and by the Austrian Genomforschung in Osterreich: Bioinformatik Integrationsnetzwerk (until summer 2007).	Benson DA, 2014, NUCLEIC ACIDS RES, V42, pD32, DOI [10.1093/nar/gkp1024, 10.1093/nar/gkt1030, 10.1093/nar/gks1195, 10.1093/nar/gkw1070, 10.1093/nar/gkq1079, 10.1093/nar/gkn723, 10.1093/nar/gkr1202, 10.1093/nar/gkx1094]; BIARDI L, 1994, J BIOL CHEM, V269, P1197; Braverman N, 1997, NAT GENET, V15, P369, DOI 10.1038/ng0497-369; Braverman N, 2002, HUM MUTAT, V20, P284, DOI 10.1002/humu.10124; BROCARD C, 1994, BIOCHEM BIOPH RES CO, V204, P1016, DOI 10.1006/bbrc.1994.2564; Chou P Y, 1978, Adv Enzymol Relat Areas Mol Biol, V47, P45; de Vet ECJM, 2000, CELL BIOCHEM BIOPHYS, V32, P117, DOI 10.1385/CBB:32:1-3:117; DEMARTIN R, 1987, EMBO J, V6, P3673, DOI 10.1002/j.1460-2075.1987.tb02700.x; Eisenhaber F, 1998, TRENDS CELL BIOL, V8, P169, DOI 10.1016/S0962-8924(98)01226-4; FAUCHERE JL, 1988, INT J PEPT PROT RES, V32, P269; Flynn CR, 1998, PLANT J, V16, P709, DOI 10.1046/j.1365-313x.1998.00344.x; Ghys K, 2002, BIOCHEM J, V365, P41, DOI 10.1042/BJ20011432; Ginalski K, 2003, BIOINFORMATICS, V19, P1015, DOI 10.1093/bioinformatics/btg124; GLOVER JR, 1994, P NATL ACAD SCI USA, V91, P10541, DOI 10.1073/pnas.91.22.10541; GLOVER JR, 1994, J BIOL CHEM, V269, P7558; GOULD SJ, 1987, J CELL BIOL, V105, P2923, DOI 10.1083/jcb.105.6.2923; Grabarek Z, 2006, J MOL BIOL, V359, P509, DOI 10.1016/j.jmb.2006.03.066; HIJIKATA M, 1987, J BIOL CHEM, V262, P8151; Holroyd C, 2001, FEBS LETT, V501, P6, DOI 10.1016/S0014-5793(01)02617-5; Hubbard TJP, 2009, NUCLEIC ACIDS RES, V37, pD690, DOI 10.1093/nar/gkn828; Jansen GA, 1996, BIOCHEM BIOPH RES CO, V229, P205, DOI 10.1006/bbrc.1996.1781; Jerng HH, 2008, J BIOL CHEM, V283, P36046, DOI 10.1074/jbc.M806852200; KARPLUS PA, 1985, NATURWISSENSCHAFTEN, V72, P212, DOI 10.1007/BF01195768; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kawashima S, 2000, NUCLEIC ACIDS RES, V28, P374, DOI 10.1093/nar/28.1.374; Kersey PJ, 2004, PROTEOMICS, V4, P1985, DOI 10.1002/pmic.200300721; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; Kuiken C, 2005, BIOINFORMATICS, V21, P379, DOI 10.1093/bioinformatics/bth485; Kurochkin IV, 2007, EMBO J, V26, P835, DOI 10.1038/sj.emboj.7601525; Lazarow PB, 2006, BBA-MOL CELL RES, V1763, P1599, DOI 10.1016/j.bbamcr.2006.08.011; Legakis JE, 2001, TRAFFIC, V2, P252, DOI 10.1034/j.1600-0854.2001.90165.x; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Liang P, 2009, J BIOL CHEM, V284, P4960, DOI 10.1074/jbc.M807704200; MARZIOCH M, 1994, EMBO J, V13, P4908, DOI 10.1002/j.1460-2075.1994.tb06818.x; Maurer-Stroh S, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-6-r55; MCNEW JA, 1994, J CELL BIOL, V127, P1245, DOI 10.1083/jcb.127.5.1245; Mihalek I, 2004, J MOL BIOL, V336, P1265, DOI 10.1016/j.jmb.2003.12.078; MIYAZAWA S, 1989, MOL CELL BIOL, V9, P83, DOI 10.1128/MCB.9.1.83; Morohashi Y, 2002, J BIOL CHEM, V277, P14965, DOI 10.1074/jbc.M200897200; Motley AM, 1997, NAT GENET, V15, P377, DOI 10.1038/ng0497-377; Motley AM, 2002, AM J HUM GENET, V70, P612, DOI 10.1086/338998; Neuberger G, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-r97; Neuberger G, 2003, J MOL BIOL, V328, P567, DOI 10.1016/S0022-2836(03)00318-8; Olivier LM, 2000, BBA-MOL CELL BIOL L, V1529, P89, DOI 10.1016/S1388-1981(00)00139-6; OSUMI T, 1992, BIOCHEM BIOPH RES CO, V186, P811, DOI 10.1016/0006-291X(92)90818-6; Passreiter M, 1998, J CELL BIOL, V141, P373, DOI 10.1083/jcb.141.2.373; Petriv OI, 2004, J MOL BIOL, V341, P119, DOI 10.1016/j.jmb.2004.05.064; Purdue PE, 1999, NEUROCHEM RES, V24, P581, DOI 10.1023/A:1023957110171; Reumann S, 2004, PLANT PHYSIOL, V135, P783, DOI 10.1104/pp.103.035584; ROBSON B, 1976, J MOL BIOL, V107, P327, DOI 10.1016/S0022-2836(76)80008-3; ROISE D, 1988, J BIOL CHEM, V263, P4509; Schneider A, 2007, BIOINFORMATICS, V23, P2180, DOI 10.1093/bioinformatics/btm295; Sharma MJ, 2003, EMBO J, V22, P6101, DOI 10.1093/emboj/cdg585; Stanley WA, 2007, FEBS LETT, V581, P4795, DOI 10.1016/j.febslet.2007.09.001; Su X, 2004, BIOCHEMISTRY-US, V43, P5033, DOI 10.1021/bi035867z; Suzek BE, 2007, BIOINFORMATICS, V23, P1282, DOI 10.1093/bioinformatics/btm098; SWINKELS BW, 1991, EMBO J, V10, P3255, DOI 10.1002/j.1460-2075.1991.tb04889.x; TSUKAMOTO T, 1994, J BIOL CHEM, V269, P6001; Vacic V, 2006, BIOINFORMATICS, V22, P1536, DOI 10.1093/bioinformatics/btl151; VANDERLEIJ I, 1993, P NATL ACAD SCI USA, V90, P11782, DOI 10.1073/pnas.90.24.11782; Wanders RJA, 2006, ANNU REV BIOCHEM, V75, P295, DOI 10.1146/annurev.biochem.74.082803.133329; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; Xiong H, 2004, MOL BRAIN RES, V128, P103, DOI 10.1016/j.molbrainres.2004.06.024; ZIMMERMAN JM, 1968, J THEOR BIOL, V21, P170, DOI 10.1016/0022-5193(68)90069-6; ZVELEBIL MJ, 1987, J MOL BIOL, V195, P957, DOI 10.1016/0022-2836(87)90501-8	65	35	35	1	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2011	286	52					45048	45062		10.1074/jbc.M111.301853	http://dx.doi.org/10.1074/jbc.M111.301853			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870CA	22057399	Green Published, hybrid			2022-12-27	WOS:000298645500072
J	Lolicato, M; Nardini, M; Gazzarrini, S; Moller, S; Bertinetti, D; Herberg, FW; Bolognesi, M; Martin, H; Fasolini, M; Bertrand, JA; Arrigoni, C; Thiel, G; Moroni, A				Lolicato, Marco; Nardini, Marco; Gazzarrini, Sabrina; Moeller, Stefan; Bertinetti, Daniela; Herberg, Friedrich W.; Bolognesi, Martino; Martin, Holger; Fasolini, Marina; Bertrand, Jay A.; Arrigoni, Cristina; Thiel, Gerhard; Moroni, Anna			Tetramerization Dynamics of C-terminal Domain Underlies Isoform-specific cAMP Gating in Hyperpolarization-activated Cyclic Nucleotide-gated Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HCN PACEMAKER CHANNELS; STRUCTURAL BASIS; LIGAND-BINDING; PROTEINS; MODULATION; MODEL; IDENTIFICATION; MECHANISMS; AMP	Hyperpolarization-activated cyclic nucleotide-gated (HCN) channels are dually activated by hyperpolarization and binding of cAMP to their cyclic nucleotide binding domain (CNBD). HCN isoforms respond differently to cAMP; binding of cAMP shifts activation of HCN2 and HCN4 by 17 mV but shifts that of HCN1 by only 2-4 mV. To explain the peculiarity of HCN1, we solved the crystal structures and performed a biochemical-biophysical characterization of the C-terminal domain (C-linker plus CNBD) of the three isoforms. Our main finding is that tetramerization of the C-terminal domain of HCN1 occurs at basal cAMP concentrations, whereas those of HCN2 and HCN4 require cAMP saturating levels. Therefore, HCN1 responds less markedly than HCN2 and HCN4 to cAMP increase because its CNBD is already partly tetrameric. This is confirmed by voltage clamp experiments showing that the right-shifted position of V-1/2 in HCN1 is correlated with its propensity to tetramerize in vitro. These data underscore that ligand-induced CNBD tetramerization removes tonic inhibition from the pore of HCN channels.	[Moroni, Anna] Univ Milan, Dept Biol, CNR IBF, I-20133 Milan, Italy; [Lolicato, Marco; Gazzarrini, Sabrina; Martin, Holger; Arrigoni, Cristina; Moroni, Anna] Univ Milan, Consiglio Nazl Ric, Ist Biofis, I-20133 Milan, Italy; [Nardini, Marco; Bolognesi, Martino] Univ Milan, Dept Biomol Sci & Biotechnol, I-20133 Milan, Italy; [Moeller, Stefan; Bertinetti, Daniela; Herberg, Friedrich W.] Univ Kassel, Dept Biochem, D-34132 Kassel, Germany; [Fasolini, Marina; Bertrand, Jay A.] Nerviano Med Sci Srl, Oncol, I-20014 Nerviano, MI, Italy; [Thiel, Gerhard] Tech Univ Darmstadt, Inst Bot, D-64287 Darmstadt, Germany	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biofisica (IBF-CNR); University of Milan; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biofisica (IBF-CNR); University of Milan; University of Milan; Universitat Kassel; Nerviano Medical Sciences S.r.l; Technical University of Darmstadt	Moroni, A (corresponding author), Univ Milan, Dept Biol, CNR IBF, Via Celoria 26, I-20133 Milan, Italy.	anna.moroni@unimi.it	Bolognesi, Martino/B-7924-2017; Bertinetti, Daniela/B-5655-2015; Nardini, Marco/B-7842-2017; Lolicato, Marco/AAL-3614-2020; moroni, anna/H-2097-2014; Lolicato, Marco/ABC-6878-2020; Herberg, Friedrich W/B-5572-2015; Arrigoni, Cristina/AAG-8176-2020	Bolognesi, Martino/0000-0002-9253-5170; Bertinetti, Daniela/0000-0003-1150-3765; Nardini, Marco/0000-0002-3718-2165; Lolicato, Marco/0000-0002-2022-7961; moroni, anna/0000-0002-1860-406X; Lolicato, Marco/0000-0002-2022-7961; Herberg, Friedrich W/0000-0001-7117-7653; gazzarrini, sabrina/0000-0003-3062-7536; Thiel, Gerhard/0000-0002-2335-1351; Arrigoni, Cristina/0000-0003-1917-1750	European Union; Progetto di Cooperazione Scientifica e Tecnologica Regione Lombardia	European Union(European Commission); Progetto di Cooperazione Scientifica e Tecnologica Regione Lombardia	This work was supported in part by European Union Grant EDICT (European Drug Initiative on Channels and Transporters) and Progetto di Cooperazione Scientifica e Tecnologica Regione Lombardia (to A. M.) and European Union grant Affinity Proteome and Affinomics (to F. W. H.).	Altomare C, 2001, J GEN PHYSIOL, V117, P519, DOI 10.1085/jgp.117.6.519; Barbuti A, 1999, J PHYSIOL-LONDON, V520, P737, DOI 10.1111/j.1469-7793.1999.00737.x; Chen C, 2001, J GEN PHYSIOL, V117, P491, DOI 10.1085/jgp.117.5.491; de la Torre JG, 2000, BIOPHYS J, V78, P719, DOI 10.1016/S0006-3495(00)76630-6; DIFRANCESCO D, 1993, ANNU REV PHYSIOL, V55, P455, DOI 10.1146/annurev.physiol.55.1.455; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Gauss R, 1998, NATURE, V393, P583, DOI 10.1038/31248; Kang M, 2004, P NATL ACAD SCI USA, V101, P5318, DOI 10.1073/pnas.0307824100; Krissinel E, 2005, LECT NOTES COMPUT SC, V3695, P163; Kusch J, 2010, NEURON, V67, P75, DOI 10.1016/j.neuron.2010.05.022; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Ludwig A, 1998, NATURE, V393, P587, DOI 10.1038/31255; Moll D, 2006, J NEURAL TRANSM, V113, P1015, DOI 10.1007/s00702-006-0515-5; Moll D, 2007, BIOL CHEM, V388, P163, DOI 10.1515/BC.2007.018; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734; Santoro B, 2003, TRENDS NEUROSCI, V26, P550, DOI 10.1016/j.tins.2003.08.003; Santoro B, 1998, CELL, V93, P717, DOI 10.1016/S0092-8674(00)81434-8; Schuck P, 2002, BIOPHYS J, V82, P1096, DOI 10.1016/S0006-3495(02)75469-6; Scott SP, 2007, BIOCHEMISTRY-US, V46, P9417, DOI 10.1021/bi6026049; Taraska JW, 2009, NAT METHODS, V6, P532, DOI 10.1038/nmeth.1341; Ulens C, 2003, NEURON, V40, P959, DOI 10.1016/S0896-6273(03)00753-0; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Wainger BJ, 2001, NATURE, V411, P805, DOI 10.1038/35081088; Wang J, 2002, NEURON, V36, P451, DOI 10.1016/S0896-6273(02)00968-6; Wang J, 2001, J GEN PHYSIOL, V118, P237, DOI 10.1085/jgp.118.3.237; WEBER IT, 1987, J MOL BIOL, V198, P311, DOI 10.1016/0022-2836(87)90315-9; Wicks NL, 2011, P NATL ACAD SCI USA, V108, P609, DOI 10.1073/pnas.1012750108; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Wu SJ, 2011, BIOPHYS J, V100, P1226, DOI 10.1016/j.bpj.2011.01.034; Xu XP, 2010, J BIOL CHEM, V285, P37082, DOI 10.1074/jbc.M110.152033; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922; Zhou L, 2004, NEURON, V44, P823, DOI 10.1016/j.neuron.2004.11.012; Zhou L, 2007, STRUCTURE, V15, P655, DOI 10.1016/j.str.2007.04.012	36	95	99	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2011	286	52					44811	44820		10.1074/jbc.M111.297606	http://dx.doi.org/10.1074/jbc.M111.297606			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870CA	22006928	Green Published, hybrid			2022-12-27	WOS:000298645500050
J	Ratelade, J; Bennett, JL; Verkman, AS				Ratelade, Julien; Bennett, Jeffrey L.; Verkman, A. S.			Evidence against Cellular Internalization in Vivo of NMO-IgG, Aquaporin-4, and Excitatory Amino Acid Transporter 2 in Neuromyelitis Optica	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WATER CHANNEL; MULTIPLE-SCLEROSIS; ORTHOGONAL ARRAYS; IMMUNOGLOBULIN-G; MARKER; AUTOANTIBODIES; LOCALIZATION; DISTINCTION; EXPRESSION; ANTIBODIES	Autoantibodies against astrocyte water channel aquaporin-4 (AQP4) are thought to be pathogenic in neuromyelitis optica (NMO). Prior work has suggested that a key component of NMO autoantibody (NMO-IgG) pathogenesis is internalization of AQP4 and the associated glutamate transporter EAAT2, leading to glutamate excitotoxicity. Here, we show selective endocytosis of NMO-IgG and AQP4 in transfected cell cultures, but little internalization in brain in vivo. AQP4-dependent endocytosis of NMO-IgG occurred rapidly in various AQP4-transfected cell lines, with efficient transport from early endosomes to lysosomes. Cell surface AQP4 was also reduced following NMO-IgG exposure. However, little or no internalization of NMO-IgG, AQP4, or EAAT2 was found in primary astrocyte cultures, nor was glutamate uptake affected by NMO-IgG exposure. Following injection of NMO-IgG into mouse brain, NMO-IgG binding and AQP4 expression showed a perivascular astrocyte distribution, without detectable cellular internalization over 24 h. We conclude that astrocyte endocytosis of NMO-IgG, AQP4, and EAAT2 is not a significant consequence of AQP4 autoantibody in vivo, challenging generally accepted views about NMO pathogenesis.	[Ratelade, Julien; Verkman, A. S.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Ratelade, Julien; Verkman, A. S.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; [Bennett, Jeffrey L.] Univ Colorado Denver, Dept Neurol, Aurora, CO 80045 USA; [Bennett, Jeffrey L.] Univ Colorado Denver, Dept Ophthalmol, Aurora, CO 80045 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Verkman, AS (corresponding author), Univ Calif San Francisco, Dept Med, 1246 Hlth Sci E Tower, San Francisco, CA 94143 USA.	alan.verkman@ucsf.edu		Ratelade, Julien/0000-0001-7968-5409	National Institutes of Health [EY13574, EB00415, DK35124, HL73856, DK86125, DK72517]; Guthy-Jackson Charitable Foundation; National Multiple Sclerosis Society [RG4320]; NATIONAL EYE INSTITUTE [R01EY013574] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073856] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000415, R37EB000415] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [RC1DK086125, P30DK072517, R37DK035124, R01DK035124] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Guthy-Jackson Charitable Foundation; National Multiple Sclerosis Society(National Multiple Sclerosis Society); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants EY13574, EB00415, DK35124, HL73856, DK86125 and DK72517 (to A. S. V.). This work was also supported by grants from the Guthy-Jackson Charitable Foundation (to A. S. V. and J.L.B.) and Grant RG4320 from the National Multiple Sclerosis Society (to J.L.B.).	Bennett JL, 2009, ANN NEUROL, V66, P617, DOI 10.1002/ana.21802; Bradl M, 2009, ANN NEUROL, V66, P630, DOI 10.1002/ana.21837; Crane JM, 2010, NEUROSCIENCE, V168, P892, DOI 10.1016/j.neuroscience.2009.08.034; Crane JM, 2008, MOL BIOL CELL, V19, P3369, DOI 10.1091/mbc.E08-03-0322; Crane JM, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.227298; FRIGERI A, 1995, J CELL SCI, V108, P2993; Hinson SR, 2007, NEUROLOGY, V69, P2221, DOI 10.1212/01.WNL.0000289761.64862.ce; Hinson SR, 2010, NEUROSCIENCE, V168, P1009, DOI 10.1016/j.neuroscience.2009.08.032; Hinson SR, 2008, J EXP MED, V205, P2473, DOI 10.1084/jem.20081241; Jarius S, 2010, NAT REV NEUROL, V6, P383, DOI 10.1038/nrneurol.2010.72; Kinoshita M, 2009, BIOCHEM BIOPH RES CO, V386, P623, DOI 10.1016/j.bbrc.2009.06.085; Lennon VA, 2004, LANCET, V364, P2106, DOI 10.1016/S0140-6736(04)17551-X; Lennon VA, 2005, J EXP MED, V202, P473, DOI 10.1084/jem.20050304; Li LH, 2011, FASEB J, V25, P1556, DOI 10.1096/fj.10-177279; Ma TH, 1997, J CLIN INVEST, V100, P957, DOI 10.1172/JCI231; Marignier R, 2010, BRAIN, V133, P2578, DOI 10.1093/brain/awq177; Misu T, 2007, BRAIN, V130, P1224, DOI 10.1093/brain/awm047; Neely JD, 2001, P NATL ACAD SCI USA, V98, P14108, DOI 10.1073/pnas.241508198; Nimmerjahn A, 2004, NAT METHODS, V1, P31, DOI 10.1038/nmeth706; Rothstein JD, 2005, NATURE, V433, P73, DOI 10.1038/nature03180; Saadoun S, 2010, BRAIN, V133, P349, DOI 10.1093/brain/awp309; Skytt DM, 2010, NEUROCHEM RES, V35, P2043, DOI 10.1007/s11064-010-0329-6; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; Tanaka K, 1997, SCIENCE, V276, P1699, DOI 10.1126/science.276.5319.1699; Valentine CD, 2012, TRAFFIC, V13, P25, DOI 10.1111/j.1600-0854.2011.01287.x; Verkman AS, 2011, ACTA PHARMACOL SIN, V32, P702, DOI 10.1038/aps.2011.27; Vincent T, 2008, J IMMUNOL, V181, P5730, DOI 10.4049/jimmunol.181.8.5730; Wingerchuk DM, 2007, LANCET NEUROL, V6, P805, DOI 10.1016/S1474-4422(07)70216-8; Zhang H, 2011, ANN NEUROL, V70, P943, DOI 10.1002/ana.22551	29	54	60	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2011	286	52					45156	45164		10.1074/jbc.M111.297275	http://dx.doi.org/10.1074/jbc.M111.297275			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870CA	22069320	Green Published, hybrid			2022-12-27	WOS:000298645500081
J	Patel, A; McKnight, JN; Genzor, P; Bowman, GD				Patel, Ashok; McKnight, Jeffrey N.; Genzor, Pavol; Bowman, Gregory D.			Identification of Residues in Chromodomain Helicase DNA-Binding Protein 1 (Chd1) Required for Coupling ATP Hydrolysis to Nucleosome Sliding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMATIN REMODELING COMPLEXES; RNA HELICASE; TRANSLOCATION; SWI2/SNF2; DOMAIN; TRIPHOSPHATASE; TRANSCRIPTION; MECHANISMS; CONTAINS; DYNAMICS	Chromatin remodelers are ATP-dependent machines responsible for directionally shifting nucleosomes along DNA. We are interested in defining which elements of the chromodomain helicase DNA-binding protein 1 (Chd1) remodeler are necessary and sufficient for sliding nucleosomes. This work focuses on the polypeptide segment that joins the ATPase motor to the C-terminal DNA-binding domain. We identify amino acid positions outside the ATPase motor that, when altered, dramatically reduce nucleosome sliding ability and yet have only similar to 3-fold reduction in ATPase stimulation by nucleosomes. These residues therefore appear to play a role in functionally coupling ATP hydrolysis to nucleosome sliding, and suggest that the ATPase motor requires cooperation with external elements to slide DNA past the histone core.	[Patel, Ashok; McKnight, Jeffrey N.; Genzor, Pavol; Bowman, Gregory D.] Johns Hopkins Univ, TC Jenkins Dept Biophys, Baltimore, MD 21218 USA	Johns Hopkins University	Bowman, GD (corresponding author), 3400 N Charles St, Baltimore, MD 21218 USA.	gdbowman@jhu.edu	Genzor, Pavol/ABA-7935-2021	Genzor, Pavol/0000-0002-3316-5659; McKnight, Jeffrey/0000-0002-1066-1879	National Institutes of Health [R01 GM084192]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084192] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM084192.	Beitz E, 2000, BIOINFORMATICS, V16, P135, DOI 10.1093/bioinformatics/16.2.135; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Corpet A, 2009, TRENDS CELL BIOL, V19, P29, DOI 10.1016/j.tcb.2008.10.002; DELMAS V, 1993, P NATL ACAD SCI USA, V90, P2414, DOI 10.1073/pnas.90.6.2414; Eberharter A, 2004, METHOD ENZYMOL, V377, P344; Fairman-Williams ME, 2010, CURR OPIN STRUC BIOL, V20, P313, DOI 10.1016/j.sbi.2010.03.011; Flaus A, 2011, FEBS J, V278, P3579, DOI 10.1111/j.1742-4658.2011.08281.x; Gangaraju VK, 2007, MUTAT RES-FUND MOL M, V618, P3, DOI 10.1016/j.mrfmmm.2006.08.015; Glatt S, 2011, CURR OPIN STRUC BIOL, V21, P335, DOI 10.1016/j.sbi.2011.02.003; GORBALENYA AE, 1993, CURR OPIN STRUC BIOL, V3, P419, DOI 10.1016/S0959-440X(05)80116-2; Gross CH, 1998, J VIROL, V72, P4729, DOI 10.1128/JVI.72.6.4729-4736.1998; Grune T, 2003, MOL CELL, V12, P449, DOI 10.1016/S1097-2765(03)00273-9; Hauk G, 2010, MOL CELL, V39, P711, DOI 10.1016/j.molcel.2010.08.012; Heilek GM, 1997, J VIROL, V71, P6264, DOI 10.1128/JVI.71.8.6264-6266.1997; Kiianitsa K, 2003, ANAL BIOCHEM, V321, P266, DOI 10.1016/S0003-2697(03)00461-5; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee JY, 2006, CELL, V127, P1349, DOI 10.1016/j.cell.2006.10.049; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Lohman TM, 2008, NAT REV MOL CELL BIO, V9, P391, DOI 10.1038/nrm2394; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Luger K, 1999, METHOD ENZYMOL, V304, P3; Lusser A, 2005, NAT STRUCT MOL BIOL, V12, P160, DOI 10.1038/nsmb884; PAUSE A, 1992, EMBO J, V11, P2643, DOI 10.1002/j.1460-2075.1992.tb05330.x; Ryan DP, 2011, CURR OPIN CHEM BIOL, V15, P649, DOI 10.1016/j.cbpa.2011.07.022; Ryan DP, 2011, EMBO J, V30, P2596, DOI 10.1038/emboj.2011.166; Saha A, 2005, NAT STRUCT MOL BIOL, V12, P747, DOI 10.1038/nsmb973; Schneider S, 2004, J BIOL CHEM, V279, P8617, DOI 10.1074/jbc.M312715200; Schwanbeck R, 2004, J BIOL CHEM, V279, P39933, DOI 10.1074/jbc.M406060200; Schwer B, 2000, EMBO J, V19, P6582, DOI 10.1093/emboj/19.23.6582; Sen P, 2011, NUCLEIC ACIDS RES, V39, P9155, DOI 10.1093/nar/gkr622; Smith CL, 2005, MOL CELL BIOL, V25, P5880, DOI 10.1128/MCB.25.14.5880-5892.2005; Solinger JA, 2002, MOL CELL, V10, P1175, DOI 10.1016/S1097-2765(02)00743-8; Soultanas P, 2000, EMBO J, V19, P3799, DOI 10.1093/emboj/19.14.3799; Stockdale C, 2006, J BIOL CHEM, V281, P16279, DOI 10.1074/jbc.M600682200; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Sukhodolets MV, 2001, GENE DEV, V15, P3330, DOI 10.1101/gad.936701; Velankar SS, 1999, CELL, V97, P75, DOI 10.1016/S0092-8674(00)80716-3; Zhang L, 2009, BIOCHEM CELL BIOL, V87, P265, DOI 10.1139/O08-101; Zofall M, 2006, NAT STRUCT MOL BIOL, V13, P339, DOI 10.1038/nsmb1071	39	32	32	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2011	286	51					43984	43993		10.1074/jbc.M111.282970	http://dx.doi.org/10.1074/jbc.M111.282970			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866SH	22039057	Green Published, hybrid			2022-12-27	WOS:000298402300039
J	Yamada, K; Tamamori-Adachi, M; Goto, I; Iizuka, M; Yasukawa, T; Aso, T; Okazaki, T; Kitajima, S				Yamada, Kazuhiko; Tamamori-Adachi, Mimi; Goto, Ikuko; Iizuka, Masayoshi; Yasukawa, Takashi; Aso, Teijiro; Okazaki, Tomoki; Kitajima, Shigetaka			Degradation of p21(Cip1) through Anaphase-promoting Complex/Cyclosome and Its Activator Cdc20 (APC/C-Cdc20) Ubiquitin Ligase Complex-mediated Ubiquitylation Is Inhibited by Cyclin-dependent Kinase 2 in Cardiomyocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REG-GAMMA-PROTEASOME; CELL-CYCLE; HEART-FAILURE; ALPHA-SUBUNIT; CDK2 KINASE; P21; PROLIFERATION; PROTEIN; EXPRESSION; D1	Cyclin-dependent kinase inhibitor p21(Cip1) plays a crucial role in regulating cell cycle arrest and differentiation. It is known that p21(Cip1) increases during terminal differentiation of cardiomyocytes, but its expression control and biological roles are not fully understood. Here, we show that the p21(Cip1) protein is stabilized in cardiomyocytes after mitogenic stimulation, due to its increased CDK2 binding and inhibition of ubiquitylation. The APC/C-Cdc20 complex is shown to be an E3 ligase mediating ubiquitylation of p21(Cip1) at the N terminus. CDK2, but not CDC2, suppressed the interaction of p21(Cip1) with Cdc20, thereby leading to inhibition of anaphase-promoting complex/cyclosome and its activator Cdc20 (APC/C-Cdc20)-mediated p21(Cip1) ubiquitylation. It was further demonstrated that p21(Cip1) accumulation caused G(2) arrest of cardiomyocytes that were forced to re-enter the cell cycle. Taken together, these data show that the stability of the p21(Cip1) protein is actively regulated in terminally differentiated cardiomyocytes and plays a role in inhibiting their uncontrolled cell cycle progression. Our study provides a novel insight on the control of p21(Cip1) by ubiquitin-mediated degradation and its implication in cell cycle arrest in terminal differentiation.	[Tamamori-Adachi, Mimi; Iizuka, Masayoshi; Okazaki, Tomoki] Teikyo Univ, Sch Med, Dept Biochem, Itabashi Ku, Tokyo 1738605, Japan; [Yasukawa, Takashi; Aso, Teijiro] Kochi Med Sch, Dept Funct Genom, Nankoku, Kochi 7838505, Japan; [Yamada, Kazuhiko; Kitajima, Shigetaka] Tokyo Med & Dent Univ, Lab Genome Struct & Regulat, Sch Biomed Sci, Bunkyo Ku, Tokyo 1138510, Japan; [Tamamori-Adachi, Mimi; Goto, Ikuko; Kitajima, Shigetaka] Tokyo Med & Dent Univ, Dept Biochem Genet, Med Res Inst, Bunkyo Ku, Tokyo 1138510, Japan	Teikyo University; Kochi University; Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU)	Tamamori-Adachi, M (corresponding author), Teikyo Univ, Sch Med, Dept Biochem, Itabashi Ku, 2-11-1 Kaga, Tokyo 1738605, Japan.	madachi@med.teikyo-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Society for the Promotion of Science; Japan Space Forum; Takeda Science Foundation; Atsuko Ouchi Memorial Fund; Grants-in-Aid for Scientific Research [22590276] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Space Forum; Takeda Science Foundation(Takeda Science Foundation (TSF)); Atsuko Ouchi Memorial Fund; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a grant-in-aid for research on priority areas from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, a grant from the Japan Society for the Promotion of Science, a grant from the Japan Space Forum, a grant from Takeda Science Foundation, and a grant from the Atsuko Ouchi Memorial Fund.	Abbas T, 2008, GENE DEV, V22, P2496, DOI 10.1101/gad.1676108; Ahuja P, 2007, PHYSIOL REV, V87, P521, DOI 10.1152/physrev.00032.2006; Amador V, 2007, MOL CELL, V27, P462, DOI 10.1016/j.molcel.2007.06.013; Bendjennat M, 2003, CELL, V114, P599, DOI 10.1016/j.cell.2003.08.001; Bicknell KA, 2007, J MOL CELL CARDIOL, V42, P706, DOI 10.1016/j.yjmcc.2007.01.006; Bloom J, 2003, CELL, V115, P71, DOI 10.1016/S0092-8674(03)00755-4; Bornstein G, 2003, J BIOL CHEM, V278, P25752, DOI 10.1074/jbc.M301774200; Burton PBJ, 1999, EUR HEART J, V20, P604, DOI 10.1053/euhj.1998.1231; Cayrol C, 1998, ONCOGENE, V17, P2437, DOI 10.1038/sj.onc.1202189; Chen XY, 2007, MOL CELL, V26, P843, DOI 10.1016/j.molcel.2007.05.022; Coleman ML, 2003, EMBO J, V22, P2036, DOI 10.1093/emboj/cdg189; Coulombe P, 2004, MOL CELL BIOL, V24, P6140, DOI 10.1128/MCB.24.14.6140-6150.2004; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; Di Stefano V, 2011, J BIOL CHEM, V286, P8644, DOI 10.1074/jbc.M110.184549; DULIC V, 1994, CELL, V76, P1013, DOI 10.1016/0092-8674(94)90379-4; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Engel FB, 2005, CELL CYCLE, V4, P1360, DOI 10.4161/cc.4.10.2081; Engel FB, 2003, MOL CELL BIOL, V23, P555, DOI 10.1128/MCB.23.2.555-565.2003; Engel FB, 2006, P NATL ACAD SCI USA, V103, P15546, DOI 10.1073/pnas.0607382103; Evans-Anderson HJ, 2008, CIRC RES, V102, P686, DOI 10.1161/CIRCRESAHA.107.163428; Fotedar R, 1996, ONCOGENE, V12, P2155; Gartel AL, 1999, EXP CELL RES, V246, P280, DOI 10.1006/excr.1998.4319; Harper JW, 2002, GENE DEV, V16, P2179, DOI 10.1101/gad.1013102; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Jin YT, 2003, EMBO J, V22, P6365, DOI 10.1093/emboj/cdg600; Kim Y, 2008, GENE DEV, V22, P2507, DOI 10.1101/gad.1703708; Li XT, 2007, MOL CELL, V26, P831, DOI 10.1016/j.molcel.2007.05.028; Mal A, 2000, J CELL BIOL, V149, P281, DOI 10.1083/jcb.149.2.281; Newton K, 2008, CELL, V134, P668, DOI 10.1016/j.cell.2008.07.039; Ono T, 2000, J BIOL CHEM, V275, P31145, DOI 10.1074/jbc.M003031200; PARKER TG, 1990, J CLIN INVEST, V85, P507, DOI 10.1172/JCI114466; Pasumarthi KBS, 2002, CIRC RES, V90, P1044, DOI 10.1161/01.RES.0000020201.44772.67; Pasumarthi KBS, 2005, CIRC RES, V96, P110, DOI 10.1161/01.RES.0000152326.91223.4F; Pavletich NP, 1999, J MOL BIOL, V287, P821, DOI 10.1006/jmbi.1999.2640; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Peters JM, 2002, MOL CELL, V9, P931, DOI 10.1016/S1097-2765(02)00540-3; Poolman RA, 1998, INT J CARDIOL, V67, P133, DOI 10.1016/S0167-5273(98)00320-9; Russo AA, 1996, NATURE, V382, P325, DOI 10.1038/382325a0; Sheaff RJ, 2000, MOL CELL, V5, P403, DOI 10.1016/S1097-2765(00)80435-9; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Stewart GS, 2009, CELL, V136, P420, DOI 10.1016/j.cell.2008.12.042; Studzinski GP, 1999, INT REV CYTOL, V189, P1, DOI 10.1016/S0074-7696(08)61384-4; Tamamori-Adachi M, 2004, J BIOL CHEM, V279, P50429, DOI 10.1074/jbc.M403084200; Tamamori-Adachi M, 2003, CIRC RES, V92, pE12, DOI 10.1161/01.RES.0000049105.15329.1C; Tamamori-Adachi M, 2002, BIOCHEM BIOPH RES CO, V296, P274, DOI 10.1016/S0006-291X(02)00854-9; Tamamori-Adachi M, 2008, CARDIOVASC RES, V80, P181, DOI 10.1093/cvr/cvn183; Tamamori-Adachi M, 2008, CELL CYCLE, V7, P3768, DOI 10.4161/cc.7.23.7239; Touitou R, 2001, EMBO J, V20, P2367, DOI 10.1093/emboj/20.10.2367; VANDENHEUVEL S, 1993, SCIENCE, V262, P2050, DOI 10.1126/science.8266103; Wang W, 2005, BIOCHEMISTRY-US, V44, P14553, DOI 10.1021/bi051071j; Woo YJ, 2006, CIRCULATION, V114, pI206, DOI 10.1161/CIRCULATIONAHA.105.000455; Wu-Baer F, 2003, J BIOL CHEM, V278, P34743, DOI 10.1074/jbc.C300249200; Yu H, 1999, J BIOL CHEM, V274, P36852, DOI 10.1074/jbc.274.52.36852; Yu H, 2007, MOL CELL, V27, P3, DOI 10.1016/j.molcel.2007.06.009; Yu ZK, 1998, P NATL ACAD SCI USA, V95, P11324, DOI 10.1073/pnas.95.19.11324; Zhu HY, 2005, J BIOL CHEM, V280, P29282, DOI 10.1074/jbc.M407352200	56	7	7	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2011	286	51					44057	44066		10.1074/jbc.M111.236711	http://dx.doi.org/10.1074/jbc.M111.236711			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866SH	22045811	Green Published, hybrid			2022-12-27	WOS:000298402300046
J	Mohammad, S; Ramos, LS; Buck, J; Levin, LR; Rubino, F; McGraw, TE				Mohammad, Sameer; Ramos, Lavoisier S.; Buck, Jochen; Levin, Lonny R.; Rubino, Francesco; McGraw, Timothy E.			Gastric Inhibitory Peptide Controls Adipose Insulin Sensitivity via Activation of cAMP-response Element-binding Protein and p110 beta Isoform of Phosphatidylinositol 3-Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STIMULATED GLUCOSE-TRANSPORT; AKT/PROTEIN KINASE-B; BETA-GAMMA-SUBUNITS; PHOSPHOINOSITIDE 3-KINASE; PLASMA-MEMBRANE; CELL-SURVIVAL; POLYPEPTIDE RECEPTOR; SELECTIVE INHIBITOR; SIGNAL-TRANSDUCTION; LIPOPROTEIN-LIPASE	Gastric inhibitory peptide (GIP) is an incretin hormone secreted in response to food intake. The best known function of GIP is to enhance glucose-dependent insulin secretion from pancreatic beta-cells. Extra-pancreatic effects of GIP primarily occur in adipose tissues. Here, we demonstrate that GIP increases insulin-dependent translocation of the Glut4 glucose transporter to the plasma membrane and exclusion of FoxO1 transcription factor from the nucleus in adipocytes, establishing that GIP has a general effect on insulin action in adipocytes. Stimulation of adipocytes with GIP alone has no effect on these processes. Using pharmacologic and molecular genetic approaches, we show that the effect of GIP on adipocyte insulin sensitivity requires activation of both the cAMP/protein kinase A/CREB signaling module and p110 beta phosphoinositol-3' kinase, establishing a novel signal transduction pathway modulating insulin action in adipocytes. This insulin-sensitizing effect is specific for GIP because isoproterenol, which elevates adipocyte cAMP and activates PKA/CREB signaling, does not affect adipocyte insulin sensitivity. The insulin-sensitizing activity points to a more central role for GIP in intestinal regulation of peripheral tissue metabolism, an emerging feature of inter-organ communication in the control of metabolism.	[Mohammad, Sameer; McGraw, Timothy E.] Cornell Univ, Weill Med Coll, Dept Biochem, New York, NY 10065 USA; [Ramos, Lavoisier S.; Buck, Jochen; Levin, Lonny R.] Cornell Univ, Weill Med Coll, Dept Pharmacol, New York, NY 10065 USA; [Rubino, Francesco] Cornell Univ, Weill Med Coll, Dept Surg, New York, NY 10065 USA	Cornell University; Cornell University; Cornell University	McGraw, TE (corresponding author), Cornell Univ, Weill Med Coll, Dept Biochem, New York, NY 10065 USA.	temcgraw@med.cornell.edu	Mohammad, Sameer/GWV-2875-2022	Mohammad, Sameer/0000-0002-1129-7685; Levin, Lonny/0000-0002-5204-6356	National Institutes of Health [DK52852, DK69982]; Weill Cornell Medical College; Qatar Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052852, R56DK052852, R01DK096925, R56DK069982, R01DK069982, R56DK096925] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Weill Cornell Medical College; Qatar Foundation(Qatar Foundation (QF)Qatar National Research Fund (QNRF)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK52852 and DK69982 (to T. E. M.). This work was also supported by the Biomedical Research Program funds at Weill Cornell Medical College, a program funded by Qatar Foundation.	Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Asmar M, 2010, AM J PHYSIOL-ENDOC M, V298, pE614, DOI 10.1152/ajpendo.00639.2009; Bae SS, 2003, J BIOL CHEM, V278, P49530, DOI 10.1074/jbc.M306782200; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Chang E, 2009, MOL CELL ENDOCRINOL, V307, P77, DOI 10.1016/j.mce.2009.03.024; CHIJIWA T, 1990, J BIOL CHEM, V265, P5267; Choi SM, 2010, MOL CELL BIOL, V30, P5009, DOI 10.1128/MCB.00797-10; Ciraolo E, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1161577; Ding JX, 2009, MOL CELL BIOL, V29, P1459, DOI 10.1128/MCB.00754-08; Drucker DJ, 2006, CELL METAB, V3, P153, DOI 10.1016/j.cmet.2006.01.004; DUPRE J, 1973, J CLIN ENDOCR METAB, V37, P826, DOI 10.1210/jcem-37-5-826; Eguez L, 2005, CELL METAB, V2, P263, DOI 10.1016/j.cmet.2005.09.005; Ehses JA, 2003, ENDOCRINOLOGY, V144, P4433, DOI 10.1210/en.2002-0068; ELKS ML, 1985, ENDOCRINOLOGY, V116, P2119, DOI 10.1210/endo-116-5-2119; FEDERMAN AD, 1992, NATURE, V356, P159, DOI 10.1038/356159a0; Galic S, 2010, MOL CELL ENDOCRINOL, V316, P129, DOI 10.1016/j.mce.2009.08.018; GIBBS EM, 1988, BIOCHEMISTRY-US, V27, P6681, DOI 10.1021/bi00418a006; Gonzalez E, 2006, MOL BIOL CELL, V17, P4484, DOI 10.1091/mbc.E06-07-0585; Gonzalez E, 2009, P NATL ACAD SCI USA, V106, P7004, DOI 10.1073/pnas.0901933106; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; Govers R, 2004, MOL CELL BIOL, V24, P6456, DOI 10.1128/MCB.24.14.6456-6466.2004; Graupera M, 2008, NATURE, V453, P662, DOI 10.1038/nature06892; GREENBERG AS, 1991, J BIOL CHEM, V266, P11341; Guillermet-Guibert J, 2008, P NATL ACAD SCI USA, V105, P8292, DOI 10.1073/pnas.0707761105; Harber MP, 2005, AM J PHYSIOL-ENDOC M, V289, pE306, DOI 10.1152/ajpendo.00069.2005; Herman MA, 2006, J CLIN INVEST, V116, P1767, DOI 10.1172/JCI29027; Huang SH, 2007, CELL METAB, V5, P237, DOI 10.1016/j.cmet.2007.03.006; Irwin N, 2009, BEST PRACT RES CL EN, V23, P499, DOI 10.1016/j.beem.2009.03.001; Jackson SP, 2005, NAT MED, V11, P507, DOI 10.1038/nm1232; Jia SD, 2008, NATURE, V454, P776, DOI 10.1038/nature07091; Jiang ZY, 2003, P NATL ACAD SCI USA, V100, P7569, DOI 10.1073/pnas.1332633100; Jones PM, 1998, ENDOCR REV, V19, P429, DOI 10.1210/er.19.4.429; JOOST HG, 1987, MOL PHARMACOL, V31, P279; Karylowski O, 2004, MOL BIOL CELL, V15, P870, DOI 10.1091/mbc.E03-07-0517; Kim SJ, 2007, J BIOL CHEM, V282, P34139, DOI 10.1074/jbc.M704896200; Kim SJ, 2007, J BIOL CHEM, V282, P8557, DOI 10.1074/jbc.M609088200; Kim SJ, 2010, J LIPID RES, V51, P3145, DOI 10.1194/jlr.M006841; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; KURODA M, 1987, J BIOL CHEM, V262, P245; Kurosu H, 1997, J BIOL CHEM, V272, P24252, DOI 10.1074/jbc.272.39.24252; Lampson MA, 2001, MOL BIOL CELL, V12, P3489, DOI 10.1091/mbc.12.11.3489; Lampson MA, 2000, J CELL SCI, V113, P4065; LU M, 1993, ENDOCRINOLOGY, V132, P94, DOI 10.1210/en.132.1.94; Maier U, 1999, J BIOL CHEM, V274, P29311, DOI 10.1074/jbc.274.41.29311; Martin OJ, 2006, J BIOL CHEM, V281, P484, DOI 10.1074/jbc.M505944200; McIntosh CHS, 2009, VITAM HORM, V80, P409, DOI 10.1016/S0083-6729(08)00615-8; Meier JJ, 2001, DIABETES, V50, P2497, DOI 10.2337/diabetes.50.11.2497; Miyawaki K, 2002, NAT MED, V8, P738, DOI 10.1038/nm727; Miyawaki K, 1999, P NATL ACAD SCI USA, V96, P14843, DOI 10.1073/pnas.96.26.14843; NAUCK MA, 1993, J CLIN INVEST, V91, P301, DOI 10.1172/JCI116186; Potti A, 2006, NEW ENGL J MED, V355, P570, DOI 10.1056/NEJMoa060467; Preitner F, 2004, J CLIN INVEST, V113, P635, DOI 10.1172/JCI200420518; Qi L, 2009, CELL METAB, V9, P277, DOI 10.1016/j.cmet.2009.01.006; RAHN T, 1994, FEBS LETT, V350, P314, DOI 10.1016/0014-5793(94)00797-7; REGEN DM, 1964, J BIOL CHEM, V239, P381; Rhoads JM, 2000, GASTROENTEROLOGY, V118, P90, DOI 10.1016/S0016-5085(00)70417-3; ROSS SA, 1978, DIABETES, V27, P327, DOI 10.2337/diabetes.27.3.327; RYDEL RE, 1988, P NATL ACAD SCI USA, V85, P1257, DOI 10.1073/pnas.85.4.1257; Sano H, 2007, CELL METAB, V5, P293, DOI 10.1016/j.cmet.2007.03.001; Schenck A, 2008, CELL, V133, P486, DOI 10.1016/j.cell.2008.02.044; SHANAHAN MF, 1986, BIOCHIM BIOPHYS ACTA, V887, P121, DOI 10.1016/0167-4889(86)90132-1; Smith FD, 2006, EUR J CELL BIOL, V85, P585, DOI 10.1016/j.ejcb.2006.01.011; Song DH, 2007, GASTROENTEROLOGY, V133, P1796, DOI 10.1053/j.gastro.2007.09.005; STARICH GH, 1985, AM J PHYSIOL, V249, pE603, DOI 10.1152/ajpendo.1985.249.6.E603; Trumper A, 2001, MOL ENDOCRINOL, V15, P1559, DOI 10.1210/me.15.9.1559; USDIN TB, 1993, ENDOCRINOLOGY, V133, P2861, DOI 10.1210/en.133.6.2861; WALTON KM, 1992, MOL ENDOCRINOL, V6, P647, DOI 10.1210/me.6.4.647; Welsh GL, 2005, BIOCHEM SOC T, V33, P346, DOI 10.1042/BST0330346; Widenmaier SB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009590; Yip RGC, 1998, ENDOCRINOLOGY, V139, P4004, DOI 10.1210/en.139.9.4004; Yip RGC, 1999, LIFE SCI, V66, P91, DOI 10.1016/S0024-3205(99)00314-8; YOUNG DA, 1985, AM J PHYSIOL, V248, pC406, DOI 10.1152/ajpcell.1985.248.5.C406; ZAWALICH WS, 1990, MOL CELL ENDOCRINOL, V70, P119, DOI 10.1016/0303-7207(90)90152-X; Zeigerer A, 2002, MOL BIOL CELL, V13, P2421, DOI 10.1091/mbc.E02-02-0071; Zhao JJ, 2005, P NATL ACAD SCI USA, V102, P18443, DOI 10.1073/pnas.0508988102	75	35	37	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					43062	43070		10.1074/jbc.M111.289009	http://dx.doi.org/10.1074/jbc.M111.289009			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22027830	hybrid, Green Published			2022-12-27	WOS:000298351300027
J	Abuhatzira, L; Shamir, A; Schones, DE; Schaffer, AA; Bustin, M				Abuhatzira, Liron; Shamir, Alon; Schones, Dustin E.; Schaeffer, Alejandro A.; Bustin, Michael			The Chromatin-binding Protein HMGN1 Regulates the Expression of Methyl CpG-binding Protein 2 (MECP2) and Affects the Behavior of Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOWN-SYNDROME; CHROMOSOMAL-PROTEINS; HISTONE DEACETYLASE; NEURONAL MECP2; RETT-SYNDROME; MOUSE; DISEASE; GENE; PHENOTYPE; ELEMENTS	High mobility group N1 protein (HMGN1), a nucleosomal-binding protein that affects the structure and function of chromatin, is encoded by a gene located on chromosome 21 and is overexpressed in Down syndrome, one of the most prevalent genomic disorders. Misexpression of HMGN1 affects the cellular transcription profile; however, the biological function of this protein is still not fully understood. We report that HMGN1 modulates the expression of methyl CpG-binding protein 2 (MeCP2), a DNA-binding protein known to affect neurological functions including autism spectrum disorders, and whose alterations in HMGN1 levels affect the behavior of mice. Quantitative PCR and Western analyses of cell lines and brain tissues from mice that either overexpress or lack HMGN1 indicate that HMGN1 is a negative regulator of MeCP2 expression. Alterations in HMGN1 levels lead to changes in chromatin structure and histone modifications in the MeCP2 promoter. Behavior analyses by open field test, elevated plus maze, Reciprocal Social Interaction, and automated sociability test link changes in HMGN1 levels to abnormalities in activity and anxiety and to social deficits in mice. Targeted analysis of the Autism Genetic Resource Exchange genotype collection reveals a non-random distribution of genotypes within 500 kbp of HMGN1 in a region affecting its expression in families predisposed to autism spectrum disorders. Our results reveal that HMGN1 affects the behavior of mice and suggest that epigenetic changes resulting from altered HMGN1 levels could play a role in the etiology of neurodevelopmental disorders.	[Abuhatzira, Liron; Bustin, Michael] NCI, Prot Sect, Lab Metab, Ctr Canc Res, Bethesda, MD 20892 USA; [Schaeffer, Alejandro A.] NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20892 USA; [Shamir, Alon] NICHD, Bethesda, MD 20892 USA; [Schones, Dustin E.] City Hope Natl Med Ctr, Duarte, CA 91010 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); City of Hope	Bustin, M (corresponding author), Bldg 37,Rm 3122, Bethesda, MD 20892 USA.	Bustin@helix.nih.gov	Schaffer, Alejandro/N-1222-2019; Schaffer, Alejandro A/F-2902-2012; Bustin, Michael/G-6155-2015	Bustin, Michael/0000-0002-5147-7242; Abuhatzira, Liron/0000-0002-2742-0908	National Institutes of Health Center for Cancer Research; NCI; National Library of Medicine; NIMH, National Institutes of Health [1U24MH081810]; NATIONAL CANCER INSTITUTE [ZIABC011154] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U24MH081810] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [ZIALM000097] Funding Source: NIH RePORTER	National Institutes of Health Center for Cancer Research; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NIMH, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported, in whole or in part, by National Institutes of Health Center for Cancer Research, the intramural program of the NCI, and by the Intramural Research Program of the National Library of Medicine.; Human brain tissue was obtained from the NICHD, National Institutes of Health Brain and Tissue Bank for Developmental Disorders at the University of Maryland, Baltimore, MD. We acknowledge the resources provided by the AGRE Consortium and the participating AGRE families. AGRE is a program of Autism Speaks and is supported, in part, by NIMH, National Institutes of Health Grant 1U24MH081810 (to Dr. Clara M. Lajonchere). We thank Dr. Vlad Kustanovich at AGRE for answering numerous questions, Dr. Stefan Wuchty for extracting the FHS data from dbGa-Pand, and Dr. Mu Yang, NIMH, National Institutes of Health for critical review of the mouse behavior test results.	Abuhatzira L, 2007, EPIGENETICS-US, V2, P214, DOI 10.4161/epi.2.4.5212; Abuhatzira L, 2009, HUM MOL GENET, V18, P1415, DOI 10.1093/hmg/ddp048; Anney R, 2010, HUM MOL GENET, V19, P4072, DOI 10.1093/hmg/ddq307; Antonarakis SE, 2006, TRENDS MOL MED, V12, P473, DOI 10.1016/j.molmed.2006.08.005; Bird A, 2008, BIOCHEM SOC T, V36, P575, DOI 10.1042/BST0360575; Birger Y, 2003, EMBO J, V22, P1665, DOI 10.1093/emboj/cdg142; BUSTIN M, 1995, SEMIN CELL BIOL, V6, P247, DOI 10.1006/scel.1995.0033; BUSTIN M, 1978, J BIOL CHEM, V253, P1694; BUSTIN M, 1990, J BIOL CHEM, V265, P20077; Bustin M, 1995, DNA CELL BIOL, V14, P997, DOI 10.1089/dna.1995.14.997; Carney RM, 2003, PEDIATR NEUROL, V28, P205, DOI 10.1016/S0887-8994(02)00624-0; Catez F, 2002, EMBO REP, V3, P760, DOI 10.1093/embo-reports/kvf156; Catez F, 2010, BBA-GENE REGUL MECH, V1799, P15, DOI 10.1016/j.bbagrm.2009.11.001; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; Collins AL, 2004, HUM MOL GENET, V13, P2679, DOI 10.1093/hmg/ddh282; CoussonsRead ME, 1996, BEHAV GENET, V26, P7, DOI 10.1007/BF02361154; Cuddapah S, 2011, MOL CELL BIOL, V31, P700, DOI 10.1128/MCB.00740-10; Dimas C, 2008, J AM PSYCHOANAL ASS, V56, P1342, DOI 10.1177/00030651080560042203; DING HF, 1994, SCIENCE, V265, P796, DOI 10.1126/science.8047885; Dubinsky MC, 2010, INFLAMM BOWEL DIS, V16, P1357, DOI 10.1002/ibd.21174; Dulac C, 2010, NATURE, V465, P728, DOI 10.1038/nature09231; Gardiner K, 2010, J NEUROSCI, V30, P14943, DOI 10.1523/JNEUROSCI.3728-10.2010; Gemelli T, 2006, BIOL PSYCHIAT, V59, P468, DOI 10.1016/j.biopsych.2005.07.025; Gerlitz G, 2009, BIOCHEM CELL BIOL, V87, P127, DOI 10.1139/O08-110; Giresi PG, 2007, GENOME RES, V17, P877, DOI 10.1101/gr.5533506; Giresi PG, 2009, METHODS, V48, P233, DOI 10.1016/j.ymeth.2009.03.003; Grafodatskaya D, 2010, J AM ACAD CHILD PSY, V49, P794, DOI 10.1016/j.jaac.2010.05.005; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; Hansen JC, 2010, IUBMB LIFE, V62, P732, DOI 10.1002/iub.386; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Kamens HM, 2007, NAT PROTOC, V2, P277, DOI 10.1038/nprot.2007.19; KOOY RF, 2010, F1000 BIOL REP, V2; Korbel JO, 2009, P NATL ACAD SCI USA, V106, P12031, DOI 10.1073/pnas.0813248106; Ku CS, 2011, HUM GENET, V129, P1, DOI 10.1007/s00439-010-0920-6; Kugathasan S, 2008, NAT GENET, V40, P1211, DOI 10.1038/ng.203; Larson MG, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S5; Lim JH, 2004, MOL CELL, V15, P573, DOI 10.1016/j.molcel.2004.08.006; Liu J, 2006, HUM MOL GENET, V15, P1769, DOI 10.1093/hmg/ddl099; Lyle R, 2009, EUR J HUM GENET, V17, P454, DOI 10.1038/ejhg.2008.214; Moretti P, 2005, HUM MOL GENET, V14, P205, DOI 10.1093/hmg/ddi016; Murata K, 2009, DEV GROWTH DIFFER, V51, P95, DOI 10.1111/j.1440-169X.2008.01084.x; Nadler JJ, 2004, GENES BRAIN BEHAV, V3, P303, DOI 10.1111/j.1601-183X.2004.00071.x; Nagarajan Raman P, 2006, Epigenetics, V1, pe1; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; O'Doherty A, 2005, SCIENCE, V309, P2033, DOI 10.1126/science.1114535; PASH J, 1990, P NATL ACAD SCI USA, V87, P3836, DOI 10.1073/pnas.87.10.3836; PASH JM, 1990, J BIOL CHEM, V265, P4197; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Postnikov Y, 2010, BBA-GENE REGUL MECH, V1799, P62, DOI 10.1016/j.bbagrm.2009.11.016; POSTNIKOV YV, 1995, J MOL BIOL, V252, P423, DOI 10.1006/jmbi.1995.0508; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ramocki MB, 2010, AM J MED GENET A, V152A, P1079, DOI 10.1002/ajmg.a.33184; Razin A, 1998, EMBO J, V17, P4905, DOI 10.1093/emboj/17.17.4905; Rochman M, 2011, NUCLEIC ACIDS RES, V39, P4076, DOI 10.1093/nar/gkq1343; Sakai Y, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002166; Samaco RC, 2008, HUM MOL GENET, V17, P1718, DOI 10.1093/hmg/ddn062; Scherr R, 2009, DIGEST DIS, V27, P236, DOI 10.1159/000228555; Silverman JL, 2010, NAT REV NEUROSCI, V11, P490, DOI 10.1038/nrn2851; SINET PM, 1994, BIOMED PHARMACOTHER, V48, P247, DOI 10.1016/0753-3322(94)90140-6; Skene PJ, 2010, MOL CELL, V37, P457, DOI 10.1016/j.molcel.2010.01.030; Ueda T, 2006, J BIOL CHEM, V281, P10182, DOI 10.1074/jbc.M600821200; van Bokhoven H, 2010, NEUROBIOL DIS, V39, P3, DOI 10.1016/j.nbd.2010.03.010; Voineagu I, 2011, NATURE, V474, P380, DOI 10.1038/nature10110; Wang K, 2009, NATURE, V459, P528, DOI 10.1038/nature07999; Yang Mu, 2011, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0826s56; Yang TP, 2010, BIOINFORMATICS, V26, P2474, DOI 10.1093/bioinformatics/btq452; Yasui DH, 2007, P NATL ACAD SCI USA, V104, P19416, DOI 10.1073/pnas.0707442104	68	34	34	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42051	42062		10.1074/jbc.M111.300541	http://dx.doi.org/10.1074/jbc.M111.300541			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	22009741	Green Published, hybrid			2022-12-27	WOS:000298180900015
J	Chen, Y; Shi, HY; Stock, SR; Stern, PH; Zhang, M				Chen, Yan; Shi, Heidi Y.; Stock, Stuart R.; Stern, Paula H.; Zhang, Ming			Regulation of Breast Cancer-induced Bone Lesions by beta-Catenin Protein Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HORMONE-RELATED PROTEIN; OSTEOBLAST DIFFERENTIATION; TRANSCRIPTION FACTORS; NEGATIVE REGULATOR; HUMAN OSTEOSARCOMA; WNT PATHWAY; CYCLIN D1; CELLS; EXPRESSION; METASTASIS	Breast cancer patients have an extremely high rate of bone metastases. Morphological analyses of the bones in most of the patients have revealed the mixed bone lesions, comprising both osteolytic and osteoblastic elements. beta-Catenin plays a key role in both embryonic skeletogenesis and postnatal bone regeneration. Although this pathway is also involved in many bone malignancy, such as osteosarcoma and prostate cancer-induced bone metastases, its regulation of breast cancer bone metastases remains unknown. Here, we provide evidence that the beta-catenin signaling pathway has a significant impact on the bone lesion phenotype. In this study, we established a novel mouse model of mixed bone lesions using intratibial injection of TM40D-MB cells, a breast cancer cell line that is highly metastatic to bone. We found that both upstream and downstream molecules of the beta-catenin pathway are up-regulated in TM40D-MB cells compared with non-bone metastatic TM40D cells. TM40D-MB cells also have a higher T cell factor (TCF) reporter activity than TM40D cells. Inactivation of beta-catenin in TM40D-MB cells through expression of a dominant negative TCF4 not only increases osteoclast differentiation in a tumor-bone co-culture system and enhances osteolytic bone destruction in mice, but also inhibits osteoblast differentiation. Surprisingly, although tumor cells overexpressing beta-catenin did induce a slight increase of osteoblast differentiation in vitro, these cells display a minimal effect on osteoblastic bone formation in mice. These data collectively demonstrate that beta-catenin acts as an important determinant in mixed bone lesions, especially in controlling osteoblastic effect within tumor-harboring bone environment.	[Chen, Yan; Shi, Heidi Y.; Stock, Stuart R.; Stern, Paula H.; Zhang, Ming] Northwestern Univ, Feinberg Sch Med, Dept Mol Pharmacol & Biol Chem, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA	Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center	Zhang, M (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Mol Pharmacol & Biol Chem, Robert H Lurie Comprehens Canc Ctr, Lurie 6-250,303 E Super St, Chicago, IL 60611 USA.	m-zhang@northwestern.edu		Stock, Stuart R./0000-0002-8886-4035	National Institutes of Health [R01 CA79736]; Susan G. Komen Breast Cancer Foundation [KG080231]; NATIONAL CANCER INSTITUTE [R01CA079736] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan G. Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA79736 (to M. Z.). This work was also supported by Susan G. Komen Breast Cancer Foundation Grant KG080231 (to M. Z.).	Akiyama T, 2000, CYTOKINE GROWTH F R, V11, P273, DOI 10.1016/S1359-6101(00)00011-3; Bain G, 2003, BIOCHEM BIOPH RES CO, V301, P84, DOI 10.1016/S0006-291X(02)02951-0; Baniwal SK, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-258; Barnes GL, 2003, CANCER RES, V63, P2631; Behrens J, 2000, J CELL SCI, V113, P911; Boras-Granic Kata, 2008, Organogenesis, V4, P116; Bu GJ, 2008, INT J CANCER, V123, P1034, DOI 10.1002/ijc.23625; Chen Y, 2007, PLOS MED, V4, P1216, DOI 10.1371/journal.pmed.0040249; Chen Y, 2007, J BIOL CHEM, V282, P526, DOI 10.1074/jbc.M602700200; Chen Y, 2009, J CELL BIOCHEM, V106, P353, DOI 10.1002/jcb.22020; Corey E, 2002, PROSTATE, V52, P20, DOI 10.1002/pros.10091; Ducy P, 2000, DEV DYNAM, V219, P461, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1074>3.0.CO;2-C; Eastman Q, 1999, CURR OPIN CELL BIOL, V11, P233, DOI 10.1016/S0955-0674(99)80031-3; Fedi P, 1999, J BIOL CHEM, V274, P19465, DOI 10.1074/jbc.274.27.19465; Gaur T, 2005, J BIOL CHEM, V280, P33132, DOI 10.1074/jbc.M500608200; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; Gonzalex-Sancho JM, 2005, ONCOGENE, V24, P1098, DOI 10.1038/sj.onc.1208303; Guise TA, 1996, J CLIN INVEST, V98, P1544, DOI 10.1172/JCI118947; Hall CL, 2005, CANCER RES, V65, P7554, DOI 10.1158/0008-5472.CAN-05-1317; Haydon RC, 2002, INT J CANCER, V102, P338, DOI 10.1002/ijc.10719; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hill TP, 2005, DEV CELL, V8, P727, DOI 10.1016/j.devcel.2005.02.013; Hoang BH, 2004, INT J CANCER, V109, P106, DOI 10.1002/ijc.11677; Howe LR, 1999, CANCER RES, V59, P1572; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; Johnson ML, 2007, CURR OPIN RHEUMATOL, V19, P376, DOI 10.1097/BOR.0b013e32816e06f9; Jones DH, 2006, NATURE, V440, P692, DOI 10.1038/nature04524; Kansara M, 2009, J CLIN INVEST, V119, P837, DOI 10.1172/JCI37175; KITTRELL FS, 1992, CANCER RES, V52, P1924; Kozlow W, 2005, J MAMMARY GLAND BIOL, V10, P169, DOI 10.1007/s10911-005-5399-8; Li ZG, 2008, CLIN EXP METASTAS, V25, P389, DOI 10.1007/s10585-007-9117-3; Miki T, 2004, INT J CANCER, V108, P511, DOI 10.1002/ijc.11586; Mohinta S, 2007, FRONT BIOSCI-LANDMRK, V12, P4020, DOI 10.2741/2368; Moon RT, 1997, TRENDS GENET, V13, P157, DOI 10.1016/S0168-9525(97)01093-7; Mourskaia AA, 2009, ONCOGENE, V28, P1005, DOI 10.1038/onc.2008.454; Mundy GR, 2002, NAT REV CANCER, V2, P584, DOI 10.1038/nrc867; Niida A, 2004, ONCOGENE, V23, P8520, DOI 10.1038/sj.onc.1207892; Schwaninger R, 2007, AM J PATHOL, V170, P160, DOI 10.2353/ajpath.2007.051276; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; Spencer GJ, 2006, J CELL SCI, V119, P1283, DOI 10.1242/jcs.02883; Stickeler E, 1999, ONCOGENE, V18, P3574, DOI 10.1038/sj.onc.1202671; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Tian E, 2003, NEW ENGL J MED, V349, P2483, DOI 10.1056/NEJMoa030847; Westendorf JJ, 2004, GENE, V341, P19, DOI 10.1016/j.gene.2004.06.044; Yang Yingzi, 2003, Birth Defects Research, V69, P305, DOI 10.1002/bdrc.10026; Yin JJ, 1999, J CLIN INVEST, V103, P197, DOI 10.1172/JCI3523	46	26	26	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42575	42584		10.1074/jbc.M111.294595	http://dx.doi.org/10.1074/jbc.M111.294595			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	22009747	Green Published, hybrid			2022-12-27	WOS:000298180900065
J	Miranda, DA; Koves, TR; Gross, DA; Chadt, A; Al-Hasani, H; Cline, GW; Schwartz, GJ; Muoio, DM; Silver, DL				Miranda, Diego A.; Koves, Timothy R.; Gross, David A.; Chadt, Alexandra; Al-Hasani, Hadi; Cline, Gary W.; Schwartz, Gary J.; Muoio, Deborah M.; Silver, David L.			Re-patterning of Skeletal Muscle Energy Metabolism by Fat Storage-inducing Transmembrane Protein 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADIPOSE TRIGLYCERIDE LIPASE; LIPID DROPLET PROTEINS; INSULIN-RESISTANCE; TRANSGENIC MICE; INTRAMUSCULAR TRIACYLGLYCEROL; GLUCOSE-TRANSPORT; RAT; EXERCISE; FAMILY; ALPHA	Triacylglyceride stored in cytosolic lipid droplets (LDs) constitutes a major energy reservoir in most eukaryotes. The regulated turnover of triacylglyceride in LDs provides fatty acids for mitochondrial beta-oxidation and ATP generation in physiological states of high demand for energy. The mechanisms for the formation of LDs in conditions of energy excess are not entirely understood. Fat storage-inducing transmembrane protein 2 (FIT2/FITM2) is the anciently conserved member of the fat storage-inducing transmembrane family of proteins implicated to be important in the formation of LDs, but its role in energy metabolism has not been tested. Here, we report that expression of FIT2 in mouse skeletal muscle had profound effects on muscle energy metabolism. Mice with skeletal muscle-specific overexpression of FIT2 (CKF2) had significantly increased intramyocellular triacylglyceride and complete protection from high fat diet-induced weight gain due to increased energy expenditure. Mass spectrometry-based metabolite profiling suggested that CKF2 skeletal muscle had increased oxidation of branched chain amino acids but decreased oxidation of fatty acids. Glucose was primarily utilized in CKF2 muscle for synthesis of the glycerol backbone of triacylglyceride and not for glycogen production. CKF2 muscle was ATP-deficient and had activated AMP kinase. Together, these studies indicate that FIT2 expression in skeletal muscle plays an unexpected function in regulating muscle energy metabolism and indicates an important role for lipid droplet formation in this process.	[Miranda, Diego A.; Gross, David A.; Schwartz, Gary J.; Silver, David L.] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA; [Schwartz, Gary J.] Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA; [Koves, Timothy R.; Muoio, Deborah M.] Duke Univ, Dept Med, Sarah W Stedman Nutr & Metab Ctr, Durham, NC 27704 USA; [Chadt, Alexandra; Al-Hasani, Hadi] German Diabet Ctr, Inst Clin Biochem & Pathobiochem, D-40225 Dusseldorf, Germany; [Cline, Gary W.] Yale Univ, Sch Med, Diabet Endocrinol Res Ctr, New Haven, CT 06520 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Duke University; Deutsches Diabetes-Zentrum (DDZ); Yale University	Silver, DL (corresponding author), Albert Einstein Coll Med, Dept Biochem, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	david.silver@einstein.yu.edu	Koves, Tim/I-4806-2012; Muoio, Debbie Marie/E-1147-2012	Koves, Tim/0000-0001-8763-5866; Muoio, Deborah/0000-0003-3760-9277; Silver, David/0000-0002-7289-9890	National Institutes of Health [HL082697, 5F31DK083919, NIHDK020541, R01-AG028930]; American Diabetes Association; The Ellison Medical Foundation [AG-NS-0548-09]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082697] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020541, F31DK083919, P30DK020541] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007288] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG028930] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); The Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants HL082697 (to D. L. S.), 5F31DK083919 (to D. A. M.), NIHDK020541 (to G. J. S.), and R01-AG028930 (to D. M.). This work was also supported by a grant from the American Diabetes Association (to D. M.) and Grant AG-NS-0548-09 from The Ellison Medical Foundation (to T. K.).	Ahmadian M, 2011, CELL METAB, V13, P739, DOI 10.1016/j.cmet.2011.05.002; Biressi S, 2007, DEV BIOL, V308, P281, DOI 10.1016/j.ydbio.2007.06.006; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; Brasaemle DL, 2004, J BIOL CHEM, V279, P46835, DOI 10.1074/jbc.M409340200; Buse MG, 1996, J BIOL CHEM, V271, P23197, DOI 10.1074/jbc.271.38.23197; Chadt A, 2008, NAT GENET, V40, P1354, DOI 10.1038/ng.244; Chandak PG, 2010, J BIOL CHEM, V285, P20192, DOI 10.1074/jbc.M110.107854; Ellis JM, 2011, MOL CELL BIOL, V31, P1252, DOI 10.1128/MCB.01085-10; Friedman EJ, 2011, J BIOL CHEM, V286, P30107, DOI 10.1074/jbc.M111.227256; Greenberg AS, 2011, J CLIN INVEST, V121, P2102, DOI 10.1172/JCI46069; Gross DA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010796; Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965; Haemmerle G, 2011, NAT MED, V17, P1076, DOI 10.1038/nm.2439; Hakimi P, 2007, J BIOL CHEM, V282, P32844, DOI 10.1074/jbc.M706127200; Hanson RW, 2003, BIOCHIMIE, V85, P1199, DOI 10.1016/j.biochi.2003.10.022; Hardie DG, 2008, INT J OBESITY, V32, pS7, DOI 10.1038/ijo.2008.116; Harris CA, 2011, J LIPID RES, V52, P657, DOI 10.1194/jlr.M013003; Kadereit B, 2008, P NATL ACAD SCI USA, V105, P94, DOI 10.1073/pnas.0708579105; Kiens B, 2006, PHYSIOL REV, V86, P205, DOI 10.1152/physrev.00023.2004; Kornberg H L, 1970, Biochem Soc Symp, V30, P155; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Kozak LP, 2010, CELL METAB, V11, P263, DOI 10.1016/j.cmet.2010.03.009; Lefterova MI, 2008, GENE DEV, V22, P2941, DOI 10.1101/gad.1709008; Levin MC, 2007, AM J PHYSIOL-ENDOC M, V293, pE1772, DOI 10.1152/ajpendo.00158.2007; Liu L, 2011, J LIPID RES, V52, P732, DOI 10.1194/jlr.M011395; Liu L, 2009, DIABETES, V58, P2516, DOI 10.2337/db08-1096; MARSHALL BA, 1993, J BIOL CHEM, V268, P18442; NISHIMURA H, 1993, J BIOL CHEM, V268, P8514; Nye CK, 2008, J BIOL CHEM, V283, P27565, DOI 10.1074/jbc.M804393200; PALFREYMAN RW, 1992, BIOCHEM J, V284, P275, DOI 10.1042/bj2840275; REN JM, 1993, J BIOL CHEM, V268, P16113; SADDIK M, 1991, J BIOL CHEM, V266, P8162; SANTALUCIA T, 1992, ENDOCRINOLOGY, V130, P837, DOI 10.1210/en.130.2.837; Savage DB, 2007, PHYSIOL REV, V87, P507, DOI 10.1152/physrev.00024.2006; She P, 2007, CELL METAB, V6, P181, DOI 10.1016/j.cmet.2007.08.003; Shimomura Y, 2001, CURR OPIN CLIN NUTR, V4, P419, DOI 10.1097/00075197-200109000-00013; Singh R, 2011, CELL METAB, V13, P495, DOI 10.1016/j.cmet.2011.04.004; Smith SJ, 2000, NAT GENET, V25, P87, DOI 10.1038/75651; Streeper RS, 2006, AM J PHYSIOL-ENDOC M, V291, pE388, DOI 10.1152/ajpendo.00621.2005; Thyfault JP, 2010, AM J PHYSIOL-REG I, V299, pR926, DOI 10.1152/ajpregu.00093.2010; Vaitheesvaran B, 2010, DIABETOLOGIA, V53, P2224, DOI 10.1007/s00125-010-1827-4; van Loon LJC, 2004, J APPL PHYSIOL, V97, P1170, DOI 10.1152/japplphysiol.00368.2004; Watt MJ, 2002, J PHYSIOL-LONDON, V541, P969, DOI 10.1113/jphysiol.2002.018820; WIBOM R, 1990, SCAND J CLIN LAB INV, V50, P143, DOI 10.3109/00365519009089146; Wolins NE, 2006, DIABETES, V55, P3418, DOI 10.2337/db06-0399; Wolins NE, 2006, FEBS LETT, V580, P5484, DOI 10.1016/j.febslet.2006.08.040; Yamaguchi T, 2006, J BIOL CHEM, V281, P14232, DOI 10.1074/jbc.M601682200; Zechner R, 2009, J LIPID RES, V50, P3, DOI 10.1194/jlr.R800031-JLR200	48	27	28	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42188	42199		10.1074/jbc.M111.297127	http://dx.doi.org/10.1074/jbc.M111.297127			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	22002063	Green Published, hybrid			2022-12-27	WOS:000298180900029
J	Sen, GS; Mohanty, S; Hossain, DMS; Bhattacharyya, S; Banerjee, S; Chakraborty, J; Saha, S; Ray, P; Bhattacharjee, P; Mandal, D; Bhattacharya, A; Chattopadhyay, S; Das, T; Sa, G				Sen, Gouri Sankar; Mohanty, Suchismita; Hossain, Dewan Md Sakib; Bhattacharyya, Sankar; Banerjee, Shuvomoy; Chakraborty, Juni; Saha, Shilpi; Ray, Pallab; Bhattacharjee, Pushpak; Mandal, Debaprasad; Bhattacharya, Arindam; Chattopadhyay, Samit; Das, Tanya; Sa, Gaurisankar			Curcumin Enhances the Efficacy of Chemotherapy by Tailoring p65NF kappa B-p300 Cross-talk in Favor of p53-p300 in Breast Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; T-CELL APOPTOSIS; NECROSIS-FACTOR-ALPHA; MULTIDRUG-RESISTANCE; GENE-EXPRESSION; CHEMOPREVENTIVE AGENT; DNA-DAMAGE; P53; ACTIVATION; CARCINOMA	Breast cancer cells often develop multiple mechanisms of drug resistance during tumor progression, which is the major reason for the failure of breast cancer therapy. High constitutive activation of NF kappa B has been found in different cancers, creating an environment conducive for chemotherapeutic resistance. Here we report that doxorubicin-induced SMAR1-dependent transcriptional repression and SMAR1-independent degradation of IkB alpha resulted in nuclear translocation of p65NF kappa B and its association with p300 histone acetylase and subsequent transcription of Bcl-2 to impart protective response in drug-resistant cells. Consistently SMAR1-silenced drug-resistant cells exhibited IkB alpha-mediated inhibition of p65NF kappa B and induction of p53-dependent apoptosis. Interestingly, curcumin pretreatment of drug-resistant cells alleviated SMAR1-mediated p65NF kappa B activation and hence restored doxorubicin sensitivity. Under such anti-survival condition, induction of p53-p300 cross-talk enhanced the transcriptional activity of p53 and intrinsic death cascade. Importantly, promyelocyte leukemia-mediated SMAR1 sequestration that relieved the repression of apoptosis-inducing genes was indispensable for such chemosensitizing ability of curcumin. A simultaneous decrease in drug-induced systemic toxicity by curcumin might also have enhanced the efficacy of doxorubicin by improving the intrinsic defense machineries of the tumor-bearer. Overall, the findings of this preclinical study clearly demonstrate the effectiveness of curcumin to combat doxorubicin-resistance. We, therefore, suggest curcumin as a potent chemo-sensitizer to improve the therapeutic index of this widely used anti-cancer drug. Taken together, these results suggest that curcumin can be developed into an adjuvant chemotherapeutic drug.	[Sen, Gouri Sankar; Mohanty, Suchismita; Hossain, Dewan Md Sakib; Bhattacharyya, Sankar; Banerjee, Shuvomoy; Chakraborty, Juni; Saha, Shilpi; Ray, Pallab; Bhattacharjee, Pushpak; Mandal, Debaprasad; Bhattacharya, Arindam; Chattopadhyay, Samit; Das, Tanya; Sa, Gaurisankar] Bose Inst, Div Mol Med, Kolkata 700054, India; [Chattopadhyay, Samit] Natl Ctr Cell Sci, Pune 411007, Maharashtra, India	Department of Science & Technology (India); Bose Institute; Department of Biotechnology (DBT) India; National Centre for Cell Science, Pune (NCCS)	Sa, G (corresponding author), Bose Inst, Div Mol Med, P-1-12,Calcutta Improvement Trust Scheme 7 M, Kolkata 700054, India.	gauri@bic.boseinst.ernet.in	Bhattacharyya, Sankar/GZH-3091-2022; Banerjee, Shuvomoy/AAZ-2479-2021; Bhattacharjee, Pushpak/AFV-4590-2022; Bhattacharyya, Sankar/AAK-2204-2020	Bhattacharyya, Sankar/0000-0002-3235-4220; Banerjee, Shuvomoy/0000-0002-6936-1950; Mandal, Deba Prasad/0000-0002-8052-6576	Department of Science and Technology, Government of India; Grants-in-Aid for Scientific Research [22659246] Funding Source: KAKEN	Department of Science and Technology, Government of India(Department of Science & Technology (India)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the grants from Department of Science and Technology, Government of India.	Angelini A, 2008, ONCOL REP, V20, P731, DOI 10.3892/or_0000067; Arafa ESA, 2011, MUTAT RES-FUND MOL M, V706, P28, DOI 10.1016/j.mrfmmm.2010.10.007; Auvinen PK, 2010, TUMORI J, V96, P271, DOI 10.1177/030089161009600214; Aylon Y, 2007, CELL, V130, P597, DOI 10.1016/j.cell.2007.08.005; Baud V, 2009, NAT REV DRUG DISCOV, V8, P33, DOI 10.1038/nrd2781; Bava SV, 2011, INT J BIOCHEM CELL B, V43, P331, DOI 10.1016/j.biocel.2010.09.011; Bhattacharyya S, 2007, J BIOL CHEM, V282, P15954, DOI 10.1074/jbc.M608189200; Bhattacharyya S, 2007, CANCER RES, V67, P362, DOI 10.1158/0008-5472.CAN-06-2583; Bhattacharyya S, 2010, CELL MOL IMMUNOL, V7, P306, DOI 10.1038/cmi.2010.11; Bourguignon LYW, 2009, J BIOL CHEM, V284, P2657, DOI 10.1074/jbc.M806708200; Campbell KJ, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-101; Chakraborty J, 2010, J BIOL CHEM, V285, P33104, DOI 10.1074/jbc.M110.122705; Chanvorachote P, 2009, CANCER INVEST, V27, P624, DOI 10.1080/07357900802653472; Chattopadhyay S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007382; Chearwae W, 2006, MOL CANCER THER, V5, P1995, DOI 10.1158/1535-7163.MCT-06-0087; Cheng AL, 2001, ANTICANCER RES, V21, P2895; Chintamani, 2011, WORLD J SURG ONCOL, V9, DOI 10.1186/1477-7819-9-19; Choi BH, 2008, CANCER LETT, V259, P111, DOI 10.1016/j.canlet.2007.10.003; Choudhuri SK, 1998, ANTI-CANCER DRUG, V9, P825, DOI 10.1097/00001813-199810000-00013; Choudhuri T, 2002, FEBS LETT, V512, P334, DOI 10.1016/S0014-5793(02)02292-5; Choudhuri T, 2005, J BIOL CHEM, V280, P20059, DOI 10.1074/jbc.M410670200; Chuang SE, 2000, CARCINOGENESIS, V21, P331, DOI 10.1093/carcin/21.2.331; Constantinidou A, 2011, ACTA ONCOL, V50, P455, DOI 10.3109/0284186X.2010.509105; Das T, 2008, J IMMUNOL, V180, P4687, DOI 10.4049/jimmunol.180.7.4687; Das T, 2008, CANCER RES, V68, P2014, DOI 10.1158/0008-5472.CAN-07-6037; Dhandapani KM, 2007, J NEUROCHEM, V102, P522, DOI 10.1111/j.1471-4159.2007.04633.x; Furia B, 2002, J BIOL CHEM, V277, P4973, DOI 10.1074/jbc.M107848200; Gionet N, 2009, J CELL BIOCHEM, V107, P448, DOI 10.1002/jcb.22141; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Iyer NG, 2004, P NATL ACAD SCI USA, V101, P7386, DOI 10.1073/pnas.0401002101; Kaul R, 2003, INT J CANCER, V103, P606, DOI 10.1002/ijc.10881; Kim DS, 2006, CANCER RES, V66, P10936, DOI 10.1158/0008-5472.CAN-06-1521; Kunnumakkara AB, 2008, CANCER LETT, V269, P199, DOI 10.1016/j.canlet.2008.03.009; Lahiry L, 2008, APOPTOSIS, V13, P771, DOI 10.1007/s10495-008-0213-x; Lahiry L, 2010, CARCINOGENESIS, V31, P259, DOI 10.1093/carcin/bgp240; LEHMANN W, 1980, ACTA BIOL MED GER, V39, P93; Lin Y, 2010, EXPERT OPIN THER TAR, V14, P45, DOI 10.1517/14728220903431069; Liu XG, 2009, JPN J CLIN ONCOL, V39, P418, DOI 10.1093/jjco/hyp037; Matsuda H, 1998, BIOORG MED CHEM LETT, V8, P339, DOI 10.1016/S0960-894X(98)00021-3; Montagut C, 2006, ENDOCR-RELAT CANCER, V13, P607, DOI 10.1677/erc.1.01171; Nanji AA, 2003, AM J PHYSIOL-GASTR L, V284, pG321, DOI 10.1152/ajpgi.00230.2002; Pal S, 2005, CANCER DETECT PREV, V29, P470, DOI 10.1016/j.cdp.2005.05.003; Pal S, 2001, BIOCHEM BIOPH RES CO, V288, P658, DOI 10.1006/bbrc.2001.5823; Patel N, 2010, TOXICOL APPL PHARM, V245, P143, DOI 10.1016/j.taap.2010.02.002; Rohwer N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012038; Roy SG, 2007, MATRIX BIOL, V26, P269, DOI 10.1016/j.matbio.2006.12.005; Ryan KM, 2011, EUR J CANCER, V47, P44, DOI 10.1016/j.ejca.2010.10.020; Sa G, 2009, CANCER RES, V69, P3095, DOI 10.1158/0008-5472.CAN-08-3776; Saeki H, 2011, CLIN CANCER RES, V17, P1731, DOI 10.1158/1078-0432.CCR-10-1996; Schneider G, 2010, ONCOGENE, V29, P2795, DOI 10.1038/onc.2010.46; Schumm K, 2006, EMBO J, V25, P4820, DOI 10.1038/sj.emboj.7601343; Scian MJ, 2005, MOL CELL BIOL, V25, P10097, DOI 10.1128/MCB.25.22.10097-10110.2005; Shankar S, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-16; Singh K, 2009, J BIOL CHEM, V284, P1267, DOI 10.1074/jbc.M801088200; SINGH S, 1995, J BIOL CHEM, V270, P24995, DOI 10.1074/jbc.270.42.24995; Sinha S, 2010, EMBO J, V29, P830, DOI 10.1038/emboj.2009.395; Tao ZM, 2008, ANAL BIOCHEM, V381, P43, DOI 10.1016/j.ab.2008.06.020; Venkatesan N, 1998, BRIT J PHARMACOL, V124, P425, DOI 10.1038/sj.bjp.0701877; Wang QE, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-24; Webster GA, 1999, MOL CELL BIOL, V19, P3485; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0	61	83	87	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42232	42247		10.1074/jbc.M111.262295	http://dx.doi.org/10.1074/jbc.M111.262295			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	22013068	Green Published, hybrid			2022-12-27	WOS:000298180900033
J	Bremmer, SC; Hall, H; Martinez, JS; Eissler, CL; Hinrichsen, TH; Rossie, S; Parker, LL; Hall, MC; Charbonneau, H				Bremmer, Steven C.; Hall, Hana; Martinez, Juan S.; Eissler, Christie L.; Hinrichsen, Thomas H.; Rossie, Sandra; Parker, Laurie L.; Hall, Mark C.; Charbonneau, Harry			Cdc14 Phosphatases Preferentially Dephosphorylate a Subset of Cyclin-dependent kinase (Cdk) Sites Containing Phosphoserine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN PHOSPHATASE; MITOTIC EXIT; BUDDING YEAST; MITOSIS; PHOSPHORYLATION; TIME; CYTOKINESIS; SEGREGATION; NUCLEOLUS; ACTIVATOR	Mitotic cell division is controlled by cyclin-dependent kinases (Cdks), which phosphorylate hundreds of protein substrates responsible for executing the division program. Cdk inactivation and reversal of Cdk-catalyzed phosphorylation are universal requirements for completing and exiting mitosis and resetting the cell cycle machinery. Mechanisms that define the timing and order of Cdk substrate dephosphorylation remain poorly understood. Cdc14 phosphatases have been implicated in Cdk inactivation and are thought to be generally specific for Cdk-type phosphorylation sites. We show that budding yeast Cdc14 possesses a strong and unusual preference for phosphoserine over phosphothreonine at Pro-directed sites in vitro. Using serine to threonine substitutions in the Cdk consensus sites of the Cdc14 substrate Acm1, we demonstrate that phosphoserine specificity exists in vivo. Furthermore, it appears to be a conserved property of all Cdc14 family phosphatases. An invariant active site residue was identified that sterically restricts phosphothreonine binding and is largely responsible for phosphoserine selectivity. Optimal Cdc14 substrates also possessed a basic residue at the +3 position relative to the phosphoserine, whereas substrates lacking this basic residue were not effectively hydrolyzed. The intrinsic selectivity of Cdc14 may help establish the order of Cdk substrate dephosphorylation during mitotic exit and contribute to roles in other cellular processes.	[Bremmer, Steven C.; Hall, Hana; Martinez, Juan S.; Eissler, Christie L.; Hinrichsen, Thomas H.; Rossie, Sandra; Hall, Mark C.; Charbonneau, Harry] Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA; [Parker, Laurie L.] Purdue Univ, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA; [Bremmer, Steven C.; Hall, Hana; Martinez, Juan S.; Eissler, Christie L.; Hinrichsen, Thomas H.; Rossie, Sandra; Parker, Laurie L.; Hall, Mark C.; Charbonneau, Harry] Purdue Univ, Purdue Ctr Canc Res, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Hall, MC (corresponding author), Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA.	mchall@purdue.edu; charb@purdue.edu	Parker, Laurie L/C-1510-2010; Hall, Mark C./D-1698-2011	Parker, Laurie L/0000-0002-6234-3346; Hall, Mark/0000-0001-6429-2506; Hall, Hana/0000-0002-7544-4437	National Science Foundation [MCB 0841748]; National Institutes of Health [CA59935]; Purdue University Center for Cancer Research; Purdue Research Foundation; NATIONAL CANCER INSTITUTE [R29CA059935, R01CA059935] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Purdue University Center for Cancer Research; Purdue Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Science Foundation Grant MCB 0841748 (to M. C. H.), National Institutes of Health Grant CA59935 (to H. C.), funds from the Purdue University Center for Cancer Research Small Grants Program, and a Purdue Research Foundation fellowship (to J. S. M.).	Azzam R, 2004, SCIENCE, V305, P516, DOI 10.1126/science.1099402; Barford D, 1998, ANNU REV BIOPH BIOM, V27, P133, DOI 10.1146/annurev.biophys.27.1.133; Bembenek J, 2005, CELL CYCLE, V4, P961, DOI 10.4161/cc.4.7.1798; BUSS JE, 1983, METHOD ENZYMOL, V99, P7; D'Amours D, 2004, GENE DEV, V18, P2581, DOI 10.1101/gad.1247304; De Wulf P, 2009, CURR OPIN CELL BIOL, V21, P806, DOI 10.1016/j.ceb.2009.08.003; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Geil C, 2008, CURR BIOL, V18, P1001, DOI 10.1016/j.cub.2008.06.025; Gray CH, 2003, EMBO J, V22, P3524, DOI 10.1093/emboj/cdg348; Gray CH, 2003, CELL CYCLE, V2, P500, DOI 10.4161/cc.2.6.556; Hall MC, 2008, J BIOL CHEM, V283, P10396, DOI 10.1074/jbc.M710011200; Holmes JK, 1996, J BIOL CHEM, V271, P25240, DOI 10.1074/jbc.271.41.25240; Holt LJ, 2009, SCIENCE, V325, P1682, DOI 10.1126/science.1172867; Jin FZ, 2008, P NATL ACAD SCI USA, V105, P16177, DOI 10.1073/pnas.0808719105; Kaiser BK, 2002, MOL BIOL CELL, V13, P2289, DOI 10.1091/mbc.01-11-0535; Khmelinskii A, 2008, CELL CYCLE, V7, P283, DOI 10.4161/cc.7.3.5349; Li LW, 1997, J BIOL CHEM, V272, P29403, DOI 10.1074/jbc.272.47.29403; Mocciaro A, 2010, J CELL SCI, V123, P2867, DOI 10.1242/jcs.074815; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; Placzek EA, 2010, ANAL BIOCHEM, V397, P73, DOI 10.1016/j.ab.2009.09.048; POON RYC, 1995, SCIENCE, V270, P90, DOI 10.1126/science.270.5233.90; Skoufias DA, 2007, J CELL BIOL, V179, P671, DOI 10.1083/jcb.200704117; Song HW, 2001, MOL CELL, V7, P615, DOI 10.1016/S1097-2765(01)00208-8; Stegmeier F, 2004, ANNU REV GENET, V38, P203, DOI 10.1146/annurev.genet.38.072902.093051; Sullivan M, 2007, NAT REV MOL CELL BIO, V8, P894, DOI 10.1038/nrm2276; Taylor GS, 1997, J BIOL CHEM, V272, P24054, DOI 10.1074/jbc.272.38.24054; Tomson BN, 2009, CURR BIOL, V19, P449, DOI 10.1016/j.cub.2009.02.024; Visintin R, 1998, MOL CELL, V2, P709, DOI 10.1016/S1097-2765(00)80286-5; Wang WQ, 2004, J BIOL CHEM, V279, P30459, DOI 10.1074/jbc.M402217200; ZHOU SY, 1994, CURR BIOL, V4, P973, DOI 10.1016/S0960-9822(00)00221-9	30	61	63	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2012	287	3					1662	1669		10.1074/jbc.M111.281105	http://dx.doi.org/10.1074/jbc.M111.281105			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879HT	22117071	hybrid, Green Published			2022-12-27	WOS:000299321000009
J	Lev, S; Katz, B; Tzarfaty, V; Minke, B				Lev, Shaya; Katz, Ben; Tzarfaty, Vered; Minke, Baruch			Signal-dependent Hydrolysis of Phosphatidylinositol 4,5-Bisphosphate without Activation of Phospholipase C IMPLICATIONS ON GATING OF DROSOPHILA TRPL (TRANSIENT RECEPTOR POTENTIAL-LIKE) CHANNEL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-SENSITIVE CHANNELS; CONSTITUTIVE ACTIVITY; INSP(3) RECEPTOR; CA2+ CHANNELS; G-PROTEIN; DIACYLGLYCEROL; PHOTOTRANSDUCTION; PHOTORECEPTORS; KINASE; BLOCK	In Drosophila, a phospholipase C (PLC)-mediated signaling cascade, couples photo-excitation of rhodopsin to the opening of the transient receptor potential (TRP) and TRP-like (TRPL) channels. A lipid product of PLC, diacylglycerol (DAG), and its metabolites, polyunsaturated fatty acids (PUFAs) may function as second messengers of channel activation. However, how can one separate between the increase in putative second messengers, change in pH, and phosphatidylinositol 4,5-bisphosphate (PI(4,5)P-2) depletion when exploring the TRPL gating mechanism? To answer this question we co-expressed the TRPL channels together with the muscarinic (M1) receptor, enabling the openings of TRPL channels via G-protein activation of PLC. To dissect PLC activation of TRPL into its molecular components, we used a powerful method that reduced plasma membrane-associated PI(4,5)P-2 in HEK cells within seconds without activating PLC. Upon the addition of a dimerizing drug, PI(4,5)P-2 was selectively hydrolyzed in the cell membrane without producing DAG, inositol trisphosphate, or calcium signals. We show that PI(4,5)P-2 is not an inhibitor of TRPL channel activation. PI(4,5)P-2 hydrolysis combined with either acidification or application of DAG analogs failed to activate the channels, whereas PUFA did activate the channels. Moreover, a reduction in PI(4,5)P-2 levels or inhibition of DAG lipase during PLC activity suppressed the PLC-activated TRPL current. This suggests that PI(4,5)P-2 is a crucial substrate for PLC-mediated activation of the channels, whereas PUFA may function as the channel activator. Together, this study defines a narrow range of possible mechanisms for TRPL gating.	[Minke, Baruch] Hebrew Univ Jerusalem, Dept Med Neurobiol, Fac Med, Inst Med Res Israel Canada,Edmond & Lily Safra Ct, IL-91120 Jerusalem, Israel; Hebrew Univ Jerusalem, Kuhne Minerva Ctr Studies Visual Transduct, Fac Med, Inst Med Res Israel Canada,Edmond & Lily Safra Ct, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem	Minke, B (corresponding author), Hebrew Univ Jerusalem, Dept Med Neurobiol, Fac Med, Inst Med Res Israel Canada,Edmond & Lily Safra Ct, POB 12272, IL-91120 Jerusalem, Israel.	baruchm@ekmd.huji.ac.il			National Institutes of Health [R01 EY 03529]; Israel Science Foundation; United States-Israel Binational Science Foundation; German-Israel Foundation; NATIONAL EYE INSTITUTE [R01EY003529] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Israel Science Foundation(Israel Science Foundation); United States-Israel Binational Science Foundation(US-Israel Binational Science Foundation); German-Israel Foundation(German-Israeli Foundation for Scientific Research and Development); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 EY 03529. This work was also supported by the Israel Science Foundation, the United States-Israel Binational Science Foundation, and the German-Israel Foundation.	Acharya JK, 1997, NEURON, V18, P881, DOI 10.1016/S0896-6273(00)80328-1; Agam K, 2000, J NEUROSCI, V20, P5748, DOI 10.1523/JNEUROSCI.20-15-05748.2000; BALLA T, 2002, SCI STKE, pL3; BLOOMQUIST BT, 1988, CELL, V54, P723, DOI 10.1016/S0092-8674(88)80017-5; Chyb S, 1999, NATURE, V397, P255, DOI 10.1038/16703; Delgado R, 2009, J NEUROPHYSIOL, V101, P2372, DOI 10.1152/jn.90578.2008; DEVARY O, 1987, P NATL ACAD SCI USA, V84, P6939, DOI 10.1073/pnas.84.19.6939; Estacion M, 2001, J PHYSIOL-LONDON, V530, P1, DOI 10.1111/j.1469-7793.2001.0001m.x; Hambrecht J, 2000, PFLUG ARCH EUR J PHY, V440, P418, DOI 10.1007/s004240000301; Hardie RC, 2002, NEURON, V36, P689, DOI 10.1016/S0896-6273(02)01048-6; Hardie RC, 1995, J NEUROPHYSIOL, V74, P2590, DOI 10.1152/jn.1995.74.6.2590; Hardie RC, 1998, CELL CALCIUM, V24, P153, DOI 10.1016/S0143-4160(98)90125-7; HARDIE RC, 1995, J NEUROSCI, V15, P889; HARDIE RC, 1993, TRENDS NEUROSCI, V16, P371, DOI 10.1016/0166-2236(93)90095-4; HARDIE RC, 1992, NEURON, V8, P643, DOI 10.1016/0896-6273(92)90086-S; Hardie RC, 2001, NEURON, V30, P149, DOI 10.1016/S0896-6273(01)00269-0; Hardie RC, 2007, J PHYSIOL-LONDON, V578, P9, DOI 10.1113/jphysiol.2006.118372; HARTENECK C, 1995, FEBS LETT, V358, P297, DOI 10.1016/0014-5793(94)01455-A; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Huang JH, 2010, CURR BIOL, V20, P189, DOI 10.1016/j.cub.2009.12.019; Katz B, 2009, FRONT CELL NEUROSCI, V3, DOI 10.3389/neuro.03.002.2009; Klein RM, 2008, J BIOL CHEM, V283, P26208, DOI 10.1074/jbc.M801912200; Leung HT, 2008, NEURON, V58, P884, DOI 10.1016/j.neuron.2008.05.001; Lev S, 2010, METHOD ENZYMOL, V484, P591, DOI [10.1016/S0076-6879(10)84029-7, 10.1016/B978-0-12-381298-8.00029-0]; Lukacs V, 2007, J NEUROSCI, V27, P7070, DOI 10.1523/JNEUROSCI.1866-07.2007; Masai I, 1997, J NEUROBIOL, V32, P695, DOI 10.1002/(SICI)1097-4695(19970620)32:7<695::AID-NEU5>3.0.CO;2-#; MINKE B, 1991, PROG RETIN RES, V11, P99, DOI 10.1016/0278-4327(91)90026-X; Minke B, 2006, CELL CALCIUM, V40, P261, DOI 10.1016/j.ceca.2006.05.002; Minke B, 2010, J NEUROGENET, V24, P216, DOI 10.3109/01677063.2010.514369; Niemeyer BA, 1996, CELL, V85, P651, DOI 10.1016/S0092-8674(00)81232-5; Parnas M, 2007, J GEN PHYSIOL, V129, P17, DOI 10.1085/jgp.200609659; Parnas M, 2009, CHANNELS, V3, P164, DOI 10.4161/chan.3.3.8873; Parnas M, 2009, J NEUROSCI, V29, P2371, DOI 10.1523/JNEUROSCI.4280-08.2009; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; PHILLIPS AM, 1992, NEURON, V8, P631, DOI 10.1016/0896-6273(92)90085-R; Raghu P, 2000, NEURON, V26, P169, DOI 10.1016/S0896-6273(00)81147-2; Raghu P, 2000, MOL CELL NEUROSCI, V15, P429, DOI 10.1006/mcne.2000.0846; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Runnels LW, 2002, NAT CELL BIOL, V4, P329, DOI 10.1038/ncb781; Suh BC, 2006, SCIENCE, V314, P1454, DOI 10.1126/science.1131163; Suh BC, 2010, NEURON, V67, P224, DOI 10.1016/j.neuron.2010.07.001; VACA L, 1994, AM J PHYSIOL-CELL PH, V267, pC1501, DOI 10.1152/ajpcell.1994.267.5.C1501; Varnai P, 2006, J CELL BIOL, V175, P377, DOI 10.1083/jcb.200607116; Venkatachalam K, 2003, J BIOL CHEM, V278, P29031, DOI 10.1074/jbc.M302751200; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Woo DH, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-42; WU L, 1995, NATURE, V373, P216, DOI 10.1038/373216a0; Xu XZS, 1997, CELL, V89, P1155, DOI 10.1016/S0092-8674(00)80302-5; Yao J, 2009, PLOS BIOL, V7, P350, DOI 10.1371/journal.pbio.1000046; Zakharian E, 2010, J NEUROSCI, V30, P12526, DOI 10.1523/JNEUROSCI.3189-10.2010	50	22	23	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					1436	1447		10.1074/jbc.M111.266585	http://dx.doi.org/10.1074/jbc.M111.266585			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22065576	Green Published, hybrid			2022-12-27	WOS:000299170300057
J	Verhalen, B; Ernst, S; Borsch, M; Wilkens, S				Verhalen, Brandy; Ernst, Stefan; Boersch, Michael; Wilkens, Stephan			Dynamic Ligand-induced Conformational Rearrangements in P-glycoprotein as Probed by Fluorescence Resonance Energy Transfer Spectroscopy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-BINDING DOMAINS; ASYMMETRIC OCCLUDED STATE; ATP-BINDING; MULTIDRUG-RESISTANCE; CATALYTIC CYCLE; ABC TRANSPORTER; DRUG-BINDING; CASSETTE TRANSPORTER; MALTOSE TRANSPORTER; ELECTRON-MICROSCOPY	P-glycoprotein (Pgp), a member of the ATP-binding cassette transporter family, functions as an ATP hydrolysis-driven efflux pump torid the cell of toxic organic compounds, including a variety of drugs used in anticancer chemotherapy. Here, we used fluorescence resonance energy transfer (FRET) spectroscopy to delineate the structural rearrangements the two nucleotide binding domains (NBDs) are undergoing during the catalytic cycle. Pairs of cysteines were introduced into equivalent regions in the N- and C-terminal NBDs for labeling with fluorescent dyes for ensemble and single-molecule FRET spectroscopy. In the ensemble FRET, a decrease of the donor to acceptor (D/A) ratio was observed upon addition of drug and ATP. Vanadate trapping further decreased the D/A ratio, indicating close association of the two NBDs. One of the cysteine mutants was further analyzed using confocal single-molecule FRET spectroscopy. Single Pgp molecules showed fast fluctuations of the FRET efficiencies, indicating movements of the NBDs on a time scale of 10-100 ms. Populations of low, medium, and high FRET efficiencies were observed during drug-stimulated MgATP hydrolysis, suggesting the presence of at least three major conformations of the NBDs during catalysis. Under conditions of vanadate trapping, most molecules displayed high FRET efficiency states, whereas with cyclosporin, more molecules showed low FRET efficiency. Different dwell times of the FRET states were found for the distinct biochemical conditions, with the fastest movements during active turnover. The FRET spectroscopy observations are discussed in context of a model of the catalytic mechanism of Pgp.	[Verhalen, Brandy; Wilkens, Stephan] SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA; [Ernst, Stefan; Boersch, Michael] Univ Jena, Single Mol Microscopy Grp, Jena Univ Hosp, D-07743 Jena, Germany	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Friedrich Schiller University of Jena	Wilkens, S (corresponding author), SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA.	wilkenss@upstate.edu		Borsch, Michael/0000-0002-0634-2963	National Institutes of Health [CA100246, GM058600]; NATIONAL CANCER INSTITUTE [R01CA100246] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058600] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA100246 and GM058600 (to S. W.).	Al-Shawi MK, 2005, J BIOENERG BIOMEMBR, V37, P489, DOI 10.1007/s10863-005-9497-5; Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Beaudet L, 1998, METHOD ENZYMOL, V292, P397; Berney C, 2003, BIOPHYS J, V84, P3992, DOI 10.1016/S0006-3495(03)75126-1; Borsch M, 2011, BIOL CHEM, V392, P135, DOI 10.1515/BC.2011.001; Borsch M, 2002, FEBS LETT, V527, P147, DOI 10.1016/S0014-5793(02)03198-8; Chen J, 2003, MOL CELL, V12, P651, DOI 10.1016/j.molcel.2003.08.004; Cohen AE, 2006, P NATL ACAD SCI USA, V103, P4362, DOI 10.1073/pnas.0509976103; Cohen AE, 2005, P SOC PHOTO-OPT INS, V5699, P296, DOI 10.1117/12.598689; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Dean M, 2001, J LIPID RES, V42, P1007; Delannoy S, 2005, BIOCHEMISTRY-US, V44, P14010, DOI 10.1021/bi0512445; Dey S, 1997, P NATL ACAD SCI USA, V94, P10594, DOI 10.1073/pnas.94.20.10594; Duser MG, 2009, EMBO J, V28, P2689, DOI 10.1038/emboj.2009.213; Duser MG, 2008, J BIOL CHEM, V283, P33602, DOI 10.1074/jbc.M805170200; Eidne KA, 2002, TRENDS ENDOCRIN MET, V13, P415, DOI 10.1016/S1043-2760(02)00669-0; Ernst S., 2011, P SOC PHOTO-OPT INS, V7902; Gottesman MM, 2006, FEBS LETT, V580, P998, DOI 10.1016/j.febslet.2005.12.060; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Gutmann DAP, 2010, TRENDS BIOCHEM SCI, V35, P36, DOI 10.1016/j.tibs.2009.07.009; Higgins CF, 2007, NATURE, V446, P749, DOI 10.1038/nature05630; Holland IB, 1999, J MOL BIOL, V293, P381, DOI 10.1006/jmbi.1999.2993; Johnson KM, 2009, BIOPOLYMERS, V91, P830, DOI 10.1002/bip.21262; Jones PM, 2011, BIOPHYS J, V100, P3025, DOI 10.1016/j.bpj.2011.05.028; Jones PM, 2009, TRENDS BIOCHEM SCI, V34, P520, DOI 10.1016/j.tibs.2009.06.004; JULIANO RL, 1976, BIOCHIM BIOPHYS ACTA, V455, P152, DOI 10.1016/0005-2736(76)90160-7; Kapanidis AN, 2004, P NATL ACAD SCI USA, V101, P8936, DOI 10.1073/pnas.0401690101; Kos V, 2009, CELL MOL LIFE SCI, V66, P3111, DOI 10.1007/s00018-009-0064-9; Lee JY, 2002, J BIOL CHEM, V277, P40125, DOI 10.1074/jbc.M206871200; Lee JY, 2008, J BIOL CHEM, V283, P5769, DOI 10.1074/jbc.M707028200; Lerner-Marmarosh N, 1999, J BIOL CHEM, V274, P34711, DOI 10.1074/jbc.274.49.34711; Liu RH, 1998, BIOCHEMISTRY-US, V37, P6503, DOI 10.1021/bi973031o; Liu RH, 1996, BIOCHEMISTRY-US, V35, P11865, DOI 10.1021/bi960823u; Loo TW, 2010, BIOCHEM BIOPH RES CO, V395, P436, DOI 10.1016/j.bbrc.2010.04.057; Loo TW, 2003, J BIOL CHEM, V278, P39706, DOI 10.1074/jbc.M308559200; Loo TW, 2003, J BIOL CHEM, V278, P1575, DOI 10.1074/jbc.M211307200; Loo TW, 2002, J BIOL CHEM, V277, P41303, DOI 10.1074/jbc.C200484200; Lu G, 2005, P NATL ACAD SCI USA, V102, P17969, DOI 10.1073/pnas.0506039102; Lugo MR, 2005, BIOCHEMISTRY-US, V44, P643, DOI 10.1021/bi0485326; McKinney SA, 2006, BIOPHYS J, V91, P1941, DOI 10.1529/biophysj.106.082487; Muller BK, 2005, BIOPHYS J, V89, P3508, DOI 10.1529/biophysj.105.064766; Oldham ML, 2007, NATURE, V450, P515, DOI 10.1038/nature06264; Oldham ML, 2011, P NATL ACAD SCI USA, V108, P15152, DOI 10.1073/pnas.1108858108; Orelle C, 2010, P NATL ACAD SCI USA, V107, P20293, DOI 10.1073/pnas.1006544107; Qu Q, 2003, BIOCHEMISTRY-US, V42, P1345, DOI 10.1021/bi0267745; Qu Q, 2003, BIOCHEMISTRY-US, V42, P1170, DOI 10.1021/bi026555j; Ramachandra M, 1998, BIOCHEMISTRY-US, V37, P5010, DOI 10.1021/bi973045u; Rees DC, 2009, NAT REV MOL CELL BIO, V10, P218, DOI 10.1038/nrm2646; Russell PL, 2006, BIOCHEM J, V399, P315, DOI 10.1042/BJ20060015; Sankaran B, 1997, BIOCHEMISTRY-US, V36, P6847, DOI 10.1021/bi970034s; Sauna ZE, 2001, J BIOL CHEM, V276, P11653, DOI 10.1074/jbc.M011294200; Sauna ZE, 2007, BIOCHEMISTRY-US, V46, P13787, DOI 10.1021/bi701385t; Schroder GF, 2003, J CHEM PHYS, V119, P9920, DOI 10.1063/1.1616511; Senior AE, 1995, FEBS LETT, V377, P285, DOI 10.1016/0014-5793(95)01345-8; Senior AE, 2011, P NATL ACAD SCI USA, V108, P15015, DOI 10.1073/pnas.1111863108; Sharom FJ, 2008, PHARMACOGENOMICS, V9, P105, DOI 10.2217/14622416.9.1.105; Siarheyeva A, 2010, J BIOL CHEM, V285, P7575, DOI 10.1074/jbc.M109.047290; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; STRYER L, 1967, P NATL ACAD SCI USA, V58, P719, DOI 10.1073/pnas.58.2.719; Tombline G, 2005, J BIOENERG BIOMEMBR, V37, P497, DOI [10.1007/s10863-005-9498-4, 10.1007/s10863-005-9498/4]; Tombline G, 2006, ARCH BIOCHEM BIOPHYS, V445, P124, DOI 10.1016/j.abb.2005.11.004; Tombline G, 2004, J BIOL CHEM, V279, P46518, DOI 10.1074/jbc.M408052200; Urbatsch IL, 2003, J BIOL CHEM, V278, P23171, DOI 10.1074/jbc.M301957200; URBATSCH IL, 1995, J BIOL CHEM, V270, P19383, DOI 10.1074/jbc.270.33.19383; Urbatsch IL, 2001, J BIOL CHEM, V276, P26980, DOI 10.1074/jbc.M010829200; Verhalen B, 2011, J BIOL CHEM, V286, P10476, DOI 10.1074/jbc.M110.193151; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; Zarrabi N, 2005, PROC SPIE, V5699, P175, DOI 10.1117/12.597967; Zimmermann B, 2005, EMBO J, V24, P2053, DOI 10.1038/sj.emboj.7600682	69	68	69	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					1112	1127		10.1074/jbc.M111.301192	http://dx.doi.org/10.1074/jbc.M111.301192			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22086917	Green Published, hybrid			2022-12-27	WOS:000299170300027
J	Glidden, EJ; Gray, LG; Vemuru, S; Li, D; Harris, TE; Mayo, MW				Glidden, Emily J.; Gray, Lisa G.; Vemuru, Suneil; Li, Duo; Harris, Thurl E.; Mayo, Marty W.			Multiple Site Acetylation of Rictor Stimulates Mammalian Target of Rapamycin Complex 2 (mTORC2)-dependent Phosphorylation of Akt Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; KINASE-B; MTOR COMPLEX; GROWTH; ACTIVATION; AKT/PKB; INSULIN; DEACETYLASES; SIRTUINS; RECEPTOR	The serine/threonine protein kinase Akt is a critical regulator of cell growth and survival in response to growth factors. A key step in Akt activation is phosphorylation at Ser-473 by the mammalian target of rapamycin (mTOR) complex 2 (mTORC2). Although Rictor is required for the stability and activity of mTORC2, little is known about functional regions or post-translational modifications within Rictor that are responsible for regulating mTORC2. Here, we demonstrate that Rictor contains two distinct central regions critical for mTORC2 function. One we refer to as the stability region because it is critical for interaction with Sin1.1 and LST8, and a second adjacent region is required for multisite acetylation. p300-mediated acetylation of Rictor increases mTORC2 activity toward Akt, whereas site-directed mutants within the acetylation region of Rictor exhibit reduced insulin-like growth factor 1 (IGF-1)-stimulated mTORC2 kinase activity. Inhibition of deacetylases, including the NAD(+)-dependent sirtuins, promotes Rictor acetylation and IGF-1-mediated Akt phosphorylation. These results suggest that multiple-site acetylation of Rictor signals for increased activation of mTORC2, providing a critical link between nutrientsensitive deacetylases and mTORC2 signaling to Akt.	[Glidden, Emily J.; Gray, Lisa G.; Vemuru, Suneil; Li, Duo; Mayo, Marty W.] Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA; [Harris, Thurl E.] Univ Virginia, Dept Pharmacol, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia	Mayo, MW (corresponding author), Univ Virginia, Dept Biochem & Mol Genet, Box 800733,Jordan Hall,Rm 6233, Charlottesville, VA 22908 USA.	mwm3y@virginia.edu			National Institutes of Health through the NCI [CA132580, CA104397]; National Institutes of Health through NIDDK [DK052753]; University of Virginia; NATIONAL CANCER INSTITUTE [R01CA104397, R01CA132580] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052753] Funding Source: NIH RePORTER	National Institutes of Health through the NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health through NIDDK; University of Virginia; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants CA132580 and CA104397 through the NCI (to M. W. M.) and Grant DK052753 through the NIDDK (to T. E. H.).; Supported by the University of Virginia Tobacco Research Program, a gift of Philip Morris USA. To whom correspondence should be addressed: Dept. of Biochemistry and Molecular Genetics, Box 800733, Jordan Hall, Rm. 6233, University of Virginia, Charlottesville, VA 22908. Tel.: 1-434-924-2509; Fax: 1-434-924-5069; E-mail: mwm3y@virginia.edu.	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Bao JJ, 2010, CELL MOL LIFE SCI, V67, P3073, DOI 10.1007/s00018-010-0402-y; Bellacosa A, 1998, ONCOGENE, V17, P313, DOI 10.1038/sj.onc.1201947; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Bondy CA, 2004, EUR J PHARMACOL, V490, P25, DOI 10.1016/j.ejphar.2004.02.042; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Clemmons DR, 2009, TRENDS ENDOCRIN MET, V20, P349, DOI 10.1016/j.tem.2009.04.002; Corradetti MN, 2006, ONCOGENE, V25, P6347, DOI 10.1038/sj.onc.1209885; Foster KG, 2010, J BIOL CHEM, V285, P80, DOI 10.1074/jbc.M109.029637; Frias MA, 2006, CURR BIOL, V16, P1865, DOI 10.1016/j.cub.2006.08.001; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Hresko RC, 2005, J BIOL CHEM, V280, P40406, DOI 10.1074/jbc.M508361200; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Madrid LV, 2000, MOL CELL BIOL, V20, P1626, DOI 10.1128/MCB.20.5.1626-1638.2000; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; North BJ, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-5-224; Rosenzweig SA, 2010, BIOCHEM PHARMACOL, V80, P1115, DOI 10.1016/j.bcp.2010.06.013; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Shiota C, 2006, DEV CELL, V11, P583, DOI 10.1016/j.devcel.2006.08.013; Song H, 2011, BIOCHEM BIOPH RES CO, V404, P68, DOI 10.1016/j.bbrc.2010.11.064; Tato I, 2011, J BIOL CHEM, V286, P6128, DOI 10.1074/jbc.M110.166991; Thompson PR, 2004, NAT STRUCT MOL BIOL, V11, P308, DOI 10.1038/nsmb740; Verdin E, 2010, TRENDS BIOCHEM SCI, V35, P669, DOI 10.1016/j.tibs.2010.07.003; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; Yang Q, 2006, GENE DEV, V20, P2820, DOI 10.1101/gad.1461206; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Zhang DL, 2004, J BIOL CHEM, V279, P19683, DOI 10.1074/jbc.M313145200; Zhang J, 2007, J BIOL CHEM, V282, P34356, DOI 10.1074/jbc.M706644200; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	30	67	67	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2012	287	1					581	588		10.1074/jbc.M111.304337	http://dx.doi.org/10.1074/jbc.M111.304337			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870PW	22084251	hybrid, Green Published			2022-12-27	WOS:000298682400056
J	Bose, JK; Huang, CC; Shen, CKJ				Bose, Jayarama Krishnan; Huang, Chi-Chen; Shen, C. -K. James			Regulation of Autophagy by Neuropathological Protein TDP-43	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; UBIQUITIN-PROTEASOME SYSTEM; BINDING PROTEIN; NEURODEGENERATIVE DISEASE; IN-VIVO; FTLD-U; DEGRADATION; DEPLETION; MICE	TDP-43 is a DNA/RNA-binding protein with multicellular functions. As a pathosignature protein of a range of neurodegenerative diseases, TDP-43 is also the major component of the polyubiquitinated inclusions in the pathological cellular samples of these diseases. In normal cells, TDP-43 is processed and degraded by both autophagy and the ubiquitin-proteasome systems. We have found, by microarray hybridization and RT-PCR analyses, that the level of the mRNA encoding the major autophagy component Atg7 is decreased upon depletion of TDP-43 by RNAi knockdown. This decrease of the Atg7 mRNA level could be rescued by overexpression of an siRNA-resistant form of TDP-43, and it appears to be the result of destabilization of the Atg7 mRNA, to which TDP-43 could bind through its RNA recognition motif 1 domain. Furthermore, depletion of TDP-43 with the consequent loss of the Atg7 mRNA/ATG7 protein causes impairment of the autophagy and facilitates the accumulation of polyubiquitinated proteins as well as the autophagy/ubiquitin-proteasome system substrate p62 in the cells. These data demonstrate the function of TDP-43 as a maintenance factor of the autophagy system, and they suggest the existence of a feedback regulatory loop between TDP-43 and autophagy. A scenario in which loss of function of TDP-43 contributes to the development of TDP-43 proteinopathies is presented.	[Bose, Jayarama Krishnan; Huang, Chi-Chen; Shen, C. -K. James] Acad Sinica, Inst Mol Biol, Taipei 11529, Taiwan	Academia Sinica - Taiwan	Shen, CKJ (corresponding author), Acad Sinica, Inst Mol Biol, N523,128 Acad Rd,Sec 2, Taipei 115, Taiwan.	ckshen@imb.sinica.edu.tw	shen, Che-Kun James/L-1343-2015		National Science Council; Academia Sinica of Taipei (Taiwan)	National Science Council(Ministry of Science and Technology, Taiwan); Academia Sinica of Taipei (Taiwan)	This work was supported by research grants from the National Science Council and the Academia Sinica of Taipei (Taiwan).	Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Ayala YM, 2005, J MOL BIOL, V348, P575, DOI 10.1016/j.jmb.2005.02.038; Ayala YM, 2011, EMBO J, V30, P277, DOI 10.1038/emboj.2010.310; Barreau C, 2005, NUCLEIC ACIDS RES, V33, P7138, DOI 10.1093/nar/gki1012; Bose JK, 2008, J BIOL CHEM, V283, P28852, DOI 10.1074/jbc.M805376200; Buratti E, 2001, EMBO J, V20, P1774, DOI 10.1093/emboj/20.7.1774; Buratti E, 2010, RNA BIOL, V7, P420, DOI 10.4161/rna.7.4.12205; Buratti E, 2009, ADV GENET, V66, P1, DOI 10.1016/S0065-2660(09)66001-6; Caccamo A, 2009, J BIOL CHEM, V284, P27416, DOI 10.1074/jbc.M109.031278; CASHMAN NR, 1992, DEV DYNAM, V194, P209, DOI 10.1002/aja.1001940306; Chen-Plotkin AS, 2010, NAT REV NEUROL, V6, P211, DOI 10.1038/nrneurol.2010.18; D'Ambrogio A, 2009, NUCLEIC ACIDS RES, V37, P4116, DOI 10.1093/nar/gkp342; Ding WX, 2007, AM J PATHOL, V171, P513, DOI 10.2353/ajpath.2007.070188; Feiguin F, 2009, FEBS LETT, V583, P1586, DOI 10.1016/j.febslet.2009.04.019; Fiesel FC, 2010, EMBO J, V29, P209, DOI 10.1038/emboj.2009.324; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; IGNATIUS SH, 1995, J VIROL, V69, P3584, DOI 10.1128/JVI.69.6.3584-3596.1995; Iguchi Y, 2009, J BIOL CHEM, V284, P22059, DOI 10.1074/jbc.M109.012195; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kabuta T, 2006, J BIOL CHEM, V281, P30524, DOI 10.1074/jbc.M603337200; Kim SH, 2009, J BIOL CHEM, V284, P8083, DOI 10.1074/jbc.M808064200; King A, 2011, NEUROPATHOLOGY, V31, P239, DOI 10.1111/j.1440-1789.2010.01171.x; Koga H, 2011, AGEING RES REV, V10, P205, DOI 10.1016/j.arr.2010.02.001; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Korolchuk VI, 2009, MOL CELL, V33, P517, DOI 10.1016/j.molcel.2009.01.021; Kraemer BC, 2010, ACTA NEUROPATHOL, V119, P409, DOI 10.1007/s00401-010-0659-0; Lagier-Tourenne C, 2010, HUM MOL GENET, V19, pR46, DOI 10.1093/hmg/ddq137; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Lin MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020371; Mercado PA, 2005, NUCLEIC ACIDS RES, V33, P6000, DOI 10.1093/nar/gki897; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; OLMSTED JB, 1970, P NATL ACAD SCI USA, V65, P129, DOI 10.1073/pnas.65.1.129; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Pesiridis GS, 2009, HUM MOL GENET, V18, pR156, DOI 10.1093/hmg/ddp303; Polymenidou M, 2011, NAT NEUROSCI, V14, P459, DOI 10.1038/nn.2779; Ravikumar B, 2010, PHYSIOL REV, V90, P1383, DOI 10.1152/physrev.00030.2009; Rothenberg C, 2010, HUM MOL GENET, V19, P3219, DOI 10.1093/hmg/ddq231; Seibenhener ML, 2007, FEBS LETT, V581, P175, DOI 10.1016/j.febslet.2006.12.027; Sephton CF, 2010, J BIOL CHEM, V285, P6826, DOI 10.1074/jbc.M109.061846; Shin J, 1998, ARCH PHARM RES, V21, P629, DOI 10.1007/BF02976748; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Strong MJ, 2007, MOL CELL NEUROSCI, V35, P320, DOI 10.1016/j.mcn.2007.03.007; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Tollervey JR, 2011, NAT NEUROSCI, V14, P452, DOI 10.1038/nn.2778; Tsai KJ, 2010, J EXP MED, V207, P1661, DOI 10.1084/jem.20092164; Urushitani M, 2010, J NEUROSCI RES, V88, P784, DOI 10.1002/jnr.22243; Wang HY, 2004, GENOMICS, V83, P130, DOI 10.1016/S0888-7543(03)00214-3; Wang IF, 2008, J NEUROCHEM, V105, P797, DOI 10.1111/j.1471-4159.2007.05190.x; Wang IF, 2008, TRENDS MOL MED, V14, P479, DOI 10.1016/j.molmed.2008.09.001; Wang IF, 2002, P NATL ACAD SCI USA, V99, P13583, DOI 10.1073/pnas.212483099; Wang XJ, 2010, NEUROSCI LETT, V469, P112, DOI 10.1016/j.neulet.2009.11.055; Wu LS, 2010, GENESIS, V48, P56, DOI 10.1002/dvg.20584	54	116	117	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2011	286	52					44441	44448		10.1074/jbc.M111.237115	http://dx.doi.org/10.1074/jbc.M111.237115			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870CA	22052911	hybrid, Green Published			2022-12-27	WOS:000298645500016
J	Mullenbrock, S; Shah, J; Cooper, GM				Mullenbrock, Steven; Shah, Janki; Cooper, Geoffrey M.			Global Expression Analysis Identified a Preferentially Nerve Growth Factor-induced Transcriptional Program Regulated by Sustained Mitogen-activated Protein Kinase/Extracellular Signal-regulated Kinase (ERK) and AP-1 Protein Activation during PC12 Cell Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMEDIATE-EARLY GENE; MAP KINASE; NEURONAL DIFFERENTIATION; PHEOCHROMOCYTOMA CELLS; NEUROTROPHIC FACTOR; NEURITE OUTGROWTH; C-FOS; TRANSDUCTION PATHWAYS; CROSS-TALK; JUN	Neuronal differentiation of PC12 cells in response to NGF is a prototypical model in which signal duration determines a biological response. Sustained ERK activity induced by NGF, as compared with transient activity induced by EGF, is critical to the differentiation of these cells. To characterize the transcriptional program activated preferentially by NGF, we compared global gene expression profiles between cells treated with NGF and EGF for 2-4 h, when sustained ERK signaling in response to NGF is most distinct from the transient signal elicited by EGF. This analysis identified 69 genes that were preferentially up-regulated in response to NGF. As expected, up-regulation of these genes was mediated by sustained ERK signaling. In addition, they were up-regulated in response to other neuritogenic treatments (pituitary adenylate cyclase-activating polypeptide and 12-O-tetradecanoylphorbol-13-acetate plus dbcAMP) and were enriched for genes related to neuronal differentiation/function. Computational analysis and chromatin immunoprecipitation identified binding of CREB and AP-1 family members (Fos, FosB, Fra1, JunB, JunD) upstream of >30 and 50%, respectively, of the preferentially NGF-induced genes. Expression of several AP-1 family members was induced by both EGF and NGF, but their induction was more robust and sustained in response to NGF. The binding of Fos family members to their target genes was similarly sustained in response to NGF and was reduced upon MEK inhibition, suggesting that AP-1 contributes significantly to the NGF transcriptional program. Interestingly, Fra1 as well as two other NGF-induced AP-1 targets (HB-EGF and miR-21) function in positive feedback loops that may contribute to sustained AP-1 activity.	[Mullenbrock, Steven; Shah, Janki; Cooper, Geoffrey M.] Boston Univ, Dept Biol, Boston, MA 02215 USA	Boston University	Cooper, GM (corresponding author), Boston Univ, Dept Biol, 5 Cummington St, Boston, MA 02215 USA.	gmcooper@bu.edu			National Institutes of Health [RO1 CA18689]; NATIONAL CANCER INSTITUTE [R01CA018689] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 CA18689 (to G. M. C.).	Aoki M, 2004, J BIOL CHEM, V279, P32643, DOI 10.1074/jbc.M313247200; Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; BARSAGI D, 1985, CELL, V42, P841, DOI 10.1016/0092-8674(85)90280-6; BERGERS G, 1995, MOL CELL BIOL, V15, P3748; Bonilla IE, 2002, J NEUROSCI, V22, P1303, DOI 10.1523/JNEUROSCI.22-04-01303.2002; BONNI A, 1995, MOL CELL NEUROSCI, V6, P168, DOI 10.1006/mcne.1995.1015; Boss V, 2001, J NEUROSCI, V21, P18, DOI 10.1523/JNEUROSCI.21-01-00018.2001; Buechner J, 2011, DIFFERENTIATION, V81, P25, DOI 10.1016/j.diff.2010.09.184; CHAO MV, 1992, CELL, V68, P995, DOI 10.1016/0092-8674(92)90068-N; Chung JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009011; COHEN DR, 1988, MOL CELL BIOL, V8, P2063, DOI 10.1128/MCB.8.5.2063; Conkright MD, 2003, MOL CELL, V11, P1101, DOI 10.1016/S1097-2765(03)00134-5; COWLEY S, 1994, CELL, V77, P841, DOI 10.1016/0092-8674(94)90133-3; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Draghetti C, 2009, J BIOL CHEM, V284, P32053, DOI 10.1074/jbc.M109.009324; Dragunow M, 2000, MOL BRAIN RES, V83, P20, DOI 10.1016/S0169-328X(00)00191-1; Eriksson M, 2007, J CELL PHYSIOL, V210, P538, DOI 10.1002/jcp.20907; Farias-Eisner R, 2000, J NEUROSCI, V20, P230, DOI 10.1523/JNEUROSCI.20-01-00230.2000; Frankel LB, 2008, J BIOL CHEM, V283, P1026, DOI 10.1074/jbc.M707224200; Fujita S, 2008, J MOL BIOL, V378, P492, DOI 10.1016/j.jmb.2008.03.015; Gallo R, 2002, J CELL BIOL, V158, P731, DOI 10.1083/jcb.200202024; Gil GA, 2004, MOL BIOL CELL, V15, P1881, DOI 10.1091/mbc.e03-09-0705; GOTOH Y, 1990, EUR J BIOCHEM, V193, P661, DOI 10.1111/j.1432-1033.1990.tb19384.x; HAGAG N, 1986, NATURE, V319, P680, DOI 10.1038/319680a0; Harada T, 2001, NAT CELL BIOL, V3, P453, DOI 10.1038/35074516; Hatley ME, 2010, CANCER CELL, V18, P282, DOI 10.1016/j.ccr.2010.08.013; Heasley LE, 1996, MOL CELL BIOL, V16, P648; Heo K, 2006, CELL SIGNAL, V18, P2182, DOI 10.1016/j.cellsig.2006.05.006; HERSCHMAN HR, 1991, ANNU REV BIOCHEM, V60, P281, DOI 10.1146/annurev.biochem.60.1.281; Hess J, 2004, J CELL SCI, V117, P5965, DOI 10.1242/jcs.01589; HIRAI SI, 1989, EMBO J, V8, P1433, DOI 10.1002/j.1460-2075.1989.tb03525.x; HOEFFLER JP, 1989, MOL ENDOCRINOL, V3, P868, DOI 10.1210/mend-3-5-868; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; HUFF K, 1981, J CELL BIOL, V88, P189, DOI 10.1083/jcb.88.1.189; Hughes JD, 2000, J MOL BIOL, V296, P1205, DOI 10.1006/jmbi.2000.3519; Jepsen K, 2007, NATURE, V450, P415, DOI 10.1038/nature06270; Jurchott K, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001231; Kerjan G, 2005, NAT NEUROSCI, V8, P1516, DOI 10.1038/nn1555; Klein R, 2001, CURR OPIN CELL BIOL, V13, P196, DOI 10.1016/S0955-0674(00)00197-6; Kwak HJ, 2011, ONCOGENE, V30, P2433, DOI 10.1038/onc.2010.620; Lang F, 2006, PHYSIOL REV, V86, P1151, DOI 10.1152/physrev.00050.2005; LEE V, 1982, BRAIN RES, V238, P169, DOI 10.1016/0006-8993(82)90779-X; Leppa S, 1998, EMBO J, V17, P4404, DOI 10.1093/emboj/17.15.4404; Leppa S, 2001, MOL CELL BIOL, V21, P4369, DOI 10.1128/MCB.21.13.4369-4378.2001; Li L, 2007, MOL CELL NEUROSCI, V35, P76, DOI 10.1016/j.mcn.2007.02.004; Liu M, 2009, CELL RES, V19, P828, DOI 10.1038/cr.2009.72; Lonn P, 2005, NEUROCHEM RES, V30, P753, DOI 10.1007/s11064-005-6868-6; Lu Z, 2008, ONCOGENE, V27, P4373, DOI 10.1038/onc.2008.72; LYFORD GL, 1995, NEURON, V14, P433, DOI 10.1016/0896-6273(95)90299-6; MACHIDA CM, 1989, NEURON, V2, P1587, DOI 10.1016/0896-6273(89)90047-0; Manna PR, 2007, J MOL ENDOCRINOL, V39, P261, DOI 10.1677/JME-07-0065; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; MASQUILIER D, 1992, J BIOL CHEM, V267, P22460; Murphy LO, 2002, NAT CELL BIOL, V4, P556, DOI 10.1038/ncb822; Murphy LO, 2004, MOL CELL BIOL, V24, P144, DOI 10.1128/MCB.24.1.144-153.2004; Nakamura K, 2007, MOL NEUROBIOL, V35, P45, DOI 10.1007/BF02700623; NGUYEN TT, 1993, J BIOL CHEM, V268, P9803; NODA M, 1985, NATURE, V318, P73, DOI 10.1038/318073a0; NORDSTROM LA, 1995, MOL CELL NEUROSCI, V6, P56, DOI 10.1006/mcne.1995.1006; PANG L, 1995, J BIOL CHEM, V270, P13585, DOI 10.1074/jbc.270.23.13585; Pellegrino MJ, 2006, J NEUROCHEM, V99, P1480, DOI 10.1111/j.1471-4159.2006.04250.x; QIU MS, 1992, NEURON, V9, P705, DOI 10.1016/0896-6273(92)90033-A; Ravni A, 2006, J NEUROCHEM, V98, P321, DOI 10.1111/J.1471-4159.2006.03884.X; Redell JB, 2011, J NEUROSCI RES, V89, P212, DOI 10.1002/jnr.22539; Robinson MJ, 1998, CURR BIOL, V8, P1141, DOI 10.1016/S0960-9822(07)00485-X; Roth A, 2003, MOL CELL NEUROSCI, V22, P353, DOI 10.1016/S1044-7431(02)00039-8; RYDER K, 1989, P NATL ACAD SCI USA, V86, P1500, DOI 10.1073/pnas.86.5.1500; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; SALTON SRJ, 1991, MOL CELL BIOL, V11, P2335, DOI 10.1128/MCB.11.5.2335; SASSONECORSI P, 1990, ONCOGENE, V5, P427; Sayed D, 2008, MOL BIOL CELL, V19, P3272, DOI 10.1091/mbc.E08-02-0159; SCHLINGENSIEPEN KH, 1994, CELL MOL NEUROBIOL, V14, P487, DOI 10.1007/BF02088833; Segal RA, 1996, ANNU REV NEUROSCI, V19, P463, DOI 10.1146/annurev.ne.19.030196.002335; Soeda S, 2008, THROMB HAEMOSTASIS, V100, P1014, DOI 10.1160/TH08-04-0259; Su F, 2007, J NEUROSCI RES, V85, P1952, DOI 10.1002/jnr.21296; Sun P, 2006, GENES CELLS, V11, P1097, DOI 10.1111/j.1365-2443.2006.01002.x; SZEBERENYI J, 1990, MOL CELL BIOL, V10, P5324, DOI 10.1128/MCB.10.10.5324; Talotta F, 2009, ONCOGENE, V28, P73, DOI 10.1038/onc.2008.370; Torocsik B, 2002, J NEUROSCI, V22, P8971; TRAVERSE S, 1992, BIOCHEM J, V288, P351, DOI 10.1042/bj2880351; TROPPMAIR J, 1992, ONCOGENE, V7, P1867; Tullai JW, 2007, J BIOL CHEM, V282, P9482, DOI 10.1074/jbc.M700067200; Tullai JW, 2004, J BIOL CHEM, V279, P20167, DOI 10.1074/jbc.M309260200; van Dam H, 2001, ONCOGENE, V20, P2453, DOI 10.1038/sj.onc.1204239; Vaudry D, 2002, SCIENCE, V296, P1648, DOI 10.1126/science.1071552; Vician L, 1997, J NEUROSCI RES, V50, P32, DOI 10.1002/(SICI)1097-4547(19971001)50:1<32::AID-JNR4>3.0.CO;2-M; Vician L, 2001, J NEUROSCI RES, V64, P108, DOI 10.1002/jnr.1058; VIRTANEN I, 1981, J CELL SCI, V50, P45; Wasserman WW, 2004, NAT REV GENET, V5, P276, DOI 10.1038/nrg1315; Weimer JM, 2006, NEURON, V49, P3, DOI 10.1016/j.neuron.2005.12.016; WOOD KW, 1993, P NATL ACAD SCI USA, V90, P5016, DOI 10.1073/pnas.90.11.5016; WOOD KW, 1992, CELL, V68, P1041, DOI 10.1016/0092-8674(92)90076-O; Xing J, 1998, MOL CELL BIOL, V18, P1946, DOI 10.1128/MCB.18.4.1946; Xu XM, 2000, J NEUROSCI, V20, P2638; Zhou Y, 2010, NEUROSIGNALS, V18, P141, DOI 10.1159/000319823	95	45	49	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2011	286	52					45131	45145		10.1074/jbc.M111.274076	http://dx.doi.org/10.1074/jbc.M111.274076			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870CA	22065583	Green Published, hybrid			2022-12-27	WOS:000298645500079
J	Schmidt, S; Mo, M; Heidrich, FM; Celic, A; Ehrlich, BE				Schmidt, Stefan; Mo, Michelle; Heidrich, Felix M.; Celic, Andjelka; Ehrlich, Barbara E.			C-terminal Domain of Chromogranin B Regulates Intracellular Calcium Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; SECRETORY GRANULES; CA2+ MOBILIZATION; ENTRY; PARVALBUMIN; ACTIVATION; TRANSIENTS; NEURONS; CHANNEL; BINDING	The versatility of intracellular calcium as a second messenger is seen in its ability to mediate opposing events such as neuronal cell growth and apoptosis. A leading hypothesis used to explain how calcium regulates such divergent signaling pathways is that molecules responsible for maintaining calcium homeostasis have multiple roles. For example, chromogranin B (CGB), a calcium binding protein found in secretory granules and in the lumen of the endoplasmic reticulum, buffers calcium and also binds to and amplifies the activity of the inositol 1,4,5-trisphosphate receptor (InsP(3)R). Previous studies have identified two conserved domains of CGB, an N-terminal domain (N-CGB) and a C-terminal domain (C-CGB). N-CGB binds to the third intraluminal loop of the InsP(3)R and inhibits binding of full-length CGB. This displacement of CGB decreases InsP(3)R-dependent calcium release and alters normal signaling patterns. In the present study, we further characterized the role of N-CGB and identified roles for C-CGB. The effect of N-CGB on calcium release depended upon endogenous levels of cellular CGB, whereas the regulatory effect of C-CGB was apparent regardless of endogenous levels of CGB. When either full-length CGB or C-CGB was expressed in cells, calcium transients were increased. Additionally, the calcium signal initiation site was altered upon C-CGB expression in neuronally differentiated PC12 and SHSY5Y cells. These results show that CGB has numerous regulatory roles and that CGB is a critical component in modulating InsP(3)R-dependent calcium signaling.	[Ehrlich, Barbara E.] Yale Univ, Dept Pharmacol, New Haven, CT 06520 USA; Yale Univ, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA	Yale University; Yale University	Ehrlich, BE (corresponding author), 333 Cedar St, New Haven, CT 06520 USA.	barbara.ehrlich@yale.edu	Celic, Andjeka S/AAC-1865-2022; /AAX-8408-2021	/0000-0001-9657-9704; Celic, Andjelka/0000-0002-1058-6872; Heidrich, M.D., Felix M./0000-0002-1972-8216; Schmidt, Stefan/0000-0001-8590-6319	National Institutes of Health [DK57751, DK61747]; German National Merit Foundation; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034989, P01DK057751, R01DK061747] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German National Merit Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK57751 and DK61747. This work was also supported by scholarships from the German National Merit Foundation (to S. S.) and the Howard Hughes Medical Institute (to M. M.).	Anelli T, 2003, EMBO J, V22, P5015, DOI 10.1093/emboj/cdg491; Bezprozvanny I, 2005, CELL CALCIUM, V38, P261, DOI 10.1016/j.ceca.2005.06.030; Caillard O, 2000, P NATL ACAD SCI USA, V97, P13372, DOI 10.1073/pnas.230362997; Choe CU, 2004, J BIOL CHEM, V279, P35551, DOI 10.1074/jbc.M311261200; Collin T, 2005, J NEUROSCI, V25, P96, DOI 10.1523/JNEUROSCI.3748-04.2005; Delmas P, 2002, NEURON, V34, P209, DOI 10.1016/S0896-6273(02)00641-4; Glombik MM, 1999, EMBO J, V18, P1059, DOI 10.1093/emboj/18.4.1059; Greene LA., 1982, ADV CELL NEUROBIOL, V3, P373, DOI [10.1016/B978-0-12-008303-9.50016-5, DOI 10.1016/B978-0-12-008303-9.50016-5]; Higo T, 2005, CELL, V120, P85, DOI 10.1016/j.cell.2004.11.048; Huh YH, 2006, BIOCHEMISTRY-US, V45, P1212, DOI 10.1021/bi051594r; Huh YH, 2005, BIOCHEMISTRY-US, V44, P6122, DOI 10.1021/bi048070w; IRVINE RF, 1990, FEBS LETT, V263, P5, DOI 10.1016/0014-5793(90)80692-C; Jacob SN, 2005, J NEUROSCI, V25, P2853, DOI 10.1523/JNEUROSCI.4313-04.2005; Johenning FW, 2002, J NEUROSCI, V22, P5344; Putney JW, 2001, J CELL SCI, V114, P2223; Thrower EC, 2003, J BIOL CHEM, V278, P49699, DOI 10.1074/jbc.M309307200; Thrower EC, 2002, J BIOL CHEM, V277, P15801, DOI 10.1074/jbc.M110139200; Treves S, 2004, J CELL BIOL, V166, P537, DOI 10.1083/jcb.200404079; Urushitani M, 2006, NAT NEUROSCI, V9, P108, DOI 10.1038/nn1603; Yoo SH, 2000, J BIOL CHEM, V275, P12553, DOI 10.1074/jbc.275.17.12553; Yoo SH, 2000, TRENDS NEUROSCI, V23, P424, DOI 10.1016/S0166-2236(00)01621-0; Zhu X, 1996, CELL, V85, P661, DOI 10.1016/S0092-8674(00)81233-7	22	4	4	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2011	286	52					44888	44896		10.1074/jbc.M111.251330	http://dx.doi.org/10.1074/jbc.M111.251330			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870CA	22016391	hybrid, Green Published			2022-12-27	WOS:000298645500057
J	Burnside, K; Lembo, A; Harrell, MI; Gurney, M; Xue, L; Tran, NTB; Connelly, JE; Jewell, KA; Schmidt, BZ; de los Reyes, M; Tao, WA; Doran, KS; Rajagopal, L				Burnside, Kellie; Lembo, Annalisa; Harrell, Maria Isabel; Gurney, Michael; Xue, Liang; Nguyen-Thao Binh Tran; Connelly, James E.; Jewell, Kelsea A.; Schmidt, Byron Z.; de los Reyes, Melissa; Tao, Weiguo Andy; Doran, Kelly S.; Rajagopal, Lakshmi			Serine/Threonine Phosphatase Stp1 Mediates Post-transcriptional Regulation of Hemolysin, Autolysis, and Virulence of Group B Streptococcus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUTROPHIL SIGNALING PATHWAYS; SERINE-THREONINE PHOSPHATASE; BRAIN-BARRIER PENETRATION; SER/THR PROTEIN-KINASE; LUNG EPITHELIAL-CELLS; EUKARYOTIC-TYPE; MYCOBACTERIUM-TUBERCULOSIS; STAPHYLOCOCCUS-AUREUS; IN-VIVO; SUBSTRATE IDENTIFICATION	Elucidating how serine/threonine phosphatases regulate kinase function and bacterial virulence is critical for our ability to combat these infections. Group B streptococci (GBS) are beta-hemolytic Gram-positive bacteria that cause invasive infections in humans. To adapt to environmental changes, GBS encodes signaling mechanisms comprising two component systems and eukaryotic-like enzymes. We have previously described the importance of the serine/threonine kinase Stk1 to GBS pathogenesis. However, how the presence or absence of the cognate serine/threonine phosphatase Stp1 affects Stk1 function and GBS virulence is not known. Here, we show that GBS deficient only in Stp1 expression are markedly reduced for their ability to cause systemic infections, exhibit decreased beta-hemolysin/cytolysin activity, and show increased sensitivity to autolysis. Although transcription of genes important for beta-hemolysin/cytolysin expression and export is similar to the wild type (WT), 294 genes (excluding stp1) showed altered expression in the stp1 mutant and included autolysin genes. Furthermore, phosphopeptide enrichment analysis identified that 35 serine/threonine phosphopeptides, corresponding to 27 proteins, were unique to the stp1 mutant. This included phosphorylation of ATP synthase, DNA and RNA helicases, and proteins important for cell division and protein synthesis. Collectively, our results indicate that Stp1 is important for appropriate regulation of Stk1 function, hemolysin activity, autolysis, and GBS virulence.	[Burnside, Kellie; Lembo, Annalisa; Harrell, Maria Isabel; Nguyen-Thao Binh Tran; Connelly, James E.; Jewell, Kelsea A.; Schmidt, Byron Z.; de los Reyes, Melissa; Rajagopal, Lakshmi] Univ Washington, Sch Med, Dept Pediat Infect Dis, Seattle, WA 98101 USA; [Burnside, Kellie; Lembo, Annalisa; Harrell, Maria Isabel; Nguyen-Thao Binh Tran; Connelly, James E.; Jewell, Kelsea A.; Schmidt, Byron Z.; de los Reyes, Melissa; Rajagopal, Lakshmi] Seattle Childrens Hosp Res Inst, Seattle, WA 98101 USA; [Gurney, Michael; Doran, Kelly S.] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Gurney, Michael; Doran, Kelly S.] San Diego State Univ, Ctr Microbial Sci, San Diego, CA 92182 USA; [Xue, Liang; Tao, Weiguo Andy] Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA	University of Washington; University of Washington Seattle; Seattle Children's Hospital; California State University System; San Diego State University; California State University System; San Diego State University; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Rajagopal, L (corresponding author), Univ Washington, Sch Med, Dept Pediat Infect Dis, Seattle, WA 98101 USA.	lakshmi.rajagopal@seattlechildrens.org	Tao, Andy/N-1290-2019; Tao, Weiguo/AAL-2777-2020; Jewell, Kelsea/AGG-9303-2022	Tao, Weiguo/0000-0002-5535-5517; Xue, Liang/0000-0003-3606-4615	National Institutes of Health (NIH) [RO1AI070749, GM088317, 5 T32 HD007233-29]; NIH, NINDS [RO1NS051247]; National Science Foundation [CAREER CHE-0645020]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007233] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070749] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088317] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051247] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH, NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Science Foundation(National Science Foundation (NSF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health (NIH) Grant RO1AI070749 (to L. R.), NIH, NINDS, Grant RO1NS051247 (to K. S. D.), and NIH Grant GM088317 (to W. A. T.). This work was also supported by the National Science Foundation CAREER CHE-0645020 award (to W. A. T.).; Supported by National Institutes of Health Training Grant 5 T32 HD007233-29 (to Lisa Frenkel).	Agarwal S, 2011, J BIOL CHEM, V286, P41368, DOI 10.1074/jbc.M111.286690; Archambaud C, 2005, MOL MICROBIOL, V56, P383, DOI 10.1111/j.1365-2958.2005.04551.x; Ausubel F.A., 1997, CURRENT PROTOCOLS MO, DOI DOI 10.1.4; Baker C., 1995, INFECT DIS FETUS NEW, V4th ed., P980; Banerjee A, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1474; Banu LD, 2010, INFECT IMMUN, V78, P2209, DOI 10.1128/IAI.01167-09; Barz C, 2000, FEBS LETT, V482, P139, DOI 10.1016/S0014-5793(00)02045-7; Bassler BL, 2006, CELL, V125, P237, DOI 10.1016/j.cell.2006.04.001; Bayles KW, 2007, NAT REV MICROBIOL, V5, P721, DOI 10.1038/nrmicro1743; Beier D, 2006, CURR OPIN MICROBIOL, V9, P143, DOI 10.1016/j.mib.2006.01.005; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Burnside K, 2011, FUTURE MICROBIOL, V6, P747, DOI [10.2217/FMB.11.62, 10.2217/fmb.11.62]; Burnside K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011071; Calva E, 2006, MICROB ECOL, V51, P166, DOI 10.1007/s00248-005-0087-1; Chaba R, 2002, EUR J BIOCHEM, V269, P1078, DOI 10.1046/j.1432-1033.2002.02778.x; Chaffin DO, 1998, GENE, V219, P91, DOI 10.1016/S0378-1119(98)00396-5; Chaffin DO, 2000, J BACTERIOL, V182, P4466, DOI 10.1128/JB.182.16.4466-4477.2000; Chaffin DO, 2005, J BACTERIOL, V187, P4615, DOI 10.1128/JB.187.13.4615-4626.2005; Cheng Q, 2005, ANTIMICROB AGENTS CH, V49, P111, DOI 10.1128/AAC.49.1.111-117.2005; Cohen P, 2002, NAT REV DRUG DISCOV, V1, P309, DOI 10.1038/nrd773; COLIGAN JE, 1998, CURRENT PROTOCOLS IM, V1; Cowley S, 2004, MOL MICROBIOL, V52, P1691, DOI 10.1111/j.1365-2958.2004.04085.x; Debarbouille M, 2009, J BACTERIOL, V191, P4070, DOI 10.1128/JB.01813-08; Doran KS, 2005, J CLIN INVEST, V115, P2499, DOI 10.1172/JCI23829; Doran KS, 2004, MOL MICROBIOL, V54, P23, DOI 10.1111/j.1365-2958.2004.04266.x; Doran KS, 2003, J CLIN INVEST, V112, P736, DOI 10.1172/JCI200317335; Doran KS, 2002, J INFECT DIS, V185, P196, DOI 10.1086/338475; Gaidenko TA, 2002, J BACTERIOL, V184, P6109, DOI 10.1128/JB.184.22.6109-6114.2002; GIAEVER I, 1984, P NATL ACAD SCI-BIOL, V81, P3761, DOI 10.1073/pnas.81.12.3761; GIAEVER I, 1993, NATURE, V366, P591, DOI 10.1038/366591a0; GIAEVER I, 1991, P NATL ACAD SCI USA, V88, P7896, DOI 10.1073/pnas.88.17.7896; Guo HH, 2011, J LIPID RES, V52, P908, DOI 10.1194/jlr.M013375; Hakansson S, 1996, MOL MICROBIOL, V20, P593, DOI 10.1046/j.1365-2958.1996.5251051.x; Harris TO, 2003, J CLIN INVEST, V111, P61, DOI 10.1172/JCI200316270; Hensler ME, 2005, J INFECT DIS, V191, P1287, DOI 10.1086/428946; HILLIER SL, 1991, AM J OBSTET GYNECOL, V165, P955, DOI 10.1016/0002-9378(91)90447-Y; HILLIER SL, 1988, NEW ENGL J MED, V319, P972, DOI 10.1056/NEJM198810133191503; Hoch JA, 1995, 2 COMPONENT SIGNAL T; HORTON RM, 1995, MOL BIOTECHNOL, V3, P93, DOI 10.1007/BF02789105; Iliuk Anton, 2009, V527, P117, DOI 10.1007/978-1-60327-834-8_10; Iliuk AB, 2010, MOL CELL PROTEOMICS, V9, P2162, DOI 10.1074/mcp.M110.000091; Jankowsky E, 2011, TRENDS BIOCHEM SCI, V36, P19, DOI 10.1016/j.tibs.2010.07.008; Jiang SM, 2008, J BACTERIOL, V190, P1956, DOI 10.1128/JB.01677-07; Jiang SM, 2005, J BACTERIOL, V187, P1105, DOI 10.1128/JB.187.3.1105-1113.2005; Jin H, 2006, J MOL BIOL, V357, P1351, DOI 10.1016/j.jmb.2006.01.020; Johnson DS, 2007, CELL, V129, P1299, DOI 10.1016/j.cell.2007.04.038; Jones AL, 2000, MOL MICROBIOL, V37, P1444, DOI 10.1046/j.1365-2958.2000.02099.x; Juris SJ, 2000, P NATL ACAD SCI USA, V97, P9431, DOI 10.1073/pnas.170281997; Kang CM, 2005, GENE DEV, V19, P1692, DOI 10.1101/gad.1311105; Kennelly PJ, 2002, FEMS MICROBIOL LETT, V206, P1, DOI 10.1016/S0378-1097(01)00479-7; Koul A, 2001, MICROBIOL-SGM, V147, P2307, DOI 10.1099/00221287-147-8-2307; Kristich CJ, 2007, P NATL ACAD SCI USA, V104, P3508, DOI 10.1073/pnas.0608742104; Lamy MC, 2004, MOL MICROBIOL, V54, P1250, DOI 10.1111/j.1365-2958.2004.04365.x; Lembo A, 2010, MOL MICROBIOL, V77, P431, DOI 10.1111/j.1365-2958.2010.07215.x; Lin WJ, 2009, MOL MICROBIOL, V71, P1477, DOI 10.1111/j.1365-2958.2009.06616.x; Lo CM, 1995, BIOPHYS J, V69, P2800, DOI 10.1016/S0006-3495(95)80153-0; Loessner MJ, 2005, CURR OPIN MICROBIOL, V8, P480, DOI 10.1016/j.mib.2005.06.002; Madec E, 2002, MOL MICROBIOL, V46, P571, DOI 10.1046/j.1365-2958.2002.03178.x; Madoff LC, 1996, P NATL ACAD SCI USA, V93, P4131, DOI 10.1073/pnas.93.9.4131; MANI N, 1993, J BACTERIOL, V175, P1493, DOI 10.1128/JB.175.5.1493-1499.1993; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; MARQUES MB, 1992, INFECT IMMUN, V60, P3986, DOI 10.1128/IAI.60.10.3986-3993.1992; Nizet V, 2002, TRENDS MICROBIOL, V10, P575, DOI 10.1016/S0966-842X(02)02473-3; Nizet V, 1996, INFECT IMMUN, V64, P3818, DOI 10.1128/IAI.64.9.3818-3826.1996; Novick RP, 2003, MOL MICROBIOL, V48, P1429, DOI 10.1046/j.1365-2958.2003.03526.x; Ochem AE, 2008, ARCH BIOCHEM BIOPHYS, V470, P1, DOI 10.1016/j.abb.2007.11.005; OKADA N, 1993, MOL MICROBIOL, V7, P893, DOI 10.1111/j.1365-2958.1993.tb01180.x; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Osaki M, 2009, J BACTERIOL, V191, P4943, DOI 10.1128/JB.00196-09; Pereira SFF, 2011, MICROBIOL MOL BIOL R, V75, P192, DOI 10.1128/MMBR.00042-10; Pritchard DG, 2004, MICROBIOL-SGM, V150, P2079, DOI 10.1099/mic.0.27063-0; Pritzlaff CA, 2001, MOL MICROBIOL, V39, P236, DOI 10.1046/j.1365-2958.2001.02211.x; Quach D, 2009, J BACTERIOL, V191, P2023, DOI 10.1128/JB.01216-08; Rajagopal L, 2005, MOL MICROBIOL, V56, P1329, DOI 10.1111/j.1365-2958.2005.04620.x; Rajagopal L, 2003, J BIOL CHEM, V278, P14429, DOI 10.1074/jbc.M212747200; Rajagopal L, 2006, MOL MICROBIOL, V62, P941, DOI 10.1111/j.1365-2958.2006.05431.x; Rajagopal L, 2009, FUTURE MICROBIOL, V4, P201, DOI 10.2217/17460913.4.2.201; Redbird RA, 2007, FASEB J, V21, pA986; Reinscheid DJ, 2001, J BACTERIOL, V183, P1175, DOI 10.1128/JB.183.4.1175-1183.2001; Ring A, 2002, J INFECT DIS, V185, P1745, DOI 10.1086/340818; Rogers JP, 2006, J MED CHEM, V49, P1658, DOI 10.1021/jm051033y; ROMERO R, 1989, AM J OBSTET GYNECOL, V161, P817, DOI 10.1016/0002-9378(89)90409-2; Shelver D, 2003, J BACTERIOL, V185, P6592, DOI 10.1128/JB.185.22.6592-6599.2003; Silvestroni A, 2009, J PROTEOME RES, V8, P2563, DOI 10.1021/pr900069n; Song JH, 2005, MOL CELLS, V19, P365; Spellerberg B, 1999, J BACTERIOL, V181, P3212, DOI 10.1128/JB.181.10.3212-3219.1999; Stins MF, 1997, IN VITRO CELL DEV-AN, V33, P243; Struglics A, 1998, BIOCHEM BIOPH RES CO, V243, P664, DOI 10.1006/bbrc.1998.8151; Sureka K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008590; Tamber S, 2010, INFECT IMMUN, V78, P3637, DOI 10.1128/IAI.00296-10; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Ulijasz AT, 2009, MOL MICROBIOL, V71, P382, DOI 10.1111/j.1365-2958.2008.06532.x; van Sorge NM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002964; Verani Jennifer R., 2010, Morbidity and Mortality Weekly Report, V59, P1; Wang IN, 2000, ANNU REV MICROBIOL, V54, P799, DOI 10.1146/annurev.micro.54.1.799; WESSELS MR, 1989, P NATL ACAD SCI USA, V86, P8983, DOI 10.1073/pnas.86.22.8983; Weston EJ, 2011, PEDIATR INFECT DIS J, V30, P937, DOI 10.1097/INF.0b013e318223bad2; Yang LQ, 2004, BIOCHEM BIOPH RES CO, V314, P622, DOI 10.1016/j.bbrc.2003.12.129	98	33	34	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2011	286	51					44197	44210		10.1074/jbc.M111.313486	http://dx.doi.org/10.1074/jbc.M111.313486			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866SH	22081606	hybrid, Green Published			2022-12-27	WOS:000298402300060
J	Kallay, LM; Brett, CL; Tukaye, DN; Wemmer, MA; Chyou, A; Odorizzi, G; Rao, R				Kallay, Laura M.; Brett, Christopher L.; Tukaye, Deepali N.; Wemmer, Megan A.; Chyou, Anthony; Odorizzi, Greg; Rao, Rajini			Endosomal Na+ (K+)/H+ Exchanger Nhx1/Vps44 Functions Independently and Downstream of Multivesicular Body Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; GTPASE-ACTIVATING PROTEIN; ESCRT COMPLEXES; VESICLE TRAFFICKING; CANDIDA-ALBICANS; VACUOLE FUSION; MEMBRANE; PATHWAY; PH; COMPARTMENT	The multivesicular body (MVB) is an endosomal intermediate containing intralumenal vesicles destined for membrane protein degradation in the lysosome. In Saccharomyces cerevisiae, the MVB pathway is composed of 17 evolutionarily conserved ESCRT (endosomal sorting complex required for transport) genes grouped by their vacuole protein sorting Class E mutant phenotypes. Only one integral membrane protein, the endosomal Na+ (K+)/H+ exchanger Nhx1/Vps44, has been assigned to this class, but its role in the MVB pathway has not been directly tested. Herein, we first evaluated the link between Nhx1 and the ESCRT proteins and then used an unbiased phenomics approach to probe the cellular role of Nhx1. Select ESCRT mutants (vps36 Delta, vps20 Delta, snf7 Delta, and bro1 Delta) with defects in cargo packaging and intralumenal vesicle formation shared multiple growth phenotypes with nhx1 Delta. However, analysis of cellular trafficking and ultrastructural examination by electron microscopy revealed that nhx1 Delta cells retain the ability to sort cargo into intralumenal vesicles. In addition, we excluded a role for Nhx1 in Snf7/Bro1-mediated cargo deubiquitylation and Rim101 response to pH stress. Genetic epistasis experiments provided evidence that NHX1 and ESCRT genes function in parallel. A genome-wide screen for single gene deletion mutants that phenocopy nhx1 Delta yielded a limited gene set enriched for endosome fusion function, including Rab signaling and actin cytoskeleton reorganization. In light of these findings and the absence of the so-called Class E compartment in nhx1 Delta, we eliminated a requirement for Nhx1 in MVB formation and suggest an alternative post-ESCRT role in endosomal membrane fusion.	[Kallay, Laura M.; Brett, Christopher L.; Tukaye, Deepali N.; Chyou, Anthony; Rao, Rajini] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; [Brett, Christopher L.] Concordia Univ, Dept Biol, Montreal, PQ H3G 1M8, Canada; [Wemmer, Megan A.; Odorizzi, Greg] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA	Johns Hopkins University; Concordia University - Canada; University of Colorado System; University of Colorado Boulder	Rao, R (corresponding author), Johns Hopkins Univ, Sch Med, Dept Physiol, 725 N Wolfe St, Baltimore, MD 21205 USA.	rrao1@jhmi.edu		Odorizzi, Greg/0000-0002-1143-1098	National Institutes of Health [DK054214, GM065505]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054214] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065505] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK054214 (to R. R.) and GM065505 (to G. O.).	Ali R, 2004, J BIOL CHEM, V279, P4498, DOI 10.1074/jbc.M307446200; Babst M, 2005, TRAFFIC, V6, P2, DOI 10.1111/j.1600-0854.2004.00246.x; Balderhaar HJK, 2010, J CELL SCI, V123, P4085, DOI 10.1242/jcs.071977; Barwell KJ, 2005, EUKARYOT CELL, V4, P890, DOI 10.1128/EC.4.5.890-899.2005; Bowers K, 2004, TRAFFIC, V5, P194, DOI 10.1111/j.1600-0854.2004.00169.x; Bowers K, 2000, MOL BIOL CELL, V11, P4277, DOI 10.1091/mbc.11.12.4277; Brett CL, 2008, J CELL BIOL, V182, P1141, DOI 10.1083/jcb.200801001; Brett CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017619; Brett CL, 2005, MOL BIOL CELL, V16, P1396, DOI 10.1091/mbc.E04-11-0999; Brett CL, 2005, AM J PHYSIOL-CELL PH, V288, pC223, DOI 10.1152/ajpcell.00360.2004; Chang FS, 2003, CURR BIOL, V13, P455, DOI 10.1016/S0960-9822(03)00131-3; Chen SH, 2005, MOL BIOL CELL, V16, P178, DOI 10.1091/mbc.E04-03-0258; Cowles CR, 1997, EMBO J, V16, P2769, DOI 10.1093/emboj/16.10.2769; Davies BA, 2010, MOL BIOL CELL, V21, P3396, DOI 10.1091/mbc.E10-06-0512; Davis DA, 2009, CURR OPIN MICROBIOL, V12, P365, DOI 10.1016/j.mib.2009.05.006; Denker SP, 2002, J CELL BIOL, V159, P1087, DOI 10.1083/jcb.200208050; Dewar H, 2002, MOL BIOL CELL, V13, P3646, DOI 10.1091/mbc.E02-05-0262; Eitzen G, 2002, J CELL BIOL, V158, P669, DOI 10.1083/jcb.200204089; Eitzen G, 2001, EMBO J, V20, P5650, DOI 10.1093/emboj/20.20.5650; Franke B, 2009, HUM GENET, V126, P13, DOI 10.1007/s00439-009-0663-4; Frantz C, 2007, J CELL BIOL, V179, P403, DOI 10.1083/jcb.200704169; Fratti RA, 2004, J CELL BIOL, V167, P1087, DOI 10.1083/jcb.200409068; Gaxiola RA, 1999, P NATL ACAD SCI USA, V96, P1480, DOI 10.1073/pnas.96.4.1480; Gerhardt B, 1998, J BIOL CHEM, V273, P15818, DOI 10.1074/jbc.273.25.15818; Gilfillan GD, 2008, AM J HUM GENET, V82, P1003, DOI 10.1016/j.ajhg.2008.01.013; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; HAAS A, 1995, EMBO J, V14, P5258, DOI 10.1002/j.1460-2075.1995.tb00210.x; Hayashi M, 2005, MOL CELL BIOL, V25, P9478, DOI 10.1128/MCB.25.21.9478-9490.2005; Hurley JH, 2006, ANNU REV BIOPH BIOM, V35, P277, DOI 10.1146/annurev.biophys.35.040405.102126; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; LI RJ, 1997, CELL BIOL, V136, P649; Luhtala N, 2004, J CELL BIOL, V166, P717, DOI 10.1083/jcb.200403139; Luo ZL, 2003, J BIOL CHEM, V278, P791, DOI 10.1074/jbc.M209120200; Mitsui K, 2011, J BIOL CHEM, V286, P37625, DOI 10.1074/jbc.M111.260612; Morrow EM, 2008, SCIENCE, V321, P218, DOI 10.1126/science.1157657; Mukherjee S, 2006, BIOCHEM J, V398, P97, DOI 10.1042/BJ20060388; Nass R, 1999, MICROBIOL-SGM, V145, P3221, DOI 10.1099/00221287-145-11-3221; Nass R, 1997, J BIOL CHEM, V272, P26145, DOI 10.1074/jbc.272.42.26145; Nass R, 1998, J BIOL CHEM, V273, P21054, DOI 10.1074/jbc.273.33.21054; Nickerson DP, 2007, EMBO REP, V8, P644, DOI 10.1038/sj.embor.7401004; Nickerson Daniel P, 2006, J Cell Biol, V175, P715, DOI 10.1083/jcb.200606113; Nordmann M, 2010, CURR BIOL, V20, P1654, DOI 10.1016/j.cub.2010.08.002; Odorizzi G, 2003, J CELL SCI, V116, P1893, DOI 10.1242/jcs.00395; PAPA FR, 1993, NATURE, V366, P313, DOI 10.1038/366313a0; Peplowska K, 2007, DEV CELL, V12, P739, DOI 10.1016/j.devcel.2007.03.006; Qiu QS, 2010, J CELL SCI, V123, P3266, DOI 10.1242/jcs.067637; RAYMOND CK, 1992, MOL BIOL CELL, V3, P1389, DOI 10.1091/mbc.3.12.1389; Richter C, 2007, EMBO J, V26, P2454, DOI 10.1038/sj.emboj.7601692; Rieder SE, 1996, MOL BIOL CELL, V7, P985, DOI 10.1091/mbc.7.6.985; ROBINSON JS, 1988, MOL CELL BIOL, V8, P4936, DOI 10.1128/MCB.8.11.4936; Schwartz ML, 2009, J CELL BIOL, V185, P535, DOI 10.1083/jcb.200811082; STROM M, 1993, NATURE, V361, P736, DOI 10.1038/361736a0; Tominaga T, 1998, MOL BIOL CELL, V9, P2287, DOI 10.1091/mbc.9.8.2287; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; von Schwedler UK, 2003, CELL, V114, P701, DOI 10.1016/S0092-8674(03)00714-1; Wemmer M, 2011, J CELL BIOL, V192, P295, DOI 10.1083/jcb.201007018; Wollert T, 2010, NATURE, V464, P864, DOI 10.1038/nature08849; Xu WJ, 2004, MOL BIOL CELL, V15, P5528, DOI 10.1091/mbc.E04-08-0666	59	15	15	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2011	286	51					44067	44077		10.1074/jbc.M111.282319	http://dx.doi.org/10.1074/jbc.M111.282319			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866SH	21998311	Green Published, hybrid			2022-12-27	WOS:000298402300047
J	Hondares, E; Rosell, M; Diaz-Delfin, J; Olmos, Y; Monsalve, M; Iglesias, R; Villarroya, F; Giralt, M				Hondares, Elayne; Rosell, Meritxell; Diaz-Delfin, Julieta; Olmos, Yolanda; Monsalve, Maria; Iglesias, Roser; Villarroya, Francesc; Giralt, Marta			Peroxisome Proliferator-activated Receptor alpha (PPAR alpha) Induces PPAR gamma Coactivator 1 alpha (PGC-1 alpha) Gene Expression and Contributes to Thermogenic Activation of Brown Fat INVOLVEMENT OF PRDM16	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNCOUPLING PROTEIN-1 GENE; ADIPOSE-TISSUE; MITOCHONDRIAL BIOGENESIS; TRANSCRIPTIONAL CONTROL; CELLULAR PLASTICITY; WHITE FAT; ADIPOCYTES; INDUCTION; MICE; COMPETENT	Peroxisome proliferator activated receptor alpha (PPAR alpha) is a distinctive marker of the brown fat phenotype that has been proposed to coordinate the transcriptional activation of genes for lipid oxidation and for thermogenic uncoupling protein 1 in brown adipose tissue. Here, we investigated the involvement of PPAR alpha in the transcriptional control of the PPAR alpha coactivator (PGC)-1 alpha gene. Treatment with PPAR alpha agonists induced PGC-1 alpha mRNA expression in brown fat in vivo and in primary brown adipocytes. This enhancement of PGC-1 alpha transcription was mediated by PPAR alpha binding to a PPAR-responsive element in the distal PGC-1 alpha gene promoter. PGC-1 alpha gene expression was decreased in PPAR alpha-null brown fat, both under basal conditions and in response to thermogenic activation. Moreover, PPAR alpha- and cAMP-mediated pathways interacted to control PGC-1 alpha transcription. PRDM16 (PRD1-BF1-RIZ1 homologous domain-containing 16) promoted PPAR alpha induction of PGC-1 alpha gene transcription, especially under conditions in which protein kinase A pathways were activated. This enhancement was associated with the interaction of PRDM16 with the PGC-1 alpha promoter at the PPAR alpha-binding site. In addition, PPAR alpha promoted the expression of the PRDM16 gene in brown adipocytes, and activation of PPAR alpha in human white adipocytes led to the appearance of a brown adipocyte pattern of gene expression, including induction of PGC-1 alpha and PRDM16. Collectively, these results suggest that PPAR alpha acts as a key component of brown fat thermogenesis by coordinately regulating lipid catabolism and thermogenic gene expression via induction of PGC-1 alpha and PRDM16.	[Hondares, Elayne; Rosell, Meritxell; Diaz-Delfin, Julieta; Iglesias, Roser; Villarroya, Francesc; Giralt, Marta] Univ Barcelona, Dept Biochem & Mol Biol, Barcelona, Catalonia, Spain; [Hondares, Elayne; Rosell, Meritxell; Diaz-Delfin, Julieta; Iglesias, Roser; Villarroya, Francesc; Giralt, Marta] Univ Barcelona, Inst Biomed IBUB, Barcelona, Catalonia, Spain; [Hondares, Elayne; Rosell, Meritxell; Diaz-Delfin, Julieta; Iglesias, Roser; Villarroya, Francesc; Giralt, Marta] CIBER Fisiopatol Obesidad & Nutr CIBERobn, Barcelona, Catalonia, Spain; [Olmos, Yolanda; Monsalve, Maria] Inst Salud Carlos III, Ctr Nacl Invest Cardiovasc, Madrid, Spain	University of Barcelona; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Centro Nacional de Investigaciones Cardiovasculares (CNIC); Instituto de Salud Carlos III	Giralt, M (corresponding author), Univ Barcelona, Fac Biol, Dept Bioquim & Biol Mol, Avda Diagonal 643, E-08028 Barcelona, Catalunya, Spain.	mgiralt@ub.edu	Giralt, Marta/A-4756-2013; Olmos, Yolanda/AAX-6661-2021; Villarroya, Francesc/K-4357-2014; Iglesias, Roser/C-5561-2017; Monsalve, Maria/K-4416-2014	Giralt, Marta/0000-0001-7968-4190; Olmos, Yolanda/0000-0002-5952-1607; Iglesias, Roser/0000-0002-7107-8097; Monsalve, Maria/0000-0003-2796-1453; Villarroya, Francesc/0000-0003-1266-9142	Instituto de Salud Carlos III [PI081715]; Ministerio de Ciencia e Innovacion, Spain [SAF2008-01896, SAF2009-07599, CSD 2007-00020]; Spanish Ministry of Science and Innovation; Pro-CNIC Foundation	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Pro-CNIC Foundation	This research was supported by Instituto de Salud Carlos III Grant PI081715 and Ministerio de Ciencia e Innovacion Grants SAF2008-01896, SAF2009-07599, and CSD 2007-00020), Spain. The CNIC is supported by the Spanish Ministry of Science and Innovation and the Pro-CNIC Foundation. CIBER Fisiopatologia de la Obesidad y Nutricion is an initiative of the Instituto de Salud Carlos III, Spain.	Arch JRS, 2002, EUR J PHARMACOL, V440, P99, DOI 10.1016/S0014-2999(02)01421-8; Barbera MJ, 2001, J BIOL CHEM, V276, P1486, DOI 10.1074/jbc.M006246200; Barbier O, 2003, J BIOL CHEM, V278, P13975, DOI 10.1074/jbc.M300749200; Bogacka I, 2005, J CLIN ENDOCR METAB, V90, P6650, DOI 10.1210/jc.2005-1024; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cao WH, 2004, MOL CELL BIOL, V24, P3057, DOI 10.1128/MCB.24.7.3057-3067.2004; Carmona MC, 2005, BIOCHEM J, V389, P47, DOI 10.1042/BJ20050009; Carmona MC, 2002, J BIOL CHEM, V277, P21489, DOI 10.1074/jbc.M201710200; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Enerback S, 2010, CELL METAB, V11, P248, DOI 10.1016/j.cmet.2010.03.008; Fajas L, 2002, DEV CELL, V3, P903, DOI 10.1016/S1534-5807(02)00360-X; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Granneman JG, 2005, AM J PHYSIOL-ENDOC M, V289, pE608, DOI 10.1152/ajpendo.00009.2005; Guerra C, 2001, J CLIN INVEST, V108, P1205, DOI 10.1172/JCI200113103; Guerra C, 1998, J CLIN INVEST, V102, P412, DOI 10.1172/JCI3155; Handschin C, 2003, P NATL ACAD SCI USA, V100, P7111, DOI 10.1073/pnas.1232352100; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Hondares E, 2007, BIOCHEM BIOPH RES CO, V354, P1021, DOI 10.1016/j.bbrc.2007.01.092; Hondares E, 2006, ENDOCRINOLOGY, V147, P2829, DOI 10.1210/en.2006-0070; ISSEMANN I, 1990, NATURE, V347, P645, DOI 10.1038/347645a0; Kajimura S, 2010, CELL METAB, V11, P257, DOI 10.1016/j.cmet.2010.03.005; Kersten S, 1999, J CLIN INVEST, V103, P1489, DOI 10.1172/JCI6223; Komatsu M, 2010, GENES CELLS, V15, P91, DOI 10.1111/j.1365-2443.2009.01368.x; Larsen TM, 2002, AM J CLIN NUTR, V76, P780, DOI 10.1093/ajcn/76.4.780; Li PP, 2005, AM J PHYSIOL-ENDOC M, V289, pE617, DOI 10.1152/ajpendo.00010.2005; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; LOWELL BB, 1993, NATURE, V366, P740, DOI 10.1038/366740a0; MacLaren R, 2008, J LIPID RES, V49, P308, DOI 10.1194/jlr.M700199-JLR200; Mandard S, 2004, CELL MOL LIFE SCI, V61, P393, DOI 10.1007/s00018-003-3216-3; MURAMATSU MA, 1989, MOL CELL BIOL, V9, P831, DOI 10.1128/MCB.9.2.831; Olmos Y, 2009, J BIOL CHEM, V284, P14476, DOI 10.1074/jbc.M807397200; Petrovic N, 2008, AM J PHYSIOL-ENDOC M, V295, pE287, DOI 10.1152/ajpendo.00035.2008; Petrovic N, 2010, J BIOL CHEM, V285, P7153, DOI 10.1074/jbc.M109.053942; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Ribet C, 2010, ENDOCRINOLOGY, V151, P123, DOI 10.1210/en.2009-0726; Rim JS, 2004, J BIOL CHEM, V279, P25916, DOI 10.1074/jbc.M402102200; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Seale P, 2007, CELL METAB, V6, P38, DOI 10.1016/j.cmet.2007.06.001; Seale P, 2011, J CLIN INVEST, V121, P96, DOI 10.1172/JCI44271; Sears IB, 1996, MOL CELL BIOL, V16, P3410; Tiraby C, 2003, J BIOL CHEM, V278, P33370, DOI 10.1074/jbc.M305235200; Tong YH, 2005, BIOCHEM BIOPH RES CO, V336, P76, DOI 10.1016/j.bbrc.2005.08.041; Uldry M, 2006, CELL METAB, V3, P333, DOI 10.1016/j.cmet.2006.04.002; Valmaseda A, 1999, MOL CELL ENDOCRINOL, V154, P101, DOI 10.1016/S0303-7207(99)00081-7; Villarroya F, 2007, PPAR RES, V2007, DOI 10.1155/2007/74364; Villena JA, 2007, P NATL ACAD SCI USA, V104, P1418, DOI 10.1073/pnas.0607696104; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Wabitsch M, 2001, INT J OBESITY, V25, P8, DOI 10.1038/sj.ijo.0801520; Xue BZ, 2005, MOL CELL BIOL, V25, P8311, DOI 10.1128/MCB.25.18.8311-8322.2005; YOUNG P, 1984, FEBS LETT, V167, P10, DOI 10.1016/0014-5793(84)80822-4; Yubero P, 1998, MOL ENDOCRINOL, V12, P1023, DOI 10.1210/me.12.7.1023; YUBERO P, 1994, BIOCHEM BIOPH RES CO, V198, P653, DOI 10.1006/bbrc.1994.1095	52	214	231	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					43112	43122		10.1074/jbc.M111.252775	http://dx.doi.org/10.1074/jbc.M111.252775			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22033933	hybrid, Green Published			2022-12-27	WOS:000298351300032
J	Sen, T; Sen, N; Huang, YP; Sinha, D; Luo, ZG; Ratovitski, EA; Sidransky, D				Sen, Tanusree; Sen, Nilkantha; Huang, Yiping; Sinha, Debasish; Luo, Zhen-Ge; Ratovitski, Edward A.; Sidransky, David			Tumor Protein p63/Nuclear Factor kappa B Feedback Loop in Regulation of Cell Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE; P53 FAMILY; TRANSCRIPTIONAL REGULATION; INDUCED APOPTOSIS; CARCINOMA-CELLS; CROSS-TALK; IN-VIVO; CANCER; AUTOPHAGY; DELTA-NP63-ALPHA	Tumor protein (TP)-p53 family members often play proapoptotic roles, whereas nuclear factor kappa B (NF-kappa B) functions as a proapoptotic and antiapoptotic regulator depending on the cellular environment. We previously showed that the NF-kappa B activation leads to the reduction of the TP63 isoform, Delta Np63 alpha, thereby rendering the cells susceptible to cell death upon DNA damage. However, the functional relationship between TP63 isotypes and NF-kappa B is poorly understood. Here, we report that the TAp63 regulates NF-kappa B transcription and protein stability subsequently leading to the cell death phenotype. We found that TAp63 beta induced the expression of the p65 subunit of NF-kappa B (RELA) and target genes involved in cell cycle arrest or apoptosis, thereby triggering cell death pathways in MCF10A cells. RELA was shown to concomitantly modulate specific cell survival pathways, making it indispensable for the TAp63 beta-dependent regulation of cell death. We showed that TAp63 beta and RELA formed protein complexes resulted in their mutual stabilization and inhibition of the RELA ubiquitination. Finally, we showed that TAp63 beta directly induced RelA transcription by binding to and activating of its promoter and, in turn, leading to activation of the NF-kappa B-dependent cell death genes. Overall, our data defined the regulatory feedback loop between TAp63 beta and NF-kappa B involved in the activation of cell death process of cancer cells.	[Ratovitski, Edward A.] Johns Hopkins Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Div Head & Neck Canc Res, Baltimore, MD 21231 USA; [Sen, Nilkantha] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21231 USA; [Huang, Yiping; Ratovitski, Edward A.] Johns Hopkins Univ, Sch Med, Dept Dermatol, Baltimore, MD 21231 USA; [Sinha, Debasish; Ratovitski, Edward A.] Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21231 USA; [Luo, Zhen-Ge] Shanghai Inst Biol Sci, Inst Neurosci, Shanghai 200031, Peoples R China	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Ratovitski, EA (corresponding author), Johns Hopkins Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Div Head & Neck Canc Res, Canc Res Bldg 2,Rm 2M05,1550 Orleans St, Baltimore, MD 21231 USA.	eratovi1@jhmi.edu	Sen, Nilkantha/AAW-9788-2020		National Institute of Health through the NIDCR [R01-DE13561]; National Institute of Health through the NEI [R01-EY018636-01]; NATIONAL EYE INSTITUTE [R01EY018636] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE013561] Funding Source: NIH RePORTER	National Institute of Health through the NIDCR; National Institute of Health through the NEI; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part by National Institutes of Health Grants R01-DE13561 through the NIDCR (to D. Sidransky and E. A. R.) and R01-EY018636-01 through the NEI (to D. Sinha and E. A. R.).	Ak P, 2010, FASEB J, V24, P3643, DOI 10.1096/fj.10-160549; Bitomsky N, 2009, FEBS J, V276, P6074, DOI 10.1111/j.1742-4658.2009.07331.x; Borrelli S, 2009, CELL DEATH DIFFER, V16, P253, DOI 10.1038/cdd.2008.147; Candi E, 2007, CELL CYCLE, V6, P274, DOI 10.4161/cc.6.3.3797; Chatterjee A, 2010, CANCER RES, V70, P1419, DOI 10.1158/0008-5472.CAN-09-2613; Dajee M, 2003, NATURE, V421, P639, DOI 10.1038/nature01283; Dey A, 2008, NAT REV DRUG DISCOV, V7, P1031, DOI 10.1038/nrd2759; Eisenberg-Lerner A, 2009, CELL DEATH DIFFER, V16, P966, DOI 10.1038/cdd.2009.33; Fan YJ, 2008, ADV EXP MED BIOL, V615, P223, DOI 10.1007/978-1-4020-6554-5_11; Fomenkov A, 2003, J BIOL CHEM, V278, P23906, DOI 10.1074/jbc.M300746200; Frank AK, 2011, MOL CELL BIOL, V31, P1201, DOI 10.1128/MCB.01136-10; Fujioka S, 2004, J BIOL CHEM, V279, P27549, DOI 10.1074/jbc.M313435200; Gressner O, 2005, EMBO J, V24, P2458, DOI 10.1038/sj.emboj.7600708; Haupt S, 2003, J CELL SCI, V116, P4077, DOI 10.1242/jcs.00739; Helton ES, 2008, ONCOGENE, V27, P2843, DOI 10.1038/sj.onc.1210948; Huang WC, 2007, MOL CELL, V26, P75, DOI 10.1016/j.molcel.2007.02.019; Huang YP, 2008, CELL CYCLE, V7, P2846, DOI 10.4161/cc.7.18.6627; Huang YP, 2010, AGING-US, V2, P959, DOI 10.18632/aging.100249; Huang YP, 2010, CELL CYCLE, V9, P328, DOI 10.4161/cc.9.2.10432; Janicke RU, 2008, CELL DEATH DIFFER, V15, P959, DOI 10.1038/cdd.2008.33; Johnstone RW, 2002, CELL, V108, P153, DOI 10.1016/S0092-8674(02)00625-6; Karin M, 1991, CURR OPIN CELL BIOL, V3, P467, DOI 10.1016/0955-0674(91)90075-A; Karl S, 2009, J CELL MOL MED, V13, P4239, DOI 10.1111/j.1582-4934.2009.00888.x; Kawauchi K, 2008, NAT CELL BIOL, V10, P611, DOI 10.1038/ncb1724; King KE, 2008, CANCER RES, V68, P5122, DOI 10.1158/0008-5472.CAN-07-6123; Kuribayashi K, 2011, CELL CYCLE, V10, P2380, DOI 10.4161/cc.10.14.16588; Leong CO, 2007, J CLIN INVEST, V117, P1370, DOI 10.1172/JCI30866; Li N, 2006, ONCOGENE, V25, P2349, DOI 10.1038/sj.onc.1209270; Lin BH, 1999, CELL DEATH DIFFER, V6, P570, DOI 10.1038/sj.cdd.4400528; Maiuri MC, 2010, CURR OPIN CELL BIOL, V22, P181, DOI 10.1016/j.ceb.2009.12.001; Martin AG, 2009, AGING-US, V1, P335, DOI 10.18632/aging.100026; Mauro C, 2009, METHODS MOL BIOL, V512, P169, DOI 10.1007/978-1-60327-530-9_10; Melino G, 2004, J BIOL CHEM, V279, P8076, DOI 10.1074/jbc.M307469200; Murray-Zmijewski F, 2006, CELL DEATH DIFFER, V13, P962, DOI 10.1038/sj.cdd.4401914; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; O'Prey J, 2010, CELL CYCLE, V9, P947, DOI 10.4161/cc.9.5.10872; Ohanna M, 2011, GENE DEV, V25, P1245, DOI 10.1101/gad.625811; Osada M, 2005, MOL CELL BIOL, V25, P6077, DOI 10.1128/MCB.25.14.6077-6089.2005; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Patturajan M, 2002, CANCER CELL, V1, P369, DOI 10.1016/S1535-6108(02)00057-0; Pietsch EC, 2008, ONCOGENE, V27, P6507, DOI 10.1038/onc.2008.315; Pommier Y, 2004, ONCOGENE, V23, P2934, DOI 10.1038/sj.onc.1207515; Rocco JW, 2006, CANCER CELL, V9, P45, DOI 10.1016/j.ccr.2005.12.013; Rosenbluth JM, 2009, AUTOPHAGY, V5, P114, DOI 10.4161/auto.5.1.7294; Ryan KM, 2000, NATURE, V404, P892, DOI 10.1038/35009130; Scherz-Shouval R, 2010, P NATL ACAD SCI USA, V107, P18511, DOI 10.1073/pnas.1006124107; Schilling T, 2009, BIOCHEM BIOPH RES CO, V387, P399, DOI 10.1016/j.bbrc.2009.07.063; Schmitt CA, 2002, CANCER CELL, V1, P289, DOI 10.1016/S1535-6108(02)00047-8; Schneider G, 2010, ONCOGENE, V29, P2795, DOI 10.1038/onc.2010.46; Schneider G, 2011, BBA-REV CANCER, V1815, P90, DOI 10.1016/j.bbcan.2010.10.003; Schuster A, 2010, CELL CYCLE, V9, P2629, DOI 10.4161/cc.9.13.12110; Seitz SJ, 2010, INT J CANCER, V126, P2049, DOI 10.1002/ijc.24861; Sen T, 2011, CANCER RES, V71, P1167, DOI 10.1158/0008-5472.CAN-10-1481; Sen T, 2010, CELL CYCLE, V9, P4841, DOI 10.4161/cc.9.24.14093; Skaug B, 2009, ANNU REV BIOCHEM, V78, P769, DOI 10.1146/annurev.biochem.78.070907.102750; Tergaonkar V, 2002, CANCER CELL, V1, P493, DOI 10.1016/S1535-6108(02)00068-5; Tergaonkar V, 2007, MOL CELL, V26, P158, DOI 10.1016/j.molcel.2007.04.006; Trink B, 2007, CELL CYCLE, V6, P240, DOI 10.4161/cc.6.3.3803; Vousden KH, 2009, AGING-US, V1, P275, DOI 10.18632/aging.100033; Vousden KH, 2009, NAT REV CANCER, V9, P691, DOI 10.1038/nrc2715; Wan FY, 2010, CELL RES, V20, P24, DOI 10.1038/cr.2009.137; Wang J, 2010, J NEUROSCI, V30, P11104, DOI 10.1523/JNEUROSCI.2118-10.2010; Wang P, 2009, CELL DEATH DIFFER, V16, P1192, DOI 10.1038/cdd.2009.51; Wu J, 2010, J CELL BIOCHEM, V109, P702, DOI 10.1002/jcb.22449; Yang XP, 2011, CANCER RES, V71, P3688, DOI 10.1158/0008-5472.CAN-10-3445; Yee KS, 2009, CELL DEATH DIFFER, V16, P1135, DOI 10.1038/cdd.2009.28; Zhou A, 2003, ONCOGENE, V22, P2054, DOI 10.1038/sj.onc.1206262	67	13	14	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					43204	43213		10.1074/jbc.M111.257105	http://dx.doi.org/10.1074/jbc.M111.257105			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	22020940	Green Published, hybrid			2022-12-27	WOS:000298351300041
J	Muir, A; Greenspan, DS				Muir, Alison; Greenspan, Daniel S.			Metalloproteinases in Drosophila to Humans That Are Central Players in Developmental Processes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							BONE MORPHOGENETIC PROTEIN-1; PROCOLLAGEN-C-PROTEINASE; MAMMALIAN TOLLOID-LIKE; FRIZZLED-RELATED PROTEIN-2; LYSYL OXIDASE; I PROCOLLAGEN; 1 GENE; POSTTRANSLATIONAL MODIFICATION; COLLAGEN FIBRILLOGENESIS; OSTEOGENESIS IMPERFECTA	Many secreted proteins are synthesized as precursors with propeptides that must be cleaved to yield the mature functional form of the molecule. In addition, various growth factors occur in extracellular latent complexes with protein antagonists and are activated upon cleavage of such antagonists. Research in the separate fields of embryonic patterning and extracellular matrix formation has identified members of the BMP1/Tolloid-like family of metalloproteinases as key players in these types of biosynthetic processing events in species ranging from Drosophila to humans.	[Muir, Alison; Greenspan, Daniel S.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Cell & Regenerat Biol, Madison, WI 53792 USA	University of Wisconsin System; University of Wisconsin Madison	Greenspan, DS (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Cell & Regenerat Biol, Madison, WI 53792 USA.	dsgreens@wisc.edu		Greenspan, Daniel/0000-0001-8096-7446	National Institutes of Health [AR53815]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR047746, R01AR053815] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007133] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant AR53815 (to D.S.G.). This minireview will be reprinted in the 2011 Minireview Compendium, which will be available in January, 2012.	Annes JP, 2003, J CELL SCI, V116, P217, DOI 10.1242/jcs.00229; Becker-Pauly C, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009233; Bekhouche M, 2010, J BIOL CHEM, V285, P15950, DOI 10.1074/jbc.M109.086447; Berry R, 2010, FEBS LETT, V584, P657, DOI 10.1016/j.febslet.2009.12.050; Berry R, 2009, P NATL ACAD SCI USA, V106, P8561, DOI 10.1073/pnas.0812178106; BIRK DE, 1990, J CELL SCI, V95, P649; Blanc G, 2007, J BIOL CHEM, V282, P16924, DOI 10.1074/jbc.M701610200; BOND JS, 1995, PROTEIN SCI, V4, P1247, DOI 10.1002/pro.5560040701; Boot-Handford RP, 2003, J BIOL CHEM, V278, P31067, DOI 10.1074/jbc.M212889200; Borel A, 2001, J BIOL CHEM, V276, P48944, DOI 10.1074/jbc.M109499200; BORK P, 1993, J MOL BIOL, V231, P539, DOI 10.1006/jmbi.1993.1305; Branam AM, 2010, DEV BIOL, V341, P444, DOI 10.1016/j.ydbio.2010.03.001; BRUCKNERTUDERMAN L, 1995, J CELL BIOL, V131, P551, DOI 10.1083/jcb.131.2.551; Canty EG, 2004, J CELL BIOL, V165, P553, DOI 10.1083/jcb.200312071; Chau P, 2007, BIOCHEMISTRY-US, V46, P8445, DOI 10.1021/bi700028u; Clark TG, 1999, DEVELOPMENT, V126, P2631; Fogelgren B, 2005, J BIOL CHEM, V280, P24690, DOI 10.1074/jbc.M412979200; Francone OL, 2011, J LIPID RES, V52, P1974, DOI 10.1194/jlr.M016527; Garrigue-Antar L, 2004, J BIOL CHEM, V279, P49835, DOI 10.1074/jbc.M408134200; Garrigue-Antar L, 2002, J BIOL CHEM, V277, P43327, DOI 10.1074/jbc.M207342200; Ge GX, 2007, P NATL ACAD SCI USA, V104, P10010, DOI 10.1073/pnas.0704179104; Ge GX, 2006, J CELL BIOL, V175, P111, DOI 10.1083/jcb.200606058; Ge GX, 2005, MOL CELL BIOL, V25, P5846, DOI 10.1128/MCB.25.14.5846-5858.2005; Ge GX, 2006, J BIOL CHEM, V281, P10786, DOI 10.1074/jbc.M511111200; Ge GX, 2004, J BIOL CHEM, V279, P41626, DOI 10.1074/jbc.M406630200; Gonzalez EM, 2005, J BIOL CHEM, V280, P7080, DOI 10.1074/jbc.M409841200; Gopalakrishnan B, 2004, J BIOL CHEM, V279, P30904, DOI 10.1074/jbc.M402252200; Grgurevic L, 2011, BIOCHEM BIOPH RES CO, V408, P26, DOI 10.1016/j.bbrc.2011.03.109; Grgurevic L, 2011, J AM SOC NEPHROL, V22, P681, DOI 10.1681/ASN.2010070722; He W, 2010, P NATL ACAD SCI USA, V107, P21110, DOI 10.1073/pnas.1004708107; HOJIMA Y, 1994, ANAL BIOCHEM, V223, P173, DOI 10.1006/abio.1994.1569; Hopkins DR, 2007, MATRIX BIOL, V26, P508, DOI 10.1016/j.matbio.2007.05.004; Huang GR, 2011, J CLIN INVEST, V121, P769, DOI 10.1172/JCI45096; Huang GR, 2009, J BIOL CHEM, V284, P25879, DOI 10.1074/jbc.M109.024125; Inomata H, 2008, CELL, V134, P854, DOI 10.1016/j.cell.2008.07.008; Jasuja R, 2007, J BIOL CHEM, V282, P9053, DOI 10.1074/jbc.M610929200; Kessler E, 1996, SCIENCE, V271, P360, DOI 10.1126/science.271.5247.360; Kim B, 2011, J BIOL CHEM, V286, P29014, DOI 10.1074/jbc.M111.252585; Kobayashi K, 2009, NAT CELL BIOL, V11, P46, DOI 10.1038/ncb1811; Kronenberg D, 2010, J INVEST DERMATOL, V130, P2727, DOI 10.1038/jid.2010.202; Kronenberg D, 2009, J BIOL CHEM, V284, P33437, DOI 10.1074/jbc.M109.046128; Lee HX, 2009, GENE DEV, V23, P2551, DOI 10.1101/gad.1839309; Lee HX, 2006, CELL, V124, P147, DOI 10.1016/j.cell.2005.12.018; Lee SB, 1997, J BIOL CHEM, V272, P19059, DOI 10.1074/jbc.272.30.19059; Lee SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001628; Leighton M, 2003, J BIOL CHEM, V278, P18478, DOI 10.1074/jbc.M213021200; Lesiak M, 2009, PHARMACOL REP, V61, P468, DOI 10.1016/S1734-1140(09)70088-X; Li SW, 1996, P NATL ACAD SCI USA, V93, P5127, DOI 10.1073/pnas.93.10.5127; Lindahl K, 2011, HUM MUTAT, V32, P598, DOI 10.1002/humu.21475; LINSENMAYER TF, 1993, J CELL BIOL, V121, P1181, DOI 10.1083/jcb.121.5.1181; Little Shawn C., 2006, Birth Defects Research, V78, P224, DOI 10.1002/bdrc.20079; Liu QR, 1997, J NEUROSCI, V17, P755; Mac Sweeney A, 2008, J MOL BIOL, V384, P228, DOI 10.1016/j.jmb.2008.09.029; Maertens B, 2007, J BIOL CHEM, V282, P10647, DOI 10.1074/jbc.M611339200; Marques G, 1997, CELL, V91, P417, DOI 10.1016/S0092-8674(00)80425-0; Maruhashi T, 2010, J BIOL CHEM, V285, P13294, DOI 10.1074/jbc.M109.088864; MENDLER M, 1989, J CELL BIOL, V108, P191, DOI 10.1083/jcb.108.1.191; Mesilaty-Gross S, 2009, CLIN CHIM ACTA, V403, P76, DOI 10.1016/j.cca.2009.01.024; Meyer F, 2006, DEVELOPMENT, V133, P4035, DOI 10.1242/dev.02580; Moali C, 2005, J BIOL CHEM, V280, P24188, DOI 10.1074/jbc.M501486200; Morimoto H, 2008, MATRIX BIOL, V27, P211, DOI 10.1016/j.matbio.2007.11.005; Pappano WN, 2003, MOL CELL BIOL, V23, P4428, DOI 10.1128/MCB.23.13.4428-4438.2003; Peluso CE, 2011, DEV CELL, V21, P375, DOI 10.1016/j.devcel.2011.06.025; Petropoulou V, 2005, J BIOL CHEM, V280, P22616, DOI 10.1074/jbc.M413468200; Piccolo S, 1997, CELL, V91, P407, DOI 10.1016/S0092-8674(00)80424-9; Ploper D, 2011, DEV BIOL, V352, P317, DOI 10.1016/j.ydbio.2011.01.029; PROCKOP DJ, 1995, ANNU REV BIOCHEM, V64, P403, DOI 10.1146/annurev.biochem.64.1.403; PROCKOP DJ, 1994, CLIN PLAST SURG, V21, P407; Rattenholl A, 2002, J BIOL CHEM, V277, P26372, DOI 10.1074/jbc.M203247200; Sabirzhanova I, 2009, DEV GROWTH DIFFER, V51, P403, DOI 10.1111/j.1440-169X.2009.01097.x; Scott IC, 2001, NATURE, V410, P475, DOI 10.1038/35068572; Scott IC, 2000, DEV DYNAM, V217, P449, DOI 10.1002/(SICI)1097-0177(200004)217:4<449::AID-DVDY12>3.0.CO;2-8; Scott IC, 1999, DEV BIOL, V213, P283, DOI 10.1006/dbio.1999.9383; Scott IC, 2000, J BIOL CHEM, V275, P30504, DOI 10.1074/jbc.M004846200; Serpe M, 2005, DEVELOPMENT, V132, P2645, DOI 10.1242/dev.01838; Serpe M, 2006, DEVELOPMENT, V133, P4969, DOI 10.1242/dev.02711; SHIMELL MJ, 1991, CELL, V67, P469, DOI 10.1016/0092-8674(91)90522-Z; St Croix B, 2000, SCIENCE, V289, P1197; Stanczak P, 2009, EUR J HUM GENET, V17, P344, DOI 10.1038/ejhg.2008.175; Steiglitz BM, 2006, MOL CELL BIOL, V26, P238, DOI 10.1128/MCB.26.1.238-249.2006; Steiglitz BM, 2004, J BIOL CHEM, V279, P980, DOI 10.1074/jbc.M310179200; Steiglitz BM, 2002, J BIOL CHEM, V277, P49820, DOI 10.1074/jbc.M209891200; Suzuki N, 1996, DEVELOPMENT, V122, P3587; TAKAHARA K, 1994, J BIOL CHEM, V269, P32572; TAKAHARA K, 1994, J BIOL CHEM, V269, P26280; Takahara K, 1996, GENOMICS, V34, P157, DOI 10.1006/geno.1996.0260; Teixeira CC, 2011, J CELL BIOCHEM, V112, P607, DOI 10.1002/jcb.22951; Unsold C, 2002, J BIOL CHEM, V277, P5596, DOI 10.1074/jbc.M110003200; Uzel MI, 2001, J BIOL CHEM, V276, P22537, DOI 10.1074/jbc.M102352200; Veitch DP, 2003, J BIOL CHEM, V278, P15661, DOI 10.1074/jbc.M210588200; von Marschall Z, 2010, MATRIX BIOL, V29, P295, DOI 10.1016/j.matbio.2010.01.002; von Marschall Z, 2010, BIOCHEM BIOPH RES CO, V391, P1374, DOI 10.1016/j.bbrc.2009.12.067; Weiss T, 2010, J BIOL CHEM, V285, P33867, DOI 10.1074/jbc.M110.141366; Werner JM, 2000, J MOL BIOL, V296, P1065, DOI 10.1006/jmbi.1999.3513; Wolfman NM, 2003, P NATL ACAD SCI USA, V100, P15842, DOI 10.1073/pnas.2534946100; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241; Gomis-Ruth FX, 2009, J BIOL CHEM, V284, P15353, DOI 10.1074/jbc.R800069200; Zhang Y, 2006, J BIOL CHEM, V281, P39096, DOI 10.1074/jbc.M601362200; Zhu J, 2009, J LIPID RES, V50, P1330, DOI 10.1194/jlr.M900034-JLR200	99	30	33	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					41905	41911		10.1074/jbc.R111.299768	http://dx.doi.org/10.1074/jbc.R111.299768			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	22027825	Green Published, hybrid			2022-12-27	WOS:000298180900001
J	Senkal, CE; Ponnusamy, S; Manevich, Y; Meyers-Needham, M; Saddoughi, SA; Mukhopadyay, A; Dent, P; Bielawski, J; Ogretmen, B				Senkal, Can E.; Ponnusamy, Suriyan; Manevich, Yefim; Meyers-Needham, Marisa; Saddoughi, Sahar A.; Mukhopadyay, Archana; Dent, Paul; Bielawski, Jacek; Ogretmen, Besim			Alteration of Ceramide Synthase 6/C-16-Ceramide Induces Activating Transcription Factor 6-mediated Endoplasmic Reticulum (ER) Stress and Apoptosis via Perturbation of Cellular Ca2+ and ER/Golgi Membrane Network	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; LONGEVITY ASSURANCE GENE-1; BREFELDIN-A; HUMAN HEAD; GOLGI PROTEINS; DISTINCT ROLES; HELA-CELLS; ATF6; DEATH; SPHINGOLIPIDS	Mechanisms that regulate endoplasmic reticulum (ER) stress-induced apoptosis in cancer cells remain enigmatic. Recent data suggest that ceramide synthase1-6 (CerS1-6)-generated ceramides, containing different fatty acid chain lengths, might exhibit distinct and opposing functions, such as apoptosis versus survival in a context-dependent manner. Here, we investigated the mechanisms involved in the activation of one of the major ER stress response proteins, ATF-6, and subsequent apoptosis by alterations of CerS6/C-16-ceramide. Induction of wild type (WT), but not the catalytically inactive mutant CerS6, increased tumor growth in SCID mice, whereas siRNA-mediated knockdown of CerS6 induced ATF-6 activation and apoptosis in multiple human cancer cells. Down-regulation of CerS6/C-16-ceramide, and not its further metabolism to glucosylceramide or sphingomyelin, activated ATF-6 upon treatment with ER stress inducers tunicamycin or SAHA (suberoylanilide hydroxamic acid). Induction of WT-CerS6 expression, but not its mutant, or ectopic expression of the dominant-negative mutant form of ATF-6 protected cells from apoptosis in response to CerS6 knockdown and tunicamycin or SAHA treatment. Mechanistically, ATF-6 activation was regulated by a concerted two-step process involving the release of Ca2+ from the ER stores ([Ca2+](ER)), which resulted in the fragmentation of Golgi membranes in response to CerS6/C16-ceramide alteration. This resulted in the accumulation of pro-ATF-6 in the disrupted ER/Golgi membrane network, where pro-ATF6 is activated. Accordingly, ectopic expression of a Ca2+ chelator calbindin prevented the Golgi fragmentation, ATF-6 activation, and apoptosis in response to CerS6/C16-ceramide down-regulation. Overall, these data suggest a novel mechanism of how CerS6/C-16-ceramide alteration activates ATF6 and induces ER-stress-mediated apoptosis in squamous cell carcinomas.	[Senkal, Can E.; Ponnusamy, Suriyan; Meyers-Needham, Marisa; Saddoughi, Sahar A.; Mukhopadyay, Archana; Bielawski, Jacek; Ogretmen, Besim] Med Univ S Carolina, Dept Biochem & Mol Biol, Hollings Canc Ctr, Charleston, SC 29425 USA; [Manevich, Yefim] Med Univ S Carolina, Dept Cell & Mol Pharmacol & Expt Therapeut, Charleston, SC 29425 USA; [Dent, Paul] Virginia Commonwealth Univ, Dept Neurosurg, Richmond, VA 23298 USA	Medical University of South Carolina; Medical University of South Carolina; Virginia Commonwealth University	Ogretmen, B (corresponding author), 86 Jonathan Lucas St,HO512, Charleston, SC 29425 USA.	ogretmen@musc.edu			National Institutes of Health [CA088932, DE016572, CA097132]; National Institutes of Health at National Center for Research Resources [C06 RR015455]; NATIONAL CANCER INSTITUTE [R01CA088932, R01CA141703, P01CA097132, R01CA150214] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015455] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE016572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052825] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [F30ES019464] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health at National Center for Research Resources; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA088932, DE016572, and CA097132.; Human HNSCC cell lines UM-SCC-1, UM-SCC-14A, and UM-SCC-22A cells were kindly provided by Dr. Thomas Carey (University of Michigan). The dominant-negative-ATF6 cDNA was kindly provided by Dr. Christopher Glembotski (University of California, San Diego). Lung cancer cell lines were obtained from Dr. Harry Drabkin (Medical University of South Carolina). The core facilities utilized for animal studies and Lipidomics were constructed using support from the National Institutes of Health (Grant C06 RR015455) at the Extramural Research Facilities Program of the National Center for Research Resources.	Balla T, 2009, CELL CALCIUM, V45, P527, DOI 10.1016/j.ceca.2009.03.013; Bauer R, 2009, EMBO J, V28, P3706, DOI 10.1038/emboj.2009.305; Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; Brini M, 2009, PHYSIOL REV, V89, P1341, DOI 10.1152/physrev.00032.2008; Citterio C, 2008, P NATL ACAD SCI USA, V105, P2877, DOI 10.1073/pnas.0712224105; D'Angelo G, 2007, NATURE, V449, P62, DOI 10.1038/nature06097; DOMS RW, 1989, J CELL BIOL, V109, P61, DOI 10.1083/jcb.109.1.61; Erez-Roman R, 2010, BIOCHEM BIOPH RES CO, V391, P219, DOI 10.1016/j.bbrc.2009.11.035; Ginzburg L, 2008, J NEUROCHEM, V104, P140, DOI 10.1111/j.1471-4159.2007.04983.x; Hanada K, 2003, NATURE, V426, P803, DOI 10.1038/nature02188; Hannun YA, 2011, J BIOL CHEM, V286, P27855, DOI 10.1074/jbc.R111.254359; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Haze K, 2001, BIOCHEM J, V355, P19, DOI 10.1042/0264-6021:3550019; Hisatsune C, 2005, J BIOL CHEM, V280, P11723, DOI 10.1074/jbc.M409535200; Karahatay S, 2007, CANCER LETT, V256, P101, DOI 10.1016/j.canlet.2007.06.003; Lahiri S, 2005, J BIOL CHEM, V280, P33735, DOI 10.1074/jbc.M506485200; Lee H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019783; Lepine S, 2011, CELL DEATH DIFFER, V18, P350, DOI 10.1038/cdd.2010.104; LIPPINCOTTSCHWARTZ J, 1989, CELL, V56, P801, DOI 10.1016/0092-8674(89)90685-5; LIPPINCOTTSCHWARTZ J, 1991, J CELL BIOL, V112, P567, DOI 10.1083/jcb.112.4.567; Ma YJ, 2002, J MOL BIOL, V318, P1351, DOI 10.1016/S0022-2836(02)00234-6; Manevich Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014151; Marciniak SJ, 2006, PHYSIOL REV, V86, P1133, DOI 10.1152/physrev.00015.2006; McCullough KD, 2001, MOL CELL BIOL, V21, P1249, DOI 10.1128/MCB.21.4.1249-1259.2001; Mesicek J, 2010, CELL SIGNAL, V22, P1300, DOI 10.1016/j.cellsig.2010.04.006; Michel C, 1997, J BIOL CHEM, V272, P22432, DOI 10.1074/jbc.272.36.22432; Mizutani Y, 2005, BIOCHEM J, V390, P263, DOI 10.1042/BJ20050291; Mukhopadhyay A, 2009, FASEB J, V23, P751, DOI 10.1096/fj.08-120550; Ogretmen B, 2004, NAT REV CANCER, V4, P604, DOI 10.1038/nrc1411; Okada T, 2002, BIOCHEM J, V366, P585, DOI 10.1042/BJ20020391; Park MA, 2010, CANCER RES, V70, P6313, DOI 10.1158/0008-5472.CAN-10-0999; Pewzner-Jung Y, 2006, J BIOL CHEM, V281, P25001, DOI 10.1074/jbc.R600010200; Ponnusamy S, 2010, FUTURE ONCOL, V6, P1603, DOI 10.2217/FON.10.116; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Schiffmann S, 2009, CARCINOGENESIS, V30, P745, DOI 10.1093/carcin/bgp061; Scorrano L, 2003, SCIENCE, V300, P135, DOI 10.1126/science.1081208; Senkal CE, 2007, MOL CANCER THER, V6, P712, DOI 10.1158/1535-7163.MCT-06-0558; Senkal CE, 2006, J PHARMACOL EXP THER, V317, P1188, DOI 10.1124/jpet.106.101949; Senkal CE, 2010, FASEB J, V24, P296, DOI 10.1096/fj.09-135087; Shen JS, 2004, J BIOL CHEM, V279, P43046, DOI 10.1074/jbc.M408466200; Sridevi P, 2010, EXP CELL RES, V316, P78, DOI 10.1016/j.yexcr.2009.09.027; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Tafesse FG, 2007, J BIOL CHEM, V282, P17537, DOI 10.1074/jbc.M702423200; Thuerauf DJ, 2001, J BIOL CHEM, V276, P48309, DOI 10.1074/jbc.M107146200; Vacaru AM, 2009, J CELL BIOL, V185, P1013, DOI 10.1083/jcb.200903152; Venkataraman K, 2002, J BIOL CHEM, V277, P35642, DOI 10.1074/jbc.M205211200; Wang XZ, 1998, EMBO J, V17, P5708, DOI 10.1093/emboj/17.19.5708; Wang Y, 2000, J BIOL CHEM, V275, P27013; Wojcikiewicz RJH, 2009, CELL CALCIUM, V46, P147, DOI 10.1016/j.ceca.2009.05.002; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	51	87	90	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42446	42458		10.1074/jbc.M111.287383	http://dx.doi.org/10.1074/jbc.M111.287383			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	22013072	hybrid, Green Published			2022-12-27	WOS:000298180900053
J	Zhang, Y; Yang, XH; Gui, B; Xie, GJ; Zhang, D; Shang, YF; Liang, J				Zhang, Yu; Yang, Xiaohan; Gui, Bin; Xie, Guojia; Zhang, Di; Shang, Yongfeng; Liang, Jing			Corepressor Protein CDYL Functions as a Molecular Bridge between Polycomb Repressor Complex 2 and Repressive Chromatin Mark Trimethylated Histone Lysine 27	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER; METHYLTRANSFERASE ACTIVITY; GENE REPRESSION; BINDING; METHYLATION; ESTROGEN; ELEMENT; CORE; PRC2; EZH2	Polycomb group proteins play essential roles in transcriptional regulation of multiple gene families involved in various pathophysiological processes. It is believed that Polycomb Repressive Complex 2 (PRC2) is targeted to chromatin by the EED subunit to methylate histone H3 lysine 27 (H3K27), leading to a repressive chromatin state that inhibits gene expression. Here we report that the chromodomain-containing protein CDYL specifically recognizes di- and tri-methylated H3K27 (H3K27me2 and H3K27me3) and directly interacts with EZH2, the catalytic subunit of PRC2. We show that CDYL dramatically enhances the methyltransferase activity of PRC2 toward oligonucleosome substrates in vitro. Genome-wide analysis of CDYL targets by ChIP sequencing revealed that CDYL and PRC2 share a number of genomic targets. CDYL is required for chromatin targeting and maximal enzymatic activity of PRC2 at their common target sites. Our experiments indicate that CDYL functions as a molecular bridge between PRC2 and the repressive chromatin mark H3K27me3, forming a positive feedback loop to facilitate the establishment and propagation of H3K27me3 modifications along the chromatin.	[Zhang, Yu; Yang, Xiaohan; Gui, Bin; Xie, Guojia; Zhang, Di; Shang, Yongfeng; Liang, Jing] Peking Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Key Lab Carcinogenesis & Translat Res,Minst Educ, Beijing 100191, Peoples R China; [Shang, Yongfeng] Tianjin Med Univ, Tianjin Key Lab Med Epigenet, Tianjin 300070, Peoples R China	Peking University; Tianjin Medical University	Liang, J (corresponding author), Peking Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Key Lab Carcinogenesis & Translat Res,Minst Educ, 38 Xue Yuan Rd, Beijing 100191, Peoples R China.	liang_jing@bjmu.edu.cn	Zhang, Di/AAE-2027-2021; Zhang, Di/AAD-6936-2021	Xie, Guojia/0000-0002-8250-6157	National Natural Science Foundation of China [30971637, 90919045, 30830032, 30921062]; Ministry of Science and Technology of China [2011CB504204]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported by Grants 30971637 and 90919045 (to J. L.) and 30830032 and 30921062 (to Y. S.) from the National Natural Science Foundation of China and Grants 973 Program: 2011CB504204 (to J. L. and Y. S.) from the Ministry of Science and Technology of China.	BAILEY TL, 1994, P 2 INT C INT SYST M, P28; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Campos EI, 2009, ANNU REV GENET, V43, P559, DOI 10.1146/annurev.genet.032608.103928; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Cao R, 2008, MOL CELL BIOL, V28, P1862, DOI 10.1128/MCB.01589-07; Caron C, 2003, EMBO REP, V4, P877, DOI 10.1038/sj.embor.embor917; Dodd IB, 2007, CELL, V129, P813, DOI 10.1016/j.cell.2007.02.053; Dorus S, 2003, HUM MOL GENET, V12, P1643, DOI 10.1093/hmg/ddg185; Franz H, 2009, J BIOL CHEM, V284, P35049, DOI 10.1074/jbc.M109.052332; Goldberg AD, 2007, CELL, V128, P635, DOI 10.1016/j.cell.2007.02.006; Iwase S, 2007, CELL, V128, P1077, DOI 10.1016/j.cell.2007.02.017; Ji XW, 2006, NUCLEIC ACIDS RES, V34, pW551, DOI 10.1093/nar/gkl322; Joseph R, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.109; Kaufman PD, 2010, CURR OPIN CELL BIOL, V22, P284, DOI 10.1016/j.ceb.2010.02.002; Kim J, 2006, EMBO REP, V7, P397, DOI 10.1038/sj.embor.7400625; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; Kuppuswamy M, 2008, MOL CELL BIOL, V28, P269, DOI 10.1128/MCB.01077-07; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Li RF, 2009, EMBO J, V28, P2763, DOI 10.1038/emboj.2009.211; Li X, 2007, TRENDS GENET, V23, P427, DOI 10.1016/j.tig.2007.06.001; Loyola A, 2003, METHODS, V31, P96, DOI 10.1016/S1046-2023(03)00093-8; Luger K, 1999, METHOD ENZYMOL, V304, P3; Luger K, 1997, J MOL BIOL, V272, P301, DOI 10.1006/jmbi.1997.1235; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Margueron R, 2009, NATURE, V461, P762, DOI 10.1038/nature08398; Moazed D, 2011, CELL, V146, P510, DOI 10.1016/j.cell.2011.07.013; MORI N, 1992, NEURON, V9, P45, DOI 10.1016/0896-6273(92)90219-4; Mortazavi A, 2006, GENOME RES, V16, P1208, DOI 10.1101/gr.4997306; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Mulligan P, 2008, MOL CELL, V32, P718, DOI 10.1016/j.molcel.2008.10.025; Sarma K, 2008, MOL CELL BIOL, V28, P2718, DOI 10.1128/MCB.02017-07; Schoeftner S, 2006, EMBO J, V25, P3110, DOI 10.1038/sj.emboj.7601187; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Shi B, 2007, MOL CELL BIOL, V27, P5105, DOI 10.1128/MCB.00162-07; Shi L, 2011, P NATL ACAD SCI USA, V108, P7541, DOI 10.1073/pnas.1017374108; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; Sims RJ, 2006, METHODS, V40, P331, DOI 10.1016/j.ymeth.2006.07.031; Sing A, 2009, CELL, V138, P885, DOI 10.1016/j.cell.2009.08.020; Tan J, 2007, GENE DEV, V21, P1050, DOI 10.1101/gad.1524107; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Tolhuis B, 2006, NAT GENET, V38, P694, DOI 10.1038/ng1792; Vermeulen M, 2010, CELL, V142, P967, DOI 10.1016/j.cell.2010.08.020; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Wang Y, 2009, CELL, V138, P660, DOI 10.1016/j.cell.2009.05.050; Wu HJ, 2005, NATURE, V438, P981, DOI 10.1038/nature04225; Xu C, 2010, P NATL ACAD SCI USA, V107, P19266, DOI 10.1073/pnas.1008937107; Yin N, 2004, CANCER RES, V64, P5870, DOI 10.1158/0008-5472.CAN-04-0655; Zhang H, 2004, GENE DEV, V18, P1753, DOI 10.1101/gad.1194704; Zhang Y, 2004, COLD SPRING HARB SYM, V69, P309, DOI 10.1101/sqb.2004.69.309; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	55	55	59	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42414	42425		10.1074/jbc.M111.271064	http://dx.doi.org/10.1074/jbc.M111.271064			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	22009739	Green Published, hybrid			2022-12-27	WOS:000298180900050
